[{"kegg_id": "hsa00562", "name": "Inositol phosphate metabolism - Homo sapiens (human)", "class": "Metabolism; Carbohydrate metabolism", "pathway_map": "hsa00562  Inositol phosphate metabolism", "module": ["hsa_M00130  Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3 => Ins(1,3,4,5)P4 [PATH:hsa00562]", "hsa_M00131  Inositol phosphate metabolism, Ins(1,3,4,5)P4 => Ins(1,3,4)P3 => myo-inositol [PATH:hsa00562]", "hsa_M00132  Inositol phosphate metabolism, Ins(1,3,4)P3 => phytate [PATH:hsa00562]"], "drug": ["D11158  Leniolisib (USAN/INN)", "D11159  Leniolisib phosphate (USAN)", "D11319  Fimepinostat (USAN/INN)", "D11322  Umbralisib (USAN/INN)", "D11323  Umbralisib tosylate (USAN)"], "dblinks": "GO: 0006020", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["5289  PIK3C3; phosphatidylinositol 3-kinase catalytic subunit type 3 [KO:K00914] [EC:2.7.1.137]", "4534  MTM1; myotubularin 1 [KO:K01108] [EC:3.1.3.64 3.1.3.95]", "8776  MTMR1; myotubularin related protein 1 [KO:K18081] [EC:3.1.3.64 3.1.3.95]", "8898  MTMR2; myotubularin related protein 2 [KO:K18081] [EC:3.1.3.64 3.1.3.95]", "8897  MTMR3; myotubularin related protein 3 [KO:K18082] [EC:3.1.3.48 3.1.3.64 3.1.3.95]", "9110  MTMR4; myotubularin related protein 4 [KO:K18082] [EC:3.1.3.48 3.1.3.64 3.1.3.95]", "55613  MTMR8; myotubularin related protein 8 [KO:K18083] [EC:3.1.3.64 3.1.3.95]", "9107  MTMR6; myotubularin related protein 6 [KO:K18083] [EC:3.1.3.64 3.1.3.95]", "9108  MTMR7; myotubularin related protein 7 [KO:K18083] [EC:3.1.3.64 3.1.3.95]", "64419  MTMR14; myotubularin related protein 14 [KO:K18086] [EC:3.1.3.64 3.1.3.95]", "5297  PI4KA; phosphatidylinositol 4-kinase alpha [KO:K00888] [EC:2.7.1.67]", "5298  PI4KB; phosphatidylinositol 4-kinase beta [KO:K19801] [EC:2.7.1.67]", "55361  PI4K2A; phosphatidylinositol 4-kinase type 2 alpha [KO:K13711] [EC:2.7.1.67]", "55300  PI4K2B; phosphatidylinositol 4-kinase type 2 beta [KO:K13711] [EC:2.7.1.67]", "22908  SACM1L; SAC1 like phosphatidylinositide phosphatase [KO:K21797] [EC:3.1.3.-]", "22876  INPP5F; inositol polyphosphate-5-phosphatase F [KO:K21798] [EC:3.1.3.-]", "23396  PIP5K1C; phosphatidylinositol-4-phosphate 5-kinase type 1 gamma [KO:K00889] [EC:2.7.1.68]", "8394  PIP5K1A; phosphatidylinositol-4-phosphate 5-kinase type 1 alpha [KO:K00889] [EC:2.7.1.68]", "8395  PIP5K1B; phosphatidylinositol-4-phosphate 5-kinase type 1 beta [KO:K00889] [EC:2.7.1.68]", "138429  PIP5KL1; phosphatidylinositol-4-phosphate 5-kinase like 1 [KO:K13712] [EC:2.7.1.68]", "4952  OCRL; OCRL inositol polyphosphate-5-phosphatase [KO:K01099] [EC:3.1.3.36]", "3633  INPP5B; inositol polyphosphate-5-phosphatase B [KO:K01099] [EC:3.1.3.36]", "56623  INPP5E; inositol polyphosphate-5-phosphatase E [KO:K20278] [EC:3.1.3.36]", "8867  SYNJ1; synaptojanin 1 [KO:K20279] [EC:3.1.3.36]", "8871  SYNJ2; synaptojanin 2 [KO:K20279] [EC:3.1.3.36]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5294  PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma [KO:K21289] [EC:2.7.1.153]", "5728  PTEN; phosphatase and tensin homolog [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]", "3635  INPP5D; inositol polyphosphate-5-phosphatase D [KO:K03084] [EC:3.1.3.86]", "3636  INPPL1; inositol polyphosphate phosphatase like 1 [KO:K15909] [EC:3.1.3.86]", "5288  PIK3C2G; phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma [KO:K00923] [EC:2.7.1.154]", "5286  PIK3C2A; phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha [KO:K00923] [EC:2.7.1.154]", "5287  PIK3C2B; phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta [KO:K00923] [EC:2.7.1.154]", "3631  INPP4A; inositol polyphosphate-4-phosphatase type I A [KO:K01109] [EC:3.1.3.66]", "8821  INPP4B; inositol polyphosphate-4-phosphatase type II B [KO:K01109] [EC:3.1.3.66]", "200576  PIKFYVE; phosphoinositide kinase, FYVE-type zinc finger containing [KO:K00921] [EC:2.7.1.150]", "9896  FIG4; FIG4 phosphoinositide 5-phosphatase [KO:K22913] [EC:3.1.3.-]", "79837  PIP4K2C; phosphatidylinositol-5-phosphate 4-kinase type 2 gamma [KO:K00920] [EC:2.7.1.149]", "5305  PIP4K2A; phosphatidylinositol-5-phosphate 4-kinase type 2 alpha [KO:K00920] [EC:2.7.1.149]", "8396  PIP4K2B; phosphatidylinositol-5-phosphate 4-kinase type 2 beta [KO:K00920] [EC:2.7.1.149]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "5333  PLCD1; phospholipase C delta 1 [KO:K05857] [EC:3.1.4.11]", "113026  PLCD3; phospholipase C delta 3 [KO:K05857] [EC:3.1.4.11]", "84812  PLCD4; phospholipase C delta 4 [KO:K05857] [EC:3.1.4.11]", "51196  PLCE1; phospholipase C epsilon 1 [KO:K05860] [EC:3.1.4.11]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]", "89869  PLCZ1; phospholipase C zeta 1 [KO:K05861] [EC:3.1.4.11]", "23007  PLCH1; phospholipase C eta 1 [KO:K19006] [EC:3.1.4.11]", "9651  PLCH2; phospholipase C eta 2 [KO:K19006] [EC:3.1.4.11]", "3613  IMPA2; inositol monophosphatase 2 [KO:K01092] [EC:3.1.3.25]", "3612  IMPA1; inositol monophosphatase 1 [KO:K01092] [EC:3.1.3.25]", "10423  CDIPT; CDP-diacylglycerol--inositol 3-phosphatidyltransferase [KO:K00999] [EC:2.7.8.11]", "51477  ISYNA1; inositol-3-phosphate synthase 1 [KO:K01858] [EC:5.5.1.4]", "3628  INPP1; inositol polyphosphate-1-phosphatase [KO:K01107] [EC:3.1.3.57]", "3632  INPP5A; inositol polyphosphate-5-phosphatase A [KO:K01106] [EC:3.1.3.56]", "51763  INPP5K; inositol polyphosphate-5-phosphatase K [KO:K24222] [EC:3.1.3.56]", "27124  INPP5J; inositol polyphosphate-5-phosphatase J [KO:K24222] [EC:3.1.3.56]", "9562  MINPP1; multiple inositol-polyphosphate phosphatase 1 [KO:K03103] [EC:3.1.3.62 3.1.3.80]", "3707  ITPKB; inositol-trisphosphate 3-kinase B [KO:K00911] [EC:2.7.1.127]", "3706  ITPKA; inositol-trisphosphate 3-kinase A [KO:K00911] [EC:2.7.1.127]", "80271  ITPKC; inositol-trisphosphate 3-kinase C [KO:K00911] [EC:2.7.1.127]", "3705  ITPK1; inositol-tetrakisphosphate 1-kinase [KO:K00913] [EC:2.7.1.159 2.7.1.134]", "253430  IPMK; inositol polyphosphate multikinase [KO:K00915] [EC:2.7.1.140 2.7.1.151]", "64768  IPPK; inositol-pentakisphosphate 2-kinase [KO:K10572] [EC:2.7.1.158]", "55586  MIOX; myo-inositol oxygenase [KO:K00469] [EC:1.13.99.1]", "4329  ALDH6A1; aldehyde dehydrogenase 6 family member A1 [KO:K00140] [EC:1.2.1.18 1.2.1.27]", "7167  TPI1; triosephosphate isomerase 1 [KO:K01803] [EC:5.3.1.1]"], "compound": ["C00024  Acetyl-CoA", "C00092  D-Glucose 6-phosphate", "C00111  Glycerone phosphate", "C00118  D-Glyceraldehyde 3-phosphate", "C00137  myo-Inositol", "C00191  D-Glucuronate", "C00222  3-Oxopropanoate", "C00558  D-Tagaturonate", "C00641  1,2-Diacyl-sn-glycerol", "C00691  2,4,6/3,5-Pentahydroxycyclohexanone", "C01177  Inositol 1-phosphate", "C01194  1-Phosphatidyl-D-myo-inositol", "C01204  Phytic acid", "C01220  1D-myo-Inositol 1,4-bisphosphate", "C01243  1D-myo-Inositol 1,3,4-trisphosphate", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C01272  1D-myo-Inositol 1,3,4,5-tetrakisphosphate", "C01277  1-Phosphatidyl-1D-myo-inositol 4-phosphate", "C01284  1D-myo-Inositol 1,3,4,5,6-pentakisphosphate", "C03546  myo-Inositol 4-phosphate", "C03659  D-Bornesitol", "C03660  L-Bornesitol", "C04006  1D-myo-Inositol 3-phosphate", "C04062  D-myo-Inositol 1,3-bisphosphate", "C04063  D-myo-Inositol 3,4-bisphosphate", "C04287  3D-3,5/4-Trihydroxycyclohexane-1,2-dione", "C04477  1D-myo-Inositol 1,3,4,6-tetrakisphosphate", "C04520  1D-myo-Inositol 3,4,5,6-tetrakisphosphate", "C04549  1-Phosphatidyl-1D-myo-inositol 3-phosphate", "C04563  D-myo-Inositol 1,2,4,5,6-pentakisphosphate", "C04579  Inositol 1,2,3,5,6-pentakisphosphate", "C04637  1-Phosphatidyl-D-myo-inositol 4,5-bisphosphate", "C05981  Phosphatidylinositol-3,4,5-trisphosphate", "C06153  scyllo-Inositol", "C06892  2-Deoxy-5-keto-D-gluconic acid", "C06893  2-Deoxy-5-keto-D-gluconic acid 6-phosphate", "C11554  1-Phosphatidyl-1D-myo-inositol 3,4-bisphosphate", "C11555  1D-myo-Inositol 1,4,5,6-tetrakisphosphate", "C11556  1-Phosphatidyl-1D-myo-inositol 3,5-bisphosphate", "C11557  1-Phosphatidyl-1D-myo-inositol 5-phosphate", "C16737  5-Deoxy-D-glucuronate", "C19794  CDP-1L-myo-inositol", "C19799  Bis(1L-myo-inositol)-3,1'-phosphate 1-phosphate", "C19891  1D-chiro-Inositol", "C20251  1-Keto-D-chiro-inositol", "C21643  3-Dehydro-scyllo-inosose", "C21644  5-Dehydro-L-gluconate"], "refs": [{"pmid": "14993306", "authors": "  Yoshida K, Yamaguchi M, Ikeda H, Omae K, Tsurusaki K, Fujita Y", "title": "The fifth gene of the iol operon of Bacillus subtilis, iolE, encodes 2-keto-myo-inositol dehydratase.", "journal": "Microbiology 150:571-80 (2004)", "doi": "10.1099/mic.0.26768-0"}], "rel_pathway": ["hsa00010  Glycolysis / Gluconeogenesis", "hsa00020  Citrate cycle (TCA cycle)", "hsa00040  Pentose and glucuronate interconversions", "hsa00564  Glycerophospholipid metabolism"], "ko_pathway": "ko00562", "genes": ["PTEN"]}, {"kegg_id": "hsa01100", "name": "Metabolic pathways - Homo sapiens (human)", "pathway_map": "hsa01100  Metabolic pathways", "module": ["hsa_M00001  Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate [PATH:hsa01100]", "hsa_M00002  Glycolysis, core module involving three-carbon compounds [PATH:hsa01100]", "hsa_M00003  Gluconeogenesis, oxaloacetate => fructose-6P [PATH:hsa01100]", "hsa_M00004  Pentose phosphate pathway (Pentose phosphate cycle) [PATH:hsa01100]", "hsa_M00005  PRPP biosynthesis, ribose 5P => PRPP [PATH:hsa01100]", "hsa_M00006  Pentose phosphate pathway, oxidative phase, glucose 6P => ribulose 5P [PATH:hsa01100]", "hsa_M00007  Pentose phosphate pathway, non-oxidative phase, fructose 6P => ribose 5P [PATH:hsa01100]", "hsa_M00009  Citrate cycle (TCA cycle, Krebs cycle) [PATH:hsa01100]", "hsa_M00010  Citrate cycle, first carbon oxidation, oxaloacetate => 2-oxoglutarate [PATH:hsa01100]", "hsa_M00011  Citrate cycle, second carbon oxidation, 2-oxoglutarate => oxaloacetate [PATH:hsa01100]", "hsa_M00014  Glucuronate pathway (uronate pathway) [PATH:hsa01100]", "hsa_M00015  Proline biosynthesis, glutamate => proline [PATH:hsa01100]", "hsa_M00020  Serine biosynthesis, glycerate-3P => serine [PATH:hsa01100]", "hsa_M00027  GABA (gamma-Aminobutyrate) shunt [PATH:hsa01100]", "hsa_M00029  Urea cycle [PATH:hsa01100]", "hsa_M00032  Lysine degradation, lysine => saccharopine => acetoacetyl-CoA [PATH:hsa01100]", "hsa_M00034  Methionine salvage pathway [PATH:hsa01100]", "hsa_M00035  Methionine degradation [PATH:hsa01100]", "hsa_M00036  Leucine degradation, leucine => acetoacetate + acetyl-CoA [PATH:hsa01100]", "hsa_M00037  Melatonin biosynthesis, animals, tryptophan => serotonin => melatonin [PATH:hsa01100]", "hsa_M00038  Tryptophan metabolism, tryptophan => kynurenine => 2-aminomuconate [PATH:hsa01100]", "hsa_M00042  Catecholamine biosynthesis, tyrosine => dopamine => noradrenaline => adrenaline [PATH:hsa01100]", "hsa_M00043  Thyroid hormone biosynthesis, tyrosine => triiodothyronine/thyroxine [PATH:hsa01100]", "hsa_M00044  Tyrosine degradation, tyrosine => homogentisate [PATH:hsa01100]", "hsa_M00045  Histidine degradation, histidine => N-formiminoglutamate => glutamate [PATH:hsa01100]", "hsa_M00046  Pyrimidine degradation, uracil => beta-alanine, thymine => 3-aminoisobutanoate [PATH:hsa01100]", "hsa_M00047  Creatine pathway [PATH:hsa01100]", "hsa_M00048  De novo purine biosynthesis, PRPP + glutamine => IMP [PATH:hsa01100]", "hsa_M00049  Adenine ribonucleotide biosynthesis, IMP => ADP,ATP [PATH:hsa01100]", "hsa_M00050  Guanine ribonucleotide biosynthesis, IMP => GDP,GTP [PATH:hsa01100]", "hsa_M00051  De novo pyrimidine biosynthesis, glutamine (+ PRPP) => UMP [PATH:hsa01100]", "hsa_M00052  Pyrimidine ribonucleotide biosynthesis, UMP => UDP/UTP,CDP/CTP [PATH:hsa01100]", "hsa_M00053  Deoxyribonucleotide biosynthesis, ADP/GDP/CDP/UDP => dATP/dGTP/dCTP/dUTP [PATH:hsa01100]", "hsa_M00055  N-glycan precursor biosynthesis [PATH:hsa01100]", "hsa_M00056  O-glycan biosynthesis, mucin type core [PATH:hsa01100]", "hsa_M00057  Glycosaminoglycan biosynthesis, linkage tetrasaccharide [PATH:hsa01100]", "hsa_M00058  Glycosaminoglycan biosynthesis, chondroitin sulfate backbone [PATH:hsa01100]", "hsa_M00059  Glycosaminoglycan biosynthesis, heparan sulfate backbone [PATH:hsa01100]", "hsa_M00065  GPI-anchor biosynthesis, core oligosaccharide [PATH:hsa01100]", "hsa_M00066  Lactosylceramide biosynthesis [PATH:hsa01100]", "hsa_M00067  Sulfoglycolipids biosynthesis, ceramide/1-alkyl-2-acylglycerol => sulfatide/seminolipid [PATH:hsa01100]", "hsa_M00068  Glycosphingolipid biosynthesis, globo-series, LacCer => Gb4Cer [PATH:hsa01100]", "hsa_M00069  Glycosphingolipid biosynthesis, ganglio series, LacCer => GT3 [PATH:hsa01100]", "hsa_M00070  Glycosphingolipid biosynthesis, lacto-series, LacCer => Lc4Cer [PATH:hsa01100]", "hsa_M00071  Glycosphingolipid biosynthesis, neolacto-series, LacCer => nLc4Cer [PATH:hsa01100]", "hsa_M00073  N-glycan precursor trimming [PATH:hsa01100]", "hsa_M00075  N-glycan biosynthesis, complex type [PATH:hsa01100]", "hsa_M00076  Dermatan sulfate degradation [PATH:hsa01100]", "hsa_M00077  Chondroitin sulfate degradation [PATH:hsa01100]", "hsa_M00078  Heparan sulfate degradation [PATH:hsa01100]", "hsa_M00079  Keratan sulfate degradation [PATH:hsa01100]", "hsa_M00082  Fatty acid biosynthesis, initiation [PATH:hsa01100]", "hsa_M00083  Fatty acid biosynthesis, elongation [PATH:hsa01100]", "hsa_M00085  Fatty acid elongation in mitochondria [PATH:hsa01100]", "hsa_M00086  beta-Oxidation, acyl-CoA synthesis [PATH:hsa01100]", "hsa_M00087  beta-Oxidation [PATH:hsa01100]", "hsa_M00089  Triacylglycerol biosynthesis [PATH:hsa01100]", "hsa_M00090  Phosphatidylcholine (PC) biosynthesis, choline => PC [PATH:hsa01100]", "hsa_M00091  Phosphatidylcholine (PC) biosynthesis, PE => PC [PATH:hsa01100]", "hsa_M00092  Phosphatidylethanolamine (PE) biosynthesis, ethanolamine => PE [PATH:hsa01100]", "hsa_M00094  Ceramide biosynthesis [PATH:hsa01100]", "hsa_M00095  C5 isoprenoid biosynthesis, mevalonate pathway [PATH:hsa01100]", "hsa_M00098  Acylglycerol degradation [PATH:hsa01100]", "hsa_M00099  Sphingosine biosynthesis [PATH:hsa01100]", "hsa_M00100  Sphingosine degradation [PATH:hsa01100]", "hsa_M00101  Cholesterol biosynthesis, FPP => cholesterol [PATH:hsa01100]", "hsa_M00103  Cholecalciferol biosynthesis [PATH:hsa01100]", "hsa_M00104  Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate [PATH:hsa01100]", "hsa_M00106  Conjugated bile acid biosynthesis, cholate => taurocholate/glycocholate [PATH:hsa01100]", "hsa_M00107  Steroid hormone biosynthesis, cholesterol => pregnenolone => progesterone [PATH:hsa01100]", "hsa_M00108  C21-Steroid hormone biosynthesis, progesterone => corticosterone/aldosterone [PATH:hsa01100]", "hsa_M00109  C21-Steroid hormone biosynthesis, progesterone => cortisol/cortisone [PATH:hsa01100]", "hsa_M00110  C19/C18-Steroid hormone biosynthesis, pregnenolone => androstenedione => estrone [PATH:hsa01100]", "hsa_M00118  Glutathione biosynthesis, glutamate => glutathione [PATH:hsa01100]", "hsa_M00120  Coenzyme A biosynthesis, pantothenate => CoA [PATH:hsa01100]", "hsa_M00128  Ubiquinone biosynthesis, eukaryotes, 4-hydroxybenzoate + polyprenyl-PP => ubiquinol [PATH:hsa01100]", "hsa_M00130  Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3 => Ins(1,3,4,5)P4 [PATH:hsa01100]", "hsa_M00131  Inositol phosphate metabolism, Ins(1,3,4,5)P4 => Ins(1,3,4)P3 => myo-inositol [PATH:hsa01100]", "hsa_M00132  Inositol phosphate metabolism, Ins(1,3,4)P3 => phytate [PATH:hsa01100]", "hsa_M00134  Polyamine biosynthesis, arginine => ornithine => putrescine [PATH:hsa01100]", "hsa_M00135  GABA biosynthesis, eukaryotes, putrescine => GABA [PATH:hsa01100]", "hsa_M00141  C1-unit interconversion, eukaryotes [PATH:hsa01100]", "hsa_M00142  NADH:ubiquinone oxidoreductase, mitochondria [PATH:hsa01100]", "hsa_M00143  NADH dehydrogenase (ubiquinone) Fe-S protein/flavoprotein complex, mitochondria [PATH:hsa01100]", "hsa_M00146  NADH dehydrogenase (ubiquinone) 1 alpha subcomplex [PATH:hsa01100]", "hsa_M00147  NADH dehydrogenase (ubiquinone) 1 beta subcomplex [PATH:hsa01100]", "hsa_M00148  Succinate dehydrogenase (ubiquinone) [PATH:hsa01100]", "hsa_M00151  Cytochrome bc1 complex respiratory unit [PATH:hsa01100]", "hsa_M00152  Cytochrome bc1 complex [PATH:hsa01100]", "hsa_M00154  Cytochrome c oxidase [PATH:hsa01100]", "hsa_M00158  F-type ATPase, eukaryotes [PATH:hsa01100]", "hsa_M00160  V-type ATPase, eukaryotes [PATH:hsa01100]", "hsa_M00307  Pyruvate oxidation, pyruvate => acetyl-CoA [PATH:hsa01100]", "hsa_M00338  Cysteine biosynthesis, homocysteine + serine => cysteine [PATH:hsa01100]", "hsa_M00367  C10-C20 isoprenoid biosynthesis, non-plant eukaryotes [PATH:hsa01100]", "hsa_M00415  Fatty acid elongation in endoplasmic reticulum [PATH:hsa01100]", "hsa_M00549  Nucleotide sugar biosynthesis, glucose => UDP-glucose [PATH:hsa01100]", "hsa_M00554  Nucleotide sugar biosynthesis, galactose => UDP-galactose [PATH:hsa01100]", "hsa_M00555  Betaine biosynthesis, choline => betaine [PATH:hsa01100]", "hsa_M00621  Glycine cleavage system [PATH:hsa01100]", "hsa_M00632  Galactose degradation, Leloir pathway, galactose => alpha-D-glucose-1P [PATH:hsa01100]", "hsa_M00741  Propanoyl-CoA metabolism, propanoyl-CoA => succinyl-CoA [PATH:hsa01100]", "hsa_M00842  Tetrahydrobiopterin biosynthesis, GTP => BH4 [PATH:hsa01100]", "hsa_M00844  Arginine biosynthesis, ornithine => arginine [PATH:hsa01100]", "hsa_M00854  Glycogen biosynthesis, glucose-1P => glycogen/starch [PATH:hsa01100]", "hsa_M00855  Glycogen degradation, glycogen => glucose-6P [PATH:hsa01100]", "hsa_M00861  beta-Oxidation, peroxisome, VLCFA [PATH:hsa01100]", "hsa_M00862  beta-Oxidation, peroxisome, tri/dihydroxycholestanoyl-CoA => choloyl/chenodeoxycholoyl-CoA [PATH:hsa01100]", "hsa_M00868  Heme biosynthesis, animals and fungi, glycine => heme [PATH:hsa01100]", "hsa_M00872  O-glycan biosynthesis, mannose type (core M3) [PATH:hsa01100]", "hsa_M00873  Fatty acid biosynthesis in mitochondria, animals [PATH:hsa01100]", "hsa_M00880  Molybdenum cofactor biosynthesis, GTP => molybdenum cofactor [PATH:hsa01100]", "hsa_M00882  Lipoic acid biosynthesis, eukaryotes, octanoyl-ACP => dihydrolipoyl-H [PATH:hsa01100]", "hsa_M00883  Lipoic acid biosynthesis, animals and bacteria, octanoyl-ACP => dihydrolipoyl-H => dihydrolipoyl-E2 [PATH:hsa01100]", "hsa_M00892  UDP-N-acetyl-D-glucosamine biosynthesis, eukaryotes, glucose => UDP-GlcNAc [PATH:hsa01100]", "hsa_M00912  NAD biosynthesis, tryptophan => quinolinate => NAD [PATH:hsa01100]", "hsa_M00938  Pyrimidine deoxyribonucleotide biosynthesis, UDP => dTTP [PATH:hsa01100]", "hsa_M00958  Adenine ribonucleotide degradation, AMP => Urate [PATH:hsa01100]", "hsa_M00959  Guanine ribonucleotide degradation, GMP => Urate [PATH:hsa01100]", "hsa_M00970  Proline degradation, proline => glutamate [PATH:hsa01100]", "hsa_M00972  Proline metabolism [PATH:hsa01100]", "hsa_M00974  Betaine metabolism, animals, betaine => glycine [PATH:hsa01100]", "hsa_M00976  C19-Steroid hormone biosynthesis, pregnenolone => testosterone => dihydrotestosterone [PATH:hsa01100]", "hsa_M00977  C19-Steroid hormone biosynthesis (androgen backdoor pathway), pregnenolone => androsterone => dihydrotestosterone [PATH:hsa01100]"], "drug": ["D01392  Mizoribine (JP18/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "rel_pathway": ["hsa00010  Glycolysis / Gluconeogenesis", "hsa00020  Citrate cycle (TCA cycle)", "hsa00030  Pentose phosphate pathway", "hsa00040  Pentose and glucuronate interconversions", "hsa00051  Fructose and mannose metabolism", "hsa00052  Galactose metabolism", "hsa00053  Ascorbate and aldarate metabolism", "hsa00061  Fatty acid biosynthesis", "hsa00062  Fatty acid elongation", "hsa00071  Fatty acid degradation", "hsa00100  Steroid biosynthesis", "hsa00120  Primary bile acid biosynthesis", "hsa00130  Ubiquinone and other terpenoid-quinone biosynthesis", "hsa00140  Steroid hormone biosynthesis", "hsa00190  Oxidative phosphorylation", "hsa00220  Arginine biosynthesis", "hsa00230  Purine metabolism", "hsa00232  Caffeine metabolism", "hsa00240  Pyrimidine metabolism", "hsa00250  Alanine, aspartate and glutamate metabolism", "hsa00260  Glycine, serine and threonine metabolism", "hsa00270  Cysteine and methionine metabolism", "hsa00280  Valine, leucine and isoleucine degradation", "hsa00290  Valine, leucine and isoleucine biosynthesis", "hsa00310  Lysine degradation", "hsa00330  Arginine and proline metabolism", "hsa00340  Histidine metabolism", "hsa00350  Tyrosine metabolism", "hsa00360  Phenylalanine metabolism", "hsa00380  Tryptophan metabolism", "hsa00400  Phenylalanine, tyrosine and tryptophan biosynthesis", "hsa00410  beta-Alanine metabolism", "hsa00430  Taurine and hypotaurine metabolism", "hsa00440  Phosphonate and phosphinate metabolism", "hsa00450  Selenocompound metabolism", "hsa00470  D-Amino acid metabolism", "hsa00480  Glutathione metabolism", "hsa00500  Starch and sucrose metabolism", "hsa00510  N-Glycan biosynthesis", "hsa00511  Other glycan degradation", "hsa00512  Mucin type O-glycan biosynthesis", "hsa00513  Various types of N-glycan biosynthesis", "hsa00514  Other types of O-glycan biosynthesis", "hsa00515  Mannose type O-glycan biosynthesis", "hsa00520  Amino sugar and nucleotide sugar metabolism", "hsa00524  Neomycin, kanamycin and gentamicin biosynthesis", "hsa00531  Glycosaminoglycan degradation", "hsa00532  Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate", "hsa00533  Glycosaminoglycan biosynthesis - keratan sulfate", "hsa00534  Glycosaminoglycan biosynthesis - heparan sulfate / heparin", "hsa00561  Glycerolipid metabolism", "hsa00562  Inositol phosphate metabolism", "hsa00563  Glycosylphosphatidylinositol (GPI)-anchor biosynthesis", "hsa00564  Glycerophospholipid metabolism", "hsa00565  Ether lipid metabolism", "hsa00590  Arachidonic acid metabolism", "hsa00591  Linoleic acid metabolism", "hsa00592  alpha-Linolenic acid metabolism", "hsa00600  Sphingolipid metabolism", "hsa00601  Glycosphingolipid biosynthesis - lacto and neolacto series", "hsa00603  Glycosphingolipid biosynthesis - globo and isoglobo series", "hsa00604  Glycosphingolipid biosynthesis - ganglio series", "hsa00620  Pyruvate metabolism", "hsa00630  Glyoxylate and dicarboxylate metabolism", "hsa00640  Propanoate metabolism", "hsa00650  Butanoate metabolism", "hsa00670  One carbon pool by folate", "hsa00730  Thiamine metabolism", "hsa00740  Riboflavin metabolism", "hsa00750  Vitamin B6 metabolism", "hsa00760  Nicotinate and nicotinamide metabolism", "hsa00770  Pantothenate and CoA biosynthesis", "hsa00780  Biotin metabolism", "hsa00785  Lipoic acid metabolism", "hsa00790  Folate biosynthesis", "hsa00830  Retinol metabolism", "hsa00860  Porphyrin metabolism", "hsa00900  Terpenoid backbone biosynthesis", "hsa00910  Nitrogen metabolism", "hsa00920  Sulfur metabolism", "hsa00980  Metabolism of xenobiotics by cytochrome P450", "hsa00982  Drug metabolism - cytochrome P450", "hsa00983  Drug metabolism - other enzymes", "hsa01040  Biosynthesis of unsaturated fatty acids"], "ko_pathway": "ko01100", "genes": ["PTEN", "RPN1", "GBA3", "GPHN", "SIRT7"]}, {"kegg_id": "hsa01521", "name": "EGFR tyrosine kinase inhibitor resistance - Homo sapiens (human)", "description": "EGFR is a tyrosine kinase that participates in the regulation of cellular homeostasis. EGFR also serves as a stimulus for cancer growth. EGFR gene mutations and protein overexpression, both of which activate down- stream pathways, are associated with cancers, especially lung cancer. Several tyrosine kinase inhibitor (TKI) therapies against EGFR are currently administered and are initially effective in cancer patients who have EGFR mutations or aberrant activation of EGFR. However, the development of TKI resistance is common and results in the recurrence of tumors. Studies over the last decade have identified mechanisms that drive resistance to EGFR TKI treatment. Most outstanding mechanisms are: the secondary EGFR mutation (T790M), activation of alternative pathways (c-Met, HGF, AXL), aberrance of the downstream pathways (K-RAS mutations, loss of PTEN), impairment of the EGFR-TKIs-mediated apoptosis pathway (BCL2-like 11/BIM deletion polymorphism), histologic transformation, etc.", "class": "Human Diseases; Drug resistance: antineoplastic", "pathway_map": "hsa01521  EGFR tyrosine kinase inhibitor resistance", "drug": ["D08950  Neratinib (USAN/INN)", "D09371  Ramucirumab (USAN)", "D10766  Osimertinib mesylate (USAN)", "D10898  Neratinib maleate", "D11244  Vanucizumab (USAN/INN)", "D11251  Icotinib", "D11307  Telisotuzumab (USAN)", "D11344  Telisotuzumab vedotin (USAN)", "D11417  Pemigatinib (JAN/USAN/INN)", "D11529  Trastuzumab deruxtecan (USAN/INN)", "D11725  Futibatinib (JAN/USAN/INN)", "D11772  Tesevatinib (USAN/INN)", "D11773  Tesevatinib tosylate (USAN)", "D11969  Mobocertinib succinate (JAN)", "D11980  Lazertinib (USAN)", "D12219  Mecbotamab (USAN)", "D12220  Mecbotamab vedotin", "D12245  Lazertinib mesilate hydrate (JAN)", "D12258  Aumolertinib (USAN/INN)", "D12259  Aumolertinib mesylate (USAN)", "D12730  Tigozertinib (USAN)"], "organism": "Homo sapiens (human) [GN:hsa]", "refs": [{"pmid": "26579470", "authors": "  Huang L, Fu L", "title": "Mechanisms of resistance to EGFR tyrosine kinase inhibitors.", "journal": "Acta Pharm Sin B 5:390-401 (2015)", "doi": "10.1016/j.apsb.2015.07.001"}, {"pmid": "23358468", "authors": "  Hrustanovic G, Lee BJ, Bivona TG", "title": "Mechanisms of resistance to EGFR targeted therapies.", "journal": "Cancer Biol Ther 14:304-14 (2013)", "doi": "10.4161/cbt.23627"}, {"pmid": "19632948", "authors": "  Nguyen KS, Kobayashi S, Costa DB", "title": "Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancers dependent on the epidermal growth factor receptor pathway.", "journal": "Clin Lung Cancer 10:281-9 (2009)", "doi": "10.3816/CLC.2009.n.039"}, {"pmid": "18483355", "authors": "  Engelman JA, Janne PA", "title": "Mechanisms of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer.", "journal": "Clin Cancer Res 14:2895-9 (2008)", "doi": "10.1158/1078-0432.CCR-07-2248"}, {"pmid": "23401451", "authors": "  Ohashi K, Maruvka YE, Michor F, Pao W", "title": "Epidermal growth factor receptor tyrosine kinase inhibitor-resistant disease.", "journal": "J Clin Oncol 31:1070-80 (2013)", "doi": "10.1200/JCO.2012.43.3912"}, {"pmid": "24307395", "authors": "  Carrera S, Buque A, Azkona E, Aresti U, Calvo B, Sancho A, Arruti M, Nuno M, Rubio I, de Lobera AR, Lopez C, Vivanco GL", "title": "Epidermal growth factor receptor tyrosine-kinase inhibitor treatment resistance in non-small cell lung cancer: biological basis and therapeutic strategies.", "journal": "Clin Transl Oncol 16:339-50 (2014)", "doi": "10.1007/s12094-013-1143-9"}, {"pmid": "22970367", "authors": "  Lin L, Bivona TG", "title": "Mechanisms of Resistance to Epidermal Growth Factor Receptor Inhibitors and Novel Therapeutic Strategies to Overcome Resistance in NSCLC Patients.", "journal": "Chemother Res Pract 2012:817297 (2012)", "doi": "10.1155/2012/817297"}, {"pmid": "24202392", "authors": "  Chong CR, Janne PA", "title": "The quest to overcome resistance to EGFR-targeted therapies in cancer.", "journal": "Nat Med 19:1389-400 (2013)", "doi": "10.1038/nm.3388"}, {"pmid": "20551942", "authors": "  Wheeler DL, Dunn EF, Harari PM", "title": "Understanding resistance to EGFR inhibitors-impact on future treatment strategies.", "journal": "Nat Rev Clin Oncol 7:493-507 (2010)", "doi": "10.1038/nrclinonc.2010.97"}, {"pmid": "23361103", "authors": "  Gonzalez de Castro D, Clarke PA, Al-Lazikani B, Workman P", "title": "Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistance.", "journal": "Clin Pharmacol Ther 93:252-9 (2013)", "doi": "10.1038/clpt.2012.237"}, {"pmid": "20966921", "authors": "  Pao W, Chmielecki J", "title": "Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer.", "journal": "Nat Rev Cancer 10:760-74 (2010)", "doi": "10.1038/nrc2947"}, {"pmid": "22956644", "authors": "  Takezawa K, Pirazzoli V, Arcila ME, Nebhan CA, Song X, de Stanchina E, Ohashi K, Janjigian YY, Spitzler PJ, Melnick MA, Riely GJ, Kris MG, Miller VA, Ladanyi M, Politi K, Pao W", "title": "HER2 amplification: a potential mechanism of acquired resistance to EGFR inhibition in EGFR-mutant lung cancers that lack the second-site EGFRT790M mutation.", "journal": "Cancer Discov 2:922-33 (2012)", "doi": "10.1158/2159-8290.CD-12-0108"}, {"pmid": "16843264", "authors": "  Zhou BB, Peyton M, He B, Liu C, Girard L, Caudler E, Lo Y, Baribaud F, Mikami I, Reguart N, Yang G, Li Y, Yao W, Vaddi K, Gazdar AF, Friedman SM, Jablons DM, Newton RC, Fridman JS, Minna JD, Scherle PA", "title": "Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer.", "journal": "Cancer Cell 10:39-50 (2006)", "doi": "10.1016/j.ccr.2006.05.024"}, {"pmid": "22474259", "authors": "  Logue JS, Morrison DK", "title": "Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapy.", "journal": "Genes Dev 26:641-50 (2012)", "doi": "10.1101/gad.186965.112"}, {"pmid": "24493829", "authors": "  Costa C, Molina MA, Drozdowskyj A, Gimenez-Capitan A, Bertran-Alamillo J, Karachaliou N, Gervais R, Massuti B, Wei J, Moran T, Majem M, Felip E, Carcereny E, Garcia-Campelo R, Viteri S, Taron M, Ono M, Giannikopoulos P, Bivona T, Rosell R", "title": "The impact of EGFR T790M mutations and BIM mRNA expression on outcome in patients with EGFR-mutant NSCLC treated with erlotinib or chemotherapy in the randomized phase III EURTAC trial.", "journal": "Clin Cancer Res 20:2001-10 (2014)", "doi": "10.1158/1078-0432.CCR-13-2233"}, {"pmid": "23071030", "authors": "  Blakely CM, Bivona TG", "title": "Resiliency of lung cancers to EGFR inhibitor treatment unveiled, offering opportunities to divide and conquer EGFR inhibitor resistance.", "journal": "Cancer Discov 2:872-5 (2012)", "doi": "10.1158/2159-8290.CD-12-0387"}, {"pmid": "25337673", "authors": "  Wu X, Liu X, Koul S, Lee CY, Zhang Z, Halmos B", "title": "AXL kinase as a novel target for cancer therapy.", "journal": "Oncotarget 5:9546-63 (2014)", "doi": "10.18632/oncotarget.2542"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04012  ErbB signaling pathway", "hsa04150  mTOR signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04210  Apoptosis", "hsa04630  JAK-STAT signaling pathway", "hsa05212  Pancreatic cancer", "hsa05214  Glioma", "hsa05223  Non-small cell lung cancer"], "ko_pathway": "ko01521", "genes": ["PTEN", "EGFR", "BRAF", "AKT2", "MET", "AKT1", "SOS1", "KDR", "NRAS", "BAX"]}, {"kegg_id": "hsa04068", "name": "FoxO signaling pathway - Homo sapiens (human)", "description": "The forkhead box O (FOXO) family of transcription factors regulates the expression of genes in cellular physiological events including apoptosis, cell-cycle control, glucose metabolism, oxidative stress resistance, and longevity. A central regulatory mechanism of FOXO proteins is phosphorylation by the serine-threonine kinase Akt/protein kinase B (Akt/PKB), downstream of phosphatidylinositol 3-kinase (PI3K), in response to insulin or several growth factors. Phosphorylation at three conserved residues results in the export of FOXO proteins from the nucleus to the cytoplasm, thereby decreasing expression of FOXO target genes. In contrast, the stress-activated c-Jun N-terminal kinase (JNK) and the energy sensing AMP-activated protein kinase (AMPK), upon oxidative and nutrient stress stimuli phosphorylate and activate FoxOs. Aside from PKB, JNK and AMPK, FOXOs are regulated by multiple players through several post-translational modifications, including phosphorylation, but also acetylation, methylation and ubiquitylation.", "class": "Environmental Information Processing; Signal transduction", "pathway_map": "hsa04068  FoxO signaling pathway", "drug": ["D11322  Umbralisib (USAN/INN)", "D11323  Umbralisib tosylate (USAN)", "D12291  Tovorafenib (USAN/INN)", "D12394  Inobrodib (USAN)", "D12768  Ficerafusp alfa (USAN)", "D12771  Mocravimod (USAN/INN)", "D12772  Mocravimod hydrochloride (USAN)"], "dblinks": "GO: 0009267", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["7040  TGFB1; transforming growth factor beta 1 [KO:K13375]", "7042  TGFB2; transforming growth factor beta 2 [KO:K13376]", "7043  TGFB3; transforming growth factor beta 3 [KO:K13377]", "7046  TGFBR1; transforming growth factor beta receptor 1 [KO:K04674] [EC:2.7.11.30]", "7048  TGFBR2; transforming growth factor beta receptor 2 [KO:K04388] [EC:2.7.11.30]", "4089  SMAD4; SMAD family member 4 [KO:K04501]", "4088  SMAD3; SMAD family member 3 [KO:K23605]", "6794  STK11; serine/threonine kinase 11 [KO:K07298] [EC:2.7.11.1]", "5562  PRKAA1; protein kinase AMP-activated catalytic subunit alpha 1 [KO:K07198] [EC:2.7.11.31]", "5563  PRKAA2; protein kinase AMP-activated catalytic subunit alpha 2 [KO:K07198] [EC:2.7.11.31]", "5564  PRKAB1; protein kinase AMP-activated non-catalytic subunit beta 1 [KO:K07199]", "5565  PRKAB2; protein kinase AMP-activated non-catalytic subunit beta 2 [KO:K07199]", "5571  PRKAG1; protein kinase AMP-activated non-catalytic subunit gamma 1 [KO:K07200]", "53632  PRKAG3; protein kinase AMP-activated non-catalytic subunit gamma 3 [KO:K07200]", "51422  PRKAG2; protein kinase AMP-activated non-catalytic subunit gamma 2 [KO:K07200]", "51701  NLK; nemo like kinase [KO:K04468] [EC:2.7.11.24]", "6502  SKP2; S-phase kinase associated protein 2 [KO:K03875]", "4193  MDM2; MDM2 proto-oncogene [KO:K06643] [EC:2.3.2.27]", "80854  SETD7; SET domain containing 7, histone lysine methyltransferase [KO:K11431] [EC:2.1.1.364]", "1387  CREBBP; CREB binding protein [KO:K04498] [EC:2.3.1.48]", "2033  EP300; E1A binding protein p300 [KO:K04498] [EC:2.3.1.48]", "23411  SIRT1; sirtuin 1 [KO:K11411] [EC:2.3.1.286]", "7874  USP7; ubiquitin specific peptidase 7 [KO:K11838] [EC:3.4.19.12]", "6517  SLC2A4; solute carrier family 2 member 4 [KO:K07191]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "6789  STK4; serine/threonine kinase 4 [KO:K04411]", "3479  IGF1; insulin like growth factor 1 [KO:K05459]", "3480  IGF1R; insulin like growth factor 1 receptor [KO:K05087] [EC:2.7.10.1]", "3630  INS; insulin [KO:K04526]", "3643  INSR; insulin receptor [KO:K04527] [EC:2.7.10.1]", "3667  IRS1; insulin receptor substrate 1 [KO:K16172]", "8660  IRS2; insulin receptor substrate 2 [KO:K07187]", "8471  IRS4; insulin receptor substrate 4 [KO:K17446]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5170  PDPK1; 3-phosphoinositide dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "5728  PTEN; phosphatase and tensin homolog [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "6446  SGK1; serum/glucocorticoid regulated kinase 1 [KO:K13302] [EC:2.7.11.1]", "10110  SGK2; serum/glucocorticoid regulated kinase 2 [KO:K13303] [EC:2.7.11.1]", "23678  SGK3; serum/glucocorticoid regulated kinase family member 3 [KO:K13304] [EC:2.7.11.1]", "100533105  C8orf44-SGK3; C8orf44-SGK3 readthrough [KO:K13304] [EC:2.7.11.1]", "2308  FOXO1; forkhead box O1 [KO:K07201]", "2309  FOXO3; forkhead box O3 [KO:K09408]", "4303  FOXO4; forkhead box O4 [KO:K12358]", "100132074  FOXO6; forkhead box O6 [KO:K17847]", "2911  GRM1; glutamate metabotropic receptor 1 [KO:K04603]", "9456  HOMER1; homer scaffold protein 1 [KO:K15010]", "9455  HOMER2; homer scaffold protein 2 [KO:K15010]", "9454  HOMER3; homer scaffold protein 3 [KO:K15010]", "116986  AGAP2; ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 [KO:K17848]", "1454  CSNK1E; casein kinase 1 epsilon [KO:K08960] [EC:2.7.11.1]", "102800317  TPTEP2-CSNK1E; TPTEP2-CSNK1E readthrough [KO:K08960] [EC:2.7.11.1]", "3569  IL6; interleukin 6 [KO:K05405]", "3586  IL10; interleukin 10 [KO:K05443]", "6774  STAT3; signal transducer and activator of transcription 3 [KO:K04692]", "1950  EGF; epidermal growth factor [KO:K04357]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "369  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "1017  CDK2; cyclin dependent kinase 2 [KO:K02206] [EC:2.7.11.22]", "3276  PRMT1; protein arginine methyltransferase 1 [KO:K11434] [EC:2.1.1.319]", "2290  FOXG1; forkhead box G1 [KO:K09385]", "891  CCNB1; cyclin B1 [KO:K05868]", "9133  CCNB2; cyclin B2 [KO:K21770]", "85417  CCNB3; cyclin B3 [KO:K21771]", "595  CCND1; cyclin D1 [KO:K04503]", "894  CCND2; cyclin D2 [KO:K10151]", "901  CCNG2; cyclin G2 [KO:K10146]", "1030  CDKN2B; cyclin dependent kinase inhibitor 2B [KO:K04685]", "1032  CDKN2D; cyclin dependent kinase inhibitor 2D [KO:K06623]", "1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]", "1027  CDKN1B; cyclin dependent kinase inhibitor 1B [KO:K06624]", "5934  RBL2; RB transcriptional corepressor like 2 [KO:K16332]", "5347  PLK1; polo like kinase 1 [KO:K06631] [EC:2.7.11.21]", "10769  PLK2; polo like kinase 2 [KO:K08861] [EC:2.7.11.21]", "1263  PLK3; polo like kinase 3 [KO:K08862] [EC:2.7.11.21]", "10733  PLK4; polo like kinase 4 [KO:K08863] [EC:2.7.11.21]", "1647  GADD45A; growth arrest and DNA damage inducible alpha [KO:K04402]", "4616  GADD45B; growth arrest and DNA damage inducible beta [KO:K04402]", "10912  GADD45G; growth arrest and DNA damage inducible gamma [KO:K04402]", "356  FASLG; Fas ligand [KO:K04389]", "10018  BCL2L11; BCL2 like 11 [KO:K16341]", "8743  TNFSF10; TNF superfamily member 10 [KO:K04721]", "604  BCL6; BCL6 transcription repressor [KO:K15618]", "664  BNIP3; BCL2 interacting protein 3 [KO:K15464]", "9140  ATG12; autophagy related 12 [KO:K08336]", "11337  GABARAP; GABA type A receptor-associated protein [KO:K08341]", "23710  GABARAPL1; GABA type A receptor associated protein like 1 [KO:K08341]", "11345  GABARAPL2; GABA type A receptor associated protein like 2 [KO:K08341]", "847  CAT; catalase [KO:K03781] [EC:1.11.1.6]", "6648  SOD2; superoxide dismutase 2 [KO:K04564] [EC:1.15.1.1]", "472  ATM; ATM serine/threonine kinase [KO:K04728] [EC:2.7.11.1]", "5105  PCK1; phosphoenolpyruvate carboxykinase 1 [KO:K01596] [EC:4.1.1.32]", "5106  PCK2; phosphoenolpyruvate carboxykinase 2, mitochondrial [KO:K01596] [EC:4.1.1.32]", "2538  G6PC1; glucose-6-phosphatase catalytic subunit 1 [KO:K01084] [EC:3.1.3.9]", "57818  G6PC2; glucose-6-phosphatase catalytic subunit 2 [KO:K01084] [EC:3.1.3.9]", "92579  G6PC3; glucose-6-phosphatase catalytic subunit 3 [KO:K01084] [EC:3.1.3.9]", "3575  IL7R; interleukin 7 receptor [KO:K05072]", "10365  KLF2; KLF transcription factor 2 [KO:K17845]", "1901  S1PR1; sphingosine-1-phosphate receptor 1 [KO:K04288]", "8698  S1PR4; sphingosine-1-phosphate receptor 4 [KO:K04293]", "5896  RAG1; recombination activating 1 [KO:K10628] [EC:2.3.2.27]", "5897  RAG2; recombination activating 2 [KO:K10988]", "26260  FBXO25; F-box protein 25 [KO:K10305]", "114907  FBXO32; F-box protein 32 [KO:K10305]"], "compound": ["C00008  ADP", "C00020  AMP", "C00025  L-Glutamate", "C00031  D-Glucose", "C05981  Phosphatidylinositol-3,4,5-trisphosphate"], "refs": [{"pmid": "17470511", "authors": "  Glauser DA, Schlegel W", "title": "The emerging role of FOXO transcription factors in pancreatic beta cells.", "journal": "J Endocrinol 193:195-207 (2007)", "doi": "10.1677/JOE-06-0191"}, {"pmid": "17522590", "authors": "  van der Horst A, Burgering BM", "title": "Stressing the role of FoxO proteins in lifespan and disease.", "journal": "Nat Rev Mol Cell Biol 8:440-50 (2007)", "doi": "10.1038/nrm2190"}, {"pmid": "21440011", "authors": "  Zhang X, Tang N, Hadden TJ, Rishi AK", "title": "Akt, FoxO and regulation of apoptosis.", "journal": "Biochim Biophys Acta 1813:1978-86 (2011)", "doi": "10.1016/j.bbamcr.2011.03.010"}, {"pmid": "23325358", "authors": "  Eijkelenboom A, Burgering BM", "title": "FOXOs: signalling integrators for homeostasis maintenance.", "journal": "Nat Rev Mol Cell Biol 14:83-97 (2013)", "doi": "10.1038/nrm3507"}, {"pmid": "17569704", "authors": "  Daitoku H, Fukamizu A", "title": "FOXO transcription factors in the regulatory networks of longevity.", "journal": "J Biochem 141:769-74 (2007)", "doi": "10.1093/jb/mvm104"}, {"pmid": "19701188", "authors": "  Hedrick SM", "title": "The cunning little vixen: Foxo and the cycle of life and death.", "journal": "Nat Immunol 10:1057-63 (2009)", "doi": "10.1038/ni.1784"}, {"pmid": "15516968", "authors": "  Coffer PJ, Burgering BM", "title": "Forkhead-box transcription factors and their role in the immune system.", "journal": "Nat Rev Immunol 4:889-99 (2004)", "doi": "10.1038/nri1488"}, {"pmid": "22902436", "authors": "  Ro SH, Liu D, Yeo H, Paik JH", "title": "FoxOs in neural stem cell fate decision.", "journal": "Arch Biochem Biophys 534:55-63 (2013)", "doi": "10.1016/j.abb.2012.07.017"}, {"pmid": "18403263", "authors": "  Maiese K, Chong ZZ, Shang YC", "title": "OutFOXOing disease and disability: the therapeutic potential of targeting FoxO proteins.", "journal": "Trends Mol Med 14:219-27 (2008)", "doi": "10.1016/j.molmed.2008.03.002"}, {"pmid": "23801966", "authors": "  Hagenbuchner J, Ausserlechner MJ", "title": "Mitochondria and FOXO3: breath or die.", "journal": "Front Physiol 4:147 (2013)", "doi": "10.3389/fphys.2013.00147"}, {"pmid": "18045156", "authors": "  Maiese K, Chong ZZ, Shang YC", "title": "\"Sly as a FOXO\": new paths with Forkhead signaling in the brain.", "journal": "Curr Neurovasc Res 4:295-302 (2007)", "doi": "10.2174/156720207782446306"}, {"pmid": "22761423", "authors": "  Oh HM, Yu CR, Dambuza I, Marrero B, Egwuagu CE", "title": "STAT3 protein interacts with Class O Forkhead transcription factors in the cytoplasm and regulates nuclear/cytoplasmic localization of FoxO1 and FoxO3a proteins in CD4(+) T cells.", "journal": "J Biol Chem 287:30436-43 (2012)", "doi": "10.1074/jbc.M112.359661"}, {"pmid": "21238503", "authors": "  Huang H, Tindall DJ", "title": "Regulation of FOXO protein stability via ubiquitination and proteasome degradation.", "journal": "Biochim Biophys Acta 1813:1961-4 (2011)", "doi": "10.1016/j.bbamcr.2011.01.007"}, {"pmid": "16288288", "authors": "  Greer EL, Brunet A", "title": "FOXO transcription factors at the interface between longevity and tumor suppression.", "journal": "Oncogene 24:7410-25 (2005)", "doi": "10.1038/sj.onc.1209086"}, {"pmid": "15084259", "authors": "  Seoane J, Le HV, Shen L, Anderson SA, Massague J", "title": "Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation.", "journal": "Cell 117:211-23 (2004)", "doi": "10.1016/S0092-8674(04)00298-3"}, {"pmid": "18951090", "authors": "  Yamagata K, Daitoku H, Takahashi Y, Namiki K, Hisatake K, Kako K, Mukai H, Kasuya Y, Fukamizu A", "title": "Arginine methylation of FOXO transcription factors inhibits their phosphorylation by Akt.", "journal": "Mol Cell 32:221-31 (2008)", "doi": "10.1016/j.molcel.2008.09.013"}, {"pmid": "16964248", "authors": "  van der Horst A, de Vries-Smits AM, Brenkman AB, van Triest MH, van den Broek N, Colland F, Maurice MM, Burgering BM", "title": "FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP.", "journal": "Nat Cell Biol 8:1064-73 (2006)", "doi": "10.1038/ncb1469"}, {"pmid": "21613825", "authors": "  Zhang Y, Gan B, Liu D, Paik JH", "title": "FoxO family members in cancer.", "journal": "Cancer Biol Ther 12:253-9 (2011)", "doi": "10.4161/cbt.12.4.15954"}], "rel_pathway": ["hsa00010  Glycolysis / Gluconeogenesis", "hsa00020  Citrate cycle (TCA cycle)", "hsa00190  Oxidative phosphorylation", "hsa04010  MAPK signaling pathway", "hsa04110  Cell cycle", "hsa04120  Ubiquitin mediated proteolysis", "hsa04140  Autophagy - animal", "hsa04151  PI3K-Akt signaling pathway", "hsa04210  Apoptosis", "hsa04350  TGF-beta signaling pathway", "hsa04630  JAK-STAT signaling pathway", "hsa04910  Insulin signaling pathway"], "ko_pathway": "ko04068", "genes": ["PTEN", "EGFR", "BRAF", "AKT2", "AKT1", "SOS1", "PLK2", "MAPK13", "NRAS"]}, {"kegg_id": "hsa04070", "name": "Phosphatidylinositol signaling system - Homo sapiens (human)", "class": "Environmental Information Processing; Signal transduction", "pathway_map": "hsa04070  Phosphatidylinositol signaling system", "drug": ["D11275  Rosiptor (USAN/INN)", "D11276  Rosiptor acetate (USAN)", "D11319  Fimepinostat (USAN/INN)", "D11322  Umbralisib (USAN/INN)", "D11323  Umbralisib tosylate (USAN)", "D12009  Zandelisib (JAN/USAN/INN)", "D12514  Amdizalisib (USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["5297  PI4KA; phosphatidylinositol 4-kinase alpha [KO:K00888] [EC:2.7.1.67]", "5298  PI4KB; phosphatidylinositol 4-kinase beta [KO:K19801] [EC:2.7.1.67]", "55361  PI4K2A; phosphatidylinositol 4-kinase type 2 alpha [KO:K13711] [EC:2.7.1.67]", "55300  PI4K2B; phosphatidylinositol 4-kinase type 2 beta [KO:K13711] [EC:2.7.1.67]", "22908  SACM1L; SAC1 like phosphatidylinositide phosphatase [KO:K21797] [EC:3.1.3.-]", "22876  INPP5F; inositol polyphosphate-5-phosphatase F [KO:K21798] [EC:3.1.3.-]", "23396  PIP5K1C; phosphatidylinositol-4-phosphate 5-kinase type 1 gamma [KO:K00889] [EC:2.7.1.68]", "8394  PIP5K1A; phosphatidylinositol-4-phosphate 5-kinase type 1 alpha [KO:K00889] [EC:2.7.1.68]", "8395  PIP5K1B; phosphatidylinositol-4-phosphate 5-kinase type 1 beta [KO:K00889] [EC:2.7.1.68]", "4952  OCRL; OCRL inositol polyphosphate-5-phosphatase [KO:K01099] [EC:3.1.3.36]", "3633  INPP5B; inositol polyphosphate-5-phosphatase B [KO:K01099] [EC:3.1.3.36]", "56623  INPP5E; inositol polyphosphate-5-phosphatase E [KO:K20278] [EC:3.1.3.36]", "8867  SYNJ1; synaptojanin 1 [KO:K20279] [EC:3.1.3.36]", "8871  SYNJ2; synaptojanin 2 [KO:K20279] [EC:3.1.3.36]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5728  PTEN; phosphatase and tensin homolog [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]", "3635  INPP5D; inositol polyphosphate-5-phosphatase D [KO:K03084] [EC:3.1.3.86]", "3636  INPPL1; inositol polyphosphate phosphatase like 1 [KO:K15909] [EC:3.1.3.86]", "3631  INPP4A; inositol polyphosphate-4-phosphatase type I A [KO:K01109] [EC:3.1.3.66]", "8821  INPP4B; inositol polyphosphate-4-phosphatase type II B [KO:K01109] [EC:3.1.3.66]", "200576  PIKFYVE; phosphoinositide kinase, FYVE-type zinc finger containing [KO:K00921] [EC:2.7.1.150]", "4534  MTM1; myotubularin 1 [KO:K01108] [EC:3.1.3.64 3.1.3.95]", "8776  MTMR1; myotubularin related protein 1 [KO:K18081] [EC:3.1.3.64 3.1.3.95]", "8898  MTMR2; myotubularin related protein 2 [KO:K18081] [EC:3.1.3.64 3.1.3.95]", "8897  MTMR3; myotubularin related protein 3 [KO:K18082] [EC:3.1.3.48 3.1.3.64 3.1.3.95]", "9110  MTMR4; myotubularin related protein 4 [KO:K18082] [EC:3.1.3.48 3.1.3.64 3.1.3.95]", "55613  MTMR8; myotubularin related protein 8 [KO:K18083] [EC:3.1.3.64 3.1.3.95]", "9107  MTMR6; myotubularin related protein 6 [KO:K18083] [EC:3.1.3.64 3.1.3.95]", "9108  MTMR7; myotubularin related protein 7 [KO:K18083] [EC:3.1.3.64 3.1.3.95]", "64419  MTMR14; myotubularin related protein 14 [KO:K18086] [EC:3.1.3.64 3.1.3.95]", "79837  PIP4K2C; phosphatidylinositol-5-phosphate 4-kinase type 2 gamma [KO:K00920] [EC:2.7.1.149]", "5305  PIP4K2A; phosphatidylinositol-5-phosphate 4-kinase type 2 alpha [KO:K00920] [EC:2.7.1.149]", "8396  PIP4K2B; phosphatidylinositol-5-phosphate 4-kinase type 2 beta [KO:K00920] [EC:2.7.1.149]", "90809  PIP4P1; phosphatidylinositol-4,5-bisphosphate 4-phosphatase 1 [KO:K13084] [EC:3.1.3.78]", "55529  PIP4P2; phosphatidylinositol-4,5-bisphosphate 4-phosphatase 2 [KO:K13084] [EC:3.1.3.78]", "5289  PIK3C3; phosphatidylinositol 3-kinase catalytic subunit type 3 [KO:K00914] [EC:2.7.1.137]", "5288  PIK3C2G; phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma [KO:K00923] [EC:2.7.1.154]", "5286  PIK3C2A; phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha [KO:K00923] [EC:2.7.1.154]", "5287  PIK3C2B; phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta [KO:K00923] [EC:2.7.1.154]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "5333  PLCD1; phospholipase C delta 1 [KO:K05857] [EC:3.1.4.11]", "113026  PLCD3; phospholipase C delta 3 [KO:K05857] [EC:3.1.4.11]", "84812  PLCD4; phospholipase C delta 4 [KO:K05857] [EC:3.1.4.11]", "51196  PLCE1; phospholipase C epsilon 1 [KO:K05860] [EC:3.1.4.11]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]", "89869  PLCZ1; phospholipase C zeta 1 [KO:K05861] [EC:3.1.4.11]", "253430  IPMK; inositol polyphosphate multikinase [KO:K00915] [EC:2.7.1.140 2.7.1.151]", "3707  ITPKB; inositol-trisphosphate 3-kinase B [KO:K00911] [EC:2.7.1.127]", "3706  ITPKA; inositol-trisphosphate 3-kinase A [KO:K00911] [EC:2.7.1.127]", "80271  ITPKC; inositol-trisphosphate 3-kinase C [KO:K00911] [EC:2.7.1.127]", "3632  INPP5A; inositol polyphosphate-5-phosphatase A [KO:K01106] [EC:3.1.3.56]", "3705  ITPK1; inositol-tetrakisphosphate 1-kinase [KO:K00913] [EC:2.7.1.159 2.7.1.134]", "64768  IPPK; inositol-pentakisphosphate 2-kinase [KO:K10572] [EC:2.7.1.158]", "9807  IP6K1; inositol hexakisphosphate kinase 1 [KO:K07756] [EC:2.7.4.21]", "51447  IP6K2; inositol hexakisphosphate kinase 2 [KO:K07756] [EC:2.7.4.21]", "117283  IP6K3; inositol hexakisphosphate kinase 3 [KO:K07756] [EC:2.7.4.21]", "9677  PPIP5K1; diphosphoinositol pentakisphosphate kinase 1 [KO:K13024] [EC:2.7.4.24]", "23262  PPIP5K2; diphosphoinositol pentakisphosphate kinase 2 [KO:K13024] [EC:2.7.4.24]", "3628  INPP1; inositol polyphosphate-1-phosphatase [KO:K01107] [EC:3.1.3.57]", "3613  IMPA2; inositol monophosphatase 2 [KO:K01092] [EC:3.1.3.25]", "3612  IMPA1; inositol monophosphatase 1 [KO:K01092] [EC:3.1.3.25]", "54928  BPNT2; 3'(2'), 5'-bisphosphate nucleotidase 2 [KO:K15759] [EC:3.1.3.7]", "8525  DGKZ; diacylglycerol kinase zeta [KO:K00901] [EC:2.7.1.107]", "8527  DGKD; diacylglycerol kinase delta [KO:K00901] [EC:2.7.1.107]", "9162  DGKI; diacylglycerol kinase iota [KO:K00901] [EC:2.7.1.107]", "1606  DGKA; diacylglycerol kinase alpha [KO:K00901] [EC:2.7.1.107]", "8526  DGKE; diacylglycerol kinase epsilon [KO:K00901] [EC:2.7.1.107]", "1607  DGKB; diacylglycerol kinase beta [KO:K00901] [EC:2.7.1.107]", "160851  DGKH; diacylglycerol kinase eta [KO:K00901] [EC:2.7.1.107]", "1608  DGKG; diacylglycerol kinase gamma [KO:K00901] [EC:2.7.1.107]", "1609  DGKQ; diacylglycerol kinase theta [KO:K00901] [EC:2.7.1.107]", "139189  DGKK; diacylglycerol kinase kappa [KO:K00901] [EC:2.7.1.107]", "1040  CDS1; CDP-diacylglycerol synthase 1 [KO:K00981] [EC:2.7.7.41]", "8760  CDS2; CDP-diacylglycerol synthase 2 [KO:K00981] [EC:2.7.7.41]", "10423  CDIPT; CDP-diacylglycerol--inositol 3-phosphatidyltransferase [KO:K00999] [EC:2.7.8.11]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "810  CALML3; calmodulin like 3 [KO:K02183]", "805  CALM2; calmodulin 2 [KO:K02183]", "808  CALM3; calmodulin 3 [KO:K02183]", "801  CALM1; calmodulin 1 [KO:K02183]", "163688  CALML6; calmodulin like 6 [KO:K02183]", "51806  CALML5; calmodulin like 5 [KO:K02183]", "91860  CALML4; calmodulin like 4 [KO:K02183]"], "compound": ["C00076  Calcium cation", "C00137  myo-Inositol", "C00269  CDP-diacylglycerol", "C00416  Phosphatidate", "C00641  1,2-Diacyl-sn-glycerol", "C01177  Inositol 1-phosphate", "C01194  1-Phosphatidyl-D-myo-inositol", "C01204  Phytic acid", "C01220  1D-myo-Inositol 1,4-bisphosphate", "C01243  1D-myo-Inositol 1,3,4-trisphosphate", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C01272  1D-myo-Inositol 1,3,4,5-tetrakisphosphate", "C01277  1-Phosphatidyl-1D-myo-inositol 4-phosphate", "C01284  1D-myo-Inositol 1,3,4,5,6-pentakisphosphate", "C03546  myo-Inositol 4-phosphate", "C04006  1D-myo-Inositol 3-phosphate", "C04062  D-myo-Inositol 1,3-bisphosphate", "C04063  D-myo-Inositol 3,4-bisphosphate", "C04477  1D-myo-Inositol 1,3,4,6-tetrakisphosphate", "C04549  1-Phosphatidyl-1D-myo-inositol 3-phosphate", "C04637  1-Phosphatidyl-D-myo-inositol 4,5-bisphosphate", "C05981  Phosphatidylinositol-3,4,5-trisphosphate", "C11174  1-Diphosinositol pentakisphosphate", "C11526  5-PP-InsP5", "C11554  1-Phosphatidyl-1D-myo-inositol 3,4-bisphosphate", "C11555  1D-myo-Inositol 1,4,5,6-tetrakisphosphate", "C11556  1-Phosphatidyl-1D-myo-inositol 3,5-bisphosphate", "C11557  1-Phosphatidyl-1D-myo-inositol 5-phosphate", "C20690  1D-myo-Inositol 1,5-bis(diphosphate) 2,3,4,6-tetrakisphosphate"], "refs": [{"pmid": "19580826", "authors": "  Sasaki T, Takasuga S, Sasaki J, Kofuji S, Eguchi S, Yamazaki M, Suzuki A", "title": "Mammalian phosphoinositide kinases and phosphatases.", "journal": "Prog Lipid Res 48:307-43 (2009)", "doi": "10.1016/j.plipres.2009.06.001"}], "rel_pathway": ["hsa04020  Calcium signaling pathway", "hsa04144  Endocytosis", "hsa04151  PI3K-Akt signaling pathway", "hsa04510  Focal adhesion"], "ko_pathway": "ko04070", "genes": ["PTEN"]}, {"kegg_id": "hsa04071", "name": "Sphingolipid signaling pathway - Homo sapiens (human)", "description": "Sphingomyelin (SM) and its metabolic products are now known to have second messenger functions in a variety of cellular signaling pathways. Particularly, the sphingolipid metabolites, ceramide (Cer) and sphingosine-1-phosphate (S1P), have emerged as a new class of potent bioactive molecules. Ceramide can be generated de novo or by hydrolysis of membrane sphingomyelin by sphingomyelinase (SMase). Ceramide is subsequently metabolized by ceramidase to generate sphingosine (Sph) which in turn produces S1P through phosphorylation by sphingosine kinases 1 and 2 (SphK1, 2). Both ceramide and S1P regulate cellular responses to stress, with generally opposing effects. S1P functions as a growth and survival factor, acting as a ligand for a family of G protein-coupled receptors, whereas ceramide activates intrinsic and extrinsic apoptotic pathways through receptor-independent mechanisms.", "class": "Environmental Information Processing; Signal transduction", "pathway_map": "hsa04071  Sphingolipid signaling pathway", "drug": ["D04187  Fingolimod hydrochloride (JAN/USAN)", "D10001  Fingolimod (INN)", "D10820  Olipudase alfa (USAN/INN)", "D10904  Amiselimod hydrochloride (USAN)", "D10905  Amiselimod (USAN/INN)", "D10930  Etrasimod (USAN)", "D10931  Etrasimod arginine (USAN)", "D10967  Ozanimod hydrochloride (JAN/USAN)", "D10968  Ozanimod (USAN/INN)", "D11072  Siponimod fumarate (USAN)", "D11215  Ponesimod (USAN/INN)", "D11283  Cenerimod (JAN/USAN/INN)", "D11460  Siponimod (USAN/INN)", "D12376  Udifitimod (USAN)", "D12377  Udifitimod hydrochloride (USAN)", "D12549  Fingolimod lauryl sulfate", "D12771  Mocravimod (USAN/INN)", "D12772  Mocravimod hydrochloride (USAN)", "D12897  Tamuzimod (USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["10558  SPTLC1; serine palmitoyltransferase long chain base subunit 1 [KO:K00654] [EC:2.3.1.50]", "9517  SPTLC2; serine palmitoyltransferase long chain base subunit 2 [KO:K00654] [EC:2.3.1.50]", "55304  SPTLC3; serine palmitoyltransferase long chain base subunit 3 [KO:K00654] [EC:2.3.1.50]", "171546  SPTSSA; serine palmitoyltransferase small subunit A [KO:K26384]", "165679  SPTSSB; serine palmitoyltransferase small subunit B [KO:K26384]", "10715  CERS1; ceramide synthase 1 [KO:K04710] [EC:2.3.1.299]", "29956  CERS2; ceramide synthase 2 [KO:K24621] [EC:2.3.1.297]", "79603  CERS4; ceramide synthase 4 [KO:K24621] [EC:2.3.1.297]", "204219  CERS3; ceramide synthase 3 [KO:K24622] [EC:2.3.1.297 2.3.1.298]", "253782  CERS6; ceramide synthase 6 [KO:K23727] [EC:2.3.1.291]", "91012  CERS5; ceramide synthase 5 [KO:K23727] [EC:2.3.1.291]", "8560  DEGS1; delta 4-desaturase, sphingolipid 1 [KO:K04712] [EC:1.14.19.17 1.14.18.5]", "123099  DEGS2; delta 4-desaturase, sphingolipid 2 [KO:K04712] [EC:1.14.19.17 1.14.18.5]", "6609  SMPD1; sphingomyelin phosphodiesterase 1 [KO:K12350] [EC:3.1.4.12]", "259230  SGMS1; sphingomyelin synthase 1 [KO:K04714] [EC:2.7.8.27]", "166929  SGMS2; sphingomyelin synthase 2 [KO:K04714] [EC:2.7.8.27]", "7124  TNF; tumor necrosis factor [KO:K03156]", "7132  TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158]", "8439  NSMAF; neutral sphingomyelinase activation associated factor [KO:K18953]", "6610  SMPD2; sphingomyelin phosphodiesterase 2 [KO:K12351] [EC:3.1.4.12]", "427  ASAH1; N-acylsphingosine amidohydrolase 1 [KO:K12348] [EC:3.5.1.23]", "56624  ASAH2; N-acylsphingosine amidohydrolase 2 [KO:K12349] [EC:3.5.1.23]", "340485  ACER2; alkaline ceramidase 2 [KO:K01441] [EC:3.5.1.23]", "125981  ACER1; alkaline ceramidase 1 [KO:K01441] [EC:3.5.1.23]", "8717  TRADD; TNFRSF1A associated via death domain [KO:K03171]", "7186  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]", "1509  CTSD; cathepsin D [KO:K01379] [EC:3.4.23.5]", "637  BID; BH3 interacting domain death agonist [KO:K04726]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "4217  MAP3K5; mitogen-activated protein kinase kinase kinase 5 [KO:K04426] [EC:2.7.11.25]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "5590  PRKCZ; protein kinase C zeta [KO:K18952] [EC:2.7.11.13]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]", "5515  PPP2CA; protein phosphatase 2 catalytic subunit alpha [KO:K04382] [EC:3.1.3.16]", "5516  PPP2CB; protein phosphatase 2 catalytic subunit beta [KO:K04382] [EC:3.1.3.16]", "5519  PPP2R1B; protein phosphatase 2 scaffold subunit Abeta [KO:K03456]", "5518  PPP2R1A; protein phosphatase 2 scaffold subunit Aalpha [KO:K03456]", "5520  PPP2R2A; protein phosphatase 2 regulatory subunit Balpha [KO:K04354]", "5521  PPP2R2B; protein phosphatase 2 regulatory subunit Bbeta [KO:K04354]", "5522  PPP2R2C; protein phosphatase 2 regulatory subunit Bgamma [KO:K04354]", "55844  PPP2R2D; protein phosphatase 2 regulatory subunit Bdelta [KO:K04354]", "28227  PPP2R3B; protein phosphatase 2 regulatory subunit B''beta [KO:K11583]", "55012  PPP2R3C; protein phosphatase 2 regulatory subunit B''gamma [KO:K11583]", "5523  PPP2R3A; protein phosphatase 2 regulatory subunit B''alpha [KO:K11583]", "5526  PPP2R5B; protein phosphatase 2 regulatory subunit B'beta [KO:K11584]", "5527  PPP2R5C; protein phosphatase 2 regulatory subunit B'gamma [KO:K11584]", "5528  PPP2R5D; protein phosphatase 2 regulatory subunit B'delta [KO:K11584]", "5529  PPP2R5E; protein phosphatase 2 regulatory subunit B'epsilon [KO:K11584]", "5525  PPP2R5A; protein phosphatase 2 regulatory subunit B'alpha [KO:K11584]", "7157  TP53; tumor protein p53 [KO:K04451]", "2205  FCER1A; Fc epsilon receptor Ia [KO:K08089]", "2206  MS4A2; membrane spanning 4-domains A2 [KO:K08090]", "2207  FCER1G; Fc epsilon receptor Ig [KO:K07983]", "2534  FYN; FYN proto-oncogene, Src family tyrosine kinase [KO:K05703] [EC:2.7.10.2]", "9846  GAB2; GRB2 associated binding protein 2 [KO:K08091]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5337  PLD1; phospholipase D1 [KO:K01115] [EC:3.1.4.4]", "5338  PLD2; phospholipase D2 [KO:K01115] [EC:3.1.4.4]", "8877  SPHK1; sphingosine kinase 1 [KO:K04718] [EC:2.7.1.91]", "56848  SPHK2; sphingosine kinase 2 [KO:K04718] [EC:2.7.1.91]", "3827  KNG1; kininogen 1 [KO:K03898]", "134  ADORA1; adenosine A1 receptor [KO:K04265]", "140  ADORA3; adenosine A3 receptor [KO:K04268]", "624  BDKRB2; bradykinin receptor B2 [KO:K03916]", "4985  OPRD1; opioid receptor delta 1 [KO:K04213]", "2770  GNAI1; G protein subunit alpha i1 [KO:K04630]", "2773  GNAI3; G protein subunit alpha i3 [KO:K04630]", "2771  GNAI2; G protein subunit alpha i2 [KO:K04630]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "5581  PRKCE; protein kinase C epsilon [KO:K18050] [EC:2.7.11.13]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "81537  SGPP1; sphingosine-1-phosphate phosphatase 1 [KO:K04716] [EC:3.1.3.-]", "130367  SGPP2; sphingosine-1-phosphate phosphatase 2 [KO:K04717] [EC:3.1.3.-]", "4363  ABCC1; ATP binding cassette subfamily C member 1 (ABCC1 blood group) [KO:K05665] [EC:7.6.2.3]", "8879  SGPL1; sphingosine-1-phosphate lyase 1 [KO:K01634] [EC:4.1.2.27]", "1901  S1PR1; sphingosine-1-phosphate receptor 1 [KO:K04288]", "9294  S1PR2; sphingosine-1-phosphate receptor 2 [KO:K04292]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5170  PDPK1; 3-phosphoinositide dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]", "4846  NOS3; nitric oxide synthase 3 [KO:K13242] [EC:1.14.13.39]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "5880  RAC2; Rac family small GTPase 2 [KO:K07860]", "5881  RAC3; Rac family small GTPase 3 [KO:K07861]", "1903  S1PR3; sphingosine-1-phosphate receptor 3 [KO:K04290]", "2776  GNAQ; G protein subunit alpha q [KO:K04634]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "8698  S1PR4; sphingosine-1-phosphate receptor 4 [KO:K04293]", "53637  S1PR5; sphingosine-1-phosphate receptor 5 [KO:K04295]", "2768  GNA12; G protein subunit alpha 12 [KO:K04346]", "10672  GNA13; G protein subunit alpha 13 [KO:K04639]", "387  RHOA; ras homolog family member A [KO:K04513]", "6093  ROCK1; Rho associated coiled-coil containing protein kinase 1 [KO:K04514] [EC:2.7.11.1]", "9475  ROCK2; Rho associated coiled-coil containing protein kinase 2 [KO:K17388] [EC:2.7.11.1]", "5728  PTEN; phosphatase and tensin homolog [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]"], "compound": ["C00065  L-Serine", "C00154  Palmitoyl-CoA", "C00165  Diacylglycerol", "C00195  N-Acylsphingosine", "C00212  Adenosine", "C00319  Sphingosine", "C00346  Ethanolamine phosphate", "C00533  Nitric oxide", "C00550  Sphingomyelin", "C00836  Sphinganine", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C05981  Phosphatidylinositol-3,4,5-trisphosphate", "C06124  Sphingosine 1-phosphate", "C12126  Dihydroceramide", "C16845  Peroxynitrite"], "refs": [{"pmid": "18216770", "authors": "  Hannun YA, Obeid LM", "title": "Principles of bioactive lipid signalling: lessons from sphingolipids.", "journal": "Nat Rev Mol Cell Biol 9:139-50 (2008)", "doi": "10.1038/nrm2329"}, {"pmid": "17161984", "authors": "  Taha TA, Mullen TD, Obeid LM", "title": "A house divided: ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell death.", "journal": "Biochim Biophys Acta 1758:2027-36 (2006)", "doi": "10.1016/j.bbamem.2006.10.018"}, {"pmid": "23919551", "authors": "  Liu J, Beckman BS, Foroozesh M", "title": "A review of ceramide analogs as potential anticancer agents.", "journal": "Future Med Chem 5:1405-21 (2013)", "doi": "10.4155/fmc.13.107"}, {"pmid": "18675379", "authors": "  Kono M, Allende ML, Proia RL", "title": "Sphingosine-1-phosphate regulation of mammalian development.", "journal": "Biochim Biophys Acta 1781:435-41 (2008)", "doi": "10.1016/j.bbalip.2008.07.001"}, {"pmid": "18403224", "authors": "  Olivera A", "title": "Unraveling the complexities of sphingosine-1-phosphate function: the mast cell model.", "journal": "Prostaglandins Other Lipid Mediat 86:1-11 (2008)", "doi": "10.1016/j.prostaglandins.2008.02.005"}, {"pmid": "25309325", "authors": "  Brunkhorst R, Vutukuri R, Pfeilschifter W", "title": "Fingolimod for the treatment of neurological diseases-state of play and future perspectives.", "journal": "Front Cell Neurosci 8:283 (2014)", "doi": "10.3389/fncel.2014.00283"}, {"pmid": "15999095", "authors": "  Rosen H, Goetzl EJ", "title": "Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network.", "journal": "Nat Rev Immunol 5:560-70 (2005)", "doi": "10.1038/nri1650"}, {"pmid": "10880336", "authors": "  Pyne S, Pyne NJ", "title": "Sphingosine 1-phosphate signalling in mammalian cells.", "journal": "Biochem J 349:385-402 (2000)", "doi": "10.1042/bj3490385"}, {"pmid": "21705677", "authors": "  Egom EE, Mohamed TM, Mamas MA, Shi Y, Liu W, Chirico D, Stringer SE, Ke Y, Shaheen M, Wang T, Chacko S, Wang X, Solaro RJ, Fath-Ordoubadi F, Cartwright EJ, Lei M", "title": "Activation of Pak1/Akt/eNOS signaling following sphingosine-1-phosphate release as part of a mechanism protecting cardiomyocytes against ischemic cell injury.", "journal": "Am J Physiol Heart Circ Physiol 301:H1487-95 (2011)", "doi": "10.1152/ajpheart.01003.2010"}, {"pmid": "15451787", "authors": "  Jin ZQ, Goetzl EJ, Karliner JS", "title": "Sphingosine kinase activation mediates ischemic preconditioning in murine heart.", "journal": "Circulation 110:1980-9 (2004)", "doi": "10.1161/01.CIR.0000143632.06471.93"}, {"pmid": "17913601", "authors": "  Melendez AJ", "title": "Sphingosine kinase signalling in immune cells: potential as novel therapeutic targets.", "journal": "Biochim Biophys Acta 1784:66-75 (2008)", "doi": "10.1016/j.bbapap.2007.07.013"}, {"pmid": "22654878", "authors": "  Halova I, Draberova L, Draber P", "title": "Mast cell chemotaxis - chemoattractants and signaling pathways.", "journal": "Front Immunol 3:119 (2012)", "doi": "10.3389/fimmu.2012.00119"}, {"pmid": "17438574", "authors": "  Kraft S, Kinet JP", "title": "New developments in FcepsilonRI regulation, function and inhibition.", "journal": "Nat Rev Immunol 7:365-78 (2007)", "doi": "10.1038/nri2072"}, {"pmid": "16470226", "authors": "  Gilfillan AM, Tkaczyk C.", "title": "Integrated signalling pathways for mast-cell activation.", "journal": "Nat Rev Immunol 6:218-30 (2006)", "doi": "10.1038/nri1782"}, {"pmid": "11418646", "authors": "  Osawa Y, Banno Y, Nagaki M, Brenner DA, Naiki T, Nozawa Y, Nakashima S, Moriwaki H", "title": "TNF-alpha-induced sphingosine 1-phosphate inhibits apoptosis through a phosphatidylinositol 3-kinase/Akt pathway in human hepatocytes.", "journal": "J Immunol 167:173-80 (2001)", "doi": "10.4049/jimmunol.167.1.173"}, {"pmid": "20534702", "authors": "  Montfort A, Martin PG, Levade T, Benoist H, Segui B", "title": "FAN (factor associated with neutral sphingomyelinase activation), a moonlighting protein in TNF-R1 signaling.", "journal": "J Leukoc Biol 88:897-903 (2010)", "doi": "10.1189/jlb.0410188"}], "rel_pathway": ["hsa00600  Sphingolipid metabolism", "hsa04010  MAPK signaling pathway", "hsa04142  Lysosome", "hsa04151  PI3K-Akt signaling pathway"], "ko_pathway": "ko04071", "genes": ["PTEN", "RAC1", "TP53", "AKT2", "AKT1", "MAPK13", "NRAS", "BAX"]}, {"kegg_id": "hsa04115", "name": "p53 signaling pathway - Homo sapiens (human)", "description": "p53 activation is induced by a number of stress signals, including DNA damage, oxidative stress and activated oncogenes. The p53 protein is employed as a transcriptional activator of p53-regulated genes. This results in three major outputs; cell cycle arrest, cellular senescence or apoptosis. Other p53-regulated gene functions communicate with adjacent cells, repair the damaged DNA or set up positive and negative feedback loops that enhance or attenuate the functions of the p53 protein and integrate these stress responses with other signal transduction pathways.", "class": "Cellular Processes; Cell growth and death", "pathway_map": "hsa04115  p53 signaling pathway", "drug": ["D00341  Hydroxyurea (USP)", "D08887  Cenersen sodium (USAN)", "D09604  Dinaciclib (USAN/INN)", "D09888  Drozitumab (USAN/INN)", "D11148  Berzosertib (USAN/INN)", "D11206  Prexasertib (USAN/INN)", "D11219  Idasanutlin (USAN/INN)", "D11455  Lerociclib (USAN)", "D11787  Ceralasertib (USAN/INN)", "D12321  Camonsertib (USAN)", "D12378  Navtemadlin (USAN/INN)", "D12399  Sulanemadlin (USAN/INN)", "D12417  Siremadlin (USAN/INN)", "D12418  Siremadlin succinate (USAN)", "D12458  Ozekibart (USAN)", "D12621  Milademetan (USAN/INN)", "D12622  Milademetan tosylate (USAN)", "D12834  Atirmociclib (USAN)", "D12842  Brigimadlin (JAN/USAN/INN)", "D12882  Tuvusertib (USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["472  ATM; ATM serine/threonine kinase [KO:K04728] [EC:2.7.11.1]", "11200  CHEK2; checkpoint kinase 2 [KO:K06641] [EC:2.7.11.1]", "545  ATR; ATR serine/threonine kinase [KO:K06640] [EC:2.7.11.1]", "1111  CHEK1; checkpoint kinase 1 [KO:K02216] [EC:2.7.11.1]", "92344  GORAB; golgin, RAB6 interacting [KO:K19748]", "1029  CDKN2A; cyclin dependent kinase inhibitor 2A [KO:K06621]", "4193  MDM2; MDM2 proto-oncogene [KO:K06643] [EC:2.3.2.27]", "4194  MDM4; MDM4 regulator of p53 [KO:K10127]", "7157  TP53; tumor protein p53 [KO:K04451]", "10848  PPP1R13L; protein phosphatase 1 regulatory subunit 13 like [KO:K27356]", "1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]", "595  CCND1; cyclin D1 [KO:K04503]", "894  CCND2; cyclin D2 [KO:K10151]", "896  CCND3; cyclin D3 [KO:K10152]", "1019  CDK4; cyclin dependent kinase 4 [KO:K02089] [EC:2.7.11.22]", "1021  CDK6; cyclin dependent kinase 6 [KO:K02091] [EC:2.7.11.22]", "898  CCNE1; cyclin E1 [KO:K06626]", "9134  CCNE2; cyclin E2 [KO:K06626]", "1017  CDK2; cyclin dependent kinase 2 [KO:K02206] [EC:2.7.11.22]", "2810  SFN; stratifin [KO:K06644]", "56475  RPRM; reprimo, TP53 dependent G2 arrest mediator homolog [KO:K10128]", "891  CCNB1; cyclin B1 [KO:K05868]", "9133  CCNB2; cyclin B2 [KO:K21770]", "983  CDK1; cyclin dependent kinase 1 [KO:K02087] [EC:2.7.11.22 2.7.11.23]", "1647  GADD45A; growth arrest and DNA damage inducible alpha [KO:K04402]", "4616  GADD45B; growth arrest and DNA damage inducible beta [KO:K04402]", "10912  GADD45G; growth arrest and DNA damage inducible gamma [KO:K04402]", "51512  GTSE1; G2 and S-phase expressed 1 [KO:K10129]", "25946  ZNF385A; zinc finger protein 385A [KO:K26543]", "355  FAS; Fas cell surface death receptor [KO:K04390]", "55367  PIDD1; p53-induced death domain protein 1 [KO:K10130]", "8797  TNFRSF10A; TNF receptor superfamily member 10a [KO:K04722]", "8795  TNFRSF10B; TNF receptor superfamily member 10b [KO:K04722]", "841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]", "637  BID; BH3 interacting domain death agonist [KO:K04726]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "5366  PMAIP1; phorbol-12-myristate-13-acetate-induced protein 1 [KO:K10131]", "27113  BBC3; BCL2 binding component 3 [KO:K10132]", "63970  TP53AIP1; tumor protein p53 regulated apoptosis inducing protein 1 [KO:K13773]", "10572  SIVA1; SIVA1 apoptosis inducing factor [KO:K22744]", "598  BCL2L1; BCL2 like 1 [KO:K04570]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]", "9540  TP53I3; tumor protein p53 inducible protein 3 [KO:K10133] [EC:1.-.-.-]", "9538  EI24; EI24 autophagy associated transmembrane protein [KO:K10134]", "51246  SHISA5; shisa family member 5 [KO:K10135]", "64065  PERP; p53 apoptosis effector related to PMP22 [KO:K10136]", "64393  ZMAT3; zinc finger matrin-type 3 [KO:K10137]", "6477  SIAH1; siah E3 ubiquitin protein ligase 1 [KO:K04506] [EC:2.3.2.27]", "54205  CYCS; cytochrome c, somatic [KO:K08738]", "317  APAF1; apoptotic peptidase activating factor 1 [KO:K02084]", "842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "84883  AIFM2; apoptosis inducing factor mitochondria associated 2 [KO:K22745]", "3486  IGFBP3; insulin like growth factor binding protein 3 [KO:K10138]", "3479  IGF1; insulin like growth factor 1 [KO:K05459]", "5054  SERPINE1; serpin family E member 1 [KO:K03982]", "575  ADGRB1; adhesion G protein-coupled receptor B1 [KO:K04596]", "3732  CD82; CD82 molecule [KO:K06509]", "7057  THBS1; thrombospondin 1 [KO:K16857]", "5268  SERPINB5; serpin family B member 5 [KO:K10139]", "1643  DDB2; damage specific DNA binding protein 2 [KO:K10140]", "50484  RRM2B; ribonucleotide reductase regulatory TP53 inducible subunit M2B [KO:K10808] [EC:1.17.4.1]", "6241  RRM2; ribonucleotide reductase regulatory subunit M2 [KO:K10808] [EC:1.17.4.1]", "27244  SESN1; sestrin 1 [KO:K10141]", "143686  SESN3; sestrin 3 [KO:K10141]", "83667  SESN2; sestrin 2 [KO:K20394]", "5728  PTEN; phosphatase and tensin homolog [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]", "7249  TSC2; TSC complex subunit 2 [KO:K07207]", "55240  STEAP3; STEAP3 metalloreductase [KO:K10142] [EC:1.16.1.-]", "64326  COP1; COP1 E3 ubiquitin ligase [KO:K10143] [EC:2.3.2.27]", "25898  RCHY1; ring finger and CHY zinc finger domain containing 1 [KO:K10144] [EC:2.3.2.27]", "900  CCNG1; cyclin G1 [KO:K10145]", "901  CCNG2; cyclin G2 [KO:K10146]", "8493  PPM1D; protein phosphatase, Mg2+/Mn2+ dependent 1D [KO:K10147] [EC:3.1.3.16]", "7161  TP73; tumor protein p73 [KO:K10148]"], "refs": [{"pmid": "16557269", "authors": "  Levine AJ, Hu W, Feng Z.", "title": "The P53 pathway: what questions remain to be explored?", "journal": "Cell Death Differ 13:1027-36 (2006)", "doi": "10.1038/sj.cdd.4401910"}, {"pmid": "15838523", "authors": "  Harris SL, Levine AJ.", "title": "The p53 pathway: positive and negative feedback loops.", "journal": "Oncogene 24:2899-908 (2005)", "doi": "10.1038/sj.onc.1208615"}, {"pmid": "11747320", "authors": "  Balint E E, Vousden KH.", "title": "Activation and activities of the p53 tumour suppressor protein.", "journal": "Br J Cancer 85:1813-23 (2001)", "doi": "10.1054/bjoc.2001.2128"}, {"pmid": "11313928", "authors": "  Taylor WR, Stark GR.", "title": "Regulation of the G2/M transition by p53.", "journal": "Oncogene 20:1803-15 (2001)", "doi": "10.1038/sj.onc.1204252"}, {"pmid": "15116721", "authors": "  Hofseth LJ, Hussain SP, Harris CC.", "title": "p53: 25 years after its discovery.", "journal": "Trends Pharmacol Sci 25:177-81 (2004)", "doi": "10.1016/j.tips.2004.02.009"}, {"pmid": "12505356", "authors": "  Pietenpol JA, Stewart ZA.", "title": "Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis.", "journal": "Toxicology 181-182:475-81 (2002)", "doi": "10.1016/S0300-483X(02)00460-2"}, {"pmid": "10714958", "authors": "  Tokino T, Nakamura Y.", "title": "The role of p53-target genes in human cancer.", "journal": "Crit Rev Oncol Hematol 33:1-6 (2000)", "doi": "10.1016/S1040-8428(99)00051-7"}, {"pmid": "16697662", "authors": "  Hermeking H, Benzinger A.", "title": "14-3-3 proteins in cell cycle regulation.", "journal": "Semin Cancer Biol 16:183-92 (2006)", "doi": "10.1016/j.semcancer.2006.03.002"}, {"pmid": "16915296", "authors": "  Sherr CJ.", "title": "Divorcing ARF and p53: an unsettled case.", "journal": "Nat Rev Cancer 6:663-73 (2006)", "doi": "10.1038/nrc1954"}, {"pmid": "17409411", "authors": "  Feng Z, Hu W, de Stanchina E, Teresky AK, Jin S, Lowe S, Levine AJ.", "title": "The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways.", "journal": "Cancer Res 67:3043-53 (2007)", "doi": "10.1158/0008-5472.CAN-06-4149"}, {"pmid": "26037915", "authors": "  Resnick-Silverman L, Manfredi JJ", "title": "Two Faces of SIVA.", "journal": "Cancer Discov 5:581-3 (2015)", "doi": "10.1158/2159-8290.CD-15-0484"}, {"pmid": "19584092", "authors": "  Resch U, Schichl YM, Winsauer G, Gudi R, Prasad K, de Martin R", "title": "Siva1 is a XIAP-interacting protein that balances NFkappaB and JNK signalling to promote apoptosis.", "journal": "J Cell Sci 122:2651-61 (2009)", "doi": "10.1242/jcs.049940"}, {"pmid": "19240372", "authors": "  Barkinge JL, Gudi R, Sarah H, Chu F, Borthakur A, Prabhakar BS, Prasad KV", "title": "The p53-induced Siva-1 plays a significant role in cisplatin-mediated apoptosis.", "journal": "J Carcinog 8:2 (2009)", "doi": "10.4103/1477-3163.45389"}, {"pmid": "12135761", "authors": "  Ohiro Y, Garkavtsev I, Kobayashi S, Sreekumar KR, Nantz R, Higashikubo BT, Duffy SL, Higashikubo R, Usheva A, Gius D, Kley N, Horikoshi N", "title": "A novel p53-inducible apoptogenic gene, PRG3, encodes a homologue of the apoptosis-inducing factor (AIF).", "journal": "FEBS Lett 524:163-71 (2002)", "doi": "10.1016/S0014-5793(02)03049-1"}], "rel_pathway": ["hsa04110  Cell cycle", "hsa04210  Apoptosis", "hsa04218  Cellular senescence"], "ko_pathway": "ko04115", "genes": ["PTEN", "TP53", "BAX"]}, {"kegg_id": "hsa04140", "name": "Autophagy - animal - Homo sapiens (human)", "description": "Autophagy (or macroautophagy) is a cellular catabolic pathway involving in protein degradation, organelle turnover, and non-selective breakdown of cytoplasmic components, which is evolutionarily conserved among eukaryotes and exquisitely regulated. This progress initiates with production of the autophagosome, a double-membrane intracellular structure of reticular origin that engulfs cytoplasmic contents and ultimately fuses with lysosomes for cargo degradation. Autophagy is regulated in response to extra- or intracellular stress and signals such as starvation, growth factor deprivation and ER stress. Constitutive level of autophagy plays an important role in cellular homeostasis and maintains quality control of essential cellular components.", "class": "Cellular Processes; Transport and catabolism", "pathway_map": "hsa04140  Autophagy - animal", "network": ["", "ELEMENT   N00155  Autophagy-vesicle nucleation/elongation/maturation, mTORC1-PI3KC3-C1", "N00156  Autophagy-vesicle nucleation/elongation/maturation, LC3-II formation", "N01142  C9orf72-mediated autophagy initiation", "N01715  Autophagy-vesicle nucleation/elongation/maturation, PI3P synthesis by PI3KC3-C1", "N01716  Autophagy-vesicle nucleation/elongation/maturation, sequestosome-1-like receptor", "N01718  Autophagy-vesicle nucleation/elongation/maturation, PACER-RUBCN-PI3KC3-C2", "N01720  Autophagosome and lysosome fusion, trans-SNARE", "N01721  Autophagosome and lysosome fusion, tethering factor", "N01722  Autophagosome and lysosome fusion, tethering factor, GRASP55"], "drug": ["D12777  Olgotrelvir (USAN)", "D12778  Olgotrelvir sodium (USAN)"], "dblinks": "GO: 0006914", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["3630  INS; insulin [KO:K04526]", "3480  IGF1R; insulin like growth factor 1 receptor [KO:K05087] [EC:2.7.10.1]", "3667  IRS1; insulin receptor substrate 1 [KO:K16172]", "8660  IRS2; insulin receptor substrate 2 [KO:K07187]", "8471  IRS4; insulin receptor substrate 4 [KO:K17446]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5170  PDPK1; 3-phosphoinositide dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "5728  PTEN; phosphatase and tensin homolog [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "22808  MRAS; muscle RAS oncogene homolog [KO:K07831]", "6237  RRAS; RAS related [KO:K07829]", "22800  RRAS2; RAS related 2 [KO:K07830]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "3091  HIF1A; hypoxia inducible factor 1 subunit alpha [KO:K08268]", "54541  DDIT4; DNA damage inducible transcript 4 [KO:K08270]", "7249  TSC2; TSC complex subunit 2 [KO:K07207]", "7248  TSC1; TSC complex subunit 1 [KO:K07206]", "664  BNIP3; BCL2 interacting protein 3 [KO:K15464]", "6009  RHEB; Ras homolog, mTORC1 binding [KO:K07208]", "57521  RPTOR; regulatory associated protein of MTOR complex 1 [KO:K07204]", "64798  DEPTOR; DEP domain containing MTOR interacting protein [KO:K20402]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "84335  AKT1S1; AKT1 substrate 1 [KO:K16184]", "64223  MLST8; MTOR associated protein, LST8 homolog [KO:K08266]", "6198  RPS6KB1; ribosomal protein S6 kinase B1 [KO:K04688] [EC:2.7.11.1]", "6199  RPS6KB2; ribosomal protein S6 kinase B2 [KO:K04688] [EC:2.7.11.1]", "3476  IGBP1; immunoglobulin binding protein 1 [KO:K17606]", "5515  PPP2CA; protein phosphatase 2 catalytic subunit alpha [KO:K04382] [EC:3.1.3.16]", "5516  PPP2CB; protein phosphatase 2 catalytic subunit beta [KO:K04382] [EC:3.1.3.16]", "8408  ULK1; unc-51 like autophagy activating kinase 1 [KO:K21357] [EC:2.7.11.1]", "9706  ULK2; unc-51 like autophagy activating kinase 2 [KO:K08269] [EC:2.7.11.1]", "9776  ATG13; autophagy related 13 [KO:K08331]", "60673  ATG101; autophagy related 101 [KO:K19730]", "9821  RB1CC1; RB1 inducible coiled-coil 1 [KO:K17589]", "23130  ATG2A; autophagy related 2A [KO:K17906]", "55102  ATG2B; autophagy related 2B [KO:K17906]", "26100  WIPI2; WD repeat domain, phosphoinositide interacting 2 [KO:K17908]", "55062  WIPI1; WD repeat domain, phosphoinositide interacting 1 [KO:K17908]", "56270  WDR45B; WD repeat domain 45B [KO:K22991]", "11152  WDR45; WD repeat domain 45 [KO:K22991]", "285973  ATG9B; autophagy related 9B [KO:K17907]", "79065  ATG9A; autophagy related 9A [KO:K17907]", "55578  SUPT20H; SPT20 homolog, SAGA complex component [KO:K21245]", "100130302  SUPT20HL1; SUPT20H like 1 [KO:K21245]", "170067  SUPT20HL2; SUPT20H like 2 [KO:K21245]", "140775  SMCR8; SMCR8-C9orf72 complex subunit [KO:K23611]", "55255  WDR41; WD repeat domain 41 [KO:K23610]", "203228  C9orf72; C9orf72-SMCR8 complex subunit [KO:K23609]", "4218  RAB8A; RAB8A, member RAS oncogene family [KO:K07901]", "116442  RAB39B; RAB39B, member RAS oncogene family [KO:K07925]", "8878  SQSTM1; sequestosome 1 [KO:K14381]", "29110  TBK1; TANK binding kinase 1 [KO:K05410] [EC:2.7.11.10]", "10010  TANK; TRAF family member associated NFKB activator [KO:K12650]", "5861  RAB1A; RAB1A, member RAS oncogene family [KO:K07874]", "10670  RRAGA; Ras related GTP binding A [KO:K16185]", "10325  RRAGB; Ras related GTP binding B [KO:K16185]", "64121  RRAGC; Ras related GTP binding C [KO:K16186]", "58528  RRAGD; Ras related GTP binding D [KO:K16186]", "6794  STK11; serine/threonine kinase 11 [KO:K07298] [EC:2.7.11.1]", "5562  PRKAA1; protein kinase AMP-activated catalytic subunit alpha 1 [KO:K07198] [EC:2.7.11.31]", "5563  PRKAA2; protein kinase AMP-activated catalytic subunit alpha 2 [KO:K07198] [EC:2.7.11.31]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "5580  PRKCD; protein kinase C delta [KO:K06068] [EC:2.7.11.13]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]", "598  BCL2L1; BCL2 like 1 [KO:K04570]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]", "8678  BECN1; beclin 1 [KO:K08334]", "441925  BECN2; beclin 2 [KO:K08334]", "29982  NRBF2; nuclear receptor binding factor 2 [KO:K21246]", "30849  PIK3R4; phosphoinositide-3-kinase regulatory subunit 4 [KO:K08333] [EC:2.7.11.1]", "5289  PIK3C3; phosphatidylinositol 3-kinase catalytic subunit type 3 [KO:K00914] [EC:2.7.1.137]", "22863  ATG14; autophagy related 14 [KO:K17889]", "55626  AMBRA1; autophagy and beclin 1 regulator 1 [KO:K17985]", "7189  TRAF6; TNF receptor associated factor 6 [KO:K03175] [EC:2.3.2.27]", "58476  TP53INP2; tumor protein p53 inducible nuclear protein 2 [KO:K21247]", "81671  VMP1; vacuole membrane protein 1 [KO:K21248]", "55014  STX17; syntaxin 17 [KO:K08491]", "7405  UVRAG; UV radiation resistance associated [KO:K21249]", "51100  SH3GLB1; SH3 domain containing GRB2 like, endophilin B1 [KO:K11248]", "9711  RUBCN; rubicon autophagy regulator [KO:K19330]", "10645  CAMKK2; calcium/calmodulin dependent protein kinase kinase 2 [KO:K07359] [EC:2.7.11.17]", "6885  MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO:K04427] [EC:2.7.11.25]", "2081  ERN1; endoplasmic reticulum to nucleus signaling 1 [KO:K08852] [EC:2.7.11.1 3.1.26.-]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "1612  DAPK1; death associated protein kinase 1 [KO:K08803] [EC:2.7.11.1]", "1613  DAPK3; death associated protein kinase 3 [KO:K08803] [EC:2.7.11.1]", "23604  DAPK2; death associated protein kinase 2 [KO:K08803] [EC:2.7.11.1]", "3146  HMGB1; high mobility group box 1 [KO:K10802]", "118471  PRAP1; proline rich acidic protein 1 [KO:K21250]", "9451  EIF2AK3; eukaryotic translation initiation factor 2 alpha kinase 3 [KO:K08860] [EC:2.7.11.1]", "440275  EIF2AK4; eukaryotic translation initiation factor 2 alpha kinase 4 [KO:K16196] [EC:2.7.11.1]", "1965  EIF2S1; eukaryotic translation initiation factor 2 subunit alpha [KO:K03237]", "8897  MTMR3; myotubularin related protein 3 [KO:K18082] [EC:3.1.3.48 3.1.3.64 3.1.3.95]", "9110  MTMR4; myotubularin related protein 4 [KO:K18082] [EC:3.1.3.48 3.1.3.64 3.1.3.95]", "64419  MTMR14; myotubularin related protein 14 [KO:K18086] [EC:3.1.3.64 3.1.3.95]", "53349  ZFYVE1; zinc finger FYVE-type containing 1 [KO:K17603]", "9140  ATG12; autophagy related 12 [KO:K08336]", "9474  ATG5; autophagy related 5 [KO:K08339]", "55054  ATG16L1; autophagy related 16 like 1 [KO:K17890]", "89849  ATG16L2; autophagy related 16 like 2 [KO:K20868]", "10533  ATG7; autophagy related 7 [KO:K08337]", "83734  ATG10; autophagy related 10 [KO:K17888]", "64422  ATG3; autophagy related 3 [KO:K08343]", "8837  CFLAR; CASP8 and FADD like apoptosis regulator [KO:K04724]", "83452  RAB33B; RAB33B, member RAS oncogene family [KO:K07920]", "5588  PRKCQ; protein kinase C theta [KO:K18052] [EC:2.7.11.13]", "11337  GABARAP; GABA type A receptor-associated protein [KO:K08341]", "23710  GABARAPL1; GABA type A receptor associated protein like 1 [KO:K08341]", "11345  GABARAPL2; GABA type A receptor associated protein like 2 [KO:K08341]", "440738  MAP1LC3C; microtubule associated protein 1 light chain 3 gamma [KO:K10435]", "81631  MAP1LC3B; microtubule associated protein 1 light chain 3 beta [KO:K10435]", "84557  MAP1LC3A; microtubule associated protein 1 light chain 3 alpha [KO:K10435]", "643246  MAP1LC3B2; microtubule associated protein 1 light chain 3 beta 2 [KO:K10435]", "115201  ATG4A; autophagy related 4A cysteine peptidase [KO:K08342] [EC:3.4.22.-]", "23192  ATG4B; autophagy related 4B cysteine peptidase [KO:K08342] [EC:3.4.22.-]", "84938  ATG4C; autophagy related 4C cysteine peptidase [KO:K08342] [EC:3.4.22.-]", "84971  ATG4D; autophagy related 4D cysteine peptidase [KO:K08342] [EC:3.4.22.-]", "4077  NBR1; NBR1 autophagy cargo receptor [KO:K17987]", "10133  OPTN; optineurin [KO:K19946]", "10241  CALCOCO2; calcium binding and coiled-coil domain 2 [KO:K21348]", "8887  TAX1BP1; Tax1 binding protein 1 [KO:K21347]", "23001  WDFY3; WD repeat and FYVE domain containing 3 [KO:K22262]", "7311  UBA52; ubiquitin A-52 residue ribosomal protein fusion product 1 [KO:K02927]", "6233  RPS27A; ribosomal protein S27a [KO:K02977]", "7314  UBB; ubiquitin B [KO:K04551]", "7316  UBC; ubiquitin C [KO:K08770]", "9342  SNAP29; synaptosome associated protein 29 [KO:K08509]", "8673  VAMP8; vesicle associated membrane protein 8 [KO:K08512]", "10652  YKT6; YKT6 v-SNARE homolog [KO:K08516]", "8417  STX7; syntaxin 7 [KO:K08488]", "57724  EPG5; ectopic P-granules 5 autophagy tethering factor [KO:K23883]", "9842  PLEKHM1; pleckstrin homology and RUN domain containing M1 [KO:K23282]", "55823  VPS11; VPS11 core subunit of CORVET and HOPS complexes [KO:K20179]", "64601  VPS16; VPS16 core subunit of CORVET and HOPS complexes [KO:K20180]", "57617  VPS18; VPS18 core subunit of CORVET and HOPS complexes [KO:K20181]", "65082  VPS33A; VPS33A core subunit of CORVET and HOPS complexes [KO:K20182]", "23339  VPS39; VPS39 subunit of HOPS complex [KO:K20183]", "27072  VPS41; VPS41 subunit of HOPS complex [KO:K20184]", "57448  BIRC6; baculoviral IAP repeat containing 6 [KO:K10586] [EC:2.3.2.23]", "26003  GORASP2; golgi reassembly stacking protein 2 [KO:K26797]", "64689  GORASP1; golgi reassembly stacking protein 1 [KO:K26797]", "7879  RAB7A; RAB7A, member RAS oncogene family [KO:K07897]", "338382  RAB7B; RAB7B, member RAS oncogene family [KO:K07898]", "3916  LAMP1; lysosomal associated membrane protein 1 [KO:K06528]", "3920  LAMP2; lysosomal associated membrane protein 2 [KO:K06528]", "1509  CTSD; cathepsin D [KO:K01379] [EC:3.4.23.5]", "1514  CTSL; cathepsin L [KO:K01365] [EC:3.4.22.15]", "1508  CTSB; cathepsin B [KO:K01363] [EC:3.4.22.1]"], "compound": ["C00035  GDP", "C00044  GTP", "C00350  Phosphatidylethanolamine", "C01194  1-Phosphatidyl-D-myo-inositol", "C04549  1-Phosphatidyl-1D-myo-inositol 3-phosphate", "C05981  Phosphatidylinositol-3,4,5-trisphosphate"], "refs": [{"pmid": "15325584", "authors": "  Meijer AJ, Codogno P.", "title": "Regulation and role of autophagy in mammalian cells.", "journal": "Int J Biochem Cell Biol 36:2445-62 (2004)", "doi": "10.1016/j.biocel.2004.02.002"}, {"pmid": "16099218", "authors": "  Deretic V.", "title": "Autophagy in innate and adaptive immunity.", "journal": "Trends Immunol 26:523-8 (2005)", "doi": "10.1016/j.it.2005.08.003"}, {"pmid": "16200202", "authors": "  Levine B, Yuan J.", "title": "Autophagy in cell death: an innocent convict?", "journal": "J Clin Invest 115:2679-88 (2005)", "doi": "10.1172/JCI26390"}, {"pmid": "15325588", "authors": "  Tanida I, Ueno T, Kominami E.", "title": "LC3 conjugation system in mammalian autophagy.", "journal": "Int J Biochem Cell Biol 36:2503-18 (2004)", "doi": "10.1016/j.biocel.2004.05.009"}, {"pmid": "15928708", "authors": "  Lum JJ, DeBerardinis RJ, Thompson CB.", "title": "Autophagy in metazoans: cell survival in the land of plenty.", "journal": "Nat Rev Mol Cell Biol 6:439-48 (2005)", "doi": "10.1038/nrm1660"}, {"pmid": "15978794", "authors": "  Reggiori F, Klionsky DJ.", "title": "Autophagosomes: biogenesis from scratch?", "journal": "Curr Opin Cell Biol 17:415-22 (2005)", "doi": "10.1016/j.ceb.2005.06.007"}, {"pmid": "11099404", "authors": "  Klionsky DJ, Emr SD.", "title": "Autophagy as a regulated pathway of cellular degradation.", "journal": "Science 290:1717-21 (2000)", "doi": "10.1126/science.290.5497.1717"}, {"pmid": "16125113", "authors": "  Bechet D, Tassa A, Taillandier D, Combaret L, Attaix D.", "title": "Lysosomal proteolysis in skeletal muscle.", "journal": "Int J Biochem Cell Biol 37:2098-114 (2005)", "doi": "10.1016/j.biocel.2005.02.029"}, {"pmid": "19653858", "authors": "  He C, Klionsky DJ", "title": "Regulation mechanisms and signaling pathways of autophagy.", "journal": "Annu Rev Genet 43:67-93 (2009)", "doi": "10.1146/annurev-genet-102808-114910"}, {"pmid": "19802558", "authors": "  Yang Z, Klionsky DJ", "title": "An overview of the molecular mechanism of autophagy.", "journal": "Curr Top Microbiol Immunol 335:1-32 (2009)", "doi": "10.1007/978-3-642-00302-8_1"}, {"pmid": "20034776", "authors": "  Yang Z, Klionsky DJ", "title": "Mammalian autophagy: core molecular machinery and signaling regulation.", "journal": "Curr Opin Cell Biol 22:124-31 (2010)", "doi": "10.1016/j.ceb.2009.11.014"}, {"pmid": "21187343", "authors": "  Chen Y, Klionsky DJ", "title": "The regulation of autophagy - unanswered questions.", "journal": "J Cell Sci 124:161-70 (2011)", "doi": "10.1242/jcs.064576"}, {"pmid": "21801009", "authors": "  Mizushima N, Yoshimori T, Ohsumi Y", "title": "The role of Atg proteins in autophagosome formation.", "journal": "Annu Rev Cell Dev Biol 27:107-32 (2011)", "doi": "10.1146/annurev-cellbio-092910-154005"}, {"pmid": "24343578", "authors": "  Russell RC, Yuan HX, Guan KL", "title": "Autophagy regulation by nutrient signaling.", "journal": "Cell Res 24:42-57 (2014)", "doi": "10.1038/cr.2013.166"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04141  Protein processing in endoplasmic reticulum", "hsa04142  Lysosome", "hsa04150  mTOR signaling pathway", "hsa04152  AMPK signaling pathway", "hsa04910  Insulin signaling pathway"], "ko_pathway": "ko04140", "genes": ["PTEN", "AKT2", "AKT1", "NRAS"]}, {"kegg_id": "hsa04150", "name": "mTOR signaling pathway - Homo sapiens (human)", "description": "The mammalian (mechanistic) target of rapamycin (mTOR) is a highly conserved serine/threonine protein kinase, which exists in two complexes termed mTOR complex 1 (mTORC1) and 2 (mTORC2). mTORC1 contains mTOR, Raptor, PRAS40, Deptor, mLST8, Tel2 and Tti1. mTORC1 is activated by the presence of growth factors, amino acids, energy status, stress and oxygen levels to regulate several biological processes, including lipid metabolism, autophagy, protein synthesis and ribosome biogenesis. On the other hand, mTORC2, which consists of mTOR, mSin1, Rictor, Protor, Deptor, mLST8, Tel2 and Tti1, responds to growth factors and controls cytoskeletal organization, metabolism and survival.", "class": "Environmental Information Processing; Signal transduction", "pathway_map": "hsa04150  mTOR signaling pathway", "network": ["", "ELEMENT   N00582  IGF-IGF1R-PI3K signaling pathway", "N01575  TSC1/2-mTORC1 signaling pathway", "N01576  STRAD/STK11- TSC signaling pathway", "N01578  GATOR1-mTORC1 signaling pathway", "N01584  FLCN-mTORC1 signaling pathway"], "drug": ["D00753  Sirolimus (JAN/USAN/INN)", "D02714  Everolimus (JAN/USAN/INN)", "D05393  Pegsunercept (USAN)", "D06068  Temsirolimus (JAN/USAN/INN)", "D06221  Triciribine phosphate (USAN)", "D06669  Zotarolimus (USAN/INN)", "D08900  Ridaforolimus (JAN/USAN/INN)", "D10076  Olcorolimus (USAN)", "D11183  Sapanisertib (USAN/INN)", "D11440  Bimiralisib (USAN/INN)", "D11501  Samotolisib (USAN)", "D11663  Onatasertib (USAN)", "D11869  Paxalisib (USAN/INN)", "D12443  Nanvuranlat hydrochloride hydrate (JAN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["8140  SLC7A5; solute carrier family 7 member 5 [KO:K13780]", "6520  SLC3A2; solute carrier family 3 member 2 [KO:K06519]", "153129  SLC38A9; solute carrier family 38 member 9 [KO:K14995]", "523  ATP6V1A; ATPase H+ transporting V1 subunit A [KO:K02145] [EC:7.1.2.2]", "525  ATP6V1B1; ATPase H+ transporting V1 subunit B1 [KO:K02147]", "526  ATP6V1B2; ATPase H+ transporting V1 subunit B2 [KO:K02147]", "245973  ATP6V1C2; ATPase H+ transporting V1 subunit C2 [KO:K02148]", "528  ATP6V1C1; ATPase H+ transporting V1 subunit C1 [KO:K02148]", "51382  ATP6V1D; ATPase H+ transporting V1 subunit D [KO:K02149]", "90423  ATP6V1E2; ATPase H+ transporting V1 subunit E2 [KO:K02150]", "529  ATP6V1E1; ATPase H+ transporting V1 subunit E1 [KO:K02150]", "9296  ATP6V1F; ATPase H+ transporting V1 subunit F [KO:K02151]", "9550  ATP6V1G1; ATPase H+ transporting V1 subunit G1 [KO:K02152]", "127124  ATP6V1G3; ATPase H+ transporting V1 subunit G3 [KO:K02152]", "534  ATP6V1G2; ATPase H+ transporting V1 subunit G2 [KO:K02152]", "51606  ATP6V1H; ATPase H+ transporting V1 subunit H [KO:K02144]", "55004  LAMTOR1; late endosomal/lysosomal adaptor, MAPK and MTOR activator 1 [KO:K20397]", "28956  LAMTOR2; late endosomal/lysosomal adaptor, MAPK and MTOR activator 2 [KO:K20398]", "8649  LAMTOR3; late endosomal/lysosomal adaptor, MAPK and MTOR activator 3 [KO:K04370]", "389541  LAMTOR4; late endosomal/lysosomal adaptor, MAPK and MTOR activator 4 [KO:K20399]", "10542  LAMTOR5; late endosomal/lysosomal adaptor, MAPK and MTOR activator 5 [KO:K16344]", "201163  FLCN; folliculin [KO:K09594]", "96459  FNIP1; folliculin interacting protein 1 [KO:K20400]", "57600  FNIP2; folliculin interacting protein 2 [KO:K20401]", "10670  RRAGA; Ras related GTP binding A [KO:K16185]", "10325  RRAGB; Ras related GTP binding B [KO:K16185]", "64121  RRAGC; Ras related GTP binding C [KO:K16186]", "58528  RRAGD; Ras related GTP binding D [KO:K16186]", "83667  SESN2; sestrin 2 [KO:K20394]", "652968  CASTOR1; cytosolic arginine sensor for mTORC1 subunit 1 [KO:K23080]", "729438  CASTOR2; cytosolic arginine sensor for mTORC1 subunit 2 [KO:K23081]", "54468  MIOS; meiosis regulator for oocyte development [KO:K20407]", "81929  SEH1L; SEH1 like nucleoporin [KO:K14299]", "84219  WDR24; WD repeat domain 24 [KO:K20408]", "79726  WDR59; WD repeat domain 59 [KO:K20409]", "6396  SEC13; SEC13 homolog, nuclear pore and COPII coat complex component [KO:K14004]", "9681  DEPDC5; DEP domain containing 5, GATOR1 subcomplex subunit [KO:K20404]", "10641  NPRL2; NPR2 like, GATOR1 complex subunit [KO:K20405]", "8131  NPRL3; NPR3 like, GATOR1 complex subunit [KO:K20406]", "6502  SKP2; S-phase kinase associated protein 2 [KO:K03875]", "220441  RNF152; ring finger protein 152 [KO:K15705] [EC:2.3.2.27]", "57521  RPTOR; regulatory associated protein of MTOR complex 1 [KO:K07204]", "84335  AKT1S1; AKT1 substrate 1 [KO:K16184]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "64798  DEPTOR; DEP domain containing MTOR interacting protein [KO:K20402]", "64223  MLST8; MTOR associated protein, LST8 homolog [KO:K08266]", "9894  TELO2; telomere maintenance 2 [KO:K11137]", "9675  TTI1; TELO2 interacting protein 1 [KO:K20403]", "6249  CLIP1; CAP-Gly domain containing linker protein 1 [KO:K10421]", "2887  GRB10; growth factor receptor bound protein 10 [KO:K20064]", "23175  LPIN1; lipin 1 [KO:K15728] [EC:3.1.3.4]", "64900  LPIN3; lipin 3 [KO:K15728] [EC:3.1.3.4]", "9663  LPIN2; lipin 2 [KO:K15728] [EC:3.1.3.4]", "8408  ULK1; unc-51 like autophagy activating kinase 1 [KO:K21357] [EC:2.7.11.1]", "9706  ULK2; unc-51 like autophagy activating kinase 2 [KO:K08269] [EC:2.7.11.1]", "1978  EIF4EBP1; eukaryotic translation initiation factor 4E binding protein 1 [KO:K07205]", "1977  EIF4E; eukaryotic translation initiation factor 4E [KO:K03259]", "9470  EIF4E2; eukaryotic translation initiation factor 4E family member 2 [KO:K03259]", "253314  EIF4E1B; eukaryotic translation initiation factor 4E family member 1B [KO:K03259]", "6198  RPS6KB1; ribosomal protein S6 kinase B1 [KO:K04688] [EC:2.7.11.1]", "6199  RPS6KB2; ribosomal protein S6 kinase B2 [KO:K04688] [EC:2.7.11.1]", "1975  EIF4B; eukaryotic translation initiation factor 4B [KO:K03258]", "6194  RPS6; ribosomal protein S6 [KO:K02991]", "92335  STRADA; STE20 related adaptor alpha [KO:K08271]", "55437  STRADB; STE20 related adaptor beta [KO:K17532]", "6794  STK11; serine/threonine kinase 11 [KO:K07298] [EC:2.7.11.1]", "51719  CAB39; calcium binding protein 39 [KO:K08272]", "81617  CAB39L; calcium binding protein 39 like [KO:K08272]", "5562  PRKAA1; protein kinase AMP-activated catalytic subunit alpha 1 [KO:K07198] [EC:2.7.11.31]", "5563  PRKAA2; protein kinase AMP-activated catalytic subunit alpha 2 [KO:K07198] [EC:2.7.11.31]", "7248  TSC1; TSC complex subunit 1 [KO:K07206]", "7249  TSC2; TSC complex subunit 2 [KO:K07207]", "51256  TBC1D7; TBC1 domain family member 7 [KO:K20396]", "107080638  TBC1D7-LOC100130357 readthrough [KO:K20396]", "6009  RHEB; Ras homolog, mTORC1 binding [KO:K07208]", "54541  DDIT4; DNA damage inducible transcript 4 [KO:K08270]", "7471  WNT1; Wnt family member 1 [KO:K03209]", "7472  WNT2; Wnt family member 2 [KO:K00182]", "7482  WNT2B; Wnt family member 2B [KO:K00182]", "7473  WNT3; Wnt family member 3 [KO:K00312]", "89780  WNT3A; Wnt family member 3A [KO:K00312]", "54361  WNT4; Wnt family member 4 [KO:K00408]", "7474  WNT5A; Wnt family member 5A [KO:K00444]", "81029  WNT5B; Wnt family member 5B [KO:K00444]", "7475  WNT6; Wnt family member 6 [KO:K00445]", "7476  WNT7A; Wnt family member 7A [KO:K00572]", "7477  WNT7B; Wnt family member 7B [KO:K00572]", "7478  WNT8A; Wnt family member 8A [KO:K00714]", "7479  WNT8B; Wnt family member 8B [KO:K00714]", "7483  WNT9A; Wnt family member 9A [KO:K01064]", "7484  WNT9B; Wnt family member 9B [KO:K01064]", "7480  WNT10B; Wnt family member 10B [KO:K01357]", "80326  WNT10A; Wnt family member 10A [KO:K01357]", "7481  WNT11; Wnt family member 11 [KO:K01384]", "51384  WNT16; Wnt family member 16 [KO:K01558]", "8321  FZD1; frizzled class receptor 1 [KO:K02432]", "8324  FZD7; frizzled class receptor 7 [KO:K02432]", "2535  FZD2; frizzled class receptor 2 [KO:K02235]", "7976  FZD3; frizzled class receptor 3 [KO:K02329]", "8322  FZD4; frizzled class receptor 4 [KO:K02354]", "7855  FZD5; frizzled class receptor 5 [KO:K02375]", "8325  FZD8; frizzled class receptor 8 [KO:K02375]", "8323  FZD6; frizzled class receptor 6 [KO:K02376]", "11211  FZD10; frizzled class receptor 10 [KO:K02842]", "8326  FZD9; frizzled class receptor 9 [KO:K02842]", "4041  LRP5; LDL receptor related protein 5 [KO:K03068]", "4040  LRP6; LDL receptor related protein 6 [KO:K03068]", "1857  DVL3; dishevelled segment polarity protein 3 [KO:K02353]", "1856  DVL2; dishevelled segment polarity protein 2 [KO:K02353]", "1855  DVL1; dishevelled segment polarity protein 1 [KO:K02353]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "7124  TNF; tumor necrosis factor [KO:K03156]", "7132  TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "3630  INS; insulin [KO:K04526]", "3479  IGF1; insulin like growth factor 1 [KO:K05459]", "3643  INSR; insulin receptor [KO:K04527] [EC:2.7.10.1]", "3480  IGF1R; insulin like growth factor 1 receptor [KO:K05087] [EC:2.7.10.1]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "6197  RPS6KA3; ribosomal protein S6 kinase A3 [KO:K04373] [EC:2.7.11.1]", "6195  RPS6KA1; ribosomal protein S6 kinase A1 [KO:K04373] [EC:2.7.11.1]", "6196  RPS6KA2; ribosomal protein S6 kinase A2 [KO:K04373] [EC:2.7.11.1]", "27330  RPS6KA6; ribosomal protein S6 kinase A6 [KO:K04373] [EC:2.7.11.1]", "3667  IRS1; insulin receptor substrate 1 [KO:K16172]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5728  PTEN; phosphatase and tensin homolog [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]", "5170  PDPK1; 3-phosphoinositide dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "79109  MAPKAP1; MAPK associated protein 1 [KO:K20410]", "253260  RICTOR; RPTOR independent companion of MTOR complex 2 [KO:K08267]", "55615  PRR5; proline rich 5 [KO:K20411]", "79899  PRR5L; proline rich 5 like [KO:K20411]", "387  RHOA; ras homolog family member A [KO:K04513]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "6446  SGK1; serum/glucocorticoid regulated kinase 1 [KO:K13302] [EC:2.7.11.1]"], "compound": ["C00020  AMP", "C00062  L-Arginine", "C00123  L-Leucine", "C05981  Phosphatidylinositol-3,4,5-trisphosphate"], "refs": [{"pmid": "27304501", "authors": "  Kennedy BK, Lamming DW", "title": "The Mechanistic Target of Rapamycin: The Grand ConducTOR of Metabolism and Aging.", "journal": "Cell Metab 23:990-1003 (2016)", "doi": "10.1016/j.cmet.2016.05.009"}, {"pmid": "24556838", "authors": "  Shimobayashi M, Hall MN", "title": "Making new contacts: the mTOR network in metabolism and signalling crosstalk.", "journal": "Nat Rev Mol Cell Biol 15:155-62 (2014)", "doi": "10.1038/nrm3757"}, {"pmid": "25242279", "authors": "  Huang K, Fingar DC", "title": "Growing knowledge of the mTOR signaling network.", "journal": "Semin Cell Dev Biol 36:79-90 (2014)", "doi": "10.1016/j.semcdb.2014.09.011"}, {"pmid": "26269525", "authors": "  Bockaert J, Marin P", "title": "mTOR in Brain Physiology and Pathologies.", "journal": "Physiol Rev 95:1157-87 (2015)", "doi": "10.1152/physrev.00038.2014"}, {"pmid": "26185979", "authors": "  Caron A, Richard D, Laplante M", "title": "The Roles of mTOR Complexes in Lipid Metabolism.", "journal": "Annu Rev Nutr 35:321-48 (2015)", "doi": "10.1146/annurev-nutr-071714-034355"}, {"pmid": "26658722", "authors": "  Shimobayashi M, Hall MN", "title": "Multiple amino acid sensing inputs to mTORC1.", "journal": "Cell Res 26:7-20 (2016)", "doi": "10.1038/cr.2015.146"}, {"pmid": "24698685", "authors": "  Bar-Peled L, Sabatini DM", "title": "Regulation of mTORC1 by amino acids.", "journal": "Trends Cell Biol 24:400-6 (2014)", "doi": "10.1016/j.tcb.2014.03.003"}, {"pmid": "26046644", "authors": "  Fingar DC", "title": "Rag Ubiquitination Recruits a GATOR1: Attenuation of Amino Acid-Induced mTORC1 Signaling.", "journal": "Mol Cell 58:713-5 (2015)", "doi": "10.1016/j.molcel.2015.05.029"}, {"pmid": "26700098", "authors": "  Cai H, Dong LQ, Liu F", "title": "Recent Advances in Adipose mTOR Signaling and Function: Therapeutic Prospects.", "journal": "Trends Pharmacol Sci 37:303-17 (2016)", "doi": "10.1016/j.tips.2015.11.011"}, {"pmid": "24842496", "authors": "  Eyre TA, Collins GP, Goldstone AH, Cwynarski K", "title": "Time now to TORC the TORC? New developments in mTOR pathway inhibition in lymphoid malignancies.", "journal": "Br J Haematol 166:336-51 (2014)", "doi": "10.1111/bjh.12945"}, {"pmid": "23465396", "authors": "  Jewell JL, Guan KL", "title": "Nutrient signaling to mTOR and cell growth.", "journal": "Trends Biochem Sci 38:233-42 (2013)", "doi": "10.1016/j.tibs.2013.01.004"}, {"pmid": "23421405", "authors": "  Wood TL, Bercury KK, Cifelli SE, Mursch LE, Min J, Dai J, Macklin WB", "title": "mTOR: a link from the extracellular milieu to transcriptional regulation of oligodendrocyte development.", "journal": "ASN Neuro 5:e00108 (2013)", "doi": "10.1042/AN20120092"}, {"pmid": "23694989", "authors": "  Kim SG, Buel GR, Blenis J", "title": "Nutrient regulation of the mTOR complex 1 signaling pathway.", "journal": "Mol Cells 35:463-73 (2013)", "doi": "10.1007/s10059-013-0138-2"}, {"pmid": "19812304", "authors": "  Laplante M, Sabatini DM", "title": "mTOR signaling at a glance.", "journal": "J Cell Sci 122:3589-94 (2009)", "doi": "10.1242/jcs.051011"}, {"pmid": "16756488", "authors": "  Alessi DR, Sakamoto K, Bayascas JR", "title": "LKB1-dependent signaling pathways.", "journal": "Annu Rev Biochem 75:137-63 (2006)", "doi": "10.1146/annurev.biochem.75.103004.142702"}, {"pmid": "27027448", "authors": "  Dan HC, Antonia RJ, Baldwin AS", "title": "PI3K/Akt promotes feedforward mTORC2 activation through IKKalpha.", "journal": "Oncotarget 7:21064-75 (2016)", "doi": "10.18632/oncotarget.8383"}], "rel_pathway": ["hsa00561  Glycerolipid metabolism", "hsa04010  MAPK signaling pathway", "hsa04140  Autophagy - animal", "hsa04151  PI3K-Akt signaling pathway", "hsa04152  AMPK signaling pathway", "hsa04810  Regulation of actin cytoskeleton", "hsa04910  Insulin signaling pathway"], "ko_pathway": "ko04150", "genes": ["PTEN", "BRAF", "AKT2", "AKT1", "FLCN", "SOS1", "NRAS"]}, {"kegg_id": "hsa04151", "name": "PI3K-Akt signaling pathway - Homo sapiens (human)", "description": "The phosphatidylinositol 3' -kinase(PI3K)-Akt signaling pathway is activated by many types of cellular stimuli or toxic insults and regulates fundamental cellular functions such as transcription, translation, proliferation, growth, and survival. The binding of growth factors to their receptor tyrosine kinase (RTK) or G protein-coupled receptors (GPCR) stimulates class Ia and Ib PI3K isoforms, respectively. PI3K catalyzes the production of phosphatidylinositol-3,4,5-triphosphate (PIP3) at the cell membrane. PIP3 in turn serves as a second messenger that helps to activate Akt. Once active, Akt can control key cellular processes by phosphorylating substrates involved in apoptosis, protein synthesis, metabolism, and cell cycle.", "class": "Environmental Information Processing; Signal transduction", "pathway_map": "hsa04151  PI3K-Akt signaling pathway", "network": ["", "ELEMENT   N00030  EGF-EGFR-RAS-PI3K signaling pathway", "N00033  EGF-EGFR-PI3K signaling pathway", "N00037  FGF-FGFR-PI3K signaling pathway", "N00039  PDGF-PDGFR-PI3K signaling pathway", "N00043  HGF-MET-PI3K signaling pathway", "N00045  KITLG-KIT-PI3K signaling pathway", "N00182  IGF-IGFR-PI3K-NFKB signaling pathway", "N00218  FLT3LG-FLT3-RAS-PI3K signaling pathway", "N00220  PTEN-PIP3-AKT signaling pathway", "N00231  TGFA-EGFR-PI3K signaling pathway", "N00234  IGF2-IGF1R-PI3K signaling pathway", "N00282  EREG-EGFR-PI3K signaling pathway", "N00284  AREG-EGFR-PI3K signaling pathway", "N00342  MAGI-PTEN signaling pathway", "N00355  PP2A-AKT signaling pathway", "N00390  EGF-EGFR-PI3K-NFKB signaling pathway", "N00582  IGF-IGF1R-PI3K signaling pathway", "N01656  GF-RTK-PI3K signaling pathway", "N01657  GPCR-PI3K signaling pathway", "N01658  GF-RTK-RAS-PI3K signaling pathway", "N01695  BCR-BCAP/CD19-PI3K signaling pathway"], "drug": ["D02937  Ancestim (USAN/INN)", "D03117  Binetrakin (USAN/INN)", "D03235  Filgrastim (USP/INN)", "D03247  Lenograstim (USAN/INN)", "D03297  Mecasermin (USAN/INN)", "D04262  Fostriecin sodium (USAN)", "D04696  Lestaurtinib (USAN/INN)", "D04870  Mecasermin rinfabate (USAN/INN)", "D05029  Midostaurin (JAN/USAN/INN)", "D05036  Milodistim (USAN/INN)", "D06005  Tandutinib (USAN/INN)", "D06221  Triciribine phosphate (USAN)", "D06285  Vatalanib (USAN/INN)", "D06402  Sunitinib malate (JAN/USAN)", "D06554  Alvespimycin hydrochloride (USAN)", "D06650  Tanespimycin (USAN)", "D06678  Motesanib (USAN)", "D06889  Pegfilgrastim (USAN/INN)", "D08279  Tozasertib (USAN)", "D08344  Tozasertib lactate (USAN)", "D08503  Toceranib (USAN)", "D08544  Toceranib phosphate (USAN)", "D08552  Sunitinib (INN)", "D08878  Brivanib alaninate (JAN/USAN/INN)", "D08907  Dovitinib lactate (USAN)", "D08947  Motesanib diphosphate (USAN)", "D08956  Omacetaxine mepesuccinate (USAN)", "D09375  Retaspimycin (USAN/INN)", "D09376  Retaspimycin hydrochloride (USAN)", "D09589  Brivanib (USAN)", "D09635  Linifanib (USAN/INN)", "D10062  Cabozantinib (USAN)", "D10095  Cabozantinib s-malate (USAN)", "D10126  Ganetespib (USAN)", "D10189  Pictilisib (USAN/INN)", "D10190  Tivozanib hydrochloride (USAN)", "D10224  Golvatinib (USAN)", "D10242  Lipegfilgrastim (USAN)", "D10310  Balugrastim (USAN/INN)", "D10354  Dupilumab (USAN/INN)", "D10365  Gandotinib (USAN/INN)", "D10372  Palbociclib (JAN/USAN)", "D10381  Afuresertib (USAN/INN)", "D10382  Afuresertib hydrochloride (USAN)", "D10395  Nesvacumab (USAN/INN)", "D10465  Golvatinib tartrate (USAN)", "D10543  Apitolisib (USAN/INN)", "D10552  Dactolisib (USAN/INN)", "D10555  Duvelisib (USAN/INN)", "D10560  Idelalisib (JAN/USAN/INN)", "D10584  Buparlisib (USAN/INN)", "D10609  Buparlisib hydrochloride (JAN/USAN)", "D10616  Dactolisib tosylate (USAN)", "D10635  Gedatolisib (USAN/INN)", "D10641  Ipatasertib (USAN/INN)", "D10646  Luminespib (USAN/INN)", "D10647  Luminespib mesylate (USAN)", "D10652  Palbociclib isethionate (USAN)", "D10688  Abemaciclib (JAN/USAN/INN)", "D10696  Capmatinib (USAN/INN)", "D10718  Omipalisib (USAN/INN)", "D10719  Onalespib (USAN/INN)", "D10797  Copanlisib hydrochloride (USAN)", "D10798  Copanlisib hydrochloride hydrate (JAN)", "D10867  Copanlisib (USAN/INN)", "D10883  Ribociclib (USAN/INN)", "D10891  Capmatinib hydrochloride (USAN)", "D10924  Dezapelisib (USAN/INN)", "D10926  Entrectinib (JAN/USAN/INN)", "D10927  Erdafitinib (JAN/USAN/INN)", "D10943  Istiratumab (USAN/INN)", "D10944  Itacitinib (USAN/INN)", "D10945  Itacitinib adipate (JAN/USAN)", "D10958  Naquotinib (USAN/INN)", "D10979  Ribociclib succinate (USAN)", "D11011  Alpelisib (JAN/USAN/INN)", "D11026  Pegteograstim (INN)", "D11073  Tepotinib hydrochloride (USAN)", "D11074  Ipatasertib hydrochloride (JAN)", "D11125  Modotuximab (USAN/INN)", "D11126  Navicixizumab (USAN/INN)", "D11130  Trilaciclib (USAN/INN)", "D11140  Sitravatinib (USAN/INN)", "D11141  Tucatinib (USAN/INN)", "D11144  Axicabtagene ciloleucel (USAN)", "D11158  Leniolisib (USAN/INN)", "D11159  Leniolisib phosphate (USAN)", "D11188  Eflapegrastim (USAN/INN)", "D11193  Somavaratan (USAN/INN)", "D11209  Entospletinib (USAN/INN)", "D11267  Nemiralisib (USAN/INN)", "D11270  Pexidartinib (USAN/INN)", "D11271  Pexidartinib hydrochloride (JAN/USAN)", "D11288  Rivoceranib (USAN/INN)", "D11289  Rivoceranib mesylate (USAN)", "D11322  Umbralisib (USAN/INN)", "D11323  Umbralisib tosylate (USAN)", "D11333  Loncastuximab (USAN)", "D11338  Loncastuximab tesirine (USAN)", "D11353  Ripretinib (USAN)", "D11354  Nemiralisib succinate (USAN)", "D11371  Capivasertib (JAN/USAN)", "D11409  Miransertib (USAN/INN)", "D11417  Pemigatinib (JAN/USAN/INN)", "D11437  Parsaclisib (USAN/INN)", "D11440  Bimiralisib (USAN/INN)", "D11455  Lerociclib (USAN)", "D11461  Derazantinib hydrochloride (USAN)", "D11501  Samotolisib (USAN)", "D11506  Parsaclisib hydrochloride (JAN/USAN)", "D11508  Miransertib mesylate (USAN)", "D11540  Razuprotafib (USAN)", "D11541  Sitravatinib malate (USAN)", "D11599  Zotiraciclib (USAN)", "D11600  Zotiraciclib citrate (USAN)", "D11601  Tafasitamab (USAN/INN)", "D11642  Dilpacimab (USAN/INN)", "D11658  Duvelisib hydrate (JAN)", "D11676  Gusacitinib (USAN/INN)", "D11677  Gusacitinib hydrochloride (USAN)", "D11717  Tepotinib (USAN/INN)", "D11727  Voxtalisib (USAN/INN)", "D11750  Duligotuzumab (USAN)", "D11757  Inebilizumab (USAN/INN)", "D11762  Lucitanib (USAN/INN)", "D11766  Onalespib lactate (USAN)", "D11768  Pacritinib (USAN/INN)", "D11772  Tesevatinib (USAN/INN)", "D11773  Tesevatinib tosylate (USAN)", "D11774  Taselisib (USAN/INN)", "D11800  Vixarelimab (USAN)", "D11869  Paxalisib (USAN/INN)", "D11880  Brexucabtagene autoleucel (USAN)", "D11885  Surufatinib (USAN/INN)", "D11894  Amivantamab (USAN/INN)", "D11896  Eganelisib (USAN)", "D11920  Pimitespib (JAN)", "D11942  Inavolisib (USAN/INN)", "D11962  Murizatoclax (USAN/INN)", "D11963  Tapotoclax (USAN/INN)", "D11977  Fruquintinib (JAN/USAN)", "D11986  Efbemalenograstim alfa (USAN/INN)", "D11987  Trilaciclib dihydrochloride", "D11990  Lisocabtagene maraleucel (USAN/INN)", "D11991  Zenocutuzumab (USAN/INN)", "D12009  Zandelisib (JAN/USAN/INN)", "D12055  Sotorasib (JAN/USAN)", "D12184  Patritumab deruxtecan (USAN/INN)", "D12185  Patritumab (USAN/INN)", "D12229  Poziotinib (USAN/INN)", "D12230  Poziotinib hydrochloride (USAN)", "D12238  Vimseltinib (USAN/INN)", "D12301  Adagrasib (USAN/INN)", "D12307  Pivekimab (USAN)", "D12308  Pivekimab sunirine (USAN)", "D12343  Fepixnebart (TN)", "D12363  Taletrectinib (USAN/INN)", "D12364  Taletrectinib adipate (USAN)", "D12386  Melredableukin alfa (USAN/INN)", "D12404  Tasurgratinib (INN)", "D12405  Tasurgratinib succinate (JAN)", "D12409  Barzolvolimab (USAN/INN)", "D12424  Davutamig (USAN)", "D12442  Tucatinib ethanolate (JAN)", "D12476  Tuspetinib (USAN/INN)", "D12502  Golidocitinib (USAN/INN)", "D12514  Amdizalisib (USAN/INN)", "D12526  Catequentinib (USAN/INN)", "D12537  Catequentinib hydrochloride (USAN)", "D12540  Briquilimab (USAN/INN)", "D12545  Tinengotinib (USAN/INN)", "D12557  Elzovantinib (USAN/INN)", "D12575  Povorcitinib (USAN/INN)", "D12576  Povorcitinib phosphate (USAN)", "D12600  Bezuclastinib (USAN/INN)", "D12601  Tagtociclib (USAN)", "D12624  Paridiprubart (USAN/INN)", "D12635  Sozinibercept (USAN/INN)", "D12639  Divarasib (USAN/INN)", "D12640  Divarasib adipate (USAN)", "D12642  Fipaxalparant (USAN/INN)", "D12650  Zanzalintinib (USAN/INN)", "D12651  Zanzalintinib fumarate (USAN)", "D12705  Gumarontinib hydrate (JAN)", "D12709  Dalmitamig (USAN)", "D12722  Bexotegrast (USAN/INN)", "D12731  Anumigilimab (USAN/INN)", "D12786  Lepzacitinib (USAN)", "D12809  Bafisontamab (USAN/INN)", "D12834  Atirmociclib (USAN)", "D12836  Risovalisib (INN)", "D12837  Risovalisib mesilate hydrate (JAN)", "D12850  Imneskibart (USAN)", "D12853  Olomorasib (USAN)"], "dblinks": "GO: 0043491", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["1950  EGF; epidermal growth factor [KO:K04357]", "7039  TGFA; transforming growth factor alpha [KO:K08774]", "2069  EREG; epiregulin [KO:K09784]", "374  AREG; amphiregulin [KO:K09782]", "2246  FGF1; fibroblast growth factor 1 [KO:K18496]", "2247  FGF2; fibroblast growth factor 2 [KO:K18497]", "2248  FGF3; fibroblast growth factor 3 [KO:K04358]", "2249  FGF4; fibroblast growth factor 4 [KO:K04358]", "8822  FGF17; fibroblast growth factor 17 [KO:K04358]", "2251  FGF6; fibroblast growth factor 6 [KO:K04358]", "2252  FGF7; fibroblast growth factor 7 [KO:K04358]", "2253  FGF8; fibroblast growth factor 8 [KO:K04358]", "2254  FGF9; fibroblast growth factor 9 [KO:K04358]", "2255  FGF10; fibroblast growth factor 10 [KO:K04358]", "8823  FGF16; fibroblast growth factor 16 [KO:K04358]", "2250  FGF5; fibroblast growth factor 5 [KO:K04358]", "8817  FGF18; fibroblast growth factor 18 [KO:K04358]", "26281  FGF20; fibroblast growth factor 20 [KO:K04358]", "27006  FGF22; fibroblast growth factor 22 [KO:K04358]", "9965  FGF19; fibroblast growth factor 19 [KO:K22603]", "26291  FGF21; fibroblast growth factor 21 [KO:K22429]", "8074  FGF23; fibroblast growth factor 23 [KO:K22428]", "4803  NGF; nerve growth factor [KO:K02582]", "627  BDNF; brain derived neurotrophic factor [KO:K04355]", "4908  NTF3; neurotrophin 3 [KO:K04356]", "4909  NTF4; neurotrophin 4 [KO:K12457]", "3630  INS; insulin [KO:K04526]", "3479  IGF1; insulin like growth factor 1 [KO:K05459]", "3481  IGF2; insulin like growth factor 2 [KO:K13769]", "5154  PDGFA; platelet derived growth factor subunit A [KO:K04359]", "5155  PDGFB; platelet derived growth factor subunit B [KO:K17386]", "56034  PDGFC; platelet derived growth factor C [KO:K05450]", "80310  PDGFD; platelet derived growth factor D [KO:K05450]", "1435  CSF1; colony stimulating factor 1 [KO:K05453]", "4254  KITLG; KIT ligand [KO:K05461]", "2323  FLT3LG; fms related receptor tyrosine kinase 3 ligand [KO:K05454]", "7422  VEGFA; vascular endothelial growth factor A [KO:K05448]", "7423  VEGFB; vascular endothelial growth factor B [KO:K16858]", "5228  PGF; placental growth factor [KO:K16859]", "7424  VEGFC; vascular endothelial growth factor C [KO:K05449]", "2277  VEGFD; vascular endothelial growth factor D [KO:K05449]", "3082  HGF; hepatocyte growth factor [KO:K05460]", "284  ANGPT1; angiopoietin 1 [KO:K05465]", "285  ANGPT2; angiopoietin 2 [KO:K05466]", "51378  ANGPT4; angiopoietin 4 [KO:K05467]", "1942  EFNA1; ephrin A1 [KO:K05462]", "1943  EFNA2; ephrin A2 [KO:K05462]", "1944  EFNA3; ephrin A3 [KO:K05462]", "1945  EFNA4; ephrin A4 [KO:K05462]", "1946  EFNA5; ephrin A5 [KO:K05462]", "2668  GDNF; glial cell derived neurotrophic factor [KO:K05452]", "4902  NRTN; neurturin [KO:K25414]", "9048  ARTN; artemin [KO:K25415]", "5623  PSPN; persephin [KO:K25416]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "2064  ERBB2; erb-b2 receptor tyrosine kinase 2 [KO:K05083] [EC:2.7.10.1]", "2065  ERBB3; erb-b2 receptor tyrosine kinase 3 [KO:K05084] [EC:2.7.10.1]", "2066  ERBB4; erb-b2 receptor tyrosine kinase 4 [KO:K05085] [EC:2.7.10.1]", "2260  FGFR1; fibroblast growth factor receptor 1 [KO:K04362] [EC:2.7.10.1]", "2263  FGFR2; fibroblast growth factor receptor 2 [KO:K05093] [EC:2.7.10.1]", "2261  FGFR3; fibroblast growth factor receptor 3 [KO:K05094] [EC:2.7.10.1]", "2264  FGFR4; fibroblast growth factor receptor 4 [KO:K05095] [EC:2.7.10.1]", "4804  NGFR; nerve growth factor receptor [KO:K02583]", "4914  NTRK1; neurotrophic receptor tyrosine kinase 1 [KO:K03176] [EC:2.7.10.1]", "4915  NTRK2; neurotrophic receptor tyrosine kinase 2 [KO:K04360] [EC:2.7.10.1]", "3643  INSR; insulin receptor [KO:K04527] [EC:2.7.10.1]", "3480  IGF1R; insulin like growth factor 1 receptor [KO:K05087] [EC:2.7.10.1]", "5156  PDGFRA; platelet derived growth factor receptor alpha [KO:K04363] [EC:2.7.10.1]", "5159  PDGFRB; platelet derived growth factor receptor beta [KO:K05089] [EC:2.7.10.1]", "1436  CSF1R; colony stimulating factor 1 receptor [KO:K05090] [EC:2.7.10.1]", "3815  KIT; KIT proto-oncogene, receptor tyrosine kinase [KO:K05091] [EC:2.7.10.1]", "2322  FLT3; fms related receptor tyrosine kinase 3 [KO:K05092] [EC:2.7.10.1]", "2321  FLT1; fms related receptor tyrosine kinase 1 [KO:K05096] [EC:2.7.10.1]", "2324  FLT4; fms related receptor tyrosine kinase 4 [KO:K05097] [EC:2.7.10.1]", "3791  KDR; kinase insert domain receptor [KO:K05098] [EC:2.7.10.1]", "4233  MET; MET proto-oncogene, receptor tyrosine kinase [KO:K05099] [EC:2.7.10.1]", "7010  TEK; TEK receptor tyrosine kinase [KO:K05121] [EC:2.7.10.1]", "1969  EPHA2; EPH receptor A2 [KO:K05103] [EC:2.7.10.1]", "5979  RET; ret proto-oncogene [KO:K05126] [EC:2.7.10.1]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "3667  IRS1; insulin receptor substrate 1 [KO:K16172]", "7097  TLR2; toll like receptor 2 [KO:K10159]", "7099  TLR4; toll like receptor 4 [KO:K10160]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "102723407  IGH; immunoglobulin heavy variable 4-38-2-like [KO:K06856]", "6850  SYK; spleen associated tyrosine kinase [KO:K05855] [EC:2.7.10.2]", "930  CD19; CD19 molecule [KO:K06465]", "118788  PIK3AP1; phosphoinositide-3-kinase adaptor protein 1 [KO:K12230]", "2688  GH1; growth hormone 1 [KO:K05438]", "2689  GH2; growth hormone 2 [KO:K05438]", "1442  CSH1; chorionic somatomammotropin hormone 1 [KO:K05438]", "1443  CSH2; chorionic somatomammotropin hormone 2 [KO:K05438]", "5617  PRL; prolactin [KO:K05439]", "5008  OSM; oncostatin M [KO:K05418]", "3558  IL2; interleukin 2 [KO:K05429]", "3562  IL3; interleukin 3 [KO:K04736]", "3569  IL6; interleukin 6 [KO:K05405]", "3565  IL4; interleukin 4 [KO:K05430]", "3574  IL7; interleukin 7 [KO:K05431]", "3439  IFNA1; interferon alpha 1 [KO:K05414]", "3440  IFNA2; interferon alpha 2 [KO:K05414]", "3441  IFNA4; interferon alpha 4 [KO:K05414]", "3442  IFNA5; interferon alpha 5 [KO:K05414]", "3443  IFNA6; interferon alpha 6 [KO:K05414]", "3444  IFNA7; interferon alpha 7 [KO:K05414]", "3445  IFNA8; interferon alpha 8 [KO:K05414]", "3446  IFNA10; interferon alpha 10 [KO:K05414]", "3447  IFNA13; interferon alpha 13 [KO:K05414]", "3448  IFNA14; interferon alpha 14 [KO:K05414]", "3449  IFNA16; interferon alpha 16 [KO:K05414]", "3451  IFNA17; interferon alpha 17 [KO:K05414]", "3452  IFNA21; interferon alpha 21 [KO:K05414]", "3456  IFNB1; interferon beta 1 [KO:K05415]", "2056  EPO; erythropoietin [KO:K05437]", "1440  CSF3; colony stimulating factor 3 [KO:K05423]", "2690  GHR; growth hormone receptor [KO:K05080]", "5618  PRLR; prolactin receptor [KO:K05081]", "9180  OSMR; oncostatin M receptor [KO:K05057]", "3559  IL2RA; interleukin 2 receptor subunit alpha [KO:K05068]", "3560  IL2RB; interleukin 2 receptor subunit beta [KO:K05069]", "3561  IL2RG; interleukin 2 receptor subunit gamma [KO:K05070]", "3563  IL3RA; interleukin 3 receptor subunit alpha [KO:K04737]", "3570  IL6R; interleukin 6 receptor [KO:K05055]", "3566  IL4R; interleukin 4 receptor [KO:K05071]", "3575  IL7R; interleukin 7 receptor [KO:K05072]", "3454  IFNAR1; interferon alpha and beta receptor subunit 1 [KO:K05130]", "3455  IFNAR2; interferon alpha and beta receptor subunit 2 [KO:K05131]", "2057  EPOR; erythropoietin receptor [KO:K05079]", "1441  CSF3R; colony stimulating factor 3 receptor [KO:K05061]", "3716  JAK1; Janus kinase 1 [KO:K11217] [EC:2.7.10.2]", "3717  JAK2; Janus kinase 2 [KO:K04447] [EC:2.7.10.2]", "3718  JAK3; Janus kinase 3 [KO:K11218] [EC:2.7.10.2]", "1277  COL1A1; collagen type I alpha 1 chain [KO:K06236]", "1278  COL1A2; collagen type I alpha 2 chain [KO:K06236]", "1280  COL2A1; collagen type II alpha 1 chain [KO:K19719]", "1284  COL4A2; collagen type IV alpha 2 chain [KO:K06237]", "1286  COL4A4; collagen type IV alpha 4 chain [KO:K06237]", "1288  COL4A6; collagen type IV alpha 6 chain [KO:K06237]", "1282  COL4A1; collagen type IV alpha 1 chain [KO:K06237]", "1287  COL4A5; collagen type IV alpha 5 chain [KO:K06237]", "1285  COL4A3; collagen type IV alpha 3 chain [KO:K06237]", "1291  COL6A1; collagen type VI alpha 1 chain [KO:K06238]", "1292  COL6A2; collagen type VI alpha 2 chain [KO:K06238]", "1293  COL6A3; collagen type VI alpha 3 chain [KO:K06238]", "131873  COL6A6; collagen type VI alpha 6 chain [KO:K06238]", "256076  COL6A5; collagen type VI alpha 5 chain [KO:K06238]", "1297  COL9A1; collagen type IX alpha 1 chain [KO:K08131]", "1298  COL9A2; collagen type IX alpha 2 chain [KO:K08131]", "1299  COL9A3; collagen type IX alpha 3 chain [KO:K08131]", "284217  LAMA1; laminin subunit alpha 1 [KO:K05637]", "3908  LAMA2; laminin subunit alpha 2 [KO:K05637]", "3909  LAMA3; laminin subunit alpha 3 [KO:K06240]", "3911  LAMA5; laminin subunit alpha 5 [KO:K06240]", "3910  LAMA4; laminin subunit alpha 4 [KO:K06241]", "3912  LAMB1; laminin subunit beta 1 [KO:K05636]", "3913  LAMB2; laminin subunit beta 2 [KO:K06243]", "3914  LAMB3; laminin subunit beta 3 [KO:K06244]", "22798  LAMB4; laminin subunit beta 4 [KO:K06245]", "3915  LAMC1; laminin subunit gamma 1 [KO:K05635]", "3918  LAMC2; laminin subunit gamma 2 [KO:K06246]", "10319  LAMC3; laminin subunit gamma 3 [KO:K06247]", "1101  CHAD; chondroadherin [KO:K06248]", "5649  RELN; reelin [KO:K06249] [EC:3.4.21.-]", "7057  THBS1; thrombospondin 1 [KO:K16857]", "1311  COMP; cartilage oligomeric matrix protein [KO:K04659]", "7058  THBS2; thrombospondin 2 [KO:K04659]", "7059  THBS3; thrombospondin 3 [KO:K04659]", "7060  THBS4; thrombospondin 4 [KO:K04659]", "2335  FN1; fibronectin 1 [KO:K05717]", "6696  SPP1; secreted phosphoprotein 1 [KO:K06250]", "7448  VTN; vitronectin [KO:K06251]", "3371  TNC; tenascin C [KO:K06252]", "63923  TNN; tenascin N [KO:K06252]", "7143  TNR; tenascin R [KO:K06252]", "7148  TNXB; tenascin XB [KO:K06252]", "7450  VWF; von Willebrand factor [KO:K03900]", "3381  IBSP; integrin binding sialoprotein [KO:K06253]", "3672  ITGA1; integrin subunit alpha 1 [KO:K06480]", "3673  ITGA2; integrin subunit alpha 2 [KO:K06481]", "3674  ITGA2B; integrin subunit alpha 2b [KO:K06476]", "3675  ITGA3; integrin subunit alpha 3 [KO:K06482]", "3676  ITGA4; integrin subunit alpha 4 [KO:K06483]", "3678  ITGA5; integrin subunit alpha 5 [KO:K06484]", "3655  ITGA6; integrin subunit alpha 6 [KO:K06485]", "3679  ITGA7; integrin subunit alpha 7 [KO:K06583]", "8516  ITGA8; integrin subunit alpha 8 [KO:K06584]", "3680  ITGA9; integrin subunit alpha 9 [KO:K06585]", "8515  ITGA10; integrin subunit alpha 10 [KO:K06586]", "22801  ITGA11; integrin subunit alpha 11 [KO:K06587]", "3685  ITGAV; integrin subunit alpha V [KO:K06487]", "3688  ITGB1; integrin subunit beta 1 [KO:K05719]", "3690  ITGB3; integrin subunit beta 3 [KO:K06493]", "3691  ITGB4; integrin subunit beta 4 [KO:K06525]", "3693  ITGB5; integrin subunit beta 5 [KO:K06588]", "3694  ITGB6; integrin subunit beta 6 [KO:K06589]", "3695  ITGB7; integrin subunit beta 7 [KO:K06590]", "3696  ITGB8; integrin subunit beta 8 [KO:K06591]", "5747  PTK2; protein tyrosine kinase 2 [KO:K05725] [EC:2.7.10.2]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "2149  F2R; coagulation factor II thrombin receptor [KO:K03914]", "1128  CHRM1; cholinergic receptor muscarinic 1 [KO:K04129]", "1129  CHRM2; cholinergic receptor muscarinic 2 [KO:K04130]", "1902  LPAR1; lysophosphatidic acid receptor 1 [KO:K04289]", "9170  LPAR2; lysophosphatidic acid receptor 2 [KO:K04291]", "23566  LPAR3; lysophosphatidic acid receptor 3 [KO:K04294]", "2846  LPAR4; lysophosphatidic acid receptor 4 [KO:K04275]", "57121  LPAR5; lysophosphatidic acid receptor 5 [KO:K08390]", "10161  LPAR6; lysophosphatidic acid receptor 6 [KO:K04273]", "2782  GNB1; G protein subunit beta 1 [KO:K04536]", "2783  GNB2; G protein subunit beta 2 [KO:K04537]", "2784  GNB3; G protein subunit beta 3 [KO:K07825]", "59345  GNB4; G protein subunit beta 4 [KO:K04538]", "10681  GNB5; G protein subunit beta 5 [KO:K04539]", "54331  GNG2; G protein subunit gamma 2 [KO:K07826]", "2785  GNG3; G protein subunit gamma 3 [KO:K04540]", "2786  GNG4; G protein subunit gamma 4 [KO:K04541]", "2787  GNG5; G protein subunit gamma 5 [KO:K04542]", "2788  GNG7; G protein subunit gamma 7 [KO:K04543]", "94235  GNG8; G protein subunit gamma 8 [KO:K04544]", "2790  GNG10; G protein subunit gamma 10 [KO:K04545]", "2791  GNG11; G protein subunit gamma 11 [KO:K04546]", "55970  GNG12; G protein subunit gamma 12 [KO:K04347]", "51764  GNG13; G protein subunit gamma 13 [KO:K04547]", "2792  GNGT1; G protein subunit gamma transducin 1 [KO:K04548]", "2793  GNGT2; G protein subunit gamma transducin 2 [KO:K04549]", "5294  PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma [KO:K21289] [EC:2.7.1.153]", "23533  PIK3R5; phosphoinositide-3-kinase regulatory subunit 5 [KO:K21290]", "146850  PIK3R6; phosphoinositide-3-kinase regulatory subunit 6 [KO:K21290]", "5170  PDPK1; 3-phosphoinositide dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]", "6794  STK11; serine/threonine kinase 11 [KO:K07298] [EC:2.7.11.1]", "5562  PRKAA1; protein kinase AMP-activated catalytic subunit alpha 1 [KO:K07198] [EC:2.7.11.31]", "5563  PRKAA2; protein kinase AMP-activated catalytic subunit alpha 2 [KO:K07198] [EC:2.7.11.31]", "54541  DDIT4; DNA damage inducible transcript 4 [KO:K08270]", "7248  TSC1; TSC complex subunit 1 [KO:K07206]", "7249  TSC2; TSC complex subunit 2 [KO:K07207]", "6009  RHEB; Ras homolog, mTORC1 binding [KO:K07208]", "64223  MLST8; MTOR associated protein, LST8 homolog [KO:K08266]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "57521  RPTOR; regulatory associated protein of MTOR complex 1 [KO:K07204]", "1978  EIF4EBP1; eukaryotic translation initiation factor 4E binding protein 1 [KO:K07205]", "1977  EIF4E; eukaryotic translation initiation factor 4E [KO:K03259]", "9470  EIF4E2; eukaryotic translation initiation factor 4E family member 2 [KO:K03259]", "253314  EIF4E1B; eukaryotic translation initiation factor 4E family member 1B [KO:K03259]", "6198  RPS6KB1; ribosomal protein S6 kinase B1 [KO:K04688] [EC:2.7.11.1]", "6199  RPS6KB2; ribosomal protein S6 kinase B2 [KO:K04688] [EC:2.7.11.1]", "1975  EIF4B; eukaryotic translation initiation factor 4B [KO:K03258]", "6194  RPS6; ribosomal protein S6 [KO:K02991]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5585  PKN1; protein kinase N1 [KO:K06071] [EC:2.7.11.13]", "5586  PKN2; protein kinase N2 [KO:K23691] [EC:2.7.11.13]", "29941  PKN3; protein kinase N3 [KO:K23692] [EC:2.7.11.13]", "6446  SGK1; serum/glucocorticoid regulated kinase 1 [KO:K13302] [EC:2.7.11.1]", "10110  SGK2; serum/glucocorticoid regulated kinase 2 [KO:K13303] [EC:2.7.11.1]", "23678  SGK3; serum/glucocorticoid regulated kinase family member 3 [KO:K13304] [EC:2.7.11.1]", "100533105  C8orf44-SGK3; C8orf44-SGK3 readthrough [KO:K13304] [EC:2.7.11.1]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "9223  MAGI1; membrane associated guanylate kinase, WW and PDZ domain containing 1 [KO:K05631]", "9863  MAGI2; membrane associated guanylate kinase, WW and PDZ domain containing 2 [KO:K05629]", "5728  PTEN; phosphatase and tensin homolog [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]", "117145  THEM4; thioesterase superfamily member 4 [KO:K16339] [EC:3.1.2.2]", "5515  PPP2CA; protein phosphatase 2 catalytic subunit alpha [KO:K04382] [EC:3.1.3.16]", "5516  PPP2CB; protein phosphatase 2 catalytic subunit beta [KO:K04382] [EC:3.1.3.16]", "5519  PPP2R1B; protein phosphatase 2 scaffold subunit Abeta [KO:K03456]", "5518  PPP2R1A; protein phosphatase 2 scaffold subunit Aalpha [KO:K03456]", "5520  PPP2R2A; protein phosphatase 2 regulatory subunit Balpha [KO:K04354]", "5521  PPP2R2B; protein phosphatase 2 regulatory subunit Bbeta [KO:K04354]", "5522  PPP2R2C; protein phosphatase 2 regulatory subunit Bgamma [KO:K04354]", "55844  PPP2R2D; protein phosphatase 2 regulatory subunit Bdelta [KO:K04354]", "28227  PPP2R3B; protein phosphatase 2 regulatory subunit B''beta [KO:K11583]", "55012  PPP2R3C; protein phosphatase 2 regulatory subunit B''gamma [KO:K11583]", "5523  PPP2R3A; protein phosphatase 2 regulatory subunit B''alpha [KO:K11583]", "5526  PPP2R5B; protein phosphatase 2 regulatory subunit B'beta [KO:K11584]", "5527  PPP2R5C; protein phosphatase 2 regulatory subunit B'gamma [KO:K11584]", "5528  PPP2R5D; protein phosphatase 2 regulatory subunit B'delta [KO:K11584]", "5529  PPP2R5E; protein phosphatase 2 regulatory subunit B'epsilon [KO:K11584]", "5525  PPP2R5A; protein phosphatase 2 regulatory subunit B'alpha [KO:K11584]", "3320  HSP90AA1; heat shock protein 90 alpha family class A member 1 [KO:K04079]", "3326  HSP90AB1; heat shock protein 90 alpha family class B member 1 [KO:K04079]", "7184  HSP90B1; heat shock protein 90 beta family member 1 [KO:K09487]", "11140  CDC37; cell division cycle 37, HSP90 cochaperone [KO:K09554]", "200186  CRTC2; CREB regulated transcription coactivator 2 [KO:K16333]", "23239  PHLPP1; PH domain and leucine rich repeat protein phosphatase 1 [KO:K16340] [EC:3.1.3.16]", "23035  PHLPP2; PH domain and leucine rich repeat protein phosphatase 2 [KO:K16340] [EC:3.1.3.16]", "8115  TCL1A; TCL1 family AKT coactivator A [KO:K10167]", "9623  TCL1B; TCL1 family AKT coactivator B [KO:K16836]", "4515  MTCP1; mature T cell proliferation 1 [KO:K16837]", "4846  NOS3; nitric oxide synthase 3 [KO:K13242] [EC:1.14.13.39]", "672  BRCA1; BRCA1 DNA repair associated [KO:K10605] [EC:2.3.2.27]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "2998  GYS2; glycogen synthase 2 [KO:K00693] [EC:2.4.1.11]", "2997  GYS1; glycogen synthase 1 [KO:K00693] [EC:2.4.1.11]", "5105  PCK1; phosphoenolpyruvate carboxykinase 1 [KO:K01596] [EC:4.1.1.32]", "5106  PCK2; phosphoenolpyruvate carboxykinase 2, mitochondrial [KO:K01596] [EC:4.1.1.32]", "2538  G6PC1; glucose-6-phosphatase catalytic subunit 1 [KO:K01084] [EC:3.1.3.9]", "57818  G6PC2; glucose-6-phosphatase catalytic subunit 2 [KO:K01084] [EC:3.1.3.9]", "92579  G6PC3; glucose-6-phosphatase catalytic subunit 3 [KO:K01084] [EC:3.1.3.9]", "4609  MYC; MYC proto-oncogene, bHLH transcription factor [KO:K04377]", "595  CCND1; cyclin D1 [KO:K04503]", "1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]", "1027  CDKN1B; cyclin dependent kinase inhibitor 1B [KO:K06624]", "1017  CDK2; cyclin dependent kinase 2 [KO:K02206] [EC:2.7.11.22]", "1019  CDK4; cyclin dependent kinase 4 [KO:K02089] [EC:2.7.11.22]", "1021  CDK6; cyclin dependent kinase 6 [KO:K02091] [EC:2.7.11.22]", "894  CCND2; cyclin D2 [KO:K10151]", "896  CCND3; cyclin D3 [KO:K10152]", "898  CCNE1; cyclin E1 [KO:K06626]", "9134  CCNE2; cyclin E2 [KO:K06626]", "2309  FOXO3; forkhead box O3 [KO:K09408]", "5934  RBL2; RB transcriptional corepressor like 2 [KO:K16332]", "356  FASLG; Fas ligand [KO:K04389]", "10018  BCL2L11; BCL2 like 11 [KO:K16341]", "7534  YWHAZ; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta [KO:K16197]", "7529  YWHAB; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta [KO:K16197]", "10971  YWHAQ; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta [KO:K16197]", "7531  YWHAE; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon [KO:K06630]", "7533  YWHAH; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta [KO:K16198]", "7532  YWHAG; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma [KO:K16198]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]", "598  BCL2L1; BCL2 like 1 [KO:K04570]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]", "842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]", "1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]", "1386  ATF2; activating transcription factor 2 [KO:K04450]", "468  ATF4; activating transcription factor 4 [KO:K04374]", "10488  CREB3; cAMP responsive element binding protein 3 [KO:K09048]", "90993  CREB3L1; cAMP responsive element binding protein 3 like 1 [KO:K09048]", "64764  CREB3L2; cAMP responsive element binding protein 3 like 2 [KO:K09048]", "84699  CREB3L3; cAMP responsive element binding protein 3 like 3 [KO:K09048]", "148327  CREB3L4; cAMP responsive element binding protein 3 like 4 [KO:K09048]", "9586  CREB5; cAMP responsive element binding protein 5 [KO:K09047]", "1388  ATF6B; activating transcription factor 6 beta [KO:K09049]", "4170  MCL1; MCL1 apoptosis regulator, BCL2 family member [KO:K02539]", "6256  RXRA; retinoid X receptor alpha [KO:K08524]", "3164  NR4A1; nuclear receptor subfamily 4 group A member 1 [KO:K04465]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "4602  MYB; MYB proto-oncogene, transcription factor [KO:K09420]", "4193  MDM2; MDM2 proto-oncogene [KO:K06643] [EC:2.3.2.27]", "7157  TP53; tumor protein p53 [KO:K04451]"], "compound": ["C00020  AMP", "C00533  Nitric oxide", "C04637  1-Phosphatidyl-D-myo-inositol 4,5-bisphosphate", "C05981  Phosphatidylinositol-3,4,5-trisphosphate"], "refs": [{"pmid": "16847462", "authors": "  Engelman JA, Luo J, Cantley LC", "title": "The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism.", "journal": "Nat Rev Genet 7:606-19 (2006)", "doi": "10.1038/nrg1879"}, {"pmid": "15784165", "authors": "  Song G, Ouyang G, Bao S", "title": "The activation of Akt/PKB signaling pathway and cell survival.", "journal": "J Cell Mol Med 9:59-71 (2005)", "doi": "10.1111/j.1582-4934.2005.tb00337.x"}, {"pmid": "21620960", "authors": "  Hers I, Vincent EE, Tavare JM", "title": "Akt signalling in health and disease.", "journal": "Cell Signal 23:1515-27 (2011)", "doi": "10.1016/j.cellsig.2011.05.004"}, {"pmid": "18842113", "authors": "  Duronio V", "title": "The life of a cell: apoptosis regulation by the PI3K/PKB pathway.", "journal": "Biochem J 415:333-44 (2008)", "doi": "10.1042/BJ20081056"}, {"pmid": "16248975", "authors": "  Kim D, Chung J.", "title": "Akt: versatile mediator of cell survival and beyond.", "journal": "J Biochem Mol Biol 35:106-15 (2002)", "doi": "10.5483/bmbrep.2002.35.1.106"}, {"pmid": "12660731", "authors": "  Koyasu S", "title": "The role of PI3K in immune cells.", "journal": "Nat Immunol 4:313-9 (2003)", "doi": "10.1038/ni0403-313"}, {"pmid": "12669022", "authors": "  Okkenhaug K, Vanhaesebroeck B.", "title": "PI3K in lymphocyte development, differentiation and activation.", "journal": "Nat Rev Immunol 3:317-30 (2003)", "doi": "10.1038/nri1056"}, {"pmid": "15209374", "authors": "  Richardson CJ, Schalm SS, Blenis J", "title": "PI3-kinase and TOR: PIKTORing cell growth.", "journal": "Semin Cell Dev Biol 15:147-59 (2004)", "doi": "10.1016/j.semcdb.2003.12.023"}, {"pmid": "21440011", "authors": "  Zhang X, Tang N, Hadden TJ, Rishi AK", "title": "Akt, FoxO and regulation of apoptosis.", "journal": "Biochim Biophys Acta 1813:1978-86 (2011)", "doi": "10.1016/j.bbamcr.2011.03.010"}, {"pmid": "21779440", "authors": "  Georgescu MM", "title": "PTEN Tumor Suppressor Network in PI3K-Akt Pathway Control.", "journal": "Genes Cancer 1:1170-7 (2010)", "doi": "10.1177/1947601911407325"}, {"pmid": "12531180", "authors": "  West KA, Castillo SS, Dennis PA", "title": "Activation of the PI3K/Akt pathway and chemotherapeutic resistance.", "journal": "Drug Resist Updat 5:234-48 (2002)", "doi": "10.1016/S1368-7646(02)00120-6"}, {"pmid": "9838078", "authors": "  Wymann MP, Pirola L", "title": "Structure and function of phosphoinositide 3-kinases.", "journal": "Biochim Biophys Acta 1436:127-50 (1998)", "doi": "10.1016/S0005-2760(98)00139-8"}, {"pmid": "12048182", "authors": "  Moelling K, Schad K, Bosse M, Zimmermann S, Schweneker M", "title": "Regulation of Raf-Akt Cross-talk.", "journal": "J Biol Chem 277:31099-106 (2002)", "doi": "10.1074/jbc.M111974200"}, {"pmid": "16187290", "authors": "  Kikani CK, Dong LQ, Liu F", "title": "\"New\"-clear functions of PDK1: beyond a master kinase in the cytosol?", "journal": "J Cell Biochem 96:1157-62 (2005)", "doi": "10.1002/jcb.20651"}, {"pmid": "11357143", "authors": "  Blume-Jensen P, Hunter T", "title": "Oncogenic kinase signalling.", "journal": "Nature 411:355-65 (2001)", "doi": "10.1038/35077225"}, {"pmid": "15505410", "authors": "  Osaki M, Oshimura M, Ito H", "title": "PI3K-Akt pathway: its functions and alterations in human cancer.", "journal": "Apoptosis 9:667-76 (2004)", "doi": "10.1023/B:APPT.0000045801.15585.dd"}, {"pmid": "17360849", "authors": "  Noguchi M, Ropars V, Roumestand C, Suizu F", "title": "Proto-oncogene TCL1: more than just a coactivator for Akt.", "journal": "FASEB J 21:2273-84 (2007)", "doi": "10.1096/fj.06-7684com"}, {"pmid": "20602996", "authors": "  Lemmon MA, Schlessinger J", "title": "Cell signaling by receptor tyrosine kinases.", "journal": "Cell 141:1117-34 (2010)", "doi": "10.1016/j.cell.2010.06.011"}], "rel_pathway": ["hsa00010  Glycolysis / Gluconeogenesis", "hsa04010  MAPK signaling pathway", "hsa04012  ErbB signaling pathway", "hsa04062  Chemokine signaling pathway", "hsa04064  NF-kappa B signaling pathway", "hsa04068  FoxO signaling pathway", "hsa04110  Cell cycle", "hsa04115  p53 signaling pathway", "hsa04150  mTOR signaling pathway", "hsa04210  Apoptosis", "hsa04370  VEGF signaling pathway", "hsa04510  Focal adhesion", "hsa04620  Toll-like receptor signaling pathway", "hsa04630  JAK-STAT signaling pathway", "hsa04662  B cell receptor signaling pathway", "hsa04910  Insulin signaling pathway"], "ko_pathway": "ko04151", "genes": ["PTEN", "IL3", "EGFR", "IL2R", "RAC1", "TP53", "CSF1", "AKT2", "MET", "TNN", "AKT1", "PGF", "SOS1", "KDR", "NRAS"]}, {"kegg_id": "hsa04218", "name": "Cellular senescence - Homo sapiens (human)", "description": "Cellular senescence is a state of irreversible cellular arrest and can be triggered by a number of factors, such as telomere shortening, oncogene activation, irradiation, DNA damage and oxidative stress. It is characterized by enlarged flattened morphology, senescence-associated beta-galactosidase (SA-b-gal) activity, secretion of inflammatory cytokines, growth factors and matrix metalloproteinases, as part of the senescence-associated secretory phenotype (SASP). Cellular senescence is functionally associated with many biological processes including aging, tumor suppression, placental biology, embryonic development, and wound healing.", "class": "Cellular Processes; Cell growth and death", "pathway_map": "hsa04218  Cellular senescence", "drug": ["D00107  Tacrolimus (USP/INN)", "D00184  Cyclosporine (USP)", "D01583  Pirfenidone (JAN/USAN/INN)", "D05480  Pimecrolimus (JAN/USAN/INN)", "D06160  Tiplasinin (USAN)", "D08556  Tacrolimus (INN)", "D08656  Aleplasinin (USAN/INN)", "D09033  Voclosporin (JAN/USAN/INN)", "D10983  Ruclosporin (USAN/INN)", "D11148  Berzosertib (USAN/INN)", "D11787  Ceralasertib (USAN/INN)", "D12181  Edasalonexent (USAN/INN)", "D12237  Zunsemetinib (USAN)", "D12321  Camonsertib (USAN)", "D12656  Adakitug (USAN)", "D12834  Atirmociclib (USAN)", "D12882  Tuvusertib (USAN/INN)"], "dblinks": "GO: 0090398", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["7040  TGFB1; transforming growth factor beta 1 [KO:K13375]", "7042  TGFB2; transforming growth factor beta 2 [KO:K13376]", "7043  TGFB3; transforming growth factor beta 3 [KO:K13377]", "7046  TGFBR1; transforming growth factor beta receptor 1 [KO:K04674] [EC:2.7.11.30]", "7048  TGFBR2; transforming growth factor beta receptor 2 [KO:K04388] [EC:2.7.11.30]", "4087  SMAD2; SMAD family member 2 [KO:K04500]", "4088  SMAD3; SMAD family member 3 [KO:K23605]", "1030  CDKN2B; cyclin dependent kinase inhibitor 2B [KO:K04685]", "1019  CDK4; cyclin dependent kinase 4 [KO:K02089] [EC:2.7.11.22]", "1021  CDK6; cyclin dependent kinase 6 [KO:K02091] [EC:2.7.11.22]", "595  CCND1; cyclin D1 [KO:K04503]", "894  CCND2; cyclin D2 [KO:K10151]", "896  CCND3; cyclin D3 [KO:K10152]", "5925  RB1; RB transcriptional corepressor 1 [KO:K06618]", "5933  RBL1; RB transcriptional corepressor like 1 [KO:K04681]", "5934  RBL2; RB transcriptional corepressor like 2 [KO:K16332]", "1869  E2F1; E2F transcription factor 1 [KO:K17454]", "1870  E2F2; E2F transcription factor 2 [KO:K09389]", "1871  E2F3; E2F transcription factor 3 [KO:K06620]", "1874  E2F4; E2F transcription factor 4 [KO:K04682]", "1875  E2F5; E2F transcription factor 5 [KO:K04682]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "2308  FOXO1; forkhead box O1 [KO:K07201]", "2309  FOXO3; forkhead box O3 [KO:K09408]", "1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]", "1017  CDK2; cyclin dependent kinase 2 [KO:K02206] [EC:2.7.11.22]", "898  CCNE1; cyclin E1 [KO:K06626]", "9134  CCNE2; cyclin E2 [KO:K06626]", "3105  HLA-A; major histocompatibility complex, class I, A [KO:K06751]", "3106  HLA-B; major histocompatibility complex, class I, B [KO:K06751]", "3107  HLA-C; major histocompatibility complex, class I, C [KO:K06751]", "3134  HLA-F; major histocompatibility complex, class I, F [KO:K06751]", "3135  HLA-G; major histocompatibility complex, class I, G [KO:K06751]", "3133  HLA-E; major histocompatibility complex, class I, E [KO:K06751]", "3805  KIR2DL4; killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4 [KO:K24231]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "6237  RRAS; RAS related [KO:K07829]", "22800  RRAS2; RAS related 2 [KO:K07830]", "22808  MRAS; muscle RAS oncogene homolog [KO:K07831]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "7248  TSC1; TSC complex subunit 1 [KO:K07206]", "7249  TSC2; TSC complex subunit 2 [KO:K07207]", "6009  RHEB; Ras homolog, mTORC1 binding [KO:K07208]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "5728  PTEN; phosphatase and tensin homolog [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]", "23411  SIRT1; sirtuin 1 [KO:K11411] [EC:2.3.1.286]", "890  CCNA2; cyclin A2 [KO:K06627]", "8900  CCNA1; cyclin A1 [KO:K06627]", "4605  MYBL2; MYB proto-oncogene like 2 [KO:K21769]", "286826  LIN9; lin-9 DREAM MuvB core complex component [KO:K21773]", "55957  LIN37; lin-37 DREAM MuvB core complex component [KO:K21774]", "91750  LIN52; lin-52 DREAM MuvB core complex component [KO:K21775]", "132660  LIN54; lin-54 DREAM MuvB core complex component [KO:K21776]", "5928  RBBP4; RB binding protein 4, chromatin remodeling factor [KO:K10752]", "2305  FOXM1; forkhead box M1 [KO:K09406]", "4609  MYC; MYC proto-oncogene, bHLH transcription factor [KO:K04377]", "1029  CDKN2A; cyclin dependent kinase inhibitor 2A [KO:K06621]", "4193  MDM2; MDM2 proto-oncogene [KO:K06643] [EC:2.3.2.27]", "7157  TP53; tumor protein p53 [KO:K04451]", "83593  RASSF5; Ras association domain family member 5 [KO:K08015]", "8945  BTRC; beta-transducin repeat containing E3 ubiquitin protein ligase [KO:K03362]", "23291  FBXW11; F-box and WD repeat domain containing 11 [KO:K03362]", "10114  HIPK3; homeodomain interacting protein kinase 3 [KO:K08826] [EC:2.7.11.1]", "204851  HIPK1; homeodomain interacting protein kinase 1 [KO:K08826] [EC:2.7.11.1]", "28996  HIPK2; homeodomain interacting protein kinase 2 [KO:K08826] [EC:2.7.11.1]", "147746  HIPK4; homeodomain interacting protein kinase 4 [KO:K08826] [EC:2.7.11.1]", "5499  PPP1CA; protein phosphatase 1 catalytic subunit alpha [KO:K06269] [EC:3.1.3.16]", "5500  PPP1CB; protein phosphatase 1 catalytic subunit beta [KO:K06269] [EC:3.1.3.16]", "5501  PPP1CC; protein phosphatase 1 catalytic subunit gamma [KO:K06269] [EC:3.1.3.16]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "2113  ETS1; ETS proto-oncogene 1, transcription factor [KO:K02678]", "5606  MAP2K3; mitogen-activated protein kinase kinase 3 [KO:K04432] [EC:2.7.12.2]", "5608  MAP2K6; mitogen-activated protein kinase kinase 6 [KO:K04433] [EC:2.7.12.2]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "1647  GADD45A; growth arrest and DNA damage inducible alpha [KO:K04402]", "4616  GADD45B; growth arrest and DNA damage inducible beta [KO:K04402]", "10912  GADD45G; growth arrest and DNA damage inducible gamma [KO:K04402]", "983  CDK1; cyclin dependent kinase 1 [KO:K02087] [EC:2.7.11.22 2.7.11.23]", "891  CCNB1; cyclin B1 [KO:K05868]", "9133  CCNB2; cyclin B2 [KO:K21770]", "85417  CCNB3; cyclin B3 [KO:K21771]", "4361  MRE11; MRE11 homolog, double strand break repair nuclease [KO:K10865]", "10111  RAD50; RAD50 double strand break repair protein [KO:K10866] [EC:3.6.-.-]", "4683  NBN; nibrin [KO:K10867]", "472  ATM; ATM serine/threonine kinase [KO:K04728] [EC:2.7.11.1]", "11200  CHEK2; checkpoint kinase 2 [KO:K06641] [EC:2.7.11.1]", "5883  RAD9A; RAD9 checkpoint clamp component A [KO:K10994] [EC:3.1.11.2]", "144715  RAD9B; RAD9 checkpoint clamp component B [KO:K10995]", "5810  RAD1; RAD1 checkpoint DNA exonuclease [KO:K02830] [EC:3.1.11.2]", "3364  HUS1; HUS1 checkpoint clamp component [KO:K10903]", "545  ATR; ATR serine/threonine kinase [KO:K06640] [EC:2.7.11.1]", "1111  CHEK1; checkpoint kinase 1 [KO:K02216] [EC:2.7.11.1]", "993  CDC25A; cell division cycle 25A [KO:K06645] [EC:3.1.3.48]", "8878  SQSTM1; sequestosome 1 [KO:K14381]", "2626  GATA4; GATA binding protein 4 [KO:K09183]", "10758  TRAF3IP2; TRAF3 interacting protein 2 [KO:K21124]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "3552  IL1A; interleukin 1 alpha [KO:K04383]", "3569  IL6; interleukin 6 [KO:K05405]", "3576  CXCL8; C-X-C motif chemokine ligand 8 [KO:K10030]", "3486  IGFBP3; insulin like growth factor binding protein 3 [KO:K10138]", "5054  SERPINE1; serpin family E member 1 [KO:K03982]", "1978  EIF4EBP1; eukaryotic translation initiation factor 4E binding protein 1 [KO:K07205]", "9261  MAPKAPK2; MAPK activated protein kinase 2 [KO:K04443] [EC:2.7.11.1]", "677  ZFP36L1; ZFP36 ring finger protein like 1 [KO:K18753]", "678  ZFP36L2; ZFP36 ring finger protein like 2 [KO:K18753]", "776  CACNA1D; calcium voltage-gated channel subunit alpha1 D [KO:K04851]", "59341  TRPV4; transient receptor potential cation channel subfamily V member 4 [KO:K04973]", "54822  TRPM7; transient receptor potential cation channel subfamily M member 7 [KO:K04982] [EC:2.7.11.1]", "823  CAPN1; calpain 1 [KO:K01367] [EC:3.4.22.52]", "824  CAPN2; calpain 2 [KO:K03853] [EC:3.4.22.53]", "810  CALML3; calmodulin like 3 [KO:K02183]", "805  CALM2; calmodulin 2 [KO:K02183]", "808  CALM3; calmodulin 3 [KO:K02183]", "801  CALM1; calmodulin 1 [KO:K02183]", "163688  CALML6; calmodulin like 6 [KO:K02183]", "51806  CALML5; calmodulin like 5 [KO:K02183]", "91860  CALML4; calmodulin like 4 [KO:K02183]", "5530  PPP3CA; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]", "5532  PPP3CB; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]", "5533  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]", "5534  PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]", "5535  PPP3R2; protein phosphatase 3 regulatory subunit B, beta [KO:K06268]", "4772  NFATC1; nuclear factor of activated T cells 1 [KO:K04446]", "4773  NFATC2; nuclear factor of activated T cells 2 [KO:K17332]", "4775  NFATC3; nuclear factor of activated T cells 3 [KO:K17333]", "4776  NFATC4; nuclear factor of activated T cells 4 [KO:K17334]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "291  SLC25A4; solute carrier family 25 member 4 [KO:K05863]", "292  SLC25A5; solute carrier family 25 member 5 [KO:K05863]", "293  SLC25A6; solute carrier family 25 member 6 [KO:K05863]", "83447  SLC25A31; solute carrier family 25 member 31 [KO:K05863]", "5481  PPID; peptidylprolyl isomerase D [KO:K05864] [EC:5.2.1.8]", "7416  VDAC1; voltage dependent anion channel 1 [KO:K05862]", "7417  VDAC2; voltage dependent anion channel 2 [KO:K15040]", "7419  VDAC3; voltage dependent anion channel 3 [KO:K15041]", "90550  MCU; mitochondrial calcium uniporter [KO:K20858]"], "compound": ["C00027  Hydrogen peroxide", "C00076  Calcium cation", "C05981  Phosphatidylinositol-3,4,5-trisphosphate", "C07909  Sirolimus", "C16844  Hydroxyl radical"], "refs": [{"pmid": "24954210", "authors": "  Munoz-Espin D, Serrano M", "title": "Cellular senescence: from physiology to pathology.", "journal": "Nat Rev Mol Cell Biol 15:482-96 (2014)", "doi": "10.1038/nrm3823"}, {"pmid": "26646499", "authors": "  Childs BG, Durik M, Baker DJ, van Deursen JM", "title": "Cellular senescence in aging and age-related disease: from mechanisms to therapy.", "journal": "Nat Med 21:1424-35 (2015)", "doi": "10.1038/nm.4000"}, {"pmid": "26105537", "authors": "  Sharpless NE, Sherr CJ", "title": "Forging a signature of in vivo senescence.", "journal": "Nat Rev Cancer 15:397-408 (2015)", "doi": "10.1038/nrc3960"}, {"pmid": "26435346", "authors": "  Fridlyanskaya I, Alekseenko L, Nikolsky N", "title": "Senescence as a general cellular response to stress: A mini-review.", "journal": "Exp Gerontol 72:124-8 (2015)", "doi": "10.1016/j.exger.2015.09.021"}, {"pmid": "27417123", "authors": "  Lujambio A", "title": "To clear, or not to clear (senescent cells)? That is the question.", "journal": "Bioessays 38 Suppl 1:S56-64 (2016)", "doi": "10.1002/bies.201670910"}, {"pmid": "26564316", "authors": "  Di Mitri D, Alimonti A", "title": "Non-Cell-Autonomous Regulation of Cellular Senescence in Cancer.", "journal": "Trends Cell Biol 26:215-26 (2016)", "doi": "10.1016/j.tcb.2015.10.005"}, {"pmid": "27574725", "authors": "  Francica P, Aebersold DM, Medova M", "title": "Senescence as biologic endpoint following pharmacological targeting of receptor tyrosine kinases in cancer.", "journal": "Biochem Pharmacol 126:1-12 (2017)", "doi": "10.1016/j.bcp.2016.08.022"}, {"pmid": "23982440", "authors": "  Bartling B", "title": "Cellular senescence in normal and premature lung aging.", "journal": "Z Gerontol Geriatr 46:613-22 (2013)", "doi": "10.1007/s00391-013-0543-3"}, {"pmid": "24238962", "authors": "  Munoz-Espin D, Canamero M, Maraver A, Gomez-Lopez G, Contreras J, Murillo-Cuesta S, Rodriguez-Baeza A, Varela-Nieto I, Ruberte J, Collado M, Serrano M", "title": "Programmed cell senescence during mammalian embryonic development.", "journal": "Cell 155:1104-18 (2013)", "doi": "10.1016/j.cell.2013.10.019"}, {"pmid": "26697828", "authors": "  Herranz N, Gallage S, Gil J", "title": "TORn about SASP regulation.", "journal": "Cell Cycle 14:3771-2 (2015)", "doi": "10.1080/15384101.2015.1105694"}, {"pmid": "28410770", "authors": "  Martin N, Bernard D", "title": "Calcium signaling and cellular senescence.", "journal": "Cell Calcium S0143-4160(17)30049-0 (2017)", "doi": "10.1016/j.ceca.2017.04.001"}, {"pmid": "25764980", "authors": "  Farfariello V, Iamshanova O, Germain E, Fliniaux I, Prevarskaya N", "title": "Calcium homeostasis in cancer: A focus on senescence.", "journal": "Biochim Biophys Acta 1853:1974-9 (2015)", "doi": "10.1016/j.bbamcr.2015.03.005"}, {"pmid": "24062309", "authors": "  McCarthy DA, Clark RR, Bartling TR, Trebak M, Melendez JA", "title": "Redox control of the senescence regulator interleukin-1alpha and the secretory phenotype.", "journal": "J Biol Chem 288:32149-59 (2013)", "doi": "10.1074/jbc.M113.493841"}, {"pmid": "27288568", "authors": "  Donninger H, Schmidt ML, Mezzanotte J, Barnoud T, Clark GJ", "title": "Ras signaling through RASSF proteins.", "journal": "Semin Cell Dev Biol 58:86-95 (2016)", "doi": "10.1016/j.semcdb.2016.06.007"}, {"pmid": "28455242", "authors": "  Barnoud T, Schmidt ML, Donninger H, Clark GJ", "title": "The role of the NORE1A tumor suppressor in Oncogene-Induced Senescence.", "journal": "Cancer Lett 400:30-36 (2017)", "doi": "10.1016/j.canlet.2017.04.030"}, {"pmid": "26404840", "authors": "  Kang C, Xu Q, Martin TD, Li MZ, Demaria M, Aron L, Lu T, Yankner BA, Campisi J, Elledge SJ", "title": "The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4.", "journal": "Science 349:aaa5612 (2015)", "doi": "10.1126/science.aaa5612"}, {"pmid": "26777575", "authors": "  Cao X, Li M", "title": "A New Pathway for Senescence Regulation.", "journal": "Genomics Proteomics Bioinformatics 13:333-5 (2015)", "doi": "10.1016/j.gpb.2015.11.002"}, {"pmid": "25564883", "authors": "  Gire V, Dulic V", "title": "Senescence from G2 arrest, revisited.", "journal": "Cell Cycle 14:297-304 (2015)", "doi": "10.1080/15384101.2014.1000134"}, {"pmid": "24981831", "authors": "  Mowla SN, Lam EW, Jat PS", "title": "Cellular senescence and aging: the role of B-MYB.", "journal": "Aging Cell 13:773-9 (2014)", "doi": "10.1111/acel.12242"}, {"pmid": "22546858", "authors": "  Yao H, Chung S, Hwang JW, Rajendrasozhan S, Sundar IK, Dean DA, McBurney MW, Guarente L, Gu W, Ronty M, Kinnula VL, Rahman I", "title": "SIRT1 protects against emphysema via FOXO3-mediated reduction of premature senescence in mice.", "journal": "J Clin Invest 122:2032-45 (2012)", "doi": "10.1172/JCI60132"}], "rel_pathway": ["hsa04020  Calcium signaling pathway", "hsa04068  FoxO signaling pathway", "hsa04110  Cell cycle", "hsa04115  p53 signaling pathway", "hsa04150  mTOR signaling pathway"], "ko_pathway": "ko04218", "genes": ["PTEN", "TP53", "AKT2", "AKT1", "MAPK13", "NRAS"]}, {"kegg_id": "hsa04510", "name": "Focal adhesion - Homo sapiens (human)", "description": "Cell-matrix adhesions play essential roles in important biological processes including cell motility, cell proliferation, cell differentiation, regulation of gene expression and cell survival. At the cell-extracellular matrix contact points, specialized structures are formed and termed focal adhesions, where bundles of actin filaments are anchored to transmembrane receptors of the integrin family through a multi-molecular complex of junctional plaque proteins. Some of the constituents of focal adhesions participate in the structural link between membrane receptors and the actin cytoskeleton, while others are signalling molecules, including different protein kinases and phosphatases, their substrates, and various adapter proteins. Integrin signaling is dependent upon the non-receptor tyrosine kinase activities of the FAK and src proteins as well as the adaptor protein functions of FAK, src and Shc to initiate downstream signaling events. These signalling events culminate in reorganization of the actin cytoskeleton; a prerequisite for changes in cell shape and motility, and gene expression. Similar morphological alterations and modulation of gene expression are initiated by the binding of growth factors to their respective receptors, emphasizing the considerable crosstalk between adhesion- and growth factor-mediated signalling.", "class": "Cellular Processes; Cellular community - eukaryotes", "pathway_map": "hsa04510  Focal adhesion", "network": ["", "ELEMENT   N00393  ITGA/B-RhoGAP-RhoA signaling pathway", "N01068  ITGA/B-FAK-RAC signaling pathway", "N01080  ITGA/B-TALIN/VINCULIN signaling pathway"], "drug": ["D03065  Becaplermin (USAN/INN)", "D03497  Cilengitide (USAN/INN)", "D04660  Lamifiban hydrochloride (USAN)", "D05819  Semaxanib (USAN/INN)", "D06319  Volociximab (USAN)", "D06590  Firategrast (USAN)", "D09328  Cixutumumab (USAN)", "D09342  Etaracizumab (USAN/INN)", "D09618  Foretinib (USAN/INN)", "D09631  Intetumumab (USAN/INN)", "D09659  Rilotumumab (USAN/INN)", "D09746  Dalotuzumab (USAN)", "D09908  Ganitumab (USAN/INN)", "D09925  Linsitinib (USAN/INN)", "D09926  Icrucumab (USAN/INN)", "D09929  Maraciclatide (USAN/INN)", "D09941  Onartuzumab (USAN/INN)", "D09945  Pegdinetanib (USAN/INN)", "D10028  Valategrast hydrochloride (USAN)", "D10056  Robatumumab (USAN/INN)", "D10123  Ficlatuzumab (USAN)", "D10173  Tivantinib (JAN/USAN/INN)", "D10190  Tivozanib hydrochloride (USAN)", "D11307  Telisotuzumab (USAN)", "D11344  Telisotuzumab vedotin (USAN)", "D11894  Amivantamab (USAN/INN)", "D11977  Fruquintinib (JAN/USAN)", "D12398  Oremepermin alfa (USAN/INN)", "D12635  Sozinibercept (USAN/INN)", "D12722  Bexotegrast (USAN/INN)"], "dblinks": "GO: 0005925", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["1277  COL1A1; collagen type I alpha 1 chain [KO:K06236]", "1278  COL1A2; collagen type I alpha 2 chain [KO:K06236]", "1280  COL2A1; collagen type II alpha 1 chain [KO:K19719]", "1284  COL4A2; collagen type IV alpha 2 chain [KO:K06237]", "1286  COL4A4; collagen type IV alpha 4 chain [KO:K06237]", "1288  COL4A6; collagen type IV alpha 6 chain [KO:K06237]", "1282  COL4A1; collagen type IV alpha 1 chain [KO:K06237]", "1287  COL4A5; collagen type IV alpha 5 chain [KO:K06237]", "1285  COL4A3; collagen type IV alpha 3 chain [KO:K06237]", "1291  COL6A1; collagen type VI alpha 1 chain [KO:K06238]", "1292  COL6A2; collagen type VI alpha 2 chain [KO:K06238]", "1293  COL6A3; collagen type VI alpha 3 chain [KO:K06238]", "131873  COL6A6; collagen type VI alpha 6 chain [KO:K06238]", "256076  COL6A5; collagen type VI alpha 5 chain [KO:K06238]", "1297  COL9A1; collagen type IX alpha 1 chain [KO:K08131]", "1298  COL9A2; collagen type IX alpha 2 chain [KO:K08131]", "1299  COL9A3; collagen type IX alpha 3 chain [KO:K08131]", "284217  LAMA1; laminin subunit alpha 1 [KO:K05637]", "3908  LAMA2; laminin subunit alpha 2 [KO:K05637]", "3909  LAMA3; laminin subunit alpha 3 [KO:K06240]", "3911  LAMA5; laminin subunit alpha 5 [KO:K06240]", "3910  LAMA4; laminin subunit alpha 4 [KO:K06241]", "3912  LAMB1; laminin subunit beta 1 [KO:K05636]", "3913  LAMB2; laminin subunit beta 2 [KO:K06243]", "3914  LAMB3; laminin subunit beta 3 [KO:K06244]", "22798  LAMB4; laminin subunit beta 4 [KO:K06245]", "3915  LAMC1; laminin subunit gamma 1 [KO:K05635]", "3918  LAMC2; laminin subunit gamma 2 [KO:K06246]", "10319  LAMC3; laminin subunit gamma 3 [KO:K06247]", "1101  CHAD; chondroadherin [KO:K06248]", "5649  RELN; reelin [KO:K06249] [EC:3.4.21.-]", "7057  THBS1; thrombospondin 1 [KO:K16857]", "1311  COMP; cartilage oligomeric matrix protein [KO:K04659]", "7058  THBS2; thrombospondin 2 [KO:K04659]", "7059  THBS3; thrombospondin 3 [KO:K04659]", "7060  THBS4; thrombospondin 4 [KO:K04659]", "2335  FN1; fibronectin 1 [KO:K05717]", "6696  SPP1; secreted phosphoprotein 1 [KO:K06250]", "7448  VTN; vitronectin [KO:K06251]", "3371  TNC; tenascin C [KO:K06252]", "63923  TNN; tenascin N [KO:K06252]", "7143  TNR; tenascin R [KO:K06252]", "7148  TNXB; tenascin XB [KO:K06252]", "7450  VWF; von Willebrand factor [KO:K03900]", "3381  IBSP; integrin binding sialoprotein [KO:K06253]", "3672  ITGA1; integrin subunit alpha 1 [KO:K06480]", "3673  ITGA2; integrin subunit alpha 2 [KO:K06481]", "3674  ITGA2B; integrin subunit alpha 2b [KO:K06476]", "3675  ITGA3; integrin subunit alpha 3 [KO:K06482]", "3676  ITGA4; integrin subunit alpha 4 [KO:K06483]", "3678  ITGA5; integrin subunit alpha 5 [KO:K06484]", "3655  ITGA6; integrin subunit alpha 6 [KO:K06485]", "3679  ITGA7; integrin subunit alpha 7 [KO:K06583]", "8516  ITGA8; integrin subunit alpha 8 [KO:K06584]", "3680  ITGA9; integrin subunit alpha 9 [KO:K06585]", "8515  ITGA10; integrin subunit alpha 10 [KO:K06586]", "22801  ITGA11; integrin subunit alpha 11 [KO:K06587]", "3685  ITGAV; integrin subunit alpha V [KO:K06487]", "3688  ITGB1; integrin subunit beta 1 [KO:K05719]", "3690  ITGB3; integrin subunit beta 3 [KO:K06493]", "3691  ITGB4; integrin subunit beta 4 [KO:K06525]", "3693  ITGB5; integrin subunit beta 5 [KO:K06588]", "3694  ITGB6; integrin subunit beta 6 [KO:K06589]", "3695  ITGB7; integrin subunit beta 7 [KO:K06590]", "3696  ITGB8; integrin subunit beta 8 [KO:K06591]", "2013  EMP2; epithelial membrane protein 2 [KO:K26256]", "5154  PDGFA; platelet derived growth factor subunit A [KO:K04359]", "5155  PDGFB; platelet derived growth factor subunit B [KO:K17386]", "56034  PDGFC; platelet derived growth factor C [KO:K05450]", "80310  PDGFD; platelet derived growth factor D [KO:K05450]", "1950  EGF; epidermal growth factor [KO:K04357]", "3479  IGF1; insulin like growth factor 1 [KO:K05459]", "7422  VEGFA; vascular endothelial growth factor A [KO:K05448]", "7423  VEGFB; vascular endothelial growth factor B [KO:K16858]", "5228  PGF; placental growth factor [KO:K16859]", "7424  VEGFC; vascular endothelial growth factor C [KO:K05449]", "2277  VEGFD; vascular endothelial growth factor D [KO:K05449]", "3082  HGF; hepatocyte growth factor [KO:K05460]", "5156  PDGFRA; platelet derived growth factor receptor alpha [KO:K04363] [EC:2.7.10.1]", "5159  PDGFRB; platelet derived growth factor receptor beta [KO:K05089] [EC:2.7.10.1]", "3480  IGF1R; insulin like growth factor 1 receptor [KO:K05087] [EC:2.7.10.1]", "3791  KDR; kinase insert domain receptor [KO:K05098] [EC:2.7.10.1]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "2321  FLT1; fms related receptor tyrosine kinase 1 [KO:K05096] [EC:2.7.10.1]", "2324  FLT4; fms related receptor tyrosine kinase 4 [KO:K05097] [EC:2.7.10.1]", "4233  MET; MET proto-oncogene, receptor tyrosine kinase [KO:K05099] [EC:2.7.10.1]", "2064  ERBB2; erb-b2 receptor tyrosine kinase 2 [KO:K05083] [EC:2.7.10.1]", "2012  EMP1; epithelial membrane protein 1 [KO:K26255]", "6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "2909  ARHGAP35; Rho GTPase activating protein 35 [KO:K05732]", "394  ARHGAP5; Rho GTPase activating protein 5 [KO:K13709]", "387  RHOA; ras homolog family member A [KO:K04513]", "1729  DIAPH1; diaphanous related formin 1 [KO:K05740]", "6093  ROCK1; Rho associated coiled-coil containing protein kinase 1 [KO:K04514] [EC:2.7.11.1]", "9475  ROCK2; Rho associated coiled-coil containing protein kinase 2 [KO:K17388] [EC:2.7.11.1]", "4633  MYL2; myosin light chain 2 [KO:K10351]", "4636  MYL5; myosin light chain 5 [KO:K12753]", "58498  MYL7; myosin light chain 7 [KO:K12754]", "10398  MYL9; myosin light chain 9 [KO:K12755]", "93408  MYL10; myosin light chain 10 [KO:K12756]", "103910  MYL12B; myosin light chain 12B [KO:K12757]", "10627  MYL12A; myosin light chain 12A [KO:K12757]", "29895  MYL11; myosin light chain 11 [KO:K12758]", "5499  PPP1CA; protein phosphatase 1 catalytic subunit alpha [KO:K06269] [EC:3.1.3.16]", "5500  PPP1CB; protein phosphatase 1 catalytic subunit beta [KO:K06269] [EC:3.1.3.16]", "5501  PPP1CC; protein phosphatase 1 catalytic subunit gamma [KO:K06269] [EC:3.1.3.16]", "4659  PPP1R12A; protein phosphatase 1 regulatory subunit 12A [KO:K06270]", "4660  PPP1R12B; protein phosphatase 1 regulatory subunit 12B [KO:K12329]", "54776  PPP1R12C; protein phosphatase 1 regulatory subunit 12C [KO:K17457]", "4638  MYLK; myosin light chain kinase [KO:K00907] [EC:2.7.11.18]", "85366  MYLK2; myosin light chain kinase 2 [KO:K00907] [EC:2.7.11.18]", "91807  MYLK3; myosin light chain kinase 3 [KO:K00907] [EC:2.7.11.18]", "340156  MYLK4; myosin light chain kinase family member 4 [KO:K00907] [EC:2.7.11.18]", "23396  PIP5K1C; phosphatidylinositol-4-phosphate 5-kinase type 1 gamma [KO:K00889] [EC:2.7.1.68]", "8394  PIP5K1A; phosphatidylinositol-4-phosphate 5-kinase type 1 alpha [KO:K00889] [EC:2.7.1.68]", "8395  PIP5K1B; phosphatidylinositol-4-phosphate 5-kinase type 1 beta [KO:K00889] [EC:2.7.1.68]", "71  ACTG1; actin gamma 1 [KO:K05692]", "60  ACTB; actin beta [KO:K05692]", "5923  RASGRF1; Ras protein specific guanine nucleotide releasing factor 1 [KO:K04349]", "824  CAPN2; calpain 2 [KO:K03853] [EC:3.4.22.53]", "87  ACTN1; actinin alpha 1 [KO:K05699]", "81  ACTN4; actinin alpha 4 [KO:K05699]", "7094  TLN1; talin 1 [KO:K06271]", "83660  TLN2; talin 2 [KO:K06271]", "2316  FLNA; filamin A [KO:K04437]", "2317  FLNB; filamin B [KO:K27392]", "5829  PXN; paxillin [KO:K05760]", "3611  ILK; integrin linked kinase [KO:K06272] [EC:2.7.11.1]", "7791  ZYX; zyxin [KO:K06273]", "7408  VASP; vasodilator stimulated phosphoprotein [KO:K06274]", "7414  VCL; vinculin [KO:K05700]", "29780  PARVB; parvin beta [KO:K06275]", "55742  PARVA; parvin alpha [KO:K06275]", "64098  PARVG; parvin gamma [KO:K06275]", "5170  PDPK1; 3-phosphoinositide dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "1499  CTNNB1; catenin beta 1 [KO:K02105]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "5747  PTK2; protein tyrosine kinase 2 [KO:K05725] [EC:2.7.10.2]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5728  PTEN; phosphatase and tensin homolog [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]", "10451  VAV3; vav guanine nucleotide exchange factor 3 [KO:K05730]", "7409  VAV1; vav guanine nucleotide exchange factor 1 [KO:K05730]", "7410  VAV2; vav guanine nucleotide exchange factor 2 [KO:K05730]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "5880  RAC2; Rac family small GTPase 2 [KO:K07860]", "5881  RAC3; Rac family small GTPase 3 [KO:K07861]", "5058  PAK1; p21 (RAC1) activated kinase 1 [KO:K04409] [EC:2.7.11.1]", "5062  PAK2; p21 (RAC1) activated kinase 2 [KO:K04410] [EC:2.7.11.1]", "5063  PAK3; p21 (RAC1) activated kinase 3 [KO:K05733] [EC:2.7.11.1]", "10298  PAK4; p21 (RAC1) activated kinase 4 [KO:K05734] [EC:2.7.11.1]", "57144  PAK5; p21 (RAC1) activated kinase 5 [KO:K05736] [EC:2.7.11.1]", "56924  PAK6; p21 (RAC1) activated kinase 6 [KO:K05735] [EC:2.7.11.1]", "106821730  BUB1B-PAK6; BUB1B-PAK6 readthrough [KO:K05735] [EC:2.7.11.1]", "998  CDC42; cell division cycle 42 [KO:K04393]", "9564  BCAR1; BCAR1 scaffold protein, Cas family member [KO:K05726]", "1398  CRK; CRK proto-oncogene, adaptor protein [KO:K04438]", "1399  CRKL; CRK like proto-oncogene, adaptor protein [KO:K04438]", "1793  DOCK1; dedicator of cytokinesis 1 [KO:K13708]", "2889  RAPGEF1; Rap guanine nucleotide exchange factor 1 [KO:K06277]", "5906  RAP1A; RAP1A, member of RAS oncogene family [KO:K04353]", "5908  RAP1B; RAP1B, member of RAS oncogene family [KO:K07836]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "857  CAV1; caveolin 1 [KO:K06278]", "858  CAV2; caveolin 2 [KO:K12958]", "859  CAV3; caveolin 3 [KO:K12959]", "2534  FYN; FYN proto-oncogene, Src family tyrosine kinase [KO:K05703] [EC:2.7.10.2]", "6464  SHC1; SHC adaptor protein 1 [KO:K06279]", "25759  SHC2; SHC adaptor protein 2 [KO:K17447]", "53358  SHC3; SHC adaptor protein 3 [KO:K17448]", "399694  SHC4; SHC adaptor protein 4 [KO:K17449]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "2002  ELK1; ETS transcription factor ELK1 [KO:K04375]", "595  CCND1; cyclin D1 [KO:K04503]", "894  CCND2; cyclin D2 [KO:K10151]", "896  CCND3; cyclin D3 [KO:K10152]", "329  BIRC2; baculoviral IAP repeat containing 2 [KO:K16060]", "330  BIRC3; baculoviral IAP repeat containing 3 [KO:K16060]", "331  XIAP; X-linked inhibitor of apoptosis [KO:K04725] [EC:2.3.2.27]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]"], "compound": ["C04637  1-Phosphatidyl-D-myo-inositol 4,5-bisphosphate", "C05981  Phosphatidylinositol-3,4,5-trisphosphate"], "refs": [{"pmid": "14756624", "authors": "  Berman AE, Kozlova NI, Morozevich GE.", "title": "Integrins: structure and signaling.", "journal": "Biochemistry (Mosc) 68:1284-99 (2003)", "doi": "10.1023/b:biry.0000011649.03634.74"}, {"pmid": "11573199", "authors": "  Danen EH, Yamada KM.", "title": "Fibronectin, integrins, and growth control.", "journal": "J Cell Physiol 189:1-13 (2001)", "doi": "10.1002/jcp.1137"}, {"pmid": "15459662", "authors": "  Guo W, Giancotti FG.", "title": "Integrin signalling during tumour progression.", "journal": "Nat Rev Mol Cell Biol 5:816-26 (2004)", "doi": "10.1038/nrm1490"}, {"pmid": "11229600", "authors": "  Petit V, Thiery JP.", "title": "Focal adhesions: structure and dynamics.", "journal": "Biol Cell 92:477-94 (2000)", "doi": "10.1016/S0248-4900(00)01101-1"}, {"pmid": "12235283", "authors": "  Stupack DG, Cheresh DA.", "title": "Get a ligand, get a life: integrins, signaling and cell survival.", "journal": "J Cell Sci 115:3729-38 (2002)", "doi": "10.1242/jcs.00071"}, {"pmid": "12640026", "authors": "  Parsons JT.", "title": "Focal adhesion kinase: the first ten years.", "journal": "J Cell Sci 116:1409-16 (2003)", "doi": "10.1242/jcs.00373"}, {"pmid": "15688067", "authors": "  Mitra SK, Hanson DA, Schlaepfer DD.", "title": "Focal adhesion kinase: in command and control of cell motility.", "journal": "Nat Rev Mol Cell Biol 6:56-68 (2005)", "doi": "10.1038/nrm1549"}, {"pmid": "14519391", "authors": "  Comoglio PM, Boccaccio C, Trusolino L.", "title": "Interactions between growth factor receptors and adhesion molecules: breaking the rules.", "journal": "Curr Opin Cell Biol 15:565-71 (2003)", "doi": "10.1016/S0955-0674(03)00096-6"}, {"pmid": "15108811", "authors": "  Schlaepfer DD, Mitra SK.", "title": "Multiple connections link FAK to cell motility and invasion.", "journal": "Curr Opin Genet Dev 14:92-101 (2004)", "doi": "10.1016/j.gde.2003.12.002"}, {"pmid": "14744429", "authors": "  Burridge K, Wennerberg K.", "title": "Rho and Rac take center stage.", "journal": "Cell 116:167-79 (2004)", "doi": "10.1016/S0092-8674(04)00003-0"}, {"pmid": "11082269", "authors": "  Schmitz AA, Govek EE, Bottner B, Van Aelst L.", "title": "Rho GTPases: signaling, migration, and invasion.", "journal": "Exp Cell Res 261:1-12 (2000)", "doi": "10.1006/excr.2000.5049"}, {"pmid": "10698680", "authors": "  Vanhaesebroeck B, Alessi DR.", "title": "The PI3K-PDK1 connection: more than just a road to PKB.", "journal": "Biochem J 346 Pt 3:561-76 (2000)", "doi": "10.1042/bj3460561"}, {"pmid": "11882383", "authors": "  Nicholson KM, Anderson NG.", "title": "The protein kinase B/Akt signalling pathway in human malignancy.", "journal": "Cell Signal 14:381-95 (2002)", "doi": "10.1016/S0898-6568(01)00271-6"}, {"pmid": "15053919", "authors": "  Oloumi A, McPhee T, Dedhar S.", "title": "Regulation of E-cadherin expression and beta-catenin/Tcf transcriptional activity by the integrin-linked kinase.", "journal": "Biochim Biophys Acta 1691:1-15 (2004)", "doi": "10.1016/j.bbamcr.2003.12.002"}, {"pmid": "11146675", "authors": "  Turner CE.", "title": "Paxillin and focal adhesion signalling.", "journal": "Nat Cell Biol 2:E231-6 (2000)", "doi": "10.1038/35046659"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04060  Cytokine-cytokine receptor interaction", "hsa04070  Phosphatidylinositol signaling system", "hsa04110  Cell cycle", "hsa04151  PI3K-Akt signaling pathway", "hsa04310  Wnt signaling pathway", "hsa04512  ECM-receptor interaction", "hsa04810  Regulation of actin cytoskeleton"], "ko_pathway": "ko04510", "genes": ["PTEN", "EGFR", "RAC1", "BRAF", "AKT2", "MET", "TNN", "BIRC3", "AKT1", "PGF", "SOS1", "KDR"]}, {"kegg_id": "hsa04931", "name": "Insulin resistance - Homo sapiens (human)", "description": "Insulin resistance is a condition where cells become resistant to the effects of insulin. It is often found in people with health disorders, including obesity, type 2 diabetes mellitus, non-alcoholic fatty liver disease, and cardiovascular diseases. In this diagram multiple mechanisms underlying insulin resistance are shown: (a) increased phosphorylation of IRS (insulin receptor substrate) protein through serine/threonine kinases, such as JNK1 and IKKB, and protein kinase C, (b) increased IRS-1 proteasome degradation via mTOR signaling pathway, (c) decreased activation of signaling molecules including PI3K and AKT, (d) increase in activity of phosphatases including PTPs, PTEN, and PP2A. Regulatory actions such as oxidative stress, mitochondrial dysfunction, accumulation of intracellular lipid derivatives (diacylglycrol and ceramides), and inflammation (via IL-6 and TNFA) contribute to these mechanisms. Consequently, insulin resistance causes reduced GLUT4 translocation, resulting in glucose takeup and glycogen synthesis in skeletal muscle as well as increased hepatic gluconeogenesis and decreased glycogen synthesis in liver. At the bottom of the diagram, interplay between O-GlcNAcylation and serine/threonine phosphorylation is shown. Studies suggested that elevated O-GlcNAc level was correlated to high glucose-induced insulin resistance. Donor UDP-GlcNAc is induced through hexosamine biosynthesis pathway and added to proteins by O-GlcNAc transferase. Elevation of O-GlcNAc modification alters phosphorylation and function of key insulin signaling proteins including IRS-1, PI3K, PDK1, Akt and other transcription factor and cofactors, resulting in the attenuation of insulin signaling cascade.", "class": "Human Diseases; Endocrine and metabolic disease", "pathway_map": "hsa04931  Insulin resistance", "network": ["", "ELEMENT   N01708  INS-AKT signaling pathway"], "drug": ["D04050  Ertiprotafib (USAN/INN)", "D06647  Sodelglitazar (USAN)", "D11034  Insulin glargine and lixisenatide", "D11567  Insulin degludec and liraglutide"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["3630  INS; insulin [KO:K04526]", "6197  RPS6KA3; ribosomal protein S6 kinase A3 [KO:K04373] [EC:2.7.11.1]", "6195  RPS6KA1; ribosomal protein S6 kinase A1 [KO:K04373] [EC:2.7.11.1]", "6196  RPS6KA2; ribosomal protein S6 kinase A2 [KO:K04373] [EC:2.7.11.1]", "27330  RPS6KA6; ribosomal protein S6 kinase A6 [KO:K04373] [EC:2.7.11.1]", "5499  PPP1CA; protein phosphatase 1 catalytic subunit alpha [KO:K06269] [EC:3.1.3.16]", "5500  PPP1CB; protein phosphatase 1 catalytic subunit beta [KO:K06269] [EC:3.1.3.16]", "5501  PPP1CC; protein phosphatase 1 catalytic subunit gamma [KO:K06269] [EC:3.1.3.16]", "5506  PPP1R3A; protein phosphatase 1 regulatory subunit 3A [KO:K07189]", "5507  PPP1R3C; protein phosphatase 1 regulatory subunit 3C [KO:K07189]", "5509  PPP1R3D; protein phosphatase 1 regulatory subunit 3D [KO:K07189]", "79660  PPP1R3B; protein phosphatase 1 regulatory subunit 3B [KO:K07189]", "90673  PPP1R3E; protein phosphatase 1 regulatory subunit 3E [KO:K07189]", "3643  INSR; insulin receptor [KO:K04527] [EC:2.7.10.1]", "3667  IRS1; insulin receptor substrate 1 [KO:K16172]", "5770  PTPN1; protein tyrosine phosphatase non-receptor type 1 [KO:K05696] [EC:3.1.3.48]", "5781  PTPN11; protein tyrosine phosphatase non-receptor type 11 [KO:K07293] [EC:3.1.3.48]", "5792  PTPRF; protein tyrosine phosphatase receptor type F [KO:K05695] [EC:3.1.3.48]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "6198  RPS6KB1; ribosomal protein S6 kinase B1 [KO:K04688] [EC:2.7.11.1]", "6199  RPS6KB2; ribosomal protein S6 kinase B2 [KO:K04688] [EC:2.7.11.1]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "3569  IL6; interleukin 6 [KO:K05405]", "6774  STAT3; signal transducer and activator of transcription 3 [KO:K04692]", "9021  SOCS3; suppressor of cytokine signaling 3 [KO:K04696]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "2998  GYS2; glycogen synthase 2 [KO:K00693] [EC:2.4.1.11]", "2997  GYS1; glycogen synthase 1 [KO:K00693] [EC:2.4.1.11]", "7124  TNF; tumor necrosis factor [KO:K03156]", "7132  TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "4846  NOS3; nitric oxide synthase 3 [KO:K13242] [EC:1.14.13.39]", "5590  PRKCZ; protein kinase C zeta [KO:K18952] [EC:2.7.11.13]", "9882  TBC1D4; TBC1 domain family member 4 [KO:K17902]", "6517  SLC2A4; solute carrier family 2 member 4 [KO:K07191]", "5562  PRKAA1; protein kinase AMP-activated catalytic subunit alpha 1 [KO:K07198] [EC:2.7.11.31]", "5563  PRKAA2; protein kinase AMP-activated catalytic subunit alpha 2 [KO:K07198] [EC:2.7.11.31]", "5564  PRKAB1; protein kinase AMP-activated non-catalytic subunit beta 1 [KO:K07199]", "5565  PRKAB2; protein kinase AMP-activated non-catalytic subunit beta 2 [KO:K07199]", "5571  PRKAG1; protein kinase AMP-activated non-catalytic subunit gamma 1 [KO:K07200]", "53632  PRKAG3; protein kinase AMP-activated non-catalytic subunit gamma 3 [KO:K07200]", "51422  PRKAG2; protein kinase AMP-activated non-catalytic subunit gamma 2 [KO:K07200]", "32  ACACB; acetyl-CoA carboxylase beta [KO:K01946] [EC:6.4.1.2 6.3.4.14 2.1.3.15]", "1375  CPT1B; carnitine palmitoyltransferase 1B [KO:K19523] [EC:2.3.1.21]", "183  AGT; angiotensinogen [KO:K09821]", "376497  SLC27A1; solute carrier family 27 member 1 [KO:K08745] [EC:6.2.1.-]", "10999  SLC27A4; solute carrier family 27 member 4 [KO:K08745] [EC:6.2.1.-]", "11001  SLC27A2; solute carrier family 27 member 2 [KO:K08746] [EC:6.2.1.- 6.2.1.3]", "11000  SLC27A3; solute carrier family 27 member 3 [KO:K08772] [EC:6.2.1.-]", "10998  SLC27A5; solute carrier family 27 member 5 [KO:K08748] [EC:6.2.1.7]", "28965  SLC27A6; solute carrier family 27 member 6 [KO:K08749]", "948  CD36; CD36 molecule (CD36 blood group) [KO:K06259]", "5588  PRKCQ; protein kinase C theta [KO:K18052] [EC:2.7.11.13]", "5580  PRKCD; protein kinase C delta [KO:K06068] [EC:2.7.11.13]", "5524  PTPA; protein phosphatase 2 phosphatase activator [KO:K17605]", "6720  SREBF1; sterol regulatory element binding transcription factor 1 [KO:K07197]", "8660  IRS2; insulin receptor substrate 2 [KO:K07187]", "57761  TRIB3; tribbles pseudokinase 3 [KO:K19518]", "5836  PYGL; glycogen phosphorylase L [KO:K00688] [EC:2.4.1.1]", "5837  PYGM; glycogen phosphorylase, muscle associated [KO:K00688] [EC:2.4.1.1]", "5834  PYGB; glycogen phosphorylase B [KO:K00688] [EC:2.4.1.1]", "2308  FOXO1; forkhead box O1 [KO:K07201]", "5105  PCK1; phosphoenolpyruvate carboxykinase 1 [KO:K01596] [EC:4.1.1.32]", "5106  PCK2; phosphoenolpyruvate carboxykinase 2, mitochondrial [KO:K01596] [EC:4.1.1.32]", "2538  G6PC1; glucose-6-phosphatase catalytic subunit 1 [KO:K01084] [EC:3.1.3.9]", "57818  G6PC2; glucose-6-phosphatase catalytic subunit 2 [KO:K01084] [EC:3.1.3.9]", "92579  G6PC3; glucose-6-phosphatase catalytic subunit 3 [KO:K01084] [EC:3.1.3.9]", "6514  SLC2A2; solute carrier family 2 member 2 [KO:K07593]", "10062  NR1H3; nuclear receptor subfamily 1 group H member 3 [KO:K08536]", "7376  NR1H2; nuclear receptor subfamily 1 group H member 2 [KO:K08535]", "133522  PPARGC1B; PPARG coactivator 1 beta [KO:K17962]", "6945  MLX; MAX dimerization protein MLX [KO:K09113]", "22877  MLXIP; MLX interacting protein [KO:K09113]", "51085  MLXIPL; MLX interacting protein like [KO:K09113]", "1374  CPT1A; carnitine palmitoyltransferase 1A [KO:K08765] [EC:2.3.1.21]", "5581  PRKCE; protein kinase C epsilon [KO:K18050] [EC:2.7.11.13]", "10891  PPARGC1A; PPARG coactivator 1 alpha [KO:K07202]", "5465  PPARA; peroxisome proliferator activated receptor alpha [KO:K07294]", "5170  PDPK1; 3-phosphoinositide dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]", "5728  PTEN; phosphatase and tensin homolog [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]", "10724  OGA; O-GlcNAcase [KO:K15719] [EC:3.2.1.169 2.3.1.48]", "8473  OGT; O-linked N-acetylglucosamine (GlcNAc) transferase [KO:K09667] [EC:2.4.1.255]", "6513  SLC2A1; solute carrier family 2 member 1 [KO:K07299]", "9945  GFPT2; glutamine-fructose-6-phosphate transaminase 2 [KO:K00820] [EC:2.6.1.16]", "2673  GFPT1; glutamine--fructose-6-phosphate transaminase 1 [KO:K00820] [EC:2.6.1.16]", "200186  CRTC2; CREB regulated transcription coactivator 2 [KO:K16333]", "1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]", "10488  CREB3; cAMP responsive element binding protein 3 [KO:K09048]", "90993  CREB3L1; cAMP responsive element binding protein 3 like 1 [KO:K09048]", "64764  CREB3L2; cAMP responsive element binding protein 3 like 2 [KO:K09048]", "84699  CREB3L3; cAMP responsive element binding protein 3 like 3 [KO:K09048]", "148327  CREB3L4; cAMP responsive element binding protein 3 like 4 [KO:K09048]", "9586  CREB5; cAMP responsive element binding protein 5 [KO:K09047]"], "compound": ["C00022  Pyruvate", "C00024  Acetyl-CoA", "C00031  D-Glucose", "C00043  UDP-N-acetyl-alpha-D-glucosamine", "C00083  Malonyl-CoA", "C00085  D-Fructose 6-phosphate", "C00092  D-Glucose 6-phosphate", "C00095  D-Fructose", "C00162  Fatty acid", "C00165  Diacylglycerol", "C00195  N-Acylsphingosine", "C00352  D-Glucosamine 6-phosphate", "C00369  Starch", "C00422  Triacylglycerol", "C00533  Nitric oxide", "C02571  O-Acetylcarnitine", "C02843  Long-chain acyl-CoA", "C05981  Phosphatidylinositol-3,4,5-trisphosphate", "C06156  alpha-D-Glucosamine 1-phosphate", "G00369"], "refs": [{"pmid": "22360800", "authors": "  Martins AR, Nachbar RT, Gorjao R, Vinolo MA, Festuccia WT, Lambertucci RH, Cury-Boaventura MF, Silveira LR, Curi R, Hirabara SM", "title": "Mechanisms underlying skeletal muscle insulin resistance induced by fatty acids: importance of the mitochondrial function.", "journal": "Lipids Health Dis 11:30 (2012)", "doi": "10.1186/1476-511X-11-30"}, {"pmid": "12765939", "authors": "  Bouzakri K, Roques M, Gual P, Espinosa S, Guebre-Egziabher F, Riou JP, Laville M, Le Marchand-Brustel Y, Tanti JF, Vidal H", "title": "Reduced activation of phosphatidylinositol-3 kinase and increased serine 636 phosphorylation of insulin receptor substrate-1 in primary culture of skeletal muscle cells from patients with type 2 diabetes.", "journal": "Diabetes 52:1319-25 (2003)", "doi": "10.2337/diabetes.52.6.1319"}, {"pmid": "20526383", "authors": "  Choi K, Kim YB", "title": "Molecular mechanism of insulin resistance in obesity and type 2 diabetes.", "journal": "Korean J Intern Med 25:119-29 (2010)", "doi": "10.3904/kjim.2010.25.2.119"}, {"pmid": "7666792", "authors": "  Ahmad F, Goldstein BJ", "title": "Increased abundance of specific skeletal muscle protein-tyrosine phosphatases in a genetic model of insulin-resistant obesity and diabetes mellitus.", "journal": "Metabolism 44:1175-84 (1995)", "doi": "10.1016/0026-0495(95)90012-8"}, {"pmid": "15166380", "authors": "  George S, Rochford JJ, Wolfrum C, Gray SL, Schinner S, Wilson JC, Soos MA, Murgatroyd PR, Williams RM, Acerini CL, Dunger DB, Barford D, Umpleby AM, Wareham NJ, Davies HA, Schafer AJ, Stoffel M, O'Rahilly S, Barroso I", "title": "A family with severe insulin resistance and diabetes due to a mutation in AKT2.", "journal": "Science 304:1325-8 (2004)", "doi": "10.1126/science.1096706"}, {"pmid": "22675355", "authors": "  Snel M, Jonker JT, Schoones J, Lamb H, de Roos A, Pijl H, Smit JW, Meinders AE, Jazet IM", "title": "Ectopic fat and insulin resistance: pathophysiology and effect of diet and lifestyle interventions.", "journal": "Int J Endocrinol 2012:983814 (2012)", "doi": "10.1155/2012/983814"}, {"pmid": "17130651", "authors": "  Morino K, Petersen KF, Shulman GI", "title": "Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction.", "journal": "Diabetes 55 Suppl 2:S9-S15 (2006)", "doi": "10.2337/db06-S002"}, {"pmid": "16186396", "authors": "  Plomgaard P, Bouzakri K, Krogh-Madsen R, Mittendorfer B, Zierath JR, Pedersen BK", "title": "Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation.", "journal": "Diabetes 54:2939-45 (2005)", "doi": "10.2337/diabetes.54.10.2939"}, {"pmid": "18309108", "authors": "  Kim JA, Wei Y, Sowers JR", "title": "Role of mitochondrial dysfunction in insulin resistance.", "journal": "Circ Res 102:401-14 (2008)", "doi": "10.1161/CIRCRESAHA.107.165472"}, {"pmid": "17141630", "authors": "  Steinberg GR, Michell BJ, van Denderen BJ, Watt MJ, Carey AL, Fam BC, Andrikopoulos S, Proietto J, Gorgun CZ, Carling D, Hotamisligil GS, Febbraio MA, Kay TW, Kemp BE", "title": "Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling.", "journal": "Cell Metab 4:465-74 (2006)", "doi": "10.1016/j.cmet.2006.11.005"}, {"pmid": "9886945", "authors": "  Ruderman NB, Saha AK, Vavvas D, Witters LA", "title": "Malonyl-CoA, fuel sensing, and insulin resistance.", "journal": "Am J Physiol 276:E1-E18 (1999)", "doi": "10.1152/ajpendo.1999.276.1.E1"}, {"pmid": "8048519", "authors": "  Saha AK, Kurowski TG, Colca JR, Ruderman NB", "title": "Lipid abnormalities in tissues of the KKAy mouse: effects of pioglitazone on malonyl-CoA and diacylglycerol.", "journal": "Am J Physiol 267:E95-101 (1994)", "doi": "10.1152/ajpendo.1994.267.1.E95"}, {"pmid": "22677645", "authors": "  Blachnio-Zabielska AU, Koutsari C, Tchkonia T, Jensen MD", "title": "Sphingolipid content of human adipose tissue: relationship to adiponectin and insulin resistance.", "journal": "Obesity (Silver Spring) 20:2341-7 (2012)", "doi": "10.1038/oby.2012.126"}, {"pmid": "16364488", "authors": "  Larter CZ, Farrell GC", "title": "Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?", "journal": "J Hepatol 44:253-61 (2006)", "doi": "10.1016/j.jhep.2005.11.030"}, {"pmid": "15107844", "authors": "  Koo SH, Satoh H, Herzig S, Lee CH, Hedrick S, Kulkarni R, Evans RM, Olefsky J, Montminy M", "title": "PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3.", "journal": "Nat Med 10:530-4 (2004)", "doi": "10.1038/nm1044"}, {"pmid": "20466550", "authors": "  Slawson C, Copeland RJ, Hart GW", "title": "O-GlcNAc signaling: a metabolic link between diabetes and cancer?", "journal": "Trends Biochem Sci 35:547-55 (2010)", "doi": "10.1016/j.tibs.2010.04.005"}, {"pmid": "23647930", "authors": "  Ruan HB, Singh JP, Li MD, Wu J, Yang X", "title": "Cracking the O-GlcNAc code in metabolism.", "journal": "Trends Endocrinol Metab 24:301-9 (2013)", "doi": "10.1016/j.tem.2013.02.002"}, {"pmid": "16756496", "authors": "  Muoio DM, Newgard CB", "title": "Obesity-related derangements in metabolic regulation.", "journal": "Annu Rev Biochem 75:367-401 (2006)", "doi": "10.1146/annurev.biochem.75.103004.142512"}], "rel_pathway": ["hsa00010  Glycolysis / Gluconeogenesis", "hsa00061  Fatty acid biosynthesis", "hsa00514  Other types of O-glycan biosynthesis", "hsa00520  Amino sugar and nucleotide sugar metabolism", "hsa04150  mTOR signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04668  TNF signaling pathway", "hsa04910  Insulin signaling pathway"], "ko_pathway": "ko04931", "genes": ["PTEN", "AKT2", "AKT1", "CD36"]}, {"kegg_id": "hsa05165", "name": "Human papillomavirus infection - Homo sapiens (human)", "description": "Human papillomavirus (HPV) is a non-enveloped, double-stranded DNA virus. HPV infect mucoal and cutaneous epithelium resulting in several types of pathologies, most notably, cervical cancer. All types of HPV share a common genomic structure and encode eight proteins: E1, E2, E4, E5, E6, and E7 (early) and L1 and L2 (late). It has been demonstrated that E1 and E2 are involved in viral transcription and replication. The functions of the E4 protein is not yet fully understood. E5, E6, and E7 act as oncoproteins. E5 inhibits the V-ATPase, prolonging EGFR signaling and thereby promoting cell proliferation. The expression of E6 and E7 not only inhibits the tumor suppressors p53 and Rb, but also alters additional signalling pathways. Among these pathways, PI3K/Akt signalling cascade plays a very important role in HPV-induced carcinogenesis. The L1 and L2 proteins form icosahedral capsids for progeny virion generation.", "class": "Human Diseases; Infectious disease: viral", "pathway_map": "hsa05165  Human papillomavirus infection", "network": ["", "ELEMENT   N00341  HPV E6 to the Scribble/Dlg/Lgl polarity module", "N00343  HPV E6 to MAGI-PTEN signaling pathway", "N00345  HPV E6 to CRB3-Pals1-PATJ complex", "N00346  HPV E6 to TLR-IRF3 signaling pathway", "N00348  HPV E6 to p300-p21-Cell cycle G1/S", "N00349  HPV E6 to p300-p21-Cell cycle G1/S", "N00350  HPV E6 to extrinsic apoptotic pathway", "N00351  HPV E6 to extrinsic apoptotic pathway", "N00352  HPV E6 to extrinsic apoptotic pathway", "N00353  HPV E6 to PTEN-PIP3-AKT signaling pathway", "N00354  HPV E6 to PTEN-PIP3-AKT signaling pathway", "N00356  HPV E7 to PP2A-AKT signaling patyway", "N00357  HPV E6 to MTOR signaling pathway", "N00358  HPV E6 to p21-cell cycle G1/S", "N00359  HPV E7 to p27-cell cycle G1/S", "N00360  HPV E7 to p27-cell cycle G1/S", "N00361  HPV E7 to cell cycle G1/S", "N00362  HPV E5 to p21-cell cycle G1/S", "N00364  HPV E5 to antigen processing and presentation by MHC class I molecules", "N00365  HPV E7 to cell cycle G1/S", "N00366  HPV E5 to EGFR-PI3K signaling pathway", "N00367  HPV E5 to EGFR-RAS-ERK signaling pathway", "N00368  HPV E5 to PDGFR-PI3K signaling pathway", "N00369  HPV E5 to PDGFR-RAS-ERK signaling pathway", "N00371  HPV E7 to pyruvate generation", "N00372  HPV E7 to p300-p21-Cell cycle G1/S", "N00373  HPV E6 to NFX1-mediated transcription", "N00375  HPV E7 to TNF-IRF1 signaling pathway", "N00376  HPV E7 to TBP1-mediated transcription", "N00377  HPV E6 to IFN signaling pathway", "N00378  HPV E6 to IFN signaling pathway", "N00379  HPV E7 to IFN signaling pathway", "N00380  HPV E6 to Notch signaling pathway", "N00381  HPV E6 to Notch signaling pathway", "N00382  HPV E6 to Notch signaling pathway", "N00383  HPV E6 to intrinsic apoptotic pathway", "N00384  HPV E6 to intrinsic apoptotic pathway"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["7471  WNT1; Wnt family member 1 [KO:K03209]", "7472  WNT2; Wnt family member 2 [KO:K00182]", "7482  WNT2B; Wnt family member 2B [KO:K00182]", "7473  WNT3; Wnt family member 3 [KO:K00312]", "89780  WNT3A; Wnt family member 3A [KO:K00312]", "54361  WNT4; Wnt family member 4 [KO:K00408]", "7474  WNT5A; Wnt family member 5A [KO:K00444]", "81029  WNT5B; Wnt family member 5B [KO:K00444]", "7475  WNT6; Wnt family member 6 [KO:K00445]", "7476  WNT7A; Wnt family member 7A [KO:K00572]", "7477  WNT7B; Wnt family member 7B [KO:K00572]", "7478  WNT8A; Wnt family member 8A [KO:K00714]", "7479  WNT8B; Wnt family member 8B [KO:K00714]", "7483  WNT9A; Wnt family member 9A [KO:K01064]", "7484  WNT9B; Wnt family member 9B [KO:K01064]", "7480  WNT10B; Wnt family member 10B [KO:K01357]", "80326  WNT10A; Wnt family member 10A [KO:K01357]", "7481  WNT11; Wnt family member 11 [KO:K01384]", "51384  WNT16; Wnt family member 16 [KO:K01558]", "8321  FZD1; frizzled class receptor 1 [KO:K02432]", "8324  FZD7; frizzled class receptor 7 [KO:K02432]", "2535  FZD2; frizzled class receptor 2 [KO:K02235]", "7976  FZD3; frizzled class receptor 3 [KO:K02329]", "8322  FZD4; frizzled class receptor 4 [KO:K02354]", "7855  FZD5; frizzled class receptor 5 [KO:K02375]", "8325  FZD8; frizzled class receptor 8 [KO:K02375]", "8323  FZD6; frizzled class receptor 6 [KO:K02376]", "11211  FZD10; frizzled class receptor 10 [KO:K02842]", "8326  FZD9; frizzled class receptor 9 [KO:K02842]", "1857  DVL3; dishevelled segment polarity protein 3 [KO:K02353]", "1856  DVL2; dishevelled segment polarity protein 2 [KO:K02353]", "1855  DVL1; dishevelled segment polarity protein 1 [KO:K02353]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "8312  AXIN1; axin 1 [KO:K02157]", "8313  AXIN2; axin 2 [KO:K04385]", "324  APC; APC regulator of WNT signaling pathway [KO:K02085]", "10297  APC2; APC regulator of WNT signaling pathway 2 [KO:K02085]", "1499  CTNNB1; catenin beta 1 [KO:K02105]", "122011  CSNK1A1L; casein kinase 1 alpha 1 like [KO:K08957] [EC:2.7.11.1]", "1452  CSNK1A1; casein kinase 1 alpha 1 [KO:K08957] [EC:2.7.11.1]", "7015  TERT; telomerase reverse transcriptase [KO:K11126] [EC:2.7.7.49]", "6932  TCF7; transcription factor 7 [KO:K02620]", "83439  TCF7L1; transcription factor 7 like 1 [KO:K04490]", "6934  TCF7L2; transcription factor 7 like 2 [KO:K04491]", "7337  UBE3A; ubiquitin protein ligase E3A [KO:K10587] [EC:2.3.2.26]", "7098  TLR3; toll like receptor 3 [KO:K05401]", "148022  TICAM1; TIR domain containing adaptor molecule 1 [KO:K05842]", "7187  TRAF3; TNF receptor associated factor 3 [KO:K03174]", "9641  IKBKE; inhibitor of nuclear factor kappa B kinase subunit epsilon [KO:K07211] [EC:2.7.11.10]", "29110  TBK1; TANK binding kinase 1 [KO:K05410] [EC:2.7.11.10]", "3661  IRF3; interferon regulatory factor 3 [KO:K05411]", "3456  IFNB1; interferon beta 1 [KO:K05415]", "1387  CREBBP; CREB binding protein [KO:K04498] [EC:2.3.1.48]", "2033  EP300; E1A binding protein p300 [KO:K04498] [EC:2.3.1.48]", "10474  TADA3; transcriptional adaptor 3 [KO:K11315]", "7157  TP53; tumor protein p53 [KO:K04451]", "9223  MAGI1; membrane associated guanylate kinase, WW and PDZ domain containing 1 [KO:K05631]", "5728  PTEN; phosphatase and tensin homolog [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]", "56288  PARD3; par-3 family cell polarity regulator [KO:K04237]", "50855  PARD6A; par-6 family cell polarity regulator alpha [KO:K06093]", "84552  PARD6G; par-6 family cell polarity regulator gamma [KO:K06093]", "84612  PARD6B; par-6 family cell polarity regulator beta [KO:K06093]", "5584  PRKCI; protein kinase C iota [KO:K06069] [EC:2.7.11.13]", "5590  PRKCZ; protein kinase C zeta [KO:K18952] [EC:2.7.11.13]", "998  CDC42; cell division cycle 42 [KO:K04393]", "23513  SCRIB; scribble planar cell polarity protein [KO:K16175]", "1739  DLG1; discs large MAGUK scaffold protein 1 [KO:K12076]", "1740  DLG2; discs large MAGUK scaffold protein 2 [KO:K12075]", "1741  DLG3; discs large MAGUK scaffold protein 3 [KO:K21098]", "3993  LLGL2; LLGL scribble cell polarity complex component 2 [KO:K06094]", "3996  LLGL1; LLGL scribble cell polarity complex component 1 [KO:K06094]", "92359  CRB3; crumbs cell polarity complex component 3 [KO:K06090]", "10207  PATJ; PATJ crumbs cell polarity complex component [KO:K06092]", "64398  PALS1; protein associated with LIN7 1, MAGUK p55 family member [KO:K06091]", "7450  VWF; von Willebrand factor [KO:K03900]", "7057  THBS1; thrombospondin 1 [KO:K16857]", "1311  COMP; cartilage oligomeric matrix protein [KO:K04659]", "7058  THBS2; thrombospondin 2 [KO:K04659]", "7059  THBS3; thrombospondin 3 [KO:K04659]", "7060  THBS4; thrombospondin 4 [KO:K04659]", "2335  FN1; fibronectin 1 [KO:K05717]", "1277  COL1A1; collagen type I alpha 1 chain [KO:K06236]", "1278  COL1A2; collagen type I alpha 2 chain [KO:K06236]", "1280  COL2A1; collagen type II alpha 1 chain [KO:K19719]", "1284  COL4A2; collagen type IV alpha 2 chain [KO:K06237]", "1286  COL4A4; collagen type IV alpha 4 chain [KO:K06237]", "1288  COL4A6; collagen type IV alpha 6 chain [KO:K06237]", "1282  COL4A1; collagen type IV alpha 1 chain [KO:K06237]", "1287  COL4A5; collagen type IV alpha 5 chain [KO:K06237]", "1285  COL4A3; collagen type IV alpha 3 chain [KO:K06237]", "1291  COL6A1; collagen type VI alpha 1 chain [KO:K06238]", "1292  COL6A2; collagen type VI alpha 2 chain [KO:K06238]", "1293  COL6A3; collagen type VI alpha 3 chain [KO:K06238]", "131873  COL6A6; collagen type VI alpha 6 chain [KO:K06238]", "256076  COL6A5; collagen type VI alpha 5 chain [KO:K06238]", "1297  COL9A1; collagen type IX alpha 1 chain [KO:K08131]", "1298  COL9A2; collagen type IX alpha 2 chain [KO:K08131]", "1299  COL9A3; collagen type IX alpha 3 chain [KO:K08131]", "284217  LAMA1; laminin subunit alpha 1 [KO:K05637]", "3908  LAMA2; laminin subunit alpha 2 [KO:K05637]", "3909  LAMA3; laminin subunit alpha 3 [KO:K06240]", "3911  LAMA5; laminin subunit alpha 5 [KO:K06240]", "3910  LAMA4; laminin subunit alpha 4 [KO:K06241]", "3912  LAMB1; laminin subunit beta 1 [KO:K05636]", "3913  LAMB2; laminin subunit beta 2 [KO:K06243]", "3914  LAMB3; laminin subunit beta 3 [KO:K06244]", "22798  LAMB4; laminin subunit beta 4 [KO:K06245]", "3915  LAMC1; laminin subunit gamma 1 [KO:K05635]", "3918  LAMC2; laminin subunit gamma 2 [KO:K06246]", "10319  LAMC3; laminin subunit gamma 3 [KO:K06247]", "1101  CHAD; chondroadherin [KO:K06248]", "5649  RELN; reelin [KO:K06249] [EC:3.4.21.-]", "6696  SPP1; secreted phosphoprotein 1 [KO:K06250]", "7448  VTN; vitronectin [KO:K06251]", "3371  TNC; tenascin C [KO:K06252]", "63923  TNN; tenascin N [KO:K06252]", "7143  TNR; tenascin R [KO:K06252]", "7148  TNXB; tenascin XB [KO:K06252]", "3381  IBSP; integrin binding sialoprotein [KO:K06253]", "3672  ITGA1; integrin subunit alpha 1 [KO:K06480]", "3673  ITGA2; integrin subunit alpha 2 [KO:K06481]", "3674  ITGA2B; integrin subunit alpha 2b [KO:K06476]", "3675  ITGA3; integrin subunit alpha 3 [KO:K06482]", "3676  ITGA4; integrin subunit alpha 4 [KO:K06483]", "3678  ITGA5; integrin subunit alpha 5 [KO:K06484]", "3655  ITGA6; integrin subunit alpha 6 [KO:K06485]", "3679  ITGA7; integrin subunit alpha 7 [KO:K06583]", "8516  ITGA8; integrin subunit alpha 8 [KO:K06584]", "3680  ITGA9; integrin subunit alpha 9 [KO:K06585]", "8515  ITGA10; integrin subunit alpha 10 [KO:K06586]", "22801  ITGA11; integrin subunit alpha 11 [KO:K06587]", "3685  ITGAV; integrin subunit alpha V [KO:K06487]", "3688  ITGB1; integrin subunit beta 1 [KO:K05719]", "3690  ITGB3; integrin subunit beta 3 [KO:K06493]", "3691  ITGB4; integrin subunit beta 4 [KO:K06525]", "3693  ITGB5; integrin subunit beta 5 [KO:K06588]", "3694  ITGB6; integrin subunit beta 6 [KO:K06589]", "3695  ITGB7; integrin subunit beta 7 [KO:K06590]", "3696  ITGB8; integrin subunit beta 8 [KO:K06591]", "5747  PTK2; protein tyrosine kinase 2 [KO:K05725] [EC:2.7.10.2]", "5829  PXN; paxillin [KO:K05760]", "7124  TNF; tumor necrosis factor [KO:K03156]", "7132  TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158]", "8717  TRADD; TNFRSF1A associated via death domain [KO:K03171]", "356  FASLG; Fas ligand [KO:K04389]", "355  FAS; Fas cell surface death receptor [KO:K04390]", "8772  FADD; Fas associated via death domain [KO:K02373]", "841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "9368  NHERF1; NHERF family PDZ scaffold protein 1 [KO:K13365]", "5515  PPP2CA; protein phosphatase 2 catalytic subunit alpha [KO:K04382] [EC:3.1.3.16]", "5516  PPP2CB; protein phosphatase 2 catalytic subunit beta [KO:K04382] [EC:3.1.3.16]", "5519  PPP2R1B; protein phosphatase 2 scaffold subunit Abeta [KO:K03456]", "5518  PPP2R1A; protein phosphatase 2 scaffold subunit Aalpha [KO:K03456]", "5520  PPP2R2A; protein phosphatase 2 regulatory subunit Balpha [KO:K04354]", "5521  PPP2R2B; protein phosphatase 2 regulatory subunit Bbeta [KO:K04354]", "5522  PPP2R2C; protein phosphatase 2 regulatory subunit Bgamma [KO:K04354]", "55844  PPP2R2D; protein phosphatase 2 regulatory subunit Bdelta [KO:K04354]", "28227  PPP2R3B; protein phosphatase 2 regulatory subunit B''beta [KO:K11583]", "55012  PPP2R3C; protein phosphatase 2 regulatory subunit B''gamma [KO:K11583]", "5523  PPP2R3A; protein phosphatase 2 regulatory subunit B''alpha [KO:K11583]", "5526  PPP2R5B; protein phosphatase 2 regulatory subunit B'beta [KO:K11584]", "5527  PPP2R5C; protein phosphatase 2 regulatory subunit B'gamma [KO:K11584]", "5528  PPP2R5D; protein phosphatase 2 regulatory subunit B'delta [KO:K11584]", "5529  PPP2R5E; protein phosphatase 2 regulatory subunit B'epsilon [KO:K11584]", "5525  PPP2R5A; protein phosphatase 2 regulatory subunit B'alpha [KO:K11584]", "7248  TSC1; TSC complex subunit 1 [KO:K07206]", "7249  TSC2; TSC complex subunit 2 [KO:K07207]", "6009  RHEB; Ras homolog, mTORC1 binding [KO:K07208]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "1978  EIF4EBP1; eukaryotic translation initiation factor 4E binding protein 1 [KO:K07205]", "6198  RPS6KB1; ribosomal protein S6 kinase B1 [KO:K04688] [EC:2.7.11.1]", "6199  RPS6KB2; ribosomal protein S6 kinase B2 [KO:K04688] [EC:2.7.11.1]", "578  BAK1; BCL2 antagonist/killer 1 [KO:K14021]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]", "5159  PDGFRB; platelet derived growth factor receptor beta [KO:K05089] [EC:2.7.10.1]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "2308  FOXO1; forkhead box O1 [KO:K07201]", "1027  CDKN1B; cyclin dependent kinase inhibitor 1B [KO:K06624]", "1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]", "595  CCND1; cyclin D1 [KO:K04503]", "894  CCND2; cyclin D2 [KO:K10151]", "896  CCND3; cyclin D3 [KO:K10152]", "1019  CDK4; cyclin dependent kinase 4 [KO:K02089] [EC:2.7.11.22]", "1021  CDK6; cyclin dependent kinase 6 [KO:K02091] [EC:2.7.11.22]", "898  CCNE1; cyclin E1 [KO:K06626]", "9134  CCNE2; cyclin E2 [KO:K06626]", "1017  CDK2; cyclin dependent kinase 2 [KO:K02206] [EC:2.7.11.22]", "5925  RB1; RB transcriptional corepressor 1 [KO:K06618]", "5933  RBL1; RB transcriptional corepressor like 1 [KO:K04681]", "5934  RBL2; RB transcriptional corepressor like 2 [KO:K16332]", "5700  PSMC1; proteasome 26S subunit, ATPase 1 [KO:K03062]", "1869  E2F1; E2F transcription factor 1 [KO:K17454]", "890  CCNA2; cyclin A2 [KO:K06627]", "8900  CCNA1; cyclin A1 [KO:K06627]", "472  ATM; ATM serine/threonine kinase [KO:K04728] [EC:2.7.11.1]", "545  ATR; ATR serine/threonine kinase [KO:K06640] [EC:2.7.11.1]", "7422  VEGFA; vascular endothelial growth factor A [KO:K05448]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "4193  MDM2; MDM2 proto-oncogene [KO:K06643] [EC:2.3.2.27]", "4799  NFX1; nuclear transcription factor, X-box binding 1 [KO:K12236]", "3065  HDAC1; histone deacetylase 1 [KO:K06067] [EC:3.5.1.98]", "3066  HDAC2; histone deacetylase 2 [KO:K06067] [EC:3.5.1.98]", "1108  CHD4; chromodomain helicase DNA binding protein 4 [KO:K11643] [EC:5.6.2.-]", "3659  IRF1; interferon regulatory factor 1 [KO:K09444]", "387332  TBPL2; TATA-box binding protein like 2 [KO:K03120]", "9519  TBPL1; TATA-box binding protein like 1 [KO:K03120]", "6908  TBP; TATA-box binding protein [KO:K03120]", "3105  HLA-A; major histocompatibility complex, class I, A [KO:K06751]", "3106  HLA-B; major histocompatibility complex, class I, B [KO:K06751]", "3107  HLA-C; major histocompatibility complex, class I, C [KO:K06751]", "3134  HLA-F; major histocompatibility complex, class I, F [KO:K06751]", "3135  HLA-G; major histocompatibility complex, class I, G [KO:K06751]", "3133  HLA-E; major histocompatibility complex, class I, E [KO:K06751]", "10134  BCAP31; B cell receptor associated protein 31 [KO:K14009]", "523  ATP6V1A; ATPase H+ transporting V1 subunit A [KO:K02145] [EC:7.1.2.2]", "525  ATP6V1B1; ATPase H+ transporting V1 subunit B1 [KO:K02147]", "526  ATP6V1B2; ATPase H+ transporting V1 subunit B2 [KO:K02147]", "245973  ATP6V1C2; ATPase H+ transporting V1 subunit C2 [KO:K02148]", "528  ATP6V1C1; ATPase H+ transporting V1 subunit C1 [KO:K02148]", "51382  ATP6V1D; ATPase H+ transporting V1 subunit D [KO:K02149]", "90423  ATP6V1E2; ATPase H+ transporting V1 subunit E2 [KO:K02150]", "529  ATP6V1E1; ATPase H+ transporting V1 subunit E1 [KO:K02150]", "9296  ATP6V1F; ATPase H+ transporting V1 subunit F [KO:K02151]", "9550  ATP6V1G1; ATPase H+ transporting V1 subunit G1 [KO:K02152]", "127124  ATP6V1G3; ATPase H+ transporting V1 subunit G3 [KO:K02152]", "534  ATP6V1G2; ATPase H+ transporting V1 subunit G2 [KO:K02152]", "51606  ATP6V1H; ATPase H+ transporting V1 subunit H [KO:K02144]", "10312  TCIRG1; T cell immune regulator 1, ATPase H+ transporting V0 subunit a3 [KO:K02154]", "23545  ATP6V0A2; ATPase H+ transporting V0 subunit a2 [KO:K02154]", "50617  ATP6V0A4; ATPase H+ transporting V0 subunit a4 [KO:K02154]", "535  ATP6V0A1; ATPase H+ transporting V0 subunit a1 [KO:K02154]", "9114  ATP6V0D1; ATPase H+ transporting V0 subunit d1 [KO:K02146]", "245972  ATP6V0D2; ATPase H+ transporting V0 subunit d2 [KO:K02146]", "8992  ATP6V0E1; ATPase H+ transporting V0 subunit e1 [KO:K02153]", "155066  ATP6V0E2; ATPase H+ transporting V0 subunit e2 [KO:K02153]", "527  ATP6V0C; ATPase H+ transporting V0 subunit c [KO:K02155]", "533  ATP6V0B; ATPase H+ transporting V0 subunit b [KO:K03661]", "537  ATP6AP1; ATPase H+ transporting accessory protein 1 [KO:K03662]", "1950  EGF; epidermal growth factor [KO:K04357]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "5743  PTGS2; prostaglandin-endoperoxide synthase 2 [KO:K11987] [EC:1.14.99.1]", "5734  PTGER4; prostaglandin E receptor 4 [KO:K04261]", "2778  GNAS; GNAS complex locus [KO:K04632]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]", "10488  CREB3; cAMP responsive element binding protein 3 [KO:K09048]", "90993  CREB3L1; cAMP responsive element binding protein 3 like 1 [KO:K09048]", "64764  CREB3L2; cAMP responsive element binding protein 3 like 2 [KO:K09048]", "84699  CREB3L3; cAMP responsive element binding protein 3 like 3 [KO:K09048]", "148327  CREB3L4; cAMP responsive element binding protein 3 like 4 [KO:K09048]", "9586  CREB5; cAMP responsive element binding protein 5 [KO:K09047]", "23352  UBR4; ubiquitin protein ligase E3 component n-recognin 4 [KO:K10691] [EC:2.3.2.27]", "27175  TUBG2; tubulin gamma 2 [KO:K10389]", "7283  TUBG1; tubulin gamma 1 [KO:K10389]", "5315  PKM; pyruvate kinase M1/2 [KO:K00873] [EC:2.7.1.40]", "3439  IFNA1; interferon alpha 1 [KO:K05414]", "3440  IFNA2; interferon alpha 2 [KO:K05414]", "3441  IFNA4; interferon alpha 4 [KO:K05414]", "3442  IFNA5; interferon alpha 5 [KO:K05414]", "3443  IFNA6; interferon alpha 6 [KO:K05414]", "3444  IFNA7; interferon alpha 7 [KO:K05414]", "3445  IFNA8; interferon alpha 8 [KO:K05414]", "3446  IFNA10; interferon alpha 10 [KO:K05414]", "3447  IFNA13; interferon alpha 13 [KO:K05414]", "3448  IFNA14; interferon alpha 14 [KO:K05414]", "3449  IFNA16; interferon alpha 16 [KO:K05414]", "3451  IFNA17; interferon alpha 17 [KO:K05414]", "3452  IFNA21; interferon alpha 21 [KO:K05414]", "3454  IFNAR1; interferon alpha and beta receptor subunit 1 [KO:K05130]", "3455  IFNAR2; interferon alpha and beta receptor subunit 2 [KO:K05131]", "3716  JAK1; Janus kinase 1 [KO:K11217] [EC:2.7.10.2]", "7297  TYK2; tyrosine kinase 2 [KO:K11219] [EC:2.7.10.2]", "6772  STAT1; signal transducer and activator of transcription 1 [KO:K11220]", "6773  STAT2; signal transducer and activator of transcription 2 [KO:K11221]", "10379  IRF9; interferon regulatory factor 9 [KO:K04693]", "5610  EIF2AK2; eukaryotic translation initiation factor 2 alpha kinase 2 [KO:K16195] [EC:2.7.11.1]", "8638  OASL; 2'-5'-oligoadenylate synthetase like [KO:K14608]", "4599  MX1; MX dynamin like GTPase 1 [KO:K14754]", "4600  MX2; MX dynamin like GTPase 2 [KO:K14754]", "9636  ISG15; ISG15 ubiquitin like modifier [KO:K12159]", "182  JAG1; jagged canonical Notch ligand 1 [KO:K06052]", "4851  NOTCH1; notch receptor 1 [KO:K02599]", "4853  NOTCH2; notch receptor 2 [KO:K20994]", "4854  NOTCH3; notch receptor 3 [KO:K20995]", "4855  NOTCH4; notch receptor 4 [KO:K20996]", "5663  PSEN1; presenilin 1 [KO:K04505] [EC:3.4.23.-]", "4242  MFNG; MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase [KO:K05948] [EC:2.4.1.222]", "3955  LFNG; LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase [KO:K05948] [EC:2.4.1.222]", "5986  RFNG; RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase [KO:K05948] [EC:2.4.1.222]", "55534  MAML3; mastermind like transcriptional coactivator 3 [KO:K06061]", "84441  MAML2; mastermind like transcriptional coactivator 2 [KO:K06061]", "9794  MAML1; mastermind like transcriptional coactivator 1 [KO:K06061]", "11317  RBPJL; recombination signal binding protein for immunoglobulin kappa J region like [KO:K06053]", "3516  RBPJ; recombination signal binding protein for immunoglobulin kappa J region [KO:K06053]", "3280  HES1; hes family bHLH transcription factor 1 [KO:K06054]", "54626  HES2; hes family bHLH transcription factor 2 [KO:K09087]", "55502  HES6; hes family bHLH transcription factor 6 [KO:K09087]", "84667  HES7; hes family bHLH transcription factor 7 [KO:K09087]", "390992  HES3; hes family bHLH transcription factor 3 [KO:K09088]", "57801  HES4; hes family bHLH transcription factor 4 [KO:K09089]", "388585  HES5; hes family bHLH transcription factor 5 [KO:K06055]", "26508  HEYL; hes related family bHLH transcription factor with YRPW motif like [KO:K09091]", "23462  HEY1; hes related family bHLH transcription factor with YRPW motif 1 [KO:K09091]", "23493  HEY2; hes related family bHLH transcription factor with YRPW motif 2 [KO:K09091]"], "compound": ["C00575  3',5'-Cyclic AMP", "C00584  Prostaglandin E2", "C05981  Phosphatidylinositol-3,4,5-trisphosphate"], "refs": [{"pmid": "20592731", "authors": "  Moody CA, Laimins LA", "title": "Human papillomavirus oncoproteins: pathways to transformation.", "journal": "Nat Rev Cancer 10:550-60 (2010)", "doi": "10.1038/nrc2886"}, {"pmid": "25752815", "authors": "  Chen J", "title": "Signaling pathways in HPV-associated cancers and therapeutic implications.", "journal": "Rev Med Virol 25 Suppl 1:24-53 (2015)", "doi": "10.1002/rmv.1823"}, {"pmid": "26008697", "authors": "  Tummers B, Burg SH", "title": "High-risk human papillomavirus targets crossroads in immune signaling.", "journal": "Viruses 7:2485-506 (2015)", "doi": "10.3390/v7052485"}, {"pmid": "19684440", "authors": "  Lehoux M, D'Abramo CM, Archambault J", "title": "Molecular mechanisms of human papillomavirus-induced carcinogenesis.", "journal": "Public Health Genomics 12:268-80 (2009)", "doi": "10.1159/000214918"}, {"pmid": "23164805", "authors": "  Pang CL, Thierry F", "title": "Human papillomavirus proteins as prospective therapeutic targets.", "journal": "Microb Pathog 58:55-65 (2013)", "doi": "10.1016/j.micpath.2012.11.002"}, {"pmid": "19156753", "authors": "  Yugawa T, Kiyono T", "title": "Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins.", "journal": "Rev Med Virol 19:97-113 (2009)", "doi": "10.1002/rmv.605"}, {"pmid": "17645777", "authors": "  Narisawa-Saito M, Kiyono T", "title": "Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins.", "journal": "Cancer Sci 98:1505-11 (2007)", "doi": "10.1111/j.1349-7006.2007.00546.x"}, {"pmid": "11486705", "authors": "  Wolf JK, Ramirez PT.", "title": "The molecular biology of cervical cancer.", "journal": "Cancer Invest 19:621-9 (2001)", "doi": "10.1081/CNV-100104290"}, {"pmid": "10793105", "authors": "  zur Hausen H", "title": "Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis.", "journal": "J Natl Cancer Inst 92:690-8 (2000)", "doi": "10.1093/jnci/92.9.690"}, {"pmid": "16259056", "authors": "  Kim YT, Zhao M", "title": "Aberrant cell cycle regulation in cervical carcinoma.", "journal": "Yonsei Med J 46:597-613 (2005)", "doi": "10.3349/ymj.2005.46.5.597"}, {"pmid": "15956361", "authors": "  McCance DJ", "title": "Human papillomaviruses and cell signaling.", "journal": "Sci STKE 2005:pe29 (2005)", "doi": "10.1126/stke.2882005pe29"}, {"pmid": "24316445", "authors": "  Tommasino M", "title": "The human papillomavirus family and its role in carcinogenesis.", "journal": "Semin Cancer Biol 26:13-21 (2014)", "doi": "10.1016/j.semcancer.2013.11.002"}, {"pmid": "26295406", "authors": "  Bello JO, Nieva LO, Paredes AC, Gonzalez AM, Zavaleta LR, Lizano M", "title": "Regulation of the Wnt/beta-Catenin Signaling Pathway by Human Papillomavirus E6 and E7 Oncoproteins.", "journal": "Viruses 7:4734-55 (2015)", "doi": "10.3390/v7082842"}, {"pmid": "26289783", "authors": "  Shah M, Anwar MA, Park S, Jafri SS, Choi S", "title": "In silico mechanistic analysis of IRF3 inactivation and high-risk HPV E6 species-dependent drug response.", "journal": "Sci Rep 5:13446 (2015)", "doi": "10.1038/srep13446"}, {"pmid": "26797638", "authors": "  James CD, Roberts S", "title": "Viral Interactions with PDZ Domain-Containing Proteins-An Oncogenic Trait?", "journal": "Pathogens 5:E8 (2016)", "doi": "10.3390/pathogens5010008"}, {"pmid": "26147797", "authors": "  Ganti K, Broniarczyk J, Manoubi W, Massimi P, Mittal S, Pim D, Szalmas A, Thatte J, Thomas M, Tomaic V, Banks L", "title": "The Human Papillomavirus E6 PDZ Binding Motif: From Life Cycle to Malignancy.", "journal": "Viruses 7:3530-51 (2015)", "doi": "10.3390/v7072785"}, {"pmid": "21954943", "authors": "  Subbaiah VK, Kranjec C, Thomas M, Banks L", "title": "PDZ domains: the building blocks regulating tumorigenesis.", "journal": "Biochem J 439:195-205 (2011)", "doi": "10.1042/BJ20110903"}, {"pmid": "23175122", "authors": "  Banks L, Pim D, Thomas M", "title": "Human tumour viruses and the deregulation of cell polarity in cancer.", "journal": "Nat Rev Cancer 12:877-86 (2012)", "doi": "10.1038/nrc3400"}, {"pmid": "19029942", "authors": "  Thomas M, Narayan N, Pim D, Tomaic V, Massimi P, Nagasaka K, Kranjec C, Gammoh N, Banks L", "title": "Human papillomaviruses, cervical cancer and cell polarity.", "journal": "Oncogene 27:7018-30 (2008)", "doi": "10.1038/onc.2008.351"}, {"pmid": "16862386", "authors": "  Garnett TO, Duerksen-Hughes PJ", "title": "Modulation of apoptosis by human papillomavirus (HPV) oncoproteins.", "journal": "Arch Virol 151:2321-35 (2006)", "doi": "10.1007/s00705-006-0821-0"}, {"pmid": "26022660", "authors": "  Zhang L, Wu J, Ling MT, Zhao L, Zhao KN", "title": "The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses.", "journal": "Mol Cancer 14:87 (2015)", "doi": "10.1186/s12943-015-0361-x"}, {"pmid": "22078316", "authors": "  Venuti A, Paolini F, Nasir L, Corteggio A, Roperto S, Campo MS, Borzacchiello G", "title": "Papillomavirus E5: the smallest oncoprotein with many functions.", "journal": "Mol Cancer 10:140 (2011)", "doi": "10.1186/1476-4598-10-140"}, {"pmid": "11753669", "authors": "  DiMaio D, Mattoon D", "title": "Mechanisms of cell transformation by papillomavirus E5 proteins.", "journal": "Oncogene 20:7866-73 (2001)", "doi": "10.1038/sj.onc.1204915"}, {"pmid": "22262402", "authors": "  Ganguly N", "title": "Human papillomavirus-16 E5 protein: oncogenic role and therapeutic value.", "journal": "Cell Oncol (Dordr) 35:67-76 (2012)", "doi": "10.1007/s13402-011-0069-x"}, {"pmid": "23731971", "authors": "  DiMaio D, Petti LM", "title": "The E5 proteins.", "journal": "Virology 445:99-114 (2013)", "doi": "10.1016/j.virol.2013.05.006"}, {"pmid": "23403708", "authors": "  De Marco F", "title": "Oxidative stress and HPV carcinogenesis.", "journal": "Viruses 5:708-31 (2013)", "doi": "10.3390/v5020708"}, {"pmid": "26643553", "authors": "  Wieringa HW, van der Zee AG, de Vries EG, van Vugt MA", "title": "Breaking the DNA damage response to improve cervical cancer treatment.", "journal": "Cancer Treat Rev 42:30-40 (2016)", "doi": "10.1016/j.ctrv.2015.11.008"}, {"pmid": "19861444", "authors": "  Chung CH, Gillison ML", "title": "Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications.", "journal": "Clin Cancer Res 15:6758-62 (2009)", "doi": "10.1158/1078-0432.CCR-09-0784"}, {"pmid": "11325599", "authors": "  Koromilas AE, Li S, Matlashewski G", "title": "Control of interferon signaling in human papillomavirus infection.", "journal": "Cytokine Growth Factor Rev 12:157-70 (2001)", "doi": "10.1016/S1359-6101(00)00023-X"}, {"pmid": "10702232", "authors": "  Park JS, Kim EJ, Kwon HJ, Hwang ES, Namkoong SE, Um SJ", "title": "Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis.", "journal": "J Biol Chem 275:6764-9 (2000)", "doi": "10.1074/jbc.275.10.6764"}, {"pmid": "22499770", "authors": "  Sandberg A, Lindell G, Kallstrom BN, Branca RM, Danielsson KG, Dahlberg M, Larson B, Forshed J, Lehtio J", "title": "Tumor proteomics by multivariate analysis on individual pathway data for characterization of vulvar cancer phenotypes.", "journal": "Mol Cell Proteomics 11:M112.016998 (2012)", "doi": "10.1074/mcp.M112.016998"}, {"pmid": "9990017", "authors": "  Zwerschke W, Mazurek S, Massimi P, Banks L, Eigenbrodt E, Jansen-Durr P", "title": "Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein.", "journal": "Proc Natl Acad Sci U S A 96:1291-6 (1999)", "doi": "10.1073/pnas.96.4.1291"}, {"pmid": "15175323", "authors": "  Lu Z, Hu X, Li Y, Zheng L, Zhou Y, Jiang H, Ning T, Basang Z, Zhang C, Ke Y", "title": "Human papillomavirus 16 E6 oncoprotein interferences with insulin signaling pathway by binding to tuberin.", "journal": "J Biol Chem 279:35664-70 (2004)", "doi": "10.1074/jbc.M403385200"}, {"pmid": "18505829", "authors": "  Xu M, Luo W, Elzi DJ, Grandori C, Galloway DA", "title": "NFX1 interacts with mSin3A/histone deacetylase to repress hTERT transcription in keratinocytes.", "journal": "Mol Cell Biol 28:4819-28 (2008)", "doi": "10.1128/MCB.01969-07"}], "rel_pathway": ["hsa04064  NF-kappa B signaling pathway", "hsa04110  Cell cycle", "hsa04115  p53 signaling pathway", "hsa04150  mTOR signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04210  Apoptosis", "hsa04310  Wnt signaling pathway", "hsa04330  Notch signaling pathway", "hsa04510  Focal adhesion", "hsa04520  Adherens junction", "hsa04530  Tight junction", "hsa04612  Antigen processing and presentation", "hsa04620  Toll-like receptor signaling pathway", "hsa04630  JAK-STAT signaling pathway"], "ko_pathway": "ko05165", "genes": ["PTEN", "EGFR", "TP53", "AKT2", "TNN", "AKT1", "CHD4", "SOS1", "NRAS", "BAX"]}, {"kegg_id": "hsa05166", "name": "Human T-cell leukemia virus 1 infection - Homo sapiens (human)", "description": "Human T-cell leukemia virus type 1 (HTLV-1) is a pathogenic retrovirus that is associated with adult T-cell leukemia/lymphoma (ATL). It is also strongly implicated in non-neoplastic chronic inflammatory diseases such as HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Expression of Tax, a viral regulatory protein is critical to the pathogenesis. Tax is a transcriptional co-factor that interfere several signaling pathways related to anti-apoptosis or cell proliferation. The modulation of the signaling by Tax involve its binding to transcription factors like CREB/ATF, NF-kappa B, and SRF.", "class": "Human Diseases; Infectious disease: viral", "pathway_map": "hsa05166  Human T-cell leukemia virus 1 infection", "network": ["", "ELEMENT   N00221  HTLV-1 Tax to spindle assembly checkpoint signaling", "N00222  HTLV-1 Tax to spindle assembly checkpoint signaling", "N00489  HTLV-1 p30II to c-myc-mediated transcription", "N00490  HTLV-1 p12 to calcineurin signaling pathway", "N00491  HTLV-1 p12 to Jak-STAT signaling pathway", "N00492  HTLV-1 p12 to antigen processing and presentation by MHC class I molecules", "N00494  HTLV-1 Tax to p16-cell cycle G1/S", "N00495  HTLV-1 Tax to p15-cell cycle G1/S", "N00497  HTLV-1 Tax to p21-cell cycle G1/S", "N00498  HTLV-1 Tax to p21-cell cycle G1/S", "N00500  HTLV-1 Tax to p21-cell cycle G2/M", "N00501  HTLV-1 Tax to EGFR-PI3K-NFKB signaling pathway", "N00502  HTLV-1 Tax to PTEN-PIP3-AKT signaling pathway", "N00503  HTLV-1 Tax to TNF-JNK signaling pathway", "N00504  HTLV-1 Tax to NFKB signaling pathway", "N00506  HTLV-1 Tax to CD40-NFKB signaling pathway", "N00507  HTLV-1 Tax to TGF-beta signaling pathway", "N00508  HTLV-1 Tax to NFY-mediated transcription", "N00509  HTLV-1 Tax to SRF-mediated transcription", "N00510  HTLV-1 Tax to CREB-mediated transcription", "N00511  HTLV-1 Tax to E47-mediated transcription", "N00512  HTLV-1 Tax to c-myc-mediated transcription"], "disease": ["H00009  Adult T-cell leukemia"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["6513  SLC2A1; solute carrier family 2 member 1 [KO:K07299]", "8829  NRP1; neuropilin 1 [KO:K06724]", "4609  MYC; MYC proto-oncogene, bHLH transcription factor [KO:K04377]", "8295  TRRAP; transformation/transcription domain associated protein [KO:K08874]", "10524  KAT5; lysine acetyltransferase 5 [KO:K11304] [EC:2.3.1.48]", "894  CCND2; cyclin D2 [KO:K10151]", "3683  ITGAL; integrin subunit alpha L [KO:K05718]", "3689  ITGB2; integrin subunit beta 2 [KO:K06464]", "3383  ICAM1; intercellular adhesion molecule 1 [KO:K06490]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "920  CD4; CD4 molecule [KO:K06454]", "7094  TLN1; talin 1 [KO:K06271]", "83660  TLN2; talin 2 [KO:K06271]", "8498  RANBP3; RAN binding protein 3 [KO:K15304]", "5901  RAN; RAN, member RAS oncogene family [KO:K07936]", "7514  XPO1; exportin 1 [KO:K14290]", "811  CALR; calreticulin [KO:K08057]", "821  CANX; calnexin [KO:K08054]", "5530  PPP3CA; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]", "5532  PPP3CB; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]", "5533  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]", "5534  PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]", "5535  PPP3R2; protein phosphatase 3 regulatory subunit B, beta [KO:K06268]", "4772  NFATC1; nuclear factor of activated T cells 1 [KO:K04446]", "4773  NFATC2; nuclear factor of activated T cells 2 [KO:K17332]", "4775  NFATC3; nuclear factor of activated T cells 3 [KO:K17333]", "4776  NFATC4; nuclear factor of activated T cells 4 [KO:K17334]", "3560  IL2RB; interleukin 2 receptor subunit beta [KO:K05069]", "3561  IL2RG; interleukin 2 receptor subunit gamma [KO:K05070]", "3716  JAK1; Janus kinase 1 [KO:K11217] [EC:2.7.10.2]", "3718  JAK3; Janus kinase 3 [KO:K11218] [EC:2.7.10.2]", "6776  STAT5A; signal transducer and activator of transcription 5A [KO:K11223]", "6777  STAT5B; signal transducer and activator of transcription 5B [KO:K11224]", "3558  IL2; interleukin 2 [KO:K05429]", "3105  HLA-A; major histocompatibility complex, class I, A [KO:K06751]", "3106  HLA-B; major histocompatibility complex, class I, B [KO:K06751]", "3107  HLA-C; major histocompatibility complex, class I, C [KO:K06751]", "3134  HLA-F; major histocompatibility complex, class I, F [KO:K06751]", "3135  HLA-G; major histocompatibility complex, class I, G [KO:K06751]", "3133  HLA-E; major histocompatibility complex, class I, E [KO:K06751]", "567  B2M; beta-2-microglobulin [KO:K08055]", "2224  FDPS; farnesyl diphosphate synthase [KO:K00787] [EC:2.5.1.1 2.5.1.10]", "7416  VDAC1; voltage dependent anion channel 1 [KO:K05862]", "291  SLC25A4; solute carrier family 25 member 4 [KO:K05863]", "292  SLC25A5; solute carrier family 25 member 5 [KO:K05863]", "293  SLC25A6; solute carrier family 25 member 6 [KO:K05863]", "83447  SLC25A31; solute carrier family 25 member 31 [KO:K05863]", "7417  VDAC2; voltage dependent anion channel 2 [KO:K15040]", "7419  VDAC3; voltage dependent anion channel 3 [KO:K15041]", "706  TSPO; translocator protein [KO:K05770]", "55697  VAC14; VAC14 component of PIKFYVE complex [KO:K15305]", "5902  RANBP1; RAN binding protein 1 [KO:K15306]", "8379  MAD1L1; mitotic arrest deficient 1 like 1 [KO:K06679]", "4085  MAD2L1; mitotic arrest deficient 2 like 1 [KO:K02537]", "701  BUB1B; BUB1 mitotic checkpoint serine/threonine kinase B [KO:K06637] [EC:2.7.11.1]", "9184  BUB3; BUB3 mitotic checkpoint protein [KO:K02180]", "64682  ANAPC1; anaphase promoting complex subunit 1 [KO:K03348]", "29882  ANAPC2; anaphase promoting complex subunit 2 [KO:K03349]", "996  CDC27; cell division cycle 27 [KO:K03350]", "29945  ANAPC4; anaphase promoting complex subunit 4 [KO:K03351]", "51433  ANAPC5; anaphase promoting complex subunit 5 [KO:K03352]", "8881  CDC16; cell division cycle 16 [KO:K03353]", "51434  ANAPC7; anaphase promoting complex subunit 7 [KO:K03354]", "8697  CDC23; cell division cycle 23 [KO:K03355]", "10393  ANAPC10; anaphase promoting complex subunit 10 [KO:K03357]", "51529  ANAPC11; anaphase promoting complex subunit 11 [KO:K03358]", "246184  CDC26; cell division cycle 26 [KO:K03359]", "25847  ANAPC13; anaphase promoting complex subunit 13 [KO:K12456]", "25906  ANAPC15; anaphase promoting complex subunit 15 [KO:K25228]", "119504  ANAPC16; anaphase promoting complex subunit 16 [KO:K25229]", "991  CDC20; cell division cycle 20 [KO:K03363]", "9232  PTTG1; PTTG1 regulator of sister chromatid separation, securin [KO:K06635]", "10744  PTTG2; pituitary tumor-transforming 2 [KO:K06635]", "9700  ESPL1; extra spindle pole bodies like 1, separase [KO:K02365] [EC:3.4.22.49]", "9133  CCNB2; cyclin B2 [KO:K21770]", "1030  CDKN2B; cyclin dependent kinase inhibitor 2B [KO:K04685]", "1029  CDKN2A; cyclin dependent kinase inhibitor 2A [KO:K06621]", "1019  CDK4; cyclin dependent kinase 4 [KO:K02089] [EC:2.7.11.22]", "595  CCND1; cyclin D1 [KO:K04503]", "896  CCND3; cyclin D3 [KO:K10152]", "1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]", "890  CCNA2; cyclin A2 [KO:K06627]", "8900  CCNA1; cyclin A1 [KO:K06627]", "898  CCNE1; cyclin E1 [KO:K06626]", "9134  CCNE2; cyclin E2 [KO:K06626]", "1017  CDK2; cyclin dependent kinase 2 [KO:K02206] [EC:2.7.11.22]", "5925  RB1; RB transcriptional corepressor 1 [KO:K06618]", "1869  E2F1; E2F transcription factor 1 [KO:K17454]", "1870  E2F2; E2F transcription factor 2 [KO:K09389]", "1871  E2F3; E2F transcription factor 3 [KO:K06620]", "472  ATM; ATM serine/threonine kinase [KO:K04728] [EC:2.7.11.1]", "545  ATR; ATR serine/threonine kinase [KO:K06640] [EC:2.7.11.1]", "1111  CHEK1; checkpoint kinase 1 [KO:K02216] [EC:2.7.11.1]", "11200  CHEK2; checkpoint kinase 2 [KO:K06641] [EC:2.7.11.1]", "7157  TP53; tumor protein p53 [KO:K04451]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "1739  DLG1; discs large MAGUK scaffold protein 1 [KO:K12076]", "5728  PTEN; phosphatase and tensin homolog [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]", "7124  TNF; tumor necrosis factor [KO:K03156]", "7132  TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158]", "4214  MAP3K1; mitogen-activated protein kinase kinase kinase 1 [KO:K04416] [EC:2.7.11.25]", "6416  MAP2K4; mitogen-activated protein kinase kinase 4 [KO:K04430] [EC:2.7.12.2]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "4316  MMP7; matrix metallopeptidase 7 [KO:K01397] [EC:3.4.24.23]", "3554  IL1R1; interleukin 1 receptor type 1 [KO:K04386]", "7850  IL1R2; interleukin 1 receptor type 2 [KO:K04387]", "915  CD3D; CD3 delta subunit of T-cell receptor complex [KO:K06450]", "916  CD3E; CD3 epsilon subunit of T-cell receptor complex [KO:K06451]", "917  CD3G; CD3 gamma subunit of T-cell receptor complex [KO:K06452]", "4215  MAP3K3; mitogen-activated protein kinase kinase kinase 3 [KO:K04421] [EC:2.7.11.25]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "2874  GPS2; G protein pathway suppressor 2 [KO:K15307]", "4055  LTBR; lymphotoxin beta receptor [KO:K03159]", "958  CD40; CD40 molecule [KO:K03160]", "115650  TNFRSF13C; TNF receptor superfamily member 13C [KO:K05151]", "9020  MAP3K14; mitogen-activated protein kinase kinase kinase 14 [KO:K04466] [EC:2.7.11.25]", "5971  RELB; RELB proto-oncogene, NF-kB subunit [KO:K09253]", "4791  NFKB2; nuclear factor kappa B subunit 2 [KO:K04469]", "7538  ZFP36; ZFP36 ring finger protein [KO:K15308]", "3559  IL2RA; interleukin 2 receptor subunit alpha [KO:K05068]", "3600  IL15; interleukin 15 [KO:K05433]", "3601  IL15RA; interleukin 15 receptor subunit alpha [KO:K05074]", "3569  IL6; interleukin 6 [KO:K05405]", "1437  CSF2; colony stimulating factor 2 [KO:K05427]", "4049  LTA; lymphotoxin alpha [KO:K05468]", "598  BCL2L1; BCL2 like 1 [KO:K04570]", "331  XIAP; X-linked inhibitor of apoptosis [KO:K04725] [EC:2.3.2.27]", "7040  TGFB1; transforming growth factor beta 1 [KO:K13375]", "7042  TGFB2; transforming growth factor beta 2 [KO:K13376]", "7043  TGFB3; transforming growth factor beta 3 [KO:K13377]", "7046  TGFBR1; transforming growth factor beta receptor 1 [KO:K04674] [EC:2.7.11.30]", "7048  TGFBR2; transforming growth factor beta receptor 2 [KO:K04388] [EC:2.7.11.30]", "4087  SMAD2; SMAD family member 2 [KO:K04500]", "4088  SMAD3; SMAD family member 3 [KO:K23605]", "4089  SMAD4; SMAD family member 4 [KO:K04501]", "107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]", "108  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]", "109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]", "196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]", "113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]", "114  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]", "115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "4801  NFYB; nuclear transcription factor Y subunit beta [KO:K08065]", "3108  HLA-DMA; major histocompatibility complex, class II, DM alpha [KO:K06752]", "3109  HLA-DMB; major histocompatibility complex, class II, DM beta [KO:K06752]", "3111  HLA-DOA; major histocompatibility complex, class II, DO alpha [KO:K06752]", "3112  HLA-DOB; major histocompatibility complex, class II, DO beta [KO:K06752]", "3113  HLA-DPA1; major histocompatibility complex, class II, DP alpha 1 [KO:K06752]", "3115  HLA-DPB1; major histocompatibility complex, class II, DP beta 1 [KO:K06752]", "3117  HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 [KO:K06752]", "3118  HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2 [KO:K06752]", "3119  HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 [KO:K06752]", "3122  HLA-DRA; major histocompatibility complex, class II, DR alpha [KO:K06752]", "3123  HLA-DRB1; major histocompatibility complex, class II, DR beta 1 [KO:K06752]", "3125  HLA-DRB3; major histocompatibility complex, class II, DR beta 3 [KO:K06752]", "3126  HLA-DRB4; major histocompatibility complex, class II, DR beta 4 [KO:K06752]", "3127  HLA-DRB5; major histocompatibility complex, class II, DR beta 5 [KO:K06752]", "6722  SRF; serum response factor [KO:K04378]", "2005  ELK4; ETS transcription factor ELK4 [KO:K04376]", "2002  ELK1; ETS transcription factor ELK1 [KO:K04375]", "6688  SPI1; Spi-1 proto-oncogene [KO:K09438]", "2113  ETS1; ETS proto-oncogene 1, transcription factor [KO:K02678]", "2114  ETS2; ETS proto-oncogene 2, transcription factor [KO:K21932]", "387332  TBPL2; TATA-box binding protein like 2 [KO:K03120]", "9519  TBPL1; TATA-box binding protein like 1 [KO:K03120]", "6908  TBP; TATA-box binding protein [KO:K03120]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "1958  EGR1; early growth response 1 [KO:K09203]", "8061  FOSL1; FOS like 1, AP-1 transcription factor subunit [KO:K04502]", "1959  EGR2; early growth response 2 [KO:K12496]", "1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]", "10488  CREB3; cAMP responsive element binding protein 3 [KO:K09048]", "90993  CREB3L1; cAMP responsive element binding protein 3 like 1 [KO:K09048]", "64764  CREB3L2; cAMP responsive element binding protein 3 like 2 [KO:K09048]", "84699  CREB3L3; cAMP responsive element binding protein 3 like 3 [KO:K09048]", "148327  CREB3L4; cAMP responsive element binding protein 3 like 4 [KO:K09048]", "1386  ATF2; activating transcription factor 2 [KO:K04450]", "468  ATF4; activating transcription factor 4 [KO:K04374]", "9586  CREB5; cAMP responsive element binding protein 5 [KO:K09047]", "1388  ATF6B; activating transcription factor 6 beta [KO:K09049]", "23373  CRTC1; CREB regulated transcription coactivator 1 [KO:K15309]", "200186  CRTC2; CREB regulated transcription coactivator 2 [KO:K16333]", "64784  CRTC3; CREB regulated transcription coactivator 3 [KO:K16334]", "1387  CREBBP; CREB binding protein [KO:K04498] [EC:2.3.1.48]", "2033  EP300; E1A binding protein p300 [KO:K04498] [EC:2.3.1.48]", "8850  KAT2B; lysine acetyltransferase 2B [KO:K06062] [EC:2.3.1.48]", "2648  KAT2A; lysine acetyltransferase 2A [KO:K06062] [EC:2.3.1.48]", "6929  TCF3; transcription factor 3 [KO:K09063]", "5423  POLB; DNA polymerase beta [KO:K02330] [EC:2.7.7.7 4.2.99.-]", "3932  LCK; LCK proto-oncogene, Src family tyrosine kinase [KO:K05856] [EC:2.7.10.2]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "1031  CDKN2C; cyclin dependent kinase inhibitor 2C [KO:K06622]", "7015  TERT; telomerase reverse transcriptase [KO:K11126] [EC:2.7.7.49]", "4487  MSX1; msh homeobox 1 [KO:K09341]", "4488  MSX2; msh homeobox 2 [KO:K09341]"], "compound": ["C00027  Hydrogen peroxide", "C00076  Calcium cation", "C00238  Potassium cation", "C00575  3',5'-Cyclic AMP", "C05981  Phosphatidylinositol-3,4,5-trisphosphate"], "refs": [{"pmid": "17384582", "authors": "  Matsuoka M, Jeang KT", "title": "Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation.", "journal": "Nat Rev Cancer 7:270-80 (2007)", "doi": "10.1038/nrc2111"}, {"pmid": "16155604", "authors": "  Grassmann R, Aboud M, Jeang KT", "title": "Molecular mechanisms of cellular transformation by HTLV-1 Tax.", "journal": "Oncogene 24:5976-85 (2005)", "doi": "10.1038/sj.onc.1208978"}, {"pmid": "18702816", "authors": "  Boxus M, Twizere JC, Legros S, Dewulf JF, Kettmann R, Willems L", "title": "The HTLV-1 Tax interactome.", "journal": "Retrovirology 5:76 (2008)", "doi": "10.1186/1742-4690-5-76"}, {"pmid": "21994754", "authors": "  Jones KS, Lambert S, Bouttier M, Benit L, Ruscetti FW, Hermine O, Pique C", "title": "Molecular aspects of HTLV-1 entry: functional domains of the HTLV-1 surface subunit (SU) and their relationships to the entry receptors.", "journal": "Viruses 3:794-810 (2011)", "doi": "10.3390/v3060794"}, {"pmid": "21114861", "authors": "  Ghez D, Lepelletier Y, Jones KS, Pique C, Hermine O", "title": "Current concepts regarding the HTLV-1 receptor complex.", "journal": "Retrovirology 7:99 (2010)", "doi": "10.1186/1742-4690-7-99"}, {"pmid": "18923409", "authors": "  Sattentau Q", "title": "Avoiding the void: cell-to-cell spread of human viruses.", "journal": "Nat Rev Microbiol 6:815-26 (2008)", "doi": "10.1038/nrmicro1972"}, {"pmid": "15040584", "authors": "  Vicente-Manzanares M, Sanchez-Madrid F", "title": "Role of the cytoskeleton during leukocyte responses.", "journal": "Nat Rev Immunol 4:110-22 (2004)", "doi": "10.1038/nri1268"}, {"pmid": "27334587", "authors": "  Dutartre H, Claviere M, Journo C, Mahieux R", "title": "Cell-Free versus Cell-to-Cell Infection by Human Immunodeficiency Virus Type 1 and Human T-Lymphotropic Virus Type 1: Exploring the Link among Viral Source, Viral Trafficking, and Viral Replication.", "journal": "J Virol 90:7607-17 (2016)", "doi": "10.1128/JVI.00407-16"}, {"pmid": "15988028", "authors": "  Awasthi S, Sharma A, Wong K, Zhang J, Matlock EF, Rogers L, Motloch P, Takemoto S, Taguchi H, Cole MD, Luscher B, Dittrich O, Tagami H, Nakatani Y, McGee M, Girard AM, Gaughan L, Robson CN, Monnat RJ Jr, Harrod R", "title": "A human T-cell lymphotropic virus type 1 enhancer of Myc transforming potential stabilizes Myc-TIP60 transcriptional interactions.", "journal": "Mol Cell Biol 25:6178-98 (2005)", "doi": "10.1128/MCB.25.14.6178-6198.2005"}, {"pmid": "21994758", "authors": "  Edwards D, Fenizia C, Gold H, de Castro-Amarante MF, Buchmann C, Pise-Masison CA, Franchini G", "title": "Orf-I and orf-II-encoded proteins in HTLV-1 infection and persistence.", "journal": "Viruses 3:861-85 (2011)", "doi": "10.3390/v3060861"}, {"pmid": "26927155", "authors": "  Nakano K, Watanabe T", "title": "HTLV-1 Rex Tunes the Cellular Environment Favorable for Viral Replication.", "journal": "Viruses 8:58 (2016)", "doi": "10.3390/v8030058"}, {"pmid": "22783232", "authors": "  Shida H", "title": "Role of Nucleocytoplasmic RNA Transport during the Life Cycle of Retroviruses.", "journal": "Front Microbiol 3:179 (2012)", "doi": "10.3389/fmicb.2012.00179"}, {"pmid": "23248621", "authors": "  Bai XT, Nicot C", "title": "Overview on HTLV-1 p12, p8, p30, p13: accomplices in persistent infection and viral pathogenesis.", "journal": "Front Microbiol 3:400 (2012)", "doi": "10.3389/fmicb.2012.00400"}, {"pmid": "18421579", "authors": "  Taylor JM, Nicot C", "title": "HTLV-1 and apoptosis: role in cellular transformation and recent advances in therapeutic approaches.", "journal": "Apoptosis 13:733-47 (2008)", "doi": "10.1007/s10495-008-0208-7"}, {"pmid": "15761473", "authors": "  D'Agostino DM, Silic-Benussi M, Hiraragi H, Lairmore MD, Ciminale V", "title": "The human T-cell leukemia virus type 1 p13II protein: effects on mitochondrial function and cell growth.", "journal": "Cell Death Differ 12 Suppl 1:905-15 (2005)", "doi": "10.1038/sj.cdd.4401576"}, {"pmid": "20332002", "authors": "  Silic-Benussi M, Biasiotto R, Andresen V, Franchini G, D'Agostino DM, Ciminale V", "title": "HTLV-1 p13, a small protein with a busy agenda.", "journal": "Mol Aspects Med 31:350-8 (2010)", "doi": "10.1016/j.mam.2010.03.001"}, {"pmid": "23741982", "authors": "  Fuentes-Gonzalez AM, Contreras-Paredes A, Manzo-Merino J, Lizano M", "title": "The modulation of apoptosis by oncogenic viruses.", "journal": "Virol J 10:182 (2013)", "doi": "10.1186/1743-422X-10-182"}, {"pmid": "21743832", "authors": "  Qu Z, Xiao G", "title": "Human T-cell lymphotropic virus: a model of NF-kappaB-associated tumorigenesis.", "journal": "Viruses 3:714-49 (2011)", "doi": "10.3390/v3060714"}, {"pmid": "21994767", "authors": "  Saggioro D", "title": "Anti-apoptotic effect of Tax: an NF-kappaB path or a CREB way?", "journal": "Viruses 3:1001-14 (2011)", "doi": "10.3390/v3071001"}, {"pmid": "16036567", "authors": "  Harhaj EW, Harhaj NS", "title": "Mechanisms of persistent NF-kappaB activation by HTLV-I tax.", "journal": "IUBMB Life 57:83-91 (2005)", "doi": "10.1080/15216540500078715"}, {"pmid": "16155602", "authors": "  Sun SC, Yamaoka S", "title": "Activation of NF-kappaB by HTLV-I and implications for cell transformation.", "journal": "Oncogene 24:5952-64 (2005)", "doi": "10.1038/sj.onc.1208969"}, {"pmid": "9710600", "authors": "  Geleziunas R, Ferrell S, Lin X, Mu Y, Cunningham ET Jr, Grant M, Connelly MA, Hambor JE, Marcu KB, Greene WC", "title": "Human T-cell leukemia virus type 1 Tax induction of NF-kappaB involves activation of the IkappaB kinase alpha (IKKalpha) and IKKbeta cellular kinases.", "journal": "Mol Cell Biol 18:5157-65 (1998)", "doi": "10.1128/MCB.18.9.5157"}, {"pmid": "21315773", "authors": "  Nakachi S, Nakazato T, Ishikawa C, Kimura R, Mann DA, Senba M, Masuzaki H, Mori N", "title": "Human T-cell leukemia virus type 1 tax transactivates the matrix metalloproteinase 7 gene via JunD/AP-1 signaling.", "journal": "Biochim Biophys Acta 1813:731-41 (2011)", "doi": "10.1016/j.bbamcr.2011.02.002"}, {"pmid": "26797638", "authors": "  James CD, Roberts S", "title": "Viral Interactions with PDZ Domain-Containing Proteins-An Oncogenic Trait?", "journal": "Pathogens 5:E8 (2016)", "doi": "10.3390/pathogens5010008"}, {"pmid": "26324707", "authors": "  Cherian MA, Baydoun HH, Al-Saleem J, Shkriabai N, Kvaratskhelia M, Green P, Ratner L", "title": "Akt Pathway Activation by Human T-cell Leukemia Virus Type 1 Tax Oncoprotein.", "journal": "J Biol Chem 290:26270-81 (2015)", "doi": "10.1074/jbc.M115.684746"}, {"pmid": "11264182", "authors": "  Mori N, Morishita M, Tsukazaki T, Giam CZ, Kumatori A, Tanaka Y, Yamamoto N", "title": "Human T-cell leukemia virus type I oncoprotein Tax represses Smad-dependent transforming growth factor beta signaling through interaction with CREB-binding protein/p300.", "journal": "Blood 97:2137-44 (2001)", "doi": "10.1182/blood.v97.7.2137"}, {"pmid": "15310405", "authors": "  Azran I, Schavinsky-Khrapunsky Y, Aboud M", "title": "Role of Tax protein in human T-cell leukemia virus type-I leukemogenicity.", "journal": "Retrovirology 1:20 (2004)", "doi": "10.1186/1742-4690-1-20"}, {"pmid": "11244044", "authors": "  Yoshida M", "title": "Multiple viral strategies of HTLV-1 for dysregulation of cell growth control.", "journal": "Annu Rev Immunol 19:475-96 (2001)", "doi": "10.1146/annurev.immunol.19.1.475"}], "rel_pathway": ["hsa03013  Nucleocytoplasmic transport", "hsa04010  MAPK signaling pathway", "hsa04064  NF-kappa B signaling pathway", "hsa04110  Cell cycle", "hsa04115  p53 signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04210  Apoptosis", "hsa04350  TGF-beta signaling pathway", "hsa04612  Antigen processing and presentation", "hsa04660  T cell receptor signaling pathway", "hsa04668  TNF signaling pathway"], "ko_pathway": "ko05166", "genes": ["PTEN", "IL2R", "TP53", "AKT2", "AKT1", "NRAS", "BAX"]}, {"kegg_id": "hsa05200", "name": "Pathways in cancer - Homo sapiens (human)", "class": "Human Diseases; Cancer: overview", "pathway_map": "hsa05200  Pathways in cancer", "drug": ["D00094  Tretinoin (JAN/USP/INN)", "D00327  Fluoxymesterone (JAN/USP/INN)", "D00408  Methyltestosterone (JP18/USP/INN)", "D00554  Ethinyl estradiol (USP)", "D00586  Flutamide (JP18/USP/INN)", "D00745  Interferon alfa-2a (USAN/INN)", "D00747  Interferon gamma-1b (USAN/INN)", "D00748  Aldesleukin (USAN/INN)", "D00753  Sirolimus (JAN/USAN/INN)", "D00958  Testosterone enanthate (JP18/USP)", "D00961  Bicalutamide (JP18/USP/INN)", "D00965  Nilutamide (USAN/INN)", "D00966  Tamoxifen citrate (JP18/USP)", "D00967  Toremifene citrate (JAN/USAN)", "D01161  Fulvestrant (JAN/USP/INN)", "D01441  Imatinib mesylate (USAN)", "D01534  Dromostanolone propionate (USAN)", "D01977  Gefitinib (JP18/USAN/INN)", "D02106  Arsenic trioxide (JP18/USAN)", "D02714  Everolimus (JAN/USAN/INN)", "D02745  Interferon alfa-2b (USAN)", "D02748  Peginterferon alfa-2b (USAN/INN)", "D02815  Alitretinoin (USAN)", "D02970  Aprinocarsen sodium (USAN)", "D03061  Batimastat (USAN/INN)", "D03106  Bexarotene (JAN/USAN/INN)", "D03218  Axitinib (JAN/USAN)", "D03235  Filgrastim (USP/INN)", "D03247  Lenograstim (USAN/INN)", "D03252  Bosutinib (USAN)", "D03257  Trastuzumab (USAN/INN)", "D03305  Interferon alfa (NAMALWA) (JP18)", "D03350  Canertinib dihydrochloride (USAN)", "D03357  Interferon gamma-1a (genetical recombination) (JAN)", "D03455  Cetuximab (USAN/INN)", "D03658  Dasatinib (JAN/INN)", "D03682  Denileukin diftitox (USAN/INN)", "D03800  Rebimastat (USAN/INN)", "D03802  Tanomastat (USAN/INN)", "D04014  Enzastaurin hydrochloride (JAN/USAN)", "D04023  Erlotinib hydrochloride (JAN/USAN)", "D04024  Lapatinib ditosylate (USAN)", "D04025  Mubritinib (USAN/INN)", "D04162  Fenretinide (USAN/INN)", "D04696  Lestaurtinib (USAN/INN)", "D04862  Masoprocol (USAN/INN)", "D05029  Midostaurin (JAN/USAN/INN)", "D05350  Panitumumab (USAN/INN)", "D05380  Pazopanib hydrochloride (JAN/USAN)", "D05386  Pegaptanib sodium (JAN/USAN)", "D05399  Pelitinib (USAN/INN)", "D05446  Pertuzumab (USAN/INN)", "D05803  Sargramostim (USP/INN)", "D05819  Semaxanib (USAN/INN)", "D06005  Tandutinib (USAN/INN)", "D06068  Temsirolimus (JAN/USAN/INN)", "D06272  Sorafenib tosylate (USAN)", "D06285  Vatalanib (USAN/INN)", "D06320  Vorinostat (JAN/USAN)", "D06402  Sunitinib malate (JAN/USAN)", "D06407  Vandetanib (JAN/USAN/INN)", "D06409  Bevacizumab (USAN)", "D06413  Nilotinib hydrochloride hydrate (JAN)", "D06414  Dasatinib (USAN)", "D06554  Alvespimycin hydrochloride (USAN)", "D06563  Belagenpumatucel-L (USAN)", "D06610  Lapuleucel-T (USAN)", "D06637  Romidepsin (JAN/USAN/INN)", "D06678  Motesanib (USAN)", "D06889  Pegfilgrastim (USAN/INN)", "D07434  Polyestradiol phosphate (INN)", "D07741  Zibotentan (JAN/USAN/INN)", "D07907  Erlotinib (INN)", "D08066  Imatinib (INN)", "D08108  Lapatinib (INN)", "D08524  Sorafenib (USAN/INN)", "D08552  Sunitinib (INN)", "D08559  Tamoxifen (INN)", "D08805  Interferon gamma-n1 (JAN)", "D08870  Belinostat (USAN/INN)", "D08881  Cediranib (USAN/INN)", "D08883  Cediranib maleate (JAN/USAN)", "D08900  Ridaforolimus (JAN/USAN/INN)", "D08917  Ezatiostat hydrochloride (USAN)", "D08947  Motesanib diphosphate (USAN)", "D08950  Neratinib (USAN/INN)", "D08953  Nilotinib (USAN/INN)", "D08956  Omacetaxine mepesuccinate (USAN)", "D08971  Plerixafor (JAN/USAN/INN)", "D09328  Cixutumumab (USAN)", "D09338  Entinostat (JAN/USAN/INN)", "D09357  Mocetinostat dihydrobromide (USAN)", "D09574  Aflibercept (USAN/INN)", "D09604  Dinaciclib (USAN/INN)", "D09629  Imetelstat (USAN/INN)", "D09630  Imetelstat sodium (USAN)", "D09635  Linifanib (USAN/INN)", "D09641  Mocetinostat (USAN/INN)", "D09659  Rilotumumab (USAN/INN)", "D09660  Rindopepimut (USAN)", "D09683  Tivozanib (USAN/INN)", "D09689  Varlitinib (USAN/INN)", "D09690  Varlitinib tosylate (USAN)", "D09724  Afatinib (USAN/INN)", "D09728  Bosutinib hydrate (JAN)", "D09731  Crizotinib (JAN/USAN/INN)", "D09733  Afatinib dimaleate (USAN)", "D09746  Dalotuzumab (USAN)", "D09864  Amuvatinib (USAN/INN)", "D09865  Amuvatinib hydrochloride (USAN)", "D09908  Ganitumab (USAN/INN)", "D09909  Gataparsen (USAN/INN)", "D09910  Gataparsen sodium (USAN)", "D09919  Lenvatinib (USAN/INN)", "D09920  Lenvatinib mesylate (USAN)", "D09939  Olaratumab (USAN/INN)", "D09941  Onartuzumab (USAN/INN)", "D09950  Ponatinib (USAN/INN)", "D09951  Ponatinib hydrochloride (JAN/USAN)", "D09955  Quizartinib (USAN/INN)", "D09956  Quizartinib dihydrochloride (USAN)", "D09959  Ruxolitinib (USAN/INN)", "D09960  Ruxolitinib phosphate (JAN/USAN)", "D09980  Trastuzumab emtansine (USAN/INN)", "D09992  Vismodegib (USAN/INN)", "D09996  Vemurafenib (JAN/USAN/INN)", "D10015  Litgenprostucel-L (USAN)", "D10019  Panobinostat lactate (JAN)", "D10031  Zalutumumab (USAN/INN)", "D10060  Abexinostat (USAN)", "D10062  Cabozantinib (USAN)", "D10064  Dabrafenib (USAN)", "D10076  Olcorolimus (USAN)", "D10084  Abexinostat hydrochloride (USAN)", "D10095  Cabozantinib s-malate (USAN)", "D10102  Crenolanib (USAN)", "D10103  Crenolanib besylate (USAN)", "D10104  Dabrafenib mesylate (USAN)", "D10119  Sonidegib (USAN/INN)", "D10123  Ficlatuzumab (USAN)", "D10137  Regorafenib hydrate (JAN)", "D10138  Regorafenib (USAN/INN)", "D10164  Sepantronium bromide (JAN/USAN)", "D10173  Tivantinib (JAN/USAN/INN)", "D10175  Trametinib (USAN)", "D10176  Trametinib dimethyl sulfoxide (JAN/USAN)", "D10189  Pictilisib (USAN/INN)", "D10190  Tivozanib hydrochloride (USAN)", "D10218  Enzalutamide (JAN/USAN)", "D10224  Golvatinib (USAN)", "D10229  Masitinib (INN)", "D10242  Lipegfilgrastim (USAN)", "D10319  Panobinostat (USAN/INN)", "D10321  Quisinostat (USAN/INN)", "D10322  Quisinostat hydrochloride (USAN)", "D10324  Patidegib (USAN/INN)", "D10325  Patidegib hydrochloride (USAN)", "D10334  Rebastinib (USAN)", "D10372  Palbociclib (JAN/USAN)", "D10381  Afuresertib (USAN/INN)", "D10382  Afuresertib hydrochloride (USAN)", "D10396  Nintedanib esylate (USAN)", "D10399  Rebastinib Tosylate (USAN)", "D10405  Cobimetinib (USAN/INN)", "D10410  Vantictumab (USAN/INN)", "D10423  Ilorasertib (USAN/INN)", "D10426  Pimasertib (USAN/INN)", "D10437  Galunisertib (USAN/INN)", "D10446  Margetuximab (USAN/INN)", "D10450  Alectinib hydrochloride (JAN)", "D10464  Firtecan pegol (USAN/INN)", "D10465  Golvatinib tartrate (USAN)", "D10481  Nintedanib (USAN/INN)", "D10486  Pimasertib hydrochloride (USAN)", "D10542  Alectinib (USAN/INN)", "D10543  Apitolisib (USAN/INN)", "D10551  Ceritinib (JAN/USAN/INN)", "D10552  Dactolisib (USAN/INN)", "D10555  Duvelisib (USAN/INN)", "D10560  Idelalisib (JAN/USAN/INN)", "D10584  Buparlisib (USAN/INN)", "D10604  Binimetinib (JAN/USAN/INN)", "D10609  Buparlisib hydrochloride (JAN/USAN)", "D10615  Cobimetinib fumarate (USAN)", "D10616  Dactolisib tosylate (USAN)", "D10635  Gedatolisib (USAN/INN)", "D10636  Glasdegib (USAN/INN)", "D10641  Ipatasertib (USAN/INN)", "D10652  Palbociclib isethionate (USAN)", "D10671  Taladegib (USAN/INN)", "D10679  Venetoclax (JAN/USAN/INN)", "D10688  Abemaciclib (JAN/USAN/INN)", "D10696  Capmatinib (USAN/INN)", "D10709  Gilteritinib (USAN/INN)", "D10717  Napabucasin (JAN/USAN/INN)", "D10718  Omipalisib (USAN/INN)", "D10729  Sonidegib phosphate (USAN)", "D10766  Osimertinib mesylate (USAN)", "D10797  Copanlisib hydrochloride (USAN)", "D10798  Copanlisib hydrochloride hydrate (JAN)", "D10800  Gilteritinib fumarate (JAN/USAN)", "D10858  Rociletinib (USAN/INN)", "D10859  Olmutinib (USAN/INN)", "D10866  Brigatinib (JAN/USAN)", "D10867  Copanlisib (USAN/INN)", "D10883  Ribociclib (USAN/INN)", "D10891  Capmatinib hydrochloride (USAN)", "D10898  Neratinib maleate", "D10924  Dezapelisib (USAN/INN)", "D10926  Entrectinib (JAN/USAN/INN)", "D10927  Erdafitinib (JAN/USAN/INN)", "D10958  Naquotinib (USAN/INN)", "D10977  Remetinostat (USAN/INN)", "D10979  Ribociclib succinate (USAN)", "D10981  Rovalpituzumab tesirine (USAN/INN)", "D10993  Tucidinostat (JAN/USAN/INN)", "D11011  Alpelisib (JAN/USAN/INN)", "D11012  Lorlatinib (JAN/USAN/INN)", "D11032  Plitidepsin (INN)", "D11038  Ulixertinib (INN)", "D11040  Apalutamide (JAN/INN)", "D11045  Darolutamide (JAN/USAN/INN)", "D11053  Encorafenib (JAN/USAN/INN)", "D11073  Tepotinib hydrochloride (USAN)", "D11074  Ipatasertib hydrochloride (JAN)", "D11107  Glasdegib maleate (JAN)", "D11115  Olmutinib hydrochloride (USAN)", "D11117  Rovalpituzumab (USAN)", "D11125  Modotuximab (USAN/INN)", "D11126  Navicixizumab (USAN/INN)", "D11130  Trilaciclib (USAN/INN)", "D11136  Glesatinib (USAN/INN)", "D11137  Larotrectinib (USAN/INN)", "D11138  Larotrectinib sulfate (JAN/USAN)", "D11139  Savolitinib (USAN/INN)", "D11140  Sitravatinib (USAN/INN)", "D11141  Tucatinib (USAN/INN)", "D11151  Crenigacestat (USAN/INN)", "D11182  Tinostamustine (USAN/INN)", "D11184  Ralaniten (USAN/INN)", "D11185  Ralaniten acetate (USAN)", "D11229  Brontictuzumab (USAN/INN)", "D11234  Emactuzumab (USAN/INN)", "D11251  Icotinib", "D11264  Brilanestrant (USAN/INN)", "D11270  Pexidartinib (USAN/INN)", "D11271  Pexidartinib hydrochloride (JAN/USAN)", "D11279  Avapritinib (USAN/INN)", "D11307  Telisotuzumab (USAN)", "D11323  Umbralisib tosylate (USAN)", "D11344  Telisotuzumab vedotin (USAN)", "D11346  Ensartinib (USAN)", "D11353  Ripretinib (USAN)", "D11356  Ensartinib hydrochloride (USAN)", "D11358  Tagraxofusp (USAN/INN)", "D11371  Capivasertib (JAN/USAN)", "D11403  Asciminib (USAN/INN)", "D11404  Asciminib hydrochloride (JAN/USAN)", "D11409  Miransertib (USAN/INN)", "D11410  Lifirafenib (USAN/INN)", "D11411  Lifirafenib maleate (USAN)", "D11417  Pemigatinib (JAN/USAN/INN)", "D11430  Nazartinib (USAN/INN)", "D11434  Nazartinib mesylate (USAN)", "D11437  Parsaclisib (USAN/INN)", "D11440  Bimiralisib (USAN/INN)", "D11442  Nanatinostat (USAN)", "D11454  Repotrectinib (JAN/USAN)", "D11455  Lerociclib (USAN)", "D11461  Derazantinib hydrochloride (USAN)", "D11501  Samotolisib (USAN)", "D11506  Parsaclisib hydrochloride (JAN/USAN)", "D11508  Miransertib mesylate (USAN)", "D11529  Trastuzumab deruxtecan (USAN/INN)", "D11541  Sitravatinib malate (USAN)", "D11589  Infigratinib (USAN/INN)", "D11599  Zotiraciclib (USAN)", "D11600  Zotiraciclib citrate (USAN)", "D11642  Dilpacimab (USAN/INN)", "D11658  Duvelisib hydrate (JAN)", "D11663  Onatasertib (USAN)", "D11669  Bempegaldesleukin (USAN/INN)", "D11671  Elacestrant (USAN/INN)", "D11672  Elacestrant hydrochloride (USAN)", "D11675  Mirdametinib (USAN)", "D11712  Pralsetinib (USAN/INN)", "D11713  Selpercatinib (JAN/USAN/INN)", "D11717  Tepotinib (USAN/INN)", "D11725  Futibatinib (JAN/USAN/INN)", "D11727  Voxtalisib (USAN/INN)", "D11737  Fisogatinib (USAN/INN)", "D11747  Inbakicept (USAN/INN)", "D11762  Lucitanib (USAN/INN)", "D11763  Merestinib (USAN/INN)", "D11768  Pacritinib (USAN/INN)", "D11772  Tesevatinib (USAN/INN)", "D11773  Tesevatinib tosylate (USAN)", "D11774  Taselisib (USAN/INN)", "D11775  Tarextumab (USAN/INN)", "D11786  Vodobatinib (USAN)", "D11803  Cetuximab sarotalocan (USAN/INN)", "D11805  Cetuximab sarotalocan sodium (genetical recombination) (JAN)", "D11821  Nogapendekin alfa (USAN/INN)", "D11872  Serclutamab (USAN/INN)", "D11874  Serclutamab talirine (USAN/INN)", "D11885  Surufatinib (USAN/INN)", "D11890  Emvododstat (USAN)", "D11894  Amivantamab (USAN/INN)", "D11935  Enzastaurin (USAN/INN)", "D11942  Inavolisib (USAN/INN)", "D11954  Belzutifan (JAN/USAN/INN)", "D11969  Mobocertinib succinate (JAN)", "D11980  Lazertinib (USAN)", "D11987  Trilaciclib dihydrochloride", "D12001  Mobocertinib (USAN/INN)", "D12009  Zandelisib (JAN/USAN/INN)", "D12011  Zanidatamab (USAN/INN)", "D12049  Camizestrant (JAN/USAN)", "D12055  Sotorasib (JAN/USAN)", "D12059  Temuterkib (USAN)", "D12060  Temuterkib mesylate (USAN)", "D12128  Balixafortide (USAN/INN)", "D12145  Amcenestrant (JAN/USAN/INN)", "D12175  Olverembatinib (USAN/INN)", "D12229  Poziotinib (USAN/INN)", "D12230  Poziotinib hydrochloride (USAN)", "D12245  Lazertinib mesilate hydrate (JAN)", "D12258  Aumolertinib (USAN/INN)", "D12259  Aumolertinib mesylate (USAN)", "D12281  Motixafortide (USAN/INN)", "D12282  Motixafortide acetate (USAN)", "D12291  Tovorafenib (USAN/INN)", "D12301  Adagrasib (USAN/INN)", "D12303  Deutenzalutamide (USAN)", "D12304  Elraglusib (USAN)", "D12307  Pivekimab (USAN)", "D12316  Bavdegalutamide (USAN)", "D12330  Zeteletinib (USAN)", "D12331  Zeteletinib adipate (USAN)", "D12354  Pralsetinib hydrate (JAN)", "D12363  Taletrectinib (USAN/INN)", "D12364  Taletrectinib adipate (USAN)", "D12399  Sulanemadlin (USAN/INN)", "D12404  Tasurgratinib (INN)", "D12405  Tasurgratinib succinate (JAN)", "D12416  Petosemtamab (USAN/INN)", "D12424  Davutamig (USAN)", "D12432  Zurletrectinib (USAN)", "D12442  Tucatinib ethanolate (JAN)", "D12444  Nilotinib hydrochloride dihydrate (JAN)", "D12445  Foscenvivint (JAN/INN)", "D12457  Tuxobertinib (USAN/INN)", "D12476  Tuspetinib (USAN/INN)", "D12506  Sunvozertinib (USAN/INN)", "D12514  Amdizalisib (USAN/INN)", "D12515  Avutometinib (USAN/INN)", "D12526  Catequentinib (USAN/INN)", "D12531  Nadofaragene firadenovec (USAN/INN)", "D12534  Avutometinib potassium (USAN)", "D12537  Catequentinib hydrochloride (USAN)", "D12545  Tinengotinib (USAN/INN)", "D12551  Bocodepsin (USAN)", "D12552  Bocodepsin besylate (USAN)", "D12557  Elzovantinib (USAN/INN)", "D12558  Emzadirib (USAN)", "D12559  Enbezotinib (USAN/INN)", "D12583  Anvatabart opadotin (USAN/INN)", "D12584  Anvatabart pactil (USAN/INN)", "D12600  Bezuclastinib (USAN/INN)", "D12601  Tagtociclib (USAN)", "D12625  Pegenzileukin (USAN/INN)", "D12628  Vepdegestrant (JAN/USAN/INN)", "D12639  Divarasib (USAN/INN)", "D12640  Divarasib adipate (USAN)", "D12641  Emirodatamab (USAN/INN)", "D12643  Masofaniten (USAN/INN)", "D12646  Paltimatrectinib (USAN/INN)", "D12650  Zanzalintinib (USAN/INN)", "D12651  Zanzalintinib fumarate (USAN)", "D12705  Gumarontinib hydrate (JAN)", "D12730  Tigozertinib (USAN)", "D12768  Ficerafusp alfa (USAN)", "D12809  Bafisontamab (USAN/INN)", "D12827  Palazestrant (USAN/INN)", "D12831  Naporafenib (USAN/INN)", "D12834  Atirmociclib (USAN)", "D12836  Risovalisib (INN)", "D12837  Risovalisib mesilate hydrate (JAN)", "D12853  Olomorasib (USAN)", "D12854  Nilotinib laurylsulfate (USAN)", "D12859  Pebezertinib (USAN)", "D12865  Beroterkib (USAN)", "D12866  Gridegalutamide (USAN)", "D12879  Zongertinib (USAN/INN)", "D12883  Sonrotoclax (USAN/INN)", "D12888  Nogapendekin alfa inbakicept"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["1630  DCC; DCC netrin 1 receptor [KO:K06765]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]", "26060  APPL1; adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1 [KO:K08733]", "999  CDH1; cadherin 1 [KO:K05689]", "1499  CTNNB1; catenin beta 1 [KO:K02105]", "29119  CTNNA3; catenin alpha 3 [KO:K05691]", "1495  CTNNA1; catenin alpha 1 [KO:K05691]", "1496  CTNNA2; catenin alpha 2 [KO:K05691]", "8312  AXIN1; axin 1 [KO:K02157]", "8313  AXIN2; axin 2 [KO:K04385]", "324  APC; APC regulator of WNT signaling pathway [KO:K02085]", "10297  APC2; APC regulator of WNT signaling pathway 2 [KO:K02085]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "6932  TCF7; transcription factor 7 [KO:K02620]", "83439  TCF7L1; transcription factor 7 like 1 [KO:K04490]", "6934  TCF7L2; transcription factor 7 like 2 [KO:K04491]", "51176  LEF1; lymphoid enhancer binding factor 1 [KO:K04492]", "332  BIRC5; baculoviral IAP repeat containing 5 [KO:K08731]", "4609  MYC; MYC proto-oncogene, bHLH transcription factor [KO:K04377]", "595  CCND1; cyclin D1 [KO:K04503]", "7471  WNT1; Wnt family member 1 [KO:K03209]", "7472  WNT2; Wnt family member 2 [KO:K00182]", "7482  WNT2B; Wnt family member 2B [KO:K00182]", "7473  WNT3; Wnt family member 3 [KO:K00312]", "89780  WNT3A; Wnt family member 3A [KO:K00312]", "54361  WNT4; Wnt family member 4 [KO:K00408]", "7474  WNT5A; Wnt family member 5A [KO:K00444]", "81029  WNT5B; Wnt family member 5B [KO:K00444]", "7475  WNT6; Wnt family member 6 [KO:K00445]", "7476  WNT7A; Wnt family member 7A [KO:K00572]", "7477  WNT7B; Wnt family member 7B [KO:K00572]", "7478  WNT8A; Wnt family member 8A [KO:K00714]", "7479  WNT8B; Wnt family member 8B [KO:K00714]", "7483  WNT9A; Wnt family member 9A [KO:K01064]", "7484  WNT9B; Wnt family member 9B [KO:K01064]", "7480  WNT10B; Wnt family member 10B [KO:K01357]", "80326  WNT10A; Wnt family member 10A [KO:K01357]", "7481  WNT11; Wnt family member 11 [KO:K01384]", "51384  WNT16; Wnt family member 16 [KO:K01558]", "8321  FZD1; frizzled class receptor 1 [KO:K02432]", "8324  FZD7; frizzled class receptor 7 [KO:K02432]", "2535  FZD2; frizzled class receptor 2 [KO:K02235]", "7976  FZD3; frizzled class receptor 3 [KO:K02329]", "8322  FZD4; frizzled class receptor 4 [KO:K02354]", "7855  FZD5; frizzled class receptor 5 [KO:K02375]", "8325  FZD8; frizzled class receptor 8 [KO:K02375]", "8323  FZD6; frizzled class receptor 6 [KO:K02376]", "11211  FZD10; frizzled class receptor 10 [KO:K02842]", "8326  FZD9; frizzled class receptor 9 [KO:K02842]", "4041  LRP5; LDL receptor related protein 5 [KO:K03068]", "4040  LRP6; LDL receptor related protein 6 [KO:K03068]", "1857  DVL3; dishevelled segment polarity protein 3 [KO:K02353]", "1856  DVL2; dishevelled segment polarity protein 2 [KO:K02353]", "1855  DVL1; dishevelled segment polarity protein 1 [KO:K02353]", "10023  FRAT1; FRAT regulator of WNT signaling pathway 1 [KO:K03069]", "23401  FRAT2; FRAT regulator of WNT signaling pathway 2 [KO:K03096]", "2147  F2; coagulation factor II, thrombin [KO:K01313] [EC:3.4.21.5]", "183  AGT; angiotensinogen [KO:K09821]", "2149  F2R; coagulation factor II thrombin receptor [KO:K03914]", "9002  F2RL3; F2R like thrombin or trypsin receptor 3 [KO:K04236]", "1902  LPAR1; lysophosphatidic acid receptor 1 [KO:K04289]", "9170  LPAR2; lysophosphatidic acid receptor 2 [KO:K04291]", "23566  LPAR3; lysophosphatidic acid receptor 3 [KO:K04294]", "2846  LPAR4; lysophosphatidic acid receptor 4 [KO:K04275]", "57121  LPAR5; lysophosphatidic acid receptor 5 [KO:K08390]", "10161  LPAR6; lysophosphatidic acid receptor 6 [KO:K04273]", "185  AGTR1; angiotensin II receptor type 1 [KO:K04166]", "2768  GNA12; G protein subunit alpha 12 [KO:K04346]", "10672  GNA13; G protein subunit alpha 13 [KO:K04639]", "23365  ARHGEF12; Rho guanine nucleotide exchange factor 12 [KO:K07532]", "9826  ARHGEF11; Rho guanine nucleotide exchange factor 11 [KO:K12331]", "9138  ARHGEF1; Rho guanine nucleotide exchange factor 1 [KO:K12330]", "57449  PLEKHG5; pleckstrin homology and RhoGEF domain containing G5 [KO:K19464]", "387  RHOA; ras homolog family member A [KO:K04513]", "6093  ROCK1; Rho associated coiled-coil containing protein kinase 1 [KO:K04514] [EC:2.7.11.1]", "9475  ROCK2; Rho associated coiled-coil containing protein kinase 2 [KO:K17388] [EC:2.7.11.1]", "6387  CXCL12; C-X-C motif chemokine ligand 12 [KO:K10031]", "7852  CXCR4; C-X-C motif chemokine receptor 4 [KO:K04189]", "2770  GNAI1; G protein subunit alpha i1 [KO:K04630]", "2773  GNAI3; G protein subunit alpha i3 [KO:K04630]", "2771  GNAI2; G protein subunit alpha i2 [KO:K04630]", "5731  PTGER1; prostaglandin E receptor 1 [KO:K04258]", "5732  PTGER2; prostaglandin E receptor 2 [KO:K04259]", "5733  PTGER3; prostaglandin E receptor 3 [KO:K04260]", "5734  PTGER4; prostaglandin E receptor 4 [KO:K04261]", "2778  GNAS; GNAS complex locus [KO:K04632]", "107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]", "108  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]", "109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]", "196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]", "113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]", "114  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]", "115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "2782  GNB1; G protein subunit beta 1 [KO:K04536]", "2783  GNB2; G protein subunit beta 2 [KO:K04537]", "2784  GNB3; G protein subunit beta 3 [KO:K07825]", "59345  GNB4; G protein subunit beta 4 [KO:K04538]", "10681  GNB5; G protein subunit beta 5 [KO:K04539]", "54331  GNG2; G protein subunit gamma 2 [KO:K07826]", "2785  GNG3; G protein subunit gamma 3 [KO:K04540]", "2786  GNG4; G protein subunit gamma 4 [KO:K04541]", "2787  GNG5; G protein subunit gamma 5 [KO:K04542]", "2788  GNG7; G protein subunit gamma 7 [KO:K04543]", "94235  GNG8; G protein subunit gamma 8 [KO:K04544]", "2790  GNG10; G protein subunit gamma 10 [KO:K04545]", "2791  GNG11; G protein subunit gamma 11 [KO:K04546]", "55970  GNG12; G protein subunit gamma 12 [KO:K04347]", "51764  GNG13; G protein subunit gamma 13 [KO:K04547]", "2792  GNGT1; G protein subunit gamma transducin 1 [KO:K04548]", "2793  GNGT2; G protein subunit gamma transducin 2 [KO:K04549]", "1284  COL4A2; collagen type IV alpha 2 chain [KO:K06237]", "1286  COL4A4; collagen type IV alpha 4 chain [KO:K06237]", "1288  COL4A6; collagen type IV alpha 6 chain [KO:K06237]", "1282  COL4A1; collagen type IV alpha 1 chain [KO:K06237]", "1287  COL4A5; collagen type IV alpha 5 chain [KO:K06237]", "1285  COL4A3; collagen type IV alpha 3 chain [KO:K06237]", "284217  LAMA1; laminin subunit alpha 1 [KO:K05637]", "3908  LAMA2; laminin subunit alpha 2 [KO:K05637]", "3909  LAMA3; laminin subunit alpha 3 [KO:K06240]", "3911  LAMA5; laminin subunit alpha 5 [KO:K06240]", "3910  LAMA4; laminin subunit alpha 4 [KO:K06241]", "3912  LAMB1; laminin subunit beta 1 [KO:K05636]", "3913  LAMB2; laminin subunit beta 2 [KO:K06243]", "3914  LAMB3; laminin subunit beta 3 [KO:K06244]", "22798  LAMB4; laminin subunit beta 4 [KO:K06245]", "3915  LAMC1; laminin subunit gamma 1 [KO:K05635]", "3918  LAMC2; laminin subunit gamma 2 [KO:K06246]", "10319  LAMC3; laminin subunit gamma 3 [KO:K06247]", "2335  FN1; fibronectin 1 [KO:K05717]", "3673  ITGA2; integrin subunit alpha 2 [KO:K06481]", "3674  ITGA2B; integrin subunit alpha 2b [KO:K06476]", "3675  ITGA3; integrin subunit alpha 3 [KO:K06482]", "3655  ITGA6; integrin subunit alpha 6 [KO:K06485]", "3685  ITGAV; integrin subunit alpha V [KO:K06487]", "3688  ITGB1; integrin subunit beta 1 [KO:K05719]", "5747  PTK2; protein tyrosine kinase 2 [KO:K05725] [EC:2.7.10.2]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5728  PTEN; phosphatase and tensin homolog [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]", "4824  NKX3-1; NK3 homeobox 1 [KO:K09348]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "4791  NFKB2; nuclear factor kappa B subunit 2 [KO:K04469]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "5743  PTGS2; prostaglandin-endoperoxide synthase 2 [KO:K11987] [EC:1.14.99.1]", "4843  NOS2; nitric oxide synthase 2 [KO:K13241] [EC:1.14.13.39]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]", "329  BIRC2; baculoviral IAP repeat containing 2 [KO:K16060]", "330  BIRC3; baculoviral IAP repeat containing 3 [KO:K16060]", "331  XIAP; X-linked inhibitor of apoptosis [KO:K04725] [EC:2.3.2.27]", "79444  BIRC7; baculoviral IAP repeat containing 7 [KO:K16061]", "598  BCL2L1; BCL2 like 1 [KO:K04570]", "7185  TRAF1; TNF receptor associated factor 1 [KO:K03172]", "7186  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]", "7187  TRAF3; TNF receptor associated factor 3 [KO:K03174]", "9618  TRAF4; TNF receptor associated factor 4 [KO:K09848]", "7188  TRAF5; TNF receptor associated factor 5 [KO:K09849]", "7189  TRAF6; TNF receptor associated factor 6 [KO:K03175] [EC:2.3.2.27]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "6198  RPS6KB1; ribosomal protein S6 kinase B1 [KO:K04688] [EC:2.7.11.1]", "6199  RPS6KB2; ribosomal protein S6 kinase B2 [KO:K04688] [EC:2.7.11.1]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]", "2308  FOXO1; forkhead box O1 [KO:K07201]", "4193  MDM2; MDM2 proto-oncogene [KO:K06643] [EC:2.3.2.27]", "7157  TP53; tumor protein p53 [KO:K04451]", "1027  CDKN1B; cyclin dependent kinase inhibitor 1B [KO:K06624]", "1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]", "613  BCR; BCR activator of RhoGEF and GTPase [KO:K08878] [EC:2.7.11.1]", "25  ABL1; ABL proto-oncogene 1, non-receptor tyrosine kinase [KO:K06619] [EC:2.7.10.2]", "1398  CRK; CRK proto-oncogene, adaptor protein [KO:K04438]", "1399  CRKL; CRK like proto-oncogene, adaptor protein [KO:K04438]", "867  CBL; Cbl proto-oncogene [KO:K04707] [EC:2.3.2.27]", "6776  STAT5A; signal transducer and activator of transcription 5A [KO:K11223]", "6777  STAT5B; signal transducer and activator of transcription 5B [KO:K11224]", "5292  PIM1; Pim-1 proto-oncogene, serine/threonine kinase [KO:K04702] [EC:2.7.11.1]", "11040  PIM2; Pim-2 proto-oncogene, serine/threonine kinase [KO:K08806] [EC:2.7.11.1]", "3827  KNG1; kininogen 1 [KO:K03898]", "1906  EDN1; endothelin 1 [KO:K16366]", "623  BDKRB1; bradykinin receptor B1 [KO:K03915]", "624  BDKRB2; bradykinin receptor B2 [KO:K03916]", "1909  EDNRA; endothelin receptor type A [KO:K04197]", "1910  EDNRB; endothelin receptor type B [KO:K04198]", "2776  GNAQ; G protein subunit alpha q [KO:K04634]", "2767  GNA11; G protein subunit alpha 11 [KO:K04635]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "3558  IL2; interleukin 2 [KO:K05429]", "3562  IL3; interleukin 3 [KO:K04736]", "3565  IL4; interleukin 4 [KO:K05430]", "3567  IL5; interleukin 5 [KO:K05428]", "3569  IL6; interleukin 6 [KO:K05405]", "3574  IL7; interleukin 7 [KO:K05431]", "3592  IL12A; interleukin 12A [KO:K05406]", "3593  IL12B; interleukin 12B [KO:K05425]", "3596  IL13; interleukin 13 [KO:K05435]", "3600  IL15; interleukin 15 [KO:K05433]", "51561  IL23A; interleukin 23 subunit alpha [KO:K05426]", "2056  EPO; erythropoietin [KO:K05437]", "3439  IFNA1; interferon alpha 1 [KO:K05414]", "3440  IFNA2; interferon alpha 2 [KO:K05414]", "3441  IFNA4; interferon alpha 4 [KO:K05414]", "3442  IFNA5; interferon alpha 5 [KO:K05414]", "3443  IFNA6; interferon alpha 6 [KO:K05414]", "3444  IFNA7; interferon alpha 7 [KO:K05414]", "3445  IFNA8; interferon alpha 8 [KO:K05414]", "3446  IFNA10; interferon alpha 10 [KO:K05414]", "3447  IFNA13; interferon alpha 13 [KO:K05414]", "3448  IFNA14; interferon alpha 14 [KO:K05414]", "3449  IFNA16; interferon alpha 16 [KO:K05414]", "3451  IFNA17; interferon alpha 17 [KO:K05414]", "3452  IFNA21; interferon alpha 21 [KO:K05414]", "3458  IFNG; interferon gamma [KO:K04687]", "3559  IL2RA; interleukin 2 receptor subunit alpha [KO:K05068]", "3560  IL2RB; interleukin 2 receptor subunit beta [KO:K05069]", "3561  IL2RG; interleukin 2 receptor subunit gamma [KO:K05070]", "3563  IL3RA; interleukin 3 receptor subunit alpha [KO:K04737]", "3566  IL4R; interleukin 4 receptor [KO:K05071]", "1439  CSF2RB; colony stimulating factor 2 receptor subunit beta [KO:K04738]", "3568  IL5RA; interleukin 5 receptor subunit alpha [KO:K05067]", "3570  IL6R; interleukin 6 receptor [KO:K05055]", "3572  IL6ST; interleukin 6 cytokine family signal transducer [KO:K05060]", "3575  IL7R; interleukin 7 receptor [KO:K05072]", "3594  IL12RB1; interleukin 12 receptor subunit beta 1 [KO:K05063]", "3595  IL12RB2; interleukin 12 receptor subunit beta 2 [KO:K05064]", "3597  IL13RA1; interleukin 13 receptor subunit alpha 1 [KO:K05076]", "3601  IL15RA; interleukin 15 receptor subunit alpha [KO:K05074]", "149233  IL23R; interleukin 23 receptor [KO:K05065]", "2057  EPOR; erythropoietin receptor [KO:K05079]", "3454  IFNAR1; interferon alpha and beta receptor subunit 1 [KO:K05130]", "3455  IFNAR2; interferon alpha and beta receptor subunit 2 [KO:K05131]", "3459  IFNGR1; interferon gamma receptor 1 [KO:K05132]", "3460  IFNGR2; interferon gamma receptor 2 [KO:K05133]", "27436  EML4; EMAP like 4 [KO:K15420]", "238  ALK; ALK receptor tyrosine kinase [KO:K05119] [EC:2.7.10.1]", "10125  RASGRP1; RAS guanyl releasing protein 1 [KO:K04350]", "10235  RASGRP2; RAS guanyl releasing protein 2 [KO:K12361]", "25780  RASGRP3; RAS guanyl releasing protein 3 [KO:K12362]", "115727  RASGRP4; RAS guanyl releasing protein 4 [KO:K12363]", "3716  JAK1; Janus kinase 1 [KO:K11217] [EC:2.7.10.2]", "3717  JAK2; Janus kinase 2 [KO:K04447] [EC:2.7.10.2]", "3718  JAK3; Janus kinase 3 [KO:K11218] [EC:2.7.10.2]", "6774  STAT3; signal transducer and activator of transcription 3 [KO:K04692]", "6772  STAT1; signal transducer and activator of transcription 1 [KO:K11220]", "6773  STAT2; signal transducer and activator of transcription 2 [KO:K11221]", "6775  STAT4; signal transducer and activator of transcription 4 [KO:K11222]", "6778  STAT6; signal transducer and activator of transcription 6 [KO:K11225]", "7422  VEGFA; vascular endothelial growth factor A [KO:K05448]", "7423  VEGFB; vascular endothelial growth factor B [KO:K16858]", "5228  PGF; placental growth factor [KO:K16859]", "7424  VEGFC; vascular endothelial growth factor C [KO:K05449]", "2277  VEGFD; vascular endothelial growth factor D [KO:K05449]", "7039  TGFA; transforming growth factor alpha [KO:K08774]", "1950  EGF; epidermal growth factor [KO:K04357]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "2064  ERBB2; erb-b2 receptor tyrosine kinase 2 [KO:K05083] [EC:2.7.10.1]", "5154  PDGFA; platelet derived growth factor subunit A [KO:K04359]", "5155  PDGFB; platelet derived growth factor subunit B [KO:K17386]", "5156  PDGFRA; platelet derived growth factor receptor alpha [KO:K04363] [EC:2.7.10.1]", "5159  PDGFRB; platelet derived growth factor receptor beta [KO:K05089] [EC:2.7.10.1]", "3479  IGF1; insulin like growth factor 1 [KO:K05459]", "3481  IGF2; insulin like growth factor 2 [KO:K13769]", "3480  IGF1R; insulin like growth factor 1 receptor [KO:K05087] [EC:2.7.10.1]", "4254  KITLG; KIT ligand [KO:K05461]", "3815  KIT; KIT proto-oncogene, receptor tyrosine kinase [KO:K05091] [EC:2.7.10.1]", "2323  FLT3LG; fms related receptor tyrosine kinase 3 ligand [KO:K05454]", "2322  FLT3; fms related receptor tyrosine kinase 3 [KO:K05092] [EC:2.7.10.1]", "3082  HGF; hepatocyte growth factor [KO:K05460]", "4233  MET; MET proto-oncogene, receptor tyrosine kinase [KO:K05099] [EC:2.7.10.1]", "2246  FGF1; fibroblast growth factor 1 [KO:K18496]", "2247  FGF2; fibroblast growth factor 2 [KO:K18497]", "2248  FGF3; fibroblast growth factor 3 [KO:K04358]", "2249  FGF4; fibroblast growth factor 4 [KO:K04358]", "8822  FGF17; fibroblast growth factor 17 [KO:K04358]", "2251  FGF6; fibroblast growth factor 6 [KO:K04358]", "2252  FGF7; fibroblast growth factor 7 [KO:K04358]", "2253  FGF8; fibroblast growth factor 8 [KO:K04358]", "2254  FGF9; fibroblast growth factor 9 [KO:K04358]", "2255  FGF10; fibroblast growth factor 10 [KO:K04358]", "8823  FGF16; fibroblast growth factor 16 [KO:K04358]", "2250  FGF5; fibroblast growth factor 5 [KO:K04358]", "8817  FGF18; fibroblast growth factor 18 [KO:K04358]", "26281  FGF20; fibroblast growth factor 20 [KO:K04358]", "27006  FGF22; fibroblast growth factor 22 [KO:K04358]", "9965  FGF19; fibroblast growth factor 19 [KO:K22603]", "26291  FGF21; fibroblast growth factor 21 [KO:K22429]", "8074  FGF23; fibroblast growth factor 23 [KO:K22428]", "2260  FGFR1; fibroblast growth factor receptor 1 [KO:K04362] [EC:2.7.10.1]", "2263  FGFR2; fibroblast growth factor receptor 2 [KO:K05093] [EC:2.7.10.1]", "2261  FGFR3; fibroblast growth factor receptor 3 [KO:K05094] [EC:2.7.10.1]", "2264  FGFR4; fibroblast growth factor receptor 4 [KO:K05095] [EC:2.7.10.1]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "369  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "2113  ETS1; ETS proto-oncogene 1, transcription factor [KO:K02678]", "4312  MMP1; matrix metallopeptidase 1 [KO:K01388] [EC:3.4.24.7]", "4313  MMP2; matrix metallopeptidase 2 [KO:K01398] [EC:3.4.24.24]", "4318  MMP9; matrix metallopeptidase 9 [KO:K01403] [EC:3.4.24.35]", "3576  CXCL8; C-X-C motif chemokine ligand 8 [KO:K10030]", "1019  CDK4; cyclin dependent kinase 4 [KO:K02089] [EC:2.7.11.22]", "9252  RPS6KA5; ribosomal protein S6 kinase A5 [KO:K04445] [EC:2.7.11.1]", "5979  RET; ret proto-oncogene [KO:K05126] [EC:2.7.10.1]", "8030  CCDC6; coiled-coil domain containing 6 [KO:K09288]", "8031  NCOA4; nuclear receptor coactivator 4 [KO:K09289]", "4914  NTRK1; neurotrophic receptor tyrosine kinase 1 [KO:K03176] [EC:2.7.10.1]", "7170  TPM3; tropomyosin 3 [KO:K09290]", "7175  TPR; translocated promoter region, nuclear basket protein [KO:K09291]", "10342  TFG; trafficking from ER to golgi regulator [KO:K09292]", "11186  RASSF1; Ras association domain family member 1 [KO:K09850]", "83593  RASSF5; Ras association domain family member 5 [KO:K08015]", "6789  STK4; serine/threonine kinase 4 [KO:K04411]", "1612  DAPK1; death associated protein kinase 1 [KO:K08803] [EC:2.7.11.1]", "1613  DAPK3; death associated protein kinase 3 [KO:K08803] [EC:2.7.11.1]", "23604  DAPK2; death associated protein kinase 2 [KO:K08803] [EC:2.7.11.1]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]", "2002  ELK1; ETS transcription factor ELK1 [KO:K04375]", "810  CALML3; calmodulin like 3 [KO:K02183]", "805  CALM2; calmodulin 2 [KO:K02183]", "808  CALM3; calmodulin 3 [KO:K02183]", "801  CALM1; calmodulin 1 [KO:K02183]", "163688  CALML6; calmodulin like 6 [KO:K02183]", "51806  CALML5; calmodulin like 5 [KO:K02183]", "91860  CALML4; calmodulin like 4 [KO:K02183]", "815  CAMK2A; calcium/calmodulin dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]", "817  CAMK2D; calcium/calmodulin dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]", "816  CAMK2B; calcium/calmodulin dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]", "818  CAMK2G; calcium/calmodulin dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]", "5900  RALGDS; ral guanine nucleotide dissociation stimulator [KO:K08732]", "5898  RALA; RAS like proto-oncogene A [KO:K07834]", "5899  RALB; RAS like proto-oncogene B [KO:K07835]", "10928  RALBP1; ralA binding protein 1 [KO:K08773]", "998  CDC42; cell division cycle 42 [KO:K04393]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "5880  RAC2; Rac family small GTPase 2 [KO:K07860]", "5881  RAC3; Rac family small GTPase 3 [KO:K07861]", "5337  PLD1; phospholipase D1 [KO:K01115] [EC:3.1.4.4]", "5338  PLD2; phospholipase D2 [KO:K01115] [EC:3.1.4.4]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "7849  PAX8; paired box 8 [KO:K09293]", "5468  PPARG; peroxisome proliferator activated receptor gamma [KO:K08530]", "6256  RXRA; retinoid X receptor alpha [KO:K08524]", "6257  RXRB; retinoid X receptor beta [KO:K08525]", "6258  RXRG; retinoid X receptor gamma [KO:K08526]", "5915  RARB; retinoic acid receptor beta [KO:K08528]", "2099  ESR1; estrogen receptor 1 [KO:K08550]", "2100  ESR2; estrogen receptor 2 [KO:K08551]", "8648  NCOA1; nuclear receptor coactivator 1 [KO:K09101] [EC:2.3.1.48]", "8202  NCOA3; nuclear receptor coactivator 3 [KO:K11256] [EC:2.3.1.48]", "6667  SP1; Sp1 transcription factor [KO:K04684]", "5467  PPARD; peroxisome proliferator activated receptor delta [KO:K04504]", "3728  JUP; junction plakoglobin [KO:K10056]", "7704  ZBTB16; zinc finger and BTB domain containing 16 [KO:K10055]", "5914  RARA; retinoic acid receptor alpha [KO:K08527]", "890  CCNA2; cyclin A2 [KO:K06627]", "8900  CCNA1; cyclin A1 [KO:K06627]", "5371  PML; PML nuclear body scaffold [KO:K10054] [EC:2.3.2.-]", "861  RUNX1; RUNX family transcription factor 1 [KO:K08367]", "862  RUNX1T1; RUNX1 partner transcriptional co-repressor 1 [KO:K10053]", "6688  SPI1; Spi-1 proto-oncogene [KO:K09438]", "1050  CEBPA; CCAAT enhancer binding protein alpha [KO:K09055]", "1438  CSF2RA; colony stimulating factor 2 receptor subunit alpha [KO:K05066]", "1441  CSF3R; colony stimulating factor 3 receptor [KO:K05061]", "1436  CSF1R; colony stimulating factor 1 receptor [KO:K05090] [EC:2.7.10.1]", "1029  CDKN2A; cyclin dependent kinase inhibitor 2A [KO:K06621]", "1869  E2F1; E2F transcription factor 1 [KO:K17454]", "1870  E2F2; E2F transcription factor 2 [KO:K09389]", "1871  E2F3; E2F transcription factor 3 [KO:K06620]", "4149  MAX; MYC associated factor X [KO:K04453]", "7709  ZBTB17; zinc finger and BTB domain containing 17 [KO:K10500]", "1030  CDKN2B; cyclin dependent kinase inhibitor 2B [KO:K04685]", "1021  CDK6; cyclin dependent kinase 6 [KO:K02091] [EC:2.7.11.22]", "894  CCND2; cyclin D2 [KO:K10151]", "896  CCND3; cyclin D3 [KO:K10152]", "1163  CKS1B; CDC28 protein kinase regulatory subunit 1B [KO:K02219]", "1164  CKS2; CDC28 protein kinase regulatory subunit 2 [KO:K02219]", "6500  SKP1; S-phase kinase associated protein 1 [KO:K03094]", "8454  CUL1; cullin 1 [KO:K03347]", "9978  RBX1; ring-box 1 [KO:K03868] [EC:2.3.2.32]", "6502  SKP2; S-phase kinase associated protein 2 [KO:K03875]", "1017  CDK2; cyclin dependent kinase 2 [KO:K02206] [EC:2.7.11.22]", "898  CCNE1; cyclin E1 [KO:K06626]", "9134  CCNE2; cyclin E2 [KO:K06626]", "5925  RB1; RB transcriptional corepressor 1 [KO:K06618]", "1647  GADD45A; growth arrest and DNA damage inducible alpha [KO:K04402]", "4616  GADD45B; growth arrest and DNA damage inducible beta [KO:K04402]", "10912  GADD45G; growth arrest and DNA damage inducible gamma [KO:K04402]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "578  BAK1; BCL2 antagonist/killer 1 [KO:K14021]", "1643  DDB2; damage specific DNA binding protein 2 [KO:K10140]", "51426  POLK; DNA polymerase kappa [KO:K03511] [EC:2.7.7.7]", "7015  TERT; telomerase reverse transcriptase [KO:K11126] [EC:2.7.7.49]", "7012  TERC; telomerase RNA component [KO:K22183]", "4286  MITF; melanocyte inducing transcription factor [KO:K09455]", "7040  TGFB1; transforming growth factor beta 1 [KO:K13375]", "7042  TGFB2; transforming growth factor beta 2 [KO:K13376]", "7043  TGFB3; transforming growth factor beta 3 [KO:K13377]", "7046  TGFBR1; transforming growth factor beta receptor 1 [KO:K04674] [EC:2.7.11.30]", "7048  TGFBR2; transforming growth factor beta receptor 2 [KO:K04388] [EC:2.7.11.30]", "4087  SMAD2; SMAD family member 2 [KO:K04500]", "4088  SMAD3; SMAD family member 3 [KO:K23605]", "4089  SMAD4; SMAD family member 4 [KO:K04501]", "2122  MECOM; MDS1 and EVI1 complex locus [KO:K04462] [EC:2.1.1.367]", "1487  CTBP1; C-terminal binding protein 1 [KO:K04496] [EC:1.1.1.428]", "1488  CTBP2; C-terminal binding protein 2 [KO:K04496] [EC:1.1.1.428]", "3065  HDAC1; histone deacetylase 1 [KO:K06067] [EC:3.5.1.98]", "3066  HDAC2; histone deacetylase 2 [KO:K06067] [EC:3.5.1.98]", "4292  MLH1; mutL homolog 1 [KO:K08734]", "4436  MSH2; mutS homolog 2 [KO:K08735]", "4437  MSH3; mutS homolog 3 [KO:K08736]", "2956  MSH6; mutS homolog 6 [KO:K08737]", "675  BRCA2; BRCA2 DNA repair associated [KO:K08775]", "5888  RAD51; RAD51 recombinase [KO:K04482]", "356  FASLG; Fas ligand [KO:K04389]", "355  FAS; Fas cell surface death receptor [KO:K04390]", "8772  FADD; Fas associated via death domain [KO:K02373]", "841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]", "637  BID; BH3 interacting domain death agonist [KO:K04726]", "5366  PMAIP1; phorbol-12-myristate-13-acetate-induced protein 1 [KO:K10131]", "27113  BBC3; BCL2 binding component 3 [KO:K10132]", "10018  BCL2L11; BCL2 like 11 [KO:K16341]", "54205  CYCS; cytochrome c, somatic [KO:K08738]", "317  APAF1; apoptotic peptidase activating factor 1 [KO:K02084]", "840  CASP7; caspase 7 [KO:K04397] [EC:3.4.22.60]", "9817  KEAP1; kelch like ECH associated protein 1 [KO:K10456]", "4780  NFE2L2; NFE2 like bZIP transcription factor 2 [KO:K05638]", "3162  HMOX1; heme oxygenase 1 [KO:K00510] [EC:1.14.14.18]", "1728  NQO1; NAD(P)H quinone dehydrogenase 1 [KO:K00355] [EC:1.6.5.2]", "221357  GSTA5; glutathione S-transferase alpha 5 [KO:K00799] [EC:2.5.1.18]", "2939  GSTA2; glutathione S-transferase alpha 2 [KO:K00799] [EC:2.5.1.18]", "2941  GSTA4; glutathione S-transferase alpha 4 [KO:K00799] [EC:2.5.1.18]", "119391  GSTO2; glutathione S-transferase omega 2 [KO:K00799] [EC:2.5.1.18]", "2948  GSTM4; glutathione S-transferase mu 4 [KO:K00799] [EC:2.5.1.18]", "2953  GSTT2; glutathione S-transferase theta 2 (gene/pseudogene) [KO:K00799] [EC:2.5.1.18]", "2952  GSTT1; glutathione S-transferase theta 1 [KO:K00799] [EC:2.5.1.18]", "2947  GSTM3; glutathione S-transferase mu 3 [KO:K00799] [EC:2.5.1.18]", "4257  MGST1; microsomal glutathione S-transferase 1 [KO:K00799] [EC:2.5.1.18]", "4259  MGST3; microsomal glutathione S-transferase 3 [KO:K00799] [EC:2.5.1.18]", "2944  GSTM1; glutathione S-transferase mu 1 [KO:K00799] [EC:2.5.1.18]", "2949  GSTM5; glutathione S-transferase mu 5 [KO:K00799] [EC:2.5.1.18]", "4258  MGST2; microsomal glutathione S-transferase 2 [KO:K00799] [EC:2.5.1.18]", "2938  GSTA1; glutathione S-transferase alpha 1 [KO:K00799] [EC:2.5.1.18]", "2946  GSTM2; glutathione S-transferase mu 2 [KO:K00799] [EC:2.5.1.18]", "2940  GSTA3; glutathione S-transferase alpha 3 [KO:K00799] [EC:2.5.1.18]", "9446  GSTO1; glutathione S-transferase omega 1 [KO:K00799] [EC:2.5.1.18]", "653689  GSTT2B; glutathione S-transferase theta 2B [KO:K00799] [EC:2.5.1.18]", "2950  GSTP1; glutathione S-transferase pi 1 [KO:K23790] [EC:2.5.1.18]", "7296  TXNRD1; thioredoxin reductase 1 [KO:K22182] [EC:1.8.1.9]", "114112  TXNRD3; thioredoxin reductase 3 [KO:K22182] [EC:1.8.1.9]", "10587  TXNRD2; thioredoxin reductase 2 [KO:K22182] [EC:1.8.1.9]", "7428  VHL; von Hippel-Lindau tumor suppressor [KO:K03871]", "6921  ELOC; elongin C [KO:K03872]", "6923  ELOB; elongin B [KO:K03873]", "8453  CUL2; cullin 2 [KO:K03870]", "54583  EGLN1; egl-9 family hypoxia inducible factor 1 [KO:K09592] [EC:1.14.11.29]", "112399  EGLN3; egl-9 family hypoxia inducible factor 3 [KO:K09592] [EC:1.14.11.29]", "112398  EGLN2; egl-9 family hypoxia inducible factor 2 [KO:K09592] [EC:1.14.11.29]", "2271  FH; fumarate hydratase [KO:K01679] [EC:4.2.1.2]", "3091  HIF1A; hypoxia inducible factor 1 subunit alpha [KO:K08268]", "2034  EPAS1; endothelial PAS domain protein 1 [KO:K09095]", "405  ARNT; aryl hydrocarbon receptor nuclear translocator [KO:K09097]", "9915  ARNT2; aryl hydrocarbon receptor nuclear translocator 2 [KO:K15589]", "1387  CREBBP; CREB binding protein [KO:K04498] [EC:2.3.1.48]", "2033  EP300; E1A binding protein p300 [KO:K04498] [EC:2.3.1.48]", "6513  SLC2A1; solute carrier family 2 member 1 [KO:K07299]", "182  JAG1; jagged canonical Notch ligand 1 [KO:K06052]", "3714  JAG2; jagged canonical Notch ligand 2 [KO:K21635]", "10683  DLL3; delta like canonical Notch ligand 3 [KO:K06051]", "28514  DLL1; delta like canonical Notch ligand 1 [KO:K06051]", "54567  DLL4; delta like canonical Notch ligand 4 [KO:K06051]", "4851  NOTCH1; notch receptor 1 [KO:K02599]", "4853  NOTCH2; notch receptor 2 [KO:K20994]", "4854  NOTCH3; notch receptor 3 [KO:K20995]", "4855  NOTCH4; notch receptor 4 [KO:K20996]", "3280  HES1; hes family bHLH transcription factor 1 [KO:K06054]", "388585  HES5; hes family bHLH transcription factor 5 [KO:K06055]", "26508  HEYL; hes related family bHLH transcription factor with YRPW motif like [KO:K09091]", "23462  HEY1; hes related family bHLH transcription factor with YRPW motif 1 [KO:K09091]", "23493  HEY2; hes related family bHLH transcription factor with YRPW motif 2 [KO:K09091]", "2324  FLT4; fms related receptor tyrosine kinase 4 [KO:K05097] [EC:2.7.10.1]", "6469  SHH; sonic hedgehog signaling molecule [KO:K11988]", "5727  PTCH1; patched 1 [KO:K06225]", "6608  SMO; smoothened, frizzled class receptor [KO:K06226]", "374654  KIF7; kinesin family member 7 [KO:K18806]", "51684  SUFU; SUFU negative regulator of hedgehog signaling [KO:K06229]", "2735  GLI1; GLI family zinc finger 1 [KO:K16797]", "2736  GLI2; GLI family zinc finger 2 [KO:K16798]", "2737  GLI3; GLI family zinc finger 3 [KO:K06230]", "650  BMP2; bone morphogenetic protein 2 [KO:K21283]", "652  BMP4; bone morphogenetic protein 4 [KO:K04662]", "64399  HHIP; hedgehog interacting protein [KO:K06231]", "8643  PTCH2; patched 2 [KO:K11101]", "367  AR; androgen receptor [KO:K08557]", "3320  HSP90AA1; heat shock protein 90 alpha family class A member 1 [KO:K04079]", "3326  HSP90AB1; heat shock protein 90 alpha family class B member 1 [KO:K04079]", "7184  HSP90B1; heat shock protein 90 beta family member 1 [KO:K09487]", "354  KLK3; kallikrein related peptidase 3 [KO:K01351] [EC:3.4.21.77]"], "compound": ["C00027  Hydrogen peroxide", "C00039  DNA", "C00076  Calcium cation", "C00122  Fumarate", "C00149  (S)-Malate", "C00165  Diacylglycerol", "C00187  Cholesterol", "C00280  Androstenedione", "C00410  Progesterone", "C00416  Phosphatidate", "C00533  Nitric oxide", "C00535  Testosterone", "C00575  3',5'-Cyclic AMP", "C00584  Prostaglandin E2", "C00681  1-Acyl-sn-glycerol 3-phosphate", "C00704  Superoxide", "C00735  Cortisol", "C00762  Cortisone", "C00777  Retinoate", "C00951  Estradiol-17beta", "C01227  Dehydroepiandrosterone", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C01471  Acrolein", "C03917  Dihydrotestosterone", "C05981  Phosphatidylinositol-3,4,5-trisphosphate", "C07653  Flutamide", "C15493  9-cis-Retinoic acid", "C16038  2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine", "C16844  Hydroxyl radical", "C21641  Hydroperoxyl radical", "C21642  4-Hydroxynonenal"], "refs": [{"pmid": "10647931", "authors": "  Hanahan D, Weinberg RA", "title": "The hallmarks of cancer.", "journal": "Cell 100:57-70 (2000)", "doi": "10.1016/S0092-8674(00)81683-9"}, {"pmid": "15000146", "authors": "  Grady WM.", "title": "Genomic instability and colon cancer.", "journal": "Cancer Metastasis Rev 23:11-27 (2004)", "doi": "10.1023/A:1025861527711"}, {"pmid": "16555243", "authors": "  Soreide K, Janssen EA, Soiland H, Korner H, Baak JP.", "title": "Microsatellite instability in colorectal cancer.", "journal": "Br J Surg 93:395-406 (2006)", "doi": "10.1002/bjs.5328"}, {"pmid": "11078609", "authors": "  Anwar S, Hall C, White J, Deakin M, Farrell W, Elder JB.", "title": "Hereditary non-polyposis colorectal cancer: an updated review.", "journal": "Eur J Surg Oncol 26:635-45 (2000)", "doi": "10.1053/ejso.2000.0974"}, {"pmid": "16699851", "authors": "  Takayama T, Miyanishi K, Hayashi T, Sato Y, Niitsu Y.", "title": "Colorectal cancer: genetics of development and metastasis.", "journal": "J Gastroenterol 41:185-92 (2006)", "doi": "10.1007/s00535-006-1801-6"}, {"pmid": "12621137", "authors": "  Lynch HT, de la Chapelle A.", "title": "Hereditary colorectal cancer.", "journal": "N Engl J Med 348:919-32 (2003)", "doi": "10.1056/NEJMra012242"}, {"pmid": "12951588", "authors": "  Rajagopalan H, Nowak MA, Vogelstein B, Lengauer C.", "title": "The significance of unstable chromosomes in colorectal cancer.", "journal": "Nat Rev Cancer 3:695-701 (2003)", "doi": "10.1038/nrc1165"}, {"pmid": "10505543", "authors": "  Behrens J.", "title": "Cadherins and catenins: role in signal transduction and tumor progression.", "journal": "Cancer Metastasis Rev 18:15-30 (1999)", "doi": "10.1023/A:1006200102166"}, {"pmid": "16042571", "authors": "  Behrens J.", "title": "The role of the Wnt signalling pathway in colorectal tumorigenesis.", "journal": "Biochem Soc Trans 33:672-5 (2005)", "doi": "10.1042/BST0330672"}, {"pmid": "15349822", "authors": "  Behrens J, Lustig B.", "title": "The Wnt connection to tumorigenesis.", "journal": "Int J Dev Biol 48:477-87 (2004)", "doi": "10.1387/ijdb.041815jb"}, {"pmid": "9196022", "authors": "  Polakis P.", "title": "The adenomatous polyposis coli (APC) tumor suppressor.", "journal": "Biochim Biophys Acta 1332:F127-47 (1997)", "doi": "10.1016/S0304-419X(97)00008-5"}, {"pmid": "12737309", "authors": "  Janssen KP.", "title": "Murine models of colorectal cancer: studying the role of oncogenic K-ras.", "journal": "Cell Mol Life Sci 60:495-506 (2003)", "doi": "10.1007/s000180300041"}, {"pmid": "11459867", "authors": "  Adjei AA.", "title": "Blocking oncogenic Ras signaling for cancer therapy.", "journal": "J Natl Cancer Inst 93:1062-74 (2001)", "doi": "10.1093/jnci/93.14.1062"}, {"pmid": "15573119", "authors": "  Arakawa H.", "title": "Netrin-1 and its receptors in tumorigenesis.", "journal": "Nat Rev Cancer 4:978-87 (2004)", "doi": "10.1038/nrc1504"}, {"pmid": "15310786", "authors": "  Mehlen P, Fearon ER.", "title": "Role of the dependence receptor DCC in colorectal cancer pathogenesis.", "journal": "J Clin Oncol 22:3420-8 (2004)", "doi": "10.1200/JCO.2004.02.019"}, {"pmid": "11223406", "authors": "  Peltomaki P.", "title": "DNA mismatch repair and cancer.", "journal": "Mutat Res 488:77-85 (2001)", "doi": "10.1016/S1383-5742(00)00058-2"}, {"pmid": "15711891", "authors": "  Li F, Cao Y, Townsend CM Jr, Ko TC.", "title": "TGF-beta signaling in colon cancer cells.", "journal": "World J Surg 29:306-11 (2005)", "doi": "10.1007/s00268-004-7813-6"}, {"pmid": "11170304", "authors": "  Roman C, Saha D, Beauchamp R.", "title": "TGF-beta and colorectal carcinogenesis.", "journal": "Microsc Res Tech 52:450-7 (2001)", "doi": "10.1002/1097-0029(20010215)52:4<450::AID-JEMT1030>3.0.CO;2-O"}, {"pmid": "16326109", "authors": "  Watson AJ.", "title": "An overview of apoptosis and the prevention of colorectal cancer.", "journal": "Crit Rev Oncol Hematol 57:107-21 (2006)", "doi": "10.1016/j.critrevonc.2005.06.005"}, {"pmid": "15479695", "authors": "  Watson AJ.", "title": "Apoptosis and colorectal cancer.", "journal": "Gut 53:1701-9 (2004)", "doi": "10.1136/gut.2004.052704"}, {"pmid": "11477132", "authors": "  Houlston RS.", "title": "What we could do now: molecular pathology of colorectal cancer.", "journal": "Mol Pathol 54:206-14 (2001)", "doi": "10.1136/mp.54.4.206"}, {"pmid": "12459728", "authors": "  Bardeesy N, DePinho RA.", "title": "Pancreatic cancer biology and genetics.", "journal": "Nat Rev Cancer 2:897-909 (2002)", "doi": "10.1038/nrc949"}, {"pmid": "11407945", "authors": "  Bardeesy N, Sharpless NE, DePinho RA, Merlino G.", "title": "The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model.", "journal": "Semin Cancer Biol 11:201-18 (2001)", "doi": "10.1006/scbi.2000.0371"}, {"pmid": "12946833", "authors": "  Cowgill SM, Muscarella P.", "title": "The genetics of pancreatic cancer.", "journal": "Am J Surg 186:279-86 (2003)", "doi": "10.1016/S0002-9610(03)00226-5"}, {"pmid": "16702400", "authors": "  Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA.", "title": "Genetics and biology of pancreatic ductal adenocarcinoma.", "journal": "Genes Dev 20:1218-49 (2006)", "doi": "10.1101/gad.1415606"}, {"pmid": "10740269", "authors": "  Shields JM, Pruitt K, McFall A, Shaub A, Der CJ.", "title": "Understanding Ras: 'it ain't over 'til it's over'.", "journal": "Trends Cell Biol 10:147-54 (2000)", "doi": "10.1016/S0962-8924(00)01740-2"}, {"pmid": "12648469", "authors": "  Holbro T, Civenni G, Hynes NE.", "title": "The ErbB receptors and their role in cancer progression.", "journal": "Exp Cell Res 284:99-110 (2003)", "doi": "10.1016/S0014-4827(02)00099-X"}, {"pmid": "14967450", "authors": "  Marmor MD, Skaria KB, Yarden Y.", "title": "Signal transduction and oncogenesis by ErbB/HER receptors.", "journal": "Int J Radiat Oncol Biol Phys 58:903-13 (2004)", "doi": "10.1016/j.ijrobp.2003.06.002"}, {"pmid": "14586404", "authors": "  DeArmond D, Brattain MG, Jessup JM, Kreisberg J, Malik S, Zhao S, Freeman JW.", "title": "Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines.", "journal": "Oncogene 22:7781-95 (2003)", "doi": "10.1038/sj.onc.1206966"}, {"pmid": "12545153", "authors": "  Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL, Xie K.", "title": "Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis.", "journal": "Oncogene 22:319-29 (2003)", "doi": "10.1038/sj.onc.1206122"}, {"pmid": "14580692", "authors": "  Toyonaga T, Nakano K, Nagano M, Zhao G, Yamaguchi K, Kuroki S, Eguchi T, Chijiiwa K, Tsuneyoshi M, Tanaka M.", "title": "Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer.", "journal": "Cancer Lett 201:107-16 (2003)", "doi": "10.1016/S0304-3835(03)00482-8"}, {"pmid": "12079267", "authors": "  Schmid RM.", "title": "Genetic basis of pancreatic cancer.", "journal": "Best Pract Res Clin Gastroenterol 16:421-33 (2002)", "doi": "10.1053/bega.2002.0316"}, {"pmid": "15774796", "authors": "  Elliott RL, Blobe GC.", "title": "Role of transforming growth factor Beta in human cancer.", "journal": "J Clin Oncol 23:2078-93 (2005)", "doi": "10.1200/JCO.2005.02.047"}, {"pmid": "15823750", "authors": "  Rudkin TM, Foulkes WD.", "title": "BRCA2: breaks, mistakes and failed separations.", "journal": "Trends Mol Med 11:145-8 (2005)", "doi": "10.1016/j.molmed.2005.02.003"}, {"pmid": "15639402", "authors": "  Soni D, King JA, Kaye AH, Hovens CM.", "title": "Genetics of glioblastoma multiforme: mitogenic signaling and cell cycle pathways converge.", "journal": "J Clin Neurosci 12:1-5 (2005)", "doi": "10.1016/j.jocn.2004.04.001"}, {"pmid": "12154354", "authors": "  Zhu Y, Parada LF.", "title": "The molecular and genetic basis of neurological tumours.", "journal": "Nat Rev Cancer 2:616-26 (2002)", "doi": "10.1038/nrc866"}, {"pmid": "11253051", "authors": "  Holland EC.", "title": "Gliomagenesis: genetic alterations and mouse models.", "journal": "Nat Rev Genet 2:120-9 (2001)", "doi": "10.1038/35052535"}, {"pmid": "16700615", "authors": "  Bansal K, Liang ML, Rutka JT.", "title": "Molecular biology of human gliomas.", "journal": "Technol Cancer Res Treat 5:185-94 (2006)", "doi": "10.1177/153303460600500302"}, {"pmid": "12762887", "authors": "  Kapoor GS, O'Rourke DM.", "title": "Mitogenic signaling cascades in glial tumors.", "journal": "Neurosurgery 52:1425-34; discussion 1434-5 (2003)", "doi": "10.1227/01.NEU.0000065135.28143.39"}, {"pmid": "16095998", "authors": "  Hulleman E, Helin K.", "title": "Molecular mechanisms in gliomagenesis.", "journal": "Adv Cancer Res 94:1-27 (2005)", "doi": "10.1016/S0065-230X(05)94001-3"}, {"pmid": "11057895", "authors": "  Schlessinger J.", "title": "Cell signaling by receptor tyrosine kinases.", "journal": "Cell 103:211-25 (2000)", "doi": "10.1016/S0092-8674(00)00114-8"}, {"pmid": "9643506", "authors": "  Ng HK, Lam PY.", "title": "The molecular genetics of central nervous system tumors.", "journal": "Pathology 30:196-202 (1998)", "doi": "10.1080/00313029800169236"}, {"pmid": "12084351", "authors": "  Knobbe CB, Merlo A, Reifenberger G.", "title": "Pten signaling in gliomas.", "journal": "Neuro-oncol 4:196-211 (2002)", "doi": "10.1093/neuonc/4.3.196"}, {"pmid": "16557281", "authors": "  Kondo T, Ezzat S, Asa SL.", "title": "Pathogenetic mechanisms in thyroid follicular-cell neoplasia.", "journal": "Nat Rev Cancer 6:292-306 (2006)", "doi": "10.1038/nrc1836"}, {"pmid": "16551846", "authors": "  Chiloeches A, Marais R.", "title": "Is BRAF the Achilles' Heel of thyroid cancer?", "journal": "Clin Cancer Res 12:1661-4 (2006)", "doi": "10.1158/1078-0432.CCR-06-0051"}, {"pmid": "16946003", "authors": "  Reddi HV, McIver B, Grebe SK, Eberhardt NL", "title": "The paired box-8/peroxisome proliferator-activated receptor-gamma oncogene in thyroid tumorigenesis.", "journal": "Endocrinology 148:932-5 (2007)", "doi": "10.1210/en.2006-0926"}, {"pmid": "17062879", "authors": "  Santoro M, Melillo RM, Fusco A.", "title": "RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture.", "journal": "Eur J Endocrinol 155:645-653 (2006)", "doi": "10.1530/eje.1.02289"}, {"pmid": "16242838", "authors": "  Pierotti MA, Greco A.", "title": "Oncogenic rearrangements of the NTRK1/NGF receptor.", "journal": "Cancer Lett 232:90-8 (2006)", "doi": "10.1016/j.canlet.2005.07.043"}, {"pmid": "16189702", "authors": "  Sobrinho-Simoes M, Preto A, Rocha AS, Castro P, Maximo V, Fonseca E, Soares P.", "title": "Molecular pathology of well-differentiated thyroid carcinomas.", "journal": "Virchows Arch 447:787-93 (2005)", "doi": "10.1007/s00428-005-0065-5"}, {"pmid": "11165748", "authors": "  Gimm O.", "title": "Thyroid cancer.", "journal": "Cancer Lett 163:143-56 (2001)", "doi": "10.1016/S0304-3835(00)00697-2"}, {"pmid": "12094241", "authors": "  Williams D.", "title": "Cancer after nuclear fallout: lessons from the Chernobyl accident.", "journal": "Nat Rev Cancer 2:543-9 (2002)", "doi": "10.1038/nrc845"}, {"pmid": "16236521", "authors": "  Steffen B, Muller-Tidow C, Schwable J, Berdel WE, Serve H.", "title": "The molecular pathogenesis of acute myeloid leukemia.", "journal": "Crit Rev Oncol Hematol 56:195-221 (2005)", "doi": "10.1016/j.critrevonc.2004.10.012"}, {"pmid": "12563308", "authors": "  Tenen DG.", "title": "Disruption of differentiation in human cancer: AML shows the way.", "journal": "Nat Rev Cancer 3:89-101 (2003)", "doi": "10.1038/nrc989"}, {"pmid": "16146838", "authors": "  Choudhary C, Muller-Tidow C, Berdel WE, Serve H.", "title": "Signal transduction of oncogenic Flt3.", "journal": "Int J Hematol 82:93-9 (2005)", "doi": "10.1532/IJH97.05090"}, {"pmid": "12951584", "authors": "  Stirewalt DL, Radich JP.", "title": "The role of FLT3 in haematopoietic malignancies.", "journal": "Nat Rev Cancer 3:650-65 (2003)", "doi": "10.1038/nrc1169"}, {"pmid": "16642045", "authors": "  Martelli AM, Nyakern M, Tabellini G, Bortul R, Tazzari PL, Evangelisti C, Cocco L.", "title": "Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia.", "journal": "Leukemia 20:911-28 (2006)", "doi": "10.1038/sj.leu.2404245"}, {"pmid": "15625120", "authors": "  Lennartsson J, Jelacic T, Linnekin D, Shivakrupa R.", "title": "Normal and oncogenic forms of the receptor tyrosine kinase kit.", "journal": "Stem Cells 23:16-43 (2005)", "doi": "10.1634/stemcells.2004-0117"}, {"pmid": "11721960", "authors": "  Lorsbach RB, Downing JR.", "title": "The role of the AML1 transcription factor in leukemogenesis.", "journal": "Int J Hematol 74:258-65 (2001)", "doi": "10.1007/BF02982058"}, {"pmid": "12468433", "authors": "  Mizuki M, Schwable J, Steur C, Choudhary C, Agrawal S, Sargin B, Steffen B, Matsumura I, Kanakura Y, Bohmer FD, Muller-Tidow C, Berdel WE, Serve H.", "title": "Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations.", "journal": "Blood 101:3164-73 (2003)", "doi": "10.1182/blood-2002-06-1677"}, {"pmid": "17554387", "authors": "  Mikesch JH, Steffen B, Berdel WE, Serve H, Muller-Tidow C.", "title": "The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia.", "journal": "Leukemia 21:1638-47 (2007)", "doi": "10.1038/sj.leu.2404732"}, {"pmid": "16352814", "authors": "  Mueller BU, Pabst T, Fos J, Petkovic V, Fey MF, Asou N, Buergi U, Tenen DG.", "title": "ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression.", "journal": "Blood 107:3330-8 (2006)", "doi": "10.1182/blood-2005-07-3068"}, {"pmid": "15719031", "authors": "  Ren R.", "title": "Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia.", "journal": "Nat Rev Cancer 5:172-83 (2005)", "doi": "10.1038/nrc1567"}, {"pmid": "14982876", "authors": "  Calabretta B, Perrotti D.", "title": "The biology of CML blast crisis.", "journal": "Blood 103:4010-22 (2004)", "doi": "10.1182/blood-2003-12-4111"}, {"pmid": "10403855", "authors": "  Faderl S, Talpaz M, Estrov Z, O'Brien S, Kurzrock R, Kantarjian HM.", "title": "The biology of chronic myeloid leukemia.", "journal": "N Engl J Med 341:164-72 (1999)", "doi": "10.1056/NEJM199907153410306"}, {"pmid": "15156182", "authors": "  Mitani K.", "title": "Molecular mechanisms of leukemogenesis by AML1/EVI-1.", "journal": "Oncogene 23:4263-9 (2004)", "doi": "10.1038/sj.onc.1207777"}, {"pmid": "16484590", "authors": "  Dong M, Blobe GC.", "title": "Role of transforming growth factor-beta in hematologic malignancies.", "journal": "Blood 107:4589-96 (2006)", "doi": "10.1182/blood-2005-10-4169"}, {"pmid": "11160144", "authors": "  Baldwin AS.", "title": "Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.", "journal": "J Clin Invest 107:241-6 (2001)", "doi": "10.1172/JCI11991"}, {"pmid": "12244301", "authors": "  Shin I, Yakes FM, Rojo F, Shin NY, Bakin AV, Baselga J, Arteaga CL.", "title": "PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization.", "journal": "Nat Med 8:1145-52 (2002)", "doi": "10.1038/nm759"}, {"pmid": "15948971", "authors": "  Tilli CM, Van Steensel MA, Krekels GA, Neumann HA, Ramaekers FC.", "title": "Molecular aetiology and pathogenesis of basal cell carcinoma.", "journal": "Br J Dermatol 152:1108-24 (2005)", "doi": "10.1111/j.1365-2133.2005.06587.x"}, {"pmid": "12588368", "authors": "  Saldanha G, Fletcher A, Slater DN.", "title": "Basal cell carcinoma: a dermatopathological and molecular biological update.", "journal": "Br J Dermatol 148:195-202 (2003)", "doi": "10.1046/j.1365-2133.2003.05151.x"}, {"pmid": "15978322", "authors": "  Daya-Grosjean L, Couve-Privat S.", "title": "Sonic hedgehog signaling in basal cell carcinomas.", "journal": "Cancer Lett 225:181-92 (2005)", "doi": "10.1016/j.canlet.2004.10.003"}, {"pmid": "15468170", "authors": "  Tsai KY, Tsao H.", "title": "The genetics of skin cancer.", "journal": "Am J Med Genet C Semin Med Genet 131C:82-92 (2004)", "doi": "10.1002/ajmg.c.30037"}, {"pmid": "16881963", "authors": "  Athar M, Tang X, Lee JL, Kopelovich L, Kim AL.", "title": "Hedgehog signalling in skin development and cancer.", "journal": "Exp Dermatol 15:667-77 (2006)", "doi": "10.1111/j.1600-0625.2006.00473.x"}, {"pmid": "16306523", "authors": "  Rubin AI, Chen EH, Ratner D.", "title": "Basal-cell carcinoma.", "journal": "N Engl J Med 353:2262-9 (2005)", "doi": "10.1056/NEJMra044151"}, {"pmid": "11276000", "authors": "  Saldanha G.", "title": "The Hedgehog signalling pathway and cancer.", "journal": "J Pathol 193:427-32 (2001)", "doi": "10.1002/1096-9896(2000)9999:9999<::AID-PATH815>3.0.CO;2-N"}, {"pmid": "15270885", "authors": "  Saldanha G, Ghura V, Potter L, Fletcher A.", "title": "Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation.", "journal": "Br J Dermatol 151:157-64 (2004)", "doi": "10.1111/j.1365-2133.2004.06048.x"}, {"pmid": "14737121", "authors": "  Pasca di Magliano M, Hebrok M.", "title": "Hedgehog signalling in cancer formation and maintenance.", "journal": "Nat Rev Cancer 3:903-11 (2003)", "doi": "10.1038/nrc1229"}, {"pmid": "15656799", "authors": "  Reifenberger J, Wolter M, Knobbe CB, Kohler B, Schonicke A, Scharwachter C, Kumar K, Blaschke B, Ruzicka T, Reifenberger G.", "title": "Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas.", "journal": "Br J Dermatol 152:43-51 (2005)", "doi": "10.1111/j.1365-2133.2005.06353.x"}, {"pmid": "14556242", "authors": "  Cohen MM Jr.", "title": "The hedgehog signaling network.", "journal": "Am J Med Genet A 123:5-28 (2003)", "doi": "10.1002/ajmg.a.20495"}, {"pmid": "11736900", "authors": "  Yamazaki F, Aragane Y, Kawada A, Tezuka T.", "title": "Immunohistochemical detection for nuclear beta-catenin in sporadic basal cell carcinoma.", "journal": "Br J Dermatol 145:771-7 (2001)", "doi": "10.1046/j.1365-2133.2001.04468.x"}, {"pmid": "16054233", "authors": "  Erb P, Ji J, Wernli M, Kump E, Glaser A, Buchner SA.", "title": "Role of apoptosis in basal cell and squamous cell carcinoma formation.", "journal": "Immunol Lett 100:68-72 (2005)", "doi": "10.1016/j.imlet.2005.06.008"}, {"pmid": "11130178", "authors": "  Toftgard R.", "title": "Hedgehog signalling in cancer.", "journal": "Cell Mol Life Sci 57:1720-31 (2000)", "doi": "10.1007/PL00000654"}, {"pmid": "16822996", "authors": "  Miller AJ, Mihm MC Jr.", "title": "Melanoma.", "journal": "N Engl J Med 355:51-65 (2006)", "doi": "10.1056/NEJMra052166"}, {"pmid": "12894244", "authors": "  Chin L.", "title": "The genetics of malignant melanoma: lessons from mouse and man.", "journal": "Nat Rev Cancer 3:559-70 (2003)", "doi": "10.1038/nrc1145"}, {"pmid": "16750612", "authors": "  Takata M, Saida T.", "title": "Genetic alterations in melanocytic tumors.", "journal": "J Dermatol Sci 43:1-10 (2006)", "doi": "10.1016/j.jdermsci.2006.05.002"}, {"pmid": "15841168", "authors": "  Chudnovsky Y, Khavari PA, Adams AE.", "title": "Melanoma genetics and the development of rational therapeutics.", "journal": "J Clin Invest 115:813-24 (2005)", "doi": "10.1172/JCI24808"}, {"pmid": "16001050", "authors": "  Merlino G.", "title": "Cancer biology: the weakest link?", "journal": "Nature 436:33-5 (2005)", "doi": "10.1038/436033a"}, {"pmid": "16001072", "authors": "  Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S, Beroukhim R, Milner DA, Granter SR, Du J, Lee C, Wagner SN, Li C, Golub TR, Rimm DL, Meyerson ML, Fisher DE, Sellers WR.", "title": "Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.", "journal": "Nature 436:117-22 (2005)", "doi": "10.1038/nature03664"}, {"pmid": "16899407", "authors": "  Levy C, Khaled M, Fisher DE.", "title": "MITF: master regulator of melanocyte development and melanoma oncogene.", "journal": "Trends Mol Med 12:406-14 (2006)", "doi": "10.1016/j.molmed.2006.07.008"}, {"pmid": "15009714", "authors": "  Tsao H, Goel V, Wu H, Yang G, Haluska FG.", "title": "Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.", "journal": "J Invest Dermatol 122:337-41 (2004)", "doi": "10.1046/j.0022-202X.2004.22243.x"}, {"pmid": "11224709", "authors": "  Gruss C, Herlyn M.", "title": "Role of cadherins and matrixins in melanoma.", "journal": "Curr Opin Oncol 13:117-23 (2001)", "doi": "10.1097/00001622-200103000-00006"}, {"pmid": "15721476", "authors": "  Thompson JF, Scolyer RA, Kefford RF.", "title": "Cutaneous melanoma.", "journal": "Lancet 365:687-701 (2005)", "doi": "10.1016/S0140-6736(05)17951-3"}, {"pmid": "15557758", "authors": "  Hussein MR.", "title": "The TP53 tumor suppressor gene and melanoma tumorigenesis: is there a relationship?", "journal": "Tumour Biol 25:200-7 (2004)", "doi": "10.1159/000081103"}, {"pmid": "10843728", "authors": "  Lazar-Molnar E, Hegyesi H, Toth S, Falus A.", "title": "Autocrine and paracrine regulation by cytokines and growth factors in melanoma.", "journal": "Cytokine 12:547-54 (2000)", "doi": "10.1006/cyto.1999.0614"}, {"pmid": "16339096", "authors": "  Cohen HT, McGovern FJ.", "title": "Renal-cell carcinoma.", "journal": "N Engl J Med 353:2477-90 (2005)", "doi": "10.1056/NEJMra043172"}, {"pmid": "15122209", "authors": "  Pavlovich CP, Schmidt LS.", "title": "Searching for the hereditary causes of renal-cell carcinoma.", "journal": "Nat Rev Cancer 4:381-93 (2004)", "doi": "10.1038/nrc1364"}, {"pmid": "14634372", "authors": "  Linehan WM, Walther MM, Zbar B.", "title": "The genetic basis of cancer of the kidney.", "journal": "J Urol 170:2163-72 (2003)", "doi": "10.1097/01.ju.0000096060.92397.ed"}, {"pmid": "14685170", "authors": "  Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF.", "title": "Met, metastasis, motility and more.", "journal": "Nat Rev Mol Cell Biol 4:915-25 (2003)", "doi": "10.1038/nrm1261"}, {"pmid": "15611513", "authors": "  Kim WY, Kaelin WG.", "title": "Role of VHL gene mutation in human cancer.", "journal": "J Clin Oncol 22:4991-5004 (2004)", "doi": "10.1200/JCO.2004.05.061"}, {"pmid": "17211469", "authors": "  Sudarshan S, Linehan WM, Neckers L.", "title": "HIF and fumarate hydratase in renal cancer.", "journal": "Br J Cancer 96:403-7 (2007)", "doi": "10.1038/sj.bjc.6603547"}, {"pmid": "17287871", "authors": "  Sudarshan S, Pinto PA, Neckers L, Linehan WM.", "title": "Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer--a distinct form of hereditary kidney cancer.", "journal": "Nat Clin Pract Urol 4:104-10 (2007)", "doi": "10.1038/ncpuro0711"}, {"pmid": "12351585", "authors": "  Bodmer D, van den Hurk W, van Groningen JJ, Eleveld MJ, Martens GJ, Weterman MA, van Kessel AG.", "title": "Understanding familial and non-familial renal cell cancer.", "journal": "Hum Mol Genet 11:2489-98 (2002)", "doi": "10.1093/hmg/11.20.2489"}, {"pmid": "17158541", "authors": "  Mitra AP, Datar RH, Cote RJ.", "title": "Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification.", "journal": "J Clin Oncol 24:5552-64 (2006)", "doi": "10.1200/JCO.2006.08.2073"}, {"pmid": "16474624", "authors": "  Wolff EM, Liang G, Jones PA.", "title": "Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer.", "journal": "Nat Clin Pract Urol 2:502-10 (2005)", "doi": "10.1038/ncpuro0318"}, {"pmid": "16110317", "authors": "  Wu XR.", "title": "Urothelial tumorigenesis: a tale of divergent pathways.", "journal": "Nat Rev Cancer 5:713-25 (2005)", "doi": "10.1038/nrc1697"}, {"pmid": "12850530", "authors": "  Bellmunt J, Hussain M, Dinney CP.", "title": "Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family.", "journal": "Crit Rev Oncol Hematol 46 Suppl:S85-104 (2003)", "doi": "10.1016/S1040-8428(03)00067-2"}, {"pmid": "17149381", "authors": "  Sugano K, Kakizoe T.", "title": "Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging.", "journal": "Nat Clin Pract Urol 3:642-52 (2006)", "doi": "10.1038/ncpuro0649"}, {"pmid": "15746962", "authors": "  Dunn KL, Espino PS, Drobic B, He S, Davie JR.", "title": "The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling.", "journal": "Biochem Cell Biol 83:1-14 (2005)", "doi": "10.1139/o04-121"}, {"pmid": "15551095", "authors": "  Williams SG, Stein JP.", "title": "Molecular pathways in bladder cancer.", "journal": "Urol Res 32:373-85 (2004)", "doi": "10.1007/s00240-003-0345-y"}, {"pmid": "12878745", "authors": "  Nelson WG, De Marzo AM, Isaacs WB.", "title": "Prostate cancer.", "journal": "N Engl J Med 349:366-81 (2003)", "doi": "10.1056/NEJMra021562"}, {"pmid": "15724144", "authors": "  Li L, Ittmann MM, Ayala G, Tsai MJ, Amato RJ, Wheeler TM, Miles BJ, Kadmon D, Thompson TC.", "title": "The emerging role of the PI3-K-Akt pathway in prostate cancer progression.", "journal": "Prostate Cancer Prostatic Dis 8:108-18 (2005)", "doi": "10.1038/sj.pcan.4500776"}, {"pmid": "16551847", "authors": "  Pienta KJ, Bradley D.", "title": "Mechanisms underlying the development of androgen-independent prostate cancer.", "journal": "Clin Cancer Res 12:1665-71 (2006)", "doi": "10.1158/1078-0432.CCR-06-0067"}, {"pmid": "11900250", "authors": "  Feldman BJ, Feldman D.", "title": "The development of androgen-independent prostate cancer.", "journal": "Nat Rev Cancer 1:34-45 (2001)", "doi": "10.1038/35094009"}, {"pmid": "15082523", "authors": "  Heinlein CA, Chang C.", "title": "Androgen receptor in prostate cancer.", "journal": "Endocr Rev 25:276-308 (2004)", "doi": "10.1210/er.2002-0032"}, {"pmid": "10835690", "authors": "  Zhao XY, Malloy PJ, Krishnan AV, Swami S, Navone NM, Peehl DM, Feldman D.", "title": "Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor.", "journal": "Nat Med 6:703-6 (2000)", "doi": "10.1038/76287"}, {"pmid": "10453277", "authors": "  Macri E, Loda M.", "title": "Role of p27 in prostate carcinogenesis.", "journal": "Cancer Metastasis Rev 17:337-44 (1998)", "doi": "10.1023/A:1006133620914"}, {"pmid": "11750244", "authors": "  Steers WD.", "title": "5alpha-reductase activity in the prostate.", "journal": "Urology 58:17-24; discussion 24 (2001)", "doi": "10.1016/S0090-4295(01)01299-7"}, {"pmid": "11527574", "authors": "  Grimes CA, Jope RS.", "title": "The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.", "journal": "Prog Neurobiol 65:391-426 (2001)", "doi": "10.1016/S0301-0082(01)00011-9"}, {"pmid": "15947972", "authors": "  Ryan AJ, Susil B, Jobling TW, Oehler MK.", "title": "Endometrial cancer.", "journal": "Cell Tissue Res 322:53-61 (2005)", "doi": "10.1007/s00441-005-1109-5"}, {"pmid": "14747944", "authors": "  Lax SF.", "title": "Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.", "journal": "Virchows Arch 444:213-23 (2004)", "doi": "10.1007/s00428-003-0947-3"}, {"pmid": "16508724", "authors": "  Shiozawa T, Konishi I.", "title": "Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.", "journal": "Int J Clin Oncol 11:13-21 (2006)", "doi": "10.1007/s10147-005-0546-1"}, {"pmid": "17028294", "authors": "  Hecht JL, Mutter GL.", "title": "Molecular and pathologic aspects of endometrial carcinogenesis.", "journal": "J Clin Oncol 24:4783-91 (2006)", "doi": "10.1200/JCO.2006.06.7173"}, {"pmid": "11431710", "authors": "  Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.", "title": "Molecular pathology of endometrial hyperplasia and carcinoma.", "journal": "Hum Pathol 32:569-77 (2001)", "doi": "10.1053/hupa.2001.25929"}, {"pmid": "15284264", "authors": "  Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.", "title": "Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.", "journal": "J Clin Oncol 22:3126-32 (2004)", "doi": "10.1200/JCO.2004.11.154"}, {"pmid": "16248975", "authors": "  Kim D, Chung J.", "title": "Akt: versatile mediator of cell survival and beyond.", "journal": "J Biochem Mol Biol 35:106-15 (2002)", "doi": "10.5483/bmbrep.2002.35.1.106"}, {"pmid": "12711111", "authors": "  Sanchez-Cespedes M.", "title": "Dissecting the genetic alterations involved in lung carcinogenesis.", "journal": "Lung Cancer 40:111-21 (2003)", "doi": "10.1016/S0169-5002(03)00033-3"}, {"pmid": "11720739", "authors": "  Kaye FJ.", "title": "Molecular biology of lung cancer.", "journal": "Lung Cancer 34 Suppl 2:S35-41 (2001)", "doi": "10.1016/S0169-5002(01)00342-7"}, {"pmid": "12616528", "authors": "  Shivapurkar N, Reddy J, Chaudhary PM, Gazdar AF.", "title": "Apoptosis and lung cancer: a review.", "journal": "J Cell Biochem 88:885-98 (2003)", "doi": "10.1002/jcb.10440"}, {"pmid": "11807782", "authors": "  Sartorius UA, Krammer PH.", "title": "Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines.", "journal": "Int J Cancer 97:584-92 (2002)", "doi": "10.1002/ijc.10096"}, {"pmid": "16064138", "authors": "  Adhikary S, Eilers M.", "title": "Transcriptional regulation and transformation by Myc proteins.", "journal": "Nat Rev Mol Cell Biol 6:635-45 (2005)", "doi": "10.1038/nrm1703"}, {"pmid": "11463388", "authors": "  Spruck C, Strohmaier H, Watson M, Smith AP, Ryan A, Krek TW, Reed SI.", "title": "A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1.", "journal": "Mol Cell 7:639-50 (2001)", "doi": "10.1016/S1097-2765(01)00210-6"}, {"pmid": "15109562", "authors": "  Buttery RC, Rintoul RC, Sethi T.", "title": "Small cell lung cancer: the importance of the extracellular matrix.", "journal": "Int J Biochem Cell Biol 36:1154-60 (2004)", "doi": "10.1016/S1357-2725(03)00261-9"}, {"pmid": "11905738", "authors": "  Rintoul RC, Sethi T.", "title": "The role of extracellular matrix in small-cell lung cancer.", "journal": "Lancet Oncol 2:437-42 (2001)", "doi": "10.1016/S1470-2045(00)00421-6"}, {"pmid": "12243753", "authors": "  Ekedahl J, Joseph B, Grigoriev MY, Muller M, Magnusson C, Lewensohn R, Zhivotovsky B.", "title": "Expression of inhibitor of apoptosis proteins in small- and non-small-cell lung carcinoma cells.", "journal": "Exp Cell Res 279:277-90 (2002)", "doi": "10.1006/excr.2002.5608"}, {"pmid": "12379883", "authors": "  Osada H, Takahashi T.", "title": "Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.", "journal": "Oncogene 21:7421-34 (2002)", "doi": "10.1038/sj.onc.1205802"}, {"pmid": "12741677", "authors": "  Yokota J, Nishioka M, Tani M, Kohno T.", "title": "Genetic alterations responsible for metastatic phenotypes of lung cancer cells.", "journal": "Clin Exp Metastasis 20:189-93 (2003)", "doi": "10.1023/a:1022978932215"}, {"pmid": "16870043", "authors": "  Aviel-Ronen S, Blackhall FH, Shepherd FA, Tsao MS.", "title": "K-ras mutations in non-small-cell lung carcinoma: a review.", "journal": "Clin Lung Cancer 8:30-8 (2006)", "doi": "10.3816/CLC.2006.n.030"}, {"pmid": "15948711", "authors": "  Pfeifer GP, Dammann R.", "title": "Methylation of the tumor suppressor gene RASSF1A in human tumors.", "journal": "Biochemistry (Mosc) 70:576-83 (2005)", "doi": "10.1007/s10541-005-0151-y"}, {"pmid": "11902573", "authors": "  Altucci L, Gronemeyer H.", "title": "The promise of retinoids to fight against cancer.", "journal": "Nat Rev Cancer 1:181-93 (2001)", "doi": "10.1038/35106036"}, {"pmid": "10944551", "authors": "  Virmani AK, Rathi A, Zochbauer-Muller S, Sacchi N, Fukuyama Y, Bryant D, Maitra A, Heda S, Fong KM, Thunnissen F, Minna JD, Gazdar AF.", "title": "Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas.", "journal": "J Natl Cancer Inst 92:1303-7 (2000)", "doi": "10.1093/jnci/92.16.1303"}, {"pmid": "12867060", "authors": "  Hirsch FR, Scagliotti GV, Langer CJ, Varella-Garcia M, Franklin WA.", "title": "Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies.", "journal": "Lung Cancer 41 Suppl 1:S29-42 (2003)", "doi": "10.1016/S0169-5002(03)00137-5"}, {"pmid": "16112428", "authors": "  Panani AD, Roussos C.", "title": "Cytogenetic and molecular aspects of lung cancer.", "journal": "Cancer Lett 239:1-9 (2006)", "doi": "10.1016/j.canlet.2005.06.030"}, {"pmid": "12407699", "authors": "  Mitsuuchi Y, Testa JR.", "title": "Cytogenetics and molecular genetics of lung cancer.", "journal": "Am J Med Genet 115:183-8 (2002)", "doi": "10.1002/ajmg.10692"}, {"pmid": "15942304", "authors": "  Breuer RH, Postmus PE, Smit EF.", "title": "Molecular pathology of non-small-cell lung cancer.", "journal": "Respiration 72:313-30 (2005)", "doi": "10.1159/000085376"}, {"pmid": "16189154", "authors": "  Awaya H, Takeshima Y, Furonaka O, Kohno N, Inai K.", "title": "Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lung.", "journal": "J Clin Pathol 58:1076-80 (2005)", "doi": "10.1136/jcp.2004.025585"}, {"pmid": "21193867", "authors": "  Lappano R, Maggiolini M", "title": "G protein-coupled receptors: novel targets for drug discovery in cancer.", "journal": "Nat Rev Drug Discov 10:47-60 (2011)", "doi": "10.1038/nrd3320"}, {"pmid": "24508914", "authors": "  O'Hayre M, Degese MS, Gutkind JS", "title": "Novel insights into G protein and G protein-coupled receptor signaling in cancer.", "journal": "Curr Opin Cell Biol 27:126-35 (2014)", "doi": "10.1016/j.ceb.2014.01.005"}], "rel_pathway": ["hsa03320  PPAR signaling pathway", "hsa04010  MAPK signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04024  cAMP signaling pathway", "hsa04060  Cytokine-cytokine receptor interaction", "hsa04066  HIF-1 signaling pathway", "hsa04110  Cell cycle", "hsa04115  p53 signaling pathway", "hsa04150  mTOR signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04210  Apoptosis", "hsa04310  Wnt signaling pathway", "hsa04330  Notch signaling pathway", "hsa04340  Hedgehog signaling pathway", "hsa04350  TGF-beta signaling pathway", "hsa04370  VEGF signaling pathway", "hsa04510  Focal adhesion", "hsa04512  ECM-receptor interaction", "hsa04520  Adherens junction", "hsa04630  JAK-STAT signaling pathway", "hsa04915  Estrogen signaling pathway"], "ko_pathway": "ko05200", "genes": ["PTEN", "IL3", "EGFR", "IL2R", "RAC1", "KLK3", "TP53", "EPAS1", "BRAF", "CUL1", "AKT2", "MET", "BIRC3", "AKT1", "PGF", "SOS1", "NRAS", "BAX", "PIM1"]}, {"kegg_id": "hsa05206", "name": "MicroRNAs in cancer - Homo sapiens (human)", "description": "MicroRNA (miRNA) is a cluster of small non-encoding RNA molecules of 21 - 23 nucleotides in length, which controls gene expression post-transcriptionally either via the degradation of target mRNAs or the inhibition of protein translation. Using high-throughput profiling, dysregulation of miRNAs has been widely observed in different stages of cancer. The upregulation (overexpression) of specific miRNAs could lead to the repression of tumor suppressor gene expression, and conversely the downregulation of specific miRNAs could result in an increase of oncogene expression; both these situations induce subsequent malignant effects on cell proliferation, differentiation, and apoptosis that lead to tumor growth and progress. The miRNA signatures of cancer observed in various studies differ significantly. These inconsistencies occur due to the differences in the study populations and methodologies used. This pathway map shows the summarized results from various studies in 9 cancers, each of which is presented in a review article.", "class": "Human Diseases; Cancer: overview", "pathway_map": "hsa05206  MicroRNAs in cancer", "drug": ["D03021  Azacitidine (JAN/USAN/INN)", "D03665  Decitabine (USAN/INN)", "D11163  Cobomarsen (USAN/INN)", "D11164  Cobomarsen sodium (USAN)", "D11444  Tazemetostat (USAN/INN)", "D11485  Tazemetostat hydrobromide (JAN/USAN)", "D11551  Valemetostat (INN)", "D11662  Valemetostat tosilate (JAN)", "D11740  Roducitabine (USAN)", "D12602  Tulmimetostat (USAN/INN)", "D12845  Mevrometostat (USAN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["406952  MIR17; microRNA 17 [KO:K17002]", "406953  MIR18A; microRNA 18a [KO:K17003]", "406979  MIR19A; microRNA 19a [KO:K17005]", "406981  MIR19B2; microRNA 19b-2 [KO:K23559]", "406980  MIR19B1; microRNA 19b-1 [KO:K23559]", "406982  MIR20A; microRNA 20a [KO:K17006]", "407048  MIR92A1; microRNA 92a-1 [KO:K17008]", "407049  MIR92A2; microRNA 92a-2 [KO:K17008]", "5728  PTEN; phosphatase and tensin homolog [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]", "407006  MIR221; microRNA 221 [KO:K17010]", "407007  MIR222; microRNA 222 [KO:K17011]", "1027  CDKN1B; cyclin dependent kinase inhibitor 1B [KO:K06624]", "406991  MIR21; microRNA 21 [KO:K16863]", "7078  TIMP3; TIMP metallopeptidase inhibitor 3 [KO:K16866]", "406881  MIRLET7A1; microRNA let-7a-1 [KO:K16980]", "406882  MIRLET7A2; microRNA let-7a-2 [KO:K16980]", "406883  MIRLET7A3; microRNA let-7a-3 [KO:K16980]", "406884  MIRLET7B; microRNA let-7b [KO:K16980]", "406886  MIRLET7D; microRNA let-7d [KO:K16980]", "406887  MIRLET7E; microRNA let-7e [KO:K16980]", "406888  MIRLET7F1; microRNA let-7f-1 [KO:K16980]", "406889  MIRLET7F2; microRNA let-7f-2 [KO:K16980]", "406890  MIRLET7G; microRNA let-7g [KO:K16980]", "406891  MIRLET7I; microRNA let-7i [KO:K16980]", "406885  MIRLET7C; microRNA let-7c [KO:K17397]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "1021  CDK6; cyclin dependent kinase 6 [KO:K02091] [EC:2.7.11.22]", "993  CDC25A; cell division cycle 25A [KO:K06645] [EC:3.1.3.48]", "994  CDC25B; cell division cycle 25B [KO:K05866] [EC:3.1.3.48]", "995  CDC25C; cell division cycle 25C [KO:K05867] [EC:3.1.3.48]", "8091  HMGA2; high mobility group AT-hook 2 [KO:K09283]", "406901  MIR107; microRNA 107 [KO:K17396]", "406948  MIR15A; microRNA 15a [KO:K16986]", "406949  MIR15B; microRNA 15b [KO:K16987]", "406950  MIR16-1; microRNA 16-1 [KO:K16988]", "406951  MIR16-2; microRNA 16-2 [KO:K16988]", "595  CCND1; cyclin D1 [KO:K04503]", "894  CCND2; cyclin D2 [KO:K10151]", "898  CCNE1; cyclin E1 [KO:K06626]", "9134  CCNE2; cyclin E2 [KO:K06626]", "406913  MIR126; microRNA 126 [KO:K16978]", "1398  CRK; CRK proto-oncogene, adaptor protein [KO:K04438]", "1399  CRKL; CRK like proto-oncogene, adaptor protein [KO:K04438]", "406904  MIR1-1; microRNA 1-1 [KO:K16972]", "406905  MIR1-2; microRNA 1-2 [KO:K16972]", "9759  HDAC4; histone deacetylase 4 [KO:K11406] [EC:3.5.1.98]", "10014  HDAC5; histone deacetylase 5 [KO:K11406] [EC:3.5.1.98]", "27086  FOXP1; forkhead box P1 [KO:K23582]", "5292  PIM1; Pim-1 proto-oncogene, serine/threonine kinase [KO:K04702] [EC:2.7.11.1]", "4233  MET; MET proto-oncogene, receptor tyrosine kinase [KO:K05099] [EC:2.7.10.1]", "407021  MIR29A; microRNA 29a [KO:K16995]", "407024  MIR29B1; microRNA 29b-1 [KO:K16996]", "407025  MIR29B2; microRNA 29b-2 [KO:K16996]", "407026  MIR29C; microRNA 29c [KO:K16997]", "1788  DNMT3A; DNA methyltransferase 3 alpha [KO:K17398] [EC:2.1.1.37]", "1789  DNMT3B; DNA methyltransferase 3 beta [KO:K17399] [EC:2.1.1.37]", "406922  MIR133A1; microRNA 133a-1 [KO:K16970]", "406923  MIR133A2; microRNA 133a-2 [KO:K16970]", "442890  MIR133B; microRNA 133b [KO:K16971]", "4170  MCL1; MCL1 apoptosis regulator, BCL2 family member [KO:K02539]", "599  BCL2L2; BCL2 like 2 [KO:K02163]", "406937  MIR145; microRNA 145 [KO:K16974]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "7422  VEGFA; vascular endothelial growth factor A [KO:K05448]", "406985  MIR200C; microRNA 200c [KO:K17017]", "6935  ZEB1; zinc finger E-box binding homeobox 1 [KO:K09299]", "406933  MIR141; microRNA 141 [KO:K17018]", "7042  TGFB2; transforming growth factor beta 2 [KO:K13376]", "406959  MIR183; microRNA 183 [KO:K17116]", "7430  EZR; ezrin [KO:K08007]", "406910  MIR125A; microRNA 125a [KO:K16993]", "406911  MIR125B1; microRNA 125b-1 [KO:K16994]", "406912  MIR125B2; microRNA 125b-2 [KO:K16994]", "27250  PDCD4; programmed cell death 4 [KO:K16865]", "406935  MIR143; microRNA 143 [KO:K17023]", "406967  MIR192; microRNA 192 [KO:K17131]", "406969  MIR194-1; microRNA 194-1 [KO:K17371]", "406970  MIR194-2; microRNA 194-2 [KO:K17371]", "1387  CREBBP; CREB binding protein [KO:K04498] [EC:2.3.1.48]", "2033  EP300; E1A binding protein p300 [KO:K04498] [EC:2.3.1.48]", "406997  MIR215; microRNA 215 [KO:K17167]", "407020  MIR28; microRNA 28 [KO:K17366]", "407034  MIR30E; microRNA 30e [KO:K17110]", "407033  MIR30D; microRNA 30d [KO:K17110]", "407029  MIR30A; microRNA 30a [KO:K17110]", "407030  MIR30B; microRNA 30b [KO:K17111]", "407031  MIR30C1; microRNA 30c-1 [KO:K17040]", "407032  MIR30C2; microRNA 30c-2 [KO:K17040]", "7168  TPM1; tropomyosin 1 [KO:K10373]", "10253  SPRY2; sprouty RTK signaling antagonist 2 [KO:K17383]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]", "5268  SERPINB5; serpin family B member 5 [KO:K10139]", "406947  MIR155; microRNA 155 [KO:K17009]", "406986  MIR203A; microRNA 203a [KO:K16975]", "100616173  MIR203B; microRNA 203b [KO:K16975]", "406988  MIR205; microRNA 205 [KO:K17150]", "407018  MIR27A; microRNA 27a [KO:K17112]", "407019  MIR27B; microRNA 27b [KO:K17113]", "6768  ST14; ST14 transmembrane serine protease matriptase [KO:K08670] [EC:3.4.21.109]", "1545  CYP1B1; cytochrome P450 family 1 subfamily B member 1 [KO:K07410] [EC:1.14.14.1]", "407035  MIR31; microRNA 31 [KO:K17183]", "407055  MIR99A; microRNA 99a [KO:K17367]", "406892  MIR100; microRNA 100 [KO:K17041]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "57521  RPTOR; regulatory associated protein of MTOR complex 1 [KO:K07204]", "1591  CYP24A1; cytochrome P450 family 24 subfamily A member 1 [KO:K07436] [EC:1.14.15.16]", "2064  ERBB2; erb-b2 receptor tyrosine kinase 2 [KO:K05083] [EC:2.7.10.1]", "2065  ERBB3; erb-b2 receptor tyrosine kinase 3 [KO:K05084] [EC:2.7.10.1]", "25  ABL1; ABL proto-oncogene 1, non-receptor tyrosine kinase [KO:K06619] [EC:2.7.10.2]", "8626  TP63; tumor protein p63 [KO:K10149]", "9839  ZEB2; zinc finger E-box binding homeobox 2 [KO:K23560]", "6624  FSCN1; fascin actin-bundling protein 1 [KO:K23551]", "494324  MIR375; microRNA 375 [KO:K16976]", "693187  MIR602; microRNA 602 [KO:K17379]", "11186  RASSF1; Ras association domain family member 1 [KO:K09850]", "406903  MIR10B; microRNA 10b [KO:K17393]", "3236  HOXD10; homeobox D10 [KO:K09295]", "54541  DDIT4; DNA damage inducible transcript 4 [KO:K08270]", "90427  BMF; Bcl2 modifying factor [KO:K17460]", "407009  MIR224; microRNA 224 [KO:K17042]", "10298  PAK4; p21 (RAC1) activated kinase 4 [KO:K05734] [EC:2.7.11.1]", "4318  MMP9; matrix metallopeptidase 9 [KO:K01403] [EC:3.4.24.35]", "574031  MIR363; microRNA 363 [KO:K17036]", "574452  MIR494; microRNA 494 [KO:K17378]", "693200  MIR615; microRNA 615 [KO:K17380]", "693210  MIR625; microRNA 625 [KO:K17381]", "407014  MIR25; microRNA 25 [KO:K17038]", "407040  MIR34A; microRNA 34a [KO:K16982]", "407053  MIR96; microRNA 96 [KO:K17114]", "406902  MIR10A; microRNA 10a [KO:K16864]", "407010  MIR23A; microRNA 23a [KO:K17165]", "407011  MIR23B; microRNA 23b [KO:K17394]", "100500809  MIR23C; microRNA 23c [KO:K17395]", "406906  MIR122; microRNA 122 [KO:K17020]", "6541  SLC7A1; solute carrier family 7 member 1 [KO:K13863]", "900  CCNG1; cyclin G1 [KO:K10145]", "3162  HMOX1; heme oxygenase 1 [KO:K00510] [EC:1.14.14.18]", "406942  MIR150; microRNA 150 [KO:K17024]", "407008  MIR223; microRNA 223 [KO:K17001]", "3925  STMN1; stathmin 1 [KO:K04381]", "442909  MIR342; microRNA 342 [KO:K17132]", "494335  MIR423; microRNA 423 [KO:K17376]", "6774  STAT3; signal transducer and activator of transcription 3 [KO:K04692]", "4609  MYC; MYC proto-oncogene, bHLH transcription factor [KO:K04377]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "406978  MIR199B; microRNA 199b [KO:K17119]", "442898  MIR324; microRNA 324 [KO:K17152]", "619552  MIR483; microRNA 483 [KO:K17137]", "407015  MIR26A1; microRNA 26a-1 [KO:K16984]", "407016  MIR26A2; microRNA 26a-2 [KO:K16984]", "407017  MIR26B; microRNA 26b [KO:K16985]", "406943  MIR152; microRNA 152 [KO:K17370]", "1786  DNMT1; DNA methyltransferase 1 [KO:K00558] [EC:2.1.1.37]", "442891  MIR135B; microRNA 135b [KO:K17144]", "406926  MIR135A2; microRNA 135a-2 [KO:K17144]", "406925  MIR135A1; microRNA 135a-1 [KO:K17144]", "324  APC; APC regulator of WNT signaling pathway [KO:K02085]", "10297  APC2; APC regulator of WNT signaling pathway 2 [KO:K02085]", "3667  IRS1; insulin receptor substrate 1 [KO:K16172]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5598  MAPK7; mitogen-activated protein kinase 7 [KO:K04464] [EC:2.7.11.24]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "406983  MIR200A; microRNA 200a [KO:K17015]", "406984  MIR200B; microRNA 200b [KO:K17016]", "3190  HNRNPK; heterogeneous nuclear ribonucleoprotein K [KO:K12886]", "8434  RECK; reversion inducing cysteine rich protein with kazal motifs [KO:K17461]", "406907  MIR124-1; microRNA 124-1 [KO:K17126]", "406909  MIR124-3; microRNA 124-3 [KO:K17126]", "406908  MIR124-2; microRNA 124-2 [KO:K17126]", "406928  MIR137; microRNA 137 [KO:K17369]", "406915  MIR128-1; microRNA 128-1 [KO:K17130]", "406916  MIR128-2; microRNA 128-2 [KO:K17130]", "1871  E2F3; E2F transcription factor 3 [KO:K06620]", "407043  MIR7-1; microRNA 7-1 [KO:K17365]", "407044  MIR7-2; microRNA 7-2 [KO:K17365]", "407045  MIR7-3; microRNA 7-3 [KO:K17365]", "8660  IRS2; insulin receptor substrate 2 [KO:K07187]", "442900  MIR326; microRNA 326 [KO:K17372]", "4851  NOTCH1; notch receptor 1 [KO:K02599]", "4853  NOTCH2; notch receptor 2 [KO:K20994]", "4854  NOTCH3; notch receptor 3 [KO:K20995]", "4855  NOTCH4; notch receptor 4 [KO:K20996]", "648  BMI1; BMI1 proto-oncogene, polycomb ring finger [KO:K11459]", "100532731  COMMD3-BMI1; COMMD3-BMI1 readthrough [KO:K11459]", "406938  MIR146A; microRNA 146a [KO:K17012]", "4325  MMP16; matrix metallopeptidase 16 [KO:K07996] [EC:3.4.24.-]", "406954  MIR181A2; microRNA 181a-2 [KO:K17025]", "406995  MIR181A1; microRNA 181a-1 [KO:K17025]", "406955  MIR181B1; microRNA 181b-1 [KO:K17026]", "406956  MIR181B2; microRNA 181b-2 [KO:K17026]", "406957  MIR181C; microRNA 181c [KO:K17027]", "574457  MIR181D; microRNA 181d [KO:K17028]", "472  ATM; ATM serine/threonine kinase [KO:K04728] [EC:2.7.11.1]", "8651  SOCS1; suppressor of cytokine signaling 1 [KO:K04694]", "442918  MIR373; microRNA 373 [KO:K17000]", "574467  MIR520A; microRNA 520a [KO:K17175]", "574484  MIR520G; microRNA 520g [KO:K17175]", "574493  MIR520H; microRNA 520h [KO:K17175]", "574473  MIR520B; microRNA 520b [KO:K17175]", "574461  MIR520E; microRNA 520e [KO:K17175]", "960  CD44; CD44 molecule (IN blood group) [KO:K06256]", "406895  MIR103A1; microRNA 103a-1 [KO:K16989]", "100302282  MIR103B2; microRNA 103b-2 [KO:K16989]", "406896  MIR103A2; microRNA 103a-2 [KO:K16989]", "100302238  MIR103B1; microRNA 103b-1 [KO:K16989]", "23405  DICER1; dicer 1, ribonuclease III [KO:K11592] [EC:3.1.26.-]", "7976  FZD3; frizzled class receptor 3 [KO:K02329]", "3678  ITGA5; integrin subunit alpha 5 [KO:K06484]", "5962  RDX; radixin [KO:K05762]", "387  RHOA; ras homolog family member A [KO:K04513]", "574455  MIR193B; microRNA 193b [KO:K17148]", "5328  PLAU; plasminogen activator, urokinase [KO:K01348] [EC:3.4.21.73]", "578  BAK1; BCL2 antagonist/killer 1 [KO:K14021]", "23414  ZFPM2; zinc finger protein, FOG family member 2 [KO:K17442]", "3690  ITGB3; integrin subunit beta 3 [KO:K06493]", "7329  UBE2I; ubiquitin conjugating enzyme E2 I [KO:K10577]", "442904  MIR335; microRNA 335 [KO:K17033]", "6659  SOX4; SRY-box transcription factor 4 [KO:K23581]", "3371  TNC; tenascin C [KO:K06252]", "63923  TNN; tenascin N [KO:K06252]", "7143  TNR; tenascin R [KO:K06252]", "7148  TNXB; tenascin XB [KO:K06252]", "406989  MIR206; microRNA 206 [KO:K16973]", "574411  MIR451A; microRNA 451a [KO:K17172]", "5243  ABCB1; ATP binding cassette subfamily B member 1 [KO:K05658] [EC:7.6.2.2]", "442910  MIR345; microRNA 345 [KO:K17375]", "4363  ABCC1; ATP binding cassette subfamily C member 1 (ABCC1 blood group) [KO:K05665] [EC:7.6.2.3]", "406996  MIR214; microRNA 214 [KO:K17151]", "672  BRCA1; BRCA1 DNA repair associated [KO:K10605] [EC:2.3.2.27]", "406900  MIR106B; microRNA 106b [KO:K17035]", "1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]", "406992  MIR210; microRNA 210 [KO:K17178]", "1942  EFNA1; ephrin A1 [KO:K05462]", "1943  EFNA2; ephrin A2 [KO:K05462]", "1944  EFNA3; ephrin A3 [KO:K05462]", "1945  EFNA4; ephrin A4 [KO:K05462]", "1946  EFNA5; ephrin A5 [KO:K05462]", "7057  THBS1; thrombospondin 1 [KO:K16857]", "10642  IGF2BP1; insulin like growth factor 2 mRNA binding protein 1 [KO:K17391]", "131405  TRIM71; tripartite motif containing 71 [KO:K12035] [EC:2.3.2.27]", "407041  MIR34B; microRNA 34b [KO:K16983]", "407042  MIR34C; microRNA 34c [KO:K23572]", "407046  MIR9-1; microRNA 9-1 [KO:K16977]", "407047  MIR9-2; microRNA 9-2 [KO:K16977]", "407051  MIR9-3; microRNA 9-3 [KO:K16977]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "406976  MIR199A1; microRNA 199a-1 [KO:K17118]", "406977  MIR199A2; microRNA 199a-2 [KO:K17118]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "5743  PTGS2; prostaglandin-endoperoxide synthase 2 [KO:K11987] [EC:1.14.99.1]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "2261  FGFR3; fibroblast growth factor receptor 3 [KO:K05094] [EC:2.7.10.1]", "9252  RPS6KA5; ribosomal protein S6 kinase A5 [KO:K04445] [EC:2.7.11.1]", "7157  TP53; tumor protein p53 [KO:K04451]", "4193  MDM2; MDM2 proto-oncogene [KO:K06643] [EC:2.3.2.27]", "4194  MDM4; MDM4 regulator of p53 [KO:K10127]", "5156  PDGFRA; platelet derived growth factor receptor alpha [KO:K04363] [EC:2.7.10.1]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]", "406893  MIR101-1; microRNA 101-1 [KO:K17129]", "406894  MIR101-2; microRNA 101-2 [KO:K17129]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "406971  MIR195; microRNA 195 [KO:K17029]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "6464  SHC1; SHC adaptor protein 1 [KO:K06279]", "5154  PDGFA; platelet derived growth factor subunit A [KO:K04359]", "406917  MIR129-1; microRNA 129-1 [KO:K17368]", "406918  MIR129-2; microRNA 129-2 [KO:K17368]", "399694  SHC4; SHC adaptor protein 4 [KO:K17449]", "5155  PDGFB; platelet derived growth factor subunit B [KO:K17386]", "5159  PDGFRB; platelet derived growth factor receptor beta [KO:K05089] [EC:2.7.10.1]", "1029  CDKN2A; cyclin dependent kinase inhibitor 2A [KO:K06621]", "1869  E2F1; E2F transcription factor 1 [KO:K17454]", "1870  E2F2; E2F transcription factor 2 [KO:K09389]", "407036  MIR32; microRNA 32 [KO:K17039]", "10018  BCL2L11; BCL2 like 11 [KO:K16341]", "4082  MARCKS; myristoylated alanine rich protein kinase C substrate [KO:K12561]", "659  BMPR2; bone morphogenetic protein receptor type 2 [KO:K04671] [EC:2.7.11.30]", "554213  MIR449A; microRNA 449a [KO:K17377]", "3065  HDAC1; histone deacetylase 1 [KO:K06067] [EC:3.5.1.98]", "3066  HDAC2; histone deacetylase 2 [KO:K06067] [EC:3.5.1.98]", "2146  EZH2; enhancer of zeste 2 polycomb repressive complex 2 subunit [KO:K11430] [EC:2.1.1.356]", "27165  GLS2; glutaminase 2 [KO:K01425] [EC:3.5.1.2]", "2744  GLS; glutaminase [KO:K01425] [EC:3.5.1.2]", "23411  SIRT1; sirtuin 1 [KO:K11411] [EC:2.3.1.286]", "7473  WNT3; Wnt family member 3 [KO:K00312]", "89780  WNT3A; Wnt family member 3A [KO:K00312]", "442902  MIR330; microRNA 330 [KO:K17373]", "442903  MIR331; microRNA 331 [KO:K17374]", "113130  CDCA5; cell division cycle associated 5 [KO:K17390]", "9493  KIF23; kinesin family member 23 [KO:K17387]", "574476  MIR520C; microRNA 520c [KO:K17389]", "6093  ROCK1; Rho associated coiled-coil containing protein kinase 1 [KO:K04514] [EC:2.7.11.1]", "5581  PRKCE; protein kinase C epsilon [KO:K18050] [EC:2.7.11.13]", "85414  SLC45A3; solute carrier family 45 member 3 [KO:K15379]", "7431  VIM; vimentin [KO:K07606]"], "refs": [{"pmid": "18817506", "authors": "  Lee YS, Dutta A", "title": "MicroRNAs in cancer.", "journal": "Annu Rev Pathol 4:199-227 (2009)", "doi": "10.1146/annurev.pathol.4.110807.092222"}, {"pmid": "21402473", "authors": "  Babashah S, Soleimani M", "title": "The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis.", "journal": "Eur J Cancer 47:1127-37 (2011)", "doi": "10.1016/j.ejca.2011.02.008"}, {"pmid": "19630570", "authors": "  Garzon R, Calin GA, Croce CM", "title": "MicroRNAs in Cancer.", "journal": "Annu Rev Med 60:167-79 (2009)", "doi": "10.1146/annurev.med.59.053006.104707"}, {"pmid": "23075324", "authors": "  Chen PS, Su JL, Hung MC", "title": "Dysregulation of microRNAs in cancer.", "journal": "J Biomed Sci 19:90 (2012)", "doi": "10.1186/1423-0127-19-90"}, {"pmid": "22035854", "authors": "  Ling H, Zhang W, Calin GA", "title": "Principles of microRNA involvement in human cancers.", "journal": "Chin J Cancer 30:739-48 (2011)", "doi": "10.5732/cjc.011.10243"}, {"pmid": "22351564", "authors": "  Iorio MV, Croce CM", "title": "MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review.", "journal": "EMBO Mol Med 4:143-59 (2012)", "doi": "10.1002/emmm.201100209"}, {"pmid": "21742789", "authors": "  Sayed D, Abdellatif M", "title": "MicroRNAs in development and disease.", "journal": "Physiol Rev 91:827-87 (2011)", "doi": "10.1152/physrev.00006.2010"}, {"pmid": "22345301", "authors": "  Wang Q, Wang S, Wang H, Li P, Ma Z", "title": "MicroRNAs: novel biomarkers for lung cancer diagnosis, prediction and treatment.", "journal": "Exp Biol Med (Maywood) 237:227-35 (2012)", "doi": "10.1258/ebm.2011.011192"}, {"pmid": "22580099", "authors": "  Song JH, Meltzer SJ", "title": "MicroRNAs in pathogenesis, diagnosis, and treatment of gastroesophageal cancers.", "journal": "Gastroenterology 143:35-47.e2 (2012)", "doi": "10.1053/j.gastro.2012.05.003"}, {"pmid": "19773200", "authors": "  Kan T, Meltzer SJ", "title": "MicroRNAs in Barrett's esophagus and esophageal adenocarcinoma.", "journal": "Curr Opin Pharmacol 9:727-32 (2009)", "doi": "10.1016/j.coph.2009.08.009"}, {"pmid": "20128019", "authors": "  Smith CM, Watson DI, Michael MZ, Hussey DJ", "title": "MicroRNAs, development of Barrett's esophagus, and progression to esophageal adenocarcinoma.", "journal": "World J Gastroenterol 16:531-7 (2010)", "doi": "10.3748/wjg.v16.i5.531"}, {"pmid": "23165235", "authors": "  Song S, Ajani JA", "title": "The role of microRNAs in cancers of the upper gastrointestinal tract.", "journal": "Nat Rev Gastroenterol Hepatol 10:109-18 (2013)", "doi": "10.1038/nrgastro.2012.210"}, {"pmid": "21565290", "authors": "  Liu WH, Yeh SH, Chen PJ", "title": "Role of microRNAs in hepatitis B virus replication and pathogenesis.", "journal": "Biochim Biophys Acta 1809:678-85 (2011)", "doi": "10.1016/j.bbagrm.2011.04.008"}, {"pmid": "23091478", "authors": "  Hrasovec S, Glavac D", "title": "MicroRNAs as Novel Biomarkers in Colorectal Cancer.", "journal": "Front Genet 3:180 (2012)", "doi": "10.3389/fgene.2012.00180"}, {"pmid": "22926415", "authors": "  Liu H", "title": "MicroRNAs in breast cancer initiation and progression.", "journal": "Cell Mol Life Sci 69:3587-99 (2012)", "doi": "10.1007/s00018-012-1128-9"}, {"pmid": "20345848", "authors": "  Li SD, Zhang JR, Wang YQ, Wan XP", "title": "The role of microRNAs in ovarian cancer initiation and progression.", "journal": "J Cell Mol Med 14:2240-9 (2010)", "doi": "10.1111/j.1582-4934.2010.01058.x"}, {"pmid": "23316212", "authors": "  Zabolotneva AA, Zhavoronkov A, Garazha AV, Roumiantsev SA, Buzdin AA", "title": "Characteristic patterns of microRNA expression in human bladder cancer.", "journal": "Front Genet 3:310 (2012)", "doi": "10.3389/fgene.2012.00310"}], "rel_pathway": ["hsa05210  Colorectal cancer", "hsa05214  Glioma", "hsa05215  Prostate cancer", "hsa05219  Bladder cancer", "hsa05222  Small cell lung cancer", "hsa05223  Non-small cell lung cancer"], "ko_pathway": "ko05206", "genes": ["PTEN", "FOXP1", "EGFR", "TP53", "EZR", "CD44", "MET", "TNN", "SOS1", "NRAS", "PIM1"]}, {"kegg_id": "hsa05208", "name": "Chemical carcinogenesis - reactive oxygen species - Homo sapiens (human)", "description": "It is well established that cancer is a multi-step process which involves initiation, promotion and progression. Chemical carcinogens can alter any of these processes to induce their carcinogenic effects. In the majority of instances, chemical carcinogens, directly or after xenobiotic metabolism, induce DNA damage and act in a 'genotoxic' manner. There is, however, a group of carcinogens that induce cancer via nongenotoxic mechanisms. The biochemical modes of action for nongenotoxic carcinogens are diverse, one example of which is induction of oxidative stress. Trace metals and organic xenobiotics are typical classes of environmental pollutants with prooxidant effects. Trace metals generate reactive oxygen species (ROS) depending on their ability to lose electrons and catalyze Haber Weiss and Fenton reactions. ROS are also generated due to induction of various cytochrome P450 isoenzymes during detoxification of chemical carcinogens. Increased ROS generation often has been linked to DNA damage that can lead to mutations and may, therefore, play an important role in the initiation and progression of multistage carcinogenesis. Besides causing DNA damage, ROS further induce multiple intracellular signaling pathways, notably NF-kappa B, JNK/SAPK/p38, as well as Erk/MAPK. These signaling routes can lead to transcriptional induction of target genes that could promote proliferation or confer apoptosis resistance to exposed cells.", "class": "Human Diseases; Cancer: overview", "pathway_map": "hsa05208  Chemical carcinogenesis - reactive oxygen species", "network": ["", "ELEMENT   N01389  Lead to SOD/Cat-mediated ROS neutralization", "N01390  p,p'-DDT to SOD/Cat-mediated ROS neutralization", "N01391  Lead to SOD/Cat-mediated ROS neutralization", "N01392  Arsenic to electron transfer in complex II", "N01393  Arsenic to electron transfer in complex II", "N01394  Arsenic to electron transfer in complex IV", "N01395  Cadmium to electron transfer in complex III", "N01396  4-Aminobiphenyl to CYP-mediated metabolism", "N01397  4-Aminobiphenyl to CYP-mediated metabolism", "N01398  Pentachlorophenol to CYP-mediated metabolism", "N01399  Benzene to CYP-mediated metabolism", "N01400  Benzene to CYP-mediated metabolism", "N01401  Benzo[a]pyrenre to CYP-mediated metabolism", "N01404  17beta-estradiol to CYP-mediated metabolism", "N01405  17beta-estradiol to CYP-mediated metabolism", "N01406  Ethanol to CYP-mediated metabolism", "N01407  Metals to JNK signaling pathway", "N01408  Metals to RAS-ERK signaling pathway", "N01409  Metals to PI3K signaling pathway", "N01410  Metals to NFKB signaling pathway", "N01411  Metals to NFKB signaling pathway", "N01412  Metals to HTF-1 signaling pathway", "N01413  Metals to KEAP1-NRF2 signalig pathway"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["57412  AS3MT; arsenite methyltransferase [KO:K07755] [EC:2.1.1.137]", "221357  GSTA5; glutathione S-transferase alpha 5 [KO:K00799] [EC:2.5.1.18]", "2939  GSTA2; glutathione S-transferase alpha 2 [KO:K00799] [EC:2.5.1.18]", "2941  GSTA4; glutathione S-transferase alpha 4 [KO:K00799] [EC:2.5.1.18]", "119391  GSTO2; glutathione S-transferase omega 2 [KO:K00799] [EC:2.5.1.18]", "2948  GSTM4; glutathione S-transferase mu 4 [KO:K00799] [EC:2.5.1.18]", "2953  GSTT2; glutathione S-transferase theta 2 (gene/pseudogene) [KO:K00799] [EC:2.5.1.18]", "2952  GSTT1; glutathione S-transferase theta 1 [KO:K00799] [EC:2.5.1.18]", "2947  GSTM3; glutathione S-transferase mu 3 [KO:K00799] [EC:2.5.1.18]", "4257  MGST1; microsomal glutathione S-transferase 1 [KO:K00799] [EC:2.5.1.18]", "4259  MGST3; microsomal glutathione S-transferase 3 [KO:K00799] [EC:2.5.1.18]", "2944  GSTM1; glutathione S-transferase mu 1 [KO:K00799] [EC:2.5.1.18]", "2949  GSTM5; glutathione S-transferase mu 5 [KO:K00799] [EC:2.5.1.18]", "4258  MGST2; microsomal glutathione S-transferase 2 [KO:K00799] [EC:2.5.1.18]", "2938  GSTA1; glutathione S-transferase alpha 1 [KO:K00799] [EC:2.5.1.18]", "2946  GSTM2; glutathione S-transferase mu 2 [KO:K00799] [EC:2.5.1.18]", "2940  GSTA3; glutathione S-transferase alpha 3 [KO:K00799] [EC:2.5.1.18]", "9446  GSTO1; glutathione S-transferase omega 1 [KO:K00799] [EC:2.5.1.18]", "653689  GSTT2B; glutathione S-transferase theta 2B [KO:K00799] [EC:2.5.1.18]", "4535  ND1; NADH dehydrogenase subunit 1 [KO:K03878] [EC:7.1.1.2]", "4536  ND2; NADH dehydrogenase subunit 2 [KO:K03879] [EC:7.1.1.2]", "4537  ND3; NADH dehydrogenase subunit 3 [KO:K03880] [EC:7.1.1.2]", "4538  ND4; NADH dehydrogenase subunit 4 [KO:K03881] [EC:7.1.1.2]", "4539  ND4L; NADH dehydrogenase subunit 4L [KO:K03882] [EC:7.1.1.2]", "4540  ND5; NADH dehydrogenase subunit 5 [KO:K03883] [EC:7.1.1.2]", "4541  ND6; NADH dehydrogenase subunit 6 [KO:K03884] [EC:7.1.1.2]", "4723  NDUFV1; NADH:ubiquinone oxidoreductase core subunit V1 [KO:K03942] [EC:7.1.1.2]", "4729  NDUFV2; NADH:ubiquinone oxidoreductase core subunit V2 [KO:K03943] [EC:7.1.1.2]", "4731  NDUFV3; NADH:ubiquinone oxidoreductase subunit V3 [KO:K03944]", "4694  NDUFA1; NADH:ubiquinone oxidoreductase subunit A1 [KO:K03945]", "4695  NDUFA2; NADH:ubiquinone oxidoreductase subunit A2 [KO:K03946]", "4696  NDUFA3; NADH:ubiquinone oxidoreductase subunit A3 [KO:K03947]", "4697  NDUFA4; NDUFA4 mitochondrial complex associated [KO:K03948]", "56901  NDUFA4L2; NDUFA4 mitochondrial complex associated like 2 [KO:K03948]", "4698  NDUFA5; NADH:ubiquinone oxidoreductase subunit A5 [KO:K03949]", "4700  NDUFA6; NADH:ubiquinone oxidoreductase subunit A6 [KO:K03950]", "4701  NDUFA7; NADH:ubiquinone oxidoreductase subunit A7 [KO:K03951]", "4702  NDUFA8; NADH:ubiquinone oxidoreductase subunit A8 [KO:K03952]", "4704  NDUFA9; NADH:ubiquinone oxidoreductase subunit A9 [KO:K03953]", "4705  NDUFA10; NADH:ubiquinone oxidoreductase subunit A10 [KO:K03954]", "4706  NDUFAB1; NADH:ubiquinone oxidoreductase subunit AB1 [KO:K03955]", "126328  NDUFA11; NADH:ubiquinone oxidoreductase subunit A11 [KO:K03956]", "55967  NDUFA12; NADH:ubiquinone oxidoreductase subunit A12 [KO:K11352]", "51079  NDUFA13; NADH:ubiquinone oxidoreductase subunit A13 [KO:K11353]", "4707  NDUFB1; NADH:ubiquinone oxidoreductase subunit B1 [KO:K03957]", "4708  NDUFB2; NADH:ubiquinone oxidoreductase subunit B2 [KO:K03958]", "4709  NDUFB3; NADH:ubiquinone oxidoreductase subunit B3 [KO:K03959]", "4710  NDUFB4; NADH:ubiquinone oxidoreductase subunit B4 [KO:K03960]", "4711  NDUFB5; NADH:ubiquinone oxidoreductase subunit B5 [KO:K03961]", "4712  NDUFB6; NADH:ubiquinone oxidoreductase subunit B6 [KO:K03962]", "4713  NDUFB7; NADH:ubiquinone oxidoreductase subunit B7 [KO:K03963]", "4714  NDUFB8; NADH:ubiquinone oxidoreductase subunit B8 [KO:K03964]", "4715  NDUFB9; NADH:ubiquinone oxidoreductase subunit B9 [KO:K03965]", "4716  NDUFB10; NADH:ubiquinone oxidoreductase subunit B10 [KO:K03966]", "54539  NDUFB11; NADH:ubiquinone oxidoreductase subunit B11 [KO:K11351]", "4719  NDUFS1; NADH:ubiquinone oxidoreductase core subunit S1 [KO:K03934] [EC:7.1.1.2]", "4720  NDUFS2; NADH:ubiquinone oxidoreductase core subunit S2 [KO:K03935] [EC:7.1.1.2]", "4722  NDUFS3; NADH:ubiquinone oxidoreductase core subunit S3 [KO:K03936] [EC:7.1.1.2]", "4724  NDUFS4; NADH:ubiquinone oxidoreductase subunit S4 [KO:K03937]", "4725  NDUFS5; NADH:ubiquinone oxidoreductase subunit S5 [KO:K03938]", "4726  NDUFS6; NADH:ubiquinone oxidoreductase subunit S6 [KO:K03939]", "374291  NDUFS7; NADH:ubiquinone oxidoreductase core subunit S7 [KO:K03940] [EC:7.1.1.2]", "4728  NDUFS8; NADH:ubiquinone oxidoreductase core subunit S8 [KO:K03941] [EC:7.1.1.2]", "4717  NDUFC1; NADH:ubiquinone oxidoreductase subunit C1 [KO:K03967]", "4718  NDUFC2; NADH:ubiquinone oxidoreductase subunit C2 [KO:K03968]", "100532726  NDUFC2-KCTD14; NDUFC2-KCTD14 readthrough [KO:K03968]", "6389  SDHA; succinate dehydrogenase complex flavoprotein subunit A [KO:K00234] [EC:1.3.5.1]", "6390  SDHB; succinate dehydrogenase complex iron sulfur subunit B [KO:K00235] [EC:1.3.5.1]", "6391  SDHC; succinate dehydrogenase complex subunit C [KO:K00236]", "6392  SDHD; succinate dehydrogenase complex subunit D [KO:K00237]", "7386  UQCRFS1; ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 [KO:K00411] [EC:7.1.1.8]", "4519  CYTB; cytochrome b [KO:K00412]", "1537  CYC1; cytochrome c1 [KO:K00413]", "7384  UQCRC1; ubiquinol-cytochrome c reductase core protein 1 [KO:K00414]", "7385  UQCRC2; ubiquinol-cytochrome c reductase core protein 2 [KO:K00415]", "7388  UQCRH; ubiquinol-cytochrome c reductase hinge protein [KO:K00416]", "440567  UQCRHL; ubiquinol-cytochrome c reductase hinge protein like [KO:K00416]", "7381  UQCRB; ubiquinol-cytochrome c reductase binding protein [KO:K00417]", "27089  UQCRQ; ubiquinol-cytochrome c reductase complex III subunit VII [KO:K00418]", "29796  UQCR10; ubiquinol-cytochrome c reductase, complex III subunit X [KO:K00419]", "10975  UQCR11; ubiquinol-cytochrome c reductase, complex III subunit XI [KO:K00420]", "4514  COX3; cytochrome c oxidase subunit III [KO:K02262]", "4512  COX1; cytochrome c oxidase subunit I [KO:K02256] [EC:7.1.1.9]", "4513  COX2; cytochrome c oxidase subunit II [KO:K02261]", "84701  COX4I2; cytochrome c oxidase subunit 4I2 [KO:K02263]", "1327  COX4I1; cytochrome c oxidase subunit 4I1 [KO:K02263]", "9377  COX5A; cytochrome c oxidase subunit 5A [KO:K02264]", "1329  COX5B; cytochrome c oxidase subunit 5B [KO:K02265]", "1337  COX6A1; cytochrome c oxidase subunit 6A1 [KO:K02266]", "1339  COX6A2; cytochrome c oxidase subunit 6A2 [KO:K02266]", "1340  COX6B1; cytochrome c oxidase subunit 6B1 [KO:K02267]", "125965  COX6B2; cytochrome c oxidase subunit 6B2 [KO:K02267]", "1345  COX6C; cytochrome c oxidase subunit 6C [KO:K02268]", "1346  COX7A1; cytochrome c oxidase subunit 7A1 [KO:K02270]", "1347  COX7A2; cytochrome c oxidase subunit 7A2 [KO:K02270]", "9167  COX7A2L; cytochrome c oxidase subunit 7A2 like [KO:K02270]", "1349  COX7B; cytochrome c oxidase subunit 7B [KO:K02271]", "170712  COX7B2; cytochrome c oxidase subunit 7B2 [KO:K02271]", "1350  COX7C; cytochrome c oxidase subunit 7C [KO:K02272]", "341947  COX8C; cytochrome c oxidase subunit 8C [KO:K02273]", "1351  COX8A; cytochrome c oxidase subunit 8A [KO:K02273]", "498  ATP5F1A; ATP synthase F1 subunit alpha [KO:K02132]", "506  ATP5F1B; ATP synthase F1 subunit beta [KO:K02133] [EC:7.1.2.2]", "509  ATP5F1C; ATP synthase F1 subunit gamma [KO:K02136]", "513  ATP5F1D; ATP synthase F1 subunit delta [KO:K02134]", "514  ATP5F1E; ATP synthase F1 subunit epsilon [KO:K02135]", "4508  ATP6; ATP synthase F0 subunit 6 [KO:K02126]", "515  ATP5PB; ATP synthase peripheral stalk-membrane subunit b [KO:K02127]", "516  ATP5MC1; ATP synthase membrane subunit c locus 1 [KO:K02128]", "517  ATP5MC2; ATP synthase membrane subunit c locus 2 [KO:K02128]", "518  ATP5MC3; ATP synthase membrane subunit c locus 3 [KO:K02128]", "10476  ATP5PD; ATP synthase peripheral stalk subunit d [KO:K02138]", "539  ATP5PO; ATP synthase peripheral stalk subunit OSCP [KO:K02137]", "522  ATP5PF; ATP synthase peripheral stalk subunit F6 [KO:K02131]", "4509  ATP8; ATP synthase F0 subunit 8 [KO:K02125]", "6648  SOD2; superoxide dismutase 2 [KO:K04564] [EC:1.15.1.1]", "7416  VDAC1; voltage dependent anion channel 1 [KO:K05862]", "7417  VDAC2; voltage dependent anion channel 2 [KO:K15040]", "7419  VDAC3; voltage dependent anion channel 3 [KO:K15041]", "291  SLC25A4; solute carrier family 25 member 4 [KO:K05863]", "292  SLC25A5; solute carrier family 25 member 5 [KO:K05863]", "293  SLC25A6; solute carrier family 25 member 6 [KO:K05863]", "83447  SLC25A31; solute carrier family 25 member 31 [KO:K05863]", "10105  PPIF; peptidylprolyl isomerase F [KO:K09565] [EC:5.2.1.8]", "6647  SOD1; superoxide dismutase 1 [KO:K04565] [EC:1.15.1.1]", "847  CAT; catalase [KO:K03781] [EC:1.11.1.6]", "10861  SLC26A1; solute carrier family 26 member 1 [KO:K14700]", "1836  SLC26A2; solute carrier family 26 member 2 [KO:K14701]", "65010  SLC26A6; solute carrier family 26 member 6 [KO:K14704]", "115019  SLC26A9; solute carrier family 26 member 9 [KO:K14706]", "1544  CYP1A2; cytochrome P450 family 1 subfamily A member 2 [KO:K07409] [EC:1.14.14.1]", "1571  CYP2E1; cytochrome P450 family 2 subfamily E member 1 [KO:K07415] [EC:1.14.14.-]", "1572  CYP2F1; cytochrome P450 family 2 subfamily F member 1 [KO:K07416] [EC:1.14.14.1]", "1543  CYP1A1; cytochrome P450 family 1 subfamily A member 1 [KO:K07408] [EC:1.14.14.1]", "1545  CYP1B1; cytochrome P450 family 1 subfamily B member 1 [KO:K07410] [EC:1.14.14.1]", "2052  EPHX1; epoxide hydrolase 1 [KO:K01253] [EC:3.3.2.9]", "2053  EPHX2; epoxide hydrolase 2 [KO:K08726] [EC:3.3.2.10 3.1.3.76]", "79852  EPHX3; epoxide hydrolase 3 [KO:K22368] [EC:3.3.2.10]", "253152  EPHX4; epoxide hydrolase 4 [KO:K22369] [EC:3.3.-.-]", "10327  AKR1A1; aldo-keto reductase family 1 member A1 [KO:K00002] [EC:1.1.1.2]", "1645  AKR1C1; aldo-keto reductase family 1 member C1 [KO:K00212] [EC:1.1.1.149 1.1.1.357 1.3.1.20]", "1646  AKR1C2; aldo-keto reductase family 1 member C2 [KO:K00089] [EC:1.1.1.213 1.1.1.357]", "8644  AKR1C3; aldo-keto reductase family 1 member C3 [KO:K04119] [EC:1.1.1.51 1.1.1.188 1.1.1.213 1.1.1.357]", "1109  AKR1C4; aldo-keto reductase family 1 member C4 [KO:K00037] [EC:1.1.1.50 1.1.1.357 1.1.1.225]", "1728  NQO1; NAD(P)H quinone dehydrogenase 1 [KO:K00355] [EC:1.6.5.2]", "873  CBR1; carbonyl reductase 1 [KO:K00079] [EC:1.1.1.184 1.1.1.189 1.1.1.197]", "196  AHR; aryl hydrocarbon receptor [KO:K09093]", "4025  LPO; lactoperoxidase [KO:K12550] [EC:1.11.1.7]", "50507  NOX4; NADPH oxidase 4 [KO:K21423] [EC:1.6.3.-]", "1535  CYBA; cytochrome b-245 alpha chain [KO:K08009]", "27035  NOX1; NADPH oxidase 1 [KO:K08008]", "653361  NCF1; neutrophil cytosolic factor 1 [KO:K08011]", "4688  NCF2; neutrophil cytosolic factor 2 [KO:K08010]", "1950  EGF; epidermal growth factor [KO:K04357]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "3082  HGF; hepatocyte growth factor [KO:K05460]", "4233  MET; MET proto-oncogene, receptor tyrosine kinase [KO:K05099] [EC:2.7.10.1]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "369  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "4217  MAP3K5; mitogen-activated protein kinase kinase kinase 5 [KO:K04426] [EC:2.7.11.25]", "6416  MAP2K4; mitogen-activated protein kinase kinase 4 [KO:K04430] [EC:2.7.12.2]", "5609  MAP2K7; mitogen-activated protein kinase kinase 7 [KO:K04431] [EC:2.7.12.2]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "5170  PDPK1; 3-phosphoinositide dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "2309  FOXO3; forkhead box O3 [KO:K09408]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]", "5770  PTPN1; protein tyrosine phosphatase non-receptor type 1 [KO:K05696] [EC:3.1.3.48]", "5728  PTEN; phosphatase and tensin homolog [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5580  PRKCD; protein kinase C delta [KO:K06068] [EC:2.7.11.13]", "5795  PTPRJ; protein tyrosine phosphatase receptor type J [KO:K05698] [EC:3.1.3.48]", "52  ACP1; acid phosphatase 1 [KO:K14394] [EC:3.1.3.2 3.1.3.48]", "5781  PTPN11; protein tyrosine phosphatase non-receptor type 11 [KO:K07293] [EC:3.1.3.48]", "6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "25  ABL1; ABL proto-oncogene 1, non-receptor tyrosine kinase [KO:K06619] [EC:2.7.10.2]", "27  ABL2; ABL proto-oncogene 2, non-receptor tyrosine kinase [KO:K08887] [EC:2.7.10.2]", "5587  PRKD1; protein kinase D1 [KO:K06070] [EC:2.7.11.13]", "23683  PRKD3; protein kinase D3 [KO:K06070] [EC:2.7.11.13]", "25865  PRKD2; protein kinase D2 [KO:K06070] [EC:2.7.11.13]", "5747  PTK2; protein tyrosine kinase 2 [KO:K05725] [EC:2.7.10.2]", "5337  PLD1; phospholipase D1 [KO:K01115] [EC:3.1.4.4]", "5338  PLD2; phospholipase D2 [KO:K01115] [EC:3.1.4.4]", "9020  MAP3K14; mitogen-activated protein kinase kinase kinase 14 [KO:K04466] [EC:2.7.11.25]", "3091  HIF1A; hypoxia inducible factor 1 subunit alpha [KO:K08268]", "405  ARNT; aryl hydrocarbon receptor nuclear translocator [KO:K09097]", "7422  VEGFA; vascular endothelial growth factor A [KO:K05448]", "9817  KEAP1; kelch like ECH associated protein 1 [KO:K10456]", "4780  NFE2L2; NFE2 like bZIP transcription factor 2 [KO:K05638]", "3162  HMOX1; heme oxygenase 1 [KO:K00510] [EC:1.14.14.18]"], "compound": ["C00001  H2O", "C00003  NAD+", "C00005  NADPH", "C00006  NADP+", "C00007  Oxygen", "C00019  S-Adenosyl-L-methionine", "C00021  S-Adenosyl-L-homocysteine", "C00023  Iron", "C00027  Hydrogen peroxide", "C00051  Glutathione", "C00070  Copper", "C00084  Acetaldehyde", "C00127  Glutathione disulfide", "C00146  Phenol", "C00291  Nickel", "C00469  Ethanol", "C00472  p-Benzoquinone", "C00530  Hydroquinone", "C00704  Superoxide", "C00951  Estradiol-17beta", "C01407  Benzene", "C01413  Cadmium", "C01782  Benzene oxide", "C02389  p-Benzosemiquinone", "C02575  Pentachlorophenol", "C02814  Benzene-1,2,4-triol", "C03434  Tetrachlorohydroquinone", "C03622  N-Hydroxy-4-aminobiphenyl", "C04623  DDT", "C05301  2-Hydroxyestradiol", "C05309  Semiquinone", "C05981  Phosphatidylinositol-3,4,5-trisphosphate", "C06268  Chromium", "C06269  Arsenic", "C06696  Lead", "C07294  Methylarsonate", "C07295  Methanearsonous acid", "C07308  Cacodylate", "C07535  Benzo[a]pyrene", "C07557  2,3,7,8-Tetrachlorodibenzodioxin", "C10998  4-Aminobiphenyl", "C14209  4-Hydroxy-17beta-estradiol", "C14850  Benzo[a]pyrene-7,8-oxide", "C14852  Benzo[a]pyrene-7,8-dihydrodiol", "C16038  2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine", "C16453  4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone", "C16844  Hydroxyl radical", "C18205  2,2',4,4'-Tetrabromodiphenyl ether", "C18933  Chloranil", "C19171  Cobalt", "C20300  Dimethylarsinous acid", "C20316  4-Nitrosobiphenyl", "C20319  Hydronitroxide radical", "C22355  Benzo[a]pyrene-7,8-diol", "C22356  Benzo[a]pyrene-7,8-dione", "C22357  17beta-Estradiol-2,3-quinone", "C22381  Reactive oxygen species"], "refs": [{"pmid": "24281075", "authors": "  Henkler F, Brinkmann J, Luch A", "title": "The role of oxidative stress in carcinogenesis induced by metals and xenobiotics.", "journal": "Cancers (Basel) 2:376-96 (2010)", "doi": "10.3390/cancers2020376"}, {"pmid": "22705365", "authors": "  Lee JC, Son YO, Pratheeshkumar P, Shi X", "title": "Oxidative stress and metal carcinogenesis.", "journal": "Free Radic Biol Med 53:742-57 (2012)", "doi": "10.1016/j.freeradbiomed.2012.06.002"}, {"pmid": "32033297", "authors": "  Hu Y, Li J, Lou B, Wu R, Wang G, Lu C, Wang H, Pi J, Xu Y", "title": "The Role of Reactive Oxygen Species in Arsenic Toxicity.", "journal": "Biomolecules 10:E240 (2020)", "doi": "10.3390/biom10020240"}, {"pmid": "33864199", "authors": "  Ozturk M, Metin M, Altay V, Bhat RA, Ejaz M, Gul A, Unal BT, Hasanuzzaman M, Nibir L, Nahar K, Bukhari A, Dervash MA, Kawano T", "title": "Arsenic and Human Health: Genotoxicity, Epigenomic Effects, and Cancer Signaling.", "journal": "Biol Trace Elem Res 10.1007/s12011-021-02719-w (2021)", "doi": "10.1007/s12011-021-02719-w"}, {"pmid": "23510327", "authors": "  Hubaux R, Becker-Santos DD, Enfield KS, Rowbotham D, Lam S, Lam WL, Martinez VD", "title": "Molecular features in arsenic-induced lung tumors.", "journal": "Mol Cancer 12:20 (2013)", "doi": "10.1186/1476-4598-12-20"}, {"pmid": "21648415", "authors": "  Naranmandura H, Xu S, Sawata T, Hao WH, Liu H, Bu N, Ogra Y, Lou YJ, Suzuki N", "title": "Mitochondria are the main target organelle for trivalent monomethylarsonous acid (MMA(III))-induced cytotoxicity.", "journal": "Chem Res Toxicol 24:1094-103 (2011)", "doi": "10.1021/tx200156k"}, {"pmid": "23583964", "authors": "  Faita F, Cori L, Bianchi F, Andreassi MG", "title": "Arsenic-induced genotoxicity and genetic susceptibility to arsenic-related pathologies.", "journal": "Int J Environ Res Public Health 10:1527-46 (2013)", "doi": "10.3390/ijerph10041527"}, {"pmid": "28179585", "authors": "  Sage AP, Minatel BC, Ng KW, Stewart GL, Dummer TJB, Lam WL, Martinez VD", "title": "Oncogenomic disruptions in arsenic-induced carcinogenesis.", "journal": "Oncotarget 8:25736-25755 (2017)", "doi": "10.18632/oncotarget.15106"}, {"pmid": "21414382", "authors": "  Jomova K, Valko M", "title": "Advances in metal-induced oxidative stress and human disease.", "journal": "Toxicology 283:65-87 (2011)", "doi": "10.1016/j.tox.2011.03.001"}, {"pmid": "16430879", "authors": "  Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M", "title": "Free radicals, metals and antioxidants in oxidative stress-induced cancer.", "journal": "Chem Biol Interact 160:1-40 (2006)", "doi": "10.1016/j.cbi.2005.12.009"}, {"pmid": "32731582", "authors": "  Tumolo M, Ancona V, De Paola D, Losacco D, Campanale C, Massarelli C, Uricchio VF", "title": "Chromium Pollution in European Water, Sources, Health Risk, and Remediation Strategies: An Overview.", "journal": "Int J Environ Res Public Health 17:E5438 (2020)", "doi": "10.3390/ijerph17155438"}, {"pmid": "28860815", "authors": "  Wang Y, Su H, Gu Y, Song X, Zhao J", "title": "Carcinogenicity of chromium and chemoprevention: a brief update.", "journal": "Onco Targets Ther 10:4065-4079 (2017)", "doi": "10.2147/OTT.S139262"}, {"pmid": "24820114", "authors": "  Jin X, Chen M, Song L, Li H, Li Z", "title": "The evaluation of p,p'-DDT exposure on cell adhesion of hepatocellular carcinoma.", "journal": "Toxicology 322:99-108 (2014)", "doi": "10.1016/j.tox.2014.05.002"}, {"pmid": "20370557", "authors": "  Liou GY, Storz P", "title": "Reactive oxygen species in cancer.", "journal": "Free Radic Res 44:479-96 (2010)", "doi": "10.3109/10715761003667554"}, {"pmid": "11275476", "authors": "  Murata M, Tamura A, Tada M, Kawanishi S", "title": "Mechanism of oxidative DNA damage induced by carcinogenic 4-aminobiphenyl.", "journal": "Free Radic Biol Med 30:765-73 (2001)", "doi": "10.1016/S0891-5849(01)00463-4"}, {"pmid": "19408893", "authors": "  Zhu BZ, Shan GQ", "title": "Potential mechanism for pentachlorophenol-induced carcinogenicity: a novel mechanism for metal-independent production of hydroxyl radicals.", "journal": "Chem Res Toxicol 22:969-77 (2009)", "doi": "10.1021/tx900030v"}, {"pmid": "22166497", "authors": "  McHale CM, Zhang L, Smith MT", "title": "Current understanding of the mechanism of benzene-induced leukemia in humans: implications for risk assessment.", "journal": "Carcinogenesis 33:240-52 (2012)", "doi": "10.1093/carcin/bgr297"}, {"pmid": "32977499", "authors": "  Scharf P, Broering MF, Oliveira da Rocha GH, Farsky SHP", "title": "Cellular and Molecular Mechanisms of Environmental Pollutants on Hematopoiesis.", "journal": "Int J Mol Sci 21:E6996 (2020)", "doi": "10.3390/ijms21196996"}, {"pmid": "23066403", "authors": "  Snyder R", "title": "Leukemia and benzene.", "journal": "Int J Environ Res Public Health 9:2875-93 (2012)", "doi": "10.3390/ijerph9082875"}, {"pmid": "9118888", "authors": "  Snyder R, Hedli CC", "title": "An overview of benzene metabolism.", "journal": "Environ Health Perspect 104 Suppl 6:1165-71 (1996)", "doi": "10.1289/ehp.961041165"}, {"pmid": "11978484", "authors": "  Kawanishi S, Hiraku Y, Murata M, Oikawa S", "title": "The role of metals in site-specific DNA damage with reference to carcinogenesis.", "journal": "Free Radic Biol Med 32:822-32 (2002)", "doi": "10.1016/S0891-5849(02)00779-7"}, {"pmid": "27919191", "authors": "  Das DN, Panda PK, Naik PP, Mukhopadhyay S, Sinha N, Bhutia SK", "title": "Phytotherapeutic approach: a new hope for polycyclic aromatic hydrocarbons induced cellular disorders, autophagic and apoptotic cell death.", "journal": "Toxicol Mech Methods 27:1-17 (2017)", "doi": "10.1080/15376516.2016.1268228"}, {"pmid": "21910479", "authors": "  Shultz CA, Quinn AM, Park JH, Harvey RG, Bolton JL, Maser E, Penning TM.", "title": "Specificity of human aldo-keto reductases, NAD(P)H:quinone oxidoreductase, and carbonyl reductases to redox-cycle polycyclic aromatic hydrocarbon diones and 4-hydroxyequilenin-o-quinone.", "journal": "Chem Res Toxicol 24:2153-66 (2011)", "doi": "10.1021/tx200294c"}, {"pmid": "25279998", "authors": "  Penning TM", "title": "Human aldo-keto reductases and the metabolic activation of polycyclic aromatic hydrocarbons.", "journal": "Chem Res Toxicol 27:1901-17 (2014)", "doi": "10.1021/tx500298n"}, {"pmid": "15963346", "authors": "  Xue W, Warshawsky D", "title": "Metabolic activation of polycyclic and heterocyclic aromatic hydrocarbons and DNA damage: a review.", "journal": "Toxicol Appl Pharmacol 206:73-93 (2005)", "doi": "10.1016/j.taap.2004.11.006"}, {"pmid": "15142886", "authors": "  Chen ZH, Hurh YJ, Na HK, Kim JH, Chun YJ, Kim DH, Kang KS, Cho MH, Surh YJ", "title": "Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells.", "journal": "Carcinogenesis 25:2005-13 (2004)", "doi": "10.1093/carcin/bgh183"}, {"pmid": "16684662", "authors": "  Rifkind AB", "title": "CYP1A in TCDD toxicity and in physiology-with particular reference to CYP dependent arachidonic acid metabolism and other endogenous substrates.", "journal": "Drug Metab Rev 38:291-335 (2006)", "doi": "10.1080/03602530600570107"}, {"pmid": "9380738", "authors": "  Cavalieri EL, Stack DE, Devanesan PD, Todorovic R, Dwivedy I, Higginbotham S, Johansson SL, Patil KD, Gross ML, Gooden JK, Ramanathan R, Cerny RL, Rogan EG", "title": "Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators.", "journal": "Proc Natl Acad Sci U S A 94:10937-42 (1997)", "doi": "10.1073/pnas.94.20.10937"}, {"pmid": "9472688", "authors": "  Zhu BT, Conney AH", "title": "Functional role of estrogen metabolism in target cells: review and perspectives.", "journal": "Carcinogenesis 19:1-27 (1998)", "doi": "10.1093/carcin/19.1.1"}, {"pmid": "19387921", "authors": "  McKillop IH, Schrum LW", "title": "Role of alcohol in liver carcinogenesis.", "journal": "Semin Liver Dis 29:222-32 (2009)", "doi": "10.1055/s-0029-1214377"}, {"pmid": "15603755", "authors": "  Gonzalez FJ", "title": "Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1.", "journal": "Mutat Res 569:101-10 (2005)", "doi": "10.1016/j.mrfmmm.2004.04.021"}, {"pmid": "31864052", "authors": "  Montalbano AM, Albano GD, Anzalone G, Moscato M, Gagliardo R, Di Sano C, Bonanno A, Ruggieri S, Cibella F, Profita M", "title": "Cytotoxic and genotoxic effects of the flame retardants (PBDE-47, PBDE-99 and PBDE-209) in human bronchial epithelial cells.", "journal": "Chemosphere 245:125600 (2020)", "doi": "10.1016/j.chemosphere.2019.125600"}, {"pmid": "33907575", "authors": "  Sun HN, Ren CX, Gong YX, Xie DP, Kwon T", "title": "Regulatory function of peroxiredoxin I on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung cancer development.", "journal": "Oncol Lett 21:465 (2021)", "doi": "10.3892/ol.2021.12726"}, {"pmid": "25372613", "authors": "  Pluchino LA, Wang HC", "title": "Chronic exposure to combined carcinogens enhances breast cell carcinogenesis with mesenchymal and stem-like cell properties.", "journal": "PLoS One 9:e108698 (2014)", "doi": "10.1371/journal.pone.0108698"}, {"pmid": "25535943", "authors": "  Pluchino LA, Liu AK, Wang HC", "title": "Reactive oxygen species-mediated breast cell carcinogenesis enhanced by multiple carcinogens and intervened by dietary ergosterol and mimosine.", "journal": "Free Radic Biol Med 80:12-26 (2015)", "doi": "10.1016/j.freeradbiomed.2014.12.015"}, {"pmid": "30327380", "authors": "  Moldogazieva NT, Lutsenko SV, Terentiev AA", "title": "Reactive Oxygen and Nitrogen Species-Induced Protein Modifications: Implication in Carcinogenesis and Anticancer Therapy.", "journal": "Cancer Res 78:6040-6047 (2018)", "doi": "10.1158/0008-5472.CAN-18-0980"}, {"pmid": "32358622", "authors": "  Kirtonia A, Sethi G, Garg M", "title": "The multifaceted role of reactive oxygen species in tumorigenesis.", "journal": "Cell Mol Life Sci 77:4459-4483 (2020)", "doi": "10.1007/s00018-020-03536-5"}, {"pmid": "29449774", "authors": "  Kumari S, Badana AK, G MM, G S, Malla R", "title": "Reactive Oxygen Species: A Key Constituent in Cancer Survival.", "journal": "Biomark Insights 13:1177271918755391 (2018)", "doi": "10.1177/1177271918755391"}, {"pmid": "28881698", "authors": "  Gao X, Schottker B", "title": "Reduction-oxidation pathways involved in cancer development: a systematic review of literature reviews.", "journal": "Oncotarget 8:51888-51906 (2017)", "doi": "10.18632/oncotarget.17128"}, {"pmid": "15769673", "authors": "  Storz P", "title": "Reactive oxygen species in tumor progression.", "journal": "Front Biosci 10:1881-96 (2005)", "doi": "10.2741/1667"}, {"pmid": "28835450", "authors": "  Assi M", "title": "The differential role of reactive oxygen species in early and late stages of cancer.", "journal": "Am J Physiol Regul Integr Comp Physiol 313:R646-R653 (2017)", "doi": "10.1152/ajpregu.00247.2017"}, {"pmid": "15024053", "authors": "  Storz P, Doppler H, Toker A", "title": "Protein kinase Cdelta selectively regulates protein kinase D-dependent activation of NF-kappaB in oxidative stress signaling.", "journal": "Mol Cell Biol 24:2614-26 (2004)", "doi": "10.1128/MCB.24.7.2614-2626.2004"}, {"pmid": "24998536", "authors": "  Nourazarian AR, Kangari P, Salmaninejad A", "title": "Roles of oxidative stress in the development and progression of breast cancer.", "journal": "Asian Pac J Cancer Prev 15:4745-51 (2014)", "doi": "10.7314/apjcp.2014.15.12.4745"}], "rel_pathway": ["hsa00190  Oxidative phosphorylation", "hsa00980  Metabolism of xenobiotics by cytochrome P450", "hsa04010  MAPK signaling pathway", "hsa04064  NF-kappa B signaling pathway", "hsa04066  HIF-1 signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04370  VEGF signaling pathway", "hsa05207  Chemical carcinogenesis - receptor activation", "hsa05211  Renal cell carcinoma", "hsa05215  Prostate cancer", "hsa05219  Bladder cancer", "hsa05221  Acute myeloid leukemia", "hsa05222  Small cell lung cancer", "hsa05223  Non-small cell lung cancer", "hsa05224  Breast cancer", "hsa05225  Hepatocellular carcinoma"], "ko_pathway": "ko05208", "genes": ["PTEN", "EGFR", "RAC1", "BRAF", "AKT2", "MET", "AKT1", "SOS1", "MAPK13", "NRAS"]}, {"kegg_id": "hsa05213", "name": "Endometrial cancer - Homo sapiens (human)", "description": "Endometrial cancer (EC) is the most common gynaecological malignancy and the fourth most common malignancy in women in the developed world after breast, colorectal and lung cancer. Two types of endometrial carcinoma are distinguished with respect to biology and clinical course. Type-I carcinoma is related to hyperestrogenism by association with endometrial hyperplasia, frequent expression of estrogen and progesterone receptors and younger age, whereas type-II carcinoma is unrelated to estrogen, associated with atrophic endometrium, frequent lack of estrogen and progesterone receptors and older age. The morphologic differences in these cancers are mirrored in their molecular genetic profile with type I showing defects in DNA-mismatch repair and mutations in PTEN, K-ras, and beta-catenin, and type II showing aneuploidy, p53 mutations, and her2/neu amplification.", "class": "Human Diseases; Cancer: specific types", "pathway_map": "hsa05213  Endometrial cancer", "network": ["", "ELEMENT   N00012  Mutation-activated KRAS/NRAS to ERK signaling pathway", "N00052  Mutation-inactivated PTEN to PI3K signaling pathway", "N00058  Mutation-activated CTNNB1 to Wnt signaling pathway", "N00115  Mutation-inactivated TP53 to transcription"], "disease": ["H00026  Endometrial cancer"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["1950  EGF; epidermal growth factor [KO:K04357]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5728  PTEN; phosphatase and tensin homolog [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]", "5170  PDPK1; 3-phosphoinositide dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]", "3611  ILK; integrin linked kinase [KO:K06272] [EC:2.7.11.1]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]", "2309  FOXO3; forkhead box O3 [KO:K09408]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "369  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "2002  ELK1; ETS transcription factor ELK1 [KO:K04375]", "4292  MLH1; mutL homolog 1 [KO:K08734]", "999  CDH1; cadherin 1 [KO:K05689]", "1499  CTNNB1; catenin beta 1 [KO:K02105]", "29119  CTNNA3; catenin alpha 3 [KO:K05691]", "1495  CTNNA1; catenin alpha 1 [KO:K05691]", "1496  CTNNA2; catenin alpha 2 [KO:K05691]", "8312  AXIN1; axin 1 [KO:K02157]", "8313  AXIN2; axin 2 [KO:K04385]", "324  APC; APC regulator of WNT signaling pathway [KO:K02085]", "10297  APC2; APC regulator of WNT signaling pathway 2 [KO:K02085]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "6932  TCF7; transcription factor 7 [KO:K02620]", "83439  TCF7L1; transcription factor 7 like 1 [KO:K04490]", "6934  TCF7L2; transcription factor 7 like 2 [KO:K04491]", "51176  LEF1; lymphoid enhancer binding factor 1 [KO:K04492]", "4609  MYC; MYC proto-oncogene, bHLH transcription factor [KO:K04377]", "595  CCND1; cyclin D1 [KO:K04503]", "7157  TP53; tumor protein p53 [KO:K04451]", "1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]", "1647  GADD45A; growth arrest and DNA damage inducible alpha [KO:K04402]", "4616  GADD45B; growth arrest and DNA damage inducible beta [KO:K04402]", "10912  GADD45G; growth arrest and DNA damage inducible gamma [KO:K04402]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "578  BAK1; BCL2 antagonist/killer 1 [KO:K14021]", "1643  DDB2; damage specific DNA binding protein 2 [KO:K10140]", "51426  POLK; DNA polymerase kappa [KO:K03511] [EC:2.7.7.7]", "2064  ERBB2; erb-b2 receptor tyrosine kinase 2 [KO:K05083] [EC:2.7.10.1]"], "compound": ["C05981  Phosphatidylinositol-3,4,5-trisphosphate"], "refs": [{"pmid": "15947972", "authors": "  Ryan AJ, Susil B, Jobling TW, Oehler MK.", "title": "Endometrial cancer.", "journal": "Cell Tissue Res 322:53-61 (2005)", "doi": "10.1007/s00441-005-1109-5"}, {"pmid": "14747944", "authors": "  Lax SF.", "title": "Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.", "journal": "Virchows Arch 444:213-23 (2004)", "doi": "10.1007/s00428-003-0947-3"}, {"pmid": "16508724", "authors": "  Shiozawa T, Konishi I.", "title": "Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.", "journal": "Int J Clin Oncol 11:13-21 (2006)", "doi": "10.1007/s10147-005-0546-1"}, {"pmid": "17028294", "authors": "  Hecht JL, Mutter GL.", "title": "Molecular and pathologic aspects of endometrial carcinogenesis.", "journal": "J Clin Oncol 24:4783-91 (2006)", "doi": "10.1200/JCO.2006.06.7173"}, {"pmid": "11431710", "authors": "  Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.", "title": "Molecular pathology of endometrial hyperplasia and carcinoma.", "journal": "Hum Pathol 32:569-77 (2001)", "doi": "10.1053/hupa.2001.25929"}, {"pmid": "15284264", "authors": "  Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.", "title": "Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.", "journal": "J Clin Oncol 22:3126-32 (2004)", "doi": "10.1200/JCO.2004.11.154"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04012  ErbB signaling pathway", "hsa04060  Cytokine-cytokine receptor interaction", "hsa04110  Cell cycle", "hsa04115  p53 signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04310  Wnt signaling pathway", "hsa04520  Adherens junction"], "ko_pathway": "ko05213", "genes": ["PTEN", "EGFR", "TP53", "BRAF", "AKT2", "AKT1", "SOS1", "NRAS", "BAX"]}, {"kegg_id": "hsa05214", "name": "Glioma - Homo sapiens (human)", "description": "Gliomas are the most common of the primary brain tumors and account for more than 40% of all central nervous system neoplasms. Gliomas include tumours that are composed predominantly of astrocytes (astrocytomas), oligodendrocytes (oligodendrogliomas), mixtures of various glial cells (for example,oligoastrocytomas) and ependymal cells (ependymomas). The most malignant form of infiltrating astrocytoma - glioblastoma multiforme (GBM) - is one of the most aggressive human cancers. GBM may develop de novo (primary glioblastoma) or by progression from low-grade or anaplastic astrocytoma (secondary glioblastoma). Primary glioblastomas develop in older patients and typically show genetic alterations (EGFR amplification, p16/INK4a deletion, and PTEN mutations) at frequencies of 24-34%. Secondary glioblastomas develop in younger patients and frequently show overexpression of PDGF and CDK4 as well as p53 mutations (65%) and loss of Rb playing major roles in such transformations. Loss of PTEN has been implicated in both pathways, although it is much more common in the pathogenesis of primary GBM.", "class": "Human Diseases; Cancer: specific types", "pathway_map": "hsa05214  Glioma", "network": ["", "ELEMENT   N00006  Amplified EGFR to RAS-ERK signaling pathway", "N00016  PDGF-overexpression to RAS-ERK signaling pathway", "N00018  Amplified PDGFR to RAS-ERK signaling pathway", "N00027  Amplified EGFR to PLCG-CAMK signaling pathway", "N00029  Amplified PDGFR to PLCG-CAMK signaling pathway", "N00035  Amplified EGFR to PI3K signaling pathway", "N00040  Amplified PDGFR to PI3K signaling pathway", "N00041  EGFR-overexpression to RAS-ERK signaling pathway", "N00042  EGFR-overexpression to PI3K signaling pathway", "N00051  Deleted PTEN to PI3K signaling pathway", "N00052  Mutation-inactivated PTEN to PI3K signaling pathway", "N00067  Deleted p14(ARF) to p21-cell cycle G1/S", "N00068  Amplified MDM2 to p21-cell cycle G1/S", "N00071  Deleted p16(INK4a) to p16-cell cycle G1/S", "N00072  Amplified CDK4 to cell cycle G1/S", "N00074  Loss of RB1 to cell cycle G1/S", "N00115  Mutation-inactivated TP53 to transcription", "N00513  Mutation-activated EGFR to RAS-ERK signaling pathway", "N00514  Mutation-activated EGFR to PI3K signaling pathway"], "disease": ["H00042  Glioma"], "drug": ["D12291  Tovorafenib (USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["1950  EGF; epidermal growth factor [KO:K04357]", "7039  TGFA; transforming growth factor alpha [KO:K08774]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "5154  PDGFA; platelet derived growth factor subunit A [KO:K04359]", "5155  PDGFB; platelet derived growth factor subunit B [KO:K17386]", "5156  PDGFRA; platelet derived growth factor receptor alpha [KO:K04363] [EC:2.7.10.1]", "5159  PDGFRB; platelet derived growth factor receptor beta [KO:K05089] [EC:2.7.10.1]", "3479  IGF1; insulin like growth factor 1 [KO:K05459]", "3480  IGF1R; insulin like growth factor 1 receptor [KO:K05087] [EC:2.7.10.1]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]", "810  CALML3; calmodulin like 3 [KO:K02183]", "805  CALM2; calmodulin 2 [KO:K02183]", "808  CALM3; calmodulin 3 [KO:K02183]", "801  CALM1; calmodulin 1 [KO:K02183]", "163688  CALML6; calmodulin like 6 [KO:K02183]", "51806  CALML5; calmodulin like 5 [KO:K02183]", "91860  CALML4; calmodulin like 4 [KO:K02183]", "57118  CAMK1D; calcium/calmodulin dependent protein kinase ID [KO:K08794] [EC:2.7.11.17]", "57172  CAMK1G; calcium/calmodulin dependent protein kinase IG [KO:K08794] [EC:2.7.11.17]", "8536  CAMK1; calcium/calmodulin dependent protein kinase I [KO:K08794] [EC:2.7.11.17]", "815  CAMK2A; calcium/calmodulin dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]", "817  CAMK2D; calcium/calmodulin dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]", "816  CAMK2B; calcium/calmodulin dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]", "818  CAMK2G; calcium/calmodulin dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]", "814  CAMK4; calcium/calmodulin dependent protein kinase IV [KO:K05869] [EC:2.7.11.17]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "6464  SHC1; SHC adaptor protein 1 [KO:K06279]", "25759  SHC2; SHC adaptor protein 2 [KO:K17447]", "53358  SHC3; SHC adaptor protein 3 [KO:K17448]", "399694  SHC4; SHC adaptor protein 4 [KO:K17449]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "369  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "5728  PTEN; phosphatase and tensin homolog [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]", "1029  CDKN2A; cyclin dependent kinase inhibitor 2A [KO:K06621]", "4193  MDM2; MDM2 proto-oncogene [KO:K06643] [EC:2.3.2.27]", "7157  TP53; tumor protein p53 [KO:K04451]", "1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]", "595  CCND1; cyclin D1 [KO:K04503]", "1019  CDK4; cyclin dependent kinase 4 [KO:K02089] [EC:2.7.11.22]", "1021  CDK6; cyclin dependent kinase 6 [KO:K02091] [EC:2.7.11.22]", "5925  RB1; RB transcriptional corepressor 1 [KO:K06618]", "1869  E2F1; E2F transcription factor 1 [KO:K17454]", "1870  E2F2; E2F transcription factor 2 [KO:K09389]", "1871  E2F3; E2F transcription factor 3 [KO:K06620]", "1647  GADD45A; growth arrest and DNA damage inducible alpha [KO:K04402]", "4616  GADD45B; growth arrest and DNA damage inducible beta [KO:K04402]", "10912  GADD45G; growth arrest and DNA damage inducible gamma [KO:K04402]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "578  BAK1; BCL2 antagonist/killer 1 [KO:K14021]", "1643  DDB2; damage specific DNA binding protein 2 [KO:K10140]", "51426  POLK; DNA polymerase kappa [KO:K03511] [EC:2.7.7.7]"], "compound": ["C00076  Calcium cation", "C00165  Diacylglycerol", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C05981  Phosphatidylinositol-3,4,5-trisphosphate"], "refs": [{"pmid": "15639402", "authors": "  Soni D, King JA, Kaye AH, Hovens CM.", "title": "Genetics of glioblastoma multiforme: mitogenic signaling and cell cycle pathways converge.", "journal": "J Clin Neurosci 12:1-5 (2005)", "doi": "10.1016/j.jocn.2004.04.001"}, {"pmid": "12154354", "authors": "  Zhu Y, Parada LF.", "title": "The molecular and genetic basis of neurological tumours.", "journal": "Nat Rev Cancer 2:616-26 (2002)", "doi": "10.1038/nrc866"}, {"pmid": "11253051", "authors": "  Holland EC.", "title": "Gliomagenesis: genetic alterations and mouse models.", "journal": "Nat Rev Genet 2:120-9 (2001)", "doi": "10.1038/35052535"}, {"pmid": "16700615", "authors": "  Bansal K, Liang ML, Rutka JT.", "title": "Molecular biology of human gliomas.", "journal": "Technol Cancer Res Treat 5:185-94 (2006)", "doi": "10.1177/153303460600500302"}, {"pmid": "12762887", "authors": "  Kapoor GS, O'Rourke DM.", "title": "Mitogenic signaling cascades in glial tumors.", "journal": "Neurosurgery 52:1425-34; discussion 1434-5 (2003)", "doi": "10.1227/01.NEU.0000065135.28143.39"}, {"pmid": "16095998", "authors": "  Hulleman E, Helin K.", "title": "Molecular mechanisms in gliomagenesis.", "journal": "Adv Cancer Res 94:1-27 (2005)", "doi": "10.1016/S0065-230X(05)94001-3"}, {"pmid": "11057895", "authors": "  Schlessinger J.", "title": "Cell signaling by receptor tyrosine kinases.", "journal": "Cell 103:211-25 (2000)", "doi": "10.1016/S0092-8674(00)00114-8"}, {"pmid": "9643506", "authors": "  Ng HK, Lam PY.", "title": "The molecular genetics of central nervous system tumors.", "journal": "Pathology 30:196-202 (1998)", "doi": "10.1080/00313029800169236"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04012  ErbB signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04060  Cytokine-cytokine receptor interaction", "hsa04110  Cell cycle", "hsa04115  p53 signaling pathway", "hsa04150  mTOR signaling pathway"], "ko_pathway": "ko05214", "genes": ["PTEN", "EGFR", "TP53", "BRAF", "AKT2", "AKT1", "SOS1", "NRAS", "BAX"]}, {"kegg_id": "hsa05215", "name": "Prostate cancer - Homo sapiens (human)", "description": "Prostate cancer constitutes a major health problem in Western countries. It is the most frequently diagnosed cancer among men and the second leading cause of male cancer deaths. The identification of key molecular alterations in prostate-cancer cells implicates carcinogen defenses (GSTP1), growth-factor-signaling pathways (NKX3.1, PTEN, and p27), and androgens (AR) as critical determinants of the phenotype of prostate-cancer cells. Glutathione S-transferases (GSTP1) are detoxifying enzymes. Cells of prostatic intraepithelial neoplasia, devoid of GSTP1, undergo genomic damage mediated by carcinogens. NKX3.1, PTEN, and p27 regulate the growth and survival of prostate cells in the normal prostate. Inadequate levels of PTEN and NKX3.1 lead to a reduction in p27 levels and to increased proliferation and decreased apoptosis. Androgen receptor (AR) is a transcription factor that is normally activated by its androgen ligand. During androgen withdrawal therapy, the AR signal transduction pathway also could be activated by amplification of the AR gene, by AR gene mutations, or by altered activity of AR coactivators. Through these mechanisms, tumor cells lead to the emergence of androgen-independent prostate cancer.", "class": "Human Diseases; Cancer: specific types", "pathway_map": "hsa05215  Prostate cancer", "network": ["", "ELEMENT   N00052  Mutation-inactivated PTEN to PI3K signaling pathway", "N00082  Loss of NKX3-1 to PI3K signaling pathway", "N00084  Amplified AR to androgen receptor signaling pathway", "N00085  Mutation-activated AR to androgen receptor signaling pathway", "N00093  Loss of CDKN1B to p27-cell cycle G1/S"], "disease": ["H00024  Prostate cancer"], "drug": ["D00586  Flutamide (JP18/USP/INN)", "D00961  Bicalutamide (JP18/USP/INN)", "D00965  Nilutamide (USAN/INN)", "D01299  Chlormadinone acetate (JP18/USAN)", "D10218  Enzalutamide (JAN/USAN)", "D11040  Apalutamide (JAN/INN)", "D11045  Darolutamide (JAN/USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["2950  GSTP1; glutathione S-transferase pi 1 [KO:K23790] [EC:2.5.1.18]", "1027  CDKN1B; cyclin dependent kinase inhibitor 1B [KO:K06624]", "1017  CDK2; cyclin dependent kinase 2 [KO:K02206] [EC:2.7.11.22]", "898  CCNE1; cyclin E1 [KO:K06626]", "9134  CCNE2; cyclin E2 [KO:K06626]", "5925  RB1; RB transcriptional corepressor 1 [KO:K06618]", "1869  E2F1; E2F transcription factor 1 [KO:K17454]", "1870  E2F2; E2F transcription factor 2 [KO:K09389]", "1871  E2F3; E2F transcription factor 3 [KO:K06620]", "7113  TMPRSS2; transmembrane serine protease 2 [KO:K09633] [EC:3.4.21.122]", "2078  ERG; ETS transcription factor ERG [KO:K09435]", "5328  PLAU; plasminogen activator, urokinase [KO:K01348] [EC:3.4.21.73]", "5327  PLAT; plasminogen activator, tissue type [KO:K01343] [EC:3.4.21.68]", "4314  MMP3; matrix metallopeptidase 3 [KO:K01394] [EC:3.4.24.17]", "4318  MMP9; matrix metallopeptidase 9 [KO:K01403] [EC:3.4.24.35]", "6935  ZEB1; zinc finger E-box binding homeobox 1 [KO:K09299]", "7850  IL1R2; interleukin 1 receptor type 2 [KO:K04387]", "6692  SPINT1; serine peptidase inhibitor, Kunitz type 1 [KO:K15619]", "2119  ETV5; ETS variant transcription factor 5 [KO:K15593]", "3630  INS; insulin [KO:K04526]", "5154  PDGFA; platelet derived growth factor subunit A [KO:K04359]", "5155  PDGFB; platelet derived growth factor subunit B [KO:K17386]", "56034  PDGFC; platelet derived growth factor C [KO:K05450]", "80310  PDGFD; platelet derived growth factor D [KO:K05450]", "1950  EGF; epidermal growth factor [KO:K04357]", "7039  TGFA; transforming growth factor alpha [KO:K08774]", "3479  IGF1; insulin like growth factor 1 [KO:K05459]", "3645  INSRR; insulin receptor related receptor [KO:K05086] [EC:2.7.10.1]", "5156  PDGFRA; platelet derived growth factor receptor alpha [KO:K04363] [EC:2.7.10.1]", "5159  PDGFRB; platelet derived growth factor receptor beta [KO:K05089] [EC:2.7.10.1]", "2260  FGFR1; fibroblast growth factor receptor 1 [KO:K04362] [EC:2.7.10.1]", "2263  FGFR2; fibroblast growth factor receptor 2 [KO:K05093] [EC:2.7.10.1]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "2064  ERBB2; erb-b2 receptor tyrosine kinase 2 [KO:K05083] [EC:2.7.10.1]", "3480  IGF1R; insulin like growth factor 1 receptor [KO:K05087] [EC:2.7.10.1]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5728  PTEN; phosphatase and tensin homolog [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]", "5170  PDPK1; 3-phosphoinositide dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]", "4824  NKX3-1; NK3 homeobox 1 [KO:K09348]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]", "2308  FOXO1; forkhead box O1 [KO:K07201]", "1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]", "4193  MDM2; MDM2 proto-oncogene [KO:K06643] [EC:2.3.2.27]", "7157  TP53; tumor protein p53 [KO:K04451]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]", "468  ATF4; activating transcription factor 4 [KO:K04374]", "10488  CREB3; cAMP responsive element binding protein 3 [KO:K09048]", "90993  CREB3L1; cAMP responsive element binding protein 3 like 1 [KO:K09048]", "64764  CREB3L2; cAMP responsive element binding protein 3 like 2 [KO:K09048]", "84699  CREB3L3; cAMP responsive element binding protein 3 like 3 [KO:K09048]", "148327  CREB3L4; cAMP responsive element binding protein 3 like 4 [KO:K09048]", "9586  CREB5; cAMP responsive element binding protein 5 [KO:K09047]", "1499  CTNNB1; catenin beta 1 [KO:K02105]", "1387  CREBBP; CREB binding protein [KO:K04498] [EC:2.3.1.48]", "2033  EP300; E1A binding protein p300 [KO:K04498] [EC:2.3.1.48]", "6932  TCF7; transcription factor 7 [KO:K02620]", "83439  TCF7L1; transcription factor 7 like 1 [KO:K04490]", "6934  TCF7L2; transcription factor 7 like 2 [KO:K04491]", "51176  LEF1; lymphoid enhancer binding factor 1 [KO:K04492]", "595  CCND1; cyclin D1 [KO:K04503]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "369  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "6716  SRD5A2; steroid 5 alpha-reductase 2 [KO:K12344] [EC:1.3.1.22]", "367  AR; androgen receptor [KO:K08557]", "3320  HSP90AA1; heat shock protein 90 alpha family class A member 1 [KO:K04079]", "3326  HSP90AB1; heat shock protein 90 alpha family class B member 1 [KO:K04079]", "7184  HSP90B1; heat shock protein 90 beta family member 1 [KO:K09487]", "354  KLK3; kallikrein related peptidase 3 [KO:K01351] [EC:3.4.21.77]"], "compound": ["C00280  Androstenedione", "C00410  Progesterone", "C00535  Testosterone", "C00735  Cortisol", "C00762  Cortisone", "C00951  Estradiol-17beta", "C01227  Dehydroepiandrosterone", "C03917  Dihydrotestosterone", "C05981  Phosphatidylinositol-3,4,5-trisphosphate", "C07653  Flutamide", "C16038  2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine"], "refs": [{"pmid": "12878745", "authors": "  Nelson WG, De Marzo AM, Isaacs WB.", "title": "Prostate cancer.", "journal": "N Engl J Med 349:366-81 (2003)", "doi": "10.1056/NEJMra021562"}, {"pmid": "15724144", "authors": "  Li L, Ittmann MM, Ayala G, Tsai MJ, Amato RJ, Wheeler TM, Miles BJ, Kadmon D, Thompson TC.", "title": "The emerging role of the PI3-K-Akt pathway in prostate cancer progression.", "journal": "Prostate Cancer Prostatic Dis 8:108-18 (2005)", "doi": "10.1038/sj.pcan.4500776"}, {"pmid": "16551847", "authors": "  Pienta KJ, Bradley D.", "title": "Mechanisms underlying the development of androgen-independent prostate cancer.", "journal": "Clin Cancer Res 12:1665-71 (2006)", "doi": "10.1158/1078-0432.CCR-06-0067"}, {"pmid": "11900250", "authors": "  Feldman BJ, Feldman D.", "title": "The development of androgen-independent prostate cancer.", "journal": "Nat Rev Cancer 1:34-45 (2001)", "doi": "10.1038/35094009"}, {"pmid": "15082523", "authors": "  Heinlein CA, Chang C.", "title": "Androgen receptor in prostate cancer.", "journal": "Endocr Rev 25:276-308 (2004)", "doi": "10.1210/er.2002-0032"}, {"pmid": "10835690", "authors": "  Zhao XY, Malloy PJ, Krishnan AV, Swami S, Navone NM, Peehl DM, Feldman D.", "title": "Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor.", "journal": "Nat Med 6:703-6 (2000)", "doi": "10.1038/76287"}, {"pmid": "10453277", "authors": "  Macri E, Loda M.", "title": "Role of p27 in prostate carcinogenesis.", "journal": "Cancer Metastasis Rev 17:337-44 (1998)", "doi": "10.1023/A:1006133620914"}, {"pmid": "11750244", "authors": "  Steers WD.", "title": "5alpha-reductase activity in the prostate.", "journal": "Urology 58:17-24; discussion 24 (2001)", "doi": "10.1016/S0090-4295(01)01299-7"}, {"pmid": "11527574", "authors": "  Grimes CA, Jope RS.", "title": "The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.", "journal": "Prog Neurobiol 65:391-426 (2001)", "doi": "10.1016/S0301-0082(01)00011-9"}, {"pmid": "21747944", "authors": "  Leshem O, Madar S, Kogan-Sakin I, Kamer I, Goldstein I, Brosh R, Cohen Y, Jacob-Hirsch J, Ehrlich M, Ben-Sasson S, Goldfinger N, Loewenthal R, Gazit E, Rotter V, Berger R", "title": "TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer model.", "journal": "PLoS One 6:e21650 (2011)", "doi": "10.1371/journal.pone.0021650"}, {"pmid": "20478527", "authors": "  Yu J, Yu J, Mani RS, Cao Q, Brenner CJ, Cao X, Wang X, Wu L, Li J, Hu M, Gong Y, Cheng H, Laxman B, Vellaichamy A, Shankar S, Li Y, Dhanasekaran SM, Morey R, Barrette T, Lonigro RJ, Tomlins SA, Varambally S, Qin ZS, Chinnaiyan AM", "title": "An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression.", "journal": "Cancer Cell 17:443-54 (2010)", "doi": "10.1016/j.ccr.2010.03.018"}, {"pmid": "19399032", "authors": "  Squire JA", "title": "TMPRSS2-ERG and PTEN loss in prostate cancer.", "journal": "Nat Genet 41:509-10 (2009)", "doi": "10.1038/ng0509-509"}, {"pmid": "25915839", "authors": "  Adamo P, Ladomery MR", "title": "The oncogene ERG: a key factor in prostate cancer.", "journal": "Oncogene 35:403-14 (2016)", "doi": "10.1038/onc.2015.109"}, {"pmid": "25485532", "authors": "  Burdova A, Bouchal J, Tavandzis S, Kolar Z", "title": "TMPRSS2-ERG gene fusion in prostate cancer.", "journal": "Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 158:502-10 (2014)", "doi": "10.5507/bp.2014.065"}, {"pmid": "18172298", "authors": "  Helgeson BE, Tomlins SA, Shah N, Laxman B, Cao Q, Prensner JR, Cao X, Singla N, Montie JE, Varambally S, Mehra R, Chinnaiyan AM", "title": "Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer.", "journal": "Cancer Res 68:73-80 (2008)", "doi": "10.1158/0008-5472.CAN-07-5352"}], "rel_pathway": ["hsa00140  Steroid hormone biosynthesis", "hsa04010  MAPK signaling pathway", "hsa04060  Cytokine-cytokine receptor interaction", "hsa04110  Cell cycle", "hsa04115  p53 signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04210  Apoptosis", "hsa05202  Transcriptional misregulation in cancer"], "ko_pathway": "ko05215", "genes": ["PTEN", "EGFR", "KLK3", "TP53", "BRAF", "AKT2", "AKT1", "SOS1", "NRAS"]}, {"kegg_id": "hsa05218", "name": "Melanoma - Homo sapiens (human)", "description": "Melanoma is a form of skin cancer that has a poor prognosis and which is on the rise in Western populations. Melanoma arises from the malignant transformation of pigment-producing cells, melanocytes. The only known environmental risk factor is exposure to ultraviolet (UV) light and in people with fair skin the risk is greatly increased. Melanoma pathogenesis is also driven by genetic factors. Oncogenic NRAS mutations activate both effector pathways Raf-MEK-ERK and PI3K-Akt. The Raf-MEK-ERK pathway may also be activated via mutations in the BRAF gene. The PI3K-Akt pathway may be activated through loss or mutation of the inhibitory tumor suppressor gene PTEN. These mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression. Melanoma development has been shown to be strongly associated with inactivation of the p16INK4a/cyclin dependent kinases 4 and 6/retinoblastoma protein (p16INK4a/CDK4,6/pRb) and p14ARF/human double minute 2/p53 (p14ARF/HMD2/p53) tumor suppressor pathways. MITF and TP53 are implicated in further melanoma progression.", "class": "Human Diseases; Cancer: specific types", "pathway_map": "hsa05218  Melanoma", "network": ["", "ELEMENT   N00012  Mutation-activated KRAS/NRAS to ERK signaling pathway", "N00013  Mutation-activated BRAF to ERK signaling pathway", "N00032  Mutation-activated KRAS/NRAS to PI3K signaling pathway", "N00051  Deleted PTEN to PI3K signaling pathway", "N00052  Mutation-inactivated PTEN to PI3K signaling pathway", "N00067  Deleted p14(ARF) to p21-cell cycle G1/S", "N00070  Mutation-inactivated p16(INK4a) to p16-cell cycle G1/S", "N00071  Deleted p16(INK4a) to p16-cell cycle G1/S", "N00073  Mutation-activated CDK4 to cell cycle G1/S", "N00076  Mutation-inactivated p14(ARF) to p21-cell cycle G1/S", "N00115  Mutation-inactivated TP53 to transcription"], "disease": ["H00038  Melanoma"], "drug": ["D09996  Vemurafenib (JAN/USAN/INN)", "D10104  Dabrafenib mesylate (USAN)", "D10175  Trametinib (USAN)", "D10176  Trametinib dimethyl sulfoxide (JAN/USAN)", "D10405  Cobimetinib (USAN/INN)", "D10604  Binimetinib (JAN/USAN/INN)", "D10615  Cobimetinib fumarate (USAN)", "D11053  Encorafenib (JAN/USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["2246  FGF1; fibroblast growth factor 1 [KO:K18496]", "2247  FGF2; fibroblast growth factor 2 [KO:K18497]", "2248  FGF3; fibroblast growth factor 3 [KO:K04358]", "2249  FGF4; fibroblast growth factor 4 [KO:K04358]", "8822  FGF17; fibroblast growth factor 17 [KO:K04358]", "2251  FGF6; fibroblast growth factor 6 [KO:K04358]", "2252  FGF7; fibroblast growth factor 7 [KO:K04358]", "2253  FGF8; fibroblast growth factor 8 [KO:K04358]", "2254  FGF9; fibroblast growth factor 9 [KO:K04358]", "2255  FGF10; fibroblast growth factor 10 [KO:K04358]", "8823  FGF16; fibroblast growth factor 16 [KO:K04358]", "2250  FGF5; fibroblast growth factor 5 [KO:K04358]", "8817  FGF18; fibroblast growth factor 18 [KO:K04358]", "26281  FGF20; fibroblast growth factor 20 [KO:K04358]", "27006  FGF22; fibroblast growth factor 22 [KO:K04358]", "9965  FGF19; fibroblast growth factor 19 [KO:K22603]", "26291  FGF21; fibroblast growth factor 21 [KO:K22429]", "8074  FGF23; fibroblast growth factor 23 [KO:K22428]", "3082  HGF; hepatocyte growth factor [KO:K05460]", "3479  IGF1; insulin like growth factor 1 [KO:K05459]", "5154  PDGFA; platelet derived growth factor subunit A [KO:K04359]", "5155  PDGFB; platelet derived growth factor subunit B [KO:K17386]", "56034  PDGFC; platelet derived growth factor C [KO:K05450]", "80310  PDGFD; platelet derived growth factor D [KO:K05450]", "1950  EGF; epidermal growth factor [KO:K04357]", "2260  FGFR1; fibroblast growth factor receptor 1 [KO:K04362] [EC:2.7.10.1]", "4233  MET; MET proto-oncogene, receptor tyrosine kinase [KO:K05099] [EC:2.7.10.1]", "3480  IGF1R; insulin like growth factor 1 receptor [KO:K05087] [EC:2.7.10.1]", "5156  PDGFRA; platelet derived growth factor receptor alpha [KO:K04363] [EC:2.7.10.1]", "5159  PDGFRB; platelet derived growth factor receptor beta [KO:K05089] [EC:2.7.10.1]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "369  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "595  CCND1; cyclin D1 [KO:K04503]", "1019  CDK4; cyclin dependent kinase 4 [KO:K02089] [EC:2.7.11.22]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]", "5728  PTEN; phosphatase and tensin homolog [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]", "1029  CDKN2A; cyclin dependent kinase inhibitor 2A [KO:K06621]", "4193  MDM2; MDM2 proto-oncogene [KO:K06643] [EC:2.3.2.27]", "7157  TP53; tumor protein p53 [KO:K04451]", "1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]", "1021  CDK6; cyclin dependent kinase 6 [KO:K02091] [EC:2.7.11.22]", "5925  RB1; RB transcriptional corepressor 1 [KO:K06618]", "1869  E2F1; E2F transcription factor 1 [KO:K17454]", "1870  E2F2; E2F transcription factor 2 [KO:K09389]", "1871  E2F3; E2F transcription factor 3 [KO:K06620]", "999  CDH1; cadherin 1 [KO:K05689]", "1647  GADD45A; growth arrest and DNA damage inducible alpha [KO:K04402]", "4616  GADD45B; growth arrest and DNA damage inducible beta [KO:K04402]", "10912  GADD45G; growth arrest and DNA damage inducible gamma [KO:K04402]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "578  BAK1; BCL2 antagonist/killer 1 [KO:K14021]", "1643  DDB2; damage specific DNA binding protein 2 [KO:K10140]", "51426  POLK; DNA polymerase kappa [KO:K03511] [EC:2.7.7.7]", "4286  MITF; melanocyte inducing transcription factor [KO:K09455]"], "compound": ["C05981  Phosphatidylinositol-3,4,5-trisphosphate"], "refs": [{"pmid": "16822996", "authors": "  Miller AJ, Mihm MC Jr.", "title": "Melanoma.", "journal": "N Engl J Med 355:51-65 (2006)", "doi": "10.1056/NEJMra052166"}, {"pmid": "12894244", "authors": "  Chin L.", "title": "The genetics of malignant melanoma: lessons from mouse and man.", "journal": "Nat Rev Cancer 3:559-70 (2003)", "doi": "10.1038/nrc1145"}, {"pmid": "16750612", "authors": "  Takata M, Saida T.", "title": "Genetic alterations in melanocytic tumors.", "journal": "J Dermatol Sci 43:1-10 (2006)", "doi": "10.1016/j.jdermsci.2006.05.002"}, {"pmid": "15841168", "authors": "  Chudnovsky Y, Khavari PA, Adams AE.", "title": "Melanoma genetics and the development of rational therapeutics.", "journal": "J Clin Invest 115:813-24 (2005)", "doi": "10.1172/JCI24808"}, {"pmid": "16001050", "authors": "  Merlino G.", "title": "Cancer biology: the weakest link?", "journal": "Nature 436:33-5 (2005)", "doi": "10.1038/436033a"}, {"pmid": "16001072", "authors": "  Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S, Beroukhim R, Milner DA, Granter SR, Du J, Lee C, Wagner SN, Li C, Golub TR, Rimm DL, Meyerson ML, Fisher DE, Sellers WR.", "title": "Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.", "journal": "Nature 436:117-22 (2005)", "doi": "10.1038/nature03664"}, {"pmid": "16899407", "authors": "  Levy C, Khaled M, Fisher DE.", "title": "MITF: master regulator of melanocyte development and melanoma oncogene.", "journal": "Trends Mol Med 12:406-14 (2006)", "doi": "10.1016/j.molmed.2006.07.008"}, {"pmid": "15009714", "authors": "  Tsao H, Goel V, Wu H, Yang G, Haluska FG.", "title": "Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.", "journal": "J Invest Dermatol 122:337-41 (2004)", "doi": "10.1046/j.0022-202X.2004.22243.x"}, {"pmid": "11224709", "authors": "  Gruss C, Herlyn M.", "title": "Role of cadherins and matrixins in melanoma.", "journal": "Curr Opin Oncol 13:117-23 (2001)", "doi": "10.1097/00001622-200103000-00006"}, {"pmid": "15721476", "authors": "  Thompson JF, Scolyer RA, Kefford RF.", "title": "Cutaneous melanoma.", "journal": "Lancet 365:687-701 (2005)", "doi": "10.1016/S0140-6736(05)17951-3"}, {"pmid": "15557758", "authors": "  Hussein MR.", "title": "The TP53 tumor suppressor gene and melanoma tumorigenesis: is there a relationship?", "journal": "Tumour Biol 25:200-7 (2004)", "doi": "10.1159/000081103"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04110  Cell cycle", "hsa04115  p53 signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04520  Adherens junction", "hsa04916  Melanogenesis"], "ko_pathway": "ko05218", "genes": ["PTEN", "EGFR", "TP53", "BRAF", "AKT2", "MET", "AKT1", "NRAS", "BAX"]}, {"kegg_id": "hsa05222", "name": "Small cell lung cancer - Homo sapiens (human)", "description": "Lung cancer is a leading cause of cancer death among men and women in industrialized countries. Small cell lung carcinoma (SCLC) is a highly aggressive neoplasm, which accounts for approximately 25% of all lung cancer cases. Molecular mechanisms altered in SCLC include induced expression of oncogene, MYC, and loss of tumorsuppressor genes, such as p53, PTEN, RB, and FHIT. The overexpression of MYC proteins in SCLC is largely a result of gene amplification. Such overexpression leads to more rapid proliferation and loss of terminal differentiation. Mutation or deletion of p53 or PTEN can lead to more rapid proliferation and reduced apoptosis. The retinoblastoma gene RB1 encodes a nuclear phosphoprotein that helps to regulate cell-cycle progression. The fragile histidine triad gene FHIT encodes the enzyme diadenosine triphosphate hydrolase, which is thought to have an indirect role in proapoptosis and cell-cycle control.", "class": "Human Diseases; Cancer: specific types", "pathway_map": "hsa05222  Small cell lung cancer", "network": ["", "ELEMENT   N00051  Deleted PTEN to PI3K signaling pathway", "N00052  Mutation-inactivated PTEN to PI3K signaling pathway", "N00074  Loss of RB1 to cell cycle G1/S", "N00075  Mutation-inactivated RB1 to cell cycle G1/S", "N00088  Amplified MYC to p15-cell cycle G1/S", "N00089  Amplified MYC to cell cycle G1/S", "N00092  Amplified MYC to p27-cell cycle G1/S", "N00100  BCL2-overexpression to intrinsic apoptotic pathway", "N00115  Mutation-inactivated TP53 to transcription"], "disease": ["H00013  Small cell lung cancer"], "drug": ["D11130  Trilaciclib (USAN/INN)", "D11987  Trilaciclib dihydrochloride"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["2272  FHIT; fragile histidine triad diadenosine triphosphatase [KO:K01522] [EC:3.6.1.29]", "5915  RARB; retinoic acid receptor beta [KO:K08528]", "6256  RXRA; retinoid X receptor alpha [KO:K08524]", "6257  RXRB; retinoid X receptor beta [KO:K08525]", "6258  RXRG; retinoid X receptor gamma [KO:K08526]", "7157  TP53; tumor protein p53 [KO:K04451]", "1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]", "1647  GADD45A; growth arrest and DNA damage inducible alpha [KO:K04402]", "4616  GADD45B; growth arrest and DNA damage inducible beta [KO:K04402]", "10912  GADD45G; growth arrest and DNA damage inducible gamma [KO:K04402]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "578  BAK1; BCL2 antagonist/killer 1 [KO:K14021]", "1643  DDB2; damage specific DNA binding protein 2 [KO:K10140]", "51426  POLK; DNA polymerase kappa [KO:K03511] [EC:2.7.7.7]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]", "54205  CYCS; cytochrome c, somatic [KO:K08738]", "317  APAF1; apoptotic peptidase activating factor 1 [KO:K02084]", "842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "4609  MYC; MYC proto-oncogene, bHLH transcription factor [KO:K04377]", "4149  MAX; MYC associated factor X [KO:K04453]", "7709  ZBTB17; zinc finger and BTB domain containing 17 [KO:K10500]", "1030  CDKN2B; cyclin dependent kinase inhibitor 2B [KO:K04685]", "1019  CDK4; cyclin dependent kinase 4 [KO:K02089] [EC:2.7.11.22]", "1021  CDK6; cyclin dependent kinase 6 [KO:K02091] [EC:2.7.11.22]", "595  CCND1; cyclin D1 [KO:K04503]", "1163  CKS1B; CDC28 protein kinase regulatory subunit 1B [KO:K02219]", "1164  CKS2; CDC28 protein kinase regulatory subunit 2 [KO:K02219]", "6502  SKP2; S-phase kinase associated protein 2 [KO:K03875]", "1027  CDKN1B; cyclin dependent kinase inhibitor 1B [KO:K06624]", "1017  CDK2; cyclin dependent kinase 2 [KO:K02206] [EC:2.7.11.22]", "898  CCNE1; cyclin E1 [KO:K06626]", "9134  CCNE2; cyclin E2 [KO:K06626]", "5925  RB1; RB transcriptional corepressor 1 [KO:K06618]", "1869  E2F1; E2F transcription factor 1 [KO:K17454]", "1870  E2F2; E2F transcription factor 2 [KO:K09389]", "1871  E2F3; E2F transcription factor 3 [KO:K06620]", "1284  COL4A2; collagen type IV alpha 2 chain [KO:K06237]", "1286  COL4A4; collagen type IV alpha 4 chain [KO:K06237]", "1288  COL4A6; collagen type IV alpha 6 chain [KO:K06237]", "1282  COL4A1; collagen type IV alpha 1 chain [KO:K06237]", "1287  COL4A5; collagen type IV alpha 5 chain [KO:K06237]", "1285  COL4A3; collagen type IV alpha 3 chain [KO:K06237]", "284217  LAMA1; laminin subunit alpha 1 [KO:K05637]", "3908  LAMA2; laminin subunit alpha 2 [KO:K05637]", "3909  LAMA3; laminin subunit alpha 3 [KO:K06240]", "3911  LAMA5; laminin subunit alpha 5 [KO:K06240]", "3910  LAMA4; laminin subunit alpha 4 [KO:K06241]", "3912  LAMB1; laminin subunit beta 1 [KO:K05636]", "3913  LAMB2; laminin subunit beta 2 [KO:K06243]", "3914  LAMB3; laminin subunit beta 3 [KO:K06244]", "22798  LAMB4; laminin subunit beta 4 [KO:K06245]", "3915  LAMC1; laminin subunit gamma 1 [KO:K05635]", "3918  LAMC2; laminin subunit gamma 2 [KO:K06246]", "10319  LAMC3; laminin subunit gamma 3 [KO:K06247]", "2335  FN1; fibronectin 1 [KO:K05717]", "3673  ITGA2; integrin subunit alpha 2 [KO:K06481]", "3674  ITGA2B; integrin subunit alpha 2b [KO:K06476]", "3675  ITGA3; integrin subunit alpha 3 [KO:K06482]", "3655  ITGA6; integrin subunit alpha 6 [KO:K06485]", "3685  ITGAV; integrin subunit alpha V [KO:K06487]", "3688  ITGB1; integrin subunit beta 1 [KO:K05719]", "5747  PTK2; protein tyrosine kinase 2 [KO:K05725] [EC:2.7.10.2]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5728  PTEN; phosphatase and tensin homolog [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "329  BIRC2; baculoviral IAP repeat containing 2 [KO:K16060]", "330  BIRC3; baculoviral IAP repeat containing 3 [KO:K16060]", "331  XIAP; X-linked inhibitor of apoptosis [KO:K04725] [EC:2.3.2.27]", "79444  BIRC7; baculoviral IAP repeat containing 7 [KO:K16061]", "598  BCL2L1; BCL2 like 1 [KO:K04570]", "7185  TRAF1; TNF receptor associated factor 1 [KO:K03172]", "7186  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]", "7187  TRAF3; TNF receptor associated factor 3 [KO:K03174]", "9618  TRAF4; TNF receptor associated factor 4 [KO:K09848]", "7188  TRAF5; TNF receptor associated factor 5 [KO:K09849]", "7189  TRAF6; TNF receptor associated factor 6 [KO:K03175] [EC:2.3.2.27]", "5743  PTGS2; prostaglandin-endoperoxide synthase 2 [KO:K11987] [EC:1.14.99.1]", "4843  NOS2; nitric oxide synthase 2 [KO:K13241] [EC:1.14.13.39]"], "compound": ["C00777  Retinoate", "C05981  Phosphatidylinositol-3,4,5-trisphosphate", "C15493  9-cis-Retinoic acid"], "refs": [{"pmid": "12379883", "authors": "  Osada H, Takahashi T.", "title": "Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.", "journal": "Oncogene 21:7421-34 (2002)", "doi": "10.1038/sj.onc.1205802"}, {"pmid": "12741677", "authors": "  Yokota J, Nishioka M, Tani M, Kohno T.", "title": "Genetic alterations responsible for metastatic phenotypes of lung cancer cells.", "journal": "Clin Exp Metastasis 20:189-93 (2003)", "doi": "10.1023/a:1022978932215"}, {"pmid": "12711111", "authors": "  Sanchez-Cespedes M.", "title": "Dissecting the genetic alterations involved in lung carcinogenesis.", "journal": "Lung Cancer 40:111-21 (2003)", "doi": "10.1016/S0169-5002(03)00033-3"}, {"pmid": "12407699", "authors": "  Mitsuuchi Y, Testa JR.", "title": "Cytogenetics and molecular genetics of lung cancer.", "journal": "Am J Med Genet 115:183-8 (2002)", "doi": "10.1002/ajmg.10692"}, {"pmid": "11720739", "authors": "  Kaye FJ.", "title": "Molecular biology of lung cancer.", "journal": "Lung Cancer 34 Suppl 2:S35-41 (2001)", "doi": "10.1016/S0169-5002(01)00342-7"}, {"pmid": "16112428", "authors": "  Panani AD, Roussos C.", "title": "Cytogenetic and molecular aspects of lung cancer.", "journal": "Cancer Lett 239:1-9 (2006)", "doi": "10.1016/j.canlet.2005.06.030"}, {"pmid": "11902573", "authors": "  Altucci L, Gronemeyer H.", "title": "The promise of retinoids to fight against cancer.", "journal": "Nat Rev Cancer 1:181-93 (2001)", "doi": "10.1038/35106036"}, {"pmid": "10944551", "authors": "  Virmani AK, Rathi A, Zochbauer-Muller S, Sacchi N, Fukuyama Y, Bryant D, Maitra A, Heda S, Fong KM, Thunnissen F, Minna JD, Gazdar AF.", "title": "Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas.", "journal": "J Natl Cancer Inst 92:1303-7 (2000)", "doi": "10.1093/jnci/92.16.1303"}, {"pmid": "11807782", "authors": "  Sartorius UA, Krammer PH.", "title": "Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines.", "journal": "Int J Cancer 97:584-92 (2002)", "doi": "10.1002/ijc.10096"}, {"pmid": "16064138", "authors": "  Adhikary S, Eilers M.", "title": "Transcriptional regulation and transformation by Myc proteins.", "journal": "Nat Rev Mol Cell Biol 6:635-45 (2005)", "doi": "10.1038/nrm1703"}, {"pmid": "11463388", "authors": "  Spruck C, Strohmaier H, Watson M, Smith AP, Ryan A, Krek TW, Reed SI.", "title": "A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1.", "journal": "Mol Cell 7:639-50 (2001)", "doi": "10.1016/S1097-2765(01)00210-6"}, {"pmid": "15109562", "authors": "  Buttery RC, Rintoul RC, Sethi T.", "title": "Small cell lung cancer: the importance of the extracellular matrix.", "journal": "Int J Biochem Cell Biol 36:1154-60 (2004)", "doi": "10.1016/S1357-2725(03)00261-9"}, {"pmid": "11905738", "authors": "  Rintoul RC, Sethi T.", "title": "The role of extracellular matrix in small-cell lung cancer.", "journal": "Lancet Oncol 2:437-42 (2001)", "doi": "10.1016/S1470-2045(00)00421-6"}, {"pmid": "12243753", "authors": "  Ekedahl J, Joseph B, Grigoriev MY, Muller M, Magnusson C, Lewensohn R, Zhivotovsky B.", "title": "Expression of inhibitor of apoptosis proteins in small- and non-small-cell lung carcinoma cells.", "journal": "Exp Cell Res 279:277-90 (2002)", "doi": "10.1006/excr.2002.5608"}, {"pmid": "12616528", "authors": "  Shivapurkar N, Reddy J, Chaudhary PM, Gazdar AF.", "title": "Apoptosis and lung cancer: a review.", "journal": "J Cell Biochem 88:885-98 (2003)", "doi": "10.1002/jcb.10440"}], "rel_pathway": ["hsa04110  Cell cycle", "hsa04115  p53 signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04210  Apoptosis", "hsa04510  Focal adhesion", "hsa04512  ECM-receptor interaction"], "ko_pathway": "ko05222", "genes": ["PTEN", "TP53", "AKT2", "BIRC3", "AKT1", "BAX"]}, {"kegg_id": "hsa05224", "name": "Breast cancer - Homo sapiens (human)", "description": "Breast cancer is the leading cause of cancer death among women worldwide. The vast majority of breast cancers are carcinomas that originate from cells lining the milk-forming ducts of the mammary gland. The molecular subtypes of breast cancer, which are based on the presence or absence of hormone receptors (estrogen and progesterone subtypes) and human epidermal growth factor receptor-2 (HER2), include: hormone receptor positive and HER2 negative (luminal A subtype), hormone receptor positive and HER2 positive (luminal B subtype), hormone receptor negative and HER2 positive (HER2 positive), and hormone receptor negative and HER2 negative (basal-like or triple-negative breast cancers (TNBCs)). Hormone receptor positive breast cancers are largely driven by the estrogen/ER pathway. In HER2 positive breast tumours, HER2 activates the PI3K/AKT and the RAS/RAF/MAPK pathways, and stimulate cell growth, survival and differentiation. In patients suffering from TNBC, the deregulation of various signalling pathways (Notch and Wnt/beta-catenin), EGFR protein have been confirmed. In the case of breast cancer only 8% of all cancers are hereditary, a phenomenon linked to genetic changes in BRCA1 or BRCA2. Somatic mutations in only three genes (TP53, PIK3CA and GATA3) occurred at >10% incidence across all breast cancers.", "class": "Human Diseases; Cancer: specific types", "pathway_map": "hsa05224  Breast cancer", "network": ["", "ELEMENT   N00020  Amplified FGFR to RAS-ERK signaling pathway", "N00022  ERBB2-overexpression to RAS-ERK signaling pathway", "N00034  ERBB2-overexpression to PI3K signaling pathway", "N00038  Amplified FGFR to PI3K signaling pathway", "N00041  EGFR-overexpression to RAS-ERK signaling pathway", "N00042  EGFR-overexpression to PI3K signaling pathway", "N00049  Mutation-activated PI3K to PI3K signaling pathway", "N00050  Amplified PI3K to PI3K signaling pathway", "N00052  Mutation-inactivated PTEN to PI3K signaling pathway", "N00059  FZD7-overexpression to Wnt signaling pathway", "N00060  LRP6-overexpression to Wnt signaling pathway", "N00087  NOTCH-overexpression to Notch signaling pathway", "N00115  Mutation-inactivated TP53 to transcription", "N00275  Amplified CCND1 to cell cycle G1/S", "N00287  ESR1-positive to nuclear-initiated estrogen signaling pathway"], "disease": ["H00031  Breast cancer"], "drug": ["D00554  Ethinyl estradiol (USP)", "D00951  Medroxyprogesterone acetate (JP18/USP)", "D00966  Tamoxifen citrate (JP18/USP)", "D00967  Toremifene citrate (JAN/USAN)", "D01161  Fulvestrant (JAN/USP/INN)", "D01602  Mepitiostane (JP18/INN)", "D02714  Everolimus (JAN/USAN/INN)", "D03257  Trastuzumab (USAN/INN)", "D04024  Lapatinib ditosylate (USAN)", "D05446  Pertuzumab (USAN/INN)", "D08108  Lapatinib (INN)", "D08950  Neratinib (USAN/INN)", "D09980  Trastuzumab emtansine (USAN/INN)", "D10372  Palbociclib (JAN/USAN)", "D10446  Margetuximab (USAN/INN)", "D10688  Abemaciclib (JAN/USAN/INN)", "D10898  Neratinib maleate", "D10979  Ribociclib succinate (USAN)", "D11011  Alpelisib (JAN/USAN/INN)", "D11141  Tucatinib (USAN/INN)", "D11671  Elacestrant (USAN/INN)", "D11672  Elacestrant hydrochloride (USAN)", "D11829  Fluoroestradiol F18", "D12442  Tucatinib ethanolate (JAN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["2099  ESR1; estrogen receptor 1 [KO:K08550]", "2100  ESR2; estrogen receptor 2 [KO:K08551]", "8648  NCOA1; nuclear receptor coactivator 1 [KO:K09101] [EC:2.3.1.48]", "8202  NCOA3; nuclear receptor coactivator 3 [KO:K11256] [EC:2.3.1.48]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "6667  SP1; Sp1 transcription factor [KO:K04684]", "595  CCND1; cyclin D1 [KO:K04503]", "4609  MYC; MYC proto-oncogene, bHLH transcription factor [KO:K04377]", "5241  PGR; progesterone receptor [KO:K08556]", "7471  WNT1; Wnt family member 1 [KO:K03209]", "54361  WNT4; Wnt family member 4 [KO:K00408]", "8600  TNFSF11; TNF superfamily member 11 [KO:K05473]", "2064  ERBB2; erb-b2 receptor tyrosine kinase 2 [KO:K05083] [EC:2.7.10.1]", "2246  FGF1; fibroblast growth factor 1 [KO:K18496]", "2247  FGF2; fibroblast growth factor 2 [KO:K18497]", "2248  FGF3; fibroblast growth factor 3 [KO:K04358]", "2249  FGF4; fibroblast growth factor 4 [KO:K04358]", "8822  FGF17; fibroblast growth factor 17 [KO:K04358]", "2251  FGF6; fibroblast growth factor 6 [KO:K04358]", "2252  FGF7; fibroblast growth factor 7 [KO:K04358]", "2253  FGF8; fibroblast growth factor 8 [KO:K04358]", "2254  FGF9; fibroblast growth factor 9 [KO:K04358]", "2255  FGF10; fibroblast growth factor 10 [KO:K04358]", "8823  FGF16; fibroblast growth factor 16 [KO:K04358]", "2250  FGF5; fibroblast growth factor 5 [KO:K04358]", "8817  FGF18; fibroblast growth factor 18 [KO:K04358]", "26281  FGF20; fibroblast growth factor 20 [KO:K04358]", "27006  FGF22; fibroblast growth factor 22 [KO:K04358]", "9965  FGF19; fibroblast growth factor 19 [KO:K22603]", "26291  FGF21; fibroblast growth factor 21 [KO:K22429]", "8074  FGF23; fibroblast growth factor 23 [KO:K22428]", "2260  FGFR1; fibroblast growth factor receptor 1 [KO:K04362] [EC:2.7.10.1]", "3479  IGF1; insulin like growth factor 1 [KO:K05459]", "3480  IGF1R; insulin like growth factor 1 receptor [KO:K05087] [EC:2.7.10.1]", "1950  EGF; epidermal growth factor [KO:K04357]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "3815  KIT; KIT proto-oncogene, receptor tyrosine kinase [KO:K05091] [EC:2.7.10.1]", "6464  SHC1; SHC adaptor protein 1 [KO:K06279]", "25759  SHC2; SHC adaptor protein 2 [KO:K17447]", "53358  SHC3; SHC adaptor protein 3 [KO:K17448]", "399694  SHC4; SHC adaptor protein 4 [KO:K17449]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "369  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5728  PTEN; phosphatase and tensin homolog [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "6198  RPS6KB1; ribosomal protein S6 kinase B1 [KO:K04688] [EC:2.7.11.1]", "6199  RPS6KB2; ribosomal protein S6 kinase B2 [KO:K04688] [EC:2.7.11.1]", "182  JAG1; jagged canonical Notch ligand 1 [KO:K06052]", "3714  JAG2; jagged canonical Notch ligand 2 [KO:K21635]", "10683  DLL3; delta like canonical Notch ligand 3 [KO:K06051]", "28514  DLL1; delta like canonical Notch ligand 1 [KO:K06051]", "54567  DLL4; delta like canonical Notch ligand 4 [KO:K06051]", "4851  NOTCH1; notch receptor 1 [KO:K02599]", "4853  NOTCH2; notch receptor 2 [KO:K20994]", "4854  NOTCH3; notch receptor 3 [KO:K20995]", "4855  NOTCH4; notch receptor 4 [KO:K20996]", "3280  HES1; hes family bHLH transcription factor 1 [KO:K06054]", "388585  HES5; hes family bHLH transcription factor 5 [KO:K06055]", "26508  HEYL; hes related family bHLH transcription factor with YRPW motif like [KO:K09091]", "23462  HEY1; hes related family bHLH transcription factor with YRPW motif 1 [KO:K09091]", "23493  HEY2; hes related family bHLH transcription factor with YRPW motif 2 [KO:K09091]", "2324  FLT4; fms related receptor tyrosine kinase 4 [KO:K05097] [EC:2.7.10.1]", "1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]", "4791  NFKB2; nuclear factor kappa B subunit 2 [KO:K04469]", "7472  WNT2; Wnt family member 2 [KO:K00182]", "7482  WNT2B; Wnt family member 2B [KO:K00182]", "7473  WNT3; Wnt family member 3 [KO:K00312]", "89780  WNT3A; Wnt family member 3A [KO:K00312]", "7474  WNT5A; Wnt family member 5A [KO:K00444]", "81029  WNT5B; Wnt family member 5B [KO:K00444]", "7475  WNT6; Wnt family member 6 [KO:K00445]", "7476  WNT7A; Wnt family member 7A [KO:K00572]", "7477  WNT7B; Wnt family member 7B [KO:K00572]", "7478  WNT8A; Wnt family member 8A [KO:K00714]", "7479  WNT8B; Wnt family member 8B [KO:K00714]", "7483  WNT9A; Wnt family member 9A [KO:K01064]", "7484  WNT9B; Wnt family member 9B [KO:K01064]", "7480  WNT10B; Wnt family member 10B [KO:K01357]", "80326  WNT10A; Wnt family member 10A [KO:K01357]", "7481  WNT11; Wnt family member 11 [KO:K01384]", "51384  WNT16; Wnt family member 16 [KO:K01558]", "8321  FZD1; frizzled class receptor 1 [KO:K02432]", "8324  FZD7; frizzled class receptor 7 [KO:K02432]", "2535  FZD2; frizzled class receptor 2 [KO:K02235]", "7976  FZD3; frizzled class receptor 3 [KO:K02329]", "8322  FZD4; frizzled class receptor 4 [KO:K02354]", "7855  FZD5; frizzled class receptor 5 [KO:K02375]", "8325  FZD8; frizzled class receptor 8 [KO:K02375]", "8323  FZD6; frizzled class receptor 6 [KO:K02376]", "11211  FZD10; frizzled class receptor 10 [KO:K02842]", "8326  FZD9; frizzled class receptor 9 [KO:K02842]", "4041  LRP5; LDL receptor related protein 5 [KO:K03068]", "4040  LRP6; LDL receptor related protein 6 [KO:K03068]", "1857  DVL3; dishevelled segment polarity protein 3 [KO:K02353]", "1856  DVL2; dishevelled segment polarity protein 2 [KO:K02353]", "1855  DVL1; dishevelled segment polarity protein 1 [KO:K02353]", "10023  FRAT1; FRAT regulator of WNT signaling pathway 1 [KO:K03069]", "23401  FRAT2; FRAT regulator of WNT signaling pathway 2 [KO:K03096]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "8312  AXIN1; axin 1 [KO:K02157]", "8313  AXIN2; axin 2 [KO:K04385]", "324  APC; APC regulator of WNT signaling pathway [KO:K02085]", "10297  APC2; APC regulator of WNT signaling pathway 2 [KO:K02085]", "1499  CTNNB1; catenin beta 1 [KO:K02105]", "122011  CSNK1A1L; casein kinase 1 alpha 1 like [KO:K08957] [EC:2.7.11.1]", "1452  CSNK1A1; casein kinase 1 alpha 1 [KO:K08957] [EC:2.7.11.1]", "6932  TCF7; transcription factor 7 [KO:K02620]", "83439  TCF7L1; transcription factor 7 like 1 [KO:K04490]", "6934  TCF7L2; transcription factor 7 like 2 [KO:K04491]", "51176  LEF1; lymphoid enhancer binding factor 1 [KO:K04492]", "7157  TP53; tumor protein p53 [KO:K04451]", "1647  GADD45A; growth arrest and DNA damage inducible alpha [KO:K04402]", "4616  GADD45B; growth arrest and DNA damage inducible beta [KO:K04402]", "10912  GADD45G; growth arrest and DNA damage inducible gamma [KO:K04402]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "578  BAK1; BCL2 antagonist/killer 1 [KO:K14021]", "1643  DDB2; damage specific DNA binding protein 2 [KO:K10140]", "51426  POLK; DNA polymerase kappa [KO:K03511] [EC:2.7.7.7]", "1019  CDK4; cyclin dependent kinase 4 [KO:K02089] [EC:2.7.11.22]", "1021  CDK6; cyclin dependent kinase 6 [KO:K02091] [EC:2.7.11.22]", "5925  RB1; RB transcriptional corepressor 1 [KO:K06618]", "1869  E2F1; E2F transcription factor 1 [KO:K17454]", "1870  E2F2; E2F transcription factor 2 [KO:K09389]", "1871  E2F3; E2F transcription factor 3 [KO:K06620]", "672  BRCA1; BRCA1 DNA repair associated [KO:K10605] [EC:2.3.2.27]", "675  BRCA2; BRCA2 DNA repair associated [KO:K08775]"], "compound": ["C00410  Progesterone", "C00951  Estradiol-17beta", "C05981  Phosphatidylinositol-3,4,5-trisphosphate"], "refs": [{"pmid": "24649067", "authors": "  Zhang MH, Man HT, Zhao XD, Dong N, Ma SL", "title": "Estrogen receptor-positive breast cancer molecular signatures and therapeutic potentials (Review).", "journal": "Biomed Rep 2:41-52 (2014)", "doi": "10.3892/br.2013.187"}, {"pmid": "27390604", "authors": "  Dai X, Xiang L, Li T, Bai Z", "title": "Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes.", "journal": "J Cancer 7:1281-94 (2016)", "doi": "10.7150/jca.13141"}, {"pmid": "20436504", "authors": "  Schnitt SJ", "title": "Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy.", "journal": "Mod Pathol 23 Suppl 2:S60-4 (2010)", "doi": "10.1038/modpathol.2010.33"}, {"pmid": "23000897", "authors": "  ", "title": "Comprehensive molecular portraits of human breast tumours.", "journal": "Nature 490:61-70 (2012)", "doi": "10.1038/nature11412"}, {"pmid": "22178455", "authors": "  Eroles P, Bosch A, Perez-Fidalgo JA, Lluch A", "title": "Molecular biology in breast cancer: intrinsic subtypes and signaling pathways.", "journal": "Cancer Treat Rev 38:698-707 (2012)", "doi": "10.1016/j.ctrv.2011.11.005"}, {"pmid": "23988612", "authors": "  Mohamed A, Krajewski K, Cakar B, Ma CX", "title": "Targeted therapy for breast cancer.", "journal": "Am J Pathol 183:1096-112 (2013)", "doi": "10.1016/j.ajpath.2013.07.005"}, {"pmid": "22722193", "authors": "  Ellis MJ, Ding L, Shen D, Luo J, Suman VJ, Wallis JW, Van Tine BA, Hoog J, Goiffon RJ, Goldstein TC, Ng S, Lin L, Crowder R, Snider J, Ballman K, Weber J, Chen K, Koboldt DC, Kandoth C, Schierding WS, McMichael JF, Miller CA, Lu C, Harris CC, McLellan MD, Wendl MC, DeSchryver K, Allred DC, Esserman L, Unzeitig G, Margenthaler J, Babiera GV, Marcom PK, Guenther JM, Leitch M, Hunt K, Olson J, Tao Y, Maher CA, Fulton LL, Fulton RS, Harrison M, Oberkfell B, Du F, Demeter R, Vickery TL, Elhammali A, Piwnica-Worms H, McDonald S, Watson M, Dooling DJ, Ota D, Chang LW, Bose R, Ley TJ, Piwnica-Worms D, Stuart JM, Wilson RK, Mardis ER", "title": "Whole-genome analysis informs breast cancer response to aromatase inhibition.", "journal": "Nature 486:353-60 (2012)", "doi": "10.1038/nature11143"}, {"pmid": "25907219", "authors": "  Ma CX, Reinert T, Chmielewska I, Ellis MJ", "title": "Mechanisms of aromatase inhibitor resistance.", "journal": "Nat Rev Cancer 15:261-75 (2015)", "doi": "10.1038/nrc3920"}, {"pmid": "16113099", "authors": "  Butt AJ, McNeil CM, Musgrove EA, Sutherland RL", "title": "Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin D1 and cyclin E.", "journal": "Endocr Relat Cancer 12 Suppl 1:S47-59 (2005)", "doi": "10.1677/erc.1.00993"}, {"pmid": "24111892", "authors": "  Dasgupta S, Lonard DM, O'Malley BW", "title": "Nuclear receptor coactivators: master regulators of human health and disease.", "journal": "Annu Rev Med 65:279-92 (2014)", "doi": "10.1146/annurev-med-051812-145316"}, {"pmid": "23702927", "authors": "  Brisken C", "title": "Progesterone signalling in breast cancer: a neglected hormone coming into the limelight.", "journal": "Nat Rev Cancer 13:385-96 (2013)", "doi": "10.1038/nrc3518"}, {"pmid": "20087430", "authors": "  Scarpin KM, Graham JD, Mote PA, Clarke CL", "title": "Progesterone action in human tissues: regulation by progesterone receptor (PR) isoform expression, nuclear positioning and coregulator expression.", "journal": "Nucl Recept Signal 7:e009 (2009)", "doi": "10.1621/nrs.07009"}, {"pmid": "24291072", "authors": "  Knutson TP, Lange CA", "title": "Tracking progesterone receptor-mediated actions in breast cancer.", "journal": "Pharmacol Ther 142:114-25 (2014)", "doi": "10.1016/j.pharmthera.2013.11.010"}, {"pmid": "25544707", "authors": "  Dittrich A, Gautrey H, Browell D, Tyson-Capper A", "title": "The HER2 Signaling Network in Breast Cancer--Like a Spider in its Web.", "journal": "J Mammary Gland Biol Neoplasia 19:253-70 (2014)", "doi": "10.1007/s10911-014-9329-5"}, {"pmid": "21965336", "authors": "  Higgins MJ, Baselga J", "title": "Targeted therapies for breast cancer.", "journal": "J Clin Invest 121:3797-803 (2011)", "doi": "10.1172/JCI57152"}, {"pmid": "26028978", "authors": "  Mukohara T", "title": "PI3K mutations in breast cancer: prognostic and therapeutic implications.", "journal": "Breast Cancer (Dove Med Press) 7:111-23 (2015)", "doi": "10.2147/BCTT.S60696"}, {"pmid": "19088017", "authors": "  Schneider BP, Winer EP, Foulkes WD, Garber J, Perou CM, Richardson A, Sledge GW, Carey LA", "title": "Triple-negative breast cancer: risk factors to potential targets.", "journal": "Clin Cancer Res 14:8010-8 (2008)", "doi": "10.1158/1078-0432.CCR-08-1208"}, {"pmid": "21898546", "authors": "  King TD, Suto MJ, Li Y", "title": "The Wnt/beta-catenin signaling pathway: a potential therapeutic target in the treatment of triple negative breast cancer.", "journal": "J Cell Biochem 113:13-8 (2012)", "doi": "10.1002/jcb.23350"}, {"pmid": "11737884", "authors": "  Brown AM", "title": "Wnt signaling in breast cancer: have we come full circle?", "journal": "Breast Cancer Res 3:351-5 (2001)", "doi": "10.1186/bcr321"}, {"pmid": "21076461", "authors": "  Geyer FC, Lacroix-Triki M, Savage K, Arnedos M, Lambros MB, MacKay A, Natrajan R, Reis-Filho JS", "title": "beta-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation.", "journal": "Mod Pathol 24:209-31 (2011)", "doi": "10.1038/modpathol.2010.205"}, {"pmid": "20971825", "authors": "  Al-Hussaini H, Subramanyam D, Reedijk M, Sridhar SS", "title": "Notch signaling pathway as a therapeutic target in breast cancer.", "journal": "Mol Cancer Ther 10:9-15 (2011)", "doi": "10.1158/1535-7163.MCT-10-0677"}, {"pmid": "26968398", "authors": "  Rangel MC, Bertolette D, Castro NP, Klauzinska M, Cuttitta F, Salomon DS", "title": "Developmental signaling pathways regulating mammary stem cells and contributing to the etiology of triple-negative breast cancer.", "journal": "Breast Cancer Res Treat 156:211-26 (2016)", "doi": "10.1007/s10549-016-3746-7"}, {"pmid": "26040571", "authors": "  Jamdade VS, Sethi N, Mundhe NA, Kumar P, Lahkar M, Sinha N", "title": "Therapeutic targets of triple-negative breast cancer: a review.", "journal": "Br J Pharmacol 172:4228-37 (2015)", "doi": "10.1111/bph.13211"}, {"pmid": "23196196", "authors": "  Karamboulas C, Ailles L", "title": "Developmental signaling pathways in cancer stem cells of solid tumors.", "journal": "Biochim Biophys Acta 1830:2481-95 (2013)", "doi": "10.1016/j.bbagen.2012.11.008"}, {"pmid": "23881035", "authors": "  Ignatiadis M, Sotiriou C", "title": "Luminal breast cancer: from biology to treatment.", "journal": "Nat Rev Clin Oncol 10:494-506 (2013)", "doi": "10.1038/nrclinonc.2013.124"}, {"pmid": "25013431", "authors": "  Shin SJ, Gong G, Lee HJ, Kang J, Bae YK, Lee A, Cho EY, Lee JS, Suh KS, Lee DW, Jung WH", "title": "Positive expression of insulin-like growth factor-1 receptor is associated with a positive hormone receptor status and a favorable prognosis in breast cancer.", "journal": "J Breast Cancer 17:113-20 (2014)", "doi": "10.4048/jbc.2014.17.2.113"}, {"pmid": "11879567", "authors": "  Gasco M, Shami S, Crook T", "title": "The p53 pathway in breast cancer.", "journal": "Breast Cancer Res 4:70-6 (2002)", "doi": "10.1186/bcr426"}], "rel_pathway": ["hsa03440  Homologous recombination", "hsa04010  MAPK signaling pathway", "hsa04110  Cell cycle", "hsa04115  p53 signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04310  Wnt signaling pathway", "hsa04330  Notch signaling pathway", "hsa04915  Estrogen signaling pathway"], "ko_pathway": "ko05224", "genes": ["PTEN", "EGFR", "TP53", "BRAF", "AKT2", "AKT1", "SOS1", "NRAS", "BAX"]}, {"kegg_id": "hsa05225", "name": "Hepatocellular carcinoma - Homo sapiens (human)", "description": "Hepatocellular carcinoma (HCC) is a major type of primary liver cancer and one of the rare human neoplasms etiologically linked to viral factors. It has been shown that, after HBV/HCV infection and alcohol or aflatoxin B1 exposure, genetic and epigenetic changes occur. The recurrent mutated genes were found to be highly enriched in multiple key driver signaling processes, including telomere maintenance, TP53, cell cycle regulation, the Wnt/beta-catenin pathway (CTNNB1 and AXIN1), the phosphatidylinositol-3 kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway. Recent studies using whole-exome sequencing have revealed recurrent mutations in new driver genes involved in the chromatin remodelling (ARID1A and ARID2) and the oxidative stress (NFE2L2) pathways.", "class": "Human Diseases; Cancer: specific types", "pathway_map": "hsa05225  Hepatocellular carcinoma", "network": ["", "ELEMENT   N00005  Mutation-activated MET to RAS-ERK signaling pathway", "N00044  Mutation-activated MET to PI3K signaling pathway", "N00049  Mutation-activated PI3K to PI3K signaling pathway", "N00052  Mutation-inactivated PTEN to PI3K signaling pathway", "N00058  Mutation-activated CTNNB1 to Wnt signaling pathway", "N00059  FZD7-overexpression to Wnt signaling pathway", "N00071  Deleted p16(INK4a) to p16-cell cycle G1/S", "N00074  Loss of RB1 to cell cycle G1/S", "N00115  Mutation-inactivated TP53 to transcription", "N00228  TGFA-overexpression to PLCG-PKC signaling pathway", "N00230  TGFA-overexpression to RAS-ERK signaling pathway", "N00232  TGFA-overexpression to PI3K signaling pathway", "N00235  IGF2-overexpression to RAS-ERK signaling pathway", "N00236  IGF2-overexpression to PI3K signaling pathway", "N00237  IGF1R-overexpression to RAS-ERK signaling pathway", "N00238  IGF1R-overexpression to PI3K signaling pathway", "N00240  TERT-overexpression to telomerase activity", "N00241  TGFBR2-reduced expression to TGF-beta signaling pathway", "N00242  Mutation-inactivated AXIN to Wnt signaling pathway", "N00244  Mutation-inactivated KEAP1 to KEAP1-NRF2 signaling pathway", "N00245  Mutation-activated NRF2 to KEAP1-NRF2 signaling pathway", "N00246  HGF-overexpression to RAS-ERK signaling pathway", "N00247  HGF-overexpression to PI3K signaling pathway", "N00248  MET-overexpression to RAS-ERK signaling pathway", "N00249  MET-overexpression to PI3K signaling pathway"], "disease": ["H00048  Hepatocellular carcinoma"], "drug": ["D06272  Sorafenib tosylate (USAN)", "D08524  Sorafenib (USAN/INN)", "D10137  Regorafenib hydrate (JAN)", "D10138  Regorafenib (USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["7039  TGFA; transforming growth factor alpha [KO:K08774]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "3481  IGF2; insulin like growth factor 2 [KO:K13769]", "3480  IGF1R; insulin like growth factor 1 receptor [KO:K05087] [EC:2.7.10.1]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "2002  ELK1; ETS transcription factor ELK1 [KO:K04375]", "6464  SHC1; SHC adaptor protein 1 [KO:K06279]", "25759  SHC2; SHC adaptor protein 2 [KO:K17447]", "53358  SHC3; SHC adaptor protein 3 [KO:K17448]", "399694  SHC4; SHC adaptor protein 4 [KO:K17449]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "369  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5728  PTEN; phosphatase and tensin homolog [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "6198  RPS6KB1; ribosomal protein S6 kinase B1 [KO:K04688] [EC:2.7.11.1]", "6199  RPS6KB2; ribosomal protein S6 kinase B2 [KO:K04688] [EC:2.7.11.1]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]", "598  BCL2L1; BCL2 like 1 [KO:K04570]", "4609  MYC; MYC proto-oncogene, bHLH transcription factor [KO:K04377]", "5925  RB1; RB transcriptional corepressor 1 [KO:K06618]", "1869  E2F1; E2F transcription factor 1 [KO:K17454]", "1870  E2F2; E2F transcription factor 2 [KO:K09389]", "1871  E2F3; E2F transcription factor 3 [KO:K06620]", "7015  TERT; telomerase reverse transcriptase [KO:K11126] [EC:2.7.7.49]", "7012  TERC; telomerase RNA component [KO:K22183]", "7157  TP53; tumor protein p53 [KO:K04451]", "1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]", "1647  GADD45A; growth arrest and DNA damage inducible alpha [KO:K04402]", "4616  GADD45B; growth arrest and DNA damage inducible beta [KO:K04402]", "10912  GADD45G; growth arrest and DNA damage inducible gamma [KO:K04402]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "578  BAK1; BCL2 antagonist/killer 1 [KO:K14021]", "1643  DDB2; damage specific DNA binding protein 2 [KO:K10140]", "51426  POLK; DNA polymerase kappa [KO:K03511] [EC:2.7.7.7]", "1029  CDKN2A; cyclin dependent kinase inhibitor 2A [KO:K06621]", "1019  CDK4; cyclin dependent kinase 4 [KO:K02089] [EC:2.7.11.22]", "1021  CDK6; cyclin dependent kinase 6 [KO:K02091] [EC:2.7.11.22]", "595  CCND1; cyclin D1 [KO:K04503]", "7040  TGFB1; transforming growth factor beta 1 [KO:K13375]", "7042  TGFB2; transforming growth factor beta 2 [KO:K13376]", "7043  TGFB3; transforming growth factor beta 3 [KO:K13377]", "7046  TGFBR1; transforming growth factor beta receptor 1 [KO:K04674] [EC:2.7.11.30]", "7048  TGFBR2; transforming growth factor beta receptor 2 [KO:K04388] [EC:2.7.11.30]", "4087  SMAD2; SMAD family member 2 [KO:K04500]", "4088  SMAD3; SMAD family member 3 [KO:K23605]", "4089  SMAD4; SMAD family member 4 [KO:K04501]", "7471  WNT1; Wnt family member 1 [KO:K03209]", "7472  WNT2; Wnt family member 2 [KO:K00182]", "7482  WNT2B; Wnt family member 2B [KO:K00182]", "7473  WNT3; Wnt family member 3 [KO:K00312]", "89780  WNT3A; Wnt family member 3A [KO:K00312]", "54361  WNT4; Wnt family member 4 [KO:K00408]", "7474  WNT5A; Wnt family member 5A [KO:K00444]", "81029  WNT5B; Wnt family member 5B [KO:K00444]", "7475  WNT6; Wnt family member 6 [KO:K00445]", "7476  WNT7A; Wnt family member 7A [KO:K00572]", "7477  WNT7B; Wnt family member 7B [KO:K00572]", "7478  WNT8A; Wnt family member 8A [KO:K00714]", "7479  WNT8B; Wnt family member 8B [KO:K00714]", "7483  WNT9A; Wnt family member 9A [KO:K01064]", "7484  WNT9B; Wnt family member 9B [KO:K01064]", "7480  WNT10B; Wnt family member 10B [KO:K01357]", "80326  WNT10A; Wnt family member 10A [KO:K01357]", "7481  WNT11; Wnt family member 11 [KO:K01384]", "51384  WNT16; Wnt family member 16 [KO:K01558]", "8321  FZD1; frizzled class receptor 1 [KO:K02432]", "8324  FZD7; frizzled class receptor 7 [KO:K02432]", "2535  FZD2; frizzled class receptor 2 [KO:K02235]", "7976  FZD3; frizzled class receptor 3 [KO:K02329]", "8322  FZD4; frizzled class receptor 4 [KO:K02354]", "7855  FZD5; frizzled class receptor 5 [KO:K02375]", "8325  FZD8; frizzled class receptor 8 [KO:K02375]", "8323  FZD6; frizzled class receptor 6 [KO:K02376]", "11211  FZD10; frizzled class receptor 10 [KO:K02842]", "8326  FZD9; frizzled class receptor 9 [KO:K02842]", "4041  LRP5; LDL receptor related protein 5 [KO:K03068]", "4040  LRP6; LDL receptor related protein 6 [KO:K03068]", "1857  DVL3; dishevelled segment polarity protein 3 [KO:K02353]", "1856  DVL2; dishevelled segment polarity protein 2 [KO:K02353]", "1855  DVL1; dishevelled segment polarity protein 1 [KO:K02353]", "10023  FRAT1; FRAT regulator of WNT signaling pathway 1 [KO:K03069]", "23401  FRAT2; FRAT regulator of WNT signaling pathway 2 [KO:K03096]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "8312  AXIN1; axin 1 [KO:K02157]", "8313  AXIN2; axin 2 [KO:K04385]", "324  APC; APC regulator of WNT signaling pathway [KO:K02085]", "10297  APC2; APC regulator of WNT signaling pathway 2 [KO:K02085]", "1499  CTNNB1; catenin beta 1 [KO:K02105]", "122011  CSNK1A1L; casein kinase 1 alpha 1 like [KO:K08957] [EC:2.7.11.1]", "1452  CSNK1A1; casein kinase 1 alpha 1 [KO:K08957] [EC:2.7.11.1]", "6932  TCF7; transcription factor 7 [KO:K02620]", "83439  TCF7L1; transcription factor 7 like 1 [KO:K04490]", "6934  TCF7L2; transcription factor 7 like 2 [KO:K04491]", "51176  LEF1; lymphoid enhancer binding factor 1 [KO:K04492]", "9817  KEAP1; kelch like ECH associated protein 1 [KO:K10456]", "4780  NFE2L2; NFE2 like bZIP transcription factor 2 [KO:K05638]", "3162  HMOX1; heme oxygenase 1 [KO:K00510] [EC:1.14.14.18]", "1728  NQO1; NAD(P)H quinone dehydrogenase 1 [KO:K00355] [EC:1.6.5.2]", "221357  GSTA5; glutathione S-transferase alpha 5 [KO:K00799] [EC:2.5.1.18]", "2939  GSTA2; glutathione S-transferase alpha 2 [KO:K00799] [EC:2.5.1.18]", "2941  GSTA4; glutathione S-transferase alpha 4 [KO:K00799] [EC:2.5.1.18]", "119391  GSTO2; glutathione S-transferase omega 2 [KO:K00799] [EC:2.5.1.18]", "2948  GSTM4; glutathione S-transferase mu 4 [KO:K00799] [EC:2.5.1.18]", "2953  GSTT2; glutathione S-transferase theta 2 (gene/pseudogene) [KO:K00799] [EC:2.5.1.18]", "2952  GSTT1; glutathione S-transferase theta 1 [KO:K00799] [EC:2.5.1.18]", "2947  GSTM3; glutathione S-transferase mu 3 [KO:K00799] [EC:2.5.1.18]", "4257  MGST1; microsomal glutathione S-transferase 1 [KO:K00799] [EC:2.5.1.18]", "4259  MGST3; microsomal glutathione S-transferase 3 [KO:K00799] [EC:2.5.1.18]", "2944  GSTM1; glutathione S-transferase mu 1 [KO:K00799] [EC:2.5.1.18]", "2949  GSTM5; glutathione S-transferase mu 5 [KO:K00799] [EC:2.5.1.18]", "4258  MGST2; microsomal glutathione S-transferase 2 [KO:K00799] [EC:2.5.1.18]", "2938  GSTA1; glutathione S-transferase alpha 1 [KO:K00799] [EC:2.5.1.18]", "2946  GSTM2; glutathione S-transferase mu 2 [KO:K00799] [EC:2.5.1.18]", "2940  GSTA3; glutathione S-transferase alpha 3 [KO:K00799] [EC:2.5.1.18]", "9446  GSTO1; glutathione S-transferase omega 1 [KO:K00799] [EC:2.5.1.18]", "653689  GSTT2B; glutathione S-transferase theta 2B [KO:K00799] [EC:2.5.1.18]", "2950  GSTP1; glutathione S-transferase pi 1 [KO:K23790] [EC:2.5.1.18]", "7296  TXNRD1; thioredoxin reductase 1 [KO:K22182] [EC:1.8.1.9]", "114112  TXNRD3; thioredoxin reductase 3 [KO:K22182] [EC:1.8.1.9]", "10587  TXNRD2; thioredoxin reductase 2 [KO:K22182] [EC:1.8.1.9]", "3082  HGF; hepatocyte growth factor [KO:K05460]", "4233  MET; MET proto-oncogene, receptor tyrosine kinase [KO:K05099] [EC:2.7.10.1]", "2549  GAB1; GRB2 associated binding protein 1 [KO:K09593]", "71  ACTG1; actin gamma 1 [KO:K05692]", "60  ACTB; actin beta [KO:K05692]", "86  ACTL6A; actin like 6A [KO:K11340]", "51412  ACTL6B; actin like 6B [KO:K11652]", "6602  SMARCD1; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 [KO:K11650]", "6603  SMARCD2; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2 [KO:K11650]", "6604  SMARCD3; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 [KO:K11650]", "55274  PHF10; PHD finger protein 10 [KO:K22197]", "8193  DPF1; double PHD fingers 1 [KO:K22198]", "8110  DPF3; double PHD fingers 3 [KO:K22198]", "57492  ARID1B; AT-rich interaction domain 1B [KO:K11653]", "8289  ARID1A; AT-rich interaction domain 1A [KO:K11653]", "6605  SMARCE1; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1 [KO:K11651]", "6598  SMARCB1; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 [KO:K11648]", "6599  SMARCC1; SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1 [KO:K11649]", "6601  SMARCC2; SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 2 [KO:K11649]", "6595  SMARCA2; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 [KO:K11647] [EC:5.6.2.-]", "6597  SMARCA4; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 [KO:K11647] [EC:5.6.2.-]", "196528  ARID2; AT-rich interaction domain 2 [KO:K11765]", "55193  PBRM1; polybromo 1 [KO:K11757]", "29117  BRD7; bromodomain containing 7 [KO:K11723]"], "compound": ["C00027  Hydrogen peroxide", "C00039  DNA", "C00076  Calcium cation", "C00165  Diacylglycerol", "C00533  Nitric oxide", "C00704  Superoxide", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C01471  Acrolein", "C05981  Phosphatidylinositol-3,4,5-trisphosphate", "C06793  Vinyl chloride", "C06800  Aflatoxin B1", "C16844  Hydroxyl radical", "C21641  Hydroperoxyl radical", "C21642  4-Hydroxynonenal"], "refs": [{"pmid": "20639898", "authors": "  Whittaker S, Marais R, Zhu AX", "title": "The role of signaling pathways in the development and treatment of hepatocellular carcinoma.", "journal": "Oncogene 29:4989-5005 (2010)", "doi": "10.1038/onc.2010.236"}, {"pmid": "26099527", "authors": "  Zucman-Rossi J, Villanueva A, Nault JC, Llovet JM", "title": "Genetic Landscape and Biomarkers of Hepatocellular Carcinoma.", "journal": "Gastroenterology 149:1226-1239.e4 (2015)", "doi": "10.1053/j.gastro.2015.05.061"}, {"pmid": "17295177", "authors": "  Villanueva A, Newell P, Chiang DY, Friedman SL, Llovet JM.", "title": "Genomics and signaling pathways in hepatocellular carcinoma.", "journal": "Semin Liver Dis 27:55-76 (2007)", "doi": "10.1055/s-2006-960171"}, {"pmid": "16799620", "authors": "  Breuhahn K, Longerich T, Schirmacher P", "title": "Dysregulation of growth factor signaling in human hepatocellular carcinoma.", "journal": "Oncogene 25:3787-800 (2006)", "doi": "10.1038/sj.onc.1209556"}, {"pmid": "19387255", "authors": "  Minguez B, Tovar V, Chiang D, Villanueva A, Llovet JM", "title": "Pathogenesis of hepatocellular carcinoma and molecular therapies.", "journal": "Curr Opin Gastroenterol 25:186-94 (2009)", "doi": "10.1097/MOG.0b013e32832962a1"}, {"pmid": "21829020", "authors": "  Kudo M", "title": "Signaling pathway and molecular-targeted therapy for hepatocellular carcinoma.", "journal": "Dig Dis 29:289-302 (2011)", "doi": "10.1159/000327562"}, {"pmid": "23994386", "authors": "  Nault JC, Zucman-Rossi J", "title": "Genetics of hepatocellular carcinoma: the next generation.", "journal": "J Hepatol 60:224-6 (2014)", "doi": "10.1016/j.jhep.2013.08.019"}, {"pmid": "11935086", "authors": "  Rocken C, Carl-McGrath S.", "title": "Pathology and pathogenesis of hepatocellular carcinoma.", "journal": "Dig Dis 19:269-78 (2001)", "doi": "10.1159/000050693"}, {"pmid": "21303380", "authors": "  Cornella H, Alsinet C, Villanueva A", "title": "Molecular pathogenesis of hepatocellular carcinoma.", "journal": "Alcohol Clin Exp Res 35:821-5 (2011)", "doi": "10.1111/j.1530-0277.2010.01406.x"}, {"pmid": "27895396", "authors": "  Niu ZS, Niu XJ, Wang WH", "title": "Genetic alterations in hepatocellular carcinoma: An update.", "journal": "World J Gastroenterol 22:9069-9095 (2016)", "doi": "10.3748/wjg.v22.i41.9069"}, {"pmid": "11956813", "authors": "  Tannapfel A, Wittekind C", "title": "Genes involved in hepatocellular carcinoma: deregulation in cell cycling and apoptosis.", "journal": "Virchows Arch 440:345-52 (2002)", "doi": "10.1007/s00428-002-0617-x"}, {"pmid": "23426905", "authors": "  Shiraha H, Yamamoto K, Namba M", "title": "Human hepatocyte carcinogenesis (review).", "journal": "Int J Oncol 42:1133-8 (2013)", "doi": "10.3892/ijo.2013.1829"}, {"pmid": "23887712", "authors": "  Nault JC, Mallet M, Pilati C, Calderaro J, Bioulac-Sage P, Laurent C, Laurent A, Cherqui D, Balabaud C, Zucman-Rossi J", "title": "High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions.", "journal": "Nat Commun 4:2218 (2013)", "doi": "10.1038/ncomms3218"}, {"pmid": "22561517", "authors": "  Guichard C, Amaddeo G, Imbeaud S, Ladeiro Y, Pelletier L, Maad IB, Calderaro J, Bioulac-Sage P, Letexier M, Degos F, Clement B, Balabaud C, Chevet E, Laurent A, Couchy G, Letouze E, Calvo F, Zucman-Rossi J", "title": "Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma.", "journal": "Nat Genet 44:694-8 (2012)", "doi": "10.1038/ng.2256"}, {"pmid": "24024136", "authors": "  Kansanen E, Kuosmanen SM, Leinonen H, Levonen AL", "title": "The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer.", "journal": "Redox Biol 1:45-9 (2013)", "doi": "10.1016/j.redox.2012.10.001"}, {"pmid": "21251164", "authors": "  Taguchi K, Motohashi H, Yamamoto M", "title": "Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution.", "journal": "Genes Cells 16:123-40 (2011)", "doi": "10.1111/j.1365-2443.2010.01473.x"}, {"pmid": "20019356", "authors": "  Klaunig JE, Kamendulis LM, Hocevar BA", "title": "Oxidative stress and oxidative damage in carcinogenesis.", "journal": "Toxicol Pathol 38:96-109 (2010)", "doi": "10.1177/0192623309356453"}, {"pmid": "11193292", "authors": "  Krupp G, Bonatz G, Parwaresch R", "title": "Telomerase, immortality and cancer.", "journal": "Biotechnol Annu Rev 6:103-40 (2000)", "doi": "10.1016/S1387-2656(00)06020-8"}, {"pmid": "27323951", "authors": "  Jafri MA, Ansari SA, Alqahtani MH, Shay JW", "title": "Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies.", "journal": "Genome Med 8:69 (2016)", "doi": "10.1186/s13073-016-0324-x"}, {"pmid": "27029895", "authors": "  Shay JW", "title": "Role of Telomeres and Telomerase in Aging and Cancer.", "journal": "Cancer Discov 6:584-93 (2016)", "doi": "10.1158/2159-8290.CD-16-0062"}, {"pmid": "27508192", "authors": "  Granito A, Guidetti E, Gramantieri L", "title": "c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma.", "journal": "J Hepatocell Carcinoma 2:29-38 (2015)", "doi": "10.2147/JHC.S77038"}, {"pmid": "16934487", "authors": "  Vita M, Henriksson M", "title": "The Myc oncoprotein as a therapeutic target for human cancer.", "journal": "Semin Cancer Biol 16:318-30 (2006)", "doi": "10.1016/j.semcancer.2006.07.015"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04110  Cell cycle", "hsa04115  p53 signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04310  Wnt signaling pathway", "hsa04350  TGF-beta signaling pathway", "hsa04932  Non-alcoholic fatty liver disease", "hsa04936  Alcoholic liver disease", "hsa05160  Hepatitis C", "hsa05161  Hepatitis B"], "ko_pathway": "ko05225", "genes": ["PTEN", "EGFR", "TP53", "BRAF", "AKT2", "MET", "AKT1", "SOS1", "NRAS", "BAX"]}, {"kegg_id": "hsa05230", "name": "Central carbon metabolism in cancer - Homo sapiens (human)", "description": "Malignant transformation of cells requires specific adaptations of cellular metabolism to support growth and survival. In the early twentieth century, Otto Warburg established that there are fundamental differences in the central metabolic pathways operating in malignant tissue. He showed that cancer cells consume a large amount of glucose, maintain high rate of glycolysis and convert a majority of glucose into lactic acid even under normal oxygen concentrations (Warburg's Effects). More recently, it has been recognized that the 'Warburg effect' encompasses a similarly increased utilization of glutamine. From the intermediate molecules provided by enhanced glycolysis and glutaminolysis, cancer cells synthesize most of the macromolecules required for the duplication of their biomass and genome. These cancer-specific alterations represent a major consequence of genetic mutations and the ensuing changes of signalling pathways in cancer cells. Three transcription factors, c-MYC, HIF-1 and p53, are key regulators and coordinate regulation of cancer metabolism in different ways, and many other oncogenes and tumor suppressor genes cluster along the signaling pathways that regulate c-MYC, HIF-1 and p53.", "class": "Human Diseases; Cancer: overview", "pathway_map": "hsa05230  Central carbon metabolism in cancer", "drug": ["D07257  Lonidamine (INN)", "D11090  Ivosidenib (JAN/USAN/INN)", "D11712  Pralsetinib (USAN/INN)", "D11713  Selpercatinib (JAN/USAN/INN)", "D11738  Telaglenastat (USAN/INN)", "D11739  Telaglenastat hydrochloride (USAN)", "D12354  Pralsetinib hydrate (JAN)", "D12443  Nanvuranlat hydrochloride hydrate (JAN)", "D12483  Olutasidenib (USAN/INN)", "D12600  Bezuclastinib (USAN/INN)", "D12708  Crelosidenib (USAN)", "D12717  Crelosidenib gentisate (USAN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["6513  SLC2A1; solute carrier family 2 member 1 [KO:K07299]", "6514  SLC2A2; solute carrier family 2 member 2 [KO:K07593]", "2645  GCK; glucokinase [KO:K12407] [EC:2.7.1.2]", "5315  PKM; pyruvate kinase M1/2 [KO:K00873] [EC:2.7.1.40]", "5161  PDHA2; pyruvate dehydrogenase E1 subunit alpha 2 [KO:K00161] [EC:1.2.4.1]", "5160  PDHA1; pyruvate dehydrogenase E1 subunit alpha 1 [KO:K00161] [EC:1.2.4.1]", "5162  PDHB; pyruvate dehydrogenase E1 subunit beta [KO:K00162] [EC:1.2.4.1]", "5163  PDK1; pyruvate dehydrogenase kinase 1 [KO:K12077] [EC:2.7.11.2]", "7157  TP53; tumor protein p53 [KO:K04451]", "9997  SCO2; synthesis of cytochrome C oxidase 2 [KO:K23755]", "6510  SLC1A5; solute carrier family 1 member 5 [KO:K05616]", "23410  SIRT3; sirtuin 3 [KO:K11413] [EC:2.3.1.286]", "9123  SLC16A3; solute carrier family 16 member 3 [KO:K08180]", "51548  SIRT6; sirtuin 6 [KO:K11416] [EC:2.3.1.286]", "4609  MYC; MYC proto-oncogene, bHLH transcription factor [KO:K04377]", "3091  HIF1A; hypoxia inducible factor 1 subunit alpha [KO:K08268]", "3815  KIT; KIT proto-oncogene, receptor tyrosine kinase [KO:K05091] [EC:2.7.10.1]", "4233  MET; MET proto-oncogene, receptor tyrosine kinase [KO:K05099] [EC:2.7.10.1]", "5979  RET; ret proto-oncogene [KO:K05126] [EC:2.7.10.1]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "2064  ERBB2; erb-b2 receptor tyrosine kinase 2 [KO:K05083] [EC:2.7.10.1]", "4914  NTRK1; neurotrophic receptor tyrosine kinase 1 [KO:K03176] [EC:2.7.10.1]", "4916  NTRK3; neurotrophic receptor tyrosine kinase 3 [KO:K05101] [EC:2.7.10.1]", "5156  PDGFRA; platelet derived growth factor receptor alpha [KO:K04363] [EC:2.7.10.1]", "5159  PDGFRB; platelet derived growth factor receptor beta [KO:K05089] [EC:2.7.10.1]", "2260  FGFR1; fibroblast growth factor receptor 1 [KO:K04362] [EC:2.7.10.1]", "2263  FGFR2; fibroblast growth factor receptor 2 [KO:K05093] [EC:2.7.10.1]", "2261  FGFR3; fibroblast growth factor receptor 3 [KO:K05094] [EC:2.7.10.1]", "2322  FLT3; fms related receptor tyrosine kinase 3 [KO:K05092] [EC:2.7.10.1]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "27165  GLS2; glutaminase 2 [KO:K01425] [EC:3.5.1.2]", "2744  GLS; glutaminase [KO:K01425] [EC:3.5.1.2]", "2539  G6PD; glucose-6-phosphate dehydrogenase [KO:K00036] [EC:1.1.1.49 1.1.1.363]", "3101  HK3; hexokinase 3 [KO:K00844] [EC:2.7.1.1]", "3098  HK1; hexokinase 1 [KO:K00844] [EC:2.7.1.1]", "3099  HK2; hexokinase 2 [KO:K00844] [EC:2.7.1.1]", "80201  HKDC1; hexokinase domain containing 1 [KO:K00844] [EC:2.7.1.1]", "5213  PFKM; phosphofructokinase, muscle [KO:K00850] [EC:2.7.1.11]", "5214  PFKP; phosphofructokinase, platelet [KO:K00850] [EC:2.7.1.11]", "5211  PFKL; phosphofructokinase, liver type [KO:K00850] [EC:2.7.1.11]", "5223  PGAM1; phosphoglycerate mutase 1 [KO:K01834] [EC:5.4.2.11]", "5224  PGAM2; phosphoglycerate mutase 2 [KO:K01834] [EC:5.4.2.11]", "441531  PGAM4; phosphoglycerate mutase family member 4 [KO:K01834] [EC:5.4.2.11]", "160287  LDHAL6A; lactate dehydrogenase A like 6A [KO:K00016] [EC:1.1.1.27]", "92483  LDHAL6B; lactate dehydrogenase A like 6B [KO:K00016] [EC:1.1.1.27]", "3939  LDHA; lactate dehydrogenase A [KO:K00016] [EC:1.1.1.27]", "3945  LDHB; lactate dehydrogenase B [KO:K00016] [EC:1.1.1.27]", "3948  LDHC; lactate dehydrogenase C [KO:K00016] [EC:1.1.1.27]", "3417  IDH1; isocitrate dehydrogenase (NADP(+)) 1 [KO:K00031] [EC:1.1.1.42]", "3418  IDH2; isocitrate dehydrogenase (NADP(+)) 2 [KO:K00031] [EC:1.1.1.42]", "57103  TIGAR; TP53 induced glycolysis regulatory phosphatase [KO:K14634] [EC:3.1.3.46]", "5728  PTEN; phosphatase and tensin homolog [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "8140  SLC7A5; solute carrier family 7 member 5 [KO:K13780]"], "compound": ["C00022  Pyruvate", "C00024  Acetyl-CoA", "C00025  L-Glutamate", "C00026  2-Oxoglutarate", "C00031  D-Glucose", "C00036  Oxaloacetate", "C00037  Glycine", "C00041  L-Alanine", "C00042  Succinate", "C00049  L-Aspartate", "C00062  L-Arginine", "C00064  L-Glutamine", "C00065  L-Serine", "C00073  L-Methionine", "C00074  Phosphoenolpyruvate", "C00078  L-Tryptophan", "C00079  L-Phenylalanine", "C00082  L-Tyrosine", "C00085  D-Fructose 6-phosphate", "C00092  D-Glucose 6-phosphate", "C00097  L-Cysteine", "C00122  Fumarate", "C00123  L-Leucine", "C00135  L-Histidine", "C00148  L-Proline", "C00149  (S)-Malate", "C00152  L-Asparagine", "C00158  Citrate", "C00183  L-Valine", "C00186  (S)-Lactate", "C00197  3-Phospho-D-glycerate", "C00311  Isocitrate", "C00354  D-Fructose 1,6-bisphosphate", "C00407  L-Isoleucine", "C00631  2-Phospho-D-glycerate", "C00665  beta-D-Fructose 2,6-bisphosphate", "C00704  Superoxide"], "refs": [{"pmid": "23279446", "authors": "  Soga T", "title": "Cancer metabolism: key players in metabolic reprogramming.", "journal": "Cancer Sci 104:275-81 (2013)", "doi": "10.1111/cas.12085"}, {"pmid": "19460998", "authors": "  Vander Heiden MG, Cantley LC, Thompson CB", "title": "Understanding the Warburg effect: the metabolic requirements of cell proliferation.", "journal": "Science 324:1029-33 (2009)", "doi": "10.1126/science.1160809"}, {"pmid": "23071355", "authors": "  Teicher BA, Linehan WM, Helman LJ", "title": "Targeting cancer metabolism.", "journal": "Clin Cancer Res 18:5537-45 (2012)", "doi": "10.1158/1078-0432.CCR-12-2587"}, {"pmid": "21127244", "authors": "  Levine AJ, Puzio-Kuter AM", "title": "The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes.", "journal": "Science 330:1340-4 (2010)", "doi": "10.1126/science.1193494"}, {"pmid": "24079832", "authors": "  Amoedo ND, Valencia JP, Rodrigues MF, Galina A, Rumjanek FD", "title": "How does the metabolism of tumour cells differ from that of normal cells.", "journal": "Biosci Rep 33:e00080 (2013)", "doi": "10.1042/BSR20130066"}, {"pmid": "21258394", "authors": "  Cairns RA, Harris IS, Mak TW", "title": "Regulation of cancer cell metabolism.", "journal": "Nat Rev Cancer 11:85-95 (2011)", "doi": "10.1038/nrc2981"}, {"pmid": "22237205", "authors": "  Munoz-Pinedo C, El Mjiyad N, Ricci JE", "title": "Cancer metabolism: current perspectives and future directions.", "journal": "Cell Death Dis 3:e248 (2012)", "doi": "10.1038/cddis.2011.123"}, {"pmid": "22156302", "authors": "  Cairns RA, Harris I, McCracken S, Mak TW", "title": "Cancer cell metabolism.", "journal": "Cold Spring Harb Symp Quant Biol 76:299-311 (2011)", "doi": "10.1101/sqb.2011.76.012856"}, {"pmid": "18538731", "authors": "  Kroemer G, Pouyssegur J", "title": "Tumor cell metabolism: cancer's Achilles' heel.", "journal": "Cancer Cell 13:472-82 (2008)", "doi": "10.1016/j.ccr.2008.05.005"}, {"pmid": "18177721", "authors": "  DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB", "title": "The biology of cancer: metabolic reprogramming fuels cell growth and proliferation.", "journal": "Cell Metab 7:11-20 (2008)", "doi": "10.1016/j.cmet.2007.10.002"}, {"pmid": "21508971", "authors": "  Koppenol WH, Bounds PL, Dang CV", "title": "Otto Warburg's contributions to current concepts of cancer metabolism.", "journal": "Nat Rev Cancer 11:325-37 (2011)", "doi": "10.1038/nrc3038"}, {"pmid": "21801601", "authors": "  Fogg VC, Lanning NJ, Mackeigan JP", "title": "Mitochondria in cancer: at the crossroads of life and death.", "journal": "Chin J Cancer 30:526-39 (2011)", "doi": "10.5732/cjc.011.10018"}, {"pmid": "16982728", "authors": "  Kim JW, Dang CV", "title": "Cancer's molecular sweet tooth and the Warburg effect.", "journal": "Cancer Res 66:8927-30 (2006)", "doi": "10.1158/0008-5472.CAN-06-1501"}, {"pmid": "18766298", "authors": "  Yeung SJ, Pan J, Lee MH", "title": "Roles of p53, MYC and HIF-1 in regulating glycolysis - the seventh hallmark of cancer.", "journal": "Cell Mol Life Sci 65:3981-99 (2008)", "doi": "10.1007/s00018-008-8224-x"}, {"pmid": "23897900", "authors": "  Li B, Simon MC", "title": "Molecular Pathways: Targeting MYC-induced metabolic reprogramming and oncogenic stress in cancer.", "journal": "Clin Cancer Res 19:5835-41 (2013)", "doi": "10.1158/1078-0432.CCR-12-3629"}, {"pmid": "22307140", "authors": "  Shen L, Sun X, Fu Z, Yang G, Li J, Yao L", "title": "The fundamental role of the p53 pathway in tumor metabolism and its implication in tumor therapy.", "journal": "Clin Cancer Res 18:1561-7 (2012)", "doi": "10.1158/1078-0432.CCR-11-3040"}, {"pmid": "19270154", "authors": "  Jones RG, Thompson CB", "title": "Tumor suppressors and cell metabolism: a recipe for cancer growth.", "journal": "Genes Dev 23:537-48 (2009)", "doi": "10.1101/gad.1756509"}, {"pmid": "21340684", "authors": "  Maddocks OD, Vousden KH", "title": "Metabolic regulation by p53.", "journal": "J Mol Med (Berl) 89:237-45 (2011)", "doi": "10.1007/s00109-011-0735-5"}, {"pmid": "22750268", "authors": "  Chen JQ, Russo J", "title": "Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells.", "journal": "Biochim Biophys Acta 1826:370-84 (2012)", "doi": "10.1016/j.bbcan.2012.06.004"}, {"pmid": "20520704", "authors": "  Kaelin WG Jr, Thompson CB", "title": "Q&amp;A: Cancer: clues from cell metabolism.", "journal": "Nature 465:562-4 (2010)", "doi": "10.1038/465562a"}, {"pmid": "24113830", "authors": "  Galluzzi L, Kepp O, Vander Heiden MG, Kroemer G", "title": "Metabolic targets for cancer therapy.", "journal": "Nat Rev Drug Discov 12:829-46 (2013)", "doi": "10.1038/nrd4145"}, {"pmid": "24738035", "authors": "  Phan LM, Yeung SC, Lee MH", "title": "Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies.", "journal": "Cancer Biol Med 11:1-19 (2014)", "doi": "10.7497/j.issn.2095-3941.2014.01.001"}, {"pmid": "22101401", "authors": "  Icard P, Poulain L, Lincet H", "title": "Understanding the central role of citrate in the metabolism of cancer cells.", "journal": "Biochim Biophys Acta 1825:111-6 (2012)", "doi": "10.1016/j.bbcan.2011.10.007"}, {"pmid": "22349059", "authors": "  Daye D, Wellen KE", "title": "Metabolic reprogramming in cancer: unraveling the role of glutamine in tumorigenesis.", "journal": "Semin Cell Dev Biol 23:362-9 (2012)", "doi": "10.1016/j.semcdb.2012.02.002"}, {"pmid": "23018234", "authors": "  Chiarugi A, Dolle C, Felici R, Ziegler M", "title": "The NAD metabolome--a key determinant of cancer cell biology.", "journal": "Nat Rev Cancer 12:741-52 (2012)", "doi": "10.1038/nrc3340"}, {"pmid": "24398961", "authors": "  Guarente L", "title": "The many faces of sirtuins: Sirtuins and the Warburg effect.", "journal": "Nat Med 20:24-5 (2014)", "doi": "10.1038/nm.3438"}], "rel_pathway": ["hsa00010  Glycolysis / Gluconeogenesis", "hsa00020  Citrate cycle (TCA cycle)", "hsa00030  Pentose phosphate pathway", "hsa00190  Oxidative phosphorylation", "hsa00250  Alanine, aspartate and glutamate metabolism", "hsa00260  Glycine, serine and threonine metabolism", "hsa00330  Arginine and proline metabolism", "hsa01212  Fatty acid metabolism", "hsa04010  MAPK signaling pathway", "hsa04066  HIF-1 signaling pathway", "hsa04150  mTOR signaling pathway", "hsa04151  PI3K-Akt signaling pathway"], "ko_pathway": "ko05230", "genes": ["PTEN", "EGFR", "TP53", "AKT2", "MET", "AKT1", "NRAS"]}, {"kegg_id": "hsa05235", "name": "PD-L1 expression and PD-1 checkpoint pathway in cancer - Homo sapiens (human)", "description": "Programmed cell death 1 (PD1) and its ligand (PDL1) are key regulatory physiological immune checkpoints that maintain self-tolerance in the organism by regulating the degree of activation of T and B  cells amongst other immune cell types. In solid tumors, the PD-1/PD-L1 inhibitory pathway can be (mis-)used to silence the immune system by increasing the expression of PD-L1 on the tumor cell surface. Up-regulation of PD-L1 is caused by activation of pro-survival pathways MAPK and PI3K/Akt as well as transcriptional factors HIF-1, STAT3 and NF-kappa B. The MAPK and PI3K signalling pathways are activated by gene mutations and growth factors. PD-L1 on tumor cells may then engage the PD-1 receptors resulting in suppression of T-cell mediated immune response. Therapeutic antibodies blocking the PD-1/PD-L1 pathway by targeting PD-L1 or PD-1 are highly effective in rescuing T cell anti-tumor effector functions.", "class": "Human Diseases; Cancer: overview", "pathway_map": "hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer", "drug": ["D10316  Nivolumab (USAN/INN)", "D10390  Pidilizumab (USAN/INN)", "D10574  Pembrolizumab (USAN)", "D10773  Atezolizumab (USAN/INN)", "D10808  Durvalumab (USAN/INN)", "D10817  Avelumab (USAN/INN)", "D11108  Cemiplimab (USAN)", "D11366  Dostarlimab (USAN)", "D11487  Tislelizumab (USAN/INN)", "D11488  Cetrelimab (USAN/INN)", "D11532  Lodapolimab (USAN)", "D11605  Spartalizumab (USAN/INN)", "D11820  Balstilimab (USAN/INN)", "D11827  Retifanlimab (USAN)", "D11893  Bintrafusp alfa (USAN/INN)", "D11946  Cosibelimab (USAN/INN)", "D11948  Pacmilimab (USAN/INN)", "D12063  Zimberelimab (USAN)", "D12119  Sintilimab (USAN/INN)", "D12143  Pimivalimab (USAN)", "D12190  Cadonilimab (USAN/INN)", "D12195  Izuralimab (USAN)", "D12198  Penpulimab (USAN)", "D12202  Toripalimab (USAN/INN)", "D12332  Zeluvalimab (USAN/INN)", "D12344  Socazolimab (USAN)", "D12347  Volrustomig (USAN)", "D12349  Danburstotug (USAN)", "D12709  Dalmitamig (USAN)", "D12750  Sugemalimab (INN)", "D12751  Serplulimab (INN)", "D12764  Rilvegostomig (USAN/INN)", "D12808  Ivonescimab (USAN/INN)", "D12833  Lifileucel (USAN/INN)", "D12839  Sasanlimab (USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["3091  HIF1A; hypoxia inducible factor 1 subunit alpha [KO:K08268]", "1950  EGF; epidermal growth factor [KO:K04357]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "27436  EML4; EMAP like 4 [KO:K15420]", "238  ALK; ALK receptor tyrosine kinase [KO:K05119] [EC:2.7.10.1]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5728  PTEN; phosphatase and tensin homolog [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "6198  RPS6KB1; ribosomal protein S6 kinase B1 [KO:K04688] [EC:2.7.11.1]", "6199  RPS6KB2; ribosomal protein S6 kinase B2 [KO:K04688] [EC:2.7.11.1]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "4793  NFKBIB; NFKB inhibitor beta [KO:K02581]", "4794  NFKBIE; NFKB inhibitor epsilon [KO:K05872]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "3458  IFNG; interferon gamma [KO:K04687]", "3459  IFNGR1; interferon gamma receptor 1 [KO:K05132]", "3460  IFNGR2; interferon gamma receptor 2 [KO:K05133]", "3716  JAK1; Janus kinase 1 [KO:K11217] [EC:2.7.10.2]", "3717  JAK2; Janus kinase 2 [KO:K04447] [EC:2.7.10.2]", "6772  STAT1; signal transducer and activator of transcription 1 [KO:K11220]", "6774  STAT3; signal transducer and activator of transcription 3 [KO:K04692]", "7097  TLR2; toll like receptor 2 [KO:K10159]", "7099  TLR4; toll like receptor 4 [KO:K10160]", "54106  TLR9; toll like receptor 9 [KO:K10161]", "114609  TIRAP; TIR domain containing adaptor protein [KO:K05403]", "4615  MYD88; MYD88 innate immune signal transduction adaptor [KO:K04729]", "7189  TRAF6; TNF receptor associated factor 6 [KO:K03175] [EC:2.3.2.27]", "4772  NFATC1; nuclear factor of activated T cells 1 [KO:K04446]", "4773  NFATC2; nuclear factor of activated T cells 2 [KO:K17332]", "4775  NFATC3; nuclear factor of activated T cells 3 [KO:K17333]", "148022  TICAM1; TIR domain containing adaptor molecule 1 [KO:K05842]", "353376  TICAM2; TIR domain containing adaptor molecule 2 [KO:K05409]", "29126  CD274; CD274 molecule [KO:K06745]", "5133  PDCD1; programmed cell death 1 [KO:K06744]", "5777  PTPN6; protein tyrosine phosphatase non-receptor type 6 [KO:K05697] [EC:3.1.3.48]", "5781  PTPN11; protein tyrosine phosphatase non-receptor type 11 [KO:K07293] [EC:3.1.3.48]", "55509  BATF3; basic leucine zipper ATF-like transcription factor 3 [KO:K09034]", "10538  BATF; basic leucine zipper ATF-like transcription factor [KO:K09034]", "116071  BATF2; basic leucine zipper ATF-like transcription factor 2 [KO:K09034]", "1457  CSNK2A1; casein kinase 2 alpha 1 [KO:K03097] [EC:2.7.11.1]", "1459  CSNK2A2; casein kinase 2 alpha 2 [KO:K03097] [EC:2.7.11.1]", "283106  CSNK2A3; casein kinase 2 alpha 3 [KO:K03097] [EC:2.7.11.1]", "1460  CSNK2B; casein kinase 2 beta [KO:K03115]", "920  CD4; CD4 molecule [KO:K06454]", "3932  LCK; LCK proto-oncogene, Src family tyrosine kinase [KO:K05856] [EC:2.7.10.2]", "916  CD3E; CD3 epsilon subunit of T-cell receptor complex [KO:K06451]", "917  CD3G; CD3 gamma subunit of T-cell receptor complex [KO:K06452]", "919  CD247; CD247 molecule [KO:K06453]", "915  CD3D; CD3 delta subunit of T-cell receptor complex [KO:K06450]", "7535  ZAP70; zeta chain of T cell receptor associated protein kinase 70 [KO:K07360] [EC:2.7.10.2]", "4215  MAP3K3; mitogen-activated protein kinase kinase kinase 3 [KO:K04421] [EC:2.7.11.25]", "5606  MAP2K3; mitogen-activated protein kinase kinase 3 [KO:K04432] [EC:2.7.12.2]", "5608  MAP2K6; mitogen-activated protein kinase kinase 6 [KO:K04433] [EC:2.7.12.2]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "27040  LAT; linker for activation of T cells [KO:K07362]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "5530  PPP3CA; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]", "5532  PPP3CB; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]", "5533  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]", "5534  PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]", "5535  PPP3R2; protein phosphatase 3 regulatory subunit B, beta [KO:K06268]", "10125  RASGRP1; RAS guanyl releasing protein 1 [KO:K04350]", "940  CD28; CD28 molecule [KO:K06470]", "5588  PRKCQ; protein kinase C theta [KO:K18052] [EC:2.7.11.13]"], "compound": ["C00076  Calcium cation", "C00165  Diacylglycerol", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C05981  Phosphatidylinositol-3,4,5-trisphosphate"], "refs": [{"pmid": "29097600", "authors": "  Kythreotou A, Siddique A, Mauri FA, Bower M, Pinato DJ", "title": "PD-L1.", "journal": "J Clin Pathol 71:189-194 (2018)", "doi": "10.1136/jclinpath-2017-204853"}, {"pmid": "27816403", "authors": "  Zhou TC, Sankin AI, Porcelli SA, Perlin DS, Schoenberg MP, Zang X", "title": "A review of the PD-1/PD-L1 checkpoint in bladder cancer: From mediator of immune escape to target for treatment.", "journal": "Urol Oncol 35:14-20 (2017)", "doi": "10.1016/j.urolonc.2016.10.004"}, {"pmid": "29910728", "authors": "  Wang Y, Wang H, Yao H, Li C, Fang JY, Xu J", "title": "Regulation of PD-L1: Emerging Routes for Targeting Tumor Immune Evasion.", "journal": "Front Pharmacol 9:536 (2018)", "doi": "10.3389/fphar.2018.00536"}, {"pmid": "30646912", "authors": "  Jiang X, Wang J, Deng X, Xiong F, Ge J, Xiang B, Wu X, Ma J, Zhou M, Li X, Li Y, Li G, Xiong W, Guo C, Zeng Z", "title": "Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape.", "journal": "Mol Cancer 18:10 (2019)", "doi": "10.1186/s12943-018-0928-4"}, {"pmid": "28018338", "authors": "  Bardhan K, Anagnostou T, Boussiotis VA", "title": "The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation.", "journal": "Front Immunol 7:550 (2016)", "doi": "10.3389/fimmu.2016.00550"}, {"pmid": "30120503", "authors": "  Shi Y", "title": "Regulatory mechanisms of PD-L1 expression in cancer cells.", "journal": "Cancer Immunol Immunother 67:1481-1489 (2018)", "doi": "10.1007/s00262-018-2226-9"}, {"pmid": "29765155", "authors": "  Zerdes I, Matikas A, Bergh J, Rassidakis GZ, Foukakis T", "title": "Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlations.", "journal": "Oncogene 37:4639-4661 (2018)", "doi": "10.1038/s41388-018-0303-3"}, {"pmid": "26681673", "authors": "  Chen J, Jiang CC, Jin L, Zhang XD", "title": "Regulation of PD-L1: a novel role of pro-survival signalling in cancer.", "journal": "Ann Oncol 27:409-16 (2016)", "doi": "10.1093/annonc/mdv615"}, {"pmid": "29262340", "authors": "  Glodde N, Holzel M", "title": "RAS and PD-L1: A Masters' Liaison in Cancer Immune Evasion.", "journal": "Immunity 47:1007-1009 (2017)", "doi": "10.1016/j.immuni.2017.12.001"}, {"pmid": "25500094", "authors": "  Ritprajak P, Azuma M", "title": "Intrinsic and extrinsic control of expression of the immunoregulatory molecule PD-L1 in epithelial cells and squamous cell carcinoma.", "journal": "Oral Oncol 51:221-8 (2015)", "doi": "10.1016/j.oraloncology.2014.11.014"}, {"pmid": "23868869", "authors": "  Nirschl CJ, Drake CG", "title": "Molecular pathways: coexpression of immune checkpoint molecules: signaling pathways and implications for cancer immunotherapy.", "journal": "Clin Cancer Res 19:4917-24 (2013)", "doi": "10.1158/1078-0432.CCR-12-1972"}, {"pmid": "30473697", "authors": "  Saeidi A, Zandi K, Cheok YY, Saeidi H, Wong WF, Lee CYQ, Cheong HC, Yong YK, Larsson M, Shankar EM", "title": "T-Cell Exhaustion in Chronic Infections: Reversing the State of Exhaustion and Reinvigorating Optimal Protective Immune Responses.", "journal": "Front Immunol 9:2569 (2018)", "doi": "10.3389/fimmu.2018.02569"}, {"pmid": "28990585", "authors": "  Sharpe AH, Pauken KE", "title": "The diverse functions of the PD1 inhibitory pathway.", "journal": "Nat Rev Immunol 18:153-167 (2018)", "doi": "10.1038/nri.2017.108"}, {"pmid": "27806234", "authors": "  Boussiotis VA", "title": "Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway.", "journal": "N Engl J Med 375:1767-1778 (2016)", "doi": "10.1056/NEJMra1514296"}, {"pmid": "28881701", "authors": "  Arasanz H, Gato-Canas M, Zuazo M, Ibanez-Vea M, Breckpot K, Kochan G, Escors D", "title": "PD1 signal transduction pathways in T cells.", "journal": "Oncotarget 8:51936-51945 (2017)", "doi": "10.18632/oncotarget.17232"}, {"pmid": "29114543", "authors": "  Zuazo M, Gato-Canas M, Llorente N, Ibanez-Vea M, Arasanz H, Kochan G, Escors D", "title": "Molecular mechanisms of programmed cell death-1 dependent T cell suppression: relevance for immunotherapy.", "journal": "Ann Transl Med 5:385 (2017)", "doi": "10.21037/atm.2017.06.11"}, {"pmid": "23732914", "authors": "  Patsoukis N, Li L, Sari D, Petkova V, Boussiotis VA", "title": "PD-1 increases PTEN phosphatase activity while decreasing PTEN protein stability by inhibiting casein kinase 2.", "journal": "Mol Cell Biol 33:3091-8 (2013)", "doi": "10.1128/MCB.00319-13"}, {"pmid": "26162965", "authors": "  Chinai JM, Janakiram M, Chen F, Chen W, Kaplan M, Zang X", "title": "New immunotherapies targeting the PD-1 pathway.", "journal": "Trends Pharmacol Sci 36:587-95 (2015)", "doi": "10.1016/j.tips.2015.06.005"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04066  HIF-1 signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04514  Cell adhesion molecules", "hsa04620  Toll-like receptor signaling pathway", "hsa04660  T cell receptor signaling pathway"], "ko_pathway": "ko05235", "genes": ["PTEN", "EGFR", "AKT2", "AKT1", "MAPK13", "NRAS"]}, {"kegg_id": "hsa05415", "name": "Diabetic cardiomyopathy - Homo sapiens (human)", "description": "Diabetic cardiomyopathy has been defined as left ventricular dysfunction that occurs among patients with diabetes mellitus independent of a recognized cause such as coronary artery disease or hypertension. The pathogenesis of diabetic cardiomyopathy broadly involves hyperglycemia, increased circulating fatty acids, and insulin resistance contributing to reactive oxygen species (ROS) generation, mitochondrial dysfunction, impaired calcium metabolism, Renin-Angiotensin System (RAS) activation, and altered substrate metabolism. These effects result in cardiac fibrosis, hypertrophy, cardiomyocyte death, contractile dysfunction, endothelial cell damage and eventually heart failure. In the process of cardiac fibrosis, cardiac fibroblasts are the final effector cell.", "class": "Human Diseases; Cardiovascular disease", "pathway_map": "hsa05415  Diabetic cardiomyopathy", "disease": ["H02498  Diabetic cardiomyopathy"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["6513  SLC2A1; solute carrier family 2 member 1 [KO:K07299]", "6517  SLC2A4; solute carrier family 2 member 4 [KO:K07191]", "9945  GFPT2; glutamine-fructose-6-phosphate transaminase 2 [KO:K00820] [EC:2.6.1.16]", "2673  GFPT1; glutamine--fructose-6-phosphate transaminase 1 [KO:K00820] [EC:2.6.1.16]", "815  CAMK2A; calcium/calmodulin dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]", "817  CAMK2D; calcium/calmodulin dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]", "816  CAMK2B; calcium/calmodulin dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]", "818  CAMK2G; calcium/calmodulin dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]", "7137  TNNI3; troponin I3, cardiac type [KO:K12044]", "6262  RYR2; ryanodine receptor 2 [KO:K04962]", "5350  PLN; phospholamban [KO:K05852]", "487  ATP2A1; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 [KO:K05853] [EC:7.2.2.10]", "489  ATP2A3; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 [KO:K05853] [EC:7.2.2.10]", "488  ATP2A2; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 [KO:K05853] [EC:7.2.2.10]", "6667  SP1; Sp1 transcription factor [KO:K04684]", "183  AGT; angiotensinogen [KO:K09821]", "5972  REN; renin [KO:K01380] [EC:3.4.23.15]", "1215  CMA1; chymase 1 [KO:K01329] [EC:3.4.21.39]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "177  AGER; advanced glycosylation end-product specific receptor [KO:K19722]", "1536  CYBB; cytochrome b-245 beta chain [KO:K21421] [EC:1.-.-.-]", "653361  NCF1; neutrophil cytosolic factor 1 [KO:K08011]", "1535  CYBA; cytochrome b-245 alpha chain [KO:K08009]", "4688  NCF2; neutrophil cytosolic factor 2 [KO:K08010]", "4689  NCF4; neutrophil cytosolic factor 4 [KO:K08012]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "5880  RAC2; Rac family small GTPase 2 [KO:K07860]", "185  AGTR1; angiotensin II receptor type 1 [KO:K04166]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "4313  MMP2; matrix metallopeptidase 2 [KO:K01398] [EC:3.4.24.24]", "4318  MMP9; matrix metallopeptidase 9 [KO:K01403] [EC:3.4.24.35]", "1277  COL1A1; collagen type I alpha 1 chain [KO:K06236]", "1278  COL1A2; collagen type I alpha 2 chain [KO:K06236]", "1281  COL3A1; collagen type III alpha 1 chain [KO:K19720]", "7040  TGFB1; transforming growth factor beta 1 [KO:K13375]", "7042  TGFB2; transforming growth factor beta 2 [KO:K13376]", "7043  TGFB3; transforming growth factor beta 3 [KO:K13377]", "948  CD36; CD36 molecule (CD36 blood group) [KO:K06259]", "5465  PPARA; peroxisome proliferator activated receptor alpha [KO:K07294]", "1375  CPT1B; carnitine palmitoyltransferase 1B [KO:K19523] [EC:2.3.1.21]", "5164  PDK2; pyruvate dehydrogenase kinase 2 [KO:K00898] [EC:2.7.11.2]", "5165  PDK3; pyruvate dehydrogenase kinase 3 [KO:K00898] [EC:2.7.11.2]", "5166  PDK4; pyruvate dehydrogenase kinase 4 [KO:K00898] [EC:2.7.11.2]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5580  PRKCD; protein kinase C delta [KO:K06068] [EC:2.7.11.13]", "5524  PTPA; protein phosphatase 2 phosphatase activator [KO:K17605]", "5499  PPP1CA; protein phosphatase 1 catalytic subunit alpha [KO:K06269] [EC:3.1.3.16]", "5500  PPP1CB; protein phosphatase 1 catalytic subunit beta [KO:K06269] [EC:3.1.3.16]", "5501  PPP1CC; protein phosphatase 1 catalytic subunit gamma [KO:K06269] [EC:3.1.3.16]", "1509  CTSD; cathepsin D [KO:K01379] [EC:3.4.23.5]", "5590  PRKCZ; protein kinase C zeta [KO:K18952] [EC:2.7.11.13]", "1376  CPT2; carnitine palmitoyltransferase 2 [KO:K08766] [EC:2.3.1.21]", "3630  INS; insulin [KO:K04526]", "3643  INSR; insulin receptor [KO:K04527] [EC:2.7.10.1]", "3667  IRS1; insulin receptor substrate 1 [KO:K16172]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5728  PTEN; phosphatase and tensin homolog [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "2998  GYS2; glycogen synthase 2 [KO:K00693] [EC:2.4.1.11]", "2997  GYS1; glycogen synthase 1 [KO:K00693] [EC:2.4.1.11]", "9882  TBC1D4; TBC1 domain family member 4 [KO:K17902]", "347411  MPC1L; mitochondrial pyruvate carrier 1 like [KO:K22138]", "51660  MPC1; mitochondrial pyruvate carrier 1 [KO:K22138]", "25874  MPC2; mitochondrial pyruvate carrier 2 [KO:K22139]", "5161  PDHA2; pyruvate dehydrogenase E1 subunit alpha 2 [KO:K00161] [EC:1.2.4.1]", "5160  PDHA1; pyruvate dehydrogenase E1 subunit alpha 1 [KO:K00161] [EC:1.2.4.1]", "5162  PDHB; pyruvate dehydrogenase E1 subunit beta [KO:K00162] [EC:1.2.4.1]", "4535  ND1; NADH dehydrogenase subunit 1 [KO:K03878] [EC:7.1.1.2]", "4536  ND2; NADH dehydrogenase subunit 2 [KO:K03879] [EC:7.1.1.2]", "4537  ND3; NADH dehydrogenase subunit 3 [KO:K03880] [EC:7.1.1.2]", "4538  ND4; NADH dehydrogenase subunit 4 [KO:K03881] [EC:7.1.1.2]", "4539  ND4L; NADH dehydrogenase subunit 4L [KO:K03882] [EC:7.1.1.2]", "4540  ND5; NADH dehydrogenase subunit 5 [KO:K03883] [EC:7.1.1.2]", "4541  ND6; NADH dehydrogenase subunit 6 [KO:K03884] [EC:7.1.1.2]", "4723  NDUFV1; NADH:ubiquinone oxidoreductase core subunit V1 [KO:K03942] [EC:7.1.1.2]", "4729  NDUFV2; NADH:ubiquinone oxidoreductase core subunit V2 [KO:K03943] [EC:7.1.1.2]", "4731  NDUFV3; NADH:ubiquinone oxidoreductase subunit V3 [KO:K03944]", "4694  NDUFA1; NADH:ubiquinone oxidoreductase subunit A1 [KO:K03945]", "4695  NDUFA2; NADH:ubiquinone oxidoreductase subunit A2 [KO:K03946]", "4696  NDUFA3; NADH:ubiquinone oxidoreductase subunit A3 [KO:K03947]", "4697  NDUFA4; NDUFA4 mitochondrial complex associated [KO:K03948]", "56901  NDUFA4L2; NDUFA4 mitochondrial complex associated like 2 [KO:K03948]", "4698  NDUFA5; NADH:ubiquinone oxidoreductase subunit A5 [KO:K03949]", "4700  NDUFA6; NADH:ubiquinone oxidoreductase subunit A6 [KO:K03950]", "4701  NDUFA7; NADH:ubiquinone oxidoreductase subunit A7 [KO:K03951]", "4702  NDUFA8; NADH:ubiquinone oxidoreductase subunit A8 [KO:K03952]", "4704  NDUFA9; NADH:ubiquinone oxidoreductase subunit A9 [KO:K03953]", "4705  NDUFA10; NADH:ubiquinone oxidoreductase subunit A10 [KO:K03954]", "4706  NDUFAB1; NADH:ubiquinone oxidoreductase subunit AB1 [KO:K03955]", "126328  NDUFA11; NADH:ubiquinone oxidoreductase subunit A11 [KO:K03956]", "55967  NDUFA12; NADH:ubiquinone oxidoreductase subunit A12 [KO:K11352]", "51079  NDUFA13; NADH:ubiquinone oxidoreductase subunit A13 [KO:K11353]", "4707  NDUFB1; NADH:ubiquinone oxidoreductase subunit B1 [KO:K03957]", "4708  NDUFB2; NADH:ubiquinone oxidoreductase subunit B2 [KO:K03958]", "4709  NDUFB3; NADH:ubiquinone oxidoreductase subunit B3 [KO:K03959]", "4710  NDUFB4; NADH:ubiquinone oxidoreductase subunit B4 [KO:K03960]", "4711  NDUFB5; NADH:ubiquinone oxidoreductase subunit B5 [KO:K03961]", "4712  NDUFB6; NADH:ubiquinone oxidoreductase subunit B6 [KO:K03962]", "4713  NDUFB7; NADH:ubiquinone oxidoreductase subunit B7 [KO:K03963]", "4714  NDUFB8; NADH:ubiquinone oxidoreductase subunit B8 [KO:K03964]", "4715  NDUFB9; NADH:ubiquinone oxidoreductase subunit B9 [KO:K03965]", "4716  NDUFB10; NADH:ubiquinone oxidoreductase subunit B10 [KO:K03966]", "54539  NDUFB11; NADH:ubiquinone oxidoreductase subunit B11 [KO:K11351]", "4719  NDUFS1; NADH:ubiquinone oxidoreductase core subunit S1 [KO:K03934] [EC:7.1.1.2]", "4720  NDUFS2; NADH:ubiquinone oxidoreductase core subunit S2 [KO:K03935] [EC:7.1.1.2]", "4722  NDUFS3; NADH:ubiquinone oxidoreductase core subunit S3 [KO:K03936] [EC:7.1.1.2]", "4724  NDUFS4; NADH:ubiquinone oxidoreductase subunit S4 [KO:K03937]", "4725  NDUFS5; NADH:ubiquinone oxidoreductase subunit S5 [KO:K03938]", "4726  NDUFS6; NADH:ubiquinone oxidoreductase subunit S6 [KO:K03939]", "374291  NDUFS7; NADH:ubiquinone oxidoreductase core subunit S7 [KO:K03940] [EC:7.1.1.2]", "4728  NDUFS8; NADH:ubiquinone oxidoreductase core subunit S8 [KO:K03941] [EC:7.1.1.2]", "4717  NDUFC1; NADH:ubiquinone oxidoreductase subunit C1 [KO:K03967]", "4718  NDUFC2; NADH:ubiquinone oxidoreductase subunit C2 [KO:K03968]", "100532726  NDUFC2-KCTD14; NDUFC2-KCTD14 readthrough [KO:K03968]", "6389  SDHA; succinate dehydrogenase complex flavoprotein subunit A [KO:K00234] [EC:1.3.5.1]", "6390  SDHB; succinate dehydrogenase complex iron sulfur subunit B [KO:K00235] [EC:1.3.5.1]", "6391  SDHC; succinate dehydrogenase complex subunit C [KO:K00236]", "6392  SDHD; succinate dehydrogenase complex subunit D [KO:K00237]", "7386  UQCRFS1; ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 [KO:K00411] [EC:7.1.1.8]", "4519  CYTB; cytochrome b [KO:K00412]", "1537  CYC1; cytochrome c1 [KO:K00413]", "7384  UQCRC1; ubiquinol-cytochrome c reductase core protein 1 [KO:K00414]", "7385  UQCRC2; ubiquinol-cytochrome c reductase core protein 2 [KO:K00415]", "7388  UQCRH; ubiquinol-cytochrome c reductase hinge protein [KO:K00416]", "440567  UQCRHL; ubiquinol-cytochrome c reductase hinge protein like [KO:K00416]", "7381  UQCRB; ubiquinol-cytochrome c reductase binding protein [KO:K00417]", "27089  UQCRQ; ubiquinol-cytochrome c reductase complex III subunit VII [KO:K00418]", "29796  UQCR10; ubiquinol-cytochrome c reductase, complex III subunit X [KO:K00419]", "10975  UQCR11; ubiquinol-cytochrome c reductase, complex III subunit XI [KO:K00420]", "4514  COX3; cytochrome c oxidase subunit III [KO:K02262]", "4512  COX1; cytochrome c oxidase subunit I [KO:K02256] [EC:7.1.1.9]", "4513  COX2; cytochrome c oxidase subunit II [KO:K02261]", "84701  COX4I2; cytochrome c oxidase subunit 4I2 [KO:K02263]", "1327  COX4I1; cytochrome c oxidase subunit 4I1 [KO:K02263]", "9377  COX5A; cytochrome c oxidase subunit 5A [KO:K02264]", "1329  COX5B; cytochrome c oxidase subunit 5B [KO:K02265]", "1337  COX6A1; cytochrome c oxidase subunit 6A1 [KO:K02266]", "1339  COX6A2; cytochrome c oxidase subunit 6A2 [KO:K02266]", "1340  COX6B1; cytochrome c oxidase subunit 6B1 [KO:K02267]", "125965  COX6B2; cytochrome c oxidase subunit 6B2 [KO:K02267]", "1345  COX6C; cytochrome c oxidase subunit 6C [KO:K02268]", "1346  COX7A1; cytochrome c oxidase subunit 7A1 [KO:K02270]", "1347  COX7A2; cytochrome c oxidase subunit 7A2 [KO:K02270]", "9167  COX7A2L; cytochrome c oxidase subunit 7A2 like [KO:K02270]", "1349  COX7B; cytochrome c oxidase subunit 7B [KO:K02271]", "170712  COX7B2; cytochrome c oxidase subunit 7B2 [KO:K02271]", "1350  COX7C; cytochrome c oxidase subunit 7C [KO:K02272]", "341947  COX8C; cytochrome c oxidase subunit 8C [KO:K02273]", "1351  COX8A; cytochrome c oxidase subunit 8A [KO:K02273]", "498  ATP5F1A; ATP synthase F1 subunit alpha [KO:K02132]", "506  ATP5F1B; ATP synthase F1 subunit beta [KO:K02133] [EC:7.1.2.2]", "509  ATP5F1C; ATP synthase F1 subunit gamma [KO:K02136]", "513  ATP5F1D; ATP synthase F1 subunit delta [KO:K02134]", "514  ATP5F1E; ATP synthase F1 subunit epsilon [KO:K02135]", "4508  ATP6; ATP synthase F0 subunit 6 [KO:K02126]", "515  ATP5PB; ATP synthase peripheral stalk-membrane subunit b [KO:K02127]", "516  ATP5MC1; ATP synthase membrane subunit c locus 1 [KO:K02128]", "517  ATP5MC2; ATP synthase membrane subunit c locus 2 [KO:K02128]", "518  ATP5MC3; ATP synthase membrane subunit c locus 3 [KO:K02128]", "10476  ATP5PD; ATP synthase peripheral stalk subunit d [KO:K02138]", "539  ATP5PO; ATP synthase peripheral stalk subunit OSCP [KO:K02137]", "522  ATP5PF; ATP synthase peripheral stalk subunit F6 [KO:K02131]", "4509  ATP8; ATP synthase F0 subunit 8 [KO:K02125]", "7416  VDAC1; voltage dependent anion channel 1 [KO:K05862]", "7417  VDAC2; voltage dependent anion channel 2 [KO:K15040]", "7419  VDAC3; voltage dependent anion channel 3 [KO:K15041]", "291  SLC25A4; solute carrier family 25 member 4 [KO:K05863]", "292  SLC25A5; solute carrier family 25 member 5 [KO:K05863]", "293  SLC25A6; solute carrier family 25 member 6 [KO:K05863]", "83447  SLC25A31; solute carrier family 25 member 31 [KO:K05863]", "10105  PPIF; peptidylprolyl isomerase F [KO:K09565] [EC:5.2.1.8]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "4846  NOS3; nitric oxide synthase 3 [KO:K13242] [EC:1.14.13.39]", "2597  GAPDH; glyceraldehyde-3-phosphate dehydrogenase [KO:K00134] [EC:1.2.1.12]", "142  PARP1; poly(ADP-ribose) polymerase 1 [KO:K24070] [EC:2.4.2.30]", "2539  G6PD; glucose-6-phosphate dehydrogenase [KO:K00036] [EC:1.1.1.49 1.1.1.363]", "2936  GSR; glutathione-disulfide reductase [KO:K00383] [EC:1.8.1.7]", "7046  TGFBR1; transforming growth factor beta receptor 1 [KO:K04674] [EC:2.7.11.30]", "7048  TGFBR2; transforming growth factor beta receptor 2 [KO:K04388] [EC:2.7.11.30]", "4087  SMAD2; SMAD family member 2 [KO:K04500]", "4088  SMAD3; SMAD family member 3 [KO:K23605]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "1636  ACE; angiotensin I converting enzyme [KO:K01283] [EC:3.4.15.1]"], "compound": ["C00001  H2O", "C00002  ATP", "C00005  NADPH", "C00006  NADP+", "C00022  Pyruvate", "C00024  Acetyl-CoA", "C00027  Hydrogen peroxide", "C00031  D-Glucose", "C00043  UDP-N-acetyl-alpha-D-glucosamine", "C00051  Glutathione", "C00076  Calcium cation", "C00085  D-Fructose 6-phosphate", "C00092  D-Glucose 6-phosphate", "C00095  D-Fructose", "C00118  D-Glyceraldehyde 3-phosphate", "C00127  Glutathione disulfide", "C00162  Fatty acid", "C00165  Diacylglycerol", "C00195  N-Acylsphingosine", "C00236  3-Phospho-D-glyceroyl phosphate", "C00318  L-Carnitine", "C00352  D-Glucosamine 6-phosphate", "C00369  Starch", "C00533  Nitric oxide", "C00546  Methylglyoxal", "C00704  Superoxide", "C00794  D-Sorbitol", "C00873  Angiotensin I", "C02135  Angiotensin II", "C02843  Long-chain acyl-CoA", "C05981  Phosphatidylinositol-3,4,5-trisphosphate", "C06156  alpha-D-Glucosamine 1-phosphate", "C16844  Hydroxyl radical", "C21011  [Protein]-N(epsilon)-(carboxymethyl)lysine", "C21012  [Protein]-N(epsilon)-(carboxyethyl)lysine", "C21013  [Protein]-pyrraline", "C21014  [Protein]-pentosidine", "C22310  Fructose 3-phosphate", "C22311  3-Deoxyglucosone"], "refs": [{"pmid": "30443826", "authors": "  Riehle C, Bauersachs J", "title": "Of mice and men: models and mechanisms of diabetic cardiomyopathy.", "journal": "Basic Res Cardiol 114:2 (2018)", "doi": "10.1007/s00395-018-0711-0"}, {"pmid": "24462787", "authors": "  Huynh K, Bernardo BC, McMullen JR, Ritchie RH", "title": "Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways.", "journal": "Pharmacol Ther 142:375-415 (2014)", "doi": "10.1016/j.pharmthera.2014.01.003"}, {"pmid": "28231848", "authors": "  Lorenzo-Almoros A, Tunon J, Orejas M, Cortes M, Egido J, Lorenzo O", "title": "Diagnostic approaches for diabetic cardiomyopathy.", "journal": "Cardiovasc Diabetol 16:28 (2017)", "doi": "10.1186/s12933-017-0506-x"}, {"pmid": "32080423", "authors": "  Tan Y, Zhang Z, Zheng C, Wintergerst KA, Keller BB, Cai L", "title": "Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence.", "journal": "Nat Rev Cardiol 17:585-607 (2020)", "doi": "10.1038/s41569-020-0339-2"}, {"pmid": "31212580", "authors": "  Zamora M, Villena JA", "title": "Contribution of Impaired Insulin Signaling to the Pathogenesis of Diabetic Cardiomyopathy.", "journal": "Int J Mol Sci 20:E2833 (2019)", "doi": "10.3390/ijms20112833"}, {"pmid": "29605388", "authors": "  Palomer X, Pizarro-Delgado J, Vazquez-Carrera M", "title": "Emerging Actors in Diabetic Cardiomyopathy: Heartbreaker Biomarkers or Therapeutic Targets?", "journal": "Trends Pharmacol Sci 39:452-467 (2018)", "doi": "10.1016/j.tips.2018.02.010"}, {"pmid": "28439258", "authors": "  Mishra PK, Ying W, Nandi SS, Bandyopadhyay GK, Patel KK, Mahata SK", "title": "Diabetic Cardiomyopathy: An Immunometabolic Perspective.", "journal": "Front Endocrinol (Lausanne) 8:72 (2017)", "doi": "10.3389/fendo.2017.00072"}, {"pmid": "28177068", "authors": "  Chong CR, Clarke K, Levelt E", "title": "Metabolic Remodeling in Diabetic Cardiomyopathy.", "journal": "Cardiovasc Res 113:422-430 (2017)", "doi": "10.1093/cvr/cvx018"}, {"pmid": "11742414", "authors": "  Brownlee M", "title": "Biochemistry and molecular cell biology of diabetic complications.", "journal": "Nature 414:813-20 (2001)", "doi": "10.1038/414813a"}, {"pmid": "32821697", "authors": "  Gollmer J, Zirlik A, Bugger H", "title": "Established and Emerging Mechanisms of Diabetic Cardiomyopathy.", "journal": "J Lipid Atheroscler 8:26-47 (2019)", "doi": "10.12997/jla.2019.8.1.26"}, {"pmid": "17592090", "authors": "  Boudina S, Abel ED", "title": "Diabetic cardiomyopathy revisited.", "journal": "Circulation 115:3213-23 (2007)", "doi": "10.1161/CIRCULATIONAHA.106.679597"}, {"pmid": "29109032", "authors": "  Varma U, Koutsifeli P, Benson VL, Mellor KM, Delbridge LMD", "title": "Molecular mechanisms of cardiac pathology in diabetes - Experimental insights.", "journal": "Biochim Biophys Acta Mol Basis Dis 1864:1949-1959 (2018)", "doi": "10.1016/j.bbadis.2017.10.035"}, {"pmid": "23147391", "authors": "  Mandavia CH, Aroor AR, Demarco VG, Sowers JR", "title": "Molecular and metabolic mechanisms of cardiac dysfunction in diabetes.", "journal": "Life Sci 92:601-8 (2013)", "doi": "10.1016/j.lfs.2012.10.028"}, {"pmid": "21626163", "authors": "  Falcao-Pires I, Leite-Moreira AF", "title": "Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment.", "journal": "Heart Fail Rev 17:325-44 (2012)", "doi": "10.1007/s10741-011-9257-z"}, {"pmid": "27148064", "authors": "  Westermeier F, Riquelme JA, Pavez M, Garrido V, Diaz A, Verdejo HE, Castro PF, Garcia L, Lavandero S", "title": "New Molecular Insights of Insulin in Diabetic Cardiomyopathy.", "journal": "Front Physiol 7:125 (2016)", "doi": "10.3389/fphys.2016.00125"}, {"pmid": "33276047", "authors": "  Randhawa VK, Dhanvantari S, Connelly K", "title": "How Diabetes and Heart Failure Modulate Each Other and Condition Management.", "journal": "Can J Cardiol S0828-282X(20)31115-6 (2020)", "doi": "10.1016/j.cjca.2020.11.014"}, {"pmid": "31641426", "authors": "  Athithan L, Gulsin GS, McCann GP, Levelt E", "title": "Diabetic cardiomyopathy: Pathophysiology, theories and evidence to date.", "journal": "World J Diabetes 10:490-510 (2019)", "doi": "10.4239/wjd.v10.i10.490"}, {"pmid": "21111987", "authors": "  Murarka S, Movahed MR", "title": "Diabetic cardiomyopathy.", "journal": "J Card Fail 16:971-9 (2010)", "doi": "10.1016/j.cardfail.2010.07.249"}, {"pmid": "25085967", "authors": "  Thomas CM, Yong QC, Rosa RM, Seqqat R, Gopal S, Casarini DE, Jones WK, Gupta S, Baker KM, Kumar R", "title": "Cardiac-specific suppression of NF-kappaB signaling prevents diabetic cardiomyopathy via inhibition of the renin-angiotensin system.", "journal": "Am J Physiol Heart Circ Physiol 307:H1036-45 (2014)", "doi": "10.1152/ajpheart.00340.2014"}, {"pmid": "28236380", "authors": "  Brahma MK, Pepin ME, Wende AR", "title": "My Sweetheart Is Broken: Role of Glucose in Diabetic Cardiomyopathy.", "journal": "Diabetes Metab J 41:1-9 (2017)", "doi": "10.4093/dmj.2017.41.1.1"}, {"pmid": "18829990", "authors": "  Singh VP, Le B, Khode R, Baker KM, Kumar R", "title": "Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis.", "journal": "Diabetes 57:3297-306 (2008)", "doi": "10.2337/db08-0805"}, {"pmid": "18296558", "authors": "  Singh VP, Baker KM, Kumar R", "title": "Activation of the intracellular renin-angiotensin system in cardiac fibroblasts by high glucose: role in extracellular matrix production.", "journal": "Am J Physiol Heart Circ Physiol 294:H1675-84 (2008)", "doi": "10.1152/ajpheart.91493.2007"}, {"pmid": "26678809", "authors": "  Jia G, DeMarco VG, Sowers JR", "title": "Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy.", "journal": "Nat Rev Endocrinol 12:144-53 (2016)", "doi": "10.1038/nrendo.2015.216"}, {"pmid": "18309108", "authors": "  Kim JA, Wei Y, Sowers JR", "title": "Role of mitochondrial dysfunction in insulin resistance.", "journal": "Circ Res 102:401-14 (2008)", "doi": "10.1161/CIRCRESAHA.107.165472"}, {"pmid": "30170598", "authors": "  Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuniga FA", "title": "Association between insulin resistance and the development of cardiovascular disease.", "journal": "Cardiovasc Diabetol 17:122 (2018)", "doi": "10.1186/s12933-018-0762-4"}, {"pmid": "31269778", "authors": "  Evangelista I, Nuti R, Picchioni T, Dotta F, Palazzuoli A", "title": "Molecular Dysfunction and Phenotypic Derangement in Diabetic Cardiomyopathy.", "journal": "Int J Mol Sci 20:E3264 (2019)", "doi": "10.3390/ijms20133264"}, {"pmid": "24307101", "authors": "  Joshi M, Kotha SR, Malireddy S, Selvaraju V, Satoskar AR, Palesty A, McFadden DW, Parinandi NL, Maulik N", "title": "Conundrum of pathogenesis of diabetic cardiomyopathy: role of vascular endothelial dysfunction, reactive oxygen species, and mitochondria.", "journal": "Mol Cell Biochem 386:233-49 (2014)", "doi": "10.1007/s11010-013-1861-x"}, {"pmid": "29867137", "authors": "  Knapp M, Tu X, Wu R", "title": "Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy.", "journal": "Acta Pharmacol Sin 40:1-8 (2019)", "doi": "10.1038/s41401-018-0042-6"}, {"pmid": "16487830", "authors": "  Asbun J, Villarreal FJ", "title": "The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy.", "journal": "J Am Coll Cardiol 47:693-700 (2006)", "doi": "10.1016/j.jacc.2005.09.050"}], "rel_pathway": ["hsa00010  Glycolysis / Gluconeogenesis", "hsa00020  Citrate cycle (TCA cycle)", "hsa00190  Oxidative phosphorylation", "hsa00520  Amino sugar and nucleotide sugar metabolism", "hsa03320  PPAR signaling pathway", "hsa04071  Sphingolipid signaling pathway", "hsa04150  mTOR signaling pathway", "hsa04210  Apoptosis", "hsa04260  Cardiac muscle contraction", "hsa04350  TGF-beta signaling pathway", "hsa04614  Renin-angiotensin system", "hsa04910  Insulin signaling pathway", "hsa04930  Type II diabetes mellitus", "hsa04931  Insulin resistance", "hsa04933  AGE-RAGE signaling pathway in diabetic complications", "hsa04940  Type I diabetes mellitus"], "ko_pathway": "ko05415", "genes": ["PTEN", "RAC1", "AKT2", "AKT1", "CD36", "MAPK13"]}, {"kegg_id": "hsa04512", "name": "ECM-receptor interaction - Homo sapiens (human)", "description": "The extracellular matrix (ECM) consists of a complex mixture of structural and functional macromolecules and serves an important role in tissue and organ morphogenesis and in the maintenance of cell and tissue structure and function. Specific interactions between cells and the ECM are mediated by transmembrane molecules, mainly integrins and perhaps also proteoglycans, CD36, or other cell-surface-associated components. These interactions lead to a direct or indirect control of cellular activities such as adhesion, migration, differentiation, proliferation, and apoptosis. In addition, integrins function as mechanoreceptors and provide a force-transmitting physical link between the ECM and the cytoskeleton. Integrins are a family of glycosylated, heterodimeric transmembrane adhesion receptors that consist of noncovalently bound alpha- and beta-subunits.", "class": "Environmental Information Processing; Signaling molecules and interaction", "pathway_map": "hsa04512  ECM-receptor interaction", "drug": ["D00709  Levetiracetam (JAN/USP/INN)", "D01914  Piracetam (JAN/USAN/INN)", "D03497  Cilengitide (USAN/INN)", "D04660  Lamifiban hydrochloride (USAN)", "D05817  Seletracetam (USAN/INN)", "D06319  Volociximab (USAN)", "D06590  Firategrast (USAN)", "D06886  Natalizumab (USAN/INN)", "D08083  Vedolizumab (USAN)", "D08879  Brivaracetam (JAN/USAN/INN)", "D09342  Etaracizumab (USAN/INN)", "D09631  Intetumumab (USAN/INN)", "D09903  Fluciclatide F 18 (USAN/INN)", "D09929  Maraciclatide (USAN/INN)", "D10028  Valategrast hydrochloride (USAN)", "D11842  Padsevonil (JAN/USAN)", "D11846  Magrolimab (USAN/INN)", "D12193  Evorpacept (USAN)", "D12385  Lemzoparlimab (USAN/INN)", "D12413  Glenzocimab (USAN/INN)", "D12722  Bexotegrast (USAN/INN)"], "dblinks": "GO: 0005201", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["1277  COL1A1; collagen type I alpha 1 chain [KO:K06236]", "1278  COL1A2; collagen type I alpha 2 chain [KO:K06236]", "1280  COL2A1; collagen type II alpha 1 chain [KO:K19719]", "1284  COL4A2; collagen type IV alpha 2 chain [KO:K06237]", "1286  COL4A4; collagen type IV alpha 4 chain [KO:K06237]", "1288  COL4A6; collagen type IV alpha 6 chain [KO:K06237]", "1282  COL4A1; collagen type IV alpha 1 chain [KO:K06237]", "1287  COL4A5; collagen type IV alpha 5 chain [KO:K06237]", "1285  COL4A3; collagen type IV alpha 3 chain [KO:K06237]", "1291  COL6A1; collagen type VI alpha 1 chain [KO:K06238]", "1292  COL6A2; collagen type VI alpha 2 chain [KO:K06238]", "1293  COL6A3; collagen type VI alpha 3 chain [KO:K06238]", "131873  COL6A6; collagen type VI alpha 6 chain [KO:K06238]", "256076  COL6A5; collagen type VI alpha 5 chain [KO:K06238]", "1297  COL9A1; collagen type IX alpha 1 chain [KO:K08131]", "1298  COL9A2; collagen type IX alpha 2 chain [KO:K08131]", "1299  COL9A3; collagen type IX alpha 3 chain [KO:K08131]", "284217  LAMA1; laminin subunit alpha 1 [KO:K05637]", "3908  LAMA2; laminin subunit alpha 2 [KO:K05637]", "3909  LAMA3; laminin subunit alpha 3 [KO:K06240]", "3911  LAMA5; laminin subunit alpha 5 [KO:K06240]", "3910  LAMA4; laminin subunit alpha 4 [KO:K06241]", "3912  LAMB1; laminin subunit beta 1 [KO:K05636]", "3913  LAMB2; laminin subunit beta 2 [KO:K06243]", "3914  LAMB3; laminin subunit beta 3 [KO:K06244]", "22798  LAMB4; laminin subunit beta 4 [KO:K06245]", "3915  LAMC1; laminin subunit gamma 1 [KO:K05635]", "3918  LAMC2; laminin subunit gamma 2 [KO:K06246]", "10319  LAMC3; laminin subunit gamma 3 [KO:K06247]", "1101  CHAD; chondroadherin [KO:K06248]", "5649  RELN; reelin [KO:K06249] [EC:3.4.21.-]", "7057  THBS1; thrombospondin 1 [KO:K16857]", "1311  COMP; cartilage oligomeric matrix protein [KO:K04659]", "7058  THBS2; thrombospondin 2 [KO:K04659]", "7059  THBS3; thrombospondin 3 [KO:K04659]", "7060  THBS4; thrombospondin 4 [KO:K04659]", "2335  FN1; fibronectin 1 [KO:K05717]", "6696  SPP1; secreted phosphoprotein 1 [KO:K06250]", "7448  VTN; vitronectin [KO:K06251]", "3371  TNC; tenascin C [KO:K06252]", "63923  TNN; tenascin N [KO:K06252]", "7143  TNR; tenascin R [KO:K06252]", "7148  TNXB; tenascin XB [KO:K06252]", "255743  NPNT; nephronectin [KO:K06824]", "80144  FRAS1; Fraser extracellular matrix complex subunit 1 [KO:K23379]", "341640  FREM2; FRAS1 related extracellular matrix 2 [KO:K23380]", "158326  FREM1; FRAS1 related extracellular matrix 1 [KO:K23380]", "1834  DSPP; dentin sialophosphoprotein [KO:K23573]", "7450  VWF; von Willebrand factor [KO:K03900]", "3381  IBSP; integrin binding sialoprotein [KO:K06253]", "1758  DMP1; dentin matrix acidic phosphoprotein 1 [KO:K23328]", "56955  MEPE; matrix extracellular phosphoglycoprotein [KO:K26442]", "375790  AGRN; agrin [KO:K06254]", "3339  HSPG2; heparan sulfate proteoglycan 2 [KO:K06255]", "3672  ITGA1; integrin subunit alpha 1 [KO:K06480]", "3673  ITGA2; integrin subunit alpha 2 [KO:K06481]", "3674  ITGA2B; integrin subunit alpha 2b [KO:K06476]", "3675  ITGA3; integrin subunit alpha 3 [KO:K06482]", "3676  ITGA4; integrin subunit alpha 4 [KO:K06483]", "3678  ITGA5; integrin subunit alpha 5 [KO:K06484]", "3655  ITGA6; integrin subunit alpha 6 [KO:K06485]", "3679  ITGA7; integrin subunit alpha 7 [KO:K06583]", "8516  ITGA8; integrin subunit alpha 8 [KO:K06584]", "3680  ITGA9; integrin subunit alpha 9 [KO:K06585]", "8515  ITGA10; integrin subunit alpha 10 [KO:K06586]", "22801  ITGA11; integrin subunit alpha 11 [KO:K06587]", "3685  ITGAV; integrin subunit alpha V [KO:K06487]", "3688  ITGB1; integrin subunit beta 1 [KO:K05719]", "3690  ITGB3; integrin subunit beta 3 [KO:K06493]", "3691  ITGB4; integrin subunit beta 4 [KO:K06525]", "3693  ITGB5; integrin subunit beta 5 [KO:K06588]", "3694  ITGB6; integrin subunit beta 6 [KO:K06589]", "3695  ITGB7; integrin subunit beta 7 [KO:K06590]", "3696  ITGB8; integrin subunit beta 8 [KO:K06591]", "960  CD44; CD44 molecule (IN blood group) [KO:K06256]", "6382  SDC1; syndecan 1 [KO:K06257]", "6385  SDC4; syndecan 4 [KO:K16338]", "22987  SV2C; synaptic vesicle glycoprotein 2C [KO:K06258]", "9899  SV2B; synaptic vesicle glycoprotein 2B [KO:K06258]", "9900  SV2A; synaptic vesicle glycoprotein 2A [KO:K06258]", "948  CD36; CD36 molecule (CD36 blood group) [KO:K06259]", "2814  GP5; glycoprotein V platelet [KO:K06260]", "2811  GP1BA; glycoprotein Ib platelet subunit alpha [KO:K06261]", "2812  GP1BB; glycoprotein Ib platelet subunit beta [KO:K06262]", "2815  GP9; glycoprotein IX platelet [KO:K06263]", "51206  GP6; glycoprotein VI platelet [KO:K06264]", "1605  DAG1; dystroglycan 1 [KO:K06265]", "961  CD47; CD47 molecule [KO:K06266]", "3161  HMMR; hyaluronan mediated motility receptor [KO:K06267]"], "compound": ["G10505  Hyaluronic acid"], "refs": [{"pmid": "11572082", "authors": "  van der Flier A, Sonnenberg A.", "title": "Function and interactions of integrins.", "journal": "Cell Tissue Res 305:285-98 (2001)", "doi": "10.1007/s004410100417"}, {"pmid": "12921709", "authors": "  Reddy KV, Mangale SS.", "title": "Integrin receptors: the dynamic modulators of endometrial function.", "journal": "Tissue Cell 35:260-73 (2003)", "doi": "10.1016/S0040-8166(03)00039-9"}, {"pmid": "12125070", "authors": "  Milner R, Campbell IL.", "title": "The integrin family of cell adhesion molecules has multiple functions within the CNS.", "journal": "J Neurosci Res 69:286-91 (2002)", "doi": "10.1002/jnr.10321"}, {"pmid": "12796473", "authors": "  Cichy J, Pure E.", "title": "The liberation of CD44.", "journal": "J Cell Biol 161:839-43 (2003)", "doi": "10.1083/jcb.200302098"}, {"pmid": "10617638", "authors": "  Son YJ, Scranton TW, Sunderland WJ, Baek SJ, Miner JH, Sanes JR, Carlson SS.", "title": "The synaptic vesicle protein SV2 is complexed with an alpha5-containing laminin on the nerve terminal surface.", "journal": "J Biol Chem 275:451-60 (2000)", "doi": "10.1074/jbc.275.1.451"}, {"pmid": "15036264", "authors": "  Sid B, Sartelet H, Bellon G, El Btaouri H, Rath G, Delorme N, Haye B, Martiny L.", "title": "Thrombospondin 1: a multifunctional protein implicated in the regulation of tumor growth.", "journal": "Crit Rev Oncol Hematol 49:245-58 (2004)", "doi": "10.1016/j.critrevonc.2003.09.009"}, {"pmid": "15381249", "authors": "  Canobbio I, Balduini C, Torti M.", "title": "Signalling through the platelet glycoprotein Ib-V-IX complex.", "journal": "Cell Signal 16:1329-44 (2004)", "doi": "10.1016/j.cellsig.2004.05.008"}, {"pmid": "11331578", "authors": "  Nieswandt B, Brakebusch C, Bergmeier W, Schulte V, Bouvard D, Mokhtari-Nejad R, Lindhout T, Heemskerk JW, Zirngibl H, Fassler R.", "title": "Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen.", "journal": "EMBO J 20:2120-30 (2001)", "doi": "10.1093/emboj/20.9.2120"}, {"pmid": "12736199", "authors": "  Martin PT.", "title": "Dystroglycan glycosylation and its role in matrix binding in skeletal muscle.", "journal": "Glycobiology 13:55R-66R (2003)", "doi": "10.1093/glycob/cwg076"}, {"pmid": "15229478", "authors": "  Toole BP.", "title": "Hyaluronan: from extracellular glue to pericellular cue.", "journal": "Nat Rev Cancer 4:528-39 (2004)", "doi": "10.1038/nrc1391"}, {"pmid": "12845610", "authors": "  Bosman FT, Stamenkovic I.", "title": "Functional structure and composition of the extracellular matrix.", "journal": "J Pathol 200:423-8 (2003)", "doi": "10.1002/path.1437"}], "rel_pathway": ["hsa04510  Focal adhesion"], "ko_pathway": "ko04512", "genes": ["SDC4", "CD44", "TNN", "CD36"]}, {"kegg_id": "hsa04514", "name": "Cell adhesion molecules - Homo sapiens (human)", "description": "Cell adhesion molecules (CAMs) are (glyco)proteins expressed on the cell surface and play a critical role in a wide array of biologic processes that include hemostasis, the immune response, inflammation, embryogenesis, and development of neuronal tissue. There are four main groups: the integrin family, the immunoglobulin superfamily, selectins, and cadherins. Membrane proteins that mediate immune cell&#8211;cell interactions fall into different categories, namely those involved in antigen recognition, costimulation and cellular adhesion. Furthermore cell-cell adhesions are important for brain morphology and highly coordinated brain functions such as memory and learning. During early development of the nervous system, neurons elongate their axons towards their targets and establish and maintain synapses through formation of cell-cell adhesions. Cell-cell adhesions also underpin axon-axon contacts and link neurons with supporting schwann cells and oligodendrocytes.", "class": "Environmental Information Processing; Signaling molecules and interaction", "pathway_map": "hsa04514  Cell adhesion molecules", "drug": ["D02800  Alefacept (USAN/INN)", "D02811  Alicaforsen sodium (USAN)", "D02967  Apolizumab (USAN/INN)", "D03066  Bectumomab (USAN/INN)", "D03114  Bimosiamose disodium (USAN)", "D03203  Abatacept (USAN/INN)", "D03222  Belatacept (USAN/INN)", "D03420  Cedelizumab (USAN/INN)", "D03497  Cilengitide (USAN/INN)", "D03959  Efalizumab (USAN/INN)", "D04000  Enlimomab (USAN/INN)", "D04036  Epratuzumab (USAN/INN)", "D04045  Erlizumab (USAN/INN)", "D04295  Galiximab (USAN/INN)", "D05610  Priliximab (USAN/INN)", "D05777  Ruplizumab (USAN/INN)", "D05847  Siplizumab (USAN/INN)", "D06071  Teneliximab (USAN/INN)", "D06194  Torapsel (USAN/INN)", "D06348  Yttrium Y 90 epratuzumab (USAN)", "D06349  Yttrium Y 90 epratuzumab tetraxetan (USAN)", "D06356  Zanolimumab (USAN/INN)", "D06570  Camobucol (USAN/INN)", "D06582  Elsibucol (USAN/INN)", "D06590  Firategrast (USAN)", "D06648  Succinobucol (USAN)", "D06657  Tremelimumab (USAN/INN)", "D08083  Vedolizumab (USAN)", "D08933  Inotuzumab ozogamicin (USAN/INN)", "D09575  Ibalizumab (USAN/INN)", "D09631  Intetumumab (USAN/INN)", "D09799  Carotegrast methyl (JAN)", "D09927  Lorvotuzumab mertansine (USAN/INN)", "D09929  Maraciclatide (USAN/INN)", "D09932  Moxetumomab pasudotox (USAN/INN)", "D10028  Valategrast hydrochloride (USAN)", "D10316  Nivolumab (USAN/INN)", "D10374  Lifitegrast (USAN/INN)", "D10390  Pidilizumab (USAN/INN)", "D10392  Lifitegrast sodium (USAN)", "D10574  Pembrolizumab (USAN)", "D10773  Atezolizumab (USAN/INN)", "D10808  Durvalumab (USAN/INN)", "D10817  Avelumab (USAN/INN)", "D11108  Cemiplimab (USAN)", "D11310  Uproleselan sodium (USAN)", "D11332  Uproleselan (USAN/INN)", "D11357  Bleselumab (USAN/INN)", "D11366  Dostarlimab (USAN)", "D11433  Vopratelimab (USAN/INN)", "D11480  Crizanlizumab (USAN/INN)", "D11482  Tiragolumab (USAN/INN)", "D11487  Tislelizumab (USAN/INN)", "D11488  Cetrelimab (USAN/INN)", "D11491  Selicrelumab (USAN/INN)", "D11515  Omburtamab (USAN/INN)", "D11527  Zolbetuximab (USAN/INN)", "D11532  Lodapolimab (USAN)", "D11593  Etigilimab (USAN/INN)", "D11597  Ravagalimab (USAN/INN)", "D11605  Spartalizumab (USAN/INN)", "D11610  Iscalimab (USAN/INN)", "D11747  Inbakicept (USAN/INN)", "D11752  Enoblituzumab (USAN/INN)", "D11795  Vibostolimab (USAN/INN)", "D11820  Balstilimab (USAN/INN)", "D11827  Retifanlimab (USAN)", "D11893  Bintrafusp alfa (USAN/INN)", "D11907  Rozibafusp alfa (USAN/INN)", "D11919  Fuzapladib sodium hydrate (JAN)", "D11930  Betibeglogene autotemcel (USAN/INN)", "D11946  Cosibelimab (USAN/INN)", "D11948  Pacmilimab (USAN/INN)", "D11959  Praluzatamab (USAN/INN)", "D11996  Feladilimab (USAN/INN)", "D12063  Zimberelimab (USAN)", "D12119  Sintilimab (USAN/INN)", "D12143  Pimivalimab (USAN)", "D12154  Mirzotamab (USAN/INN)", "D12178  Sotigalimab (USAN)", "D12186  Vudalimab (USAN)", "D12190  Cadonilimab (USAN/INN)", "D12195  Izuralimab (USAN)", "D12198  Penpulimab (USAN)", "D12202  Toripalimab (USAN/INN)", "D12223  Rosnilimab (USAN)", "D12231  Peresolimab (USAN)", "D12233  Quavonlimab (USAN/INN)", "D12283  Ociperlimab (USAN/INN)", "D12300  Acazicolcept (USAN/INN)", "D12317  Bavunalimab (USAN/INN)", "D12332  Zeluvalimab (USAN/INN)", "D12344  Socazolimab (USAN)", "D12347  Volrustomig (USAN)", "D12348  Belrestotug (USAN)", "D12349  Danburstotug (USAN)", "D12367  Domvanalimab (USAN/INN)", "D12426  Itolizumab (USAN/INN)", "D12448  Botensilimab (USAN/INN)", "D12463  Davoceticept (USAN/INN)", "D12517  Vobramitamab (USAN/INN)", "D12518  Voramitamab duocarmazine (USAN/INN)", "D12592  Omidubicel (USAN)", "D12620  Frexalimab (USAN/INN)", "D12722  Bexotegrast (USAN/INN)", "D12749  Exagamglogene autotemcel (USAN/INN)", "D12750  Sugemalimab (INN)", "D12751  Serplulimab (INN)", "D12753  Ifinatamab deruxtecan (INN)", "D12764  Rilvegostomig (USAN/INN)", "D12765  Lovotibeglogene autotemcel (USAN/INN)", "D12781  Osemitamab (USAN/INN)", "D12839  Sasanlimab (USAN/INN)", "D12877  Atidarsagene autotemcel (USAN/INN)"], "dblinks": "GO: 0050839", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["965  CD58; CD58 molecule [KO:K06492]", "914  CD2; CD2 molecule [KO:K06449]", "64115  VSIR; V-set immunoregulatory receptor [KO:K23268]", "152404  IGSF11; immunoglobulin superfamily member 11 [KO:K06791]", "941  CD80; CD80 molecule [KO:K05412]", "29126  CD274; CD274 molecule [KO:K06745]", "940  CD28; CD28 molecule [KO:K06470]", "942  CD86; CD86 molecule [KO:K05413]", "1493  CTLA4; cytotoxic T-lymphocyte associated protein 4 [KO:K06538]", "23308  ICOSLG; inducible T cell costimulator ligand [KO:K06710]", "102723996  ICOS ligand [KO:K06710]", "29851  ICOS; inducible T cell costimulator [KO:K06713]", "3108  HLA-DMA; major histocompatibility complex, class II, DM alpha [KO:K06752]", "3109  HLA-DMB; major histocompatibility complex, class II, DM beta [KO:K06752]", "3111  HLA-DOA; major histocompatibility complex, class II, DO alpha [KO:K06752]", "3112  HLA-DOB; major histocompatibility complex, class II, DO beta [KO:K06752]", "3113  HLA-DPA1; major histocompatibility complex, class II, DP alpha 1 [KO:K06752]", "3115  HLA-DPB1; major histocompatibility complex, class II, DP beta 1 [KO:K06752]", "3117  HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 [KO:K06752]", "3118  HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2 [KO:K06752]", "3119  HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 [KO:K06752]", "3122  HLA-DRA; major histocompatibility complex, class II, DR alpha [KO:K06752]", "3123  HLA-DRB1; major histocompatibility complex, class II, DR beta 1 [KO:K06752]", "3125  HLA-DRB3; major histocompatibility complex, class II, DR beta 3 [KO:K06752]", "3126  HLA-DRB4; major histocompatibility complex, class II, DR beta 4 [KO:K06752]", "3127  HLA-DRB5; major histocompatibility complex, class II, DR beta 5 [KO:K06752]", "920  CD4; CD4 molecule [KO:K06454]", "3105  HLA-A; major histocompatibility complex, class I, A [KO:K06751]", "3106  HLA-B; major histocompatibility complex, class I, B [KO:K06751]", "3107  HLA-C; major histocompatibility complex, class I, C [KO:K06751]", "3134  HLA-F; major histocompatibility complex, class I, F [KO:K06751]", "3135  HLA-G; major histocompatibility complex, class I, G [KO:K06751]", "3133  HLA-E; major histocompatibility complex, class I, E [KO:K06751]", "925  CD8A; CD8 subunit alpha [KO:K06458]", "926  CD8B; CD8 subunit beta [KO:K06459]", "927  CD8B2; CD8B family member 2 [KO:K06459]", "80380  PDCD1LG2; programmed cell death 1 ligand 2 [KO:K06708]", "80381  CD276; CD276 molecule [KO:K06746]", "79679  VTCN1; V-set domain containing T cell activation inhibitor 1 [KO:K06747]", "5133  PDCD1; programmed cell death 1 [KO:K06744]", "958  CD40; CD40 molecule [KO:K03160]", "959  CD40LG; CD40 ligand [KO:K03161]", "214  ALCAM; activated leukocyte cell adhesion molecule [KO:K06547]", "923  CD6; CD6 molecule [KO:K06456]", "5817  PVR; PVR cell adhesion molecule [KO:K06539]", "10666  CD226; CD226 molecule [KO:K06567]", "5819  NECTIN2; nectin cell adhesion molecule 2 [KO:K06531]", "201633  TIGIT; T cell immunoreceptor with Ig and ITIM domains [KO:K16350]", "3683  ITGAL; integrin subunit alpha L [KO:K05718]", "3689  ITGB2; integrin subunit beta 2 [KO:K06464]", "3383  ICAM1; intercellular adhesion molecule 1 [KO:K06490]", "3384  ICAM2; intercellular adhesion molecule 2 [KO:K06523]", "3385  ICAM3; intercellular adhesion molecule 3 [KO:K06486]", "933  CD22; CD22 molecule [KO:K06467]", "5788  PTPRC; protein tyrosine phosphatase receptor type C [KO:K06478] [EC:3.1.3.48]", "6614  SIGLEC1; sialic acid binding Ig like lectin 1 [KO:K06548]", "6693  SPN; sialophorin [KO:K06477]", "25945  NECTIN3; nectin cell adhesion molecule 3 [KO:K06592]", "1364  CLDN4; claudin 4 [KO:K06087]", "1365  CLDN3; claudin 3 [KO:K06087]", "1366  CLDN7; claudin 7 [KO:K06087]", "149461  CLDN19; claudin 19 [KO:K06087]", "10686  CLDN16; claudin 16 [KO:K06087]", "23562  CLDN14; claudin 14 [KO:K06087]", "24146  CLDN15; claudin 15 [KO:K06087]", "26285  CLDN17; claudin 17 [KO:K06087]", "49861  CLDN20; claudin 20 [KO:K06087]", "5010  CLDN11; claudin 11 [KO:K06087]", "51208  CLDN18; claudin 18 [KO:K06087]", "53842  CLDN22; claudin 22 [KO:K06087]", "7122  CLDN5; claudin 5 [KO:K06087]", "9071  CLDN10; claudin 10 [KO:K06087]", "9073  CLDN8; claudin 8 [KO:K06087]", "9074  CLDN6; claudin 6 [KO:K06087]", "9075  CLDN2; claudin 2 [KO:K06087]", "9076  CLDN1; claudin 1 [KO:K06087]", "9080  CLDN9; claudin 9 [KO:K06087]", "137075  CLDN23; claudin 23 [KO:K06087]", "100288814  CLDN34; claudin 34 [KO:K06087]", "644672  CLDN25; claudin 25 [KO:K06087]", "100132463  CLDN24; claudin 24 [KO:K06087]", "9069  CLDN12; claudin 12 [KO:K06087]", "100506658  OCLN; occludin [KO:K06088]", "50848  F11R; F11 receptor [KO:K06089]", "58494  JAM2; junctional adhesion molecule 2 [KO:K06735]", "83700  JAM3; junctional adhesion molecule 3 [KO:K06785]", "90952  ESAM; endothelial cell adhesion molecule [KO:K06787]", "1003  CDH5; cadherin 5 [KO:K06533]", "5175  PECAM1; platelet and endothelial cell adhesion molecule 1 [KO:K06471]", "4267  CD99; CD99 molecule (Xg blood group) [KO:K06520]", "83692  CD99L2; CD99 molecule like 2 [KO:K06520]", "3684  ITGAM; integrin subunit alpha M [KO:K06461]", "6404  SELPLG; selectin P ligand [KO:K06544]", "6403  SELP; selectin P [KO:K06496]", "3676  ITGA4; integrin subunit alpha 4 [KO:K06483]", "3688  ITGB1; integrin subunit beta 1 [KO:K05719]", "3680  ITGA9; integrin subunit alpha 9 [KO:K06585]", "7412  VCAM1; vascular cell adhesion molecule 1 [KO:K06527]", "3695  ITGB7; integrin subunit beta 7 [KO:K06590]", "8174  MADCAM1; mucosal vascular addressin cell adhesion molecule 1 [KO:K06779]", "6402  SELL; selectin L [KO:K06495]", "947  CD34; CD34 molecule [KO:K06474]", "2734  GLG1; golgi glycoprotein 1 [KO:K06816]", "6401  SELE; selectin E [KO:K06494]", "5818  NECTIN1; nectin cell adhesion molecule 1 [KO:K06081]", "1000  CDH2; cadherin 2 [KO:K06736]", "4684  NCAM1; neural cell adhesion molecule 1 [KO:K06491]", "4685  NCAM2; neural cell adhesion molecule 2 [KO:K06491]", "3897  L1CAM; L1 cell adhesion molecule [KO:K06550]", "23705  CADM1; cell adhesion molecule 1 [KO:K06781]", "257194  NEGR1; neuronal growth regulator 1 [KO:K06775]", "22854  NTNG1; netrin G1 [KO:K07522]", "57689  LRRC4C; leucine rich repeat containing 4C [KO:K07523]", "84628  NTNG2; netrin G2 [KO:K16359]", "64101  LRRC4; leucine rich repeat containing 4 [KO:K16351]", "5792  PTPRF; protein tyrosine phosphatase receptor type F [KO:K05695] [EC:3.1.3.48]", "94030  LRRC4B; leucine rich repeat containing 4B [KO:K16360]", "6382  SDC1; syndecan 1 [KO:K06257]", "6383  SDC2; syndecan 2 [KO:K16336]", "9672  SDC3; syndecan 3 [KO:K16337]", "6385  SDC4; syndecan 4 [KO:K16338]", "3685  ITGAV; integrin subunit alpha V [KO:K06487]", "3696  ITGB8; integrin subunit beta 8 [KO:K06591]", "8516  ITGA8; integrin subunit alpha 8 [KO:K06584]", "9378  NRXN1; neurexin 1 [KO:K07377]", "9379  NRXN2; neurexin 2 [KO:K07377]", "9369  NRXN3; neurexin 3 [KO:K07377]", "22871  NLGN1; neuroligin 1 [KO:K07378]", "57555  NLGN2; neuroligin 2 [KO:K07378]", "54413  NLGN3; neuroligin 3 [KO:K07378]", "57502  NLGN4X; neuroligin 4 X-linked [KO:K07378]", "22829  NLGN4Y; neuroligin 4 Y-linked [KO:K07378]", "5802  PTPRS; protein tyrosine phosphatase receptor type S [KO:K06778] [EC:3.1.3.48]", "114798  SLITRK1; SLIT and NTRK like family member 1 [KO:K25832]", "84631  SLITRK2; SLIT and NTRK like family member 2 [KO:K25833]", "139065  SLITRK4; SLIT and NTRK like family member 4 [KO:K25835]", "26050  SLITRK5; SLIT and NTRK like family member 5 [KO:K25836]", "84189  SLITRK6; SLIT and NTRK like family member 6 [KO:K25837]", "5789  PTPRD; protein tyrosine phosphatase receptor type D [KO:K06777] [EC:3.1.3.48]", "22865  SLITRK3; SLIT and NTRK like family member 3 [KO:K25834]", "57863  CADM3; cell adhesion molecule 3 [KO:K06780]", "4897  NRCAM; neuronal cell adhesion molecule [KO:K06756]", "1272  CNTN1; contactin 1 [KO:K06759]", "5797  PTPRM; protein tyrosine phosphatase receptor type M [KO:K05693] [EC:3.1.3.48]", "6900  CNTN2; contactin 2 [KO:K06760]", "23114  NFASC; neurofascin [KO:K06757]", "8506  CNTNAP1; contactin associated protein 1 [KO:K07379]", "26047  CNTNAP2; contactin associated protein 2 [KO:K07380]", "4359  MPZ; myelin protein zero [KO:K06770]", "4099  MAG; myelin associated glycoprotein [KO:K06771]", "999  CDH1; cadherin 1 [KO:K05689]", "1462  VCAN; versican [KO:K06793]", "3655  ITGA6; integrin subunit alpha 6 [KO:K06485]", "1001  CDH3; cadherin 3 [KO:K06796]", "1002  CDH4; cadherin 4 [KO:K06797]", "1013  CDH15; cadherin 15 [KO:K06809]", "4756  NEO1; neogenin 1 [KO:K06766]"], "refs": [{"pmid": "14690046", "authors": "  Barclay AN.", "title": "Membrane proteins with immunoglobulin-like domains--a master superfamily of interaction molecules.", "journal": "Semin Immunol 15:215-23 (2003)", "doi": "10.1016/S1044-5323(03)00047-2"}, {"pmid": "11910893", "authors": "  Sharpe AH, Freeman GJ.", "title": "The B7-CD28 superfamily.", "journal": "Nat Rev Immunol 2:116-26 (2002)", "doi": "10.1038/nri727"}, {"pmid": "9597126", "authors": "  Grewal IS, Flavell RA.", "title": "CD40 and CD154 in cell-mediated immunity.", "journal": "Annu Rev Immunol 16:111-35 (1998)", "doi": "10.1146/annurev.immunol.16.1.111"}, {"pmid": "16034094", "authors": "  Dardalhon V, Schubart AS, Reddy J, Meyers JH, Monney L, Sabatos CA, Ahuja R, Nguyen K, Freeman GJ, Greenfield EA, Sobel RA, Kuchroo VK.", "title": "CD226 is specifically expressed on the surface of Th1 cells and regulates their expansion and effector functions.", "journal": "J Immunol 175:1558-65 (2005)", "doi": "10.4049/jimmunol.175.3.1558"}, {"pmid": "12234363", "authors": "  Montoya MC, Sancho D, Vicente-Manzanares M, Sanchez-Madrid F.", "title": "Cell adhesion and polarity during immune interactions.", "journal": "Immunol Rev 186:68-82 (2002)", "doi": "10.1034/j.1600-065X.2002.18607.x"}, {"pmid": "15071551", "authors": "  Dejana E.", "title": "Endothelial cell-cell junctions: happy together.", "journal": "Nat Rev Mol Cell Biol 5:261-70 (2004)", "doi": "10.1038/nrm1357"}, {"pmid": "14519386", "authors": "  Bazzoni G.", "title": "The JAM family of junctional adhesion molecules.", "journal": "Curr Opin Cell Biol 15:525-30 (2003)", "doi": "10.1016/S0955-0674(03)00104-2"}, {"pmid": "10798271", "authors": "  Becker BF, Heindl B, Kupatt C, Zahler S.", "title": "Endothelial function and hemostasis.", "journal": "Z Kardiol 89:160-7 (2000)", "doi": "10.1007/PL00007320"}, {"pmid": "9150551", "authors": "  Elangbam CS, Qualls CW Jr, Dahlgren RR.", "title": "Cell adhesion molecules--update.", "journal": "Vet Pathol 34:61-73 (1997)", "doi": "10.1177/030098589703400113"}, {"pmid": "12810109", "authors": "  Muller WA.", "title": "Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response.", "journal": "Trends Immunol 24:327-34 (2003)", "doi": "10.1016/S1471-4906(03)00117-0"}, {"pmid": "14519398", "authors": "  Yamagata M, Sanes JR, Weiner JA.", "title": "Synaptic adhesion molecules.", "journal": "Curr Opin Cell Biol 15:621-32 (2003)", "doi": "10.1016/S0955-0674(03)00107-8"}, {"pmid": "15882774", "authors": "  Ethell IM, Pasquale EB.", "title": "Molecular mechanisms of dendritic spine development and remodeling.", "journal": "Prog Neurobiol 75:161-205 (2005)", "doi": "10.1016/j.pneurobio.2005.02.003"}, {"pmid": "11050419", "authors": "  Benson DL, Schnapp LM, Shapiro L, Huntley GW.", "title": "Making memories stick: cell-adhesion molecules in synaptic plasticity.", "journal": "Trends Cell Biol 10:473-82 (2000)", "doi": "10.1016/S0962-8924(00)01838-9"}, {"pmid": "11860281", "authors": "  Rosdahl JA, Mourton TL, Brady-Kalnay SM.", "title": "Protein kinase C delta (PKCdelta) is required for protein tyrosine phosphatase mu (PTPmu)-dependent neurite outgrowth.", "journal": "Mol Cell Neurosci 19:292-306 (2002)", "doi": "10.1006/mcne.2001.1071"}, {"pmid": "10964748", "authors": "  Dunican DJ, Doherty P.", "title": "The generation of localized calcium rises mediated by cell adhesion molecules and their role in neuronal growth cone motility.", "journal": "Mol Cell Biol Res Commun 3:255-63 (2000)", "doi": "10.1006/mcbr.2000.0225"}, {"pmid": "12367625", "authors": "  Girault JA, Peles E.", "title": "Development of nodes of Ranvier.", "journal": "Curr Opin Neurobiol 12:476-85 (2002)", "doi": "10.1016/S0959-4388(02)00370-7"}, {"pmid": "10664064", "authors": "  Arroyo EJ, Scherer SS.", "title": "On the molecular architecture of myelinated fibers.", "journal": "Histochem Cell Biol 113:1-18 (2000)", "doi": "10.1007/s004180050001"}, {"pmid": "14556710", "authors": "  Salzer JL.", "title": "Polarized domains of myelinated axons.", "journal": "Neuron 40:297-318 (2003)", "doi": "10.1016/S0896-6273(03)00628-7"}, {"pmid": "15561584", "authors": "  Irie K, Shimizu K, Sakisaka T, Ikeda W, Takai Y.", "title": "Roles and modes of action of nectins in cell-cell adhesion.", "journal": "Semin Cell Dev Biol 15:643-56 (2004)", "doi": "10.1016/j.semcdb.2004.09.002"}, {"pmid": "15551862", "authors": "  Nakanishi H, Takai Y.", "title": "Roles of nectins in cell adhesion, migration and polarization.", "journal": "Biol Chem 385:885-92 (2004)", "doi": "10.1515/BC.2004.116"}, {"pmid": "15115723", "authors": "  Siu MK, Cheng CY.", "title": "Extracellular matrix: recent advances on its role in junction dynamics in the seminiferous epithelium during spermatogenesis.", "journal": "Biol Reprod 71:375-91 (2004)", "doi": "10.1095/biolreprod.104.028225"}, {"pmid": "15056568", "authors": "  Lee NP, Cheng CY.", "title": "Adaptors, junction dynamics, and spermatogenesis.", "journal": "Biol Reprod 71:392-404 (2004)", "doi": "10.1095/biolreprod.104.027268"}, {"pmid": "15728677", "authors": "  Inagaki M, Irie K, Ishizaki H, Tanaka-Okamoto M, Morimoto K, Inoue E, Ohtsuka T, Miyoshi J, Takai Y.", "title": "Roles of cell-adhesion molecules nectin 1 and nectin 3 in ciliary body development.", "journal": "Development 132:1525-37 (2005)", "doi": "10.1242/dev.01697"}, {"pmid": "12500939", "authors": "  Marthiens V, Gavard J, Lambert M, Mege RM.", "title": "Cadherin-based cell adhesion in neuromuscular development.", "journal": "Biol Cell 94:315-26 (2002)", "doi": "10.1016/S0248-4900(02)00005-9"}], "rel_pathway": ["hsa04520  Adherens junction", "hsa04530  Tight junction", "hsa04610  Complement and coagulation cascades", "hsa04660  T cell receptor signaling pathway", "hsa04670  Leukocyte transendothelial migration"], "ko_pathway": "ko04514", "genes": ["SDC4", "CD22"]}, {"kegg_id": "hsa04820", "name": "Cytoskeleton in muscle cells - Homo sapiens (human)", "class": "Cellular Processes; Cell motility", "pathway_map": "hsa04820  Cytoskeleton in muscle cells", "network": ["", "ELEMENT   N01758  Desmosome - Vimentin filaments", "N01814  Extracellular matrix - Basal lamina", "N01815  Vinculin-talin-integrin macromolecular complex", "N01816  Costamere", "N01817  Myosin thick filament", "N01818  Actin thin filament, muscle contraction", "N01819  Actin thin filament, length regulation", "N01821  Sarcomere, M-band", "N01822  Linker of nucleoskeleton and cytoskeleton (LINC) complex"], "drug": ["D12902  Sevasemten (USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["1277  COL1A1; collagen type I alpha 1 chain [KO:K06236]", "1278  COL1A2; collagen type I alpha 2 chain [KO:K06236]", "1281  COL3A1; collagen type III alpha 1 chain [KO:K19720]", "1289  COL5A1; collagen type V alpha 1 chain [KO:K19721]", "1290  COL5A2; collagen type V alpha 2 chain [KO:K19721]", "50509  COL5A3; collagen type V alpha 3 chain [KO:K19721]", "1301  COL11A1; collagen type XI alpha 1 chain [KO:K19721]", "255631  COL24A1; collagen type XXIV alpha 1 chain [KO:K19721]", "85301  COL27A1; collagen type XXVII alpha 1 chain [KO:K19721]", "1302  COL11A2; collagen type XI alpha 2 chain [KO:K19721]", "1297  COL9A1; collagen type IX alpha 1 chain [KO:K08131]", "1298  COL9A2; collagen type IX alpha 2 chain [KO:K08131]", "1299  COL9A3; collagen type IX alpha 3 chain [KO:K08131]", "1634  DCN; decorin [KO:K04660]", "1462  VCAN; versican [KO:K06793]", "2006  ELN; elastin [KO:K14211]", "1291  COL6A1; collagen type VI alpha 1 chain [KO:K06238]", "1292  COL6A2; collagen type VI alpha 2 chain [KO:K06238]", "1293  COL6A3; collagen type VI alpha 3 chain [KO:K06238]", "131873  COL6A6; collagen type VI alpha 6 chain [KO:K06238]", "256076  COL6A5; collagen type VI alpha 5 chain [KO:K06238]", "7057  THBS1; thrombospondin 1 [KO:K16857]", "1311  COMP; cartilage oligomeric matrix protein [KO:K04659]", "7058  THBS2; thrombospondin 2 [KO:K04659]", "7059  THBS3; thrombospondin 3 [KO:K04659]", "7060  THBS4; thrombospondin 4 [KO:K04659]", "2200  FBN1; fibrillin 1 [KO:K06825]", "2201  FBN2; fibrillin 2 [KO:K23342]", "84467  FBN3; fibrillin 3 [KO:K23342]", "1284  COL4A2; collagen type IV alpha 2 chain [KO:K06237]", "1286  COL4A4; collagen type IV alpha 4 chain [KO:K06237]", "1288  COL4A6; collagen type IV alpha 6 chain [KO:K06237]", "1282  COL4A1; collagen type IV alpha 1 chain [KO:K06237]", "1287  COL4A5; collagen type IV alpha 5 chain [KO:K06237]", "1285  COL4A3; collagen type IV alpha 3 chain [KO:K06237]", "2192  FBLN1; fibulin 1 [KO:K17307]", "2199  FBLN2; fibulin 2 [KO:K17307]", "3339  HSPG2; heparan sulfate proteoglycan 2 [KO:K06255]", "4811  NID1; nidogen 1 [KO:K06826]", "22795  NID2; nidogen 2 [KO:K06826]", "2335  FN1; fibronectin 1 [KO:K05717]", "6382  SDC1; syndecan 1 [KO:K06257]", "6383  SDC2; syndecan 2 [KO:K16336]", "9672  SDC3; syndecan 3 [KO:K16337]", "6385  SDC4; syndecan 4 [KO:K16338]", "375790  AGRN; agrin [KO:K06254]", "633  BGN; biglycan [KO:K08118]", "1824  DSC2; desmocollin 2 [KO:K07601]", "1829  DSG2; desmoglein 2 [KO:K07597]", "5318  PKP2; plakophilin 2 [KO:K12642]", "3728  JUP; junction plakoglobin [KO:K10056]", "1832  DSP; desmoplakin [KO:K10381]", "7431  VIM; vimentin [KO:K07606]", "1674  DES; desmin [KO:K07610]", "284217  LAMA1; laminin subunit alpha 1 [KO:K05637]", "3908  LAMA2; laminin subunit alpha 2 [KO:K05637]", "3672  ITGA1; integrin subunit alpha 1 [KO:K06480]", "3673  ITGA2; integrin subunit alpha 2 [KO:K06481]", "3674  ITGA2B; integrin subunit alpha 2b [KO:K06476]", "3675  ITGA3; integrin subunit alpha 3 [KO:K06482]", "3676  ITGA4; integrin subunit alpha 4 [KO:K06483]", "3678  ITGA5; integrin subunit alpha 5 [KO:K06484]", "3655  ITGA6; integrin subunit alpha 6 [KO:K06485]", "3679  ITGA7; integrin subunit alpha 7 [KO:K06583]", "8516  ITGA8; integrin subunit alpha 8 [KO:K06584]", "3680  ITGA9; integrin subunit alpha 9 [KO:K06585]", "8515  ITGA10; integrin subunit alpha 10 [KO:K06586]", "22801  ITGA11; integrin subunit alpha 11 [KO:K06587]", "3685  ITGAV; integrin subunit alpha V [KO:K06487]", "3688  ITGB1; integrin subunit beta 1 [KO:K05719]", "3690  ITGB3; integrin subunit beta 3 [KO:K06493]", "3691  ITGB4; integrin subunit beta 4 [KO:K06525]", "3693  ITGB5; integrin subunit beta 5 [KO:K06588]", "3694  ITGB6; integrin subunit beta 6 [KO:K06589]", "3695  ITGB7; integrin subunit beta 7 [KO:K06590]", "3696  ITGB8; integrin subunit beta 8 [KO:K06591]", "7094  TLN1; talin 1 [KO:K06271]", "83660  TLN2; talin 2 [KO:K06271]", "7414  VCL; vinculin [KO:K05700]", "89  ACTN3; actinin alpha 3 [KO:K21073]", "88  ACTN2; actinin alpha 2 [KO:K21073]", "71  ACTG1; actin gamma 1 [KO:K05692]", "60  ACTB; actin beta [KO:K05692]", "72  ACTG2; actin gamma 2, smooth muscle [KO:K12315]", "1605  DAG1; dystroglycan 1 [KO:K06265]", "6442  SGCA; sarcoglycan alpha [KO:K12565]", "8910  SGCE; sarcoglycan epsilon [KO:K27061]", "6443  SGCB; sarcoglycan beta [KO:K12566]", "6444  SGCD; sarcoglycan delta [KO:K12563]", "6445  SGCG; sarcoglycan gamma [KO:K12564]", "137868  SGCZ; sarcoglycan zeta [KO:K27062]", "8082  SSPN; sarcospan [KO:K22194]", "1756  DMD; dystrophin [KO:K10366]", "6640  SNTA1; syntrophin alpha 1 [KO:K24063]", "6645  SNTB2; syntrophin beta 2 [KO:K24064]", "6641  SNTB1; syntrophin beta 1 [KO:K24064]", "1837  DTNA; dystrobrevin alpha [KO:K26998]", "2318  FLNC; filamin C [KO:K27393]", "476  ATP1A1; ATPase Na+/K+ transporting subunit alpha 1 [KO:K01539] [EC:7.2.2.13]", "477  ATP1A2; ATPase Na+/K+ transporting subunit alpha 2 [KO:K01539] [EC:7.2.2.13]", "478  ATP1A3; ATPase Na+/K+ transporting subunit alpha 3 [KO:K01539] [EC:7.2.2.13]", "480  ATP1A4; ATPase Na+/K+ transporting subunit alpha 4 [KO:K01539] [EC:7.2.2.13]", "23439  ATP1B4; ATPase Na+/K+ transporting family member beta 4 [KO:K01540]", "481  ATP1B1; ATPase Na+/K+ transporting subunit beta 1 [KO:K01540]", "482  ATP1B2; ATPase Na+/K+ transporting subunit beta 2 [KO:K01540]", "483  ATP1B3; ATPase Na+/K+ transporting subunit beta 3 [KO:K01540]", "288  ANK3; ankyrin 3 [KO:K09259]", "6709  SPTAN1; spectrin alpha, non-erythrocytic 1 [KO:K06114]", "51332  SPTBN5; spectrin beta, non-erythrocytic 5 [KO:K06115]", "57731  SPTBN4; spectrin beta, non-erythrocytic 4 [KO:K06115]", "6711  SPTBN1; spectrin beta, non-erythrocytic 1 [KO:K06115]", "6712  SPTBN2; spectrin beta, non-erythrocytic 2 [KO:K23932]", "1465  CSRP1; cysteine and glycine rich protein 1 [KO:K09377]", "1466  CSRP2; cysteine and glycine rich protein 2 [KO:K09377]", "8048  CSRP3; cysteine and glycine rich protein 3 [KO:K09377]", "4619  MYH1; myosin heavy chain 1 [KO:K24220]", "4622  MYH4; myosin heavy chain 4 [KO:K24220]", "4626  MYH8; myosin heavy chain 8 [KO:K24220]", "4620  MYH2; myosin heavy chain 2 [KO:K24220]", "4621  MYH3; myosin heavy chain 3 [KO:K24220]", "57644  MYH7B; myosin heavy chain 7B [KO:K24220]", "22989  MYH15; myosin heavy chain 15 [KO:K24220]", "8735  MYH13; myosin heavy chain 13 [KO:K24220]", "4625  MYH7; myosin heavy chain 7 [KO:K17751]", "4624  MYH6; myosin heavy chain 6 [KO:K17751]", "4627  MYH9; myosin heavy chain 9 [KO:K10352]", "4628  MYH10; myosin heavy chain 10 [KO:K10352]", "4629  MYH11; myosin heavy chain 11 [KO:K10352]", "79784  MYH14; myosin heavy chain 14 [KO:K10352]", "4632  MYL1; myosin light chain 1 [KO:K05738]", "4634  MYL3; myosin light chain 3 [KO:K12749]", "4635  MYL4; myosin light chain 4 [KO:K12750]", "4633  MYL2; myosin light chain 2 [KO:K10351]", "4636  MYL5; myosin light chain 5 [KO:K12753]", "58498  MYL7; myosin light chain 7 [KO:K12754]", "10398  MYL9; myosin light chain 9 [KO:K12755]", "29895  MYL11; myosin light chain 11 [KO:K12758]", "4604  MYBPC1; myosin binding protein C1 [KO:K12557]", "4606  MYBPC2; myosin binding protein C2 [KO:K12558]", "4607  MYBPC3; myosin binding protein C3 [KO:K12568]", "4608  MYBPH; myosin binding protein H [KO:K24494]", "343263  MYBPHL; myosin binding protein H like [KO:K24494]", "58  ACTA1; actin alpha 1, skeletal muscle [KO:K10354]", "70  ACTC1; actin alpha cardiac muscle 1 [KO:K12314]", "7134  TNNC1; troponin C1, slow skeletal and cardiac type [KO:K05865]", "7135  TNNI1; troponin I1, slow skeletal type [KO:K10371]", "7138  TNNT1; troponin T1, slow skeletal type [KO:K10372]", "7125  TNNC2; troponin C2, fast skeletal type [KO:K12042]", "7136  TNNI2; troponin I2, fast skeletal type [KO:K12043]", "7140  TNNT3; troponin T3, fast skeletal type [KO:K12046]", "7137  TNNI3; troponin I3, cardiac type [KO:K12044]", "7139  TNNT2; troponin T2, cardiac type [KO:K12045]", "7168  TPM1; tropomyosin 1 [KO:K10373]", "7169  TPM2; tropomyosin 2 [KO:K10374]", "7170  TPM3; tropomyosin 3 [KO:K09290]", "7171  TPM4; tropomyosin 4 [KO:K10375]", "7273  TTN; titin [KO:K12567] [EC:2.7.11.1]", "9499  MYOT; myotilin [KO:K19875]", "8557  TCAP; titin-cap [KO:K19879]", "171024  SYNPO2; synaptopodin 2 [KO:K24066]", "4703  NEB; nebulin [KO:K18267]", "10529  NEBL; nebulette [KO:K25865]", "58529  MYOZ1; myozenin 1 [KO:K26050]", "51778  MYOZ2; myozenin 2 [KO:K26050]", "91977  MYOZ3; myozenin 3 [KO:K26050]", "27295  PDLIM3; PDZ and LIM domain 3 [KO:K23353]", "64236  PDLIM2; PDZ and LIM domain 2 [KO:K23353]", "8572  PDLIM4; PDZ and LIM domain 4 [KO:K23353]", "9124  PDLIM1; PDZ and LIM domain 1 [KO:K23353]", "829  CAPZA1; capping actin protein of muscle Z-line subunit alpha 1 [KO:K10364]", "830  CAPZA2; capping actin protein of muscle Z-line subunit alpha 2 [KO:K10364]", "93661  CAPZA3; capping actin protein of muscle Z-line subunit alpha 3 [KO:K10364]", "832  CAPZB; capping actin protein of muscle Z-line subunit beta [KO:K10365]", "165904  XIRP1; xin actin binding repeat containing 1 [KO:K27381]", "129446  XIRP2; xin actin binding repeat containing 2 [KO:K27381]", "4892  NRAP; nebulin related anchoring protein [KO:K24421]", "84665  MYPN; myopalladin [KO:K22028]", "11155  LDB3; LIM domain binding 3 [KO:K19867]", "10611  PDLIM5; PDZ and LIM domain 5 [KO:K19867]", "9260  PDLIM7; PDZ and LIM domain 7 [KO:K19867]", "29765  TMOD4; tropomodulin 4 [KO:K10370]", "29766  TMOD3; tropomodulin 3 [KO:K10370]", "29767  TMOD2; tropomodulin 2 [KO:K10370]", "7111  TMOD1; tropomodulin 1 [KO:K10370]", "7791  ZYX; zyxin [KO:K06273]", "2273  FHL1; four and a half LIM domains 1 [KO:K14365]", "2274  FHL2; four and a half LIM domains 2 [KO:K14380]", "2275  FHL3; four and a half LIM domains 3 [KO:K24414]", "442721  LMOD2; leiomodin 2 [KO:K22030]", "25802  LMOD1; leiomodin 1 [KO:K22030]", "56203  LMOD3; leiomodin 3 [KO:K22030]", "27063  ANKRD1; ankyrin repeat domain 1 [KO:K21433]", "26287  ANKRD2; ankyrin repeat domain 2 [KO:K21434]", "200539  ANKRD23; ankyrin repeat domain 23 [KO:K21438]", "114793  FMNL2; formin like 2 [KO:K23957]", "752  FMNL1; formin like 1 [KO:K23957]", "91010  FMNL3; formin like 3 [KO:K23957]", "64423  INF2; inverted formin 2 [KO:K23958]", "23002  DAAM1; dishevelled associated activator of morphogenesis 1 [KO:K04512]", "23500  DAAM2; dishevelled associated activator of morphogenesis 2 [KO:K04512]", "1729  DIAPH1; diaphanous related formin 1 [KO:K05740]", "1730  DIAPH2; diaphanous related formin 2 [KO:K05741]", "81624  DIAPH3; diaphanous related formin 3 [KO:K05745]", "56776  FMN2; formin 2 [KO:K02184]", "8736  MYOM1; myomesin 1 [KO:K24495]", "9172  MYOM2; myomesin 2 [KO:K24495]", "127294  MYOM3; myomesin 3 [KO:K24495]", "2027  ENO3; enolase 3 [KO:K01689] [EC:4.2.1.11]", "2026  ENO2; enolase 2 [KO:K01689] [EC:4.2.1.11]", "2023  ENO1; enolase 1 [KO:K01689] [EC:4.2.1.11]", "287  ANK2; ankyrin 2 [KO:K09255]", "1158  CKM; creatine kinase, M-type [KO:K27382] [EC:2.7.3.2]", "57159  TRIM54; tripartite motif containing 54 [KO:K10653]", "84675  TRIM55; tripartite motif containing 55 [KO:K10654]", "84676  TRIM63; tripartite motif containing 63 [KO:K10655] [EC:2.3.2.27]", "271  AMPD2; adenosine monophosphate deaminase 2 [KO:K01490] [EC:3.5.4.6]", "272  AMPD3; adenosine monophosphate deaminase 3 [KO:K01490] [EC:3.5.4.6]", "270  AMPD1; adenosine monophosphate deaminase 1 [KO:K01490] [EC:3.5.4.6]", "84033  OBSCN; obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF [KO:K17531] [EC:2.7.11.1]", "825  CAPN3; calpain 3 [KO:K08573] [EC:3.4.22.54]", "5339  PLEC; plectin [KO:K10388]", "161176  SYNE3; spectrin repeat containing nuclear envelope family member 3 [KO:K21761]", "23345  SYNE1; spectrin repeat containing nuclear envelope protein 1 [KO:K19326]", "23224  SYNE2; spectrin repeat containing nuclear envelope protein 2 [KO:K19346]", "23353  SUN1; Sad1 and UNC84 domain containing 1 [KO:K19347]", "25777  SUN2; Sad1 and UNC84 domain containing 2 [KO:K19347]", "79188  TMEM43; transmembrane protein 43 [KO:K27488]", "2010  EMD; emerin [KO:K12569]", "3930  LBR; lamin B receptor [KO:K19532] [EC:1.3.1.70]", "4000  LMNA; lamin A/C [KO:K12641]", "4001  LMNB1; lamin B1 [KO:K07611]", "84823  LMNB2; lamin B2 [KO:K07611]"], "refs": [{"pmid": "12142273", "authors": "  Clark KA, McElhinny AS, Beckerle MC, Gregorio CC", "title": "Striated muscle cytoarchitecture: an intricate web of form and function.", "journal": "Annu Rev Cell Dev Biol 18:637-706 (2002)", "doi": "10.1146/annurev.cellbio.18.012502.105840"}, {"pmid": "31407867", "authors": "  Mukund K, Subramaniam S", "title": "Skeletal muscle: A review of molecular structure and function, in health and disease.", "journal": "Wiley Interdiscip Rev Syst Biol Med 12:e1462 (2020)", "doi": "10.1002/wsbm.1462"}, {"pmid": "24481844", "authors": "  Stroud MJ, Banerjee I, Veevers J, Chen J", "title": "Linker of nucleoskeleton and cytoskeleton complex proteins in cardiac structure, function, and disease.", "journal": "Circ Res 114:538-48 (2014)", "doi": "10.1161/CIRCRESAHA.114.301236"}, {"pmid": "28640448", "authors": "  Henderson CA, Gomez CG, Novak SM, Mi-Mi L, Gregorio CC", "title": "Overview of the Muscle Cytoskeleton.", "journal": "Compr Physiol 7:891-944 (2017)", "doi": "10.1002/cphy.c160033"}, {"pmid": "32265741", "authors": "  Csapo R, Gumpenberger M, Wessner B", "title": "Skeletal Muscle Extracellular Matrix - What Do We Know About Its Composition, Regulation, and Physiological Roles? A Narrative Review.", "journal": "Front Physiol 11:253 (2020)", "doi": "10.3389/fphys.2020.00253"}, {"pmid": "27114860", "authors": "  Pinch M, Guth R, Samanta MP, Chaidez A, Unguez GA", "title": "The myogenic electric organ of Sternopygus macrurus: a non-contractile tissue with a skeletal muscle transcriptome.", "journal": "PeerJ 4:e1828 (2016)", "doi": "10.7717/peerj.1828"}, {"pmid": "23860255", "authors": "  Sequeira V, Nijenkamp LL, Regan JA, van der Velden J", "title": "The physiological role of cardiac cytoskeleton and its alterations in heart failure.", "journal": "Biochim Biophys Acta 1838:700-22 (2014)", "doi": "10.1016/j.bbamem.2013.07.011"}, {"pmid": "36960155", "authors": "  Zhang B, Powers JD, McCulloch AD, Chi NC", "title": "Nuclear mechanosignaling in striated muscle diseases.", "journal": "Front Physiol 14:1126111 (2023)", "doi": "10.3389/fphys.2023.1126111"}, {"pmid": "21464301", "authors": "  Al-Amoudi A, Castano-Diez D, Devos DP, Russell RB, Johnson GT, Frangakis AS", "title": "The three-dimensional molecular structure of the desmosomal plaque.", "journal": "Proc Natl Acad Sci U S A 108:6480-5 (2011)", "doi": "10.1073/pnas.1019469108"}, {"pmid": "33067392", "authors": "  Sikora M, Ermel UH, Seybold A, Kunz M, Calloni G, Reitz J, Vabulas RM, Hummer G, Frangakis AS", "title": "Desmosome architecture derived from molecular dynamics simulations and cryo-electron tomography.", "journal": "Proc Natl Acad Sci U S A 117:27132-27140 (2020)", "doi": "10.1073/pnas.2004563117"}, {"pmid": "26910421", "authors": "  Xu XP, Kim E, Swift M, Smith JW, Volkmann N, Hanein D", "title": "Three-Dimensional Structures of Full-Length, Membrane-Embedded Human alpha(IIb)beta(3) Integrin Complexes.", "journal": "Biophys J 110:798-809 (2016)", "doi": "10.1016/j.bpj.2016.01.016"}, {"pmid": "22945352", "authors": "  Wang W, Shi Z, Jiao S, Chen C, Wang H, Liu G, Wang Q, Zhao Y, Greene MI, Zhou Z", "title": "Structural insights into SUN-KASH complexes across the nuclear envelope.", "journal": "Cell Res 22:1440-52 (2012)", "doi": "10.1038/cr.2012.126"}, {"pmid": "23597672", "authors": "  Sosa BA, Kutay U, Schwartz TU", "title": "Structural insights into LINC complexes.", "journal": "Curr Opin Struct Biol 23:285-91 (2013)", "doi": "10.1016/j.sbi.2013.03.005"}, {"pmid": "33058875", "authors": "  Cruz VE, Esra Demircioglu F, Schwartz TU", "title": "Structural Analysis of Different LINC Complexes Reveals Distinct Binding Modes.", "journal": "J Mol Biol 432:6028-6041 (2020)", "doi": "10.1016/j.jmb.2020.09.019"}, {"pmid": "36523505", "authors": "  Schuler SC, Liu Y, Dumontier S, Grandbois M, Le Moal E, Cornelison D, Bentzinger CF", "title": "Extracellular matrix: Brick and mortar in the skeletal muscle stem cell niche.", "journal": "Front Cell Dev Biol 10:1056523 (2022)", "doi": "10.3389/fcell.2022.1056523"}, {"pmid": "30425656", "authors": "  Brull A, Morales Rodriguez B, Bonne G, Muchir A, Bertrand AT", "title": "The Pathogenesis and Therapies of Striated Muscle Laminopathies.", "journal": "Front Physiol 9:1533 (2018)", "doi": "10.3389/fphys.2018.01533"}], "rel_pathway": ["hsa04512  ECM-receptor interaction", "hsa04814  Motor proteins"], "ko_pathway": "ko04820", "genes": ["SDC4", "TPM4", "FHL2", "TTN"]}, {"kegg_id": "hsa05205", "name": "Proteoglycans in cancer - Homo sapiens (human)", "description": "Many proteoglycans (PGs) in the tumor microenvironment have been shown to be key macromolecules that contribute to biology of various types of cancer including proliferation, adhesion, angiogenesis and metastasis, affecting tumor progress. The four main types of proteoglycans include hyaluronan (HA), which does not occur as a PG but in free form, heparan sulfate proteoglycans (HSPGs), chondroitin sulfate proteoglycans (CSPGs), dematan sulfate proteoglycans (DSPG) and keratan sulfate proteoglycans (KSPGs) [BR:00535]. Among these proteoglycans such as HA, acting with CD44, promotes tumor cell growth and migration, whereas other proteoglycans such as syndecans (-1~-4), glypican (-1, -3) and perlecan may interact with growth factors, cytokines, morphogens and enzymes through HS chains [BR:00536], also leading to tumor growth and invasion. In contrast, some of the small leucine-rich proteolgycans, such as decorin and lumican, can function as tumor repressors, and modulate the signaling pathways by the interaction of their core proteins and multiple receptors.", "class": "Human Diseases; Cancer: overview", "pathway_map": "hsa05205  Proteoglycans in cancer", "drug": ["D08620  Toremifene (INN)", "D09992  Vismodegib (USAN/INN)", "D10381  Afuresertib (USAN/INN)", "D10382  Afuresertib hydrochloride (USAN)", "D10514  Dacomitinib (USAN)", "D11239  Lumretuzumab (USAN/INN)", "D11611  Infigratinib phosphate (USAN)", "D11764  Necuparanib (USAN/INN)", "D11765  Necuparanib sodium (USAN)", "D12650  Zanzalintinib (USAN/INN)", "D12651  Zanzalintinib fumarate (USAN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["960  CD44; CD44 molecule (IN blood group) [KO:K06256]", "6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "2017  CTTN; cortactin [KO:K06106]", "3059  HCLS1; hematopoietic cell-specific Lyn substrate 1 [KO:K06106]", "2064  ERBB2; erb-b2 receptor tyrosine kinase 2 [KO:K05083] [EC:2.7.10.1]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "10451  VAV3; vav guanine nucleotide exchange factor 3 [KO:K05730]", "7409  VAV1; vav guanine nucleotide exchange factor 1 [KO:K05730]", "7410  VAV2; vav guanine nucleotide exchange factor 2 [KO:K05730]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "6237  RRAS; RAS related [KO:K07829]", "22800  RRAS2; RAS related 2 [KO:K07830]", "22808  MRAS; muscle RAS oncogene homolog [KO:K07831]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "369  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "8826  IQGAP1; IQ motif containing GTPase activating protein 1 [KO:K16848]", "998  CDC42; cell division cycle 42 [KO:K04393]", "2002  ELK1; ETS transcription factor ELK1 [KO:K04375]", "2099  ESR1; estrogen receptor 1 [KO:K08550]", "595  CCND1; cyclin D1 [KO:K04503]", "71  ACTG1; actin gamma 1 [KO:K05692]", "60  ACTB; actin beta [KO:K05692]", "2316  FLNA; filamin A [KO:K04437]", "5058  PAK1; p21 (RAC1) activated kinase 1 [KO:K04409] [EC:2.7.11.1]", "7074  TIAM1; TIAM Rac1 associated GEF 1 [KO:K05731]", "9138  ARHGEF1; Rho guanine nucleotide exchange factor 1 [KO:K12330]", "387  RHOA; ras homolog family member A [KO:K04513]", "6093  ROCK1; Rho associated coiled-coil containing protein kinase 1 [KO:K04514] [EC:2.7.11.1]", "9475  ROCK2; Rho associated coiled-coil containing protein kinase 2 [KO:K17388] [EC:2.7.11.1]", "286  ANK1; ankyrin 1 [KO:K10380]", "287  ANK2; ankyrin 2 [KO:K09255]", "288  ANK3; ankyrin 3 [KO:K09259]", "2549  GAB1; GRB2 associated binding protein 1 [KO:K09593]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "6548  SLC9A1; solute carrier family 9 member A1 [KO:K05742]", "5499  PPP1CA; protein phosphatase 1 catalytic subunit alpha [KO:K06269] [EC:3.1.3.16]", "5500  PPP1CB; protein phosphatase 1 catalytic subunit beta [KO:K06269] [EC:3.1.3.16]", "5501  PPP1CC; protein phosphatase 1 catalytic subunit gamma [KO:K06269] [EC:3.1.3.16]", "4659  PPP1R12A; protein phosphatase 1 regulatory subunit 12A [KO:K06270]", "4660  PPP1R12B; protein phosphatase 1 regulatory subunit 12B [KO:K12329]", "54776  PPP1R12C; protein phosphatase 1 regulatory subunit 12C [KO:K17457]", "23365  ARHGEF12; Rho guanine nucleotide exchange factor 12 [KO:K07532]", "51196  PLCE1; phospholipase C epsilon 1 [KO:K05860] [EC:3.1.4.11]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "815  CAMK2A; calcium/calmodulin dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]", "817  CAMK2D; calcium/calmodulin dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]", "816  CAMK2B; calcium/calmodulin dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]", "818  CAMK2G; calcium/calmodulin dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]", "79923  NANOG; Nanog homeobox [KO:K10164]", "388112  NANOGP8; Nanog homeobox retrogene P8 [KO:K10164]", "1655  DDX5; DEAD-box helicase 5 [KO:K12823] [EC:5.6.2.7]", "29102  DROSHA; drosha ribonuclease III [KO:K03685] [EC:3.1.26.3]", "6774  STAT3; signal transducer and activator of transcription 3 [KO:K04692]", "406991  MIR21; microRNA 21 [KO:K16863]", "7291  TWIST1; twist family bHLH transcription factor 1 [KO:K09069]", "117581  TWIST2; twist family bHLH transcription factor 2 [KO:K09069]", "406902  MIR10A; microRNA 10a [KO:K16864]", "406903  MIR10B; microRNA 10b [KO:K17393]", "3236  HOXD10; homeobox D10 [KO:K09295]", "1634  DCN; decorin [KO:K04660]", "3479  IGF1; insulin like growth factor 1 [KO:K05459]", "3480  IGF1R; insulin like growth factor 1 receptor [KO:K05087] [EC:2.7.10.1]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "5170  PDPK1; 3-phosphoinositide dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]", "6198  RPS6KB1; ribosomal protein S6 kinase B1 [KO:K04688] [EC:2.7.11.1]", "6199  RPS6KB2; ribosomal protein S6 kinase B2 [KO:K04688] [EC:2.7.11.1]", "1975  EIF4B; eukaryotic translation initiation factor 4B [KO:K03258]", "6194  RPS6; ribosomal protein S6 [KO:K02991]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "857  CAV1; caveolin 1 [KO:K06278]", "858  CAV2; caveolin 2 [KO:K12958]", "859  CAV3; caveolin 3 [KO:K12959]", "967  CD63; CD63 molecule [KO:K06497]", "1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "7040  TGFB1; transforming growth factor beta 1 [KO:K13375]", "7097  TLR2; toll like receptor 2 [KO:K10159]", "7099  TLR4; toll like receptor 4 [KO:K10160]", "27250  PDCD4; programmed cell death 4 [KO:K16865]", "7124  TNF; tumor necrosis factor [KO:K03156]", "3593  IL12B; interleukin 12B [KO:K05425]", "2065  ERBB3; erb-b2 receptor tyrosine kinase 3 [KO:K05084] [EC:2.7.10.1]", "2066  ERBB4; erb-b2 receptor tyrosine kinase 4 [KO:K05085] [EC:2.7.10.1]", "4609  MYC; MYC proto-oncogene, bHLH transcription factor [KO:K04377]", "1499  CTNNB1; catenin beta 1 [KO:K02105]", "3091  HIF1A; hypoxia inducible factor 1 subunit alpha [KO:K08268]", "7023  TFAP4; transcription factor AP-4 [KO:K09108]", "7422  VEGFA; vascular endothelial growth factor A [KO:K05448]", "3791  KDR; kinase insert domain receptor [KO:K05098] [EC:2.7.10.1]", "4233  MET; MET proto-oncogene, receptor tyrosine kinase [KO:K05099] [EC:2.7.10.1]", "867  CBL; Cbl proto-oncogene [KO:K04707] [EC:2.3.2.27]", "7078  TIMP3; TIMP metallopeptidase inhibitor 3 [KO:K16866]", "7057  THBS1; thrombospondin 1 [KO:K16857]", "4313  MMP2; matrix metallopeptidase 2 [KO:K01398] [EC:3.4.24.24]", "4318  MMP9; matrix metallopeptidase 9 [KO:K01403] [EC:3.4.24.35]", "4060  LUM; lumican [KO:K08122]", "356  FASLG; Fas ligand [KO:K04389]", "355  FAS; Fas cell surface death receptor [KO:K04390]", "4193  MDM2; MDM2 proto-oncogene [KO:K06643] [EC:2.3.2.27]", "7157  TP53; tumor protein p53 [KO:K04451]", "7042  TGFB2; transforming growth factor beta 2 [KO:K13376]", "4087  SMAD2; SMAD family member 2 [KO:K04500]", "10855  HPSE; heparanase [KO:K07964] [EC:3.2.1.166]", "60495  HPSE2; heparanase 2 (inactive) [KO:K07965] [EC:3.2.1.-]", "6382  SDC1; syndecan 1 [KO:K06257]", "5328  PLAU; plasminogen activator, urokinase [KO:K01348] [EC:3.4.21.73]", "5329  PLAUR; plasminogen activator, urokinase receptor [KO:K03985]", "1277  COL1A1; collagen type I alpha 1 chain [KO:K06236]", "1278  COL1A2; collagen type I alpha 2 chain [KO:K06236]", "3673  ITGA2; integrin subunit alpha 2 [KO:K06481]", "3688  ITGB1; integrin subunit beta 1 [KO:K05719]", "7448  VTN; vitronectin [KO:K06251]", "3685  ITGAV; integrin subunit alpha V [KO:K06487]", "3690  ITGB3; integrin subunit beta 3 [KO:K06493]", "2335  FN1; fibronectin 1 [KO:K05717]", "3693  ITGB5; integrin subunit beta 5 [KO:K06588]", "3082  HGF; hepatocyte growth factor [KO:K05460]", "7471  WNT1; Wnt family member 1 [KO:K03209]", "8321  FZD1; frizzled class receptor 1 [KO:K02432]", "8324  FZD7; frizzled class receptor 7 [KO:K02432]", "2535  FZD2; frizzled class receptor 2 [KO:K02235]", "7976  FZD3; frizzled class receptor 3 [KO:K02329]", "8322  FZD4; frizzled class receptor 4 [KO:K02354]", "7855  FZD5; frizzled class receptor 5 [KO:K02375]", "8325  FZD8; frizzled class receptor 8 [KO:K02375]", "8323  FZD6; frizzled class receptor 6 [KO:K02376]", "11211  FZD10; frizzled class receptor 10 [KO:K02842]", "8326  FZD9; frizzled class receptor 9 [KO:K02842]", "3678  ITGA5; integrin subunit alpha 5 [KO:K06484]", "6383  SDC2; syndecan 2 [KO:K16336]", "7430  EZR; ezrin [KO:K08007]", "5962  RDX; radixin [KO:K05762]", "4478  MSN; moesin [KO:K05763]", "6385  SDC4; syndecan 4 [KO:K16338]", "2247  FGF2; fibroblast growth factor 2 [KO:K18497]", "2260  FGFR1; fibroblast growth factor receptor 1 [KO:K04362] [EC:2.7.10.1]", "10818  FRS2; fibroblast growth factor receptor substrate 2 [KO:K12461]", "5781  PTPN11; protein tyrosine phosphatase non-receptor type 11 [KO:K07293] [EC:3.1.3.48]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "84309  NUDT16L1; nudix hydrolase 16 like 1 [KO:K16867]", "5829  PXN; paxillin [KO:K05760]", "5747  PTK2; protein tyrosine kinase 2 [KO:K05725] [EC:2.7.10.2]", "1839  HBEGF; heparin binding EGF like growth factor [KO:K08523]", "2817  GPC1; glypican 1 [KO:K08107]", "3481  IGF2; insulin like growth factor 2 [KO:K13769]", "2719  GPC3; glypican 3 [KO:K08109]", "7472  WNT2; Wnt family member 2 [KO:K00182]", "7482  WNT2B; Wnt family member 2B [KO:K00182]", "7473  WNT3; Wnt family member 3 [KO:K00312]", "89780  WNT3A; Wnt family member 3A [KO:K00312]", "54361  WNT4; Wnt family member 4 [KO:K00408]", "7474  WNT5A; Wnt family member 5A [KO:K00444]", "81029  WNT5B; Wnt family member 5B [KO:K00444]", "7475  WNT6; Wnt family member 6 [KO:K00445]", "7476  WNT7A; Wnt family member 7A [KO:K00572]", "7477  WNT7B; Wnt family member 7B [KO:K00572]", "7478  WNT8A; Wnt family member 8A [KO:K00714]", "7479  WNT8B; Wnt family member 8B [KO:K00714]", "7483  WNT9A; Wnt family member 9A [KO:K01064]", "7484  WNT9B; Wnt family member 9B [KO:K01064]", "7480  WNT10B; Wnt family member 10B [KO:K01357]", "80326  WNT10A; Wnt family member 10A [KO:K01357]", "7481  WNT11; Wnt family member 11 [KO:K01384]", "51384  WNT16; Wnt family member 16 [KO:K01558]", "6469  SHH; sonic hedgehog signaling molecule [KO:K11988]", "3549  IHH; Indian hedgehog signaling molecule [KO:K11989]", "5727  PTCH1; patched 1 [KO:K06225]", "6608  SMO; smoothened, frizzled class receptor [KO:K06226]", "3339  HSPG2; heparan sulfate proteoglycan 2 [KO:K06255]", "1514  CTSL; cathepsin L [KO:K01365] [EC:3.4.22.15]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "3316  HSPB2; heat shock protein family B (small) member 2 [KO:K09543]", "5777  PTPN6; protein tyrosine phosphatase non-receptor type 6 [KO:K05697] [EC:3.1.3.48]"], "compound": ["C00426  Dermatan sulfate", "C00573  Keratan sulfate", "C00607  Chondroitin sulfate", "C00925  Heparan sulfate", "G10505  Hyaluronic acid", "G13063  Binding domain for FGF2 in heparin/heparan sulfate", "G13064  Binding domain for HGF in heparin/heparan sulfate"], "refs": [{"pmid": "18450475", "authors": "  Bourguignon LY", "title": "Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression.", "journal": "Semin Cancer Biol 18:251-9 (2008)", "doi": "10.1016/j.semcancer.2008.03.007"}, {"pmid": "12729888", "authors": "  Briggs MW, Sacks DB", "title": "IQGAP1 as signal integrator: Ca2+, calmodulin, Cdc42 and the cytoskeleton.", "journal": "FEBS Lett 542:7-11 (2003)", "doi": "10.1016/S0014-5793(03)00333-8"}, {"pmid": "12748184", "authors": "  Bourguignon LY, Singleton PA, Zhu H, Diedrich F", "title": "Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression.", "journal": "J Biol Chem 278:29420-34 (2003)", "doi": "10.1074/jbc.M301885200"}, {"pmid": "15655247", "authors": "  Bourguignon LY, Gilad E, Rothman K, Peyrollier K", "title": "Hyaluronan-CD44 interaction with IQGAP1 promotes Cdc42 and ERK signaling, leading to actin binding, Elk-1/estrogen receptor transcriptional activation, and ovarian cancer progression.", "journal": "J Biol Chem 280:11961-72 (2005)", "doi": "10.1074/jbc.M411985200"}, {"pmid": "11717317", "authors": "  Turley EA, Noble PW, Bourguignon LY", "title": "Signaling properties of hyaluronan receptors.", "journal": "J Biol Chem 277:4589-92 (2002)", "doi": "10.1074/jbc.R100038200"}, {"pmid": "9346940", "authors": "  Bourguignon LY, Zhu H, Chu A, Iida N, Zhang L, Hung MC", "title": "Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation.", "journal": "J Biol Chem 272:27913-8 (1997)", "doi": "10.1074/jbc.272.44.27913"}, {"pmid": "22735579", "authors": "  Neill T, Schaefer L, Iozzo RV", "title": "Decorin: a guardian from the matrix.", "journal": "Am J Pathol 181:380-7 (2012)", "doi": "10.1016/j.ajpath.2012.04.029"}, {"pmid": "22194599", "authors": "  Neill T, Painter H, Buraschi S, Owens RT, Lisanti MP, Schaefer L, Iozzo RV", "title": "Decorin antagonizes the angiogenic network: concurrent inhibition of Met, hypoxia inducible factor 1alpha, vascular endothelial growth factor A, and induction of thrombospondin-1 and TIMP3.", "journal": "J Biol Chem 287:5492-506 (2012)", "doi": "10.1074/jbc.M111.283499"}, {"pmid": "19433454", "authors": "  Goldoni S, Humphries A, Nystrom A, Sattar S, Owens RT, McQuillan DJ, Ireton K, Iozzo RV", "title": "Decorin is a novel antagonistic ligand of the Met receptor.", "journal": "J Cell Biol 185:743-54 (2009)", "doi": "10.1083/jcb.200901129"}, {"pmid": "15994311", "authors": "  Zhu JX, Goldoni S, Bix G, Owens RT, McQuillan DJ, Reed CC, Iozzo RV", "title": "Decorin evokes protracted internalization and degradation of the epidermal growth factor receptor via caveolar endocytosis.", "journal": "J Biol Chem 280:32468-79 (2005)", "doi": "10.1074/jbc.M503833200"}, {"pmid": "20974860", "authors": "  Buraschi S, Pal N, Tyler-Rubinstein N, Owens RT, Neill T, Iozzo RV", "title": "Decorin antagonizes Met receptor activity and down-regulates {beta}-catenin and Myc levels.", "journal": "J Biol Chem 285:42075-85 (2010)", "doi": "10.1074/jbc.M110.172841"}, {"pmid": "18798267", "authors": "  Goldoni S, Iozzo RV", "title": "Tumor microenvironment: Modulation by decorin and related molecules harboring leucine-rich tandem motifs.", "journal": "Int J Cancer 123:2473-9 (2008)", "doi": "10.1002/ijc.23930"}, {"pmid": "23058688", "authors": "  Sofeu Feugaing DD, Gotte M, Viola M", "title": "More than matrix: the multifaceted role of decorin in cancer.", "journal": "Eur J Cell Biol 92:1-11 (2013)", "doi": "10.1016/j.ejcb.2012.08.004"}, {"pmid": "22087031", "authors": "  Merline R, Moreth K, Beckmann J, Nastase MV, Zeng-Brouwers J, Tralhao JG, Lemarchand P, Pfeilschifter J, Schaefer RM, Iozzo RV, Schaefer L", "title": "Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and MicroRNA-21.", "journal": "Sci Signal 4:ra75 (2011)", "doi": "10.1126/scisignal.2001868"}, {"pmid": "22033227", "authors": "  Teng YH, Aquino RS, Park PW", "title": "Molecular functions of syndecan-1 in disease.", "journal": "Matrix Biol 31:3-16 (2012)", "doi": "10.1016/j.matbio.2011.10.001"}, {"pmid": "11830493", "authors": "  Derksen PW, Keehnen RM, Evers LM, van Oers MH, Spaargaren M, Pals ST", "title": "Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma.", "journal": "Blood 99:1405-10 (2002)", "doi": "10.1182/blood.V99.4.1405"}, {"pmid": "19733083", "authors": "  Fux L, Ilan N, Sanderson RD, Vlodavsky I", "title": "Heparanase: busy at the cell surface.", "journal": "Trends Biochem Sci 34:511-9 (2009)", "doi": "10.1016/j.tibs.2009.06.005"}, {"pmid": "18812315", "authors": "  Purushothaman A, Chen L, Yang Y, Sanderson RD", "title": "Heparanase stimulation of protease expression implicates it as a master regulator of the aggressive tumor phenotype in myeloma.", "journal": "J Biol Chem 283:32628-36 (2008)", "doi": "10.1074/jbc.M806266200"}, {"pmid": "19255147", "authors": "  Beauvais DM, Ell BJ, McWhorter AR, Rapraeger AC", "title": "Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor.", "journal": "J Exp Med 206:691-705 (2009)", "doi": "10.1084/jem.20081278"}, {"pmid": "20655987", "authors": "  Mahtouk K, Tjin EP, Spaargaren M, Pals ST", "title": "The HGF/MET pathway as target for the treatment of multiple myeloma and B-cell lymphomas.", "journal": "Biochim Biophys Acta 1806:208-19 (2010)", "doi": "10.1016/j.bbcan.2010.07.006"}, {"pmid": "11931647", "authors": "  Munesue S, Kusano Y, Oguri K, Itano N, Yoshitomi Y, Nakanishi H, Yamashina I, Okayama M", "title": "The role of syndecan-2 in regulation of actin-cytoskeletal organization of Lewis lung carcinoma-derived metastatic clones.", "journal": "Biochem J 363:201-9 (2002)", "doi": "10.1042/bj3630201"}, {"pmid": "10687947", "authors": "  Nugent MA, Iozzo RV", "title": "Fibroblast growth factor-2.", "journal": "Int J Biochem Cell Biol 32:115-20 (2000)", "doi": "10.1016/S1357-2725(99)00123-5"}, {"pmid": "12509413", "authors": "  Thodeti CK, Albrechtsen R, Grauslund M, Asmar M, Larsson C, Takada Y, Mercurio AM, Couchman JR, Wewer UM", "title": "ADAM12/syndecan-4 signaling promotes beta 1 integrin-dependent cell spreading through protein kinase Calpha and RhoA.", "journal": "J Biol Chem 278:9576-84 (2003)", "doi": "10.1074/jbc.M208937200"}, {"pmid": "14711376", "authors": "  Beauvais DM, Rapraeger AC", "title": "Syndecans in tumor cell adhesion and signaling.", "journal": "Reprod Biol Endocrinol 2:3 (2004)", "doi": "10.1186/1477-7827-2-3"}, {"pmid": "17971838", "authors": "  Morgan MR, Humphries MJ, Bass MD", "title": "Synergistic control of cell adhesion by integrins and syndecans.", "journal": "Nat Rev Mol Cell Biol 8:957-69 (2007)", "doi": "10.1038/nrm2289"}, {"pmid": "18505598", "authors": "  Filmus J, Capurro M, Rast J", "title": "Glypicans.", "journal": "Genome Biol 9:224 (2008)", "doi": "10.1186/gb-2008-9-5-224"}, {"pmid": "23305321", "authors": "  Filmus J, Capurro M", "title": "Glypican-3: a marker and a therapeutic target in hepatocellular carcinoma.", "journal": "FEBS J 280:2471-6 (2013)", "doi": "10.1111/febs.12126"}, {"pmid": "24412155", "authors": "  Filmus J, Capurro M", "title": "The role of glypicans in Hedgehog signaling.", "journal": "Matrix Biol 35:248-52 (2014)", "doi": "10.1016/j.matbio.2013.12.007"}, {"pmid": "18413366", "authors": "  Cheng W, Tseng CJ, Lin TT, Cheng I, Pan HW, Hsu HC, Lee YM", "title": "Glypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathway.", "journal": "Carcinogenesis 29:1319-26 (2008)", "doi": "10.1093/carcin/bgn091"}, {"pmid": "21155971", "authors": "  Iozzo RV, Sanderson RD", "title": "Proteoglycans in cancer biology, tumour microenvironment and angiogenesis.", "journal": "J Cell Mol Med 15:1013-31 (2011)", "doi": "10.1111/j.1582-4934.2010.01236.x"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04066  HIF-1 signaling pathway", "hsa04150  mTOR signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04210  Apoptosis", "hsa04310  Wnt signaling pathway", "hsa04340  Hedgehog signaling pathway", "hsa04350  TGF-beta signaling pathway", "hsa04370  VEGF signaling pathway", "hsa04510  Focal adhesion", "hsa04520  Adherens junction", "hsa04810  Regulation of actin cytoskeleton"], "ko_pathway": "ko05205", "genes": ["SDC4", "EGFR", "RAC1", "TP53", "BRAF", "EZR", "CD44", "ANK1", "AKT2", "MET", "AKT1", "SOS1", "MAPK13", "KDR", "NRAS"]}, {"kegg_id": "hsa05418", "name": "Fluid shear stress and atherosclerosis - Homo sapiens (human)", "description": "Shear stress represents the frictional force that the flow of blood exerts at the endothelial surface of the vessel wall and plays a central role in vascular biology and contributes to the progress of atherosclerosis. Sustained laminar flow with high shear stress upregulates expressions of endothelial cell (EC) genes and proteins that are protective against atherosclerosis. The key shear stress-induced transcription factors that govern the expression of these genes are Kruppel-like factor 2 (KLF2) and nuclear factor erythroid 2-like 2 (Nrf2). On the other hand, disturbed flow with associated reciprocating, low shear stress generally upregulates the EC genes and proteins that promote oxidative and inflammatory states in the artery wall, resulting in atherogenesis. Important transcriptional events that reflect this condition of ECs in disturbed flow include the activation of activator protein 1 (AP-1) and nuclear factor kappaB (NF-kappaB).", "class": "Human Diseases; Cardiovascular disease", "pathway_map": "hsa05418  Fluid shear stress and atherosclerosis", "drug": ["D09670  Sotatercept (USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["3320  HSP90AA1; heat shock protein 90 alpha family class A member 1 [KO:K04079]", "3326  HSP90AB1; heat shock protein 90 alpha family class B member 1 [KO:K04079]", "7184  HSP90B1; heat shock protein 90 beta family member 1 [KO:K09487]", "4846  NOS3; nitric oxide synthase 3 [KO:K13242] [EC:1.14.13.39]", "857  CAV1; caveolin 1 [KO:K06278]", "858  CAV2; caveolin 2 [KO:K12958]", "859  CAV3; caveolin 3 [KO:K12959]", "810  CALML3; calmodulin like 3 [KO:K02183]", "805  CALM2; calmodulin 2 [KO:K02183]", "808  CALM3; calmodulin 3 [KO:K02183]", "801  CALM1; calmodulin 1 [KO:K02183]", "163688  CALML6; calmodulin like 6 [KO:K02183]", "51806  CALML5; calmodulin like 5 [KO:K02183]", "91860  CALML4; calmodulin like 4 [KO:K02183]", "2817  GPC1; glypican 1 [KO:K08107]", "6382  SDC1; syndecan 1 [KO:K06257]", "6383  SDC2; syndecan 2 [KO:K16336]", "6385  SDC4; syndecan 4 [KO:K16338]", "59341  TRPV4; transient receptor potential cation channel subfamily V member 4 [KO:K04973]", "9817  KEAP1; kelch like ECH associated protein 1 [KO:K10456]", "4780  NFE2L2; NFE2 like bZIP transcription factor 2 [KO:K05638]", "3162  HMOX1; heme oxygenase 1 [KO:K00510] [EC:1.14.14.18]", "221357  GSTA5; glutathione S-transferase alpha 5 [KO:K00799] [EC:2.5.1.18]", "2939  GSTA2; glutathione S-transferase alpha 2 [KO:K00799] [EC:2.5.1.18]", "2941  GSTA4; glutathione S-transferase alpha 4 [KO:K00799] [EC:2.5.1.18]", "119391  GSTO2; glutathione S-transferase omega 2 [KO:K00799] [EC:2.5.1.18]", "2948  GSTM4; glutathione S-transferase mu 4 [KO:K00799] [EC:2.5.1.18]", "2953  GSTT2; glutathione S-transferase theta 2 (gene/pseudogene) [KO:K00799] [EC:2.5.1.18]", "2952  GSTT1; glutathione S-transferase theta 1 [KO:K00799] [EC:2.5.1.18]", "2947  GSTM3; glutathione S-transferase mu 3 [KO:K00799] [EC:2.5.1.18]", "4257  MGST1; microsomal glutathione S-transferase 1 [KO:K00799] [EC:2.5.1.18]", "4259  MGST3; microsomal glutathione S-transferase 3 [KO:K00799] [EC:2.5.1.18]", "2944  GSTM1; glutathione S-transferase mu 1 [KO:K00799] [EC:2.5.1.18]", "2949  GSTM5; glutathione S-transferase mu 5 [KO:K00799] [EC:2.5.1.18]", "4258  MGST2; microsomal glutathione S-transferase 2 [KO:K00799] [EC:2.5.1.18]", "2938  GSTA1; glutathione S-transferase alpha 1 [KO:K00799] [EC:2.5.1.18]", "2946  GSTM2; glutathione S-transferase mu 2 [KO:K00799] [EC:2.5.1.18]", "2940  GSTA3; glutathione S-transferase alpha 3 [KO:K00799] [EC:2.5.1.18]", "9446  GSTO1; glutathione S-transferase omega 1 [KO:K00799] [EC:2.5.1.18]", "653689  GSTT2B; glutathione S-transferase theta 2B [KO:K00799] [EC:2.5.1.18]", "2950  GSTP1; glutathione S-transferase pi 1 [KO:K23790] [EC:2.5.1.18]", "1728  NQO1; NAD(P)H quinone dehydrogenase 1 [KO:K00355] [EC:1.6.5.2]", "8878  SQSTM1; sequestosome 1 [KO:K14381]", "7295  TXN; thioredoxin [KO:K03671]", "25828  TXN2; thioredoxin 2 [KO:K03671]", "4880  NPPC; natriuretic peptide C [KO:K12336]", "445  ASS1; argininosuccinate synthase 1 [KO:K01940] [EC:6.3.4.5]", "7056  THBD; thrombomodulin [KO:K03907]", "5327  PLAT; plasminogen activator, tissue type [KO:K01343] [EC:3.4.21.68]", "1003  CDH5; cadherin 5 [KO:K06533]", "3791  KDR; kinase insert domain receptor [KO:K05098] [EC:2.7.10.1]", "1499  CTNNB1; catenin beta 1 [KO:K02105]", "5562  PRKAA1; protein kinase AMP-activated catalytic subunit alpha 1 [KO:K07198] [EC:2.7.11.31]", "5563  PRKAA2; protein kinase AMP-activated catalytic subunit alpha 2 [KO:K07198] [EC:2.7.11.31]", "5175  PECAM1; platelet and endothelial cell adhesion molecule 1 [KO:K06471]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "5607  MAP2K5; mitogen-activated protein kinase kinase 5 [KO:K04463] [EC:2.7.12.2]", "5598  MAPK7; mitogen-activated protein kinase 7 [KO:K04464] [EC:2.7.11.24]", "4205  MEF2A; myocyte enhancer factor 2A [KO:K09260]", "4208  MEF2C; myocyte enhancer factor 2C [KO:K04454]", "10365  KLF2; KLF transcription factor 2 [KO:K17845]", "3674  ITGA2B; integrin subunit alpha 2b [KO:K06476]", "3685  ITGAV; integrin subunit alpha V [KO:K06487]", "3690  ITGB3; integrin subunit beta 3 [KO:K06493]", "6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "5747  PTK2; protein tyrosine kinase 2 [KO:K05725] [EC:2.7.10.2]", "9181  ARHGEF2; Rho/Rac guanine nucleotide exchange factor 2 [KO:K12791]", "387  RHOA; ras homolog family member A [KO:K04513]", "71  ACTG1; actin gamma 1 [KO:K05692]", "60  ACTB; actin beta [KO:K05692]", "1843  DUSP1; dual specificity phosphatase 1 [KO:K21278] [EC:3.1.3.16 3.1.3.48]", "406902  MIR10A; microRNA 10a [KO:K16864]", "7132  TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158]", "3554  IL1R1; interleukin 1 receptor type 1 [KO:K04386]", "7850  IL1R2; interleukin 1 receptor type 2 [KO:K04387]", "6885  MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO:K04427] [EC:2.7.11.25]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "4217  MAP3K5; mitogen-activated protein kinase kinase kinase 5 [KO:K04426] [EC:2.7.11.25]", "6416  MAP2K4; mitogen-activated protein kinase kinase 4 [KO:K04430] [EC:2.7.12.2]", "5609  MAP2K7; mitogen-activated protein kinase kinase 7 [KO:K04431] [EC:2.7.12.2]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "5608  MAP2K6; mitogen-activated protein kinase kinase 6 [KO:K04433] [EC:2.7.12.2]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "4313  MMP2; matrix metallopeptidase 2 [KO:K01398] [EC:3.4.24.24]", "4318  MMP9; matrix metallopeptidase 9 [KO:K01403] [EC:3.4.24.35]", "1514  CTSL; cathepsin L [KO:K01365] [EC:3.4.22.15]", "6347  CCL2; C-C motif chemokine ligand 2 [KO:K14624]", "7412  VCAM1; vascular cell adhesion molecule 1 [KO:K06527]", "3383  ICAM1; intercellular adhesion molecule 1 [KO:K06490]", "6401  SELE; selectin E [KO:K06494]", "7124  TNF; tumor necrosis factor [KO:K03156]", "3552  IL1A; interleukin 1 alpha [KO:K04383]", "3553  IL1B; interleukin 1 beta [KO:K04519]", "3458  IFNG; interferon gamma [KO:K04687]", "5154  PDGFA; platelet derived growth factor subunit A [KO:K04359]", "5155  PDGFB; platelet derived growth factor subunit B [KO:K17386]", "1906  EDN1; endothelin 1 [KO:K16366]", "7422  VEGFA; vascular endothelial growth factor A [KO:K05448]", "652  BMP4; bone morphogenetic protein 4 [KO:K04662]", "659  BMPR2; bone morphogenetic protein receptor type 2 [KO:K04671] [EC:2.7.11.30]", "92  ACVR2A; activin A receptor type 2A [KO:K04670] [EC:2.7.11.30]", "93  ACVR2B; activin A receptor type 2B [KO:K13596] [EC:2.7.11.30]", "90  ACVR1; activin A receptor type 1 [KO:K04675] [EC:2.7.11.30]", "657  BMPR1A; bone morphogenetic protein receptor type 1A [KO:K04673] [EC:2.7.11.30]", "658  BMPR1B; bone morphogenetic protein receptor type 1B [KO:K13578] [EC:2.7.11.30]", "27035  NOX1; NADPH oxidase 1 [KO:K08008]", "1535  CYBA; cytochrome b-245 alpha chain [KO:K08009]", "653361  NCF1; neutrophil cytosolic factor 1 [KO:K08011]", "4688  NCF2; neutrophil cytosolic factor 2 [KO:K08010]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "5880  RAC2; Rac family small GTPase 2 [KO:K07860]", "5881  RAC3; Rac family small GTPase 3 [KO:K07861]", "5590  PRKCZ; protein kinase C zeta [KO:K18952] [EC:2.7.11.13]", "51588  PIAS4; protein inhibitor of activated STAT 4 [KO:K16065] [EC:2.3.2.27]", "7157  TP53; tumor protein p53 [KO:K04451]", "6612  SUMO3; small ubiquitin like modifier 3 [KO:K12160]", "6613  SUMO2; small ubiquitin like modifier 2 [KO:K12160]", "7341  SUMO1; small ubiquitin like modifier 1 [KO:K12160]", "387082  SUMO4; small ubiquitin like modifier 4 [KO:K12160]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]"], "compound": ["C00076  Calcium cation", "C00272  Tetrahydrobiopterin", "C00518  Hyaluronate", "C00533  Nitric oxide", "C00607  Chondroitin sulfate", "C00704  Superoxide", "C00925  Heparan sulfate", "C16845  Peroxynitrite"], "refs": [{"pmid": "21050140", "authors": "  Nigro P, Abe J, Berk BC", "title": "Flow shear stress and atherosclerosis: a matter of site specificity.", "journal": "Antioxid Redox Signal 15:1405-14 (2011)", "doi": "10.1089/ars.2010.3679"}, {"pmid": "26597822", "authors": "  McSweeney SR, Warabi E, Siow RC", "title": "Nrf2 as an Endothelial Mechanosensitive Transcription Factor: Going With the Flow.", "journal": "Hypertension 67:20-9 (2016)", "doi": "10.1161/HYPERTENSIONAHA.115.06146"}, {"pmid": "22076424", "authors": "  Heo KS, Fujiwara K, Abe J", "title": "Disturbed-flow-mediated vascular reactive oxygen species induce endothelial dysfunction.", "journal": "Circ J 75:2722-30 (2011)", "doi": "10.1253/circj.CJ-11-1124"}, {"pmid": "24573382", "authors": "  Wild J, Soehnlein O, Dietel B, Urschel K, Garlichs CD, Cicha I", "title": "Rubbing salt into wounded endothelium: sodium potentiates proatherogenic effects of TNF-alpha under non-uniform shear stress.", "journal": "Thromb Haemost 112:183-95 (2014)", "doi": "10.1160/TH13-11-0908"}, {"pmid": "21457103", "authors": "  Noguchi N, Jo H", "title": "Redox going with vascular shear stress.", "journal": "Antioxid Redox Signal 15:1367-8 (2011)", "doi": "10.1089/ars.2011.4011"}, {"pmid": "25165867", "authors": "  Li X, Yang Q, Wang Z, Wei D", "title": "Shear stress in atherosclerotic plaque determination.", "journal": "DNA Cell Biol 33:830-8 (2014)", "doi": "10.1089/dna.2014.2480"}, {"pmid": "17599600", "authors": "  Chatzizisis YS, Coskun AU, Jonas M, Edelman ER, Feldman CL, Stone PH", "title": "Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior.", "journal": "J Am Coll Cardiol 49:2379-93 (2007)", "doi": "10.1016/j.jacc.2007.02.059"}, {"pmid": "21733876", "authors": "  Lu D, Kassab GS", "title": "Role of shear stress and stretch in vascular mechanobiology.", "journal": "J R Soc Interface 8:1379-85 (2011)", "doi": "10.1098/rsif.2011.0177"}, {"pmid": "27027326", "authors": "  Givens C, Tzima E", "title": "Endothelial Mechanosignaling: Does One Sensor Fit All?", "journal": "Antioxid Redox Signal 25:373-88 (2016)", "doi": "10.1089/ars.2015.6493"}, {"pmid": "16765337", "authors": "  Paravicini TM, Touyz RM", "title": "Redox signaling in hypertension.", "journal": "Cardiovasc Res 71:247-58 (2006)", "doi": "10.1016/j.cardiores.2006.05.001"}, {"pmid": "24947523", "authors": "  Bryan MT, Duckles H, Feng S, Hsiao ST, Kim HR, Serbanovic-Canic J, Evans PC", "title": "Mechanoresponsive networks controlling vascular inflammation.", "journal": "Arterioscler Thromb Vasc Biol 34:2199-205 (2014)", "doi": "10.1161/ATVBAHA.114.303424"}, {"pmid": "26822720", "authors": "  Brown AJ, Teng Z, Evans PC, Gillard JH, Samady H, Bennett MR", "title": "Role of biomechanical forces in the natural history of coronary atherosclerosis.", "journal": "Nat Rev Cardiol 13:210-20 (2016)", "doi": "10.1038/nrcardio.2015.203"}, {"pmid": "24876354", "authors": "  Zhou J, Li YS, Chien S", "title": "Shear stress-initiated signaling and its regulation of endothelial function.", "journal": "Arterioscler Thromb Vasc Biol 34:2191-8 (2014)", "doi": "10.1161/ATVBAHA.114.303422"}, {"pmid": "23429585", "authors": "  Liu HB, Zhang J, Xin SY, Liu C, Wang CY, Zhao D, Zhang ZR", "title": "Mechanosensitive properties in the endothelium and their roles in the regulation of endothelial function.", "journal": "J Cardiovasc Pharmacol 61:461-70 (2013)", "doi": "10.1097/FJC.0b013e31828c0933"}, {"pmid": "20032497", "authors": "  Boon RA, Leyen TA, Fontijn RD, Fledderus JO, Baggen JM, Volger OL, van Nieuw Amerongen GP, Horrevoets AJ", "title": "KLF2-induced actin shear fibers control both alignment to flow and JNK signaling in vascular endothelium.", "journal": "Blood 115:2533-42 (2010)", "doi": "10.1182/blood-2009-06-228726"}, {"pmid": "20353494", "authors": "  Whyte JJ, Laughlin MH", "title": "The effects of acute and chronic exercise on the vasculature.", "journal": "Acta Physiol (Oxf) 199:441-50 (2010)", "doi": "10.1111/j.1748-1716.2010.02127.x"}, {"pmid": "25638487", "authors": "  Quillon A, Fromy B, Debret R", "title": "Endothelium microenvironment sensing leading to nitric oxide mediated vasodilation: a review of nervous and biomechanical signals.", "journal": "Nitric Oxide 45:20-6 (2015)", "doi": "10.1016/j.niox.2015.01.006"}, {"pmid": "15388638", "authors": "  Sorescu GP, Song H, Tressel SL, Hwang J, Dikalov S, Smith DA, Boyd NL, Platt MO, Lassegue B, Griendling KK, Jo H", "title": "Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress induces monocyte adhesion by stimulating reactive oxygen species production from a nox1-based NADPH oxidase.", "journal": "Circ Res 95:773-9 (2004)", "doi": "10.1161/01.RES.0000145728.22878.45"}, {"pmid": "23899566", "authors": "  Hopkins PN", "title": "Molecular biology of atherosclerosis.", "journal": "Physiol Rev 93:1317-542 (2013)", "doi": "10.1152/physrev.00004.2012"}, {"pmid": "22003002", "authors": "  Johnson BD, Mather KJ, Wallace JP", "title": "Mechanotransduction of shear in the endothelium: basic studies and clinical implications.", "journal": "Vasc Med 16:365-77 (2011)", "doi": "10.1177/1358863X11422109"}, {"pmid": "23555159", "authors": "  Hu LS, George J, Wang JH", "title": "Current concepts on the role of nitric oxide in portal hypertension.", "journal": "World J Gastroenterol 19:1707-17 (2013)", "doi": "10.3748/wjg.v19.i11.1707"}, {"pmid": "23084990", "authors": "  Collins C, Guilluy C, Welch C, O'Brien ET, Hahn K, Superfine R, Burridge K, Tzima E", "title": "Localized tensional forces on PECAM-1 elicit a global mechanotransduction response via the integrin-RhoA pathway.", "journal": "Curr Biol 22:2087-94 (2012)", "doi": "10.1016/j.cub.2012.08.051"}, {"pmid": "24190880", "authors": "  Conway DE, Schwartz MA", "title": "Flow-dependent cellular mechanotransduction in atherosclerosis.", "journal": "J Cell Sci 126:5101-9 (2013)", "doi": "10.1242/jcs.138313"}, {"pmid": "26212910", "authors": "  Chen J, Green J, Yurdagul A Jr, Albert P, McInnis MC, Orr AW", "title": "alphavbeta3 Integrins Mediate Flow-Induced NF-kappaB Activation, Proinflammatory Gene Expression, and Early Atherogenic Inflammation.", "journal": "Am J Pathol 185:2575-89 (2015)", "doi": "10.1016/j.ajpath.2015.05.013"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04064  NF-kappa B signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04210  Apoptosis", "hsa04270  Vascular smooth muscle contraction", "hsa04510  Focal adhesion", "hsa04514  Cell adhesion molecules", "hsa04670  Leukocyte transendothelial migration"], "ko_pathway": "ko05418", "genes": ["SDC4", "RAC1", "TP53", "AKT2", "AKT1", "MAPK13", "KDR"]}, {"kegg_id": "hsa00510", "name": "N-Glycan biosynthesis - Homo sapiens (human)", "description": "N-glycans or asparagine-linked glycans are major constituents of glycoproteins in eukaryotes. N-glycans are covalently attached to asparagine with the consensus sequence of Asn-X-Ser/Thr by an N-glycosidic bond, GlcNAc b1- Asn. Biosynthesis of N-glycans begins on the cytoplasmic face of the ER membrane with the transferase reaction of UDP-GlcNAc and the lipid-like precursor P-Dol (dolichol phosphate) to generate GlcNAc a1- PP-Dol. After sequential addition of monosaccharides by ALG glycosyltransferases [MD:M00055], the N-glycan precursor is attached by the OST (oligosaccharyltransferase) complex to the polypeptide chain that is being synthesized and translocated through the ER membrane. The protein-bound N-glycan precursor is subsequently trimmed, extended, and modified in the ER and Golgi by a complex series of reactions catalyzed by membrane-bound glycosidases and glycosyltransferases. N-glycans thus synthesized are classified into three types: high-mannose type, complex type, and hybrid type. Defects in N-glycan biosynthesis lead to a variety of human diseases known as congenital disorders of glycosylation [DS:H00118 H00119].", "class": "Metabolism; Glycan biosynthesis and metabolism", "pathway_map": "hsa00510  N-Glycan biosynthesis", "module": ["hsa_M00055  N-glycan precursor biosynthesis [PATH:hsa00510]", "hsa_M00073  N-glycan precursor trimming [PATH:hsa00510]", "hsa_M00075  N-glycan biosynthesis, complex type [PATH:hsa00510]"], "network": ["", "ELEMENT   N00653  N-Glycan precursor biosynthesis, ALG7 to ALG11", "N00667  N-Glycan precursor biosynthesis, Glc-6P to Man-P-Dol", "N00675  N-Glycan precursor biosynthesis, farnesy-PP to P-Dol", "N00680  N-Glycan precursor biosynthesis, ALG3 to ALG9", "N00681  N-Glycan precursor biosynthesis, ALG6 to OST", "N00682  N-Glycan precursor biosynthesis, P-Dol to Glc-P-Dol", "N00820  N-Glycan biosynthesis"], "dblinks": "GO: 0006487", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["79644  SRD5A3; steroid 5 alpha-reductase 3 [KO:K12345] [EC:1.3.1.22 1.3.1.94]", "22845  DOLK; dolichol kinase [KO:K00902] [EC:2.7.1.108]", "1798  DPAGT1; dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 [KO:K01001] [EC:2.7.8.15]", "29880  ALG5; ALG5 dolichyl-phosphate beta-glucosyltransferase [KO:K00729] [EC:2.4.1.117]", "79868  ALG13; ALG13 UDP-N-acetylglucosaminyltransferase subunit [KO:K07432] [EC:2.4.1.141]", "199857  ALG14; ALG14 UDP-N-acetylglucosaminyltransferase subunit [KO:K07441] [EC:2.4.1.141]", "8813  DPM1; dolichyl-phosphate mannosyltransferase subunit 1, catalytic [KO:K00721] [EC:2.4.1.83]", "8818  DPM2; dolichyl-phosphate mannosyltransferase subunit 2, regulatory [KO:K09658]", "54344  DPM3; dolichyl-phosphate mannosyltransferase subunit 3, regulatory [KO:K09659]", "56052  ALG1; ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase [KO:K03842] [EC:2.4.1.142]", "85365  ALG2; ALG2 alpha-1,3/1,6-mannosyltransferase [KO:K03843] [EC:2.4.1.132 2.4.1.257]", "440138  ALG11; ALG11 alpha-1,2-mannosyltransferase [KO:K03844] [EC:2.4.1.131]", "10195  ALG3; ALG3 alpha-1,3- mannosyltransferase [KO:K03845] [EC:2.4.1.258]", "79796  ALG9; ALG9 alpha-1,2-mannosyltransferase [KO:K03846] [EC:2.4.1.259 2.4.1.261]", "79087  ALG12; ALG12 alpha-1,6-mannosyltransferase [KO:K03847] [EC:2.4.1.260]", "29929  ALG6; ALG6 alpha-1,3-glucosyltransferase [KO:K03848] [EC:2.4.1.267]", "79053  ALG8; ALG8 alpha-1,3-glucosyltransferase [KO:K03849] [EC:2.4.1.265]", "84920  ALG10; ALG10 alpha-1,2-glucosyltransferase [KO:K03850] [EC:2.4.1.256]", "144245  ALG10B; ALG10 alpha-1,2-glucosyltransferase B [KO:K03850] [EC:2.4.1.256]", "3703  STT3A; STT3 oligosaccharyltransferase complex catalytic subunit A [KO:K07151] [EC:2.4.99.18]", "201595  STT3B; STT3 oligosaccharyltransferase complex catalytic subunit B [KO:K07151] [EC:2.4.99.18]", "6184  RPN1; ribophorin I [KO:K12666]", "6185  RPN2; ribophorin II [KO:K12667]", "1603  DAD1; defender against cell death 1 [KO:K12668]", "1650  DDOST; dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit [KO:K12670]", "84061  MAGT1; magnesium transporter 1 [KO:K19478]", "7991  TUSC3; tumor suppressor candidate 3 [KO:K19478]", "58505  OSTC; oligosaccharyltransferase complex non-catalytic subunit [KO:K26501]", "746  TMEM258; transmembrane protein 258 [KO:K26502]", "57171  DOLPP1; dolichyldiphosphatase 1 [KO:K07252] [EC:3.6.1.43]", "7841  MOGS; mannosyl-oligosaccharide glucosidase [KO:K01228] [EC:3.2.1.106]", "23193  GANAB; glucosidase II alpha subunit [KO:K05546] [EC:3.2.1.207]", "11253  MAN1B1; mannosidase alpha class 1B member 1 [KO:K23741] [EC:3.2.1.209]", "10905  MAN1A2; mannosidase alpha class 1A member 2 [KO:K01230] [EC:3.2.1.113]", "57134  MAN1C1; mannosidase alpha class 1C member 1 [KO:K01230] [EC:3.2.1.113]", "4121  MAN1A1; mannosidase alpha class 1A member 1 [KO:K01230] [EC:3.2.1.113]", "4245  MGAT1; alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase [KO:K00726] [EC:2.4.1.101]", "4124  MAN2A1; mannosidase alpha class 2A member 1 [KO:K01231] [EC:3.2.1.114]", "4122  MAN2A2; mannosidase alpha class 2A member 2 [KO:K01231] [EC:3.2.1.114]", "4247  MGAT2; alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase [KO:K00736] [EC:2.4.1.143]", "2530  FUT8; fucosyltransferase 8 [KO:K00717] [EC:2.4.1.68]", "2683  B4GALT1; beta-1,4-galactosyltransferase 1 [KO:K07966] [EC:2.4.1.22 2.4.1.90 2.4.1.38 2.4.1.-]", "8704  B4GALT2; beta-1,4-galactosyltransferase 2 [KO:K07967] [EC:2.4.1.22 2.4.1.90 2.4.1.38 2.4.1.-]", "8703  B4GALT3; beta-1,4-galactosyltransferase 3 [KO:K07968] [EC:2.4.1.90 2.4.1.38 2.4.1.-]", "6480  ST6GAL1; ST6 beta-galactoside alpha-2,6-sialyltransferase 1 [KO:K00778] [EC:2.4.3.1]", "84620  ST6GAL2; ST6 beta-galactoside alpha-2,6-sialyltransferase 2 [KO:K00779] [EC:2.4.3.1]", "4248  MGAT3; beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase [KO:K00737] [EC:2.4.1.144]", "11320  MGAT4A; alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A [KO:K00738] [EC:2.4.1.145]", "11282  MGAT4B; alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B [KO:K00738] [EC:2.4.1.145]", "152586  MGAT4D; MGAT4 family member D [KO:K00738] [EC:2.4.1.145]", "4249  MGAT5; alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase [KO:K00744] [EC:2.4.1.155]", "146664  MGAT5B; alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B [KO:K09661] [EC:2.4.1.-]", "25834  MGAT4C; MGAT4 family member C [KO:K13748] [EC:2.4.1.201 2.4.1.145]"], "compound": ["C00096  GDP-mannose", "C00110  Dolichyl phosphate", "C00381  Dolichol", "C00621  Dolichyl diphosphate", "C01246  Dolichyl beta-D-glucosyl phosphate", "C03021  Protein asparagine", "C03862  Dolichyl phosphate D-mannose", "C06081  Polyprenol", "G00001  N-Acetyl-D-glucosaminyldiphosphodolichol", "G00002  N,N'-Chitobiosyldiphosphodolichol", "G00003", "G00004", "G00005", "G00006", "G00007", "G00008", "G00009", "G00010", "G00011", "G00012", "G00013", "G00014", "G00015", "G00016  Core fucose", "G00017", "G00018  DS 3", "G00019", "G00020", "G00021", "G00022", "G00171", "G10526", "G10595", "G10596", "G10597", "G10598", "G10599", "G10694"], "refs": [{"pmid": "9111134", "authors": "  Schutzbach JS.", "title": "The role of the lipid matrix in the biosynthesis of dolichyl-linked oligosaccharides.", "journal": "Glycoconj J 14:175-82 (1997)", "doi": "10.1023/A:1018533620002"}, {"pmid": "12200473", "authors": "  Oriol R, Martinez-Duncker I, Chantret I, Mollicone R, Codogno P.", "title": "Common origin and evolution of glycosyltransferases using Dol-P-monosaccharides as donor substrate.", "journal": "Mol Biol Evol 19:1451-63 (2002)", "doi": "10.1093/oxfordjournals.molbev.a004208"}, {"pmid": "12684507", "authors": "  Thiel C, Schwarz M, Peng J, Grzmil M, Hasilik M, Braulke T, Kohlschutter A, von Figura K, Lehle L, Korner C.", "title": "A new type of congenital disorders of glycosylation (CDG-Ii) provides new insights into the early steps of dolichol-linked oligosaccharide biosynthesis.", "journal": "J Biol Chem 278:22498-505 (2003)", "doi": "10.1074/jbc.M302850200"}, {"pmid": "11278778", "authors": "  Cipollo JF, Trimble RB, Chi JH, Yan Q, Dean N.", "title": "The yeast ALG11 gene specifies addition of the terminal alpha 1,2-Man to the Man5GlcNAc2-PP-dolichol N-glycosylation intermediate formed on the cytosolic side of the endoplasmic reticulum.", "journal": "J Biol Chem 276:21828-40 (2001)", "doi": "10.1074/jbc.M010896200"}, {"pmid": "15987956", "authors": "  Frank CG, Aebi M.", "title": "ALG9 mannosyltransferase is involved in two different steps of lipid-linked oligosaccharide biosynthesis.", "journal": "Glycobiology 15:1156-63 (2005)", "doi": "10.1093/glycob/cwj002"}], "rel_pathway": ["hsa00051  Fructose and mannose metabolism", "hsa00511  Other glycan degradation", "hsa00513  Various types of N-glycan biosynthesis", "hsa00515  Mannose type O-glycan biosynthesis", "hsa00520  Amino sugar and nucleotide sugar metabolism", "hsa00533  Glycosaminoglycan biosynthesis - keratan sulfate", "hsa00563  Glycosylphosphatidylinositol (GPI)-anchor biosynthesis", "hsa00900  Terpenoid backbone biosynthesis"], "ko_pathway": "ko00510", "genes": ["RPN1"]}, {"kegg_id": "hsa00513", "name": "Various types of N-glycan biosynthesis - Homo sapiens (human)", "class": "Metabolism; Glycan biosynthesis and metabolism", "pathway_map": "hsa00513  Various types of N-glycan biosynthesis", "dblinks": "GO: 0006487", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["79868  ALG13; ALG13 UDP-N-acetylglucosaminyltransferase subunit [KO:K07432] [EC:2.4.1.141]", "199857  ALG14; ALG14 UDP-N-acetylglucosaminyltransferase subunit [KO:K07441] [EC:2.4.1.141]", "56052  ALG1; ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase [KO:K03842] [EC:2.4.1.142]", "85365  ALG2; ALG2 alpha-1,3/1,6-mannosyltransferase [KO:K03843] [EC:2.4.1.132 2.4.1.257]", "440138  ALG11; ALG11 alpha-1,2-mannosyltransferase [KO:K03844] [EC:2.4.1.131]", "10195  ALG3; ALG3 alpha-1,3- mannosyltransferase [KO:K03845] [EC:2.4.1.258]", "79796  ALG9; ALG9 alpha-1,2-mannosyltransferase [KO:K03846] [EC:2.4.1.259 2.4.1.261]", "79087  ALG12; ALG12 alpha-1,6-mannosyltransferase [KO:K03847] [EC:2.4.1.260]", "3703  STT3A; STT3 oligosaccharyltransferase complex catalytic subunit A [KO:K07151] [EC:2.4.99.18]", "201595  STT3B; STT3 oligosaccharyltransferase complex catalytic subunit B [KO:K07151] [EC:2.4.99.18]", "6184  RPN1; ribophorin I [KO:K12666]", "6185  RPN2; ribophorin II [KO:K12667]", "1603  DAD1; defender against cell death 1 [KO:K12668]", "1650  DDOST; dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit [KO:K12670]", "84061  MAGT1; magnesium transporter 1 [KO:K19478]", "7991  TUSC3; tumor suppressor candidate 3 [KO:K19478]", "58505  OSTC; oligosaccharyltransferase complex non-catalytic subunit [KO:K26501]", "746  TMEM258; transmembrane protein 258 [KO:K26502]", "11253  MAN1B1; mannosidase alpha class 1B member 1 [KO:K23741] [EC:3.2.1.209]", "10905  MAN1A2; mannosidase alpha class 1A member 2 [KO:K01230] [EC:3.2.1.113]", "57134  MAN1C1; mannosidase alpha class 1C member 1 [KO:K01230] [EC:3.2.1.113]", "4121  MAN1A1; mannosidase alpha class 1A member 1 [KO:K01230] [EC:3.2.1.113]", "4245  MGAT1; alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase [KO:K00726] [EC:2.4.1.101]", "4124  MAN2A1; mannosidase alpha class 2A member 1 [KO:K01231] [EC:3.2.1.114]", "4122  MAN2A2; mannosidase alpha class 2A member 2 [KO:K01231] [EC:3.2.1.114]", "4247  MGAT2; alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase [KO:K00736] [EC:2.4.1.143]", "3073  HEXA; hexosaminidase subunit alpha [KO:K12373] [EC:3.2.1.52]", "3074  HEXB; hexosaminidase subunit beta [KO:K12373] [EC:3.2.1.52]", "2530  FUT8; fucosyltransferase 8 [KO:K00717] [EC:2.4.1.68]", "284004  HEXD; hexosaminidase D [KO:K14459] [EC:3.2.1.52]", "25834  MGAT4C; MGAT4 family member C [KO:K13748] [EC:2.4.1.201 2.4.1.145]", "11320  MGAT4A; alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A [KO:K00738] [EC:2.4.1.145]", "11282  MGAT4B; alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B [KO:K00738] [EC:2.4.1.145]", "152586  MGAT4D; MGAT4 family member D [KO:K00738] [EC:2.4.1.145]", "2683  B4GALT1; beta-1,4-galactosyltransferase 1 [KO:K07966] [EC:2.4.1.22 2.4.1.90 2.4.1.38 2.4.1.-]", "8704  B4GALT2; beta-1,4-galactosyltransferase 2 [KO:K07967] [EC:2.4.1.22 2.4.1.90 2.4.1.38 2.4.1.-]", "8703  B4GALT3; beta-1,4-galactosyltransferase 3 [KO:K07968] [EC:2.4.1.90 2.4.1.38 2.4.1.-]", "6487  ST3GAL3; ST3 beta-galactoside alpha-2,3-sialyltransferase 3 [KO:K00781] [EC:2.4.3.6]", "283358  B4GALNT3; beta-1,4-N-acetyl-galactosaminyltransferase 3 [KO:K09656] [EC:2.4.1.244]", "338707  B4GALNT4; beta-1,4-N-acetyl-galactosaminyltransferase 4 [KO:K09657] [EC:2.4.1.244]", "64377  CHST8; carbohydrate sulfotransferase 8 [KO:K09672] [EC:2.8.2.-]", "83539  CHST9; carbohydrate sulfotransferase 9 [KO:K09673] [EC:2.8.2.-]"], "compound": ["G00011", "G00012", "G00013", "G00014", "G00015", "G00016  Core fucose", "G00017", "G00179", "G01813", "G05477", "G10665", "G10694", "G10716", "G10770", "G10841", "G10920", "G11000", "G11040", "G11933", "G12617", "G12625", "G12626", "G13047", "G13048", "G13049", "G13050", "G13055", "G13056", "G13057", "G13058", "G13059"], "refs": [{"pmid": "11412862", "authors": "  Munro S.", "title": "What can yeast tell us about N-linked glycosylation in the Golgi apparatus?", "journal": "FEBS Lett 498:223-7 (2001)", "doi": "10.1016/S0014-5793(01)02488-7"}, {"pmid": "9878803", "authors": "  Dean N.", "title": "Asparagine-linked glycosylation in the yeast Golgi.", "journal": "Biochim Biophys Acta 1426:309-22 (1999)", "doi": "10.1016/S0304-4165(98)00132-9"}, {"pmid": "9878780", "authors": "  Herscovics A.", "title": "Processing glycosidases of Saccharomyces cerevisiae.", "journal": "Biochim Biophys Acta 1426:275-85 (1999)", "doi": "10.1016/S0304-4165(98)00129-9"}, {"pmid": "9218445", "authors": "  Wang XH, Nakayama K, Shimma Y, Tanaka A, Jigami Y.", "title": "MNN6, a member of the KRE2/MNT1 family, is the gene for mannosylphosphate transfer in Saccharomyces cerevisiae.", "journal": "J Biol Chem 272:18117-24 (1997)", "doi": "10.1074/jbc.272.29.18117"}, {"pmid": "9756928", "authors": "  Rayner JC, Munro S.", "title": "Identification of the MNN2 and MNN5 mannosyltransferases required for forming and extending the mannose branches of the outer chain mannans of Saccharomyces cerevisiae.", "journal": "J Biol Chem 273:26836-43 (1998)", "doi": "10.1074/jbc.273.41.26836"}, {"pmid": "10037752", "authors": "  Jungmann J, Rayner JC, Munro S.", "title": "The Saccharomyces cerevisiae protein Mnn10p/Bed1p is a subunit of a Golgi mannosyltransferase complex.", "journal": "J Biol Chem 274:6579-85 (1999)", "doi": "10.1074/jbc.274.10.6579"}], "rel_pathway": ["hsa00510  N-Glycan biosynthesis"], "ko_pathway": "ko00513", "genes": ["RPN1"]}, {"kegg_id": "hsa04141", "name": "Protein processing in endoplasmic reticulum - Homo sapiens (human)", "description": "The endoplasmic reticulum (ER) is a subcellular organelle where proteins are folded with the help of lumenal chaperones. Newly synthesized peptides enter the ER via the sec61 pore and are glycosylated. Correctly folded proteins are packaged into transport vesicles that shuttle them to the Golgi complex. Misfolded proteins are retained within the ER lumen in complex with molecular chaperones. Proteins that are terminally misfolded bind to BiP and are directed toward degradation through the proteasome in a process called ER-associated degradation (ERAD). Accumulation of misfolded proteins in the ER causes ER stress and activates a signaling pathway called the unfolded protein response (UPR). In certain severe situations, however, the protective mechanisms activated by the UPR are not sufficient to restore normal ER function and cells die by apoptosis.", "class": "Genetic Information Processing; Folding, sorting and degradation", "pathway_map": "hsa04141  Protein processing in endoplasmic reticulum", "network": ["", "ELEMENT   N01009  PERK-ATF4 signaling pathway", "N01011  IRE1a-XBP1 signaling pathway", "N01013  IRE1a-JNK signaling pathway", "N01015  ATF6-mediated transcription", "N01289  COPII vesicle formation"], "drug": ["D10964  Omaveloxolone (USAN/INN)"], "dblinks": "GO: 0030433 0034976", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["29927  SEC61A1; SEC61 translocon subunit alpha 1 [KO:K10956]", "55176  SEC61A2; SEC61 translocon subunit alpha 2 [KO:K10956]", "10952  SEC61B; SEC61 translocon subunit beta [KO:K09481]", "23480  SEC61G; SEC61 translocon subunit gamma [KO:K07342]", "7095  SEC62; SEC62 homolog, preprotein translocation factor [KO:K12275]", "11231  SEC63; SEC63 homolog, protein translocation regulator [KO:K09540]", "6184  RPN1; ribophorin I [KO:K12666]", "6185  RPN2; ribophorin II [KO:K12667]", "1603  DAD1; defender against cell death 1 [KO:K12668]", "1650  DDOST; dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit [KO:K12670]", "3703  STT3A; STT3 oligosaccharyltransferase complex catalytic subunit A [KO:K07151] [EC:2.4.99.18]", "201595  STT3B; STT3 oligosaccharyltransferase complex catalytic subunit B [KO:K07151] [EC:2.4.99.18]", "84061  MAGT1; magnesium transporter 1 [KO:K19478]", "7991  TUSC3; tumor suppressor candidate 3 [KO:K19478]", "58505  OSTC; oligosaccharyltransferase complex non-catalytic subunit [KO:K26501]", "746  TMEM258; transmembrane protein 258 [KO:K26502]", "7841  MOGS; mannosyl-oligosaccharide glucosidase [KO:K01228] [EC:3.2.1.106]", "10970  CKAP4; cytoskeleton associated protein 4 [KO:K13999]", "6238  RRBP1; ribosome binding protein 1 [KO:K14000]", "64374  SIL1; SIL1 nucleotide exchange factor [KO:K14001]", "10525  HYOU1; hypoxia up-regulated 1 [KO:K09486]", "3309  HSPA5; heat shock protein family A (Hsp70) member 5 [KO:K09490] [EC:3.6.4.10]", "51726  DNAJB11; DnaJ heat shock protein family (Hsp40) member B11 [KO:K09517]", "64215  DNAJC1; DnaJ heat shock protein family (Hsp40) member C1 [KO:K09521]", "5611  DNAJC3; DnaJ heat shock protein family (Hsp40) member C3 [KO:K09523]", "54431  DNAJC10; DnaJ heat shock protein family (Hsp40) member C10 [KO:K09530] [EC:1.8.4.-]", "7184  HSP90B1; heat shock protein 90 beta family member 1 [KO:K09487]", "23193  GANAB; glucosidase II alpha subunit [KO:K05546] [EC:3.2.1.207]", "5589  PRKCSH; PRKCSH beta subunit of glucosidase II [KO:K08288]", "821  CANX; calnexin [KO:K08054]", "2923  PDIA3; protein disulfide isomerase family A member 3 [KO:K08056] [EC:5.3.4.1]", "811  CALR; calreticulin [KO:K08057]", "10905  MAN1A2; mannosidase alpha class 1A member 2 [KO:K01230] [EC:3.2.1.113]", "57134  MAN1C1; mannosidase alpha class 1C member 1 [KO:K01230] [EC:3.2.1.113]", "4121  MAN1A1; mannosidase alpha class 1A member 1 [KO:K01230] [EC:3.2.1.113]", "11253  MAN1B1; mannosidase alpha class 1B member 1 [KO:K23741] [EC:3.2.1.209]", "10960  LMAN2; lectin, mannose binding 2 [KO:K10082]", "3998  LMAN1; lectin, mannose binding 1 [KO:K10080]", "79748  LMAN1L; lectin, mannose binding 1 like [KO:K10081]", "10113  PREB; prolactin regulatory element binding [KO:K14003]", "56681  SAR1A; secretion associated Ras related GTPase 1A [KO:K07953] [EC:3.6.5.-]", "51128  SAR1B; secretion associated Ras related GTPase 1B [KO:K07953] [EC:3.6.5.-]", "6396  SEC13; SEC13 homolog, nuclear pore and COPII coat complex component [KO:K14004]", "22872  SEC31A; SEC31 homolog A, COPII coat complex component [KO:K14005]", "25956  SEC31B; SEC31 homolog B, COPII coat complex component [KO:K14005]", "10483  SEC23B; SEC23 homolog B, COPII coat complex component [KO:K14006]", "10484  SEC23A; SEC23 homolog A, COPII coat complex component [KO:K14006]", "10427  SEC24B; SEC24 homolog B, COPII coat complex component [KO:K14007]", "10802  SEC24A; SEC24 homolog A, COPII coat complex component [KO:K14007]", "9632  SEC24C; SEC24 homolog C, COPII coat complex component [KO:K14007]", "9871  SEC24D; SEC24 homolog D, COPII coat complex component [KO:K14007]", "55757  UGGT2; UDP-glucose glycoprotein glucosyltransferase 2 [KO:K11718] [EC:2.4.1.-]", "56886  UGGT1; UDP-glucose glycoprotein glucosyltransferase 1 [KO:K11718] [EC:2.4.1.-]", "9695  EDEM1; ER degradation enhancing alpha-mannosidase like protein 1 [KO:K10084]", "55741  EDEM2; ER degradation enhancing alpha-mannosidase like protein 2 [KO:K10085]", "111089941  MMP24-AS1-EDEM2; MMP24-AS1-EDEM2 readthrough [KO:K10085]", "80267  EDEM3; ER degradation enhancing alpha-mannosidase like protein 3 [KO:K10086]", "5034  P4HB; prolyl 4-hydroxylase subunit beta [KO:K09580] [EC:5.3.4.1]", "9601  PDIA4; protein disulfide isomerase family A member 4 [KO:K09582] [EC:5.3.4.1]", "10130  PDIA6; protein disulfide isomerase family A member 6 [KO:K09584] [EC:5.3.4.1]", "10961  ERP29; endoplasmic reticulum protein 29 [KO:K09586]", "81567  TXNDC5; thioredoxin domain containing 5 [KO:K13984] [EC:5.3.4.1]", "30001  ERO1A; endoplasmic reticulum oxidoreductase 1 alpha [KO:K10950] [EC:1.8.4.-]", "56605  ERO1B; endoplasmic reticulum oxidoreductase 1 beta [KO:K10976] [EC:1.8.4.-]", "10956  OS9; OS9 endoplasmic reticulum lectin [KO:K10088]", "27248  ERLEC1; endoplasmic reticulum lectin 1 [KO:K14008]", "6745  SSR1; signal sequence receptor subunit 1 [KO:K13249]", "6746  SSR2; signal sequence receptor subunit 2 [KO:K13250]", "6747  SSR3; signal sequence receptor subunit 3 [KO:K13251]", "6748  SSR4; signal sequence receptor subunit 4 [KO:K04571]", "10134  BCAP31; B cell receptor associated protein 31 [KO:K14009]", "23471  TRAM1; translocation associated membrane protein 1 [KO:K14010]", "133022  TRAM1L1; translocation associated membrane protein 1 like 1 [KO:K14010]", "79139  DERL1; derlin 1 [KO:K11519]", "51009  DERL2; derlin 2 [KO:K13989]", "91319  DERL3; derlin 3 [KO:K13989]", "23190  UBXN4; UBX domain protein 4 [KO:K24348]", "51035  UBXN1; UBX domain protein 1 [KO:K24348]", "165324  UBXN2A; UBX domain protein 2A [KO:K24349]", "80700  UBXN6; UBX domain protein 6 [KO:K14011]", "7993  UBXN8; UBX domain protein 8 [KO:K24351]", "55968  NSFL1C; NSFL1 cofactor [KO:K14012]", "258010  SVIP; small VCP interacting protein [KO:K14014]", "7415  VCP; valosin containing protein [KO:K13525]", "55666  NPLOC4; NPL4 homolog, ubiquitin recognition factor [KO:K14015]", "7353  UFD1; ubiquitin recognition factor in ER associated degradation 1 [KO:K14016]", "3312  HSPA8; heat shock protein family A (Hsp70) member 8 [KO:K03283]", "3303  HSPA1A; heat shock protein family A (Hsp70) member 1A [KO:K03283]", "3305  HSPA1L; heat shock protein family A (Hsp70) member 1 like [KO:K03283]", "3304  HSPA1B; heat shock protein family A (Hsp70) member 1B [KO:K03283]", "3310  HSPA6; heat shock protein family A (Hsp70) member 6 [KO:K03283]", "3301  DNAJA1; DnaJ heat shock protein family (Hsp40) member A1 [KO:K09502]", "10294  DNAJA2; DnaJ heat shock protein family (Hsp40) member A2 [KO:K09503]", "3337  DNAJB1; DnaJ heat shock protein family (Hsp40) member B1 [KO:K09507]", "3300  DNAJB2; DnaJ heat shock protein family (Hsp40) member B2 [KO:K09508]", "54788  DNAJB12; DnaJ heat shock protein family (Hsp40) member B12 [KO:K09518]", "80331  DNAJC5; DnaJ heat shock protein family (Hsp40) member C5 [KO:K09525]", "85479  DNAJC5B; DnaJ heat shock protein family (Hsp40) member C5 beta [KO:K09525]", "285126  DNAJC5G; DnaJ heat shock protein family (Hsp40) member C5 gamma [KO:K09525]", "3320  HSP90AA1; heat shock protein 90 alpha family class A member 1 [KO:K04079]", "3326  HSP90AB1; heat shock protein 90 alpha family class B member 1 [KO:K04079]", "10808  HSPH1; heat shock protein family H (Hsp110) member 1 [KO:K09485]", "22824  HSPA4L; heat shock protein family A (Hsp70) member 4 like [KO:K09485]", "573  BAG1; BAG cochaperone 1 [KO:K09555]", "9532  BAG2; BAG cochaperone 2 [KO:K09556]", "23640  HSPBP1; HSPA (Hsp70) binding protein 1 [KO:K09562]", "1409  CRYAA; crystallin alpha A [KO:K09541]", "102724652  CRYAA; crystallin alpha A2 [KO:K09541]", "1410  CRYAB; crystallin alpha B [KO:K09542]", "55432  YOD1; YOD1 deubiquitinase [KO:K13719] [EC:3.1.2.-]", "9373  PLAA; phospholipase A2 activating protein [KO:K14018]", "5887  RAD23B; RAD23 homolog B, nucleotide excision repair protein [KO:K10839]", "5886  RAD23A; RAD23 homolog A, nucleotide excision repair protein [KO:K10839]", "29979  UBQLN1; ubiquilin 1 [KO:K04523]", "29978  UBQLN2; ubiquilin 2 [KO:K04523]", "50613  UBQLN3; ubiquilin 3 [KO:K04523]", "56893  UBQLN4; ubiquilin 4 [KO:K04523]", "55768  NGLY1; N-glycanase 1 [KO:K01456] [EC:3.5.1.52]", "4287  ATXN3; ataxin 3 [KO:K11863] [EC:3.4.22.-]", "92552  ATXN3L; ataxin 3 like [KO:K11863] [EC:3.4.22.-]", "10277  UBE4B; ubiquitination factor E4B [KO:K10597] [EC:2.3.2.27]", "9451  EIF2AK3; eukaryotic translation initiation factor 2 alpha kinase 3 [KO:K08860] [EC:2.7.11.1]", "1965  EIF2S1; eukaryotic translation initiation factor 2 subunit alpha [KO:K03237]", "4780  NFE2L2; NFE2 like bZIP transcription factor 2 [KO:K05638]", "468  ATF4; activating transcription factor 4 [KO:K04374]", "23645  PPP1R15A; protein phosphatase 1 regulatory subunit 15A [KO:K14019]", "1649  DDIT3; DNA damage inducible transcript 3 [KO:K04452]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]", "22926  ATF6; activating transcription factor 6 [KO:K09054]", "1388  ATF6B; activating transcription factor 6 beta [KO:K09049]", "7466  WFS1; wolframin ER transmembrane glycoprotein [KO:K14020]", "8720  MBTPS1; membrane bound transcription factor peptidase, site 1 [KO:K08653] [EC:3.4.21.112]", "51360  MBTPS2; membrane bound transcription factor peptidase, site 2 [KO:K07765] [EC:3.4.24.85]", "7494  XBP1; X-box binding protein 1 [KO:K09027]", "2081  ERN1; endoplasmic reticulum to nucleus signaling 1 [KO:K08852] [EC:2.7.11.1 3.1.26.-]", "7186  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]", "4217  MAP3K5; mitogen-activated protein kinase kinase kinase 5 [KO:K04426] [EC:2.7.11.25]", "5609  MAP2K7; mitogen-activated protein kinase kinase 7 [KO:K04431] [EC:2.7.12.2]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "578  BAK1; BCL2 antagonist/killer 1 [KO:K14021]", "823  CAPN1; calpain 1 [KO:K01367] [EC:3.4.22.52]", "824  CAPN2; calpain 2 [KO:K03853] [EC:3.4.22.53]", "100506742  CASP12; caspase 12 (gene/pseudogene) [KO:K04741] [EC:3.4.22.-]", "10299  MARCHF6; membrane associated ring-CH-type finger 6 [KO:K10661] [EC:2.3.2.27]", "51465  UBE2J1; ubiquitin conjugating enzyme E2 J1 [KO:K10578] [EC:2.3.2.23]", "118424  UBE2J2; ubiquitin conjugating enzyme E2 J2 [KO:K04554] [EC:2.3.2.23]", "7326  UBE2G1; ubiquitin conjugating enzyme E2 G1 [KO:K10575] [EC:2.3.2.23]", "7327  UBE2G2; ubiquitin conjugating enzyme E2 G2 [KO:K04555] [EC:2.3.2.23]", "84447  SYVN1; synoviolin 1 [KO:K10601] [EC:2.3.2.27]", "6048  RNF5; ring finger protein 5 [KO:K10666] [EC:2.3.2.27]", "91445  RNF185; ring finger protein 185 [KO:K10666] [EC:2.3.2.27]", "55829  SELENOS; selenoprotein S [KO:K14025]", "6400  SEL1L; SEL1L adaptor subunit of SYVN1 ubiquitin ligase [KO:K14026]", "80343  SEL1L2; SEL1L2 adaptor subunit of SYVN1 ubiquitin ligase [KO:K14026]", "9709  HERPUD1; homocysteine inducible ER protein with ubiquitin like domain 1 [KO:K14027]", "267  AMFR; autocrine motility factor receptor [KO:K10636] [EC:2.3.2.36]", "10273  STUB1; STIP1 homology and U-box containing protein 1 [KO:K09561] [EC:2.3.2.27]", "51619  UBE2D4; ubiquitin conjugating enzyme E2 D4 (putative) [KO:K06689] [EC:2.3.2.23]", "7321  UBE2D1; ubiquitin conjugating enzyme E2 D1 [KO:K06689] [EC:2.3.2.23]", "7322  UBE2D2; ubiquitin conjugating enzyme E2 D2 [KO:K06689] [EC:2.3.2.23]", "7323  UBE2D3; ubiquitin conjugating enzyme E2 D3 [KO:K06689] [EC:2.3.2.23]", "5071  PRKN; parkin RBR E3 ubiquitin protein ligase [KO:K04556] [EC:2.3.2.31]", "9978  RBX1; ring-box 1 [KO:K03868] [EC:2.3.2.32]", "8454  CUL1; cullin 1 [KO:K03347]", "6500  SKP1; S-phase kinase associated protein 1 [KO:K03094]", "26232  FBXO2; F-box protein 2 [KO:K10099]", "26270  FBXO6; F-box protein 6 [KO:K10100]"], "compound": ["C00076  Calcium cation", "G00009", "G00010", "G00011", "G00012", "G10694"], "refs": [{"pmid": "19491040", "authors": "  Naidoo N", "title": "ER and aging-Protein folding and the ER stress response.", "journal": "Ageing Res Rev 8:150-9 (2009)", "doi": "10.1016/j.arr.2009.03.001"}, {"pmid": "18023214", "authors": "  Malhotra JD, Kaufman RJ", "title": "The endoplasmic reticulum and the unfolded protein response.", "journal": "Semin Cell Dev Biol 18:716-31 (2007)", "doi": "10.1016/j.semcdb.2007.09.003"}, {"pmid": "20347046", "authors": "  Maattanen P, Gehring K, Bergeron JJ, Thomas DY", "title": "Protein quality control in the ER: the recognition of misfolded proteins.", "journal": "Semin Cell Dev Biol 21:500-11 (2010)", "doi": "10.1016/j.semcdb.2010.03.006"}, {"pmid": "20219571", "authors": "  Stolz A, Wolf DH", "title": "Endoplasmic reticulum associated protein degradation: a chaperone assisted journey to hell.", "journal": "Biochim Biophys Acta 1803:694-705 (2010)", "doi": "10.1016/j.bbamcr.2010.02.005"}], "rel_pathway": ["hsa00510  N-Glycan biosynthesis", "hsa03050  Proteasome", "hsa03060  Protein export", "hsa04210  Apoptosis", "hsa04930  Type II diabetes mellitus", "hsa05010  Alzheimer disease", "hsa05012  Parkinson disease", "hsa05020  Prion disease"], "ko_pathway": "ko04141", "genes": ["RPN1", "CUL1", "BAX"]}, {"kegg_id": "hsa04260", "name": "Cardiac muscle contraction - Homo sapiens (human)", "description": "Contraction of the heart is a complex process initiated by the electrical excitation of cardiac myocytes (excitation-contraction coupling, ECC). In cardiac myocytes, Ca2+ influx induced by activation of voltage-dependent L-type Ca channels (DHP receptors) upon membrane depolarization triggers the release of Ca2+ via Ca2+ release channels (ryanodine receptors) of sarcoplasmic reticulum (SR) through a Ca2+ -induced Ca release (CICR) mechanism. Ca2+ ions released via the CICR mechanism diffuse through the cytosolic space to contractile proteins to bind to troponinC resulting in the release of inhibition induced by troponinI. The Ca2+ binding to troponinC thereby triggers the sliding of thin and thick filaments, that is, the activation of a crossbridge and subsequent cardiac force development and/or cell shortening. Recovery occurs as Ca2+ is pumped out of the cell by the Na+/Ca2+ exchanger (NCX) or is returned to the sarcoplasmic reticulum (SR) by sarco(endo)plasmic Ca2+ -ATPase (SERCA) pumps on the non-junctional region of the SR.", "class": "Organismal Systems; Circulatory system", "pathway_map": "hsa04260  Cardiac muscle contraction", "drug": ["D00112  G-Strophanthin (JAN)", "D00297  Digitoxin (JAN/USP/INN)", "D00298  Digoxin (JP18/USP)", "D00319  Felodipine (JP18/USP/INN)", "D00349  Isradipine (USP/INN)", "D00437  Nifedipine (JP18/USP/INN)", "D00438  Nimodipine (USP/INN)", "D00615  Amlodipine besylate (USP)", "D00616  Diltiazem hydrochloride (JP18/USP)", "D00617  Nicardipine hydrochloride (JP18/USAN)", "D00618  Nisoldipine (JAN/USAN/INN)", "D00619  Verapamil hydrochloride (JP18/USP)", "D00629  Nitrendipine (JP18/USAN/INN)", "D00631  Bepridil hydrochloride (USAN)", "D00645  Bretylium tosylate (USP)", "D01104  Barnidipine hydrochloride (JAN)", "D01145  Azelnidipine (JP18/INN)", "D01151  Lemildipine (JAN/INN)", "D01171  Monatepil maleate (JAN/USAN)", "D01173  Cilnidipine (JP18/INN)", "D01240  Deslanoside (JP18/USP/INN)", "D01369  Bevantolol hydrochloride (JAN/USAN)", "D01379  Proscillaridin (JAN/USAN/INN)", "D01553  Manidipine hydrochloride (JP18)", "D01562  Aranidipine (JAN/INN)", "D01604  Efonidipine hydrochloride ethanolate (JAN)", "D01849  Lercanidipine hydrochloride (JAN/USAN)", "D01908  Nilvadipine (JP18/USAN/INN)", "D01933  Vatanidipine hydrochloride (JAN)", "D01969  Gallopamil hydrochloride (JAN)", "D01972  Lanatoside C (JAN/INN)", "D02045  Benidipine hydrochloride (JP18)", "D02356  Verapamil (USAN/INN)", "D02537  Dronedarone (INN)", "D02587  Metildigoxin (JP18)", "D02914  Amlodipine maleate (USAN)", "D03067  Belfosdil (USAN/INN)", "D03406  Cariporide mesylate (USAN)", "D03536  Clentiazem maleate (JAN/USAN)", "D03655  Darodipine (USAN/INN)", "D03830  Diltiazem malate (USAN)", "D03914  Dronedarone hydrochloride (USP)", "D04193  Flordipine (USAN/INN)", "D04510  Imciromab pentetate (USAN)", "D04657  Lacidipine (USAN/INN)", "D05024  Mibefradil dihydrochloride (USAN)", "D05442  Perhexiline maleate (USAN)", "D06129  Tiapamil hydrochloride (USAN)", "D06881  Acetyldigitoxin (INN)", "D07147  Gitoformate (INN)", "D07185  Fendiline (INN)", "D07450  Amlodipine (USP/INN)", "D07494  Barnidipine (INN)", "D07509  Benidipine (INN)", "D07520  Bepridil (INN)", "D07555  Acetyldigoxin", "D07556  beta-Acetyldigoxin", "D07845  Diltiazem (INN)", "D07886  Efonidipine (INN)", "D07943  Fendiline hydrochloride", "D08009  Gallopamil (INN)", "D08111  Lercanidipine (INN)", "D08155  Manidipine (INN)", "D08217  Mibefradil (INN)", "D08270  Nicardipine (INN)", "D08340  Perhexiline (INN)", "D08892  Clevidipine (USAN/INN)", "D08941  Levamlodipine malate (USAN)", "D09036  Zoniporide mesylate (INN/USAN)", "D09789  Kirenidipine hydrochloride (JAN)", "D09833  Levosemotiadil fumarate (JAN)", "D09847  Metildigoxin (INN)", "D10932  Etripamil (USAN/INN)", "D11723  Levamlodipine maleate (USAN)", "D11881  Amlodipine benzoate", "D12253  Aficamten (USAN/INN)", "D12265  Mavacamten (JAN/USAN/INN)", "D12804  Nelutroctiv (USAN/INN)"], "dblinks": "GO: 0060048", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["775  CACNA1C; calcium voltage-gated channel subunit alpha1 C [KO:K04850]", "776  CACNA1D; calcium voltage-gated channel subunit alpha1 D [KO:K04851]", "778  CACNA1F; calcium voltage-gated channel subunit alpha1 F [KO:K04853]", "779  CACNA1S; calcium voltage-gated channel subunit alpha1 S [KO:K04857]", "782  CACNB1; calcium voltage-gated channel auxiliary subunit beta 1 [KO:K04862]", "783  CACNB2; calcium voltage-gated channel auxiliary subunit beta 2 [KO:K04863]", "784  CACNB3; calcium voltage-gated channel auxiliary subunit beta 3 [KO:K04864]", "785  CACNB4; calcium voltage-gated channel auxiliary subunit beta 4 [KO:K04865]", "781  CACNA2D1; calcium voltage-gated channel auxiliary subunit alpha2delta 1 [KO:K04858]", "9254  CACNA2D2; calcium voltage-gated channel auxiliary subunit alpha2delta 2 [KO:K04859]", "55799  CACNA2D3; calcium voltage-gated channel auxiliary subunit alpha2delta 3 [KO:K04860]", "93589  CACNA2D4; calcium voltage-gated channel auxiliary subunit alpha2delta 4 [KO:K04861]", "786  CACNG1; calcium voltage-gated channel auxiliary subunit gamma 1 [KO:K04866]", "10369  CACNG2; calcium voltage-gated channel auxiliary subunit gamma 2 [KO:K04867]", "10368  CACNG3; calcium voltage-gated channel auxiliary subunit gamma 3 [KO:K04868]", "27092  CACNG4; calcium voltage-gated channel auxiliary subunit gamma 4 [KO:K04869]", "27091  CACNG5; calcium voltage-gated channel auxiliary subunit gamma 5 [KO:K04870]", "59285  CACNG6; calcium voltage-gated channel auxiliary subunit gamma 6 [KO:K04871]", "59284  CACNG7; calcium voltage-gated channel auxiliary subunit gamma 7 [KO:K04872]", "59283  CACNG8; calcium voltage-gated channel auxiliary subunit gamma 8 [KO:K04873]", "6262  RYR2; ryanodine receptor 2 [KO:K04962]", "444  ASPH; aspartate beta-hydroxylase [KO:K00476] [EC:1.14.11.16]", "845  CASQ2; calsequestrin 2 [KO:K23445]", "10345  TRDN; triadin [KO:K23449]", "3270  HRC; histidine rich calcium binding protein [KO:K23450]", "487  ATP2A1; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 [KO:K05853] [EC:7.2.2.10]", "489  ATP2A3; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 [KO:K05853] [EC:7.2.2.10]", "488  ATP2A2; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 [KO:K05853] [EC:7.2.2.10]", "7134  TNNC1; troponin C1, slow skeletal and cardiac type [KO:K05865]", "7137  TNNI3; troponin I3, cardiac type [KO:K12044]", "7139  TNNT2; troponin T2, cardiac type [KO:K12045]", "7168  TPM1; tropomyosin 1 [KO:K10373]", "7169  TPM2; tropomyosin 2 [KO:K10374]", "7170  TPM3; tropomyosin 3 [KO:K09290]", "7171  TPM4; tropomyosin 4 [KO:K10375]", "70  ACTC1; actin alpha cardiac muscle 1 [KO:K12314]", "4625  MYH7; myosin heavy chain 7 [KO:K17751]", "4624  MYH6; myosin heavy chain 6 [KO:K17751]", "4633  MYL2; myosin light chain 2 [KO:K10351]", "4634  MYL3; myosin light chain 3 [KO:K12749]", "4635  MYL4; myosin light chain 4 [KO:K12750]", "7386  UQCRFS1; ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 [KO:K00411] [EC:7.1.1.8]", "4519  CYTB; cytochrome b [KO:K00412]", "1537  CYC1; cytochrome c1 [KO:K00413]", "7384  UQCRC1; ubiquinol-cytochrome c reductase core protein 1 [KO:K00414]", "7385  UQCRC2; ubiquinol-cytochrome c reductase core protein 2 [KO:K00415]", "7388  UQCRH; ubiquinol-cytochrome c reductase hinge protein [KO:K00416]", "440567  UQCRHL; ubiquinol-cytochrome c reductase hinge protein like [KO:K00416]", "7381  UQCRB; ubiquinol-cytochrome c reductase binding protein [KO:K00417]", "27089  UQCRQ; ubiquinol-cytochrome c reductase complex III subunit VII [KO:K00418]", "29796  UQCR10; ubiquinol-cytochrome c reductase, complex III subunit X [KO:K00419]", "10975  UQCR11; ubiquinol-cytochrome c reductase, complex III subunit XI [KO:K00420]", "4514  COX3; cytochrome c oxidase subunit III [KO:K02262]", "4512  COX1; cytochrome c oxidase subunit I [KO:K02256] [EC:7.1.1.9]", "4513  COX2; cytochrome c oxidase subunit II [KO:K02261]", "84701  COX4I2; cytochrome c oxidase subunit 4I2 [KO:K02263]", "1327  COX4I1; cytochrome c oxidase subunit 4I1 [KO:K02263]", "9377  COX5A; cytochrome c oxidase subunit 5A [KO:K02264]", "1329  COX5B; cytochrome c oxidase subunit 5B [KO:K02265]", "1337  COX6A1; cytochrome c oxidase subunit 6A1 [KO:K02266]", "1339  COX6A2; cytochrome c oxidase subunit 6A2 [KO:K02266]", "1340  COX6B1; cytochrome c oxidase subunit 6B1 [KO:K02267]", "125965  COX6B2; cytochrome c oxidase subunit 6B2 [KO:K02267]", "1345  COX6C; cytochrome c oxidase subunit 6C [KO:K02268]", "1346  COX7A1; cytochrome c oxidase subunit 7A1 [KO:K02270]", "1347  COX7A2; cytochrome c oxidase subunit 7A2 [KO:K02270]", "9167  COX7A2L; cytochrome c oxidase subunit 7A2 like [KO:K02270]", "1349  COX7B; cytochrome c oxidase subunit 7B [KO:K02271]", "170712  COX7B2; cytochrome c oxidase subunit 7B2 [KO:K02271]", "1350  COX7C; cytochrome c oxidase subunit 7C [KO:K02272]", "341947  COX8C; cytochrome c oxidase subunit 8C [KO:K02273]", "1351  COX8A; cytochrome c oxidase subunit 8A [KO:K02273]", "6546  SLC8A1; solute carrier family 8 member A1 [KO:K05849]", "6543  SLC8A2; solute carrier family 8 member A2 [KO:K05849]", "6547  SLC8A3; solute carrier family 8 member A3 [KO:K05849]", "10479  SLC9A6; solute carrier family 9 member A6 [KO:K12041]", "84679  SLC9A7; solute carrier family 9 member A7 [KO:K12041]", "476  ATP1A1; ATPase Na+/K+ transporting subunit alpha 1 [KO:K01539] [EC:7.2.2.13]", "477  ATP1A2; ATPase Na+/K+ transporting subunit alpha 2 [KO:K01539] [EC:7.2.2.13]", "478  ATP1A3; ATPase Na+/K+ transporting subunit alpha 3 [KO:K01539] [EC:7.2.2.13]", "480  ATP1A4; ATPase Na+/K+ transporting subunit alpha 4 [KO:K01539] [EC:7.2.2.13]", "23439  ATP1B4; ATPase Na+/K+ transporting family member beta 4 [KO:K01540]", "481  ATP1B1; ATPase Na+/K+ transporting subunit beta 1 [KO:K01540]", "482  ATP1B2; ATPase Na+/K+ transporting subunit beta 2 [KO:K01540]", "483  ATP1B3; ATPase Na+/K+ transporting subunit beta 3 [KO:K01540]", "486  FXYD2; FXYD domain containing ion transport regulator 2 [KO:K01538]", "6548  SLC9A1; solute carrier family 9 member A1 [KO:K05742]"], "compound": ["C00076  Calcium cation", "C00080  H+", "C00238  Potassium cation", "C01330  Sodium cation"], "refs": [{"pmid": "17988210", "authors": "  Bers DM", "title": "Calcium cycling and signaling in cardiac myocytes.", "journal": "Annu Rev Physiol 70:23-49 (2008)", "doi": "10.1146/annurev.physiol.70.113006.100455"}, {"pmid": "11805843", "authors": "  Bers DM", "title": "Cardiac excitation-contraction coupling.", "journal": "Nature 415:198-205 (2002)", "doi": "10.1038/415198a"}, {"pmid": "16799263", "authors": "  Endoh M", "title": "Signal transduction and Ca2+ signaling in intact myocardium.", "journal": "J Pharmacol Sci 100:525-37 (2006)", "doi": "10.1254/jphs.CPJ06009X"}, {"pmid": "18981594", "authors": "  Endoh M", "title": "Cardiac Ca2+ signaling and Ca2+ sensitizers.", "journal": "Circ J 72:1915-25 (2008)", "doi": "10.1253/circj.CJ-08-0838"}, {"pmid": "16552170", "authors": "  Bers DM, Despa S", "title": "Cardiac myocytes Ca2+ and Na+ regulation in normal and failing hearts.", "journal": "J Pharmacol Sci 100:315-22 (2006)", "doi": "10.1254/jphs.CPJ06001X"}, {"pmid": "10747208", "authors": "  Gordon AM, Homsher E, Regnier M", "title": "Regulation of contraction in striated muscle.", "journal": "Physiol Rev 80:853-924 (2000)", "doi": "10.1152/physrev.2000.80.2.853"}, {"pmid": "16701909", "authors": "  Phrommintikul A, Chattipakorn N", "title": "Roles of cardiac ryanodine receptor in heart failure and sudden cardiac death.", "journal": "Int J Cardiol 112:142-52 (2006)", "doi": "10.1016/j.ijcard.2005.11.106"}, {"pmid": "12763850", "authors": "  Lingrel J, Moseley A, Dostanic I, Cougnon M, He S, James P, Woo A, O'Connor K, Neumann J", "title": "Functional roles of the alpha isoforms of the Na,K-ATPase.", "journal": "Ann N Y Acad Sci 986:354-9 (2003)", "doi": "10.1111/j.1749-6632.2003.tb07214.x"}, {"pmid": "11294886", "authors": "  Berg JS, Powell BC, Cheney RE", "title": "A millennial myosin census.", "journal": "Mol Biol Cell 12:780-94 (2001)", "doi": "10.1091/mbc.12.4.780"}, {"pmid": "15736582", "authors": "  Parmacek MS, Solaro RJ", "title": "Biology of the troponin complex in cardiac myocytes.", "journal": "Prog Cardiovasc Dis 47:159-76 (2004)", "doi": "10.1016/j.pcad.2004.07.003"}, {"pmid": "14659803", "authors": "  Yamashita H, Sugiura S, Fujita H, Yasuda S, Nagai R, Saeki Y, Sunagawa K, Sugi H", "title": "Myosin light chain isoforms modify force-generating ability of cardiac myosin by changing the kinetics of actin-myosin interaction.", "journal": "Cardiovasc Res 60:580-8 (2003)", "doi": "10.1016/j.cardiores.2003.09.011"}, {"pmid": "19403607", "authors": "  Pritchard TJ, Kranias EG", "title": "Junctin and the histidine-rich Ca2+ binding protein: potential roles in heart failure and arrhythmogenesis.", "journal": "J Physiol 587:3125-33 (2009)", "doi": "10.1113/jphysiol.2009.172171"}], "rel_pathway": ["hsa04020  Calcium signaling pathway"], "ko_pathway": "ko04260", "genes": ["TPM4"]}, {"kegg_id": "hsa04261", "name": "Adrenergic signaling in cardiomyocytes - Homo sapiens (human)", "description": "Cardiac myocytes express at least six subtypes of adrenergic receptor (AR) which include three subtypes of beta-AR (beta-1, beta-2, beta-3) and three subtypes of the alpha-1-AR (alpha-1A, alpha-1B, and alpha-1C). In the human heart the beta-1-AR is the pre- dominate receptor. Acute sympathetic stimulation of cardiac beta-1-ARs induces positive inotropic and chronotropic effects, the most effective mechanism to acutely increase output of the heart, by coupling to Gs, formation of cAMP by adenylyl cyclase (AC), and PKA- dependent phosphorylation of various target proteins (e.g., ryanodine receptor [RyR]; phospholamban [PLB], troponin I [TnI], and the L-type Ca2+ channel [LTCC]). Chronic beta-1-AR stimulation is detrimental and induces cardiomyocyte hypertrophy and apoptosis. beta-2-AR coupled to Gs exerts a proapoptotic action as well as beta-1-AR, while beta-2-AR coupled to Gi exerts an antiapoptotic action.", "class": "Organismal Systems; Circulatory system", "pathway_map": "hsa04261  Adrenergic signaling in cardiomyocytes", "network": ["", "ELEMENT   N01345  EP/NE-ADRB-cAMP signaling pathway", "N01347  EP/NE-ADRB-PI3K signaling pathway"], "drug": ["D00076  Noradrenaline (JP18)", "D00095  Epinephrine (USP/INN)", "D00112  G-Strophanthin (JAN)", "D00124  Ephedrine (USP)", "D00150  Angiotensin II (INN)", "D00199  Ajmaline (JP18)", "D00235  Atenolol (JP18/USP/INN)", "D00255  Carvedilol (JP18/USP/INN)", "D00297  Digitoxin (JAN/USP/INN)", "D00298  Digoxin (JP18/USP)", "D00303  Disopyramide (JP18/USAN/INN)", "D00319  Felodipine (JP18/USP/INN)", "D00349  Isradipine (USP/INN)", "D00357  Losartan potassium (JP18/USP)", "D00358  Lidocaine (JP18/USP/INN)", "D00378  Timolol (USAN)", "D00400  Valsartan (JP18/USP/INN)", "D00432  Nadolol (JP18/USP/INN)", "D00437  Nifedipine (JP18/USP/INN)", "D00438  Nimodipine (USP/INN)", "D00477  Procainamide hydrochloride (JP18/USP)", "D00483  Propranolol hydrochloride (JP18/USP)", "D00509  Phentolamine mesylate (USP)", "D00511  Phenylephrine hydrochloride (JP18/USP)", "D00513  Pindolol (JP18/USP/INN)", "D00522  Candesartan (USAN/INN)", "D00523  Irbesartan (JP18/USP/INN)", "D00597  Acebutolol hydrochloride (JP18/USP)", "D00598  Betaxolol hydrochloride (JP18/USP)", "D00599  Carteolol hydrochloride (JP18/USP)", "D00600  Labetalol hydrochloride (JP18/USP)", "D00601  Metoprolol tartrate (JP18/USP)", "D00602  Penbutolol sulfate (JP18/USP)", "D00603  Timolol maleate (JP18/USP)", "D00608  Doxazosin mesylate (USP)", "D00609  Prazosin hydrochloride (JP18/USP)", "D00615  Amlodipine besylate (USP)", "D00616  Diltiazem hydrochloride (JP18/USP)", "D00617  Nicardipine hydrochloride (JP18/USAN)", "D00618  Nisoldipine (JAN/USAN/INN)", "D00626  Candesartan cilexetil (JP18/USP)", "D00627  Telmisartan (JP18/USP/INN)", "D00629  Nitrendipine (JP18/USAN/INN)", "D00632  Dobutamine hydrochloride (JP18/USP)", "D00634  Bisoprolol fumarate (JP18/USP)", "D00635  Metoprolol succinate (USP)", "D00636  Amiodarone hydrochloride (JP18/USP)", "D00637  Disopyramide phosphate (JAN/USP)", "D00638  Flecainide acetate (JP18/USP)", "D00639  Mexiletine hydrochloride (JP18/USP)", "D00640  Propafenone hydrochloride (JP18/USP)", "D00642  Quinidine gluconate (USP)", "D00643  Quinidine polygalacturonate", "D00644  Esmolol hydrochloride (JAN/USP)", "D00645  Bretylium tosylate (USP)", "D00996  Epinephrine hydrochloride (JAN)", "D00997  Tolazoline hydrochloride (JAN/USP)", "D01019  Metaraminol bitartrate (JAN/USP)", "D01020  Methoxamine hydrochloride (JAN)", "D01026  Sotalol hydrochloride (JAN/USP)", "D01041  Sparteine (INN)", "D01104  Barnidipine hydrochloride (JAN)", "D01145  Azelnidipine (JP18/INN)", "D01151  Lemildipine (JAN/INN)", "D01171  Monatepil maleate (JAN/USAN)", "D01173  Cilnidipine (JP18/INN)", "D01182  Alprenolol hydrochloride (JP18/USAN)", "D01204  Olmesartan medoxomil (JP18/USP)", "D01240  Deslanoside (JP18/USP/INN)", "D01277  Droxidopa (JP18/USAN/INN)", "D01326  Aprindine hydrochloride (JP18/USAN)", "D01333  Urapidil (JP18/INN)", "D01369  Bevantolol hydrochloride (JAN/USAN)", "D01379  Proscillaridin (JAN/USAN/INN)", "D01386  Ephedrine hydrochloride (JP18/USP)", "D01390  Isoproterenol hydrochloride (USP)", "D01444  Bunitrolol hydrochloride (JAN)", "D01454  Bupranolol hydrochloride (JP18)", "D01455  Cifenline succinate (USAN)", "D01469  Amosulalol hydrochloride (JP18)", "D01471  Esatenolol (JAN/INN)", "D01492  Bucumolol hydrochloride (JP18)", "D01504  Bufetolol hydrochloride (JP18)", "D01553  Manidipine hydrochloride (JP18)", "D01562  Aranidipine (JAN/INN)", "D01573  Etilefrine hydrochloride (JP18)", "D01604  Efonidipine hydrochloride ethanolate (JAN)", "D01691  Nipradilol (JAN/INN)", "D01697  Colforsin daropate hydrochloride (JAN)", "D01741  Celiprolol hydrochloride (JAN/USAN)", "D01748  Isoxsuprine hydrochloride (JP18/USP)", "D01785  Pirmenol hydrochloride hydrate (JAN)", "D01794  Bopindolol malonate (JAN)", "D01795  Tilisolol hydrochloride (JAN)", "D01806  Oxprenolol hydrochloride (JP18/USP)", "D01830  Arotinolol hydrochloride (JP18)", "D01847  Landiolol hydrochloride (JAN/USAN)", "D01849  Lercanidipine hydrochloride (JAN/USAN)", "D01903  Docarpamine (JAN/INN)", "D01906  Dilevalol hydrochloride (JAN/USAN)", "D01908  Nilvadipine (JP18/USAN/INN)", "D01933  Vatanidipine hydrochloride (JAN)", "D01958  Indenolol hydrochloride (JP18)", "D01969  Gallopamil hydrochloride (JAN)", "D01972  Lanatoside C (JAN/INN)", "D02014  Angiotensin II (USAN)", "D02045  Benidipine hydrochloride (JP18)", "D02066  Isoproterenol sulfate (USP)", "D02082  Eprosartan mesylate (USAN)", "D02086  Lidocaine hydrochloride (JAN/USP)", "D02087  Moricizine hydrochloride (USP)", "D02088  Tocainide hydrochloride (USP)", "D02109  dl-Methylephedrine hydrochloride (JP18)", "D02149  Epinephrine bitartrate (JAN/USP)", "D02150  l-Isoprenaline hydrochloride (JP18)", "D02239  Sparteine sulfate (JAN/USAN)", "D02272  Quinidine sulfate (USP)", "D02338  Acebutolol (USAN/INN)", "D02342  Bisoprolol (JAN/USAN/INN)", "D02358  Metoprolol (USAN/INN)", "D02389  Primidolol (USAN/INN)", "D02537  Dronedarone (INN)", "D02587  Metildigoxin (JP18)", "D02614  Denopamine (JAN/INN)", "D02762  Actisomide (USAN/INN)", "D02765  Adaprolol maleate (USAN)", "D02834  Alprenoxime hydrochloride (USAN)", "D02901  Amidephrine mesylate (USAN)", "D02910  Amiodarone (USAN/INN)", "D02914  Amlodipine maleate (USAN)", "D02939  Angiotensin amide (USAN)", "D02976  Arbutamine hydrochloride (USAN)", "D03067  Belfosdil (USAN/INN)", "D03170  Bucindolol hydrochloride (USAN)", "D03195  Butopamine (USAN/INN)", "D03406  Cariporide mesylate (USAN)", "D03415  Carvedilol phosphate (USAN)", "D03449  Cetamolol hydrochloride (USAN)", "D03490  Cicloprolol hydrochloride (USAN)", "D03492  Cifenline (USAN)", "D03536  Clentiazem maleate (JAN/USAN)", "D03655  Darodipine (USAN/INN)", "D03729  Dexpropranolol hydrochloride (USAN)", "D03759  Diacetolol hydrochloride (USAN)", "D03830  Diltiazem malate (USAN)", "D03879  Dobutamine (USAN/INN)", "D03880  Dobutamine lactobionate (USAN)", "D03881  Dobutamine tartrate (USAN)", "D03891  Dopexamine (USAN/INN)", "D03892  Dopexamine hydrochloride (USAN)", "D03914  Dronedarone hydrochloride (USP)", "D03991  Encainide hydrochloride (USAN)", "D04018  Ephedrine sulfate (USP)", "D04040  Eprosartan (USAN/INN)", "D04120  Exaprolol hydrochloride (USAN)", "D04190  Flestolol sulfate (USAN)", "D04193  Flordipine (USAN/INN)", "D04243  Forasartan (USAN/INN)", "D04510  Imciromab pentetate (USAN)", "D04521  Indecainide hydrochloride (USAN)", "D04531  Indoramin (USAN/INN)", "D04532  Indoramin hydrochloride (USAN)", "D04657  Lacidipine (USAN/INN)", "D04708  Levdobutamine lactobionate (USAN)", "D04710  Levobetaxolol hydrochloride (USAN)", "D04774  Lorajmine hydrochloride (USAN)", "D04888  Medroxalol (USAN/INN)", "D04889  Medroxalol hydrochloride (USAN)", "D05011  Metoprolol fumarate (USP)", "D05024  Mibefradil dihydrochloride (USAN)", "D05077  Moricizine (USAN)", "D05127  Nebivolol (USAN/INN)", "D05206  Norepinephrine bitartrate (USP)", "D05228  Octodrine (USAN/INN)", "D05246  Olmesartan (USAN/INN)", "D05345  Pamatolol sulfate (USAN)", "D05442  Perhexiline maleate (USAN)", "D05587  Practolol (USAN)", "D05801  Saprisartan potassium (USAN)", "D06010  Tasosartan (USAN/INN)", "D06014  Tazolol hydrochloride (USAN)", "D06162  Tiprenolol hydrochloride (USAN)", "D06172  Tocainide (USAN/INN)", "D06176  Tolamolol (USAN/INN)", "D06203  Transcainide (USAN/INN)", "D06234  Trimazosin hydrochloride (USAN)", "D06328  Xamoterol (USAN)", "D06329  Xamoterol fumarate (USAN)", "D06517  Pirmenol hydrochloride (USAN)", "D06622  Nebivolol hydrochloride (USAN)", "D06646  Epanolol (USAN/INN)", "D06665  Vernakalant hydrochloride (USAN)", "D06881  Acetyldigitoxin (INN)", "D07147  Gitoformate (INN)", "D07156  Alprenolol (INN)", "D07181  Mepindolol (INN)", "D07182  Tertatolol (INN)", "D07183  Cloranolol (INN)", "D07184  Talinolol (INN)", "D07185  Fendiline (INN)", "D07450  Amlodipine (USP/INN)", "D07451  Amosulalol (INN)", "D07465  Arotinolol (INN)", "D07494  Barnidipine (INN)", "D07509  Benidipine (INN)", "D07526  Betaxolol (INN)", "D07537  Bopindolol (INN)", "D07555  Acetyldigoxin", "D07556  beta-Acetyldigoxin", "D07590  Bupranolol (INN)", "D07624  Carteolol (INN)", "D07660  Celiprolol (INN)", "D07845  Diltiazem (INN)", "D07874  Doxazosin (INN)", "D07886  Efonidipine (INN)", "D07894  Encainide (INN)", "D07916  Esmolol (INN)", "D07931  Etilefrine (INN)", "D07943  Fendiline hydrochloride", "D07962  Flecainide (INN)", "D08009  Gallopamil (INN)", "D08067  Azilsartan medoxomil (USAN)", "D08074  Penbutolol (INN)", "D08078  Indenolol (INN)", "D08090  Isoprenaline (INN)", "D08092  Isoxsuprine (INN)", "D08093  Isoxsuprine lactate", "D08106  Labetalol (INN)", "D08111  Lercanidipine (INN)", "D08127  Lidocaine hydrochloride monohydrate", "D08146  Losartan (INN)", "D08155  Manidipine (INN)", "D08192  Metaraminol (INN)", "D08201  Methoxamine (BAN)", "D08206  Methylephedrine (BAN)", "D08212  Trimazosin (INN)", "D08215  Mexiletine (INN)", "D08217  Mibefradil (INN)", "D08270  Nicardipine (INN)", "D08284  Norepinephrine hydrochoride", "D08318  Oxprenolol (INN)", "D08340  Perhexiline (INN)", "D08362  Phentolamine (INN)", "D08365  Phenylephrine (INN)", "D08366  Phenylephrine tartrate", "D08394  Pirmenol (INN)", "D08411  Prazosin (INN)", "D08421  Procainamide (INN)", "D08435  Propafenone (INN)", "D08443  Propranolol (INN)", "D08458  Quinidine (BAN)", "D08459  Quinidine phenylethylbarbiturate", "D08525  Sotalol (INN)", "D08572  Tertatolol hydrochloride", "D08598  Tilisolol (INN)", "D08600  Timolol (INN)", "D08614  Tolazoline (INN)", "D08662  Urapidil hydrochloride", "D08865  Azilsartan kamedoxomil (USAN)", "D08892  Clevidipine (USAN/INN)", "D08941  Levamlodipine malate (USAN)", "D08966  Phenylephrine bitartrate (USP)", "D09789  Kirenidipine hydrochloride (JAN)", "D09794  Norepinephrine hydrochloride (JAN)", "D09833  Levosemotiadil fumarate (JAN)", "D09843  Beradilol monoethyl maleate (JAN)", "D09847  Metildigoxin (INN)", "D10556  Fimasartan (INN)", "D11142  Angiotensin II acetate (USAN)", "D11155  Eleclazine (USAN/INN)", "D11585  Terazosin hydrochloride anhydrous", "D11723  Levamlodipine maleate (USAN)", "D11881  Amlodipine benzoate", "D12253  Aficamten (USAN/INN)", "D12265  Mavacamten (JAN/USAN/INN)", "D12410  Landiolol (USAN/INN)", "D12616  Bliretrigine (JAN/INN)", "D12804  Nelutroctiv (USAN/INN)", "D12840  Zilebesiran sodium (JAN/USAN)"], "dblinks": "GO: 0001997", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["153  ADRB1; adrenoceptor beta 1 [KO:K04141]", "154  ADRB2; adrenoceptor beta 2 [KO:K04142]", "2778  GNAS; GNAS complex locus [KO:K04632]", "107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]", "108  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]", "109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]", "196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]", "113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]", "114  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]", "115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]", "11149  BVES; blood vessel epicardial substance [KO:K21108]", "64091  POPDC2; popeye domain containing 2 [KO:K26206]", "64208  POPDC3; popeye domain containing 3 [KO:K26207]", "3776  KCNK2; potassium two pore domain channel subfamily K member 2 [KO:K04913]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "476  ATP1A1; ATPase Na+/K+ transporting subunit alpha 1 [KO:K01539] [EC:7.2.2.13]", "477  ATP1A2; ATPase Na+/K+ transporting subunit alpha 2 [KO:K01539] [EC:7.2.2.13]", "478  ATP1A3; ATPase Na+/K+ transporting subunit alpha 3 [KO:K01539] [EC:7.2.2.13]", "480  ATP1A4; ATPase Na+/K+ transporting subunit alpha 4 [KO:K01539] [EC:7.2.2.13]", "23439  ATP1B4; ATPase Na+/K+ transporting family member beta 4 [KO:K01540]", "481  ATP1B1; ATPase Na+/K+ transporting subunit beta 1 [KO:K01540]", "482  ATP1B2; ATPase Na+/K+ transporting subunit beta 2 [KO:K01540]", "483  ATP1B3; ATPase Na+/K+ transporting subunit beta 3 [KO:K01540]", "486  FXYD2; FXYD domain containing ion transport regulator 2 [KO:K01538]", "6548  SLC9A1; solute carrier family 9 member A1 [KO:K05742]", "3784  KCNQ1; potassium voltage-gated channel subfamily Q member 1 [KO:K04926]", "3753  KCNE1; potassium voltage-gated channel subfamily E regulatory subunit 1 [KO:K04894]", "102723475  KCNE1B; potassium voltage-gated channel subfamily E regulatory subunit 1B [KO:K04894]", "490  ATP2B1; ATPase plasma membrane Ca2+ transporting 1 [KO:K05850] [EC:7.2.2.10]", "492  ATP2B3; ATPase plasma membrane Ca2+ transporting 3 [KO:K05850] [EC:7.2.2.10]", "493  ATP2B4; ATPase plasma membrane Ca2+ transporting 4 [KO:K05850] [EC:7.2.2.10]", "491  ATP2B2; ATPase plasma membrane Ca2+ transporting 2 [KO:K05850] [EC:7.2.2.10]", "6546  SLC8A1; solute carrier family 8 member A1 [KO:K05849]", "6543  SLC8A2; solute carrier family 8 member A2 [KO:K05849]", "6547  SLC8A3; solute carrier family 8 member A3 [KO:K05849]", "6331  SCN5A; sodium voltage-gated channel alpha subunit 5 [KO:K04838]", "6332  SCN7A; sodium voltage-gated channel alpha subunit 7 [KO:K04839]", "6324  SCN1B; sodium voltage-gated channel beta subunit 1 [KO:K04845]", "6330  SCN4B; sodium voltage-gated channel beta subunit 4 [KO:K04848]", "775  CACNA1C; calcium voltage-gated channel subunit alpha1 C [KO:K04850]", "776  CACNA1D; calcium voltage-gated channel subunit alpha1 D [KO:K04851]", "778  CACNA1F; calcium voltage-gated channel subunit alpha1 F [KO:K04853]", "779  CACNA1S; calcium voltage-gated channel subunit alpha1 S [KO:K04857]", "782  CACNB1; calcium voltage-gated channel auxiliary subunit beta 1 [KO:K04862]", "783  CACNB2; calcium voltage-gated channel auxiliary subunit beta 2 [KO:K04863]", "784  CACNB3; calcium voltage-gated channel auxiliary subunit beta 3 [KO:K04864]", "785  CACNB4; calcium voltage-gated channel auxiliary subunit beta 4 [KO:K04865]", "781  CACNA2D1; calcium voltage-gated channel auxiliary subunit alpha2delta 1 [KO:K04858]", "9254  CACNA2D2; calcium voltage-gated channel auxiliary subunit alpha2delta 2 [KO:K04859]", "55799  CACNA2D3; calcium voltage-gated channel auxiliary subunit alpha2delta 3 [KO:K04860]", "93589  CACNA2D4; calcium voltage-gated channel auxiliary subunit alpha2delta 4 [KO:K04861]", "786  CACNG1; calcium voltage-gated channel auxiliary subunit gamma 1 [KO:K04866]", "10369  CACNG2; calcium voltage-gated channel auxiliary subunit gamma 2 [KO:K04867]", "10368  CACNG3; calcium voltage-gated channel auxiliary subunit gamma 3 [KO:K04868]", "27092  CACNG4; calcium voltage-gated channel auxiliary subunit gamma 4 [KO:K04869]", "27091  CACNG5; calcium voltage-gated channel auxiliary subunit gamma 5 [KO:K04870]", "59285  CACNG6; calcium voltage-gated channel auxiliary subunit gamma 6 [KO:K04871]", "59284  CACNG7; calcium voltage-gated channel auxiliary subunit gamma 7 [KO:K04872]", "59283  CACNG8; calcium voltage-gated channel auxiliary subunit gamma 8 [KO:K04873]", "810  CALML3; calmodulin like 3 [KO:K02183]", "805  CALM2; calmodulin 2 [KO:K02183]", "808  CALM3; calmodulin 3 [KO:K02183]", "801  CALM1; calmodulin 1 [KO:K02183]", "163688  CALML6; calmodulin like 6 [KO:K02183]", "51806  CALML5; calmodulin like 5 [KO:K02183]", "91860  CALML4; calmodulin like 4 [KO:K02183]", "815  CAMK2A; calcium/calmodulin dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]", "817  CAMK2D; calcium/calmodulin dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]", "816  CAMK2B; calcium/calmodulin dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]", "818  CAMK2G; calcium/calmodulin dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]", "6262  RYR2; ryanodine receptor 2 [KO:K04962]", "5515  PPP2CA; protein phosphatase 2 catalytic subunit alpha [KO:K04382] [EC:3.1.3.16]", "5516  PPP2CB; protein phosphatase 2 catalytic subunit beta [KO:K04382] [EC:3.1.3.16]", "5519  PPP2R1B; protein phosphatase 2 scaffold subunit Abeta [KO:K03456]", "5518  PPP2R1A; protein phosphatase 2 scaffold subunit Aalpha [KO:K03456]", "5520  PPP2R2A; protein phosphatase 2 regulatory subunit Balpha [KO:K04354]", "5521  PPP2R2B; protein phosphatase 2 regulatory subunit Bbeta [KO:K04354]", "5522  PPP2R2C; protein phosphatase 2 regulatory subunit Bgamma [KO:K04354]", "55844  PPP2R2D; protein phosphatase 2 regulatory subunit Bdelta [KO:K04354]", "28227  PPP2R3B; protein phosphatase 2 regulatory subunit B''beta [KO:K11583]", "55012  PPP2R3C; protein phosphatase 2 regulatory subunit B''gamma [KO:K11583]", "5523  PPP2R3A; protein phosphatase 2 regulatory subunit B''alpha [KO:K11583]", "5526  PPP2R5B; protein phosphatase 2 regulatory subunit B'beta [KO:K11584]", "5527  PPP2R5C; protein phosphatase 2 regulatory subunit B'gamma [KO:K11584]", "5528  PPP2R5D; protein phosphatase 2 regulatory subunit B'delta [KO:K11584]", "5529  PPP2R5E; protein phosphatase 2 regulatory subunit B'epsilon [KO:K11584]", "5525  PPP2R5A; protein phosphatase 2 regulatory subunit B'alpha [KO:K11584]", "5499  PPP1CA; protein phosphatase 1 catalytic subunit alpha [KO:K06269] [EC:3.1.3.16]", "5500  PPP1CB; protein phosphatase 1 catalytic subunit beta [KO:K06269] [EC:3.1.3.16]", "5501  PPP1CC; protein phosphatase 1 catalytic subunit gamma [KO:K06269] [EC:3.1.3.16]", "7134  TNNC1; troponin C1, slow skeletal and cardiac type [KO:K05865]", "7137  TNNI3; troponin I3, cardiac type [KO:K12044]", "7139  TNNT2; troponin T2, cardiac type [KO:K12045]", "7168  TPM1; tropomyosin 1 [KO:K10373]", "7169  TPM2; tropomyosin 2 [KO:K10374]", "7170  TPM3; tropomyosin 3 [KO:K09290]", "7171  TPM4; tropomyosin 4 [KO:K10375]", "70  ACTC1; actin alpha cardiac muscle 1 [KO:K12314]", "4625  MYH7; myosin heavy chain 7 [KO:K17751]", "4624  MYH6; myosin heavy chain 6 [KO:K17751]", "4633  MYL2; myosin light chain 2 [KO:K10351]", "4634  MYL3; myosin light chain 3 [KO:K12749]", "4635  MYL4; myosin light chain 4 [KO:K12750]", "5350  PLN; phospholamban [KO:K05852]", "487  ATP2A1; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 [KO:K05853] [EC:7.2.2.10]", "489  ATP2A3; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 [KO:K05853] [EC:7.2.2.10]", "488  ATP2A2; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 [KO:K05853] [EC:7.2.2.10]", "183  AGT; angiotensinogen [KO:K09821]", "185  AGTR1; angiotensin II receptor type 1 [KO:K04166]", "186  AGTR2; angiotensin II receptor type 2 [KO:K04167]", "148  ADRA1A; adrenoceptor alpha 1A [KO:K04135]", "147  ADRA1B; adrenoceptor alpha 1B [KO:K04136]", "146  ADRA1D; adrenoceptor alpha 1D [KO:K04137]", "2776  GNAQ; G protein subunit alpha q [KO:K04634]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5502  PPP1R1A; protein phosphatase 1 regulatory inhibitor subunit 1A [KO:K08050]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "9252  RPS6KA5; ribosomal protein S6 kinase A5 [KO:K04445] [EC:2.7.11.1]", "1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]", "1386  ATF2; activating transcription factor 2 [KO:K04450]", "468  ATF4; activating transcription factor 4 [KO:K04374]", "10488  CREB3; cAMP responsive element binding protein 3 [KO:K09048]", "90993  CREB3L1; cAMP responsive element binding protein 3 like 1 [KO:K09048]", "64764  CREB3L2; cAMP responsive element binding protein 3 like 2 [KO:K09048]", "84699  CREB3L3; cAMP responsive element binding protein 3 like 3 [KO:K09048]", "148327  CREB3L4; cAMP responsive element binding protein 3 like 4 [KO:K09048]", "9586  CREB5; cAMP responsive element binding protein 5 [KO:K09047]", "1388  ATF6B; activating transcription factor 6 beta [KO:K09049]", "1390  CREM; cAMP responsive element modulator [KO:K09052]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]", "10411  RAPGEF3; Rap guanine nucleotide exchange factor 3 [KO:K08014]", "11069  RAPGEF4; Rap guanine nucleotide exchange factor 4 [KO:K04351]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "2770  GNAI1; G protein subunit alpha i1 [KO:K04630]", "2773  GNAI3; G protein subunit alpha i3 [KO:K04630]", "2771  GNAI2; G protein subunit alpha i2 [KO:K04630]", "5294  PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma [KO:K21289] [EC:2.7.1.153]", "23533  PIK3R5; phosphoinositide-3-kinase regulatory subunit 5 [KO:K21290]", "146850  PIK3R6; phosphoinositide-3-kinase regulatory subunit 6 [KO:K21290]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]"], "compound": ["C00076  Calcium cation", "C00080  H+", "C00165  Diacylglycerol", "C00238  Potassium cation", "C00547  L-Noradrenaline", "C00575  3',5'-Cyclic AMP", "C00788  L-Adrenaline", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C01330  Sodium cation", "C07056  Isoproterenol"], "refs": [{"pmid": "19883653", "authors": "  Grimm M, Brown JH", "title": "Beta-adrenergic receptor signaling in the heart: role of CaMKII.", "journal": "J Mol Cell Cardiol 48:322-30 (2010)", "doi": "10.1016/j.yjmcc.2009.10.016"}, {"pmid": "21212391", "authors": "  Yang JH, Saucerman JJ", "title": "Computational models reduce complexity and accelerate insight into cardiac signaling networks.", "journal": "Circ Res 108:85-97 (2011)", "doi": "10.1161/CIRCRESAHA.110.223602"}, {"pmid": "16765984", "authors": "  Schaub MC, Hefti MA, Zaugg M", "title": "Integration of calcium with the signaling network in cardiac myocytes.", "journal": "J Mol Cell Cardiol 41:183-214 (2006)", "doi": "10.1016/j.yjmcc.2006.04.005"}, {"pmid": "22022314", "authors": "  Taggart P, Boyett MR, Logantha S, Lambiase PD", "title": "Anger, emotion, and arrhythmias: from brain to heart.", "journal": "Front Physiol 2:67 (2011)", "doi": "10.3389/fphys.2011.00067"}, {"pmid": "17988210", "authors": "  Bers DM", "title": "Calcium cycling and signaling in cardiac myocytes.", "journal": "Annu Rev Physiol 70:23-49 (2008)", "doi": "10.1146/annurev.physiol.70.113006.100455"}, {"pmid": "20923637", "authors": "  Soltis AR, Saucerman JJ", "title": "Synergy between CaMKII substrates and beta-adrenergic signaling in regulation of cardiac myocyte Ca(2+) handling.", "journal": "Biophys J 99:2038-47 (2010)", "doi": "10.1016/j.bpj.2010.08.016"}, {"pmid": "12439640", "authors": "  Wallukat G", "title": "The beta-adrenergic receptors.", "journal": "Herz 27:683-90 (2002)", "doi": "10.1007/s00059-002-2434-z"}, {"pmid": "11604549", "authors": "  Xiao RP", "title": "Beta-adrenergic signaling in the heart: dual coupling of the beta2-adrenergic receptor to G(s) and G(i) proteins.", "journal": "Sci STKE 2001:re15 (2001)", "doi": "10.1126/stke.2001.104.re15"}, {"pmid": "10571541", "authors": "  Xiao RP, Cheng H, Zhou YY, Kuschel M, Lakatta EG", "title": "Recent advances in cardiac beta(2)-adrenergic signal transduction.", "journal": "Circ Res 85:1092-100 (1999)", "doi": "10.1161/01.RES.85.11.1092"}, {"pmid": "15979723", "authors": "  Zheng M, Zhu W, Han Q, Xiao RP", "title": "Emerging concepts and therapeutic implications of beta-adrenergic receptor subtype signaling.", "journal": "Pharmacol Ther 108:257-68 (2005)", "doi": "10.1016/j.pharmthera.2005.04.006"}, {"pmid": "17826821", "authors": "  Kuzumoto M, Takeuchi A, Nakai H, Oka C, Noma A, Matsuoka S", "title": "Simulation analysis of intracellular Na+ and Cl- homeostasis during beta 1-adrenergic stimulation of cardiac myocyte.", "journal": "Prog Biophys Mol Biol 96:171-86 (2008)", "doi": "10.1016/j.pbiomolbio.2007.07.005"}, {"pmid": "11805843", "authors": "  Bers DM", "title": "Cardiac excitation-contraction coupling.", "journal": "Nature 415:198-205 (2002)", "doi": "10.1038/415198a"}, {"pmid": "20658186", "authors": "  Ho D, Yan L, Iwatsubo K, Vatner DE, Vatner SF", "title": "Modulation of beta-adrenergic receptor signaling in heart failure and longevity: targeting adenylyl cyclase type 5.", "journal": "Heart Fail Rev 15:495-512 (2010)", "doi": "10.1007/s10741-010-9183-5"}, {"pmid": "15142747", "authors": "  Saucerman JJ, McCulloch AD", "title": "Mechanistic systems models of cell signaling networks: a case study of myocyte adrenergic regulation.", "journal": "Prog Biophys Mol Biol 85:261-78 (2004)", "doi": "10.1016/j.pbiomolbio.2004.01.005"}, {"pmid": "15765137", "authors": "  Yano M, Ikeda Y, Matsuzaki M", "title": "Altered intracellular Ca2+ handling in heart failure.", "journal": "J Clin Invest 115:556-64 (2005)", "doi": "10.1172/JCI24159"}, {"pmid": "15232578", "authors": "  Wehrens XH, Marks AR", "title": "Novel therapeutic approaches for heart failure by normalizing calcium cycling.", "journal": "Nat Rev Drug Discov 3:565-73 (2004)", "doi": "10.1038/nrd1440"}, {"pmid": "19874988", "authors": "  Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G, Butler J", "title": "The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.", "journal": "J Am Coll Cardiol 54:1747-62 (2009)", "doi": "10.1016/j.jacc.2009.05.015"}], "rel_pathway": ["hsa04020  Calcium signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04260  Cardiac muscle contraction"], "ko_pathway": "ko04261", "genes": ["TPM4", "AKT2", "AKT1", "MAPK13"]}, {"kegg_id": "hsa04814", "name": "Motor proteins - Homo sapiens (human)", "class": "Cellular Processes; Cell motility", "pathway_map": "hsa04814  Motor proteins", "drug": ["D12804  Nelutroctiv (USAN/INN)", "D12902  Sevasemten (USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["1778  DYNC1H1; dynein cytoplasmic 1 heavy chain 1 [KO:K10413]", "79659  DYNC2H1; dynein cytoplasmic 2 heavy chain 1 [KO:K10414]", "1780  DYNC1I1; dynein cytoplasmic 1 intermediate chain 1 [KO:K10415]", "1781  DYNC1I2; dynein cytoplasmic 1 intermediate chain 2 [KO:K10415]", "1783  DYNC1LI2; dynein cytoplasmic 1 light intermediate chain 2 [KO:K10416]", "51143  DYNC1LI1; dynein cytoplasmic 1 light intermediate chain 1 [KO:K10416]", "51626  DYNC2LI1; dynein cytoplasmic 2 light intermediate chain 1 [KO:K10417]", "8655  DYNLL1; dynein light chain LC8-type 1 [KO:K10418]", "140735  DYNLL2; dynein light chain LC8-type 2 [KO:K10418]", "83658  DYNLRB1; dynein light chain roadblock-type 1 [KO:K10419]", "83657  DYNLRB2; dynein light chain roadblock-type 2 [KO:K10419]", "6993  DYNLT1; dynein light chain Tctex-type 1 [KO:K10420]", "6990  DYNLT3; dynein light chain Tctex-type 3 [KO:K10420]", "6991  DYNLT2; dynein light chain Tctex-type 2 [KO:K25419]", "343521  DYNLT4; dynein light chain Tctex-type 4 [KO:K25420]", "200132  DYNLT5; dynein light chain Tctex-type family member 5 [KO:K25421]", "25981  DNAH1; dynein axonemal heavy chain 1 [KO:K10408]", "55567  DNAH3; dynein axonemal heavy chain 3 [KO:K10408]", "146754  DNAH2; dynein axonemal heavy chain 2 [KO:K10408]", "56171  DNAH7; dynein axonemal heavy chain 7 [KO:K10408]", "1767  DNAH5; dynein axonemal heavy chain 5 [KO:K10408]", "1768  DNAH6; dynein axonemal heavy chain 6 [KO:K10408]", "1770  DNAH9; dynein axonemal heavy chain 9 [KO:K10408]", "8701  DNAH11; dynein axonemal heavy chain 11 [KO:K10408]", "201625  DNAH12; dynein axonemal heavy chain 12 [KO:K10408]", "127602  DNAH14; dynein axonemal heavy chain 14 [KO:K10408]", "1769  DNAH8; dynein axonemal heavy chain 8 [KO:K10408]", "196385  DNAH10; dynein axonemal heavy chain 10 [KO:K10408]", "8632  DNAH17; dynein axonemal heavy chain 17 [KO:K10408]", "27019  DNAI1; dynein axonemal intermediate chain 1 [KO:K10409]", "64446  DNAI2; dynein axonemal intermediate chain 2 [KO:K11143]", "126820  DNAI3; dynein axonemal intermediate chain 3 [KO:K24722]", "79819  DNAI4; dynein axonemal intermediate chain 4 [KO:K24723]", "7802  DNALI1; dynein axonemal light intermediate chain 1 [KO:K10410]", "83544  DNAL1; dynein axonemal light chain 1 [KO:K10411]", "10126  DNAL4; dynein axonemal light chain 4 [KO:K10412]", "1639  DCTN1; dynactin subunit 1 [KO:K04648]", "10540  DCTN2; dynactin subunit 2 [KO:K10424]", "11258  DCTN3; dynactin subunit 3 [KO:K10425]", "51164  DCTN4; dynactin subunit 4 [KO:K10426]", "84516  DCTN5; dynactin subunit 5 [KO:K10427]", "10671  DCTN6; dynactin subunit 6 [KO:K10428]", "10121  ACTR1A; actin related protein 1A [KO:K16575]", "10120  ACTR1B; actin related protein 1B [KO:K16575]", "55860  ACTR10; actin related protein 10 [KO:K16576]", "829  CAPZA1; capping actin protein of muscle Z-line subunit alpha 1 [KO:K10364]", "830  CAPZA2; capping actin protein of muscle Z-line subunit alpha 2 [KO:K10364]", "93661  CAPZA3; capping actin protein of muscle Z-line subunit alpha 3 [KO:K10364]", "832  CAPZB; capping actin protein of muscle Z-line subunit beta [KO:K10365]", "92558  BICDL1; BICD family like cargo adaptor 1 [KO:K16756]", "146439  BICDL2; BICD family like cargo adaptor 2 [KO:K16756]", "84376  HOOK3; hook microtubule tethering protein 3 [KO:K16536]", "10376  TUBA1B; tubulin alpha 1b [KO:K07374]", "7277  TUBA4A; tubulin alpha 4a [KO:K07374]", "7278  TUBA3C; tubulin alpha 3c [KO:K07374]", "7846  TUBA1A; tubulin alpha 1a [KO:K07374]", "84790  TUBA1C; tubulin alpha 1c [KO:K07374]", "51807  TUBA8; tubulin alpha 8 [KO:K07374]", "112714  TUBA3E; tubulin alpha 3e [KO:K07374]", "113457  TUBA3D; tubulin alpha 3d [KO:K07374]", "79861  TUBAL3; tubulin alpha like 3 [KO:K07374]", "84617  TUBB6; tubulin beta 6 class V [KO:K07375]", "203068  TUBB; tubulin beta class I [KO:K07375]", "81027  TUBB1; tubulin beta 1 class VI [KO:K07375]", "7280  TUBB2A; tubulin beta 2A class IIa [KO:K07375]", "10381  TUBB3; tubulin beta 3 class III [KO:K07375]", "10382  TUBB4A; tubulin beta 4A class IVa [KO:K07375]", "347688  TUBB8; tubulin beta 8 class VIII [KO:K07375]", "347733  TUBB2B; tubulin beta 2B class IIb [KO:K07375]", "10383  TUBB4B; tubulin beta 4B class IVb [KO:K07375]", "27175  TUBG2; tubulin gamma 2 [KO:K10389]", "7283  TUBG1; tubulin gamma 1 [KO:K10389]", "51174  TUBD1; tubulin delta 1 [KO:K10390]", "51175  TUBE1; tubulin epsilon 1 [KO:K10391]", "3798  KIF5A; kinesin family member 5A [KO:K10396]", "3799  KIF5B; kinesin family member 5B [KO:K10396]", "3800  KIF5C; kinesin family member 5C [KO:K10396]", "147700  KLC3; kinesin light chain 3 [KO:K10407]", "3831  KLC1; kinesin light chain 1 [KO:K10407]", "64837  KLC2; kinesin light chain 2 [KO:K10407]", "89953  KLC4; kinesin light chain 4 [KO:K10407]", "11127  KIF3A; kinesin family member 3A [KO:K10394]", "9371  KIF3B; kinesin family member 3B [KO:K20196]", "22920  KIFAP3; kinesin associated protein 3 [KO:K25388]", "3797  KIF3C; kinesin family member 3C [KO:K20197]", "57576  KIF17; kinesin family member 17 [KO:K20198]", "23095  KIF1B; kinesin family member 1B [KO:K10392]", "547  KIF1A; kinesin family member 1A [KO:K10392]", "10749  KIF1C; kinesin family member 1C [KO:K10392]", "23303  KIF13B; kinesin family member 13B [KO:K17914]", "63971  KIF13A; kinesin family member 13A [KO:K17914]", "9928  KIF14; kinesin family member 14 [KO:K17915]", "55614  KIF16B; kinesin family member 16B [KO:K17916]", "57519  STARD9; StAR related lipid transfer domain containing 9 [KO:K16491]", "24137  KIF4A; kinesin family member 4A [KO:K10395]", "285643  KIF4B; kinesin family member 4B [KO:K10395]", "374654  KIF7; kinesin family member 7 [KO:K18806]", "23046  KIF21B; kinesin family member 21B [KO:K24185]", "55605  KIF21A; kinesin family member 21A [KO:K24185]", "55582  KIF27; kinesin family member 27 [KO:K24186]", "3832  KIF11; kinesin family member 11 [KO:K10398]", "10112  KIF20A; kinesin family member 20A [KO:K10402]", "9585  KIF20B; kinesin family member 20B [KO:K10402]", "9493  KIF23; kinesin family member 23 [KO:K17387]", "1062  CENPE; centromere protein E [KO:K11498]", "81930  KIF18A; kinesin family member 18A [KO:K10401]", "146909  KIF18B; kinesin family member 18B [KO:K26156]", "124602  KIF19; kinesin family member 19 [KO:K26157]", "221458  KIF6; kinesin family member 6 [KO:K10397]", "64147  KIF9; kinesin family member 9 [KO:K10397]", "3835  KIF22; kinesin family member 22 [KO:K10403]", "26153  KIF26A; kinesin family member 26A [KO:K10404]", "55083  KIF26B; kinesin family member 26B [KO:K10404]", "113220  KIF12; kinesin family member 12 [KO:K10399]", "56992  KIF15; kinesin family member 15 [KO:K10400]", "84643  KIF2B; kinesin family member 2B [KO:K10393]", "11004  KIF2C; kinesin family member 2C [KO:K10393]", "347240  KIF24; kinesin family member 24 [KO:K10393]", "3796  KIF2A; kinesin family member 2A [KO:K10393]", "3833  KIFC1; kinesin family member C1 [KO:K10405]", "3801  KIFC3; kinesin family member C3 [KO:K10406]", "90990  KIFC2; kinesin family member C2 [KO:K10406]", "3834  KIF25; kinesin family member 25 [KO:K18627]", "283446  MYO1H; myosin IH [KO:K10356]", "4430  MYO1B; myosin IB [KO:K10356]", "4542  MYO1F; myosin IF [KO:K10356]", "4640  MYO1A; myosin IA [KO:K10356]", "4641  MYO1C; myosin IC [KO:K10356]", "4642  MYO1D; myosin ID [KO:K10356]", "4643  MYO1E; myosin IE [KO:K10356]", "64005  MYO1G; myosin IG [KO:K10356]", "140469  MYO3B; myosin IIIB [KO:K08834] [EC:2.7.11.1]", "53904  MYO3A; myosin IIIA [KO:K08834] [EC:2.7.11.1]", "4644  MYO5A; myosin VA [KO:K10357]", "4645  MYO5B; myosin VB [KO:K10357]", "55930  MYO5C; myosin VC [KO:K10357]", "4646  MYO6; myosin VI [KO:K10358]", "4647  MYO7A; myosin VIIA [KO:K10359]", "4648  MYO7B; myosin VIIB [KO:K21868]", "4649  MYO9A; myosin IXA [KO:K10360]", "4650  MYO9B; myosin IXB [KO:K10360]", "4651  MYO10; myosin X [KO:K12559]", "51168  MYO15A; myosin XVA [KO:K10361]", "80022  MYO15B; myosin XVB [KO:K10361]", "23026  MYO16; myosin XVI [KO:K17481]", "399687  MYO18A; myosin XVIIIA [KO:K10362]", "84700  MYO18B; myosin XVIIIB [KO:K10362]", "80179  MYO19; myosin XIX [KO:K25838]", "4619  MYH1; myosin heavy chain 1 [KO:K24220]", "4622  MYH4; myosin heavy chain 4 [KO:K24220]", "4626  MYH8; myosin heavy chain 8 [KO:K24220]", "4620  MYH2; myosin heavy chain 2 [KO:K24220]", "4621  MYH3; myosin heavy chain 3 [KO:K24220]", "57644  MYH7B; myosin heavy chain 7B [KO:K24220]", "22989  MYH15; myosin heavy chain 15 [KO:K24220]", "8735  MYH13; myosin heavy chain 13 [KO:K24220]", "4625  MYH7; myosin heavy chain 7 [KO:K17751]", "4624  MYH6; myosin heavy chain 6 [KO:K17751]", "4627  MYH9; myosin heavy chain 9 [KO:K10352]", "4628  MYH10; myosin heavy chain 10 [KO:K10352]", "4629  MYH11; myosin heavy chain 11 [KO:K10352]", "79784  MYH14; myosin heavy chain 14 [KO:K10352]", "4632  MYL1; myosin light chain 1 [KO:K05738]", "4634  MYL3; myosin light chain 3 [KO:K12749]", "4635  MYL4; myosin light chain 4 [KO:K12750]", "140465  MYL6B; myosin light chain 6B [KO:K12751]", "4637  MYL6; myosin light chain 6 [KO:K12751]", "4633  MYL2; myosin light chain 2 [KO:K10351]", "4636  MYL5; myosin light chain 5 [KO:K12753]", "58498  MYL7; myosin light chain 7 [KO:K12754]", "10398  MYL9; myosin light chain 9 [KO:K12755]", "93408  MYL10; myosin light chain 10 [KO:K12756]", "103910  MYL12B; myosin light chain 12B [KO:K12757]", "10627  MYL12A; myosin light chain 12A [KO:K12757]", "29895  MYL11; myosin light chain 11 [KO:K12758]", "58  ACTA1; actin alpha 1, skeletal muscle [KO:K10354]", "59  ACTA2; actin alpha 2, smooth muscle [KO:K12313]", "70  ACTC1; actin alpha cardiac muscle 1 [KO:K12314]", "72  ACTG2; actin gamma 2, smooth muscle [KO:K12315]", "71  ACTG1; actin gamma 1 [KO:K05692]", "60  ACTB; actin beta [KO:K05692]", "7134  TNNC1; troponin C1, slow skeletal and cardiac type [KO:K05865]", "7135  TNNI1; troponin I1, slow skeletal type [KO:K10371]", "7138  TNNT1; troponin T1, slow skeletal type [KO:K10372]", "7125  TNNC2; troponin C2, fast skeletal type [KO:K12042]", "7136  TNNI2; troponin I2, fast skeletal type [KO:K12043]", "7140  TNNT3; troponin T3, fast skeletal type [KO:K12046]", "7137  TNNI3; troponin I3, cardiac type [KO:K12044]", "7139  TNNT2; troponin T2, cardiac type [KO:K12045]", "7168  TPM1; tropomyosin 1 [KO:K10373]", "7169  TPM2; tropomyosin 2 [KO:K10374]", "7170  TPM3; tropomyosin 3 [KO:K09290]", "7171  TPM4; tropomyosin 4 [KO:K10375]"], "refs": [{"pmid": "21092854", "authors": "  Hirokawa N, Niwa S, Tanaka Y", "title": "Molecular motors in neurons: transport mechanisms and roles in brain function, development, and disease.", "journal": "Neuron 68:610-38 (2010)", "doi": "10.1016/j.neuron.2010.09.039"}, {"pmid": "25470043 (PDB:4RH7)", "authors": "  Schmidt H, Zalyte R, Urnavicius L, Carter AP", "title": "Structure of human cytoplasmic dynein-2 primed for its power stroke.", "journal": "Nature 518:435-438 (2015)", "doi": "10.1038/nature14023"}, {"pmid": "22398446 (PDB:3VKG 3VKH)", "authors": "  Kon T, Oyama T, Shimo-Kon R, Imamula K, Shima T, Sutoh K, Kurisu G", "title": "The 2.8 A crystal structure of the dynein motor domain.", "journal": "Nature 484:345-50 (2012)", "doi": "10.1038/nature10955"}, {"pmid": "22997337 (PDB:3J1T 3J1U)", "authors": "  Redwine WB, Hernandez-Lopez R, Zou S, Huang J, Reck-Peterson SL, Leschziner AE", "title": "Structural basis for microtubule binding and release by dynein.", "journal": "Science 337:1532-1536 (2012)", "doi": "10.1126/science.1224151"}, {"pmid": "26410600", "authors": "  Gibbs KL, Greensmith L, Schiavo G", "title": "Regulation of Axonal Transport by Protein Kinases.", "journal": "Trends Biochem Sci 40:597-610 (2015)", "doi": "10.1016/j.tibs.2015.08.003"}, {"pmid": "28602352 (PDB:5NUG 5NVS 5NVU 5NW4)", "authors": "  Zhang K, Foster HE, Rondelet A, Lacey SE, Bahi-Buisson N, Bird AW, Carter AP", "title": "Cryo-EM Reveals How Human Cytoplasmic Dynein Is Auto-inhibited and Activated.", "journal": "Cell 169:1303-1314.e18 (2017)", "doi": "10.1016/j.cell.2017.05.025"}, {"pmid": "25814576 (PDB:5ADX 5AFR 5AFU)", "authors": "  Urnavicius L, Zhang K, Diamant AG, Motz C, Schlager MA, Yu M, Patel NA, Robinson CV, Carter AP", "title": "The structure of the dynactin complex and its interaction with dynein.", "journal": "Science 347:1441-1446 (2015)", "doi": "10.1126/science.aaa4080"}, {"pmid": "29420470 (PDB:5OWO 6F1T 6F1U 6F1V 6F1Y 6F1Z 6F38 6F3A)", "authors": "  Urnavicius L, Lau CK, Elshenawy MM, Morales-Rios E, Motz C, Yildiz A, Carter AP", "title": "Cryo-EM shows how dynactin recruits two dyneins for faster movement.", "journal": "Nature 554:202-206 (2018)", "doi": "10.1038/nature25462"}, {"pmid": "29662141", "authors": "  Reck-Peterson SL, Redwine WB, Vale RD, Carter AP", "title": "The cytoplasmic dynein transport machinery and its many cargoes.", "journal": "Nat Rev Mol Cell Biol 19:382-398 (2018)", "doi": "10.1038/s41580-018-0004-3"}, {"pmid": "23434508 (PDB:3J2U)", "authors": "  Asenjo AB, Chatterjee C, Tan D, DePaoli V, Rice WJ, Diaz-Avalos R, Silvestry M, Sosa H", "title": "Structural model for tubulin recognition and deformation by kinesin-13 microtubule depolymerases.", "journal": "Cell Rep 3:759-68 (2013)", "doi": "10.1016/j.celrep.2013.01.030"}, {"pmid": "10338210 (PDB:1B7T)", "authors": "  Houdusse A, Kalabokis VN, Himmel D, Szent-Gyorgyi AG, Cohen C", "title": "Atomic structure of scallop myosin subfragment S1 complexed with MgADP: a novel conformation of the myosin head.", "journal": "Cell 97:459-70 (1999)", "doi": "10.1016/s0092-8674(00)80756-4"}, {"pmid": "9428521 (PDB:3KIN)", "authors": "  Kozielski F, Sack S, Marx A, Thormahlen M, Schonbrunn E, Biou V, Thompson A, Mandelkow EM, Mandelkow E", "title": "The crystal structure of dimeric kinesin and implications for microtubule-dependent motility.", "journal": "Cell 91:985-94 (1997)", "doi": "10.1016/s0092-8674(00)80489-4"}, {"pmid": "8316857 (PDB:2MYS)", "authors": "  Rayment I, Rypniewski WR, Schmidt-Base K, Smith R, Tomchick DR, Benning MM, Winkelmann DA, Wesenberg G, Holden HM", "title": "Three-dimensional structure of myosin subfragment-1: a molecular motor.", "journal": "Science 261:50-8 (1993)", "doi": "10.1126/science.8316857"}, {"pmid": "20428469", "authors": "  Parker D, Bryant Z, Delp SL", "title": "Coarse-Grained Structural Modeling of Molecular Motors Using Multibody Dynamics.", "journal": "Cell Mol Bioeng 2:366-374 (2009)", "doi": "10.1007/s12195-009-0084-4"}, {"pmid": "21314430", "authors": "  Dominguez R, Holmes KC", "title": "Actin structure and function.", "journal": "Annu Rev Biophys 40:169-86 (2011)", "doi": "10.1146/annurev-biophys-042910-155359"}, {"pmid": "31919429 (PDB:6KN7 6KN8)", "authors": "  Yamada Y, Namba K, Fujii T", "title": "Cardiac muscle thin filament structures reveal calcium regulatory mechanism.", "journal": "Nat Commun 11:153 (2020)", "doi": "10.1038/s41467-019-14008-1"}], "ko_pathway": "ko04814", "genes": ["TPM4"]}, {"kegg_id": "hsa05410", "name": "Hypertrophic cardiomyopathy - Homo sapiens (human)", "description": "Hypertrophic cardiomyopathy (HCM) is a primary myocardial disorder with an autosomal dominant pattern of inheritance that is characterized by hypertrophy of the left ventricles with histological features of myocyte hypertrophy, myfibrillar disarray, and interstitial fibrosis. HCM is one of the most common inherited cardiac disorders, with a prevalence in young adults of 1 in 500. Hundreds of mutations in the genes that encode protein constituents of the sarcomere have been identified in HCM. These mutations increase the Ca2+ sensitivity of cardiac myofilaments. Increased myofilament Ca2+ sensitivity is expected to increase the ATP utilization by actomyosin at submaximal Ca2+ concentrations, which might cause an imbalance in energy supply and demand in the heart under severe stress. The inefficient use of ATP suggests that an inability to maintain normal ATP levels could be the central abnormality. This theory might be supported by the discovery of the role of a mutant PRKAG2 gene in HCM, which in active form acts as a central sensing mechanism protecting cells from depletion of ATP supplies. The increase in the myfilament Ca2+ sensitivity well account for the diastolic dysfunction of model animals as well as human patients of HCM. It has been widely proposed that left ventricular hypertrophy is not a primary manifestation but develops as compensatory response to sarcomere dysfunction.", "class": "Human Diseases; Cardiovascular disease", "pathway_map": "hsa05410  Hypertrophic cardiomyopathy", "disease": ["H00292  Hypertrophic cardiomyopathy"], "drug": ["D12253  Aficamten (USAN/INN)", "D12265  Mavacamten (JAN/USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["3672  ITGA1; integrin subunit alpha 1 [KO:K06480]", "3673  ITGA2; integrin subunit alpha 2 [KO:K06481]", "3674  ITGA2B; integrin subunit alpha 2b [KO:K06476]", "3675  ITGA3; integrin subunit alpha 3 [KO:K06482]", "3676  ITGA4; integrin subunit alpha 4 [KO:K06483]", "3678  ITGA5; integrin subunit alpha 5 [KO:K06484]", "3655  ITGA6; integrin subunit alpha 6 [KO:K06485]", "3679  ITGA7; integrin subunit alpha 7 [KO:K06583]", "8516  ITGA8; integrin subunit alpha 8 [KO:K06584]", "3680  ITGA9; integrin subunit alpha 9 [KO:K06585]", "8515  ITGA10; integrin subunit alpha 10 [KO:K06586]", "22801  ITGA11; integrin subunit alpha 11 [KO:K06587]", "3685  ITGAV; integrin subunit alpha V [KO:K06487]", "3688  ITGB1; integrin subunit beta 1 [KO:K05719]", "3690  ITGB3; integrin subunit beta 3 [KO:K06493]", "3691  ITGB4; integrin subunit beta 4 [KO:K06525]", "3693  ITGB5; integrin subunit beta 5 [KO:K06588]", "3694  ITGB6; integrin subunit beta 6 [KO:K06589]", "3695  ITGB7; integrin subunit beta 7 [KO:K06590]", "3696  ITGB8; integrin subunit beta 8 [KO:K06591]", "8082  SSPN; sarcospan [KO:K22194]", "6442  SGCA; sarcoglycan alpha [KO:K12565]", "6443  SGCB; sarcoglycan beta [KO:K12566]", "6445  SGCG; sarcoglycan gamma [KO:K12564]", "6444  SGCD; sarcoglycan delta [KO:K12563]", "8910  SGCE; sarcoglycan epsilon [KO:K27061]", "137868  SGCZ; sarcoglycan zeta [KO:K27062]", "284217  LAMA1; laminin subunit alpha 1 [KO:K05637]", "3908  LAMA2; laminin subunit alpha 2 [KO:K05637]", "1605  DAG1; dystroglycan 1 [KO:K06265]", "859  CAV3; caveolin 3 [KO:K12959]", "4842  NOS1; nitric oxide synthase 1 [KO:K13240] [EC:1.14.13.39]", "6640  SNTA1; syntrophin alpha 1 [KO:K24063]", "6645  SNTB2; syntrophin beta 2 [KO:K24064]", "6641  SNTB1; syntrophin beta 1 [KO:K24064]", "1837  DTNA; dystrobrevin alpha [KO:K26998]", "1674  DES; desmin [KO:K07610]", "1756  DMD; dystrophin [KO:K10366]", "71  ACTG1; actin gamma 1 [KO:K05692]", "60  ACTB; actin beta [KO:K05692]", "7273  TTN; titin [KO:K12567] [EC:2.7.11.1]", "7139  TNNT2; troponin T2, cardiac type [KO:K12045]", "7134  TNNC1; troponin C1, slow skeletal and cardiac type [KO:K05865]", "7137  TNNI3; troponin I3, cardiac type [KO:K12044]", "70  ACTC1; actin alpha cardiac muscle 1 [KO:K12314]", "7168  TPM1; tropomyosin 1 [KO:K10373]", "7169  TPM2; tropomyosin 2 [KO:K10374]", "7170  TPM3; tropomyosin 3 [KO:K09290]", "7171  TPM4; tropomyosin 4 [KO:K10375]", "4607  MYBPC3; myosin binding protein C3 [KO:K12568]", "4634  MYL3; myosin light chain 3 [KO:K12749]", "4633  MYL2; myosin light chain 2 [KO:K10351]", "4625  MYH7; myosin heavy chain 7 [KO:K17751]", "4624  MYH6; myosin heavy chain 6 [KO:K17751]", "2010  EMD; emerin [KO:K12569]", "4000  LMNA; lamin A/C [KO:K12641]", "775  CACNA1C; calcium voltage-gated channel subunit alpha1 C [KO:K04850]", "776  CACNA1D; calcium voltage-gated channel subunit alpha1 D [KO:K04851]", "778  CACNA1F; calcium voltage-gated channel subunit alpha1 F [KO:K04853]", "779  CACNA1S; calcium voltage-gated channel subunit alpha1 S [KO:K04857]", "782  CACNB1; calcium voltage-gated channel auxiliary subunit beta 1 [KO:K04862]", "783  CACNB2; calcium voltage-gated channel auxiliary subunit beta 2 [KO:K04863]", "784  CACNB3; calcium voltage-gated channel auxiliary subunit beta 3 [KO:K04864]", "785  CACNB4; calcium voltage-gated channel auxiliary subunit beta 4 [KO:K04865]", "781  CACNA2D1; calcium voltage-gated channel auxiliary subunit alpha2delta 1 [KO:K04858]", "9254  CACNA2D2; calcium voltage-gated channel auxiliary subunit alpha2delta 2 [KO:K04859]", "55799  CACNA2D3; calcium voltage-gated channel auxiliary subunit alpha2delta 3 [KO:K04860]", "93589  CACNA2D4; calcium voltage-gated channel auxiliary subunit alpha2delta 4 [KO:K04861]", "786  CACNG1; calcium voltage-gated channel auxiliary subunit gamma 1 [KO:K04866]", "10369  CACNG2; calcium voltage-gated channel auxiliary subunit gamma 2 [KO:K04867]", "10368  CACNG3; calcium voltage-gated channel auxiliary subunit gamma 3 [KO:K04868]", "27092  CACNG4; calcium voltage-gated channel auxiliary subunit gamma 4 [KO:K04869]", "27091  CACNG5; calcium voltage-gated channel auxiliary subunit gamma 5 [KO:K04870]", "59285  CACNG6; calcium voltage-gated channel auxiliary subunit gamma 6 [KO:K04871]", "59284  CACNG7; calcium voltage-gated channel auxiliary subunit gamma 7 [KO:K04872]", "59283  CACNG8; calcium voltage-gated channel auxiliary subunit gamma 8 [KO:K04873]", "6262  RYR2; ryanodine receptor 2 [KO:K04962]", "487  ATP2A1; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 [KO:K05853] [EC:7.2.2.10]", "489  ATP2A3; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 [KO:K05853] [EC:7.2.2.10]", "488  ATP2A2; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 [KO:K05853] [EC:7.2.2.10]", "5562  PRKAA1; protein kinase AMP-activated catalytic subunit alpha 1 [KO:K07198] [EC:2.7.11.31]", "5563  PRKAA2; protein kinase AMP-activated catalytic subunit alpha 2 [KO:K07198] [EC:2.7.11.31]", "5564  PRKAB1; protein kinase AMP-activated non-catalytic subunit beta 1 [KO:K07199]", "5565  PRKAB2; protein kinase AMP-activated non-catalytic subunit beta 2 [KO:K07199]", "5571  PRKAG1; protein kinase AMP-activated non-catalytic subunit gamma 1 [KO:K07200]", "53632  PRKAG3; protein kinase AMP-activated non-catalytic subunit gamma 3 [KO:K07200]", "51422  PRKAG2; protein kinase AMP-activated non-catalytic subunit gamma 2 [KO:K07200]", "1636  ACE; angiotensin I converting enzyme [KO:K01283] [EC:3.4.15.1]", "3479  IGF1; insulin like growth factor 1 [KO:K05459]", "7040  TGFB1; transforming growth factor beta 1 [KO:K13375]", "7042  TGFB2; transforming growth factor beta 2 [KO:K13376]", "7043  TGFB3; transforming growth factor beta 3 [KO:K13377]", "7124  TNF; tumor necrosis factor [KO:K03156]", "3569  IL6; interleukin 6 [KO:K05405]", "1906  EDN1; endothelin 1 [KO:K16366]", "183  AGT; angiotensinogen [KO:K09821]", "6546  SLC8A1; solute carrier family 8 member A1 [KO:K05849]", "6543  SLC8A2; solute carrier family 8 member A2 [KO:K05849]", "6547  SLC8A3; solute carrier family 8 member A3 [KO:K05849]"], "compound": ["C00002  ATP", "C00076  Calcium cation", "C01330  Sodium cation"], "refs": [{"pmid": "12270949", "authors": "  Fatkin D, Graham RM", "title": "Molecular mechanisms of inherited cardiomyopathies.", "journal": "Physiol Rev 82:945-80 (2002)", "doi": "10.1152/physrev.00012.2002"}, {"pmid": "14711353", "authors": "  Taylor MR, Carniel E, Mestroni L", "title": "Familial hypertrophic cardiomyopathy: clinical features, molecular genetics and molecular genetic testing.", "journal": "Expert Rev Mol Diagn 4:99-113 (2004)", "doi": "10.1586/14737159.4.1.99"}, {"pmid": "10615904", "authors": "  Marian AJ", "title": "Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy.", "journal": "Lancet 355:58-60 (2000)", "doi": "10.1016/S0140-6736(99)06187-5"}, {"pmid": "11371514", "authors": "  Blair E, Redwood C, Ashrafian H, Oliveira M, Broxholme J, Kerr B, Salmon A, Ostman-Smith I, Watkins H", "title": "Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis.", "journal": "Hum Mol Genet 10:1215-20 (2001)", "doi": "10.1093/hmg/10.11.1215"}, {"pmid": "11716909", "authors": "  Franz WM, Muller OJ, Katus HA", "title": "Cardiomyopathies: from genetics to the prospect of treatment.", "journal": "Lancet 358:1627-37 (2001)", "doi": "10.1016/S0140-6736(01)06657-0"}, {"pmid": "18056765", "authors": "  Morimoto S", "title": "Sarcomeric proteins and inherited cardiomyopathies.", "journal": "Cardiovasc Res 77:659-66 (2008)", "doi": "10.1093/cvr/cvm084"}, {"pmid": "19136482", "authors": "  Cambronero F, Marin F, Roldan V, Hernandez-Romero D, Valdes M, Lip GY", "title": "Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis.", "journal": "Eur Heart J 30:139-51 (2009)", "doi": "10.1093/eurheartj/ehn538"}, {"pmid": "11805847", "authors": "  Towbin JA, Bowles NE", "title": "The failing heart.", "journal": "Nature 415:227-33 (2002)", "doi": "10.1038/415227a"}, {"pmid": "11225594", "authors": "  Sorajja P, Elliott PM, McKenna WJ", "title": "The molecular genetics of hypertrophic cardiomyopathy: prognostic implications.", "journal": "Europace 2:4-14 (2000)", "doi": "10.1053/eupc.1999.0067"}], "rel_pathway": ["hsa04260  Cardiac muscle contraction", "hsa04350  TGF-beta signaling pathway", "hsa04512  ECM-receptor interaction", "hsa04614  Renin-angiotensin system", "hsa04630  JAK-STAT signaling pathway"], "ko_pathway": "ko05410", "genes": ["TPM4", "TTN"]}, {"kegg_id": "hsa05414", "name": "Dilated cardiomyopathy - Homo sapiens (human)", "description": "Dilated cardiomyopathy (DCM) is a heart muscle disease characterised by dilation and impaired contraction of the left or both ventricles that results in progressive heart failure and sudden cardiac death from ventricular arrhythmia. Genetically inherited forms of DCM (\"familial\" DCM) have been identified in 25-35% of patients presenting with this disease, and the inherited gene defects are an important cause of \"familial\" DCM. The pathophysiology may be separated into two categories: defects in force generation and defects in force transmission. In cases where an underlying pathology cannot be identified, the patient is diagnosed with an \"idiopathic\" DCM. Current hypotheses regarding causes of \"idiopathic\" DCM focus on myocarditis induced by enterovirus and subsequent autoimmune myocardium impairments. Antibodies to the beta1-adrenergic receptor (beta1AR), which are detected in a substantial number of patients with \"idiopathic\" DCM, may increase the concentration of intracellular cAMP and intracellular Ca2+, a condition often leading to a transient hyper-performance of the heart followed by depressed heart function and heart failure.", "class": "Human Diseases; Cardiovascular disease", "pathway_map": "hsa05414  Dilated cardiomyopathy", "disease": ["H00294  Dilated cardiomyopathy"], "drug": ["D00255  Carvedilol (JP18/USP/INN)", "D00634  Bisoprolol fumarate (JP18/USP)", "D03415  Carvedilol phosphate (USAN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["3672  ITGA1; integrin subunit alpha 1 [KO:K06480]", "3673  ITGA2; integrin subunit alpha 2 [KO:K06481]", "3674  ITGA2B; integrin subunit alpha 2b [KO:K06476]", "3675  ITGA3; integrin subunit alpha 3 [KO:K06482]", "3676  ITGA4; integrin subunit alpha 4 [KO:K06483]", "3678  ITGA5; integrin subunit alpha 5 [KO:K06484]", "3655  ITGA6; integrin subunit alpha 6 [KO:K06485]", "3679  ITGA7; integrin subunit alpha 7 [KO:K06583]", "8516  ITGA8; integrin subunit alpha 8 [KO:K06584]", "3680  ITGA9; integrin subunit alpha 9 [KO:K06585]", "8515  ITGA10; integrin subunit alpha 10 [KO:K06586]", "22801  ITGA11; integrin subunit alpha 11 [KO:K06587]", "3685  ITGAV; integrin subunit alpha V [KO:K06487]", "3688  ITGB1; integrin subunit beta 1 [KO:K05719]", "3690  ITGB3; integrin subunit beta 3 [KO:K06493]", "3691  ITGB4; integrin subunit beta 4 [KO:K06525]", "3693  ITGB5; integrin subunit beta 5 [KO:K06588]", "3694  ITGB6; integrin subunit beta 6 [KO:K06589]", "3695  ITGB7; integrin subunit beta 7 [KO:K06590]", "3696  ITGB8; integrin subunit beta 8 [KO:K06591]", "8082  SSPN; sarcospan [KO:K22194]", "6442  SGCA; sarcoglycan alpha [KO:K12565]", "6443  SGCB; sarcoglycan beta [KO:K12566]", "6445  SGCG; sarcoglycan gamma [KO:K12564]", "6444  SGCD; sarcoglycan delta [KO:K12563]", "8910  SGCE; sarcoglycan epsilon [KO:K27061]", "137868  SGCZ; sarcoglycan zeta [KO:K27062]", "284217  LAMA1; laminin subunit alpha 1 [KO:K05637]", "3908  LAMA2; laminin subunit alpha 2 [KO:K05637]", "1605  DAG1; dystroglycan 1 [KO:K06265]", "859  CAV3; caveolin 3 [KO:K12959]", "4842  NOS1; nitric oxide synthase 1 [KO:K13240] [EC:1.14.13.39]", "6640  SNTA1; syntrophin alpha 1 [KO:K24063]", "6645  SNTB2; syntrophin beta 2 [KO:K24064]", "6641  SNTB1; syntrophin beta 1 [KO:K24064]", "1837  DTNA; dystrobrevin alpha [KO:K26998]", "1756  DMD; dystrophin [KO:K10366]", "1674  DES; desmin [KO:K07610]", "71  ACTG1; actin gamma 1 [KO:K05692]", "60  ACTB; actin beta [KO:K05692]", "7273  TTN; titin [KO:K12567] [EC:2.7.11.1]", "7139  TNNT2; troponin T2, cardiac type [KO:K12045]", "7134  TNNC1; troponin C1, slow skeletal and cardiac type [KO:K05865]", "7137  TNNI3; troponin I3, cardiac type [KO:K12044]", "70  ACTC1; actin alpha cardiac muscle 1 [KO:K12314]", "7168  TPM1; tropomyosin 1 [KO:K10373]", "7169  TPM2; tropomyosin 2 [KO:K10374]", "7170  TPM3; tropomyosin 3 [KO:K09290]", "7171  TPM4; tropomyosin 4 [KO:K10375]", "4607  MYBPC3; myosin binding protein C3 [KO:K12568]", "4634  MYL3; myosin light chain 3 [KO:K12749]", "4633  MYL2; myosin light chain 2 [KO:K10351]", "4625  MYH7; myosin heavy chain 7 [KO:K17751]", "4624  MYH6; myosin heavy chain 6 [KO:K17751]", "2010  EMD; emerin [KO:K12569]", "4000  LMNA; lamin A/C [KO:K12641]", "102723407  IGH; immunoglobulin heavy variable 4-38-2-like [KO:K06856]", "153  ADRB1; adrenoceptor beta 1 [KO:K04141]", "2778  GNAS; GNAS complex locus [KO:K04632]", "107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]", "108  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]", "109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]", "196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]", "113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]", "114  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]", "115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "775  CACNA1C; calcium voltage-gated channel subunit alpha1 C [KO:K04850]", "776  CACNA1D; calcium voltage-gated channel subunit alpha1 D [KO:K04851]", "778  CACNA1F; calcium voltage-gated channel subunit alpha1 F [KO:K04853]", "779  CACNA1S; calcium voltage-gated channel subunit alpha1 S [KO:K04857]", "782  CACNB1; calcium voltage-gated channel auxiliary subunit beta 1 [KO:K04862]", "783  CACNB2; calcium voltage-gated channel auxiliary subunit beta 2 [KO:K04863]", "784  CACNB3; calcium voltage-gated channel auxiliary subunit beta 3 [KO:K04864]", "785  CACNB4; calcium voltage-gated channel auxiliary subunit beta 4 [KO:K04865]", "781  CACNA2D1; calcium voltage-gated channel auxiliary subunit alpha2delta 1 [KO:K04858]", "9254  CACNA2D2; calcium voltage-gated channel auxiliary subunit alpha2delta 2 [KO:K04859]", "55799  CACNA2D3; calcium voltage-gated channel auxiliary subunit alpha2delta 3 [KO:K04860]", "93589  CACNA2D4; calcium voltage-gated channel auxiliary subunit alpha2delta 4 [KO:K04861]", "786  CACNG1; calcium voltage-gated channel auxiliary subunit gamma 1 [KO:K04866]", "10369  CACNG2; calcium voltage-gated channel auxiliary subunit gamma 2 [KO:K04867]", "10368  CACNG3; calcium voltage-gated channel auxiliary subunit gamma 3 [KO:K04868]", "27092  CACNG4; calcium voltage-gated channel auxiliary subunit gamma 4 [KO:K04869]", "27091  CACNG5; calcium voltage-gated channel auxiliary subunit gamma 5 [KO:K04870]", "59285  CACNG6; calcium voltage-gated channel auxiliary subunit gamma 6 [KO:K04871]", "59284  CACNG7; calcium voltage-gated channel auxiliary subunit gamma 7 [KO:K04872]", "59283  CACNG8; calcium voltage-gated channel auxiliary subunit gamma 8 [KO:K04873]", "6262  RYR2; ryanodine receptor 2 [KO:K04962]", "487  ATP2A1; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 [KO:K05853] [EC:7.2.2.10]", "489  ATP2A3; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 [KO:K05853] [EC:7.2.2.10]", "488  ATP2A2; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 [KO:K05853] [EC:7.2.2.10]", "5350  PLN; phospholamban [KO:K05852]", "6546  SLC8A1; solute carrier family 8 member A1 [KO:K05849]", "6543  SLC8A2; solute carrier family 8 member A2 [KO:K05849]", "6547  SLC8A3; solute carrier family 8 member A3 [KO:K05849]", "3479  IGF1; insulin like growth factor 1 [KO:K05459]", "7040  TGFB1; transforming growth factor beta 1 [KO:K13375]", "7042  TGFB2; transforming growth factor beta 2 [KO:K13376]", "7043  TGFB3; transforming growth factor beta 3 [KO:K13377]", "7124  TNF; tumor necrosis factor [KO:K03156]", "183  AGT; angiotensinogen [KO:K09821]"], "compound": ["C00076  Calcium cation", "C00575  3',5'-Cyclic AMP", "C01330  Sodium cation"], "refs": [{"pmid": "12270949", "authors": "  Fatkin D, Graham RM", "title": "Molecular mechanisms of inherited cardiomyopathies.", "journal": "Physiol Rev 82:945-80 (2002)", "doi": "10.1152/physrev.00012.2002"}, {"pmid": "18672201", "authors": "  Lappe JM, Pelfrey CM, Tang WH", "title": "Recent insights into the role of autoimmunity in idiopathic dilated cardiomyopathy.", "journal": "J Card Fail 14:521-30 (2008)", "doi": "10.1016/j.cardfail.2008.02.016"}, {"pmid": "19273156", "authors": "  Zhao P, Sharma AC, Ren J", "title": "Pathogenesis and therapy of autoimmunity-induced dilated cardiomyopathy.", "journal": "Front Biosci 14:1708-15 (2009)", "doi": "10.2741/3334"}, {"pmid": "11716909", "authors": "  Franz WM, Muller OJ, Katus HA", "title": "Cardiomyopathies: from genetics to the prospect of treatment.", "journal": "Lancet 358:1627-37 (2001)", "doi": "10.1016/S0140-6736(01)06657-0"}, {"pmid": "11805847", "authors": "  Towbin JA, Bowles NE", "title": "The failing heart.", "journal": "Nature 415:227-33 (2002)", "doi": "10.1038/415227a"}, {"pmid": "19017683", "authors": "  Luk A, Ahn E, Soor GS, Butany J", "title": "Dilated cardiomyopathy: a review.", "journal": "J Clin Pathol 62:219-25 (2009)", "doi": "10.1136/jcp.2008.060731"}, {"pmid": "19246813", "authors": "  Yoshikawa T, Baba A, Nagatomo Y", "title": "Autoimmune mechanisms underlying dilated cardiomyopathy.", "journal": "Circ J 73:602-7 (2009)", "doi": "10.1253/circj.CJ-08-1151"}, {"pmid": "14522402", "authors": "  Mason JW", "title": "Myocarditis and dilated cardiomyopathy: an inflammatory link.", "journal": "Cardiovasc Res 60:5-10 (2003)", "doi": "10.1016/S0008-6363(03)00437-1"}, {"pmid": "15146239", "authors": "  Jahns R, Boivin V, Hein L, Triebel S, Angermann CE, Ertl G, Lohse MJ", "title": "Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy.", "journal": "J Clin Invest 113:1419-29 (2004)", "doi": "10.1172/JCI20149"}, {"pmid": "11524405", "authors": "  Liu PP, Mason JW", "title": "Advances in the understanding of myocarditis.", "journal": "Circulation 104:1076-82 (2001)", "doi": "10.1161/hc3401.095198"}], "rel_pathway": ["hsa04260  Cardiac muscle contraction", "hsa04350  TGF-beta signaling pathway", "hsa04512  ECM-receptor interaction", "hsa04614  Renin-angiotensin system", "hsa05416  Viral myocarditis"], "ko_pathway": "ko05414", "genes": ["TPM4", "TTN"]}, {"kegg_id": "hsa04060", "name": "Cytokine-cytokine receptor interaction - Homo sapiens (human)", "description": "Cytokines are soluble extracellular proteins or glycoproteins that are crucial intercellular regulators and mobilizers of cells engaged in innate as well as adaptive inflammatory host defenses, cell growth, differentiation, cell death, angiogenesis, and development and repair processes aimed at the restoration of homeostasis. Cytokines are released by various cells in the body, usually in response to an activating stimulus, and they induce responses through binding to specific receptors on the cell surface of target cells. Cytokines can be grouped by structure into different families and their receptors can likewise be grouped.", "class": "Environmental Information Processing; Signaling molecules and interaction", "pathway_map": "hsa04060  Cytokine-cytokine receptor interaction", "network": ["", "ELEMENT   N01455  BMP15 signaling pathway", "N01457  Myostatin signaling pathway"], "drug": ["D00742  Etanercept (USAN/INN)", "D00745  Interferon alfa-2a (USAN/INN)", "D00746  Interferon beta-1b (USAN/INN)", "D00747  Interferon gamma-1b (USAN/INN)", "D00748  Aldesleukin (USAN/INN)", "D00754  Thalidomide (JAN/USP/INN)", "D01583  Pirfenidone (JAN/USAN/INN)", "D02596  Tocilizumab (USAN/INN)", "D02597  Adalimumab (USAN/INN)", "D02598  Infliximab (USAN/INN)", "D02664  Mirimostim (JAN/INN)", "D02691  Somatropin (USP/INN)", "D02743  Celmoleukin (genetical recombination) (JP18)", "D02744  Interferon alfacon-1 (USAN/INN)", "D02745  Interferon alfa-2b (USAN)", "D02747  Peginterferon alfa-2a (USAN/INN)", "D02748  Peginterferon alfa-2b (USAN/INN)", "D02749  Teceleukin (USAN)", "D02934  Anakinra (USAN/INN)", "D03058  Basiliximab (USAN/INN)", "D03068  Belimumab (USAN)", "D03117  Binetrakin (USAN/INN)", "D03210  Ancriviroc (USAN/INN)", "D03231  Epoetin alfa (USAN/INN)", "D03232  Epoetin beta (USAN/INN)", "D03235  Filgrastim (USP/INN)", "D03245  Nartograstim (genetical recombination) (JP18)", "D03247  Lenograstim (USAN/INN)", "D03304  Interferon beta (JAN)", "D03305  Interferon alfa (NAMALWA) (JP18)", "D03357  Interferon gamma-1a (genetical recombination) (JAN)", "D03441  Certolizumab pegol (USAN/INN)", "D03639  Daclizumab (USAN/INN)", "D03645  Daniplestim (USAN/INN)", "D03647  Dapiclermin (USAN/INN)", "D03651  Darbepoetin alfa (USAN/INN)", "D03682  Denileukin diftitox (USAN/INN)", "D03684  Denosumab (USAN)", "D03779  Dibotermin alfa (USAN/INN)", "D03978  Eltrombopag olamine (JAN/USAN)", "D04032  Epoetin delta (USAN)", "D04242  Fontolizumab (USAN/INN)", "D04358  Golimumab (USAN/INN)", "D04487  Iboctadekin (USAN/INN)", "D04505  Ilodecakin (USAN/INN)", "D04552  Interferon alfa-n1 (USAN)", "D04553  Interferon alfa-n3 (USAN)", "D04554  Interferon beta-1a (USAN)", "D04612  Iratumumab (USAN)", "D04687  Lenalidomide (JAN/USAN/INN)", "D04690  Lenercept (USAN/INN)", "D04695  Leridistim (USAN/INN)", "D04858  Mapatumumab (USAN/INN)", "D04923  Mepolizumab (USAN/INN)", "D05014  Metreleptin (USAN/INN)", "D05036  Milodistim (USAN/INN)", "D05066  Molgramostim (USAN/INN)", "D05090  Muplestim (USAN/INN)", "D05146  Nerelimomab (USAN/INN)", "D05263  Onercept (USAN/INN)", "D05266  Oprelvekin (USAN/INN)", "D05377  Pascolizumab (USAN/INN)", "D05389  Pegnartograstim (USAN/INN)", "D05393  Pegsunercept (USAN)", "D05394  Pegvisomant (USAN/INN)", "D05610  Priliximab (USAN/INN)", "D05777  Ruplizumab (USAN/INN)", "D05803  Sargramostim (USP/INN)", "D05884  Somatrem (USAN)", "D05917  Stamulumab (USAN)", "D06071  Teneliximab (USAN/INN)", "D06193  Toralizumab (USAN/INN)", "D06297  Vicriviroc maleate (USAN)", "D06356  Zanolimumab (USAN/INN)", "D06556  Apilimod mesylate (USAN)", "D06557  Aplaviroc hydrochloride (USAN)", "D06563  Belagenpumatucel-L (USAN)", "D06635  Rilonacept (USAN/INN)", "D06670  Maraviroc (JAN/INN)", "D06889  Pegfilgrastim (USAN/INN)", "D07436  Afelimomab (INN)", "D08562  Tasonermin (INN)", "D08805  Interferon gamma-n1 (JAN)", "D08844  Albinterferon alfa-2b (USAN)", "D08866  Baminercept (USAN/INN)", "D08877  Briobacept (USAN)", "D08971  Plerixafor (JAN/USAN/INN)", "D08976  Pomalidomide (JAN/USAN/INN)", "D08984  Reparixin (USAN/INN)", "D08985  Reslizumab (USAN)", "D08990  Romiplostim (USAN/INN)", "D09024  Totrombopag choline (USAN)", "D09214  Ustekinumab (USAN/INN)", "D09315  Canakinumab (USAN/INN)", "D09332  Denenicokin (USAN/INN)", "D09575  Ibalizumab (USAN/INN)", "D09587  Brentuximab vedotin (USAN/INN)", "D09588  Briakinumab (USAN/INN)", "D09620  Fresolimumab (USAN/INN)", "D09633  Lebrikizumab (USAN/INN)", "D09635  Linifanib (USAN/INN)", "D09669  Siltuximab (USAN/INN)", "D09670  Sotatercept (USAN/INN)", "D09704  Atacicept (USAN/INN)", "D09761  Mogamulizumab (USAN)", "D09813  Lenalidomide hydrate (JAN)", "D09874  Benralizumab (USAN/INN)", "D09877  Carlumab (USAN)", "D09878  Cenicriviroc (USAN/INN)", "D09879  Cenicriviroc mesylate (USAN)", "D09888  Drozitumab (USAN/INN)", "D09896  Enavatuzumab (USAN/INN)", "D09897  Enokizumab (USAN/INN)", "D09911  Gevokizumab (USAN/INN)", "D09930  Mavrilimumab (USAN/INN)", "D09943  Oxelumab (USAN/INN)", "D09944  Ozoralizumab (USAN)", "D09946  Peginesatide (USAN/INN)", "D09947  Peginesatide acetate (JAN/USAN)", "D09967  Secukinumab (USAN/INN)", "D09979  Tralokinumab (USAN/INN)", "D09984  Urelumab (USAN/INN)", "D09998  Epoetin beta pegol (genetical recombination) (JAN)", "D10000  Epoetin epsilon (INN)", "D10015  Litgenprostucel-L (USAN)", "D10061  Brodalumab (USAN)", "D10071  Ixekizumab (USAN)", "D10075  Navarixin (USAN)", "D10078  Peginterferon lambda-1a (USAN)", "D10080  Sirukumab (USAN)", "D10083  Tabalumab (USAN)", "D10161  Sarilumab (USAN)", "D10187  Pateclizumab (USAN)", "D10242  Lipegfilgrastim (USAN)", "D10306  Avatrombopag (USAN/INN)", "D10307  Avatrombopag maleate (JAN/USAN)", "D10310  Balugrastim (USAN/INN)", "D10332  Elubrixin (USAN)", "D10341  Vorsetuzumab mafodotin (USAN/INN)", "D10342  Vorsetuzumab (USAN/INN)", "D10347  Ramatercept (USAN/INN)", "D10354  Dupilumab (USAN/INN)", "D10378  Vercirnon (USAN/INN)", "D10379  Vercirnon sodium (USAN)", "D10387  Danirixin (USAN/INN)", "D10400  Tildrakizumab (USAN)", "D10420  Elubrixin tosylate (USAN)", "D10438  Guselkumab (USAN/INN)", "D10476  Lusutrombopag (JAN/USAN/INN)", "D10483  Peginterferon beta-1a (USAN/INN)", "D10846  Epoetin theta (INN)", "D10847  Epoetin zeta (INN)", "D10889  Momelotinib hydrochloride hydrate (JAN)", "D10902  Afasevikumab (USAN/INN)", "D10912  Brazikumab (USAN/INN)", "D10972  Plozalizumab (USAN/INN)", "D11026  Pegteograstim (INN)", "D11027  Ropeginterferon alfa-2b (INN)", "D11028  Cenegermin (INN)", "D11047  Domagrozumab (USAN/INN)", "D11052  Risankizumab (USAN/INN)", "D11079  Satralizumab (USAN/INN)", "D11080  Nemolizumab (USAN/INN)", "D11082  Anifrolumab (USAN)", "D11121  Gimsilumab (USAN/INN)", "D11122  Letolizumab (USAN/INN)", "D11123  Mirikizumab (USAN/INN)", "D11127  Tibulizumab (USAN/INN)", "D11161  Atesidorsen (USAN/INN)", "D11162  Atesidorsen sodium (USNA)", "D11188  Eflapegrastim (USAN/INN)", "D11193  Somavaratan (USAN/INN)", "D11200  Pegilodecakin (USAN/INN)", "D11234  Emactuzumab (USAN/INN)", "D11235  Landogrozumab (USAN/INN)", "D11236  Lenzilumab (USAN/INN)", "D11242  Trevogrumab (USAN/INN)", "D11253  Bermekimab (USAN)", "D11265  Taldefgrobep alfa (USAN/INN)", "D11268  Vonlerolizumab (USAN/INN)", "D11270  Pexidartinib (USAN/INN)", "D11271  Pexidartinib hydrochloride (JAN/USAN)", "D11324  Camidanlumab (USAN)", "D11325  Camidanlumab tesirine (USAN)", "D11343  Otilimab (USAN)", "D11357  Bleselumab (USAN/INN)", "D11378  Edicotinib (USAN)", "D11379  Edicotinib hydrochloride (USAN)", "D11399  Leronlimab (USAN/INN)", "D11449  Etokimab (USAN)", "D11491  Selicrelumab (USAN/INN)", "D11498  Quetmolimab (USAN)", "D11510  Mavorixafor (USAN)", "D11550  Bimekizumab (USAN/INN)", "D11556  Idecabtagene vicleucel (USAN)", "D11594  Belantamab (USAN/INN)", "D11595  Belantamab mafodotin (USAN)", "D11597  Ravagalimab (USAN/INN)", "D11598  Romilkimab (USAN/INN)", "D11610  Iscalimab (USAN/INN)", "D11669  Bempegaldesleukin (USAN/INN)", "D11701  Luspatercept (USAN/INN)", "D11703  Opinercept (INN)", "D11709  Ascrinvacumab (USAN/INN)", "D11741  Lazucirnon (USAN)", "D11742  Lazucirnon hydrochloride (USAN)", "D11747  Inbakicept (USAN/INN)", "D11756  Fletikumab (USAN/INN)", "D11759  Isunakinra (USAN/INN)", "D11771  Tezepelumab (USAN/INN)", "D11796  Melrilimab (USAN)", "D11797  Apitegromab (USAN)", "D11800  Vixarelimab (USAN)", "D11821  Nogapendekin alfa (USAN/INN)", "D11832  Astegolimab (USAN/INN)", "D11892  Imsidolimab (USAN)", "D11893  Bintrafusp alfa (USAN/INN)", "D11907  Rozibafusp alfa (USAN/INN)", "D11909  Ponsegromab (USAN)", "D11953  Efmarodocokin alfa (USAN/INN)", "D11986  Efbemalenograstim alfa (USAN/INN)", "D11992  Pavurutamab (USAN)", "D11997  Ilacirnon (USAN)", "D11998  Ilacirnon sodium (USAN)", "D11999  Itepekimab (USAN/INN)", "D12010  Pacanalotamab (USAN)", "D12066  Spesolimab (USAN/INN)", "D12128  Balixafortide (USAN/INN)", "D12151  Ianalumab (USAN/INN)", "D12165  Ragifilimab (USAN/INN)", "D12169  Depemokimab (USAN)", "D12177  Teclistamab (USAN/INN)", "D12178  Sotigalimab (USAN)", "D12222  Linvoseltamab (USAN)", "D12238  Vimseltinib (USAN/INN)", "D12256  Boserolimab (USAN)", "D12278  Izokibep (USAN/INN)", "D12281  Motixafortide (USAN/INN)", "D12282  Motixafortide acetate (USAN)", "D12306  Ordesekimab (USAN)", "D12307  Pivekimab (USAN)", "D12308  Pivekimab sunirine (USAN)", "D12315  Ciltacabtagene autoleucel (USAN/INN)", "D12328  Rezpegaldesleukin (USAN)", "D12350  Vilamakitug (USAN)", "D12371  Nemvaleukin alfa (USAN/INN)", "D12374  Sibeprenlimab (INN)", "D12375  Tozorakimab (USAN/INN)", "D12386  Melredableukin alfa (USAN/INN)", "D12458  Ozekibart (USAN)", "D12464  Dazukibart (USAN)", "D12479  Lusvertikimab (USAN/INN)", "D12487  Olokizumab (INN)", "D12543  Rocatinlimab (USAN/INN)", "D12547  Zilurgisertib (USAN/INN)", "D12548  Zilurgisertib fumarate (USAN)", "D12550  Amlitelimab (USAN/INN)", "D12556  Eltrekibart (USAN)", "D12620  Frexalimab (USAN/INN)", "D12623  Nanrilkefusp alfa (USAN/INN)", "D12625  Pegenzileukin (USAN/INN)", "D12648  Quisovalimab (USAN/INN)", "D12654  Emapticap pegol (INN)", "D12655  Olaptesed pegol (INN)", "D12656  Adakitug (USAN)", "D12711  Fidrisertib (USAN/INN)", "D12731  Anumigilimab (USAN/INN)", "D12739  Bempikibart (USAN/INN)", "D12748  Levilimab (INN)", "D12760  Tulisokibart (USAN/INN)", "D12784  Casdozokitug (USAN/INN)", "D12791  Eciskafusp alfa (USAN/INN)", "D12800  Zigakibart (USAN/INN)", "D12801  Linavonkibart (USAN/INN)", "D12803  Povetacicept (USAN/INN)", "D12807  Ziltivekimab (USAN/INN)", "D12810  Falbikitug (USAN/INN)", "D12815  Eltrombopag choline", "D12824  Temtokibart (USAN/INN)", "D12833  Lifileucel (USAN/INN)", "D12849  Imzokitug (USAN)", "D12850  Imneskibart (USAN)", "D12851  Lunlekitug (USAN)", "D12852  Rilogrotug (USAN)", "D12884  Tivumecirnon (USAN/INN)", "D12885  Tivumecirnon besylate (USAN)", "D12888  Nogapendekin alfa inbakicept", "D12891  Elritercept (USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["6346  CCL1; C-C motif chemokine ligand 1 [KO:K05514]", "6370  CCL25; C-C motif chemokine ligand 25 [KO:K13072]", "6363  CCL19; C-C motif chemokine ligand 19 [KO:K05512]", "6366  CCL21; C-C motif chemokine ligand 21 [KO:K16062]", "6348  CCL3; C-C motif chemokine ligand 3 [KO:K05408]", "6349  CCL3L1; C-C motif chemokine ligand 3 like 1 [KO:K05408]", "414062  CCL3L3; C-C motif chemokine ligand 3 like 3 [KO:K05408]", "6351  CCL4; C-C motif chemokine ligand 4 [KO:K12964]", "9560  CCL4L2; C-C motif chemokine ligand 4 like 2 [KO:K12964]", "388372  CCL4L1; C-C motif chemokine ligand 4 like 1 [KO:K12964]", "6361  CCL17; C-C motif chemokine ligand 17 [KO:K21083]", "6367  CCL22; C-C motif chemokine ligand 22 [KO:K21095]", "6352  CCL5; C-C motif chemokine ligand 5 [KO:K12499]", "6355  CCL8; C-C motif chemokine ligand 8 [KO:K16596]", "6358  CCL14; C-C motif chemokine ligand 14 [KO:K21092]", "6360  CCL16; C-C motif chemokine ligand 16 [KO:K21093]", "6359  CCL15; C-C motif chemokine ligand 15 [KO:K05511]", "6368  CCL23; C-C motif chemokine ligand 23 [KO:K05511]", "6357  CCL13; C-C motif chemokine ligand 13 [KO:K16595]", "6354  CCL7; C-C motif chemokine ligand 7 [KO:K05509]", "6347  CCL2; C-C motif chemokine ligand 2 [KO:K14624]", "6356  CCL11; C-C motif chemokine ligand 11 [KO:K16597]", "6369  CCL24; C-C motif chemokine ligand 24 [KO:K21097]", "10344  CCL26; C-C motif chemokine ligand 26 [KO:K21096]", "10850  CCL27; C-C motif chemokine ligand 27 [KO:K16598]", "56477  CCL28; C-C motif chemokine ligand 28 [KO:K05513]", "6362  CCL18; C-C motif chemokine ligand 18 [KO:K21094]", "6364  CCL20; C-C motif chemokine ligand 20 [KO:K14625]", "2919  CXCL1; C-X-C motif chemokine ligand 1 [KO:K05505]", "2920  CXCL2; C-X-C motif chemokine ligand 2 [KO:K05505]", "2921  CXCL3; C-X-C motif chemokine ligand 3 [KO:K05505]", "6374  CXCL5; C-X-C motif chemokine ligand 5 [KO:K05506]", "6372  CXCL6; C-X-C motif chemokine ligand 6 [KO:K05506]", "3576  CXCL8; C-X-C motif chemokine ligand 8 [KO:K10030]", "5473  PPBP; pro-platelet basic protein [KO:K10029]", "5196  PF4; platelet factor 4 [KO:K05407]", "5197  PF4V1; platelet factor 4 variant 1 [KO:K05407]", "4283  CXCL9; C-X-C motif chemokine ligand 9 [KO:K05416]", "3627  CXCL10; C-X-C motif chemokine ligand 10 [KO:K12671]", "6373  CXCL11; C-X-C motif chemokine ligand 11 [KO:K12672]", "10563  CXCL13; C-X-C motif chemokine ligand 13 [KO:K10032]", "6387  CXCL12; C-X-C motif chemokine ligand 12 [KO:K10031]", "58191  CXCL16; C-X-C motif chemokine ligand 16 [KO:K10035]", "9547  CXCL14; C-X-C motif chemokine ligand 14 [KO:K10033]", "284340  CXCL17; C-X-C motif chemokine ligand 17 [KO:K22627]", "6375  XCL1; X-C motif chemokine ligand 1 [KO:K05507]", "6846  XCL2; X-C motif chemokine ligand 2 [KO:K22675]", "6376  CX3CL1; C-X3-C motif chemokine ligand 1 [KO:K05508]", "3558  IL2; interleukin 2 [KO:K05429]", "3565  IL4; interleukin 4 [KO:K05430]", "3574  IL7; interleukin 7 [KO:K05431]", "3578  IL9; interleukin 9 [KO:K05432]", "3600  IL15; interleukin 15 [KO:K05433]", "59067  IL21; interleukin 21 [KO:K05434]", "85480  TSLP; thymic stromal lymphopoietin [KO:K05436]", "3562  IL3; interleukin 3 [KO:K04736]", "3567  IL5; interleukin 5 [KO:K05428]", "1437  CSF2; colony stimulating factor 2 [KO:K05427]", "3596  IL13; interleukin 13 [KO:K05435]", "2056  EPO; erythropoietin [KO:K05437]", "2688  GH1; growth hormone 1 [KO:K05438]", "2689  GH2; growth hormone 2 [KO:K05438]", "1442  CSH1; chorionic somatomammotropin hormone 1 [KO:K05438]", "1443  CSH2; chorionic somatomammotropin hormone 2 [KO:K05438]", "5617  PRL; prolactin [KO:K05439]", "7066  THPO; thrombopoietin [KO:K06854]", "1440  CSF3; colony stimulating factor 3 [KO:K05423]", "3952  LEP; leptin [KO:K05424]", "3569  IL6; interleukin 6 [KO:K05405]", "3589  IL11; interleukin 11 [KO:K05417]", "3592  IL12A; interleukin 12A [KO:K05406]", "3593  IL12B; interleukin 12B [KO:K05425]", "51561  IL23A; interleukin 23 subunit alpha [KO:K05426]", "246778  IL27; interleukin 27 [KO:K22629]", "10148  EBI3; Epstein-Barr virus induced 3 [KO:K24476]", "386653  IL31; interleukin 31 [KO:K22631]", "23529  CLCF1; cardiotrophin like cytokine factor 1 [KO:K05421]", "1270  CNTF; ciliary neurotrophic factor [KO:K05420]", "1489  CTF1; cardiotrophin 1 [KO:K05422]", "3976  LIF; LIF interleukin 6 family cytokine [KO:K05419]", "5008  OSM; oncostatin M [KO:K05418]", "3586  IL10; interleukin 10 [KO:K05443]", "29949  IL19; interleukin 19 [KO:K05444]", "50604  IL20; interleukin 20 [KO:K22667]", "11009  IL24; interleukin 24 [KO:K22668]", "50616  IL22; interleukin 22 [KO:K05445]", "55801  IL26; interleukin 26 [KO:K05446]", "282616  IFNL2; interferon lambda 2 [KO:K22669]", "282617  IFNL3; interferon lambda 3 [KO:K22669]", "282618  IFNL1; interferon lambda 1 [KO:K05447]", "3439  IFNA1; interferon alpha 1 [KO:K05414]", "3440  IFNA2; interferon alpha 2 [KO:K05414]", "3441  IFNA4; interferon alpha 4 [KO:K05414]", "3442  IFNA5; interferon alpha 5 [KO:K05414]", "3443  IFNA6; interferon alpha 6 [KO:K05414]", "3444  IFNA7; interferon alpha 7 [KO:K05414]", "3445  IFNA8; interferon alpha 8 [KO:K05414]", "3446  IFNA10; interferon alpha 10 [KO:K05414]", "3447  IFNA13; interferon alpha 13 [KO:K05414]", "3448  IFNA14; interferon alpha 14 [KO:K05414]", "3449  IFNA16; interferon alpha 16 [KO:K05414]", "3451  IFNA17; interferon alpha 17 [KO:K05414]", "3452  IFNA21; interferon alpha 21 [KO:K05414]", "3456  IFNB1; interferon beta 1 [KO:K05415]", "3467  IFNW1; interferon omega 1 [KO:K05440]", "56832  IFNK; interferon kappa [KO:K05441]", "338376  IFNE; interferon epsilon [KO:K05442]", "3458  IFNG; interferon gamma [KO:K04687]", "3552  IL1A; interleukin 1 alpha [KO:K04383]", "3553  IL1B; interleukin 1 beta [KO:K04519]", "3557  IL1RN; interleukin 1 receptor antagonist [KO:K05481]", "26525  IL36RN; interleukin 36 receptor antagonist [KO:K05483]", "27179  IL36A; interleukin 36 alpha [KO:K05484]", "27177  IL36B; interleukin 36 beta [KO:K05486]", "56300  IL36G; interleukin 36 gamma [KO:K05487]", "84639  IL1F10; interleukin 1 family member 10 [KO:K05488]", "27178  IL37; interleukin 37 [KO:K05485]", "3606  IL18; interleukin 18 [KO:K05482]", "90865  IL33; interleukin 33 [KO:K12967]", "3605  IL17A; interleukin 17A [KO:K05489]", "112744  IL17F; interleukin 17F [KO:K05494]", "27190  IL17B; interleukin 17B [KO:K05490]", "27189  IL17C; interleukin 17C [KO:K05491]", "53342  IL17D; interleukin 17D [KO:K05492]", "64806  IL25; interleukin 25 [KO:K05493]", "3603  IL16; interleukin 16 [KO:K22628]", "9235  IL32; interleukin 32 [KO:K22632]", "146433  IL34; interleukin 34 [KO:K22633]", "1435  CSF1; colony stimulating factor 1 [KO:K05453]", "7124  TNF; tumor necrosis factor [KO:K03156]", "4049  LTA; lymphotoxin alpha [KO:K05468]", "4050  LTB; lymphotoxin beta [KO:K03157]", "8740  TNFSF14; TNF superfamily member 14 [KO:K05477]", "356  FASLG; Fas ligand [KO:K04389]", "9966  TNFSF15; TNF superfamily member 15 [KO:K05478]", "8743  TNFSF10; TNF superfamily member 10 [KO:K04721]", "1896  EDA; ectodysplasin A [KO:K05480]", "4803  NGF; nerve growth factor [KO:K02582]", "8600  TNFSF11; TNF superfamily member 11 [KO:K05473]", "8742  TNFSF12; TNF superfamily member 12 [KO:K05474]", "970  CD70; CD70 molecule [KO:K05470]", "944  TNFSF8; TNF superfamily member 8 [KO:K05471]", "959  CD40LG; CD40 ligand [KO:K03161]", "8744  TNFSF9; TNF superfamily member 9 [KO:K05472]", "7292  TNFSF4; TNF superfamily member 4 [KO:K05469]", "8995  TNFSF18; TNF superfamily member 18 [KO:K05479]", "8741  TNFSF13; TNF superfamily member 13 [KO:K05475]", "10673  TNFSF13B; TNF superfamily member 13b [KO:K05476]", "7040  TGFB1; transforming growth factor beta 1 [KO:K13375]", "7042  TGFB2; transforming growth factor beta 2 [KO:K13376]", "7043  TGFB3; transforming growth factor beta 3 [KO:K13377]", "9518  GDF15; growth differentiation factor 15 [KO:K05504]", "2658  GDF2; growth differentiation factor 2 [KO:K05503]", "27302  BMP10; bone morphogenetic protein 10 [KO:K22670]", "3623  INHA; inhibin subunit alpha [KO:K05500]", "651  BMP3; bone morphogenetic protein 3 [KO:K05496]", "2662  GDF10; growth differentiation factor 10 [KO:K22674]", "10220  GDF11; growth differentiation factor 11 [KO:K22679]", "2660  MSTN; myostatin [KO:K05497]", "3624  INHBA; inhibin subunit beta A [KO:K04667]", "3625  INHBB; inhibin subunit beta B [KO:K22687]", "2657  GDF1; growth differentiation factor 1 [KO:K05495]", "9573  GDF3; growth differentiation factor 3 [KO:K22672]", "4838  NODAL; nodal growth differentiation factor [KO:K04666]", "2661  GDF9; growth differentiation factor 9 [KO:K22673]", "3626  INHBC; inhibin subunit beta C [KO:K22688]", "83729  INHBE; inhibin subunit beta E [KO:K22689]", "268  AMH; anti-Mullerian hormone [KO:K04665]", "650  BMP2; bone morphogenetic protein 2 [KO:K21283]", "652  BMP4; bone morphogenetic protein 4 [KO:K04662]", "8200  GDF5; growth differentiation factor 5 [KO:K04664]", "392255  GDF6; growth differentiation factor 6 [KO:K20012]", "151449  GDF7; growth differentiation factor 7 [KO:K20013]", "9210  BMP15; bone morphogenetic protein 15 [KO:K05498]", "653  BMP5; bone morphogenetic protein 5 [KO:K04663]", "654  BMP6; bone morphogenetic protein 6 [KO:K16620]", "655  BMP7; bone morphogenetic protein 7 [KO:K16621]", "656  BMP8B; bone morphogenetic protein 8b [KO:K16622]", "353500  BMP8A; bone morphogenetic protein 8a [KO:K16622]", "1237  CCR8; C-C motif chemokine receptor 8 [KO:K04183]", "10803  CCR9; C-C motif chemokine receptor 9 [KO:K04184]", "51554  ACKR4; atypical chemokine receptor 4 [KO:K04186]", "1236  CCR7; C-C motif chemokine receptor 7 [KO:K04182]", "1233  CCR4; C-C motif chemokine receptor 4 [KO:K04179]", "1234  CCR5; C-C motif chemokine receptor 5 [KO:K04180]", "1232  CCR3; C-C motif chemokine receptor 3 [KO:K04178]", "729230  CCR2; C-C motif chemokine receptor 2 [KO:K04177]", "1230  CCR1; C-C motif chemokine receptor 1 [KO:K04176]", "2826  CCR10; C-C motif chemokine receptor 10 [KO:K04185]", "1235  CCR6; C-C motif chemokine receptor 6 [KO:K04181]", "3577  CXCR1; C-X-C motif chemokine receptor 1 [KO:K04175]", "3579  CXCR2; C-X-C motif chemokine receptor 2 [KO:K05050]", "2833  CXCR3; C-X-C motif chemokine receptor 3 [KO:K04188]", "643  CXCR5; C-X-C motif chemokine receptor 5 [KO:K04190]", "7852  CXCR4; C-X-C motif chemokine receptor 4 [KO:K04189]", "57007  ACKR3; atypical chemokine receptor 3 [KO:K04304]", "10663  CXCR6; C-X-C motif chemokine receptor 6 [KO:K04191]", "2829  XCR1; X-C motif chemokine receptor 1 [KO:K04193]", "1524  CX3CR1; C-X3-C motif chemokine receptor 1 [KO:K04192]", "3559  IL2RA; interleukin 2 receptor subunit alpha [KO:K05068]", "3560  IL2RB; interleukin 2 receptor subunit beta [KO:K05069]", "3561  IL2RG; interleukin 2 receptor subunit gamma [KO:K05070]", "3566  IL4R; interleukin 4 receptor [KO:K05071]", "3575  IL7R; interleukin 7 receptor [KO:K05072]", "3581  IL9R; interleukin 9 receptor [KO:K05073]", "3601  IL15RA; interleukin 15 receptor subunit alpha [KO:K05074]", "50615  IL21R; interleukin 21 receptor [KO:K05075]", "64109  CRLF2; cytokine receptor like factor 2 [KO:K05078]", "3563  IL3RA; interleukin 3 receptor subunit alpha [KO:K04737]", "1439  CSF2RB; colony stimulating factor 2 receptor subunit beta [KO:K04738]", "3568  IL5RA; interleukin 5 receptor subunit alpha [KO:K05067]", "1438  CSF2RA; colony stimulating factor 2 receptor subunit alpha [KO:K05066]", "3597  IL13RA1; interleukin 13 receptor subunit alpha 1 [KO:K05076]", "3598  IL13RA2; interleukin 13 receptor subunit alpha 2 [KO:K05077]", "2057  EPOR; erythropoietin receptor [KO:K05079]", "2690  GHR; growth hormone receptor [KO:K05080]", "5618  PRLR; prolactin receptor [KO:K05081]", "4352  MPL; MPL proto-oncogene, thrombopoietin receptor [KO:K05082]", "1441  CSF3R; colony stimulating factor 3 receptor [KO:K05061]", "3953  LEPR; leptin receptor [KO:K05062]", "3570  IL6R; interleukin 6 receptor [KO:K05055]", "3572  IL6ST; interleukin 6 cytokine family signal transducer [KO:K05060]", "3590  IL11RA; interleukin 11 receptor subunit alpha [KO:K05056]", "3594  IL12RB1; interleukin 12 receptor subunit beta 1 [KO:K05063]", "3595  IL12RB2; interleukin 12 receptor subunit beta 2 [KO:K05064]", "149233  IL23R; interleukin 23 receptor [KO:K05065]", "9466  IL27RA; interleukin 27 receptor subunit alpha [KO:K19598]", "133396  IL31RA; interleukin 31 receptor A [KO:K22630]", "1271  CNTFR; ciliary neurotrophic factor receptor [KO:K05059]", "3977  LIFR; LIF receptor subunit alpha [KO:K05058]", "9180  OSMR; oncostatin M receptor [KO:K05057]", "3587  IL10RA; interleukin 10 receptor subunit alpha [KO:K05134]", "3588  IL10RB; interleukin 10 receptor subunit beta [KO:K05135]", "53832  IL20RA; interleukin 20 receptor subunit alpha [KO:K05136]", "53833  IL20RB; interleukin 20 receptor subunit beta [KO:K05137]", "58985  IL22RA1; interleukin 22 receptor subunit alpha 1 [KO:K05138]", "163702  IFNLR1; interferon lambda receptor 1 [KO:K05140]", "3454  IFNAR1; interferon alpha and beta receptor subunit 1 [KO:K05130]", "3455  IFNAR2; interferon alpha and beta receptor subunit 2 [KO:K05131]", "3459  IFNGR1; interferon gamma receptor 1 [KO:K05132]", "3460  IFNGR2; interferon gamma receptor 2 [KO:K05133]", "3554  IL1R1; interleukin 1 receptor type 1 [KO:K04386]", "3556  IL1RAP; interleukin 1 receptor accessory protein [KO:K04723]", "7850  IL1R2; interleukin 1 receptor type 2 [KO:K04387]", "8808  IL1RL2; interleukin 1 receptor like 2 [KO:K05172]", "8809  IL18R1; interleukin 18 receptor 1 [KO:K05173]", "8807  IL18RAP; interleukin 18 receptor accessory protein [KO:K05174]", "9173  IL1RL1; interleukin 1 receptor like 1 [KO:K05171]", "23765  IL17RA; interleukin 17 receptor A [KO:K05164]", "84818  IL17RC; interleukin 17 receptor C [KO:K05166]", "55540  IL17RB; interleukin 17 receptor B [KO:K05165]", "132014  IL17RE; interleukin 17 receptor E [KO:K05168]", "920  CD4; CD4 molecule [KO:K06454]", "1436  CSF1R; colony stimulating factor 1 receptor [KO:K05090] [EC:2.7.10.1]", "7132  TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158]", "7133  TNFRSF1B; TNF receptor superfamily member 1B [KO:K05141]", "4055  LTBR; lymphotoxin beta receptor [KO:K03159]", "8764  TNFRSF14; TNF receptor superfamily member 14 [KO:K05152]", "8771  TNFRSF6B; TNF receptor superfamily member 6b [KO:K05143]", "355  FAS; Fas cell surface death receptor [KO:K04390]", "8718  TNFRSF25; TNF receptor superfamily member 25 [KO:K05160]", "8797  TNFRSF10A; TNF receptor superfamily member 10a [KO:K04722]", "8795  TNFRSF10B; TNF receptor superfamily member 10b [KO:K04722]", "8794  TNFRSF10C; TNF receptor superfamily member 10c [KO:K22701]", "8793  TNFRSF10D; TNF receptor superfamily member 10d [KO:K22702]", "27242  TNFRSF21; TNF receptor superfamily member 21 [KO:K05157]", "10913  EDAR; ectodysplasin A receptor [KO:K05162]", "60401  EDA2R; ectodysplasin A2 receptor [KO:K05163]", "4804  NGFR; nerve growth factor receptor [KO:K02583]", "4982  TNFRSF11B; TNF receptor superfamily member 11b [KO:K05148]", "8792  TNFRSF11A; TNF receptor superfamily member 11a [KO:K05147]", "51330  TNFRSF12A; TNF receptor superfamily member 12A [KO:K05149]", "939  CD27; CD27 molecule [KO:K05144]", "943  TNFRSF8; TNF receptor superfamily member 8 [KO:K05145]", "958  CD40; CD40 molecule [KO:K03160]", "3604  TNFRSF9; TNF receptor superfamily member 9 [KO:K05146]", "7293  TNFRSF4; TNF receptor superfamily member 4 [KO:K05142]", "8784  TNFRSF18; TNF receptor superfamily member 18 [KO:K05154]", "608  TNFRSF17; TNF receptor superfamily member 17 [KO:K05153]", "23495  TNFRSF13B; TNF receptor superfamily member 13B [KO:K05150]", "115650  TNFRSF13C; TNF receptor superfamily member 13C [KO:K05151]", "55504  TNFRSF19; TNF receptor superfamily member 19 [KO:K05155]", "84957  RELT; RELT TNF receptor [KO:K05156]", "285613  RELL2; RELT like 2 [KO:K26541]", "768211  RELL1; RELT like 1 [KO:K26541]", "7046  TGFBR1; transforming growth factor beta receptor 1 [KO:K04674] [EC:2.7.11.30]", "7048  TGFBR2; transforming growth factor beta receptor 2 [KO:K04388] [EC:2.7.11.30]", "94  ACVRL1; activin A receptor like type 1 [KO:K13594] [EC:2.7.11.30]", "92  ACVR2A; activin A receptor type 2A [KO:K04670] [EC:2.7.11.30]", "659  BMPR2; bone morphogenetic protein receptor type 2 [KO:K04671] [EC:2.7.11.30]", "93  ACVR2B; activin A receptor type 2B [KO:K13596] [EC:2.7.11.30]", "91  ACVR1B; activin A receptor type 1B [KO:K13567] [EC:2.7.11.30]", "130399  ACVR1C; activin A receptor type 1C [KO:K13568] [EC:2.7.11.30]", "90  ACVR1; activin A receptor type 1 [KO:K04675] [EC:2.7.11.30]", "269  AMHR2; anti-Mullerian hormone receptor type 2 [KO:K04672] [EC:2.7.11.30]", "657  BMPR1A; bone morphogenetic protein receptor type 1A [KO:K04673] [EC:2.7.11.30]", "658  BMPR1B; bone morphogenetic protein receptor type 1B [KO:K13578] [EC:2.7.11.30]"], "refs": [{"pmid": "24892271", "authors": "  Turner MD, Nedjai B, Hurst T, Pennington DJ", "title": "Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease.", "journal": "Biochim Biophys Acta 1843:2563-2582 (2014)", "doi": "10.1016/j.bbamcr.2014.05.014"}, {"pmid": "21106488", "authors": "  Brocker C, Thompson D, Matsumoto A, Nebert DW, Vasiliou V", "title": "Evolutionary divergence and functions of the human interleukin (IL) gene family.", "journal": "Hum Genomics 5:30-55 (2010)", "doi": "10.1186/1479-7364-5-1-30"}, {"pmid": "27577879", "authors": "  Akdis M, Aab A, Altunbulakli C, Azkur K, Costa RA, Crameri R, Duan S, Eiwegger T, Eljaszewicz A, Ferstl R, Frei R, Garbani M, Globinska A, Hess L, Huitema C, Kubo T, Komlosi Z, Konieczna P, Kovacs N, Kucuksezer UC, Meyer N, Morita H, Olzhausen J, O'Mahony L, Pezer M, Prati M, Rebane A, Rhyner C, Rinaldi A, Sokolowska M, Stanic B, Sugita K, Treis A, van de Veen W, Wanke K, Wawrzyniak M, Wawrzyniak P, Wirz OF, Zakzuk JS, Akdis CA", "title": "Interleukins (from IL-1 to IL-38), interferons, transforming growth factor beta, and TNF-alpha: Receptors, functions, and roles in diseases.", "journal": "J Allergy Clin Immunol 138:984-1010 (2016)", "doi": "10.1016/j.jaci.2016.06.033"}, {"pmid": "15500860", "authors": "  Boulanger MJ, Garcia KC", "title": "Shared cytokine signaling receptors: structural insights from the gp130 system.", "journal": "Adv Protein Chem 68:107-46 (2004)", "doi": "10.1016/S0065-3233(04)68004-1"}, {"pmid": "16034365", "authors": "  Allan SM, Tyrrell PJ, Rothwell NJ", "title": "Interleukin-1 and neuronal injury.", "journal": "Nat Rev Immunol 5:629-40 (2005)", "doi": "10.1038/nri1664"}, {"pmid": "23847622", "authors": "  Lopetuso LR, Chowdhry S, Pizarro TT", "title": "Opposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease.", "journal": "Front Immunol 4:181 (2013)", "doi": "10.3389/fimmu.2013.00181"}, {"pmid": "21349428", "authors": "  Iwakura Y, Ishigame H, Saijo S, Nakae S", "title": "Functional specialization of interleukin-17 family members.", "journal": "Immunity 34:149-62 (2011)", "doi": "10.1016/j.immuni.2011.02.012"}, {"pmid": "17530315", "authors": "  Fischer P, Hilfiker-Kleiner D", "title": "Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis.", "journal": "Basic Res Cardiol 102:279-97 (2007)", "doi": "10.1007/s00395-007-0658-z"}, {"pmid": "24381786", "authors": "  Richards CD", "title": "The enigmatic cytokine oncostatin m and roles in disease.", "journal": "ISRN Inflamm 2013:512103 (2013)", "doi": "10.1155/2013/512103"}, {"pmid": "18926762", "authors": "  Zhang Q, Putheti P, Zhou Q, Liu Q, Gao W", "title": "Structures and biological functions of IL-31 and IL-31 receptors.", "journal": "Cytokine Growth Factor Rev 19:347-56 (2008)", "doi": "10.1016/j.cytogfr.2008.08.003"}, {"pmid": "21155715", "authors": "  Meenhuis A, Verwijmeren C, Roovers O, Touw IP", "title": "The deubiquitinating enzyme DUB2A enhances CSF3 signalling by attenuating lysosomal routing of the CSF3 receptor.", "journal": "Biochem J 434:343-51 (2011)", "doi": "10.1042/BJ20101628"}, {"pmid": "22410872", "authors": "  de Weerd NA, Nguyen T", "title": "The interferons and their receptors--distribution and regulation.", "journal": "Immunol Cell Biol 90:483-91 (2012)", "doi": "10.1038/icb.2012.9"}, {"pmid": "12949498", "authors": "  Aggarwal BB", "title": "Signalling pathways of the TNF superfamily: a double-edged sword.", "journal": "Nat Rev Immunol 3:745-56 (2003)", "doi": "10.1038/nri1184"}, {"pmid": "12189384", "authors": "  Ashkenazi A", "title": "Targeting death and decoy receptors of the tumour-necrosis factor superfamily.", "journal": "Nat Rev Cancer 2:420-30 (2002)", "doi": "10.1038/nrc821"}, {"pmid": "26115564", "authors": "  Seeger P, Musso T, Sozzani S", "title": "The TGF-beta superfamily in dendritic cell biology.", "journal": "Cytokine Growth Factor Rev 26:647-57 (2015)", "doi": "10.1016/j.cytogfr.2015.06.002"}, {"pmid": "23612460", "authors": "  Wakefield LM, Hill CS", "title": "Beyond TGFbeta: roles of other TGFbeta superfamily members in cancer.", "journal": "Nat Rev Cancer 13:328-41 (2013)", "doi": "10.1038/nrc3500"}], "ko_pathway": "ko04060", "genes": ["IL3", "IL2R", "CSF1"]}, {"kegg_id": "hsa04210", "name": "Apoptosis - Homo sapiens (human)", "description": "Apoptosis is a genetically programmed process for the elimination of damaged or redundant cells by activation of caspases (aspartate-specific cysteine proteases). The onset of apoptosis is controlled by numerous interrelating processes. The 'extrinsic' pathway involves stimulation of members of the tumor necrosis factor (TNF) receptor subfamily, such as TNFRI, CD95/Fas or TRAILR (death receptors), located at the cell surface, by their specific ligands, such as TNF-alpha, FasL or TRAIL, respectively. The 'intrinsic' pathway is activated mainly by non-receptor stimuli, such as DNA damage, ER stress, metabolic stress, UV radiation or growth-factor deprivation. The central event in the 'intrinsic' pathway is the mitochondrial outer membrane permeabilization (MOMP), which leads to the release of cytochrome c. These two pathways converge at the level of effector caspases, such as caspase-3 and caspase-7. The third major pathway is initiated by the constituents of cytotoxic granules (e.g. Perforin and Granzyme B) that are released by CTLs (cytotoxic T-cells) and NK (natural killer) cells. Granzyme B, similarly to the caspases, cleaves its substrates after aspartic acid residues, suggesting that this protease has the ability to activate members of the caspase family directly. It is the balance between the pro-apoptotic and anti-apoptotic signals that eventually determines whether cells will undergo apoptosis, survive or proliferate. TNF family of ligands activates anti-apoptotic or cell-survival signals as well as apoptotic signals. NGF and Interleukin-3 promotes the survival, proliferation and differentiation of neurons or hematopoietic cells, respectively. Withdrawal of these growth factors leads to cell death, as described above.", "class": "Cellular Processes; Cell growth and death", "pathway_map": "hsa04210  Apoptosis", "network": ["", "ELEMENT   N00098  Intrinsic apoptotic pathway", "N00145  Extrinsic apoptotic pathway", "N00146  Crosstalk between extrinsic and intrinsic apoptotic pathways", "N00984  mGluR5-Ca2+ -apoptotic pathway", "N01056  FAS-JNK signaling pathway"], "drug": ["D00742  Etanercept (USAN/INN)", "D02597  Adalimumab (USAN/INN)", "D02598  Infliximab (USAN/INN)", "D03441  Certolizumab pegol (USAN/INN)", "D03645  Daniplestim (USAN/INN)", "D04358  Golimumab (USAN/INN)", "D04687  Lenalidomide (JAN/USAN/INN)", "D04858  Mapatumumab (USAN/INN)", "D05146  Nerelimomab (USAN/INN)", "D05216  Oblimersen sodium (USAN)", "D06634  Relacatib (USAN/INN)", "D07436  Afelimomab (INN)", "D08290  Oblimersen (INN)", "D08954  Obatoclax mesylate (USAN)", "D08976  Pomalidomide (JAN/USAN/INN)", "D09692  Veliparib (JAN/USAN/INN)", "D09730  Olaparib (JAN/USAN/INN)", "D09813  Lenalidomide hydrate (JAN)", "D09888  Drozitumab (USAN/INN)", "D09907  Fulranumab (USAN/INN)", "D09913  Iniparib (USAN/INN)", "D10079  Rucaparib (USAN/INN)", "D10140  Niraparib (USAN)", "D10157  Rucaparib phosphate (USAN)", "D10381  Afuresertib (USAN/INN)", "D10382  Afuresertib hydrochloride (USAN)", "D10560  Idelalisib (JAN/USAN/INN)", "D10679  Venetoclax (JAN/USAN/INN)", "D10732  Talazoparib (USAN/INN)", "D10733  Talazoparib tosylate (USAN)", "D10982  Rucaparib camsylate (USAN)", "D10988  Selonsertib (JAN/USAN/INN)", "D11195  Rimiducid (USAN/INN)", "D11358  Tagraxofusp (USAN/INN)", "D11426  Pamiparib (USAN/INN)", "D11895  Niraparib tosilate hydrate (JAN)", "D11962  Murizatoclax (USAN/INN)", "D11963  Tapotoclax (USAN/INN)", "D12120  Brensocatib (USAN/INN)", "D12352  Eclitasertib (USAN/INN)", "D12458  Ozekibart (USAN)", "D12565  Xevinapant (JAN/USAN/INN)", "D12746  Brensocatib hydrate (JAN)", "D12821  Flizasertib (USAN/INN)", "D12846  Ocadusertib (USAN)", "D12883  Sonrotoclax (USAN/INN)"], "dblinks": "GO: 0006915", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["8743  TNFSF10; TNF superfamily member 10 [KO:K04721]", "8797  TNFRSF10A; TNF receptor superfamily member 10a [KO:K04722]", "8795  TNFRSF10B; TNF receptor superfamily member 10b [KO:K04722]", "356  FASLG; Fas ligand [KO:K04389]", "355  FAS; Fas cell surface death receptor [KO:K04390]", "8772  FADD; Fas associated via death domain [KO:K02373]", "7124  TNF; tumor necrosis factor [KO:K03156]", "7132  TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158]", "8717  TRADD; TNFRSF1A associated via death domain [KO:K03171]", "8837  CFLAR; CASP8 and FADD like apoptosis regulator [KO:K04724]", "841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]", "843  CASP10; caspase 10 [KO:K04400] [EC:3.4.22.63]", "839  CASP6; caspase 6 [KO:K04396] [EC:3.4.22.59]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "840  CASP7; caspase 7 [KO:K04397] [EC:3.4.22.60]", "637  BID; BH3 interacting domain death agonist [KO:K04726]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "578  BAK1; BCL2 antagonist/killer 1 [KO:K14021]", "56616  DIABLO; diablo IAP-binding mitochondrial protein [KO:K10522]", "5414  SEPTIN4; septin 4 [KO:K16943]", "27429  HTRA2; HtrA serine peptidase 2 [KO:K08669] [EC:3.4.21.108]", "54205  CYCS; cytochrome c, somatic [KO:K08738]", "317  APAF1; apoptotic peptidase activating factor 1 [KO:K02084]", "842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]", "5551  PRF1; perforin 1 [KO:K07818]", "3002  GZMB; granzyme B [KO:K01353] [EC:3.4.21.79]", "10376  TUBA1B; tubulin alpha 1b [KO:K07374]", "7277  TUBA4A; tubulin alpha 4a [KO:K07374]", "7278  TUBA3C; tubulin alpha 3c [KO:K07374]", "7846  TUBA1A; tubulin alpha 1a [KO:K07374]", "84790  TUBA1C; tubulin alpha 1c [KO:K07374]", "51807  TUBA8; tubulin alpha 8 [KO:K07374]", "112714  TUBA3E; tubulin alpha 3e [KO:K07374]", "113457  TUBA3D; tubulin alpha 3d [KO:K07374]", "79861  TUBAL3; tubulin alpha like 3 [KO:K07374]", "4170  MCL1; MCL1 apoptosis regulator, BCL2 family member [KO:K02539]", "71  ACTG1; actin gamma 1 [KO:K05692]", "60  ACTB; actin beta [KO:K05692]", "6709  SPTAN1; spectrin alpha, non-erythrocytic 1 [KO:K06114]", "4000  LMNA; lamin A/C [KO:K12641]", "4001  LMNB1; lamin B1 [KO:K07611]", "84823  LMNB2; lamin B2 [KO:K07611]", "142  PARP1; poly(ADP-ribose) polymerase 1 [KO:K24070] [EC:2.4.2.30]", "10038  PARP2; poly(ADP-ribose) polymerase 2 [KO:K10798] [EC:2.4.2.30]", "10039  PARP3; poly(ADP-ribose) polymerase family member 3 [KO:K10798] [EC:2.4.2.30]", "143  PARP4; poly(ADP-ribose) polymerase family member 4 [KO:K10798] [EC:2.4.2.30]", "1676  DFFA; DNA fragmentation factor subunit alpha [KO:K02310]", "1677  DFFB; DNA fragmentation factor subunit beta [KO:K02311] [EC:3.-.-.-]", "2021  ENDOG; endonuclease G [KO:K01173]", "9131  AIFM1; apoptosis inducing factor mitochondria associated 1 [KO:K04727] [EC:1.-.-.-]", "2081  ERN1; endoplasmic reticulum to nucleus signaling 1 [KO:K08852] [EC:2.7.11.1 3.1.26.-]", "7186  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "823  CAPN1; calpain 1 [KO:K01367] [EC:3.4.22.52]", "824  CAPN2; calpain 2 [KO:K03853] [EC:3.4.22.53]", "100506742  CASP12; caspase 12 (gene/pseudogene) [KO:K04741] [EC:3.4.22.-]", "9451  EIF2AK3; eukaryotic translation initiation factor 2 alpha kinase 3 [KO:K08860] [EC:2.7.11.1]", "1965  EIF2S1; eukaryotic translation initiation factor 2 subunit alpha [KO:K03237]", "468  ATF4; activating transcription factor 4 [KO:K04374]", "1649  DDIT3; DNA damage inducible transcript 3 [KO:K04452]", "1508  CTSB; cathepsin B [KO:K01363] [EC:3.4.22.1]", "1075  CTSC; cathepsin C [KO:K01275] [EC:3.4.14.1]", "1509  CTSD; cathepsin D [KO:K01379] [EC:3.4.23.5]", "8722  CTSF; cathepsin F [KO:K01373] [EC:3.4.22.41]", "1512  CTSH; cathepsin H [KO:K01366] [EC:3.4.22.16]", "1513  CTSK; cathepsin K [KO:K01371] [EC:3.4.22.38]", "1514  CTSL; cathepsin L [KO:K01365] [EC:3.4.22.15]", "1519  CTSO; cathepsin O [KO:K01374] [EC:3.4.22.42]", "1520  CTSS; cathepsin S [KO:K01368] [EC:3.4.22.27]", "1515  CTSV; cathepsin V [KO:K01375] [EC:3.4.22.43]", "1521  CTSW; cathepsin W [KO:K08569] [EC:3.4.22.-]", "1522  CTSZ; cathepsin Z [KO:K08568] [EC:3.4.18.1]", "329  BIRC2; baculoviral IAP repeat containing 2 [KO:K16060]", "330  BIRC3; baculoviral IAP repeat containing 3 [KO:K16060]", "331  XIAP; X-linked inhibitor of apoptosis [KO:K04725] [EC:2.3.2.27]", "332  BIRC5; baculoviral IAP repeat containing 5 [KO:K08731]", "10018  BCL2L11; BCL2 like 11 [KO:K16341]", "598  BCL2L1; BCL2 like 1 [KO:K04570]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]", "1616  DAXX; death domain associated protein [KO:K02308]", "8737  RIPK1; receptor interacting serine/threonine kinase 1 [KO:K02861] [EC:2.7.11.1]", "153090  DAB2IP; DAB2 interacting protein [KO:K19901]", "4217  MAP3K5; mitogen-activated protein kinase kinase kinase 5 [KO:K04426] [EC:2.7.11.25]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "7157  TP53; tumor protein p53 [KO:K04451]", "8739  HRK; harakiri, BCL2 interacting protein [KO:K02512]", "9020  MAP3K14; mitogen-activated protein kinase kinase kinase 14 [KO:K04466] [EC:2.7.11.25]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "5783  PTPN13; protein tyrosine phosphatase non-receptor type 13 [KO:K02374]", "1647  GADD45A; growth arrest and DNA damage inducible alpha [KO:K04402]", "4616  GADD45B; growth arrest and DNA damage inducible beta [KO:K04402]", "10912  GADD45G; growth arrest and DNA damage inducible gamma [KO:K04402]", "7185  TRAF1; TNF receptor associated factor 1 [KO:K03172]", "597  BCL2A1; BCL2 related protein A1 [KO:K02162]", "472  ATM; ATM serine/threonine kinase [KO:K04728] [EC:2.7.11.1]", "55367  PIDD1; p53-induced death domain protein 1 [KO:K10130]", "63970  TP53AIP1; tumor protein p53 regulated apoptosis inducing protein 1 [KO:K13773]", "27113  BBC3; BCL2 binding component 3 [KO:K10132]", "5366  PMAIP1; phorbol-12-myristate-13-acetate-induced protein 1 [KO:K10131]", "835  CASP2; caspase 2 [KO:K02186] [EC:3.4.22.55]", "4803  NGF; nerve growth factor [KO:K02582]", "4914  NTRK1; neurotrophic receptor tyrosine kinase 1 [KO:K03176] [EC:2.7.10.1]", "3562  IL3; interleukin 3 [KO:K04736]", "3563  IL3RA; interleukin 3 receptor subunit alpha [KO:K04737]", "1439  CSF2RB; colony stimulating factor 2 receptor subunit beta [KO:K04738]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5170  PDPK1; 3-phosphoinositide dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]"], "compound": ["C00027  Hydrogen peroxide", "C00076  Calcium cation", "C00319  Sphingosine", "C05981  Phosphatidylinositol-3,4,5-trisphosphate"], "refs": [{"pmid": "26615431", "authors": "  Savitskaya MA, Onishchenko GE", "title": "Mechanisms of Apoptosis.", "journal": "Biochemistry (Mosc) 80:1393-417 (2015)", "doi": "10.1134/S0006297915110012"}, {"pmid": "23803157", "authors": "  Schleich K, Lavrik IN", "title": "Mathematical modeling of apoptosis.", "journal": "Cell Commun Signal 11:44 (2013)", "doi": "10.1186/1478-811X-11-44"}, {"pmid": "15654015", "authors": "  Lavrik I, Golks A, Krammer PH", "title": "Death receptor signaling.", "journal": "J Cell Sci 118:265-7 (2005)", "doi": "10.1242/jcs.01610"}, {"pmid": "15725726", "authors": "  Jin Z, El-Deiry WS", "title": "Overview of cell death signaling pathways.", "journal": "Cancer Biol Ther 4:139-63 (2005)", "doi": "10.4161/cbt.4.2.1508"}, {"pmid": "15322527", "authors": "  Benn SC, Woolf CJ", "title": "Adult neuron survival strategies--slamming on the brakes.", "journal": "Nat Rev Neurosci 5:686-700 (2004)", "doi": "10.1038/nrn1477"}, {"pmid": "12838338", "authors": "  Orrenius S, Zhivotovsky B, Nicotera P", "title": "Regulation of cell death: the calcium-apoptosis link.", "journal": "Nat Rev Mol Cell Biol 4:552-65 (2003)", "doi": "10.1038/nrm1150"}, {"pmid": "19148180", "authors": "  Clarke P, Tyler KL", "title": "Apoptosis in animal models of virus-induced disease.", "journal": "Nat Rev Microbiol 7:144-55 (2009)", "doi": "10.1038/nrmicro2071"}, {"pmid": "22429822", "authors": "  Wen X, Lin ZQ, Liu B, Wei YQ", "title": "Caspase-mediated programmed cell death pathways as potential therapeutic targets in cancer.", "journal": "Cell Prolif 45:217-24 (2012)", "doi": "10.1111/j.1365-2184.2012.00814.x"}, {"pmid": "25526085", "authors": "  Shalini S, Dorstyn L, Dawar S, Kumar S", "title": "Old, new and emerging functions of caspases.", "journal": "Cell Death Differ 22:526-39 (2015)", "doi": "10.1038/cdd.2014.216"}, {"pmid": "15601572", "authors": "  Philchenkov A", "title": "Caspases: potential targets for regulating cell death.", "journal": "J Cell Mol Med 8:432-44 (2004)", "doi": "10.1111/j.1582-4934.2004.tb00468.x"}, {"pmid": "9894605", "authors": "  Stroh C, Schulze-Osthoff K", "title": "Death by a thousand cuts: an ever increasing list of caspase substrates.", "journal": "Cell Death Differ 5:997-1000 (1998)", "doi": "10.1038/sj.cdd.4400451"}, {"pmid": "18304445", "authors": "  Jeong SY, Seol DW", "title": "The role of mitochondria in apoptosis.", "journal": "BMB Rep 41:11-22 (2008)", "doi": "10.5483/bmbrep.2008.41.1.011"}, {"pmid": "20533903", "authors": "  Parsons MJ, Green DR", "title": "Mitochondria in cell death.", "journal": "Essays Biochem 47:99-114 (2010)", "doi": "10.1042/bse0470099"}, {"pmid": "15719025", "authors": "  Strasser A", "title": "The role of BH3-only proteins in the immune system.", "journal": "Nat Rev Immunol 5:189-200 (2005)", "doi": "10.1038/nri1568"}, {"pmid": "24278747", "authors": "  Schonthal AH", "title": "Endoplasmic reticulum stress: its role in disease and novel prospects for therapy.", "journal": "Scientifica (Cairo) 2012:857516 (2012)", "doi": "10.6064/2012/857516"}, {"pmid": "21145844", "authors": "  Malhi H, Kaufman RJ", "title": "Endoplasmic reticulum stress in liver disease.", "journal": "J Hepatol 54:795-809 (2011)", "doi": "10.1016/j.jhep.2010.11.005"}, {"pmid": "18023214", "authors": "  Malhotra JD, Kaufman RJ", "title": "The endoplasmic reticulum and the unfolded protein response.", "journal": "Semin Cell Dev Biol 18:716-31 (2007)", "doi": "10.1016/j.semcdb.2007.09.003"}, {"pmid": "16397578", "authors": "  Wu J, Kaufman RJ", "title": "From acute ER stress to physiological roles of the Unfolded Protein Response.", "journal": "Cell Death Differ 13:374-84 (2006)", "doi": "10.1038/sj.cdd.4401840"}, {"pmid": "21914490", "authors": "  Repnik U, Stoka V, Turk V, Turk B", "title": "Lysosomes and lysosomal cathepsins in cell death.", "journal": "Biochim Biophys Acta 1824:22-33 (2012)", "doi": "10.1016/j.bbapap.2011.08.016"}, {"pmid": "22465226", "authors": "  Cesen MH, Pegan K, Spes A, Turk B", "title": "Lysosomal pathways to cell death and their therapeutic applications.", "journal": "Exp Cell Res 318:1245-51 (2012)", "doi": "10.1016/j.yexcr.2012.03.005"}, {"pmid": "26231733", "authors": "  Dashzeveg N, Yoshida K", "title": "Cell death decision by p53 via control of the mitochondrial membrane.", "journal": "Cancer Lett 367:108-12 (2015)", "doi": "10.1016/j.canlet.2015.07.019"}, {"pmid": "22075987", "authors": "  Bouchier-Hayes L, Green DR", "title": "Caspase-2: the orphan caspase.", "journal": "Cell Death Differ 19:51-7 (2012)", "doi": "10.1038/cdd.2011.157"}, {"pmid": "18238895", "authors": "  Baptiste-Okoh N, Barsotti AM, Prives C", "title": "A role for caspase 2 and PIDD in the process of p53-mediated apoptosis.", "journal": "Proc Natl Acad Sci U S A 105:1937-42 (2008)", "doi": "10.1073/pnas.0711800105"}, {"pmid": "12949498", "authors": "  Aggarwal BB", "title": "Signalling pathways of the TNF superfamily: a double-edged sword.", "journal": "Nat Rev Immunol 3:745-56 (2003)", "doi": "10.1038/nri1184"}, {"pmid": "14737178", "authors": "  Steelman LS, Pohnert SC, Shelton JG, Franklin RA, Bertrand FE, McCubrey JA.", "title": "JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis.", "journal": "Leukemia 18:189-218 (2004)", "doi": "10.1038/sj.leu.2403241"}, {"pmid": "9916983", "authors": "  Dragovich T, Rudin CM, Thompson CB", "title": "Signal transduction pathways that regulate cell survival and cell death.", "journal": "Oncogene 17:3207-13 (1998)", "doi": "10.1038/sj.onc.1202587"}, {"pmid": "11520933", "authors": "  Sofroniew MV, Howe CL, Mobley WC", "title": "Nerve growth factor signaling, neuroprotection, and neural repair.", "journal": "Annu Rev Neurosci 24:1217-81 (2001)", "doi": "10.1146/annurev.neuro.24.1.1217"}, {"pmid": "24769728", "authors": "  Kristiansen M, Ham J", "title": "Programmed cell death during neuronal development: the sympathetic neuron model.", "journal": "Cell Death Differ 21:1025-35 (2014)", "doi": "10.1038/cdd.2014.47"}, {"pmid": "18208375", "authors": "  Logue SE, Martin SJ", "title": "Caspase activation cascades in apoptosis.", "journal": "Biochem Soc Trans 36:1-9 (2008)", "doi": "10.1042/BST0360001"}, {"pmid": "19770840", "authors": "  Boivin WA, Cooper DM, Hiebert PR, Granville DJ", "title": "Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma.", "journal": "Lab Invest 89:1195-220 (2009)", "doi": "10.1038/labinvest.2009.91"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04064  NF-kappa B signaling pathway", "hsa04115  p53 signaling pathway", "hsa04141  Protein processing in endoplasmic reticulum", "hsa04151  PI3K-Akt signaling pathway", "hsa04650  Natural killer cell mediated cytotoxicity", "hsa04668  TNF signaling pathway"], "ko_pathway": "ko04210", "genes": ["IL3", "TP53", "AKT2", "BIRC3", "AKT1", "NRAS", "BAX"]}, {"kegg_id": "hsa04630", "name": "JAK-STAT signaling pathway - Homo sapiens (human)", "description": "The Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway is one of a handful of pleiotropic cascades used to transduce a multitude of signals for development and homeostasis in animals, from humans to flies. In mammals, the JAK/STAT pathway is the principal signaling mechanism for a wide array of cytokines and growth factors. Following the binding of cytokines to their cognate receptor, STATs are activated by members of the JAK family of tyrosine kinases. Once activated, they dimerize and translocate to the nucleus and modulate the expression of target genes. In addition to the activation of STATs, JAKs mediate the recruitment of other molecules such as the MAP kinases, PI3 kinase etc. These molecules process downstream signals via the Ras-Raf-MAP kinase and PI3 kinase pathways which results in the activation of additional transcription factors.", "class": "Environmental Information Processing; Signal transduction", "pathway_map": "hsa04630  JAK-STAT signaling pathway", "network": ["", "ELEMENT   N00053  Cytokine-Jak-STAT signaling pathway", "N00094  EGF-Jak-STAT signaling pathway", "N00415  IL10 family to Jak-STAT signaling pathway", "N01554  IL2 family to Jak-STAT signaling pathway", "N01555  Hormone-like-cytokine to Jak-STAT signaling pathway", "N01556  IL6 family to Jak-STAT signaling pathway", "N01557  IL12/23 to Jak-STAT signaling pathway", "N01558  Type I interferon to Jak-STAT signaling pathway", "N01559  Type II interferon to Jak-STAT signaling pathway", "N01804  IL3 family to Jak-STAT signaling pathway"], "drug": ["D00745  Interferon alfa-2a (USAN/INN)", "D00746  Interferon beta-1b (USAN/INN)", "D00747  Interferon gamma-1b (USAN/INN)", "D00748  Aldesleukin (USAN/INN)", "D02596  Tocilizumab (USAN/INN)", "D02743  Celmoleukin (genetical recombination) (JP18)", "D02744  Interferon alfacon-1 (USAN/INN)", "D02745  Interferon alfa-2b (USAN)", "D02747  Peginterferon alfa-2a (USAN/INN)", "D02748  Peginterferon alfa-2b (USAN/INN)", "D02749  Teceleukin (USAN)", "D03058  Basiliximab (USAN/INN)", "D03117  Binetrakin (USAN/INN)", "D03231  Epoetin alfa (USAN/INN)", "D03232  Epoetin beta (USAN/INN)", "D03235  Filgrastim (USP/INN)", "D03245  Nartograstim (genetical recombination) (JP18)", "D03247  Lenograstim (USAN/INN)", "D03304  Interferon beta (JAN)", "D03305  Interferon alfa (NAMALWA) (JP18)", "D03357  Interferon gamma-1a (genetical recombination) (JAN)", "D03639  Daclizumab (USAN/INN)", "D03645  Daniplestim (USAN/INN)", "D03647  Dapiclermin (USAN/INN)", "D03651  Darbepoetin alfa (USAN/INN)", "D03682  Denileukin diftitox (USAN/INN)", "D03978  Eltrombopag olamine (JAN/USAN)", "D04032  Epoetin delta (USAN)", "D04552  Interferon alfa-n1 (USAN)", "D04553  Interferon alfa-n3 (USAN)", "D04554  Interferon beta-1a (USAN)", "D04695  Leridistim (USAN/INN)", "D04923  Mepolizumab (USAN/INN)", "D05036  Milodistim (USAN/INN)", "D05066  Molgramostim (USAN/INN)", "D05090  Muplestim (USAN/INN)", "D05266  Oprelvekin (USAN/INN)", "D05377  Pascolizumab (USAN/INN)", "D05389  Pegnartograstim (USAN/INN)", "D05803  Sargramostim (USP/INN)", "D06556  Apilimod mesylate (USAN)", "D06889  Pegfilgrastim (USAN/INN)", "D08805  Interferon gamma-n1 (JAN)", "D08844  Albinterferon alfa-2b (USAN)", "D08985  Reslizumab (USAN)", "D08990  Romiplostim (USAN/INN)", "D09024  Totrombopag choline (USAN)", "D09214  Ustekinumab (USAN/INN)", "D09332  Denenicokin (USAN/INN)", "D09588  Briakinumab (USAN/INN)", "D09633  Lebrikizumab (USAN/INN)", "D09669  Siltuximab (USAN/INN)", "D09783  Tofacitinib citrate (JAN/USAN)", "D09897  Enokizumab (USAN/INN)", "D09930  Mavrilimumab (USAN/INN)", "D09946  Peginesatide (USAN/INN)", "D09947  Peginesatide acetate (JAN/USAN)", "D09959  Ruxolitinib (USAN/INN)", "D09960  Ruxolitinib phosphate (JAN/USAN)", "D09970  Tofacitinib (USAN)", "D09979  Tralokinumab (USAN/INN)", "D09998  Epoetin beta pegol (genetical recombination) (JAN)", "D10000  Epoetin epsilon (INN)", "D10015  Litgenprostucel-L (USAN)", "D10078  Peginterferon lambda-1a (USAN)", "D10080  Sirukumab (USAN)", "D10161  Sarilumab (USAN)", "D10242  Lipegfilgrastim (USAN)", "D10306  Avatrombopag (USAN/INN)", "D10307  Avatrombopag maleate (JAN/USAN)", "D10308  Baricitinib (JAN/USAN/INN)", "D10310  Balugrastim (USAN/INN)", "D10354  Dupilumab (USAN/INN)", "D10365  Gandotinib (USAN/INN)", "D10438  Guselkumab (USAN/INN)", "D10476  Lusutrombopag (JAN/USAN/INN)", "D10483  Peginterferon beta-1a (USAN/INN)", "D10630  Fedratinib (USAN/INN)", "D10717  Napabucasin (JAN/USAN/INN)", "D10846  Epoetin theta (INN)", "D10847  Epoetin zeta (INN)", "D10871  Filgotinib (USAN/INN)", "D10872  Filgotinib hydrochloride (USAN)", "D10889  Momelotinib hydrochloride hydrate (JAN)", "D10944  Itacitinib (USAN/INN)", "D10945  Itacitinib adipate (JAN/USAN)", "D10994  Upadacitinib (USAN/INN)", "D10995  Upadacitinib tartrate (USAN)", "D11026  Pegteograstim (INN)", "D11027  Ropeginterferon alfa-2b (INN)", "D11046  Delgocitinib (JAN/USAN/INN)", "D11048  Upadacitinib hydrate (JAN)", "D11052  Risankizumab (USAN/INN)", "D11079  Satralizumab (USAN/INN)", "D11106  Filgotinib maleate (JAN/USAN)", "D11123  Mirikizumab (USAN/INN)", "D11188  Eflapegrastim (USAN/INN)", "D11193  Somavaratan (USAN/INN)", "D11200  Pegilodecakin (USAN/INN)", "D11296  Fedratinib hydrochloride (USAN)", "D11400  Abrocitinib (JAN/USAN)", "D11537  Brepocitinib (USAN)", "D11538  Brepocitinib tosylate (USAN)", "D11598  Romilkimab (USAN/INN)", "D11676  Gusacitinib (USAN/INN)", "D11677  Gusacitinib hydrochloride (USAN)", "D11747  Inbakicept (USAN/INN)", "D11756  Fletikumab (USAN/INN)", "D11771  Tezepelumab (USAN/INN)", "D11800  Vixarelimab (USAN)", "D11817  Deucravacitinib (JAN/USAN)", "D11821  Nogapendekin alfa (USAN/INN)", "D11866  Deuruxolitinib (USAN)", "D11867  Deuruxolitinib phosphate (USAN)", "D11953  Efmarodocokin alfa (USAN/INN)", "D11962  Murizatoclax (USAN/INN)", "D11963  Tapotoclax (USAN/INN)", "D11970  Ritlecitinib tosylate (USAN)", "D11986  Efbemalenograstim alfa (USAN/INN)", "D12056  Ropsacitinib (USAN)", "D12118  Nezulcitinib (USAN)", "D12169  Depemokimab (USAN)", "D12211  Ivarmacitinib (USAN)", "D12212  Ivarmacitinib sulfate (USAN)", "D12306  Ordesekimab (USAN)", "D12307  Pivekimab (USAN)", "D12308  Pivekimab sunirine (USAN)", "D12328  Rezpegaldesleukin (USAN)", "D12371  Nemvaleukin alfa (USAN/INN)", "D12386  Melredableukin alfa (USAN/INN)", "D12479  Lusvertikimab (USAN/INN)", "D12487  Olokizumab (INN)", "D12502  Golidocitinib (USAN/INN)", "D12575  Povorcitinib (USAN/INN)", "D12576  Povorcitinib phosphate (USAN)", "D12623  Nanrilkefusp alfa (USAN/INN)", "D12625  Pegenzileukin (USAN/INN)", "D12709  Dalmitamig (USAN)", "D12725  Lomedeucitinib (USAN)", "D12731  Anumigilimab (USAN/INN)", "D12739  Bempikibart (USAN/INN)", "D12748  Levilimab (INN)", "D12784  Casdozokitug (USAN/INN)", "D12786  Lepzacitinib (USAN)", "D12807  Ziltivekimab (USAN/INN)", "D12810  Falbikitug (USAN/INN)", "D12815  Eltrombopag choline", "D12824  Temtokibart (USAN/INN)", "D12850  Imneskibart (USAN)", "D12888  Nogapendekin alfa inbakicept"], "dblinks": "GO: 0007259", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["3558  IL2; interleukin 2 [KO:K05429]", "3565  IL4; interleukin 4 [KO:K05430]", "3574  IL7; interleukin 7 [KO:K05431]", "3578  IL9; interleukin 9 [KO:K05432]", "3600  IL15; interleukin 15 [KO:K05433]", "59067  IL21; interleukin 21 [KO:K05434]", "85480  TSLP; thymic stromal lymphopoietin [KO:K05436]", "3559  IL2RA; interleukin 2 receptor subunit alpha [KO:K05068]", "3560  IL2RB; interleukin 2 receptor subunit beta [KO:K05069]", "3561  IL2RG; interleukin 2 receptor subunit gamma [KO:K05070]", "3566  IL4R; interleukin 4 receptor [KO:K05071]", "3575  IL7R; interleukin 7 receptor [KO:K05072]", "3581  IL9R; interleukin 9 receptor [KO:K05073]", "3601  IL15RA; interleukin 15 receptor subunit alpha [KO:K05074]", "50615  IL21R; interleukin 21 receptor [KO:K05075]", "64109  CRLF2; cytokine receptor like factor 2 [KO:K05078]", "3562  IL3; interleukin 3 [KO:K04736]", "3567  IL5; interleukin 5 [KO:K05428]", "1437  CSF2; colony stimulating factor 2 [KO:K05427]", "3563  IL3RA; interleukin 3 receptor subunit alpha [KO:K04737]", "3568  IL5RA; interleukin 5 receptor subunit alpha [KO:K05067]", "1438  CSF2RA; colony stimulating factor 2 receptor subunit alpha [KO:K05066]", "1439  CSF2RB; colony stimulating factor 2 receptor subunit beta [KO:K04738]", "3569  IL6; interleukin 6 [KO:K05405]", "3589  IL11; interleukin 11 [KO:K05417]", "3596  IL13; interleukin 13 [KO:K05435]", "246778  IL27; interleukin 27 [KO:K22629]", "386653  IL31; interleukin 31 [KO:K22631]", "5008  OSM; oncostatin M [KO:K05418]", "3976  LIF; LIF interleukin 6 family cytokine [KO:K05419]", "1270  CNTF; ciliary neurotrophic factor [KO:K05420]", "1489  CTF1; cardiotrophin 1 [KO:K05422]", "23529  CLCF1; cardiotrophin like cytokine factor 1 [KO:K05421]", "3570  IL6R; interleukin 6 receptor [KO:K05055]", "3572  IL6ST; interleukin 6 cytokine family signal transducer [KO:K05060]", "3590  IL11RA; interleukin 11 receptor subunit alpha [KO:K05056]", "3597  IL13RA1; interleukin 13 receptor subunit alpha 1 [KO:K05076]", "3598  IL13RA2; interleukin 13 receptor subunit alpha 2 [KO:K05077]", "9466  IL27RA; interleukin 27 receptor subunit alpha [KO:K19598]", "133396  IL31RA; interleukin 31 receptor A [KO:K22630]", "9180  OSMR; oncostatin M receptor [KO:K05057]", "3977  LIFR; LIF receptor subunit alpha [KO:K05058]", "1271  CNTFR; ciliary neurotrophic factor receptor [KO:K05059]", "3586  IL10; interleukin 10 [KO:K05443]", "29949  IL19; interleukin 19 [KO:K05444]", "50616  IL22; interleukin 22 [KO:K05445]", "50604  IL20; interleukin 20 [KO:K22667]", "11009  IL24; interleukin 24 [KO:K22668]", "55801  IL26; interleukin 26 [KO:K05446]", "3587  IL10RA; interleukin 10 receptor subunit alpha [KO:K05134]", "3588  IL10RB; interleukin 10 receptor subunit beta [KO:K05135]", "53832  IL20RA; interleukin 20 receptor subunit alpha [KO:K05136]", "53833  IL20RB; interleukin 20 receptor subunit beta [KO:K05137]", "58985  IL22RA1; interleukin 22 receptor subunit alpha 1 [KO:K05138]", "116379  IL22RA2; interleukin 22 receptor subunit alpha 2 [KO:K05139]", "3592  IL12A; interleukin 12A [KO:K05406]", "3593  IL12B; interleukin 12B [KO:K05425]", "51561  IL23A; interleukin 23 subunit alpha [KO:K05426]", "3594  IL12RB1; interleukin 12 receptor subunit beta 1 [KO:K05063]", "3595  IL12RB2; interleukin 12 receptor subunit beta 2 [KO:K05064]", "149233  IL23R; interleukin 23 receptor [KO:K05065]", "2056  EPO; erythropoietin [KO:K05437]", "2688  GH1; growth hormone 1 [KO:K05438]", "2689  GH2; growth hormone 2 [KO:K05438]", "1442  CSH1; chorionic somatomammotropin hormone 1 [KO:K05438]", "1443  CSH2; chorionic somatomammotropin hormone 2 [KO:K05438]", "5617  PRL; prolactin [KO:K05439]", "7066  THPO; thrombopoietin [KO:K06854]", "1440  CSF3; colony stimulating factor 3 [KO:K05423]", "3952  LEP; leptin [KO:K05424]", "2057  EPOR; erythropoietin receptor [KO:K05079]", "2690  GHR; growth hormone receptor [KO:K05080]", "5618  PRLR; prolactin receptor [KO:K05081]", "4352  MPL; MPL proto-oncogene, thrombopoietin receptor [KO:K05082]", "1441  CSF3R; colony stimulating factor 3 receptor [KO:K05061]", "3953  LEPR; leptin receptor [KO:K05062]", "3439  IFNA1; interferon alpha 1 [KO:K05414]", "3440  IFNA2; interferon alpha 2 [KO:K05414]", "3441  IFNA4; interferon alpha 4 [KO:K05414]", "3442  IFNA5; interferon alpha 5 [KO:K05414]", "3443  IFNA6; interferon alpha 6 [KO:K05414]", "3444  IFNA7; interferon alpha 7 [KO:K05414]", "3445  IFNA8; interferon alpha 8 [KO:K05414]", "3446  IFNA10; interferon alpha 10 [KO:K05414]", "3447  IFNA13; interferon alpha 13 [KO:K05414]", "3448  IFNA14; interferon alpha 14 [KO:K05414]", "3449  IFNA16; interferon alpha 16 [KO:K05414]", "3451  IFNA17; interferon alpha 17 [KO:K05414]", "3452  IFNA21; interferon alpha 21 [KO:K05414]", "3456  IFNB1; interferon beta 1 [KO:K05415]", "338376  IFNE; interferon epsilon [KO:K05442]", "56832  IFNK; interferon kappa [KO:K05441]", "282618  IFNL1; interferon lambda 1 [KO:K05447]", "282616  IFNL2; interferon lambda 2 [KO:K22669]", "282617  IFNL3; interferon lambda 3 [KO:K22669]", "3467  IFNW1; interferon omega 1 [KO:K05440]", "3454  IFNAR1; interferon alpha and beta receptor subunit 1 [KO:K05130]", "3455  IFNAR2; interferon alpha and beta receptor subunit 2 [KO:K05131]", "163702  IFNLR1; interferon lambda receptor 1 [KO:K05140]", "3458  IFNG; interferon gamma [KO:K04687]", "3459  IFNGR1; interferon gamma receptor 1 [KO:K05132]", "3460  IFNGR2; interferon gamma receptor 2 [KO:K05133]", "1950  EGF; epidermal growth factor [KO:K04357]", "5154  PDGFA; platelet derived growth factor subunit A [KO:K04359]", "5155  PDGFB; platelet derived growth factor subunit B [KO:K17386]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "5156  PDGFRA; platelet derived growth factor receptor alpha [KO:K04363] [EC:2.7.10.1]", "5159  PDGFRB; platelet derived growth factor receptor beta [KO:K05089] [EC:2.7.10.1]", "3716  JAK1; Janus kinase 1 [KO:K11217] [EC:2.7.10.2]", "3717  JAK2; Janus kinase 2 [KO:K04447] [EC:2.7.10.2]", "3718  JAK3; Janus kinase 3 [KO:K11218] [EC:2.7.10.2]", "7297  TYK2; tyrosine kinase 2 [KO:K11219] [EC:2.7.10.2]", "6772  STAT1; signal transducer and activator of transcription 1 [KO:K11220]", "6773  STAT2; signal transducer and activator of transcription 2 [KO:K11221]", "6774  STAT3; signal transducer and activator of transcription 3 [KO:K04692]", "6775  STAT4; signal transducer and activator of transcription 4 [KO:K11222]", "6776  STAT5A; signal transducer and activator of transcription 5A [KO:K11223]", "6777  STAT5B; signal transducer and activator of transcription 5B [KO:K11224]", "6778  STAT6; signal transducer and activator of transcription 6 [KO:K11225]", "10379  IRF9; interferon regulatory factor 9 [KO:K04693]", "1154  CISH; cytokine inducible SH2 containing protein [KO:K04701]", "8651  SOCS1; suppressor of cytokine signaling 1 [KO:K04694]", "8835  SOCS2; suppressor of cytokine signaling 2 [KO:K04695]", "9021  SOCS3; suppressor of cytokine signaling 3 [KO:K04696]", "122809  SOCS4; suppressor of cytokine signaling 4 [KO:K04697]", "9655  SOCS5; suppressor of cytokine signaling 5 [KO:K04698]", "30837  SOCS7; suppressor of cytokine signaling 7 [KO:K04699]", "9306  SOCS6; suppressor of cytokine signaling 6 [KO:K04699]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]", "4170  MCL1; MCL1 apoptosis regulator, BCL2 family member [KO:K02539]", "598  BCL2L1; BCL2 like 1 [KO:K04570]", "5292  PIM1; Pim-1 proto-oncogene, serine/threonine kinase [KO:K04702] [EC:2.7.11.1]", "4609  MYC; MYC proto-oncogene, bHLH transcription factor [KO:K04377]", "595  CCND1; cyclin D1 [KO:K04503]", "894  CCND2; cyclin D2 [KO:K10151]", "896  CCND3; cyclin D3 [KO:K10152]", "1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]", "316  AOX1; aldehyde oxidase 1 [KO:K00157] [EC:1.2.3.1]", "2670  GFAP; glial fibrillary acidic protein [KO:K05640]", "10254  STAM2; signal transducing adaptor molecule 2 [KO:K04705]", "8027  STAM; signal transducing adaptor molecule [KO:K04705]", "5771  PTPN2; protein tyrosine phosphatase non-receptor type 2 [KO:K18026] [EC:3.1.3.48]", "5777  PTPN6; protein tyrosine phosphatase non-receptor type 6 [KO:K05697] [EC:3.1.3.48]", "1387  CREBBP; CREB binding protein [KO:K04498] [EC:2.3.1.48]", "2033  EP300; E1A binding protein p300 [KO:K04498] [EC:2.3.1.48]", "8554  PIAS1; protein inhibitor of activated STAT 1 [KO:K04706] [EC:2.3.2.-]", "9063  PIAS2; protein inhibitor of activated STAT 2 [KO:K16063] [EC:2.3.2.-]", "10401  PIAS3; protein inhibitor of activated STAT 3 [KO:K16064] [EC:2.3.2.-]", "51588  PIAS4; protein inhibitor of activated STAT 4 [KO:K16065] [EC:2.3.2.27]", "2273  FHL1; four and a half LIM domains 1 [KO:K14365]", "5781  PTPN11; protein tyrosine phosphatase non-receptor type 11 [KO:K07293] [EC:3.1.3.48]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]"], "refs": [{"pmid": "22383755", "authors": "  Harrison DA", "title": "The Jak/STAT pathway.", "journal": "Cold Spring Harb Perspect Biol 4:a011205 (2012)", "doi": "10.1101/cshperspect.a011205"}, {"pmid": "22339650", "authors": "  Kiu H, Nicholson SE", "title": "Biology and significance of the JAK/STAT signalling pathways.", "journal": "Growth Factors 30:88-106 (2012)", "doi": "10.3109/08977194.2012.660936"}, {"pmid": "21372217", "authors": "  Hervas-Stubbs S, Perez-Gracia JL, Rouzaut A, Sanmamed MF, Le Bon A, Melero I", "title": "Direct effects of type I interferons on cells of the immune system.", "journal": "Clin Cancer Res 17:2619-27 (2011)", "doi": "10.1158/1078-0432.CCR-10-1114"}, {"pmid": "25217450", "authors": "  Fish EN, Platanias LC", "title": "Interferon receptor signaling in malignancy: a network of cellular pathways defining biological outcomes.", "journal": "Mol Cancer Res 12:1691-703 (2014)", "doi": "10.1158/1541-7786.MCR-14-0450"}, {"pmid": "21034406", "authors": "  Ivanenkov YA, Balakin KV, Lavrovsky Y", "title": "Small molecule inhibitors of NF-kB and JAK/STAT signal transduction pathways as promising anti-inflammatory therapeutics.", "journal": "Mini Rev Med Chem 11:55-78 (2011)", "doi": "10.2174/138955711793564079"}, {"pmid": "25587654", "authors": "  O'Shea JJ, Schwartz DM, Villarino AV, Gadina M, McInnes IB, Laurence A", "title": "The JAK-STAT pathway: impact on human disease and therapeutic intervention.", "journal": "Annu Rev Med 66:311-28 (2015)", "doi": "10.1146/annurev-med-051113-024537"}, {"pmid": "24069565", "authors": "  Zoranovic T, Grmai L, Bach EA", "title": "Regulation of proliferation, cell competition, and cellular growth by the Drosophila JAK-STAT pathway.", "journal": "JAKSTAT 2:e25408 (2013)", "doi": "10.4161/jkst.25408"}, {"pmid": "16204702", "authors": "  Ungureanu D, Silvennoinen O", "title": "SLIM trims STATs: ubiquitin E3 ligases provide insights for specificity in the regulation of cytokine signaling.", "journal": "Sci STKE 2005:pe49 (2005)", "doi": "10.1126/stke.3042005pe49"}, {"pmid": "23735217", "authors": "  Richard AJ, Stephens JM", "title": "The role of JAK-STAT signaling in adipose tissue function.", "journal": "Biochim Biophys Acta 1842:431-9 (2014)", "doi": "10.1016/j.bbadis.2013.05.030"}, {"pmid": "24606160", "authors": "  Sun Y, Lehmbecker A, Kalkuhl A, Deschl U, Sun W, Rohn K, Tzvetanova ID, Nave KA, Baumgartner W, Ulrich R", "title": "STAT3 represents a molecular switch possibly inducing astroglial instead of oligodendroglial differentiation of oligodendroglial progenitor cells in Theiler's murine encephalomyelitis.", "journal": "Neuropathol Appl Neurobiol 41:347-70 (2015)", "doi": "10.1111/nan.12133"}, {"pmid": "10851053", "authors": "  Hirano T, Ishihara K, Hibi M", "title": "Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors.", "journal": "Oncogene 19:2548-56 (2000)", "doi": "10.1038/sj.onc.1203551"}, {"pmid": "11114747", "authors": "  Rane SG, Reddy EP", "title": "Janus kinases: components of multiple signaling pathways.", "journal": "Oncogene 19:5662-79 (2000)", "doi": "10.1038/sj.onc.1203925"}, {"pmid": "8682149", "authors": "  Heim MH", "title": "The Jak-STAT pathway: specific signal transduction from the cell membrane to the nucleus.", "journal": "Eur J Clin Invest 26:1-12 (1996)", "doi": "10.1046/j.1365-2362.1996.103248.x"}, {"pmid": "30267440", "authors": "  Morris R, Kershaw NJ, Babon JJ", "title": "The molecular details of cytokine signaling via the JAK/STAT pathway.", "journal": "Protein Sci 27:1984-2009 (2018)", "doi": "10.1002/pro.3519"}, {"pmid": "34492272", "authors": "  Tzeng HT, Chyuan IT, Lai JH", "title": "Targeting the JAK-STAT pathway in autoimmune diseases and cancers: A focus on molecular mechanisms and therapeutic potential.", "journal": "Biochem Pharmacol 193:114760 (2021)", "doi": "10.1016/j.bcp.2021.114760"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04060  Cytokine-cytokine receptor interaction", "hsa04110  Cell cycle", "hsa04120  Ubiquitin mediated proteolysis", "hsa04151  PI3K-Akt signaling pathway", "hsa04210  Apoptosis"], "ko_pathway": "ko04630", "genes": ["IL3", "EGFR", "IL2R", "AKT2", "AKT1", "SOS1", "PIM1"]}, {"kegg_id": "hsa04640", "name": "Hematopoietic cell lineage - Homo sapiens (human)", "description": "Blood-cell development progresses from a hematopoietic stem cell (HSC), which can undergo either self-renewal or differentiation into a multilineage committed progenitor cell: a common lymphoid progenitor (CLP) or a common myeloid progenitor (CMP). A CLP gives rise to the lymphoid lineage of white blood cells or leukocytes-the natural killer (NK) cells and the T and B lymphocytes. A CMP gives rise to the myeloid lineage, which comprises the rest of the leukocytes, the erythrocytes (red blood cells), and the megakaryocytes that produce platelets important in blood clotting. Cells undergoing these differentiation process express a stage- and lineage-specific set of surface markers. Therefore cellular stages are identified by the specific expression patterns of these genes.", "class": "Organismal Systems; Immune system", "pathway_map": "hsa04640  Hematopoietic cell lineage", "drug": ["D00754  Thalidomide (JAN/USP/INN)", "D01029  Tirofiban hydrochloride (USAN)", "D01583  Pirfenidone (JAN/USAN/INN)", "D02596  Tocilizumab (USAN/INN)", "D02664  Mirimostim (JAN/INN)", "D02778  Abciximab (USAN/INN)", "D02937  Ancestim (USAN/INN)", "D02994  Rituximab (USAN/INN)", "D03058  Basiliximab (USAN/INN)", "D03231  Epoetin alfa (USAN/INN)", "D03232  Epoetin beta (USAN/INN)", "D03235  Filgrastim (USP/INN)", "D03247  Lenograstim (USAN/INN)", "D03259  Gemtuzumab ozogamicin (USAN)", "D03497  Cilengitide (USAN/INN)", "D03639  Daclizumab (USAN/INN)", "D03645  Daniplestim (USAN/INN)", "D03651  Darbepoetin alfa (USAN/INN)", "D03971  Elarofiban (USAN)", "D04032  Epoetin delta (USAN)", "D04036  Epratuzumab (USAN/INN)", "D04489  Ibritumomab tiuxetan (USAN/INN)", "D04659  Lamifiban (USAN/INN)", "D04687  Lenalidomide (JAN/USAN/INN)", "D04695  Leridistim (USAN/INN)", "D04785  Lotrafiban hydrochloride (USAN)", "D04923  Mepolizumab (USAN/INN)", "D05036  Milodistim (USAN/INN)", "D05066  Molgramostim (USAN/INN)", "D05090  Muplestim (USAN/INN)", "D05218  Ocrelizumab (USAN)", "D05266  Oprelvekin (USAN/INN)", "D05267  Orbofiban acetate (USAN)", "D05772  Roxifiban acetate (USAN)", "D05803  Sargramostim (USP/INN)", "D05834  Sibrafiban (USAN/INN)", "D05847  Siplizumab (USAN/INN)", "D06335  Xemilofiban hydrochloride (USAN)", "D06348  Yttrium Y 90 epratuzumab (USAN)", "D06349  Yttrium Y 90 epratuzumab tetraxetan (USAN)", "D06381  Zolimomab aritox (USAN)", "D06463  Lumiliximab (USAN/INN)", "D06649  Tadocizumab (USAN)", "D06888  Eptifibatide (INN)", "D06889  Pegfilgrastim (USAN/INN)", "D08607  Tirofiban (INN)", "D08621  Tositumomab (INN)", "D08622  Tositumomab 131 iodine", "D08933  Inotuzumab ozogamicin (USAN/INN)", "D08976  Pomalidomide (JAN/USAN/INN)", "D09031  Veltuzumab (USAN)", "D09190  Anti-human thymocyte immunoglobulin, rabbit (JAN)", "D09207  Catumaxomab (INN)", "D09314  Ofatumumab (USAN/INN)", "D09321  Obinutuzumab (USAN/INN)", "D09813  Lenalidomide hydrate (JAN)", "D09932  Moxetumomab pasudotox (USAN/INN)", "D09955  Quizartinib (USAN/INN)", "D09956  Quizartinib dihydrochloride (USAN)", "D10000  Epoetin epsilon (INN)", "D10026  Tosedostat (USAN/INN)", "D10028  Valategrast hydrochloride (USAN)", "D10225  Sacubitril (JAN/USAN/INN)", "D10242  Lipegfilgrastim (USAN)", "D10310  Balugrastim (USAN/INN)", "D10354  Dupilumab (USAN/INN)", "D10777  Daratumumab (USAN)", "D10800  Gilteritinib fumarate (JAN/USAN)", "D10846  Epoetin theta (INN)", "D10847  Epoetin zeta (INN)", "D10993  Tucidinostat (JAN/USAN/INN)", "D11026  Pegteograstim (INN)", "D11050  Isatuximab (USAN/INN)", "D11144  Axicabtagene ciloleucel (USAN)", "D11188  Eflapegrastim (USAN/INN)", "D11231  Denintuzumab (USAN/INN)", "D11232  Denintuzumab mafodotin (USAN/INN)", "D11236  Lenzilumab (USAN/INN)", "D11243  Ublituximab (USAN/INN)", "D11294  Vadastuximab (USAN/INN)", "D11295  Vadastuximab talirine (USAN)", "D11306  Flotetuzumab (USAN/INN)", "D11324  Camidanlumab (USAN)", "D11325  Camidanlumab tesirine (USAN)", "D11333  Loncastuximab (USAN)", "D11338  Loncastuximab tesirine (USAN)", "D11358  Tagraxofusp (USAN/INN)", "D11372  Duvortuxizumab (USAN)", "D11386  Tisagenlecleucel-T (USAN)", "D11463  Mosunetuzumab (USAN/INN)", "D11489  Cibisatamab (USAN/INN)", "D11534  Odronextamab (USAN)", "D11599  Zotiraciclib (USAN)", "D11600  Zotiraciclib citrate (USAN)", "D11601  Tafasitamab (USAN/INN)", "D11686  Plamotamab (USAN/INN)", "D11757  Inebilizumab (USAN/INN)", "D11768  Pacritinib (USAN/INN)", "D11812  Pabinafusp alfa (genetical recombination) (JAN)", "D11833  Glofitamab (USAN/INN)", "D11841  Vibecotamab (USAN/INN)", "D11880  Brexucabtagene autoleucel (USAN)", "D11930  Betibeglogene autotemcel (USAN/INN)", "D11945  Mezagitamab (USAN/INN)", "D11986  Efbemalenograstim alfa (USAN/INN)", "D11990  Lisocabtagene maraleucel (USAN/INN)", "D11992  Pavurutamab (USAN)", "D12051  Zalunfiban (USAN)", "D12058  Elranatamab (USAN)", "D12124  Lilotomab (USAN/INN)", "D12125  Lutetium (177Lu) lilotomab satetraxetan (USAN/INN)", "D12141  Emerfetamab (USAN)", "D12152  Eluvixtamab (USAN)", "D12163  Zalunfiban acetate (USAN)", "D12177  Teclistamab (USAN/INN)", "D12180  Talquetamab (USAN/INN)", "D12307  Pivekimab (USAN)", "D12308  Pivekimab sunirine (USAN)", "D12315  Ciltacabtagene autoleucel (USAN/INN)", "D12368  Epcoritamab (USAN/INN)", "D12476  Tuspetinib (USAN/INN)", "D12509  Trontinemab (USAN/INN)", "D12540  Briquilimab (USAN/INN)", "D12567  Imvotamab (USAN/INN)", "D12592  Omidubicel (USAN)", "D12641  Emirodatamab (USAN/INN)", "D12721  Avitotamig (USAN)", "D12722  Bexotegrast (USAN/INN)", "D12724  Forimtamig (USAN/INN)", "D12747  Divozilimab (INN)", "D12749  Exagamglogene autotemcel (USAN/INN)", "D12765  Lovotibeglogene autotemcel (USAN/INN)", "D12806  Tividenofusp alfa (USAN/INN)", "D12833  Lifileucel (USAN/INN)", "D12862  Noraramtide (USAN)", "D12877  Atidarsagene autotemcel (USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["4254  KITLG; KIT ligand [KO:K05461]", "3574  IL7; interleukin 7 [KO:K05431]", "3565  IL4; interleukin 4 [KO:K05430]", "1437  CSF2; colony stimulating factor 2 [KO:K05427]", "2323  FLT3LG; fms related receptor tyrosine kinase 3 ligand [KO:K05454]", "3567  IL5; interleukin 5 [KO:K05428]", "1440  CSF3; colony stimulating factor 3 [KO:K05423]", "3562  IL3; interleukin 3 [KO:K04736]", "3569  IL6; interleukin 6 [KO:K05405]", "3589  IL11; interleukin 11 [KO:K05417]", "3552  IL1A; interleukin 1 alpha [KO:K04383]", "3553  IL1B; interleukin 1 beta [KO:K04519]", "7124  TNF; tumor necrosis factor [KO:K03156]", "1435  CSF1; colony stimulating factor 1 [KO:K05453]", "2056  EPO; erythropoietin [KO:K05437]", "7066  THPO; thrombopoietin [KO:K06854]", "947  CD34; CD34 molecule [KO:K06474]", "2322  FLT3; fms related receptor tyrosine kinase 3 [KO:K05092] [EC:2.7.10.1]", "1791  DNTT; DNA nucleotidylexotransferase [KO:K00977] [EC:2.7.7.31]", "3108  HLA-DMA; major histocompatibility complex, class II, DM alpha [KO:K06752]", "3109  HLA-DMB; major histocompatibility complex, class II, DM beta [KO:K06752]", "3111  HLA-DOA; major histocompatibility complex, class II, DO alpha [KO:K06752]", "3112  HLA-DOB; major histocompatibility complex, class II, DO beta [KO:K06752]", "3113  HLA-DPA1; major histocompatibility complex, class II, DP alpha 1 [KO:K06752]", "3115  HLA-DPB1; major histocompatibility complex, class II, DP beta 1 [KO:K06752]", "3117  HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 [KO:K06752]", "3118  HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2 [KO:K06752]", "3119  HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 [KO:K06752]", "3122  HLA-DRA; major histocompatibility complex, class II, DR alpha [KO:K06752]", "3123  HLA-DRB1; major histocompatibility complex, class II, DR beta 1 [KO:K06752]", "3125  HLA-DRB3; major histocompatibility complex, class II, DR beta 3 [KO:K06752]", "3126  HLA-DRB4; major histocompatibility complex, class II, DR beta 4 [KO:K06752]", "3127  HLA-DRB5; major histocompatibility complex, class II, DR beta 5 [KO:K06752]", "960  CD44; CD44 molecule (IN blood group) [KO:K06256]", "3815  KIT; KIT proto-oncogene, receptor tyrosine kinase [KO:K05091] [EC:2.7.10.1]", "3559  IL2RA; interleukin 2 receptor subunit alpha [KO:K05068]", "3575  IL7R; interleukin 7 receptor [KO:K05072]", "7037  TFRC; transferrin receptor [KO:K06503]", "952  CD38; CD38 molecule [KO:K01242] [EC:3.2.2.6 2.4.99.20]", "924  CD7; CD7 molecule [KO:K06457]", "914  CD2; CD2 molecule [KO:K06449]", "921  CD5; CD5 molecule [KO:K06455]", "909  CD1A; CD1a molecule [KO:K06448]", "910  CD1B; CD1b molecule [KO:K06448]", "911  CD1C; CD1c molecule [KO:K06448]", "912  CD1D; CD1d molecule [KO:K06448]", "913  CD1E; CD1e molecule [KO:K06448]", "920  CD4; CD4 molecule [KO:K06454]", "925  CD8A; CD8 subunit alpha [KO:K06458]", "926  CD8B; CD8 subunit beta [KO:K06459]", "927  CD8B2; CD8B family member 2 [KO:K06459]", "915  CD3D; CD3 delta subunit of T-cell receptor complex [KO:K06450]", "916  CD3E; CD3 epsilon subunit of T-cell receptor complex [KO:K06451]", "917  CD3G; CD3 gamma subunit of T-cell receptor complex [KO:K06452]", "4311  MME; membrane metalloendopeptidase [KO:K01389] [EC:3.4.24.11]", "928  CD9; CD9 molecule [KO:K06460]", "930  CD19; CD19 molecule [KO:K06465]", "933  CD22; CD22 molecule [KO:K06467]", "100133941  CD24; CD24 molecule [KO:K06469]", "931  MS4A1; membrane spanning 4-domains A1 [KO:K06466]", "1380  CR2; complement C3d receptor 2 [KO:K04012]", "951  CD37; CD37 molecule [KO:K06475]", "102723407  IGH; immunoglobulin heavy variable 4-38-2-like [KO:K06856]", "2208  FCER2; Fc epsilon receptor II [KO:K06468]", "1378  CR1; complement C3b/C4b receptor 1 (Knops blood group) [KO:K04011]", "1379  CR1L; complement C3b/C4b receptor 1 like [KO:K04011]", "1438  CSF2RA; colony stimulating factor 2 receptor subunit alpha [KO:K05066]", "3563  IL3RA; interleukin 3 receptor subunit alpha [KO:K04737]", "945  CD33; CD33 molecule [KO:K06473]", "3566  IL4R; interleukin 4 receptor [KO:K05071]", "3570  IL6R; interleukin 6 receptor [KO:K05055]", "2209  FCGR1A; Fc gamma receptor Ia [KO:K06498]", "1436  CSF1R; colony stimulating factor 1 receptor [KO:K05090] [EC:2.7.10.1]", "290  ANPEP; alanyl aminopeptidase, membrane [KO:K11140] [EC:3.4.11.2]", "3684  ITGAM; integrin subunit alpha M [KO:K06461]", "929  CD14; CD14 molecule [KO:K04391]", "3581  IL9R; interleukin 9 receptor [KO:K05073]", "3554  IL1R1; interleukin 1 receptor type 1 [KO:K04386]", "7850  IL1R2; interleukin 1 receptor type 2 [KO:K04387]", "1441  CSF3R; colony stimulating factor 3 receptor [KO:K05061]", "3568  IL5RA; interleukin 5 receptor subunit alpha [KO:K05067]", "2057  EPOR; erythropoietin receptor [KO:K05079]", "948  CD36; CD36 molecule (CD36 blood group) [KO:K06259]", "2993  GYPA; glycophorin A (MNS blood group) [KO:K06575]", "1604  CD55; CD55 molecule (Cromer blood group) [KO:K04006]", "966  CD59; CD59 molecule (CD59 blood group) [KO:K04008]", "3590  IL11RA; interleukin 11 receptor subunit alpha [KO:K05056]", "3690  ITGB3; integrin subunit beta 3 [KO:K06493]", "3674  ITGA2B; integrin subunit alpha 2b [KO:K06476]", "2815  GP9; glycoprotein IX platelet [KO:K06263]", "2811  GP1BA; glycoprotein Ib platelet subunit alpha [KO:K06261]", "2812  GP1BB; glycoprotein Ib platelet subunit beta [KO:K06262]", "2814  GP5; glycoprotein V platelet [KO:K06260]", "3672  ITGA1; integrin subunit alpha 1 [KO:K06480]", "3673  ITGA2; integrin subunit alpha 2 [KO:K06481]", "3675  ITGA3; integrin subunit alpha 3 [KO:K06482]", "3676  ITGA4; integrin subunit alpha 4 [KO:K06483]", "3678  ITGA5; integrin subunit alpha 5 [KO:K06484]", "3655  ITGA6; integrin subunit alpha 6 [KO:K06485]"], "refs": [{"pmid": "15771582", "authors": "  Rothenberg EV, Taghon T.", "title": "Molecular genetics of T cell development.", "journal": "Annu Rev Immunol 23:601-49 (2005)", "doi": "10.1146/annurev.immunol.23.021704.115737"}, {"pmid": "12415312", "authors": "  Ceredig R, Rolink T.", "title": "A positive look at double-negative thymocytes.", "journal": "Nat Rev Immunol 2:888-97 (2002)", "doi": "10.1038/nri937"}, {"pmid": "15156179", "authors": "  de Bruijn MF, Speck NA.", "title": "Core-binding factors in hematopoiesis and immune function.", "journal": "Oncogene 23:4238-48 (2004)", "doi": "10.1038/sj.onc.1207763"}, {"pmid": "14985712", "authors": "  Radtke F, Wilson A, Mancini SJ, MacDonald HR.", "title": "Notch regulation of lymphocyte development and function.", "journal": "Nat Immunol 5:247-53 (2004)", "doi": "10.1038/ni1045"}, {"pmid": "12360214", "authors": "  Spits H.", "title": "Development of alphabeta T cells in the human thymus.", "journal": "Nat Rev Immunol 2:760-72 (2002)", "doi": "10.1038/nri913"}, {"pmid": "9927518", "authors": "  Di Santo JP, Aifantis I, Rosmaraki E, Garcia C, Feinberg J, Fehling HJ, Fischer A, von Boehmer H, Rocha B.", "title": "The common cytokine receptor gamma chain and the pre-T cell receptor provide independent but critically overlapping signals in early alpha/beta T cell development.", "journal": "J Exp Med 189:563-74 (1999)", "doi": "10.1084/jem.189.3.563"}, {"pmid": "11905810", "authors": "  Mak TW, Penninger JM, Ohashi PS.", "title": "Knockout mice: a paradigm shift in modern immunology.", "journal": "Nat Rev Immunol 1:11-9 (2001)", "doi": "10.1038/35095551"}, {"pmid": "15738953", "authors": "  Shapiro-Shelef M, Calame K.", "title": "Regulation of plasma-cell development.", "journal": "Nat Rev Immunol 5:230-42 (2005)", "doi": "10.1038/nri1572"}, {"pmid": "14670296", "authors": "  Maillard I, Adler SH, Pear WS.", "title": "Notch and the immune system.", "journal": "Immunity 19:781-91 (2003)", "doi": "10.1016/S1074-7613(03)00325-X"}], "ko_pathway": "ko04640", "genes": ["IL3", "CD22", "IL2R", "CSF1", "CD44", "CD36"]}, {"kegg_id": "hsa04664", "name": "Fc epsilon RI signaling pathway - Homo sapiens (human)", "description": "Fc epsilon RI-mediated signaling pathways in mast cells are initiated by the interaction of antigen (Ag) with IgE bound to the extracellular domain of the alpha chain of Fc epsilon RI. The activation pathways are regulated both positively and negatively by the interactions of numerous signaling molecules. Mast cells that are thus activated release preformed granules which contain biogenic amines (especially histamines) and proteoglycans (especially heparin). The activation of phospholipase A2 causes the release of membrane lipids followed by development of lipid mediators such as leukotrienes (LTC4, LTD4 and LTE4) and prostaglandins (especially PDG2). There is also secretion of cytokines, the most important of which are TNF-alpha, IL-4 and IL-5. These mediators and cytokines contribute to inflammatory responses.", "class": "Organismal Systems; Immune system", "pathway_map": "hsa04664  Fc epsilon RI signaling pathway", "drug": ["D03095  Benzylpenicilloyl polylysine (USP)", "D03117  Binetrakin (USAN/INN)", "D04358  Golimumab (USAN/INN)", "D05251  Omalizumab (USAN/INN)", "D05671  Quiflapon sodium (USAN)", "D06664  Veliflapon (USAN/INN)", "D10069  Fiboflapon (USAN)", "D10122  Fiboflapon sodium (USAN)", "D11070  Tirabrutinib hydrochloride (JAN/USAN)", "D11275  Rosiptor (USAN/INN)", "D11276  Rosiptor acetate (USAN)", "D11873  Rilzabrutinib (JAN/USAN/INN)", "D12158  Elsubrutinib (USAN/INN)", "D12160  Orelabrutinib (USAN/INN)", "D12285  Remibrutinib (JAN/USAN/INN)", "D12489  Atuzabrutinib (USAN/INN)", "D12594  Tirabrutinib (USAN/INN)"], "dblinks": "GO: 0045576", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["102723407  IGH; immunoglobulin heavy variable 4-38-2-like [KO:K06856]", "2205  FCER1A; Fc epsilon receptor Ia [KO:K08089]", "2206  MS4A2; membrane spanning 4-domains A2 [KO:K08090]", "2207  FCER1G; Fc epsilon receptor Ig [KO:K07983]", "6850  SYK; spleen associated tyrosine kinase [KO:K05855] [EC:2.7.10.2]", "4067  LYN; LYN proto-oncogene, Src family tyrosine kinase [KO:K05854] [EC:2.7.10.2]", "695  BTK; Bruton tyrosine kinase [KO:K07370] [EC:2.7.10.2]", "3635  INPP5D; inositol polyphosphate-5-phosphatase D [KO:K03084] [EC:3.1.3.86]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5170  PDPK1; 3-phosphoinositide dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "5880  RAC2; Rac family small GTPase 2 [KO:K07860]", "5881  RAC3; Rac family small GTPase 3 [KO:K07861]", "6416  MAP2K4; mitogen-activated protein kinase kinase 4 [KO:K04430] [EC:2.7.12.2]", "5609  MAP2K7; mitogen-activated protein kinase kinase 7 [KO:K04431] [EC:2.7.12.2]", "5606  MAP2K3; mitogen-activated protein kinase kinase 3 [KO:K04432] [EC:2.7.12.2]", "5608  MAP2K6; mitogen-activated protein kinase kinase 6 [KO:K04433] [EC:2.7.12.2]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "3565  IL4; interleukin 4 [KO:K05430]", "3596  IL13; interleukin 13 [KO:K05435]", "3562  IL3; interleukin 3 [KO:K04736]", "3567  IL5; interleukin 5 [KO:K05428]", "1437  CSF2; colony stimulating factor 2 [KO:K05427]", "7124  TNF; tumor necrosis factor [KO:K03156]", "3937  LCP2; lymphocyte cytosolic protein 2 [KO:K07361]", "10451  VAV3; vav guanine nucleotide exchange factor 3 [KO:K05730]", "7409  VAV1; vav guanine nucleotide exchange factor 1 [KO:K05730]", "7410  VAV2; vav guanine nucleotide exchange factor 2 [KO:K05730]", "2534  FYN; FYN proto-oncogene, Src family tyrosine kinase [KO:K05703] [EC:2.7.10.2]", "9846  GAB2; GRB2 associated binding protein 2 [KO:K08091]", "27040  LAT; linker for activation of T cells [KO:K07362]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "123745  PLA2G4E; phospholipase A2 group IVE [KO:K16342] [EC:3.1.1.4]", "5321  PLA2G4A; phospholipase A2 group IVA [KO:K16342] [EC:3.1.1.4]", "8681  JMJD7-PLA2G4B; JMJD7-PLA2G4B readthrough [KO:K16342] [EC:3.1.1.4]", "100137049  PLA2G4B; phospholipase A2 group IVB [KO:K16342] [EC:3.1.1.4]", "8605  PLA2G4C; phospholipase A2 group IVC [KO:K16342] [EC:3.1.1.4]", "283748  PLA2G4D; phospholipase A2 group IVD [KO:K16342] [EC:3.1.1.4]", "255189  PLA2G4F; phospholipase A2 group IVF [KO:K16342] [EC:3.1.1.4]", "240  ALOX5; arachidonate 5-lipoxygenase [KO:K00461] [EC:1.13.11.34]", "241  ALOX5AP; arachidonate 5-lipoxygenase activating protein [KO:K20735]"], "compound": ["C00076  Calcium cation", "C00165  Diacylglycerol", "C00219  Arachidonate", "C00374  Heparin", "C00388  Histamine", "C00696  Prostaglandin D2", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C02166  Leukotriene C4", "C05951  Leukotriene D4", "C05952  Leukotriene E4", "C05981  Phosphatidylinositol-3,4,5-trisphosphate"], "refs": [{"pmid": "12360215", "authors": "  Kawakami T, Galli SJ.", "title": "Regulation of mast-cell and basophil function and survival by IgE.", "journal": "Nat Rev Immunol 2:773-86 (2002)", "doi": "10.1038/nri914"}, {"pmid": "14630197", "authors": "  Siraganian RP.", "title": "Mast cell signal transduction from the high-affinity IgE receptor.", "journal": "Curr Opin Immunol 15:639-46 (2003)", "doi": "10.1016/j.coi.2003.09.010"}, {"pmid": "10586892", "authors": "  Turner H, Kinet JP.", "title": "Signalling through the high-affinity IgE receptor Fc epsilonRI.", "journal": "Nature 402:B24-30 (1999)", "doi": "10.1038/35037021"}, {"pmid": "16470226", "authors": "  Gilfillan AM, Tkaczyk C.", "title": "Integrated signalling pathways for mast-cell activation.", "journal": "Nat Rev Immunol 6:218-30 (2006)", "doi": "10.1038/nri1782"}, {"pmid": "11079101", "authors": "  Nadler MJ, Matthews SA, Turner H, Kinet JP.", "title": "Signal transduction by the high-affinity immunoglobulin E receptor Fc epsilon RI: coupling form to function.", "journal": "Adv Immunol 76:325-55 (2000)", "doi": "10.1016/S0065-2776(01)76022-1"}, {"pmid": "11449275", "authors": "  Gu H, Saito K, Klaman LD, Shen J, Fleming T, Wang Y, Pratt JC, Lin G, Lim B, Kinet JP, Neel BG.", "title": "Essential role for Gab2 in the allergic response.", "journal": "Nature 412:186-90 (2001)", "doi": "10.1038/35084076"}], "rel_pathway": ["hsa00590  Arachidonic acid metabolism", "hsa04010  MAPK signaling pathway", "hsa04070  Phosphatidylinositol signaling system"], "ko_pathway": "ko04664", "genes": ["IL3", "RAC1", "AKT2", "AKT1", "SOS1", "MAPK13", "NRAS"]}, {"kegg_id": "hsa05202", "name": "Transcriptional misregulation in cancer - Homo sapiens (human)", "description": "In tumor cells, genes encoding transcription factors (TFs) are often amplified, deleted, rearranged via chromosomal translocation and inversion, or subjected to point mutations that result in a gain- or loss-of- function. In hematopoietic cancers and solid tumors, the translocations and inversions increase or deregulate transcription of the oncogene. Recurrent chromosome translocations generate novel fusion oncoproteins, which are common in myeloid cancers and soft-tissue sarcomas. The fusion proteins have aberrant transcriptional function compared to their wild-type counterparts. These fusion transcription factors alter expression of target genes, and thereby result in a variety of altered cellular properties that contribute to the tumourigenic process.", "class": "Human Diseases; Cancer: overview", "pathway_map": "hsa05202  Transcriptional misregulation in cancer", "drug": ["D00094  Tretinoin (JAN/USP/INN)", "D10891  Capmatinib hydrochloride (USAN)", "D11073  Tepotinib hydrochloride (USAN)", "D11768  Pacritinib (USAN/INN)", "D11889  Unesblin (USAN)", "D12419  Ziftomenib (USAN/INN)", "D12525  Enitociclib (USAN/INN)", "D12705  Gumarontinib hydrate (JAN)", "D12727  Icovamenib (USAN)", "D12728  Revumenib (USAN/INN)", "D12729  Revumenib citrate (USAN)", "D12868  Istisociclib (USAN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["861  RUNX1; RUNX family transcription factor 1 [KO:K08367]", "1436  CSF1R; colony stimulating factor 1 receptor [KO:K05090] [EC:2.7.10.1]", "4353  MPO; myeloperoxidase [KO:K10789] [EC:1.11.2.2]", "1437  CSF2; colony stimulating factor 2 [KO:K05427]", "3562  IL3; interleukin 3 [KO:K04736]", "862  RUNX1T1; RUNX1 partner transcriptional co-repressor 1 [KO:K10053]", "3065  HDAC1; histone deacetylase 1 [KO:K06067] [EC:3.5.1.98]", "3066  HDAC2; histone deacetylase 2 [KO:K06067] [EC:3.5.1.98]", "25942  SIN3A; SIN3 transcription regulator family member A [KO:K11644]", "9611  NCOR1; nuclear receptor corepressor 1 [KO:K04650]", "1050  CEBPA; CCAAT enhancer binding protein alpha [KO:K09055]", "8864  PER2; period circadian regulator 2 [KO:K02633]", "6688  SPI1; Spi-1 proto-oncogene [KO:K09438]", "929  CD14; CD14 molecule [KO:K04391]", "3684  ITGAM; integrin subunit alpha M [KO:K06461]", "2209  FCGR1A; Fc gamma receptor Ia [KO:K06498]", "3728  JUP; junction plakoglobin [KO:K10056]", "5371  PML; PML nuclear body scaffold [KO:K10054] [EC:2.3.2.-]", "5914  RARA; retinoic acid receptor alpha [KO:K08527]", "890  CCNA2; cyclin A2 [KO:K06627]", "8900  CCNA1; cyclin A1 [KO:K06627]", "1053  CEBPE; CCAAT enhancer binding protein epsilon [KO:K10051]", "597  BCL2A1; BCL2 related protein A1 [KO:K02162]", "7704  ZBTB16; zinc finger and BTB domain containing 16 [KO:K10055]", "4609  MYC; MYC proto-oncogene, bHLH transcription factor [KO:K04377]", "1848  DUSP6; dual specificity phosphatase 6 [KO:K21946] [EC:3.1.3.16 3.1.3.48]", "6929  TCF3; transcription factor 3 [KO:K09063]", "5087  PBX1; PBX homeobox 1 [KO:K09355]", "51384  WNT16; Wnt family member 16 [KO:K01558]", "2120  ETV6; ETS variant transcription factor 6 [KO:K03211]", "51513  ETV7; ETS variant transcription factor 7 [KO:K03211]", "1667  DEFA1; defensin alpha 1 [KO:K05230]", "1668  DEFA3; defensin alpha 3 [KO:K05230]", "1669  DEFA4; defensin alpha 4 [KO:K05230]", "1670  DEFA5; defensin alpha 5 [KO:K05230]", "1671  DEFA6; defensin alpha 6 [KO:K05230]", "728358  DEFA1B; defensin alpha 1B [KO:K05230]", "1991  ELANE; elastase, neutrophil expressed [KO:K01327] [EC:3.4.21.37]", "3002  GZMB; granzyme B [KO:K01353] [EC:3.4.21.79]", "4297  KMT2A; lysine methyltransferase 2A [KO:K09186] [EC:2.1.1.354]", "4299  AFF1; ALF transcription elongation factor 1 [KO:K15184]", "1025  CDK9; cyclin dependent kinase 9 [KO:K02211] [EC:2.7.11.22 2.7.11.23]", "904  CCNT1; cyclin T1 [KO:K15188]", "905  CCNT2; cyclin T2 [KO:K15188]", "4298  MLLT1; MLLT1 super elongation complex subunit [KO:K15187]", "4300  MLLT3; MLLT3 super elongation complex subunit [KO:K15187]", "84444  DOT1L; DOT1 like histone lysine methyltransferase [KO:K11427] [EC:2.1.1.360]", "4005  LMO2; LIM domain only 2 [KO:K15612]", "5090  PBX3; PBX homeobox 3 [KO:K15610]", "860  RUNX2; RUNX family transcription factor 2 [KO:K09278]", "4086  SMAD1; SMAD family member 1 [KO:K04676]", "51274  KLF3; KLF transcription factor 3 [KO:K15605]", "4208  MEF2C; myocyte enhancer factor 2C [KO:K04454]", "3205  HOXA9; homeobox A9 [KO:K21950]", "3206  HOXA10; homeobox A10 [KO:K17443]", "221037  JMJD1C; jumonji domain containing 1C [KO:K11449] [EC:1.14.11.-]", "8091  HMGA2; high mobility group AT-hook 2 [KO:K09283]", "7403  KDM6A; lysine demethylase 6A [KO:K11447] [EC:1.14.11.68]", "8464  SUPT3H; SPT3 homolog, SAGA and STAGA complex component [KO:K11313]", "8842  PROM1; prominin 1 [KO:K06532]", "2322  FLT3; fms related receptor tyrosine kinase 3 [KO:K05092] [EC:2.7.10.1]", "55589  BMP2K; BMP2 inducible kinase [KO:K08854] [EC:2.7.11.1]", "3480  IGF1R; insulin like growth factor 1 receptor [KO:K05087] [EC:2.7.10.1]", "1027  CDKN1B; cyclin dependent kinase inhibitor 1B [KO:K06624]", "5218  CDK14; cyclin dependent kinase 14 [KO:K08821] [EC:2.7.11.22]", "4211  MEIS1; Meis homeobox 1 [KO:K15613]", "3207  HOXA11; homeobox A11 [KO:K21951]", "6495  SIX1; SIX homeobox 1 [KO:K15614]", "51804  SIX4; SIX homeobox 4 [KO:K15615]", "2138  EYA1; EYA transcriptional coactivator and phosphatase 1 [KO:K15616] [EC:3.1.3.48]", "1031  CDKN2C; cyclin dependent kinase inhibitor 2C [KO:K06622]", "3248  HPGD; 15-hydroxyprostaglandin dehydrogenase [KO:K00069] [EC:1.1.1.141]", "2892  GRIA3; glutamate ionotropic receptor AMPA type subunit 3 [KO:K05199]", "2530  FUT8; fucosyltransferase 8 [KO:K00717] [EC:2.4.1.68]", "30012  TLX3; T cell leukemia homeobox 3 [KO:K15607]", "3195  TLX1; T cell leukemia homeobox 1 [KO:K09340]", "64919  BCL11B; BCL11 transcription factor B [KO:K22046]", "8861  LDB1; LIM domain binding 1 [KO:K15617]", "4066  LYL1; LYL1 basic helix-loop-helix family member [KO:K15604]", "3087  HHEX; hematopoietically expressed homeobox [KO:K08024]", "171558  PTCRA; pre T cell antigen receptor alpha [KO:K06056]", "5966  REL; REL proto-oncogene, NF-kB subunit [KO:K09254]", "894  CCND2; cyclin D2 [KO:K10151]", "329  BIRC2; baculoviral IAP repeat containing 2 [KO:K16060]", "330  BIRC3; baculoviral IAP repeat containing 3 [KO:K16060]", "7185  TRAF1; TNF receptor associated factor 1 [KO:K03172]", "598  BCL2L1; BCL2 like 1 [KO:K04570]", "942  CD86; CD86 molecule [KO:K05413]", "958  CD40; CD40 molecule [KO:K03160]", "604  BCL6; BCL6 transcription repressor [KO:K15618]", "102723407  IGH; immunoglobulin heavy variable 4-38-2-like [KO:K06856]", "4094  MAF; MAF bZIP transcription factor [KO:K09035]", "3695  ITGB7; integrin subunit beta 7 [KO:K06590]", "7468  NSD2; nuclear receptor binding SET domain protein 2 [KO:K11424] [EC:2.1.1.357]", "440093  H3-5; H3.5 histone [KO:K11253]", "3021  H3-3B; H3.3 histone B [KO:K11253]", "8351  H3C4; H3 clustered histone 4 [KO:K11253]", "8352  H3C3; H3 clustered histone 3 [KO:K11253]", "8350  H3C1; H3 clustered histone 1 [KO:K11253]", "3020  H3-3A; H3.3 histone A [KO:K11253]", "8290  H3-4; H3.4 histone, cluster member [KO:K11253]", "126961  H3C14; H3 clustered histone 14 [KO:K11253]", "333932  H3C15; H3 clustered histone 15 [KO:K11253]", "653604  H3C13; H3 clustered histone 13 [KO:K11253]", "8353  H3C6; H3 clustered histone 6 [KO:K11253]", "8354  H3C11; H3 clustered histone 11 [KO:K11253]", "8355  H3C8; H3 clustered histone 8 [KO:K11253]", "8356  H3C12; H3 clustered histone 12 [KO:K11253]", "8357  H3C10; H3 clustered histone 10 [KO:K11253]", "8358  H3C2; H3 clustered histone 2 [KO:K11253]", "8968  H3C7; H3 clustered histone 7 [KO:K11253]", "5079  PAX5; paired box 5 [KO:K09383]", "7849  PAX8; paired box 8 [KO:K09293]", "5468  PPARG; peroxisome proliferator activated receptor gamma [KO:K08530]", "6256  RXRA; retinoid X receptor alpha [KO:K08524]", "6257  RXRB; retinoid X receptor beta [KO:K08525]", "6258  RXRG; retinoid X receptor gamma [KO:K08526]", "5546  PRCC; proline rich mitotic checkpoint control factor [KO:K13105]", "7030  TFE3; transcription factor binding to IGHM enhancer 3 [KO:K09105]", "1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]", "7113  TMPRSS2; transmembrane serine protease 2 [KO:K09633] [EC:3.4.21.122]", "2078  ERG; ETS transcription factor ERG [KO:K09435]", "5328  PLAU; plasminogen activator, urokinase [KO:K01348] [EC:3.4.21.73]", "5327  PLAT; plasminogen activator, tissue type [KO:K01343] [EC:3.4.21.68]", "4314  MMP3; matrix metallopeptidase 3 [KO:K01394] [EC:3.4.24.17]", "4318  MMP9; matrix metallopeptidase 9 [KO:K01403] [EC:3.4.24.35]", "6935  ZEB1; zinc finger E-box binding homeobox 1 [KO:K09299]", "7850  IL1R2; interleukin 1 receptor type 2 [KO:K04387]", "6692  SPINT1; serine peptidase inhibitor, Kunitz type 1 [KO:K15619]", "2115  ETV1; ETS variant transcription factor 1 [KO:K09431]", "2118  ETV4; ETS variant transcription factor 4 [KO:K15592]", "2119  ETV5; ETS variant transcription factor 5 [KO:K15593]", "85414  SLC45A3; solute carrier family 45 member 3 [KO:K15379]", "2005  ELK4; ETS transcription factor ELK4 [KO:K04376]", "1655  DDX5; DEAD-box helicase 5 [KO:K12823] [EC:5.6.2.7]", "4613  MYCN; MYCN proto-oncogene, bHLH transcription factor [KO:K09109]", "4149  MAX; MYC associated factor X [KO:K04453]", "4193  MDM2; MDM2 proto-oncogene [KO:K06643] [EC:2.3.2.27]", "5747  PTK2; protein tyrosine kinase 2 [KO:K05725] [EC:2.7.10.2]", "7157  TP53; tumor protein p53 [KO:K04451]", "648  BMI1; BMI1 proto-oncogene, polycomb ring finger [KO:K11459]", "100532731  COMMD3-BMI1; COMMD3-BMI1 readthrough [KO:K11459]", "6667  SP1; Sp1 transcription factor [KO:K04684]", "7709  ZBTB17; zinc finger and BTB domain containing 17 [KO:K10500]", "4914  NTRK1; neurotrophic receptor tyrosine kinase 1 [KO:K03176] [EC:2.7.10.1]", "4804  NGFR; nerve growth factor receptor [KO:K02583]", "4221  MEN1; menin 1 [KO:K14970]", "2130  EWSR1; EWS RNA binding protein 1 [KO:K13209]", "2313  FLI1; Fli-1 proto-oncogene, ETS transcription factor [KO:K09436]", "3479  IGF1; insulin like growth factor 1 [KO:K05459]", "3398  ID2; inhibitor of DNA binding 2 [KO:K17693]", "7048  TGFBR2; transforming growth factor beta receptor 2 [KO:K04388] [EC:2.7.11.30]", "3486  IGFBP3; insulin like growth factor binding protein 3 [KO:K10138]", "54738  FEV; FEV transcription factor, ETS family member [KO:K09437]", "466  ATF1; activating transcription factor 1 [KO:K09053]", "9915  ARNT2; aryl hydrocarbon receptor nuclear translocator 2 [KO:K15589]", "472  ATM; ATM serine/threonine kinase [KO:K04728] [EC:2.7.11.1]", "4286  MITF; melanocyte inducing transcription factor [KO:K09455]", "7490  WT1; WT1 transcription factor [KO:K09234]", "5154  PDGFA; platelet derived growth factor subunit A [KO:K04359]", "3560  IL2RB; interleukin 2 receptor subunit beta [KO:K05069]", "8938  BAIAP3; BAI1 associated protein 3 [KO:K15621]", "7102  TSPAN7; tetraspanin 7 [KO:K06571]", "4291  MLF1; myeloid leukemia factor 1 [KO:K15622]", "8013  NR4A3; nuclear receptor subfamily 4 group A member 3 [KO:K08559]", "8148  TAF15; TATA-box binding protein associated factor 15 [KO:K14651]", "2521  FUS; FUS RNA binding protein [KO:K13098]", "1649  DDIT3; DNA damage inducible transcript 3 [KO:K04452]", "1051  CEBPB; CCAAT enhancer binding protein beta [KO:K10048]", "3569  IL6; interleukin 6 [KO:K05405]", "64332  NFKBIZ; NFKB inhibitor zeta [KO:K14242]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "3576  CXCL8; C-X-C motif chemokine ligand 8 [KO:K10030]", "5081  PAX7; paired box 7 [KO:K09381]", "5077  PAX3; paired box 3 [KO:K09381]", "2308  FOXO1; forkhead box O1 [KO:K07201]", "2321  FLT1; fms related receptor tyrosine kinase 1 [KO:K05096] [EC:2.7.10.1]", "26039  SS18L1; SS18L1 subunit of BAF chromatin remodeling complex [KO:K15623]", "6760  SS18; SS18 subunit of BAF chromatin remodeling complex [KO:K15623]", "6756  SSX1; SSX family member 1 [KO:K15624]", "6757  SSX2; SSX family member 2 [KO:K15625]", "727837  SSX2B; SSX family member 2B [KO:K15625]", "26471  NUPR1; nuclear protein 1, transcriptional regulator [KO:K15626]", "79058  ASPSCR1; ASPSCR1 tether for SLC2A4, UBX domain containing [KO:K15627]", "4233  MET; MET proto-oncogene, receptor tyrosine kinase [KO:K05099] [EC:2.7.10.1]", "1647  GADD45A; growth arrest and DNA damage inducible alpha [KO:K04402]", "4616  GADD45B; growth arrest and DNA damage inducible beta [KO:K04402]", "10912  GADD45G; growth arrest and DNA damage inducible gamma [KO:K04402]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "578  BAK1; BCL2 antagonist/killer 1 [KO:K14021]", "1643  DDB2; damage specific DNA binding protein 2 [KO:K10140]", "51426  POLK; DNA polymerase kappa [KO:K03511] [EC:2.7.7.7]"], "refs": [{"pmid": "11607818", "authors": "  Alcalay M, Orleth A, Sebastiani C, Meani N, Chiaradonna F, Casciari C, Sciurpi MT, Gelmetti V, Riganelli D, Minucci S, Fagioli M, Pelicci PG", "title": "Common themes in the pathogenesis of acute myeloid leukemia.", "journal": "Oncogene 20:5680-94 (2001)", "doi": "10.1038/sj.onc.1204642"}, {"pmid": "12032780", "authors": "  Scandura JM, Boccuni P, Cammenga J, Nimer SD", "title": "Transcription factor fusions in acute leukemia: variations on a theme.", "journal": "Oncogene 21:3422-44 (2002)", "doi": "10.1038/sj.onc.1205315"}, {"pmid": "12529654", "authors": "  Roumier C, Fenaux P, Lafage M, Imbert M, Eclache V, Preudhomme C", "title": "New mechanisms of AML1 gene alteration in hematological malignancies.", "journal": "Leukemia 17:9-16 (2003)", "doi": "10.1038/sj.leu.2402766"}, {"pmid": "10717473", "authors": "  Lutterbach B, Hiebert SW", "title": "Role of the transcription factor AML-1 in acute leukemia and hematopoietic differentiation.", "journal": "Gene 245:223-35 (2000)", "doi": "10.1016/S0378-1119(00)00014-7"}, {"pmid": "19075268", "authors": "  Koschmieder S, Halmos B, Levantini E, Tenen DG", "title": "Dysregulation of the C/EBPalpha differentiation pathway in human cancer.", "journal": "J Clin Oncol 27:619-28 (2009)", "doi": "10.1200/JCO.2008.17.9812"}, {"pmid": "11340171", "authors": "  Johansen LM, Iwama A, Lodie TA, Sasaki K, Felsher DW, Golub TR, Tenen DG", "title": "c-Myc is a critical target for c/EBPalpha in granulopoiesis.", "journal": "Mol Cell Biol 21:3789-806 (2001)", "doi": "10.1128/MCB.21.11.3789-3806.2001"}, {"pmid": "15985538", "authors": "  Gery S, Gombart AF, Yi WS, Koeffler C, Hofmann WK, Koeffler HP", "title": "Transcription profiling of C/EBP targets identifies Per2 as a gene implicated in myeloid leukemia.", "journal": "Blood 106:2827-36 (2005)", "doi": "10.1182/blood-2005-01-0358"}, {"pmid": "12393465", "authors": "  Vangala RK, Heiss-Neumann MS, Rangatia JS, Singh SM, Schoch C, Tenen DG, Hiddemann W, Behre G", "title": "The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia.", "journal": "Blood 101:270-7 (2003)", "doi": "10.1182/blood-2002-04-1288"}, {"pmid": "12130514", "authors": "  Mueller BU, Pabst T, Osato M, Asou N, Johansen LM, Minden MD, Behre G, Hiddemann W, Ito Y, Tenen DG", "title": "Heterozygous PU.1 mutations are associated with acute myeloid leukemia.", "journal": "Blood 100:998-1007 (2002)", "doi": "10.1182/blood.V100.3.998"}, {"pmid": "15160934", "authors": "  Jing Y", "title": "The PML-RARalpha fusion protein and targeted therapy for acute promyelocytic leukemia.", "journal": "Leuk Lymphoma 45:639-48 (2004)", "doi": "10.1080/10428190310001609933"}, {"pmid": "15024077", "authors": "  Muller-Tidow C, Steffen B, Cauvet T, Tickenbrock L, Ji P, Diederichs S, Sargin B, Kohler G, Stelljes M, Puccetti E, Ruthardt M, deVos S, Hiebert SW, Koeffler HP, Berdel WE, Serve H", "title": "Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells.", "journal": "Mol Cell Biol 24:2890-904 (2004)", "doi": "10.1128/MCB.24.7.2890-2904.2004"}, {"pmid": "19855079", "authors": "  Rice KL, Hormaeche I, Doulatov S, Flatow JM, Grimwade D, Mills KI, Leiva M, Ablain J, Ambardekar C, McConnell MJ, Dick JE, Licht JD", "title": "Comprehensive genomic screens identify a role for PLZF-RARalpha as a positive regulator of cell proliferation via direct regulation of c-MYC.", "journal": "Blood 114:5499-511 (2009)", "doi": "10.1182/blood-2009-03-206524"}, {"pmid": "10500199", "authors": "  McWhirter JR, Neuteboom ST, Wancewicz EV, Monia BP, Downing JR, Murre C", "title": "Oncogenic homeodomain transcription factor E2A-Pbx1 activates a novel WNT gene in pre-B acute lymphoblastoid leukemia.", "journal": "Proc Natl Acad Sci U S A 96:11464-9 (1999)", "doi": "10.1073/pnas.96.20.11464"}, {"pmid": "15156184", "authors": "  Zelent A, Greaves M, Enver T", "title": "Role of the TEL-AML1 fusion gene in the molecular pathogenesis of childhood acute lymphoblastic leukaemia.", "journal": "Oncogene 23:4275-83 (2004)", "doi": "10.1038/sj.onc.1207672"}, {"pmid": "14630078", "authors": "  Sawinska M, Ladon D", "title": "Mechanism, detection and clinical significance of the reciprocal translocation t(12;21)(p12;q22) in the children suffering from acute lymphoblastic leukaemia.", "journal": "Leuk Res 28:35-42 (2004)", "doi": "10.1016/S0145-2126(03)00160-7"}, {"pmid": "19141473", "authors": "  Guenther MG, Lawton LN, Rozovskaia T, Frampton GM, Levine SS, Volkert TL, Croce CM, Nakamura T, Canaani E, Young RA", "title": "Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia.", "journal": "Genes Dev 22:3403-8 (2008)", "doi": "10.1101/gad.1741408"}, {"pmid": "16169901", "authors": "  Xia ZB, Popovic R, Chen J, Theisler C, Stuart T, Santillan DA, Erfurth F, Diaz MO, Zeleznik-Le NJ", "title": "The MLL fusion gene, MLL-AF4, regulates cyclin-dependent kinase inhibitor CDKN1B (p27kip1) expression.", "journal": "Proc Natl Acad Sci U S A 102:14028-33 (2005)", "doi": "10.1073/pnas.0506464102"}, {"pmid": "21518926", "authors": "  Wang QF, Wu G, Mi S, He F, Wu J, Dong J, Luo RT, Mattison R, Kaberlein JJ, Prabhakar S, Ji H, Thirman MJ", "title": "MLL fusion proteins preferentially regulate a subset of wild-type MLL target genes in the leukemic genome.", "journal": "Blood 117:6895-905 (2011)", "doi": "10.1182/blood-2010-12-324699"}, {"pmid": "14701735", "authors": "  Zeisig BB, Milne T, Garcia-Cuellar MP, Schreiner S, Martin ME, Fuchs U, Borkhardt A, Chanda SK, Walker J, Soden R, Hess JL, Slany RK", "title": "Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization.", "journal": "Mol Cell Biol 24:617-28 (2004)", "doi": "10.1128/MCB.24.2.617-628.2004"}, {"pmid": "19133982", "authors": "  Riz I, Hawley TS, Johnston H, Hawley RG", "title": "Role of TLX1 in T-cell acute lymphoblastic leukaemia pathogenesis.", "journal": "Br J Haematol 145:140-3 (2009)", "doi": "10.1111/j.1365-2141.2008.07556.x"}, {"pmid": "12511414", "authors": "  Barth TF, Martin-Subero JI, Joos S, Menz CK, Hasel C, Mechtersheimer G, Parwaresch RM, Lichter P, Siebert R, Mooller P", "title": "Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma.", "journal": "Blood 101:3681-6 (2003)", "doi": "10.1182/blood-2002-08-2577"}, {"pmid": "11313274", "authors": "  Hinz M, Loser P, Mathas S, Krappmann D, Dorken B, Scheidereit C", "title": "Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells.", "journal": "Blood 97:2798-807 (2001)", "doi": "10.1182/blood.V97.9.2798"}, {"pmid": "12670461", "authors": "  Zuzel M, Cawley JC.", "title": "The biology of hairy cells.", "journal": "Best Pract Res Clin Haematol 16:1-13 (2003)", "doi": "10.1016/S1521-6926(02)00082-8"}, {"pmid": "14998494", "authors": "  Hurt EM, Wiestner A, Rosenwald A, Shaffer AL, Campo E, Grogan T, Bergsagel PL, Kuehl WM, Staudt LM", "title": "Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma.", "journal": "Cancer Cell 5:191-9 (2004)", "doi": "10.1016/S1535-6108(04)00019-4"}, {"pmid": "20974671", "authors": "  Martinez-Garcia E, Popovic R, Min DJ, Sweet SM, Thomas PM, Zamdborg L, Heffner A, Will C, Lamy L, Staudt LM, Levens DL, Kelleher NL, Licht JD", "title": "The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells.", "journal": "Blood 117:211-20 (2011)", "doi": "10.1182/blood-2010-07-298349"}, {"pmid": "19059936", "authors": "  Brito JL, Walker B, Jenner M, Dickens NJ, Brown NJ, Ross FM, Avramidou A, Irving JA, Gonzalez D, Davies FE, Morgan GJ", "title": "MMSET deregulation affects cell cycle progression and adhesion regulons in t(4;14) myeloma plasma cells.", "journal": "Haematologica 94:78-86 (2009)", "doi": "10.3324/haematol.13426"}, {"pmid": "10350329", "authors": "  Iida S, Rao PH, Ueda R, Chaganti RS, Dalla-Favera R", "title": "Chromosomal rearrangement of the PAX-5 locus in lymphoplasmacytic lymphoma with t(9;14)(p13;q32).", "journal": "Leuk Lymphoma 34:25-33 (1999)", "doi": "10.3109/10428199909083377"}, {"pmid": "10784387", "authors": "  Ohno H, Ueda C, Akasaka T", "title": "The t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma.", "journal": "Leuk Lymphoma 36:435-45 (2000)", "doi": "10.3109/10428190009148390"}, {"pmid": "19233641", "authors": "  Prensner JR, Chinnaiyan AM", "title": "Oncogenic gene fusions in epithelial carcinomas.", "journal": "Curr Opin Genet Dev 19:82-91 (2009)", "doi": "10.1016/j.gde.2008.11.008"}, {"pmid": "19406209", "authors": "  Brenner JC, Chinnaiyan AM", "title": "Translocations in epithelial cancers.", "journal": "Biochim Biophys Acta 1796:201-15 (2009)", "doi": "10.1016/j.bbcan.2009.04.005"}, {"pmid": "16946003", "authors": "  Reddi HV, McIver B, Grebe SK, Eberhardt NL", "title": "The paired box-8/peroxisome proliferator-activated receptor-gamma oncogene in thyroid tumorigenesis.", "journal": "Endocrinology 148:932-5 (2007)", "doi": "10.1210/en.2006-0926"}, {"pmid": "19422821", "authors": "  Medendorp K, van Groningen JJ, Vreede L, Hetterschijt L, Brugmans L, van den Hurk WH, van Kessel AG", "title": "The renal cell carcinoma-associated oncogenic fusion protein PRCCTFE3 provokes p21 WAF1/CIP1-mediated cell cycle delay.", "journal": "Exp Cell Res 315:2399-409 (2009)", "doi": "10.1016/j.yexcr.2009.04.022"}, {"pmid": "18563191", "authors": "  Kumar-Sinha C, Tomlins SA, Chinnaiyan AM", "title": "Recurrent gene fusions in prostate cancer.", "journal": "Nat Rev Cancer 8:497-511 (2008)", "doi": "10.1038/nrc2402"}, {"pmid": "20478527", "authors": "  Yu J, Yu J, Mani RS, Cao Q, Brenner CJ, Cao X, Wang X, Wu L, Li J, Hu M, Gong Y, Cheng H, Laxman B, Vellaichamy A, Shankar S, Li Y, Dhanasekaran SM, Morey R, Barrette T, Lonigro RJ, Tomlins SA, Varambally S, Qin ZS, Chinnaiyan AM", "title": "An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression.", "journal": "Cancer Cell 17:443-54 (2010)", "doi": "10.1016/j.ccr.2010.03.018"}, {"pmid": "21747944", "authors": "  Leshem O, Madar S, Kogan-Sakin I, Kamer I, Goldstein I, Brosh R, Cohen Y, Jacob-Hirsch J, Ehrlich M, Ben-Sasson S, Goldfinger N, Loewenthal R, Gazit E, Rotter V, Berger R", "title": "TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer model.", "journal": "PLoS One 6:e21650 (2011)", "doi": "10.1371/journal.pone.0021650"}, {"pmid": "17505060", "authors": "  Cai C, Hsieh CL, Omwancha J, Zheng Z, Chen SY, Baert JL, Shemshedini L", "title": "ETV1 is a novel androgen receptor-regulated gene that mediates prostate cancer cell invasion.", "journal": "Mol Endocrinol 21:1835-46 (2007)", "doi": "10.1210/me.2006-0480"}, {"pmid": "18172298", "authors": "  Helgeson BE, Tomlins SA, Shah N, Laxman B, Cao Q, Prensner JR, Cao X, Singla N, Montie JE, Varambally S, Mehra R, Chinnaiyan AM", "title": "Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer.", "journal": "Cancer Res 68:73-80 (2008)", "doi": "10.1158/0008-5472.CAN-07-5352"}, {"pmid": "21849159", "authors": "  Westermark UK, Wilhelm M, Frenzel A, Henriksson MA", "title": "The MYCN oncogene and differentiation in neuroblastoma.", "journal": "Semin Cancer Biol 21:256-66 (2011)", "doi": "10.1016/j.semcancer.2011.08.001"}, {"pmid": "20153925", "authors": "  Bell E, Chen L, Liu T, Marshall GM, Lunec J, Tweddle DA", "title": "MYCN oncoprotein targets and their therapeutic potential.", "journal": "Cancer Lett 293:144-57 (2010)", "doi": "10.1016/j.canlet.2010.01.015"}, {"pmid": "15644444", "authors": "  Slack A, Chen Z, Tonelli R, Pule M, Hunt L, Pession A, Shohet JM", "title": "The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma.", "journal": "Proc Natl Acad Sci U S A 102:731-6 (2005)", "doi": "10.1073/pnas.0405495102"}, {"pmid": "20190806", "authors": "  Ochiai H, Takenobu H, Nakagawa A, Yamaguchi Y, Kimura M, Ohira M, Okimoto Y, Fujimura Y, Koseki H, Kohno Y, Nakagawara A, Kamijo T", "title": "Bmi1 is a MYCN target gene that regulates tumorigenesis through repression of KIF1Bbeta and TSLC1 in neuroblastoma.", "journal": "Oncogene 29:2681-90 (2010)", "doi": "10.1038/onc.2010.22"}, {"pmid": "20145147", "authors": "  Chen L, Iraci N, Gherardi S, Gamble LD, Wood KM, Perini G, Lunec J, Tweddle DA", "title": "p53 is a direct transcriptional target of MYCN in neuroblastoma.", "journal": "Cancer Res 70:1377-88 (2010)", "doi": "10.1158/0008-5472.CAN-09-2598"}, {"pmid": "17327229", "authors": "  Beierle EA, Trujillo A, Nagaram A, Kurenova EV, Finch R, Ma X, Vella J, Cance WG, Golubovskaya VM", "title": "N-MYC regulates focal adhesion kinase expression in human neuroblastoma.", "journal": "J Biol Chem 282:12503-16 (2007)", "doi": "10.1074/jbc.M701450200"}, {"pmid": "21123453", "authors": "  Iraci N, Diolaiti D, Papa A, Porro A, Valli E, Gherardi S, Herold S, Eilers M, Bernardoni R, Della Valle G, Perini G", "title": "A SP1/MIZ1/MYCN repression complex recruits HDAC1 at the TRKA and p75NTR promoters and affects neuroblastoma malignancy by inhibiting the cell response to NGF.", "journal": "Cancer Res 71:404-12 (2011)", "doi": "10.1158/0008-5472.CAN-10-2627"}, {"pmid": "17024155", "authors": "  Dreijerink KM, Hoppener JW, Timmers HM, Lips CJ", "title": "Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation.", "journal": "Nat Clin Pract Endocrinol Metab 2:562-70 (2006)", "doi": "10.1038/ncpendmet0292"}, {"pmid": "19075677", "authors": "  Wu X, Hua X", "title": "Menin, histone h3 methyltransferases, and regulation of cell proliferation: current knowledge and perspective.", "journal": "Curr Mol Med 8:805-15 (2008)", "doi": "10.2174/156652408786733702"}, {"pmid": "19564705", "authors": "  Sakurai A, Murakami A, Sano K, Uchino S, Fukushima Y", "title": "Unusual clinical and pathological presentation of a neuroendocrine tumor in a patient with multiple endocrine neoplasia type 1.", "journal": "Endocr J 56:887-95 (2009)", "doi": "10.1507/endocrj.K09E-126"}, {"pmid": "17222504", "authors": "  Yang Y, Hua X", "title": "In search of tumor suppressing functions of menin.", "journal": "Mol Cell Endocrinol 265-266:34-41 (2007)", "doi": "10.1016/j.mce.2006.12.032"}, {"pmid": "15826838", "authors": "  Aman P", "title": "Fusion oncogenes in tumor development.", "journal": "Semin Cancer Biol 15:236-43 (2005)", "doi": "10.1016/j.semcancer.2005.01.009"}, {"pmid": "12527902", "authors": "  Fukuma M, Okita H, Hata J, Umezawa A", "title": "Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma.", "journal": "Oncogene 22:1-9 (2003)", "doi": "10.1038/sj.onc.1206055"}, {"pmid": "18648544", "authors": "  Cironi L, Riggi N, Provero P, Wolf N, Suva ML, Suva D, Kindler V, Stamenkovic I", "title": "IGF1 is a common target gene of Ewing's sarcoma fusion proteins in mesenchymal progenitor cells.", "journal": "PLoS One 3:e2634 (2008)", "doi": "10.1371/journal.pone.0002634"}, {"pmid": "17250957", "authors": "  Riggi N, Stamenkovic I.", "title": "The Biology of Ewing sarcoma.", "journal": "Cancer Lett 254:1-10 (2007)", "doi": "10.1016/j.canlet.2006.12.009"}, {"pmid": "19738075", "authors": "  Ordonez JL, Osuna D, Herrero D, de Alava E, Madoz-Gurpide J", "title": "Advances in Ewing's sarcoma research: where are we now and what lies ahead?", "journal": "Cancer Res 69:7140-50 (2009)", "doi": "10.1158/0008-5472.CAN-08-4041"}, {"pmid": "12527906", "authors": "  Jishage M, Fujino T, Yamazaki Y, Kuroda H, Nakamura T", "title": "Identification of target genes for EWS/ATF-1 chimeric transcription factor.", "journal": "Oncogene 22:41-9 (2003)", "doi": "10.1038/sj.onc.1206074"}, {"pmid": "15826834", "authors": "  Gerald WL, Haber DA", "title": "The EWS-WT1 gene fusion in desmoplastic small round cell tumor.", "journal": "Semin Cancer Biol 15:197-205 (2005)", "doi": "10.1016/j.semcancer.2005.01.005"}, {"pmid": "18855877", "authors": "  Filion C, Motoi T, Olshen AB, Lae M, Emnett RJ, Gutmann DH, Perry A, Ladanyi M, Labelle Y", "title": "The EWSR1/NR4A3 fusion protein of extraskeletal myxoid chondrosarcoma activates the PPARG nuclear receptor gene.", "journal": "J Pathol 217:83-93 (2009)", "doi": "10.1002/path.2445"}, {"pmid": "18330902", "authors": "  Kim S, Lee HJ, Jun HJ, Kim J", "title": "The hTAF II 68-TEC fusion protein functions as a strong transcriptional activator.", "journal": "Int J Cancer 122:2446-53 (2008)", "doi": "10.1002/ijc.23379"}, {"pmid": "15688424", "authors": "  Goransson M, Elias E, Stahlberg A, Olofsson A, Andersson C, Aman P", "title": "Myxoid liposarcoma FUS-DDIT3 fusion oncogene induces C/EBP beta-mediated interleukin 6 expression.", "journal": "Int J Cancer 115:556-60 (2005)", "doi": "10.1002/ijc.20893"}, {"pmid": "18850010", "authors": "  Goransson M, Andersson MK, Forni C, Stahlberg A, Andersson C, Olofsson A, Mantovani R, Aman P", "title": "The myxoid liposarcoma FUS-DDIT3 fusion oncoprotein deregulates NF-kappaB target genes by interaction with NFKBIZ.", "journal": "Oncogene 28:270-8 (2009)", "doi": "10.1038/onc.2008.378"}, {"pmid": "20863376", "authors": "  Willems SM, Schrage YM, Bruijn IH, Szuhai K, Hogendoorn PC, Bovee JV", "title": "Kinome profiling of myxoid liposarcoma reveals NF-kappaB-pathway kinase activity and casein kinase II inhibition as a potential treatment option.", "journal": "Mol Cancer 9:257 (2010)", "doi": "10.1186/1476-4598-9-257"}, {"pmid": "18457914", "authors": "  Linardic CM", "title": "PAX3-FOXO1 fusion gene in rhabdomyosarcoma.", "journal": "Cancer Lett 270:10-8 (2008)", "doi": "10.1016/j.canlet.2008.03.035"}, {"pmid": "11863357", "authors": "  Barber TD, Barber MC, Tomescu O, Barr FG, Ruben S, Friedman TB", "title": "Identification of target genes regulated by PAX3 and PAX3-FKHR in embryogenesis and alveolar rhabdomyosarcoma.", "journal": "Genomics 79:278-84 (2002)", "doi": "10.1006/geno.2002.6703"}, {"pmid": "17101797", "authors": "  Ishida M, Miyamoto M, Naitoh S, Tatsuda D, Hasegawa T, Nemoto T, Yokozeki H, Nishioka K, Matsukage A, Ohki M, Ohta T", "title": "The SYT-SSX fusion protein down-regulates the cell proliferation regulator COM1 in t(x;18) synovial sarcoma.", "journal": "Mol Cell Biol 27:1348-55 (2007)", "doi": "10.1128/MCB.00658-06"}, {"pmid": "19472090", "authors": "  Jun HJ, Lee J, Lim do H, Park JO, Ahn G, Seo SW, Sung KS, Lim do H, Yoo KH, Choi YL", "title": "Expression of MET in alveolar soft part sarcoma.", "journal": "Med Oncol 27:459-65 (2010)", "doi": "10.1007/s12032-009-9234-8"}, {"pmid": "21779514", "authors": "  Rivlin N, Brosh R, Oren M, Rotter V", "title": "Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis.", "journal": "Genes Cancer 2:466-74 (2011)", "doi": "10.1177/1947601911408889"}], "rel_pathway": ["hsa04115  p53 signaling pathway", "hsa05211  Renal cell carcinoma", "hsa05215  Prostate cancer", "hsa05216  Thyroid cancer", "hsa05221  Acute myeloid leukemia"], "ko_pathway": "ko05202", "genes": ["IL3", "MLF1", "TP53", "MET", "ETV4", "BIRC3", "BAX"]}, {"kegg_id": "hsa05221", "name": "Acute myeloid leukemia - Homo sapiens (human)", "description": "Acute myeloid leukemia (AML) is a disease that is characterized by uncontrolled proliferation of clonal neoplastic cells and accumulation in the bone marrow of blasts with an impaired differentiation program. AML accounts for approximately 80% of all adult leukemias and remains the most common cause of leukemia death. Two major types of genetic events have been described that are crucial for leukemic transformation. A proposed necessary first event is disordered cell growth and upregulation of cell survival genes. The most common of these activating events were observed in the RTK Flt3, in N-Ras and K-Ras, in Kit, and sporadically in other RTKs. Alterations in myeloid transcription factors governing hematopoietic differentiation provide second necessary event for leukemogenesis. Transcription factor fusion proteins such as AML-ETO, PML-RARalpha or PLZF-RARalpha block myeloid cell differentiation by repressing target genes. In other cases, the transcription factors themselves are mutated.", "class": "Human Diseases; Cancer: specific types", "pathway_map": "hsa05221  Acute myeloid leukemia", "network": ["", "ELEMENT   N00003  Mutation-activated KIT to RAS-ERK signaling pathway", "N00004  Duplication or mutation-activated FLT3 to RAS-ERK signaling pathway", "N00012  Mutation-activated KRAS/NRAS to ERK signaling pathway", "N00031  Duplication or mutation-activated FLT3 to RAS-PI3K signaling pathway", "N00032  Mutation-activated KRAS/NRAS to PI3K signaling pathway", "N00046  Mutation-activated KIT to PI3K signaling pathway", "N00054  Duplication or mutation-activated FLT3 to Jak-STAT signaling pathway", "N00108  AML1-ETO fusion to transcriptional activtion", "N00109  PML-RARA fusion to transcriptional activtion", "N00110  PLZF-RARA fusion to transcriptional activtion", "N00111  AML1-ETO fusion to CEBPA-mediated transcription", "N00112  AML1-ETO fusion to PU.1-mediated transcription", "N00113  PML-RARA fusion to transcriptional repression", "N00114  PLZF-RARA fusion to transcriptional repression", "N00116  Mutation-inactivated RUNX1 to transcription"], "disease": ["H00003  Acute myeloid leukemia"], "drug": ["D00094  Tretinoin (JAN/USP/INN)", "D05029  Midostaurin (JAN/USAN/INN)", "D10800  Gilteritinib fumarate (JAN/USAN)", "D12476  Tuspetinib (USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["3815  KIT; KIT proto-oncogene, receptor tyrosine kinase [KO:K05091] [EC:2.7.10.1]", "2322  FLT3; fms related receptor tyrosine kinase 3 [KO:K05092] [EC:2.7.10.1]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "1978  EIF4EBP1; eukaryotic translation initiation factor 4E binding protein 1 [KO:K07205]", "6198  RPS6KB1; ribosomal protein S6 kinase B1 [KO:K04688] [EC:2.7.11.1]", "6199  RPS6KB2; ribosomal protein S6 kinase B2 [KO:K04688] [EC:2.7.11.1]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "369  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "6774  STAT3; signal transducer and activator of transcription 3 [KO:K04692]", "6776  STAT5A; signal transducer and activator of transcription 5A [KO:K11223]", "6777  STAT5B; signal transducer and activator of transcription 5B [KO:K11224]", "5292  PIM1; Pim-1 proto-oncogene, serine/threonine kinase [KO:K04702] [EC:2.7.11.1]", "11040  PIM2; Pim-2 proto-oncogene, serine/threonine kinase [KO:K08806] [EC:2.7.11.1]", "861  RUNX1; RUNX family transcription factor 1 [KO:K08367]", "1436  CSF1R; colony stimulating factor 1 receptor [KO:K05090] [EC:2.7.10.1]", "4353  MPO; myeloperoxidase [KO:K10789] [EC:1.11.2.2]", "1437  CSF2; colony stimulating factor 2 [KO:K05427]", "3562  IL3; interleukin 3 [KO:K04736]", "862  RUNX1T1; RUNX1 partner transcriptional co-repressor 1 [KO:K10053]", "5371  PML; PML nuclear body scaffold [KO:K10054] [EC:2.3.2.-]", "5914  RARA; retinoic acid receptor alpha [KO:K08527]", "7704  ZBTB16; zinc finger and BTB domain containing 16 [KO:K10055]", "1050  CEBPA; CCAAT enhancer binding protein alpha [KO:K09055]", "8864  PER2; period circadian regulator 2 [KO:K02633]", "6688  SPI1; Spi-1 proto-oncogene [KO:K09438]", "929  CD14; CD14 molecule [KO:K04391]", "3684  ITGAM; integrin subunit alpha M [KO:K06461]", "2209  FCGR1A; Fc gamma receptor Ia [KO:K06498]", "1053  CEBPE; CCAAT enhancer binding protein epsilon [KO:K10051]", "597  BCL2A1; BCL2 related protein A1 [KO:K02162]", "890  CCNA2; cyclin A2 [KO:K06627]", "8900  CCNA1; cyclin A1 [KO:K06627]", "4609  MYC; MYC proto-oncogene, bHLH transcription factor [KO:K04377]", "1848  DUSP6; dual specificity phosphatase 6 [KO:K21946] [EC:3.1.3.16 3.1.3.48]", "3728  JUP; junction plakoglobin [KO:K10056]", "6932  TCF7; transcription factor 7 [KO:K02620]", "83439  TCF7L1; transcription factor 7 like 1 [KO:K04490]", "6934  TCF7L2; transcription factor 7 like 2 [KO:K04491]", "51176  LEF1; lymphoid enhancer binding factor 1 [KO:K04492]", "595  CCND1; cyclin D1 [KO:K04503]", "5467  PPARD; peroxisome proliferator activated receptor delta [KO:K04504]"], "compound": ["C05981  Phosphatidylinositol-3,4,5-trisphosphate"], "refs": [{"pmid": "16236521", "authors": "  Steffen B, Muller-Tidow C, Schwable J, Berdel WE, Serve H.", "title": "The molecular pathogenesis of acute myeloid leukemia.", "journal": "Crit Rev Oncol Hematol 56:195-221 (2005)", "doi": "10.1016/j.critrevonc.2004.10.012"}, {"pmid": "12563308", "authors": "  Tenen DG.", "title": "Disruption of differentiation in human cancer: AML shows the way.", "journal": "Nat Rev Cancer 3:89-101 (2003)", "doi": "10.1038/nrc989"}, {"pmid": "16146838", "authors": "  Choudhary C, Muller-Tidow C, Berdel WE, Serve H.", "title": "Signal transduction of oncogenic Flt3.", "journal": "Int J Hematol 82:93-9 (2005)", "doi": "10.1532/IJH97.05090"}, {"pmid": "12951584", "authors": "  Stirewalt DL, Radich JP.", "title": "The role of FLT3 in haematopoietic malignancies.", "journal": "Nat Rev Cancer 3:650-65 (2003)", "doi": "10.1038/nrc1169"}, {"pmid": "16642045", "authors": "  Martelli AM, Nyakern M, Tabellini G, Bortul R, Tazzari PL, Evangelisti C, Cocco L.", "title": "Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia.", "journal": "Leukemia 20:911-28 (2006)", "doi": "10.1038/sj.leu.2404245"}, {"pmid": "15625120", "authors": "  Lennartsson J, Jelacic T, Linnekin D, Shivakrupa R.", "title": "Normal and oncogenic forms of the receptor tyrosine kinase kit.", "journal": "Stem Cells 23:16-43 (2005)", "doi": "10.1634/stemcells.2004-0117"}, {"pmid": "11721960", "authors": "  Lorsbach RB, Downing JR.", "title": "The role of the AML1 transcription factor in leukemogenesis.", "journal": "Int J Hematol 74:258-65 (2001)", "doi": "10.1007/BF02982058"}, {"pmid": "12468433", "authors": "  Mizuki M, Schwable J, Steur C, Choudhary C, Agrawal S, Sargin B, Steffen B, Matsumura I, Kanakura Y, Bohmer FD, Muller-Tidow C, Berdel WE, Serve H.", "title": "Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations.", "journal": "Blood 101:3164-73 (2003)", "doi": "10.1182/blood-2002-06-1677"}, {"pmid": "16352814", "authors": "  Mueller BU, Pabst T, Fos J, Petkovic V, Fey MF, Asou N, Buergi U, Tenen DG.", "title": "ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression.", "journal": "Blood 107:3330-8 (2006)", "doi": "10.1182/blood-2005-07-3068"}, {"pmid": "12529654", "authors": "  Roumier C, Fenaux P, Lafage M, Imbert M, Eclache V, Preudhomme C", "title": "New mechanisms of AML1 gene alteration in hematological malignancies.", "journal": "Leukemia 17:9-16 (2003)", "doi": "10.1038/sj.leu.2402766"}, {"pmid": "12032780", "authors": "  Scandura JM, Boccuni P, Cammenga J, Nimer SD", "title": "Transcription factor fusions in acute leukemia: variations on a theme.", "journal": "Oncogene 21:3422-44 (2002)", "doi": "10.1038/sj.onc.1205315"}, {"pmid": "10717473", "authors": "  Lutterbach B, Hiebert SW", "title": "Role of the transcription factor AML-1 in acute leukemia and hematopoietic differentiation.", "journal": "Gene 245:223-35 (2000)", "doi": "10.1016/S0378-1119(00)00014-7"}, {"pmid": "19075268", "authors": "  Koschmieder S, Halmos B, Levantini E, Tenen DG", "title": "Dysregulation of the C/EBPalpha differentiation pathway in human cancer.", "journal": "J Clin Oncol 27:619-28 (2009)", "doi": "10.1200/JCO.2008.17.9812"}, {"pmid": "15985538", "authors": "  Gery S, Gombart AF, Yi WS, Koeffler C, Hofmann WK, Koeffler HP", "title": "Transcription profiling of C/EBP targets identifies Per2 as a gene implicated in myeloid leukemia.", "journal": "Blood 106:2827-36 (2005)", "doi": "10.1182/blood-2005-01-0358"}, {"pmid": "12130514", "authors": "  Mueller BU, Pabst T, Osato M, Asou N, Johansen LM, Minden MD, Behre G, Hiddemann W, Ito Y, Tenen DG", "title": "Heterozygous PU.1 mutations are associated with acute myeloid leukemia.", "journal": "Blood 100:998-1007 (2002)", "doi": "10.1182/blood.V100.3.998"}, {"pmid": "12393465", "authors": "  Vangala RK, Heiss-Neumann MS, Rangatia JS, Singh SM, Schoch C, Tenen DG, Hiddemann W, Behre G", "title": "The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia.", "journal": "Blood 101:270-7 (2003)", "doi": "10.1182/blood-2002-04-1288"}, {"pmid": "15024077", "authors": "  Muller-Tidow C, Steffen B, Cauvet T, Tickenbrock L, Ji P, Diederichs S, Sargin B, Kohler G, Stelljes M, Puccetti E, Ruthardt M, deVos S, Hiebert SW, Koeffler HP, Berdel WE, Serve H", "title": "Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells.", "journal": "Mol Cell Biol 24:2890-904 (2004)", "doi": "10.1128/MCB.24.7.2890-2904.2004"}, {"pmid": "15160934", "authors": "  Jing Y", "title": "The PML-RARalpha fusion protein and targeted therapy for acute promyelocytic leukemia.", "journal": "Leuk Lymphoma 45:639-48 (2004)", "doi": "10.1080/10428190310001609933"}, {"pmid": "11607818", "authors": "  Alcalay M, Orleth A, Sebastiani C, Meani N, Chiaradonna F, Casciari C, Sciurpi MT, Gelmetti V, Riganelli D, Minucci S, Fagioli M, Pelicci PG", "title": "Common themes in the pathogenesis of acute myeloid leukemia.", "journal": "Oncogene 20:5680-94 (2001)", "doi": "10.1038/sj.onc.1204642"}, {"pmid": "19855079", "authors": "  Rice KL, Hormaeche I, Doulatov S, Flatow JM, Grimwade D, Mills KI, Leiva M, Ablain J, Ambardekar C, McConnell MJ, Dick JE, Licht JD", "title": "Comprehensive genomic screens identify a role for PLZF-RARalpha as a positive regulator of cell proliferation via direct regulation of c-MYC.", "journal": "Blood 114:5499-511 (2009)", "doi": "10.1182/blood-2009-03-206524"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04110  Cell cycle", "hsa04150  mTOR signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04210  Apoptosis", "hsa04630  JAK-STAT signaling pathway", "hsa04640  Hematopoietic cell lineage"], "ko_pathway": "ko05221", "genes": ["IL3", "BRAF", "AKT2", "AKT1", "SOS1", "NRAS", "PIM1"]}, {"kegg_id": "hsa05310", "name": "Asthma - Homo sapiens (human)", "description": "Asthma is a complex syndrome with many clinical phenotypes in both adults and children. Its major characteristics include a variable degree of airflow obstruction, bronchial hyperresponsiveness, and airway inflammation. Inhaled allergens encounter antigen presenting cells (APC) that line the airway. Upon recognition of the antigen and activation by APC, naive T cells differentiate into TH2 cells. Activated TH2 stimulate the formation of IgE by B cells. IgE molecules bind to IgE receptors located on mast cells. The crosslinking of mast-cell-bound IgE by allergens leads to the release of biologically active mediators (histamine, leukotrienes) by means of degranulation and, so, to the immediate symptoms of allergy. Mast cells also release chemotactic factors that contribute to the recruitment of inflammatory cells, particularly eosinophils, whose proliferation and differentiation from bone marrow progenitors is promoted by IL-5. The activation of eosinophils leads to release of toxic granules and oxygen free radicals that lead to tissue damage and promote the development of chronic inflammation.", "class": "Human Diseases; Immune disease", "pathway_map": "hsa05310  Asthma", "disease": ["H00079  Asthma"], "drug": ["D04923  Mepolizumab (USAN/INN)", "D05251  Omalizumab (USAN/INN)", "D09897  Enokizumab (USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["3108  HLA-DMA; major histocompatibility complex, class II, DM alpha [KO:K06752]", "3109  HLA-DMB; major histocompatibility complex, class II, DM beta [KO:K06752]", "3111  HLA-DOA; major histocompatibility complex, class II, DO alpha [KO:K06752]", "3112  HLA-DOB; major histocompatibility complex, class II, DO beta [KO:K06752]", "3113  HLA-DPA1; major histocompatibility complex, class II, DP alpha 1 [KO:K06752]", "3115  HLA-DPB1; major histocompatibility complex, class II, DP beta 1 [KO:K06752]", "3117  HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 [KO:K06752]", "3118  HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2 [KO:K06752]", "3119  HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 [KO:K06752]", "3122  HLA-DRA; major histocompatibility complex, class II, DR alpha [KO:K06752]", "3123  HLA-DRB1; major histocompatibility complex, class II, DR beta 1 [KO:K06752]", "3125  HLA-DRB3; major histocompatibility complex, class II, DR beta 3 [KO:K06752]", "3126  HLA-DRB4; major histocompatibility complex, class II, DR beta 4 [KO:K06752]", "3127  HLA-DRB5; major histocompatibility complex, class II, DR beta 5 [KO:K06752]", "3565  IL4; interleukin 4 [KO:K05430]", "959  CD40LG; CD40 ligand [KO:K03161]", "958  CD40; CD40 molecule [KO:K03160]", "102723407  IGH; immunoglobulin heavy variable 4-38-2-like [KO:K06856]", "2205  FCER1A; Fc epsilon receptor Ia [KO:K08089]", "2206  MS4A2; membrane spanning 4-domains A2 [KO:K08090]", "2207  FCER1G; Fc epsilon receptor Ig [KO:K07983]", "3578  IL9; interleukin 9 [KO:K05432]", "3586  IL10; interleukin 10 [KO:K05443]", "3596  IL13; interleukin 13 [KO:K05435]", "3567  IL5; interleukin 5 [KO:K05428]", "6356  CCL11; C-C motif chemokine ligand 11 [KO:K16597]", "7124  TNF; tumor necrosis factor [KO:K03156]", "3562  IL3; interleukin 3 [KO:K04736]", "5553  PRG2; proteoglycan 2, pro eosinophil major basic protein [KO:K10786]", "6037  RNASE3; ribonuclease A family member 3 [KO:K10787] [EC:3.1.27.-]", "8288  EPX; eosinophil peroxidase [KO:K10788] [EC:1.11.1.7]"], "compound": ["C00388  Histamine", "C00696  Prostaglandin D2", "C02166  Leukotriene C4", "C04598  2-Acetyl-1-alkyl-sn-glycero-3-phosphocholine", "C05951  Leukotriene D4"], "refs": [{"pmid": "11172168", "authors": "  Busse WW, Lemanske RF Jr.", "title": "Asthma.", "journal": "N Engl J Med 344:350-62 (2001)", "doi": "10.1056/NEJM200102013440507"}, {"pmid": "11477111", "authors": "  Renauld JC.", "title": "New insights into the role of cytokines in asthma.", "journal": "J Clin Pathol 54:577-89 (2001)", "doi": "10.1136/jcp.54.8.577"}, {"pmid": "10719286", "authors": "  Romagnani S.", "title": "The role of lymphocytes in allergic disease.", "journal": "J Allergy Clin Immunol 105:399-408 (2000)", "doi": "10.1067/mai.2000.104575"}, {"pmid": "17976144", "authors": "  Averbeck M, Gebhardt C, Emmrich F, Treudler R, Simon JC.", "title": "Immunologic principles of allergic disease.", "journal": "J Dtsch Dermatol Ges 5:1015-28 (2007)", "doi": "10.1111/j.1610-0387.2007.06538.x"}, {"pmid": "11686879", "authors": "  Conroy DM, Williams TJ.", "title": "Eotaxin and the attraction of eosinophils to the asthmatic lung.", "journal": "Respir Res 2:150-6 (2001)", "doi": "10.1186/rr52"}, {"pmid": "17133123", "authors": "  Effros RM, Nagaraj H.", "title": "Asthma: new developments concerning immune mechanisms, diagnosis and treatment.", "journal": "Curr Opin Pulm Med 13:37-43 (2007)", "doi": "10.1097/MCP.0b013e3280108757"}, {"pmid": "18274560", "authors": "  Barnes PJ.", "title": "Immunology of asthma and chronic obstructive pulmonary disease.", "journal": "Nat Rev Immunol 8:183-92 (2008)", "doi": "10.1038/nri2254"}, {"pmid": "18274559", "authors": "  Holgate ST, Polosa R.", "title": "Treatment strategies for allergy and asthma.", "journal": "Nat Rev Immunol 8:218-30 (2008)", "doi": "10.1038/nri2262"}, {"pmid": "12093011", "authors": "  Valenta R.", "title": "The future of antigen-specific immunotherapy of allergy.", "journal": "Nat Rev Immunol 2:446-53 (2002)", "doi": "10.1038/nri824"}, {"pmid": "17364144", "authors": "  Trivedi SG, Lloyd CM.", "title": "Eosinophils in the pathogenesis of allergic airways disease.", "journal": "Cell Mol Life Sci 64:1269-89 (2007)", "doi": "10.1007/s00018-007-6527-y"}], "rel_pathway": ["hsa04060  Cytokine-cytokine receptor interaction", "hsa04514  Cell adhesion molecules", "hsa04612  Antigen processing and presentation", "hsa04630  JAK-STAT signaling pathway", "hsa04660  T cell receptor signaling pathway", "hsa04662  B cell receptor signaling pathway", "hsa04664  Fc epsilon RI signaling pathway"], "ko_pathway": "ko05310", "genes": ["IL3"]}, {"kegg_id": "hsa04662", "name": "B cell receptor signaling pathway - Homo sapiens (human)", "description": "B cells are an important component of adaptive immunity. They produce and secrete millions of different antibody molecules, each of which recognizes a different (foreign) antigen. The B cell receptor (BCR) is an integral membrane protein complex that is composed of two immunoglobulin (Ig) heavy chains, two Ig light chains and two heterodimers of Ig-alpha and Ig-beta. After BCR ligation by antigen, three main protein tyrosine kinases (PTKs) -the SRC-family kinase LYN, SYK and the TEC-family kinase BTK- are activated. Phosphatidylinositol 3-kinase (PI3K) and phospholipase C-gamma 2 (PLC-gamma 2) are important downstream effectors of BCR signalling. This signalling ultimately results in the expression of immediate early genes that further activate the expression of other genes involved in B cell proliferation, differentiation and Ig production as well as other processes.", "class": "Organismal Systems; Immune system", "pathway_map": "hsa04662  B cell receptor signaling pathway", "network": ["", "ELEMENT   N00487  BCR-PLCG-Calcineurin signaling pathway", "N01695  BCR-BCAP/CD19-PI3K signaling pathway"], "drug": ["D03066  Bectumomab (USAN/INN)", "D04036  Epratuzumab (USAN/INN)", "D06348  Yttrium Y 90 epratuzumab (USAN)", "D06349  Yttrium Y 90 epratuzumab tetraxetan (USAN)", "D08933  Inotuzumab ozogamicin (USAN/INN)", "D09325  Blinatumomab (USAN/INN)", "D09347  Fostamatinib (USAN)", "D09348  Fostamatinib disodium (USAN)", "D09932  Moxetumomab pasudotox (USAN/INN)", "D10223  Ibrutinib (JAN/USAN)", "D10560  Idelalisib (JAN/USAN/INN)", "D10730  Spebrutinib (USAN/INN)", "D10731  Spebrutinib besylate (USAN)", "D10761  Polatuzumab vedotin (USAN)", "D10893  Acalabrutinib (JAN/USAN/INN)", "D11070  Tirabrutinib hydrochloride (JAN/USAN)", "D11144  Axicabtagene ciloleucel (USAN)", "D11231  Denintuzumab (USAN/INN)", "D11232  Denintuzumab mafodotin (USAN/INN)", "D11322  Umbralisib (USAN/INN)", "D11323  Umbralisib tosylate (USAN)", "D11339  Valziflocept (USAN)", "D11372  Duvortuxizumab (USAN)", "D11386  Tisagenlecleucel-T (USAN)", "D11422  Zanubrutinib (JAN/USAN/INN)", "D11428  Vecabrutinib (USAN/INN)", "D11437  Parsaclisib (USAN/INN)", "D11457  Fenebrutinib (USAN/INN)", "D11478  Branebrutinib (USAN)", "D11496  Obexelimab (USAN/INN)", "D11502  Vecabrutinib succinate (USAN)", "D11506  Parsaclisib hydrochloride (JAN/USAN)", "D11601  Tafasitamab (USAN/INN)", "D11720  Acalabrutinib maleate (USAN)", "D11757  Inebilizumab (USAN/INN)", "D11778  Daxdilimab (USAN)", "D11789  Mivavotinib (USAN/INN)", "D11790  Mivavotinib citrate (USAN)", "D11873  Rilzabrutinib (JAN/USAN/INN)", "D11880  Brexucabtagene autoleucel (USAN)", "D11942  Inavolisib (USAN/INN)", "D11990  Lisocabtagene maraleucel (USAN/INN)", "D12050  Pirtobrutinib (JAN/USAN)", "D12052  Luxeptinib (USAN)", "D12158  Elsubrutinib (USAN/INN)", "D12160  Orelabrutinib (USAN/INN)", "D12213  Tolebrutinib (JAN/USAN/INN)", "D12285  Remibrutinib (JAN/USAN/INN)", "D12383  Edralbrutinib (USAN/INN)", "D12467  Evobrutinib (USAN/INN)", "D12489  Atuzabrutinib (USAN/INN)", "D12504  Nemtabrutinib (USAN/INN)", "D12594  Tirabrutinib (USAN/INN)", "D12704  Acalabrutinib maleate hydrate (JAN)", "D12775  Polzastobart (USAN/INN)", "D12858  Zelebrudomide (USAN)"], "dblinks": "GO: 0050853", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["102723407  IGH; immunoglobulin heavy variable 4-38-2-like [KO:K06856]", "973  CD79A; CD79a molecule [KO:K06506]", "974  CD79B; CD79b molecule [KO:K06507]", "4067  LYN; LYN proto-oncogene, Src family tyrosine kinase [KO:K05854] [EC:2.7.10.2]", "6850  SYK; spleen associated tyrosine kinase [KO:K05855] [EC:2.7.10.2]", "695  BTK; Bruton tyrosine kinase [KO:K07370] [EC:2.7.10.2]", "27071  DAPP1; dual adaptor of phosphotyrosine and 3-phosphoinositides 1 [KO:K12229]", "29760  BLNK; B cell linker [KO:K07371]", "10451  VAV3; vav guanine nucleotide exchange factor 3 [KO:K05730]", "7409  VAV1; vav guanine nucleotide exchange factor 1 [KO:K05730]", "7410  VAV2; vav guanine nucleotide exchange factor 2 [KO:K05730]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "5880  RAC2; Rac family small GTPase 2 [KO:K07860]", "5881  RAC3; Rac family small GTPase 3 [KO:K07861]", "55024  BANK1; B cell scaffold protein with ankyrin repeats 1 [KO:K26239]", "640  BLK; BLK proto-oncogene, Src family tyrosine kinase [KO:K08890] [EC:2.7.10.2]", "5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]", "5530  PPP3CA; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]", "5532  PPP3CB; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]", "5533  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]", "5534  PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]", "5535  PPP3R2; protein phosphatase 3 regulatory subunit B, beta [KO:K06268]", "4772  NFATC1; nuclear factor of activated T cells 1 [KO:K04446]", "4773  NFATC2; nuclear factor of activated T cells 2 [KO:K17332]", "4775  NFATC3; nuclear factor of activated T cells 3 [KO:K17333]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "25780  RASGRP3; RAS guanyl releasing protein 3 [KO:K12362]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "84433  CARD11; caspase recruitment domain family member 11 [KO:K07367]", "8915  BCL10; BCL10 immune signaling adaptor [KO:K07368]", "10892  MALT1; MALT1 paracaspase [KO:K07369] [EC:3.4.22.-]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "4793  NFKBIB; NFKB inhibitor beta [KO:K02581]", "4794  NFKBIE; NFKB inhibitor epsilon [KO:K05872]", "8519  IFITM1; interferon induced transmembrane protein 1 [KO:K19831]", "975  CD81; CD81 molecule [KO:K06508]", "930  CD19; CD19 molecule [KO:K06465]", "1380  CR2; complement C3d receptor 2 [KO:K04012]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "2213  FCGR2B; Fc gamma receptor IIb [KO:K12560]", "3635  INPP5D; inositol polyphosphate-5-phosphatase D [KO:K03084] [EC:3.1.3.86]", "3636  INPPL1; inositol polyphosphate phosphatase like 1 [KO:K15909] [EC:3.1.3.86]", "10288  LILRB2; leukocyte immunoglobulin like receptor B2 [KO:K06512]", "10859  LILRB1; leukocyte immunoglobulin like receptor B1 [KO:K06512]", "10990  LILRB5; leukocyte immunoglobulin like receptor B5 [KO:K06512]", "11006  LILRB4; leukocyte immunoglobulin like receptor B4 [KO:K06512]", "11024  LILRA1; leukocyte immunoglobulin like receptor A1 [KO:K06512]", "11025  LILRB3; leukocyte immunoglobulin like receptor B3 [KO:K06512]", "11026  LILRA3; leukocyte immunoglobulin like receptor A3 [KO:K06512]", "11027  LILRA2; leukocyte immunoglobulin like receptor A2 [KO:K06512]", "23547  LILRA4; leukocyte immunoglobulin like receptor A4 [KO:K06512]", "79168  LILRA6; leukocyte immunoglobulin like receptor A6 [KO:K06512]", "353514  LILRA5; leukocyte immunoglobulin like receptor A5 [KO:K06512]", "102725035  leukocyte immunoglobulin-like receptor subfamily B member 3 [KO:K06512]", "107987425  leukocyte immunoglobulin-like receptor subfamily B member 3 [KO:K06512]", "107987462  leukocyte immunoglobulin-like receptor subfamily B member 3 [KO:K06512]", "112268336  leukocyte immunoglobulin-like receptor subfamily B member 3 [KO:K06512]", "112268337  leukocyte immunoglobulin-like receptor subfamily B member 3 [KO:K06512]", "112268340  leukocyte immunoglobulin-like receptor subfamily B member 3 [KO:K06512]", "107987441  leukocyte immunoglobulin-like receptor subfamily B member 3 [KO:K06512]", "933  CD22; CD22 molecule [KO:K06467]", "971  CD72; CD72 molecule [KO:K06504]", "5777  PTPN6; protein tyrosine phosphatase non-receptor type 6 [KO:K05697] [EC:3.1.3.48]", "118788  PIK3AP1; phosphoinositide-3-kinase adaptor protein 1 [KO:K12230]"], "compound": ["C00076  Calcium cation", "C00165  Diacylglycerol", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C05981  Phosphatidylinositol-3,4,5-trisphosphate"], "refs": [{"pmid": "12461567", "authors": "  Niiro H, Clark EA.", "title": "Regulation of B-cell fate by antigen-receptor signals.", "journal": "Nat Rev Immunol 2:945-56 (2002)", "doi": "10.1038/nri955"}, {"pmid": "10358768", "authors": "  Kurosaki T.", "title": "Genetic analysis of B cell antigen receptor signaling.", "journal": "Annu Rev Immunol 17:555-92 (1999)", "doi": "10.1146/annurev.immunol.17.1.555"}, {"pmid": "15886119", "authors": "  Nitschke L.", "title": "The role of CD22 and other inhibitory co-receptors in B-cell activation.", "journal": "Curr Opin Immunol 17:290-7 (2005)", "doi": "10.1016/j.coi.2005.03.005"}, {"pmid": "15752555", "authors": "  Morgan BP, Marchbank KJ, Longhi MP, Harris CL, Gallimore AM.", "title": "Complement: central to innate immunity and bridging to adaptive responses.", "journal": "Immunol Lett 97:171-9 (2005)", "doi": "10.1016/j.imlet.2004.11.010"}, {"pmid": "12033741", "authors": "  Kurosaki T.", "title": "Regulation of B-cell signal transduction by adaptor proteins.", "journal": "Nat Rev Immunol 2:354-63 (2002)", "doi": "10.1038/nri801"}, {"pmid": "15364057", "authors": "  Nitschke L, Tsubata T.", "title": "Molecular interactions regulate BCR signal inhibition by CD22 and CD72.", "journal": "Trends Immunol 25:543-50 (2004)", "doi": "10.1016/j.it.2004.08.002"}, {"pmid": "15771577", "authors": "  Jumaa H, Hendriks RW, Reth M.", "title": "B cell signaling and tumorigenesis.", "journal": "Annu Rev Immunol 23:415-45 (2005)", "doi": "10.1146/annurev.immunol.23.021704.115606"}, {"pmid": "15886112", "authors": "  Rickert RC.", "title": "Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex.", "journal": "Curr Opin Immunol 17:237-43 (2005)", "doi": "10.1016/j.coi.2005.03.001"}, {"pmid": "15457440", "authors": "  Zouali M, Sarmay G", "title": "B lymphocyte signaling pathways in systemic autoimmunity: implications for pathogenesis and treatment.", "journal": "Arthritis Rheum 50:2730-41 (2004)", "doi": "10.1002/art.20487"}, {"pmid": "15322145", "authors": "  Chiles TC.", "title": "Regulation and function of cyclin D2 in B lymphocyte subsets.", "journal": "J Immunol 173:2901-7 (2004)", "doi": "10.4049/jimmunol.173.5.2901"}, {"pmid": "15626471", "authors": "  Allam A, Marshall AJ", "title": "Role of the adaptor proteins Bam32, TAPP1 and TAPP2 in lymphocyte activation.", "journal": "Immunol Lett 97:7-17 (2005)", "doi": "10.1016/j.imlet.2004.09.019"}, {"pmid": "12119152", "authors": "  Gold MR", "title": "To make antibodies or not: signaling by the B-cell antigen receptor.", "journal": "Trends Pharmacol Sci 23:316-24 (2002)", "doi": "10.1016/S0165-6147(02)02045-X"}, {"pmid": "9697839", "authors": "  Fu C, Turck CW, Kurosaki T, Chan AC", "title": "BLNK: a central linker protein in B cell activation.", "journal": "Immunity 9:93-103 (1998)", "doi": "10.1016/S1074-7613(00)80591-9"}, {"pmid": "11163197", "authors": "  Okada T, Maeda A, Iwamatsu A, Gotoh K, Kurosaki T", "title": "BCAP: the tyrosine kinase substrate that connects B cell receptor to phosphoinositide 3-kinase activation.", "journal": "Immunity 13:817-27 (2000)", "doi": "10.1016/S1074-7613(00)00079-0"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04064  NF-kappa B signaling pathway", "hsa04120  Ubiquitin mediated proteolysis", "hsa04151  PI3K-Akt signaling pathway", "hsa04610  Complement and coagulation cascades", "hsa04810  Regulation of actin cytoskeleton"], "ko_pathway": "ko04662", "genes": ["CD22", "MALT1", "RAC1", "AKT2", "AKT1", "SOS1", "NRAS"]}, {"kegg_id": "hsa01522", "name": "Endocrine resistance - Homo sapiens (human)", "description": "Endocrine therapy is a key treatment strategy to control or eradicate hormone-responsive breast cancer. The most commonly used endocrine therapy agents are selective estrogen receptor modulators (SERMs, e.g. tamoxifen), estrogen synthesis inhibitors (e.g. aromatase inhibitors (AIs) such as anastrozole, letrozole, and exemestane), and selective estrogen receptor down-regulators (SERDs, e.g. fulvestrant). However, resistance to these agents has become a major clinical obstacle. Mechanisms of endocrine resistance include loss of ER-alpha expression, altered expression of coactivators or coregulators that play a critical role in ER-mediated gene transcription, ligand-independent growth factor signaling cascades that activate kinases and ER-phosphorylation, altered availability of active tamoxifen metabolites regulated by drug-metabolizing enzymes, such as CYP2D6, and deregulation of the cell cycle and apoptotic machinery.", "class": "Human Diseases; Drug resistance: antineoplastic", "pathway_map": "hsa01522  Endocrine resistance", "drug": ["D03793  Ilomastat (USAN/INN)", "D03795  Marimastat (USAN/INN)", "D03797  Prinomastat (USAN/INN)", "D03802  Tanomastat (USAN/INN)", "D07928  Ethinylestradiol propanesulfonate", "D11262  Andecaliximab (USAN/INN)", "D12628  Vepdegestrant (JAN/USAN/INN)", "D12827  Palazestrant (USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "refs": [{"pmid": "23344024", "authors": "  Garcia-Becerra R, Santos N, Diaz L, Camacho J", "title": "Mechanisms of resistance to endocrine therapy in breast cancer: focus on signaling pathways, miRNAs and genetically based resistance.", "journal": "Int J Mol Sci 14:108-45 (2012)", "doi": "10.3390/ijms14010108"}, {"pmid": "19701242", "authors": "  Musgrove EA, Sutherland RL", "title": "Biological determinants of endocrine resistance in breast cancer.", "journal": "Nat Rev Cancer 9:631-43 (2009)", "doi": "10.1038/nrc2713"}, {"pmid": "22015292", "authors": "  Giuliano M, Schifp R, Osborne CK, Trivedi MV", "title": "Biological mechanisms and clinical implications of endocrine resistance in breast cancer.", "journal": "Breast 20 Suppl 3:S42-9 (2011)", "doi": "10.1016/S0960-9776(11)70293-4"}, {"pmid": "25907219", "authors": "  Ma CX, Reinert T, Chmielewska I, Ellis MJ", "title": "Mechanisms of aromatase inhibitor resistance.", "journal": "Nat Rev Cancer 15:261-75 (2015)", "doi": "10.1038/nrc3920"}, {"pmid": "24841429", "authors": "  Viedma-Rodriguez R, Baiza-Gutman L, Salamanca-Gomez F, Diaz-Zaragoza M, Martinez-Hernandez G, Ruiz Esparza-Garrido R, Velazquez-Flores MA, Arenas-Aranda D", "title": "Mechanisms associated with resistance to tamoxifen in estrogen receptor-positive breast cancer (review).", "journal": "Oncol Rep 32:3-15 (2014)", "doi": "10.3892/or.2014.3190"}, {"pmid": "26849149", "authors": "  Luqmani YA, Alam-Eldin N", "title": "Overcoming Resistance to Endocrine Therapy in Breast Cancer: New Approaches to a Nagging Problem.", "journal": "Med Princ Pract 25 Suppl 2:28-40 (2016)", "doi": "10.1159/000444451"}, {"pmid": "22771991", "authors": "  Bianco S, Gevry N", "title": "Endocrine resistance in breast cancer: from cellular signaling pathways to epigenetic mechanisms.", "journal": "Transcription 3:165-70 (2012)", "doi": "10.4161/trns.20496"}, {"pmid": "20887199", "authors": "  Osborne CK, Schiff R", "title": "Mechanisms of endocrine resistance in breast cancer.", "journal": "Annu Rev Med 62:233-47 (2011)", "doi": "10.1146/annurev-med-070909-182917"}, {"pmid": "23714450", "authors": "  Miller TW", "title": "Endocrine resistance: what do we know?", "journal": "Am Soc Clin Oncol Educ Book 0011300037 (2013)", "doi": "10.1200/EdBook_AM.2013.33.e37"}, {"pmid": "23625614", "authors": "  Lonning PE, Eikesdal HP", "title": "Aromatase inhibition 2013: clinical state of the art and questions that remain to be solved.", "journal": "Endocr Relat Cancer 20:R183-201 (2013)", "doi": "10.1530/ERC-13-0099"}, {"pmid": "26473850", "authors": "  Egeland NG, Lunde S, Jonsdottir K, Lende TH, Cronin-Fenton D, Gilje B, Janssen EA, Soiland H", "title": "The Role of MicroRNAs as Predictors of Response to Tamoxifen Treatment in Breast Cancer Patients.", "journal": "Int J Mol Sci 16:24243-75 (2015)", "doi": "10.3390/ijms161024243"}, {"pmid": "24130921", "authors": "  Chang M", "title": "Tamoxifen resistance in breast cancer.", "journal": "Biomol Ther (Seoul) 20:256-67 (2012)", "doi": "10.4062/biomolther.2012.20.3.256"}, {"pmid": "18804516", "authors": "  Zilli M, Grassadonia A, Tinari N, Di Giacobbe A, Gildetti S, Giampietro J, Natoli C, Iacobelli S", "title": "Molecular mechanisms of endocrine resistance and their implication in the therapy of breast cancer.", "journal": "Biochim Biophys Acta 1795:62-81 (2009)", "doi": "10.1016/j.bbcan.2008.08.003"}, {"pmid": "24289103", "authors": "  Mo Z, Liu M, Yang F, Luo H, Li Z, Tu G, Yang G", "title": "GPR30 as an initiator of tamoxifen resistance in hormone-dependent breast cancer.", "journal": "Breast Cancer Res 15:R114 (2013)", "doi": "10.1186/bcr3581"}, {"pmid": "24415977", "authors": "  Hasson SP, Rubinek T, Ryvo L, Wolf I", "title": "Endocrine resistance in breast cancer: focus on the phosphatidylinositol 3-kinase/akt/mammalian target of rapamycin signaling pathway.", "journal": "Breast Care (Basel) 8:248-55 (2013)", "doi": "10.1159/000354757"}, {"pmid": "15613444", "authors": "  Ring A, Dowsett M", "title": "Mechanisms of tamoxifen resistance.", "journal": "Endocr Relat Cancer 11:643-58 (2004)", "doi": "10.1677/erc.1.00776"}, {"pmid": "24565562", "authors": "  Ribeiro JR, Freiman RN", "title": "Estrogen signaling crosstalk: Implications for endocrine resistance in ovarian cancer.", "journal": "J Steroid Biochem Mol Biol 143:160-73 (2014)", "doi": "10.1016/j.jsbmb.2014.02.010"}, {"pmid": "20960099", "authors": "  Wang D, Hu L, Zhang G, Zhang L, Chen C", "title": "G protein-coupled receptor 30 in tumor development.", "journal": "Endocrine 38:29-37 (2010)", "doi": "10.1007/s12020-010-9363-z"}], "rel_pathway": ["hsa00982  Drug metabolism - cytochrome P450", "hsa04010  MAPK signaling pathway", "hsa04024  cAMP signaling pathway", "hsa04110  Cell cycle", "hsa04151  PI3K-Akt signaling pathway", "hsa04210  Apoptosis", "hsa04330  Notch signaling pathway", "hsa04913  Ovarian steroidogenesis"], "ko_pathway": "ko01522", "genes": ["EGFR", "TP53", "BRAF", "AKT2", "AKT1", "SOS1", "MAPK13", "NRAS", "BAX"]}, {"kegg_id": "hsa04010", "name": "MAPK signaling pathway - Homo sapiens (human)", "description": "The mitogen-activated protein kinase (MAPK) cascade is a highly conserved module that is involved in various cellular functions, including cell proliferation, differentiation and migration. Mammals express at least four distinctly regulated groups of MAPKs, extracellular signal-related kinases (ERK)-1/2, Jun amino-terminal kinases (JNK1/2/3), p38 proteins (p38alpha/beta/gamma/delta) and ERK5, that are activated by specific MAPKKs: MEK1/2 for ERK1/2, MKK3/6 for the p38, MKK4/7 (JNKK1/2) for the JNKs, and MEK5 for ERK5. Each MAPKK, however, can be activated by more than one MAPKKK, increasing the complexity and diversity of MAPK signalling. Presumably each MAPKKK confers responsiveness to distinct stimuli. For example, activation of ERK1/2 by growth factors depends on the MAPKKK c-Raf, but other MAPKKKs may activate ERK1/2 in response to pro-inflammatory stimuli.", "class": "Environmental Information Processing; Signal transduction", "pathway_map": "hsa04010  MAPK signaling pathway", "network": ["", "ELEMENT   N00001  EGF-EGFR-RAS-ERK signaling pathway", "N00015  PDGF-PDGFR-RAS-ERK signaling pathway", "N00019  FGF-FGFR-RAS-ERK signaling pathway", "N00186  IL1-IL1R-p38 signaling pathway", "N00188  IL1-IL1R-JNK signaling pathway", "N00215  KITLG-KIT-RAS-ERK signaling pathway", "N00216  HGF-MET-RAS-ERK signaling pathway", "N00217  FLT3LG-FLT3-RAS-ERK signaling pathway", "N00229  TGFA-EGFR-RAS-ERK signaling pathway", "N00233  IGF-IGF1R-RAS-ERK signaling pathway", "N00277  EREG-EGFR-RAS-ERK signaling pathway", "N00279  AREG-EGFR-RAS-ERK signaling pathway", "N00542  EGF-EGFR-RAS-JNK signaling pathway", "N01119  RAC/CDC42-PAK-ERK signaling pathway", "N01592  GF-RTK-RAS-ERK signaling pathway", "N01593  Regulation of GF-RTK-RAS-ERK signaling, PTP", "N01594  MLK-JNK signaling pathway", "N01597  Regulation of GF-RTK-RAS-ERK signaling, SPRED and NF1", "N01600  Regulation of GF-RTK-RAS-ERK signaling, RasGAP", "N01601  ERK-RSK signaling", "N01602  ERK-MYC signaling pathway"], "drug": ["D00107  Tacrolimus (USP/INN)", "D00184  Cyclosporine (USP)", "D00332  Gabapentin (JAN/USP/INN)", "D00404  Methsuximide (USP)", "D00495  Paramethadione (INN)", "D00538  Zonisamide (JP18/USP/INN)", "D00539  Ethosuximide (JP18/USP/INN)", "D00619  Verapamil hydrochloride (JP18/USP)", "D00631  Bepridil hydrochloride (USAN)", "D00742  Etanercept (USAN/INN)", "D01441  Imatinib mesylate (USAN)", "D01977  Gefitinib (JP18/USAN/INN)", "D02356  Verapamil (USAN/INN)", "D02537  Dronedarone (INN)", "D02597  Adalimumab (USAN/INN)", "D02598  Infliximab (USAN/INN)", "D02630  Penfluridol (USAN/INN)", "D02716  Pregabalin (JAN/USAN/INN)", "D02970  Aprinocarsen sodium (USAN)", "D03065  Becaplermin (USAN/INN)", "D03218  Axitinib (JAN/USAN)", "D03350  Canertinib dihydrochloride (USAN)", "D03441  Certolizumab pegol (USAN/INN)", "D03455  Cetuximab (USAN/INN)", "D03658  Dasatinib (JAN/INN)", "D03736  Doramapimod (USAN/INN)", "D03914  Dronedarone hydrochloride (USP)", "D04023  Erlotinib hydrochloride (JAN/USAN)", "D04024  Lapatinib ditosylate (USAN)", "D04358  Golimumab (USAN/INN)", "D04696  Lestaurtinib (USAN/INN)", "D04862  Masoprocol (USAN/INN)", "D05024  Mibefradil dihydrochloride (USAN)", "D05029  Midostaurin (JAN/USAN/INN)", "D05146  Nerelimomab (USAN/INN)", "D05263  Onercept (USAN/INN)", "D05350  Panitumumab (USAN/INN)", "D05380  Pazopanib hydrochloride (JAN/USAN)", "D05393  Pegsunercept (USAN)", "D05399  Pelitinib (USAN/INN)", "D05480  Pimecrolimus (JAN/USAN/INN)", "D06005  Tandutinib (USAN/INN)", "D06129  Tiapamil hydrochloride (USAN)", "D06272  Sorafenib tosylate (USAN)", "D06285  Vatalanib (USAN/INN)", "D06402  Sunitinib malate (JAN/USAN)", "D06407  Vandetanib (JAN/USAN/INN)", "D06413  Nilotinib hydrochloride hydrate (JAN)", "D06414  Dasatinib (USAN)", "D06635  Rilonacept (USAN/INN)", "D06678  Motesanib (USAN)", "D07436  Afelimomab (INN)", "D07520  Bepridil (INN)", "D07907  Erlotinib (INN)", "D08066  Imatinib (INN)", "D08108  Lapatinib (INN)", "D08217  Mibefradil (INN)", "D08279  Tozasertib (USAN)", "D08344  Tozasertib lactate (USAN)", "D08503  Toceranib (USAN)", "D08524  Sorafenib (USAN/INN)", "D08544  Toceranib phosphate (USAN)", "D08552  Sunitinib (INN)", "D08556  Tacrolimus (INN)", "D08878  Brivanib alaninate (JAN/USAN/INN)", "D08881  Cediranib (USAN/INN)", "D08883  Cediranib maleate (JAN/USAN)", "D08907  Dovitinib lactate (USAN)", "D08947  Motesanib diphosphate (USAN)", "D08953  Nilotinib (USAN/INN)", "D08956  Omacetaxine mepesuccinate (USAN)", "D08963  Pamapimod (INN/USAN)", "D09033  Voclosporin (JAN/USAN/INN)", "D09315  Canakinumab (USAN/INN)", "D09386  Talmapimod (USAN/INN)", "D09539  Gabapentin enacarbil (JAN/USAN/INN)", "D09589  Brivanib (USAN)", "D09602  Dilmapimod (USAN/INN)", "D09603  Dilmapimod tosylate (USAN)", "D09620  Fresolimumab (USAN/INN)", "D09635  Linifanib (USAN/INN)", "D09660  Rindopepimut (USAN)", "D09666  Selumetinib (USAN/INN)", "D09683  Tivozanib (USAN/INN)", "D09724  Afatinib (USAN/INN)", "D09733  Afatinib dimaleate (USAN)", "D09907  Fulranumab (USAN/INN)", "D09911  Gevokizumab (USAN/INN)", "D09919  Lenvatinib (USAN/INN)", "D09920  Lenvatinib mesylate (USAN)", "D09939  Olaratumab (USAN/INN)", "D09944  Ozoralizumab (USAN)", "D09996  Vemurafenib (JAN/USAN/INN)", "D10018  Necitumumab (USAN/INN)", "D10024  Selumetinib sulfate (JAN/USAN)", "D10031  Zalutumumab (USAN/INN)", "D10062  Cabozantinib (USAN)", "D10064  Dabrafenib (USAN)", "D10095  Cabozantinib s-malate (USAN)", "D10102  Crenolanib (USAN)", "D10103  Crenolanib besylate (USAN)", "D10104  Dabrafenib mesylate (USAN)", "D10137  Regorafenib hydrate (JAN)", "D10138  Regorafenib (USAN/INN)", "D10175  Trametinib (USAN)", "D10176  Trametinib dimethyl sulfoxide (JAN/USAN)", "D10190  Tivozanib hydrochloride (USAN)", "D10224  Golvatinib (USAN)", "D10229  Masitinib (INN)", "D10396  Nintedanib esylate (USAN)", "D10405  Cobimetinib (USAN/INN)", "D10426  Pimasertib (USAN/INN)", "D10465  Golvatinib tartrate (USAN)", "D10481  Nintedanib (USAN/INN)", "D10486  Pimasertib hydrochloride (USAN)", "D10604  Binimetinib (JAN/USAN/INN)", "D10615  Cobimetinib fumarate (USAN)", "D10766  Osimertinib mesylate (USAN)", "D10790  Mirogabalin besylate (USAN)", "D10858  Rociletinib (USAN/INN)", "D10859  Olmutinib (USAN/INN)", "D10913  Burosumab (USAN/INN)", "D10943  Istiratumab (USAN/INN)", "D10958  Naquotinib (USAN/INN)", "D10959  Neflamapimod (USAN/INN)", "D10983  Ruclosporin (USAN/INN)", "D10988  Selonsertib (JAN/USAN/INN)", "D11032  Plitidepsin (INN)", "D11038  Ulixertinib (INN)", "D11053  Encorafenib (JAN/USAN/INN)", "D11115  Olmutinib hydrochloride (USAN)", "D11136  Glesatinib (USAN/INN)", "D11139  Savolitinib (USAN/INN)", "D11140  Sitravatinib (USAN/INN)", "D11141  Tucatinib (USAN/INN)", "D11203  Mirogabalin (USAN/INN)", "D11210  Flortaucipir F 18 (USAN)", "D11244  Vanucizumab (USAN/INN)", "D11270  Pexidartinib (USAN/INN)", "D11271  Pexidartinib hydrochloride (JAN/USAN)", "D11279  Avapritinib (USAN/INN)", "D11285  Ravoxertinib (USAN/INN)", "D11288  Rivoceranib (USAN/INN)", "D11289  Rivoceranib mesylate (USAN)", "D11293  Gosuranemab (USAN)", "D11378  Edicotinib (USAN)", "D11379  Edicotinib hydrochloride (USAN)", "D11384  Hydromethylthionine mesylate (USAN)", "D11410  Lifirafenib (USAN/INN)", "D11411  Lifirafenib maleate (USAN)", "D11427  Hydromethylthionine (USAN/INN)", "D11430  Nazartinib (USAN/INN)", "D11434  Nazartinib mesylate (USAN)", "D11452  Tomivosertib (USAN/INN)", "D11481  Tomivosertib hydrochloride (USAN)", "D11484  Pegcantratinib (USAN/INN)", "D11533  Zagotenemab (USAN)", "D11540  Razuprotafib (USAN)", "D11541  Sitravatinib malate (USAN)", "D11589  Infigratinib (USAN/INN)", "D11611  Infigratinib phosphate (USAN)", "D11675  Mirdametinib (USAN)", "D11687  Semorinemab (USAN/INN)", "D11703  Opinercept (INN)", "D11725  Futibatinib (JAN/USAN/INN)", "D11750  Duligotuzumab (USAN)", "D11762  Lucitanib (USAN/INN)", "D11763  Merestinib (USAN/INN)", "D11772  Tesevatinib (USAN/INN)", "D11773  Tesevatinib tosylate (USAN)", "D11803  Cetuximab sarotalocan (USAN/INN)", "D11805  Cetuximab sarotalocan sodium (genetical recombination) (JAN)", "D11840  Tilavonemab (USAN/INN)", "D11872  Serclutamab (USAN/INN)", "D11874  Serclutamab talirine (USAN/INN)", "D11885  Surufatinib (USAN/INN)", "D11894  Amivantamab (USAN/INN)", "D11904  Zansecimab (USAN)", "D11969  Mobocertinib succinate (JAN)", "D11977  Fruquintinib (JAN/USAN)", "D11980  Lazertinib (USAN)", "D12001  Mobocertinib (USAN/INN)", "D12061  Suvecaltamide (USAN)", "D12062  Suvecaltamide hydrocloride (USAN)", "D12184  Patritumab deruxtecan (USAN/INN)", "D12185  Patritumab (USAN/INN)", "D12228  Bepranemab (USAN/INN)", "D12229  Poziotinib (USAN/INN)", "D12230  Poziotinib hydrochloride (USAN)", "D12237  Zunsemetinib (USAN)", "D12238  Vimseltinib (USAN/INN)", "D12245  Lazertinib mesilate hydrate (JAN)", "D12258  Aumolertinib (USAN/INN)", "D12259  Aumolertinib mesylate (USAN)", "D12287  Terevalefim (USAN/INN)", "D12291  Tovorafenib (USAN/INN)", "D12343  Fepixnebart (TN)", "D12350  Vilamakitug (USAN)", "D12392  Fosgonimeton (USAN/INN)", "D12393  Fosgonimeton sodium (USAN)", "D12409  Barzolvolimab (USAN/INN)", "D12411  Emavusertib (USAN/INN)", "D12412  Emavusertib hydrochloride (USAN)", "D12442  Tucatinib ethanolate (JAN)", "D12450  Elenestinib (USAN)", "D12455  Lirafugratinib (USAN)", "D12456  Lirafugratinib hydrochloride (USAN)", "D12457  Tuxobertinib (USAN/INN)", "D12473  Zapnometinib (USAN/INN)", "D12476  Tuspetinib (USAN/INN)", "D12506  Sunvozertinib (USAN/INN)", "D12526  Catequentinib (USAN/INN)", "D12532  Emavusertib mesylate (USAN)", "D12533  Emavusertib maleate (USAN)", "D12537  Catequentinib hydrochloride (USAN)", "D12538  Emavusertib phosphate (USAN)", "D12539  emavusertib tosylate (USAN)", "D12540  Briquilimab (USAN/INN)", "D12545  Tinengotinib (USAN/INN)", "D12560  Gamcemetinib (USAN)", "D12600  Bezuclastinib (USAN/INN)", "D12635  Sozinibercept (USAN/INN)", "D12636  Posdinemab (USAN/INN)", "D12650  Zanzalintinib (USAN/INN)", "D12651  Zanzalintinib fumarate (USAN)", "D12730  Tigozertinib (USAN)", "D12768  Ficerafusp alfa (USAN)", "D12809  Bafisontamab (USAN/INN)", "D12819  Ulixacaltamide (USAN/INN)", "D12820  Ulixacaltamide hydrochloride (USAN)", "D12831  Naporafenib (USAN/INN)", "D12848  Etalanetug (USAN)", "D12851  Lunlekitug (USAN)", "D12854  Nilotinib laurylsulfate (USAN)", "D12859  Pebezertinib (USAN)", "D12865  Beroterkib (USAN)"], "dblinks": "GO: 0000165", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["773  CACNA1A; calcium voltage-gated channel subunit alpha1 A [KO:K04344]", "774  CACNA1B; calcium voltage-gated channel subunit alpha1 B [KO:K04849]", "775  CACNA1C; calcium voltage-gated channel subunit alpha1 C [KO:K04850]", "776  CACNA1D; calcium voltage-gated channel subunit alpha1 D [KO:K04851]", "777  CACNA1E; calcium voltage-gated channel subunit alpha1 E [KO:K04852]", "778  CACNA1F; calcium voltage-gated channel subunit alpha1 F [KO:K04853]", "8913  CACNA1G; calcium voltage-gated channel subunit alpha1 G [KO:K04854]", "8912  CACNA1H; calcium voltage-gated channel subunit alpha1 H [KO:K04855]", "8911  CACNA1I; calcium voltage-gated channel subunit alpha1 I [KO:K04856]", "779  CACNA1S; calcium voltage-gated channel subunit alpha1 S [KO:K04857]", "781  CACNA2D1; calcium voltage-gated channel auxiliary subunit alpha2delta 1 [KO:K04858]", "9254  CACNA2D2; calcium voltage-gated channel auxiliary subunit alpha2delta 2 [KO:K04859]", "55799  CACNA2D3; calcium voltage-gated channel auxiliary subunit alpha2delta 3 [KO:K04860]", "93589  CACNA2D4; calcium voltage-gated channel auxiliary subunit alpha2delta 4 [KO:K04861]", "782  CACNB1; calcium voltage-gated channel auxiliary subunit beta 1 [KO:K04862]", "783  CACNB2; calcium voltage-gated channel auxiliary subunit beta 2 [KO:K04863]", "784  CACNB3; calcium voltage-gated channel auxiliary subunit beta 3 [KO:K04864]", "785  CACNB4; calcium voltage-gated channel auxiliary subunit beta 4 [KO:K04865]", "786  CACNG1; calcium voltage-gated channel auxiliary subunit gamma 1 [KO:K04866]", "10369  CACNG2; calcium voltage-gated channel auxiliary subunit gamma 2 [KO:K04867]", "10368  CACNG3; calcium voltage-gated channel auxiliary subunit gamma 3 [KO:K04868]", "27092  CACNG4; calcium voltage-gated channel auxiliary subunit gamma 4 [KO:K04869]", "27091  CACNG5; calcium voltage-gated channel auxiliary subunit gamma 5 [KO:K04870]", "59285  CACNG6; calcium voltage-gated channel auxiliary subunit gamma 6 [KO:K04871]", "59284  CACNG7; calcium voltage-gated channel auxiliary subunit gamma 7 [KO:K04872]", "59283  CACNG8; calcium voltage-gated channel auxiliary subunit gamma 8 [KO:K04873]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "2768  GNA12; G protein subunit alpha 12 [KO:K04346]", "55970  GNG12; G protein subunit gamma 12 [KO:K04347]", "5530  PPP3CA; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]", "5532  PPP3CB; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]", "5533  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]", "5534  PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]", "5535  PPP3R2; protein phosphatase 3 regulatory subunit B, beta [KO:K06268]", "5923  RASGRF1; Ras protein specific guanine nucleotide releasing factor 1 [KO:K04349]", "5924  RASGRF2; Ras protein specific guanine nucleotide releasing factor 2 [KO:K12326]", "10125  RASGRP1; RAS guanyl releasing protein 1 [KO:K04350]", "10235  RASGRP2; RAS guanyl releasing protein 2 [KO:K12361]", "25780  RASGRP3; RAS guanyl releasing protein 3 [KO:K12362]", "115727  RASGRP4; RAS guanyl releasing protein 4 [KO:K12363]", "9693  RAPGEF2; Rap guanine nucleotide exchange factor 2 [KO:K08018]", "4763  NF1; neurofibromin 1 [KO:K08052]", "5921  RASA1; RAS p21 protein activator 1 [KO:K04352]", "5922  RASA2; RAS p21 protein activator 2 [KO:K08053]", "5906  RAP1A; RAP1A, member of RAS oncogene family [KO:K04353]", "5908  RAP1B; RAP1B, member of RAS oncogene family [KO:K07836]", "1950  EGF; epidermal growth factor [KO:K04357]", "7039  TGFA; transforming growth factor alpha [KO:K08774]", "2069  EREG; epiregulin [KO:K09784]", "374  AREG; amphiregulin [KO:K09782]", "2246  FGF1; fibroblast growth factor 1 [KO:K18496]", "2247  FGF2; fibroblast growth factor 2 [KO:K18497]", "2248  FGF3; fibroblast growth factor 3 [KO:K04358]", "2249  FGF4; fibroblast growth factor 4 [KO:K04358]", "8822  FGF17; fibroblast growth factor 17 [KO:K04358]", "2251  FGF6; fibroblast growth factor 6 [KO:K04358]", "2252  FGF7; fibroblast growth factor 7 [KO:K04358]", "2253  FGF8; fibroblast growth factor 8 [KO:K04358]", "2254  FGF9; fibroblast growth factor 9 [KO:K04358]", "2255  FGF10; fibroblast growth factor 10 [KO:K04358]", "8823  FGF16; fibroblast growth factor 16 [KO:K04358]", "2250  FGF5; fibroblast growth factor 5 [KO:K04358]", "8817  FGF18; fibroblast growth factor 18 [KO:K04358]", "26281  FGF20; fibroblast growth factor 20 [KO:K04358]", "27006  FGF22; fibroblast growth factor 22 [KO:K04358]", "9965  FGF19; fibroblast growth factor 19 [KO:K22603]", "26291  FGF21; fibroblast growth factor 21 [KO:K22429]", "8074  FGF23; fibroblast growth factor 23 [KO:K22428]", "4803  NGF; nerve growth factor [KO:K02582]", "627  BDNF; brain derived neurotrophic factor [KO:K04355]", "4908  NTF3; neurotrophin 3 [KO:K04356]", "4909  NTF4; neurotrophin 4 [KO:K12457]", "3630  INS; insulin [KO:K04526]", "3479  IGF1; insulin like growth factor 1 [KO:K05459]", "3481  IGF2; insulin like growth factor 2 [KO:K13769]", "5154  PDGFA; platelet derived growth factor subunit A [KO:K04359]", "5155  PDGFB; platelet derived growth factor subunit B [KO:K17386]", "56034  PDGFC; platelet derived growth factor C [KO:K05450]", "80310  PDGFD; platelet derived growth factor D [KO:K05450]", "1435  CSF1; colony stimulating factor 1 [KO:K05453]", "4254  KITLG; KIT ligand [KO:K05461]", "2323  FLT3LG; fms related receptor tyrosine kinase 3 ligand [KO:K05454]", "7422  VEGFA; vascular endothelial growth factor A [KO:K05448]", "7423  VEGFB; vascular endothelial growth factor B [KO:K16858]", "5228  PGF; placental growth factor [KO:K16859]", "7424  VEGFC; vascular endothelial growth factor C [KO:K05449]", "2277  VEGFD; vascular endothelial growth factor D [KO:K05449]", "3082  HGF; hepatocyte growth factor [KO:K05460]", "284  ANGPT1; angiopoietin 1 [KO:K05465]", "285  ANGPT2; angiopoietin 2 [KO:K05466]", "51378  ANGPT4; angiopoietin 4 [KO:K05467]", "1942  EFNA1; ephrin A1 [KO:K05462]", "1943  EFNA2; ephrin A2 [KO:K05462]", "1944  EFNA3; ephrin A3 [KO:K05462]", "1945  EFNA4; ephrin A4 [KO:K05462]", "1946  EFNA5; ephrin A5 [KO:K05462]", "2668  GDNF; glial cell derived neurotrophic factor [KO:K05452]", "4902  NRTN; neurturin [KO:K25414]", "9048  ARTN; artemin [KO:K25415]", "5623  PSPN; persephin [KO:K25416]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "2064  ERBB2; erb-b2 receptor tyrosine kinase 2 [KO:K05083] [EC:2.7.10.1]", "2065  ERBB3; erb-b2 receptor tyrosine kinase 3 [KO:K05084] [EC:2.7.10.1]", "2066  ERBB4; erb-b2 receptor tyrosine kinase 4 [KO:K05085] [EC:2.7.10.1]", "2260  FGFR1; fibroblast growth factor receptor 1 [KO:K04362] [EC:2.7.10.1]", "2263  FGFR2; fibroblast growth factor receptor 2 [KO:K05093] [EC:2.7.10.1]", "2261  FGFR3; fibroblast growth factor receptor 3 [KO:K05094] [EC:2.7.10.1]", "2264  FGFR4; fibroblast growth factor receptor 4 [KO:K05095] [EC:2.7.10.1]", "4804  NGFR; nerve growth factor receptor [KO:K02583]", "4914  NTRK1; neurotrophic receptor tyrosine kinase 1 [KO:K03176] [EC:2.7.10.1]", "4915  NTRK2; neurotrophic receptor tyrosine kinase 2 [KO:K04360] [EC:2.7.10.1]", "3643  INSR; insulin receptor [KO:K04527] [EC:2.7.10.1]", "3480  IGF1R; insulin like growth factor 1 receptor [KO:K05087] [EC:2.7.10.1]", "5156  PDGFRA; platelet derived growth factor receptor alpha [KO:K04363] [EC:2.7.10.1]", "5159  PDGFRB; platelet derived growth factor receptor beta [KO:K05089] [EC:2.7.10.1]", "1436  CSF1R; colony stimulating factor 1 receptor [KO:K05090] [EC:2.7.10.1]", "3815  KIT; KIT proto-oncogene, receptor tyrosine kinase [KO:K05091] [EC:2.7.10.1]", "2322  FLT3; fms related receptor tyrosine kinase 3 [KO:K05092] [EC:2.7.10.1]", "2321  FLT1; fms related receptor tyrosine kinase 1 [KO:K05096] [EC:2.7.10.1]", "2324  FLT4; fms related receptor tyrosine kinase 4 [KO:K05097] [EC:2.7.10.1]", "3791  KDR; kinase insert domain receptor [KO:K05098] [EC:2.7.10.1]", "4233  MET; MET proto-oncogene, receptor tyrosine kinase [KO:K05099] [EC:2.7.10.1]", "7010  TEK; TEK receptor tyrosine kinase [KO:K05121] [EC:2.7.10.1]", "1969  EPHA2; EPH receptor A2 [KO:K05103] [EC:2.7.10.1]", "5979  RET; ret proto-oncogene [KO:K05126] [EC:2.7.10.1]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "6237  RRAS; RAS related [KO:K07829]", "22800  RRAS2; RAS related 2 [KO:K07830]", "22808  MRAS; muscle RAS oncogene homolog [KO:K07831]", "369  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "8649  LAMTOR3; late endosomal/lysosomal adaptor, MAPK and MTOR activator 3 [KO:K04370]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "8569  MKNK1; MAPK interacting serine/threonine kinase 1 [KO:K04372] [EC:2.7.11.1]", "2872  MKNK2; MAPK interacting serine/threonine kinase 2 [KO:K04372] [EC:2.7.11.1]", "6197  RPS6KA3; ribosomal protein S6 kinase A3 [KO:K04373] [EC:2.7.11.1]", "6195  RPS6KA1; ribosomal protein S6 kinase A1 [KO:K04373] [EC:2.7.11.1]", "6196  RPS6KA2; ribosomal protein S6 kinase A2 [KO:K04373] [EC:2.7.11.1]", "27330  RPS6KA6; ribosomal protein S6 kinase A6 [KO:K04373] [EC:2.7.11.1]", "468  ATF4; activating transcription factor 4 [KO:K04374]", "2002  ELK1; ETS transcription factor ELK1 [KO:K04375]", "2005  ELK4; ETS transcription factor ELK4 [KO:K04376]", "4609  MYC; MYC proto-oncogene, bHLH transcription factor [KO:K04377]", "6722  SRF; serum response factor [KO:K04378]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "4137  MAPT; microtubule associated protein tau [KO:K04380]", "3925  STMN1; stathmin 1 [KO:K04381]", "123745  PLA2G4E; phospholipase A2 group IVE [KO:K16342] [EC:3.1.1.4]", "5321  PLA2G4A; phospholipase A2 group IVA [KO:K16342] [EC:3.1.1.4]", "8681  JMJD7-PLA2G4B; JMJD7-PLA2G4B readthrough [KO:K16342] [EC:3.1.1.4]", "100137049  PLA2G4B; phospholipase A2 group IVB [KO:K16342] [EC:3.1.1.4]", "8605  PLA2G4C; phospholipase A2 group IVC [KO:K16342] [EC:3.1.1.4]", "283748  PLA2G4D; phospholipase A2 group IVD [KO:K16342] [EC:3.1.1.4]", "255189  PLA2G4F; phospholipase A2 group IVF [KO:K16342] [EC:3.1.1.4]", "7124  TNF; tumor necrosis factor [KO:K03156]", "3552  IL1A; interleukin 1 alpha [KO:K04383]", "3553  IL1B; interleukin 1 beta [KO:K04519]", "7040  TGFB1; transforming growth factor beta 1 [KO:K13375]", "7042  TGFB2; transforming growth factor beta 2 [KO:K13376]", "7043  TGFB3; transforming growth factor beta 3 [KO:K13377]", "7132  TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158]", "3554  IL1R1; interleukin 1 receptor type 1 [KO:K04386]", "3556  IL1RAP; interleukin 1 receptor accessory protein [KO:K04723]", "7046  TGFBR1; transforming growth factor beta receptor 1 [KO:K04674] [EC:2.7.11.30]", "7048  TGFBR2; transforming growth factor beta receptor 2 [KO:K04388] [EC:2.7.11.30]", "356  FASLG; Fas ligand [KO:K04389]", "355  FAS; Fas cell surface death receptor [KO:K04390]", "929  CD14; CD14 molecule [KO:K04391]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "5880  RAC2; Rac family small GTPase 2 [KO:K07860]", "5881  RAC3; Rac family small GTPase 3 [KO:K07861]", "998  CDC42; cell division cycle 42 [KO:K04393]", "8717  TRADD; TNFRSF1A associated via death domain [KO:K03171]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "7186  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]", "1616  DAXX; death domain associated protein [KO:K02308]", "4615  MYD88; MYD88 innate immune signal transduction adaptor [KO:K04729]", "3654  IRAK1; interleukin 1 receptor associated kinase 1 [KO:K04730] [EC:2.7.11.1]", "51135  IRAK4; interleukin 1 receptor associated kinase 4 [KO:K04733] [EC:2.7.11.1]", "7189  TRAF6; TNF receptor associated factor 6 [KO:K03175] [EC:2.3.2.27]", "1647  GADD45A; growth arrest and DNA damage inducible alpha [KO:K04402]", "4616  GADD45B; growth arrest and DNA damage inducible beta [KO:K04402]", "10912  GADD45G; growth arrest and DNA damage inducible gamma [KO:K04402]", "10454  TAB1; TGF-beta activated kinase 1 (MAP3K7) binding protein 1 [KO:K04403]", "23118  TAB2; TGF-beta activated kinase 1 (MAP3K7) binding protein 2 [KO:K04404]", "51295  ECSIT; ECSIT signaling integrator [KO:K04405]", "8491  MAP4K3; mitogen-activated protein kinase kinase kinase kinase 3 [KO:K04406] [EC:2.7.11.1]", "9448  MAP4K4; mitogen-activated protein kinase kinase kinase kinase 4 [KO:K04407] [EC:2.7.11.1]", "11184  MAP4K1; mitogen-activated protein kinase kinase kinase kinase 1 [KO:K04408] [EC:2.7.11.1]", "5058  PAK1; p21 (RAC1) activated kinase 1 [KO:K04409] [EC:2.7.11.1]", "5062  PAK2; p21 (RAC1) activated kinase 2 [KO:K04410] [EC:2.7.11.1]", "6789  STK4; serine/threonine kinase 4 [KO:K04411]", "6788  STK3; serine/threonine kinase 3 [KO:K04412]", "5871  MAP4K2; mitogen-activated protein kinase kinase kinase kinase 2 [KO:K04414] [EC:2.7.11.1]", "1326  MAP3K8; mitogen-activated protein kinase kinase kinase 8 [KO:K04415] [EC:2.7.11.25]", "4214  MAP3K1; mitogen-activated protein kinase kinase kinase 1 [KO:K04416] [EC:2.7.11.25]", "4296  MAP3K11; mitogen-activated protein kinase kinase kinase 11 [KO:K04419] [EC:2.7.11.25]", "10746  MAP3K2; mitogen-activated protein kinase kinase kinase 2 [KO:K04420] [EC:2.7.11.25]", "4215  MAP3K3; mitogen-activated protein kinase kinase kinase 3 [KO:K04421] [EC:2.7.11.25]", "4293  MAP3K9; mitogen-activated protein kinase kinase kinase 9 [KO:K04417] [EC:2.7.11.25]", "4294  MAP3K10; mitogen-activated protein kinase kinase kinase 10 [KO:K04418] [EC:2.7.11.25]", "84451  MAP3K21; mitogen-activated protein kinase kinase kinase 21 [KO:K17534] [EC:2.7.11.25]", "7786  MAP3K12; mitogen-activated protein kinase kinase kinase 12 [KO:K04423] [EC:2.7.11.25]", "9175  MAP3K13; mitogen-activated protein kinase kinase kinase 13 [KO:K04422] [EC:2.7.11.25]", "51776  MAP3K20; mitogen-activated protein kinase kinase kinase 20 [KO:K04424] [EC:2.7.11.25]", "9064  MAP3K6; mitogen-activated protein kinase kinase kinase 6 [KO:K04425] [EC:2.7.11.25]", "4217  MAP3K5; mitogen-activated protein kinase kinase kinase 5 [KO:K04426] [EC:2.7.11.25]", "6885  MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO:K04427] [EC:2.7.11.25]", "4216  MAP3K4; mitogen-activated protein kinase kinase kinase 4 [KO:K04428] [EC:2.7.11.25]", "9344  TAOK2; TAO kinase 2 [KO:K04429] [EC:2.7.11.1]", "51347  TAOK3; TAO kinase 3 [KO:K04429] [EC:2.7.11.1]", "57551  TAOK1; TAO kinase 1 [KO:K04429] [EC:2.7.11.1]", "6416  MAP2K4; mitogen-activated protein kinase kinase 4 [KO:K04430] [EC:2.7.12.2]", "5609  MAP2K7; mitogen-activated protein kinase kinase 7 [KO:K04431] [EC:2.7.12.2]", "5606  MAP2K3; mitogen-activated protein kinase kinase 3 [KO:K04432] [EC:2.7.12.2]", "5608  MAP2K6; mitogen-activated protein kinase kinase 6 [KO:K04433] [EC:2.7.12.2]", "9479  MAPK8IP1; mitogen-activated protein kinase 8 interacting protein 1 [KO:K04434]", "23542  MAPK8IP2; mitogen-activated protein kinase 8 interacting protein 2 [KO:K04435]", "23162  MAPK8IP3; mitogen-activated protein kinase 8 interacting protein 3 [KO:K04436]", "2316  FLNA; filamin A [KO:K04437]", "1398  CRK; CRK proto-oncogene, adaptor protein [KO:K04438]", "1399  CRKL; CRK like proto-oncogene, adaptor protein [KO:K04438]", "408  ARRB1; arrestin beta 1 [KO:K04439]", "409  ARRB2; arrestin beta 2 [KO:K04439]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "8550  MAPKAPK5; MAPK activated protein kinase 5 [KO:K04442] [EC:2.7.11.1]", "9261  MAPKAPK2; MAPK activated protein kinase 2 [KO:K04443] [EC:2.7.11.1]", "7867  MAPKAPK3; MAPK activated protein kinase 3 [KO:K04444] [EC:2.7.11.1]", "9252  RPS6KA5; ribosomal protein S6 kinase A5 [KO:K04445] [EC:2.7.11.1]", "8986  RPS6KA4; ribosomal protein S6 kinase A4 [KO:K16510] [EC:2.7.11.1]", "994  CDC25B; cell division cycle 25B [KO:K05866] [EC:3.1.3.48]", "4772  NFATC1; nuclear factor of activated T cells 1 [KO:K04446]", "4775  NFATC3; nuclear factor of activated T cells 3 [KO:K17333]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "3727  JUND; JunD proto-oncogene, AP-1 transcription factor subunit [KO:K04449]", "1386  ATF2; activating transcription factor 2 [KO:K04450]", "7157  TP53; tumor protein p53 [KO:K04451]", "1649  DDIT3; DNA damage inducible transcript 3 [KO:K04452]", "4149  MAX; MYC associated factor X [KO:K04453]", "4208  MEF2C; myocyte enhancer factor 2C [KO:K04454]", "3315  HSPB1; heat shock protein family B (small) member 1 [KO:K04455]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "5494  PPM1A; protein phosphatase, Mg2+/Mn2+ dependent 1A [KO:K04457] [EC:3.1.3.16]", "5801  PTPRR; protein tyrosine phosphatase receptor type R [KO:K04458] [EC:3.1.3.48]", "84867  PTPN5; protein tyrosine phosphatase non-receptor type 5 [KO:K18018] [EC:3.1.3.48]", "5778  PTPN7; protein tyrosine phosphatase non-receptor type 7 [KO:K18019] [EC:3.1.3.48]", "1843  DUSP1; dual specificity phosphatase 1 [KO:K21278] [EC:3.1.3.16 3.1.3.48]", "1846  DUSP4; dual specificity phosphatase 4 [KO:K04459] [EC:3.1.3.16 3.1.3.48]", "1844  DUSP2; dual specificity phosphatase 2 [KO:K04459] [EC:3.1.3.16 3.1.3.48]", "1849  DUSP7; dual specificity phosphatase 7 [KO:K04459] [EC:3.1.3.16 3.1.3.48]", "1850  DUSP8; dual specificity phosphatase 8 [KO:K04459] [EC:3.1.3.16 3.1.3.48]", "1847  DUSP5; dual specificity phosphatase 5 [KO:K04459] [EC:3.1.3.16 3.1.3.48]", "80824  DUSP16; dual specificity phosphatase 16 [KO:K04459] [EC:3.1.3.16 3.1.3.48]", "1848  DUSP6; dual specificity phosphatase 6 [KO:K21946] [EC:3.1.3.16 3.1.3.48]", "1852  DUSP9; dual specificity phosphatase 9 [KO:K18498] [EC:3.1.3.16 3.1.3.48]", "11221  DUSP10; dual specificity phosphatase 10 [KO:K20216] [EC:3.1.3.16 3.1.3.48]", "1845  DUSP3; dual specificity phosphatase 3 [KO:K17614] [EC:3.1.3.16 3.1.3.48]", "5536  PPP5C; protein phosphatase 5 catalytic subunit [KO:K04460] [EC:3.1.3.16]", "5495  PPM1B; protein phosphatase, Mg2+/Mn2+ dependent 1B [KO:K04461] [EC:3.1.3.16]", "3312  HSPA8; heat shock protein family A (Hsp70) member 8 [KO:K03283]", "3303  HSPA1A; heat shock protein family A (Hsp70) member 1A [KO:K03283]", "3305  HSPA1L; heat shock protein family A (Hsp70) member 1 like [KO:K03283]", "3304  HSPA1B; heat shock protein family A (Hsp70) member 1B [KO:K03283]", "3310  HSPA6; heat shock protein family A (Hsp70) member 6 [KO:K03283]", "2122  MECOM; MDS1 and EVI1 complex locus [KO:K04462] [EC:2.1.1.367]", "5607  MAP2K5; mitogen-activated protein kinase kinase 5 [KO:K04463] [EC:2.7.12.2]", "5598  MAPK7; mitogen-activated protein kinase 7 [KO:K04464] [EC:2.7.11.24]", "3164  NR4A1; nuclear receptor subfamily 4 group A member 1 [KO:K04465]", "9020  MAP3K14; mitogen-activated protein kinase kinase kinase 14 [KO:K04466] [EC:2.7.11.25]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "51701  NLK; nemo like kinase [KO:K04468] [EC:2.7.11.24]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "4791  NFKB2; nuclear factor kappa B subunit 2 [KO:K04469]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "5971  RELB; RELB proto-oncogene, NF-kB subunit [KO:K09253]"], "compound": ["C00076  Calcium cation", "C00165  Diacylglycerol", "C00338  Lipopolysaccharide", "C00575  3',5'-Cyclic AMP", "C01245  D-myo-Inositol 1,4,5-trisphosphate"], "refs": [{"pmid": "11749383", "authors": "  Chen Z, Gibson TB, Robinson F, Silvestro L, Pearson G, Xu B, Wright A, Vanderbilt C, Cobb MH.", "title": "MAP kinases.", "journal": "Chem Rev 101:2449-76 (2001)", "doi": "10.1021/cr000241p"}, {"pmid": "12191611", "authors": "  Tanoue T, Nishida E.", "title": "Docking interactions in the mitogen-activated protein kinase cascades.", "journal": "Pharmacol Ther 93:193-202 (2002)", "doi": "10.1016/S0163-7258(02)00188-2"}, {"pmid": "12947395", "authors": "  Dent P, Yacoub A, Fisher PB, Hagan MP, Grant S.", "title": "MAPK pathways in radiation responses.", "journal": "Oncogene 22:5885-96 (2003)", "doi": "10.1038/sj.onc.1206701"}, {"pmid": "12676795", "authors": "  Huang EJ, Reichardt LF.", "title": "Trk receptors: roles in neuronal signal transduction.", "journal": "Annu Rev Biochem 72:609-42 (2003)", "doi": "10.1146/annurev.biochem.72.121801.161629"}, {"pmid": "11369511", "authors": "  Harper SJ, LoGrasso P.", "title": "Signalling for survival and death in neurones: the role of stress-activated kinases, JNK and p38.", "journal": "Cell Signal 13:299-310 (2001)", "doi": "10.1016/S0898-6568(01)00148-6"}, {"pmid": "12390245", "authors": "  Takeda K, Ichijo H", "title": "Neuronal p38 MAPK signalling: an emerging regulator of cell fate and function in the nervous system.", "journal": "Genes Cells 7:1099-111 (2002)", "doi": "10.1046/j.1365-2443.2002.00591.x"}, {"pmid": "14597384", "authors": "  Yang SH, Sharrocks AD, Whitmarsh AJ.", "title": "Transcriptional regulation by the MAP kinase signaling cascades.", "journal": "Gene 320:3-21 (2003)", "doi": "10.1016/S0378-1119(03)00816-3"}, {"pmid": "12566928", "authors": "  Zhu X, Lee HG, Raina AK, Perry G, Smith MA.", "title": "The role of mitogen-activated protein kinase pathways in Alzheimer's disease.", "journal": "Neurosignals 11:270-81 (2002)", "doi": "10.1159/000067426"}, {"pmid": "12849693", "authors": "  Cho H, Lee J, Kwak NJ, Lee KH, Rha S, Kim YH, Cho YY, Yang KH, Kim K, Lim Y.", "title": "Silica induces nuclear factor-kappaB activation through TAK1 and NIK in Rat2 cell line.", "journal": "Toxicol Lett 143:323-30 (2003)", "doi": "10.1016/S0378-4274(03)00193-0"}, {"pmid": "20602996", "authors": "  Lemmon MA, Schlessinger J", "title": "Cell signaling by receptor tyrosine kinases.", "journal": "Cell 141:1117-34 (2010)", "doi": "10.1016/j.cell.2010.06.011"}, {"pmid": "22367796", "authors": "  Skaper SD", "title": "The neurotrophin family of neurotrophic factors: an overview.", "journal": "Methods Mol Biol 846:1-12 (2012)", "doi": "10.1007/978-1-61779-536-7_1"}, {"pmid": "23085193", "authors": "  Chu WM", "title": "Tumor necrosis factor.", "journal": "Cancer Lett 328:222-5 (2013)", "doi": "10.1016/j.canlet.2012.10.014"}, {"pmid": "22296764", "authors": "  Newton K, Dixit VM", "title": "Signaling in innate immunity and inflammation.", "journal": "Cold Spring Harb Perspect Biol 4:a006049 (2012)", "doi": "10.1101/cshperspect.a006049"}, {"pmid": "19483709", "authors": "  Gaestel M, Kotlyarov A, Kracht M", "title": "Targeting innate immunity protein kinase signalling in inflammation.", "journal": "Nat Rev Drug Discov 8:480-99 (2009)", "doi": "10.1038/nrd2829"}, {"pmid": "23664135", "authors": "  Ajibade AA, Wang HY, Wang RF", "title": "Cell type-specific function of TAK1 in innate immune signaling.", "journal": "Trends Immunol 34:307-16 (2013)", "doi": "10.1016/j.it.2013.03.007"}], "rel_pathway": ["hsa04070  Phosphatidylinositol signaling system", "hsa04110  Cell cycle", "hsa04115  p53 signaling pathway", "hsa04210  Apoptosis", "hsa04310  Wnt signaling pathway", "hsa04668  TNF signaling pathway"], "ko_pathway": "ko04010", "genes": ["EGFR", "RAC1", "TP53", "BRAF", "CSF1", "AKT2", "MET", "AKT1", "PGF", "SOS1", "MAPK13", "KDR", "NRAS"]}, {"kegg_id": "hsa04012", "name": "ErbB signaling pathway - Homo sapiens (human)", "description": "The ErbB family of receptor tyrosine kinases (RTKs) couples binding of extracellular growth factor ligands to intracellular signaling pathways regulating diverse biologic responses, including proliferation, differentiation, cell motility, and survival. Ligand binding to the four closely related members of this RTK family -epidermal growth factor receptor (EGFR, also known as ErbB-1 or HER1), ErbB-2 (HER2), ErbB-3 (HER3), and ErbB-4 (HER4)-induces the formation of receptor homo- and heterodimers and the activation of the intrinsic kinase domain, resulting in phosphorylation on specific tyrosine residues (pY) within the cytoplasmic tail. Signaling effectors containing binding pockets for pY-containing peptides are recruited to activated receptors and induce the various signaling pathways. The Shc- and/or Grb2-activated mitogen-activated protein kinase (MAPK) pathway is a common target downstream of all ErbB receptors. Similarly, the phosphatidylinositol-3-kinase (PI-3K) pathway is directly or indirectly activated by most ErbBs. Several cytoplasmic docking proteins appear to be recruited by specific ErbB receptors and less exploited by others. These include the adaptors Crk, Nck, the phospholipase C gamma (PLCgamma), the intracellular tyrosine kinase Src, or the Cbl E3 ubiquitin protein ligase.", "class": "Environmental Information Processing; Signal transduction", "pathway_map": "hsa04012  ErbB signaling pathway", "network": ["", "ELEMENT   N00021  EGF-ERBB2-RAS-ERK signaling pathway", "N00231  TGFA-EGFR-PI3K signaling pathway", "N01163  NRG-ERBB4-PI3K signaling pathway"], "drug": ["D01977  Gefitinib (JP18/USAN/INN)", "D02714  Everolimus (JAN/USAN/INN)", "D03252  Bosutinib (USAN)", "D03257  Trastuzumab (USAN/INN)", "D03350  Canertinib dihydrochloride (USAN)", "D03455  Cetuximab (USAN/INN)", "D03658  Dasatinib (JAN/INN)", "D04023  Erlotinib hydrochloride (JAN/USAN)", "D04024  Lapatinib ditosylate (USAN)", "D04025  Mubritinib (USAN/INN)", "D04862  Masoprocol (USAN/INN)", "D05350  Panitumumab (USAN/INN)", "D05399  Pelitinib (USAN/INN)", "D05446  Pertuzumab (USAN/INN)", "D06068  Temsirolimus (JAN/USAN/INN)", "D06272  Sorafenib tosylate (USAN)", "D06407  Vandetanib (JAN/USAN/INN)", "D06413  Nilotinib hydrochloride hydrate (JAN)", "D06414  Dasatinib (USAN)", "D06610  Lapuleucel-T (USAN)", "D07907  Erlotinib (INN)", "D08108  Lapatinib (INN)", "D08279  Tozasertib (USAN)", "D08344  Tozasertib lactate (USAN)", "D08524  Sorafenib (USAN/INN)", "D08950  Neratinib (USAN/INN)", "D08953  Nilotinib (USAN/INN)", "D09660  Rindopepimut (USAN)", "D09664  Saracatinib (USAN/INN)", "D09665  Saracatinib difumarate (USAN)", "D09666  Selumetinib (USAN/INN)", "D09689  Varlitinib (USAN/INN)", "D09690  Varlitinib tosylate (USAN)", "D09724  Afatinib (USAN/INN)", "D09728  Bosutinib hydrate (JAN)", "D09733  Afatinib dimaleate (USAN)", "D09883  Dacomitinib (INN)", "D09980  Trastuzumab emtansine (USAN/INN)", "D09996  Vemurafenib (JAN/USAN/INN)", "D10018  Necitumumab (USAN/INN)", "D10031  Zalutumumab (USAN/INN)", "D10064  Dabrafenib (USAN)", "D10104  Dabrafenib mesylate (USAN)", "D10175  Trametinib (USAN)", "D10176  Trametinib dimethyl sulfoxide (JAN/USAN)", "D10426  Pimasertib (USAN/INN)", "D10446  Margetuximab (USAN/INN)", "D10486  Pimasertib hydrochloride (USAN)", "D10514  Dacomitinib (USAN)", "D10766  Osimertinib mesylate (USAN)", "D10858  Rociletinib (USAN/INN)", "D10859  Olmutinib (USAN/INN)", "D10898  Neratinib maleate", "D10943  Istiratumab (USAN/INN)", "D10958  Naquotinib (USAN/INN)", "D11053  Encorafenib (JAN/USAN/INN)", "D11115  Olmutinib hydrochloride (USAN)", "D11141  Tucatinib (USAN/INN)", "D11239  Lumretuzumab (USAN/INN)", "D11410  Lifirafenib (USAN/INN)", "D11411  Lifirafenib maleate (USAN)", "D11430  Nazartinib (USAN/INN)", "D11434  Nazartinib mesylate (USAN)", "D11529  Trastuzumab deruxtecan (USAN/INN)", "D11750  Duligotuzumab (USAN)", "D11777  Seribantumab (USAN/INN)", "D11803  Cetuximab sarotalocan (USAN/INN)", "D11805  Cetuximab sarotalocan sodium (genetical recombination) (JAN)", "D11869  Paxalisib (USAN/INN)", "D11872  Serclutamab (USAN/INN)", "D11874  Serclutamab talirine (USAN/INN)", "D11969  Mobocertinib succinate (JAN)", "D11980  Lazertinib (USAN)", "D11991  Zenocutuzumab (USAN/INN)", "D12001  Mobocertinib (USAN/INN)", "D12011  Zanidatamab (USAN/INN)", "D12184  Patritumab deruxtecan (USAN/INN)", "D12185  Patritumab (USAN/INN)", "D12229  Poziotinib (USAN/INN)", "D12230  Poziotinib hydrochloride (USAN)", "D12236  Runimotamab (USAN/INN)", "D12245  Lazertinib mesilate hydrate (JAN)", "D12258  Aumolertinib (USAN/INN)", "D12259  Aumolertinib mesylate (USAN)", "D12343  Fepixnebart (TN)", "D12416  Petosemtamab (USAN/INN)", "D12444  Nilotinib hydrochloride dihydrate (JAN)", "D12457  Tuxobertinib (USAN/INN)", "D12506  Sunvozertinib (USAN/INN)", "D12730  Tigozertinib (USAN)", "D12859  Pebezertinib (USAN)", "D12879  Zongertinib (USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["1950  EGF; epidermal growth factor [KO:K04357]", "7039  TGFA; transforming growth factor alpha [KO:K08774]", "374  AREG; amphiregulin [KO:K09782]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "2064  ERBB2; erb-b2 receptor tyrosine kinase 2 [KO:K05083] [EC:2.7.10.1]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]", "815  CAMK2A; calcium/calmodulin dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]", "817  CAMK2D; calcium/calmodulin dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]", "816  CAMK2B; calcium/calmodulin dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]", "818  CAMK2G; calcium/calmodulin dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "867  CBL; Cbl proto-oncogene [KO:K04707] [EC:2.3.2.27]", "868  CBLB; Cbl proto-oncogene B [KO:K22517] [EC:2.3.2.27]", "6776  STAT5A; signal transducer and activator of transcription 5A [KO:K11223]", "6777  STAT5B; signal transducer and activator of transcription 5B [KO:K11224]", "6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "5747  PTK2; protein tyrosine kinase 2 [KO:K05725] [EC:2.7.10.2]", "1398  CRK; CRK proto-oncogene, adaptor protein [KO:K04438]", "1399  CRKL; CRK like proto-oncogene, adaptor protein [KO:K04438]", "25  ABL1; ABL proto-oncogene 1, non-receptor tyrosine kinase [KO:K06619] [EC:2.7.10.2]", "27  ABL2; ABL proto-oncogene 2, non-receptor tyrosine kinase [KO:K08887] [EC:2.7.10.2]", "4690  NCK1; NCK adaptor protein 1 [KO:K07365]", "8440  NCK2; NCK adaptor protein 2 [KO:K19862]", "5058  PAK1; p21 (RAC1) activated kinase 1 [KO:K04409] [EC:2.7.11.1]", "5062  PAK2; p21 (RAC1) activated kinase 2 [KO:K04410] [EC:2.7.11.1]", "5063  PAK3; p21 (RAC1) activated kinase 3 [KO:K05733] [EC:2.7.11.1]", "10298  PAK4; p21 (RAC1) activated kinase 4 [KO:K05734] [EC:2.7.11.1]", "57144  PAK5; p21 (RAC1) activated kinase 5 [KO:K05736] [EC:2.7.11.1]", "56924  PAK6; p21 (RAC1) activated kinase 6 [KO:K05735] [EC:2.7.11.1]", "106821730  BUB1B-PAK6; BUB1B-PAK6 readthrough [KO:K05735] [EC:2.7.11.1]", "6416  MAP2K4; mitogen-activated protein kinase kinase 4 [KO:K04430] [EC:2.7.12.2]", "5609  MAP2K7; mitogen-activated protein kinase kinase 7 [KO:K04431] [EC:2.7.12.2]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "2002  ELK1; ETS transcription factor ELK1 [KO:K04375]", "685  BTC; betacellulin [KO:K09783]", "1839  HBEGF; heparin binding EGF like growth factor [KO:K08523]", "2069  EREG; epiregulin [KO:K09784]", "2065  ERBB3; erb-b2 receptor tyrosine kinase 3 [KO:K05084] [EC:2.7.10.1]", "3084  NRG1; neuregulin 1 [KO:K05455]", "9542  NRG2; neuregulin 2 [KO:K05456]", "2066  ERBB4; erb-b2 receptor tyrosine kinase 4 [KO:K05085] [EC:2.7.10.1]", "6464  SHC1; SHC adaptor protein 1 [KO:K06279]", "25759  SHC2; SHC adaptor protein 2 [KO:K17447]", "53358  SHC3; SHC adaptor protein 3 [KO:K17448]", "399694  SHC4; SHC adaptor protein 4 [KO:K17449]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "369  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "4609  MYC; MYC proto-oncogene, bHLH transcription factor [KO:K04377]", "2549  GAB1; GRB2 associated binding protein 1 [KO:K09593]", "10718  NRG3; neuregulin 3 [KO:K05457]", "145957  NRG4; neuregulin 4 [KO:K05458]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "6198  RPS6KB1; ribosomal protein S6 kinase B1 [KO:K04688] [EC:2.7.11.1]", "6199  RPS6KB2; ribosomal protein S6 kinase B2 [KO:K04688] [EC:2.7.11.1]", "1978  EIF4EBP1; eukaryotic translation initiation factor 4E binding protein 1 [KO:K07205]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "1027  CDKN1B; cyclin dependent kinase inhibitor 1B [KO:K06624]", "1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]"], "compound": ["C00076  Calcium cation", "C00165  Diacylglycerol", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C05981  Phosphatidylinositol-3,4,5-trisphosphate"], "refs": [{"pmid": "14967450", "authors": "  Marmor MD, Skaria KB, Yarden Y.", "title": "Signal transduction and oncogenesis by ErbB/HER receptors.", "journal": "Int J Radiat Oncol Biol Phys 58:903-13 (2004)", "doi": "10.1016/j.ijrobp.2003.06.002"}, {"pmid": "11252954", "authors": "  Yarden Y, Sliwkowski MX.", "title": "Untangling the ErbB signalling network.", "journal": "Nat Rev Mol Cell Biol 2:127-37 (2001)", "doi": "10.1038/35052073"}, {"pmid": "16829981", "authors": "  Citri A, Yarden Y.", "title": "EGF-ERBB signalling: towards the systems level.", "journal": "Nat Rev Mol Cell Biol 7:505-16 (2006)", "doi": "10.1038/nrm1962"}, {"pmid": "17000658", "authors": "  Scaltriti M, Baselga J.", "title": "The epidermal growth factor receptor pathway: a model for targeted therapy.", "journal": "Clin Cancer Res 12:5268-72 (2006)", "doi": "10.1158/1078-0432.CCR-05-1554"}, {"pmid": "16377102", "authors": "  Normanno N, De Luca A, Bianco C, Strizzi L, Mancino M, Maiello MR, Carotenuto A, De Feo G, Caponigro F, Salomon DS.", "title": "Epidermal growth factor receptor (EGFR) signaling in cancer.", "journal": "Gene 366:2-16 (2006)", "doi": "10.1016/j.gene.2005.10.018"}, {"pmid": "14744244", "authors": "  Holbro T, Hynes NE.", "title": "ErbB receptors: directing key signaling networks throughout life.", "journal": "Annu Rev Pharmacol Toxicol 44:195-217 (2004)", "doi": "10.1146/annurev.pharmtox.44.101802.121440"}, {"pmid": "12851486", "authors": "  Liang J, Slingerland JM.", "title": "Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression.", "journal": "Cell Cycle 2:339-45 (2003)", "doi": "10.4161/cc.2.4.433"}, {"pmid": "15864276", "authors": "  Hynes NE, Lane HA.", "title": "ERBB receptors and cancer: the complexity of targeted inhibitors.", "journal": "Nat Rev Cancer 5:341-54 (2005)", "doi": "10.1038/nrc1609"}, {"pmid": "16729045", "authors": "  Oda K, Matsuoka Y, Funahashi A, Kitano H.", "title": "A comprehensive pathway map of epidermal growth factor receptor signaling.", "journal": "Mol Syst Biol 1:2005.0010 (2005)", "doi": "10.1038/msb4100014"}, {"pmid": "16729043", "authors": "  Schulze WX, Deng L, Mann M.", "title": "Phosphotyrosine interactome of the ErbB-receptor kinase family.", "journal": "Mol Syst Biol 1:2005.0008 (2005)", "doi": "10.1038/msb4100012"}, {"pmid": "10880430", "authors": "  Olayioye MA, Neve RM, Lane HA, Hynes NE.", "title": "The ErbB signaling network: receptor heterodimerization in development and cancer.", "journal": "EMBO J 19:3159-67 (2000)", "doi": "10.1093/emboj/19.13.3159"}, {"pmid": "9872057", "authors": "  McCarty JH.", "title": "The Nck SH2/SH3 adaptor protein: a regulator of multiple intracellular signal transduction events.", "journal": "Bioessays 20:913-21 (1998)", "doi": "10.1002/(SICI)1521-1878(199811)20:11<913::AID-BIES6>3.0.CO;2-T"}, {"pmid": "15863494", "authors": "  Clark DE, Williams CC, Duplessis TT, Moring KL, Notwick AR, Long W, Lane WS, Beuvink I, Hynes NE, Jones FE.", "title": "ERBB4/HER4 potentiates STAT5A transcriptional activity by regulating novel STAT5A serine phosphorylation events.", "journal": "J Biol Chem 280:24175-80 (2005)", "doi": "10.1074/jbc.M414044200"}, {"pmid": "10490623", "authors": "  Muthuswamy SK, Gilman M, Brugge JS.", "title": "Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers.", "journal": "Mol Cell Biol 19:6845-57 (1999)", "doi": "10.1128/MCB.19.10.6845"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04110  Cell cycle", "hsa04150  mTOR signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa05212  Pancreatic cancer", "hsa05213  Endometrial cancer", "hsa05214  Glioma", "hsa05223  Non-small cell lung cancer"], "ko_pathway": "ko04012", "genes": ["EGFR", "BRAF", "AKT2", "AKT1", "SOS1", "NRAS"]}, {"kegg_id": "hsa04014", "name": "Ras signaling pathway - Homo sapiens (human)", "description": "The Ras proteins are GTPases that function as molecular switches for signaling pathways regulating cell proliferation, survival, growth, migration, differentiation or cytoskeletal dynamism. Ras proteins transduce signals from extracellular growth factors by cycling between inactive GDP-bound and active GTP-bound states. The exchange of GTP for GDP on RAS is regulated by guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs). Activated RAS (RAS-GTP) regulates multiple cellular functions through effectors including Raf, phosphatidylinositol 3-kinase (PI3K) and Ral guanine nucleotide-dissociation stimulator (RALGDS).", "class": "Environmental Information Processing; Signal transduction", "pathway_map": "hsa04014  Ras signaling pathway", "network": ["", "ELEMENT   N00096  EGF-EGFR-RAS-RASSF1 signaling pathway", "N00103  EGF-EGFR-RAS-RalGDS signaling pathway", "N01595  Regulation of GF-RTK-RAS-ERK signaling pathway, adaptor proteins", "N01598  Regulation of GF-RTK-RAS-ERK signaling, MRAS-SHOC2-PP1 holophosphatase"], "drug": ["D00967  Toremifene citrate (JAN/USAN)", "D02970  Aprinocarsen sodium (USAN)", "D04014  Enzastaurin hydrochloride (JAN/USAN)", "D06402  Sunitinib malate (JAN/USAN)", "D08279  Tozasertib (USAN)", "D08344  Tozasertib lactate (USAN)", "D08552  Sunitinib (INN)", "D08620  Toremifene (INN)", "D09371  Ramucirumab (USAN)", "D10024  Selumetinib sulfate (JAN/USAN)", "D10062  Cabozantinib (USAN)", "D10095  Cabozantinib s-malate (USAN)", "D10173  Tivantinib (JAN/USAN/INN)", "D10190  Tivozanib hydrochloride (USAN)", "D10224  Golvatinib (USAN)", "D10465  Golvatinib tartrate (USAN)", "D10696  Capmatinib (USAN/INN)", "D10800  Gilteritinib fumarate (JAN/USAN)", "D10891  Capmatinib hydrochloride (USAN)", "D11038  Ulixertinib (INN)", "D11073  Tepotinib hydrochloride (USAN)", "D11125  Modotuximab (USAN/INN)", "D11126  Navicixizumab (USAN/INN)", "D11279  Avapritinib (USAN/INN)", "D11285  Ravoxertinib (USAN/INN)", "D11642  Dilpacimab (USAN/INN)", "D11717  Tepotinib (USAN/INN)", "D11786  Vodobatinib (USAN)", "D11885  Surufatinib (USAN/INN)", "D11894  Amivantamab (USAN/INN)", "D11935  Enzastaurin (USAN/INN)", "D12055  Sotorasib (JAN/USAN)", "D12059  Temuterkib (USAN)", "D12060  Temuterkib mesylate (USAN)", "D12175  Olverembatinib (USAN/INN)", "D12301  Adagrasib (USAN/INN)", "D12392  Fosgonimeton (USAN/INN)", "D12393  Fosgonimeton sodium (USAN)", "D12404  Tasurgratinib (INN)", "D12405  Tasurgratinib succinate (JAN)", "D12416  Petosemtamab (USAN/INN)", "D12424  Davutamig (USAN)", "D12444  Nilotinib hydrochloride dihydrate (JAN)", "D12450  Elenestinib (USAN)", "D12476  Tuspetinib (USAN/INN)", "D12515  Avutometinib (USAN/INN)", "D12534  Avutometinib potassium (USAN)", "D12557  Elzovantinib (USAN/INN)", "D12600  Bezuclastinib (USAN/INN)", "D12635  Sozinibercept (USAN/INN)", "D12639  Divarasib (USAN/INN)", "D12640  Divarasib adipate (USAN)", "D12650  Zanzalintinib (USAN/INN)", "D12651  Zanzalintinib fumarate (USAN)", "D12705  Gumarontinib hydrate (JAN)", "D12799  Vociprotafib (USAN/INN)", "D12808  Ivonescimab (USAN/INN)", "D12809  Bafisontamab (USAN/INN)", "D12853  Olomorasib (USAN)", "D12854  Nilotinib laurylsulfate (USAN)", "D12865  Beroterkib (USAN)", "D12892  Migoprotafib (USAN/INN)"], "dblinks": "GO: 0032318", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["1950  EGF; epidermal growth factor [KO:K04357]", "7039  TGFA; transforming growth factor alpha [KO:K08774]", "2246  FGF1; fibroblast growth factor 1 [KO:K18496]", "2247  FGF2; fibroblast growth factor 2 [KO:K18497]", "2248  FGF3; fibroblast growth factor 3 [KO:K04358]", "2249  FGF4; fibroblast growth factor 4 [KO:K04358]", "8822  FGF17; fibroblast growth factor 17 [KO:K04358]", "2251  FGF6; fibroblast growth factor 6 [KO:K04358]", "2252  FGF7; fibroblast growth factor 7 [KO:K04358]", "2253  FGF8; fibroblast growth factor 8 [KO:K04358]", "2254  FGF9; fibroblast growth factor 9 [KO:K04358]", "2255  FGF10; fibroblast growth factor 10 [KO:K04358]", "8823  FGF16; fibroblast growth factor 16 [KO:K04358]", "2250  FGF5; fibroblast growth factor 5 [KO:K04358]", "8817  FGF18; fibroblast growth factor 18 [KO:K04358]", "26281  FGF20; fibroblast growth factor 20 [KO:K04358]", "27006  FGF22; fibroblast growth factor 22 [KO:K04358]", "9965  FGF19; fibroblast growth factor 19 [KO:K22603]", "26291  FGF21; fibroblast growth factor 21 [KO:K22429]", "8074  FGF23; fibroblast growth factor 23 [KO:K22428]", "4803  NGF; nerve growth factor [KO:K02582]", "627  BDNF; brain derived neurotrophic factor [KO:K04355]", "4908  NTF3; neurotrophin 3 [KO:K04356]", "4909  NTF4; neurotrophin 4 [KO:K12457]", "3630  INS; insulin [KO:K04526]", "3479  IGF1; insulin like growth factor 1 [KO:K05459]", "3481  IGF2; insulin like growth factor 2 [KO:K13769]", "5154  PDGFA; platelet derived growth factor subunit A [KO:K04359]", "5155  PDGFB; platelet derived growth factor subunit B [KO:K17386]", "56034  PDGFC; platelet derived growth factor C [KO:K05450]", "80310  PDGFD; platelet derived growth factor D [KO:K05450]", "1435  CSF1; colony stimulating factor 1 [KO:K05453]", "4254  KITLG; KIT ligand [KO:K05461]", "2323  FLT3LG; fms related receptor tyrosine kinase 3 ligand [KO:K05454]", "7422  VEGFA; vascular endothelial growth factor A [KO:K05448]", "7423  VEGFB; vascular endothelial growth factor B [KO:K16858]", "5228  PGF; placental growth factor [KO:K16859]", "7424  VEGFC; vascular endothelial growth factor C [KO:K05449]", "2277  VEGFD; vascular endothelial growth factor D [KO:K05449]", "3082  HGF; hepatocyte growth factor [KO:K05460]", "284  ANGPT1; angiopoietin 1 [KO:K05465]", "285  ANGPT2; angiopoietin 2 [KO:K05466]", "51378  ANGPT4; angiopoietin 4 [KO:K05467]", "1942  EFNA1; ephrin A1 [KO:K05462]", "1943  EFNA2; ephrin A2 [KO:K05462]", "1944  EFNA3; ephrin A3 [KO:K05462]", "1945  EFNA4; ephrin A4 [KO:K05462]", "1946  EFNA5; ephrin A5 [KO:K05462]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "2260  FGFR1; fibroblast growth factor receptor 1 [KO:K04362] [EC:2.7.10.1]", "2263  FGFR2; fibroblast growth factor receptor 2 [KO:K05093] [EC:2.7.10.1]", "2261  FGFR3; fibroblast growth factor receptor 3 [KO:K05094] [EC:2.7.10.1]", "2264  FGFR4; fibroblast growth factor receptor 4 [KO:K05095] [EC:2.7.10.1]", "4804  NGFR; nerve growth factor receptor [KO:K02583]", "4914  NTRK1; neurotrophic receptor tyrosine kinase 1 [KO:K03176] [EC:2.7.10.1]", "4915  NTRK2; neurotrophic receptor tyrosine kinase 2 [KO:K04360] [EC:2.7.10.1]", "3643  INSR; insulin receptor [KO:K04527] [EC:2.7.10.1]", "3480  IGF1R; insulin like growth factor 1 receptor [KO:K05087] [EC:2.7.10.1]", "5156  PDGFRA; platelet derived growth factor receptor alpha [KO:K04363] [EC:2.7.10.1]", "5159  PDGFRB; platelet derived growth factor receptor beta [KO:K05089] [EC:2.7.10.1]", "1436  CSF1R; colony stimulating factor 1 receptor [KO:K05090] [EC:2.7.10.1]", "3815  KIT; KIT proto-oncogene, receptor tyrosine kinase [KO:K05091] [EC:2.7.10.1]", "2322  FLT3; fms related receptor tyrosine kinase 3 [KO:K05092] [EC:2.7.10.1]", "2321  FLT1; fms related receptor tyrosine kinase 1 [KO:K05096] [EC:2.7.10.1]", "2324  FLT4; fms related receptor tyrosine kinase 4 [KO:K05097] [EC:2.7.10.1]", "3791  KDR; kinase insert domain receptor [KO:K05098] [EC:2.7.10.1]", "4233  MET; MET proto-oncogene, receptor tyrosine kinase [KO:K05099] [EC:2.7.10.1]", "7010  TEK; TEK receptor tyrosine kinase [KO:K05121] [EC:2.7.10.1]", "1969  EPHA2; EPH receptor A2 [KO:K05103] [EC:2.7.10.1]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "2549  GAB1; GRB2 associated binding protein 1 [KO:K09593]", "9846  GAB2; GRB2 associated binding protein 2 [KO:K08091]", "6464  SHC1; SHC adaptor protein 1 [KO:K06279]", "25759  SHC2; SHC adaptor protein 2 [KO:K17447]", "53358  SHC3; SHC adaptor protein 3 [KO:K17448]", "399694  SHC4; SHC adaptor protein 4 [KO:K17449]", "5781  PTPN11; protein tyrosine phosphatase non-receptor type 11 [KO:K07293] [EC:3.1.3.48]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]", "10125  RASGRP1; RAS guanyl releasing protein 1 [KO:K04350]", "10235  RASGRP2; RAS guanyl releasing protein 2 [KO:K12361]", "25780  RASGRP3; RAS guanyl releasing protein 3 [KO:K12362]", "115727  RASGRP4; RAS guanyl releasing protein 4 [KO:K12363]", "7535  ZAP70; zeta chain of T cell receptor associated protein kinase 70 [KO:K07360] [EC:2.7.10.2]", "27040  LAT; linker for activation of T cells [KO:K07362]", "3363  HTR7; 5-hydroxytryptamine receptor 7 [KO:K04163]", "2782  GNB1; G protein subunit beta 1 [KO:K04536]", "2783  GNB2; G protein subunit beta 2 [KO:K04537]", "2784  GNB3; G protein subunit beta 3 [KO:K07825]", "59345  GNB4; G protein subunit beta 4 [KO:K04538]", "10681  GNB5; G protein subunit beta 5 [KO:K04539]", "54331  GNG2; G protein subunit gamma 2 [KO:K07826]", "2785  GNG3; G protein subunit gamma 3 [KO:K04540]", "2786  GNG4; G protein subunit gamma 4 [KO:K04541]", "2787  GNG5; G protein subunit gamma 5 [KO:K04542]", "2788  GNG7; G protein subunit gamma 7 [KO:K04543]", "94235  GNG8; G protein subunit gamma 8 [KO:K04544]", "2790  GNG10; G protein subunit gamma 10 [KO:K04545]", "2791  GNG11; G protein subunit gamma 11 [KO:K04546]", "55970  GNG12; G protein subunit gamma 12 [KO:K04347]", "51764  GNG13; G protein subunit gamma 13 [KO:K04547]", "2792  GNGT1; G protein subunit gamma transducin 1 [KO:K04548]", "2793  GNGT2; G protein subunit gamma transducin 2 [KO:K04549]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "5923  RASGRF1; Ras protein specific guanine nucleotide releasing factor 1 [KO:K04349]", "5924  RASGRF2; Ras protein specific guanine nucleotide releasing factor 2 [KO:K12326]", "2902  GRIN1; glutamate ionotropic receptor NMDA type subunit 1 [KO:K05208]", "2903  GRIN2A; glutamate ionotropic receptor NMDA type subunit 2A [KO:K05209]", "2904  GRIN2B; glutamate ionotropic receptor NMDA type subunit 2B [KO:K05210]", "810  CALML3; calmodulin like 3 [KO:K02183]", "805  CALM2; calmodulin 2 [KO:K02183]", "808  CALM3; calmodulin 3 [KO:K02183]", "801  CALM1; calmodulin 1 [KO:K02183]", "163688  CALML6; calmodulin like 6 [KO:K02183]", "51806  CALML5; calmodulin like 5 [KO:K02183]", "91860  CALML4; calmodulin like 4 [KO:K02183]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "22808  MRAS; muscle RAS oncogene homolog [KO:K07831]", "6237  RRAS; RAS related [KO:K07829]", "22800  RRAS2; RAS related 2 [KO:K07830]", "4763  NF1; neurofibromin 1 [KO:K08052]", "5921  RASA1; RAS p21 protein activator 1 [KO:K04352]", "5922  RASA2; RAS p21 protein activator 2 [KO:K08053]", "22821  RASA3; RAS p21 protein activator 3 [KO:K12380]", "10156  RASA4; RAS p21 protein activator 4 [KO:K17630]", "100271927  RASA4B; RAS p21 protein activator 4B [KO:K17630]", "8831  SYNGAP1; synaptic Ras GTPase activating protein 1 [KO:K17631]", "8437  RASAL1; RAS protein activator like 1 [KO:K17632]", "9462  RASAL2; RAS protein activator like 2 [KO:K17633]", "64926  RASAL3; RAS protein activator like 3 [KO:K17634]", "11186  RASSF1; Ras association domain family member 1 [KO:K09850]", "83593  RASSF5; Ras association domain family member 5 [KO:K08015]", "6789  STK4; serine/threonine kinase 4 [KO:K04411]", "7074  TIAM1; TIAM Rac1 associated GEF 1 [KO:K05731]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "5880  RAC2; Rac family small GTPase 2 [KO:K07860]", "5881  RAC3; Rac family small GTPase 3 [KO:K07861]", "5058  PAK1; p21 (RAC1) activated kinase 1 [KO:K04409] [EC:2.7.11.1]", "5062  PAK2; p21 (RAC1) activated kinase 2 [KO:K04410] [EC:2.7.11.1]", "5063  PAK3; p21 (RAC1) activated kinase 3 [KO:K05733] [EC:2.7.11.1]", "10298  PAK4; p21 (RAC1) activated kinase 4 [KO:K05734] [EC:2.7.11.1]", "57144  PAK5; p21 (RAC1) activated kinase 5 [KO:K05736] [EC:2.7.11.1]", "56924  PAK6; p21 (RAC1) activated kinase 6 [KO:K05735] [EC:2.7.11.1]", "106821730  BUB1B-PAK6; BUB1B-PAK6 readthrough [KO:K05735] [EC:2.7.11.1]", "387  RHOA; ras homolog family member A [KO:K04513]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]", "598  BCL2L1; BCL2 like 1 [KO:K04570]", "4303  FOXO4; forkhead box O4 [KO:K12358]", "356  FASLG; Fas ligand [KO:K04389]", "253959  RALGAPA1; Ral GTPase activating protein catalytic subunit alpha 1 [KO:K25768]", "57186  RALGAPA2; Ral GTPase activating protein catalytic subunit alpha 2 [KO:K25768]", "57148  RALGAPB; Ral GTPase activating protein non-catalytic subunit beta [KO:K25769]", "5900  RALGDS; ral guanine nucleotide dissociation stimulator [KO:K08732]", "23179  RGL1; ral guanine nucleotide dissociation stimulator like 1 [KO:K17635]", "5863  RGL2; ral guanine nucleotide dissociation stimulator like 2 [KO:K17636]", "5898  RALA; RAS like proto-oncogene A [KO:K07834]", "5899  RALB; RAS like proto-oncogene B [KO:K07835]", "5337  PLD1; phospholipase D1 [KO:K01115] [EC:3.1.4.4]", "5338  PLD2; phospholipase D2 [KO:K01115] [EC:3.1.4.4]", "55770  EXOC2; exocyst complex component 2 [KO:K17637]", "29110  TBK1; TANK binding kinase 1 [KO:K05410] [EC:2.7.11.10]", "5966  REL; REL proto-oncogene, NF-kB subunit [KO:K09254]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "10928  RALBP1; ralA binding protein 1 [KO:K08773]", "998  CDC42; cell division cycle 42 [KO:K04393]", "4301  AFDN; afadin, adherens junction formation factor [KO:K05702]", "8036  SHOC2; SHOC2 leucine rich repeat scaffold protein [KO:K19613]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "51365  PLA1A; phospholipase A1 member A [KO:K13618] [EC:3.1.1.111]", "8399  PLA2G10; phospholipase A2 group X [KO:K01047] [EC:3.1.1.4]", "26279  PLA2G2D; phospholipase A2 group IID [KO:K01047] [EC:3.1.1.4]", "30814  PLA2G2E; phospholipase A2 group IIE [KO:K01047] [EC:3.1.1.4]", "50487  PLA2G3; phospholipase A2 group III [KO:K01047] [EC:3.1.1.4]", "64600  PLA2G2F; phospholipase A2 group IIF [KO:K01047] [EC:3.1.1.4]", "81579  PLA2G12A; phospholipase A2 group XIIA [KO:K01047] [EC:3.1.1.4]", "84647  PLA2G12B; phospholipase A2 group XIIB [KO:K01047] [EC:3.1.1.4]", "5319  PLA2G1B; phospholipase A2 group IB [KO:K01047] [EC:3.1.1.4]", "5322  PLA2G5; phospholipase A2 group V [KO:K01047] [EC:3.1.1.4]", "5320  PLA2G2A; phospholipase A2 group IIA [KO:K01047] [EC:3.1.1.4]", "391013  PLA2G2C; phospholipase A2 group IIC [KO:K01047] [EC:3.1.1.4]", "123745  PLA2G4E; phospholipase A2 group IVE [KO:K16342] [EC:3.1.1.4]", "5321  PLA2G4A; phospholipase A2 group IVA [KO:K16342] [EC:3.1.1.4]", "8681  JMJD7-PLA2G4B; JMJD7-PLA2G4B readthrough [KO:K16342] [EC:3.1.1.4]", "100137049  PLA2G4B; phospholipase A2 group IVB [KO:K16342] [EC:3.1.1.4]", "8605  PLA2G4C; phospholipase A2 group IVC [KO:K16342] [EC:3.1.1.4]", "283748  PLA2G4D; phospholipase A2 group IVD [KO:K16342] [EC:3.1.1.4]", "255189  PLA2G4F; phospholipase A2 group IVF [KO:K16342] [EC:3.1.1.4]", "8398  PLA2G6; phospholipase A2 group VI [KO:K16343] [EC:3.1.1.4]", "11145  PLAAT3; phospholipase A and acyltransferase 3 [KO:K16817] [EC:3.1.1.32 3.1.1.4]", "54979  PLAAT2; phospholipase A and acyltransferase 2 [KO:K16817] [EC:3.1.1.32 3.1.1.4]", "2002  ELK1; ETS transcription factor ELK1 [KO:K04375]", "2113  ETS1; ETS proto-oncogene 1, transcription factor [KO:K02678]", "2114  ETS2; ETS proto-oncogene 2, transcription factor [KO:K21932]", "8315  BRAP; BRCA1 associated protein [KO:K10632] [EC:2.3.2.27]", "8844  KSR1; kinase suppressor of ras 1 [KO:K14958]", "283455  KSR2; kinase suppressor of ras 2 [KO:K18529] [EC:2.7.11.1]", "9771  RAPGEF5; Rap guanine nucleotide exchange factor 5 [KO:K08019]", "5906  RAP1A; RAP1A, member of RAS oncogene family [KO:K04353]", "5908  RAP1B; RAP1B, member of RAS oncogene family [KO:K07836]", "51196  PLCE1; phospholipase C epsilon 1 [KO:K05860] [EC:3.1.4.11]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "9610  RIN1; Ras and Rab interactor 1 [KO:K17638]", "25  ABL1; ABL proto-oncogene 1, non-receptor tyrosine kinase [KO:K06619] [EC:2.7.10.2]", "27  ABL2; ABL proto-oncogene 2, non-receptor tyrosine kinase [KO:K08887] [EC:2.7.10.2]", "5868  RAB5A; RAB5A, member RAS oncogene family [KO:K07887]", "5869  RAB5B; RAB5B, member RAS oncogene family [KO:K07888]", "5878  RAB5C; RAB5C, member RAS oncogene family [KO:K07889]", "382  ARF6; ADP ribosylation factor 6 [KO:K07941]"], "compound": ["C00035  GDP", "C00044  GTP", "C00076  Calcium cation", "C00165  Diacylglycerol", "C00575  3',5'-Cyclic AMP", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C05981  Phosphatidylinositol-3,4,5-trisphosphate"], "refs": [{"pmid": "18568040", "authors": "  Karnoub AE, Weinberg RA", "title": "Ras oncogenes: split personalities.", "journal": "Nat Rev Mol Cell Biol 9:517-31 (2008)", "doi": "10.1038/nrm2438"}, {"pmid": "12778136", "authors": "  Malumbres M, Barbacid M", "title": "RAS oncogenes: the first 30 years.", "journal": "Nat Rev Cancer 3:459-65 (2003)", "doi": "10.1038/nrc1097"}, {"pmid": "21686117", "authors": "  Cox AD, Der CJ", "title": "Ras history: The saga continues.", "journal": "Small GTPases 1:2-27 (2010)", "doi": "10.4161/sgtp.1.1.12178"}, {"pmid": "12642680", "authors": "  Cox AD, Der CJ", "title": "Ras family signaling: therapeutic targeting.", "journal": "Cancer Biol Ther 1:599-606 (2002)", "doi": "10.4161/cbt.306"}, {"pmid": "17428555", "authors": "  Rajalingam K, Schreck R, Rapp UR, Albert S", "title": "Ras oncogenes and their downstream targets.", "journal": "Biochim Biophys Acta 1773:1177-95 (2007)", "doi": "10.1016/j.bbamcr.2007.01.012"}, {"pmid": "17384584", "authors": "  Schubbert S, Shannon K, Bollag G", "title": "Hyperactive Ras in developmental disorders and cancer.", "journal": "Nat Rev Cancer 7:295-308 (2007)", "doi": "10.1038/nrc2109"}, {"pmid": "22233291", "authors": "  Poulogiannis G, Luo F, Arends MJ", "title": "RAS signalling in the colorectum in health and disease.", "journal": "Cell Commun Adhes 19:1-9 (2012)", "doi": "10.3109/15419061.2011.649380"}, {"pmid": "22020205", "authors": "  Berndt N, Hamilton AD, Sebti SM", "title": "Targeting protein prenylation for cancer therapy.", "journal": "Nat Rev Cancer 11:775-91 (2011)", "doi": "10.1038/nrc3151"}, {"pmid": "21196257", "authors": "  Overmeyer JH, Maltese WA", "title": "Death pathways triggered by activated Ras in cancer cells.", "journal": "Front Biosci (Landmark Ed) 16:1693-713 (2011)", "doi": "10.2741/3814"}, {"pmid": "16869784", "authors": "  Rodriguez-Viciana P, Tetsu O, Oda K, Okada J, Rauen K, McCormick F", "title": "Cancer targets in the Ras pathway.", "journal": "Cold Spring Harb Symp Quant Biol 70:461-7 (2005)", "doi": "10.1101/sqb.2005.70.044"}, {"pmid": "14663478", "authors": "  Cox AD, Der CJ", "title": "The dark side of Ras: regulation of apoptosis.", "journal": "Oncogene 22:8999-9006 (2003)", "doi": "10.1038/sj.onc.1207111"}, {"pmid": "18413813", "authors": "  Braun BS, Shannon K", "title": "Targeting Ras in myeloid leukemias.", "journal": "Clin Cancer Res 14:2249-52 (2008)", "doi": "10.1158/1078-0432.CCR-07-1005"}, {"pmid": "20420946", "authors": "  Pino MS, Chung DC", "title": "The chromosomal instability pathway in colon cancer.", "journal": "Gastroenterology 138:2059-72 (2010)", "doi": "10.1053/j.gastro.2009.12.065"}, {"pmid": "12217381", "authors": "  Schrader JW, Schallhorn A, Grill B, Guo X", "title": "Activation of small GTPases of the Ras and Rho family by growth factors active on mast cells.", "journal": "Mol Immunol 38:1181-6 (2002)", "doi": "10.1016/S0161-5890(02)00060-3"}, {"pmid": "22189424", "authors": "  Ahearn IM, Haigis K, Bar-Sagi D, Philips MR", "title": "Regulating the regulator: post-translational modification of RAS.", "journal": "Nat Rev Mol Cell Biol 13:39-51 (2012)", "doi": "10.1038/nrm3255"}, {"pmid": "11313946", "authors": "  Ehrhardt GR, Korherr C, Wieler JS, Knaus M, Schrader JW", "title": "A novel potential effector of M-Ras and p21 Ras negatively regulates p21 Ras-mediated gene induction and cell growth.", "journal": "Oncogene 20:188-97 (2001)", "doi": "10.1038/sj.onc.1204053"}, {"pmid": "16966426", "authors": "  Goldfinger LE, Ptak C, Jeffery ED, Shabanowitz J, Hunt DF, Ginsberg MH", "title": "RLIP76 (RalBP1) is an R-Ras effector that mediates adhesion-dependent Rac activation and cell migration.", "journal": "J Cell Biol 174:877-88 (2006)", "doi": "10.1083/jcb.200603111"}, {"pmid": "23506953", "authors": "  Kortum RL, Rouquette-Jazdanian AK, Samelson LE", "title": "Ras and extracellular signal-regulated kinase signaling in thymocytes and T cells.", "journal": "Trends Immunol 34:259-68 (2013)", "doi": "10.1016/j.it.2013.02.004"}, {"pmid": "15572660", "authors": "  Roberts DM, Anderson AL, Hidaka M, Swetenburg RL, Patterson C, Stanford WL, Bautch VL", "title": "A vascular gene trap screen defines RasGRP3 as an angiogenesis-regulated gene required for the endothelial response to phorbol esters.", "journal": "Mol Cell Biol 24:10515-28 (2004)", "doi": "10.1128/MCB.24.24.10515-10528.2004"}, {"pmid": "10712923", "authors": "  Reuther GW, Der CJ", "title": "The Ras branch of small GTPases: Ras family members don't fall far from the tree.", "journal": "Curr Opin Cell Biol 12:157-65 (2000)", "doi": "10.1016/S0955-0674(99)00071-X"}, {"pmid": "21111786", "authors": "  Fernandez-Medarde A, Santos E", "title": "The RasGrf family of mammalian guanine nucleotide exchange factors.", "journal": "Biochim Biophys Acta 1815:170-88 (2011)", "doi": "10.1016/j.bbcan.2010.11.001"}, {"pmid": "18437264", "authors": "  Iwashita S, Song SY", "title": "RasGAPs: a crucial regulator of extracellular stimuli for homeostasis of cellular functions.", "journal": "Mol Biosyst 4:213-22 (2008)", "doi": "10.1039/b716357f"}, {"pmid": "15062121", "authors": "  Ory S, Morrison DK", "title": "Signal transduction: implications for Ras-dependent ERK signaling.", "journal": "Curr Biol 14:R277-8 (2004)", "doi": "10.1016/j.cub.2004.03.023"}, {"pmid": "19091743", "authors": "  Matheny SA, White MA", "title": "Signaling threshold regulation by the Ras effector IMP.", "journal": "J Biol Chem 284:11007-11 (2009)", "doi": "10.1074/jbc.R800082200"}, {"pmid": "20602996", "authors": "  Lemmon MA, Schlessinger J", "title": "Cell signaling by receptor tyrosine kinases.", "journal": "Cell 141:1117-34 (2010)", "doi": "10.1016/j.cell.2010.06.011"}, {"pmid": "22367796", "authors": "  Skaper SD", "title": "The neurotrophin family of neurotrophic factors: an overview.", "journal": "Methods Mol Biol 846:1-12 (2012)", "doi": "10.1007/978-1-61779-536-7_1"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04015  Rap1 signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04144  Endocytosis", "hsa04151  PI3K-Akt signaling pathway", "hsa04660  T cell receptor signaling pathway", "hsa04720  Long-term potentiation", "hsa04810  Regulation of actin cytoskeleton"], "ko_pathway": "ko04014", "genes": ["EGFR", "RAC1", "CSF1", "AKT2", "MET", "AKT1", "PGF", "SOS1", "KDR", "NRAS"]}, {"kegg_id": "hsa04015", "name": "Rap1 signaling pathway - Homo sapiens (human)", "description": "Rap1 is a small GTPase that controls diverse processes, such as cell adhesion, cell-cell junction formation and cell polarity. Like all G proteins, Rap1 cycles between an inactive GDP-bound and an active GTP-bound conformation. A variety of extracellular signals control this cycle through the regulation of several unique guanine nucleotide exchange factors (GEFs) and GTPase activating proteins (GAPs). Rap1 plays a dominant role in the control of cell-cell and cell-matrix interactions by regulating the function of integrins and other adhesion molecules in various cell types. Rap1 also regulates MAP kinase (MAPK) activity in a manner highly dependent on the context of cell types.", "class": "Environmental Information Processing; Signal transduction", "pathway_map": "hsa04015  Rap1 signaling pathway", "drug": ["D10190  Tivozanib hydrochloride (USAN)", "D10224  Golvatinib (USAN)", "D10374  Lifitegrast (USAN/INN)", "D10392  Lifitegrast sodium (USAN)", "D10465  Golvatinib tartrate (USAN)", "D11885  Surufatinib (USAN/INN)", "D11894  Amivantamab (USAN/INN)", "D12369  Etrumadenant (USAN/INN)", "D12635  Sozinibercept (USAN/INN)", "D12733  Dordaviprone (USAN/INN)", "D12734  Dordaviprone hydrochloride (JAN/USAN)", "D12809  Bafisontamab (USAN/INN)", "D12831  Naporafenib (USAN/INN)"], "dblinks": "GO: 0007264", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["5906  RAP1A; RAP1A, member of RAS oncogene family [KO:K04353]", "5908  RAP1B; RAP1B, member of RAS oncogene family [KO:K07836]", "22808  MRAS; muscle RAS oncogene homolog [KO:K07831]", "9771  RAPGEF5; Rap guanine nucleotide exchange factor 5 [KO:K08019]", "9732  DOCK4; dedicator of cytokinesis 4 [KO:K17697]", "2902  GRIN1; glutamate ionotropic receptor NMDA type subunit 1 [KO:K05208]", "2903  GRIN2A; glutamate ionotropic receptor NMDA type subunit 2A [KO:K05209]", "2904  GRIN2B; glutamate ionotropic receptor NMDA type subunit 2B [KO:K05210]", "810  CALML3; calmodulin like 3 [KO:K02183]", "805  CALM2; calmodulin 2 [KO:K02183]", "808  CALM3; calmodulin 3 [KO:K02183]", "801  CALM1; calmodulin 1 [KO:K02183]", "163688  CALML6; calmodulin like 6 [KO:K02183]", "51806  CALML5; calmodulin like 5 [KO:K02183]", "91860  CALML4; calmodulin like 4 [KO:K02183]", "2149  F2R; coagulation factor II thrombin receptor [KO:K03914]", "9002  F2RL3; F2R like thrombin or trypsin receptor 3 [KO:K04236]", "5028  P2RY1; purinergic receptor P2Y1 [KO:K04270]", "2357  FPR1; formyl peptide receptor 1 [KO:K04172]", "1902  LPAR1; lysophosphatidic acid receptor 1 [KO:K04289]", "9170  LPAR2; lysophosphatidic acid receptor 2 [KO:K04291]", "23566  LPAR3; lysophosphatidic acid receptor 3 [KO:K04294]", "2846  LPAR4; lysophosphatidic acid receptor 4 [KO:K04275]", "57121  LPAR5; lysophosphatidic acid receptor 5 [KO:K08390]", "135  ADORA2A; adenosine A2a receptor [KO:K04266]", "136  ADORA2B; adenosine A2b receptor [KO:K04267]", "2778  GNAS; GNAS complex locus [KO:K04632]", "107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]", "108  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]", "109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]", "196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]", "113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]", "114  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]", "115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]", "10411  RAPGEF3; Rap guanine nucleotide exchange factor 3 [KO:K08014]", "11069  RAPGEF4; Rap guanine nucleotide exchange factor 4 [KO:K04351]", "2776  GNAQ; G protein subunit alpha q [KO:K04634]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "25780  RASGRP3; RAS guanyl releasing protein 3 [KO:K12362]", "10235  RASGRP2; RAS guanyl releasing protein 2 [KO:K12361]", "1950  EGF; epidermal growth factor [KO:K04357]", "2246  FGF1; fibroblast growth factor 1 [KO:K18496]", "2247  FGF2; fibroblast growth factor 2 [KO:K18497]", "2248  FGF3; fibroblast growth factor 3 [KO:K04358]", "2249  FGF4; fibroblast growth factor 4 [KO:K04358]", "8822  FGF17; fibroblast growth factor 17 [KO:K04358]", "2251  FGF6; fibroblast growth factor 6 [KO:K04358]", "2252  FGF7; fibroblast growth factor 7 [KO:K04358]", "2253  FGF8; fibroblast growth factor 8 [KO:K04358]", "2254  FGF9; fibroblast growth factor 9 [KO:K04358]", "2255  FGF10; fibroblast growth factor 10 [KO:K04358]", "8823  FGF16; fibroblast growth factor 16 [KO:K04358]", "2250  FGF5; fibroblast growth factor 5 [KO:K04358]", "8817  FGF18; fibroblast growth factor 18 [KO:K04358]", "26281  FGF20; fibroblast growth factor 20 [KO:K04358]", "27006  FGF22; fibroblast growth factor 22 [KO:K04358]", "9965  FGF19; fibroblast growth factor 19 [KO:K22603]", "26291  FGF21; fibroblast growth factor 21 [KO:K22429]", "8074  FGF23; fibroblast growth factor 23 [KO:K22428]", "4803  NGF; nerve growth factor [KO:K02582]", "3630  INS; insulin [KO:K04526]", "3479  IGF1; insulin like growth factor 1 [KO:K05459]", "5154  PDGFA; platelet derived growth factor subunit A [KO:K04359]", "5155  PDGFB; platelet derived growth factor subunit B [KO:K17386]", "56034  PDGFC; platelet derived growth factor C [KO:K05450]", "80310  PDGFD; platelet derived growth factor D [KO:K05450]", "1435  CSF1; colony stimulating factor 1 [KO:K05453]", "4254  KITLG; KIT ligand [KO:K05461]", "7422  VEGFA; vascular endothelial growth factor A [KO:K05448]", "7423  VEGFB; vascular endothelial growth factor B [KO:K16858]", "5228  PGF; placental growth factor [KO:K16859]", "7424  VEGFC; vascular endothelial growth factor C [KO:K05449]", "2277  VEGFD; vascular endothelial growth factor D [KO:K05449]", "3082  HGF; hepatocyte growth factor [KO:K05460]", "284  ANGPT1; angiopoietin 1 [KO:K05465]", "285  ANGPT2; angiopoietin 2 [KO:K05466]", "51378  ANGPT4; angiopoietin 4 [KO:K05467]", "1942  EFNA1; ephrin A1 [KO:K05462]", "1943  EFNA2; ephrin A2 [KO:K05462]", "1944  EFNA3; ephrin A3 [KO:K05462]", "1945  EFNA4; ephrin A4 [KO:K05462]", "1946  EFNA5; ephrin A5 [KO:K05462]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "2260  FGFR1; fibroblast growth factor receptor 1 [KO:K04362] [EC:2.7.10.1]", "2263  FGFR2; fibroblast growth factor receptor 2 [KO:K05093] [EC:2.7.10.1]", "2261  FGFR3; fibroblast growth factor receptor 3 [KO:K05094] [EC:2.7.10.1]", "2264  FGFR4; fibroblast growth factor receptor 4 [KO:K05095] [EC:2.7.10.1]", "4804  NGFR; nerve growth factor receptor [KO:K02583]", "3643  INSR; insulin receptor [KO:K04527] [EC:2.7.10.1]", "3480  IGF1R; insulin like growth factor 1 receptor [KO:K05087] [EC:2.7.10.1]", "5156  PDGFRA; platelet derived growth factor receptor alpha [KO:K04363] [EC:2.7.10.1]", "5159  PDGFRB; platelet derived growth factor receptor beta [KO:K05089] [EC:2.7.10.1]", "1436  CSF1R; colony stimulating factor 1 receptor [KO:K05090] [EC:2.7.10.1]", "3815  KIT; KIT proto-oncogene, receptor tyrosine kinase [KO:K05091] [EC:2.7.10.1]", "2321  FLT1; fms related receptor tyrosine kinase 1 [KO:K05096] [EC:2.7.10.1]", "2324  FLT4; fms related receptor tyrosine kinase 4 [KO:K05097] [EC:2.7.10.1]", "3791  KDR; kinase insert domain receptor [KO:K05098] [EC:2.7.10.1]", "4233  MET; MET proto-oncogene, receptor tyrosine kinase [KO:K05099] [EC:2.7.10.1]", "7010  TEK; TEK receptor tyrosine kinase [KO:K05121] [EC:2.7.10.1]", "1969  EPHA2; EPH receptor A2 [KO:K05103] [EC:2.7.10.1]", "1398  CRK; CRK proto-oncogene, adaptor protein [KO:K04438]", "1399  CRKL; CRK like proto-oncogene, adaptor protein [KO:K04438]", "2889  RAPGEF1; Rap guanine nucleotide exchange factor 1 [KO:K06277]", "9564  BCAR1; BCAR1 scaffold protein, Cas family member [KO:K05726]", "999  CDH1; cadherin 1 [KO:K05689]", "1499  CTNNB1; catenin beta 1 [KO:K02105]", "9223  MAGI1; membrane associated guanylate kinase, WW and PDZ domain containing 1 [KO:K05631]", "9863  MAGI2; membrane associated guanylate kinase, WW and PDZ domain containing 2 [KO:K05629]", "260425  MAGI3; membrane associated guanylate kinase, WW and PDZ domain containing 3 [KO:K06112]", "9693  RAPGEF2; Rap guanine nucleotide exchange factor 2 [KO:K08018]", "51735  RAPGEF6; Rap guanine nucleotide exchange factor 6 [KO:K08020]", "27040  LAT; linker for activation of T cells [KO:K07362]", "2533  FYB1; FYN binding protein 1 [KO:K17698]", "3937  LCP2; lymphocyte cytosolic protein 2 [KO:K07361]", "8631  SKAP1; src kinase associated phosphoprotein 1 [KO:K17699]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "5587  PRKD1; protein kinase D1 [KO:K06070] [EC:2.7.11.13]", "23683  PRKD3; protein kinase D3 [KO:K06070] [EC:2.7.11.13]", "25865  PRKD2; protein kinase D2 [KO:K06070] [EC:2.7.11.13]", "1813  DRD2; dopamine receptor D2 [KO:K04145]", "1268  CNR1; cannabinoid receptor 1 [KO:K04277]", "2770  GNAI1; G protein subunit alpha i1 [KO:K04630]", "2773  GNAI3; G protein subunit alpha i3 [KO:K04630]", "2771  GNAI2; G protein subunit alpha i2 [KO:K04630]", "2775  GNAO1; G protein subunit alpha o1 [KO:K04534]", "5909  RAP1GAP; RAP1 GTPase activating protein [KO:K17700]", "26037  SIPA1L1; signal induced proliferation associated 1 like 1 [KO:K17701]", "6494  SIPA1; signal-induced proliferation-associated 1 [KO:K08013]", "57568  SIPA1L2; signal induced proliferation associated 1 like 2 [KO:K17702]", "23094  SIPA1L3; signal induced proliferation associated 1 like 3 [KO:K17703]", "3397  ID1; inhibitor of DNA binding 1 [KO:K04680]", "7057  THBS1; thrombospondin 1 [KO:K16857]", "5900  RALGDS; ral guanine nucleotide dissociation stimulator [KO:K08732]", "5898  RALA; RAS like proto-oncogene A [KO:K07834]", "5899  RALB; RAS like proto-oncogene B [KO:K07835]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "5880  RAC2; Rac family small GTPase 2 [KO:K07860]", "5881  RAC3; Rac family small GTPase 3 [KO:K07861]", "54518  APBB1IP; amyloid beta precursor protein binding family B member 1 interacting protein [KO:K17704]", "7094  TLN1; talin 1 [KO:K06271]", "83660  TLN2; talin 2 [KO:K06271]", "3674  ITGA2B; integrin subunit alpha 2b [KO:K06476]", "3690  ITGB3; integrin subunit beta 3 [KO:K06493]", "345456  PFN3; profilin 3 [KO:K05759]", "5216  PFN1; profilin 1 [KO:K05759]", "5217  PFN2; profilin 2 [KO:K05759]", "375189  PFN4; profilin family member 4 [KO:K05759]", "7408  VASP; vasodilator stimulated phosphoprotein [KO:K06274]", "55740  ENAH; ENAH actin regulator [KO:K05746]", "51466  EVL; Enah/Vasp-like [KO:K23487]", "71  ACTG1; actin gamma 1 [KO:K05692]", "60  ACTB; actin beta [KO:K05692]", "64411  ARAP3; ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 [KO:K12490]", "387  RHOA; ras homolog family member A [KO:K04513]", "6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "9855  FARP2; FERM, ARH/RhoGEF and pleckstrin domain protein 2 [KO:K06082]", "998  CDC42; cell division cycle 42 [KO:K04393]", "10451  VAV3; vav guanine nucleotide exchange factor 3 [KO:K05730]", "7409  VAV1; vav guanine nucleotide exchange factor 1 [KO:K05730]", "7410  VAV2; vav guanine nucleotide exchange factor 2 [KO:K05730]", "7074  TIAM1; TIAM Rac1 associated GEF 1 [KO:K05731]", "56288  PARD3; par-3 family cell polarity regulator [KO:K04237]", "50855  PARD6A; par-6 family cell polarity regulator alpha [KO:K06093]", "84552  PARD6G; par-6 family cell polarity regulator gamma [KO:K06093]", "84612  PARD6B; par-6 family cell polarity regulator beta [KO:K06093]", "5590  PRKCZ; protein kinase C zeta [KO:K18952] [EC:2.7.11.13]", "5584  PRKCI; protein kinase C iota [KO:K06069] [EC:2.7.11.13]", "4301  AFDN; afadin, adherens junction formation factor [KO:K05702]", "1500  CTNND1; catenin delta 1 [KO:K05690]", "889  KRIT1; KRIT1 ankyrin repeat containing [KO:K17705]", "10636  RGS14; regulator of G protein signaling 14 [KO:K17706]", "83593  RASSF5; Ras association domain family member 5 [KO:K08015]", "3683  ITGAL; integrin subunit alpha L [KO:K05718]", "3684  ITGAM; integrin subunit alpha M [KO:K06461]", "3689  ITGB2; integrin subunit beta 2 [KO:K06464]", "3688  ITGB1; integrin subunit beta 1 [KO:K05719]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "5606  MAP2K3; mitogen-activated protein kinase kinase 3 [KO:K04432] [EC:2.7.12.2]", "5608  MAP2K6; mitogen-activated protein kinase kinase 6 [KO:K04433] [EC:2.7.12.2]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "51196  PLCE1; phospholipase C epsilon 1 [KO:K05860] [EC:3.1.4.11]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "6237  RRAS; RAS related [KO:K07829]"], "compound": ["C00035  GDP", "C00044  GTP", "C00076  Calcium cation", "C00165  Diacylglycerol", "C00575  3',5'-Cyclic AMP"], "refs": [{"pmid": "17182900", "authors": "  Kooistra MR, Dube N, Bos JL", "title": "Rap1: a key regulator in cell-cell junction formation.", "journal": "J Cell Sci 120:17-22 (2007)", "doi": "10.1242/jcs.03306"}, {"pmid": "11331911", "authors": "  Bos JL, de Rooij J, Reedquist KA", "title": "Rap1 signalling: adhering to new models.", "journal": "Nat Rev Mol Cell Biol 2:369-77 (2001)", "doi": "10.1038/35073073"}, {"pmid": "17383543", "authors": "  Minato N, Kometani K, Hattori M", "title": "Regulation of immune responses and hematopoiesis by the Rap1 signal.", "journal": "Adv Immunol 93:229-64 (2007)", "doi": "10.1016/S0065-2776(06)93006-5"}, {"pmid": "15780587", "authors": "  Bos JL", "title": "Linking Rap to cell adhesion.", "journal": "Curr Opin Cell Biol 17:123-8 (2005)", "doi": "10.1016/j.ceb.2005.02.009"}, {"pmid": "12508104", "authors": "  Caron E", "title": "Cellular functions of the Rap1 GTP-binding protein: a pattern emerges.", "journal": "J Cell Sci 116:435-40 (2003)", "doi": "10.1242/jcs.00238"}, {"pmid": "10579920", "authors": "  Zwartkruis FJ, Bos JL", "title": "Ras and Rap1: two highly related small GTPases with distinct function.", "journal": "Exp Cell Res 253:157-65 (1999)", "doi": "10.1006/excr.1999.4695"}, {"pmid": "14607972", "authors": "  Hattori M, Minato N", "title": "Rap1 GTPase: functions, regulation, and malignancy.", "journal": "J Biochem 134:479-84 (2003)", "doi": "10.1093/jb/mvg180"}, {"pmid": "19159611", "authors": "  Pannekoek WJ, Kooistra MR, Zwartkruis FJ, Bos JL", "title": "Cell-cell junction formation: the role of Rap1 and Rap1 guanine nucleotide exchange factors.", "journal": "Biochim Biophys Acta 1788:790-6 (2009)", "doi": "10.1016/j.bbamem.2008.12.010"}, {"pmid": "19615876", "authors": "  Boettner B, Van Aelst L", "title": "Control of cell adhesion dynamics by Rap1 signaling.", "journal": "Curr Opin Cell Biol 21:684-93 (2009)", "doi": "10.1016/j.ceb.2009.06.004"}, {"pmid": "15803158", "authors": "  Xia Z, Storm DR.", "title": "The role of calmodulin as a signal integrator for synaptic plasticity.", "journal": "Nat Rev Neurosci 6:267-76 (2005)", "doi": "10.1038/nrn1647"}, {"pmid": "17624948", "authors": "  Mor A, Dustin ML, Philips MR", "title": "Small GTPases and LFA-1 reciprocally modulate adhesion and signaling.", "journal": "Immunol Rev 218:114-25 (2007)", "doi": "10.1111/j.1600-065X.2007.00538.x"}, {"pmid": "17624944", "authors": "  Burbach BJ, Medeiros RB, Mueller KL, Shimizu Y", "title": "T-cell receptor signaling to integrins.", "journal": "Immunol Rev 218:65-81 (2007)", "doi": "10.1111/j.1600-065X.2007.00527.x"}, {"pmid": "12765839", "authors": "  Stork PJ", "title": "Does Rap1 deserve a bad Rap?", "journal": "Trends Biochem Sci 28:267-75 (2003)", "doi": "10.1016/S0968-0004(03)00087-2"}, {"pmid": "12351703", "authors": "  Banihashemi B, Albert PR", "title": "Dopamine-D2S receptor inhibition of calcium influx, adenylyl cyclase, and mitogen-activated protein kinase in pituitary cells: distinct Galpha and Gbetagamma requirements.", "journal": "Mol Endocrinol 16:2393-404 (2002)", "doi": "10.1210/me.2001-0220"}, {"pmid": "18363565", "authors": "  Banno A, Ginsberg MH", "title": "Integrin activation.", "journal": "Biochem Soc Trans 36:229-34 (2008)", "doi": "10.1042/BST0360229"}, {"pmid": "19710505", "authors": "  Doebele RC, Schulze-Hoepfner FT, Hong J, Chlenski A, Zeitlin BD, Goel K, Gomes S, Liu Y, Abe MK, Nor JE, Lingen MW, Rosner MR", "title": "A novel interplay between Epac/Rap1 and mitogen-activated protein kinase kinase 5/extracellular signal-regulated kinase 5 (MEK5/ERK5) regulates thrombospondin to control angiogenesis.", "journal": "Blood 114:4592-600 (2009)", "doi": "10.1182/blood-2009-04-217042"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04014  Ras signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04510  Focal adhesion", "hsa04520  Adherens junction", "hsa04660  T cell receptor signaling pathway", "hsa04810  Regulation of actin cytoskeleton"], "ko_pathway": "ko04015", "genes": ["EGFR", "RAC1", "BRAF", "CSF1", "AKT2", "MET", "AKT1", "PGF", "MAPK13", "KDR", "NRAS"]}, {"kegg_id": "hsa04020", "name": "Calcium signaling pathway - Homo sapiens (human)", "description": "Ca2+ that enters the cell from the outside is a principal source of signal Ca2+. Entry of Ca2+ is driven by the presence of a large electrochemical gradient across the plasma membrane. Cells use this external source of signal Ca2+ by activating various entry channels with widely different properties. The voltage-operated channels (VOCs) are found in excitable cells and generate the rapid Ca2+ fluxes that control fast cellular processes. There are many other Ca2+-entry channels, such as the receptor-operated channels (ROCs), for example the NMDA (N-methyl-D-aspartate) receptors (NMDARs) that respond to glutamate. There also are second-messenger-operated channels (SMOCs) and store-operated channels (SOCs).\nThe other principal source of Ca2+ for signalling is the internal stores that are located primarily in the endoplasmic/sarcoplasmic reticulum (ER/SR), in which inositol-1,4,5-trisphosphate receptors (IP3Rs) or ryanodine receptors (RYRs) regulate the release of Ca2+. The principal activator of these channels is Ca2+ itself and this process of Ca2+-induced Ca2+ release is central to the mechanism of Ca2+ signalling. Various second messengers or modulators also control the release of Ca2+. IP3, which is generated by pathways using different isoforms of phospholipase C (PLCbeta, delta, epsilon, gamma and zeta), regulates the IP3Rs. Cyclic ADP-ribose (cADPR) releases Ca2+ via RYRs. Nicotinic acid adenine dinucleotide phosphate (NAADP) may activate a distinct Ca2+ release mechanism on separate acidic Ca2+ stores. Ca2+ release via the NAADP-sensitive mechanism may also feedback onto either RYRs or IP3Rs. cADPR and NAADP are generated by CD38. This enzyme might be sensitive to the cellular metabolism, as ATP and NADH inhibit it.\nThe influx of Ca2+ from the environment or release from internal stores causes a very rapid and dramatic increase in cytoplasmic calcium concentration, which has been widely exploited for signal transduction. Some proteins, such as troponin C (TnC) involved in muscle contraction, directly bind to and sense Ca2+. However, in other cases Ca2+ is sensed through intermediate calcium sensors such as calmodulin (CALM).", "class": "Environmental Information Processing; Signal transduction", "pathway_map": "hsa04020  Calcium signaling pathway", "network": ["", "ELEMENT   N00023  EGF-EGFR-PLCG-ERK signaling pathway", "N00026  EGF-EGFR-PLCG-CAMK signaling pathway", "N00028  PDGF-PDGFR-PLCG-CAMK signaling pathway", "N00147  EGF-EGFR-PLCG-calcineurin signaling pathway", "N00227  TGFA-EGFR-PLCG-PKC signaling pathway", "N00401  CXCR4-GNAQ-PLCB/G-calcineurin signaling pathway", "N01000  mAChR-Ca2+ -apoptotic pathway", "N01106  TCR-PLCG-ITPR signaling pathway", "N01429  Cytosolic Ca2+ removal, PMCA", "N01637  Ca2+ entry, Voltage-gated Ca2+ channel", "N01638  Skeletal-type VGCC-RYR signaling", "N01639  Cardiac-type VGCC-RYR signaling", "N01640  GPCR-PLCB-ITPR signaling pathway", "N01641  RTK-PLCG-ITPR signaling pathway", "N01642  Ca2+ entry, Ligand-gated Ca2+ channel", "N01643  Ca2+ entry, Store-operated Ca2+ channel", "N01644  Lysosomal Ca2+ release", "N01645  Cytosolic Ca2+ removal, SERCA", "N01646  Regulation of SERCA", "N01647  Ca2+/CAM-CN signaling pathway", "N01648  Ca2+/CAM-CAMK signaling pathway", "N01655  Ca2+-PLCD-ITPR signaling pathway", "N01741  Ca2+/TRPC3 signaling pathway"], "drug": ["D00059  Levodopa (JP18/USP/INN)", "D00076  Noradrenaline (JP18)", "D00081  Dinoprost (JP18/USAN/INN)", "D00095  Epinephrine (USP/INN)", "D00101  Vasopressin (JP18/USP)", "D00113  Atropine (USP)", "D00124  Ephedrine (USP)", "D00147  Hyoscyamine (USP)", "D00150  Angiotensin II (INN)", "D00176  Protirelin (JP18/USAN/INN)", "D00180  Alprostadil (JP18/USP/INN)", "D00193  Dexpanthenol (USP/INN)", "D00227  Aminophylline (USP/INN)", "D00255  Carvedilol (JP18/USP/INN)", "D00274  Cisapride (USP/INN)", "D00295  Cimetidine (JP18/USP/INN)", "D00300  Diphenhydramine (JP18/INN)", "D00304  Divalproex sodium (USP)", "D00318  Famotidine (JP18/USP/INN)", "D00319  Felodipine (JP18/USP/INN)", "D00349  Isradipine (USP/INN)", "D00356  Latanoprost (JAN/USP/INN)", "D00366  Lypressin (USAN/INN)", "D00371  Theophylline (JP18)", "D00378  Timolol (USAN)", "D00397  Tropicamide (JP18/USP/INN)", "D00399  Valproic acid (USP)", "D00404  Methsuximide (USP)", "D00411  Zafirlukast (JAN/USAN/INN)", "D00422  Ranitidine (USAN/INN)", "D00432  Nadolol (JP18/USP/INN)", "D00437  Nifedipine (JP18/USP/INN)", "D00438  Nimodipine (USP/INN)", "D00440  Nizatidine (JP18/USP/INN)", "D00465  Oxybutynin (USAN/INN)", "D00480  Promethazine hydrochloride (JP18/USP)", "D00481  Propantheline bromide (JP18/USP/INN)", "D00494  Promethazine (JAN/INN)", "D00495  Paramethadione (INN)", "D00511  Phenylephrine hydrochloride (JP18/USP)", "D00520  Dimenhydrinate (JP18/USP/INN)", "D00528  Caffeine (USP)", "D00529  Montelukast sodium (JP18/USP)", "D00537  Topiramate (JAN/USP/INN)", "D00538  Zonisamide (JP18/USP/INN)", "D00539  Ethosuximide (JP18/USP/INN)", "D00540  Glycopyrrolate (USP)", "D00598  Betaxolol hydrochloride (JP18/USP)", "D00599  Carteolol hydrochloride (JP18/USP)", "D00600  Labetalol hydrochloride (JP18/USP)", "D00602  Penbutolol sulfate (JP18/USP)", "D00603  Timolol maleate (JP18/USP)", "D00607  Guanadrel sulfate (USAN)", "D00613  Fenoldopam mesylate (USP)", "D00615  Amlodipine besylate (USP)", "D00617  Nicardipine hydrochloride (JP18/USAN)", "D00618  Nisoldipine (JAN/USAN/INN)", "D00619  Verapamil hydrochloride (JP18/USP)", "D00629  Nitrendipine (JP18/USAN/INN)", "D00631  Bepridil hydrochloride (USAN)", "D00632  Dobutamine hydrochloride (JP18/USP)", "D00633  Dopamine hydrochloride (JP18/USP)", "D00634  Bisoprolol fumarate (JP18/USP)", "D00636  Amiodarone hydrochloride (JP18/USP)", "D00646  Tolterodine (USAN/INN)", "D00659  Azelastine hydrochloride (JP18/USP)", "D00666  Clemastine fumarate (JP18/USP)", "D00669  Diphenhydramine hydrochloride (JP18/USP)", "D00672  Hydroxyzine hydrochloride (JP18/USP)", "D00673  Ranitidine hydrochloride (JP18/USP)", "D00679  Ergotamine tartrate (JP18/USP)", "D00680  Methylergonovine maleate (USP)", "D00682  Carboprost tromethamine (USP)", "D00683  Albuterol sulfate (USP)", "D00684  Bitolterol mesylate (USAN)", "D00685  Metaproterenol sulfate (USP)", "D00686  Pirbuterol acetate (USAN)", "D00687  Salmeterol xinafoate (JAN/USP)", "D00688  Terbutaline sulfate (JP18/USP)", "D00710  Valproate sodium (USAN)", "D00711  Ketamine hydrochloride (JP18/USP)", "D00717  Dicyclomine hydrochloride (JAN/USP)", "D00719  Hyoscyamine sulfate (USP)", "D00720  Mepenzolate bromide (JP18/INN)", "D00721  Methanthelinium bromide (INN)", "D00722  Oxybutynin chloride (USP)", "D00723  Tridihexethyl chloride (BAN)", "D00774  Orphenadrine citrate (USP)", "D00996  Epinephrine hydrochloride (JAN)", "D00999  Acetylcholine chloride (JP18/USP/INN)", "D01003  Hexocyclium metilsulfate (INN)", "D01005  Isopropamide iodide (JAN/USP/INN)", "D01007  Propiverine hydrochloride (JP18)", "D01019  Metaraminol bitartrate (JAN/USP)", "D01020  Methoxamine hydrochloride (JAN)", "D01025  Levobunolol hydrochloride (JAN/USP)", "D01026  Sotalol hydrochloride (JAN/USP)", "D01077  Methylatropine nitrate (USAN)", "D01096  Hydroxyzine pamoate (JP18/USP)", "D01104  Barnidipine hydrochloride (JAN)", "D01128  Ramatroban (JAN/INN)", "D01131  Lafutidine (JP18/INN)", "D01143  Isothipendyl hydrochloride (JAN)", "D01145  Azelnidipine (JP18/INN)", "D01148  Tolterodine tartrate (JAN/USP)", "D01151  Lemildipine (JAN/INN)", "D01163  Ergonovine maleate (USP)", "D01165  Piperidolate hydrochloride (JAN)", "D01171  Monatepil maleate (JAN/USAN)", "D01173  Cilnidipine (JP18/INN)", "D01174  Pheniramine maleate (JAN/USP)", "D01175  Carpronium chloride (JAN/INN)", "D01192  Olopatadine hydrochloride (JP18/USP)", "D01201  Tiemonium iodide (JAN/INN)", "D01238  Bucladesine sodium (JAN)", "D01242  Promethazine teoclate (JAN/INN)", "D01263  Ritodrine hydrochloride (JP18/USP)", "D01269  Solifenacin succinate (JAN/USAN/INN)", "D01295  Cinnarizine (JAN/USAN/INN)", "D01297  Pirenzepine hydrochloride (USAN)", "D01303  Flunarizine hydrochloride (JAN/USAN)", "D01307  Midodrine hydrochloride (JAN/USP)", "D01324  Mequitazine (JP18/INN)", "D01343  Dimethindene maleate (USAN)", "D01347  Tramazoline hydrochloride (JAN/USAN)", "D01349  Pirbuterol hydrochloride (JAN/USAN)", "D01352  Dinoprost tromethamine (JAN/USP)", "D01360  Clenbuterol hydrochloride (JAN/USP)", "D01362  Tulobuterol hydrochloride (JP18)", "D01369  Bevantolol hydrochloride (JAN/USAN)", "D01373  Formoterol fumarate (USP)", "D01377  Prifinium bromide (JAN/INN)", "D01386  Ephedrine hydrochloride (JP18/USP)", "D01390  Isoproterenol hydrochloride (USP)", "D01428  Fenoterol hydrobromide (JAN)", "D01444  Bunitrolol hydrochloride (JAN)", "D01451  Scopolamine butylbromide (JP18)", "D01452  Isopropyl unoprostone (JAN)", "D01453  Caffeine hydrate (JP18)", "D01454  Bupranolol hydrochloride (JP18)", "D01467  Roxatidine acetate hydrochloride (JP18/USAN)", "D01469  Amosulalol hydrochloride (JP18)", "D01491  Butropium bromide (JP18/INN)", "D01504  Bufetolol hydrochloride (JP18)", "D01512  Befunolol hydrochloride (JAN)", "D01538  Valethamate bromide (JAN)", "D01553  Manidipine hydrochloride (JP18)", "D01562  Aranidipine (JAN/INN)", "D01573  Etilefrine hydrochloride (JP18)", "D01589  Mabuterol hydrochloride (JAN)", "D01592  Betahistine mesilate (JP18)", "D01604  Efonidipine hydrochloride ethanolate (JAN)", "D01635  Methoxyphenamine hydrochloride (JAN)", "D01648  Hyoscyamine methylbromide (JAN)", "D01654  Bepotastine besylate (USAN)", "D01674  Naftopidil (JP18/INN)", "D01691  Nipradilol (JAN/INN)", "D01697  Colforsin daropate hydrochloride (JAN)", "D01712  Theophylline sodium acetate (JAN)", "D01717  Levocabastine hydrochloride (JAN/USP)", "D01771  Proxyphylline (JAN/INN)", "D01794  Bopindolol malonate (JAN)", "D01801  Thonzylamine hydrochloride (JAN/USAN)", "D01830  Arotinolol hydrochloride (JP18)", "D01835  Clorprenaline hydrochloride (JAN/USAN)", "D01849  Lercanidipine hydrochloride (JAN/USAN)", "D01869  Ornoprostil (JAN/INN)", "D01887  Bunazosin hydrochloride (JP18)", "D01902  Fonazine mesylate (USAN)", "D01908  Nilvadipine (JP18/USAN/INN)", "D01922  Pratosartan (JAN/INN)", "D01925  Taltirelin hydrate (JP18)", "D01929  Tiotropium bromide hydrate (JAN)", "D01933  Vatanidipine hydrochloride (JAN)", "D01946  Oxitropium bromide (JAN/INN)", "D01955  Aclatonium napadisilate (JAN)", "D01958  Indenolol hydrochloride (JP18)", "D01964  Travoprost (JAN/USP/INN)", "D01969  Gallopamil hydrochloride (JAN)", "D01976  N-Methylscopolamine methylsulfate (JAN)", "D01978  Trimetoquinol hydrochloride", "D02007  Protirelin tartrate hydrate (JP18)", "D02014  Angiotensin II (USAN)", "D02017  Oxtriphylline (USP)", "D02045  Benidipine hydrochloride (JP18)", "D02066  Isoproterenol sulfate (USP)", "D02069  Atropine sulfate (JP18/USP)", "D02073  Gemeprost (JAN/USAN/INN)", "D02081  Metipranolol hydrochloride", "D02091  Tripelennamine hydrochloride (USP)", "D02092  Cisapride (JAN)", "D02093  Isoetharine hydrochloride (USP)", "D02109  dl-Methylephedrine hydrochloride (JP18)", "D02147  Albuterol (USP)", "D02149  Epinephrine bitartrate (JAN/USP)", "D02150  l-Isoprenaline hydrochloride (JP18)", "D02151  Tulobuterol (JP18/INN)", "D02218  Papaverine hydrochloride (JP18/USP)", "D02281  Levalbuterol hydrochloride (USP)", "D02342  Bisoprolol (JAN/USAN/INN)", "D02343  Carboprost (USAN/INN)", "D02356  Verapamil (USAN/INN)", "D02359  Ritodrine (USAN/INN)", "D02363  Ketanserin (USAN/INN)", "D02372  Perospirone hydrochloride hydrate (JAN)", "D02374  Metipranolol (USAN/INN)", "D02384  Verlukast (USAN/INN)", "D02389  Primidolol (USAN/INN)", "D02396  Hexoprenaline sulfate (USAN)", "D02404  Procaterol hydrochloride (USAN)", "D02419  Diphenhydramine salicylate (JAN)", "D02535  Timepidium bromide hydrate (JP18)", "D02537  Dronedarone (INN)", "D02577  Flibanserin (USAN/INN)", "D02599  Orphenadrine hydrochloride", "D02614  Denopamine (JAN/INN)", "D02630  Penfluridol (USAN/INN)", "D02633  Lomerizine hydrochloride (JAN)", "D02641  Butaclamol hydrochloride (USAN)", "D02702  Talibegron hydrochloride (USAN)", "D02705  Alprostadil alfadex (JP18)", "D02719  Rosaprostol (INN)", "D02722  Limaprost (INN)", "D02724  Bimatoprost (JAN/USAN/INN)", "D02732  Pranlukast hydrate (JP18)", "D02765  Adaprolol maleate (USAN)", "D02767  Adatanserin hydrochloride (USAN)", "D02834  Alprenoxime hydrochloride (USAN)", "D02860  Limaprost alfadex (JP18)", "D02910  Amiodarone (USAN/INN)", "D02914  Amlodipine maleate (USAN)", "D02939  Angiotensin amide (USAN)", "D02950  Antazoline phosphate (USP)", "D02976  Arbutamine hydrochloride (USAN)", "D02981  Arformoterol tartrate (USAN)", "D02983  Argipressin tannate (USAN)", "D03008  Atosiban (USAN/INN)", "D03067  Belfosdil (USAN/INN)", "D03088  Benzilonium bromide (USAN/INN)", "D03102  Betahistine hydrochloride (USP)", "D03195  Butopamine (USAN/INN)", "D03198  Butoxamine hydrochloride (USAN)", "D03285  Diphenhydramine tannate (JP18)", "D03290  Promethazine methylenedisalicylate (JAN)", "D03350  Canertinib dihydrochloride (USAN)", "D03360  Diphenhydramine laurylsulfate (JAN)", "D03399  Carboprost methyl (USAN)", "D03402  Carbuterol hydrochloride (USAN)", "D03415  Carvedilol phosphate (USAN)", "D03478  Choriogonadotropin alfa (USAN/INN)", "D03503  Cimetidine hydrochloride (USP)", "D03535  Clemastine (USAN)", "D03536  Clentiazem maleate (JAN/USAN)", "D03584  Colforsin (USAN/INN)", "D03654  Darifenacin (USAN/INN)", "D03655  Darodipine (USAN/INN)", "D03729  Dexpropranolol hydrochloride (USAN)", "D03814  Atropine methylbromide (JAN)", "D03854  Diphenhydramine citrate (USP)", "D03879  Dobutamine (USAN/INN)", "D03880  Dobutamine lactobionate (USAN)", "D03881  Dobutamine tartrate (USAN)", "D03914  Dronedarone hydrochloride (USP)", "D04018  Ephedrine sulfate (USP)", "D04057  Esoxybutynin chloride (USAN)", "D04072  Etafedrine hydrochloride (USAN)", "D04074  Etalocib (USAN)", "D04157  Fenoterol (USAN/INN)", "D04193  Flordipine (USAN/INN)", "D04479  Hyoscyamine hydrobromide (USP)", "D04488  Ibopamine (USAN/INN)", "D04625  Isoetharine (USP)", "D04626  Isoetharine mesylate (USP)", "D04657  Lacidipine (USAN/INN)", "D04701  Levalbuterol sulfate (USAN)", "D04703  Levalbuterol tartrate (USAN)", "D04708  Levdobutamine lactobionate (USAN)", "D04710  Levobetaxolol hydrochloride (USAN)", "D04868  Mebeverine hydrochloride (USAN)", "D04970  Methacholine chloride (JAN/USP/INN)", "D05024  Mibefradil dihydrochloride (USAN)", "D05037  Trimetoquinol hydrochloride hydrate (JP18)", "D05206  Norepinephrine bitartrate (USP)", "D05276  Pirenzepine hydrochloride hydrate (JP18)", "D05277  Formoterol fumarate hydrate (JP18)", "D05345  Pamatolol sulfate (USAN)", "D05366  Procaterol hydrochloride hydrate (JP18)", "D05399  Pelitinib (USAN/INN)", "D05429  Aminophylline hydrate (JP18)", "D05442  Perhexiline maleate (USAN)", "D05479  Pimagedine hydrochloride (USAN)", "D05660  Pyrilamine maleate (USP)", "D05699  Ranitidine bismuth citrate (USAN)", "D05714  Remacemide hydrochloride (USAN)", "D05718  Reproterol hydrochloride (USAN)", "D05727  Ridogrel (USAN/INN)", "D05792  Salmeterol (USAN/INN)", "D06103  Theophylline (USP)", "D06104  Theophylline sodium glycinate (USP)", "D06129  Tiapamil hydrochloride (USAN)", "D06246  Tripelennamine citrate", "D06274  Tafluprost (JAN/USAN/INN)", "D06363  Ziconotide (USAN/INN)", "D06633  Pruvanserin hydrochloride (USAN)", "D06672  Terlipressin (USAN/INN)", "D06877  Oxyphenonium bromide (INN)", "D07072  Niperotidine (INN)", "D07078  Rociverine (INN)", "D07079  Difemerine (INN)", "D07083  Otilonium bromide (INN)", "D07089  Moxaverine (INN)", "D07094  Pinaverium bromide (INN)", "D07097  Isometheptene mucate (USP)", "D07099  Cimetropium bromide (JAN/INN)", "D07181  Mepindolol (INN)", "D07183  Cloranolol (INN)", "D07185  Fendiline (INN)", "D07194  Thenalidine (INN)", "D07195  Chloropyramine (INN)", "D07196  Tolpropamine (INN)", "D07197  Bamipine (INN)", "D07198  Chlorphenoxamine (INN)", "D07226  Fesoterodine (INN)", "D07227  Ornipressin (INN)", "D07377  Bambuterol (INN)", "D07425  Papaverine (BAN)", "D07439  Papaverine sulfate", "D07450  Amlodipine (USP/INN)", "D07451  Amosulalol (INN)", "D07458  Antazoline (INN)", "D07459  Antazoline hydrochloride", "D07463  Arformoterol (INN)", "D07465  Arotinolol (INN)", "D07475  Atosiban acetate", "D07477  Atropine oxide (INN)", "D07483  Azelastine (INN)", "D07489  Bambuterol hydrochloride", "D07492  Bamipine dihydrochloride", "D07493  Bamipine lactate", "D07494  Barnidipine (INN)", "D07496  Befunolol (INN)", "D07509  Benidipine (INN)", "D07520  Bepridil (INN)", "D07522  Betahistine (INN)", "D07526  Betaxolol (INN)", "D07534  Bitolterol (INN)", "D07537  Bopindolol (INN)", "D07546  Bucladesine (INN)", "D07550  Bunazosin (INN)", "D07590  Bupranolol (INN)", "D07603  Caffeine citrate (USP)", "D07624  Carteolol (INN)", "D07679  Chloropyramine hydrochloride", "D07684  Chlorphenoxamine hydrochloride", "D07713  Clenbuterol (INN)", "D07734  Cinnarizine dihydrochloride", "D07820  Dicycloverine (INN)", "D07853  Dimetindene (INN)", "D07854  Dimetotiazine (INN)", "D07870  Dopamine (INN)", "D07886  Efonidipine (INN)", "D07905  Ergometrine (INN)", "D07906  Ergotamine (INN)", "D07931  Etilefrine (INN)", "D07943  Fendiline hydrochloride", "D07946  Fenoldopam (INN)", "D07951  Fentonium bromide (INN)", "D07971  Flunarizine (INN)", "D07990  Formoterol (INN)", "D08009  Gallopamil (INN)", "D08039  Hexoprenaline (INN)", "D08040  Histamine (DCF)", "D08054  Hydroxyzine (INN)", "D08057  Ibopamine hydrochloride", "D08074  Penbutolol (INN)", "D08078  Indenolol (INN)", "D08090  Isoprenaline (INN)", "D08091  Isothipendyl (INN)", "D08098  Ketamine (INN)", "D08099  Ketanserin tartrate", "D08106  Labetalol (INN)", "D08111  Lercanidipine (INN)", "D08115  Levobunolol (INN)", "D08117  Levocabastine (INN)", "D08124  Levosalbutamol (INN)", "D08155  Manidipine (INN)", "D08160  Mebeverine (INN)", "D08183  Mepyramine (INN)", "D08192  Metaraminol (INN)", "D08201  Methoxamine (BAN)", "D08207  Methylergometrine (INN)", "D08217  Mibefradil (INN)", "D08220  Midodrine (INN)", "D08229  Montelukast (INN)", "D08236  Mosapride (INN)", "D08238  Moxaverine hydrochloride", "D08270  Nicardipine (INN)", "D08284  Norepinephrine hydrochoride", "D08293  Olopatadine (INN)", "D08300  Orciprenaline (INN)", "D08305  Orphenadrine (INN)", "D08340  Perhexiline (INN)", "D08355  Pheniramine (INN)", "D08365  Phenylephrine (INN)", "D08366  Phenylephrine tartrate", "D08382  Piperidolate (INN)", "D08387  Pirbuterol (INN)", "D08389  Pirenzepine (USAN/INN)", "D08408  Pranlukast (INN)", "D08424  Procaterol (INN)", "D08432  Promethazine maleate", "D08441  Propiverine (INN)", "D08474  Reproterol (INN)", "D08494  Roxatidine (INN)", "D08495  Roxatidine acetate (BAN)", "D08508  Sarpogrelate (INN)", "D08522  Solifenacin (INN)", "D08525  Sotalol (INN)", "D08570  Terbutaline (INN)", "D08571  Terlipressin acetate (JAN)", "D08587  Thonzylamine (INN)", "D08591  Tiaprost (INN)", "D08595  Tiemonium methylsulfate", "D08598  Tilisolol (INN)", "D08600  Timolol (INN)", "D08624  Tramazoline (INN)", "D08629  Tretoquinol (INN)", "D08645  Tripelennamine (INN)", "D08661  Unoprostone (INN)", "D08667  Calcium valproate", "D08686  Ziconotide acetate", "D08768  Promethazine hibenzate", "D08837  Aclidinium bromide (JAN/USAN/INN)", "D08864  Azilsartan (JAN/USAN/INN)", "D08892  Clevidipine (USAN/INN)", "D08923  Fesoterodine fumarate (JAN/USAN)", "D08937  Labradimil (INN/USAN)", "D08941  Levamlodipine malate (USAN)", "D08945  Milveterol hydrochloride (USAN)", "D08966  Phenylephrine bitartrate (USP)", "D08986  Retosiban (USAN)", "D09003  Sonedenoson (USAN)", "D09318  Indacaterol (USAN/INN)", "D09319  Indacaterol maleate (JAN/USAN)", "D09402  Darotropium bromide (USAN/INN)", "D09535  Mirabegron (JAN/USAN/INN)", "D09645  Nelotanserin (USAN/INN)", "D09693  Velusetrag (USAN/INN)", "D09694  Velusetrag hydrochloride (USAN)", "D09696  Vilanterol (USAN/INN)", "D09697  Vilanterol trifenatate (JAN/USAN)", "D09705  Bepotastine (USAN/INN)", "D09732  Ritobegron ethyl hydrochloride (JAN)", "D09752  Carpronium chloride hydrate (JAN)", "D09765  Vorapaxar (USAN/INN)", "D09766  Vorapaxar sulfate (JAN/USAN)", "D09774  Imitrodast sodium (JAN)", "D09784  Garomefrine hydrochloride (JAN)", "D09789  Kirenidipine hydrochloride (JAN)", "D09794  Norepinephrine hydrochloride (JAN)", "D09797  Cargutocin (INN/JAN)", "D09820  Vasopressin tannate (JAN)", "D09822  Theosalicin (JAN)", "D09866  Atopaxar (USAN)", "D09867  Atopaxar hydrobromide (USAN)", "D09883  Dacomitinib (INN)", "D09933  Naronapride (USAN/INN)", "D09934  Naronapride dihydrochloride (USAN)", "D09976  Temanogrel (USAN/INN)", "D09977  Temanogrel hydrochloride (USAN)", "D10006  Eplivanserin (USAN/INN)", "D10020  Olodaterol hydrochloride (JAN/USAN)", "D10099  Cerlapirdine (USAN)", "D10100  Cerlapirdine hydrochloride (USAN)", "D10117  Epelsiban (USAN)", "D10118  Epelsiban besylate (USAN)", "D10145  Olodaterol (USAN/INN)", "D10180  Umeclidinium (USAN)", "D10181  Umeclidinium bromide (JAN/USAN)", "D10219  Abediterol (USAN/INN)", "D10220  Abediterol napadisylate (USAN)", "D10514  Dacomitinib (USAN)", "D10545  Batefenterol (USAN)", "D10546  Batefenterol succinate (USAN)", "D10853  Desfesoterodine (INN)", "D10932  Etripamil (USAN/INN)", "D11009  Indacaterol acetate (JAN)", "D11102  Tamolarizine hydrochloride (JAN)", "D11142  Angiotensin II acetate (USAN)", "D11363  Reldesemtiv (USAN)", "D11630  Aminophylline dihydrate", "D11723  Levamlodipine maleate (USAN)", "D11776  Sparsentan (USAN/INN)", "D11881  Amlodipine benzoate", "D11900  Navafenterol (USAN)", "D11901  Navafenterol saccharinate (USAN)", "D11976  Fezolinetant (USAN)", "D12061  Suvecaltamide (USAN)", "D12062  Suvecaltamide hydrocloride (USAN)", "D12123  Elinzanetant (USAN/INN)", "D12157  Felcisetrag (USAN/INN)", "D12599  Bimatoprost grenod (USAN)", "D12804  Nelutroctiv (USAN/INN)", "D12819  Ulixacaltamide (USAN/INN)", "D12820  Ulixacaltamide hydrochloride (USAN)", "D12867  Ismidenon (USAN)"], "dblinks": "GO: 0019722", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["6546  SLC8A1; solute carrier family 8 member A1 [KO:K05849]", "6543  SLC8A2; solute carrier family 8 member A2 [KO:K05849]", "6547  SLC8A3; solute carrier family 8 member A3 [KO:K05849]", "490  ATP2B1; ATPase plasma membrane Ca2+ transporting 1 [KO:K05850] [EC:7.2.2.10]", "492  ATP2B3; ATPase plasma membrane Ca2+ transporting 3 [KO:K05850] [EC:7.2.2.10]", "493  ATP2B4; ATPase plasma membrane Ca2+ transporting 4 [KO:K05850] [EC:7.2.2.10]", "491  ATP2B2; ATPase plasma membrane Ca2+ transporting 2 [KO:K05850] [EC:7.2.2.10]", "1128  CHRM1; cholinergic receptor muscarinic 1 [KO:K04129]", "1131  CHRM3; cholinergic receptor muscarinic 3 [KO:K04131]", "1133  CHRM5; cholinergic receptor muscarinic 5 [KO:K04133]", "135  ADORA2A; adenosine A2a receptor [KO:K04266]", "136  ADORA2B; adenosine A2b receptor [KO:K04267]", "153  ADRB1; adrenoceptor beta 1 [KO:K04141]", "154  ADRB2; adrenoceptor beta 2 [KO:K04142]", "155  ADRB3; adrenoceptor beta 3 [KO:K04143]", "1812  DRD1; dopamine receptor D1 [KO:K04144]", "1816  DRD5; dopamine receptor D5 [KO:K05840]", "3274  HRH2; histamine receptor H2 [KO:K04150]", "3360  HTR4; 5-hydroxytryptamine receptor 4 [KO:K04160]", "3361  HTR5A; 5-hydroxytryptamine receptor 5A [KO:K04161]", "3362  HTR6; 5-hydroxytryptamine receptor 6 [KO:K04162]", "3363  HTR7; 5-hydroxytryptamine receptor 7 [KO:K04163]", "2778  GNAS; GNAS complex locus [KO:K04632]", "2774  GNAL; G protein subunit alpha L [KO:K04633]", "107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]", "108  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]", "109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]", "196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]", "113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]", "114  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]", "115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "5350  PLN; phospholamban [KO:K05852]", "6588  SLN; sarcolipin [KO:K22642]", "100507027  MRLN; myoregulin [KO:K22643]", "401152  C4orf3; chromosome 4 open reading frame 3 [KO:K26467]", "100130933  SMIM6; small integral membrane protein 6 [KO:K26468]", "487  ATP2A1; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 [KO:K05853] [EC:7.2.2.10]", "489  ATP2A3; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 [KO:K05853] [EC:7.2.2.10]", "488  ATP2A2; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 [KO:K05853] [EC:7.2.2.10]", "3270  HRC; histidine rich calcium binding protein [KO:K23450]", "6786  STIM1; stromal interaction molecule 1 [KO:K16059]", "57620  STIM2; stromal interaction molecule 2 [KO:K18196]", "84876  ORAI1; ORAI calcium release-activated calcium modulator 1 [KO:K16056]", "80228  ORAI2; ORAI calcium release-activated calcium modulator 2 [KO:K16057]", "93129  ORAI3; ORAI calcium release-activated calcium modulator 3 [KO:K16058]", "775  CACNA1C; calcium voltage-gated channel subunit alpha1 C [KO:K04850]", "776  CACNA1D; calcium voltage-gated channel subunit alpha1 D [KO:K04851]", "778  CACNA1F; calcium voltage-gated channel subunit alpha1 F [KO:K04853]", "779  CACNA1S; calcium voltage-gated channel subunit alpha1 S [KO:K04857]", "773  CACNA1A; calcium voltage-gated channel subunit alpha1 A [KO:K04344]", "774  CACNA1B; calcium voltage-gated channel subunit alpha1 B [KO:K04849]", "777  CACNA1E; calcium voltage-gated channel subunit alpha1 E [KO:K04852]", "8913  CACNA1G; calcium voltage-gated channel subunit alpha1 G [KO:K04854]", "8912  CACNA1H; calcium voltage-gated channel subunit alpha1 H [KO:K04855]", "8911  CACNA1I; calcium voltage-gated channel subunit alpha1 I [KO:K04856]", "1139  CHRNA7; cholinergic receptor nicotinic alpha 7 subunit [KO:K04809]", "2902  GRIN1; glutamate ionotropic receptor NMDA type subunit 1 [KO:K05208]", "2903  GRIN2A; glutamate ionotropic receptor NMDA type subunit 2A [KO:K05209]", "2904  GRIN2B; glutamate ionotropic receptor NMDA type subunit 2B [KO:K05210]", "2905  GRIN2C; glutamate ionotropic receptor NMDA type subunit 2C [KO:K05211]", "2906  GRIN2D; glutamate ionotropic receptor NMDA type subunit 2D [KO:K05212]", "116443  GRIN3A; glutamate ionotropic receptor NMDA type subunit 3A [KO:K05213]", "116444  GRIN3B; glutamate ionotropic receptor NMDA type subunit 3B [KO:K05214]", "5023  P2RX1; purinergic receptor P2X 1 [KO:K05215]", "22953  P2RX2; purinergic receptor P2X 2 [KO:K05216]", "5024  P2RX3; purinergic receptor P2X 3 [KO:K05217]", "5025  P2RX4; purinergic receptor P2X 4 [KO:K05218]", "5026  P2RX5; purinergic receptor P2X 5 [KO:K05219]", "9127  P2RX6; purinergic receptor P2X 6 [KO:K05221]", "5027  P2RX7; purinergic receptor P2X 7 [KO:K05220]", "6261  RYR1; ryanodine receptor 1 [KO:K04961]", "6262  RYR2; ryanodine receptor 2 [KO:K04962]", "6263  RYR3; ryanodine receptor 3 [KO:K04963]", "10345  TRDN; triadin [KO:K23449]", "844  CASQ1; calsequestrin 1 [KO:K23468]", "845  CASQ2; calsequestrin 2 [KO:K23445]", "444  ASPH; aspartate beta-hydroxylase [KO:K00476] [EC:1.14.11.16]", "10800  CYSLTR1; cysteinyl leukotriene receptor 1 [KO:K04322]", "57105  CYSLTR2; cysteinyl leukotriene receptor 2 [KO:K04323]", "1129  CHRM2; cholinergic receptor muscarinic 2 [KO:K04130]", "148  ADRA1A; adrenoceptor alpha 1A [KO:K04135]", "147  ADRA1B; adrenoceptor alpha 1B [KO:K04136]", "146  ADRA1D; adrenoceptor alpha 1D [KO:K04137]", "185  AGTR1; angiotensin II receptor type 1 [KO:K04166]", "1909  EDNRA; endothelin receptor type A [KO:K04197]", "1910  EDNRB; endothelin receptor type B [KO:K04198]", "2149  F2R; coagulation factor II thrombin receptor [KO:K03914]", "2911  GRM1; glutamate metabotropic receptor 1 [KO:K04603]", "2915  GRM5; glutamate metabotropic receptor 5 [KO:K04604]", "2925  GRPR; gastrin releasing peptide receptor [KO:K04169]", "3269  HRH1; histamine receptor H1 [KO:K04149]", "3356  HTR2A; 5-hydroxytryptamine receptor 2A [KO:K04157]", "3357  HTR2B; 5-hydroxytryptamine receptor 2B [KO:K04157]", "3358  HTR2C; 5-hydroxytryptamine receptor 2C [KO:K04157]", "3973  LHCGR; luteinizing hormone/choriogonadotropin receptor [KO:K04248]", "4923  NTSR1; neurotensin receptor 1 [KO:K04211]", "5021  OXTR; oxytocin receptor [KO:K04229]", "552  AVPR1A; arginine vasopressin receptor 1A [KO:K04226]", "553  AVPR1B; arginine vasopressin receptor 1B [KO:K04227]", "56413  LTB4R2; leukotriene B4 receptor 2 [KO:K04297]", "5724  PTAFR; platelet activating factor receptor [KO:K04279]", "5731  PTGER1; prostaglandin E receptor 1 [KO:K04258]", "5733  PTGER3; prostaglandin E receptor 3 [KO:K04260]", "5737  PTGFR; prostaglandin F receptor [KO:K04262]", "623  BDKRB1; bradykinin receptor B1 [KO:K03915]", "624  BDKRB2; bradykinin receptor B2 [KO:K03916]", "6869  TACR1; tachykinin receptor 1 [KO:K04222]", "6865  TACR2; tachykinin receptor 2 [KO:K04223]", "6870  TACR3; tachykinin receptor 3 [KO:K04224]", "6915  TBXA2R; thromboxane A2 receptor [KO:K04264]", "7201  TRHR; thyrotropin releasing hormone receptor [KO:K04282]", "886  CCKAR; cholecystokinin A receptor [KO:K04194]", "887  CCKBR; cholecystokinin B receptor [KO:K04195]", "7852  CXCR4; C-X-C motif chemokine receptor 4 [KO:K04189]", "2776  GNAQ; G protein subunit alpha q [KO:K04634]", "2767  GNA11; G protein subunit alpha 11 [KO:K04635]", "9630  GNA14; G protein subunit alpha 14 [KO:K04636]", "2769  GNA15; G protein subunit alpha 15 [KO:K04637]", "1950  EGF; epidermal growth factor [KO:K04357]", "7039  TGFA; transforming growth factor alpha [KO:K08774]", "5154  PDGFA; platelet derived growth factor subunit A [KO:K04359]", "5155  PDGFB; platelet derived growth factor subunit B [KO:K17386]", "56034  PDGFC; platelet derived growth factor C [KO:K05450]", "80310  PDGFD; platelet derived growth factor D [KO:K05450]", "2246  FGF1; fibroblast growth factor 1 [KO:K18496]", "2247  FGF2; fibroblast growth factor 2 [KO:K18497]", "2248  FGF3; fibroblast growth factor 3 [KO:K04358]", "2249  FGF4; fibroblast growth factor 4 [KO:K04358]", "8822  FGF17; fibroblast growth factor 17 [KO:K04358]", "2251  FGF6; fibroblast growth factor 6 [KO:K04358]", "2252  FGF7; fibroblast growth factor 7 [KO:K04358]", "2253  FGF8; fibroblast growth factor 8 [KO:K04358]", "2254  FGF9; fibroblast growth factor 9 [KO:K04358]", "2255  FGF10; fibroblast growth factor 10 [KO:K04358]", "8823  FGF16; fibroblast growth factor 16 [KO:K04358]", "2250  FGF5; fibroblast growth factor 5 [KO:K04358]", "8817  FGF18; fibroblast growth factor 18 [KO:K04358]", "26281  FGF20; fibroblast growth factor 20 [KO:K04358]", "27006  FGF22; fibroblast growth factor 22 [KO:K04358]", "9965  FGF19; fibroblast growth factor 19 [KO:K22603]", "26291  FGF21; fibroblast growth factor 21 [KO:K22429]", "8074  FGF23; fibroblast growth factor 23 [KO:K22428]", "7422  VEGFA; vascular endothelial growth factor A [KO:K05448]", "7423  VEGFB; vascular endothelial growth factor B [KO:K16858]", "7424  VEGFC; vascular endothelial growth factor C [KO:K05449]", "2277  VEGFD; vascular endothelial growth factor D [KO:K05449]", "4803  NGF; nerve growth factor [KO:K02582]", "3082  HGF; hepatocyte growth factor [KO:K05460]", "4485  MST1; macrophage stimulating 1 [KO:K23441]", "2668  GDNF; glial cell derived neurotrophic factor [KO:K05452]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "2064  ERBB2; erb-b2 receptor tyrosine kinase 2 [KO:K05083] [EC:2.7.10.1]", "2065  ERBB3; erb-b2 receptor tyrosine kinase 3 [KO:K05084] [EC:2.7.10.1]", "2066  ERBB4; erb-b2 receptor tyrosine kinase 4 [KO:K05085] [EC:2.7.10.1]", "5156  PDGFRA; platelet derived growth factor receptor alpha [KO:K04363] [EC:2.7.10.1]", "5159  PDGFRB; platelet derived growth factor receptor beta [KO:K05089] [EC:2.7.10.1]", "2260  FGFR1; fibroblast growth factor receptor 1 [KO:K04362] [EC:2.7.10.1]", "2263  FGFR2; fibroblast growth factor receptor 2 [KO:K05093] [EC:2.7.10.1]", "2261  FGFR3; fibroblast growth factor receptor 3 [KO:K05094] [EC:2.7.10.1]", "2264  FGFR4; fibroblast growth factor receptor 4 [KO:K05095] [EC:2.7.10.1]", "2321  FLT1; fms related receptor tyrosine kinase 1 [KO:K05096] [EC:2.7.10.1]", "2324  FLT4; fms related receptor tyrosine kinase 4 [KO:K05097] [EC:2.7.10.1]", "3791  KDR; kinase insert domain receptor [KO:K05098] [EC:2.7.10.1]", "4914  NTRK1; neurotrophic receptor tyrosine kinase 1 [KO:K03176] [EC:2.7.10.1]", "4915  NTRK2; neurotrophic receptor tyrosine kinase 2 [KO:K04360] [EC:2.7.10.1]", "4916  NTRK3; neurotrophic receptor tyrosine kinase 3 [KO:K05101] [EC:2.7.10.1]", "4233  MET; MET proto-oncogene, receptor tyrosine kinase [KO:K05099] [EC:2.7.10.1]", "4486  MST1R; macrophage stimulating 1 receptor [KO:K05100] [EC:2.7.10.1]", "5979  RET; ret proto-oncogene [KO:K05126] [EC:2.7.10.1]", "102723407  IGH; immunoglobulin heavy variable 4-38-2-like [KO:K06856]", "5333  PLCD1; phospholipase C delta 1 [KO:K05857] [EC:3.1.4.11]", "113026  PLCD3; phospholipase C delta 3 [KO:K05857] [EC:3.1.4.11]", "84812  PLCD4; phospholipase C delta 4 [KO:K05857] [EC:3.1.4.11]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]", "51196  PLCE1; phospholipase C epsilon 1 [KO:K05860] [EC:3.1.4.11]", "89869  PLCZ1; phospholipase C zeta 1 [KO:K05861] [EC:3.1.4.11]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "952  CD38; CD38 molecule [KO:K01242] [EC:3.2.2.6 2.4.99.20]", "53373  TPCN1; two pore segment channel 1 [KO:K16896]", "219931  TPCN2; two pore segment channel 2 [KO:K14077]", "57192  MCOLN1; mucolipin TRP cation channel 1 [KO:K04992]", "255231  MCOLN2; mucolipin TRP cation channel 2 [KO:K04993]", "55283  MCOLN3; mucolipin TRP cation channel 3 [KO:K04994]", "8877  SPHK1; sphingosine kinase 1 [KO:K04718] [EC:2.7.1.91]", "56848  SPHK2; sphingosine kinase 2 [KO:K04718] [EC:2.7.1.91]", "90550  MCU; mitochondrial calcium uniporter [KO:K20858]", "7416  VDAC1; voltage dependent anion channel 1 [KO:K05862]", "7417  VDAC2; voltage dependent anion channel 2 [KO:K15040]", "7419  VDAC3; voltage dependent anion channel 3 [KO:K15041]", "291  SLC25A4; solute carrier family 25 member 4 [KO:K05863]", "292  SLC25A5; solute carrier family 25 member 5 [KO:K05863]", "293  SLC25A6; solute carrier family 25 member 6 [KO:K05863]", "83447  SLC25A31; solute carrier family 25 member 31 [KO:K05863]", "10105  PPIF; peptidylprolyl isomerase F [KO:K09565] [EC:5.2.1.8]", "7134  TNNC1; troponin C1, slow skeletal and cardiac type [KO:K05865]", "7125  TNNC2; troponin C2, fast skeletal type [KO:K12042]", "810  CALML3; calmodulin like 3 [KO:K02183]", "805  CALM2; calmodulin 2 [KO:K02183]", "808  CALM3; calmodulin 3 [KO:K02183]", "801  CALM1; calmodulin 1 [KO:K02183]", "163688  CALML6; calmodulin like 6 [KO:K02183]", "51806  CALML5; calmodulin like 5 [KO:K02183]", "91860  CALML4; calmodulin like 4 [KO:K02183]", "5260  PHKG1; phosphorylase kinase catalytic subunit gamma 1 [KO:K00871] [EC:2.7.11.19]", "5261  PHKG2; phosphorylase kinase catalytic subunit gamma 2 [KO:K00871] [EC:2.7.11.19]", "5257  PHKB; phosphorylase kinase regulatory subunit beta [KO:K07190]", "5256  PHKA2; phosphorylase kinase regulatory subunit alpha 2 [KO:K07190]", "5255  PHKA1; phosphorylase kinase regulatory subunit alpha 1 [KO:K07190]", "4638  MYLK; myosin light chain kinase [KO:K00907] [EC:2.7.11.18]", "85366  MYLK2; myosin light chain kinase 2 [KO:K00907] [EC:2.7.11.18]", "91807  MYLK3; myosin light chain kinase 3 [KO:K00907] [EC:2.7.11.18]", "340156  MYLK4; myosin light chain kinase family member 4 [KO:K00907] [EC:2.7.11.18]", "57118  CAMK1D; calcium/calmodulin dependent protein kinase ID [KO:K08794] [EC:2.7.11.17]", "57172  CAMK1G; calcium/calmodulin dependent protein kinase IG [KO:K08794] [EC:2.7.11.17]", "8536  CAMK1; calcium/calmodulin dependent protein kinase I [KO:K08794] [EC:2.7.11.17]", "815  CAMK2A; calcium/calmodulin dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]", "817  CAMK2D; calcium/calmodulin dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]", "816  CAMK2B; calcium/calmodulin dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]", "818  CAMK2G; calcium/calmodulin dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]", "814  CAMK4; calcium/calmodulin dependent protein kinase IV [KO:K05869] [EC:2.7.11.17]", "5530  PPP3CA; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]", "5532  PPP3CB; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]", "5533  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]", "5534  PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]", "5535  PPP3R2; protein phosphatase 3 regulatory subunit B, beta [KO:K06268]", "7942  TFEB; transcription factor EB [KO:K15590]", "4772  NFATC1; nuclear factor of activated T cells 1 [KO:K04446]", "4773  NFATC2; nuclear factor of activated T cells 2 [KO:K17332]", "4775  NFATC3; nuclear factor of activated T cells 3 [KO:K17333]", "4776  NFATC4; nuclear factor of activated T cells 4 [KO:K17334]", "4842  NOS1; nitric oxide synthase 1 [KO:K13240] [EC:1.14.13.39]", "4843  NOS2; nitric oxide synthase 2 [KO:K13241] [EC:1.14.13.39]", "4846  NOS3; nitric oxide synthase 3 [KO:K13242] [EC:1.14.13.39]", "5136  PDE1A; phosphodiesterase 1A [KO:K13755] [EC:3.1.4.17]", "5153  PDE1B; phosphodiesterase 1B [KO:K13755] [EC:3.1.4.17]", "5137  PDE1C; phosphodiesterase 1C [KO:K13755] [EC:3.1.4.17]", "2185  PTK2B; protein tyrosine kinase 2 beta [KO:K05871] [EC:2.7.10.2]", "3707  ITPKB; inositol-trisphosphate 3-kinase B [KO:K00911] [EC:2.7.1.127]", "3706  ITPKA; inositol-trisphosphate 3-kinase A [KO:K00911] [EC:2.7.1.127]", "80271  ITPKC; inositol-trisphosphate 3-kinase C [KO:K00911] [EC:2.7.1.127]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]"], "compound": ["C00002  ATP", "C00004  NADH", "C00076  Calcium cation", "C00165  Diacylglycerol", "C00575  3',5'-Cyclic AMP", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C01330  Sodium cation", "C06124  Sphingosine 1-phosphate", "C11556  1-Phosphatidyl-1D-myo-inositol 3,5-bisphosphate", "C13050  Cyclic ADP-ribose", "C13051  Nicotinic acid adenine dinucleotide phosphate"], "refs": [{"pmid": "12838335", "authors": "  Berridge MJ, Bootman MD, Roderick HL.", "title": "Calcium signalling: dynamics, homeostasis and remodelling.", "journal": "Nat Rev Mol Cell Biol 4:517-29 (2003)", "doi": "10.1038/nrm1155"}, {"pmid": "11413485", "authors": "  Berridge MJ, Lipp P, Bootman MD.", "title": "The versatility and universality of calcium signalling.", "journal": "Nat Rev Mol Cell Biol 1:11-21 (2000)", "doi": "10.1038/35036035"}, {"pmid": "15111104", "authors": "  Wang MC, Dolphin A, Kitmitto A.", "title": "L-type voltage-gated calcium channels: understanding function through structure.", "journal": "FEBS Lett 564:245-50 (2004)", "doi": "10.1016/S0014-5793(04)00253-4"}, {"pmid": "11299192", "authors": "  Ferrier GR, Howlett SE.", "title": "Cardiac excitation-contraction coupling: role of membrane potential in regulation of contraction.", "journal": "Am J Physiol Heart Circ Physiol 280:H1928-44 (2001)", "doi": "10.1152/ajpheart.2001.280.5.H1928"}, {"pmid": "11698232", "authors": "  Keef KD, Hume JR, Zhong J.", "title": "Regulation of cardiac and smooth muscle Ca(2+) channels (Ca(V)1.2a,b) by protein kinases.", "journal": "Am J Physiol Cell Physiol 281:C1743-56 (2001)", "doi": "10.1152/ajpcell.2001.281.6.C1743"}, {"pmid": "15000521", "authors": "  Yunker AM.", "title": "Modulation and pharmacology of low voltage-activated (\"T-Type\") calcium channels.", "journal": "J Bioenerg Biomembr 35:577-98 (2003)", "doi": "10.1023/B:JOBB.0000008025.65675.37"}, {"pmid": "9149541", "authors": "  Yakel JL.", "title": "Calcineurin regulation of synaptic function: from ion channels to transmitter release and gene transcription.", "journal": "Trends Pharmacol Sci 18:124-34 (1997)", "doi": "10.1016/S0165-6147(97)01046-8"}, {"pmid": "10997573", "authors": "  Fukunaga K, Miyamoto E.", "title": "A working model of CaM kinase II activity in hippocampal long-term potentiation and memory.", "journal": "Neurosci Res 38:3-17 (2000)", "doi": "10.1016/S0168-0102(00)00139-5"}, {"pmid": "9235901", "authors": "  Della Rocca GJ, van Biesen T, Daaka Y, Luttrell DK, Luttrell LM, Lefkowitz RJ.", "title": "Ras-dependent mitogen-activated protein kinase activation by G protein-coupled receptors. Convergence of Gi- and Gq-mediated pathways on calcium/calmodulin, Pyk2, and Src kinase.", "journal": "J Biol Chem 272:19125-32 (1997)", "doi": "10.1074/jbc.272.31.19125"}, {"pmid": "7861177", "authors": "  Furuichi T, Mikoshiba K.", "title": "Inositol 1, 4, 5-trisphosphate receptor-mediated Ca2+ signaling in the brain.", "journal": "J Neurochem 64:953-60 (1995)", "doi": "10.1046/j.1471-4159.1995.64030953.x"}, {"pmid": "14572802", "authors": "  Bruce JI, Straub SV, Yule DI.", "title": "Crosstalk between cAMP and Ca2+ signaling in non-excitable cells.", "journal": "Cell Calcium 34:431-44 (2003)", "doi": "10.1016/S0143-4160(03)00150-7"}, {"pmid": "10331643", "authors": "  Lee HC, Munshi C, Graeff R.", "title": "Structures and activities of cyclic ADP-ribose, NAADP and their metabolic enzymes.", "journal": "Mol Cell Biochem 193:89-98 (1999)", "doi": "10.1007/978-1-4419-8740-2_13"}, {"pmid": "11080247", "authors": "  Crompton M.", "title": "Mitochondrial intermembrane junctional complexes and their role in cell death.", "journal": "J Physiol 529 Pt 1:11-21 (2000)", "doi": "10.1111/j.1469-7793.2000.00011.x"}, {"pmid": "10508738", "authors": "  Grewal SS, York RD, Stork PJ.", "title": "Extracellular-signal-regulated kinase signalling in neurons.", "journal": "Curr Opin Neurobiol 9:544-53 (1999)", "doi": "10.1016/S0959-4388(99)00010-0"}, {"pmid": "12972622", "authors": "  Trushin SA, Pennington KN, Carmona EM, Asin S, Savoy DN, Billadeau DD, Paya CV.", "title": "Protein kinase Calpha (PKCalpha) acts upstream of PKCtheta to activate IkappaB kinase and NF-kappaB in T lymphocytes.", "journal": "Mol Cell Biol 23:7068-81 (2003)", "doi": "10.1128/MCB.23.19.7068-7081.2003"}, {"pmid": "14517314", "authors": "  Hutchins JR, Dikovskaya D, Clarke PR.", "title": "Regulation of Cdc2/cyclin B activation in Xenopus egg extracts via inhibitory phosphorylation of Cdc25C phosphatase by Ca(2+)/calmodulin-dependent protein [corrected] kinase II.", "journal": "Mol Biol Cell 14:4003-14 (2003)", "doi": "10.1091/mbc.E03-02-0061"}, {"pmid": "21338471", "authors": "  Tornquist K", "title": "Sphingosine 1-phosphate, sphingosine kinase and autocrine calcium signalling in thyroid cells.", "journal": "Acta Physiol (Oxf) 204:151-7 (2012)", "doi": "10.1111/j.1748-1716.2011.02265.x"}, {"pmid": "22129055", "authors": "  Feske S", "title": "Immunodeficiency due to defects in store-operated calcium entry.", "journal": "Ann N Y Acad Sci 1238:74-90 (2011)", "doi": "10.1111/j.1749-6632.2011.06240.x"}, {"pmid": "22002090", "authors": "  Giachini FR, Lima VV, Hannan JL, Carneiro FS, Webb RC, Tostes RC", "title": "STIM1/Orai1-mediated store-operated Ca2+ entry: the tip of the iceberg.", "journal": "Braz J Med Biol Res 44:1080-7 (2011)", "doi": "10.1590/S0100-879X2011007500133"}, {"pmid": "19475418", "authors": "  Galione A, Evans AM, Ma J, Parrington J, Arredouani A, Cheng X, Zhu MX", "title": "The acid test: the discovery of two-pore channels (TPCs) as NAADP-gated endolysosomal Ca(2+) release channels.", "journal": "Pflugers Arch 458:869-76 (2009)", "doi": "10.1007/s00424-009-0682-y"}, {"pmid": "19434403", "authors": "  Beard NA, Wei L, Dulhunty AF", "title": "Ca(2+) signaling in striated muscle: the elusive roles of triadin, junctin, and calsequestrin.", "journal": "Eur Biophys J 39:27-36 (2009)", "doi": "10.1007/s00249-009-0449-6"}, {"pmid": "26228554", "authors": "  Marty I", "title": "Triadin regulation of the ryanodine receptor complex.", "journal": "J Physiol 593:3261-6 (2015)", "doi": "10.1113/jphysiol.2014.281147"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04070  Phosphatidylinositol signaling system", "hsa04210  Apoptosis", "hsa04720  Long-term potentiation", "hsa04730  Long-term depression"], "ko_pathway": "ko04020", "genes": ["EGFR", "MET", "KDR"]}, {"kegg_id": "hsa04066", "name": "HIF-1 signaling pathway - Homo sapiens (human)", "description": "Hypoxia-inducible factor 1 (HIF-1) is a transcription factor that functions as a master regulator of oxygen homeostasis. It consists of two subunits: an inducibly-expressed HIF-1alpha subunit and a constitutively-expressed HIF-1beta subunit. Under normoxia, HIF-1 alpha undergoes hydroxylation at specific prolyl residues which leads to an immediate ubiquitination and subsequent proteasomal degradation of the subunit. In contrast, under hypoxia, HIF-1 alpha subunit becomes stable and interacts with coactivators such as p300/CBP to modulate its transcriptional activity. Eventually, HIF-1 acts as a master regulator of numerous hypoxia-inducible genes under hypoxic conditions. The target genes of HIF-1 encode proteins that increase O2 delivery and mediate adaptive responses to O2 deprivation. Despite its name, HIF-1 is induced not only in response to reduced oxygen availability but also by other stimulants, such as nitric oxide, or various growth factors.", "class": "Environmental Information Processing; Signal transduction", "pathway_map": "hsa04066  HIF-1 signaling pathway", "network": ["", "ELEMENT   N00079  HIF-1 signaling pathway"], "drug": ["D09926  Icrucumab (USAN/INN)", "D10334  Rebastinib (USAN)", "D10386  Cindunistat (USAN/INN)", "D10395  Nesvacumab (USAN/INN)", "D10399  Rebastinib Tosylate (USAN)", "D10419  Cindunistat hydrochloride maleate (USAN)", "D10464  Firtecan pegol (USAN/INN)", "D10593  Roxadustat (JAN/USAN/INN)", "D10874  Daprodustat (JAN/USAN/INN)", "D11078  Vadadustat (JAN/USAN/INN)", "D11273  Molidustat sodium (JAN/USAN)", "D11452  Tomivosertib (USAN/INN)", "D11481  Tomivosertib hydrochloride (USAN)", "D11523  Enarodustat (JAN)", "D11540  Razuprotafib (USAN)", "D11812  Pabinafusp alfa (genetical recombination) (JAN)", "D12122  Molidustat (USAN/INN)", "D12394  Inobrodib (USAN)", "D12509  Trontinemab (USAN/INN)", "D12806  Tividenofusp alfa (USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["3569  IL6; interleukin 6 [KO:K05405]", "3570  IL6R; interleukin 6 receptor [KO:K05055]", "6774  STAT3; signal transducer and activator of transcription 3 [KO:K04692]", "7099  TLR4; toll like receptor 4 [KO:K10160]", "3458  IFNG; interferon gamma [KO:K04687]", "3459  IFNGR1; interferon gamma receptor 1 [KO:K05132]", "3460  IFNGR2; interferon gamma receptor 2 [KO:K05133]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "3630  INS; insulin [KO:K04526]", "1950  EGF; epidermal growth factor [KO:K04357]", "3479  IGF1; insulin like growth factor 1 [KO:K05459]", "3643  INSR; insulin receptor [KO:K04527] [EC:2.7.10.1]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "3480  IGF1R; insulin like growth factor 1 receptor [KO:K05087] [EC:2.7.10.1]", "2064  ERBB2; erb-b2 receptor tyrosine kinase 2 [KO:K05083] [EC:2.7.10.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "8569  MKNK1; MAPK interacting serine/threonine kinase 1 [KO:K04372] [EC:2.7.11.1]", "2872  MKNK2; MAPK interacting serine/threonine kinase 2 [KO:K04372] [EC:2.7.11.1]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "1978  EIF4EBP1; eukaryotic translation initiation factor 4E binding protein 1 [KO:K07205]", "1977  EIF4E; eukaryotic translation initiation factor 4E [KO:K03259]", "9470  EIF4E2; eukaryotic translation initiation factor 4E family member 2 [KO:K03259]", "253314  EIF4E1B; eukaryotic translation initiation factor 4E family member 1B [KO:K03259]", "6198  RPS6KB1; ribosomal protein S6 kinase B1 [KO:K04688] [EC:2.7.11.1]", "6199  RPS6KB2; ribosomal protein S6 kinase B2 [KO:K04688] [EC:2.7.11.1]", "6194  RPS6; ribosomal protein S6 [KO:K02991]", "3091  HIF1A; hypoxia inducible factor 1 subunit alpha [KO:K08268]", "7428  VHL; von Hippel-Lindau tumor suppressor [KO:K03871]", "9978  RBX1; ring-box 1 [KO:K03868] [EC:2.3.2.32]", "6921  ELOC; elongin C [KO:K03872]", "6923  ELOB; elongin B [KO:K03873]", "8453  CUL2; cullin 2 [KO:K03870]", "54583  EGLN1; egl-9 family hypoxia inducible factor 1 [KO:K09592] [EC:1.14.11.29]", "112399  EGLN3; egl-9 family hypoxia inducible factor 3 [KO:K09592] [EC:1.14.11.29]", "112398  EGLN2; egl-9 family hypoxia inducible factor 2 [KO:K09592] [EC:1.14.11.29]", "405  ARNT; aryl hydrocarbon receptor nuclear translocator [KO:K09097]", "1387  CREBBP; CREB binding protein [KO:K04498] [EC:2.3.1.48]", "2033  EP300; E1A binding protein p300 [KO:K04498] [EC:2.3.1.48]", "1536  CYBB; cytochrome b-245 beta chain [KO:K21421] [EC:1.-.-.-]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "815  CAMK2A; calcium/calmodulin dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]", "817  CAMK2D; calcium/calmodulin dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]", "816  CAMK2B; calcium/calmodulin dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]", "818  CAMK2G; calcium/calmodulin dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]", "7076  TIMP1; TIMP metallopeptidase inhibitor 1 [KO:K16451]", "4055  LTBR; lymphotoxin beta receptor [KO:K03159]", "2056  EPO; erythropoietin [KO:K05437]", "7018  TF; transferrin [KO:K14736]", "7037  TFRC; transferrin receptor [KO:K06503]", "7422  VEGFA; vascular endothelial growth factor A [KO:K05448]", "2321  FLT1; fms related receptor tyrosine kinase 1 [KO:K05096] [EC:2.7.10.1]", "5054  SERPINE1; serpin family E member 1 [KO:K03982]", "284  ANGPT1; angiopoietin 1 [KO:K05465]", "285  ANGPT2; angiopoietin 2 [KO:K05466]", "51378  ANGPT4; angiopoietin 4 [KO:K05467]", "7010  TEK; TEK receptor tyrosine kinase [KO:K05121] [EC:2.7.10.1]", "1906  EDN1; endothelin 1 [KO:K16366]", "4843  NOS2; nitric oxide synthase 2 [KO:K13241] [EC:1.14.13.39]", "4846  NOS3; nitric oxide synthase 3 [KO:K13242] [EC:1.14.13.39]", "3162  HMOX1; heme oxygenase 1 [KO:K00510] [EC:1.14.14.18]", "4878  NPPA; natriuretic peptide A [KO:K12334]", "6513  SLC2A1; solute carrier family 2 member 1 [KO:K07299]", "5163  PDK1; pyruvate dehydrogenase kinase 1 [KO:K12077] [EC:2.7.11.2]", "3101  HK3; hexokinase 3 [KO:K00844] [EC:2.7.1.1]", "3098  HK1; hexokinase 1 [KO:K00844] [EC:2.7.1.1]", "3099  HK2; hexokinase 2 [KO:K00844] [EC:2.7.1.1]", "80201  HKDC1; hexokinase domain containing 1 [KO:K00844] [EC:2.7.1.1]", "5213  PFKM; phosphofructokinase, muscle [KO:K00850] [EC:2.7.1.11]", "5214  PFKP; phosphofructokinase, platelet [KO:K00850] [EC:2.7.1.11]", "5211  PFKL; phosphofructokinase, liver type [KO:K00850] [EC:2.7.1.11]", "2597  GAPDH; glyceraldehyde-3-phosphate dehydrogenase [KO:K00134] [EC:1.2.1.12]", "230  ALDOC; aldolase, fructose-bisphosphate C [KO:K01623] [EC:4.1.2.13]", "226  ALDOA; aldolase, fructose-bisphosphate A [KO:K01623] [EC:4.1.2.13]", "229  ALDOB; aldolase, fructose-bisphosphate B [KO:K01623] [EC:4.1.2.13]", "2027  ENO3; enolase 3 [KO:K01689] [EC:4.2.1.11]", "2026  ENO2; enolase 2 [KO:K01689] [EC:4.2.1.11]", "2023  ENO1; enolase 1 [KO:K01689] [EC:4.2.1.11]", "5232  PGK2; phosphoglycerate kinase 2 [KO:K00927] [EC:2.7.2.3]", "5230  PGK1; phosphoglycerate kinase 1 [KO:K00927] [EC:2.7.2.3]", "5209  PFKFB3; 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 [KO:K01103] [EC:2.7.1.105 3.1.3.46]", "160287  LDHAL6A; lactate dehydrogenase A like 6A [KO:K00016] [EC:1.1.1.27]", "92483  LDHAL6B; lactate dehydrogenase A like 6B [KO:K00016] [EC:1.1.1.27]", "3939  LDHA; lactate dehydrogenase A [KO:K00016] [EC:1.1.1.27]", "3945  LDHB; lactate dehydrogenase B [KO:K00016] [EC:1.1.1.27]", "3948  LDHC; lactate dehydrogenase C [KO:K00016] [EC:1.1.1.27]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]", "1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]", "1027  CDKN1B; cyclin dependent kinase inhibitor 1B [KO:K06624]", "5161  PDHA2; pyruvate dehydrogenase E1 subunit alpha 2 [KO:K00161] [EC:1.2.4.1]", "5160  PDHA1; pyruvate dehydrogenase E1 subunit alpha 1 [KO:K00161] [EC:1.2.4.1]", "5162  PDHB; pyruvate dehydrogenase E1 subunit beta [KO:K00162] [EC:1.2.4.1]"], "compound": ["C00002  ATP", "C00007  Oxygen", "C00022  Pyruvate", "C00024  Acetyl-CoA", "C00026  2-Oxoglutarate", "C00031  D-Glucose", "C00072  Ascorbate", "C00076  Calcium cation", "C00165  Diacylglycerol", "C00186  (S)-Lactate", "C00338  Lipopolysaccharide", "C00533  Nitric oxide", "C00704  Superoxide", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C14818  Fe2+"], "refs": [{"pmid": "20836033", "authors": "  Semenza GL", "title": "Oxygen homeostasis.", "journal": "Wiley Interdiscip Rev Syst Biol Med 2:336-61 (2010)", "doi": "10.1002/wsbm.69"}, {"pmid": "17955264", "authors": "  Mole DR, Ratcliffe PJ", "title": "Cellular oxygen sensing in health and disease.", "journal": "Pediatr Nephrol 23:681-94 (2008)", "doi": "10.1007/s00467-007-0632-x"}, {"pmid": "18498744", "authors": "  Kaelin WG Jr, Ratcliffe PJ", "title": "Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.", "journal": "Mol Cell 30:393-402 (2008)", "doi": "10.1016/j.molcel.2008.04.009"}, {"pmid": "22205687", "authors": "  Palazon A, Aragones J, Morales-Kastresana A, de Landazuri MO, Melero I", "title": "Molecular pathways: hypoxia response in immune cells fighting or promoting cancer.", "journal": "Clin Cancer Res 18:1207-13 (2012)", "doi": "10.1158/1078-0432.CCR-11-1591"}, {"pmid": "20965423", "authors": "  Majmundar AJ, Wong WJ, Simon MC", "title": "Hypoxia-inducible factors and the response to hypoxic stress.", "journal": "Mol Cell 40:294-309 (2010)", "doi": "10.1016/j.molcel.2010.09.022"}, {"pmid": "22562152", "authors": "  Greer SN, Metcalf JL, Wang Y, Ohh M", "title": "The updated biology of hypoxia-inducible factor.", "journal": "EMBO J 31:2448-60 (2012)", "doi": "10.1038/emboj.2012.125"}, {"pmid": "19364912", "authors": "  Semenza GL", "title": "Regulation of oxygen homeostasis by hypoxia-inducible factor 1.", "journal": "Physiology (Bethesda) 24:97-106 (2009)", "doi": "10.1152/physiol.00045.2008"}, {"pmid": "16234508", "authors": "  Wenger RH, Stiehl DP, Camenisch G", "title": "Integration of oxygen signaling at the consensus HRE.", "journal": "Sci STKE 2005:re12 (2005)", "doi": "10.1126/stke.3062005re12"}, {"pmid": "15031665", "authors": "  Lee JW, Bae SH, Jeong JW, Kim SH, Kim KW", "title": "Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions.", "journal": "Exp Mol Med 36:1-12 (2004)", "doi": "10.1038/emm.2004.1"}, {"pmid": "18259201", "authors": "  Weidemann A, Johnson RS", "title": "Biology of HIF-1alpha.", "journal": "Cell Death Differ 15:621-7 (2008)", "doi": "10.1038/cdd.2008.12"}, {"pmid": "11902584", "authors": "  Harris AL", "title": "Hypoxia--a key regulatory factor in tumour growth.", "journal": "Nat Rev Cancer 2:38-47 (2002)", "doi": "10.1038/nrc704"}, {"pmid": "19147540", "authors": "  Knaup KX, Jozefowski K, Schmidt R, Bernhardt WM, Weidemann A, Juergensen JS, Warnecke C, Eckardt KU, Wiesener MS", "title": "Mutual regulation of hypoxia-inducible factor and mammalian target of rapamycin as a function of oxygen availability.", "journal": "Mol Cancer Res 7:88-98 (2009)", "doi": "10.1158/1541-7786.MCR-08-0288"}, {"pmid": "18505681", "authors": "  Kaluz S, Kaluzova M, Stanbridge EJ", "title": "Regulation of gene expression by hypoxia: integration of the HIF-transduced hypoxic signal at the hypoxia-responsive element.", "journal": "Clin Chim Acta 395:6-13 (2008)", "doi": "10.1016/j.cca.2008.05.002"}, {"pmid": "20679415", "authors": "  Cadenas S, Aragones J, Landazuri MO", "title": "Mitochondrial reprogramming through cardiac oxygen sensors in ischaemic heart disease.", "journal": "Cardiovasc Res 88:219-28 (2010)", "doi": "10.1093/cvr/cvq256"}], "rel_pathway": ["hsa00020  Citrate cycle (TCA cycle)", "hsa04010  MAPK signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04120  Ubiquitin mediated proteolysis", "hsa04150  mTOR signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04370  VEGF signaling pathway"], "ko_pathway": "ko04066", "genes": ["EGFR", "AKT2", "AKT1"]}, {"kegg_id": "hsa04072", "name": "Phospholipase D signaling pathway - Homo sapiens (human)", "description": "Phospholipase D (PLD) is an essential enzyme responsible for the production of the lipid second messenger phosphatidic acid (PA), which is involved in fundamental cellular processes, including membrane trafficking, actin cytoskeleton remodeling, cell proliferation and cell survival. PLD activity can be stimulated by a large number of cell surface receptors and is elaborately regulated by intracellular factors, including protein kinase C isoforms, small GTPases of the ARF, Rho and Ras families and the phosphoinositide, phosphatidylinositol 4,5-bisphosphate (PIP2). The PLD-produced PA activates signaling proteins and acts as a node within the membrane to which signaling proteins translocate. Several signaling proteins, including Raf-1 and mTOR, directly bind PA to mediate translocation or activation, respectively.", "class": "Environmental Information Processing; Signal transduction", "pathway_map": "hsa04072  Phospholipase D signaling pathway", "drug": ["D03938  Ecopladib (USAN/INN)", "D11353  Ripretinib (USAN)", "D12409  Barzolvolimab (USAN/INN)", "D12642  Fipaxalparant (USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["1950  EGF; epidermal growth factor [KO:K04357]", "5154  PDGFA; platelet derived growth factor subunit A [KO:K04359]", "5155  PDGFB; platelet derived growth factor subunit B [KO:K17386]", "56034  PDGFC; platelet derived growth factor C [KO:K05450]", "80310  PDGFD; platelet derived growth factor D [KO:K05450]", "4254  KITLG; KIT ligand [KO:K05461]", "3630  INS; insulin [KO:K04526]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "5156  PDGFRA; platelet derived growth factor receptor alpha [KO:K04363] [EC:2.7.10.1]", "5159  PDGFRB; platelet derived growth factor receptor beta [KO:K05089] [EC:2.7.10.1]", "3815  KIT; KIT proto-oncogene, receptor tyrosine kinase [KO:K05091] [EC:2.7.10.1]", "3643  INSR; insulin receptor [KO:K04527] [EC:2.7.10.1]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "2549  GAB1; GRB2 associated binding protein 1 [KO:K09593]", "9846  GAB2; GRB2 associated binding protein 2 [KO:K08091]", "6464  SHC1; SHC adaptor protein 1 [KO:K06279]", "25759  SHC2; SHC adaptor protein 2 [KO:K17447]", "53358  SHC3; SHC adaptor protein 3 [KO:K17448]", "399694  SHC4; SHC adaptor protein 4 [KO:K17449]", "5781  PTPN11; protein tyrosine phosphatase non-receptor type 11 [KO:K07293] [EC:3.1.3.48]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "22808  MRAS; muscle RAS oncogene homolog [KO:K07831]", "6237  RRAS; RAS related [KO:K07829]", "22800  RRAS2; RAS related 2 [KO:K07830]", "5900  RALGDS; ral guanine nucleotide dissociation stimulator [KO:K08732]", "5898  RALA; RAS like proto-oncogene A [KO:K07834]", "5899  RALB; RAS like proto-oncogene B [KO:K07835]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "7248  TSC1; TSC complex subunit 1 [KO:K07206]", "7249  TSC2; TSC complex subunit 2 [KO:K07207]", "6009  RHEB; Ras homolog, mTORC1 binding [KO:K07208]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "387  RHOA; ras homolog family member A [KO:K04513]", "375  ARF1; ADP ribosylation factor 1 [KO:K07937]", "382  ARF6; ADP ribosylation factor 6 [KO:K07941]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]", "102723407  IGH; immunoglobulin heavy variable 4-38-2-like [KO:K06856]", "2205  FCER1A; Fc epsilon receptor Ia [KO:K08089]", "2206  MS4A2; membrane spanning 4-domains A2 [KO:K08090]", "2207  FCER1G; Fc epsilon receptor Ig [KO:K07983]", "2534  FYN; FYN proto-oncogene, Src family tyrosine kinase [KO:K05703] [EC:2.7.10.2]", "6850  SYK; spleen associated tyrosine kinase [KO:K05855] [EC:2.7.10.2]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5337  PLD1; phospholipase D1 [KO:K01115] [EC:3.1.4.4]", "5338  PLD2; phospholipase D2 [KO:K01115] [EC:3.1.4.4]", "123745  PLA2G4E; phospholipase A2 group IVE [KO:K16342] [EC:3.1.1.4]", "5321  PLA2G4A; phospholipase A2 group IVA [KO:K16342] [EC:3.1.1.4]", "8681  JMJD7-PLA2G4B; JMJD7-PLA2G4B readthrough [KO:K16342] [EC:3.1.1.4]", "100137049  PLA2G4B; phospholipase A2 group IVB [KO:K16342] [EC:3.1.1.4]", "8605  PLA2G4C; phospholipase A2 group IVC [KO:K16342] [EC:3.1.1.4]", "283748  PLA2G4D; phospholipase A2 group IVD [KO:K16342] [EC:3.1.1.4]", "255189  PLA2G4F; phospholipase A2 group IVF [KO:K16342] [EC:3.1.1.4]", "10554  AGPAT1; 1-acylglycerol-3-phosphate O-acyltransferase 1 [KO:K13509] [EC:2.3.1.51]", "10555  AGPAT2; 1-acylglycerol-3-phosphate O-acyltransferase 2 [KO:K13509] [EC:2.3.1.51]", "56894  AGPAT3; 1-acylglycerol-3-phosphate O-acyltransferase 3 [KO:K13523] [EC:2.3.1.51 2.3.1.-]", "56895  AGPAT4; 1-acylglycerol-3-phosphate O-acyltransferase 4 [KO:K13523] [EC:2.3.1.51 2.3.1.-]", "55326  AGPAT5; 1-acylglycerol-3-phosphate O-acyltransferase 5 [KO:K19007] [EC:2.3.1.51]", "8877  SPHK1; sphingosine kinase 1 [KO:K04718] [EC:2.7.1.91]", "56848  SPHK2; sphingosine kinase 2 [KO:K04718] [EC:2.7.1.91]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "23396  PIP5K1C; phosphatidylinositol-4-phosphate 5-kinase type 1 gamma [KO:K00889] [EC:2.7.1.68]", "8394  PIP5K1A; phosphatidylinositol-4-phosphate 5-kinase type 1 alpha [KO:K00889] [EC:2.7.1.68]", "8395  PIP5K1B; phosphatidylinositol-4-phosphate 5-kinase type 1 beta [KO:K00889] [EC:2.7.1.68]", "8525  DGKZ; diacylglycerol kinase zeta [KO:K00901] [EC:2.7.1.107]", "8527  DGKD; diacylglycerol kinase delta [KO:K00901] [EC:2.7.1.107]", "9162  DGKI; diacylglycerol kinase iota [KO:K00901] [EC:2.7.1.107]", "1606  DGKA; diacylglycerol kinase alpha [KO:K00901] [EC:2.7.1.107]", "8526  DGKE; diacylglycerol kinase epsilon [KO:K00901] [EC:2.7.1.107]", "1607  DGKB; diacylglycerol kinase beta [KO:K00901] [EC:2.7.1.107]", "160851  DGKH; diacylglycerol kinase eta [KO:K00901] [EC:2.7.1.107]", "1608  DGKG; diacylglycerol kinase gamma [KO:K00901] [EC:2.7.1.107]", "1609  DGKQ; diacylglycerol kinase theta [KO:K00901] [EC:2.7.1.107]", "139189  DGKK; diacylglycerol kinase kappa [KO:K00901] [EC:2.7.1.107]", "8611  PLPP1; phospholipid phosphatase 1 [KO:K01080] [EC:3.1.3.4]", "8613  PLPP3; phospholipid phosphatase 3 [KO:K01080] [EC:3.1.3.4]", "8612  PLPP2; phospholipid phosphatase 2 [KO:K01080] [EC:3.1.3.4]", "2147  F2; coagulation factor II, thrombin [KO:K01313] [EC:3.4.21.5]", "183  AGT; angiotensinogen [KO:K09821]", "551  AVP; arginine vasopressin [KO:K05242]", "3576  CXCL8; C-X-C motif chemokine ligand 8 [KO:K10030]", "185  AGTR1; angiotensin II receptor type 1 [KO:K04166]", "2149  F2R; coagulation factor II thrombin receptor [KO:K03914]", "2911  GRM1; glutamate metabotropic receptor 1 [KO:K04603]", "2912  GRM2; glutamate metabotropic receptor 2 [KO:K04605]", "2913  GRM3; glutamate metabotropic receptor 3 [KO:K04606]", "2914  GRM4; glutamate metabotropic receptor 4 [KO:K04607]", "2915  GRM5; glutamate metabotropic receptor 5 [KO:K04604]", "2916  GRM6; glutamate metabotropic receptor 6 [KO:K04608]", "2917  GRM7; glutamate metabotropic receptor 7 [KO:K04609]", "2918  GRM8; glutamate metabotropic receptor 8 [KO:K04610]", "552  AVPR1A; arginine vasopressin receptor 1A [KO:K04226]", "553  AVPR1B; arginine vasopressin receptor 1B [KO:K04227]", "554  AVPR2; arginine vasopressin receptor 2 [KO:K04228]", "1902  LPAR1; lysophosphatidic acid receptor 1 [KO:K04289]", "9170  LPAR2; lysophosphatidic acid receptor 2 [KO:K04291]", "23566  LPAR3; lysophosphatidic acid receptor 3 [KO:K04294]", "2846  LPAR4; lysophosphatidic acid receptor 4 [KO:K04275]", "57121  LPAR5; lysophosphatidic acid receptor 5 [KO:K08390]", "10161  LPAR6; lysophosphatidic acid receptor 6 [KO:K04273]", "5737  PTGFR; prostaglandin F receptor [KO:K04262]", "3577  CXCR1; C-X-C motif chemokine receptor 1 [KO:K04175]", "3579  CXCR2; C-X-C motif chemokine receptor 2 [KO:K05050]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "2768  GNA12; G protein subunit alpha 12 [KO:K04346]", "2185  PTK2B; protein tyrosine kinase 2 beta [KO:K05871] [EC:2.7.10.2]", "10672  GNA13; G protein subunit alpha 13 [KO:K04639]", "5294  PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma [KO:K21289] [EC:2.7.1.153]", "23533  PIK3R5; phosphoinositide-3-kinase regulatory subunit 5 [KO:K21290]", "146850  PIK3R6; phosphoinositide-3-kinase regulatory subunit 6 [KO:K21290]", "9265  CYTH3; cytohesin 3 [KO:K18441]", "27128  CYTH4; cytohesin 4 [KO:K18441]", "9266  CYTH2; cytohesin 2 [KO:K18441]", "9267  CYTH1; cytohesin 1 [KO:K18441]", "2778  GNAS; GNAS complex locus [KO:K04632]", "107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]", "108  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]", "109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]", "196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]", "113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]", "114  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]", "115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]", "10411  RAPGEF3; Rap guanine nucleotide exchange factor 3 [KO:K08014]", "11069  RAPGEF4; Rap guanine nucleotide exchange factor 4 [KO:K04351]", "1759  DNM1; dynamin 1 [KO:K01528] [EC:3.6.5.5]", "26052  DNM3; dynamin 3 [KO:K01528] [EC:3.6.5.5]", "1785  DNM2; dynamin 2 [KO:K23484] [EC:3.6.5.5]"], "compound": ["C00025  L-Glutamate", "C00076  Calcium cation", "C00165  Diacylglycerol", "C00416  Phosphatidate", "C00575  3',5'-Cyclic AMP", "C00639  Prostaglandin F2alpha", "C00681  1-Acyl-sn-glycerol 3-phosphate", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C04637  1-Phosphatidyl-D-myo-inositol 4,5-bisphosphate", "C05981  Phosphatidylinositol-3,4,5-trisphosphate", "C06124  Sphingosine 1-phosphate"], "refs": [{"pmid": "17245604", "authors": "  Oude Weernink PA, Lopez de Jesus M, Schmidt M", "title": "Phospholipase D signaling: orchestration by PIP2 and small GTPases.", "journal": "Naunyn Schmiedebergs Arch Pharmacol 374:399-411 (2007)", "doi": "10.1007/s00210-007-0131-4"}, {"pmid": "21936578", "authors": "  Selvy PE, Lavieri RR, Lindsley CW, Brown HA", "title": "Phospholipase D: enzymology, functionality, and chemical modulation.", "journal": "Chem Rev 111:6064-119 (2011)", "doi": "10.1021/cr200296t"}, {"pmid": "24995811", "authors": "  Brandenburg LO, Pufe T, Koch T", "title": "Role of phospholipase d in g-protein coupled receptor function.", "journal": "Membranes (Basel) 4:302-18 (2014)", "doi": "10.3390/membranes4030302"}, {"pmid": "17054901", "authors": "  Oude Weernink PA, Han L, Jakobs KH, Schmidt M", "title": "Dynamic phospholipid signaling by G protein-coupled receptors.", "journal": "Biochim Biophys Acta 1768:888-900 (2007)", "doi": "10.1016/j.bbamem.2006.09.012"}, {"pmid": "24990952", "authors": "  Foster DA, Salloum D, Menon D, Frias MA", "title": "Phospholipase D and the maintenance of phosphatidic acid levels for regulation of mammalian target of rapamycin (mTOR).", "journal": "J Biol Chem 289:22583-8 (2014)", "doi": "10.1074/jbc.R114.566091"}, {"pmid": "16143829", "authors": "  Jenkins GM, Frohman MA", "title": "Phospholipase D: a lipid centric review.", "journal": "Cell Mol Life Sci 62:2305-16 (2005)", "doi": "10.1007/s00018-005-5195-z"}, {"pmid": "19815110", "authors": "  Metcalfe DD, Peavy RD, Gilfillan AM", "title": "Mechanisms of mast cell signaling in anaphylaxis.", "journal": "J Allergy Clin Immunol 124:639-46; quiz 647-8 (2009)", "doi": "10.1016/j.jaci.2009.08.035"}, {"pmid": "18936782", "authors": "  Kalesnikoff J, Galli SJ", "title": "New developments in mast cell biology.", "journal": "Nat Immunol 9:1215-23 (2008)", "doi": "10.1038/ni.f.216"}, {"pmid": "12217395", "authors": "  Cockcroft S, Way G, O'Luanaigh N, Pardo R, Sarri E, Fensome A", "title": "Signalling role for ARF and phospholipase D in mast cell exocytosis stimulated by crosslinking of the high affinity FcepsilonR1 receptor.", "journal": "Mol Immunol 38:1277-82 (2002)", "doi": "10.1016/S0161-5890(02)00075-5"}, {"pmid": "19410013", "authors": "  Lee CS, Kim KL, Jang JH, Choi YS, Suh PG, Ryu SH", "title": "The roles of phospholipase D in EGFR signaling.", "journal": "Biochim Biophys Acta 1791:862-8 (2009)", "doi": "10.1016/j.bbalip.2009.04.007"}, {"pmid": "16622417", "authors": "  Lee CS, Kim IS, Park JB, Lee MN, Lee HY, Suh PG, Ryu SH", "title": "The phox homology domain of phospholipase D activates dynamin GTPase activity and accelerates EGFR endocytosis.", "journal": "Nat Cell Biol 8:477-84 (2006)", "doi": "10.1038/ncb1401"}, {"pmid": "14769825", "authors": "  Kam Y, Exton JH", "title": "Role of phospholipase D1 in the regulation of mTOR activity by lysophosphatidic acid.", "journal": "FASEB J 18:311-9 (2004)", "doi": "10.1096/fj.03-0731com"}, {"pmid": "9310372", "authors": "  Kozawa O, Blume-Jensen P, Heldin CH, Ronnstrand L", "title": "Involvement of phosphatidylinositol 3'-kinase in stem-cell-factor-induced phospholipase D activation and arachidonic acid release.", "journal": "Eur J Biochem 248:149-55 (1997)", "doi": "10.1111/j.1432-1033.1997.00149.x"}, {"pmid": "11042115", "authors": "  Slaaby R, Du G, Altshuller YM, Frohman MA, Seedorf K", "title": "Insulin-induced phospholipase D1 and phospholipase D2 activity in human embryonic kidney-293 cells mediated by the phospholipase C gamma and protein kinase C alpha signalling cascade.", "journal": "Biochem J 351 Pt 3:613-9 (2000)", "doi": "10.1042/bj3510613"}, {"pmid": "11991733", "authors": "  Fahimi-Vahid M, Gosau N, Michalek C, Han L, Jakobs KH, Schmidt M, Roberts N, Avkiran M, Wieland T", "title": "Distinct signaling pathways mediate cardiomyocyte phospholipase D stimulation by endothelin-1 and thrombin.", "journal": "J Mol Cell Cardiol 34:441-53 (2002)", "doi": "10.1006/jmcc.2002.1525"}, {"pmid": "10666319", "authors": "  Freeman EJ", "title": "The Ang II-induced growth of vascular smooth muscle cells involves a phospholipase D-mediated signaling mechanism.", "journal": "Arch Biochem Biophys 374:363-70 (2000)", "doi": "10.1006/abbi.1999.1608"}, {"pmid": "9119890", "authors": "  Naro F, Donchenko V, Minotti S, Zolla L, Molinaro M, Adamo S", "title": "Role of phospholipase C and D signalling pathways in vasopressin-dependent myogenic differentiation.", "journal": "J Cell Physiol 171:34-42 (1997)", "doi": "10.1002/(SICI)1097-4652(199704)171:1<34::AID-JCP5>3.0.CO;2-I"}, {"pmid": "8135758", "authors": "  Sugiyama T, Sakai T, Nozawa Y, Oka N", "title": "Prostaglandin F2 alpha-stimulated phospholipase D activation in osteoblast-like MC3T3-E1 cells: involvement in sustained 1,2-diacylglycerol production.", "journal": "Biochem J 298 ( Pt 2):479-84 (1994)", "doi": "10.1042/bj2980479"}, {"pmid": "17210675", "authors": "  Foster DA", "title": "Regulation of mTOR by phosphatidic acid?", "journal": "Cancer Res 67:1-4 (2007)", "doi": "10.1158/0008-5472.CAN-06-3016"}, {"pmid": "15310762", "authors": "  Delon C, Manifava M, Wood E, Thompson D, Krugmann S, Pyne S, Ktistakis NT", "title": "Sphingosine kinase 1 is an intracellular effector of phosphatidic acid.", "journal": "J Biol Chem 279:44763-74 (2004)", "doi": "10.1074/jbc.M405771200"}, {"pmid": "23076158", "authors": "  Park JB, Lee CS, Jang JH, Ghim J, Kim YJ, You S, Hwang D, Suh PG, Ryu SH", "title": "Phospholipase signalling networks in cancer.", "journal": "Nat Rev Cancer 12:782-92 (2012)", "doi": "10.1038/nrc3379"}], "rel_pathway": ["hsa00561  Glycerolipid metabolism", "hsa04010  MAPK signaling pathway", "hsa04014  Ras signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04024  cAMP signaling pathway", "hsa04071  Sphingolipid signaling pathway", "hsa04144  Endocytosis", "hsa04150  mTOR signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04664  Fc epsilon RI signaling pathway"], "ko_pathway": "ko04072", "genes": ["EGFR", "AKT2", "AKT1", "SOS1", "NRAS"]}, {"kegg_id": "hsa04144", "name": "Endocytosis - Homo sapiens (human)", "description": "Endocytosis is a mechanism for cells to remove ligands, nutrients, and plasma membrane (PM) proteins, and lipids from the cell surface, bringing them into the cell interior. Transmembrane proteins entering through clathrin-dependent endocytosis (CDE) have sequences in their cytoplasmic domains that bind to the APs (adaptor-related protein complexes) and enable their rapid removal from the PM. In addition to APs and clathrin, there are numerous accessory proteins including dynamin. Depending on the various proteins that enter the endosome membrane, these cargoes are sorted to distinct destinations. Some cargoes, such as nutrient receptors, are recycled back to the PM. Ubiquitylated membrane proteins, such as activated growth-factor receptors, are sorted into intraluminal vesicles and eventually end up in the lysosome lumen via multivesicular endosomes (MVEs). There are distinct mechanisms of clathrin-independent endocytosis (CIE) depending upon the cargo and the cell type.", "class": "Cellular Processes; Transport and catabolism", "pathway_map": "hsa04144  Endocytosis", "drug": ["D03058  Basiliximab (USAN/INN)", "D03210  Ancriviroc (USAN/INN)", "D03639  Daclizumab (USAN/INN)", "D03682  Denileukin diftitox (USAN/INN)", "D06297  Vicriviroc maleate (USAN)", "D06557  Aplaviroc hydrochloride (USAN)", "D06670  Maraviroc (JAN/INN)", "D09878  Cenicriviroc (USAN/INN)", "D09879  Cenicriviroc mesylate (USAN)", "D10434  Vintafolide (USAN/INN)", "D10954  Mirvetuximab soravtansine (USAN/INN)", "D11399  Leronlimab (USAN/INN)", "D11812  Pabinafusp alfa (genetical recombination) (JAN)", "D12183  Farletuzumab ecteribulin (USAN)", "D12249  Pafolacianine (USAN/INN)", "D12250  Pafolacianine sodium (USAN)", "D12509  Trontinemab (USAN/INN)", "D12556  Eltrekibart (USAN)", "D12768  Ficerafusp alfa (USAN)", "D12806  Tividenofusp alfa (USAN/INN)", "D12880  Pasifolate exatecan (USAN)"], "dblinks": "GO: 0006897", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["382  ARF6; ADP ribosylation factor 6 [KO:K07941]", "23396  PIP5K1C; phosphatidylinositol-4-phosphate 5-kinase type 1 gamma [KO:K00889] [EC:2.7.1.68]", "8394  PIP5K1A; phosphatidylinositol-4-phosphate 5-kinase type 1 alpha [KO:K00889] [EC:2.7.1.68]", "8395  PIP5K1B; phosphatidylinositol-4-phosphate 5-kinase type 1 beta [KO:K00889] [EC:2.7.1.68]", "138429  PIP5KL1; phosphatidylinositol-4-phosphate 5-kinase like 1 [KO:K13712] [EC:2.7.1.68]", "5337  PLD1; phospholipase D1 [KO:K01115] [EC:3.1.4.4]", "5338  PLD2; phospholipase D2 [KO:K01115] [EC:3.1.4.4]", "1759  DNM1; dynamin 1 [KO:K01528] [EC:3.6.5.5]", "26052  DNM3; dynamin 3 [KO:K01528] [EC:3.6.5.5]", "1785  DNM2; dynamin 2 [KO:K23484] [EC:3.6.5.5]", "1211  CLTA; clathrin light chain A [KO:K04644]", "1212  CLTB; clathrin light chain B [KO:K04645]", "1213  CLTC; clathrin heavy chain [KO:K04646]", "8218  CLTCL1; clathrin heavy chain like 1 [KO:K04646]", "161  AP2A2; adaptor related protein complex 2 subunit alpha 2 [KO:K11824]", "160  AP2A1; adaptor related protein complex 2 subunit alpha 1 [KO:K11824]", "163  AP2B1; adaptor related protein complex 2 subunit beta 1 [KO:K11825]", "1173  AP2M1; adaptor related protein complex 2 subunit mu 1 [KO:K11826]", "1175  AP2S1; adaptor related protein complex 2 subunit sigma 1 [KO:K11827]", "30846  EHD2; EH domain containing 2 [KO:K12469]", "7046  TGFBR1; transforming growth factor beta receptor 1 [KO:K04674] [EC:2.7.11.30]", "7048  TGFBR2; transforming growth factor beta receptor 2 [KO:K04388] [EC:2.7.11.30]", "9372  ZFYVE9; zinc finger FYVE-type containing 9 [KO:K04679]", "9765  ZFYVE16; zinc finger FYVE-type containing 16 [KO:K04679]", "5371  PML; PML nuclear body scaffold [KO:K10054] [EC:2.3.2.-]", "4087  SMAD2; SMAD family member 2 [KO:K04500]", "4088  SMAD3; SMAD family member 3 [KO:K23605]", "7037  TFRC; transferrin receptor [KO:K06503]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "5156  PDGFRA; platelet derived growth factor receptor alpha [KO:K04363] [EC:2.7.10.1]", "2263  FGFR2; fibroblast growth factor receptor 2 [KO:K05093] [EC:2.7.10.1]", "2261  FGFR3; fibroblast growth factor receptor 3 [KO:K05094] [EC:2.7.10.1]", "2264  FGFR4; fibroblast growth factor receptor 4 [KO:K05095] [EC:2.7.10.1]", "3480  IGF1R; insulin like growth factor 1 receptor [KO:K05087] [EC:2.7.10.1]", "867  CBL; Cbl proto-oncogene [KO:K04707] [EC:2.3.2.27]", "868  CBLB; Cbl proto-oncogene B [KO:K22517] [EC:2.3.2.27]", "23624  CBLC; Cbl proto-oncogene C [KO:K22518] [EC:2.3.2.27]", "30011  SH3KBP1; SH3 domain containing kinase binding protein 1 [KO:K12470]", "6457  SH3GL3; SH3 domain containing GRB2 like 3, endophilin A3 [KO:K11247]", "6456  SH3GL2; SH3 domain containing GRB2 like 2, endophilin A1 [KO:K11247]", "6455  SH3GL1; SH3 domain containing GRB2 like 1, endophilin A2 [KO:K11247]", "51100  SH3GLB1; SH3 domain containing GRB2 like, endophilin B1 [KO:K11248]", "56904  SH3GLB2; SH3 domain containing GRB2 like, endophilin B2 [KO:K21269]", "273  AMPH; amphiphysin [KO:K12562]", "274  BIN1; bridging integrator 1 [KO:K12562]", "29924  EPN1; epsin 1 [KO:K12471]", "55040  EPN3; epsin 3 [KO:K12471]", "22905  EPN2; epsin 2 [KO:K12471]", "2060  EPS15; epidermal growth factor receptor pathway substrate 15 [KO:K12472]", "58513  EPS15L1; epidermal growth factor receptor pathway substrate 15 like 1 [KO:K12472]", "23111  SPART; spartin [KO:K19366]", "4734  NEDD4; NEDD4 E3 ubiquitin protein ligase [KO:K10591] [EC:2.3.2.26]", "23327  NEDD4L; NEDD4 like E3 ubiquitin protein ligase [KO:K13305] [EC:2.3.2.26]", "4193  MDM2; MDM2 proto-oncogene [KO:K06643] [EC:2.3.2.27]", "7189  TRAF6; TNF receptor associated factor 6 [KO:K03175] [EC:2.3.2.27]", "10193  RNF41; ring finger protein 41 [KO:K11981] [EC:2.3.2.27]", "83737  ITCH; itchy E3 ubiquitin protein ligase [KO:K05632] [EC:2.3.2.26]", "57154  SMURF1; SMAD specific E3 ubiquitin protein ligase 1 [KO:K04678] [EC:2.3.2.26]", "64750  SMURF2; SMAD specific E3 ubiquitin protein ligase 2 [KO:K04678] [EC:2.3.2.26]", "11059  WWP1; WW domain containing E3 ubiquitin protein ligase 1 [KO:K05633] [EC:2.3.2.26]", "3949  LDLR; low density lipoprotein receptor [KO:K12473]", "26119  LDLRAP1; low density lipoprotein receptor adaptor protein 1 [KO:K12474]", "1601  DAB2; DAB adaptor protein 2 [KO:K12475]", "1234  CCR5; C-C motif chemokine receptor 5 [KO:K04180]", "3577  CXCR1; C-X-C motif chemokine receptor 1 [KO:K04175]", "3579  CXCR2; C-X-C motif chemokine receptor 2 [KO:K05050]", "7852  CXCR4; C-X-C motif chemokine receptor 4 [KO:K04189]", "131890  GRK7; G protein-coupled receptor kinase 7 [KO:K00909] [EC:2.7.11.14]", "6011  GRK1; G protein-coupled receptor kinase 1 [KO:K00909] [EC:2.7.11.14]", "156  GRK2; G protein-coupled receptor kinase 2 [KO:K00910] [EC:2.7.11.15]", "157  GRK3; G protein-coupled receptor kinase 3 [KO:K00910] [EC:2.7.11.15]", "2868  GRK4; G protein-coupled receptor kinase 4 [KO:K08291] [EC:2.7.11.16]", "2869  GRK5; G protein-coupled receptor kinase 5 [KO:K08291] [EC:2.7.11.16]", "2870  GRK6; G protein-coupled receptor kinase 6 [KO:K08291] [EC:2.7.11.16]", "408  ARRB1; arrestin beta 1 [KO:K04439]", "409  ARRB2; arrestin beta 2 [KO:K04439]", "8976  WASL; WASP like actin nucleation promoting factor [KO:K23612]", "10097  ACTR2; actin related protein 2 [KO:K17260]", "57180  ACTR3B; actin related protein 3B [KO:K18584]", "653857  ACTR3C; actin related protein 3C [KO:K18584]", "10096  ACTR3; actin related protein 3 [KO:K18584]", "10095  ARPC1B; actin related protein 2/3 complex subunit 1B [KO:K05757]", "10552  ARPC1A; actin related protein 2/3 complex subunit 1A [KO:K05757]", "10109  ARPC2; actin related protein 2/3 complex subunit 2 [KO:K05758]", "10094  ARPC3; actin related protein 2/3 complex subunit 3 [KO:K05756]", "10093  ARPC4; actin related protein 2/3 complex subunit 4 [KO:K05755]", "10092  ARPC5; actin related protein 2/3 complex subunit 5 [KO:K05754]", "81873  ARPC5L; actin related protein 2/3 complex subunit 5 like [KO:K05754]", "147179  WIPF2; WAS/WASL interacting protein family member 2 [KO:K19475]", "7456  WIPF1; WAS/WASL interacting protein family member 1 [KO:K19475]", "644150  WIPF3; WAS/WASL interacting protein family member 3 [KO:K19475]", "3312  HSPA8; heat shock protein family A (Hsp70) member 8 [KO:K03283]", "3303  HSPA1A; heat shock protein family A (Hsp70) member 1A [KO:K03283]", "3305  HSPA1L; heat shock protein family A (Hsp70) member 1 like [KO:K03283]", "3304  HSPA1B; heat shock protein family A (Hsp70) member 1B [KO:K03283]", "3310  HSPA6; heat shock protein family A (Hsp70) member 6 [KO:K03283]", "9829  DNAJC6; DnaJ heat shock protein family (Hsp40) member C6 [KO:K09526]", "23325  WASHC4; WASH complex subunit 4 [KO:K18465]", "9897  WASHC5; WASH complex subunit 5 [KO:K18464]", "253725  WASHC2C; WASH complex subunit 2C [KO:K18462]", "387680  WASHC2A; WASH complex subunit 2A [KO:K18462]", "100287171  WASHC1; WASH complex subunit 1 [KO:K18461]", "51019  WASHC3; WASH complex subunit 3 [KO:K18463]", "829  CAPZA1; capping actin protein of muscle Z-line subunit alpha 1 [KO:K10364]", "830  CAPZA2; capping actin protein of muscle Z-line subunit alpha 2 [KO:K10364]", "93661  CAPZA3; capping actin protein of muscle Z-line subunit alpha 3 [KO:K10364]", "832  CAPZB; capping actin protein of muscle Z-line subunit beta [KO:K10365]", "51699  VPS29; VPS29 retromer complex component [KO:K18467]", "112936  VPS26B; VPS26 retromer complex component B [KO:K18466]", "9559  VPS26A; VPS26 retromer complex component A [KO:K18466]", "55737  VPS35; VPS35 retromer complex component [KO:K18468]", "29934  SNX12; sorting nexin 12 [KO:K17918]", "8724  SNX3; sorting nexin 3 [KO:K17918]", "9101  USP8; ubiquitin specific peptidase 8 [KO:K11839] [EC:3.4.19.12]", "10617  STAMBP; STAM binding protein [KO:K11866] [EC:3.4.19.12]", "7879  RAB7A; RAB7A, member RAS oncogene family [KO:K07897]", "9146  HGS; hepatocyte growth factor-regulated tyrosine kinase substrate [KO:K12182]", "10254  STAM2; signal transducing adaptor molecule 2 [KO:K04705]", "8027  STAM; signal transducing adaptor molecule [KO:K04705]", "7251  TSG101; tumor susceptibility 101 [KO:K12183]", "93343  MVB12A; multivesicular body subunit 12A [KO:K12186]", "89853  MVB12B; multivesicular body subunit 12B [KO:K12186]", "51160  VPS28; VPS28 subunit of ESCRT-I [KO:K12184]", "155382  VPS37D; VPS37D subunit of ESCRT-I [KO:K12185]", "137492  VPS37A; VPS37A subunit of ESCRT-I [KO:K12185]", "79720  VPS37B; VPS37B subunit of ESCRT-I [KO:K12185]", "55048  VPS37C; VPS37C subunit of ESCRT-I [KO:K12185]", "11267  SNF8; SNF8 subunit of ESCRT-II [KO:K12188]", "51028  VPS36; vacuolar protein sorting 36 homolog [KO:K12190]", "84313  VPS25; vacuolar protein sorting 25 homolog [KO:K12189]", "79643  CHMP6; charged multivesicular body protein 6 [KO:K12195]", "128866  CHMP4B; charged multivesicular body protein 4B [KO:K12194]", "29082  CHMP4A; charged multivesicular body protein 4A [KO:K12194]", "92421  CHMP4C; charged multivesicular body protein 4C [KO:K24782]", "51652  CHMP3; charged multivesicular body protein 3 [KO:K12193]", "100526767  RNF103-CHMP3; RNF103-CHMP3 readthrough [KO:K12193]", "27243  CHMP2A; charged multivesicular body protein 2A [KO:K12191]", "25978  CHMP2B; charged multivesicular body protein 2B [KO:K12192]", "91782  CHMP7; charged multivesicular body protein 7 [KO:K15053]", "9525  VPS4B; vacuolar protein sorting 4 homolog B [KO:K12196]", "27183  VPS4A; vacuolar protein sorting 4 homolog A [KO:K12196]", "51534  VTA1; vesicle trafficking 1 [KO:K12199]", "57132  CHMP1B; charged multivesicular body protein 1B [KO:K12197]", "5119  CHMP1A; charged multivesicular body protein 1A [KO:K12197]", "51510  CHMP5; charged multivesicular body protein 5 [KO:K12198]", "9798  IST1; IST1 factor associated with ESCRT-III [KO:K19476]", "10015  PDCD6IP; programmed cell death 6 interacting protein [KO:K12200]", "51324  SPG21; SPG21 abhydrolase domain containing, maspardin [KO:K19367]", "3482  IGF2R; insulin like growth factor 2 receptor [KO:K06564]", "6642  SNX1; sorting nexin 1 [KO:K17917]", "6643  SNX2; sorting nexin 2 [KO:K17917]", "254122  SNX32; sorting nexin 32 [KO:K17920]", "27131  SNX5; sorting nexin 5 [KO:K17920]", "58533  SNX6; sorting nexin 6 [KO:K17920]", "6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3559  IL2RA; interleukin 2 receptor subunit alpha [KO:K05068]", "3560  IL2RB; interleukin 2 receptor subunit beta [KO:K05069]", "3561  IL2RG; interleukin 2 receptor subunit gamma [KO:K05070]", "387  RHOA; ras homolog family member A [KO:K04513]", "3105  HLA-A; major histocompatibility complex, class I, A [KO:K06751]", "3106  HLA-B; major histocompatibility complex, class I, B [KO:K06751]", "3107  HLA-C; major histocompatibility complex, class I, C [KO:K06751]", "3134  HLA-F; major histocompatibility complex, class I, F [KO:K06751]", "3135  HLA-G; major histocompatibility complex, class I, G [KO:K06751]", "3133  HLA-E; major histocompatibility complex, class I, E [KO:K06751]", "2348  FOLR1; folate receptor alpha [KO:K13649]", "2350  FOLR2; folate receptor beta [KO:K13649]", "2352  FOLR3; folate receptor gamma [KO:K13649]", "857  CAV1; caveolin 1 [KO:K06278]", "858  CAV2; caveolin 2 [KO:K12958]", "859  CAV3; caveolin 3 [KO:K12959]", "30845  EHD3; EH domain containing 3 [KO:K12476]", "30844  EHD4; EH domain containing 4 [KO:K12477]", "8411  EEA1; early endosome antigen 1 [KO:K12478]", "5868  RAB5A; RAB5A, member RAS oncogene family [KO:K07887]", "5869  RAB5B; RAB5B, member RAS oncogene family [KO:K07888]", "5878  RAB5C; RAB5C, member RAS oncogene family [KO:K07889]", "9135  RABEP1; rabaptin, RAB GTPase binding effector protein 1 [KO:K12480]", "64145  RBSN; rabenosyn, RAB effector [KO:K12481]", "5867  RAB4A; RAB4A, member RAS oncogene family [KO:K07879]", "80230  RUFY1; RUN and FYVE domain containing 1 [KO:K12482]", "55680  RUFY2; RUN and FYVE domain containing 2 [KO:K12482]", "10938  EHD1; EH domain containing 1 [KO:K12483]", "11311  VPS45; vacuolar protein sorting 45 homolog [KO:K12479]", "8723  SNX4; sorting nexin 4 [KO:K17919]", "57403  RAB22A; RAB22A, member RAS oncogene family [KO:K07891]", "11031  RAB31; RAB31, member RAS oncogene family [KO:K07891]", "10890  RAB10; RAB10, member RAS oncogene family [KO:K07903]", "4218  RAB8A; RAB8A, member RAS oncogene family [KO:K07901]", "11021  RAB35; RAB35, member RAS oncogene family [KO:K07876]", "8766  RAB11A; RAB11A, member RAS oncogene family [KO:K07904]", "9230  RAB11B; RAB11B, member RAS oncogene family [KO:K07905]", "22841  RAB11FIP2; RAB11 family interacting protein 2 [KO:K12484]", "80223  RAB11FIP1; RAB11 family interacting protein 1 [KO:K12484]", "26056  RAB11FIP5; RAB11 family interacting protein 5 [KO:K12484]", "118813  ZFYVE27; zinc finger FYVE-type containing 27 [KO:K19368]", "3798  KIF5A; kinesin family member 5A [KO:K10396]", "3799  KIF5B; kinesin family member 5B [KO:K10396]", "3800  KIF5C; kinesin family member 5C [KO:K10396]", "84440  RAB11FIP4; RAB11 family interacting protein 4 [KO:K12485]", "9727  RAB11FIP3; RAB11 family interacting protein 3 [KO:K12485]", "56288  PARD3; par-3 family cell polarity regulator [KO:K04237]", "50855  PARD6A; par-6 family cell polarity regulator alpha [KO:K06093]", "84552  PARD6G; par-6 family cell polarity regulator gamma [KO:K06093]", "84612  PARD6B; par-6 family cell polarity regulator beta [KO:K06093]", "5590  PRKCZ; protein kinase C zeta [KO:K18952] [EC:2.7.11.13]", "5584  PRKCI; protein kinase C iota [KO:K06069] [EC:2.7.11.13]", "998  CDC42; cell division cycle 42 [KO:K04393]", "64744  SMAP2; small ArfGAP2 [KO:K12486]", "60682  SMAP1; small ArfGAP 1 [KO:K12486]", "28964  GIT1; GIT ArfGAP 1 [KO:K05737]", "9815  GIT2; GIT ArfGAP 2 [KO:K12487]", "50807  ASAP1; ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 [KO:K12488]", "55616  ASAP3; ArfGAP with SH3 domain, ankyrin repeat and PH domain 3 [KO:K12488]", "8853  ASAP2; ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 [KO:K12488]", "116983  ACAP3; ArfGAP with coiled-coil, ankyrin repeat and PH domains 3 [KO:K12489]", "23527  ACAP2; ArfGAP with coiled-coil, ankyrin repeat and PH domains 2 [KO:K12489]", "9744  ACAP1; ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 [KO:K12489]", "116985  ARAP1; ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 [KO:K18439]", "116984  ARAP2; ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 [KO:K18440]", "64411  ARAP3; ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 [KO:K12490]", "116987  AGAP1; ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 [KO:K12491]", "116988  AGAP3; ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 [KO:K12491]", "119016  AGAP4; ArfGAP with GTPase domain, ankyrin repeat and PH domain 4 [KO:K12491]", "414189  AGAP6; ArfGAP with GTPase domain, ankyrin repeat and PH domain 6 [KO:K12491]", "642517  AGAP9; ArfGAP with GTPase domain, ankyrin repeat and PH domain 9 [KO:K12491]", "729092  AGAP5; ArfGAP with GTPase domain, ankyrin repeat and PH domain 5 [KO:K12491]", "116986  AGAP2; ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 [KO:K17848]", "55738  ARFGAP1; ADP ribosylation factor GTPase activating protein 1 [KO:K12492]", "26286  ARFGAP3; ADP ribosylation factor GTPase activating protein 3 [KO:K12493]", "84364  ARFGAP2; ADP ribosylation factor GTPase activating protein 2 [KO:K12493]", "23362  PSD3; pleckstrin and Sec7 domain containing 3 [KO:K12494]", "23550  PSD4; pleckstrin and Sec7 domain containing 4 [KO:K12494]", "5662  PSD; pleckstrin and Sec7 domain containing [KO:K12494]", "84249  PSD2; pleckstrin and Sec7 domain containing 2 [KO:K12494]", "23096  IQSEC2; IQ motif and Sec7 domain ArfGEF 2 [KO:K12495]", "9922  IQSEC1; IQ motif and Sec7 domain ArfGEF 1 [KO:K12495]", "440073  IQSEC3; IQ motif and Sec7 domain ArfGEF 3 [KO:K12495]", "9265  CYTH3; cytohesin 3 [KO:K18441]", "27128  CYTH4; cytohesin 4 [KO:K18441]", "9266  CYTH2; cytohesin 2 [KO:K18441]", "9267  CYTH1; cytohesin 1 [KO:K18441]", "10564  ARFGEF2; ADP ribosylation factor guanine nucleotide exchange factor 2 [KO:K18442]", "10565  ARFGEF1; ADP ribosylation factor guanine nucleotide exchange factor 1 [KO:K18442]", "8729  GBF1; golgi brefeldin A resistant guanine nucleotide exchange factor 1 [KO:K18443]", "375  ARF1; ADP ribosylation factor 1 [KO:K07937]", "377  ARF3; ADP ribosylation factor 3 [KO:K07938]", "378  ARF4; ADP ribosylation factor 4 [KO:K07939]", "381  ARF5; ADP ribosylation factor 5 [KO:K07940]"], "compound": ["C00035  GDP", "C00044  GTP", "C04549  1-Phosphatidyl-1D-myo-inositol 3-phosphate", "C04637  1-Phosphatidyl-D-myo-inositol 4,5-bisphosphate", "C05981  Phosphatidylinositol-3,4,5-trisphosphate", "C11556  1-Phosphatidyl-1D-myo-inositol 3,5-bisphosphate"], "refs": [{"pmid": "19007773", "authors": "  Acconcia F, Sigismund S, Polo S", "title": "Ubiquitin in trafficking: the network at work.", "journal": "Exp Cell Res 315:1610-8 (2009)", "doi": "10.1016/j.yexcr.2008.10.014"}, {"pmid": "18647649", "authors": "  Donaldson JG, Porat-Shliom N, Cohen LA", "title": "Clathrin-independent endocytosis: a unique platform for cell signaling and PM remodeling.", "journal": "Cell Signal 21:1-6 (2009)", "doi": "10.1016/j.cellsig.2008.06.020"}, {"pmid": "15261671", "authors": "  Sorkin A", "title": "Cargo recognition during clathrin-mediated endocytosis: a team effort.", "journal": "Curr Opin Cell Biol 16:392-9 (2004)", "doi": "10.1016/j.ceb.2004.06.001"}, {"pmid": "19325624", "authors": "  Raiborg C, Stenmark H", "title": "The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins.", "journal": "Nature 458:445-52 (2009)", "doi": "10.1038/nature07961"}, {"pmid": "20110990", "authors": "  Scita G, Di Fiore PP", "title": "The endocytic matrix.", "journal": "Nature 463:464-73 (2010)", "doi": "10.1038/nature08910"}, {"pmid": "15687999", "authors": "  Le Roy C, Wrana JL", "title": "Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling.", "journal": "Nat Rev Mol Cell Biol 6:112-26 (2005)", "doi": "10.1038/nrm1571"}, {"pmid": "19924646", "authors": "  Jovic M, Sharma M, Rahajeng J, Caplan S", "title": "The early endosome: a busy sorting station for proteins at the crossroads.", "journal": "Histol Histopathol 25:99-112 (2010)", "doi": "10.14670/HH-25.99"}, {"pmid": "16203612", "authors": "  Pietiainen VM, Marjomaki V, Heino J, Hyypia T", "title": "Viral entry, lipid rafts and caveosomes.", "journal": "Ann Med 37:394-403 (2005)", "doi": "10.1080/07853890510011976"}, {"pmid": "19696797", "authors": "  Grant BD, Donaldson JG", "title": "Pathways and mechanisms of endocytic recycling.", "journal": "Nat Rev Mol Cell Biol 10:597-608 (2009)", "doi": "10.1038/nrm2755"}], "rel_pathway": ["hsa04060  Cytokine-cytokine receptor interaction", "hsa04070  Phosphatidylinositol signaling system", "hsa04130  SNARE interactions in vesicular transport", "hsa04142  Lysosome", "hsa04350  TGF-beta signaling pathway"], "ko_pathway": "ko04144", "genes": ["EGFR", "IL2R"]}, {"kegg_id": "hsa04520", "name": "Adherens junction - Homo sapiens (human)", "description": "Cell-cell adherens junctions (AJs), the most common type of intercellular adhesions, are important for maintaining tissue architecture and cell polarity and can limit cell movement and proliferation. At AJs, E-cadherin serves as an essential cell adhesion molecules (CAMs). The cytoplasmic tail binds beta-catenin, which in turn binds alpha-catenin. Alpha-catenin is associated with F-actin bundles directly and indirectly. The integrity of the cadherin-catenin complex is negatively regulated by phosphorylation of beta-catenin by receptor tyrosine kinases (RTKs) and cytoplasmic tyrosine kinases (Fer, Fyn, Yes, and Src), which leads to dissociation of the cadherin-catenin complex. Integrity of this complex is positively regulated by beta -catenin phosphorylation by casein kinase II, and dephosphorylation by protein tyrosine phosphatases. Changes in the phosphorylation state of beta-catenin affect cell-cell adhesion, cell migration and the level of signaling beta-catenin. Wnt signaling acts as a positive regulator of beta-catenin by inhibiting beta-catenin degradation, which stabilizes beta-catenin, and causes its accumulation. Cadherin may acts as a negative regulator of signaling beta-catenin as it binds beta-catenin at the cell surface and thereby sequesters it from the nucleus. Nectins also function as CAMs at AJs, but are more highly concentrated at AJs than E-cadherin. Nectins transduce signals through Cdc42 and Rac, which reorganize the actin cytoskeleton, regulate the formation of AJs, and strengthen cell-cell adhesion.", "class": "Cellular Processes; Cellular community - eukaryotes", "pathway_map": "hsa04520  Adherens junction", "drug": ["D05716  Repifermin (USAN/INN)", "D09328  Cixutumumab (USAN)", "D09746  Dalotuzumab (USAN)", "D09908  Ganitumab (USAN/INN)", "D09925  Linsitinib (USAN/INN)", "D09941  Onartuzumab (USAN/INN)", "D10056  Robatumumab (USAN/INN)", "D10173  Tivantinib (JAN/USAN/INN)", "D11307  Telisotuzumab (USAN)", "D11344  Telisotuzumab vedotin (USAN)", "D11524  Enfortumab (USAN)", "D11525  Enfortumab vedotin (USAN)", "D11894  Amivantamab (USAN/INN)", "D12287  Terevalefim (USAN/INN)", "D12768  Ficerafusp alfa (USAN)"], "dblinks": "GO: 0005912", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["5818  NECTIN1; nectin cell adhesion molecule 1 [KO:K06081]", "5819  NECTIN2; nectin cell adhesion molecule 2 [KO:K06531]", "25945  NECTIN3; nectin cell adhesion molecule 3 [KO:K06592]", "81607  NECTIN4; nectin cell adhesion molecule 4 [KO:K06593]", "56288  PARD3; par-3 family cell polarity regulator [KO:K04237]", "6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "9855  FARP2; FERM, ARH/RhoGEF and pleckstrin domain protein 2 [KO:K06082]", "998  CDC42; cell division cycle 42 [KO:K04393]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "5880  RAC2; Rac family small GTPase 2 [KO:K07860]", "5881  RAC3; Rac family small GTPase 3 [KO:K07861]", "8976  WASL; WASP like actin nucleation promoting factor [KO:K23612]", "7454  WAS; WASP actin nucleation promoting factor [KO:K05747]", "8826  IQGAP1; IQ motif containing GTPase activating protein 1 [KO:K16848]", "10458  BAIAP2; BAR/IMD domain containing adaptor protein 2 [KO:K05627]", "8936  WASF1; WASP family member 1 [KO:K05753]", "10163  WASF2; WASP family member 2 [KO:K05748]", "10810  WASF3; WASP family member 3 [KO:K06083]", "4301  AFDN; afadin, adherens junction formation factor [KO:K05702]", "4008  LMO7; LIM domain 7 [KO:K06084]", "117178  SSX2IP; SSX family member 2 interacting protein [KO:K06085]", "10580  SORBS1; sorbin and SH3 domain containing 1 [KO:K06086]", "87  ACTN1; actinin alpha 1 [KO:K05699]", "81  ACTN4; actinin alpha 4 [KO:K05699]", "7414  VCL; vinculin [KO:K05700]", "7082  TJP1; tight junction protein 1 [KO:K05701]", "999  CDH1; cadherin 1 [KO:K05689]", "1500  CTNND1; catenin delta 1 [KO:K05690]", "1499  CTNNB1; catenin beta 1 [KO:K02105]", "29119  CTNNA3; catenin alpha 3 [KO:K05691]", "1495  CTNNA1; catenin alpha 1 [KO:K05691]", "1496  CTNNA2; catenin alpha 2 [KO:K05691]", "71  ACTG1; actin gamma 1 [KO:K05692]", "60  ACTB; actin beta [KO:K05692]", "387  RHOA; ras homolog family member A [KO:K04513]", "52  ACP1; acid phosphatase 1 [KO:K14394] [EC:3.1.3.2 3.1.3.48]", "5797  PTPRM; protein tyrosine phosphatase receptor type M [KO:K05693] [EC:3.1.3.48]", "5787  PTPRB; protein tyrosine phosphatase receptor type B [KO:K05694] [EC:3.1.3.48]", "5792  PTPRF; protein tyrosine phosphatase receptor type F [KO:K05695] [EC:3.1.3.48]", "5770  PTPN1; protein tyrosine phosphatase non-receptor type 1 [KO:K05696] [EC:3.1.3.48]", "5777  PTPN6; protein tyrosine phosphatase non-receptor type 6 [KO:K05697] [EC:3.1.3.48]", "5795  PTPRJ; protein tyrosine phosphatase receptor type J [KO:K05698] [EC:3.1.3.48]", "1457  CSNK2A1; casein kinase 2 alpha 1 [KO:K03097] [EC:2.7.11.1]", "1459  CSNK2A2; casein kinase 2 alpha 2 [KO:K03097] [EC:2.7.11.1]", "283106  CSNK2A3; casein kinase 2 alpha 3 [KO:K03097] [EC:2.7.11.1]", "1460  CSNK2B; casein kinase 2 beta [KO:K03115]", "6932  TCF7; transcription factor 7 [KO:K02620]", "83439  TCF7L1; transcription factor 7 like 1 [KO:K04490]", "6934  TCF7L2; transcription factor 7 like 2 [KO:K04491]", "51176  LEF1; lymphoid enhancer binding factor 1 [KO:K04492]", "3480  IGF1R; insulin like growth factor 1 receptor [KO:K05087] [EC:2.7.10.1]", "3643  INSR; insulin receptor [KO:K04527] [EC:2.7.10.1]", "4233  MET; MET proto-oncogene, receptor tyrosine kinase [KO:K05099] [EC:2.7.10.1]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "2064  ERBB2; erb-b2 receptor tyrosine kinase 2 [KO:K05083] [EC:2.7.10.1]", "2260  FGFR1; fibroblast growth factor receptor 1 [KO:K04362] [EC:2.7.10.1]", "2241  FER; FER tyrosine kinase [KO:K08889] [EC:2.7.10.2]", "2534  FYN; FYN proto-oncogene, Src family tyrosine kinase [KO:K05703] [EC:2.7.10.2]", "7525  YES1; YES proto-oncogene 1, Src family tyrosine kinase [KO:K05705] [EC:2.7.10.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "6591  SNAI2; snail family transcriptional repressor 2 [KO:K05706]", "6615  SNAI1; snail family transcriptional repressor 1 [KO:K05707]", "7046  TGFBR1; transforming growth factor beta receptor 1 [KO:K04674] [EC:2.7.11.30]", "7048  TGFBR2; transforming growth factor beta receptor 2 [KO:K04388] [EC:2.7.11.30]", "4088  SMAD3; SMAD family member 3 [KO:K23605]", "4089  SMAD4; SMAD family member 4 [KO:K04501]", "1387  CREBBP; CREB binding protein [KO:K04498] [EC:2.3.1.48]", "2033  EP300; E1A binding protein p300 [KO:K04498] [EC:2.3.1.48]", "6885  MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO:K04427] [EC:2.7.11.25]", "51701  NLK; nemo like kinase [KO:K04468] [EC:2.7.11.24]", "1003  CDH5; cadherin 5 [KO:K06533]", "57493  HEG1; heart development protein with EGF like domains 1 [KO:K24472]", "889  KRIT1; KRIT1 ankyrin repeat containing [KO:K17705]", "83605  CCM2; CCM2 scaffold protein [KO:K26416]", "11235  PDCD10; programmed cell death 10 [KO:K18269]", "57154  SMURF1; SMAD specific E3 ubiquitin protein ligase 1 [KO:K04678] [EC:2.3.2.26]", "64750  SMURF2; SMAD specific E3 ubiquitin protein ligase 2 [KO:K04678] [EC:2.3.2.26]", "5906  RAP1A; RAP1A, member of RAS oncogene family [KO:K04353]", "5908  RAP1B; RAP1B, member of RAS oncogene family [KO:K07836]", "54922  RASIP1; Ras interacting protein 1 [KO:K26417]", "55698  RADIL; Rap associating with DIL domain [KO:K26418]", "9411  ARHGAP29; Rho GTPase activating protein 29 [KO:K20644]", "6093  ROCK1; Rho associated coiled-coil containing protein kinase 1 [KO:K04514] [EC:2.7.11.1]", "9475  ROCK2; Rho associated coiled-coil containing protein kinase 2 [KO:K17388] [EC:2.7.11.1]", "4633  MYL2; myosin light chain 2 [KO:K10351]", "4636  MYL5; myosin light chain 5 [KO:K12753]", "58498  MYL7; myosin light chain 7 [KO:K12754]", "10398  MYL9; myosin light chain 9 [KO:K12755]", "93408  MYL10; myosin light chain 10 [KO:K12756]", "103910  MYL12B; myosin light chain 12B [KO:K12757]", "10627  MYL12A; myosin light chain 12A [KO:K12757]", "29895  MYL11; myosin light chain 11 [KO:K12758]"], "refs": [{"pmid": "15001769", "authors": "  Nelson WJ, Nusse R.", "title": "Convergence of Wnt, beta-catenin, and cadherin pathways.", "journal": "Science 303:1483-7 (2004)", "doi": "10.1126/science.1094291"}, {"pmid": "10204118", "authors": "  Potter E, Bergwitz C, Brabant G.", "title": "The cadherin-catenin system: implications for growth and differentiation of endocrine tissues.", "journal": "Endocr Rev 20:207-39 (1999)", "doi": "10.1210/edrv.20.2.0362"}, {"pmid": "10959047", "authors": "  Beavon IR.", "title": "The E-cadherin-catenin complex in tumour metastasis: structure, function and regulation.", "journal": "Eur J Cancer 36:1607-20 (2000)", "doi": "10.1016/S0959-8049(00)00158-1"}, {"pmid": "15489912", "authors": "  Reynolds AB, Roczniak-Ferguson A.", "title": "Emerging roles for p120-catenin in cell adhesion and cancer.", "journal": "Oncogene 23:7947-56 (2004)", "doi": "10.1038/sj.onc.1208161"}, {"pmid": "11984870", "authors": "  Lilien J, Balsamo J, Arregui C, Xu G.", "title": "Turn-off, drop-out: functional state switching of cadherins.", "journal": "Dev Dyn 224:18-29 (2002)", "doi": "10.1002/dvdy.10087"}, {"pmid": "12640114", "authors": "  Piedra J, Miravet S, Castano J, Palmer HG, Heisterkamp N, Garcia de Herreros A, Dunach M.", "title": "p120 Catenin-associated Fer and Fyn tyrosine kinases regulate beta-catenin Tyr-142 phosphorylation and beta-catenin-alpha-catenin Interaction.", "journal": "Mol Cell Biol 23:2287-97 (2003)", "doi": "10.1128/MCB.23.7.2287-2297.2003"}, {"pmid": "14623871", "authors": "  Conacci-Sorrell M, Simcha I, Ben-Yedidia T, Blechman J, Savagner P, Ben-Ze'ev A.", "title": "Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK.", "journal": "J Cell Biol 163:847-57 (2003)", "doi": "10.1083/jcb.200308162"}, {"pmid": "11703922", "authors": "  Ciruna B, Rossant J.", "title": "FGF signaling regulates mesoderm cell fate specification and morphogenetic movement at the primitive streak.", "journal": "Dev Cell 1:37-49 (2001)", "doi": "10.1016/S1534-5807(01)00017-X"}, {"pmid": "12665527", "authors": "  Peinado H, Quintanilla M, Cano A.", "title": "Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions.", "journal": "J Biol Chem 278:21113-23 (2003)", "doi": "10.1074/jbc.M211304200"}, {"pmid": "10890911", "authors": "  Labbe E, Letamendia A, Attisano L.", "title": "Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways.", "journal": "Proc Natl Acad Sci U S A 97:8358-63 (2000)", "doi": "10.1073/pnas.150152697"}, {"pmid": "15551862", "authors": "  Nakanishi H, Takai Y.", "title": "Roles of nectins in cell adhesion, migration and polarization.", "journal": "Biol Chem 385:885-92 (2004)", "doi": "10.1515/BC.2004.116"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04060  Cytokine-cytokine receptor interaction", "hsa04310  Wnt signaling pathway", "hsa04350  TGF-beta signaling pathway", "hsa04530  Tight junction", "hsa04810  Regulation of actin cytoskeleton"], "ko_pathway": "ko04520", "genes": ["EGFR", "RAC1", "MET"]}, {"kegg_id": "hsa04540", "name": "Gap junction - Homo sapiens (human)", "description": "Gap junctions contain intercellular channels that allow direct communication between the cytosolic compartments of adjacent cells. Each gap junction channel is formed by docking of two 'hemichannels', each containing six connexins, contributed by each neighboring cell. These channels permit the direct transfer of small molecules including ions, amino acids, nucleotides, second messengers and other metabolites between adjacent cells. Gap junctional communication is essential for many physiological events, including embryonic development, electrical coupling, metabolic transport, apoptosis, and tissue homeostasis. Communication through Gap Junction is sensitive to a variety of stimuli, including changes in the level of intracellular Ca2+, pH, transjunctional applied voltage and phosphorylation/dephosphorylation processes. This figure represents the possible activation routes of different protein kinases involved in Cx43 and Cx36 phosphorylation.", "class": "Cellular Processes; Cellular community - eukaryotes", "pathway_map": "hsa04540  Gap junction", "drug": ["D00491  Paclitaxel (JAN/USP/INN)", "D00570  Colchicine (JP18/USP)", "D00599  Carteolol hydrochloride (JP18/USP)", "D01068  Vinblastine sulfate (JP18/USP)", "D01105  Moperone hydrochloride (JAN)", "D01769  Vindesine sulfate (JAN/USAN)", "D01919  Soblidotin (JAN/INN)", "D01935  Vinorelbine tartrate (USP)", "D02035  Timiperone (JAN)", "D02165  Docetaxel (USP)", "D02197  Vincristine sulfate (JP18/USP)", "D02371  Clocapramine hydrochloride hydrate (JP18)", "D02372  Perospirone hydrochloride hydrate (JAN)", "D02605  Methoxypromazine maleate", "D02623  Moperone (INN)", "D02641  Butaclamol hydrochloride (USAN)", "D02670  Mazapertine succinate (USAN)", "D02681  Piquindone hydrochloride (USAN)", "D02682  Remoxipride (USAN)", "D02683  Remoxipride hydrochloride (USAN)", "D03059  Batabulin sodium (USAN)", "D03065  Becaplermin (USAN/INN)", "D03364  Cantuzumab mertansine (USAN)", "D04645  Ixabepilone (JAN/USAN/INN)", "D04864  Maytansine (USAN)", "D05062  Mivobulin isethionate (USAN)", "D05333  Paclitaxel poliglumex (USAN/INN)", "D06001  Taltobulin (USAN/INN)", "D06009  Tasidotin hydrochloride (USAN)", "D06304  Vindesine (USAN/INN)", "D06305  Vinepidine sulfate (USAN)", "D06306  Vinglycinate sulfate (USAN)", "D06307  Vinleurosine sulfate (USAN)", "D06308  Vinrosidine sulfate (USAN)", "D06309  Vinzolidine sulfate (USAN)", "D06560  Batabulin (USAN/INN)", "D06576  Cevipabulin fumarate (USAN)", "D07624  Carteolol (INN)", "D07718  Clocapramine (INN)", "D07866  Docetaxel (JAN/INN)", "D08675  Vinblastine (INN)", "D08679  Vincristine (INN)", "D08680  Vinorelbine (INN)", "D08889  Cevipabulin succinate (USAN)", "D08914  Eribulin mesylate (USAN)", "D09032  Vinflunine ditartrate (USAN)", "D09755  Cabazitaxel (USAN/INN)", "D09927  Lorvotuzumab mertansine (USAN/INN)", "D10029  Verubulin (USAN/INN)", "D10030  Verubulin hydrochloride (USAN)", "D10452  Cabazitaxel acetonate (JAN)", "D10454  Cantuzumab ravtansine (USAN/INN)", "D11228  Soravtansine (USAN)", "D11238  Lifastuzumab vedotin (USAN/INN)", "D11494  Lisavanbulin (USAN/INN)", "D11525  Enfortumab vedotin (USAN)", "D11681  Avanbulin (USAN/INN)", "D11691  Tirbanibulin (JAN/USAN/INN)", "D11692  Tirbanibulin mesylate (USAN)", "D11814  Tisotumab vedotin (USAN/INN)", "D12183  Farletuzumab ecteribulin (USAN)", "D12516  Zagociguat (USAN/INN)", "D12519  Sabizabulin (USAN/INN)", "D12520  Sabizabulin hydrochloride (USAN)", "D12642  Fipaxalparant (USAN/INN)", "D12657  Admilparant (USAN)", "D12733  Dordaviprone (USAN/INN)", "D12734  Dordaviprone hydrochloride (JAN/USAN)", "D12881  Psilocybin (USAN)"], "dblinks": "GO: 0005921", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["2697  GJA1; gap junction protein alpha 1 [KO:K07372]", "57369  GJD2; gap junction protein delta 2 [KO:K07373]", "1902  LPAR1; lysophosphatidic acid receptor 1 [KO:K04289]", "2770  GNAI1; G protein subunit alpha i1 [KO:K04630]", "2773  GNAI3; G protein subunit alpha i3 [KO:K04630]", "2771  GNAI2; G protein subunit alpha i2 [KO:K04630]", "5154  PDGFA; platelet derived growth factor subunit A [KO:K04359]", "5155  PDGFB; platelet derived growth factor subunit B [KO:K17386]", "56034  PDGFC; platelet derived growth factor C [KO:K05450]", "80310  PDGFD; platelet derived growth factor D [KO:K05450]", "1950  EGF; epidermal growth factor [KO:K04357]", "5156  PDGFRA; platelet derived growth factor receptor alpha [KO:K04363] [EC:2.7.10.1]", "5159  PDGFRB; platelet derived growth factor receptor beta [KO:K05089] [EC:2.7.10.1]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "10746  MAP3K2; mitogen-activated protein kinase kinase kinase 2 [KO:K04420] [EC:2.7.11.25]", "5607  MAP2K5; mitogen-activated protein kinase kinase 5 [KO:K04463] [EC:2.7.12.2]", "5598  MAPK7; mitogen-activated protein kinase 7 [KO:K04464] [EC:2.7.11.24]", "10376  TUBA1B; tubulin alpha 1b [KO:K07374]", "7277  TUBA4A; tubulin alpha 4a [KO:K07374]", "7278  TUBA3C; tubulin alpha 3c [KO:K07374]", "7846  TUBA1A; tubulin alpha 1a [KO:K07374]", "84790  TUBA1C; tubulin alpha 1c [KO:K07374]", "51807  TUBA8; tubulin alpha 8 [KO:K07374]", "112714  TUBA3E; tubulin alpha 3e [KO:K07374]", "113457  TUBA3D; tubulin alpha 3d [KO:K07374]", "79861  TUBAL3; tubulin alpha like 3 [KO:K07374]", "84617  TUBB6; tubulin beta 6 class V [KO:K07375]", "203068  TUBB; tubulin beta class I [KO:K07375]", "81027  TUBB1; tubulin beta 1 class VI [KO:K07375]", "7280  TUBB2A; tubulin beta 2A class IIa [KO:K07375]", "10381  TUBB3; tubulin beta 3 class III [KO:K07375]", "10382  TUBB4A; tubulin beta 4A class IVa [KO:K07375]", "347688  TUBB8; tubulin beta 8 class VIII [KO:K07375]", "347733  TUBB2B; tubulin beta 2B class IIb [KO:K07375]", "10383  TUBB4B; tubulin beta 4B class IVb [KO:K07375]", "1453  CSNK1D; casein kinase 1 delta [KO:K08959] [EC:2.7.11.1]", "983  CDK1; cyclin dependent kinase 1 [KO:K02087] [EC:2.7.11.22 2.7.11.23]", "7082  TJP1; tight junction protein 1 [KO:K05701]", "153  ADRB1; adrenoceptor beta 1 [KO:K04141]", "1812  DRD1; dopamine receptor D1 [KO:K04144]", "2778  GNAS; GNAS complex locus [KO:K04632]", "1813  DRD2; dopamine receptor D2 [KO:K04145]", "107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]", "108  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]", "109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]", "196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]", "113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]", "114  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]", "115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "3356  HTR2A; 5-hydroxytryptamine receptor 2A [KO:K04157]", "3357  HTR2B; 5-hydroxytryptamine receptor 2B [KO:K04157]", "3358  HTR2C; 5-hydroxytryptamine receptor 2C [KO:K04157]", "2911  GRM1; glutamate metabotropic receptor 1 [KO:K04603]", "2915  GRM5; glutamate metabotropic receptor 5 [KO:K04604]", "2767  GNA11; G protein subunit alpha 11 [KO:K04635]", "2776  GNAQ; G protein subunit alpha q [KO:K04634]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "2977  GUCY1A2; guanylate cyclase 1 soluble subunit alpha 2 [KO:K12318] [EC:4.6.1.2]", "2982  GUCY1A1; guanylate cyclase 1 soluble subunit alpha 1 [KO:K12318] [EC:4.6.1.2]", "2983  GUCY1B1; guanylate cyclase 1 soluble subunit beta 1 [KO:K12319] [EC:4.6.1.2]", "5592  PRKG1; protein kinase cGMP-dependent 1 [KO:K07376] [EC:2.7.11.12]", "5593  PRKG2; protein kinase cGMP-dependent 2 [KO:K19477] [EC:2.7.11.12]"], "compound": ["C00025  L-Glutamate", "C00076  Calcium cation", "C00165  Diacylglycerol", "C00533  Nitric oxide", "C00547  L-Noradrenaline", "C00575  3',5'-Cyclic AMP", "C00681  1-Acyl-sn-glycerol 3-phosphate", "C00780  Serotonin", "C00942  3',5'-Cyclic GMP", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C03758  Dopamine"], "refs": [{"pmid": "14506308", "authors": "  Saez JC, Berthoud VM, Branes MC, Martinez AD, Beyer EC.", "title": "Plasma membrane channels formed by connexins: their regulation and functions.", "journal": "Physiol Rev 83:1359-400 (2003)", "doi": "10.1152/physrev.00007.2003"}, {"pmid": "15033580", "authors": "  Warn-Cramer BJ, Lau AF.", "title": "Regulation of gap junctions by tyrosine protein kinases.", "journal": "Biochim Biophys Acta 1662:81-95 (2004)", "doi": "10.1016/j.bbamem.2003.10.018"}, {"pmid": "9535909", "authors": "  Warn-Cramer BJ, Cottrell GT, Burt JM, Lau AF.", "title": "Regulation of connexin-43 gap junctional intercellular communication by mitogen-activated protein kinase.", "journal": "J Biol Chem 273:9188-96 (1998)", "doi": "10.1074/jbc.273.15.9188"}, {"pmid": "10751659", "authors": "  Roerig B, Feller MB.", "title": "Neurotransmitters and gap junctions in developing neural circuits.", "journal": "Brain Res Brain Res Rev 32:86-114 (2000)", "doi": "10.1016/S0165-0173(99)00069-7"}, {"pmid": "10873290", "authors": "  Hatton GI.", "title": "Synaptic modulation of neuronal coupling.", "journal": "Cell Biol Int 22:765-80 (1998)", "doi": "10.1006/cbir.1998.0386"}, {"pmid": "12566218", "authors": "  Cruciani V, Mikalsen SO.", "title": "Connexins, gap junctional intercellular communication and kinases.", "journal": "Biol Cell 94:433-43 (2002)", "doi": "10.1016/S0248-4900(02)00014-X"}, {"pmid": "15094344", "authors": "  Giepmans BN.", "title": "Gap junctions and connexin-interacting proteins.", "journal": "Cardiovasc Res 62:233-45 (2004)", "doi": "10.1016/j.cardiores.2003.12.009"}, {"pmid": "15955302", "authors": "  Laird DW.", "title": "Connexin phosphorylation as a regulatory event linked to gap junction internalization and degradation.", "journal": "Biochim Biophys Acta 1711:172-82 (2005)", "doi": "10.1016/j.bbamem.2004.09.009"}, {"pmid": "15033579", "authors": "  Peracchia C.", "title": "Chemical gating of gap junction channels; roles of calcium, pH and calmodulin.", "journal": "Biochim Biophys Acta 1662:61-80 (2004)", "doi": "10.1016/j.bbamem.2003.10.020"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04060  Cytokine-cytokine receptor interaction", "hsa04070  Phosphatidylinositol signaling system", "hsa04080  Neuroactive ligand-receptor interaction"], "ko_pathway": "ko04540", "genes": ["EGFR", "SOS1", "NRAS"]}, {"kegg_id": "hsa04810", "name": "Regulation of actin cytoskeleton - Homo sapiens (human)", "class": "Cellular Processes; Cell motility", "pathway_map": "hsa04810  Regulation of actin cytoskeleton", "network": ["", "ELEMENT   N00405  CXCR4-GNA12/13-Rho signaling pathway", "N01068  ITGA/B-FAK-RAC signaling pathway", "N01097  LPA-GNA12/13-RhoA signaling pathway", "N01161  Actin polymerization", "N01768  CXCR4-GNA12/13 signaling pathway"], "drug": ["D01175  Carpronium chloride (JAN/INN)", "D01840  Fasudil hydrochloride (JAN)", "D03065  Becaplermin (USAN/INN)", "D03115  Fasudil hydrochloride hydrate (JAN)", "D03497  Cilengitide (USAN/INN)", "D03722  Efegatran sulfate (USAN)", "D03728  Napsagatran (USAN)", "D04492  Icatibant acetate (JAN/USAN)", "D05338  Palifermin (USAN/INN)", "D05716  Repifermin (USAN/INN)", "D06319  Volociximab (USAN)", "D07941  Fasudil (INN)", "D09342  Etaracizumab (USAN/INN)", "D09752  Carpronium chloride hydrate (JAN)", "D10028  Valategrast hydrochloride (USAN)", "D10374  Lifitegrast (USAN/INN)", "D10392  Lifitegrast sodium (USAN)", "D10463  Ripasudil hydrochloride hydrate (JAN)", "D12722  Bexotegrast (USAN/INN)"], "dblinks": "GO: 0030036", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["1902  LPAR1; lysophosphatidic acid receptor 1 [KO:K04289]", "9170  LPAR2; lysophosphatidic acid receptor 2 [KO:K04291]", "2846  LPAR4; lysophosphatidic acid receptor 4 [KO:K04275]", "57121  LPAR5; lysophosphatidic acid receptor 5 [KO:K08390]", "6387  CXCL12; C-X-C motif chemokine ligand 12 [KO:K10031]", "7852  CXCR4; C-X-C motif chemokine receptor 4 [KO:K04189]", "2147  F2; coagulation factor II, thrombin [KO:K01313] [EC:3.4.21.5]", "2149  F2R; coagulation factor II thrombin receptor [KO:K03914]", "3630  INS; insulin [KO:K04526]", "1950  EGF; epidermal growth factor [KO:K04357]", "2246  FGF1; fibroblast growth factor 1 [KO:K18496]", "2247  FGF2; fibroblast growth factor 2 [KO:K18497]", "2248  FGF3; fibroblast growth factor 3 [KO:K04358]", "2249  FGF4; fibroblast growth factor 4 [KO:K04358]", "8822  FGF17; fibroblast growth factor 17 [KO:K04358]", "2251  FGF6; fibroblast growth factor 6 [KO:K04358]", "2252  FGF7; fibroblast growth factor 7 [KO:K04358]", "2253  FGF8; fibroblast growth factor 8 [KO:K04358]", "2254  FGF9; fibroblast growth factor 9 [KO:K04358]", "2255  FGF10; fibroblast growth factor 10 [KO:K04358]", "8823  FGF16; fibroblast growth factor 16 [KO:K04358]", "2250  FGF5; fibroblast growth factor 5 [KO:K04358]", "8817  FGF18; fibroblast growth factor 18 [KO:K04358]", "26281  FGF20; fibroblast growth factor 20 [KO:K04358]", "27006  FGF22; fibroblast growth factor 22 [KO:K04358]", "9965  FGF19; fibroblast growth factor 19 [KO:K22603]", "26291  FGF21; fibroblast growth factor 21 [KO:K22429]", "8074  FGF23; fibroblast growth factor 23 [KO:K22428]", "5154  PDGFA; platelet derived growth factor subunit A [KO:K04359]", "5155  PDGFB; platelet derived growth factor subunit B [KO:K17386]", "56034  PDGFC; platelet derived growth factor C [KO:K05450]", "80310  PDGFD; platelet derived growth factor D [KO:K05450]", "3645  INSRR; insulin receptor related receptor [KO:K05086] [EC:2.7.10.1]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "2260  FGFR1; fibroblast growth factor receptor 1 [KO:K04362] [EC:2.7.10.1]", "2263  FGFR2; fibroblast growth factor receptor 2 [KO:K05093] [EC:2.7.10.1]", "2261  FGFR3; fibroblast growth factor receptor 3 [KO:K05094] [EC:2.7.10.1]", "2264  FGFR4; fibroblast growth factor receptor 4 [KO:K05095] [EC:2.7.10.1]", "5156  PDGFRA; platelet derived growth factor receptor alpha [KO:K04363] [EC:2.7.10.1]", "5159  PDGFRB; platelet derived growth factor receptor beta [KO:K05089] [EC:2.7.10.1]", "2335  FN1; fibronectin 1 [KO:K05717]", "3672  ITGA1; integrin subunit alpha 1 [KO:K06480]", "3673  ITGA2; integrin subunit alpha 2 [KO:K06481]", "3674  ITGA2B; integrin subunit alpha 2b [KO:K06476]", "3675  ITGA3; integrin subunit alpha 3 [KO:K06482]", "3676  ITGA4; integrin subunit alpha 4 [KO:K06483]", "3678  ITGA5; integrin subunit alpha 5 [KO:K06484]", "3655  ITGA6; integrin subunit alpha 6 [KO:K06485]", "3679  ITGA7; integrin subunit alpha 7 [KO:K06583]", "8516  ITGA8; integrin subunit alpha 8 [KO:K06584]", "3680  ITGA9; integrin subunit alpha 9 [KO:K06585]", "8515  ITGA10; integrin subunit alpha 10 [KO:K06586]", "22801  ITGA11; integrin subunit alpha 11 [KO:K06587]", "3685  ITGAV; integrin subunit alpha V [KO:K06487]", "3683  ITGAL; integrin subunit alpha L [KO:K05718]", "3684  ITGAM; integrin subunit alpha M [KO:K06461]", "3687  ITGAX; integrin subunit alpha X [KO:K06462]", "3681  ITGAD; integrin subunit alpha D [KO:K06594]", "3682  ITGAE; integrin subunit alpha E [KO:K06524]", "3688  ITGB1; integrin subunit beta 1 [KO:K05719]", "3689  ITGB2; integrin subunit beta 2 [KO:K06464]", "3690  ITGB3; integrin subunit beta 3 [KO:K06493]", "3691  ITGB4; integrin subunit beta 4 [KO:K06525]", "3693  ITGB5; integrin subunit beta 5 [KO:K06588]", "3694  ITGB6; integrin subunit beta 6 [KO:K06589]", "3695  ITGB7; integrin subunit beta 7 [KO:K06590]", "3696  ITGB8; integrin subunit beta 8 [KO:K06591]", "3827  KNG1; kininogen 1 [KO:K03898]", "623  BDKRB1; bradykinin receptor B1 [KO:K03915]", "624  BDKRB2; bradykinin receptor B2 [KO:K03916]", "1128  CHRM1; cholinergic receptor muscarinic 1 [KO:K04129]", "1129  CHRM2; cholinergic receptor muscarinic 2 [KO:K04130]", "1131  CHRM3; cholinergic receptor muscarinic 3 [KO:K04131]", "1132  CHRM4; cholinergic receptor muscarinic 4 [KO:K04132]", "1133  CHRM5; cholinergic receptor muscarinic 5 [KO:K04133]", "727  C5; complement C5 [KO:K03994]", "729  C6; complement C6 [KO:K03995]", "730  C7; complement C7 [KO:K03996]", "731  C8A; complement C8 alpha chain [KO:K03997]", "732  C8B; complement C8 beta chain [KO:K03998]", "733  C8G; complement C8 gamma chain [KO:K03999]", "735  C9; complement C9 [KO:K04000]", "2768  GNA12; G protein subunit alpha 12 [KO:K04346]", "10672  GNA13; G protein subunit alpha 13 [KO:K04639]", "55970  GNG12; G protein subunit gamma 12 [KO:K04347]", "2245  FGD1; FYVE, RhoGEF and PH domain containing 1 [KO:K05720]", "89846  FGD3; FYVE, RhoGEF and PH domain containing 3 [KO:K05722]", "5747  PTK2; protein tyrosine kinase 2 [KO:K05725] [EC:2.7.10.2]", "9564  BCAR1; BCAR1 scaffold protein, Cas family member [KO:K05726]", "1398  CRK; CRK proto-oncogene, adaptor protein [KO:K04438]", "1399  CRKL; CRK like proto-oncogene, adaptor protein [KO:K04438]", "1793  DOCK1; dedicator of cytokinesis 1 [KO:K13708]", "6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "6237  RRAS; RAS related [KO:K07829]", "22800  RRAS2; RAS related 2 [KO:K07830]", "22808  MRAS; muscle RAS oncogene homolog [KO:K07831]", "9459  ARHGEF6; Rac/Cdc42 guanine nucleotide exchange factor 6 [KO:K05729]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "10451  VAV3; vav guanine nucleotide exchange factor 3 [KO:K05730]", "7409  VAV1; vav guanine nucleotide exchange factor 1 [KO:K05730]", "7410  VAV2; vav guanine nucleotide exchange factor 2 [KO:K05730]", "7074  TIAM1; TIAM Rac1 associated GEF 1 [KO:K05731]", "369  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "4342  MOS; MOS proto-oncogene, serine/threonine kinase [KO:K04367] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "28984  RGCC; regulator of cell cycle [KO:K26108]", "9138  ARHGEF1; Rho guanine nucleotide exchange factor 1 [KO:K12330]", "23365  ARHGEF12; Rho guanine nucleotide exchange factor 12 [KO:K07532]", "2909  ARHGAP35; Rho GTPase activating protein 35 [KO:K05732]", "387  RHOA; ras homolog family member A [KO:K04513]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "5880  RAC2; Rac family small GTPase 2 [KO:K07860]", "5881  RAC3; Rac family small GTPase 3 [KO:K07861]", "998  CDC42; cell division cycle 42 [KO:K04393]", "5058  PAK1; p21 (RAC1) activated kinase 1 [KO:K04409] [EC:2.7.11.1]", "5062  PAK2; p21 (RAC1) activated kinase 2 [KO:K04410] [EC:2.7.11.1]", "5063  PAK3; p21 (RAC1) activated kinase 3 [KO:K05733] [EC:2.7.11.1]", "10298  PAK4; p21 (RAC1) activated kinase 4 [KO:K05734] [EC:2.7.11.1]", "57144  PAK5; p21 (RAC1) activated kinase 5 [KO:K05736] [EC:2.7.11.1]", "56924  PAK6; p21 (RAC1) activated kinase 6 [KO:K05735] [EC:2.7.11.1]", "106821730  BUB1B-PAK6; BUB1B-PAK6 readthrough [KO:K05735] [EC:2.7.11.1]", "8874  ARHGEF7; Rho guanine nucleotide exchange factor 7 [KO:K13710]", "28964  GIT1; GIT ArfGAP 1 [KO:K05737]", "6093  ROCK1; Rho associated coiled-coil containing protein kinase 1 [KO:K04514] [EC:2.7.11.1]", "9475  ROCK2; Rho associated coiled-coil containing protein kinase 2 [KO:K17388] [EC:2.7.11.1]", "4638  MYLK; myosin light chain kinase [KO:K00907] [EC:2.7.11.18]", "85366  MYLK2; myosin light chain kinase 2 [KO:K00907] [EC:2.7.11.18]", "91807  MYLK3; myosin light chain kinase 3 [KO:K00907] [EC:2.7.11.18]", "340156  MYLK4; myosin light chain kinase family member 4 [KO:K00907] [EC:2.7.11.18]", "5499  PPP1CA; protein phosphatase 1 catalytic subunit alpha [KO:K06269] [EC:3.1.3.16]", "5500  PPP1CB; protein phosphatase 1 catalytic subunit beta [KO:K06269] [EC:3.1.3.16]", "5501  PPP1CC; protein phosphatase 1 catalytic subunit gamma [KO:K06269] [EC:3.1.3.16]", "4659  PPP1R12A; protein phosphatase 1 regulatory subunit 12A [KO:K06270]", "4660  PPP1R12B; protein phosphatase 1 regulatory subunit 12B [KO:K12329]", "54776  PPP1R12C; protein phosphatase 1 regulatory subunit 12C [KO:K17457]", "4633  MYL2; myosin light chain 2 [KO:K10351]", "4636  MYL5; myosin light chain 5 [KO:K12753]", "58498  MYL7; myosin light chain 7 [KO:K12754]", "10398  MYL9; myosin light chain 9 [KO:K12755]", "93408  MYL10; myosin light chain 10 [KO:K12756]", "103910  MYL12B; myosin light chain 12B [KO:K12757]", "10627  MYL12A; myosin light chain 12A [KO:K12757]", "29895  MYL11; myosin light chain 11 [KO:K12758]", "4627  MYH9; myosin heavy chain 9 [KO:K10352]", "4628  MYH10; myosin heavy chain 10 [KO:K10352]", "4629  MYH11; myosin heavy chain 11 [KO:K10352]", "79784  MYH14; myosin heavy chain 14 [KO:K10352]", "1729  DIAPH1; diaphanous related formin 1 [KO:K05740]", "1730  DIAPH2; diaphanous related formin 2 [KO:K05741]", "6548  SLC9A1; solute carrier family 9 member A1 [KO:K05742]", "23396  PIP5K1C; phosphatidylinositol-4-phosphate 5-kinase type 1 gamma [KO:K00889] [EC:2.7.1.68]", "8394  PIP5K1A; phosphatidylinositol-4-phosphate 5-kinase type 1 alpha [KO:K00889] [EC:2.7.1.68]", "8395  PIP5K1B; phosphatidylinositol-4-phosphate 5-kinase type 1 beta [KO:K00889] [EC:2.7.1.68]", "79837  PIP4K2C; phosphatidylinositol-5-phosphate 4-kinase type 2 gamma [KO:K00920] [EC:2.7.1.149]", "5305  PIP4K2A; phosphatidylinositol-5-phosphate 4-kinase type 2 alpha [KO:K00920] [EC:2.7.1.149]", "8396  PIP4K2B; phosphatidylinositol-5-phosphate 4-kinase type 2 beta [KO:K00920] [EC:2.7.1.149]", "200576  PIKFYVE; phosphoinositide kinase, FYVE-type zinc finger containing [KO:K00921] [EC:2.7.1.150]", "3984  LIMK1; LIM domain kinase 1 [KO:K05743] [EC:2.7.11.1]", "3985  LIMK2; LIM domain kinase 2 [KO:K05744] [EC:2.7.11.1]", "81624  DIAPH3; diaphanous related formin 3 [KO:K05745]", "10458  BAIAP2; BAR/IMD domain containing adaptor protein 2 [KO:K05627]", "55740  ENAH; ENAH actin regulator [KO:K05746]", "8976  WASL; WASP like actin nucleation promoting factor [KO:K23612]", "10163  WASF2; WASP family member 2 [KO:K05748]", "23191  CYFIP1; cytoplasmic FMR1 interacting protein 1 [KO:K05749]", "26999  CYFIP2; cytoplasmic FMR1 interacting protein 2 [KO:K05749]", "10787  NCKAP1; NCK associated protein 1 [KO:K05750]", "3071  NCKAP1L; NCK associated protein 1 like [KO:K05750]", "10152  ABI2; abl interactor 2 [KO:K05751]", "55845  BRK1; BRICK1 subunit of SCAR/WAVE actin nucleating complex [KO:K05752]", "8936  WASF1; WASP family member 1 [KO:K05753]", "10097  ACTR2; actin related protein 2 [KO:K17260]", "57180  ACTR3B; actin related protein 3B [KO:K18584]", "653857  ACTR3C; actin related protein 3C [KO:K18584]", "10096  ACTR3; actin related protein 3 [KO:K18584]", "10095  ARPC1B; actin related protein 2/3 complex subunit 1B [KO:K05757]", "10552  ARPC1A; actin related protein 2/3 complex subunit 1A [KO:K05757]", "10109  ARPC2; actin related protein 2/3 complex subunit 2 [KO:K05758]", "10094  ARPC3; actin related protein 2/3 complex subunit 3 [KO:K05756]", "10093  ARPC4; actin related protein 2/3 complex subunit 4 [KO:K05755]", "10092  ARPC5; actin related protein 2/3 complex subunit 5 [KO:K05754]", "81873  ARPC5L; actin related protein 2/3 complex subunit 5 like [KO:K05754]", "71  ACTG1; actin gamma 1 [KO:K05692]", "60  ACTB; actin beta [KO:K05692]", "345456  PFN3; profilin 3 [KO:K05759]", "5216  PFN1; profilin 1 [KO:K05759]", "5217  PFN2; profilin 2 [KO:K05759]", "375189  PFN4; profilin family member 4 [KO:K05759]", "5829  PXN; paxillin [KO:K05760]", "7430  EZR; ezrin [KO:K08007]", "5962  RDX; radixin [KO:K05762]", "4478  MSN; moesin [KO:K05763]", "7114  TMSB4X; thymosin beta 4 X-linked [KO:K05764]", "9087  TMSB4Y; thymosin beta 4 Y-linked [KO:K05764]", "1072  CFL1; cofilin 1 [KO:K05765]", "1073  CFL2; cofilin 2 [KO:K05765]", "54434  SSH1; slingshot protein phosphatase 1 [KO:K05766] [EC:3.1.3.16 3.1.3.48]", "54961  SSH3; slingshot protein phosphatase 3 [KO:K05766] [EC:3.1.3.16 3.1.3.48]", "85464  SSH2; slingshot protein phosphatase 2 [KO:K05766] [EC:3.1.3.16 3.1.3.48]", "7414  VCL; vinculin [KO:K05700]", "8826  IQGAP1; IQ motif containing GTPase activating protein 1 [KO:K16848]", "10788  IQGAP2; IQ motif containing GTPase activating protein 2 [KO:K05767]", "128239  IQGAP3; IQ motif containing GTPase activating protein 3 [KO:K05767]", "2934  GSN; gelsolin [KO:K05768]", "85477  SCIN; scinderin [KO:K05768]", "87  ACTN1; actinin alpha 1 [KO:K05699]", "81  ACTN4; actinin alpha 4 [KO:K05699]", "324  APC; APC regulator of WNT signaling pathway [KO:K02085]", "10297  APC2; APC regulator of WNT signaling pathway 2 [KO:K02085]", "50649  ARHGEF4; Rho guanine nucleotide exchange factor 4 [KO:K05769]", "221178  SPATA13; spermatogenesis associated 13 [KO:K05769]"], "compound": ["C00681  1-Acyl-sn-glycerol 3-phosphate", "C01996  Acetylcholine", "C04637  1-Phosphatidyl-D-myo-inositol 4,5-bisphosphate", "C05981  Phosphatidylinositol-3,4,5-trisphosphate", "C11554  1-Phosphatidyl-1D-myo-inositol 3,4-bisphosphate"], "refs": [{"pmid": "14744429", "authors": "  Burridge K, Wennerberg K.", "title": "Rho and Rac take center stage.", "journal": "Cell 116:167-79 (2004)", "doi": "10.1016/S0092-8674(04)00003-0"}, {"pmid": "11082269", "authors": "  Schmitz AA, Govek EE, Bottner B, Van Aelst L.", "title": "Rho GTPases: signaling, migration, and invasion.", "journal": "Exp Cell Res 261:1-12 (2000)", "doi": "10.1006/excr.2000.5049"}, {"pmid": "11152757", "authors": "  Takai Y, Sasaki T, Matozaki T.", "title": "Small GTP-binding proteins.", "journal": "Physiol Rev 81:153-208 (2001)", "doi": "10.1152/physrev.2001.81.1.153"}, {"pmid": "12700767", "authors": "  Pollard TD.", "title": "The cytoskeleton, cellular motility and the reductionist agenda.", "journal": "Nature 422:741-5 (2003)", "doi": "10.1038/nature01598"}, {"pmid": "14657486", "authors": "  Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, Horwitz AR.", "title": "Cell migration: integrating signals from front to back.", "journal": "Science 302:1704-9 (2003)", "doi": "10.1126/science.1092053"}, {"pmid": "11082272", "authors": "  Sastry SK, Burridge K.", "title": "Focal adhesions: a nexus for intracellular signaling and cytoskeletal dynamics.", "journal": "Exp Cell Res 261:25-36 (2000)", "doi": "10.1006/excr.2000.5043"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04510  Focal adhesion", "hsa04520  Adherens junction"], "ko_pathway": "ko04810", "genes": ["EGFR", "RAC1", "BRAF", "EZR", "AKT2", "AKT1", "SOS1", "NRAS"]}, {"kegg_id": "hsa04912", "name": "GnRH signaling pathway - Homo sapiens (human)", "description": "Gonadotropin-releasing hormone (GnRH) secretion from the hypothalamus acts upon its receptor in the anterior pituitary to regulate the production and release of the gonadotropins, LH and FSH. The GnRHR is coupled to Gq/11 proteins to activate phospholipase C which transmits its signal to diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3). DAG activates the intracellular protein kinase C (PKC) pathway and IP3 stimulates release of intracellular calcium. In addition to the classical Gq/11, coupling of Gs is occasionally observed in a cell-specific fashion. Signaling downstream of protein kinase C (PKC) leads to transactivation of the epidermal growth factor (EGF) receptor and activation of mitogen-activated protein kinases (MAPKs), including extracellular-signal-regulated kinase (ERK), Jun N-terminal kinase (JNK) and p38 MAPK. Active MAPKs translocate to the nucleus, resulting in activation of transcription factors and rapid induction of early genes.", "class": "Organismal Systems; Endocrine system", "pathway_map": "hsa04912  GnRH signaling pathway", "network": ["", "ELEMENT   N00873  GnRH-GnRHR-PLCB-PKC signaling pathway"], "drug": ["D00573  Goserelin acetate (JAN/USP)", "D00988  Gonadorelin hydrochloride (USP)", "D00989  Leuprolide acetate (USP)", "D00990  Nafarelin acetate (USAN)", "D01685  Cetrorelix acetate (JAN/USAN)", "D01831  Buserelin acetate (JAN/USAN)", "D02116  Histrelin acetate", "D02369  Histrelin (USAN/INN)", "D02738  Abarelix (USAN/INN)", "D03267  Gonadorelin diacetate (JP18)", "D03701  Detirelix acetate (USAN)", "D04302  Ganirelix acetate (JAN/USAN)", "D04361  Gonadorelin acetate (USP)", "D04405  Goserelin (USAN/INN)", "D04644  Iturelix (USAN/INN)", "D04823  Lutrelin acetate (USAN)", "D05599  Prazarelix acetate (USAN)", "D06247  Triptorelin (USAN/INN)", "D06248  Triptorelin pamoate (USAN)", "D07259  Buserelin (INN)", "D07665  Cetrorelix (INN)", "D07957  Fertirelin (INN)", "D08010  Ganirelix (INN)", "D08027  Gonadorelin (INN)", "D08113  Leuprorelin (INN)", "D08241  Nafarelin (INN)", "D08635  Degarelix acetate (USAN)", "D08649  Triptorelin acetate", "D08901  Degarelix (INN/USAN)", "D09335  Elagolix (USAN/INN)", "D09336  Elagolix sodium (USAN)", "D09400  Degarelix acetate (JAN)", "D10618  Defactinib (USAN/INN)", "D10888  Relugolix (JAN/USAN/INN)", "D11351  Opigolix (USAN/INN)", "D11608  Linzagolix (USAN/INN)", "D11609  Linzagolix choline (JAN/USAN)", "D12337  Leuprolide mesylate"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["2796  GNRH1; gonadotropin releasing hormone 1 [KO:K05252]", "2797  GNRH2; gonadotropin releasing hormone 2 [KO:K05252]", "2798  GNRHR; gonadotropin releasing hormone receptor [KO:K04280]", "2778  GNAS; GNAS complex locus [KO:K04632]", "107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]", "108  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]", "109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]", "196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]", "113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]", "114  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]", "115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "468  ATF4; activating transcription factor 4 [KO:K04374]", "2776  GNAQ; G protein subunit alpha q [KO:K04634]", "2767  GNA11; G protein subunit alpha 11 [KO:K04635]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "810  CALML3; calmodulin like 3 [KO:K02183]", "805  CALM2; calmodulin 2 [KO:K02183]", "808  CALM3; calmodulin 3 [KO:K02183]", "801  CALM1; calmodulin 1 [KO:K02183]", "163688  CALML6; calmodulin like 6 [KO:K02183]", "51806  CALML5; calmodulin like 5 [KO:K02183]", "91860  CALML4; calmodulin like 4 [KO:K02183]", "815  CAMK2A; calcium/calmodulin dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]", "817  CAMK2D; calcium/calmodulin dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]", "816  CAMK2B; calcium/calmodulin dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]", "818  CAMK2G; calcium/calmodulin dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5580  PRKCD; protein kinase C delta [KO:K06068] [EC:2.7.11.13]", "775  CACNA1C; calcium voltage-gated channel subunit alpha1 C [KO:K04850]", "776  CACNA1D; calcium voltage-gated channel subunit alpha1 D [KO:K04851]", "778  CACNA1F; calcium voltage-gated channel subunit alpha1 F [KO:K04853]", "779  CACNA1S; calcium voltage-gated channel subunit alpha1 S [KO:K04857]", "4214  MAP3K1; mitogen-activated protein kinase kinase kinase 1 [KO:K04416] [EC:2.7.11.25]", "10746  MAP3K2; mitogen-activated protein kinase kinase kinase 2 [KO:K04420] [EC:2.7.11.25]", "4215  MAP3K3; mitogen-activated protein kinase kinase kinase 3 [KO:K04421] [EC:2.7.11.25]", "4216  MAP3K4; mitogen-activated protein kinase kinase kinase 4 [KO:K04428] [EC:2.7.11.25]", "5606  MAP2K3; mitogen-activated protein kinase kinase 3 [KO:K04432] [EC:2.7.12.2]", "5608  MAP2K6; mitogen-activated protein kinase kinase 6 [KO:K04433] [EC:2.7.12.2]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "5598  MAPK7; mitogen-activated protein kinase 7 [KO:K04464] [EC:2.7.11.24]", "123745  PLA2G4E; phospholipase A2 group IVE [KO:K16342] [EC:3.1.1.4]", "5321  PLA2G4A; phospholipase A2 group IVA [KO:K16342] [EC:3.1.1.4]", "8681  JMJD7-PLA2G4B; JMJD7-PLA2G4B readthrough [KO:K16342] [EC:3.1.1.4]", "100137049  PLA2G4B; phospholipase A2 group IVB [KO:K16342] [EC:3.1.1.4]", "8605  PLA2G4C; phospholipase A2 group IVC [KO:K16342] [EC:3.1.1.4]", "283748  PLA2G4D; phospholipase A2 group IVD [KO:K16342] [EC:3.1.1.4]", "255189  PLA2G4F; phospholipase A2 group IVF [KO:K16342] [EC:3.1.1.4]", "5337  PLD1; phospholipase D1 [KO:K01115] [EC:3.1.4.4]", "5338  PLD2; phospholipase D2 [KO:K01115] [EC:3.1.4.4]", "6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "998  CDC42; cell division cycle 42 [KO:K04393]", "6416  MAP2K4; mitogen-activated protein kinase kinase 4 [KO:K04430] [EC:2.7.12.2]", "5609  MAP2K7; mitogen-activated protein kinase kinase 7 [KO:K04431] [EC:2.7.12.2]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "3972  LHB; luteinizing hormone subunit beta [KO:K08521]", "1081  CGA; glycoprotein hormones, alpha polypeptide [KO:K08522]", "2488  FSHB; follicle stimulating hormone subunit beta [KO:K05250]", "2185  PTK2B; protein tyrosine kinase 2 beta [KO:K05871] [EC:2.7.10.2]", "4313  MMP2; matrix metallopeptidase 2 [KO:K01398] [EC:3.4.24.24]", "4323  MMP14; matrix metallopeptidase 14 [KO:K07763] [EC:3.4.24.80]", "1839  HBEGF; heparin binding EGF like growth factor [KO:K08523]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "2002  ELK1; ETS transcription factor ELK1 [KO:K04375]", "1958  EGR1; early growth response 1 [KO:K09203]"], "compound": ["C00076  Calcium cation", "C00165  Diacylglycerol", "C00219  Arachidonate", "C00416  Phosphatidate", "C00575  3',5'-Cyclic AMP", "C01245  D-myo-Inositol 1,4,5-trisphosphate"], "refs": [{"pmid": "15350605", "authors": "  Ruf F, Sealfon SC.", "title": "Genomics view of gonadotrope signaling circuits.", "journal": "Trends Endocrinol Metab 15:331-8 (2004)", "doi": "10.1016/j.tem.2004.07.008"}, {"pmid": "15613448", "authors": "  Harrison GS, Wierman ME, Nett TM, Glode LM.", "title": "Gonadotropin-releasing hormone and its receptor in normal and malignant cells.", "journal": "Endocr Relat Cancer 11:725-48 (2004)", "doi": "10.1677/erc.1.00777"}, {"pmid": "15982836", "authors": "  Pawson AJ, McNeilly AS.", "title": "The pituitary effects of GnRH.", "journal": "Anim Reprod Sci 88:75-94 (2005)", "doi": "10.1016/j.anireprosci.2005.05.010"}, {"pmid": "10707049", "authors": "  Naor Z, Benard O, Seger R.", "title": "Activation of MAPK cascades by G-protein-coupled receptors: the case of gonadotropin-releasing hormone receptor.", "journal": "Trends Endocrinol Metab 11:91-9 (2000)", "doi": "10.1016/S1043-2760(99)00232-5"}, {"pmid": "14596811", "authors": "  Ruf F, Fink MY, Sealfon SC.", "title": "Structure of the GnRH receptor-stimulated signaling network: insights from genomics.", "journal": "Front Neuroendocrinol 24:181-99 (2003)", "doi": "10.1016/S0091-3022(03)00027-X"}, {"pmid": "12943720", "authors": "  Farshori PQ, Shah BH, Arora KK, Martinez-Fuentes A, Catt KJ.", "title": "Activation and nuclear translocation of PKCdelta, Pyk2 and ERK1/2 by gonadotropin releasing hormone in HEK293 cells.", "journal": "J Steroid Biochem Mol Biol 85:337-47 (2003)", "doi": "10.1016/S0960-0760(03)00226-7"}, {"pmid": "15080147", "authors": "  Shah BH, Catt KJ.", "title": "Matrix metalloproteinases in reproductive endocrinology.", "journal": "Trends Endocrinol Metab 15:47-9 (2004)", "doi": "10.1016/j.tem.2004.01.004"}, {"pmid": "12963732", "authors": "  Roelle S, Grosse R, Aigner A, Krell HW, Czubayko F, Gudermann T.", "title": "Matrix metalloproteinases 2 and 9 mediate epidermal growth factor receptor transactivation by gonadotropin-releasing hormone.", "journal": "J Biol Chem 278:47307-18 (2003)", "doi": "10.1074/jbc.M304377200"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04024  cAMP signaling pathway", "hsa04060  Cytokine-cytokine receptor interaction", "hsa04080  Neuroactive ligand-receptor interaction"], "ko_pathway": "ko04912", "genes": ["EGFR", "SOS1", "MAPK13", "NRAS"]}, {"kegg_id": "hsa04915", "name": "Estrogen signaling pathway - Homo sapiens (human)", "description": "Estrogens are steroid hormones that regulate a plethora of physiological processes in mammals, including reproduction, cardiovascular protection, bone integrity, cellular homeostasis, and behavior. Estrogen mediates its cellular actions through two signaling pathways classified as \"nuclear-initiated steroid signaling\" and \"membrane-initiated steroid signaling\". In the \"nuclear\" pathway, estrogen binds either ERalpha or ERbeta, which in turn translocates to the nucleus, binds DNA at ERE elements and activates the expression of ERE-dependent genes. In \"membrane\" pathway, Estrogen can exert its actions through a subpopulation of ER at the plasma membrane (mER) or novel G-protein coupled E2 receptors (GPER). Upon activation of these receptors various signaling pathways (i.e. Ca2+, cAMP, protein kinase cascades) are rapidly activated and ultimately influence downstream transcription factors.", "class": "Organismal Systems; Endocrine system", "pathway_map": "hsa04915  Estrogen signaling pathway", "network": ["", "ELEMENT   N00286  Nuclear-initiated estrogen signaling pathway", "N01351  E2-ER-RAS-ERK signaling pathway"], "drug": ["D00066  Progesterone (JP18/USP/INN)", "D00067  Estrone (JAN/USP/INN)", "D00105  Estradiol (JAN/USP/INN)", "D00182  Norethindrone (USP)", "D00185  Estriol (JP18/USP)", "D00269  Chlorotrianisene (INN)", "D00289  Danazol (JP18/USP/INN)", "D00312  Estrone sodium sulfate", "D00554  Ethinyl estradiol (USP)", "D00575  Mestranol (JP18/USP/INN)", "D00576  Quinestrol (USAN/INN)", "D00577  Diethylstilbestrol (USP/INN)", "D00585  Mifepristone (JAN/USAN/INN)", "D00898  Dienestrol (USP/INN)", "D00946  Diethylstilbestrol diphosphate (USP)", "D00948  Estropipate (USP)", "D00949  Hydroxyprogesterone caproate (JAN/USP/INN)", "D00950  Levonorgestrel (JAN/USP/INN)", "D00951  Medroxyprogesterone acetate (JP18/USP)", "D00952  Megestrol acetate (USP)", "D00953  Norethindrone acetate (USP)", "D00954  Norgestrel (JP18/USP/INN)", "D00962  Clomiphene citrate (USP)", "D00966  Tamoxifen citrate (JP18/USP)", "D00967  Toremifene citrate (JAN/USAN)", "D01159  Gestonorone caproate (JAN/USAN)", "D01161  Fulvestrant (JAN/USP/INN)", "D01217  Dydrogesterone (JP18/USP/INN)", "D01265  Epitiostanol (JAN/INN)", "D01294  Ethynodiol diacetate (JAN/USP)", "D01299  Chlormadinone acetate (JP18/USAN)", "D01374  Allylestrenol (JAN/INN)", "D01413  Estradiol valerate (JAN/USP/INN)", "D01414  Ethylestrenol (USAN/INN)", "D01580  Lynestrenol (JAN/USAN)", "D01602  Mepitiostane (JP18/INN)", "D01616  Sodium prasterone sulfate hydrate (JP18)", "D01617  Estradiol dipropionate (JAN)", "D01639  Tibolone (JAN/USAN/INN)", "D01641  Hexestrol (JAN/INN)", "D01853  Miproxifene phosphate (JAN)", "D01953  Estradiol benzoate (JP18/USP)", "D01986  Estriol tripropionate (JAN)", "D01989  Estriol diacetate benzoate (JAN)", "D02018  Hexestrol diacetate (JAN)", "D02217  Raloxifene hydrochloride (JAN/USP)", "D02367  Desogestrel (USAN/INN)", "D02758  Acolbifene hydrochloride (USAN)", "D02993  Arzoxifene hydrochloride (USAN)", "D02996  Asoprisnil (USAN/INN)", "D03062  Bazedoxifene acetate (JAN/USAN)", "D03551  Clometherone (USAN/INN)", "D03799  Dienogest (JAN/USAN/INN)", "D03911  Droloxifene (USAN/INN)", "D03912  Droloxifene citrate (USAN)", "D03917  Drospirenone (JAN/USP/INN)", "D04041  Equilin (USP)", "D04061  Estradiol acetate (USAN)", "D04063  Estradiol cypionate (USP)", "D04064  Estradiol enanthate (USAN)", "D04065  Estradiol undecylate (USAN/INN)", "D04071  Estrogens, esterified (USP)", "D04104  Etonogestrel (USAN/INN)", "D04162  Fenretinide (USAN/INN)", "D04315  Gestaclone (USAN/INN)", "D04316  Gestodene (USAN/INN)", "D04496  Idoxifene (USAN/INN)", "D04672  Lasofoxifene tartrate (JAN/USAN)", "D04885  Medrogestone (USAN/INN)", "D05009  Metogest (USAN/INN)", "D05106  Nafoxidine hydrochloride (USAN)", "D05192  Nitromifene citrate (USAN)", "D05679  Quingestanol acetate (USAN)", "D05680  Quingestrone (USAN/INN)", "D06003  Tanaproget (USAN/INN)", "D06145  Tigestol (USAN/INN)", "D06197  Tosagestin (USAN/INN)", "D06235  Trimegestone (USAN/INN)", "D06245  Trioxifene mesylate (USAN)", "D06551  Afimoxifene (USAN/INN)", "D06554  Alvespimycin hydrochloride (USAN)", "D06631  Prinaberel (USAN/INN)", "D06650  Tanespimycin (USAN)", "D07096  Aglepristone (INN)", "D07121  Alfatradiol (INN)", "D07220  Norgestrienone (INN)", "D07221  Promestriene (INN)", "D07222  Nomegestrol (USAN/INN)", "D07223  Demegestone (INN)", "D07434  Polyestradiol phosphate (INN)", "D07670  Chlormadinone (INN)", "D07726  Clomifene (INN)", "D07783  Delmadinone (INN)", "D07826  Hexestrol diphosphate sodium", "D07918  Estradiol hemihydrate", "D07919  Estradiol 17 beta-hemisuccinate", "D07920  Estriol succinate", "D07921  Estriol sodium succinate (BAN)", "D07939  Etynodiol (INN)", "D07968  Flugestone (INN)", "D08052  Hydroxyprogesterone (INN)", "D08053  Hydroxyprogesterone 17alfa-acetate", "D08166  Medroxyprogesterone (INN)", "D08167  Megestrol (INN)", "D08281  Nomegestrol acetate (USAN)", "D08285  Norethisterone enantate", "D08301  Ormeloxifene (INN)", "D08409  Prasterone (USAN/INN)", "D08431  Promegestone (INN)", "D08465  Raloxifene (INN)", "D08559  Tamoxifen (INN)", "D08620  Toremifene (INN)", "D08910  Enclomiphene (USAN)", "D08958  Ospemifene (INN/USAN/BAN)", "D09375  Retaspimycin (USAN/INN)", "D09376  Retaspimycin hydrochloride (USAN)", "D09567  Ulipristal (USAN/INN)", "D09687  Ulipristal acetate (JAN/USAN)", "D09834  Levormeloxifene fumarate (JAN)", "D10016  Lonaprisan (USAN/INN)", "D10126  Ganetespib (USAN)", "D10606  Raloxifene hydrochloride hydrate (JAN)", "D10646  Luminespib (USAN/INN)", "D10647  Luminespib mesylate (USAN)", "D10719  Onalespib (USAN/INN)", "D10876  Enclomiphene citrate (USAN)", "D10986  Segesterone acetate (USAN)", "D10987  Segesterone (USAN/INN)", "D11181  Vilaprisan (JAN/USAN/INN)", "D11264  Brilanestrant (USAN/INN)", "D11513  Estetrol (USAN)", "D11514  Estetrol (JAN/USAN)", "D11671  Elacestrant (USAN/INN)", "D11672  Elacestrant hydrochloride (USAN)", "D11766  Onalespib lactate (USAN)", "D11920  Pimitespib (JAN)", "D12049  Camizestrant (JAN/USAN)", "D12145  Amcenestrant (JAN/USAN/INN)", "D12628  Vepdegestrant (JAN/USAN/INN)", "D12827  Palazestrant (USAN/INN)"], "dblinks": "GO: 0030520", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["2099  ESR1; estrogen receptor 1 [KO:K08550]", "2100  ESR2; estrogen receptor 2 [KO:K08551]", "3320  HSP90AA1; heat shock protein 90 alpha family class A member 1 [KO:K04079]", "3326  HSP90AB1; heat shock protein 90 alpha family class B member 1 [KO:K04079]", "7184  HSP90B1; heat shock protein 90 beta family member 1 [KO:K09487]", "2288  FKBP4; FKBP prolyl isomerase 4 [KO:K09571] [EC:5.2.1.8]", "2289  FKBP5; FKBP prolyl isomerase 5 [KO:K09571] [EC:5.2.1.8]", "3312  HSPA8; heat shock protein family A (Hsp70) member 8 [KO:K03283]", "3303  HSPA1A; heat shock protein family A (Hsp70) member 1A [KO:K03283]", "3305  HSPA1L; heat shock protein family A (Hsp70) member 1 like [KO:K03283]", "3304  HSPA1B; heat shock protein family A (Hsp70) member 1B [KO:K03283]", "3310  HSPA6; heat shock protein family A (Hsp70) member 6 [KO:K03283]", "8648  NCOA1; nuclear receptor coactivator 1 [KO:K09101] [EC:2.3.1.48]", "10499  NCOA2; nuclear receptor coactivator 2 [KO:K11255]", "8202  NCOA3; nuclear receptor coactivator 3 [KO:K11256] [EC:2.3.1.48]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]", "9166  EBAG9; estrogen receptor binding site associated antigen 9 [KO:K22455]", "3857  KRT9; keratin 9 [KO:K07604]", "3858  KRT10; keratin 10 [KO:K07604]", "3859  KRT12; keratin 12 [KO:K07604]", "3860  KRT13; keratin 13 [KO:K07604]", "3861  KRT14; keratin 14 [KO:K07604]", "3866  KRT15; keratin 15 [KO:K07604]", "3868  KRT16; keratin 16 [KO:K07604]", "3872  KRT17; keratin 17 [KO:K07604]", "3875  KRT18; keratin 18 [KO:K07604]", "3880  KRT19; keratin 19 [KO:K07604]", "3881  KRT31; keratin 31 [KO:K07604]", "3882  KRT32; keratin 32 [KO:K07604]", "3883  KRT33A; keratin 33A [KO:K07604]", "3884  KRT33B; keratin 33B [KO:K07604]", "3885  KRT34; keratin 34 [KO:K07604]", "3886  KRT35; keratin 35 [KO:K07604]", "125115  KRT40; keratin 40 [KO:K07604]", "390792  KRT39; keratin 39 [KO:K07604]", "25984  KRT23; keratin 23 [KO:K07604]", "147183  KRT25; keratin 25 [KO:K07604]", "162605  KRT28; keratin 28 [KO:K07604]", "192666  KRT24; keratin 24 [KO:K07604]", "342574  KRT27; keratin 27 [KO:K07604]", "54474  KRT20; keratin 20 [KO:K07604]", "8687  KRT38; keratin 38 [KO:K07604]", "8688  KRT37; keratin 37 [KO:K07604]", "8689  KRT36; keratin 36 [KO:K07604]", "100653049  keratin, type I cuticular Ha4 [KO:K07604]", "353288  KRT26; keratin 26 [KO:K07604]", "1509  CTSD; cathepsin D [KO:K01379] [EC:3.4.23.5]", "9687  GREB1; growth regulating estrogen receptor binding 1 [KO:K27477]", "7031  TFF1; trefoil factor 1 [KO:K22456]", "5241  PGR; progesterone receptor [KO:K08556]", "7039  TGFA; transforming growth factor alpha [KO:K08774]", "5914  RARA; retinoic acid receptor alpha [KO:K08527]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "6667  SP1; Sp1 transcription factor [KO:K04684]", "2852  GPER1; G protein-coupled estrogen receptor 1 [KO:K04246]", "2778  GNAS; GNAS complex locus [KO:K04632]", "6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "4313  MMP2; matrix metallopeptidase 2 [KO:K01398] [EC:3.4.24.24]", "4318  MMP9; matrix metallopeptidase 9 [KO:K01403] [EC:3.4.24.35]", "1839  HBEGF; heparin binding EGF like growth factor [KO:K08523]", "107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]", "108  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]", "109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]", "196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]", "113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]", "114  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]", "115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]", "1386  ATF2; activating transcription factor 2 [KO:K04450]", "468  ATF4; activating transcription factor 4 [KO:K04374]", "10488  CREB3; cAMP responsive element binding protein 3 [KO:K09048]", "90993  CREB3L1; cAMP responsive element binding protein 3 like 1 [KO:K09048]", "64764  CREB3L2; cAMP responsive element binding protein 3 like 2 [KO:K09048]", "84699  CREB3L3; cAMP responsive element binding protein 3 like 3 [KO:K09048]", "148327  CREB3L4; cAMP responsive element binding protein 3 like 4 [KO:K09048]", "9586  CREB5; cAMP responsive element binding protein 5 [KO:K09047]", "1388  ATF6B; activating transcription factor 6 beta [KO:K09049]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "6464  SHC1; SHC adaptor protein 1 [KO:K06279]", "25759  SHC2; SHC adaptor protein 2 [KO:K17447]", "53358  SHC3; SHC adaptor protein 3 [KO:K17448]", "399694  SHC4; SHC adaptor protein 4 [KO:K17449]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "2550  GABBR1; gamma-aminobutyric acid type B receptor subunit 1 [KO:K04615]", "9568  GABBR2; gamma-aminobutyric acid type B receptor subunit 2 [KO:K04615]", "2770  GNAI1; G protein subunit alpha i1 [KO:K04630]", "2773  GNAI3; G protein subunit alpha i3 [KO:K04630]", "2771  GNAI2; G protein subunit alpha i2 [KO:K04630]", "2775  GNAO1; G protein subunit alpha o1 [KO:K04534]", "3760  KCNJ3; potassium inwardly rectifying channel subfamily J member 3 [KO:K04997]", "3763  KCNJ6; potassium inwardly rectifying channel subfamily J member 6 [KO:K05000]", "3765  KCNJ9; potassium inwardly rectifying channel subfamily J member 9 [KO:K05002]", "3762  KCNJ5; potassium inwardly rectifying channel subfamily J member 5 [KO:K04999]", "5443  POMC; proopiomelanocortin [KO:K05228]", "4988  OPRM1; opioid receptor mu 1 [KO:K04215]", "5580  PRKCD; protein kinase C delta [KO:K06068] [EC:2.7.11.13]", "2776  GNAQ; G protein subunit alpha q [KO:K04634]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "810  CALML3; calmodulin like 3 [KO:K02183]", "805  CALM2; calmodulin 2 [KO:K02183]", "808  CALM3; calmodulin 3 [KO:K02183]", "801  CALM1; calmodulin 1 [KO:K02183]", "163688  CALML6; calmodulin like 6 [KO:K02183]", "51806  CALML5; calmodulin like 5 [KO:K02183]", "91860  CALML4; calmodulin like 4 [KO:K02183]", "4846  NOS3; nitric oxide synthase 3 [KO:K13242] [EC:1.14.13.39]", "2911  GRM1; glutamate metabotropic receptor 1 [KO:K04603]"], "compound": ["C00076  Calcium cation", "C00165  Diacylglycerol", "C00238  Potassium cation", "C00334  4-Aminobutanoate", "C00533  Nitric oxide", "C00575  3',5'-Cyclic AMP", "C00951  Estradiol-17beta", "C01245  D-myo-Inositol 1,4,5-trisphosphate"], "refs": [{"pmid": "16516516", "authors": "  Zhang D, Trudeau VL", "title": "Integration of membrane and nuclear estrogen receptor signaling.", "journal": "Comp Biochem Physiol A Mol Integr Physiol 144:306-15 (2006)", "doi": "10.1016/j.cbpa.2006.01.025"}, {"pmid": "19187465", "authors": "  Roepke TA, Qiu J, Bosch MA, Ronnekleiv OK, Kelly MJ", "title": "Cross-talk between membrane-initiated and nuclear-initiated oestrogen signalling in the hypothalamus.", "journal": "J Neuroendocrinol 21:263-70 (2009)", "doi": "10.1111/j.1365-2826.2009.01846.x"}, {"pmid": "19700741", "authors": "  McCarthy MM", "title": "The two faces of estradiol: effects on the developing brain.", "journal": "Neuroscientist 15:599-610 (2009)", "doi": "10.1177/1073858409340924"}, {"pmid": "18538919", "authors": "  Kelly MJ, Ronnekleiv OK", "title": "Membrane-initiated estrogen signaling in hypothalamic neurons.", "journal": "Mol Cell Endocrinol 290:14-23 (2008)", "doi": "10.1016/j.mce.2008.04.014"}, {"pmid": "16112267", "authors": "  Kelly MJ, Qiu J, Ronnekleiv OK", "title": "Estrogen signaling in the hypothalamus.", "journal": "Vitam Horm 71:123-45 (2005)", "doi": "10.1016/S0083-6729(05)71005-0"}, {"pmid": "18253054", "authors": "  Raz L, Khan MM, Mahesh VB, Vadlamudi RK, Brann DW", "title": "Rapid estrogen signaling in the brain.", "journal": "Neurosignals 16:140-53 (2008)", "doi": "10.1159/000111559"}, {"pmid": "15862823", "authors": "  Malyala A, Kelly MJ, Ronnekleiv OK", "title": "Estrogen modulation of hypothalamic neurons: activation of multiple signaling pathways and gene expression changes.", "journal": "Steroids 70:397-406 (2005)", "doi": "10.1016/j.steroids.2005.03.004"}, {"pmid": "14573532", "authors": "  Qiu J, Bosch MA, Tobias SC, Grandy DK, Scanlan TS, Ronnekleiv OK, Kelly MJ", "title": "Rapid signaling of estrogen in hypothalamic neurons involves a novel G-protein-coupled estrogen receptor that activates protein kinase C.", "journal": "J Neurosci 23:9529-40 (2003)", "doi": "10.1523/JNEUROSCI.23-29-09529.2003"}, {"pmid": "14993035", "authors": "  Kelly MJ, Qiu J, Ronnekleiv OK", "title": "Estrogen modulation of G-protein-coupled receptor activation of potassium channels in the central nervous system.", "journal": "Ann N Y Acad Sci 1007:6-16 (2003)", "doi": "10.1196/annals.1286.001"}, {"pmid": "19549587", "authors": "  Meyer MR, Haas E, Prossnitz ER, Barton M", "title": "Non-genomic regulation of vascular cell function and growth by estrogen.", "journal": "Mol Cell Endocrinol 308:9-16 (2009)", "doi": "10.1016/j.mce.2009.03.009"}, {"pmid": "20694192", "authors": "  do Nascimento GR, Barros YV, Wells AK, Khalil RA", "title": "Research into Specific Modulators of Vascular Sex Hormone Receptors in the Management of Postmenopausal Cardiovascular Disease.", "journal": "Curr Hypertens Rev 5:283-306 (2009)", "doi": "10.2174/157340209789587717"}, {"pmid": "15695368", "authors": "  Bjornstrom L, Sjoberg M", "title": "Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes.", "journal": "Mol Endocrinol 19:833-42 (2005)", "doi": "10.1210/me.2004-0486"}, {"pmid": "16270355", "authors": "  Manavathi B, Kumar R", "title": "Steering estrogen signals from the plasma membrane to the nucleus: two sides of the coin.", "journal": "J Cell Physiol 207:594-604 (2006)", "doi": "10.1002/jcp.20551"}, {"pmid": "21844907", "authors": "  Prossnitz ER, Barton M", "title": "The G-protein-coupled estrogen receptor GPER in health and disease.", "journal": "Nat Rev Endocrinol 7:715-26 (2011)", "doi": "10.1038/nrendo.2011.122"}, {"pmid": "21742056", "authors": "  Meyer MR, Prossnitz ER, Barton M", "title": "The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function.", "journal": "Vascul Pharmacol 55:17-25 (2011)", "doi": "10.1016/j.vph.2011.06.003"}, {"pmid": "19767412", "authors": "  Maggiolini M, Picard D", "title": "The unfolding stories of GPR30, a new membrane-bound estrogen receptor.", "journal": "J Endocrinol 204:105-14 (2010)", "doi": "10.1677/JOE-09-0242"}, {"pmid": "19464786", "authors": "  Prossnitz ER, Maggiolini M", "title": "Mechanisms of estrogen signaling and gene expression via GPR30.", "journal": "Mol Cell Endocrinol 308:32-8 (2009)", "doi": "10.1016/j.mce.2009.03.026"}, {"pmid": "12650715", "authors": "  Kelly MJ, Qiu J, Wagner EJ, Ronnekleiv OK", "title": "Rapid effects of estrogen on G protein-coupled receptor activation of potassium channels in the central nervous system (CNS).", "journal": "J Steroid Biochem Mol Biol 83:187-93 (2002)", "doi": "10.1016/S0960-0760(02)00249-2"}, {"pmid": "9278514", "authors": "  Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J, Kushner PJ, Scanlan TS", "title": "Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites.", "journal": "Science 277:1508-10 (1997)", "doi": "10.1126/science.277.5331.1508"}, {"pmid": "12421825", "authors": "  Razandi M, Pedram A, Park ST, Levin ER", "title": "Proximal events in signaling by plasma membrane estrogen receptors.", "journal": "J Biol Chem 278:2701-12 (2003)", "doi": "10.1074/jbc.M205692200"}, {"pmid": "18755790", "authors": "  Roepke TA, Xue C, Bosch MA, Scanlan TS, Kelly MJ, Ronnekleiv OK", "title": "Genes associated with membrane-initiated signaling of estrogen and energy homeostasis.", "journal": "Endocrinology 149:6113-24 (2008)", "doi": "10.1210/en.2008-0769"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04270  Vascular smooth muscle contraction", "hsa04727  GABAergic synapse", "hsa04913  Ovarian steroidogenesis"], "ko_pathway": "ko04915", "genes": ["EGFR", "AKT2", "AKT1", "SOS1", "NRAS"]}, {"kegg_id": "hsa04921", "name": "Oxytocin signaling pathway - Homo sapiens (human)", "description": "Oxytocin (OT) is a nonapeptide synthesized by the magno-cellular neurons located in the supraoptic (SON) and paraventricular (PVN) nuclei of the hypothalamus. It exerts a wide variety of central and peripheral effects. However, its best-known and most well-established roles are stimulation of uterine contractions during parturition and milk release during lactation. Oxytocin also influences cardiovascular regulation and various social behaviors. The actions of OT are all mediated by one type of OT receptor (OTR). This is a transmembrane receptor belonging to the G-protein-coupled receptor superfamily. The main signaling pathway is the Gq/PLC/Ins3 pathway, but the MAPK and the RhoA/Rho kinase pathways are also activated, contributing to increased prostaglandin production and direct contractile effect on myometrial cells. In the cardiovascular system, OTR is associated with the ANP-cGMP and NO-cGMP pathways, which reduce the force and rate of contraction and increase vasodilatation.", "class": "Organismal Systems; Endocrine system", "pathway_map": "hsa04921  Oxytocin signaling pathway", "drug": ["D00089  Oxytocin (JP18/USP/INN)", "D01840  Fasudil hydrochloride (JAN)", "D03115  Fasudil hydrochloride hydrate (JAN)", "D07228  Demoxytocin (INN)", "D07229  Carbetocin (USAN/INN/BAN)", "D07941  Fasudil (INN)", "D11190  Vosoritide (USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["5020  OXT; oxytocin/neurophysin I prepropeptide [KO:K05243]", "5021  OXTR; oxytocin receptor [KO:K04229]", "2776  GNAQ; G protein subunit alpha q [KO:K04634]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "123745  PLA2G4E; phospholipase A2 group IVE [KO:K16342] [EC:3.1.1.4]", "5321  PLA2G4A; phospholipase A2 group IVA [KO:K16342] [EC:3.1.1.4]", "8681  JMJD7-PLA2G4B; JMJD7-PLA2G4B readthrough [KO:K16342] [EC:3.1.1.4]", "100137049  PLA2G4B; phospholipase A2 group IVB [KO:K16342] [EC:3.1.1.4]", "8605  PLA2G4C; phospholipase A2 group IVC [KO:K16342] [EC:3.1.1.4]", "283748  PLA2G4D; phospholipase A2 group IVD [KO:K16342] [EC:3.1.1.4]", "255189  PLA2G4F; phospholipase A2 group IVF [KO:K16342] [EC:3.1.1.4]", "5743  PTGS2; prostaglandin-endoperoxide synthase 2 [KO:K11987] [EC:1.14.99.1]", "5607  MAP2K5; mitogen-activated protein kinase kinase 5 [KO:K04463] [EC:2.7.12.2]", "5598  MAPK7; mitogen-activated protein kinase 7 [KO:K04464] [EC:2.7.11.24]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "4208  MEF2C; myocyte enhancer factor 2C [KO:K04454]", "595  CCND1; cyclin D1 [KO:K04503]", "2002  ELK1; ETS transcription factor ELK1 [KO:K04375]", "6261  RYR1; ryanodine receptor 1 [KO:K04961]", "6262  RYR2; ryanodine receptor 2 [KO:K04962]", "6263  RYR3; ryanodine receptor 3 [KO:K04963]", "952  CD38; CD38 molecule [KO:K01242] [EC:3.2.2.6 2.4.99.20]", "7226  TRPM2; transient receptor potential cation channel subfamily M member 2 [KO:K04977] [EC:3.6.1.13]", "3759  KCNJ2; potassium inwardly rectifying channel subfamily J member 2 [KO:K04996]", "3768  KCNJ12; potassium inwardly rectifying channel subfamily J member 12 [KO:K05005]", "100134444  KCNJ18; potassium inwardly rectifying channel subfamily J member 18 [KO:K05005]", "3761  KCNJ4; potassium inwardly rectifying channel subfamily J member 4 [KO:K04998]", "3770  KCNJ14; potassium inwardly rectifying channel subfamily J member 14 [KO:K05007]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "29904  EEF2K; eukaryotic elongation factor 2 kinase [KO:K08292] [EC:2.7.11.20]", "1938  EEF2; eukaryotic translation elongation factor 2 [KO:K03234]", "775  CACNA1C; calcium voltage-gated channel subunit alpha1 C [KO:K04850]", "776  CACNA1D; calcium voltage-gated channel subunit alpha1 D [KO:K04851]", "778  CACNA1F; calcium voltage-gated channel subunit alpha1 F [KO:K04853]", "779  CACNA1S; calcium voltage-gated channel subunit alpha1 S [KO:K04857]", "782  CACNB1; calcium voltage-gated channel auxiliary subunit beta 1 [KO:K04862]", "783  CACNB2; calcium voltage-gated channel auxiliary subunit beta 2 [KO:K04863]", "784  CACNB3; calcium voltage-gated channel auxiliary subunit beta 3 [KO:K04864]", "785  CACNB4; calcium voltage-gated channel auxiliary subunit beta 4 [KO:K04865]", "781  CACNA2D1; calcium voltage-gated channel auxiliary subunit alpha2delta 1 [KO:K04858]", "9254  CACNA2D2; calcium voltage-gated channel auxiliary subunit alpha2delta 2 [KO:K04859]", "55799  CACNA2D3; calcium voltage-gated channel auxiliary subunit alpha2delta 3 [KO:K04860]", "93589  CACNA2D4; calcium voltage-gated channel auxiliary subunit alpha2delta 4 [KO:K04861]", "786  CACNG1; calcium voltage-gated channel auxiliary subunit gamma 1 [KO:K04866]", "10369  CACNG2; calcium voltage-gated channel auxiliary subunit gamma 2 [KO:K04867]", "10368  CACNG3; calcium voltage-gated channel auxiliary subunit gamma 3 [KO:K04868]", "27092  CACNG4; calcium voltage-gated channel auxiliary subunit gamma 4 [KO:K04869]", "27091  CACNG5; calcium voltage-gated channel auxiliary subunit gamma 5 [KO:K04870]", "59285  CACNG6; calcium voltage-gated channel auxiliary subunit gamma 6 [KO:K04871]", "59284  CACNG7; calcium voltage-gated channel auxiliary subunit gamma 7 [KO:K04872]", "59283  CACNG8; calcium voltage-gated channel auxiliary subunit gamma 8 [KO:K04873]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "810  CALML3; calmodulin like 3 [KO:K02183]", "805  CALM2; calmodulin 2 [KO:K02183]", "808  CALM3; calmodulin 3 [KO:K02183]", "801  CALM1; calmodulin 1 [KO:K02183]", "163688  CALML6; calmodulin like 6 [KO:K02183]", "51806  CALML5; calmodulin like 5 [KO:K02183]", "91860  CALML4; calmodulin like 4 [KO:K02183]", "5530  PPP3CA; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]", "5532  PPP3CB; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]", "5533  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]", "5534  PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]", "5535  PPP3R2; protein phosphatase 3 regulatory subunit B, beta [KO:K06268]", "4772  NFATC1; nuclear factor of activated T cells 1 [KO:K04446]", "4773  NFATC2; nuclear factor of activated T cells 2 [KO:K17332]", "4775  NFATC3; nuclear factor of activated T cells 3 [KO:K17333]", "4776  NFATC4; nuclear factor of activated T cells 4 [KO:K17334]", "5997  RGS2; regulator of G protein signaling 2 [KO:K18154]", "1827  RCAN1; regulator of calcineurin 1 [KO:K17901]", "10645  CAMKK2; calcium/calmodulin dependent protein kinase kinase 2 [KO:K07359] [EC:2.7.11.17]", "5562  PRKAA1; protein kinase AMP-activated catalytic subunit alpha 1 [KO:K07198] [EC:2.7.11.31]", "5563  PRKAA2; protein kinase AMP-activated catalytic subunit alpha 2 [KO:K07198] [EC:2.7.11.31]", "5564  PRKAB1; protein kinase AMP-activated non-catalytic subunit beta 1 [KO:K07199]", "5565  PRKAB2; protein kinase AMP-activated non-catalytic subunit beta 2 [KO:K07199]", "5571  PRKAG1; protein kinase AMP-activated non-catalytic subunit gamma 1 [KO:K07200]", "53632  PRKAG3; protein kinase AMP-activated non-catalytic subunit gamma 3 [KO:K07200]", "51422  PRKAG2; protein kinase AMP-activated non-catalytic subunit gamma 2 [KO:K07200]", "57118  CAMK1D; calcium/calmodulin dependent protein kinase ID [KO:K08794] [EC:2.7.11.17]", "57172  CAMK1G; calcium/calmodulin dependent protein kinase IG [KO:K08794] [EC:2.7.11.17]", "8536  CAMK1; calcium/calmodulin dependent protein kinase I [KO:K08794] [EC:2.7.11.17]", "815  CAMK2A; calcium/calmodulin dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]", "817  CAMK2D; calcium/calmodulin dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]", "816  CAMK2B; calcium/calmodulin dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]", "818  CAMK2G; calcium/calmodulin dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]", "814  CAMK4; calcium/calmodulin dependent protein kinase IV [KO:K05869] [EC:2.7.11.17]", "4846  NOS3; nitric oxide synthase 3 [KO:K13242] [EC:1.14.13.39]", "2977  GUCY1A2; guanylate cyclase 1 soluble subunit alpha 2 [KO:K12318] [EC:4.6.1.2]", "2982  GUCY1A1; guanylate cyclase 1 soluble subunit alpha 1 [KO:K12318] [EC:4.6.1.2]", "2983  GUCY1B1; guanylate cyclase 1 soluble subunit beta 1 [KO:K12319] [EC:4.6.1.2]", "4878  NPPA; natriuretic peptide A [KO:K12334]", "4881  NPR1; natriuretic peptide receptor 1 [KO:K12323] [EC:4.6.1.2]", "4882  NPR2; natriuretic peptide receptor 2 [KO:K12324] [EC:4.6.1.2]", "4638  MYLK; myosin light chain kinase [KO:K00907] [EC:2.7.11.18]", "85366  MYLK2; myosin light chain kinase 2 [KO:K00907] [EC:2.7.11.18]", "91807  MYLK3; myosin light chain kinase 3 [KO:K00907] [EC:2.7.11.18]", "340156  MYLK4; myosin light chain kinase family member 4 [KO:K00907] [EC:2.7.11.18]", "140465  MYL6B; myosin light chain 6B [KO:K12751]", "4637  MYL6; myosin light chain 6 [KO:K12751]", "10398  MYL9; myosin light chain 9 [KO:K12755]", "71  ACTG1; actin gamma 1 [KO:K05692]", "60  ACTB; actin beta [KO:K05692]", "387  RHOA; ras homolog family member A [KO:K04513]", "6093  ROCK1; Rho associated coiled-coil containing protein kinase 1 [KO:K04514] [EC:2.7.11.1]", "9475  ROCK2; Rho associated coiled-coil containing protein kinase 2 [KO:K17388] [EC:2.7.11.1]", "5499  PPP1CA; protein phosphatase 1 catalytic subunit alpha [KO:K06269] [EC:3.1.3.16]", "5500  PPP1CB; protein phosphatase 1 catalytic subunit beta [KO:K06269] [EC:3.1.3.16]", "5501  PPP1CC; protein phosphatase 1 catalytic subunit gamma [KO:K06269] [EC:3.1.3.16]", "4659  PPP1R12A; protein phosphatase 1 regulatory subunit 12A [KO:K06270]", "4660  PPP1R12B; protein phosphatase 1 regulatory subunit 12B [KO:K12329]", "54776  PPP1R12C; protein phosphatase 1 regulatory subunit 12C [KO:K17457]", "2778  GNAS; GNAS complex locus [KO:K04632]", "107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]", "108  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]", "109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]", "196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]", "113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]", "114  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]", "115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "2770  GNAI1; G protein subunit alpha i1 [KO:K04630]", "2773  GNAI3; G protein subunit alpha i3 [KO:K04630]", "2771  GNAI2; G protein subunit alpha i2 [KO:K04630]", "2775  GNAO1; G protein subunit alpha o1 [KO:K04534]", "5294  PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma [KO:K21289] [EC:2.7.1.153]", "23533  PIK3R5; phosphoinositide-3-kinase regulatory subunit 5 [KO:K21290]", "146850  PIK3R6; phosphoinositide-3-kinase regulatory subunit 6 [KO:K21290]", "6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "3760  KCNJ3; potassium inwardly rectifying channel subfamily J member 3 [KO:K04997]", "3763  KCNJ6; potassium inwardly rectifying channel subfamily J member 6 [KO:K05000]", "3765  KCNJ9; potassium inwardly rectifying channel subfamily J member 9 [KO:K05002]", "3762  KCNJ5; potassium inwardly rectifying channel subfamily J member 5 [KO:K04999]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]"], "compound": ["C00076  Calcium cation", "C00165  Diacylglycerol", "C00219  Arachidonate", "C00238  Potassium cation", "C00427  Prostaglandin H2", "C00533  Nitric oxide", "C00575  3',5'-Cyclic AMP", "C00584  Prostaglandin E2", "C00639  Prostaglandin F2alpha", "C00942  3',5'-Cyclic GMP", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C13050  Cyclic ADP-ribose"], "refs": [{"pmid": "18655881", "authors": "  Devost D, Wrzal P, Zingg HH", "title": "Oxytocin receptor signalling.", "journal": "Prog Brain Res 170:167-76 (2008)", "doi": "10.1016/S0079-6123(08)00415-9"}, {"pmid": "20626426", "authors": "  Viero C, Shibuya I, Kitamura N, Verkhratsky A, Fujihara H, Katoh A, Ueta Y, Zingg HH, Chvatal A, Sykova E, Dayanithi G", "title": "REVIEW: Oxytocin: Crossing the bridge between basic science and pharmacotherapy.", "journal": "CNS Neurosci Ther 16:e138-56 (2010)", "doi": "10.1111/j.1755-5949.2010.00185.x"}, {"pmid": "21981277", "authors": "  Gutkowska J, Jankowski M", "title": "Oxytocin revisited: its role in cardiovascular regulation.", "journal": "J Neuroendocrinol 24:599-608 (2012)", "doi": "10.1111/j.1365-2826.2011.02235.x"}, {"pmid": "22190926", "authors": "  Vrachnis N, Malamas FM, Sifakis S, Deligeoroglou E, Iliodromiti Z", "title": "The oxytocin-oxytocin receptor system and its antagonists as tocolytic agents.", "journal": "Int J Endocrinol 2011:350546 (2011)", "doi": "10.1155/2011/350546"}, {"pmid": "19840865", "authors": "  Tom N, Assinder SJ", "title": "Oxytocin in health and disease.", "journal": "Int J Biochem Cell Biol 42:202-5 (2010)", "doi": "10.1016/j.biocel.2009.10.008"}, {"pmid": "9575824", "authors": "  Strakova Z, Copland JA, Lolait SJ, Soloff MS", "title": "ERK2 mediates oxytocin-stimulated PGE2 synthesis.", "journal": "Am J Physiol 274:E634-41 (1998)", "doi": "10.1152/ajpendo.1998.274.4.E634"}, {"pmid": "16787565", "authors": "  Shmygol A, Gullam J, Blanks A, Thornton S", "title": "Multiple mechanisms involved in oxytocin-induced modulation of myometrial contractility.", "journal": "Acta Pharmacol Sin 27:827-32 (2006)", "doi": "10.1111/j.1745-7254.2006.00393.x"}, {"pmid": "11861513", "authors": "  Tahara M, Morishige K, Sawada K, Ikebuchi Y, Kawagishi R, Tasaka K, Murata Y", "title": "RhoA/Rho-kinase cascade is involved in oxytocin-induced rat uterine contraction.", "journal": "Endocrinology 143:920-9 (2002)", "doi": "10.1210/endo.143.3.8696"}, {"pmid": "12433531", "authors": "  Slattery MM, Morrison JJ", "title": "Preterm delivery.", "journal": "Lancet 360:1489-97 (2002)", "doi": "10.1016/S0140-6736(02)11476-0"}, {"pmid": "22902539", "authors": "  Pont JN, McArdle CA, Lopez Bernal A", "title": "Oxytocin-stimulated NFAT transcriptional activation in human myometrial cells.", "journal": "Mol Endocrinol 26:1743-56 (2012)", "doi": "10.1210/me.2012-1057"}, {"pmid": "9326674", "authors": "  Gutkowska J, Jankowski M, Lambert C, Mukaddam-Daher S, Zingg HH, McCann SM", "title": "Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart.", "journal": "Proc Natl Acad Sci U S A 94:11704-9 (1997)", "doi": "10.1073/pnas.94.21.11704"}, {"pmid": "14715914", "authors": "  Antunes-Rodrigues J, de Castro M, Elias LL, Valenca MM, McCann SM", "title": "Neuroendocrine control of body fluid metabolism.", "journal": "Physiol Rev 84:169-208 (2004)", "doi": "10.1152/physrev.00017.2003"}, {"pmid": "18555543", "authors": "  Lee ES, Uhm KO, Lee YM, Kwon J, Park SH, Soo KH", "title": "Oxytocin stimulates glucose uptake in skeletal muscle cells through the calcium-CaMKK-AMPK pathway.", "journal": "Regul Pept 151:71-4 (2008)", "doi": "10.1016/j.regpep.2008.05.001"}, {"pmid": "9219843", "authors": "  Cassoni P, Sapino A, Fortunati N, Munaron L, Chini B, Bussolati G", "title": "Oxytocin inhibits the proliferation of MDA-MB231 human breast-cancer cells via cyclic adenosine monophosphate and protein kinase A.", "journal": "Int J Cancer 72:340-4 (1997)", "doi": "10.1002/(SICI)1097-0215(19970717)72:2<340::AID-IJC23>3.0.CO;2-I"}, {"pmid": "23356278", "authors": "  Busnelli M, Peverelli E, Mantovani G, Spada A, Chini B", "title": "Deciphering the specific role of G(alphai/o) isoforms: functional selective oxytocin ligands and somatostatin SST5 receptor mutants.", "journal": "Biochem Soc Trans 41:166-71 (2013)", "doi": "10.1042/BST20120306"}, {"pmid": "16966388", "authors": "  Reversi A, Rimoldi V, Brambillasca S, Chini B", "title": "Effects of cholesterol manipulation on the signaling of the human oxytocin receptor.", "journal": "Am J Physiol Regul Integr Comp Physiol 291:R861-9 (2006)", "doi": "10.1152/ajpregu.00333.2006"}, {"pmid": "20141572", "authors": "  Salmina AB, Lopatina O, Ekimova MV, Mikhutkina SV, Higashida H", "title": "CD38/cyclic ADP-ribose system: a new player for oxytocin secretion and regulation of social behaviour.", "journal": "J Neuroendocrinol 22:380-92 (2010)", "doi": "10.1111/j.1365-2826.2010.01970.x"}, {"pmid": "22227279", "authors": "  Higashida H, Yokoyama S, Kikuchi M, Munesue T", "title": "CD38 and its role in oxytocin secretion and social behavior.", "journal": "Horm Behav 61:351-8 (2012)", "doi": "10.1016/j.yhbeh.2011.12.011"}, {"pmid": "23335873", "authors": "  Lopatina O, Inzhutova A, Salmina AB, Higashida H", "title": "The roles of oxytocin and CD38 in social or parental behaviors.", "journal": "Front Neurosci 6:182 (2012)", "doi": "10.3389/fnins.2012.00182"}], "rel_pathway": ["hsa00590  Arachidonic acid metabolism", "hsa04010  MAPK signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04110  Cell cycle"], "ko_pathway": "ko04921", "genes": ["EGFR", "NRAS"]}, {"kegg_id": "hsa04926", "name": "Relaxin signaling pathway - Homo sapiens (human)", "description": "Human relaxin-2 (\"relaxin\"), originally identified as a peptidic hormone of pregnancy, is now known to exert a range of pleiotropic effects including vasodilatory, anti-fibrotic and angiogenic effects in both males and females. It belongs to the so-called relaxin peptide family which includes the insulin-like peptides INSL3 and INSL5, and relaxin-3 (H3) as well as relaxin. INSL3 has clearly defined specialist roles in male and female reproduction, relaxin-3 is primarily a neuropeptide involved in stress and metabolic control, and INSL5 is widely distributed particularly in the gastrointestinal tract. These members of relaxin peptide family exert such effects binding to different kinds of receptors, classified as relaxin family peptide (RXFP) receptors: RXFP1, RXFP2, RXFP3, and RXFP4. These G protein-coupled receptors predominantly bind relaxin, INSL3, relaxin-3, and INSL-5, respectively. RXFP1 activates a wide spectrum of signaling pathways to generate second messengers that include cAMP and nitric oxide, whereas RXFP2 activates a subset of these pathways. Both RXFP3 and RXFP4 inhibit cAMP production, and RXFP3 activate MAP kinases.", "class": "Organismal Systems; Endocrine system", "pathway_map": "hsa04926  Relaxin signaling pathway", "drug": ["D03517  Cipemastat (USAN/INN)", "D10488  Serelaxin (USAN/INN)", "D12181  Edasalonexent (USAN/INN)", "D12768  Ficerafusp alfa (USAN)", "D12783  Volenrelaxin (USAN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["6013  RLN1; relaxin 1 [KO:K21998]", "6019  RLN2; relaxin 2 [KO:K21998]", "59350  RXFP1; relaxin family peptide receptor 1 [KO:K04306]", "2775  GNAO1; G protein subunit alpha o1 [KO:K04534]", "2770  GNAI1; G protein subunit alpha i1 [KO:K04630]", "2773  GNAI3; G protein subunit alpha i3 [KO:K04630]", "2771  GNAI2; G protein subunit alpha i2 [KO:K04630]", "2778  GNAS; GNAS complex locus [KO:K04632]", "2782  GNB1; G protein subunit beta 1 [KO:K04536]", "2783  GNB2; G protein subunit beta 2 [KO:K04537]", "2784  GNB3; G protein subunit beta 3 [KO:K07825]", "59345  GNB4; G protein subunit beta 4 [KO:K04538]", "10681  GNB5; G protein subunit beta 5 [KO:K04539]", "54331  GNG2; G protein subunit gamma 2 [KO:K07826]", "2785  GNG3; G protein subunit gamma 3 [KO:K04540]", "2786  GNG4; G protein subunit gamma 4 [KO:K04541]", "2787  GNG5; G protein subunit gamma 5 [KO:K04542]", "2788  GNG7; G protein subunit gamma 7 [KO:K04543]", "94235  GNG8; G protein subunit gamma 8 [KO:K04544]", "2790  GNG10; G protein subunit gamma 10 [KO:K04545]", "2791  GNG11; G protein subunit gamma 11 [KO:K04546]", "55970  GNG12; G protein subunit gamma 12 [KO:K04347]", "51764  GNG13; G protein subunit gamma 13 [KO:K04547]", "2792  GNGT1; G protein subunit gamma transducin 1 [KO:K04548]", "2793  GNGT2; G protein subunit gamma transducin 2 [KO:K04549]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]", "1386  ATF2; activating transcription factor 2 [KO:K04450]", "468  ATF4; activating transcription factor 4 [KO:K04374]", "10488  CREB3; cAMP responsive element binding protein 3 [KO:K09048]", "90993  CREB3L1; cAMP responsive element binding protein 3 like 1 [KO:K09048]", "64764  CREB3L2; cAMP responsive element binding protein 3 like 2 [KO:K09048]", "84699  CREB3L3; cAMP responsive element binding protein 3 like 3 [KO:K09048]", "148327  CREB3L4; cAMP responsive element binding protein 3 like 4 [KO:K09048]", "9586  CREB5; cAMP responsive element binding protein 5 [KO:K09047]", "1388  ATF6B; activating transcription factor 6 beta [KO:K09049]", "7422  VEGFA; vascular endothelial growth factor A [KO:K05448]", "7423  VEGFB; vascular endothelial growth factor B [KO:K16858]", "7424  VEGFC; vascular endothelial growth factor C [KO:K05449]", "2277  VEGFD; vascular endothelial growth factor D [KO:K05449]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "4843  NOS2; nitric oxide synthase 2 [KO:K13241] [EC:1.14.13.39]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5590  PRKCZ; protein kinase C zeta [KO:K18952] [EC:2.7.11.13]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "4313  MMP2; matrix metallopeptidase 2 [KO:K01398] [EC:3.4.24.24]", "4318  MMP9; matrix metallopeptidase 9 [KO:K01403] [EC:3.4.24.35]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "4846  NOS3; nitric oxide synthase 3 [KO:K13242] [EC:1.14.13.39]", "4842  NOS1; nitric oxide synthase 1 [KO:K13240] [EC:1.14.13.39]", "1906  EDN1; endothelin 1 [KO:K16366]", "1910  EDNRB; endothelin receptor type B [KO:K04198]", "4312  MMP1; matrix metallopeptidase 1 [KO:K01388] [EC:3.4.24.7]", "4322  MMP13; matrix metallopeptidase 13 [KO:K07994] [EC:3.4.24.-]", "7040  TGFB1; transforming growth factor beta 1 [KO:K13375]", "7046  TGFBR1; transforming growth factor beta receptor 1 [KO:K04674] [EC:2.7.11.30]", "7048  TGFBR2; transforming growth factor beta receptor 2 [KO:K04388] [EC:2.7.11.30]", "4087  SMAD2; SMAD family member 2 [KO:K04500]", "59  ACTA2; actin alpha 2, smooth muscle [KO:K12313]", "1277  COL1A1; collagen type I alpha 1 chain [KO:K06236]", "1278  COL1A2; collagen type I alpha 2 chain [KO:K06236]", "1281  COL3A1; collagen type III alpha 1 chain [KO:K19720]", "1284  COL4A2; collagen type IV alpha 2 chain [KO:K06237]", "1286  COL4A4; collagen type IV alpha 4 chain [KO:K06237]", "1288  COL4A6; collagen type IV alpha 6 chain [KO:K06237]", "1282  COL4A1; collagen type IV alpha 1 chain [KO:K06237]", "1287  COL4A5; collagen type IV alpha 5 chain [KO:K06237]", "1285  COL4A3; collagen type IV alpha 3 chain [KO:K06237]", "3640  INSL3; insulin like 3 [KO:K21999]", "122042  RXFP2; relaxin family peptide receptor 2 [KO:K04307]", "117579  RLN3; relaxin 3 [KO:K22000]", "51289  RXFP3; relaxin family peptide receptor 3 [KO:K08397]", "107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]", "108  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]", "109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]", "196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]", "112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]", "113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]", "114  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]", "115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "6416  MAP2K4; mitogen-activated protein kinase kinase 4 [KO:K04430] [EC:2.7.12.2]", "5609  MAP2K7; mitogen-activated protein kinase kinase 7 [KO:K04431] [EC:2.7.12.2]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "6464  SHC1; SHC adaptor protein 1 [KO:K06279]", "25759  SHC2; SHC adaptor protein 2 [KO:K17447]", "53358  SHC3; SHC adaptor protein 3 [KO:K17448]", "399694  SHC4; SHC adaptor protein 4 [KO:K17449]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "408  ARRB1; arrestin beta 1 [KO:K04439]", "409  ARRB2; arrestin beta 2 [KO:K04439]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "10022  INSL5; insulin like 5 [KO:K22001]", "339403  RXFP4; relaxin family peptide/INSL5 receptor 4 [KO:K08398]", "2769  GNA15; G protein subunit alpha 15 [KO:K04637]"], "compound": ["C00076  Calcium cation", "C00165  Diacylglycerol", "C00533  Nitric oxide", "C00575  3',5'-Cyclic AMP", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C05981  Phosphatidylinositol-3,4,5-trisphosphate"], "refs": [{"pmid": "23303914", "authors": "  Bathgate RA, Halls ML, van der Westhuizen ET, Callander GE, Kocan M, Summers RJ", "title": "Relaxin family peptides and their receptors.", "journal": "Physiol Rev 93:405-80 (2013)", "doi": "10.1152/physrev.00001.2012"}, {"pmid": "23401142", "authors": "  Cernaro V, Lacquaniti A, Lupica R, Buemi A, Trimboli D, Giorgianni G, Bolignano D, Buemi M", "title": "Relaxin: new pathophysiological aspects and pharmacological perspectives for an old protein.", "journal": "Med Res Rev 34:77-105 (2014)", "doi": "10.1002/med.21277"}, {"pmid": "18675759", "authors": "  van der Westhuizen ET, Halls ML, Samuel CS, Bathgate RA, Unemori EN, Sutton SW, Summers RJ", "title": "Relaxin family peptide receptors--from orphans to therapeutic targets.", "journal": "Drug Discov Today 13:640-51 (2008)", "doi": "10.1016/j.drudis.2008.04.002"}, {"pmid": "17293890", "authors": "  Halls ML, van der Westhuizen ET, Bathgate RA, Summers RJ", "title": "Relaxin family peptide receptors--former orphans reunite with their parent ligands to activate multiple signalling pathways.", "journal": "Br J Pharmacol 150:677-91 (2007)", "doi": "10.1038/sj.bjp.0707140"}, {"pmid": "16507880", "authors": "  Bathgate RA, Ivell R, Sanborn BM, Sherwood OD, Summers RJ", "title": "International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides.", "journal": "Pharmacol Rev 58:7-31 (2006)", "doi": "10.1124/pr.58.1.9"}, {"pmid": "19935741", "authors": "  Du XJ, Bathgate RA, Samuel CS, Dart AM, Summers RJ", "title": "Cardiovascular effects of relaxin: from basic science to clinical therapy.", "journal": "Nat Rev Cardiol 7:48-58 (2010)", "doi": "10.1038/nrcardio.2009.198"}, {"pmid": "12646076", "authors": "  Nistri S, Bani D", "title": "Relaxin receptors and nitric oxide synthases: search for the missing link.", "journal": "Reprod Biol Endocrinol 1:5 (2003)", "doi": "10.1186/1477-7827-1-5"}, {"pmid": "17458501", "authors": "  Samuel CS, Hewitson TD, Unemori EN, Tang ML", "title": "Drugs of the future: the hormone relaxin.", "journal": "Cell Mol Life Sci 64:1539-57 (2007)", "doi": "10.1007/s00018-007-6543-y"}, {"pmid": "23883673", "authors": "  Sasser JM", "title": "The emerging role of relaxin as a novel therapeutic pathway in the treatment of chronic kidney disease.", "journal": "Am J Physiol Regul Integr Comp Physiol 305:R559-65 (2013)", "doi": "10.1152/ajpregu.00528.2012"}, {"pmid": "27239943", "authors": "  Sarwar M, Du XJ, Dschietzig TB, Summers RJ", "title": "The actions of relaxin on the human cardiovascular system.", "journal": "Br J Pharmacol 174:933-949 (2017)", "doi": "10.1111/bph.13523"}, {"pmid": "15956688", "authors": "  Bathgate RA, Ivell R, Sanborn BM, Sherwood OD, Summers RJ", "title": "Receptors for relaxin family peptides.", "journal": "Ann N Y Acad Sci 1041:61-76 (2005)", "doi": "10.1196/annals.1282.010"}, {"pmid": "22936987", "authors": "  Chow BS, Chew EG, Zhao C, Bathgate RA, Hewitson TD, Samuel CS", "title": "Relaxin signals through a RXFP1-pERK-nNOS-NO-cGMP-dependent pathway to up-regulate matrix metalloproteinases: the additional involvement of iNOS.", "journal": "PLoS One 7:e42714 (2012)", "doi": "10.1371/journal.pone.0042714"}, {"pmid": "16814863", "authors": "  Samuel CS, Du XJ, Bathgate RA, Summers RJ", "title": "'Relaxin' the stiffened heart and arteries: the therapeutic potential for relaxin in the treatment of cardiovascular disease.", "journal": "Pharmacol Ther 112:529-52 (2006)", "doi": "10.1016/j.pharmthera.2005.05.012"}, {"pmid": "25759289", "authors": "  Wilson SS, Ayaz SI, Levy PD", "title": "Relaxin: a novel agent for the treatment of acute heart failure.", "journal": "Pharmacotherapy 35:315-27 (2015)", "doi": "10.1002/phar.1548"}, {"pmid": "16569707", "authors": "  Halls ML, Bathgate RA, Summers RJ", "title": "Relaxin family peptide receptors RXFP1 and RXFP2 modulate cAMP signaling by distinct mechanisms.", "journal": "Mol Pharmacol 70:214-26 (2006)", "doi": "10.1124/mol.105.021691"}, {"pmid": "26294284", "authors": "  Kocan M, Ang SY, Summers RJ", "title": "Orthosteric, Allosteric and Biased Signalling at the Relaxin-3 Receptor RXFP3.", "journal": "Neurochem Res 41:610-9 (2016)", "doi": "10.1007/s11064-015-1701-3"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04024  cAMP signaling pathway", "hsa04064  NF-kappa B signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04270  Vascular smooth muscle contraction", "hsa04350  TGF-beta signaling pathway", "hsa04370  VEGF signaling pathway"], "ko_pathway": "ko04926", "genes": ["EGFR", "AKT2", "AKT1", "SOS1", "MAPK13", "NRAS"]}, {"kegg_id": "hsa04928", "name": "Parathyroid hormone synthesis, secretion and action - Homo sapiens (human)", "description": "Parathyroid hormone (PTH) is a key regulator of calcium and phosphorus homeostasis. The principal regulators of PTH secretion are extracellular ionized calcium (Ca2+) and 1,25-dihydroxyvitamin D (1,25(OH)2D3). Under conditions of dietary Ca restriction, a decrement in serum Ca concentration induces release of PTH from the parathyroid gland. PTH acts on bone and kidney to stimulate bone turnover, increase the circulating levels of 1,25(OH)2D3 and calcium and inhibit the reabsorption of phosphate from the glomerular filtrate. This hormone exerts its actions via binding to the PTH/PTH-related peptide receptor (PTH1R). PTH1R primarily activates two sub-types of heterotrimeric Gproteins: Gs and Gq , which in turn regulate the activity of adenylyl cyclases and phospholipase C (PLC) that control the flow of cAMP/PKA and IP/PKC signaling cascades, respectively.", "class": "Organismal Systems; Endocrine system", "pathway_map": "hsa04928  Parathyroid hormone synthesis, secretion and action", "network": ["", "ELEMENT   N00288  PTH-PTH1R-PKA signaling pathway", "N00291  CaSR-PTH signaling pathway", "N00293  GCM2-mediated transcription", "N01823  FGF23-NCC/NPT signaling pathway", "N01824  SGK1-NHERF1+NPT signaling pathway"], "drug": ["D00930  Paricalcitol (JAN/USP/INN)", "D01009  Doxercalciferol (USAN/INN)", "D03358  Teriparatide acetate (JAN)", "D03504  Cinacalcet (USAN)", "D03505  Cinacalcet hydrochloride (JAN/USAN)", "D05364  Parathyroid hormone (human) (USAN)", "D06078  Teriparatide (USP/INN)", "D06546  Teriparatide acetate (USAN)", "D10676  Etelcalcetide (USAN/INN)", "D10677  Etelcalcetide hydrochloride (JAN/USAN)", "D11063  Evocalcet (JAN/INN)", "D11237  Lifastuzumab (USAN)", "D11238  Lifastuzumab vedotin (USAN/INN)", "D11563  Abaloparatide acetate (JAN)", "D11564  Upacicalcet sodium hydrate (JAN)", "D12395  Palopegteriparatide (JAN/USAN/INN)", "D12805  Eneboparatide (USAN/INN)", "D12822  Idrebormilast (USAN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["846  CASR; calcium sensing receptor [KO:K04612]", "2770  GNAI1; G protein subunit alpha i1 [KO:K04630]", "2773  GNAI3; G protein subunit alpha i3 [KO:K04630]", "2771  GNAI2; G protein subunit alpha i2 [KO:K04630]", "107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]", "108  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]", "109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]", "196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]", "113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]", "114  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]", "115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]", "2776  GNAQ; G protein subunit alpha q [KO:K04634]", "2767  GNA11; G protein subunit alpha 11 [KO:K04635]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "8521  GCM1; glial cells missing transcription factor 1 [KO:K21598]", "9247  GCM2; glial cells missing transcription factor 2 [KO:K21598]", "9935  MAFB; MAF bZIP transcription factor B [KO:K09036]", "2625  GATA3; GATA binding protein 3 [KO:K17895]", "6667  SP1; Sp1 transcription factor [KO:K04684]", "7421  VDR; vitamin D receptor [KO:K08539]", "6256  RXRA; retinoid X receptor alpha [KO:K08524]", "6257  RXRB; retinoid X receptor beta [KO:K08525]", "6258  RXRG; retinoid X receptor gamma [KO:K08526]", "8074  FGF23; fibroblast growth factor 23 [KO:K22428]", "2260  FGFR1; fibroblast growth factor receptor 1 [KO:K04362] [EC:2.7.10.1]", "9365  KL; klotho [KO:K14756] [EC:3.2.1.31]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "1958  EGR1; early growth response 1 [KO:K09203]", "5741  PTH; parathyroid hormone [KO:K05261]", "6446  SGK1; serum/glucocorticoid regulated kinase 1 [KO:K13302] [EC:2.7.11.1]", "65125  WNK1; WNK lysine deficient protein kinase 1 [KO:K08867] [EC:2.7.11.1]", "65266  WNK4; WNK lysine deficient protein kinase 4 [KO:K08867] [EC:2.7.11.1]", "65267  WNK3; WNK lysine deficient protein kinase 3 [KO:K08867] [EC:2.7.11.1]", "65268  WNK2; WNK lysine deficient protein kinase 2 [KO:K08867] [EC:2.7.11.1]", "9943  OXSR1; oxidative stress responsive kinase 1 [KO:K08835] [EC:2.7.11.1]", "27347  STK39; serine/threonine kinase 39 [KO:K08835] [EC:2.7.11.1]", "6559  SLC12A3; solute carrier family 12 member 3 [KO:K14426]", "5744  PTHLH; parathyroid hormone like hormone [KO:K22608]", "5745  PTH1R; parathyroid hormone 1 receptor [KO:K04585]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "56302  TRPV5; transient receptor potential cation channel subfamily V member 5 [KO:K04974]", "6569  SLC34A1; solute carrier family 34 member 1 [KO:K14683]", "10568  SLC34A2; solute carrier family 34 member 2 [KO:K14683]", "142680  SLC34A3; solute carrier family 34 member 3 [KO:K14683]", "9368  NHERF1; NHERF family PDZ scaffold protein 1 [KO:K13365]", "2778  GNAS; GNAS complex locus [KO:K04632]", "5141  PDE4A; phosphodiesterase 4A [KO:K13293] [EC:3.1.4.53]", "5142  PDE4B; phosphodiesterase 4B [KO:K13293] [EC:3.1.4.53]", "5143  PDE4C; phosphodiesterase 4C [KO:K13293] [EC:3.1.4.53]", "5144  PDE4D; phosphodiesterase 4D [KO:K13293] [EC:3.1.4.53]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "1594  CYP27B1; cytochrome P450 family 27 subfamily B member 1 [KO:K07438] [EC:1.14.15.18]", "1591  CYP24A1; cytochrome P450 family 24 subfamily A member 1 [KO:K07436] [EC:1.14.15.16]", "4205  MEF2A; myocyte enhancer factor 2A [KO:K09260]", "4208  MEF2C; myocyte enhancer factor 2C [KO:K04454]", "4209  MEF2D; myocyte enhancer factor 2D [KO:K09262]", "50964  SOST; sclerostin [KO:K16834]", "4929  NR4A2; nuclear receptor subfamily 4 group A member 2 [KO:K08558]", "4666  NACA; nascent polypeptide associated complex subunit alpha [KO:K03626]", "3727  JUND; JunD proto-oncogene, AP-1 transcription factor subunit [KO:K04449]", "632  BGLAP; bone gamma-carboxyglutamate protein [KO:K22609]", "4041  LRP5; LDL receptor related protein 5 [KO:K03068]", "4040  LRP6; LDL receptor related protein 6 [KO:K03068]", "1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]", "1386  ATF2; activating transcription factor 2 [KO:K04450]", "10488  CREB3; cAMP responsive element binding protein 3 [KO:K09048]", "90993  CREB3L1; cAMP responsive element binding protein 3 like 1 [KO:K09048]", "64764  CREB3L2; cAMP responsive element binding protein 3 like 2 [KO:K09048]", "84699  CREB3L3; cAMP responsive element binding protein 3 like 3 [KO:K09048]", "148327  CREB3L4; cAMP responsive element binding protein 3 like 4 [KO:K09048]", "468  ATF4; activating transcription factor 4 [KO:K04374]", "9586  CREB5; cAMP responsive element binding protein 5 [KO:K09047]", "1388  ATF6B; activating transcription factor 6 beta [KO:K09049]", "8600  TNFSF11; TNF superfamily member 11 [KO:K05473]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]", "1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "860  RUNX2; RUNX family transcription factor 2 [KO:K09278]", "4322  MMP13; matrix metallopeptidase 13 [KO:K07994] [EC:3.4.24.-]", "2768  GNA12; G protein subunit alpha 12 [KO:K04346]", "10672  GNA13; G protein subunit alpha 13 [KO:K04639]", "9138  ARHGEF1; Rho guanine nucleotide exchange factor 1 [KO:K12330]", "9826  ARHGEF11; Rho guanine nucleotide exchange factor 11 [KO:K12331]", "11214  AKAP13; A-kinase anchoring protein 13 [KO:K16529]", "387  RHOA; ras homolog family member A [KO:K04513]", "5337  PLD1; phospholipase D1 [KO:K01115] [EC:3.1.4.4]", "5338  PLD2; phospholipase D2 [KO:K01115] [EC:3.1.4.4]", "408  ARRB1; arrestin beta 1 [KO:K04439]", "409  ARRB2; arrestin beta 2 [KO:K04439]", "369  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "4323  MMP14; matrix metallopeptidase 14 [KO:K07763] [EC:3.4.24.80]", "4324  MMP15; matrix metallopeptidase 15 [KO:K07995] [EC:3.4.24.-]", "4325  MMP16; matrix metallopeptidase 16 [KO:K07996] [EC:3.4.24.-]", "4326  MMP17; matrix metallopeptidase 17 [KO:K07997] [EC:3.4.24.-]", "10893  MMP24; matrix metallopeptidase 24 [KO:K08002] [EC:3.4.24.-]", "64386  MMP25; matrix metallopeptidase 25 [KO:K08003] [EC:3.4.24.-]", "1839  HBEGF; heparin binding EGF like growth factor [KO:K08523]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]"], "compound": ["C00009  Orthophosphate", "C00020  AMP", "C00076  Calcium cation", "C00165  Diacylglycerol", "C00575  3',5'-Cyclic AMP", "C00698  Cl-", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C01330  Sodium cation", "C01561  Calcidiol", "C01673  Calcitriol", "C18231  Calcitetrol"], "refs": [{"pmid": "27065162", "authors": "  Khundmiri SJ, Murray RD, Lederer E", "title": "PTH and Vitamin D.", "journal": "Compr Physiol 6:561-601 (2016)", "doi": "10.1002/cphy.c140071"}, {"pmid": "28363951", "authors": "  Bastepe M, Turan S, He Q", "title": "Heterotrimeric G proteins in the control of parathyroid hormone actions.", "journal": "J Mol Endocrinol 58:R203-R224 (2017)", "doi": "10.1530/JME-16-0221"}, {"pmid": "20703892", "authors": "  Vilardaga JP, Romero G, Friedman PA, Gardella TJ", "title": "Molecular basis of parathyroid hormone receptor signaling and trafficking: a family B GPCR paradigm.", "journal": "Cell Mol Life Sci 68:1-13 (2011)", "doi": "10.1007/s00018-010-0465-9"}, {"pmid": "29291826", "authors": "  Naveh-Many T, Silver J", "title": "Transcription factors that determine parathyroid development power PTH expression.", "journal": "Kidney Int 93:7-9 (2018)", "doi": "10.1016/j.kint.2017.08.026"}, {"pmid": "25917456", "authors": "  Han SI, Tsunekage Y, Kataoka K", "title": "Gata3 cooperates with Gcm2 and MafB to activate parathyroid hormone gene expression by interacting with SP1.", "journal": "Mol Cell Endocrinol 411:113-20 (2015)", "doi": "10.1016/j.mce.2015.04.018"}, {"pmid": "22622503", "authors": "  Ferre S, Hoenderop JG, Bindels RJ", "title": "Sensing mechanisms involved in Ca2+ and Mg2+ homeostasis.", "journal": "Kidney Int 82:1157-66 (2012)", "doi": "10.1038/ki.2012.179"}, {"pmid": "20010546", "authors": "  Komaba H, Fukagawa M", "title": "FGF23-parathyroid interaction: implications in chronic kidney disease.", "journal": "Kidney Int 77:292-8 (2010)", "doi": "10.1038/ki.2009.466"}, {"pmid": "27194212", "authors": "  Bilezikian JP, Cusano NE, Khan AA, Liu JM, Marcocci C, Bandeira F", "title": "Primary hyperparathyroidism.", "journal": "Nat Rev Dis Primers 2:16033 (2016)", "doi": "10.1038/nrdp.2016.33"}, {"pmid": "21576356", "authors": "  de Groot T, Kovalevskaya NV, Verkaart S, Schilderink N, Felici M, van der Hagen EA, Bindels RJ, Vuister GW, Hoenderop JG", "title": "Molecular mechanisms of calmodulin action on TRPV5 and modulation by parathyroid hormone.", "journal": "Mol Cell Biol 31:2845-53 (2011)", "doi": "10.1128/MCB.01319-10"}, {"pmid": "17975663", "authors": "  Hernando N, Wagner C, Biber J, Murer H", "title": "Kidney kinase network regulates renal ion cotransport.", "journal": "J Clin Invest 117:3179-82 (2007)", "doi": "10.1172/JCI33859"}, {"pmid": "22628548", "authors": "  Wang B, Means CK, Yang Y, Mamonova T, Bisello A, Altschuler DL, Scott JD, Friedman PA", "title": "Ezrin-anchored protein kinase A coordinates phosphorylation-dependent disassembly of a NHERF1 ternary complex to regulate hormone-sensitive phosphate transport.", "journal": "J Biol Chem 287:24148-63 (2012)", "doi": "10.1074/jbc.M112.369405"}, {"pmid": "21097685", "authors": "  Crenshaw TD, Rortvedt LA, Hassen Z", "title": "Triennial Growth Symposium: a novel pathway for vitamin D-mediated phosphate homeostasis: implications for skeleton growth and mineralization.", "journal": "J Anim Sci 89:1957-64 (2011)", "doi": "10.2527/jas.2010-3411"}, {"pmid": "11698670", "authors": "  Zierold C, Mings JA, DeLuca HF", "title": "Parathyroid hormone regulates 25-hydroxyvitamin D(3)-24-hydroxylase mRNA by altering its stability.", "journal": "Proc Natl Acad Sci U S A 98:13572-6 (2001)", "doi": "10.1073/pnas.241516798"}, {"pmid": "20074973", "authors": "  Kramer I, Keller H, Leupin O, Kneissel M", "title": "Does osteocytic SOST suppression mediate PTH bone anabolism?", "journal": "Trends Endocrinol Metab 21:237-44 (2010)", "doi": "10.1016/j.tem.2009.12.002"}, {"pmid": "17696759", "authors": "  Leupin O, Kramer I, Collette NM, Loots GG, Natt F, Kneissel M, Keller H", "title": "Control of the SOST bone enhancer by PTH using MEF2 transcription factors.", "journal": "J Bone Miner Res 22:1957-67 (2007)", "doi": "10.1359/jbmr.070804"}, {"pmid": "24940803", "authors": "  Meir T, Durlacher K, Pan Z, Amir G, Richards WG, Silver J, Naveh-Many T", "title": "Parathyroid hormone activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription.", "journal": "Kidney Int 86:1106-15 (2014)", "doi": "10.1038/ki.2014.215"}, {"pmid": "29413898", "authors": "  Pellicelli M, Hariri H, Miller JA, St-Arnaud R", "title": "Lrp6 is a target of the PTH-activated alphaNAC transcriptional coregulator.", "journal": "Biochim Biophys Acta 1861:61-71 (2018)", "doi": "10.1016/j.bbagrm.2018.01.008"}, {"pmid": "12364326", "authors": "  Fu Q, Jilka RL, Manolagas SC, O'Brien CA", "title": "Parathyroid hormone stimulates receptor activator of NFkappa B ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein.", "journal": "J Biol Chem 277:48868-75 (2002)", "doi": "10.1074/jbc.M208494200"}, {"pmid": "19716455", "authors": "  O'Brien CA", "title": "Control of RANKL gene expression.", "journal": "Bone 46:911-9 (2010)", "doi": "10.1016/j.bone.2009.08.050"}, {"pmid": "17517365", "authors": "  Jilka RL", "title": "Molecular and cellular mechanisms of the anabolic effect of intermittent PTH.", "journal": "Bone 40:1434-46 (2007)", "doi": "10.1016/j.bone.2007.03.017"}, {"pmid": "8810350", "authors": "  Pearman AT, Chou WY, Bergman KD, Pulumati MR, Partridge NC", "title": "Parathyroid hormone induces c-fos promoter activity in osteoblastic cells through phosphorylated cAMP response element (CRE)-binding protein binding to the major CRE.", "journal": "J Biol Chem 271:25715-21 (1996)", "doi": "10.1074/jbc.271.41.25715"}, {"pmid": "16164977", "authors": "  Boumah CE, Selvamurugan N, Partridge NC", "title": "Transcription in the osteoblast: regulatory mechanisms utilized by parathyroid hormone and transforming growth factor-beta.", "journal": "Prog Nucleic Acid Res Mol Biol 80:287-321 (2005)", "doi": "10.1016/S0079-6603(05)80007-8"}, {"pmid": "11274169", "authors": "  Hess J, Porte D, Munz C, Angel P", "title": "AP-1 and Cbfa/runt physically interact and regulate parathyroid hormone-dependent MMP13 expression in osteoblasts through a new osteoblast-specific element 2/AP-1  composite element.", "journal": "J Biol Chem 276:20029-38 (2001)", "doi": "10.1074/jbc.M010601200"}, {"pmid": "15705779", "authors": "  Singh AT, Gilchrist A, Voyno-Yasenetskaya T, Radeff-Huang JM, Stern PH", "title": "G alpha12/G alpha13 subunits of heterotrimeric G proteins mediate parathyroid hormone activation of phospholipase D in UMR-106 osteoblastic cells.", "journal": "Endocrinology 146:2171-5 (2005)", "doi": "10.1210/en.2004-1283"}, {"pmid": "12738761", "authors": "  Ahmed I, Gesty-Palmer D, Drezner MK, Luttrell LM", "title": "Transactivation of the epidermal growth factor receptor mediates parathyroid hormone and prostaglandin F2 alpha-stimulated mitogen-activated protein kinase activation in cultured transgenic murine osteoblasts.", "journal": "Mol Endocrinol 17:1607-21 (2003)", "doi": "10.1210/me.2002-0040"}, {"pmid": "17107942", "authors": "  Sneddon WB, Yang Y, Ba J, Harinstein LM, Friedman PA", "title": "Extracellular signal-regulated kinase activation by parathyroid hormone in distal tubule cells.", "journal": "Am J Physiol Renal Physiol 292:F1028-34 (2007)", "doi": "10.1152/ajprenal.00288.2006"}, {"pmid": "32982979", "authors": "  Agoro R, Ni P, Noonan ML, White KE", "title": "Osteocytic FGF23 and Its Kidney Function.", "journal": "Front Endocrinol (Lausanne) 11:592 (2020)", "doi": "10.3389/fendo.2020.00592"}, {"pmid": "27622885", "authors": "  Erben RG, Andrukhova O", "title": "FGF23-Klotho signaling axis in the kidney.", "journal": "Bone 100:62-68 (2017)", "doi": "10.1016/j.bone.2016.09.010"}], "rel_pathway": ["hsa04012  ErbB signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04024  cAMP signaling pathway", "hsa04310  Wnt signaling pathway", "hsa04380  Osteoclast differentiation", "hsa04961  Endocrine and other factor-regulated calcium reabsorption"], "ko_pathway": "ko04928", "genes": ["EGFR", "BRAF"]}, {"kegg_id": "hsa04934", "name": "Cushing syndrome - Homo sapiens (human)", "description": "Cushing syndrome (CS) is a rare disorder resulting from prolonged exposure to excess glucocorticoids via exogenous and endogenous sources. The typical clinical features of CS are related to hypercortisolism and include accumulation of central fat, moon facies, neuromuscular weakness, osteoporosis or bone fractures, metabolic complications, and mood changes. Traditionally, endogenous CS is classified as adrenocorticotropic hormone (ACTH)-dependent (about 80%) or ACTH- independent (about 20%). Among ACTH-dependent forms, pituitary corticotroph adenoma (Cushing's disease) is most common. Most pituitary tumors are sporadic, resulting from monoclonal expansion of a single mutated cell. Recently recurrent activating somatic driver mutations in the ubiquitin-specific protease 8 gene (USP8) were identified in almost half of corticotroph adenoma. Germline mutations in MEN1 (encoding menin), AIP (encoding aryl-hydrocarbon receptor-interacting protein), PRKAR1A (encoding cAMP-dependent protein kinase type I alpha regulatory subunit) and CDKN1B (encoding cyclin-dependent kinase inhibitor 1B; also known as p27 Kip1) have been identified in familial forms of pituitary adenomas. However, the frequency of familial pituitary adenomas is less than 5% in patients with pituitary adenomas. Among ACTH-independent CS, adrenal adenoma is most common. Rare adrenal causes of CS include primary bilateral macronodular adrenal hyperplasia (BMAH) or primary pigmented nodular adrenocortical disease (PPNAD).", "class": "Human Diseases; Endocrine and metabolic disease", "pathway_map": "hsa04934  Cushing syndrome", "network": ["", "ELEMENT   N00290  Mutation-inactivated MEN1 to transcription", "N00315  Mutation-inactivated AIP to AhR-mediated transcription", "N00316  Mutation-inactivated CDKN1B to p27-cell cycle G1/S", "N00319  Mutation-activated USP8 to EGFR-ERK-ACTH signaling pathway", "N00320  Mutation-activated PRKACA to ACTH-cortisol signaling pathway", "N00321  Mutation-activated GNAS to ACTH-cortisol signaling pathway", "N00322  Mutation-inactivated PRKAR1A to ACTH-cortisol signaling pathway", "N00323  Mutation-inactivated PDE11A/PDE8B to ACTH-cortisol signaling pathway", "N00325  Mutation-inactivated RASD1 to CRHR-PKA-ACTH signaling pathway", "N00326  Mutation-activated GNAS to CRHR-PKA-ACTH signaling pathway", "N00327  Mutation-inactivated PRKAR1A to CRHR-PKA-ACTH signaling pathway"], "disease": ["H01431  Cushing syndrome"], "drug": ["D00420  Mitotane (JAN/USP/INN)", "D01180  Trilostane (JAN/USAN)", "D10950  Levoketoconazole (USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["1392  CRH; corticotropin releasing hormone [KO:K05256]", "1394  CRHR1; corticotropin releasing hormone receptor 1 [KO:K04578]", "1395  CRHR2; corticotropin releasing hormone receptor 2 [KO:K04579]", "2778  GNAS; GNAS complex locus [KO:K04632]", "107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]", "108  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]", "109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]", "196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]", "113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]", "114  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]", "115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]", "1386  ATF2; activating transcription factor 2 [KO:K04450]", "468  ATF4; activating transcription factor 4 [KO:K04374]", "10488  CREB3; cAMP responsive element binding protein 3 [KO:K09048]", "90993  CREB3L1; cAMP responsive element binding protein 3 like 1 [KO:K09048]", "64764  CREB3L2; cAMP responsive element binding protein 3 like 2 [KO:K09048]", "84699  CREB3L3; cAMP responsive element binding protein 3 like 3 [KO:K09048]", "148327  CREB3L4; cAMP responsive element binding protein 3 like 4 [KO:K09048]", "9586  CREB5; cAMP responsive element binding protein 5 [KO:K09047]", "1388  ATF6B; activating transcription factor 6 beta [KO:K09049]", "4221  MEN1; menin 1 [KO:K14970]", "9070  ASH2L; ASH2 like, histone lysine methyltransferase complex subunit [KO:K14964]", "5929  RBBP5; RB binding protein 5, histone lysine methyltransferase complex subunit [KO:K14961]", "11091  WDR5; WD repeat domain 5 [KO:K14963]", "54554  WDR5B; WD repeat domain 5B [KO:K14963]", "4297  KMT2A; lysine methyltransferase 2A [KO:K09186] [EC:2.1.1.354]", "8085  KMT2D; lysine methyltransferase 2D [KO:K09187] [EC:2.1.1.354]", "1031  CDKN2C; cyclin dependent kinase inhibitor 2C [KO:K06622]", "1030  CDKN2B; cyclin dependent kinase inhibitor 2B [KO:K04685]", "1029  CDKN2A; cyclin dependent kinase inhibitor 2A [KO:K06621]", "1019  CDK4; cyclin dependent kinase 4 [KO:K02089] [EC:2.7.11.22]", "1021  CDK6; cyclin dependent kinase 6 [KO:K02091] [EC:2.7.11.22]", "595  CCND1; cyclin D1 [KO:K04503]", "5925  RB1; RB transcriptional corepressor 1 [KO:K06618]", "1869  E2F1; E2F transcription factor 1 [KO:K17454]", "1870  E2F2; E2F transcription factor 2 [KO:K09389]", "1871  E2F3; E2F transcription factor 3 [KO:K06620]", "51655  RASD1; ras related dexamethasone induced 1 [KO:K07843]", "2770  GNAI1; G protein subunit alpha i1 [KO:K04630]", "2773  GNAI3; G protein subunit alpha i3 [KO:K04630]", "2771  GNAI2; G protein subunit alpha i2 [KO:K04630]", "196  AHR; aryl hydrocarbon receptor [KO:K09093]", "23746  AIPL1; aryl hydrocarbon receptor interacting protein like 1 [KO:K17767]", "9049  AIP; aryl hydrocarbon receptor interacting protein [KO:K17767]", "405  ARNT; aryl hydrocarbon receptor nuclear translocator [KO:K09097]", "1027  CDKN1B; cyclin dependent kinase inhibitor 1B [KO:K06624]", "1017  CDK2; cyclin dependent kinase 2 [KO:K02206] [EC:2.7.11.22]", "898  CCNE1; cyclin E1 [KO:K06626]", "9134  CCNE2; cyclin E2 [KO:K06626]", "1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]", "775  CACNA1C; calcium voltage-gated channel subunit alpha1 C [KO:K04850]", "776  CACNA1D; calcium voltage-gated channel subunit alpha1 D [KO:K04851]", "778  CACNA1F; calcium voltage-gated channel subunit alpha1 F [KO:K04853]", "779  CACNA1S; calcium voltage-gated channel subunit alpha1 S [KO:K04857]", "815  CAMK2A; calcium/calmodulin dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]", "817  CAMK2D; calcium/calmodulin dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]", "816  CAMK2B; calcium/calmodulin dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]", "818  CAMK2G; calcium/calmodulin dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]", "5906  RAP1A; RAP1A, member of RAS oncogene family [KO:K04353]", "5908  RAP1B; RAP1B, member of RAS oncogene family [KO:K07836]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "3164  NR4A1; nuclear receptor subfamily 4 group A member 1 [KO:K04465]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "9101  USP8; ubiquitin specific peptidase 8 [KO:K11839] [EC:3.4.19.12]", "5443  POMC; proopiomelanocortin [KO:K05228]", "4158  MC2R; melanocortin 2 receptor [KO:K04200]", "56246  MRAP; melanocortin 2 receptor accessory protein [KO:K22398]", "8622  PDE8B; phosphodiesterase 8B [KO:K18437] [EC:3.1.4.53]", "5151  PDE8A; phosphodiesterase 8A [KO:K18437] [EC:3.1.4.53]", "50940  PDE11A; phosphodiesterase 11A [KO:K13298] [EC:3.1.4.17 3.1.4.35]", "2516  NR5A1; nuclear receptor subfamily 5 group A member 1 [KO:K08560]", "6667  SP1; Sp1 transcription factor [KO:K04684]", "5087  PBX1; PBX homeobox 1 [KO:K09355]", "1584  CYP11B1; cytochrome P450 family 11 subfamily B member 1 [KO:K00497] [EC:1.14.15.4]", "1586  CYP17A1; cytochrome P450 family 17 subfamily A member 1 [KO:K00512] [EC:1.14.14.19 1.14.14.32]", "6770  STAR; steroidogenic acute regulatory protein [KO:K16931]", "57552  NCEH1; neutral cholesterol ester hydrolase 1 [KO:K14349] [EC:3.1.1.-]", "79798  ARMC5; armadillo repeat containing 5 [KO:K22499]", "183  AGT; angiotensinogen [KO:K09821]", "185  AGTR1; angiotensin II receptor type 1 [KO:K04166]", "2776  GNAQ; G protein subunit alpha q [KO:K04634]", "2767  GNA11; G protein subunit alpha 11 [KO:K04635]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "3776  KCNK2; potassium two pore domain channel subfamily K member 2 [KO:K04913]", "8913  CACNA1G; calcium voltage-gated channel subunit alpha1 G [KO:K04854]", "8912  CACNA1H; calcium voltage-gated channel subunit alpha1 H [KO:K04855]", "8911  CACNA1I; calcium voltage-gated channel subunit alpha1 I [KO:K04856]", "84876  ORAI1; ORAI calcium release-activated calcium modulator 1 [KO:K16056]", "3739  KCNA4; potassium voltage-gated channel subfamily A member 4 [KO:K04877]", "3777  KCNK3; potassium two pore domain channel subfamily K member 3 [KO:K04914]", "3949  LDLR; low density lipoprotein receptor [KO:K12473]", "949  SCARB1; scavenger receptor class B member 1 [KO:K13885]", "1583  CYP11A1; cytochrome P450 family 11 subfamily A member 1 [KO:K00498] [EC:1.14.15.6]", "3283  HSD3B1; hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 [KO:K00070] [EC:1.1.1.145 5.3.3.1]", "3284  HSD3B2; hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 [KO:K00070] [EC:1.1.1.145 5.3.3.1]", "1589  CYP21A2; cytochrome P450 family 21 subfamily A member 2 [KO:K00513] [EC:1.14.14.16]", "2271  FH; fumarate hydratase [KO:K01679] [EC:4.2.1.2]", "7471  WNT1; Wnt family member 1 [KO:K03209]", "7472  WNT2; Wnt family member 2 [KO:K00182]", "7482  WNT2B; Wnt family member 2B [KO:K00182]", "7473  WNT3; Wnt family member 3 [KO:K00312]", "89780  WNT3A; Wnt family member 3A [KO:K00312]", "54361  WNT4; Wnt family member 4 [KO:K00408]", "7474  WNT5A; Wnt family member 5A [KO:K00444]", "81029  WNT5B; Wnt family member 5B [KO:K00444]", "7475  WNT6; Wnt family member 6 [KO:K00445]", "7476  WNT7A; Wnt family member 7A [KO:K00572]", "7477  WNT7B; Wnt family member 7B [KO:K00572]", "7478  WNT8A; Wnt family member 8A [KO:K00714]", "7479  WNT8B; Wnt family member 8B [KO:K00714]", "7483  WNT9A; Wnt family member 9A [KO:K01064]", "7484  WNT9B; Wnt family member 9B [KO:K01064]", "7480  WNT10B; Wnt family member 10B [KO:K01357]", "80326  WNT10A; Wnt family member 10A [KO:K01357]", "7481  WNT11; Wnt family member 11 [KO:K01384]", "51384  WNT16; Wnt family member 16 [KO:K01558]", "8321  FZD1; frizzled class receptor 1 [KO:K02432]", "8324  FZD7; frizzled class receptor 7 [KO:K02432]", "2535  FZD2; frizzled class receptor 2 [KO:K02235]", "7976  FZD3; frizzled class receptor 3 [KO:K02329]", "8322  FZD4; frizzled class receptor 4 [KO:K02354]", "7855  FZD5; frizzled class receptor 5 [KO:K02375]", "8325  FZD8; frizzled class receptor 8 [KO:K02375]", "8323  FZD6; frizzled class receptor 6 [KO:K02376]", "11211  FZD10; frizzled class receptor 10 [KO:K02842]", "8326  FZD9; frizzled class receptor 9 [KO:K02842]", "1857  DVL3; dishevelled segment polarity protein 3 [KO:K02353]", "1856  DVL2; dishevelled segment polarity protein 2 [KO:K02353]", "1855  DVL1; dishevelled segment polarity protein 1 [KO:K02353]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "8312  AXIN1; axin 1 [KO:K02157]", "8313  AXIN2; axin 2 [KO:K04385]", "1499  CTNNB1; catenin beta 1 [KO:K02105]", "324  APC; APC regulator of WNT signaling pathway [KO:K02085]", "10297  APC2; APC regulator of WNT signaling pathway 2 [KO:K02085]", "6932  TCF7; transcription factor 7 [KO:K02620]", "83439  TCF7L1; transcription factor 7 like 1 [KO:K04490]", "6934  TCF7L2; transcription factor 7 like 2 [KO:K04491]", "51176  LEF1; lymphoid enhancer binding factor 1 [KO:K04492]"], "compound": ["C00020  AMP", "C00076  Calcium cation", "C00187  Cholesterol", "C00238  Potassium cation", "C00410  Progesterone", "C00575  3',5'-Cyclic AMP", "C00735  Cortisol", "C01176  17alpha-Hydroxyprogesterone", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C01953  Pregnenolone", "C05138  17alpha-Hydroxypregnenolone", "C05488  11-Deoxycortisol", "C07557  2,3,7,8-Tetrachlorodibenzodioxin"], "refs": [{"pmid": "26004339", "authors": "  Lacroix A, Feelders RA, Stratakis CA, Nieman LK", "title": "Cushing's syndrome.", "journal": "Lancet 386:913-27 (2015)", "doi": "10.1016/S0140-6736(14)61375-1"}, {"pmid": "27588171", "authors": "  Xiong Q, Ge W", "title": "Gene mutations in Cushing's disease.", "journal": "Biomed Rep 5:277-282 (2016)", "doi": "10.3892/br.2016.729"}, {"pmid": "25877147", "authors": "  Fukuoka H, Takahashi Y", "title": "The role of genetic and epigenetic changes in pituitary tumorigenesis.", "journal": "Neurol Med Chir (Tokyo) 54 Suppl 3:943-57 (2014)", "doi": "10.2176/nmc.suppl.2014-3"}, {"pmid": "18987159", "authors": "  Quereda V, Malumbres M", "title": "Cell cycle control of pituitary development and disease.", "journal": "J Mol Endocrinol 42:75-86 (2009)", "doi": "10.1677/JME-08-0146"}, {"pmid": "27742789", "authors": "  Caimari F, Korbonits M", "title": "Novel Genetic Causes of Pituitary Adenomas.", "journal": "Clin Cancer Res 22:5030-5042 (2016)", "doi": "10.1158/1078-0432.CCR-16-0452"}, {"pmid": "25350067", "authors": "  Lecoq AL, Kamenicky P, Guiochon-Mantel A, Chanson P", "title": "Genetic mutations in sporadic pituitary adenomas--what to screen for?", "journal": "Nat Rev Endocrinol 11:43-54 (2015)", "doi": "10.1038/nrendo.2014.181"}, {"pmid": "27625633", "authors": "  Hannah-Shmouni F, Faucz FR, Stratakis CA", "title": "Alterations of Phosphodiesterases in Adrenocortical Tumors.", "journal": "Front Endocrinol (Lausanne) 7:111 (2016)", "doi": "10.3389/fendo.2016.00111"}, {"pmid": "21423242", "authors": "  Melmed S", "title": "Pathogenesis of pituitary tumors.", "journal": "Nat Rev Endocrinol 7:257-66 (2011)", "doi": "10.1038/nrendo.2011.40"}, {"pmid": "19407507", "authors": "  Daly AF, Tichomirowa MA, Beckers A", "title": "Genetic, molecular and clinical features of familial isolated pituitary adenomas.", "journal": "Horm Res 71 Suppl 2:116-22 (2009)", "doi": "10.1159/000192448"}, {"pmid": "28850717", "authors": "  Albani A, Theodoropoulou M, Reincke M", "title": "Genetics of Cushing's disease.", "journal": "Clin Endocrinol (Oxf) 88:3-12 (2018)", "doi": "10.1111/cen.13457"}, {"pmid": "26045561", "authors": "  Duan K, Hernandez KG, Mete O", "title": "Clinicopathological correlates of adrenal Cushing's syndrome.", "journal": "Postgrad Med J 91:331-42 (2015)", "doi": "10.1136/postgradmedj-2014-202612rep"}, {"pmid": "26264719", "authors": "  Drougat L, Espiard S, Bertherat J", "title": "Genetics of primary bilateral macronodular adrenal hyperplasia: a model for early diagnosis of Cushing's syndrome?", "journal": "Eur J Endocrinol 173:M121-31 (2015)", "doi": "10.1530/EJE-15-0532"}, {"pmid": "17955016", "authors": "  Stratakis CA, Boikos SA", "title": "Genetics of adrenal tumors associated with Cushing's syndrome: a new classification for bilateral adrenocortical hyperplasias.", "journal": "Nat Clin Pract Endocrinol Metab 3:748-57 (2007)", "doi": "10.1038/ncpendmet0648"}, {"pmid": "19906235", "authors": "  Refojo D, Holsboer F", "title": "CRH signaling. Molecular specificity for drug targeting in the CNS.", "journal": "Ann N Y Acad Sci 1179:106-19 (2009)", "doi": "10.1111/j.1749-6632.2009.04983.x"}, {"pmid": "12089357", "authors": "  Kovalovsky D, Refojo D, Liberman AC, Hochbaum D, Pereda MP, Coso OA, Stalla GK, Holsboer F, Arzt E", "title": "Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways.", "journal": "Mol Endocrinol 16:1638-51 (2002)", "doi": "10.1210/mend.16.7.0863"}, {"pmid": "15380809", "authors": "  Lacroix A, Baldacchino V, Bourdeau I, Hamet P, Tremblay J", "title": "Cushing's syndrome variants secondary to aberrant hormone receptors.", "journal": "Trends Endocrinol Metab 15:375-82 (2004)", "doi": "10.1016/j.tem.2004.08.007"}, {"pmid": "25485838", "authors": "  Reincke M, Sbiera S, Hayakawa A, Theodoropoulou M, Osswald A, Beuschlein F, Meitinger T, Mizuno-Yamasaki E, Kawaguchi K, Saeki Y, Tanaka K, Wieland T, Graf E, Saeger W, Ronchi CL, Allolio B, Buchfelder M, Strom TM, Fassnacht M, Komada M", "title": "Mutations in the deubiquitinase gene USP8 cause Cushing's disease.", "journal": "Nat Genet 47:31-8 (2015)", "doi": "10.1038/ng.3166"}, {"pmid": "25930709", "authors": "  Kaiser UB", "title": "Cushing's disease: towards precision medicine.", "journal": "Cell Res 25:649-50 (2015)", "doi": "10.1038/cr.2015.53"}, {"pmid": "28487882", "authors": "  Uzilov AV, Cheesman KC, Fink MY, Newman LC, Pandya C, Lalazar Y, Hefti M, Fowkes M, Deikus G, Lau CY, Moe AS, Kinoshita Y, Kasai Y, Zweig M, Gupta A, Starcevic D, Mahajan M, Schadt EE, Post KD, Donovan MJ, Sebra R, Chen R, Geer EB", "title": "Identification of a novel RASD1 somatic mutation in a USP8-mutated corticotroph adenoma.", "journal": "Cold Spring Harb Mol Case Stud 3:a001602 (2017)", "doi": "10.1101/mcs.a001602"}, {"pmid": "26285834", "authors": "  Huang C, Shi Y, Zhao Y", "title": "USP8 mutation in Cushing's disease.", "journal": "Oncotarget 6:18240-1 (2015)", "doi": "10.18632/oncotarget.4856"}, {"pmid": "26012588", "authors": "  Theodoropoulou M, Reincke M, Fassnacht M, Komada M", "title": "Decoding the genetic basis of Cushing's disease: USP8 in the spotlight.", "journal": "Eur J Endocrinol 173:M73-83 (2015)", "doi": "10.1530/EJE-15-0320"}, {"pmid": "29370219", "authors": "  Yu L, Zhang J, Guo X, Chen X, He Z, He Q", "title": "ARMC5 mutations in familial and sporadic primary bilateral macronodular adrenal hyperplasia.", "journal": "PLoS One 13:e0191602 (2018)", "doi": "10.1371/journal.pone.0191602"}, {"pmid": "19075677", "authors": "  Wu X, Hua X", "title": "Menin, histone h3 methyltransferases, and regulation of cell proliferation: current knowledge and perspective.", "journal": "Curr Mol Med 8:805-15 (2008)", "doi": "10.2174/156652408786733702"}], "rel_pathway": ["hsa00020  Citrate cycle (TCA cycle)", "hsa00140  Steroid hormone biosynthesis", "hsa04020  Calcium signaling pathway", "hsa04024  cAMP signaling pathway", "hsa04110  Cell cycle", "hsa04310  Wnt signaling pathway", "hsa04927  Cortisol synthesis and secretion", "hsa04960  Aldosterone-regulated sodium reabsorption"], "ko_pathway": "ko04934", "genes": ["EGFR", "BRAF"]}, {"kegg_id": "hsa05120", "name": "Epithelial cell signaling in Helicobacter pylori infection - Homo sapiens (human)", "description": "Two major virulence factors of H. pylori are the vacuolating cytotoxin (VacA) and the cag type-IV secretion system (T4SS) and its translocated effector protein, cytotoxin-associated antigen A (CagA).\nVacA binds to lipid rafts and glycosylphosphatidylinositol-anchored proteins (GPI-APs) of the target cell membrane. After insertion into the plasma membrane, VacA channels are endocytosed and eventually reach late endosomal compartments, increasing their permeability to anions with enhancement of the electrogenic vacuolar ATPase (v-ATPase) proton pump. In the presence of weak bases, osmotically active acidotropic ions will accumulate in the endosomes. This leads to water influx and vesicle swelling, an essential step in vacuole formation. In addition, it is reported that the VacA cleavage product binds to the tyrosine phosphatase receptor zeta (Ptprz) on epithelial cells and the induced signaling leads to the phosphorylation of the G protein-coupled receptor kinase-interactor 1 (Git1) and induces ulcerogenesis in mice.\nThe other virulence factor cag T4SS mediates the translocation of the effector protein CagA, which is subsequently phosphorylated by a Src kinase. Phosphorylated CagA interacts with the protein tyrosine phosphatase SHP-2, thus stimulating its phosphatase activity. Activated SHP-2 is able to induce MAPK signalling through Ras/Raf-dependent and -independent mechanisms. Deregulation of this pathway by CagA may lead to abnormal proliferation and movement of gastric epithelial cells.", "class": "Human Diseases; Infectious disease: bacterial", "pathway_map": "hsa05120  Epithelial cell signaling in Helicobacter pylori infection", "disease": ["H00320  Helicobacter pylori infection"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["5781  PTPN11; protein tyrosine phosphatase non-receptor type 11 [KO:K07293] [EC:3.1.3.48]", "4233  MET; MET proto-oncogene, receptor tyrosine kinase [KO:K05099] [EC:2.7.10.1]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]", "7082  TJP1; tight junction protein 1 [KO:K05701]", "50848  F11R; F11 receptor [KO:K06089]", "58494  JAM2; junctional adhesion molecule 2 [KO:K06735]", "83700  JAM3; junctional adhesion molecule 3 [KO:K06785]", "150084  IGSF5; immunoglobulin superfamily member 5 [KO:K06786]", "6868  ADAM17; ADAM metallopeptidase domain 17 [KO:K06059] [EC:3.4.24.86]", "1839  HBEGF; heparin binding EGF like growth factor [KO:K08523]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "3576  CXCL8; C-X-C motif chemokine ligand 8 [KO:K10030]", "3577  CXCR1; C-X-C motif chemokine receptor 1 [KO:K04175]", "3579  CXCR2; C-X-C motif chemokine receptor 2 [KO:K05050]", "102  ADAM10; ADAM metallopeptidase domain 10 [KO:K06704] [EC:3.4.24.81]", "6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "4067  LYN; LYN proto-oncogene, Src family tyrosine kinase [KO:K05854] [EC:2.7.10.2]", "1445  CSK; C-terminal Src kinase [KO:K05728] [EC:2.7.10.2]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "998  CDC42; cell division cycle 42 [KO:K04393]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "5058  PAK1; p21 (RAC1) activated kinase 1 [KO:K04409] [EC:2.7.11.1]", "6416  MAP2K4; mitogen-activated protein kinase kinase 4 [KO:K04430] [EC:2.7.12.2]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "9020  MAP3K14; mitogen-activated protein kinase kinase kinase 14 [KO:K04466] [EC:2.7.11.25]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "10392  NOD1; nucleotide binding oligomerization domain containing 1 [KO:K08727]", "2919  CXCL1; C-X-C motif chemokine ligand 1 [KO:K05505]", "2920  CXCL2; C-X-C motif chemokine ligand 2 [KO:K05505]", "2921  CXCL3; C-X-C motif chemokine ligand 3 [KO:K05505]", "6352  CCL5; C-C motif chemokine ligand 5 [KO:K12499]", "5803  PTPRZ1; protein tyrosine phosphatase receptor type Z1 [KO:K08114] [EC:3.1.3.48]", "28964  GIT1; GIT ArfGAP 1 [KO:K05737]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "523  ATP6V1A; ATPase H+ transporting V1 subunit A [KO:K02145] [EC:7.1.2.2]", "525  ATP6V1B1; ATPase H+ transporting V1 subunit B1 [KO:K02147]", "526  ATP6V1B2; ATPase H+ transporting V1 subunit B2 [KO:K02147]", "245973  ATP6V1C2; ATPase H+ transporting V1 subunit C2 [KO:K02148]", "528  ATP6V1C1; ATPase H+ transporting V1 subunit C1 [KO:K02148]", "51382  ATP6V1D; ATPase H+ transporting V1 subunit D [KO:K02149]", "90423  ATP6V1E2; ATPase H+ transporting V1 subunit E2 [KO:K02150]", "529  ATP6V1E1; ATPase H+ transporting V1 subunit E1 [KO:K02150]", "9296  ATP6V1F; ATPase H+ transporting V1 subunit F [KO:K02151]", "9550  ATP6V1G1; ATPase H+ transporting V1 subunit G1 [KO:K02152]", "127124  ATP6V1G3; ATPase H+ transporting V1 subunit G3 [KO:K02152]", "534  ATP6V1G2; ATPase H+ transporting V1 subunit G2 [KO:K02152]", "8992  ATP6V0E1; ATPase H+ transporting V0 subunit e1 [KO:K02153]", "155066  ATP6V0E2; ATPase H+ transporting V0 subunit e2 [KO:K02153]", "10312  TCIRG1; T cell immune regulator 1, ATPase H+ transporting V0 subunit a3 [KO:K02154]", "23545  ATP6V0A2; ATPase H+ transporting V0 subunit a2 [KO:K02154]", "50617  ATP6V0A4; ATPase H+ transporting V0 subunit a4 [KO:K02154]", "535  ATP6V0A1; ATPase H+ transporting V0 subunit a1 [KO:K02154]", "9114  ATP6V0D1; ATPase H+ transporting V0 subunit d1 [KO:K02146]", "245972  ATP6V0D2; ATPase H+ transporting V0 subunit d2 [KO:K02146]", "51606  ATP6V1H; ATPase H+ transporting V1 subunit H [KO:K02144]", "537  ATP6AP1; ATPase H+ transporting accessory protein 1 [KO:K03662]", "527  ATP6V0C; ATPase H+ transporting V0 subunit c [KO:K02155]", "533  ATP6V0B; ATPase H+ transporting V0 subunit b [KO:K03661]"], "compound": ["C00014  Ammonia", "C00080  H+", "C00086  Urea", "C00698  Cl-", "C01342  NH4+", "G00242  Sialyl Lewis x antigen", "G00263  Lewis b antigen"], "refs": [{"pmid": "14700549", "authors": "  Naumann M, Crabtree JE.", "title": "Helicobacter pylori-induced epithelial cell signalling in gastric carcinogenesis.", "journal": "Trends Microbiol 12:29-36 (2004)", "doi": "10.1016/j.tim.2003.11.005"}, {"pmid": "15694859", "authors": "  Rieder G, Fischer W, Haas R.", "title": "Interaction of Helicobacter pylori with host cells: function of secreted and translocated molecules.", "journal": "Curr Opin Microbiol 8:67-73 (2005)", "doi": "10.1016/j.mib.2004.12.004"}, {"pmid": "11389469", "authors": "  Montecucco C, Rappuoli R.", "title": "Living dangerously: how Helicobacter pylori survives in the human stomach.", "journal": "Nat Rev Mol Cell Biol 2:457-66 (2001)", "doi": "10.1038/35073084"}], "rel_pathway": ["hsa00190  Oxidative phosphorylation", "hsa04010  MAPK signaling pathway", "hsa04210  Apoptosis", "hsa04530  Tight junction"], "ko_pathway": "ko05120", "genes": ["EGFR", "RAC1", "NOD1", "MET", "MAPK13"]}, {"kegg_id": "hsa05131", "name": "Shigellosis - Homo sapiens (human)", "description": "Shigellosis, or bacillary dysentery, is an intestinal infection caused by Shigella, a genus of enterobacteria. Shigella are potential food-borne pathogens that are capable of colonizing the intestinal epithelium by exploiting epithelial-cell functions and circumventing the host innate immune response. During basolateral entry into the host-cell cytoplasm, Shigella deliver a subset of effectors into the host cells through the type III secretion system. The effectors induce membrane ruffling through the stimulation of the Rac1-WAVE-Arp2/3 pathway, enabling bacterial entry into the epithelial cells. During multiplication within the cells, Shigella secrete another subset of effectors. VirG induces actin polymerization at one pole of the bacteria, allowing the bacteria to spread intracellularly and to infect adjacent cells. OspF, OspG and IpaH(9.8) downregulate the production of proinflammatory cytokines such as IL-8, helping bacteria circumvent the innate immune response.", "class": "Human Diseases; Infectious disease: bacterial", "pathway_map": "hsa05131  Shigellosis", "network": ["", "ELEMENT   N00927  Escherichia/Shigella NleE/OspZ to TNF-NFKB signaling pathway", "N00941  Shigella IpaH9.8 to NOD-NFKB signaling pathway", "N00942  Shigella OspG to TNF-NFKB signaling pathway", "N00943  Shigella IpaH4.5 to TNF-NFKB signaling pathway", "N00944  Shigella OspI to TNF-NFKB signaling pathway", "N00945  Shigella IpaH1.4/2.5 to TNF-NFKB signaling pathway", "N00946  Shigella IpaJ to cGAS-STING signaling pathway", "N00947  Shigella Ipa4.5 to cGAS-STING signaling pathway", "N00948  Shigella IpaH7.8 to NLRP3 Inflammasome signaling pathway", "N00949  Shigella IpaB to NLRC4 Inflammasome signaling pathway", "N00950  Shigella FimA to crosstalk between extrinsic and intrinsic apoptotic pathways", "N00952  Shigella IpgB1 to ITGA/B-RHOG-RAC signaling pathway", "N01067  Shigella IpgD to ARNO-ARF-ACTB_G signaling pathway", "N01069  Shigella IpgB1 to ITGA/B-FAK-RAC signaling pathway", "N01071  Shigella IpgB1 to ITGA/B-FAK-CDC42 signaling pathway", "N01073  Shigella IpgB2 to ITGA/B-RhoGEF-RhoA signaling pathway", "N01074  Shigella IpaA to ITGA/B-RhoGEF-RhoA signaling pathway", "N01075  Shigella IcsB to ITGA/B-RhoGEF-RhoA signaling pathway", "N01076  Shigella IcsB to ITGA/B-FAK-CDC42 signaling pathway", "N01077  Shigella IcsB to ITGA/B-FAK-RAC signaling pathway", "N01079  Shigella IpaC to Actin signaling pathway", "N01081  Shigella IpaB/C/D to ITGA/B-TALIN/VINCULIN signaling pathway", "N01082  Shigella IpaA to ITGA/B-TALIN/VINCULIN signaling pathway", "N01083  Shigella OspE to ITGA/B-TALIN/VINCULIN signaling pathway", "N01283  Shigella OspF to TLR2/4-MAPK signaling pathway", "N01284  Shigella IcsP to Autophagy-vesicle elongation"], "disease": ["H00299  Shigellosis"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["960  CD44; CD44 molecule (IN blood group) [KO:K06256]", "3678  ITGA5; integrin subunit alpha 5 [KO:K06484]", "3688  ITGB1; integrin subunit beta 1 [KO:K05719]", "6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "5747  PTK2; protein tyrosine kinase 2 [KO:K05725] [EC:2.7.10.2]", "1398  CRK; CRK proto-oncogene, adaptor protein [KO:K04438]", "1399  CRKL; CRK like proto-oncogene, adaptor protein [KO:K04438]", "9564  BCAR1; BCAR1 scaffold protein, Cas family member [KO:K05726]", "2017  CTTN; cortactin [KO:K06106]", "3059  HCLS1; hematopoietic cell-specific Lyn substrate 1 [KO:K06106]", "5829  PXN; paxillin [KO:K05760]", "9844  ELMO1; engulfment and cell motility 1 [KO:K12366]", "63916  ELMO2; engulfment and cell motility 2 [KO:K18985]", "1793  DOCK1; dedicator of cytokinesis 1 [KO:K13708]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "8936  WASF1; WASP family member 1 [KO:K05753]", "10163  WASF2; WASP family member 2 [KO:K05748]", "10097  ACTR2; actin related protein 2 [KO:K17260]", "57180  ACTR3B; actin related protein 3B [KO:K18584]", "653857  ACTR3C; actin related protein 3C [KO:K18584]", "10096  ACTR3; actin related protein 3 [KO:K18584]", "10095  ARPC1B; actin related protein 2/3 complex subunit 1B [KO:K05757]", "10552  ARPC1A; actin related protein 2/3 complex subunit 1A [KO:K05757]", "10109  ARPC2; actin related protein 2/3 complex subunit 2 [KO:K05758]", "10094  ARPC3; actin related protein 2/3 complex subunit 3 [KO:K05756]", "10093  ARPC4; actin related protein 2/3 complex subunit 4 [KO:K05755]", "10092  ARPC5; actin related protein 2/3 complex subunit 5 [KO:K05754]", "81873  ARPC5L; actin related protein 2/3 complex subunit 5 like [KO:K05754]", "71  ACTG1; actin gamma 1 [KO:K05692]", "60  ACTB; actin beta [KO:K05692]", "387  RHOA; ras homolog family member A [KO:K04513]", "1729  DIAPH1; diaphanous related formin 1 [KO:K05740]", "6093  ROCK1; Rho associated coiled-coil containing protein kinase 1 [KO:K04514] [EC:2.7.11.1]", "9475  ROCK2; Rho associated coiled-coil containing protein kinase 2 [KO:K17388] [EC:2.7.11.1]", "4633  MYL2; myosin light chain 2 [KO:K10351]", "4636  MYL5; myosin light chain 5 [KO:K12753]", "58498  MYL7; myosin light chain 7 [KO:K12754]", "10398  MYL9; myosin light chain 9 [KO:K12755]", "93408  MYL10; myosin light chain 10 [KO:K12756]", "103910  MYL12B; myosin light chain 12B [KO:K12757]", "10627  MYL12A; myosin light chain 12A [KO:K12757]", "29895  MYL11; myosin light chain 11 [KO:K12758]", "87  ACTN1; actinin alpha 1 [KO:K05699]", "81  ACTN4; actinin alpha 4 [KO:K05699]", "3611  ILK; integrin linked kinase [KO:K06272] [EC:2.7.11.1]", "7094  TLN1; talin 1 [KO:K06271]", "83660  TLN2; talin 2 [KO:K06271]", "7414  VCL; vinculin [KO:K05700]", "998  CDC42; cell division cycle 42 [KO:K04393]", "8976  WASL; WASP like actin nucleation promoting factor [KO:K23612]", "345456  PFN3; profilin 3 [KO:K05759]", "5216  PFN1; profilin 1 [KO:K05759]", "5217  PFN2; profilin 2 [KO:K05759]", "375189  PFN4; profilin family member 4 [KO:K05759]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "9265  CYTH3; cytohesin 3 [KO:K18441]", "27128  CYTH4; cytohesin 4 [KO:K18441]", "9266  CYTH2; cytohesin 2 [KO:K18441]", "9267  CYTH1; cytohesin 1 [KO:K18441]", "382  ARF6; ADP ribosylation factor 6 [KO:K07941]", "375  ARF1; ADP ribosylation factor 1 [KO:K07937]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "2308  FOXO1; forkhead box O1 [KO:K07201]", "2309  FOXO3; forkhead box O3 [KO:K09408]", "4303  FOXO4; forkhead box O4 [KO:K12358]", "100132074  FOXO6; forkhead box O6 [KO:K17847]", "2931  GSK3A; glycogen synthase kinase 3 alpha [KO:K08822] [EC:2.7.11.26]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "6198  RPS6KB1; ribosomal protein S6 kinase B1 [KO:K04688] [EC:2.7.11.1]", "6199  RPS6KB2; ribosomal protein S6 kinase B2 [KO:K04688] [EC:2.7.11.1]", "4193  MDM2; MDM2 proto-oncogene [KO:K06643] [EC:2.3.2.27]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "5333  PLCD1; phospholipase C delta 1 [KO:K05857] [EC:3.1.4.11]", "113026  PLCD3; phospholipase C delta 3 [KO:K05857] [EC:3.1.4.11]", "84812  PLCD4; phospholipase C delta 4 [KO:K05857] [EC:3.1.4.11]", "51196  PLCE1; phospholipase C epsilon 1 [KO:K05860] [EC:3.1.4.11]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]", "89869  PLCZ1; phospholipase C zeta 1 [KO:K05861] [EC:3.1.4.11]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "831  CAST; calpastatin [KO:K04281]", "823  CAPN1; calpain 1 [KO:K01367] [EC:3.4.22.52]", "824  CAPN2; calpain 2 [KO:K03853] [EC:3.4.22.53]", "826  CAPNS1; calpain small subunit 1 [KO:K08583]", "472  ATM; ATM serine/threonine kinase [KO:K04728] [EC:2.7.11.1]", "7157  TP53; tumor protein p53 [KO:K04451]", "598  BCL2L1; BCL2 like 1 [KO:K04570]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]", "3101  HK3; hexokinase 3 [KO:K00844] [EC:2.7.1.1]", "3098  HK1; hexokinase 1 [KO:K00844] [EC:2.7.1.1]", "3099  HK2; hexokinase 2 [KO:K00844] [EC:2.7.1.1]", "80201  HKDC1; hexokinase domain containing 1 [KO:K00844] [EC:2.7.1.1]", "7416  VDAC1; voltage dependent anion channel 1 [KO:K05862]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "54205  CYCS; cytochrome c, somatic [KO:K08738]", "664  BNIP3; BCL2 interacting protein 3 [KO:K15464]", "5481  PPID; peptidylprolyl isomerase D [KO:K05864] [EC:5.2.1.8]", "837  CASP4; caspase 4 [KO:K04394] [EC:3.4.22.57 3.4.22.64]", "3553  IL1B; interleukin 1 beta [KO:K04519]", "3606  IL18; interleukin 18 [KO:K05482]", "7124  TNF; tumor necrosis factor [KO:K03156]", "7132  TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158]", "8717  TRADD; TNFRSF1A associated via death domain [KO:K03171]", "7186  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]", "7188  TRAF5; TNF receptor associated factor 5 [KO:K09849]", "8737  RIPK1; receptor interacting serine/threonine kinase 1 [KO:K02861] [EC:2.7.11.1]", "6885  MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO:K04427] [EC:2.7.11.25]", "10454  TAB1; TGF-beta activated kinase 1 (MAP3K7) binding protein 1 [KO:K04403]", "23118  TAB2; TGF-beta activated kinase 1 (MAP3K7) binding protein 2 [KO:K04404]", "257397  TAB3; TGF-beta activated kinase 1 (MAP3K7) binding protein 3 [KO:K12793]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "4793  NFKBIB; NFKB inhibitor beta [KO:K02581]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "3576  CXCL8; C-X-C motif chemokine ligand 8 [KO:K10030]", "92610  TIFA; TRAF interacting protein with forkhead associated domain [KO:K23826]", "3554  IL1R1; interleukin 1 receptor type 1 [KO:K04386]", "929  CD14; CD14 molecule [KO:K04391]", "7099  TLR4; toll like receptor 4 [KO:K10160]", "7100  TLR5; toll like receptor 5 [KO:K10168]", "7189  TRAF6; TNF receptor associated factor 6 [KO:K03175] [EC:2.3.2.27]", "5580  PRKCD; protein kinase C delta [KO:K06068] [EC:2.7.11.13]", "5581  PRKCE; protein kinase C epsilon [KO:K18050] [EC:2.7.11.13]", "5588  PRKCQ; protein kinase C theta [KO:K18052] [EC:2.7.11.13]", "10892  MALT1; MALT1 paracaspase [KO:K07369] [EC:3.4.22.-]", "8915  BCL10; BCL10 immune signaling adaptor [KO:K07368]", "10392  NOD1; nucleotide binding oligomerization domain containing 1 [KO:K08727]", "9181  ARHGEF2; Rho/Rac guanine nucleotide exchange factor 2 [KO:K12791]", "8767  RIPK2; receptor interacting serine/threonine kinase 2 [KO:K08846] [EC:2.7.11.1]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "7335  UBE2V1; ubiquitin conjugating enzyme E2 V1 [KO:K10704]", "7336  UBE2V2; ubiquitin conjugating enzyme E2 V2 [KO:K10704]", "389898  UBE2NL; ubiquitin conjugating enzyme E2 N like (gene/pseudogene) [KO:K10580] [EC:2.3.2.23]", "7334  UBE2N; ubiquitin conjugating enzyme E2 N [KO:K10580] [EC:2.3.2.23]", "10616  RBCK1; RANBP2-type and C3HC4-type zinc finger containing 1 [KO:K10630] [EC:2.3.2.31]", "55072  RNF31; ring finger protein 31 [KO:K11974] [EC:2.3.2.31]", "81858  SHARPIN; SHANK associated RH domain interactor [KO:K20894]", "10318  TNIP1; TNFAIP3 interacting protein 1 [KO:K23829]", "51619  UBE2D4; ubiquitin conjugating enzyme E2 D4 (putative) [KO:K06689] [EC:2.3.2.23]", "7321  UBE2D1; ubiquitin conjugating enzyme E2 D1 [KO:K06689] [EC:2.3.2.23]", "7322  UBE2D2; ubiquitin conjugating enzyme E2 D2 [KO:K06689] [EC:2.3.2.23]", "7323  UBE2D3; ubiquitin conjugating enzyme E2 D3 [KO:K06689] [EC:2.3.2.23]", "9978  RBX1; ring-box 1 [KO:K03868] [EC:2.3.2.32]", "8454  CUL1; cullin 1 [KO:K03347]", "6500  SKP1; S-phase kinase associated protein 1 [KO:K03094]", "8945  BTRC; beta-transducin repeat containing E3 ubiquitin protein ligase [KO:K03362]", "23291  FBXW11; F-box and WD repeat domain containing 11 [KO:K03362]", "115004  CGAS; cyclic GMP-AMP synthase [KO:K17834] [EC:2.7.7.86]", "340061  STING1; stimulator of interferon response cGAMP interactor 1 [KO:K12654]", "4615  MYD88; MYD88 innate immune signal transduction adaptor [KO:K04729]", "29110  TBK1; TANK binding kinase 1 [KO:K05410] [EC:2.7.11.10]", "3661  IRF3; interferon regulatory factor 3 [KO:K05411]", "3456  IFNB1; interferon beta 1 [KO:K05415]", "7307  U2AF1; U2 small nuclear RNA auxiliary factor 1 [KO:K12836]", "102724594  U2AF1L5; U2 small nuclear RNA auxiliary factor 1 like 5 [KO:K12836]", "199746  U2AF1L4; U2 small nuclear RNA auxiliary factor 1 like 4 [KO:K12836]", "6352  CCL5; C-C motif chemokine ligand 5 [KO:K12499]", "1437  CSF2; colony stimulating factor 2 [KO:K05427]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "9252  RPS6KA5; ribosomal protein S6 kinase A5 [KO:K04445] [EC:2.7.11.1]", "440093  H3-5; H3.5 histone [KO:K11253]", "3021  H3-3B; H3.3 histone B [KO:K11253]", "8351  H3C4; H3 clustered histone 4 [KO:K11253]", "8352  H3C3; H3 clustered histone 3 [KO:K11253]", "8350  H3C1; H3 clustered histone 1 [KO:K11253]", "3020  H3-3A; H3.3 histone A [KO:K11253]", "8290  H3-4; H3.4 histone, cluster member [KO:K11253]", "126961  H3C14; H3 clustered histone 14 [KO:K11253]", "333932  H3C15; H3 clustered histone 15 [KO:K11253]", "653604  H3C13; H3 clustered histone 13 [KO:K11253]", "8353  H3C6; H3 clustered histone 6 [KO:K11253]", "8354  H3C11; H3 clustered histone 11 [KO:K11253]", "8355  H3C8; H3 clustered histone 8 [KO:K11253]", "8356  H3C12; H3 clustered histone 12 [KO:K11253]", "8357  H3C10; H3 clustered histone 10 [KO:K11253]", "8358  H3C2; H3 clustered histone 2 [KO:K11253]", "8968  H3C7; H3 clustered histone 7 [KO:K11253]", "11335  CBX3; chromobox 3 [KO:K11586]", "8678  BECN1; beclin 1 [KO:K08334]", "441925  BECN2; beclin 2 [KO:K08334]", "22863  ATG14; autophagy related 14 [KO:K17889]", "30849  PIK3R4; phosphoinositide-3-kinase regulatory subunit 4 [KO:K08333] [EC:2.7.11.1]", "5289  PIK3C3; phosphatidylinositol 3-kinase catalytic subunit type 3 [KO:K00914] [EC:2.7.1.137]", "10670  RRAGA; Ras related GTP binding A [KO:K16185]", "10325  RRAGB; Ras related GTP binding B [KO:K16185]", "64121  RRAGC; Ras related GTP binding C [KO:K16186]", "58528  RRAGD; Ras related GTP binding D [KO:K16186]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "57521  RPTOR; regulatory associated protein of MTOR complex 1 [KO:K07204]", "84335  AKT1S1; AKT1 substrate 1 [KO:K16184]", "55054  ATG16L1; autophagy related 16 like 1 [KO:K17890]", "9474  ATG5; autophagy related 5 [KO:K08339]", "9140  ATG12; autophagy related 12 [KO:K08336]", "440738  MAP1LC3C; microtubule associated protein 1 light chain 3 gamma [KO:K10435]", "81631  MAP1LC3B; microtubule associated protein 1 light chain 3 beta [KO:K10435]", "84557  MAP1LC3A; microtubule associated protein 1 light chain 3 alpha [KO:K10435]", "643246  MAP1LC3B2; microtubule associated protein 1 light chain 3 beta 2 [KO:K10435]", "718  C3; complement C3 [KO:K03990]", "8878  SQSTM1; sequestosome 1 [KO:K14381]", "10241  CALCOCO2; calcium binding and coiled-coil domain 2 [KO:K21348]", "7311  UBA52; ubiquitin A-52 residue ribosomal protein fusion product 1 [KO:K02927]", "6233  RPS27A; ribosomal protein S27a [KO:K02977]", "7314  UBB; ubiquitin B [KO:K04551]", "7316  UBC; ubiquitin C [KO:K08770]", "4735  SEPTIN2; septin 2 [KO:K16942]", "10801  SEPTIN9; septin 9 [KO:K16938]", "124404  SEPTIN12; septin 12 [KO:K16938]", "55964  SEPTIN3; septin 3 [KO:K16938]", "23157  SEPTIN6; septin 6 [KO:K16939]", "55752  SEPTIN11; septin 11 [KO:K16939]", "23176  SEPTIN8; septin 8 [KO:K16939]", "989  SEPTIN7; septin 7 [KO:K16944]", "26100  WIPI2; WD repeat domain, phosphoinositide interacting 2 [KO:K17908]", "55062  WIPI1; WD repeat domain, phosphoinositide interacting 1 [KO:K17908]", "25851  TECPR1; tectonin beta-propeller repeat containing 1 [KO:K17988]", "23048  FNBP1; formin binding protein 1 [KO:K20121]", "54874  FNBP1L; formin binding protein 1 like [KO:K20121]", "11146  GLMN; glomulin, FKBP associated protein [KO:K23345]", "114548  NLRP3; NLR family pyrin domain containing 3 [KO:K12800]", "4671  NAIP; NLR family apoptosis inhibitory protein [KO:K12807]", "58484  NLRC4; NLR family CARD domain containing 4 [KO:K12805]", "29108  PYCARD; PYD and CARD domain containing [KO:K12799]", "834  CASP1; caspase 1 [KO:K01370] [EC:3.4.22.36]"], "compound": ["C00076  Calcium cation", "C00123  L-Leucine", "C00165  Diacylglycerol", "C00238  Potassium cation", "C00338  Lipopolysaccharide", "C00407  L-Isoleucine", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C04549  1-Phosphatidyl-1D-myo-inositol 3-phosphate", "C04637  1-Phosphatidyl-D-myo-inositol 4,5-bisphosphate", "C04737  alpha-D-Galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide", "C05981  Phosphatidylinositol-3,4,5-trisphosphate", "C11472  D-glycero-beta-D-manno-Heptose 1,7-bisphosphate", "C11557  1-Phosphatidyl-1D-myo-inositol 5-phosphate", "C20640  Cyclic GMP-AMP"], "refs": [{"pmid": "30953429", "authors": "  Schnupf P, Sansonetti PJ", "title": "Shigella Pathogenesis: New Insights through Advanced Methodologies.", "journal": "Microbiol Spectr 7:BAI-0023-2019 (2019)", "doi": "10.1128/microbiolspec.BAI-0023-2019"}, {"pmid": "28393050", "authors": "  Mattock E, Blocker AJ", "title": "How Do the Virulence Factors of Shigella Work Together to Cause Disease?", "journal": "Front Cell Infect Microbiol 7:64 (2017)", "doi": "10.3389/fcimb.2017.00064"}, {"pmid": "25999954", "authors": "  Ashida H, Mimuro H, Sasakawa C", "title": "Shigella manipulates host immune responses by delivering effector proteins with specific roles.", "journal": "Front Immunol 6:219 (2015)", "doi": "10.3389/fimmu.2015.00219"}, {"pmid": "20228623", "authors": "  Sasakawa C", "title": "A new paradigm of bacteria-gut interplay brought through the study of Shigella.", "journal": "Proc Jpn Acad Ser B Phys Biol Sci 86:229-43 (2010)", "doi": "10.2183/pjab.86.229"}, {"pmid": "25264025", "authors": "  Ashida H, Kim M, Sasakawa C", "title": "Manipulation of the host cell death pathway by Shigella.", "journal": "Cell Microbiol 16:1757-66 (2014)", "doi": "10.1111/cmi.12367"}, {"pmid": "29875765", "authors": "  Siqueira MDS, Ribeiro RM, Travassos LH", "title": "Autophagy and Its Interaction With Intracellular Bacterial Pathogens.", "journal": "Front Immunol 9:935 (2018)", "doi": "10.3389/fimmu.2018.00935"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04064  NF-kappa B signaling pathway", "hsa04140  Autophagy - animal", "hsa04210  Apoptosis", "hsa04510  Focal adhesion", "hsa04621  NOD-like receptor signaling pathway", "hsa04623  Cytosolic DNA-sensing pathway", "hsa04810  Regulation of actin cytoskeleton"], "ko_pathway": "ko05131", "genes": ["EGFR", "MALT1", "RAC1", "NOD1", "TP53", "CUL1", "CD44", "AKT2", "AKT1", "MAPK13", "BAX"]}, {"kegg_id": "hsa05160", "name": "Hepatitis C - Homo sapiens (human)", "description": "Hepatitis C virus (HCV) is a major cause of chronic liver disease. The HCV employ several strategies to perturb host cell immunity. After invasion, HCV RNA genome functions directly as an mRNA in the cytoplasm of the host cell and forms membrane-associated replication complexes along with non-structural proteins. Viral RNA can trigger the RIG-I pathway and interferon production during this process. Translated HCV protein products regulate immune response to inhibit the action of interferon. HCV core and NS5A proteins appear to be the most important molecules with regulatory functions that modulate transcription, cellular proliferation, and apoptosis.", "class": "Human Diseases; Infectious disease: viral", "pathway_map": "hsa05160  Hepatitis C", "network": ["", "ELEMENT   N00269  HCV core to TNF-NFKB signaling pathway", "N00270  HCV Core to IFN signaling pathway", "N00271  HCV NS3/4A to RIG-I-like receptor signaling pathway", "N00272  HCV NS5A to PI3K signaling pathway", "N00273  HCV NS5A to oligoadenylate synthetase (OAS)/RNase L pathway", "N00274  HCV NS5A to RAS-ERK signaling pathway", "N00516  HCV NS3/4A to TLR3-IRF3 signaling pathway", "N00517  HCV NS3/4A to TLR3-IRF3 signaling pathway", "N00518  HCV Core to ERK signaling pathway", "N00519  HCV Core to ERK signaling pathway", "N00520  HCV NS5A to p21-cell cycle G1/S", "N00521  HCV Core to p21-cell cycle G1/S", "N00522  HCV NS3 to p21-cell cycle G1/S", "N00523  HCV Core to p21-cell cycle G1/S", "N00524  HCV NS5A to extrinsic apoptotic pathway", "N00525  HCV NS5A to TNF-NFKB signaling pathway", "N00526  HCV NS3 to crosstalk between extrinsic and intrinsic apoptotic pathways", "N00527  HCV Core to crosstalk between extrinsic and intrinsic apoptotic pathways", "N00528  HCV core to extrinsic apoptotic pathway", "N00529  HCV core to RXRA/PPARA-mediated transcription", "N00530  HCV core to RXRA/LXRA-mediated transcription"], "disease": ["H00413  Hepatitis C"], "drug": ["D02745  Interferon alfa-2b (USAN)", "D02747  Peginterferon alfa-2a (USAN/INN)", "D02748  Peginterferon alfa-2b (USAN/INN)", "D03304  Interferon beta (JAN)", "D03305  Interferon alfa (NAMALWA) (JP18)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["3949  LDLR; low density lipoprotein receptor [KO:K12473]", "949  SCARB1; scavenger receptor class B member 1 [KO:K13885]", "975  CD81; CD81 molecule [KO:K06508]", "1364  CLDN4; claudin 4 [KO:K06087]", "1365  CLDN3; claudin 3 [KO:K06087]", "1366  CLDN7; claudin 7 [KO:K06087]", "149461  CLDN19; claudin 19 [KO:K06087]", "10686  CLDN16; claudin 16 [KO:K06087]", "23562  CLDN14; claudin 14 [KO:K06087]", "24146  CLDN15; claudin 15 [KO:K06087]", "26285  CLDN17; claudin 17 [KO:K06087]", "49861  CLDN20; claudin 20 [KO:K06087]", "5010  CLDN11; claudin 11 [KO:K06087]", "51208  CLDN18; claudin 18 [KO:K06087]", "53842  CLDN22; claudin 22 [KO:K06087]", "7122  CLDN5; claudin 5 [KO:K06087]", "9071  CLDN10; claudin 10 [KO:K06087]", "9073  CLDN8; claudin 8 [KO:K06087]", "9074  CLDN6; claudin 6 [KO:K06087]", "9075  CLDN2; claudin 2 [KO:K06087]", "9076  CLDN1; claudin 1 [KO:K06087]", "9080  CLDN9; claudin 9 [KO:K06087]", "137075  CLDN23; claudin 23 [KO:K06087]", "100288814  CLDN34; claudin 34 [KO:K06087]", "644672  CLDN25; claudin 25 [KO:K06087]", "100132463  CLDN24; claudin 24 [KO:K06087]", "9069  CLDN12; claudin 12 [KO:K06087]", "100506658  OCLN; occludin [KO:K06088]", "4938  OAS1; 2'-5'-oligoadenylate synthetase 1 [KO:K14216] [EC:2.7.7.84]", "4939  OAS2; 2'-5'-oligoadenylate synthetase 2 [KO:K14216] [EC:2.7.7.84]", "4940  OAS3; 2'-5'-oligoadenylate synthetase 3 [KO:K14216] [EC:2.7.7.84]", "6041  RNASEL; ribonuclease L [KO:K01165]", "23586  RIGI; RNA sensor RIG-I [KO:K12646] [EC:5.6.2.6]", "57506  MAVS; mitochondrial antiviral signaling protein [KO:K12648]", "7187  TRAF3; TNF receptor associated factor 3 [KO:K03174]", "29110  TBK1; TANK binding kinase 1 [KO:K05410] [EC:2.7.11.10]", "9641  IKBKE; inhibitor of nuclear factor kappa B kinase subunit epsilon [KO:K07211] [EC:2.7.11.10]", "3661  IRF3; interferon regulatory factor 3 [KO:K05411]", "3665  IRF7; interferon regulatory factor 7 [KO:K09447]", "3439  IFNA1; interferon alpha 1 [KO:K05414]", "3440  IFNA2; interferon alpha 2 [KO:K05414]", "3441  IFNA4; interferon alpha 4 [KO:K05414]", "3442  IFNA5; interferon alpha 5 [KO:K05414]", "3443  IFNA6; interferon alpha 6 [KO:K05414]", "3444  IFNA7; interferon alpha 7 [KO:K05414]", "3445  IFNA8; interferon alpha 8 [KO:K05414]", "3446  IFNA10; interferon alpha 10 [KO:K05414]", "3447  IFNA13; interferon alpha 13 [KO:K05414]", "3448  IFNA14; interferon alpha 14 [KO:K05414]", "3449  IFNA16; interferon alpha 16 [KO:K05414]", "3451  IFNA17; interferon alpha 17 [KO:K05414]", "3452  IFNA21; interferon alpha 21 [KO:K05414]", "3456  IFNB1; interferon beta 1 [KO:K05415]", "3458  IFNG; interferon gamma [KO:K04687]", "7098  TLR3; toll like receptor 3 [KO:K05401]", "148022  TICAM1; TIR domain containing adaptor molecule 1 [KO:K05842]", "7189  TRAF6; TNF receptor associated factor 6 [KO:K03175] [EC:2.3.2.27]", "8737  RIPK1; receptor interacting serine/threonine kinase 1 [KO:K02861] [EC:2.7.11.1]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "7124  TNF; tumor necrosis factor [KO:K03156]", "3627  CXCL10; C-X-C motif chemokine ligand 10 [KO:K12671]", "27102  EIF2AK1; eukaryotic translation initiation factor 2 alpha kinase 1 [KO:K16194] [EC:2.7.11.1]", "5610  EIF2AK2; eukaryotic translation initiation factor 2 alpha kinase 2 [KO:K16195] [EC:2.7.11.1]", "9451  EIF2AK3; eukaryotic translation initiation factor 2 alpha kinase 3 [KO:K08860] [EC:2.7.11.1]", "440275  EIF2AK4; eukaryotic translation initiation factor 2 alpha kinase 4 [KO:K16196] [EC:2.7.11.1]", "3434  IFIT1; interferon induced protein with tetratricopeptide repeats 1 [KO:K14217]", "439996  IFIT1B; interferon induced protein with tetratricopeptide repeats 1B [KO:K14217]", "3646  EIF3E; eukaryotic translation initiation factor 3 subunit E [KO:K03250]", "1965  EIF2S1; eukaryotic translation initiation factor 2 subunit alpha [KO:K03237]", "6774  STAT3; signal transducer and activator of transcription 3 [KO:K04692]", "9021  SOCS3; suppressor of cytokine signaling 3 [KO:K04696]", "3454  IFNAR1; interferon alpha and beta receptor subunit 1 [KO:K05130]", "3455  IFNAR2; interferon alpha and beta receptor subunit 2 [KO:K05131]", "3716  JAK1; Janus kinase 1 [KO:K11217] [EC:2.7.10.2]", "7297  TYK2; tyrosine kinase 2 [KO:K11219] [EC:2.7.10.2]", "6772  STAT1; signal transducer and activator of transcription 1 [KO:K11220]", "6773  STAT2; signal transducer and activator of transcription 2 [KO:K11221]", "10379  IRF9; interferon regulatory factor 9 [KO:K04693]", "4599  MX1; MX dynamin like GTPase 1 [KO:K14754]", "4600  MX2; MX dynamin like GTPase 2 [KO:K14754]", "91543  RSAD2; radical S-adenosyl methionine domain containing 2 [KO:K15045]", "5519  PPP2R1B; protein phosphatase 2 scaffold subunit Abeta [KO:K03456]", "5518  PPP2R1A; protein phosphatase 2 scaffold subunit Aalpha [KO:K03456]", "5520  PPP2R2A; protein phosphatase 2 regulatory subunit Balpha [KO:K04354]", "5521  PPP2R2B; protein phosphatase 2 regulatory subunit Bbeta [KO:K04354]", "5522  PPP2R2C; protein phosphatase 2 regulatory subunit Bgamma [KO:K04354]", "55844  PPP2R2D; protein phosphatase 2 regulatory subunit Bdelta [KO:K04354]", "5515  PPP2CA; protein phosphatase 2 catalytic subunit alpha [KO:K04382] [EC:3.1.3.16]", "5516  PPP2CB; protein phosphatase 2 catalytic subunit beta [KO:K04382] [EC:3.1.3.16]", "8554  PIAS1; protein inhibitor of activated STAT 1 [KO:K04706] [EC:2.3.2.-]", "1950  EGF; epidermal growth factor [KO:K04357]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "369  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]", "7534  YWHAZ; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta [KO:K16197]", "7529  YWHAB; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta [KO:K16197]", "10971  YWHAQ; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta [KO:K16197]", "7531  YWHAE; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon [KO:K06630]", "7533  YWHAH; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta [KO:K16198]", "7532  YWHAG; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma [KO:K16198]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "1499  CTNNB1; catenin beta 1 [KO:K02105]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]", "1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]", "7157  TP53; tumor protein p53 [KO:K04451]", "1017  CDK2; cyclin dependent kinase 2 [KO:K02206] [EC:2.7.11.22]", "1019  CDK4; cyclin dependent kinase 4 [KO:K02089] [EC:2.7.11.22]", "1021  CDK6; cyclin dependent kinase 6 [KO:K02091] [EC:2.7.11.22]", "5925  RB1; RB transcriptional corepressor 1 [KO:K06618]", "1869  E2F1; E2F transcription factor 1 [KO:K17454]", "1870  E2F2; E2F transcription factor 2 [KO:K09389]", "1871  E2F3; E2F transcription factor 3 [KO:K06620]", "7132  TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158]", "8717  TRADD; TNFRSF1A associated via death domain [KO:K03171]", "7186  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]", "356  FASLG; Fas ligand [KO:K04389]", "355  FAS; Fas cell surface death receptor [KO:K04390]", "8772  FADD; Fas associated via death domain [KO:K02373]", "841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "8837  CFLAR; CASP8 and FADD like apoptosis regulator [KO:K04724]", "637  BID; BH3 interacting domain death agonist [KO:K04726]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "578  BAK1; BCL2 antagonist/killer 1 [KO:K14021]", "54205  CYCS; cytochrome c, somatic [KO:K08738]", "317  APAF1; apoptotic peptidase activating factor 1 [KO:K02084]", "842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]", "10197  PSME3; proteasome activator subunit 3 [KO:K06698]", "6256  RXRA; retinoid X receptor alpha [KO:K08524]", "5465  PPARA; peroxisome proliferator activated receptor alpha [KO:K07294]", "10062  NR1H3; nuclear receptor subfamily 1 group H member 3 [KO:K08536]", "595  CCND1; cyclin D1 [KO:K04503]", "4609  MYC; MYC proto-oncogene, bHLH transcription factor [KO:K04377]"], "compound": ["C05981  Phosphatidylinositol-3,4,5-trisphosphate", "C20935  2-5A"], "refs": [{"pmid": "24520529", "authors": "  Hassan M, Selimovic D, El-Khattouti A, Ghozlan H, Haikel Y, Abdelkader O", "title": "Hepatitis C virus-host interactions: Etiopathogenesis and therapeutic strategies.", "journal": "World J Exp Med 2:7-25 (2012)", "doi": "10.5493/wjem.v2.i2.7"}, {"pmid": "23641066", "authors": "  Yamauchi Y, Helenius A", "title": "Virus entry at a glance.", "journal": "J Cell Sci 126:1289-95 (2013)", "doi": "10.1242/jcs.119685"}, {"pmid": "24509809", "authors": "  Feneant L, Levy S, Cocquerel L", "title": "CD81 and hepatitis C virus (HCV) infection.", "journal": "Viruses 6:535-72 (2014)", "doi": "10.3390/v6020535"}, {"pmid": "18081727", "authors": "  Dubuisson J, Helle F, Cocquerel L", "title": "Early steps of the hepatitis C virus life cycle.", "journal": "Cell Microbiol 10:821-7 (2008)", "doi": "10.1111/j.1462-5822.2007.01107.x"}, {"pmid": "23675659", "authors": "  Liang TJ, Ghany MG", "title": "Current and future therapies for hepatitis C virus infection.", "journal": "N Engl J Med 368:1907-17 (2013)", "doi": "10.1056/NEJMra1213651"}, {"pmid": "23836234", "authors": "  Scheel TK, Rice CM", "title": "Understanding the hepatitis C virus life cycle paves the way for highly effective therapies.", "journal": "Nat Med 19:837-49 (2013)", "doi": "10.1038/nm.3248"}, {"pmid": "26586968", "authors": "  Holmes JA, Thompson AJ", "title": "Interferon-free combination therapies for the treatment of hepatitis C: current insights.", "journal": "Hepat Med 7:51-70 (2015)", "doi": "10.2147/HMER.S55864"}, {"pmid": "15039538", "authors": "  Taguchi T, Nagano-Fujii M, Akutsu M, Kadoya H, Ohgimoto S, Ishido S, Hotta H", "title": "Hepatitis C virus NS5A protein interacts with 2',5'-oligoadenylate synthetase and inhibits antiviral activity of IFN in an IFN sensitivity-determining region-independent manner.", "journal": "J Gen Virol 85:959-69 (2004)", "doi": "10.1099/vir.0.19513-0"}, {"pmid": "19708811", "authors": "  Horner SM, Gale M Jr", "title": "Intracellular innate immune cascades and interferon defenses that control hepatitis C virus.", "journal": "J Interferon Cytokine Res 29:489-98 (2009)", "doi": "10.1089/jir.2009.0063"}, {"pmid": "20457596", "authors": "  Lemon SM", "title": "Induction and evasion of innate antiviral responses by hepatitis C virus.", "journal": "J Biol Chem 285:22741-7 (2010)", "doi": "10.1074/jbc.R109.099556"}, {"pmid": "23836238", "authors": "  Horner SM, Gale M Jr", "title": "Regulation of hepatic innate immunity by hepatitis C virus.", "journal": "Nat Med 19:879-88 (2013)", "doi": "10.1038/nm.3253"}, {"pmid": "28862649", "authors": "  Ortega-Prieto AM, Dorner M", "title": "Immune Evasion Strategies during Chronic Hepatitis B and C Virus Infection.", "journal": "Vaccines (Basel) 5:E24 (2017)", "doi": "10.3390/vaccines5030024"}, {"pmid": "25852264", "authors": "  Yang DR, Zhu HZ", "title": "Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?", "journal": "World J Gastroenterol 21:3786-800 (2015)", "doi": "10.3748/wjg.v21.i13.3786"}, {"pmid": "16107833", "authors": "  Gale M Jr, Foy EM", "title": "Evasion of intracellular host defence by hepatitis C virus.", "journal": "Nature 436:939-45 (2005)", "doi": "10.1038/nature04078"}, {"pmid": "17467654", "authors": "  Bode JG, Brenndorfer ED, Haussinger D", "title": "Subversion of innate host antiviral strategies by the hepatitis C virus.", "journal": "Arch Biochem Biophys 462:254-65 (2007)", "doi": "10.1016/j.abb.2007.03.033"}, {"pmid": "12686421", "authors": "  Panteva M, Korkaya H, Jameel S", "title": "Hepatitis viruses and the MAPK pathway: is this a survival strategy?", "journal": "Virus Res 92:131-40 (2003)", "doi": "10.1016/S0168-1702(02)00356-8"}, {"pmid": "16239065", "authors": "  Pang R, Tse E, Poon RT", "title": "Molecular pathways in hepatocellular carcinoma.", "journal": "Cancer Lett 240:157-69 (2006)", "doi": "10.1016/j.canlet.2005.08.031"}, {"pmid": "15302943", "authors": "  Macdonald A, Harris M", "title": "Hepatitis C virus NS5A: tales of a promiscuous protein.", "journal": "J Gen Virol 85:2485-502 (2004)", "doi": "10.1099/vir.0.80204-0"}, {"pmid": "12101418", "authors": "  Lan KH, Sheu ML, Hwang SJ, Yen SH, Chen SY, Wu JC, Wang YJ, Kato N, Omata M, Chang FY, Lee SD", "title": "HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis.", "journal": "Oncogene 21:4801-11 (2002)", "doi": "10.1038/sj.onc.1205589"}, {"pmid": "11886269", "authors": "  Majumder M, Ghosh AK, Steele R, Zhou XY, Phillips NJ, Ray R, Ray RB", "title": "Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice.", "journal": "Virology 294:94-105 (2002)", "doi": "10.1006/viro.2001.1309"}, {"pmid": "15381253", "authors": "  Hassan M, Ghozlan H, Abdel-Kader O", "title": "Activation of RB/E2F signaling pathway is required for the modulation of hepatitis C virus core protein-induced cell growth in liver and non-liver cells.", "journal": "Cell Signal 16:1375-85 (2004)", "doi": "10.1016/j.cellsig.2004.04.005"}, {"pmid": "11514734", "authors": "  Kwun HJ, Jung EY, Ahn JY, Lee MN, Jang KL", "title": "p53-dependent transcriptional repression of p21(waf1) by hepatitis C virus NS3.", "journal": "J Gen Virol 82:2235-41 (2001)", "doi": "10.1099/0022-1317-82-9-2235"}, {"pmid": "12056797", "authors": "  Yamanaka T, Uchida M, Doi T", "title": "Innate form of HCV core protein plays an important role in the localization and the function of HCV core protein.", "journal": "Biochem Biophys Res Commun 294:521-7 (2002)", "doi": "10.1016/S0006-291X(02)00507-7"}, {"pmid": "22611309", "authors": "  Lim EJ, Chin R, Angus PW, Torresi J", "title": "Enhanced apoptosis in post-liver transplant hepatitis C: effects of virus and immunosuppressants.", "journal": "World J Gastroenterol 18:2172-9 (2012)", "doi": "10.3748/wjg.v18.i18.2172"}, {"pmid": "17828818", "authors": "  Fischer R, Baumert T, Blum HE", "title": "Hepatitis C virus infection and apoptosis.", "journal": "World J Gastroenterol 13:4865-72 (2007)", "doi": "10.3748/wjg.v13.i36.4865"}, {"pmid": "16611896", "authors": "  Saito K, Meyer K, Warner R, Basu A, Ray RB, Ray R", "title": "Hepatitis C virus core protein inhibits tumor necrosis factor alpha-mediated apoptosis by a protective effect involving cellular FLICE inhibitory protein.", "journal": "J Virol 80:4372-9 (2006)", "doi": "10.1128/JVI.80.9.4372-4379.2006"}, {"pmid": "19148799", "authors": "  Koike K", "title": "Steatosis, liver injury, and hepatocarcinogenesis in hepatitis C viral infection.", "journal": "J Gastroenterol 44 Suppl 19:82-8 (2009)", "doi": "10.1007/s00535-008-2276-4"}, {"pmid": "17764115", "authors": "  Tanaka N, Moriya K, Kiyosawa K, Koike K, Aoyama T", "title": "Hepatitis C virus core protein induces spontaneous and persistent activation of peroxisome proliferator-activated receptor alpha in transgenic mice: implications for HCV-associated hepatocarcinogenesis.", "journal": "Int J Cancer 122:124-31 (2008)", "doi": "10.1002/ijc.23056"}], "rel_pathway": ["hsa03320  PPAR signaling pathway", "hsa04010  MAPK signaling pathway", "hsa04144  Endocytosis", "hsa04210  Apoptosis", "hsa04514  Cell adhesion molecules", "hsa04620  Toll-like receptor signaling pathway", "hsa04622  RIG-I-like receptor signaling pathway", "hsa04630  JAK-STAT signaling pathway", "hsa04668  TNF signaling pathway"], "ko_pathway": "ko05160", "genes": ["EGFR", "TP53", "BRAF", "AKT2", "AKT1", "SOS1", "NRAS", "BAX"]}, {"kegg_id": "hsa05163", "name": "Human cytomegalovirus infection - Homo sapiens (human)", "description": "Human cytomegalovirus (HCMV) is an enveloped, double-stranded DNA virus that is a member of beta-herpesvirus family. HCMV is best known for causing significant morbidity and mortality in immunocompromised populations. As with other herpesviruses, HCMV gB and gH/gL envelope glycoproteins are essential for virus entry. HCMV gB could activate the PDGFRA, and induce activation of the oncogenic PI3-K/AKT pathway. Though it is unlikely that HCMV by itself can act as an oncogenic factor, HCMV may have an oncomodulatory role, to catalyze an oncogenic process that has already been initiated. US28, one of the four HCMV-encoded vGPCRs (US27, US28, UL33 and UL78), also has a specific role in the oncomodulatory properties. In addition, HCMV has developed numerous mechanisms for manipulating the host immune system. The virally encoded US2, US3, US6 and US11 gene products all interfere with major histocompatibility complex (MHC) class I antigen presentation. HCMV encodes several immediate early (IE) antiapoptotic proteins (IE1, IE2, vMIA and vICA). These proteins might avoid immune clearance of infected tumor cells by cytotoxic lymphocytes and NK cells.", "class": "Human Diseases; Infectious disease: viral", "pathway_map": "hsa05163  Human cytomegalovirus infection", "network": ["", "ELEMENT   N00385  HCMV gB to PDGFR-PI3K signaling pathway", "N00386  HCMV gB to PDGFR-RAS-ERK signaling pathway", "N00387  HCMV IE1-72/IE2-86 to PI3K signaling pathway", "N00388  HCMV UL38 to MTOR signaling pathway", "N00389  HCMV IE1-72 to transcription", "N00391  HCMV gB to EGFR-PI3K-NFKB signaling pathway", "N00392  HCMV gB to EGFR-RAS-ERK signaling pathway", "N00394  HCMV gH to ITGA/B-RhoA signaling pathway", "N00396  HCMV UL82 to cGAS-STING signaling pathway", "N00397  HCMV UL26 to NFKB signaling pathway", "N00398  HCMV IE2-86 to TNF-NFKB signaling pathway", "N00400  HCMV US28 to GNB/G-PI3K-NFKB signaling pathway", "N00402  HCMV US28 to GNAQ-PLCB/G-calcineurin signaling pathway", "N00404  HCMV US28 to GNAI-AC-PKA signaling pathway", "N00406  HCMV US28 to GNA12/13-Rho signaling pathway", "N00407  HCMV UL33 to GNAQ-PLCB/G-calcineurin signaling pathway", "N00409  HCMV UL33 to GNB/G-Rho signaling pathway", "N00411  HCMV UL33 to GNAS-AC-PKA signaling pathway", "N00412  HCMV UL33 to GNAI-AC-PKA signaling pathway", "N00414  HCMV US27 to CXCR4-GNB/G-PLCB-PKC signaling pathway", "N00416  HCMV vIL10 to IL10-JAK-STAT signaling pathway", "N00417  HCMV US6 to antigen processing and presentation by MHC class I molecules", "N00418  HCMV US2/11 to antigen processing and presentation by MHC class I molecules", "N00419  HCMV US3/10 to antigen processing and presentation by MHC class I molecules", "N00420  HCMV IE2-86 to p21-cell cycle G1/S", "N00421  HCMV IE2-86 to p21-cell cycle G1/S", "N00422  HCMV IE2-86 to cell cycle G1/S", "N00423  HCMV IE1-72 to cell cycle G1/S", "N00424  HCMV pp71 to cell cycle G1/S", "N00425  HCMV UL36 to crosstalk between extrinsic and intrinsic apoptotic pathways", "N00426  HCMV UL37x1 to crosstalk between extrinsic and intrinsic apoptotic pathways", "N00427  HCMV vCXCL to CXCR-GNB/G-PI3K-AKT signaling pathway", "N00429  HCMV UL22A to CCR5-GNB/G-PLCB/G-PKC signaling pathway"], "disease": ["H00368  Cytomegalovirus infection"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["5156  PDGFRA; platelet derived growth factor receptor alpha [KO:K04363] [EC:2.7.10.1]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "7248  TSC1; TSC complex subunit 1 [KO:K07206]", "7249  TSC2; TSC complex subunit 2 [KO:K07207]", "6009  RHEB; Ras homolog, mTORC1 binding [KO:K07208]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "1978  EIF4EBP1; eukaryotic translation initiation factor 4E binding protein 1 [KO:K07205]", "6198  RPS6KB1; ribosomal protein S6 kinase B1 [KO:K04688] [EC:2.7.11.1]", "6199  RPS6KB2; ribosomal protein S6 kinase B2 [KO:K04688] [EC:2.7.11.1]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "2002  ELK1; ETS transcription factor ELK1 [KO:K04375]", "6667  SP1; Sp1 transcription factor [KO:K04684]", "3685  ITGAV; integrin subunit alpha V [KO:K06487]", "3690  ITGB3; integrin subunit beta 3 [KO:K06493]", "6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "5880  RAC2; Rac family small GTPase 2 [KO:K07860]", "5881  RAC3; Rac family small GTPase 3 [KO:K07861]", "387  RHOA; ras homolog family member A [KO:K04513]", "115004  CGAS; cyclic GMP-AMP synthase [KO:K17834] [EC:2.7.7.86]", "340061  STING1; stimulator of interferon response cGAMP interactor 1 [KO:K12654]", "29110  TBK1; TANK binding kinase 1 [KO:K05410] [EC:2.7.11.10]", "3661  IRF3; interferon regulatory factor 3 [KO:K05411]", "3439  IFNA1; interferon alpha 1 [KO:K05414]", "3440  IFNA2; interferon alpha 2 [KO:K05414]", "3441  IFNA4; interferon alpha 4 [KO:K05414]", "3442  IFNA5; interferon alpha 5 [KO:K05414]", "3443  IFNA6; interferon alpha 6 [KO:K05414]", "3444  IFNA7; interferon alpha 7 [KO:K05414]", "3445  IFNA8; interferon alpha 8 [KO:K05414]", "3446  IFNA10; interferon alpha 10 [KO:K05414]", "3447  IFNA13; interferon alpha 13 [KO:K05414]", "3448  IFNA14; interferon alpha 14 [KO:K05414]", "3449  IFNA16; interferon alpha 16 [KO:K05414]", "3451  IFNA17; interferon alpha 17 [KO:K05414]", "3452  IFNA21; interferon alpha 21 [KO:K05414]", "3456  IFNB1; interferon beta 1 [KO:K05415]", "7124  TNF; tumor necrosis factor [KO:K03156]", "7132  TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158]", "8737  RIPK1; receptor interacting serine/threonine kinase 1 [KO:K02861] [EC:2.7.11.1]", "8717  TRADD; TNFRSF1A associated via death domain [KO:K03171]", "7188  TRAF5; TNF receptor associated factor 5 [KO:K09849]", "7186  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]", "3553  IL1B; interleukin 1 beta [KO:K04519]", "3554  IL1R1; interleukin 1 receptor type 1 [KO:K04386]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "6347  CCL2; C-C motif chemokine ligand 2 [KO:K14624]", "6352  CCL5; C-C motif chemokine ligand 5 [KO:K12499]", "3576  CXCL8; C-X-C motif chemokine ligand 8 [KO:K10030]", "3569  IL6; interleukin 6 [KO:K05405]", "2782  GNB1; G protein subunit beta 1 [KO:K04536]", "2783  GNB2; G protein subunit beta 2 [KO:K04537]", "2784  GNB3; G protein subunit beta 3 [KO:K07825]", "59345  GNB4; G protein subunit beta 4 [KO:K04538]", "10681  GNB5; G protein subunit beta 5 [KO:K04539]", "54331  GNG2; G protein subunit gamma 2 [KO:K07826]", "2785  GNG3; G protein subunit gamma 3 [KO:K04540]", "2786  GNG4; G protein subunit gamma 4 [KO:K04541]", "2787  GNG5; G protein subunit gamma 5 [KO:K04542]", "2788  GNG7; G protein subunit gamma 7 [KO:K04543]", "94235  GNG8; G protein subunit gamma 8 [KO:K04544]", "2790  GNG10; G protein subunit gamma 10 [KO:K04545]", "2791  GNG11; G protein subunit gamma 11 [KO:K04546]", "55970  GNG12; G protein subunit gamma 12 [KO:K04347]", "51764  GNG13; G protein subunit gamma 13 [KO:K04547]", "2792  GNGT1; G protein subunit gamma transducin 1 [KO:K04548]", "2793  GNGT2; G protein subunit gamma transducin 2 [KO:K04549]", "2776  GNAQ; G protein subunit alpha q [KO:K04634]", "2767  GNA11; G protein subunit alpha 11 [KO:K04635]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "810  CALML3; calmodulin like 3 [KO:K02183]", "805  CALM2; calmodulin 2 [KO:K02183]", "808  CALM3; calmodulin 3 [KO:K02183]", "801  CALM1; calmodulin 1 [KO:K02183]", "163688  CALML6; calmodulin like 6 [KO:K02183]", "51806  CALML5; calmodulin like 5 [KO:K02183]", "91860  CALML4; calmodulin like 4 [KO:K02183]", "5530  PPP3CA; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]", "5532  PPP3CB; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]", "5533  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]", "5534  PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]", "5535  PPP3R2; protein phosphatase 3 regulatory subunit B, beta [KO:K06268]", "4772  NFATC1; nuclear factor of activated T cells 1 [KO:K04446]", "4773  NFATC2; nuclear factor of activated T cells 2 [KO:K17332]", "4775  NFATC3; nuclear factor of activated T cells 3 [KO:K17333]", "4776  NFATC4; nuclear factor of activated T cells 4 [KO:K17334]", "5743  PTGS2; prostaglandin-endoperoxide synthase 2 [KO:K11987] [EC:1.14.99.1]", "2770  GNAI1; G protein subunit alpha i1 [KO:K04630]", "2773  GNAI3; G protein subunit alpha i3 [KO:K04630]", "2771  GNAI2; G protein subunit alpha i2 [KO:K04630]", "2775  GNAO1; G protein subunit alpha o1 [KO:K04534]", "107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]", "108  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]", "109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]", "196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]", "113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]", "114  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]", "115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "6348  CCL3; C-C motif chemokine ligand 3 [KO:K05408]", "6349  CCL3L1; C-C motif chemokine ligand 3 like 1 [KO:K05408]", "414062  CCL3L3; C-C motif chemokine ligand 3 like 3 [KO:K05408]", "6351  CCL4; C-C motif chemokine ligand 4 [KO:K12964]", "9560  CCL4L2; C-C motif chemokine ligand 4 like 2 [KO:K12964]", "388372  CCL4L1; C-C motif chemokine ligand 4 like 1 [KO:K12964]", "6376  CX3CL1; C-X3-C motif chemokine ligand 1 [KO:K05508]", "2768  GNA12; G protein subunit alpha 12 [KO:K04346]", "10672  GNA13; G protein subunit alpha 13 [KO:K04639]", "9138  ARHGEF1; Rho guanine nucleotide exchange factor 1 [KO:K12330]", "9826  ARHGEF11; Rho guanine nucleotide exchange factor 11 [KO:K12331]", "23365  ARHGEF12; Rho guanine nucleotide exchange factor 12 [KO:K07532]", "11214  AKAP13; A-kinase anchoring protein 13 [KO:K16529]", "6093  ROCK1; Rho associated coiled-coil containing protein kinase 1 [KO:K04514] [EC:2.7.11.1]", "9475  ROCK2; Rho associated coiled-coil containing protein kinase 2 [KO:K17388] [EC:2.7.11.1]", "1499  CTNNB1; catenin beta 1 [KO:K02105]", "5731  PTGER1; prostaglandin E receptor 1 [KO:K04258]", "5732  PTGER2; prostaglandin E receptor 2 [KO:K04259]", "5733  PTGER3; prostaglandin E receptor 3 [KO:K04260]", "5734  PTGER4; prostaglandin E receptor 4 [KO:K04261]", "2778  GNAS; GNAS complex locus [KO:K04632]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "595  CCND1; cyclin D1 [KO:K04503]", "4609  MYC; MYC proto-oncogene, bHLH transcription factor [KO:K04377]", "3570  IL6R; interleukin 6 receptor [KO:K05055]", "3716  JAK1; Janus kinase 1 [KO:K11217] [EC:2.7.10.2]", "6774  STAT3; signal transducer and activator of transcription 3 [KO:K04692]", "7422  VEGFA; vascular endothelial growth factor A [KO:K05448]", "5608  MAP2K6; mitogen-activated protein kinase kinase 6 [KO:K04433] [EC:2.7.12.2]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]", "1386  ATF2; activating transcription factor 2 [KO:K04450]", "468  ATF4; activating transcription factor 4 [KO:K04374]", "10488  CREB3; cAMP responsive element binding protein 3 [KO:K09048]", "90993  CREB3L1; cAMP responsive element binding protein 3 like 1 [KO:K09048]", "64764  CREB3L2; cAMP responsive element binding protein 3 like 2 [KO:K09048]", "84699  CREB3L3; cAMP responsive element binding protein 3 like 3 [KO:K09048]", "148327  CREB3L4; cAMP responsive element binding protein 3 like 4 [KO:K09048]", "9586  CREB5; cAMP responsive element binding protein 5 [KO:K09047]", "1388  ATF6B; activating transcription factor 6 beta [KO:K09049]", "6387  CXCL12; C-X-C motif chemokine ligand 12 [KO:K10031]", "7852  CXCR4; C-X-C motif chemokine receptor 4 [KO:K04189]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "2185  PTK2B; protein tyrosine kinase 2 beta [KO:K05871] [EC:2.7.10.2]", "5747  PTK2; protein tyrosine kinase 2 [KO:K05725] [EC:2.7.10.2]", "9564  BCAR1; BCAR1 scaffold protein, Cas family member [KO:K05726]", "1398  CRK; CRK proto-oncogene, adaptor protein [KO:K04438]", "1399  CRKL; CRK like proto-oncogene, adaptor protein [KO:K04438]", "5829  PXN; paxillin [KO:K05760]", "3587  IL10RA; interleukin 10 receptor subunit alpha [KO:K05134]", "3588  IL10RB; interleukin 10 receptor subunit beta [KO:K05135]", "3579  CXCR2; C-X-C motif chemokine receptor 2 [KO:K05050]", "1230  CCR1; C-C motif chemokine receptor 1 [KO:K04176]", "1232  CCR3; C-C motif chemokine receptor 3 [KO:K04178]", "1234  CCR5; C-C motif chemokine receptor 5 [KO:K04180]", "6890  TAP1; transporter 1, ATP binding cassette subfamily B member [KO:K05653] [EC:7.4.2.14]", "6891  TAP2; transporter 2, ATP binding cassette subfamily B member [KO:K05654] [EC:7.4.2.14]", "6892  TAPBP; TAP binding protein [KO:K08058]", "2923  PDIA3; protein disulfide isomerase family A member 3 [KO:K08056] [EC:5.3.4.1]", "811  CALR; calreticulin [KO:K08057]", "3105  HLA-A; major histocompatibility complex, class I, A [KO:K06751]", "3106  HLA-B; major histocompatibility complex, class I, B [KO:K06751]", "3107  HLA-C; major histocompatibility complex, class I, C [KO:K06751]", "3134  HLA-F; major histocompatibility complex, class I, F [KO:K06751]", "3135  HLA-G; major histocompatibility complex, class I, G [KO:K06751]", "3133  HLA-E; major histocompatibility complex, class I, E [KO:K06751]", "567  B2M; beta-2-microglobulin [KO:K08055]", "1029  CDKN2A; cyclin dependent kinase inhibitor 2A [KO:K06621]", "4193  MDM2; MDM2 proto-oncogene [KO:K06643] [EC:2.3.2.27]", "7157  TP53; tumor protein p53 [KO:K04451]", "1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]", "1019  CDK4; cyclin dependent kinase 4 [KO:K02089] [EC:2.7.11.22]", "1021  CDK6; cyclin dependent kinase 6 [KO:K02091] [EC:2.7.11.22]", "5925  RB1; RB transcriptional corepressor 1 [KO:K06618]", "1869  E2F1; E2F transcription factor 1 [KO:K17454]", "1870  E2F2; E2F transcription factor 2 [KO:K09389]", "1871  E2F3; E2F transcription factor 3 [KO:K06620]", "356  FASLG; Fas ligand [KO:K04389]", "355  FAS; Fas cell surface death receptor [KO:K04390]", "8772  FADD; Fas associated via death domain [KO:K02373]", "841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]", "637  BID; BH3 interacting domain death agonist [KO:K04726]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "578  BAK1; BCL2 antagonist/killer 1 [KO:K14021]", "54205  CYCS; cytochrome c, somatic [KO:K08738]", "842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]"], "compound": ["C00076  Calcium cation", "C00165  Diacylglycerol", "C00584  Prostaglandin E2", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C05981  Phosphatidylinositol-3,4,5-trisphosphate", "C20640  Cyclic GMP-AMP"], "refs": [{"pmid": "19107226", "authors": "  Michaelis M, Doerr HW, Cinatl J", "title": "The story of human cytomegalovirus and cancer: increasing evidence and open questions.", "journal": "Neoplasia 11:1-9 (2009)", "doi": "10.1593/neo.81178"}, {"pmid": "24839861", "authors": "  Roy S, Arav-Boger R", "title": "New cell-signaling pathways for controlling cytomegalovirus replication.", "journal": "Am J Transplant 14:1249-58 (2014)", "doi": "10.1111/ajt.12725"}, {"pmid": "14720582", "authors": "  Cinatl J, Scholz M, Kotchetkov R, Vogel JU, Doerr HW", "title": "Molecular mechanisms of the modulatory effects of HCMV infection in tumor cell biology.", "journal": "Trends Mol Med 10:19-23 (2004)", "doi": "10.1016/j.molmed.2003.11.002"}, {"pmid": "15380778", "authors": "  Evers DL, Wang X, Huang ES", "title": "Cellular stress and signal transduction responses to human cytomegalovirus infection.", "journal": "Microbes Infect 6:1084-93 (2004)", "doi": "10.1016/j.micinf.2004.05.026"}, {"pmid": "29547547", "authors": "  Murray MJ, Peters NE, Reeves MB", "title": "Navigating the Host Cell Response during Entry into Sites of Latent Cytomegalovirus Infection.", "journal": "Pathogens 7:E30 (2018)", "doi": "10.3390/pathogens7010030"}, {"pmid": "27501260", "authors": "  Campadelli-Fiume G, Collins-McMillen D, Gianni T, Yurochko AD", "title": "Integrins as Herpesvirus Receptors and Mediators of the Host Signalosome.", "journal": "Annu Rev Virol 3:215-236 (2016)", "doi": "10.1146/annurev-virology-110615-035618"}, {"pmid": "28132838", "authors": "  Fu YZ, Su S, Gao YQ, Wang PP, Huang ZF, Hu MM, Luo WW, Li S, Luo MH, Wang YY, Shu HB", "title": "Human Cytomegalovirus Tegument Protein UL82 Inhibits STING-Mediated Signaling to Evade Antiviral Immunity.", "journal": "Cell Host Microbe 21:231-243 (2017)", "doi": "10.1016/j.chom.2017.01.001"}, {"pmid": "21383764", "authors": "  Rahman MM, McFadden G", "title": "Modulation of NF-kappaB signalling by microbial pathogens.", "journal": "Nat Rev Microbiol 9:291-306 (2011)", "doi": "10.1038/nrmicro2539"}, {"pmid": "27060663", "authors": "  Zhang J, Feng H, Xu S, Feng P", "title": "Hijacking GPCRs by viral pathogens and tumor.", "journal": "Biochem Pharmacol 114:69-81 (2016)", "doi": "10.1016/j.bcp.2016.03.021"}, {"pmid": "28035083", "authors": "  Lee S, Chung YH, Lee C", "title": "US28, a Virally-Encoded GPCR as an Antiviral Target for Human Cytomegalovirus Infection.", "journal": "Biomol Ther (Seoul) 25:69-79 (2017)", "doi": "10.4062/biomolther.2016.208"}, {"pmid": "23145028", "authors": "  Langemeijer EV, Slinger E, de Munnik S, Schreiber A, Maussang D, Vischer H, Verkaar F, Leurs R, Siderius M, Smit MJ", "title": "Constitutive beta-catenin signaling by the viral chemokine receptor US28.", "journal": "PLoS One 7:e48935 (2012)", "doi": "10.1371/journal.pone.0048935"}, {"pmid": "15990176", "authors": "  Couty JP, Gershengorn MC", "title": "G-protein-coupled receptors encoded by human herpesviruses.", "journal": "Trends Pharmacol Sci 26:405-11 (2005)", "doi": "10.1016/j.tips.2005.06.004"}, {"pmid": "25549333", "authors": "  Fiallos E, Judkins J, Matlaf L, Prichard M, Dittmer D, Cobbs C, Soroceanu L", "title": "Human cytomegalovirus gene expression in long-term infected glioma stem cells.", "journal": "PLoS One 9:e116178 (2014)", "doi": "10.1371/journal.pone.0116178"}, {"pmid": "24445563", "authors": "  Vischer HF, Siderius M, Leurs R, Smit MJ", "title": "Herpesvirus-encoded GPCRs: neglected players in inflammatory and proliferative diseases?", "journal": "Nat Rev Drug Discov 13:123-39 (2014)", "doi": "10.1038/nrd4189"}, {"pmid": "20398729", "authors": "  Slinger E, Langemeijer E, Siderius M, Vischer HF, Smit MJ", "title": "Herpesvirus-encoded GPCRs rewire cellular signaling.", "journal": "Mol Cell Endocrinol 331:179-84 (2011)", "doi": "10.1016/j.mce.2010.04.007"}, {"pmid": "11175803", "authors": "  Murphy PM", "title": "Viral exploitation and subversion of the immune system through chemokine mimicry.", "journal": "Nat Immunol 2:116-22 (2001)", "doi": "10.1038/84214"}, {"pmid": "16352349", "authors": "  Vischer HF, Leurs R, Smit MJ", "title": "HCMV-encoded G-protein-coupled receptors as constitutively active modulators of cellular signaling networks.", "journal": "Trends Pharmacol Sci 27:56-63 (2006)", "doi": "10.1016/j.tips.2005.11.006"}, {"pmid": "25805993", "authors": "  de Munnik SM, Smit MJ, Leurs R, Vischer HF", "title": "Modulation of cellular signaling by herpesvirus-encoded G protein-coupled receptors.", "journal": "Front Pharmacol 6:40 (2015)", "doi": "10.3389/fphar.2015.00040"}, {"pmid": "15172446", "authors": "  Michelson S", "title": "Consequences of human cytomegalovirus mimicry.", "journal": "Hum Immunol 65:465-75 (2004)", "doi": "10.1016/j.humimm.2004.02.002"}, {"pmid": "29237840", "authors": "  Tu CC, Arnolds KL, O'Connor CM, Spencer JV", "title": "Human Cytomegalovirus UL111A and US27 Gene Products Enhance the CXCL12/CXCR4 Signaling Axis via Distinct Mechanisms.", "journal": "J Virol 92:e01981-17 (2018)", "doi": "10.1128/JVI.01981-17"}, {"pmid": "17169327", "authors": "  Busillo JM, Benovic JL", "title": "Regulation of CXCR4 signaling.", "journal": "Biochim Biophys Acta 1768:952-63 (2007)", "doi": "10.1016/j.bbamem.2006.11.002"}, {"pmid": "22454101", "authors": "  Noriega V, Redmann V, Gardner T, Tortorella D", "title": "Diverse immune evasion strategies by human cytomegalovirus.", "journal": "Immunol Res 54:140-51 (2012)", "doi": "10.1007/s12026-012-8304-8"}, {"pmid": "17145306", "authors": "  Loureiro J, Ploegh HL", "title": "Antigen presentation and the ubiquitin-proteasome system in host-pathogen interactions.", "journal": "Adv Immunol 92:225-305 (2006)", "doi": "10.1016/S0065-2776(06)92006-9"}, {"pmid": "10707064", "authors": "  Fortunato EA, McElroy AK, Sanchez I, Spector DH", "title": "Exploitation of cellular signaling and regulatory pathways by human cytomegalovirus.", "journal": "Trends Microbiol 8:111-9 (2000)", "doi": "10.1016/S0966-842X(00)01699-1"}, {"pmid": "15389728", "authors": "  Cinatl J Jr, Scholz M, Doerr HW", "title": "Role of tumor cell immune escape mechanisms in cytomegalovirus-mediated oncomodulation.", "journal": "Med Res Rev 25:167-85 (2005)", "doi": "10.1002/med.20018"}, {"pmid": "14975530", "authors": "  Cinatl J Jr, Vogel JU, Kotchetkov R, Wilhelm Doerr H", "title": "Oncomodulatory signals by regulatory proteins encoded by human cytomegalovirus: a novel role for viral infection in tumor progression.", "journal": "FEMS Microbiol Rev 28:59-77 (2004)", "doi": "10.1016/j.femsre.2003.07.005"}, {"pmid": "12062798", "authors": "  Castillo JP, Kowalik TF", "title": "Human cytomegalovirus immediate early proteins and cell growth control.", "journal": "Gene 290:19-34 (2002)", "doi": "10.1016/S0378-1119(02)00566-8"}, {"pmid": "15352160", "authors": "  Kalejta RF", "title": "Human cytomegalovirus pp71: a new viral tool to probe the mechanisms of cell cycle progression and oncogenesis controlled by the retinoblastoma family of tumor suppressors.", "journal": "J Cell Biochem 93:37-45 (2004)", "doi": "10.1002/jcb.20177"}, {"pmid": "20969904", "authors": "  Brune W", "title": "Inhibition of programmed cell death by cytomegaloviruses.", "journal": "Virus Res 157:144-50 (2011)", "doi": "10.1016/j.virusres.2010.10.012"}, {"pmid": "28869497", "authors": "  Brune W, Andoniou CE", "title": "Die Another Day: Inhibition of Cell Death Pathways by Cytomegalovirus.", "journal": "Viruses 9:E249 (2017)", "doi": "10.3390/v9090249"}, {"pmid": "27160907", "authors": "  Yamin R, Lecker LSM, Weisblum Y, Vitenshtein A, Le-Trilling VTK, Wolf DG, Mandelboim O", "title": "HCMV vCXCL1 Binds Several Chemokine Receptors and Preferentially Attracts Neutrophils over NK Cells by Interacting with CXCR2.", "journal": "Cell Rep 15:1542-1553 (2016)", "doi": "10.1016/j.celrep.2016.04.042"}], "rel_pathway": ["hsa00590  Arachidonic acid metabolism", "hsa03050  Proteasome", "hsa04010  MAPK signaling pathway", "hsa04064  NF-kappa B signaling pathway", "hsa04110  Cell cycle", "hsa04150  mTOR signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04210  Apoptosis", "hsa04612  Antigen processing and presentation", "hsa04623  Cytosolic DNA-sensing pathway", "hsa04630  JAK-STAT signaling pathway", "hsa04668  TNF signaling pathway", "hsa04810  Regulation of actin cytoskeleton"], "ko_pathway": "ko05163", "genes": ["EGFR", "RAC1", "TP53", "AKT2", "AKT1", "SOS1", "MAPK13", "NRAS", "BAX"]}, {"kegg_id": "hsa05171", "name": "Coronavirus disease - COVID-19 - Homo sapiens (human)", "description": "Coronavirus disease of 2019 (COVID-19) is a highly contagious respiratory infection that is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 infects alveolar epithelial cells [mainly alveolar epithelial type 2 (AEC2) cells] through the angiotensin-converting enzyme 2 (ACE2) receptor. Upon the occupancy of ACE2 by SARS-CoV-2, the increased serum level of free Angiotensin II (Ang II) due to a reduction of ACE2-mediated degradation promotes activation of the NF-kappa B pathway via Ang II type 1 receptor (AT1R), followed by  interleukin-6 (IL-6) production. SARS-CoV-2 also activates the innate immune system; macrophage stimulation triggers the overproduction of pro-inflammatory cytokines, including IL-6, and the \"cytokine storm\", which results in systemic inflammatory response syndrome and multiple organ failure. The combined effects of complement activation, dysregulated neutrophilia, endothelial injury, and hypercoagulability appear to be intertwined to drive the severe features of COVID-19.", "class": "Human Diseases; Infectious disease: viral", "pathway_map": "hsa05171  Coronavirus disease - COVID-19", "network": ["", "ELEMENT   N01307  SARS-CoV-2 S to AngII-AT1R-NOX2 signaling pathway", "N01309  SARS-CoV-2 nsp3 to MDA5-IRF7/3 signaling pathway", "N01310  SARS-CoV-2 nsp13 to RIG-I-IRF7/3 signaling pathway", "N01312  SARS-CoV-2 S to lectin pathway of complement cascade", "N01314  SARS-CoV-2 S to classical pathway of complement cascade", "N01316  SARS-CoV-2 S/N to lectin pathway of coagulation cascade", "N01318  SARS-CoV-2 nsp1 to translation initiation", "N01319  SARS-CoV-2 nsp6 and ORF6 to RIG-I-IRF7/3 signaling pathway", "N01320  SARS-CoV-2 nsp3 to RIG-I-IRF7/3 signaling pathway", "N01321  SARS-CoV-2 nsp1/6/13, ORF3a/6/7b and M to IFN signaling pathway", "N01322  SARS-CoV-2 nsp6/13 and ORF7a/7b to IFN signaling pathway"], "disease": ["H02398  COVID-19"], "drug": ["D10308  Baricitinib (JAN/USAN/INN)", "D12118  Nezulcitinib (USAN)", "D12261  Enpatoran (USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["7113  TMPRSS2; transmembrane serine protease 2 [KO:K09633] [EC:3.4.21.122]", "59272  ACE2; angiotensin converting enzyme 2 [KO:K09708] [EC:3.4.17.23]", "8829  NRP1; neuropilin 1 [KO:K06724]", "1636  ACE; angiotensin I converting enzyme [KO:K01283] [EC:3.4.15.1]", "4142  MAS1; MAS1 proto-oncogene, G protein-coupled receptor [KO:K04303]", "185  AGTR1; angiotensin II receptor type 1 [KO:K04166]", "1536  CYBB; cytochrome b-245 beta chain [KO:K21421] [EC:1.-.-.-]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "7124  TNF; tumor necrosis factor [KO:K03156]", "3569  IL6; interleukin 6 [KO:K05405]", "3553  IL1B; interleukin 1 beta [KO:K04519]", "3592  IL12A; interleukin 12A [KO:K05406]", "3593  IL12B; interleukin 12B [KO:K05425]", "4314  MMP3; matrix metallopeptidase 3 [KO:K01394] [EC:3.4.24.17]", "4312  MMP1; matrix metallopeptidase 1 [KO:K01388] [EC:3.4.24.7]", "6347  CCL2; C-C motif chemokine ligand 2 [KO:K14624]", "3576  CXCL8; C-X-C motif chemokine ligand 8 [KO:K10030]", "6868  ADAM17; ADAM metallopeptidase domain 17 [KO:K06059] [EC:3.4.24.86]", "7132  TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "4793  NFKBIB; NFKB inhibitor beta [KO:K02581]", "1839  HBEGF; heparin binding EGF like growth factor [KO:K08523]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "3570  IL6R; interleukin 6 receptor [KO:K05055]", "3572  IL6ST; interleukin 6 cytokine family signal transducer [KO:K05060]", "3716  JAK1; Janus kinase 1 [KO:K11217] [EC:2.7.10.2]", "7297  TYK2; tyrosine kinase 2 [KO:K11219] [EC:2.7.10.2]", "6774  STAT3; signal transducer and activator of transcription 3 [KO:K04692]", "3558  IL2; interleukin 2 [KO:K05429]", "1440  CSF3; colony stimulating factor 3 [KO:K05423]", "1437  CSF2; colony stimulating factor 2 [KO:K05427]", "3627  CXCL10; C-X-C motif chemokine ligand 10 [KO:K12671]", "6187  RPS2; ribosomal protein S2 [KO:K02981]", "6188  RPS3; ribosomal protein S3 [KO:K02985]", "6189  RPS3A; ribosomal protein S3A [KO:K02984]", "6192  RPS4Y1; ribosomal protein S4 Y-linked 1 [KO:K02987]", "6191  RPS4X; ribosomal protein S4 X-linked [KO:K02987]", "140032  RPS4Y2; ribosomal protein S4 Y-linked 2 [KO:K02987]", "6193  RPS5; ribosomal protein S5 [KO:K02989]", "6194  RPS6; ribosomal protein S6 [KO:K02991]", "6201  RPS7; ribosomal protein S7 [KO:K02993]", "6202  RPS8; ribosomal protein S8 [KO:K02995]", "6203  RPS9; ribosomal protein S9 [KO:K02997]", "6204  RPS10; ribosomal protein S10 [KO:K02947]", "100529239  RPS10-NUDT3; RPS10-NUDT3 readthrough [KO:K02947]", "6205  RPS11; ribosomal protein S11 [KO:K02949]", "6206  RPS12; ribosomal protein S12 [KO:K02951]", "6207  RPS13; ribosomal protein S13 [KO:K02953]", "6208  RPS14; ribosomal protein S14 [KO:K02955]", "6209  RPS15; ribosomal protein S15 [KO:K02958]", "6210  RPS15A; ribosomal protein S15a [KO:K02957]", "6217  RPS16; ribosomal protein S16 [KO:K02960]", "6218  RPS17; ribosomal protein S17 [KO:K02962]", "6222  RPS18; ribosomal protein S18 [KO:K02964]", "6223  RPS19; ribosomal protein S19 [KO:K02966]", "6224  RPS20; ribosomal protein S20 [KO:K02969]", "6227  RPS21; ribosomal protein S21 [KO:K02971]", "6228  RPS23; ribosomal protein S23 [KO:K02973]", "6229  RPS24; ribosomal protein S24 [KO:K02974]", "6230  RPS25; ribosomal protein S25 [KO:K02975]", "6231  RPS26; ribosomal protein S26 [KO:K02976]", "6232  RPS27; ribosomal protein S27 [KO:K02978]", "51065  RPS27L; ribosomal protein S27 like [KO:K02978]", "6233  RPS27A; ribosomal protein S27a [KO:K02977]", "6234  RPS28; ribosomal protein S28 [KO:K02979]", "6235  RPS29; ribosomal protein S29 [KO:K02980]", "2197  FAU; FAU ubiquitin like and ribosomal protein S30 fusion [KO:K02983]", "3921  RPSA; ribosomal protein SA [KO:K02998]", "388524  RPSA2; ribosomal protein SA 2 [KO:K02998]", "6123  RPL3L; ribosomal protein L3 like [KO:K02925]", "6122  RPL3; ribosomal protein L3 [KO:K02925]", "6124  RPL4; ribosomal protein L4 [KO:K02930]", "6125  RPL5; ribosomal protein L5 [KO:K02932]", "6128  RPL6; ribosomal protein L6 [KO:K02934]", "6129  RPL7; ribosomal protein L7 [KO:K02937]", "6130  RPL7A; ribosomal protein L7a [KO:K02936]", "6132  RPL8; ribosomal protein L8 [KO:K02938]", "6133  RPL9; ribosomal protein L9 [KO:K02940]", "140801  RPL10L; ribosomal protein L10 like [KO:K02866]", "6134  RPL10; ribosomal protein L10 [KO:K02866]", "4736  RPL10A; ribosomal protein L10a [KO:K02865]", "6135  RPL11; ribosomal protein L11 [KO:K02868]", "6136  RPL12; ribosomal protein L12 [KO:K02870]", "6137  RPL13; ribosomal protein L13 [KO:K02873]", "23521  RPL13A; ribosomal protein L13a [KO:K02872]", "9045  RPL14; ribosomal protein L14 [KO:K02875]", "6138  RPL15; ribosomal protein L15 [KO:K02877]", "6139  RPL17; ribosomal protein L17 [KO:K02880]", "100526842  RPL17-C18orf32; RPL17-C18orf32 readthrough [KO:K02880]", "6141  RPL18; ribosomal protein L18 [KO:K02883]", "6142  RPL18A; ribosomal protein L18a [KO:K02882]", "6143  RPL19; ribosomal protein L19 [KO:K02885]", "6144  RPL21; ribosomal protein L21 [KO:K02889]", "200916  RPL22L1; ribosomal protein L22 like 1 [KO:K02891]", "6146  RPL22; ribosomal protein L22 [KO:K02891]", "9349  RPL23; ribosomal protein L23 [KO:K02894]", "6147  RPL23A; ribosomal protein L23a [KO:K02893]", "51187  RSL24D1; ribosomal L24 domain containing 1 [KO:K02896]", "6152  RPL24; ribosomal protein L24 [KO:K02896]", "6154  RPL26; ribosomal protein L26 [KO:K02898]", "51121  RPL26L1; ribosomal protein L26 like 1 [KO:K02898]", "6155  RPL27; ribosomal protein L27 [KO:K02901]", "6157  RPL27A; ribosomal protein L27a [KO:K02900]", "6158  RPL28; ribosomal protein L28 [KO:K02903]", "6159  RPL29; ribosomal protein L29 [KO:K02905]", "6156  RPL30; ribosomal protein L30 [KO:K02908]", "6160  RPL31; ribosomal protein L31 [KO:K02910]", "6161  RPL32; ribosomal protein L32 [KO:K02912]", "6164  RPL34; ribosomal protein L34 [KO:K02915]", "11224  RPL35; ribosomal protein L35 [KO:K02918]", "6165  RPL35A; ribosomal protein L35a [KO:K02917]", "25873  RPL36; ribosomal protein L36 [KO:K02920]", "6167  RPL37; ribosomal protein L37 [KO:K02922]", "6168  RPL37A; ribosomal protein L37a [KO:K02921]", "6169  RPL38; ribosomal protein L38 [KO:K02923]", "6170  RPL39; ribosomal protein L39 [KO:K02924]", "7311  UBA52; ubiquitin A-52 residue ribosomal protein fusion product 1 [KO:K02927]", "6171  RPL41; ribosomal protein L41 [KO:K02928]", "6166  RPL36AL; ribosomal protein L36a like [KO:K02929]", "6173  RPL36A; ribosomal protein L36a [KO:K02929]", "100529097  RPL36A-HNRNPH2; RPL36A-HNRNPH2 readthrough [KO:K02929]", "6175  RPLP0; ribosomal protein lateral stalk subunit P0 [KO:K02941]", "6176  RPLP1; ribosomal protein lateral stalk subunit P1 [KO:K02942]", "6181  RPLP2; ribosomal protein lateral stalk subunit P2 [KO:K02943]", "102723407  IGH; immunoglobulin heavy variable 4-38-2-like [KO:K06856]", "2212  FCGR2A; Fc gamma receptor IIa [KO:K06472]", "6850  SYK; spleen associated tyrosine kinase [KO:K05855] [EC:2.7.10.2]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "7097  TLR2; toll like receptor 2 [KO:K10159]", "7099  TLR4; toll like receptor 4 [KO:K10160]", "4615  MYD88; MYD88 innate immune signal transduction adaptor [KO:K04729]", "51284  TLR7; toll like receptor 7 [KO:K05404]", "51311  TLR8; toll like receptor 8 [KO:K10170]", "51135  IRAK4; interleukin 1 receptor associated kinase 4 [KO:K04733] [EC:2.7.11.1]", "3654  IRAK1; interleukin 1 receptor associated kinase 1 [KO:K04730] [EC:2.7.11.1]", "7189  TRAF6; TNF receptor associated factor 6 [KO:K03175] [EC:2.3.2.27]", "6885  MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO:K04427] [EC:2.7.11.25]", "23118  TAB2; TGF-beta activated kinase 1 (MAP3K7) binding protein 2 [KO:K04404]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "114548  NLRP3; NLR family pyrin domain containing 3 [KO:K12800]", "834  CASP1; caspase 1 [KO:K01370] [EC:3.4.22.36]", "7098  TLR3; toll like receptor 3 [KO:K05401]", "23586  RIGI; RNA sensor RIG-I [KO:K12646] [EC:5.6.2.6]", "9636  ISG15; ISG15 ubiquitin like modifier [KO:K12159]", "64135  IFIH1; interferon induced with helicase C domain 1 [KO:K12647] [EC:5.6.2.6]", "57506  MAVS; mitochondrial antiviral signaling protein [KO:K12648]", "7187  TRAF3; TNF receptor associated factor 3 [KO:K03174]", "9641  IKBKE; inhibitor of nuclear factor kappa B kinase subunit epsilon [KO:K07211] [EC:2.7.11.10]", "29110  TBK1; TANK binding kinase 1 [KO:K05410] [EC:2.7.11.10]", "3661  IRF3; interferon regulatory factor 3 [KO:K05411]", "115004  CGAS; cyclic GMP-AMP synthase [KO:K17834] [EC:2.7.7.86]", "340061  STING1; stimulator of interferon response cGAMP interactor 1 [KO:K12654]", "3439  IFNA1; interferon alpha 1 [KO:K05414]", "3440  IFNA2; interferon alpha 2 [KO:K05414]", "3441  IFNA4; interferon alpha 4 [KO:K05414]", "3442  IFNA5; interferon alpha 5 [KO:K05414]", "3443  IFNA6; interferon alpha 6 [KO:K05414]", "3444  IFNA7; interferon alpha 7 [KO:K05414]", "3445  IFNA8; interferon alpha 8 [KO:K05414]", "3446  IFNA10; interferon alpha 10 [KO:K05414]", "3447  IFNA13; interferon alpha 13 [KO:K05414]", "3448  IFNA14; interferon alpha 14 [KO:K05414]", "3449  IFNA16; interferon alpha 16 [KO:K05414]", "3451  IFNA17; interferon alpha 17 [KO:K05414]", "3452  IFNA21; interferon alpha 21 [KO:K05414]", "3456  IFNB1; interferon beta 1 [KO:K05415]", "3454  IFNAR1; interferon alpha and beta receptor subunit 1 [KO:K05130]", "3455  IFNAR2; interferon alpha and beta receptor subunit 2 [KO:K05131]", "6772  STAT1; signal transducer and activator of transcription 1 [KO:K11220]", "6773  STAT2; signal transducer and activator of transcription 2 [KO:K11221]", "10379  IRF9; interferon regulatory factor 9 [KO:K04693]", "103  ADAR; adenosine deaminase RNA specific [KO:K12968] [EC:3.5.4.37]", "4938  OAS1; 2'-5'-oligoadenylate synthetase 1 [KO:K14216] [EC:2.7.7.84]", "4939  OAS2; 2'-5'-oligoadenylate synthetase 2 [KO:K14216] [EC:2.7.7.84]", "4940  OAS3; 2'-5'-oligoadenylate synthetase 3 [KO:K14216] [EC:2.7.7.84]", "4599  MX1; MX dynamin like GTPase 1 [KO:K14754]", "4600  MX2; MX dynamin like GTPase 2 [KO:K14754]", "5610  EIF2AK2; eukaryotic translation initiation factor 2 alpha kinase 2 [KO:K16195] [EC:2.7.11.1]", "728  C5AR1; complement C5a receptor 1 [KO:K04010]", "719  C3AR1; complement C3a receptor 1 [KO:K04009]", "718  C3; complement C3 [KO:K03990]", "629  CFB; complement factor B [KO:K01335] [EC:3.4.21.47]", "1675  CFD; complement factor D [KO:K01334] [EC:3.4.21.46]", "727  C5; complement C5 [KO:K03994]", "729  C6; complement C6 [KO:K03995]", "730  C7; complement C7 [KO:K03996]", "731  C8A; complement C8 alpha chain [KO:K03997]", "732  C8B; complement C8 beta chain [KO:K03998]", "733  C8G; complement C8 gamma chain [KO:K03999]", "735  C9; complement C9 [KO:K04000]", "6403  SELP; selectin P [KO:K06496]", "7450  VWF; von Willebrand factor [KO:K03900]", "712  C1QA; complement C1q A chain [KO:K03986]", "713  C1QB; complement C1q B chain [KO:K03987]", "714  C1QC; complement C1q C chain [KO:K03988]", "715  C1R; complement C1r [KO:K01330] [EC:3.4.21.41]", "716  C1S; complement C1s [KO:K01331] [EC:3.4.21.42]", "717  C2; complement C2 [KO:K01332] [EC:3.4.21.43]", "720  C4A; complement C4A (Chido/Rodgers blood group) [KO:K03989]", "721  C4B; complement C4B (Chido/Rodgers blood group) [KO:K03989]", "4153  MBL2; mannose binding lectin 2 [KO:K03991]", "5648  MASP1; MBL associated serine protease 1 [KO:K03992] [EC:3.4.21.-]", "10747  MASP2; MBL associated serine protease 2 [KO:K03993] [EC:3.4.21.104]", "2147  F2; coagulation factor II, thrombin [KO:K01313] [EC:3.4.21.5]", "2162  F13A1; coagulation factor XIII A chain [KO:K03917] [EC:2.3.2.13]", "2165  F13B; coagulation factor XIII B chain [KO:K03906]", "2243  FGA; fibrinogen alpha chain [KO:K03903]", "2244  FGB; fibrinogen beta chain [KO:K03904]", "2266  FGG; fibrinogen gamma chain [KO:K03905]"], "compound": ["C00027  Hydrogen peroxide", "C00046  RNA", "C00165  Diacylglycerol", "C00290  Fibrin", "C00533  Nitric oxide", "C00704  Superoxide", "C00873  Angiotensin I", "C02135  Angiotensin II", "C15850  Angiotensin (1-7)", "C20640  Cyclic GMP-AMP"], "refs": [{"pmid": "33132005", "authors": "  Harrison AG, Lin T, Wang P", "title": "Mechanisms of SARS-CoV-2 Transmission and Pathogenesis.", "journal": "Trends Immunol S1471-4906(20)30233-7 (2020)", "doi": "10.1016/j.it.2020.10.004"}, {"pmid": "33077917", "authors": "  Perico L, Benigni A, Casiraghi F, Ng LFP, Renia L, Remuzzi G", "title": "Immunity, endothelial injury and complement-induced coagulopathy in COVID-19.", "journal": "Nat Rev Nephrol 10.1038/s41581-020-00357-4 (2020)", "doi": "10.1038/s41581-020-00357-4"}, {"pmid": "32820801", "authors": "  Battagello DS, Dragunas G, Klein MO, Ayub ALP, Velloso FJ, Correa RG", "title": "Unpuzzling COVID-19: tissue-related signaling pathways associated with SARS-CoV-2 infection and transmission.", "journal": "Clin Sci (Lond) 134:2137-2160 (2020)", "doi": "10.1042/CS20200904"}, {"pmid": "32353634", "authors": "  Felsenstein S, Herbert JA, McNamara PS, Hedrich CM", "title": "COVID-19: Immunology and treatment options.", "journal": "Clin Immunol 215:108448 (2020)", "doi": "10.1016/j.clim.2020.108448"}, {"pmid": "33014208", "authors": "  Hojyo S, Uchida M, Tanaka K, Hasebe R, Tanaka Y, Murakami M, Hirano T", "title": "How COVID-19 induces cytokine storm with high mortality.", "journal": "Inflamm Regen 40:37 (2020)", "doi": "10.1186/s41232-020-00146-3"}, {"pmid": "32544563", "authors": "  Mahmudpour M, Roozbeh J, Keshavarz M, Farrokhi S, Nabipour I", "title": "COVID-19 cytokine storm: The anger of inflammation.", "journal": "Cytokine 133:155151 (2020)", "doi": "10.1016/j.cyto.2020.155151"}, {"pmid": "32635353", "authors": "  Farooqi F, Dhawan N, Morgan R, Dinh J, Nedd K, Yatzkan G", "title": "Treatment of Severe COVID-19 with Tocilizumab Mitigates Cytokine Storm and Averts Mechanical Ventilation During Acute Respiratory Distress: A Case Report and Literature Review.", "journal": "Trop Med Infect Dis 5:E112 (2020)", "doi": "10.3390/tropicalmed5030112"}, {"pmid": "32376392", "authors": "  Jamilloux Y, Henry T, Belot A, Viel S, Fauter M, El Jammal T, Walzer T, Francois B, Seve P", "title": "Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions.", "journal": "Autoimmun Rev 19:102567 (2020)", "doi": "10.1016/j.autrev.2020.102567"}, {"pmid": "32722596", "authors": "  Kiselevskiy M, Shubina I, Chikileva I, Sitdikova S, Samoylenko I, Anisimova N, Kirgizov K, Suleimanova A, Gorbunova T, Varfolomeeva S", "title": "Immune Pathogenesis of COVID-19 Intoxication: Storm or Silence?", "journal": "Pharmaceuticals (Basel) 13:E166 (2020)", "doi": "10.3390/ph13080166"}, {"pmid": "32922297", "authors": "  Curran CS, Rivera DR, Kopp JB", "title": "COVID-19 Usurps Host Regulatory Networks.", "journal": "Front Pharmacol 11:1278 (2020)", "doi": "10.3389/fphar.2020.01278"}, {"pmid": "33055229", "authors": "  Quan C, Li C, Ma H, Li Y, Zhang H", "title": "Immunopathogenesis of Coronavirus-Induced Acute Respiratory Distress Syndrome (ARDS): Potential Infection-Associated Hemophagocytic Lymphohistiocytosis.", "journal": "Clin Microbiol Rev 34:e00074-20 (2020)", "doi": "10.1128/CMR.00074-20"}, {"pmid": "32973803", "authors": "  Ahmed-Hassan H, Sisson B, Shukla RK, Wijewantha Y, Funderburg NT, Li Z, Hayes D Jr, Demberg T, Liyanage NPM", "title": "Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections.", "journal": "Front Immunol 11:1979 (2020)", "doi": "10.3389/fimmu.2020.01979"}, {"pmid": "32346093", "authors": "  Tay MZ, Poh CM, Renia L, MacAry PA, Ng LFP", "title": "The trinity of COVID-19: immunity, inflammation and intervention.", "journal": "Nat Rev Immunol 20:363-374 (2020)", "doi": "10.1038/s41577-020-0311-8"}, {"pmid": "32979938", "authors": "  Xia H, Cao Z, Xie X, Zhang X, Chen JY, Wang H, Menachery VD, Rajsbaum R, Shi PY", "title": "Evasion of Type I Interferon by SARS-CoV-2.", "journal": "Cell Rep 33:108234 (2020)", "doi": "10.1016/j.celrep.2020.108234"}, {"pmid": "32661197", "authors": "  Hartenian E, Nandakumar D, Lari A, Ly M, Tucker JM, Glaunsinger BA", "title": "The molecular virology of coronaviruses.", "journal": "J Biol Chem 295:12910-12934 (2020)", "doi": "10.1074/jbc.REV120.013930"}, {"pmid": "32978971", "authors": "  Amor S, Fernandez Blanco L, Baker D", "title": "Innate immunity during SARS-CoV-2: evasion strategies and activation trigger hypoxia and vascular damage.", "journal": "Clin Exp Immunol 202:193-209 (2020)", "doi": "10.1111/cei.13523"}, {"pmid": "32467561", "authors": "  Catanzaro M, Fagiani F, Racchi M, Corsini E, Govoni S, Lanni C", "title": "Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2.", "journal": "Signal Transduct Target Ther 5:84 (2020)", "doi": "10.1038/s41392-020-0191-1"}, {"pmid": "32687918", "authors": "  Jafarzadeh A, Chauhan P, Saha B, Jafarzadeh S, Nemati M", "title": "Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions.", "journal": "Life Sci 257:118102 (2020)", "doi": "10.1016/j.lfs.2020.118102"}, {"pmid": "32376901", "authors": "  Merad M, Martin JC", "title": "Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages.", "journal": "Nat Rev Immunol 20:355-362 (2020)", "doi": "10.1038/s41577-020-0331-4"}, {"pmid": "32246101", "authors": "  South AM, Tomlinson L, Edmonston D, Hiremath S, Sparks MA", "title": "Controversies of renin-angiotensin system inhibition during the COVID-19 pandemic.", "journal": "Nat Rev Nephrol 16:305-307 (2020)", "doi": "10.1038/s41581-020-0279-4"}, {"pmid": "32433641", "authors": "  Furuhashi M, Moniwa N, Takizawa H, Ura N, Shimamoto K", "title": "Potential differential effects of renin-angiotensin system inhibitors on SARS-CoV-2 infection and lung injury in COVID-19.", "journal": "Hypertens Res 43:837-840 (2020)", "doi": "10.1038/s41440-020-0478-1"}, {"pmid": "32423094", "authors": "  Gemmati D, Bramanti B, Serino ML, Secchiero P, Zauli G, Tisato V", "title": "COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?", "journal": "Int J Mol Sci 21:E3474 (2020)", "doi": "10.3390/ijms21103474"}, {"pmid": "33184193", "authors": "  Kielian M", "title": "Enhancing host cell infection by SARS-CoV-2.", "journal": "Science 370:765-766 (2020)", "doi": "10.1126/science.abf0732"}, {"pmid": "32327719", "authors": "  Risitano AM, Mastellos DC, Huber-Lang M, Yancopoulou D, Garlanda C, Ciceri F, Lambris JD", "title": "Complement as a target in COVID-19?", "journal": "Nat Rev Immunol 20:343-344 (2020)", "doi": "10.1038/s41577-020-0320-7"}, {"pmid": "32461141", "authors": "  Noris M, Benigni A, Remuzzi G", "title": "The case of complement activation in COVID-19 multiorgan impact.", "journal": "Kidney Int 98:314-322 (2020)", "doi": "10.1016/j.kint.2020.05.013"}, {"pmid": "32559343", "authors": "  Polycarpou A, Howard M, Farrar CA, Greenlaw R, Fanelli G, Wallis R, Klavinskis LS, Sacks S", "title": "Rationale for targeting complement in COVID-19.", "journal": "EMBO Mol Med 12:e12642 (2020)", "doi": "10.15252/emmm.202012642"}, {"pmid": "32439870", "authors": "  Teuwen LA, Geldhof V, Pasut A, Carmeliet P", "title": "COVID-19: the vasculature unleashed.", "journal": "Nat Rev Immunol 20:389-391 (2020)", "doi": "10.1038/s41577-020-0343-0"}, {"pmid": "32643798", "authors": "  Jodele S, Kohl J", "title": "Tackling COVID-19 infection through complement-targeted immunotherapy.", "journal": "Br J Pharmacol 178:2832-2848 (2021)", "doi": "10.1111/bph.15187"}, {"pmid": "32608159", "authors": "  Chauhan AJ, Wiffen LJ, Brown TP", "title": "COVID-19: A collision of complement, coagulation and inflammatory pathways.", "journal": "J Thromb Haemost 18:2110-2117 (2020)", "doi": "10.1111/jth.14981"}, {"pmid": "32558620", "authors": "  Colling ME, Kanthi Y", "title": "COVID-19-associated coagulopathy: An exploration of mechanisms.", "journal": "Vasc Med 25:471-478 (2020)", "doi": "10.1177/1358863X20932640"}, {"pmid": "32586214", "authors": "  McFadyen JD, Stevens H, Peter K", "title": "The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications.", "journal": "Circ Res 127:571-587 (2020)", "doi": "10.1161/CIRCRESAHA.120.317447"}, {"pmid": "32995777", "authors": "  Shi M, Wang L, Fontana P, Vora S, Zhang Y, Fu TM, Lieberman J, Wu H", "title": "SARS-CoV-2 Nsp1 suppresses host but not viral translation through a bipartite mechanism.", "journal": "bioRxiv 2020.09.18.302901 (2020)", "doi": "10.1101/2020.09.18.302901"}, {"pmid": "32693241", "authors": "  Paniri A, Akhavan-Niaki H", "title": "Emerging role of IL-6 and NLRP3 inflammasome as potential therapeutic targets to combat COVID-19: Role of lncRNAs in cytokine storm modulation.", "journal": "Life Sci 257:118114 (2020)", "doi": "10.1016/j.lfs.2020.118114"}, {"pmid": "32405269", "authors": "  Omarjee L, Janin A, Perrot F, Laviolle B, Meilhac O, Mahe G", "title": "Targeting T-cell senescence and cytokine storm with rapamycin to prevent severe progression in COVID-19.", "journal": "Clin Immunol 216:108464 (2020)", "doi": "10.1016/j.clim.2020.108464"}], "rel_pathway": ["hsa03015  mRNA surveillance pathway", "hsa04144  Endocytosis", "hsa04270  Vascular smooth muscle contraction", "hsa04610  Complement and coagulation cascades", "hsa04611  Platelet activation", "hsa04613  Neutrophil extracellular trap formation", "hsa04614  Renin-angiotensin system", "hsa04620  Toll-like receptor signaling pathway", "hsa04621  NOD-like receptor signaling pathway", "hsa04622  RIG-I-like receptor signaling pathway", "hsa04623  Cytosolic DNA-sensing pathway", "hsa04630  JAK-STAT signaling pathway", "hsa04650  Natural killer cell mediated cytotoxicity", "hsa04666  Fc gamma R-mediated phagocytosis", "hsa04668  TNF signaling pathway", "hsa04670  Leukocyte transendothelial migration"], "ko_pathway": "ko05171", "genes": ["EGFR", "MAPK13"]}, {"kegg_id": "hsa05207", "name": "Chemical carcinogenesis - receptor activation - Homo sapiens (human)", "description": "Carcinogenesis is a multistage process that consists of initiation, promotion, and progression stages. Chemicals or environmental factors may act at any of these stages to induce and/or enhance the carcinogenic process. Based on their mode-of-action, carcinogens can be classified as genotoxic or non-genotoxic. Genotoxic agent begins their action at the deoxyribonucleic acid (DNA) level, causing DNA damage through several mechanisms. Non-genotoxic carcinogens are chemicals that cause the development of tumors through multiple non-genotoxic events and epigenetic alterations without direct interaction with DNA. One non-genotoxic mechanism involves receptor activation. Biological mechanisms involving receptor activation fall into two broad categories: (i) those that involve cell surface receptors and some intracellular receptors that activate signal transduction pathways, resulting in biological responses, including gene transcription, and (ii) those that involve intracellular receptors that translocate into the nucleus and act as transcription factors regulating gene expression. Both classes of receptors can be involved in mechanisms of carcinogenesis.", "class": "Human Diseases; Cancer: overview", "pathway_map": "hsa05207  Chemical carcinogenesis - receptor activation", "network": ["", "ELEMENT   N01337  NNK/NNN to CHRNA7-E2F signaling pathway", "N01339  NNK/NNN to PI3K signaling pathway", "N01341  NNK/NNN to Jak-STAT signaling pathway", "N01342  Nicotine to Jak-STAT signaling pathway", "N01344  NNK/NNN to RAS-ERK signaling pathway", "N01346  Nicotine/NNK to cAMP signaling pathway", "N01348  Nicotine/NNK to PI3K signaling pathway", "N01350  NNK/NNN to PI3K signaling pathway", "N01352  BPA to RAS-ERK signaling pathway", "N01353  E2 to RAS-ERK signaling pathway", "N01354  BPA to RAS-ERK signaling pathway", "N01355  Arsenic to PI3K signaling pathway", "N01357  P4/MPA to membrane-initiated progesterone signaling pathway", "N01359  P4/MPA to PR-PI3K signaling pathway", "N01361  P4/MPA to PR-RAS-ERK signaling pathway", "N01363  P4/MPA to nuclear-initiated progesterone signaling pathway", "N01364  E2 to nuclear-initiated estrogen signaling pathway", "N01365  TCDD to Ahr signaling pathway", "N01366  BaP to Ahr signaling pathway", "N01367  PCB to Ahr signaling pathway", "N01368  HCB to Ahr signaling pathway"], "drug": ["D11045  Darolutamide (JAN/USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["1139  CHRNA7; cholinergic receptor nicotinic alpha 7 subunit [KO:K04809]", "408  ARRB1; arrestin beta 1 [KO:K04439]", "409  ARRB2; arrestin beta 2 [KO:K04439]", "6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5925  RB1; RB transcriptional corepressor 1 [KO:K06618]", "1869  E2F1; E2F transcription factor 1 [KO:K17454]", "332  BIRC5; baculoviral IAP repeat containing 5 [KO:K08731]", "331  XIAP; X-linked inhibitor of apoptosis [KO:K04725] [EC:2.3.2.27]", "990  CDC6; cell division cycle 6 [KO:K02213]", "993  CDC25A; cell division cycle 25A [KO:K06645] [EC:3.1.3.48]", "3717  JAK2; Janus kinase 2 [KO:K04447] [EC:2.7.10.2]", "6774  STAT3; signal transducer and activator of transcription 3 [KO:K04692]", "9641  IKBKE; inhibitor of nuclear factor kappa B kinase subunit epsilon [KO:K07211] [EC:2.7.11.10]", "595  CCND1; cyclin D1 [KO:K04503]", "1137  CHRNA4; cholinergic receptor nicotinic alpha 4 subunit [KO:K04806]", "1141  CHRNB2; cholinergic receptor nicotinic beta 2 subunit [KO:K04813]", "1136  CHRNA3; cholinergic receptor nicotinic alpha 3 subunit [KO:K04805]", "1143  CHRNB4; cholinergic receptor nicotinic beta 4 subunit [KO:K04815]", "775  CACNA1C; calcium voltage-gated channel subunit alpha1 C [KO:K04850]", "776  CACNA1D; calcium voltage-gated channel subunit alpha1 D [KO:K04851]", "778  CACNA1F; calcium voltage-gated channel subunit alpha1 F [KO:K04853]", "779  CACNA1S; calcium voltage-gated channel subunit alpha1 S [KO:K04857]", "774  CACNA1B; calcium voltage-gated channel subunit alpha1 B [KO:K04849]", "773  CACNA1A; calcium voltage-gated channel subunit alpha1 A [KO:K04344]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "4609  MYC; MYC proto-oncogene, bHLH transcription factor [KO:K04377]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "7422  VEGFA; vascular endothelial growth factor A [KO:K05448]", "2247  FGF2; fibroblast growth factor 2 [KO:K18497]", "153  ADRB1; adrenoceptor beta 1 [KO:K04141]", "154  ADRB2; adrenoceptor beta 2 [KO:K04142]", "155  ADRB3; adrenoceptor beta 3 [KO:K04143]", "2778  GNAS; GNAS complex locus [KO:K04632]", "107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]", "108  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]", "109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]", "196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]", "113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]", "114  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]", "115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]", "1386  ATF2; activating transcription factor 2 [KO:K04450]", "468  ATF4; activating transcription factor 4 [KO:K04374]", "10488  CREB3; cAMP responsive element binding protein 3 [KO:K09048]", "90993  CREB3L1; cAMP responsive element binding protein 3 like 1 [KO:K09048]", "64764  CREB3L2; cAMP responsive element binding protein 3 like 2 [KO:K09048]", "84699  CREB3L3; cAMP responsive element binding protein 3 like 3 [KO:K09048]", "148327  CREB3L4; cAMP responsive element binding protein 3 like 4 [KO:K09048]", "9586  CREB5; cAMP responsive element binding protein 5 [KO:K09047]", "1388  ATF6B; activating transcription factor 6 beta [KO:K09049]", "2770  GNAI1; G protein subunit alpha i1 [KO:K04630]", "2773  GNAI3; G protein subunit alpha i3 [KO:K04630]", "2771  GNAI2; G protein subunit alpha i2 [KO:K04630]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]", "55584  CHRNA9; cholinergic receptor nicotinic alpha 9 subunit [KO:K04810]", "6197  RPS6KA3; ribosomal protein S6 kinase A3 [KO:K04373] [EC:2.7.11.1]", "6195  RPS6KA1; ribosomal protein S6 kinase A1 [KO:K04373] [EC:2.7.11.1]", "6196  RPS6KA2; ribosomal protein S6 kinase A2 [KO:K04373] [EC:2.7.11.1]", "27330  RPS6KA6; ribosomal protein S6 kinase A6 [KO:K04373] [EC:2.7.11.1]", "2099  ESR1; estrogen receptor 1 [KO:K08550]", "2100  ESR2; estrogen receptor 2 [KO:K08551]", "7421  VDR; vitamin D receptor [KO:K08539]", "896  CCND3; cyclin D3 [KO:K10152]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "1978  EIF4EBP1; eukaryotic translation initiation factor 4E binding protein 1 [KO:K07205]", "6198  RPS6KB1; ribosomal protein S6 kinase B1 [KO:K04688] [EC:2.7.11.1]", "6199  RPS6KB2; ribosomal protein S6 kinase B2 [KO:K04688] [EC:2.7.11.1]", "164091  PAQR7; progestin and adipoQ receptor family member 7 [KO:K25039]", "85315  PAQR8; progestin and adipoQ receptor family member 8 [KO:K25040]", "54852  PAQR5; progestin and adipoQ receptor family member 5 [KO:K25041]", "5241  PGR; progesterone receptor [KO:K08556]", "8600  TNFSF11; TNF superfamily member 11 [KO:K05473]", "6776  STAT5A; signal transducer and activator of transcription 5A [KO:K11223]", "6777  STAT5B; signal transducer and activator of transcription 5B [KO:K11224]", "604  BCL6; BCL6 transcription repressor [KO:K15618]", "688  KLF5; KLF transcription factor 5 [KO:K09206]", "9314  KLF4; KLF transcription factor 4 [KO:K17846]", "7471  WNT1; Wnt family member 1 [KO:K03209]", "4853  NOTCH2; notch receptor 2 [KO:K20994]", "182  JAG1; jagged canonical Notch ligand 1 [KO:K06052]", "406933  MIR141; microRNA 141 [KO:K17018]", "407021  MIR29A; microRNA 29a [KO:K16995]", "407024  MIR29B1; microRNA 29b-1 [KO:K16996]", "407025  MIR29B2; microRNA 29b-2 [KO:K16996]", "407026  MIR29C; microRNA 29c [KO:K16997]", "367  AR; androgen receptor [KO:K08557]", "406881  MIRLET7A1; microRNA let-7a-1 [KO:K16980]", "406882  MIRLET7A2; microRNA let-7a-2 [KO:K16980]", "406883  MIRLET7A3; microRNA let-7a-3 [KO:K16980]", "406884  MIRLET7B; microRNA let-7b [KO:K16980]", "406886  MIRLET7D; microRNA let-7d [KO:K16980]", "406887  MIRLET7E; microRNA let-7e [KO:K16980]", "406888  MIRLET7F1; microRNA let-7f-1 [KO:K16980]", "406889  MIRLET7F2; microRNA let-7f-2 [KO:K16980]", "406890  MIRLET7G; microRNA let-7g [KO:K16980]", "406891  MIRLET7I; microRNA let-7i [KO:K16980]", "1950  EGF; epidermal growth factor [KO:K04357]", "2248  FGF3; fibroblast growth factor 3 [KO:K04358]", "2249  FGF4; fibroblast growth factor 4 [KO:K04358]", "8822  FGF17; fibroblast growth factor 17 [KO:K04358]", "2251  FGF6; fibroblast growth factor 6 [KO:K04358]", "2252  FGF7; fibroblast growth factor 7 [KO:K04358]", "2253  FGF8; fibroblast growth factor 8 [KO:K04358]", "2254  FGF9; fibroblast growth factor 9 [KO:K04358]", "2255  FGF10; fibroblast growth factor 10 [KO:K04358]", "8823  FGF16; fibroblast growth factor 16 [KO:K04358]", "2250  FGF5; fibroblast growth factor 5 [KO:K04358]", "8817  FGF18; fibroblast growth factor 18 [KO:K04358]", "26281  FGF20; fibroblast growth factor 20 [KO:K04358]", "27006  FGF22; fibroblast growth factor 22 [KO:K04358]", "10683  DLL3; delta like canonical Notch ligand 3 [KO:K06051]", "28514  DLL1; delta like canonical Notch ligand 1 [KO:K06051]", "54567  DLL4; delta like canonical Notch ligand 4 [KO:K06051]", "10728  PTGES3; prostaglandin E synthase 3 [KO:K15730] [EC:5.3.99.3]", "23746  AIPL1; aryl hydrocarbon receptor interacting protein like 1 [KO:K17767]", "9049  AIP; aryl hydrocarbon receptor interacting protein [KO:K17767]", "196  AHR; aryl hydrocarbon receptor [KO:K09093]", "3320  HSP90AA1; heat shock protein 90 alpha family class A member 1 [KO:K04079]", "3326  HSP90AB1; heat shock protein 90 alpha family class B member 1 [KO:K04079]", "7184  HSP90B1; heat shock protein 90 beta family member 1 [KO:K09487]", "3836  KPNA1; karyopherin subunit alpha 1 [KO:K23940]", "3838  KPNA2; karyopherin subunit alpha 2 [KO:K15043]", "402569  KPNA7; karyopherin subunit alpha 7 [KO:K15043]", "3839  KPNA3; karyopherin subunit alpha 3 [KO:K23583]", "3840  KPNA4; karyopherin subunit alpha 4 [KO:K23583]", "23633  KPNA6; karyopherin subunit alpha 6 [KO:K15042]", "3841  KPNA5; karyopherin subunit alpha 5 [KO:K15042]", "3837  KPNB1; karyopherin subunit beta 1 [KO:K14293]", "405  ARNT; aryl hydrocarbon receptor nuclear translocator [KO:K09097]", "1543  CYP1A1; cytochrome P450 family 1 subfamily A member 1 [KO:K07408] [EC:1.14.14.1]", "1545  CYP1B1; cytochrome P450 family 1 subfamily B member 1 [KO:K07410] [EC:1.14.14.1]", "2052  EPHX1; epoxide hydrolase 1 [KO:K01253] [EC:3.3.2.9]", "2053  EPHX2; epoxide hydrolase 2 [KO:K08726] [EC:3.3.2.10 3.1.3.76]", "79852  EPHX3; epoxide hydrolase 3 [KO:K22368] [EC:3.3.2.10]", "253152  EPHX4; epoxide hydrolase 4 [KO:K22369] [EC:3.3.-.-]", "221357  GSTA5; glutathione S-transferase alpha 5 [KO:K00799] [EC:2.5.1.18]", "2939  GSTA2; glutathione S-transferase alpha 2 [KO:K00799] [EC:2.5.1.18]", "2941  GSTA4; glutathione S-transferase alpha 4 [KO:K00799] [EC:2.5.1.18]", "119391  GSTO2; glutathione S-transferase omega 2 [KO:K00799] [EC:2.5.1.18]", "2948  GSTM4; glutathione S-transferase mu 4 [KO:K00799] [EC:2.5.1.18]", "2953  GSTT2; glutathione S-transferase theta 2 (gene/pseudogene) [KO:K00799] [EC:2.5.1.18]", "2952  GSTT1; glutathione S-transferase theta 1 [KO:K00799] [EC:2.5.1.18]", "2947  GSTM3; glutathione S-transferase mu 3 [KO:K00799] [EC:2.5.1.18]", "4257  MGST1; microsomal glutathione S-transferase 1 [KO:K00799] [EC:2.5.1.18]", "4259  MGST3; microsomal glutathione S-transferase 3 [KO:K00799] [EC:2.5.1.18]", "2944  GSTM1; glutathione S-transferase mu 1 [KO:K00799] [EC:2.5.1.18]", "2949  GSTM5; glutathione S-transferase mu 5 [KO:K00799] [EC:2.5.1.18]", "4258  MGST2; microsomal glutathione S-transferase 2 [KO:K00799] [EC:2.5.1.18]", "2938  GSTA1; glutathione S-transferase alpha 1 [KO:K00799] [EC:2.5.1.18]", "2946  GSTM2; glutathione S-transferase mu 2 [KO:K00799] [EC:2.5.1.18]", "2940  GSTA3; glutathione S-transferase alpha 3 [KO:K00799] [EC:2.5.1.18]", "9446  GSTO1; glutathione S-transferase omega 1 [KO:K00799] [EC:2.5.1.18]", "653689  GSTT2B; glutathione S-transferase theta 2B [KO:K00799] [EC:2.5.1.18]", "10941  UGT2A1; UDP glucuronosyltransferase family 2 member A1 complex locus [KO:K00699] [EC:2.4.1.17]", "79799  UGT2A3; UDP glucuronosyltransferase family 2 member A3 [KO:K00699] [EC:2.4.1.17]", "7367  UGT2B17; UDP glucuronosyltransferase family 2 member B17 [KO:K00699] [EC:2.4.1.17]", "10720  UGT2B11; UDP glucuronosyltransferase family 2 member B11 [KO:K00699] [EC:2.4.1.17]", "54490  UGT2B28; UDP glucuronosyltransferase family 2 member B28 [KO:K00699] [EC:2.4.1.17]", "54578  UGT1A6; UDP glucuronosyltransferase family 1 member A6 [KO:K00699] [EC:2.4.1.17]", "54657  UGT1A4; UDP glucuronosyltransferase family 1 member A4 [KO:K00699] [EC:2.4.1.17]", "54658  UGT1A1; UDP glucuronosyltransferase family 1 member A1 [KO:K00699] [EC:2.4.1.17]", "54659  UGT1A3; UDP glucuronosyltransferase family 1 member A3 [KO:K00699] [EC:2.4.1.17]", "7365  UGT2B10; UDP glucuronosyltransferase family 2 member B10 [KO:K00699] [EC:2.4.1.17]", "54600  UGT1A9; UDP glucuronosyltransferase family 1 member A9 [KO:K00699] [EC:2.4.1.17]", "7364  UGT2B7; UDP glucuronosyltransferase family 2 member B7 [KO:K00699] [EC:2.4.1.17]", "54575  UGT1A10; UDP glucuronosyltransferase family 1 member A10 [KO:K00699] [EC:2.4.1.17]", "54576  UGT1A8; UDP glucuronosyltransferase family 1 member A8 [KO:K00699] [EC:2.4.1.17]", "54579  UGT1A5; UDP glucuronosyltransferase family 1 member A5 [KO:K00699] [EC:2.4.1.17]", "7366  UGT2B15; UDP glucuronosyltransferase family 2 member B15 [KO:K00699] [EC:2.4.1.17]", "54577  UGT1A7; UDP glucuronosyltransferase family 1 member A7 [KO:K00699] [EC:2.4.1.17]", "7363  UGT2B4; UDP glucuronosyltransferase family 2 member B4 [KO:K00699] [EC:2.4.1.17]", "574537  UGT2A2; UDP glucuronosyltransferase family 2 member A2 [KO:K00699] [EC:2.4.1.17]", "1555  CYP2B6; cytochrome P450 family 2 subfamily B member 6 [KO:K17709] [EC:1.14.14.-]", "9970  NR1I3; nuclear receptor subfamily 1 group I member 3 [KO:K08541]", "6256  RXRA; retinoid X receptor alpha [KO:K08524]", "6257  RXRB; retinoid X receptor beta [KO:K08525]", "6258  RXRG; retinoid X receptor gamma [KO:K08526]", "1576  CYP3A4; cytochrome P450 family 3 subfamily A member 4 [KO:K17689] [EC:1.14.13.32 1.14.14.55 1.14.14.56 1.14.14.57 1.14.14.73 1.14.14.-]", "1544  CYP1A2; cytochrome P450 family 1 subfamily A member 2 [KO:K07409] [EC:1.14.14.1]", "5465  PPARA; peroxisome proliferator activated receptor alpha [KO:K07294]"], "compound": ["C00076  Calcium cation", "C00410  Progesterone", "C00547  L-Noradrenaline", "C00575  3',5'-Cyclic AMP", "C00745  Nicotine", "C00780  Serotonin", "C00788  L-Adrenaline", "C00951  Estradiol-17beta", "C03690  Bis(2-ethylhexyl)phthalate", "C04623  DDT", "C05981  Phosphatidylinositol-3,4,5-trisphosphate", "C06697  Arsenite", "C06790  Trichloroethene", "C06916  Clofibrate", "C07020  Gemfibrozil", "C07434  Phenobarbital", "C07535  Benzo[a]pyrene", "C07557  2,3,7,8-Tetrachlorodibenzodioxin", "C08150  Medroxyprogesterone acetate", "C11042  Hexachlorobenzene", "C11150  Trichloroacetate", "C11371  Nafenopin", "C11906  Sodium arsenite", "C13624  Bisphenol A", "C14240  Di(2-ethylhexyl) adipate", "C14573  3,3',4,4',5-Pentachlorobiphenyl", "C15995  Bombesin", "C16452  N'-Nitrosonornicotine", "C16453  4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone"], "refs": [{"pmid": "15660110", "authors": "  Luch A.", "title": "Nature and nurture - lessons from chemical carcinogenesis.", "journal": "Nat Rev Cancer 5:113-25 (2005)", "doi": "10.1038/nrc1546"}, {"pmid": "19631282", "authors": "  Hernandez LG, van Steeg H, Luijten M, van Benthem J", "title": "Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approach.", "journal": "Mutat Res 682:94-109 (2009)", "doi": "10.1016/j.mrrev.2009.07.002"}, {"pmid": "21444681", "authors": "  Wu CH, Lee CH, Ho YS", "title": "Nicotinic acetylcholine receptor-based blockade: applications of molecular targets for cancer therapy.", "journal": "Clin Cancer Res 17:3533-41 (2011)", "doi": "10.1158/1078-0432.CCR-10-2434"}, {"pmid": "19194381", "authors": "  Schuller HM", "title": "Is cancer triggered by altered signalling of nicotinic acetylcholine receptors?", "journal": "Nat Rev Cancer 9:195-205 (2009)", "doi": "10.1038/nrc2590"}, {"pmid": "21541211", "authors": "  Singh S, Pillai S, Chellappan S", "title": "Nicotinic acetylcholine receptor signaling in tumor growth and metastasis.", "journal": "J Oncol 2011:456743 (2011)", "doi": "10.1155/2011/456743"}, {"pmid": "31956359", "authors": "  Cheng WL, Chen KY, Lee KY, Feng PH, Wu SM", "title": "Nicotinic-nAChR signaling mediates drug resistance in lung cancer.", "journal": "J Cancer 11:1125-1140 (2020)", "doi": "10.7150/jca.36359"}, {"pmid": "24827506", "authors": "  Grando SA", "title": "Connections of nicotine to cancer.", "journal": "Nat Rev Cancer 14:419-29 (2014)", "doi": "10.1038/nrc3725"}, {"pmid": "24398389", "authors": "  Schaal C, Chellappan SP", "title": "Nicotine-mediated cell proliferation and tumor progression in smoking-related cancers.", "journal": "Mol Cancer Res 12:14-23 (2014)", "doi": "10.1158/1541-7786.MCR-13-0541"}, {"pmid": "21640716", "authors": "  Improgo MR, Tapper AR, Gardner PD", "title": "Nicotinic acetylcholine receptor-mediated mechanisms in lung cancer.", "journal": "Biochem Pharmacol 82:1015-21 (2011)", "doi": "10.1016/j.bcp.2011.05.020"}, {"pmid": "18262664", "authors": "  Egleton RD, Brown KC, Dasgupta P", "title": "Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and inhibition of apoptosis.", "journal": "Trends Pharmacol Sci 29:151-8 (2008)", "doi": "10.1016/j.tips.2007.12.006"}, {"pmid": "24830349", "authors": "  Xue J, Yang S, Seng S", "title": "Mechanisms of Cancer Induction by Tobacco-Specific NNK and NNN.", "journal": "Cancers (Basel) 6:1138-56 (2014)", "doi": "10.3390/cancers6021138"}, {"pmid": "21801603", "authors": "  Wen J, Fu JH, Zhang W, Guo M", "title": "Lung carcinoma signaling pathways activated by smoking.", "journal": "Chin J Cancer 30:551-8 (2011)", "doi": "10.5732/cjc.011.10059"}, {"pmid": "28664511", "authors": "  Gankhuyag N, Lee KH, Cho JY", "title": "The Role of Nitrosamine (NNK) in Breast Cancer Carcinogenesis.", "journal": "J Mammary Gland Biol Neoplasia 22:159-170 (2017)", "doi": "10.1007/s10911-017-9381-z"}, {"pmid": "22330135", "authors": "  Guo J, Kim D, Gao J, Kurtyka C, Chen H, Yu C, Wu D, Mittal A, Beg AA, Chellappan SP, Haura EB, Cheng JQ", "title": "IKBKE is induced by STAT3 and tobacco carcinogen and determines chemosensitivity in non-small cell lung cancer.", "journal": "Oncogene 32:151-9 (2013)", "doi": "10.1038/onc.2012.39"}, {"pmid": "20106947", "authors": "  Chen RJ, Ho YS, Guo HR, Wang YJ", "title": "Long-term nicotine exposure-induced chemoresistance is mediated by activation of Stat3 and downregulation of ERK1/2 via nAChR and beta-adrenoceptors in human bladder cancer cells.", "journal": "Toxicol Sci 115:118-30 (2010)", "doi": "10.1093/toxsci/kfq028"}, {"pmid": "20953833", "authors": "  Lee CH, Chang YC, Chen CS, Tu SH, Wang YJ, Chen LC, Chang YJ, Wei PL, Chang HW, Chang CH, Huang CS, Wu CH, Ho YS", "title": "Crosstalk between nicotine and estrogen-induced estrogen receptor activation induces alpha9-nicotinic acetylcholine receptor expression in human breast cancer cells.", "journal": "Breast Cancer Res Treat 129:331-45 (2011)", "doi": "10.1007/s10549-010-1209-0"}, {"pmid": "16421368", "authors": "  Yager JD, Davidson NE", "title": "Estrogen carcinogenesis in breast cancer.", "journal": "N Engl J Med 354:270-82 (2006)", "doi": "10.1056/NEJMra050776"}, {"pmid": "29229539", "authors": "  Murata M, Kang JH", "title": "Bisphenol A (BPA) and cell signaling pathways.", "journal": "Biotechnol Adv 36:311-327 (2018)", "doi": "10.1016/j.biotechadv.2017.12.002"}, {"pmid": "28251049", "authors": "  Wang Z, Liu H, Liu S", "title": "Low-Dose Bisphenol A Exposure: A Seemingly Instigating Carcinogenic Effect on Breast Cancer.", "journal": "Adv Sci (Weinh) 4:1600248 (2017)", "doi": "10.1002/advs.201600248"}, {"pmid": "28426875", "authors": "  Sauer SJ, Tarpley M, Shah I, Save AV, Lyerly HK, Patierno SR, Williams KP, Devi GR", "title": "Bisphenol A activates EGFR and ERK promoting proliferation, tumor spheroid formation and resistance to EGFR pathway inhibition in estrogen receptor-negative inflammatory breast cancer cells.", "journal": "Carcinogenesis 38:252-260 (2017)", "doi": "10.1093/carcin/bgx003"}, {"pmid": "29769245", "authors": "  Chen QY, Costa M", "title": "PI3K/Akt/mTOR Signaling Pathway and the Biphasic Effect of Arsenic in Carcinogenesis.", "journal": "Mol Pharmacol 94:784-792 (2018)", "doi": "10.1124/mol.118.112268"}, {"pmid": "32867363", "authors": "  Pedroza DA, Subramani R, Lakshmanaswamy R", "title": "Classical and Non-Classical Progesterone Signaling in Breast Cancers.", "journal": "Cancers (Basel) 12:E2440 (2020)", "doi": "10.3390/cancers12092440"}, {"pmid": "26265122", "authors": "  Finlay-Schultz J, Sartorius CA", "title": "Steroid hormones, steroid receptors, and breast cancer stem cells.", "journal": "J Mammary Gland Biol Neoplasia 20:39-50 (2015)", "doi": "10.1007/s10911-015-9340-5"}, {"pmid": "27368976", "authors": "  Valadez-Cosmes P, Vazquez-Martinez ER, Cerbon M, Camacho-Arroyo I", "title": "Membrane progesterone receptors in reproduction and cancer.", "journal": "Mol Cell Endocrinol 434:166-75 (2016)", "doi": "10.1016/j.mce.2016.06.027"}, {"pmid": "33014829", "authors": "  Chen B, Ye P, Chen Y, Liu T, Cha JH, Yan X, Yang WH", "title": "Involvement of the Estrogen and Progesterone Axis in Cancer Stemness: Elucidating Molecular Mechanisms and Clinical Significance.", "journal": "Front Oncol 10:1657 (2020)", "doi": "10.3389/fonc.2020.01657"}, {"pmid": "25568920", "authors": "  Murray IA, Patterson AD, Perdew GH", "title": "Aryl hydrocarbon receptor ligands in cancer: friend and foe.", "journal": "Nat Rev Cancer 14:801-14 (2014)", "doi": "10.1038/nrc3846"}, {"pmid": "30003042", "authors": "  Larigot L, Juricek L, Dairou J, Coumoul X", "title": "AhR signaling pathways and regulatory functions.", "journal": "Biochim Open 7:1-9 (2018)", "doi": "10.1016/j.biopen.2018.05.001"}, {"pmid": "27980293", "authors": "  Kawajiri K, Fujii-Kuriyama Y", "title": "The aryl hydrocarbon receptor: a multifunctional chemical sensor for host defense and homeostatic maintenance.", "journal": "Exp Anim 66:75-89 (2017)", "doi": "10.1538/expanim.16-0092"}, {"pmid": "31552251", "authors": "  Hidaka T, Fujimura T, Aiba S", "title": "Aryl Hydrocarbon Receptor Modulates Carcinogenesis and Maintenance of Skin Cancers.", "journal": "Front Med (Lausanne) 6:194 (2019)", "doi": "10.3389/fmed.2019.00194"}, {"pmid": "15900503", "authors": "  Mandal PK", "title": "Dioxin: a review of its environmental effects and its aryl hydrocarbon receptor biology.", "journal": "J Comp Physiol B 175:221-30 (2005)", "doi": "10.1007/s00360-005-0483-3"}, {"pmid": "30951959", "authors": "  Miret NV, Pontillo CA, Zarate LV, Kleiman de Pisarev D, Cocca C, Randi AS", "title": "Impact of endocrine disruptor hexachlorobenzene on the mammary gland and breast cancer: The story thus far.", "journal": "Environ Res 173:330-341 (2019)", "doi": "10.1016/j.envres.2019.03.054"}, {"pmid": "32526215", "authors": "  Zarate LV, Pontillo CA, Espanol A, Miret NV, Chiappini F, Cocca C, Alvarez L, de Pisarev DK, Sales ME, Randi AS", "title": "Angiogenesis signaling in breast cancer models is induced by hexachlorobenzene and chlorpyrifos, pesticide ligands of the aryl hydrocarbon receptor.", "journal": "Toxicol Appl Pharmacol 401:115093 (2020)", "doi": "10.1016/j.taap.2020.115093"}, {"pmid": "25257533", "authors": "  L'Heritier F, Marques M, Fauteux M, Gaudreau L", "title": "Defining molecular sensors to assess long-term effects of pesticides on carcinogenesis.", "journal": "Int J Mol Sci 15:17148-61 (2014)", "doi": "10.3390/ijms150917148"}, {"pmid": "17189671", "authors": "  Kitamura M, Kasai A", "title": "Cigarette smoke as a trigger for the dioxin receptor-mediated signaling pathway.", "journal": "Cancer Lett 252:184-94 (2007)", "doi": "10.1016/j.canlet.2006.11.015"}, {"pmid": "26600562", "authors": "  Smith MT, Guyton KZ, Gibbons CF, Fritz JM, Portier CJ, Rusyn I, DeMarini DM, Caldwell JC, Kavlock RJ, Lambert PF, Hecht SS, Bucher JR, Stewart BW, Baan RA, Cogliano VJ, Straif K", "title": "Key Characteristics of Carcinogens as a Basis for Organizing Data on Mechanisms of Carcinogenesis.", "journal": "Environ Health Perspect 124:713-21 (2016)", "doi": "10.1289/ehp.1509912"}, {"pmid": "31366862", "authors": "  Yoshinari K", "title": "Role of Nuclear Receptors PXR and CAR in Xenobiotic-Induced Hepatocyte Proliferation and Chemical Carcinogenesis.", "journal": "Biol Pharm Bull 42:1243-1252 (2019)", "doi": "10.1248/bpb.b19-00267"}, {"pmid": "26136231", "authors": "  Yoo HS, Cichocki JA, Kim S, Venkatratnam A, Iwata Y, Kosyk O, Bodnar W, Sweet S, Knap A, Wade T, Campbell J, Clewell HJ, Melnyk SB, Chiu WA, Rusyn I", "title": "The Contribution of Peroxisome Proliferator-Activated Receptor Alpha to the Relationship Between Toxicokinetics and Toxicodynamics of Trichloroethylene.", "journal": "Toxicol Sci 147:339-49 (2015)", "doi": "10.1093/toxsci/kfv134"}, {"pmid": "20414453", "authors": "  Pyper SR, Viswakarma N, Yu S, Reddy JK", "title": "PPARalpha: energy combustion, hypolipidemia, inflammation and cancer.", "journal": "Nucl Recept Signal 8:e002 (2010)", "doi": "10.1621/nrs.08002"}], "rel_pathway": ["hsa00980  Metabolism of xenobiotics by cytochrome P450", "hsa03320  PPAR signaling pathway", "hsa04010  MAPK signaling pathway", "hsa04024  cAMP signaling pathway", "hsa04150  mTOR signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04370  VEGF signaling pathway", "hsa04915  Estrogen signaling pathway", "hsa05204  Chemical carcinogenesis - DNA adducts", "hsa05206  MicroRNAs in cancer", "hsa05208  Chemical carcinogenesis - reactive oxygen species"], "ko_pathway": "ko05207", "genes": ["EGFR", "AKT2", "AKT1", "SOS1", "NRAS"]}, {"kegg_id": "hsa05210", "name": "Colorectal cancer - Homo sapiens (human)", "description": "Colorectal cancer (CRC) is the second largest cause of cancer-related deaths in Western countries. CRC arises from the colorectal epithelium as a result of the accumulation of genetic alterations in defined oncogenes and tumour suppressor genes (TSG). Two major mechanisms of genomic instability have been identified in sporadic CRC progression. The first, known as chromosomal instability (CIN), results from a series of genetic changes that involve the activation of oncogenes such as K-ras and inactivation of TSG such as p53, DCC/Smad4, and APC. The second, known as microsatellite instability (MSI), results from inactivation of the DNA mismatch repair genes MLH1 and/or MSH2 by hypermethylation of their promoter, and secondary mutation of genes with coding microsatellites, such as transforming growth factor receptor II (TGF-RII) and BAX. Hereditary syndromes have germline mutations in specific genes (mutation in the tumour suppressor gene APC on chromosome 5q in FAP, mutated DNA mismatch repair genes in HNPCC).", "class": "Human Diseases; Cancer: specific types", "pathway_map": "hsa05210  Colorectal cancer", "network": ["", "ELEMENT   N00012  Mutation-activated KRAS/NRAS to ERK signaling pathway", "N00032  Mutation-activated KRAS/NRAS to PI3K signaling pathway", "N00041  EGFR-overexpression to RAS-ERK signaling pathway", "N00042  EGFR-overexpression to PI3K signaling pathway", "N00057  Mutation-inactivated APC to Wnt signaling pathway", "N00058  Mutation-activated CTNNB1 to Wnt signaling pathway", "N00064  Mutation-inactivated TGFBR2 to TGF-beta signaling pathway", "N00065  Mutation-inactivated SMAD2 to TGF-beta signaling pathway", "N00099  Mutation-inactivated BAX to apoptotic pathway", "N00102  Loss of DCC to DCC-apoptotic pathway", "N00104  Mutation-activated KRAS to RalGDS signaling pathway", "N00115  Mutation-inactivated TP53 to transcription", "N00230  TGFA-overexpression to RAS-ERK signaling pathway", "N00232  TGFA-overexpression to PI3K signaling pathway", "N00276  EGF-overexpression to RAS-ERK signaling pathway", "N00278  EREG-overexpression to RAS-ERK signaling pathway", "N00280  AREG-overexpression to RAS-ERK signaling pathway", "N00281  EGF-overexpression to PI3K signaling pathway", "N00283  EREG-overexpression to PI3K signaling pathway", "N00285  AREG-overexpression to PI3K signaling pathway"], "disease": ["H00020  Colorectal cancer"], "drug": ["D10137  Regorafenib hydrate (JAN)", "D10138  Regorafenib (USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "8312  AXIN1; axin 1 [KO:K02157]", "8313  AXIN2; axin 2 [KO:K04385]", "1499  CTNNB1; catenin beta 1 [KO:K02105]", "324  APC; APC regulator of WNT signaling pathway [KO:K02085]", "10297  APC2; APC regulator of WNT signaling pathway 2 [KO:K02085]", "6932  TCF7; transcription factor 7 [KO:K02620]", "83439  TCF7L1; transcription factor 7 like 1 [KO:K04490]", "6934  TCF7L2; transcription factor 7 like 2 [KO:K04491]", "51176  LEF1; lymphoid enhancer binding factor 1 [KO:K04492]", "332  BIRC5; baculoviral IAP repeat containing 5 [KO:K08731]", "4609  MYC; MYC proto-oncogene, bHLH transcription factor [KO:K04377]", "595  CCND1; cyclin D1 [KO:K04503]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]", "842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]", "369  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "5900  RALGDS; ral guanine nucleotide dissociation stimulator [KO:K08732]", "5898  RALA; RAS like proto-oncogene A [KO:K07834]", "5899  RALB; RAS like proto-oncogene B [KO:K07835]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "5880  RAC2; Rac family small GTPase 2 [KO:K07860]", "5881  RAC3; Rac family small GTPase 3 [KO:K07861]", "387  RHOA; ras homolog family member A [KO:K04513]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "1630  DCC; DCC netrin 1 receptor [KO:K06765]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "26060  APPL1; adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1 [KO:K08733]", "7040  TGFB1; transforming growth factor beta 1 [KO:K13375]", "7042  TGFB2; transforming growth factor beta 2 [KO:K13376]", "7043  TGFB3; transforming growth factor beta 3 [KO:K13377]", "7046  TGFBR1; transforming growth factor beta receptor 1 [KO:K04674] [EC:2.7.11.30]", "7048  TGFBR2; transforming growth factor beta receptor 2 [KO:K04388] [EC:2.7.11.30]", "4087  SMAD2; SMAD family member 2 [KO:K04500]", "4088  SMAD3; SMAD family member 3 [KO:K23605]", "4089  SMAD4; SMAD family member 4 [KO:K04501]", "4292  MLH1; mutL homolog 1 [KO:K08734]", "4436  MSH2; mutS homolog 2 [KO:K08735]", "4437  MSH3; mutS homolog 3 [KO:K08736]", "2956  MSH6; mutS homolog 6 [KO:K08737]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "5366  PMAIP1; phorbol-12-myristate-13-acetate-induced protein 1 [KO:K10131]", "10018  BCL2L11; BCL2 like 11 [KO:K16341]", "27113  BBC3; BCL2 binding component 3 [KO:K10132]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]", "54205  CYCS; cytochrome c, somatic [KO:K08738]", "7157  TP53; tumor protein p53 [KO:K04451]", "1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]", "1647  GADD45A; growth arrest and DNA damage inducible alpha [KO:K04402]", "4616  GADD45B; growth arrest and DNA damage inducible beta [KO:K04402]", "10912  GADD45G; growth arrest and DNA damage inducible gamma [KO:K04402]", "578  BAK1; BCL2 antagonist/killer 1 [KO:K14021]", "1643  DDB2; damage specific DNA binding protein 2 [KO:K10140]", "51426  POLK; DNA polymerase kappa [KO:K03511] [EC:2.7.7.7]", "1950  EGF; epidermal growth factor [KO:K04357]", "7039  TGFA; transforming growth factor alpha [KO:K08774]", "2069  EREG; epiregulin [KO:K09784]", "374  AREG; amphiregulin [KO:K09782]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "6198  RPS6KB1; ribosomal protein S6 kinase B1 [KO:K04688] [EC:2.7.11.1]", "6199  RPS6KB2; ribosomal protein S6 kinase B2 [KO:K04688] [EC:2.7.11.1]"], "compound": ["C05981  Phosphatidylinositol-3,4,5-trisphosphate"], "refs": [{"pmid": "15000146", "authors": "  Grady WM.", "title": "Genomic instability and colon cancer.", "journal": "Cancer Metastasis Rev 23:11-27 (2004)", "doi": "10.1023/A:1025861527711"}, {"pmid": "16555243", "authors": "  Soreide K, Janssen EA, Soiland H, Korner H, Baak JP.", "title": "Microsatellite instability in colorectal cancer.", "journal": "Br J Surg 93:395-406 (2006)", "doi": "10.1002/bjs.5328"}, {"pmid": "11078609", "authors": "  Anwar S, Hall C, White J, Deakin M, Farrell W, Elder JB.", "title": "Hereditary non-polyposis colorectal cancer: an updated review.", "journal": "Eur J Surg Oncol 26:635-45 (2000)", "doi": "10.1053/ejso.2000.0974"}, {"pmid": "16699851", "authors": "  Takayama T, Miyanishi K, Hayashi T, Sato Y, Niitsu Y.", "title": "Colorectal cancer: genetics of development and metastasis.", "journal": "J Gastroenterol 41:185-92 (2006)", "doi": "10.1007/s00535-006-1801-6"}, {"pmid": "12621137", "authors": "  Lynch HT, de la Chapelle A.", "title": "Hereditary colorectal cancer.", "journal": "N Engl J Med 348:919-32 (2003)", "doi": "10.1056/NEJMra012242"}, {"pmid": "12951588", "authors": "  Rajagopalan H, Nowak MA, Vogelstein B, Lengauer C.", "title": "The significance of unstable chromosomes in colorectal cancer.", "journal": "Nat Rev Cancer 3:695-701 (2003)", "doi": "10.1038/nrc1165"}, {"pmid": "10505543", "authors": "  Behrens J.", "title": "Cadherins and catenins: role in signal transduction and tumor progression.", "journal": "Cancer Metastasis Rev 18:15-30 (1999)", "doi": "10.1023/A:1006200102166"}, {"pmid": "16042571", "authors": "  Behrens J.", "title": "The role of the Wnt signalling pathway in colorectal tumorigenesis.", "journal": "Biochem Soc Trans 33:672-5 (2005)", "doi": "10.1042/BST0330672"}, {"pmid": "15349822", "authors": "  Behrens J, Lustig B.", "title": "The Wnt connection to tumorigenesis.", "journal": "Int J Dev Biol 48:477-87 (2004)", "doi": "10.1387/ijdb.041815jb"}, {"pmid": "9196022", "authors": "  Polakis P.", "title": "The adenomatous polyposis coli (APC) tumor suppressor.", "journal": "Biochim Biophys Acta 1332:F127-47 (1997)", "doi": "10.1016/S0304-419X(97)00008-5"}, {"pmid": "12737309", "authors": "  Janssen KP.", "title": "Murine models of colorectal cancer: studying the role of oncogenic K-ras.", "journal": "Cell Mol Life Sci 60:495-506 (2003)", "doi": "10.1007/s000180300041"}, {"pmid": "11459867", "authors": "  Adjei AA.", "title": "Blocking oncogenic Ras signaling for cancer therapy.", "journal": "J Natl Cancer Inst 93:1062-74 (2001)", "doi": "10.1093/jnci/93.14.1062"}, {"pmid": "15573119", "authors": "  Arakawa H.", "title": "Netrin-1 and its receptors in tumorigenesis.", "journal": "Nat Rev Cancer 4:978-87 (2004)", "doi": "10.1038/nrc1504"}, {"pmid": "15310786", "authors": "  Mehlen P, Fearon ER.", "title": "Role of the dependence receptor DCC in colorectal cancer pathogenesis.", "journal": "J Clin Oncol 22:3420-8 (2004)", "doi": "10.1200/JCO.2004.02.019"}, {"pmid": "11223406", "authors": "  Peltomaki P.", "title": "DNA mismatch repair and cancer.", "journal": "Mutat Res 488:77-85 (2001)", "doi": "10.1016/S1383-5742(00)00058-2"}, {"pmid": "15711891", "authors": "  Li F, Cao Y, Townsend CM Jr, Ko TC.", "title": "TGF-beta signaling in colon cancer cells.", "journal": "World J Surg 29:306-11 (2005)", "doi": "10.1007/s00268-004-7813-6"}, {"pmid": "11170304", "authors": "  Roman C, Saha D, Beauchamp R.", "title": "TGF-beta and colorectal carcinogenesis.", "journal": "Microsc Res Tech 52:450-7 (2001)", "doi": "10.1002/1097-0029(20010215)52:4<450::AID-JEMT1030>3.0.CO;2-O"}, {"pmid": "16326109", "authors": "  Watson AJ.", "title": "An overview of apoptosis and the prevention of colorectal cancer.", "journal": "Crit Rev Oncol Hematol 57:107-21 (2006)", "doi": "10.1016/j.critrevonc.2005.06.005"}, {"pmid": "15479695", "authors": "  Watson AJ.", "title": "Apoptosis and colorectal cancer.", "journal": "Gut 53:1701-9 (2004)", "doi": "10.1136/gut.2004.052704"}, {"pmid": "11477132", "authors": "  Houlston RS.", "title": "What we could do now: molecular pathology of colorectal cancer.", "journal": "Mol Pathol 54:206-14 (2001)", "doi": "10.1136/mp.54.4.206"}, {"pmid": "19167459", "authors": "  Hector S, Prehn JH", "title": "Apoptosis signaling proteins as prognostic biomarkers in colorectal cancer: a review.", "journal": "Biochim Biophys Acta 1795:117-29 (2009)", "doi": "10.1016/j.bbcan.2008.12.002"}, {"pmid": "18568040", "authors": "  Karnoub AE, Weinberg RA", "title": "Ras oncogenes: split personalities.", "journal": "Nat Rev Mol Cell Biol 9:517-31 (2008)", "doi": "10.1038/nrm2438"}, {"pmid": "24213116", "authors": "  Wang D, Xia D, Dubois RN", "title": "The Crosstalk of PTGS2 and EGF Signaling Pathways in Colorectal Cancer.", "journal": "Cancers (Basel) 3:3894-908 (2011)", "doi": "10.3390/cancers3043894"}, {"pmid": "20554751", "authors": "  Dasari A, Messersmith WA", "title": "New strategies in colorectal cancer: biomarkers of response to epidermal growth factor receptor monoclonal antibodies and potential therapeutic targets in phosphoinositide 3-kinase and mitogen-activated protein kinase pathways.", "journal": "Clin Cancer Res 16:3811-8 (2010)", "doi": "10.1158/1078-0432.CCR-09-2283"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04012  ErbB signaling pathway", "hsa04110  Cell cycle", "hsa04115  p53 signaling pathway", "hsa04150  mTOR signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04210  Apoptosis", "hsa04310  Wnt signaling pathway", "hsa04350  TGF-beta signaling pathway"], "ko_pathway": "ko05210", "genes": ["EGFR", "RAC1", "TP53", "BRAF", "AKT2", "AKT1", "SOS1", "NRAS", "BAX"]}, {"kegg_id": "hsa05212", "name": "Pancreatic cancer - Homo sapiens (human)", "description": "Infiltrating ductal adenocarcinoma is the most common malignancy of the pancreas. When most investigators use the term 'pancreatic cancer' they are referring to pancreatic ductal adenocarcinoma (PDA). Normal duct epithelium progresses to infiltrating cancer through a series of histologically defined precursors (PanINs). The overexpression of HER-2/neu and activating point mutations in the K-ras gene occur early, inactivation of the p16 gene at an intermediate stage, and the inactivation of p53, SMAD4, and BRCA2 occur relatively late. Activated K-ras engages multiple effector pathways. Although EGF receptors are conventionally regarded as upstream activators of RAS proteins, they can also act as RAS signal transducers via RAS-induced autocrine activation of the EGFR family ligands. Moreover, PDA shows extensive genomic instability and aneuploidy. Telomere attrition and mutations in p53 and BRCA2 are likely to contribute to these phenotypes. Inactivation of the SMAD4 tumour suppressor gene leads to loss of the inhibitory influence of the transforming growth factor-beta signalling pathway.", "class": "Human Diseases; Cancer: specific types", "pathway_map": "hsa05212  Pancreatic cancer", "network": ["", "ELEMENT   N00012  Mutation-activated KRAS/NRAS to ERK signaling pathway", "N00032  Mutation-activated KRAS/NRAS to PI3K signaling pathway", "N00034  ERBB2-overexpression to PI3K signaling pathway", "N00070  Mutation-inactivated p16(INK4a) to p16-cell cycle G1/S", "N00071  Deleted p16(INK4a) to p16-cell cycle G1/S", "N00095  ERBB2-overexpression to EGF-Jak-STAT signaling pathway", "N00104  Mutation-activated KRAS to RalGDS signaling pathway", "N00115  Mutation-inactivated TP53 to transcription"], "disease": ["H00019  Pancreatic cancer"], "drug": ["D04023  Erlotinib hydrochloride (JAN/USAN)", "D07907  Erlotinib (INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "9459  ARHGEF6; Rac/Cdc42 guanine nucleotide exchange factor 6 [KO:K05729]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "5880  RAC2; Rac family small GTPase 2 [KO:K07860]", "5881  RAC3; Rac family small GTPase 3 [KO:K07861]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]", "598  BCL2L1; BCL2 like 1 [KO:K04570]", "842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]", "369  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "5900  RALGDS; ral guanine nucleotide dissociation stimulator [KO:K08732]", "5898  RALA; RAS like proto-oncogene A [KO:K07834]", "5899  RALB; RAS like proto-oncogene B [KO:K07835]", "10928  RALBP1; ralA binding protein 1 [KO:K08773]", "998  CDC42; cell division cycle 42 [KO:K04393]", "5337  PLD1; phospholipase D1 [KO:K01115] [EC:3.1.4.4]", "5338  PLD2; phospholipase D2 [KO:K01115] [EC:3.1.4.4]", "7039  TGFA; transforming growth factor alpha [KO:K08774]", "1950  EGF; epidermal growth factor [KO:K04357]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "2064  ERBB2; erb-b2 receptor tyrosine kinase 2 [KO:K05083] [EC:2.7.10.1]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "6198  RPS6KB1; ribosomal protein S6 kinase B1 [KO:K04688] [EC:2.7.11.1]", "6199  RPS6KB2; ribosomal protein S6 kinase B2 [KO:K04688] [EC:2.7.11.1]", "3716  JAK1; Janus kinase 1 [KO:K11217] [EC:2.7.10.2]", "6774  STAT3; signal transducer and activator of transcription 3 [KO:K04692]", "6772  STAT1; signal transducer and activator of transcription 1 [KO:K11220]", "7422  VEGFA; vascular endothelial growth factor A [KO:K05448]", "1029  CDKN2A; cyclin dependent kinase inhibitor 2A [KO:K06621]", "1019  CDK4; cyclin dependent kinase 4 [KO:K02089] [EC:2.7.11.22]", "1021  CDK6; cyclin dependent kinase 6 [KO:K02091] [EC:2.7.11.22]", "595  CCND1; cyclin D1 [KO:K04503]", "5925  RB1; RB transcriptional corepressor 1 [KO:K06618]", "1869  E2F1; E2F transcription factor 1 [KO:K17454]", "1870  E2F2; E2F transcription factor 2 [KO:K09389]", "1871  E2F3; E2F transcription factor 3 [KO:K06620]", "7157  TP53; tumor protein p53 [KO:K04451]", "1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]", "1647  GADD45A; growth arrest and DNA damage inducible alpha [KO:K04402]", "4616  GADD45B; growth arrest and DNA damage inducible beta [KO:K04402]", "10912  GADD45G; growth arrest and DNA damage inducible gamma [KO:K04402]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "578  BAK1; BCL2 antagonist/killer 1 [KO:K14021]", "1643  DDB2; damage specific DNA binding protein 2 [KO:K10140]", "51426  POLK; DNA polymerase kappa [KO:K03511] [EC:2.7.7.7]", "7040  TGFB1; transforming growth factor beta 1 [KO:K13375]", "7042  TGFB2; transforming growth factor beta 2 [KO:K13376]", "7043  TGFB3; transforming growth factor beta 3 [KO:K13377]", "7046  TGFBR1; transforming growth factor beta receptor 1 [KO:K04674] [EC:2.7.11.30]", "7048  TGFBR2; transforming growth factor beta receptor 2 [KO:K04388] [EC:2.7.11.30]", "4087  SMAD2; SMAD family member 2 [KO:K04500]", "4088  SMAD3; SMAD family member 3 [KO:K23605]", "4089  SMAD4; SMAD family member 4 [KO:K04501]", "675  BRCA2; BRCA2 DNA repair associated [KO:K08775]", "5888  RAD51; RAD51 recombinase [KO:K04482]"], "compound": ["C00416  Phosphatidate", "C05981  Phosphatidylinositol-3,4,5-trisphosphate"], "refs": [{"pmid": "12459728", "authors": "  Bardeesy N, DePinho RA.", "title": "Pancreatic cancer biology and genetics.", "journal": "Nat Rev Cancer 2:897-909 (2002)", "doi": "10.1038/nrc949"}, {"pmid": "11407945", "authors": "  Bardeesy N, Sharpless NE, DePinho RA, Merlino G.", "title": "The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model.", "journal": "Semin Cancer Biol 11:201-18 (2001)", "doi": "10.1006/scbi.2000.0371"}, {"pmid": "12946833", "authors": "  Cowgill SM, Muscarella P.", "title": "The genetics of pancreatic cancer.", "journal": "Am J Surg 186:279-86 (2003)", "doi": "10.1016/S0002-9610(03)00226-5"}, {"pmid": "16702400", "authors": "  Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA.", "title": "Genetics and biology of pancreatic ductal adenocarcinoma.", "journal": "Genes Dev 20:1218-49 (2006)", "doi": "10.1101/gad.1415606"}, {"pmid": "10740269", "authors": "  Shields JM, Pruitt K, McFall A, Shaub A, Der CJ.", "title": "Understanding Ras: 'it ain't over 'til it's over'.", "journal": "Trends Cell Biol 10:147-54 (2000)", "doi": "10.1016/S0962-8924(00)01740-2"}, {"pmid": "12648469", "authors": "  Holbro T, Civenni G, Hynes NE.", "title": "The ErbB receptors and their role in cancer progression.", "journal": "Exp Cell Res 284:99-110 (2003)", "doi": "10.1016/S0014-4827(02)00099-X"}, {"pmid": "14967450", "authors": "  Marmor MD, Skaria KB, Yarden Y.", "title": "Signal transduction and oncogenesis by ErbB/HER receptors.", "journal": "Int J Radiat Oncol Biol Phys 58:903-13 (2004)", "doi": "10.1016/j.ijrobp.2003.06.002"}, {"pmid": "14586404", "authors": "  DeArmond D, Brattain MG, Jessup JM, Kreisberg J, Malik S, Zhao S, Freeman JW.", "title": "Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines.", "journal": "Oncogene 22:7781-95 (2003)", "doi": "10.1038/sj.onc.1206966"}, {"pmid": "12545153", "authors": "  Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL, Xie K.", "title": "Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis.", "journal": "Oncogene 22:319-29 (2003)", "doi": "10.1038/sj.onc.1206122"}, {"pmid": "14580692", "authors": "  Toyonaga T, Nakano K, Nagano M, Zhao G, Yamaguchi K, Kuroki S, Eguchi T, Chijiiwa K, Tsuneyoshi M, Tanaka M.", "title": "Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer.", "journal": "Cancer Lett 201:107-16 (2003)", "doi": "10.1016/S0304-3835(03)00482-8"}, {"pmid": "12079267", "authors": "  Schmid RM.", "title": "Genetic basis of pancreatic cancer.", "journal": "Best Pract Res Clin Gastroenterol 16:421-33 (2002)", "doi": "10.1053/bega.2002.0316"}, {"pmid": "15774796", "authors": "  Elliott RL, Blobe GC.", "title": "Role of transforming growth factor Beta in human cancer.", "journal": "J Clin Oncol 23:2078-93 (2005)", "doi": "10.1200/JCO.2005.02.047"}, {"pmid": "15823750", "authors": "  Rudkin TM, Foulkes WD.", "title": "BRCA2: breaks, mistakes and failed separations.", "journal": "Trends Mol Med 11:145-8 (2005)", "doi": "10.1016/j.molmed.2005.02.003"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04012  ErbB signaling pathway", "hsa04110  Cell cycle", "hsa04115  p53 signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04210  Apoptosis", "hsa04350  TGF-beta signaling pathway", "hsa04370  VEGF signaling pathway", "hsa04630  JAK-STAT signaling pathway"], "ko_pathway": "ko05212", "genes": ["EGFR", "RAC1", "TP53", "BRAF", "AKT2", "AKT1", "BAX"]}, {"kegg_id": "hsa05219", "name": "Bladder cancer - Homo sapiens (human)", "description": "The urothelium covers the luminal surface of almost the entire urinary tract, extending from the renal pelvis, through the ureter and bladder, to the proximal urethra. The majority of urothelial carcinoma are bladder carcinomas, and urothelial carcinomas of the renal pelvis and ureter account for only approximately 7% of the total. Urothelial tumours arise and evolve through divergent phenotypic pathways. Some tumours progress from urothelial hyperplasia to low-grade non-invasive superficial papillary tumours. More aggressive variants arise either from flat, high-grade carcinoma in situ (CIS) and progress to invasive tumours, or they arise de novo as invasive tumours. Low-grade papillary tumors frequently show a constitutive activation of the receptor tyrosine kinase-Ras pathway, exhibiting activating mutations in the HRAS and fibroblast growth factor receptor 3 (FGFR3) genes. In contrast, CIS and invasive tumors frequently show alterations in the TP53 and RB genes and pathways. Invasion and metastases are promoted by several factors that alter the tumour microenvironment, including the aberrant expression of E-cadherins (E-cad), matrix metalloproteinases (MMPs), angiogenic factors such as vascular endothelial growth factor (VEGF).", "class": "Human Diseases; Cancer: specific types", "pathway_map": "hsa05219  Bladder cancer", "network": ["", "ELEMENT   N00006  Amplified EGFR to RAS-ERK signaling pathway", "N00011  Mutation-activated FGFR3 to RAS-ERK signaling pathway", "N00022  ERBB2-overexpression to RAS-ERK signaling pathway", "N00041  EGFR-overexpression to RAS-ERK signaling pathway", "N00067  Deleted p14(ARF) to p21-cell cycle G1/S", "N00071  Deleted p16(INK4a) to p16-cell cycle G1/S", "N00074  Loss of RB1 to cell cycle G1/S", "N00075  Mutation-inactivated RB1 to cell cycle G1/S", "N00077  HRAS-overexpression to ERK signaling pathway", "N00078  Mutation-activated HRAS to ERK signaling pathway", "N00115  Mutation-inactivated TP53 to transcription"], "disease": ["H00022  Bladder cancer"], "drug": ["D10927  Erdafitinib (JAN/USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["2261  FGFR3; fibroblast growth factor receptor 3 [KO:K05094] [EC:2.7.10.1]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "369  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "9252  RPS6KA5; ribosomal protein S6 kinase A5 [KO:K04445] [EC:2.7.11.1]", "4609  MYC; MYC proto-oncogene, bHLH transcription factor [KO:K04377]", "11186  RASSF1; Ras association domain family member 1 [KO:K09850]", "1612  DAPK1; death associated protein kinase 1 [KO:K08803] [EC:2.7.11.1]", "1613  DAPK3; death associated protein kinase 3 [KO:K08803] [EC:2.7.11.1]", "23604  DAPK2; death associated protein kinase 2 [KO:K08803] [EC:2.7.11.1]", "1029  CDKN2A; cyclin dependent kinase inhibitor 2A [KO:K06621]", "4193  MDM2; MDM2 proto-oncogene [KO:K06643] [EC:2.3.2.27]", "7157  TP53; tumor protein p53 [KO:K04451]", "1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]", "595  CCND1; cyclin D1 [KO:K04503]", "1019  CDK4; cyclin dependent kinase 4 [KO:K02089] [EC:2.7.11.22]", "5925  RB1; RB transcriptional corepressor 1 [KO:K06618]", "1869  E2F1; E2F transcription factor 1 [KO:K17454]", "1870  E2F2; E2F transcription factor 2 [KO:K09389]", "1871  E2F3; E2F transcription factor 3 [KO:K06620]", "7057  THBS1; thrombospondin 1 [KO:K16857]", "1839  HBEGF; heparin binding EGF like growth factor [KO:K08523]", "4313  MMP2; matrix metallopeptidase 2 [KO:K01398] [EC:3.4.24.24]", "4318  MMP9; matrix metallopeptidase 9 [KO:K01403] [EC:3.4.24.35]", "7380  UPK3A; uroplakin 3A [KO:K19520]", "6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "1950  EGF; epidermal growth factor [KO:K04357]", "2064  ERBB2; erb-b2 receptor tyrosine kinase 2 [KO:K05083] [EC:2.7.10.1]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "1890  TYMP; thymidine phosphorylase [KO:K00758] [EC:2.4.2.4]", "7422  VEGFA; vascular endothelial growth factor A [KO:K05448]", "4312  MMP1; matrix metallopeptidase 1 [KO:K01388] [EC:3.4.24.7]", "3576  CXCL8; C-X-C motif chemokine ligand 8 [KO:K10030]", "999  CDH1; cadherin 1 [KO:K05689]"], "refs": [{"pmid": "17158541", "authors": "  Mitra AP, Datar RH, Cote RJ.", "title": "Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification.", "journal": "J Clin Oncol 24:5552-64 (2006)", "doi": "10.1200/JCO.2006.08.2073"}, {"pmid": "16474624", "authors": "  Wolff EM, Liang G, Jones PA.", "title": "Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer.", "journal": "Nat Clin Pract Urol 2:502-10 (2005)", "doi": "10.1038/ncpuro0318"}, {"pmid": "16110317", "authors": "  Wu XR.", "title": "Urothelial tumorigenesis: a tale of divergent pathways.", "journal": "Nat Rev Cancer 5:713-25 (2005)", "doi": "10.1038/nrc1697"}, {"pmid": "12850530", "authors": "  Bellmunt J, Hussain M, Dinney CP.", "title": "Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family.", "journal": "Crit Rev Oncol Hematol 46 Suppl:S85-104 (2003)", "doi": "10.1016/S1040-8428(03)00067-2"}, {"pmid": "17149381", "authors": "  Sugano K, Kakizoe T.", "title": "Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging.", "journal": "Nat Clin Pract Urol 3:642-52 (2006)", "doi": "10.1038/ncpuro0649"}, {"pmid": "15746962", "authors": "  Dunn KL, Espino PS, Drobic B, He S, Davie JR.", "title": "The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling.", "journal": "Biochem Cell Biol 83:1-14 (2005)", "doi": "10.1139/o04-121"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04012  ErbB signaling pathway", "hsa04110  Cell cycle", "hsa04115  p53 signaling pathway", "hsa04370  VEGF signaling pathway", "hsa04520  Adherens junction"], "ko_pathway": "ko05219", "genes": ["EGFR", "TP53", "BRAF", "NRAS"]}, {"kegg_id": "hsa05223", "name": "Non-small cell lung cancer - Homo sapiens (human)", "description": "Lung cancer is a leading cause of cancer death among men and women in industrialized countries. Non-small-cell lung cancer (NSCLC) accounts for approximately 85% of lung cancer and represents a heterogeneous group of cancers, consisting mainly of squamous cell (SCC), adeno (AC) and large-cell carcinoma. Molecular mechanisms altered in NSCLC include activation of oncogenes, such as K-RAS, EGFR and EML4-ALK, and inactivation of tumorsuppressor genes, such as p53, p16INK4a, RAR-beta, and RASSF1. Point mutations within the K-RAS gene inactivate GTPase activity and the p21-RAS protein continuously transmits growth signals to the nucleus. Mutations or overexpression of EGFR leads to a proliferative advantage. EML4-ALK fusion leads to constitutive ALK activation, which causes cell proliferation, invasion, and inhibition of apoptosis. Inactivating mutation of p53 can lead to more rapid proliferation and reduced apoptosis. The protein encoded by the p16INK4a inhibits formation of CDK-cyclin-D complexes by competitive binding of CDK4 and CDK6. Loss of p16INK4a expression is a common feature of NSCLC. RAR-beta is a nuclear receptor that bears vitamin-A-dependent transcriptional activity. RASSF1A is able to form heterodimers with Nore-1, an RAS effector.Therefore loss of RASSF1A might shift the balance of RAS activity towards a growth-promoting effect.", "class": "Human Diseases; Cancer: specific types", "pathway_map": "hsa05223  Non-small cell lung cancer", "network": ["", "ELEMENT   N00007  EML4-ALK fusion kinase to RAS-ERK signaling pathway", "N00008  RET fusion kinase to RAS-ERK signaling pathway", "N00012  Mutation-activated KRAS/NRAS to ERK signaling pathway", "N00014  Mutation-activated EGFR to RAS-ERK signaling pathway", "N00022  ERBB2-overexpression to RAS-ERK signaling pathway", "N00024  Mutation-activated EGFR to PLCG-ERK signaling pathway", "N00025  EML4-ALK fusion kinase to PLCG-ERK signaling pathway", "N00032  Mutation-activated KRAS/NRAS to PI3K signaling pathway", "N00036  Mutation-activated EGFR to PI3K signaling pathway", "N00041  EGFR-overexpression to RAS-ERK signaling pathway", "N00047  EML4-ALK fusion kinase to PI3K signaling pathway", "N00070  Mutation-inactivated p16(INK4a) to p16-cell cycle G1/S", "N00097  Loss of RASSF1 to RAS-RASSF1 signaling pathway", "N00105  EML4-ALK fusion kinase to Jak-STAT signaling pathway", "N00115  Mutation-inactivated TP53 to transcription", "N01062  Mutation-activated MET to RAS-ERK signaling pathway", "N01063  Mutation-activated MET to PI3K signaling pathway"], "disease": ["H00014  Non-small cell lung cancer"], "drug": ["D01977  Gefitinib (JP18/USAN/INN)", "D04023  Erlotinib hydrochloride (JAN/USAN)", "D07907  Erlotinib (INN)", "D09731  Crizotinib (JAN/USAN/INN)", "D09733  Afatinib dimaleate (USAN)", "D10018  Necitumumab (USAN/INN)", "D10450  Alectinib hydrochloride (JAN)", "D10514  Dacomitinib (USAN)", "D10542  Alectinib (USAN/INN)", "D10551  Ceritinib (JAN/USAN/INN)", "D10766  Osimertinib mesylate (USAN)", "D10866  Brigatinib (JAN/USAN)", "D10891  Capmatinib hydrochloride (USAN)", "D11012  Lorlatinib (JAN/USAN/INN)", "D11073  Tepotinib hydrochloride (USAN)", "D11712  Pralsetinib (USAN/INN)", "D11713  Selpercatinib (JAN/USAN/INN)", "D11894  Amivantamab (USAN/INN)", "D11969  Mobocertinib succinate (JAN)", "D12055  Sotorasib (JAN/USAN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["2272  FHIT; fragile histidine triad diadenosine triphosphatase [KO:K01522] [EC:3.6.1.29]", "5915  RARB; retinoic acid receptor beta [KO:K08528]", "6256  RXRA; retinoid X receptor alpha [KO:K08524]", "6257  RXRB; retinoid X receptor beta [KO:K08525]", "6258  RXRG; retinoid X receptor gamma [KO:K08526]", "1029  CDKN2A; cyclin dependent kinase inhibitor 2A [KO:K06621]", "1019  CDK4; cyclin dependent kinase 4 [KO:K02089] [EC:2.7.11.22]", "1021  CDK6; cyclin dependent kinase 6 [KO:K02091] [EC:2.7.11.22]", "595  CCND1; cyclin D1 [KO:K04503]", "5925  RB1; RB transcriptional corepressor 1 [KO:K06618]", "1869  E2F1; E2F transcription factor 1 [KO:K17454]", "1870  E2F2; E2F transcription factor 2 [KO:K09389]", "1871  E2F3; E2F transcription factor 3 [KO:K06620]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "11186  RASSF1; Ras association domain family member 1 [KO:K09850]", "83593  RASSF5; Ras association domain family member 5 [KO:K08015]", "6789  STK4; serine/threonine kinase 4 [KO:K04411]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5170  PDPK1; 3-phosphoinositide dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]", "842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]", "2309  FOXO3; forkhead box O3 [KO:K09408]", "1950  EGF; epidermal growth factor [KO:K04357]", "7039  TGFA; transforming growth factor alpha [KO:K08774]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "2064  ERBB2; erb-b2 receptor tyrosine kinase 2 [KO:K05083] [EC:2.7.10.1]", "3082  HGF; hepatocyte growth factor [KO:K05460]", "4233  MET; MET proto-oncogene, receptor tyrosine kinase [KO:K05099] [EC:2.7.10.1]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "369  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "7157  TP53; tumor protein p53 [KO:K04451]", "1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]", "1647  GADD45A; growth arrest and DNA damage inducible alpha [KO:K04402]", "4616  GADD45B; growth arrest and DNA damage inducible beta [KO:K04402]", "10912  GADD45G; growth arrest and DNA damage inducible gamma [KO:K04402]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "578  BAK1; BCL2 antagonist/killer 1 [KO:K14021]", "1643  DDB2; damage specific DNA binding protein 2 [KO:K10140]", "51426  POLK; DNA polymerase kappa [KO:K03511] [EC:2.7.7.7]", "3798  KIF5A; kinesin family member 5A [KO:K10396]", "3799  KIF5B; kinesin family member 5B [KO:K10396]", "3800  KIF5C; kinesin family member 5C [KO:K10396]", "5979  RET; ret proto-oncogene [KO:K05126] [EC:2.7.10.1]", "27436  EML4; EMAP like 4 [KO:K15420]", "238  ALK; ALK receptor tyrosine kinase [KO:K05119] [EC:2.7.10.1]", "3718  JAK3; Janus kinase 3 [KO:K11218] [EC:2.7.10.2]", "6774  STAT3; signal transducer and activator of transcription 3 [KO:K04692]", "6776  STAT5A; signal transducer and activator of transcription 5A [KO:K11223]", "6777  STAT5B; signal transducer and activator of transcription 5B [KO:K11224]"], "compound": ["C00076  Calcium cation", "C00165  Diacylglycerol", "C00777  Retinoate", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C05981  Phosphatidylinositol-3,4,5-trisphosphate", "C15493  9-cis-Retinoic acid"], "refs": [{"pmid": "12379883", "authors": "  Osada H, Takahashi T.", "title": "Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.", "journal": "Oncogene 21:7421-34 (2002)", "doi": "10.1038/sj.onc.1205802"}, {"pmid": "12741677", "authors": "  Yokota J, Nishioka M, Tani M, Kohno T.", "title": "Genetic alterations responsible for metastatic phenotypes of lung cancer cells.", "journal": "Clin Exp Metastasis 20:189-93 (2003)", "doi": "10.1023/a:1022978932215"}, {"pmid": "16870043", "authors": "  Aviel-Ronen S, Blackhall FH, Shepherd FA, Tsao MS.", "title": "K-ras mutations in non-small-cell lung carcinoma: a review.", "journal": "Clin Lung Cancer 8:30-8 (2006)", "doi": "10.3816/CLC.2006.n.030"}, {"pmid": "15948711", "authors": "  Pfeifer GP, Dammann R.", "title": "Methylation of the tumor suppressor gene RASSF1A in human tumors.", "journal": "Biochemistry (Mosc) 70:576-83 (2005)", "doi": "10.1007/s10541-005-0151-y"}, {"pmid": "11902573", "authors": "  Altucci L, Gronemeyer H.", "title": "The promise of retinoids to fight against cancer.", "journal": "Nat Rev Cancer 1:181-93 (2001)", "doi": "10.1038/35106036"}, {"pmid": "10944551", "authors": "  Virmani AK, Rathi A, Zochbauer-Muller S, Sacchi N, Fukuyama Y, Bryant D, Maitra A, Heda S, Fong KM, Thunnissen F, Minna JD, Gazdar AF.", "title": "Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas.", "journal": "J Natl Cancer Inst 92:1303-7 (2000)", "doi": "10.1093/jnci/92.16.1303"}, {"pmid": "12867060", "authors": "  Hirsch FR, Scagliotti GV, Langer CJ, Varella-Garcia M, Franklin WA.", "title": "Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies.", "journal": "Lung Cancer 41 Suppl 1:S29-42 (2003)", "doi": "10.1016/S0169-5002(03)00137-5"}, {"pmid": "16112428", "authors": "  Panani AD, Roussos C.", "title": "Cytogenetic and molecular aspects of lung cancer.", "journal": "Cancer Lett 239:1-9 (2006)", "doi": "10.1016/j.canlet.2005.06.030"}, {"pmid": "12407699", "authors": "  Mitsuuchi Y, Testa JR.", "title": "Cytogenetics and molecular genetics of lung cancer.", "journal": "Am J Med Genet 115:183-8 (2002)", "doi": "10.1002/ajmg.10692"}, {"pmid": "15942304", "authors": "  Breuer RH, Postmus PE, Smit EF.", "title": "Molecular pathology of non-small-cell lung cancer.", "journal": "Respiration 72:313-30 (2005)", "doi": "10.1159/000085376"}, {"pmid": "16189154", "authors": "  Awaya H, Takeshima Y, Furonaka O, Kohno N, Inai K.", "title": "Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lung.", "journal": "J Clin Pathol 58:1076-80 (2005)", "doi": "10.1136/jcp.2004.025585"}, {"pmid": "17625570", "authors": "  Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, Fujiwara S, Watanabe H, Kurashina K, Hatanaka H, Bando M, Ohno S, Ishikawa Y, Aburatani H, Niki T, Sohara Y, Sugiyama Y, Mano H", "title": "Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.", "journal": "Nature 448:561-6 (2007)", "doi": "10.1038/nature05945"}, {"pmid": "18593892", "authors": "  Choi YL, Takeuchi K, Soda M, Inamura K, Togashi Y, Hatano S, Enomoto M, Hamada T, Haruta H, Watanabe H, Kurashina K, Hatanaka H, Ueno T, Takada S, Yamashita Y, Sugiyama Y, Ishikawa Y, Mano H", "title": "Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancer.", "journal": "Cancer Res 68:4971-6 (2008)", "doi": "10.1158/0008-5472.CAN-07-6158"}, {"pmid": "19629074", "authors": "  Janne PA, Gray N, Settleman J", "title": "Factors underlying sensitivity of cancers to small-molecule kinase inhibitors.", "journal": "Nat Rev Drug Discov 8:709-23 (2009)", "doi": "10.1038/nrd2871"}, {"pmid": "23201355", "authors": "  Roskoski R Jr", "title": "Anaplastic lymphoma kinase (ALK): structure, oncogenic activation, and pharmacological inhibition.", "journal": "Pharmacol Res 68:68-94 (2013)", "doi": "10.1016/j.phrs.2012.11.007"}, {"pmid": "22154278", "authors": "  Reungwetwattana T, Weroha SJ, Molina JR", "title": "Oncogenic pathways, molecularly targeted therapies, and highlighted clinical trials in non-small-cell lung cancer (NSCLC).", "journal": "Clin Lung Cancer 13:252-66 (2012)", "doi": "10.1016/j.cllc.2011.09.004"}, {"pmid": "21855164", "authors": "  Popat S, Gonzalez D, Min T, Swansbury J, Dainton M, Croud JG, Rice AJ, Nicholson AG", "title": "ALK translocation is associated with ALK immunoreactivity and extensive signet-ring morphology in primary lung adenocarcinoma.", "journal": "Lung Cancer 75:300-5 (2012)", "doi": "10.1016/j.lungcan.2011.07.017"}, {"pmid": "21753699", "authors": "  Yoshida A, Tsuta K, Nakamura H, Kohno T, Takahashi F, Asamura H, Sekine I, Fukayama M, Shibata T, Furuta K, Tsuda H", "title": "Comprehensive histologic analysis of ALK-rearranged lung carcinomas.", "journal": "Am J Surg Pathol 35:1226-34 (2011)", "doi": "10.1097/PAS.0b013e3182233e06"}, {"pmid": "22736493", "authors": "  Shaozhang Z, Xiaomei L, Aiping Z, Jianbo H, Xiangqun S, Qitao Y", "title": "Detection of EML4-ALK fusion genes in non-small cell lung cancer patients with clinical features associated with EGFR mutations.", "journal": "Genes Chromosomes Cancer 51:925-32 (2012)", "doi": "10.1002/gcc.21976"}, {"pmid": "21850578", "authors": "  Toyooka S, Mitsudomi T, Soh J, Aokage K, Yamane M, Oto T, Kiura K, Miyoshi S", "title": "Molecular oncology of lung cancer.", "journal": "Gen Thorac Cardiovasc Surg 59:527-37 (2011)", "doi": "10.1007/s11748-010-0743-3"}, {"pmid": "23733083", "authors": "  Koudelakova V, Kneblova M, Trojanec R, Drabek J, Hajduch M", "title": "Non-small cell lung cancer--genetic predictors.", "journal": "Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 157:125-36 (2013)", "doi": "10.5507/bp.2013.034"}, {"pmid": "30941048", "authors": "  Takeuchi K", "title": "Discovery Stories of RET Fusions in Lung Cancer: A Mini-Review.", "journal": "Front Physiol 10:216 (2019)", "doi": "10.3389/fphys.2019.00216"}, {"pmid": "29128428", "authors": "  Ferrara R, Auger N, Auclin E, Besse B", "title": "Clinical and Translational Implications of RET Rearrangements in Non-Small Cell Lung Cancer.", "journal": "J Thorac Oncol 13:27-45 (2018)", "doi": "10.1016/j.jtho.2017.10.021"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04012  ErbB signaling pathway", "hsa04014  Ras signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04110  Cell cycle", "hsa04115  p53 signaling pathway", "hsa04151  PI3K-Akt signaling pathway"], "ko_pathway": "ko05223", "genes": ["EGFR", "TP53", "BRAF", "AKT2", "MET", "AKT1", "SOS1", "NRAS", "BAX"]}, {"kegg_id": "hsa05226", "name": "Gastric cancer - Homo sapiens (human)", "description": "Gastric cancer (GC) is one of the world's most common cancers. According to Lauren's histological classification gastric cancer is divided into two distinct histological groups - the intestinal and diffuse types. Several genetic changes have been identified in intestinal-type GC. The intestinal metaplasia is characterized by mutations in p53 gene, reduced expression of retinoic acid receptor beta (RAR-beta) and hTERT expression. Gastric adenomas furthermore display mutations in the APC gene, reduced p27 expression and cyclin E amplification. In addition, amplification and overexpression of c-ErbB2, reduced TGF-beta receptor type I (TGFBRI) expression and complete loss of p27 expression are commonly observed in more advanced GC. The main molecular changes observed in diffuse-type GCs include loss of E-cadherin function by mutations in CDH1 and amplification of MET and FGFR2F.", "class": "Human Diseases; Cancer: specific types", "pathway_map": "hsa05226  Gastric cancer", "network": ["", "ELEMENT   N00012  Mutation-activated KRAS/NRAS to ERK signaling pathway", "N00020  Amplified FGFR to RAS-ERK signaling pathway", "N00038  Amplified FGFR to PI3K signaling pathway", "N00057  Mutation-inactivated APC to Wnt signaling pathway", "N00115  Mutation-inactivated TP53 to transcription", "N00240  TERT-overexpression to telomerase activity", "N00250  CDX2-overexpression to transcriptional activation", "N00251  CDX2-overexpression to transcriptional repression", "N00252  Amplified ERBB2 to RAS-ERK signaling pathway", "N00253  Amplified ERBB2 to PI3K signaling pathway", "N00254  CDKN1B-reduced expression to p27-cell cycle G1/S", "N00255  Amplified CCNE to cell cycle G1/S", "N00256  TGFBR1-reduced expression to TGF-beta signaling pathway", "N00257  Loss of CDH1 to beta-catenin signaling pathway", "N00258  Mutation-inactivated CDH1 to beta-catenin signaling pathway", "N00259  Amplified MET to RAS-ERK signaling pathway", "N00260  Amplified MET to PI3K signaling pathway"], "disease": ["H00018  Gastric cancer"], "drug": ["D03257  Trastuzumab (USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["1045  CDX2; caudal type homeobox 2 [KO:K22234]", "4583  MUC2; mucin 2, oligomeric mucus/gel-forming [KO:K10955]", "1015  CDH17; cadherin 17 [KO:K06811]", "83998  REG4; regenerating family member 4 [KO:K22244]", "5243  ABCB1; ATP binding cassette subfamily B member 1 [KO:K05658] [EC:7.6.2.2]", "6469  SHH; sonic hedgehog signaling molecule [KO:K11988]", "7157  TP53; tumor protein p53 [KO:K04451]", "1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]", "1647  GADD45A; growth arrest and DNA damage inducible alpha [KO:K04402]", "4616  GADD45B; growth arrest and DNA damage inducible beta [KO:K04402]", "10912  GADD45G; growth arrest and DNA damage inducible gamma [KO:K04402]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "578  BAK1; BCL2 antagonist/killer 1 [KO:K14021]", "1643  DDB2; damage specific DNA binding protein 2 [KO:K10140]", "51426  POLK; DNA polymerase kappa [KO:K03511] [EC:2.7.7.7]", "5915  RARB; retinoic acid receptor beta [KO:K08528]", "6256  RXRA; retinoid X receptor alpha [KO:K08524]", "6257  RXRB; retinoid X receptor beta [KO:K08525]", "6258  RXRG; retinoid X receptor gamma [KO:K08526]", "7471  WNT1; Wnt family member 1 [KO:K03209]", "7472  WNT2; Wnt family member 2 [KO:K00182]", "7482  WNT2B; Wnt family member 2B [KO:K00182]", "7473  WNT3; Wnt family member 3 [KO:K00312]", "89780  WNT3A; Wnt family member 3A [KO:K00312]", "54361  WNT4; Wnt family member 4 [KO:K00408]", "7474  WNT5A; Wnt family member 5A [KO:K00444]", "81029  WNT5B; Wnt family member 5B [KO:K00444]", "7475  WNT6; Wnt family member 6 [KO:K00445]", "7476  WNT7A; Wnt family member 7A [KO:K00572]", "7477  WNT7B; Wnt family member 7B [KO:K00572]", "7478  WNT8A; Wnt family member 8A [KO:K00714]", "7479  WNT8B; Wnt family member 8B [KO:K00714]", "7483  WNT9A; Wnt family member 9A [KO:K01064]", "7484  WNT9B; Wnt family member 9B [KO:K01064]", "7480  WNT10B; Wnt family member 10B [KO:K01357]", "80326  WNT10A; Wnt family member 10A [KO:K01357]", "7481  WNT11; Wnt family member 11 [KO:K01384]", "51384  WNT16; Wnt family member 16 [KO:K01558]", "8321  FZD1; frizzled class receptor 1 [KO:K02432]", "8324  FZD7; frizzled class receptor 7 [KO:K02432]", "2535  FZD2; frizzled class receptor 2 [KO:K02235]", "7976  FZD3; frizzled class receptor 3 [KO:K02329]", "8322  FZD4; frizzled class receptor 4 [KO:K02354]", "7855  FZD5; frizzled class receptor 5 [KO:K02375]", "8325  FZD8; frizzled class receptor 8 [KO:K02375]", "8323  FZD6; frizzled class receptor 6 [KO:K02376]", "11211  FZD10; frizzled class receptor 10 [KO:K02842]", "8326  FZD9; frizzled class receptor 9 [KO:K02842]", "4041  LRP5; LDL receptor related protein 5 [KO:K03068]", "4040  LRP6; LDL receptor related protein 6 [KO:K03068]", "1857  DVL3; dishevelled segment polarity protein 3 [KO:K02353]", "1856  DVL2; dishevelled segment polarity protein 2 [KO:K02353]", "1855  DVL1; dishevelled segment polarity protein 1 [KO:K02353]", "10023  FRAT1; FRAT regulator of WNT signaling pathway 1 [KO:K03069]", "23401  FRAT2; FRAT regulator of WNT signaling pathway 2 [KO:K03096]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "8312  AXIN1; axin 1 [KO:K02157]", "8313  AXIN2; axin 2 [KO:K04385]", "324  APC; APC regulator of WNT signaling pathway [KO:K02085]", "10297  APC2; APC regulator of WNT signaling pathway 2 [KO:K02085]", "1499  CTNNB1; catenin beta 1 [KO:K02105]", "122011  CSNK1A1L; casein kinase 1 alpha 1 like [KO:K08957] [EC:2.7.11.1]", "1452  CSNK1A1; casein kinase 1 alpha 1 [KO:K08957] [EC:2.7.11.1]", "6932  TCF7; transcription factor 7 [KO:K02620]", "83439  TCF7L1; transcription factor 7 like 1 [KO:K04490]", "6934  TCF7L2; transcription factor 7 like 2 [KO:K04491]", "51176  LEF1; lymphoid enhancer binding factor 1 [KO:K04492]", "4609  MYC; MYC proto-oncogene, bHLH transcription factor [KO:K04377]", "595  CCND1; cyclin D1 [KO:K04503]", "7015  TERT; telomerase reverse transcriptase [KO:K11126] [EC:2.7.7.49]", "7012  TERC; telomerase RNA component [KO:K22183]", "1950  EGF; epidermal growth factor [KO:K04357]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "2064  ERBB2; erb-b2 receptor tyrosine kinase 2 [KO:K05083] [EC:2.7.10.1]", "6464  SHC1; SHC adaptor protein 1 [KO:K06279]", "25759  SHC2; SHC adaptor protein 2 [KO:K17447]", "53358  SHC3; SHC adaptor protein 3 [KO:K17448]", "399694  SHC4; SHC adaptor protein 4 [KO:K17449]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "369  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "6198  RPS6KB1; ribosomal protein S6 kinase B1 [KO:K04688] [EC:2.7.11.1]", "6199  RPS6KB2; ribosomal protein S6 kinase B2 [KO:K04688] [EC:2.7.11.1]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]", "4292  MLH1; mutL homolog 1 [KO:K08734]", "1027  CDKN1B; cyclin dependent kinase inhibitor 1B [KO:K06624]", "1017  CDK2; cyclin dependent kinase 2 [KO:K02206] [EC:2.7.11.22]", "898  CCNE1; cyclin E1 [KO:K06626]", "9134  CCNE2; cyclin E2 [KO:K06626]", "5925  RB1; RB transcriptional corepressor 1 [KO:K06618]", "1869  E2F1; E2F transcription factor 1 [KO:K17454]", "1870  E2F2; E2F transcription factor 2 [KO:K09389]", "1871  E2F3; E2F transcription factor 3 [KO:K06620]", "7040  TGFB1; transforming growth factor beta 1 [KO:K13375]", "7042  TGFB2; transforming growth factor beta 2 [KO:K13376]", "7043  TGFB3; transforming growth factor beta 3 [KO:K13377]", "7046  TGFBR1; transforming growth factor beta receptor 1 [KO:K04674] [EC:2.7.11.30]", "7048  TGFBR2; transforming growth factor beta receptor 2 [KO:K04388] [EC:2.7.11.30]", "4087  SMAD2; SMAD family member 2 [KO:K04500]", "4088  SMAD3; SMAD family member 3 [KO:K23605]", "4089  SMAD4; SMAD family member 4 [KO:K04501]", "1030  CDKN2B; cyclin dependent kinase inhibitor 2B [KO:K04685]", "999  CDH1; cadherin 1 [KO:K05689]", "29119  CTNNA3; catenin alpha 3 [KO:K05691]", "1495  CTNNA1; catenin alpha 1 [KO:K05691]", "1496  CTNNA2; catenin alpha 2 [KO:K05691]", "3728  JUP; junction plakoglobin [KO:K10056]", "3082  HGF; hepatocyte growth factor [KO:K05460]", "4233  MET; MET proto-oncogene, receptor tyrosine kinase [KO:K05099] [EC:2.7.10.1]", "2246  FGF1; fibroblast growth factor 1 [KO:K18496]", "2247  FGF2; fibroblast growth factor 2 [KO:K18497]", "2248  FGF3; fibroblast growth factor 3 [KO:K04358]", "2249  FGF4; fibroblast growth factor 4 [KO:K04358]", "8822  FGF17; fibroblast growth factor 17 [KO:K04358]", "2251  FGF6; fibroblast growth factor 6 [KO:K04358]", "2252  FGF7; fibroblast growth factor 7 [KO:K04358]", "2253  FGF8; fibroblast growth factor 8 [KO:K04358]", "2254  FGF9; fibroblast growth factor 9 [KO:K04358]", "2255  FGF10; fibroblast growth factor 10 [KO:K04358]", "8823  FGF16; fibroblast growth factor 16 [KO:K04358]", "2250  FGF5; fibroblast growth factor 5 [KO:K04358]", "8817  FGF18; fibroblast growth factor 18 [KO:K04358]", "26281  FGF20; fibroblast growth factor 20 [KO:K04358]", "27006  FGF22; fibroblast growth factor 22 [KO:K04358]", "9965  FGF19; fibroblast growth factor 19 [KO:K22603]", "26291  FGF21; fibroblast growth factor 21 [KO:K22429]", "8074  FGF23; fibroblast growth factor 23 [KO:K22428]", "2263  FGFR2; fibroblast growth factor receptor 2 [KO:K05093] [EC:2.7.10.1]", "2549  GAB1; GRB2 associated binding protein 1 [KO:K09593]"], "compound": ["C00039  DNA", "C00777  Retinoate", "C05981  Phosphatidylinositol-3,4,5-trisphosphate", "C15493  9-cis-Retinoic acid"], "refs": [{"pmid": "26073375", "authors": "  Tan P, Yeoh KG", "title": "Genetics and Molecular Pathogenesis of Gastric Adenocarcinoma.", "journal": "Gastroenterology 149:1153-1162.e3 (2015)", "doi": "10.1053/j.gastro.2015.05.059"}, {"pmid": "26267324", "authors": "  Riquelme I, Saavedra K, Espinoza JA, Weber H, Garcia P, Nervi B, Garrido M, Corvalan AH, Roa JC, Bizama C", "title": "Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy.", "journal": "Oncotarget 6:24750-79 (2015)", "doi": "10.18632/oncotarget.4990"}, {"pmid": "16154715", "authors": "  Stock M, Otto F", "title": "Gene deregulation in gastric cancer.", "journal": "Gene 360:1-19 (2005)", "doi": "10.1016/j.gene.2005.06.026"}, {"pmid": "18381231", "authors": "  Panani AD", "title": "Cytogenetic and molecular aspects of gastric cancer: clinical implications.", "journal": "Cancer Lett 266:99-115 (2008)", "doi": "10.1016/j.canlet.2008.02.053"}, {"pmid": "16997151", "authors": "  Vauhkonen M, Vauhkonen H, Sipponen P", "title": "Pathology and molecular biology of gastric cancer.", "journal": "Best Pract Res Clin Gastroenterol 20:651-74 (2006)", "doi": "10.1016/j.bpg.2006.03.016"}, {"pmid": "16718776", "authors": "  Smith MG, Hold GL, Tahara E, El-Omar EM.", "title": "Cellular and molecular aspects of gastric cancer.", "journal": "World J Gastroenterol 12:2979-90 (2006)", "doi": "10.3748/wjg.v12.i19.2979"}, {"pmid": "15224192", "authors": "  Zheng L, Wang L, Ajani J, Xie K.", "title": "Molecular basis of gastric cancer development and progression.", "journal": "Gastric Cancer 7:61-77 (2004)", "doi": "10.1007/s10120-004-0277-4"}, {"pmid": "12894247", "authors": "  Yuasa Y", "title": "Control of gut differentiation and intestinal-type gastric carcinogenesis.", "journal": "Nat Rev Cancer 3:592-600 (2003)", "doi": "10.1038/nrc1141"}, {"pmid": "28427431", "authors": "  Wessler S, Krisch LM, Elmer DP, Aberger F", "title": "From inflammation to gastric cancer - the importance of Hedgehog/GLI signaling in Helicobacter pylori-induced chronic inflammatory and neoplastic diseases.", "journal": "Cell Commun Signal 15:15 (2017)", "doi": "10.1186/s12964-017-0171-4"}, {"pmid": "24744585", "authors": "  Yan LH, Wei WY, Xie YB, Xiao Q", "title": "New insights into the functions and localization of the homeotic gene CDX2 in gastric cancer.", "journal": "World J Gastroenterol 20:3960-6 (2014)", "doi": "10.3748/wjg.v20.i14.3960"}, {"pmid": "11683489", "authors": "  Hayashi K, Yokozaki H, Goodison S, Oue N, Suzuki T, Lotan R, Yasui W, Tahara E", "title": "Inactivation of retinoic acid receptor beta by promoter CpG hypermethylation in gastric cancer.", "journal": "Differentiation 68:13-21 (2001)", "doi": "10.1046/j.1432-0436.2001.068001013.x"}, {"pmid": "26857262", "authors": "  Li X, Wu WK, Xing R, Wong SH, Liu Y, Fang X, Zhang Y, Wang M, Wang J, Li L, Zhou Y, Tang S, Peng S, Qiu K, Chen L, Chen K, Yang H, Zhang W, Chan MT, Lu Y, Sung JJ, Yu J", "title": "Distinct Subtypes of Gastric Cancer Defined by Molecular Characterization Include Novel Mutational Signatures with Prognostic Capability.", "journal": "Cancer Res 76:1724-32 (2016)", "doi": "10.1158/0008-5472.CAN-15-2443"}, {"pmid": "24061039", "authors": "  Wadhwa R, Song S, Lee JS, Yao Y, Wei Q, Ajani JA", "title": "Gastric cancer-molecular and clinical dimensions.", "journal": "Nat Rev Clin Oncol 10:643-55 (2013)", "doi": "10.1038/nrclinonc.2013.170"}, {"pmid": "26071484", "authors": "  Bertotti A, Sassi F", "title": "Molecular Pathways: Sensitivity and Resistance to Anti-EGFR Antibodies.", "journal": "Clin Cancer Res 21:3377-83 (2015)", "doi": "10.1158/1078-0432.CCR-14-0848"}, {"pmid": "22042966", "authors": "  Appleman LJ", "title": "MET signaling pathway: a rational target for cancer therapy.", "journal": "J Clin Oncol 29:4837-8 (2011)", "doi": "10.1200/JCO.2011.37.7929"}, {"pmid": "19318488", "authors": "  Eder JP, Vande Woude GF, Boerner SA, LoRusso PM", "title": "Novel therapeutic inhibitors of the c-Met signaling pathway in cancer.", "journal": "Clin Cancer Res 15:2207-14 (2009)", "doi": "10.1158/1078-0432.CCR-08-1306"}, {"pmid": "22586678", "authors": "  Feng Y, Ma PC", "title": "Anti-MET targeted therapy has come of age: the first durable complete response with MetMAb in metastatic gastric cancer.", "journal": "Cancer Discov 1:550-4 (2011)", "doi": "10.1158/2159-8290.CD-11-0289"}, {"pmid": "23696246", "authors": "  Katoh M, Nakagama H", "title": "FGF receptors: cancer biology and therapeutics.", "journal": "Med Res Rev 34:280-300 (2014)", "doi": "10.1002/med.21288"}, {"pmid": "19387476", "authors": "  Katoh M", "title": "FGFR2 abnormalities underlie a spectrum of bone, skin, and cancer pathologies.", "journal": "J Invest Dermatol 129:1861-7 (2009)", "doi": "10.1038/jid.2009.97"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04110  Cell cycle", "hsa04115  p53 signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04310  Wnt signaling pathway", "hsa04350  TGF-beta signaling pathway", "hsa04520  Adherens junction", "hsa05120  Epithelial cell signaling in Helicobacter pylori infection"], "ko_pathway": "ko05226", "genes": ["EGFR", "TP53", "BRAF", "AKT2", "MET", "AKT1", "SOS1", "NRAS", "BAX"]}, {"kegg_id": "hsa05231", "name": "Choline metabolism in cancer - Homo sapiens (human)", "description": "Abnormal choline metabolism is emerging as a metabolic hallmark that is associated with oncogenesis and tumour progression. Following transformation, oncogenic signalling via pathways such as the RAS and PI3K-AKT pathways, and transcription factors associated with oncogenesis such as hypoxia-inducible factor 1 (HIF1) mediate overexpression and activation of choline cycle enzymes, which causes increased levels of choline-containing precursors and breakdown products of membrane phospholipids. These products of choline phospholipid metabolism, such as phosphocholine (PCho), diacylglycerol (DAG) and phosphatidic acid, may function as second messengers that are essential for the mitogenic activity of growth factors, particularly in the activation of the ras-raf-1-MAPK cascade and protein kinase C pathway.", "class": "Human Diseases; Cancer: overview", "pathway_map": "hsa05231  Choline metabolism in cancer", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["1950  EGF; epidermal growth factor [KO:K04357]", "5154  PDGFA; platelet derived growth factor subunit A [KO:K04359]", "5155  PDGFB; platelet derived growth factor subunit B [KO:K17386]", "56034  PDGFC; platelet derived growth factor C [KO:K05450]", "80310  PDGFD; platelet derived growth factor D [KO:K05450]", "1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]", "5156  PDGFRA; platelet derived growth factor receptor alpha [KO:K04363] [EC:2.7.10.1]", "5159  PDGFRB; platelet derived growth factor receptor beta [KO:K05089] [EC:2.7.10.1]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "5900  RALGDS; ral guanine nucleotide dissociation stimulator [KO:K08732]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "123745  PLA2G4E; phospholipase A2 group IVE [KO:K16342] [EC:3.1.1.4]", "5321  PLA2G4A; phospholipase A2 group IVA [KO:K16342] [EC:3.1.1.4]", "8681  JMJD7-PLA2G4B; JMJD7-PLA2G4B readthrough [KO:K16342] [EC:3.1.1.4]", "100137049  PLA2G4B; phospholipase A2 group IVB [KO:K16342] [EC:3.1.1.4]", "8605  PLA2G4C; phospholipase A2 group IVC [KO:K16342] [EC:3.1.1.4]", "283748  PLA2G4D; phospholipase A2 group IVD [KO:K16342] [EC:3.1.1.4]", "255189  PLA2G4F; phospholipase A2 group IVF [KO:K16342] [EC:3.1.1.4]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5170  PDPK1; 3-phosphoinositide dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "7248  TSC1; TSC complex subunit 1 [KO:K07206]", "7249  TSC2; TSC complex subunit 2 [KO:K07207]", "6009  RHEB; Ras homolog, mTORC1 binding [KO:K07208]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "6198  RPS6KB1; ribosomal protein S6 kinase B1 [KO:K04688] [EC:2.7.11.1]", "6199  RPS6KB2; ribosomal protein S6 kinase B2 [KO:K04688] [EC:2.7.11.1]", "1978  EIF4EBP1; eukaryotic translation initiation factor 4E binding protein 1 [KO:K07205]", "23396  PIP5K1C; phosphatidylinositol-4-phosphate 5-kinase type 1 gamma [KO:K00889] [EC:2.7.1.68]", "8394  PIP5K1A; phosphatidylinositol-4-phosphate 5-kinase type 1 alpha [KO:K00889] [EC:2.7.1.68]", "8395  PIP5K1B; phosphatidylinositol-4-phosphate 5-kinase type 1 beta [KO:K00889] [EC:2.7.1.68]", "7454  WAS; WASP actin nucleation promoting factor [KO:K05747]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "5880  RAC2; Rac family small GTPase 2 [KO:K07860]", "5881  RAC3; Rac family small GTPase 3 [KO:K07861]", "8936  WASF1; WASP family member 1 [KO:K05753]", "10163  WASF2; WASP family member 2 [KO:K05748]", "10810  WASF3; WASP family member 3 [KO:K06083]", "6667  SP1; Sp1 transcription factor [KO:K04684]", "5337  PLD1; phospholipase D1 [KO:K01115] [EC:3.1.4.4]", "5338  PLD2; phospholipase D2 [KO:K01115] [EC:3.1.4.4]", "60482  SLC5A7; solute carrier family 5 member 7 [KO:K14387]", "23446  SLC44A1; solute carrier family 44 member 1 [KO:K06515]", "80736  SLC44A4; solute carrier family 44 member 4 [KO:K15377]", "204962  SLC44A5; solute carrier family 44 member 5 [KO:K15377]", "57153  SLC44A2; solute carrier family 44 member 2 (CTL2 blood group) [KO:K15377]", "126969  SLC44A3; solute carrier family 44 member 3 [KO:K15282]", "6580  SLC22A1; solute carrier family 22 member 1 [KO:K08198]", "6582  SLC22A2; solute carrier family 22 member 2 [KO:K08199]", "6581  SLC22A3; solute carrier family 22 member 3 [KO:K08200]", "6584  SLC22A5; solute carrier family 22 member 5 [KO:K08202]", "6583  SLC22A4; solute carrier family 22 member 4 [KO:K08202]", "1119  CHKA; choline kinase alpha [KO:K14156] [EC:2.7.1.32 2.7.1.82]", "1120  CHKB; choline kinase beta [KO:K14156] [EC:2.7.1.32 2.7.1.82]", "3091  HIF1A; hypoxia inducible factor 1 subunit alpha [KO:K08268]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "9468  PCYT1B; phosphate cytidylyltransferase 1B, choline [KO:K00968] [EC:2.7.7.15]", "5130  PCYT1A; phosphate cytidylyltransferase 1A, choline [KO:K00968] [EC:2.7.7.15]", "56994  CHPT1; choline phosphotransferase 1 [KO:K00994] [EC:2.7.8.2]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "8611  PLPP1; phospholipid phosphatase 1 [KO:K01080] [EC:3.1.3.4]", "8613  PLPP3; phospholipid phosphatase 3 [KO:K01080] [EC:3.1.3.4]", "8612  PLPP2; phospholipid phosphatase 2 [KO:K01080] [EC:3.1.3.4]", "8525  DGKZ; diacylglycerol kinase zeta [KO:K00901] [EC:2.7.1.107]", "8527  DGKD; diacylglycerol kinase delta [KO:K00901] [EC:2.7.1.107]", "9162  DGKI; diacylglycerol kinase iota [KO:K00901] [EC:2.7.1.107]", "1606  DGKA; diacylglycerol kinase alpha [KO:K00901] [EC:2.7.1.107]", "8526  DGKE; diacylglycerol kinase epsilon [KO:K00901] [EC:2.7.1.107]", "1607  DGKB; diacylglycerol kinase beta [KO:K00901] [EC:2.7.1.107]", "160851  DGKH; diacylglycerol kinase eta [KO:K00901] [EC:2.7.1.107]", "1608  DGKG; diacylglycerol kinase gamma [KO:K00901] [EC:2.7.1.107]", "1609  DGKQ; diacylglycerol kinase theta [KO:K00901] [EC:2.7.1.107]", "139189  DGKK; diacylglycerol kinase kappa [KO:K00901] [EC:2.7.1.107]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "10434  LYPLA1; lysophospholipase 1 [KO:K06128] [EC:3.1.1.5]", "56261  GPCPD1; glycerophosphocholine phosphodiesterase 1 [KO:K18695] [EC:3.1.4.2]"], "compound": ["C00093  sn-Glycerol 3-phosphate", "C00114  Choline", "C00157  Phosphatidylcholine", "C00162  Fatty acid", "C00165  Diacylglycerol", "C00307  CDP-choline", "C00416  Phosphatidate", "C00588  Choline phosphate", "C00670  sn-Glycero-3-phosphocholine", "C04230  1-Acyl-sn-glycero-3-phosphocholine", "C05981  Phosphatidylinositol-3,4,5-trisphosphate"], "refs": [{"pmid": "22089420", "authors": "  Glunde K, Bhujwalla ZM, Ronen SM", "title": "Choline metabolism in malignant transformation.", "journal": "Nat Rev Cancer 11:835-48 (2011)", "doi": "10.1038/nrc3162"}, {"pmid": "19935796", "authors": "  Beloueche-Babari M, Chung YL, Al-Saffar NM, Falck-Miniotis M, Leach MO", "title": "Metabolic assessment of the action of targeted cancer therapeutics using magnetic resonance spectroscopy.", "journal": "Br J Cancer 102:1-7 (2010)", "doi": "10.1038/sj.bjc.6605457"}, {"pmid": "22429397", "authors": "  Abalsamo L, Spadaro F, Bozzuto G, Paris L, Cecchetti S, Lugini L, Iorio E, Molinari A, Ramoni C, Podo F", "title": "Inhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cells.", "journal": "Breast Cancer Res 14:R50 (2012)", "doi": "10.1186/bcr3151"}, {"pmid": "19264150", "authors": "  Foster DA", "title": "Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells.", "journal": "Biochim Biophys Acta 1791:949-55 (2009)", "doi": "10.1016/j.bbalip.2009.02.009"}, {"pmid": "16432178", "authors": "  Beloueche-Babari M, Jackson LE, Al-Saffar NM, Eccles SA, Raynaud FI, Workman P, Leach MO, Ronen SM", "title": "Identification of magnetic resonance detectable metabolic changes associated with inhibition of phosphoinositide 3-kinase signaling in human breast cancer cells.", "journal": "Mol Cancer Ther 5:187-96 (2006)", "doi": "10.1158/1535-7163.MCT-03-0220"}, {"pmid": "23350810", "authors": "  Ridgway ND", "title": "The role of phosphatidylcholine and choline metabolites to cell proliferation and survival.", "journal": "Crit Rev Biochem Mol Biol 48:20-38 (2013)", "doi": "10.3109/10409238.2012.735643"}, {"pmid": "22921309", "authors": "  Awwad HM, Geisel J, Obeid R", "title": "The role of choline in prostate cancer.", "journal": "Clin Biochem 45:1548-53 (2012)", "doi": "10.1016/j.clinbiochem.2012.08.012"}, {"pmid": "16230400", "authors": "  Iorio E, Mezzanzanica D, Alberti P, Spadaro F, Ramoni C, D'Ascenzo S, Millimaggi D, Pavan A, Dolo V, Canevari S, Podo F", "title": "Alterations of choline phospholipid metabolism in ovarian tumor progression.", "journal": "Cancer Res 65:9369-76 (2005)", "doi": "10.1158/0008-5472.CAN-05-1146"}, {"pmid": "14523987", "authors": "  Ackerstaff E, Glunde K, Bhujwalla ZM", "title": "Choline phospholipid metabolism: a target in cancer cells?", "journal": "J Cell Biochem 90:525-33 (2003)", "doi": "10.1002/jcb.10659"}, {"pmid": "23076158", "authors": "  Park JB, Lee CS, Jang JH, Ghim J, Kim YJ, You S, Hwang D, Suh PG, Ryu SH", "title": "Phospholipase signalling networks in cancer.", "journal": "Nat Rev Cancer 12:782-92 (2012)", "doi": "10.1038/nrc3379"}, {"pmid": "19855431", "authors": "  Yalcin A, Clem B, Makoni S, Clem A, Nelson K, Thornburg J, Siow D, Lane AN, Brock SE, Goswami U, Eaton JW, Telang S, Chesney J", "title": "Selective inhibition of choline kinase simultaneously attenuates MAPK and PI3K/AKT signaling.", "journal": "Oncogene 29:139-49 (2010)", "doi": "10.1038/onc.2009.317"}, {"pmid": "21793073", "authors": "  Glunde K, Jiang L, Moestue SA, Gribbestad IS", "title": "MRS and MRSI guidance in molecular medicine: targeting and monitoring of choline and glucose metabolism in cancer.", "journal": "NMR Biomed 24:673-90 (2011)", "doi": "10.1002/nbm.1751"}, {"pmid": "19136975", "authors": "  Scott SA, Selvy PE, Buck JR, Cho HP, Criswell TL, Thomas AL, Armstrong MD, Arteaga CL, Lindsley CW, Brown HA", "title": "Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness.", "journal": "Nat Chem Biol 5:108-17 (2009)", "doi": "10.1038/nchembio.140"}], "rel_pathway": ["hsa00564  Glycerophospholipid metabolism", "hsa04010  MAPK signaling pathway", "hsa04150  mTOR signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04810  Regulation of actin cytoskeleton"], "ko_pathway": "ko05231", "genes": ["EGFR", "RAC1", "AKT2", "AKT1", "SOS1", "NRAS"]}, {"kegg_id": "hsa04061", "name": "Viral protein interaction with cytokine and cytokine receptor - Homo sapiens (human)", "description": "Viruses have evolved diverse mechanisms to evade detection and destruction by the immune system, including copying and repurposing host cytokine and cytokine receptor genes. Viral cytokines and cytokine receptors, together with a group of structurally unique, soluble, cytokine-binding or cytokine receptor-binding proteins, represent the three major molecular strategies for subversion and modulation of the host cytokine networks mainly in large DNA viruses. Viral cytokines and cytokine receptor homologs, including other binding proteins, may activate or inhibit cytokine signaling and possibly affect different aspects of immunity.", "class": "Environmental Information Processing; Signaling molecules and interaction", "pathway_map": "hsa04061  Viral protein interaction with cytokine and cytokine receptor", "network": ["", "ELEMENT   N00350  HPV E6 to extrinsic apoptotic pathway", "N00416  HCMV vIL10 to IL10-JAK-STAT signaling pathway", "N00427  HCMV vCXCL to CXCR-GNB/G-PI3K-AKT signaling pathway", "N00429  HCMV UL22A to CCR5-GNB/G-PLCB/G-PKC signaling pathway", "N00491  HTLV-1 p12 to Jak-STAT signaling pathway", "N00560  HSV gD to HVEM-NFKB signaling pathway"], "drug": ["D03210  Ancriviroc (USAN/INN)", "D06297  Vicriviroc maleate (USAN)", "D06557  Aplaviroc hydrochloride (USAN)", "D06670  Maraviroc (JAN/INN)", "D09878  Cenicriviroc (USAN/INN)", "D11399  Leronlimab (USAN/INN)", "D12648  Quisovalimab (USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["6352  CCL5; C-C motif chemokine ligand 5 [KO:K12499]", "6348  CCL3; C-C motif chemokine ligand 3 [KO:K05408]", "6349  CCL3L1; C-C motif chemokine ligand 3 like 1 [KO:K05408]", "414062  CCL3L3; C-C motif chemokine ligand 3 like 3 [KO:K05408]", "6355  CCL8; C-C motif chemokine ligand 8 [KO:K16596]", "6358  CCL14; C-C motif chemokine ligand 14 [KO:K21092]", "6360  CCL16; C-C motif chemokine ligand 16 [KO:K21093]", "6359  CCL15; C-C motif chemokine ligand 15 [KO:K05511]", "6368  CCL23; C-C motif chemokine ligand 23 [KO:K05511]", "6357  CCL13; C-C motif chemokine ligand 13 [KO:K16595]", "6354  CCL7; C-C motif chemokine ligand 7 [KO:K05509]", "6347  CCL2; C-C motif chemokine ligand 2 [KO:K14624]", "10850  CCL27; C-C motif chemokine ligand 27 [KO:K16598]", "6356  CCL11; C-C motif chemokine ligand 11 [KO:K16597]", "6369  CCL24; C-C motif chemokine ligand 24 [KO:K21097]", "10344  CCL26; C-C motif chemokine ligand 26 [KO:K21096]", "56477  CCL28; C-C motif chemokine ligand 28 [KO:K05513]", "6361  CCL17; C-C motif chemokine ligand 17 [KO:K21083]", "6367  CCL22; C-C motif chemokine ligand 22 [KO:K21095]", "6351  CCL4; C-C motif chemokine ligand 4 [KO:K12964]", "9560  CCL4L2; C-C motif chemokine ligand 4 like 2 [KO:K12964]", "388372  CCL4L1; C-C motif chemokine ligand 4 like 1 [KO:K12964]", "6364  CCL20; C-C motif chemokine ligand 20 [KO:K14625]", "6346  CCL1; C-C motif chemokine ligand 1 [KO:K05514]", "6370  CCL25; C-C motif chemokine ligand 25 [KO:K13072]", "6362  CCL18; C-C motif chemokine ligand 18 [KO:K21094]", "6363  CCL19; C-C motif chemokine ligand 19 [KO:K05512]", "6366  CCL21; C-C motif chemokine ligand 21 [KO:K16062]", "2919  CXCL1; C-X-C motif chemokine ligand 1 [KO:K05505]", "2920  CXCL2; C-X-C motif chemokine ligand 2 [KO:K05505]", "2921  CXCL3; C-X-C motif chemokine ligand 3 [KO:K05505]", "6374  CXCL5; C-X-C motif chemokine ligand 5 [KO:K05506]", "6372  CXCL6; C-X-C motif chemokine ligand 6 [KO:K05506]", "3576  CXCL8; C-X-C motif chemokine ligand 8 [KO:K10030]", "5473  PPBP; pro-platelet basic protein [KO:K10029]", "5196  PF4; platelet factor 4 [KO:K05407]", "5197  PF4V1; platelet factor 4 variant 1 [KO:K05407]", "4283  CXCL9; C-X-C motif chemokine ligand 9 [KO:K05416]", "3627  CXCL10; C-X-C motif chemokine ligand 10 [KO:K12671]", "6373  CXCL11; C-X-C motif chemokine ligand 11 [KO:K12672]", "10563  CXCL13; C-X-C motif chemokine ligand 13 [KO:K10032]", "6387  CXCL12; C-X-C motif chemokine ligand 12 [KO:K10031]", "9547  CXCL14; C-X-C motif chemokine ligand 14 [KO:K10033]", "6375  XCL1; X-C motif chemokine ligand 1 [KO:K05507]", "6846  XCL2; X-C motif chemokine ligand 2 [KO:K22675]", "6376  CX3CL1; C-X3-C motif chemokine ligand 1 [KO:K05508]", "3586  IL10; interleukin 10 [KO:K05443]", "3569  IL6; interleukin 6 [KO:K05405]", "3558  IL2; interleukin 2 [KO:K05429]", "3606  IL18; interleukin 18 [KO:K05482]", "27178  IL37; interleukin 37 [KO:K05485]", "29949  IL19; interleukin 19 [KO:K05444]", "50604  IL20; interleukin 20 [KO:K22667]", "11009  IL24; interleukin 24 [KO:K22668]", "7124  TNF; tumor necrosis factor [KO:K03156]", "4049  LTA; lymphotoxin alpha [KO:K05468]", "8740  TNFSF14; TNF superfamily member 14 [KO:K05477]", "8743  TNFSF10; TNF superfamily member 10 [KO:K04721]", "146433  IL34; interleukin 34 [KO:K22633]", "1435  CSF1; colony stimulating factor 1 [KO:K05453]", "1230  CCR1; C-C motif chemokine receptor 1 [KO:K04176]", "729230  CCR2; C-C motif chemokine receptor 2 [KO:K04177]", "1232  CCR3; C-C motif chemokine receptor 3 [KO:K04178]", "1233  CCR4; C-C motif chemokine receptor 4 [KO:K04179]", "1234  CCR5; C-C motif chemokine receptor 5 [KO:K04180]", "1235  CCR6; C-C motif chemokine receptor 6 [KO:K04181]", "1237  CCR8; C-C motif chemokine receptor 8 [KO:K04183]", "10803  CCR9; C-C motif chemokine receptor 9 [KO:K04184]", "51554  ACKR4; atypical chemokine receptor 4 [KO:K04186]", "2826  CCR10; C-C motif chemokine receptor 10 [KO:K04185]", "1236  CCR7; C-C motif chemokine receptor 7 [KO:K04182]", "3577  CXCR1; C-X-C motif chemokine receptor 1 [KO:K04175]", "3579  CXCR2; C-X-C motif chemokine receptor 2 [KO:K05050]", "2833  CXCR3; C-X-C motif chemokine receptor 3 [KO:K04188]", "643  CXCR5; C-X-C motif chemokine receptor 5 [KO:K04190]", "7852  CXCR4; C-X-C motif chemokine receptor 4 [KO:K04189]", "57007  ACKR3; atypical chemokine receptor 3 [KO:K04304]", "2829  XCR1; X-C motif chemokine receptor 1 [KO:K04193]", "1524  CX3CR1; C-X3-C motif chemokine receptor 1 [KO:K04192]", "3587  IL10RA; interleukin 10 receptor subunit alpha [KO:K05134]", "3588  IL10RB; interleukin 10 receptor subunit beta [KO:K05135]", "3570  IL6R; interleukin 6 receptor [KO:K05055]", "3572  IL6ST; interleukin 6 cytokine family signal transducer [KO:K05060]", "3559  IL2RA; interleukin 2 receptor subunit alpha [KO:K05068]", "3560  IL2RB; interleukin 2 receptor subunit beta [KO:K05069]", "3561  IL2RG; interleukin 2 receptor subunit gamma [KO:K05070]", "8809  IL18R1; interleukin 18 receptor 1 [KO:K05173]", "8807  IL18RAP; interleukin 18 receptor accessory protein [KO:K05174]", "53832  IL20RA; interleukin 20 receptor subunit alpha [KO:K05136]", "53833  IL20RB; interleukin 20 receptor subunit beta [KO:K05137]", "58985  IL22RA1; interleukin 22 receptor subunit alpha 1 [KO:K05138]", "7132  TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158]", "7133  TNFRSF1B; TNF receptor superfamily member 1B [KO:K05141]", "4055  LTBR; lymphotoxin beta receptor [KO:K03159]", "8764  TNFRSF14; TNF receptor superfamily member 14 [KO:K05152]", "8797  TNFRSF10A; TNF receptor superfamily member 10a [KO:K04722]", "8795  TNFRSF10B; TNF receptor superfamily member 10b [KO:K04722]", "8794  TNFRSF10C; TNF receptor superfamily member 10c [KO:K22701]", "8793  TNFRSF10D; TNF receptor superfamily member 10d [KO:K22702]", "1436  CSF1R; colony stimulating factor 1 receptor [KO:K05090] [EC:2.7.10.1]"], "refs": [{"pmid": "12511874", "authors": "  Alcami A", "title": "Viral mimicry of cytokines, chemokines and their receptors.", "journal": "Nat Rev Immunol 3:36-50 (2003)", "doi": "10.1038/nri980"}, {"pmid": "28848041", "authors": "  Pontejo SM, Murphy PM", "title": "Chemokines encoded by herpesviruses.", "journal": "J Leukoc Biol 102:1199-1217 (2017)", "doi": "10.1189/jlb.4RU0417-145RR"}, {"pmid": "25805993", "authors": "  de Munnik SM, Smit MJ, Leurs R, Vischer HF", "title": "Modulation of cellular signaling by herpesvirus-encoded G protein-coupled receptors.", "journal": "Front Pharmacol 6:40 (2015)", "doi": "10.3389/fphar.2015.00040"}, {"pmid": "24445563", "authors": "  Vischer HF, Siderius M, Leurs R, Smit MJ", "title": "Herpesvirus-encoded GPCRs: neglected players in inflammatory and proliferative diseases?", "journal": "Nat Rev Drug Discov 13:123-39 (2014)", "doi": "10.1038/nrd4189"}, {"pmid": "9325239", "authors": "  Smith CA, Smith TD, Smolak PJ, Friend D, Hagen H, Gerhart M, Park L, Pickup DJ, Torrance D, Mohler K, Schooley K, Goodwin RG", "title": "Poxvirus genomes encode a secreted, soluble protein that preferentially inhibits beta chemokine activity yet lacks sequence homology to known chemokine receptors.", "journal": "Virology 236:316-27 (1997)", "doi": "10.1006/viro.1997.8730"}, {"pmid": "9621074", "authors": "  Isegawa Y, Ping Z, Nakano K, Sugimoto N, Yamanishi K", "title": "Human herpesvirus 6 open reading frame U12 encodes a functional beta-chemokine receptor.", "journal": "J Virol 72:6104-12 (1998)", "doi": "10.1128/JVI.72.7.6104-6112.1998"}, {"pmid": "9600978", "authors": "  Damon I, Murphy PM, Moss B", "title": "Broad spectrum chemokine antagonistic activity of a human poxvirus chemokine homolog.", "journal": "Proc Natl Acad Sci U S A 95:6403-7 (1998)", "doi": "10.1073/pnas.95.11.6403"}, {"pmid": "16365449", "authors": "  Dewin DR, Catusse J, Gompels UA", "title": "Identification and characterization of U83A viral chemokine, a broad and potent beta-chemokine agonist for human CCRs with unique selectivity and inhibition by spliced isoform.", "journal": "J Immunol 176:544-56 (2006)", "doi": "10.4049/jimmunol.176.1.544"}, {"pmid": "16332987", "authors": "  Fitzsimons CP, Gompels UA, Verzijl D, Vischer HF, Mattick C, Leurs R, Smit MJ", "title": "Chemokine-directed trafficking of receptor stimulus to different g proteins: selective inducible and constitutive signaling by human herpesvirus 6-encoded chemokine receptor U51.", "journal": "Mol Pharmacol 69:888-98 (2006)", "doi": "10.1124/mol.105.015222"}, {"pmid": "15536129", "authors": "  Wang D, Bresnahan W, Shenk T", "title": "Human cytomegalovirus encodes a highly specific RANTES decoy receptor.", "journal": "Proc Natl Acad Sci U S A 101:16642-7 (2004)", "doi": "10.1073/pnas.0407233101"}, {"pmid": "22319442", "authors": "  Viejo-Borbolla A, Martinez-Martin N, Nel HJ, Rueda P, Martin R, Blanco S, Arenzana-Seisdedos F, Thelen M, Fallon PG, Alcami A", "title": "Enhancement of chemokine function as an immunomodulatory strategy employed by human herpesviruses.", "journal": "PLoS Pathog 8:e1002497 (2012)", "doi": "10.1371/journal.ppat.1002497"}, {"pmid": "16581912", "authors": "  Alejo A, Ruiz-Arguello MB, Ho Y, Smith VP, Saraiva M, Alcami A", "title": "A chemokine-binding domain in the tumor necrosis factor receptor from variola (smallpox) virus.", "journal": "Proc Natl Acad Sci U S A 103:5995-6000 (2006)", "doi": "10.1073/pnas.0510462103"}, {"pmid": "15890946", "authors": "  Tadagaki K, Nakano K, Yamanishi K", "title": "Human herpesvirus 7 open reading frames U12 and U51 encode functional beta-chemokine receptors.", "journal": "J Virol 79:7068-76 (2005)", "doi": "10.1128/JVI.79.11.7068-7076.2005"}, {"pmid": "12960231", "authors": "  Lee C, Liu QH, Tomkowicz B, Yi Y, Freedman BD, Collman RG", "title": "Macrophage activation through CCR5- and CXCR4-mediated gp120-elicited signaling pathways.", "journal": "J Leukoc Biol 74:676-82 (2003)", "doi": "10.1189/jlb.0503206"}, {"pmid": "14645913", "authors": "  Najarro P, Lee HJ, Fox J, Pease J, Smith GL", "title": "Yaba-like disease virus protein 7L is a cell-surface receptor for chemokine CCL1.", "journal": "J Gen Virol 84:3325-36 (2003)", "doi": "10.1099/vir.0.19591-0"}, {"pmid": "16528029", "authors": "  Najarro P, Gubser C, Hollinshead M, Fox J, Pease J, Smith GL", "title": "Yaba-like disease virus chemokine receptor 7L, a CCR8 orthologue.", "journal": "J Gen Virol 87:809-16 (2006)", "doi": "10.1099/vir.0.81427-0"}, {"pmid": "18286574", "authors": "  Catusse J, Spinks J, Mattick C, Dyer A, Laing K, Fitzsimons C, Smit MJ, Gompels UA", "title": "Immunomodulation by herpesvirus U51A chemokine receptor via CCL5 and FOG-2 down-regulation plus XCR1 and CCR7 mimicry in human leukocytes.", "journal": "Eur J Immunol 38:763-77 (2008)", "doi": "10.1002/eji.200737618"}, {"pmid": "15837194", "authors": "  Yoon SI, Jones BC, Logsdon NJ, Walter MR", "title": "Same structure, different function crystal structure of the Epstein-Barr virus IL-10 bound to the soluble IL-10R1 chain.", "journal": "Structure 13:551-64 (2005)", "doi": "10.1016/j.str.2005.01.016"}, {"pmid": "10677520", "authors": "  Kotenko SV, Saccani S, Izotova LS, Mirochnitchenko OV, Pestka S", "title": "Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10).", "journal": "Proc Natl Acad Sci U S A 97:1695-700 (2000)", "doi": "10.1073/pnas.97.4.1695"}, {"pmid": "15280480", "authors": "  Chang WL, Baumgarth N, Yu D, Barry PA", "title": "Human cytomegalovirus-encoded interleukin-10 homolog inhibits maturation of dendritic cells and alters their functionality.", "journal": "J Virol 78:8720-31 (2004)", "doi": "10.1128/JVI.78.16.8720-8731.2004"}, {"pmid": "11238858", "authors": "  Li H, Wang H, Nicholas J", "title": "Detection of direct binding of human herpesvirus 8-encoded interleukin-6 (vIL-6) to both gp130 and IL-6 receptor (IL-6R) and identification of amino acid residues of vIL-6 important for IL-6R-dependent and -independent signaling.", "journal": "J Virol 75:3325-34 (2001)", "doi": "10.1128/JVI.75.7.3325-3334.2001"}, {"pmid": "11468184", "authors": "  Nicot C, Mulloy JC, Ferrari MG, Johnson JM, Fu K, Fukumoto R, Trovato R, Fullen J, Leonard WJ, Franchini G", "title": "HTLV-1 p12(I) protein enhances STAT5 activation and decreases the interleukin-2 requirement for proliferation of primary human peripheral blood mononuclear cells.", "journal": "Blood 98:823-9 (2001)", "doi": "10.1182/blood.v98.3.823"}, {"pmid": "10500212", "authors": "  Xiang Y, Moss B", "title": "IL-18 binding and inhibition of interferon gamma induction by human poxvirus-encoded proteins.", "journal": "Proc Natl Acad Sci U S A 96:11537-42 (1999)", "doi": "10.1073/pnas.96.20.11537"}, {"pmid": "15166422", "authors": "  Bartlett NW, Dumoutier L, Renauld JC, Kotenko SV, McVey CE, Lee HJ, Smith GL", "title": "A new member of the interleukin 10-related cytokine family encoded by a poxvirus.", "journal": "J Gen Virol 85:1401-12 (2004)", "doi": "10.1099/vir.0.79980-0"}, {"pmid": "9557689", "authors": "  Strockbine LD, Cohen JI, Farrah T, Lyman SD, Wagener F, DuBose RF, Armitage RJ, Spriggs MK", "title": "The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor.", "journal": "J Virol 72:4015-21 (1998)", "doi": "10.1128/JVI.72.5.4015-4021.1998"}, {"pmid": "17229074", "authors": "  Snow AL, Martinez OM", "title": "Epstein-Barr virus: evasive maneuvers in the development of PTLD.", "journal": "Am J Transplant 7:271-7 (2007)", "doi": "10.1111/j.1600-6143.2006.01650.x"}, {"pmid": "22826234", "authors": "  Shim AH, Chang RA, Chen X, Longnecker R, He X", "title": "Multipronged attenuation of macrophage-colony stimulating factor signaling by Epstein-Barr virus BARF1.", "journal": "Proc Natl Acad Sci U S A 109:12962-7 (2012)", "doi": "10.1073/pnas.1205309109"}, {"pmid": "11934887", "authors": "  Filippova M, Song H, Connolly JL, Dermody TS, Duerksen-Hughes PJ", "title": "The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis.", "journal": "J Biol Chem 277:21730-9 (2002)", "doi": "10.1074/jbc.M200113200"}, {"pmid": "12676996", "authors": "  Brunetti CR, Paulose-Murphy M, Singh R, Qin J, Barrett JW, Tardivel A, Schneider P, Essani K, McFadden G", "title": "A secreted high-affinity inhibitor of human TNF from Tanapox virus.", "journal": "Proc Natl Acad Sci U S A 100:4831-6 (2003)", "doi": "10.1073/pnas.0737244100"}, {"pmid": "18723002", "authors": "  Sciortino MT, Medici MA, Marino-Merlo F, Zaccaria D, Giuffre-Cuculletto M, Venuti A, Grelli S, Bramanti P, Mastino A", "title": "Involvement of gD/HVEM interaction in NF-kB-dependent inhibition of apoptosis by HSV-1 gD.", "journal": "Biochem Pharmacol 76:1522-32 (2008)", "doi": "10.1016/j.bcp.2008.07.030"}], "ko_pathway": "ko04061", "genes": ["IL2R", "CSF1"]}, {"kegg_id": "hsa04658", "name": "Th1 and Th2 cell differentiation - Homo sapiens (human)", "description": "Immunity to different classes of microorganisms is orchestrated by separate lineages of effector T helper (TH)-cells, which differentiate from naive CD4+ precursor cells in response to cues provided by antigen presenting cells (APC) and include T helper type 1 (Th1) and Th2. Th1 cells are characterized by the transcription factor T-bet and signal transducer and activator of transcription (STAT) 4, and the production of IFN-gamma. These cells stimulate strong cell-mediated immune responses, particularly against intracellular pathogens. On the other hand, transcription factors like GATA-3 and STAT6 drive the generation of Th2 cells that produce IL-4, IL-5 and IL-13 and are necessary for inducing the humoral response to combat parasitic helminths (type 2 immunity) and isotype switching to IgG1 and IgE. The balance between Th1/Th2 subsets determines the susceptibility to disease states, where the improper development of Th2 cells can lead to allergy, while an overactive Th1 response can lead to autoimmunity.", "class": "Organismal Systems; Immune system", "pathway_map": "hsa04658  Th1 and Th2 cell differentiation", "drug": ["D00107  Tacrolimus (USP/INN)", "D00184  Cyclosporine (USP)", "D05092  Muromonab-CD3 (JAN/USAN/INN)", "D05480  Pimecrolimus (JAN/USAN/INN)", "D08556  Tacrolimus (INN)", "D09013  Teplizumab (USAN/INN)", "D09033  Voclosporin (JAN/USAN/INN)", "D09190  Anti-human thymocyte immunoglobulin, rabbit (JAN)", "D10871  Filgotinib (USAN/INN)", "D10872  Filgotinib hydrochloride (USAN)", "D10981  Rovalpituzumab tesirine (USAN/INN)", "D11046  Delgocitinib (JAN/USAN/INN)", "D11106  Filgotinib maleate (JAN/USAN)", "D11117  Rovalpituzumab (USAN)", "D11400  Abrocitinib (JAN/USAN)", "D11537  Brepocitinib (USAN)", "D11538  Brepocitinib tosylate (USAN)", "D11817  Deucravacitinib (JAN/USAN)", "D12118  Nezulcitinib (USAN)", "D12211  Ivarmacitinib (USAN)", "D12212  Ivarmacitinib sulfate (USAN)", "D12368  Epcoritamab (USAN/INN)", "D12721  Avitotamig (USAN)", "D12724  Forimtamig (USAN/INN)", "D12725  Lomedeucitinib (USAN)", "D12786  Lepzacitinib (USAN)"], "dblinks": "GO: 0045063  0045064", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["10683  DLL3; delta like canonical Notch ligand 3 [KO:K06051]", "28514  DLL1; delta like canonical Notch ligand 1 [KO:K06051]", "54567  DLL4; delta like canonical Notch ligand 4 [KO:K06051]", "4854  NOTCH3; notch receptor 3 [KO:K20995]", "55534  MAML3; mastermind like transcriptional coactivator 3 [KO:K06061]", "84441  MAML2; mastermind like transcriptional coactivator 2 [KO:K06061]", "9794  MAML1; mastermind like transcriptional coactivator 1 [KO:K06061]", "11317  RBPJL; recombination signal binding protein for immunoglobulin kappa J region like [KO:K06053]", "3516  RBPJ; recombination signal binding protein for immunoglobulin kappa J region [KO:K06053]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "3458  IFNG; interferon gamma [KO:K04687]", "3459  IFNGR1; interferon gamma receptor 1 [KO:K05132]", "3460  IFNGR2; interferon gamma receptor 2 [KO:K05133]", "3716  JAK1; Janus kinase 1 [KO:K11217] [EC:2.7.10.2]", "3717  JAK2; Janus kinase 2 [KO:K04447] [EC:2.7.10.2]", "6772  STAT1; signal transducer and activator of transcription 1 [KO:K11220]", "3592  IL12A; interleukin 12A [KO:K05406]", "3593  IL12B; interleukin 12B [KO:K05425]", "3594  IL12RB1; interleukin 12 receptor subunit beta 1 [KO:K05063]", "3595  IL12RB2; interleukin 12 receptor subunit beta 2 [KO:K05064]", "7297  TYK2; tyrosine kinase 2 [KO:K11219] [EC:2.7.10.2]", "6775  STAT4; signal transducer and activator of transcription 4 [KO:K11222]", "30009  TBX21; T-box transcription factor 21 [KO:K10166]", "864  RUNX3; RUNX family transcription factor 3 [KO:K09279]", "3108  HLA-DMA; major histocompatibility complex, class II, DM alpha [KO:K06752]", "3109  HLA-DMB; major histocompatibility complex, class II, DM beta [KO:K06752]", "3111  HLA-DOA; major histocompatibility complex, class II, DO alpha [KO:K06752]", "3112  HLA-DOB; major histocompatibility complex, class II, DO beta [KO:K06752]", "3113  HLA-DPA1; major histocompatibility complex, class II, DP alpha 1 [KO:K06752]", "3115  HLA-DPB1; major histocompatibility complex, class II, DP beta 1 [KO:K06752]", "3117  HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 [KO:K06752]", "3118  HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2 [KO:K06752]", "3119  HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 [KO:K06752]", "3122  HLA-DRA; major histocompatibility complex, class II, DR alpha [KO:K06752]", "3123  HLA-DRB1; major histocompatibility complex, class II, DR beta 1 [KO:K06752]", "3125  HLA-DRB3; major histocompatibility complex, class II, DR beta 3 [KO:K06752]", "3126  HLA-DRB4; major histocompatibility complex, class II, DR beta 4 [KO:K06752]", "3127  HLA-DRB5; major histocompatibility complex, class II, DR beta 5 [KO:K06752]", "920  CD4; CD4 molecule [KO:K06454]", "3932  LCK; LCK proto-oncogene, Src family tyrosine kinase [KO:K05856] [EC:2.7.10.2]", "916  CD3E; CD3 epsilon subunit of T-cell receptor complex [KO:K06451]", "917  CD3G; CD3 gamma subunit of T-cell receptor complex [KO:K06452]", "919  CD247; CD247 molecule [KO:K06453]", "915  CD3D; CD3 delta subunit of T-cell receptor complex [KO:K06450]", "7535  ZAP70; zeta chain of T cell receptor associated protein kinase 70 [KO:K07360] [EC:2.7.10.2]", "27040  LAT; linker for activation of T cells [KO:K07362]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "5530  PPP3CA; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]", "5532  PPP3CB; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]", "5533  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]", "5534  PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]", "5535  PPP3R2; protein phosphatase 3 regulatory subunit B, beta [KO:K06268]", "4772  NFATC1; nuclear factor of activated T cells 1 [KO:K04446]", "4773  NFATC2; nuclear factor of activated T cells 2 [KO:K17332]", "4775  NFATC3; nuclear factor of activated T cells 3 [KO:K17333]", "5588  PRKCQ; protein kinase C theta [KO:K18052] [EC:2.7.11.13]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "4793  NFKBIB; NFKB inhibitor beta [KO:K02581]", "4794  NFKBIE; NFKB inhibitor epsilon [KO:K05872]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "3558  IL2; interleukin 2 [KO:K05429]", "3559  IL2RA; interleukin 2 receptor subunit alpha [KO:K05068]", "3560  IL2RB; interleukin 2 receptor subunit beta [KO:K05069]", "3561  IL2RG; interleukin 2 receptor subunit gamma [KO:K05070]", "3718  JAK3; Janus kinase 3 [KO:K11218] [EC:2.7.10.2]", "6776  STAT5A; signal transducer and activator of transcription 5A [KO:K11223]", "6777  STAT5B; signal transducer and activator of transcription 5B [KO:K11224]", "3565  IL4; interleukin 4 [KO:K05430]", "3566  IL4R; interleukin 4 receptor [KO:K05071]", "6778  STAT6; signal transducer and activator of transcription 6 [KO:K11225]", "2625  GATA3; GATA binding protein 3 [KO:K17895]", "3567  IL5; interleukin 5 [KO:K05428]", "3596  IL13; interleukin 13 [KO:K05435]", "4094  MAF; MAF bZIP transcription factor [KO:K09035]", "182  JAG1; jagged canonical Notch ligand 1 [KO:K06052]", "3714  JAG2; jagged canonical Notch ligand 2 [KO:K21635]", "4851  NOTCH1; notch receptor 1 [KO:K02599]", "4853  NOTCH2; notch receptor 2 [KO:K20994]"], "compound": ["C00076  Calcium cation", "C00165  Diacylglycerol", "C01245  D-myo-Inositol 1,4,5-trisphosphate"], "refs": [{"pmid": "19375293", "authors": "  Amsen D, Spilianakis CG, Flavell RA", "title": "How are T(H)1 and T(H)2 effector cells made?", "journal": "Curr Opin Immunol 21:153-60 (2009)", "doi": "10.1016/j.coi.2009.03.010"}, {"pmid": "22044277", "authors": "  Knosp CA, Johnston JA", "title": "Regulation of CD4+ T-cell polarization by suppressor of cytokine signalling proteins.", "journal": "Immunology 135:101-11 (2012)", "doi": "10.1111/j.1365-2567.2011.03520.x"}, {"pmid": "11752608", "authors": "  Dong C, Flavell RA", "title": "Control of T helper cell differentiation--in search of master genes.", "journal": "Sci STKE 2000:pe1 (2000)", "doi": "10.1126/stke.2000.49.pe1"}, {"pmid": "11121747", "authors": "  O'Garra A, Arai N", "title": "The molecular basis of T helper 1 and T helper 2 cell differentiation.", "journal": "Trends Cell Biol 10:542-50 (2000)", "doi": "10.1016/S0962-8924(00)01856-0"}, {"pmid": "23624818", "authors": "  Hong CC, Yao S, McCann SE, Dolnick RY, Wallace PK, Gong Z, Quan L, Lee KP, Evans SS, Repasky EA, Edge SB, Ambrosone CB", "title": "Pretreatment levels of circulating Th1 and Th2 cytokines, and their ratios, are associated with ER-negative and triple negative breast cancers.", "journal": "Breast Cancer Res Treat 139:477-88 (2013)", "doi": "10.1007/s10549-013-2549-3"}, {"pmid": "23405903", "authors": "  Kolls JK", "title": "CD4(+) T-cell subsets and host defense in the lung.", "journal": "Immunol Rev 252:156-63 (2013)", "doi": "10.1111/imr.12030"}, {"pmid": "20969597", "authors": "  Zhu J, Paul WE", "title": "Peripheral CD4+ T-cell differentiation regulated by networks of cytokines and transcription factors.", "journal": "Immunol Rev 238:247-62 (2010)", "doi": "10.1111/j.1600-065X.2010.00951.x"}, {"pmid": "19151746", "authors": "  Wilson CB, Rowell E, Sekimata M", "title": "Epigenetic control of T-helper-cell differentiation.", "journal": "Nat Rev Immunol 9:91-105 (2009)", "doi": "10.1038/nri2487"}, {"pmid": "15819694", "authors": "  Callard RE, Yates AJ", "title": "Immunology and mathematics: crossing the divide.", "journal": "Immunology 115:21-33 (2005)", "doi": "10.1111/j.1365-2567.2005.02142.x"}, {"pmid": "24113868", "authors": "  Lazarevic V, Glimcher LH, Lord GM", "title": "T-bet: a bridge between innate and adaptive immunity.", "journal": "Nat Rev Immunol 13:777-89 (2013)", "doi": "10.1038/nri3536"}, {"pmid": "12171942", "authors": "  Weigmann B, Neurath MF", "title": "T-bet and mucosal Th1 responses in the gastrointestinal tract.", "journal": "Gut 51:301-3 (2002)", "doi": "10.1136/gut.51.3.301"}, {"pmid": "19362457", "authors": "  Adamson AS, Collins K, Laurence A, O'Shea JJ", "title": "The Current STATus of lymphocyte signaling: new roles for old players.", "journal": "Curr Opin Immunol 21:161-6 (2009)", "doi": "10.1016/j.coi.2009.03.013"}, {"pmid": "20065998", "authors": "  Zhu J", "title": "Transcriptional regulation of Th2 cell differentiation.", "journal": "Immunol Cell Biol 88:244-9 (2010)", "doi": "10.1038/icb.2009.114"}, {"pmid": "26044597", "authors": "  Zhu J", "title": "T helper 2 (Th2) cell differentiation, type 2 innate lymphoid cell (ILC2) development and regulation of interleukin-4 (IL-4) and IL-13 production.", "journal": "Cytokine 75:14-24 (2015)", "doi": "10.1016/j.cyto.2015.05.010"}, {"pmid": "19151747", "authors": "  Ho IC, Tai TS, Pai SY", "title": "GATA3 and the T-cell lineage: essential functions before and after T-helper-2-cell differentiation.", "journal": "Nat Rev Immunol 9:125-35 (2009)", "doi": "10.1038/nri2476"}, {"pmid": "19165228", "authors": "  Amsen D, Antov A, Flavell RA", "title": "The different faces of Notch in T-helper-cell differentiation.", "journal": "Nat Rev Immunol 9:116-24 (2009)", "doi": "10.1038/nri2488"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04064  NF-kappa B signaling pathway", "hsa04330  Notch signaling pathway", "hsa04514  Cell adhesion molecules", "hsa04630  JAK-STAT signaling pathway", "hsa04660  T cell receptor signaling pathway"], "ko_pathway": "ko04658", "genes": ["IL2R", "MAPK13"]}, {"kegg_id": "hsa04659", "name": "Th17 cell differentiation - Homo sapiens (human)", "description": "Interleukin (IL)-17-producing helper T (Th17) cells serve as a subset of CD4+ T cells involved in epithelial cell- and neutrophil mediated immune responses against extracellular microbes and in the pathogenesis of autoimmune diseases. In vivo, Th17 differentiation requires antigen presentation and co-stimulation, and activation of antigen presenting-cells (APCs) to produce TGF-beta, IL-6, IL-1, IL-23 and IL-21. This initial activation results in the activation and up-regulation of STAT3, ROR(gamma)t and other transcriptional factors in CD4+ T cells, which bind to the promoter regions of the IL-17, IL-21 and IL-22 genes and induce IL-17, IL-21 and IL-22. In contrast, the differentiation of Th17 cells and their IL-17 expression are negatively regulated by IL-2, Th2 cytokine IL-4, IL-27 and Th1 cytokine IFN-gamma through STAT5, STAT6 and STAT1 activation, respectively. Retinoid acid and the combination of IL-2 and TGF-beta upregulate Foxp3, which also downregulates cytokines like IL-17 and IL-21. The inhibition of Th17 differentiation may serve as a protective strategy to 'fine-tune' the expression IL-17 so it does not cause excessive inflammation. Thus, balanced differentiation of Th cells is crucial for immunity and host protection.", "class": "Organismal Systems; Immune system", "pathway_map": "hsa04659  Th17 cell differentiation", "drug": ["D00094  Tretinoin (JAN/USP/INN)", "D00107  Tacrolimus (USP/INN)", "D00184  Cyclosporine (USP)", "D00316  Etretinate (JAN/USAN/INN)", "D00348  Isotretinoin (JAN/USP)", "D01112  Adapalene (JAN/USP/INN)", "D01132  Tazarotene (JAN/USAN/INN)", "D01516  Tretinoin tocoferil (JAN)", "D02754  Acitretin (USP/INN)", "D02815  Alitretinoin (USAN)", "D04636  Isotretinoin anisatil (USAN)", "D05092  Muromonab-CD3 (JAN/USAN/INN)", "D05480  Pimecrolimus (JAN/USAN/INN)", "D08556  Tacrolimus (INN)", "D09013  Teplizumab (USAN/INN)", "D09033  Voclosporin (JAN/USAN/INN)", "D09190  Anti-human thymocyte immunoglobulin, rabbit (JAN)", "D10871  Filgotinib (USAN/INN)", "D10872  Filgotinib hydrochloride (USAN)", "D10902  Afasevikumab (USAN/INN)", "D11046  Delgocitinib (JAN/USAN/INN)", "D11052  Risankizumab (USAN/INN)", "D11106  Filgotinib maleate (JAN/USAN)", "D11365  Tapinarof (JAN/USAN)", "D11537  Brepocitinib (USAN)", "D11538  Brepocitinib tosylate (USAN)", "D11817  Deucravacitinib (JAN/USAN)", "D11953  Efmarodocokin alfa (USAN/INN)", "D12211  Ivarmacitinib (USAN)", "D12212  Ivarmacitinib sulfate (USAN)", "D12274  Cedirogant (USAN/INN)", "D12278  Izokibep (USAN/INN)", "D12368  Epcoritamab (USAN/INN)", "D12721  Avitotamig (USAN)", "D12724  Forimtamig (USAN/INN)", "D12725  Lomedeucitinib (USAN)", "D12748  Levilimab (INN)", "D12784  Casdozokitug (USAN/INN)", "D12786  Lepzacitinib (USAN)"], "dblinks": "GO: 0072539", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["3553  IL1B; interleukin 1 beta [KO:K04519]", "3554  IL1R1; interleukin 1 receptor type 1 [KO:K04386]", "3556  IL1RAP; interleukin 1 receptor accessory protein [KO:K04723]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "3662  IRF4; interferon regulatory factor 4 [KO:K09445]", "7040  TGFB1; transforming growth factor beta 1 [KO:K13375]", "7046  TGFBR1; transforming growth factor beta receptor 1 [KO:K04674] [EC:2.7.11.30]", "7048  TGFBR2; transforming growth factor beta receptor 2 [KO:K04388] [EC:2.7.11.30]", "4087  SMAD2; SMAD family member 2 [KO:K04500]", "4088  SMAD3; SMAD family member 3 [KO:K23605]", "4089  SMAD4; SMAD family member 4 [KO:K04501]", "59067  IL21; interleukin 21 [KO:K05434]", "50615  IL21R; interleukin 21 receptor [KO:K05075]", "3561  IL2RG; interleukin 2 receptor subunit gamma [KO:K05070]", "3716  JAK1; Janus kinase 1 [KO:K11217] [EC:2.7.10.2]", "3718  JAK3; Janus kinase 3 [KO:K11218] [EC:2.7.10.2]", "3569  IL6; interleukin 6 [KO:K05405]", "3570  IL6R; interleukin 6 receptor [KO:K05055]", "3572  IL6ST; interleukin 6 cytokine family signal transducer [KO:K05060]", "3717  JAK2; Janus kinase 2 [KO:K04447] [EC:2.7.10.2]", "51561  IL23A; interleukin 23 subunit alpha [KO:K05426]", "149233  IL23R; interleukin 23 receptor [KO:K05065]", "3594  IL12RB1; interleukin 12 receptor subunit beta 1 [KO:K05063]", "7297  TYK2; tyrosine kinase 2 [KO:K11219] [EC:2.7.10.2]", "6774  STAT3; signal transducer and activator of transcription 3 [KO:K04692]", "6097  RORC; RAR related orphan receptor C [KO:K08534]", "6095  RORA; RAR related orphan receptor A [KO:K08532]", "3091  HIF1A; hypoxia inducible factor 1 subunit alpha [KO:K08268]", "3320  HSP90AA1; heat shock protein 90 alpha family class A member 1 [KO:K04079]", "3326  HSP90AB1; heat shock protein 90 alpha family class B member 1 [KO:K04079]", "196  AHR; aryl hydrocarbon receptor [KO:K09093]", "3605  IL17A; interleukin 17A [KO:K05489]", "112744  IL17F; interleukin 17F [KO:K05494]", "50616  IL22; interleukin 22 [KO:K05445]", "3108  HLA-DMA; major histocompatibility complex, class II, DM alpha [KO:K06752]", "3109  HLA-DMB; major histocompatibility complex, class II, DM beta [KO:K06752]", "3111  HLA-DOA; major histocompatibility complex, class II, DO alpha [KO:K06752]", "3112  HLA-DOB; major histocompatibility complex, class II, DO beta [KO:K06752]", "3113  HLA-DPA1; major histocompatibility complex, class II, DP alpha 1 [KO:K06752]", "3115  HLA-DPB1; major histocompatibility complex, class II, DP beta 1 [KO:K06752]", "3117  HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 [KO:K06752]", "3118  HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2 [KO:K06752]", "3119  HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 [KO:K06752]", "3122  HLA-DRA; major histocompatibility complex, class II, DR alpha [KO:K06752]", "3123  HLA-DRB1; major histocompatibility complex, class II, DR beta 1 [KO:K06752]", "3125  HLA-DRB3; major histocompatibility complex, class II, DR beta 3 [KO:K06752]", "3126  HLA-DRB4; major histocompatibility complex, class II, DR beta 4 [KO:K06752]", "3127  HLA-DRB5; major histocompatibility complex, class II, DR beta 5 [KO:K06752]", "920  CD4; CD4 molecule [KO:K06454]", "3932  LCK; LCK proto-oncogene, Src family tyrosine kinase [KO:K05856] [EC:2.7.10.2]", "916  CD3E; CD3 epsilon subunit of T-cell receptor complex [KO:K06451]", "917  CD3G; CD3 gamma subunit of T-cell receptor complex [KO:K06452]", "919  CD247; CD247 molecule [KO:K06453]", "915  CD3D; CD3 delta subunit of T-cell receptor complex [KO:K06450]", "7535  ZAP70; zeta chain of T cell receptor associated protein kinase 70 [KO:K07360] [EC:2.7.10.2]", "27040  LAT; linker for activation of T cells [KO:K07362]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "5530  PPP3CA; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]", "5532  PPP3CB; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]", "5533  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]", "5534  PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]", "5535  PPP3R2; protein phosphatase 3 regulatory subunit B, beta [KO:K06268]", "4772  NFATC1; nuclear factor of activated T cells 1 [KO:K04446]", "4773  NFATC2; nuclear factor of activated T cells 2 [KO:K17332]", "4775  NFATC3; nuclear factor of activated T cells 3 [KO:K17333]", "5588  PRKCQ; protein kinase C theta [KO:K18052] [EC:2.7.11.13]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "4793  NFKBIB; NFKB inhibitor beta [KO:K02581]", "4794  NFKBIE; NFKB inhibitor epsilon [KO:K05872]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "3565  IL4; interleukin 4 [KO:K05430]", "3566  IL4R; interleukin 4 receptor [KO:K05071]", "6778  STAT6; signal transducer and activator of transcription 6 [KO:K11225]", "2625  GATA3; GATA binding protein 3 [KO:K17895]", "861  RUNX1; RUNX family transcription factor 1 [KO:K08367]", "246778  IL27; interleukin 27 [KO:K22629]", "10148  EBI3; Epstein-Barr virus induced 3 [KO:K24476]", "9466  IL27RA; interleukin 27 receptor subunit alpha [KO:K19598]", "3458  IFNG; interferon gamma [KO:K04687]", "3459  IFNGR1; interferon gamma receptor 1 [KO:K05132]", "3460  IFNGR2; interferon gamma receptor 2 [KO:K05133]", "6772  STAT1; signal transducer and activator of transcription 1 [KO:K11220]", "30009  TBX21; T-box transcription factor 21 [KO:K10166]", "3558  IL2; interleukin 2 [KO:K05429]", "3559  IL2RA; interleukin 2 receptor subunit alpha [KO:K05068]", "3560  IL2RB; interleukin 2 receptor subunit beta [KO:K05069]", "6776  STAT5A; signal transducer and activator of transcription 5A [KO:K11223]", "6777  STAT5B; signal transducer and activator of transcription 5B [KO:K11224]", "50943  FOXP3; forkhead box P3 [KO:K10163]", "5914  RARA; retinoic acid receptor alpha [KO:K08527]", "6256  RXRA; retinoid X receptor alpha [KO:K08524]", "6257  RXRB; retinoid X receptor beta [KO:K08525]", "6258  RXRG; retinoid X receptor gamma [KO:K08526]"], "compound": ["C00076  Calcium cation", "C00165  Diacylglycerol", "C00777  Retinoate", "C01245  D-myo-Inositol 1,4,5-trisphosphate"], "refs": [{"pmid": "23325835", "authors": "  Muranski P, Restifo NP", "title": "Essentials of Th17 cell commitment and plasticity.", "journal": "Blood 121:2402-14 (2013)", "doi": "10.1182/blood-2012-09-378653"}, {"pmid": "19379825", "authors": "  O'Shea JJ, Steward-Tharp SM, Laurence A, Watford WT, Wei L, Adamson AS, Fan S", "title": "Signal transduction and Th17 cell differentiation.", "journal": "Microbes Infect 11:599-611 (2009)", "doi": "10.1016/j.micinf.2009.04.007"}, {"pmid": "21084214", "authors": "  Hirahara K, Ghoreschi K, Laurence A, Yang XP, Kanno Y, O'Shea JJ", "title": "Signal transduction pathways and transcriptional regulation in Th17 cell differentiation.", "journal": "Cytokine Growth Factor Rev 21:425-34 (2010)", "doi": "10.1016/j.cytogfr.2010.10.006"}, {"pmid": "18166487", "authors": "  Chen Z, Laurence A, O'Shea JJ", "title": "Signal transduction pathways and transcriptional regulation in the control of Th17 differentiation.", "journal": "Semin Immunol 19:400-8 (2007)", "doi": "10.1016/j.smim.2007.10.015"}, {"pmid": "22640807", "authors": "  Maddur MS, Miossec P, Kaveri SV, Bayry J", "title": "Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies.", "journal": "Am J Pathol 181:8-18 (2012)", "doi": "10.1016/j.ajpath.2012.03.044"}, {"pmid": "23036716", "authors": "  Hemdan NY, Birkenmeier G, Wichmann G", "title": "Key molecules in the differentiation and commitment program of T helper 17 (Th17) cells up-to-date.", "journal": "Immunol Lett 148:97-109 (2012)", "doi": "10.1016/j.imlet.2012.09.007"}, {"pmid": "18408735", "authors": "  Dong C", "title": "TH17 cells in development: an updated view of their molecular identity and genetic programming.", "journal": "Nat Rev Immunol 8:337-48 (2008)", "doi": "10.1038/nri2295"}, {"pmid": "20054607", "authors": "  Torchinsky MB, Blander JM", "title": "T helper 17 cells: discovery, function, and physiological trigger.", "journal": "Cell Mol Life Sci 67:1407-21 (2010)", "doi": "10.1007/s00018-009-0248-3"}, {"pmid": "19381306", "authors": "  Jetten AM", "title": "Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism.", "journal": "Nucl Recept Signal 7:e003 (2009)", "doi": "10.1621/nrs.07003"}, {"pmid": "22133865", "authors": "  Oestreich KJ, Weinmann AS", "title": "T-bet employs diverse regulatory mechanisms to repress transcription.", "journal": "Trends Immunol 33:78-83 (2012)", "doi": "10.1016/j.it.2011.10.005"}, {"pmid": "24325586", "authors": "  Manni ML, Robinson KM, Alcorn JF", "title": "A tale of two cytokines: IL-17 and IL-22 in asthma and infection.", "journal": "Expert Rev Respir Med 8:25-42 (2014)", "doi": "10.1586/17476348.2014.854167"}, {"pmid": "21776333", "authors": "  Sha Y, Markovic-Plese S", "title": "A role of IL-1R1 signaling in the differentiation of Th17 cells and the development of autoimmune diseases.", "journal": "Self Nonself 2:35-42 (2011)", "doi": "10.4161/self.2.1.15639"}, {"pmid": "20488727", "authors": "  Nakayama T, Yamashita M", "title": "The TCR-mediated signaling pathways that control the direction of helper T cell differentiation.", "journal": "Semin Immunol 22:303-9 (2010)", "doi": "10.1016/j.smim.2010.04.010"}, {"pmid": "21151104", "authors": "  Lazarevic V, Chen X, Shim JH, Hwang ES, Jang E, Bolm AN, Oukka M, Kuchroo VK, Glimcher LH", "title": "T-bet represses T(H)17 differentiation by preventing Runx1-mediated activation of the gene encoding RORgammat.", "journal": "Nat Immunol 12:96-104 (2011)", "doi": "10.1038/ni.1969"}, {"pmid": "22754770", "authors": "  Pan F, Barbi J, Pardoll DM", "title": "Hypoxia-inducible factor 1: A link between metabolism and T cell differentiation and a potential therapeutic target.", "journal": "Oncoimmunology 1:510-515 (2012)", "doi": "10.4161/onci.19457"}, {"pmid": "18362914", "authors": "  Veldhoen M, Hirota K, Westendorf AM, Buer J, Dumoutier L, Renauld JC, Stockinger B", "title": "The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins.", "journal": "Nature 453:106-9 (2008)", "doi": "10.1038/nature06881"}, {"pmid": "17768419", "authors": "  Deenick EK, Tangye SG", "title": "Autoimmunity: IL-21: a new player in Th17-cell differentiation.", "journal": "Immunol Cell Biol 85:503-5 (2007)", "doi": "10.1038/sj.icb.7100114"}, {"pmid": "26253381", "authors": "  Meka RR, Venkatesha SH, Dudics S, Acharya B, Moudgil KD", "title": "IL-27-induced modulation of autoimmunity and its therapeutic potential.", "journal": "Autoimmun Rev 14:1131-41 (2015)", "doi": "10.1016/j.autrev.2015.08.001"}, {"pmid": "16200068", "authors": "  Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q, Dong C", "title": "A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17.", "journal": "Nat Immunol 6:1133-41 (2005)", "doi": "10.1038/ni1261"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04064  NF-kappa B signaling pathway", "hsa04066  HIF-1 signaling pathway", "hsa04350  TGF-beta signaling pathway", "hsa04514  Cell adhesion molecules", "hsa04620  Toll-like receptor signaling pathway", "hsa04630  JAK-STAT signaling pathway", "hsa04660  T cell receptor signaling pathway", "hsa05321  Inflammatory bowel disease", "hsa05323  Rheumatoid arthritis"], "ko_pathway": "ko04659", "genes": ["IL2R", "MAPK13"]}, {"kegg_id": "hsa05162", "name": "Measles - Homo sapiens (human)", "description": "Measles virus (MV) is highly contagious virus that leads infant death worldwide. Humans are the unique natural reservoir for this virus. MV infection is characterized by virus-induced immune suppression that can lead to increased susceptibility to secondary bacterial and viral infections. The P, V and C proteins act as virulence factors to suppress innate immune response in host by inhibiting signaling for both type I IFN induction and JAK/STAT-mediated interferon-stimulated gene (ISG) induction. Moreover,  H protein expressed on viral particles and binding to SLAM or CD46,  as well as N protein liberated from infected cells and interacting with Fc-gamma R, causes an inhibition of IL-12 synthesis in dendritic cells. IL-12 is a key cytokine inducing cellular immune responses to protect host from the harm caused by pathogenic infections.", "class": "Human Diseases; Infectious disease: viral", "pathway_map": "hsa05162  Measles", "network": ["", "ELEMENT   N00684  MV F/H to CD28-PI3K signaling pathway", "N00685  MV V to RIG-I-IRF7/3 signaling pathway", "N00686  MV N to RIG-I-IRF7/3 signaling pathway", "N00687  MV V/C to RIG-I-IRF7/3 signaling pathway", "N00689  MV V/P/C to RIG-I-NFKB signaling pathway", "N00691  MV V to TLR7/9-IRF7 signaling pathway", "N00692  MV P to TLR2/4-NFKB signaling pathway", "N00693  MV V/P to IFN signaling pathway", "N00694  MV V/P/C to IFN signaling pathway", "N00695  MV V to p73-mediated transcription", "N00696  MV C to PKR-eIF2alpha signaling pathway", "N00697  HV P to p53-mediated transcription"], "disease": ["H00394  Measles"], "drug": ["D03305  Interferon alfa (NAMALWA) (JP18)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["4179  CD46; CD46 molecule [KO:K04007]", "4478  MSN; moesin [KO:K05763]", "6504  SLAMF1; signaling lymphocytic activation molecule family member 1 [KO:K06536]", "10332  CLEC4M; C-type lectin domain family 4 member M [KO:K06563]", "30835  CD209; CD209 molecule [KO:K06563]", "23586  RIGI; RNA sensor RIG-I [KO:K12646] [EC:5.6.2.6]", "64135  IFIH1; interferon induced with helicase C domain 1 [KO:K12647] [EC:5.6.2.6]", "57506  MAVS; mitochondrial antiviral signaling protein [KO:K12648]", "7187  TRAF3; TNF receptor associated factor 3 [KO:K03174]", "9641  IKBKE; inhibitor of nuclear factor kappa B kinase subunit epsilon [KO:K07211] [EC:2.7.11.10]", "29110  TBK1; TANK binding kinase 1 [KO:K05410] [EC:2.7.11.10]", "3661  IRF3; interferon regulatory factor 3 [KO:K05411]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "4793  NFKBIB; NFKB inhibitor beta [KO:K02581]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "51284  TLR7; toll like receptor 7 [KO:K05404]", "54106  TLR9; toll like receptor 9 [KO:K10161]", "4615  MYD88; MYD88 innate immune signal transduction adaptor [KO:K04729]", "3654  IRAK1; interleukin 1 receptor associated kinase 1 [KO:K04730] [EC:2.7.11.1]", "51135  IRAK4; interleukin 1 receptor associated kinase 4 [KO:K04733] [EC:2.7.11.1]", "3665  IRF7; interferon regulatory factor 7 [KO:K09447]", "3439  IFNA1; interferon alpha 1 [KO:K05414]", "3440  IFNA2; interferon alpha 2 [KO:K05414]", "3441  IFNA4; interferon alpha 4 [KO:K05414]", "3442  IFNA5; interferon alpha 5 [KO:K05414]", "3443  IFNA6; interferon alpha 6 [KO:K05414]", "3444  IFNA7; interferon alpha 7 [KO:K05414]", "3445  IFNA8; interferon alpha 8 [KO:K05414]", "3446  IFNA10; interferon alpha 10 [KO:K05414]", "3447  IFNA13; interferon alpha 13 [KO:K05414]", "3448  IFNA14; interferon alpha 14 [KO:K05414]", "3449  IFNA16; interferon alpha 16 [KO:K05414]", "3451  IFNA17; interferon alpha 17 [KO:K05414]", "3452  IFNA21; interferon alpha 21 [KO:K05414]", "3456  IFNB1; interferon beta 1 [KO:K05415]", "7097  TLR2; toll like receptor 2 [KO:K10159]", "7099  TLR4; toll like receptor 4 [KO:K10160]", "7189  TRAF6; TNF receptor associated factor 6 [KO:K03175] [EC:2.3.2.27]", "1457  CSNK2A1; casein kinase 2 alpha 1 [KO:K03097] [EC:2.7.11.1]", "1459  CSNK2A2; casein kinase 2 alpha 2 [KO:K03097] [EC:2.7.11.1]", "283106  CSNK2A3; casein kinase 2 alpha 3 [KO:K03097] [EC:2.7.11.1]", "1460  CSNK2B; casein kinase 2 beta [KO:K03115]", "7128  TNFAIP3; TNF alpha induced protein 3 [KO:K11859] [EC:3.4.19.12]", "6885  MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO:K04427] [EC:2.7.11.25]", "23118  TAB2; TGF-beta activated kinase 1 (MAP3K7) binding protein 2 [KO:K04404]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "3552  IL1A; interleukin 1 alpha [KO:K04383]", "3553  IL1B; interleukin 1 beta [KO:K04519]", "3569  IL6; interleukin 6 [KO:K05405]", "3592  IL12A; interleukin 12A [KO:K05406]", "3593  IL12B; interleukin 12B [KO:K05425]", "3454  IFNAR1; interferon alpha and beta receptor subunit 1 [KO:K05130]", "3455  IFNAR2; interferon alpha and beta receptor subunit 2 [KO:K05131]", "10399  RACK1; receptor for activated C kinase 1 [KO:K14753]", "3716  JAK1; Janus kinase 1 [KO:K11217] [EC:2.7.10.2]", "7297  TYK2; tyrosine kinase 2 [KO:K11219] [EC:2.7.10.2]", "6772  STAT1; signal transducer and activator of transcription 1 [KO:K11220]", "6773  STAT2; signal transducer and activator of transcription 2 [KO:K11221]", "10379  IRF9; interferon regulatory factor 9 [KO:K04693]", "4938  OAS1; 2'-5'-oligoadenylate synthetase 1 [KO:K14216] [EC:2.7.7.84]", "4939  OAS2; 2'-5'-oligoadenylate synthetase 2 [KO:K14216] [EC:2.7.7.84]", "4940  OAS3; 2'-5'-oligoadenylate synthetase 3 [KO:K14216] [EC:2.7.7.84]", "103  ADAR; adenosine deaminase RNA specific [KO:K12968] [EC:3.5.4.37]", "4599  MX1; MX dynamin like GTPase 1 [KO:K14754]", "4600  MX2; MX dynamin like GTPase 2 [KO:K14754]", "27102  EIF2AK1; eukaryotic translation initiation factor 2 alpha kinase 1 [KO:K16194] [EC:2.7.11.1]", "5610  EIF2AK2; eukaryotic translation initiation factor 2 alpha kinase 2 [KO:K16195] [EC:2.7.11.1]", "9451  EIF2AK3; eukaryotic translation initiation factor 2 alpha kinase 3 [KO:K08860] [EC:2.7.11.1]", "440275  EIF2AK4; eukaryotic translation initiation factor 2 alpha kinase 4 [KO:K16196] [EC:2.7.11.1]", "9367  RAB9A; RAB9A, member RAS oncogene family [KO:K07899]", "51209  RAB9B; RAB9B, member RAS oncogene family [KO:K07900]", "3312  HSPA8; heat shock protein family A (Hsp70) member 8 [KO:K03283]", "3303  HSPA1A; heat shock protein family A (Hsp70) member 1A [KO:K03283]", "3305  HSPA1L; heat shock protein family A (Hsp70) member 1 like [KO:K03283]", "3304  HSPA1B; heat shock protein family A (Hsp70) member 1B [KO:K03283]", "3310  HSPA6; heat shock protein family A (Hsp70) member 6 [KO:K03283]", "8667  EIF3H; eukaryotic translation initiation factor 3 subunit H [KO:K03247]", "1965  EIF2S1; eukaryotic translation initiation factor 2 subunit alpha [KO:K03237]", "25898  RCHY1; ring finger and CHY zinc finger domain containing 1 [KO:K10144] [EC:2.3.2.27]", "7157  TP53; tumor protein p53 [KO:K04451]", "7161  TP73; tumor protein p73 [KO:K10148]", "27113  BBC3; BCL2 binding component 3 [KO:K10132]", "356  FASLG; Fas ligand [KO:K04389]", "355  FAS; Fas cell surface death receptor [KO:K04390]", "8717  TRADD; TNFRSF1A associated via death domain [KO:K03171]", "8772  FADD; Fas associated via death domain [KO:K02373]", "841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]", "637  BID; BH3 interacting domain death agonist [KO:K04726]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "578  BAK1; BCL2 antagonist/killer 1 [KO:K14021]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]", "598  BCL2L1; BCL2 like 1 [KO:K04570]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]", "54205  CYCS; cytochrome c, somatic [KO:K08738]", "317  APAF1; apoptotic peptidase activating factor 1 [KO:K02084]", "842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "1027  CDKN1B; cyclin dependent kinase inhibitor 1B [KO:K06624]", "595  CCND1; cyclin D1 [KO:K04503]", "894  CCND2; cyclin D2 [KO:K10151]", "896  CCND3; cyclin D3 [KO:K10152]", "898  CCNE1; cyclin E1 [KO:K06626]", "9134  CCNE2; cyclin E2 [KO:K06626]", "1019  CDK4; cyclin dependent kinase 4 [KO:K02089] [EC:2.7.11.22]", "1021  CDK6; cyclin dependent kinase 6 [KO:K02091] [EC:2.7.11.22]", "1017  CDK2; cyclin dependent kinase 2 [KO:K02206] [EC:2.7.11.22]", "915  CD3D; CD3 delta subunit of T-cell receptor complex [KO:K06450]", "916  CD3E; CD3 epsilon subunit of T-cell receptor complex [KO:K06451]", "917  CD3G; CD3 gamma subunit of T-cell receptor complex [KO:K06452]", "940  CD28; CD28 molecule [KO:K06470]", "3558  IL2; interleukin 2 [KO:K05429]", "3559  IL2RA; interleukin 2 receptor subunit alpha [KO:K05068]", "3560  IL2RB; interleukin 2 receptor subunit beta [KO:K05069]", "3561  IL2RG; interleukin 2 receptor subunit gamma [KO:K05070]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "868  CBLB; Cbl proto-oncogene B [KO:K22517] [EC:2.3.2.27]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "3718  JAK3; Janus kinase 3 [KO:K11218] [EC:2.7.10.2]", "6774  STAT3; signal transducer and activator of transcription 3 [KO:K04692]", "6776  STAT5A; signal transducer and activator of transcription 5A [KO:K11223]", "6777  STAT5B; signal transducer and activator of transcription 5B [KO:K11224]", "2213  FCGR2B; Fc gamma receptor IIb [KO:K12560]"], "compound": ["C05981  Phosphatidylinositol-3,4,5-trisphosphate"], "refs": [{"pmid": "19203113", "authors": "  Schneider-Schaulies S, Schneider-Schaulies J", "title": "Measles virus-induced immunosuppression.", "journal": "Curr Top Microbiol Immunol 330:243-69 (2009)", "doi": "10.1007/978-3-540-70617-5_12"}, {"pmid": "19203114", "authors": "  Hahm B", "title": "Hostile communication of measles virus with host innate immunity and dendritic cells.", "journal": "Curr Top Microbiol Immunol 330:271-87 (2009)", "doi": "10.1007/978-3-540-70617-5_13"}, {"pmid": "19198566", "authors": "  Gerlier D, Valentin H", "title": "Measles virus interaction with host cells and impact on innate immunity.", "journal": "Curr Top Microbiol Immunol 329:163-91 (2009)", "doi": "10.1007/978-3-540-70523-9_8"}, {"pmid": "16690907", "authors": "  Schneider-Schaulies S, Dittmer U", "title": "Silencing T cells or T-cell silencing: concepts in virus-induced immunosuppression.", "journal": "J Gen Virol 87:1423-38 (2006)", "doi": "10.1099/vir.0.81713-0"}, {"pmid": "22049305", "authors": "  Avota E, Gassert E, Schneider-Schaulies S", "title": "Cytoskeletal dynamics: concepts in measles virus replication and immunomodulation.", "journal": "Viruses 3:102-17 (2011)", "doi": "10.3390/v3020102"}, {"pmid": "27854326", "authors": "  Jiang Y, Qin Y, Chen M", "title": "Host-Pathogen Interactions in Measles Virus Replication and Anti-Viral Immunity.", "journal": "Viruses 8:E308 (2016)", "doi": "10.3390/v8110308"}, {"pmid": "18922877", "authors": "  Pfaller CK, Conzelmann KK", "title": "Measles virus V protein is a decoy substrate for IkappaB kinase alpha and prevents Toll-like receptor 7/9-mediated interferon induction.", "journal": "J Virol 82:12365-73 (2008)", "doi": "10.1128/JVI.01321-08"}, {"pmid": "17720800", "authors": "  Yokota S, Okabayashi T, Yokosawa N, Fujii N", "title": "Measles virus P protein suppresses Toll-like receptor signal through up-regulation of ubiquitin-modifying enzyme A20.", "journal": "FASEB J 22:74-83 (2008)", "doi": "10.1096/fj.07-8976com"}, {"pmid": "23146309", "authors": "  Delpeut S, Noyce RS, Siu RW, Richardson CD", "title": "Host factors and measles virus replication.", "journal": "Curr Opin Virol 2:773-83 (2012)", "doi": "10.1016/j.coviro.2012.10.008"}, {"pmid": "26878224", "authors": "  Shah M, Anwar MA, Kim JH, Choi S", "title": "Advances in Antiviral Therapies Targeting Toll-like Receptors.", "journal": "Expert Opin Investig Drugs 25:437-53 (2016)", "doi": "10.1517/13543784.2016.1154040"}, {"pmid": "12620806", "authors": "  Yokota S, Saito H, Kubota T, Yokosawa N, Amano K, Fujii N", "title": "Measles virus suppresses interferon-alpha signaling pathway: suppression of Jak1 phosphorylation and association of viral accessory proteins, C and V, with interferon-alpha receptor complex.", "journal": "Virology 306:135-46 (2003)", "doi": "10.1016/S0042-6822(02)00026-0"}, {"pmid": "12804771", "authors": "  Takeuchi K, Kadota SI, Takeda M, Miyajima N, Nagata K", "title": "Measles virus V protein blocks interferon (IFN)-alpha/beta but not IFN-gamma signaling by inhibiting STAT1 and STAT2 phosphorylation.", "journal": "FEBS Lett 545:177-82 (2003)", "doi": "10.1016/S0014-5793(03)00528-3"}, {"pmid": "12805463", "authors": "  Palosaari H, Parisien JP, Rodriguez JJ, Ulane CM, Horvath CM", "title": "STAT protein interference and suppression of cytokine signal transduction by measles virus V protein.", "journal": "J Virol 77:7635-44 (2003)", "doi": "10.1128/JVI.77.13.7635-7644.2003"}, {"pmid": "14585342", "authors": "  Shaffer JA, Bellini WJ, Rota PA", "title": "The C protein of measles virus inhibits the type I interferon response.", "journal": "Virology 315:389-97 (2003)", "doi": "10.1016/S0042-6822(03)00537-3"}, {"pmid": "16971451", "authors": "  Carsillo T, Traylor Z, Choi C, Niewiesk S, Oglesbee M", "title": "hsp72, a host determinant of measles virus neurovirulence.", "journal": "J Virol 80:11031-9 (2006)", "doi": "10.1128/JVI.01438-06"}, {"pmid": "15914229", "authors": "  Zhang X, Bourhis JM, Longhi S, Carsillo T, Buccellato M, Morin B, Canard B, Oglesbee M", "title": "Hsp72 recognizes a P binding motif in the measles virus N protein C-terminus.", "journal": "Virology 337:162-74 (2005)", "doi": "10.1016/j.virol.2005.03.035"}, {"pmid": "29712906", "authors": "  Ke Z, Strauss JD, Hampton CM, Brindley MA, Dillard RS, Leon F, Lamb KM, Plemper RK, Wright ER", "title": "Promotion of virus assembly and organization by the measles virus matrix protein.", "journal": "Nat Commun 9:1736 (2018)", "doi": "10.1038/s41467-018-04058-2"}, {"pmid": "24155404", "authors": "  Pfaller CK, Radeke MJ, Cattaneo R, Samuel CE", "title": "Measles virus C protein impairs production of defective copyback double-stranded viral RNA and activation of protein kinase R.", "journal": "J Virol 88:456-68 (2014)", "doi": "10.1128/JVI.02572-13"}, {"pmid": "17686838", "authors": "  Sato H, Masuda M, Kanai M, Tsukiyama-Kohara K, Yoneda M, Kai C", "title": "Measles virus N protein inhibits host translation by binding to eIF3-p40.", "journal": "J Virol 81:11569-76 (2007)", "doi": "10.1128/JVI.00570-07"}, {"pmid": "19895323", "authors": "  Sion-Vardy N, Lasarov I, Delgado B, Gopas J, Benharroch D, Ariad S", "title": "Measles virus: evidence for association with lung cancer.", "journal": "Exp Lung Res 35:701-12 (2009)", "doi": "10.3109/01902140902853176"}, {"pmid": "16140759", "authors": "  Chen M, Cortay JC, Logan IR, Sapountzi V, Robson CN, Gerlier D", "title": "Inhibition of ubiquitination and stabilization of human ubiquitin E3 ligase PIRH2 by measles virus phosphoprotein.", "journal": "J Virol 79:11824-36 (2005)", "doi": "10.1128/JVI.79.18.11824-11836.2005"}, {"pmid": "16699046", "authors": "  Cruz CD, Palosaari H, Parisien JP, Devaux P, Cattaneo R, Ouchi T, Horvath CM", "title": "Measles virus V protein inhibits p53 family member p73.", "journal": "J Virol 80:5644-50 (2006)", "doi": "10.1128/JVI.02400-05"}, {"pmid": "10756053", "authors": "  Servet-Delprat C, Vidalain PO, Azocar O, Le Deist F, Fischer A, Rabourdin-Combe C", "title": "Consequences of Fas-mediated human dendritic cell apoptosis induced by measles virus.", "journal": "J Virol 74:4387-93 (2000)", "doi": "10.1128/JVI.74.9.4387-4393.2000"}, {"pmid": "20601611", "authors": "  Kushwah R, Hu J", "title": "Dendritic cell apoptosis: regulation of tolerance versus immunity.", "journal": "J Immunol 185:795-802 (2010)", "doi": "10.4049/jimmunol.1000325"}, {"pmid": "10590149", "authors": "  Vidalain PO, Azocar O, Lamouille B, Astier A, Rabourdin-Combe C, Servet-Delprat C", "title": "Measles virus induces functional TRAIL production by human dendritic cells.", "journal": "J Virol 74:556-9 (2000)", "doi": "10.1128/JVI.74.1.556-559.2000"}, {"pmid": "11846228", "authors": "  Vidalain PO, Azocar O, Rabourdin-Combe C, Servet-Delprat C", "title": "Measle virus-infected dendritic cells develop immunosuppressive and cytotoxic activities.", "journal": "Immunobiology 204:629-38 (2001)", "doi": "10.1078/0171-2985-00102"}, {"pmid": "10423127", "authors": "  Engelking O, Fedorov LM, Lilischkis R, ter Meulen V, Schneider-Schaulies S", "title": "Measles virus-induced immunosuppression in vitro is associated with deregulation of G1 cell cycle control proteins.", "journal": "J Gen Virol 80 ( Pt 7):1599-608 (1999)", "doi": "10.1099/0022-1317-80-7-1599"}, {"pmid": "30510918", "authors": "  Fan Y, Sanyal S, Bruzzone R", "title": "Breaking Bad: How Viruses Subvert the Cell Cycle.", "journal": "Front Cell Infect Microbiol 8:396 (2018)", "doi": "10.3389/fcimb.2018.00396"}, {"pmid": "20636817", "authors": "  Griffin DE", "title": "Measles virus-induced suppression of immune responses.", "journal": "Immunol Rev 236:176-89 (2010)", "doi": "10.1111/j.1600-065X.2010.00925.x"}, {"pmid": "11385511", "authors": "  Avota E, Avots A, Niewiesk S, Kane LP, Bommhardt U, ter Meulen V, Schneider-Schaulies S", "title": "Disruption of Akt kinase activation is important for immunosuppression induced by measles virus.", "journal": "Nat Med 7:725-31 (2001)", "doi": "10.1038/89106"}, {"pmid": "15308747", "authors": "  Avota E, Muller N, Klett M, Schneider-Schaulies S", "title": "Measles virus interacts with and alters signal transduction in T-cell lipid rafts.", "journal": "J Virol 78:9552-9 (2004)", "doi": "10.1128/JVI.78.17.9552-9559.2004"}, {"pmid": "16963735", "authors": "  Yanagi Y, Takeda M, Ohno S", "title": "Measles virus: cellular receptors, tropism and pathogenesis.", "journal": "J Gen Virol 87:2767-79 (2006)", "doi": "10.1099/vir.0.82221-0"}], "rel_pathway": ["hsa04110  Cell cycle", "hsa04115  p53 signaling pathway", "hsa04120  Ubiquitin mediated proteolysis", "hsa04210  Apoptosis", "hsa04620  Toll-like receptor signaling pathway", "hsa04622  RIG-I-like receptor signaling pathway", "hsa04630  JAK-STAT signaling pathway", "hsa04658  Th1 and Th2 cell differentiation", "hsa04660  T cell receptor signaling pathway"], "ko_pathway": "ko05162", "genes": ["IL2R", "TP53", "AKT2", "AKT1", "BAX"]}, {"kegg_id": "hsa04064", "name": "NF-kappa B signaling pathway - Homo sapiens (human)", "description": "Nuclear factor-kappa B (NF-kappa B) is the generic name of a family of transcription factors that function as dimers and regulate genes involved in immunity, inflammation and cell survival. There are several pathways leading to NF-kappa B-activation. The canonical pathway is induced by tumour necrosis factor-alpha (TNF-alpha), interleukin-1 (IL-1) or byproducts of bacterial and viral infections. This pathway relies on IKK- mediated IkappaB-alpha phosphorylation on Ser32 and 36, leading to its degradation, which allows the p50/p65 NF-kappa B dimer to enter the nucleus and activate gene transcription. Atypical pathways are IKK-independent and rely on phosphorylation of IkappaB-alpha on Tyr42 or on Ser residues in IkappaB-alpha PEST domain. The non-canonical pathway is triggered by particular members of the TNFR superfamily, such as lymphotoxin-beta (LT-beta) or BAFF. It involves NIK and IKK-alpha-mediated p100 phosphorylation and processing to p52, resulting in nuclear translocation of p52/RelB heterodimers.", "class": "Environmental Information Processing; Signal transduction", "pathway_map": "hsa04064  NF-kappa B signaling pathway", "network": ["", "ELEMENT   N00151  TNF-NFKB signaling pathway", "N00505  CD40-NFKB signaling pathway", "N00559  LIGHT-HVEM-NFKB signaling pathway", "N01797  EDA-EDAR signaling pathway", "N01798  TNFSF11-TNFRSF11A signaling pathway"], "drug": ["D00742  Etanercept (USAN/INN)", "D00754  Thalidomide (JAN/USP/INN)", "D01146  Iguratimod (JAN/INN)", "D02979  Ardenermin (USAN)", "D03068  Belimumab (USAN)", "D04687  Lenalidomide (JAN/USAN/INN)", "D04690  Lenercept (USAN/INN)", "D05263  Onercept (USAN/INN)", "D05393  Pegsunercept (USAN)", "D06193  Toralizumab (USAN/INN)", "D06619  Mifamurtide (USAN)", "D06635  Rilonacept (USAN/INN)", "D08562  Tasonermin (INN)", "D08866  Baminercept (USAN/INN)", "D08877  Briobacept (USAN)", "D09347  Fostamatinib (USAN)", "D09348  Fostamatinib disodium (USAN)", "D09730  Olaparib (JAN/USAN/INN)", "D09813  Lenalidomide hydrate (JAN)", "D10733  Talazoparib tosylate (USAN)", "D11122  Letolizumab (USAN/INN)", "D11127  Tibulizumab (USAN/INN)", "D11209  Entospletinib (USAN/INN)", "D11457  Fenebrutinib (USAN/INN)", "D11478  Branebrutinib (USAN)", "D11703  Opinercept (INN)", "D11789  Mivavotinib (USAN/INN)", "D11790  Mivavotinib citrate (USAN)", "D11873  Rilzabrutinib (JAN/USAN/INN)", "D11907  Rozibafusp alfa (USAN/INN)", "D12151  Ianalumab (USAN/INN)", "D12158  Elsubrutinib (USAN/INN)", "D12160  Orelabrutinib (USAN/INN)", "D12167  Zimlovisertib (USAN)", "D12181  Edasalonexent (USAN/INN)", "D12213  Tolebrutinib (JAN/USAN/INN)", "D12285  Remibrutinib (JAN/USAN/INN)", "D12352  Eclitasertib (USAN/INN)", "D12383  Edralbrutinib (USAN/INN)", "D12411  Emavusertib (USAN/INN)", "D12412  Emavusertib hydrochloride (USAN)", "D12467  Evobrutinib (USAN/INN)", "D12504  Nemtabrutinib (USAN/INN)", "D12532  Emavusertib mesylate (USAN)", "D12533  Emavusertib maleate (USAN)", "D12538  Emavusertib phosphate (USAN)", "D12539  emavusertib tosylate (USAN)", "D12648  Quisovalimab (USAN/INN)", "D12656  Adakitug (USAN)", "D12821  Flizasertib (USAN/INN)", "D12846  Ocadusertib (USAN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["3932  LCK; LCK proto-oncogene, Src family tyrosine kinase [KO:K05856] [EC:2.7.10.2]", "7535  ZAP70; zeta chain of T cell receptor associated protein kinase 70 [KO:K07360] [EC:2.7.10.2]", "27040  LAT; linker for activation of T cells [KO:K07362]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "5588  PRKCQ; protein kinase C theta [KO:K18052] [EC:2.7.11.13]", "102723407  IGH; immunoglobulin heavy variable 4-38-2-like [KO:K06856]", "6850  SYK; spleen associated tyrosine kinase [KO:K05855] [EC:2.7.10.2]", "4067  LYN; LYN proto-oncogene, Src family tyrosine kinase [KO:K05854] [EC:2.7.10.2]", "29760  BLNK; B cell linker [KO:K07371]", "695  BTK; Bruton tyrosine kinase [KO:K07370] [EC:2.7.10.2]", "5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "29775  CARD10; caspase recruitment domain family member 10 [KO:K20912]", "84433  CARD11; caspase recruitment domain family member 11 [KO:K07367]", "79092  CARD14; caspase recruitment domain family member 14 [KO:K20913]", "8915  BCL10; BCL10 immune signaling adaptor [KO:K07368]", "10892  MALT1; MALT1 paracaspase [KO:K07369] [EC:3.4.22.-]", "3553  IL1B; interleukin 1 beta [KO:K04519]", "3554  IL1R1; interleukin 1 receptor type 1 [KO:K04386]", "4615  MYD88; MYD88 innate immune signal transduction adaptor [KO:K04729]", "3654  IRAK1; interleukin 1 receptor associated kinase 1 [KO:K04730] [EC:2.7.11.1]", "51135  IRAK4; interleukin 1 receptor associated kinase 4 [KO:K04733] [EC:2.7.11.1]", "7189  TRAF6; TNF receptor associated factor 6 [KO:K03175] [EC:2.3.2.27]", "7124  TNF; tumor necrosis factor [KO:K03156]", "7132  TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158]", "8737  RIPK1; receptor interacting serine/threonine kinase 1 [KO:K02861] [EC:2.7.11.1]", "8717  TRADD; TNFRSF1A associated via death domain [KO:K03171]", "7186  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]", "7188  TRAF5; TNF receptor associated factor 5 [KO:K09849]", "329  BIRC2; baculoviral IAP repeat containing 2 [KO:K16060]", "330  BIRC3; baculoviral IAP repeat containing 3 [KO:K16060]", "1896  EDA; ectodysplasin A [KO:K05480]", "10913  EDAR; ectodysplasin A receptor [KO:K05162]", "128178  EDARADD; EDAR associated via death domain [KO:K23324]", "1540  CYLD; CYLD lysine 63 deubiquitinase [KO:K08601] [EC:3.4.19.12]", "60401  EDA2R; ectodysplasin A2 receptor [KO:K05163]", "23586  RIGI; RNA sensor RIG-I [KO:K12646] [EC:5.6.2.6]", "7706  TRIM25; tripartite motif containing 25 [KO:K10652] [EC:2.3.2.27]", "3929  LBP; lipopolysaccharide binding protein [KO:K05399]", "929  CD14; CD14 molecule [KO:K04391]", "7099  TLR4; toll like receptor 4 [KO:K10160]", "23643  LY96; lymphocyte antigen 96 [KO:K05400]", "114609  TIRAP; TIR domain containing adaptor protein [KO:K05403]", "353376  TICAM2; TIR domain containing adaptor molecule 2 [KO:K05409]", "148022  TICAM1; TIR domain containing adaptor molecule 1 [KO:K05842]", "959  CD40LG; CD40 ligand [KO:K03161]", "958  CD40; CD40 molecule [KO:K03160]", "7187  TRAF3; TNF receptor associated factor 3 [KO:K03174]", "8600  TNFSF11; TNF superfamily member 11 [KO:K05473]", "8792  TNFRSF11A; TNF receptor superfamily member 11a [KO:K05147]", "4049  LTA; lymphotoxin alpha [KO:K05468]", "4050  LTB; lymphotoxin beta [KO:K03157]", "8740  TNFSF14; TNF superfamily member 14 [KO:K05477]", "4055  LTBR; lymphotoxin beta receptor [KO:K03159]", "9020  MAP3K14; mitogen-activated protein kinase kinase kinase 14 [KO:K04466] [EC:2.7.11.25]", "6885  MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO:K04427] [EC:2.7.11.25]", "10454  TAB1; TGF-beta activated kinase 1 (MAP3K7) binding protein 1 [KO:K04403]", "23118  TAB2; TGF-beta activated kinase 1 (MAP3K7) binding protein 2 [KO:K04404]", "257397  TAB3; TGF-beta activated kinase 1 (MAP3K7) binding protein 3 [KO:K12793]", "10673  TNFSF13B; TNF superfamily member 13b [KO:K05476]", "115650  TNFRSF13C; TNF receptor superfamily member 13C [KO:K05151]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "142  PARP1; poly(ADP-ribose) polymerase 1 [KO:K24070] [EC:2.4.2.30]", "51588  PIAS4; protein inhibitor of activated STAT 4 [KO:K16065] [EC:2.3.2.27]", "7329  UBE2I; ubiquitin conjugating enzyme E2 I [KO:K10577]", "472  ATM; ATM serine/threonine kinase [KO:K04728] [EC:2.7.11.1]", "55367  PIDD1; p53-induced death domain protein 1 [KO:K10130]", "23085  ERC1; ELKS/RAB6-interacting/CAST family member 1 [KO:K16072]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "10848  PPP1R13L; protein phosphatase 1 regulatory subunit 13 like [KO:K27356]", "8837  CFLAR; CASP8 and FADD like apoptosis regulator [KO:K04724]", "331  XIAP; X-linked inhibitor of apoptosis [KO:K04725] [EC:2.3.2.27]", "598  BCL2L1; BCL2 like 1 [KO:K04570]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]", "1647  GADD45A; growth arrest and DNA damage inducible alpha [KO:K04402]", "4616  GADD45B; growth arrest and DNA damage inducible beta [KO:K04402]", "10912  GADD45G; growth arrest and DNA damage inducible gamma [KO:K04402]", "7185  TRAF1; TNF receptor associated factor 1 [KO:K03172]", "597  BCL2A1; BCL2 related protein A1 [KO:K02162]", "4791  NFKB2; nuclear factor kappa B subunit 2 [KO:K04469]", "3576  CXCL8; C-X-C motif chemokine ligand 8 [KO:K10030]", "7128  TNFAIP3; TNF alpha induced protein 3 [KO:K11859] [EC:3.4.19.12]", "5743  PTGS2; prostaglandin-endoperoxide synthase 2 [KO:K11987] [EC:1.14.99.1]", "6351  CCL4; C-C motif chemokine ligand 4 [KO:K12964]", "9560  CCL4L2; C-C motif chemokine ligand 4 like 2 [KO:K12964]", "388372  CCL4L1; C-C motif chemokine ligand 4 like 1 [KO:K12964]", "2919  CXCL1; C-X-C motif chemokine ligand 1 [KO:K05505]", "2920  CXCL2; C-X-C motif chemokine ligand 2 [KO:K05505]", "2921  CXCL3; C-X-C motif chemokine ligand 3 [KO:K05505]", "7412  VCAM1; vascular cell adhesion molecule 1 [KO:K06527]", "5328  PLAU; plasminogen activator, urokinase [KO:K01348] [EC:3.4.21.73]", "1457  CSNK2A1; casein kinase 2 alpha 1 [KO:K03097] [EC:2.7.11.1]", "1459  CSNK2A2; casein kinase 2 alpha 2 [KO:K03097] [EC:2.7.11.1]", "283106  CSNK2A3; casein kinase 2 alpha 3 [KO:K03097] [EC:2.7.11.1]", "1460  CSNK2B; casein kinase 2 beta [KO:K03115]", "5971  RELB; RELB proto-oncogene, NF-kB subunit [KO:K09253]", "6357  CCL13; C-C motif chemokine ligand 13 [KO:K16595]", "6363  CCL19; C-C motif chemokine ligand 19 [KO:K05512]", "6366  CCL21; C-C motif chemokine ligand 21 [KO:K16062]", "6387  CXCL12; C-X-C motif chemokine ligand 12 [KO:K10031]", "3383  ICAM1; intercellular adhesion molecule 1 [KO:K06490]"], "compound": ["C00076  Calcium cation", "C00165  Diacylglycerol", "C01245  D-myo-Inositol 1,4,5-trisphosphate"], "refs": [{"pmid": "21772278", "authors": "  Oeckinghaus A, Hayden MS, Ghosh S", "title": "Crosstalk in NF-kappaB signaling pathways.", "journal": "Nat Immunol 12:695-708 (2011)", "doi": "10.1038/ni.2065"}, {"pmid": "19203223", "authors": "  Gloire G, Piette J", "title": "Redox regulation of nuclear post-translational modifications during NF-kappaB activation.", "journal": "Antioxid Redox Signal 11:2209-22 (2009)", "doi": "10.1089/ARS.2009.2463"}, {"pmid": "17183360", "authors": "  Perkins ND", "title": "Integrating cell-signalling pathways with NF-kappaB and IKK function.", "journal": "Nat Rev Mol Cell Biol 8:49-62 (2007)", "doi": "10.1038/nrm2083"}, {"pmid": "16264088", "authors": "  Lindstrom TM, Bennett PR", "title": "The role of nuclear factor kappa B in human labour.", "journal": "Reproduction 130:569-81 (2005)", "doi": "10.1530/rep.1.00197"}, {"pmid": "22017430", "authors": "  Razani B, Reichardt AD, Cheng G", "title": "Non-canonical NF-kappaB signaling activation and regulation: principles and perspectives.", "journal": "Immunol Rev 244:44-54 (2011)", "doi": "10.1111/j.1600-065X.2011.01059.x"}, {"pmid": "21173796", "authors": "  Sun SC", "title": "Non-canonical NF-kappaB signaling pathway.", "journal": "Cell Res 21:71-85 (2011)", "doi": "10.1038/cr.2010.177"}, {"pmid": "17431096", "authors": "  Neumann M, Naumann M", "title": "Beyond IkappaBs: alternative regulation of NF-kappaB activity.", "journal": "FASEB J 21:2642-54 (2007)", "doi": "10.1096/fj.06-7615rev"}, {"pmid": "22119011", "authors": "  Verhelst K, Carpentier I, Beyaert R", "title": "Regulation of TNF-induced NF-kappaB activation by different cytoplasmic ubiquitination events.", "journal": "Cytokine Growth Factor Rev 22:277-86 (2011)", "doi": "10.1016/j.cytogfr.2011.11.002"}, {"pmid": "22017435", "authors": "  Rickert RC, Jellusova J, Miletic AV", "title": "Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease.", "journal": "Immunol Rev 244:115-33 (2011)", "doi": "10.1111/j.1600-065X.2011.01067.x"}, {"pmid": "21232019", "authors": "  Naude PJ, den Boer JA, Luiten PG, Eisel UL", "title": "Tumor necrosis factor receptor cross-talk.", "journal": "FEBS J 278:888-98 (2011)", "doi": "10.1111/j.1742-4658.2011.08017.x"}, {"pmid": "16984817", "authors": "  Grivennikov SI, Kuprash DV, Liu ZG, Nedospasov SA", "title": "Intracellular signals and events activated by cytokines of the tumor necrosis factor superfamily: From simple paradigms to complex mechanisms.", "journal": "Int Rev Cytol 252:129-61 (2006)", "doi": "10.1016/S0074-7696(06)52002-9"}, {"pmid": "16356770", "authors": "  Wada T, Nakashima T, Hiroshi N, Penninger JM", "title": "RANKL-RANK signaling in osteoclastogenesis and bone disease.", "journal": "Trends Mol Med 12:17-25 (2006)", "doi": "10.1016/j.molmed.2005.11.007"}, {"pmid": "17098202", "authors": "  Schulze-Luehrmann J, Ghosh S", "title": "Antigen-receptor signaling to nuclear factor kappa B.", "journal": "Immunity 25:701-15 (2006)", "doi": "10.1016/j.immuni.2006.10.010"}, {"pmid": "15134788", "authors": "  Weil R, Israel A", "title": "T-cell-receptor- and B-cell-receptor-mediated activation of NF-kappaB in lymphocytes.", "journal": "Curr Opin Immunol 16:374-81 (2004)", "doi": "10.1016/j.coi.2004.03.003"}, {"pmid": "15905862", "authors": "  Siebenlist U, Brown K, Claudio E", "title": "Control of lymphocyte development by nuclear factor-kappaB.", "journal": "Nat Rev Immunol 5:435-45 (2005)", "doi": "10.1038/nri1629"}, {"pmid": "14657271", "authors": "  Lucas PC, McAllister-Lucas LM, Nunez G", "title": "NF-kappaB signaling in lymphocytes: a new cast of characters.", "journal": "J Cell Sci 117:31-9 (2004)", "doi": "10.1242/jcs.00904"}, {"pmid": "19726767", "authors": "  Khan WN", "title": "B cell receptor and BAFF receptor signaling regulation of B cell homeostasis.", "journal": "J Immunol 183:3561-7 (2009)", "doi": "10.4049/jimmunol.0800933"}, {"pmid": "19302050", "authors": "  Vallabhapurapu S, Karin M", "title": "Regulation and function of NF-kappaB transcription factors in the immune system.", "journal": "Annu Rev Immunol 27:693-733 (2009)", "doi": "10.1146/annurev.immunol.021908.132641"}, {"pmid": "17047224", "authors": "  Hacker H, Karin M", "title": "Regulation and function of IKK and IKK-related kinases.", "journal": "Sci STKE 2006:re13 (2006)", "doi": "10.1126/stke.3572006re13"}, {"pmid": "21872579", "authors": "  Sabatel H, Pirlot C, Piette J, Habraken Y", "title": "Importance of PIKKs in NF-kappaB activation by genotoxic stress.", "journal": "Biochem Pharmacol 82:1371-83 (2011)", "doi": "10.1016/j.bcp.2011.07.105"}, {"pmid": "21187855", "authors": "  Miyamoto S", "title": "Nuclear initiated NF-kappaB signaling: NEMO and ATM take center stage.", "journal": "Cell Res 21:116-30 (2011)", "doi": "10.1038/cr.2010.179"}, {"pmid": "18832076", "authors": "  Brzoska K, Szumiel I", "title": "Signalling loops and linear pathways: NF-kappaB activation in response to genotoxic stress.", "journal": "Mutagenesis 24:1-8 (2009)", "doi": "10.1093/mutage/gen056"}, {"pmid": "17607554", "authors": "  Wu ZH, Miyamoto S", "title": "Many faces of NF-kappaB signaling induced by genotoxic stress.", "journal": "J Mol Med (Berl) 85:1187-202 (2007)", "doi": "10.1007/s00109-007-0227-9"}, {"pmid": "22390971", "authors": "  Maelfait J, Beyaert R", "title": "Emerging role of ubiquitination in antiviral RIG-I signaling.", "journal": "Microbiol Mol Biol Rev 76:33-45 (2012)", "doi": "10.1128/MMBR.05012-11"}, {"pmid": "18613837", "authors": "  Ware CF", "title": "Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways.", "journal": "Immunol Rev 223:186-201 (2008)", "doi": "10.1111/j.1600-065X.2008.00629.x"}, {"pmid": "15546385", "authors": "  Schneider K, Potter KG, Ware CF", "title": "Lymphotoxin and LIGHT signaling pathways and target genes.", "journal": "Immunol Rev 202:49-66 (2004)", "doi": "10.1111/j.0105-2896.2004.00206.x"}, {"pmid": "22152226", "authors": "  Remouchamps C, Boutaffala L, Ganeff C, Dejardin E", "title": "Biology and signal transduction pathways of the Lymphotoxin-alphabeta/LTbetaR system.", "journal": "Cytokine Growth Factor Rev 22:301-10 (2011)", "doi": "10.1016/j.cytogfr.2011.11.007"}, {"pmid": "21135871", "authors": "  Liu S, Chen ZJ", "title": "Expanding role of ubiquitination in NF-kappaB signaling.", "journal": "Cell Res 21:6-21 (2011)", "doi": "10.1038/cr.2010.170"}, {"pmid": "19489733", "authors": "  Skaug B, Jiang X, Chen ZJ", "title": "The role of ubiquitin in NF-kappaB regulatory pathways.", "journal": "Annu Rev Biochem 78:769-96 (2009)", "doi": "10.1146/annurev.biochem.78.070907.102750"}, {"pmid": "20300215", "authors": "  Wertz IE, Dixit VM", "title": "Signaling to NF-kappaB: regulation by ubiquitination.", "journal": "Cold Spring Harb Perspect Biol 2:a003350 (2010)", "doi": "10.1101/cshperspect.a003350"}, {"pmid": "11875461", "authors": "  Karin M, Lin A", "title": "NF-kappaB at the crossroads of life and death.", "journal": "Nat Immunol 3:221-7 (2002)", "doi": "10.1038/ni0302-221"}, {"pmid": "12654254", "authors": "  Lin A, Karin M", "title": "NF-kappaB in cancer: a marked target.", "journal": "Semin Cancer Biol 13:107-14 (2003)", "doi": "10.1016/S1044-579X(02)00128-1"}, {"pmid": "16251197", "authors": "  Morlon A, Munnich A, Smahi A", "title": "TAB2, TRAF6 and TAK1 are involved in NF-kappaB activation induced by the TNF-receptor, Edar and its adaptator Edaradd.", "journal": "Hum Mol Genet 14:3751-7 (2005)", "doi": "10.1093/hmg/ddi405"}, {"pmid": "24070496", "authors": "  Sadier A, Viriot L, Pantalacci S, Laudet V", "title": "The ectodysplasin pathway: from diseases to adaptations.", "journal": "Trends Genet 30:24-31 (2014)", "doi": "10.1016/j.tig.2013.08.006"}, {"pmid": "26260321", "authors": "  Verhelst K, Gardam S, Borghi A, Kreike M, Carpentier I, Beyaert R", "title": "XEDAR activates the non-canonical NF-kappaB pathway.", "journal": "Biochem Biophys Res Commun 465:275-80 (2015)", "doi": "10.1016/j.bbrc.2015.08.019"}, {"pmid": "27508514", "authors": "  McDaniel DK, Eden K, Ringel VM, Allen IC", "title": "Emerging Roles for Noncanonical NF-kappaB Signaling in the Modulation of Inflammatory Bowel Disease Pathobiology.", "journal": "Inflamm Bowel Dis 22:2265-79 (2016)", "doi": "10.1097/MIB.0000000000000858"}, {"pmid": "12787560", "authors": "  Mikkola ML, Thesleff I", "title": "Ectodysplasin signaling in development.", "journal": "Cytokine Growth Factor Rev 14:211-24 (2003)", "doi": "10.1016/S1359-6101(03)00020-0"}], "rel_pathway": ["hsa03050  Proteasome", "hsa04020  Calcium signaling pathway", "hsa04060  Cytokine-cytokine receptor interaction", "hsa04120  Ubiquitin mediated proteolysis", "hsa04210  Apoptosis", "hsa04380  Osteoclast differentiation", "hsa04620  Toll-like receptor signaling pathway", "hsa04622  RIG-I-like receptor signaling pathway", "hsa04660  T cell receptor signaling pathway", "hsa04662  B cell receptor signaling pathway"], "ko_pathway": "ko04064", "genes": ["MALT1", "BIRC3"]}, {"kegg_id": "hsa04625", "name": "C-type lectin receptor signaling pathway - Homo sapiens (human)", "description": "C-type lectin receptors (CLRs) are a large superfamily of proteins characterized by the presence of one or more C-type lectin-like domains (CTLDs). CLRs function as pattern-recognition receptors (PRRs) for pathogen-derived ligands in dendric cells, macrophages, neutrophils, etc., such as Dectin-1 and Dectin-2 for recognition of fungi-derived B-glucan and high mannose-type carbohydrates. Upon ligand binding, CLRs stimulate intracellular signaling cascades that induce the production of inflammatory cytokines and chemokines, consequently triggering innate and adaptive immunity to pathogens.", "class": "Organismal Systems; Immune system", "pathway_map": "hsa04625  C-type lectin receptor signaling pathway", "drug": ["D12237  Zunsemetinib (USAN)", "D12422  Selnoflast (USAN/INN)", "D12423  Selnoflast potassium (USAN)", "D12720  Nibrozetone (USAN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["64581  CLEC7A; C-type lectin domain containing 7A [KO:K10074]", "4046  LSP1; lymphocyte specific protein 1 [KO:K14957]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "22808  MRAS; muscle RAS oncogene homolog [KO:K07831]", "6237  RRAS; RAS related [KO:K07829]", "22800  RRAS2; RAS related 2 [KO:K07830]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "5971  RELB; RELB proto-oncogene, NF-kB subunit [KO:K09253]", "3592  IL12A; interleukin 12A [KO:K05406]", "3593  IL12B; interleukin 12B [KO:K05425]", "3553  IL1B; interleukin 1 beta [KO:K04519]", "6850  SYK; spleen associated tyrosine kinase [KO:K05855] [EC:2.7.10.2]", "5781  PTPN11; protein tyrosine phosphatase non-receptor type 11 [KO:K07293] [EC:3.1.3.48]", "9020  MAP3K14; mitogen-activated protein kinase kinase kinase 14 [KO:K04466] [EC:2.7.11.25]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "4791  NFKB2; nuclear factor kappa B subunit 2 [KO:K04469]", "5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "810  CALML3; calmodulin like 3 [KO:K02183]", "805  CALM2; calmodulin 2 [KO:K02183]", "808  CALM3; calmodulin 3 [KO:K02183]", "801  CALM1; calmodulin 1 [KO:K02183]", "163688  CALML6; calmodulin like 6 [KO:K02183]", "51806  CALML5; calmodulin like 5 [KO:K02183]", "91860  CALML4; calmodulin like 4 [KO:K02183]", "5530  PPP3CA; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]", "5532  PPP3CB; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]", "5533  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]", "5534  PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]", "5535  PPP3R2; protein phosphatase 3 regulatory subunit B, beta [KO:K06268]", "4772  NFATC1; nuclear factor of activated T cells 1 [KO:K04446]", "4773  NFATC2; nuclear factor of activated T cells 2 [KO:K17332]", "4775  NFATC3; nuclear factor of activated T cells 3 [KO:K17333]", "4776  NFATC4; nuclear factor of activated T cells 4 [KO:K17334]", "3558  IL2; interleukin 2 [KO:K05429]", "3586  IL10; interleukin 10 [KO:K05443]", "1959  EGR2; early growth response 2 [KO:K12496]", "1960  EGR3; early growth response 3 [KO:K12497]", "5743  PTGS2; prostaglandin-endoperoxide synthase 2 [KO:K11987] [EC:1.14.99.1]", "5580  PRKCD; protein kinase C delta [KO:K06068] [EC:2.7.11.13]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "114548  NLRP3; NLR family pyrin domain containing 3 [KO:K12800]", "29108  PYCARD; PYD and CARD domain containing [KO:K12799]", "834  CASP1; caspase 1 [KO:K01370] [EC:3.4.22.36]", "64170  CARD9; caspase recruitment domain family member 9 [KO:K12794]", "8915  BCL10; BCL10 immune signaling adaptor [KO:K07368]", "10892  MALT1; MALT1 paracaspase [KO:K07369] [EC:3.4.22.-]", "841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "7124  TNF; tumor necrosis factor [KO:K03156]", "3569  IL6; interleukin 6 [KO:K05405]", "51561  IL23A; interleukin 23 subunit alpha [KO:K05426]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "868  CBLB; Cbl proto-oncogene B [KO:K22517] [EC:2.3.2.27]", "93978  CLEC6A; C-type lectin domain containing 6A [KO:K17514]", "2207  FCER1G; Fc epsilon receptor Ig [KO:K07983]", "10332  CLEC4M; C-type lectin domain family 4 member M [KO:K06563]", "30835  CD209; CD209 molecule [KO:K06563]", "23365  ARHGEF12; Rho guanine nucleotide exchange factor 12 [KO:K07532]", "387  RHOA; ras homolog family member A [KO:K04513]", "5058  PAK1; p21 (RAC1) activated kinase 1 [KO:K04409] [EC:2.7.11.1]", "8844  KSR1; kinase suppressor of ras 1 [KO:K14958]", "1263  PLK3; polo like kinase 3 [KO:K08862] [EC:2.7.11.21]", "6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "9641  IKBKE; inhibitor of nuclear factor kappa B kinase subunit epsilon [KO:K07211] [EC:2.7.11.10]", "6772  STAT1; signal transducer and activator of transcription 1 [KO:K11220]", "10379  IRF9; interferon regulatory factor 9 [KO:K04693]", "6773  STAT2; signal transducer and activator of transcription 2 [KO:K11221]", "53342  IL17D; interleukin 17D [KO:K05492]", "1540  CYLD; CYLD lysine 63 deubiquitinase [KO:K08601] [EC:3.4.19.12]", "602  BCL3; BCL3 transcription coactivator [KO:K09258]", "6361  CCL17; C-C motif chemokine ligand 17 [KO:K21083]", "6367  CCL22; C-C motif chemokine ligand 22 [KO:K21095]", "9261  MAPKAPK2; MAPK activated protein kinase 2 [KO:K04443] [EC:2.7.11.1]", "26253  CLEC4E; C-type lectin domain family 4 member E [KO:K10059]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "4193  MDM2; MDM2 proto-oncogene [KO:K06643] [EC:2.3.2.27]", "3659  IRF1; interferon regulatory factor 1 [KO:K09444]", "338339  CLEC4D; C-type lectin domain family 4 member D [KO:K10058]", "51266  CLEC1B; C-type lectin domain family 1 member B [KO:K10070]"], "compound": ["C00027  Hydrogen peroxide", "C00076  Calcium cation", "C00159  D-Mannose", "C00165  Diacylglycerol", "C00584  Prostaglandin E2", "C00965  1,3-beta-D-Glucan", "C01019  L-Fucose", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C16844  Hydroxyl radical", "C21790  Mycobacterial trehalose dimycolate", "C21791  Rhodocytin", "G13115  Mannose-capped lipoarabinomannan"], "refs": [{"pmid": "27291962", "authors": "  Geijtenbeek TB, Gringhuis SI", "title": "C-type lectin receptors in the control of T helper cell differentiation.", "journal": "Nat Rev Immunol 16:433-48 (2016)", "doi": "10.1038/nri.2016.55"}, {"pmid": "21350579", "authors": "  Hajishengallis G, Lambris JD", "title": "Microbial manipulation of receptor crosstalk in innate immunity.", "journal": "Nat Rev Immunol 11:187-200 (2011)", "doi": "10.1038/nri2918"}, {"pmid": "28604735", "authors": "  Iliev ID, Leonardi I", "title": "Fungal dysbiosis: immunity and interactions at mucosal barriers.", "journal": "Nat Rev Immunol 17:635-646 (2017)", "doi": "10.1038/nri.2017.55"}, {"pmid": "25002863", "authors": "  Richardson MB, Williams SJ", "title": "MCL and Mincle: C-Type Lectin Receptors That Sense Damaged Self and Pathogen-Associated Molecular Patterns.", "journal": "Front Immunol 5:288 (2014)", "doi": "10.3389/fimmu.2014.00288"}, {"pmid": "21924922", "authors": "  Vautier S, MacCallum DM, Brown GD", "title": "C-type lectin receptors and cytokines in fungal immunity.", "journal": "Cytokine 58:89-99 (2012)", "doi": "10.1016/j.cyto.2011.08.031"}, {"pmid": "22170181", "authors": "  Gauglitz GG, Callenberg H, Weindl G, Korting HC", "title": "Host defence against Candida albicans and the role of pattern-recognition receptors.", "journal": "Acta Derm Venereol 92:291-8 (2012)", "doi": "10.2340/00015555-1250"}, {"pmid": "22973279", "authors": "  Cunha C, Carvalho A, Esposito A, Bistoni F, Romani L", "title": "DAMP signaling in fungal infections and diseases.", "journal": "Front Immunol 3:286 (2012)", "doi": "10.3389/fimmu.2012.00286"}, {"pmid": "29449845", "authors": "  Tang J, Lin G, Langdon WY, Tao L, Zhang J", "title": "Regulation of C-Type Lectin Receptor-Mediated Antifungal Immunity.", "journal": "Front Immunol 9:123 (2018)", "doi": "10.3389/fimmu.2018.00123"}, {"pmid": "27999992", "authors": "  Mayer S, Raulf MK, Lepenies B", "title": "C-type lectins: their network and roles in pathogen recognition and immunity.", "journal": "Histochem Cell Biol 147:223-237 (2017)", "doi": "10.1007/s00418-016-1523-7"}, {"pmid": "23570314", "authors": "  Plato A, Willment JA, Brown GD", "title": "C-type lectin-like receptors of the dectin-1 cluster: ligands and signaling pathways.", "journal": "Int Rev Immunol 32:134-56 (2013)", "doi": "10.3109/08830185.2013.777065"}, {"pmid": "22344277", "authors": "  Dupaul-Chicoine J, Saleh M", "title": "A new path to IL-1beta production controlled by caspase-8.", "journal": "Nat Immunol 13:211-2 (2012)", "doi": "10.1038/ni.2241"}, {"pmid": "24009832", "authors": "  Batbayar S, Lee DH, Kim HW", "title": "Immunomodulation of Fungal beta-Glucan in Host Defense Signaling by Dectin-1.", "journal": "Biomol Ther (Seoul) 20:433-45 (2012)", "doi": "10.4062/biomolther.2012.20.5.433"}, {"pmid": "28606994", "authors": "  Bendickova K, Tidu F, Fric J", "title": "Calcineurin-NFAT signalling in myeloid leucocytes: new prospects and pitfalls in immunosuppressive therapy.", "journal": "EMBO Mol Med 9:990-999 (2017)", "doi": "10.15252/emmm.201707698"}, {"pmid": "18998127", "authors": "  den Dunnen J, Gringhuis SI, Geijtenbeek TB", "title": "Innate signaling by the C-type lectin DC-SIGN dictates immune responses.", "journal": "Cancer Immunol Immunother 58:1149-57 (2009)", "doi": "10.1007/s00262-008-0615-1"}, {"pmid": "28640912", "authors": "  Marakalala MJ, Ndlovu H", "title": "Signaling C-type lectin receptors in antimycobacterial immunity.", "journal": "PLoS Pathog 13:e1006333 (2017)", "doi": "10.1371/journal.ppat.1006333"}, {"pmid": "24867235", "authors": "  Gringhuis SI, Kaptein TM, Wevers BA, Mesman AW, Geijtenbeek TB", "title": "Fucose-specific DC-SIGN signalling directs T helper cell type-2 responses via IKKepsilon- and CYLD-dependent Bcl3 activation.", "journal": "Nat Commun 5:3898 (2014)", "doi": "10.1038/ncomms4898"}, {"pmid": "19521399", "authors": "  Geijtenbeek TB, Gringhuis SI", "title": "Signalling through C-type lectin receptors: shaping immune responses.", "journal": "Nat Rev Immunol 9:465-79 (2009)", "doi": "10.1038/nri2569"}], "rel_pathway": ["hsa04658  Th1 and Th2 cell differentiation", "hsa04659  Th17 cell differentiation"], "ko_pathway": "ko04625", "genes": ["MALT1", "AKT2", "AKT1", "MAPK13", "NRAS"]}, {"kegg_id": "hsa04660", "name": "T cell receptor signaling pathway - Homo sapiens (human)", "description": "Activation of T lymphocytes is a key event for an efficient response of the immune system. It requires the involvement of the T-cell receptor (TCR) as well as costimulatory molecules such as CD28. Engagement of these receptors through the interaction with a foreign antigen associated with major histocompatibility complex molecules and CD28 counter-receptors B7.1/B7.2, respectively, results in a series of signaling cascades. These cascades comprise an array of protein-tyrosine kinases, phosphatases, GTP-binding proteins and adaptor proteins that regulate generic and specialised functions, leading to T-cell proliferation, cytokine production and differentiation into effector cells.", "class": "Organismal Systems; Immune system", "pathway_map": "hsa04660  T cell receptor signaling pathway", "network": ["", "ELEMENT   N00683  CD80/CD86-CD28-PI3K signaling pathway", "N01106  TCR-PLCG-ITPR signaling pathway", "N01165  PDL/PD1-SHP-PI3K signaling pathway", "N01579  CD80/CD86-CTLA4-PP2A signaling pathway", "N01696  ICOSLG/ICOS-PI3K signaling pathway"], "drug": ["D00107  Tacrolimus (USP/INN)", "D00184  Cyclosporine (USP)", "D03420  Cedelizumab (USAN/INN)", "D04603  Ipilimumab (USAN/INN)", "D05092  Muromonab-CD3 (JAN/USAN/INN)", "D05480  Pimecrolimus (JAN/USAN/INN)", "D05610  Priliximab (USAN/INN)", "D05777  Ruplizumab (USAN/INN)", "D06193  Toralizumab (USAN/INN)", "D06314  Visilizumab (USAN/INN)", "D06657  Tremelimumab (USAN/INN)", "D08556  Tacrolimus (INN)", "D08959  Otelixizumab (USAN)", "D08976  Pomalidomide (JAN/USAN/INN)", "D09013  Teplizumab (USAN/INN)", "D09033  Voclosporin (JAN/USAN/INN)", "D09190  Anti-human thymocyte immunoglobulin, rabbit (JAN)", "D09207  Catumaxomab (INN)", "D09325  Blinatumomab (USAN/INN)", "D09575  Ibalizumab (USAN/INN)", "D09671  Sotrastaurin (USAN/INN)", "D09718  Sotrastaurin acetate (USAN)", "D10316  Nivolumab (USAN/INN)", "D10390  Pidilizumab (USAN/INN)", "D10574  Pembrolizumab (USAN)", "D10983  Ruclosporin (USAN/INN)", "D10993  Tucidinostat (JAN/USAN/INN)", "D11108  Cemiplimab (USAN)", "D11122  Letolizumab (USAN/INN)", "D11366  Dostarlimab (USAN)", "D11372  Duvortuxizumab (USAN)", "D11433  Vopratelimab (USAN/INN)", "D11487  Tislelizumab (USAN/INN)", "D11488  Cetrelimab (USAN/INN)", "D11489  Cibisatamab (USAN/INN)", "D11605  Spartalizumab (USAN/INN)", "D11820  Balstilimab (USAN/INN)", "D11823  Zalifrelimab (USAN/INN)", "D11827  Retifanlimab (USAN)", "D11948  Pacmilimab (USAN/INN)", "D11992  Pavurutamab (USAN)", "D11996  Feladilimab (USAN/INN)", "D12007  Ubamatamab (USAN)", "D12058  Elranatamab (USAN)", "D12063  Zimberelimab (USAN)", "D12119  Sintilimab (USAN/INN)", "D12180  Talquetamab (USAN/INN)", "D12186  Vudalimab (USAN)", "D12190  Cadonilimab (USAN/INN)", "D12195  Izuralimab (USAN)", "D12198  Penpulimab (USAN)", "D12202  Toripalimab (USAN/INN)", "D12223  Rosnilimab (USAN)", "D12231  Peresolimab (USAN)", "D12233  Quavonlimab (USAN/INN)", "D12296  Tebentafusp (USAN/INN)", "D12300  Acazicolcept (USAN/INN)", "D12317  Bavunalimab (USAN/INN)", "D12332  Zeluvalimab (USAN/INN)", "D12347  Volrustomig (USAN)", "D12368  Epcoritamab (USAN/INN)", "D12448  Botensilimab (USAN/INN)", "D12620  Frexalimab (USAN/INN)", "D12625  Pegenzileukin (USAN/INN)", "D12709  Dalmitamig (USAN)", "D12721  Avitotamig (USAN)", "D12724  Forimtamig (USAN/INN)", "D12751  Serplulimab (INN)", "D12762  Soquelitinib (USAN)", "D12764  Rilvegostomig (USAN/INN)", "D12791  Eciskafusp alfa (USAN/INN)", "D12808  Ivonescimab (USAN/INN)", "D12833  Lifileucel (USAN/INN)", "D12839  Sasanlimab (USAN/INN)", "D12850  Imneskibart (USAN)"], "dblinks": "GO: 0050852", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["915  CD3D; CD3 delta subunit of T-cell receptor complex [KO:K06450]", "916  CD3E; CD3 epsilon subunit of T-cell receptor complex [KO:K06451]", "917  CD3G; CD3 gamma subunit of T-cell receptor complex [KO:K06452]", "919  CD247; CD247 molecule [KO:K06453]", "920  CD4; CD4 molecule [KO:K06454]", "925  CD8A; CD8 subunit alpha [KO:K06458]", "926  CD8B; CD8 subunit beta [KO:K06459]", "927  CD8B2; CD8B family member 2 [KO:K06459]", "5788  PTPRC; protein tyrosine phosphatase receptor type C [KO:K06478] [EC:3.1.3.48]", "3932  LCK; LCK proto-oncogene, Src family tyrosine kinase [KO:K05856] [EC:2.7.10.2]", "2534  FYN; FYN proto-oncogene, Src family tyrosine kinase [KO:K05703] [EC:2.7.10.2]", "7535  ZAP70; zeta chain of T cell receptor associated protein kinase 70 [KO:K07360] [EC:2.7.10.2]", "3937  LCP2; lymphocyte cytosolic protein 2 [KO:K07361]", "27040  LAT; linker for activation of T cells [KO:K07362]", "3702  ITK; IL2 inducible T cell kinase [KO:K07363] [EC:2.7.10.2]", "7006  TEC; tec protein tyrosine kinase [KO:K07364] [EC:2.7.10.2]", "4690  NCK1; NCK adaptor protein 1 [KO:K07365]", "8440  NCK2; NCK adaptor protein 2 [KO:K19862]", "10451  VAV3; vav guanine nucleotide exchange factor 3 [KO:K05730]", "7409  VAV1; vav guanine nucleotide exchange factor 1 [KO:K05730]", "7410  VAV2; vav guanine nucleotide exchange factor 2 [KO:K05730]", "9402  GRAP2; GRB2 related adaptor protein 2 [KO:K07366]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "5058  PAK1; p21 (RAC1) activated kinase 1 [KO:K04409] [EC:2.7.11.1]", "5062  PAK2; p21 (RAC1) activated kinase 2 [KO:K04410] [EC:2.7.11.1]", "5063  PAK3; p21 (RAC1) activated kinase 3 [KO:K05733] [EC:2.7.11.1]", "10298  PAK4; p21 (RAC1) activated kinase 4 [KO:K05734] [EC:2.7.11.1]", "57144  PAK5; p21 (RAC1) activated kinase 5 [KO:K05736] [EC:2.7.11.1]", "56924  PAK6; p21 (RAC1) activated kinase 6 [KO:K05735] [EC:2.7.11.1]", "106821730  BUB1B-PAK6; BUB1B-PAK6 readthrough [KO:K05735] [EC:2.7.11.1]", "387  RHOA; ras homolog family member A [KO:K04513]", "998  CDC42; cell division cycle 42 [KO:K04393]", "1739  DLG1; discs large MAGUK scaffold protein 1 [KO:K12076]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "5530  PPP3CA; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]", "5532  PPP3CB; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]", "5533  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]", "5534  PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]", "5535  PPP3R2; protein phosphatase 3 regulatory subunit B, beta [KO:K06268]", "4772  NFATC1; nuclear factor of activated T cells 1 [KO:K04446]", "4773  NFATC2; nuclear factor of activated T cells 2 [KO:K17332]", "4775  NFATC3; nuclear factor of activated T cells 3 [KO:K17333]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "10125  RASGRP1; RAS guanyl releasing protein 1 [KO:K04350]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "5588  PRKCQ; protein kinase C theta [KO:K18052] [EC:2.7.11.13]", "84433  CARD11; caspase recruitment domain family member 11 [KO:K07367]", "8915  BCL10; BCL10 immune signaling adaptor [KO:K07368]", "10892  MALT1; MALT1 paracaspase [KO:K07369] [EC:3.4.22.-]", "6885  MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO:K04427] [EC:2.7.11.25]", "5609  MAP2K7; mitogen-activated protein kinase kinase 7 [KO:K04431] [EC:2.7.12.2]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "4793  NFKBIB; NFKB inhibitor beta [KO:K02581]", "4794  NFKBIE; NFKB inhibitor epsilon [KO:K05872]", "940  CD28; CD28 molecule [KO:K06470]", "29851  ICOS; inducible T cell costimulator [KO:K06713]", "959  CD40LG; CD40 ligand [KO:K03161]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5170  PDPK1; 3-phosphoinositide dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "1326  MAP3K8; mitogen-activated protein kinase kinase kinase 8 [KO:K04415] [EC:2.7.11.25]", "9020  MAP3K14; mitogen-activated protein kinase kinase kinase 14 [KO:K04466] [EC:2.7.11.25]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "5133  PDCD1; programmed cell death 1 [KO:K06744]", "1493  CTLA4; cytotoxic T-lymphocyte associated protein 4 [KO:K06538]", "5777  PTPN6; protein tyrosine phosphatase non-receptor type 6 [KO:K05697] [EC:3.1.3.48]", "5781  PTPN11; protein tyrosine phosphatase non-receptor type 11 [KO:K07293] [EC:3.1.3.48]", "5515  PPP2CA; protein phosphatase 2 catalytic subunit alpha [KO:K04382] [EC:3.1.3.16]", "5516  PPP2CB; protein phosphatase 2 catalytic subunit beta [KO:K04382] [EC:3.1.3.16]", "5519  PPP2R1B; protein phosphatase 2 scaffold subunit Abeta [KO:K03456]", "5518  PPP2R1A; protein phosphatase 2 scaffold subunit Aalpha [KO:K03456]", "5520  PPP2R2A; protein phosphatase 2 regulatory subunit Balpha [KO:K04354]", "5521  PPP2R2B; protein phosphatase 2 regulatory subunit Bbeta [KO:K04354]", "5522  PPP2R2C; protein phosphatase 2 regulatory subunit Bgamma [KO:K04354]", "55844  PPP2R2D; protein phosphatase 2 regulatory subunit Bdelta [KO:K04354]", "28227  PPP2R3B; protein phosphatase 2 regulatory subunit B''beta [KO:K11583]", "55012  PPP2R3C; protein phosphatase 2 regulatory subunit B''gamma [KO:K11583]", "5523  PPP2R3A; protein phosphatase 2 regulatory subunit B''alpha [KO:K11583]", "5526  PPP2R5B; protein phosphatase 2 regulatory subunit B'beta [KO:K11584]", "5527  PPP2R5C; protein phosphatase 2 regulatory subunit B'gamma [KO:K11584]", "5528  PPP2R5D; protein phosphatase 2 regulatory subunit B'delta [KO:K11584]", "5529  PPP2R5E; protein phosphatase 2 regulatory subunit B'epsilon [KO:K11584]", "5525  PPP2R5A; protein phosphatase 2 regulatory subunit B'alpha [KO:K11584]", "868  CBLB; Cbl proto-oncogene B [KO:K22517] [EC:2.3.2.27]", "3558  IL2; interleukin 2 [KO:K05429]", "3565  IL4; interleukin 4 [KO:K05430]", "3567  IL5; interleukin 5 [KO:K05428]", "3586  IL10; interleukin 10 [KO:K05443]", "3458  IFNG; interferon gamma [KO:K04687]", "1437  CSF2; colony stimulating factor 2 [KO:K05427]", "7124  TNF; tumor necrosis factor [KO:K03156]", "1019  CDK4; cyclin dependent kinase 4 [KO:K02089] [EC:2.7.11.22]"], "compound": ["C00076  Calcium cation", "C00165  Diacylglycerol", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C05981  Phosphatidylinositol-3,4,5-trisphosphate"], "refs": [{"pmid": "15122199", "authors": "  Chen L.", "title": "Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity.", "journal": "Nat Rev Immunol 4:336-47 (2004)", "doi": "10.1038/nri1349"}, {"pmid": "15928679", "authors": "  Macian F.", "title": "NFAT proteins: key regulators of T-cell development and function.", "journal": "Nat Rev Immunol 5:472-84 (2005)", "doi": "10.1038/nri1632"}, {"pmid": "15771581", "authors": "  Berg LJ, Finkelstein LD, Lucas JA, Schwartzberg PL.", "title": "Tec family kinases in T lymphocyte development and function.", "journal": "Annu Rev Immunol 23:549-600 (2005)", "doi": "10.1146/annurev.immunol.22.012703.104743"}, {"pmid": "15084594", "authors": "  Huang Y, Wange RL.", "title": "T cell receptor signaling: beyond complex complexes.", "journal": "J Biol Chem 279:28827-30 (2004)", "doi": "10.1074/jbc.R400012200"}, {"pmid": "14656980", "authors": "  Schmitz ML, Bacher S, Dienz O.", "title": "NF-kappaB activation pathways induced by T cell costimulation.", "journal": "FASEB J 17:2187-93 (2003)", "doi": "10.1096/fj.02-1100rev"}, {"pmid": "11905831", "authors": "  Alegre ML, Frauwirth KA, Thompson CB.", "title": "T-cell regulation by CD28 and CTLA-4.", "journal": "Nat Rev Immunol 1:220-8 (2001)", "doi": "10.1038/35105024"}, {"pmid": "15286727", "authors": "  Horejsi V, Zhang W, Schraven B.", "title": "Transmembrane adaptor proteins: organizers of immunoreceptor signalling.", "journal": "Nat Rev Immunol 4:603-16 (2004)", "doi": "10.1038/nri1414"}, {"pmid": "15343367", "authors": "  Baniyash M.", "title": "TCR zeta-chain downregulation: curtailing an excessive inflammatory immune response.", "journal": "Nat Rev Immunol 4:675-87 (2004)", "doi": "10.1038/nri1434"}, {"pmid": "15099566", "authors": "  Sechi AS, Wehland J.", "title": "Interplay between TCR signalling and actin cytoskeleton dynamics.", "journal": "Trends Immunol 25:257-65 (2004)", "doi": "10.1016/j.it.2004.03.003"}, {"pmid": "12669022", "authors": "  Okkenhaug K, Vanhaesebroeck B.", "title": "PI3K in lymphocyte development, differentiation and activation.", "journal": "Nat Rev Immunol 3:317-30 (2003)", "doi": "10.1038/nri1056"}, {"pmid": "15489916", "authors": "  Palacios EH, Weiss A.", "title": "Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation.", "journal": "Oncogene 23:7990-8000 (2004)", "doi": "10.1038/sj.onc.1208074"}, {"pmid": "12133805", "authors": "  Kane LP, Lin J, Weiss A.", "title": "It's all Rel-ative: NF-kappaB and CD28 costimulation of T-cell activation.", "journal": "Trends Immunol 23:413-20 (2002)", "doi": "10.1016/S1471-4906(02)02264-0"}, {"pmid": "14647476", "authors": "  Acuto O, Michel F.", "title": "CD28-mediated co-stimulation: a quantitative support for TCR signalling.", "journal": "Nat Rev Immunol 3:939-51 (2003)", "doi": "10.1038/nri1248"}, {"pmid": "15308211", "authors": "  Finkelstein LD, Schwartzberg PL.", "title": "Tec kinases: shaping T-cell activation through actin.", "journal": "Trends Cell Biol 14:443-51 (2004)", "doi": "10.1016/j.tcb.2003.07.001"}, {"pmid": "15345216", "authors": "  Duan L, Reddi AL, Ghosh A, Dimri M, Band H.", "title": "The Cbl family and other ubiquitin ligases: destructive forces in control of antigen receptor signaling.", "journal": "Immunity 21:7-17 (2004)", "doi": "10.1016/j.immuni.2004.06.012"}, {"pmid": "14617194", "authors": "  Schrum AG, Turka LA, Palmer E.", "title": "Surface T-cell antigen receptor expression and availability for long-term antigenic signaling.", "journal": "Immunol Rev 196:7-24 (2003)", "doi": "10.1046/j.1600-065X.2003.00083.x"}, {"pmid": "19132916", "authors": "  Smith-Garvin JE, Koretzky GA, Jordan MS", "title": "T cell activation.", "journal": "Annu Rev Immunol 27:591-619 (2009)", "doi": "10.1146/annurev.immunol.021908.132706"}, {"pmid": "12195013", "authors": "  Diehn M, Alizadeh AA, Rando OJ, Liu CL, Stankunas K, Botstein D, Crabtree GR, Brown PO", "title": "Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation.", "journal": "Proc Natl Acad Sci U S A 99:11796-801 (2002)", "doi": "10.1073/pnas.092284399"}, {"pmid": "19290929", "authors": "  Blonska M, Lin X", "title": "CARMA1-mediated NF-kappaB and JNK activation in lymphocytes.", "journal": "Immunol Rev 228:199-211 (2009)", "doi": "10.1111/j.1600-065X.2008.00749.x"}, {"pmid": "17395537", "authors": "  Rebeaud F, Hailfinger S, Thome M", "title": "Dlgh1 and Carma1 MAGUK proteins contribute to signal specificity downstream of TCR activation.", "journal": "Trends Immunol 28:196-200 (2007)", "doi": "10.1016/j.it.2007.03.004"}, {"pmid": "16799472", "authors": "  Ashwell JD", "title": "The many paths to p38 mitogen-activated protein kinase activation in the immune system.", "journal": "Nat Rev Immunol 6:532-40 (2006)", "doi": "10.1038/nri1865"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04064  NF-kappa B signaling pathway", "hsa04120  Ubiquitin mediated proteolysis", "hsa04151  PI3K-Akt signaling pathway", "hsa04514  Cell adhesion molecules", "hsa04810  Regulation of actin cytoskeleton"], "ko_pathway": "ko04660", "genes": ["MALT1", "AKT2", "AKT1", "SOS1", "MAPK13", "NRAS"]}, {"kegg_id": "hsa05152", "name": "Tuberculosis - Homo sapiens (human)", "description": "Tuberculosis, or TB, is an infectious disease caused by Mycobacterium tuberculosis. One third of the world's population is thought to be infected with TB. About 90% of those infected result in latent infections, and about 10% of latent infections develop active diseases when their immune system is impaired due to the age, other diseases such as AIDS or exposure to immunosuppressive drugs. TB is transmitted through the air and primarily attacks the lungs, then it can spread by the circulatory system to other parts of body. Once TB bacilli have entered the host by the respiratory route and infected macrophages in the lungs, they interfere with phagosomal maturation, antigen presentation, apoptosis and host immune system to establish persistent or latent infection.", "class": "Human Diseases; Infectious disease: bacterial", "pathway_map": "hsa05152  Tuberculosis", "disease": ["H00342  Tuberculosis"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["7124  TNF; tumor necrosis factor [KO:K03156]", "7132  TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158]", "8717  TRADD; TNFRSF1A associated via death domain [KO:K03171]", "8772  FADD; Fas associated via death domain [KO:K02373]", "841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]", "843  CASP10; caspase 10 [KO:K04400] [EC:3.4.22.63]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "637  BID; BH3 interacting domain death agonist [KO:K04726]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "54205  CYCS; cytochrome c, somatic [KO:K08738]", "842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]", "317  APAF1; apoptotic peptidase activating factor 1 [KO:K02084]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]", "815  CAMK2A; calcium/calmodulin dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]", "817  CAMK2D; calcium/calmodulin dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]", "816  CAMK2B; calcium/calmodulin dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]", "818  CAMK2G; calcium/calmodulin dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]", "3458  IFNG; interferon gamma [KO:K04687]", "3459  IFNGR1; interferon gamma receptor 1 [KO:K05132]", "3460  IFNGR2; interferon gamma receptor 2 [KO:K05133]", "3716  JAK1; Janus kinase 1 [KO:K11217] [EC:2.7.10.2]", "3717  JAK2; Janus kinase 2 [KO:K04447] [EC:2.7.10.2]", "6772  STAT1; signal transducer and activator of transcription 1 [KO:K11220]", "4261  CIITA; class II major histocompatibility complex transactivator [KO:K08060] [EC:2.7.11.1]", "5993  RFX5; regulatory factor X5 [KO:K08061]", "8625  RFXANK; regulatory factor X associated ankyrin containing protein [KO:K08062]", "5994  RFXAP; regulatory factor X associated protein [KO:K08063]", "4800  NFYA; nuclear transcription factor Y subunit alpha [KO:K08064]", "4801  NFYB; nuclear transcription factor Y subunit beta [KO:K08065]", "4802  NFYC; nuclear transcription factor Y subunit gamma [KO:K08066]", "1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]", "3108  HLA-DMA; major histocompatibility complex, class II, DM alpha [KO:K06752]", "3109  HLA-DMB; major histocompatibility complex, class II, DM beta [KO:K06752]", "3111  HLA-DOA; major histocompatibility complex, class II, DO alpha [KO:K06752]", "3112  HLA-DOB; major histocompatibility complex, class II, DO beta [KO:K06752]", "3113  HLA-DPA1; major histocompatibility complex, class II, DP alpha 1 [KO:K06752]", "3115  HLA-DPB1; major histocompatibility complex, class II, DP beta 1 [KO:K06752]", "3117  HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 [KO:K06752]", "3118  HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2 [KO:K06752]", "3119  HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 [KO:K06752]", "3122  HLA-DRA; major histocompatibility complex, class II, DR alpha [KO:K06752]", "3123  HLA-DRB1; major histocompatibility complex, class II, DR beta 1 [KO:K06752]", "3125  HLA-DRB3; major histocompatibility complex, class II, DR beta 3 [KO:K06752]", "3126  HLA-DRB4; major histocompatibility complex, class II, DR beta 4 [KO:K06752]", "3127  HLA-DRB5; major histocompatibility complex, class II, DR beta 5 [KO:K06752]", "972  CD74; CD74 molecule [KO:K06505]", "1387  CREBBP; CREB binding protein [KO:K04498] [EC:2.3.1.48]", "2033  EP300; E1A binding protein p300 [KO:K04498] [EC:2.3.1.48]", "3586  IL10; interleukin 10 [KO:K05443]", "3587  IL10RA; interleukin 10 receptor subunit alpha [KO:K05134]", "3588  IL10RB; interleukin 10 receptor subunit beta [KO:K05135]", "1520  CTSS; cathepsin S [KO:K01368] [EC:3.4.22.27]", "26253  CLEC4E; C-type lectin domain family 4 member E [KO:K10059]", "2207  FCER1G; Fc epsilon receptor Ig [KO:K07983]", "64581  CLEC7A; C-type lectin domain containing 7A [KO:K10074]", "6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "6850  SYK; spleen associated tyrosine kinase [KO:K05855] [EC:2.7.10.2]", "64170  CARD9; caspase recruitment domain family member 9 [KO:K12794]", "10892  MALT1; MALT1 paracaspase [KO:K07369] [EC:3.4.22.-]", "8915  BCL10; BCL10 immune signaling adaptor [KO:K07368]", "64127  NOD2; nucleotide binding oligomerization domain containing 2 [KO:K10165]", "8767  RIPK2; receptor interacting serine/threonine kinase 2 [KO:K08846] [EC:2.7.11.1]", "3313  HSPA9; heat shock protein family A (Hsp70) member 9 [KO:K04043]", "3329  HSPD1; heat shock protein family D (Hsp60) member 1 [KO:K04077] [EC:5.6.1.7]", "3929  LBP; lipopolysaccharide binding protein [KO:K05399]", "7097  TLR2; toll like receptor 2 [KO:K10159]", "7096  TLR1; toll like receptor 1 [KO:K05398]", "10333  TLR6; toll like receptor 6 [KO:K10169]", "7099  TLR4; toll like receptor 4 [KO:K10160]", "929  CD14; CD14 molecule [KO:K04391]", "114609  TIRAP; TIR domain containing adaptor protein [KO:K05403]", "4615  MYD88; MYD88 innate immune signal transduction adaptor [KO:K04729]", "51135  IRAK4; interleukin 1 receptor associated kinase 4 [KO:K04733] [EC:2.7.11.1]", "3654  IRAK1; interleukin 1 receptor associated kinase 1 [KO:K04730] [EC:2.7.11.1]", "3656  IRAK2; interleukin 1 receptor associated kinase 2 [KO:K04731] [EC:2.7.11.1]", "7189  TRAF6; TNF receptor associated factor 6 [KO:K03175] [EC:2.3.2.27]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "4843  NOS2; nitric oxide synthase 2 [KO:K13241] [EC:1.14.13.39]", "3569  IL6; interleukin 6 [KO:K05405]", "3592  IL12A; interleukin 12A [KO:K05406]", "3593  IL12B; interleukin 12B [KO:K05425]", "3606  IL18; interleukin 18 [KO:K05482]", "51561  IL23A; interleukin 23 subunit alpha [KO:K05426]", "3552  IL1A; interleukin 1 alpha [KO:K04383]", "3553  IL1B; interleukin 1 beta [KO:K04519]", "1051  CEBPB; CCAAT enhancer binding protein beta [KO:K10048]", "1054  CEBPG; CCAAT enhancer binding protein gamma [KO:K10049]", "54106  TLR9; toll like receptor 9 [KO:K10161]", "3439  IFNA1; interferon alpha 1 [KO:K05414]", "3440  IFNA2; interferon alpha 2 [KO:K05414]", "3441  IFNA4; interferon alpha 4 [KO:K05414]", "3442  IFNA5; interferon alpha 5 [KO:K05414]", "3443  IFNA6; interferon alpha 6 [KO:K05414]", "3444  IFNA7; interferon alpha 7 [KO:K05414]", "3445  IFNA8; interferon alpha 8 [KO:K05414]", "3446  IFNA10; interferon alpha 10 [KO:K05414]", "3447  IFNA13; interferon alpha 13 [KO:K05414]", "3448  IFNA14; interferon alpha 14 [KO:K05414]", "3449  IFNA16; interferon alpha 16 [KO:K05414]", "3451  IFNA17; interferon alpha 17 [KO:K05414]", "3452  IFNA21; interferon alpha 21 [KO:K05414]", "3456  IFNB1; interferon beta 1 [KO:K05415]", "10332  CLEC4M; C-type lectin domain family 4 member M [KO:K06563]", "30835  CD209; CD209 molecule [KO:K06563]", "23365  ARHGEF12; Rho guanine nucleotide exchange factor 12 [KO:K07532]", "387  RHOA; ras homolog family member A [KO:K04513]", "4046  LSP1; lymphocyte specific protein 1 [KO:K14957]", "1263  PLK3; polo like kinase 3 [KO:K08862] [EC:2.7.11.21]", "8844  KSR1; kinase suppressor of ras 1 [KO:K14958]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "7040  TGFB1; transforming growth factor beta 1 [KO:K13375]", "7042  TGFB2; transforming growth factor beta 2 [KO:K13376]", "7043  TGFB3; transforming growth factor beta 3 [KO:K13377]", "1594  CYP27B1; cytochrome P450 family 27 subfamily B member 1 [KO:K07438] [EC:1.14.15.18]", "7421  VDR; vitamin D receptor [KO:K08539]", "820  CAMP; cathelicidin antimicrobial peptide [KO:K13916]", "718  C3; complement C3 [KO:K03990]", "1378  CR1; complement C3b/C4b receptor 1 (Knops blood group) [KO:K04011]", "1379  CR1L; complement C3b/C4b receptor 1 like [KO:K04011]", "3687  ITGAX; integrin subunit alpha X [KO:K06462]", "3689  ITGB2; integrin subunit beta 2 [KO:K06464]", "3684  ITGAM; integrin subunit alpha M [KO:K06461]", "22925  PLA2R1; phospholipase A2 receptor 1 [KO:K06560]", "4360  MRC1; mannose receptor C-type 1 [KO:K06560]", "9902  MRC2; mannose receptor C type 2 [KO:K06560]", "8877  SPHK1; sphingosine kinase 1 [KO:K04718] [EC:2.7.1.91]", "56848  SPHK2; sphingosine kinase 2 [KO:K04718] [EC:2.7.1.91]", "810  CALML3; calmodulin like 3 [KO:K02183]", "805  CALM2; calmodulin 2 [KO:K02183]", "808  CALM3; calmodulin 3 [KO:K02183]", "801  CALM1; calmodulin 1 [KO:K02183]", "163688  CALML6; calmodulin like 6 [KO:K02183]", "51806  CALML5; calmodulin like 5 [KO:K02183]", "91860  CALML4; calmodulin like 4 [KO:K02183]", "5289  PIK3C3; phosphatidylinositol 3-kinase catalytic subunit type 3 [KO:K00914] [EC:2.7.1.137]", "5868  RAB5A; RAB5A, member RAS oncogene family [KO:K07887]", "5869  RAB5B; RAB5B, member RAS oncogene family [KO:K07888]", "5878  RAB5C; RAB5C, member RAS oncogene family [KO:K07889]", "8411  EEA1; early endosome antigen 1 [KO:K12478]", "7879  RAB7A; RAB7A, member RAS oncogene family [KO:K07897]", "1509  CTSD; cathepsin D [KO:K01379] [EC:3.4.23.5]", "10312  TCIRG1; T cell immune regulator 1, ATPase H+ transporting V0 subunit a3 [KO:K02154]", "23545  ATP6V0A2; ATPase H+ transporting V0 subunit a2 [KO:K02154]", "50617  ATP6V0A4; ATPase H+ transporting V0 subunit a4 [KO:K02154]", "535  ATP6V0A1; ATPase H+ transporting V0 subunit a1 [KO:K02154]", "9114  ATP6V0D1; ATPase H+ transporting V0 subunit d1 [KO:K02146]", "245972  ATP6V0D2; ATPase H+ transporting V0 subunit d2 [KO:K02146]", "51606  ATP6V1H; ATPase H+ transporting V1 subunit H [KO:K02144]", "537  ATP6AP1; ATPase H+ transporting accessory protein 1 [KO:K03662]", "527  ATP6V0C; ATPase H+ transporting V0 subunit c [KO:K02155]", "533  ATP6V0B; ATPase H+ transporting V0 subunit b [KO:K03661]", "3916  LAMP1; lysosomal associated membrane protein 1 [KO:K06528]", "3920  LAMP2; lysosomal associated membrane protein 2 [KO:K06528]", "5530  PPP3CA; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]", "5532  PPP3CB; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]", "5533  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]", "5534  PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]", "5535  PPP3R2; protein phosphatase 3 regulatory subunit B, beta [KO:K06268]", "11151  CORO1A; coronin 1A [KO:K13882]", "102723407  IGH; immunoglobulin heavy variable 4-38-2-like [KO:K06856]", "2209  FCGR1A; Fc gamma receptor Ia [KO:K06498]", "2212  FCGR2A; Fc gamma receptor IIa [KO:K06472]", "2213  FCGR2B; Fc gamma receptor IIb [KO:K12560]", "9103  FCGR2C; Fc gamma receptor IIc (gene/pseudogene) [KO:K16824]", "2214  FCGR3A; Fc gamma receptor IIIa [KO:K06463]", "2215  FCGR3B; Fc gamma receptor IIIb [KO:K06463]"], "compound": ["C00076  Calcium cation", "C00338  Lipopolysaccharide", "C01194  1-Phosphatidyl-D-myo-inositol", "C01561  Calcidiol", "C01673  Calcitriol", "C04549  1-Phosphatidyl-1D-myo-inositol 3-phosphate", "C06124  Sphingosine 1-phosphate", "C19190  Trehalose-6,6'-dibehenate", "C21790  Mycobacterial trehalose dimycolate", "G13101  Lipomannan", "G13105  Triacylated phosphatidyl-myo-inositol pentamannoside", "G13106  Triacylated phosphatidyl-myo-inositol hexamannoside", "G13108  Triacylated phosphatidyl-myo-inositol dimannoside", "G13109  Tetraacylated phosphatidyl-myo-inositol dimannoside", "G13112  Tetraacylated phosphatidyl-myo-inositol hexamannoside", "G13113  Tetraacylated phosphatidyl-myo-inositol pentamannoside", "G13114  Lipoarabinomannan", "G13115  Mannose-capped lipoarabinomannan"], "refs": [{"pmid": "21274449", "authors": "  Saiga H, Shimada Y, Takeda K", "title": "Innate immune effectors in mycobacterial infection.", "journal": "Clin Dev Immunol 2011:347594 (2011)", "doi": "10.1155/2011/347594"}, {"pmid": "20415982", "authors": "  Dheda K, Schwander SK, Zhu B, van Zyl-Smit RN, Zhang Y", "title": "The immunology of tuberculosis: from bench to bedside.", "journal": "Respirology 15:433-50 (2010)", "doi": "10.1111/j.1440-1843.2010.01739.x"}, {"pmid": "11932234", "authors": "  van Crevel R, Ottenhoff TH, van der Meer JW", "title": "Innate immunity to Mycobacterium tuberculosis.", "journal": "Clin Microbiol Rev 15:294-309 (2002)", "doi": "10.1128/CMR.15.2.294-309.2002"}, {"pmid": "18288961", "authors": "  Torrelles JB, Azad AK, Henning LN, Carlson TK, Schlesinger LS", "title": "Role of C-type lectins in mycobacterial infections.", "journal": "Curr Drug Targets 9:102-12 (2008)", "doi": "10.2174/138945008783502467"}, {"pmid": "17359235", "authors": "  Jo EK, Yang CS, Choi CH, Harding CV", "title": "Intracellular signalling cascades regulating innate immune responses to Mycobacteria: branching out from Toll-like receptors.", "journal": "Cell Microbiol 9:1087-98 (2007)", "doi": "10.1111/j.1462-5822.2007.00914.x"}, {"pmid": "21274433", "authors": "  Marakalala MJ, Graham LM, Brown GD", "title": "The role of Syk/CARD9-coupled C-type lectin receptors in immunity to Mycobacterium tuberculosis infections.", "journal": "Clin Dev Immunol 2010:567571 (2010)", "doi": "10.1155/2010/567571"}, {"pmid": "15083155", "authors": "  Koul A, Herget T, Klebl B, Ullrich A", "title": "Interplay between mycobacteria and host signalling pathways.", "journal": "Nat Rev Microbiol 2:189-202 (2004)", "doi": "10.1038/nrmicro840"}, {"pmid": "20199890", "authors": "  Torrelles JB, Schlesinger LS", "title": "Diversity in Mycobacterium tuberculosis mannosylated cell wall determinants impacts adaptation to the host.", "journal": "Tuberculosis (Edinb) 90:84-93 (2010)", "doi": "10.1016/j.tube.2010.02.003"}, {"pmid": "15228522", "authors": "  Briken V, Porcelli SA, Besra GS, Kremer L", "title": "Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response.", "journal": "Mol Microbiol 53:391-403 (2004)", "doi": "10.1111/j.1365-2958.2004.04183.x"}, {"pmid": "19563525", "authors": "  Baena A, Porcelli SA", "title": "Evasion and subversion of antigen presentation by Mycobacterium tuberculosis.", "journal": "Tissue Antigens 74:189-204 (2009)", "doi": "10.1111/j.1399-0039.2009.01301.x"}, {"pmid": "19369951", "authors": "  Flannagan RS, Cosio G, Grinstein S", "title": "Antimicrobial mechanisms of phagocytes and bacterial evasion strategies.", "journal": "Nat Rev Microbiol 7:355-66 (2009)", "doi": "10.1038/nrmicro2128"}, {"pmid": "18541216", "authors": "  Pieters J", "title": "Mycobacterium tuberculosis and the macrophage: maintaining a balance.", "journal": "Cell Host Microbe 3:399-407 (2008)", "doi": "10.1016/j.chom.2008.05.006"}, {"pmid": "16200082", "authors": "  Reith W, LeibundGut-Landmann S, Waldburger JM.", "title": "Regulation of MHC class II gene expression by the class II transactivator.", "journal": "Nat Rev Immunol 5:793-806 (2005)", "doi": "10.1038/nri1708"}, {"pmid": "17785780", "authors": "  Rothfuchs AG, Bafica A, Feng CG, Egen JG, Williams DL, Brown GD, Sher A", "title": "Dectin-1 interaction with Mycobacterium tuberculosis leads to enhanced IL-12p40 production by splenic dendritic cells.", "journal": "J Immunol 179:3463-71 (2007)", "doi": "10.4049/jimmunol.179.6.3463"}, {"pmid": "18407066", "authors": "  Master SS, Rampini SK, Davis AS, Keller C, Ehlers S, Springer B, Timmins GS, Sander P, Deretic V", "title": "Mycobacterium tuberculosis prevents inflammasome activation.", "journal": "Cell Host Microbe 3:224-32 (2008)", "doi": "10.1016/j.chom.2008.03.003"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04210  Apoptosis", "hsa04612  Antigen processing and presentation", "hsa04620  Toll-like receptor signaling pathway", "hsa04621  NOD-like receptor signaling pathway", "hsa04630  JAK-STAT signaling pathway"], "ko_pathway": "ko05152", "genes": ["MALT1", "AKT2", "AKT1", "MAPK13", "BAX"]}, {"kegg_id": "hsa00500", "name": "Starch and sucrose metabolism - Homo sapiens (human)", "class": "Metabolism; Carbohydrate metabolism", "pathway_map": "hsa00500  Starch and sucrose metabolism", "module": ["hsa_M00854  Glycogen biosynthesis, glucose-1P => glycogen/starch [PATH:hsa00500]", "hsa_M00855  Glycogen degradation, glycogen => glucose-6P [PATH:hsa00500]"], "network": ["", "ELEMENT   N00713  Glycogen biosynthesis", "N00718  Glycogen degradation", "N00720  Glycogen degradation (amylase)"], "drug": ["D00216  Acarbose (JAN/USAN/INN)", "D00625  Miglitol (JP18/USAN/INN)", "D01665  Voglibose (JP18/USAN/INN)", "D03207  Alglucosidase alfa (USAN/INN)", "D03342  Camiglibose (USAN)", "D04537  Ingliforib (USAN/INN)", "D09605  Duvoglustat (USAN/INN)", "D09606  Duvoglustat hydrochloride (USAN)", "D11744  Avalglucosidase alfa (USAN/INN)", "D11798  Cipaglucosidase alfa (USAN)", "D11828  Clervonafusp alfa (USAN/INN)"], "dblinks": "GO: 0005982 0005985", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["8972  MGAM; maltase-glucoamylase [KO:K12047] [EC:3.2.1.20 3.2.1.3]", "93432  MGAM2; maltase-glucoamylase 2 (putative) [KO:K12047] [EC:3.2.1.20 3.2.1.3]", "2548  GAA; alpha glucosidase [KO:K12316] [EC:3.2.1.20]", "2595  GANC; glucosidase alpha, neutral C [KO:K12317] [EC:3.2.1.20]", "6476  SI; sucrase-isomaltase [KO:K01203] [EC:3.2.1.48 3.2.1.10]", "7360  UGP2; UDP-glucose pyrophosphorylase 2 [KO:K00963] [EC:2.7.7.9]", "5167  ENPP1; ectonucleotide pyrophosphatase/phosphodiesterase 1 [KO:K01513] [EC:3.1.4.1 3.6.1.9]", "5169  ENPP3; ectonucleotide pyrophosphatase/phosphodiesterase 3 [KO:K01513] [EC:3.1.4.1 3.6.1.9]", "57733  GBA3; glucosylceramidase beta 3 (gene/pseudogene) [KO:K05350] [EC:3.2.1.21]", "2998  GYS2; glycogen synthase 2 [KO:K00693] [EC:2.4.1.11]", "2997  GYS1; glycogen synthase 1 [KO:K00693] [EC:2.4.1.11]", "2992  GYG1; glycogenin 1 [KO:K00750] [EC:2.4.1.186]", "8908  GYG2; glycogenin 2 [KO:K00750] [EC:2.4.1.186]", "2632  GBE1; 1,4-alpha-glucan branching enzyme 1 [KO:K00700] [EC:2.4.1.18]", "5836  PYGL; glycogen phosphorylase L [KO:K00688] [EC:2.4.1.1]", "5837  PYGM; glycogen phosphorylase, muscle associated [KO:K00688] [EC:2.4.1.1]", "5834  PYGB; glycogen phosphorylase B [KO:K00688] [EC:2.4.1.1]", "178  AGL; amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase [KO:K01196] [EC:2.4.1.25 3.2.1.33]", "278  AMY1C; amylase alpha 1C [KO:K01176] [EC:3.2.1.1]", "279  AMY2A; amylase alpha 2A [KO:K01176] [EC:3.2.1.1]", "276  AMY1A; amylase alpha 1A [KO:K01176] [EC:3.2.1.1]", "280  AMY2B; amylase alpha 2B [KO:K01176] [EC:3.2.1.1]", "277  AMY1B; amylase alpha 1B [KO:K01176] [EC:3.2.1.1]", "11181  TREH; trehalase [KO:K01194] [EC:3.2.1.28]", "5236  PGM1; phosphoglucomutase 1 [KO:K01835] [EC:5.4.2.2]", "55276  PGM2; phosphoglucomutase 2 [KO:K15779] [EC:5.4.2.2 5.4.2.7]", "3101  HK3; hexokinase 3 [KO:K00844] [EC:2.7.1.1]", "3098  HK1; hexokinase 1 [KO:K00844] [EC:2.7.1.1]", "3099  HK2; hexokinase 2 [KO:K00844] [EC:2.7.1.1]", "80201  HKDC1; hexokinase domain containing 1 [KO:K00844] [EC:2.7.1.1]", "2645  GCK; glucokinase [KO:K12407] [EC:2.7.1.2]", "2538  G6PC1; glucose-6-phosphatase catalytic subunit 1 [KO:K01084] [EC:3.1.3.9]", "57818  G6PC2; glucose-6-phosphatase catalytic subunit 2 [KO:K01084] [EC:3.1.3.9]", "92579  G6PC3; glucose-6-phosphatase catalytic subunit 3 [KO:K01084] [EC:3.1.3.9]", "283209  PGM2L1; phosphoglucomutase 2 like 1 [KO:K11809] [EC:2.7.1.106]", "2821  GPI; glucose-6-phosphate isomerase [KO:K01810] [EC:5.3.1.9]"], "compound": ["C00029  UDP-glucose", "C00031  D-Glucose", "C00085  D-Fructose 6-phosphate", "C00089  Sucrose", "C00092  D-Glucose 6-phosphate", "C00095  D-Fructose", "C00103  D-Glucose 1-phosphate", "C00185  Cellobiose", "C00208  Maltose", "C00252  Isomaltose", "C00369  Starch", "C00372  Dextran", "C00394  GDP-glucose", "C00498  ADP-glucose", "C00501  CDP-glucose", "C00663  beta-D-Glucose 1-phosphate", "C00689  alpha,alpha'-Trehalose 6-phosphate", "C00718  Amylose", "C00721  Dextrin", "C00760  Cellulose", "C00963  beta-D-Glucoside", "C00965  1,3-beta-D-Glucan", "C00973  Cyclomaltodextrin", "C01083  alpha,alpha-Trehalose", "C01231  alpha-D-Glucose 1,6-bisphosphate", "C01725  Levanbiose", "C01898  Cellodextrin", "C01935  Maltodextrin", "C02591  Sucrose 6'-phosphate", "C02995  Maltose 6'-phosphate", "C03323  (2,1-beta-D-Fructosyl)n", "C04534  6-Phospho-beta-D-glucosyl-(1,4)-D-glucose", "C05731  3-Ketosucrose", "C06215  Levan", "C06400  1-alpha-D-[(1->4)-alpha-D-Glucosyl](n-1)-alpha-D-glucopyranoside", "C16688  Sucrose 6-phosphate", "C20237  alpha-Maltose 1-phosphate"], "rel_pathway": ["hsa00010  Glycolysis / Gluconeogenesis", "hsa00520  Amino sugar and nucleotide sugar metabolism"], "ko_pathway": "ko00500", "genes": ["GBA3"]}, {"kegg_id": "hsa04024", "name": "cAMP signaling pathway - Homo sapiens (human)", "description": "cAMP is one of the most common and universal second messengers, and its formation is promoted by adenylyl cyclase (AC) activation after ligation of G protein-coupled receptors (GPCRs) by ligands including hormones, neurotransmitters, and other signaling molecules. cAMP regulates pivotal physiologic processes including metabolism, secretion, calcium homeostasis, muscle contraction, cell fate, and gene transcription. cAMP acts directly on three main targets: protein kinase A (PKA), the exchange protein activated by cAMP (Epac), and cyclic nucleotide-gated ion channels (CNGCs). PKA modulates, via phosphorylation, a number of cellular substrates, including transcription factors, ion channels, transporters, exchangers, intracellular Ca2+ -handling proteins, and the contractile machinery. Epac proteins function as guanine nucleotide exchange factors (GEFs) for both Rap1 and Rap2. Various effector proteins, including adaptor proteins implicated in modulation of the actin cytoskeleton, regulators of G proteins of the Rho family, and phospholipases, relay signaling downstream from Rap.", "class": "Environmental Information Processing; Signal transduction", "pathway_map": "hsa04024  cAMP signaling pathway", "network": ["", "ELEMENT   N00324  CRHR-PKA-ACTH signaling pathway", "N00885  LHCGR-GNAS-PKA signaling pathway", "N00922  FSHR-GNAS-PKA signaling pathway"], "drug": ["D00095  Epinephrine (USP/INN)", "D00138  Scopolamine (INN)", "D00227  Aminophylline (USP/INN)", "D00231  Inamrinone (USP)", "D00241  Baclofen (JP18/USP/INN)", "D00255  Carvedilol (JP18/USP/INN)", "D00302  Dipyridamole (JP18/USP/INN)", "D00371  Theophylline (JP18)", "D00378  Timolol (USAN)", "D00417  Milrinone (JAN/USP/INN)", "D00419  Misoprostol (JAN/USP/INN)", "D00432  Nadolol (JP18/USP/INN)", "D00442  Octreotide (USAN/INN)", "D00481  Propantheline bromide (JP18/USP/INN)", "D00528  Caffeine (USP)", "D00598  Betaxolol hydrochloride (JP18/USP)", "D00599  Carteolol hydrochloride (JP18/USP)", "D00600  Labetalol hydrochloride (JP18/USP)", "D00603  Timolol maleate (JP18/USP)", "D00616  Diltiazem hydrochloride (JP18/USP)", "D00631  Bepridil hydrochloride (USAN)", "D00632  Dobutamine hydrochloride (JP18/USP)", "D00634  Bisoprolol fumarate (JP18/USP)", "D00636  Amiodarone hydrochloride (JP18/USP)", "D00683  Albuterol sulfate (USP)", "D00684  Bitolterol mesylate (USAN)", "D00685  Metaproterenol sulfate (USP)", "D00686  Pirbuterol acetate (USAN)", "D00687  Salmeterol xinafoate (JAN/USP)", "D00688  Terbutaline sulfate (JP18/USP)", "D00691  Dyphylline (USP)", "D00717  Dicyclomine hydrochloride (JAN/USP)", "D00718  Flavoxate hydrochloride (JP18/USP)", "D00996  Epinephrine hydrochloride (JAN)", "D01006  Oxyphencyclimine hydrochloride (JAN)", "D01103  Trospium chloride (JAN/USP/INN)", "D01133  Pimobendan (JAN/USAN/INN)", "D01165  Piperidolate hydrochloride (JAN)", "D01171  Monatepil maleate (JAN/USAN)", "D01201  Tiemonium iodide (JAN/INN)", "D01220  Trapidil (JP18/INN)", "D01238  Bucladesine sodium (JAN)", "D01263  Ritodrine hydrochloride (JP18/USP)", "D01349  Pirbuterol hydrochloride (JAN/USAN)", "D01360  Clenbuterol hydrochloride (JAN/USP)", "D01362  Tulobuterol hydrochloride (JP18)", "D01373  Formoterol fumarate (USP)", "D01377  Prifinium bromide (JAN/INN)", "D01385  Ibudilast (JP18/INN)", "D01428  Fenoterol hydrobromide (JAN)", "D01453  Caffeine hydrate (JP18)", "D01469  Amosulalol hydrochloride (JP18)", "D01573  Etilefrine hydrochloride (JP18)", "D01589  Mabuterol hydrochloride (JAN)", "D01630  Propentofylline (JAN/INN)", "D01635  Methoxyphenamine hydrochloride (JAN)", "D01691  Nipradilol (JAN/INN)", "D01697  Colforsin daropate hydrochloride (JAN)", "D01704  Cilomilast (JAN/USAN/INN)", "D01712  Theophylline sodium acetate (JAN)", "D01771  Proxyphylline (JAN/INN)", "D01783  Rolipram (JAN/USAN/INN)", "D01830  Arotinolol hydrochloride (JP18)", "D01835  Clorprenaline hydrochloride (JAN/USAN)", "D01891  Enprostil (JAN/USAN/INN)", "D01896  Cilostazol (JP18/USP/INN)", "D01903  Docarpamine (JAN/INN)", "D01958  Indenolol hydrochloride (JP18)", "D01978  Trimetoquinol hydrochloride", "D02017  Oxtriphylline (USP)", "D02071  Scopolamine hydrobromide (USP)", "D02084  Inamrinone ethylenelactate", "D02085  Milrinone lactate", "D02093  Isoetharine hydrochloride (USP)", "D02147  Albuterol (USP)", "D02149  Epinephrine bitartrate (JAN/USP)", "D02151  Tulobuterol (JP18/INN)", "D02212  Ipratropium bromide (USP)", "D02218  Papaverine hydrochloride (JP18/USP)", "D02250  Octreotide acetate (JAN)", "D02281  Levalbuterol hydrochloride (USP)", "D02342  Bisoprolol (JAN/USAN/INN)", "D02359  Ritodrine (USAN/INN)", "D02396  Hexoprenaline sulfate (USAN)", "D02404  Procaterol hydrochloride (USAN)", "D02417  Flutropium bromide (JAN)", "D02535  Timepidium bromide hydrate (JP18)", "D02655  Etazolate hydrochloride (USAN)", "D02910  Amiodarone (USAN/INN)", "D02976  Arbutamine hydrochloride (USAN)", "D02981  Arformoterol tartrate (USAN)", "D02985  Arofylline (USAN/INN)", "D03051  Bamifylline hydrochloride (USAN)", "D03075  Bemoradan (USAN/INN)", "D03088  Benzilonium bromide (USAN/INN)", "D03177  Bunolol hydrochloride (USAN)", "D03187  Butaprost (USAN/INN)", "D03328  Carperitide (USAN/INN)", "D03402  Carbuterol hydrochloride (USAN)", "D03415  Carvedilol phosphate (USAN)", "D03516  Cipamfylline (USAN/INN)", "D03584  Colforsin (USAN/INN)", "D03587  Colterol mesylate (USAN)", "D03655  Darodipine (USAN/INN)", "D03830  Diltiazem malate (USAN)", "D03879  Dobutamine (USAN/INN)", "D03891  Dopexamine (USAN/INN)", "D03892  Dopexamine hydrochloride (USAN)", "D03898  Doxofylline (USAN/INN)", "D04004  Enoximone (USAN/INN)", "D04006  Enprofylline (USAN/INN)", "D04026  Epinephryl borate (USP)", "D04072  Etafedrine hydrochloride (USAN)", "D04157  Fenoterol (USAN/INN)", "D04185  Filaminast (USAN/INN)", "D04508  Imazodan hydrochloride (USAN)", "D04529  Indolidan (USAN/INN)", "D04625  Isoetharine (USP)", "D04626  Isoetharine mesylate (USP)", "D04628  Isomazole hydrochloride (USAN)", "D04666  Lanreotide acetate (JAN/USAN)", "D04701  Levalbuterol sulfate (USAN)", "D04703  Levalbuterol tartrate (USAN)", "D04710  Levobetaxolol hydrochloride (USAN)", "D04720  Levosimendan (USAN/INN)", "D04751  Lixazinone sulfate (USAN)", "D04868  Mebeverine hydrochloride (USAN)", "D04954  Metaproterenol polistirex (USAN)", "D05037  Trimetoquinol hydrochloride hydrate (JP18)", "D05230  Octreotide pamoate (USAN)", "D05277  Formoterol fumarate hydrate (JP18)", "D05278  Oxagrelate (USAN/INN)", "D05366  Procaterol hydrochloride hydrate (JP18)", "D05429  Aminophylline hydrate (JP18)", "D05474  Piclamilast (USAN/INN)", "D05476  Picumeterol fumarate (USAN)", "D05514  Piroximone (USAN)", "D05612  Prinoxodan (USAN/INN)", "D05677  Quinelorane hydrochloride (USAN)", "D05682  Quinpirole hydrochloride (USAN)", "D05688  Racepinephrine (USP/INN)", "D05689  Racepinephrine hydrochloride (USP)", "D05711  Regadenoson (USAN)", "D05718  Reproterol hydrochloride (USAN)", "D05730  Rimiterol hydrobromide (USAN)", "D05744  Roflumilast (JAN/USAN/INN)", "D05792  Salmeterol (USAN/INN)", "D05812  Seglitide acetate (USAN)", "D05832  Sibenadet hydrochloride (USAN)", "D05902  Soterenol hydrochloride (USAN)", "D06103  Theophylline (USP)", "D06104  Theophylline sodium glycinate (USP)", "D06132  Tibenelast sodium (USAN)", "D06374  Zinterol hydrochloride (USAN)", "D06495  Octreotide acetate (USP)", "D06562  Bedoradrine sulfate (USAN)", "D06877  Oxyphenonium bromide (INN)", "D07079  Difemerine (INN)", "D07088  Drotaverine (INN)", "D07089  Moxaverine (INN)", "D07094  Pinaverium bromide (INN)", "D07165  Ivabradine (USAN/INN)", "D07181  Mepindolol (INN)", "D07377  Bambuterol (INN)", "D07425  Papaverine (BAN)", "D07439  Papaverine sulfate", "D07451  Amosulalol (INN)", "D07463  Arformoterol (INN)", "D07465  Arotinolol (INN)", "D07489  Bambuterol hydrochloride", "D07491  Bamifylline (INN)", "D07520  Bepridil (INN)", "D07526  Betaxolol (INN)", "D07534  Bitolterol (INN)", "D07546  Bucladesine (INN)", "D07603  Caffeine citrate (USP)", "D07624  Carteolol (INN)", "D07682  Clazosentan sodium (JAN/USAN)", "D07713  Clenbuterol (INN)", "D07820  Dicycloverine (INN)", "D07835  Dihydroergocryptine", "D07845  Diltiazem (INN)", "D07879  Drotaverine hydrochloride", "D07931  Etilefrine (INN)", "D07961  Flavoxate (INN)", "D07990  Formoterol (INN)", "D08039  Hexoprenaline (INN)", "D08078  Indenolol (INN)", "D08095  Ivabradine hydrochloride (JAN/USAN)", "D08106  Labetalol (INN)", "D08124  Levosalbutamol (INN)", "D08160  Mebeverine (INN)", "D08238  Moxaverine hydrochloride", "D08300  Orciprenaline (INN)", "D08325  Oxyphencyclimine (INN)", "D08382  Piperidolate (INN)", "D08387  Pirbuterol (INN)", "D08424  Procaterol (INN)", "D08474  Reproterol (INN)", "D08570  Terbutaline (INN)", "D08600  Timolol (INN)", "D08629  Tretoquinol (INN)", "D08860  Apremilast (JAN/USAN)", "D08861  Arbaclofen placarbil (USAN/INN)", "D08945  Milveterol hydrochloride (USAN)", "D09318  Indacaterol (USAN/INN)", "D09319  Indacaterol maleate (JAN/USAN)", "D09696  Vilanterol (USAN/INN)", "D09697  Vilanterol trifenatate (JAN/USAN)", "D09765  Vorapaxar (USAN/INN)", "D09766  Vorapaxar sulfate (JAN/USAN)", "D09791  Arbaclofen (USAN)", "D09822  Theosalicin (JAN)", "D09833  Levosemotiadil fumarate (JAN)", "D10020  Olodaterol hydrochloride (JAN/USAN)", "D10145  Olodaterol (USAN/INN)", "D10147  Pasireotide (USAN)", "D10219  Abediterol (USAN/INN)", "D10220  Abediterol napadisylate (USAN)", "D10497  Pasireotide diaspartate", "D10545  Batefenterol (USAN)", "D10546  Batefenterol succinate (USAN)", "D10562  Macimorelin acetate (USAN)", "D10563  Macimorelin (USAN)", "D10566  Pasireotide pamoate (JAN)", "D10932  Etripamil (USAN/INN)", "D11009  Indacaterol acetate (JAN)", "D11033  Lutetium (177Lu) oxodotreotide (INN)", "D11102  Tamolarizine hydrochloride (JAN)", "D11171  Mardepodect (USAN/INN)", "D11192  Veldoreotide (USAN/INN)", "D11204  Octreotide hydrochloride (USAN)", "D11245  Balipodect (USAN/INN)", "D11305  Lotamilast (USAN/INN)", "D11314  Difamilast (JAN/USAN)", "D11360  Tirzepatide (JAN/USAN)", "D11547  Ciforadenant (USAN)", "D11630  Aminophylline dihydrate", "D11664  Clazosentan (USAN/INN)", "D11743  Ensifentrine (USAN/INN)", "D11845  Tidutamab (USAN/INN)", "D11910  Danuglipron (USAN)", "D11911  Danuglipron tromethamine (USAN)", "D11978  Inupadenant (USAN)", "D11979  Inupadenant hydrochloride (USAN)", "D12157  Felcisetrag (USAN/INN)", "D12173  Zatolmilast (USAN)", "D12225  Mazdutide (USAN)", "D12240  Valiloxybate (USAN)", "D12394  Inobrodib (USAN)", "D12397  Tranimilast (USAN/INN)", "D12477  Paltusotine (USAN/INN)", "D12478  Paltusotine hydrochloride (USAN)", "D12529  Orforglipron calcium (USAN)", "D12536  Orforglipron (USAN)", "D12568  Regadenoson (INN)", "D12733  Dordaviprone (USAN/INN)", "D12734  Dordaviprone hydrochloride (JAN/USAN)", "D12804  Nelutroctiv (USAN/INN)", "D12822  Idrebormilast (USAN)", "D12861  Pemvidutide (USAN/INN)", "D12898  Survodutide (USAN/INN)"], "dblinks": "GO: 0019933", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["7432  VIP; vasoactive intestinal peptide [KO:K05264]", "1392  CRH; corticotropin releasing hormone [KO:K05256]", "1081  CGA; glycoprotein hormones, alpha polypeptide [KO:K08522]", "3972  LHB; luteinizing hormone subunit beta [KO:K08521]", "170589  GPHA2; glycoprotein hormone subunit alpha 2 [KO:K25483]", "122876  GPHB5; glycoprotein hormone subunit beta 5 [KO:K25484]", "7252  TSHB; thyroid stimulating hormone subunit beta [KO:K05251]", "5443  POMC; proopiomelanocortin [KO:K05228]", "2641  GCG; glucagon [KO:K05259]", "2695  GIP; gastric inhibitory polypeptide [KO:K05258]", "2488  FSHB; follicle stimulating hormone subunit beta [KO:K05250]", "4878  NPPA; natriuretic peptide A [KO:K12334]", "116  ADCYAP1; adenylate cyclase activating polypeptide 1 [KO:K05262]", "153  ADRB1; adrenoceptor beta 1 [KO:K04141]", "154  ADRB2; adrenoceptor beta 2 [KO:K04142]", "1812  DRD1; dopamine receptor D1 [KO:K04144]", "1816  DRD5; dopamine receptor D5 [KO:K05840]", "135  ADORA2A; adenosine A2a receptor [KO:K04266]", "3360  HTR4; 5-hydroxytryptamine receptor 4 [KO:K04160]", "3362  HTR6; 5-hydroxytryptamine receptor 6 [KO:K04162]", "5732  PTGER2; prostaglandin E receptor 2 [KO:K04259]", "117  ADCYAP1R1; ADCYAP receptor type I [KO:K04587]", "7434  VIPR2; vasoactive intestinal peptide receptor 2 [KO:K04590]", "1394  CRHR1; corticotropin releasing hormone receptor 1 [KO:K04578]", "1395  CRHR2; corticotropin releasing hormone receptor 2 [KO:K04579]", "3973  LHCGR; luteinizing hormone/choriogonadotropin receptor [KO:K04248]", "7253  TSHR; thyroid stimulating hormone receptor [KO:K04249]", "4158  MC2R; melanocortin 2 receptor [KO:K04200]", "2740  GLP1R; glucagon like peptide 1 receptor [KO:K04581]", "2696  GIPR; gastric inhibitory polypeptide receptor [KO:K04580]", "139760  GPR119; G protein-coupled receptor 119 [KO:K08424]", "2492  FSHR; follicle stimulating hormone receptor [KO:K04247]", "4881  NPR1; natriuretic peptide receptor 1 [KO:K12323] [EC:4.6.1.2]", "2778  GNAS; GNAS complex locus [KO:K04632]", "1906  EDN1; endothelin 1 [KO:K16366]", "1907  EDN2; endothelin 2 [KO:K16367]", "1908  EDN3; endothelin 3 [KO:K05227]", "6750  SST; somatostatin [KO:K05237]", "4852  NPY; neuropeptide Y [KO:K05232]", "51738  GHRL; ghrelin and obestatin prepropeptide [KO:K05254]", "5020  OXT; oxytocin/neurophysin I prepropeptide [KO:K05243]", "3350  HTR1A; 5-hydroxytryptamine receptor 1A [KO:K04153]", "3351  HTR1B; 5-hydroxytryptamine receptor 1B [KO:K04153]", "3352  HTR1D; 5-hydroxytryptamine receptor 1D [KO:K04153]", "3354  HTR1E; 5-hydroxytryptamine receptor 1E [KO:K04153]", "3355  HTR1F; 5-hydroxytryptamine receptor 1F [KO:K04153]", "1128  CHRM1; cholinergic receptor muscarinic 1 [KO:K04129]", "1129  CHRM2; cholinergic receptor muscarinic 2 [KO:K04130]", "1813  DRD2; dopamine receptor D2 [KO:K04145]", "2550  GABBR1; gamma-aminobutyric acid type B receptor subunit 1 [KO:K04615]", "9568  GABBR2; gamma-aminobutyric acid type B receptor subunit 2 [KO:K04615]", "134  ADORA1; adenosine A1 receptor [KO:K04265]", "1909  EDNRA; endothelin receptor type A [KO:K04197]", "4886  NPY1R; neuropeptide Y receptor Y1 [KO:K04204]", "6751  SSTR1; somatostatin receptor 1 [KO:K04217]", "6752  SSTR2; somatostatin receptor 2 [KO:K04218]", "6755  SSTR5; somatostatin receptor 5 [KO:K04221]", "27198  HCAR1; hydroxycarboxylic acid receptor 1 [KO:K08401]", "338442  HCAR2; hydroxycarboxylic acid receptor 2 [KO:K08402]", "8843  HCAR3; hydroxycarboxylic acid receptor 3 [KO:K08402]", "2867  FFAR2; free fatty acid receptor 2 [KO:K04328]", "56670  SUCNR1; succinate receptor 1 [KO:K10042]", "5733  PTGER3; prostaglandin E receptor 3 [KO:K04260]", "5021  OXTR; oxytocin receptor [KO:K04229]", "2693  GHSR; growth hormone secretagogue receptor [KO:K04284]", "2770  GNAI1; G protein subunit alpha i1 [KO:K04630]", "2773  GNAI3; G protein subunit alpha i3 [KO:K04630]", "2771  GNAI2; G protein subunit alpha i2 [KO:K04630]", "107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]", "108  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]", "109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]", "196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]", "113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]", "114  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]", "115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]", "55811  ADCY10; adenylate cyclase 10 [KO:K11265] [EC:4.6.1.1]", "1259  CNGA1; cyclic nucleotide gated channel subunit alpha 1 [KO:K04948]", "1260  CNGA2; cyclic nucleotide gated channel subunit alpha 2 [KO:K04949]", "1261  CNGA3; cyclic nucleotide gated channel subunit alpha 3 [KO:K04950]", "1262  CNGA4; cyclic nucleotide gated channel subunit alpha 4 [KO:K04951]", "1258  CNGB1; cyclic nucleotide gated channel subunit beta 1 [KO:K04952]", "54714  CNGB3; cyclic nucleotide gated channel subunit beta 3 [KO:K04953]", "810  CALML3; calmodulin like 3 [KO:K02183]", "805  CALM2; calmodulin 2 [KO:K02183]", "808  CALM3; calmodulin 3 [KO:K02183]", "801  CALM1; calmodulin 1 [KO:K02183]", "163688  CALML6; calmodulin like 6 [KO:K02183]", "51806  CALML5; calmodulin like 5 [KO:K02183]", "91860  CALML4; calmodulin like 4 [KO:K02183]", "815  CAMK2A; calcium/calmodulin dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]", "817  CAMK2D; calcium/calmodulin dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]", "816  CAMK2B; calcium/calmodulin dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]", "818  CAMK2G; calcium/calmodulin dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]", "814  CAMK4; calcium/calmodulin dependent protein kinase IV [KO:K05869] [EC:2.7.11.17]", "11149  BVES; blood vessel epicardial substance [KO:K21108]", "64091  POPDC2; popeye domain containing 2 [KO:K26206]", "64208  POPDC3; popeye domain containing 3 [KO:K26207]", "3776  KCNK2; potassium two pore domain channel subfamily K member 2 [KO:K04913]", "610  HCN2; hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2 [KO:K04955]", "10021  HCN4; hyperpolarization activated cyclic nucleotide gated potassium channel 4 [KO:K04957]", "10257  ABCC4; ATP binding cassette subfamily C member 4 (PEL blood group) [KO:K05673]", "10411  RAPGEF3; Rap guanine nucleotide exchange factor 3 [KO:K08014]", "11069  RAPGEF4; Rap guanine nucleotide exchange factor 4 [KO:K04351]", "6237  RRAS; RAS related [KO:K07829]", "22800  RRAS2; RAS related 2 [KO:K07830]", "5337  PLD1; phospholipase D1 [KO:K01115] [EC:3.1.4.4]", "5338  PLD2; phospholipase D2 [KO:K01115] [EC:3.1.4.4]", "51196  PLCE1; phospholipase C epsilon 1 [KO:K05860] [EC:3.1.4.11]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "5906  RAP1A; RAP1A, member of RAS oncogene family [KO:K04353]", "5908  RAP1B; RAP1B, member of RAS oncogene family [KO:K07836]", "7074  TIAM1; TIAM Rac1 associated GEF 1 [KO:K05731]", "10451  VAV3; vav guanine nucleotide exchange factor 3 [KO:K05730]", "7409  VAV1; vav guanine nucleotide exchange factor 1 [KO:K05730]", "7410  VAV2; vav guanine nucleotide exchange factor 2 [KO:K05730]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "5880  RAC2; Rac family small GTPase 2 [KO:K07860]", "5881  RAC3; Rac family small GTPase 3 [KO:K07861]", "5058  PAK1; p21 (RAC1) activated kinase 1 [KO:K04409] [EC:2.7.11.1]", "64411  ARAP3; ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 [KO:K12490]", "387  RHOA; ras homolog family member A [KO:K04513]", "4301  AFDN; afadin, adherens junction formation factor [KO:K05702]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "84152  PPP1R1B; protein phosphatase 1 regulatory inhibitor subunit 1B [KO:K15494]", "5499  PPP1CA; protein phosphatase 1 catalytic subunit alpha [KO:K06269] [EC:3.1.3.16]", "5500  PPP1CB; protein phosphatase 1 catalytic subunit beta [KO:K06269] [EC:3.1.3.16]", "5501  PPP1CC; protein phosphatase 1 catalytic subunit gamma [KO:K06269] [EC:3.1.3.16]", "1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]", "10488  CREB3; cAMP responsive element binding protein 3 [KO:K09048]", "90993  CREB3L1; cAMP responsive element binding protein 3 like 1 [KO:K09048]", "64764  CREB3L2; cAMP responsive element binding protein 3 like 2 [KO:K09048]", "84699  CREB3L3; cAMP responsive element binding protein 3 like 3 [KO:K09048]", "148327  CREB3L4; cAMP responsive element binding protein 3 like 4 [KO:K09048]", "9586  CREB5; cAMP responsive element binding protein 5 [KO:K09047]", "1387  CREBBP; CREB binding protein [KO:K04498] [EC:2.3.1.48]", "2033  EP300; E1A binding protein p300 [KO:K04498] [EC:2.3.1.48]", "627  BDNF; brain derived neurotrophic factor [KO:K04355]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "2737  GLI3; GLI family zinc finger 3 [KO:K06230]", "2735  GLI1; GLI family zinc finger 1 [KO:K16797]", "5727  PTCH1; patched 1 [KO:K06225]", "64399  HHIP; hedgehog interacting protein [KO:K06231]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "6662  SOX9; SRY-box transcription factor 9 [KO:K18435]", "268  AMH; anti-Mullerian hormone [KO:K04665]", "5465  PPARA; peroxisome proliferator activated receptor alpha [KO:K07294]", "8310  ACOX3; acyl-CoA oxidase 3, pristanoyl [KO:K00232] [EC:1.3.3.6]", "51  ACOX1; acyl-CoA oxidase 1 [KO:K00232] [EC:1.3.3.6]", "4772  NFATC1; nuclear factor of activated T cells 1 [KO:K04446]", "2149  F2R; coagulation factor II thrombin receptor [KO:K03914]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]", "3991  LIPE; lipase E, hormone sensitive type [KO:K07188] [EC:3.1.1.79]", "6093  ROCK1; Rho associated coiled-coil containing protein kinase 1 [KO:K04514] [EC:2.7.11.1]", "9475  ROCK2; Rho associated coiled-coil containing protein kinase 2 [KO:K17388] [EC:2.7.11.1]", "4659  PPP1R12A; protein phosphatase 1 regulatory subunit 12A [KO:K06270]", "10398  MYL9; myosin light chain 9 [KO:K12755]", "7137  TNNI3; troponin I3, cardiac type [KO:K12044]", "5350  PLN; phospholamban [KO:K05852]", "487  ATP2A1; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 [KO:K05853] [EC:7.2.2.10]", "489  ATP2A3; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 [KO:K05853] [EC:7.2.2.10]", "488  ATP2A2; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 [KO:K05853] [EC:7.2.2.10]", "6262  RYR2; ryanodine receptor 2 [KO:K04962]", "2902  GRIN1; glutamate ionotropic receptor NMDA type subunit 1 [KO:K05208]", "2903  GRIN2A; glutamate ionotropic receptor NMDA type subunit 2A [KO:K05209]", "2904  GRIN2B; glutamate ionotropic receptor NMDA type subunit 2B [KO:K05210]", "2905  GRIN2C; glutamate ionotropic receptor NMDA type subunit 2C [KO:K05211]", "2906  GRIN2D; glutamate ionotropic receptor NMDA type subunit 2D [KO:K05212]", "116443  GRIN3A; glutamate ionotropic receptor NMDA type subunit 3A [KO:K05213]", "116444  GRIN3B; glutamate ionotropic receptor NMDA type subunit 3B [KO:K05214]", "2890  GRIA1; glutamate ionotropic receptor AMPA type subunit 1 [KO:K05197]", "2891  GRIA2; glutamate ionotropic receptor AMPA type subunit 2 [KO:K05198]", "2892  GRIA3; glutamate ionotropic receptor AMPA type subunit 3 [KO:K05199]", "2893  GRIA4; glutamate ionotropic receptor AMPA type subunit 4 [KO:K05200]", "1080  CFTR; CF transmembrane conductance regulator [KO:K05031] [EC:5.6.1.6]", "476  ATP1A1; ATPase Na+/K+ transporting subunit alpha 1 [KO:K01539] [EC:7.2.2.13]", "477  ATP1A2; ATPase Na+/K+ transporting subunit alpha 2 [KO:K01539] [EC:7.2.2.13]", "478  ATP1A3; ATPase Na+/K+ transporting subunit alpha 3 [KO:K01539] [EC:7.2.2.13]", "480  ATP1A4; ATPase Na+/K+ transporting subunit alpha 4 [KO:K01539] [EC:7.2.2.13]", "23439  ATP1B4; ATPase Na+/K+ transporting family member beta 4 [KO:K01540]", "481  ATP1B1; ATPase Na+/K+ transporting subunit beta 1 [KO:K01540]", "482  ATP1B2; ATPase Na+/K+ transporting subunit beta 2 [KO:K01540]", "483  ATP1B3; ATPase Na+/K+ transporting subunit beta 3 [KO:K01540]", "486  FXYD2; FXYD domain containing ion transport regulator 2 [KO:K01538]", "5348  FXYD1; FXYD domain containing ion transport regulator 1 [KO:K13360]", "6548  SLC9A1; solute carrier family 9 member A1 [KO:K05742]", "84876  ORAI1; ORAI calcium release-activated calcium modulator 1 [KO:K16056]", "490  ATP2B1; ATPase plasma membrane Ca2+ transporting 1 [KO:K05850] [EC:7.2.2.10]", "492  ATP2B3; ATPase plasma membrane Ca2+ transporting 3 [KO:K05850] [EC:7.2.2.10]", "493  ATP2B4; ATPase plasma membrane Ca2+ transporting 4 [KO:K05850] [EC:7.2.2.10]", "491  ATP2B2; ATPase plasma membrane Ca2+ transporting 2 [KO:K05850] [EC:7.2.2.10]", "775  CACNA1C; calcium voltage-gated channel subunit alpha1 C [KO:K04850]", "776  CACNA1D; calcium voltage-gated channel subunit alpha1 D [KO:K04851]", "778  CACNA1F; calcium voltage-gated channel subunit alpha1 F [KO:K04853]", "779  CACNA1S; calcium voltage-gated channel subunit alpha1 S [KO:K04857]", "5139  PDE3A; phosphodiesterase 3A [KO:K19021] [EC:3.1.4.17]", "5140  PDE3B; phosphodiesterase 3B [KO:K13296] [EC:3.1.4.17]", "5141  PDE4A; phosphodiesterase 4A [KO:K13293] [EC:3.1.4.53]", "5142  PDE4B; phosphodiesterase 4B [KO:K13293] [EC:3.1.4.53]", "5143  PDE4C; phosphodiesterase 4C [KO:K13293] [EC:3.1.4.53]", "5144  PDE4D; phosphodiesterase 4D [KO:K13293] [EC:3.1.4.53]", "10846  PDE10A; phosphodiesterase 10A [KO:K18438] [EC:3.1.4.17 3.1.4.35]"], "compound": ["C00020  AMP", "C00042  Succinate", "C00076  Calcium cation", "C00080  H+", "C00165  Diacylglycerol", "C00186  (S)-Lactate", "C00212  Adenosine", "C00238  Potassium cation", "C00288  HCO3-", "C00334  4-Aminobutanoate", "C00416  Phosphatidate", "C00547  L-Noradrenaline", "C00575  3',5'-Cyclic AMP", "C00584  Prostaglandin E2", "C00698  Cl-", "C00780  Serotonin", "C00788  L-Adrenaline", "C01089  (R)-3-Hydroxybutanoate", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C01312  Prostaglandin I2", "C01330  Sodium cation", "C01996  Acetylcholine", "C03758  Dopamine", "C20792  Oleoylethanolamide", "C20793  3-Hydroxyoctanoate"], "refs": [{"pmid": "18323530", "authors": "  Serezani CH, Ballinger MN, Aronoff DM, Peters-Golden M", "title": "Cyclic AMP: master regulator of innate immune cell function.", "journal": "Am J Respir Cell Mol Biol 39:127-32 (2008)", "doi": "10.1165/rcmb.2008-0091TR"}, {"pmid": "24281338", "authors": "  Oldenburger A, Maarsingh H, Schmidt M", "title": "Multiple facets of cAMP signalling and physiological impact: cAMP compartmentalization in the lung.", "journal": "Pharmaceuticals (Basel) 5:1291-331 (2012)", "doi": "10.3390/ph5121291"}, {"pmid": "24613710", "authors": "  Ahuja M, Jha A, Maleth J, Park S, Muallem S", "title": "cAMP and Ca signaling in secretory epithelia: Crosstalk and synergism.", "journal": "Cell Calcium 55:385-393 (2014)", "doi": "10.1016/j.ceca.2014.01.006"}, {"pmid": "22082266", "authors": "  Shirshev SV", "title": "Role of Epac proteins in mechanisms of cAMP-dependent immunoregulation.", "journal": "Biochemistry (Mosc) 76:981-98 (2011)", "doi": "10.1134/S000629791109001X"}, {"pmid": "18176800", "authors": "  Roscioni SS, Elzinga CR, Schmidt M", "title": "Epac: effectors and biological functions.", "journal": "Naunyn Schmiedebergs Arch Pharmacol 377:345-57 (2008)", "doi": "10.1007/s00210-007-0246-7"}, {"pmid": "24450633", "authors": "  Roberts OL, Dart C", "title": "cAMP signalling in the vasculature: the role of Epac (exchange protein directly activated by cAMP).", "journal": "Biochem Soc Trans 42:89-97 (2014)", "doi": "10.1042/BST20130253"}, {"pmid": "16765984", "authors": "  Schaub MC, Hefti MA, Zaugg M", "title": "Integration of calcium with the signaling network in cardiac myocytes.", "journal": "J Mol Cell Cardiol 41:183-214 (2006)", "doi": "10.1016/j.yjmcc.2006.04.005"}, {"pmid": "19874988", "authors": "  Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G, Butler J", "title": "The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.", "journal": "J Am Coll Cardiol 54:1747-62 (2009)", "doi": "10.1016/j.jacc.2009.05.015"}, {"pmid": "15142747", "authors": "  Saucerman JJ, McCulloch AD", "title": "Mechanistic systems models of cell signaling networks: a case study of myocyte adrenergic regulation.", "journal": "Prog Biophys Mol Biol 85:261-78 (2004)", "doi": "10.1016/j.pbiomolbio.2004.01.005"}, {"pmid": "21212391", "authors": "  Yang JH, Saucerman JJ", "title": "Computational models reduce complexity and accelerate insight into cardiac signaling networks.", "journal": "Circ Res 108:85-97 (2011)", "doi": "10.1161/CIRCRESAHA.110.223602"}, {"pmid": "22022314", "authors": "  Taggart P, Boyett MR, Logantha S, Lambiase PD", "title": "Anger, emotion, and arrhythmias: from brain to heart.", "journal": "Front Physiol 2:67 (2011)", "doi": "10.3389/fphys.2011.00067"}, {"pmid": "21852968", "authors": "  Bozzi Y, Dunleavy M, Henshall DC", "title": "Cell signaling underlying epileptic behavior.", "journal": "Front Behav Neurosci 5:45 (2011)", "doi": "10.3389/fnbeh.2011.00045"}, {"pmid": "10880354", "authors": "  Lizcano JM, Morrice N, Cohen P", "title": "Regulation of BAD by cAMP-dependent protein kinase is mediated via phosphorylation of a novel site, Ser155.", "journal": "Biochem J 349:547-57 (2000)", "doi": "10.1042/bj3490547"}, {"pmid": "21744067", "authors": "  Gerlo S, Kooijman R, Beck IM, Kolmus K, Spooren A, Haegeman G", "title": "Cyclic AMP: a selective modulator of NF-kappaB action.", "journal": "Cell Mol Life Sci 68:3823-41 (2011)", "doi": "10.1007/s00018-011-0757-8"}, {"pmid": "7688165", "authors": "  Lauder JM", "title": "Neurotransmitters as growth regulatory signals: role of receptors and second messengers.", "journal": "Trends Neurosci 16:233-40 (1993)", "doi": "10.1016/0166-2236(93)90162-F"}, {"pmid": "17077866", "authors": "  Voglis G, Tavernarakis N", "title": "The role of synaptic ion channels in synaptic plasticity.", "journal": "EMBO Rep 7:1104-10 (2006)", "doi": "10.1038/sj.embor.7400830"}, {"pmid": "21346730", "authors": "  Altarejos JY, Montminy M", "title": "CREB and the CRTC co-activators: sensors for hormonal and metabolic signals.", "journal": "Nat Rev Mol Cell Biol 12:141-51 (2011)", "doi": "10.1038/nrm3072"}, {"pmid": "24062645", "authors": "  Bozzi Y, Borrelli E", "title": "The role of dopamine signaling in epileptogenesis.", "journal": "Front Cell Neurosci 7:157 (2013)", "doi": "10.3389/fncel.2013.00157"}, {"pmid": "14715909", "authors": "  Ceulemans H, Bollen M", "title": "Functional diversity of protein phosphatase-1, a cellular economizer and reset button.", "journal": "Physiol Rev 84:1-39 (2004)", "doi": "10.1152/physrev.00013.2003"}, {"pmid": "16571352", "authors": "  Lipinski RJ, Gipp JJ, Zhang J, Doles JD, Bushman W", "title": "Unique and complimentary activities of the Gli transcription factors in Hedgehog signaling.", "journal": "Exp Cell Res 312:1925-38 (2006)", "doi": "10.1016/j.yexcr.2006.02.019"}, {"pmid": "21693691", "authors": "  Lasala C, Schteingart HF, Arouche N, Bedecarras P, Grinspon RP, Picard JY, Josso N, di Clemente N, Rey RA", "title": "SOX9 and SF1 are involved in cyclic AMP-mediated upregulation of anti-Mullerian gene expression in the testicular prepubertal Sertoli cell line SMAT1.", "journal": "Am J Physiol Endocrinol Metab 301:E539-47 (2011)", "doi": "10.1152/ajpendo.00187.2011"}, {"pmid": "19460777", "authors": "  Rosenkranz AC, Rauch BH, Freidel K, Schror K", "title": "Regulation of protease-activated receptor-1 by vasodilatory prostaglandins via NFAT.", "journal": "Cardiovasc Res 83:778-84 (2009)", "doi": "10.1093/cvr/cvp163"}, {"pmid": "11117527", "authors": "  Lazennec G, Canaple L, Saugy D, Wahli W", "title": "Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators.", "journal": "Mol Endocrinol 14:1962-75 (2000)", "doi": "10.1210/mend.14.12.0575"}, {"pmid": "16460276", "authors": "  Murthy KS", "title": "Signaling for contraction and relaxation in smooth muscle of the gut.", "journal": "Annu Rev Physiol 68:345-74 (2006)", "doi": "10.1146/annurev.physiol.68.040504.094707"}, {"pmid": "18064650", "authors": "  Birukova AA, Zagranichnaya T, Alekseeva E, Bokoch GM, Birukov KG", "title": "Epac/Rap and PKA are novel mechanisms of ANP-induced Rac-mediated pulmonary endothelial barrier protection.", "journal": "J Cell Physiol 215:715-24 (2008)", "doi": "10.1002/jcp.21354"}], "rel_pathway": ["hsa00071  Fatty acid degradation", "hsa04015  Rap1 signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04210  Apoptosis", "hsa04260  Cardiac muscle contraction", "hsa04340  Hedgehog signaling pathway", "hsa04720  Long-term potentiation", "hsa04740  Olfactory transduction", "hsa04972  Pancreatic secretion", "hsa04976  Bile secretion"], "ko_pathway": "ko04024", "genes": ["RAC1", "BRAF", "AKT2", "AKT1"]}, {"kegg_id": "hsa04062", "name": "Chemokine signaling pathway - Homo sapiens (human)", "description": "Inflammatory immune response requires the recruitment of leukocytes to the site of inflammation upon foreign insult. Chemokines are small chemoattractant peptides that provide directional cues for the cell trafficking and thus are vital for protective host response. In addition, chemokines regulate plethora of biological processes of hematopoietic cells to lead cellular activation, differentiation and survival.\nThe chemokine signal is transduced by chemokine receptors (G-protein coupled receptors) expressed on the immune cells. After receptor activation, the alpha- and beta-gamma-subunits of G protein dissociate to activate diverse downstream pathways resulting in cellular polarization and actin reorganization. Various members of small GTPases are involved in this process. Induction of nitric oxide and production of reactive oxygen species are as well regulated by chemokine signal via calcium mobilization and diacylglycerol production.", "class": "Organismal Systems; Immune system", "pathway_map": "hsa04062  Chemokine signaling pathway", "network": ["", "ELEMENT   N00152  CXCR-GNB/G-ERK signaling pathway", "N00153  CCR/CXCR-GNB/G-PI3K-RAC signaling pathway", "N00154  CXCR-GNB/G-PI3K-AKT signaling pathway", "N00399  CCR2-GNB/G-PI3K-NFKB signaling pathway", "N00401  CXCR4-GNAQ-PLCB/G-calcineurin signaling pathway", "N00403  CX3CR1-GNAI-AC-PKA signaling pathway", "N00413  CXCR4-GNB/G-PLCB-PKC signaling pathway", "N00428  CCR5-GNB/G-PLCB/G-PKC signaling pathway", "N00430  CXCR4-GNAI-PI3K-BAD signaling pathway", "N00433  CXCR4-GNB/G-RAC signaling pathway", "N00546  CXCL12-CXCR4-PKC-ERK signaling pathaway", "N01746  CCR/CXCR-GNB/G-PI3K signaling pathway", "N01765  CXCR4-GNAQ-PLCB/G signaling pathway", "N01766  CX3CR1-GNAI-AC signaling pathway", "N01767  CXCR4-GNAI-Src signaling pathway", "N01769  CCR5-GNB/G-PLCB/G signaling pathway", "N01770  CCR2-GNB/G-PI3K signaling pathway", "N01771  CXCR4-GNB/G signaling pathway"], "drug": ["D03116  Bindarit (USAN/INN)", "D03210  Ancriviroc (USAN/INN)", "D06182  Tolimidone (USAN)", "D06297  Vicriviroc maleate (USAN)", "D06557  Aplaviroc hydrochloride (USAN)", "D06670  Maraviroc (JAN/INN)", "D08971  Plerixafor (JAN/USAN/INN)", "D08984  Reparixin (USAN/INN)", "D09664  Saracatinib (USAN/INN)", "D09665  Saracatinib difumarate (USAN)", "D09761  Mogamulizumab (USAN)", "D09783  Tofacitinib citrate (JAN/USAN)", "D09877  Carlumab (USAN)", "D09878  Cenicriviroc (USAN/INN)", "D09879  Cenicriviroc mesylate (USAN)", "D09959  Ruxolitinib (USAN/INN)", "D09960  Ruxolitinib phosphate (JAN/USAN)", "D09970  Tofacitinib (USAN)", "D10075  Navarixin (USAN)", "D10308  Baricitinib (JAN/USAN/INN)", "D10332  Elubrixin (USAN)", "D10378  Vercirnon (USAN/INN)", "D10379  Vercirnon sodium (USAN)", "D10387  Danirixin (USAN/INN)", "D10420  Elubrixin tosylate (USAN)", "D10618  Defactinib (USAN/INN)", "D10972  Plozalizumab (USAN/INN)", "D11046  Delgocitinib (JAN/USAN/INN)", "D11267  Nemiralisib (USAN/INN)", "D11322  Umbralisib (USAN/INN)", "D11323  Umbralisib tosylate (USAN)", "D11354  Nemiralisib succinate (USAN)", "D11399  Leronlimab (USAN/INN)", "D11498  Quetmolimab (USAN)", "D11510  Mavorixafor (USAN)", "D11741  Lazucirnon (USAN)", "D11742  Lazucirnon hydrochloride (USAN)", "D11815  Belumosudil (USAN)", "D11816  Belumosudil mesylate (USAN)", "D11970  Ritlecitinib tosylate (USAN)", "D11997  Ilacirnon (USAN)", "D11998  Ilacirnon sodium (USAN)", "D12128  Balixafortide (USAN/INN)", "D12196  Laduviglusib (USAN)", "D12281  Motixafortide (USAN/INN)", "D12282  Motixafortide acetate (USAN)", "D12304  Elraglusib (USAN)", "D12556  Eltrekibart (USAN)", "D12654  Emapticap pegol (INN)", "D12655  Olaptesed pegol (INN)", "D12656  Adakitug (USAN)", "D12762  Soquelitinib (USAN)", "D12849  Imzokitug (USAN)", "D12884  Tivumecirnon (USAN/INN)", "D12885  Tivumecirnon besylate (USAN)"], "dblinks": "GO: 0070098", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["2919  CXCL1; C-X-C motif chemokine ligand 1 [KO:K05505]", "2920  CXCL2; C-X-C motif chemokine ligand 2 [KO:K05505]", "2921  CXCL3; C-X-C motif chemokine ligand 3 [KO:K05505]", "6374  CXCL5; C-X-C motif chemokine ligand 5 [KO:K05506]", "6372  CXCL6; C-X-C motif chemokine ligand 6 [KO:K05506]", "5473  PPBP; pro-platelet basic protein [KO:K10029]", "3576  CXCL8; C-X-C motif chemokine ligand 8 [KO:K10030]", "4283  CXCL9; C-X-C motif chemokine ligand 9 [KO:K05416]", "3627  CXCL10; C-X-C motif chemokine ligand 10 [KO:K12671]", "6373  CXCL11; C-X-C motif chemokine ligand 11 [KO:K12672]", "6387  CXCL12; C-X-C motif chemokine ligand 12 [KO:K10031]", "10563  CXCL13; C-X-C motif chemokine ligand 13 [KO:K10032]", "58191  CXCL16; C-X-C motif chemokine ligand 16 [KO:K10035]", "5196  PF4; platelet factor 4 [KO:K05407]", "5197  PF4V1; platelet factor 4 variant 1 [KO:K05407]", "9547  CXCL14; C-X-C motif chemokine ligand 14 [KO:K10033]", "6375  XCL1; X-C motif chemokine ligand 1 [KO:K05507]", "6846  XCL2; X-C motif chemokine ligand 2 [KO:K22675]", "6376  CX3CL1; C-X3-C motif chemokine ligand 1 [KO:K05508]", "6346  CCL1; C-C motif chemokine ligand 1 [KO:K05514]", "6347  CCL2; C-C motif chemokine ligand 2 [KO:K14624]", "6348  CCL3; C-C motif chemokine ligand 3 [KO:K05408]", "6349  CCL3L1; C-C motif chemokine ligand 3 like 1 [KO:K05408]", "414062  CCL3L3; C-C motif chemokine ligand 3 like 3 [KO:K05408]", "6351  CCL4; C-C motif chemokine ligand 4 [KO:K12964]", "9560  CCL4L2; C-C motif chemokine ligand 4 like 2 [KO:K12964]", "388372  CCL4L1; C-C motif chemokine ligand 4 like 1 [KO:K12964]", "6352  CCL5; C-C motif chemokine ligand 5 [KO:K12499]", "6354  CCL7; C-C motif chemokine ligand 7 [KO:K05509]", "6355  CCL8; C-C motif chemokine ligand 8 [KO:K16596]", "6356  CCL11; C-C motif chemokine ligand 11 [KO:K16597]", "6357  CCL13; C-C motif chemokine ligand 13 [KO:K16595]", "6358  CCL14; C-C motif chemokine ligand 14 [KO:K21092]", "6359  CCL15; C-C motif chemokine ligand 15 [KO:K05511]", "6368  CCL23; C-C motif chemokine ligand 23 [KO:K05511]", "6360  CCL16; C-C motif chemokine ligand 16 [KO:K21093]", "6361  CCL17; C-C motif chemokine ligand 17 [KO:K21083]", "6362  CCL18; C-C motif chemokine ligand 18 [KO:K21094]", "6363  CCL19; C-C motif chemokine ligand 19 [KO:K05512]", "6364  CCL20; C-C motif chemokine ligand 20 [KO:K14625]", "6366  CCL21; C-C motif chemokine ligand 21 [KO:K16062]", "6367  CCL22; C-C motif chemokine ligand 22 [KO:K21095]", "6369  CCL24; C-C motif chemokine ligand 24 [KO:K21097]", "6370  CCL25; C-C motif chemokine ligand 25 [KO:K13072]", "10344  CCL26; C-C motif chemokine ligand 26 [KO:K21096]", "10850  CCL27; C-C motif chemokine ligand 27 [KO:K16598]", "56477  CCL28; C-C motif chemokine ligand 28 [KO:K05513]", "3579  CXCR2; C-X-C motif chemokine receptor 2 [KO:K05050]", "3577  CXCR1; C-X-C motif chemokine receptor 1 [KO:K04175]", "2833  CXCR3; C-X-C motif chemokine receptor 3 [KO:K04188]", "7852  CXCR4; C-X-C motif chemokine receptor 4 [KO:K04189]", "643  CXCR5; C-X-C motif chemokine receptor 5 [KO:K04190]", "10663  CXCR6; C-X-C motif chemokine receptor 6 [KO:K04191]", "2829  XCR1; X-C motif chemokine receptor 1 [KO:K04193]", "1524  CX3CR1; C-X3-C motif chemokine receptor 1 [KO:K04192]", "1237  CCR8; C-C motif chemokine receptor 8 [KO:K04183]", "1235  CCR6; C-C motif chemokine receptor 6 [KO:K04181]", "10803  CCR9; C-C motif chemokine receptor 9 [KO:K04184]", "1233  CCR4; C-C motif chemokine receptor 4 [KO:K04179]", "1236  CCR7; C-C motif chemokine receptor 7 [KO:K04182]", "729230  CCR2; C-C motif chemokine receptor 2 [KO:K04177]", "1234  CCR5; C-C motif chemokine receptor 5 [KO:K04180]", "1230  CCR1; C-C motif chemokine receptor 1 [KO:K04176]", "1232  CCR3; C-C motif chemokine receptor 3 [KO:K04178]", "2826  CCR10; C-C motif chemokine receptor 10 [KO:K04185]", "3717  JAK2; Janus kinase 2 [KO:K04447] [EC:2.7.10.2]", "3718  JAK3; Janus kinase 3 [KO:K11218] [EC:2.7.10.2]", "6772  STAT1; signal transducer and activator of transcription 1 [KO:K11220]", "6773  STAT2; signal transducer and activator of transcription 2 [KO:K11221]", "6774  STAT3; signal transducer and activator of transcription 3 [KO:K04692]", "6777  STAT5B; signal transducer and activator of transcription 5B [KO:K11224]", "2770  GNAI1; G protein subunit alpha i1 [KO:K04630]", "2773  GNAI3; G protein subunit alpha i3 [KO:K04630]", "2771  GNAI2; G protein subunit alpha i2 [KO:K04630]", "107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]", "108  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]", "109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]", "196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]", "113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]", "114  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]", "115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "4067  LYN; LYN proto-oncogene, Src family tyrosine kinase [KO:K05854] [EC:2.7.10.2]", "3055  HCK; HCK proto-oncogene, Src family tyrosine kinase [KO:K08893] [EC:2.7.10.2]", "2268  FGR; FGR proto-oncogene, Src family tyrosine kinase [KO:K08891] [EC:2.7.10.2]", "6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "6464  SHC1; SHC adaptor protein 1 [KO:K06279]", "25759  SHC2; SHC adaptor protein 2 [KO:K17447]", "53358  SHC3; SHC adaptor protein 3 [KO:K17448]", "399694  SHC4; SHC adaptor protein 4 [KO:K17449]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5294  PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma [KO:K21289] [EC:2.7.1.153]", "23533  PIK3R5; phosphoinositide-3-kinase regulatory subunit 5 [KO:K21290]", "146850  PIK3R6; phosphoinositide-3-kinase regulatory subunit 6 [KO:K21290]", "5590  PRKCZ; protein kinase C zeta [KO:K18952] [EC:2.7.11.13]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "2309  FOXO3; forkhead box O3 [KO:K09408]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "4793  NFKBIB; NFKB inhibitor beta [KO:K02581]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]", "2931  GSK3A; glycogen synthase kinase 3 alpha [KO:K08822] [EC:2.7.11.26]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "3702  ITK; IL2 inducible T cell kinase [KO:K07363] [EC:2.7.10.2]", "10451  VAV3; vav guanine nucleotide exchange factor 3 [KO:K05730]", "7409  VAV1; vav guanine nucleotide exchange factor 1 [KO:K05730]", "7410  VAV2; vav guanine nucleotide exchange factor 2 [KO:K05730]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "5880  RAC2; Rac family small GTPase 2 [KO:K07860]", "5881  RAC3; Rac family small GTPase 3 [KO:K07861]", "5058  PAK1; p21 (RAC1) activated kinase 1 [KO:K04409] [EC:2.7.11.1]", "998  CDC42; cell division cycle 42 [KO:K04393]", "7454  WAS; WASP actin nucleation promoting factor [KO:K05747]", "387  RHOA; ras homolog family member A [KO:K04513]", "6093  ROCK1; Rho associated coiled-coil containing protein kinase 1 [KO:K04514] [EC:2.7.11.1]", "9475  ROCK2; Rho associated coiled-coil containing protein kinase 2 [KO:K17388] [EC:2.7.11.1]", "2782  GNB1; G protein subunit beta 1 [KO:K04536]", "2783  GNB2; G protein subunit beta 2 [KO:K04537]", "2784  GNB3; G protein subunit beta 3 [KO:K07825]", "59345  GNB4; G protein subunit beta 4 [KO:K04538]", "10681  GNB5; G protein subunit beta 5 [KO:K04539]", "54331  GNG2; G protein subunit gamma 2 [KO:K07826]", "2785  GNG3; G protein subunit gamma 3 [KO:K04540]", "2786  GNG4; G protein subunit gamma 4 [KO:K04541]", "2787  GNG5; G protein subunit gamma 5 [KO:K04542]", "2788  GNG7; G protein subunit gamma 7 [KO:K04543]", "94235  GNG8; G protein subunit gamma 8 [KO:K04544]", "2790  GNG10; G protein subunit gamma 10 [KO:K04545]", "2791  GNG11; G protein subunit gamma 11 [KO:K04546]", "55970  GNG12; G protein subunit gamma 12 [KO:K04347]", "51764  GNG13; G protein subunit gamma 13 [KO:K04547]", "2792  GNGT1; G protein subunit gamma transducin 1 [KO:K04548]", "2793  GNGT2; G protein subunit gamma transducin 2 [KO:K04549]", "57580  PREX1; phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1 [KO:K12365]", "9844  ELMO1; engulfment and cell motility 1 [KO:K12366]", "1794  DOCK2; dedicator of cytokinesis 2 [KO:K12367]", "5747  PTK2; protein tyrosine kinase 2 [KO:K05725] [EC:2.7.10.2]", "5829  PXN; paxillin [KO:K05760]", "9564  BCAR1; BCAR1 scaffold protein, Cas family member [KO:K05726]", "1398  CRK; CRK proto-oncogene, adaptor protein [KO:K04438]", "1399  CRKL; CRK like proto-oncogene, adaptor protein [KO:K04438]", "2185  PTK2B; protein tyrosine kinase 2 beta [KO:K05871] [EC:2.7.10.2]", "2776  GNAQ; G protein subunit alpha q [KO:K04634]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]", "10235  RASGRP2; RAS guanyl releasing protein 2 [KO:K12361]", "5906  RAP1A; RAP1A, member of RAS oncogene family [KO:K04353]", "5908  RAP1B; RAP1B, member of RAS oncogene family [KO:K07836]", "56288  PARD3; par-3 family cell polarity regulator [KO:K04237]", "7074  TIAM1; TIAM Rac1 associated GEF 1 [KO:K05731]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5580  PRKCD; protein kinase C delta [KO:K06068] [EC:2.7.11.13]", "653361  NCF1; neutrophil cytosolic factor 1 [KO:K08011]", "131890  GRK7; G protein-coupled receptor kinase 7 [KO:K00909] [EC:2.7.11.14]", "6011  GRK1; G protein-coupled receptor kinase 1 [KO:K00909] [EC:2.7.11.14]", "156  GRK2; G protein-coupled receptor kinase 2 [KO:K00910] [EC:2.7.11.15]", "157  GRK3; G protein-coupled receptor kinase 3 [KO:K00910] [EC:2.7.11.15]", "2868  GRK4; G protein-coupled receptor kinase 4 [KO:K08291] [EC:2.7.11.16]", "2869  GRK5; G protein-coupled receptor kinase 5 [KO:K08291] [EC:2.7.11.16]", "2870  GRK6; G protein-coupled receptor kinase 6 [KO:K08291] [EC:2.7.11.16]", "408  ARRB1; arrestin beta 1 [KO:K04439]", "409  ARRB2; arrestin beta 2 [KO:K04439]"], "compound": ["C00076  Calcium cation", "C00165  Diacylglycerol", "C00575  3',5'-Cyclic AMP", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C05981  Phosphatidylinositol-3,4,5-trisphosphate"], "refs": [{"pmid": "12495636", "authors": "  Wong MM, Fish EN", "title": "Chemokines: attractive mediators of the immune response.", "journal": "Semin Immunol 15:5-14 (2003)", "doi": "10.1016/S1044-5323(02)00123-9"}, {"pmid": "11872087", "authors": "  Curnock AP, Logan MK, Ward SG", "title": "Chemokine signalling: pivoting around multiple phosphoinositide 3-kinases.", "journal": "Immunology 105:125-36 (2002)", "doi": "10.1046/j.1365-2567.2002.01345.x"}, {"pmid": "12069927", "authors": "  Olson TS, Ley K", "title": "Chemokines and chemokine receptors in leukocyte trafficking.", "journal": "Am J Physiol Regul Integr Comp Physiol 283:R7-28 (2002)", "doi": "10.1152/ajpregu.00738.2001"}, {"pmid": "17169327", "authors": "  Busillo JM, Benovic JL", "title": "Regulation of CXCR4 signaling.", "journal": "Biochim Biophys Acta 1768:952-63 (2007)", "doi": "10.1016/j.bbamem.2006.11.002"}, {"pmid": "11244042", "authors": "  Mellado M, Rodriguez-Frade JM, Manes S, Martinez-A C", "title": "Chemokine signaling and functional responses: the role of receptor dimerization and TK pathway activation.", "journal": "Annu Rev Immunol 19:397-421 (2001)", "doi": "10.1146/annurev.immunol.19.1.397"}, {"pmid": "8576262", "authors": "  Knall C, Young S, Nick JA, Buhl AM, Worthen GS, Johnson GL", "title": "Interleukin-8 regulation of the Ras/Raf/mitogen-activated protein kinase pathway in human neutrophils.", "journal": "J Biol Chem 271:2832-8 (1996)", "doi": "10.1074/jbc.271.5.2832"}, {"pmid": "17537990", "authors": "  Patrussi L, Ulivieri C, Lucherini OM, Paccani SR, Gamberucci A, Lanfrancone L, Pelicci PG, Baldari CT", "title": "p52Shc is required for CXCR4-dependent signaling and chemotaxis in T cells.", "journal": "Blood 110:1730-8 (2007)", "doi": "10.1182/blood-2007-01-068411"}, {"pmid": "18662984", "authors": "  Sai J, Raman D, Liu Y, Wikswo J, Richmond A", "title": "Parallel phosphatidylinositol 3-kinase (PI3K)-dependent and Src-dependent pathways lead to CXCL8-mediated Rac2 activation and chemotaxis.", "journal": "J Biol Chem 283:26538-47 (2008)", "doi": "10.1074/jbc.M805611200"}, {"pmid": "10852130", "authors": "  Hauck CR, Klingbeil CK, Schlaepfer DD", "title": "Focal adhesion kinase functions as a receptor-proximal signaling component required for directed cell migration.", "journal": "Immunol Res 21:293-303 (2000)", "doi": "10.1385/IR:21:2-3:293"}, {"pmid": "14625285", "authors": "  Chandrasekar B, Bysani S, Mummidi S", "title": "CXCL16 signals via Gi, phosphatidylinositol 3-kinase, Akt, I kappa B kinase, and nuclear factor-kappa B and induces cell-cell adhesion and aortic smooth muscle cell proliferation.", "journal": "J Biol Chem 279:3188-96 (2004)", "doi": "10.1074/jbc.M311660200"}, {"pmid": "17371236", "authors": "  Smith L, Webb A, Ward SG", "title": "T-lymphocyte navigation and migration: beyond the PI3K paradigm.", "journal": "Biochem Soc Trans 35:193-8 (2007)", "doi": "10.1042/BST0350193"}, {"pmid": "16144840", "authors": "  Huttenrauch F, Pollok-Kopp B, Oppermann M", "title": "G protein-coupled receptor kinases promote phosphorylation and beta-arrestin-mediated internalization of CCR5 homo- and hetero-oligomers.", "journal": "J Biol Chem 280:37503-15 (2005)", "doi": "10.1074/jbc.M500535200"}, {"pmid": "18711432", "authors": "  Thelen M, Stein JV", "title": "How chemokines invite leukocytes to dance.", "journal": "Nat Immunol 9:953-9 (2008)", "doi": "10.1038/ni.f.207"}, {"pmid": "19159344", "authors": "  Ward SG, Marelli-Berg FM", "title": "Mechanisms of chemokine and antigen-dependent T-lymphocyte navigation.", "journal": "Biochem J 418:13-27 (2009)", "doi": "10.1042/BJ20081969"}, {"pmid": "15803148", "authors": "  Schwartzberg PL, Finkelstein LD, Readinger JA", "title": "TEC-family kinases: regulators of T-helper-cell differentiation.", "journal": "Nat Rev Immunol 5:284-95 (2005)", "doi": "10.1038/nri1591"}, {"pmid": "15771581", "authors": "  Berg LJ, Finkelstein LD, Lucas JA, Schwartzberg PL.", "title": "Tec family kinases in T lymphocyte development and function.", "journal": "Annu Rev Immunol 23:549-600 (2005)", "doi": "10.1146/annurev.immunol.22.012703.104743"}, {"pmid": "17496928", "authors": "  Ticchioni M, Essafi M, Jeandel PY, Davi F, Cassuto JP, Deckert M, Bernard A", "title": "Homeostatic chemokines increase survival of B-chronic lymphocytic leukemia cells through inactivation of transcription factor FOXO3a.", "journal": "Oncogene 26:7081-91 (2007)", "doi": "10.1038/sj.onc.1210519"}, {"pmid": "9765254", "authors": "  Korchak HM, Rossi MW, Kilpatrick LE", "title": "Selective role for beta-protein kinase C in signaling for O-2 generation but not degranulation or adherence in differentiated HL60 cells.", "journal": "J Biol Chem 273:27292-9 (1998)", "doi": "10.1074/jbc.273.42.27292"}, {"pmid": "15046611", "authors": "  Johnson Z, Power CA, Weiss C, Rintelen F, Ji H, Ruckle T, Camps M, Wells TN, Schwarz MK, Proudfoot AE, Rommel C", "title": "Chemokine inhibition--why, when, where, which and how?", "journal": "Biochem Soc Trans 32:366-77 (2004)", "doi": "10.1042/bst0320366"}, {"pmid": "12051620", "authors": "  Zhelev DV, Alteraifi A", "title": "Signaling in the motility responses of the human neutrophil.", "journal": "Ann Biomed Eng 30:356-70 (2002)", "doi": "10.1114/1.1477446"}, {"pmid": "17675482", "authors": "  Bach TL, Chen QM, Kerr WT, Wang Y, Lian L, Choi JK, Wu D, Kazanietz MG, Koretzky GA, Zigmond S, Abrams CS", "title": "Phospholipase cbeta is critical for T cell chemotaxis.", "journal": "J Immunol 179:2223-7 (2007)", "doi": "10.4049/jimmunol.179.4.2223"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04060  Cytokine-cytokine receptor interaction", "hsa04120  Ubiquitin mediated proteolysis", "hsa04630  JAK-STAT signaling pathway", "hsa04670  Leukocyte transendothelial migration", "hsa04810  Regulation of actin cytoskeleton"], "ko_pathway": "ko04062", "genes": ["RAC1", "BRAF", "AKT2", "AKT1", "SOS1", "NRAS"]}, {"kegg_id": "hsa04145", "name": "Phagosome - Homo sapiens (human)", "description": "Phagocytosis is the process of taking in relatively large particles by a cell, and is a central mechanism in the tissue remodeling, inflammation, and defense against infectious agents. A phagosome is formed when the specific receptors on the phagocyte surface recognize ligands on the particle surface. After formation, nascent phagosomes progressively acquire digestive characteristics. This maturation of phagosomes involves regulated interaction with the other membrane organelles, including recycling endosomes, late endosomes and lysosomes. The fusion of phagosomes and lysosomes releases toxic products that kill most bacteria and degrade them into fragments. However, some bacteria have strategies to escape the bactericidal mechanisms associated with phagocytosis and survive within host phagocytes.", "class": "Cellular Processes; Transport and catabolism", "pathway_map": "hsa04145  Phagosome", "network": ["", "ELEMENT   N01295  Rab7-regulated microtubule minus-end directed transport", "N01302  Early endosomal fusion"], "drug": ["D00570  Colchicine (JP18/USP)", "D10028  Valategrast hydrochloride (USAN)", "D11525  Enfortumab vedotin (USAN)", "D11684  Verdiperstat (USAN/INN)", "D11812  Pabinafusp alfa (genetical recombination) (JAN)", "D12333  Zelpultide alfa (USAN/INN)", "D12509  Trontinemab (USAN/INN)", "D12624  Paridiprubart (USAN/INN)", "D12647  Mitiperstat (USAN/INN)", "D12777  Olgotrelvir (USAN)", "D12778  Olgotrelvir sodium (USAN)", "D12806  Tividenofusp alfa (USAN/INN)"], "dblinks": "GO: 0045335", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["9341  VAMP3; vesicle associated membrane protein 3 [KO:K13505]", "23673  STX12; syntaxin 12 [KO:K13813]", "8417  STX7; syntaxin 7 [KO:K08488]", "71  ACTG1; actin gamma 1 [KO:K05692]", "60  ACTB; actin beta [KO:K05692]", "11151  CORO1A; coronin 1A [KO:K13882]", "53407  STX18; syntaxin 18 [KO:K08492]", "9554  SEC22B; SEC22 homolog B, vesicle trafficking protein [KO:K08517]", "3105  HLA-A; major histocompatibility complex, class I, A [KO:K06751]", "3106  HLA-B; major histocompatibility complex, class I, B [KO:K06751]", "3107  HLA-C; major histocompatibility complex, class I, C [KO:K06751]", "3134  HLA-F; major histocompatibility complex, class I, F [KO:K06751]", "3135  HLA-G; major histocompatibility complex, class I, G [KO:K06751]", "3133  HLA-E; major histocompatibility complex, class I, E [KO:K06751]", "3108  HLA-DMA; major histocompatibility complex, class II, DM alpha [KO:K06752]", "3109  HLA-DMB; major histocompatibility complex, class II, DM beta [KO:K06752]", "3111  HLA-DOA; major histocompatibility complex, class II, DO alpha [KO:K06752]", "3112  HLA-DOB; major histocompatibility complex, class II, DO beta [KO:K06752]", "3113  HLA-DPA1; major histocompatibility complex, class II, DP alpha 1 [KO:K06752]", "3115  HLA-DPB1; major histocompatibility complex, class II, DP beta 1 [KO:K06752]", "3117  HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 [KO:K06752]", "3118  HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2 [KO:K06752]", "3119  HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 [KO:K06752]", "3122  HLA-DRA; major histocompatibility complex, class II, DR alpha [KO:K06752]", "3123  HLA-DRB1; major histocompatibility complex, class II, DR beta 1 [KO:K06752]", "3125  HLA-DRB3; major histocompatibility complex, class II, DR beta 3 [KO:K06752]", "3126  HLA-DRB4; major histocompatibility complex, class II, DR beta 4 [KO:K06752]", "3127  HLA-DRB5; major histocompatibility complex, class II, DR beta 5 [KO:K06752]", "5868  RAB5A; RAB5A, member RAS oncogene family [KO:K07887]", "5869  RAB5B; RAB5B, member RAS oncogene family [KO:K07888]", "5878  RAB5C; RAB5C, member RAS oncogene family [KO:K07889]", "8411  EEA1; early endosome antigen 1 [KO:K12478]", "5289  PIK3C3; phosphatidylinositol 3-kinase catalytic subunit type 3 [KO:K00914] [EC:2.7.1.137]", "7037  TFRC; transferrin receptor [KO:K06503]", "9146  HGS; hepatocyte growth factor-regulated tyrosine kinase substrate [KO:K12182]", "523  ATP6V1A; ATPase H+ transporting V1 subunit A [KO:K02145] [EC:7.1.2.2]", "525  ATP6V1B1; ATPase H+ transporting V1 subunit B1 [KO:K02147]", "526  ATP6V1B2; ATPase H+ transporting V1 subunit B2 [KO:K02147]", "245973  ATP6V1C2; ATPase H+ transporting V1 subunit C2 [KO:K02148]", "528  ATP6V1C1; ATPase H+ transporting V1 subunit C1 [KO:K02148]", "51382  ATP6V1D; ATPase H+ transporting V1 subunit D [KO:K02149]", "90423  ATP6V1E2; ATPase H+ transporting V1 subunit E2 [KO:K02150]", "529  ATP6V1E1; ATPase H+ transporting V1 subunit E1 [KO:K02150]", "9296  ATP6V1F; ATPase H+ transporting V1 subunit F [KO:K02151]", "9550  ATP6V1G1; ATPase H+ transporting V1 subunit G1 [KO:K02152]", "127124  ATP6V1G3; ATPase H+ transporting V1 subunit G3 [KO:K02152]", "534  ATP6V1G2; ATPase H+ transporting V1 subunit G2 [KO:K02152]", "8992  ATP6V0E1; ATPase H+ transporting V0 subunit e1 [KO:K02153]", "155066  ATP6V0E2; ATPase H+ transporting V0 subunit e2 [KO:K02153]", "10312  TCIRG1; T cell immune regulator 1, ATPase H+ transporting V0 subunit a3 [KO:K02154]", "23545  ATP6V0A2; ATPase H+ transporting V0 subunit a2 [KO:K02154]", "50617  ATP6V0A4; ATPase H+ transporting V0 subunit a4 [KO:K02154]", "535  ATP6V0A1; ATPase H+ transporting V0 subunit a1 [KO:K02154]", "9114  ATP6V0D1; ATPase H+ transporting V0 subunit d1 [KO:K02146]", "245972  ATP6V0D2; ATPase H+ transporting V0 subunit d2 [KO:K02146]", "51606  ATP6V1H; ATPase H+ transporting V1 subunit H [KO:K02144]", "527  ATP6V0C; ATPase H+ transporting V0 subunit c [KO:K02155]", "533  ATP6V0B; ATPase H+ transporting V0 subunit b [KO:K03661]", "537  ATP6AP1; ATPase H+ transporting accessory protein 1 [KO:K03662]", "7879  RAB7A; RAB7A, member RAS oncogene family [KO:K07897]", "338382  RAB7B; RAB7B, member RAS oncogene family [KO:K07898]", "83547  RILP; Rab interacting lysosomal protein [KO:K13883]", "1778  DYNC1H1; dynein cytoplasmic 1 heavy chain 1 [KO:K10413]", "79659  DYNC2H1; dynein cytoplasmic 2 heavy chain 1 [KO:K10414]", "1780  DYNC1I1; dynein cytoplasmic 1 intermediate chain 1 [KO:K10415]", "1781  DYNC1I2; dynein cytoplasmic 1 intermediate chain 2 [KO:K10415]", "1783  DYNC1LI2; dynein cytoplasmic 1 light intermediate chain 2 [KO:K10416]", "51143  DYNC1LI1; dynein cytoplasmic 1 light intermediate chain 1 [KO:K10416]", "10376  TUBA1B; tubulin alpha 1b [KO:K07374]", "7277  TUBA4A; tubulin alpha 4a [KO:K07374]", "7278  TUBA3C; tubulin alpha 3c [KO:K07374]", "7846  TUBA1A; tubulin alpha 1a [KO:K07374]", "84790  TUBA1C; tubulin alpha 1c [KO:K07374]", "51807  TUBA8; tubulin alpha 8 [KO:K07374]", "112714  TUBA3E; tubulin alpha 3e [KO:K07374]", "113457  TUBA3D; tubulin alpha 3d [KO:K07374]", "79861  TUBAL3; tubulin alpha like 3 [KO:K07374]", "84617  TUBB6; tubulin beta 6 class V [KO:K07375]", "203068  TUBB; tubulin beta class I [KO:K07375]", "81027  TUBB1; tubulin beta 1 class VI [KO:K07375]", "7280  TUBB2A; tubulin beta 2A class IIa [KO:K07375]", "10381  TUBB3; tubulin beta 3 class III [KO:K07375]", "10382  TUBB4A; tubulin beta 4A class IVa [KO:K07375]", "347688  TUBB8; tubulin beta 8 class VIII [KO:K07375]", "347733  TUBB2B; tubulin beta 2B class IIb [KO:K07375]", "10383  TUBB4B; tubulin beta 4B class IVb [KO:K07375]", "3916  LAMP1; lysosomal associated membrane protein 1 [KO:K06528]", "3920  LAMP2; lysosomal associated membrane protein 2 [KO:K06528]", "200576  PIKFYVE; phosphoinositide kinase, FYVE-type zinc finger containing [KO:K00921] [EC:2.7.1.150]", "4074  M6PR; mannose-6-phosphate receptor, cation dependent [KO:K10089]", "4842  NOS1; nitric oxide synthase 1 [KO:K13240] [EC:1.14.13.39]", "4353  MPO; myeloperoxidase [KO:K10789] [EC:1.11.2.2]", "1514  CTSL; cathepsin L [KO:K01365] [EC:3.4.22.15]", "1520  CTSS; cathepsin S [KO:K01368] [EC:3.4.22.27]", "29927  SEC61A1; SEC61 translocon subunit alpha 1 [KO:K10956]", "55176  SEC61A2; SEC61 translocon subunit alpha 2 [KO:K10956]", "10952  SEC61B; SEC61 translocon subunit beta [KO:K09481]", "23480  SEC61G; SEC61 translocon subunit gamma [KO:K07342]", "6890  TAP1; transporter 1, ATP binding cassette subfamily B member [KO:K05653] [EC:7.4.2.14]", "6891  TAP2; transporter 2, ATP binding cassette subfamily B member [KO:K05654] [EC:7.4.2.14]", "811  CALR; calreticulin [KO:K08057]", "821  CANX; calnexin [KO:K08054]", "2204  FCAR; Fc alpha receptor [KO:K06513]", "2209  FCGR1A; Fc gamma receptor Ia [KO:K06498]", "2212  FCGR2A; Fc gamma receptor IIa [KO:K06472]", "2213  FCGR2B; Fc gamma receptor IIb [KO:K12560]", "9103  FCGR2C; Fc gamma receptor IIc (gene/pseudogene) [KO:K16824]", "2214  FCGR3A; Fc gamma receptor IIIa [KO:K06463]", "2215  FCGR3B; Fc gamma receptor IIIb [KO:K06463]", "102723407  IGH; immunoglobulin heavy variable 4-38-2-like [KO:K06856]", "715  C1R; complement C1r [KO:K01330] [EC:3.4.21.41]", "3684  ITGAM; integrin subunit alpha M [KO:K06461]", "3689  ITGB2; integrin subunit beta 2 [KO:K06464]", "718  C3; complement C3 [KO:K03990]", "78989  COLEC11; collectin subfamily member 11 [KO:K10066]", "81035  COLEC12; collectin subfamily member 12 [KO:K10062]", "4153  MBL2; mannose binding lectin 2 [KO:K03991]", "653509  SFTPA1; surfactant protein A1 [KO:K10067]", "729238  SFTPA2; surfactant protein A2 [KO:K10067]", "6441  SFTPD; surfactant protein D [KO:K10068]", "3685  ITGAV; integrin subunit alpha V [KO:K06487]", "3673  ITGA2; integrin subunit alpha 2 [KO:K06481]", "3678  ITGA5; integrin subunit alpha 5 [KO:K06484]", "3688  ITGB1; integrin subunit beta 1 [KO:K05719]", "3690  ITGB3; integrin subunit beta 3 [KO:K06493]", "3693  ITGB5; integrin subunit beta 5 [KO:K06588]", "7057  THBS1; thrombospondin 1 [KO:K16857]", "1311  COMP; cartilage oligomeric matrix protein [KO:K04659]", "7058  THBS2; thrombospondin 2 [KO:K04659]", "7059  THBS3; thrombospondin 3 [KO:K04659]", "7060  THBS4; thrombospondin 4 [KO:K04659]", "7097  TLR2; toll like receptor 2 [KO:K10159]", "10333  TLR6; toll like receptor 6 [KO:K10169]", "7099  TLR4; toll like receptor 4 [KO:K10160]", "929  CD14; CD14 molecule [KO:K04391]", "22925  PLA2R1; phospholipase A2 receptor 1 [KO:K06560]", "4360  MRC1; mannose receptor C-type 1 [KO:K06560]", "9902  MRC2; mannose receptor C type 2 [KO:K06560]", "10332  CLEC4M; C-type lectin domain family 4 member M [KO:K06563]", "30835  CD209; CD209 molecule [KO:K06563]", "64581  CLEC7A; C-type lectin domain containing 7A [KO:K10074]", "4481  MSR1; macrophage scavenger receptor 1 [KO:K06558]", "8685  MARCO; macrophage receptor with collagenous structure [KO:K13884]", "4973  OLR1; oxidized low density lipoprotein receptor 1 [KO:K08763]", "949  SCARB1; scavenger receptor class B member 1 [KO:K13885]", "948  CD36; CD36 molecule (CD36 blood group) [KO:K06259]", "1535  CYBA; cytochrome b-245 alpha chain [KO:K08009]", "1536  CYBB; cytochrome b-245 beta chain [KO:K21421] [EC:1.-.-.-]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "653361  NCF1; neutrophil cytosolic factor 1 [KO:K08011]", "4688  NCF2; neutrophil cytosolic factor 2 [KO:K08010]", "4689  NCF4; neutrophil cytosolic factor 4 [KO:K08012]"], "compound": ["C04549  1-Phosphatidyl-1D-myo-inositol 3-phosphate"], "refs": [{"pmid": "15894272", "authors": "  Stuart LM, Ezekowitz RA", "title": "Phagocytosis: elegant complexity.", "journal": "Immunity 22:539-50 (2005)", "doi": "10.1016/j.immuni.2005.05.002"}, {"pmid": "10684585", "authors": "  Tjelle TE, Lovdal T, Berg T", "title": "Phagosome dynamics and function.", "journal": "Bioessays 22:255-63 (2000)", "doi": "10.1002/(SICI)1521-1878(200003)22:3<255::AID-BIES7>3.0.CO;2-R"}, {"pmid": "18492791", "authors": "  Dupuy AG, Caron E", "title": "Integrin-dependent phagocytosis: spreading from microadhesion to new concepts.", "journal": "J Cell Sci 121:1773-83 (2008)", "doi": "10.1242/jcs.018036"}, {"pmid": "15036145", "authors": "  Brumell JH, Grinstein S", "title": "Salmonella redirects phagosomal maturation.", "journal": "Curr Opin Microbiol 7:78-84 (2004)", "doi": "10.1016/j.mib.2003.12.005"}, {"pmid": "17245426", "authors": "  Huynh KK, Eskelinen EL, Scott CC, Malevanets A, Saftig P, Grinstein S", "title": "LAMP proteins are required for fusion of lysosomes with phagosomes.", "journal": "EMBO J 26:313-24 (2007)", "doi": "10.1038/sj.emboj.7601511"}, {"pmid": "17637737", "authors": "  Luzio JP, Pryor PR, Bright NA", "title": "Lysosomes: fusion and function.", "journal": "Nat Rev Mol Cell Biol 8:622-32 (2007)", "doi": "10.1038/nrm2217"}], "rel_pathway": ["hsa04142  Lysosome", "hsa04144  Endocytosis", "hsa04610  Complement and coagulation cascades", "hsa04612  Antigen processing and presentation", "hsa04620  Toll-like receptor signaling pathway", "hsa04666  Fc gamma R-mediated phagocytosis"], "ko_pathway": "ko04145", "genes": ["RAC1", "CD36"]}, {"kegg_id": "hsa04148", "name": "Efferocytosis - Homo sapiens (human)", "class": "Cellular Processes; Transport and catabolism", "pathway_map": "hsa04148  Efferocytosis", "network": ["", "ELEMENT   N01747  Find-me signal (nucleotide)", "N01748  Find-me signal (LPC)", "N01749  Find-me signal (CX3CL1)", "N01750  Find-me signal (S1P)", "N01751  Macrophage EPO signaling", "N01753  Exposure of phosphatidylserine to the outer leaflet", "N01754  Activation of XKR8", "N01761  Activation of CRK-DOCK-Rac1 pathway", "N01762  MERTK-mediated recognition and engulfment", "N01763  MEGF10-mediated recognition and engulfment", "N01764  Calreticulin-LRP1 mediated recognition and engulfment", "N01772  Induction of the PTGS2", "N01773  PTGS2-PGE2-TGFB1 pathway", "N01774  ERK-DUSP4 negative feedback pathway", "N01775  Inactivation of CaMKII by inducing SERCA2", "N01776  CaMK2-p38-MK2-ALOX5 pathway", "N01777  Efferocytosis-induced NAD production", "N01778  Production of IL10 via the Sirtuin1 signaling cascade", "N01779  Continual efferocytosis enhanced by the AC-derived arginine and ornithine", "N01780  Hydrolyzing AC-derived cholesterol esters in the lysosome", "N01781  Activation of LXRs by oxysterols", "N01784  Glucose uptake and lactate release induced by efferocytosis", "N01785  Don't eat me signal (CD47)", "N01786  Don't eat me signal (CD24)"], "drug": ["D10930  Etrasimod (USAN)", "D10931  Etrasimod arginine (USAN)", "D12771  Mocravimod (USAN/INN)", "D12772  Mocravimod hydrochloride (USAN)", "D12798  Verzistobart (USAN/INN)", "D12799  Vociprotafib (USAN/INN)", "D12826  Maplirpacept (USAN/INN)", "D12892  Migoprotafib (USAN/INN)", "D12897  Tamuzimod (USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "840  CASP7; caspase 7 [KO:K04397] [EC:3.4.22.60]", "834  CASP1; caspase 1 [KO:K01370] [EC:3.4.22.36]", "24145  PANX1; pannexin 1 [KO:K03443]", "5029  P2RY2; purinergic receptor P2Y2 [KO:K04269]", "5031  P2RY6; pyrimidinergic receptor P2Y6 [KO:K04272]", "64805  P2RY12; purinergic receptor P2Y12 [KO:K04298]", "8877  SPHK1; sphingosine kinase 1 [KO:K04718] [EC:2.7.1.91]", "56848  SPHK2; sphingosine kinase 2 [KO:K04718] [EC:2.7.1.91]", "1901  S1PR1; sphingosine-1-phosphate receptor 1 [KO:K04288]", "8398  PLA2G6; phospholipase A2 group VI [KO:K16343] [EC:3.1.1.4]", "19  ABCA1; ATP binding cassette subfamily A member 1 [KO:K05641]", "29933  GPR132; G protein-coupled receptor 132 [KO:K08426]", "6868  ADAM17; ADAM metallopeptidase domain 17 [KO:K06059] [EC:3.4.24.86]", "102  ADAM10; ADAM metallopeptidase domain 10 [KO:K06704] [EC:3.4.24.81]", "6376  CX3CL1; C-X3-C motif chemokine ligand 1 [KO:K05508]", "1524  CX3CR1; C-X3-C motif chemokine receptor 1 [KO:K04192]", "4773  NFATC2; nuclear factor of activated T cells 2 [KO:K17332]", "4772  NFATC1; nuclear factor of activated T cells 1 [KO:K04446]", "4775  NFATC3; nuclear factor of activated T cells 3 [KO:K17333]", "4776  NFATC4; nuclear factor of activated T cells 4 [KO:K17334]", "3091  HIF1A; hypoxia inducible factor 1 subunit alpha [KO:K08268]", "405  ARNT; aryl hydrocarbon receptor nuclear translocator [KO:K09097]", "2056  EPO; erythropoietin [KO:K05437]", "2057  EPOR; erythropoietin receptor [KO:K05079]", "3717  JAK2; Janus kinase 2 [KO:K04447] [EC:2.7.10.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "1051  CEBPB; CCAAT enhancer binding protein beta [KO:K10048]", "5468  PPARG; peroxisome proliferator activated receptor gamma [KO:K08530]", "6256  RXRA; retinoid X receptor alpha [KO:K08524]", "4240  MFGE8; milk fat globule EGF and factor V/VIII domain containing [KO:K17253]", "2621  GAS6; growth arrest specific 6 [KO:K05464]", "10461  MERTK; MER proto-oncogene, tyrosine kinase [KO:K05117] [EC:2.7.10.1]", "948  CD36; CD36 molecule (CD36 blood group) [KO:K06259]", "7057  THBS1; thrombospondin 1 [KO:K16857]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5743  PTGS2; prostaglandin-endoperoxide synthase 2 [KO:K11987] [EC:1.14.99.1]", "5732  PTGER2; prostaglandin E receptor 2 [KO:K04259]", "5734  PTGER4; prostaglandin E receptor 4 [KO:K04261]", "1788  DNMT3A; DNA methyltransferase 3 alpha [KO:K17398] [EC:2.1.1.37]", "1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]", "7040  TGFB1; transforming growth factor beta 1 [KO:K13375]", "487  ATP2A1; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 [KO:K05853] [EC:7.2.2.10]", "489  ATP2A3; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 [KO:K05853] [EC:7.2.2.10]", "488  ATP2A2; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 [KO:K05853] [EC:7.2.2.10]", "815  CAMK2A; calcium/calmodulin dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]", "817  CAMK2D; calcium/calmodulin dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]", "816  CAMK2B; calcium/calmodulin dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]", "818  CAMK2G; calcium/calmodulin dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "9261  MAPKAPK2; MAPK activated protein kinase 2 [KO:K04443] [EC:2.7.11.1]", "240  ALOX5; arachidonate 5-lipoxygenase [KO:K00461] [EC:1.13.11.34]", "246  ALOX15; arachidonate 15-lipoxygenase [KO:K00460] [EC:1.13.11.33]", "1846  DUSP4; dual specificity phosphatase 4 [KO:K04459] [EC:3.1.3.16 3.1.3.48]", "1844  DUSP2; dual specificity phosphatase 2 [KO:K04459] [EC:3.1.3.16 3.1.3.48]", "1849  DUSP7; dual specificity phosphatase 7 [KO:K04459] [EC:3.1.3.16 3.1.3.48]", "1850  DUSP8; dual specificity phosphatase 8 [KO:K04459] [EC:3.1.3.16 3.1.3.48]", "1847  DUSP5; dual specificity phosphatase 5 [KO:K04459] [EC:3.1.3.16 3.1.3.48]", "80824  DUSP16; dual specificity phosphatase 16 [KO:K04459] [EC:3.1.3.16 3.1.3.48]", "196527  ANO6; anoctamin 6 [KO:K19500]", "63982  ANO3; anoctamin 3 [KO:K19498]", "121601  ANO4; anoctamin 4 [KO:K19499]", "203859  ANO5; anoctamin 5 [KO:K19480]", "50636  ANO7; anoctamin 7 [KO:K19501]", "338440  ANO9; anoctamin 9 [KO:K19503]", "682  BSG; basigin (Ok blood group) [KO:K06535]", "55113  XKR8; XK related 8 [KO:K26813]", "389668  XKR9; XK related 9 [KO:K26814]", "343702  XKR7; XK related 7 [KO:K26811]", "114786  XKR4; XK related 4 [KO:K26811]", "286046  XKR6; XK related 6 [KO:K26811]", "10396  ATP8A1; ATPase phospholipid transporting 8A1 [KO:K14802] [EC:7.6.2.1]", "51761  ATP8A2; ATPase phospholipid transporting 8A2 [KO:K14802] [EC:7.6.2.1]", "23200  ATP11B; ATPase phospholipid transporting 11B (putative) [KO:K26934] [EC:7.6.2.1]", "23250  ATP11A; ATPase phospholipid transporting 11A [KO:K26934] [EC:7.6.2.1]", "286410  ATP11C; ATPase phospholipid transporting 11C [KO:K26934] [EC:7.6.2.1]", "55754  TMEM30A; transmembrane protein 30A [KO:K26935]", "5627  PROS1; protein S [KO:K03908]", "3685  ITGAV; integrin subunit alpha V [KO:K06487]", "3690  ITGB3; integrin subunit beta 3 [KO:K06493]", "3693  ITGB5; integrin subunit beta 5 [KO:K06588]", "558  AXL; AXL receptor tyrosine kinase [KO:K05115] [EC:2.7.10.1]", "7301  TYRO3; TYRO3 protein tyrosine kinase [KO:K05116] [EC:2.7.10.1]", "575  ADGRB1; adhesion G protein-coupled receptor B1 [KO:K04596]", "91937  TIMD4; T cell immunoglobulin and mucin domain containing 4 [KO:K26936]", "26762  HAVCR1; hepatitis A virus cellular receptor 1 [KO:K20413]", "84868  HAVCR2; hepatitis A virus cellular receptor 2 [KO:K20414]", "177  AGER; advanced glycosylation end-product specific receptor [KO:K19722]", "23166  STAB1; stabilin 1 [KO:K19020]", "55576  STAB2; stabilin 2 [KO:K19013]", "5747  PTK2; protein tyrosine kinase 2 [KO:K05725] [EC:2.7.10.2]", "9564  BCAR1; BCAR1 scaffold protein, Cas family member [KO:K05726]", "1398  CRK; CRK proto-oncogene, adaptor protein [KO:K04438]", "1399  CRKL; CRK like proto-oncogene, adaptor protein [KO:K04438]", "9844  ELMO1; engulfment and cell motility 1 [KO:K12366]", "1793  DOCK1; dedicator of cytokinesis 1 [KO:K13708]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "8754  ADAM9; ADAM metallopeptidase domain 9 [KO:K06834] [EC:3.4.24.-]", "811  CALR; calreticulin [KO:K08057]", "712  C1QA; complement C1q A chain [KO:K03986]", "713  C1QB; complement C1q B chain [KO:K03987]", "714  C1QC; complement C1q C chain [KO:K03988]", "4035  LRP1; LDL receptor related protein 1 [KO:K04550]", "84466  MEGF10; multiple EGF like domains 10 [KO:K24068]", "84465  MEGF11; multiple EGF like domains 11 [KO:K24068]", "8578  SCARF1; scavenger receptor class F member 1 [KO:K24318]", "51454  GULP1; GULP PTB domain containing engulfment adaptor 1 [KO:K23285]", "64284  RAB17; RAB17, member RAS oncogene family [KO:K07909]", "5868  RAB5A; RAB5A, member RAS oncogene family [KO:K07887]", "5869  RAB5B; RAB5B, member RAS oncogene family [KO:K07888]", "5878  RAB5C; RAB5C, member RAS oncogene family [KO:K07889]", "9392  TGFBRAP1; transforming growth factor beta receptor associated protein 1 [KO:K20177]", "23355  VPS8; VPS8 subunit of CORVET complex [KO:K20178]", "55823  VPS11; VPS11 core subunit of CORVET and HOPS complexes [KO:K20179]", "64601  VPS16; VPS16 core subunit of CORVET and HOPS complexes [KO:K20180]", "57617  VPS18; VPS18 core subunit of CORVET and HOPS complexes [KO:K20181]", "65082  VPS33A; VPS33A core subunit of CORVET and HOPS complexes [KO:K20182]", "51552  RAB14; RAB14, member RAS oncogene family [KO:K07881]", "23339  VPS39; VPS39 subunit of HOPS complex [KO:K20183]", "27072  VPS41; VPS41 subunit of HOPS complex [KO:K20184]", "7879  RAB7A; RAB7A, member RAS oncogene family [KO:K07897]", "338382  RAB7B; RAB7B, member RAS oncogene family [KO:K07898]", "54896  SLC66A1; solute carrier family 66 member 1 [KO:K23678]", "384  ARG2; arginase 2 [KO:K01476] [EC:3.5.3.1]", "383  ARG1; arginase 1 [KO:K01476] [EC:3.5.3.1]", "4953  ODC1; ornithine decarboxylase 1 [KO:K01581] [EC:4.1.1.17]", "9023  CH25H; cholesterol 25-hydroxylase [KO:K10223] [EC:1.14.99.38]", "10062  NR1H3; nuclear receptor subfamily 1 group H member 3 [KO:K08536]", "7376  NR1H2; nuclear receptor subfamily 1 group H member 2 [KO:K08535]", "1374  CPT1A; carnitine palmitoyltransferase 1A [KO:K08765] [EC:2.3.1.21]", "1375  CPT1B; carnitine palmitoyltransferase 1B [KO:K19523] [EC:2.3.1.21]", "126129  CPT1C; carnitine palmitoyltransferase 1C [KO:K19524] [EC:2.3.1.21]", "7386  UQCRFS1; ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 [KO:K00411] [EC:7.1.1.8]", "23411  SIRT1; sirtuin 1 [KO:K11411] [EC:2.3.1.286]", "5087  PBX1; PBX homeobox 1 [KO:K09355]", "3586  IL10; interleukin 10 [KO:K05443]", "3988  LIPA; lipase A, lysosomal acid type [KO:K01052] [EC:3.1.1.13]", "23659  PLA2G15; phospholipase A2 group XV [KO:K06129] [EC:3.1.1.5]", "5467  PPARD; peroxisome proliferator activated receptor delta [KO:K04504]", "6513  SLC2A1; solute carrier family 2 member 1 [KO:K07299]", "6566  SLC16A1; solute carrier family 16 member 1 [KO:K08179]", "6446  SGK1; serum/glucocorticoid regulated kinase 1 [KO:K13302] [EC:2.7.11.1]", "961  CD47; CD47 molecule [KO:K06266]", "100133941  CD24; CD24 molecule [KO:K06469]", "5175  PECAM1; platelet and endothelial cell adhesion molecule 1 [KO:K06471]", "89790  SIGLEC10; sialic acid binding Ig like lectin 10 [KO:K06749]", "140885  SIRPA; signal regulatory protein alpha [KO:K06551]", "55423  SIRPG; signal regulatory protein gamma [KO:K06551]", "10326  SIRPB1; signal regulatory protein beta 1 [KO:K06551]", "5777  PTPN6; protein tyrosine phosphatase non-receptor type 6 [KO:K05697] [EC:3.1.3.48]", "5781  PTPN11; protein tyrosine phosphatase non-receptor type 11 [KO:K07293] [EC:3.1.3.48]"], "compound": ["C00002  ATP", "C00003  NAD+", "C00019  S-Adenosyl-L-methionine", "C00031  D-Glucose", "C00062  L-Arginine", "C00073  L-Methionine", "C00075  UTP", "C00077  L-Ornithine", "C00134  Putrescine", "C00162  Fatty acid", "C00186  (S)-Lactate", "C00187  Cholesterol", "C00584  Prostaglandin E2", "C02530  Cholesterol ester", "C02737  Phosphatidylserine", "C04230  1-Acyl-sn-glycero-3-phosphocholine", "C06124  Sphingosine 1-phosphate", "C06314  Lipoxin A4", "C15519  25-Hydroxycholesterol", "C15610  Cholest-5-ene-3beta,26-diol", "C18178  Resolvin D1"], "refs": [{"pmid": "31822793", "authors": "  Doran AC, Yurdagul A Jr, Tabas I", "title": "Efferocytosis in health and disease.", "journal": "Nat Rev Immunol 20:254-267 (2020)", "doi": "10.1038/s41577-019-0240-6"}, {"pmid": "36028471", "authors": "  Zhang J, Ding W, Zhao M, Liu J, Xu Y, Wan J, Wang M", "title": "Mechanisms of efferocytosis in determining inflammation resolution: Therapeutic potential and the association with cardiovascular disease.", "journal": "Br J Pharmacol 179:5151-5171 (2022)", "doi": "10.1111/bph.15939"}, {"pmid": "30165442", "authors": "  Kawano M, Nagata S", "title": "Efferocytosis and autoimmune disease.", "journal": "Int Immunol 30:551-558 (2018)", "doi": "10.1093/intimm/dxy055"}, {"pmid": "35650427", "authors": "  Mehrotra P, Ravichandran KS", "title": "Drugging the efferocytosis process: concepts and opportunities.", "journal": "Nat Rev Drug Discov 21:601-620 (2022)", "doi": "10.1038/s41573-022-00470-y"}, {"pmid": "28496201", "authors": "  Park SY, Kim IS", "title": "Engulfment signals and the phagocytic machinery for apoptotic cell clearance.", "journal": "Exp Mol Med 49:e331 (2017)", "doi": "10.1038/emm.2017.52"}], "rel_pathway": ["hsa00010  Glycolysis / Gluconeogenesis", "hsa04140  Autophagy - animal", "hsa04145  Phagosome"], "ko_pathway": "ko04148", "genes": ["RAC1", "CD36", "MAPK13"]}, {"kegg_id": "hsa04310", "name": "Wnt signaling pathway - Homo sapiens (human)", "description": "Wnt proteins are secreted morphogens that are required for basic developmental processes, such as cell-fate specification, progenitor-cell proliferation and the control of asymmetric cell division, in many different species and organs. There are at least three different Wnt pathways: the canonical pathway, the planar cell polarity (PCP) pathway and the Wnt/Ca2+ pathway. In the canonical Wnt pathway, the major effect of Wnt ligand binding to its receptor is the stabilization of cytoplasmic beta-catenin through inhibition of the bea-catenin degradation complex. Beta-catenin is then free to enter the nucleus and activate Wnt-regulated genes through its interaction with TCF (T-cell factor) family transcription factors and concomitant recruitment of coactivators. Planar cell polarity (PCP) signaling leads to the activation of the small GTPases RHOA (RAS homologue gene-family member A) and RAC1, which activate the stress kinase JNK (Jun N-terminal kinase) and ROCK (RHO-associated coiled-coil-containing protein kinase 1) and leads to remodelling of the cytoskeleton and changes in cell adhesion and motility. WNT-Ca2+ signalling is mediated through G proteins and phospholipases and leads to transient increases in cytoplasmic free calcium that subsequently activate the kinase PKC (protein kinase C) and CAMKII (calcium calmodulin mediated kinase II) and the phosphatase calcineurin.", "class": "Environmental Information Processing; Signal transduction", "pathway_map": "hsa04310  Wnt signaling pathway", "network": ["", "ELEMENT   N00056  Wnt signaling pathway", "N01427  WNT5A-ROR signaling pathway", "N01440  Wnt signaling modulation, LGR/RSPO", "N01441  Wnt signaling modulation, SOST/LRP4", "N01442  Wnt signaling modulation, Wnt inhibitor", "N01443  Wnt signaling modulation, Wnt acylation"], "drug": ["D10094  Blosozumab (USAN)", "D10156  Romosozumab (USAN)", "D10410  Vantictumab (USAN/INN)", "D11322  Umbralisib (USAN/INN)", "D11323  Umbralisib tosylate (USAN)", "D11369  Rosmantuzumab (USAN)", "D11758  Ipafricept (USAN/INN)", "D12209  Ozuriftamab (USAN)", "D12210  Ozuriftmab vedotin (USAN)", "D12235  Osugacestat (USAN/INN)", "D12416  Petosemtamab (USAN/INN)", "D12445  Foscenvivint (JAN/INN)"], "dblinks": "GO: 0016055", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["64840  PORCN; porcupine O-acyltransferase [KO:K00181] [EC:2.3.1.250]", "7471  WNT1; Wnt family member 1 [KO:K03209]", "7472  WNT2; Wnt family member 2 [KO:K00182]", "7482  WNT2B; Wnt family member 2B [KO:K00182]", "7473  WNT3; Wnt family member 3 [KO:K00312]", "89780  WNT3A; Wnt family member 3A [KO:K00312]", "54361  WNT4; Wnt family member 4 [KO:K00408]", "7474  WNT5A; Wnt family member 5A [KO:K00444]", "81029  WNT5B; Wnt family member 5B [KO:K00444]", "7475  WNT6; Wnt family member 6 [KO:K00445]", "7476  WNT7A; Wnt family member 7A [KO:K00572]", "7477  WNT7B; Wnt family member 7B [KO:K00572]", "7478  WNT8A; Wnt family member 8A [KO:K00714]", "7479  WNT8B; Wnt family member 8B [KO:K00714]", "7483  WNT9A; Wnt family member 9A [KO:K01064]", "7484  WNT9B; Wnt family member 9B [KO:K01064]", "7480  WNT10B; Wnt family member 10B [KO:K01357]", "80326  WNT10A; Wnt family member 10A [KO:K01357]", "7481  WNT11; Wnt family member 11 [KO:K01384]", "51384  WNT16; Wnt family member 16 [KO:K01558]", "9350  CER1; cerberus 1, DAN family BMP antagonist [KO:K01645]", "147111  NOTUM; notum, palmitoleoyl-protein carboxylesterase [KO:K19882] [EC:3.1.1.98]", "11197  WIF1; WNT inhibitory factor 1 [KO:K01691]", "50964  SOST; sclerostin [KO:K16834]", "22943  DKK1; dickkopf WNT signaling pathway inhibitor 1 [KO:K02165]", "27123  DKK2; dickkopf WNT signaling pathway inhibitor 2 [KO:K02165]", "27121  DKK4; dickkopf WNT signaling pathway inhibitor 4 [KO:K02165]", "5176  SERPINF1; serpin family F member 1 [KO:K19614]", "6422  SFRP1; secreted frizzled related protein 1 [KO:K02166]", "6423  SFRP2; secreted frizzled related protein 2 [KO:K02176]", "2487  FRZB; frizzled related protein [KO:K25481]", "6424  SFRP4; secreted frizzled related protein 4 [KO:K02185]", "6425  SFRP5; secreted frizzled related protein 5 [KO:K02222]", "284654  RSPO1; R-spondin 1 [KO:K19471]", "340419  RSPO2; R-spondin 2 [KO:K23097]", "84870  RSPO3; R-spondin 3 [KO:K23098]", "343637  RSPO4; R-spondin 4 [KO:K23099]", "55366  LGR4; leucine rich repeat containing G protein-coupled receptor 4 [KO:K04309]", "8549  LGR5; leucine rich repeat containing G protein-coupled receptor 5 [KO:K04308]", "59352  LGR6; leucine rich repeat containing G protein-coupled receptor 6 [KO:K08399]", "54894  RNF43; ring finger protein 43 [KO:K15694] [EC:2.3.2.27]", "84133  ZNRF3; zinc and ring finger 3 [KO:K16273] [EC:2.3.2.27]", "8321  FZD1; frizzled class receptor 1 [KO:K02432]", "8324  FZD7; frizzled class receptor 7 [KO:K02432]", "2535  FZD2; frizzled class receptor 2 [KO:K02235]", "7976  FZD3; frizzled class receptor 3 [KO:K02329]", "8322  FZD4; frizzled class receptor 4 [KO:K02354]", "7855  FZD5; frizzled class receptor 5 [KO:K02375]", "8325  FZD8; frizzled class receptor 8 [KO:K02375]", "8323  FZD6; frizzled class receptor 6 [KO:K02376]", "11211  FZD10; frizzled class receptor 10 [KO:K02842]", "8326  FZD9; frizzled class receptor 9 [KO:K02842]", "4041  LRP5; LDL receptor related protein 5 [KO:K03068]", "4040  LRP6; LDL receptor related protein 6 [KO:K03068]", "25805  BAMBI; BMP and activin membrane bound inhibitor [KO:K10162]", "147495  APCDD1; APC down-regulated 1 [KO:K25812]", "164284  APCDD1L; APC down-regulated 1 like [KO:K25812]", "1454  CSNK1E; casein kinase 1 epsilon [KO:K08960] [EC:2.7.11.1]", "102800317  TPTEP2-CSNK1E; TPTEP2-CSNK1E readthrough [KO:K08960] [EC:2.7.11.1]", "440193  CCDC88C; coiled-coil domain containing 88C [KO:K25811]", "1857  DVL3; dishevelled segment polarity protein 3 [KO:K02353]", "1856  DVL2; dishevelled segment polarity protein 2 [KO:K02353]", "1855  DVL1; dishevelled segment polarity protein 1 [KO:K02353]", "10023  FRAT1; FRAT regulator of WNT signaling pathway 1 [KO:K03069]", "23401  FRAT2; FRAT regulator of WNT signaling pathway 2 [KO:K03096]", "1457  CSNK2A1; casein kinase 2 alpha 1 [KO:K03097] [EC:2.7.11.1]", "1459  CSNK2A2; casein kinase 2 alpha 2 [KO:K03097] [EC:2.7.11.1]", "283106  CSNK2A3; casein kinase 2 alpha 3 [KO:K03097] [EC:2.7.11.1]", "1460  CSNK2B; casein kinase 2 beta [KO:K03115]", "85407  NKD1; NKD inhibitor of WNT signaling pathway 1 [KO:K03213]", "85409  NKD2; NKD inhibitor of WNT signaling pathway 2 [KO:K03213]", "80319  CXXC4; CXXC finger protein 4 [KO:K03344]", "59343  SENP2; SUMO specific peptidase 2 [KO:K03345] [EC:3.4.22.68]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "1499  CTNNB1; catenin beta 1 [KO:K02105]", "8312  AXIN1; axin 1 [KO:K02157]", "8313  AXIN2; axin 2 [KO:K04385]", "324  APC; APC regulator of WNT signaling pathway [KO:K02085]", "10297  APC2; APC regulator of WNT signaling pathway 2 [KO:K02085]", "122011  CSNK1A1L; casein kinase 1 alpha 1 like [KO:K08957] [EC:2.7.11.1]", "1452  CSNK1A1; casein kinase 1 alpha 1 [KO:K08957] [EC:2.7.11.1]", "6932  TCF7; transcription factor 7 [KO:K02620]", "83439  TCF7L1; transcription factor 7 like 1 [KO:K04490]", "6934  TCF7L2; transcription factor 7 like 2 [KO:K04491]", "51176  LEF1; lymphoid enhancer binding factor 1 [KO:K04492]", "84445  LZTS2; leucine zipper tumor suppressor 2 [KO:K26471]", "56998  CTNNBIP1; catenin beta interacting protein 1 [KO:K04493]", "25776  CBY1; chibby 1, beta catenin antagonist [KO:K23402]", "57680  CHD8; chromodomain helicase DNA binding protein 8 [KO:K04494] [EC:5.6.2.-]", "4163  MCC; MCC regulator of WNT signaling pathway [KO:K26734]", "57805  CCAR2; cell cycle and apoptosis regulator 2 [KO:K25816]", "23411  SIRT1; sirtuin 1 [KO:K11411] [EC:2.3.1.286]", "64321  SOX17; SRY-box transcription factor 17 [KO:K04495]", "1487  CTBP1; C-terminal binding protein 1 [KO:K04496] [EC:1.1.1.428]", "1488  CTBP2; C-terminal binding protein 2 [KO:K04496] [EC:1.1.1.428]", "102723796  TLE7; TLE family member 7 [KO:K04497]", "7088  TLE1; TLE family member 1, transcriptional corepressor [KO:K04497]", "7089  TLE2; TLE family member 2, transcriptional corepressor [KO:K04497]", "7090  TLE3; TLE family member 3, transcriptional corepressor [KO:K04497]", "7091  TLE4; TLE family member 4, transcriptional corepressor [KO:K04497]", "79816  TLE6; TLE family member 6, subcortical maternal complex member [KO:K04497]", "1501  CTNND2; catenin delta 2 [KO:K23491]", "1387  CREBBP; CREB binding protein [KO:K04498] [EC:2.3.1.48]", "2033  EP300; E1A binding protein p300 [KO:K04498] [EC:2.3.1.48]", "8607  RUVBL1; RuvB like AAA ATPase 1 [KO:K04499] [EC:5.6.2.4]", "4089  SMAD4; SMAD family member 4 [KO:K04501]", "4088  SMAD3; SMAD family member 3 [KO:K23605]", "6885  MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO:K04427] [EC:2.7.11.25]", "51701  NLK; nemo like kinase [KO:K04468] [EC:2.7.11.24]", "4609  MYC; MYC proto-oncogene, bHLH transcription factor [KO:K04377]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "8061  FOSL1; FOS like 1, AP-1 transcription factor subunit [KO:K04502]", "595  CCND1; cyclin D1 [KO:K04503]", "894  CCND2; cyclin D2 [KO:K10151]", "896  CCND3; cyclin D3 [KO:K10152]", "8840  CCN4; cellular communication network factor 4 [KO:K22471]", "5467  PPARD; peroxisome proliferator activated receptor delta [KO:K04504]", "4316  MMP7; matrix metallopeptidase 7 [KO:K01397] [EC:3.4.24.23]", "5663  PSEN1; presenilin 1 [KO:K04505] [EC:3.4.23.-]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "7157  TP53; tumor protein p53 [KO:K04451]", "6477  SIAH1; siah E3 ubiquitin protein ligase 1 [KO:K04506] [EC:2.3.2.27]", "27101  CACYBP; calcyclin binding protein [KO:K04507]", "6500  SKP1; S-phase kinase associated protein 1 [KO:K03094]", "6907  TBL1X; transducin beta like 1 X-linked [KO:K04508]", "90665  TBL1Y; transducin beta like 1 Y-linked [KO:K04508]", "79718  TBL1XR1; TBL1X/Y related 1 [KO:K04508]", "8945  BTRC; beta-transducin repeat containing E3 ubiquitin protein ligase [KO:K03362]", "23291  FBXW11; F-box and WD repeat domain containing 11 [KO:K03362]", "8454  CUL1; cullin 1 [KO:K03347]", "9978  RBX1; ring-box 1 [KO:K03868] [EC:2.3.2.32]", "2239  GPC4; glypican 4 [KO:K08110]", "4919  ROR1; receptor tyrosine kinase like orphan receptor 1 [KO:K05122] [EC:2.7.10.1]", "4920  ROR2; receptor tyrosine kinase like orphan receptor 2 [KO:K05123] [EC:2.7.10.1]", "6259  RYK; receptor like tyrosine kinase [KO:K05128] [EC:2.7.10.1]", "57216  VANGL2; VANGL planar cell polarity protein 2 [KO:K04510]", "81839  VANGL1; VANGL planar cell polarity protein 1 [KO:K04510]", "144165  PRICKLE1; prickle planar cell polarity protein 1 [KO:K04511]", "166336  PRICKLE2; prickle planar cell polarity protein 2 [KO:K04511]", "29964  PRICKLE4; prickle planar cell polarity protein 4 [KO:K04511]", "4007  PRICKLE3; prickle planar cell polarity protein 3 [KO:K04511]", "27130  INVS; inversin [KO:K19626]", "23002  DAAM1; dishevelled associated activator of morphogenesis 1 [KO:K04512]", "23500  DAAM2; dishevelled associated activator of morphogenesis 2 [KO:K04512]", "387  RHOA; ras homolog family member A [KO:K04513]", "9475  ROCK2; Rho associated coiled-coil containing protein kinase 2 [KO:K17388] [EC:2.7.11.1]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "5880  RAC2; Rac family small GTPase 2 [KO:K07860]", "5881  RAC3; Rac family small GTPase 3 [KO:K07861]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "815  CAMK2A; calcium/calmodulin dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]", "817  CAMK2D; calcium/calmodulin dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]", "816  CAMK2B; calcium/calmodulin dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]", "818  CAMK2G; calcium/calmodulin dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]", "5530  PPP3CA; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]", "5532  PPP3CB; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]", "5533  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]", "5534  PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]", "5535  PPP3R2; protein phosphatase 3 regulatory subunit B, beta [KO:K06268]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "4772  NFATC1; nuclear factor of activated T cells 1 [KO:K04446]", "4773  NFATC2; nuclear factor of activated T cells 2 [KO:K17332]", "4775  NFATC3; nuclear factor of activated T cells 3 [KO:K17333]", "4776  NFATC4; nuclear factor of activated T cells 4 [KO:K17334]"], "compound": ["C00076  Calcium cation"], "refs": [{"pmid": "14635791", "authors": "  Hatsell S, Rowlands T, Hiremath M, Cowin P.", "title": "Beta-catenin and Tcfs in mammary development and cancer.", "journal": "J Mammary Gland Biol Neoplasia 8:145-58 (2003)", "doi": "10.1023/A:1025944723047"}, {"pmid": "14745971", "authors": "  Yang Y.", "title": "Wnts and wing: Wnt signaling in vertebrate limb development and musculoskeletal morphogenesis.", "journal": "Birth Defects Res Part C Embryo Today 69:305-17 (2003)", "doi": "10.1002/bdrc.10026"}, {"pmid": "12446114", "authors": "  Kalderon D.", "title": "Similarities between the Hedgehog and Wnt signaling pathways.", "journal": "Trends Cell Biol 12:523-31 (2002)", "doi": "10.1016/S0962-8924(02)02388-7"}, {"pmid": "14530294", "authors": "  Nusse R.", "title": "Wnts and Hedgehogs: lipid-modified proteins and similarities in signaling mechanisms at the cell surface.", "journal": "Development 130:5297-305 (2003)", "doi": "10.1242/dev.00821"}, {"pmid": "15102436", "authors": "  Jope RS, Johnson GV.", "title": "The glamour and gloom of glycogen synthase kinase-3.", "journal": "Trends Biochem Sci 29:95-102 (2004)", "doi": "10.1016/j.tibs.2003.12.004"}, {"pmid": "12967557", "authors": "  Veeman MT, Axelrod JD, Moon RT.", "title": "A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling.", "journal": "Dev Cell 5:367-77 (2003)", "doi": "10.1016/S1534-5807(03)00266-1"}, {"pmid": "11433294", "authors": "  Sun TQ, Lu B, Feng JJ, Reinhard C, Jan YN, Fantl WJ, Williams LT.", "title": "PAR-1 is a Dishevelled-associated kinase and a positive regulator of Wnt signalling.", "journal": "Nat Cell Biol 3:628-36 (2001)", "doi": "10.1038/35083016"}, {"pmid": "23256519", "authors": "  Saito-Diaz K, Chen TW, Wang X, Thorne CA, Wallace HA, Page-McCaw A, Lee E", "title": "The way Wnt works: Components and mechanism.", "journal": "Growth Factors 31:1-31 (2013)", "doi": "10.3109/08977194.2012.752737"}, {"pmid": "19482104", "authors": "  Carethers JM", "title": "Intersection of transforming growth factor-beta and Wnt signaling pathways in colorectal cancer and metastasis.", "journal": "Gastroenterology 137:33-6 (2009)", "doi": "10.1053/j.gastro.2009.05.011"}, {"pmid": "18838381", "authors": "  Lin Z, Gao C, Ning Y, He X, Wu W, Chen YG", "title": "The pseudoreceptor BMP and activin membrane-bound inhibitor positively modulates Wnt/beta-catenin signaling.", "journal": "J Biol Chem 283:33053-8 (2008)", "doi": "10.1074/jbc.M804039200"}, {"pmid": "23151663", "authors": "  Niehrs C", "title": "The complex world of WNT receptor signalling.", "journal": "Nat Rev Mol Cell Biol 13:767-79 (2012)", "doi": "10.1038/nrm3470"}, {"pmid": "28522145", "authors": "  Abou Ziki MD, Mani A", "title": "Wnt signaling, a novel pathway regulating blood pressure? State of the art review.", "journal": "Atherosclerosis 262:171-178 (2017)", "doi": "10.1016/j.atherosclerosis.2017.05.001"}, {"pmid": "25808920", "authors": "  He Y, Ki H, Kim H, Kim K", "title": "delta-Catenin interacts with LEF-1 and negatively regulates its transcriptional activity.", "journal": "Cell Biol Int 39:954-61 (2015)", "doi": "10.1002/cbin.10465"}, {"pmid": "32888647", "authors": "  Esaki N, Enomoto A, Takagishi M, Mizutani Y, Iida T, Ushida K, Shiraki Y, Mii S, Takahashi M", "title": "The Daple-CK1epsilon complex regulates Dvl2 phosphorylation and canonical Wnt signaling.", "journal": "Biochem Biophys Res Commun 532:406-413 (2020)", "doi": "10.1016/j.bbrc.2020.08.066"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04110  Cell cycle", "hsa04115  p53 signaling pathway", "hsa04120  Ubiquitin mediated proteolysis", "hsa04350  TGF-beta signaling pathway", "hsa04510  Focal adhesion", "hsa04520  Adherens junction", "hsa05010  Alzheimer disease"], "ko_pathway": "ko04310", "genes": ["RAC1", "TP53", "CUL1"]}, {"kegg_id": "hsa04360", "name": "Axon guidance - Homo sapiens (human)", "description": "Axon guidance represents a key stage in the formation of neuronal network. Axons are guided by a variety of guidance factors, such as netrins, ephrins, Slits, and semaphorins. These guidance cues are read by growth cone receptors, and signal transduction pathways downstream of these receptors converge onto the Rho GTPases to elicit changes in cytoskeletal organization that determine which way the growth cone will turn.", "class": "Organismal Systems; Development and regeneration", "pathway_map": "hsa04360  Axon guidance", "drug": ["D01705  Clemizole hydrochloride (JAN)", "D02013  Clemizole undecylate (JAN)", "D10028  Valategrast hydrochloride (USAN)", "D10494  Vesencumab (USAN/INN)", "D11355  Elezanumab (USAN/INN)", "D11469  Pepinemab (USAN)", "D12287  Terevalefim (USAN/INN)", "D12649  Unasnemab (USAN/INN)", "D12828  Risvodetinib (USAN/INN)", "D12829  Risvodetinib succinate (USAN)"], "dblinks": "GO: 0007411", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["22854  NTNG1; netrin G1 [KO:K07522]", "84628  NTNG2; netrin G2 [KO:K16359]", "57689  LRRC4C; leucine rich repeat containing 4C [KO:K07523]", "64101  LRRC4; leucine rich repeat containing 4 [KO:K16351]", "9423  NTN1; netrin 1 [KO:K06843]", "4917  NTN3; netrin 3 [KO:K06844]", "59277  NTN4; netrin 4 [KO:K06845]", "1630  DCC; DCC netrin 1 receptor [KO:K06765]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]", "7220  TRPC1; transient receptor potential cation channel subfamily C member 1 [KO:K04964]", "7222  TRPC3; transient receptor potential cation channel subfamily C member 3 [KO:K04966]", "7223  TRPC4; transient receptor potential cation channel subfamily C member 4 [KO:K04967]", "7224  TRPC5; transient receptor potential cation channel subfamily C member 5 [KO:K04968]", "7225  TRPC6; transient receptor potential cation channel subfamily C member 6 [KO:K04969]", "5530  PPP3CA; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]", "5532  PPP3CB; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]", "5533  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]", "5534  PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]", "5535  PPP3R2; protein phosphatase 3 regulatory subunit B, beta [KO:K06268]", "4773  NFATC2; nuclear factor of activated T cells 2 [KO:K17332]", "4775  NFATC3; nuclear factor of activated T cells 3 [KO:K17333]", "4776  NFATC4; nuclear factor of activated T cells 4 [KO:K17334]", "5747  PTK2; protein tyrosine kinase 2 [KO:K05725] [EC:2.7.10.2]", "2534  FYN; FYN proto-oncogene, Src family tyrosine kinase [KO:K05703] [EC:2.7.10.2]", "6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "5880  RAC2; Rac family small GTPase 2 [KO:K07860]", "5881  RAC3; Rac family small GTPase 3 [KO:K07861]", "998  CDC42; cell division cycle 42 [KO:K04393]", "3983  ABLIM1; actin binding LIM protein 1 [KO:K07520]", "22885  ABLIM3; actin binding LIM protein family member 3 [KO:K07520]", "84448  ABLIM2; actin binding LIM protein family member 2 [KO:K07520]", "4690  NCK1; NCK adaptor protein 1 [KO:K07365]", "5058  PAK1; p21 (RAC1) activated kinase 1 [KO:K04409] [EC:2.7.11.1]", "5062  PAK2; p21 (RAC1) activated kinase 2 [KO:K04410] [EC:2.7.11.1]", "5063  PAK3; p21 (RAC1) activated kinase 3 [KO:K05733] [EC:2.7.11.1]", "10298  PAK4; p21 (RAC1) activated kinase 4 [KO:K05734] [EC:2.7.11.1]", "57144  PAK5; p21 (RAC1) activated kinase 5 [KO:K05736] [EC:2.7.11.1]", "56924  PAK6; p21 (RAC1) activated kinase 6 [KO:K05735] [EC:2.7.11.1]", "106821730  BUB1B-PAK6; BUB1B-PAK6 readthrough [KO:K05735] [EC:2.7.11.1]", "387  RHOA; ras homolog family member A [KO:K04513]", "6093  ROCK1; Rho associated coiled-coil containing protein kinase 1 [KO:K04514] [EC:2.7.11.1]", "9475  ROCK2; Rho associated coiled-coil containing protein kinase 2 [KO:K17388] [EC:2.7.11.1]", "90249  UNC5A; unc-5 netrin receptor A [KO:K07521]", "219699  UNC5B; unc-5 netrin receptor B [KO:K07521]", "8633  UNC5C; unc-5 netrin receptor C [KO:K07521]", "137970  UNC5D; unc-5 netrin receptor D [KO:K07521]", "5781  PTPN11; protein tyrosine phosphatase non-receptor type 11 [KO:K07293] [EC:3.1.3.48]", "56963  RGMA; repulsive guidance molecule BMP co-receptor a [KO:K23096]", "4756  NEO1; neogenin 1 [KO:K06766]", "4636  MYL5; myosin light chain 5 [KO:K12753]", "10398  MYL9; myosin light chain 9 [KO:K12755]", "103910  MYL12B; myosin light chain 12B [KO:K12757]", "10627  MYL12A; myosin light chain 12A [KO:K12757]", "23365  ARHGEF12; Rho guanine nucleotide exchange factor 12 [KO:K07532]", "9860  LRIG2; leucine rich repeats and immunoglobulin like domains 2 [KO:K24609]", "1942  EFNA1; ephrin A1 [KO:K05462]", "1943  EFNA2; ephrin A2 [KO:K05462]", "1944  EFNA3; ephrin A3 [KO:K05462]", "1945  EFNA4; ephrin A4 [KO:K05462]", "1946  EFNA5; ephrin A5 [KO:K05462]", "1947  EFNB1; ephrin B1 [KO:K05463]", "1948  EFNB2; ephrin B2 [KO:K05463]", "1949  EFNB3; ephrin B3 [KO:K05463]", "2041  EPHA1; EPH receptor A1 [KO:K05102] [EC:2.7.10.1]", "1969  EPHA2; EPH receptor A2 [KO:K05103] [EC:2.7.10.1]", "2042  EPHA3; EPH receptor A3 [KO:K05104] [EC:2.7.10.1]", "2043  EPHA4; EPH receptor A4 [KO:K05105] [EC:2.7.10.1]", "2044  EPHA5; EPH receptor A5 [KO:K05106] [EC:2.7.10.1]", "285220  EPHA6; EPH receptor A6 [KO:K05107] [EC:2.7.10.1]", "2045  EPHA7; EPH receptor A7 [KO:K05108] [EC:2.7.10.1]", "2046  EPHA8; EPH receptor A8 [KO:K05109] [EC:2.7.10.1]", "2047  EPHB1; EPH receptor B1 [KO:K05110] [EC:2.7.10.1]", "2048  EPHB2; EPH receptor B2 [KO:K05111] [EC:2.7.10.1]", "2049  EPHB3; EPH receptor B3 [KO:K05112] [EC:2.7.10.1]", "2050  EPHB4; EPH receptor B4 [KO:K05113] [EC:2.7.10.1]", "2051  EPHB6; EPH receptor B6 [KO:K05114] [EC:2.7.10.1]", "25  ABL1; ABL proto-oncogene 1, non-receptor tyrosine kinase [KO:K06619] [EC:2.7.10.2]", "55740  ENAH; ENAH actin regulator [KO:K05746]", "5921  RASA1; RAS p21 protein activator 1 [KO:K04352]", "25791  NGEF; neuronal guanine nucleotide exchange factor [KO:K07525]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "8440  NCK2; NCK adaptor protein 2 [KO:K19862]", "5998  RGS3; regulator of G protein signaling 3 [KO:K07524]", "6387  CXCL12; C-X-C motif chemokine ligand 12 [KO:K10031]", "7852  CXCR4; C-X-C motif chemokine receptor 4 [KO:K04189]", "2770  GNAI1; G protein subunit alpha i1 [KO:K04630]", "2773  GNAI3; G protein subunit alpha i3 [KO:K04630]", "2771  GNAI2; G protein subunit alpha i2 [KO:K04630]", "6585  SLIT1; slit guidance ligand 1 [KO:K06838]", "9353  SLIT2; slit guidance ligand 2 [KO:K06839]", "6586  SLIT3; slit guidance ligand 3 [KO:K06850]", "6091  ROBO1; roundabout guidance receptor 1 [KO:K06753]", "6092  ROBO2; roundabout guidance receptor 2 [KO:K06754]", "64221  ROBO3; roundabout guidance receptor 3 [KO:K06755]", "23380  SRGAP2; SLIT-ROBO Rho GTPase activating protein 2 [KO:K07526]", "57522  SRGAP1; SLIT-ROBO Rho GTPase activating protein 1 [KO:K07526]", "9901  SRGAP3; SLIT-ROBO Rho GTPase activating protein 3 [KO:K07526]", "10371  SEMA3A; semaphorin 3A [KO:K06840]", "7869  SEMA3B; semaphorin 3B [KO:K06840]", "10512  SEMA3C; semaphorin 3C [KO:K06840]", "223117  SEMA3D; semaphorin 3D [KO:K06840]", "9723  SEMA3E; semaphorin 3E [KO:K06840]", "6405  SEMA3F; semaphorin 3F [KO:K06840]", "56920  SEMA3G; semaphorin 3G [KO:K06840]", "5362  PLXNA2; plexin A2 [KO:K06820]", "55558  PLXNA3; plexin A3 [KO:K06820]", "5361  PLXNA1; plexin A1 [KO:K06820]", "91584  PLXNA4; plexin A4 [KO:K06820]", "8829  NRP1; neuropilin 1 [KO:K06724]", "3897  L1CAM; L1 cell adhesion molecule [KO:K06550]", "3984  LIMK1; LIM domain kinase 1 [KO:K05743] [EC:2.7.11.1]", "3985  LIMK2; LIM domain kinase 2 [KO:K05744] [EC:2.7.11.1]", "1072  CFL1; cofilin 1 [KO:K05765]", "1073  CFL2; cofilin 2 [KO:K05765]", "29984  RHOD; ras homolog family member D [KO:K07530]", "27289  RND1; Rho family GTPase 1 [KO:K07531]", "2242  FES; FES proto-oncogene, tyrosine kinase [KO:K07527] [EC:2.7.10.2]", "56896  DPYSL5; dihydropyrimidinase like 5 [KO:K07529]", "1808  DPYSL2; dihydropyrimidinase like 2 [KO:K07528]", "1020  CDK5; cyclin dependent kinase 5 [KO:K02090] [EC:2.7.11.22]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "10505  SEMA4F; ssemaphorin 4F [KO:K06521]", "10507  SEMA4D; semaphorin 4D [KO:K06521]", "10509  SEMA4B; semaphorin 4B [KO:K06521]", "54910  SEMA4C; semaphorin 4C [KO:K06521]", "57715  SEMA4G; semaphorin 4G [KO:K06521]", "64218  SEMA4A; semaphorin 4A [KO:K06521]", "9037  SEMA5A; semaphorin 5A [KO:K06841]", "54437  SEMA5B; semaphorin 5B [KO:K06841]", "57556  SEMA6A; semaphorin 6A [KO:K06842]", "10501  SEMA6B; semaphorin 6B [KO:K06842]", "10500  SEMA6C; semaphorin 6C [KO:K06842]", "80031  SEMA6D; semaphorin 6D [KO:K06842]", "5364  PLXNB1; plexin B1 [KO:K06821]", "23654  PLXNB2; plexin B2 [KO:K06821]", "5365  PLXNB3; plexin B3 [KO:K06821]", "4233  MET; MET proto-oncogene, receptor tyrosine kinase [KO:K05099] [EC:2.7.10.1]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "6237  RRAS; RAS related [KO:K07829]", "8482  SEMA7A; semaphorin 7A (JohnMiltonHagen blood group) [KO:K06529]", "10154  PLXNC1; plexin C1 [KO:K06572]", "3688  ITGB1; integrin subunit beta 1 [KO:K05719]", "6469  SHH; sonic hedgehog signaling molecule [KO:K11988]", "5727  PTCH1; patched 1 [KO:K06225]", "6608  SMO; smoothened, frizzled class receptor [KO:K06226]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "3611  ILK; integrin linked kinase [KO:K06272] [EC:2.7.11.1]", "91653  BOC; BOC cell adhesion associated, oncogene regulated [KO:K20020]", "7474  WNT5A; Wnt family member 5A [KO:K00444]", "81029  WNT5B; Wnt family member 5B [KO:K00444]", "7976  FZD3; frizzled class receptor 3 [KO:K02329]", "6259  RYK; receptor like tyrosine kinase [KO:K05128] [EC:2.7.10.1]", "815  CAMK2A; calcium/calmodulin dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]", "817  CAMK2D; calcium/calmodulin dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]", "816  CAMK2B; calcium/calmodulin dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]", "818  CAMK2G; calcium/calmodulin dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]", "54361  WNT4; Wnt family member 4 [KO:K00408]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5170  PDPK1; 3-phosphoinositide dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]", "56288  PARD3; par-3 family cell polarity regulator [KO:K04237]", "5590  PRKCZ; protein kinase C zeta [KO:K18952] [EC:2.7.11.13]", "50855  PARD6A; par-6 family cell polarity regulator alpha [KO:K06093]", "84552  PARD6G; par-6 family cell polarity regulator gamma [KO:K06093]", "84612  PARD6B; par-6 family cell polarity regulator beta [KO:K06093]", "54434  SSH1; slingshot protein phosphatase 1 [KO:K05766] [EC:3.1.3.16 3.1.3.48]", "54961  SSH3; slingshot protein phosphatase 3 [KO:K05766] [EC:3.1.3.16 3.1.3.48]", "85464  SSH2; slingshot protein phosphatase 2 [KO:K05766] [EC:3.1.3.16 3.1.3.48]", "655  BMP7; bone morphogenetic protein 7 [KO:K16621]", "151449  GDF7; growth differentiation factor 7 [KO:K20013]", "659  BMPR2; bone morphogenetic protein receptor type 2 [KO:K04671] [EC:2.7.11.30]", "658  BMPR1B; bone morphogenetic protein receptor type 1B [KO:K13578] [EC:2.7.11.30]"], "compound": ["C00076  Calcium cation"], "refs": [{"pmid": "14682358", "authors": "  Guan KL, Rao Y.", "title": "Signalling mechanisms mediating neuronal responses to guidance cues.", "journal": "Nat Rev Neurosci 4:941-56 (2003)", "doi": "10.1038/nrn1254"}, {"pmid": "15630019", "authors": "  Govek EE, Newey SE, Van Aelst L.", "title": "The role of the Rho GTPases in neuronal development.", "journal": "Genes Dev 19:1-49 (2005)", "doi": "10.1101/gad.1256405"}, {"pmid": "12677003", "authors": "  Huber AB, Kolodkin AL, Ginty DD, Cloutier JF.", "title": "Signaling at the growth cone: ligand-receptor complexes and the control of axon growth and guidance.", "journal": "Annu Rev Neurosci 26:509-63 (2003)", "doi": "10.1146/annurev.neuro.26.010302.081139"}, {"pmid": "15818466", "authors": "  Negishi M, Oinuma I, Katoh H.", "title": "Plexins: axon guidance and signal transduction.", "journal": "Cell Mol Life Sci 62:1363-71 (2005)", "doi": "10.1007/s00018-005-5018-2"}, {"pmid": "15363605", "authors": "  Huot J.", "title": "Ephrin signaling in axon guidance.", "journal": "Prog Neuropsychopharmacol Biol Psychiatry 28:813-8 (2004)", "doi": "10.1016/j.pnpbp.2004.05.025"}, {"pmid": "11891122", "authors": "  Patel BN, Van Vactor DL.", "title": "Axon guidance: the cytoplasmic tail.", "journal": "Curr Opin Cell Biol 14:221-9 (2002)", "doi": "10.1016/S0955-0674(02)00308-3"}, {"pmid": "11687826", "authors": "  Yu TW, Bargmann CI.", "title": "Dynamic regulation of axon guidance.", "journal": "Nat Neurosci 4 Suppl:1169-76 (2001)", "doi": "10.1038/nn748"}, {"pmid": "12471249", "authors": "  Dickson BJ.", "title": "Molecular mechanisms of axon guidance.", "journal": "Science 298:1959-64 (2002)", "doi": "10.1126/science.1072165"}, {"pmid": "15960985", "authors": "  Barallobre MJ, Pascual M, Del Rio JA, Soriano E.", "title": "The Netrin family of guidance factors: emphasis on Netrin-1 signalling.", "journal": "Brain Res Brain Res Rev 49:22-47 (2005)", "doi": "10.1016/j.brainresrev.2004.11.003"}, {"pmid": "15084255", "authors": "  Sabatier C, Plump AS, Le Ma, Brose K, Tamada A, Murakami F, Lee EY, Tessier-Lavigne M.", "title": "The divergent Robo family protein rig-1/Robo3 is a negative regulator of slit responsiveness required for midline crossing by commissural axons.", "journal": "Cell 117:157-69 (2004)", "doi": "10.1016/S0092-8674(04)00303-4"}, {"pmid": "25374504", "authors": "  Fujita Y, Yamashita T", "title": "Axon growth inhibition by RhoA/ROCK in the central nervous system.", "journal": "Front Neurosci 8:338 (2014)", "doi": "10.3389/fnins.2014.00338"}, {"pmid": "17169551", "authors": "  Yamashita T, Mueller BK, Hata K", "title": "Neogenin and repulsive guidance molecule signaling in the central nervous system.", "journal": "Curr Opin Neurobiol 17:29-34 (2007)", "doi": "10.1016/j.conb.2006.12.001"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04060  Cytokine-cytokine receptor interaction", "hsa04310  Wnt signaling pathway", "hsa04810  Regulation of actin cytoskeleton"], "ko_pathway": "ko04360", "genes": ["RAC1", "MET", "NRAS"]}, {"kegg_id": "hsa04370", "name": "VEGF signaling pathway - Homo sapiens (human)", "description": "There is now much evidence that VEGFR-2 is the major mediator of VEGF-driven responses in endothelial cells and it is considered to be a crucial signal transducer in both physiologic and pathologic angiogenesis. The binding of VEGF to VEGFR-2 leads to a cascade of different signaling pathways, resulting in the up-regulation of genes involved in mediating the proliferation and migration of endothelial cells and promoting their survival and vascular permeability. For example, the binding of VEGF to VEGFR-2 leads to dimerization of the receptor, followed by intracellular activation of the PLCgamma;PKC-Raf kinase-MEK-mitogen-activated protein kinase (MAPK) pathway and subsequent initiation of DNA synthesis and cell growth, whereas activation of the phosphatidylinositol 3' -kinase (PI3K)-Akt pathway leads to increased endothelial-cell survival. Activation of PI3K, FAK, and p38 MAPK is implicated in cell migration signaling.", "class": "Environmental Information Processing; Signal transduction", "pathway_map": "hsa04370  VEGF signaling pathway", "drug": ["D03218  Axitinib (JAN/USAN)", "D03658  Dasatinib (JAN/INN)", "D03736  Doramapimod (USAN/INN)", "D05029  Midostaurin (JAN/USAN/INN)", "D05386  Pegaptanib sodium (JAN/USAN)", "D05697  Ranibizumab (USAN/INN)", "D05819  Semaxanib (USAN/INN)", "D06272  Sorafenib tosylate (USAN)", "D06285  Vatalanib (USAN/INN)", "D06402  Sunitinib malate (JAN/USAN)", "D06407  Vandetanib (JAN/USAN/INN)", "D06409  Bevacizumab (USAN)", "D06414  Dasatinib (USAN)", "D08503  Toceranib (USAN)", "D08524  Sorafenib (USAN/INN)", "D08544  Toceranib phosphate (USAN)", "D08552  Sunitinib (INN)", "D08874  Bevasiranib sodium (USAN)", "D08878  Brivanib alaninate (JAN/USAN/INN)", "D08881  Cediranib (USAN/INN)", "D08883  Cediranib maleate (JAN/USAN)", "D08947  Motesanib diphosphate (USAN)", "D08963  Pamapimod (INN/USAN)", "D09371  Ramucirumab (USAN)", "D09386  Talmapimod (USAN/INN)", "D09574  Aflibercept (USAN/INN)", "D09589  Brivanib (USAN)", "D09602  Dilmapimod (USAN/INN)", "D09603  Dilmapimod tosylate (USAN)", "D09618  Foretinib (USAN/INN)", "D09635  Linifanib (USAN/INN)", "D09639  Losmapimod (USAN/INN)", "D09664  Saracatinib (USAN/INN)", "D09665  Saracatinib difumarate (USAN)", "D09683  Tivozanib (USAN/INN)", "D09919  Lenvatinib (USAN/INN)", "D09920  Lenvatinib mesylate (USAN)", "D09945  Pegdinetanib (USAN/INN)", "D10062  Cabozantinib (USAN)", "D10095  Cabozantinib s-malate (USAN)", "D10137  Regorafenib hydrate (JAN)", "D10138  Regorafenib (USAN/INN)", "D10190  Tivozanib hydrochloride (USAN)", "D10224  Golvatinib (USAN)", "D10396  Nintedanib esylate (USAN)", "D10426  Pimasertib (USAN/INN)", "D10465  Golvatinib tartrate (USAN)", "D10481  Nintedanib (USAN/INN)", "D10486  Pimasertib hydrochloride (USAN)", "D11083  Brolucizumab (USAN/INN)", "D11126  Navicixizumab (USAN/INN)", "D11244  Vanucizumab (USAN/INN)", "D11288  Rivoceranib (USAN/INN)", "D11289  Rivoceranib mesylate (USAN)", "D11517  Abicipar pegol (USAN/INN)", "D11642  Dilpacimab (USAN/INN)", "D11890  Emvododstat (USAN)", "D12237  Zunsemetinib (USAN)", "D12507  Tarcocimab (INN)", "D12508  Tarcocimab tedromer (INN)", "D12560  Gamcemetinib (USAN)", "D12808  Ivonescimab (USAN/INN)"], "dblinks": "GO: 0048010", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["7422  VEGFA; vascular endothelial growth factor A [KO:K05448]", "3791  KDR; kinase insert domain receptor [KO:K05098] [EC:2.7.10.1]", "9047  SH2D2A; SH2 domain containing 2A [KO:K08273]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "8877  SPHK1; sphingosine kinase 1 [KO:K04718] [EC:2.7.1.91]", "56848  SPHK2; sphingosine kinase 2 [KO:K04718] [EC:2.7.1.91]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "123745  PLA2G4E; phospholipase A2 group IVE [KO:K16342] [EC:3.1.1.4]", "5321  PLA2G4A; phospholipase A2 group IVA [KO:K16342] [EC:3.1.1.4]", "8681  JMJD7-PLA2G4B; JMJD7-PLA2G4B readthrough [KO:K16342] [EC:3.1.1.4]", "100137049  PLA2G4B; phospholipase A2 group IVB [KO:K16342] [EC:3.1.1.4]", "8605  PLA2G4C; phospholipase A2 group IVC [KO:K16342] [EC:3.1.1.4]", "283748  PLA2G4D; phospholipase A2 group IVD [KO:K16342] [EC:3.1.1.4]", "255189  PLA2G4F; phospholipase A2 group IVF [KO:K16342] [EC:3.1.1.4]", "5530  PPP3CA; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]", "5532  PPP3CB; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]", "5533  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]", "5534  PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]", "5535  PPP3R2; protein phosphatase 3 regulatory subunit B, beta [KO:K06268]", "4773  NFATC2; nuclear factor of activated T cells 2 [KO:K17332]", "5743  PTGS2; prostaglandin-endoperoxide synthase 2 [KO:K11987] [EC:1.14.99.1]", "5747  PTK2; protein tyrosine kinase 2 [KO:K05725] [EC:2.7.10.2]", "25759  SHC2; SHC adaptor protein 2 [KO:K17447]", "5829  PXN; paxillin [KO:K05760]", "998  CDC42; cell division cycle 42 [KO:K04393]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "9261  MAPKAPK2; MAPK activated protein kinase 2 [KO:K04443] [EC:2.7.11.1]", "7867  MAPKAPK3; MAPK activated protein kinase 3 [KO:K04444] [EC:2.7.11.1]", "3315  HSPB1; heat shock protein family B (small) member 1 [KO:K04455]", "6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "5880  RAC2; Rac family small GTPase 2 [KO:K07860]", "5881  RAC3; Rac family small GTPase 3 [KO:K07861]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "4846  NOS3; nitric oxide synthase 3 [KO:K13242] [EC:1.14.13.39]", "842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]"], "compound": ["C00076  Calcium cation", "C00165  Diacylglycerol", "C00533  Nitric oxide", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C01312  Prostaglandin I2", "C05981  Phosphatidylinositol-3,4,5-trisphosphate"], "refs": [{"pmid": "13678960", "authors": "  Cross MJ, Dixelius J, Matsumoto T, Claesson-Welsh L.", "title": "VEGF-receptor signal transduction.", "journal": "Trends Biochem Sci 28:488-94 (2003)", "doi": "10.1016/S0968-0004(03)00193-2"}, {"pmid": "11741095", "authors": "  Matsumoto T, Claesson-Welsh L.", "title": "VEGF receptor signal transduction.", "journal": "Sci STKE 2001:RE21 (2001)", "doi": "10.1126/stke.2001.112.re21"}, {"pmid": "15602010", "authors": "  Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA.", "title": "Vascular endothelial growth factor and angiogenesis.", "journal": "Pharmacol Rev 56:549-80 (2004)", "doi": "10.1124/pr.56.4.3"}, {"pmid": "16104843", "authors": "  Takahashi H, Shibuya M.", "title": "The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions.", "journal": "Clin Sci (Lond) 109:227-41 (2005)", "doi": "10.1042/CS20040370"}, {"pmid": "14641020", "authors": "  Zachary I.", "title": "VEGF signalling: integration and multi-tasking in endothelial cell biology.", "journal": "Biochem Soc Trans 31:1171-7 (2003)", "doi": "10.1042/bst0311171"}, {"pmid": "15338053", "authors": "  Munoz-Chapuli R, Quesada AR, Angel Medina M.", "title": "Angiogenesis and signal transduction in endothelial cells.", "journal": "Cell Mol Life Sci 61:2224-43 (2004)", "doi": "10.1007/s00018-004-4070-7"}, {"pmid": "14724572", "authors": "  Lamalice L, Houle F, Jourdan G, Huot J.", "title": "Phosphorylation of tyrosine 1214 on VEGFR2 is required for VEGF-induced activation of Cdc42 upstream of SAPK2/p38.", "journal": "Oncogene 23:434-45 (2004)", "doi": "10.1038/sj.onc.1207034"}], "rel_pathway": ["hsa00590  Arachidonic acid metabolism", "hsa04010  MAPK signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04510  Focal adhesion"], "ko_pathway": "ko04370", "genes": ["RAC1", "AKT2", "AKT1", "MAPK13", "KDR", "NRAS"]}, {"kegg_id": "hsa04380", "name": "Osteoclast differentiation - Homo sapiens (human)", "description": "The osteoclasts, multinucleared cells originating from the hematopoietic monocyte-macrophage lineage, are responsible for bone resorption. Osteoclastogenesis is mainly regulated by signaling pathways activated by RANK and immune receptors, whose ligands are expressed on the surface of osteoblasts. Signaling from RANK changes gene expression patterns through transcription factors like NFATc1 and characterizes the active osteoclast.", "class": "Organismal Systems; Development and regeneration", "pathway_map": "hsa04380  Osteoclast differentiation", "drug": ["D00107  Tacrolimus (USP/INN)", "D00184  Cyclosporine (USP)", "D00249  Calcitonin salmon (JP18/USP/INN)", "D00742  Etanercept (USAN/INN)", "D01146  Iguratimod (JAN/INN)", "D02597  Adalimumab (USAN/INN)", "D02598  Infliximab (USAN/INN)", "D03287  Elcatonin (JP18/INN)", "D03441  Certolizumab pegol (USAN/INN)", "D03684  Denosumab (USAN)", "D03736  Doramapimod (USAN/INN)", "D04358  Golimumab (USAN/INN)", "D05480  Pimecrolimus (JAN/USAN/INN)", "D06634  Relacatib (USAN/INN)", "D08556  Tacrolimus (INN)", "D08955  Odanacatib (JAN/USAN)", "D08963  Pamapimod (INN/USAN)", "D09033  Voclosporin (JAN/USAN/INN)", "D09386  Talmapimod (USAN/INN)", "D09602  Dilmapimod (USAN/INN)", "D09603  Dilmapimod tosylate (USAN)", "D10308  Baricitinib (JAN/USAN/INN)", "D11234  Emactuzumab (USAN/INN)", "D11270  Pexidartinib (USAN/INN)", "D11271  Pexidartinib hydrochloride (JAN/USAN)", "D11778  Daxdilimab (USAN)", "D11817  Deucravacitinib (JAN/USAN)", "D12158  Elsubrutinib (USAN/INN)", "D12238  Vimseltinib (USAN/INN)", "D12342  Anzurstobart (USAN)", "D12383  Edralbrutinib (USAN/INN)", "D12467  Evobrutinib (USAN/INN)", "D12504  Nemtabrutinib (USAN/INN)", "D12725  Lomedeucitinib (USAN)", "D12775  Polzastobart (USAN/INN)", "D12826  Maplirpacept (USAN/INN)"], "dblinks": "GO: 0030316", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["1435  CSF1; colony stimulating factor 1 [KO:K05453]", "1436  CSF1R; colony stimulating factor 1 receptor [KO:K05090] [EC:2.7.10.1]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "3458  IFNG; interferon gamma [KO:K04687]", "3459  IFNGR1; interferon gamma receptor 1 [KO:K05132]", "3460  IFNGR2; interferon gamma receptor 2 [KO:K05133]", "6772  STAT1; signal transducer and activator of transcription 1 [KO:K11220]", "3552  IL1A; interleukin 1 alpha [KO:K04383]", "3553  IL1B; interleukin 1 beta [KO:K04519]", "3554  IL1R1; interleukin 1 receptor type 1 [KO:K04386]", "7124  TNF; tumor necrosis factor [KO:K03156]", "7132  TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158]", "7040  TGFB1; transforming growth factor beta 1 [KO:K13375]", "7042  TGFB2; transforming growth factor beta 2 [KO:K13376]", "7046  TGFBR1; transforming growth factor beta receptor 1 [KO:K04674] [EC:2.7.11.30]", "7048  TGFBR2; transforming growth factor beta receptor 2 [KO:K04388] [EC:2.7.11.30]", "8600  TNFSF11; TNF superfamily member 11 [KO:K05473]", "8792  TNFRSF11A; TNF receptor superfamily member 11a [KO:K05147]", "4982  TNFRSF11B; TNF receptor superfamily member 11b [KO:K05148]", "7186  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]", "7189  TRAF6; TNF receptor associated factor 6 [KO:K03175] [EC:2.3.2.27]", "3932  LCK; LCK proto-oncogene, Src family tyrosine kinase [KO:K05856] [EC:2.7.10.2]", "2534  FYN; FYN proto-oncogene, Src family tyrosine kinase [KO:K05703] [EC:2.7.10.2]", "9020  MAP3K14; mitogen-activated protein kinase kinase kinase 14 [KO:K04466] [EC:2.7.11.25]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "5971  RELB; RELB proto-oncogene, NF-kB subunit [KO:K09253]", "4791  NFKB2; nuclear factor kappa B subunit 2 [KO:K04469]", "6885  MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO:K04427] [EC:2.7.11.25]", "10454  TAB1; TGF-beta activated kinase 1 (MAP3K7) binding protein 1 [KO:K04403]", "23118  TAB2; TGF-beta activated kinase 1 (MAP3K7) binding protein 2 [KO:K04404]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "4773  NFATC2; nuclear factor of activated T cells 2 [KO:K17332]", "4772  NFATC1; nuclear factor of activated T cells 1 [KO:K04446]", "3456  IFNB1; interferon beta 1 [KO:K05415]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5608  MAP2K6; mitogen-activated protein kinase kinase 6 [KO:K04433] [EC:2.7.12.2]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "5609  MAP2K7; mitogen-activated protein kinase kinase 7 [KO:K04431] [EC:2.7.12.2]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "2354  FOSB; FosB proto-oncogene, AP-1 transcription factor subunit [KO:K09029]", "2355  FOSL2; FOS like 2, AP-1 transcription factor subunit [KO:K09030]", "8061  FOSL1; FOS like 1, AP-1 transcription factor subunit [KO:K04502]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "3727  JUND; JunD proto-oncogene, AP-1 transcription factor subunit [KO:K04449]", "3726  JUNB; JunB proto-oncogene, AP-1 transcription factor subunit [KO:K09028]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "27035  NOX1; NADPH oxidase 1 [KO:K08008]", "1535  CYBA; cytochrome b-245 alpha chain [KO:K08009]", "4688  NCF2; neutrophil cytosolic factor 2 [KO:K08010]", "653361  NCF1; neutrophil cytosolic factor 1 [KO:K08011]", "4689  NCF4; neutrophil cytosolic factor 4 [KO:K08012]", "695  BTK; Bruton tyrosine kinase [KO:K07370] [EC:2.7.10.2]", "7006  TEC; tec protein tyrosine kinase [KO:K07364] [EC:2.7.10.2]", "126014  OSCAR; osteoclast associated Ig-like receptor [KO:K14377]", "10288  LILRB2; leukocyte immunoglobulin like receptor B2 [KO:K06512]", "10859  LILRB1; leukocyte immunoglobulin like receptor B1 [KO:K06512]", "10990  LILRB5; leukocyte immunoglobulin like receptor B5 [KO:K06512]", "11006  LILRB4; leukocyte immunoglobulin like receptor B4 [KO:K06512]", "11024  LILRA1; leukocyte immunoglobulin like receptor A1 [KO:K06512]", "11025  LILRB3; leukocyte immunoglobulin like receptor B3 [KO:K06512]", "11026  LILRA3; leukocyte immunoglobulin like receptor A3 [KO:K06512]", "11027  LILRA2; leukocyte immunoglobulin like receptor A2 [KO:K06512]", "23547  LILRA4; leukocyte immunoglobulin like receptor A4 [KO:K06512]", "79168  LILRA6; leukocyte immunoglobulin like receptor A6 [KO:K06512]", "353514  LILRA5; leukocyte immunoglobulin like receptor A5 [KO:K06512]", "102725035  leukocyte immunoglobulin-like receptor subfamily B member 3 [KO:K06512]", "107987425  leukocyte immunoglobulin-like receptor subfamily B member 3 [KO:K06512]", "107987462  leukocyte immunoglobulin-like receptor subfamily B member 3 [KO:K06512]", "112268336  leukocyte immunoglobulin-like receptor subfamily B member 3 [KO:K06512]", "112268337  leukocyte immunoglobulin-like receptor subfamily B member 3 [KO:K06512]", "112268340  leukocyte immunoglobulin-like receptor subfamily B member 3 [KO:K06512]", "107987441  leukocyte immunoglobulin-like receptor subfamily B member 3 [KO:K06512]", "2209  FCGR1A; Fc gamma receptor Ia [KO:K06498]", "2212  FCGR2A; Fc gamma receptor IIa [KO:K06472]", "2213  FCGR2B; Fc gamma receptor IIb [KO:K12560]", "9103  FCGR2C; Fc gamma receptor IIc (gene/pseudogene) [KO:K16824]", "2214  FCGR3A; Fc gamma receptor IIIa [KO:K06463]", "2215  FCGR3B; Fc gamma receptor IIIb [KO:K06463]", "54209  TREM2; triggering receptor expressed on myeloid cells 2 [KO:K14378]", "140885  SIRPA; signal regulatory protein alpha [KO:K06551]", "55423  SIRPG; signal regulatory protein gamma [KO:K06551]", "10326  SIRPB1; signal regulatory protein beta 1 [KO:K06551]", "7305  TYROBP; transmembrane immune signaling adaptor TYROBP [KO:K07992]", "6850  SYK; spleen associated tyrosine kinase [KO:K05855] [EC:2.7.10.2]", "29760  BLNK; B cell linker [KO:K07371]", "3937  LCP2; lymphocyte cytosolic protein 2 [KO:K07361]", "5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "487  ATP2A1; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 [KO:K05853] [EC:7.2.2.10]", "489  ATP2A3; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 [KO:K05853] [EC:7.2.2.10]", "488  ATP2A2; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 [KO:K05853] [EC:7.2.2.10]", "169200  TMEM64; transmembrane protein 64 [KO:K26770]", "5530  PPP3CA; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]", "5532  PPP3CB; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]", "5533  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]", "5534  PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]", "5535  PPP3R2; protein phosphatase 3 regulatory subunit B, beta [KO:K06268]", "814  CAMK4; calcium/calmodulin dependent protein kinase IV [KO:K05869] [EC:2.7.11.17]", "1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]", "6688  SPI1; Spi-1 proto-oncogene [KO:K09438]", "4286  MITF; melanocyte inducing transcription factor [KO:K09455]", "1513  CTSK; cathepsin K [KO:K01371] [EC:3.4.22.38]", "54  ACP5; acid phosphatase 5, tartrate resistant [KO:K14379] [EC:3.1.3.2]", "799  CALCR; calcitonin receptor [KO:K04576]", "3690  ITGB3; integrin subunit beta 3 [KO:K06493]", "5468  PPARG; peroxisome proliferator activated receptor gamma [KO:K08530]", "3454  IFNAR1; interferon alpha and beta receptor subunit 1 [KO:K05130]", "3455  IFNAR2; interferon alpha and beta receptor subunit 2 [KO:K05131]", "3716  JAK1; Janus kinase 1 [KO:K11217] [EC:2.7.10.2]", "7297  TYK2; tyrosine kinase 2 [KO:K11219] [EC:2.7.10.2]", "6773  STAT2; signal transducer and activator of transcription 2 [KO:K11221]", "10379  IRF9; interferon regulatory factor 9 [KO:K04693]", "8651  SOCS1; suppressor of cytokine signaling 1 [KO:K04694]", "9021  SOCS3; suppressor of cytokine signaling 3 [KO:K04696]", "9846  GAB2; GRB2 associated binding protein 2 [KO:K08091]", "2274  FHL2; four and a half LIM domains 2 [KO:K14380]", "1540  CYLD; CYLD lysine 63 deubiquitinase [KO:K08601] [EC:3.4.19.12]", "8878  SQSTM1; sequestosome 1 [KO:K14381]"], "compound": ["C00027  Hydrogen peroxide", "C00076  Calcium cation", "C01245  D-myo-Inositol 1,4,5-trisphosphate"], "refs": [{"pmid": "16313349", "authors": "  Takayanagi H, Sato K, Takaoka A, Taniguchi T", "title": "Interplay between interferon and other cytokine systems in bone metabolism.", "journal": "Immunol Rev 208:181-93 (2005)", "doi": "10.1111/j.0105-2896.2005.00337.x"}, {"pmid": "20392226", "authors": "  Takayanagi H", "title": "New immune connections in osteoclast formation.", "journal": "Ann N Y Acad Sci 1192:117-23 (2010)", "doi": "10.1111/j.1749-6632.2009.05303.x"}, {"pmid": "19585227", "authors": "  Nakashima T, Takayanagi H", "title": "Osteoimmunology: crosstalk between the immune and bone systems.", "journal": "J Clin Immunol 29:555-67 (2009)", "doi": "10.1007/s10875-009-9316-6"}, {"pmid": "18722561", "authors": "  Caetano-Lopes J, Canhao H, Fonseca JE", "title": "Osteoimmunology--the hidden immune regulation of bone.", "journal": "Autoimmun Rev 8:250-5 (2009)", "doi": "10.1016/j.autrev.2008.07.038"}, {"pmid": "18451259", "authors": "  Lorenzo J, Horowitz M, Choi Y", "title": "Osteoimmunology: interactions of the bone and immune system.", "journal": "Endocr Rev 29:403-40 (2008)", "doi": "10.1210/er.2007-0038"}, {"pmid": "17869613", "authors": "  David JP", "title": "Osteoimmunology: a view from the bone.", "journal": "Adv Immunol 95:149-65 (2007)", "doi": "10.1016/S0065-2776(07)95005-1"}, {"pmid": "16313342", "authors": "  Jimi E, Ghosh S", "title": "Role of nuclear factor-kappaB in the immune system and bone.", "journal": "Immunol Rev 208:80-7 (2005)", "doi": "10.1111/j.0105-2896.2005.00329.x"}, {"pmid": "12748652", "authors": "  Boyle WJ, Simonet WS, Lacey DL", "title": "Osteoclast differentiation and activation.", "journal": "Nature 423:337-42 (2003)", "doi": "10.1038/nature01658"}, {"pmid": "17633024", "authors": "  Darnay BG, Besse A, Poblenz AT, Lamothe B, Jacoby JJ", "title": "TRAFs in RANK signaling.", "journal": "Adv Exp Med Biol 597:152-9 (2007)", "doi": "10.1007/978-0-387-70630-6_12"}, {"pmid": "15122243", "authors": "  Baron R", "title": "Arming the osteoclast.", "journal": "Nat Med 10:458-60 (2004)", "doi": "10.1038/nm0504-458"}, {"pmid": "17380158", "authors": "  Takayanagi H", "title": "Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems.", "journal": "Nat Rev Immunol 7:292-304 (2007)", "doi": "10.1038/nri2062"}, {"pmid": "20703218", "authors": "  Krum SA, Chang J, Miranda-Carboni G, Wang CY", "title": "Novel functions for NFkappaB: inhibition of bone formation.", "journal": "Nat Rev Rheumatol 6:607-11 (2010)", "doi": "10.1038/nrrheum.2010.133"}, {"pmid": "15817678", "authors": "  Lee NK, Choi YG, Baik JY, Han SY, Jeong DW, Bae YS, Kim N, Lee SY", "title": "A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation.", "journal": "Blood 106:852-9 (2005)", "doi": "10.1182/blood-2004-09-3662"}, {"pmid": "18329366", "authors": "  Shinohara M, Koga T, Okamoto K, Sakaguchi S, Arai K, Yasuda H, Takai T, Kodama T, Morio T, Geha RS, Kitamura D, Kurosaki T, Ellmeier W, Takayanagi H", "title": "Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals.", "journal": "Cell 132:794-806 (2008)", "doi": "10.1016/j.cell.2007.12.037"}, {"pmid": "15546140", "authors": "  Takayanagi H, Kim S, Koga T, Taniguchi T", "title": "Stat1-mediated cytoplasmic attenuation in osteoimmunology.", "journal": "J Cell Biochem 94:232-40 (2005)", "doi": "10.1002/jcb.20316"}, {"pmid": "18382763", "authors": "  Jin W, Chang M, Paul EM, Babu G, Lee AJ, Reiley W, Wright A, Zhang M, You J, Sun SC", "title": "Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice.", "journal": "J Clin Invest 118:1858-66 (2008)", "doi": "10.1172/JCI34257"}, {"pmid": "16184196", "authors": "  Bai S, Kitaura H, Zhao H, Chen J, Muller JM, Schule R, Darnay B, Novack DV, Ross FP, Teitelbaum SL", "title": "FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner.", "journal": "J Clin Invest 115:2742-51 (2005)", "doi": "10.1172/JCI24921"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04064  NF-kappa B signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04630  JAK-STAT signaling pathway"], "ko_pathway": "ko04380", "genes": ["RAC1", "FHL2", "CSF1", "AKT2", "AKT1", "MAPK13"]}, {"kegg_id": "hsa04530", "name": "Tight junction - Homo sapiens (human)", "description": "Tight junctions (TJs) are essential for establishing a selectively permeable barrier to diffusion through the paracellular space between neighboring cells. TJs are composed of at least three types of transmembrane protein -occludin, claudin and junctional adhesion molecules (JAMs)- and a cytoplasmic 'plaque' consisting of many different proteins that form large complexes. These are proposed to be involved in junction assembly, barrier regulation, cell polarity, gene transcription, and other pathways.", "class": "Cellular Processes; Cellular community - eukaryotes", "pathway_map": "hsa04530  Tight junction", "network": ["", "ELEMENT   N00340  The Scribble/Dlg/Lgl polarity module", "N00344  CRB3-Pals1-PATJ complex", "N01287  Tight junction-Actin signaling pathway"], "drug": ["D11527  Zolbetuximab (USAN/INN)", "D12722  Bexotegrast (USAN/INN)", "D12781  Osemitamab (USAN/INN)"], "dblinks": "GO: 0005923", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["92359  CRB3; crumbs cell polarity complex component 3 [KO:K06090]", "1364  CLDN4; claudin 4 [KO:K06087]", "1365  CLDN3; claudin 3 [KO:K06087]", "1366  CLDN7; claudin 7 [KO:K06087]", "149461  CLDN19; claudin 19 [KO:K06087]", "10686  CLDN16; claudin 16 [KO:K06087]", "23562  CLDN14; claudin 14 [KO:K06087]", "24146  CLDN15; claudin 15 [KO:K06087]", "26285  CLDN17; claudin 17 [KO:K06087]", "49861  CLDN20; claudin 20 [KO:K06087]", "5010  CLDN11; claudin 11 [KO:K06087]", "51208  CLDN18; claudin 18 [KO:K06087]", "53842  CLDN22; claudin 22 [KO:K06087]", "7122  CLDN5; claudin 5 [KO:K06087]", "9071  CLDN10; claudin 10 [KO:K06087]", "9073  CLDN8; claudin 8 [KO:K06087]", "9074  CLDN6; claudin 6 [KO:K06087]", "9075  CLDN2; claudin 2 [KO:K06087]", "9076  CLDN1; claudin 1 [KO:K06087]", "9080  CLDN9; claudin 9 [KO:K06087]", "137075  CLDN23; claudin 23 [KO:K06087]", "100288814  CLDN34; claudin 34 [KO:K06087]", "644672  CLDN25; claudin 25 [KO:K06087]", "100132463  CLDN24; claudin 24 [KO:K06087]", "9069  CLDN12; claudin 12 [KO:K06087]", "100506658  OCLN; occludin [KO:K06088]", "50848  F11R; F11 receptor [KO:K06089]", "58494  JAM2; junctional adhesion molecule 2 [KO:K06735]", "83700  JAM3; junctional adhesion molecule 3 [KO:K06785]", "11149  BVES; blood vessel epicardial substance [KO:K21108]", "998  CDC42; cell division cycle 42 [KO:K04393]", "50855  PARD6A; par-6 family cell polarity regulator alpha [KO:K06093]", "84552  PARD6G; par-6 family cell polarity regulator gamma [KO:K06093]", "84612  PARD6B; par-6 family cell polarity regulator beta [KO:K06093]", "64398  PALS1; protein associated with LIN7 1, MAGUK p55 family member [KO:K06091]", "58538  MPP4; MAGUK p55 scaffold protein 4 [KO:K21109]", "27134  TJP3; tight junction protein 3 [KO:K06097]", "10207  PATJ; PATJ crumbs cell polarity complex component [KO:K06092]", "8777  MPDZ; multiple PDZ domain crumbs cell polarity complex component [KO:K06095]", "5590  PRKCZ; protein kinase C zeta [KO:K18952] [EC:2.7.11.13]", "5584  PRKCI; protein kinase C iota [KO:K06069] [EC:2.7.11.13]", "154796  AMOT; angiomotin [KO:K16819]", "154810  AMOTL1; angiomotin like 1 [KO:K06104]", "51421  AMOTL2; angiomotin like 2 [KO:K06104]", "55114  ARHGAP17; Rho GTPase activating protein 17 [KO:K20638]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "4771  NF2; NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor [KO:K16684]", "3993  LLGL2; LLGL scribble cell polarity complex component 2 [KO:K06094]", "3996  LLGL1; LLGL scribble cell polarity complex component 1 [KO:K06094]", "1739  DLG1; discs large MAGUK scaffold protein 1 [KO:K12076]", "23513  SCRIB; scribble planar cell polarity protein [KO:K16175]", "5515  PPP2CA; protein phosphatase 2 catalytic subunit alpha [KO:K04382] [EC:3.1.3.16]", "5516  PPP2CB; protein phosphatase 2 catalytic subunit beta [KO:K04382] [EC:3.1.3.16]", "5519  PPP2R1B; protein phosphatase 2 scaffold subunit Abeta [KO:K03456]", "5518  PPP2R1A; protein phosphatase 2 scaffold subunit Aalpha [KO:K03456]", "5520  PPP2R2A; protein phosphatase 2 regulatory subunit Balpha [KO:K04354]", "5521  PPP2R2B; protein phosphatase 2 regulatory subunit Bbeta [KO:K04354]", "5522  PPP2R2C; protein phosphatase 2 regulatory subunit Bgamma [KO:K04354]", "55844  PPP2R2D; protein phosphatase 2 regulatory subunit Bdelta [KO:K04354]", "56288  PARD3; par-3 family cell polarity regulator [KO:K04237]", "7074  TIAM1; TIAM Rac1 associated GEF 1 [KO:K05731]", "7082  TJP1; tight junction protein 1 [KO:K05701]", "93643  TJAP1; tight junction associated protein 1 [KO:K06105]", "1740  DLG2; discs large MAGUK scaffold protein 2 [KO:K12075]", "1741  DLG3; discs large MAGUK scaffold protein 3 [KO:K21098]", "4734  NEDD4; NEDD4 E3 ubiquitin protein ligase [KO:K10591] [EC:2.3.2.26]", "23327  NEDD4L; NEDD4 like E3 ubiquitin protein ligase [KO:K13305] [EC:2.3.2.26]", "57530  CGN; cingulin [KO:K06102]", "84952  CGNL1; cingulin like 1 [KO:K21110]", "9181  ARHGEF2; Rho/Rac guanine nucleotide exchange factor 2 [KO:K12791]", "387  RHOA; ras homolog family member A [KO:K04513]", "2626  GATA4; GATA binding protein 4 [KO:K09183]", "91862  MARVELD3; MARVEL domain containing 3 [KO:K21099]", "4214  MAP3K1; mitogen-activated protein kinase kinase kinase 1 [KO:K04416] [EC:2.7.11.25]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "909  CD1A; CD1a molecule [KO:K06448]", "910  CD1B; CD1b molecule [KO:K06448]", "911  CD1C; CD1c molecule [KO:K06448]", "912  CD1D; CD1d molecule [KO:K06448]", "913  CD1E; CD1e molecule [KO:K06448]", "1080  CFTR; CF transmembrane conductance regulator [KO:K05031] [EC:5.6.1.6]", "1019  CDK4; cyclin dependent kinase 4 [KO:K02089] [EC:2.7.11.22]", "8531  YBX3; Y-box binding protein 3 [KO:K06099]", "8189  SYMPK; symplekin scaffold protein [KO:K06100]", "5111  PCNA; proliferating cell nuclear antigen [KO:K04802]", "595  CCND1; cyclin D1 [KO:K04503]", "2064  ERBB2; erb-b2 receptor tyrosine kinase 2 [KO:K05083] [EC:2.7.10.1]", "861  RUNX1; RUNX family transcription factor 1 [KO:K08367]", "3308  HSPA4; heat shock protein family A (Hsp70) member 4 [KO:K09489]", "9368  NHERF1; NHERF family PDZ scaffold protein 1 [KO:K13365]", "7430  EZR; ezrin [KO:K08007]", "5962  RDX; radixin [KO:K05762]", "4478  MSN; moesin [KO:K05763]", "5581  PRKCE; protein kinase C epsilon [KO:K18050] [EC:2.7.11.13]", "71  ACTG1; actin gamma 1 [KO:K05692]", "60  ACTB; actin beta [KO:K05692]", "776  CACNA1D; calcium voltage-gated channel subunit alpha1 D [KO:K04851]", "4217  MAP3K5; mitogen-activated protein kinase kinase kinase 5 [KO:K04426] [EC:2.7.11.25]", "5609  MAP2K7; mitogen-activated protein kinase kinase 7 [KO:K04431] [EC:2.7.12.2]", "6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "2017  CTTN; cortactin [KO:K06106]", "3059  HCLS1; hematopoietic cell-specific Lyn substrate 1 [KO:K06106]", "10097  ACTR2; actin related protein 2 [KO:K17260]", "57180  ACTR3B; actin related protein 3B [KO:K18584]", "653857  ACTR3C; actin related protein 3C [KO:K18584]", "10096  ACTR3; actin related protein 3 [KO:K18584]", "10095  ARPC1B; actin related protein 2/3 complex subunit 1B [KO:K05757]", "10552  ARPC1A; actin related protein 2/3 complex subunit 1A [KO:K05757]", "10109  ARPC2; actin related protein 2/3 complex subunit 2 [KO:K05758]", "10094  ARPC3; actin related protein 2/3 complex subunit 3 [KO:K05756]", "10093  ARPC4; actin related protein 2/3 complex subunit 4 [KO:K05755]", "10092  ARPC5; actin related protein 2/3 complex subunit 5 [KO:K05754]", "81873  ARPC5L; actin related protein 2/3 complex subunit 5 like [KO:K05754]", "123720  WHAMM; WASP homolog associated with actin, golgi membranes and microtubules [KO:K20479]", "7454  WAS; WASP actin nucleation promoting factor [KO:K05747]", "7408  VASP; vasodilator stimulated phosphoprotein [KO:K06274]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "5872  RAB13; RAB13, member RAS oncogene family [KO:K06109]", "23370  ARHGEF18; Rho/Rac guanine nucleotide exchange factor 18 [KO:K21066]", "6093  ROCK1; Rho associated coiled-coil containing protein kinase 1 [KO:K04514] [EC:2.7.11.1]", "9475  ROCK2; Rho associated coiled-coil containing protein kinase 2 [KO:K17388] [EC:2.7.11.1]", "4633  MYL2; myosin light chain 2 [KO:K10351]", "54566  EPB41L4B; erythrocyte membrane protein band 4.1 like 4B [KO:K21111]", "6794  STK11; serine/threonine kinase 11 [KO:K07298] [EC:2.7.11.1]", "5562  PRKAA1; protein kinase AMP-activated catalytic subunit alpha 1 [KO:K07198] [EC:2.7.11.31]", "5563  PRKAA2; protein kinase AMP-activated catalytic subunit alpha 2 [KO:K07198] [EC:2.7.11.31]", "5564  PRKAB1; protein kinase AMP-activated non-catalytic subunit beta 1 [KO:K07199]", "5565  PRKAB2; protein kinase AMP-activated non-catalytic subunit beta 2 [KO:K07199]", "5571  PRKAG1; protein kinase AMP-activated non-catalytic subunit gamma 1 [KO:K07200]", "53632  PRKAG3; protein kinase AMP-activated non-catalytic subunit gamma 3 [KO:K07200]", "51422  PRKAG2; protein kinase AMP-activated non-catalytic subunit gamma 2 [KO:K07200]", "4627  MYH9; myosin heavy chain 9 [KO:K10352]", "4628  MYH10; myosin heavy chain 10 [KO:K10352]", "4629  MYH11; myosin heavy chain 11 [KO:K10352]", "79784  MYH14; myosin heavy chain 14 [KO:K10352]", "140465  MYL6B; myosin light chain 6B [KO:K12751]", "4637  MYL6; myosin light chain 6 [KO:K12751]", "10398  MYL9; myosin light chain 9 [KO:K12755]", "103910  MYL12B; myosin light chain 12B [KO:K12757]", "10627  MYL12A; myosin light chain 12A [KO:K12757]", "150084  IGSF5; immunoglobulin superfamily member 5 [KO:K06786]", "9223  MAGI1; membrane associated guanylate kinase, WW and PDZ domain containing 1 [KO:K05631]", "11346  SYNPO; synaptopodin [KO:K21112]", "87  ACTN1; actinin alpha 1 [KO:K05699]", "81  ACTN4; actinin alpha 4 [KO:K05699]", "79778  MICALL2; MICAL like 2 [KO:K21068]", "4218  RAB8A; RAB8A, member RAS oncogene family [KO:K07901]", "51762  RAB8B; RAB8B, member RAS oncogene family [KO:K07902]", "51735  RAPGEF6; Rap guanine nucleotide exchange factor 6 [KO:K08020]", "5906  RAP1A; RAP1A, member of RAS oncogene family [KO:K04353]", "3688  ITGB1; integrin subunit beta 1 [KO:K05719]", "4301  AFDN; afadin, adherens junction formation factor [KO:K05702]", "9414  TJP2; tight junction protein 2 [KO:K06098]", "9693  RAPGEF2; Rap guanine nucleotide exchange factor 2 [KO:K08018]", "57826  RAP2C; RAP2C, member of RAS oncogene family [KO:K07839]", "153562  MARVELD2; MARVEL domain containing 2 [KO:K17291]", "10376  TUBA1B; tubulin alpha 1b [KO:K07374]", "7277  TUBA4A; tubulin alpha 4a [KO:K07374]", "7278  TUBA3C; tubulin alpha 3c [KO:K07374]", "7846  TUBA1A; tubulin alpha 1a [KO:K07374]", "84790  TUBA1C; tubulin alpha 1c [KO:K07374]", "51807  TUBA8; tubulin alpha 8 [KO:K07374]", "112714  TUBA3E; tubulin alpha 3e [KO:K07374]", "113457  TUBA3D; tubulin alpha 3d [KO:K07374]", "79861  TUBAL3; tubulin alpha like 3 [KO:K07374]"], "compound": ["C00076  Calcium cation"], "refs": [{"pmid": "27353478", "authors": "  Zihni C, Mills C, Matter K, Balda MS", "title": "Tight junctions: from simple barriers to multifunctional molecular gates.", "journal": "Nat Rev Mol Cell Biol 17:564-80 (2016)", "doi": "10.1038/nrm.2016.80"}, {"pmid": "22169974", "authors": "  Martin-Belmonte F, Perez-Moreno M", "title": "Epithelial cell polarity, stem cells and cancer.", "journal": "Nat Rev Cancer 12:23-38 (2011)", "doi": "10.1038/nrc3169"}, {"pmid": "17525755", "authors": "  Weber C, Fraemohs L, Dejana E", "title": "The role of junctional adhesion molecules in vascular inflammation.", "journal": "Nat Rev Immunol 7:467-77 (2007)", "doi": "10.1038/nri2096"}, {"pmid": "15820555", "authors": "  Miyoshi J, Takai Y", "title": "Molecular perspective on tight-junction assembly and epithelial polarity.", "journal": "Adv Drug Deliv Rev 57:815-55 (2005)", "doi": "10.1016/j.addr.2005.01.008"}, {"pmid": "16650994", "authors": "  Mertens AE, Pegtel DM, Collard JG", "title": "Tiam1 takes PARt in cell polarity.", "journal": "Trends Cell Biol 16:308-16 (2006)", "doi": "10.1016/j.tcb.2006.04.001"}, {"pmid": "16771626", "authors": "  Shin K, Fogg VC, Margolis B", "title": "Tight junctions and cell polarity.", "journal": "Annu Rev Cell Dev Biol 22:207-35 (2006)", "doi": "10.1146/annurev.cellbio.22.010305.104219"}, {"pmid": "17182900", "authors": "  Kooistra MR, Dube N, Bos JL", "title": "Rap1: a key regulator in cell-cell junction formation.", "journal": "J Cell Sci 120:17-22 (2007)", "doi": "10.1242/jcs.03306"}, {"pmid": "17950242", "authors": "  Gonzalez-Mariscal L, Tapia R, Chamorro D", "title": "Crosstalk of tight junction components with signaling pathways.", "journal": "Biochim Biophys Acta 1778:729-56 (2008)", "doi": "10.1016/j.bbamem.2007.08.018"}, {"pmid": "18005931", "authors": "  Assemat E, Bazellieres E, Pallesi-Pocachard E, Le Bivic A, Massey-Harroche D", "title": "Polarity complex proteins.", "journal": "Biochim Biophys Acta 1778:614-30 (2008)", "doi": "10.1016/j.bbamem.2007.08.029"}, {"pmid": "18946474", "authors": "  Iden S, Collard JG", "title": "Crosstalk between small GTPases and polarity proteins in cell polarization.", "journal": "Nat Rev Mol Cell Biol 9:846-59 (2008)", "doi": "10.1038/nrm2521"}, {"pmid": "20094051", "authors": "  Rosse C, Linch M, Kermorgant S, Cameron AJ, Boeckeler K, Parker PJ", "title": "PKC and the control of localized signal dynamics.", "journal": "Nat Rev Mol Cell Biol 11:103-12 (2010)", "doi": "10.1038/nrm2847"}, {"pmid": "20134025", "authors": "  Terry S, Nie M, Matter K, Balda MS", "title": "Rho signaling and tight junction functions.", "journal": "Physiology (Bethesda) 25:16-26 (2010)", "doi": "10.1152/physiol.00034.2009"}, {"pmid": "21283798", "authors": "  Russ PK, Pino CJ, Williams CS, Bader DM, Haselton FR, Chang MS", "title": "Bves modulates tight junction associated signaling.", "journal": "PLoS One 6:e14563 (2011)", "doi": "10.1371/journal.pone.0014563"}, {"pmid": "21781017", "authors": "  Citi S, Spadaro D, Schneider Y, Stutz J, Pulimeno P", "title": "Regulation of small GTPases at epithelial cell-cell junctions.", "journal": "Mol Membr Biol 28:427-44 (2011)", "doi": "10.3109/09687688.2011.603101"}, {"pmid": "22896795", "authors": "  Lickert H, Van Campenhout CA", "title": "Evolution of the Discs large gene family provides new insights into the establishment of apical epithelial polarity and the etiology of mental retardation.", "journal": "Commun Integr Biol 5:287-90 (2012)", "doi": "10.4161/cib.19792"}, {"pmid": "22928510", "authors": "  Spadaro D, Tapia R, Pulimeno P, Citi S", "title": "The control of gene expression and cell proliferation by the epithelial apical junctional complex.", "journal": "Essays Biochem 53:83-93 (2012)", "doi": "10.1042/bse0530083"}, {"pmid": "24548561", "authors": "  Moleirinho S, Guerrant W, Kissil JL", "title": "The Angiomotins--from discovery to function.", "journal": "FEBS Lett 588:2693-703 (2014)", "doi": "10.1016/j.febslet.2014.02.006"}, {"pmid": "24651541", "authors": "  Rodriguez-Boulan E, Macara IG", "title": "Organization and execution of the epithelial polarity programme.", "journal": "Nat Rev Mol Cell Biol 15:225-42 (2014)", "doi": "10.1038/nrm3775"}, {"pmid": "25152334", "authors": "  Gonzalez-Mariscal L, Dominguez-Calderon A, Raya-Sandino A, Ortega-Olvera JM, Vargas-Sierra O, Martinez-Revollar G", "title": "Tight junctions and the regulation of gene expression.", "journal": "Semin Cell Dev Biol 36:213-23 (2014)", "doi": "10.1016/j.semcdb.2014.08.009"}, {"pmid": "25469537", "authors": "  Mack NA, Georgiou M", "title": "The interdependence of the Rho GTPases and apicobasal cell polarity.", "journal": "Small GTPases 5:10 (2014)", "doi": "10.4161/21541248.2014.973768"}, {"pmid": "25483301", "authors": "  Citi S, Guerrera D, Spadaro D, Shah J", "title": "Epithelial junctions and Rho family GTPases: the zonular signalosome.", "journal": "Small GTPases 5:1-15 (2014)", "doi": "10.4161/21541248.2014.973760"}, {"pmid": "25757376", "authors": "  Zihni C, Terry SJ", "title": "RhoGTPase signalling at epithelial tight junctions: Bridging the GAP between polarity and cancer.", "journal": "Int J Biochem Cell Biol 64:120-5 (2015)", "doi": "10.1016/j.biocel.2015.02.020"}, {"pmid": "22892070", "authors": "  Nakano A, Takashima S", "title": "LKB1 and AMP-activated protein kinase: regulators of cell polarity.", "journal": "Genes Cells 17:737-47 (2012)", "doi": "10.1111/j.1365-2443.2012.01629.x"}, {"pmid": "12042308", "authors": "  Patrie KM, Drescher AJ, Welihinda A, Mundel P, Margolis B", "title": "Interaction of two actin-binding proteins, synaptopodin and alpha-actinin-4, with the tight junction protein MAGI-1.", "journal": "J Biol Chem 277:30183-90 (2002)", "doi": "10.1074/jbc.M203072200"}, {"pmid": "18094055", "authors": "  Yamamura R, Nishimura N, Nakatsuji H, Arase S, Sasaki T", "title": "The interaction of JRAB/MICAL-L2 with Rab8 and Rab13 coordinates the assembly of tight junctions and adherens junctions.", "journal": "Mol Biol Cell 19:971-83 (2008)", "doi": "10.1091/mbc.E07-06-0551"}], "rel_pathway": ["hsa04520  Adherens junction", "hsa04810  Regulation of actin cytoskeleton"], "ko_pathway": "ko04530", "genes": ["RAC1", "EZR"]}, {"kegg_id": "hsa04613", "name": "Neutrophil extracellular trap formation - Homo sapiens (human)", "description": "Neutrophils play a central role in innate immune defense. One of the mechanisms of neutrophil action is the formation of neutrophil extracellular traps (NETs), the extracellular structures composed of chromatin coated with histones, proteases and granular and cytosolic proteins that help catch and kill microorganisms. NETs are formed by a process known as \"NETosis\" that can be triggered by microorganisms and endogenous stimuli, such as damage-associated molecular patterns and immune complexes, and involves activation in most cases of nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase, which produces reactive oxygen species (ROS). Recent study has reported that there are two different mechanisms of NETosis, including a lytic NETosis and a vital NETosis. Lytic NETosis begins with nuclear delobulation and the disassembly of the nuclear envelope and continues with loss of cellular polarization, chromatin decondensation and plasma membrane rupture. Vital NETosis can occur independently of cell death and involves the secreted expulsion of nuclear chromatin that is accompanied by the release of granule proteins through degranulation.", "class": "Organismal Systems; Immune system", "pathway_map": "hsa04613  Neutrophil extracellular trap formation", "drug": ["D01666  Bropirimine (JAN/USAN/INN)", "D02500  Imiquimod (JAN/USP/INN)", "D04619  Isatoribine (USAN)", "D04787  Loxoribine (USAN/INN)", "D09892  Egaptivon pegol (USAN)", "D11003  Vesatolimod (USAN/INN)", "D11480  Crizanlizumab (USAN/INN)", "D11871  Selgantolimod (USAN/INN)", "D12261  Enpatoran (USAN/INN)", "D12356  Zilucoplan sodium (JAN)", "D12357  Zilucoplan (USAN/INN)", "D12453  Guretolimod (USAN/INN)", "D12521  Ruzotolimod (USAN/INN)", "D12551  Bocodepsin (USAN)", "D12552  Bocodepsin besylate (USAN)", "D12624  Paridiprubart (USAN/INN)", "D12647  Mitiperstat (USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["2214  FCGR3A; Fc gamma receptor IIIa [KO:K06463]", "2215  FCGR3B; Fc gamma receptor IIIb [KO:K06463]", "6850  SYK; spleen associated tyrosine kinase [KO:K05855] [EC:2.7.10.2]", "6885  MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO:K04427] [EC:2.7.11.25]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "27180  SIGLEC9; sialic acid binding Ig like lectin 9 [KO:K06740]", "1536  CYBB; cytochrome b-245 beta chain [KO:K21421] [EC:1.-.-.-]", "653361  NCF1; neutrophil cytosolic factor 1 [KO:K08011]", "1535  CYBA; cytochrome b-245 alpha chain [KO:K08009]", "4688  NCF2; neutrophil cytosolic factor 2 [KO:K08010]", "4689  NCF4; neutrophil cytosolic factor 4 [KO:K08012]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "5880  RAC2; Rac family small GTPase 2 [KO:K07860]", "51284  TLR7; toll like receptor 7 [KO:K05404]", "51311  TLR8; toll like receptor 8 [KO:K10170]", "1991  ELANE; elastase, neutrophil expressed [KO:K01327] [EC:3.4.21.37]", "4353  MPO; myeloperoxidase [KO:K10789] [EC:1.11.2.2]", "71  ACTG1; actin gamma 1 [KO:K05692]", "60  ACTB; actin beta [KO:K05692]", "7416  VDAC1; voltage dependent anion channel 1 [KO:K05862]", "7417  VDAC2; voltage dependent anion channel 2 [KO:K15040]", "7419  VDAC3; voltage dependent anion channel 3 [KO:K15041]", "291  SLC25A4; solute carrier family 25 member 4 [KO:K05863]", "292  SLC25A5; solute carrier family 25 member 5 [KO:K05863]", "293  SLC25A6; solute carrier family 25 member 6 [KO:K05863]", "83447  SLC25A31; solute carrier family 25 member 31 [KO:K05863]", "10105  PPIF; peptidylprolyl isomerase F [KO:K09565] [EC:5.2.1.8]", "23569  PADI4; peptidyl arginine deiminase 4 [KO:K24669] [EC:3.5.3.15]", "102723407  IGH; immunoglobulin heavy variable 4-38-2-like [KO:K06856]", "2209  FCGR1A; Fc gamma receptor Ia [KO:K06498]", "2212  FCGR2A; Fc gamma receptor IIa [KO:K06472]", "3684  ITGAM; integrin subunit alpha M [KO:K06461]", "3689  ITGB2; integrin subunit beta 2 [KO:K06464]", "3683  ITGAL; integrin subunit alpha L [KO:K05718]", "64581  CLEC7A; C-type lectin domain containing 7A [KO:K10074]", "6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "10533  ATG7; autophagy related 7 [KO:K08337]", "2357  FPR1; formyl peptide receptor 1 [KO:K04172]", "2359  FPR3; formyl peptide receptor 3 [KO:K04173]", "2358  FPR2; formyl peptide receptor 2 [KO:K04173]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "718  C3; complement C3 [KO:K03990]", "1378  CR1; complement C3b/C4b receptor 1 (Knops blood group) [KO:K04011]", "1379  CR1L; complement C3b/C4b receptor 1 like [KO:K04011]", "727  C5; complement C5 [KO:K03994]", "728  C5AR1; complement C5a receptor 1 [KO:K04010]", "3146  HMGB1; high mobility group box 1 [KO:K10802]", "7097  TLR2; toll like receptor 2 [KO:K10159]", "7099  TLR4; toll like receptor 4 [KO:K10160]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "3674  ITGA2B; integrin subunit alpha 2b [KO:K06476]", "3690  ITGB3; integrin subunit beta 3 [KO:K06493]", "2243  FGA; fibrinogen alpha chain [KO:K03903]", "2244  FGB; fibrinogen beta chain [KO:K03904]", "2266  FGG; fibrinogen gamma chain [KO:K03905]", "2811  GP1BA; glycoprotein Ib platelet subunit alpha [KO:K06261]", "7450  VWF; von Willebrand factor [KO:K03900]", "6403  SELP; selectin P [KO:K06496]", "6404  SELPLG; selectin P ligand [KO:K06544]", "177  AGER; advanced glycosylation end-product specific receptor [KO:K19722]", "837  CASP4; caspase 4 [KO:K04394] [EC:3.4.22.57 3.4.22.64]", "834  CASP1; caspase 1 [KO:K01370] [EC:3.4.22.36]", "79792  GSDMD; gasdermin D [KO:K20917]", "8520  HAT1; histone acetyltransferase 1 [KO:K11303] [EC:2.3.1.48]", "3014  H2AX; H2A.X variant histone [KO:K11251]", "8338  H2AC20; H2A clustered histone 20 [KO:K11251]", "85235  H2AC12; H2A clustered histone 12 [KO:K11251]", "221613  H2AC1; H2A clustered histone 1 [KO:K11251]", "92815  H2AC25; H2A clustered histone 25 [KO:K11251]", "83740  H2AB3; H2A.B variant histone 3 [KO:K11251]", "3012  H2AC8; H2A clustered histone 8 [KO:K11251]", "8335  H2AC4; H2A clustered histone 4 [KO:K11251]", "55506  MACROH2A2; macroH2A.2 histone [KO:K11251]", "9555  MACROH2A1; macroH2A.1 histone [KO:K11251]", "723790  H2AC19; H2A clustered histone 19 [KO:K11251]", "55766  H2AJ; H2A.J histone [KO:K11251]", "474382  H2AB1; H2A.B variant histone 1 [KO:K11251]", "8336  H2AC17; H2A clustered histone 17 [KO:K11251]", "8337  H2AC18; H2A clustered histone 18 [KO:K11251]", "8969  H2AC11; H2A clustered histone 11 [KO:K11251]", "317772  H2AC21; H2A clustered histone 21 [KO:K11251]", "94239  H2AZ2; H2A.Z variant histone 2 [KO:K11251]", "3013  H2AC7; H2A clustered histone 7 [KO:K11251]", "3015  H2AZ1; H2A.Z variant histone 1 [KO:K11251]", "8330  H2AC15; H2A clustered histone 15 [KO:K11251]", "8334  H2AC6; H2A clustered histone 6 [KO:K11251]", "8329  H2AC13; H2A clustered histone 13 [KO:K11251]", "8331  H2AC14; H2A clustered histone 14 [KO:K11251]", "8332  H2AC16; H2A clustered histone 16 [KO:K11251]", "474381  H2AB2; H2A.B variant histone 2 [KO:K11251]", "115482686  H2AL3; H2A.L variant histone 3 [KO:K11251]", "8341  H2BC15; H2B clustered histone 15 [KO:K11252]", "8345  H2BC9; H2B clustered histone 9 [KO:K11252]", "8342  H2BC14; H2B clustered histone 14 [KO:K11252]", "158983  H2BW1; H2B.W histone 1 [KO:K11252]", "255626  H2BC1; H2B clustered histone 1 [KO:K11252]", "440689  H2BC18; H2B clustered histone 18 [KO:K11252]", "8348  H2BC17; H2B clustered histone 17 [KO:K11252]", "3018  H2BC3; H2B clustered histone 3 [KO:K11252]", "8339  H2BC8; H2B clustered histone 8 [KO:K11252]", "8340  H2BC13; H2B clustered histone 13 [KO:K11252]", "8347  H2BC4; H2B clustered histone 4 [KO:K11252]", "3017  H2BC5; H2B clustered histone 5 [KO:K11252]", "8344  H2BC6; H2B clustered histone 6 [KO:K11252]", "8346  H2BC10; H2B clustered histone 10 [KO:K11252]", "8349  H2BC21; H2B clustered histone 21 [KO:K11252]", "8970  H2BC11; H2B clustered histone 11 [KO:K11252]", "85236  H2BC12; H2B clustered histone 12 [KO:K11252]", "128312  H2BC26; H2B clustered histone 26 [KO:K11252]", "8343  H2BC7; H2B clustered histone 7 [KO:K11252]", "286436  H2BW2; H2B.W histone 2 [KO:K11252]", "102724334  histone H2B type F-S-like [KO:K11252]", "114483833  H2BK1; H2B.K variant histone 1 [KO:K11252]", "54145  H2BC12L; H2B clustered histone 12 like [KO:K11252]", "121504  H4C16; H4 histone 16 [KO:K11254]", "554313  H4C15; H4 clustered histone 15 [KO:K11254]", "8294  H4C9; H4 clustered histone 9 [KO:K11254]", "8360  H4C4; H4 clustered histone 4 [KO:K11254]", "8361  H4C6; H4 clustered histone 6 [KO:K11254]", "8362  H4C12; H4 clustered histone 12 [KO:K11254]", "8363  H4C11; H4 clustered histone 11 [KO:K11254]", "8364  H4C3; H4 clustered histone 3 [KO:K11254]", "8365  H4C8; H4 clustered histone 8 [KO:K11254]", "8366  H4C2; H4 clustered histone 2 [KO:K11254]", "8367  H4C5; H4 clustered histone 5 [KO:K11254]", "8368  H4C13; H4 clustered histone 13 [KO:K11254]", "8370  H4C14; H4 clustered histone 14 [KO:K11254]", "8359  H4C1; H4 clustered histone 1 [KO:K11254]", "8369  H4C7; H4 clustered histone 7 [KO:K11254]", "440093  H3-5; H3.5 histone [KO:K11253]", "3021  H3-3B; H3.3 histone B [KO:K11253]", "8351  H3C4; H3 clustered histone 4 [KO:K11253]", "8352  H3C3; H3 clustered histone 3 [KO:K11253]", "8350  H3C1; H3 clustered histone 1 [KO:K11253]", "3020  H3-3A; H3.3 histone A [KO:K11253]", "8290  H3-4; H3.4 histone, cluster member [KO:K11253]", "126961  H3C14; H3 clustered histone 14 [KO:K11253]", "333932  H3C15; H3 clustered histone 15 [KO:K11253]", "653604  H3C13; H3 clustered histone 13 [KO:K11253]", "8353  H3C6; H3 clustered histone 6 [KO:K11253]", "8354  H3C11; H3 clustered histone 11 [KO:K11253]", "8355  H3C8; H3 clustered histone 8 [KO:K11253]", "8356  H3C12; H3 clustered histone 12 [KO:K11253]", "8357  H3C10; H3 clustered histone 10 [KO:K11253]", "8358  H3C2; H3 clustered histone 2 [KO:K11253]", "8968  H3C7; H3 clustered histone 7 [KO:K11253]", "3065  HDAC1; histone deacetylase 1 [KO:K06067] [EC:3.5.1.98]", "3066  HDAC2; histone deacetylase 2 [KO:K06067] [EC:3.5.1.98]", "8841  HDAC3; histone deacetylase 3 [KO:K11404] [EC:3.5.1.98]", "9759  HDAC4; histone deacetylase 4 [KO:K11406] [EC:3.5.1.98]", "10014  HDAC5; histone deacetylase 5 [KO:K11406] [EC:3.5.1.98]", "10013  HDAC6; histone deacetylase 6 [KO:K11407] [EC:3.5.1.98]", "51564  HDAC7; histone deacetylase 7 [KO:K11408] [EC:3.5.1.98]", "55869  HDAC8; histone deacetylase 8 [KO:K11405] [EC:3.5.1.98]", "9734  HDAC9; histone deacetylase 9 [KO:K11409] [EC:3.5.1.98]", "83933  HDAC10; histone deacetylase 10 [KO:K18671] [EC:3.5.1.98]", "79885  HDAC11; histone deacetylase 11 [KO:K11418] [EC:3.5.1.98]", "566  AZU1; azurocidin 1 [KO:K24665]", "1511  CTSG; cathepsin G [KO:K01319] [EC:3.4.21.20]", "820  CAMP; cathelicidin antimicrobial peptide [KO:K13916]", "1182  CLCN3; chloride voltage-gated channel 3 [KO:K05012]", "1183  CLCN4; chloride voltage-gated channel 4 [KO:K05012]", "1184  CLCN5; chloride voltage-gated channel 5 [KO:K05012]", "366  AQP9; aquaporin 9 [KO:K09877]"], "compound": ["C00027  Hydrogen peroxide", "C00039  DNA", "C00076  Calcium cation", "C00165  Diacylglycerol", "C00338  Lipopolysaccharide", "C00464  Mannan", "C00518  Hyaluronate", "C00551  beta-D-Glucan", "C00704  Superoxide", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C05151  12-O-Tetradecanoylphorbol 13-acetate", "C05981  Phosphatidylinositol-3,4,5-trisphosphate", "C11221  Formylmethionyl-leucyl-phenylalanine methyl ester"], "refs": [{"pmid": "29543328", "authors": "  Van Avondt K, Hartl D", "title": "Mechanisms and disease relevance of neutrophil extracellular trap formation.", "journal": "Eur J Clin Invest 48 Suppl 2:e12919 (2018)", "doi": "10.1111/eci.12919"}, {"pmid": "31518165", "authors": "  Sorvillo N, Cherpokova D, Martinod K, Wagner DD", "title": "Extracellular DNA NET-Works With Dire Consequences for Health.", "journal": "Circ Res 125:470-488 (2019)", "doi": "10.1161/CIRCRESAHA.119.314581"}, {"pmid": "28990587", "authors": "  Papayannopoulos V", "title": "Neutrophil extracellular traps in immunity and disease.", "journal": "Nat Rev Immunol 18:134-147 (2018)", "doi": "10.1038/nri.2017.105"}, {"pmid": "24837201", "authors": "  Liu FC, Chuang YH, Tsai YF, Yu HP", "title": "Role of neutrophil extracellular traps following injury.", "journal": "Shock 41:491-8 (2014)", "doi": "10.1097/SHK.0000000000000146"}, {"pmid": "27570525", "authors": "  Yang H, Biermann MH, Brauner JM, Liu Y, Zhao Y, Herrmann M", "title": "New Insights into Neutrophil Extracellular Traps: Mechanisms of Formation and Role in Inflammation.", "journal": "Front Immunol 7:302 (2016)", "doi": "10.3389/fimmu.2016.00302"}, {"pmid": "28983472", "authors": "  Zawrotniak M, Bochenska O, Karkowska-Kuleta J, Seweryn-Ozog K, Aoki W, Ueda M, Kozik A, Rapala-Kozik M", "title": "Aspartic Proteases and Major Cell Wall Components in Candida albicans Trigger the Release of Neutrophil Extracellular Traps.", "journal": "Front Cell Infect Microbiol 7:414 (2017)", "doi": "10.3389/fcimb.2017.00414"}, {"pmid": "29382950", "authors": "  Honda M, Kubes P", "title": "Neutrophils and neutrophil extracellular traps in the liver and gastrointestinal system.", "journal": "Nat Rev Gastroenterol Hepatol 15:206-221 (2018)", "doi": "10.1038/nrgastro.2017.183"}, {"pmid": "31416265", "authors": "  Hamam HJ, Palaniyar N", "title": "Post-Translational Modifications in NETosis and NETs-Mediated Diseases.", "journal": "Biomolecules 9:E369 (2019)", "doi": "10.3390/biom9080369"}, {"pmid": "31767647", "authors": "  Burgener SS, Schroder K", "title": "Neutrophil Extracellular Traps in Host Defense.", "journal": "Cold Spring Harb Perspect Biol 12:a037028 (2020)", "doi": "10.1101/cshperspect.a037028"}, {"pmid": "33202203", "authors": "  Vorobjeva NV, Chernyak BV", "title": "NETosis: Molecular Mechanisms, Role in Physiology and Pathology.", "journal": "Biochemistry (Mosc) 85:1178-1190 (2020)", "doi": "10.1134/S0006297920100065"}, {"pmid": "31416173", "authors": "  Ravindran M, Khan MA, Palaniyar N", "title": "Neutrophil Extracellular Trap Formation: Physiology, Pathology, and Pharmacology.", "journal": "Biomolecules 9:E365 (2019)", "doi": "10.3390/biom9080365"}, {"pmid": "28267716", "authors": "  Jorch SK, Kubes P", "title": "An emerging role for neutrophil extracellular traps in noninfectious disease.", "journal": "Nat Med 23:279-287 (2017)", "doi": "10.1038/nm.4294"}, {"pmid": "31342866", "authors": "  Goggs R, Jeffery U, LeVine DN, Li RHL", "title": "Neutrophil-Extracellular Traps, Cell-Free DNA, and Immunothrombosis in Companion Animals: A Review.", "journal": "Vet Pathol 57:6-23 (2020)", "doi": "10.1177/0300985819861721"}, {"pmid": "27876233", "authors": "  Kim SJ, Jenne CN", "title": "Role of platelets in neutrophil extracellular trap (NET) production and tissue injury.", "journal": "Semin Immunol 28:546-554 (2016)", "doi": "10.1016/j.smim.2016.10.013"}, {"pmid": "29572545", "authors": "  de Bont CM, Boelens WC, Pruijn GJM", "title": "NETosis, complement, and coagulation: a triangular relationship.", "journal": "Cell Mol Immunol 16:19-27 (2019)", "doi": "10.1038/s41423-018-0024-0"}, {"pmid": "31129510", "authors": "  Zawrotniak M, Bartnicka D, Rapala-Kozik M", "title": "UVA and UVB radiation induce the formation of neutrophil extracellular traps by human polymorphonuclear cells.", "journal": "J Photochem Photobiol B 196:111511 (2019)", "doi": "10.1016/j.jphotobiol.2019.111511"}, {"pmid": "21293492", "authors": "  Remijsen Q, Kuijpers TW, Wirawan E, Lippens S, Vandenabeele P, Vanden Berghe T", "title": "Dying for a cause: NETosis, mechanisms behind an antimicrobial cell death modality.", "journal": "Cell Death Differ 18:581-8 (2011)", "doi": "10.1038/cdd.2011.1"}, {"pmid": "28373871", "authors": "  Rosales C", "title": "Fcgamma Receptor Heterogeneity in Leukocyte Functional Responses.", "journal": "Front Immunol 8:280 (2017)", "doi": "10.3389/fimmu.2017.00280"}, {"pmid": "25716722", "authors": "  Vorobjeva NV, Pinegin BV", "title": "Neutrophil extracellular traps: mechanisms of formation and role in health and disease.", "journal": "Biochemistry (Mosc) 79:1286-96 (2014)", "doi": "10.1134/S0006297914120025"}, {"pmid": "28220120", "authors": "  Delgado-Rizo V, Martinez-Guzman MA, Iniguez-Gutierrez L, Garcia-Orozco A, Alvarado-Navarro A, Fafutis-Morris M", "title": "Neutrophil Extracellular Traps and Its Implications in Inflammation: An Overview.", "journal": "Front Immunol 8:81 (2017)", "doi": "10.3389/fimmu.2017.00081"}, {"pmid": "30023352", "authors": "  Fonseca Z, Diaz-Godinez C, Mora N, Aleman OR, Uribe-Querol E, Carrero JC, Rosales C", "title": "Entamoeba histolytica Induce Signaling via Raf/MEK/ERK for Neutrophil Extracellular Trap (NET) Formation.", "journal": "Front Cell Infect Microbiol 8:226 (2018)", "doi": "10.3389/fcimb.2018.00226"}, {"pmid": "27923601", "authors": "  Agraz-Cibrian JM, Giraldo DM, Mary FM, Urcuqui-Inchima S", "title": "Understanding the molecular mechanisms of NETs and their role in antiviral innate immunity.", "journal": "Virus Res 228:124-133 (2017)", "doi": "10.1016/j.virusres.2016.11.033"}, {"pmid": "27698656", "authors": "  Schonrich G, Raftery MJ", "title": "Neutrophil Extracellular Traps Go Viral.", "journal": "Front Immunol 7:366 (2016)", "doi": "10.3389/fimmu.2016.00366"}, {"pmid": "22817992", "authors": "  Saitoh T, Komano J, Saitoh Y, Misawa T, Takahama M, Kozaki T, Uehata T, Iwasaki H, Omori H, Yamaoka S, Yamamoto N, Akira S", "title": "Neutrophil extracellular traps mediate a host defense response to human immunodeficiency virus-1.", "journal": "Cell Host Microbe 12:109-16 (2012)", "doi": "10.1016/j.chom.2012.05.015"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04140  Autophagy - animal", "hsa04151  PI3K-Akt signaling pathway", "hsa04610  Complement and coagulation cascades", "hsa04611  Platelet activation", "hsa04620  Toll-like receptor signaling pathway", "hsa04621  NOD-like receptor signaling pathway", "hsa04666  Fc gamma R-mediated phagocytosis"], "ko_pathway": "ko04613", "genes": ["RAC1", "AKT2", "AKT1", "MAPK13"]}, {"kegg_id": "hsa04620", "name": "Toll-like receptor signaling pathway - Homo sapiens (human)", "description": "Specific families of pattern recognition receptors are responsible for detecting microbial pathogens and generating innate immune responses. Toll-like receptors (TLRs) are membrane-bound receptors identified as homologs of Toll in Drosophila. Mammalian TLRs are expressed on innate immune cells, such as macrophages and dendritic cells, and respond to the membrane components of Gram-positive or Gram-negative bacteria. Pathogen recognition by TLRs provokes rapid activation of innate immunity by inducing production of proinflammatory cytokines and upregulation of costimulatory molecules. TLR signaling pathways are separated into two groups: a MyD88-dependent pathway that leads to the production of proinflammatory cytokines with quick activation of NF-{kappa}B and MAPK, and a MyD88-independent pathway associated with the induction of IFN-beta and IFN-inducible genes, and maturation of dendritic cells with slow activation of NF-{kappa}B and MAPK.", "class": "Organismal Systems; Immune system", "pathway_map": "hsa04620  Toll-like receptor signaling pathway", "network": ["", "ELEMENT   N00148  TLR3-IRF7 signaling pathway", "N00149  TLR3-IRF3 signaling pathway", "N00150  Type I IFN signaling pathway", "N00435  TLR1/2/4-NFKB signaling pathway", "N00438  TLR2/4-MAPK signaling pathway", "N00553  TLR4-IRF3/7 signaling pathway", "N00563  TLR3-NFKB signaling pathway", "N00690  TLR7/9-IRF7 signaling pathway", "N01543  TLR7/8/9-IRF5 signaling pathway", "N01566  TLR5-NFKB signaling pathway"], "drug": ["D00745  Interferon alfa-2a (USAN/INN)", "D00746  Interferon beta-1b (USAN/INN)", "D01666  Bropirimine (JAN/USAN/INN)", "D02500  Imiquimod (JAN/USP/INN)", "D02744  Interferon alfacon-1 (USAN/INN)", "D02745  Interferon alfa-2b (USAN)", "D02747  Peginterferon alfa-2a (USAN/INN)", "D02748  Peginterferon alfa-2b (USAN/INN)", "D03304  Interferon beta (JAN)", "D03305  Interferon alfa (NAMALWA) (JP18)", "D03441  Certolizumab pegol (USAN/INN)", "D04043  Eritoran tetrasodium (USAN)", "D04295  Galiximab (USAN/INN)", "D04552  Interferon alfa-n1 (USAN)", "D04553  Interferon alfa-n3 (USAN)", "D04554  Interferon beta-1a (USAN)", "D04619  Isatoribine (USAN)", "D04787  Loxoribine (USAN/INN)", "D06071  Teneliximab (USAN/INN)", "D06619  Mifamurtide (USAN)", "D06634  Relacatib (USAN/INN)", "D06635  Rilonacept (USAN/INN)", "D08841  Agatolimod (USAN)", "D08842  Agatolimod sodium (USAN)", "D08844  Albinterferon alfa-2b (USAN)", "D08955  Odanacatib (JAN/USAN)", "D09573  Eritoran sodium (JAN)", "D09639  Losmapimod (USAN/INN)", "D09661  Rintatolimod (USAN/INN)", "D10483  Peginterferon beta-1a (USAN/INN)", "D11003  Vesatolimod (USAN/INN)", "D11027  Ropeginterferon alfa-2b (INN)", "D11357  Bleselumab (USAN/INN)", "D11491  Selicrelumab (USAN/INN)", "D11503  Tomaralimab (USAN)", "D11504  Tilsotolimod (USAN/INN)", "D11505  Tilsotolimod sodium (USAN)", "D11597  Ravagalimab (USAN/INN)", "D11610  Iscalimab (USAN/INN)", "D11668  Mosedipimod (USAN/INN)", "D11871  Selgantolimod (USAN/INN)", "D12167  Zimlovisertib (USAN)", "D12178  Sotigalimab (USAN)", "D12261  Enpatoran (USAN/INN)", "D12275  Cobitolimod (USAN/INN)", "D12276  Cobitolimod sodium (USAN)", "D12352  Eclitasertib (USAN/INN)", "D12411  Emavusertib (USAN/INN)", "D12412  Emavusertib hydrochloride (USAN)", "D12453  Guretolimod (USAN/INN)", "D12463  Davoceticept (USAN/INN)", "D12464  Dazukibart (USAN)", "D12521  Ruzotolimod (USAN/INN)", "D12532  Emavusertib mesylate (USAN)", "D12533  Emavusertib maleate (USAN)", "D12538  Emavusertib phosphate (USAN)", "D12539  emavusertib tosylate (USAN)", "D12624  Paridiprubart (USAN/INN)", "D12725  Lomedeucitinib (USAN)", "D12821  Flizasertib (USAN/INN)", "D12846  Ocadusertib (USAN)", "D12855  Nelitolimod (USAN)", "D12856  Nelitolimod sodium (USAN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["7096  TLR1; toll like receptor 1 [KO:K05398]", "7097  TLR2; toll like receptor 2 [KO:K10159]", "10333  TLR6; toll like receptor 6 [KO:K10169]", "3929  LBP; lipopolysaccharide binding protein [KO:K05399]", "929  CD14; CD14 molecule [KO:K04391]", "23643  LY96; lymphocyte antigen 96 [KO:K05400]", "7098  TLR3; toll like receptor 3 [KO:K05401]", "7099  TLR4; toll like receptor 4 [KO:K10160]", "7100  TLR5; toll like receptor 5 [KO:K10168]", "51284  TLR7; toll like receptor 7 [KO:K05404]", "51311  TLR8; toll like receptor 8 [KO:K10170]", "1513  CTSK; cathepsin K [KO:K01371] [EC:3.4.22.38]", "54106  TLR9; toll like receptor 9 [KO:K10161]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "54472  TOLLIP; toll interacting protein [KO:K05402]", "4615  MYD88; MYD88 innate immune signal transduction adaptor [KO:K04729]", "114609  TIRAP; TIR domain containing adaptor protein [KO:K05403]", "8772  FADD; Fas associated via death domain [KO:K02373]", "841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]", "51135  IRAK4; interleukin 1 receptor associated kinase 4 [KO:K04733] [EC:2.7.11.1]", "3654  IRAK1; interleukin 1 receptor associated kinase 1 [KO:K04730] [EC:2.7.11.1]", "7189  TRAF6; TNF receptor associated factor 6 [KO:K03175] [EC:2.3.2.27]", "10454  TAB1; TGF-beta activated kinase 1 (MAP3K7) binding protein 1 [KO:K04403]", "23118  TAB2; TGF-beta activated kinase 1 (MAP3K7) binding protein 2 [KO:K04404]", "6885  MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO:K04427] [EC:2.7.11.25]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "1326  MAP3K8; mitogen-activated protein kinase kinase kinase 8 [KO:K04415] [EC:2.7.11.25]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "5606  MAP2K3; mitogen-activated protein kinase kinase 3 [KO:K04432] [EC:2.7.12.2]", "5608  MAP2K6; mitogen-activated protein kinase kinase 6 [KO:K04433] [EC:2.7.12.2]", "6416  MAP2K4; mitogen-activated protein kinase kinase 4 [KO:K04430] [EC:2.7.12.2]", "5609  MAP2K7; mitogen-activated protein kinase kinase 7 [KO:K04431] [EC:2.7.12.2]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "7124  TNF; tumor necrosis factor [KO:K03156]", "3553  IL1B; interleukin 1 beta [KO:K04519]", "3569  IL6; interleukin 6 [KO:K05405]", "3592  IL12A; interleukin 12A [KO:K05406]", "3593  IL12B; interleukin 12B [KO:K05425]", "3576  CXCL8; C-X-C motif chemokine ligand 8 [KO:K10030]", "6352  CCL5; C-C motif chemokine ligand 5 [KO:K12499]", "6348  CCL3; C-C motif chemokine ligand 3 [KO:K05408]", "6349  CCL3L1; C-C motif chemokine ligand 3 like 1 [KO:K05408]", "414062  CCL3L3; C-C motif chemokine ligand 3 like 3 [KO:K05408]", "6351  CCL4; C-C motif chemokine ligand 4 [KO:K12964]", "9560  CCL4L2; C-C motif chemokine ligand 4 like 2 [KO:K12964]", "388372  CCL4L1; C-C motif chemokine ligand 4 like 1 [KO:K12964]", "353376  TICAM2; TIR domain containing adaptor molecule 2 [KO:K05409]", "148022  TICAM1; TIR domain containing adaptor molecule 1 [KO:K05842]", "8737  RIPK1; receptor interacting serine/threonine kinase 1 [KO:K02861] [EC:2.7.11.1]", "3663  IRF5; interferon regulatory factor 5 [KO:K09446]", "3665  IRF7; interferon regulatory factor 7 [KO:K09447]", "6696  SPP1; secreted phosphoprotein 1 [KO:K06250]", "9641  IKBKE; inhibitor of nuclear factor kappa B kinase subunit epsilon [KO:K07211] [EC:2.7.11.10]", "29110  TBK1; TANK binding kinase 1 [KO:K05410] [EC:2.7.11.10]", "7187  TRAF3; TNF receptor associated factor 3 [KO:K03174]", "3661  IRF3; interferon regulatory factor 3 [KO:K05411]", "958  CD40; CD40 molecule [KO:K03160]", "941  CD80; CD80 molecule [KO:K05412]", "942  CD86; CD86 molecule [KO:K05413]", "3439  IFNA1; interferon alpha 1 [KO:K05414]", "3440  IFNA2; interferon alpha 2 [KO:K05414]", "3441  IFNA4; interferon alpha 4 [KO:K05414]", "3442  IFNA5; interferon alpha 5 [KO:K05414]", "3443  IFNA6; interferon alpha 6 [KO:K05414]", "3444  IFNA7; interferon alpha 7 [KO:K05414]", "3445  IFNA8; interferon alpha 8 [KO:K05414]", "3446  IFNA10; interferon alpha 10 [KO:K05414]", "3447  IFNA13; interferon alpha 13 [KO:K05414]", "3448  IFNA14; interferon alpha 14 [KO:K05414]", "3449  IFNA16; interferon alpha 16 [KO:K05414]", "3451  IFNA17; interferon alpha 17 [KO:K05414]", "3452  IFNA21; interferon alpha 21 [KO:K05414]", "3456  IFNB1; interferon beta 1 [KO:K05415]", "3454  IFNAR1; interferon alpha and beta receptor subunit 1 [KO:K05130]", "3455  IFNAR2; interferon alpha and beta receptor subunit 2 [KO:K05131]", "3716  JAK1; Janus kinase 1 [KO:K11217] [EC:2.7.10.2]", "7297  TYK2; tyrosine kinase 2 [KO:K11219] [EC:2.7.10.2]", "6772  STAT1; signal transducer and activator of transcription 1 [KO:K11220]", "6773  STAT2; signal transducer and activator of transcription 2 [KO:K11221]", "10379  IRF9; interferon regulatory factor 9 [KO:K04693]", "3627  CXCL10; C-X-C motif chemokine ligand 10 [KO:K12671]", "4283  CXCL9; C-X-C motif chemokine ligand 9 [KO:K05416]", "6373  CXCL11; C-X-C motif chemokine ligand 11 [KO:K12672]"], "refs": [{"pmid": "17275323", "authors": "  Kawai T, Akira S.", "title": "TLR signaling.", "journal": "Semin Immunol 19:24-32 (2007)", "doi": "10.1016/j.smim.2006.12.004"}, {"pmid": "17457343", "authors": "  O'Neill LA, Bowie AG.", "title": "The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling.", "journal": "Nat Rev Immunol 7:353-64 (2007)", "doi": "10.1038/nri2079"}, {"pmid": "16932750", "authors": "  Honda K, Taniguchi T.", "title": "IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors.", "journal": "Nat Rev Immunol 6:644-58 (2006)", "doi": "10.1038/nri1900"}, {"pmid": "17395581", "authors": "  Uematsu S, Akira S.", "title": "Toll-like receptors and Type I interferons.", "journal": "J Biol Chem 282:15319-23 (2007)", "doi": "10.1074/jbc.R700009200"}, {"pmid": "16497588", "authors": "  Akira S, Uematsu S, Takeuchi O.", "title": "Pathogen recognition and innate immunity.", "journal": "Cell 124:783-801 (2006)", "doi": "10.1016/j.cell.2006.02.015"}, {"pmid": "14698224", "authors": "  Yamamoto M, Takeda K, Akira S.", "title": "TIR domain-containing adaptors define the specificity of TLR signaling.", "journal": "Mol Immunol 40:861-8 (2004)", "doi": "10.1016/j.molimm.2003.10.006"}, {"pmid": "12734364", "authors": "  Means TK, Hayashi F, Smith KD, Aderem A, Luster AD.", "title": "The Toll-like receptor 5 stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells.", "journal": "J Immunol 170:5165-75 (2003)", "doi": "10.4049/jimmunol.170.10.5165"}, {"pmid": "14751764", "authors": "  Aderem A, Smith KD.", "title": "A systems approach to dissecting immunity and inflammation.", "journal": "Semin Immunol 16:55-67 (2004)", "doi": "10.1016/j.smim.2003.10.002"}, {"pmid": "17637696", "authors": "  Banerjee A, Gerondakis S.", "title": "Coordinating TLR-activated signaling pathways in cells of the immune system.", "journal": "Immunol Cell Biol 85:420-4 (2007)", "doi": "10.1038/sj.icb.7100098"}, {"pmid": "17507094", "authors": "  Loniewski KJ, Patial S, Parameswaran N.", "title": "Sensitivity of TLR4- and -7-induced NF kappa B1 p105-TPL2-ERK pathway to TNF-receptor-associated-factor-6 revealed by RNAi in mouse macrophages.", "journal": "Mol Immunol 44:3715-23 (2007)", "doi": "10.1016/j.molimm.2007.04.002"}, {"pmid": "11101877", "authors": "  Arbibe L, Mira JP, Teusch N, Kline L, Guha M, Mackman N, Godowski PJ, Ulevitch RJ, Knaus UG.", "title": "Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway.", "journal": "Nat Immunol 1:533-40 (2000)", "doi": "10.1038/82797"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04060  Cytokine-cytokine receptor interaction", "hsa04064  NF-kappa B signaling pathway", "hsa04120  Ubiquitin mediated proteolysis", "hsa04151  PI3K-Akt signaling pathway", "hsa04210  Apoptosis", "hsa04610  Complement and coagulation cascades", "hsa04630  JAK-STAT signaling pathway"], "ko_pathway": "ko04620", "genes": ["RAC1", "AKT2", "AKT1", "MAPK13"]}, {"kegg_id": "hsa04650", "name": "Natural killer cell mediated cytotoxicity - Homo sapiens (human)", "description": "Natural killer (NK) cells are lymphocytes of the innate immune system that are involved in early defenses against both allogeneic (nonself) cells and autologous cells undergoing various forms of stress, such as infection with viruses, bacteria, or parasites or malignant transformation. Although NK cells do not express classical antigen receptors of the immunoglobulin gene family, such as the antibodies produced by B cells or the T cell receptor expressed by T cells, they are equipped with various receptors whose engagement allows them to discriminate between target and nontarget cells. Activating receptors bind ligands on the target cell surface and trigger NK cell activation and target cell lysis. However Inhibitory receptors recognize MHC class I molecules (HLA) and inhibit killing by NK cells by overruling the actions of the activating receptors. This inhibitory signal is lost when the target cells do not express MHC class I and perhaps also in cells infected with virus, which might inhibit MHC class I exprssion or alter its conformation. The mechanism of NK cell killing is the same as that used by the cytotoxic T cells generated in an adaptive immune response; cytotoxic granules are released onto the surface of the bound target cell, and the effector proteins they contain penetrate the cell membrane and induce programmed cell death.", "class": "Organismal Systems; Immune system", "pathway_map": "hsa04650  Natural killer cell mediated cytotoxicity", "drug": ["D00107  Tacrolimus (USP/INN)", "D00184  Cyclosporine (USP)", "D00745  Interferon alfa-2a (USAN/INN)", "D00746  Interferon beta-1b (USAN/INN)", "D00747  Interferon gamma-1b (USAN/INN)", "D02597  Adalimumab (USAN/INN)", "D02744  Interferon alfacon-1 (USAN/INN)", "D02745  Interferon alfa-2b (USAN)", "D02747  Peginterferon alfa-2a (USAN/INN)", "D02748  Peginterferon alfa-2b (USAN/INN)", "D02811  Alicaforsen sodium (USAN)", "D03304  Interferon beta (JAN)", "D03305  Interferon alfa (NAMALWA) (JP18)", "D03357  Interferon gamma-1a (genetical recombination) (JAN)", "D03441  Certolizumab pegol (USAN/INN)", "D03959  Efalizumab (USAN/INN)", "D04000  Enlimomab (USAN/INN)", "D04045  Erlizumab (USAN/INN)", "D04552  Interferon alfa-n1 (USAN)", "D04553  Interferon alfa-n3 (USAN)", "D04554  Interferon beta-1a (USAN)", "D04687  Lenalidomide (JAN/USAN/INN)", "D05480  Pimecrolimus (JAN/USAN/INN)", "D08556  Tacrolimus (INN)", "D08805  Interferon gamma-n1 (JAN)", "D08844  Albinterferon alfa-2b (USAN)", "D08976  Pomalidomide (JAN/USAN/INN)", "D09033  Voclosporin (JAN/USAN/INN)", "D09813  Lenalidomide hydrate (JAN)", "D10374  Lifitegrast (USAN/INN)", "D10392  Lifitegrast sodium (USAN)", "D10483  Peginterferon beta-1a (USAN/INN)", "D10618  Defactinib (USAN/INN)", "D10983  Ruclosporin (USAN/INN)", "D10993  Tucidinostat (JAN/USAN/INN)", "D11027  Ropeginterferon alfa-2b (INN)", "D12179  Tesnatilimab (USAN/INN)", "D12458  Ozekibart (USAN)", "D12893  Zimistobart (USAN)"], "dblinks": "GO: 0042267", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["3105  HLA-A; major histocompatibility complex, class I, A [KO:K06751]", "3106  HLA-B; major histocompatibility complex, class I, B [KO:K06751]", "3107  HLA-C; major histocompatibility complex, class I, C [KO:K06751]", "3135  HLA-G; major histocompatibility complex, class I, G [KO:K06751]", "3133  HLA-E; major histocompatibility complex, class I, E [KO:K06751]", "3812  KIR3DL2; killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2 [KO:K07980]", "3811  KIR3DL1; killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1 [KO:K07980]", "115653  KIR3DL3; killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 3 [KO:K07980]", "3803  KIR2DL2; killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 2 [KO:K07981]", "3802  KIR2DL1; killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1 [KO:K07981]", "3804  KIR2DL3; killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 3 [KO:K07981]", "57292  KIR2DL5A; killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 5A [KO:K24232]", "3821  KLRC1; killer cell lectin like receptor C1 [KO:K06541]", "3824  KLRD1; killer cell lectin like receptor D1 [KO:K06516]", "5777  PTPN6; protein tyrosine phosphatase non-receptor type 6 [KO:K05697] [EC:3.1.3.48]", "5781  PTPN11; protein tyrosine phosphatase non-receptor type 11 [KO:K07293] [EC:3.1.3.48]", "3383  ICAM1; intercellular adhesion molecule 1 [KO:K06490]", "3384  ICAM2; intercellular adhesion molecule 2 [KO:K06523]", "3683  ITGAL; integrin subunit alpha L [KO:K05718]", "3689  ITGB2; integrin subunit beta 2 [KO:K06464]", "2185  PTK2B; protein tyrosine kinase 2 beta [KO:K05871] [EC:2.7.10.2]", "10451  VAV3; vav guanine nucleotide exchange factor 3 [KO:K05730]", "7409  VAV1; vav guanine nucleotide exchange factor 1 [KO:K05730]", "7410  VAV2; vav guanine nucleotide exchange factor 2 [KO:K05730]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "5880  RAC2; Rac family small GTPase 2 [KO:K07860]", "5881  RAC3; Rac family small GTPase 3 [KO:K07861]", "5058  PAK1; p21 (RAC1) activated kinase 1 [KO:K04409] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "7124  TNF; tumor necrosis factor [KO:K03156]", "1437  CSF2; colony stimulating factor 2 [KO:K05427]", "3458  IFNG; interferon gamma [KO:K04687]", "3806  KIR2DS1; killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 1 [KO:K07982]", "3808  KIR2DS3; killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 3 [KO:K07982]", "3809  KIR2DS4; killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 4 [KO:K07982]", "3810  KIR2DS5; killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 5 [KO:K07982]", "100132285  KIR2DS2; killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 2 [KO:K07982]", "3822  KLRC2; killer cell lectin like receptor C2 [KO:K24233]", "3823  KLRC3; killer cell lectin like receptor C3 [KO:K24233]", "9436  NCR2; natural cytotoxicity triggering receptor 2 [KO:K06742]", "7305  TYROBP; transmembrane immune signaling adaptor TYROBP [KO:K07992]", "3932  LCK; LCK proto-oncogene, Src family tyrosine kinase [KO:K05856] [EC:2.7.10.2]", "102723407  IGH; immunoglobulin heavy variable 4-38-2-like [KO:K06856]", "2214  FCGR3A; Fc gamma receptor IIIa [KO:K06463]", "2215  FCGR3B; Fc gamma receptor IIIb [KO:K06463]", "9437  NCR1; natural cytotoxicity triggering receptor 1 [KO:K06741]", "259197  NCR3; natural cytotoxicity triggering receptor 3 [KO:K06743]", "2207  FCER1G; Fc epsilon receptor Ig [KO:K07983]", "919  CD247; CD247 molecule [KO:K06453]", "7535  ZAP70; zeta chain of T cell receptor associated protein kinase 70 [KO:K07360] [EC:2.7.10.2]", "6850  SYK; spleen associated tyrosine kinase [KO:K05855] [EC:2.7.10.2]", "3937  LCP2; lymphocyte cytosolic protein 2 [KO:K07361]", "27040  LAT; linker for activation of T cells [KO:K07362]", "7462  LAT2; linker for activation of T cells family member 2 [KO:K26356]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]", "6452  SH3BP2; SH3 domain binding protein 2 [KO:K07984]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "2534  FYN; FYN proto-oncogene, Src family tyrosine kinase [KO:K05703] [EC:2.7.10.2]", "6464  SHC1; SHC adaptor protein 1 [KO:K06279]", "25759  SHC2; SHC adaptor protein 2 [KO:K17447]", "53358  SHC3; SHC adaptor protein 3 [KO:K17448]", "399694  SHC4; SHC adaptor protein 4 [KO:K17449]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "369  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "4277  MICB; MHC class I polypeptide-related sequence B [KO:K07985]", "100507436  MICA; MHC class I polypeptide-related sequence A [KO:K07985]", "80329  ULBP1; UL16 binding protein 1 [KO:K07986]", "80328  ULBP2; UL16 binding protein 2 [KO:K07986]", "79465  ULBP3; UL16 binding protein 3 [KO:K07986]", "22914  KLRK1; killer cell lectin like receptor K1 [KO:K06728]", "100528032  KLRC4-KLRK1; KLRC4-KLRK1 readthrough [KO:K06728]", "10870  HCST; hematopoietic cell signal transducer [KO:K07988]", "962  CD48; CD48 molecule [KO:K06479]", "51744  CD244; CD244 molecule [KO:K06582]", "5530  PPP3CA; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]", "5532  PPP3CB; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]", "5533  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]", "5534  PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]", "5535  PPP3R2; protein phosphatase 3 regulatory subunit B, beta [KO:K06268]", "4772  NFATC1; nuclear factor of activated T cells 1 [KO:K04446]", "4773  NFATC2; nuclear factor of activated T cells 2 [KO:K17332]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "117157  SH2D1B; SH2 domain containing 1B [KO:K07989]", "4068  SH2D1A; SH2 domain containing 1A [KO:K07990]", "3459  IFNGR1; interferon gamma receptor 1 [KO:K05132]", "3460  IFNGR2; interferon gamma receptor 2 [KO:K05133]", "3439  IFNA1; interferon alpha 1 [KO:K05414]", "3440  IFNA2; interferon alpha 2 [KO:K05414]", "3441  IFNA4; interferon alpha 4 [KO:K05414]", "3442  IFNA5; interferon alpha 5 [KO:K05414]", "3443  IFNA6; interferon alpha 6 [KO:K05414]", "3444  IFNA7; interferon alpha 7 [KO:K05414]", "3445  IFNA8; interferon alpha 8 [KO:K05414]", "3446  IFNA10; interferon alpha 10 [KO:K05414]", "3447  IFNA13; interferon alpha 13 [KO:K05414]", "3448  IFNA14; interferon alpha 14 [KO:K05414]", "3449  IFNA16; interferon alpha 16 [KO:K05414]", "3451  IFNA17; interferon alpha 17 [KO:K05414]", "3452  IFNA21; interferon alpha 21 [KO:K05414]", "3456  IFNB1; interferon beta 1 [KO:K05415]", "3454  IFNAR1; interferon alpha and beta receptor subunit 1 [KO:K05130]", "3455  IFNAR2; interferon alpha and beta receptor subunit 2 [KO:K05131]", "8743  TNFSF10; TNF superfamily member 10 [KO:K04721]", "8797  TNFRSF10A; TNF receptor superfamily member 10a [KO:K04722]", "8795  TNFRSF10B; TNF receptor superfamily member 10b [KO:K04722]", "356  FASLG; Fas ligand [KO:K04389]", "355  FAS; Fas cell surface death receptor [KO:K04390]", "3002  GZMB; granzyme B [KO:K01353] [EC:3.4.21.79]", "5551  PRF1; perforin 1 [KO:K07818]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "637  BID; BH3 interacting domain death agonist [KO:K04726]", "353091  RAET1G; retinoic acid early transcript 1G [KO:K07987]", "154064  RAET1L; retinoic acid early transcript 1L [KO:K07987]", "135250  RAET1E; retinoic acid early transcript 1E [KO:K07987]"], "compound": ["C00076  Calcium cation", "C00165  Diacylglycerol", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C05981  Phosphatidylinositol-3,4,5-trisphosphate"], "refs": [{"pmid": "15607802", "authors": "  Chiesa S, Tomasello E, Vivier E, Vely F.", "title": "Coordination of activating and inhibitory signals in natural killer cells.", "journal": "Mol Immunol 42:477-84 (2005)", "doi": "10.1016/j.molimm.2004.07.030"}, {"pmid": "16109839", "authors": "  Maghazachi AA.", "title": "Insights into seven and single transmembrane-spanning domain receptors and their signaling pathways in human natural killer cells.", "journal": "Pharmacol Rev 57:339-57 (2005)", "doi": "10.1124/pr.57.3.5"}, {"pmid": "15567854", "authors": "  Vivier E, Nunes JA, Vely F.", "title": "Natural killer cell signaling pathways.", "journal": "Science 306:1517-9 (2004)", "doi": "10.1126/science.1103478"}, {"pmid": "12205470", "authors": "  Colucci F, Di Santo JP, Leibson PJ.", "title": "Natural killer cell activation in mice and men: different triggers for similar weapons?", "journal": "Nat Immunol 3:807-13 (2002)", "doi": "10.1038/ni0902-807"}, {"pmid": "11062493", "authors": "  Perussia B.", "title": "Signaling for cytotoxicity.", "journal": "Nat Immunol 1:372-4 (2000)", "doi": "10.1038/80808"}, {"pmid": "15607806", "authors": "  Smyth MJ, Cretney E, Kelly JM, Westwood JA, Street SE, Yagita H, Takeda K, van Dommelen SL, Degli-Esposti MA, Hayakawa Y.", "title": "Activation of NK cell cytotoxicity.", "journal": "Mol Immunol 42:501-10 (2005)", "doi": "10.1016/j.molimm.2004.07.034"}, {"pmid": "12530970", "authors": "  Smyth MJ, Takeda K, Hayakawa Y, Peschon JJ, van den Brink MR, Yagita H.", "title": "Nature's TRAIL--on a path to cancer immunotherapy.", "journal": "Immunity 18:1-6 (2003)", "doi": "10.1016/S1074-7613(02)00502-2"}, {"pmid": "16177799", "authors": "  Colonna M.", "title": "Fine-tuning NK cell responses: it's a family affair.", "journal": "Nat Immunol 6:961-2 (2005)", "doi": "10.1038/ni1005-961"}, {"pmid": "16002670", "authors": "  Tassi I, Presti R, Kim S, Yokoyama WM, Gilfillan S, Colonna M.", "title": "Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors.", "journal": "J Immunol 175:749-54 (2005)", "doi": "10.4049/jimmunol.175.2.749"}, {"pmid": "9143705", "authors": "  Rao A, Luo C, Hogan PG.", "title": "Transcription factors of the NFAT family: regulation and function.", "journal": "Annu Rev Immunol 15:707-47 (1997)", "doi": "10.1146/annurev.immunol.15.1.707"}, {"pmid": "14710949", "authors": "  Wu J, Lanier LL.", "title": "Natural killer cells and cancer.", "journal": "Adv Cancer Res 90:127-56 (2003)", "doi": "10.1016/S0065-230X(03)90004-2"}, {"pmid": "11905813", "authors": "  Cerwenka A, Lanier LL.", "title": "Natural killer cells, viruses and cancer.", "journal": "Nat Rev Immunol 1:41-9 (2001)", "doi": "10.1038/35095564"}, {"pmid": "11836514", "authors": "  Blott EJ, Griffiths GM.", "title": "Secretory lysosomes.", "journal": "Nat Rev Mol Cell Biol 3:122-31 (2002)", "doi": "10.1038/nrm732"}, {"pmid": "12766758", "authors": "  Lieberman J.", "title": "The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal.", "journal": "Nat Rev Immunol 3:361-70 (2003)", "doi": "10.1038/nri1083"}, {"pmid": "12752668", "authors": "  Lord SJ, Rajotte RV, Korbutt GS, Bleackley RC.", "title": "Granzyme B: a natural born killer.", "journal": "Immunol Rev 193:31-8 (2003)", "doi": "10.1034/j.1600-065X.2003.00044.x"}, {"pmid": "15618404", "authors": "  Liu D, Xu L, Yang F, Li D, Gong F, Xu T.", "title": "Rapid biogenesis and sensitization of secretory lysosomes in NK cells mediated by target-cell recognition.", "journal": "Proc Natl Acad Sci U S A 102:123-7 (2005)", "doi": "10.1073/pnas.0405737102"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04060  Cytokine-cytokine receptor interaction", "hsa04210  Apoptosis", "hsa04630  JAK-STAT signaling pathway"], "ko_pathway": "ko04650", "genes": ["RAC1", "BRAF", "SOS1", "NRAS"]}, {"kegg_id": "hsa04666", "name": "Fc gamma R-mediated phagocytosis - Homo sapiens (human)", "description": "Phagocytosis plays an essential role in host-defense mechanisms through the uptake and destruction of infectious pathogens. Specialized cell types including macrophages, neutrophils, and monocytes take part in this process in higher organisms. After opsonization with antibodies (IgG), foreign extracellular materials are recognized by Fc gamma receptors. Cross-linking of Fc gamma receptors initiates a variety of signals mediated by tyrosine phosphorylation of multiple proteins, which lead through the actin cytoskeleton rearrangements and membrane remodeling to the formation of phagosomes. Nascent phagosomes undergo a process of maturation that involves fusion with lysosomes. The acquisition of lysosomal proteases and release of reactive oxygen species are crucial for digestion of engulfed materials in phagosomes.", "class": "Organismal Systems; Immune system", "pathway_map": "hsa04666  Fc gamma R-mediated phagocytosis", "network": ["", "ELEMENT   N01090  IGG-FCGR-RAC signaling pathway"], "drug": ["D11275  Rosiptor (USAN/INN)", "D11276  Rosiptor acetate (USAN)", "D11339  Valziflocept (USAN)"], "dblinks": "GO: 0006909", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["102723407  IGH; immunoglobulin heavy variable 4-38-2-like [KO:K06856]", "2209  FCGR1A; Fc gamma receptor Ia [KO:K06498]", "2212  FCGR2A; Fc gamma receptor IIa [KO:K06472]", "2214  FCGR3A; Fc gamma receptor IIIa [KO:K06463]", "2215  FCGR3B; Fc gamma receptor IIIb [KO:K06463]", "5788  PTPRC; protein tyrosine phosphatase receptor type C [KO:K06478] [EC:3.1.3.48]", "3055  HCK; HCK proto-oncogene, Src family tyrosine kinase [KO:K08893] [EC:2.7.10.2]", "4067  LYN; LYN proto-oncogene, Src family tyrosine kinase [KO:K05854] [EC:2.7.10.2]", "6850  SYK; spleen associated tyrosine kinase [KO:K05855] [EC:2.7.10.2]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "6198  RPS6KB1; ribosomal protein S6 kinase B1 [KO:K04688] [EC:2.7.11.1]", "6199  RPS6KB2; ribosomal protein S6 kinase B2 [KO:K04688] [EC:2.7.11.1]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]", "5580  PRKCD; protein kinase C delta [KO:K06068] [EC:2.7.11.13]", "5581  PRKCE; protein kinase C epsilon [KO:K18050] [EC:2.7.11.13]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "123745  PLA2G4E; phospholipase A2 group IVE [KO:K16342] [EC:3.1.1.4]", "5321  PLA2G4A; phospholipase A2 group IVA [KO:K16342] [EC:3.1.1.4]", "8681  JMJD7-PLA2G4B; JMJD7-PLA2G4B readthrough [KO:K16342] [EC:3.1.1.4]", "100137049  PLA2G4B; phospholipase A2 group IVB [KO:K16342] [EC:3.1.1.4]", "8605  PLA2G4C; phospholipase A2 group IVC [KO:K16342] [EC:3.1.1.4]", "283748  PLA2G4D; phospholipase A2 group IVD [KO:K16342] [EC:3.1.1.4]", "255189  PLA2G4F; phospholipase A2 group IVF [KO:K16342] [EC:3.1.1.4]", "8398  PLA2G6; phospholipase A2 group VI [KO:K16343] [EC:3.1.1.4]", "4082  MARCKS; myristoylated alanine rich protein kinase C substrate [KO:K12561]", "65108  MARCKSL1; MARCKS like 1 [KO:K13536]", "5337  PLD1; phospholipase D1 [KO:K01115] [EC:3.1.4.4]", "5338  PLD2; phospholipase D2 [KO:K01115] [EC:3.1.4.4]", "8611  PLPP1; phospholipid phosphatase 1 [KO:K01080] [EC:3.1.3.4]", "8613  PLPP3; phospholipid phosphatase 3 [KO:K01080] [EC:3.1.3.4]", "8612  PLPP2; phospholipid phosphatase 2 [KO:K01080] [EC:3.1.3.4]", "8877  SPHK1; sphingosine kinase 1 [KO:K04718] [EC:2.7.1.91]", "56848  SPHK2; sphingosine kinase 2 [KO:K04718] [EC:2.7.1.91]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "653361  NCF1; neutrophil cytosolic factor 1 [KO:K08011]", "2934  GSN; gelsolin [KO:K05768]", "85477  SCIN; scinderin [KO:K05768]", "10451  VAV3; vav guanine nucleotide exchange factor 3 [KO:K05730]", "7409  VAV1; vav guanine nucleotide exchange factor 1 [KO:K05730]", "7410  VAV2; vav guanine nucleotide exchange factor 2 [KO:K05730]", "998  CDC42; cell division cycle 42 [KO:K04393]", "7454  WAS; WASP actin nucleation promoting factor [KO:K05747]", "7408  VASP; vasodilator stimulated phosphoprotein [KO:K06274]", "10097  ACTR2; actin related protein 2 [KO:K17260]", "57180  ACTR3B; actin related protein 3B [KO:K18584]", "653857  ACTR3C; actin related protein 3C [KO:K18584]", "10096  ACTR3; actin related protein 3 [KO:K18584]", "10095  ARPC1B; actin related protein 2/3 complex subunit 1B [KO:K05757]", "10552  ARPC1A; actin related protein 2/3 complex subunit 1A [KO:K05757]", "10109  ARPC2; actin related protein 2/3 complex subunit 2 [KO:K05758]", "10094  ARPC3; actin related protein 2/3 complex subunit 3 [KO:K05756]", "10093  ARPC4; actin related protein 2/3 complex subunit 4 [KO:K05755]", "10092  ARPC5; actin related protein 2/3 complex subunit 5 [KO:K05754]", "81873  ARPC5L; actin related protein 2/3 complex subunit 5 like [KO:K05754]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "5880  RAC2; Rac family small GTPase 2 [KO:K07860]", "8936  WASF1; WASP family member 1 [KO:K05753]", "10163  WASF2; WASP family member 2 [KO:K05748]", "10810  WASF3; WASP family member 3 [KO:K06083]", "5058  PAK1; p21 (RAC1) activated kinase 1 [KO:K04409] [EC:2.7.11.1]", "3984  LIMK1; LIM domain kinase 1 [KO:K05743] [EC:2.7.11.1]", "3985  LIMK2; LIM domain kinase 2 [KO:K05744] [EC:2.7.11.1]", "1072  CFL1; cofilin 1 [KO:K05765]", "1073  CFL2; cofilin 2 [KO:K05765]", "23396  PIP5K1C; phosphatidylinositol-4-phosphate 5-kinase type 1 gamma [KO:K00889] [EC:2.7.1.68]", "8394  PIP5K1A; phosphatidylinositol-4-phosphate 5-kinase type 1 alpha [KO:K00889] [EC:2.7.1.68]", "8395  PIP5K1B; phosphatidylinositol-4-phosphate 5-kinase type 1 beta [KO:K00889] [EC:2.7.1.68]", "382  ARF6; ADP ribosylation factor 6 [KO:K07941]", "1398  CRK; CRK proto-oncogene, adaptor protein [KO:K04438]", "1399  CRKL; CRK like proto-oncogene, adaptor protein [KO:K04438]", "1793  DOCK1; dedicator of cytokinesis 1 [KO:K13708]", "50807  ASAP1; ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 [KO:K12488]", "55616  ASAP3; ArfGAP with SH3 domain, ankyrin repeat and PH domain 3 [KO:K12488]", "8853  ASAP2; ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 [KO:K12488]", "2213  FCGR2B; Fc gamma receptor IIb [KO:K12560]", "3635  INPP5D; inositol polyphosphate-5-phosphatase D [KO:K03084] [EC:3.1.3.86]", "3636  INPPL1; inositol polyphosphate phosphatase like 1 [KO:K15909] [EC:3.1.3.86]", "9846  GAB2; GRB2 associated binding protein 2 [KO:K08091]", "27040  LAT; linker for activation of T cells [KO:K07362]", "1785  DNM2; dynamin 2 [KO:K23484] [EC:3.6.5.5]", "273  AMPH; amphiphysin [KO:K12562]", "274  BIN1; bridging integrator 1 [KO:K12562]", "4651  MYO10; myosin X [KO:K12559]"], "compound": ["C00076  Calcium cation", "C00165  Diacylglycerol", "C00219  Arachidonate", "C00416  Phosphatidate", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C04637  1-Phosphatidyl-D-myo-inositol 4,5-bisphosphate", "C05981  Phosphatidylinositol-3,4,5-trisphosphate", "C06124  Sphingosine 1-phosphate"], "refs": [{"pmid": "12488490", "authors": "  Garcia-Garcia E, Rosales C", "title": "Signal transduction during Fc receptor-mediated phagocytosis.", "journal": "J Leukoc Biol 72:1092-108 (2002)", "doi": "10.1189/jlb.72.6.1092"}, {"pmid": "11708889", "authors": "  Cox D, Greenberg S", "title": "Phagocytic signaling strategies: Fc(gamma)receptor-mediated phagocytosis as a model system.", "journal": "Semin Immunol 13:339-45 (2001)", "doi": "10.1006/smim.2001.0330"}, {"pmid": "15466916", "authors": "  Swanson JA, Hoppe AD", "title": "The coordination of signaling during Fc receptor-mediated phagocytosis.", "journal": "J Leukoc Biol 76:1093-103 (2004)", "doi": "10.1189/jlb.0804439"}, {"pmid": "11244038", "authors": "  Ravetch JV, Bolland S", "title": "IgG Fc receptors.", "journal": "Annu Rev Immunol 19:275-90 (2001)", "doi": "10.1146/annurev.immunol.19.1.275"}, {"pmid": "18322649", "authors": "  Groves E, Dart AE, Covarelli V, Caron E", "title": "Molecular mechanisms of phagocytic uptake in mammalian cells.", "journal": "Cell Mol Life Sci 65:1957-76 (2008)", "doi": "10.1007/s00018-008-7578-4"}, {"pmid": "10376013", "authors": "  Kwiatkowska K, Sobota A", "title": "Signaling pathways in phagocytosis.", "journal": "Bioessays 21:422-31 (1999)", "doi": "10.1002/(SICI)1521-1878(199905)21:5<422::AID-BIES9>3.0.CO;2-#"}, {"pmid": "10577498", "authors": "  Greenberg S", "title": "Modular components of phagocytosis.", "journal": "J Leukoc Biol 66:712-7 (1999)", "doi": "10.1002/jlb.66.5.712"}, {"pmid": "10224668", "authors": "  Lennartz MR", "title": "Phospholipases and phagocytosis: the role of phospholipid-derived second messengers in phagocytosis.", "journal": "Int J Biochem Cell Biol 31:415-30 (1999)", "doi": "10.1016/S1357-2725(98)00108-3"}, {"pmid": "17050193", "authors": "  Joshi T, Butchar JP, Tridandapani S", "title": "Fcgamma receptor signaling in phagocytes.", "journal": "Int J Hematol 84:210-6 (2006)", "doi": "10.1532/IJH97.06140"}, {"pmid": "17308335", "authors": "  Lee WL, Cosio G, Ireton K, Grinstein S", "title": "Role of CrkII in Fcgamma receptor-mediated phagocytosis.", "journal": "J Biol Chem 282:11135-43 (2007)", "doi": "10.1074/jbc.M700823200"}, {"pmid": "11304556", "authors": "  Uchida H, Kondo A, Yoshimura Y, Mazaki Y, Sabe H", "title": "PAG3/Papalpha/KIAA0400, a GTPase-activating protein for ADP-ribosylation factor (ARF), regulates ARF6 in Fcgamma receptor-mediated phagocytosis of macrophages.", "journal": "J Exp Med 193:955-66 (2001)", "doi": "10.1084/jem.193.8.955"}, {"pmid": "15485887", "authors": "  Ganesan LP, Wei G, Pengal RA, Moldovan L, Moldovan N, Ostrowski MC, Tridandapani S", "title": "The serine/threonine kinase Akt Promotes Fc gamma receptor-mediated phagocytosis in murine macrophages through the activation of p70S6 kinase.", "journal": "J Biol Chem 279:54416-25 (2004)", "doi": "10.1074/jbc.M408188200"}, {"pmid": "9545263", "authors": "  Melendez A, Floto RA, Gillooly DJ, Harnett MM, Allen JM", "title": "FcgammaRI coupling to phospholipase D initiates sphingosine kinase-mediated calcium mobilization and vesicular trafficking.", "journal": "J Biol Chem 273:9393-402 (1998)", "doi": "10.1074/jbc.273.16.9393"}, {"pmid": "12821647", "authors": "  Gu H, Botelho RJ, Yu M, Grinstein S, Neel BG", "title": "Critical role for scaffolding adapter Gab2 in Fc gamma R-mediated phagocytosis.", "journal": "J Cell Biol 161:1151-61 (2003)", "doi": "10.1083/jcb.200212158"}, {"pmid": "9417101", "authors": "  Dana R, Leto TL, Malech HL, Levy R", "title": "Essential requirement of cytosolic phospholipase A2 for activation of the phagocyte NADPH oxidase.", "journal": "J Biol Chem 273:441-5 (1998)", "doi": "10.1074/jbc.273.1.441"}, {"pmid": "10601359", "authors": "  Gold ES, Underhill DM, Morrissette NS, Guo J, McNiven MA, Aderem A", "title": "Dynamin 2 is required for phagocytosis in macrophages.", "journal": "J Exp Med 190:1849-56 (1999)", "doi": "10.1084/jem.190.12.1849"}, {"pmid": "10755615", "authors": "  Gold ES, Morrissette NS, Underhill DM, Guo J, Bassetti M, Aderem A", "title": "Amphiphysin IIm, a novel amphiphysin II isoform, is required for macrophage phagocytosis.", "journal": "Immunity 12:285-92 (2000)", "doi": "10.1016/S1074-7613(00)80181-8"}, {"pmid": "9581795", "authors": "  Sanchez-Mejorada G, Rosales C", "title": "Signal transduction by immunoglobulin Fc receptors.", "journal": "J Leukoc Biol 63:521-33 (1998)", "doi": "10.1002/jlb.63.5.521"}], "rel_pathway": ["hsa04020  Calcium signaling pathway", "hsa04142  Lysosome", "hsa04144  Endocytosis", "hsa04810  Regulation of actin cytoskeleton"], "ko_pathway": "ko04666", "genes": ["RAC1", "AKT2", "AKT1"]}, {"kegg_id": "hsa04670", "name": "Leukocyte transendothelial migration - Homo sapiens (human)", "description": "Leukocyte migaration from the blood into tissues is vital for immune surveillance and inflammation. During this diapedesis of leukocytes, the leukocytes bind to endothelial cell adhesion molecules (CAM) and then migrate across the vascular endothelium. A leukocyte adherent to CAMs on the endothelial cells moves forward by leading-edge protrusion and retraction of its tail. In this process, alphaL /beta2 integrin activates through Vav1, RhoA, which subsequently activates the kinase p160ROCK. ROCK activation leads to MLC phosphorylation, resulting in retraction of the actin cytoskeleton. Moreover, Leukocytes activate endothelial cell signals that stimulate endothelial cell retraction during localized dissociation of the endothelial cell junctions. ICAM-1-mediated signals activate an endothelial cell calcium flux and PKC, which are required for ICAM-1 dependent leukocyte migration. VCAM-1 is involved in the opening of the \"endothelial passage\" through which leukocytes can extravasate. In this regard, VCAM-1 ligation induces NADPH oxidase activation and the production of reactive oxygen species (ROS) in a Rac-mediated manner, with subsequent activation of matrix metallopoteinases and loss of VE-cadherin-mediated adhesion.", "class": "Organismal Systems; Immune system", "pathway_map": "hsa04670  Leukocyte transendothelial migration", "drug": ["D02811  Alicaforsen sodium (USAN)", "D03061  Batimastat (USAN/INN)", "D03793  Ilomastat (USAN/INN)", "D03795  Marimastat (USAN/INN)", "D03797  Prinomastat (USAN/INN)", "D03800  Rebimastat (USAN/INN)", "D03802  Tanomastat (USAN/INN)", "D04000  Enlimomab (USAN/INN)", "D04045  Erlizumab (USAN/INN)", "D05029  Midostaurin (JAN/USAN/INN)", "D06886  Natalizumab (USAN/INN)", "D09799  Carotegrast methyl (JAN)", "D10028  Valategrast hydrochloride (USAN)", "D10374  Lifitegrast (USAN/INN)", "D10392  Lifitegrast sodium (USAN)", "D10463  Ripasudil hydrochloride hydrate (JAN)", "D10618  Defactinib (USAN/INN)", "D11527  Zolbetuximab (USAN/INN)", "D12655  Olaptesed pegol (INN)", "D12762  Soquelitinib (USAN)", "D12781  Osemitamab (USAN/INN)", "D12799  Vociprotafib (USAN/INN)", "D12892  Migoprotafib (USAN/INN)"], "dblinks": "GO: 0050900", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["83700  JAM3; junctional adhesion molecule 3 [KO:K06785]", "3684  ITGAM; integrin subunit alpha M [KO:K06461]", "3689  ITGB2; integrin subunit beta 2 [KO:K06464]", "58494  JAM2; junctional adhesion molecule 2 [KO:K06735]", "3676  ITGA4; integrin subunit alpha 4 [KO:K06483]", "3688  ITGB1; integrin subunit beta 1 [KO:K05719]", "5175  PECAM1; platelet and endothelial cell adhesion molecule 1 [KO:K06471]", "4267  CD99; CD99 molecule (Xg blood group) [KO:K06520]", "83692  CD99L2; CD99 molecule like 2 [KO:K06520]", "3683  ITGAL; integrin subunit alpha L [KO:K05718]", "50848  F11R; F11 receptor [KO:K06089]", "1003  CDH5; cadherin 5 [KO:K06533]", "1364  CLDN4; claudin 4 [KO:K06087]", "1365  CLDN3; claudin 3 [KO:K06087]", "1366  CLDN7; claudin 7 [KO:K06087]", "149461  CLDN19; claudin 19 [KO:K06087]", "10686  CLDN16; claudin 16 [KO:K06087]", "23562  CLDN14; claudin 14 [KO:K06087]", "24146  CLDN15; claudin 15 [KO:K06087]", "26285  CLDN17; claudin 17 [KO:K06087]", "49861  CLDN20; claudin 20 [KO:K06087]", "5010  CLDN11; claudin 11 [KO:K06087]", "51208  CLDN18; claudin 18 [KO:K06087]", "53842  CLDN22; claudin 22 [KO:K06087]", "7122  CLDN5; claudin 5 [KO:K06087]", "9071  CLDN10; claudin 10 [KO:K06087]", "9073  CLDN8; claudin 8 [KO:K06087]", "9074  CLDN6; claudin 6 [KO:K06087]", "9075  CLDN2; claudin 2 [KO:K06087]", "9076  CLDN1; claudin 1 [KO:K06087]", "9080  CLDN9; claudin 9 [KO:K06087]", "137075  CLDN23; claudin 23 [KO:K06087]", "100288814  CLDN34; claudin 34 [KO:K06087]", "644672  CLDN25; claudin 25 [KO:K06087]", "100132463  CLDN24; claudin 24 [KO:K06087]", "9069  CLDN12; claudin 12 [KO:K06087]", "100506658  OCLN; occludin [KO:K06088]", "90952  ESAM; endothelial cell adhesion molecule [KO:K06787]", "7412  VCAM1; vascular cell adhesion molecule 1 [KO:K06527]", "7430  EZR; ezrin [KO:K08007]", "4478  MSN; moesin [KO:K05763]", "71  ACTG1; actin gamma 1 [KO:K05692]", "60  ACTB; actin beta [KO:K05692]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "1536  CYBB; cytochrome b-245 beta chain [KO:K21421] [EC:1.-.-.-]", "1535  CYBA; cytochrome b-245 alpha chain [KO:K08009]", "4688  NCF2; neutrophil cytosolic factor 2 [KO:K08010]", "653361  NCF1; neutrophil cytosolic factor 1 [KO:K08011]", "4689  NCF4; neutrophil cytosolic factor 4 [KO:K08012]", "1499  CTNNB1; catenin beta 1 [KO:K02105]", "1500  CTNND1; catenin delta 1 [KO:K05690]", "29119  CTNNA3; catenin alpha 3 [KO:K05691]", "1495  CTNNA1; catenin alpha 1 [KO:K05691]", "1496  CTNNA2; catenin alpha 2 [KO:K05691]", "5781  PTPN11; protein tyrosine phosphatase non-receptor type 11 [KO:K07293] [EC:3.1.3.48]", "4313  MMP2; matrix metallopeptidase 2 [KO:K01398] [EC:3.4.24.24]", "4318  MMP9; matrix metallopeptidase 9 [KO:K01403] [EC:3.4.24.35]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "3383  ICAM1; intercellular adhesion molecule 1 [KO:K06490]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "5747  PTK2; protein tyrosine kinase 2 [KO:K05725] [EC:2.7.10.2]", "5829  PXN; paxillin [KO:K05760]", "9564  BCAR1; BCAR1 scaffold protein, Cas family member [KO:K05726]", "7070  THY1; Thy-1 cell surface antigen [KO:K06514]", "2909  ARHGAP35; Rho GTPase activating protein 35 [KO:K05732]", "394  ARHGAP5; Rho GTPase activating protein 5 [KO:K13709]", "387  RHOA; ras homolog family member A [KO:K04513]", "6093  ROCK1; Rho associated coiled-coil containing protein kinase 1 [KO:K04514] [EC:2.7.11.1]", "9475  ROCK2; Rho associated coiled-coil containing protein kinase 2 [KO:K17388] [EC:2.7.11.1]", "4633  MYL2; myosin light chain 2 [KO:K10351]", "4636  MYL5; myosin light chain 5 [KO:K12753]", "58498  MYL7; myosin light chain 7 [KO:K12754]", "10398  MYL9; myosin light chain 9 [KO:K12755]", "93408  MYL10; myosin light chain 10 [KO:K12756]", "103910  MYL12B; myosin light chain 12B [KO:K12757]", "10627  MYL12A; myosin light chain 12A [KO:K12757]", "29895  MYL11; myosin light chain 11 [KO:K12758]", "4301  AFDN; afadin, adherens junction formation factor [KO:K05702]", "5906  RAP1A; RAP1A, member of RAS oncogene family [KO:K04353]", "5908  RAP1B; RAP1B, member of RAS oncogene family [KO:K07836]", "6494  SIPA1; signal-induced proliferation-associated 1 [KO:K08013]", "7408  VASP; vasodilator stimulated phosphoprotein [KO:K06274]", "87  ACTN1; actinin alpha 1 [KO:K05699]", "81  ACTN4; actinin alpha 4 [KO:K05699]", "7414  VCL; vinculin [KO:K05700]", "6387  CXCL12; C-X-C motif chemokine ligand 12 [KO:K10031]", "7852  CXCR4; C-X-C motif chemokine receptor 4 [KO:K04189]", "2770  GNAI1; G protein subunit alpha i1 [KO:K04630]", "2773  GNAI3; G protein subunit alpha i3 [KO:K04630]", "2771  GNAI2; G protein subunit alpha i2 [KO:K04630]", "10411  RAPGEF3; Rap guanine nucleotide exchange factor 3 [KO:K08014]", "11069  RAPGEF4; Rap guanine nucleotide exchange factor 4 [KO:K04351]", "83593  RASSF5; Ras association domain family member 5 [KO:K08015]", "2185  PTK2B; protein tyrosine kinase 2 beta [KO:K05871] [EC:2.7.10.2]", "3702  ITK; IL2 inducible T cell kinase [KO:K07363] [EC:2.7.10.2]", "7294  TXK; TXK tyrosine kinase [KO:K08016] [EC:2.7.10.2]", "10451  VAV3; vav guanine nucleotide exchange factor 3 [KO:K05730]", "7409  VAV1; vav guanine nucleotide exchange factor 1 [KO:K05730]", "7410  VAV2; vav guanine nucleotide exchange factor 2 [KO:K05730]", "5880  RAC2; Rac family small GTPase 2 [KO:K07860]", "998  CDC42; cell division cycle 42 [KO:K04393]", "399  RHOH; ras homolog family member H [KO:K07873]"], "compound": ["C00027  Hydrogen peroxide", "C00076  Calcium cation", "C00575  3',5'-Cyclic AMP", "C04637  1-Phosphatidyl-D-myo-inositol 4,5-bisphosphate"], "refs": [{"pmid": "14976004", "authors": "  van Buul JD, Hordijk PL.", "title": "Signaling in leukocyte transendothelial migration.", "journal": "Arterioscler Thromb Vasc Biol 24:824-33 (2004)", "doi": "10.1161/01.ATV.0000122854.76267.5c"}, {"pmid": "15604886", "authors": "  Wittchen ES, van Buul JD, Burridge K, Worthylake RA.", "title": "Trading spaces: Rap, Rac, and Rho as architects of transendothelial migration.", "journal": "Curr Opin Hematol 12:14-21 (2005)", "doi": "10.1097/01.moh.0000147892.83713.a7"}, {"pmid": "14977592", "authors": "  Barreiro O, Vicente-Manzanares M, Urzainqui A, Yanez-Mo M, Sanchez-Madrid F.", "title": "Interactive protrusive structures during leukocyte adhesion and transendothelial migration.", "journal": "Front Biosci 9:1849-63 (2004)", "doi": "10.2741/1285"}, {"pmid": "15629883", "authors": "  Cook-Mills JM, Deem TL.", "title": "Active participation of endothelial cells in inflammation.", "journal": "J Leukoc Biol 77:487-95 (2005)", "doi": "10.1189/jlb.0904554"}, {"pmid": "15173832", "authors": "  Imhof BA, Aurrand-Lions M.", "title": "Adhesion mechanisms regulating the migration of monocytes.", "journal": "Nat Rev Immunol 4:432-44 (2004)", "doi": "10.1038/nri1375"}, {"pmid": "15265790", "authors": "  Deem TL, Cook-Mills JM.", "title": "Vascular cell adhesion molecule 1 (VCAM-1) activation of endothelial cell matrix metalloproteinases: role of reactive oxygen species.", "journal": "Blood 104:2385-93 (2004)", "doi": "10.1182/blood-2004-02-0665"}, {"pmid": "10975856", "authors": "  Etienne-Manneville S, Manneville JB, Adamson P, Wilbourn B, Greenwood J, Couraud PO.", "title": "ICAM-1-coupled cytoskeletal rearrangements and transendothelial lymphocyte migration involve intracellular calcium signaling in brain endothelial cell lines.", "journal": "J Immunol 165:3375-83 (2000)", "doi": "10.4049/jimmunol.165.6.3375"}, {"pmid": "12540948", "authors": "  Chavakis T, Preissner KT, Santoso S.", "title": "Leukocyte trans-endothelial migration: JAMs add new pieces to the puzzle.", "journal": "Thromb Haemost 89:13-7 (2003)", "doi": "10.1055/s-0037-1613537"}], "rel_pathway": ["hsa04514  Cell adhesion molecules", "hsa04810  Regulation of actin cytoskeleton"], "ko_pathway": "ko04670", "genes": ["RAC1", "EZR", "MAPK13"]}, {"kegg_id": "hsa04722", "name": "Neurotrophin signaling pathway - Homo sapiens (human)", "description": "Neurotrophins are a family of trophic factors involved in differentiation and survival of neural cells. The neurotrophin family consists of nerve growth factor (NGF), brain derived neurotrophic factor (BDNF), neurotrophin 3 (NT-3), and neurotrophin 4 (NT-4). Neurotrophins exert their functions through engagement of Trk tyrosine kinase receptors or p75 neurotrophin receptor (p75NTR). Neurotrophin/Trk signaling is regulated by connecting a variety of intracellular signaling cascades, which include MAPK pathway, PI-3 kinase pathway, and PLC pathway, transmitting positive signals like enhanced survival and growth. On the other hand, p75NTR transmits both positive and nagative signals. These signals play an important role for neural development and additional higher-order activities such as learning and memory.", "class": "Organismal Systems; Nervous system", "pathway_map": "hsa04722  Neurotrophin signaling pathway", "drug": ["D08869  Begacestat (USAN/INN)", "D09010  Tarenflurbil (USAN/INN)", "D09377  Semagacestat (USAN/INN)", "D09869  Avagacestat (USAN)", "D09907  Fulranumab (USAN/INN)", "D10334  Rebastinib (USAN)", "D10399  Rebastinib Tosylate (USAN)", "D11028  Cenegermin (INN)", "D11137  Larotrectinib (USAN/INN)", "D11138  Larotrectinib sulfate (JAN/USAN)", "D11454  Repotrectinib (JAN/USAN)", "D11484  Pegcantratinib (USAN/INN)", "D11786  Vodobatinib (USAN)", "D12181  Edasalonexent (USAN/INN)", "D12235  Osugacestat (USAN/INN)", "D12237  Zunsemetinib (USAN)", "D12363  Taletrectinib (USAN/INN)", "D12364  Taletrectinib adipate (USAN)", "D12427  Latozinemab (USAN/INN)", "D12432  Zurletrectinib (USAN)", "D12580  Sudotaxel zendusortide (USAN/INN)", "D12581  Zendusortide (USAN/INN)", "D12646  Paltimatrectinib (USAN/INN)", "D12828  Risvodetinib (USAN/INN)", "D12829  Risvodetinib succinate (USAN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["4803  NGF; nerve growth factor [KO:K02582]", "627  BDNF; brain derived neurotrophic factor [KO:K04355]", "4909  NTF4; neurotrophin 4 [KO:K12457]", "4908  NTF3; neurotrophin 3 [KO:K04356]", "4914  NTRK1; neurotrophic receptor tyrosine kinase 1 [KO:K03176] [EC:2.7.10.1]", "4915  NTRK2; neurotrophic receptor tyrosine kinase 2 [KO:K04360] [EC:2.7.10.1]", "4916  NTRK3; neurotrophic receptor tyrosine kinase 3 [KO:K05101] [EC:2.7.10.1]", "10603  SH2B2; SH2B adaptor protein 2 [KO:K07193]", "25970  SH2B1; SH2B adaptor protein 1 [KO:K12459]", "10019  SH2B3; SH2B adaptor protein 3 [KO:K12459]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "6197  RPS6KA3; ribosomal protein S6 kinase A3 [KO:K04373] [EC:2.7.11.1]", "6195  RPS6KA1; ribosomal protein S6 kinase A1 [KO:K04373] [EC:2.7.11.1]", "6196  RPS6KA2; ribosomal protein S6 kinase A2 [KO:K04373] [EC:2.7.11.1]", "27330  RPS6KA6; ribosomal protein S6 kinase A6 [KO:K04373] [EC:2.7.11.1]", "9252  RPS6KA5; ribosomal protein S6 kinase A5 [KO:K04445] [EC:2.7.11.1]", "468  ATF4; activating transcription factor 4 [KO:K04374]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]", "57498  KIDINS220; kinase D interacting substrate 220 [KO:K12460]", "10818  FRS2; fibroblast growth factor receptor substrate 2 [KO:K12461]", "1398  CRK; CRK proto-oncogene, adaptor protein [KO:K04438]", "1399  CRKL; CRK like proto-oncogene, adaptor protein [KO:K04438]", "2889  RAPGEF1; Rap guanine nucleotide exchange factor 1 [KO:K06277]", "5906  RAP1A; RAP1A, member of RAS oncogene family [KO:K04353]", "5908  RAP1B; RAP1B, member of RAS oncogene family [KO:K07836]", "4215  MAP3K3; mitogen-activated protein kinase kinase kinase 3 [KO:K04421] [EC:2.7.11.25]", "5607  MAP2K5; mitogen-activated protein kinase kinase 5 [KO:K04463] [EC:2.7.12.2]", "5598  MAPK7; mitogen-activated protein kinase 7 [KO:K04464] [EC:2.7.11.24]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "9261  MAPKAPK2; MAPK activated protein kinase 2 [KO:K04443] [EC:2.7.11.1]", "6464  SHC1; SHC adaptor protein 1 [KO:K06279]", "25759  SHC2; SHC adaptor protein 2 [KO:K17447]", "53358  SHC3; SHC adaptor protein 3 [KO:K17448]", "399694  SHC4; SHC adaptor protein 4 [KO:K17449]", "2549  GAB1; GRB2 associated binding protein 1 [KO:K09593]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "4793  NFKBIB; NFKB inhibitor beta [KO:K02581]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "4794  NFKBIE; NFKB inhibitor epsilon [KO:K05872]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "2309  FOXO3; forkhead box O3 [KO:K09408]", "356  FASLG; Fas ligand [KO:K04389]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "5170  PDPK1; 3-phosphoinositide dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]", "3667  IRS1; insulin receptor substrate 1 [KO:K16172]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]", "5580  PRKCD; protein kinase C delta [KO:K06068] [EC:2.7.11.13]", "810  CALML3; calmodulin like 3 [KO:K02183]", "805  CALM2; calmodulin 2 [KO:K02183]", "808  CALM3; calmodulin 3 [KO:K02183]", "801  CALM1; calmodulin 1 [KO:K02183]", "163688  CALML6; calmodulin like 6 [KO:K02183]", "51806  CALML5; calmodulin like 5 [KO:K02183]", "91860  CALML4; calmodulin like 4 [KO:K02183]", "815  CAMK2A; calcium/calmodulin dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]", "817  CAMK2D; calcium/calmodulin dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]", "816  CAMK2B; calcium/calmodulin dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]", "818  CAMK2G; calcium/calmodulin dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]", "814  CAMK4; calcium/calmodulin dependent protein kinase IV [KO:K05869] [EC:2.7.11.17]", "25  ABL1; ABL proto-oncogene 1, non-receptor tyrosine kinase [KO:K06619] [EC:2.7.10.2]", "5781  PTPN11; protein tyrosine phosphatase non-receptor type 11 [KO:K07293] [EC:3.1.3.48]", "4145  MATK; megakaryocyte-associated tyrosine kinase [KO:K08888] [EC:2.7.10.2]", "4804  NGFR; nerve growth factor receptor [KO:K02583]", "397  ARHGDIB; Rho GDP dissociation inhibitor beta [KO:K12462]", "396  ARHGDIA; Rho GDP dissociation inhibitor alpha [KO:K12462]", "398  ARHGDIG; Rho GDP dissociation inhibitor gamma [KO:K12462]", "387  RHOA; ras homolog family member A [KO:K04513]", "998  CDC42; cell division cycle 42 [KO:K04393]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "4214  MAP3K1; mitogen-activated protein kinase kinase kinase 1 [KO:K04416] [EC:2.7.11.25]", "4217  MAP3K5; mitogen-activated protein kinase kinase kinase 5 [KO:K04426] [EC:2.7.11.25]", "5609  MAP2K7; mitogen-activated protein kinase kinase 7 [KO:K04431] [EC:2.7.12.2]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "7157  TP53; tumor protein p53 [KO:K04451]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "7161  TP73; tumor protein p73 [KO:K10148]", "7189  TRAF6; TNF receptor associated factor 6 [KO:K03175] [EC:2.3.2.27]", "10782  ZNF274; zinc finger protein 274 [KO:K12458]", "11108  PRDM4; PR/SET domain 4 [KO:K12463] [EC:2.1.1.-]", "9500  MAGED1; MAGE family member D1 [KO:K12464]", "27018  BEX3; brain expressed X-linked 3 [KO:K12465]", "7531  YWHAE; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon [KO:K06630]", "8767  RIPK2; receptor interacting serine/threonine kinase 2 [KO:K08846] [EC:2.7.11.1]", "3654  IRAK1; interleukin 1 receptor associated kinase 1 [KO:K04730] [EC:2.7.11.1]", "3656  IRAK2; interleukin 1 receptor associated kinase 2 [KO:K04731] [EC:2.7.11.1]", "11213  IRAK3; interleukin 1 receptor associated kinase 3 [KO:K04732] [EC:2.7.11.1]", "51135  IRAK4; interleukin 1 receptor associated kinase 4 [KO:K04733] [EC:2.7.11.1]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "6272  SORT1; sortilin 1 [KO:K12388]", "5663  PSEN1; presenilin 1 [KO:K04505] [EC:3.4.23.-]", "5664  PSEN2; presenilin 2 [KO:K04522] [EC:3.4.23.-]"], "compound": ["C00076  Calcium cation", "C00165  Diacylglycerol", "C00195  N-Acylsphingosine", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C05981  Phosphatidylinositol-3,4,5-trisphosphate"], "refs": [{"pmid": "12676795", "authors": "  Huang EJ, Reichardt LF.", "title": "Trk receptors: roles in neuronal signal transduction.", "journal": "Annu Rev Biochem 72:609-42 (2003)", "doi": "10.1146/annurev.biochem.72.121801.161629"}, {"pmid": "11399424", "authors": "  Patapoutian A, Reichardt LF", "title": "Trk receptors: mediators of neurotrophin action.", "journal": "Curr Opin Neurobiol 11:272-80 (2001)", "doi": "10.1016/S0959-4388(00)00208-7"}, {"pmid": "16699811", "authors": "  Arevalo JC, Wu SH", "title": "Neurotrophin signaling: many exciting surprises!", "journal": "Cell Mol Life Sci 63:1523-37 (2006)", "doi": "10.1007/s00018-006-6010-1"}, {"pmid": "14704852", "authors": "  Teng KK, Hempstead BL", "title": "Neurotrophins and their receptors: signaling trios in complex biological systems.", "journal": "Cell Mol Life Sci 61:35-48 (2004)", "doi": "10.1007/s00018-003-3099-3"}, {"pmid": "11529497", "authors": "  Miller FD, Kaplan DR", "title": "Neurotrophin signalling pathways regulating neuronal apoptosis.", "journal": "Cell Mol Life Sci 58:1045-53 (2001)", "doi": "10.1007/PL00000919"}, {"pmid": "10851172", "authors": "  Kaplan DR, Miller FD", "title": "Neurotrophin signal transduction in the nervous system.", "journal": "Curr Opin Neurobiol 10:381-91 (2000)", "doi": "10.1016/S0959-4388(00)00092-1"}, {"pmid": "16939974", "authors": "  Reichardt LF", "title": "Neurotrophin-regulated signalling pathways.", "journal": "Philos Trans R Soc Lond B Biol Sci 361:1545-64 (2006)", "doi": "10.1098/rstb.2006.1894"}, {"pmid": "16856873", "authors": "  Zampieri N, Chao MV", "title": "Mechanisms of neurotrophin receptor signalling.", "journal": "Biochem Soc Trans 34:607-11 (2006)", "doi": "10.1042/BST0340607"}, {"pmid": "15499580", "authors": "  Rose CR, Blum R, Kafitz KW, Kovalchuk Y, Konnerth A", "title": "From modulator to mediator: rapid effects of BDNF on ion channels.", "journal": "Bioessays 26:1185-94 (2004)", "doi": "10.1002/bies.20118"}, {"pmid": "10812966", "authors": "  Yano H, Chao MV", "title": "Neurotrophin receptor structure and interactions.", "journal": "Pharm Acta Helv 74:253-60 (2000)", "doi": "10.1016/s0031-6865(99)00036-9"}, {"pmid": "10764727", "authors": "  Mukai J, Hachiya T, Shoji-Hoshino S, Kimura MT, Nadano D, Suvanto P, Hanaoka T, Li Y, Irie S, Greene LA, Sato TA", "title": "NADE, a p75NTR-associated cell death executor, is involved in signal transduction mediated by the common neurotrophin receptor p75NTR.", "journal": "J Biol Chem 275:17566-70 (2000)", "doi": "10.1074/jbc.C000140200"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04120  Ubiquitin mediated proteolysis", "hsa04210  Apoptosis", "hsa04720  Long-term potentiation", "hsa04810  Regulation of actin cytoskeleton"], "ko_pathway": "ko04722", "genes": ["RAC1", "TP53", "BRAF", "AKT2", "AKT1", "SOS1", "MAPK13", "NRAS", "BAX"]}, {"kegg_id": "hsa04932", "name": "Non-alcoholic fatty liver disease - Homo sapiens (human)", "description": "Non-alcoholic fatty liver disease (NAFLD) represents a spectrum ranging from simple steatosis to more severe steatohepatitis with hepatic inflammation and fibrosis, known as nonalcoholic steatohepatitis (NASH). NASH may further lead to cirrhosis and hepatocellular carcinoma (HCC). This map shows a stage-dependent progression of NAFLD. In the first stage of NAFLD, excess lipid accumulation has been demonstrated. The main cause is the induction of insulin resistance, which leads to a defect in insulin suppression of free fatty acids (FAAs) disposal. In addition, two transcription factors, SREBP-1c and PPAR-alpha, activate key enzymes of lipogenesis and increase the synthesis of FAAs in liver. In the second stage, as a consequence of the progression to NASH, the production of reactive oxygen species (ROS) is enhanced due to oxidation stress through mitochondrial beta-oxidation of fatty acids and endoplamic reticulum (ER) stress, leading to lipid peroxidation. The lipid peroxidation can further cause the production of cytokines (Fas ligand, TNF-alpha, IL-8 and TGF), promoting cell death, inflammation and fibrosis. The activation of JNK, which is induced by ER stress, TNF-alpha and FAAs, is also associated with NAFLD progression. Increased JNK promotes cytokine production and initiation of HCC.", "class": "Human Diseases; Endocrine and metabolic disease", "pathway_map": "hsa04932  Non-alcoholic fatty liver disease", "disease": ["H01333  Non-alcoholic fatty liver disease"], "drug": ["D10988  Selonsertib (JAN/USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["3569  IL6; interleukin 6 [KO:K05405]", "3570  IL6R; interleukin 6 receptor [KO:K05055]", "9021  SOCS3; suppressor of cytokine signaling 3 [KO:K04696]", "7124  TNF; tumor necrosis factor [KO:K03156]", "7132  TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "3630  INS; insulin [KO:K04526]", "3643  INSR; insulin receptor [KO:K04527] [EC:2.7.10.1]", "3667  IRS1; insulin receptor substrate 1 [KO:K16172]", "8660  IRS2; insulin receptor substrate 2 [KO:K07187]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "2931  GSK3A; glycogen synthase kinase 3 alpha [KO:K08822] [EC:2.7.11.26]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "10062  NR1H3; nuclear receptor subfamily 1 group H member 3 [KO:K08536]", "6256  RXRA; retinoid X receptor alpha [KO:K08524]", "6720  SREBF1; sterol regulatory element binding transcription factor 1 [KO:K07197]", "6945  MLX; MAX dimerization protein MLX [KO:K09113]", "22877  MLXIP; MLX interacting protein [KO:K09113]", "51085  MLXIPL; MLX interacting protein like [KO:K09113]", "5313  PKLR; pyruvate kinase L/R [KO:K12406] [EC:2.7.1.40]", "3952  LEP; leptin [KO:K05424]", "3953  LEPR; leptin receptor [KO:K05062]", "9370  ADIPOQ; adiponectin, C1Q and collagen domain containing [KO:K07296]", "51094  ADIPOR1; adiponectin receptor 1 [KO:K07297]", "79602  ADIPOR2; adiponectin receptor 2 [KO:K07297]", "5562  PRKAA1; protein kinase AMP-activated catalytic subunit alpha 1 [KO:K07198] [EC:2.7.11.31]", "5563  PRKAA2; protein kinase AMP-activated catalytic subunit alpha 2 [KO:K07198] [EC:2.7.11.31]", "5564  PRKAB1; protein kinase AMP-activated non-catalytic subunit beta 1 [KO:K07199]", "5565  PRKAB2; protein kinase AMP-activated non-catalytic subunit beta 2 [KO:K07199]", "5571  PRKAG1; protein kinase AMP-activated non-catalytic subunit gamma 1 [KO:K07200]", "53632  PRKAG3; protein kinase AMP-activated non-catalytic subunit gamma 3 [KO:K07200]", "51422  PRKAG2; protein kinase AMP-activated non-catalytic subunit gamma 2 [KO:K07200]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "5465  PPARA; peroxisome proliferator activated receptor alpha [KO:K07294]", "5468  PPARG; peroxisome proliferator activated receptor gamma [KO:K08530]", "998  CDC42; cell division cycle 42 [KO:K04393]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "4296  MAP3K11; mitogen-activated protein kinase kinase kinase 11 [KO:K04419] [EC:2.7.11.25]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "83737  ITCH; itchy E3 ubiquitin protein ligase [KO:K05632] [EC:2.3.2.26]", "2081  ERN1; endoplasmic reticulum to nucleus signaling 1 [KO:K08852] [EC:2.7.11.1 3.1.26.-]", "7186  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]", "4217  MAP3K5; mitogen-activated protein kinase kinase kinase 5 [KO:K04426] [EC:2.7.11.25]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "3552  IL1A; interleukin 1 alpha [KO:K04383]", "3553  IL1B; interleukin 1 beta [KO:K04519]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "7494  XBP1; X-box binding protein 1 [KO:K09027]", "1050  CEBPA; CCAAT enhancer binding protein alpha [KO:K09055]", "1571  CYP2E1; cytochrome P450 family 2 subfamily E member 1 [KO:K07415] [EC:1.14.14.-]", "356  FASLG; Fas ligand [KO:K04389]", "3576  CXCL8; C-X-C motif chemokine ligand 8 [KO:K10030]", "7040  TGFB1; transforming growth factor beta 1 [KO:K13375]", "9451  EIF2AK3; eukaryotic translation initiation factor 2 alpha kinase 3 [KO:K08860] [EC:2.7.11.1]", "1965  EIF2S1; eukaryotic translation initiation factor 2 subunit alpha [KO:K03237]", "468  ATF4; activating transcription factor 4 [KO:K04374]", "1649  DDIT3; DNA damage inducible transcript 3 [KO:K04452]", "10018  BCL2L11; BCL2 like 11 [KO:K16341]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "355  FAS; Fas cell surface death receptor [KO:K04390]", "841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]", "637  BID; BH3 interacting domain death agonist [KO:K04726]", "54205  CYCS; cytochrome c, somatic [KO:K08738]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "840  CASP7; caspase 7 [KO:K04397] [EC:3.4.22.60]", "4723  NDUFV1; NADH:ubiquinone oxidoreductase core subunit V1 [KO:K03942] [EC:7.1.1.2]", "4729  NDUFV2; NADH:ubiquinone oxidoreductase core subunit V2 [KO:K03943] [EC:7.1.1.2]", "4731  NDUFV3; NADH:ubiquinone oxidoreductase subunit V3 [KO:K03944]", "4694  NDUFA1; NADH:ubiquinone oxidoreductase subunit A1 [KO:K03945]", "4695  NDUFA2; NADH:ubiquinone oxidoreductase subunit A2 [KO:K03946]", "4696  NDUFA3; NADH:ubiquinone oxidoreductase subunit A3 [KO:K03947]", "4697  NDUFA4; NDUFA4 mitochondrial complex associated [KO:K03948]", "56901  NDUFA4L2; NDUFA4 mitochondrial complex associated like 2 [KO:K03948]", "4698  NDUFA5; NADH:ubiquinone oxidoreductase subunit A5 [KO:K03949]", "4700  NDUFA6; NADH:ubiquinone oxidoreductase subunit A6 [KO:K03950]", "4701  NDUFA7; NADH:ubiquinone oxidoreductase subunit A7 [KO:K03951]", "4702  NDUFA8; NADH:ubiquinone oxidoreductase subunit A8 [KO:K03952]", "4704  NDUFA9; NADH:ubiquinone oxidoreductase subunit A9 [KO:K03953]", "4705  NDUFA10; NADH:ubiquinone oxidoreductase subunit A10 [KO:K03954]", "4706  NDUFAB1; NADH:ubiquinone oxidoreductase subunit AB1 [KO:K03955]", "126328  NDUFA11; NADH:ubiquinone oxidoreductase subunit A11 [KO:K03956]", "55967  NDUFA12; NADH:ubiquinone oxidoreductase subunit A12 [KO:K11352]", "51079  NDUFA13; NADH:ubiquinone oxidoreductase subunit A13 [KO:K11353]", "4707  NDUFB1; NADH:ubiquinone oxidoreductase subunit B1 [KO:K03957]", "4708  NDUFB2; NADH:ubiquinone oxidoreductase subunit B2 [KO:K03958]", "4709  NDUFB3; NADH:ubiquinone oxidoreductase subunit B3 [KO:K03959]", "4710  NDUFB4; NADH:ubiquinone oxidoreductase subunit B4 [KO:K03960]", "4711  NDUFB5; NADH:ubiquinone oxidoreductase subunit B5 [KO:K03961]", "4712  NDUFB6; NADH:ubiquinone oxidoreductase subunit B6 [KO:K03962]", "4713  NDUFB7; NADH:ubiquinone oxidoreductase subunit B7 [KO:K03963]", "4714  NDUFB8; NADH:ubiquinone oxidoreductase subunit B8 [KO:K03964]", "4715  NDUFB9; NADH:ubiquinone oxidoreductase subunit B9 [KO:K03965]", "4716  NDUFB10; NADH:ubiquinone oxidoreductase subunit B10 [KO:K03966]", "54539  NDUFB11; NADH:ubiquinone oxidoreductase subunit B11 [KO:K11351]", "4719  NDUFS1; NADH:ubiquinone oxidoreductase core subunit S1 [KO:K03934] [EC:7.1.1.2]", "4720  NDUFS2; NADH:ubiquinone oxidoreductase core subunit S2 [KO:K03935] [EC:7.1.1.2]", "4722  NDUFS3; NADH:ubiquinone oxidoreductase core subunit S3 [KO:K03936] [EC:7.1.1.2]", "4724  NDUFS4; NADH:ubiquinone oxidoreductase subunit S4 [KO:K03937]", "4725  NDUFS5; NADH:ubiquinone oxidoreductase subunit S5 [KO:K03938]", "4726  NDUFS6; NADH:ubiquinone oxidoreductase subunit S6 [KO:K03939]", "374291  NDUFS7; NADH:ubiquinone oxidoreductase core subunit S7 [KO:K03940] [EC:7.1.1.2]", "4728  NDUFS8; NADH:ubiquinone oxidoreductase core subunit S8 [KO:K03941] [EC:7.1.1.2]", "4717  NDUFC1; NADH:ubiquinone oxidoreductase subunit C1 [KO:K03967]", "4718  NDUFC2; NADH:ubiquinone oxidoreductase subunit C2 [KO:K03968]", "100532726  NDUFC2-KCTD14; NDUFC2-KCTD14 readthrough [KO:K03968]", "6389  SDHA; succinate dehydrogenase complex flavoprotein subunit A [KO:K00234] [EC:1.3.5.1]", "6390  SDHB; succinate dehydrogenase complex iron sulfur subunit B [KO:K00235] [EC:1.3.5.1]", "6391  SDHC; succinate dehydrogenase complex subunit C [KO:K00236]", "6392  SDHD; succinate dehydrogenase complex subunit D [KO:K00237]", "7386  UQCRFS1; ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 [KO:K00411] [EC:7.1.1.8]", "4519  CYTB; cytochrome b [KO:K00412]", "1537  CYC1; cytochrome c1 [KO:K00413]", "7384  UQCRC1; ubiquinol-cytochrome c reductase core protein 1 [KO:K00414]", "7385  UQCRC2; ubiquinol-cytochrome c reductase core protein 2 [KO:K00415]", "7388  UQCRH; ubiquinol-cytochrome c reductase hinge protein [KO:K00416]", "440567  UQCRHL; ubiquinol-cytochrome c reductase hinge protein like [KO:K00416]", "7381  UQCRB; ubiquinol-cytochrome c reductase binding protein [KO:K00417]", "27089  UQCRQ; ubiquinol-cytochrome c reductase complex III subunit VII [KO:K00418]", "29796  UQCR10; ubiquinol-cytochrome c reductase, complex III subunit X [KO:K00419]", "10975  UQCR11; ubiquinol-cytochrome c reductase, complex III subunit XI [KO:K00420]", "4514  COX3; cytochrome c oxidase subunit III [KO:K02262]", "4512  COX1; cytochrome c oxidase subunit I [KO:K02256] [EC:7.1.1.9]", "4513  COX2; cytochrome c oxidase subunit II [KO:K02261]", "84701  COX4I2; cytochrome c oxidase subunit 4I2 [KO:K02263]", "1327  COX4I1; cytochrome c oxidase subunit 4I1 [KO:K02263]", "9377  COX5A; cytochrome c oxidase subunit 5A [KO:K02264]", "1329  COX5B; cytochrome c oxidase subunit 5B [KO:K02265]", "1337  COX6A1; cytochrome c oxidase subunit 6A1 [KO:K02266]", "1339  COX6A2; cytochrome c oxidase subunit 6A2 [KO:K02266]", "1340  COX6B1; cytochrome c oxidase subunit 6B1 [KO:K02267]", "125965  COX6B2; cytochrome c oxidase subunit 6B2 [KO:K02267]", "1345  COX6C; cytochrome c oxidase subunit 6C [KO:K02268]", "1346  COX7A1; cytochrome c oxidase subunit 7A1 [KO:K02270]", "1347  COX7A2; cytochrome c oxidase subunit 7A2 [KO:K02270]", "9167  COX7A2L; cytochrome c oxidase subunit 7A2 like [KO:K02270]", "1349  COX7B; cytochrome c oxidase subunit 7B [KO:K02271]", "170712  COX7B2; cytochrome c oxidase subunit 7B2 [KO:K02271]", "1350  COX7C; cytochrome c oxidase subunit 7C [KO:K02272]", "341947  COX8C; cytochrome c oxidase subunit 8C [KO:K02273]", "1351  COX8A; cytochrome c oxidase subunit 8A [KO:K02273]"], "compound": ["C00031  D-Glucose", "C00162  Fatty acid"], "refs": [{"pmid": "23545492", "authors": "  Naik A, Kosir R, Rozman D", "title": "Genomic aspects of NAFLD pathogenesis.", "journal": "Genomics 102:84-95 (2013)", "doi": "10.1016/j.ygeno.2013.03.007"}, {"pmid": "19352614", "authors": "  Malaguarnera M, Di Rosa M, Nicoletti F, Malaguarnera L", "title": "Molecular mechanisms involved in NAFLD progression.", "journal": "J Mol Med (Berl) 87:679-95 (2009)", "doi": "10.1007/s00109-009-0464-1"}, {"pmid": "22705006", "authors": "  Seki E, Brenner DA, Karin M", "title": "A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches.", "journal": "Gastroenterology 143:307-20 (2012)", "doi": "10.1053/j.gastro.2012.06.004"}, {"pmid": "21038418", "authors": "  Tilg H, Moschen AR", "title": "Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis.", "journal": "Hepatology 52:1836-46 (2010)", "doi": "10.1002/hep.24001"}, {"pmid": "16364488", "authors": "  Larter CZ, Farrell GC", "title": "Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?", "journal": "J Hepatol 44:253-61 (2006)", "doi": "10.1016/j.jhep.2005.11.030"}, {"pmid": "22570745", "authors": "  Farrell GC, van Rooyen D, Gan L, Chitturi S", "title": "NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications.", "journal": "Gut Liver 6:149-71 (2012)", "doi": "10.5009/gnl.2012.6.2.149"}, {"pmid": "20619513", "authors": "  Shapiro H, Tehilla M, Attal-Singer J, Bruck R, Luzzatti R, Singer P", "title": "The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease.", "journal": "Clin Nutr 30:6-19 (2011)", "doi": "10.1016/j.clnu.2010.06.001"}, {"pmid": "20303879", "authors": "  Hotamisligil GS", "title": "Endoplasmic reticulum stress and the inflammatory basis of metabolic disease.", "journal": "Cell 140:900-17 (2010)", "doi": "10.1016/j.cell.2010.02.034"}, {"pmid": "17498512", "authors": "  Parekh S, Anania FA", "title": "Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease.", "journal": "Gastroenterology 132:2191-207 (2007)", "doi": "10.1053/j.gastro.2007.03.055"}, {"pmid": "16374858", "authors": "  Schattenberg JM, Singh R, Wang Y, Lefkowitch JH, Rigoli RM, Scherer PE, Czaja MJ", "title": "JNK1 but not JNK2 promotes the development of steatohepatitis in mice.", "journal": "Hepatology 43:163-72 (2006)", "doi": "10.1002/hep.20999"}, {"pmid": "22940046", "authors": "  Leung TM, Nieto N", "title": "CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease.", "journal": "J Hepatol 58:395-8 (2013)", "doi": "10.1016/j.jhep.2012.08.018"}, {"pmid": "14685853", "authors": "  Zafrani ES", "title": "Non-alcoholic fatty liver disease: an emerging pathological spectrum.", "journal": "Virchows Arch 444:3-12 (2004)", "doi": "10.1007/s00428-003-0943-7"}, {"pmid": "12891546", "authors": "  Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, Gores GJ", "title": "Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis.", "journal": "Gastroenterology 125:437-43 (2003)", "doi": "10.1016/S0016-5085(03)00907-7"}, {"pmid": "16406828", "authors": "  Begriche K, Igoudjil A, Pessayre D, Fromenty B", "title": "Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it.", "journal": "Mitochondrion 6:1-28 (2006)", "doi": "10.1016/j.mito.2005.10.004"}, {"pmid": "9285483", "authors": "  Leonarduzzi G, Scavazza A, Biasi F, Chiarpotto E, Camandola S, Vogel S, Dargel R, Poli G", "title": "The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor beta1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis.", "journal": "FASEB J 11:851-7 (1997)", "doi": "10.1096/fasebj.11.11.9285483"}, {"pmid": "21145844", "authors": "  Malhi H, Kaufman RJ", "title": "Endoplasmic reticulum stress in liver disease.", "journal": "J Hepatol 54:795-809 (2011)", "doi": "10.1016/j.jhep.2010.11.005"}, {"pmid": "18242193", "authors": "  Mantena SK, King AL, Andringa KK, Eccleston HB, Bailey SM", "title": "Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases.", "journal": "Free Radic Biol Med 44:1259-72 (2008)", "doi": "10.1016/j.freeradbiomed.2007.12.029"}, {"pmid": "18061659", "authors": "  Serviddio G, Sastre J, Bellanti F, Vina J, Vendemiale G, Altomare E", "title": "Mitochondrial involvement in non-alcoholic steatohepatitis.", "journal": "Mol Aspects Med 29:22-35 (2008)", "doi": "10.1016/j.mam.2007.09.014"}], "rel_pathway": ["hsa00061  Fatty acid biosynthesis", "hsa00190  Oxidative phosphorylation", "hsa03320  PPAR signaling pathway", "hsa04141  Protein processing in endoplasmic reticulum", "hsa04151  PI3K-Akt signaling pathway", "hsa04210  Apoptosis", "hsa04668  TNF signaling pathway", "hsa04920  Adipocytokine signaling pathway", "hsa04930  Type II diabetes mellitus"], "ko_pathway": "ko04932", "genes": ["RAC1", "AKT2", "AKT1", "MAPK13", "BAX"]}, {"kegg_id": "hsa04933", "name": "AGE-RAGE signaling pathway in diabetic complications - Homo sapiens (human)", "description": "Advanced glycation end products (AGEs) are a complex group of compounds produced through the non-enzymatic glycation and oxidation of proteins, lipids and nucleic acids, primarily due to aging and under certain pathologic condition such as huperglycemia. Some of the best chemically characterized AGEs include N-epsilon-carboxy-methyl-lysine (CML), N-epsilon-carboxy-ethyl-lysine (CEL), and Imidazolone. The major receptor for AGEs, known as receptor for advanced glycation end products (RAGE or AGER), belongs to the immunoglobulin superfamily and has been described as a pattern recognition receptor. AGE/RAGE signaling elicits activation of multiple intracellular signal pathways involving NADPH oxidase, protein kinase C, and MAPKs, then resulting in NF-kappaB activity. NF-kappa B promotes the expression of pro-inflammatory cytokines such as IL-1, IL-6 and TNF-alpha and a variety of atherosclerosis-related genes, including VCAM-1, tissue factor, VEGF, and RAGE. In addition, JAK-STAT-mediated and PI3K-Akt-dependent pathways are induced via RAGE, which in turn participate in cell proliferation and apoptosis respectively. Hypoxia-mediated induction of Egr-1 was also shown to require the AGE-RAGE interaction. The results of these signal transductions have been reported to be the possible mechanism that initates diabetic complications.", "class": "Human Diseases; Endocrine and metabolic disease", "pathway_map": "hsa04933  AGE-RAGE signaling pathway in diabetic complications", "drug": ["D11814  Tisotumab vedotin (USAN/INN)", "D12654  Emapticap pegol (INN)"], "dblinks": "GO: 1904603", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["7042  TGFB2; transforming growth factor beta 2 [KO:K13376]", "7043  TGFB3; transforming growth factor beta 3 [KO:K13377]", "7040  TGFB1; transforming growth factor beta 1 [KO:K13375]", "7046  TGFBR1; transforming growth factor beta receptor 1 [KO:K04674] [EC:2.7.11.30]", "7048  TGFBR2; transforming growth factor beta receptor 2 [KO:K04388] [EC:2.7.11.30]", "4087  SMAD2; SMAD family member 2 [KO:K04500]", "4088  SMAD3; SMAD family member 3 [KO:K23605]", "4089  SMAD4; SMAD family member 4 [KO:K04501]", "1027  CDKN1B; cyclin dependent kinase inhibitor 1B [KO:K06624]", "2335  FN1; fibronectin 1 [KO:K05717]", "1277  COL1A1; collagen type I alpha 1 chain [KO:K06236]", "1278  COL1A2; collagen type I alpha 2 chain [KO:K06236]", "1281  COL3A1; collagen type III alpha 1 chain [KO:K19720]", "1284  COL4A2; collagen type IV alpha 2 chain [KO:K06237]", "1286  COL4A4; collagen type IV alpha 4 chain [KO:K06237]", "1288  COL4A6; collagen type IV alpha 6 chain [KO:K06237]", "1282  COL4A1; collagen type IV alpha 1 chain [KO:K06237]", "1287  COL4A5; collagen type IV alpha 5 chain [KO:K06237]", "1285  COL4A3; collagen type IV alpha 3 chain [KO:K06237]", "183  AGT; angiotensinogen [KO:K09821]", "185  AGTR1; angiotensin II receptor type 1 [KO:K04166]", "177  AGER; advanced glycosylation end-product specific receptor [KO:K19722]", "27035  NOX1; NADPH oxidase 1 [KO:K08008]", "1536  CYBB; cytochrome b-245 beta chain [KO:K21421] [EC:1.-.-.-]", "50507  NOX4; NADPH oxidase 4 [KO:K21423] [EC:1.6.3.-]", "5333  PLCD1; phospholipase C delta 1 [KO:K05857] [EC:3.1.4.11]", "113026  PLCD3; phospholipase C delta 3 [KO:K05857] [EC:3.1.4.11]", "84812  PLCD4; phospholipase C delta 4 [KO:K05857] [EC:3.1.4.11]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]", "51196  PLCE1; phospholipase C epsilon 1 [KO:K05860] [EC:3.1.4.11]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5580  PRKCD; protein kinase C delta [KO:K06068] [EC:2.7.11.13]", "5581  PRKCE; protein kinase C epsilon [KO:K18050] [EC:2.7.11.13]", "5590  PRKCZ; protein kinase C zeta [KO:K18952] [EC:2.7.11.13]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "7422  VEGFA; vascular endothelial growth factor A [KO:K05448]", "7423  VEGFB; vascular endothelial growth factor B [KO:K16858]", "7424  VEGFC; vascular endothelial growth factor C [KO:K05449]", "2277  VEGFD; vascular endothelial growth factor D [KO:K05449]", "6347  CCL2; C-C motif chemokine ligand 2 [KO:K14624]", "5054  SERPINE1; serpin family E member 1 [KO:K03982]", "6401  SELE; selectin E [KO:K06494]", "7412  VCAM1; vascular cell adhesion molecule 1 [KO:K06527]", "3383  ICAM1; intercellular adhesion molecule 1 [KO:K06490]", "4313  MMP2; matrix metallopeptidase 2 [KO:K01398] [EC:3.4.24.24]", "3552  IL1A; interleukin 1 alpha [KO:K04383]", "3553  IL1B; interleukin 1 beta [KO:K04519]", "3569  IL6; interleukin 6 [KO:K05405]", "3576  CXCL8; C-X-C motif chemokine ligand 8 [KO:K10030]", "7124  TNF; tumor necrosis factor [KO:K03156]", "2152  F3; coagulation factor III, tissue factor [KO:K03901]", "1906  EDN1; endothelin 1 [KO:K16366]", "7056  THBD; thrombomodulin [KO:K03907]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "1729  DIAPH1; diaphanous related formin 1 [KO:K05740]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "998  CDC42; cell division cycle 42 [KO:K04393]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "4846  NOS3; nitric oxide synthase 3 [KO:K13242] [EC:1.14.13.39]", "2308  FOXO1; forkhead box O1 [KO:K07201]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "3717  JAK2; Janus kinase 2 [KO:K04447] [EC:2.7.10.2]", "6774  STAT3; signal transducer and activator of transcription 3 [KO:K04692]", "5292  PIM1; Pim-1 proto-oncogene, serine/threonine kinase [KO:K04702] [EC:2.7.11.1]", "4772  NFATC1; nuclear factor of activated T cells 1 [KO:K04446]", "6772  STAT1; signal transducer and activator of transcription 1 [KO:K11220]", "6776  STAT5A; signal transducer and activator of transcription 5A [KO:K11223]", "6777  STAT5B; signal transducer and activator of transcription 5B [KO:K11224]", "595  CCND1; cyclin D1 [KO:K04503]", "1019  CDK4; cyclin dependent kinase 4 [KO:K02089] [EC:2.7.11.22]", "1958  EGR1; early growth response 1 [KO:K09203]"], "compound": ["C00031  D-Glucose", "C00076  Calcium cation", "C00165  Diacylglycerol", "C00195  N-Acylsphingosine", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C21011  [Protein]-N(epsilon)-(carboxymethyl)lysine", "C21012  [Protein]-N(epsilon)-(carboxyethyl)lysine", "C21013  [Protein]-pyrraline", "C21014  [Protein]-pentosidine"], "refs": [{"pmid": "21261520", "authors": "  Kanwar YS, Sun L, Xie P, Liu FY, Chen S", "title": "A glimpse of various pathogenetic mechanisms of diabetic nephropathy.", "journal": "Annu Rev Pathol 6:395-423 (2011)", "doi": "10.1146/annurev.pathol.4.110807.092150"}, {"pmid": "21111800", "authors": "  Yamagishi S", "title": "Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes.", "journal": "Exp Gerontol 46:217-24 (2011)", "doi": "10.1016/j.exger.2010.11.007"}, {"pmid": "23961320", "authors": "  Roy B", "title": "Biomolecular basis of the role of diabetes mellitus in osteoporosis and bone fractures.", "journal": "World J Diabetes 4:101-13 (2013)", "doi": "10.4239/wjd.v4.i4.101"}, {"pmid": "22558488", "authors": "  Hegab Z, Gibbons S, Neyses L, Mamas MA", "title": "Role of advanced glycation end products in cardiovascular disease.", "journal": "World J Cardiol 4:90-102 (2012)", "doi": "10.4330/wjc.v4.i4.90"}, {"pmid": "19404313", "authors": "  Calcutt NA, Cooper ME, Kern TS, Schmidt AM", "title": "Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials.", "journal": "Nat Rev Drug Discov 8:417-29 (2009)", "doi": "10.1038/nrd2476"}, {"pmid": "11180401", "authors": "  Huang JS, Guh JY, Chen HC, Hung WC, Lai YH, Chuang LY", "title": "Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells.", "journal": "J Cell Biochem 81:102-13 (2001)", "doi": "10.1002/1097-4644(20010401)81:1<102::AID-JCB1027>3.0.CO;2-Y"}, {"pmid": "21680901", "authors": "  Meloche J, Paulin R, Courboulin A, Lambert C, Barrier M, Bonnet P, Bisserier M, Roy M, Sussman MA, Agharazii M, Bonnet S", "title": "RAGE-dependent activation of the oncoprotein Pim1 plays a critical role in systemic vascular remodeling processes.", "journal": "Arterioscler Thromb Vasc Biol 31:2114-24 (2011)", "doi": "10.1161/ATVBAHA.111.230573"}, {"pmid": "11684565", "authors": "  Guh JY, Huang JS, Chen HC, Hung WC, Lai YH, Chuang LY", "title": "Advanced glycation end product-induced proliferation in NRK-49F cells is dependent on the JAK2/STAT5 pathway and cyclin D1.", "journal": "Am J Kidney Dis 38:1096-104 (2001)", "doi": "10.1053/ajkd.2001.28616"}, {"pmid": "16894049", "authors": "  Goldin A, Beckman JA, Schmidt AM, Creager MA", "title": "Advanced glycation end products: sparking the development of diabetic vascular injury.", "journal": "Circulation 114:597-605 (2006)", "doi": "10.1161/CIRCULATIONAHA.106.621854"}, {"pmid": "21590515", "authors": "  Zong H, Ward M, Stitt AW", "title": "AGEs, RAGE, and diabetic retinopathy.", "journal": "Curr Diab Rep 11:244-52 (2011)", "doi": "10.1007/s11892-011-0198-7"}, {"pmid": "21440603", "authors": "  Yamagishi S, Maeda S, Matsui T, Ueda S, Fukami K, Okuda S", "title": "Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes.", "journal": "Biochim Biophys Acta 1820:663-71 (2012)", "doi": "10.1016/j.bbagen.2011.03.014"}, {"pmid": "23776698", "authors": "  Shi L, Yu X, Yang H, Wu X", "title": "Advanced glycation end products induce human corneal epithelial cells apoptosis through generation of reactive oxygen species and activation of JNK and p38 MAPK pathways.", "journal": "PLoS One 8:e66781 (2013)", "doi": "10.1371/journal.pone.0066781"}, {"pmid": "17005604", "authors": "  Alikhani M, Maclellan CM, Raptis M, Vora S, Trackman PC, Graves DT", "title": "Advanced glycation end products induce apoptosis in fibroblasts through activation of ROS, MAP kinases, and the FOXO1 transcription factor.", "journal": "Am J Physiol Cell Physiol 292:C850-6 (2007)", "doi": "10.1152/ajpcell.00356.2006"}, {"pmid": "20470857", "authors": "  Sheikpranbabu S, Haribalaganesh R, Lee KJ, Gurunathan S", "title": "Pigment epithelium-derived factor inhibits advanced glycation end products-induced retinal vascular permeability.", "journal": "Biochimie 92:1040-51 (2010)", "doi": "10.1016/j.biochi.2010.05.004"}, {"pmid": "18922799", "authors": "  Hudson BI, Kalea AZ, Del Mar Arriero M, Harja E, Boulanger E, D'Agati V, Schmidt AM", "title": "Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42.", "journal": "J Biol Chem 283:34457-68 (2008)", "doi": "10.1074/jbc.M801465200"}, {"pmid": "11375353", "authors": "  Yeh CH, Sturgis L, Haidacher J, Zhang XN, Sherwood SJ, Bjercke RJ, Juhasz O, Crow MT, Tilton RG, Denner L", "title": "Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion.", "journal": "Diabetes 50:1495-504 (2001)", "doi": "10.2337/diabetes.50.6.1495"}, {"pmid": "12709399", "authors": "  Li JH, Huang XR, Zhu HJ, Oldfield M, Cooper M, Truong LD, Johnson RJ, Lan HY", "title": "Advanced glycation end products activate Smad signaling via TGF-beta-dependent and independent mechanisms: implications for diabetic renal and vascular disease.", "journal": "FASEB J 18:176-8 (2004)", "doi": "10.1096/fj.02-1117fje"}, {"pmid": "18323529", "authors": "  Chang JS, Wendt T, Qu W, Kong L, Zou YS, Schmidt AM, Yan SF", "title": "Oxygen deprivation triggers upregulation of early growth response-1 by the receptor for advanced glycation end products.", "journal": "Circ Res 102:905-13 (2008)", "doi": "10.1161/CIRCRESAHA.107.165308"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04110  Cell cycle", "hsa04151  PI3K-Akt signaling pathway", "hsa04350  TGF-beta signaling pathway", "hsa04614  Renin-angiotensin system", "hsa04630  JAK-STAT signaling pathway"], "ko_pathway": "ko04933", "genes": ["RAC1", "AKT2", "AKT1", "MAPK13", "NRAS", "BAX", "PIM1"]}, {"kegg_id": "hsa04972", "name": "Pancreatic secretion - Homo sapiens (human)", "description": "The pancreas performs both exocrine and endocrine functions. The exocrine pancreas consists of two parts, the acinar and duct cells. The primary functions of pancreatic acinar cells are to synthesize and secrete digestive enzymes. Stimulation of the cell by secretagogues such as acetylcholine (ACh) and cholecystokinin (CCK) causes the generation of an intracellular Ca2+ signal. This signal, in turn, triggers the fusion of the zymogen granules with the apical plasma membrane, leading to the polarised secretion of the enzymes. The major task of pancreatic duct cells is the secretion of fluid and bicarbonate ions (HCO3-), which neutralize the acidity of gastric contents that enter the duodenum. An increase in intracellular cAMP by secretin is one of the major signals of pancreatic HCO3- secretion. Activation of the CFTR Cl- channel and the CFTR-dependent Cl-/HCO3- exchange activities is responsible for cAMP-induced HCO3- secretion.", "class": "Organismal Systems; Digestive system", "pathway_map": "hsa04972  Pancreatic secretion", "drug": ["D00216  Acarbose (JAN/USAN/INN)", "D00717  Dicyclomine hydrochloride (JAN/USP)", "D01006  Oxyphencyclimine hydrochloride (JAN)", "D01113  Loxiglumide (JAN/INN)", "D01165  Piperidolate hydrochloride (JAN)", "D01297  Pirenzepine hydrochloride (USAN)", "D01323  Azosemide (JP18/USAN/INN)", "D01491  Butropium bromide (JP18/INN)", "D01955  Aclatonium napadisilate (JAN)", "D02021  Secretin (JAN/USAN/INN)", "D02535  Timepidium bromide hydrate (JP18)", "D02693  Devazepide (USAN/INN)", "D02710  Tarazepide (INN)", "D03442  Ceruletide (USAN/INN)", "D03443  Ceruletide diethylamine (USAN)", "D03605  Crofelemer (USAN)", "D04028  Orlistat (JAN/USP/INN)", "D04057  Esoxybutynin chloride (USAN)", "D04970  Methacholine chloride (JAN/USP/INN)", "D05183  Ulinastatin (JP18)", "D05276  Pirenzepine hydrochloride hydrate (JP18)", "D07820  Dicycloverine (INN)", "D08325  Oxyphencyclimine (INN)", "D08382  Piperidolate (INN)", "D08389  Pirenzepine (USAN/INN)", "D09208  Cetilistat (JAN/USAN/INN)", "D10134  Lumacaftor (USAN/INN)", "D10685  Lumacaftor and ivacaftor", "D11042  Tezacaftor and ivacaftor", "D11700  Elexacaftor, ivacaftor and tezacaftor", "D11724  Galicaftor (USAN/INN)", "D12140  Navocaftor (USAN/INN)", "D12454  Icenticaftor (USAN/INN)", "D12718  Vanzacaftor (USAN/INN)", "D12719  Vanzacaftor calcium (USAN)"], "dblinks": "GO: 0030157", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["1131  CHRM3; cholinergic receptor muscarinic 3 [KO:K04131]", "885  CCK; cholecystokinin [KO:K05226]", "886  CCKAR; cholecystokinin A receptor [KO:K04194]", "2776  GNAQ; G protein subunit alpha q [KO:K04634]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "9545  RAB3D; RAB3D, member RAS oncogene family [KO:K07884]", "4218  RAB8A; RAB8A, member RAS oncogene family [KO:K07901]", "8766  RAB11A; RAB11A, member RAS oncogene family [KO:K07904]", "5874  RAB27B; RAB27B, member RAS oncogene family [KO:K07886]", "5906  RAP1A; RAP1A, member of RAS oncogene family [KO:K04353]", "5908  RAP1B; RAP1B, member of RAS oncogene family [KO:K07836]", "387  RHOA; ras homolog family member A [KO:K04513]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "278  AMY1C; amylase alpha 1C [KO:K01176] [EC:3.2.1.1]", "279  AMY2A; amylase alpha 2A [KO:K01176] [EC:3.2.1.1]", "276  AMY1A; amylase alpha 1A [KO:K01176] [EC:3.2.1.1]", "280  AMY2B; amylase alpha 2B [KO:K01176] [EC:3.2.1.1]", "277  AMY1B; amylase alpha 1B [KO:K01176] [EC:3.2.1.1]", "5646  PRSS3; serine protease 3 [KO:K01312] [EC:3.4.21.4]", "5645  PRSS2; serine protease 2 [KO:K01312] [EC:3.4.21.4]", "5644  PRSS1; serine protease 1 [KO:K01312] [EC:3.4.21.4]", "440387  CTRB2; chymotrypsinogen B2 [KO:K01310] [EC:3.4.21.1]", "1504  CTRB1; chymotrypsinogen B1 [KO:K01310] [EC:3.4.21.1]", "1506  CTRL; chymotrypsin like [KO:K09632] [EC:3.4.21.-]", "63036  CELA2A; chymotrypsin like elastase 2A [KO:K01346] [EC:3.4.21.71]", "51032  CELA2B; chymotrypsin like elastase 2B [KO:K01346] [EC:3.4.21.71]", "10136  CELA3A; chymotrypsin like elastase 3A [KO:K01345] [EC:3.4.21.70]", "23436  CELA3B; chymotrypsin like elastase 3B [KO:K01345] [EC:3.4.21.70]", "1357  CPA1; carboxypeptidase A1 [KO:K08779] [EC:3.4.17.1]", "1358  CPA2; carboxypeptidase A2 [KO:K01298] [EC:3.4.17.15]", "1359  CPA3; carboxypeptidase A3 [KO:K08780] [EC:3.4.17.1]", "1360  CPB1; carboxypeptidase B1 [KO:K01291] [EC:3.4.17.2]", "1361  CPB2; carboxypeptidase B2 [KO:K01300] [EC:3.4.17.20]", "5406  PNLIP; pancreatic lipase [KO:K14073] [EC:3.1.1.3]", "5407  PNLIPRP1; pancreatic lipase related protein 1 [KO:K14074] [EC:3.1.1.3]", "5408  PNLIPRP2; pancreatic lipase related protein 2 (gene/pseudogene) [KO:K14075] [EC:3.1.1.3]", "1056  CEL; carboxyl ester lipase [KO:K12298] [EC:3.1.1.13 3.1.1.3]", "8399  PLA2G10; phospholipase A2 group X [KO:K01047] [EC:3.1.1.4]", "26279  PLA2G2D; phospholipase A2 group IID [KO:K01047] [EC:3.1.1.4]", "30814  PLA2G2E; phospholipase A2 group IIE [KO:K01047] [EC:3.1.1.4]", "50487  PLA2G3; phospholipase A2 group III [KO:K01047] [EC:3.1.1.4]", "64600  PLA2G2F; phospholipase A2 group IIF [KO:K01047] [EC:3.1.1.4]", "81579  PLA2G12A; phospholipase A2 group XIIA [KO:K01047] [EC:3.1.1.4]", "84647  PLA2G12B; phospholipase A2 group XIIB [KO:K01047] [EC:3.1.1.4]", "5319  PLA2G1B; phospholipase A2 group IB [KO:K01047] [EC:3.1.1.4]", "5322  PLA2G5; phospholipase A2 group V [KO:K01047] [EC:3.1.1.4]", "5320  PLA2G2A; phospholipase A2 group IIA [KO:K01047] [EC:3.1.1.4]", "391013  PLA2G2C; phospholipase A2 group IIC [KO:K01047] [EC:3.1.1.4]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "6262  RYR2; ryanodine receptor 2 [KO:K04962]", "952  CD38; CD38 molecule [KO:K01242] [EC:3.2.2.6 2.4.99.20]", "683  BST1; bone marrow stromal cell antigen 1 [KO:K18152] [EC:3.2.2.6 2.4.99.20]", "219931  TPCN2; two pore segment channel 2 [KO:K14077]", "487  ATP2A1; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 [KO:K05853] [EC:7.2.2.10]", "489  ATP2A3; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 [KO:K05853] [EC:7.2.2.10]", "488  ATP2A2; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 [KO:K05853] [EC:7.2.2.10]", "1179  CLCA1; chloride channel accessory 1 [KO:K05027]", "9635  CLCA2; chloride channel accessory 2 [KO:K05028]", "22802  CLCA4; chloride channel accessory 4 [KO:K05030]", "7220  TRPC1; transient receptor potential cation channel subfamily C member 1 [KO:K04964]", "6558  SLC12A2; solute carrier family 12 member 2 [KO:K10951]", "476  ATP1A1; ATPase Na+/K+ transporting subunit alpha 1 [KO:K01539] [EC:7.2.2.13]", "477  ATP1A2; ATPase Na+/K+ transporting subunit alpha 2 [KO:K01539] [EC:7.2.2.13]", "478  ATP1A3; ATPase Na+/K+ transporting subunit alpha 3 [KO:K01539] [EC:7.2.2.13]", "480  ATP1A4; ATPase Na+/K+ transporting subunit alpha 4 [KO:K01539] [EC:7.2.2.13]", "23439  ATP1B4; ATPase Na+/K+ transporting family member beta 4 [KO:K01540]", "481  ATP1B1; ATPase Na+/K+ transporting subunit beta 1 [KO:K01540]", "482  ATP1B2; ATPase Na+/K+ transporting subunit beta 2 [KO:K01540]", "483  ATP1B3; ATPase Na+/K+ transporting subunit beta 3 [KO:K01540]", "486  FXYD2; FXYD domain containing ion transport regulator 2 [KO:K01538]", "3784  KCNQ1; potassium voltage-gated channel subfamily Q member 1 [KO:K04926]", "3778  KCNMA1; potassium calcium-activated channel subfamily M alpha 1 [KO:K04936]", "490  ATP2B1; ATPase plasma membrane Ca2+ transporting 1 [KO:K05850] [EC:7.2.2.10]", "492  ATP2B3; ATPase plasma membrane Ca2+ transporting 3 [KO:K05850] [EC:7.2.2.10]", "493  ATP2B4; ATPase plasma membrane Ca2+ transporting 4 [KO:K05850] [EC:7.2.2.10]", "491  ATP2B2; ATPase plasma membrane Ca2+ transporting 2 [KO:K05850] [EC:7.2.2.10]", "6548  SLC9A1; solute carrier family 9 member A1 [KO:K05742]", "6522  SLC4A2; solute carrier family 4 member 2 [KO:K13855]", "6343  SCT; secretin [KO:K05263]", "6344  SCTR; secretin receptor [KO:K04588]", "2778  GNAS; GNAS complex locus [KO:K04632]", "107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]", "108  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]", "109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]", "196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]", "113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]", "114  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]", "115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]", "1080  CFTR; CF transmembrane conductance regulator [KO:K05031] [EC:5.6.1.6]", "1811  SLC26A3; solute carrier family 26 member 3 [KO:K14078]", "8671  SLC4A4; solute carrier family 4 member 4 [KO:K13575]", "760  CA2; carbonic anhydrase 2 [KO:K18245] [EC:4.2.1.1]"], "compound": ["C00001  H2O", "C00011  CO2", "C00076  Calcium cation", "C00080  H+", "C00165  Diacylglycerol", "C00238  Potassium cation", "C00288  HCO3-", "C00575  3',5'-Cyclic AMP", "C00698  Cl-", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C01330  Sodium cation", "C01353  Carbonic acid", "C01996  Acetylcholine", "C13050  Cyclic ADP-ribose", "C13051  Nicotinic acid adenine dinucleotide phosphate"], "refs": [{"pmid": "17850212", "authors": "  Petersen OH, Tepikin AV", "title": "Polarized calcium signaling in exocrine gland cells.", "journal": "Annu Rev Physiol 70:273-99 (2008)", "doi": "10.1146/annurev.physiol.70.113006.100618"}, {"pmid": "20625287", "authors": "  Williams JA", "title": "Regulation of acinar cell function in the pancreas.", "journal": "Curr Opin Gastroenterol 26:478-83 (2010)", "doi": "10.1097/MOG.0b013e32833d11c6"}, {"pmid": "16891880", "authors": "  Williams JA", "title": "Regulation of pancreatic acinar cell function.", "journal": "Curr Opin Gastroenterol 22:498-504 (2006)", "doi": "10.1097/01.mog.0000239863.96833.c0"}, {"pmid": "15689674", "authors": "  Bi Y, Williams JA", "title": "Receptor biology and signal transduction in pancreatic acinar cells.", "journal": "Curr Opin Gastroenterol 20:427-34 (2004)", "doi": "10.1097/00001574-200409000-00002"}, {"pmid": "14660554", "authors": "  Yamasaki M, Masgrau R, Morgan AJ, Churchill GC, Patel S, Ashcroft SJ, Galione A", "title": "Organelle selection determines agonist-specific Ca2+ signals in pancreatic acinar and beta cells.", "journal": "J Biol Chem 279:7234-40 (2004)", "doi": "10.1074/jbc.M311088200"}, {"pmid": "18626068", "authors": "  Heitzmann D, Warth R", "title": "Physiology and pathophysiology of potassium channels in gastrointestinal epithelia.", "journal": "Physiol Rev 88:1119-82 (2008)", "doi": "10.1152/physrev.00020.2007"}, {"pmid": "14637169", "authors": "  Konturek SJ, Zabielski R, Konturek JW, Czarnecki J", "title": "Neuroendocrinology of the pancreas; role of brain-gut axis in pancreatic secretion.", "journal": "Eur J Pharmacol 481:1-14 (2003)", "doi": "10.1016/j.ejphar.2003.08.042"}, {"pmid": "16888148", "authors": "  Chu JY, Yung WH, Chow BK", "title": "Secretin: a pleiotrophic hormone.", "journal": "Ann N Y Acad Sci 1070:27-50 (2006)", "doi": "10.1196/annals.1317.013"}, {"pmid": "16930743", "authors": "  Siu FK, Lam IP, Chu JY, Chow BK", "title": "Signaling mechanisms of secretin receptor.", "journal": "Regul Pept 137:95-104 (2006)", "doi": "10.1016/j.regpep.2006.02.011"}, {"pmid": "15709963", "authors": "  Steward MC, Ishiguro H, Case RM", "title": "Mechanisms of bicarbonate secretion in the pancreatic duct.", "journal": "Annu Rev Physiol 67:377-409 (2005)", "doi": "10.1146/annurev.physiol.67.031103.153247"}, {"pmid": "20224219", "authors": "  Kim D, Steward MC", "title": "The role of CFTR in bicarbonate secretion by pancreatic duct and airway epithelia.", "journal": "J Med Invest 56 Suppl:336-42 (2009)", "doi": "10.2152/jmi.56.336"}, {"pmid": "17205399", "authors": "  Whitcomb DC, Lowe ME", "title": "Human pancreatic digestive enzymes.", "journal": "Dig Dis Sci 52:1-17 (2007)", "doi": "10.1007/s10620-006-9589-z"}, {"pmid": "10835353", "authors": "  Cancela JM, Gerasimenko OV, Gerasimenko JV, Tepikin AV, Petersen OH", "title": "Two different but converging messenger pathways to intracellular Ca(2+) release: the roles of nicotinic acid adenine dinucleotide phosphate, cyclic ADP-ribose and inositol trisphosphate.", "journal": "EMBO J 19:2549-57 (2000)", "doi": "10.1093/emboj/19.11.2549"}, {"pmid": "10078532", "authors": "  Cancela JM, Churchill GC, Galione A", "title": "Coordination of agonist-induced Ca2+-signalling patterns by NAADP in pancreatic acinar cells.", "journal": "Nature 398:74-6 (1999)", "doi": "10.1038/18032"}, {"pmid": "11087843", "authors": "  Parekh AB", "title": "Calcium signaling and acute pancreatitis: specific response to a promiscuous messenger.", "journal": "Proc Natl Acad Sci U S A 97:12933-4 (2000)", "doi": "10.1073/pnas.97.24.12933"}], "rel_pathway": ["hsa04020  Calcium signaling pathway", "hsa04530  Tight junction", "hsa04973  Carbohydrate digestion and absorption", "hsa04974  Protein digestion and absorption", "hsa04975  Fat digestion and absorption", "hsa04977  Vitamin digestion and absorption"], "ko_pathway": "ko04972", "genes": ["RAC1"]}, {"kegg_id": "hsa05014", "name": "Amyotrophic lateral sclerosis - Homo sapiens (human)", "description": "Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder characterized by a progressive degeneration of motor neurons in the brain and spinal cord. In 90% of patients, ALS is sporadic, with no clear genetic linkage. On the other hand, the remaining 10% of cases show familial inheritance, with mutations in SOD1, TDP43(TARDBP), FUS, or C9orf72 genes being the most frequent causes. In spite of such difference, familial ALS and sporadic ALS have similarities in their pathological features. Proposed disease mechanisms contributing to motor neuron degeneration in ALS are: impaired proteostasis, aberrant RNA processing, mitochondrial disfunction and oxidative stress, microglia activation, and axonal dysfunction.", "class": "Human Diseases; Neurodegenerative disease", "pathway_map": "hsa05014  Amyotrophic lateral sclerosis", "network": ["", "ELEMENT   N01135  Mutation-caused aberrant SOD1 to intrinsic apoptotic pathway", "N01136  Mutation-caused aberrant TDP43 to electron transfer in Complex I", "N01138  Mutation-inactivated OPTN to PINK-Parkin-mediated autophagosome formation", "N01139  Mutation-inactivated p62 to PINK-Parkin-mediated autophagosome formation", "N01141  Mutation-inactivated TBK1 to TBK1-mediated autophagosome formation", "N01143  Mutation-inactivated C9orf72 to C9orf72-mediated autophagy initiation", "N01144  Mutation-caused aberrant SOD1 to 26S proteasome-mediated protein degradation", "N01145  Mutation-inactivated VCP to 26S proteasome-mediated protein degradation", "N01146  Mutation-inactivated UBQLN2 to 26S proteasome-mediated protein degradation", "N01147  Mutation-caused aberrant SOD1 to ATF6-mediated transcription", "N01148  Mutation-caused aberrant SOD1 to IRE1a-XBP1 signaling pathway", "N01149  Mutation-caused aberrant SOD1 to PERK-ATF4 signaling pathway", "N01150  Mutation-inactivated VAPB to ATF6-mediated transcription", "N01151  Mutation-inactivated SIGMAR1 to Ca2+ -apoptotic pathway", "N01153  Mutation-caused aberrant GLE1 to nuclear export of mRNA", "N01155  Mutation-caused aberrant TDP43 to TDP-43-regulated splicing", "N01157  Mutation-caused aberrant FUS to FUS-regulated splicing", "N01158  Mutation-caused aberrant DCTN1 to retrograde axonal transport", "N01159  Mutation-caused aberrant TUBA4A to retrograde axonal transport", "N01160  Mutation-caused aberrant SOD1 to retrograde axonal transport", "N01162  Mutation-caused aberrant PFN1 to actin polymerization", "N01164  Mutation-inactivated ERBB4 to NRG-ERBB4-PI3K signaling pathway"], "disease": ["H00058  Amyotrophic lateral sclerosis (ALS)"], "drug": ["D00775  Riluzole (JAN/USP/INN)", "D10416  Belnacasan (USAN/INN)", "D11811  Tofersen (JAN/USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["7157  TP53; tumor protein p53 [KO:K04451]", "834  CASP1; caspase 1 [KO:K01370] [EC:3.4.22.36]", "637  BID; BH3 interacting domain death agonist [KO:K04726]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]", "598  BCL2L1; BCL2 like 1 [KO:K04570]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]", "317  APAF1; apoptotic peptidase activating factor 1 [KO:K02084]", "54205  CYCS; cytochrome c, somatic [KO:K08738]", "842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "6647  SOD1; superoxide dismutase 1 [KO:K04565] [EC:1.15.1.1]", "4535  ND1; NADH dehydrogenase subunit 1 [KO:K03878] [EC:7.1.1.2]", "4536  ND2; NADH dehydrogenase subunit 2 [KO:K03879] [EC:7.1.1.2]", "4537  ND3; NADH dehydrogenase subunit 3 [KO:K03880] [EC:7.1.1.2]", "4538  ND4; NADH dehydrogenase subunit 4 [KO:K03881] [EC:7.1.1.2]", "4539  ND4L; NADH dehydrogenase subunit 4L [KO:K03882] [EC:7.1.1.2]", "4540  ND5; NADH dehydrogenase subunit 5 [KO:K03883] [EC:7.1.1.2]", "4541  ND6; NADH dehydrogenase subunit 6 [KO:K03884] [EC:7.1.1.2]", "4723  NDUFV1; NADH:ubiquinone oxidoreductase core subunit V1 [KO:K03942] [EC:7.1.1.2]", "4729  NDUFV2; NADH:ubiquinone oxidoreductase core subunit V2 [KO:K03943] [EC:7.1.1.2]", "4731  NDUFV3; NADH:ubiquinone oxidoreductase subunit V3 [KO:K03944]", "4694  NDUFA1; NADH:ubiquinone oxidoreductase subunit A1 [KO:K03945]", "4695  NDUFA2; NADH:ubiquinone oxidoreductase subunit A2 [KO:K03946]", "4696  NDUFA3; NADH:ubiquinone oxidoreductase subunit A3 [KO:K03947]", "4697  NDUFA4; NDUFA4 mitochondrial complex associated [KO:K03948]", "56901  NDUFA4L2; NDUFA4 mitochondrial complex associated like 2 [KO:K03948]", "4698  NDUFA5; NADH:ubiquinone oxidoreductase subunit A5 [KO:K03949]", "4700  NDUFA6; NADH:ubiquinone oxidoreductase subunit A6 [KO:K03950]", "4701  NDUFA7; NADH:ubiquinone oxidoreductase subunit A7 [KO:K03951]", "4702  NDUFA8; NADH:ubiquinone oxidoreductase subunit A8 [KO:K03952]", "4704  NDUFA9; NADH:ubiquinone oxidoreductase subunit A9 [KO:K03953]", "4705  NDUFA10; NADH:ubiquinone oxidoreductase subunit A10 [KO:K03954]", "4706  NDUFAB1; NADH:ubiquinone oxidoreductase subunit AB1 [KO:K03955]", "126328  NDUFA11; NADH:ubiquinone oxidoreductase subunit A11 [KO:K03956]", "55967  NDUFA12; NADH:ubiquinone oxidoreductase subunit A12 [KO:K11352]", "51079  NDUFA13; NADH:ubiquinone oxidoreductase subunit A13 [KO:K11353]", "4707  NDUFB1; NADH:ubiquinone oxidoreductase subunit B1 [KO:K03957]", "4708  NDUFB2; NADH:ubiquinone oxidoreductase subunit B2 [KO:K03958]", "4709  NDUFB3; NADH:ubiquinone oxidoreductase subunit B3 [KO:K03959]", "4710  NDUFB4; NADH:ubiquinone oxidoreductase subunit B4 [KO:K03960]", "4711  NDUFB5; NADH:ubiquinone oxidoreductase subunit B5 [KO:K03961]", "4712  NDUFB6; NADH:ubiquinone oxidoreductase subunit B6 [KO:K03962]", "4713  NDUFB7; NADH:ubiquinone oxidoreductase subunit B7 [KO:K03963]", "4714  NDUFB8; NADH:ubiquinone oxidoreductase subunit B8 [KO:K03964]", "4715  NDUFB9; NADH:ubiquinone oxidoreductase subunit B9 [KO:K03965]", "4716  NDUFB10; NADH:ubiquinone oxidoreductase subunit B10 [KO:K03966]", "54539  NDUFB11; NADH:ubiquinone oxidoreductase subunit B11 [KO:K11351]", "4719  NDUFS1; NADH:ubiquinone oxidoreductase core subunit S1 [KO:K03934] [EC:7.1.1.2]", "4720  NDUFS2; NADH:ubiquinone oxidoreductase core subunit S2 [KO:K03935] [EC:7.1.1.2]", "4722  NDUFS3; NADH:ubiquinone oxidoreductase core subunit S3 [KO:K03936] [EC:7.1.1.2]", "4724  NDUFS4; NADH:ubiquinone oxidoreductase subunit S4 [KO:K03937]", "4725  NDUFS5; NADH:ubiquinone oxidoreductase subunit S5 [KO:K03938]", "4726  NDUFS6; NADH:ubiquinone oxidoreductase subunit S6 [KO:K03939]", "374291  NDUFS7; NADH:ubiquinone oxidoreductase core subunit S7 [KO:K03940] [EC:7.1.1.2]", "4728  NDUFS8; NADH:ubiquinone oxidoreductase core subunit S8 [KO:K03941] [EC:7.1.1.2]", "4717  NDUFC1; NADH:ubiquinone oxidoreductase subunit C1 [KO:K03967]", "4718  NDUFC2; NADH:ubiquinone oxidoreductase subunit C2 [KO:K03968]", "100532726  NDUFC2-KCTD14; NDUFC2-KCTD14 readthrough [KO:K03968]", "6389  SDHA; succinate dehydrogenase complex flavoprotein subunit A [KO:K00234] [EC:1.3.5.1]", "6390  SDHB; succinate dehydrogenase complex iron sulfur subunit B [KO:K00235] [EC:1.3.5.1]", "6391  SDHC; succinate dehydrogenase complex subunit C [KO:K00236]", "6392  SDHD; succinate dehydrogenase complex subunit D [KO:K00237]", "7386  UQCRFS1; ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 [KO:K00411] [EC:7.1.1.8]", "4519  CYTB; cytochrome b [KO:K00412]", "1537  CYC1; cytochrome c1 [KO:K00413]", "7384  UQCRC1; ubiquinol-cytochrome c reductase core protein 1 [KO:K00414]", "7385  UQCRC2; ubiquinol-cytochrome c reductase core protein 2 [KO:K00415]", "7388  UQCRH; ubiquinol-cytochrome c reductase hinge protein [KO:K00416]", "440567  UQCRHL; ubiquinol-cytochrome c reductase hinge protein like [KO:K00416]", "7381  UQCRB; ubiquinol-cytochrome c reductase binding protein [KO:K00417]", "27089  UQCRQ; ubiquinol-cytochrome c reductase complex III subunit VII [KO:K00418]", "29796  UQCR10; ubiquinol-cytochrome c reductase, complex III subunit X [KO:K00419]", "10975  UQCR11; ubiquinol-cytochrome c reductase, complex III subunit XI [KO:K00420]", "4514  COX3; cytochrome c oxidase subunit III [KO:K02262]", "4512  COX1; cytochrome c oxidase subunit I [KO:K02256] [EC:7.1.1.9]", "4513  COX2; cytochrome c oxidase subunit II [KO:K02261]", "84701  COX4I2; cytochrome c oxidase subunit 4I2 [KO:K02263]", "1327  COX4I1; cytochrome c oxidase subunit 4I1 [KO:K02263]", "9377  COX5A; cytochrome c oxidase subunit 5A [KO:K02264]", "1329  COX5B; cytochrome c oxidase subunit 5B [KO:K02265]", "1337  COX6A1; cytochrome c oxidase subunit 6A1 [KO:K02266]", "1339  COX6A2; cytochrome c oxidase subunit 6A2 [KO:K02266]", "1340  COX6B1; cytochrome c oxidase subunit 6B1 [KO:K02267]", "125965  COX6B2; cytochrome c oxidase subunit 6B2 [KO:K02267]", "1345  COX6C; cytochrome c oxidase subunit 6C [KO:K02268]", "1346  COX7A1; cytochrome c oxidase subunit 7A1 [KO:K02270]", "1347  COX7A2; cytochrome c oxidase subunit 7A2 [KO:K02270]", "9167  COX7A2L; cytochrome c oxidase subunit 7A2 like [KO:K02270]", "1349  COX7B; cytochrome c oxidase subunit 7B [KO:K02271]", "170712  COX7B2; cytochrome c oxidase subunit 7B2 [KO:K02271]", "1350  COX7C; cytochrome c oxidase subunit 7C [KO:K02272]", "341947  COX8C; cytochrome c oxidase subunit 8C [KO:K02273]", "1351  COX8A; cytochrome c oxidase subunit 8A [KO:K02273]", "498  ATP5F1A; ATP synthase F1 subunit alpha [KO:K02132]", "506  ATP5F1B; ATP synthase F1 subunit beta [KO:K02133] [EC:7.1.2.2]", "509  ATP5F1C; ATP synthase F1 subunit gamma [KO:K02136]", "513  ATP5F1D; ATP synthase F1 subunit delta [KO:K02134]", "514  ATP5F1E; ATP synthase F1 subunit epsilon [KO:K02135]", "4508  ATP6; ATP synthase F0 subunit 6 [KO:K02126]", "515  ATP5PB; ATP synthase peripheral stalk-membrane subunit b [KO:K02127]", "516  ATP5MC1; ATP synthase membrane subunit c locus 1 [KO:K02128]", "517  ATP5MC2; ATP synthase membrane subunit c locus 2 [KO:K02128]", "518  ATP5MC3; ATP synthase membrane subunit c locus 3 [KO:K02128]", "10476  ATP5PD; ATP synthase peripheral stalk subunit d [KO:K02138]", "539  ATP5PO; ATP synthase peripheral stalk subunit OSCP [KO:K02137]", "522  ATP5PF; ATP synthase peripheral stalk subunit F6 [KO:K02131]", "4509  ATP8; ATP synthase F0 subunit 8 [KO:K02125]", "7416  VDAC1; voltage dependent anion channel 1 [KO:K05862]", "10452  TOMM40; translocase of outer mitochondrial membrane 40 [KO:K11518]", "84134  TOMM40L; translocase of outer mitochondrial membrane 40 like [KO:K11518]", "90550  MCU; mitochondrial calcium uniporter [KO:K20858]", "65018  PINK1; PTEN induced kinase 1 [KO:K05688] [EC:2.7.11.1]", "5071  PRKN; parkin RBR E3 ubiquitin protein ligase [KO:K04556] [EC:2.3.2.31]", "10133  OPTN; optineurin [KO:K19946]", "8878  SQSTM1; sequestosome 1 [KO:K14381]", "440738  MAP1LC3C; microtubule associated protein 1 light chain 3 gamma [KO:K10435]", "81631  MAP1LC3B; microtubule associated protein 1 light chain 3 beta [KO:K10435]", "84557  MAP1LC3A; microtubule associated protein 1 light chain 3 alpha [KO:K10435]", "643246  MAP1LC3B2; microtubule associated protein 1 light chain 3 beta 2 [KO:K10435]", "29110  TBK1; TANK binding kinase 1 [KO:K05410] [EC:2.7.11.10]", "10010  TANK; TRAF family member associated NFKB activator [KO:K12650]", "55255  WDR41; WD repeat domain 41 [KO:K23610]", "140775  SMCR8; SMCR8-C9orf72 complex subunit [KO:K23611]", "203228  C9orf72; C9orf72-SMCR8 complex subunit [KO:K23609]", "4218  RAB8A; RAB8A, member RAS oncogene family [KO:K07901]", "116442  RAB39B; RAB39B, member RAS oncogene family [KO:K07925]", "5861  RAB1A; RAB1A, member RAS oncogene family [KO:K07874]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "8408  ULK1; unc-51 like autophagy activating kinase 1 [KO:K21357] [EC:2.7.11.1]", "9706  ULK2; unc-51 like autophagy activating kinase 2 [KO:K08269] [EC:2.7.11.1]", "60673  ATG101; autophagy related 101 [KO:K19730]", "9776  ATG13; autophagy related 13 [KO:K08331]", "9821  RB1CC1; RB1 inducible coiled-coil 1 [KO:K17589]", "55626  AMBRA1; autophagy and beclin 1 regulator 1 [KO:K17985]", "8678  BECN1; beclin 1 [KO:K08334]", "441925  BECN2; beclin 2 [KO:K08334]", "30849  PIK3R4; phosphoinositide-3-kinase regulatory subunit 4 [KO:K08333] [EC:2.7.11.1]", "22863  ATG14; autophagy related 14 [KO:K17889]", "29982  NRBF2; nuclear receptor binding factor 2 [KO:K21246]", "5289  PIK3C3; phosphatidylinositol 3-kinase catalytic subunit type 3 [KO:K00914] [EC:2.7.1.137]", "23130  ATG2A; autophagy related 2A [KO:K17906]", "55102  ATG2B; autophagy related 2B [KO:K17906]", "26100  WIPI2; WD repeat domain, phosphoinositide interacting 2 [KO:K17908]", "55062  WIPI1; WD repeat domain, phosphoinositide interacting 1 [KO:K17908]", "57679  ALS2; alsin Rho guanine nucleotide exchange factor ALS2 [KO:K04575]", "5868  RAB5A; RAB5A, member RAS oncogene family [KO:K07887]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "25978  CHMP2B; charged multivesicular body protein 2B [KO:K12192]", "9896  FIG4; FIG4 phosphoinositide 5-phosphatase [KO:K22913] [EC:3.1.3.-]", "80208  SPG11; SPG11 vesicle trafficking associated, spatacsin [KO:K19026]", "5530  PPP3CA; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]", "5532  PPP3CB; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]", "5533  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]", "5534  PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]", "5535  PPP3R2; protein phosphatase 3 regulatory subunit B, beta [KO:K06268]", "29979  UBQLN1; ubiquilin 1 [KO:K04523]", "29978  UBQLN2; ubiquilin 2 [KO:K04523]", "50613  UBQLN3; ubiquilin 3 [KO:K04523]", "56893  UBQLN4; ubiquilin 4 [KO:K04523]", "7415  VCP; valosin containing protein [KO:K13525]", "79139  DERL1; derlin 1 [KO:K11519]", "5687  PSMA6; proteasome 20S subunit alpha 6 [KO:K02730] [EC:3.4.25.1]", "5683  PSMA2; proteasome 20S subunit alpha 2 [KO:K02726] [EC:3.4.25.1]", "5685  PSMA4; proteasome 20S subunit alpha 4 [KO:K02728] [EC:3.4.25.1]", "5688  PSMA7; proteasome 20S subunit alpha 7 [KO:K02731] [EC:3.4.25.1]", "143471  PSMA8; proteasome 20S subunit alpha 8 [KO:K02731] [EC:3.4.25.1]", "5686  PSMA5; proteasome 20S subunit alpha 5 [KO:K02729] [EC:3.4.25.1]", "5682  PSMA1; proteasome 20S subunit alpha 1 [KO:K02725] [EC:3.4.25.1]", "5684  PSMA3; proteasome 20S subunit alpha 3 [KO:K02727] [EC:3.4.25.1]", "5694  PSMB6; proteasome 20S subunit beta 6 [KO:K02738] [EC:3.4.25.1]", "5695  PSMB7; proteasome 20S subunit beta 7 [KO:K02739] [EC:3.4.25.1]", "5691  PSMB3; proteasome 20S subunit beta 3 [KO:K02735] [EC:3.4.25.1]", "5690  PSMB2; proteasome 20S subunit beta 2 [KO:K02734] [EC:3.4.25.1]", "5693  PSMB5; proteasome 20S subunit beta 5 [KO:K02737] [EC:3.4.25.1]", "5689  PSMB1; proteasome 20S subunit beta 1 [KO:K02732] [EC:3.4.25.1]", "5692  PSMB4; proteasome 20S subunit beta 4 [KO:K02736] [EC:3.4.25.1]", "5701  PSMC2; proteasome 26S subunit, ATPase 2 [KO:K03061]", "5700  PSMC1; proteasome 26S subunit, ATPase 1 [KO:K03062]", "5704  PSMC4; proteasome 26S subunit, ATPase 4 [KO:K03063]", "5706  PSMC6; proteasome 26S subunit, ATPase 6 [KO:K03064]", "5702  PSMC3; proteasome 26S subunit, ATPase 3 [KO:K03065]", "5705  PSMC5; proteasome 26S subunit, ATPase 5 [KO:K03066]", "5708  PSMD2; proteasome 26S subunit ubiquitin receptor, non-ATPase 2 [KO:K03028]", "5707  PSMD1; proteasome 26S subunit, non-ATPase 1 [KO:K03032]", "5709  PSMD3; proteasome 26S subunit, non-ATPase 3 [KO:K03033]", "5715  PSMD9; proteasome 26S subunit, non-ATPase 9 [KO:K06693]", "5718  PSMD12; proteasome 26S subunit, non-ATPase 12 [KO:K03035]", "5717  PSMD11; proteasome 26S subunit, non-ATPase 11 [KO:K03036]", "9861  PSMD6; proteasome 26S subunit, non-ATPase 6 [KO:K03037]", "5713  PSMD7; proteasome 26S subunit, non-ATPase 7 [KO:K03038]", "5719  PSMD13; proteasome 26S subunit, non-ATPase 13 [KO:K03039]", "5710  PSMD4; proteasome 26S subunit ubiquitin receptor, non-ATPase 4 [KO:K03029]", "10213  PSMD14; proteasome 26S subunit, non-ATPase 14 [KO:K03030]", "5714  PSMD8; proteasome 26S subunit, non-ATPase 8 [KO:K03031]", "11047  ADRM1; ADRM1 26S proteasome ubiquitin receptor [KO:K06691]", "7979  SEM1; SEM1 26S proteasome subunit [KO:K10881]", "10013  HDAC6; histone deacetylase 6 [KO:K11407] [EC:3.5.1.98]", "23435  TARDBP; TAR DNA binding protein [KO:K23600]", "2521  FUS; FUS RNA binding protein [KO:K13098]", "220988  HNRNPA3; heterogeneous nuclear ribonucleoprotein A3 [KO:K12741]", "3178  HNRNPA1; heterogeneous nuclear ribonucleoprotein A1 [KO:K12741]", "144983  HNRNPA1L2; heterogeneous nuclear ribonucleoprotein A1 like 2 [KO:K12741]", "3181  HNRNPA2B1; heterogeneous nuclear ribonucleoprotein A2/B1 [KO:K13158]", "11273  ATXN2L; ataxin 2 like [KO:K23625]", "6311  ATXN2; ataxin 2 [KO:K23625]", "9782  MATR3; matrin 3 [KO:K13213]", "283  ANG; angiogenin [KO:K16631] [EC:3.1.27.-]", "4686  NCBP1; nuclear cap binding protein subunit 1 [KO:K12882]", "10189  ALYREF; Aly/REF export factor [KO:K12881]", "6428  SRSF3; serine and arginine rich splicing factor 3 [KO:K12892]", "6432  SRSF7; serine and arginine rich splicing factor 7 [KO:K12896]", "10482  NXF1; nuclear RNA export factor 1 [KO:K14284]", "56001  NXF2; nuclear RNA export factor 2 [KO:K14284]", "728343  NXF2B; nuclear RNA export factor 2B [KO:K14284]", "56000  NXF3; nuclear RNA export factor 3 [KO:K14284]", "29107  NXT1; nuclear transport factor 2 like export factor 1 [KO:K14285]", "55916  NXT2; nuclear transport factor 2 like export factor 2 [KO:K14285]", "2733  GLE1; GLE1 RNA export mediator [KO:K18723]", "7175  TPR; translocated promoter region, nuclear basket protein [KO:K09291]", "10762  NUP50; nucleoporin 50 [KO:K14295]", "9972  NUP153; nucleoporin 153 [KO:K14296]", "4928  NUP98; nucleoporin 98 and 96 precursor [KO:K14297]", "8480  RAE1; ribonucleic acid export 1 [KO:K14298]", "6396  SEC13; SEC13 homolog, nuclear pore and COPII coat complex component [KO:K14004]", "81929  SEH1L; SEH1 like nucleoporin [KO:K14299]", "55746  NUP133; nucleoporin 133 [KO:K14300]", "57122  NUP107; nucleoporin 107 [KO:K14301]", "79023  NUP37; nucleoporin 37 [KO:K14302]", "23279  NUP160; nucleoporin 160 [KO:K14303]", "79902  NUP85; nucleoporin 85 [KO:K14304]", "348995  NUP43; nucleoporin 43 [KO:K14305]", "23636  NUP62; nucleoporin 62 [KO:K14306]", "9818  NUP58; nucleoporin 58 [KO:K14307]", "53371  NUP54; nucleoporin 54 [KO:K14308]", "9688  NUP93; nucleoporin 93 [KO:K14309]", "23165  NUP205; nucleoporin 205 [KO:K14310]", "23511  NUP188; nucleoporin 188 [KO:K14311]", "9631  NUP155; nucleoporin 155 [KO:K14312]", "129401  NUP35; nucleoporin 35 [KO:K14313]", "23225  NUP210; nucleoporin 210 [KO:K14314]", "91181  NUP210L; nucleoporin 210 like [KO:K14314]", "55706  NDC1; NDC1 transmembrane nucleoporin [KO:K14315]", "100101267  POM121C; POM121 transmembrane nucleoporin C [KO:K14316]", "9883  POM121; POM121 transmembrane nucleoporin [KO:K14316]", "94026  POM121L2; POM121 transmembrane nucleoporin like 2 [KO:K14316]", "8021  NUP214; nucleoporin 214 [KO:K14317]", "4927  NUP88; nucleoporin 88 [KO:K14318]", "5903  RANBP2; RAN binding protein 2 [KO:K12172] [EC:2.3.2.-]", "23064  SETX; senataxin [KO:K10706] [EC:5.6.2.5 5.6.2.3]", "400916  CHCHD10; coiled-coil-helix-coiled-coil-helix domain containing 10 [KO:K22759]", "3309  HSPA5; heat shock protein family A (Hsp70) member 5 [KO:K09490] [EC:3.6.4.10]", "9217  VAPB; VAMP associated protein B and C [KO:K10707]", "22926  ATF6; activating transcription factor 6 [KO:K09054]", "1649  DDIT3; DNA damage inducible transcript 3 [KO:K04452]", "2081  ERN1; endoplasmic reticulum to nucleus signaling 1 [KO:K08852] [EC:2.7.11.1 3.1.26.-]", "7494  XBP1; X-box binding protein 1 [KO:K09027]", "7186  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]", "4217  MAP3K5; mitogen-activated protein kinase kinase kinase 5 [KO:K04426] [EC:2.7.11.25]", "100506742  CASP12; caspase 12 (gene/pseudogene) [KO:K04741] [EC:3.4.22.-]", "9451  EIF2AK3; eukaryotic translation initiation factor 2 alpha kinase 3 [KO:K08860] [EC:2.7.11.1]", "1965  EIF2S1; eukaryotic translation initiation factor 2 subunit alpha [KO:K03237]", "468  ATF4; activating transcription factor 4 [KO:K04374]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "10280  SIGMAR1; sigma non-opioid intracellular receptor 1 [KO:K20719]", "7124  TNF; tumor necrosis factor [KO:K03156]", "7132  TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158]", "7133  TNFRSF1B; TNF receptor superfamily member 1B [KO:K05141]", "1616  DAXX; death domain associated protein [KO:K02308]", "5606  MAP2K3; mitogen-activated protein kinase kinase 3 [KO:K04432] [EC:2.7.12.2]", "5608  MAP2K6; mitogen-activated protein kinase kinase 6 [KO:K04433] [EC:2.7.12.2]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "4842  NOS1; nitric oxide synthase 1 [KO:K13240] [EC:1.14.13.39]", "9973  CCS; copper chaperone for superoxide dismutase [KO:K04569]", "257202  GPX6; glutathione peroxidase 6 [KO:K00432] [EC:1.11.1.9]", "2882  GPX7; glutathione peroxidase 7 [KO:K00432] [EC:1.11.1.9]", "2877  GPX2; glutathione peroxidase 2 [KO:K00432] [EC:1.11.1.9]", "2878  GPX3; glutathione peroxidase 3 [KO:K00432] [EC:1.11.1.9]", "2876  GPX1; glutathione peroxidase 1 [KO:K00432] [EC:1.11.1.9]", "2880  GPX5; glutathione peroxidase 5 [KO:K00432] [EC:1.11.1.9]", "493869  GPX8; glutathione peroxidase 8 (putative) [KO:K00432] [EC:1.11.1.9]", "847  CAT; catalase [KO:K03781] [EC:1.11.1.6]", "5630  PRPH; peripherin [KO:K07607]", "4747  NEFL; neurofilament light chain [KO:K04572]", "4741  NEFM; neurofilament medium chain [KO:K04573]", "4744  NEFH; neurofilament heavy chain [KO:K04574]", "345456  PFN3; profilin 3 [KO:K05759]", "5216  PFN1; profilin 1 [KO:K05759]", "5217  PFN2; profilin 2 [KO:K05759]", "375189  PFN4; profilin family member 4 [KO:K05759]", "71  ACTG1; actin gamma 1 [KO:K05692]", "60  ACTB; actin beta [KO:K05692]", "310  ANXA7; annexin A7 [KO:K17095]", "311  ANXA11; annexin A11 [KO:K17095]", "3798  KIF5A; kinesin family member 5A [KO:K10396]", "3799  KIF5B; kinesin family member 5B [KO:K10396]", "3800  KIF5C; kinesin family member 5C [KO:K10396]", "147700  KLC3; kinesin light chain 3 [KO:K10407]", "3831  KLC1; kinesin light chain 1 [KO:K10407]", "64837  KLC2; kinesin light chain 2 [KO:K10407]", "89953  KLC4; kinesin light chain 4 [KO:K10407]", "10376  TUBA1B; tubulin alpha 1b [KO:K07374]", "7277  TUBA4A; tubulin alpha 4a [KO:K07374]", "7278  TUBA3C; tubulin alpha 3c [KO:K07374]", "7846  TUBA1A; tubulin alpha 1a [KO:K07374]", "84790  TUBA1C; tubulin alpha 1c [KO:K07374]", "51807  TUBA8; tubulin alpha 8 [KO:K07374]", "112714  TUBA3E; tubulin alpha 3e [KO:K07374]", "113457  TUBA3D; tubulin alpha 3d [KO:K07374]", "79861  TUBAL3; tubulin alpha like 3 [KO:K07374]", "84617  TUBB6; tubulin beta 6 class V [KO:K07375]", "203068  TUBB; tubulin beta class I [KO:K07375]", "81027  TUBB1; tubulin beta 1 class VI [KO:K07375]", "7280  TUBB2A; tubulin beta 2A class IIa [KO:K07375]", "10381  TUBB3; tubulin beta 3 class III [KO:K07375]", "10382  TUBB4A; tubulin beta 4A class IVa [KO:K07375]", "347688  TUBB8; tubulin beta 8 class VIII [KO:K07375]", "347733  TUBB2B; tubulin beta 2B class IIb [KO:K07375]", "10383  TUBB4B; tubulin beta 4B class IVb [KO:K07375]", "1639  DCTN1; dynactin subunit 1 [KO:K04648]", "10540  DCTN2; dynactin subunit 2 [KO:K10424]", "11258  DCTN3; dynactin subunit 3 [KO:K10425]", "51164  DCTN4; dynactin subunit 4 [KO:K10426]", "84516  DCTN5; dynactin subunit 5 [KO:K10427]", "10671  DCTN6; dynactin subunit 6 [KO:K10428]", "10121  ACTR1A; actin related protein 1A [KO:K16575]", "10120  ACTR1B; actin related protein 1B [KO:K16575]", "55860  ACTR10; actin related protein 10 [KO:K16576]", "9001  HAP1; huntingtin associated protein 1 [KO:K04647]", "25981  DNAH1; dynein axonemal heavy chain 1 [KO:K10408]", "55567  DNAH3; dynein axonemal heavy chain 3 [KO:K10408]", "146754  DNAH2; dynein axonemal heavy chain 2 [KO:K10408]", "56171  DNAH7; dynein axonemal heavy chain 7 [KO:K10408]", "1767  DNAH5; dynein axonemal heavy chain 5 [KO:K10408]", "1768  DNAH6; dynein axonemal heavy chain 6 [KO:K10408]", "1770  DNAH9; dynein axonemal heavy chain 9 [KO:K10408]", "8701  DNAH11; dynein axonemal heavy chain 11 [KO:K10408]", "201625  DNAH12; dynein axonemal heavy chain 12 [KO:K10408]", "127602  DNAH14; dynein axonemal heavy chain 14 [KO:K10408]", "1769  DNAH8; dynein axonemal heavy chain 8 [KO:K10408]", "196385  DNAH10; dynein axonemal heavy chain 10 [KO:K10408]", "8632  DNAH17; dynein axonemal heavy chain 17 [KO:K10408]", "7802  DNALI1; dynein axonemal light intermediate chain 1 [KO:K10410]", "27019  DNAI1; dynein axonemal intermediate chain 1 [KO:K10409]", "64446  DNAI2; dynein axonemal intermediate chain 2 [KO:K11143]", "83544  DNAL1; dynein axonemal light chain 1 [KO:K10411]", "10126  DNAL4; dynein axonemal light chain 4 [KO:K10412]", "6506  SLC1A2; solute carrier family 1 member 2 [KO:K05613]", "4843  NOS2; nitric oxide synthase 2 [KO:K13241] [EC:1.14.13.39]", "2890  GRIA1; glutamate ionotropic receptor AMPA type subunit 1 [KO:K05197]", "2891  GRIA2; glutamate ionotropic receptor AMPA type subunit 2 [KO:K05198]", "2902  GRIN1; glutamate ionotropic receptor NMDA type subunit 1 [KO:K05208]", "2903  GRIN2A; glutamate ionotropic receptor NMDA type subunit 2A [KO:K05209]", "2904  GRIN2B; glutamate ionotropic receptor NMDA type subunit 2B [KO:K05210]", "2905  GRIN2C; glutamate ionotropic receptor NMDA type subunit 2C [KO:K05211]", "2906  GRIN2D; glutamate ionotropic receptor NMDA type subunit 2D [KO:K05212]", "3084  NRG1; neuregulin 1 [KO:K05455]", "9542  NRG2; neuregulin 2 [KO:K05456]", "10718  NRG3; neuregulin 3 [KO:K05457]", "145957  NRG4; neuregulin 4 [KO:K05458]", "2066  ERBB4; erb-b2 receptor tyrosine kinase 4 [KO:K05085] [EC:2.7.10.1]"], "compound": ["C00001  H2O", "C00008  ADP", "C00025  L-Glutamate", "C00027  Hydrogen peroxide", "C00039  DNA", "C00046  RNA", "C00062  L-Arginine", "C00070  Copper", "C00076  Calcium cation", "C00533  Nitric oxide", "C00704  Superoxide", "C04549  1-Phosphatidyl-1D-myo-inositol 3-phosphate", "C16844  Hydroxyl radical", "C16845  Peroxynitrite"], "refs": [{"pmid": "28700839", "authors": "  Brown RH, Al-Chalabi A", "title": "Amyotrophic Lateral Sclerosis.", "journal": "N Engl J Med 377:162-172 (2017)", "doi": "10.1056/NEJMra1603471"}, {"pmid": "28512398", "authors": "  Webster CP, Smith EF, Shaw PJ, De Vos KJ", "title": "Protein Homeostasis in Amyotrophic Lateral Sclerosis: Therapeutic Opportunities?", "journal": "Front Mol Neurosci 10:123 (2017)", "doi": "10.3389/fnmol.2017.00123"}, {"pmid": "30879475", "authors": "  Valko K, Ciesla L", "title": "Amyotrophic lateral sclerosis.", "journal": "Prog Med Chem 58:63-117 (2019)", "doi": "10.1016/bs.pmch.2018.12.001"}, {"pmid": "30870681", "authors": "  Mathis S, Goizet C, Soulages A, Vallat JM, Masson GL", "title": "Genetics of amyotrophic lateral sclerosis: A review.", "journal": "J Neurol Sci 399:217-226 (2019)", "doi": "10.1016/j.jns.2019.02.030"}, {"pmid": "23415570", "authors": "  Turner MR, Hardiman O, Benatar M, Brooks BR, Chio A, de Carvalho M, Ince PG, Lin C, Miller RG, Mitsumoto H, Nicholson G, Ravits J, Shaw PJ, Swash M, Talbot K, Traynor BJ, Van den Berg LH, Veldink JH, Vucic S, Kiernan MC", "title": "Controversies and priorities in amyotrophic lateral sclerosis.", "journal": "Lancet Neurol 12:310-22 (2013)", "doi": "10.1016/S1474-4422(13)70036-X"}, {"pmid": "16924260", "authors": "  Pasinelli P, Brown RH", "title": "Molecular biology of amyotrophic lateral sclerosis: insights from genetics.", "journal": "Nat Rev Neurosci 7:710-23 (2006)", "doi": "10.1038/nrn1971"}, {"pmid": "16723044", "authors": "  Goodall EF, Morrison KE", "title": "Amyotrophic lateral sclerosis (motor neuron disease): proposed mechanisms and pathways to treatment.", "journal": "Expert Rev Mol Med 8:1-22 (2006)", "doi": "10.1017/S1462399406010854"}, {"pmid": "28669745", "authors": "  Smith EF, Shaw PJ, De Vos KJ", "title": "The role of mitochondria in amyotrophic lateral sclerosis.", "journal": "Neurosci Lett 710:132933 (2019)", "doi": "10.1016/j.neulet.2017.06.052"}, {"pmid": "32344665", "authors": "  Kodavati M, Wang H, Hegde ML", "title": "Altered Mitochondrial Dynamics in Motor Neuron Disease: An Emerging Perspective.", "journal": "Cells 9:E1065 (2020)", "doi": "10.3390/cells9041065"}, {"pmid": "16372325", "authors": "  Hervias I, Beal MF, Manfredi G", "title": "Mitochondrial dysfunction and amyotrophic lateral sclerosis.", "journal": "Muscle Nerve 33:598-608 (2006)", "doi": "10.1002/mus.20489"}, {"pmid": "16603792", "authors": "  Bacman SR, Bradley WG, Moraes CT", "title": "Mitochondrial involvement in amyotrophic lateral sclerosis: trigger or target?", "journal": "Mol Neurobiol 33:113-31 (2006)", "doi": "10.1385/MN:33:2:113"}, {"pmid": "17051205", "authors": "  Lin MT, Beal MF", "title": "Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases.", "journal": "Nature 443:787-95 (2006)", "doi": "10.1038/nature05292"}, {"pmid": "16909017", "authors": "  Bendotti C, Bao Cutrona M, Cheroni C, Grignaschi G, Lo Coco D, Peviani M, Tortarolo M, Veglianese P, Zennaro E", "title": "Inter- and intracellular signaling in amyotrophic lateral sclerosis: role of p38 mitogen-activated protein kinase.", "journal": "Neurodegener Dis 2:128-34 (2005)", "doi": "10.1159/000089617"}, {"pmid": "14569202", "authors": "  Simpson EP, Yen AA, Appel SH", "title": "Oxidative Stress: a common denominator in the pathogenesis of amyotrophic lateral sclerosis.", "journal": "Curr Opin Rheumatol 15:730-6 (2003)", "doi": "10.1097/00002281-200311000-00008"}, {"pmid": "15310460", "authors": "  Bendotti C, Carri MT", "title": "Lessons from models of SOD1-linked familial ALS.", "journal": "Trends Mol Med 10:393-400 (2004)", "doi": "10.1016/j.molmed.2004.06.009"}, {"pmid": "12595144", "authors": "  Robertson J, Kriz J, Nguyen MD, Julien JP", "title": "Pathways to motor neuron degeneration in transgenic mouse models.", "journal": "Biochimie 84:1151-60 (2002)", "doi": "10.1016/S0300-9084(02)00025-1"}, {"pmid": "17434459", "authors": "  Eve DJ, Dennis JS, Citron BA", "title": "Transcription factor p53 in degenerating spinal cords.", "journal": "Brain Res 1150:174-81 (2007)", "doi": "10.1016/j.brainres.2007.02.088"}, {"pmid": "27649160", "authors": "  Bahar E, Kim H, Yoon H", "title": "ER Stress-Mediated Signaling: Action Potential and Ca(2+) as Key Players.", "journal": "Int J Mol Sci 17:E1558 (2016)", "doi": "10.3390/ijms17091558"}, {"pmid": "19230774", "authors": "  Bezprozvanny I", "title": "Calcium signaling and neurodegenerative diseases.", "journal": "Trends Mol Med 15:89-100 (2009)", "doi": "10.1016/j.molmed.2009.01.001"}, {"pmid": "16026864", "authors": "  von Lewinski F, Keller BU", "title": "Ca2+, mitochondria and selective motoneuron vulnerability: implications for ALS.", "journal": "Trends Neurosci 28:494-500 (2005)", "doi": "10.1016/j.tins.2005.07.001"}, {"pmid": "11239414", "authors": "  Julien JP.", "title": "Amyotrophic lateral sclerosis. unfolding the toxicity of the misfolded.", "journal": "Cell 104:581-91 (2001)", "doi": "10.1016/S0092-8674(01)00244-6"}, {"pmid": "11870681", "authors": "  Hand CK, Rouleau GA", "title": "Familial amyotrophic lateral sclerosis.", "journal": "Muscle Nerve 25:135-59 (2002)", "doi": "10.1002/mus.10000"}, {"pmid": "16713195", "authors": "  Barber SC, Mead RJ, Shaw PJ", "title": "Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target.", "journal": "Biochim Biophys Acta 1762:1051-67 (2006)", "doi": "10.1016/j.bbadis.2006.03.008"}, {"pmid": "30837838", "authors": "  Prasad A, Bharathi V, Sivalingam V, Girdhar A, Patel BK", "title": "Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis.", "journal": "Front Mol Neurosci 12:25 (2019)", "doi": "10.3389/fnmol.2019.00025"}, {"pmid": "29626651", "authors": "  Nguyen DKH, Thombre R, Wang J", "title": "Autophagy as a common pathway in amyotrophic lateral sclerosis.", "journal": "Neurosci Lett 697:34-48 (2019)", "doi": "10.1016/j.neulet.2018.04.006"}, {"pmid": "26264610", "authors": "  Lee JK, Shin JH, Lee JE, Choi EJ", "title": "Role of autophagy in the pathogenesis of amyotrophic lateral sclerosis.", "journal": "Biochim Biophys Acta 1852:2517-24 (2015)", "doi": "10.1016/j.bbadis.2015.08.005"}, {"pmid": "28148298", "authors": "  Oakes JA, Davies MC, Collins MO", "title": "TBK1: a new player in ALS linking autophagy and neuroinflammation.", "journal": "Mol Brain 10:5 (2017)", "doi": "10.1186/s13041-017-0287-x"}, {"pmid": "28878620", "authors": "  Ramesh N, Pandey UB", "title": "Autophagy Dysregulation in ALS: When Protein Aggregates Get Out of Hand.", "journal": "Front Mol Neurosci 10:263 (2017)", "doi": "10.3389/fnmol.2017.00263"}, {"pmid": "17409386", "authors": "  Kunita R, Otomo A, Mizumura H, Suzuki-Utsunomiya K, Hadano S, Ikeda JE", "title": "The Rab5 activator ALS2/alsin acts as a novel Rac1 effector through Rac1-activated endocytosis.", "journal": "J Biol Chem 282:16599-611 (2007)", "doi": "10.1074/jbc.M610682200"}, {"pmid": "17566607", "authors": "  Hadano S, Kunita R, Otomo A, Suzuki-Utsunomiya K, Ikeda JE", "title": "Molecular and cellular function of ALS2/alsin: implication of membrane dynamics in neuronal development and degeneration.", "journal": "Neurochem Int 51:74-84 (2007)", "doi": "10.1016/j.neuint.2007.04.010"}, {"pmid": "26388731", "authors": "  Ruffoli R, Bartalucci A, Frati A, Fornai F", "title": "Ultrastructural studies of ALS mitochondria connect altered function and permeability with defects of mitophagy and mitochondriogenesis.", "journal": "Front Cell Neurosci 9:341 (2015)", "doi": "10.3389/fncel.2015.00341"}, {"pmid": "25991442", "authors": "  Menzies FM, Fleming A, Rubinsztein DC", "title": "Compromised autophagy and neurodegenerative diseases.", "journal": "Nat Rev Neurosci 16:345-57 (2015)", "doi": "10.1038/nrn3961"}, {"pmid": "32119873", "authors": "  Casterton RL, Hunt RJ, Fanto M", "title": "Pathomechanism Heterogeneity in the Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Disease Spectrum: Providing Focus Through the Lens of Autophagy.", "journal": "J Mol Biol 432:2692-2713 (2020)", "doi": "10.1016/j.jmb.2020.02.018"}, {"pmid": "28057298", "authors": "  Lin G, Mao D, Bellen HJ", "title": "Amyotrophic Lateral Sclerosis Pathogenesis Converges on Defects in Protein Homeostasis Associated with TDP-43 Mislocalization and Proteasome-Mediated Degradation Overload.", "journal": "Curr Top Dev Biol 121:111-171 (2017)", "doi": "10.1016/bs.ctdb.2016.07.004"}, {"pmid": "24619348", "authors": "  Hetz C, Mollereau B", "title": "Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases.", "journal": "Nat Rev Neurosci 15:233-49 (2014)", "doi": "10.1038/nrn3689"}, {"pmid": "27815720", "authors": "  Xiang C, Wang Y, Zhang H, Han F", "title": "The role of endoplasmic reticulum stress in neurodegenerative disease.", "journal": "Apoptosis 22:1-26 (2017)", "doi": "10.1007/s10495-016-1296-4"}, {"pmid": "29476642", "authors": "  Hughes D, Mallucci GR", "title": "The unfolded protein response in neurodegenerative disorders - therapeutic modulation of the PERK pathway.", "journal": "FEBS J 286:342-355 (2019)", "doi": "10.1111/febs.14422"}, {"pmid": "21722302", "authors": "  Doyle KM, Kennedy D, Gorman AM, Gupta S, Healy SJ, Samali A", "title": "Unfolded proteins and endoplasmic reticulum stress in neurodegenerative disorders.", "journal": "J Cell Mol Med 15:2025-39 (2011)", "doi": "10.1111/j.1582-4934.2011.01374.x"}, {"pmid": "16472115", "authors": "  Turner BJ, Atkin JD", "title": "ER stress and UPR in familial amyotrophic lateral sclerosis.", "journal": "Curr Mol Med 6:79-86 (2006)", "doi": "10.2174/156652406775574550"}, {"pmid": "18519638", "authors": "  Nishitoh H, Kadowaki H, Nagai A, Maruyama T, Yokota T, Fukutomi H, Noguchi T, Matsuzawa A, Takeda K, Ichijo H", "title": "ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1.", "journal": "Genes Dev 22:1451-64 (2008)", "doi": "10.1101/gad.1640108"}, {"pmid": "21834058", "authors": "  Walker AK, Atkin JD", "title": "Stress signaling from the endoplasmic reticulum: A central player in the pathogenesis of amyotrophic lateral sclerosis.", "journal": "IUBMB Life 63:754-63 (2011)", "doi": "10.1002/iub.520"}, {"pmid": "31319884", "authors": "  Renaud L, Picher-Martel V, Codron P, Julien JP", "title": "Key role of UBQLN2 in pathogenesis of amyotrophic lateral sclerosis and frontotemporal dementia.", "journal": "Acta Neuropathol Commun 7:103 (2019)", "doi": "10.1186/s40478-019-0758-7"}, {"pmid": "29605155", "authors": "  Nguyen HP, Van Broeckhoven C, van der Zee J", "title": "ALS Genes in the Genomic Era and their Implications for FTD.", "journal": "Trends Genet 34:404-423 (2018)", "doi": "10.1016/j.tig.2018.03.001"}, {"pmid": "25071440", "authors": "  Atkin G, Paulson H", "title": "Ubiquitin pathways in neurodegenerative disease.", "journal": "Front Mol Neurosci 7:63 (2014)", "doi": "10.3389/fnmol.2014.00063"}, {"pmid": "29299811", "authors": "  Kim JM, Billington E, Reyes A, Notarianni T, Sage J, Agbas E, Taylor M, Monast I, Stanford JA, Agbas A", "title": "Impaired Cu-Zn Superoxide Dismutase (SOD1) and Calcineurin (Cn) Interaction in ALS: A Presumed Consequence for TDP-43 and Zinc Aggregation in Tg SOD1(G93A) Rodent Spinal Cord Tissue.", "journal": "Neurochem Res 44:228-233 (2019)", "doi": "10.1007/s11064-017-2461-z"}, {"pmid": "30242016", "authors": "  Benarroch EE", "title": "Sigma-1 receptor and amyotrophic lateral sclerosis.", "journal": "Neurology 91:743-747 (2018)", "doi": "10.1212/WNL.0000000000006347"}], "rel_pathway": ["hsa00190  Oxidative phosphorylation", "hsa03013  Nucleocytoplasmic transport", "hsa03050  Proteasome", "hsa04010  MAPK signaling pathway", "hsa04012  ErbB signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04115  p53 signaling pathway", "hsa04137  Mitophagy - animal", "hsa04140  Autophagy - animal", "hsa04141  Protein processing in endoplasmic reticulum", "hsa04210  Apoptosis", "hsa04724  Glutamatergic synapse", "hsa04810  Regulation of actin cytoskeleton"], "ko_pathway": "ko05014", "genes": ["RAC1", "TP53", "MAPK13", "BAX"]}, {"kegg_id": "hsa05020", "name": "Prion disease - Homo sapiens (human)", "description": "Prion diseases, also termed transmissible spongiform encephalopathies (TSEs), are a group of fatal neurodegenerative diseases that affect humans and a number of other animal species. The etiology of these diseases is thought to be associated with the conversion of a normal protein, PrPC, into an infectious, pathogenic form, PrPSc. The conversion is induced by prion infections (for example, variant Creutzfeldt-Jakob disease (vCJD), iatrogenic CJD, Kuru), mutations (familial CJD, Gerstmann-Straussler-Scheinker syndrome, fatal familial insomnia (FFI)) or unknown factors (sporadic CJD (sCJD)), and is thought to occur after PrPC has reached the plasma membrane or is re-internalized for degradation. The PrPSc form shows greater protease resistance than PrPC and accumulates in affected individuals, often in the form of extracellular plaques. Pathways that may lead to neuronal death comprise oxidative stress, regulated activation of complement, ubiquitin-proteasome and endosomal-lysosomal systems, synaptic alterations and dendritic atrophy, corticosteroid response, and endoplasmic reticulum stress. In addition, the conformational transition could lead to the lost of a beneficial activity of the natively folded protein, PrPC.", "class": "Human Diseases; Neurodegenerative disease", "pathway_map": "hsa05020  Prion disease", "network": ["", "ELEMENT   N01197  Scrapie conformation PrPSc to 26S proteasome-mediated protein degradation", "N01198  Scrapie conformation PrPSc to PERK-ATF4 signaling pathway", "N01199  Scrapie conformation PrPSc to mGluR5-Ca2+ -apoptotic pathway", "N01200  Scrapie conformation PrPSc to transport of calcium", "N01201  Scrapie conformation PrPSc to VGCC-Ca2+ -apoptotic pathway", "N01202  Oligomeric conformation PrPc to anterograde axonal transport", "N01203  Scrapie conformation PrPSc to Notch singling pathway", "N01205  Scrapie conformation PrPSc to PRNP-PI3K-NOX2 signaling pathway"], "disease": ["H00061  Prion disease"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["5621  PRNP; prion protein (Kanno blood group) [KO:K05634]", "4684  NCAM1; neural cell adhesion molecule 1 [KO:K06491]", "4685  NCAM2; neural cell adhesion molecule 2 [KO:K06491]", "3915  LAMC1; laminin subunit gamma 1 [KO:K05635]", "6647  SOD1; superoxide dismutase 1 [KO:K04565] [EC:1.15.1.1]", "10963  STIP1; stress induced phosphoprotein 1 [KO:K09553]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "2534  FYN; FYN proto-oncogene, Src family tyrosine kinase [KO:K05703] [EC:2.7.10.2]", "2902  GRIN1; glutamate ionotropic receptor NMDA type subunit 1 [KO:K05208]", "2903  GRIN2A; glutamate ionotropic receptor NMDA type subunit 2A [KO:K05209]", "2904  GRIN2B; glutamate ionotropic receptor NMDA type subunit 2B [KO:K05210]", "2905  GRIN2C; glutamate ionotropic receptor NMDA type subunit 2C [KO:K05211]", "2906  GRIN2D; glutamate ionotropic receptor NMDA type subunit 2D [KO:K05212]", "116443  GRIN3A; glutamate ionotropic receptor NMDA type subunit 3A [KO:K05213]", "116444  GRIN3B; glutamate ionotropic receptor NMDA type subunit 3B [KO:K05214]", "774  CACNA1B; calcium voltage-gated channel subunit alpha1 B [KO:K04849]", "775  CACNA1C; calcium voltage-gated channel subunit alpha1 C [KO:K04850]", "776  CACNA1D; calcium voltage-gated channel subunit alpha1 D [KO:K04851]", "778  CACNA1F; calcium voltage-gated channel subunit alpha1 F [KO:K04853]", "779  CACNA1S; calcium voltage-gated channel subunit alpha1 S [KO:K04857]", "3309  HSPA5; heat shock protein family A (Hsp70) member 5 [KO:K09490] [EC:3.6.4.10]", "9451  EIF2AK3; eukaryotic translation initiation factor 2 alpha kinase 3 [KO:K08860] [EC:2.7.11.1]", "1965  EIF2S1; eukaryotic translation initiation factor 2 subunit alpha [KO:K03237]", "468  ATF4; activating transcription factor 4 [KO:K04374]", "1649  DDIT3; DNA damage inducible transcript 3 [KO:K04452]", "6261  RYR1; ryanodine receptor 1 [KO:K04961]", "6262  RYR2; ryanodine receptor 2 [KO:K04962]", "6263  RYR3; ryanodine receptor 3 [KO:K04963]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "100506742  CASP12; caspase 12 (gene/pseudogene) [KO:K04741] [EC:3.4.22.-]", "5530  PPP3CA; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]", "5532  PPP3CB; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]", "5533  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]", "5534  PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]", "5535  PPP3R2; protein phosphatase 3 regulatory subunit B, beta [KO:K06268]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]", "7416  VDAC1; voltage dependent anion channel 1 [KO:K05862]", "7417  VDAC2; voltage dependent anion channel 2 [KO:K15040]", "7419  VDAC3; voltage dependent anion channel 3 [KO:K15041]", "291  SLC25A4; solute carrier family 25 member 4 [KO:K05863]", "292  SLC25A5; solute carrier family 25 member 5 [KO:K05863]", "293  SLC25A6; solute carrier family 25 member 6 [KO:K05863]", "83447  SLC25A31; solute carrier family 25 member 31 [KO:K05863]", "10105  PPIF; peptidylprolyl isomerase F [KO:K09565] [EC:5.2.1.8]", "317  APAF1; apoptotic peptidase activating factor 1 [KO:K02084]", "54205  CYCS; cytochrome c, somatic [KO:K08738]", "842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "90550  MCU; mitochondrial calcium uniporter [KO:K20858]", "4535  ND1; NADH dehydrogenase subunit 1 [KO:K03878] [EC:7.1.1.2]", "4536  ND2; NADH dehydrogenase subunit 2 [KO:K03879] [EC:7.1.1.2]", "4537  ND3; NADH dehydrogenase subunit 3 [KO:K03880] [EC:7.1.1.2]", "4538  ND4; NADH dehydrogenase subunit 4 [KO:K03881] [EC:7.1.1.2]", "4539  ND4L; NADH dehydrogenase subunit 4L [KO:K03882] [EC:7.1.1.2]", "4540  ND5; NADH dehydrogenase subunit 5 [KO:K03883] [EC:7.1.1.2]", "4541  ND6; NADH dehydrogenase subunit 6 [KO:K03884] [EC:7.1.1.2]", "4723  NDUFV1; NADH:ubiquinone oxidoreductase core subunit V1 [KO:K03942] [EC:7.1.1.2]", "4729  NDUFV2; NADH:ubiquinone oxidoreductase core subunit V2 [KO:K03943] [EC:7.1.1.2]", "4731  NDUFV3; NADH:ubiquinone oxidoreductase subunit V3 [KO:K03944]", "4694  NDUFA1; NADH:ubiquinone oxidoreductase subunit A1 [KO:K03945]", "4695  NDUFA2; NADH:ubiquinone oxidoreductase subunit A2 [KO:K03946]", "4696  NDUFA3; NADH:ubiquinone oxidoreductase subunit A3 [KO:K03947]", "4697  NDUFA4; NDUFA4 mitochondrial complex associated [KO:K03948]", "56901  NDUFA4L2; NDUFA4 mitochondrial complex associated like 2 [KO:K03948]", "4698  NDUFA5; NADH:ubiquinone oxidoreductase subunit A5 [KO:K03949]", "4700  NDUFA6; NADH:ubiquinone oxidoreductase subunit A6 [KO:K03950]", "4701  NDUFA7; NADH:ubiquinone oxidoreductase subunit A7 [KO:K03951]", "4702  NDUFA8; NADH:ubiquinone oxidoreductase subunit A8 [KO:K03952]", "4704  NDUFA9; NADH:ubiquinone oxidoreductase subunit A9 [KO:K03953]", "4705  NDUFA10; NADH:ubiquinone oxidoreductase subunit A10 [KO:K03954]", "4706  NDUFAB1; NADH:ubiquinone oxidoreductase subunit AB1 [KO:K03955]", "126328  NDUFA11; NADH:ubiquinone oxidoreductase subunit A11 [KO:K03956]", "55967  NDUFA12; NADH:ubiquinone oxidoreductase subunit A12 [KO:K11352]", "51079  NDUFA13; NADH:ubiquinone oxidoreductase subunit A13 [KO:K11353]", "4707  NDUFB1; NADH:ubiquinone oxidoreductase subunit B1 [KO:K03957]", "4708  NDUFB2; NADH:ubiquinone oxidoreductase subunit B2 [KO:K03958]", "4709  NDUFB3; NADH:ubiquinone oxidoreductase subunit B3 [KO:K03959]", "4710  NDUFB4; NADH:ubiquinone oxidoreductase subunit B4 [KO:K03960]", "4711  NDUFB5; NADH:ubiquinone oxidoreductase subunit B5 [KO:K03961]", "4712  NDUFB6; NADH:ubiquinone oxidoreductase subunit B6 [KO:K03962]", "4713  NDUFB7; NADH:ubiquinone oxidoreductase subunit B7 [KO:K03963]", "4714  NDUFB8; NADH:ubiquinone oxidoreductase subunit B8 [KO:K03964]", "4715  NDUFB9; NADH:ubiquinone oxidoreductase subunit B9 [KO:K03965]", "4716  NDUFB10; NADH:ubiquinone oxidoreductase subunit B10 [KO:K03966]", "54539  NDUFB11; NADH:ubiquinone oxidoreductase subunit B11 [KO:K11351]", "4719  NDUFS1; NADH:ubiquinone oxidoreductase core subunit S1 [KO:K03934] [EC:7.1.1.2]", "4720  NDUFS2; NADH:ubiquinone oxidoreductase core subunit S2 [KO:K03935] [EC:7.1.1.2]", "4722  NDUFS3; NADH:ubiquinone oxidoreductase core subunit S3 [KO:K03936] [EC:7.1.1.2]", "4724  NDUFS4; NADH:ubiquinone oxidoreductase subunit S4 [KO:K03937]", "4725  NDUFS5; NADH:ubiquinone oxidoreductase subunit S5 [KO:K03938]", "4726  NDUFS6; NADH:ubiquinone oxidoreductase subunit S6 [KO:K03939]", "374291  NDUFS7; NADH:ubiquinone oxidoreductase core subunit S7 [KO:K03940] [EC:7.1.1.2]", "4728  NDUFS8; NADH:ubiquinone oxidoreductase core subunit S8 [KO:K03941] [EC:7.1.1.2]", "4717  NDUFC1; NADH:ubiquinone oxidoreductase subunit C1 [KO:K03967]", "4718  NDUFC2; NADH:ubiquinone oxidoreductase subunit C2 [KO:K03968]", "100532726  NDUFC2-KCTD14; NDUFC2-KCTD14 readthrough [KO:K03968]", "6389  SDHA; succinate dehydrogenase complex flavoprotein subunit A [KO:K00234] [EC:1.3.5.1]", "6390  SDHB; succinate dehydrogenase complex iron sulfur subunit B [KO:K00235] [EC:1.3.5.1]", "6391  SDHC; succinate dehydrogenase complex subunit C [KO:K00236]", "6392  SDHD; succinate dehydrogenase complex subunit D [KO:K00237]", "7386  UQCRFS1; ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 [KO:K00411] [EC:7.1.1.8]", "4519  CYTB; cytochrome b [KO:K00412]", "1537  CYC1; cytochrome c1 [KO:K00413]", "7384  UQCRC1; ubiquinol-cytochrome c reductase core protein 1 [KO:K00414]", "7385  UQCRC2; ubiquinol-cytochrome c reductase core protein 2 [KO:K00415]", "7388  UQCRH; ubiquinol-cytochrome c reductase hinge protein [KO:K00416]", "440567  UQCRHL; ubiquinol-cytochrome c reductase hinge protein like [KO:K00416]", "7381  UQCRB; ubiquinol-cytochrome c reductase binding protein [KO:K00417]", "27089  UQCRQ; ubiquinol-cytochrome c reductase complex III subunit VII [KO:K00418]", "29796  UQCR10; ubiquinol-cytochrome c reductase, complex III subunit X [KO:K00419]", "10975  UQCR11; ubiquinol-cytochrome c reductase, complex III subunit XI [KO:K00420]", "4514  COX3; cytochrome c oxidase subunit III [KO:K02262]", "4512  COX1; cytochrome c oxidase subunit I [KO:K02256] [EC:7.1.1.9]", "4513  COX2; cytochrome c oxidase subunit II [KO:K02261]", "84701  COX4I2; cytochrome c oxidase subunit 4I2 [KO:K02263]", "1327  COX4I1; cytochrome c oxidase subunit 4I1 [KO:K02263]", "9377  COX5A; cytochrome c oxidase subunit 5A [KO:K02264]", "1329  COX5B; cytochrome c oxidase subunit 5B [KO:K02265]", "1337  COX6A1; cytochrome c oxidase subunit 6A1 [KO:K02266]", "1339  COX6A2; cytochrome c oxidase subunit 6A2 [KO:K02266]", "1340  COX6B1; cytochrome c oxidase subunit 6B1 [KO:K02267]", "125965  COX6B2; cytochrome c oxidase subunit 6B2 [KO:K02267]", "1345  COX6C; cytochrome c oxidase subunit 6C [KO:K02268]", "1346  COX7A1; cytochrome c oxidase subunit 7A1 [KO:K02270]", "1347  COX7A2; cytochrome c oxidase subunit 7A2 [KO:K02270]", "9167  COX7A2L; cytochrome c oxidase subunit 7A2 like [KO:K02270]", "1349  COX7B; cytochrome c oxidase subunit 7B [KO:K02271]", "170712  COX7B2; cytochrome c oxidase subunit 7B2 [KO:K02271]", "1350  COX7C; cytochrome c oxidase subunit 7C [KO:K02272]", "341947  COX8C; cytochrome c oxidase subunit 8C [KO:K02273]", "1351  COX8A; cytochrome c oxidase subunit 8A [KO:K02273]", "498  ATP5F1A; ATP synthase F1 subunit alpha [KO:K02132]", "506  ATP5F1B; ATP synthase F1 subunit beta [KO:K02133] [EC:7.1.2.2]", "509  ATP5F1C; ATP synthase F1 subunit gamma [KO:K02136]", "513  ATP5F1D; ATP synthase F1 subunit delta [KO:K02134]", "514  ATP5F1E; ATP synthase F1 subunit epsilon [KO:K02135]", "4508  ATP6; ATP synthase F0 subunit 6 [KO:K02126]", "515  ATP5PB; ATP synthase peripheral stalk-membrane subunit b [KO:K02127]", "516  ATP5MC1; ATP synthase membrane subunit c locus 1 [KO:K02128]", "517  ATP5MC2; ATP synthase membrane subunit c locus 2 [KO:K02128]", "518  ATP5MC3; ATP synthase membrane subunit c locus 3 [KO:K02128]", "10476  ATP5PD; ATP synthase peripheral stalk subunit d [KO:K02138]", "539  ATP5PO; ATP synthase peripheral stalk subunit OSCP [KO:K02137]", "522  ATP5PF; ATP synthase peripheral stalk subunit F6 [KO:K02131]", "4509  ATP8; ATP synthase F0 subunit 8 [KO:K02125]", "5687  PSMA6; proteasome 20S subunit alpha 6 [KO:K02730] [EC:3.4.25.1]", "5683  PSMA2; proteasome 20S subunit alpha 2 [KO:K02726] [EC:3.4.25.1]", "5685  PSMA4; proteasome 20S subunit alpha 4 [KO:K02728] [EC:3.4.25.1]", "5688  PSMA7; proteasome 20S subunit alpha 7 [KO:K02731] [EC:3.4.25.1]", "143471  PSMA8; proteasome 20S subunit alpha 8 [KO:K02731] [EC:3.4.25.1]", "5686  PSMA5; proteasome 20S subunit alpha 5 [KO:K02729] [EC:3.4.25.1]", "5682  PSMA1; proteasome 20S subunit alpha 1 [KO:K02725] [EC:3.4.25.1]", "5684  PSMA3; proteasome 20S subunit alpha 3 [KO:K02727] [EC:3.4.25.1]", "5694  PSMB6; proteasome 20S subunit beta 6 [KO:K02738] [EC:3.4.25.1]", "5695  PSMB7; proteasome 20S subunit beta 7 [KO:K02739] [EC:3.4.25.1]", "5691  PSMB3; proteasome 20S subunit beta 3 [KO:K02735] [EC:3.4.25.1]", "5690  PSMB2; proteasome 20S subunit beta 2 [KO:K02734] [EC:3.4.25.1]", "5693  PSMB5; proteasome 20S subunit beta 5 [KO:K02737] [EC:3.4.25.1]", "5689  PSMB1; proteasome 20S subunit beta 1 [KO:K02732] [EC:3.4.25.1]", "5692  PSMB4; proteasome 20S subunit beta 4 [KO:K02736] [EC:3.4.25.1]", "5701  PSMC2; proteasome 26S subunit, ATPase 2 [KO:K03061]", "5700  PSMC1; proteasome 26S subunit, ATPase 1 [KO:K03062]", "5704  PSMC4; proteasome 26S subunit, ATPase 4 [KO:K03063]", "5706  PSMC6; proteasome 26S subunit, ATPase 6 [KO:K03064]", "5702  PSMC3; proteasome 26S subunit, ATPase 3 [KO:K03065]", "5705  PSMC5; proteasome 26S subunit, ATPase 5 [KO:K03066]", "5708  PSMD2; proteasome 26S subunit ubiquitin receptor, non-ATPase 2 [KO:K03028]", "5707  PSMD1; proteasome 26S subunit, non-ATPase 1 [KO:K03032]", "5709  PSMD3; proteasome 26S subunit, non-ATPase 3 [KO:K03033]", "5715  PSMD9; proteasome 26S subunit, non-ATPase 9 [KO:K06693]", "5718  PSMD12; proteasome 26S subunit, non-ATPase 12 [KO:K03035]", "5717  PSMD11; proteasome 26S subunit, non-ATPase 11 [KO:K03036]", "9861  PSMD6; proteasome 26S subunit, non-ATPase 6 [KO:K03037]", "5713  PSMD7; proteasome 26S subunit, non-ATPase 7 [KO:K03038]", "5719  PSMD13; proteasome 26S subunit, non-ATPase 13 [KO:K03039]", "5710  PSMD4; proteasome 26S subunit ubiquitin receptor, non-ATPase 4 [KO:K03029]", "10213  PSMD14; proteasome 26S subunit, non-ATPase 14 [KO:K03030]", "5714  PSMD8; proteasome 26S subunit, non-ATPase 8 [KO:K03031]", "11047  ADRM1; ADRM1 26S proteasome ubiquitin receptor [KO:K06691]", "7979  SEM1; SEM1 26S proteasome subunit [KO:K10881]", "727  C5; complement C5 [KO:K03994]", "729  C6; complement C6 [KO:K03995]", "730  C7; complement C7 [KO:K03996]", "731  C8A; complement C8 alpha chain [KO:K03997]", "732  C8B; complement C8 beta chain [KO:K03998]", "733  C8G; complement C8 gamma chain [KO:K03999]", "735  C9; complement C9 [KO:K04000]", "712  C1QA; complement C1q A chain [KO:K03986]", "713  C1QB; complement C1q B chain [KO:K03987]", "714  C1QC; complement C1q C chain [KO:K03988]", "3312  HSPA8; heat shock protein family A (Hsp70) member 8 [KO:K03283]", "3303  HSPA1A; heat shock protein family A (Hsp70) member 1A [KO:K03283]", "3305  HSPA1L; heat shock protein family A (Hsp70) member 1 like [KO:K03283]", "3304  HSPA1B; heat shock protein family A (Hsp70) member 1B [KO:K03283]", "3310  HSPA6; heat shock protein family A (Hsp70) member 6 [KO:K03283]", "4851  NOTCH1; notch receptor 1 [KO:K02599]", "857  CAV1; caveolin 1 [KO:K06278]", "858  CAV2; caveolin 2 [KO:K12958]", "859  CAV3; caveolin 3 [KO:K12959]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5580  PRKCD; protein kinase C delta [KO:K06068] [EC:2.7.11.13]", "1536  CYBB; cytochrome b-245 beta chain [KO:K21421] [EC:1.-.-.-]", "1535  CYBA; cytochrome b-245 alpha chain [KO:K08009]", "4689  NCF4; neutrophil cytosolic factor 4 [KO:K08012]", "653361  NCF1; neutrophil cytosolic factor 1 [KO:K08011]", "4688  NCF2; neutrophil cytosolic factor 2 [KO:K08010]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "5880  RAC2; Rac family small GTPase 2 [KO:K07860]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]", "1386  ATF2; activating transcription factor 2 [KO:K04450]", "10488  CREB3; cAMP responsive element binding protein 3 [KO:K09048]", "90993  CREB3L1; cAMP responsive element binding protein 3 like 1 [KO:K09048]", "64764  CREB3L2; cAMP responsive element binding protein 3 like 2 [KO:K09048]", "84699  CREB3L3; cAMP responsive element binding protein 3 like 3 [KO:K09048]", "148327  CREB3L4; cAMP responsive element binding protein 3 like 4 [KO:K09048]", "9586  CREB5; cAMP responsive element binding protein 5 [KO:K09047]", "1388  ATF6B; activating transcription factor 6 beta [KO:K09049]", "1958  EGR1; early growth response 1 [KO:K09203]", "6352  CCL5; C-C motif chemokine ligand 5 [KO:K12499]", "3552  IL1A; interleukin 1 alpha [KO:K04383]", "3553  IL1B; interleukin 1 beta [KO:K04519]", "3569  IL6; interleukin 6 [KO:K05405]", "7124  TNF; tumor necrosis factor [KO:K03156]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "1457  CSNK2A1; casein kinase 2 alpha 1 [KO:K03097] [EC:2.7.11.1]", "1459  CSNK2A2; casein kinase 2 alpha 2 [KO:K03097] [EC:2.7.11.1]", "283106  CSNK2A3; casein kinase 2 alpha 3 [KO:K03097] [EC:2.7.11.1]", "1460  CSNK2B; casein kinase 2 beta [KO:K03115]", "3798  KIF5A; kinesin family member 5A [KO:K10396]", "3799  KIF5B; kinesin family member 5B [KO:K10396]", "3800  KIF5C; kinesin family member 5C [KO:K10396]", "147700  KLC3; kinesin light chain 3 [KO:K10407]", "3831  KLC1; kinesin light chain 1 [KO:K10407]", "64837  KLC2; kinesin light chain 2 [KO:K10407]", "89953  KLC4; kinesin light chain 4 [KO:K10407]", "10376  TUBA1B; tubulin alpha 1b [KO:K07374]", "7277  TUBA4A; tubulin alpha 4a [KO:K07374]", "7278  TUBA3C; tubulin alpha 3c [KO:K07374]", "7846  TUBA1A; tubulin alpha 1a [KO:K07374]", "84790  TUBA1C; tubulin alpha 1c [KO:K07374]", "51807  TUBA8; tubulin alpha 8 [KO:K07374]", "112714  TUBA3E; tubulin alpha 3e [KO:K07374]", "113457  TUBA3D; tubulin alpha 3d [KO:K07374]", "79861  TUBAL3; tubulin alpha like 3 [KO:K07374]", "84617  TUBB6; tubulin beta 6 class V [KO:K07375]", "203068  TUBB; tubulin beta class I [KO:K07375]", "81027  TUBB1; tubulin beta 1 class VI [KO:K07375]", "7280  TUBB2A; tubulin beta 2A class IIa [KO:K07375]", "10381  TUBB3; tubulin beta 3 class III [KO:K07375]", "10382  TUBB4A; tubulin beta 4A class IVa [KO:K07375]", "347688  TUBB8; tubulin beta 8 class VIII [KO:K07375]", "347733  TUBB2B; tubulin beta 2B class IIb [KO:K07375]", "10383  TUBB4B; tubulin beta 4B class IVb [KO:K07375]"], "compound": ["C00027  Hydrogen peroxide", "C00076  Calcium cation", "C00575  3',5'-Cyclic AMP", "C00704  Superoxide", "C02140  Corticosterone"], "refs": [{"pmid": "27055367", "authors": "  Saa P, Harris DA, Cervenakova L", "title": "Mechanisms of prion-induced neurodegeneration.", "journal": "Expert Rev Mol Med 18:e5 (2016)", "doi": "10.1017/erm.2016.8"}, {"pmid": "25584786", "authors": "  Goold R, McKinnon C, Tabrizi SJ", "title": "Prion degradation pathways: Potential for therapeutic intervention.", "journal": "Mol Cell Neurosci 66:12-20 (2015)", "doi": "10.1016/j.mcn.2014.12.009"}, {"pmid": "20889378", "authors": "  Soto C, Satani N", "title": "The intricate mechanisms of neurodegeneration in prion diseases.", "journal": "Trends Mol Med 17:14-24 (2011)", "doi": "10.1016/j.molmed.2010.09.001"}, {"pmid": "27060771", "authors": "  Mays CE, Soto C", "title": "The stress of prion disease.", "journal": "Brain Res 1648:553-560 (2016)", "doi": "10.1016/j.brainres.2016.04.009"}, {"pmid": "32565065", "authors": "  Jones E, Mead S", "title": "Genetic risk factors for Creutzfeldt-Jakob disease.", "journal": "Neurobiol Dis 142:104973 (2020)", "doi": "10.1016/j.nbd.2020.104973"}, {"pmid": "18245809", "authors": "  Kovacs GG, Budka H", "title": "Prion diseases: from protein to cell pathology.", "journal": "Am J Pathol 172:555-65 (2008)", "doi": "10.2353/ajpath.2008.070442"}, {"pmid": "15695097", "authors": "  Campana V, Sarnataro D, Zurzolo C", "title": "The highways and byways of prion protein trafficking.", "journal": "Trends Cell Biol 15:102-11 (2005)", "doi": "10.1016/j.tcb.2004.12.002"}, {"pmid": "17051207", "authors": "  Caughey B, Baron GS", "title": "Prions and their partners in crime.", "journal": "Nature 443:803-10 (2006)", "doi": "10.1038/nature05294"}, {"pmid": "11592845", "authors": "  Chiesa R, Harris DA", "title": "Prion diseases: what is the neurotoxic molecule?", "journal": "Neurobiol Dis 8:743-63 (2001)", "doi": "10.1006/nbdi.2001.0433"}, {"pmid": "17085779", "authors": "  Fasano C, Campana V, Zurzolo C", "title": "Prions: protein only or something more? Overview of potential prion cofactors.", "journal": "J Mol Neurosci 29:195-214 (2006)", "doi": "10.1385/JMN:29:3:195"}, {"pmid": "14705136", "authors": "  Roucou X, Gains M, LeBlanc AC", "title": "Neuroprotective functions of prion protein.", "journal": "J Neurosci Res 75:153-61 (2004)", "doi": "10.1002/jnr.10864"}, {"pmid": "15890824", "authors": "  Novakofski J, Brewer MS, Mateus-Pinilla N, Killefer J, McCusker RH", "title": "Prion biology relevant to bovine spongiform encephalopathy.", "journal": "J Anim Sci 83:1455-76 (2005)", "doi": "10.2527/2005.8361455x"}, {"pmid": "27581199", "authors": "  Peggion C, Bertoli A, Sorgato MC", "title": "Almost a century of prion protein(s): From pathology to physiology, and back to pathology.", "journal": "Biochem Biophys Res Commun 483:1148-1155 (2017)", "doi": "10.1016/j.bbrc.2016.07.118"}, {"pmid": "31618844", "authors": "  Ryskalin L, Busceti CL, Biagioni F, Limanaqi F, Familiari P, Frati A, Fornai F", "title": "Prion Protein in Glioblastoma Multiforme.", "journal": "Int J Mol Sci 20:E5107 (2019)", "doi": "10.3390/ijms20205107"}, {"pmid": "31795242", "authors": "  Ureshino RP, Erustes AG, Bassani TB, Wachilewski P, Guarache GC, Nascimento AC, Costa AJ, Smaili SS, Pereira GJDS", "title": "The Interplay between Ca(2+) Signaling Pathways and Neurodegeneration.", "journal": "Int J Mol Sci 20:E6004 (2019)", "doi": "10.3390/ijms20236004"}, {"pmid": "30710214", "authors": "  Meneghetti E, Gasperini L, Virgilio T, Moda F, Tagliavini F, Benetti F, Legname G", "title": "Prions Strongly Reduce NMDA Receptor S-Nitrosylation Levels at Pre-symptomatic and Terminal Stages of Prion Diseases.", "journal": "Mol Neurobiol 56:6035-6045 (2019)", "doi": "10.1007/s12035-019-1505-6"}, {"pmid": "23439666", "authors": "  Song Z, Zhao D, Yang L", "title": "Molecular mechanisms of neurodegeneration mediated by dysfunctional subcellular organelles in transmissible spongiform encephalopathies.", "journal": "Acta Biochim Biophys Sin (Shanghai) 45:452-64 (2013)", "doi": "10.1093/abbs/gmt014"}, {"pmid": "28643372", "authors": "  Halliday M, Hughes D, Mallucci GR", "title": "Fine-tuning PERK signaling for neuroprotection.", "journal": "J Neurochem 142:812-826 (2017)", "doi": "10.1111/jnc.14112"}, {"pmid": "29194372", "authors": "  Hughes D, Halliday M", "title": "What Is Our Current Understanding of PrP(Sc)-Associated Neurotoxicity and Its Molecular Underpinnings?", "journal": "Pathogens 6:E63 (2017)", "doi": "10.3390/pathogens6040063"}, {"pmid": "24619348", "authors": "  Hetz C, Mollereau B", "title": "Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases.", "journal": "Nat Rev Neurosci 15:233-49 (2014)", "doi": "10.1038/nrn3689"}, {"pmid": "29476642", "authors": "  Hughes D, Mallucci GR", "title": "The unfolded protein response in neurodegenerative disorders - therapeutic modulation of the PERK pathway.", "journal": "FEBS J 286:342-355 (2019)", "doi": "10.1111/febs.14422"}, {"pmid": "21722302", "authors": "  Doyle KM, Kennedy D, Gorman AM, Gupta S, Healy SJ, Samali A", "title": "Unfolded proteins and endoplasmic reticulum stress in neurodegenerative disorders.", "journal": "J Cell Mol Med 15:2025-39 (2011)", "doi": "10.1111/j.1582-4934.2011.01374.x"}, {"pmid": "18420416", "authors": "  Ferreiro E, Oliveira CR, Pereira CM", "title": "The release of calcium from the endoplasmic reticulum induced by amyloid-beta and prion peptides activates the mitochondrial apoptotic pathway.", "journal": "Neurobiol Dis 30:331-42 (2008)", "doi": "10.1016/j.nbd.2008.02.003"}, {"pmid": "16844381", "authors": "  Ferreiro E, Resende R, Costa R, Oliveira CR, Pereira CM", "title": "An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity.", "journal": "Neurobiol Dis 23:669-78 (2006)", "doi": "10.1016/j.nbd.2006.05.011"}, {"pmid": "21980554", "authors": "  Torres M, Encina G, Soto C, Hetz C", "title": "Abnormal calcium homeostasis and protein folding stress at the ER: A common factor in familial and infectious prion disorders.", "journal": "Commun Integr Biol 4:258-61 (2011)", "doi": "10.4161/cib.4.3.15019"}, {"pmid": "25766616", "authors": "  Ciechanover A, Kwon YT", "title": "Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.", "journal": "Exp Mol Med 47:e147 (2015)", "doi": "10.1038/emm.2014.117"}, {"pmid": "17466621", "authors": "  Kristiansen M, Deriziotis P, Dimcheff DE, Jackson GS, Ovaa H, Naumann H, Clarke AR, van Leeuwen FW, Menendez-Benito V, Dantuma NP, Portis JL, Collinge J, Tabrizi SJ", "title": "Disease-associated prion protein oligomers inhibit the 26S proteasome.", "journal": "Mol Cell 26:175-88 (2007)", "doi": "10.1016/j.molcel.2007.04.001"}, {"pmid": "10195903", "authors": "  Wang HG, Pathan N, Ethell IM, Krajewski S, Yamaguchi Y, Shibasaki F, McKeon F, Bobo T, Franke TF, Reed JC.", "title": "Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD.", "journal": "Science 284:339-43 (1999)", "doi": "10.1126/science.284.5412.339"}, {"pmid": "14532116", "authors": "  Hetz C, Russelakis-Carneiro M, Maundrell K, Castilla J, Soto C", "title": "Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein.", "journal": "EMBO J 22:5435-45 (2003)", "doi": "10.1093/emboj/cdg537"}, {"pmid": "31417367", "authors": "  Zamponi E, Pigino GF", "title": "Protein Misfolding, Signaling Abnormalities and Altered Fast Axonal Transport: Implications for Alzheimer and Prion Diseases.", "journal": "Front Cell Neurosci 13:350 (2019)", "doi": "10.3389/fncel.2019.00350"}, {"pmid": "29261664", "authors": "  Zamponi E, Buratti F, Cataldi G, Caicedo HH, Song Y, Jungbauer LM, LaDu MJ, Bisbal M, Lorenzo A, Ma J, Helguera PR, Morfini GA, Brady ST, Pigino GF", "title": "Prion protein inhibits fast axonal transport through a mechanism involving casein kinase 2.", "journal": "PLoS One 12:e0188340 (2017)", "doi": "10.1371/journal.pone.0188340"}, {"pmid": "21196165", "authors": "  Schneider B, Pietri M, Pradines E, Loubet D, Launay JM, Kellermann O, Mouillet-Richard S", "title": "Understanding the neurospecificity of Prion protein signaling.", "journal": "Front Biosci (Landmark Ed) 16:169-86 (2011)", "doi": "10.2741/3682"}, {"pmid": "23479001", "authors": "  Didonna A", "title": "Prion protein and its role in signal transduction.", "journal": "Cell Mol Biol Lett 18:209-30 (2013)", "doi": "10.2478/s11658-013-0085-0"}, {"pmid": "28507517", "authors": "  Shah SZA, Zhao D, Hussain T, Yang L", "title": "The Role of Unfolded Protein Response and Mitogen-Activated Protein Kinase Signaling in Neurodegenerative Diseases with Special Focus on Prion Diseases.", "journal": "Front Aging Neurosci 9:120 (2017)", "doi": "10.3389/fnagi.2017.00120"}, {"pmid": "15528202", "authors": "  Marella M, Gaggioli C, Batoz M, Deckert M, Tartare-Deckert S, Chabry J", "title": "Pathological prion protein exposure switches on neuronal mitogen-activated protein kinase pathway resulting in microglia recruitment.", "journal": "J Biol Chem 280:1529-34 (2005)", "doi": "10.1074/jbc.M410966200"}, {"pmid": "15640354", "authors": "  Ishikura N, Clever JL, Bouzamondo-Bernstein E, Samayoa E, Prusiner SB, Huang EJ, DeArmond SJ", "title": "Notch-1 activation and dendritic atrophy in prion disease.", "journal": "Proc Natl Acad Sci U S A 102:886-91 (2005)", "doi": "10.1073/pnas.0408612101"}, {"pmid": "20205843", "authors": "  Dearmond SJ, Bajsarowicz K", "title": "PrPSc accumulation in neuronal plasma membranes links Notch-1 activation to dendritic degeneration in prion diseases.", "journal": "Mol Neurodegener 5:6 (2010)", "doi": "10.1186/1750-1326-5-6"}, {"pmid": "29998397", "authors": "  Hirsch TZ, Martin-Lanneree S, Reine F, Hernandez-Rapp J, Herzog L, Dron M, Privat N, Passet B, Halliez S, Villa-Diaz A, Lacroux C, Klein V, Haik S, Andreoletti O, Torres JM, Vilotte JL, Beringue V, Mouillet-Richard S", "title": "Epigenetic Control of the Notch and Eph Signaling Pathways by the Prion Protein: Implications for Prion Diseases.", "journal": "Mol Neurobiol 56:2159-2173 (2019)", "doi": "10.1007/s12035-018-1193-7"}, {"pmid": "28714865", "authors": "  Aguzzi A, Zhu C", "title": "Microglia in prion diseases.", "journal": "J Clin Invest 127:3230-3239 (2017)", "doi": "10.1172/JCI90605"}, {"pmid": "15342004", "authors": "  Mabbott NA", "title": "The complement system in prion diseases.", "journal": "Curr Opin Immunol 16:587-93 (2004)", "doi": "10.1016/j.coi.2004.07.002"}], "rel_pathway": ["hsa00190  Oxidative phosphorylation", "hsa03050  Proteasome", "hsa04020  Calcium signaling pathway", "hsa04140  Autophagy - animal", "hsa04141  Protein processing in endoplasmic reticulum", "hsa04142  Lysosome", "hsa04144  Endocytosis", "hsa04210  Apoptosis", "hsa04330  Notch signaling pathway", "hsa04610  Complement and coagulation cascades", "hsa04668  TNF signaling pathway"], "ko_pathway": "ko05020", "genes": ["RAC1", "MAPK13", "BAX"]}, {"kegg_id": "hsa05022", "name": "Pathways of neurodegeneration - multiple diseases - Homo sapiens (human)", "description": "Neurodegeneration is generally defined as progressive, irreversible loss of neurons, which may affect either the peripheral or central nervous system (CNS). Neurodegenerative diseases (NDs) include highly debilitating illnesses, such as Alzheimer (AD), Parkinson disease (PD), amyotrophic lateral sclerosis, Huntington disease, spinocerebellar ataxias, and prion diseases (PrD). The hallmark event, which is thought to be at the root of these diseases, is the progressive accumulation of misfolded protein aggregates. Major basic processes include abnormal protein dynamics due to deficiency of the ubiquitin-proteosome-autophagy system, oxidative stress and free radical formation, endoplasmic reticulum stress, mitochondrial dysfunction and (secondary) disruptions of axonal transport.", "class": "Human Diseases; Neurodegenerative disease", "pathway_map": "hsa05022  Pathways of neurodegeneration - multiple diseases", "drug": ["D04148  Fenfluramine hydrochloride (JAN/USAN)", "D07945  Fenfluramine (INN)", "D11293  Gosuranemab (USAN)", "D11384  Hydromethylthionine mesylate (USAN)", "D11427  Hydromethylthionine (USAN/INN)", "D11533  Zagotenemab (USAN)", "D11687  Semorinemab (USAN/INN)", "D11811  Tofersen (JAN/USAN/INN)", "D11840  Tilavonemab (USAN/INN)", "D12228  Bepranemab (USAN/INN)", "D12553  Nevadistinel (USAN)", "D12636  Posdinemab (USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["351  APP; amyloid beta precursor protein [KO:K04520]", "4137  MAPT; microtubule associated protein tau [KO:K04380]", "6622  SNCA; synuclein alpha [KO:K04528]", "23435  TARDBP; TAR DNA binding protein [KO:K23600]", "2521  FUS; FUS RNA binding protein [KO:K13098]", "6647  SOD1; superoxide dismutase 1 [KO:K04565] [EC:1.15.1.1]", "11273  ATXN2L; ataxin 2 like [KO:K23625]", "6311  ATXN2; ataxin 2 [KO:K23625]", "3064  HTT; huntingtin [KO:K04533]", "342371  ATXN1L; ataxin 1 like [KO:K23616]", "6310  ATXN1; ataxin 1 [KO:K23616]", "4287  ATXN3; ataxin 3 [KO:K11863] [EC:3.4.22.-]", "92552  ATXN3L; ataxin 3 like [KO:K11863] [EC:3.4.22.-]", "5621  PRNP; prion protein (Kanno blood group) [KO:K05634]", "1128  CHRM1; cholinergic receptor muscarinic 1 [KO:K04129]", "1131  CHRM3; cholinergic receptor muscarinic 3 [KO:K04131]", "1133  CHRM5; cholinergic receptor muscarinic 5 [KO:K04133]", "6712  SPTBN2; spectrin beta, non-erythrocytic 2 [KO:K23932]", "2911  GRM1; glutamate metabotropic receptor 1 [KO:K04603]", "2915  GRM5; glutamate metabotropic receptor 5 [KO:K04604]", "2776  GNAQ; G protein subunit alpha q [KO:K04634]", "5071  PRKN; parkin RBR E3 ubiquitin protein ligase [KO:K04556] [EC:2.3.2.31]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "7222  TRPC3; transient receptor potential cation channel subfamily C member 3 [KO:K04966]", "10280  SIGMAR1; sigma non-opioid intracellular receptor 1 [KO:K20719]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "6261  RYR1; ryanodine receptor 1 [KO:K04961]", "6262  RYR2; ryanodine receptor 2 [KO:K04962]", "6263  RYR3; ryanodine receptor 3 [KO:K04963]", "5173  PDYN; prodynorphin [KO:K15840]", "1742  DLG4; discs large MAGUK scaffold protein 4 [KO:K11828]", "2902  GRIN1; glutamate ionotropic receptor NMDA type subunit 1 [KO:K05208]", "2903  GRIN2A; glutamate ionotropic receptor NMDA type subunit 2A [KO:K05209]", "2904  GRIN2B; glutamate ionotropic receptor NMDA type subunit 2B [KO:K05210]", "2905  GRIN2C; glutamate ionotropic receptor NMDA type subunit 2C [KO:K05211]", "2906  GRIN2D; glutamate ionotropic receptor NMDA type subunit 2D [KO:K05212]", "2890  GRIA1; glutamate ionotropic receptor AMPA type subunit 1 [KO:K05197]", "2891  GRIA2; glutamate ionotropic receptor AMPA type subunit 2 [KO:K05198]", "2892  GRIA3; glutamate ionotropic receptor AMPA type subunit 3 [KO:K05199]", "2893  GRIA4; glutamate ionotropic receptor AMPA type subunit 4 [KO:K05200]", "774  CACNA1B; calcium voltage-gated channel subunit alpha1 B [KO:K04849]", "775  CACNA1C; calcium voltage-gated channel subunit alpha1 C [KO:K04850]", "776  CACNA1D; calcium voltage-gated channel subunit alpha1 D [KO:K04851]", "778  CACNA1F; calcium voltage-gated channel subunit alpha1 F [KO:K04853]", "779  CACNA1S; calcium voltage-gated channel subunit alpha1 S [KO:K04857]", "6804  STX1A; syntaxin 1A [KO:K04560]", "1139  CHRNA7; cholinergic receptor nicotinic alpha 7 subunit [KO:K04809]", "487  ATP2A1; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 [KO:K05853] [EC:7.2.2.10]", "489  ATP2A3; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 [KO:K05853] [EC:7.2.2.10]", "488  ATP2A2; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 [KO:K05853] [EC:7.2.2.10]", "5663  PSEN1; presenilin 1 [KO:K04505] [EC:3.4.23.-]", "5664  PSEN2; presenilin 2 [KO:K04522] [EC:3.4.23.-]", "79139  DERL1; derlin 1 [KO:K11519]", "7415  VCP; valosin containing protein [KO:K13525]", "7311  UBA52; ubiquitin A-52 residue ribosomal protein fusion product 1 [KO:K02927]", "6233  RPS27A; ribosomal protein S27a [KO:K02977]", "7314  UBB; ubiquitin B [KO:K04551]", "7316  UBC; ubiquitin C [KO:K08770]", "5687  PSMA6; proteasome 20S subunit alpha 6 [KO:K02730] [EC:3.4.25.1]", "5683  PSMA2; proteasome 20S subunit alpha 2 [KO:K02726] [EC:3.4.25.1]", "5685  PSMA4; proteasome 20S subunit alpha 4 [KO:K02728] [EC:3.4.25.1]", "5688  PSMA7; proteasome 20S subunit alpha 7 [KO:K02731] [EC:3.4.25.1]", "143471  PSMA8; proteasome 20S subunit alpha 8 [KO:K02731] [EC:3.4.25.1]", "5686  PSMA5; proteasome 20S subunit alpha 5 [KO:K02729] [EC:3.4.25.1]", "5682  PSMA1; proteasome 20S subunit alpha 1 [KO:K02725] [EC:3.4.25.1]", "5684  PSMA3; proteasome 20S subunit alpha 3 [KO:K02727] [EC:3.4.25.1]", "5694  PSMB6; proteasome 20S subunit beta 6 [KO:K02738] [EC:3.4.25.1]", "5695  PSMB7; proteasome 20S subunit beta 7 [KO:K02739] [EC:3.4.25.1]", "5691  PSMB3; proteasome 20S subunit beta 3 [KO:K02735] [EC:3.4.25.1]", "5690  PSMB2; proteasome 20S subunit beta 2 [KO:K02734] [EC:3.4.25.1]", "5693  PSMB5; proteasome 20S subunit beta 5 [KO:K02737] [EC:3.4.25.1]", "5689  PSMB1; proteasome 20S subunit beta 1 [KO:K02732] [EC:3.4.25.1]", "5692  PSMB4; proteasome 20S subunit beta 4 [KO:K02736] [EC:3.4.25.1]", "5701  PSMC2; proteasome 26S subunit, ATPase 2 [KO:K03061]", "5700  PSMC1; proteasome 26S subunit, ATPase 1 [KO:K03062]", "5704  PSMC4; proteasome 26S subunit, ATPase 4 [KO:K03063]", "5706  PSMC6; proteasome 26S subunit, ATPase 6 [KO:K03064]", "5702  PSMC3; proteasome 26S subunit, ATPase 3 [KO:K03065]", "5705  PSMC5; proteasome 26S subunit, ATPase 5 [KO:K03066]", "5708  PSMD2; proteasome 26S subunit ubiquitin receptor, non-ATPase 2 [KO:K03028]", "5707  PSMD1; proteasome 26S subunit, non-ATPase 1 [KO:K03032]", "5709  PSMD3; proteasome 26S subunit, non-ATPase 3 [KO:K03033]", "5715  PSMD9; proteasome 26S subunit, non-ATPase 9 [KO:K06693]", "5718  PSMD12; proteasome 26S subunit, non-ATPase 12 [KO:K03035]", "5717  PSMD11; proteasome 26S subunit, non-ATPase 11 [KO:K03036]", "9861  PSMD6; proteasome 26S subunit, non-ATPase 6 [KO:K03037]", "5713  PSMD7; proteasome 26S subunit, non-ATPase 7 [KO:K03038]", "5719  PSMD13; proteasome 26S subunit, non-ATPase 13 [KO:K03039]", "5710  PSMD4; proteasome 26S subunit ubiquitin receptor, non-ATPase 4 [KO:K03029]", "10213  PSMD14; proteasome 26S subunit, non-ATPase 14 [KO:K03030]", "5714  PSMD8; proteasome 26S subunit, non-ATPase 8 [KO:K03031]", "11047  ADRM1; ADRM1 26S proteasome ubiquitin receptor [KO:K06691]", "7979  SEM1; SEM1 26S proteasome subunit [KO:K10881]", "7345  UCHL1; ubiquitin C-terminal hydrolase L1 [KO:K05611] [EC:3.4.19.12]", "7317  UBA1; ubiquitin like modifier activating enzyme 1 [KO:K03178] [EC:6.2.1.45]", "7318  UBA7; ubiquitin like modifier activating enzyme 7 [KO:K10698] [EC:6.2.1.45]", "7332  UBE2L3; ubiquitin conjugating enzyme E2 L3 [KO:K04552] [EC:2.3.2.23]", "9246  UBE2L6; ubiquitin conjugating enzyme E2 L6 [KO:K04553] [EC:2.3.2.23]", "118424  UBE2J2; ubiquitin conjugating enzyme E2 J2 [KO:K04554] [EC:2.3.2.23]", "51465  UBE2J1; ubiquitin conjugating enzyme E2 J1 [KO:K10578] [EC:2.3.2.23]", "7327  UBE2G2; ubiquitin conjugating enzyme E2 G2 [KO:K04555] [EC:2.3.2.23]", "7326  UBE2G1; ubiquitin conjugating enzyme E2 G1 [KO:K10575] [EC:2.3.2.23]", "2861  GPR37; G protein-coupled receptor 37 [KO:K04243]", "5413  SEPTIN5; septin 5 [KO:K04557]", "9627  SNCAIP; synuclein alpha interacting protein [KO:K04558]", "3309  HSPA5; heat shock protein family A (Hsp70) member 5 [KO:K09490] [EC:3.6.4.10]", "9217  VAPB; VAMP associated protein B and C [KO:K10707]", "22926  ATF6; activating transcription factor 6 [KO:K09054]", "1649  DDIT3; DNA damage inducible transcript 3 [KO:K04452]", "7494  XBP1; X-box binding protein 1 [KO:K09027]", "2081  ERN1; endoplasmic reticulum to nucleus signaling 1 [KO:K08852] [EC:2.7.11.1 3.1.26.-]", "7186  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]", "4217  MAP3K5; mitogen-activated protein kinase kinase kinase 5 [KO:K04426] [EC:2.7.11.25]", "5609  MAP2K7; mitogen-activated protein kinase kinase 7 [KO:K04431] [EC:2.7.12.2]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "100506742  CASP12; caspase 12 (gene/pseudogene) [KO:K04741] [EC:3.4.22.-]", "4294  MAP3K10; mitogen-activated protein kinase kinase kinase 10 [KO:K04418] [EC:2.7.11.25]", "9451  EIF2AK3; eukaryotic translation initiation factor 2 alpha kinase 3 [KO:K08860] [EC:2.7.11.1]", "1965  EIF2S1; eukaryotic translation initiation factor 2 subunit alpha [KO:K03237]", "468  ATF4; activating transcription factor 4 [KO:K04374]", "6531  SLC6A3; solute carrier family 6 member 3 [KO:K05036]", "65018  PINK1; PTEN induced kinase 1 [KO:K05688] [EC:2.7.11.1]", "4535  ND1; NADH dehydrogenase subunit 1 [KO:K03878] [EC:7.1.1.2]", "4536  ND2; NADH dehydrogenase subunit 2 [KO:K03879] [EC:7.1.1.2]", "4537  ND3; NADH dehydrogenase subunit 3 [KO:K03880] [EC:7.1.1.2]", "4538  ND4; NADH dehydrogenase subunit 4 [KO:K03881] [EC:7.1.1.2]", "4539  ND4L; NADH dehydrogenase subunit 4L [KO:K03882] [EC:7.1.1.2]", "4540  ND5; NADH dehydrogenase subunit 5 [KO:K03883] [EC:7.1.1.2]", "4541  ND6; NADH dehydrogenase subunit 6 [KO:K03884] [EC:7.1.1.2]", "4723  NDUFV1; NADH:ubiquinone oxidoreductase core subunit V1 [KO:K03942] [EC:7.1.1.2]", "4729  NDUFV2; NADH:ubiquinone oxidoreductase core subunit V2 [KO:K03943] [EC:7.1.1.2]", "4731  NDUFV3; NADH:ubiquinone oxidoreductase subunit V3 [KO:K03944]", "4694  NDUFA1; NADH:ubiquinone oxidoreductase subunit A1 [KO:K03945]", "4695  NDUFA2; NADH:ubiquinone oxidoreductase subunit A2 [KO:K03946]", "4696  NDUFA3; NADH:ubiquinone oxidoreductase subunit A3 [KO:K03947]", "4697  NDUFA4; NDUFA4 mitochondrial complex associated [KO:K03948]", "56901  NDUFA4L2; NDUFA4 mitochondrial complex associated like 2 [KO:K03948]", "4698  NDUFA5; NADH:ubiquinone oxidoreductase subunit A5 [KO:K03949]", "4700  NDUFA6; NADH:ubiquinone oxidoreductase subunit A6 [KO:K03950]", "4701  NDUFA7; NADH:ubiquinone oxidoreductase subunit A7 [KO:K03951]", "4702  NDUFA8; NADH:ubiquinone oxidoreductase subunit A8 [KO:K03952]", "4704  NDUFA9; NADH:ubiquinone oxidoreductase subunit A9 [KO:K03953]", "4705  NDUFA10; NADH:ubiquinone oxidoreductase subunit A10 [KO:K03954]", "4706  NDUFAB1; NADH:ubiquinone oxidoreductase subunit AB1 [KO:K03955]", "126328  NDUFA11; NADH:ubiquinone oxidoreductase subunit A11 [KO:K03956]", "55967  NDUFA12; NADH:ubiquinone oxidoreductase subunit A12 [KO:K11352]", "51079  NDUFA13; NADH:ubiquinone oxidoreductase subunit A13 [KO:K11353]", "4707  NDUFB1; NADH:ubiquinone oxidoreductase subunit B1 [KO:K03957]", "4708  NDUFB2; NADH:ubiquinone oxidoreductase subunit B2 [KO:K03958]", "4709  NDUFB3; NADH:ubiquinone oxidoreductase subunit B3 [KO:K03959]", "4710  NDUFB4; NADH:ubiquinone oxidoreductase subunit B4 [KO:K03960]", "4711  NDUFB5; NADH:ubiquinone oxidoreductase subunit B5 [KO:K03961]", "4712  NDUFB6; NADH:ubiquinone oxidoreductase subunit B6 [KO:K03962]", "4713  NDUFB7; NADH:ubiquinone oxidoreductase subunit B7 [KO:K03963]", "4714  NDUFB8; NADH:ubiquinone oxidoreductase subunit B8 [KO:K03964]", "4715  NDUFB9; NADH:ubiquinone oxidoreductase subunit B9 [KO:K03965]", "4716  NDUFB10; NADH:ubiquinone oxidoreductase subunit B10 [KO:K03966]", "54539  NDUFB11; NADH:ubiquinone oxidoreductase subunit B11 [KO:K11351]", "4719  NDUFS1; NADH:ubiquinone oxidoreductase core subunit S1 [KO:K03934] [EC:7.1.1.2]", "4720  NDUFS2; NADH:ubiquinone oxidoreductase core subunit S2 [KO:K03935] [EC:7.1.1.2]", "4722  NDUFS3; NADH:ubiquinone oxidoreductase core subunit S3 [KO:K03936] [EC:7.1.1.2]", "4724  NDUFS4; NADH:ubiquinone oxidoreductase subunit S4 [KO:K03937]", "4725  NDUFS5; NADH:ubiquinone oxidoreductase subunit S5 [KO:K03938]", "4726  NDUFS6; NADH:ubiquinone oxidoreductase subunit S6 [KO:K03939]", "374291  NDUFS7; NADH:ubiquinone oxidoreductase core subunit S7 [KO:K03940] [EC:7.1.1.2]", "4728  NDUFS8; NADH:ubiquinone oxidoreductase core subunit S8 [KO:K03941] [EC:7.1.1.2]", "4717  NDUFC1; NADH:ubiquinone oxidoreductase subunit C1 [KO:K03967]", "4718  NDUFC2; NADH:ubiquinone oxidoreductase subunit C2 [KO:K03968]", "100532726  NDUFC2-KCTD14; NDUFC2-KCTD14 readthrough [KO:K03968]", "6389  SDHA; succinate dehydrogenase complex flavoprotein subunit A [KO:K00234] [EC:1.3.5.1]", "6390  SDHB; succinate dehydrogenase complex iron sulfur subunit B [KO:K00235] [EC:1.3.5.1]", "6391  SDHC; succinate dehydrogenase complex subunit C [KO:K00236]", "6392  SDHD; succinate dehydrogenase complex subunit D [KO:K00237]", "7386  UQCRFS1; ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 [KO:K00411] [EC:7.1.1.8]", "4519  CYTB; cytochrome b [KO:K00412]", "1537  CYC1; cytochrome c1 [KO:K00413]", "7384  UQCRC1; ubiquinol-cytochrome c reductase core protein 1 [KO:K00414]", "7385  UQCRC2; ubiquinol-cytochrome c reductase core protein 2 [KO:K00415]", "7388  UQCRH; ubiquinol-cytochrome c reductase hinge protein [KO:K00416]", "440567  UQCRHL; ubiquinol-cytochrome c reductase hinge protein like [KO:K00416]", "7381  UQCRB; ubiquinol-cytochrome c reductase binding protein [KO:K00417]", "27089  UQCRQ; ubiquinol-cytochrome c reductase complex III subunit VII [KO:K00418]", "29796  UQCR10; ubiquinol-cytochrome c reductase, complex III subunit X [KO:K00419]", "10975  UQCR11; ubiquinol-cytochrome c reductase, complex III subunit XI [KO:K00420]", "4514  COX3; cytochrome c oxidase subunit III [KO:K02262]", "4512  COX1; cytochrome c oxidase subunit I [KO:K02256] [EC:7.1.1.9]", "4513  COX2; cytochrome c oxidase subunit II [KO:K02261]", "84701  COX4I2; cytochrome c oxidase subunit 4I2 [KO:K02263]", "1327  COX4I1; cytochrome c oxidase subunit 4I1 [KO:K02263]", "9377  COX5A; cytochrome c oxidase subunit 5A [KO:K02264]", "1329  COX5B; cytochrome c oxidase subunit 5B [KO:K02265]", "1337  COX6A1; cytochrome c oxidase subunit 6A1 [KO:K02266]", "1339  COX6A2; cytochrome c oxidase subunit 6A2 [KO:K02266]", "1340  COX6B1; cytochrome c oxidase subunit 6B1 [KO:K02267]", "125965  COX6B2; cytochrome c oxidase subunit 6B2 [KO:K02267]", "1345  COX6C; cytochrome c oxidase subunit 6C [KO:K02268]", "1346  COX7A1; cytochrome c oxidase subunit 7A1 [KO:K02270]", "1347  COX7A2; cytochrome c oxidase subunit 7A2 [KO:K02270]", "9167  COX7A2L; cytochrome c oxidase subunit 7A2 like [KO:K02270]", "1349  COX7B; cytochrome c oxidase subunit 7B [KO:K02271]", "170712  COX7B2; cytochrome c oxidase subunit 7B2 [KO:K02271]", "1350  COX7C; cytochrome c oxidase subunit 7C [KO:K02272]", "341947  COX8C; cytochrome c oxidase subunit 8C [KO:K02273]", "1351  COX8A; cytochrome c oxidase subunit 8A [KO:K02273]", "498  ATP5F1A; ATP synthase F1 subunit alpha [KO:K02132]", "506  ATP5F1B; ATP synthase F1 subunit beta [KO:K02133] [EC:7.1.2.2]", "509  ATP5F1C; ATP synthase F1 subunit gamma [KO:K02136]", "513  ATP5F1D; ATP synthase F1 subunit delta [KO:K02134]", "514  ATP5F1E; ATP synthase F1 subunit epsilon [KO:K02135]", "4508  ATP6; ATP synthase F0 subunit 6 [KO:K02126]", "515  ATP5PB; ATP synthase peripheral stalk-membrane subunit b [KO:K02127]", "516  ATP5MC1; ATP synthase membrane subunit c locus 1 [KO:K02128]", "517  ATP5MC2; ATP synthase membrane subunit c locus 2 [KO:K02128]", "518  ATP5MC3; ATP synthase membrane subunit c locus 3 [KO:K02128]", "10476  ATP5PD; ATP synthase peripheral stalk subunit d [KO:K02138]", "539  ATP5PO; ATP synthase peripheral stalk subunit OSCP [KO:K02137]", "522  ATP5PF; ATP synthase peripheral stalk subunit F6 [KO:K02131]", "4509  ATP8; ATP synthase F0 subunit 8 [KO:K02125]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]", "7416  VDAC1; voltage dependent anion channel 1 [KO:K05862]", "10452  TOMM40; translocase of outer mitochondrial membrane 40 [KO:K11518]", "84134  TOMM40L; translocase of outer mitochondrial membrane 40 like [KO:K11518]", "90550  MCU; mitochondrial calcium uniporter [KO:K20858]", "810  CALML3; calmodulin like 3 [KO:K02183]", "805  CALM2; calmodulin 2 [KO:K02183]", "808  CALM3; calmodulin 3 [KO:K02183]", "801  CALM1; calmodulin 1 [KO:K02183]", "163688  CALML6; calmodulin like 6 [KO:K02183]", "51806  CALML5; calmodulin like 5 [KO:K02183]", "91860  CALML4; calmodulin like 4 [KO:K02183]", "5530  PPP3CA; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]", "5532  PPP3CB; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]", "5533  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]", "5534  PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]", "5535  PPP3R2; protein phosphatase 3 regulatory subunit B, beta [KO:K06268]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]", "356  FASLG; Fas ligand [KO:K04389]", "355  FAS; Fas cell surface death receptor [KO:K04390]", "8772  FADD; Fas associated via death domain [KO:K02373]", "841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]", "637  BID; BH3 interacting domain death agonist [KO:K04726]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "578  BAK1; BCL2 antagonist/killer 1 [KO:K14021]", "120892  LRRK2; leucine rich repeat kinase 2 [KO:K08844] [EC:2.7.11.1]", "27429  HTRA2; HtrA serine peptidase 2 [KO:K08669] [EC:3.4.21.108]", "10131  TRAP1; TNF receptor associated protein 1 [KO:K09488]", "7417  VDAC2; voltage dependent anion channel 2 [KO:K15040]", "7419  VDAC3; voltage dependent anion channel 3 [KO:K15041]", "291  SLC25A4; solute carrier family 25 member 4 [KO:K05863]", "292  SLC25A5; solute carrier family 25 member 5 [KO:K05863]", "293  SLC25A6; solute carrier family 25 member 6 [KO:K05863]", "83447  SLC25A31; solute carrier family 25 member 31 [KO:K05863]", "10105  PPIF; peptidylprolyl isomerase F [KO:K09565] [EC:5.2.1.8]", "54205  CYCS; cytochrome c, somatic [KO:K08738]", "317  APAF1; apoptotic peptidase activating factor 1 [KO:K02084]", "842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "3092  HIP1; huntingtin interacting protein 1 [KO:K04559]", "55081  IFT57; intraflagellar transport 57 [KO:K04638]", "3028  HSD17B10; hydroxysteroid 17-beta dehydrogenase 10 [KO:K08683] [EC:1.1.1.35 1.1.1.178]", "5481  PPID; peptidylprolyl isomerase D [KO:K05864] [EC:5.2.1.8]", "11315  PARK7; Parkinsonism associated deglycase [KO:K05687] [EC:3.5.1.124]", "598  BCL2L1; BCL2 like 1 [KO:K04570]", "55669  MFN1; mitofusin 1 [KO:K21356] [EC:3.6.5.-]", "9927  MFN2; mitofusin 2 [KO:K06030] [EC:3.6.5.-]", "10133  OPTN; optineurin [KO:K19946]", "8878  SQSTM1; sequestosome 1 [KO:K14381]", "440738  MAP1LC3C; microtubule associated protein 1 light chain 3 gamma [KO:K10435]", "81631  MAP1LC3B; microtubule associated protein 1 light chain 3 beta [KO:K10435]", "84557  MAP1LC3A; microtubule associated protein 1 light chain 3 alpha [KO:K10435]", "643246  MAP1LC3B2; microtubule associated protein 1 light chain 3 beta 2 [KO:K10435]", "29110  TBK1; TANK binding kinase 1 [KO:K05410] [EC:2.7.11.10]", "10010  TANK; TRAF family member associated NFKB activator [KO:K12650]", "55255  WDR41; WD repeat domain 41 [KO:K23610]", "140775  SMCR8; SMCR8-C9orf72 complex subunit [KO:K23611]", "203228  C9orf72; C9orf72-SMCR8 complex subunit [KO:K23609]", "4218  RAB8A; RAB8A, member RAS oncogene family [KO:K07901]", "116442  RAB39B; RAB39B, member RAS oncogene family [KO:K07925]", "5861  RAB1A; RAB1A, member RAS oncogene family [KO:K07874]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "8408  ULK1; unc-51 like autophagy activating kinase 1 [KO:K21357] [EC:2.7.11.1]", "9706  ULK2; unc-51 like autophagy activating kinase 2 [KO:K08269] [EC:2.7.11.1]", "60673  ATG101; autophagy related 101 [KO:K19730]", "9776  ATG13; autophagy related 13 [KO:K08331]", "9821  RB1CC1; RB1 inducible coiled-coil 1 [KO:K17589]", "55626  AMBRA1; autophagy and beclin 1 regulator 1 [KO:K17985]", "8678  BECN1; beclin 1 [KO:K08334]", "441925  BECN2; beclin 2 [KO:K08334]", "30849  PIK3R4; phosphoinositide-3-kinase regulatory subunit 4 [KO:K08333] [EC:2.7.11.1]", "22863  ATG14; autophagy related 14 [KO:K17889]", "29982  NRBF2; nuclear receptor binding factor 2 [KO:K21246]", "5289  PIK3C3; phosphatidylinositol 3-kinase catalytic subunit type 3 [KO:K00914] [EC:2.7.1.137]", "23130  ATG2A; autophagy related 2A [KO:K17906]", "55102  ATG2B; autophagy related 2B [KO:K17906]", "26100  WIPI2; WD repeat domain, phosphoinositide interacting 2 [KO:K17908]", "55062  WIPI1; WD repeat domain, phosphoinositide interacting 1 [KO:K17908]", "53349  ZFYVE1; zinc finger FYVE-type containing 1 [KO:K17603]", "57679  ALS2; alsin Rho guanine nucleotide exchange factor ALS2 [KO:K04575]", "5868  RAB5A; RAB5A, member RAS oncogene family [KO:K07887]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "25978  CHMP2B; charged multivesicular body protein 2B [KO:K12192]", "9896  FIG4; FIG4 phosphoinositide 5-phosphatase [KO:K22913] [EC:3.1.3.-]", "80208  SPG11; SPG11 vesicle trafficking associated, spatacsin [KO:K19026]", "7124  TNF; tumor necrosis factor [KO:K03156]", "7132  TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158]", "7133  TNFRSF1B; TNF receptor superfamily member 1B [KO:K05141]", "1616  DAXX; death domain associated protein [KO:K02308]", "5606  MAP2K3; mitogen-activated protein kinase kinase 3 [KO:K04432] [EC:2.7.12.2]", "5608  MAP2K6; mitogen-activated protein kinase kinase 6 [KO:K04433] [EC:2.7.12.2]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "4842  NOS1; nitric oxide synthase 1 [KO:K13240] [EC:1.14.13.39]", "9973  CCS; copper chaperone for superoxide dismutase [KO:K04569]", "257202  GPX6; glutathione peroxidase 6 [KO:K00432] [EC:1.11.1.9]", "2882  GPX7; glutathione peroxidase 7 [KO:K00432] [EC:1.11.1.9]", "2877  GPX2; glutathione peroxidase 2 [KO:K00432] [EC:1.11.1.9]", "2878  GPX3; glutathione peroxidase 3 [KO:K00432] [EC:1.11.1.9]", "2876  GPX1; glutathione peroxidase 1 [KO:K00432] [EC:1.11.1.9]", "2880  GPX5; glutathione peroxidase 5 [KO:K00432] [EC:1.11.1.9]", "493869  GPX8; glutathione peroxidase 8 (putative) [KO:K00432] [EC:1.11.1.9]", "847  CAT; catalase [KO:K03781] [EC:1.11.1.6]", "5630  PRPH; peripherin [KO:K07607]", "4747  NEFL; neurofilament light chain [KO:K04572]", "4741  NEFM; neurofilament medium chain [KO:K04573]", "4744  NEFH; neurofilament heavy chain [KO:K04574]", "3798  KIF5A; kinesin family member 5A [KO:K10396]", "3799  KIF5B; kinesin family member 5B [KO:K10396]", "3800  KIF5C; kinesin family member 5C [KO:K10396]", "147700  KLC3; kinesin light chain 3 [KO:K10407]", "3831  KLC1; kinesin light chain 1 [KO:K10407]", "64837  KLC2; kinesin light chain 2 [KO:K10407]", "89953  KLC4; kinesin light chain 4 [KO:K10407]", "10376  TUBA1B; tubulin alpha 1b [KO:K07374]", "7277  TUBA4A; tubulin alpha 4a [KO:K07374]", "7278  TUBA3C; tubulin alpha 3c [KO:K07374]", "7846  TUBA1A; tubulin alpha 1a [KO:K07374]", "84790  TUBA1C; tubulin alpha 1c [KO:K07374]", "51807  TUBA8; tubulin alpha 8 [KO:K07374]", "112714  TUBA3E; tubulin alpha 3e [KO:K07374]", "113457  TUBA3D; tubulin alpha 3d [KO:K07374]", "79861  TUBAL3; tubulin alpha like 3 [KO:K07374]", "84617  TUBB6; tubulin beta 6 class V [KO:K07375]", "203068  TUBB; tubulin beta class I [KO:K07375]", "81027  TUBB1; tubulin beta 1 class VI [KO:K07375]", "7280  TUBB2A; tubulin beta 2A class IIa [KO:K07375]", "10381  TUBB3; tubulin beta 3 class III [KO:K07375]", "10382  TUBB4A; tubulin beta 4A class IVa [KO:K07375]", "347688  TUBB8; tubulin beta 8 class VIII [KO:K07375]", "347733  TUBB2B; tubulin beta 2B class IIb [KO:K07375]", "10383  TUBB4B; tubulin beta 4B class IVb [KO:K07375]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "1457  CSNK2A1; casein kinase 2 alpha 1 [KO:K03097] [EC:2.7.11.1]", "1459  CSNK2A2; casein kinase 2 alpha 2 [KO:K03097] [EC:2.7.11.1]", "283106  CSNK2A3; casein kinase 2 alpha 3 [KO:K03097] [EC:2.7.11.1]", "1460  CSNK2B; casein kinase 2 beta [KO:K03115]", "627  BDNF; brain derived neurotrophic factor [KO:K04355]", "1639  DCTN1; dynactin subunit 1 [KO:K04648]", "10540  DCTN2; dynactin subunit 2 [KO:K10424]", "11258  DCTN3; dynactin subunit 3 [KO:K10425]", "51164  DCTN4; dynactin subunit 4 [KO:K10426]", "84516  DCTN5; dynactin subunit 5 [KO:K10427]", "10671  DCTN6; dynactin subunit 6 [KO:K10428]", "10121  ACTR1A; actin related protein 1A [KO:K16575]", "10120  ACTR1B; actin related protein 1B [KO:K16575]", "55860  ACTR10; actin related protein 10 [KO:K16576]", "9001  HAP1; huntingtin associated protein 1 [KO:K04647]", "25981  DNAH1; dynein axonemal heavy chain 1 [KO:K10408]", "55567  DNAH3; dynein axonemal heavy chain 3 [KO:K10408]", "146754  DNAH2; dynein axonemal heavy chain 2 [KO:K10408]", "56171  DNAH7; dynein axonemal heavy chain 7 [KO:K10408]", "1767  DNAH5; dynein axonemal heavy chain 5 [KO:K10408]", "1768  DNAH6; dynein axonemal heavy chain 6 [KO:K10408]", "1770  DNAH9; dynein axonemal heavy chain 9 [KO:K10408]", "8701  DNAH11; dynein axonemal heavy chain 11 [KO:K10408]", "201625  DNAH12; dynein axonemal heavy chain 12 [KO:K10408]", "127602  DNAH14; dynein axonemal heavy chain 14 [KO:K10408]", "1769  DNAH8; dynein axonemal heavy chain 8 [KO:K10408]", "196385  DNAH10; dynein axonemal heavy chain 10 [KO:K10408]", "8632  DNAH17; dynein axonemal heavy chain 17 [KO:K10408]", "7802  DNALI1; dynein axonemal light intermediate chain 1 [KO:K10410]", "27019  DNAI1; dynein axonemal intermediate chain 1 [KO:K10409]", "64446  DNAI2; dynein axonemal intermediate chain 2 [KO:K11143]", "83544  DNAL1; dynein axonemal light chain 1 [KO:K10411]", "10126  DNAL4; dynein axonemal light chain 4 [KO:K10412]", "815  CAMK2A; calcium/calmodulin dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]", "817  CAMK2D; calcium/calmodulin dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]", "816  CAMK2B; calcium/calmodulin dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]", "818  CAMK2G; calcium/calmodulin dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]", "823  CAPN1; calpain 1 [KO:K01367] [EC:3.4.22.52]", "824  CAPN2; calpain 2 [KO:K03853] [EC:3.4.22.53]", "8851  CDK5R1; cyclin dependent kinase 5 regulatory subunit 1 [KO:K11716]", "1020  CDK5; cyclin dependent kinase 5 [KO:K02090] [EC:2.7.11.22]", "840  CASP7; caspase 7 [KO:K04397] [EC:3.4.22.60]", "22943  DKK1; dickkopf WNT signaling pathway inhibitor 1 [KO:K02165]", "27123  DKK2; dickkopf WNT signaling pathway inhibitor 2 [KO:K02165]", "27121  DKK4; dickkopf WNT signaling pathway inhibitor 4 [KO:K02165]", "7471  WNT1; Wnt family member 1 [KO:K03209]", "7472  WNT2; Wnt family member 2 [KO:K00182]", "7482  WNT2B; Wnt family member 2B [KO:K00182]", "7473  WNT3; Wnt family member 3 [KO:K00312]", "89780  WNT3A; Wnt family member 3A [KO:K00312]", "54361  WNT4; Wnt family member 4 [KO:K00408]", "7474  WNT5A; Wnt family member 5A [KO:K00444]", "81029  WNT5B; Wnt family member 5B [KO:K00444]", "7475  WNT6; Wnt family member 6 [KO:K00445]", "7476  WNT7A; Wnt family member 7A [KO:K00572]", "7477  WNT7B; Wnt family member 7B [KO:K00572]", "7478  WNT8A; Wnt family member 8A [KO:K00714]", "7479  WNT8B; Wnt family member 8B [KO:K00714]", "7483  WNT9A; Wnt family member 9A [KO:K01064]", "7484  WNT9B; Wnt family member 9B [KO:K01064]", "7480  WNT10B; Wnt family member 10B [KO:K01357]", "80326  WNT10A; Wnt family member 10A [KO:K01357]", "7481  WNT11; Wnt family member 11 [KO:K01384]", "51384  WNT16; Wnt family member 16 [KO:K01558]", "8321  FZD1; frizzled class receptor 1 [KO:K02432]", "8324  FZD7; frizzled class receptor 7 [KO:K02432]", "2535  FZD2; frizzled class receptor 2 [KO:K02235]", "7976  FZD3; frizzled class receptor 3 [KO:K02329]", "8322  FZD4; frizzled class receptor 4 [KO:K02354]", "7855  FZD5; frizzled class receptor 5 [KO:K02375]", "8325  FZD8; frizzled class receptor 8 [KO:K02375]", "8323  FZD6; frizzled class receptor 6 [KO:K02376]", "11211  FZD10; frizzled class receptor 10 [KO:K02842]", "8326  FZD9; frizzled class receptor 9 [KO:K02842]", "4041  LRP5; LDL receptor related protein 5 [KO:K03068]", "4040  LRP6; LDL receptor related protein 6 [KO:K03068]", "1454  CSNK1E; casein kinase 1 epsilon [KO:K08960] [EC:2.7.11.1]", "102800317  TPTEP2-CSNK1E; TPTEP2-CSNK1E readthrough [KO:K08960] [EC:2.7.11.1]", "1857  DVL3; dishevelled segment polarity protein 3 [KO:K02353]", "1856  DVL2; dishevelled segment polarity protein 2 [KO:K02353]", "1855  DVL1; dishevelled segment polarity protein 1 [KO:K02353]", "10023  FRAT1; FRAT regulator of WNT signaling pathway 1 [KO:K03069]", "23401  FRAT2; FRAT regulator of WNT signaling pathway 2 [KO:K03096]", "8312  AXIN1; axin 1 [KO:K02157]", "8313  AXIN2; axin 2 [KO:K04385]", "324  APC; APC regulator of WNT signaling pathway [KO:K02085]", "10297  APC2; APC regulator of WNT signaling pathway 2 [KO:K02085]", "1499  CTNNB1; catenin beta 1 [KO:K02105]", "122011  CSNK1A1L; casein kinase 1 alpha 1 like [KO:K08957] [EC:2.7.11.1]", "1452  CSNK1A1; casein kinase 1 alpha 1 [KO:K08957] [EC:2.7.11.1]", "177  AGER; advanced glycosylation end-product specific receptor [KO:K19722]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "369  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "27035  NOX1; NADPH oxidase 1 [KO:K08008]", "1536  CYBB; cytochrome b-245 beta chain [KO:K21421] [EC:1.-.-.-]", "50507  NOX4; NADPH oxidase 4 [KO:K21423] [EC:1.6.3.-]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "4843  NOS2; nitric oxide synthase 2 [KO:K13241] [EC:1.14.13.39]", "5743  PTGS2; prostaglandin-endoperoxide synthase 2 [KO:K11987] [EC:1.14.99.1]", "3569  IL6; interleukin 6 [KO:K05405]", "3552  IL1A; interleukin 1 alpha [KO:K04383]", "3553  IL1B; interleukin 1 beta [KO:K04519]", "1435  CSF1; colony stimulating factor 1 [KO:K05453]"], "compound": ["C00001  H2O", "C00002  ATP", "C00008  ADP", "C00009  Orthophosphate", "C00012  Peptide", "C00013  Diphosphate", "C00017  Protein", "C00020  AMP", "C00025  L-Glutamate", "C00027  Hydrogen peroxide", "C00062  L-Arginine", "C00070  Copper", "C00076  Calcium cation", "C00165  Diacylglycerol", "C00533  Nitric oxide", "C00704  Superoxide", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C01330  Sodium cation", "C01996  Acetylcholine", "C04549  1-Phosphatidyl-1D-myo-inositol 3-phosphate", "C04599  1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "C07593  Rotenone", "C11310  1-Methyl-4-phenylpyridinium", "C15231  Maneb", "C16514  Amyloid beta protein 40", "C16515  Amyloid beta protein 42", "C16844  Hydroxyl radical", "C16845  Peroxynitrite", "C21011  [Protein]-N(epsilon)-(carboxymethyl)lysine", "C21012  [Protein]-N(epsilon)-(carboxyethyl)lysine", "C21013  [Protein]-pyrraline", "C21014  [Protein]-pentosidine"], "refs": [{"pmid": "30258237", "authors": "  Gan L, Cookson MR, Petrucelli L, La Spada AR", "title": "Converging pathways in neurodegeneration, from genetics to mechanisms.", "journal": "Nat Neurosci 21:1300-1309 (2018)", "doi": "10.1038/s41593-018-0237-7"}, {"pmid": "28062563", "authors": "  Dugger BN, Dickson DW", "title": "Pathology of Neurodegenerative Diseases.", "journal": "Cold Spring Harb Perspect Biol 9:a028035 (2017)", "doi": "10.1101/cshperspect.a028035"}, {"pmid": "20070435", "authors": "  Jellinger KA", "title": "Basic mechanisms of neurodegeneration: a critical update.", "journal": "J Cell Mol Med 14:457-87 (2010)", "doi": "10.1111/j.1582-4934.2010.01010.x"}, {"pmid": "19707851", "authors": "  Jellinger KA", "title": "Recent advances in our understanding of neurodegeneration.", "journal": "J Neural Transm (Vienna) 116:1111-62 (2009)", "doi": "10.1007/s00702-009-0240-y"}, {"pmid": "30743990", "authors": "  Van Bulck M, Sierra-Magro A, Alarcon-Gil J, Perez-Castillo A, Morales-Garcia JA", "title": "Novel Approaches for the Treatment of Alzheimer's and Parkinson's Disease.", "journal": "Int J Mol Sci 20:E719 (2019)", "doi": "10.3390/ijms20030719"}, {"pmid": "15272267", "authors": "  Ross CA, Poirier MA", "title": "Protein aggregation and neurodegenerative disease.", "journal": "Nat Med 10 Suppl:S10-7 (2004)", "doi": "10.1038/nm1066"}, {"pmid": "30250260", "authors": "  Soto C, Pritzkow S", "title": "Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases.", "journal": "Nat Neurosci 21:1332-1340 (2018)", "doi": "10.1038/s41593-018-0235-9"}, {"pmid": "25132814", "authors": "  Dantuma NP, Bott LC", "title": "The ubiquitin-proteasome system in neurodegenerative diseases: precipitating factor, yet part of the solution.", "journal": "Front Mol Neurosci 7:70 (2014)", "doi": "10.3389/fnmol.2014.00070"}, {"pmid": "25413678", "authors": "  Zheng C, Geetha T, Babu JR", "title": "Failure of ubiquitin proteasome system: risk for neurodegenerative diseases.", "journal": "Neurodegener Dis 14:161-75 (2014)", "doi": "10.1159/000367694"}, {"pmid": "32397599", "authors": "  Park H, Kang JH, Lee S", "title": "Autophagy in Neurodegenerative Diseases: A Hunter for Aggregates.", "journal": "Int J Mol Sci 21:E3369 (2020)", "doi": "10.3390/ijms21093369"}, {"pmid": "31783880", "authors": "  Malik BR, Maddison DC, Smith GA, Peters OM", "title": "Autophagic and endo-lysosomal dysfunction in neurodegenerative disease.", "journal": "Mol Brain 12:100 (2019)", "doi": "10.1186/s13041-019-0504-x"}, {"pmid": "29734735", "authors": "  Metaxakis A, Ploumi C, Tavernarakis N", "title": "Autophagy in Age-Associated Neurodegeneration.", "journal": "Cells 7:E37 (2018)", "doi": "10.3390/cells7050037"}, {"pmid": "25270767", "authors": "  Vidal RL, Matus S, Bargsted L, Hetz C", "title": "Targeting autophagy in neurodegenerative diseases.", "journal": "Trends Pharmacol Sci 35:583-91 (2014)", "doi": "10.1016/j.tips.2014.09.002"}, {"pmid": "28279350", "authors": "  Menzies FM, Fleming A, Caricasole A, Bento CF, Andrews SP, Ashkenazi A, Fullgrabe J, Jackson A, Jimenez Sanchez M, Karabiyik C, Licitra F, Lopez Ramirez A, Pavel M, Puri C, Renna M, Ricketts T, Schlotawa L, Vicinanza M, Won H, Zhu Y, Skidmore J, Rubinsztein DC", "title": "Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic Opportunities.", "journal": "Neuron 93:1015-1034 (2017)", "doi": "10.1016/j.neuron.2017.01.022"}, {"pmid": "30030024", "authors": "  Chu CT", "title": "Mechanisms of selective autophagy and mitophagy: Implications for neurodegenerative diseases.", "journal": "Neurobiol Dis 122:23-34 (2019)", "doi": "10.1016/j.nbd.2018.07.015"}, {"pmid": "19043451", "authors": "  Kim I, Xu W, Reed JC", "title": "Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities.", "journal": "Nat Rev Drug Discov 7:1013-30 (2008)", "doi": "10.1038/nrd2755"}, {"pmid": "21722302", "authors": "  Doyle KM, Kennedy D, Gorman AM, Gupta S, Healy SJ, Samali A", "title": "Unfolded proteins and endoplasmic reticulum stress in neurodegenerative disorders.", "journal": "J Cell Mol Med 15:2025-39 (2011)", "doi": "10.1111/j.1582-4934.2011.01374.x"}, {"pmid": "28643372", "authors": "  Halliday M, Hughes D, Mallucci GR", "title": "Fine-tuning PERK signaling for neuroprotection.", "journal": "J Neurochem 142:812-826 (2017)", "doi": "10.1111/jnc.14112"}, {"pmid": "32204380", "authors": "  Rozpedek-Kaminska W, Siwecka N, Wawrzynkiewicz A, Wojtczak R, Pytel D, Diehl JA, Majsterek I", "title": "The PERK-Dependent Molecular Mechanisms as a Novel Therapeutic Target for Neurodegenerative Diseases.", "journal": "Int J Mol Sci 21:E2108 (2020)", "doi": "10.3390/ijms21062108"}, {"pmid": "24619348", "authors": "  Hetz C, Mollereau B", "title": "Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases.", "journal": "Nat Rev Neurosci 15:233-49 (2014)", "doi": "10.1038/nrn3689"}, {"pmid": "19230774", "authors": "  Bezprozvanny I", "title": "Calcium signaling and neurodegenerative diseases.", "journal": "Trends Mol Med 15:89-100 (2009)", "doi": "10.1016/j.molmed.2009.01.001"}, {"pmid": "31795242", "authors": "  Ureshino RP, Erustes AG, Bassani TB, Wachilewski P, Guarache GC, Nascimento AC, Costa AJ, Smaili SS, Pereira GJDS", "title": "The Interplay between Ca(2+) Signaling Pathways and Neurodegeneration.", "journal": "Int J Mol Sci 20:E6004 (2019)", "doi": "10.3390/ijms20236004"}, {"pmid": "27873462", "authors": "  Golpich M, Amini E, Mohamed Z, Azman Ali R, Mohamed Ibrahim N, Ahmadiani A", "title": "Mitochondrial Dysfunction and Biogenesis in Neurodegenerative diseases: Pathogenesis and Treatment.", "journal": "CNS Neurosci Ther 23:5-22 (2017)", "doi": "10.1111/cns.12655"}, {"pmid": "19828789", "authors": "  Morfini GA, Burns M, Binder LI, Kanaan NM, LaPointe N, Bosco DA, Brown RH Jr, Brown H, Tiwari A, Hayward L, Edgar J, Nave KA, Garberrn J, Atagi Y, Song Y, Pigino G, Brady ST", "title": "Axonal transport defects in neurodegenerative diseases.", "journal": "J Neurosci 29:12776-86 (2009)", "doi": "10.1523/JNEUROSCI.3463-09.2009"}, {"pmid": "26410600", "authors": "  Gibbs KL, Greensmith L, Schiavo G", "title": "Regulation of Axonal Transport by Protein Kinases.", "journal": "Trends Biochem Sci 40:597-610 (2015)", "doi": "10.1016/j.tibs.2015.08.003"}, {"pmid": "23361386", "authors": "  Millecamps S, Julien JP", "title": "Axonal transport deficits and neurodegenerative diseases.", "journal": "Nat Rev Neurosci 14:161-76 (2013)", "doi": "10.1038/nrn3380"}, {"pmid": "31558780", "authors": "  Sleigh JN, Rossor AM, Fellows AD, Tosolini AP, Schiavo G", "title": "Axonal transport and neurological disease.", "journal": "Nat Rev Neurol 15:691-703 (2019)", "doi": "10.1038/s41582-019-0257-2"}], "rel_pathway": ["hsa00190  Oxidative phosphorylation", "hsa03050  Proteasome", "hsa04020  Calcium signaling pathway", "hsa04120  Ubiquitin mediated proteolysis", "hsa04137  Mitophagy - animal", "hsa04140  Autophagy - animal", "hsa04141  Protein processing in endoplasmic reticulum", "hsa04142  Lysosome", "hsa04210  Apoptosis", "hsa04310  Wnt signaling pathway", "hsa04724  Glutamatergic synapse", "hsa04933  AGE-RAGE signaling pathway in diabetic complications"], "ko_pathway": "ko05022", "genes": ["RAC1", "BRAF", "CSF1", "MAPK13", "NRAS", "BAX"]}, {"kegg_id": "hsa05100", "name": "Bacterial invasion of epithelial cells - Homo sapiens (human)", "description": "Many pathogenic bacteria can invade phagocytic and non-phagocytic cells and colonize them intracellularly, then become disseminated to other cells. Invasive bacteria induce their own uptake by non-phagocytic host cells (e.g. epithelial cells) using two mechanisms referred to as zipper model and trigger model. Listeria, Staphylococcus, Streptococcus, and Yersinia are examples of bacteria that enter using the zipper model. These bacteria express proteins on their surfaces that interact with cellular receptors, initiating signalling cascades that result in close apposition of the cellular membrane around the entering bacteria. Shigella and Salmonella are the examples of bacteria entering cells using the trigger model. These bacteria use type III secretion systems to inject protein effectors that interact with the actin cytoskeleton.", "class": "Human Diseases; Infectious disease: bacterial", "pathway_map": "hsa05100  Bacterial invasion of epithelial cells", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["999  CDH1; cadherin 1 [KO:K05689]", "1499  CTNNB1; catenin beta 1 [KO:K02105]", "29119  CTNNA3; catenin alpha 3 [KO:K05691]", "1495  CTNNA1; catenin alpha 1 [KO:K05691]", "1496  CTNNA2; catenin alpha 2 [KO:K05691]", "79658  ARHGAP10; Rho GTPase activating protein 10 [KO:K13736]", "4233  MET; MET proto-oncogene, receptor tyrosine kinase [KO:K05099] [EC:2.7.10.1]", "2549  GAB1; GRB2 associated binding protein 1 [KO:K09593]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "1398  CRK; CRK proto-oncogene, adaptor protein [KO:K04438]", "1399  CRKL; CRK like proto-oncogene, adaptor protein [KO:K04438]", "1793  DOCK1; dedicator of cytokinesis 1 [KO:K13708]", "998  CDC42; cell division cycle 42 [KO:K04393]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "8976  WASL; WASP like actin nucleation promoting factor [KO:K23612]", "8936  WASF1; WASP family member 1 [KO:K05753]", "10163  WASF2; WASP family member 2 [KO:K05748]", "10097  ACTR2; actin related protein 2 [KO:K17260]", "57180  ACTR3B; actin related protein 3B [KO:K18584]", "653857  ACTR3C; actin related protein 3C [KO:K18584]", "10096  ACTR3; actin related protein 3 [KO:K18584]", "10095  ARPC1B; actin related protein 2/3 complex subunit 1B [KO:K05757]", "10552  ARPC1A; actin related protein 2/3 complex subunit 1A [KO:K05757]", "10109  ARPC2; actin related protein 2/3 complex subunit 2 [KO:K05758]", "10094  ARPC3; actin related protein 2/3 complex subunit 3 [KO:K05756]", "10093  ARPC4; actin related protein 2/3 complex subunit 4 [KO:K05755]", "10092  ARPC5; actin related protein 2/3 complex subunit 5 [KO:K05754]", "81873  ARPC5L; actin related protein 2/3 complex subunit 5 like [KO:K05754]", "71  ACTG1; actin gamma 1 [KO:K05692]", "60  ACTB; actin beta [KO:K05692]", "1731  SEPTIN1; septin 1 [KO:K13737]", "4735  SEPTIN2; septin 2 [KO:K16942]", "10801  SEPTIN9; septin 9 [KO:K16938]", "124404  SEPTIN12; septin 12 [KO:K16938]", "55964  SEPTIN3; septin 3 [KO:K16938]", "23157  SEPTIN6; septin 6 [KO:K16939]", "55752  SEPTIN11; septin 11 [KO:K16939]", "23176  SEPTIN8; septin 8 [KO:K16939]", "867  CBL; Cbl proto-oncogene [KO:K04707] [EC:2.3.2.27]", "6464  SHC1; SHC adaptor protein 1 [KO:K06279]", "25759  SHC2; SHC adaptor protein 2 [KO:K17447]", "53358  SHC3; SHC adaptor protein 3 [KO:K17448]", "399694  SHC4; SHC adaptor protein 4 [KO:K17449]", "23607  CD2AP; CD2 associated protein [KO:K13738]", "1759  DNM1; dynamin 1 [KO:K01528] [EC:3.6.5.5]", "26052  DNM3; dynamin 3 [KO:K01528] [EC:3.6.5.5]", "1785  DNM2; dynamin 2 [KO:K23484] [EC:3.6.5.5]", "1211  CLTA; clathrin light chain A [KO:K04644]", "1212  CLTB; clathrin light chain B [KO:K04645]", "1213  CLTC; clathrin heavy chain [KO:K04646]", "8218  CLTCL1; clathrin heavy chain like 1 [KO:K04646]", "857  CAV1; caveolin 1 [KO:K06278]", "858  CAV2; caveolin 2 [KO:K12958]", "859  CAV3; caveolin 3 [KO:K12959]", "2017  CTTN; cortactin [KO:K06106]", "3059  HCLS1; hematopoietic cell-specific Lyn substrate 1 [KO:K06106]", "6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "5747  PTK2; protein tyrosine kinase 2 [KO:K05725] [EC:2.7.10.2]", "9564  BCAR1; BCAR1 scaffold protein, Cas family member [KO:K05726]", "5829  PXN; paxillin [KO:K05760]", "2335  FN1; fibronectin 1 [KO:K05717]", "3678  ITGA5; integrin subunit alpha 5 [KO:K06484]", "3688  ITGB1; integrin subunit beta 1 [KO:K05719]", "3611  ILK; integrin linked kinase [KO:K06272] [EC:2.7.11.1]", "10459  MAD2L2; mitotic arrest deficient 2 like 2 [KO:K13728]", "26084  ARHGEF26; Rho guanine nucleotide exchange factor 26 [KO:K13744]", "391  RHOG; ras homolog family member G [KO:K07863]", "9844  ELMO1; engulfment and cell motility 1 [KO:K12366]", "63916  ELMO2; engulfment and cell motility 2 [KO:K18985]", "79767  ELMO3; engulfment and cell motility 3 [KO:K19241]", "387  RHOA; ras homolog family member A [KO:K04513]", "7414  VCL; vinculin [KO:K05700]"], "refs": [{"pmid": "19296488", "authors": "  Mostowy S, Cossart P", "title": "Cytoskeleton rearrangements during Listeria infection: clathrin and septins as new players in the game.", "journal": "Cell Motil Cytoskeleton 66:816-23 (2009)", "doi": "10.1002/cm.20353"}, {"pmid": "16406780", "authors": "  Hauck CR, Ohlsen K", "title": "Sticky connections: extracellular matrix protein recognition and integrin-mediated cellular invasion by Staphylococcus aureus.", "journal": "Curr Opin Microbiol 9:5-11 (2006)", "doi": "10.1016/j.mib.2005.12.002"}, {"pmid": "17298394", "authors": "  Wang B, Li S, Dedhar S, Cleary PP", "title": "Paxillin phosphorylation: bifurcation point downstream of integrin-linked kinase (ILK) in streptococcal invasion.", "journal": "Cell Microbiol 9:1519-28 (2007)", "doi": "10.1111/j.1462-5822.2007.00889.x"}, {"pmid": "19185531", "authors": "  Matsumoto H, Young GM", "title": "Translocated effectors of Yersinia.", "journal": "Curr Opin Microbiol 12:94-100 (2009)", "doi": "10.1016/j.mib.2008.12.005"}, {"pmid": "19157959", "authors": "  McGhie EJ, Brawn LC, Hume PJ, Humphreys D, Koronakis V", "title": "Salmonella takes control: effector-driven manipulation of the host.", "journal": "Curr Opin Microbiol 12:117-24 (2009)", "doi": "10.1016/j.mib.2008.12.001"}], "rel_pathway": ["hsa04110  Cell cycle", "hsa04144  Endocytosis", "hsa04510  Focal adhesion", "hsa04512  ECM-receptor interaction", "hsa04810  Regulation of actin cytoskeleton"], "ko_pathway": "ko05100", "genes": ["RAC1", "MET"]}, {"kegg_id": "hsa05130", "name": "Pathogenic Escherichia coli infection - Homo sapiens (human)", "description": "Enteropathogenic E. coli (EPEC) and enterohemorrhagic E. coli (EHEC) are closely related pathogenic strains of Escherichia coli. The hallmark of EPEC/EHEC infections [DS:H00278 H00277] is induction of attaching and effacing (A/E) lesions that damage intestinal epithelial cells. The capacity to form A/E lesions is encoded mainly by the locus of enterocyte effacement (LEE) pathogenicity island. Tir, Map, EspF, EspG are known LEE-encoded effector proteins secreted via the type III secretion system, which is also LEE-encoded, into the host cell. EPEC and EHEC Tir's link the extracellular bacterium to the cell cytoskeleton. Map and EspF are involved in mitochondrion membrane permeabilization. EspG interacts with tubulins and stimulates microtubule destabilization. LEE-encoded adhesin or intimin (Eae) is exported via the general secretory pathway to the periplasm, where it is inserted into the outer membrane. In addition to Tir, two potential host cell-carried intimin receptors, beta1 integrin (ITGB1) and nucleolin (NCL), have so far been identified. The distinguishing feature of EHEC is the elaboration of Shiga-like toxin (Stx). Stx cleaves ribosomal RNA, thereby disrupting protein synthesis and killing the intoxicated epithelial or endothelial cells.", "class": "Human Diseases; Infectious disease: bacterial", "pathway_map": "hsa05130  Pathogenic Escherichia coli infection", "network": ["", "ELEMENT   N00926  Escherichia Tir to TLR2/4-MAPK signaling pathway", "N00927  Escherichia/Shigella NleE/OspZ to TNF-NFKB signaling pathway", "N00928  Escherichia NleB to TNF-NFKB signaling pathway", "N00929  Escherichia NleC to TNF-NFKB signaling pathway", "N00930  Escherichia NleD to TNF-JNK signaling pathway", "N00931  Escherichia NleD to TNF-p38 signaling pathway", "N00932  Escherichia NleH1 to TNF-NFKB signaling pathway", "N00933  Escherichia NleA to NLRP3 inflammasome signaling pathway", "N00935  Escherichia NleF to non-canonical inflammasome signaling pathway", "N00936  Escherichia NleB1 to crosstalk between extrinsic and intrinsic apoptotic pathways", "N00937  Escherichia NleF to extrinsic apoptotic pathway", "N00938  Escherichia NleH to intrinsic apoptotic pathway", "N00939  Escherichia EspF to intrinsic apoptotic pathway", "N01084  Escherichia EspG to ARNO-ARF-ACTB/G signaling pathway", "N01085  Escherichia EspG to ARNO-ARF-ACTB/G signaling pathway", "N01086  Escherichia EspT to RAC signaling pathway", "N01087  Escherichia EspW to RAC signaling pathway", "N01088  Escherichia EspH to LPA-GNA12/13-RhoA signaling pathway", "N01089  Escherichia EspM to LPA-GNA12/13-Rho signaling pathway", "N01091  Escherichia EspJ to IGG-FCGR-RAC signaling pathway", "N01092  Escherichia Eae/Tir to Actin signaling pathway", "N01093  Escherichia EspJ/Tir to Actin signaling pathway", "N01094  Escherichia Eae/Tir/TccP to Actin signaling pathway", "N01095  Escherichia Map to LPA-GNA12/13-RhoA signaling pathway", "N01096  Escherichia Map to CDC42 signaling pathway", "N01286  Escherichia EspG to Microtubule-RHOA signaling pathway", "N01288  Escherichia EspF to Tight junction-Actin signaling pathway", "N01290  Escherichia NleA to COPII vesicle formation", "N01292  Escherichia EspG to RAB1 signaling pathway", "N01294  Escherichia NleF to COPI vesicle formation"], "disease": ["H00277  Enterohemorrhagic Escherichia coli (EHEC) infection", "H00278  Enteropathogenic Escherichia coli (EPEC) infection"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["102723407  IGH; immunoglobulin heavy variable 4-38-2-like [KO:K06856]", "6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "2212  FCGR2A; Fc gamma receptor IIa [KO:K06472]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "9265  CYTH3; cytohesin 3 [KO:K18441]", "27128  CYTH4; cytohesin 4 [KO:K18441]", "9266  CYTH2; cytohesin 2 [KO:K18441]", "9267  CYTH1; cytohesin 1 [KO:K18441]", "382  ARF6; ADP ribosylation factor 6 [KO:K07941]", "375  ARF1; ADP ribosylation factor 1 [KO:K07937]", "10787  NCKAP1; NCK associated protein 1 [KO:K05750]", "3071  NCKAP1L; NCK associated protein 1 like [KO:K05750]", "23191  CYFIP1; cytoplasmic FMR1 interacting protein 1 [KO:K05749]", "26999  CYFIP2; cytoplasmic FMR1 interacting protein 2 [KO:K05749]", "10006  ABI1; abl interactor 1 [KO:K23649]", "55845  BRK1; BRICK1 subunit of SCAR/WAVE actin nucleating complex [KO:K05752]", "8936  WASF1; WASP family member 1 [KO:K05753]", "10163  WASF2; WASP family member 2 [KO:K05748]", "10810  WASF3; WASP family member 3 [KO:K06083]", "10097  ACTR2; actin related protein 2 [KO:K17260]", "57180  ACTR3B; actin related protein 3B [KO:K18584]", "653857  ACTR3C; actin related protein 3C [KO:K18584]", "10096  ACTR3; actin related protein 3 [KO:K18584]", "10095  ARPC1B; actin related protein 2/3 complex subunit 1B [KO:K05757]", "10552  ARPC1A; actin related protein 2/3 complex subunit 1A [KO:K05757]", "10109  ARPC2; actin related protein 2/3 complex subunit 2 [KO:K05758]", "10094  ARPC3; actin related protein 2/3 complex subunit 3 [KO:K05756]", "10093  ARPC4; actin related protein 2/3 complex subunit 4 [KO:K05755]", "10092  ARPC5; actin related protein 2/3 complex subunit 5 [KO:K05754]", "81873  ARPC5L; actin related protein 2/3 complex subunit 5 like [KO:K05754]", "71  ACTG1; actin gamma 1 [KO:K05692]", "60  ACTB; actin beta [KO:K05692]", "9138  ARHGEF1; Rho guanine nucleotide exchange factor 1 [KO:K12330]", "387  RHOA; ras homolog family member A [KO:K04513]", "998  CDC42; cell division cycle 42 [KO:K04393]", "283446  MYO1H; myosin IH [KO:K10356]", "4430  MYO1B; myosin IB [KO:K10356]", "4542  MYO1F; myosin IF [KO:K10356]", "4640  MYO1A; myosin IA [KO:K10356]", "4641  MYO1C; myosin IC [KO:K10356]", "4642  MYO1D; myosin ID [KO:K10356]", "4643  MYO1E; myosin IE [KO:K10356]", "64005  MYO1G; myosin IG [KO:K10356]", "4644  MYO5A; myosin VA [KO:K10357]", "4645  MYO5B; myosin VB [KO:K10357]", "55930  MYO5C; myosin VC [KO:K10357]", "4646  MYO6; myosin VI [KO:K10358]", "4651  MYO10; myosin X [KO:K12559]", "4627  MYH9; myosin heavy chain 9 [KO:K10352]", "4628  MYH10; myosin heavy chain 10 [KO:K10352]", "4629  MYH11; myosin heavy chain 11 [KO:K10352]", "79784  MYH14; myosin heavy chain 14 [KO:K10352]", "8976  WASL; WASP like actin nucleation promoting factor [KO:K23612]", "9368  NHERF1; NHERF family PDZ scaffold protein 1 [KO:K13365]", "7430  EZR; ezrin [KO:K08007]", "2147  F2; coagulation factor II, thrombin [KO:K01313] [EC:3.4.21.5]", "1902  LPAR1; lysophosphatidic acid receptor 1 [KO:K04289]", "9170  LPAR2; lysophosphatidic acid receptor 2 [KO:K04291]", "2846  LPAR4; lysophosphatidic acid receptor 4 [KO:K04275]", "57121  LPAR5; lysophosphatidic acid receptor 5 [KO:K08390]", "2149  F2R; coagulation factor II thrombin receptor [KO:K03914]", "2768  GNA12; G protein subunit alpha 12 [KO:K04346]", "10672  GNA13; G protein subunit alpha 13 [KO:K04639]", "9826  ARHGEF11; Rho guanine nucleotide exchange factor 11 [KO:K12331]", "23365  ARHGEF12; Rho guanine nucleotide exchange factor 12 [KO:K07532]", "10376  TUBA1B; tubulin alpha 1b [KO:K07374]", "7277  TUBA4A; tubulin alpha 4a [KO:K07374]", "7278  TUBA3C; tubulin alpha 3c [KO:K07374]", "7846  TUBA1A; tubulin alpha 1a [KO:K07374]", "84790  TUBA1C; tubulin alpha 1c [KO:K07374]", "51807  TUBA8; tubulin alpha 8 [KO:K07374]", "112714  TUBA3E; tubulin alpha 3e [KO:K07374]", "113457  TUBA3D; tubulin alpha 3d [KO:K07374]", "79861  TUBAL3; tubulin alpha like 3 [KO:K07374]", "84617  TUBB6; tubulin beta 6 class V [KO:K07375]", "203068  TUBB; tubulin beta class I [KO:K07375]", "81027  TUBB1; tubulin beta 1 class VI [KO:K07375]", "7280  TUBB2A; tubulin beta 2A class IIa [KO:K07375]", "10381  TUBB3; tubulin beta 3 class III [KO:K07375]", "10382  TUBB4A; tubulin beta 4A class IVa [KO:K07375]", "347688  TUBB8; tubulin beta 8 class VIII [KO:K07375]", "347733  TUBB2B; tubulin beta 2B class IIb [KO:K07375]", "10383  TUBB4B; tubulin beta 4B class IVb [KO:K07375]", "9181  ARHGEF2; Rho/Rac guanine nucleotide exchange factor 2 [KO:K12791]", "6093  ROCK1; Rho associated coiled-coil containing protein kinase 1 [KO:K04514] [EC:2.7.11.1]", "9475  ROCK2; Rho associated coiled-coil containing protein kinase 2 [KO:K17388] [EC:2.7.11.1]", "2534  FYN; FYN proto-oncogene, Src family tyrosine kinase [KO:K05703] [EC:2.7.10.2]", "25  ABL1; ABL proto-oncogene 1, non-receptor tyrosine kinase [KO:K06619] [EC:2.7.10.2]", "55971  BAIAP2L1; BAR/IMD domain containing adaptor protein 2 like 1 [KO:K20127]", "10458  BAIAP2; BAR/IMD domain containing adaptor protein 2 [KO:K05627]", "4690  NCK1; NCK adaptor protein 1 [KO:K07365]", "8440  NCK2; NCK adaptor protein 2 [KO:K19862]", "147179  WIPF2; WAS/WASL interacting protein family member 2 [KO:K19475]", "7456  WIPF1; WAS/WASL interacting protein family member 1 [KO:K19475]", "644150  WIPF3; WAS/WASL interacting protein family member 3 [KO:K19475]", "2017  CTTN; cortactin [KO:K06106]", "3059  HCLS1; hematopoietic cell-specific Lyn substrate 1 [KO:K06106]", "4691  NCL; nucleolin [KO:K11294]", "3688  ITGB1; integrin subunit beta 1 [KO:K05719]", "3553  IL1B; interleukin 1 beta [KO:K04519]", "3554  IL1R1; interleukin 1 receptor type 1 [KO:K04386]", "7099  TLR4; toll like receptor 4 [KO:K10160]", "114609  TIRAP; TIR domain containing adaptor protein [KO:K05403]", "4615  MYD88; MYD88 innate immune signal transduction adaptor [KO:K04729]", "7100  TLR5; toll like receptor 5 [KO:K10168]", "3654  IRAK1; interleukin 1 receptor associated kinase 1 [KO:K04730] [EC:2.7.11.1]", "51135  IRAK4; interleukin 1 receptor associated kinase 4 [KO:K04733] [EC:2.7.11.1]", "5777  PTPN6; protein tyrosine phosphatase non-receptor type 6 [KO:K05697] [EC:3.1.3.48]", "5781  PTPN11; protein tyrosine phosphatase non-receptor type 11 [KO:K07293] [EC:3.1.3.48]", "7189  TRAF6; TNF receptor associated factor 6 [KO:K03175] [EC:2.3.2.27]", "7124  TNF; tumor necrosis factor [KO:K03156]", "7132  TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158]", "8717  TRADD; TNFRSF1A associated via death domain [KO:K03171]", "2597  GAPDH; glyceraldehyde-3-phosphate dehydrogenase [KO:K00134] [EC:1.2.1.12]", "7186  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]", "8737  RIPK1; receptor interacting serine/threonine kinase 1 [KO:K02861] [EC:2.7.11.1]", "6885  MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO:K04427] [EC:2.7.11.25]", "10454  TAB1; TGF-beta activated kinase 1 (MAP3K7) binding protein 1 [KO:K04403]", "23118  TAB2; TGF-beta activated kinase 1 (MAP3K7) binding protein 2 [KO:K04404]", "257397  TAB3; TGF-beta activated kinase 1 (MAP3K7) binding protein 3 [KO:K12793]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "4793  NFKBIB; NFKB inhibitor beta [KO:K02581]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "6188  RPS3; ribosomal protein S3 [KO:K02985]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "3569  IL6; interleukin 6 [KO:K05405]", "3576  CXCL8; C-X-C motif chemokine ligand 8 [KO:K10030]", "8743  TNFSF10; TNF superfamily member 10 [KO:K04721]", "8797  TNFRSF10A; TNF receptor superfamily member 10a [KO:K04722]", "8795  TNFRSF10B; TNF receptor superfamily member 10b [KO:K04722]", "356  FASLG; Fas ligand [KO:K04389]", "355  FAS; Fas cell surface death receptor [KO:K04390]", "8772  FADD; Fas associated via death domain [KO:K02373]", "841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]", "7009  TMBIM6; transmembrane BAX inhibitor motif containing 6 [KO:K21889]", "578  BAK1; BCL2 antagonist/killer 1 [KO:K14021]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "54205  CYCS; cytochrome c, somatic [KO:K08738]", "842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "840  CASP7; caspase 7 [KO:K04397] [EC:3.4.22.60]", "10061  ABCF2; ATP binding cassette subfamily F member 2 [KO:K06185]", "4671  NAIP; NLR family apoptosis inhibitory protein [KO:K12807]", "147945  NLRP4; NLR family pyrin domain containing 4 [KO:K22265]", "114548  NLRP3; NLR family pyrin domain containing 3 [KO:K12800]", "29108  PYCARD; PYD and CARD domain containing [KO:K12799]", "834  CASP1; caspase 1 [KO:K01370] [EC:3.4.22.36]", "837  CASP4; caspase 4 [KO:K04394] [EC:3.4.22.57 3.4.22.64]", "3606  IL18; interleukin 18 [KO:K05482]", "5058  PAK1; p21 (RAC1) activated kinase 1 [KO:K04409] [EC:2.7.11.1]", "5062  PAK2; p21 (RAC1) activated kinase 2 [KO:K04410] [EC:2.7.11.1]", "5063  PAK3; p21 (RAC1) activated kinase 3 [KO:K05733] [EC:2.7.11.1]", "5861  RAB1A; RAB1A, member RAS oncogene family [KO:K07874]", "10427  SEC24B; SEC24 homolog B, COPII coat complex component [KO:K14007]", "10802  SEC24A; SEC24 homolog A, COPII coat complex component [KO:K14007]", "9632  SEC24C; SEC24 homolog C, COPII coat complex component [KO:K14007]", "9871  SEC24D; SEC24 homolog D, COPII coat complex component [KO:K14007]", "10972  TMED10; transmembrane p24 trafficking protein 10 [KO:K20352]", "100506658  OCLN; occludin [KO:K06088]", "1364  CLDN4; claudin 4 [KO:K06087]", "1365  CLDN3; claudin 3 [KO:K06087]", "1366  CLDN7; claudin 7 [KO:K06087]", "149461  CLDN19; claudin 19 [KO:K06087]", "10686  CLDN16; claudin 16 [KO:K06087]", "23562  CLDN14; claudin 14 [KO:K06087]", "24146  CLDN15; claudin 15 [KO:K06087]", "26285  CLDN17; claudin 17 [KO:K06087]", "49861  CLDN20; claudin 20 [KO:K06087]", "5010  CLDN11; claudin 11 [KO:K06087]", "51208  CLDN18; claudin 18 [KO:K06087]", "53842  CLDN22; claudin 22 [KO:K06087]", "7122  CLDN5; claudin 5 [KO:K06087]", "9071  CLDN10; claudin 10 [KO:K06087]", "9073  CLDN8; claudin 8 [KO:K06087]", "9074  CLDN6; claudin 6 [KO:K06087]", "9075  CLDN2; claudin 2 [KO:K06087]", "9076  CLDN1; claudin 1 [KO:K06087]", "9080  CLDN9; claudin 9 [KO:K06087]", "137075  CLDN23; claudin 23 [KO:K06087]", "100288814  CLDN34; claudin 34 [KO:K06087]", "644672  CLDN25; claudin 25 [KO:K06087]", "100132463  CLDN24; claudin 24 [KO:K06087]", "9069  CLDN12; claudin 12 [KO:K06087]", "7082  TJP1; tight junction protein 1 [KO:K05701]"], "compound": ["C00338  Lipopolysaccharide", "C00350  Phosphatidylethanolamine", "C00681  1-Acyl-sn-glycerol 3-phosphate"], "refs": [{"pmid": "29477730", "authors": "  Pinaud L, Sansonetti PJ, Phalipon A", "title": "Host Cell Targeting by Enteropathogenic Bacteria T3SS Effectors.", "journal": "Trends Microbiol 26:266-283 (2018)", "doi": "10.1016/j.tim.2018.01.010"}, {"pmid": "25588886", "authors": "  Santos AS, Finlay BB", "title": "Bringing down the host: enteropathogenic and enterohaemorrhagic Escherichia coli effector-mediated subversion of host innate immune pathways.", "journal": "Cell Microbiol 17:318-32 (2015)", "doi": "10.1111/cmi.12412"}, {"pmid": "26104206", "authors": "  Pearson JS, Hartland EL", "title": "The Inflammatory Response during Enterohemorrhagic Escherichia coli Infection.", "journal": "Microbiol Spectr 2:EHEC-0012-2013 (2014)", "doi": "10.1128/microbiolspec.EHEC-0012-2013"}, {"pmid": "21488979", "authors": "  Wong AR, Pearson JS, Bright MD, Munera D, Robinson KS, Lee SF, Frankel G, Hartland EL", "title": "Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements.", "journal": "Mol Microbiol 80:1420-38 (2011)", "doi": "10.1111/j.1365-2958.2011.07661.x"}, {"pmid": "23927593", "authors": "  Lai Y, Rosenshine I, Leong JM, Frankel G", "title": "Intimate host attachment: enteropathogenic and enterohaemorrhagic Escherichia coli.", "journal": "Cell Microbiol 15:1796-808 (2013)", "doi": "10.1111/cmi.12179"}, {"pmid": "27606286", "authors": "  Ugalde-Silva P, Gonzalez-Lugo O, Navarro-Garcia F", "title": "Tight Junction Disruption Induced by Type 3 Secretion System Effectors Injected by Enteropathogenic and Enterohemorrhagic Escherichia coli.", "journal": "Front Cell Infect Microbiol 6:87 (2016)", "doi": "10.3389/fcimb.2016.00087"}, {"pmid": "27617233", "authors": "  Yen H, Karino M, Tobe T", "title": "Modulation of the Inflammasome Signaling Pathway by Enteropathogenic and Enterohemorrhagic Escherichia coli.", "journal": "Front Cell Infect Microbiol 6:89 (2016)", "doi": "10.3389/fcimb.2016.00089"}, {"pmid": "27732847", "authors": "  Humphreys D, Singh V, Koronakis V", "title": "Inhibition of WAVE Regulatory Complex Activation by a Bacterial Virulence Effector Counteracts Pathogen Phagocytosis.", "journal": "Cell Rep 17:697-707 (2016)", "doi": "10.1016/j.celrep.2016.09.039"}, {"pmid": "20300064", "authors": "  Dong N, Liu L, Shao F", "title": "A bacterial effector targets host DH-PH domain RhoGEFs and antagonizes macrophage phagocytosis.", "journal": "EMBO J 29:1363-76 (2010)", "doi": "10.1038/emboj.2010.33"}], "rel_pathway": ["hsa04064  NF-kappa B signaling pathway", "hsa04210  Apoptosis", "hsa04530  Tight junction", "hsa04620  Toll-like receptor signaling pathway", "hsa04621  NOD-like receptor signaling pathway", "hsa04666  Fc gamma R-mediated phagocytosis", "hsa04810  Regulation of actin cytoskeleton"], "ko_pathway": "ko05130", "genes": ["RAC1", "EZR", "MAPK13", "BAX"]}, {"kegg_id": "hsa05132", "name": "Salmonella infection - Homo sapiens (human)", "description": "Salmonella infection usually presents as a self-limiting gastroenteritis or the more severe typhoid fever and bacteremia. The common disease-causing Salmonella species in human is a single species, Salmonella enterica, which has numerous serovars.\nFollowing intestinal colonization Salmonella inject effector proteins into the host cells using a type III secretion system (T3SS), T3SS1. Then a small group of effector proteins induce rearrangement of the actin cytoskeleton resulting in membrane ruffles and rapid internalization of the bacteria.The T3SS2 is responsible for translocating effector proteins that direct Salmonella-containing vacuole (SCV) maturation. The majority of the bacteria are known to survive and replicate in SCV.", "class": "Human Diseases; Infectious disease: bacterial", "pathway_map": "hsa05132  Salmonella infection", "network": ["", "ELEMENT   N01112  Salmonella SopE/E2 to NOD-NFKB signaling pathway", "N01113  Salmonella SseK1 to TNF-NFKB signaling pathway", "N01114  Salmonella SseK3 to TNF-NFKB signaling pathway", "N01116  Salmonella SseL to TNF-NFKB signaling pathway", "N01117  Salmonella GogB to TNF-NFKB signaling pathway", "N01118  Salmonella SpvD to TNF-NFKB signaling pathway", "N01120  Salmonella SptP to RAC/CDC42-PAK-ERK signaling pathway", "N01121  Salmonella SpvC to ERK signaling pathway", "N01122  Salmonella PipA/GogA/GtgA to TNF-NFKB signaling pathway", "N01123  Salmonella AvrA to TNF-NFKB signaling pathway", "N01124  Salmonella AvrA to beta-catenin signaling pathway", "N01125  Salmonella AvrA to TNF-JNK signaling pathway", "N01126  Salmonella SipB to Inflammasome signaling pathway", "N01127  Salmonella SopE to Inflammasome signaling pathway", "N01128  Salmonella SopE to RAC signaling pathway", "N01129  Salmonella SopB to ARNO-ARF-ACTB/G signaling pathway", "N01130  Salmonella SopB to RhoA signaling pathway", "N01131  Salmonella SopE/E2 to RhoA signaling pathway", "N01132  Salmonella SopE/E2 to RhoG signaling pathway", "N01133  Salmonella SopB to RhoG signaling pathway", "N01134  Salmonella SopB to CDC42 signaling pathway", "N01296  Salmonella SopD2 to Rab7-regulated microtubule minus-end directed transport", "N01298  Salmonella SifA to microtubule plus-end directed transport", "N01299  Salmonella PipB2 to microtubule plus-end directed transport", "N01301  Salmonella SifA to Tethering of late endosomes and lysosomes", "N01303  Salmonella SopB to Early endosomal fusion", "N01305  Salmonella SopB to ANXA2-S100A10-regulated actin cytoskeleton"], "disease": ["H00111  Typhoid fever"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["5420  PODXL; podocalyxin like [KO:K06817]", "5788  PTPRC; protein tyrosine phosphatase receptor type C [KO:K06478] [EC:3.1.3.48]", "5868  RAB5A; RAB5A, member RAS oncogene family [KO:K07887]", "5869  RAB5B; RAB5B, member RAS oncogene family [KO:K07888]", "5878  RAB5C; RAB5C, member RAS oncogene family [KO:K07889]", "5289  PIK3C3; phosphatidylinositol 3-kinase catalytic subunit type 3 [KO:K00914] [EC:2.7.1.137]", "7879  RAB7A; RAB7A, member RAS oncogene family [KO:K07897]", "338382  RAB7B; RAB7B, member RAS oncogene family [KO:K07898]", "9842  PLEKHM1; pleckstrin homology and RUN domain containing M1 [KO:K23282]", "55823  VPS11; VPS11 core subunit of CORVET and HOPS complexes [KO:K20179]", "64601  VPS16; VPS16 core subunit of CORVET and HOPS complexes [KO:K20180]", "57617  VPS18; VPS18 core subunit of CORVET and HOPS complexes [KO:K20181]", "65082  VPS33A; VPS33A core subunit of CORVET and HOPS complexes [KO:K20182]", "23339  VPS39; VPS39 subunit of HOPS complex [KO:K20183]", "27072  VPS41; VPS41 subunit of HOPS complex [KO:K20184]", "83547  RILP; Rab interacting lysosomal protein [KO:K13883]", "1778  DYNC1H1; dynein cytoplasmic 1 heavy chain 1 [KO:K10413]", "79659  DYNC2H1; dynein cytoplasmic 2 heavy chain 1 [KO:K10414]", "1780  DYNC1I1; dynein cytoplasmic 1 intermediate chain 1 [KO:K10415]", "1781  DYNC1I2; dynein cytoplasmic 1 intermediate chain 2 [KO:K10415]", "1783  DYNC1LI2; dynein cytoplasmic 1 light intermediate chain 2 [KO:K10416]", "51143  DYNC1LI1; dynein cytoplasmic 1 light intermediate chain 1 [KO:K10416]", "51626  DYNC2LI1; dynein cytoplasmic 2 light intermediate chain 1 [KO:K10417]", "8655  DYNLL1; dynein light chain LC8-type 1 [KO:K10418]", "140735  DYNLL2; dynein light chain LC8-type 2 [KO:K10418]", "83658  DYNLRB1; dynein light chain roadblock-type 1 [KO:K10419]", "83657  DYNLRB2; dynein light chain roadblock-type 2 [KO:K10419]", "6993  DYNLT1; dynein light chain Tctex-type 1 [KO:K10420]", "6990  DYNLT3; dynein light chain Tctex-type 3 [KO:K10420]", "1639  DCTN1; dynactin subunit 1 [KO:K04648]", "10540  DCTN2; dynactin subunit 2 [KO:K10424]", "11258  DCTN3; dynactin subunit 3 [KO:K10425]", "51164  DCTN4; dynactin subunit 4 [KO:K10426]", "84516  DCTN5; dynactin subunit 5 [KO:K10427]", "10671  DCTN6; dynactin subunit 6 [KO:K10428]", "10121  ACTR1A; actin related protein 1A [KO:K16575]", "10120  ACTR1B; actin related protein 1B [KO:K16575]", "55860  ACTR10; actin related protein 10 [KO:K16576]", "10376  TUBA1B; tubulin alpha 1b [KO:K07374]", "7277  TUBA4A; tubulin alpha 4a [KO:K07374]", "7278  TUBA3C; tubulin alpha 3c [KO:K07374]", "7846  TUBA1A; tubulin alpha 1a [KO:K07374]", "84790  TUBA1C; tubulin alpha 1c [KO:K07374]", "51807  TUBA8; tubulin alpha 8 [KO:K07374]", "112714  TUBA3E; tubulin alpha 3e [KO:K07374]", "113457  TUBA3D; tubulin alpha 3d [KO:K07374]", "79861  TUBAL3; tubulin alpha like 3 [KO:K07374]", "84617  TUBB6; tubulin beta 6 class V [KO:K07375]", "203068  TUBB; tubulin beta class I [KO:K07375]", "81027  TUBB1; tubulin beta 1 class VI [KO:K07375]", "7280  TUBB2A; tubulin beta 2A class IIa [KO:K07375]", "10381  TUBB3; tubulin beta 3 class III [KO:K07375]", "10382  TUBB4A; tubulin beta 4A class IVa [KO:K07375]", "347688  TUBB8; tubulin beta 8 class VIII [KO:K07375]", "347733  TUBB2B; tubulin beta 2B class IIb [KO:K07375]", "10383  TUBB4B; tubulin beta 4B class IVb [KO:K07375]", "79443  FYCO1; FYVE and coiled-coil domain autophagy adaptor 1 [KO:K21954]", "127829  ARL8A; ADP ribosylation factor like GTPase 8A [KO:K07955]", "55207  ARL8B; ADP ribosylation factor like GTPase 8B [KO:K07955]", "23207  PLEKHM2; pleckstrin homology and RUN domain containing M2 [KO:K15348]", "3798  KIF5A; kinesin family member 5A [KO:K10396]", "3799  KIF5B; kinesin family member 5B [KO:K10396]", "3800  KIF5C; kinesin family member 5C [KO:K10396]", "147700  KLC3; kinesin light chain 3 [KO:K10407]", "3831  KLC1; kinesin light chain 1 [KO:K10407]", "64837  KLC2; kinesin light chain 2 [KO:K10407]", "89953  KLC4; kinesin light chain 4 [KO:K10407]", "64746  ACBD3; acyl-CoA binding domain containing 3 [KO:K23935]", "387  RHOA; ras homolog family member A [KO:K04513]", "4074  M6PR; mannose-6-phosphate receptor, cation dependent [KO:K10089]", "9367  RAB9A; RAB9A, member RAS oncogene family [KO:K07899]", "51209  RAB9B; RAB9B, member RAS oncogene family [KO:K07900]", "9648  GCC2; GRIP and coiled-coil domain containing 2 [KO:K20282]", "8677  STX10; syntaxin 10 [KO:K23937]", "345456  PFN3; profilin 3 [KO:K05759]", "5216  PFN1; profilin 1 [KO:K05759]", "5217  PFN2; profilin 2 [KO:K05759]", "375189  PFN4; profilin family member 4 [KO:K05759]", "2316  FLNA; filamin A [KO:K04437]", "23265  EXOC7; exocyst complex component 7 [KO:K07195]", "10640  EXOC5; exocyst complex component 5 [KO:K19984]", "60412  EXOC4; exocyst complex component 4 [KO:K06111]", "55770  EXOC2; exocyst complex component 2 [KO:K17637]", "5898  RALA; RAS like proto-oncogene A [KO:K07834]", "71  ACTG1; actin gamma 1 [KO:K05692]", "60  ACTB; actin beta [KO:K05692]", "6281  S100A10; S100 calcium binding protein A10 [KO:K17274]", "302  ANXA2; annexin A2 [KO:K17092]", "79026  AHNAK; AHNAK nucleoprotein [KO:K23934]", "113146  AHNAK2; AHNAK nucleoprotein 2 [KO:K23934]", "57381  RHOJ; ras homolog family member J [KO:K07864]", "26084  ARHGEF26; Rho guanine nucleotide exchange factor 26 [KO:K13744]", "391  RHOG; ras homolog family member G [KO:K07863]", "9844  ELMO1; engulfment and cell motility 1 [KO:K12366]", "63916  ELMO2; engulfment and cell motility 2 [KO:K18985]", "9475  ROCK2; Rho associated coiled-coil containing protein kinase 2 [KO:K17388] [EC:2.7.11.1]", "4633  MYL2; myosin light chain 2 [KO:K10351]", "4636  MYL5; myosin light chain 5 [KO:K12753]", "58498  MYL7; myosin light chain 7 [KO:K12754]", "10398  MYL9; myosin light chain 9 [KO:K12755]", "93408  MYL10; myosin light chain 10 [KO:K12756]", "103910  MYL12B; myosin light chain 12B [KO:K12757]", "10627  MYL12A; myosin light chain 12A [KO:K12757]", "29895  MYL11; myosin light chain 11 [KO:K12758]", "29109  FHOD1; formin homology 2 domain containing 1 [KO:K23938]", "998  CDC42; cell division cycle 42 [KO:K04393]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "10787  NCKAP1; NCK associated protein 1 [KO:K05750]", "3071  NCKAP1L; NCK associated protein 1 like [KO:K05750]", "23191  CYFIP1; cytoplasmic FMR1 interacting protein 1 [KO:K05749]", "26999  CYFIP2; cytoplasmic FMR1 interacting protein 2 [KO:K05749]", "10006  ABI1; abl interactor 1 [KO:K23649]", "55845  BRK1; BRICK1 subunit of SCAR/WAVE actin nucleating complex [KO:K05752]", "10810  WASF3; WASP family member 3 [KO:K06083]", "10097  ACTR2; actin related protein 2 [KO:K17260]", "57180  ACTR3B; actin related protein 3B [KO:K18584]", "653857  ACTR3C; actin related protein 3C [KO:K18584]", "10096  ACTR3; actin related protein 3 [KO:K18584]", "10095  ARPC1B; actin related protein 2/3 complex subunit 1B [KO:K05757]", "10552  ARPC1A; actin related protein 2/3 complex subunit 1A [KO:K05757]", "10109  ARPC2; actin related protein 2/3 complex subunit 2 [KO:K05758]", "10094  ARPC3; actin related protein 2/3 complex subunit 3 [KO:K05756]", "10093  ARPC4; actin related protein 2/3 complex subunit 4 [KO:K05755]", "10092  ARPC5; actin related protein 2/3 complex subunit 5 [KO:K05754]", "81873  ARPC5L; actin related protein 2/3 complex subunit 5 like [KO:K05754]", "5058  PAK1; p21 (RAC1) activated kinase 1 [KO:K04409] [EC:2.7.11.1]", "5063  PAK3; p21 (RAC1) activated kinase 3 [KO:K05733] [EC:2.7.11.1]", "4646  MYO6; myosin VI [KO:K10358]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5294  PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma [KO:K21289] [EC:2.7.1.153]", "5288  PIK3C2G; phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma [KO:K00923] [EC:2.7.1.154]", "5286  PIK3C2A; phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha [KO:K00923] [EC:2.7.1.154]", "5287  PIK3C2B; phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta [KO:K00923] [EC:2.7.1.154]", "9265  CYTH3; cytohesin 3 [KO:K18441]", "27128  CYTH4; cytohesin 4 [KO:K18441]", "9266  CYTH2; cytohesin 2 [KO:K18441]", "9267  CYTH1; cytohesin 1 [KO:K18441]", "382  ARF6; ADP ribosylation factor 6 [KO:K07941]", "375  ARF1; ADP ribosylation factor 1 [KO:K07937]", "112574  SNX18; sorting nexin 18 [KO:K17923]", "257364  SNX33; sorting nexin 33 [KO:K17923]", "51429  SNX9; sorting nexin 9 [KO:K17923]", "8976  WASL; WASP like actin nucleation promoting factor [KO:K23612]", "1785  DNM2; dynamin 2 [KO:K23484] [EC:3.6.5.5]", "10333  TLR6; toll like receptor 6 [KO:K10169]", "7097  TLR2; toll like receptor 2 [KO:K10159]", "114609  TIRAP; TIR domain containing adaptor protein [KO:K05403]", "4615  MYD88; MYD88 innate immune signal transduction adaptor [KO:K04729]", "929  CD14; CD14 molecule [KO:K04391]", "7099  TLR4; toll like receptor 4 [KO:K10160]", "23643  LY96; lymphocyte antigen 96 [KO:K05400]", "7100  TLR5; toll like receptor 5 [KO:K10168]", "54106  TLR9; toll like receptor 9 [KO:K10161]", "3654  IRAK1; interleukin 1 receptor associated kinase 1 [KO:K04730] [EC:2.7.11.1]", "51135  IRAK4; interleukin 1 receptor associated kinase 4 [KO:K04733] [EC:2.7.11.1]", "7189  TRAF6; TNF receptor associated factor 6 [KO:K03175] [EC:2.3.2.27]", "6885  MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO:K04427] [EC:2.7.11.25]", "10454  TAB1; TGF-beta activated kinase 1 (MAP3K7) binding protein 1 [KO:K04403]", "23118  TAB2; TGF-beta activated kinase 1 (MAP3K7) binding protein 2 [KO:K04404]", "257397  TAB3; TGF-beta activated kinase 1 (MAP3K7) binding protein 3 [KO:K12793]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "10392  NOD1; nucleotide binding oligomerization domain containing 1 [KO:K08727]", "3320  HSP90AA1; heat shock protein 90 alpha family class A member 1 [KO:K04079]", "3326  HSP90AB1; heat shock protein 90 alpha family class B member 1 [KO:K04079]", "7184  HSP90B1; heat shock protein 90 beta family member 1 [KO:K09487]", "8767  RIPK2; receptor interacting serine/threonine kinase 2 [KO:K08846] [EC:2.7.11.1]", "1434  CSE1L; chromosome segregation 1 like [KO:K18423]", "3836  KPNA1; karyopherin subunit alpha 1 [KO:K23940]", "3839  KPNA3; karyopherin subunit alpha 3 [KO:K23583]", "3840  KPNA4; karyopherin subunit alpha 4 [KO:K23583]", "6188  RPS3; ribosomal protein S3 [KO:K02985]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "5606  MAP2K3; mitogen-activated protein kinase kinase 3 [KO:K04432] [EC:2.7.12.2]", "5608  MAP2K6; mitogen-activated protein kinase kinase 6 [KO:K04433] [EC:2.7.12.2]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "6416  MAP2K4; mitogen-activated protein kinase kinase 4 [KO:K04430] [EC:2.7.12.2]", "5609  MAP2K7; mitogen-activated protein kinase kinase 7 [KO:K04431] [EC:2.7.12.2]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "7124  TNF; tumor necrosis factor [KO:K03156]", "3553  IL1B; interleukin 1 beta [KO:K04519]", "3569  IL6; interleukin 6 [KO:K05405]", "3576  CXCL8; C-X-C motif chemokine ligand 8 [KO:K10030]", "1499  CTNNB1; catenin beta 1 [KO:K02105]", "6932  TCF7; transcription factor 7 [KO:K02620]", "83439  TCF7L1; transcription factor 7 like 1 [KO:K04490]", "6934  TCF7L2; transcription factor 7 like 2 [KO:K04491]", "51176  LEF1; lymphoid enhancer binding factor 1 [KO:K04492]", "4609  MYC; MYC proto-oncogene, bHLH transcription factor [KO:K04377]", "5585  PKN1; protein kinase N1 [KO:K06071] [EC:2.7.11.13]", "26263  FBXO22; F-box protein 22 [KO:K10302]", "6500  SKP1; S-phase kinase associated protein 1 [KO:K03094]", "7132  TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158]", "7186  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]", "8717  TRADD; TNFRSF1A associated via death domain [KO:K03171]", "329  BIRC2; baculoviral IAP repeat containing 2 [KO:K16060]", "330  BIRC3; baculoviral IAP repeat containing 3 [KO:K16060]", "8737  RIPK1; receptor interacting serine/threonine kinase 1 [KO:K02861] [EC:2.7.11.1]", "2597  GAPDH; glyceraldehyde-3-phosphate dehydrogenase [KO:K00134] [EC:1.2.1.12]", "8743  TNFSF10; TNF superfamily member 10 [KO:K04721]", "8797  TNFRSF10A; TNF receptor superfamily member 10a [KO:K04722]", "8795  TNFRSF10B; TNF receptor superfamily member 10b [KO:K04722]", "8772  FADD; Fas associated via death domain [KO:K02373]", "841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]", "11035  RIPK3; receptor interacting serine/threonine kinase 3 [KO:K08847] [EC:2.7.11.1]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "578  BAK1; BCL2 antagonist/killer 1 [KO:K14021]", "54205  CYCS; cytochrome c, somatic [KO:K08738]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "840  CASP7; caspase 7 [KO:K04397] [EC:3.4.22.60]", "388  RHOB; ras homolog family member B [KO:K07856]", "399  RHOH; ras homolog family member H [KO:K07873]", "6237  RRAS; RAS related [KO:K07829]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "197259  MLKL; mixed lineage kinase domain like pseudokinase [KO:K08849] [EC:2.7.11.1]", "7295  TXN; thioredoxin [KO:K03671]", "25828  TXN2; thioredoxin 2 [KO:K03671]", "114548  NLRP3; NLR family pyrin domain containing 3 [KO:K12800]", "4671  NAIP; NLR family apoptosis inhibitory protein [KO:K12807]", "58484  NLRC4; NLR family CARD domain containing 4 [KO:K12805]", "29108  PYCARD; PYD and CARD domain containing [KO:K12799]", "834  CASP1; caspase 1 [KO:K01370] [EC:3.4.22.36]", "3606  IL18; interleukin 18 [KO:K05482]", "837  CASP4; caspase 4 [KO:K04394] [EC:3.4.22.57 3.4.22.64]", "838  CASP5; caspase 5 [KO:K04395] [EC:3.4.22.58]", "79792  GSDMD; gasdermin D [KO:K20917]"], "compound": ["C00338  Lipopolysaccharide", "C01194  1-Phosphatidyl-D-myo-inositol", "C04549  1-Phosphatidyl-1D-myo-inositol 3-phosphate", "C05981  Phosphatidylinositol-3,4,5-trisphosphate", "C11554  1-Phosphatidyl-1D-myo-inositol 3,4-bisphosphate"], "refs": [{"pmid": "28875943", "authors": "  Bernal-Bayard J, Ramos-Morales F", "title": "Molecular Mechanisms Used by Salmonella to Evade the Immune System.", "journal": "Curr Issues Mol Biol 25:133-168 (2018)", "doi": "10.21775/cimb.025.133"}, {"pmid": "28848711", "authors": "  Hume PJ, Singh V, Davidson AC, Koronakis V", "title": "Swiss Army Pathogen: The Salmonella Entry Toolkit.", "journal": "Front Cell Infect Microbiol 7:348 (2017)", "doi": "10.3389/fcimb.2017.00348"}, {"pmid": "31402916", "authors": "  Wemyss MA, Pearson JS", "title": "Host Cell Death Responses to Non-typhoidal Salmonella Infection.", "journal": "Front Immunol 10:1758 (2019)", "doi": "10.3389/fimmu.2019.01758"}, {"pmid": "27974148", "authors": "  Bierschenk D, Boucher D, Schroder K", "title": "Salmonella-induced inflammasome activation in humans.", "journal": "Mol Immunol 86:38-43 (2017)", "doi": "10.1016/j.molimm.2016.11.009"}, {"pmid": "29477730", "authors": "  Pinaud L, Sansonetti PJ, Phalipon A", "title": "Host Cell Targeting by Enteropathogenic Bacteria T3SS Effectors.", "journal": "Trends Microbiol 26:266-283 (2018)", "doi": "10.1016/j.tim.2018.01.010"}, {"pmid": "25749450", "authors": "  LaRock DL, Chaudhary A, Miller SI", "title": "Salmonellae interactions with host processes.", "journal": "Nat Rev Microbiol 13:191-205 (2015)", "doi": "10.1038/nrmicro3420"}, {"pmid": "17983751", "authors": "  Ramsden AE, Holden DW, Mota LJ", "title": "Membrane dynamics and spatial distribution of Salmonella-containing vacuoles.", "journal": "Trends Microbiol 15:516-24 (2007)", "doi": "10.1016/j.tim.2007.10.002"}, {"pmid": "22702524", "authors": "  van der Heijden J, Finlay BB", "title": "Type III effector-mediated processes in Salmonella infection.", "journal": "Future Microbiol 7:685-703 (2012)", "doi": "10.2217/fmb.12.49"}, {"pmid": "27222578", "authors": "  Galan JE", "title": "Typhoid toxin provides a window into typhoid fever and the biology of Salmonella Typhi.", "journal": "Proc Natl Acad Sci U S A 113:6338-44 (2016)", "doi": "10.1073/pnas.1606335113"}, {"pmid": "19157959", "authors": "  McGhie EJ, Brawn LC, Hume PJ, Humphreys D, Koronakis V", "title": "Salmonella takes control: effector-driven manipulation of the host.", "journal": "Curr Opin Microbiol 12:117-24 (2009)", "doi": "10.1016/j.mib.2008.12.001"}, {"pmid": "12675800", "authors": "  Miao EA, Brittnacher M, Haraga A, Jeng RL, Welch MD, Miller SI", "title": "Salmonella effectors translocated across the vacuolar membrane interact with the actin cytoskeleton.", "journal": "Mol Microbiol 48:401-15 (2003)", "doi": "10.1046/j.1365-2958.2003.t01-1-03456.x"}, {"pmid": "17074883", "authors": "  Patel JC, Galan JE", "title": "Differential activation and function of Rho GTPases during Salmonella-host cell interactions.", "journal": "J Cell Biol 175:453-63 (2006)", "doi": "10.1083/jcb.200605144"}, {"pmid": "18411289", "authors": "  Wasylnka JA, Bakowski MA, Szeto J, Ohlson MB, Trimble WS, Miller SI, Brumell JH", "title": "Role for myosin II in regulating positioning of Salmonella-containing vacuoles and intracellular replication.", "journal": "Infect Immun 76:2722-35 (2008)", "doi": "10.1128/IAI.00152-08"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04064  NF-kappa B signaling pathway", "hsa04210  Apoptosis", "hsa04217  Necroptosis", "hsa04621  NOD-like receptor signaling pathway"], "ko_pathway": "ko05132", "genes": ["RAC1", "NOD1", "AKT2", "BIRC3", "AKT1", "MAPK13", "BAX"]}, {"kegg_id": "hsa05135", "name": "Yersinia infection - Homo sapiens (human)", "description": "Pathogenic Yersinia injects virulent Yersinia outer proteins (Yops) into the host cell through a type three secretion system (T3SS) to express its pathogenicity. Through inactivation of small GTPases by YopT protease, YopE GTPase-activating protein, and YpkA/YopO sequestration of GDP-bound small GTPases, Yersinia prevents its uptake by phagocytic cells and disrupts the actin cytoskeleton. YopH phosphatase shuts down phagocytosis by dephosphorylating key host proteins as well as suppresses T cell activation. Yersinia induces macrophage pyroptosis via YopB/YopD activation of canonical and noncanonical inflammasomes and YopT/YopE-mediated activation of pyrin. These effects are counteracted by YopK and YopM. YopP/J is a member of an ubiquitin-like protein cysteine protease family and simultaneously targets signaling components of the MAPK and NF-kappaB signaling pathways following activation of Toll-like receptor4 to inhibit production of proinflammatory cytokines.", "class": "Human Diseases; Infectious disease: bacterial", "pathway_map": "hsa05135  Yersinia infection", "network": ["", "ELEMENT   N00859  Yersinia YopP/J to TLR2/4-NFKB signaling pathway", "N00862  Yersinia YopP/J to TLR2/4-MAPK signaling pathway", "N00863  Yersinia YopM to NLRP3 Inflammasome signaling pathway", "N00864  Yersinia YopK to NLRP3 Inflammasome signaling pathway", "N00865  Yersinia YopK to NLRC4 Inflammasome signaling pathway", "N00866  Yersinia YopM to Pyrin Inflammasome signaling pathway", "N01098  Yersinia YopT to ITGA/B-RhoGEF-RhoA signaling pathway", "N01099  Yersinia YopE to RhoA signaling pathway", "N01100  Yersinia YopE to ITGA/B-RHOG-RAC signaling pathway", "N01101  Yersinia YopT to ITGA/B-RHOG-RAC signaling pathway", "N01102  Yersinia YopE to ITGA/B-RHOG-RAC signaling pathway", "N01103  Yersinia YpkA to IGG-FCGR-RAC signaling pathway", "N01105  Yersinia YpkA to LPA-GNAQ-RhoA signaling pathway", "N01107  Yersinia YopH to TCR-NFAT signaling pathway", "N01108  Yersinia YopH to TCR-NFAT signaling pathway", "N01109  Yersinia YopH to ITGA/B-FAK-RAC signaling pathway", "N01110  Yersinia YopH to ITGA/B-FAK-RAC signaling pathway", "N01111  Yersinia YopH to ITGA/B-FAK-RAC signaling pathway"], "disease": ["H00298  Yersiniosis"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["2335  FN1; fibronectin 1 [KO:K05717]", "3676  ITGA4; integrin subunit alpha 4 [KO:K06483]", "3678  ITGA5; integrin subunit alpha 5 [KO:K06484]", "3688  ITGB1; integrin subunit beta 1 [KO:K05719]", "391  RHOG; ras homolog family member G [KO:K07863]", "6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "5747  PTK2; protein tyrosine kinase 2 [KO:K05725] [EC:2.7.10.2]", "2185  PTK2B; protein tyrosine kinase 2 beta [KO:K05871] [EC:2.7.10.2]", "1398  CRK; CRK proto-oncogene, adaptor protein [KO:K04438]", "1399  CRKL; CRK like proto-oncogene, adaptor protein [KO:K04438]", "9564  BCAR1; BCAR1 scaffold protein, Cas family member [KO:K05726]", "9844  ELMO1; engulfment and cell motility 1 [KO:K12366]", "63916  ELMO2; engulfment and cell motility 2 [KO:K18985]", "1793  DOCK1; dedicator of cytokinesis 1 [KO:K13708]", "102723407  IGH; immunoglobulin heavy variable 4-38-2-like [KO:K06856]", "2212  FCGR2A; Fc gamma receptor IIa [KO:K06472]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "5880  RAC2; Rac family small GTPase 2 [KO:K07860]", "5881  RAC3; Rac family small GTPase 3 [KO:K07861]", "23396  PIP5K1C; phosphatidylinositol-4-phosphate 5-kinase type 1 gamma [KO:K00889] [EC:2.7.1.68]", "8394  PIP5K1A; phosphatidylinositol-4-phosphate 5-kinase type 1 alpha [KO:K00889] [EC:2.7.1.68]", "8395  PIP5K1B; phosphatidylinositol-4-phosphate 5-kinase type 1 beta [KO:K00889] [EC:2.7.1.68]", "382  ARF6; ADP ribosylation factor 6 [KO:K07941]", "8976  WASL; WASP like actin nucleation promoting factor [KO:K23612]", "10097  ACTR2; actin related protein 2 [KO:K17260]", "57180  ACTR3B; actin related protein 3B [KO:K18584]", "653857  ACTR3C; actin related protein 3C [KO:K18584]", "10096  ACTR3; actin related protein 3 [KO:K18584]", "10095  ARPC1B; actin related protein 2/3 complex subunit 1B [KO:K05757]", "10552  ARPC1A; actin related protein 2/3 complex subunit 1A [KO:K05757]", "10109  ARPC2; actin related protein 2/3 complex subunit 2 [KO:K05758]", "10094  ARPC3; actin related protein 2/3 complex subunit 3 [KO:K05756]", "10093  ARPC4; actin related protein 2/3 complex subunit 4 [KO:K05755]", "10092  ARPC5; actin related protein 2/3 complex subunit 5 [KO:K05754]", "81873  ARPC5L; actin related protein 2/3 complex subunit 5 like [KO:K05754]", "71  ACTG1; actin gamma 1 [KO:K05692]", "60  ACTB; actin beta [KO:K05692]", "147179  WIPF2; WAS/WASL interacting protein family member 2 [KO:K19475]", "7456  WIPF1; WAS/WASL interacting protein family member 1 [KO:K19475]", "644150  WIPF3; WAS/WASL interacting protein family member 3 [KO:K19475]", "10458  BAIAP2; BAR/IMD domain containing adaptor protein 2 [KO:K05627]", "10163  WASF2; WASP family member 2 [KO:K05748]", "5829  PXN; paxillin [KO:K05760]", "9815  GIT2; GIT ArfGAP 2 [KO:K12487]", "8874  ARHGEF7; Rho guanine nucleotide exchange factor 7 [KO:K13710]", "998  CDC42; cell division cycle 42 [KO:K04393]", "7454  WAS; WASP actin nucleation promoting factor [KO:K05747]", "2776  GNAQ; G protein subunit alpha q [KO:K04634]", "23365  ARHGEF12; Rho guanine nucleotide exchange factor 12 [KO:K07532]", "9138  ARHGEF1; Rho guanine nucleotide exchange factor 1 [KO:K12330]", "64283  ARHGEF28; Rho guanine nucleotide exchange factor 28 [KO:K21072]", "387  RHOA; ras homolog family member A [KO:K04513]", "6093  ROCK1; Rho associated coiled-coil containing protein kinase 1 [KO:K04514] [EC:2.7.11.1]", "9475  ROCK2; Rho associated coiled-coil containing protein kinase 2 [KO:K17388] [EC:2.7.11.1]", "2533  FYB1; FYN binding protein 1 [KO:K17698]", "8935  SKAP2; src kinase associated phosphoprotein 2 [KO:K23471]", "114548  NLRP3; NLR family pyrin domain containing 3 [KO:K12800]", "58484  NLRC4; NLR family CARD domain containing 4 [KO:K12805]", "5585  PKN1; protein kinase N1 [KO:K06071] [EC:2.7.11.13]", "5586  PKN2; protein kinase N2 [KO:K23691] [EC:2.7.11.13]", "6197  RPS6KA3; ribosomal protein S6 kinase A3 [KO:K04373] [EC:2.7.11.1]", "6195  RPS6KA1; ribosomal protein S6 kinase A1 [KO:K04373] [EC:2.7.11.1]", "6196  RPS6KA2; ribosomal protein S6 kinase A2 [KO:K04373] [EC:2.7.11.1]", "27330  RPS6KA6; ribosomal protein S6 kinase A6 [KO:K04373] [EC:2.7.11.1]", "4210  MEFV; MEFV innate immunity regulator, pyrin [KO:K12803]", "3984  LIMK1; LIM domain kinase 1 [KO:K05743] [EC:2.7.11.1]", "29108  PYCARD; PYD and CARD domain containing [KO:K12799]", "834  CASP1; caspase 1 [KO:K01370] [EC:3.4.22.36]", "3606  IL18; interleukin 18 [KO:K05482]", "3553  IL1B; interleukin 1 beta [KO:K04519]", "7099  TLR4; toll like receptor 4 [KO:K10160]", "4615  MYD88; MYD88 innate immune signal transduction adaptor [KO:K04729]", "51135  IRAK4; interleukin 1 receptor associated kinase 4 [KO:K04733] [EC:2.7.11.1]", "3654  IRAK1; interleukin 1 receptor associated kinase 1 [KO:K04730] [EC:2.7.11.1]", "7189  TRAF6; TNF receptor associated factor 6 [KO:K03175] [EC:2.3.2.27]", "7186  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]", "10454  TAB1; TGF-beta activated kinase 1 (MAP3K7) binding protein 1 [KO:K04403]", "23118  TAB2; TGF-beta activated kinase 1 (MAP3K7) binding protein 2 [KO:K04404]", "6885  MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO:K04427] [EC:2.7.11.25]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "5606  MAP2K3; mitogen-activated protein kinase kinase 3 [KO:K04432] [EC:2.7.12.2]", "5608  MAP2K6; mitogen-activated protein kinase kinase 6 [KO:K04433] [EC:2.7.12.2]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "6416  MAP2K4; mitogen-activated protein kinase kinase 4 [KO:K04430] [EC:2.7.12.2]", "5609  MAP2K7; mitogen-activated protein kinase kinase 7 [KO:K04431] [EC:2.7.12.2]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "148022  TICAM1; TIR domain containing adaptor molecule 1 [KO:K05842]", "29110  TBK1; TANK binding kinase 1 [KO:K05410] [EC:2.7.11.10]", "3661  IRF3; interferon regulatory factor 3 [KO:K05411]", "7124  TNF; tumor necrosis factor [KO:K03156]", "3569  IL6; interleukin 6 [KO:K05405]", "3576  CXCL8; C-X-C motif chemokine ligand 8 [KO:K10030]", "3456  IFNB1; interferon beta 1 [KO:K05415]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "6347  CCL2; C-C motif chemokine ligand 2 [KO:K14624]", "920  CD4; CD4 molecule [KO:K06454]", "925  CD8A; CD8 subunit alpha [KO:K06458]", "926  CD8B; CD8 subunit beta [KO:K06459]", "927  CD8B2; CD8B family member 2 [KO:K06459]", "3932  LCK; LCK proto-oncogene, Src family tyrosine kinase [KO:K05856] [EC:2.7.10.2]", "7535  ZAP70; zeta chain of T cell receptor associated protein kinase 70 [KO:K07360] [EC:2.7.10.2]", "27040  LAT; linker for activation of T cells [KO:K07362]", "3937  LCP2; lymphocyte cytosolic protein 2 [KO:K07361]", "10451  VAV3; vav guanine nucleotide exchange factor 3 [KO:K05730]", "7409  VAV1; vav guanine nucleotide exchange factor 1 [KO:K05730]", "7410  VAV2; vav guanine nucleotide exchange factor 2 [KO:K05730]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "4772  NFATC1; nuclear factor of activated T cells 1 [KO:K04446]", "4773  NFATC2; nuclear factor of activated T cells 2 [KO:K17332]", "4775  NFATC3; nuclear factor of activated T cells 3 [KO:K17333]", "3558  IL2; interleukin 2 [KO:K05429]", "3586  IL10; interleukin 10 [KO:K05443]"], "compound": ["C00076  Calcium cation", "C00338  Lipopolysaccharide", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C04637  1-Phosphatidyl-D-myo-inositol 4,5-bisphosphate", "C05981  Phosphatidylinositol-3,4,5-trisphosphate"], "refs": [{"pmid": "26981193", "authors": "  Pha K, Navarro L", "title": "Yersinia type III effectors perturb host innate immune responses.", "journal": "World J Biol Chem 7:1-13 (2016)", "doi": "10.4331/wjbc.v7.i1.1"}, {"pmid": "29477730", "authors": "  Pinaud L, Sansonetti PJ, Phalipon A", "title": "Host Cell Targeting by Enteropathogenic Bacteria T3SS Effectors.", "journal": "Trends Microbiol 26:266-283 (2018)", "doi": "10.1016/j.tim.2018.01.010"}, {"pmid": "19339545", "authors": "  Huveneers S, Danen EH", "title": "Adhesion signaling - crosstalk between integrins, Src and Rho.", "journal": "J Cell Sci 122:1059-69 (2009)", "doi": "10.1242/jcs.039446"}, {"pmid": "17257058", "authors": "  Angot A, Vergunst A, Genin S, Peeters N", "title": "Exploitation of eukaryotic ubiquitin signaling pathways by effectors translocated by bacterial type III and type IV secretion systems.", "journal": "PLoS Pathog 3:e3 (2007)", "doi": "10.1371/journal.ppat.0030003"}, {"pmid": "10785635", "authors": "  Bliska JB", "title": "Yop effectors of Yersinia spp. and actin rearrangements.", "journal": "Trends Microbiol 8:205-8 (2000)", "doi": "10.1016/S0966-842X(00)01738-8"}, {"pmid": "15044442", "authors": "  Gustavsson A, Yuan M, Fallman M", "title": "Temporal dissection of beta1-integrin signaling indicates a role for p130Cas-Crk in filopodia formation.", "journal": "J Biol Chem 279:22893-901 (2004)", "doi": "10.1074/jbc.M309693200"}, {"pmid": "11734206", "authors": "  McGee K, Zettl M, Way M, Fallman M", "title": "A role for N-WASP in invasin-promoted internalisation.", "journal": "FEBS Lett 509:59-65 (2001)", "doi": "10.1016/S0014-5793(01)03139-8"}, {"pmid": "15516995", "authors": "  Pizarro-Cerda J, Cossart P", "title": "Subversion of phosphoinositide metabolism by intracellular bacterial pathogens.", "journal": "Nat Cell Biol 6:1026-33 (2004)", "doi": "10.1038/ncb1104-1026"}, {"pmid": "27569559", "authors": "  Chung LK, Park YH, Zheng Y, Brodsky IE, Hearing P, Kastner DL, Chae JJ, Bliska JB", "title": "The Yersinia Virulence Factor YopM Hijacks Host Kinases to Inhibit Type III Effector-Triggered Activation of the Pyrin Inflammasome.", "journal": "Cell Host Microbe 20:296-306 (2016)", "doi": "10.1016/j.chom.2016.07.018"}, {"pmid": "15060067", "authors": "  Schotte P, Denecker G, Van Den Broeke A, Vandenabeele P, Cornelis GR, Beyaert R", "title": "Targeting Rac1 by the Yersinia effector protein YopE inhibits caspase-1-mediated maturation and release of interleukin-1beta.", "journal": "J Biol Chem 279:25134-42 (2004)", "doi": "10.1074/jbc.M401245200"}, {"pmid": "10489373", "authors": "  Orth K, Palmer LE, Bao ZQ, Stewart S, Rudolph AE, Bliska JB, Dixon JE", "title": "Inhibition of the mitogen-activated protein kinase kinase superfamily by a Yersinia effector.", "journal": "Science 285:1920-3 (1999)", "doi": "10.1126/science.285.5435.1920"}, {"pmid": "16301742", "authors": "  Zhou H, Monack DM, Kayagaki N, Wertz I, Yin J, Wolf B, Dixit VM", "title": "Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-kappa B activation.", "journal": "J Exp Med 202:1327-32 (2005)", "doi": "10.1084/jem.20051194"}, {"pmid": "16339560", "authors": "  Haase R, Richter K, Pfaffinger G, Courtois G, Ruckdeschel K", "title": "Yersinia outer protein P suppresses TGF-beta-activated kinase-1 activity to impair innate immune signaling in Yersinia enterocolitica-infected cells.", "journal": "J Immunol 175:8209-17 (2005)", "doi": "10.4049/jimmunol.175.12.8209"}, {"pmid": "16845370", "authors": "  Thiefes A, Wolf A, Doerrie A, Grassl GA, Matsumoto K, Autenrieth I, Bohn E, Sakurai H, Niedenthal R, Resch K, Kracht M", "title": "The Yersinia enterocolitica effector YopP inhibits host cell signalling by inactivating the protein kinase TAK1 in the IL-1 signalling pathway.", "journal": "EMBO Rep 7:838-44 (2006)", "doi": "10.1038/sj.embor.7400754"}, {"pmid": "26651944", "authors": "  Rosadini CV, Zanoni I, Odendall C, Green ER, Paczosa MK, Philip NH, Brodsky IE, Mecsas J, Kagan JC", "title": "A Single Bacterial Immune Evasion Strategy Dismantles Both MyD88 and TRIF Signaling Pathways Downstream of TLR4.", "journal": "Cell Host Microbe 18:682-93 (2015)", "doi": "10.1016/j.chom.2015.11.006"}, {"pmid": "24034616", "authors": "  Rolan HG, Durand EA, Mecsas J", "title": "Identifying Yersinia YopH-targeted signal transduction pathways that impair neutrophil responses during in vivo murine infection.", "journal": "Cell Host Microbe 14:306-17 (2013)", "doi": "10.1016/j.chom.2013.08.013"}], "rel_pathway": ["hsa04510  Focal adhesion", "hsa04620  Toll-like receptor signaling pathway", "hsa04621  NOD-like receptor signaling pathway", "hsa04660  T cell receptor signaling pathway", "hsa04666  Fc gamma R-mediated phagocytosis", "hsa04810  Regulation of actin cytoskeleton"], "ko_pathway": "ko05135", "genes": ["RAC1", "AKT2", "AKT1", "MAPK13"]}, {"kegg_id": "hsa05167", "name": "Kaposi sarcoma-associated herpesvirus infection - Homo sapiens (human)", "description": "Kaposi sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8 (HHV-8), is the most recently identified human tumor virus, and is associated with the pathogenesis of Kaposi's sarcoma (KS), primary effusion lymphoma (PEL), and Multicentric Castleman's disease (MCD). Like all other herpesviruses, KSHV displays two modes of life cycle, latency and lytic replication, which are characterized by the patterns of viral gene expression. Genes expressed in latency (LANA, v-cyclin, v-FLIP, Kaposins A, B and C and viral miRNAs) are mainly thought to facilitate the establishment of life long latency in its host and survival against the host innate, and adaptive immune surveillance mechanisms. Among the viral proteins shown to be expressed during lytic replication are potent signaling molecules such as vGPCR, vIL6, vIRFs, vCCLs, K1 and K15, which have been implicated experimentally in the angiogenic and inflammatory phenotype observed in KS lesions. Several of these latent viral and lytic proteins are known to transform host cells, linking KSHV with the development of severe human malignancies.", "class": "Human Diseases; Infectious disease: viral", "pathway_map": "hsa05167  Kaposi sarcoma-associated herpesvirus infection", "network": ["", "ELEMENT   N00157  KSHV vGPCR to GNB/G-ERK signaling pathway", "N00158  KSHV vGPCR to GNB/G-PI3K-AKT signaling pathway", "N00159  KSHV K1 to PI3K signaling pathway", "N00160  KSHV K1 to RAS-ERK signaling pathway", "N00161  KSHV vIRF1/2 to TLR3-IRF3 signaling pathway", "N00162  KSHV vIRF3 to TLR3-IRF7 signaling pathway", "N00163  KSHV KIE1/2 to TLR3-IRF7 signaling pathway", "N00164  KSHV vBCL2 to crosstalk between extrinsic and intrinsic apoptotic pathways", "N00165  KSHV vIAP to crosstalk between extrinsic and intrinsic apoptotic pathways", "N00166  KSHV vFLIP to crosstalk between extrinsic and intrinsic apoptotic pathways", "N00167  KSHV vIRF1/3 to p21-cell cycle G1/S", "N00168  KSHV vCyclin to cell cycle G1/S", "N00169  KSHV LANA to p21-cell cycle G1/S", "N00170  KSHV LANA to cell cycle G1/S", "N00171  KSHV vFLIP to NFKB signaling pathway", "N00172  KSHV K15 to PLCG-calcineurin signaling pathway", "N00173  KSHV K15 to TNF-NFKB signaling pathway", "N00174  KSHV vFLIP to TNF-NFKB signaling pathway", "N00175  KSHV LANA to Wnt signaling pathway", "N00176  KSHV vFLIP to autophagy-vesicle elongation", "N00177  KSHV vBCL2 to autophagy-vesicle nucleation", "N00178  KSHV vGPCR to GNB/G-PI3K-JNK signaling pathway", "N00179  KSHV K1 to PI3K-NFKB signaling pathway", "N00180  KSHV K1 to PLCG-calcineurin signaling pathway", "N00181  KSHV vIL-6 to Jak-STAT signaling pathway", "N00184  KSHV MIR1/2 to antigen processing and presentation by MHC class I molecules", "N00185  KSHV MIR2 to cell surface molecule-endocytosis", "N00187  KSHV Kaposin B to p38 signaling pathway", "N00189  KSHV K15 to JNK signaling pathway", "N00212  KSHV vCCL2 to CCR signaling pathway", "N00213  KSHV Kaposin to alternative pathway of complement cascade", "N00261  KSHV vIRF2 to IFN signaling pathway", "N00462  KSHV vCCL1/2/3 to CCR signaling pathway", "N01527  KSHV Kaposin to classical/Lectin pathway of complement cascade, C4b breakdown", "N01528  KSHV Kaposin to alternative pathway of complement cascade, C3b breakdown"], "disease": ["H00041  Kaposi sarcoma"], "drug": ["D02745  Interferon alfa-2b (USAN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["718  C3; complement C3 [KO:K03990]", "7098  TLR3; toll like receptor 3 [KO:K05401]", "148022  TICAM1; TIR domain containing adaptor molecule 1 [KO:K05842]", "7187  TRAF3; TNF receptor associated factor 3 [KO:K03174]", "9641  IKBKE; inhibitor of nuclear factor kappa B kinase subunit epsilon [KO:K07211] [EC:2.7.11.10]", "29110  TBK1; TANK binding kinase 1 [KO:K05410] [EC:2.7.11.10]", "3665  IRF7; interferon regulatory factor 7 [KO:K09447]", "3439  IFNA1; interferon alpha 1 [KO:K05414]", "3440  IFNA2; interferon alpha 2 [KO:K05414]", "3441  IFNA4; interferon alpha 4 [KO:K05414]", "3442  IFNA5; interferon alpha 5 [KO:K05414]", "3443  IFNA6; interferon alpha 6 [KO:K05414]", "3444  IFNA7; interferon alpha 7 [KO:K05414]", "3445  IFNA8; interferon alpha 8 [KO:K05414]", "3446  IFNA10; interferon alpha 10 [KO:K05414]", "3447  IFNA13; interferon alpha 13 [KO:K05414]", "3448  IFNA14; interferon alpha 14 [KO:K05414]", "3449  IFNA16; interferon alpha 16 [KO:K05414]", "3451  IFNA17; interferon alpha 17 [KO:K05414]", "3452  IFNA21; interferon alpha 21 [KO:K05414]", "3661  IRF3; interferon regulatory factor 3 [KO:K05411]", "1387  CREBBP; CREB binding protein [KO:K04498] [EC:2.3.1.48]", "2033  EP300; E1A binding protein p300 [KO:K04498] [EC:2.3.1.48]", "3456  IFNB1; interferon beta 1 [KO:K05415]", "3454  IFNAR1; interferon alpha and beta receptor subunit 1 [KO:K05130]", "3455  IFNAR2; interferon alpha and beta receptor subunit 2 [KO:K05131]", "3716  JAK1; Janus kinase 1 [KO:K11217] [EC:2.7.10.2]", "7297  TYK2; tyrosine kinase 2 [KO:K11219] [EC:2.7.10.2]", "6772  STAT1; signal transducer and activator of transcription 1 [KO:K11220]", "6773  STAT2; signal transducer and activator of transcription 2 [KO:K11221]", "10379  IRF9; interferon regulatory factor 9 [KO:K04693]", "5610  EIF2AK2; eukaryotic translation initiation factor 2 alpha kinase 2 [KO:K16195] [EC:2.7.11.1]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "9261  MAPKAPK2; MAPK activated protein kinase 2 [KO:K04443] [EC:2.7.11.1]", "5608  MAP2K6; mitogen-activated protein kinase kinase 6 [KO:K04433] [EC:2.7.12.2]", "7538  ZFP36; ZFP36 ring finger protein [KO:K15308]", "3569  IL6; interleukin 6 [KO:K05405]", "1437  CSF2; colony stimulating factor 2 [KO:K05427]", "1232  CCR3; C-C motif chemokine receptor 3 [KO:K04178]", "1234  CCR5; C-C motif chemokine receptor 5 [KO:K04180]", "1230  CCR1; C-C motif chemokine receptor 1 [KO:K04176]", "1233  CCR4; C-C motif chemokine receptor 4 [KO:K04179]", "1237  CCR8; C-C motif chemokine receptor 8 [KO:K04183]", "355  FAS; Fas cell surface death receptor [KO:K04390]", "8772  FADD; Fas associated via death domain [KO:K02373]", "841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]", "637  BID; BH3 interacting domain death agonist [KO:K04726]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "578  BAK1; BCL2 antagonist/killer 1 [KO:K14021]", "54205  CYCS; cytochrome c, somatic [KO:K08738]", "842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "7132  TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158]", "8717  TRADD; TNFRSF1A associated via death domain [KO:K03171]", "7186  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "7157  TP53; tumor protein p53 [KO:K04451]", "1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]", "1019  CDK4; cyclin dependent kinase 4 [KO:K02089] [EC:2.7.11.22]", "1021  CDK6; cyclin dependent kinase 6 [KO:K02091] [EC:2.7.11.22]", "5925  RB1; RB transcriptional corepressor 1 [KO:K06618]", "1869  E2F1; E2F transcription factor 1 [KO:K17454]", "1870  E2F2; E2F transcription factor 2 [KO:K09389]", "1871  E2F3; E2F transcription factor 3 [KO:K06620]", "3105  HLA-A; major histocompatibility complex, class I, A [KO:K06751]", "3106  HLA-B; major histocompatibility complex, class I, B [KO:K06751]", "3107  HLA-C; major histocompatibility complex, class I, C [KO:K06751]", "3134  HLA-F; major histocompatibility complex, class I, F [KO:K06751]", "3135  HLA-G; major histocompatibility complex, class I, G [KO:K06751]", "3133  HLA-E; major histocompatibility complex, class I, E [KO:K06751]", "3459  IFNGR1; interferon gamma receptor 1 [KO:K05132]", "3383  ICAM1; intercellular adhesion molecule 1 [KO:K06490]", "942  CD86; CD86 molecule [KO:K05413]", "4277  MICB; MHC class I polypeptide-related sequence B [KO:K07985]", "100507436  MICA; MHC class I polypeptide-related sequence A [KO:K07985]", "9976  CLEC2B; C-type lectin domain family 2 member B [KO:K10071]", "7311  UBA52; ubiquitin A-52 residue ribosomal protein fusion product 1 [KO:K02927]", "6233  RPS27A; ribosomal protein S27a [KO:K02977]", "7314  UBB; ubiquitin B [KO:K04551]", "7316  UBC; ubiquitin C [KO:K08770]", "8678  BECN1; beclin 1 [KO:K08334]", "441925  BECN2; beclin 2 [KO:K08334]", "22863  ATG14; autophagy related 14 [KO:K17889]", "5289  PIK3C3; phosphatidylinositol 3-kinase catalytic subunit type 3 [KO:K00914] [EC:2.7.1.137]", "64422  ATG3; autophagy related 3 [KO:K08343]", "440738  MAP1LC3C; microtubule associated protein 1 light chain 3 gamma [KO:K10435]", "81631  MAP1LC3B; microtubule associated protein 1 light chain 3 beta [KO:K10435]", "84557  MAP1LC3A; microtubule associated protein 1 light chain 3 alpha [KO:K10435]", "643246  MAP1LC3B2; microtubule associated protein 1 light chain 3 beta 2 [KO:K10435]", "2782  GNB1; G protein subunit beta 1 [KO:K04536]", "2783  GNB2; G protein subunit beta 2 [KO:K04537]", "2784  GNB3; G protein subunit beta 3 [KO:K07825]", "59345  GNB4; G protein subunit beta 4 [KO:K04538]", "10681  GNB5; G protein subunit beta 5 [KO:K04539]", "54331  GNG2; G protein subunit gamma 2 [KO:K07826]", "2785  GNG3; G protein subunit gamma 3 [KO:K04540]", "2786  GNG4; G protein subunit gamma 4 [KO:K04541]", "2787  GNG5; G protein subunit gamma 5 [KO:K04542]", "2788  GNG7; G protein subunit gamma 7 [KO:K04543]", "94235  GNG8; G protein subunit gamma 8 [KO:K04544]", "2790  GNG10; G protein subunit gamma 10 [KO:K04545]", "2791  GNG11; G protein subunit gamma 11 [KO:K04546]", "55970  GNG12; G protein subunit gamma 12 [KO:K04347]", "51764  GNG13; G protein subunit gamma 13 [KO:K04547]", "2792  GNGT1; G protein subunit gamma transducin 1 [KO:K04548]", "2793  GNGT2; G protein subunit gamma transducin 2 [KO:K04549]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "3091  HIF1A; hypoxia inducible factor 1 subunit alpha [KO:K08268]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "5294  PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma [KO:K21289] [EC:2.7.1.153]", "23533  PIK3R5; phosphoinositide-3-kinase regulatory subunit 5 [KO:K21290]", "146850  PIK3R6; phosphoinositide-3-kinase regulatory subunit 6 [KO:K21290]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "57580  PREX1; phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1 [KO:K12365]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "344807  CD200R1L; CD200 receptor 1 like [KO:K21668]", "131450  CD200R1; CD200 receptor 1 [KO:K21668]", "6850  SYK; spleen associated tyrosine kinase [KO:K05855] [EC:2.7.10.2]", "6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "3055  HCK; HCK proto-oncogene, Src family tyrosine kinase [KO:K08893] [EC:2.7.10.2]", "4067  LYN; LYN proto-oncogene, Src family tyrosine kinase [KO:K05854] [EC:2.7.10.2]", "6416  MAP2K4; mitogen-activated protein kinase kinase 4 [KO:K04430] [EC:2.7.12.2]", "5609  MAP2K7; mitogen-activated protein kinase kinase 7 [KO:K04431] [EC:2.7.12.2]", "5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "810  CALML3; calmodulin like 3 [KO:K02183]", "805  CALM2; calmodulin 2 [KO:K02183]", "808  CALM3; calmodulin 3 [KO:K02183]", "801  CALM1; calmodulin 1 [KO:K02183]", "163688  CALML6; calmodulin like 6 [KO:K02183]", "51806  CALML5; calmodulin like 5 [KO:K02183]", "91860  CALML4; calmodulin like 4 [KO:K02183]", "5530  PPP3CA; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]", "5532  PPP3CB; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]", "5533  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]", "5534  PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]", "5535  PPP3R2; protein phosphatase 3 regulatory subunit B, beta [KO:K06268]", "4772  NFATC1; nuclear factor of activated T cells 1 [KO:K04446]", "4773  NFATC2; nuclear factor of activated T cells 2 [KO:K17332]", "4775  NFATC3; nuclear factor of activated T cells 3 [KO:K17333]", "4776  NFATC4; nuclear factor of activated T cells 4 [KO:K17334]", "3576  CXCL8; C-X-C motif chemokine ligand 8 [KO:K10030]", "5743  PTGS2; prostaglandin-endoperoxide synthase 2 [KO:K11987] [EC:1.14.99.1]", "2919  CXCL1; C-X-C motif chemokine ligand 1 [KO:K05505]", "2920  CXCL2; C-X-C motif chemokine ligand 2 [KO:K05505]", "2921  CXCL3; C-X-C motif chemokine ligand 3 [KO:K05505]", "1827  RCAN1; regulator of calcineurin 1 [KO:K17901]", "2247  FGF2; fibroblast growth factor 2 [KO:K18497]", "7422  VEGFA; vascular endothelial growth factor A [KO:K05448]", "5155  PDGFB; platelet derived growth factor subunit B [KO:K17386]", "285  ANGPT2; angiopoietin 2 [KO:K05466]", "3572  IL6ST; interleukin 6 cytokine family signal transducer [KO:K05060]", "3717  JAK2; Janus kinase 2 [KO:K04447] [EC:2.7.10.2]", "6774  STAT3; signal transducer and activator of transcription 3 [KO:K04692]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "1499  CTNNB1; catenin beta 1 [KO:K02105]", "6932  TCF7; transcription factor 7 [KO:K02620]", "83439  TCF7L1; transcription factor 7 like 1 [KO:K04490]", "6934  TCF7L2; transcription factor 7 like 2 [KO:K04491]", "51176  LEF1; lymphoid enhancer binding factor 1 [KO:K04492]", "1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]", "595  CCND1; cyclin D1 [KO:K04503]", "4609  MYC; MYC proto-oncogene, bHLH transcription factor [KO:K04377]"], "compound": ["C00076  Calcium cation", "C00165  Diacylglycerol", "C00350  Phosphatidylethanolamine", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C05981  Phosphatidylinositol-3,4,5-trisphosphate"], "refs": [{"pmid": "22403573", "authors": "  Lee HR, Brulois K, Wong L, Jung JU", "title": "Modulation of Immune System by Kaposi's Sarcoma-Associated Herpesvirus: Lessons from Viral Evasion Strategies.", "journal": "Front Microbiol 3:44 (2012)", "doi": "10.3389/fmicb.2012.00044"}, {"pmid": "18948197", "authors": "  Liang C, Lee JS, Jung JU", "title": "Immune evasion in Kaposi's sarcoma-associated herpes virus associated oncogenesis.", "journal": "Semin Cancer Biol 18:423-36 (2008)", "doi": "10.1016/j.semcancer.2008.09.003"}, {"pmid": "21040832", "authors": "  Cai Q, Verma SC, Lu J, Robertson ES", "title": "Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis.", "journal": "Adv Virus Res 78:87-142 (2010)", "doi": "10.1016/B978-0-12-385032-4.00003-3"}, {"pmid": "16760382", "authors": "  Rezaee SA, Cunningham C, Davison AJ, Blackbourn DJ", "title": "Kaposi's sarcoma-associated herpesvirus immune modulation: an overview.", "journal": "J Gen Virol 87:1781-804 (2006)", "doi": "10.1099/vir.0.81919-0"}, {"pmid": "19230674", "authors": "  Areste C, Blackbourn DJ", "title": "Modulation of the immune system by Kaposi's sarcoma-associated herpesvirus.", "journal": "Trends Microbiol 17:119-29 (2009)", "doi": "10.1016/j.tim.2008.12.001"}, {"pmid": "16905191", "authors": "  Mark L, Spiller OB, Villoutreix BO, Blom AM", "title": "Kaposi's sarcoma-associated herpes virus complement control protein: KCP--complement inhibition and more.", "journal": "Mol Immunol 44:11-22 (2007)", "doi": "10.1016/j.molimm.2006.06.018"}, {"pmid": "11500830", "authors": "  Weber KS, Grone HJ, Rocken M, Klier C, Gu S, Wank R, Proudfoot AE, Nelson PJ, Weber C", "title": "Selective recruitment of Th2-type cells and evasion from a cytotoxic immune response mediated by viral macrophage inhibitory protein-II.", "journal": "Eur J Immunol 31:2458-66 (2001)", "doi": "10.1002/1521-4141(200108)31:8<2458::AID-IMMU2458>3.0.CO;2-L"}, {"pmid": "26431609", "authors": "  Schulz TF, Cesarman E", "title": "Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis.", "journal": "Curr Opin Virol 14:116-28 (2015)", "doi": "10.1016/j.coviro.2015.08.016"}, {"pmid": "10377196", "authors": "  Endres MJ, Garlisi CG, Xiao H, Shan L, Hedrick JA", "title": "The Kaposi's sarcoma-related herpesvirus (KSHV)-encoded chemokine vMIP-I is a specific agonist for the CC chemokine receptor (CCR)8.", "journal": "J Exp Med 189:1993-8 (1999)", "doi": "10.1084/jem.189.12.1993"}, {"pmid": "18434408", "authors": "  Choi YB, Nicholas J", "title": "Autocrine and paracrine promotion of cell survival and virus replication by human herpesvirus 8 chemokines.", "journal": "J Virol 82:6501-13 (2008)", "doi": "10.1128/JVI.02396-07"}, {"pmid": "15692053", "authors": "  McCormick C, Ganem D", "title": "The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs.", "journal": "Science 307:739-41 (2005)", "doi": "10.1126/science.1105779"}, {"pmid": "15967719", "authors": "  Wang HW, Boshoff C", "title": "Linking Kaposi virus to cancer-associated cytokines.", "journal": "Trends Mol Med 11:309-12 (2005)", "doi": "10.1016/j.molmed.2005.06.002"}, {"pmid": "16828973", "authors": "  Jarviluoma A, Ojala PM", "title": "Cell signaling pathways engaged by KSHV.", "journal": "Biochim Biophys Acta 1766:140-58 (2006)", "doi": "10.1016/j.bbcan.2006.05.001"}, {"pmid": "12032073", "authors": "  Wang HW, Sharp TV, Koumi A, Koentges G, Boshoff C", "title": "Characterization of an anti-apoptotic glycoprotein encoded by Kaposi's sarcoma-associated herpesvirus which resembles a spliced variant of human survivin.", "journal": "EMBO J 21:2602-15 (2002)", "doi": "10.1093/emboj/21.11.2602"}, {"pmid": "10510092", "authors": "  Djerbi M, Screpanti V, Catrina AI, Bogen B, Biberfeld P, Grandien A", "title": "The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors.", "journal": "J Exp Med 190:1025-32 (1999)", "doi": "10.1084/jem.190.7.1025"}, {"pmid": "10523854", "authors": "  Chaudhary PM, Jasmin A, Eby MT, Hood L", "title": "Modulation of the NF-kappa B pathway by virally encoded death effector domains-containing proteins.", "journal": "Oncogene 18:5738-46 (1999)", "doi": "10.1038/sj.onc.1202976"}, {"pmid": "12890756", "authors": "  Field N, Low W, Daniels M, Howell S, Daviet L, Boshoff C, Collins M", "title": "KSHV vFLIP binds to IKK-gamma to activate IKK.", "journal": "J Cell Sci 116:3721-8 (2003)", "doi": "10.1242/jcs.00691"}, {"pmid": "20865011", "authors": "  Mesri EA, Cesarman E, Boshoff C", "title": "Kaposi's sarcoma and its associated herpesvirus.", "journal": "Nat Rev Cancer 10:707-19 (2010)", "doi": "10.1038/nrc2888"}, {"pmid": "10799607", "authors": "  Ishido S, Wang C, Lee BS, Cohen GB, Jung JU", "title": "Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins.", "journal": "J Virol 74:5300-9 (2000)", "doi": "10.1128/JVI.74.11.5300-5309.2000"}, {"pmid": "17166914", "authors": "  Li Q, Means R, Lang S, Jung JU", "title": "Downregulation of gamma interferon receptor 1 by Kaposi's sarcoma-associated herpesvirus K3 and K5.", "journal": "J Virol 81:2117-27 (2007)", "doi": "10.1128/JVI.01961-06"}, {"pmid": "18230726", "authors": "  Thomas M, Boname JM, Field S, Nejentsev S, Salio M, Cerundolo V, Wills M, Lehner PJ", "title": "Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity.", "journal": "Proc Natl Acad Sci U S A 105:1656-61 (2008)", "doi": "10.1073/pnas.0707883105"}, {"pmid": "11413168", "authors": "  Coscoy L, Ganem D", "title": "A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation.", "journal": "J Clin Invest 107:1599-606 (2001)", "doi": "10.1172/JCI12432"}, {"pmid": "24710493", "authors": "  Pratt ZL, Sugden B", "title": "How human tumor viruses make use of autophagy.", "journal": "Cells 1:617-30 (2012)", "doi": "10.3390/cells1030617"}, {"pmid": "10354594", "authors": "  Schulz TF, Moore PS", "title": "Kaposi's sarcoma-associated herpesvirus: a new human tumor virus, but how?", "journal": "Trends Microbiol 7:196-200 (1999)", "doi": "10.1016/S0966-842X(99)01495-X"}, {"pmid": "9594662", "authors": "  Moore PS, Chang Y", "title": "Antiviral activity of tumor-suppressor pathways: clues from molecular piracy by KSHV.", "journal": "Trends Genet 14:144-50 (1998)", "doi": "10.1016/S0168-9525(98)01408-5"}, {"pmid": "12770701", "authors": "  Verma SC, Robertson ES", "title": "Molecular biology and pathogenesis of Kaposi sarcoma-associated herpesvirus.", "journal": "FEMS Microbiol Lett 222:155-63 (2003)", "doi": "10.1016/S0378-1097(03)00261-1"}, {"pmid": "11960692", "authors": "  Jenner RG, Boshoff C", "title": "The molecular pathology of Kaposi's sarcoma-associated herpesvirus.", "journal": "Biochim Biophys Acta 1602:1-22 (2002)", "doi": "10.1016/S0304-419X(01)00040-3"}, {"pmid": "15220441", "authors": "  Foster-Cuevas M, Wright GJ, Puklavec MJ, Brown MH, Barclay AN", "title": "Human herpesvirus 8 K14 protein mimics CD200 in down-regulating macrophage activation through CD200 receptor.", "journal": "J Virol 78:7667-76 (2004)", "doi": "10.1128/JVI.78.14.7667-7676.2004"}, {"pmid": "27518127", "authors": "  Abere B, Schulz TF", "title": "KSHV non-structural membrane proteins involved in the activation of intracellular signaling pathways and the pathogenesis of Kaposi's sarcoma.", "journal": "Curr Opin Virol 20:11-19 (2016)", "doi": "10.1016/j.coviro.2016.07.008"}, {"pmid": "15573137", "authors": "  Sodhi A, Montaner S, Gutkind JS", "title": "Viral hijacking of G-protein-coupled-receptor signalling networks.", "journal": "Nat Rev Mol Cell Biol 5:998-1012 (2004)", "doi": "10.1038/nrm1529"}, {"pmid": "17329974", "authors": "  Montaner S", "title": "Akt/TSC/mTOR activation by the KSHV G protein-coupled receptor: emerging insights into the molecular oncogenesis and treatment of Kaposi's sarcoma.", "journal": "Cell Cycle 6:438-43 (2007)", "doi": "10.4161/cc.6.4.3843"}, {"pmid": "23028325", "authors": "  Bala K, Bosco R, Gramolelli S, Haas DA, Kati S, Pietrek M, Havemeier A, Yakushko Y, Singh VV, Dittrich-Breiholz O, Kracht M, Schulz TF", "title": "Kaposi's sarcoma herpesvirus K15 protein contributes to virus-induced angiogenesis by recruiting PLCgamma1 and activating NFAT1-dependent RCAN1 expression.", "journal": "PLoS Pathog 8:e1002927 (2012)", "doi": "10.1371/journal.ppat.1002927"}, {"pmid": "10318948", "authors": "  Lagunoff M, Majeti R, Weiss A, Ganem D", "title": "Deregulated signal transduction by the K1 gene product of Kaposi's sarcoma-associated herpesvirus.", "journal": "Proc Natl Acad Sci U S A 96:5704-9 (1999)", "doi": "10.1073/pnas.96.10.5704"}, {"pmid": "26192396", "authors": "  Sousa-Squiavinato AC, Silvestre RN, Elgui De Oliveira D", "title": "Biology and oncogenicity of the Kaposi sarcoma herpesvirus K1 protein.", "journal": "Rev Med Virol 25:273-85 (2015)", "doi": "10.1002/rmv.1843"}, {"pmid": "25187543", "authors": "  Havemeier A, Gramolelli S, Pietrek M, Jochmann R, Sturzl M, Schulz TF", "title": "Activation of NF-kappaB by the Kaposi's sarcoma-associated herpesvirus K15 protein involves recruitment of the NF-kappaB-inducing kinase, IkappaB kinases, and phosphorylation of p65.", "journal": "J Virol 88:13161-72 (2014)", "doi": "10.1128/JVI.01766-14"}, {"pmid": "17050609", "authors": "  Brinkmann MM, Pietrek M, Dittrich-Breiholz O, Kracht M, Schulz TF", "title": "Modulation of host gene expression by the K15 protein of Kaposi's sarcoma-associated herpesvirus.", "journal": "J Virol 81:42-58 (2007)", "doi": "10.1128/JVI.00648-06"}, {"pmid": "16585191", "authors": "  Wang L, Dittmer DP, Tomlinson CC, Fakhari FD, Damania B", "title": "Immortalization of primary endothelial cells by the K1 protein of Kaposi's sarcoma-associated herpesvirus.", "journal": "Cancer Res 66:3658-66 (2006)", "doi": "10.1158/0008-5472.CAN-05-3680"}, {"pmid": "22521915", "authors": "  Morris VA, Punjabi AS, Wells RC, Wittkopp CJ, Vart R, Lagunoff M", "title": "The KSHV viral IL-6 homolog is sufficient to induce blood to lymphatic endothelial cell differentiation.", "journal": "Virology 428:112-20 (2012)", "doi": "10.1016/j.virol.2012.03.013"}, {"pmid": "25594835", "authors": "  Purushothaman P, Uppal T, Verma SC", "title": "Molecular biology of KSHV lytic reactivation.", "journal": "Viruses 7:116-53 (2015)", "doi": "10.3390/v7010116"}, {"pmid": "14991150", "authors": "  Fujimuro M, Hayward SD", "title": "Manipulation of glycogen-synthase kinase-3 activity in KSHV-associated cancers.", "journal": "J Mol Med (Berl) 82:223-31 (2004)", "doi": "10.1007/s00109-003-0519-7"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04064  NF-kappa B signaling pathway", "hsa04110  Cell cycle", "hsa04115  p53 signaling pathway", "hsa04140  Autophagy - animal", "hsa04144  Endocytosis", "hsa04151  PI3K-Akt signaling pathway", "hsa04210  Apoptosis", "hsa04310  Wnt signaling pathway", "hsa04610  Complement and coagulation cascades", "hsa04620  Toll-like receptor signaling pathway", "hsa04630  JAK-STAT signaling pathway", "hsa04650  Natural killer cell mediated cytotoxicity", "hsa04668  TNF signaling pathway"], "ko_pathway": "ko05167", "genes": ["RAC1", "TP53", "AKT2", "AKT1", "MAPK13", "NRAS", "BAX"]}, {"kegg_id": "hsa05169", "name": "Epstein-Barr virus infection - Homo sapiens (human)", "description": "Epstein-Barr virus (EBV) is a gamma-herpes virus that widely infects human populations predominantly at an early age but remains mostly asymptomatic. EBV has been linked to a wide spectrum of human malignancies, including nasopharyngeal carcinoma and other hematologic cancers, like Hodgkin's lymphoma, Burkitt's lymphoma (BL), B-cell immunoblastic lymphoma in HIV patients, and posttransplant-associated lymphoproliferative diseases.  EBV has the unique ability to establish life-long latent infection in primary human B lymphocytes. During latent infection, EBV expresses a small subset of genes, including 6 nuclear antigens (EBNA-1, -2, -3A, -3B, -3C, and -LP), 3 latent membrane proteins (LMP-1, -2A, and -2B), 2 small noncoding RNAs (EBER-1 and 2). On the basis of these latent gene expression, three different latency patterns associated with the types of cancers are recognized.", "class": "Human Diseases; Infectious disease: viral", "pathway_map": "hsa05169  Epstein-Barr virus infection", "network": ["", "ELEMENT   N00223  EBV EBNA1 to p53-mediated transcription", "N00224  EBV EBNALP RBP-Jk-mediated transcription", "N00225  EBV EBNA2 to RBP-Jk-mediated transcription", "N00226  EBV EBNA3A/3B/3C to RBP-Jk-mediated transcription", "N00262  EBV EBNA3C to intrinsic apoptotic pathway", "N00263  EBV EBNA3C to p53-mediated transcription", "N00264  EBV EBNA3C to p27-Cell cycle G1/S", "N00265  EBV LMP1 to NFKB signaling pathway", "N00266  EBV LMP2A to PI3K signaling pathway", "N00466  EBV BPLF1 to TLR2/4-NFKB signaling pathway", "N00467  EBV BPLF1 to TLR2/4-NFKB signaling pathway", "N00468  EBV BPLF1 to TLR2/4-NFKB signaling pathway", "N00470  EBV BGLF4 to RIG-I-like receptor signaling pathway", "N00471  EBV LMP2A/2B to IFN signaling pathway", "N00472  EBV LMP1 to IFN signaling pathway", "N00473  EBV BGLF4 to IFN signaling pathway", "N00474  EBV BHRF1 to intrinsic apoptotic pathway", "N00475  EBV BHRF1 to intrinsic apoptotic pathway", "N00476  EBV BHRF1 to intrinsic apoptotic pathway", "N00477  EBV BHRF1 to crosstalk between extrinsic and intrinsic apoptotic pathways", "N00478  EBV BARF1 to intrinsic apoptotic pathway", "N00479  EBV BNLF2a to antigen processing and presentation by MHC class I molecules", "N00480  EBV BILF1 to antigen processing and presentation by MHC class I molecules", "N00481  EBV BZLF1 to p53-mediated transcription", "N00482  EBV EBNA3C to p27-Cell cycle G1/S", "N00483  EBV EBNA3C to cell cycle G1/S", "N00484  EBV EBNA3C to cell cycle G1/S", "N00485  EBV LMP1 to PI3K signaling pathway", "N00486  EBV LMP1 to Jak-STAT signaling pathway", "N00488  EBV LMP2A to BCR signaling pathway"], "disease": ["H00367  Infectious mononucleosis"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["1380  CR2; complement C3d receptor 2 [KO:K04012]", "930  CD19; CD19 molecule [KO:K06465]", "3108  HLA-DMA; major histocompatibility complex, class II, DM alpha [KO:K06752]", "3109  HLA-DMB; major histocompatibility complex, class II, DM beta [KO:K06752]", "3111  HLA-DOA; major histocompatibility complex, class II, DO alpha [KO:K06752]", "3112  HLA-DOB; major histocompatibility complex, class II, DO beta [KO:K06752]", "3113  HLA-DPA1; major histocompatibility complex, class II, DP alpha 1 [KO:K06752]", "3115  HLA-DPB1; major histocompatibility complex, class II, DP beta 1 [KO:K06752]", "3117  HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 [KO:K06752]", "3118  HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2 [KO:K06752]", "3119  HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 [KO:K06752]", "3122  HLA-DRA; major histocompatibility complex, class II, DR alpha [KO:K06752]", "3123  HLA-DRB1; major histocompatibility complex, class II, DR beta 1 [KO:K06752]", "3125  HLA-DRB3; major histocompatibility complex, class II, DR beta 3 [KO:K06752]", "3126  HLA-DRB4; major histocompatibility complex, class II, DR beta 4 [KO:K06752]", "3127  HLA-DRB5; major histocompatibility complex, class II, DR beta 5 [KO:K06752]", "7097  TLR2; toll like receptor 2 [KO:K10159]", "4615  MYD88; MYD88 innate immune signal transduction adaptor [KO:K04729]", "51135  IRAK4; interleukin 1 receptor associated kinase 4 [KO:K04733] [EC:2.7.11.1]", "3654  IRAK1; interleukin 1 receptor associated kinase 1 [KO:K04730] [EC:2.7.11.1]", "7189  TRAF6; TNF receptor associated factor 6 [KO:K03175] [EC:2.3.2.27]", "10454  TAB1; TGF-beta activated kinase 1 (MAP3K7) binding protein 1 [KO:K04403]", "23118  TAB2; TGF-beta activated kinase 1 (MAP3K7) binding protein 2 [KO:K04404]", "6885  MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO:K04427] [EC:2.7.11.25]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "7124  TNF; tumor necrosis factor [KO:K03156]", "3569  IL6; interleukin 6 [KO:K05405]", "23586  RIGI; RNA sensor RIG-I [KO:K12646] [EC:5.6.2.6]", "57506  MAVS; mitochondrial antiviral signaling protein [KO:K12648]", "7187  TRAF3; TNF receptor associated factor 3 [KO:K03174]", "29110  TBK1; TANK binding kinase 1 [KO:K05410] [EC:2.7.11.10]", "9641  IKBKE; inhibitor of nuclear factor kappa B kinase subunit epsilon [KO:K07211] [EC:2.7.11.10]", "3665  IRF7; interferon regulatory factor 7 [KO:K09447]", "3661  IRF3; interferon regulatory factor 3 [KO:K05411]", "3439  IFNA1; interferon alpha 1 [KO:K05414]", "3440  IFNA2; interferon alpha 2 [KO:K05414]", "3441  IFNA4; interferon alpha 4 [KO:K05414]", "3442  IFNA5; interferon alpha 5 [KO:K05414]", "3443  IFNA6; interferon alpha 6 [KO:K05414]", "3444  IFNA7; interferon alpha 7 [KO:K05414]", "3445  IFNA8; interferon alpha 8 [KO:K05414]", "3446  IFNA10; interferon alpha 10 [KO:K05414]", "3447  IFNA13; interferon alpha 13 [KO:K05414]", "3448  IFNA14; interferon alpha 14 [KO:K05414]", "3449  IFNA16; interferon alpha 16 [KO:K05414]", "3451  IFNA17; interferon alpha 17 [KO:K05414]", "3452  IFNA21; interferon alpha 21 [KO:K05414]", "3456  IFNB1; interferon beta 1 [KO:K05415]", "3454  IFNAR1; interferon alpha and beta receptor subunit 1 [KO:K05130]", "3455  IFNAR2; interferon alpha and beta receptor subunit 2 [KO:K05131]", "3716  JAK1; Janus kinase 1 [KO:K11217] [EC:2.7.10.2]", "7297  TYK2; tyrosine kinase 2 [KO:K11219] [EC:2.7.10.2]", "6772  STAT1; signal transducer and activator of transcription 1 [KO:K11220]", "6773  STAT2; signal transducer and activator of transcription 2 [KO:K11221]", "10379  IRF9; interferon regulatory factor 9 [KO:K04693]", "5610  EIF2AK2; eukaryotic translation initiation factor 2 alpha kinase 2 [KO:K16195] [EC:2.7.11.1]", "4938  OAS1; 2'-5'-oligoadenylate synthetase 1 [KO:K14216] [EC:2.7.7.84]", "4939  OAS2; 2'-5'-oligoadenylate synthetase 2 [KO:K14216] [EC:2.7.7.84]", "4940  OAS3; 2'-5'-oligoadenylate synthetase 3 [KO:K14216] [EC:2.7.7.84]", "3627  CXCL10; C-X-C motif chemokine ligand 10 [KO:K12671]", "9636  ISG15; ISG15 ubiquitin like modifier [KO:K12159]", "355  FAS; Fas cell surface death receptor [KO:K04390]", "8772  FADD; Fas associated via death domain [KO:K02373]", "841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]", "637  BID; BH3 interacting domain death agonist [KO:K04726]", "10018  BCL2L11; BCL2 like 11 [KO:K16341]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "578  BAK1; BCL2 antagonist/killer 1 [KO:K14021]", "54205  CYCS; cytochrome c, somatic [KO:K08738]", "317  APAF1; apoptotic peptidase activating factor 1 [KO:K02084]", "842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "916  CD3E; CD3 epsilon subunit of T-cell receptor complex [KO:K06451]", "917  CD3G; CD3 gamma subunit of T-cell receptor complex [KO:K06452]", "915  CD3D; CD3 delta subunit of T-cell receptor complex [KO:K06450]", "919  CD247; CD247 molecule [KO:K06453]", "5701  PSMC2; proteasome 26S subunit, ATPase 2 [KO:K03061]", "5700  PSMC1; proteasome 26S subunit, ATPase 1 [KO:K03062]", "5704  PSMC4; proteasome 26S subunit, ATPase 4 [KO:K03063]", "5706  PSMC6; proteasome 26S subunit, ATPase 6 [KO:K03064]", "5702  PSMC3; proteasome 26S subunit, ATPase 3 [KO:K03065]", "5705  PSMC5; proteasome 26S subunit, ATPase 5 [KO:K03066]", "5708  PSMD2; proteasome 26S subunit ubiquitin receptor, non-ATPase 2 [KO:K03028]", "5707  PSMD1; proteasome 26S subunit, non-ATPase 1 [KO:K03032]", "5709  PSMD3; proteasome 26S subunit, non-ATPase 3 [KO:K03033]", "5718  PSMD12; proteasome 26S subunit, non-ATPase 12 [KO:K03035]", "5717  PSMD11; proteasome 26S subunit, non-ATPase 11 [KO:K03036]", "9861  PSMD6; proteasome 26S subunit, non-ATPase 6 [KO:K03037]", "5713  PSMD7; proteasome 26S subunit, non-ATPase 7 [KO:K03038]", "5719  PSMD13; proteasome 26S subunit, non-ATPase 13 [KO:K03039]", "5710  PSMD4; proteasome 26S subunit ubiquitin receptor, non-ATPase 4 [KO:K03029]", "10213  PSMD14; proteasome 26S subunit, non-ATPase 14 [KO:K03030]", "5714  PSMD8; proteasome 26S subunit, non-ATPase 8 [KO:K03031]", "11047  ADRM1; ADRM1 26S proteasome ubiquitin receptor [KO:K06691]", "7979  SEM1; SEM1 26S proteasome subunit [KO:K10881]", "6890  TAP1; transporter 1, ATP binding cassette subfamily B member [KO:K05653] [EC:7.4.2.14]", "6891  TAP2; transporter 2, ATP binding cassette subfamily B member [KO:K05654] [EC:7.4.2.14]", "6892  TAPBP; TAP binding protein [KO:K08058]", "2923  PDIA3; protein disulfide isomerase family A member 3 [KO:K08056] [EC:5.3.4.1]", "811  CALR; calreticulin [KO:K08057]", "3105  HLA-A; major histocompatibility complex, class I, A [KO:K06751]", "3106  HLA-B; major histocompatibility complex, class I, B [KO:K06751]", "3107  HLA-C; major histocompatibility complex, class I, C [KO:K06751]", "3134  HLA-F; major histocompatibility complex, class I, F [KO:K06751]", "3135  HLA-G; major histocompatibility complex, class I, G [KO:K06751]", "3133  HLA-E; major histocompatibility complex, class I, E [KO:K06751]", "567  B2M; beta-2-microglobulin [KO:K08055]", "22938  SNW1; SNW domain containing 1 [KO:K06063]", "25942  SIN3A; SIN3 transcription regulator family member A [KO:K11644]", "3065  HDAC1; histone deacetylase 1 [KO:K06067] [EC:3.5.1.98]", "3066  HDAC2; histone deacetylase 2 [KO:K06067] [EC:3.5.1.98]", "9612  NCOR2; nuclear receptor corepressor 2 [KO:K06065]", "8819  SAP30; Sin3A associated protein 30 [KO:K19202]", "79685  SAP30L; SAP30 like [KO:K19202]", "9541  CIR1; corepressor interacting with RBPJ, CIR1 [KO:K06066]", "11317  RBPJL; recombination signal binding protein for immunoglobulin kappa J region like [KO:K06053]", "3516  RBPJ; recombination signal binding protein for immunoglobulin kappa J region [KO:K06053]", "3280  HES1; hes family bHLH transcription factor 1 [KO:K06054]", "2208  FCER2; Fc epsilon receptor II [KO:K06468]", "864  RUNX3; RUNX family transcription factor 3 [KO:K09279]", "4609  MYC; MYC proto-oncogene, bHLH transcription factor [KO:K04377]", "7874  USP7; ubiquitin specific peptidase 7 [KO:K11838] [EC:3.4.19.12]", "4193  MDM2; MDM2 proto-oncogene [KO:K06643] [EC:2.3.2.27]", "7157  TP53; tumor protein p53 [KO:K04451]", "1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]", "1647  GADD45A; growth arrest and DNA damage inducible alpha [KO:K04402]", "4616  GADD45B; growth arrest and DNA damage inducible beta [KO:K04402]", "10912  GADD45G; growth arrest and DNA damage inducible gamma [KO:K04402]", "1643  DDB2; damage specific DNA binding protein 2 [KO:K10140]", "51426  POLK; DNA polymerase kappa [KO:K03511] [EC:2.7.7.7]", "7188  TRAF5; TNF receptor associated factor 5 [KO:K09849]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "9020  MAP3K14; mitogen-activated protein kinase kinase kinase 14 [KO:K04466] [EC:2.7.11.25]", "5971  RELB; RELB proto-oncogene, NF-kB subunit [KO:K09253]", "4791  NFKB2; nuclear factor kappa B subunit 2 [KO:K04469]", "8717  TRADD; TNFRSF1A associated via death domain [KO:K03171]", "4793  NFKBIB; NFKB inhibitor beta [KO:K02581]", "4794  NFKBIE; NFKB inhibitor epsilon [KO:K05872]", "6416  MAP2K4; mitogen-activated protein kinase kinase 4 [KO:K04430] [EC:2.7.12.2]", "5609  MAP2K7; mitogen-activated protein kinase kinase 7 [KO:K04431] [EC:2.7.12.2]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "7186  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]", "8737  RIPK1; receptor interacting serine/threonine kinase 1 [KO:K02861] [EC:2.7.11.1]", "5606  MAP2K3; mitogen-activated protein kinase kinase 3 [KO:K04432] [EC:2.7.12.2]", "5608  MAP2K6; mitogen-activated protein kinase kinase 6 [KO:K04433] [EC:2.7.12.2]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "956  ENTPD3; ectonucleoside triphosphate diphosphohydrolase 3 [KO:K01510] [EC:3.6.1.5]", "377841  ENTPD8; ectonucleoside triphosphate diphosphohydrolase 8 [KO:K01510] [EC:3.6.1.5]", "953  ENTPD1; ectonucleoside triphosphate diphosphohydrolase 1 [KO:K01510] [EC:3.6.1.5]", "958  CD40; CD40 molecule [KO:K03160]", "960  CD44; CD44 molecule (IN blood group) [KO:K06256]", "3683  ITGAL; integrin subunit alpha L [KO:K05718]", "965  CD58; CD58 molecule [KO:K06492]", "3383  ICAM1; intercellular adhesion molecule 1 [KO:K06490]", "7431  VIM; vimentin [KO:K07606]", "7128  TNFAIP3; TNF alpha induced protein 3 [KO:K11859] [EC:3.4.19.12]", "3718  JAK3; Janus kinase 3 [KO:K11218] [EC:2.7.10.2]", "6774  STAT3; signal transducer and activator of transcription 3 [KO:K04692]", "4067  LYN; LYN proto-oncogene, Src family tyrosine kinase [KO:K05854] [EC:2.7.10.2]", "6850  SYK; spleen associated tyrosine kinase [KO:K05855] [EC:2.7.10.2]", "4734  NEDD4; NEDD4 E3 ubiquitin protein ligase [KO:K10591] [EC:2.3.2.26]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "102723407  IGH; immunoglobulin heavy variable 4-38-2-like [KO:K06856]", "695  BTK; Bruton tyrosine kinase [KO:K07370] [EC:2.7.10.2]", "29760  BLNK; B cell linker [KO:K07371]", "5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]", "6502  SKP2; S-phase kinase associated protein 2 [KO:K03875]", "1027  CDKN1B; cyclin dependent kinase inhibitor 1B [KO:K06624]", "595  CCND1; cyclin D1 [KO:K04503]", "894  CCND2; cyclin D2 [KO:K10151]", "896  CCND3; cyclin D3 [KO:K10152]", "1019  CDK4; cyclin dependent kinase 4 [KO:K02089] [EC:2.7.11.22]", "1021  CDK6; cyclin dependent kinase 6 [KO:K02091] [EC:2.7.11.22]", "890  CCNA2; cyclin A2 [KO:K06627]", "8900  CCNA1; cyclin A1 [KO:K06627]", "898  CCNE1; cyclin E1 [KO:K06626]", "9134  CCNE2; cyclin E2 [KO:K06626]", "1017  CDK2; cyclin dependent kinase 2 [KO:K02206] [EC:2.7.11.22]", "5925  RB1; RB transcriptional corepressor 1 [KO:K06618]", "1869  E2F1; E2F transcription factor 1 [KO:K17454]", "1870  E2F2; E2F transcription factor 2 [KO:K09389]", "1871  E2F3; E2F transcription factor 3 [KO:K06620]"], "compound": ["C00076  Calcium cation", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C05981  Phosphatidylinositol-3,4,5-trisphosphate"], "refs": [{"pmid": "15510157", "authors": "  Young LS, Rickinson AB.", "title": "Epstein-Barr virus: 40 years on.", "journal": "Nat Rev Cancer 4:757-68 (2004)", "doi": "10.1038/nrc1452"}, {"pmid": "21372216", "authors": "  Saha A, Robertson ES", "title": "Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes.", "journal": "Clin Cancer Res 17:3056-63 (2011)", "doi": "10.1158/1078-0432.CCR-10-2578"}, {"pmid": "21429244", "authors": "  Ning S", "title": "Innate immune modulation in EBV infection.", "journal": "Herpesviridae 2:1 (2011)", "doi": "10.1186/2042-4280-2-1"}, {"pmid": "28408983", "authors": "  Stanfield BA, Luftig MA", "title": "Recent advances in understanding Epstein-Barr virus.", "journal": "F1000Res 6:386 (2017)", "doi": "10.12688/f1000research.10591.1"}, {"pmid": "24586164", "authors": "  van Gent M, Braem SG, de Jong A, Delagic N, Peeters JG, Boer IG, Moynagh PN, Kremmer E, Wiertz EJ, Ovaa H, Griffin BD, Ressing ME", "title": "Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling.", "journal": "PLoS Pathog 10:e1003960 (2014)", "doi": "10.1371/journal.ppat.1003960"}, {"pmid": "23850008", "authors": "  Rajsbaum R, Garcia-Sastre A", "title": "Viral evasion mechanisms of early antiviral responses involving regulation of ubiquitin pathways.", "journal": "Trends Microbiol 21:421-9 (2013)", "doi": "10.1016/j.tim.2013.06.006"}, {"pmid": "25704559", "authors": "  Hoffmann HH, Schneider WM, Rice CM", "title": "Interferons and viruses: an evolutionary arms race of molecular interactions.", "journal": "Trends Immunol 36:124-38 (2015)", "doi": "10.1016/j.it.2015.01.004"}, {"pmid": "22110506", "authors": "  Spender LC, Inman GJ", "title": "Inhibition of germinal centre apoptotic programmes by epstein-barr virus.", "journal": "Adv Hematol 2011:829525 (2011)", "doi": "10.1155/2011/829525"}, {"pmid": "23303627", "authors": "  Fu Q, He C, Mao ZR", "title": "Epstein-Barr virus interactions with the Bcl-2 protein family and apoptosis in human tumor cells.", "journal": "J Zhejiang Univ Sci B 14:8-24 (2013)", "doi": "10.1631/jzus.B1200189"}, {"pmid": "29116588", "authors": "  Wang Y, Banerjee S, Ding L, Cai C, Wei F, Cai Q", "title": "The regulatory role of protein phosphorylation in human gammaherpesvirus associated cancers.", "journal": "Virol Sin 32:357-368 (2017)", "doi": "10.1007/s12250-017-4081-9"}, {"pmid": "23435233", "authors": "  Melchjorsen J", "title": "Learning from the messengers: innate sensing of viruses and cytokine regulation of immunity - clues for treatments and vaccines.", "journal": "Viruses 5:470-527 (2013)", "doi": "10.3390/v5020470"}, {"pmid": "19498380", "authors": "  Hansen TH, Bouvier M", "title": "MHC class I antigen presentation: learning from viral evasion strategies.", "journal": "Nat Rev Immunol 9:503-13 (2009)", "doi": "10.1038/nri2575"}, {"pmid": "18977445", "authors": "  Ressing ME, Horst D, Griffin BD, Tellam J, Zuo J, Khanna R, Rowe M, Wiertz EJ", "title": "Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.", "journal": "Semin Cancer Biol 18:397-408 (2008)", "doi": "10.1016/j.semcancer.2008.10.008"}, {"pmid": "21146386", "authors": "  Horst D, Verweij MC, Davison AJ, Ressing ME, Wiertz EJ", "title": "Viral evasion of T cell immunity: ancient mechanisms offering new applications.", "journal": "Curr Opin Immunol 23:96-103 (2011)", "doi": "10.1016/j.coi.2010.11.005"}, {"pmid": "27886133", "authors": "  Ghosh Roy S, Robertson ES, Saha A", "title": "Epigenetic Impact on EBV Associated B-Cell Lymphomagenesis.", "journal": "Biomolecules 6:E46 (2016)", "doi": "10.3390/biom6040046"}, {"pmid": "22249143", "authors": "  Dawson CW, Port RJ, Young LS", "title": "The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC).", "journal": "Semin Cancer Biol 22:144-53 (2012)", "doi": "10.1016/j.semcancer.2012.01.004"}, {"pmid": "25613730", "authors": "  Cai Q, Chen K, Young KH", "title": "Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorders.", "journal": "Exp Mol Med 47:e133 (2015)", "doi": "10.1038/emm.2014.105"}, {"pmid": "23793113", "authors": "  Ersing I, Bernhardt K, Gewurz BE", "title": "NF-kappaB and IRF7 pathway activation by Epstein-Barr virus Latent Membrane Protein 1.", "journal": "Viruses 5:1587-606 (2013)", "doi": "10.3390/v5061587"}, {"pmid": "28835489", "authors": "  Wang LW, Jiang S, Gewurz BE", "title": "Epstein-Barr Virus LMP1-Mediated Oncogenicity.", "journal": "J Virol 91:e01718-16 (2017)", "doi": "10.1128/JVI.01718-16"}, {"pmid": "12740915", "authors": "  Mori N, Morishita M, Tsukazaki T, Yamamoto N", "title": "Repression of Smad-dependent transforming growth factor-beta signaling by Epstein-Barr virus latent membrane protein 1 through nuclear factor-kappaB.", "journal": "Int J Cancer 105:661-8 (2003)", "doi": "10.1002/ijc.11146"}, {"pmid": "25873381", "authors": "  Edwards RH, Marquitz AR, Raab-Traub N", "title": "Changes in expression induced by Epstein-Barr Virus LMP1-CTAR1: potential role of bcl3.", "journal": "MBio 6:e00441-15 (2015)", "doi": "10.1128/mBio.00441-15"}, {"pmid": "11905817", "authors": "  Thorley-Lawson DA", "title": "Epstein-Barr virus: exploiting the immune system.", "journal": "Nat Rev Immunol 1:75-82 (2001)", "doi": "10.1038/35095584"}, {"pmid": "11669605", "authors": "  Eliopoulos AG, Young LS", "title": "LMP1 structure and signal transduction.", "journal": "Semin Cancer Biol 11:435-44 (2001)", "doi": "10.1006/scbi.2001.0410"}, {"pmid": "14506283", "authors": "  Holowaty MN, Sheng Y, Nguyen T, Arrowsmith C, Frappier L", "title": "Protein interaction domains of the ubiquitin-specific protease, USP7/HAUSP.", "journal": "J Biol Chem 278:47753-61 (2003)", "doi": "10.1074/jbc.M307200200"}, {"pmid": "25403939", "authors": "  Kang H, Kiess A, Chung CH", "title": "Emerging biomarkers in head and neck cancer in the era of genomics.", "journal": "Nat Rev Clin Oncol 12:11-26 (2015)", "doi": "10.1038/nrclinonc.2014.192"}, {"pmid": "29932446", "authors": "  Tornesello ML, Annunziata C, Tornesello AL, Buonaguro L, Buonaguro FM", "title": "Human Oncoviruses and p53 Tumor Suppressor Pathway Deregulation at the Origin of Human Cancers.", "journal": "Cancers (Basel) 10:E213 (2018)", "doi": "10.3390/cancers10070213"}, {"pmid": "19649319", "authors": "  Sato Y, Kamura T, Shirata N, Murata T, Kudoh A, Iwahori S, Nakayama S, Isomura H, Nishiyama Y, Tsurumi T", "title": "Degradation of phosphorylated p53 by viral protein-ECS E3 ligase complex.", "journal": "PLoS Pathog 5:e1000530 (2009)", "doi": "10.1371/journal.ppat.1000530"}, {"pmid": "19244339", "authors": "  Saha A, Murakami M, Kumar P, Bajaj B, Sims K, Robertson ES", "title": "Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2.", "journal": "J Virol 83:4652-69 (2009)", "doi": "10.1128/JVI.02408-08"}, {"pmid": "19394062", "authors": "  Yi F, Saha A, Murakami M, Kumar P, Knight JS, Cai Q, Choudhuri T, Robertson ES", "title": "Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities.", "journal": "Virology 388:236-47 (2009)", "doi": "10.1016/j.virol.2009.03.027"}, {"pmid": "25635182", "authors": "  Kumar P, Murakami M, Kaul R, Saha A, Cai Q, Robertson ES", "title": "Deregulation of the cell cycle machinery by Epstein-Barr virus nuclear antigen 3C.", "journal": "Future Virol 4:79-91 (2009)", "doi": "10.2217/17460794.4.1.79"}, {"pmid": "10818681", "authors": "  Longnecker R", "title": "Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence?", "journal": "Adv Cancer Res 79:175-200 (2000)", "doi": "10.1016/s0065-230x(00)79006-3"}, {"pmid": "30116721", "authors": "  El-Sharkawy A, Al Zaidan L, Malki A", "title": "Epstein-Barr Virus-Associated Malignancies: Roles of Viral Oncoproteins in Carcinogenesis.", "journal": "Front Oncol 8:265 (2018)", "doi": "10.3389/fonc.2018.00265"}, {"pmid": "12811813", "authors": "  Dolcetti R, Masucci MG", "title": "Epstein-Barr virus: induction and control of cell transformation.", "journal": "J Cell Physiol 196:207-18 (2003)", "doi": "10.1002/jcp.10263"}], "rel_pathway": ["hsa03050  Proteasome", "hsa04010  MAPK signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04064  NF-kappa B signaling pathway", "hsa04110  Cell cycle", "hsa04115  p53 signaling pathway", "hsa04210  Apoptosis", "hsa04612  Antigen processing and presentation", "hsa04620  Toll-like receptor signaling pathway", "hsa04622  RIG-I-like receptor signaling pathway", "hsa04630  JAK-STAT signaling pathway", "hsa04662  B cell receptor signaling pathway"], "ko_pathway": "ko05169", "genes": ["RAC1", "TP53", "CD44", "AKT2", "AKT1", "MAPK13", "BAX"]}, {"kegg_id": "hsa05170", "name": "Human immunodeficiency virus 1 infection - Homo sapiens (human)", "description": "Human immunodeficiency virus type 1 (HIV-1) , the causative agent of AIDS (acquired immunodeficiency syndrome), is a lentivirus belonging to the Retroviridae family. The primary cell surface receptor for HIV-1, the CD4 protein, and the co-receptor for HIV-1, either CCR5 or CXCR4, are found on macrophages and T lymphocytes. At the earliest step, sequential binding of virus envelope (Env) glycoprotein gp120 to CD4 and the co-receptor CCR5 or CXCR4 facilitates HIV-1 entry and has the potential to trigger critical signaling that may favor viral replication. At advanced stages of the disease, HIV-1 infection results in dramatic induction of T-cell (CD4+ T and CD8+ T cell) apoptosis both in infected and uninfected bystander T cells, a hallmark of HIV-1 pathogenesis. On the contrary, macrophages are resistant to the cytopathic effect of HIV-1 and produce virus for longer periods of time.", "class": "Human Diseases; Infectious disease: viral", "pathway_map": "hsa05170  Human immunodeficiency virus 1 infection", "network": ["", "ELEMENT   N00431  HIV gp120 to CXCR4-GNAI-PI3K-BAD signaling pathway", "N00432  HIV gp120 to CXCR4-GNAQ-PLCB/G-calcineurin", "N00434  HIV gp120 to CXCR4-GNB/G-RAC signaling pathway", "N00436  HIV Tat to TLR2/4-NFKB signaling pathway", "N00437  HIV Vpu to TLR2/4-NFKB signaling pathway", "N00439  HIV Nef to TLR2/4-MAPK signaling pathway", "N00440  HIV Vpu/Vif/Vpr to cGAS-STING signaling pathway", "N00441  HIV gp120 to TNF-NFKB signaling pathway", "N00442  HIV Nef to TNF-NFKB signaling pathway", "N00443  HIV Vpr/Nef/Tat to TNF-NFKB signaling pathway", "N00445  HIV Tat/Nef to TNF-p38 signaling pathway", "N00447  HIV Vpr/Tat to TNF-JNK signaling pathway", "N00448  HIV Tat/Nef to crosstalk between extrinsic and intrinsic apoptotic pathways", "N00449  HIV Tat/Nef to crosstalk between extrinsic and intrinsic apoptotic pathways", "N00450  HIV Tat to intrinsic apoptotic pathway", "N00451  HIV Tat to intrinsic apoptotic pathway", "N00452  HIV Nef to intrinsic apoptotic pathway", "N00453  HIV Vpr to intrinsic apoptotic pathway", "N00454  HIV Vpr to intrinsic apoptotic pathway", "N00456  HIV Vpr to CDC25-cell cycle G2M", "N00457  HIV Vpr to cell cycle G2M", "N00458  HIV Vpr to CDC25-cell cycle G2M", "N00460  HIV Vpr to WEE1-cell cycle G2M", "N00461  HIV Nef to antigen processing and presentation by MHC class I molecules"], "disease": ["H00406  Acquired immunodeficiency syndrome (AIDS)", "H01563  HIV infection"], "drug": ["D06670  Maraviroc (JAN/INN)", "D09575  Ibalizumab (USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["920  CD4; CD4 molecule [KO:K06454]", "8945  BTRC; beta-transducin repeat containing E3 ubiquitin protein ligase [KO:K03362]", "23291  FBXW11; F-box and WD repeat domain containing 11 [KO:K03362]", "6500  SKP1; S-phase kinase associated protein 1 [KO:K03094]", "8454  CUL1; cullin 1 [KO:K03347]", "9978  RBX1; ring-box 1 [KO:K03868] [EC:2.3.2.32]", "7852  CXCR4; C-X-C motif chemokine receptor 4 [KO:K04189]", "1234  CCR5; C-C motif chemokine receptor 5 [KO:K04180]", "2770  GNAI1; G protein subunit alpha i1 [KO:K04630]", "2773  GNAI3; G protein subunit alpha i3 [KO:K04630]", "2771  GNAI2; G protein subunit alpha i2 [KO:K04630]", "2775  GNAO1; G protein subunit alpha o1 [KO:K04534]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5747  PTK2; protein tyrosine kinase 2 [KO:K05725] [EC:2.7.10.2]", "2185  PTK2B; protein tyrosine kinase 2 beta [KO:K05871] [EC:2.7.10.2]", "5829  PXN; paxillin [KO:K05760]", "1398  CRK; CRK proto-oncogene, adaptor protein [KO:K04438]", "1399  CRKL; CRK like proto-oncogene, adaptor protein [KO:K04438]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "6198  RPS6KB1; ribosomal protein S6 kinase B1 [KO:K04688] [EC:2.7.11.1]", "6199  RPS6KB2; ribosomal protein S6 kinase B2 [KO:K04688] [EC:2.7.11.1]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "2776  GNAQ; G protein subunit alpha q [KO:K04634]", "2767  GNA11; G protein subunit alpha 11 [KO:K04635]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "810  CALML3; calmodulin like 3 [KO:K02183]", "805  CALM2; calmodulin 2 [KO:K02183]", "808  CALM3; calmodulin 3 [KO:K02183]", "801  CALM1; calmodulin 1 [KO:K02183]", "163688  CALML6; calmodulin like 6 [KO:K02183]", "51806  CALML5; calmodulin like 5 [KO:K02183]", "91860  CALML4; calmodulin like 4 [KO:K02183]", "5530  PPP3CA; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]", "5532  PPP3CB; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]", "5533  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]", "5534  PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]", "5535  PPP3R2; protein phosphatase 3 regulatory subunit B, beta [KO:K06268]", "4772  NFATC1; nuclear factor of activated T cells 1 [KO:K04446]", "4773  NFATC2; nuclear factor of activated T cells 2 [KO:K17332]", "4775  NFATC3; nuclear factor of activated T cells 3 [KO:K17333]", "4776  NFATC4; nuclear factor of activated T cells 4 [KO:K17334]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "2782  GNB1; G protein subunit beta 1 [KO:K04536]", "2783  GNB2; G protein subunit beta 2 [KO:K04537]", "2784  GNB3; G protein subunit beta 3 [KO:K07825]", "59345  GNB4; G protein subunit beta 4 [KO:K04538]", "10681  GNB5; G protein subunit beta 5 [KO:K04539]", "54331  GNG2; G protein subunit gamma 2 [KO:K07826]", "2785  GNG3; G protein subunit gamma 3 [KO:K04540]", "2786  GNG4; G protein subunit gamma 4 [KO:K04541]", "2787  GNG5; G protein subunit gamma 5 [KO:K04542]", "2788  GNG7; G protein subunit gamma 7 [KO:K04543]", "94235  GNG8; G protein subunit gamma 8 [KO:K04544]", "2790  GNG10; G protein subunit gamma 10 [KO:K04545]", "2791  GNG11; G protein subunit gamma 11 [KO:K04546]", "55970  GNG12; G protein subunit gamma 12 [KO:K04347]", "51764  GNG13; G protein subunit gamma 13 [KO:K04547]", "2792  GNGT1; G protein subunit gamma transducin 1 [KO:K04548]", "2793  GNGT2; G protein subunit gamma transducin 2 [KO:K04549]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "5880  RAC2; Rac family small GTPase 2 [KO:K07860]", "5881  RAC3; Rac family small GTPase 3 [KO:K07861]", "5058  PAK1; p21 (RAC1) activated kinase 1 [KO:K04409] [EC:2.7.11.1]", "5062  PAK2; p21 (RAC1) activated kinase 2 [KO:K04410] [EC:2.7.11.1]", "5063  PAK3; p21 (RAC1) activated kinase 3 [KO:K05733] [EC:2.7.11.1]", "10298  PAK4; p21 (RAC1) activated kinase 4 [KO:K05734] [EC:2.7.11.1]", "57144  PAK5; p21 (RAC1) activated kinase 5 [KO:K05736] [EC:2.7.11.1]", "56924  PAK6; p21 (RAC1) activated kinase 6 [KO:K05735] [EC:2.7.11.1]", "106821730  BUB1B-PAK6; BUB1B-PAK6 readthrough [KO:K05735] [EC:2.7.11.1]", "3984  LIMK1; LIM domain kinase 1 [KO:K05743] [EC:2.7.11.1]", "3985  LIMK2; LIM domain kinase 2 [KO:K05744] [EC:2.7.11.1]", "1072  CFL1; cofilin 1 [KO:K05765]", "1073  CFL2; cofilin 2 [KO:K05765]", "7124  TNF; tumor necrosis factor [KO:K03156]", "7133  TNFRSF1B; TNF receptor superfamily member 1B [KO:K05141]", "598  BCL2L1; BCL2 like 1 [KO:K04570]", "7097  TLR2; toll like receptor 2 [KO:K10159]", "7099  TLR4; toll like receptor 4 [KO:K10160]", "4615  MYD88; MYD88 innate immune signal transduction adaptor [KO:K04729]", "51135  IRAK4; interleukin 1 receptor associated kinase 4 [KO:K04733] [EC:2.7.11.1]", "3654  IRAK1; interleukin 1 receptor associated kinase 1 [KO:K04730] [EC:2.7.11.1]", "7189  TRAF6; TNF receptor associated factor 6 [KO:K03175] [EC:2.3.2.27]", "10454  TAB1; TGF-beta activated kinase 1 (MAP3K7) binding protein 1 [KO:K04403]", "23118  TAB2; TGF-beta activated kinase 1 (MAP3K7) binding protein 2 [KO:K04404]", "6885  MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO:K04427] [EC:2.7.11.25]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "3439  IFNA1; interferon alpha 1 [KO:K05414]", "3440  IFNA2; interferon alpha 2 [KO:K05414]", "3441  IFNA4; interferon alpha 4 [KO:K05414]", "3442  IFNA5; interferon alpha 5 [KO:K05414]", "3443  IFNA6; interferon alpha 6 [KO:K05414]", "3444  IFNA7; interferon alpha 7 [KO:K05414]", "3445  IFNA8; interferon alpha 8 [KO:K05414]", "3446  IFNA10; interferon alpha 10 [KO:K05414]", "3447  IFNA13; interferon alpha 13 [KO:K05414]", "3448  IFNA14; interferon alpha 14 [KO:K05414]", "3449  IFNA16; interferon alpha 16 [KO:K05414]", "3451  IFNA17; interferon alpha 17 [KO:K05414]", "3452  IFNA21; interferon alpha 21 [KO:K05414]", "3456  IFNB1; interferon beta 1 [KO:K05415]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "115004  CGAS; cyclic GMP-AMP synthase [KO:K17834] [EC:2.7.7.86]", "340061  STING1; stimulator of interferon response cGAMP interactor 1 [KO:K12654]", "29110  TBK1; TANK binding kinase 1 [KO:K05410] [EC:2.7.11.10]", "3661  IRF3; interferon regulatory factor 3 [KO:K05411]", "164668  APOBEC3H; apolipoprotein B mRNA editing enzyme catalytic subunit 3H [KO:K18750] [EC:3.5.4.-]", "200316  APOBEC3F; apolipoprotein B mRNA editing enzyme catalytic subunit 3F [KO:K18750] [EC:3.5.4.-]", "100913187  APOBEC3A_B; APOBEC3A and APOBEC3B deletion hybrid [KO:K18750] [EC:3.5.4.-]", "140564  APOBEC3D; apolipoprotein B mRNA editing enzyme catalytic subunit 3D [KO:K18750] [EC:3.5.4.-]", "200315  APOBEC3A; apolipoprotein B mRNA editing enzyme catalytic subunit 3A [KO:K18750] [EC:3.5.4.-]", "27350  APOBEC3C; apolipoprotein B mRNA editing enzyme catalytic subunit 3C [KO:K18750] [EC:3.5.4.-]", "60489  APOBEC3G; apolipoprotein B mRNA editing enzyme catalytic subunit 3G [KO:K18750] [EC:3.5.4.-]", "9582  APOBEC3B; apolipoprotein B mRNA editing enzyme catalytic subunit 3B [KO:K18750] [EC:3.5.4.-]", "25939  SAMHD1; SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1 [KO:K22544] [EC:3.1.5.-]", "85363  TRIM5; tripartite motif containing 5 [KO:K10648] [EC:2.3.2.27]", "684  BST2; bone marrow stromal cell antigen 2 [KO:K06731]", "7132  TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158]", "8737  RIPK1; receptor interacting serine/threonine kinase 1 [KO:K02861] [EC:2.7.11.1]", "8717  TRADD; TNFRSF1A associated via death domain [KO:K03171]", "7188  TRAF5; TNF receptor associated factor 5 [KO:K09849]", "7186  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]", "5606  MAP2K3; mitogen-activated protein kinase kinase 3 [KO:K04432] [EC:2.7.12.2]", "5608  MAP2K6; mitogen-activated protein kinase kinase 6 [KO:K04433] [EC:2.7.12.2]", "5609  MAP2K7; mitogen-activated protein kinase kinase 7 [KO:K04431] [EC:2.7.12.2]", "356  FASLG; Fas ligand [KO:K04389]", "355  FAS; Fas cell surface death receptor [KO:K04390]", "8772  FADD; Fas associated via death domain [KO:K02373]", "841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]", "637  BID; BH3 interacting domain death agonist [KO:K04726]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "578  BAK1; BCL2 antagonist/killer 1 [KO:K14021]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]", "54205  CYCS; cytochrome c, somatic [KO:K08738]", "842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "916  CD3E; CD3 epsilon subunit of T-cell receptor complex [KO:K06451]", "917  CD3G; CD3 gamma subunit of T-cell receptor complex [KO:K06452]", "915  CD3D; CD3 delta subunit of T-cell receptor complex [KO:K06450]", "919  CD247; CD247 molecule [KO:K06453]", "6890  TAP1; transporter 1, ATP binding cassette subfamily B member [KO:K05653] [EC:7.4.2.14]", "6891  TAP2; transporter 2, ATP binding cassette subfamily B member [KO:K05654] [EC:7.4.2.14]", "6892  TAPBP; TAP binding protein [KO:K08058]", "2923  PDIA3; protein disulfide isomerase family A member 3 [KO:K08056] [EC:5.3.4.1]", "811  CALR; calreticulin [KO:K08057]", "3105  HLA-A; major histocompatibility complex, class I, A [KO:K06751]", "3106  HLA-B; major histocompatibility complex, class I, B [KO:K06751]", "3107  HLA-C; major histocompatibility complex, class I, C [KO:K06751]", "3134  HLA-F; major histocompatibility complex, class I, F [KO:K06751]", "3135  HLA-G; major histocompatibility complex, class I, G [KO:K06751]", "3133  HLA-E; major histocompatibility complex, class I, E [KO:K06751]", "162  AP1B1; adaptor related protein complex 1 subunit beta 1 [KO:K12392]", "164  AP1G1; adaptor related protein complex 1 subunit gamma 1 [KO:K12391]", "8906  AP1G2; adaptor related protein complex 1 subunit gamma 2 [KO:K12391]", "8907  AP1M1; adaptor related protein complex 1 subunit mu 1 [KO:K12393]", "10053  AP1M2; adaptor related protein complex 1 subunit mu 2 [KO:K12393]", "1174  AP1S1; adaptor related protein complex 1 subunit sigma 1 [KO:K12394]", "8905  AP1S2; adaptor related protein complex 1 subunit sigma 2 [KO:K12394]", "130340  AP1S3; adaptor related protein complex 1 subunit sigma 3 [KO:K12395]", "567  B2M; beta-2-microglobulin [KO:K08055]", "6923  ELOB; elongin B [KO:K03873]", "6921  ELOC; elongin C [KO:K03872]", "8065  CUL5; cullin 5 [KO:K10612]", "9616  RNF7; ring finger protein 7 [KO:K10611]", "9730  DCAF1; DDB1 and CUL4 associated factor 1 [KO:K11789] [EC:2.7.11.1]", "1642  DDB1; damage specific DNA binding protein 1 [KO:K10610]", "8450  CUL4B; cullin 4B [KO:K10609]", "8451  CUL4A; cullin 4A [KO:K10609]", "472  ATM; ATM serine/threonine kinase [KO:K04728] [EC:2.7.11.1]", "545  ATR; ATR serine/threonine kinase [KO:K06640] [EC:2.7.11.1]", "1111  CHEK1; checkpoint kinase 1 [KO:K02216] [EC:2.7.11.1]", "995  CDC25C; cell division cycle 25C [KO:K05867] [EC:3.1.3.48]", "7465  WEE1; WEE1 G2 checkpoint kinase [KO:K06632] [EC:2.7.11.1]", "494551  WEE2; WEE2 oocyte meiosis inhibiting kinase [KO:K06632] [EC:2.7.11.1]", "891  CCNB1; cyclin B1 [KO:K05868]", "9133  CCNB2; cyclin B2 [KO:K21770]", "85417  CCNB3; cyclin B3 [KO:K21771]", "983  CDK1; cyclin dependent kinase 1 [KO:K02087] [EC:2.7.11.22 2.7.11.23]"], "compound": ["C00076  Calcium cation", "C00165  Diacylglycerol", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C05981  Phosphatidylinositol-3,4,5-trisphosphate", "C20640  Cyclic GMP-AMP"], "refs": [{"pmid": "22749173", "authors": "  Evans VA, Khoury G, Saleh S, Cameron PU, Lewin SR", "title": "HIV persistence: chemokines and their signalling pathways.", "journal": "Cytokine Growth Factor Rev 23:151-7 (2012)", "doi": "10.1016/j.cytogfr.2012.05.002"}, {"pmid": "23806647", "authors": "  Abbas W, Herbein G", "title": "Plasma membrane signaling in HIV-1 infection.", "journal": "Biochim Biophys Acta 1838:1132-42 (2014)", "doi": "10.1016/j.bbamem.2013.06.020"}, {"pmid": "20041213", "authors": "  Wu Y, Yoder A", "title": "Chemokine coreceptor signaling in HIV-1 infection and pathogenesis.", "journal": "PLoS Pathog 5:e1000520 (2009)", "doi": "10.1371/journal.ppat.1000520"}, {"pmid": "22085380", "authors": "  Choi WT, Duggineni S, Xu Y, Huang Z, An J", "title": "Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4).", "journal": "J Med Chem 55:977-94 (2012)", "doi": "10.1021/jm200568c"}, {"pmid": "21321123", "authors": "  Vorster PJ, Guo J, Yoder A, Wang W, Zheng Y, Xu X, Yu D, Spear M, Wu Y", "title": "LIM kinase 1 modulates cortical actin and CXCR4 cycling and is activated by HIV-1 to initiate viral infection.", "journal": "J Biol Chem 286:12554-64 (2011)", "doi": "10.1074/jbc.M110.182238"}, {"pmid": "24822052", "authors": "  Roy N, Pacini G, Berlioz-Torrent C, Janvier K", "title": "Mechanisms underlying HIV-1 Vpu-mediated viral egress.", "journal": "Front Microbiol 5:177 (2014)", "doi": "10.3389/fmicb.2014.00177"}, {"pmid": "22090097", "authors": "  Magadan JG, Bonifacino JS", "title": "Transmembrane domain determinants of CD4 Downregulation by HIV-1 Vpu.", "journal": "J Virol 86:757-72 (2012)", "doi": "10.1128/JVI.05933-11"}, {"pmid": "26056579", "authors": "  Kumar A, Herbein G", "title": "The macrophage: a therapeutic target in HIV-1 infection.", "journal": "Mol Cell Ther 2:10 (2014)", "doi": "10.1186/2052-8426-2-10"}, {"pmid": "20672047", "authors": "  Yokota S, Okabayashi T, Fujii N", "title": "The battle between virus and host: modulation of Toll-like receptor signaling pathways by virus infection.", "journal": "Mediators Inflamm 2010:184328 (2010)", "doi": "10.1155/2010/184328"}, {"pmid": "26628325", "authors": "  Sauter D, Kirchhoff F", "title": "HIV replication: a game of hide and sense.", "journal": "Curr Opin HIV AIDS 11:173-81 (2016)", "doi": "10.1097/COH.0000000000000233"}, {"pmid": "25988887", "authors": "  Altfeld M, Gale M Jr", "title": "Innate immunity against HIV-1 infection.", "journal": "Nat Immunol 16:554-62 (2015)", "doi": "10.1038/ni.3157"}, {"pmid": "28358311", "authors": "  Pasquereau S, Kumar A, Herbein G", "title": "Targeting TNF and TNF Receptor Pathway in HIV-1 Infection: from Immune Activation to Viral Reservoirs.", "journal": "Viruses 9:E64 (2017)", "doi": "10.3390/v9040064"}, {"pmid": "18178131", "authors": "  Herbein G, Khan KA", "title": "Is HIV infection a TNF receptor signalling-driven disease?", "journal": "Trends Immunol 29:61-7 (2008)", "doi": "10.1016/j.it.2007.10.008"}, {"pmid": "24453421", "authors": "  Kumar A, Abbas W, Herbein G", "title": "TNF and TNF receptor superfamily members in HIV infection: new cellular targets for therapy?", "journal": "Mediators Inflamm 2013:484378 (2013)", "doi": "10.1155/2013/484378"}, {"pmid": "23986795", "authors": "  Abbas W, Herbein G", "title": "T-Cell Signaling in HIV-1 Infection.", "journal": "Open Virol J 7:57-71 (2013)", "doi": "10.2174/1874357920130621001"}, {"pmid": "21368875", "authors": "  Cummins NW, Badley AD", "title": "Mechanisms of HIV-associated lymphocyte apoptosis: 2010.", "journal": "Cell Death Dis 1:e99 (2010)", "doi": "10.1038/cddis.2010.77"}, {"pmid": "12766761", "authors": "  Gougeon ML", "title": "Apoptosis as an HIV strategy to escape immune attack.", "journal": "Nat Rev Immunol 3:392-404 (2003)", "doi": "10.1038/nri1087"}, {"pmid": "21994747", "authors": "  Fevrier M, Dorgham K, Rebollo A", "title": "CD4+ T cell depletion in human immunodeficiency virus (HIV) infection: role of apoptosis.", "journal": "Viruses 3:586-612 (2011)", "doi": "10.3390/v3050586"}, {"pmid": "11237054", "authors": "  Ross TM", "title": "Using death to one's advantage: HIV modulation of apoptosis.", "journal": "Leukemia 15:332-41 (2001)", "doi": "10.1038/sj.leu.2402028"}, {"pmid": "22767237", "authors": "  Hurley JH, Bonifacino JS", "title": "Nef-arious goings-on at the Golgi.", "journal": "Nat Struct Mol Biol 19:661-2 (2012)", "doi": "10.1038/nsmb.2304"}, {"pmid": "21762823", "authors": "  Wonderlich ER, Leonard JA, Collins KL", "title": "HIV immune evasion disruption of antigen presentation by the HIV Nef protein.", "journal": "Adv Virus Res 80:103-27 (2011)", "doi": "10.1016/B978-0-12-385987-7.00005-1"}, {"pmid": "20594957", "authors": "  Laguette N, Bregnard C, Benichou S, Basmaciogullari S", "title": "Human immunodeficiency virus (HIV) type-1, HIV-2 and simian immunodeficiency virus Nef proteins.", "journal": "Mol Aspects Med 31:418-33 (2010)", "doi": "10.1016/j.mam.2010.05.003"}, {"pmid": "27161574", "authors": "  Pereira EA, daSilva LL", "title": "HIV-1 Nef: Taking Control of Protein Trafficking.", "journal": "Traffic 17:976-96 (2016)", "doi": "10.1111/tra.12412"}, {"pmid": "26950141", "authors": "  Sugden SM, Bego MG, Pham TN, Cohen EA", "title": "Remodeling of the Host Cell Plasma Membrane by HIV-1 Nef and Vpu: A Strategy to Ensure Viral Fitness and Persistence.", "journal": "Viruses 8:67 (2016)", "doi": "10.3390/v8030067"}, {"pmid": "24906315", "authors": "  Bagga S, Bouchard MJ", "title": "Cell cycle regulation during viral infection.", "journal": "Methods Mol Biol 1170:165-227 (2014)", "doi": "10.1007/978-1-4939-0888-2_10"}, {"pmid": "15638722", "authors": "  Andersen JL, Planelles V", "title": "The role of Vpr in HIV-1 pathogenesis.", "journal": "Curr HIV Res 3:43-51 (2005)", "doi": "10.2174/1570162052772988"}, {"pmid": "17140287", "authors": "  Andersen JL, DeHart JL, Zimmerman ES, Ardon O, Kim B, Jacquot G, Benichou S, Planelles V", "title": "HIV-1 Vpr-induced apoptosis is cell cycle dependent and requires Bax but not ANT.", "journal": "PLoS Pathog 2:e127 (2006)", "doi": "10.1371/journal.ppat.0020127"}, {"pmid": "23430691", "authors": "  Takaori-Kondo A, Shindo K", "title": "HIV-1 Vif: a guardian of the virus that opens up a new era in the research field of restriction factors.", "journal": "Front Microbiol 4:34 (2013)", "doi": "10.3389/fmicb.2013.00034"}, {"pmid": "19038776", "authors": "  Malim MH", "title": "APOBEC proteins and intrinsic resistance to HIV-1 infection.", "journal": "Philos Trans R Soc Lond B Biol Sci 364:675-87 (2009)", "doi": "10.1098/rstb.2008.0185"}], "rel_pathway": ["hsa03050  Proteasome", "hsa04010  MAPK signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04064  NF-kappa B signaling pathway", "hsa04110  Cell cycle", "hsa04141  Protein processing in endoplasmic reticulum", "hsa04142  Lysosome", "hsa04150  mTOR signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04210  Apoptosis", "hsa04612  Antigen processing and presentation", "hsa04620  Toll-like receptor signaling pathway", "hsa04623  Cytosolic DNA-sensing pathway", "hsa04668  TNF signaling pathway", "hsa04810  Regulation of actin cytoskeleton"], "ko_pathway": "ko05170", "genes": ["RAC1", "CUL1", "AKT2", "AKT1", "MAPK13", "NRAS", "BAX"]}, {"kegg_id": "hsa05203", "name": "Viral carcinogenesis - Homo sapiens (human)", "description": "There is a strong association between viruses and the development of human malignancies. We now know that at least six human viruses, Epstein-Barr virus (EBV), hepatitis B virus (HBV), hepatitis C virus (HCV), human papilloma virus (HPV), human T-cell lymphotropic virus (HTLV-1) and Kaposi's associated sarcoma virus (KSHV) contribute to 10-15% of the cancers worldwide. Via expression of many potent oncoproteins, these tumor viruses promote an aberrant cell-proliferation via modulating cellular cell-signaling pathways and escape from cellular defense system such as blocking apoptosis. Human tumor virus oncoproteins can also disrupt pathways that are necessary for the maintenance of the integrity of host cellular genome. Viruses that encode such activities can contribute to initiation as well as progression of human cancers.", "class": "Human Diseases; Cancer: overview", "pathway_map": "hsa05203  Viral carcinogenesis", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]", "1386  ATF2; activating transcription factor 2 [KO:K04450]", "468  ATF4; activating transcription factor 4 [KO:K04374]", "10488  CREB3; cAMP responsive element binding protein 3 [KO:K09048]", "90993  CREB3L1; cAMP responsive element binding protein 3 like 1 [KO:K09048]", "64764  CREB3L2; cAMP responsive element binding protein 3 like 2 [KO:K09048]", "84699  CREB3L3; cAMP responsive element binding protein 3 like 3 [KO:K09048]", "148327  CREB3L4; cAMP responsive element binding protein 3 like 4 [KO:K09048]", "9586  CREB5; cAMP responsive element binding protein 5 [KO:K09047]", "1388  ATF6B; activating transcription factor 6 beta [KO:K09049]", "1642  DDB1; damage specific DNA binding protein 1 [KO:K10610]", "7534  YWHAZ; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta [KO:K16197]", "7529  YWHAB; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta [KO:K16197]", "10971  YWHAQ; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta [KO:K16197]", "7531  YWHAE; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon [KO:K06630]", "7533  YWHAH; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta [KO:K16198]", "7532  YWHAG; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma [KO:K16198]", "3716  JAK1; Janus kinase 1 [KO:K11217] [EC:2.7.10.2]", "6774  STAT3; signal transducer and activator of transcription 3 [KO:K04692]", "6776  STAT5A; signal transducer and activator of transcription 5A [KO:K11223]", "6777  STAT5B; signal transducer and activator of transcription 5B [KO:K11224]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "3249  HPN; hepsin [KO:K08665] [EC:3.4.21.106]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "5966  REL; REL proto-oncogene, NF-kB subunit [KO:K09254]", "4791  NFKB2; nuclear factor kappa B subunit 2 [KO:K04469]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "7157  TP53; tumor protein p53 [KO:K04451]", "898  CCNE1; cyclin E1 [KO:K06626]", "9134  CCNE2; cyclin E2 [KO:K06626]", "1017  CDK2; cyclin dependent kinase 2 [KO:K02206] [EC:2.7.11.22]", "1959  EGR2; early growth response 2 [KO:K12496]", "1960  EGR3; early growth response 3 [KO:K12497]", "7419  VDAC3; voltage dependent anion channel 3 [KO:K15041]", "4055  LTBR; lymphotoxin beta receptor [KO:K03159]", "6672  SP100; SP100 nuclear antigen [KO:K15413]", "3190  HNRNPK; heterogeneous nuclear ribonucleoprotein K [KO:K12886]", "1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]", "1654  DDX3X; DEAD-box helicase 3 X-linked [KO:K11594] [EC:5.6.2.7]", "5610  EIF2AK2; eukaryotic translation initiation factor 2 alpha kinase 2 [KO:K16195] [EC:2.7.11.1]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "8341  H2BC15; H2B clustered histone 15 [KO:K11252]", "8345  H2BC9; H2B clustered histone 9 [KO:K11252]", "8342  H2BC14; H2B clustered histone 14 [KO:K11252]", "158983  H2BW1; H2B.W histone 1 [KO:K11252]", "255626  H2BC1; H2B clustered histone 1 [KO:K11252]", "440689  H2BC18; H2B clustered histone 18 [KO:K11252]", "8348  H2BC17; H2B clustered histone 17 [KO:K11252]", "3018  H2BC3; H2B clustered histone 3 [KO:K11252]", "8339  H2BC8; H2B clustered histone 8 [KO:K11252]", "8340  H2BC13; H2B clustered histone 13 [KO:K11252]", "8347  H2BC4; H2B clustered histone 4 [KO:K11252]", "3017  H2BC5; H2B clustered histone 5 [KO:K11252]", "8344  H2BC6; H2B clustered histone 6 [KO:K11252]", "8346  H2BC10; H2B clustered histone 10 [KO:K11252]", "8349  H2BC21; H2B clustered histone 21 [KO:K11252]", "8970  H2BC11; H2B clustered histone 11 [KO:K11252]", "85236  H2BC12; H2B clustered histone 12 [KO:K11252]", "128312  H2BC26; H2B clustered histone 26 [KO:K11252]", "8343  H2BC7; H2B clustered histone 7 [KO:K11252]", "286436  H2BW2; H2B.W histone 2 [KO:K11252]", "102724334  histone H2B type F-S-like [KO:K11252]", "114483833  H2BK1; H2B.K variant histone 1 [KO:K11252]", "54145  H2BC12L; H2B clustered histone 12 like [KO:K11252]", "121504  H4C16; H4 histone 16 [KO:K11254]", "554313  H4C15; H4 clustered histone 15 [KO:K11254]", "8294  H4C9; H4 clustered histone 9 [KO:K11254]", "8360  H4C4; H4 clustered histone 4 [KO:K11254]", "8361  H4C6; H4 clustered histone 6 [KO:K11254]", "8362  H4C12; H4 clustered histone 12 [KO:K11254]", "8363  H4C11; H4 clustered histone 11 [KO:K11254]", "8364  H4C3; H4 clustered histone 3 [KO:K11254]", "8365  H4C8; H4 clustered histone 8 [KO:K11254]", "8366  H4C2; H4 clustered histone 2 [KO:K11254]", "8367  H4C5; H4 clustered histone 5 [KO:K11254]", "8368  H4C13; H4 clustered histone 13 [KO:K11254]", "8370  H4C14; H4 clustered histone 14 [KO:K11254]", "8359  H4C1; H4 clustered histone 1 [KO:K11254]", "8369  H4C7; H4 clustered histone 7 [KO:K11254]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "8717  TRADD; TNFRSF1A associated via death domain [KO:K03171]", "983  CDK1; cyclin dependent kinase 1 [KO:K02087] [EC:2.7.11.22 2.7.11.23]", "387332  TBPL2; TATA-box binding protein like 2 [KO:K03120]", "9519  TBPL1; TATA-box binding protein like 1 [KO:K03120]", "6908  TBP; TATA-box binding protein [KO:K03120]", "7874  USP7; ubiquitin specific peptidase 7 [KO:K11838] [EC:3.4.19.12]", "4193  MDM2; MDM2 proto-oncogene [KO:K06643] [EC:2.3.2.27]", "11317  RBPJL; recombination signal binding protein for immunoglobulin kappa J region like [KO:K06053]", "3516  RBPJ; recombination signal binding protein for immunoglobulin kappa J region [KO:K06053]", "22938  SNW1; SNW domain containing 1 [KO:K06063]", "2965  GTF2H1; general transcription factor IIH subunit 1 [KO:K03141]", "2966  GTF2H2; general transcription factor IIH subunit 2 [KO:K03142]", "730394  GTF2H2C_2; GTF2H2 family member C, copy 2 [KO:K03142]", "728340  GTF2H2C; GTF2H2 family member C [KO:K03142]", "2967  GTF2H3; general transcription factor IIH subunit 3 [KO:K03143]", "2968  GTF2H4; general transcription factor IIH subunit 4 [KO:K03144]", "2960  GTF2E1; general transcription factor IIE subunit 1 [KO:K03136]", "2961  GTF2E2; general transcription factor IIE subunit 2 [KO:K03137]", "27044  SND1; staphylococcal nuclease and tudor domain containing 1 [KO:K15979]", "1387  CREBBP; CREB binding protein [KO:K04498] [EC:2.3.1.48]", "2033  EP300; E1A binding protein p300 [KO:K04498] [EC:2.3.1.48]", "2959  GTF2B; general transcription factor IIB [KO:K03124]", "595  CCND1; cyclin D1 [KO:K04503]", "894  CCND2; cyclin D2 [KO:K10151]", "896  CCND3; cyclin D3 [KO:K10152]", "1021  CDK6; cyclin dependent kinase 6 [KO:K02091] [EC:2.7.11.22]", "890  CCNA2; cyclin A2 [KO:K06627]", "8900  CCNA1; cyclin A1 [KO:K06627]", "6502  SKP2; S-phase kinase associated protein 2 [KO:K03875]", "28973  MRPS18B; mitochondrial ribosomal protein S18B [KO:K16174]", "7185  TRAF1; TNF receptor associated factor 1 [KO:K03172]", "7186  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]", "7187  TRAF3; TNF receptor associated factor 3 [KO:K03174]", "7188  TRAF5; TNF receptor associated factor 5 [KO:K09849]", "3718  JAK3; Janus kinase 3 [KO:K11218] [EC:2.7.10.2]", "4067  LYN; LYN proto-oncogene, Src family tyrosine kinase [KO:K05854] [EC:2.7.10.2]", "6850  SYK; spleen associated tyrosine kinase [KO:K05855] [EC:2.7.10.2]", "9114  ATP6V0D1; ATPase H+ transporting V0 subunit d1 [KO:K02146]", "245972  ATP6V0D2; ATPase H+ transporting V0 subunit d2 [KO:K02146]", "7337  UBE3A; ubiquitin protein ligase E3A [KO:K10587] [EC:2.3.2.26]", "1739  DLG1; discs large MAGUK scaffold protein 1 [KO:K12076]", "23513  SCRIB; scribble planar cell polarity protein [KO:K16175]", "5829  PXN; paxillin [KO:K05760]", "578  BAK1; BCL2 antagonist/killer 1 [KO:K14021]", "3661  IRF3; interferon regulatory factor 3 [KO:K05411]", "5700  PSMC1; proteasome 26S subunit, ATPase 1 [KO:K03062]", "5925  RB1; RB transcriptional corepressor 1 [KO:K06618]", "5933  RBL1; RB transcriptional corepressor like 1 [KO:K04681]", "5934  RBL2; RB transcriptional corepressor like 2 [KO:K16332]", "1027  CDKN1B; cyclin dependent kinase inhibitor 1B [KO:K06624]", "23352  UBR4; ubiquitin protein ligase E3 component n-recognin 4 [KO:K10691] [EC:2.3.2.27]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "1108  CHD4; chromodomain helicase DNA binding protein 4 [KO:K11643] [EC:5.6.2.-]", "3065  HDAC1; histone deacetylase 1 [KO:K06067] [EC:3.5.1.98]", "3066  HDAC2; histone deacetylase 2 [KO:K06067] [EC:3.5.1.98]", "8841  HDAC3; histone deacetylase 3 [KO:K11404] [EC:3.5.1.98]", "9759  HDAC4; histone deacetylase 4 [KO:K11406] [EC:3.5.1.98]", "10014  HDAC5; histone deacetylase 5 [KO:K11406] [EC:3.5.1.98]", "10013  HDAC6; histone deacetylase 6 [KO:K11407] [EC:3.5.1.98]", "51564  HDAC7; histone deacetylase 7 [KO:K11408] [EC:3.5.1.98]", "55869  HDAC8; histone deacetylase 8 [KO:K11405] [EC:3.5.1.98]", "9734  HDAC9; histone deacetylase 9 [KO:K11409] [EC:3.5.1.98]", "83933  HDAC10; histone deacetylase 10 [KO:K18671] [EC:3.5.1.98]", "79885  HDAC11; histone deacetylase 11 [KO:K11418] [EC:3.5.1.98]", "5315  PKM; pyruvate kinase M1/2 [KO:K00873] [EC:2.7.1.40]", "10379  IRF9; interferon regulatory factor 9 [KO:K04693]", "9093  DNAJA3; DnaJ heat shock protein family (Hsp40) member A3 [KO:K09504]", "8850  KAT2B; lysine acetyltransferase 2B [KO:K06062] [EC:2.3.1.48]", "2648  KAT2A; lysine acetyltransferase 2A [KO:K06062] [EC:2.3.1.48]", "11036  GTF2A1L; general transcription factor IIA subunit 1 like [KO:K03122]", "2957  GTF2A1; general transcription factor IIA subunit 1 [KO:K03122]", "2958  GTF2A2; general transcription factor IIA subunit 2 [KO:K03123]", "6722  SRF; serum response factor [KO:K04378]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "5922  RASA2; RAS p21 protein activator 2 [KO:K08053]", "998  CDC42; cell division cycle 42 [KO:K04393]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "387  RHOA; ras homolog family member A [KO:K04513]", "2934  GSN; gelsolin [KO:K05768]", "85477  SCIN; scinderin [KO:K05768]", "87  ACTN1; actinin alpha 1 [KO:K05699]", "81  ACTN4; actinin alpha 4 [KO:K05699]", "1019  CDK4; cyclin dependent kinase 4 [KO:K02089] [EC:2.7.11.22]", "1029  CDKN2A; cyclin dependent kinase inhibitor 2A [KO:K06621]", "1030  CDKN2B; cyclin dependent kinase inhibitor 2B [KO:K04685]", "1111  CHEK1; checkpoint kinase 1 [KO:K02216] [EC:2.7.11.1]", "991  CDC20; cell division cycle 20 [KO:K03363]", "8379  MAD1L1; mitotic arrest deficient 1 like 1 [KO:K06679]", "55697  VAC14; VAC14 component of PIKFYVE complex [KO:K15305]", "5902  RANBP1; RAN binding protein 1 [KO:K15306]", "5423  POLB; DNA polymerase beta [KO:K02330] [EC:2.7.7.7 4.2.99.-]", "3665  IRF7; interferon regulatory factor 7 [KO:K09447]", "3572  IL6ST; interleukin 6 cytokine family signal transducer [KO:K05060]", "1234  CCR5; C-C motif chemokine receptor 5 [KO:K04180]", "1237  CCR8; C-C motif chemokine receptor 8 [KO:K04183]", "1232  CCR3; C-C motif chemokine receptor 3 [KO:K04178]", "1233  CCR4; C-C motif chemokine receptor 4 [KO:K04179]", "9261  MAPKAPK2; MAPK activated protein kinase 2 [KO:K04443] [EC:2.7.11.1]", "841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]", "5366  PMAIP1; phorbol-12-myristate-13-acetate-induced protein 1 [KO:K10131]", "718  C3; complement C3 [KO:K03990]", "3105  HLA-A; major histocompatibility complex, class I, A [KO:K06751]", "3106  HLA-B; major histocompatibility complex, class I, B [KO:K06751]", "3107  HLA-C; major histocompatibility complex, class I, C [KO:K06751]", "3134  HLA-F; major histocompatibility complex, class I, F [KO:K06751]", "3135  HLA-G; major histocompatibility complex, class I, G [KO:K06751]", "3133  HLA-E; major histocompatibility complex, class I, E [KO:K06751]"], "refs": [{"pmid": "18201576", "authors": "  McLaughlin-Drubin ME, Munger K", "title": "Viruses associated with human cancer.", "journal": "Biochim Biophys Acta 1782:127-50 (2008)", "doi": "10.1016/j.bbadis.2007.12.005"}, {"pmid": "21102637", "authors": "  Moore PS, Chang Y", "title": "Why do viruses cause cancer? Highlights of the first century of human tumour virology.", "journal": "Nat Rev Cancer 10:878-89 (2010)", "doi": "10.1038/nrc2961"}, {"pmid": "19400863", "authors": "  Kalland KH, Ke XS, Oyan AM", "title": "Tumour virology--history, status and future challenges.", "journal": "APMIS 117:382-99 (2009)", "doi": "10.1111/j.1600-0463.2009.02452.x"}, {"pmid": "17979705", "authors": "  Boccardo E, Villa LL", "title": "Viral origins of human cancer.", "journal": "Curr Med Chem 14:2526-39 (2007)", "doi": "10.2174/092986707782023316"}, {"pmid": "21084867", "authors": "  Saha A, Kaul R, Murakami M, Robertson ES", "title": "Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention.", "journal": "Cancer Biol Ther 10:961-78 (2010)", "doi": "10.4161/cbt.10.10.13923"}, {"pmid": "21152115", "authors": "  Zheng ZM", "title": "Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses.", "journal": "Int J Biol Sci 6:730-55 (2010)", "doi": "10.7150/ijbs.6.730"}, {"pmid": "19956178", "authors": "  Martin D, Gutkind JS", "title": "Human tumor-associated viruses and new insights into the molecular mechanisms of cancer.", "journal": "Oncogene 27 Suppl 2:S31-42 (2008)", "doi": "10.1038/onc.2009.351"}, {"pmid": "16459163", "authors": "  Zhang X, Zhang H, Ye L", "title": "Effects of hepatitis B virus X protein on the development of liver cancer.", "journal": "J Lab Clin Med 147:58-66 (2006)", "doi": "10.1016/j.lab.2005.10.003"}, {"pmid": "12686421", "authors": "  Panteva M, Korkaya H, Jameel S", "title": "Hepatitis viruses and the MAPK pathway: is this a survival strategy?", "journal": "Virus Res 92:131-40 (2003)", "doi": "10.1016/S0168-1702(02)00356-8"}, {"pmid": "21647825", "authors": "  Ng SA, Lee C", "title": "Hepatitis B virus X gene and hepatocarcinogenesis.", "journal": "J Gastroenterol 46:974-90 (2011)", "doi": "10.1007/s00535-011-0415-9"}, {"pmid": "21966251", "authors": "  Nishida N, Goel A", "title": "Genetic and epigenetic signatures in human hepatocellular carcinoma: a systematic review.", "journal": "Curr Genomics 12:130-7 (2011)", "doi": "10.2174/138920211795564359"}, {"pmid": "19854353", "authors": "  Benhenda S, Cougot D, Buendia MA, Neuveut C", "title": "Hepatitis B virus X protein molecular functions and its role in virus life cycle and pathogenesis.", "journal": "Adv Cancer Res 103:75-109 (2009)", "doi": "10.1016/S0065-230X(09)03004-8"}, {"pmid": "18251977", "authors": "  Tan A, Yeh SH, Liu CJ, Cheung C, Chen PJ", "title": "Viral hepatocarcinogenesis: from infection to cancer.", "journal": "Liver Int 28:175-88 (2008)", "doi": "10.1111/j.1478-3231.2007.01652.x"}, {"pmid": "9343405", "authors": "  Klein NP, Schneider RJ", "title": "Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras.", "journal": "Mol Cell Biol 17:6427-36 (1997)", "doi": "10.1128/MCB.17.11.6427"}, {"pmid": "16039586", "authors": "  Ding Q, Xia W, Liu JC, Yang JY, Lee DF, Xia J, Bartholomeusz G, Li Y, Pan Y, Li Z, Bargou RC, Qin J, Lai CC, Tsai FJ, Tsai CH, Hung MC", "title": "Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin.", "journal": "Mol Cell 19:159-70 (2005)", "doi": "10.1016/j.molcel.2005.06.009"}, {"pmid": "21994562", "authors": "  Benhenda S, Cougot D, Neuveut C, Buendia MA", "title": "Liver cell transformation in chronic HBV infection.", "journal": "Viruses 1:630-46 (2009)", "doi": "10.3390/v1030630"}, {"pmid": "11099494", "authors": "  Diao J, Khine AA, Sarangi F, Hsu E, Iorio C, Tibbles LA, Woodgett JR, Penninger J, Richardson CD", "title": "X protein of hepatitis B virus inhibits Fas-mediated apoptosis and is associated with up-regulation of the SAPK/JNK pathway.", "journal": "J Biol Chem 276:8328-40 (2001)", "doi": "10.1074/jbc.M006026200"}, {"pmid": "10824878", "authors": "  Arbuthnot P, Capovilla A, Kew M", "title": "Putative role of hepatitis B virus X protein in hepatocarcinogenesis: effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways.", "journal": "J Gastroenterol Hepatol 15:357-68 (2000)", "doi": "10.1046/j.1440-1746.2000.02069.x"}, {"pmid": "9837909", "authors": "  Gottlob K, Fulco M, Levrero M, Graessmann A", "title": "The hepatitis B virus HBx protein inhibits caspase 3 activity.", "journal": "J Biol Chem 273:33347-53 (1998)", "doi": "10.1074/jbc.273.50.33347"}, {"pmid": "15614436", "authors": "  Zhang JL, Zhao WG, Wu KL, Wang K, Zhang X, Gu CF, Li Y, Zhu Y, Wu JG", "title": "Human hepatitis B virus X protein promotes cell proliferation and inhibits cell apoptosis through interacting with a serine protease Hepsin.", "journal": "Arch Virol 150:721-41 (2005)", "doi": "10.1007/s00705-004-0446-0"}, {"pmid": "15105524", "authors": "  Cooray S", "title": "The pivotal role of phosphatidylinositol 3-kinase-Akt signal transduction in virus survival.", "journal": "J Gen Virol 85:1065-76 (2004)", "doi": "10.1099/vir.0.19771-0"}, {"pmid": "16939421", "authors": "  Mukherji A, Janbandhu VC, Kumar V", "title": "HBx-dependent cell cycle deregulation involves interaction with cyclin E/A-cdk2 complex and destabilization of p27Kip1.", "journal": "Biochem J 401:247-56 (2007)", "doi": "10.1042/BJ20061091"}, {"pmid": "15173177", "authors": "  Yoo YG, Lee MO", "title": "Hepatitis B virus X protein induces expression of Fas ligand gene through enhancing transcriptional activity of early growth response factor.", "journal": "J Biol Chem 279:36242-9 (2004)", "doi": "10.1074/jbc.M401290200"}, {"pmid": "11604508", "authors": "  Waris G, Huh KW, Siddiqui A", "title": "Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress.", "journal": "Mol Cell Biol 21:7721-30 (2001)", "doi": "10.1128/MCB.21.22.7721-7730.2001"}, {"pmid": "17894800", "authors": "  Kasprzak A, Adamek A", "title": "Role of hepatitis C virus proteins (C, NS3, NS5A) in hepatic oncogenesis.", "journal": "Hepatol Res 38:1-26 (2008)", "doi": "10.1111/j.1872-034X.2007.00261.x"}, {"pmid": "9882379", "authors": "  You LR, Chen CM, Lee YH", "title": "Hepatitis C virus core protein enhances NF-kappaB signal pathway triggering by lymphotoxin-beta receptor ligand and tumor necrosis factor alpha.", "journal": "J Virol 73:1672-81 (1999)", "doi": "10.1128/JVI.73.2.1672-1681.1999"}, {"pmid": "16581947", "authors": "  Sato Y, Kato J, Takimoto R, Takada K, Kawano Y, Miyanishi K, Kobune M, Sato Y, Takayama T, Matunaga T, Niitsu Y", "title": "Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor alpha expression via activation of nuclear factor-kappaB.", "journal": "Gut 55:1801-8 (2006)", "doi": "10.1136/gut.2005.070417"}, {"pmid": "14559998", "authors": "  Watashi K, Hijikata M, Tagawa A, Doi T, Marusawa H, Shimotohno K", "title": "Modulation of retinoid signaling by a cytoplasmic viral protein via sequestration of Sp110b, a potent transcriptional corepressor of retinoic acid receptor, from the nucleus.", "journal": "Mol Cell Biol 23:7498-509 (2003)", "doi": "10.1128/MCB.23.21.7498-7509.2003"}, {"pmid": "9651361", "authors": "  Hsieh TY, Matsumoto M, Chou HC, Schneider R, Hwang SB, Lee AS, Lai MM", "title": "Hepatitis C virus core protein interacts with heterogeneous nuclear ribonucleoprotein K.", "journal": "J Biol Chem 273:17651-9 (1998)", "doi": "10.1074/jbc.273.28.17651"}, {"pmid": "10873631", "authors": "  Wang F, Yoshida I, Takamatsu M, Ishido S, Fujita T, Oka K, Hotta H", "title": "Complex formation between hepatitis C virus core protein and p21Waf1/Cip1/Sdi1.", "journal": "Biochem Biophys Res Commun 273:479-84 (2000)", "doi": "10.1006/bbrc.2000.2970"}, {"pmid": "10074132", "authors": "  You LR, Chen CM, Yeh TS, Tsai TY, Mai RT, Lin CH, Lee YH", "title": "Hepatitis C virus core protein interacts with cellular putative RNA helicase.", "journal": "J Virol 73:2841-53 (1999)", "doi": "10.1128/JVI.73.4.2841-2853.1999"}, {"pmid": "10644344", "authors": "  Aoki H, Hayashi J, Moriyama M, Arakawa Y, Hino O", "title": "Hepatitis C virus core protein interacts with 14-3-3 protein and activates the kinase Raf-1.", "journal": "J Virol 74:1736-41 (2000)", "doi": "10.1128/JVI.74.4.1736-1741.2000"}, {"pmid": "17267064", "authors": "  Yan XB, Battaglia S, Boucreux D, Chen Z, Brechot C, Pavio N", "title": "Mapping of the interacting domains of hepatitis C virus core protein and the double-stranded RNA-activated protein kinase PKR.", "journal": "Virus Res 125:79-87 (2007)", "doi": "10.1016/j.virusres.2006.12.010"}, {"pmid": "9060639", "authors": "  Borowski P, Oehlmann K, Heiland M, Laufs R", "title": "Nonstructural protein 3 of hepatitis C virus blocks the distribution of the free catalytic subunit of cyclic AMP-dependent protein kinase.", "journal": "J Virol 71:2838-43 (1997)", "doi": "10.1128/JVI.71.4.2838-2843.1997"}, {"pmid": "10405893", "authors": "  Borowski P, Kuhl R, Laufs R, Schulze zur Wiesch J, Heiland M", "title": "Identification and characterization of a histone binding site of the non-structural protein 3 of hepatitis C virus.", "journal": "J Clin Virol 13:61-9 (1999)", "doi": "10.1016/S1386-6532(99)00007-4"}, {"pmid": "12101418", "authors": "  Lan KH, Sheu ML, Hwang SJ, Yen SH, Chen SY, Wu JC, Wang YJ, Kato N, Omata M, Chang FY, Lee SD", "title": "HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis.", "journal": "Oncogene 21:4801-11 (2002)", "doi": "10.1038/sj.onc.1205589"}, {"pmid": "12925958", "authors": "  Chung YL, Sheu ML, Yen SH", "title": "Hepatitis C virus NS5A as a potential viral Bcl-2 homologue interacts with Bax and inhibits apoptosis in hepatocellular carcinoma.", "journal": "Int J Cancer 107:65-73 (2003)", "doi": "10.1002/ijc.11303"}, {"pmid": "10400746", "authors": "  Gale M Jr, Kwieciszewski B, Dossett M, Nakao H, Katze MG", "title": "Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase.", "journal": "J Virol 73:6506-16 (1999)", "doi": "10.1128/JVI.73.8.6506-6516.1999"}, {"pmid": "12186904", "authors": "  He Y, Nakao H, Tan SL, Polyak SJ, Neddermann P, Vijaysri S, Jacobs BL, Katze MG", "title": "Subversion of cell signaling pathways by hepatitis C virus nonstructural 5A protein via interaction with Grb2 and P85 phosphatidylinositol 3-kinase.", "journal": "J Virol 76:9207-17 (2002)", "doi": "10.1128/JVI.76.18.9207-9217.2002"}, {"pmid": "15795286", "authors": "  Street A, Macdonald A, McCormick C, Harris M", "title": "Hepatitis C virus NS5A-mediated activation of phosphoinositide 3-kinase results in stabilization of cellular beta-catenin and stimulation of beta-catenin-responsive transcription.", "journal": "J Virol 79:5006-16 (2005)", "doi": "10.1128/JVI.79.8.5006-5016.2005"}, {"pmid": "11886269", "authors": "  Majumder M, Ghosh AK, Steele R, Zhou XY, Phillips NJ, Ray R, Ray RB", "title": "Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice.", "journal": "Virology 294:94-105 (2002)", "doi": "10.1006/viro.2001.1309"}, {"pmid": "11278402", "authors": "  Arima N, Kao CY, Licht T, Padmanabhan R, Sasaguri Y, Padmanabhan R", "title": "Modulation of cell growth by the hepatitis C virus nonstructural protein NS5A.", "journal": "J Biol Chem 276:12675-84 (2001)", "doi": "10.1074/jbc.M008329200"}, {"pmid": "12379483", "authors": "  Qadri I, Iwahashi M, Simon F", "title": "Hepatitis C virus NS5A protein binds TBP and p53, inhibiting their DNA binding and p53 interactions with TBP and ERCC3.", "journal": "Biochim Biophys Acta 1592:193-204 (2002)", "doi": "10.1016/S0167-4889(02)00315-4"}, {"pmid": "22110506", "authors": "  Spender LC, Inman GJ", "title": "Inhibition of germinal centre apoptotic programmes by epstein-barr virus.", "journal": "Adv Hematol 2011:829525 (2011)", "doi": "10.1155/2011/829525"}, {"pmid": "20494113", "authors": "  Klein G, Klein E, Kashuba E", "title": "Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes.", "journal": "Biochem Biophys Res Commun 396:67-73 (2010)", "doi": "10.1016/j.bbrc.2010.02.146"}, {"pmid": "21372216", "authors": "  Saha A, Robertson ES", "title": "Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes.", "journal": "Clin Cancer Res 17:3056-63 (2011)", "doi": "10.1158/1078-0432.CCR-10-2578"}, {"pmid": "15510157", "authors": "  Young LS, Rickinson AB.", "title": "Epstein-Barr virus: 40 years on.", "journal": "Nat Rev Cancer 4:757-68 (2004)", "doi": "10.1038/nrc1452"}, {"pmid": "14506283", "authors": "  Holowaty MN, Sheng Y, Nguyen T, Arrowsmith C, Frappier L", "title": "Protein interaction domains of the ubiquitin-specific protease, USP7/HAUSP.", "journal": "J Biol Chem 278:47753-61 (2003)", "doi": "10.1074/jbc.M307200200"}, {"pmid": "11160754", "authors": "  Harada S, Yalamanchili R, Kieff E", "title": "Epstein-Barr virus nuclear protein 2 has at least two N-terminal domains that mediate self-association.", "journal": "J Virol 75:2482-7 (2001)", "doi": "10.1128/JVI.75.5.2482-2487.2001"}, {"pmid": "15452270", "authors": "  Peng CW, Zhao B, Kieff E", "title": "Four EBNA2 domains are important for EBNALP coactivation.", "journal": "J Virol 78:11439-42 (2004)", "doi": "10.1128/JVI.78.20.11439-11442.2004"}, {"pmid": "15767449", "authors": "  Peng R, Moses SC, Tan J, Kremmer E, Ling PD", "title": "The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter.", "journal": "J Virol 79:4492-505 (2005)", "doi": "10.1128/JVI.79.7.4492-4505.2005"}, {"pmid": "21177815", "authors": "  Saha A, Bamidele A, Murakami M, Robertson ES", "title": "EBNA3C attenuates the function of p53 through interaction with inhibitor of growth family proteins 4 and 5.", "journal": "J Virol 85:2079-88 (2011)", "doi": "10.1128/JVI.02279-10"}, {"pmid": "21347341", "authors": "  Saha A, Halder S, Upadhyay SK, Lu J, Kumar P, Murakami M, Cai Q, Robertson ES", "title": "Epstein-Barr virus nuclear antigen 3C facilitates G1-S transition by stabilizing and enhancing the function of cyclin D1.", "journal": "PLoS Pathog 7:e1001275 (2011)", "doi": "10.1371/journal.ppat.1001275"}, {"pmid": "15542638", "authors": "  Knight JS, Sharma N, Kalman DE, Robertson ES", "title": "A cyclin-binding motif within the amino-terminal homology domain of EBNA3C binds cyclin A and modulates cyclin A-dependent kinase activity in Epstein-Barr virus-infected cells.", "journal": "J Virol 78:12857-67 (2004)", "doi": "10.1128/JVI.78.23.12857-12867.2004"}, {"pmid": "14747563", "authors": "  Knight JS, Robertson ES", "title": "Epstein-Barr virus nuclear antigen 3C regulates cyclin A/p27 complexes and enhances cyclin A-dependent kinase activity.", "journal": "J Virol 78:1981-91 (2004)", "doi": "10.1128/JVI.78.4.1981-1991.2004"}, {"pmid": "16352731", "authors": "  Knight JS, Sharma N, Robertson ES", "title": "Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase.", "journal": "Proc Natl Acad Sci U S A 102:18562-6 (2005)", "doi": "10.1073/pnas.0503886102"}, {"pmid": "18391203", "authors": "  Kashuba E, Yurchenko M, Yenamandra SP, Snopok B, Isaguliants M, Szekely L, Klein G", "title": "EBV-encoded EBNA-6 binds and targets MRS18-2 to the nucleus, resulting in the disruption of pRb-E2F1 complexes.", "journal": "Proc Natl Acad Sci U S A 105:5489-94 (2008)", "doi": "10.1073/pnas.0801053105"}, {"pmid": "11091847", "authors": "  Young LS, Dawson CW, Eliopoulos AG", "title": "The expression and function of Epstein-Barr virus encoded latent genes.", "journal": "Mol Pathol 53:238-47 (2000)", "doi": "10.1136/mp.53.5.238"}, {"pmid": "19078975", "authors": "  Kuppers R", "title": "The biology of Hodgkin's lymphoma.", "journal": "Nat Rev Cancer 9:15-27 (2009)", "doi": "10.1038/nrc2542"}, {"pmid": "17049016", "authors": "  Pattle SB, Farrell PJ", "title": "The role of Epstein-Barr virus in cancer.", "journal": "Expert Opin Biol Ther 6:1193-205 (2006)", "doi": "10.1517/14712598.6.11.1193"}, {"pmid": "11905817", "authors": "  Thorley-Lawson DA", "title": "Epstein-Barr virus: exploiting the immune system.", "journal": "Nat Rev Immunol 1:75-82 (2001)", "doi": "10.1038/35095584"}, {"pmid": "11669605", "authors": "  Eliopoulos AG, Young LS", "title": "LMP1 structure and signal transduction.", "journal": "Semin Cancer Biol 11:435-44 (2001)", "doi": "10.1006/scbi.2001.0410"}, {"pmid": "11766888", "authors": "  Dell G, Gaston K", "title": "Human papillomaviruses and their role in cervical cancer.", "journal": "Cell Mol Life Sci 58:1923-42 (2001)", "doi": "10.1007/PL00000827"}, {"pmid": "10793105", "authors": "  zur Hausen H", "title": "Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis.", "journal": "J Natl Cancer Inst 92:690-8 (2000)", "doi": "10.1093/jnci/92.9.690"}, {"pmid": "19156753", "authors": "  Yugawa T, Kiyono T", "title": "Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins.", "journal": "Rev Med Virol 19:97-113 (2009)", "doi": "10.1002/rmv.605"}, {"pmid": "17645777", "authors": "  Narisawa-Saito M, Kiyono T", "title": "Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins.", "journal": "Cancer Sci 98:1505-11 (2007)", "doi": "10.1111/j.1349-7006.2007.00546.x"}, {"pmid": "20592731", "authors": "  Moody CA, Laimins LA", "title": "Human papillomavirus oncoproteins: pathways to transformation.", "journal": "Nat Rev Cancer 10:550-60 (2010)", "doi": "10.1038/nrc2886"}, {"pmid": "15956361", "authors": "  McCance DJ", "title": "Human papillomaviruses and cell signaling.", "journal": "Sci STKE 2005:pe29 (2005)", "doi": "10.1126/stke.2882005pe29"}, {"pmid": "18385245", "authors": "  Wade R, Brimer N, Vande Pol S", "title": "Transformation by bovine papillomavirus type 1 E6 requires paxillin.", "journal": "J Virol 82:5962-6 (2008)", "doi": "10.1128/JVI.02747-07"}, {"pmid": "9374493", "authors": "  Berezutskaya E, Bagchi S", "title": "The human papillomavirus E7 oncoprotein functionally interacts with the S4 subunit of the 26 S proteasome.", "journal": "J Biol Chem 272:30135-40 (1997)", "doi": "10.1074/jbc.272.48.30135"}, {"pmid": "16381817", "authors": "  Zhang B, Chen W, Roman A", "title": "The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation.", "journal": "Proc Natl Acad Sci U S A 103:437-42 (2006)", "doi": "10.1073/pnas.0510012103"}, {"pmid": "12970441", "authors": "  He W, Staples D, Smith C, Fisher C", "title": "Direct activation of cyclin-dependent kinase 2 by human papillomavirus E7.", "journal": "J Virol 77:10566-74 (2003)", "doi": "10.1128/JVI.77.19.10566-10574.2003"}, {"pmid": "9349482", "authors": "  Massimi P, Pim D, Banks L", "title": "Human papillomavirus type 16 E7 binds to the conserved carboxy-terminal region of the TATA box binding protein and this contributes to E7 transforming activity.", "journal": "J Gen Virol 78 ( Pt 10):2607-13 (1997)", "doi": "10.1099/0022-1317-78-10-2607"}, {"pmid": "8617242", "authors": "  Antinore MJ, Birrer MJ, Patel D, Nader L, McCance DJ", "title": "The human papillomavirus type 16 E7 gene product interacts with and trans-activates the AP1 family of transcription factors.", "journal": "EMBO J 15:1950-60 (1996)", "doi": "10.1002/j.1460-2075.1996.tb00546.x"}, {"pmid": "9990017", "authors": "  Zwerschke W, Mazurek S, Massimi P, Banks L, Eigenbrodt E, Jansen-Durr P", "title": "Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein.", "journal": "Proc Natl Acad Sci U S A 96:1291-6 (1999)", "doi": "10.1073/pnas.96.4.1291"}, {"pmid": "17384582", "authors": "  Matsuoka M, Jeang KT", "title": "Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation.", "journal": "Nat Rev Cancer 7:270-80 (2007)", "doi": "10.1038/nrc2111"}, {"pmid": "15310405", "authors": "  Azran I, Schavinsky-Khrapunsky Y, Aboud M", "title": "Role of Tax protein in human T-cell leukemia virus type-I leukemogenicity.", "journal": "Retrovirology 1:20 (2004)", "doi": "10.1186/1742-4690-1-20"}, {"pmid": "12910250", "authors": "  Matsuoka M", "title": "Human T-cell leukemia virus type I and adult T-cell leukemia.", "journal": "Oncogene 22:5131-40 (2003)", "doi": "10.1038/sj.onc.1206551"}, {"pmid": "11244044", "authors": "  Yoshida M", "title": "Multiple viral strategies of HTLV-1 for dysregulation of cell growth control.", "journal": "Annu Rev Immunol 19:475-96 (2001)", "doi": "10.1146/annurev.immunol.19.1.475"}, {"pmid": "18702816", "authors": "  Boxus M, Twizere JC, Legros S, Dewulf JF, Kettmann R, Willems L", "title": "The HTLV-1 Tax interactome.", "journal": "Retrovirology 5:76 (2008)", "doi": "10.1186/1742-4690-5-76"}, {"pmid": "8223437", "authors": "  Caron C, Rousset R, Beraud C, Moncollin V, Egly JM, Jalinot P", "title": "Functional and biochemical interaction of the HTLV-I Tax1 transactivator with TBP.", "journal": "EMBO J 12:4269-78 (1993)", "doi": "10.1002/j.1460-2075.1993.tb06111.x"}, {"pmid": "8756622", "authors": "  Clemens KE, Piras G, Radonovich MF, Choi KS, Duvall JF, DeJong J, Roeder R, Brady JN", "title": "Interaction of the human T-cell lymphotropic virus type 1 tax transactivator with transcription factor IIA.", "journal": "Mol Cell Biol 16:4656-64 (1996)", "doi": "10.1128/MCB.16.9.4656"}, {"pmid": "16036567", "authors": "  Harhaj EW, Harhaj NS", "title": "Mechanisms of persistent NF-kappaB activation by HTLV-I tax.", "journal": "IUBMB Life 57:83-91 (2005)", "doi": "10.1080/15216540500078715"}, {"pmid": "21743832", "authors": "  Qu Z, Xiao G", "title": "Human T-cell lymphotropic virus: a model of NF-kappaB-associated tumorigenesis.", "journal": "Viruses 3:714-49 (2011)", "doi": "10.3390/v3060714"}, {"pmid": "16155601", "authors": "  Kashanchi F, Brady JN", "title": "Transcriptional and post-transcriptional gene regulation of HTLV-1.", "journal": "Oncogene 24:5938-51 (2005)", "doi": "10.1038/sj.onc.1208973"}, {"pmid": "14530271", "authors": "  Wu K, Bottazzi ME, de la Fuente C, Deng L, Gitlin SD, Maddukuri A, Dadgar S, Li H, Vertes A, Pumfery A, Kashanchi F", "title": "Protein profile of tax-associated complexes.", "journal": "J Biol Chem 279:495-508 (2004)", "doi": "10.1074/jbc.M310069200"}, {"pmid": "16155604", "authors": "  Grassmann R, Aboud M, Jeang KT", "title": "Molecular mechanisms of cellular transformation by HTLV-1 Tax.", "journal": "Oncogene 24:5976-85 (2005)", "doi": "10.1038/sj.onc.1208978"}, {"pmid": "16308315", "authors": "  Tabakin-Fix Y, Azran I, Schavinky-Khrapunsky Y, Levy O, Aboud M", "title": "Functional inactivation of p53 by human T-cell leukemia virus type 1 Tax protein: mechanisms and clinical implications.", "journal": "Carcinogenesis 27:673-81 (2006)", "doi": "10.1093/carcin/bgi274"}, {"pmid": "16760382", "authors": "  Rezaee SA, Cunningham C, Davison AJ, Blackbourn DJ", "title": "Kaposi's sarcoma-associated herpesvirus immune modulation: an overview.", "journal": "J Gen Virol 87:1781-804 (2006)", "doi": "10.1099/vir.0.81919-0"}, {"pmid": "17457345", "authors": "  Coscoy L", "title": "Immune evasion by Kaposi's sarcoma-associated herpesvirus.", "journal": "Nat Rev Immunol 7:391-401 (2007)", "doi": "10.1038/nri2076"}, {"pmid": "21040832", "authors": "  Cai Q, Verma SC, Lu J, Robertson ES", "title": "Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis.", "journal": "Adv Virus Res 78:87-142 (2010)", "doi": "10.1016/B978-0-12-385032-4.00003-3"}, {"pmid": "16828973", "authors": "  Jarviluoma A, Ojala PM", "title": "Cell signaling pathways engaged by KSHV.", "journal": "Biochim Biophys Acta 1766:140-58 (2006)", "doi": "10.1016/j.bbcan.2006.05.001"}, {"pmid": "18948197", "authors": "  Liang C, Lee JS, Jung JU", "title": "Immune evasion in Kaposi's sarcoma-associated herpes virus associated oncogenesis.", "journal": "Semin Cancer Biol 18:423-36 (2008)", "doi": "10.1016/j.semcancer.2008.09.003"}, {"pmid": "19715458", "authors": "  Lee HR, Kim MH, Lee JS, Liang C, Jung JU", "title": "Viral interferon regulatory factors.", "journal": "J Interferon Cytokine Res 29:621-7 (2009)", "doi": "10.1089/jir.2009.0067"}, {"pmid": "22566809", "authors": "  Jacobs SR, Damania B", "title": "The Viral Interferon Regulatory Factors of KSHV: Immunosuppressors or Oncogenes?", "journal": "Front Immunol 2:19 (2011)", "doi": "10.3389/fimmu.2011.00019"}, {"pmid": "19651473", "authors": "  Wen KW, Damania B", "title": "Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis.", "journal": "Cancer Lett 289:140-50 (2010)", "doi": "10.1016/j.canlet.2009.07.004"}, {"pmid": "15967719", "authors": "  Wang HW, Boshoff C", "title": "Linking Kaposi virus to cancer-associated cytokines.", "journal": "Trends Mol Med 11:309-12 (2005)", "doi": "10.1016/j.molmed.2005.06.002"}, {"pmid": "15692053", "authors": "  McCormick C, Ganem D", "title": "The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs.", "journal": "Science 307:739-41 (2005)", "doi": "10.1126/science.1105779"}, {"pmid": "12770701", "authors": "  Verma SC, Robertson ES", "title": "Molecular biology and pathogenesis of Kaposi sarcoma-associated herpesvirus.", "journal": "FEMS Microbiol Lett 222:155-63 (2003)", "doi": "10.1016/S0378-1097(03)00261-1"}, {"pmid": "10354594", "authors": "  Schulz TF, Moore PS", "title": "Kaposi's sarcoma-associated herpesvirus: a new human tumor virus, but how?", "journal": "Trends Microbiol 7:196-200 (1999)", "doi": "10.1016/S0966-842X(99)01495-X"}, {"pmid": "10855768", "authors": "  Schulz TF", "title": "Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8): epidemiology and pathogenesis.", "journal": "J Antimicrob Chemother 45 Suppl T3:15-27 (2000)", "doi": "10.1093/jac/45.suppl_4.15"}, {"pmid": "9594662", "authors": "  Moore PS, Chang Y", "title": "Antiviral activity of tumor-suppressor pathways: clues from molecular piracy by KSHV.", "journal": "Trends Genet 14:144-50 (1998)", "doi": "10.1016/S0168-9525(98)01408-5"}, {"pmid": "20534855", "authors": "  Pietrek M, Brinkmann MM, Glowacka I, Enlund A, Havemeier A, Dittrich-Breiholz O, Kracht M, Lewitzky M, Saksela K, Feller SM, Schulz TF", "title": "Role of the Kaposi's sarcoma-associated herpesvirus K15 SH3 binding site in inflammatory signaling and B-cell activation.", "journal": "J Virol 84:8231-40 (2010)", "doi": "10.1128/JVI.01696-09"}, {"pmid": "21421561", "authors": "  Bagneris C, Briggs LC, Savva R, Ebrahimi B, Barrett TE", "title": "Crystal structure of a KSHV-SOX-DNA complex: insights into the molecular mechanisms underlying DNase activity and host shutoff.", "journal": "Nucleic Acids Res 39:5744-56 (2011)", "doi": "10.1093/nar/gkr111"}], "rel_pathway": ["hsa03022  Basal transcription factors", "hsa03320  PPAR signaling pathway", "hsa04010  MAPK signaling pathway", "hsa04062  Chemokine signaling pathway", "hsa04064  NF-kappa B signaling pathway", "hsa04110  Cell cycle", "hsa04115  p53 signaling pathway", "hsa04142  Lysosome", "hsa04151  PI3K-Akt signaling pathway", "hsa04210  Apoptosis", "hsa04630  JAK-STAT signaling pathway", "hsa04662  B cell receptor signaling pathway", "hsa04810  Regulation of actin cytoskeleton", "hsa05160  Hepatitis C", "hsa05161  Hepatitis B", "hsa05165  Human papillomavirus infection", "hsa05166  Human T-cell leukemia virus 1 infection", "hsa05167  Kaposi sarcoma-associated herpesvirus infection", "hsa05169  Epstein-Barr virus infection"], "ko_pathway": "ko05203", "genes": ["RAC1", "TP53", "CHD4", "NRAS", "BAX"]}, {"kegg_id": "hsa05211", "name": "Renal cell carcinoma - Homo sapiens (human)", "description": "Renal cell cancer (RCC) accounts for ~3% of human malignancies and its incidence appears to be rising. Although most cases of RCC seem to occur sporadically, an inherited predisposition to renal cancer accounts for 1-4% of cases. RCC is not a single disease, it has several morphological subtypes. Conventional RCC (clear cell RCC) accounts for ~80% of cases, followed by papillary RCC (10-15%), chromophobe RCC (5%), and collecting duct RCC (<1%). Genes potentially involved in sporadic neoplasms of each particular type are VHL, MET, BHD, and FH respectively. In the absence of VHL, hypoxia-inducible factor alpha (HIF-alpha) accumulates, leading to production of several growth factors, including vascular endothelial growth factor and platelet-derived growth factor. Activated MET mediates a number of biological effects including motility, invasion of extracellular matrix, cellular transformation, prevention of apoptosis and metastasis formation. Loss of functional FH leads to accumulation of fumarate in the cell, triggering inhibition of HPH and preventing targeted pVHL-mediated degradation of HIF-alpha. BHD mutations cause the Birt-Hogg-Dube syndrome and its associated chromophobe, hybrid oncocytic, and conventional (clear cell) RCC.", "class": "Human Diseases; Cancer: specific types", "pathway_map": "hsa05211  Renal cell carcinoma", "network": ["", "ELEMENT   N00005  Mutation-activated MET to RAS-ERK signaling pathway", "N00044  Mutation-activated MET to PI3K signaling pathway", "N00080  Loss of VHL to HIF-1 signaling pathway", "N00081  Mutation-inactivated VHL to HIF-1 signaling pathway"], "disease": ["H00021  Renal cell carcinoma"], "drug": ["D06272  Sorafenib tosylate (USAN)", "D06409  Bevacizumab (USAN)", "D08524  Sorafenib (USAN/INN)", "D10095  Cabozantinib s-malate (USAN)", "D11954  Belzutifan (JAN/USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["3091  HIF1A; hypoxia inducible factor 1 subunit alpha [KO:K08268]", "2034  EPAS1; endothelial PAS domain protein 1 [KO:K09095]", "54583  EGLN1; egl-9 family hypoxia inducible factor 1 [KO:K09592] [EC:1.14.11.29]", "112399  EGLN3; egl-9 family hypoxia inducible factor 3 [KO:K09592] [EC:1.14.11.29]", "112398  EGLN2; egl-9 family hypoxia inducible factor 2 [KO:K09592] [EC:1.14.11.29]", "7428  VHL; von Hippel-Lindau tumor suppressor [KO:K03871]", "6921  ELOC; elongin C [KO:K03872]", "6923  ELOB; elongin B [KO:K03873]", "9978  RBX1; ring-box 1 [KO:K03868] [EC:2.3.2.32]", "8453  CUL2; cullin 2 [KO:K03870]", "405  ARNT; aryl hydrocarbon receptor nuclear translocator [KO:K09097]", "9915  ARNT2; aryl hydrocarbon receptor nuclear translocator 2 [KO:K15589]", "1387  CREBBP; CREB binding protein [KO:K04498] [EC:2.3.1.48]", "2033  EP300; E1A binding protein p300 [KO:K04498] [EC:2.3.1.48]", "6513  SLC2A1; solute carrier family 2 member 1 [KO:K07299]", "7422  VEGFA; vascular endothelial growth factor A [KO:K05448]", "7040  TGFB1; transforming growth factor beta 1 [KO:K13375]", "7042  TGFB2; transforming growth factor beta 2 [KO:K13376]", "7043  TGFB3; transforming growth factor beta 3 [KO:K13377]", "5155  PDGFB; platelet derived growth factor subunit B [KO:K17386]", "7039  TGFA; transforming growth factor alpha [KO:K08774]", "3082  HGF; hepatocyte growth factor [KO:K05460]", "4233  MET; MET proto-oncogene, receptor tyrosine kinase [KO:K05099] [EC:2.7.10.1]", "2549  GAB1; GRB2 associated binding protein 1 [KO:K09593]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]", "1398  CRK; CRK proto-oncogene, adaptor protein [KO:K04438]", "1399  CRKL; CRK like proto-oncogene, adaptor protein [KO:K04438]", "2889  RAPGEF1; Rap guanine nucleotide exchange factor 1 [KO:K06277]", "5906  RAP1A; RAP1A, member of RAS oncogene family [KO:K04353]", "5908  RAP1B; RAP1B, member of RAS oncogene family [KO:K07836]", "5781  PTPN11; protein tyrosine phosphatase non-receptor type 11 [KO:K07293] [EC:3.1.3.48]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "369  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "2113  ETS1; ETS proto-oncogene 1, transcription factor [KO:K02678]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "998  CDC42; cell division cycle 42 [KO:K04393]", "5058  PAK1; p21 (RAC1) activated kinase 1 [KO:K04409] [EC:2.7.11.1]", "5062  PAK2; p21 (RAC1) activated kinase 2 [KO:K04410] [EC:2.7.11.1]", "5063  PAK3; p21 (RAC1) activated kinase 3 [KO:K05733] [EC:2.7.11.1]", "10298  PAK4; p21 (RAC1) activated kinase 4 [KO:K05734] [EC:2.7.11.1]", "57144  PAK5; p21 (RAC1) activated kinase 5 [KO:K05736] [EC:2.7.11.1]", "56924  PAK6; p21 (RAC1) activated kinase 6 [KO:K05735] [EC:2.7.11.1]", "106821730  BUB1B-PAK6; BUB1B-PAK6 readthrough [KO:K05735] [EC:2.7.11.1]", "5546  PRCC; proline rich mitotic checkpoint control factor [KO:K13105]", "7030  TFE3; transcription factor binding to IGHM enhancer 3 [KO:K09105]", "1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]", "2271  FH; fumarate hydratase [KO:K01679] [EC:4.2.1.2]", "201163  FLCN; folliculin [KO:K09594]"], "compound": ["C00007  Oxygen", "C00122  Fumarate", "C00149  (S)-Malate"], "refs": [{"pmid": "16339096", "authors": "  Cohen HT, McGovern FJ.", "title": "Renal-cell carcinoma.", "journal": "N Engl J Med 353:2477-90 (2005)", "doi": "10.1056/NEJMra043172"}, {"pmid": "15122209", "authors": "  Pavlovich CP, Schmidt LS.", "title": "Searching for the hereditary causes of renal-cell carcinoma.", "journal": "Nat Rev Cancer 4:381-93 (2004)", "doi": "10.1038/nrc1364"}, {"pmid": "14634372", "authors": "  Linehan WM, Walther MM, Zbar B.", "title": "The genetic basis of cancer of the kidney.", "journal": "J Urol 170:2163-72 (2003)", "doi": "10.1097/01.ju.0000096060.92397.ed"}, {"pmid": "15611513", "authors": "  Kim WY, Kaelin WG.", "title": "Role of VHL gene mutation in human cancer.", "journal": "J Clin Oncol 22:4991-5004 (2004)", "doi": "10.1200/JCO.2004.05.061"}, {"pmid": "17211469", "authors": "  Sudarshan S, Linehan WM, Neckers L.", "title": "HIF and fumarate hydratase in renal cancer.", "journal": "Br J Cancer 96:403-7 (2007)", "doi": "10.1038/sj.bjc.6603547"}, {"pmid": "17287871", "authors": "  Sudarshan S, Pinto PA, Neckers L, Linehan WM.", "title": "Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer--a distinct form of hereditary kidney cancer.", "journal": "Nat Clin Pract Urol 4:104-10 (2007)", "doi": "10.1038/ncpuro0711"}, {"pmid": "14685170", "authors": "  Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF.", "title": "Met, metastasis, motility and more.", "journal": "Nat Rev Mol Cell Biol 4:915-25 (2003)", "doi": "10.1038/nrm1261"}, {"pmid": "18358634", "authors": "  Muller-Hocker J, Babaryka G, Schmid I, Jung A", "title": "Overexpression of cyclin D1, D3, and p21 in an infantile renal carcinoma with Xp11.2 TFE3-gene fusion.", "journal": "Pathol Res Pract 204:589-97 (2008)", "doi": "10.1016/j.prp.2008.01.010"}, {"pmid": "12351585", "authors": "  Bodmer D, van den Hurk W, van Groningen JJ, Eleveld MJ, Martens GJ, Weterman MA, van Kessel AG.", "title": "Understanding familial and non-familial renal cell cancer.", "journal": "Hum Mol Genet 11:2489-98 (2002)", "doi": "10.1093/hmg/11.20.2489"}, {"pmid": "25048860", "authors": "  Kauffman EC, Ricketts CJ, Rais-Bahrami S, Yang Y, Merino MJ, Bottaro DP, Srinivasan R, Linehan WM", "title": "Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers.", "journal": "Nat Rev Urol 11:465-75 (2014)", "doi": "10.1038/nrurol.2014.162"}, {"pmid": "11313942", "authors": "  Skalsky YM, Ajuh PM, Parker C, Lamond AI, Goodwin G, Cooper CS", "title": "PRCC, the commonest TFE3 fusion partner in papillary renal carcinoma is associated with pre-mRNA splicing factors.", "journal": "Oncogene 20:178-87 (2001)", "doi": "10.1038/sj.onc.1204056"}], "rel_pathway": ["hsa00020  Citrate cycle (TCA cycle)", "hsa04010  MAPK signaling pathway", "hsa04066  HIF-1 signaling pathway", "hsa04120  Ubiquitin mediated proteolysis", "hsa04350  TGF-beta signaling pathway", "hsa04370  VEGF signaling pathway"], "ko_pathway": "ko05211", "genes": ["RAC1", "EPAS1", "BRAF", "AKT2", "MET", "AKT1", "FLCN", "SOS1", "NRAS"]}, {"kegg_id": "hsa05416", "name": "Viral myocarditis - Homo sapiens (human)", "description": "Myocarditis is a cardiac disease associated with inflammation and injury of the myocardium. It results from various etiologies, both noninfectious and infectious, but coxsackievirus B3 (CVB3) is still considered the dominant etiological agent. Myocarditis may be caused by direct cytopathic effects of virus, a pathologic immune response to persistent virus, or autoimmunity triggered by the viral infection. The virus enters the myocyte through internalization of the coxsackie-adenoviral receptor (CAR) and its coreceptor, decay-accelerating factor (DAF). Viral proteases cleave various proteins in the host cell. One example is viral protease 2A, which cleaves eukaryote initiation factor 4G (eIF4G) and the dystrophin protein, resulting in a complete shutdown of cap-dependent RNA translation and cytoskeletal destruction in infected cardiomyocytes, respectively. CVB3 also cleaves the member of the Bcl-2 family Bid, leading to apoptosis. CVB3 infection also induces the cleavage of cyclin D protein through a proteasome-dependent pathway, leading to the host cell-growth arrest. Viral infection and necrosis of myocytes may lead to the release of intracellular antigens, resulting in activation of self-reactive T cells. CVB infection is a significant cause of dilated cardiomyopathy (DCM) as well as myocarditis. Epidemiologically, myocarditis underlies a significant portion of patients with DCM.", "class": "Human Diseases; Cardiovascular disease", "pathway_map": "hsa05416  Viral myocarditis", "disease": ["H00295  Viral myocarditis"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["1525  CXADR; CXADR Ig-like cell adhesion molecule [KO:K06788]", "1604  CD55; CD55 molecule (Cromer blood group) [KO:K04006]", "2534  FYN; FYN proto-oncogene, Src family tyrosine kinase [KO:K05703] [EC:2.7.10.2]", "857  CAV1; caveolin 1 [KO:K06278]", "25  ABL1; ABL proto-oncogene 1, non-receptor tyrosine kinase [KO:K06619] [EC:2.7.10.2]", "27  ABL2; ABL proto-oncogene 2, non-receptor tyrosine kinase [KO:K08887] [EC:2.7.10.2]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "5880  RAC2; Rac family small GTPase 2 [KO:K07860]", "5881  RAC3; Rac family small GTPase 3 [KO:K07861]", "8082  SSPN; sarcospan [KO:K22194]", "6442  SGCA; sarcoglycan alpha [KO:K12565]", "6443  SGCB; sarcoglycan beta [KO:K12566]", "6445  SGCG; sarcoglycan gamma [KO:K12564]", "6444  SGCD; sarcoglycan delta [KO:K12563]", "8910  SGCE; sarcoglycan epsilon [KO:K27061]", "137868  SGCZ; sarcoglycan zeta [KO:K27062]", "284217  LAMA1; laminin subunit alpha 1 [KO:K05637]", "3908  LAMA2; laminin subunit alpha 2 [KO:K05637]", "1605  DAG1; dystroglycan 1 [KO:K06265]", "859  CAV3; caveolin 3 [KO:K12959]", "4842  NOS1; nitric oxide synthase 1 [KO:K13240] [EC:1.14.13.39]", "6640  SNTA1; syntrophin alpha 1 [KO:K24063]", "6645  SNTB2; syntrophin beta 2 [KO:K24064]", "6641  SNTB1; syntrophin beta 1 [KO:K24064]", "1837  DTNA; dystrobrevin alpha [KO:K26998]", "1756  DMD; dystrophin [KO:K10366]", "71  ACTG1; actin gamma 1 [KO:K05692]", "60  ACTB; actin beta [KO:K05692]", "8672  EIF4G3; eukaryotic translation initiation factor 4 gamma 3 [KO:K03260]", "1981  EIF4G1; eukaryotic translation initiation factor 4 gamma 1 [KO:K03260]", "1982  EIF4G2; eukaryotic translation initiation factor 4 gamma 2 [KO:K03260]", "595  CCND1; cyclin D1 [KO:K04503]", "841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]", "637  BID; BH3 interacting domain death agonist [KO:K04726]", "54205  CYCS; cytochrome c, somatic [KO:K08738]", "842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "4625  MYH7; myosin heavy chain 7 [KO:K17751]", "4624  MYH6; myosin heavy chain 6 [KO:K17751]", "959  CD40LG; CD40 ligand [KO:K03161]", "958  CD40; CD40 molecule [KO:K03160]", "3108  HLA-DMA; major histocompatibility complex, class II, DM alpha [KO:K06752]", "3109  HLA-DMB; major histocompatibility complex, class II, DM beta [KO:K06752]", "3111  HLA-DOA; major histocompatibility complex, class II, DO alpha [KO:K06752]", "3112  HLA-DOB; major histocompatibility complex, class II, DO beta [KO:K06752]", "3113  HLA-DPA1; major histocompatibility complex, class II, DP alpha 1 [KO:K06752]", "3115  HLA-DPB1; major histocompatibility complex, class II, DP beta 1 [KO:K06752]", "3117  HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 [KO:K06752]", "3118  HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2 [KO:K06752]", "3119  HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 [KO:K06752]", "3122  HLA-DRA; major histocompatibility complex, class II, DR alpha [KO:K06752]", "3123  HLA-DRB1; major histocompatibility complex, class II, DR beta 1 [KO:K06752]", "3125  HLA-DRB3; major histocompatibility complex, class II, DR beta 3 [KO:K06752]", "3126  HLA-DRB4; major histocompatibility complex, class II, DR beta 4 [KO:K06752]", "3127  HLA-DRB5; major histocompatibility complex, class II, DR beta 5 [KO:K06752]", "3105  HLA-A; major histocompatibility complex, class I, A [KO:K06751]", "3106  HLA-B; major histocompatibility complex, class I, B [KO:K06751]", "3107  HLA-C; major histocompatibility complex, class I, C [KO:K06751]", "3134  HLA-F; major histocompatibility complex, class I, F [KO:K06751]", "3135  HLA-G; major histocompatibility complex, class I, G [KO:K06751]", "3133  HLA-E; major histocompatibility complex, class I, E [KO:K06751]", "941  CD80; CD80 molecule [KO:K05412]", "942  CD86; CD86 molecule [KO:K05413]", "940  CD28; CD28 molecule [KO:K06470]", "5551  PRF1; perforin 1 [KO:K07818]", "3683  ITGAL; integrin subunit alpha L [KO:K05718]", "3689  ITGB2; integrin subunit beta 2 [KO:K06464]", "3383  ICAM1; intercellular adhesion molecule 1 [KO:K06490]", "102723407  IGH; immunoglobulin heavy variable 4-38-2-like [KO:K06856]"], "refs": [{"pmid": "18039131", "authors": "  Esfandiarei M, McManus BM", "title": "Molecular biology and pathogenesis of viral myocarditis.", "journal": "Annu Rev Pathol 3:127-55 (2008)", "doi": "10.1146/annurev.pathmechdis.3.121806.151534"}, {"pmid": "12920582", "authors": "  Badorff C, Knowlton KU", "title": "Dystrophin disruption in enterovirus-induced myocarditis and dilated cardiomyopathy: from bench to bedside.", "journal": "Med Microbiol Immunol 193:121-6 (2004)", "doi": "10.1007/s00430-003-0189-7"}, {"pmid": "17200452", "authors": "  Maekawa Y, Ouzounian M, Opavsky MA, Liu PP", "title": "Connecting the missing link between dilated cardiomyopathy and viral myocarditis: virus, cytoskeleton, and innate immunity.", "journal": "Circulation 115:5-8 (2007)", "doi": "10.1161/CIRCULATIONAHA.106.670554"}, {"pmid": "12439638", "authors": "  Pankuweit S, Portig I, Maisch B", "title": "Pathophysiology of cardiac inflammation: molecular mechanisms.", "journal": "Herz 27:669-76 (2002)", "doi": "10.1007/s00059-002-2421-4"}, {"pmid": "16845885", "authors": "  Gao G, Luo H", "title": "The ubiquitin-proteasome pathway in viral infections.", "journal": "Can J Physiol Pharmacol 84:5-14 (2006)", "doi": "10.1139/y05-144"}, {"pmid": "16413486", "authors": "  Coyne CB, Bergelson JM", "title": "Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions.", "journal": "Cell 124:119-31 (2006)", "doi": "10.1016/j.cell.2005.10.035"}, {"pmid": "10904843", "authors": "  Badorff C, Lee GH, Knowlton KU", "title": "Enteroviral cardiomyopathy: bad news for the dystrophin-glycoprotein complex.", "journal": "Herz 25:227-32 (2000)", "doi": "10.1007/s000590050011"}, {"pmid": "18357777", "authors": "  Knowlton KU", "title": "CVB infection and mechanisms of viral cardiomyopathy.", "journal": "Curr Top Microbiol Immunol 323:315-35 (2008)", "doi": "10.1007/978-3-540-75546-3_15"}, {"pmid": "18545064", "authors": "  Castellano G, Affuso F, Di Conza P, Fazio S", "title": "Myocarditis and dilated cardiomyopathy: possible connections and treatments.", "journal": "J Cardiovasc Med (Hagerstown) 9:666-71 (2008)", "doi": "10.2459/JCM.0b013e3282f3e9c2"}, {"pmid": "19357408", "authors": "  Cooper LT Jr", "title": "Myocarditis.", "journal": "N Engl J Med 360:1526-38 (2009)", "doi": "10.1056/NEJMra0800028"}, {"pmid": "10051305", "authors": "  Kawai C", "title": "From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future.", "journal": "Circulation 99:1091-100 (1999)", "doi": "10.1161/01.CIR.99.8.1091"}, {"pmid": "11524405", "authors": "  Liu PP, Mason JW", "title": "Advances in the understanding of myocarditis.", "journal": "Circulation 104:1076-82 (2001)", "doi": "10.1161/hc3401.095198"}, {"pmid": "14522402", "authors": "  Mason JW", "title": "Myocarditis and dilated cardiomyopathy: an inflammatory link.", "journal": "Cardiovasc Res 60:5-10 (2003)", "doi": "10.1016/S0008-6363(03)00437-1"}], "rel_pathway": ["hsa03050  Proteasome", "hsa04110  Cell cycle", "hsa04210  Apoptosis", "hsa04260  Cardiac muscle contraction", "hsa04512  ECM-receptor interaction", "hsa04612  Antigen processing and presentation", "hsa04660  T cell receptor signaling pathway", "hsa05414  Dilated cardiomyopathy"], "ko_pathway": "ko05416", "genes": ["RAC1"]}, {"kegg_id": "hsa05417", "name": "Lipid and atherosclerosis - Homo sapiens (human)", "description": "Atherosclerosis is a chronic inflammatory disease marked by a narrowing of the arteries from lipid-rich plaques present within the walls of arterial blood vessels. It represents the root cause of the majority of cardiovascular diseases (CVDs) and their complications, including conditions such as coronary artery disease, myocardial infarction and stroke.  An elevated level of low density lipoprotein (LDL) cholesterol constitutes a major risk factor for genesis of atherosclerosis. LDL can accumulate within the blood vessel wall and undergo modification by oxidation. Oxidized LDL (oxLDL) leads to endothelial dysfunction leading to expression of adhesion molecules and recruitment of monocyte in subendothelial space. The monocytes proliferate, differentiate into macrophages, and take up the lipoproteins, forming cholesterol-engorged \"foam cells.\" With the time, the foam cells die, leaving a 'necrotic core' of crystalline cholesterol and cell debris. Smooth muscle cells proliferate and migrate into the region, laying down a protective cap over the lesion. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), which mediates the recognition and internalization of oxLDL, is involved in all of these events critical in the pathogenesis of atherosclerosis.", "class": "Human Diseases; Cardiovascular disease", "pathway_map": "hsa05417  Lipid and atherosclerosis", "disease": ["H02505  Atherosclerosis"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["338  APOB; apolipoprotein B [KO:K14462]", "337  APOA4; apolipoprotein A4 [KO:K08760]", "335  APOA1; apolipoprotein A1 [KO:K08757]", "3949  LDLR; low density lipoprotein receptor [KO:K12473]", "4973  OLR1; oxidized low density lipoprotein receptor 1 [KO:K08763]", "9138  ARHGEF1; Rho guanine nucleotide exchange factor 1 [KO:K12330]", "4312  MMP1; matrix metallopeptidase 1 [KO:K01388] [EC:3.4.24.7]", "387  RHOA; ras homolog family member A [KO:K04513]", "9475  ROCK2; Rho associated coiled-coil containing protein kinase 2 [KO:K17388] [EC:2.7.11.1]", "4846  NOS3; nitric oxide synthase 3 [KO:K13242] [EC:1.14.13.39]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]", "598  BCL2L1; BCL2 like 1 [KO:K04570]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "6648  SOD2; superoxide dismutase 2 [KO:K04564] [EC:1.15.1.1]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5451  POU2F1; POU class 2 homeobox 1 [KO:K09364]", "5452  POU2F2; POU class 2 homeobox 2 [KO:K09364]", "25833  POU2F3; POU class 2 homeobox 3 [KO:K09364]", "958  CD40; CD40 molecule [KO:K03160]", "959  CD40LG; CD40 ligand [KO:K03161]", "1543  CYP1A1; cytochrome P450 family 1 subfamily A member 1 [KO:K07408] [EC:1.14.14.1]", "1548  CYP2A6; cytochrome P450 family 2 subfamily A member 6 [KO:K17683] [EC:1.14.14.-]", "1549  CYP2A7; cytochrome P450 family 2 subfamily A member 7 [KO:K17683] [EC:1.14.14.-]", "1555  CYP2B6; cytochrome P450 family 2 subfamily B member 6 [KO:K17709] [EC:1.14.14.-]", "1558  CYP2C8; cytochrome P450 family 2 subfamily C member 8 [KO:K17718] [EC:1.14.14.1]", "1559  CYP2C9; cytochrome P450 family 2 subfamily C member 9 [KO:K17719] [EC:1.14.14.51 1.14.14.52 1.14.14.53 1.14.14.-]", "1573  CYP2J2; cytochrome P450 family 2 subfamily J member 2 [KO:K07418] [EC:1.14.14.1 1.14.14.73 1.14.14.74 1.14.14.75]", "177  AGER; advanced glycosylation end-product specific receptor [KO:K19722]", "27035  NOX1; NADPH oxidase 1 [KO:K08008]", "1536  CYBB; cytochrome b-245 beta chain [KO:K21421] [EC:1.-.-.-]", "653361  NCF1; neutrophil cytosolic factor 1 [KO:K08011]", "1535  CYBA; cytochrome b-245 alpha chain [KO:K08009]", "4688  NCF2; neutrophil cytosolic factor 2 [KO:K08010]", "4689  NCF4; neutrophil cytosolic factor 4 [KO:K08012]", "5879  RAC1; Rac family small GTPase 1 [KO:K04392]", "6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "3717  JAK2; Janus kinase 2 [KO:K04447] [EC:2.7.10.2]", "6774  STAT3; signal transducer and activator of transcription 3 [KO:K04692]", "998  CDC42; cell division cycle 42 [KO:K04393]", "6416  MAP2K4; mitogen-activated protein kinase kinase 4 [KO:K04430] [EC:2.7.12.2]", "5609  MAP2K7; mitogen-activated protein kinase kinase 7 [KO:K04431] [EC:2.7.12.2]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "6347  CCL2; C-C motif chemokine ligand 2 [KO:K14624]", "3383  ICAM1; intercellular adhesion molecule 1 [KO:K06490]", "3576  CXCL8; C-X-C motif chemokine ligand 8 [KO:K10030]", "5606  MAP2K3; mitogen-activated protein kinase kinase 3 [KO:K04432] [EC:2.7.12.2]", "5608  MAP2K6; mitogen-activated protein kinase kinase 6 [KO:K04433] [EC:2.7.12.2]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "6401  SELE; selectin E [KO:K06494]", "6403  SELP; selectin P [KO:K06496]", "7412  VCAM1; vascular cell adhesion molecule 1 [KO:K06527]", "4314  MMP3; matrix metallopeptidase 3 [KO:K01394] [EC:3.4.24.17]", "4318  MMP9; matrix metallopeptidase 9 [KO:K01403] [EC:3.4.24.35]", "355  FAS; Fas cell surface death receptor [KO:K04390]", "3553  IL1B; interleukin 1 beta [KO:K04519]", "3569  IL6; interleukin 6 [KO:K05405]", "7124  TNF; tumor necrosis factor [KO:K03156]", "3329  HSPD1; heat shock protein family D (Hsp60) member 1 [KO:K04077] [EC:5.6.1.7]", "3312  HSPA8; heat shock protein family A (Hsp70) member 8 [KO:K03283]", "3303  HSPA1A; heat shock protein family A (Hsp70) member 1A [KO:K03283]", "3305  HSPA1L; heat shock protein family A (Hsp70) member 1 like [KO:K03283]", "3304  HSPA1B; heat shock protein family A (Hsp70) member 1B [KO:K03283]", "3310  HSPA6; heat shock protein family A (Hsp70) member 6 [KO:K03283]", "3306  HSPA2; heat shock protein family A (Hsp70) member 2 [KO:K26598]", "3308  HSPA4; heat shock protein family A (Hsp70) member 4 [KO:K09489]", "3320  HSP90AA1; heat shock protein 90 alpha family class A member 1 [KO:K04079]", "3326  HSP90AB1; heat shock protein 90 alpha family class B member 1 [KO:K04079]", "7184  HSP90B1; heat shock protein 90 beta family member 1 [KO:K09487]", "7097  TLR2; toll like receptor 2 [KO:K10159]", "3929  LBP; lipopolysaccharide binding protein [KO:K05399]", "929  CD14; CD14 molecule [KO:K04391]", "23643  LY96; lymphocyte antigen 96 [KO:K05400]", "7099  TLR4; toll like receptor 4 [KO:K10160]", "114609  TIRAP; TIR domain containing adaptor protein [KO:K05403]", "4615  MYD88; MYD88 innate immune signal transduction adaptor [KO:K04729]", "51135  IRAK4; interleukin 1 receptor associated kinase 4 [KO:K04733] [EC:2.7.11.1]", "3654  IRAK1; interleukin 1 receptor associated kinase 1 [KO:K04730] [EC:2.7.11.1]", "7189  TRAF6; TNF receptor associated factor 6 [KO:K03175] [EC:2.3.2.27]", "10454  TAB1; TGF-beta activated kinase 1 (MAP3K7) binding protein 1 [KO:K04403]", "23118  TAB2; TGF-beta activated kinase 1 (MAP3K7) binding protein 2 [KO:K04404]", "6885  MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO:K04427] [EC:2.7.11.25]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "353376  TICAM2; TIR domain containing adaptor molecule 2 [KO:K05409]", "148022  TICAM1; TIR domain containing adaptor molecule 1 [KO:K05842]", "7187  TRAF3; TNF receptor associated factor 3 [KO:K03174]", "57534  MIB1; MIB E3 ubiquitin protein ligase 1 [KO:K10645] [EC:2.3.2.27]", "142678  MIB2; MIB E3 ubiquitin protein ligase 2 [KO:K10645] [EC:2.3.2.27]", "10010  TANK; TRAF family member associated NFKB activator [KO:K12650]", "9641  IKBKE; inhibitor of nuclear factor kappa B kinase subunit epsilon [KO:K07211] [EC:2.7.11.10]", "29110  TBK1; TANK binding kinase 1 [KO:K05410] [EC:2.7.11.10]", "3665  IRF7; interferon regulatory factor 7 [KO:K09447]", "3661  IRF3; interferon regulatory factor 3 [KO:K05411]", "3439  IFNA1; interferon alpha 1 [KO:K05414]", "3440  IFNA2; interferon alpha 2 [KO:K05414]", "3441  IFNA4; interferon alpha 4 [KO:K05414]", "3442  IFNA5; interferon alpha 5 [KO:K05414]", "3443  IFNA6; interferon alpha 6 [KO:K05414]", "3444  IFNA7; interferon alpha 7 [KO:K05414]", "3445  IFNA8; interferon alpha 8 [KO:K05414]", "3446  IFNA10; interferon alpha 10 [KO:K05414]", "3447  IFNA13; interferon alpha 13 [KO:K05414]", "3448  IFNA14; interferon alpha 14 [KO:K05414]", "3449  IFNA16; interferon alpha 16 [KO:K05414]", "3451  IFNA17; interferon alpha 17 [KO:K05414]", "3452  IFNA21; interferon alpha 21 [KO:K05414]", "3456  IFNB1; interferon beta 1 [KO:K05415]", "948  CD36; CD36 molecule (CD36 blood group) [KO:K06259]", "5468  PPARG; peroxisome proliferator activated receptor gamma [KO:K08530]", "6256  RXRA; retinoid X receptor alpha [KO:K08524]", "6257  RXRB; retinoid X receptor beta [KO:K08525]", "6258  RXRG; retinoid X receptor gamma [KO:K08526]", "4067  LYN; LYN proto-oncogene, Src family tyrosine kinase [KO:K05854] [EC:2.7.10.2]", "5747  PTK2; protein tyrosine kinase 2 [KO:K05725] [EC:2.7.10.2]", "10451  VAV3; vav guanine nucleotide exchange factor 3 [KO:K05730]", "7409  VAV1; vav guanine nucleotide exchange factor 1 [KO:K05730]", "7410  VAV2; vav guanine nucleotide exchange factor 2 [KO:K05730]", "10333  TLR6; toll like receptor 6 [KO:K10169]", "5906  RAP1A; RAP1A, member of RAS oncogene family [KO:K04353]", "5908  RAP1B; RAP1B, member of RAS oncogene family [KO:K07836]", "6352  CCL5; C-C motif chemokine ligand 5 [KO:K12499]", "6348  CCL3; C-C motif chemokine ligand 3 [KO:K05408]", "6349  CCL3L1; C-C motif chemokine ligand 3 like 1 [KO:K05408]", "414062  CCL3L3; C-C motif chemokine ligand 3 like 3 [KO:K05408]", "2919  CXCL1; C-X-C motif chemokine ligand 1 [KO:K05505]", "2920  CXCL2; C-X-C motif chemokine ligand 2 [KO:K05505]", "2921  CXCL3; C-X-C motif chemokine ligand 3 [KO:K05505]", "3592  IL12A; interleukin 12A [KO:K05406]", "3593  IL12B; interleukin 12B [KO:K05425]", "114548  NLRP3; NLR family pyrin domain containing 3 [KO:K12800]", "3606  IL18; interleukin 18 [KO:K05482]", "3309  HSPA5; heat shock protein family A (Hsp70) member 5 [KO:K09490] [EC:3.6.4.10]", "22926  ATF6; activating transcription factor 6 [KO:K09054]", "1649  DDIT3; DNA damage inducible transcript 3 [KO:K04452]", "30001  ERO1A; endoplasmic reticulum oxidoreductase 1 alpha [KO:K10950] [EC:1.8.4.-]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "815  CAMK2A; calcium/calmodulin dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]", "817  CAMK2D; calcium/calmodulin dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]", "816  CAMK2B; calcium/calmodulin dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]", "818  CAMK2G; calcium/calmodulin dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]", "9451  EIF2AK3; eukaryotic translation initiation factor 2 alpha kinase 3 [KO:K08860] [EC:2.7.11.1]", "1965  EIF2S1; eukaryotic translation initiation factor 2 subunit alpha [KO:K03237]", "468  ATF4; activating transcription factor 4 [KO:K04374]", "2081  ERN1; endoplasmic reticulum to nucleus signaling 1 [KO:K08852] [EC:2.7.11.1 3.1.26.-]", "7186  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]", "4217  MAP3K5; mitogen-activated protein kinase kinase kinase 5 [KO:K04426] [EC:2.7.11.25]", "7494  XBP1; X-box binding protein 1 [KO:K09027]", "19  ABCA1; ATP binding cassette subfamily A member 1 [KO:K05641]", "9619  ABCG1; ATP binding cassette subfamily G member 1 [KO:K05679]", "4780  NFE2L2; NFE2 like bZIP transcription factor 2 [KO:K05638]", "29108  PYCARD; PYD and CARD domain containing [KO:K12799]", "834  CASP1; caspase 1 [KO:K01370] [EC:3.4.22.36]", "7436  VLDLR; very low density lipoprotein receptor [KO:K20053]", "5170  PDPK1; 3-phosphoinositide dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "4772  NFATC1; nuclear factor of activated T cells 1 [KO:K04446]", "4773  NFATC2; nuclear factor of activated T cells 2 [KO:K17332]", "4775  NFATC3; nuclear factor of activated T cells 3 [KO:K17333]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "810  CALML3; calmodulin like 3 [KO:K02183]", "805  CALM2; calmodulin 2 [KO:K02183]", "808  CALM3; calmodulin 3 [KO:K02183]", "801  CALM1; calmodulin 1 [KO:K02183]", "163688  CALML6; calmodulin like 6 [KO:K02183]", "51806  CALML5; calmodulin like 5 [KO:K02183]", "91860  CALML4; calmodulin like 4 [KO:K02183]", "5530  PPP3CA; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]", "5532  PPP3CB; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]", "5533  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]", "5534  PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]", "5535  PPP3R2; protein phosphatase 3 regulatory subunit B, beta [KO:K06268]", "8743  TNFSF10; TNF superfamily member 10 [KO:K04721]", "8797  TNFRSF10A; TNF receptor superfamily member 10a [KO:K04722]", "8795  TNFRSF10B; TNF receptor superfamily member 10b [KO:K04722]", "7132  TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158]", "356  FASLG; Fas ligand [KO:K04389]", "841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]", "637  BID; BH3 interacting domain death agonist [KO:K04726]", "54205  CYCS; cytochrome c, somatic [KO:K08738]", "317  APAF1; apoptotic peptidase activating factor 1 [KO:K02084]", "842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]", "839  CASP6; caspase 6 [KO:K04396] [EC:3.4.22.59]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "840  CASP7; caspase 7 [KO:K04397] [EC:3.4.22.60]", "7157  TP53; tumor protein p53 [KO:K04451]"], "compound": ["C00027  Hydrogen peroxide", "C00076  Calcium cation", "C00187  Cholesterol", "C00338  Lipopolysaccharide", "C00422  Triacylglycerol", "C00704  Superoxide", "C00865  Phospholipid", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C02530  Cholesterol ester", "C05981  Phosphatidylinositol-3,4,5-trisphosphate", "C21011  [Protein]-N(epsilon)-(carboxymethyl)lysine", "C21012  [Protein]-N(epsilon)-(carboxyethyl)lysine", "C21013  [Protein]-pyrraline", "C21014  [Protein]-pentosidine"], "refs": [{"pmid": "23899566", "authors": "  Hopkins PN", "title": "Molecular biology of atherosclerosis.", "journal": "Physiol Rev 93:1317-542 (2013)", "doi": "10.1152/physrev.00004.2012"}, {"pmid": "22064431", "authors": "  Weber C, Noels H", "title": "Atherosclerosis: current pathogenesis and therapeutic options.", "journal": "Nat Med 17:1410-22 (2011)", "doi": "10.1038/nm.2538"}, {"pmid": "25869663", "authors": "  Tabas I, Garcia-Cardena G, Owens GK", "title": "Recent insights into the cellular biology of atherosclerosis.", "journal": "J Cell Biol 209:13-22 (2015)", "doi": "10.1083/jcb.201412052"}, {"pmid": "25614320", "authors": "  Tall AR, Yvan-Charvet L", "title": "Cholesterol, inflammation and innate immunity.", "journal": "Nat Rev Immunol 15:104-16 (2015)", "doi": "10.1038/nri3793"}, {"pmid": "31336709", "authors": "  Kattoor AJ, Goel A, Mehta JL", "title": "LOX-1: Regulation, Signaling and Its Role in Atherosclerosis.", "journal": "Antioxidants (Basel) 8:E218 (2019)", "doi": "10.3390/antiox8070218"}, {"pmid": "11985903", "authors": "  Mehta JL, Li D", "title": "Identification, regulation and function of a novel lectin-like oxidized low-density lipoprotein receptor.", "journal": "J Am Coll Cardiol 39:1429-35 (2002)", "doi": "10.1016/s0735-1097(02)01803-x"}, {"pmid": "19286611", "authors": "  Li D, Mehta JL", "title": "Intracellular signaling of LOX-1 in endothelial cell apoptosis.", "journal": "Circ Res 104:566-8 (2009)", "doi": "10.1161/CIRCRESAHA.109.194209"}, {"pmid": "24886290", "authors": "  Lubrano V, Balzan S", "title": "LOX-1 and ROS, inseparable factors in the process of endothelial damage.", "journal": "Free Radic Res 48:841-8 (2014)", "doi": "10.3109/10715762.2014.929122"}, {"pmid": "23124189", "authors": "  Xu S, Ogura S, Chen J, Little PJ, Moss J, Liu P", "title": "LOX-1 in atherosclerosis: biological functions and pharmacological modifiers.", "journal": "Cell Mol Life Sci 70:2859-72 (2013)", "doi": "10.1007/s00018-012-1194-z"}, {"pmid": "21947818", "authors": "  Mitra S, Goyal T, Mehta JL", "title": "Oxidized LDL, LOX-1 and atherosclerosis.", "journal": "Cardiovasc Drugs Ther 25:419-29 (2011)", "doi": "10.1007/s10557-011-6341-5"}, {"pmid": "21338316", "authors": "  Lu J, Mitra S, Wang X, Khaidakov M, Mehta JL", "title": "Oxidative stress and lectin-like ox-LDL-receptor LOX-1 in atherogenesis and tumorigenesis.", "journal": "Antioxid Redox Signal 15:2301-33 (2011)", "doi": "10.1089/ars.2010.3792"}, {"pmid": "20203069", "authors": "  Ou HC, Song TY, Yeh YC, Huang CY, Yang SF, Chiu TH, Tsai KL, Chen KL, Wu YJ, Tsai CS, Chang LY, Kuo WW, Lee SD", "title": "EGCG protects against oxidized LDL-induced endothelial dysfunction by inhibiting LOX-1-mediated signaling.", "journal": "J Appl Physiol (1985) 108:1745-56 (2010)", "doi": "10.1152/japplphysiol.00879.2009"}, {"pmid": "17614937", "authors": "  Chen XP, Zhang TT, Du GH", "title": "Lectin-like oxidized low-density lipoprotein receptor-1, a new promising target for the therapy of atherosclerosis?", "journal": "Cardiovasc Drug Rev 25:146-61 (2007)", "doi": "10.1111/j.1527-3466.2007.00009.x"}, {"pmid": "20181930", "authors": "  Mattaliano MD, Wooters J, Shih HH, Paulsen JE", "title": "ROCK2 associates with lectin-like oxidized LDL receptor-1 and mediates oxidized LDL-induced IL-8 production.", "journal": "Am J Physiol Cell Physiol 298:C1180-7 (2010)", "doi": "10.1152/ajpcell.00483.2009"}, {"pmid": "27073018", "authors": "  Salvador B, Arranz A, Francisco S, Cordoba L, Punzon C, Llamas MA, Fresno M", "title": "Modulation of endothelial function by Toll like receptors.", "journal": "Pharmacol Res 108:46-56 (2016)", "doi": "10.1016/j.phrs.2016.03.038"}, {"pmid": "23995626", "authors": "  Moore KJ, Sheedy FJ, Fisher EA", "title": "Macrophages in atherosclerosis: a dynamic balance.", "journal": "Nat Rev Immunol 13:709-21 (2013)", "doi": "10.1038/nri3520"}, {"pmid": "25403963", "authors": "  Butoi E, Gan AM, Manduteanu I", "title": "Molecular and functional interactions among monocytes/macrophages and smooth muscle cells and their relevance for atherosclerosis.", "journal": "Crit Rev Eukaryot Gene Expr 24:341-55 (2014)", "doi": "10.1615/critreveukaryotgeneexpr.2014012157"}, {"pmid": "24048132", "authors": "  Sheedy FJ, Moore KJ", "title": "IL-1 signaling in atherosclerosis: sibling rivalry.", "journal": "Nat Immunol 14:1030-2 (2013)", "doi": "10.1038/ni.2711"}, {"pmid": "21529710", "authors": "  Moore KJ, Tabas I", "title": "Macrophages in the pathogenesis of atherosclerosis.", "journal": "Cell 145:341-55 (2011)", "doi": "10.1016/j.cell.2011.04.005"}, {"pmid": "22577254", "authors": "  Gui T, Shimokado A, Sun Y, Akasaka T, Muragaki Y", "title": "Diverse roles of macrophages in atherosclerosis: from inflammatory biology to biomarker discovery.", "journal": "Mediators Inflamm 2012:693083 (2012)", "doi": "10.1155/2012/693083"}, {"pmid": "17442283", "authors": "  Collot-Teixeira S, Martin J, McDermott-Roe C, Poston R, McGregor JL", "title": "CD36 and macrophages in atherosclerosis.", "journal": "Cardiovasc Res 75:468-77 (2007)", "doi": "10.1016/j.cardiores.2007.03.010"}, {"pmid": "19065049", "authors": "  Park YM, Febbraio M, Silverstein RL", "title": "CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima.", "journal": "J Clin Invest 119:136-45 (2009)", "doi": "10.1172/JCI35535"}, {"pmid": "24903227", "authors": "  Park YM", "title": "CD36, a scavenger receptor implicated in atherosclerosis.", "journal": "Exp Mol Med 46:e99 (2014)", "doi": "10.1038/emm.2014.38"}, {"pmid": "21035758", "authors": "  Seimon TA, Nadolski MJ, Liao X, Magallon J, Nguyen M, Feric NT, Koschinsky ML, Harkewicz R, Witztum JL, Tsimikas S, Golenbock D, Moore KJ, Tabas I", "title": "Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress.", "journal": "Cell Metab 12:467-82 (2010)", "doi": "10.1016/j.cmet.2010.09.010"}, {"pmid": "25869517", "authors": "  Nimgulkar C, Ghosh S, Sankar AB, Uday KP, Surekha MV, Madhusudhanachary P, Annapurna BR, Raghu P, Bharatraj DK", "title": "Combination of spices and herbal extract restores macrophage foam cell migration and abrogates the athero-inflammatory signalling cascade of atherogenesis.", "journal": "Vascul Pharmacol 72:53-63 (2015)", "doi": "10.1016/j.vph.2015.02.014"}, {"pmid": "23928573", "authors": "  Canton J, Neculai D, Grinstein S", "title": "Scavenger receptors in homeostasis and immunity.", "journal": "Nat Rev Immunol 13:621-34 (2013)", "doi": "10.1038/nri3515"}, {"pmid": "20375591", "authors": "  Erridge C", "title": "The roles of Toll-like receptors in atherosclerosis.", "journal": "J Innate Immun 1:340-9 (2009)", "doi": "10.1159/000191413"}, {"pmid": "21884686", "authors": "  Seneviratne AN, Sivagurunathan B, Monaco C", "title": "Toll-like receptors and macrophage activation in atherosclerosis.", "journal": "Clin Chim Acta 413:3-14 (2012)", "doi": "10.1016/j.cca.2011.08.021"}, {"pmid": "21252151", "authors": "  Miller YI, Choi SH, Wiesner P, Fang L, Harkewicz R, Hartvigsen K, Boullier A, Gonen A, Diehl CJ, Que X, Montano E, Shaw PX, Tsimikas S, Binder CJ, Witztum JL", "title": "Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity.", "journal": "Circ Res 108:235-48 (2011)", "doi": "10.1161/CIRCRESAHA.110.223875"}, {"pmid": "20884885", "authors": "  Tabas I", "title": "The role of endoplasmic reticulum stress in the progression of atherosclerosis.", "journal": "Circ Res 107:839-50 (2010)", "doi": "10.1161/CIRCRESAHA.110.224766"}, {"pmid": "29360955", "authors": "  Grootaert MOJ, Moulis M, Roth L, Martinet W, Vindis C, Bennett MR, De Meyer GRY", "title": "Vascular smooth muscle cell death, autophagy and senescence in atherosclerosis.", "journal": "Cardiovasc Res 114:622-634 (2018)", "doi": "10.1093/cvr/cvy007"}, {"pmid": "12730091", "authors": "  Lipskaia L, Pourci ML, Delomenie C, Combettes L, Goudouneche D, Paul JL, Capiod T, Lompre AM", "title": "Phosphatidylinositol 3-kinase and calcium-activated transcription pathways are required for VLDL-induced smooth muscle cell proliferation.", "journal": "Circ Res 92:1115-22 (2003)", "doi": "10.1161/01.RES.0000074880.25540.D0"}, {"pmid": "28230726", "authors": "  Cervantes Gracia K, Llanas-Cornejo D, Husi H", "title": "CVD and Oxidative Stress.", "journal": "J Clin Med 6:E22 (2017)", "doi": "10.3390/jcm6020022"}, {"pmid": "21321594", "authors": "  Hansson GK, Hermansson A", "title": "The immune system in atherosclerosis.", "journal": "Nat Immunol 12:204-12 (2011)", "doi": "10.1038/ni.2001"}, {"pmid": "19301036", "authors": "  Roy H, Bhardwaj S, Yla-Herttuala S", "title": "Molecular genetics of atherosclerosis.", "journal": "Hum Genet 125:467-91 (2009)", "doi": "10.1007/s00439-009-0654-5"}, {"pmid": "15451808", "authors": "  Lusis AJ, Fogelman AM, Fonarow GC", "title": "Genetic basis of atherosclerosis: part I: new genes and pathways.", "journal": "Circulation 110:1868-73 (2004)", "doi": "10.1161/01.CIR.0000143041.58692.CC"}], "rel_pathway": ["hsa04020  Calcium signaling pathway", "hsa04115  p53 signaling pathway", "hsa04141  Protein processing in endoplasmic reticulum", "hsa04151  PI3K-Akt signaling pathway", "hsa04210  Apoptosis", "hsa04620  Toll-like receptor signaling pathway", "hsa04621  NOD-like receptor signaling pathway", "hsa04668  TNF signaling pathway", "hsa04670  Leukocyte transendothelial migration", "hsa04975  Fat digestion and absorption", "hsa04979  Cholesterol metabolism", "hsa05418  Fluid shear stress and atherosclerosis"], "ko_pathway": "ko05417", "genes": ["RAC1", "TP53", "AKT2", "AKT1", "CD36", "MIB1", "MAPK13", "NRAS", "BAX"]}, {"kegg_id": "hsa04621", "name": "NOD-like receptor signaling pathway - Homo sapiens (human)", "description": "Specific families of pattern recognition receptors are responsible for detecting various pathogens and generating innate immune responses. The intracellular NOD-like receptor (NLR) family contains more than 20 members in mammals and plays a pivotal role in the recognition of intracellular ligands. NOD1 and NOD2, two prototypic NLRs, sense the cytosolic presence of the bacterial peptidoglycan fragments that escaped from endosomal compartments, driving the activation of NF-{kappa}B and MAPK, cytokine production and apoptosis. On the other hand, a different set of NLRs induces caspase-1 activation through the assembly of multiprotein complexes called inflammasomes. The activated of caspase-1 regulates maturation of the pro-inflammatory cytokines IL-1B, IL-18 and drives pyroptosis.", "class": "Organismal Systems; Immune system", "pathway_map": "hsa04621  NOD-like receptor signaling pathway", "network": ["", "ELEMENT   N00515  Oligoadenylate synthetase (OAS)/RNase L pathway", "N00742  NLRP3 inflammasome signaling pathway", "N00867  NLRC4 inflammasome signaling pathway", "N00868  Pyrin inflammasome signaling pathway", "N00934  Non-canonical inflammasome signaling pathway", "N00940  NOD-NFKB signaling pathway", "N01567  NLRP1 inflammasome signaling pathway", "N01568  Regulation of NLRP3 inflammasome signaling pathway, NLRP3 inhibition", "N01569  NALP12 inflammasome signaling pathway", "N01570  Regulation of Pyrin inflammasome signaling pathway, PSTPIP1"], "drug": ["D03504  Cinacalcet (USAN)", "D03505  Cinacalcet hydrochloride (JAN/USAN)", "D06619  Mifamurtide (USAN)", "D08978  Pralnacasan (USAN/INN)", "D09315  Canakinumab (USAN/INN)", "D09911  Gevokizumab (USAN/INN)", "D10416  Belnacasan (USAN/INN)", "D10676  Etelcalcetide (USAN/INN)", "D10677  Etelcalcetide hydrochloride (JAN/USAN)", "D11063  Evocalcet (JAN/INN)", "D11385  Inarigivir soproxil (USAN)", "D11564  Upacicalcet sodium hydrate (JAN)", "D11817  Deucravacitinib (JAN/USAN)", "D12167  Zimlovisertib (USAN)", "D12352  Eclitasertib (USAN/INN)", "D12411  Emavusertib (USAN/INN)", "D12412  Emavusertib hydrochloride (USAN)", "D12422  Selnoflast (USAN/INN)", "D12423  Selnoflast potassium (USAN)", "D12464  Dazukibart (USAN)", "D12532  Emavusertib mesylate (USAN)", "D12533  Emavusertib maleate (USAN)", "D12538  Emavusertib phosphate (USAN)", "D12539  emavusertib tosylate (USAN)", "D12575  Povorcitinib (USAN/INN)", "D12576  Povorcitinib phosphate (USAN)", "D12720  Nibrozetone (USAN)", "D12725  Lomedeucitinib (USAN)", "D12821  Flizasertib (USAN/INN)", "D12846  Ocadusertib (USAN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["10392  NOD1; nucleotide binding oligomerization domain containing 1 [KO:K08727]", "8767  RIPK2; receptor interacting serine/threonine kinase 2 [KO:K08846] [EC:2.7.11.1]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "4793  NFKBIB; NFKB inhibitor beta [KO:K02581]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "3553  IL1B; interleukin 1 beta [KO:K04519]", "3606  IL18; interleukin 18 [KO:K05482]", "3569  IL6; interleukin 6 [KO:K05405]", "7124  TNF; tumor necrosis factor [KO:K03156]", "3576  CXCL8; C-X-C motif chemokine ligand 8 [KO:K10030]", "2919  CXCL1; C-X-C motif chemokine ligand 1 [KO:K05505]", "2920  CXCL2; C-X-C motif chemokine ligand 2 [KO:K05505]", "2921  CXCL3; C-X-C motif chemokine ligand 3 [KO:K05505]", "6347  CCL2; C-C motif chemokine ligand 2 [KO:K14624]", "6352  CCL5; C-C motif chemokine ligand 5 [KO:K12499]", "820  CAMP; cathelicidin antimicrobial peptide [KO:K13916]", "1667  DEFA1; defensin alpha 1 [KO:K05230]", "1668  DEFA3; defensin alpha 3 [KO:K05230]", "1669  DEFA4; defensin alpha 4 [KO:K05230]", "1670  DEFA5; defensin alpha 5 [KO:K05230]", "1671  DEFA6; defensin alpha 6 [KO:K05230]", "728358  DEFA1B; defensin alpha 1B [KO:K05230]", "1673  DEFB4A; defensin beta 4A [KO:K21100]", "100289462  DEFB4B; defensin beta 4B [KO:K21100]", "414325  DEFB103A; defensin beta 103A [KO:K23126]", "55894  DEFB103B; defensin beta 103B [KO:K23126]", "64127  NOD2; nucleotide binding oligomerization domain containing 2 [KO:K10165]", "6885  MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO:K04427] [EC:2.7.11.25]", "10454  TAB1; TGF-beta activated kinase 1 (MAP3K7) binding protein 1 [KO:K04403]", "23118  TAB2; TGF-beta activated kinase 1 (MAP3K7) binding protein 2 [KO:K04404]", "257397  TAB3; TGF-beta activated kinase 1 (MAP3K7) binding protein 3 [KO:K12793]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "55054  ATG16L1; autophagy related 16 like 1 [KO:K17890]", "9474  ATG5; autophagy related 5 [KO:K08339]", "9140  ATG12; autophagy related 12 [KO:K08336]", "11337  GABARAP; GABA type A receptor-associated protein [KO:K08341]", "23710  GABARAPL1; GABA type A receptor associated protein like 1 [KO:K08341]", "11345  GABARAPL2; GABA type A receptor associated protein like 2 [KO:K08341]", "440738  MAP1LC3C; microtubule associated protein 1 light chain 3 gamma [KO:K10435]", "81631  MAP1LC3B; microtubule associated protein 1 light chain 3 beta [KO:K10435]", "84557  MAP1LC3A; microtubule associated protein 1 light chain 3 alpha [KO:K10435]", "643246  MAP1LC3B2; microtubule associated protein 1 light chain 3 beta 2 [KO:K10435]", "10910  SUGT1; SGT1 homolog, MIS12 kinetochore complex assembly cochaperone [KO:K12795]", "81858  SHARPIN; SHANK associated RH domain interactor [KO:K20894]", "10616  RBCK1; RANBP2-type and C3HC4-type zinc finger containing 1 [KO:K10630] [EC:2.3.2.31]", "55072  RNF31; ring finger protein 31 [KO:K11974] [EC:2.3.2.31]", "331  XIAP; X-linked inhibitor of apoptosis [KO:K04725] [EC:2.3.2.27]", "84674  CARD6; caspase recruitment domain family member 6 [KO:K12797]", "7205  TRIP6; thyroid hormone receptor interactor 6 [KO:K12792]", "55914  ERBIN; erbb2 interacting protein [KO:K12796]", "329  BIRC2; baculoviral IAP repeat containing 2 [KO:K16060]", "330  BIRC3; baculoviral IAP repeat containing 3 [KO:K16060]", "7186  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]", "7188  TRAF5; TNF receptor associated factor 5 [KO:K09849]", "7189  TRAF6; TNF receptor associated factor 6 [KO:K03175] [EC:2.3.2.27]", "64170  CARD9; caspase recruitment domain family member 9 [KO:K12794]", "7128  TNFAIP3; TNF alpha induced protein 3 [KO:K11859] [EC:3.4.19.12]", "57506  MAVS; mitochondrial antiviral signaling protein [KO:K12648]", "7187  TRAF3; TNF receptor associated factor 3 [KO:K03174]", "29110  TBK1; TANK binding kinase 1 [KO:K05410] [EC:2.7.11.10]", "9641  IKBKE; inhibitor of nuclear factor kappa B kinase subunit epsilon [KO:K07211] [EC:2.7.11.10]", "10010  TANK; TRAF family member associated NFKB activator [KO:K12650]", "3661  IRF3; interferon regulatory factor 3 [KO:K05411]", "3665  IRF7; interferon regulatory factor 7 [KO:K09447]", "3439  IFNA1; interferon alpha 1 [KO:K05414]", "3440  IFNA2; interferon alpha 2 [KO:K05414]", "3441  IFNA4; interferon alpha 4 [KO:K05414]", "3442  IFNA5; interferon alpha 5 [KO:K05414]", "3443  IFNA6; interferon alpha 6 [KO:K05414]", "3444  IFNA7; interferon alpha 7 [KO:K05414]", "3445  IFNA8; interferon alpha 8 [KO:K05414]", "3446  IFNA10; interferon alpha 10 [KO:K05414]", "3447  IFNA13; interferon alpha 13 [KO:K05414]", "3448  IFNA14; interferon alpha 14 [KO:K05414]", "3449  IFNA16; interferon alpha 16 [KO:K05414]", "3451  IFNA17; interferon alpha 17 [KO:K05414]", "3452  IFNA21; interferon alpha 21 [KO:K05414]", "3456  IFNB1; interferon beta 1 [KO:K05415]", "79671  NLRX1; NLR family member X1 [KO:K12653]", "118429  ANTXR2; ANTXR cell adhesion molecule 2 [KO:K20909]", "84168  ANTXR1; ANTXR cell adhesion molecule 1 [KO:K20909]", "22861  NLRP1; NLR family pyrin domain containing 1 [KO:K12798]", "29108  PYCARD; PYD and CARD domain containing [KO:K12799]", "834  CASP1; caspase 1 [KO:K01370] [EC:3.4.22.36]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]", "598  BCL2L1; BCL2 like 1 [KO:K04570]", "1508  CTSB; cathepsin B [KO:K01363] [EC:3.4.22.1]", "114548  NLRP3; NLR family pyrin domain containing 3 [KO:K12800]", "24145  PANX1; pannexin 1 [KO:K03443]", "5027  P2RX7; purinergic receptor P2X 7 [KO:K05220]", "7226  TRPM2; transient receptor potential cation channel subfamily M member 2 [KO:K04977] [EC:3.6.1.13]", "54822  TRPM7; transient receptor potential cation channel subfamily M member 7 [KO:K04982] [EC:2.7.11.1]", "51393  TRPV2; transient receptor potential cation channel subfamily V member 2 [KO:K04971]", "846  CASR; calcium sensing receptor [KO:K04612]", "222545  GPRC6A; G protein-coupled receptor class C group 6 member A [KO:K04622]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "7416  VDAC1; voltage dependent anion channel 1 [KO:K05862]", "7417  VDAC2; voltage dependent anion channel 2 [KO:K15040]", "7419  VDAC3; voltage dependent anion channel 3 [KO:K15041]", "90550  MCU; mitochondrial calcium uniporter [KO:K20858]", "4938  OAS1; 2'-5'-oligoadenylate synthetase 1 [KO:K14216] [EC:2.7.7.84]", "4939  OAS2; 2'-5'-oligoadenylate synthetase 2 [KO:K14216] [EC:2.7.7.84]", "4940  OAS3; 2'-5'-oligoadenylate synthetase 3 [KO:K14216] [EC:2.7.7.84]", "6041  RNASEL; ribonuclease L [KO:K01165]", "56919  DHX33; DEAH-box helicase 33 [KO:K17820] [EC:5.6.2.6]", "55669  MFN1; mitofusin 1 [KO:K21356] [EC:3.6.5.-]", "9927  MFN2; mitofusin 2 [KO:K06030] [EC:3.6.5.-]", "8737  RIPK1; receptor interacting serine/threonine kinase 1 [KO:K02861] [EC:2.7.11.1]", "11035  RIPK3; receptor interacting serine/threonine kinase 3 [KO:K08847] [EC:2.7.11.1]", "10059  DNM1L; dynamin 1 like [KO:K17065] [EC:3.6.5.5]", "10135  NAMPT; nicotinamide phosphoribosyltransferase [KO:K03462] [EC:2.4.2.12]", "1536  CYBB; cytochrome b-245 beta chain [KO:K21421] [EC:1.-.-.-]", "1535  CYBA; cytochrome b-245 alpha chain [KO:K08009]", "10628  TXNIP; thioredoxin interacting protein [KO:K20910]", "7295  TXN; thioredoxin [KO:K03671]", "25828  TXN2; thioredoxin 2 [KO:K03671]", "140609  NEK7; NIMA related kinase 7 [KO:K20876] [EC:2.7.11.34]", "79184  BRCC3; BRCA1/BRCA2-containing complex subunit 3 [KO:K11864] [EC:3.4.19.-]", "3320  HSP90AA1; heat shock protein 90 alpha family class A member 1 [KO:K04079]", "3326  HSP90AB1; heat shock protein 90 alpha family class B member 1 [KO:K04079]", "22900  CARD8; caspase recruitment domain family member 8 [KO:K12801]", "63940  GPSM3; G protein signaling modulator 3 [KO:K15838]", "345611  IRGM; immunity related GTPase M [KO:K14139] [EC:3.6.5.-]", "260434  PYDC1; pyrin domain containing 1 [KO:K12802]", "152138  PYDC2; pyrin domain containing 2 [KO:K20911]", "4210  MEFV; MEFV innate immunity regulator, pyrin [KO:K12803]", "9051  PSTPIP1; proline-serine-threonine phosphatase interacting protein 1 [KO:K12804]", "841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]", "8772  FADD; Fas associated via death domain [KO:K02373]", "100506742  CASP12; caspase 12 (gene/pseudogene) [KO:K04741] [EC:3.4.22.-]", "59082  CARD18; caspase recruitment domain family member 18 [KO:K12806]", "114769  CARD16; caspase recruitment domain family member 16 [KO:K12806]", "171389  NLRP6; NLR family pyrin domain containing 6 [KO:K20863]", "199713  NLRP7; NLR family pyrin domain containing 7 [KO:K20864]", "91662  NLRP12; NLR family pyrin domain containing 12 [KO:K20865]", "4671  NAIP; NLR family apoptosis inhibitory protein [KO:K12807]", "58484  NLRC4; NLR family CARD domain containing 4 [KO:K12805]", "5580  PRKCD; protein kinase C delta [KO:K06068] [EC:2.7.11.13]", "2634  GBP2; guanylate binding protein 2 [KO:K20897]", "115362  GBP5; guanylate binding protein 5 [KO:K20898]", "9447  AIM2; absent in melanoma 2 [KO:K12966]", "3428  IFI16; interferon gamma inducible protein 16 [KO:K20914]", "7158  TP53BP1; tumor protein p53 binding protein 1 [KO:K20915]", "107181291  PYDC5; pyrin domain containing 5 [KO:K20916]", "387  RHOA; ras homolog family member A [KO:K04513]", "5585  PKN1; protein kinase N1 [KO:K06071] [EC:2.7.11.13]", "5586  PKN2; protein kinase N2 [KO:K23691] [EC:2.7.11.13]", "7531  YWHAE; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon [KO:K06630]", "2633  GBP1; guanylate binding protein 1 [KO:K20899]", "2635  GBP3; guanylate binding protein 3 [KO:K20899]", "115361  GBP4; guanylate binding protein 4 [KO:K20899]", "388646  GBP7; guanylate binding protein 7 [KO:K20899]", "838  CASP5; caspase 5 [KO:K04395] [EC:3.4.22.58]", "837  CASP4; caspase 4 [KO:K04394] [EC:3.4.22.57 3.4.22.64]", "79792  GSDMD; gasdermin D [KO:K20917]", "3454  IFNAR1; interferon alpha and beta receptor subunit 1 [KO:K05130]", "3455  IFNAR2; interferon alpha and beta receptor subunit 2 [KO:K05131]", "3716  JAK1; Janus kinase 1 [KO:K11217] [EC:2.7.10.2]", "7297  TYK2; tyrosine kinase 2 [KO:K11219] [EC:2.7.10.2]", "6772  STAT1; signal transducer and activator of transcription 1 [KO:K11220]", "6773  STAT2; signal transducer and activator of transcription 2 [KO:K11221]", "10379  IRF9; interferon regulatory factor 9 [KO:K04693]", "7099  TLR4; toll like receptor 4 [KO:K10160]", "148022  TICAM1; TIR domain containing adaptor molecule 1 [KO:K05842]", "4615  MYD88; MYD88 innate immune signal transduction adaptor [KO:K04729]", "51135  IRAK4; interleukin 1 receptor associated kinase 4 [KO:K04733] [EC:2.7.11.1]", "340061  STING1; stimulator of interferon response cGAMP interactor 1 [KO:K12654]"], "compound": ["C00002  ATP", "C00076  Calcium cation", "C00155  L-Homocysteine", "C00238  Potassium cation", "C00533  Nitric oxide", "C01245  D-myo-Inositol 1,4,5-trisphosphate"], "refs": [{"pmid": "23124073", "authors": "  Vandenabeele P, Bertrand MJ", "title": "The role of the IAP E3 ubiquitin ligases in regulating pattern-recognition receptor signalling.", "journal": "Nat Rev Immunol 12:833-44 (2012)", "doi": "10.1038/nri3325"}, {"pmid": "16493424", "authors": "  Strober W, Murray PJ, Kitani A, Watanabe T", "title": "Signalling pathways and molecular interactions of NOD1 and NOD2.", "journal": "Nat Rev Immunol 6:9-20 (2006)", "doi": "10.1038/nri1747"}, {"pmid": "24718315", "authors": "  Estornes Y, Bertrand MJ", "title": "IAPs, regulators of innate immunity and inflammation.", "journal": "Semin Cell Dev Biol 39:106-14 (2015)", "doi": "10.1016/j.semcdb.2014.03.035"}, {"pmid": "24707857", "authors": "  Jakopin Z", "title": "Nucleotide-binding oligomerization domain (NOD) inhibitors: a rational approach toward inhibition of NOD signaling pathway.", "journal": "J Med Chem 57:6897-918 (2014)", "doi": "10.1021/jm401841p"}, {"pmid": "25526305", "authors": "  Caruso R, Warner N, Inohara N, Nunez G", "title": "NOD1 and NOD2: signaling, host defense, and inflammatory disease.", "journal": "Immunity 41:898-908 (2014)", "doi": "10.1016/j.immuni.2014.12.010"}, {"pmid": "19767725", "authors": "  Murray PJ", "title": "Beyond peptidoglycan for Nod2.", "journal": "Nat Immunol 10:1053-4 (2009)", "doi": "10.1038/ni1009-1053"}, {"pmid": "20643110", "authors": "  Lecat A, Piette J, Legrand-Poels S", "title": "The protein Nod2: an innate receptor more complex than previously assumed.", "journal": "Biochem Pharmacol 80:2021-31 (2010)", "doi": "10.1016/j.bcp.2010.07.016"}, {"pmid": "26655628", "authors": "  Man SM, Kanneganti TD", "title": "Converging roles of caspases in inflammasome activation, cell death and innate immunity.", "journal": "Nat Rev Immunol 16:7-21 (2016)", "doi": "10.1038/nri.2015.7"}, {"pmid": "27291964", "authors": "  Broz P, Dixit VM", "title": "Inflammasomes: mechanism of assembly, regulation and signalling.", "journal": "Nat Rev Immunol 16:407-20 (2016)", "doi": "10.1038/nri.2016.58"}, {"pmid": "25879280", "authors": "  Man SM, Kanneganti TD", "title": "Regulation of inflammasome activation.", "journal": "Immunol Rev 265:6-21 (2015)", "doi": "10.1111/imr.12296"}, {"pmid": "26549800", "authors": "  Jo EK, Kim JK, Shin DM, Sasakawa C", "title": "Molecular mechanisms regulating NLRP3 inflammasome activation.", "journal": "Cell Mol Immunol 13:148-59 (2016)", "doi": "10.1038/cmi.2015.95"}, {"pmid": "23846113", "authors": "  Broz P, Monack DM", "title": "Newly described pattern recognition receptors team up against intracellular pathogens.", "journal": "Nat Rev Immunol 13:551-65 (2013)", "doi": "10.1038/nri3479"}, {"pmid": "22430786", "authors": "  Rathinam VA, Vanaja SK, Fitzgerald KA", "title": "Regulation of inflammasome signaling.", "journal": "Nat Immunol 13:333-42 (2012)", "doi": "10.1038/ni.2237"}, {"pmid": "24840700", "authors": "  Sutterwala FS, Haasken S, Cassel SL", "title": "Mechanism of NLRP3 inflammasome activation.", "journal": "Ann N Y Acad Sci 1319:82-95 (2014)", "doi": "10.1111/nyas.12458"}, {"pmid": "23702978", "authors": "  Latz E, Xiao TS, Stutz A", "title": "Activation and regulation of the inflammasomes.", "journal": "Nat Rev Immunol 13:397-411 (2013)", "doi": "10.1038/nri3452"}, {"pmid": "25145756", "authors": "  Blander JM", "title": "A long-awaited merger of the pathways mediating host defence and programmed cell death.", "journal": "Nat Rev Immunol 14:601-18 (2014)", "doi": "10.1038/nri3720"}, {"pmid": "23215645", "authors": "  von Moltke J, Ayres JS, Kofoed EM, Chavarria-Smith J, Vance RE", "title": "Recognition of bacteria by inflammasomes.", "journal": "Annu Rev Immunol 31:73-106 (2013)", "doi": "10.1146/annurev-immunol-032712-095944"}, {"pmid": "25330206", "authors": "  Abais JM, Xia M, Zhang Y, Boini KM, Li PL", "title": "Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector?", "journal": "Antioxid Redox Signal 22:1111-29 (2015)", "doi": "10.1089/ars.2014.5994"}, {"pmid": "25879288", "authors": "  Storek KM, Monack DM", "title": "Bacterial recognition pathways that lead to inflammasome activation.", "journal": "Immunol Rev 265:112-29 (2015)", "doi": "10.1111/imr.12289"}, {"pmid": "27012466", "authors": "  Hu H, Sun SC", "title": "Ubiquitin signaling in immune responses.", "journal": "Cell Res 26:457-83 (2016)", "doi": "10.1038/cr.2016.40"}, {"pmid": "26121197", "authors": "  Guo H, Callaway JB, Ting JP", "title": "Inflammasomes: mechanism of action, role in disease, and therapeutics.", "journal": "Nat Med 21:677-87 (2015)", "doi": "10.1038/nm.3893"}, {"pmid": "26482951", "authors": "  Man SM, Kanneganti TD", "title": "Gasdermin D: the long-awaited executioner of pyroptosis.", "journal": "Cell Res 25:1183-4 (2015)", "doi": "10.1038/cr.2015.124"}, {"pmid": "22819539", "authors": "  Rathinam VA, Vanaja SK, Waggoner L, Sokolovska A, Becker C, Stuart LM, Leong JM, Fitzgerald KA", "title": "TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gram-negative bacteria.", "journal": "Cell 150:606-19 (2012)", "doi": "10.1016/j.cell.2012.07.007"}, {"pmid": "21575908", "authors": "  Kerur N, Veettil MV, Sharma-Walia N, Bottero V, Sadagopan S, Otageri P, Chandran B", "title": "IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi Sarcoma-associated herpesvirus infection.", "journal": "Cell Host Microbe 9:363-75 (2011)", "doi": "10.1016/j.chom.2011.04.008"}, {"pmid": "29148036", "authors": "  Heilig R, Broz P", "title": "Function and mechanism of the pyrin inflammasome.", "journal": "Eur J Immunol 48:230-238 (2018)", "doi": "10.1002/eji.201746947"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04064  NF-kappa B signaling pathway", "hsa04140  Autophagy - animal", "hsa04620  Toll-like receptor signaling pathway"], "ko_pathway": "ko04621", "genes": ["NOD1", "BIRC3", "MAPK13"]}, {"kegg_id": "hsa05133", "name": "Pertussis - Homo sapiens (human)", "description": "Pertussis, also known as whooping cough, is an acute respiratory infectious disease caused by a bacteria called Bordetella Pertussis. The characteristic symptoms are paroxysmal cough, inspiratory wheezing and post-tussive vomiting.\nFollowing the inhalation of respiratory secretions from an infected individual, bacteria enter the upper respiratory tract and adhere to epithelial cells. Several adhesion factors have been implicated: the filamentous hemagglutinin (FHA), fimbriae, and pertactin (Prn).\nPertussis toxin (Ptx) and adenylate cyclase toxin (ACT) have been identified so far as major protein toxins of B. pertussis. PTX is a hexameric AB5-type exotoxin. Catalytic A subunit catalyzes the ADP-ribosylation of the Gi subunits of the heterotrimeric G protein, then inhibits multiple downstream pathways. ACT is able to penetrate the cytoplasmic membrane of host cells and becomes activated through the cleavage and the binding of calmodulin (CaM). Activated ACT converts ATP to cyclic AMP and subverts cellular signaling pathways.", "class": "Human Diseases; Infectious disease: bacterial", "pathway_map": "hsa05133  Pertussis", "disease": ["H00319  Pertussis"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["3678  ITGA5; integrin subunit alpha 5 [KO:K06484]", "3688  ITGB1; integrin subunit beta 1 [KO:K05719]", "3684  ITGAM; integrin subunit alpha M [KO:K06461]", "3689  ITGB2; integrin subunit beta 2 [KO:K06464]", "810  CALML3; calmodulin like 3 [KO:K02183]", "805  CALM2; calmodulin 2 [KO:K02183]", "808  CALM3; calmodulin 3 [KO:K02183]", "801  CALM1; calmodulin 1 [KO:K02183]", "163688  CALML6; calmodulin like 6 [KO:K02183]", "51806  CALML5; calmodulin like 5 [KO:K02183]", "91860  CALML4; calmodulin like 4 [KO:K02183]", "387  RHOA; ras homolog family member A [KO:K04513]", "1072  CFL1; cofilin 1 [KO:K05765]", "1073  CFL2; cofilin 2 [KO:K05765]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "840  CASP7; caspase 7 [KO:K04397] [EC:3.4.22.60]", "834  CASP1; caspase 1 [KO:K01370] [EC:3.4.22.36]", "29108  PYCARD; PYD and CARD domain containing [KO:K12799]", "114548  NLRP3; NLR family pyrin domain containing 3 [KO:K12800]", "3553  IL1B; interleukin 1 beta [KO:K04519]", "712  C1QA; complement C1q A chain [KO:K03986]", "713  C1QB; complement C1q B chain [KO:K03987]", "714  C1QC; complement C1q C chain [KO:K03988]", "715  C1R; complement C1r [KO:K01330] [EC:3.4.21.41]", "716  C1S; complement C1s [KO:K01331] [EC:3.4.21.42]", "717  C2; complement C2 [KO:K01332] [EC:3.4.21.43]", "720  C4A; complement C4A (Chido/Rodgers blood group) [KO:K03989]", "721  C4B; complement C4B (Chido/Rodgers blood group) [KO:K03989]", "718  C3; complement C3 [KO:K03990]", "727  C5; complement C5 [KO:K03994]", "710  SERPING1; serpin family G member 1 [KO:K04001]", "722  C4BPA; complement component 4 binding protein alpha [KO:K04002]", "725  C4BPB; complement component 4 binding protein beta [KO:K04003]", "23643  LY96; lymphocyte antigen 96 [KO:K05400]", "7099  TLR4; toll like receptor 4 [KO:K10160]", "929  CD14; CD14 molecule [KO:K04391]", "114609  TIRAP; TIR domain containing adaptor protein [KO:K05403]", "4615  MYD88; MYD88 innate immune signal transduction adaptor [KO:K04729]", "51135  IRAK4; interleukin 1 receptor associated kinase 4 [KO:K04733] [EC:2.7.11.1]", "3654  IRAK1; interleukin 1 receptor associated kinase 1 [KO:K04730] [EC:2.7.11.1]", "7189  TRAF6; TNF receptor associated factor 6 [KO:K03175] [EC:2.3.2.27]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "353376  TICAM2; TIR domain containing adaptor molecule 2 [KO:K05409]", "148022  TICAM1; TIR domain containing adaptor molecule 1 [KO:K05842]", "3661  IRF3; interferon regulatory factor 3 [KO:K05411]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "3569  IL6; interleukin 6 [KO:K05405]", "3592  IL12A; interleukin 12A [KO:K05406]", "3593  IL12B; interleukin 12B [KO:K05425]", "51561  IL23A; interleukin 23 subunit alpha [KO:K05426]", "7124  TNF; tumor necrosis factor [KO:K03156]", "3586  IL10; interleukin 10 [KO:K05443]", "3659  IRF1; interferon regulatory factor 1 [KO:K09444]", "3394  IRF8; interferon regulatory factor 8 [KO:K10155]", "653509  SFTPA1; surfactant protein A1 [KO:K10067]", "729238  SFTPA2; surfactant protein A2 [KO:K10067]", "2770  GNAI1; G protein subunit alpha i1 [KO:K04630]", "2773  GNAI3; G protein subunit alpha i3 [KO:K04630]", "2771  GNAI2; G protein subunit alpha i2 [KO:K04630]", "3576  CXCL8; C-X-C motif chemokine ligand 8 [KO:K10030]", "6374  CXCL5; C-X-C motif chemokine ligand 5 [KO:K05506]", "6372  CXCL6; C-X-C motif chemokine ligand 6 [KO:K05506]", "10392  NOD1; nucleotide binding oligomerization domain containing 1 [KO:K08727]", "3552  IL1A; interleukin 1 alpha [KO:K04383]", "4843  NOS2; nitric oxide synthase 2 [KO:K13241] [EC:1.14.13.39]"], "compound": ["C00002  ATP", "C00076  Calcium cation", "C00238  Potassium cation", "C00253  Nicotinate", "C00338  Lipopolysaccharide", "C00374  Heparin", "C00575  3',5'-Cyclic AMP", "C05005  Glycolipid", "C12505  Magnesium sulfate", "C19596  Lipooligosaccharide"], "refs": [{"pmid": "21204863", "authors": "  de Gouw D, Diavatopoulos DA, Bootsma HJ, Hermans PW, Mooi FR", "title": "Pertussis: a matter of immune modulation.", "journal": "FEMS Microbiol Rev 35:441-74 (2011)", "doi": "10.1111/j.1574-6976.2010.00257.x"}, {"pmid": "20210554", "authors": "  Carbonetti NH", "title": "Pertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella pertussis and cell biology tools.", "journal": "Future Microbiol 5:455-69 (2010)", "doi": "10.2217/fmb.09.133"}, {"pmid": "10540218", "authors": "  van den Berg BM, van Furth R, Hazenbos WL", "title": "Activation of complement receptor 3 on human monocytes by cross-linking of very-late antigen-5 is mediated via protein tyrosine kinases.", "journal": "Immunology 98:197-202 (1999)", "doi": "10.1046/j.1365-2567.1999.00871.x"}, {"pmid": "16999837", "authors": "  Mazar J, Cotter PA", "title": "Topology and maturation of filamentous haemagglutinin suggest a new model for two-partner secretion.", "journal": "Mol Microbiol 62:641-54 (2006)", "doi": "10.1111/j.1365-2958.2006.05392.x"}, {"pmid": "16390441", "authors": "  Hewlett EL, Donato GM, Gray MC", "title": "Macrophage cytotoxicity produced by adenylate cyclase toxin from Bordetella pertussis: more than just making cyclic AMP!", "journal": "Mol Microbiol 59:447-59 (2006)", "doi": "10.1111/j.1365-2958.2005.04958.x"}, {"pmid": "20610650", "authors": "  Dunne A, Ross PJ, Pospisilova E, Masin J, Meaney A, Sutton CE, Iwakura Y, Tschopp J, Sebo P, Mills KH", "title": "Inflammasome activation by adenylate cyclase toxin directs Th17 responses and protection against Bordetella pertussis.", "journal": "J Immunol 185:1711-9 (2010)", "doi": "10.4049/jimmunol.1000105"}, {"pmid": "18401006", "authors": "  Hickey FB, Brereton CF, Mills KH", "title": "Adenylate cycalse toxin of Bordetella pertussis inhibits TLR-induced IRF-1 and IRF-8 activation and IL-12 production and enhances IL-10 through MAPK activation in dendritic cells.", "journal": "J Leukoc Biol 84:234-43 (2008)", "doi": "10.1189/jlb.0208113"}, {"pmid": "16622221", "authors": "  Spensieri F, Fedele G, Fazio C, Nasso M, Stefanelli P, Mastrantonio P, Ausiello CM", "title": "Bordetella pertussis inhibition of interleukin-12 (IL-12) p70 in human monocyte-derived dendritic cells blocks IL-12 p35 through adenylate cyclase toxin-dependent cyclic AMP induction.", "journal": "Infect Immun 74:2831-8 (2006)", "doi": "10.1128/IAI.74.5.2831-2838.2006"}, {"pmid": "17148436", "authors": "  Fiser R, Masin J, Basler M, Krusek J, Spulakova V, Konopasek I, Sebo P", "title": "Third activity of Bordetella adenylate cyclase (AC) toxin-hemolysin. Membrane translocation of AC domain polypeptide promotes calcium influx into CD11b+ monocytes independently of the catalytic and hemolytic activities.", "journal": "J Biol Chem 282:2808-20 (2007)", "doi": "10.1074/jbc.M609979200"}, {"pmid": "16863919", "authors": "  Wang ZY, Yang D, Chen Q, Leifer CA, Segal DM, Su SB, Caspi RR, Howard ZO, Oppenheim JJ", "title": "Induction of dendritic cell maturation by pertussis toxin and its B subunit differentially initiate Toll-like receptor 4-dependent signal transduction pathways.", "journal": "Exp Hematol 34:1115-24 (2006)", "doi": "10.1016/j.exphem.2006.04.025"}, {"pmid": "15201703", "authors": "  Fan H, Peck OM, Tempel GE, Halushka PV, Cook JA", "title": "Toll-like receptor 4 coupled GI protein signaling pathways regulate extracellular signal-regulated kinase phosphorylation and AP-1 activation independent of NFkappaB activation.", "journal": "Shock 22:57-62 (2004)", "doi": "10.1097/01.shk.0000129759.58490.d6"}, {"pmid": "17328678", "authors": "  Lee MS, Kim YJ", "title": "Signaling pathways downstream of pattern-recognition receptors and their cross talk.", "journal": "Annu Rev Biochem 76:447-80 (2007)", "doi": "10.1146/annurev.biochem.76.060605.122847"}, {"pmid": "20404851", "authors": "  Kawai T, Akira S", "title": "The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.", "journal": "Nat Immunol 11:373-84 (2010)", "doi": "10.1038/ni.1863"}, {"pmid": "21423776", "authors": "  Han HJ, Kuwae A, Abe A, Arakawa Y, Kamachi K", "title": "Differential expression of type III effector BteA protein due to IS481 insertion in Bordetella pertussis.", "journal": "PLoS One 6:e17797 (2011)", "doi": "10.1371/journal.pone.0017797"}, {"pmid": "16481212", "authors": "  Beier D, Gross R", "title": "Regulation of bacterial virulence by two-component systems.", "journal": "Curr Opin Microbiol 9:143-52 (2006)", "doi": "10.1016/j.mib.2006.01.005"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04210  Apoptosis", "hsa04610  Complement and coagulation cascades", "hsa04620  Toll-like receptor signaling pathway"], "ko_pathway": "ko05133", "genes": ["NOD1", "MAPK13"]}, {"kegg_id": "hsa01524", "name": "Platinum drug resistance - Homo sapiens (human)", "description": "Platinum-based drugs cisplatin, carboplatin and oxaliplatin are widely used in the therapy of solid malignancies, including testicular, ovarian, head and neck, colorectal, bladder and lung cancers. The mechanism of action of Platinum-based drugs involves covalent binding to purine DNA bases, which primarily leads to cellular apoptosis. Their clinical success is, however, limited due to severe side effects and intrinsic or acquired resistance to the treatment. Platinum resistance could arise from decreased drug influx, increased drug efflux, intracellular detoxification by glutathione, etc., decreased binding (e.g., due to high intracellular pH), increased DNA repair, decreased mismatch repair, defective apoptosis, and altered oncogene expression.", "class": "Human Diseases; Drug resistance: antineoplastic", "pathway_map": "hsa01524  Platinum drug resistance", "organism": "Homo sapiens (human) [GN:hsa]", "refs": [{"pmid": "14576837", "authors": "  Siddik ZH", "title": "Cisplatin: mode of cytotoxic action and molecular basis of resistance.", "journal": "Oncogene 22:7265-79 (2003)", "doi": "10.1038/sj.onc.1206933"}, {"pmid": "26184483", "authors": "  Martinez-Balibrea E, Martinez-Cardus A, Gines A, Ruiz de Porras V, Moutinho C, Layos L, Manzano JL, Buges C, Bystrup S, Esteller M, Abad A", "title": "Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance.", "journal": "Mol Cancer Ther 14:1767-76 (2015)", "doi": "10.1158/1535-7163.MCT-14-0636"}, {"pmid": "17625587", "authors": "  Kelland L", "title": "The resurgence of platinum-based cancer chemotherapy.", "journal": "Nat Rev Cancer 7:573-84 (2007)", "doi": "10.1038/nrc2167"}, {"pmid": "26886018", "authors": "  Dilruba S, Kalayda GV", "title": "Platinum-based drugs: past, present and future.", "journal": "Cancer Chemother Pharmacol 77:1103-24 (2016)", "doi": "10.1007/s00280-016-2976-z"}, {"pmid": "23442359", "authors": "  Lu HP, Chao CC", "title": "Cancer cells acquire resistance to anticancer drugs: an update.", "journal": "Biomed J 35:464-72 (2012)", "doi": "10.4103/2319-4170.104411"}, {"pmid": "24074238", "authors": "  Koster R, van Vugt MA, Timmer-Bosscha H, Gietema JA, de Jong S", "title": "Unravelling mechanisms of cisplatin sensitivity and resistance in testicular cancer.", "journal": "Expert Rev Mol Med 15:e12 (2013)", "doi": "10.1017/erm.2013.13"}, {"pmid": "21892204", "authors": "  Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O, Castedo M, Kroemer G", "title": "Molecular mechanisms of cisplatin resistance.", "journal": "Oncogene 31:1869-83 (2012)", "doi": "10.1038/onc.2011.384"}, {"pmid": "17336087", "authors": "  Stewart DJ", "title": "Mechanisms of resistance to cisplatin and carboplatin.", "journal": "Crit Rev Oncol Hematol 63:12-31 (2007)", "doi": "10.1016/j.critrevonc.2007.02.001"}, {"pmid": "20647037", "authors": "  Koberle B, Tomicic MT, Usanova S, Kaina B", "title": "Cisplatin resistance: preclinical findings and clinical implications.", "journal": "Biochim Biophys Acta 1806:172-82 (2010)", "doi": "10.1016/j.bbcan.2010.07.004"}, {"pmid": "25546083", "authors": "  Jacobsen C, Honecker F", "title": "Cisplatin resistance in germ cell tumours: models and mechanisms.", "journal": "Andrology 3:111-21 (2015)", "doi": "10.1111/andr.299"}, {"pmid": "14609433", "authors": "  Fraser M, Leung B, Jahani-Asl A, Yan X, Thompson WE, Tsang BK", "title": "Chemoresistance in human ovarian cancer: the role of apoptotic regulators.", "journal": "Reprod Biol Endocrinol 1:66 (2003)", "doi": "10.1186/1477-7827-1-66"}, {"pmid": "24874729", "authors": "  Galluzzi L, Vitale I, Michels J, Brenner C, Szabadkai G, Harel-Bellan A, Castedo M, Kroemer G", "title": "Systems biology of cisplatin resistance: past, present and future.", "journal": "Cell Death Dis 5:e1257 (2014)", "doi": "10.1038/cddis.2013.428"}, {"pmid": "25058905", "authors": "  Dasari S, Tchounwou PB", "title": "Cisplatin in cancer therapy: molecular mechanisms of action.", "journal": "Eur J Pharmacol 740:364-78 (2014)", "doi": "10.1016/j.ejphar.2014.07.025"}, {"pmid": "20811617", "authors": "  Basu A, Krishnamurthy S", "title": "Cellular responses to Cisplatin-induced DNA damage.", "journal": "J Nucleic Acids 2010:201367 (2010)", "doi": "10.4061/2010/201367"}, {"pmid": "19190080", "authors": "  Chaudhry P, Asselin E", "title": "Resistance to chemotherapy and hormone therapy in endometrial cancer.", "journal": "Endocr Relat Cancer 16:363-80 (2009)", "doi": "10.1677/ERC-08-0266"}, {"pmid": "26867799", "authors": "  Li X, Lin Z, Zhang B, Guo L, Liu S, Li H, Zhang J, Ye Q", "title": "beta-elemene sensitizes hepatocellular carcinoma cells to oxaliplatin by preventing oxaliplatin-induced degradation of copper transporter 1.", "journal": "Sci Rep 6:21010 (2016)", "doi": "10.1038/srep21010"}], "rel_pathway": ["hsa03420  Nucleotide excision repair", "hsa03430  Mismatch repair", "hsa04012  ErbB signaling pathway", "hsa04110  Cell cycle", "hsa04115  p53 signaling pathway", "hsa04210  Apoptosis"], "ko_pathway": "ko01524", "genes": ["TP53", "AKT2", "BIRC3", "AKT1", "BAX"]}, {"kegg_id": "hsa04110", "name": "Cell cycle - Homo sapiens (human)", "description": "Mitotic cell cycle progression is accomplished through a reproducible sequence of events, DNA replication (S phase) and mitosis (M phase) separated temporally by gaps known as G1 and G2 phases. Cyclin-dependent kinases (CDKs) are key regulatory enzymes, each consisting of a catalytic CDK subunit and an activating cyclin subunit. CDKs regulate the cell's progression through the phases of the cell cycle by modulating the activity of key substrates. Downstream targets of CDKs include transcription factor E2F and its regulator Rb. Precise activation and inactivation of CDKs at specific points in the cell cycle are required for orderly cell division. Cyclin-CDK inhibitors (CKIs), such as p16Ink4a, p15Ink4b, p27Kip1, and p21Cip1, are involved in the negative regulation of CDK activities, thus providing a pathway through which the cell cycle is negatively regulated.\nEukaryotic cells respond to DNA damage by activating signaling pathways that promote cell cycle arrest and DNA repair. In response to DNA damage, the checkpoint kinase ATM phosphorylates and activates Chk2, which in turn directly phosphorylates and activates p53 tumor suppressor protein. p53 and its transcriptional targets play an important role in both G1 and G2 checkpoints. ATR-Chk1-mediated protein degradation of Cdc25A protein phosphatase is also a mechanism conferring intra-S-phase checkpoint activation.", "class": "Cellular Processes; Cell growth and death", "pathway_map": "hsa04110  Cell cycle", "network": ["", "ELEMENT   N00066  MDM2-p21-Cell cycle G1/S", "N00069  p16-Cell cycle G1/S", "N00090  p15-Cell cycle G1/S", "N00091  p27-Cell cycle G1/S", "N00347  p300-p21-Cell cycle G1/S", "N00455  CDC25-Cell cycle G2/M", "N00459  WEE1-Cell cycle G2/M", "N00493  Spindle assembly checkpoint signaling", "N00499  ATR-p21-Cell cycle G2/M", "N00536  MDM2-p21-Cell cycle G1/S", "N01468  DNA replication licensing", "N01470  Pre-IC formation", "N01471  Origin unwinding and elongation", "N01482  Cohesin loading", "N01486  Cohesin dissociation in anaphase", "N01529  Recruitment and formation of the MCC", "N01533  Disassembly of MCC"], "drug": ["D05988  Tacedinaline (USAN/INN)", "D06320  Vorinostat (JAN/USAN)", "D06637  Romidepsin (JAN/USAN/INN)", "D08870  Belinostat (USAN/INN)", "D09338  Entinostat (JAN/USAN/INN)", "D09357  Mocetinostat dihydrobromide (USAN)", "D09604  Dinaciclib (USAN/INN)", "D09641  Mocetinostat (USAN/INN)", "D10019  Panobinostat lactate (JAN)", "D10060  Abexinostat (USAN)", "D10084  Abexinostat hydrochloride (USAN)", "D10154  Rigosertib (USAN)", "D10155  Rigosertib sodium (JAN/USAN)", "D10182  Volasertib (USAN)", "D10183  Volasertib trihydrochloride (USAN)", "D10319  Panobinostat (USAN/INN)", "D10321  Quisinostat (USAN/INN)", "D10322  Quisinostat hydrochloride (USAN)", "D10372  Palbociclib (JAN/USAN)", "D10397  Rabusertib (USAN/INN)", "D10652  Palbociclib isethionate (USAN)", "D10688  Abemaciclib (JAN/USAN/INN)", "D10883  Ribociclib (USAN/INN)", "D10977  Remetinostat (USAN/INN)", "D10979  Ribociclib succinate (USAN)", "D10993  Tucidinostat (JAN/USAN/INN)", "D11130  Trilaciclib (USAN/INN)", "D11148  Berzosertib (USAN/INN)", "D11182  Tinostamustine (USAN/INN)", "D11206  Prexasertib (USAN/INN)", "D11319  Fimepinostat (USAN/INN)", "D11361  Adavosertib (USAN)", "D11442  Nanatinostat (USAN)", "D11455  Lerociclib (USAN)", "D11458  Onvansertib (USAN)", "D11459  Onvansertib fumarate (USAN)", "D11599  Zotiraciclib (USAN)", "D11600  Zotiraciclib citrate (USAN)", "D11787  Ceralasertib (USAN/INN)", "D11987  Trilaciclib dihydrochloride", "D12176  Simurosertib (USAN/INN)", "D12304  Elraglusib (USAN)", "D12321  Camonsertib (USAN)", "D12394  Inobrodib (USAN)", "D12551  Bocodepsin (USAN)", "D12552  Bocodepsin besylate (USAN)", "D12601  Tagtociclib (USAN)", "D12828  Risvodetinib (USAN/INN)", "D12829  Risvodetinib succinate (USAN)", "D12834  Atirmociclib (USAN)", "D12882  Tuvusertib (USAN/INN)"], "dblinks": "GO: 0000278", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["595  CCND1; cyclin D1 [KO:K04503]", "894  CCND2; cyclin D2 [KO:K10151]", "896  CCND3; cyclin D3 [KO:K10152]", "1019  CDK4; cyclin dependent kinase 4 [KO:K02089] [EC:2.7.11.22]", "1021  CDK6; cyclin dependent kinase 6 [KO:K02091] [EC:2.7.11.22]", "5925  RB1; RB transcriptional corepressor 1 [KO:K06618]", "5933  RBL1; RB transcriptional corepressor like 1 [KO:K04681]", "5934  RBL2; RB transcriptional corepressor like 2 [KO:K16332]", "25  ABL1; ABL proto-oncogene 1, non-receptor tyrosine kinase [KO:K06619] [EC:2.7.10.2]", "3065  HDAC1; histone deacetylase 1 [KO:K06067] [EC:3.5.1.98]", "3066  HDAC2; histone deacetylase 2 [KO:K06067] [EC:3.5.1.98]", "1869  E2F1; E2F transcription factor 1 [KO:K17454]", "1870  E2F2; E2F transcription factor 2 [KO:K09389]", "1871  E2F3; E2F transcription factor 3 [KO:K06620]", "1874  E2F4; E2F transcription factor 4 [KO:K04682]", "1875  E2F5; E2F transcription factor 5 [KO:K04682]", "7027  TFDP1; transcription factor Dp-1 [KO:K04683]", "7029  TFDP2; transcription factor Dp-2 [KO:K09392]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "7040  TGFB1; transforming growth factor beta 1 [KO:K13375]", "7042  TGFB2; transforming growth factor beta 2 [KO:K13376]", "7043  TGFB3; transforming growth factor beta 3 [KO:K13377]", "4087  SMAD2; SMAD family member 2 [KO:K04500]", "4088  SMAD3; SMAD family member 3 [KO:K23605]", "4089  SMAD4; SMAD family member 4 [KO:K04501]", "4609  MYC; MYC proto-oncogene, bHLH transcription factor [KO:K04377]", "7709  ZBTB17; zinc finger and BTB domain containing 17 [KO:K10500]", "1029  CDKN2A; cyclin dependent kinase inhibitor 2A [KO:K06621]", "1030  CDKN2B; cyclin dependent kinase inhibitor 2B [KO:K04685]", "1031  CDKN2C; cyclin dependent kinase inhibitor 2C [KO:K06622]", "1032  CDKN2D; cyclin dependent kinase inhibitor 2D [KO:K06623]", "1027  CDKN1B; cyclin dependent kinase inhibitor 1B [KO:K06624]", "1028  CDKN1C; cyclin dependent kinase inhibitor 1C [KO:K09993]", "1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]", "898  CCNE1; cyclin E1 [KO:K06626]", "9134  CCNE2; cyclin E2 [KO:K06626]", "1017  CDK2; cyclin dependent kinase 2 [KO:K02206] [EC:2.7.11.22]", "6500  SKP1; S-phase kinase associated protein 1 [KO:K03094]", "8454  CUL1; cullin 1 [KO:K03347]", "9978  RBX1; ring-box 1 [KO:K03868] [EC:2.3.2.32]", "6502  SKP2; S-phase kinase associated protein 2 [KO:K03875]", "890  CCNA2; cyclin A2 [KO:K06627]", "8900  CCNA1; cyclin A1 [KO:K06627]", "990  CDC6; cell division cycle 6 [KO:K02213]", "81620  CDT1; chromatin licensing and DNA replication factor 1 [KO:K10727]", "4998  ORC1; origin recognition complex subunit 1 [KO:K02603]", "4999  ORC2; origin recognition complex subunit 2 [KO:K02604]", "23595  ORC3; origin recognition complex subunit 3 [KO:K02605]", "5000  ORC4; origin recognition complex subunit 4 [KO:K02606]", "5001  ORC5; origin recognition complex subunit 5 [KO:K02607]", "23594  ORC6; origin recognition complex subunit 6 [KO:K02608]", "4171  MCM2; minichromosome maintenance complex component 2 [KO:K02540] [EC:5.6.2.3]", "4172  MCM3; minichromosome maintenance complex component 3 [KO:K02541] [EC:5.6.2.3]", "4173  MCM4; minichromosome maintenance complex component 4 [KO:K02212] [EC:5.6.2.3]", "4174  MCM5; minichromosome maintenance complex component 5 [KO:K02209] [EC:5.6.2.3]", "4175  MCM6; minichromosome maintenance complex component 6 [KO:K02542] [EC:5.6.2.3]", "4176  MCM7; minichromosome maintenance complex component 7 [KO:K02210] [EC:5.6.2.3]", "8318  CDC45; cell division cycle 45 [KO:K06628]", "90381  TICRR; TOPBP1 interacting checkpoint and replication regulator [KO:K26117]", "27085  MTBP; MDM2 binding protein [KO:K26116]", "8317  CDC7; cell division cycle 7 [KO:K02214] [EC:2.7.11.1]", "10926  DBF4; DBF4-CDC7 kinase regulatory subunit [KO:K06629]", "80174  DBF4B; DBF4B-CDC7 kinase regulatory subunit [KO:K06629]", "983  CDK1; cyclin dependent kinase 1 [KO:K02087] [EC:2.7.11.22 2.7.11.23]", "891  CCNB1; cyclin B1 [KO:K05868]", "9133  CCNB2; cyclin B2 [KO:K21770]", "85417  CCNB3; cyclin B3 [KO:K21771]", "994  CDC25B; cell division cycle 25B [KO:K05866] [EC:3.1.3.48]", "995  CDC25C; cell division cycle 25C [KO:K05867] [EC:3.1.3.48]", "7534  YWHAZ; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta [KO:K16197]", "7529  YWHAB; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta [KO:K16197]", "10971  YWHAQ; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta [KO:K16197]", "7531  YWHAE; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon [KO:K06630]", "7533  YWHAH; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta [KO:K16198]", "7532  YWHAG; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma [KO:K16198]", "5347  PLK1; polo like kinase 1 [KO:K06631] [EC:2.7.11.21]", "7465  WEE1; WEE1 G2 checkpoint kinase [KO:K06632] [EC:2.7.11.1]", "494551  WEE2; WEE2 oocyte meiosis inhibiting kinase [KO:K06632] [EC:2.7.11.1]", "9088  PKMYT1; protein kinase, membrane associated tyrosine/threonine 1 [KO:K06633] [EC:2.7.11.1]", "902  CCNH; cyclin H [KO:K06634]", "1022  CDK7; cyclin dependent kinase 7 [KO:K02202] [EC:2.7.11.22 2.7.11.23]", "64682  ANAPC1; anaphase promoting complex subunit 1 [KO:K03348]", "29882  ANAPC2; anaphase promoting complex subunit 2 [KO:K03349]", "996  CDC27; cell division cycle 27 [KO:K03350]", "29945  ANAPC4; anaphase promoting complex subunit 4 [KO:K03351]", "51433  ANAPC5; anaphase promoting complex subunit 5 [KO:K03352]", "8881  CDC16; cell division cycle 16 [KO:K03353]", "51434  ANAPC7; anaphase promoting complex subunit 7 [KO:K03354]", "8697  CDC23; cell division cycle 23 [KO:K03355]", "10393  ANAPC10; anaphase promoting complex subunit 10 [KO:K03357]", "51529  ANAPC11; anaphase promoting complex subunit 11 [KO:K03358]", "246184  CDC26; cell division cycle 26 [KO:K03359]", "25847  ANAPC13; anaphase promoting complex subunit 13 [KO:K12456]", "25906  ANAPC15; anaphase promoting complex subunit 15 [KO:K25228]", "119504  ANAPC16; anaphase promoting complex subunit 16 [KO:K25229]", "991  CDC20; cell division cycle 20 [KO:K03363]", "9232  PTTG1; PTTG1 regulator of sister chromatid separation, securin [KO:K06635]", "10744  PTTG2; pituitary tumor-transforming 2 [KO:K06635]", "9700  ESPL1; extra spindle pole bodies like 1, separase [KO:K02365] [EC:3.4.22.49]", "8243  SMC1A; structural maintenance of chromosomes 1A [KO:K06636]", "27127  SMC1B; structural maintenance of chromosomes 1B [KO:K06636]", "9126  SMC3; structural maintenance of chromosomes 3 [KO:K06669]", "5885  RAD21; RAD21 cohesin complex component [KO:K06670]", "10735  STAG2; STAG2 cohesin complex component [KO:K06671]", "10274  STAG1; STAG1 cohesin complex component [KO:K06671]", "546  ATRX; ATRX chromatin remodeler [KO:K10779]", "1663  DDX11; DEAD/H-box helicase 11 [KO:K11273] [EC:5.6.2.7]", "25836  NIPBL; NIPBL cohesin loading factor [KO:K06672]", "23383  MAU2; MAU2 sister chromatid cohesion factor [KO:K11266]", "55869  HDAC8; histone deacetylase 8 [KO:K11405] [EC:3.5.1.98]", "114799  ESCO1; establishment of sister chromatid cohesion N-acetyltransferase 1 [KO:K11268] [EC:2.3.1.-]", "157570  ESCO2; establishment of sister chromatid cohesion N-acetyltransferase 2 [KO:K11268] [EC:2.3.1.-]", "23244  PDS5A; PDS5 cohesin associated factor A [KO:K11267]", "23047  PDS5B; PDS5 cohesin associated factor B [KO:K11267]", "23063  WAPL; WAPL cohesin release factor [KO:K25163]", "113130  CDCA5; cell division cycle associated 5 [KO:K17390]", "9212  AURKB; aurora kinase B [KO:K11479] [EC:2.7.11.1]", "151648  SGO1; shugoshin 1 [KO:K11580]", "5515  PPP2CA; protein phosphatase 2 catalytic subunit alpha [KO:K04382] [EC:3.1.3.16]", "5516  PPP2CB; protein phosphatase 2 catalytic subunit beta [KO:K04382] [EC:3.1.3.16]", "5519  PPP2R1B; protein phosphatase 2 scaffold subunit Abeta [KO:K03456]", "5518  PPP2R1A; protein phosphatase 2 scaffold subunit Aalpha [KO:K03456]", "5526  PPP2R5B; protein phosphatase 2 regulatory subunit B'beta [KO:K11584]", "5527  PPP2R5C; protein phosphatase 2 regulatory subunit B'gamma [KO:K11584]", "5528  PPP2R5D; protein phosphatase 2 regulatory subunit B'delta [KO:K11584]", "5529  PPP2R5E; protein phosphatase 2 regulatory subunit B'epsilon [KO:K11584]", "5525  PPP2R5A; protein phosphatase 2 regulatory subunit B'alpha [KO:K11584]", "10403  NDC80; NDC80 kinetochore complex component [KO:K11547]", "57082  KNL1; kinetochore scaffold 1 [KO:K11542]", "7272  TTK; TTK protein kinase [KO:K08866] [EC:2.7.12.1]", "8379  MAD1L1; mitotic arrest deficient 1 like 1 [KO:K06679]", "4085  MAD2L1; mitotic arrest deficient 2 like 1 [KO:K02537]", "10459  MAD2L2; mitotic arrest deficient 2 like 2 [KO:K13728]", "701  BUB1B; BUB1 mitotic checkpoint serine/threonine kinase B [KO:K06637] [EC:2.7.11.1]", "9184  BUB3; BUB3 mitotic checkpoint protein [KO:K02180]", "699  BUB1; BUB1 mitotic checkpoint serine/threonine kinase [KO:K02178] [EC:2.7.11.1]", "9319  TRIP13; thyroid hormone receptor interactor 13 [KO:K22399]", "9587  MAD2L1BP; MAD2L1 binding protein [KO:K26093]", "51343  FZR1; fizzy and cell division cycle 20 related 1 [KO:K03364]", "26271  FBXO5; F-box protein 5 [KO:K10292]", "8555  CDC14B; cell division cycle 14B [KO:K06639] [EC:3.1.3.16 3.1.3.48]", "8556  CDC14A; cell division cycle 14A [KO:K06639] [EC:3.1.3.16 3.1.3.48]", "1387  CREBBP; CREB binding protein [KO:K04498] [EC:2.3.1.48]", "2033  EP300; E1A binding protein p300 [KO:K04498] [EC:2.3.1.48]", "5591  PRKDC; protein kinase, DNA-activated, catalytic subunit [KO:K06642] [EC:2.7.11.1]", "545  ATR; ATR serine/threonine kinase [KO:K06640] [EC:2.7.11.1]", "472  ATM; ATM serine/threonine kinase [KO:K04728] [EC:2.7.11.1]", "4193  MDM2; MDM2 proto-oncogene [KO:K06643] [EC:2.3.2.27]", "7157  TP53; tumor protein p53 [KO:K04451]", "1647  GADD45A; growth arrest and DNA damage inducible alpha [KO:K04402]", "4616  GADD45B; growth arrest and DNA damage inducible beta [KO:K04402]", "10912  GADD45G; growth arrest and DNA damage inducible gamma [KO:K04402]", "5111  PCNA; proliferating cell nuclear antigen [KO:K04802]", "2810  SFN; stratifin [KO:K06644]", "1111  CHEK1; checkpoint kinase 1 [KO:K02216] [EC:2.7.11.1]", "11200  CHEK2; checkpoint kinase 2 [KO:K06641] [EC:2.7.11.1]", "993  CDC25A; cell division cycle 25A [KO:K06645] [EC:3.1.3.48]"], "refs": [{"pmid": "8242749", "authors": "  Welch PJ, Wang JY", "title": "A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle.", "journal": "Cell 75:779-90 (1993)", "doi": "10.1016/0092-8674(93)90497-E"}, {"pmid": "16936746", "authors": "  Macaluso M, Montanari M, Giordano A", "title": "Rb family proteins as modulators of gene expression and new aspects regarding the interaction with chromatin remodeling enzymes.", "journal": "Oncogene 25:5263-7 (2006)", "doi": "10.1038/sj.onc.1209680"}, {"pmid": "15838516", "authors": "  Cobrinik D", "title": "Pocket proteins and cell cycle control.", "journal": "Oncogene 24:2796-809 (2005)", "doi": "10.1038/sj.onc.1208619"}, {"pmid": "17568790", "authors": "  Boutros R, Lobjois V, Ducommun B", "title": "CDC25 phosphatases in cancer cells: key players? Good targets?", "journal": "Nat Rev Cancer 7:495-507 (2007)", "doi": "10.1038/nrc2169"}, {"pmid": "9832503", "authors": "  Diehl JA, Cheng M, Roussel MF, Sherr CJ", "title": "Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization.", "journal": "Genes Dev 12:3499-511 (1998)", "doi": "10.1101/gad.12.22.3499"}, {"pmid": "19020303", "authors": "  Klein EA, Assoian RK", "title": "Transcriptional regulation of the cyclin D1 gene at a glance.", "journal": "J Cell Sci 121:3853-7 (2008)", "doi": "10.1242/jcs.039131"}, {"pmid": "10385618", "authors": "  Sherr CJ, Roberts JM", "title": "CDK inhibitors: positive and negative regulators of G1-phase progression.", "journal": "Genes Dev 13:1501-12 (1999)", "doi": "10.1101/gad.13.12.1501"}, {"pmid": "12809600", "authors": "  Shi Y, Massague J.", "title": "Mechanisms of TGF-beta signaling from cell membrane to the nucleus.", "journal": "Cell 113:685-700 (2003)", "doi": "10.1016/S0092-8674(03)00432-X"}, {"pmid": "12925736", "authors": "  Kamura T, Hara T, Kotoshiba S, Yada M, Ishida N, Imaki H, Hatakeyama S, Nakayama K, Nakayama KI", "title": "Degradation of p57Kip2 mediated by SCFSkp2-dependent ubiquitylation.", "journal": "Proc Natl Acad Sci U S A 100:10231-6 (2003)", "doi": "10.1073/pnas.1831009100"}, {"pmid": "16212951", "authors": "  Bond M, Sala-Newby GB, Wu YJ, Newby AC", "title": "Biphasic effect of p21Cip1 on smooth muscle cell proliferation: role of PI 3-kinase and Skp2-mediated degradation.", "journal": "Cardiovasc Res 69:198-206 (2006)", "doi": "10.1016/j.cardiores.2005.08.020"}, {"pmid": "15838523", "authors": "  Harris SL, Levine AJ.", "title": "The p53 pathway: positive and negative feedback loops.", "journal": "Oncogene 24:2899-908 (2005)", "doi": "10.1038/sj.onc.1208615"}, {"pmid": "11099028", "authors": "  Vogelstein B, Lane D, Levine AJ", "title": "Surfing the p53 network.", "journal": "Nature 408:307-10 (2000)", "doi": "10.1038/35042675"}, {"pmid": "7973727", "authors": "  Smith ML, Chen IT, Zhan Q, Bae I, Chen CY, Gilmer TM, Kastan MB, O'Connor PM, Fornace AJ Jr", "title": "Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen.", "journal": "Science 266:1376-80 (1994)", "doi": "10.1126/science.7973727"}, {"pmid": "9889196", "authors": "  Petersen BO, Lukas J, Sorensen CS, Bartek J, Helin K", "title": "Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localization.", "journal": "EMBO J 18:396-410 (1999)", "doi": "10.1093/emboj/18.2.396"}, {"pmid": "17018296", "authors": "  Sheu YJ, Stillman B", "title": "Cdc7-Dbf4 phosphorylates MCM proteins via a docking site-mediated mechanism to promote S phase progression.", "journal": "Mol Cell 24:101-13 (2006)", "doi": "10.1016/j.molcel.2006.07.033"}, {"pmid": "9029154", "authors": "  Martinez AM, Afshar M, Martin F, Cavadore JC, Labbe JC, Doree M", "title": "Dual phosphorylation of the T-loop in cdk7: its role in controlling cyclin H binding and CAK activity.", "journal": "EMBO J 16:343-54 (1997)", "doi": "10.1093/emboj/16.2.343"}, {"pmid": "15876871", "authors": "  Lolli G, Johnson LN", "title": "CAK-Cyclin-dependent Activating Kinase: a key kinase in cell cycle control and a target for drugs?", "journal": "Cell Cycle 4:572-7 (2005)", "doi": "10.4161/cc.4.4.1607"}, {"pmid": "17426725", "authors": "  Musacchio A, Salmon ED", "title": "The spindle-assembly checkpoint in space and time.", "journal": "Nat Rev Mol Cell Biol 8:379-93 (2007)", "doi": "10.1038/nrm2163"}, {"pmid": "12573239", "authors": "  Uhlmann F", "title": "Chromosome cohesion and separation: from men and molecules.", "journal": "Curr Biol 13:R104-14 (2003)", "doi": "10.1016/S0960-9822(03)00039-3"}, {"pmid": "15568976", "authors": "  Stegmeier F, Amon A", "title": "Closing mitosis: the functions of the Cdc14 phosphatase and its regulation.", "journal": "Annu Rev Genet 38:203-32 (2004)", "doi": "10.1146/annurev.genet.38.072902.093051"}, {"pmid": "9618481", "authors": "  Moustakas A, Kardassis D", "title": "Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members.", "journal": "Proc Natl Acad Sci U S A 95:6733-8 (1998)", "doi": "10.1073/pnas.95.12.6733"}, {"pmid": "26650195", "authors": "  de Boer HR, Guerrero Llobet S, van Vugt MA", "title": "Controlling the response to DNA damage by the APC/C-Cdh1.", "journal": "Cell Mol Life Sci 73:949-60 (2016)", "doi": "10.1007/s00018-015-2096-7"}], "rel_pathway": ["hsa03030  DNA replication", "hsa04010  MAPK signaling pathway", "hsa04120  Ubiquitin mediated proteolysis", "hsa04210  Apoptosis"], "ko_pathway": "ko04110", "genes": ["TP53", "CUL1"]}, {"kegg_id": "hsa04137", "name": "Mitophagy - animal - Homo sapiens (human)", "description": "Mitochondria act as the energy powerhouse of the cell, and are essential for eukaryotic cells to grow and function normally. However, deleterious byproducts of oxidative phosphorylation process called reactive oxidative species (ROS) lead to mitochondrial dysfunction. If the damage is too excessive to be repaired, such mitochondria are selectively recognized and targeted for degradation by a specific mode of autophagy, termed mitophagy. The loss of the mitochondrial membrane potential can induce mitophagy, involving the kinase PINK1 and the E3 ligase Parkin. PINK1 serves as the sensor for the mitochondrial depolarization and recruits Parkin, followed by ubiquitin-dependent recruitment of mitophagy receptors. There are also several PINK1/Parkin-independent mitophagy pathways, in which a group of LIR-containing receptors are required in response to different stimuli. Mitophagy contributes to the maintenance of a healthy mitochondrial network and the prevention of programmed cell death.", "class": "Cellular Processes; Transport and catabolism", "pathway_map": "hsa04137  Mitophagy - animal", "network": ["", "ELEMENT   N01052  PINK1-Parkin-mediated MFN2 degradation", "N01137  PINK-Parkin-mediated autophagosome formation", "N01140  TBK1-mediated autophagosome formation", "N01756  PINK-Parkin-independent ubiquitin-mediated mitophagy", "N01757  PINK-Parkin-independent ubiquitin-mediated mitophagy, ubiquitin E3 ligase", "N01759  INK1-Parkin-mediated MFN2 degradation, VCP-OPA1", "N01760  Endosomal Rab cycles"], "dblinks": "GO: 0000422", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["55626  AMBRA1; autophagy and beclin 1 regulator 1 [KO:K17985]", "65018  PINK1; PTEN induced kinase 1 [KO:K05688] [EC:2.7.11.1]", "54543  TOMM7; translocase of outer mitochondrial membrane 7 [KO:K17771]", "10452  TOMM40; translocase of outer mitochondrial membrane 40 [KO:K11518]", "84134  TOMM40L; translocase of outer mitochondrial membrane 40 like [KO:K11518]", "387990  TOMM20L; translocase of outer mitochondrial membrane 20 like [KO:K17770]", "9804  TOMM20; translocase of outer mitochondrial membrane 20 [KO:K17770]", "9868  TOMM70; translocase of outer mitochondrial membrane 70 [KO:K17768]", "5071  PRKN; parkin RBR E3 ubiquitin protein ligase [KO:K04556] [EC:2.3.2.31]", "54708  MARCHF5; membrane associated ring-CH-type finger 5 [KO:K10660] [EC:2.3.2.27]", "7186  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]", "57154  SMURF1; SMAD specific E3 ubiquitin protein ligase 1 [KO:K04678] [EC:2.3.2.26]", "64750  SMURF2; SMAD specific E3 ubiquitin protein ligase 2 [KO:K04678] [EC:2.3.2.26]", "267  AMFR; autocrine motility factor receptor [KO:K10636] [EC:2.3.2.36]", "79594  MUL1; mitochondrial E3 ubiquitin protein ligase 1 [KO:K15688] [EC:2.3.2.27]", "10075  HUWE1; HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1 [KO:K10592] [EC:2.3.2.26]", "6477  SIAH1; siah E3 ubiquitin protein ligase 1 [KO:K04506] [EC:2.3.2.27]", "25820  ARIH1; ariadne RBR E3 ubiquitin protein ligase 1 [KO:K11968] [EC:2.3.2.31]", "55669  MFN1; mitofusin 1 [KO:K21356] [EC:3.6.5.-]", "9927  MFN2; mitofusin 2 [KO:K06030] [EC:3.6.5.-]", "55288  RHOT1; ras homolog family member T1 [KO:K07870] [EC:3.6.5.-]", "89941  RHOT2; ras homolog family member T2 [KO:K07871] [EC:3.6.5.-]", "7311  UBA52; ubiquitin A-52 residue ribosomal protein fusion product 1 [KO:K02927]", "6233  RPS27A; ribosomal protein S27a [KO:K02977]", "7314  UBB; ubiquitin B [KO:K04551]", "7316  UBC; ubiquitin C [KO:K08770]", "8887  TAX1BP1; Tax1 binding protein 1 [KO:K21347]", "8878  SQSTM1; sequestosome 1 [KO:K14381]", "10241  CALCOCO2; calcium binding and coiled-coil domain 2 [KO:K21348]", "10133  OPTN; optineurin [KO:K19946]", "4077  NBR1; NBR1 autophagy cargo receptor [KO:K17987]", "29110  TBK1; TANK binding kinase 1 [KO:K05410] [EC:2.7.11.10]", "11337  GABARAP; GABA type A receptor-associated protein [KO:K08341]", "23710  GABARAPL1; GABA type A receptor associated protein like 1 [KO:K08341]", "11345  GABARAPL2; GABA type A receptor associated protein like 2 [KO:K08341]", "440738  MAP1LC3C; microtubule associated protein 1 light chain 3 gamma [KO:K10435]", "81631  MAP1LC3B; microtubule associated protein 1 light chain 3 beta [KO:K10435]", "84557  MAP1LC3A; microtubule associated protein 1 light chain 3 alpha [KO:K10435]", "643246  MAP1LC3B2; microtubule associated protein 1 light chain 3 beta 2 [KO:K10435]", "8678  BECN1; beclin 1 [KO:K08334]", "441925  BECN2; beclin 2 [KO:K08334]", "9101  USP8; ubiquitin specific peptidase 8 [KO:K11839] [EC:3.4.19.12]", "9958  USP15; ubiquitin specific peptidase 15 [KO:K21343] [EC:3.4.19.12]", "84749  USP30; ubiquitin specific peptidase 30 [KO:K11851] [EC:3.4.19.12]", "598  BCL2L1; BCL2 like 1 [KO:K04570]", "192111  PGAM5; PGAM family member 5, mitochondrial serine/threonine protein phosphatase [KO:K15637] [EC:3.1.3.16]", "1457  CSNK2A1; casein kinase 2 alpha 1 [KO:K03097] [EC:2.7.11.1]", "1459  CSNK2A2; casein kinase 2 alpha 2 [KO:K03097] [EC:2.7.11.1]", "283106  CSNK2A3; casein kinase 2 alpha 3 [KO:K03097] [EC:2.7.11.1]", "1460  CSNK2B; casein kinase 2 beta [KO:K03115]", "6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "8408  ULK1; unc-51 like autophagy activating kinase 1 [KO:K21357] [EC:2.7.11.1]", "139341  FUNDC1; FUN14 domain containing 1 [KO:K17986]", "664  BNIP3; BCL2 interacting protein 3 [KO:K15464]", "665  BNIP3L; BCL2 interacting protein 3 like [KO:K15465]", "23786  BCL2L13; BCL2 like 13 [KO:K15485]", "23770  FKBP8; FKBP prolyl isomerase 8 [KO:K09574] [EC:5.2.1.8]", "25813  SAMM50; SAMM50 sorting and assembly machinery component [KO:K07277]", "11331  PHB2; prohibitin 2 [KO:K17081]", "79671  NLRX1; NLR family member X1 [KO:K12653]", "345778  MTX3; metaxin 3 [KO:K17776]", "4580  MTX1; metaxin 1 [KO:K17776]", "10651  MTX2; metaxin 2 [KO:K17776]", "9451  EIF2AK3; eukaryotic translation initiation factor 2 alpha kinase 3 [KO:K08860] [EC:2.7.11.1]", "1965  EIF2S1; eukaryotic translation initiation factor 2 subunit alpha [KO:K03237]", "468  ATF4; activating transcription factor 4 [KO:K04374]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "22808  MRAS; muscle RAS oncogene homolog [KO:K07831]", "6237  RRAS; RAS related [KO:K07829]", "22800  RRAS2; RAS related 2 [KO:K07830]", "1869  E2F1; E2F transcription factor 1 [KO:K17454]", "3091  HIF1A; hypoxia inducible factor 1 subunit alpha [KO:K08268]", "6667  SP1; Sp1 transcription factor [KO:K04684]", "7157  TP53; tumor protein p53 [KO:K04451]", "2309  FOXO3; forkhead box O3 [KO:K09408]", "10370  CITED2; Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2 [KO:K21361]", "4286  MITF; melanocyte inducing transcription factor [KO:K09455]", "7942  TFEB; transcription factor EB [KO:K15590]", "7030  TFE3; transcription factor binding to IGHM enhancer 3 [KO:K09105]", "27342  RABGEF1; RAB guanine nucleotide exchange factor 1 [KO:K20131]", "5868  RAB5A; RAB5A, member RAS oncogene family [KO:K07887]", "5869  RAB5B; RAB5B, member RAS oncogene family [KO:K07888]", "5878  RAB5C; RAB5C, member RAS oncogene family [KO:K07889]", "22879  MON1B; MON1 homolog B, secretory trafficking associated [KO:K20195]", "84315  MON1A; MON1 homolog A, secretory trafficking associated [KO:K20195]", "221960  CCZ1B; CCZ1 homolog B, vacuolar protein trafficking and biogenesis associated [KO:K27045]", "51622  CCZ1; CCZ1 homolog, vacuolar protein trafficking and biogenesis associated [KO:K27045]", "7879  RAB7A; RAB7A, member RAS oncogene family [KO:K07897]", "338382  RAB7B; RAB7B, member RAS oncogene family [KO:K07898]", "64786  TBC1D15; TBC1 domain family member 15 [KO:K20168]", "79735  TBC1D17; TBC1 domain family member 17 [KO:K19945]", "51024  FIS1; fission, mitochondrial 1 [KO:K17969]", "285973  ATG9B; autophagy related 9B [KO:K17907]", "79065  ATG9A; autophagy related 9A [KO:K17907]", "4976  OPA1; OPA1 mitochondrial dynamin like GTPase [KO:K17079] [EC:3.6.5.5]", "7415  VCP; valosin containing protein [KO:K13525]"], "compound": ["C00035  GDP", "C00044  GTP"], "refs": [{"pmid": "25611507", "authors": "  Pickrell AM, Youle RJ", "title": "The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease.", "journal": "Neuron 85:257-73 (2015)", "doi": "10.1016/j.neuron.2014.12.007"}, {"pmid": "25995186", "authors": "  Durcan TM, Fon EA", "title": "The three 'P's of mitophagy: PARKIN, PINK1, and post-translational modifications.", "journal": "Genes Dev 29:989-99 (2015)", "doi": "10.1101/gad.262758.115"}, {"pmid": "25999423", "authors": "  Shirihai OS, Song M, Dorn GW 2nd", "title": "How mitochondrial dynamism orchestrates mitophagy.", "journal": "Circ Res 116:1835-49 (2015)", "doi": "10.1161/CIRCRESAHA.116.306374"}, {"pmid": "26611876", "authors": "  Hamacher-Brady A, Brady NR", "title": "Mitophagy programs: mechanisms and physiological implications of mitochondrial targeting by autophagy.", "journal": "Cell Mol Life Sci 73:775-95 (2016)", "doi": "10.1007/s00018-015-2087-8"}, {"pmid": "26882551", "authors": "  Yamano K, Matsuda N, Tanaka K", "title": "The ubiquitin signal and autophagy: an orchestrated dance leading to mitochondrial degradation.", "journal": "EMBO Rep 17:300-16 (2016)", "doi": "10.15252/embr.201541486"}, {"pmid": "27021519", "authors": "  Yamaguchi O, Murakawa T, Nishida K, Otsu K", "title": "Receptor-mediated mitophagy.", "journal": "J Mol Cell Cardiol 95:50-6 (2016)", "doi": "10.1016/j.yjmcc.2016.03.010"}, {"pmid": "27443527", "authors": "  Roberts RF, Tang MY, Fon EA, Durcan TM", "title": "Defending the mitochondria: The pathways of mitophagy and mitochondrial-derived vesicles.", "journal": "Int J Biochem Cell Biol 79:427-436 (2016)", "doi": "10.1016/j.biocel.2016.07.020"}], "rel_pathway": ["hsa04140  Autophagy - animal", "hsa04210  Apoptosis"], "ko_pathway": "ko04137", "genes": ["TP53", "NRAS"]}, {"kegg_id": "hsa04211", "name": "Longevity regulating pathway - Homo sapiens (human)", "description": "Regulation of longevity depends on genetic and environmental factors. Caloric restriction (CR), that is limiting food intake, is recognized in mammals as the best characterized and most reproducible strategy for extending lifespan. Four pathways have been implicated in mediating the CR effect. These are the insulin like growth factor (IGF-1)/insulin signaling pathway, the sirtuin pathway, the adenosine monophosphate (AMP) activated protein kinase (AMPK) pathway and the target of rapamycin (TOR) pathway. The collective response of these pathways to CR is believed to promote cellular fitness and ultimately longevity via activation of autophagy, stress defense mechanisms, and survival pathways while attenuating proinflammatory mediators and cellular growth. Furthermore, there is evidence supporting that life span extension can be achieved with pharmacologic agents that mimic the effects of caloric restriction, such as rapamycin, via mTOR signaling blockade, resveratrol, by activating SIRT1 activity, and metformin, which seems to be a robust stimulator of AMPK activity. As an aging suppressor, Klotho is an important molecule in aging processes and its overexpression results in longevity.", "class": "Organismal Systems; Aging", "pathway_map": "hsa04211  Longevity regulating pathway", "drug": ["D12181  Edasalonexent (USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["3630  INS; insulin [KO:K04526]", "3643  INSR; insulin receptor [KO:K04527] [EC:2.7.10.1]", "3479  IGF1; insulin like growth factor 1 [KO:K05459]", "3480  IGF1R; insulin like growth factor 1 receptor [KO:K05087] [EC:2.7.10.1]", "3667  IRS1; insulin receptor substrate 1 [KO:K16172]", "8660  IRS2; insulin receptor substrate 2 [KO:K07187]", "8471  IRS4; insulin receptor substrate 4 [KO:K17446]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]", "108  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]", "109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]", "196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]", "113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]", "114  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]", "115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]", "1386  ATF2; activating transcription factor 2 [KO:K04450]", "10488  CREB3; cAMP responsive element binding protein 3 [KO:K09048]", "90993  CREB3L1; cAMP responsive element binding protein 3 like 1 [KO:K09048]", "64764  CREB3L2; cAMP responsive element binding protein 3 like 2 [KO:K09048]", "84699  CREB3L3; cAMP responsive element binding protein 3 like 3 [KO:K09048]", "148327  CREB3L4; cAMP responsive element binding protein 3 like 4 [KO:K09048]", "468  ATF4; activating transcription factor 4 [KO:K04374]", "9586  CREB5; cAMP responsive element binding protein 5 [KO:K09047]", "1388  ATF6B; activating transcription factor 6 beta [KO:K09049]", "10919  EHMT2; euchromatic histone lysine methyltransferase 2 [KO:K11420] [EC:2.1.1.355]", "79813  EHMT1; euchromatic histone lysine methyltransferase 1 [KO:K11420] [EC:2.1.1.355]", "2308  FOXO1; forkhead box O1 [KO:K07201]", "2309  FOXO3; forkhead box O3 [KO:K09408]", "6648  SOD2; superoxide dismutase 2 [KO:K04564] [EC:1.15.1.1]", "847  CAT; catalase [KO:K03781] [EC:1.11.1.6]", "9474  ATG5; autophagy related 5 [KO:K08339]", "9365  KL; klotho [KO:K14756] [EC:3.2.1.31]", "7248  TSC1; TSC complex subunit 1 [KO:K07206]", "7249  TSC2; TSC complex subunit 2 [KO:K07207]", "6009  RHEB; Ras homolog, mTORC1 binding [KO:K07208]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "57521  RPTOR; regulatory associated protein of MTOR complex 1 [KO:K07204]", "84335  AKT1S1; AKT1 substrate 1 [KO:K16184]", "8408  ULK1; unc-51 like autophagy activating kinase 1 [KO:K21357] [EC:2.7.11.1]", "9776  ATG13; autophagy related 13 [KO:K08331]", "9821  RB1CC1; RB1 inducible coiled-coil 1 [KO:K17589]", "60673  ATG101; autophagy related 101 [KO:K19730]", "6198  RPS6KB1; ribosomal protein S6 kinase B1 [KO:K04688] [EC:2.7.11.1]", "6199  RPS6KB2; ribosomal protein S6 kinase B2 [KO:K04688] [EC:2.7.11.1]", "1978  EIF4EBP1; eukaryotic translation initiation factor 4E binding protein 1 [KO:K07205]", "1977  EIF4E; eukaryotic translation initiation factor 4E [KO:K03259]", "9470  EIF4E2; eukaryotic translation initiation factor 4E family member 2 [KO:K03259]", "253314  EIF4E1B; eukaryotic translation initiation factor 4E family member 1B [KO:K03259]", "9370  ADIPOQ; adiponectin, C1Q and collagen domain containing [KO:K07296]", "51094  ADIPOR1; adiponectin receptor 1 [KO:K07297]", "79602  ADIPOR2; adiponectin receptor 2 [KO:K07297]", "26060  APPL1; adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1 [KO:K08733]", "10645  CAMKK2; calcium/calmodulin dependent protein kinase kinase 2 [KO:K07359] [EC:2.7.11.17]", "5562  PRKAA1; protein kinase AMP-activated catalytic subunit alpha 1 [KO:K07198] [EC:2.7.11.31]", "5563  PRKAA2; protein kinase AMP-activated catalytic subunit alpha 2 [KO:K07198] [EC:2.7.11.31]", "5564  PRKAB1; protein kinase AMP-activated non-catalytic subunit beta 1 [KO:K07199]", "5565  PRKAB2; protein kinase AMP-activated non-catalytic subunit beta 2 [KO:K07199]", "5571  PRKAG1; protein kinase AMP-activated non-catalytic subunit gamma 1 [KO:K07200]", "53632  PRKAG3; protein kinase AMP-activated non-catalytic subunit gamma 3 [KO:K07200]", "51422  PRKAG2; protein kinase AMP-activated non-catalytic subunit gamma 2 [KO:K07200]", "23411  SIRT1; sirtuin 1 [KO:K11411] [EC:2.3.1.286]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "7157  TP53; tumor protein p53 [KO:K04451]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "5468  PPARG; peroxisome proliferator activated receptor gamma [KO:K08530]", "10891  PPARGC1A; PPARG coactivator 1 alpha [KO:K07202]", "6794  STK11; serine/threonine kinase 11 [KO:K07298] [EC:2.7.11.1]", "27244  SESN1; sestrin 1 [KO:K10141]", "143686  SESN3; sestrin 3 [KO:K10141]", "83667  SESN2; sestrin 2 [KO:K20394]", "814  CAMK4; calcium/calmodulin dependent protein kinase IV [KO:K05869] [EC:2.7.11.17]"], "compound": ["C00003  NAD+", "C00020  AMP", "C00076  Calcium cation", "C00575  3',5'-Cyclic AMP", "C03582  Resveratrol", "C05981  Phosphatidylinositol-3,4,5-trisphosphate", "C07151  Metformin", "C07909  Sirolimus"], "refs": [{"pmid": "22618766", "authors": "  Barzilai N, Huffman DM, Muzumdar RH, Bartke A", "title": "The critical role of metabolic pathways in aging.", "journal": "Diabetes 61:1315-22 (2012)", "doi": "10.2337/db11-1300"}, {"pmid": "20395504", "authors": "  Fontana L, Partridge L, Longo VD", "title": "Extending healthy life span--from yeast to humans.", "journal": "Science 328:321-6 (2010)", "doi": "10.1126/science.1172539"}, {"pmid": "21779512", "authors": "  Feng Z, Lin M, Wu R", "title": "The Regulation of Aging and Longevity: A New and Complex Role of p53.", "journal": "Genes Cancer 2:443-52 (2011)", "doi": "10.1177/1947601911410223"}, {"pmid": "20336132", "authors": "  Kenyon CJ", "title": "The genetics of ageing.", "journal": "Nature 464:504-12 (2010)", "doi": "10.1038/nature08980"}, {"pmid": "24905167", "authors": "  Cheng CW, Adams GB, Perin L, Wei M, Zhou X, Lam BS, Da Sacco S, Mirisola M, Quinn DI, Dorff TB, Kopchick JJ, Longo VD", "title": "Prolonged fasting reduces IGF-1/PKA to promote hematopoietic-stem-cell-based regeneration and reverse immunosuppression.", "journal": "Cell Stem Cell 14:810-23 (2014)", "doi": "10.1016/j.stem.2014.04.014"}, {"pmid": "25832544", "authors": "  Morris BJ, Willcox DC, Donlon TA, Willcox BJ", "title": "FOXO3: A Major Gene for Human Longevity - A Mini-Review.", "journal": "Gerontology 61:515-25 (2015)", "doi": "10.1159/000375235"}, {"pmid": "23939249", "authors": "  Pyo JO, Yoo SM, Ahn HH, Nah J, Hong SH, Kam TI, Jung S, Jung YK", "title": "Overexpression of Atg5 in mice activates autophagy and extends lifespan.", "journal": "Nat Commun 4:2300 (2013)", "doi": "10.1038/ncomms3300"}, {"pmid": "25654554", "authors": "  Madeo F, Zimmermann A, Maiuri MC, Kroemer G", "title": "Essential role for autophagy in life span extension.", "journal": "J Clin Invest 125:85-93 (2015)", "doi": "10.1172/JCI73946"}, {"pmid": "23061800", "authors": "  Passtoors WM, Beekman M, Deelen J, van der Breggen R, Maier AB, Guigas B, Derhovanessian E, van Heemst D, de Craen AJ, Gunn DA, Pawelec G, Slagboom PE", "title": "Gene expression analysis of mTOR pathway: association with human longevity.", "journal": "Aging Cell 12:24-31 (2013)", "doi": "10.1111/acel.12015"}, {"pmid": "23594965", "authors": "  Markaki M, Tavernarakis N", "title": "Metabolic control by target of rapamycin and autophagy during ageing - a mini-review.", "journal": "Gerontology 59:340-8 (2013)", "doi": "10.1159/000348599"}, {"pmid": "17701476", "authors": "  Dali-Youcef N, Lagouge M, Froelich S, Koehl C, Schoonjans K, Auwerx J", "title": "Sirtuins: the 'magnificent seven', function, metabolism and longevity.", "journal": "Ann Med 39:335-45 (2007)", "doi": "10.1080/07853890701408194"}, {"pmid": "20103737", "authors": "  Ruderman NB, Xu XJ, Nelson L, Cacicedo JM, Saha AK, Lan F, Ido Y", "title": "AMPK and SIRT1: a long-standing partnership?", "journal": "Am J Physiol Endocrinol Metab 298:E751-60 (2010)", "doi": "10.1152/ajpendo.00745.2009"}, {"pmid": "20357764", "authors": "  Iwabu M, Yamauchi T, Okada-Iwabu M, Sato K, Nakagawa T, Funata M, Yamaguchi M, Namiki S, Nakayama R, Tabata M, Ogata H, Kubota N, Takamoto I, Hayashi YK, Yamauchi N, Waki H, Fukayama M, Nishino I, Tokuyama K, Ueki K, Oike Y, Ishii S, Hirose K, Shimizu T, Touhara K, Kadowaki T", "title": "Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1.", "journal": "Nature 464:1313-9 (2010)", "doi": "10.1038/nature08991"}, {"pmid": "25824609", "authors": "  Ramis MR, Esteban S, Miralles A, Tan DX, Reiter RJ", "title": "Caloric restriction, resveratrol and melatonin: Role of SIRT1 and implications for aging and related-diseases.", "journal": "Mech Ageing Dev 146-148:28-41 (2015)", "doi": "10.1016/j.mad.2015.03.008"}, {"pmid": "19262508", "authors": "  Canto C, Gerhart-Hines Z, Feige JN, Lagouge M, Noriega L, Milne JC, Elliott PJ, Puigserver P, Auwerx J", "title": "AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity.", "journal": "Nature 458:1056-60 (2009)", "doi": "10.1038/nature07813"}, {"pmid": "24997879", "authors": "  Esmaili S, Xu A, George J", "title": "The multifaceted and controversial immunometabolic actions of adiponectin.", "journal": "Trends Endocrinol Metab 25:444-51 (2014)", "doi": "10.1016/j.tem.2014.06.001"}, {"pmid": "20848587", "authors": "  Mouchiroud L, Molin L, Dalliere N, Solari F", "title": "Life span extension by resveratrol, rapamycin, and metformin: The promise of dietary restriction mimetics for an healthy aging.", "journal": "Biofactors 36:377-82 (2010)", "doi": "10.1002/biof.127"}, {"pmid": "22983298", "authors": "  Tucci P", "title": "Caloric restriction: is mammalian life extension linked to p53?", "journal": "Aging (Albany NY) 4:525-34 (2012)", "doi": "10.18632/aging.100481"}, {"pmid": "18692468", "authors": "  Budanov AV, Karin M", "title": "p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling.", "journal": "Cell 134:451-60 (2008)", "doi": "10.1016/j.cell.2008.06.028"}, {"pmid": "25601466", "authors": "  Sopjani M, Rinnerthaler M, Kruja J, Dermaku-Sopjani M", "title": "Intracellular signaling of the aging suppressor protein Klotho.", "journal": "Curr Mol Med 15:27-37 (2015)", "doi": "10.2174/1566524015666150114111258"}], "rel_pathway": ["hsa04064  NF-kappa B signaling pathway", "hsa04068  FoxO signaling pathway", "hsa04115  p53 signaling pathway", "hsa04140  Autophagy - animal", "hsa04150  mTOR signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04152  AMPK signaling pathway", "hsa04910  Insulin signaling pathway"], "ko_pathway": "ko04211", "genes": ["TP53", "AKT2", "AKT1", "NRAS", "BAX"]}, {"kegg_id": "hsa04216", "name": "Ferroptosis - Homo sapiens (human)", "description": "Ferroptosis is a regulated form of cell death and characterized by a production of reactive oxygen species (ROS) from accumulated iron and lipid peroxidation. It can be induced by experimental compounds (e.g.,erastin, RSL3) or clinical drugs(e.g., sulfasalazine, sorafenib) in cancer cell and certain normal cells. It is involved in multiple physiological and pathological processes, such as cancer cell death, neurodegenerative disease, tissue damage and acute renal failure.", "class": "Cellular Processes; Cell growth and death", "pathway_map": "hsa04216  Ferroptosis", "network": ["", "ELEMENT   N01587  Fe-TF transport", "N01588  Fe3+ Ferritin transport", "N01589  Glutathione biosynthesis", "N01590  Arachidonate/Adrenic acid metabolism", "N01591  Fe2+ Ferroportin transport"], "drug": ["D11812  Pabinafusp alfa (genetical recombination) (JAN)", "D12289  Vamifeport (USAN/INN)", "D12290  Vamifeport trihydrochloride (USAN)", "D12509  Trontinemab (USAN/INN)", "D12510  Utreloxastat (JAN/USAN/INN)", "D12806  Tividenofusp alfa (USAN/INN)"], "dblinks": "GO: 0097707", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["6520  SLC3A2; solute carrier family 3 member 2 [KO:K06519]", "23657  SLC7A11; solute carrier family 7 member 11 [KO:K13869]", "7157  TP53; tumor protein p53 [KO:K04451]", "2729  GCLC; glutamate-cysteine ligase catalytic subunit [KO:K11204] [EC:6.3.2.2]", "2730  GCLM; glutamate-cysteine ligase modifier subunit [KO:K11205]", "2937  GSS; glutathione synthetase [KO:K21456] [EC:6.3.2.3]", "2879  GPX4; glutathione peroxidase 4 [KO:K05361] [EC:1.11.1.12]", "23305  ACSL6; acyl-CoA synthetase long chain family member 6 [KO:K01897] [EC:6.2.1.3]", "2182  ACSL4; acyl-CoA synthetase long chain family member 4 [KO:K01897] [EC:6.2.1.3]", "2180  ACSL1; acyl-CoA synthetase long chain family member 1 [KO:K01897] [EC:6.2.1.3]", "51703  ACSL5; acyl-CoA synthetase long chain family member 5 [KO:K01897] [EC:6.2.1.3]", "2181  ACSL3; acyl-CoA synthetase long chain family member 3 [KO:K01897] [EC:6.2.1.3]", "10162  LPCAT3; lysophosphatidylcholine acyltransferase 3 [KO:K13515] [EC:2.3.1.23 2.3.1.-]", "246  ALOX15; arachidonate 15-lipoxygenase [KO:K00460] [EC:1.13.11.33]", "112483  SAT2; spermidine/spermine N1-acetyltransferase family member 2 [KO:K00657] [EC:2.3.1.57]", "6303  SAT1; spermidine/spermine N1-acetyltransferase 1 [KO:K00657] [EC:2.3.1.57]", "7018  TF; transferrin [KO:K14736]", "7037  TFRC; transferrin receptor [KO:K06503]", "55240  STEAP3; STEAP3 metalloreductase [KO:K10142] [EC:1.16.1.-]", "4891  SLC11A2; solute carrier family 11 member 2 [KO:K21398]", "64116  SLC39A8; solute carrier family 39 member 8 [KO:K14714]", "23516  SLC39A14; solute carrier family 39 member 14 [KO:K14720]", "5094  PCBP2; poly(rC) binding protein 2 [KO:K13162]", "30061  SLC40A1; solute carrier family 40 member 1 [KO:K14685]", "1356  CP; ceruloplasmin [KO:K13624] [EC:1.16.3.1]", "5093  PCBP1; poly(rC) binding protein 1 [KO:K12889]", "2495  FTH1; ferritin heavy chain 1 [KO:K00522] [EC:1.16.3.1]", "2512  FTL; ferritin light chain [KO:K13625]", "440738  MAP1LC3C; microtubule associated protein 1 light chain 3 gamma [KO:K10435]", "81631  MAP1LC3B; microtubule associated protein 1 light chain 3 beta [KO:K10435]", "84557  MAP1LC3A; microtubule associated protein 1 light chain 3 alpha [KO:K10435]", "643246  MAP1LC3B2; microtubule associated protein 1 light chain 3 beta 2 [KO:K10435]", "9474  ATG5; autophagy related 5 [KO:K08339]", "10533  ATG7; autophagy related 7 [KO:K08337]", "8031  NCOA4; nuclear receptor coactivator 4 [KO:K09289]", "5621  PRNP; prion protein (Kanno blood group) [KO:K05634]", "3162  HMOX1; heme oxygenase 1 [KO:K00510] [EC:1.14.14.18]", "7417  VDAC2; voltage dependent anion channel 2 [KO:K15040]", "7419  VDAC3; voltage dependent anion channel 3 [KO:K15041]", "1536  CYBB; cytochrome b-245 beta chain [KO:K21421] [EC:1.-.-.-]", "94033  FTMT; ferritin mitochondrial [KO:K18495] [EC:1.16.3.1]"], "compound": ["C00010  CoA", "C00024  Acetyl-CoA", "C00025  L-Glutamate", "C00027  Hydrogen peroxide", "C00032  Heme", "C00051  Glutathione", "C00097  L-Cysteine", "C00127  Glutathione disulfide", "C00129  Isopentenyl diphosphate", "C00219  Arachidonate", "C00356  (S)-3-Hydroxy-3-methylglutaryl-CoA", "C00418  (R)-Mevalonate", "C00491  L-Cystine", "C00669  gamma-L-Glutamyl-L-cysteine", "C02249  Arachidonyl-CoA", "C02477  alpha-Tocopherol", "C11378  Ubiquinone-10", "C14818  Fe2+", "C14819  Fe3+", "C16170  (7Z,10Z,13Z,16Z)-Docosatetraenoyl-CoA", "C16527  Adrenic acid", "C16844  Hydroxyl radical", "C21478  Erastin", "C21479  RSL3", "C21480  1-Octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphoethanolamine", "C21481  1-Octadecanoyl-2-(7Z,10Z,13Z,16Z-docosatetraenoyl)-sn-glycero-3-phosphoethanolamine", "C21482  1-Octadecanoyl-2-(15S-hydroxy-5Z,8Z,11Z,13E-eicosatetraenoyl)-sn-glycero-3-phosphoethanolamine", "C21483  1-Octadecanoyl-2-(15S-hydroperoxy-5Z,8Z,11Z,13E-eicosatetraenoyl)-sn-glycero-3-phosphoethanolamine", "C21484  1-Octadecanoyl-sn-glycero-3-phosphoethanolamine", "D00448  Sulfasalazine (USP/INN)", "D08524  Sorafenib (USAN/INN)"], "refs": [{"pmid": "26775689", "authors": "  Conrad M, Angeli JP, Vandenabeele P, Stockwell BR", "title": "Regulated necrosis: disease relevance and therapeutic opportunities.", "journal": "Nat Rev Drug Discov 15:348-66 (2016)", "doi": "10.1038/nrd.2015.6"}, {"pmid": "26653790", "authors": "  Yang WS, Stockwell BR", "title": "Ferroptosis: Death by Lipid Peroxidation.", "journal": "Trends Cell Biol 26:165-76 (2016)", "doi": "10.1016/j.tcb.2015.10.014"}, {"pmid": "27842066", "authors": "  Kagan VE, Mao G, Qu F, Angeli JP, Doll S, Croix CS, Dar HH, Liu B, Tyurin VA, Ritov VB, Kapralov AA, Amoscato AA, Jiang J, Anthonymuthu T, Mohammadyani D, Yang Q, Proneth B, Klein-Seetharaman J, Watkins S, Bahar I, Greenberger J, Mallampalli RK, Stockwell BR, Tyurina YY, Conrad M, Bayir H", "title": "Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis.", "journal": "Nat Chem Biol 13:81-90 (2017)", "doi": "10.1038/nchembio.2238"}, {"pmid": "27842067", "authors": "  D'Herde K, Krysko DV", "title": "Ferroptosis: Oxidized PEs trigger death.", "journal": "Nat Chem Biol 13:4-5 (2017)", "doi": "10.1038/nchembio.2261"}, {"pmid": "28082232", "authors": "  Guiney SJ, Adlard PA, Bush AI, Finkelstein DI, Ayton S", "title": "Ferroptosis and cell death mechanisms in Parkinson's disease.", "journal": "Neurochem Int 104:34-48 (2017)", "doi": "10.1016/j.neuint.2017.01.004"}, {"pmid": "26725301", "authors": "  Bogdan AR, Miyazawa M, Hashimoto K, Tsuji Y", "title": "Regulators of Iron Homeostasis: New Players in Metabolism, Cell Death, and Disease.", "journal": "Trends Biochem Sci 41:274-86 (2016)", "doi": "10.1016/j.tibs.2015.11.012"}, {"pmid": "26794443", "authors": "  Xie Y, Hou W, Song X, Yu Y, Huang J, Sun X, Kang R, Tang D", "title": "Ferroptosis: process and function.", "journal": "Cell Death Differ 23:369-79 (2016)", "doi": "10.1038/cdd.2015.158"}, {"pmid": "27791175", "authors": "  Murphy ME", "title": "Ironing out how p53 regulates ferroptosis.", "journal": "Proc Natl Acad Sci U S A 113:12350-12352 (2016)", "doi": "10.1073/pnas.1615159113"}, {"pmid": "28129536", "authors": "  Muckenthaler MU, Rivella S, Hentze MW, Galy B", "title": "A Red Carpet for Iron Metabolism.", "journal": "Cell 168:344-361 (2017)", "doi": "10.1016/j.cell.2016.12.034"}, {"pmid": "27860262", "authors": "  Yu H, Guo P, Xie X, Wang Y, Chen G", "title": "Ferroptosis, a new form of cell death, and its relationships with tumourous diseases.", "journal": "J Cell Mol Med 21:648-657 (2017)", "doi": "10.1111/jcmm.13008"}, {"pmid": "27314071", "authors": "  Wang SJ, Ou Y, Jiang L, Gu W", "title": "Ferroptosis: A missing puzzle piece in the p53 blueprint?", "journal": "Mol Cell Oncol 3:e1046581 (2016)", "doi": "10.1080/23723556.2015.1046581"}, {"pmid": "27048822", "authors": "  Cao JY, Dixon SJ", "title": "Mechanisms of ferroptosis.", "journal": "Cell Mol Life Sci 73:2195-209 (2016)", "doi": "10.1007/s00018-016-2194-1"}, {"pmid": "26436293", "authors": "  Mancias JD, Pontano Vaites L, Nissim S, Biancur DE, Kim AJ, Wang X, Liu Y, Goessling W, Kimmelman AC, Harper JW", "title": "Ferritinophagy via NCOA4 is required for erythropoiesis and is regulated by iron dependent HERC2-mediated proteolysis.", "journal": "Elife 4:e10308 (2015)", "doi": "10.7554/eLife.10308"}, {"pmid": "28066232", "authors": "  Wang YQ, Chang SY, Wu Q, Gou YJ, Jia L, Cui YM, Yu P, Shi ZH, Wu WS, Gao G, Chang YZ", "title": "The Protective Role of Mitochondrial Ferritin on Erastin-Induced Ferroptosis.", "journal": "Front Aging Neurosci 8:308 (2016)", "doi": "10.3389/fnagi.2016.00308"}, {"pmid": "26405158", "authors": "  Kwon MY, Park E, Lee SJ, Chung SW", "title": "Heme oxygenase-1 accelerates erastin-induced ferroptotic cell death.", "journal": "Oncotarget 6:24393-403 (2015)", "doi": "10.18632/oncotarget.5162"}], "rel_pathway": ["hsa00480  Glutathione metabolism", "hsa00900  Terpenoid backbone biosynthesis"], "ko_pathway": "ko04216", "genes": ["TP53"]}, {"kegg_id": "hsa04919", "name": "Thyroid hormone signaling pathway - Homo sapiens (human)", "description": "The thyroid hormones (THs) are important regulators of growth, development and metabolism. The action of TH is mainly mediated by T3 (3,5,3'-triiodo-L-thyronine). Thyroid hormones, L-thyroxine (T4) and T3 enter the cell through transporter proteins. Although the major form of TH in the blood is T4, it is converted to the more active hormone T3 within cells. T3 binds to nuclear thyroid hormone receptors (TRs), which functions as a ligand-dependent transcription factor and controls the expression of target genes (genomic action). Nongenomic mechanisms of action is initiated at the integrin receptor. The plasma membrane alpha(v)beta(3)-integrin has distinct binding sites for T3 and T4. One binding site binds only T3 and activates the phosphatidylinositol 3-kinase (PI3K) pathway. The other binding site binds both T3 and T4 and activates the ERK1/2 MAP kinase pathway.", "class": "Organismal Systems; Endocrine system", "pathway_map": "hsa04919  Thyroid hormone signaling pathway", "network": ["", "ELEMENT   N00798  Thyroid hormone signaling pathway"], "drug": ["D00562  Propylthiouracil (JP18/USP/INN)", "D01010  Levothyroxine sodium (USP)", "D01011  Liothyronine sodium (JP18/USP)", "D01012  Dried thyroid (JP18)", "D03750  Dextrothyroxine sodium (USAN)", "D06482  Thyroid (USP)", "D07214  Tiratricol (INN)", "D08125  Levothyroxine (BAN)", "D11113  Levothyroxine sodium (INN)", "D11602  Resmetirom (USAN/INN)"], "dblinks": "GO: 0002154", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "3685  ITGAV; integrin subunit alpha V [KO:K06487]", "3690  ITGB3; integrin subunit beta 3 [KO:K06493]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "6772  STAT1; signal transducer and activator of transcription 1 [KO:K11220]", "7157  TP53; tumor protein p53 [KO:K04451]", "2099  ESR1; estrogen receptor 1 [KO:K08550]", "7068  THRB; thyroid hormone receptor beta [KO:K08362]", "9611  NCOR1; nuclear receptor corepressor 1 [KO:K04650]", "25942  SIN3A; SIN3 transcription regulator family member A [KO:K11644]", "3065  HDAC1; histone deacetylase 1 [KO:K06067] [EC:3.5.1.98]", "3066  HDAC2; histone deacetylase 2 [KO:K06067] [EC:3.5.1.98]", "8841  HDAC3; histone deacetylase 3 [KO:K11404] [EC:3.5.1.98]", "7067  THRA; thyroid hormone receptor alpha [KO:K05547]", "6256  RXRA; retinoid X receptor alpha [KO:K08524]", "6257  RXRB; retinoid X receptor beta [KO:K08525]", "6258  RXRG; retinoid X receptor gamma [KO:K08526]", "8850  KAT2B; lysine acetyltransferase 2B [KO:K06062] [EC:2.3.1.48]", "2648  KAT2A; lysine acetyltransferase 2A [KO:K06062] [EC:2.3.1.48]", "8648  NCOA1; nuclear receptor coactivator 1 [KO:K09101] [EC:2.3.1.48]", "10499  NCOA2; nuclear receptor coactivator 2 [KO:K11255]", "8202  NCOA3; nuclear receptor coactivator 3 [KO:K11256] [EC:2.3.1.48]", "1387  CREBBP; CREB binding protein [KO:K04498] [EC:2.3.1.48]", "2033  EP300; E1A binding protein p300 [KO:K04498] [EC:2.3.1.48]", "29079  MED4; mediator complex subunit 4 [KO:K15146]", "116931  MED12L; mediator complex subunit 12L [KO:K15162]", "9968  MED12; mediator complex subunit 12 [KO:K15162]", "23389  MED13L; mediator complex subunit 13L [KO:K15164]", "9969  MED13; mediator complex subunit 13 [KO:K15164]", "9282  MED14; mediator complex subunit 14 [KO:K15156]", "10025  MED16; mediator complex subunit 16 [KO:K15159]", "9440  MED17; mediator complex subunit 17 [KO:K15133]", "9862  MED24; mediator complex subunit 24 [KO:K15167]", "9442  MED27; mediator complex subunit 27 [KO:K15170]", "90390  MED30; mediator complex subunit 30 [KO:K15143]", "5469  MED1; mediator complex subunit 1 [KO:K15144]", "595  CCND1; cyclin D1 [KO:K04503]", "2626  GATA4; GATA binding protein 4 [KO:K09183]", "1827  RCAN1; regulator of calcineurin 1 [KO:K17901]", "3091  HIF1A; hypoxia inducible factor 1 subunit alpha [KO:K08268]", "4609  MYC; MYC proto-oncogene, bHLH transcription factor [KO:K04377]", "4625  MYH7; myosin heavy chain 7 [KO:K17751]", "4624  MYH6; myosin heavy chain 6 [KO:K17751]", "487  ATP2A1; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 [KO:K05853] [EC:7.2.2.10]", "489  ATP2A3; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 [KO:K05853] [EC:7.2.2.10]", "488  ATP2A2; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 [KO:K05853] [EC:7.2.2.10]", "5350  PLN; phospholamban [KO:K05852]", "54361  WNT4; Wnt family member 4 [KO:K00408]", "1499  CTNNB1; catenin beta 1 [KO:K02105]", "4851  NOTCH1; notch receptor 1 [KO:K02599]", "4853  NOTCH2; notch receptor 2 [KO:K20994]", "4854  NOTCH3; notch receptor 3 [KO:K20995]", "4855  NOTCH4; notch receptor 4 [KO:K20996]", "652  BMP4; bone morphogenetic protein 4 [KO:K04662]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "5333  PLCD1; phospholipase C delta 1 [KO:K05857] [EC:3.1.4.11]", "113026  PLCD3; phospholipase C delta 3 [KO:K05857] [EC:3.1.4.11]", "84812  PLCD4; phospholipase C delta 4 [KO:K05857] [EC:3.1.4.11]", "51196  PLCE1; phospholipase C epsilon 1 [KO:K05860] [EC:3.1.4.11]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]", "89869  PLCZ1; phospholipase C zeta 1 [KO:K05861] [EC:3.1.4.11]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "6548  SLC9A1; solute carrier family 9 member A1 [KO:K05742]", "476  ATP1A1; ATPase Na+/K+ transporting subunit alpha 1 [KO:K01539] [EC:7.2.2.13]", "477  ATP1A2; ATPase Na+/K+ transporting subunit alpha 2 [KO:K01539] [EC:7.2.2.13]", "478  ATP1A3; ATPase Na+/K+ transporting subunit alpha 3 [KO:K01539] [EC:7.2.2.13]", "480  ATP1A4; ATPase Na+/K+ transporting subunit alpha 4 [KO:K01539] [EC:7.2.2.13]", "23439  ATP1B4; ATPase Na+/K+ transporting family member beta 4 [KO:K01540]", "481  ATP1B1; ATPase Na+/K+ transporting subunit beta 1 [KO:K01540]", "482  ATP1B2; ATPase Na+/K+ transporting subunit beta 2 [KO:K01540]", "483  ATP1B3; ATPase Na+/K+ transporting subunit beta 3 [KO:K01540]", "486  FXYD2; FXYD domain containing ion transport regulator 2 [KO:K01538]", "6567  SLC16A2; solute carrier family 16 member 2 [KO:K08231]", "117247  SLC16A10; solute carrier family 16 member 10 [KO:K08187]", "6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5170  PDPK1; 3-phosphoinositide dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "4193  MDM2; MDM2 proto-oncogene [KO:K06643] [EC:2.3.2.27]", "7249  TSC2; TSC complex subunit 2 [KO:K07207]", "6009  RHEB; Ras homolog, mTORC1 binding [KO:K07208]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "9882  TBC1D4; TBC1 domain family member 4 [KO:K17902]", "5208  PFKFB2; 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 [KO:K19029] [EC:2.7.1.105 3.1.3.46]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]", "2308  FOXO1; forkhead box O1 [KO:K07201]", "842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]", "10231  RCAN2; regulator of calcineurin 2 [KO:K17903]", "6513  SLC2A1; solute carrier family 2 member 1 [KO:K07299]", "5213  PFKM; phosphofructokinase, muscle [KO:K00850] [EC:2.7.1.11]", "5214  PFKP; phosphofructokinase, platelet [KO:K00850] [EC:2.7.1.11]", "5211  PFKL; phosphofructokinase, liver type [KO:K00850] [EC:2.7.1.11]", "53919  SLCO1C1; solute carrier organic anion transporter family member 1C1 [KO:K08747]", "1733  DIO1; iodothyronine deiodinase 1 [KO:K01562] [EC:1.21.99.4]", "1734  DIO2; iodothyronine deiodinase 2 [KO:K17904] [EC:1.21.99.4]", "1735  DIO3; iodothyronine deiodinase 3 [KO:K07754] [EC:1.21.99.3]", "71  ACTG1; actin gamma 1 [KO:K05692]", "60  ACTB; actin beta [KO:K05692]"], "compound": ["C00076  Calcium cation", "C00080  H+", "C00165  Diacylglycerol", "C00238  Potassium cation", "C00575  3',5'-Cyclic AMP", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C01330  Sodium cation", "C01829  Thyroxine", "C02465  Triiodothyronine", "C05981  Phosphatidylinositol-3,4,5-trisphosphate", "C07639  3,3',5'-Triiodo-L-thyronine"], "refs": [{"pmid": "20051527", "authors": "  Cheng SY, Leonard JL, Davis PJ", "title": "Molecular aspects of thyroid hormone actions.", "journal": "Endocr Rev 31:139-70 (2010)", "doi": "10.1210/er.2009-0007"}, {"pmid": "16214361", "authors": "  Davis PJ, Davis FB, Cody V", "title": "Membrane receptors mediating thyroid hormone action.", "journal": "Trends Endocrinol Metab 16:429-35 (2005)", "doi": "10.1016/j.tem.2005.09.007"}, {"pmid": "18329679", "authors": "  Davis PJ, Davis FB, Lin HY", "title": "Promotion by thyroid hormone of cytoplasm-to-nucleus shuttling of thyroid hormone receptors.", "journal": "Steroids 73:1013-7 (2008)", "doi": "10.1016/j.steroids.2007.12.030"}, {"pmid": "22484490", "authors": "  Pascual A, Aranda A", "title": "Thyroid hormone receptors, cell growth and differentiation.", "journal": "Biochim Biophys Acta 1830:3908-16 (2013)", "doi": "10.1016/j.bbagen.2012.03.012"}, {"pmid": "17983645", "authors": "  Davis PJ, Leonard JL, Davis FB", "title": "Mechanisms of nongenomic actions of thyroid hormone.", "journal": "Front Neuroendocrinol 29:211-8 (2008)", "doi": "10.1016/j.yfrne.2007.09.003"}, {"pmid": "19755667", "authors": "  Davis PJ, Davis FB, Lin HY, Mousa SA, Zhou M, Luidens MK", "title": "Translational implications of nongenomic actions of thyroid hormone initiated at its integrin receptor.", "journal": "Am J Physiol Endocrinol Metab 297:E1238-46 (2009)", "doi": "10.1152/ajpendo.00480.2009"}, {"pmid": "20868274", "authors": "  Davis PJ, Davis FB, Mousa SA, Luidens MK, Lin HY", "title": "Membrane receptor for thyroid hormone: physiologic and pharmacologic implications.", "journal": "Annu Rev Pharmacol Toxicol 51:99-115 (2011)", "doi": "10.1146/annurev-pharmtox-010510-100512"}, {"pmid": "21835053", "authors": "  Moeller LC, Broecker-Preuss M", "title": "Transcriptional regulation by nonclassical action of thyroid hormone.", "journal": "Thyroid Res 4 Suppl 1:S6 (2011)", "doi": "10.1186/1756-6614-4-S1-S6"}, {"pmid": "19295177", "authors": "  Bhargava M, Lei J, Ingbar DH", "title": "Nongenomic actions of L-thyroxine and 3,5,3'-triiodo-L-thyronine. Focus on \"L-Thyroxine vs. 3,5,3'-triiodo-L-thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase\".", "journal": "Am J Physiol Cell Physiol 296:C977-9 (2009)", "doi": "10.1152/ajpcell.00116.2009"}, {"pmid": "17574003", "authors": "  Oetting A, Yen PM", "title": "New insights into thyroid hormone action.", "journal": "Best Pract Res Clin Endocrinol Metab 21:193-208 (2007)", "doi": "10.1016/j.beem.2007.04.004"}, {"pmid": "20005976", "authors": "  Ojamaa K", "title": "Signaling mechanisms in thyroid hormone-induced cardiac hypertrophy.", "journal": "Vascul Pharmacol 52:113-9 (2010)", "doi": "10.1016/j.vph.2009.11.008"}, {"pmid": "19716314", "authors": "  Aranda A, Martinez-Iglesias O, Ruiz-Llorente L, Garcia-Carpizo V, Zambrano A", "title": "Thyroid receptor: roles in cancer.", "journal": "Trends Endocrinol Metab 20:318-24 (2009)", "doi": "10.1016/j.tem.2009.03.011"}, {"pmid": "16951130", "authors": "  Otulakowski G, O'Brodovich H", "title": "Thyroid hormone and Na+-K+-ATPase: more than simple transcription.", "journal": "Am J Physiol Lung Cell Mol Physiol 292:L4-5 (2007)", "doi": "10.1152/ajplung.00332.2006"}, {"pmid": "16051672", "authors": "  Moeller LC, Dumitrescu AM, Refetoff S", "title": "Cytosolic action of thyroid hormone leads to induction of hypoxia-inducible factor-1alpha and glycolytic genes.", "journal": "Mol Endocrinol 19:2955-63 (2005)", "doi": "10.1210/me.2004-0542"}], "rel_pathway": ["hsa00010  Glycolysis / Gluconeogenesis", "hsa04010  MAPK signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04066  HIF-1 signaling pathway", "hsa04115  p53 signaling pathway", "hsa04150  mTOR signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04260  Cardiac muscle contraction", "hsa04310  Wnt signaling pathway", "hsa04330  Notch signaling pathway", "hsa04810  Regulation of actin cytoskeleton", "hsa04918  Thyroid hormone synthesis"], "ko_pathway": "ko04919", "genes": ["TP53", "AKT2", "AKT1", "NRAS"]}, {"kegg_id": "hsa05012", "name": "Parkinson disease - Homo sapiens (human)", "description": "Parkinson disease (PD) is a progressive neurodegenerative movement disorder that results primarily from the death of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNc). Both environmental factors and mutations in familial PD-linked genes such as SNCA, Parkin, DJ-1, PINK1 and LRRK2 are associated with PD pathogenesis. These pathogenic mutations and environmental factors are known to cause disease due to oxidative stress, intracellular Ca2+ homeostasis impairment, mitochondrial dysfunctions and altered protein handling compromising key roles of DA neuronal function and survival. The demise of DA neurons located in the SNc leads to a drop in the dopaminergic input to the striatum, which is hypothesized to impede movement by inducing hypo and hyper activity in striatal spiny projection neurons (SPNs) of the direct (dSPNs) and indirect (iSPNs) pathways in the basal ganglia, respectively.", "class": "Human Diseases; Neurodegenerative disease", "pathway_map": "hsa05012  Parkinson disease", "network": ["", "ELEMENT   N01020  Mutation-inactivated PRKN to Parkin-mediated ubiquitination", "N01022  Mutation-inactivated PRKN to Parkin-mediated ubiquitination", "N01024  Mutation-inactivated PRKN to Parkin-mediated ubiquitination", "N01026  Mutation-inactivated PRKN to Parkin-mediated ubiquitination", "N01028  Mutation-inactivated UCHL1 to UCHL1-mediated hydrolysis", "N01030  Mutation-caused aberrant SNCA to 26S proteasome-mediated protein degradation", "N01031  Mutation-caused aberrant SNCA to VGCC-Ca2+ -apoptotic pathway", "N01032  Mutation-inactivated PRKN to mGluR1 signaling pathway", "N01033  Mutation-caused aberrant SNCA to ATF6-mediated transcription", "N01034  Mutation-caused aberrant SNCA to IRE1a-XBP1 signaling pathway", "N01035  Mutation-caused aberrant SNCA to PERK-ATF4 signaling pathway", "N01037  Mutation-caused aberrant SNCA to L-DOPA generation", "N01039  Mutation-inactivated PRKN to DOPAL generation", "N01041  Mutation-caused aberrant SNCA to transport of dopamine", "N01042  Mutation-caused aberrant SNCA to electron transfer in Complex I", "N01043  Mutation-inactivated PINK1 to electron transfer in Complex I", "N01044  MPP+ to electron transfer in Complex I", "N01045  Rotenone to electron transfer in Complex I", "N01046  Maneb to electron transfer in Complex III", "N01047  Mutation-activated LRRK2 to intrinsic apoptotic pathway", "N01048  Mutation-inactivated PINK1 to intrinsic apoptotic pathway", "N01049  Mutation-inactivated PRKN to intrinsic apoptotic pathway", "N01050  Mutation-inactivated PINK1 to intrinsic apoptotic pathway", "N01051  Mutation-inactivated DJ1 to intrinsic apoptotic pathway", "N01053  Mutation-inactivated PINK1 to PINK1-Parkin-mediated MFN2 degradation", "N01054  Mutation-inactivated PRKN to PINK1-Parkin-mediated MFN2 degradation", "N01055  Mutation-caused aberrant SNCA to anterograde axonal transport", "N01057  Mutation-inactivated DJ1 to FAS-JNK signaling patwhay", "N01058  Mutation-inactivated DJ1 to to p53-mediated transcription", "N01059  Mutation-inactivated DJ1 to KEAP1-NRF2 signaling pathway", "N01402  Manganese to electron transfer in Complex II", "N01417  Paraquat to FAS-JNK signaling pathway"], "disease": ["H00057  Parkinson disease"], "drug": ["D00059  Levodopa (JP18/USP/INN)", "D00502  Pergolide mesylate (USP)", "D00559  Pramipexole dihydrochloride (USP)", "D00780  Bromocriptine mesylate (USP)", "D00784  Ropinirole hydrochloride (JAN/USP)", "D00987  Cabergoline (JP18/USP/INN)", "D01505  Talipexole hydrochloride (JAN)", "D02004  Apomorphine hydrochloride (USP)", "D03165  Bromocriptine (USAN/INN)", "D04641  Istradefylline (JAN/USAN/INN)", "D05575  Pramipexole (USAN/INN)", "D05768  Rotigotine (JAN/USAN/INN)", "D05804  Sarizotan hydrochloride (USAN)", "D07460  Apomorphine (BAN)", "D08339  Pergolide (INN)", "D08489  Ropinirole (USAN/INN)", "D10014  Ioflupane I 123 (USAN)", "D11420  Prasinezumab (USAN/INN)", "D11467  Cinpanemab (USAN)", "D12796  Minzasolmin (USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["135  ADORA2A; adenosine A2a receptor [KO:K04266]", "2774  GNAL; G protein subunit alpha L [KO:K04633]", "2778  GNAS; GNAS complex locus [KO:K04632]", "1813  DRD2; dopamine receptor D2 [KO:K04145]", "2770  GNAI1; G protein subunit alpha i1 [KO:K04630]", "2773  GNAI3; G protein subunit alpha i3 [KO:K04630]", "2771  GNAI2; G protein subunit alpha i2 [KO:K04630]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "1812  DRD1; dopamine receptor D1 [KO:K04144]", "7317  UBA1; ubiquitin like modifier activating enzyme 1 [KO:K03178] [EC:6.2.1.45]", "7318  UBA7; ubiquitin like modifier activating enzyme 7 [KO:K10698] [EC:6.2.1.45]", "7311  UBA52; ubiquitin A-52 residue ribosomal protein fusion product 1 [KO:K02927]", "6233  RPS27A; ribosomal protein S27a [KO:K02977]", "7314  UBB; ubiquitin B [KO:K04551]", "7316  UBC; ubiquitin C [KO:K08770]", "7332  UBE2L3; ubiquitin conjugating enzyme E2 L3 [KO:K04552] [EC:2.3.2.23]", "9246  UBE2L6; ubiquitin conjugating enzyme E2 L6 [KO:K04553] [EC:2.3.2.23]", "118424  UBE2J2; ubiquitin conjugating enzyme E2 J2 [KO:K04554] [EC:2.3.2.23]", "51465  UBE2J1; ubiquitin conjugating enzyme E2 J1 [KO:K10578] [EC:2.3.2.23]", "7327  UBE2G2; ubiquitin conjugating enzyme E2 G2 [KO:K04555] [EC:2.3.2.23]", "7326  UBE2G1; ubiquitin conjugating enzyme E2 G1 [KO:K10575] [EC:2.3.2.23]", "5071  PRKN; parkin RBR E3 ubiquitin protein ligase [KO:K04556] [EC:2.3.2.31]", "6622  SNCA; synuclein alpha [KO:K04528]", "2861  GPR37; G protein-coupled receptor 37 [KO:K04243]", "5413  SEPTIN5; septin 5 [KO:K04557]", "9627  SNCAIP; synuclein alpha interacting protein [KO:K04558]", "5687  PSMA6; proteasome 20S subunit alpha 6 [KO:K02730] [EC:3.4.25.1]", "5683  PSMA2; proteasome 20S subunit alpha 2 [KO:K02726] [EC:3.4.25.1]", "5685  PSMA4; proteasome 20S subunit alpha 4 [KO:K02728] [EC:3.4.25.1]", "5688  PSMA7; proteasome 20S subunit alpha 7 [KO:K02731] [EC:3.4.25.1]", "143471  PSMA8; proteasome 20S subunit alpha 8 [KO:K02731] [EC:3.4.25.1]", "5686  PSMA5; proteasome 20S subunit alpha 5 [KO:K02729] [EC:3.4.25.1]", "5682  PSMA1; proteasome 20S subunit alpha 1 [KO:K02725] [EC:3.4.25.1]", "5684  PSMA3; proteasome 20S subunit alpha 3 [KO:K02727] [EC:3.4.25.1]", "5694  PSMB6; proteasome 20S subunit beta 6 [KO:K02738] [EC:3.4.25.1]", "5695  PSMB7; proteasome 20S subunit beta 7 [KO:K02739] [EC:3.4.25.1]", "5691  PSMB3; proteasome 20S subunit beta 3 [KO:K02735] [EC:3.4.25.1]", "5690  PSMB2; proteasome 20S subunit beta 2 [KO:K02734] [EC:3.4.25.1]", "5693  PSMB5; proteasome 20S subunit beta 5 [KO:K02737] [EC:3.4.25.1]", "5689  PSMB1; proteasome 20S subunit beta 1 [KO:K02732] [EC:3.4.25.1]", "5692  PSMB4; proteasome 20S subunit beta 4 [KO:K02736] [EC:3.4.25.1]", "5701  PSMC2; proteasome 26S subunit, ATPase 2 [KO:K03061]", "5700  PSMC1; proteasome 26S subunit, ATPase 1 [KO:K03062]", "5704  PSMC4; proteasome 26S subunit, ATPase 4 [KO:K03063]", "5706  PSMC6; proteasome 26S subunit, ATPase 6 [KO:K03064]", "5702  PSMC3; proteasome 26S subunit, ATPase 3 [KO:K03065]", "5705  PSMC5; proteasome 26S subunit, ATPase 5 [KO:K03066]", "5708  PSMD2; proteasome 26S subunit ubiquitin receptor, non-ATPase 2 [KO:K03028]", "5707  PSMD1; proteasome 26S subunit, non-ATPase 1 [KO:K03032]", "5709  PSMD3; proteasome 26S subunit, non-ATPase 3 [KO:K03033]", "5715  PSMD9; proteasome 26S subunit, non-ATPase 9 [KO:K06693]", "5718  PSMD12; proteasome 26S subunit, non-ATPase 12 [KO:K03035]", "5717  PSMD11; proteasome 26S subunit, non-ATPase 11 [KO:K03036]", "9861  PSMD6; proteasome 26S subunit, non-ATPase 6 [KO:K03037]", "5713  PSMD7; proteasome 26S subunit, non-ATPase 7 [KO:K03038]", "5719  PSMD13; proteasome 26S subunit, non-ATPase 13 [KO:K03039]", "5710  PSMD4; proteasome 26S subunit ubiquitin receptor, non-ATPase 4 [KO:K03029]", "10213  PSMD14; proteasome 26S subunit, non-ATPase 14 [KO:K03030]", "5714  PSMD8; proteasome 26S subunit, non-ATPase 8 [KO:K03031]", "11047  ADRM1; ADRM1 26S proteasome ubiquitin receptor [KO:K06691]", "7979  SEM1; SEM1 26S proteasome subunit [KO:K10881]", "7345  UCHL1; ubiquitin C-terminal hydrolase L1 [KO:K05611] [EC:3.4.19.12]", "810  CALML3; calmodulin like 3 [KO:K02183]", "805  CALM2; calmodulin 2 [KO:K02183]", "808  CALM3; calmodulin 3 [KO:K02183]", "801  CALM1; calmodulin 1 [KO:K02183]", "163688  CALML6; calmodulin like 6 [KO:K02183]", "51806  CALML5; calmodulin like 5 [KO:K02183]", "91860  CALML4; calmodulin like 4 [KO:K02183]", "815  CAMK2A; calcium/calmodulin dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]", "817  CAMK2D; calcium/calmodulin dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]", "816  CAMK2B; calcium/calmodulin dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]", "818  CAMK2G; calcium/calmodulin dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]", "4137  MAPT; microtubule associated protein tau [KO:K04380]", "6263  RYR3; ryanodine receptor 3 [KO:K04963]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "3309  HSPA5; heat shock protein family A (Hsp70) member 5 [KO:K09490] [EC:3.6.4.10]", "22926  ATF6; activating transcription factor 6 [KO:K09054]", "1649  DDIT3; DNA damage inducible transcript 3 [KO:K04452]", "2081  ERN1; endoplasmic reticulum to nucleus signaling 1 [KO:K08852] [EC:2.7.11.1 3.1.26.-]", "7494  XBP1; X-box binding protein 1 [KO:K09027]", "9451  EIF2AK3; eukaryotic translation initiation factor 2 alpha kinase 3 [KO:K08860] [EC:2.7.11.1]", "1965  EIF2S1; eukaryotic translation initiation factor 2 subunit alpha [KO:K03237]", "468  ATF4; activating transcription factor 4 [KO:K04374]", "7054  TH; tyrosine hydroxylase [KO:K00501] [EC:1.14.16.2]", "4129  MAOB; monoamine oxidase B [KO:K00274] [EC:1.4.3.4]", "4128  MAOA; monoamine oxidase A [KO:K00274] [EC:1.4.3.4]", "6531  SLC6A3; solute carrier family 6 member 3 [KO:K05036]", "6570  SLC18A1; solute carrier family 18 member A1 [KO:K08155]", "6571  SLC18A2; solute carrier family 18 member A2 [KO:K08155]", "4891  SLC11A2; solute carrier family 11 member 2 [KO:K21398]", "29986  SLC39A2; solute carrier family 39 member 2 [KO:K14709]", "29985  SLC39A3; solute carrier family 39 member 3 [KO:K14709]", "27173  SLC39A1; solute carrier family 39 member 1 [KO:K14709]", "55630  SLC39A4; solute carrier family 39 member 4 [KO:K14710]", "283375  SLC39A5; solute carrier family 39 member 5 [KO:K14711]", "25800  SLC39A6; solute carrier family 39 member 6 [KO:K14712]", "7922  SLC39A7; solute carrier family 39 member 7 [KO:K14713]", "64116  SLC39A8; solute carrier family 39 member 8 [KO:K14714]", "55334  SLC39A9; solute carrier family 39 member 9 [KO:K14715]", "57181  SLC39A10; solute carrier family 39 member 10 [KO:K14716]", "201266  SLC39A11; solute carrier family 39 member 11 [KO:K14717]", "221074  SLC39A12; solute carrier family 39 member 12 [KO:K14718]", "91252  SLC39A13; solute carrier family 39 member 13 [KO:K14719]", "23516  SLC39A14; solute carrier family 39 member 14 [KO:K14720]", "4535  ND1; NADH dehydrogenase subunit 1 [KO:K03878] [EC:7.1.1.2]", "4536  ND2; NADH dehydrogenase subunit 2 [KO:K03879] [EC:7.1.1.2]", "4537  ND3; NADH dehydrogenase subunit 3 [KO:K03880] [EC:7.1.1.2]", "4538  ND4; NADH dehydrogenase subunit 4 [KO:K03881] [EC:7.1.1.2]", "4539  ND4L; NADH dehydrogenase subunit 4L [KO:K03882] [EC:7.1.1.2]", "4540  ND5; NADH dehydrogenase subunit 5 [KO:K03883] [EC:7.1.1.2]", "4541  ND6; NADH dehydrogenase subunit 6 [KO:K03884] [EC:7.1.1.2]", "4723  NDUFV1; NADH:ubiquinone oxidoreductase core subunit V1 [KO:K03942] [EC:7.1.1.2]", "4729  NDUFV2; NADH:ubiquinone oxidoreductase core subunit V2 [KO:K03943] [EC:7.1.1.2]", "4731  NDUFV3; NADH:ubiquinone oxidoreductase subunit V3 [KO:K03944]", "4694  NDUFA1; NADH:ubiquinone oxidoreductase subunit A1 [KO:K03945]", "4695  NDUFA2; NADH:ubiquinone oxidoreductase subunit A2 [KO:K03946]", "4696  NDUFA3; NADH:ubiquinone oxidoreductase subunit A3 [KO:K03947]", "4697  NDUFA4; NDUFA4 mitochondrial complex associated [KO:K03948]", "56901  NDUFA4L2; NDUFA4 mitochondrial complex associated like 2 [KO:K03948]", "4698  NDUFA5; NADH:ubiquinone oxidoreductase subunit A5 [KO:K03949]", "4700  NDUFA6; NADH:ubiquinone oxidoreductase subunit A6 [KO:K03950]", "4701  NDUFA7; NADH:ubiquinone oxidoreductase subunit A7 [KO:K03951]", "4702  NDUFA8; NADH:ubiquinone oxidoreductase subunit A8 [KO:K03952]", "4704  NDUFA9; NADH:ubiquinone oxidoreductase subunit A9 [KO:K03953]", "4705  NDUFA10; NADH:ubiquinone oxidoreductase subunit A10 [KO:K03954]", "4706  NDUFAB1; NADH:ubiquinone oxidoreductase subunit AB1 [KO:K03955]", "126328  NDUFA11; NADH:ubiquinone oxidoreductase subunit A11 [KO:K03956]", "55967  NDUFA12; NADH:ubiquinone oxidoreductase subunit A12 [KO:K11352]", "51079  NDUFA13; NADH:ubiquinone oxidoreductase subunit A13 [KO:K11353]", "4707  NDUFB1; NADH:ubiquinone oxidoreductase subunit B1 [KO:K03957]", "4708  NDUFB2; NADH:ubiquinone oxidoreductase subunit B2 [KO:K03958]", "4709  NDUFB3; NADH:ubiquinone oxidoreductase subunit B3 [KO:K03959]", "4710  NDUFB4; NADH:ubiquinone oxidoreductase subunit B4 [KO:K03960]", "4711  NDUFB5; NADH:ubiquinone oxidoreductase subunit B5 [KO:K03961]", "4712  NDUFB6; NADH:ubiquinone oxidoreductase subunit B6 [KO:K03962]", "4713  NDUFB7; NADH:ubiquinone oxidoreductase subunit B7 [KO:K03963]", "4714  NDUFB8; NADH:ubiquinone oxidoreductase subunit B8 [KO:K03964]", "4715  NDUFB9; NADH:ubiquinone oxidoreductase subunit B9 [KO:K03965]", "4716  NDUFB10; NADH:ubiquinone oxidoreductase subunit B10 [KO:K03966]", "54539  NDUFB11; NADH:ubiquinone oxidoreductase subunit B11 [KO:K11351]", "4719  NDUFS1; NADH:ubiquinone oxidoreductase core subunit S1 [KO:K03934] [EC:7.1.1.2]", "4720  NDUFS2; NADH:ubiquinone oxidoreductase core subunit S2 [KO:K03935] [EC:7.1.1.2]", "4722  NDUFS3; NADH:ubiquinone oxidoreductase core subunit S3 [KO:K03936] [EC:7.1.1.2]", "4724  NDUFS4; NADH:ubiquinone oxidoreductase subunit S4 [KO:K03937]", "4725  NDUFS5; NADH:ubiquinone oxidoreductase subunit S5 [KO:K03938]", "4726  NDUFS6; NADH:ubiquinone oxidoreductase subunit S6 [KO:K03939]", "374291  NDUFS7; NADH:ubiquinone oxidoreductase core subunit S7 [KO:K03940] [EC:7.1.1.2]", "4728  NDUFS8; NADH:ubiquinone oxidoreductase core subunit S8 [KO:K03941] [EC:7.1.1.2]", "4717  NDUFC1; NADH:ubiquinone oxidoreductase subunit C1 [KO:K03967]", "4718  NDUFC2; NADH:ubiquinone oxidoreductase subunit C2 [KO:K03968]", "100532726  NDUFC2-KCTD14; NDUFC2-KCTD14 readthrough [KO:K03968]", "6389  SDHA; succinate dehydrogenase complex flavoprotein subunit A [KO:K00234] [EC:1.3.5.1]", "6390  SDHB; succinate dehydrogenase complex iron sulfur subunit B [KO:K00235] [EC:1.3.5.1]", "6391  SDHC; succinate dehydrogenase complex subunit C [KO:K00236]", "6392  SDHD; succinate dehydrogenase complex subunit D [KO:K00237]", "7386  UQCRFS1; ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 [KO:K00411] [EC:7.1.1.8]", "4519  CYTB; cytochrome b [KO:K00412]", "1537  CYC1; cytochrome c1 [KO:K00413]", "7384  UQCRC1; ubiquinol-cytochrome c reductase core protein 1 [KO:K00414]", "7385  UQCRC2; ubiquinol-cytochrome c reductase core protein 2 [KO:K00415]", "7388  UQCRH; ubiquinol-cytochrome c reductase hinge protein [KO:K00416]", "440567  UQCRHL; ubiquinol-cytochrome c reductase hinge protein like [KO:K00416]", "7381  UQCRB; ubiquinol-cytochrome c reductase binding protein [KO:K00417]", "27089  UQCRQ; ubiquinol-cytochrome c reductase complex III subunit VII [KO:K00418]", "29796  UQCR10; ubiquinol-cytochrome c reductase, complex III subunit X [KO:K00419]", "10975  UQCR11; ubiquinol-cytochrome c reductase, complex III subunit XI [KO:K00420]", "4514  COX3; cytochrome c oxidase subunit III [KO:K02262]", "4512  COX1; cytochrome c oxidase subunit I [KO:K02256] [EC:7.1.1.9]", "4513  COX2; cytochrome c oxidase subunit II [KO:K02261]", "84701  COX4I2; cytochrome c oxidase subunit 4I2 [KO:K02263]", "1327  COX4I1; cytochrome c oxidase subunit 4I1 [KO:K02263]", "9377  COX5A; cytochrome c oxidase subunit 5A [KO:K02264]", "1329  COX5B; cytochrome c oxidase subunit 5B [KO:K02265]", "1337  COX6A1; cytochrome c oxidase subunit 6A1 [KO:K02266]", "1339  COX6A2; cytochrome c oxidase subunit 6A2 [KO:K02266]", "1340  COX6B1; cytochrome c oxidase subunit 6B1 [KO:K02267]", "125965  COX6B2; cytochrome c oxidase subunit 6B2 [KO:K02267]", "1345  COX6C; cytochrome c oxidase subunit 6C [KO:K02268]", "1346  COX7A1; cytochrome c oxidase subunit 7A1 [KO:K02270]", "1347  COX7A2; cytochrome c oxidase subunit 7A2 [KO:K02270]", "9167  COX7A2L; cytochrome c oxidase subunit 7A2 like [KO:K02270]", "1349  COX7B; cytochrome c oxidase subunit 7B [KO:K02271]", "170712  COX7B2; cytochrome c oxidase subunit 7B2 [KO:K02271]", "1350  COX7C; cytochrome c oxidase subunit 7C [KO:K02272]", "341947  COX8C; cytochrome c oxidase subunit 8C [KO:K02273]", "1351  COX8A; cytochrome c oxidase subunit 8A [KO:K02273]", "498  ATP5F1A; ATP synthase F1 subunit alpha [KO:K02132]", "506  ATP5F1B; ATP synthase F1 subunit beta [KO:K02133] [EC:7.1.2.2]", "509  ATP5F1C; ATP synthase F1 subunit gamma [KO:K02136]", "513  ATP5F1D; ATP synthase F1 subunit delta [KO:K02134]", "514  ATP5F1E; ATP synthase F1 subunit epsilon [KO:K02135]", "4508  ATP6; ATP synthase F0 subunit 6 [KO:K02126]", "515  ATP5PB; ATP synthase peripheral stalk-membrane subunit b [KO:K02127]", "516  ATP5MC1; ATP synthase membrane subunit c locus 1 [KO:K02128]", "517  ATP5MC2; ATP synthase membrane subunit c locus 2 [KO:K02128]", "518  ATP5MC3; ATP synthase membrane subunit c locus 3 [KO:K02128]", "10476  ATP5PD; ATP synthase peripheral stalk subunit d [KO:K02138]", "539  ATP5PO; ATP synthase peripheral stalk subunit OSCP [KO:K02137]", "522  ATP5PF; ATP synthase peripheral stalk subunit F6 [KO:K02131]", "4509  ATP8; ATP synthase F0 subunit 8 [KO:K02125]", "65018  PINK1; PTEN induced kinase 1 [KO:K05688] [EC:2.7.11.1]", "90550  MCU; mitochondrial calcium uniporter [KO:K20858]", "120892  LRRK2; leucine rich repeat kinase 2 [KO:K08844] [EC:2.7.11.1]", "27429  HTRA2; HtrA serine peptidase 2 [KO:K08669] [EC:3.4.21.108]", "10131  TRAP1; TNF receptor associated protein 1 [KO:K09488]", "7416  VDAC1; voltage dependent anion channel 1 [KO:K05862]", "7417  VDAC2; voltage dependent anion channel 2 [KO:K15040]", "7419  VDAC3; voltage dependent anion channel 3 [KO:K15041]", "291  SLC25A4; solute carrier family 25 member 4 [KO:K05863]", "292  SLC25A5; solute carrier family 25 member 5 [KO:K05863]", "293  SLC25A6; solute carrier family 25 member 6 [KO:K05863]", "83447  SLC25A31; solute carrier family 25 member 31 [KO:K05863]", "10105  PPIF; peptidylprolyl isomerase F [KO:K09565] [EC:5.2.1.8]", "54205  CYCS; cytochrome c, somatic [KO:K08738]", "317  APAF1; apoptotic peptidase activating factor 1 [KO:K02084]", "842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "11315  PARK7; Parkinsonism associated deglycase [KO:K05687] [EC:3.5.1.124]", "598  BCL2L1; BCL2 like 1 [KO:K04570]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "55669  MFN1; mitofusin 1 [KO:K21356] [EC:3.6.5.-]", "9927  MFN2; mitofusin 2 [KO:K06030] [EC:3.6.5.-]", "3798  KIF5A; kinesin family member 5A [KO:K10396]", "3799  KIF5B; kinesin family member 5B [KO:K10396]", "3800  KIF5C; kinesin family member 5C [KO:K10396]", "147700  KLC3; kinesin light chain 3 [KO:K10407]", "3831  KLC1; kinesin light chain 1 [KO:K10407]", "64837  KLC2; kinesin light chain 2 [KO:K10407]", "89953  KLC4; kinesin light chain 4 [KO:K10407]", "10376  TUBA1B; tubulin alpha 1b [KO:K07374]", "7277  TUBA4A; tubulin alpha 4a [KO:K07374]", "7278  TUBA3C; tubulin alpha 3c [KO:K07374]", "7846  TUBA1A; tubulin alpha 1a [KO:K07374]", "84790  TUBA1C; tubulin alpha 1c [KO:K07374]", "51807  TUBA8; tubulin alpha 8 [KO:K07374]", "112714  TUBA3E; tubulin alpha 3e [KO:K07374]", "113457  TUBA3D; tubulin alpha 3d [KO:K07374]", "79861  TUBAL3; tubulin alpha like 3 [KO:K07374]", "84617  TUBB6; tubulin beta 6 class V [KO:K07375]", "203068  TUBB; tubulin beta class I [KO:K07375]", "81027  TUBB1; tubulin beta 1 class VI [KO:K07375]", "7280  TUBB2A; tubulin beta 2A class IIa [KO:K07375]", "10381  TUBB3; tubulin beta 3 class III [KO:K07375]", "10382  TUBB4A; tubulin beta 4A class IVa [KO:K07375]", "347688  TUBB8; tubulin beta 8 class VIII [KO:K07375]", "347733  TUBB2B; tubulin beta 2B class IIb [KO:K07375]", "10383  TUBB4B; tubulin beta 4B class IVb [KO:K07375]", "7157  TP53; tumor protein p53 [KO:K04451]", "1843  DUSP1; dual specificity phosphatase 1 [KO:K21278] [EC:3.1.3.16 3.1.3.48]", "4780  NFE2L2; NFE2 like bZIP transcription factor 2 [KO:K05638]", "7295  TXN; thioredoxin [KO:K03671]", "25828  TXN2; thioredoxin 2 [KO:K03671]", "1616  DAXX; death domain associated protein [KO:K02308]", "4217  MAP3K5; mitogen-activated protein kinase kinase kinase 5 [KO:K04426] [EC:2.7.11.25]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "6647  SOD1; superoxide dismutase 1 [KO:K04565] [EC:1.15.1.1]", "9817  KEAP1; kelch like ECH associated protein 1 [KO:K10456]"], "compound": ["C00002  ATP", "C00007  Oxygen", "C00008  ADP", "C00009  Orthophosphate", "C00013  Diphosphate", "C00020  AMP", "C00027  Hydrogen peroxide", "C00034  Manganese", "C00076  Calcium cation", "C00082  L-Tyrosine", "C00165  Diacylglycerol", "C00212  Adenosine", "C00355  3,4-Dihydroxy-L-phenylalanine", "C00575  3',5'-Cyclic AMP", "C00704  Superoxide", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C03758  Dopamine", "C04043  3,4-Dihydroxyphenylacetaldehyde", "C04599  1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "C07593  Rotenone", "C11310  1-Methyl-4-phenylpyridinium", "C14701  Paraquat", "C15231  Maneb", "C16844  Hydroxyl radical", "C17755  Dopamine quinone", "C22381  Reactive oxygen species"], "refs": [{"pmid": "16495942", "authors": "  Abou-Sleiman PM, Muqit MM, Wood NW", "title": "Expanding insights of mitochondrial dysfunction in Parkinson's disease.", "journal": "Nat Rev Neurosci 7:207-19 (2006)", "doi": "10.1038/nrn1868"}, {"pmid": "12938733", "authors": "  Lim KL, Lim TM", "title": "Molecular mechanisms of neurodegeneration in Parkinson's disease: clues from Mendelian syndromes.", "journal": "IUBMB Life 55:315-22 (2003)", "doi": "10.1080/1521654031000153030"}, {"pmid": "26501339", "authors": "  Bobela W, Aebischer P, Schneider BL", "title": "Alphalpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson's Disease.", "journal": "Biomolecules 5:2675-700 (2015)", "doi": "10.3390/biom5042675"}, {"pmid": "15767499", "authors": "  Eriksen JL, Wszolek Z, Petrucelli L", "title": "Molecular pathogenesis of Parkinson disease.", "journal": "Arch Neurol 62:353-7 (2005)", "doi": "10.1001/archneur.62.3.353"}, {"pmid": "16972273", "authors": "  Olanow CW, McNaught KS", "title": "Ubiquitin-proteasome system and Parkinson's disease.", "journal": "Mov Disord 21:1806-23 (2006)", "doi": "10.1002/mds.21013"}, {"pmid": "18047737", "authors": "  Lim KL, Tan JM", "title": "Role of the ubiquitin proteasome system in Parkinson's disease.", "journal": "BMC Biochem 8 Suppl 1:S13 (2007)", "doi": "10.1186/1471-2091-8-S1-S13"}, {"pmid": "29090092", "authors": "  Maiti P, Manna J, Dunbar GL", "title": "Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments.", "journal": "Transl Neurodegener 6:28 (2017)", "doi": "10.1186/s40035-017-0099-z"}, {"pmid": "12814656", "authors": "  Dev KK, van der Putten H, Sommer B, Rovelli G", "title": "Part I: parkin-associated proteins and Parkinson's disease.", "journal": "Neuropharmacology 45:1-13 (2003)", "doi": "10.1016/s0028-3908(02)00337-4"}, {"pmid": "20495568", "authors": "  Obeso JA, Rodriguez-Oroz MC, Goetz CG, Marin C, Kordower JH, Rodriguez M, Hirsch EC, Farrer M, Schapira AH, Halliday G", "title": "Missing pieces in the Parkinson's disease puzzle.", "journal": "Nat Med 16:653-61 (2010)", "doi": "10.1038/nm.2165"}, {"pmid": "24781149", "authors": "  Cali T, Ottolini D, Brini M", "title": "Calcium signaling in Parkinson's disease.", "journal": "Cell Tissue Res 357:439-54 (2014)", "doi": "10.1007/s00441-014-1866-0"}, {"pmid": "19230774", "authors": "  Bezprozvanny I", "title": "Calcium signaling and neurodegenerative diseases.", "journal": "Trends Mol Med 15:89-100 (2009)", "doi": "10.1016/j.molmed.2009.01.001"}, {"pmid": "28468938", "authors": "  Zaichick SV, McGrath KM, Caraveo G", "title": "The role of Ca(2+) signaling in Parkinson's disease.", "journal": "Dis Model Mech 10:519-535 (2017)", "doi": "10.1242/dmm.028738"}, {"pmid": "28838811", "authors": "  Ludtmann MHR, Abramov AY", "title": "Mitochondrial calcium imbalance in Parkinson's disease.", "journal": "Neurosci Lett 663:86-90 (2018)", "doi": "10.1016/j.neulet.2017.08.044"}, {"pmid": "19663908", "authors": "  Sandebring A, Dehvari N, Perez-Manso M, Thomas KJ, Karpilovski E, Cookson MR, Cowburn RF, Cedazo-Minguez A", "title": "Parkin deficiency disrupts calcium homeostasis by modulating phospholipase C signalling.", "journal": "FEBS J 276:5041-52 (2009)", "doi": "10.1111/j.1742-4658.2009.07201.x"}, {"pmid": "23352769", "authors": "  Mercado G, Valdes P, Hetz C", "title": "An ERcentric view of Parkinson's disease.", "journal": "Trends Mol Med 19:165-75 (2013)", "doi": "10.1016/j.molmed.2012.12.005"}, {"pmid": "27103567", "authors": "  Mercado G, Castillo V, Soto P, Sidhu A", "title": "ER stress and Parkinson's disease: Pathological inputs that converge into the secretory pathway.", "journal": "Brain Res 1648:626-632 (2016)", "doi": "10.1016/j.brainres.2016.04.042"}, {"pmid": "26297973", "authors": "  Tsujii S, Ishisaka M, Hara H", "title": "Modulation of endoplasmic reticulum stress in Parkinson's disease.", "journal": "Eur J Pharmacol 765:154-6 (2015)", "doi": "10.1016/j.ejphar.2015.08.033"}, {"pmid": "31100053", "authors": "  Shah A, Chao J, Legido-Quigley C, Chang RC", "title": "Oxyresveratrol exerts ATF4- and Grp78-mediated neuroprotection against endoplasmic reticulum stress in experimental Parkinson's disease.", "journal": "Nutr Neurosci 1-16 (2019)", "doi": "10.1080/1028415X.2019.1613764"}, {"pmid": "24548101", "authors": "  Segura-Aguilar J, Paris I, Munoz P, Ferrari E, Zecca L, Zucca FA", "title": "Protective and toxic roles of dopamine in Parkinson's disease.", "journal": "J Neurochem 129:898-915 (2014)", "doi": "10.1111/jnc.12686"}, {"pmid": "15189334", "authors": "  Perez RG, Hastings TG", "title": "Could a loss of alpha-synuclein function put dopaminergic neurons at risk?", "journal": "J Neurochem 89:1318-24 (2004)", "doi": "10.1111/j.1471-4159.2004.02423.x"}, {"pmid": "26487845", "authors": "  Segura-Aguilar J", "title": "A new mechanism for protection of dopaminergic neurons mediated by astrocytes.", "journal": "Neural Regen Res 10:1225-7 (2015)", "doi": "10.4103/1673-5374.162750"}, {"pmid": "27546335", "authors": "  Bose A, Beal MF", "title": "Mitochondrial dysfunction in Parkinson's disease.", "journal": "J Neurochem 139 Suppl 1:216-231 (2016)", "doi": "10.1111/jnc.13731"}, {"pmid": "27581196", "authors": "  Cieri D, Brini M, Cali T", "title": "Emerging (and converging) pathways in Parkinson's disease: keeping mitochondrial wellness.", "journal": "Biochem Biophys Res Commun 483:1020-1030 (2017)", "doi": "10.1016/j.bbrc.2016.08.153"}, {"pmid": "27829983", "authors": "  Mack JM, Schamne MG, Sampaio TB, Pertile RA, Fernandes PA, Markus RP, Prediger RD", "title": "Melatoninergic System in Parkinson's Disease: From Neuroprotection to the Management of Motor and Nonmotor Symptoms.", "journal": "Oxid Med Cell Longev 2016:3472032 (2016)", "doi": "10.1155/2016/3472032"}, {"pmid": "21674642", "authors": "  Cali T, Ottolini D, Brini M", "title": "Mitochondria, calcium, and endoplasmic reticulum stress in Parkinson's disease.", "journal": "Biofactors 37:228-40 (2011)", "doi": "10.1002/biof.159"}, {"pmid": "24522549", "authors": "  Gaki GS, Papavassiliou AG", "title": "Oxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson's disease.", "journal": "Neuromolecular Med 16:217-30 (2014)", "doi": "10.1007/s12017-014-8294-x"}, {"pmid": "25761946", "authors": "  Franco-Iborra S, Vila M, Perier C", "title": "The Parkinson Disease Mitochondrial Hypothesis: Where Are We at?", "journal": "Neuroscientist 22:266-77 (2016)", "doi": "10.1177/1073858415574600"}, {"pmid": "22926193", "authors": "  de Vries RL, Przedborski S", "title": "Mitophagy and Parkinson's disease: be eaten to stay healthy.", "journal": "Mol Cell Neurosci 55:37-43 (2013)", "doi": "10.1016/j.mcn.2012.07.008"}, {"pmid": "20736035", "authors": "  Deas E, Wood NW, Plun-Favreau H", "title": "Mitophagy and Parkinson's disease: the PINK1-parkin link.", "journal": "Biochim Biophys Acta 1813:623-33 (2011)", "doi": "10.1016/j.bbamcr.2010.08.007"}, {"pmid": "25611507", "authors": "  Pickrell AM, Youle RJ", "title": "The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease.", "journal": "Neuron 85:257-73 (2015)", "doi": "10.1016/j.neuron.2014.12.007"}, {"pmid": "27911343", "authors": "  Truban D, Hou X, Caulfield TR, Fiesel FC, Springer W", "title": "PINK1, Parkin, and Mitochondrial Quality Control: What can we Learn about Parkinson's Disease Pathobiology?", "journal": "J Parkinsons Dis 7:13-29 (2017)", "doi": "10.3233/JPD-160989"}, {"pmid": "28823929", "authors": "  Biosa A, Sandrelli F, Beltramini M, Greggio E, Bubacco L, Bisaglia M", "title": "Recent findings on the physiological function of DJ-1: Beyond Parkinson's disease.", "journal": "Neurobiol Dis 108:65-72 (2017)", "doi": "10.1016/j.nbd.2017.08.005"}, {"pmid": "29147906", "authors": "  Oh SE, Mouradian MM", "title": "Regulation of Signal Transduction by DJ-1.", "journal": "Adv Exp Med Biol 1037:97-131 (2017)", "doi": "10.1007/978-981-10-6583-5_8"}, {"pmid": "31054074", "authors": "  Dolgacheva LP, Berezhnov AV, Fedotova EI, Zinchenko VP, Abramov AY", "title": "Role of DJ-1 in the mechanism of pathogenesis of Parkinson's disease.", "journal": "J Bioenerg Biomembr 51:175-188 (2019)", "doi": "10.1007/s10863-019-09798-4"}, {"pmid": "30370500", "authors": "  Melo TQ, Copray SJCVM, Ferrari MFR", "title": "Alpha-Synuclein Toxicity on Protein Quality Control, Mitochondria and Endoplasmic Reticulum.", "journal": "Neurochem Res 43:2212-2223 (2018)", "doi": "10.1007/s11064-018-2673-x"}, {"pmid": "30937538", "authors": "  Zhai S, Shen W, Graves SM, Surmeier DJ", "title": "Dopaminergic modulation of striatal function and Parkinson's disease.", "journal": "J Neural Transm (Vienna) 126:411-422 (2019)", "doi": "10.1007/s00702-019-01997-y"}], "rel_pathway": ["hsa00190  Oxidative phosphorylation", "hsa00350  Tyrosine metabolism", "hsa03050  Proteasome", "hsa04020  Calcium signaling pathway", "hsa04120  Ubiquitin mediated proteolysis", "hsa04137  Mitophagy - animal", "hsa04141  Protein processing in endoplasmic reticulum", "hsa04210  Apoptosis", "hsa04728  Dopaminergic synapse"], "ko_pathway": "ko05012", "genes": ["TP53", "BAX"]}, {"kegg_id": "hsa05016", "name": "Huntington disease - Homo sapiens (human)", "description": "Huntington disease (HD) is an autosomal-dominant neurodegenerative disorder that primarily affects medium spiny striatal neurons (MSN). The symptoms are choreiform, involuntary movements, personality changes and dementia. HD is caused by a CAG repeat expansion in the IT15 gene, which results in a long stretch of polyglutamine (polyQ) close to the amino-terminus of the HD protein huntingtin (Htt). Mutant Htt (mHtt) has effects both in the cytoplasm and in the nucleus. Full-length huntingtin is cleaved by proteases in the cytoplasm, leading to the formation of cytoplasmic and neuritic aggregates. mHtt also alters vesicular transport and recycling, causes cytosolic and mitochondrial Ca2+  overload, triggers endoplasmic reticulum stress through proteasomal dysfunction, and impairs autophagy function, increasing neuronal death susceptibility. N-terminal fragments containing the polyQ strech translocate to the nucleus where they impair transcription and induce neuronal death.", "class": "Human Diseases; Neurodegenerative disease", "pathway_map": "hsa05016  Huntington disease", "network": ["", "ELEMENT   N00977  Mutation-caused aberrant Htt to retrograde axonal transport", "N00979  Mutation-caused aberrant Htt to anterograde axonal transport", "N00980  Mutation-caused aberrant Htt to REST-mediated transcriptional repression", "N00981  Mutation-caused aberrant Htt to CREB-mediated transcription", "N00982  Mutation-caused aberrant Htt to p53-mediated transcription", "N00983  Mutation-caused aberrant Htt to extrinsic apoptotic pathway", "N00985  Mutation-caused aberrant Htt to mGluR5-Ca2+ -apoptotic pathway", "N00986  Mutation-caused aberrant Htt to VGCC-Ca2+ -apoptotic pathway", "N00987  Mutation-caused aberrant Htt to transport of calcium", "N00989  Mutation-caused aberrant Htt to electron transfer in Complex II", "N00991  Mutation-caused aberrant Htt to electron transfer in Complex III", "N00992  Mutation-caused aberrant Htt to TNF-JNK signaling pathway", "N00993  Mutation-caused aberrant Htt to autophagy-vesicle nucleation", "N01061  Mutation-caused aberrant Htt to 26S proteasome-mediated protein degradation"], "disease": ["H00059  Huntington disease"], "drug": ["D12012  Tominersen sodium (JAN)", "D12013  Tominersen (USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["1211  CLTA; clathrin light chain A [KO:K04644]", "1212  CLTB; clathrin light chain B [KO:K04645]", "1213  CLTC; clathrin heavy chain [KO:K04646]", "8218  CLTCL1; clathrin heavy chain like 1 [KO:K04646]", "3092  HIP1; huntingtin interacting protein 1 [KO:K04559]", "161  AP2A2; adaptor related protein complex 2 subunit alpha 2 [KO:K11824]", "160  AP2A1; adaptor related protein complex 2 subunit alpha 1 [KO:K11824]", "163  AP2B1; adaptor related protein complex 2 subunit beta 1 [KO:K11825]", "1173  AP2M1; adaptor related protein complex 2 subunit mu 1 [KO:K11826]", "1175  AP2S1; adaptor related protein complex 2 subunit sigma 1 [KO:K11827]", "3064  HTT; huntingtin [KO:K04533]", "1639  DCTN1; dynactin subunit 1 [KO:K04648]", "10540  DCTN2; dynactin subunit 2 [KO:K10424]", "11258  DCTN3; dynactin subunit 3 [KO:K10425]", "51164  DCTN4; dynactin subunit 4 [KO:K10426]", "84516  DCTN5; dynactin subunit 5 [KO:K10427]", "10671  DCTN6; dynactin subunit 6 [KO:K10428]", "10121  ACTR1A; actin related protein 1A [KO:K16575]", "10120  ACTR1B; actin related protein 1B [KO:K16575]", "55860  ACTR10; actin related protein 10 [KO:K16576]", "9001  HAP1; huntingtin associated protein 1 [KO:K04647]", "25981  DNAH1; dynein axonemal heavy chain 1 [KO:K10408]", "55567  DNAH3; dynein axonemal heavy chain 3 [KO:K10408]", "146754  DNAH2; dynein axonemal heavy chain 2 [KO:K10408]", "56171  DNAH7; dynein axonemal heavy chain 7 [KO:K10408]", "1767  DNAH5; dynein axonemal heavy chain 5 [KO:K10408]", "1768  DNAH6; dynein axonemal heavy chain 6 [KO:K10408]", "1770  DNAH9; dynein axonemal heavy chain 9 [KO:K10408]", "8701  DNAH11; dynein axonemal heavy chain 11 [KO:K10408]", "201625  DNAH12; dynein axonemal heavy chain 12 [KO:K10408]", "127602  DNAH14; dynein axonemal heavy chain 14 [KO:K10408]", "1769  DNAH8; dynein axonemal heavy chain 8 [KO:K10408]", "196385  DNAH10; dynein axonemal heavy chain 10 [KO:K10408]", "8632  DNAH17; dynein axonemal heavy chain 17 [KO:K10408]", "7802  DNALI1; dynein axonemal light intermediate chain 1 [KO:K10410]", "27019  DNAI1; dynein axonemal intermediate chain 1 [KO:K10409]", "64446  DNAI2; dynein axonemal intermediate chain 2 [KO:K11143]", "83544  DNAL1; dynein axonemal light chain 1 [KO:K10411]", "10126  DNAL4; dynein axonemal light chain 4 [KO:K10412]", "10376  TUBA1B; tubulin alpha 1b [KO:K07374]", "7277  TUBA4A; tubulin alpha 4a [KO:K07374]", "7278  TUBA3C; tubulin alpha 3c [KO:K07374]", "7846  TUBA1A; tubulin alpha 1a [KO:K07374]", "84790  TUBA1C; tubulin alpha 1c [KO:K07374]", "51807  TUBA8; tubulin alpha 8 [KO:K07374]", "112714  TUBA3E; tubulin alpha 3e [KO:K07374]", "113457  TUBA3D; tubulin alpha 3d [KO:K07374]", "79861  TUBAL3; tubulin alpha like 3 [KO:K07374]", "84617  TUBB6; tubulin beta 6 class V [KO:K07375]", "203068  TUBB; tubulin beta class I [KO:K07375]", "81027  TUBB1; tubulin beta 1 class VI [KO:K07375]", "7280  TUBB2A; tubulin beta 2A class IIa [KO:K07375]", "10381  TUBB3; tubulin beta 3 class III [KO:K07375]", "10382  TUBB4A; tubulin beta 4A class IVa [KO:K07375]", "347688  TUBB8; tubulin beta 8 class VIII [KO:K07375]", "347733  TUBB2B; tubulin beta 2B class IIb [KO:K07375]", "10383  TUBB4B; tubulin beta 4B class IVb [KO:K07375]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "3798  KIF5A; kinesin family member 5A [KO:K10396]", "3799  KIF5B; kinesin family member 5B [KO:K10396]", "3800  KIF5C; kinesin family member 5C [KO:K10396]", "147700  KLC3; kinesin light chain 3 [KO:K10407]", "3831  KLC1; kinesin light chain 1 [KO:K10407]", "64837  KLC2; kinesin light chain 2 [KO:K10407]", "89953  KLC4; kinesin light chain 4 [KO:K10407]", "55081  IFT57; intraflagellar transport 57 [KO:K04638]", "841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "2915  GRM5; glutamate metabotropic receptor 5 [KO:K04604]", "2776  GNAQ; G protein subunit alpha q [KO:K04634]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "6804  STX1A; syntaxin 1A [KO:K04560]", "774  CACNA1B; calcium voltage-gated channel subunit alpha1 B [KO:K04849]", "2902  GRIN1; glutamate ionotropic receptor NMDA type subunit 1 [KO:K05208]", "2904  GRIN2B; glutamate ionotropic receptor NMDA type subunit 2B [KO:K05210]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "1742  DLG4; discs large MAGUK scaffold protein 4 [KO:K11828]", "2890  GRIA1; glutamate ionotropic receptor AMPA type subunit 1 [KO:K05197]", "2891  GRIA2; glutamate ionotropic receptor AMPA type subunit 2 [KO:K05198]", "2892  GRIA3; glutamate ionotropic receptor AMPA type subunit 3 [KO:K05199]", "2893  GRIA4; glutamate ionotropic receptor AMPA type subunit 4 [KO:K05200]", "7052  TGM2; transglutaminase 2 [KO:K05625] [EC:2.3.2.13]", "6507  SLC1A3; solute carrier family 1 member 3 [KO:K05614]", "6506  SLC1A2; solute carrier family 1 member 2 [KO:K05613]", "3766  KCNJ10; potassium inwardly rectifying channel subfamily J member 10 [KO:K05003]", "5978  REST; RE1 silencing transcription factor [KO:K09222]", "25942  SIN3A; SIN3 transcription regulator family member A [KO:K11644]", "23186  RCOR1; REST corepressor 1 [KO:K11829]", "3065  HDAC1; histone deacetylase 1 [KO:K06067] [EC:3.5.1.98]", "3066  HDAC2; histone deacetylase 2 [KO:K06067] [EC:3.5.1.98]", "5430  POLR2A; RNA polymerase II subunit A [KO:K03006] [EC:2.7.7.6]", "5431  POLR2B; RNA polymerase II subunit B [KO:K03010] [EC:2.7.7.6]", "5432  POLR2C; RNA polymerase II subunit C [KO:K03011]", "5433  POLR2D; RNA polymerase II subunit D [KO:K03012]", "5434  POLR2E; RNA polymerase II, I and III subunit E [KO:K03013]", "5435  POLR2F; RNA polymerase II, I and III subunit F [KO:K03014]", "5436  POLR2G; RNA polymerase II subunit G [KO:K03015]", "5437  POLR2H; RNA polymerase II, I and III subunit H [KO:K03016]", "5438  POLR2I; RNA polymerase II subunit I [KO:K03017]", "5441  POLR2L; RNA polymerase II, I and III subunit L [KO:K03007]", "5439  POLR2J; RNA polymerase II subunit J [KO:K03008]", "548644  POLR2J3; RNA polymerase II subunit J3 [KO:K03008]", "246721  POLR2J2; RNA polymerase II subunit J2 [KO:K03008]", "5440  POLR2K; RNA polymerase II, I and III subunit K [KO:K03009]", "627  BDNF; brain derived neurotrophic factor [KO:K04355]", "1387  CREBBP; CREB binding protein [KO:K04498] [EC:2.3.1.48]", "2033  EP300; E1A binding protein p300 [KO:K04498] [EC:2.3.1.48]", "6875  TAF4B; TATA-box binding protein associated factor 4b [KO:K03129]", "6874  TAF4; TATA-box binding protein associated factor 4 [KO:K03129]", "387332  TBPL2; TATA-box binding protein like 2 [KO:K03120]", "9519  TBPL1; TATA-box binding protein like 1 [KO:K03120]", "6908  TBP; TATA-box binding protein [KO:K03120]", "6667  SP1; Sp1 transcription factor [KO:K04684]", "1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]", "10488  CREB3; cAMP responsive element binding protein 3 [KO:K09048]", "90993  CREB3L1; cAMP responsive element binding protein 3 like 1 [KO:K09048]", "64764  CREB3L2; cAMP responsive element binding protein 3 like 2 [KO:K09048]", "84699  CREB3L3; cAMP responsive element binding protein 3 like 3 [KO:K09048]", "148327  CREB3L4; cAMP responsive element binding protein 3 like 4 [KO:K09048]", "9586  CREB5; cAMP responsive element binding protein 5 [KO:K09047]", "10891  PPARGC1A; PPARG coactivator 1 alpha [KO:K07202]", "5468  PPARG; peroxisome proliferator activated receptor gamma [KO:K08530]", "7019  TFAM; transcription factor A, mitochondrial [KO:K11830]", "4899  NRF1; nuclear respiratory factor 1 [KO:K11831]", "6647  SOD1; superoxide dismutase 1 [KO:K04565] [EC:1.15.1.1]", "6648  SOD2; superoxide dismutase 2 [KO:K04564] [EC:1.15.1.1]", "257202  GPX6; glutathione peroxidase 6 [KO:K00432] [EC:1.11.1.9]", "2882  GPX7; glutathione peroxidase 7 [KO:K00432] [EC:1.11.1.9]", "2877  GPX2; glutathione peroxidase 2 [KO:K00432] [EC:1.11.1.9]", "2878  GPX3; glutathione peroxidase 3 [KO:K00432] [EC:1.11.1.9]", "2876  GPX1; glutathione peroxidase 1 [KO:K00432] [EC:1.11.1.9]", "2880  GPX5; glutathione peroxidase 5 [KO:K00432] [EC:1.11.1.9]", "493869  GPX8; glutathione peroxidase 8 (putative) [KO:K00432] [EC:1.11.1.9]", "7350  UCP1; uncoupling protein 1 [KO:K08769]", "7157  TP53; tumor protein p53 [KO:K04451]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "27113  BBC3; BCL2 binding component 3 [KO:K10132]", "4535  ND1; NADH dehydrogenase subunit 1 [KO:K03878] [EC:7.1.1.2]", "4536  ND2; NADH dehydrogenase subunit 2 [KO:K03879] [EC:7.1.1.2]", "4537  ND3; NADH dehydrogenase subunit 3 [KO:K03880] [EC:7.1.1.2]", "4538  ND4; NADH dehydrogenase subunit 4 [KO:K03881] [EC:7.1.1.2]", "4539  ND4L; NADH dehydrogenase subunit 4L [KO:K03882] [EC:7.1.1.2]", "4540  ND5; NADH dehydrogenase subunit 5 [KO:K03883] [EC:7.1.1.2]", "4541  ND6; NADH dehydrogenase subunit 6 [KO:K03884] [EC:7.1.1.2]", "4723  NDUFV1; NADH:ubiquinone oxidoreductase core subunit V1 [KO:K03942] [EC:7.1.1.2]", "4729  NDUFV2; NADH:ubiquinone oxidoreductase core subunit V2 [KO:K03943] [EC:7.1.1.2]", "4731  NDUFV3; NADH:ubiquinone oxidoreductase subunit V3 [KO:K03944]", "4694  NDUFA1; NADH:ubiquinone oxidoreductase subunit A1 [KO:K03945]", "4695  NDUFA2; NADH:ubiquinone oxidoreductase subunit A2 [KO:K03946]", "4696  NDUFA3; NADH:ubiquinone oxidoreductase subunit A3 [KO:K03947]", "4697  NDUFA4; NDUFA4 mitochondrial complex associated [KO:K03948]", "56901  NDUFA4L2; NDUFA4 mitochondrial complex associated like 2 [KO:K03948]", "4698  NDUFA5; NADH:ubiquinone oxidoreductase subunit A5 [KO:K03949]", "4700  NDUFA6; NADH:ubiquinone oxidoreductase subunit A6 [KO:K03950]", "4701  NDUFA7; NADH:ubiquinone oxidoreductase subunit A7 [KO:K03951]", "4702  NDUFA8; NADH:ubiquinone oxidoreductase subunit A8 [KO:K03952]", "4704  NDUFA9; NADH:ubiquinone oxidoreductase subunit A9 [KO:K03953]", "4705  NDUFA10; NADH:ubiquinone oxidoreductase subunit A10 [KO:K03954]", "4706  NDUFAB1; NADH:ubiquinone oxidoreductase subunit AB1 [KO:K03955]", "126328  NDUFA11; NADH:ubiquinone oxidoreductase subunit A11 [KO:K03956]", "55967  NDUFA12; NADH:ubiquinone oxidoreductase subunit A12 [KO:K11352]", "51079  NDUFA13; NADH:ubiquinone oxidoreductase subunit A13 [KO:K11353]", "4707  NDUFB1; NADH:ubiquinone oxidoreductase subunit B1 [KO:K03957]", "4708  NDUFB2; NADH:ubiquinone oxidoreductase subunit B2 [KO:K03958]", "4709  NDUFB3; NADH:ubiquinone oxidoreductase subunit B3 [KO:K03959]", "4710  NDUFB4; NADH:ubiquinone oxidoreductase subunit B4 [KO:K03960]", "4711  NDUFB5; NADH:ubiquinone oxidoreductase subunit B5 [KO:K03961]", "4712  NDUFB6; NADH:ubiquinone oxidoreductase subunit B6 [KO:K03962]", "4713  NDUFB7; NADH:ubiquinone oxidoreductase subunit B7 [KO:K03963]", "4714  NDUFB8; NADH:ubiquinone oxidoreductase subunit B8 [KO:K03964]", "4715  NDUFB9; NADH:ubiquinone oxidoreductase subunit B9 [KO:K03965]", "4716  NDUFB10; NADH:ubiquinone oxidoreductase subunit B10 [KO:K03966]", "54539  NDUFB11; NADH:ubiquinone oxidoreductase subunit B11 [KO:K11351]", "4719  NDUFS1; NADH:ubiquinone oxidoreductase core subunit S1 [KO:K03934] [EC:7.1.1.2]", "4720  NDUFS2; NADH:ubiquinone oxidoreductase core subunit S2 [KO:K03935] [EC:7.1.1.2]", "4722  NDUFS3; NADH:ubiquinone oxidoreductase core subunit S3 [KO:K03936] [EC:7.1.1.2]", "4724  NDUFS4; NADH:ubiquinone oxidoreductase subunit S4 [KO:K03937]", "4725  NDUFS5; NADH:ubiquinone oxidoreductase subunit S5 [KO:K03938]", "4726  NDUFS6; NADH:ubiquinone oxidoreductase subunit S6 [KO:K03939]", "374291  NDUFS7; NADH:ubiquinone oxidoreductase core subunit S7 [KO:K03940] [EC:7.1.1.2]", "4728  NDUFS8; NADH:ubiquinone oxidoreductase core subunit S8 [KO:K03941] [EC:7.1.1.2]", "4717  NDUFC1; NADH:ubiquinone oxidoreductase subunit C1 [KO:K03967]", "4718  NDUFC2; NADH:ubiquinone oxidoreductase subunit C2 [KO:K03968]", "100532726  NDUFC2-KCTD14; NDUFC2-KCTD14 readthrough [KO:K03968]", "6389  SDHA; succinate dehydrogenase complex flavoprotein subunit A [KO:K00234] [EC:1.3.5.1]", "6390  SDHB; succinate dehydrogenase complex iron sulfur subunit B [KO:K00235] [EC:1.3.5.1]", "6391  SDHC; succinate dehydrogenase complex subunit C [KO:K00236]", "6392  SDHD; succinate dehydrogenase complex subunit D [KO:K00237]", "7386  UQCRFS1; ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 [KO:K00411] [EC:7.1.1.8]", "4519  CYTB; cytochrome b [KO:K00412]", "1537  CYC1; cytochrome c1 [KO:K00413]", "7384  UQCRC1; ubiquinol-cytochrome c reductase core protein 1 [KO:K00414]", "7385  UQCRC2; ubiquinol-cytochrome c reductase core protein 2 [KO:K00415]", "7388  UQCRH; ubiquinol-cytochrome c reductase hinge protein [KO:K00416]", "440567  UQCRHL; ubiquinol-cytochrome c reductase hinge protein like [KO:K00416]", "7381  UQCRB; ubiquinol-cytochrome c reductase binding protein [KO:K00417]", "27089  UQCRQ; ubiquinol-cytochrome c reductase complex III subunit VII [KO:K00418]", "29796  UQCR10; ubiquinol-cytochrome c reductase, complex III subunit X [KO:K00419]", "10975  UQCR11; ubiquinol-cytochrome c reductase, complex III subunit XI [KO:K00420]", "4514  COX3; cytochrome c oxidase subunit III [KO:K02262]", "4512  COX1; cytochrome c oxidase subunit I [KO:K02256] [EC:7.1.1.9]", "4513  COX2; cytochrome c oxidase subunit II [KO:K02261]", "84701  COX4I2; cytochrome c oxidase subunit 4I2 [KO:K02263]", "1327  COX4I1; cytochrome c oxidase subunit 4I1 [KO:K02263]", "9377  COX5A; cytochrome c oxidase subunit 5A [KO:K02264]", "1329  COX5B; cytochrome c oxidase subunit 5B [KO:K02265]", "1337  COX6A1; cytochrome c oxidase subunit 6A1 [KO:K02266]", "1339  COX6A2; cytochrome c oxidase subunit 6A2 [KO:K02266]", "1340  COX6B1; cytochrome c oxidase subunit 6B1 [KO:K02267]", "125965  COX6B2; cytochrome c oxidase subunit 6B2 [KO:K02267]", "1345  COX6C; cytochrome c oxidase subunit 6C [KO:K02268]", "1346  COX7A1; cytochrome c oxidase subunit 7A1 [KO:K02270]", "1347  COX7A2; cytochrome c oxidase subunit 7A2 [KO:K02270]", "9167  COX7A2L; cytochrome c oxidase subunit 7A2 like [KO:K02270]", "1349  COX7B; cytochrome c oxidase subunit 7B [KO:K02271]", "170712  COX7B2; cytochrome c oxidase subunit 7B2 [KO:K02271]", "1350  COX7C; cytochrome c oxidase subunit 7C [KO:K02272]", "341947  COX8C; cytochrome c oxidase subunit 8C [KO:K02273]", "1351  COX8A; cytochrome c oxidase subunit 8A [KO:K02273]", "498  ATP5F1A; ATP synthase F1 subunit alpha [KO:K02132]", "506  ATP5F1B; ATP synthase F1 subunit beta [KO:K02133] [EC:7.1.2.2]", "509  ATP5F1C; ATP synthase F1 subunit gamma [KO:K02136]", "513  ATP5F1D; ATP synthase F1 subunit delta [KO:K02134]", "514  ATP5F1E; ATP synthase F1 subunit epsilon [KO:K02135]", "4508  ATP6; ATP synthase F0 subunit 6 [KO:K02126]", "515  ATP5PB; ATP synthase peripheral stalk-membrane subunit b [KO:K02127]", "516  ATP5MC1; ATP synthase membrane subunit c locus 1 [KO:K02128]", "517  ATP5MC2; ATP synthase membrane subunit c locus 2 [KO:K02128]", "518  ATP5MC3; ATP synthase membrane subunit c locus 3 [KO:K02128]", "10476  ATP5PD; ATP synthase peripheral stalk subunit d [KO:K02138]", "539  ATP5PO; ATP synthase peripheral stalk subunit OSCP [KO:K02137]", "522  ATP5PF; ATP synthase peripheral stalk subunit F6 [KO:K02131]", "4509  ATP8; ATP synthase F0 subunit 8 [KO:K02125]", "7416  VDAC1; voltage dependent anion channel 1 [KO:K05862]", "7417  VDAC2; voltage dependent anion channel 2 [KO:K15040]", "7419  VDAC3; voltage dependent anion channel 3 [KO:K15041]", "291  SLC25A4; solute carrier family 25 member 4 [KO:K05863]", "292  SLC25A5; solute carrier family 25 member 5 [KO:K05863]", "293  SLC25A6; solute carrier family 25 member 6 [KO:K05863]", "83447  SLC25A31; solute carrier family 25 member 31 [KO:K05863]", "10105  PPIF; peptidylprolyl isomerase F [KO:K09565] [EC:5.2.1.8]", "54205  CYCS; cytochrome c, somatic [KO:K08738]", "317  APAF1; apoptotic peptidase activating factor 1 [KO:K02084]", "842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]", "5687  PSMA6; proteasome 20S subunit alpha 6 [KO:K02730] [EC:3.4.25.1]", "5683  PSMA2; proteasome 20S subunit alpha 2 [KO:K02726] [EC:3.4.25.1]", "5685  PSMA4; proteasome 20S subunit alpha 4 [KO:K02728] [EC:3.4.25.1]", "5688  PSMA7; proteasome 20S subunit alpha 7 [KO:K02731] [EC:3.4.25.1]", "143471  PSMA8; proteasome 20S subunit alpha 8 [KO:K02731] [EC:3.4.25.1]", "5686  PSMA5; proteasome 20S subunit alpha 5 [KO:K02729] [EC:3.4.25.1]", "5682  PSMA1; proteasome 20S subunit alpha 1 [KO:K02725] [EC:3.4.25.1]", "5684  PSMA3; proteasome 20S subunit alpha 3 [KO:K02727] [EC:3.4.25.1]", "5694  PSMB6; proteasome 20S subunit beta 6 [KO:K02738] [EC:3.4.25.1]", "5695  PSMB7; proteasome 20S subunit beta 7 [KO:K02739] [EC:3.4.25.1]", "5691  PSMB3; proteasome 20S subunit beta 3 [KO:K02735] [EC:3.4.25.1]", "5690  PSMB2; proteasome 20S subunit beta 2 [KO:K02734] [EC:3.4.25.1]", "5693  PSMB5; proteasome 20S subunit beta 5 [KO:K02737] [EC:3.4.25.1]", "5689  PSMB1; proteasome 20S subunit beta 1 [KO:K02732] [EC:3.4.25.1]", "5692  PSMB4; proteasome 20S subunit beta 4 [KO:K02736] [EC:3.4.25.1]", "5701  PSMC2; proteasome 26S subunit, ATPase 2 [KO:K03061]", "5700  PSMC1; proteasome 26S subunit, ATPase 1 [KO:K03062]", "5704  PSMC4; proteasome 26S subunit, ATPase 4 [KO:K03063]", "5706  PSMC6; proteasome 26S subunit, ATPase 6 [KO:K03064]", "5702  PSMC3; proteasome 26S subunit, ATPase 3 [KO:K03065]", "5705  PSMC5; proteasome 26S subunit, ATPase 5 [KO:K03066]", "5708  PSMD2; proteasome 26S subunit ubiquitin receptor, non-ATPase 2 [KO:K03028]", "5707  PSMD1; proteasome 26S subunit, non-ATPase 1 [KO:K03032]", "5709  PSMD3; proteasome 26S subunit, non-ATPase 3 [KO:K03033]", "5715  PSMD9; proteasome 26S subunit, non-ATPase 9 [KO:K06693]", "5718  PSMD12; proteasome 26S subunit, non-ATPase 12 [KO:K03035]", "5717  PSMD11; proteasome 26S subunit, non-ATPase 11 [KO:K03036]", "9861  PSMD6; proteasome 26S subunit, non-ATPase 6 [KO:K03037]", "5713  PSMD7; proteasome 26S subunit, non-ATPase 7 [KO:K03038]", "5719  PSMD13; proteasome 26S subunit, non-ATPase 13 [KO:K03039]", "5710  PSMD4; proteasome 26S subunit ubiquitin receptor, non-ATPase 4 [KO:K03029]", "10213  PSMD14; proteasome 26S subunit, non-ATPase 14 [KO:K03030]", "5714  PSMD8; proteasome 26S subunit, non-ATPase 8 [KO:K03031]", "11047  ADRM1; ADRM1 26S proteasome ubiquitin receptor [KO:K06691]", "7979  SEM1; SEM1 26S proteasome subunit [KO:K10881]", "4294  MAP3K10; mitogen-activated protein kinase kinase kinase 10 [KO:K04418] [EC:2.7.11.25]", "2081  ERN1; endoplasmic reticulum to nucleus signaling 1 [KO:K08852] [EC:2.7.11.1 3.1.26.-]", "7186  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]", "4217  MAP3K5; mitogen-activated protein kinase kinase kinase 5 [KO:K04426] [EC:2.7.11.25]", "5609  MAP2K7; mitogen-activated protein kinase kinase 7 [KO:K04431] [EC:2.7.12.2]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "8408  ULK1; unc-51 like autophagy activating kinase 1 [KO:K21357] [EC:2.7.11.1]", "9706  ULK2; unc-51 like autophagy activating kinase 2 [KO:K08269] [EC:2.7.11.1]", "60673  ATG101; autophagy related 101 [KO:K19730]", "9776  ATG13; autophagy related 13 [KO:K08331]", "9821  RB1CC1; RB1 inducible coiled-coil 1 [KO:K17589]", "55626  AMBRA1; autophagy and beclin 1 regulator 1 [KO:K17985]", "8678  BECN1; beclin 1 [KO:K08334]", "441925  BECN2; beclin 2 [KO:K08334]", "30849  PIK3R4; phosphoinositide-3-kinase regulatory subunit 4 [KO:K08333] [EC:2.7.11.1]", "22863  ATG14; autophagy related 14 [KO:K17889]", "29982  NRBF2; nuclear receptor binding factor 2 [KO:K21246]", "5289  PIK3C3; phosphatidylinositol 3-kinase catalytic subunit type 3 [KO:K00914] [EC:2.7.1.137]", "23130  ATG2A; autophagy related 2A [KO:K17906]", "55102  ATG2B; autophagy related 2B [KO:K17906]", "26100  WIPI2; WD repeat domain, phosphoinositide interacting 2 [KO:K17908]", "55062  WIPI1; WD repeat domain, phosphoinositide interacting 1 [KO:K17908]"], "compound": ["C00025  L-Glutamate", "C00076  Calcium cation", "C00238  Potassium cation", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C01330  Sodium cation", "C04549  1-Phosphatidyl-1D-myo-inositol 3-phosphate"], "refs": [{"pmid": "15459747", "authors": "  Landles C, Bates GP", "title": "Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series.", "journal": "EMBO Rep 5:958-63 (2004)", "doi": "10.1038/sj.embor.7400250"}, {"pmid": "17041811", "authors": "  Borrell-Pages M, Zala D, Humbert S, Saudou F", "title": "Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies.", "journal": "Cell Mol Life Sci 63:2642-60 (2006)", "doi": "10.1007/s00018-006-6242-0"}, {"pmid": "18951640", "authors": "  Bossy-Wetzel E, Petrilli A, Knott AB", "title": "Mutant huntingtin and mitochondrial dysfunction.", "journal": "Trends Neurosci 31:609-16 (2008)", "doi": "10.1016/j.tins.2008.09.004"}, {"pmid": "16288298", "authors": "  Cattaneo E, Zuccato C, Tartari M", "title": "Normal huntingtin function: an alternative approach to Huntington's disease.", "journal": "Nat Rev Neurosci 6:919-30 (2005)", "doi": "10.1038/nrn1806"}, {"pmid": "15336977", "authors": "  Bezprozvanny I, Hayden MR", "title": "Deranged neuronal calcium signaling and Huntington disease.", "journal": "Biochem Biophys Res Commun 322:1310-7 (2004)", "doi": "10.1016/j.bbrc.2004.08.035"}, {"pmid": "14526190", "authors": "  Sawa A, Tomoda T, Bae BI", "title": "Mechanisms of neuronal cell death in Huntington's disease.", "journal": "Cytogenet Genome Res 100:287-95 (2003)", "doi": "10.1159/000072864"}, {"pmid": "12372277", "authors": "  Ross CA.", "title": "Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders.", "journal": "Neuron 35:819-22 (2002)", "doi": "10.1016/S0896-6273(02)00872-3"}, {"pmid": "15242639", "authors": "  Ross CA", "title": "Huntington's disease: new paths to pathogenesis.", "journal": "Cell 118:4-7 (2004)", "doi": "10.1016/j.cell.2004.06.022"}, {"pmid": "24739785", "authors": "  Coffey ET", "title": "Nuclear and cytosolic JNK signalling in neurons.", "journal": "Nat Rev Neurosci 15:285-99 (2014)", "doi": "10.1038/nrn3729"}, {"pmid": "19525941", "authors": "  Morfini GA, You YM, Pollema SL, Kaminska A, Liu K, Yoshioka K, Bjorkblom B, Coffey ET, Bagnato C, Han D, Huang CF, Banker G, Pigino G, Brady ST", "title": "Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin.", "journal": "Nat Neurosci 12:864-71 (2009)", "doi": "10.1038/nn.2346"}, {"pmid": "26920688", "authors": "  Kumar P, Kumar D, Jha SK, Jha NK, Ambasta RK", "title": "Ion Channels in Neurological Disorders.", "journal": "Adv Protein Chem Struct Biol 103:97-136 (2016)", "doi": "10.1016/bs.apcsb.2015.10.006"}, {"pmid": "25191533", "authors": "  Proft J, Weiss N", "title": "Rectifying rectifier channels in Huntington disease.", "journal": "Commun Integr Biol 7:e29410 (2014)", "doi": "10.4161/cib.29410"}, {"pmid": "15695335", "authors": "  Tang TS, Slow E, Lupu V, Stavrovskaya IG, Sugimori M, Llinas R, Kristal BS, Hayden MR, Bezprozvanny I", "title": "Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease.", "journal": "Proc Natl Acad Sci U S A 102:2602-7 (2005)", "doi": "10.1073/pnas.0409402102"}, {"pmid": "29427371", "authors": "  Mackay JP, Nassrallah WB, Raymond LA", "title": "Cause or compensation?-Altered neuronal Ca(2+) handling in Huntington's disease.", "journal": "CNS Neurosci Ther 24:301-310 (2018)", "doi": "10.1111/cns.12817"}, {"pmid": "11807533", "authors": "  Mattson MP.", "title": "Accomplices to neuronal death.", "journal": "Nature 415:377-9 (2002)", "doi": "10.1038/415377a"}, {"pmid": "17081970", "authors": "  McGill JK, Beal MF", "title": "PGC-1alpha, a new therapeutic target in Huntington's disease?", "journal": "Cell 127:465-8 (2006)", "doi": "10.1016/j.cell.2006.10.023"}, {"pmid": "30941017", "authors": "  Intihar TA, Martinez EA, Gomez-Pastor R", "title": "Mitochondrial Dysfunction in Huntington's Disease; Interplay Between HSF1, p53 and PGC-1alpha Transcription Factors.", "journal": "Front Cell Neurosci 13:103 (2019)", "doi": "10.3389/fncel.2019.00103"}, {"pmid": "15996541", "authors": "  La Spada AR, Morrison RS", "title": "The power of the dark side: Huntington's disease protein and p53 form a deadly alliance.", "journal": "Neuron 47:1-3 (2005)", "doi": "10.1016/j.neuron.2005.06.023"}, {"pmid": "11738471", "authors": "  Lesort M, Chun W, Tucholski J, Johnson GV", "title": "Does tissue transglutaminase play a role in Huntington's disease?", "journal": "Neurochem Int 40:37-52 (2002)", "doi": "10.1016/S0197-0186(01)00059-6"}, {"pmid": "15996546", "authors": "  Bae BI, Xu H, Igarashi S, Fujimuro M, Agrawal N, Taya Y, Hayward SD, Moran TH, Montell C, Ross CA, Snyder SH, Sawa A", "title": "p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease.", "journal": "Neuron 47:29-41 (2005)", "doi": "10.1016/j.neuron.2005.06.005"}, {"pmid": "11839795", "authors": "  Li SH, Cheng AL, Zhou H, Lam S, Rao M, Li H, Li XJ", "title": "Interaction of Huntington disease protein with transcriptional activator Sp1.", "journal": "Mol Cell Biol 22:1277-87 (2002)", "doi": "10.1128/MCB.22.5.1277-1287.2002"}, {"pmid": "25270767", "authors": "  Vidal RL, Matus S, Bargsted L, Hetz C", "title": "Targeting autophagy in neurodegenerative diseases.", "journal": "Trends Pharmacol Sci 35:583-91 (2014)", "doi": "10.1016/j.tips.2014.09.002"}], "rel_pathway": ["hsa00190  Oxidative phosphorylation", "hsa03020  RNA polymerase", "hsa03022  Basal transcription factors", "hsa03050  Proteasome", "hsa04020  Calcium signaling pathway", "hsa04115  p53 signaling pathway", "hsa04140  Autophagy - animal", "hsa04141  Protein processing in endoplasmic reticulum", "hsa04144  Endocytosis", "hsa04210  Apoptosis", "hsa04724  Glutamatergic synapse"], "ko_pathway": "ko05016", "genes": ["TP53", "BAX"]}, {"kegg_id": "hsa05161", "name": "Hepatitis B - Homo sapiens (human)", "description": "Hepatitis B virus (HBV) is an enveloped virus and contains a partially double-stranded relaxed circular DNA (RC-DNA) genome. After entry into hepatocytes, HBV RC-DNA is transported to the nucleus and converted into a covalently closed circular molecule cccDNA. The cccDNA is the template for transcription of all viral RNAs including the pregenomic RNA (pgRNA), encoding for 7 viral proteins: large, middle, and small envelope proteins (LHBs, MHBs, and SHBs) that form the surface antigen (HBsAg), the core antigen (HBcAg), the e antigen (HBeAg), the HBV polymerase, and the regulatory protein X (HBx). The pgRNA interacts with the viral polymerase protein to initiate the encapsidation into the core particles. Through endoplasmic reticulum, the core particles finish assembling with the envelope proteins and are released. HBV infection leads to a wide spectrum of liver diseases raging from chronic hepatitis, cirrhosis to hepatocellular carcinoma. The mechanism of liver injury is still not clear. However, HBV proteins target host proteins, involved in a variety of functions, thus regulating transcription, cellular signaling cascades, proliferation, differentiation, and apoptosis.", "class": "Human Diseases; Infectious disease: viral", "pathway_map": "hsa05161  Hepatitis B", "network": ["", "ELEMENT   N00267  HBV HBx to PI3K signaling pathway", "N00268  HBV HBx to RIG-I-like receptor signaling pathway", "N00531  HBV HBx to TGF-beta signaling pathway", "N00532  HBV HBx to Egr-mediated transcription", "N00533  HBV HBx to Crosstalk between extrinsic and intrinsic apoptotic pathways", "N00534  HBV HBx to Crosstalk between extrinsic and intrinsic apoptotic pathways", "N00535  HBV HBx to p53-mediated transcription", "N00537  HBV HBx to cell cycle G1/S", "N00539  HBV HBx to Ca2+-PYK2-RAS-ERK signaling pathway", "N00540  HBV HBx to RAS-ERK signaling pathway", "N00541  HBV HBx to RAS-ERK signaling pathway", "N00543  HBV HBx to JNK signaling pathway", "N00544  HBV HBx to CREB-mediated transcription", "N00545  HBV HBx to ERK signaling pathway", "N00547  HBV LHBs to PKC-ERK signaling pathway", "N00548  HBV HBx to Jak-STAT signaling pathway", "N00549  HBV HBeAg to TLR2/4-NFKB signaling pathway", "N00550  HBV HBeAg to TLR2/4-NFKB signaling pathway", "N00551  HBV HBs to TLR2/4-MAPK signaling pathway", "N00552  HBV pol to TLR3-IRF3 signaling pathway", "N00554  HBV HBe to TLR4-IRF3/7 signaling pathway", "N00555  HBV HBe to TLR4-IRF3/7 signaling pathway", "N00556  HBV HBe to TLR2/4-NFKB signaling pathway", "N00557  HBV HBe to TLR2/4-NFKB signaling pathway", "N00558  HBV pol to IFN signaling pathway"], "disease": ["H00412  Hepatitis B"], "drug": ["D02745  Interferon alfa-2b (USAN)", "D02747  Peginterferon alfa-2a (USAN/INN)", "D03305  Interferon alfa (NAMALWA) (JP18)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["3339  HSPG2; heparan sulfate proteoglycan 2 [KO:K06255]", "6554  SLC10A1; solute carrier family 10 member 1 [KO:K14341]", "7040  TGFB1; transforming growth factor beta 1 [KO:K13375]", "7042  TGFB2; transforming growth factor beta 2 [KO:K13376]", "7043  TGFB3; transforming growth factor beta 3 [KO:K13377]", "7046  TGFBR1; transforming growth factor beta receptor 1 [KO:K04674] [EC:2.7.11.30]", "7048  TGFBR2; transforming growth factor beta receptor 2 [KO:K04388] [EC:2.7.11.30]", "4088  SMAD3; SMAD family member 3 [KO:K23605]", "1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "4609  MYC; MYC proto-oncogene, bHLH transcription factor [KO:K04377]", "1959  EGR2; early growth response 2 [KO:K12496]", "1960  EGR3; early growth response 3 [KO:K12497]", "1387  CREBBP; CREB binding protein [KO:K04498] [EC:2.3.1.48]", "2033  EP300; E1A binding protein p300 [KO:K04498] [EC:2.3.1.48]", "356  FASLG; Fas ligand [KO:K04389]", "1642  DDB1; damage specific DNA binding protein 1 [KO:K10610]", "1643  DDB2; damage specific DNA binding protein 2 [KO:K10140]", "4214  MAP3K1; mitogen-activated protein kinase kinase kinase 1 [KO:K04416] [EC:2.7.11.25]", "7534  YWHAZ; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta [KO:K16197]", "7529  YWHAB; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta [KO:K16197]", "10971  YWHAQ; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta [KO:K16197]", "6416  MAP2K4; mitogen-activated protein kinase kinase 4 [KO:K04430] [EC:2.7.12.2]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "4318  MMP9; matrix metallopeptidase 9 [KO:K01403] [EC:3.4.24.35]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]", "355  FAS; Fas cell surface death receptor [KO:K04390]", "8772  FADD; Fas associated via death domain [KO:K02373]", "841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]", "843  CASP10; caspase 10 [KO:K04400] [EC:3.4.22.63]", "637  BID; BH3 interacting domain death agonist [KO:K04726]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "317  APAF1; apoptotic peptidase activating factor 1 [KO:K02084]", "54205  CYCS; cytochrome c, somatic [KO:K08738]", "842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "100506742  CASP12; caspase 12 (gene/pseudogene) [KO:K04741] [EC:3.4.22.-]", "332  BIRC5; baculoviral IAP repeat containing 5 [KO:K08731]", "7157  TP53; tumor protein p53 [KO:K04451]", "890  CCNA2; cyclin A2 [KO:K06627]", "8900  CCNA1; cyclin A1 [KO:K06627]", "1017  CDK2; cyclin dependent kinase 2 [KO:K02206] [EC:2.7.11.22]", "898  CCNE1; cyclin E1 [KO:K06626]", "9134  CCNE2; cyclin E2 [KO:K06626]", "5925  RB1; RB transcriptional corepressor 1 [KO:K06618]", "1869  E2F1; E2F transcription factor 1 [KO:K17454]", "1870  E2F2; E2F transcription factor 2 [KO:K09389]", "1871  E2F3; E2F transcription factor 3 [KO:K06620]", "537  ATP6AP1; ATPase H+ transporting accessory protein 1 [KO:K03662]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "4772  NFATC1; nuclear factor of activated T cells 1 [KO:K04446]", "4773  NFATC2; nuclear factor of activated T cells 2 [KO:K17332]", "4775  NFATC3; nuclear factor of activated T cells 3 [KO:K17333]", "4776  NFATC4; nuclear factor of activated T cells 4 [KO:K17334]", "7124  TNF; tumor necrosis factor [KO:K03156]", "3716  JAK1; Janus kinase 1 [KO:K11217] [EC:2.7.10.2]", "3717  JAK2; Janus kinase 2 [KO:K04447] [EC:2.7.10.2]", "3718  JAK3; Janus kinase 3 [KO:K11218] [EC:2.7.10.2]", "7297  TYK2; tyrosine kinase 2 [KO:K11219] [EC:2.7.10.2]", "6774  STAT3; signal transducer and activator of transcription 3 [KO:K04692]", "6772  STAT1; signal transducer and activator of transcription 1 [KO:K11220]", "6773  STAT2; signal transducer and activator of transcription 2 [KO:K11221]", "6775  STAT4; signal transducer and activator of transcription 4 [KO:K11222]", "6776  STAT5A; signal transducer and activator of transcription 5A [KO:K11223]", "6777  STAT5B; signal transducer and activator of transcription 5B [KO:K11224]", "6778  STAT6; signal transducer and activator of transcription 6 [KO:K11225]", "7419  VDAC3; voltage dependent anion channel 3 [KO:K15041]", "2185  PTK2B; protein tyrosine kinase 2 beta [KO:K05871] [EC:2.7.10.2]", "6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "4089  SMAD4; SMAD family member 4 [KO:K04501]", "1386  ATF2; activating transcription factor 2 [KO:K04450]", "1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]", "10488  CREB3; cAMP responsive element binding protein 3 [KO:K09048]", "90993  CREB3L1; cAMP responsive element binding protein 3 like 1 [KO:K09048]", "64764  CREB3L2; cAMP responsive element binding protein 3 like 2 [KO:K09048]", "84699  CREB3L3; cAMP responsive element binding protein 3 like 3 [KO:K09048]", "148327  CREB3L4; cAMP responsive element binding protein 3 like 4 [KO:K09048]", "468  ATF4; activating transcription factor 4 [KO:K04374]", "9586  CREB5; cAMP responsive element binding protein 5 [KO:K09047]", "1388  ATF6B; activating transcription factor 6 beta [KO:K09049]", "3576  CXCL8; C-X-C motif chemokine ligand 8 [KO:K10030]", "5111  PCNA; proliferating cell nuclear antigen [KO:K04802]", "369  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "2002  ELK1; ETS transcription factor ELK1 [KO:K04375]", "7097  TLR2; toll like receptor 2 [KO:K10159]", "4615  MYD88; MYD88 innate immune signal transduction adaptor [KO:K04729]", "114609  TIRAP; TIR domain containing adaptor protein [KO:K05403]", "7099  TLR4; toll like receptor 4 [KO:K10160]", "51135  IRAK4; interleukin 1 receptor associated kinase 4 [KO:K04733] [EC:2.7.11.1]", "3654  IRAK1; interleukin 1 receptor associated kinase 1 [KO:K04730] [EC:2.7.11.1]", "7189  TRAF6; TNF receptor associated factor 6 [KO:K03175] [EC:2.3.2.27]", "10454  TAB1; TGF-beta activated kinase 1 (MAP3K7) binding protein 1 [KO:K04403]", "23118  TAB2; TGF-beta activated kinase 1 (MAP3K7) binding protein 2 [KO:K04404]", "6885  MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO:K04427] [EC:2.7.11.25]", "3569  IL6; interleukin 6 [KO:K05405]", "5606  MAP2K3; mitogen-activated protein kinase kinase 3 [KO:K04432] [EC:2.7.12.2]", "5608  MAP2K6; mitogen-activated protein kinase kinase 6 [KO:K04433] [EC:2.7.12.2]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "5609  MAP2K7; mitogen-activated protein kinase kinase 7 [KO:K04431] [EC:2.7.12.2]", "353376  TICAM2; TIR domain containing adaptor molecule 2 [KO:K05409]", "7098  TLR3; toll like receptor 3 [KO:K05401]", "148022  TICAM1; TIR domain containing adaptor molecule 1 [KO:K05842]", "23586  RIGI; RNA sensor RIG-I [KO:K12646] [EC:5.6.2.6]", "64135  IFIH1; interferon induced with helicase C domain 1 [KO:K12647] [EC:5.6.2.6]", "57506  MAVS; mitochondrial antiviral signaling protein [KO:K12648]", "7187  TRAF3; TNF receptor associated factor 3 [KO:K03174]", "9641  IKBKE; inhibitor of nuclear factor kappa B kinase subunit epsilon [KO:K07211] [EC:2.7.11.10]", "29110  TBK1; TANK binding kinase 1 [KO:K05410] [EC:2.7.11.10]", "1654  DDX3X; DEAD-box helicase 3 X-linked [KO:K11594] [EC:5.6.2.7]", "3661  IRF3; interferon regulatory factor 3 [KO:K05411]", "3665  IRF7; interferon regulatory factor 7 [KO:K09447]", "3439  IFNA1; interferon alpha 1 [KO:K05414]", "3440  IFNA2; interferon alpha 2 [KO:K05414]", "3441  IFNA4; interferon alpha 4 [KO:K05414]", "3442  IFNA5; interferon alpha 5 [KO:K05414]", "3443  IFNA6; interferon alpha 6 [KO:K05414]", "3444  IFNA7; interferon alpha 7 [KO:K05414]", "3445  IFNA8; interferon alpha 8 [KO:K05414]", "3446  IFNA10; interferon alpha 10 [KO:K05414]", "3447  IFNA13; interferon alpha 13 [KO:K05414]", "3448  IFNA14; interferon alpha 14 [KO:K05414]", "3449  IFNA16; interferon alpha 16 [KO:K05414]", "3451  IFNA17; interferon alpha 17 [KO:K05414]", "3452  IFNA21; interferon alpha 21 [KO:K05414]", "3456  IFNB1; interferon beta 1 [KO:K05415]", "3454  IFNAR1; interferon alpha and beta receptor subunit 1 [KO:K05130]"], "compound": ["C00076  Calcium cation"], "refs": [{"pmid": "30059722", "authors": "  Caballero A, Tabernero D, Buti M, Rodriguez-Frias F", "title": "Hepatitis B virus: The challenge of an ancient virus with multiple faces and a remarkable replication strategy.", "journal": "Antiviral Res 158:34-44 (2018)", "doi": "10.1016/j.antiviral.2018.07.019"}, {"pmid": "22869468", "authors": "  Walsh R, Locarnini S", "title": "Hepatitis B precore protein: pathogenic potential and therapeutic promise.", "journal": "Yonsei Med J 53:875-85 (2012)", "doi": "10.3349/ymj.2012.53.5.875"}, {"pmid": "26239691", "authors": "  Liang TJ, Block TM, McMahon BJ, Ghany MG, Urban S, Guo JT, Locarnini S, Zoulim F, Chang KM, Lok AS", "title": "Present and future therapies of hepatitis B: From discovery to cure.", "journal": "Hepatology 62:1893-908 (2015)", "doi": "10.1002/hep.28025"}, {"pmid": "26776362", "authors": "  Morikawa K, Suda G, Sakamoto N", "title": "Viral life cycle of hepatitis B virus: Host factors and druggable targets.", "journal": "Hepatol Res 46:871-7 (2016)", "doi": "10.1111/hepr.12650"}, {"pmid": "19201080", "authors": "  Feitelson MA, Reis HM, Tufan NL, Sun B, Pan J, Lian Z", "title": "Putative roles of hepatitis B x antigen in the pathogenesis of chronic liver disease.", "journal": "Cancer Lett 286:69-79 (2009)", "doi": "10.1016/j.canlet.2008.12.010"}, {"pmid": "19263472", "authors": "  Murata M, Matsuzaki K, Yoshida K, Sekimoto G, Tahashi Y, Mori S, Uemura Y, Sakaida N, Fujisawa J, Seki T, Kobayashi K, Yokote K, Koike K, Okazaki K", "title": "Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B.", "journal": "Hepatology 49:1203-17 (2009)", "doi": "10.1002/hep.22765"}, {"pmid": "15173177", "authors": "  Yoo YG, Lee MO", "title": "Hepatitis B virus X protein induces expression of Fas ligand gene through enhancing transcriptional activity of early growth response factor.", "journal": "J Biol Chem 279:36242-9 (2004)", "doi": "10.1074/jbc.M401290200"}, {"pmid": "16459163", "authors": "  Zhang X, Zhang H, Ye L", "title": "Effects of hepatitis B virus X protein on the development of liver cancer.", "journal": "J Lab Clin Med 147:58-66 (2006)", "doi": "10.1016/j.lab.2005.10.003"}, {"pmid": "19854353", "authors": "  Benhenda S, Cougot D, Buendia MA, Neuveut C", "title": "Hepatitis B virus X protein molecular functions and its role in virus life cycle and pathogenesis.", "journal": "Adv Cancer Res 103:75-109 (2009)", "doi": "10.1016/S0065-230X(09)03004-8"}, {"pmid": "21994562", "authors": "  Benhenda S, Cougot D, Neuveut C, Buendia MA", "title": "Liver cell transformation in chronic HBV infection.", "journal": "Viruses 1:630-46 (2009)", "doi": "10.3390/v1030630"}, {"pmid": "11099494", "authors": "  Diao J, Khine AA, Sarangi F, Hsu E, Iorio C, Tibbles LA, Woodgett JR, Penninger J, Richardson CD", "title": "X protein of hepatitis B virus inhibits Fas-mediated apoptosis and is associated with up-regulation of the SAPK/JNK pathway.", "journal": "J Biol Chem 276:8328-40 (2001)", "doi": "10.1074/jbc.M006026200"}, {"pmid": "16891440", "authors": "  Park NH, Song IH, Chung YH", "title": "Chronic hepatitis B in hepatocarcinogenesis.", "journal": "Postgrad Med J 82:507-15 (2006)", "doi": "10.1136/pgmj.2006.047431"}, {"pmid": "28820498", "authors": "  Lin S, Zhang YJ", "title": "Interference of Apoptosis by Hepatitis B Virus.", "journal": "Viruses 9:E230 (2017)", "doi": "10.3390/v9080230"}, {"pmid": "16173017", "authors": "  Zhang X, Dong N, Yin L, Cai N, Ma H, You J, Zhang H, Wang H, He R, Ye L", "title": "Hepatitis B virus X protein upregulates survivin expression in hepatoma tissues.", "journal": "J Med Virol 77:374-81 (2005)", "doi": "10.1002/jmv.20466"}, {"pmid": "18481805", "authors": "  Kim HJ, Kim SY, Kim J, Lee H, Choi M, Kim JK, Ahn JK", "title": "Hepatitis B virus X protein induces apoptosis by enhancing translocation of Bax to mitochondria.", "journal": "IUBMB Life 60:473-80 (2008)", "doi": "10.1002/iub.68"}, {"pmid": "21647825", "authors": "  Ng SA, Lee C", "title": "Hepatitis B virus X gene and hepatocarcinogenesis.", "journal": "J Gastroenterol 46:974-90 (2011)", "doi": "10.1007/s00535-011-0415-9"}, {"pmid": "9195957", "authors": "  Cong YS, Yao YL, Yang WM, Kuzhandaivelu N, Seto E", "title": "The hepatitis B virus X-associated protein, XAP3, is a protein kinase C-binding protein.", "journal": "J Biol Chem 272:16482-9 (1997)", "doi": "10.1074/jbc.272.26.16482"}, {"pmid": "12686421", "authors": "  Panteva M, Korkaya H, Jameel S", "title": "Hepatitis viruses and the MAPK pathway: is this a survival strategy?", "journal": "Virus Res 92:131-40 (2003)", "doi": "10.1016/S0168-1702(02)00356-8"}, {"pmid": "9738022", "authors": "  Lee YH, Yun Y", "title": "HBx protein of hepatitis B virus activates Jak1-STAT signaling.", "journal": "J Biol Chem 273:25510-5 (1998)", "doi": "10.1074/jbc.273.39.25510"}, {"pmid": "18251977", "authors": "  Tan A, Yeh SH, Liu CJ, Cheung C, Chen PJ", "title": "Viral hepatocarcinogenesis: from infection to cancer.", "journal": "Liver Int 28:175-88 (2008)", "doi": "10.1111/j.1478-3231.2007.01652.x"}, {"pmid": "17059849", "authors": "  Chami M, Oules B, Paterlini-Brechot P", "title": "Cytobiological consequences of calcium-signaling alterations induced by human viral proteins.", "journal": "Biochim Biophys Acta 1763:1344-62 (2006)", "doi": "10.1016/j.bbamcr.2006.09.025"}, {"pmid": "11743185", "authors": "  Ganem D", "title": "Virology. The X files--one step closer to closure.", "journal": "Science 294:2299-300 (2001)", "doi": "10.1126/science.1067850"}, {"pmid": "15132991", "authors": "  Chung TW, Lee YC, Kim CH", "title": "Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential.", "journal": "FASEB J 18:1123-5 (2004)", "doi": "10.1096/fj.03-1429fje"}, {"pmid": "18605975", "authors": "  Gurtsevitch VE", "title": "Human oncogenic viruses: hepatitis B and hepatitis C viruses and their role in hepatocarcinogenesis.", "journal": "Biochemistry (Mosc) 73:504-13 (2008)", "doi": "10.1134/S0006297908050039"}, {"pmid": "21994545", "authors": "  Schadler S, Hildt E", "title": "HBV life cycle: entry and morphogenesis.", "journal": "Viruses 1:185-209 (2009)", "doi": "10.3390/v1020185"}, {"pmid": "28862649", "authors": "  Ortega-Prieto AM, Dorner M", "title": "Immune Evasion Strategies during Chronic Hepatitis B and C Virus Infection.", "journal": "Vaccines (Basel) 5:E24 (2017)", "doi": "10.3390/vaccines5030024"}, {"pmid": "28704708", "authors": "  Nosratabadi R, Alavian SM, Zare-Bidaki M, Shahrokhi VM, Arababadi MK", "title": "Innate immunity related pathogen recognition receptors and chronic hepatitis B infection.", "journal": "Mol Immunol 90:64-73 (2017)", "doi": "10.1016/j.molimm.2017.07.002"}, {"pmid": "24530748", "authors": "  Bagheri V, Askari A, Arababadi MK, Kennedy D", "title": "Can Toll-Like Receptor (TLR) 2 be considered as a new target for immunotherapy against hepatitis B infection?", "journal": "Hum Immunol 75:549-54 (2014)", "doi": "10.1016/j.humimm.2014.02.018"}, {"pmid": "25550115", "authors": "  Zhang E, Lu M", "title": "Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection.", "journal": "Med Microbiol Immunol 204:11-20 (2015)", "doi": "10.1007/s00430-014-0370-1"}, {"pmid": "20375222", "authors": "  Yu S, Chen J, Wu M, Chen H, Kato N, Yuan Z", "title": "Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilon and DDX3.", "journal": "J Gen Virol 91:2080-90 (2010)", "doi": "10.1099/vir.0.020552-0"}, {"pmid": "23363957", "authors": "  Revill P, Yuan Z", "title": "New insights into how HBV manipulates the innate immune response to establish acute and persistent infection.", "journal": "Antivir Ther 18:1-15 (2013)", "doi": "10.3851/IMP2542"}, {"pmid": "28893934", "authors": "  Hopcraft SE, Damania B", "title": "Tumour viruses and innate immunity.", "journal": "Philos Trans R Soc Lond B Biol Sci 372:20160267 (2017)", "doi": "10.1098/rstb.2016.0267"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04064  NF-kappa B signaling pathway", "hsa04110  Cell cycle", "hsa04115  p53 signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04210  Apoptosis", "hsa04620  Toll-like receptor signaling pathway", "hsa04622  RIG-I-like receptor signaling pathway", "hsa04630  JAK-STAT signaling pathway"], "ko_pathway": "ko05161", "genes": ["TP53", "BRAF", "AKT2", "AKT1", "SOS1", "MAPK13", "NRAS", "BAX"]}, {"kegg_id": "hsa05168", "name": "Herpes simplex virus 1 infection - Homo sapiens (human)", "description": "Herpes simplex virus 1(HSV-1) is a common human pathogen, which initially infects orofacial mucosal surfaces. The virus replicates in epithelial cells at these sites, causing clinically overt disease characterized by vesicular lesions. HSV-1 then penetrates to the nervous system and establishes latency in sensory neurons. Throughout the lifetime of the host, HSV-1 may reactivate from its latent state and reinitiate a lytic infection cycle. HSV-1 has developed various mechanisms to escape its host innate immune responses and increased its capacity to replicate and to persist. ICP34.5, ICP0, ICP27, Us11 and Vhs (UL41) are the proteins involved in viral interference.", "class": "Human Diseases; Infectious disease: viral", "pathway_map": "hsa05168  Herpes simplex virus 1 infection", "network": ["", "ELEMENT   N00560  HSV gD to HVEM-NFKB signaling pathway", "N00561  HSV ICP0 to TLR2/4-NFKB signaling pathway", "N00562  HSV US3 to TLR2/4-NFKB signaling pathway", "N00564  HSV US3 to TLR3-NFKB signaling pathway", "N00565  HSV US11 to RIG-I-like receptor signaling pathway", "N00566  HSV UL36USP to RIG-I-like receptor signaling pathway", "N00567  HSV ICP34.5 to TBK1 signaling pathway", "N00568  HSV US3 to IRF3 signaling pathway", "N00569  HSV UL41 to cGAS-STING signaling pathway", "N00570  HSV ICP0 to cGAS-STING signaling pathway", "N00572  HSV ICP34.5 to PKR-eIF2alpha signaling pathway", "N00573  HSV US11 to PKR-eIF2alpha signaling pathway", "N00574  HSV US11 to oligoadenylate synthetase (OAS)/RNase L pathway", "N00575  HSV ICP27 to IFN signaling pathway", "N00576  HSV UL41/UL13 to IFN signaling pathway", "N00577  HSV UL41 to IFN signaling pathway", "N00578  HSV UL41 to IFN signaling pathway", "N00579  HSV ICP6 to extrinsic apoptotic pathway", "N00580  HSV ICP0 to crosstalk between extrinsic and intrinsic apoptotic pathways", "N00581  HSV ICP47 to antigen processing and presentation by MHC class I molecules", "N00583  HSV VP11/12 to PI3K signaling pathway", "N00584  HSV US3 to MTOR signaling pathway", "N00585  HSV US3 to intrinsic apoptotic pathway", "N00587  HSV ICP27 to Nuclear export of mRNA", "N00588  HSV VP16 to Oct-1-mediated transcription", "N00589  HSV gC to alternative pathway of complement cascade", "N00591  HSV gB to antigen processing and presentation by MHC class II molecules", "N00592  HSV ICP0 to p53-mediated transcription"], "disease": ["H00365  Herpes simplex virus infection"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["4049  LTA; lymphotoxin alpha [KO:K05468]", "8740  TNFSF14; TNF superfamily member 14 [KO:K05477]", "8764  TNFRSF14; TNF receptor superfamily member 14 [KO:K05152]", "7186  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]", "7188  TRAF5; TNF receptor associated factor 5 [KO:K09849]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "329  BIRC2; baculoviral IAP repeat containing 2 [KO:K16060]", "330  BIRC3; baculoviral IAP repeat containing 3 [KO:K16060]", "6347  CCL2; C-C motif chemokine ligand 2 [KO:K14624]", "5818  NECTIN1; nectin cell adhesion molecule 1 [KO:K06081]", "5819  NECTIN2; nectin cell adhesion molecule 2 [KO:K06531]", "29992  PILRA; paired immunoglobin like type 2 receptor alpha [KO:K15411]", "29990  PILRB; paired immunoglobin like type 2 receptor beta [KO:K15411]", "5781  PTPN11; protein tyrosine phosphatase non-receptor type 11 [KO:K07293] [EC:3.1.3.48]", "3678  ITGA5; integrin subunit alpha 5 [KO:K06484]", "3690  ITGB3; integrin subunit beta 3 [KO:K06493]", "6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "6850  SYK; spleen associated tyrosine kinase [KO:K05855] [EC:2.7.10.2]", "64170  CARD9; caspase recruitment domain family member 9 [KO:K12794]", "3661  IRF3; interferon regulatory factor 3 [KO:K05411]", "3456  IFNB1; interferon beta 1 [KO:K05415]", "7157  TP53; tumor protein p53 [KO:K04451]", "718  C3; complement C3 [KO:K03990]", "727  C5; complement C5 [KO:K03994]", "5199  CFP; complement factor properdin [KO:K15412]", "7097  TLR2; toll like receptor 2 [KO:K10159]", "54106  TLR9; toll like receptor 9 [KO:K10161]", "4615  MYD88; MYD88 innate immune signal transduction adaptor [KO:K04729]", "3665  IRF7; interferon regulatory factor 7 [KO:K09447]", "7098  TLR3; toll like receptor 3 [KO:K05401]", "148022  TICAM1; TIR domain containing adaptor molecule 1 [KO:K05842]", "51135  IRAK4; interleukin 1 receptor associated kinase 4 [KO:K04733] [EC:2.7.11.1]", "3654  IRAK1; interleukin 1 receptor associated kinase 1 [KO:K04730] [EC:2.7.11.1]", "7189  TRAF6; TNF receptor associated factor 6 [KO:K03175] [EC:2.3.2.27]", "6885  MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO:K04427] [EC:2.7.11.25]", "10454  TAB1; TGF-beta activated kinase 1 (MAP3K7) binding protein 1 [KO:K04403]", "23118  TAB2; TGF-beta activated kinase 1 (MAP3K7) binding protein 2 [KO:K04404]", "3553  IL1B; interleukin 1 beta [KO:K04519]", "6352  CCL5; C-C motif chemokine ligand 5 [KO:K12499]", "3569  IL6; interleukin 6 [KO:K05405]", "7124  TNF; tumor necrosis factor [KO:K03156]", "3592  IL12A; interleukin 12A [KO:K05406]", "3593  IL12B; interleukin 12B [KO:K05425]", "23586  RIGI; RNA sensor RIG-I [KO:K12646] [EC:5.6.2.6]", "64135  IFIH1; interferon induced with helicase C domain 1 [KO:K12647] [EC:5.6.2.6]", "57506  MAVS; mitochondrial antiviral signaling protein [KO:K12648]", "7187  TRAF3; TNF receptor associated factor 3 [KO:K03174]", "9641  IKBKE; inhibitor of nuclear factor kappa B kinase subunit epsilon [KO:K07211] [EC:2.7.11.10]", "29110  TBK1; TANK binding kinase 1 [KO:K05410] [EC:2.7.11.10]", "3439  IFNA1; interferon alpha 1 [KO:K05414]", "3440  IFNA2; interferon alpha 2 [KO:K05414]", "3441  IFNA4; interferon alpha 4 [KO:K05414]", "3442  IFNA5; interferon alpha 5 [KO:K05414]", "3443  IFNA6; interferon alpha 6 [KO:K05414]", "3444  IFNA7; interferon alpha 7 [KO:K05414]", "3445  IFNA8; interferon alpha 8 [KO:K05414]", "3446  IFNA10; interferon alpha 10 [KO:K05414]", "3447  IFNA13; interferon alpha 13 [KO:K05414]", "3448  IFNA14; interferon alpha 14 [KO:K05414]", "3449  IFNA16; interferon alpha 16 [KO:K05414]", "3451  IFNA17; interferon alpha 17 [KO:K05414]", "3452  IFNA21; interferon alpha 21 [KO:K05414]", "115004  CGAS; cyclic GMP-AMP synthase [KO:K17834] [EC:2.7.7.86]", "340061  STING1; stimulator of interferon response cGAMP interactor 1 [KO:K12654]", "5499  PPP1CA; protein phosphatase 1 catalytic subunit alpha [KO:K06269] [EC:3.1.3.16]", "5500  PPP1CB; protein phosphatase 1 catalytic subunit beta [KO:K06269] [EC:3.1.3.16]", "5501  PPP1CC; protein phosphatase 1 catalytic subunit gamma [KO:K06269] [EC:3.1.3.16]", "27102  EIF2AK1; eukaryotic translation initiation factor 2 alpha kinase 1 [KO:K16194] [EC:2.7.11.1]", "5610  EIF2AK2; eukaryotic translation initiation factor 2 alpha kinase 2 [KO:K16195] [EC:2.7.11.1]", "9451  EIF2AK3; eukaryotic translation initiation factor 2 alpha kinase 3 [KO:K08860] [EC:2.7.11.1]", "440275  EIF2AK4; eukaryotic translation initiation factor 2 alpha kinase 4 [KO:K16196] [EC:2.7.11.1]", "1965  EIF2S1; eukaryotic translation initiation factor 2 subunit alpha [KO:K03237]", "1967  EIF2B1; eukaryotic translation initiation factor 2B subunit alpha [KO:K03239]", "8892  EIF2B2; eukaryotic translation initiation factor 2B subunit beta [KO:K03754]", "8891  EIF2B3; eukaryotic translation initiation factor 2B subunit gamma [KO:K03241]", "8890  EIF2B4; eukaryotic translation initiation factor 2B subunit delta [KO:K03680]", "8893  EIF2B5; eukaryotic translation initiation factor 2B subunit epsilon [KO:K03240]", "4938  OAS1; 2'-5'-oligoadenylate synthetase 1 [KO:K14216] [EC:2.7.7.84]", "4939  OAS2; 2'-5'-oligoadenylate synthetase 2 [KO:K14216] [EC:2.7.7.84]", "4940  OAS3; 2'-5'-oligoadenylate synthetase 3 [KO:K14216] [EC:2.7.7.84]", "6041  RNASEL; ribonuclease L [KO:K01165]", "3054  HCFC1; host cell factor C1 [KO:K14966]", "29915  HCFC2; host cell factor C2 [KO:K27390]", "5451  POU2F1; POU class 2 homeobox 1 [KO:K09364]", "5452  POU2F2; POU class 2 homeobox 2 [KO:K09364]", "25833  POU2F3; POU class 2 homeobox 3 [KO:K09364]", "3454  IFNAR1; interferon alpha and beta receptor subunit 1 [KO:K05130]", "3455  IFNAR2; interferon alpha and beta receptor subunit 2 [KO:K05131]", "9021  SOCS3; suppressor of cytokine signaling 3 [KO:K04696]", "3716  JAK1; Janus kinase 1 [KO:K11217] [EC:2.7.10.2]", "7297  TYK2; tyrosine kinase 2 [KO:K11219] [EC:2.7.10.2]", "6772  STAT1; signal transducer and activator of transcription 1 [KO:K11220]", "6773  STAT2; signal transducer and activator of transcription 2 [KO:K11221]", "10379  IRF9; interferon regulatory factor 9 [KO:K04693]", "147949  ZNF583; zinc finger protein 583 [KO:K09228]", "148156  ZNF558; zinc finger protein 558 [KO:K09228]", "148198  ZNF98; zinc finger protein 98 [KO:K09228]", "148254  ZNF555; zinc finger protein 555 [KO:K09228]", "148266  ZNF569; zinc finger protein 569 [KO:K09228]", "148268  ZNF570; zinc finger protein 570 [KO:K09228]", "152687  ZNF595; zinc finger protein 595 [KO:K09228]", "155054  ZNF425; zinc finger protein 425 [KO:K09228]", "155061  ZNF746; zinc finger protein 746 [KO:K09228]", "158431  ZNF782; zinc finger protein 782 [KO:K09228]", "162655  ZNF519; zinc finger protein 519 [KO:K09228]", "162962  ZNF836; zinc finger protein 836 [KO:K09228]", "162963  ZNF610; zinc finger protein 610 [KO:K09228]", "162967  ZNF320; zinc finger protein 320 [KO:K09228]", "162972  ZNF550; zinc finger protein 550 [KO:K09228]", "162993  ZNF846; zinc finger protein 846 [KO:K09228]", "163049  ZNF791; zinc finger protein 791 [KO:K09228]", "163050  ZNF564; zinc finger protein 564 [KO:K09228]", "163051  ZNF709; zinc finger protein 709 [KO:K09228]", "163059  ZNF433; zinc finger protein 433 [KO:K09228]", "163087  ZNF383; zinc finger protein 383 [KO:K09228]", "163131  ZNF780B; zinc finger protein 780B [KO:K09228]", "163227  ZNF100; zinc finger protein 100 [KO:K09228]", "163255  ZNF540; zinc finger protein 540 [KO:K09228]", "169270  ZNF596; zinc finger protein 596 [KO:K09228]", "169841  ZNF169; zinc finger protein 169 [KO:K09228]", "170959  ZNF431; zinc finger protein 431 [KO:K09228]", "171392  ZNF675; zinc finger protein 675 [KO:K09228]", "199692  ZNF627; zinc finger protein 627 [KO:K09228]", "201514  ZNF584; zinc finger protein 584 [KO:K09228]", "219749  ZNF25; zinc finger protein 25 [KO:K09228]", "22835  ZFP30; ZFP30 zinc finger protein [KO:K09228]", "22869  ZNF510; zinc finger protein 510 [KO:K09228]", "253639  ZNF620; zinc finger protein 620 [KO:K09228]", "255403  ZNF718; zinc finger protein 718 [KO:K09228]", "256051  ZNF549; zinc finger protein 549 [KO:K09228]", "25799  ZNF324; zinc finger protein 324 [KO:K09228]", "25888  ZNF473; zinc finger protein 473 [KO:K09228]", "26149  ZNF658; zinc finger protein 658 [KO:K09228]", "26152  ZNF337; zinc finger protein 337 [KO:K09228]", "26974  ZNF285; zinc finger protein 285 [KO:K09228]", "27153  ZNF777; zinc finger protein 777 [KO:K09228]", "27300  ZNF544; zinc finger protein 544 [KO:K09228]", "282890  ZNF311; zinc finger protein 311 [KO:K09228]", "284306  ZNF547; zinc finger protein 547 [KO:K09228]", "284307  ZIK1; zinc finger protein interacting with K protein 1 [KO:K09228]", "284370  ZNF615; zinc finger protein 615 [KO:K09228]", "284390  ZNF763; zinc finger protein 763 [KO:K09228]", "284406  ZFP82; ZFP82 zinc finger protein [KO:K09228]", "284459  ZNF875; zinc finger protein 875 [KO:K09228]", "10172  ZNF256; zinc finger protein 256 [KO:K09228]", "10224  ZNF443; zinc finger protein 443 [KO:K09228]", "10308  ZNF267; zinc finger protein 267 [KO:K09228]", "10520  ZNF211; zinc finger protein 211 [KO:K09228]", "10780  ZNF234; zinc finger protein 234 [KO:K09228]", "10793  ZNF273; zinc finger protein 273 [KO:K09228]", "10794  ZNF460; zinc finger protein 460 [KO:K09228]", "10795  ZNF268; zinc finger protein 268 [KO:K09228]", "10838  ZNF275; zinc finger protein 275 [KO:K09228]", "113835  ZNF257; zinc finger protein 257 [KO:K09228]", "114026  ZIM3; zinc finger imprinted 3 [KO:K09228]", "115196  ZNF554; zinc finger protein 554 [KO:K09228]", "115509  ZNF689; zinc finger protein 689 [KO:K09228]", "117608  ZNF354B; zinc finger protein 354B [KO:K09228]", "121274  ZNF641; zinc finger protein 641 [KO:K09228]", "125893  ZNF816; zinc finger protein 816 [KO:K09228]", "125919  ZNF543; zinc finger protein 543 [KO:K09228]", "126017  ZNF813; zinc finger protein 813 [KO:K09228]", "7559  ZNF12; zinc finger protein 12 [KO:K09228]", "7561  ZNF14; zinc finger protein 14 [KO:K09228]", "7562  ZNF708; zinc finger protein 708 [KO:K09228]", "7565  ZNF17; zinc finger protein 17 [KO:K09228]", "7567  ZNF19; zinc finger protein 19 [KO:K09228]", "7568  ZNF20; zinc finger protein 20 [KO:K09228]", "7569  ZNF182; zinc finger protein 182 [KO:K09228]", "7574  ZNF26; zinc finger protein 26 [KO:K09228]", "7581  ZNF33A; zinc finger protein 33A [KO:K09228]", "7582  ZNF33B; zinc finger protein 33B [KO:K09228]", "7587  ZNF37A; zinc finger protein 37A [KO:K09228]", "7592  ZNF41; zinc finger protein 41 [KO:K09228]", "7594  ZNF43; zinc finger protein 43 [KO:K09228]", "7596  ZNF45; zinc finger protein 45 [KO:K09228]", "7633  ZNF79; zinc finger protein 79 [KO:K09228]", "7637  ZNF84; zinc finger protein 84 [KO:K09228]", "7638  ZNF221; zinc finger protein 221 [KO:K09228]", "7639  ZNF85; zinc finger protein 85 [KO:K09228]", "7644  ZNF91; zinc finger protein 91 [KO:K09228]", "7652  ZNF99; zinc finger protein 99 [KO:K09228]", "7673  ZNF222; zinc finger protein 222 [KO:K09228]", "7678  ZNF124; zinc finger protein 124 [KO:K09228]", "7691  ZNF132; zinc finger protein 132 [KO:K09228]", "7692  ZNF133; zinc finger protein 133 [KO:K09228]", "7694  ZNF135; zinc finger protein 135 [KO:K09228]", "7695  ZNF136; zinc finger protein 136 [KO:K09228]", "7699  ZNF140; zinc finger protein 140 [KO:K09228]", "7700  ZNF141; zinc finger protein 141 [KO:K09228]", "7710  ZNF154; zinc finger protein 154 [KO:K09228]", "7711  ZNF155; zinc finger protein 155 [KO:K09228]", "7712  ZNF157; zinc finger protein 157 [KO:K09228]", "7728  ZNF175; zinc finger protein 175 [KO:K09228]", "7730  ZNF177; zinc finger protein 177 [KO:K09228]", "7733  ZNF180; zinc finger protein 180 [KO:K09228]", "7738  ZNF184; zinc finger protein 184 [KO:K09228]", "7743  ZNF189; zinc finger protein 189 [KO:K09228]", "7748  ZNF195; zinc finger protein 195 [KO:K09228]", "7755  ZNF205; zinc finger protein 205 [KO:K09228]", "7757  ZNF208; zinc finger protein 208 [KO:K09228]", "7761  ZNF214; zinc finger protein 214 [KO:K09228]", "7766  ZNF223; zinc finger protein 223 [KO:K09228]", "7767  ZNF224; zinc finger protein 224 [KO:K09228]", "7768  ZNF225; zinc finger protein 225 [KO:K09228]", "7769  ZNF226; zinc finger protein 226 [KO:K09228]", "7770  ZNF227; zinc finger protein 227 [KO:K09228]", "7771  ZNF112; zinc finger protein 112 [KO:K09228]", "7772  ZNF229; zinc finger protein 229 [KO:K09228]", "7773  ZNF230; zinc finger protein 230 [KO:K09228]", "79088  ZNF426; zinc finger protein 426 [KO:K09228]", "79175  ZNF343; zinc finger protein 343 [KO:K09228]", "79230  ZNF557; zinc finger protein 557 [KO:K09228]", "79744  ZNF419; zinc finger protein 419 [KO:K09228]", "79788  ZNF665; zinc finger protein 665 [KO:K09228]", "79818  ZNF552; zinc finger protein 552 [KO:K09228]", "79862  ZNF669; zinc finger protein 669 [KO:K09228]", "7988  ZNF212; zinc finger protein 212 [KO:K09228]", "79891  ZNF671; zinc finger protein 671 [KO:K09228]", "79898  ZNF613; zinc finger protein 613 [KO:K09228]", "79973  ZNF442; zinc finger protein 442 [KO:K09228]", "80032  ZNF556; zinc finger protein 556 [KO:K09228]", "80095  ZNF606; zinc finger protein 606 [KO:K09228]", "80110  ZNF614; zinc finger protein 614 [KO:K09228]", "80264  ZNF430; zinc finger protein 430 [KO:K09228]", "80778  ZNF34; zinc finger protein 34 [KO:K09228]", "80818  ZNF436; zinc finger protein 436 [KO:K09228]", "81856  ZNF611; zinc finger protein 611 [KO:K09228]", "81931  ZNF93; zinc finger protein 93 [KO:K09228]", "8427  ZNF282; zinc finger protein 282 [KO:K09228]", "84436  ZNF528; zinc finger protein 528 [KO:K09228]", "84449  ZNF333; zinc finger protein 333 [KO:K09228]", "84503  ZNF527; zinc finger protein 527 [KO:K09228]", "84527  ZNF559; zinc finger protein 559 [KO:K09228]", "84671  ZNF347; zinc finger protein 347 [KO:K09228]", "84765  ZNF577; zinc finger protein 577 [KO:K09228]", "84775  ZNF607; zinc finger protein 607 [KO:K09228]", "84874  ZNF514; zinc finger protein 514 [KO:K09228]", "84911  ZNF382; zinc finger protein 382 [KO:K09228]", "84914  ZNF587; zinc finger protein 587 [KO:K09228]", "84924  ZNF566; zinc finger protein 566 [KO:K09228]", "90233  ZNF551; zinc finger protein 551 [KO:K09228]", "90317  ZNF616; zinc finger protein 616 [KO:K09228]", "90321  ZNF766; zinc finger protein 766 [KO:K09228]", "90333  ZNF468; zinc finger protein 468 [KO:K09228]", "90338  ZNF160; zinc finger protein 160 [KO:K09228]", "90576  ZNF799; zinc finger protein 799 [KO:K09228]", "90592  ZNF700; zinc finger protein 700 [KO:K09228]", "90594  ZNF439; zinc finger protein 439 [KO:K09228]", "90649  ZNF486; zinc finger protein 486 [KO:K09228]", "90827  ZNF479; zinc finger protein 479 [KO:K09228]", "91120  ZNF682; zinc finger protein 682 [KO:K09228]", "91661  ZNF765; zinc finger protein 765 [KO:K09228]", "91975  ZNF300; zinc finger protein 300 [KO:K09228]", "92283  ZNF461; zinc finger protein 461 [KO:K09228]", "92285  ZNF585B; zinc finger protein 585B [KO:K09228]", "92595  ZNF764; zinc finger protein 764 [KO:K09228]", "9310  ZNF235; zinc finger protein 235 [KO:K09228]", "93474  ZNF670; zinc finger protein 670 [KO:K09228]", "94039  ZNF101; zinc finger protein 101 [KO:K09228]", "9534  ZNF254; zinc finger protein 254 [KO:K09228]", "9668  ZNF432; zinc finger protein 432 [KO:K09228]", "163071  ZNF114; zinc finger protein 114 [KO:K09228]", "126070  ZNF440; zinc finger protein 440 [KO:K09228]", "126295  ZNF57; zinc finger protein 57 [KO:K09228]", "127396  ZNF684; zinc finger protein 684 [KO:K09228]", "136051  ZNF786; zinc finger protein 786 [KO:K09228]", "139735  ZFP92; ZFP92 zinc finger protein [KO:K09228]", "140612  ZFP28; ZFP28 zinc finger protein [KO:K09228]", "146198  ZFP90; ZFP90 zinc finger protein [KO:K09228]", "146434  ZNF597; zinc finger protein 597 [KO:K09228]", "146540  ZNF785; zinc finger protein 785 [KO:K09228]", "147657  ZNF480; zinc finger protein 480 [KO:K09228]", "147658  ZNF534; zinc finger protein 534 [KO:K09228]", "147686  ZNF418; zinc finger protein 418 [KO:K09228]", "147687  ZNF417; zinc finger protein 417 [KO:K09228]", "147694  ZNF548; zinc finger protein 548 [KO:K09228]", "147741  ZNF560; zinc finger protein 560 [KO:K09228]", "147837  ZNF563; zinc finger protein 563 [KO:K09228]", "147923  ZNF420; zinc finger protein 420 [KO:K09228]", "147929  ZNF565; zinc finger protein 565 [KO:K09228]", "147948  ZNF582; zinc finger protein 582 [KO:K09228]", "285268  ZNF621; zinc finger protein 621 [KO:K09228]", "285676  ZNF454; zinc finger protein 454 [KO:K09228]", "286075  ZNF707; zinc finger protein 707 [KO:K09228]", "30832  ZNF354C; zinc finger protein 354C [KO:K09228]", "339327  ZNF546; zinc finger protein 546 [KO:K09228]", "339559  ZFP69; ZFP69 zinc finger protein [KO:K09228]", "340252  ZNF680; zinc finger protein 680 [KO:K09228]", "340385  ZNF517; zinc finger protein 517 [KO:K09228]", "342908  ZNF404; zinc finger protein 404 [KO:K09228]", "342909  ZNF284; zinc finger protein 284 [KO:K09228]", "342926  ZNF677; zinc finger protein 677 [KO:K09228]", "344787  ZNF860; zinc finger protein 860 [KO:K09228]", "346171  ZFP57; ZFP57 zinc finger protein [KO:K09228]", "348327  ZNF530; zinc finger protein 530 [KO:K09228]", "349075  ZNF713; zinc finger protein 713 [KO:K09228]", "353088  ZNF429; zinc finger protein 429 [KO:K09228]", "353355  ZNF233; zinc finger protein 233 [KO:K09228]", "374879  ZNF699; zinc finger protein 699 [KO:K09228]", "374900  ZNF568; zinc finger protein 568 [KO:K09228]", "374928  ZNF773; zinc finger protein 773 [KO:K09228]", "388536  ZNF790; zinc finger protein 790 [KO:K09228]", "388566  ZNF470; zinc finger protein 470 [KO:K09228]", "388569  ZNF324B; zinc finger protein 324B [KO:K09228]", "390927  ZNF793; zinc finger protein 793 [KO:K09228]", "400720  ZNF772; zinc finger protein 772 [KO:K09228]", "440077  ZNF705A; zinc finger protein 705A [KO:K09228]", "440515  ZNF506; zinc finger protein 506 [KO:K09228]", "441234  ZNF716; zinc finger protein 716 [KO:K09228]", "51276  ZNF571; zinc finger protein 571 [KO:K09228]", "51385  ZNF589; zinc finger protein 589 [KO:K09228]", "51710  ZNF44; zinc finger protein 44 [KO:K09228]", "54753  ZNF853; zinc finger protein 853 [KO:K09228]", "54925  ZSCAN32; zinc finger and SCAN domain containing 32 [KO:K09228]", "55422  ZNF331; zinc finger protein 331 [KO:K09228]", "55552  ZNF823; zinc finger protein 823 [KO:K09228]", "55659  ZNF416; zinc finger protein 416 [KO:K09228]", "55713  ZNF334; zinc finger protein 334 [KO:K09228]", "55762  ZNF701; zinc finger protein 701 [KO:K09228]", "55786  ZNF415; zinc finger protein 415 [KO:K09228]", "55900  ZNF302; zinc finger protein 302 [KO:K09228]", "56242  ZNF253; zinc finger protein 253 [KO:K09228]", "57209  ZNF248; zinc finger protein 248 [KO:K09228]", "57335  ZNF286A; zinc finger protein 286A [KO:K09228]", "57343  ZNF304; zinc finger protein 304 [KO:K09228]", "57474  ZNF490; zinc finger protein 490 [KO:K09228]", "57547  ZNF624; zinc finger protein 624 [KO:K09228]", "57573  ZNF471; zinc finger protein 471 [KO:K09228]", "57615  ZNF492; zinc finger protein 492 [KO:K09228]", "57677  ZFP14; ZFP14 zinc finger protein [KO:K09228]", "57693  ZNF317; zinc finger protein 317 [KO:K09228]", "57786  RBAK; RB associated KRAB zinc finger [KO:K09228]", "58492  ZNF77; zinc finger protein 77 [KO:K09228]", "58500  ZNF250; zinc finger protein 250 [KO:K09228]", "59348  ZNF350; zinc finger protein 350 [KO:K09228]", "63934  ZNF667; zinc finger protein 667 [KO:K09228]", "641339  ZNF674; zinc finger protein 674 [KO:K09228]", "65251  ZNF649; zinc finger protein 649 [KO:K09228]", "6940  ZNF354A; zinc finger protein 354A [KO:K09228]", "728927  ZNF736; zinc finger protein 736 [KO:K09228]", "728957  ZNF705D; zinc finger protein 705D [KO:K09228]", "729747  ZNF878; zinc finger protein 878 [KO:K09228]", "7539  ZFP37; ZFP37 zinc finger protein [KO:K09228]", "7551  ZNF3; zinc finger protein 3 [KO:K09228]", "7553  ZNF7; zinc finger protein 7 [KO:K09228]", "7554  ZNF8; zinc finger protein 8 [KO:K09228]", "7556  ZNF10; zinc finger protein 10 [KO:K09228]", "83744  ZNF484; zinc finger protein 484 [KO:K09228]", "162239  ZFP1; ZFP1 zinc finger protein [KO:K09228]", "163081  ZNF567; zinc finger protein 567 [KO:K09228]", "126375  ZNF792; zinc finger protein 792 [KO:K09228]", "374899  ZNF829; zinc finger protein 829 [KO:K09228]", "7643  ZNF90; zinc finger protein 90 [KO:K09228]", "347344  ZNF81; zinc finger protein 81 [KO:K09228]", "90075  ZNF30; zinc finger protein 30 [KO:K09228]", "90987  ZNF251; zinc finger protein 251 [KO:K09228]", "146542  ZNF688; zinc finger protein 688 [KO:K09228]", "7549  ZNF2; zinc finger protein 2 [KO:K09228]", "7571  ZNF23; zinc finger protein 23 [KO:K09228]", "93134  ZNF561; zinc finger protein 561 [KO:K09228]", "100129543  ZNF730; zinc finger protein 730 [KO:K09228]", "148103  ZNF599; zinc finger protein 599 [KO:K09228]", "100289678  ZNF783; zinc finger protein 783 [KO:K09228]", "57541  ZNF398; zinc finger protein 398 [KO:K09228]", "284349  ZNF283; zinc finger protein 283 [KO:K09228]", "345462  ZNF879; zinc finger protein 879 [KO:K09228]", "389114  ZNF662; zinc finger protein 662 [KO:K09228]", "54811  ZNF562; zinc finger protein 562 [KO:K09228]", "57232  ZNF630; zinc finger protein 630 [KO:K09228]", "7752  ZNF200; zinc finger protein 200 [KO:K09228]", "197320  ZNF778; zinc finger protein 778 [KO:K09228]", "9831  ZNF623; zinc finger protein 623 [KO:K09228]", "442319  ZNF727; zinc finger protein 727 [KO:K09228]", "168417  ZNF679; zinc finger protein 679 [KO:K09228]", "79724  ZNF768; zinc finger protein 768 [KO:K09228]", "65243  ZFP69B; ZFP69 zinc finger protein B [KO:K09228]", "339318  ZNF181; zinc finger protein 181 [KO:K09228]", "100287226  ZNF729; zinc finger protein 729 [KO:K09228]", "342892  ZNF850; zinc finger protein 850 [KO:K09228]", "100289635  ZNF605; zinc finger protein 605 [KO:K09228]", "100529215  ZNF559-ZNF177; ZNF559-ZNF177 readthrough [KO:K09228]", "101060200  ZNF891; zinc finger protein 891 [KO:K09228]", "148206  ZNF714; zinc finger protein 714 [KO:K09228]", "163223  ZNF676; zinc finger protein 676 [KO:K09228]", "170960  ZNF721; zinc finger protein 721 [KO:K09228]", "199704  ZNF585A; zinc finger protein 585A [KO:K09228]", "285267  ZNF619; zinc finger protein 619 [KO:K09228]", "388561  ZNF761; zinc finger protein 761 [KO:K09228]", "51427  ZNF107; zinc finger protein 107 [KO:K09228]", "55769  ZNF83; zinc finger protein 83 [KO:K09228]", "57711  ZNF529; zinc finger protein 529 [KO:K09228]", "730051  ZNF814; zinc finger protein 814 [KO:K09228]", "730291  ZNF735; zinc finger protein 735 [KO:K09228]", "91664  ZNF845; zinc finger protein 845 [KO:K09228]", "388567  ZNF749; zinc finger protein 749 [KO:K09228]", "284371  ZNF841; zinc finger protein 841 [KO:K09228]", "100131017  ZNF316; zinc finger protein 316 [KO:K09228]", "100131827  ZNF717; zinc finger protein 717 [KO:K09228]", "284323  ZNF780A; zinc finger protein 780A [KO:K09228]", "7625  ZNF74; zinc finger protein 74 [KO:K09228]", "730087  ZNF726; zinc finger protein 726 [KO:K09228]", "162966  ZNF600; zinc finger protein 600 [KO:K09228]", "100129842  ZNF737; zinc finger protein 737 [KO:K09228]", "388558  ZNF808; zinc finger protein 808 [KO:K09228]", "388559  ZNF888; zinc finger protein 888 [KO:K09228]", "390980  ZNF805; zinc finger protein 805 [KO:K09228]", "126068  ZNF441; zinc finger protein 441 [KO:K09228]", "126231  ZNF573; zinc finger protein 573 [KO:K09228]", "147660  ZNF578; zinc finger protein 578 [KO:K09228]", "9422  ZNF264; zinc finger protein 264 [KO:K09228]", "170958  ZNF525; zinc finger protein 525 [KO:K09228]", "110116772  ZNF765-ZNF761; ZNF765-ZNF761 readthrough [KO:K09228]", "7576  ZNF28; zinc finger protein 28 [KO:K09228]", "440519  ZNF724; zinc finger protein 724 [KO:K09228]", "7617  ZNF66; zinc finger protein 66 [KO:K09228]", "388523  ZNF728; zinc finger protein 728 [KO:K09228]", "148213  ZNF681; zinc finger protein 681 [KO:K09228]", "122539214  Zinc finger protein LOC122539214 [KO:K09228]", "168374  ZNF92; zinc finger protein 92 [KO:K09228]", "654254  ZNF732; zinc finger protein 732 [KO:K09228]", "400713  ZNF880; zinc finger protein 880 [KO:K09228]", "148203  ZNF738; zinc finger protein 738 [KO:K09228]", "199777  ZNF626; zinc finger protein 626 [KO:K09228]", "220992  ZNF485; zinc finger protein 485 [KO:K09228]", "284309  ZNF776; zinc finger protein 776 [KO:K09228]", "54807  ZNF586; zinc finger protein 586 [KO:K09228]", "344065  ZNF892; zinc finger protein 892 [KO:K09228]", "100131980  ZNF705G; zinc finger protein 705G [KO:K09228]", "100132396  ZNF705B; zinc finger protein 705B [KO:K09228]", "162968  ZNF497; zinc finger protein 497 [KO:K09228]", "684  BST2; bone marrow stromal cell antigen 2 [KO:K06731]", "3458  IFNG; interferon gamma [KO:K04687]", "3459  IFNGR1; interferon gamma receptor 1 [KO:K05132]", "3460  IFNGR2; interferon gamma receptor 2 [KO:K05133]", "3717  JAK2; Janus kinase 2 [KO:K04447] [EC:2.7.10.2]", "1616  DAXX; death domain associated protein [KO:K02308]", "6672  SP100; SP100 nuclear antigen [KO:K15413]", "5371  PML; PML nuclear body scaffold [KO:K10054] [EC:2.3.2.-]", "6890  TAP1; transporter 1, ATP binding cassette subfamily B member [KO:K05653] [EC:7.4.2.14]", "6891  TAP2; transporter 2, ATP binding cassette subfamily B member [KO:K05654] [EC:7.4.2.14]", "6892  TAPBP; TAP binding protein [KO:K08058]", "2923  PDIA3; protein disulfide isomerase family A member 3 [KO:K08056] [EC:5.3.4.1]", "811  CALR; calreticulin [KO:K08057]", "3105  HLA-A; major histocompatibility complex, class I, A [KO:K06751]", "3106  HLA-B; major histocompatibility complex, class I, B [KO:K06751]", "3107  HLA-C; major histocompatibility complex, class I, C [KO:K06751]", "3134  HLA-F; major histocompatibility complex, class I, F [KO:K06751]", "3135  HLA-G; major histocompatibility complex, class I, G [KO:K06751]", "3133  HLA-E; major histocompatibility complex, class I, E [KO:K06751]", "567  B2M; beta-2-microglobulin [KO:K08055]", "3108  HLA-DMA; major histocompatibility complex, class II, DM alpha [KO:K06752]", "3109  HLA-DMB; major histocompatibility complex, class II, DM beta [KO:K06752]", "3111  HLA-DOA; major histocompatibility complex, class II, DO alpha [KO:K06752]", "3112  HLA-DOB; major histocompatibility complex, class II, DO beta [KO:K06752]", "3113  HLA-DPA1; major histocompatibility complex, class II, DP alpha 1 [KO:K06752]", "3115  HLA-DPB1; major histocompatibility complex, class II, DP beta 1 [KO:K06752]", "3117  HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 [KO:K06752]", "3118  HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2 [KO:K06752]", "3119  HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 [KO:K06752]", "3122  HLA-DRA; major histocompatibility complex, class II, DR alpha [KO:K06752]", "3123  HLA-DRB1; major histocompatibility complex, class II, DR beta 1 [KO:K06752]", "3125  HLA-DRB3; major histocompatibility complex, class II, DR beta 3 [KO:K06752]", "3126  HLA-DRB4; major histocompatibility complex, class II, DR beta 4 [KO:K06752]", "3127  HLA-DRB5; major histocompatibility complex, class II, DR beta 5 [KO:K06752]", "972  CD74; CD74 molecule [KO:K06505]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "7248  TSC1; TSC complex subunit 1 [KO:K07206]", "7249  TSC2; TSC complex subunit 2 [KO:K07207]", "6009  RHEB; Ras homolog, mTORC1 binding [KO:K07208]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "1978  EIF4EBP1; eukaryotic translation initiation factor 4E binding protein 1 [KO:K07205]", "6732  SRPK1; SRSF protein kinase 1 [KO:K15409] [EC:2.7.11.1]", "6426  SRSF1; serine and arginine rich splicing factor 1 [KO:K12890]", "6427  SRSF2; serine and arginine rich splicing factor 2 [KO:K12891]", "10929  SRSF8; serine and arginine rich splicing factor 8 [KO:K12891]", "6428  SRSF3; serine and arginine rich splicing factor 3 [KO:K12892]", "6429  SRSF4; serine and arginine rich splicing factor 4 [KO:K12893]", "6430  SRSF5; serine and arginine rich splicing factor 5 [KO:K12893]", "6431  SRSF6; serine and arginine rich splicing factor 6 [KO:K12893]", "6432  SRSF7; serine and arginine rich splicing factor 7 [KO:K12896]", "8683  SRSF9; serine and arginine rich splicing factor 9 [KO:K21123]", "10482  NXF1; nuclear RNA export factor 1 [KO:K14284]", "56001  NXF2; nuclear RNA export factor 2 [KO:K14284]", "728343  NXF2B; nuclear RNA export factor 2B [KO:K14284]", "56000  NXF3; nuclear RNA export factor 3 [KO:K14284]", "10189  ALYREF; Aly/REF export factor [KO:K12881]", "356  FASLG; Fas ligand [KO:K04389]", "355  FAS; Fas cell surface death receptor [KO:K04390]", "7132  TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158]", "8717  TRADD; TNFRSF1A associated via death domain [KO:K03171]", "8772  FADD; Fas associated via death domain [KO:K02373]", "841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]", "637  BID; BH3 interacting domain death agonist [KO:K04726]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "578  BAK1; BCL2 antagonist/killer 1 [KO:K14021]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]", "598  BCL2L1; BCL2 like 1 [KO:K04570]", "54205  CYCS; cytochrome c, somatic [KO:K08738]", "317  APAF1; apoptotic peptidase activating factor 1 [KO:K02084]", "842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]"], "compound": ["C05981  Phosphatidylinositol-3,4,5-trisphosphate", "C20640  Cyclic GMP-AMP", "C20935  2-5A"], "refs": [{"pmid": "12787566", "authors": "  Granger SW, Rickert S", "title": "LIGHT-HVEM signaling and the regulation of T cell-mediated immunity.", "journal": "Cytokine Growth Factor Rev 14:289-96 (2003)", "doi": "10.1016/S1359-6101(03)00031-5"}, {"pmid": "19495760", "authors": "  Steinberg MW, Shui JW, Ware CF, Kronenberg M", "title": "Regulating the mucosal immune system: the contrasting roles of LIGHT, HVEM, and their various partners.", "journal": "Semin Immunopathol 31:207-21 (2009)", "doi": "10.1007/s00281-009-0157-4"}, {"pmid": "20221426", "authors": "  MacLeod IJ, Minson T", "title": "Binding of herpes simplex virus type-1 virions leads to the induction of intracellular signalling in the absence of virus entry.", "journal": "PLoS One 5:e9560 (2010)", "doi": "10.1371/journal.pone.0009560"}, {"pmid": "23150579", "authors": "  Gianni T, Leoni V, Chesnokova LS, Hutt-Fletcher LM, Campadelli-Fiume G", "title": "alphavbeta3-integrin is a major sensor and activator of innate immunity to herpes simplex virus-1.", "journal": "Proc Natl Acad Sci U S A 109:19792-7 (2012)", "doi": "10.1073/pnas.1212597109"}, {"pmid": "25375272", "authors": "  Gianni T, Campadelli-Fiume G", "title": "The epithelial alphavbeta3-integrin boosts the MYD88-dependent TLR2 signaling in response to viral and bacterial components.", "journal": "PLoS Pathog 10:e1004477 (2014)", "doi": "10.1371/journal.ppat.1004477"}, {"pmid": "15056211", "authors": "  Spear PG", "title": "Herpes simplex virus: receptors and ligands for cell entry.", "journal": "Cell Microbiol 6:401-10 (2004)", "doi": "10.1111/j.1462-5822.2004.00389.x"}, {"pmid": "12855695", "authors": "  Boutell C, Everett RD", "title": "The herpes simplex virus type 1 (HSV-1) regulatory protein ICP0 interacts with and Ubiquitinates p53.", "journal": "J Biol Chem 278:36596-602 (2003)", "doi": "10.1074/jbc.M300776200"}, {"pmid": "24262390", "authors": "  Ma Y, He B", "title": "Recognition of herpes simplex viruses: toll-like receptors and beyond.", "journal": "J Mol Biol 426:1133-47 (2014)", "doi": "10.1016/j.jmb.2013.11.012"}, {"pmid": "26952111", "authors": "  Su C, Zhan G, Zheng C", "title": "Evasion of host antiviral innate immunity by HSV-1, an update.", "journal": "Virol J 13:38 (2016)", "doi": "10.1186/s12985-016-0495-5"}, {"pmid": "21994567", "authors": "  Melchjorsen J, Matikainen S, Paludan SR", "title": "Activation and evasion of innate antiviral immunity by herpes simplex virus.", "journal": "Viruses 1:737-59 (2009)", "doi": "10.3390/v1030737"}, {"pmid": "15276609", "authors": "  Morrison LA", "title": "The Toll of herpes simplex virus infection.", "journal": "Trends Microbiol 12:353-6 (2004)", "doi": "10.1016/j.tim.2004.06.001"}, {"pmid": "29298887", "authors": "  Zheng C", "title": "Evasion of Cytosolic DNA-Stimulated Innate Immune Responses by Herpes Simplex Virus 1.", "journal": "J Virol 92:e00099-17 (2018)", "doi": "10.1128/JVI.00099-17"}, {"pmid": "19344302", "authors": "  Grandi P, Peruzzi P, Reinhart B, Cohen JB, Chiocca EA, Glorioso JC", "title": "Design and application of oncolytic HSV vectors for glioblastoma therapy.", "journal": "Expert Rev Neurother 9:505-17 (2009)", "doi": "10.1586/ern.09.9"}, {"pmid": "23115300", "authors": "  Lussignol M, Queval C, Bernet-Camard MF, Cotte-Laffitte J, Beau I, Codogno P, Esclatine A", "title": "The herpes simplex virus 1 Us11 protein inhibits autophagy through its interaction with the protein kinase PKR.", "journal": "J Virol 87:859-71 (2013)", "doi": "10.1128/JVI.01158-12"}, {"pmid": "17229694", "authors": "  Sanchez R, Mohr I", "title": "Inhibition of cellular 2'-5' oligoadenylate synthetase by the herpes simplex virus type 1 Us11 protein.", "journal": "J Virol 81:3455-64 (2007)", "doi": "10.1128/JVI.02520-06"}, {"pmid": "12826401", "authors": "  Wysocka J, Herr W", "title": "The herpes simplex virus VP16-induced complex: the makings of a regulatory switch.", "journal": "Trends Biochem Sci 28:294-304 (2003)", "doi": "10.1016/S0968-0004(03)00088-4"}, {"pmid": "27367734", "authors": "  Fleming SB", "title": "Viral Inhibition of the IFN-Induced JAK/STAT Signalling Pathway: Development of Live Attenuated Vaccines by Mutation of Viral-Encoded IFN-Antagonists.", "journal": "Vaccines (Basel) 4:E23 (2016)", "doi": "10.3390/vaccines4030023"}, {"pmid": "15163721", "authors": "  Yokota S, Yokosawa N, Okabayashi T, Suzutani T, Miura S, Jimbow K, Fujii N", "title": "Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 contributes to inhibition of the interferon signaling pathway.", "journal": "J Virol 78:6282-6 (2004)", "doi": "10.1128/JVI.78.12.6282-6286.2004"}, {"pmid": "23864622", "authors": "  Gu H, Zheng Y, Roizman B", "title": "Interaction of herpes simplex virus ICP0 with ND10 bodies: a sequential process of adhesion, fusion, and retention.", "journal": "J Virol 87:10244-54 (2013)", "doi": "10.1128/JVI.01487-13"}, {"pmid": "21994592", "authors": "  Tavalai N, Stamminger T", "title": "Interplay between Herpesvirus Infection and Host Defense by PML Nuclear Bodies.", "journal": "Viruses 1:1240-64 (2009)", "doi": "10.3390/v1031240"}, {"pmid": "21146386", "authors": "  Horst D, Verweij MC, Davison AJ, Ressing ME, Wiertz EJ", "title": "Viral evasion of T cell immunity: ancient mechanisms offering new applications.", "journal": "Curr Opin Immunol 23:96-103 (2011)", "doi": "10.1016/j.coi.2010.11.005"}, {"pmid": "12960333", "authors": "  Neumann J, Eis-Hubinger AM, Koch N", "title": "Herpes simplex virus type 1 targets the MHC class II processing pathway for immune evasion.", "journal": "J Immunol 171:3075-83 (2003)", "doi": "10.4049/jimmunol.171.6.3075"}, {"pmid": "25798530", "authors": "  Liu X, Cohen JI", "title": "The role of PI3K/Akt in human herpesvirus infection: From the bench to the bedside.", "journal": "Virology 479-480:568-77 (2015)", "doi": "10.1016/j.virol.2015.02.040"}, {"pmid": "28468873", "authors": "  Vink EI, Smiley JR, Mohr I", "title": "Subversion of Host Responses to Energy Insufficiency by Us3 Supports Herpes Simplex Virus 1 Replication during Stress.", "journal": "J Virol 91:e00295-17 (2017)", "doi": "10.1128/JVI.00295-17"}, {"pmid": "18508584", "authors": "  Sandri-Goldin RM", "title": "The many roles of the regulatory protein ICP27 during herpes simplex virus infection.", "journal": "Front Biosci 13:5241-56 (2008)", "doi": "10.2741/3078"}, {"pmid": "15078920", "authors": "  Sandri-Goldin RM", "title": "Viral regulation of mRNA export.", "journal": "J Virol 78:4389-96 (2004)", "doi": "10.1128/JVI.78.9.4389-4396.2004"}], "rel_pathway": ["hsa03040  Spliceosome", "hsa03050  Proteasome", "hsa04115  p53 signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04210  Apoptosis", "hsa04610  Complement and coagulation cascades", "hsa04612  Antigen processing and presentation", "hsa04620  Toll-like receptor signaling pathway", "hsa04622  RIG-I-like receptor signaling pathway", "hsa04630  JAK-STAT signaling pathway"], "ko_pathway": "ko05168", "genes": ["TP53", "AKT2", "BIRC3", "AKT1", "BAX"]}, {"kegg_id": "hsa05216", "name": "Thyroid cancer - Homo sapiens (human)", "description": "Thyroid cancer is the most common endocrine malignancy and accounts for the majority of endocrine cancer- related deaths each year. More than 95% of thyroid carcinomas are derived from follicular cells. Their behavior varies from the indolent growing, well-differentiated papillary and follicular carcinomas (PTC and FTC, respectively) to the extremely aggressive undifferentiated carcinoma (UC). Somatic rearrangements of RET and TRK are almost exclusively found in PTC and may be found in early stages. The most distinctive molecular features of FTC are the prominence of aneuploidy and the high prevalence of RAS mutations and PAX8-PPAR{gamma} rearrangements. p53 seems to play a crucial role in the dedifferentiation process of thyroid carcinoma.", "class": "Human Diseases; Cancer: specific types", "pathway_map": "hsa05216  Thyroid cancer", "network": ["", "ELEMENT   N00008  RET fusion kinase to RAS-ERK signaling pathway", "N00009  TRK fusion kinase to RAS-ERK signaling pathway", "N00012  Mutation-activated KRAS/NRAS to ERK signaling pathway", "N00013  Mutation-activated BRAF to ERK signaling pathway", "N00061  CDH1-reduced expression to beta-catenin signaling pathway", "N00115  Mutation-inactivated TP53 to transcription", "N00126  PAX8-PPARG fusion to PPARG-mediated transcription"], "disease": ["H00032  Thyroid cancer"], "drug": ["D06272  Sorafenib tosylate (USAN)", "D06407  Vandetanib (JAN/USAN/INN)", "D08524  Sorafenib (USAN/INN)", "D09919  Lenvatinib (USAN/INN)", "D09920  Lenvatinib mesylate (USAN)", "D11713  Selpercatinib (JAN/USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["5979  RET; ret proto-oncogene [KO:K05126] [EC:2.7.10.1]", "8030  CCDC6; coiled-coil domain containing 6 [KO:K09288]", "8031  NCOA4; nuclear receptor coactivator 4 [KO:K09289]", "4914  NTRK1; neurotrophic receptor tyrosine kinase 1 [KO:K03176] [EC:2.7.10.1]", "7170  TPM3; tropomyosin 3 [KO:K09290]", "7175  TPR; translocated promoter region, nuclear basket protein [KO:K09291]", "10342  TFG; trafficking from ER to golgi regulator [KO:K09292]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "7849  PAX8; paired box 8 [KO:K09293]", "5468  PPARG; peroxisome proliferator activated receptor gamma [KO:K08530]", "6256  RXRA; retinoid X receptor alpha [KO:K08524]", "6257  RXRB; retinoid X receptor beta [KO:K08525]", "6258  RXRG; retinoid X receptor gamma [KO:K08526]", "7157  TP53; tumor protein p53 [KO:K04451]", "1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]", "1647  GADD45A; growth arrest and DNA damage inducible alpha [KO:K04402]", "4616  GADD45B; growth arrest and DNA damage inducible beta [KO:K04402]", "10912  GADD45G; growth arrest and DNA damage inducible gamma [KO:K04402]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "578  BAK1; BCL2 antagonist/killer 1 [KO:K14021]", "1643  DDB2; damage specific DNA binding protein 2 [KO:K10140]", "51426  POLK; DNA polymerase kappa [KO:K03511] [EC:2.7.7.7]", "999  CDH1; cadherin 1 [KO:K05689]", "1499  CTNNB1; catenin beta 1 [KO:K02105]", "6932  TCF7; transcription factor 7 [KO:K02620]", "83439  TCF7L1; transcription factor 7 like 1 [KO:K04490]", "6934  TCF7L2; transcription factor 7 like 2 [KO:K04491]", "51176  LEF1; lymphoid enhancer binding factor 1 [KO:K04492]", "4609  MYC; MYC proto-oncogene, bHLH transcription factor [KO:K04377]", "595  CCND1; cyclin D1 [KO:K04503]"], "refs": [{"pmid": "16557281", "authors": "  Kondo T, Ezzat S, Asa SL.", "title": "Pathogenetic mechanisms in thyroid follicular-cell neoplasia.", "journal": "Nat Rev Cancer 6:292-306 (2006)", "doi": "10.1038/nrc1836"}, {"pmid": "16551846", "authors": "  Chiloeches A, Marais R.", "title": "Is BRAF the Achilles' Heel of thyroid cancer?", "journal": "Clin Cancer Res 12:1661-4 (2006)", "doi": "10.1158/1078-0432.CCR-06-0051"}, {"pmid": "16946003", "authors": "  Reddi HV, McIver B, Grebe SK, Eberhardt NL", "title": "The paired box-8/peroxisome proliferator-activated receptor-gamma oncogene in thyroid tumorigenesis.", "journal": "Endocrinology 148:932-5 (2007)", "doi": "10.1210/en.2006-0926"}, {"pmid": "17062879", "authors": "  Santoro M, Melillo RM, Fusco A.", "title": "RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture.", "journal": "Eur J Endocrinol 155:645-653 (2006)", "doi": "10.1530/eje.1.02289"}, {"pmid": "16242838", "authors": "  Pierotti MA, Greco A.", "title": "Oncogenic rearrangements of the NTRK1/NGF receptor.", "journal": "Cancer Lett 232:90-8 (2006)", "doi": "10.1016/j.canlet.2005.07.043"}, {"pmid": "16189702", "authors": "  Sobrinho-Simoes M, Preto A, Rocha AS, Castro P, Maximo V, Fonseca E, Soares P.", "title": "Molecular pathology of well-differentiated thyroid carcinomas.", "journal": "Virchows Arch 447:787-93 (2005)", "doi": "10.1007/s00428-005-0065-5"}, {"pmid": "11165748", "authors": "  Gimm O.", "title": "Thyroid cancer.", "journal": "Cancer Lett 163:143-56 (2001)", "doi": "10.1016/S0304-3835(00)00697-2"}], "rel_pathway": ["hsa03320  PPAR signaling pathway", "hsa04010  MAPK signaling pathway", "hsa04115  p53 signaling pathway", "hsa04310  Wnt signaling pathway", "hsa04520  Adherens junction"], "ko_pathway": "ko05216", "genes": ["TP53", "BRAF", "NRAS", "BAX"]}, {"kegg_id": "hsa05217", "name": "Basal cell carcinoma - Homo sapiens (human)", "description": "Cancer of the skin is the most common cancer in Caucasians and basal cell carcinomas (BCC) account for 90% of all skin cancers. The vast majority of BCC cases are sporadic, though there is a rare familial syndrome basal cell nevus syndrome (BCNS, or Gorlin syndrome) that predisposes to development of BCC. In addition, there is strong epidemiological and genetic evidence that demonstrates UV exposure as a risk factor of prime importance. The development of basal cell carcinoma is associated with constitutive activation of sonic hedgehog signaling. The mutations in SMOH, PTCH1, and SHH in BCCs result in continuous activation of target genes. At a cellular level, sonic hedgehog signaling promotes cell proliferation. Mutations in TP53 are also found with high frequency (>50%) in sporadic BCC.", "class": "Human Diseases; Cancer: specific types", "pathway_map": "hsa05217  Basal cell carcinoma", "network": ["", "ELEMENT   N00010  Mutation-inactivated PTCH1 to Hedgehog signaling pathway", "N00017  Mutation-activated SMO to Hedgehog signaling pathway", "N00115  Mutation-inactivated TP53 to transcription"], "disease": ["H00039  Basal cell carcinoma"], "drug": ["D09992  Vismodegib (USAN/INN)", "D10119  Sonidegib (USAN/INN)", "D10729  Sonidegib phosphate (USAN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["7157  TP53; tumor protein p53 [KO:K04451]", "1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]", "1647  GADD45A; growth arrest and DNA damage inducible alpha [KO:K04402]", "4616  GADD45B; growth arrest and DNA damage inducible beta [KO:K04402]", "10912  GADD45G; growth arrest and DNA damage inducible gamma [KO:K04402]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "578  BAK1; BCL2 antagonist/killer 1 [KO:K14021]", "1643  DDB2; damage specific DNA binding protein 2 [KO:K10140]", "51426  POLK; DNA polymerase kappa [KO:K03511] [EC:2.7.7.7]", "6469  SHH; sonic hedgehog signaling molecule [KO:K11988]", "5727  PTCH1; patched 1 [KO:K06225]", "6608  SMO; smoothened, frizzled class receptor [KO:K06226]", "374654  KIF7; kinesin family member 7 [KO:K18806]", "51684  SUFU; SUFU negative regulator of hedgehog signaling [KO:K06229]", "2735  GLI1; GLI family zinc finger 1 [KO:K16797]", "2736  GLI2; GLI family zinc finger 2 [KO:K16798]", "2737  GLI3; GLI family zinc finger 3 [KO:K06230]", "650  BMP2; bone morphogenetic protein 2 [KO:K21283]", "652  BMP4; bone morphogenetic protein 4 [KO:K04662]", "64399  HHIP; hedgehog interacting protein [KO:K06231]", "8643  PTCH2; patched 2 [KO:K11101]", "7471  WNT1; Wnt family member 1 [KO:K03209]", "7472  WNT2; Wnt family member 2 [KO:K00182]", "7482  WNT2B; Wnt family member 2B [KO:K00182]", "7473  WNT3; Wnt family member 3 [KO:K00312]", "89780  WNT3A; Wnt family member 3A [KO:K00312]", "54361  WNT4; Wnt family member 4 [KO:K00408]", "7474  WNT5A; Wnt family member 5A [KO:K00444]", "81029  WNT5B; Wnt family member 5B [KO:K00444]", "7475  WNT6; Wnt family member 6 [KO:K00445]", "7476  WNT7A; Wnt family member 7A [KO:K00572]", "7477  WNT7B; Wnt family member 7B [KO:K00572]", "7478  WNT8A; Wnt family member 8A [KO:K00714]", "7479  WNT8B; Wnt family member 8B [KO:K00714]", "7483  WNT9A; Wnt family member 9A [KO:K01064]", "7484  WNT9B; Wnt family member 9B [KO:K01064]", "7480  WNT10B; Wnt family member 10B [KO:K01357]", "80326  WNT10A; Wnt family member 10A [KO:K01357]", "7481  WNT11; Wnt family member 11 [KO:K01384]", "51384  WNT16; Wnt family member 16 [KO:K01558]", "8321  FZD1; frizzled class receptor 1 [KO:K02432]", "8324  FZD7; frizzled class receptor 7 [KO:K02432]", "2535  FZD2; frizzled class receptor 2 [KO:K02235]", "7976  FZD3; frizzled class receptor 3 [KO:K02329]", "8322  FZD4; frizzled class receptor 4 [KO:K02354]", "7855  FZD5; frizzled class receptor 5 [KO:K02375]", "8325  FZD8; frizzled class receptor 8 [KO:K02375]", "8323  FZD6; frizzled class receptor 6 [KO:K02376]", "11211  FZD10; frizzled class receptor 10 [KO:K02842]", "8326  FZD9; frizzled class receptor 9 [KO:K02842]", "1857  DVL3; dishevelled segment polarity protein 3 [KO:K02353]", "1856  DVL2; dishevelled segment polarity protein 2 [KO:K02353]", "1855  DVL1; dishevelled segment polarity protein 1 [KO:K02353]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "8312  AXIN1; axin 1 [KO:K02157]", "8313  AXIN2; axin 2 [KO:K04385]", "324  APC; APC regulator of WNT signaling pathway [KO:K02085]", "10297  APC2; APC regulator of WNT signaling pathway 2 [KO:K02085]", "1499  CTNNB1; catenin beta 1 [KO:K02105]", "6932  TCF7; transcription factor 7 [KO:K02620]", "83439  TCF7L1; transcription factor 7 like 1 [KO:K04490]", "6934  TCF7L2; transcription factor 7 like 2 [KO:K04491]", "51176  LEF1; lymphoid enhancer binding factor 1 [KO:K04492]"], "compound": ["C00187  Cholesterol"], "refs": [{"pmid": "15948971", "authors": "  Tilli CM, Van Steensel MA, Krekels GA, Neumann HA, Ramaekers FC.", "title": "Molecular aetiology and pathogenesis of basal cell carcinoma.", "journal": "Br J Dermatol 152:1108-24 (2005)", "doi": "10.1111/j.1365-2133.2005.06587.x"}, {"pmid": "12588368", "authors": "  Saldanha G, Fletcher A, Slater DN.", "title": "Basal cell carcinoma: a dermatopathological and molecular biological update.", "journal": "Br J Dermatol 148:195-202 (2003)", "doi": "10.1046/j.1365-2133.2003.05151.x"}, {"pmid": "15978322", "authors": "  Daya-Grosjean L, Couve-Privat S.", "title": "Sonic hedgehog signaling in basal cell carcinomas.", "journal": "Cancer Lett 225:181-92 (2005)", "doi": "10.1016/j.canlet.2004.10.003"}, {"pmid": "15468170", "authors": "  Tsai KY, Tsao H.", "title": "The genetics of skin cancer.", "journal": "Am J Med Genet C Semin Med Genet 131C:82-92 (2004)", "doi": "10.1002/ajmg.c.30037"}, {"pmid": "16881963", "authors": "  Athar M, Tang X, Lee JL, Kopelovich L, Kim AL.", "title": "Hedgehog signalling in skin development and cancer.", "journal": "Exp Dermatol 15:667-77 (2006)", "doi": "10.1111/j.1600-0625.2006.00473.x"}, {"pmid": "16306523", "authors": "  Rubin AI, Chen EH, Ratner D.", "title": "Basal-cell carcinoma.", "journal": "N Engl J Med 353:2262-9 (2005)", "doi": "10.1056/NEJMra044151"}, {"pmid": "11276000", "authors": "  Saldanha G.", "title": "The Hedgehog signalling pathway and cancer.", "journal": "J Pathol 193:427-32 (2001)", "doi": "10.1002/1096-9896(2000)9999:9999<::AID-PATH815>3.0.CO;2-N"}, {"pmid": "15270885", "authors": "  Saldanha G, Ghura V, Potter L, Fletcher A.", "title": "Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation.", "journal": "Br J Dermatol 151:157-64 (2004)", "doi": "10.1111/j.1365-2133.2004.06048.x"}, {"pmid": "14737121", "authors": "  Pasca di Magliano M, Hebrok M.", "title": "Hedgehog signalling in cancer formation and maintenance.", "journal": "Nat Rev Cancer 3:903-11 (2003)", "doi": "10.1038/nrc1229"}, {"pmid": "15656799", "authors": "  Reifenberger J, Wolter M, Knobbe CB, Kohler B, Schonicke A, Scharwachter C, Kumar K, Blaschke B, Ruzicka T, Reifenberger G.", "title": "Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas.", "journal": "Br J Dermatol 152:43-51 (2005)", "doi": "10.1111/j.1365-2133.2005.06353.x"}, {"pmid": "14556242", "authors": "  Cohen MM Jr.", "title": "The hedgehog signaling network.", "journal": "Am J Med Genet A 123:5-28 (2003)", "doi": "10.1002/ajmg.a.20495"}, {"pmid": "11736900", "authors": "  Yamazaki F, Aragane Y, Kawada A, Tezuka T.", "title": "Immunohistochemical detection for nuclear beta-catenin in sporadic basal cell carcinoma.", "journal": "Br J Dermatol 145:771-7 (2001)", "doi": "10.1046/j.1365-2133.2001.04468.x"}, {"pmid": "16054233", "authors": "  Erb P, Ji J, Wernli M, Kump E, Glaser A, Buchner SA.", "title": "Role of apoptosis in basal cell and squamous cell carcinoma formation.", "journal": "Immunol Lett 100:68-72 (2005)", "doi": "10.1016/j.imlet.2005.06.008"}, {"pmid": "11130178", "authors": "  Toftgard R.", "title": "Hedgehog signalling in cancer.", "journal": "Cell Mol Life Sci 57:1720-31 (2000)", "doi": "10.1007/PL00000654"}, {"pmid": "28286127", "authors": "  Wu F, Zhang Y, Sun B, McMahon AP, Wang Y", "title": "Hedgehog Signaling: From Basic Biology to Cancer Therapy.", "journal": "Cell Chem Biol 24:252-280 (2017)", "doi": "10.1016/j.chembiol.2017.02.010"}], "rel_pathway": ["hsa04110  Cell cycle", "hsa04115  p53 signaling pathway", "hsa04310  Wnt signaling pathway", "hsa04340  Hedgehog signaling pathway", "hsa04350  TGF-beta signaling pathway"], "ko_pathway": "ko05217", "genes": ["TP53", "BAX"]}, {"kegg_id": "hsa05220", "name": "Chronic myeloid leukemia - Homo sapiens (human)", "description": "Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP), which is characterized by expansion of functionally normal myeloid cells, followed by an accelerated phase (AP) and finally a more aggressive blast phase (BP), with loss of terminal differentiation capacity. On the cellular level, CML is associated with a specific chromosome abnormality, the t(9; 22) reciprocal translocation that forms the Philadelphia (Ph) chromosome. The Ph chromosome is the result of a molecular rearrangement between the c-ABL proto-oncogene on chromosome 9 and the BCR (breakpoint cluster region) gene on chromosome 22. The BCR/ABL fusion gene encodes p210 BCR/ABL, an oncoprotein, which, unlike the normal p145 c-Abl, has constitutive tyrosine kinase activity and is predominantly localized in the cytoplasm. While fusion of c-ABL and BCR is believed to be the primary cause of the chronic phase of CML, progression to blast crisis requires other molecular changes. Common secondary abnormalities include mutations in TP53, RB, and p16/INK4A, or overexpression of genes such as EVI1. Additional chromosome translocations are also observed,such as t(3;21)(q26;q22), which generates AML1-EVI1.", "class": "Human Diseases; Cancer: specific types", "pathway_map": "hsa05220  Chronic myeloid leukemia", "network": ["", "ELEMENT   N00002  BCR-ABL fusion kinase to RAS-ERK signaling pathway", "N00048  BCR-ABL fusion kinase to PI3K signaling pathway", "N00055  BCR-ABL fusion kinase to Jak-STAT signaling pathway", "N00067  Deleted p14(ARF) to p21-cell cycle G1/S", "N00070  Mutation-inactivated p16(INK4a) to p16-cell cycle G1/S", "N00074  Loss of RB1 to cell cycle G1/S", "N00106  AML1-EVI1 fusion to TGF-beta signaling pathway", "N00107  EVI-1 overexpression to TGF-beta signaling pathway", "N00115  Mutation-inactivated TP53 to transcription"], "disease": ["H00004  Chronic myeloid leukemia"], "drug": ["D01441  Imatinib mesylate (USAN)", "D03252  Bosutinib (USAN)", "D03658  Dasatinib (JAN/INN)", "D06413  Nilotinib hydrochloride hydrate (JAN)", "D06414  Dasatinib (USAN)", "D08066  Imatinib (INN)", "D08953  Nilotinib (USAN/INN)", "D08956  Omacetaxine mepesuccinate (USAN)", "D09728  Bosutinib hydrate (JAN)", "D09950  Ponatinib (USAN/INN)", "D09951  Ponatinib hydrochloride (JAN/USAN)", "D10202  Bafetinib (USAN)", "D11404  Asciminib hydrochloride (JAN/USAN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["613  BCR; BCR activator of RhoGEF and GTPase [KO:K08878] [EC:2.7.11.1]", "25  ABL1; ABL proto-oncogene 1, non-receptor tyrosine kinase [KO:K06619] [EC:2.7.10.2]", "1398  CRK; CRK proto-oncogene, adaptor protein [KO:K04438]", "1399  CRKL; CRK like proto-oncogene, adaptor protein [KO:K04438]", "867  CBL; Cbl proto-oncogene [KO:K04707] [EC:2.3.2.27]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]", "598  BCL2L1; BCL2 like 1 [KO:K04570]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "4193  MDM2; MDM2 proto-oncogene [KO:K06643] [EC:2.3.2.27]", "7157  TP53; tumor protein p53 [KO:K04451]", "1027  CDKN1B; cyclin dependent kinase inhibitor 1B [KO:K06624]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "9846  GAB2; GRB2 associated binding protein 2 [KO:K08091]", "5781  PTPN11; protein tyrosine phosphatase non-receptor type 11 [KO:K07293] [EC:3.1.3.48]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "369  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "6464  SHC1; SHC adaptor protein 1 [KO:K06279]", "25759  SHC2; SHC adaptor protein 2 [KO:K17447]", "53358  SHC3; SHC adaptor protein 3 [KO:K17448]", "399694  SHC4; SHC adaptor protein 4 [KO:K17449]", "4609  MYC; MYC proto-oncogene, bHLH transcription factor [KO:K04377]", "6776  STAT5A; signal transducer and activator of transcription 5A [KO:K11223]", "6777  STAT5B; signal transducer and activator of transcription 5B [KO:K11224]", "1029  CDKN2A; cyclin dependent kinase inhibitor 2A [KO:K06621]", "1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]", "595  CCND1; cyclin D1 [KO:K04503]", "1019  CDK4; cyclin dependent kinase 4 [KO:K02089] [EC:2.7.11.22]", "1021  CDK6; cyclin dependent kinase 6 [KO:K02091] [EC:2.7.11.22]", "5925  RB1; RB transcriptional corepressor 1 [KO:K06618]", "1869  E2F1; E2F transcription factor 1 [KO:K17454]", "1870  E2F2; E2F transcription factor 2 [KO:K09389]", "1871  E2F3; E2F transcription factor 3 [KO:K06620]", "1647  GADD45A; growth arrest and DNA damage inducible alpha [KO:K04402]", "4616  GADD45B; growth arrest and DNA damage inducible beta [KO:K04402]", "10912  GADD45G; growth arrest and DNA damage inducible gamma [KO:K04402]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "578  BAK1; BCL2 antagonist/killer 1 [KO:K14021]", "1643  DDB2; damage specific DNA binding protein 2 [KO:K10140]", "51426  POLK; DNA polymerase kappa [KO:K03511] [EC:2.7.7.7]", "7040  TGFB1; transforming growth factor beta 1 [KO:K13375]", "7042  TGFB2; transforming growth factor beta 2 [KO:K13376]", "7043  TGFB3; transforming growth factor beta 3 [KO:K13377]", "7046  TGFBR1; transforming growth factor beta receptor 1 [KO:K04674] [EC:2.7.11.30]", "7048  TGFBR2; transforming growth factor beta receptor 2 [KO:K04388] [EC:2.7.11.30]", "4088  SMAD3; SMAD family member 3 [KO:K23605]", "4089  SMAD4; SMAD family member 4 [KO:K04501]", "2122  MECOM; MDS1 and EVI1 complex locus [KO:K04462] [EC:2.1.1.367]", "861  RUNX1; RUNX family transcription factor 1 [KO:K08367]", "1487  CTBP1; C-terminal binding protein 1 [KO:K04496] [EC:1.1.1.428]", "1488  CTBP2; C-terminal binding protein 2 [KO:K04496] [EC:1.1.1.428]", "3065  HDAC1; histone deacetylase 1 [KO:K06067] [EC:3.5.1.98]", "3066  HDAC2; histone deacetylase 2 [KO:K06067] [EC:3.5.1.98]"], "compound": ["C05981  Phosphatidylinositol-3,4,5-trisphosphate"], "refs": [{"pmid": "15719031", "authors": "  Ren R.", "title": "Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia.", "journal": "Nat Rev Cancer 5:172-83 (2005)", "doi": "10.1038/nrc1567"}, {"pmid": "14982876", "authors": "  Calabretta B, Perrotti D.", "title": "The biology of CML blast crisis.", "journal": "Blood 103:4010-22 (2004)", "doi": "10.1182/blood-2003-12-4111"}, {"pmid": "10403855", "authors": "  Faderl S, Talpaz M, Estrov Z, O'Brien S, Kurzrock R, Kantarjian HM.", "title": "The biology of chronic myeloid leukemia.", "journal": "N Engl J Med 341:164-72 (1999)", "doi": "10.1056/NEJM199907153410306"}, {"pmid": "15156182", "authors": "  Mitani K.", "title": "Molecular mechanisms of leukemogenesis by AML1/EVI-1.", "journal": "Oncogene 23:4263-9 (2004)", "doi": "10.1038/sj.onc.1207777"}, {"pmid": "16484590", "authors": "  Dong M, Blobe GC.", "title": "Role of transforming growth factor-beta in hematologic malignancies.", "journal": "Blood 107:4589-96 (2006)", "doi": "10.1182/blood-2005-10-4169"}, {"pmid": "11160144", "authors": "  Baldwin AS.", "title": "Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.", "journal": "J Clin Invest 107:241-6 (2001)", "doi": "10.1172/JCI11991"}, {"pmid": "12244301", "authors": "  Shin I, Yakes FM, Rojo F, Shin NY, Bakin AV, Baselga J, Arteaga CL.", "title": "PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization.", "journal": "Nat Med 8:1145-52 (2002)", "doi": "10.1038/nm759"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04110  Cell cycle", "hsa04115  p53 signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04210  Apoptosis", "hsa04350  TGF-beta signaling pathway", "hsa04640  Hematopoietic cell lineage"], "ko_pathway": "ko05220", "genes": ["TP53", "BRAF", "AKT2", "AKT1", "SOS1", "NRAS", "BAX"]}, {"kegg_id": "hsa04614", "name": "Renin-angiotensin system - Homo sapiens (human)", "description": "The renin-angiotensin system (RAS) is a peptidergic system with endocrine characteristics regarding to the regulation of the blood pressure and hydro-electrolytic balance. In the classical RAS, the enzyme renin cleaves its substrate angiotensinogen (Agt) forming the decapeptide angiotensin I that is in turn cleaved by angiotensin-converting enzyme (ACE) to produce the angiotensin II (Ang II), a key player of this system. Ang II activates its AT1 receptor (AT1R), the principal receptor that mediates the majority of the known actions of Ang II in the kidney, including vasoconstriction, renal sodium (Na+) reabsorption, and aldosterone secretion, increasing blood pressure and contributing to the development of hypertension. In addition to (ACE)/Ang II/AT1R and AT2R axis, other signaling pathways in the RAS, such as ACE2/angiotensin-(1-7)/Mas and Ang IV/IRAP, and other active peptide of the RAS, with physiological relevance as Ang III, Ang A and alamandine, are now widely recognized.", "class": "Organismal Systems; Endocrine system", "pathway_map": "hsa04614  Renin-angiotensin system", "network": ["", "ELEMENT   N01743  Renin-angiotensin signaling pathway"], "drug": ["D00150  Angiotensin II (INN)", "D00251  Captopril (JP18/USP/INN)", "D00357  Losartan potassium (JP18/USP)", "D00362  Lisinopril (USP)", "D00383  Trandolapril (JAN/USP/INN)", "D00400  Valsartan (JP18/USP/INN)", "D00421  Ramipril (USP/INN)", "D00459  Quinapril hydrochloride (JP18/USP)", "D00522  Candesartan (USAN/INN)", "D00523  Irbesartan (JP18/USP/INN)", "D00620  Benazepril hydrochloride (JAN/USP)", "D00621  Enalapril maleate (JP18/USP)", "D00622  Fosinopril sodium (USP)", "D00623  Moexipril hydrochloride (USP)", "D00624  Perindopril erbumine (JAN/USP)", "D00626  Candesartan cilexetil (JP18/USP)", "D00627  Telmisartan (JP18/USP/INN)", "D01069  Cilazapril (USAN)", "D01070  Candoxatril (JAN/USAN/INN)", "D01119  Temocapril hydrochloride (JP18/USAN)", "D01204  Olmesartan medoxomil (JP18/USP)", "D01549  Imidapril hydrochloride (JP18)", "D01667  Delapril hydrochloride (JAN/USAN)", "D01900  Alacepril (JP18/INN)", "D01922  Pratosartan (JAN/INN)", "D01970  Omapatrilat (JAN/USAN/INN)", "D02014  Angiotensin II (USAN)", "D02082  Eprosartan mesylate (USAN)", "D02939  Angiotensin amide (USAN)", "D03077  Benazeprilat (USAN/INN)", "D03208  Aliskiren (USAN/INN)", "D03349  Candoxatrilat (USAN/INN)", "D03440  Ceronapril (USAN/INN)", "D03738  Enalkiren (USAN/INN)", "D03741  Ditekiren (USAN)", "D03743  Terlakiren (USAN/INN)", "D03745  Zankiren hydrochloride (USAN)", "D03752  Quinapril (INN)", "D03753  Perindopril (USAN/INN)", "D03756  Indolapril hydrochloride (USAN)", "D03758  Libenzapril (USAN/INN)", "D03763  Pivopril (USAN/INN)", "D03765  Spirapril hydrochloride (USAN)", "D03767  Zofenopril calcium (USAN)", "D03769  Enalaprilat (USP)", "D03772  Fosinoprilat (USAN/INN)", "D03773  Quinaprilat (USAN/INN)", "D03775  Spiraprilat (USAN/INN)", "D03776  Zofenoprilat arginine (USAN)", "D03929  Ecadotril (USAN/INN)", "D04040  Eprosartan (USAN/INN)", "D04126  Saralasin acetate (USAN)", "D04243  Forasartan (USAN/INN)", "D04312  Gemopatrilat (USAN/INN)", "D05246  Olmesartan (USAN/INN)", "D05801  Saprisartan potassium (USAN)", "D06010  Tasosartan (USAN/INN)", "D06076  Teprotide (USAN/INN)", "D06412  Aliskiren fumarate (JAN/USAN)", "D07499  Benazepril (INN)", "D07699  Cilazapril (INN)", "D07781  Delapril (INN)", "D07892  Enalapril (INN)", "D07992  Fosinopril (INN)", "D08067  Azilsartan medoxomil (USAN)", "D08068  Imidapril (INN)", "D08131  Lisinopril (INN)", "D08146  Losartan (INN)", "D08225  Moexipril (INN)", "D08529  Spirapril (INN)", "D08566  Temocapril (INN)", "D08688  Zofenopril (INN)", "D08864  Azilsartan (JAN/USAN/INN)", "D08865  Azilsartan kamedoxomil (USAN)", "D09038  Remikiren (INN)", "D10225  Sacubitril (JAN/USAN/INN)", "D10226  Sacubitril valsartan sodium hydrate (JAN)", "D10556  Fimasartan (INN)", "D11142  Angiotensin II acetate (USAN)", "D11580  Perindopril arginine", "D12830  Rinvecalinase alfa (USAN/INN)", "D12840  Zilebesiran sodium (JAN/USAN)"], "dblinks": "GO: 0002003", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["183  AGT; angiotensinogen [KO:K09821]", "5972  REN; renin [KO:K01380] [EC:3.4.23.15]", "1636  ACE; angiotensin I converting enzyme [KO:K01283] [EC:3.4.15.1]", "1215  CMA1; chymase 1 [KO:K01329] [EC:3.4.21.39]", "1511  CTSG; cathepsin G [KO:K01319] [EC:3.4.21.20]", "3817  KLK2; kallikrein related peptidase 2 [KO:K01325] [EC:3.4.21.35]", "3816  KLK1; kallikrein 1 [KO:K01325] [EC:3.4.21.35]", "2028  ENPEP; glutamyl aminopeptidase [KO:K11141] [EC:3.4.11.7]", "290  ANPEP; alanyl aminopeptidase, membrane [KO:K11140] [EC:3.4.11.2]", "5550  PREP; prolyl endopeptidase [KO:K01322] [EC:3.4.21.26]", "59272  ACE2; angiotensin converting enzyme 2 [KO:K09708] [EC:3.4.17.23]", "5476  CTSA; cathepsin A [KO:K13289] [EC:3.4.16.5]", "1359  CPA3; carboxypeptidase A3 [KO:K08780] [EC:3.4.17.1]", "4311  MME; membrane metalloendopeptidase [KO:K01389] [EC:3.4.24.11]", "7064  THOP1; thimet oligopeptidase 1 [KO:K01392] [EC:3.4.24.15]", "57486  NLN; neurolysin [KO:K01393] [EC:3.4.24.16]", "5547  PRCP; prolylcarboxypeptidase [KO:K01285] [EC:3.4.16.2]", "4142  MAS1; MAS1 proto-oncogene, G protein-coupled receptor [KO:K04303]", "116512  MRGPRD; MAS related GPR family member D [KO:K08392]", "185  AGTR1; angiotensin II receptor type 1 [KO:K04166]", "186  AGTR2; angiotensin II receptor type 2 [KO:K04167]", "4012  LNPEP; leucyl and cystinyl aminopeptidase [KO:K01257] [EC:3.4.11.3]", "10159  ATP6AP2; ATPase H+ transporting accessory protein 2 [KO:K19514]"], "compound": ["C00873  Angiotensin I", "C02135  Angiotensin II", "C15848  Angiotensin III", "C15849  Angiotensin IV", "C15850  Angiotensin (1-7)", "C15851  Angiotensin (1-9)", "C15852  Angiotensin (1-5)", "C20970  Angiotensin A", "C20971  Alamandine", "C20972  Angiotensin (5-8)", "C20973  Angiotensin (5-7)"], "refs": [{"pmid": "15549172", "authors": "  Danilczyk U, Eriksson U, Oudit GY, Penninger JM.", "title": "Physiological roles of angiotensin-converting enzyme 2.", "journal": "Cell Mol Life Sci 61:2714-9 (2004)", "doi": "10.1007/s00018-004-4241-6"}, {"pmid": "15549171", "authors": "  Warner FJ, Smith AI, Hooper NM, Turner AJ.", "title": "Angiotensin-converting enzyme-2: a molecular and cellular perspective.", "journal": "Cell Mol Life Sci 61:2704-13 (2004)", "doi": "10.1007/s00018-004-4240-7"}, {"pmid": "15833268", "authors": "  Kurdi M, De Mello WC, Booz GW.", "title": "Working outside the system: an update on the unconventional behavior of the renin-angiotensin system components.", "journal": "Int J Biochem Cell Biol 37:1357-67 (2005)", "doi": "10.1016/j.biocel.2005.01.012"}, {"pmid": "15109615", "authors": "  Burrell LM, Johnston CI, Tikellis C, Cooper ME.", "title": "ACE2, a new regulator of the renin-angiotensin system.", "journal": "Trends Endocrinol Metab 15:166-9 (2004)", "doi": "10.1016/j.tem.2004.03.001"}, {"pmid": "16555051", "authors": "  von Bohlen und Halbach O, Albrecht D.", "title": "The CNS renin-angiotensin system.", "journal": "Cell Tissue Res 326:599-616 (2006)", "doi": "10.1007/s00441-006-0190-8"}, {"pmid": "12793984", "authors": "  Schmaier AH", "title": "The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction.", "journal": "Am J Physiol Regul Integr Comp Physiol 285:R1-13 (2003)", "doi": "10.1152/ajpregu.00535.2002"}, {"pmid": "12419208", "authors": "  Eriksson U, Danilczyk U, Penninger JM.", "title": "Just the beginning: novel functions for angiotensin-converting enzymes.", "journal": "Curr Biol 12:R745-52 (2002)", "doi": "10.1016/S0960-9822(02)01255-1"}, {"pmid": "16286563", "authors": "  Dielis AW, Smid M, Spronk HM, Hamulyak K, Kroon AA, ten Cate H, de Leeuw PW.", "title": "The prothrombotic paradox of hypertension: role of the renin-angiotensin and kallikrein-kinin systems.", "journal": "Hypertension 46:1236-42 (2005)", "doi": "10.1161/01.HYP.0000193538.20705.23"}, {"pmid": "16581295", "authors": "  Kuba K, Imai Y, Penninger JM.", "title": "Angiotensin-converting enzyme 2 in lung diseases.", "journal": "Curr Opin Pharmacol 6:271-6 (2006)", "doi": "10.1016/j.coph.2006.03.001"}, {"pmid": "12505055", "authors": "  Erdos EG, Jackman HL, Brovkovych V, Tan F, Deddish PA.", "title": "Products of angiotensin I hydrolysis by human cardiac enzymes potentiate bradykinin.", "journal": "J Mol Cell Cardiol 34:1569-76 (2002)", "doi": "10.1006/jmcc.2002.2080"}, {"pmid": "12372844", "authors": "  Shrimpton CN, Smith AI, Lew RA.", "title": "Soluble metalloendopeptidases and neuroendocrine signaling.", "journal": "Endocr Rev 23:647-64 (2002)", "doi": "10.1210/er.2001-0032"}, {"pmid": "12019279", "authors": "  Jackman HL, Massad MG, Sekosan M, Tan F, Brovkovych V, Marcic BM, Erdos EG.", "title": "Angiotensin 1-9 and 1-7 release in human heart: role of cathepsin A.", "journal": "Hypertension 39:976-81 (2002)", "doi": "10.1161/01.HYP.0000017283.67962.02"}, {"pmid": "15173164", "authors": "  Lundequist A, Tchougounova E, Abrink M, Pejler G.", "title": "Cooperation between mast cell carboxypeptidase A and the chymase mouse mast cell protease 4 in the formation and degradation of angiotensin II.", "journal": "J Biol Chem 279:32339-44 (2004)", "doi": "10.1074/jbc.M405576200"}, {"pmid": "17362841", "authors": "  Kehoe PG, Wilcock GK.", "title": "Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?", "journal": "Lancet Neurol 6:373-8 (2007)", "doi": "10.1016/S1474-4422(07)70077-7"}, {"pmid": "25332897", "authors": "  Ferrao FM, Lara LS, Lowe J", "title": "Renin-angiotensin system in the kidney: What is new?", "journal": "World J Nephrol 3:64-76 (2014)", "doi": "10.5527/wjn.v3.i3.64"}, {"pmid": "24273531", "authors": "  Zhuo JL, Ferrao FM, Zheng Y, Li XC", "title": "New frontiers in the intrarenal Renin-Angiotensin system: a critical review of classical and new paradigms.", "journal": "Front Endocrinol (Lausanne) 4:166 (2013)", "doi": "10.3389/fendo.2013.00166"}, {"pmid": "21951628", "authors": "  Unger T, Paulis L, Sica DA", "title": "Therapeutic perspectives in hypertension: novel means for renin-angiotensin-aldosterone system modulation and emerging device-based approaches.", "journal": "Eur Heart J 32:2739-47 (2011)", "doi": "10.1093/eurheartj/ehr253"}, {"pmid": "18793332", "authors": "  Fyhrquist F, Saijonmaa O", "title": "Renin-angiotensin system revisited.", "journal": "J Intern Med 264:224-36 (2008)", "doi": "10.1111/j.1365-2796.2008.01981.x"}, {"pmid": "23692861", "authors": "  Yugandhar VG, Clark MA", "title": "Angiotensin III: a physiological relevant peptide of the renin angiotensin system.", "journal": "Peptides 46:26-32 (2013)", "doi": "10.1016/j.peptides.2013.04.014"}], "rel_pathway": ["hsa04270  Vascular smooth muscle contraction", "hsa04610  Complement and coagulation cascades", "hsa04924  Renin secretion", "hsa04925  Aldosterone synthesis and secretion"], "ko_pathway": "ko04614", "genes": ["KLK2"]}, {"kegg_id": "hsa04961", "name": "Endocrine and other factor-regulated calcium reabsorption - Homo sapiens (human)", "description": "Calcium (Ca2+) is essential for numerous physiological functions including intracellular signalling processes, neuronal excitability, muscle contraction and bone formation. Therefore, its homeostasis is finely maintained through the coordination of intestinal absorption, renal reabsorption, and bone resorption. In kidney, the late part of the distal convoluted tubule (DCT) and the connecting tubule (CNT) are the site of active Ca2+ transport and precisely regulate Ca2+ reabsorption. Following Ca2+ entry through TRPV5, Ca2+ bound to calbindin-D28K diffuses to the basolateral side, where it is extruded into the blood compartment through NCX1 and to a lesser extent PMCA1b. In the urinary compartment, both klotho and tissue kallikrein (TK) increase the apical abundance of TRPV5. In the blood compartment, PTH, 1,25(OH)2D3 and estrogen increase the transcription and protein expression of the luminal Ca2+ channels, calbindins, and the extrusion systems.", "class": "Organismal Systems; Excretory system", "pathway_map": "hsa04961  Endocrine and other factor-regulated calcium reabsorption", "network": ["", "ELEMENT   N00288  PTH-PTH1R-PKA signaling pathway"], "drug": ["D00105  Estradiol (JAN/USP/INN)", "D00122  Calcifediol (USP/INN)", "D00129  Calcitriol (JAN/USP/INN)", "D00185  Estriol (JP18/USP)", "D00187  Ergocalciferol (JP18/USP)", "D00188  Cholecalciferol (JP18/USP)", "D00299  Dihydrotachysterol (JAN/USP/INN)", "D00628  Secalciferol (JAN/USAN/INN)", "D00930  Paricalcitol (JAN/USP/INN)", "D01009  Doxercalciferol (USAN/INN)", "D01098  Maxacalcitol (JAN/USAN/INN)", "D01125  Calcipotriene (USP)", "D01472  Tacalcitol hydrate (JP18)", "D01518  Alfacalcidol (JAN/INN)", "D01662  Falecalcitriol (JAN/INN)", "D02217  Raloxifene hydrochloride (JAN/USP)", "D03062  Bazedoxifene acetate (JAN/USAN)", "D03358  Teriparatide acetate (JAN)", "D03930  Ecalcidene (USAN/INN)", "D04492  Icatibant acetate (JAN/USAN)", "D04672  Lasofoxifene tartrate (JAN/USAN)", "D05364  Parathyroid hormone (human) (USAN)", "D06078  Teriparatide (USP/INN)", "D06546  Teriparatide acetate (USAN)", "D07578  Eldecalcitol (JAN/INN)", "D08465  Raloxifene (INN)", "D08554  Tacalcitol (INN)", "D08868  Becocalcidiol (USAN/INN)", "D09834  Levormeloxifene fumarate (JAN)", "D10008  Fispemifene (USAN/INN)", "D10198  Calcipotriol hydrate (JAN)", "D10606  Raloxifene hydrochloride hydrate (JAN)", "D11563  Abaloparatide acetate (JAN)", "D12395  Palopegteriparatide (JAN/USAN/INN)", "D12628  Vepdegestrant (JAN/USAN/INN)", "D12805  Eneboparatide (USAN/INN)", "D12827  Palazestrant (USAN/INN)", "D12830  Rinvecalinase alfa (USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["5741  PTH; parathyroid hormone [KO:K05261]", "5745  PTH1R; parathyroid hormone 1 receptor [KO:K04585]", "2778  GNAS; GNAS complex locus [KO:K04632]", "112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]", "115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "7421  VDR; vitamin D receptor [KO:K08539]", "2099  ESR1; estrogen receptor 1 [KO:K08550]", "56302  TRPV5; transient receptor potential cation channel subfamily V member 5 [KO:K04974]", "9365  KL; klotho [KO:K14756] [EC:3.2.1.31]", "1759  DNM1; dynamin 1 [KO:K01528] [EC:3.6.5.5]", "26052  DNM3; dynamin 3 [KO:K01528] [EC:3.6.5.5]", "1785  DNM2; dynamin 2 [KO:K23484] [EC:3.6.5.5]", "161  AP2A2; adaptor related protein complex 2 subunit alpha 2 [KO:K11824]", "160  AP2A1; adaptor related protein complex 2 subunit alpha 1 [KO:K11824]", "163  AP2B1; adaptor related protein complex 2 subunit beta 1 [KO:K11825]", "1173  AP2M1; adaptor related protein complex 2 subunit mu 1 [KO:K11826]", "1175  AP2S1; adaptor related protein complex 2 subunit sigma 1 [KO:K11827]", "1211  CLTA; clathrin light chain A [KO:K04644]", "1212  CLTB; clathrin light chain B [KO:K04645]", "1213  CLTC; clathrin heavy chain [KO:K04646]", "8218  CLTCL1; clathrin heavy chain like 1 [KO:K04646]", "8766  RAB11A; RAB11A, member RAS oncogene family [KO:K07904]", "793  CALB1; calbindin 1 [KO:K14757]", "476  ATP1A1; ATPase Na+/K+ transporting subunit alpha 1 [KO:K01539] [EC:7.2.2.13]", "477  ATP1A2; ATPase Na+/K+ transporting subunit alpha 2 [KO:K01539] [EC:7.2.2.13]", "478  ATP1A3; ATPase Na+/K+ transporting subunit alpha 3 [KO:K01539] [EC:7.2.2.13]", "480  ATP1A4; ATPase Na+/K+ transporting subunit alpha 4 [KO:K01539] [EC:7.2.2.13]", "23439  ATP1B4; ATPase Na+/K+ transporting family member beta 4 [KO:K01540]", "481  ATP1B1; ATPase Na+/K+ transporting subunit beta 1 [KO:K01540]", "482  ATP1B2; ATPase Na+/K+ transporting subunit beta 2 [KO:K01540]", "483  ATP1B3; ATPase Na+/K+ transporting subunit beta 3 [KO:K01540]", "486  FXYD2; FXYD domain containing ion transport regulator 2 [KO:K01538]", "6546  SLC8A1; solute carrier family 8 member A1 [KO:K05849]", "6543  SLC8A2; solute carrier family 8 member A2 [KO:K05849]", "6547  SLC8A3; solute carrier family 8 member A3 [KO:K05849]", "490  ATP2B1; ATPase plasma membrane Ca2+ transporting 1 [KO:K05850] [EC:7.2.2.10]", "492  ATP2B3; ATPase plasma membrane Ca2+ transporting 3 [KO:K05850] [EC:7.2.2.10]", "493  ATP2B4; ATPase plasma membrane Ca2+ transporting 4 [KO:K05850] [EC:7.2.2.10]", "491  ATP2B2; ATPase plasma membrane Ca2+ transporting 2 [KO:K05850] [EC:7.2.2.10]", "3817  KLK2; kallikrein related peptidase 2 [KO:K01325] [EC:3.4.21.35]", "3816  KLK1; kallikrein 1 [KO:K01325] [EC:3.4.21.35]", "624  BDKRB2; bradykinin receptor B2 [KO:K03916]", "2776  GNAQ; G protein subunit alpha q [KO:K04634]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]"], "compound": ["C00076  Calcium cation", "C00165  Diacylglycerol", "C00238  Potassium cation", "C00575  3',5'-Cyclic AMP", "C00951  Estradiol-17beta", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C01330  Sodium cation", "C01673  Calcitriol"], "refs": [{"pmid": "18989697", "authors": "  Boros S, Bindels RJ, Hoenderop JG", "title": "Active Ca(2+) reabsorption in the connecting tubule.", "journal": "Pflugers Arch 458:99-109 (2009)", "doi": "10.1007/s00424-008-0602-6"}, {"pmid": "16518325", "authors": "  Lambers TT, Bindels RJ, Hoenderop JG", "title": "Coordinated control of renal Ca2+ handling.", "journal": "Kidney Int 69:650-4 (2006)", "doi": "10.1038/sj.ki.5000169"}, {"pmid": "18596722", "authors": "  de Groot T, Bindels RJ, Hoenderop JG", "title": "TRPV5: an ingeniously controlled calcium channel.", "journal": "Kidney Int 74:1241-6 (2008)", "doi": "10.1038/ki.2008.320"}, {"pmid": "20969972", "authors": "  Markadieu N, Bindels RJ, Hoenderop JG", "title": "The renal connecting tubule: Resolved and unresolved issues in Ca(2+) transport.", "journal": "Int J Biochem Cell Biol 43:1-4 (2011)", "doi": "10.1016/j.biocel.2010.10.006"}, {"pmid": "15618484", "authors": "  Hoenderop JG, Nilius B, Bindels RJ", "title": "Calcium absorption across epithelia.", "journal": "Physiol Rev 85:373-422 (2005)", "doi": "10.1152/physrev.00003.2004"}, {"pmid": "15747113", "authors": "  van Abel M, Hoenderop JG, Bindels RJ", "title": "The epithelial calcium channels TRPV5 and TRPV6: regulation and implications for disease.", "journal": "Naunyn Schmiedebergs Arch Pharmacol 371:295-306 (2005)", "doi": "10.1007/s00210-005-1021-2"}, {"pmid": "16044309", "authors": "  Nijenhuis T, Hoenderop JG, Bindels RJ", "title": "TRPV5 and TRPV6 in Ca(2+) (re)absorption: regulating Ca(2+) entry at the gate.", "journal": "Pflugers Arch 451:181-92 (2005)", "doi": "10.1007/s00424-005-1430-6"}, {"pmid": "12684797", "authors": "  Hoenderop JG, Nilius B, Bindels RJ", "title": "Epithelial calcium channels: from identification to function and regulation.", "journal": "Pflugers Arch 446:304-8 (2003)", "doi": "10.1007/s00424-003-1045-8"}, {"pmid": "17006539", "authors": "  Gkika D, Topala CN, Chang Q, Picard N, Thebault S, Houillier P, Hoenderop JG, Bindels RJ", "title": "Tissue kallikrein stimulates Ca(2+) reabsorption via PKC-dependent plasma membrane accumulation of TRPV5.", "journal": "EMBO J 25:4707-16 (2006)", "doi": "10.1038/sj.emboj.7601357"}, {"pmid": "17233615", "authors": "  Schoeber JP, Hoenderop JG, Bindels RJ", "title": "Concerted action of associated proteins in the regulation of TRPV5 and TRPV6.", "journal": "Biochem Soc Trans 35:115-9 (2007)", "doi": "10.1042/BST0350115"}, {"pmid": "18293139", "authors": "  Renkema KY, Alexander RT, Bindels RJ, Hoenderop JG", "title": "Calcium and phosphate homeostasis: concerted interplay of new regulators.", "journal": "Ann Med 40:82-91 (2008)", "doi": "10.1080/07853890701689645"}], "rel_pathway": ["hsa04144  Endocytosis", "hsa04530  Tight junction"], "ko_pathway": "ko04961", "genes": ["KLK2"]}, {"kegg_id": "hsa04270", "name": "Vascular smooth muscle contraction - Homo sapiens (human)", "description": "The vascular smooth muscle cell (VSMC) is a highly specialized cell whose principal function is contraction. On contraction, VSMCs shorten, thereby decreasing the diameter of a blood vessel to regulate the blood flow and pressure.\nThe principal mechanisms that regulate the contractile state of VSMCs are changes in cytosolic Ca2+ concentration ([Ca2+]c). In response to vasoconstrictor stimuli, Ca2+ is mobilized from intracellular stores and/or the extracellular space to increase [Ca2+]c in VSMCs. The increase in [Ca2+]c, in turn, activates the Ca2+-CaM-MLCK pathway and stimulates MLC20 phosphorylation, leading to myosin-actin interactions and, hence, the development of contractile force. The sensitivity of contractile myofilaments or MLC20 phosphorylation to Ca2+ can be secondarily modulated by other signaling pathways. During receptor stimulation, the contractile force is greatly enhanced by the inhibition of myosin phosphatase. Rho/Rho kinase, PKC, and arachidonic acid have been proposed to play a pivotal role in this enhancement.\nThe signaling events that mediate relaxation include the removal of a contractile agonist (passive relaxation) and activation of cyclic nucleotide-dependent signaling pathways in the continued presence of a contractile agonist (active relaxation). Active relaxation occurs through the inhibition of both Ca2+ mobilization and myofilament Ca2+ sensitivity in VSMCs.", "class": "Organismal Systems; Circulatory system", "pathway_map": "hsa04270  Vascular smooth muscle contraction", "drug": ["D00045  Adenosine (JAN/USP)", "D00076  Noradrenaline (JP18)", "D00095  Epinephrine (USP/INN)", "D00101  Vasopressin (JP18/USP)", "D00106  Epoprostenol (USAN/INN)", "D00124  Ephedrine (USP)", "D00150  Angiotensin II (INN)", "D00227  Aminophylline (USP/INN)", "D00255  Carvedilol (JP18/USP/INN)", "D00319  Felodipine (JP18/USP/INN)", "D00349  Isradipine (USP/INN)", "D00357  Losartan potassium (JP18/USP)", "D00366  Lypressin (USAN/INN)", "D00371  Theophylline (JP18)", "D00400  Valsartan (JP18/USP/INN)", "D00437  Nifedipine (JP18/USP/INN)", "D00438  Nimodipine (USP/INN)", "D00485  Pseudoephedrine hydrochloride (USP)", "D00507  Phenoxybenzamine hydrochloride (USP)", "D00509  Phentolamine mesylate (USP)", "D00511  Phenylephrine hydrochloride (JP18/USP)", "D00517  Amyl nitrite (JP18/USP)", "D00522  Candesartan (USAN/INN)", "D00523  Irbesartan (JP18/USP/INN)", "D00528  Caffeine (USP)", "D00600  Labetalol hydrochloride (JP18/USP)", "D00607  Guanadrel sulfate (USAN)", "D00608  Doxazosin mesylate (USP)", "D00609  Prazosin hydrochloride (JP18/USP)", "D00610  Terazosin hydrochloride (USP)", "D00615  Amlodipine besylate (USP)", "D00616  Diltiazem hydrochloride (JP18/USP)", "D00617  Nicardipine hydrochloride (JP18/USAN)", "D00618  Nisoldipine (JAN/USAN/INN)", "D00619  Verapamil hydrochloride (JP18/USP)", "D00626  Candesartan cilexetil (JP18/USP)", "D00627  Telmisartan (JP18/USP/INN)", "D00629  Nitrendipine (JP18/USAN/INN)", "D00631  Bepridil hydrochloride (USAN)", "D00636  Amiodarone hydrochloride (JP18/USP)", "D00679  Ergotamine tartrate (JP18/USP)", "D00680  Methylergonovine maleate (USP)", "D00691  Dyphylline (USP)", "D00756  Tetrahydrozoline nitrate (JAN)", "D00757  Xylometazoline hydrochloride (USP)", "D00996  Epinephrine hydrochloride (JAN)", "D00997  Tolazoline hydrochloride (JAN/USP)", "D01017  Dipivefrin hydrochloride (USP)", "D01019  Metaraminol bitartrate (JAN/USP)", "D01020  Methoxamine hydrochloride (JAN)", "D01021  Naphazoline nitrate (JP18)", "D01022  Oxymetazoline hydrochloride (JAN/USP)", "D01023  Tetrahydrozoline hydrochloride (JAN/USP)", "D01024  Tamsulosin hydrochloride (JP18/USP)", "D01104  Barnidipine hydrochloride (JAN)", "D01145  Azelnidipine (JP18/INN)", "D01151  Lemildipine (JAN/INN)", "D01163  Ergonovine maleate (USP)", "D01171  Monatepil maleate (JAN/USAN)", "D01173  Cilnidipine (JP18/INN)", "D01188  Pimilprost (JAN/INN)", "D01204  Olmesartan medoxomil (JP18/USP)", "D01224  Phenylpropanolamine hydrochloride (JAN/USP)", "D01227  Bosentan (USAN)", "D01290  Nicergoline (JP18/USAN/INN)", "D01307  Midodrine hydrochloride (JAN/USP)", "D01333  Urapidil (JP18/INN)", "D01337  Epoprostenol sodium (JAN/USAN)", "D01347  Tramazoline hydrochloride (JAN/USAN)", "D01369  Bevantolol hydrochloride (JAN/USAN)", "D01385  Ibudilast (JP18/INN)", "D01386  Ephedrine hydrochloride (JP18/USP)", "D01444  Bunitrolol hydrochloride (JAN)", "D01445  Ifenprodil tartrate (JP18)", "D01453  Caffeine hydrate (JP18)", "D01469  Amosulalol hydrochloride (JP18)", "D01551  Beraprost sodium (JP18/USAN)", "D01553  Manidipine hydrochloride (JP18)", "D01562  Aranidipine (JAN/INN)", "D01571  Moxisylyte hydrochloride (JAN)", "D01573  Etilefrine hydrochloride (JP18)", "D01604  Efonidipine hydrochloride ethanolate (JAN)", "D01674  Naftopidil (JP18/INN)", "D01691  Nipradilol (JAN/INN)", "D01692  Alfuzosin hydrochloride (JAN/USAN)", "D01697  Colforsin daropate hydrochloride (JAN)", "D01712  Theophylline sodium acetate (JAN)", "D01771  Proxyphylline (JAN/INN)", "D01810  Nicorandil (JP18/USAN/INN)", "D01830  Arotinolol hydrochloride (JP18)", "D01840  Fasudil hydrochloride (JAN)", "D01849  Lercanidipine hydrochloride (JAN/USAN)", "D01887  Bunazosin hydrochloride (JP18)", "D01908  Nilvadipine (JP18/USAN/INN)", "D01922  Pratosartan (JAN/INN)", "D01933  Vatanidipine hydrochloride (JAN)", "D01952  L-Methylephedrine hydrochloride (JAN)", "D01965  Silodosin (JP18/INN)", "D01969  Gallopamil hydrochloride (JAN)", "D02014  Angiotensin II (USAN)", "D02045  Benidipine hydrochloride (JP18)", "D02048  Clinprost (JAN/INN)", "D02082  Eprosartan mesylate (USAN)", "D02109  dl-Methylephedrine hydrochloride (JP18)", "D02149  Epinephrine bitartrate (JAN/USP)", "D02268  Ergoloid mesylates (USP)", "D02349  Dipivefrin (USAN)", "D02356  Verapamil (USAN/INN)", "D02537  Dronedarone (INN)", "D02720  Beraprost (USAN)", "D02721  Iloprost (USAN/INN)", "D02774  Adrenalone (USAN/INN)", "D02910  Amiodarone (USAN/INN)", "D02914  Amlodipine maleate (USAN)", "D02935  Anaritide acetate (USAN)", "D02939  Angiotensin amide (USAN)", "D02983  Argipressin tannate (USAN)", "D03067  Belfosdil (USAN/INN)", "D03115  Fasudil hydrochloride hydrate (JAN)", "D03120  Binodenoson (USAN/INN)", "D03212  Apadenoson (USAN)", "D03328  Carperitide (USAN/INN)", "D03415  Carvedilol phosphate (USAN)", "D03536  Clentiazem maleate (JAN/USAN)", "D03584  Colforsin (USAN/INN)", "D03648  Dapiprazole hydrochloride (USAN)", "D03655  Darodipine (USAN/INN)", "D03830  Diltiazem malate (USAN)", "D03887  Domazoline fumarate (USAN)", "D03914  Dronedarone hydrochloride (USP)", "D03953  Edonentan (USAN)", "D04006  Enprofylline (USAN/INN)", "D04018  Ephedrine sulfate (USP)", "D04040  Eprosartan (USAN/INN)", "D04051  Erythrityl tetranitrate (USAN)", "D04126  Saralasin acetate (USAN)", "D04128  Fandosentan potassium (USAN)", "D04137  Felypressin (USAN/INN)", "D04184  Fiduxosin hydrochloride (USAN)", "D04192  Flindokalner (USAN/INN)", "D04193  Flordipine (USAN/INN)", "D04243  Forasartan (USAN/INN)", "D04531  Indoramin (USAN/INN)", "D04532  Indoramin hydrochloride (USAN)", "D04657  Lacidipine (USAN/INN)", "D05024  Mibefradil dihydrochloride (USAN)", "D05147  Nesiritide (USAN/INN)", "D05148  Nesiritide citrate (USAN)", "D05206  Norepinephrine bitartrate (USP)", "D05228  Octodrine (USAN/INN)", "D05246  Olmesartan (USAN/INN)", "D05395  Pelanserin hydrochloride (USAN)", "D05429  Aminophylline hydrate (JP18)", "D05442  Perhexiline maleate (USAN)", "D05466  Phenylpropanolamine polistirex (USAN)", "D05637  Propylhexedrine (USP/INN)", "D05648  Pseudoephedrine polistirex (USAN)", "D05649  Pseudoephedrine sulfate (USP)", "D05711  Regadenoson (USAN)", "D05801  Saprisartan potassium (USAN)", "D06010  Tasosartan (USAN/INN)", "D06103  Theophylline (USP)", "D06104  Theophylline sodium glycinate (USP)", "D06129  Tiapamil hydrochloride (USAN)", "D06213  Treprostinil (JAN/USAN/INN)", "D06234  Trimazosin hydrochloride (USAN)", "D06380  Zolertine hydrochloride (USAN)", "D06394  Dabuzalgron hydrochloride (USAN)", "D06672  Terlipressin (USAN/INN)", "D07077  Ambrisentan (JAN/INN)", "D07097  Isometheptene mucate (USP)", "D07124  Alfuzosin (INN)", "D07171  Sitaxentan (USAN/INN)", "D07185  Fendiline (INN)", "D07227  Ornipressin (INN)", "D07450  Amlodipine (USP/INN)", "D07451  Amosulalol (INN)", "D07465  Arotinolol (INN)", "D07494  Barnidipine (INN)", "D07509  Benidipine (INN)", "D07520  Bepridil (INN)", "D07538  Bosentan (INN)", "D07550  Bunazosin (INN)", "D07560  Adrenalone hydrochloride", "D07577  Cinaciguat (JAN/INN)", "D07603  Caffeine citrate (USP)", "D07682  Clazosentan sodium (JAN/USAN)", "D07775  Dapiprazole (INN)", "D07833  Dihydroergocristine mesilate (BAN)", "D07834  Dihydroergocristine (BAN)", "D07845  Diltiazem (INN)", "D07874  Doxazosin (INN)", "D07886  Efonidipine (INN)", "D07905  Ergometrine (INN)", "D07906  Ergotamine (INN)", "D07931  Etilefrine (INN)", "D07941  Fasudil (INN)", "D07943  Fendiline hydrochloride", "D08009  Gallopamil (INN)", "D08064  Ifenprodil (INN)", "D08065  Iloprost tromethamine", "D08067  Azilsartan medoxomil (USAN)", "D08106  Labetalol (INN)", "D08111  Lercanidipine (INN)", "D08146  Losartan (INN)", "D08155  Manidipine (INN)", "D08192  Metaraminol (INN)", "D08201  Methoxamine (BAN)", "D08206  Methylephedrine (BAN)", "D08207  Methylergometrine (INN)", "D08212  Trimazosin (INN)", "D08217  Mibefradil (INN)", "D08220  Midodrine (INN)", "D08239  Moxisylyte (INN)", "D08253  Naphazoline (INN)", "D08270  Nicardipine (INN)", "D08271  Nicergoline tartrate", "D08284  Norepinephrine hydrochoride", "D08322  Oxymetazoline (INN)", "D08340  Perhexiline (INN)", "D08358  Phenoxybenzamine (INN)", "D08362  Phentolamine (INN)", "D08365  Phenylephrine (INN)", "D08366  Phenylephrine tartrate", "D08368  Phenylpropanolamine (INN)", "D08411  Prazosin (INN)", "D08444  Propylhexedrine hydrochloride", "D08449  Pseudoephedrine (INN)", "D08517  Sitaxentan sodium (USAN)", "D08560  Tamsulosin (INN)", "D08569  Terazosin (INN)", "D08571  Terlipressin acetate (JAN)", "D08578  Tetryzoline (INN)", "D08614  Tolazoline (INN)", "D08624  Tramazoline (INN)", "D08628  Treprostinil monosodium salt", "D08662  Urapidil hydrochloride", "D08684  Xylometazoline (INN)", "D08864  Azilsartan (JAN/USAN/INN)", "D08865  Azilsartan kamedoxomil (USAN)", "D08892  Clevidipine (USAN/INN)", "D08941  Levamlodipine malate (USAN)", "D08966  Phenylephrine bitartrate (USP)", "D09003  Sonedenoson (USAN)", "D09391  Telcagepant (USAN)", "D09392  Telcagepant potassium (USAN)", "D09572  Riociguat (JAN/USAN/INN)", "D09789  Kirenidipine hydrochloride (JAN)", "D09794  Norepinephrine hydrochloride (JAN)", "D09820  Vasopressin tannate (JAN)", "D09833  Levosemotiadil fumarate (JAN)", "D09842  dl-Methylephedrine saccharinate (JAN)", "D09994  Selexipag (JAN/USAN/INN)", "D10063  Cenderitide (USAN)", "D10135  Macitentan (JAN/USAN)", "D10430  Treprostinil diolamine (USAN)", "D10463  Ripasudil hydrochloride hydrate (JAN)", "D10556  Fimasartan (INN)", "D10628  Esuberaprost (USAN/INN)", "D10673  Ubrogepant (USAN/INN)", "D10703  Esuberaprost sodium (USAN)", "D10725  Ralinepag (USAN/INN)", "D10737  Verosudil (USAN/INN)", "D10738  Verosudil hydrochloride (USAN)", "D10928  Erenumab (USAN/INN)", "D10932  Etripamil (USAN/INN)", "D11030  Netarsudil (USAN/INN)", "D11031  Netarsudil mesylate (USAN)", "D11051  Vericiguat (JAN/USAN/INN)", "D11102  Tamolarizine hydrochloride (JAN)", "D11142  Angiotensin II acetate (USAN)", "D11190  Vosoritide (USAN/INN)", "D11274  Praliciguat (USAN/INN)", "D11303  Eptinezumab (USAN)", "D11313  Atogepant (USAN)", "D11441  Aprocitentan (USAN/INN)", "D11446  Esuberaprost potassium (USAN)", "D11475  Olinciguat (USAN/INN)", "D11585  Terazosin hydrochloride anhydrous", "D11630  Aminophylline dihydrate", "D11664  Clazosentan (USAN/INN)", "D11723  Levamlodipine maleate (USAN)", "D11776  Sparsentan (USAN/INN)", "D11881  Amlodipine benzoate", "D11898  Zavegepant (USAN)", "D11899  Zavegepant hydrochloride (USAN)", "D11974  Centhaquine (USAN)", "D11975  Centhaquine citrate (USAN)", "D12005  Treprostinil palmitil (USAN/INN)", "D12369  Etrumadenant (USAN/INN)", "D12568  Regadenoson (INN)", "D12629  Treprostinil phosphate (USAN)", "D12840  Zilebesiran sodium (JAN/USAN)"], "dblinks": "GO: 0014829", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["148  ADRA1A; adrenoceptor alpha 1A [KO:K04135]", "147  ADRA1B; adrenoceptor alpha 1B [KO:K04136]", "146  ADRA1D; adrenoceptor alpha 1D [KO:K04137]", "183  AGT; angiotensinogen [KO:K09821]", "185  AGTR1; angiotensin II receptor type 1 [KO:K04166]", "1906  EDN1; endothelin 1 [KO:K16366]", "1907  EDN2; endothelin 2 [KO:K16367]", "1908  EDN3; endothelin 3 [KO:K05227]", "1909  EDNRA; endothelin receptor type A [KO:K04197]", "551  AVP; arginine vasopressin [KO:K05242]", "552  AVPR1A; arginine vasopressin receptor 1A [KO:K04226]", "553  AVPR1B; arginine vasopressin receptor 1B [KO:K04227]", "2776  GNAQ; G protein subunit alpha q [KO:K04634]", "2767  GNA11; G protein subunit alpha 11 [KO:K04635]", "8399  PLA2G10; phospholipase A2 group X [KO:K01047] [EC:3.1.1.4]", "26279  PLA2G2D; phospholipase A2 group IID [KO:K01047] [EC:3.1.1.4]", "30814  PLA2G2E; phospholipase A2 group IIE [KO:K01047] [EC:3.1.1.4]", "50487  PLA2G3; phospholipase A2 group III [KO:K01047] [EC:3.1.1.4]", "64600  PLA2G2F; phospholipase A2 group IIF [KO:K01047] [EC:3.1.1.4]", "81579  PLA2G12A; phospholipase A2 group XIIA [KO:K01047] [EC:3.1.1.4]", "84647  PLA2G12B; phospholipase A2 group XIIB [KO:K01047] [EC:3.1.1.4]", "5319  PLA2G1B; phospholipase A2 group IB [KO:K01047] [EC:3.1.1.4]", "5322  PLA2G5; phospholipase A2 group V [KO:K01047] [EC:3.1.1.4]", "5320  PLA2G2A; phospholipase A2 group IIA [KO:K01047] [EC:3.1.1.4]", "391013  PLA2G2C; phospholipase A2 group IIC [KO:K01047] [EC:3.1.1.4]", "123745  PLA2G4E; phospholipase A2 group IVE [KO:K16342] [EC:3.1.1.4]", "5321  PLA2G4A; phospholipase A2 group IVA [KO:K16342] [EC:3.1.1.4]", "8681  JMJD7-PLA2G4B; JMJD7-PLA2G4B readthrough [KO:K16342] [EC:3.1.1.4]", "100137049  PLA2G4B; phospholipase A2 group IVB [KO:K16342] [EC:3.1.1.4]", "8605  PLA2G4C; phospholipase A2 group IVC [KO:K16342] [EC:3.1.1.4]", "283748  PLA2G4D; phospholipase A2 group IVD [KO:K16342] [EC:3.1.1.4]", "255189  PLA2G4F; phospholipase A2 group IVF [KO:K16342] [EC:3.1.1.4]", "8398  PLA2G6; phospholipase A2 group VI [KO:K16343] [EC:3.1.1.4]", "3778  KCNMA1; potassium calcium-activated channel subfamily M alpha 1 [KO:K04936]", "157855  KCNU1; potassium calcium-activated channel subfamily U member 1 [KO:K05274]", "3779  KCNMB1; potassium calcium-activated channel subfamily M regulatory beta subunit 1 [KO:K04937]", "10242  KCNMB2; potassium calcium-activated channel subfamily M regulatory beta subunit 2 [KO:K04938]", "27094  KCNMB3; potassium calcium-activated channel subfamily M regulatory beta subunit 3 [KO:K04939]", "27345  KCNMB4; potassium calcium-activated channel subfamily M regulatory beta subunit 4 [KO:K04941]", "775  CACNA1C; calcium voltage-gated channel subunit alpha1 C [KO:K04850]", "776  CACNA1D; calcium voltage-gated channel subunit alpha1 D [KO:K04851]", "778  CACNA1F; calcium voltage-gated channel subunit alpha1 F [KO:K04853]", "779  CACNA1S; calcium voltage-gated channel subunit alpha1 S [KO:K04857]", "810  CALML3; calmodulin like 3 [KO:K02183]", "805  CALM2; calmodulin 2 [KO:K02183]", "808  CALM3; calmodulin 3 [KO:K02183]", "801  CALM1; calmodulin 1 [KO:K02183]", "163688  CALML6; calmodulin like 6 [KO:K02183]", "51806  CALML5; calmodulin like 5 [KO:K02183]", "91860  CALML4; calmodulin like 4 [KO:K02183]", "4638  MYLK; myosin light chain kinase [KO:K00907] [EC:2.7.11.18]", "85366  MYLK2; myosin light chain kinase 2 [KO:K00907] [EC:2.7.11.18]", "91807  MYLK3; myosin light chain kinase 3 [KO:K00907] [EC:2.7.11.18]", "340156  MYLK4; myosin light chain kinase family member 4 [KO:K00907] [EC:2.7.11.18]", "140465  MYL6B; myosin light chain 6B [KO:K12751]", "4637  MYL6; myosin light chain 6 [KO:K12751]", "10398  MYL9; myosin light chain 9 [KO:K12755]", "4627  MYH9; myosin heavy chain 9 [KO:K10352]", "4628  MYH10; myosin heavy chain 10 [KO:K10352]", "4629  MYH11; myosin heavy chain 11 [KO:K10352]", "79784  MYH14; myosin heavy chain 14 [KO:K10352]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "5580  PRKCD; protein kinase C delta [KO:K06068] [EC:2.7.11.13]", "5581  PRKCE; protein kinase C epsilon [KO:K18050] [EC:2.7.11.13]", "5583  PRKCH; protein kinase C eta [KO:K18051] [EC:2.7.11.13]", "5588  PRKCQ; protein kinase C theta [KO:K18052] [EC:2.7.11.13]", "369  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "800  CALD1; caldesmon 1 [KO:K12327]", "59  ACTA2; actin alpha 2, smooth muscle [KO:K12313]", "72  ACTG2; actin gamma 2, smooth muscle [KO:K12315]", "94274  PPP1R14A; protein phosphatase 1 regulatory inhibitor subunit 14A [KO:K12328]", "5499  PPP1CA; protein phosphatase 1 catalytic subunit alpha [KO:K06269] [EC:3.1.3.16]", "5500  PPP1CB; protein phosphatase 1 catalytic subunit beta [KO:K06269] [EC:3.1.3.16]", "5501  PPP1CC; protein phosphatase 1 catalytic subunit gamma [KO:K06269] [EC:3.1.3.16]", "4659  PPP1R12A; protein phosphatase 1 regulatory subunit 12A [KO:K06270]", "4660  PPP1R12B; protein phosphatase 1 regulatory subunit 12B [KO:K12329]", "54776  PPP1R12C; protein phosphatase 1 regulatory subunit 12C [KO:K17457]", "2768  GNA12; G protein subunit alpha 12 [KO:K04346]", "10672  GNA13; G protein subunit alpha 13 [KO:K04639]", "23365  ARHGEF12; Rho guanine nucleotide exchange factor 12 [KO:K07532]", "9138  ARHGEF1; Rho guanine nucleotide exchange factor 1 [KO:K12330]", "9826  ARHGEF11; Rho guanine nucleotide exchange factor 11 [KO:K12331]", "387  RHOA; ras homolog family member A [KO:K04513]", "6093  ROCK1; Rho associated coiled-coil containing protein kinase 1 [KO:K04514] [EC:2.7.11.1]", "9475  ROCK2; Rho associated coiled-coil containing protein kinase 2 [KO:K17388] [EC:2.7.11.1]", "135  ADORA2A; adenosine A2a receptor [KO:K04266]", "136  ADORA2B; adenosine A2b receptor [KO:K04267]", "5739  PTGIR; prostaglandin I2 receptor [KO:K04263]", "796  CALCA; calcitonin related polypeptide alpha [KO:K12332]", "797  CALCB; calcitonin related polypeptide beta [KO:K12332]", "133  ADM; adrenomedullin [KO:K12333]", "79924  ADM2; adrenomedullin 2 [KO:K25343]", "10203  CALCRL; calcitonin receptor like receptor [KO:K04577]", "10267  RAMP1; receptor activity modifying protein 1 [KO:K08447]", "10266  RAMP2; receptor activity modifying protein 2 [KO:K08448]", "10268  RAMP3; receptor activity modifying protein 3 [KO:K08449]", "2778  GNAS; GNAS complex locus [KO:K04632]", "107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]", "108  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]", "109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]", "196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]", "113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]", "114  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]", "115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "4878  NPPA; natriuretic peptide A [KO:K12334]", "4879  NPPB; natriuretic peptide B [KO:K12335]", "4881  NPR1; natriuretic peptide receptor 1 [KO:K12323] [EC:4.6.1.2]", "4880  NPPC; natriuretic peptide C [KO:K12336]", "4882  NPR2; natriuretic peptide receptor 2 [KO:K12324] [EC:4.6.1.2]", "5592  PRKG1; protein kinase cGMP-dependent 1 [KO:K07376] [EC:2.7.11.12]", "10335  IRAG1; inositol 1,4,5-triphosphate receptor associated 1 [KO:K12337]", "2977  GUCY1A2; guanylate cyclase 1 soluble subunit alpha 2 [KO:K12318] [EC:4.6.1.2]", "2982  GUCY1A1; guanylate cyclase 1 soluble subunit alpha 1 [KO:K12318] [EC:4.6.1.2]", "2983  GUCY1B1; guanylate cyclase 1 soluble subunit beta 1 [KO:K12319] [EC:4.6.1.2]"], "compound": ["C00076  Calcium cation", "C00165  Diacylglycerol", "C00212  Adenosine", "C00219  Arachidonate", "C00238  Potassium cation", "C00533  Nitric oxide", "C00547  L-Noradrenaline", "C00575  3',5'-Cyclic AMP", "C00942  3',5'-Cyclic GMP", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C01312  Prostaglandin I2", "C14748  20-HETE", "C14768  5,6-EET", "C14769  8,9-EET", "C14770  11,12-EET", "C14771  14,15-EET"], "refs": [{"pmid": "17458653", "authors": "  Akata T", "title": "Cellular and molecular mechanisms regulating vascular tone. Part 2: regulatory mechanisms modulating Ca2+ mobilization and/or myofilament Ca2+ sensitivity in vascular smooth muscle cells.", "journal": "J Anesth 21:232-42 (2007)", "doi": "10.1007/s00540-006-0488-4"}, {"pmid": "12689814", "authors": "  Ogut O, Brozovich FV", "title": "Regulation of force in vascular smooth muscle.", "journal": "J Mol Cell Cardiol 35:347-55 (2003)", "doi": "10.1016/S0022-2828(03)00045-2"}, {"pmid": "16339747", "authors": "  Hilgers RH, Webb RC", "title": "Molecular aspects of arterial smooth muscle contraction: focus on Rho.", "journal": "Exp Biol Med (Maywood) 230:829-35 (2005)", "doi": "10.1177/153537020523001107"}, {"pmid": "12693609", "authors": "  Schlossmann J, Feil R, Hofmann F", "title": "Signaling through NO and cGMP-dependent protein kinases.", "journal": "Ann Med 35:21-7 (2003)", "doi": "10.1080/07853890310004093"}, {"pmid": "16870827", "authors": "  Mehta PK, Griendling KK", "title": "Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system.", "journal": "Am J Physiol Cell Physiol 292:C82-97 (2007)", "doi": "10.1152/ajpcell.00287.2006"}, {"pmid": "19120701", "authors": "  Kim HR, Appel S, Vetterkind S, Gangopadhyay SS, Morgan KG", "title": "Smooth muscle signalling pathways in health and disease.", "journal": "J Cell Mol Med 12:2165-80 (2008)", "doi": "10.1111/j.1582-4934.2008.00552.x"}, {"pmid": "11165670", "authors": "  Fukata Y, Amano M, Kaibuchi K", "title": "Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells.", "journal": "Trends Pharmacol Sci 22:32-9 (2001)", "doi": "10.1016/S0165-6147(00)01596-0"}, {"pmid": "17158339", "authors": "  Dimopoulos GJ, Semba S, Kitazawa K, Eto M, Kitazawa T", "title": "Ca2+-dependent rapid Ca2+ sensitization of contraction in arterial smooth muscle.", "journal": "Circ Res 100:121-9 (2007)", "doi": "10.1161/01.RES.0000253902.90489.df"}, {"pmid": "17200683", "authors": "  Hynynen MM, Khalil RA", "title": "The vascular endothelin system in hypertension--recent patents and discoveries.", "journal": "Recent Pat Cardiovasc Drug Discov 1:95-108 (2006)", "doi": "10.2174/157489006775244263"}, {"pmid": "15269340", "authors": "  Brain SD, Grant AD", "title": "Vascular actions of calcitonin gene-related peptide and adrenomedullin.", "journal": "Physiol Rev 84:903-34 (2004)", "doi": "10.1152/physrev.00037.2003"}, {"pmid": "11773611", "authors": "  Roman RJ", "title": "P-450 metabolites of arachidonic acid in the control of cardiovascular function.", "journal": "Physiol Rev 82:131-85 (2002)", "doi": "10.1152/physrev.00021.2001"}, {"pmid": "18040024", "authors": "  Surks HK", "title": "cGMP-dependent protein kinase I and smooth muscle relaxation: a tale of two isoforms.", "journal": "Circ Res 101:1078-80 (2007)", "doi": "10.1161/CIRCRESAHA.107.165779"}, {"pmid": "15026027", "authors": "  Vanhoutte PM", "title": "Endothelium-dependent hyperpolarizations: the history.", "journal": "Pharmacol Res 49:503-8 (2004)", "doi": "10.1016/j.phrs.2003.11.015"}, {"pmid": "10221985", "authors": "  Davis MJ, Hill MA", "title": "Signaling mechanisms underlying the vascular myogenic response.", "journal": "Physiol Rev 79:387-423 (1999)", "doi": "10.1152/physrev.1999.79.2.387"}, {"pmid": "11679404", "authors": "  Fleming I.", "title": "Cytochrome p450 and vascular homeostasis.", "journal": "Circ Res 89:753-62 (2001)", "doi": "10.1161/hh2101.099268"}, {"pmid": "10911373", "authors": "  Carvajal JA, Germain AM, Huidobro-Toro JP, Weiner CP", "title": "Molecular mechanism of cGMP-mediated smooth muscle relaxation.", "journal": "J Cell Physiol 184:409-20 (2000)", "doi": "10.1002/1097-4652(200009)184:3<409::AID-JCP16>3.0.CO;2-K"}, {"pmid": "18552454", "authors": "  Ko EA, Han J, Jung ID, Park WS", "title": "Physiological roles of K+ channels in vascular smooth muscle cells.", "journal": "J Smooth Muscle Res 44:65-81 (2008)", "doi": "10.1540/jsmr.44.65"}, {"pmid": "18703404", "authors": "  Woodard GE, Rosado JA", "title": "Natriuretic peptides in vascular physiology and pathology.", "journal": "Int Rev Cell Mol Biol 268:59-93 (2008)", "doi": "10.1016/S1937-6448(08)00803-4"}, {"pmid": "11709400", "authors": "  Berry C, Touyz R, Dominiczak AF, Webb RC, Johns DG", "title": "Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide.", "journal": "Am J Physiol Heart Circ Physiol 281:H2337-65 (2001)", "doi": "10.1152/ajpheart.2001.281.6.H2337"}, {"pmid": "15725705", "authors": "  Hirano K, Hirano M, Kanaide H", "title": "Regulation of myosin phosphorylation and myofilament Ca2+ sensitivity in vascular smooth muscle.", "journal": "J Smooth Muscle Res 40:219-36 (2004)", "doi": "10.1540/jsmr.40.219"}, {"pmid": "9458738", "authors": "  Freeman EJ, Ruehr ML, Dorman RV", "title": "ANG II-induced translocation of cytosolic PLA2 to the nucleus in vascular smooth muscle cells.", "journal": "Am J Physiol 274:C282-8 (1998)", "doi": "10.1152/ajpcell.1998.274.1.C282"}], "rel_pathway": ["hsa00590  Arachidonic acid metabolism", "hsa04020  Calcium signaling pathway"], "ko_pathway": "ko04270", "genes": ["BRAF"]}, {"kegg_id": "hsa04720", "name": "Long-term potentiation - Homo sapiens (human)", "description": "Hippocampal long-term potentiation (LTP), a long-lasting increase in synaptic efficacy, is the molecular basis for learning and memory. Tetanic stimulation of afferents in the CA1 region of the hippocampus induces glutamate release and activation of glutamate receptors in dendritic spines. A large increase in [Ca2+]i resulting from influx through NMDA receptors leads to constitutive activation of CaM kinase II (CaM KII) . Constitutively active CaM kinase II phosphorylates AMPA receptors, resulting in potentiation of the ionic conductance of AMPA receptors. Early-phase LTP (E-LTP) expression is due, in part, to this phosphorylation of the AMPA receptor. It is hypothesized that postsynaptic Ca2+ increases generated through NMDA receptors activate several signal transduction pathways including the Erk/MAP kinase and cAMP regulatory pathways. The convergence of these pathways at the level of the CREB/CRE transcriptional pathway may increase expression of a family of genes required for late-phase LTP (L-LTP).", "class": "Organismal Systems; Nervous system", "pathway_map": "hsa04720  Long-term potentiation", "network": ["", "ELEMENT   N00984  mGluR5-Ca2+ -apoptotic pathway"], "dblinks": "GO: 0048169", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["2890  GRIA1; glutamate ionotropic receptor AMPA type subunit 1 [KO:K05197]", "2891  GRIA2; glutamate ionotropic receptor AMPA type subunit 2 [KO:K05198]", "107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]", "114  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "5502  PPP1R1A; protein phosphatase 1 regulatory inhibitor subunit 1A [KO:K08050]", "5499  PPP1CA; protein phosphatase 1 catalytic subunit alpha [KO:K06269] [EC:3.1.3.16]", "5500  PPP1CB; protein phosphatase 1 catalytic subunit beta [KO:K06269] [EC:3.1.3.16]", "5501  PPP1CC; protein phosphatase 1 catalytic subunit gamma [KO:K06269] [EC:3.1.3.16]", "815  CAMK2A; calcium/calmodulin dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]", "817  CAMK2D; calcium/calmodulin dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]", "816  CAMK2B; calcium/calmodulin dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]", "818  CAMK2G; calcium/calmodulin dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]", "10411  RAPGEF3; Rap guanine nucleotide exchange factor 3 [KO:K08014]", "5906  RAP1A; RAP1A, member of RAS oncogene family [KO:K04353]", "5908  RAP1B; RAP1B, member of RAS oncogene family [KO:K07836]", "5530  PPP3CA; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]", "5532  PPP3CB; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]", "5533  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]", "5534  PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]", "5535  PPP3R2; protein phosphatase 3 regulatory subunit B, beta [KO:K06268]", "2902  GRIN1; glutamate ionotropic receptor NMDA type subunit 1 [KO:K05208]", "2903  GRIN2A; glutamate ionotropic receptor NMDA type subunit 2A [KO:K05209]", "2904  GRIN2B; glutamate ionotropic receptor NMDA type subunit 2B [KO:K05210]", "2905  GRIN2C; glutamate ionotropic receptor NMDA type subunit 2C [KO:K05211]", "2906  GRIN2D; glutamate ionotropic receptor NMDA type subunit 2D [KO:K05212]", "775  CACNA1C; calcium voltage-gated channel subunit alpha1 C [KO:K04850]", "810  CALML3; calmodulin like 3 [KO:K02183]", "805  CALM2; calmodulin 2 [KO:K02183]", "808  CALM3; calmodulin 3 [KO:K02183]", "801  CALM1; calmodulin 1 [KO:K02183]", "163688  CALML6; calmodulin like 6 [KO:K02183]", "51806  CALML5; calmodulin like 5 [KO:K02183]", "91860  CALML4; calmodulin like 4 [KO:K02183]", "1387  CREBBP; CREB binding protein [KO:K04498] [EC:2.3.1.48]", "2033  EP300; E1A binding protein p300 [KO:K04498] [EC:2.3.1.48]", "468  ATF4; activating transcription factor 4 [KO:K04374]", "814  CAMK4; calcium/calmodulin dependent protein kinase IV [KO:K05869] [EC:2.7.11.17]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "369  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "6197  RPS6KA3; ribosomal protein S6 kinase A3 [KO:K04373] [EC:2.7.11.1]", "6195  RPS6KA1; ribosomal protein S6 kinase A1 [KO:K04373] [EC:2.7.11.1]", "6196  RPS6KA2; ribosomal protein S6 kinase A2 [KO:K04373] [EC:2.7.11.1]", "27330  RPS6KA6; ribosomal protein S6 kinase A6 [KO:K04373] [EC:2.7.11.1]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "2911  GRM1; glutamate metabotropic receptor 1 [KO:K04603]", "2915  GRM5; glutamate metabotropic receptor 5 [KO:K04604]", "2776  GNAQ; G protein subunit alpha q [KO:K04634]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]"], "compound": ["C00025  L-Glutamate", "C00076  Calcium cation", "C00165  Diacylglycerol", "C00305  Magnesium cation", "C00575  3',5'-Cyclic AMP", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C01330  Sodium cation"], "refs": [{"pmid": "15652868", "authors": "  Blitzer RD, Iyengar R, Landau EM.", "title": "Postsynaptic signaling networks: cellular cogwheels underlying long-term plasticity.", "journal": "Biol Psychiatry 57:113-9 (2005)", "doi": "10.1016/j.biopsych.2004.02.031"}, {"pmid": "10652548", "authors": "  Soderling TR, Derkach VA.", "title": "Postsynaptic protein phosphorylation and LTP.", "journal": "Trends Neurosci 23:75-80 (2000)", "doi": "10.1016/S0166-2236(99)01490-3"}, {"pmid": "11378299", "authors": "  Poser S, Storm DR.", "title": "Role of Ca2+-stimulated adenylyl cyclases in LTP and memory formation.", "journal": "Int J Dev Neurosci 19:387-94 (2001)", "doi": "10.1016/S0736-5748(00)00094-0"}, {"pmid": "15803158", "authors": "  Xia Z, Storm DR.", "title": "The role of calmodulin as a signal integrator for synaptic plasticity.", "journal": "Nat Rev Neurosci 6:267-76 (2005)", "doi": "10.1038/nrn1647"}, {"pmid": "14715912", "authors": "  Lynch MA.", "title": "Long-term potentiation and memory.", "journal": "Physiol Rev 84:87-136 (2004)", "doi": "10.1152/physrev.00014.2003"}, {"pmid": "15857686", "authors": "  Kelly PT, Mackinnon RL 2nd, Dietz RV, Maher BJ, Wang J.", "title": "Postsynaptic IP3 receptor-mediated Ca2+ release modulates synaptic transmission in hippocampal neurons.", "journal": "Brain Res Mol Brain Res 135:232-48 (2005)", "doi": "10.1016/j.molbrainres.2004.12.018"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04724  Glutamatergic synapse"], "ko_pathway": "ko04720", "genes": ["BRAF", "NRAS"]}, {"kegg_id": "hsa04726", "name": "Serotonergic synapse - Homo sapiens (human)", "description": "Serotonin (5-Hydroxytryptamine, 5-HT) is a monoamine neurotransmitter that plays important roles in physiological functions such as learning and memory, emotion, sleep, pain, motor function and endocrine secretion, as well as in pathological states including abnormal mood and cognition. Once released from presynaptic axonal terminals, 5-HT binds to receptors, which have been divided into 7 subfamilies on the basis of conserved structures and signaling mechanisms. These families include the ionotropic 5-HT3 receptors and G-protein-coupled 5-HT receptors, the 5-HT1 (Gi /Go -coupled), 5-HT2(Gq-coupled), 5-HT4/6/7 (Gs-coupled) and 5-HT5 receptors. Presynaptically localized 5-HT1B receptors are thought to be the autoreceptors that suppress excess 5-HT release. 5-HT's actions are terminated by transporter- mediated reuptake into neurons, leading to catabolism by monoamine oxidase.", "class": "Organismal Systems; Nervous system", "pathway_map": "hsa04726  Serotonergic synapse", "drug": ["D00110  Cocaine (USP)", "D00197  Reserpine (JP18/USP/INN)", "D00228  Amoxapine (JP18/USP/INN)", "D00270  Chlorpromazine (USP/INN)", "D00274  Cisapride (USP/INN)", "D00283  Clozapine (JAN/USP/INN)", "D00326  Fluoxetine (USAN/INN)", "D00367  Mazindol (JAN/USP/INN)", "D00394  Trimipramine (USAN/INN)", "D00415  Zolmitriptan (JAN/USP/INN)", "D00426  Risperidone (JP18/USP/INN)", "D00451  Sumatriptan (JAN/USP/INN)", "D00454  Olanzapine (JAN/USP/INN)", "D00456  Ondansetron (JAN/USP/INN)", "D00458  Quetiapine fumarate (JP18/USP)", "D00484  Protriptyline hydrochloride (USP)", "D00505  Phenelzine sulfate (USP)", "D00558  Carbidopa (USP)", "D00561  Sertindole (USAN/INN)", "D00563  Mirtazapine (JAN/USP/INN)", "D00674  Naratriptan hydrochloride (JAN/USP)", "D00675  Rizatriptan benzoate (JAN/USP)", "D00676  Sumatriptan succinate (JAN/USP)", "D00677  Granisetron hydrochloride (JAN/USP)", "D00678  Ondansetron hydrochloride hydrate (JAN/USP)", "D00681  Methysergide maleate (USP)", "D00702  Buspirone hydrochloride (USP)", "D00725  Dolasetron mesylate (USP)", "D00730  Butamben (USP)", "D00785  Selegiline hydrochloride (JAN/USP)", "D00789  Chlorpromazine hydrochloride (JP18/USP)", "D00794  Loxapine succinate (USP)", "D00795  Mesoridazine besylate (USP)", "D00809  Amitriptyline hydrochloride (JP18/USP)", "D00811  Clomipramine hydrochloride (JP18/USP)", "D00812  Desipramine hydrochloride (JAN/USP)", "D00814  Doxepin hydrochloride (USP)", "D00815  Imipramine hydrochloride (JP18/USP)", "D00816  Nortriptyline hydrochloride (JP18/USP/INN)", "D00819  Nefazodone hydrochloride (USP)", "D00820  Trazodone hydrochloride (JAN/USP)", "D00821  Venlafaxine hydrochloride (JAN/USP)", "D00822  Citalopram hydrobromide (USP)", "D00823  Fluoxetine hydrochloride (JAN/USP)", "D00824  Fluvoxamine maleate (JP18/USP)", "D00825  Sertraline hydrochloride (JAN/USP)", "D00826  Tranylcypromine sulfate (USP)", "D01097  Lazabemide hydrochloride (JAN/USAN)", "D01107  Milnacipran hydrochloride (JAN/USAN)", "D01164  Aripiprazole (JAN/USP/INN)", "D01176  Blonanserin (JAN/INN)", "D01179  Duloxetine hydrochloride (JAN/USP)", "D01285  Lofepramine hydrochloride (JAN/USAN)", "D01321  Zotepine (JAN/INN)", "D01358  Mianserin hydrochloride (JAN/USAN)", "D01477  Opipramol hydrochloride (JAN/USAN)", "D01485  Propericiazine (JAN)", "D01537  Xaliproden hydrochloride (JAN)", "D01546  Dothiepin hydrochloride (USAN)", "D01613  Azasetron hydrochloride (JAN)", "D01624  Sarpogrelate hydrochloride (JP18)", "D01653  Benserazide hydrochloride (JP18)", "D01838  Fabesetron hydrochloride (JAN)", "D01888  Safrazine hydrochloride (JAN)", "D01939  Ziprasidone hydrochloride (USP)", "D01973  Eletriptan hydrobromide (JAN/USAN)", "D01992  Tandospirone citrate (JAN/USAN)", "D01994  Mosapride citrate hydrate (JP18)", "D02016  Ramosetron hydrochloride (JAN)", "D02041  Tropisetron hydrochloride (JAN)", "D02092  Cisapride (JAN)", "D02100  Ziprasidone mesylate (USAN)", "D02130  Tropisetron (INN)", "D02170  Indeloxazine hydrochloride (JAN/USAN)", "D02182  Cocaine hydrochloride (JP18/USP)", "D02211  Dihydroergotamine mesylate (USP)", "D02234  Cyproheptadine hydrochloride (JP18/USP)", "D02242  Methamphetamine hydrochloride (JP18/USP)", "D02260  Paroxetine hydrochloride hemihydrate (USP)", "D02290  Flurbiprofen sodium (USP)", "D02340  Loxapine (USAN/INN)", "D02357  Methysergide (USAN/INN)", "D02360  Sertraline (INN)", "D02362  Paroxetine (USP/INN)", "D02363  Ketanserin (USAN/INN)", "D02408  Trimipramine maleate (JAN/USP)", "D02559  Toloxatone (INN)", "D02560  Brofaromine (INN)", "D02561  Moclobemide (USAN/INN)", "D02562  Rasagiline mesylate (USAN)", "D02563  Befloxatone (INN)", "D02564  Pargyline hydrochloride (USAN)", "D02567  Escitalopram oxalate (JAN/USP)", "D02568  Flesinoxan (INN)", "D02569  Sunepitron hydrochloride (USAN)", "D02570  Desvenlafaxine succinate (USAN)", "D02571  Sibutramine hydrochloride (USP)", "D02576  Eptapirone (INN)", "D02577  Flibanserin (USAN/INN)", "D02578  Agomelatine (INN)", "D02579  Iproniazid (INN)", "D02580  Isocarboxazid (INN)", "D02581  Cimoxatone (INN)", "D02632  Indisetron hydrochloride (JAN)", "D02656  Fananserin (USAN/INN)", "D02666  Iloperidone (USAN/INN)", "D02671  Mesoridazine (USAN/INN)", "D02675  Ocaperidone (USAN)", "D02680  Pipotiazine palmitate (USAN)", "D02686  Setoperone (USAN/INN)", "D02688  Tiospirone hydrochloride (USAN)", "D02730  Tegaserod maleate (USAN)", "D02767  Adatanserin hydrochloride (USAN)", "D02787  Alaproclate (USAN/INN)", "D02824  Almotriptan (USAN)", "D02825  Almotriptan malate (USP)", "D02826  Alniditan dihydrochloride (USAN)", "D02829  Alosetron hydrochloride (USAN)", "D02833  Alpidem (USAN/INN)", "D02836  Altanserin tartrate (USAN)", "D02893  Amesergide (USAN/INN)", "D02995  Asenapine maleate (JAN/USAN)", "D03005  Atiprosin maleate (USAN)", "D03014  Avitriptan fumarate (USAN)", "D03060  Batanopride hydrochloride (USAN)", "D03073  Bemesetron (USAN/INN)", "D03082  Benserazide (USAN/INN)", "D03239  Ladostigil tartrate (USAN)", "D03248  Clorgiline (INN)", "D03274  Chlorpromazine hibenzate (JAN)", "D03409  Caroxazone (USAN/INN)", "D03491  Cidoxepin hydrochloride (USAN)", "D03495  Cilansetron (USAN/INN)", "D03496  Cilansetron hydrochloride (USAN)", "D03649  Dapoxetine hydrochloride (USAN)", "D03662  Dazopride fumarate (USAN)", "D03713  Dexfenfluramine hydrochloride (USAN)", "D03721  Dexmethylphenidate hydrochloride (USAN)", "D03731  Selegiline (USAN/INN)", "D03733  Mofegiline hydrochloride (USAN)", "D03740  Dextroamphetamine (USAN)", "D03982  Elzasonan citrate (USAN)", "D03983  Elzasonan hydrochloride (USAN)", "D04034  Chlorpromazine phenolphthalinate (JAN)", "D04055  Esmirtazapine maleate (USAN)", "D04092  Etryptamine acetate (USAN)", "D04148  Fenfluramine hydrochloride (JAN/USAN)", "D04264  Frovatriptan succinate (USAN)", "D04294  Galdansetron hydrochloride (USAN)", "D04314  Gepirone hydrochloride (USAN)", "D04320  Glemanserin (USAN/INN)", "D04370  Granisetron (JAN/USAN/INN)", "D04533  Indorenate hydrochloride (USAN)", "D04611  Ipsapirone hydrochloride (USAN)", "D04642  Itasetron (USAN/INN)", "D04681  Lazabemide (USAN/INN)", "D04683  Lecozotan hydrochloride (USAN)", "D04788  Lubazodone hydrochloride (USAN)", "D04820  Lurasidone hydrochloride (JAN/USAN)", "D04821  Lurosetron mesylate (USAN)", "D05015  Metrenperone (USAN/INN)", "D05033  Milacemide hydrochloride (USAN)", "D05039  Minaprine (USAN/INN)", "D05040  Minaprine hydrochloride (USAN)", "D05050  Mirisetron maleate (USAN)", "D05339  Paliperidone (JAN/USP/INN)", "D05340  Paliperidone palmitate (JAN/USAN)", "D05343  Palonosetron hydrochloride (JAN/USP)", "D05348  Pancopride (USAN/INN)", "D05374  Paroxetine hydrochloride (USP)", "D05375  Paroxetine mesylate (USAN)", "D05395  Pelanserin hydrochloride (USAN)", "D05458  Phentermine (USAN/INN)", "D05459  Phentermine hydrochloride (USP)", "D05471  Piboserod hydrochloride (USAN)", "D05523  Pizotyline (USAN)", "D05685  Quipazine maleate (USAN)", "D05738  Ritanserin (USAN/INN)", "D05740  Rizatriptan sulfate (USAN)", "D05804  Sarizotan hydrochloride (USAN)", "D05829  Sergolexole maleate (USAN)", "D05941  Sulamserod hydrochloride (USAN)", "D05980  Suritozole (USAN/INN)", "D06056  Tegaserod (USAN/INN)", "D06253  Tropanserin hydrochloride (USAN)", "D06327  Xaliproden (USAN)", "D06353  Zacopride hydrochloride (USAN)", "D06354  Zalospirone hydrochloride (USAN)", "D06358  Zatosetron maleate (USAN)", "D06396  Renzapride (INN)", "D06566  Bifeprunox (USAN/INN)", "D06567  Bifeprunox mesylate (USAN)", "D06613  Lorcaserin hydrochloride (USAN)", "D06623  Olanzapine pamoate (USAN)", "D06632  Pruvanserin (USAN/INN)", "D06633  Pruvanserin hydrochloride (USAN)", "D06660  Vabicaserin hydrochloride (USAN)", "D07097  Isometheptene mucate (USP)", "D07129  Alosetron (INN)", "D07175  Palonosetron (INN)", "D07307  Cyamemazine (INN)", "D07316  Captodiame (BAN)", "D07334  Imipraminoxide (INN)", "D07337  Nialamide (INN)", "D07338  Iproclozide (INN)", "D07445  Amfetamine (INN)", "D07448  Amitriptyline (INN)", "D07449  Amitriptylinoxide (INN)", "D07481  Azasetron (INN)", "D07514  Benzfetamine (INN)", "D07515  Benzfetamine hydrochloride", "D07593  Buspirone (INN)", "D07700  Cinitapride (INN)", "D07701  Cinitapride tartrate", "D07704  Citalopram (USP/INN)", "D07705  Citalopram hydrochloride", "D07727  Clomipramine (INN)", "D07756  Cyamemazine tartrate", "D07765  Cyproheptadine (INN)", "D07791  Desipramine (INN)", "D07793  Desvenlafaxine (INN)", "D07805  Dexfenfluramine (INN)", "D07806  Dexmethylphenidate (INN)", "D07837  Dihydroergotamine (INN)", "D07838  Dihydroergotamine tartrate", "D07867  Dolasetron (INN)", "D07872  Dosulepin (INN)", "D07875  Doxepin (INN)", "D07880  Duloxetine (INN)", "D07887  Eletriptan (INN)", "D07913  Escitalopram (INN)", "D07945  Fenfluramine (INN)", "D07984  Fluvoxamine (INN)", "D07997  Frovatriptan (INN)", "D08070  Imipramine (INN)", "D08071  Imipramine pamoate (USP)", "D08072  Imipraminoxide hydrochloride", "D08077  Indeloxazine (INN)", "D08085  Iproniazid phosphate", "D08099  Ketanserin tartrate", "D08140  Lofepramine (INN)", "D08148  Loxapine hydrochloride", "D08187  Metamfetamine (INN)", "D08216  Mianserin (INN)", "D08222  Milnacipran (INN)", "D08236  Mosapride (INN)", "D08255  Naratriptan (INN)", "D08257  Nefazodone (INN)", "D08288  Nortriptyline (INN)", "D08297  Opipramol (INN)", "D08349  Phenelzine (BAN)", "D08385  Pipotiazine (INN)", "D08392  Pirlindole (INN)", "D08393  Pirlindole hydrochloride", "D08397  Pizotifen malate", "D08447  Protriptyline (INN)", "D08453  Pargyline (INN)", "D08456  Quetiapine (INN)", "D08466  Ramosetron (INN)", "D08469  Rasagiline (USAN/INN)", "D08485  Rizatriptan (INN)", "D08508  Sarpogrelate (INN)", "D08513  Sibutramine (INN)", "D08561  Tandospirone (INN)", "D08575  Tetrabenazine (JAN/INN)", "D08625  Tranylcypromine (INN)", "D08626  Trazodone (INN)", "D08670  Venlafaxine (INN)", "D08687  Ziprasidone (INN)", "D08969  Pimavanserin tartrate (USAN)", "D09205  Prucalopride (USAN/INN)", "D09358  Naluzotan (USAN/INN)", "D09359  Naluzotan hydrochloride (USAN)", "D09366  Pardoprunox hydrochloride (USAN)", "D09397  Pardoprunox (USAN/INN)", "D09645  Nelotanserin (USAN/INN)", "D09693  Velusetrag (USAN/INN)", "D09694  Velusetrag hydrochloride (USAN)", "D09698  Vilazodone (USAN/INN)", "D09699  Vilazodone hydrochloride (USAN)", "D09749  Itasetron hydrochloride hydrate (JAN)", "D09819  Chlorpromazine tannate (JAN)", "D09876  Cariprazine hydrochloride (JAN/USAN)", "D09933  Naronapride (USAN/INN)", "D09934  Naronapride dihydrochloride (USAN)", "D09973  Telotristat (USAN/INN)", "D09974  Telotristat ethyl (USAN)", "D09975  Telotristat etiprate (USAN)", "D09997  Cariprazine (USAN/INN)", "D10006  Eplivanserin (USAN/INN)", "D10072  Levomilnacipran (USAN/INN)", "D10088  Amitifadine (USAN)", "D10089  Amitifadine hydrochloride (USAN)", "D10099  Cerlapirdine (USAN)", "D10100  Cerlapirdine hydrochloride (USAN)", "D10133  Levomilnacipran hydrochloride (USAN)", "D10152  Prucalopride succinate (USAN)", "D10158  Safinamide (USAN/INN)", "D10170  Tedatioxetine (USAN)", "D10171  Tedatioxetine hydrobromide (USAN)", "D10184  Vortioxetine (USAN)", "D10185  Vortioxetine hydrobromide (JAN/USAN)", "D10191  Safinamide mesylate (USAN)", "D10309  Brexpiprazole (JAN/USAN/INN)", "D10338  Lasmiditan (USAN/INN)", "D10355  Aripiprazole cavoxil (USAN)", "D10364  Aripiprazole lauroxil (USAN)", "D10424  Lasmiditan succinate (JAN/USAN)", "D10443  Liafensine (USAN/INN)", "D10516  Aripiprazole hydrate (JAN)", "D10675  Valbenazine (USAN/INN)", "D10697  Centanafadine (USAN/INN)", "D10698  Centanafadine hydrochloride (USAN)", "D10701  Deutetrabenazine (USAN/INN)", "D10747  Idalopirdine hydrochloride (JAN)", "D10829  Rasagiline tartrate", "D10999  Valbenazine tosylate (USAN)", "D11056  Mirtazapine hydrate (JAN)", "D11169  Lumateperone (USAN/INN)", "D11170  Lumateperone tosylate (USAN)", "D11172  Midomafetamine (USAN/INN)", "D11220  Relenopride (USAN/INN)", "D11221  Relenopride hydrochloride (USAN)", "D11224  Sembragiline (USAN/INN)", "D11317  Rodatristat (USAN)", "D11318  Rodatristat ethyl (USAN)", "D11566  Lorcaserin hydrochloride hemihydrate", "D11617  Eletriptan hydrobromide monohydrate", "D11619  Desvenlafaxine succinate anhydrous", "D11622  Amphetamine aspartate monohydrate", "D11688  Ampreloxetine (USAN/INN)", "D11689  Ampreloxetine hydrochloride (USAN)", "D11769  Asenapine (INN)", "D11940  Toludesvenlafaxine (USAN/INN)", "D11941  Toludesvenlafaxine hydrochloride (USAN)", "D12157  Felcisetrag (USAN/INN)", "D12403  Venlafaxine besylate monohydrate", "D12474  Ulotaront (USAN/INN)", "D12475  Ulotaront hydrochloride (JAN/USAN)", "D12510  Utreloxastat (JAN/USAN/INN)", "D12544  Vortioxetine hemihydrobromide (USAN)", "D12707  Brolamfetamine (INN)", "D12881  Psilocybin (USAN)"], "dblinks": "GO: 0007210", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["121278  TPH2; tryptophan hydroxylase 2 [KO:K00502] [EC:1.14.16.4]", "7166  TPH1; tryptophan hydroxylase 1 [KO:K00502] [EC:1.14.16.4]", "1644  DDC; dopa decarboxylase [KO:K01593] [EC:4.1.1.28 4.1.1.105]", "6570  SLC18A1; solute carrier family 18 member A1 [KO:K08155]", "6571  SLC18A2; solute carrier family 18 member A2 [KO:K08155]", "775  CACNA1C; calcium voltage-gated channel subunit alpha1 C [KO:K04850]", "776  CACNA1D; calcium voltage-gated channel subunit alpha1 D [KO:K04851]", "778  CACNA1F; calcium voltage-gated channel subunit alpha1 F [KO:K04853]", "779  CACNA1S; calcium voltage-gated channel subunit alpha1 S [KO:K04857]", "3356  HTR2A; 5-hydroxytryptamine receptor 2A [KO:K04157]", "3357  HTR2B; 5-hydroxytryptamine receptor 2B [KO:K04157]", "3358  HTR2C; 5-hydroxytryptamine receptor 2C [KO:K04157]", "2776  GNAQ; G protein subunit alpha q [KO:K04634]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "123745  PLA2G4E; phospholipase A2 group IVE [KO:K16342] [EC:3.1.1.4]", "5321  PLA2G4A; phospholipase A2 group IVA [KO:K16342] [EC:3.1.1.4]", "8681  JMJD7-PLA2G4B; JMJD7-PLA2G4B readthrough [KO:K16342] [EC:3.1.1.4]", "100137049  PLA2G4B; phospholipase A2 group IVB [KO:K16342] [EC:3.1.1.4]", "8605  PLA2G4C; phospholipase A2 group IVC [KO:K16342] [EC:3.1.1.4]", "283748  PLA2G4D; phospholipase A2 group IVD [KO:K16342] [EC:3.1.1.4]", "255189  PLA2G4F; phospholipase A2 group IVF [KO:K16342] [EC:3.1.1.4]", "1558  CYP2C8; cytochrome P450 family 2 subfamily C member 8 [KO:K17718] [EC:1.14.14.1]", "1559  CYP2C9; cytochrome P450 family 2 subfamily C member 9 [KO:K17719] [EC:1.14.14.51 1.14.14.52 1.14.14.53 1.14.14.-]", "1562  CYP2C18; cytochrome P450 family 2 subfamily C member 18 [KO:K17720] [EC:1.14.14.1]", "1557  CYP2C19; cytochrome P450 family 2 subfamily C member 19 [KO:K17721] [EC:1.14.14.51 1.14.14.52 1.14.14.53 1.14.14.75 1.14.14.-]", "1565  CYP2D6; cytochrome P450 family 2 subfamily D member 6 [KO:K17712] [EC:1.14.14.1]", "107987478  cytochrome P450 2D6-like [KO:K17712] [EC:1.14.14.1]", "1564  CYP2D7; cytochrome P450 family 2 subfamily D member 7 (gene/pseudogene) [KO:K17712] [EC:1.14.14.1]", "107987479  CYP2D6; cytochrome P450 2D6 [KO:K17712] [EC:1.14.14.1]", "1573  CYP2J2; cytochrome P450 family 2 subfamily J member 2 [KO:K07418] [EC:1.14.14.1 1.14.14.73 1.14.14.74 1.14.14.75]", "260293  CYP4X1; cytochrome P450 family 4 subfamily X member 1 [KO:K07428] [EC:1.14.14.1]", "240  ALOX5; arachidonate 5-lipoxygenase [KO:K00461] [EC:1.13.11.34]", "239  ALOX12; arachidonate 12-lipoxygenase, 12S type [KO:K00458] [EC:1.13.11.31]", "242  ALOX12B; arachidonate 12-lipoxygenase, 12R type [KO:K08021] [EC:1.13.11.-]", "246  ALOX15; arachidonate 15-lipoxygenase [KO:K00460] [EC:1.13.11.33]", "247  ALOX15B; arachidonate 15-lipoxygenase type B [KO:K08022] [EC:1.13.11.33 1.13.11.-]", "5742  PTGS1; prostaglandin-endoperoxide synthase 1 [KO:K00509] [EC:1.14.99.1]", "5743  PTGS2; prostaglandin-endoperoxide synthase 2 [KO:K11987] [EC:1.14.99.1]", "3359  HTR3A; 5-hydroxytryptamine receptor 3A [KO:K04819]", "285242  HTR3E; 5-hydroxytryptamine receptor 3E [KO:K04819]", "200909  HTR3D; 5-hydroxytryptamine receptor 3D [KO:K04819]", "170572  HTR3C; 5-hydroxytryptamine receptor 3C [KO:K04819]", "9177  HTR3B; 5-hydroxytryptamine receptor 3B [KO:K04819]", "3360  HTR4; 5-hydroxytryptamine receptor 4 [KO:K04160]", "3362  HTR6; 5-hydroxytryptamine receptor 6 [KO:K04162]", "3363  HTR7; 5-hydroxytryptamine receptor 7 [KO:K04163]", "2778  GNAS; GNAS complex locus [KO:K04632]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "3781  KCNN2; potassium calcium-activated channel subfamily N member 2 [KO:K04943]", "3751  KCND2; potassium voltage-gated channel subfamily D member 2 [KO:K04892]", "2560  GABRB1; gamma-aminobutyric acid type A receptor subunit beta1 [KO:K05181]", "2562  GABRB3; gamma-aminobutyric acid type A receptor subunit beta3 [KO:K05181]", "2561  GABRB2; gamma-aminobutyric acid type A receptor subunit beta2 [KO:K05181]", "10411  RAPGEF3; Rap guanine nucleotide exchange factor 3 [KO:K08014]", "351  APP; amyloid beta precursor protein [KO:K04520]", "3350  HTR1A; 5-hydroxytryptamine receptor 1A [KO:K04153]", "3351  HTR1B; 5-hydroxytryptamine receptor 1B [KO:K04153]", "3352  HTR1D; 5-hydroxytryptamine receptor 1D [KO:K04153]", "3354  HTR1E; 5-hydroxytryptamine receptor 1E [KO:K04153]", "3355  HTR1F; 5-hydroxytryptamine receptor 1F [KO:K04153]", "3361  HTR5A; 5-hydroxytryptamine receptor 5A [KO:K04161]", "2770  GNAI1; G protein subunit alpha i1 [KO:K04630]", "2773  GNAI3; G protein subunit alpha i3 [KO:K04630]", "2771  GNAI2; G protein subunit alpha i2 [KO:K04630]", "2775  GNAO1; G protein subunit alpha o1 [KO:K04534]", "2782  GNB1; G protein subunit beta 1 [KO:K04536]", "2783  GNB2; G protein subunit beta 2 [KO:K04537]", "2784  GNB3; G protein subunit beta 3 [KO:K07825]", "59345  GNB4; G protein subunit beta 4 [KO:K04538]", "10681  GNB5; G protein subunit beta 5 [KO:K04539]", "54331  GNG2; G protein subunit gamma 2 [KO:K07826]", "2785  GNG3; G protein subunit gamma 3 [KO:K04540]", "2786  GNG4; G protein subunit gamma 4 [KO:K04541]", "2787  GNG5; G protein subunit gamma 5 [KO:K04542]", "2788  GNG7; G protein subunit gamma 7 [KO:K04543]", "94235  GNG8; G protein subunit gamma 8 [KO:K04544]", "2790  GNG10; G protein subunit gamma 10 [KO:K04545]", "2791  GNG11; G protein subunit gamma 11 [KO:K04546]", "55970  GNG12; G protein subunit gamma 12 [KO:K04347]", "51764  GNG13; G protein subunit gamma 13 [KO:K04547]", "2792  GNGT1; G protein subunit gamma transducin 1 [KO:K04548]", "2793  GNGT2; G protein subunit gamma transducin 2 [KO:K04549]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "1843  DUSP1; dual specificity phosphatase 1 [KO:K21278] [EC:3.1.3.16 3.1.3.48]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "369  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "773  CACNA1A; calcium voltage-gated channel subunit alpha1 A [KO:K04344]", "774  CACNA1B; calcium voltage-gated channel subunit alpha1 B [KO:K04849]", "3760  KCNJ3; potassium inwardly rectifying channel subfamily J member 3 [KO:K04997]", "3763  KCNJ6; potassium inwardly rectifying channel subfamily J member 6 [KO:K05000]", "3765  KCNJ9; potassium inwardly rectifying channel subfamily J member 9 [KO:K05002]", "3762  KCNJ5; potassium inwardly rectifying channel subfamily J member 5 [KO:K04999]", "7220  TRPC1; transient receptor potential cation channel subfamily C member 1 [KO:K04964]", "6532  SLC6A4; solute carrier family 6 member 4 [KO:K05037]", "4129  MAOB; monoamine oxidase B [KO:K00274] [EC:1.4.3.4]", "4128  MAOA; monoamine oxidase A [KO:K00274] [EC:1.4.3.4]"], "compound": ["C00076  Calcium cation", "C00078  L-Tryptophan", "C00165  Diacylglycerol", "C00219  Arachidonate", "C00238  Potassium cation", "C00427  Prostaglandin H2", "C00575  3',5'-Cyclic AMP", "C00584  Prostaglandin E2", "C00639  Prostaglandin F2alpha", "C00643  5-Hydroxy-L-tryptophan", "C00696  Prostaglandin D2", "C00780  Serotonin", "C00909  Leukotriene A4", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C01330  Sodium cation", "C02165  Leukotriene B4", "C02166  Leukotriene C4", "C02198  Thromboxane A2", "C04822  8(R)-HPETE", "C05356  5(S)-HPETE", "C05635  5-Hydroxyindoleacetate", "C05953  Prostaglandin A2", "C05954  Prostaglandin B2", "C05955  Prostaglandin C2", "C05956  Prostaglandin G2", "C05957  Prostaglandin J2", "C05963  Thromboxane B2", "C05964  11-Dehydro-thromboxane B2", "C05965  12(S)-HPETE", "C05966  15(S)-HPETE", "C14768  5,6-EET", "C14769  8,9-EET", "C14770  11,12-EET", "C14771  14,15-EET", "C14772  5,6-DHET", "C14773  8,9-DHET", "C14774  11,12-DHET", "C14775  14,15-DHET", "C14812  12(R)-HPETE", "C14820  11(R)-HPETE", "C14821  9(S)-HPETE", "C14823  8(S)-HPETE"], "refs": [{"pmid": "18676031", "authors": "  Millan MJ, Marin P, Bockaert J, Mannoury la Cour C", "title": "Signaling at G-protein-coupled serotonin receptors: recent advances and future research directions.", "journal": "Trends Pharmacol Sci 29:454-64 (2008)", "doi": "10.1016/j.tips.2008.06.007"}, {"pmid": "16896947", "authors": "  Bockaert J, Claeysen S, Becamel C, Dumuis A, Marin P", "title": "Neuronal 5-HT metabotropic receptors: fine-tuning of their structure, signaling, and roles in synaptic modulation.", "journal": "Cell Tissue Res 326:553-72 (2006)", "doi": "10.1007/s00441-006-0286-1"}, {"pmid": "11916537", "authors": "  Raymond JR, Mukhin YV, Gelasco A, Turner J, Collinsworth G, Gettys TW, Grewal JS, Garnovskaya MN", "title": "Multiplicity of mechanisms of serotonin receptor signal transduction.", "journal": "Pharmacol Ther 92:179-212 (2001)", "doi": "10.1016/S0163-7258(01)00169-3"}, {"pmid": "15034221", "authors": "  Noda M, Higashida H, Aoki S, Wada K", "title": "Multiple signal transduction pathways mediated by 5-HT receptors.", "journal": "Mol Neurobiol 29:31-9 (2004)", "doi": "10.1385/MN:29:1:31"}, {"pmid": "20561690", "authors": "  Daubert EA, Condron BG", "title": "Serotonin: a regulator of neuronal morphology and circuitry.", "journal": "Trends Neurosci 33:424-34 (2010)", "doi": "10.1016/j.tins.2010.05.005"}, {"pmid": "16826372", "authors": "  Chameau P, van Hooft JA", "title": "Serotonin 5-HT(3) receptors in the central nervous system.", "journal": "Cell Tissue Res 326:573-81 (2006)", "doi": "10.1007/s00441-006-0255-8"}, {"pmid": "9651340", "authors": "  Tournois C, Mutel V, Manivet P, Launay JM, Kellermann O", "title": "Cross-talk between 5-hydroxytryptamine receptors in a serotonergic cell line. Involvement of arachidonic acid metabolism.", "journal": "J Biol Chem 273:17498-503 (1998)", "doi": "10.1074/jbc.273.28.17498"}, {"pmid": "19545642", "authors": "  Iliff JJ, Jia J, Nelson J, Goyagi T, Klaus J, Alkayed NJ", "title": "Epoxyeicosanoid signaling in CNS function and disease.", "journal": "Prostaglandins Other Lipid Mediat 91:68-84 (2010)", "doi": "10.1016/j.prostaglandins.2009.06.004"}, {"pmid": "12676358", "authors": "  Adayev T, Ray I, Sondhi R, Sobocki T, Banerjee P", "title": "The G protein-coupled 5-HT1A receptor causes suppression of caspase-3 through MAPK and protein kinase Calpha.", "journal": "Biochim Biophys Acta 1640:85-96 (2003)", "doi": "10.1016/S0167-4889(03)00023-5"}, {"pmid": "11701344", "authors": "  Albert PR, Tiberi M", "title": "Receptor signaling and structure: insights from serotonin-1 receptors.", "journal": "Trends Endocrinol Metab 12:453-60 (2001)", "doi": "10.1016/S1043-2760(01)00498-2"}, {"pmid": "9658404", "authors": "  Durham PL, Russo AF", "title": "Serotonergic repression of mitogen-activated protein kinase control of the calcitonin gene-related peptide enhancer.", "journal": "Mol Endocrinol 12:1002-9 (1998)", "doi": "10.1210/mend.12.7.0135"}, {"pmid": "15710402", "authors": "  Robert S, Maillet M, Morel E, Launay JM, Fischmeister R, Mercken L, Lezoualc'h F", "title": "Regulation of the amyloid precursor protein ectodomain shedding by the 5-HT4 receptor and Epac.", "journal": "FEBS Lett 579:1136-42 (2005)", "doi": "10.1016/j.febslet.2005.01.010"}, {"pmid": "12543273", "authors": "  Lezoualc'h F, Robert SJ", "title": "The serotonin 5-HT4 receptor and the amyloid precursor protein processing.", "journal": "Exp Gerontol 38:159-66 (2003)", "doi": "10.1016/S0531-5565(02)00157-2"}, {"pmid": "11043573", "authors": "  Durham PL, Russo AF", "title": "Differential regulation of mitogen-activated protein kinase-responsive genes by the duration of a calcium signal.", "journal": "Mol Endocrinol 14:1570-82 (2000)", "doi": "10.1210/mend.14.10.0529"}, {"pmid": "9542727", "authors": "  Hagberg GB, Blomstrand F, Nilsson M, Tamir H, Hansson E", "title": "Stimulation of 5-HT2A receptors on astrocytes in primary culture opens voltage-independent Ca2+ channels.", "journal": "Neurochem Int 32:153-62 (1998)", "doi": "10.1016/S0197-0186(97)00087-9"}], "rel_pathway": ["hsa00380  Tryptophan metabolism", "hsa00590  Arachidonic acid metabolism", "hsa04020  Calcium signaling pathway", "hsa04721  Synaptic vesicle cycle", "hsa04976  Bile secretion"], "ko_pathway": "ko04726", "genes": ["BRAF", "NRAS"]}, {"kegg_id": "hsa04730", "name": "Long-term depression - Homo sapiens (human)", "description": "Cerebellar long-term depression (LTD), thought to be a molecular and cellular basis for cerebellar learning, is a process involving a decrease in the synaptic strength between parallel fiber (PF) and Purkinje cells (PCs) induced by the conjunctive activation of PFs and climbing fiber (CF). Multiple signal transduction pathways have been shown to be involved in this process. Activation of PFs terminating on spines in dendritic branchlets leads to glutamate release and activation of both AMPA and mGluRs. Activation of CFs, which make multiple synaptic contacts on proximal dendrites, also via AMPA receptors, opens voltage-gated calcium channels (VGCCs) and causes a generalized influx of calcium. These cellular signals, generated from two different synaptic origins, trigger a cascade of events culminating in a phosphorylation-dependent, long-term reduction in AMPA receptor sensitivity at the PF-PC synapse. This may take place either through receptor internalization and/or through receptor desensitization.", "class": "Organismal Systems; Nervous system", "pathway_map": "hsa04730  Long-term depression", "network": ["", "ELEMENT   N00953  mGluR1-TRPC3 signaling pathway"], "drug": ["D12516  Zagociguat (USAN/INN)"], "dblinks": "GO: 0048169", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["4842  NOS1; nitric oxide synthase 1 [KO:K13240] [EC:1.14.13.39]", "2977  GUCY1A2; guanylate cyclase 1 soluble subunit alpha 2 [KO:K12318] [EC:4.6.1.2]", "2982  GUCY1A1; guanylate cyclase 1 soluble subunit alpha 1 [KO:K12318] [EC:4.6.1.2]", "2983  GUCY1B1; guanylate cyclase 1 soluble subunit beta 1 [KO:K12319] [EC:4.6.1.2]", "5592  PRKG1; protein kinase cGMP-dependent 1 [KO:K07376] [EC:2.7.11.12]", "5593  PRKG2; protein kinase cGMP-dependent 2 [KO:K19477] [EC:2.7.11.12]", "10842  PPP1R17; protein phosphatase 1 regulatory subunit 17 [KO:K08067]", "5519  PPP2R1B; protein phosphatase 2 scaffold subunit Abeta [KO:K03456]", "5518  PPP2R1A; protein phosphatase 2 scaffold subunit Aalpha [KO:K03456]", "5515  PPP2CA; protein phosphatase 2 catalytic subunit alpha [KO:K04382] [EC:3.1.3.16]", "5516  PPP2CB; protein phosphatase 2 catalytic subunit beta [KO:K04382] [EC:3.1.3.16]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "369  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "2895  GRID2; glutamate ionotropic receptor delta type subunit 2 [KO:K05207]", "2911  GRM1; glutamate metabotropic receptor 1 [KO:K04603]", "2770  GNAI1; G protein subunit alpha i1 [KO:K04630]", "2773  GNAI3; G protein subunit alpha i3 [KO:K04630]", "2771  GNAI2; G protein subunit alpha i2 [KO:K04630]", "2775  GNAO1; G protein subunit alpha o1 [KO:K04534]", "2781  GNAZ; G protein subunit alpha z [KO:K04535]", "2778  GNAS; GNAS complex locus [KO:K04632]", "2768  GNA12; G protein subunit alpha 12 [KO:K04346]", "10672  GNA13; G protein subunit alpha 13 [KO:K04639]", "123745  PLA2G4E; phospholipase A2 group IVE [KO:K16342] [EC:3.1.1.4]", "5321  PLA2G4A; phospholipase A2 group IVA [KO:K16342] [EC:3.1.1.4]", "8681  JMJD7-PLA2G4B; JMJD7-PLA2G4B readthrough [KO:K16342] [EC:3.1.1.4]", "100137049  PLA2G4B; phospholipase A2 group IVB [KO:K16342] [EC:3.1.1.4]", "8605  PLA2G4C; phospholipase A2 group IVC [KO:K16342] [EC:3.1.1.4]", "283748  PLA2G4D; phospholipase A2 group IVD [KO:K16342] [EC:3.1.1.4]", "255189  PLA2G4F; phospholipase A2 group IVF [KO:K16342] [EC:3.1.1.4]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "2776  GNAQ; G protein subunit alpha q [KO:K04634]", "2767  GNA11; G protein subunit alpha 11 [KO:K04635]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "2890  GRIA1; glutamate ionotropic receptor AMPA type subunit 1 [KO:K05197]", "2891  GRIA2; glutamate ionotropic receptor AMPA type subunit 2 [KO:K05198]", "2892  GRIA3; glutamate ionotropic receptor AMPA type subunit 3 [KO:K05199]", "4067  LYN; LYN proto-oncogene, Src family tyrosine kinase [KO:K05854] [EC:2.7.10.2]", "773  CACNA1A; calcium voltage-gated channel subunit alpha1 A [KO:K04344]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "6261  RYR1; ryanodine receptor 1 [KO:K04961]", "1392  CRH; corticotropin releasing hormone [KO:K05256]", "1394  CRHR1; corticotropin releasing hormone receptor 1 [KO:K04578]", "3479  IGF1; insulin like growth factor 1 [KO:K05459]", "3480  IGF1R; insulin like growth factor 1 receptor [KO:K05087] [EC:2.7.10.1]"], "compound": ["C00025  L-Glutamate", "C00076  Calcium cation", "C00165  Diacylglycerol", "C00219  Arachidonate", "C00533  Nitric oxide", "C00641  1,2-Diacyl-sn-glycerol", "C00942  3',5'-Cyclic GMP", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C01330  Sodium cation"], "refs": [{"pmid": "12415297", "authors": "  Ito M.", "title": "The molecular organization of cerebellar long-term depression.", "journal": "Nat Rev Neurosci 3:896-902 (2002)", "doi": "10.1038/nrn962"}, {"pmid": "11427694", "authors": "  Ito M.", "title": "Cerebellar long-term depression: characterization, signal transduction, and functional roles.", "journal": "Physiol Rev 81:1143-95 (2001)", "doi": "10.1152/physrev.2001.81.3.1143"}, {"pmid": "9735948", "authors": "  Daniel H, Levenes C, Crepel F.", "title": "Cellular mechanisms of cerebellar LTD.", "journal": "Trends Neurosci 21:401-7 (1998)", "doi": "10.1016/S0166-2236(98)01304-6"}, {"pmid": "9602501", "authors": "  Levenes C, Daniel H, Crepel F.", "title": "Long-term depression of synaptic transmission in the cerebellum: cellular and molecular mechanisms revisited.", "journal": "Prog Neurobiol 55:79-91 (1998)", "doi": "10.1016/S0301-0082(97)00096-8"}], "rel_pathway": ["hsa04020  Calcium signaling pathway", "hsa04724  Glutamatergic synapse"], "ko_pathway": "ko04730", "genes": ["BRAF", "NRAS"]}, {"kegg_id": "hsa04910", "name": "Insulin signaling pathway - Homo sapiens (human)", "description": "Insulin binding to its receptor results in the tyrosine phosphorylation of insulin receptor substrates (IRS) by the insulin receptor tyrosine kinase (INSR). This allows association of IRSs with the regulatory subunit of phosphoinositide 3-kinase (PI3K). PI3K activates 3-phosphoinositide-dependent protein kinase 1 (PDK1), which activates Akt, a serine kinase. Akt in turn deactivates glycogen synthase kinase 3 (GSK-3), leading to activation of glycogen synthase (GYS) and thus glycogen synthesis. Activation of Akt also results in the translocation of GLUT4 vesicles from their intracellular pool to the plasma membrane, where they allow uptake of glucose into the cell. Akt also leads to mTOR-mediated activation of protein synthesis by eIF4 and p70S6K. The translocation of GLUT4 protein is also elicited through the CAP/Cbl/TC10 pathway, once Cbl is phosphorylated by INSR.\nOther signal transduction proteins interact with IRS including GRB2. GRB2 is part of the cascade including SOS, RAS, RAF and MEK that leads to activation of mitogen-activated protein kinase (MAPK) and mitogenic responses in the form of gene transcription. SHC is another substrate of INSR. When tyrosine phosphorylated, SHC associates with GRB2 and can thus activate the RAS/MAPK pathway independently of IRS-1.", "class": "Organismal Systems; Endocrine system", "pathway_map": "hsa04910  Insulin signaling pathway", "network": ["", "ELEMENT   N01708  INS-AKT signaling pathway"], "drug": ["D00085  Insulin (JAN/USP)", "D00595  Buformin (USAN/INN)", "D00944  Metformin hydrochloride (JP18/USP)", "D01238  Bucladesine sodium (JAN)", "D01896  Cilostazol (JP18/USP/INN)", "D02206  Buformin hydrochloride (JP18)", "D03230  Insulin human (USP/INN)", "D03250  Insulin glargine (USAN/INN)", "D04050  Ertiprotafib (USAN/INN)", "D04475  Insulin aspart (USP/INN)", "D04477  Insulin lispro (USP/INN)", "D04537  Ingliforib (USAN/INN)", "D04539  Insulin detemir (USAN/INN)", "D04540  Insulin glulisine (USAN/INN)", "D04541  Insulin human, isophane (USP)", "D04542  Insulin human zinc (USP)", "D04543  Insulin human zinc, extended (USP)", "D04544  Insulin I 125 (USAN)", "D04545  Insulin I 131 (USAN)", "D04546  Insulin, dalanated (USAN)", "D04547  Insulin, isophane (USP)", "D04548  Insulin, neutral (USAN)", "D04549  Insulin zinc, extended (USP)", "D04550  Insulin zinc, prompt (USP)", "D04551  Insulin zinc (USP)", "D04966  Metformin (USAN/INN)", "D05622  Proinsulin human (USAN)", "D07546  Bucladesine (INN)", "D08080  Insulin injection, biphasic isophane (BAN)", "D08351  Phenformin (BAN)", "D08352  Phenformin hydrochloride", "D09727  Insulin degludec (USAN/INN)", "D10473  Insulin peglispro (USAN/INN)", "D11034  Insulin glargine and lixisenatide", "D11567  Insulin degludec and liraglutide", "D11640  Firsocostat (USAN/INN)", "D11902  Clesacostat (USAN)", "D11903  Clesacostat tromethamine (USAN)", "D12304  Elraglusib (USAN)", "D12358  Insulin icodec (USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["3630  INS; insulin [KO:K04526]", "3643  INSR; insulin receptor [KO:K04527] [EC:2.7.10.1]", "3667  IRS1; insulin receptor substrate 1 [KO:K16172]", "8660  IRS2; insulin receptor substrate 2 [KO:K07187]", "8471  IRS4; insulin receptor substrate 4 [KO:K17446]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5170  PDPK1; 3-phosphoinositide dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "2998  GYS2; glycogen synthase 2 [KO:K00693] [EC:2.4.1.11]", "2997  GYS1; glycogen synthase 1 [KO:K00693] [EC:2.4.1.11]", "5499  PPP1CA; protein phosphatase 1 catalytic subunit alpha [KO:K06269] [EC:3.1.3.16]", "5500  PPP1CB; protein phosphatase 1 catalytic subunit beta [KO:K06269] [EC:3.1.3.16]", "5501  PPP1CC; protein phosphatase 1 catalytic subunit gamma [KO:K06269] [EC:3.1.3.16]", "5506  PPP1R3A; protein phosphatase 1 regulatory subunit 3A [KO:K07189]", "5507  PPP1R3C; protein phosphatase 1 regulatory subunit 3C [KO:K07189]", "5509  PPP1R3D; protein phosphatase 1 regulatory subunit 3D [KO:K07189]", "79660  PPP1R3B; protein phosphatase 1 regulatory subunit 3B [KO:K07189]", "90673  PPP1R3E; protein phosphatase 1 regulatory subunit 3E [KO:K07189]", "89801  PPP1R3F; protein phosphatase 1 regulatory subunit 3F [KO:K17453]", "5260  PHKG1; phosphorylase kinase catalytic subunit gamma 1 [KO:K00871] [EC:2.7.11.19]", "5261  PHKG2; phosphorylase kinase catalytic subunit gamma 2 [KO:K00871] [EC:2.7.11.19]", "5257  PHKB; phosphorylase kinase regulatory subunit beta [KO:K07190]", "5256  PHKA2; phosphorylase kinase regulatory subunit alpha 2 [KO:K07190]", "5255  PHKA1; phosphorylase kinase regulatory subunit alpha 1 [KO:K07190]", "810  CALML3; calmodulin like 3 [KO:K02183]", "805  CALM2; calmodulin 2 [KO:K02183]", "808  CALM3; calmodulin 3 [KO:K02183]", "801  CALM1; calmodulin 1 [KO:K02183]", "163688  CALML6; calmodulin like 6 [KO:K02183]", "51806  CALML5; calmodulin like 5 [KO:K02183]", "91860  CALML4; calmodulin like 4 [KO:K02183]", "5836  PYGL; glycogen phosphorylase L [KO:K00688] [EC:2.4.1.1]", "5837  PYGM; glycogen phosphorylase, muscle associated [KO:K00688] [EC:2.4.1.1]", "5834  PYGB; glycogen phosphorylase B [KO:K00688] [EC:2.4.1.1]", "5140  PDE3B; phosphodiesterase 3B [KO:K13296] [EC:3.1.4.17]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "5573  PRKAR1A; protein kinase cAMP-dependent type I regulatory subunit alpha [KO:K04739]", "5576  PRKAR2A; protein kinase cAMP-dependent type II regulatory subunit alpha [KO:K04739]", "5577  PRKAR2B; protein kinase cAMP-dependent type II regulatory subunit beta [KO:K04739]", "5575  PRKAR1B; protein kinase cAMP-dependent type I regulatory subunit beta [KO:K04739]", "3991  LIPE; lipase E, hormone sensitive type [KO:K07188] [EC:3.1.1.79]", "5590  PRKCZ; protein kinase C zeta [KO:K18952] [EC:2.7.11.13]", "5584  PRKCI; protein kinase C iota [KO:K06069] [EC:2.7.11.13]", "6517  SLC2A4; solute carrier family 2 member 4 [KO:K07191]", "2319  FLOT2; flotillin 2 [KO:K07192]", "10211  FLOT1; flotillin 1 [KO:K07192]", "10603  SH2B2; SH2B adaptor protein 2 [KO:K07193]", "10580  SORBS1; sorbin and SH3 domain containing 1 [KO:K06086]", "867  CBL; Cbl proto-oncogene [KO:K04707] [EC:2.3.2.27]", "868  CBLB; Cbl proto-oncogene B [KO:K22517] [EC:2.3.2.27]", "1398  CRK; CRK proto-oncogene, adaptor protein [KO:K04438]", "1399  CRKL; CRK like proto-oncogene, adaptor protein [KO:K04438]", "2889  RAPGEF1; Rap guanine nucleotide exchange factor 1 [KO:K06277]", "23433  RHOQ; ras homolog family member Q [KO:K07194]", "23265  EXOC7; exocyst complex component 7 [KO:K07195]", "9322  TRIP10; thyroid hormone receptor interactor 10 [KO:K07196]", "6720  SREBF1; sterol regulatory element binding transcription factor 1 [KO:K07197]", "31  ACACA; acetyl-CoA carboxylase alpha [KO:K11262] [EC:6.4.1.2 6.3.4.14 2.1.3.15]", "32  ACACB; acetyl-CoA carboxylase beta [KO:K01946] [EC:6.4.1.2 6.3.4.14 2.1.3.15]", "2194  FASN; fatty acid synthase [KO:K00665] [EC:2.3.1.85]", "5313  PKLR; pyruvate kinase L/R [KO:K12406] [EC:2.7.1.40]", "3101  HK3; hexokinase 3 [KO:K00844] [EC:2.7.1.1]", "3098  HK1; hexokinase 1 [KO:K00844] [EC:2.7.1.1]", "3099  HK2; hexokinase 2 [KO:K00844] [EC:2.7.1.1]", "80201  HKDC1; hexokinase domain containing 1 [KO:K00844] [EC:2.7.1.1]", "2645  GCK; glucokinase [KO:K12407] [EC:2.7.1.2]", "5562  PRKAA1; protein kinase AMP-activated catalytic subunit alpha 1 [KO:K07198] [EC:2.7.11.31]", "5563  PRKAA2; protein kinase AMP-activated catalytic subunit alpha 2 [KO:K07198] [EC:2.7.11.31]", "5564  PRKAB1; protein kinase AMP-activated non-catalytic subunit beta 1 [KO:K07199]", "5565  PRKAB2; protein kinase AMP-activated non-catalytic subunit beta 2 [KO:K07199]", "5571  PRKAG1; protein kinase AMP-activated non-catalytic subunit gamma 1 [KO:K07200]", "53632  PRKAG3; protein kinase AMP-activated non-catalytic subunit gamma 3 [KO:K07200]", "51422  PRKAG2; protein kinase AMP-activated non-catalytic subunit gamma 2 [KO:K07200]", "2308  FOXO1; forkhead box O1 [KO:K07201]", "10891  PPARGC1A; PPARG coactivator 1 alpha [KO:K07202]", "2538  G6PC1; glucose-6-phosphatase catalytic subunit 1 [KO:K01084] [EC:3.1.3.9]", "57818  G6PC2; glucose-6-phosphatase catalytic subunit 2 [KO:K01084] [EC:3.1.3.9]", "92579  G6PC3; glucose-6-phosphatase catalytic subunit 3 [KO:K01084] [EC:3.1.3.9]", "2203  FBP1; fructose-bisphosphatase 1 [KO:K03841] [EC:3.1.3.11]", "8789  FBP2; fructose-bisphosphatase 2 [KO:K03841] [EC:3.1.3.11]", "5105  PCK1; phosphoenolpyruvate carboxykinase 1 [KO:K01596] [EC:4.1.1.32]", "5106  PCK2; phosphoenolpyruvate carboxykinase 2, mitochondrial [KO:K01596] [EC:4.1.1.32]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "57521  RPTOR; regulatory associated protein of MTOR complex 1 [KO:K07204]", "6198  RPS6KB1; ribosomal protein S6 kinase B1 [KO:K04688] [EC:2.7.11.1]", "6199  RPS6KB2; ribosomal protein S6 kinase B2 [KO:K04688] [EC:2.7.11.1]", "6194  RPS6; ribosomal protein S6 [KO:K02991]", "1978  EIF4EBP1; eukaryotic translation initiation factor 4E binding protein 1 [KO:K07205]", "1977  EIF4E; eukaryotic translation initiation factor 4E [KO:K03259]", "9470  EIF4E2; eukaryotic translation initiation factor 4E family member 2 [KO:K03259]", "253314  EIF4E1B; eukaryotic translation initiation factor 4E family member 1B [KO:K03259]", "7248  TSC1; TSC complex subunit 1 [KO:K07206]", "7249  TSC2; TSC complex subunit 2 [KO:K07207]", "6009  RHEB; Ras homolog, mTORC1 binding [KO:K07208]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]", "6464  SHC1; SHC adaptor protein 1 [KO:K06279]", "25759  SHC2; SHC adaptor protein 2 [KO:K17447]", "53358  SHC3; SHC adaptor protein 3 [KO:K17448]", "399694  SHC4; SHC adaptor protein 4 [KO:K17449]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "369  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "8569  MKNK1; MAPK interacting serine/threonine kinase 1 [KO:K04372] [EC:2.7.11.1]", "2872  MKNK2; MAPK interacting serine/threonine kinase 2 [KO:K04372] [EC:2.7.11.1]", "2002  ELK1; ETS transcription factor ELK1 [KO:K04375]", "8651  SOCS1; suppressor of cytokine signaling 1 [KO:K04694]", "8835  SOCS2; suppressor of cytokine signaling 2 [KO:K04695]", "9021  SOCS3; suppressor of cytokine signaling 3 [KO:K04696]", "122809  SOCS4; suppressor of cytokine signaling 4 [KO:K04697]", "5770  PTPN1; protein tyrosine phosphatase non-receptor type 1 [KO:K05696] [EC:3.1.3.48]", "5792  PTPRF; protein tyrosine phosphatase receptor type F [KO:K05695] [EC:3.1.3.48]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "3636  INPPL1; inositol polyphosphate phosphatase like 1 [KO:K15909] [EC:3.1.3.86]", "3632  INPP5A; inositol polyphosphate-5-phosphatase A [KO:K01106] [EC:3.1.3.56]"], "compound": ["C00031  D-Glucose", "C00369  Starch", "C00575  3',5'-Cyclic AMP", "C05981  Phosphatidylinositol-3,4,5-trisphosphate"], "refs": [{"pmid": "12867054", "authors": "  Kanzaki M, Pessin JE.", "title": "Insulin signaling: GLUT4 vesicles exit via the exocyst.", "journal": "Curr Biol 13:R574-6 (2003)", "doi": "10.1016/S0960-9822(03)00478-0"}, {"pmid": "10196204", "authors": "  Moodie SA, Alleman-Sposeto J, Gustafson TA.", "title": "Identification of the APS protein as a novel insulin receptor substrate.", "journal": "J Biol Chem 274:11186-93 (1999)", "doi": "10.1074/jbc.274.16.11186"}, {"pmid": "15733744", "authors": "  Gual P, Le Marchand-Brustel Y, Tanti JF.", "title": "Positive and negative regulation of insulin signaling through IRS-1 phosphorylation.", "journal": "Biochimie 87:99-109 (2005)", "doi": "10.1016/j.biochi.2004.10.019"}, {"pmid": "9748166", "authors": "  Le Good JA, Ziegler WH, Parekh DB, Alessi DR, Cohen P, Parker PJ.", "title": "Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1.", "journal": "Science 281:2042-5 (1998)", "doi": "10.1126/science.281.5385.2042"}, {"pmid": "11742412", "authors": "  Saltiel AR, Kahn CR.", "title": "Insulin signalling and the regulation of glucose and lipid metabolism.", "journal": "Nature 414:799-806 (2001)", "doi": "10.1038/414799a"}, {"pmid": "15624019", "authors": "  Inoki K, Corradetti MN, Guan KL.", "title": "Dysregulation of the TSC-mTOR pathway in human disease.", "journal": "Nat Genet 37:19-24 (2005)", "doi": "10.1038/ng1494"}, {"pmid": "16288289", "authors": "  Ruggero D, Sonenberg N.", "title": "The Akt of translational control.", "journal": "Oncogene 24:7426-34 (2005)", "doi": "10.1038/sj.onc.1209098"}, {"pmid": "10567225", "authors": "  Nave BT, Ouwens M, Withers DJ, Alessi DR, Shepherd PR.", "title": "Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation.", "journal": "Biochem J 344 Pt 2:427-31 (1999)", "doi": "10.1042/bj3440427"}, {"pmid": "9445476", "authors": "  Pullen N, Dennis PB, Andjelkovic M, Dufner A, Kozma SC, Hemmings BA, Thomas G.", "title": "Phosphorylation and activation of p70s6k by PDK1.", "journal": "Science 279:707-10 (1998)", "doi": "10.1126/science.279.5351.707"}, {"pmid": "15229476", "authors": "  Pollak MN, Schernhammer ES, Hankinson SE.", "title": "Insulin-like growth factors and neoplasia.", "journal": "Nat Rev Cancer 4:505-18 (2004)", "doi": "10.1038/nrc1387"}, {"pmid": "9346240", "authors": "  Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME.", "title": "Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery.", "journal": "Cell 91:231-41 (1997)", "doi": "10.1016/S0092-8674(00)80405-5"}, {"pmid": "17344645", "authors": "  Ferre P, Foufelle F", "title": "SREBP-1c transcription factor and lipid homeostasis: clinical perspective.", "journal": "Horm Res 68:72-82 (2007)", "doi": "10.1159/000100426"}, {"pmid": "18291668", "authors": "  Raghow R, Yellaturu C, Deng X, Park EA, Elam MB", "title": "SREBPs: the crossroads of physiological and pathological lipid homeostasis.", "journal": "Trends Endocrinol Metab 19:65-73 (2008)", "doi": "10.1016/j.tem.2007.10.009"}, {"pmid": "11343120", "authors": "  Clement S, Krause U, Desmedt F, Tanti JF, Behrends J, Pesesse X, Sasaki T, Penninger J, Doherty M, Malaisse W, Dumont JE, Le Marchand-Brustel Y, Erneux C, Hue L, Schurmans S", "title": "The lipid phosphatase SHIP2 controls insulin sensitivity.", "journal": "Nature 409:92-7 (2001)", "doi": "10.1038/35051094"}], "rel_pathway": ["hsa00010  Glycolysis / Gluconeogenesis", "hsa00061  Fatty acid biosynthesis", "hsa00500  Starch and sucrose metabolism", "hsa04010  MAPK signaling pathway", "hsa04070  Phosphatidylinositol signaling system", "hsa04210  Apoptosis"], "ko_pathway": "ko04910", "genes": ["BRAF", "AKT2", "AKT1", "SOS1", "NRAS"]}, {"kegg_id": "hsa04914", "name": "Progesterone-mediated oocyte maturation - Homo sapiens (human)", "description": "Xenopus oocytes are naturally arrested at G2 of meiosis I. Exposure to either insulin/IGF-1 or the steroid hormone progesterone breaks this arrest and induces resumption of the two meiotic division cycles and maturation of the oocyte into a mature, fertilizable egg. This process is termed oocyte maturation. The transition is accompanied by an increase in maturation promoting factor (MPF or Cdc2/cyclin B) which precedes germinal vesicle breakdown (GVBD). Most reports point towards the Mos-MEK1-ERK2 pathway [where ERK is an extracellular signal-related protein kinase, MEK is a MAPK/ERK kinase and Mos is a p42(MAPK) activator] and the polo-like kinase/CDC25 pathway as responsible for the activation of MPF in meiosis, most likely triggered by a decrease in cAMP.", "class": "Organismal Systems; Endocrine system", "pathway_map": "hsa04914  Progesterone-mediated oocyte maturation", "drug": ["D00066  Progesterone (JP18/USP/INN)", "D00182  Norethindrone (USP)", "D00289  Danazol (JP18/USP/INN)", "D00585  Mifepristone (JAN/USAN/INN)", "D00949  Hydroxyprogesterone caproate (JAN/USP/INN)", "D00950  Levonorgestrel (JAN/USP/INN)", "D00951  Medroxyprogesterone acetate (JP18/USP)", "D00952  Megestrol acetate (USP)", "D00953  Norethindrone acetate (USP)", "D00954  Norgestrel (JP18/USP/INN)", "D01159  Gestonorone caproate (JAN/USAN)", "D01217  Dydrogesterone (JP18/USP/INN)", "D01294  Ethynodiol diacetate (JAN/USP)", "D01299  Chlormadinone acetate (JP18/USAN)", "D01374  Allylestrenol (JAN/INN)", "D01580  Lynestrenol (JAN/USAN)", "D02367  Desogestrel (USAN/INN)", "D02996  Asoprisnil (USAN/INN)", "D03799  Dienogest (JAN/USAN/INN)", "D03917  Drospirenone (JAN/USP/INN)", "D04104  Etonogestrel (USAN/INN)", "D04315  Gestaclone (USAN/INN)", "D04316  Gestodene (USAN/INN)", "D04885  Medrogestone (USAN/INN)", "D05003  Methynodiol diacetate (USAN)", "D05009  Metogest (USAN/INN)", "D05205  Norelgestromin (USP/INN)", "D05207  Norethynodrel (USAN)", "D05209  Norgestimate (USP/INN)", "D05308  Oxogestone phenpropionate (USAN)", "D05679  Quingestanol acetate (USAN)", "D05680  Quingestrone (USAN/INN)", "D06003  Tanaproget (USAN/INN)", "D06145  Tigestol (USAN/INN)", "D06197  Tosagestin (USAN/INN)", "D06235  Trimegestone (USAN/INN)", "D07096  Aglepristone (INN)", "D07220  Norgestrienone (INN)", "D07222  Nomegestrol (USAN/INN)", "D07223  Demegestone (INN)", "D07670  Chlormadinone (INN)", "D07939  Etynodiol (INN)", "D07968  Flugestone (INN)", "D08052  Hydroxyprogesterone (INN)", "D08053  Hydroxyprogesterone 17alfa-acetate", "D08166  Medroxyprogesterone (INN)", "D08167  Megestrol (INN)", "D08281  Nomegestrol acetate (USAN)", "D08285  Norethisterone enantate", "D08431  Promegestone (INN)", "D09567  Ulipristal (USAN/INN)", "D09571  Onapristone (INN)", "D09687  Ulipristal acetate (JAN/USAN)", "D09972  Telapristone acetate (USAN)", "D10986  Segesterone acetate (USAN)", "D10987  Segesterone (USAN/INN)", "D11181  Vilaprisan (JAN/USAN/INN)", "D12736  Lunresertib (USAN)"], "dblinks": "GO: 0001556", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["5241  PGR; progesterone receptor [KO:K08556]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "2770  GNAI1; G protein subunit alpha i1 [KO:K04630]", "2773  GNAI3; G protein subunit alpha i3 [KO:K04630]", "2771  GNAI2; G protein subunit alpha i2 [KO:K04630]", "107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]", "108  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]", "109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]", "196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]", "113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]", "114  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]", "115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "6790  AURKA; aurora kinase A [KO:K11481] [EC:2.7.11.1]", "64506  CPEB1; cytoplasmic polyadenylation element binding protein 1 [KO:K02602]", "132864  CPEB2; cytoplasmic polyadenylation element binding protein 2 [KO:K02602]", "22849  CPEB3; cytoplasmic polyadenylation element binding protein 3 [KO:K02602]", "80315  CPEB4; cytoplasmic polyadenylation element binding protein 4 [KO:K02602]", "245711  SPDYA; speedy/RINGO cell cycle regulator family member A [KO:K08694]", "387778  SPDYC; speedy/RINGO cell cycle regulator family member C [KO:K08694]", "100310812  SPDYE2B; speedy/RINGO cell cycle regulator family member E2B [KO:K08694]", "100505767  SPDYE18; speedy/RINGO cell cycle regulator family member E18 [KO:K08694]", "100996746  SPDYE11; speedy/RINGO cell cycle regulator family member E11 [KO:K08694]", "102723555  SPDYE16; speedy/RINGO cell cycle regulator family member E16 [KO:K08694]", "102723849  SPDYE17; speedy/RINGO cell cycle regulator family member E17 [KO:K08694]", "285955  SPDYE1; speedy/RINGO cell cycle regulator family member E1 [KO:K08694]", "388333  SPDYE4; speedy/RINGO cell cycle regulator family member E4 [KO:K08694]", "441272  SPDYE3; speedy/RINGO cell cycle regulator family member E3 [KO:K08694]", "441273  SPDYE2; speedy/RINGO cell cycle regulator family member E2 [KO:K08694]", "442590  SPDYE5; speedy/RINGO cell cycle regulator family member E5 [KO:K08694]", "729597  SPDYE6; speedy/RINGO cell cycle regulator family member E6 [KO:K08694]", "105180391  SPDYE15; speedy/RINGO cell cycle regulator family member E15 [KO:K08694]", "100101268  SPDYE12; speedy/RINGO cell cycle regulator family member E12 [KO:K08694]", "124906603  putative speedy protein E9 [KO:K08694]", "643862  SPDYE10; speedy/RINGO cell cycle regulator family member E10 [KO:K08694]", "643909  SPDYE9; speedy/RINGO cell cycle regulator family member E9 [KO:K08694]", "728524  SPDYE8; speedy/RINGO cell cycle regulator family member E8 [KO:K08694]", "105180390  SPDYE13; speedy/RINGO cell cycle regulator family member E13 [KO:K08694]", "641776  SPDYE14; speedy/RINGO cell cycle regulator family member E14 [KO:K08694]", "1017  CDK2; cyclin dependent kinase 2 [KO:K02206] [EC:2.7.11.22]", "983  CDK1; cyclin dependent kinase 1 [KO:K02087] [EC:2.7.11.22 2.7.11.23]", "890  CCNA2; cyclin A2 [KO:K06627]", "8900  CCNA1; cyclin A1 [KO:K06627]", "4342  MOS; MOS proto-oncogene, serine/threonine kinase [KO:K04367] [EC:2.7.11.1]", "3320  HSP90AA1; heat shock protein 90 alpha family class A member 1 [KO:K04079]", "3326  HSP90AB1; heat shock protein 90 alpha family class B member 1 [KO:K04079]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "6197  RPS6KA3; ribosomal protein S6 kinase A3 [KO:K04373] [EC:2.7.11.1]", "6195  RPS6KA1; ribosomal protein S6 kinase A1 [KO:K04373] [EC:2.7.11.1]", "6196  RPS6KA2; ribosomal protein S6 kinase A2 [KO:K04373] [EC:2.7.11.1]", "27330  RPS6KA6; ribosomal protein S6 kinase A6 [KO:K04373] [EC:2.7.11.1]", "9088  PKMYT1; protein kinase, membrane associated tyrosine/threonine 1 [KO:K06633] [EC:2.7.11.1]", "891  CCNB1; cyclin B1 [KO:K05868]", "9133  CCNB2; cyclin B2 [KO:K21770]", "85417  CCNB3; cyclin B3 [KO:K21771]", "6793  STK10; serine/threonine kinase 10 [KO:K08837] [EC:2.7.11.1]", "5347  PLK1; polo like kinase 1 [KO:K06631] [EC:2.7.11.21]", "993  CDC25A; cell division cycle 25A [KO:K06645] [EC:3.1.3.48]", "994  CDC25B; cell division cycle 25B [KO:K05866] [EC:3.1.3.48]", "995  CDC25C; cell division cycle 25C [KO:K05867] [EC:3.1.3.48]", "3630  INS; insulin [KO:K04526]", "3479  IGF1; insulin like growth factor 1 [KO:K05459]", "3480  IGF1R; insulin like growth factor 1 receptor [KO:K05087] [EC:2.7.10.1]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "5140  PDE3B; phosphodiesterase 3B [KO:K13296] [EC:3.1.4.17]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "369  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "699  BUB1; BUB1 mitotic checkpoint serine/threonine kinase [KO:K02178] [EC:2.7.11.1]", "8379  MAD1L1; mitotic arrest deficient 1 like 1 [KO:K06679]", "4085  MAD2L1; mitotic arrest deficient 2 like 1 [KO:K02537]", "10459  MAD2L2; mitotic arrest deficient 2 like 2 [KO:K13728]", "51343  FZR1; fizzy and cell division cycle 20 related 1 [KO:K03364]", "64682  ANAPC1; anaphase promoting complex subunit 1 [KO:K03348]", "29882  ANAPC2; anaphase promoting complex subunit 2 [KO:K03349]", "996  CDC27; cell division cycle 27 [KO:K03350]", "29945  ANAPC4; anaphase promoting complex subunit 4 [KO:K03351]", "51433  ANAPC5; anaphase promoting complex subunit 5 [KO:K03352]", "8881  CDC16; cell division cycle 16 [KO:K03353]", "51434  ANAPC7; anaphase promoting complex subunit 7 [KO:K03354]", "8697  CDC23; cell division cycle 23 [KO:K03355]", "10393  ANAPC10; anaphase promoting complex subunit 10 [KO:K03357]", "51529  ANAPC11; anaphase promoting complex subunit 11 [KO:K03358]", "246184  CDC26; cell division cycle 26 [KO:K03359]", "25847  ANAPC13; anaphase promoting complex subunit 13 [KO:K12456]", "25906  ANAPC15; anaphase promoting complex subunit 15 [KO:K25228]", "119504  ANAPC16; anaphase promoting complex subunit 16 [KO:K25229]", "3835  KIF22; kinesin family member 22 [KO:K10403]"], "compound": ["C00410  Progesterone", "C00575  3',5'-Cyclic AMP", "C05981  Phosphatidylinositol-3,4,5-trisphosphate", "C11554  1-Phosphatidyl-1D-myo-inositol 3,4-bisphosphate"], "refs": [{"pmid": "12084906", "authors": "  Cato AC, Nestl A, Mink S.", "title": "Rapid actions of steroid receptors in cellular signaling pathways.", "journal": "Sci STKE 2002:RE9 (2002)", "doi": "10.1126/stke.2002.138.re9"}, {"pmid": "11730319", "authors": "  Maller JL, Schwab MS, Roberts BT, Gross SD, Taieb FE, Tunquist BJ.", "title": "The pathway of MAP kinase mediation of CSF arrest in Xenopus oocytes.", "journal": "Biol Cell 93:27-33 (2001)", "doi": "10.1016/S0248-4900(01)01127-3"}, {"pmid": "11063930", "authors": "  Nebreda AR, Ferby I.", "title": "Regulation of the meiotic cell cycle in oocytes.", "journal": "Curr Opin Cell Biol 12:666-75 (2000)", "doi": "10.1016/S0955-0674(00)00150-2"}, {"pmid": "10497333", "authors": "  Ferrell JE Jr.", "title": "Xenopus oocyte maturation: new lessons from a good egg.", "journal": "Bioessays 21:833-42 (1999)", "doi": "10.1002/(SICI)1521-1878(199910)21:10<833::AID-BIES5>3.0.CO;2-P"}, {"pmid": "12374568", "authors": "  Andersen CB, Sakaue H, Nedachi T, Kovacina KS, Clayberger C, Conti M, Roth RA.", "title": "Protein kinase B/Akt is essential for the insulin- but not progesterone-stimulated resumption of meiosis in Xenopus oocytes.", "journal": "Biochem J 369:227-38 (2003)", "doi": "10.1042/BJ20021243"}, {"pmid": "12477927", "authors": "  Duckworth BC, Weaver JS, Ruderman JV.", "title": "G2 arrest in Xenopus oocytes depends on phosphorylation of cdc25 by protein kinase A.", "journal": "Proc Natl Acad Sci U S A 99:16794-9 (2002)", "doi": "10.1073/pnas.222661299"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04110  Cell cycle"], "ko_pathway": "ko04914", "genes": ["BRAF", "AKT2", "AKT1", "MAPK13"]}, {"kegg_id": "hsa05010", "name": "Alzheimer disease - Homo sapiens (human)", "description": "Alzheimer disease (AD) is a chronic disorder that slowly destroys neurons and causes serious cognitive disability. AD is associated with senile plaques and neurofibrillary tangles (NFTs). Amyloid-beta (Abeta), a major component of senile plaques, has various pathological effects on cell and organelle function. To date genetic studies have revealed four genes that may be linked to autosomal dominant or familial early onset AD (FAD). These four genes include: amyloid precursor protein (APP), presenilin 1 (PS1), presenilin 2 (PS2) and apolipoprotein E (ApoE). All mutations associated with APP and PS proteins can lead to an increase in the production of Abeta peptides, specfically the more amyloidogenic form, Abeta42. It was proposed that Abeta form Ca2+ permeable pores and bind to and modulate multiple synaptic proteins, including NMDAR, mGluR5 and VGCC, leading to the overfilling of neurons with calcium ions. Consequently, cellular Ca2+ disruptions will lead to neuronal apoptosis, autophagy deficits, mitochondrial abnormality, defective neurotransmission, impaired synaptic plasticity and neurodegeneration in AD. FAD-linked PS1 mutation downregulates the unfolded protein response and leads to vulnerability to ER stress.", "class": "Human Diseases; Neurodegenerative disease", "pathway_map": "hsa05010  Alzheimer disease", "network": ["", "ELEMENT   N00996  Mutation-caused aberrant Abeta to AGE-RAGE signaling pathway", "N00997  Mutation-caused aberrant Abeta to electron transfer in Complex I", "N00999  Mutation-caused aberrant Abeta to electron transfer in Complex IV", "N01001  Mutation-caused aberrant Abeta to mAchR-Ca2+ -apoptotic pathway", "N01002  Mutation-caused aberrant Abeta to mGluR5-Ca2+ -apoptotic pathway", "N01003  Mutation-caused aberrant Abeta to transport of calcium", "N01004  Mutation-caused aberrant Abeta to VGCC-Ca2+ -apoptotic pathway", "N01005  Mutation-caused aberrant Abeta to crosstalk between extrinsic and intrinsic apoptotic pathways", "N01006  Mutation-caused aberrant Abeta to VGCC-Ca2+ -apoptotic pathway", "N01007  Mutation-caused aberrant PSEN to mGluR5-Ca2+ -apoptotic pathway", "N01008  Mutation-caused aberrant PSEN1 to mGluR5-Ca2+ -apoptotic pathway", "N01010  Mutation-caused aberrant PSEN1 to PERK-ATF4 signaling pathway", "N01012  Mutation-caused aberrant PSEN1 to IRE1a-XBP1 signaling pathway", "N01014  Mutation-caused aberrant Abeta to IRE1a-JNK signaling pathway", "N01016  Mutation-caused aberrant PSEN1 to ATF6-mediated transcription", "N01017  Mutation-caused aberrant PSEN1 to anterograde axonal transport", "N01018  Mutation-caused aberrant Abeta to anterograde axonal transport", "N01060  Mutation-caused aberrant Abeta to 26S proteasome-mediated protein degradation", "N01402  Manganese to electron transfer in Complex II", "N01403  Zn to anterograde axonal transport", "N01414  Iron to anterograde axonal transport", "N01416  Mercury to NEP-mediated Abeta degradation"], "disease": ["H00056  Alzheimer disease"], "drug": ["D04905  Memantine hydrochloride (JAN/USP)", "D08174  Memantine (INN)", "D08869  Begacestat (USAN/INN)", "D09010  Tarenflurbil (USAN/INN)", "D09377  Semagacestat (USAN/INN)", "D09869  Avagacestat (USAN)", "D10739  Verubecestat (JAN/USAN/INN)", "D10946  Lanabecestat (USAN/INN)", "D10947  Lanabecestat camsylate (USAN)", "D11210  Flortaucipir F 18 (USAN)", "D11293  Gosuranemab (USAN)", "D11384  Hydromethylthionine mesylate (USAN)", "D11427  Hydromethylthionine (USAN/INN)", "D11456  Atabecestat (USAN/INN)", "D11509  Elenbecestat (JAN/USAN)", "D11533  Zagotenemab (USAN)", "D11687  Semorinemab (USAN/INN)", "D11690  Umibecestat (USAN/INN)", "D11840  Tilavonemab (USAN/INN)", "D12228  Bepranemab (USAN/INN)", "D12553  Nevadistinel (USAN)", "D12636  Posdinemab (USAN/INN)", "D12848  Etalanetug (USAN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["102  ADAM10; ADAM metallopeptidase domain 10 [KO:K06704] [EC:3.4.24.81]", "6868  ADAM17; ADAM metallopeptidase domain 17 [KO:K06059] [EC:3.4.24.86]", "351  APP; amyloid beta precursor protein [KO:K04520]", "8883  NAE1; NEDD8 activating enzyme E1 subunit 1 [KO:K04532]", "322  APBB1; amyloid beta precursor protein binding family B member 1 [KO:K04529]", "2597  GAPDH; glyceraldehyde-3-phosphate dehydrogenase [KO:K00134] [EC:1.2.1.12]", "23621  BACE1; beta-secretase 1 [KO:K04521] [EC:3.4.23.46]", "25825  BACE2; beta-secretase 2 [KO:K07747] [EC:3.4.23.45]", "10313  RTN3; reticulon 3 [KO:K20723]", "57142  RTN4; reticulon 4 [KO:K20720]", "55851  PSENEN; presenilin enhancer, gamma-secretase subunit [KO:K06170]", "5663  PSEN1; presenilin 1 [KO:K04505] [EC:3.4.23.-]", "5664  PSEN2; presenilin 2 [KO:K04522] [EC:3.4.23.-]", "23385  NCSTN; nicastrin [KO:K06171]", "51107  APH1A; aph-1 homolog A, gamma-secretase subunit [KO:K06172]", "83464  APH1B; aph-1 homolog B, gamma-secretase subunit [KO:K06172]", "3416  IDE; insulin degrading enzyme [KO:K01408] [EC:3.4.24.56]", "4311  MME; membrane metalloendopeptidase [KO:K01389] [EC:3.4.24.11]", "4137  MAPT; microtubule associated protein tau [KO:K04380]", "4535  ND1; NADH dehydrogenase subunit 1 [KO:K03878] [EC:7.1.1.2]", "4536  ND2; NADH dehydrogenase subunit 2 [KO:K03879] [EC:7.1.1.2]", "4537  ND3; NADH dehydrogenase subunit 3 [KO:K03880] [EC:7.1.1.2]", "4538  ND4; NADH dehydrogenase subunit 4 [KO:K03881] [EC:7.1.1.2]", "4539  ND4L; NADH dehydrogenase subunit 4L [KO:K03882] [EC:7.1.1.2]", "4540  ND5; NADH dehydrogenase subunit 5 [KO:K03883] [EC:7.1.1.2]", "4541  ND6; NADH dehydrogenase subunit 6 [KO:K03884] [EC:7.1.1.2]", "4723  NDUFV1; NADH:ubiquinone oxidoreductase core subunit V1 [KO:K03942] [EC:7.1.1.2]", "4729  NDUFV2; NADH:ubiquinone oxidoreductase core subunit V2 [KO:K03943] [EC:7.1.1.2]", "4731  NDUFV3; NADH:ubiquinone oxidoreductase subunit V3 [KO:K03944]", "4694  NDUFA1; NADH:ubiquinone oxidoreductase subunit A1 [KO:K03945]", "4695  NDUFA2; NADH:ubiquinone oxidoreductase subunit A2 [KO:K03946]", "4696  NDUFA3; NADH:ubiquinone oxidoreductase subunit A3 [KO:K03947]", "4697  NDUFA4; NDUFA4 mitochondrial complex associated [KO:K03948]", "56901  NDUFA4L2; NDUFA4 mitochondrial complex associated like 2 [KO:K03948]", "4698  NDUFA5; NADH:ubiquinone oxidoreductase subunit A5 [KO:K03949]", "4700  NDUFA6; NADH:ubiquinone oxidoreductase subunit A6 [KO:K03950]", "4701  NDUFA7; NADH:ubiquinone oxidoreductase subunit A7 [KO:K03951]", "4702  NDUFA8; NADH:ubiquinone oxidoreductase subunit A8 [KO:K03952]", "4704  NDUFA9; NADH:ubiquinone oxidoreductase subunit A9 [KO:K03953]", "4705  NDUFA10; NADH:ubiquinone oxidoreductase subunit A10 [KO:K03954]", "4706  NDUFAB1; NADH:ubiquinone oxidoreductase subunit AB1 [KO:K03955]", "126328  NDUFA11; NADH:ubiquinone oxidoreductase subunit A11 [KO:K03956]", "55967  NDUFA12; NADH:ubiquinone oxidoreductase subunit A12 [KO:K11352]", "51079  NDUFA13; NADH:ubiquinone oxidoreductase subunit A13 [KO:K11353]", "4707  NDUFB1; NADH:ubiquinone oxidoreductase subunit B1 [KO:K03957]", "4708  NDUFB2; NADH:ubiquinone oxidoreductase subunit B2 [KO:K03958]", "4709  NDUFB3; NADH:ubiquinone oxidoreductase subunit B3 [KO:K03959]", "4710  NDUFB4; NADH:ubiquinone oxidoreductase subunit B4 [KO:K03960]", "4711  NDUFB5; NADH:ubiquinone oxidoreductase subunit B5 [KO:K03961]", "4712  NDUFB6; NADH:ubiquinone oxidoreductase subunit B6 [KO:K03962]", "4713  NDUFB7; NADH:ubiquinone oxidoreductase subunit B7 [KO:K03963]", "4714  NDUFB8; NADH:ubiquinone oxidoreductase subunit B8 [KO:K03964]", "4715  NDUFB9; NADH:ubiquinone oxidoreductase subunit B9 [KO:K03965]", "4716  NDUFB10; NADH:ubiquinone oxidoreductase subunit B10 [KO:K03966]", "54539  NDUFB11; NADH:ubiquinone oxidoreductase subunit B11 [KO:K11351]", "4719  NDUFS1; NADH:ubiquinone oxidoreductase core subunit S1 [KO:K03934] [EC:7.1.1.2]", "4720  NDUFS2; NADH:ubiquinone oxidoreductase core subunit S2 [KO:K03935] [EC:7.1.1.2]", "4722  NDUFS3; NADH:ubiquinone oxidoreductase core subunit S3 [KO:K03936] [EC:7.1.1.2]", "4724  NDUFS4; NADH:ubiquinone oxidoreductase subunit S4 [KO:K03937]", "4725  NDUFS5; NADH:ubiquinone oxidoreductase subunit S5 [KO:K03938]", "4726  NDUFS6; NADH:ubiquinone oxidoreductase subunit S6 [KO:K03939]", "374291  NDUFS7; NADH:ubiquinone oxidoreductase core subunit S7 [KO:K03940] [EC:7.1.1.2]", "4728  NDUFS8; NADH:ubiquinone oxidoreductase core subunit S8 [KO:K03941] [EC:7.1.1.2]", "4717  NDUFC1; NADH:ubiquinone oxidoreductase subunit C1 [KO:K03967]", "4718  NDUFC2; NADH:ubiquinone oxidoreductase subunit C2 [KO:K03968]", "100532726  NDUFC2-KCTD14; NDUFC2-KCTD14 readthrough [KO:K03968]", "6389  SDHA; succinate dehydrogenase complex flavoprotein subunit A [KO:K00234] [EC:1.3.5.1]", "6390  SDHB; succinate dehydrogenase complex iron sulfur subunit B [KO:K00235] [EC:1.3.5.1]", "6391  SDHC; succinate dehydrogenase complex subunit C [KO:K00236]", "6392  SDHD; succinate dehydrogenase complex subunit D [KO:K00237]", "7386  UQCRFS1; ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 [KO:K00411] [EC:7.1.1.8]", "4519  CYTB; cytochrome b [KO:K00412]", "1537  CYC1; cytochrome c1 [KO:K00413]", "7384  UQCRC1; ubiquinol-cytochrome c reductase core protein 1 [KO:K00414]", "7385  UQCRC2; ubiquinol-cytochrome c reductase core protein 2 [KO:K00415]", "7388  UQCRH; ubiquinol-cytochrome c reductase hinge protein [KO:K00416]", "440567  UQCRHL; ubiquinol-cytochrome c reductase hinge protein like [KO:K00416]", "7381  UQCRB; ubiquinol-cytochrome c reductase binding protein [KO:K00417]", "27089  UQCRQ; ubiquinol-cytochrome c reductase complex III subunit VII [KO:K00418]", "29796  UQCR10; ubiquinol-cytochrome c reductase, complex III subunit X [KO:K00419]", "10975  UQCR11; ubiquinol-cytochrome c reductase, complex III subunit XI [KO:K00420]", "4514  COX3; cytochrome c oxidase subunit III [KO:K02262]", "4512  COX1; cytochrome c oxidase subunit I [KO:K02256] [EC:7.1.1.9]", "4513  COX2; cytochrome c oxidase subunit II [KO:K02261]", "84701  COX4I2; cytochrome c oxidase subunit 4I2 [KO:K02263]", "1327  COX4I1; cytochrome c oxidase subunit 4I1 [KO:K02263]", "9377  COX5A; cytochrome c oxidase subunit 5A [KO:K02264]", "1329  COX5B; cytochrome c oxidase subunit 5B [KO:K02265]", "1337  COX6A1; cytochrome c oxidase subunit 6A1 [KO:K02266]", "1339  COX6A2; cytochrome c oxidase subunit 6A2 [KO:K02266]", "1340  COX6B1; cytochrome c oxidase subunit 6B1 [KO:K02267]", "125965  COX6B2; cytochrome c oxidase subunit 6B2 [KO:K02267]", "1345  COX6C; cytochrome c oxidase subunit 6C [KO:K02268]", "1346  COX7A1; cytochrome c oxidase subunit 7A1 [KO:K02270]", "1347  COX7A2; cytochrome c oxidase subunit 7A2 [KO:K02270]", "9167  COX7A2L; cytochrome c oxidase subunit 7A2 like [KO:K02270]", "1349  COX7B; cytochrome c oxidase subunit 7B [KO:K02271]", "170712  COX7B2; cytochrome c oxidase subunit 7B2 [KO:K02271]", "1350  COX7C; cytochrome c oxidase subunit 7C [KO:K02272]", "341947  COX8C; cytochrome c oxidase subunit 8C [KO:K02273]", "1351  COX8A; cytochrome c oxidase subunit 8A [KO:K02273]", "498  ATP5F1A; ATP synthase F1 subunit alpha [KO:K02132]", "506  ATP5F1B; ATP synthase F1 subunit beta [KO:K02133] [EC:7.1.2.2]", "509  ATP5F1C; ATP synthase F1 subunit gamma [KO:K02136]", "513  ATP5F1D; ATP synthase F1 subunit delta [KO:K02134]", "514  ATP5F1E; ATP synthase F1 subunit epsilon [KO:K02135]", "4508  ATP6; ATP synthase F0 subunit 6 [KO:K02126]", "515  ATP5PB; ATP synthase peripheral stalk-membrane subunit b [KO:K02127]", "516  ATP5MC1; ATP synthase membrane subunit c locus 1 [KO:K02128]", "517  ATP5MC2; ATP synthase membrane subunit c locus 2 [KO:K02128]", "518  ATP5MC3; ATP synthase membrane subunit c locus 3 [KO:K02128]", "10476  ATP5PD; ATP synthase peripheral stalk subunit d [KO:K02138]", "539  ATP5PO; ATP synthase peripheral stalk subunit OSCP [KO:K02137]", "522  ATP5PF; ATP synthase peripheral stalk subunit F6 [KO:K02131]", "4509  ATP8; ATP synthase F0 subunit 8 [KO:K02125]", "3028  HSD17B10; hydroxysteroid 17-beta dehydrogenase 10 [KO:K08683] [EC:1.1.1.35 1.1.1.178]", "5481  PPID; peptidylprolyl isomerase D [KO:K05864] [EC:5.2.1.8]", "7416  VDAC1; voltage dependent anion channel 1 [KO:K05862]", "7417  VDAC2; voltage dependent anion channel 2 [KO:K15040]", "7419  VDAC3; voltage dependent anion channel 3 [KO:K15041]", "291  SLC25A4; solute carrier family 25 member 4 [KO:K05863]", "292  SLC25A5; solute carrier family 25 member 5 [KO:K05863]", "293  SLC25A6; solute carrier family 25 member 6 [KO:K05863]", "83447  SLC25A31; solute carrier family 25 member 31 [KO:K05863]", "10105  PPIF; peptidylprolyl isomerase F [KO:K09565] [EC:5.2.1.8]", "4023  LPL; lipoprotein lipase [KO:K01059] [EC:3.1.1.34]", "348  APOE; apolipoprotein E [KO:K04524]", "4035  LRP1; LDL receptor related protein 1 [KO:K04550]", "355  FAS; Fas cell surface death receptor [KO:K04390]", "7132  TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158]", "8772  FADD; Fas associated via death domain [KO:K02373]", "841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]", "637  BID; BH3 interacting domain death agonist [KO:K04726]", "810  CALML3; calmodulin like 3 [KO:K02183]", "805  CALM2; calmodulin 2 [KO:K02183]", "808  CALM3; calmodulin 3 [KO:K02183]", "801  CALM1; calmodulin 1 [KO:K02183]", "163688  CALML6; calmodulin like 6 [KO:K02183]", "51806  CALML5; calmodulin like 5 [KO:K02183]", "91860  CALML4; calmodulin like 4 [KO:K02183]", "5530  PPP3CA; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]", "5532  PPP3CB; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]", "5533  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]", "5534  PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]", "5535  PPP3R2; protein phosphatase 3 regulatory subunit B, beta [KO:K06268]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]", "54205  CYCS; cytochrome c, somatic [KO:K08738]", "317  APAF1; apoptotic peptidase activating factor 1 [KO:K02084]", "842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "1128  CHRM1; cholinergic receptor muscarinic 1 [KO:K04129]", "1131  CHRM3; cholinergic receptor muscarinic 3 [KO:K04131]", "1133  CHRM5; cholinergic receptor muscarinic 5 [KO:K04133]", "2915  GRM5; glutamate metabotropic receptor 5 [KO:K04604]", "2776  GNAQ; G protein subunit alpha q [KO:K04634]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "2902  GRIN1; glutamate ionotropic receptor NMDA type subunit 1 [KO:K05208]", "2903  GRIN2A; glutamate ionotropic receptor NMDA type subunit 2A [KO:K05209]", "2904  GRIN2B; glutamate ionotropic receptor NMDA type subunit 2B [KO:K05210]", "2905  GRIN2C; glutamate ionotropic receptor NMDA type subunit 2C [KO:K05211]", "2906  GRIN2D; glutamate ionotropic receptor NMDA type subunit 2D [KO:K05212]", "775  CACNA1C; calcium voltage-gated channel subunit alpha1 C [KO:K04850]", "776  CACNA1D; calcium voltage-gated channel subunit alpha1 D [KO:K04851]", "778  CACNA1F; calcium voltage-gated channel subunit alpha1 F [KO:K04853]", "779  CACNA1S; calcium voltage-gated channel subunit alpha1 S [KO:K04857]", "1139  CHRNA7; cholinergic receptor nicotinic alpha 7 subunit [KO:K04809]", "90550  MCU; mitochondrial calcium uniporter [KO:K20858]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "6263  RYR3; ryanodine receptor 3 [KO:K04963]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "487  ATP2A1; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 [KO:K05853] [EC:7.2.2.10]", "489  ATP2A3; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 [KO:K05853] [EC:7.2.2.10]", "488  ATP2A2; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 [KO:K05853] [EC:7.2.2.10]", "22926  ATF6; activating transcription factor 6 [KO:K09054]", "7494  XBP1; X-box binding protein 1 [KO:K09027]", "1649  DDIT3; DNA damage inducible transcript 3 [KO:K04452]", "2081  ERN1; endoplasmic reticulum to nucleus signaling 1 [KO:K08852] [EC:2.7.11.1 3.1.26.-]", "9451  EIF2AK3; eukaryotic translation initiation factor 2 alpha kinase 3 [KO:K08860] [EC:2.7.11.1]", "7186  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]", "4217  MAP3K5; mitogen-activated protein kinase kinase kinase 5 [KO:K04426] [EC:2.7.11.25]", "5609  MAP2K7; mitogen-activated protein kinase kinase 7 [KO:K04431] [EC:2.7.12.2]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "1965  EIF2S1; eukaryotic translation initiation factor 2 subunit alpha [KO:K03237]", "468  ATF4; activating transcription factor 4 [KO:K04374]", "5687  PSMA6; proteasome 20S subunit alpha 6 [KO:K02730] [EC:3.4.25.1]", "5683  PSMA2; proteasome 20S subunit alpha 2 [KO:K02726] [EC:3.4.25.1]", "5685  PSMA4; proteasome 20S subunit alpha 4 [KO:K02728] [EC:3.4.25.1]", "5688  PSMA7; proteasome 20S subunit alpha 7 [KO:K02731] [EC:3.4.25.1]", "143471  PSMA8; proteasome 20S subunit alpha 8 [KO:K02731] [EC:3.4.25.1]", "5686  PSMA5; proteasome 20S subunit alpha 5 [KO:K02729] [EC:3.4.25.1]", "5682  PSMA1; proteasome 20S subunit alpha 1 [KO:K02725] [EC:3.4.25.1]", "5684  PSMA3; proteasome 20S subunit alpha 3 [KO:K02727] [EC:3.4.25.1]", "5694  PSMB6; proteasome 20S subunit beta 6 [KO:K02738] [EC:3.4.25.1]", "5695  PSMB7; proteasome 20S subunit beta 7 [KO:K02739] [EC:3.4.25.1]", "5691  PSMB3; proteasome 20S subunit beta 3 [KO:K02735] [EC:3.4.25.1]", "5690  PSMB2; proteasome 20S subunit beta 2 [KO:K02734] [EC:3.4.25.1]", "5693  PSMB5; proteasome 20S subunit beta 5 [KO:K02737] [EC:3.4.25.1]", "5689  PSMB1; proteasome 20S subunit beta 1 [KO:K02732] [EC:3.4.25.1]", "5692  PSMB4; proteasome 20S subunit beta 4 [KO:K02736] [EC:3.4.25.1]", "5701  PSMC2; proteasome 26S subunit, ATPase 2 [KO:K03061]", "5700  PSMC1; proteasome 26S subunit, ATPase 1 [KO:K03062]", "5704  PSMC4; proteasome 26S subunit, ATPase 4 [KO:K03063]", "5706  PSMC6; proteasome 26S subunit, ATPase 6 [KO:K03064]", "5702  PSMC3; proteasome 26S subunit, ATPase 3 [KO:K03065]", "5705  PSMC5; proteasome 26S subunit, ATPase 5 [KO:K03066]", "5708  PSMD2; proteasome 26S subunit ubiquitin receptor, non-ATPase 2 [KO:K03028]", "5707  PSMD1; proteasome 26S subunit, non-ATPase 1 [KO:K03032]", "5709  PSMD3; proteasome 26S subunit, non-ATPase 3 [KO:K03033]", "5715  PSMD9; proteasome 26S subunit, non-ATPase 9 [KO:K06693]", "5718  PSMD12; proteasome 26S subunit, non-ATPase 12 [KO:K03035]", "5717  PSMD11; proteasome 26S subunit, non-ATPase 11 [KO:K03036]", "9861  PSMD6; proteasome 26S subunit, non-ATPase 6 [KO:K03037]", "5713  PSMD7; proteasome 26S subunit, non-ATPase 7 [KO:K03038]", "5719  PSMD13; proteasome 26S subunit, non-ATPase 13 [KO:K03039]", "5710  PSMD4; proteasome 26S subunit ubiquitin receptor, non-ATPase 4 [KO:K03029]", "10213  PSMD14; proteasome 26S subunit, non-ATPase 14 [KO:K03030]", "5714  PSMD8; proteasome 26S subunit, non-ATPase 8 [KO:K03031]", "11047  ADRM1; ADRM1 26S proteasome ubiquitin receptor [KO:K06691]", "7979  SEM1; SEM1 26S proteasome subunit [KO:K10881]", "100506742  CASP12; caspase 12 (gene/pseudogene) [KO:K04741] [EC:3.4.22.-]", "4842  NOS1; nitric oxide synthase 1 [KO:K13240] [EC:1.14.13.39]", "823  CAPN1; calpain 1 [KO:K01367] [EC:3.4.22.52]", "824  CAPN2; calpain 2 [KO:K03853] [EC:3.4.22.53]", "8851  CDK5R1; cyclin dependent kinase 5 regulatory subunit 1 [KO:K11716]", "29986  SLC39A2; solute carrier family 39 member 2 [KO:K14709]", "29985  SLC39A3; solute carrier family 39 member 3 [KO:K14709]", "27173  SLC39A1; solute carrier family 39 member 1 [KO:K14709]", "55630  SLC39A4; solute carrier family 39 member 4 [KO:K14710]", "283375  SLC39A5; solute carrier family 39 member 5 [KO:K14711]", "25800  SLC39A6; solute carrier family 39 member 6 [KO:K14712]", "7922  SLC39A7; solute carrier family 39 member 7 [KO:K14713]", "64116  SLC39A8; solute carrier family 39 member 8 [KO:K14714]", "55334  SLC39A9; solute carrier family 39 member 9 [KO:K14715]", "57181  SLC39A10; solute carrier family 39 member 10 [KO:K14716]", "201266  SLC39A11; solute carrier family 39 member 11 [KO:K14717]", "221074  SLC39A12; solute carrier family 39 member 12 [KO:K14718]", "91252  SLC39A13; solute carrier family 39 member 13 [KO:K14719]", "23516  SLC39A14; solute carrier family 39 member 14 [KO:K14720]", "4891  SLC11A2; solute carrier family 11 member 2 [KO:K21398]", "1020  CDK5; cyclin dependent kinase 5 [KO:K02090] [EC:2.7.11.22]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "840  CASP7; caspase 7 [KO:K04397] [EC:3.4.22.60]", "22943  DKK1; dickkopf WNT signaling pathway inhibitor 1 [KO:K02165]", "27123  DKK2; dickkopf WNT signaling pathway inhibitor 2 [KO:K02165]", "27121  DKK4; dickkopf WNT signaling pathway inhibitor 4 [KO:K02165]", "7471  WNT1; Wnt family member 1 [KO:K03209]", "7472  WNT2; Wnt family member 2 [KO:K00182]", "7482  WNT2B; Wnt family member 2B [KO:K00182]", "7473  WNT3; Wnt family member 3 [KO:K00312]", "89780  WNT3A; Wnt family member 3A [KO:K00312]", "54361  WNT4; Wnt family member 4 [KO:K00408]", "7474  WNT5A; Wnt family member 5A [KO:K00444]", "81029  WNT5B; Wnt family member 5B [KO:K00444]", "7475  WNT6; Wnt family member 6 [KO:K00445]", "7476  WNT7A; Wnt family member 7A [KO:K00572]", "7477  WNT7B; Wnt family member 7B [KO:K00572]", "7478  WNT8A; Wnt family member 8A [KO:K00714]", "7479  WNT8B; Wnt family member 8B [KO:K00714]", "7483  WNT9A; Wnt family member 9A [KO:K01064]", "7484  WNT9B; Wnt family member 9B [KO:K01064]", "7480  WNT10B; Wnt family member 10B [KO:K01357]", "80326  WNT10A; Wnt family member 10A [KO:K01357]", "7481  WNT11; Wnt family member 11 [KO:K01384]", "51384  WNT16; Wnt family member 16 [KO:K01558]", "8321  FZD1; frizzled class receptor 1 [KO:K02432]", "8324  FZD7; frizzled class receptor 7 [KO:K02432]", "2535  FZD2; frizzled class receptor 2 [KO:K02235]", "7976  FZD3; frizzled class receptor 3 [KO:K02329]", "8322  FZD4; frizzled class receptor 4 [KO:K02354]", "7855  FZD5; frizzled class receptor 5 [KO:K02375]", "8325  FZD8; frizzled class receptor 8 [KO:K02375]", "8323  FZD6; frizzled class receptor 6 [KO:K02376]", "11211  FZD10; frizzled class receptor 10 [KO:K02842]", "8326  FZD9; frizzled class receptor 9 [KO:K02842]", "4041  LRP5; LDL receptor related protein 5 [KO:K03068]", "4040  LRP6; LDL receptor related protein 6 [KO:K03068]", "1454  CSNK1E; casein kinase 1 epsilon [KO:K08960] [EC:2.7.11.1]", "102800317  TPTEP2-CSNK1E; TPTEP2-CSNK1E readthrough [KO:K08960] [EC:2.7.11.1]", "1857  DVL3; dishevelled segment polarity protein 3 [KO:K02353]", "1856  DVL2; dishevelled segment polarity protein 2 [KO:K02353]", "1855  DVL1; dishevelled segment polarity protein 1 [KO:K02353]", "10023  FRAT1; FRAT regulator of WNT signaling pathway 1 [KO:K03069]", "23401  FRAT2; FRAT regulator of WNT signaling pathway 2 [KO:K03096]", "1457  CSNK2A1; casein kinase 2 alpha 1 [KO:K03097] [EC:2.7.11.1]", "1459  CSNK2A2; casein kinase 2 alpha 2 [KO:K03097] [EC:2.7.11.1]", "283106  CSNK2A3; casein kinase 2 alpha 3 [KO:K03097] [EC:2.7.11.1]", "1460  CSNK2B; casein kinase 2 beta [KO:K03115]", "8312  AXIN1; axin 1 [KO:K02157]", "8313  AXIN2; axin 2 [KO:K04385]", "324  APC; APC regulator of WNT signaling pathway [KO:K02085]", "10297  APC2; APC regulator of WNT signaling pathway 2 [KO:K02085]", "1499  CTNNB1; catenin beta 1 [KO:K02105]", "122011  CSNK1A1L; casein kinase 1 alpha 1 like [KO:K08957] [EC:2.7.11.1]", "1452  CSNK1A1; casein kinase 1 alpha 1 [KO:K08957] [EC:2.7.11.1]", "3798  KIF5A; kinesin family member 5A [KO:K10396]", "3799  KIF5B; kinesin family member 5B [KO:K10396]", "3800  KIF5C; kinesin family member 5C [KO:K10396]", "147700  KLC3; kinesin light chain 3 [KO:K10407]", "3831  KLC1; kinesin light chain 1 [KO:K10407]", "64837  KLC2; kinesin light chain 2 [KO:K10407]", "89953  KLC4; kinesin light chain 4 [KO:K10407]", "10376  TUBA1B; tubulin alpha 1b [KO:K07374]", "7277  TUBA4A; tubulin alpha 4a [KO:K07374]", "7278  TUBA3C; tubulin alpha 3c [KO:K07374]", "7846  TUBA1A; tubulin alpha 1a [KO:K07374]", "84790  TUBA1C; tubulin alpha 1c [KO:K07374]", "51807  TUBA8; tubulin alpha 8 [KO:K07374]", "112714  TUBA3E; tubulin alpha 3e [KO:K07374]", "113457  TUBA3D; tubulin alpha 3d [KO:K07374]", "79861  TUBAL3; tubulin alpha like 3 [KO:K07374]", "84617  TUBB6; tubulin beta 6 class V [KO:K07375]", "203068  TUBB; tubulin beta class I [KO:K07375]", "81027  TUBB1; tubulin beta 1 class VI [KO:K07375]", "7280  TUBB2A; tubulin beta 2A class IIa [KO:K07375]", "10381  TUBB3; tubulin beta 3 class III [KO:K07375]", "10382  TUBB4A; tubulin beta 4A class IVa [KO:K07375]", "347688  TUBB8; tubulin beta 8 class VIII [KO:K07375]", "347733  TUBB2B; tubulin beta 2B class IIb [KO:K07375]", "10383  TUBB4B; tubulin beta 4B class IVb [KO:K07375]", "177  AGER; advanced glycosylation end-product specific receptor [KO:K19722]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "369  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "27035  NOX1; NADPH oxidase 1 [KO:K08008]", "1536  CYBB; cytochrome b-245 beta chain [KO:K21421] [EC:1.-.-.-]", "50507  NOX4; NADPH oxidase 4 [KO:K21423] [EC:1.6.3.-]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "4843  NOS2; nitric oxide synthase 2 [KO:K13241] [EC:1.14.13.39]", "5743  PTGS2; prostaglandin-endoperoxide synthase 2 [KO:K11987] [EC:1.14.99.1]", "7124  TNF; tumor necrosis factor [KO:K03156]", "3569  IL6; interleukin 6 [KO:K05405]", "3552  IL1A; interleukin 1 alpha [KO:K04383]", "3553  IL1B; interleukin 1 beta [KO:K04519]", "1435  CSF1; colony stimulating factor 1 [KO:K05453]", "6622  SNCA; synuclein alpha [KO:K04528]", "5610  EIF2AK2; eukaryotic translation initiation factor 2 alpha kinase 2 [KO:K16195] [EC:2.7.11.1]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "3630  INS; insulin [KO:K04526]", "3643  INSR; insulin receptor [KO:K04527] [EC:2.7.10.1]", "3667  IRS1; insulin receptor substrate 1 [KO:K16172]", "8660  IRS2; insulin receptor substrate 2 [KO:K07187]", "8471  IRS4; insulin receptor substrate 4 [KO:K17446]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "8408  ULK1; unc-51 like autophagy activating kinase 1 [KO:K21357] [EC:2.7.11.1]", "9706  ULK2; unc-51 like autophagy activating kinase 2 [KO:K08269] [EC:2.7.11.1]", "60673  ATG101; autophagy related 101 [KO:K19730]", "9776  ATG13; autophagy related 13 [KO:K08331]", "9821  RB1CC1; RB1 inducible coiled-coil 1 [KO:K17589]", "55626  AMBRA1; autophagy and beclin 1 regulator 1 [KO:K17985]", "8678  BECN1; beclin 1 [KO:K08334]", "441925  BECN2; beclin 2 [KO:K08334]", "30849  PIK3R4; phosphoinositide-3-kinase regulatory subunit 4 [KO:K08333] [EC:2.7.11.1]", "22863  ATG14; autophagy related 14 [KO:K17889]", "29982  NRBF2; nuclear receptor binding factor 2 [KO:K21246]", "5289  PIK3C3; phosphatidylinositol 3-kinase catalytic subunit type 3 [KO:K00914] [EC:2.7.1.137]", "23130  ATG2A; autophagy related 2A [KO:K17906]", "55102  ATG2B; autophagy related 2B [KO:K17906]", "26100  WIPI2; WD repeat domain, phosphoinositide interacting 2 [KO:K17908]", "55062  WIPI1; WD repeat domain, phosphoinositide interacting 1 [KO:K17908]"], "compound": ["C00027  Hydrogen peroxide", "C00038  Zinc cation", "C00070  Copper", "C00076  Calcium cation", "C00533  Nitric oxide", "C00704  Superoxide", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C01319  Hg", "C04549  1-Phosphatidyl-1D-myo-inositol 3-phosphate", "C05981  Phosphatidylinositol-3,4,5-trisphosphate", "C14818  Fe2+", "C16514  Amyloid beta protein 40", "C16515  Amyloid beta protein 42", "C16845  Peroxynitrite", "C19610  Manganese(2+)", "C21011  [Protein]-N(epsilon)-(carboxymethyl)lysine", "C21012  [Protein]-N(epsilon)-(carboxyethyl)lysine", "C21013  [Protein]-pyrraline", "C21014  [Protein]-pentosidine"], "refs": [{"pmid": "15232608", "authors": "  Dickson DW", "title": "Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: cause or effect?", "journal": "J Clin Invest 114:23-7 (2004)", "doi": "10.1172/JCI22317"}, {"pmid": "15750290", "authors": "  Takuma K, Yan SS, Stern DM, Yamada K", "title": "Mitochondrial dysfunction, endoplasmic reticulum stress, and apoptosis in Alzheimer's disease.", "journal": "J Pharmacol Sci 97:312-6 (2005)", "doi": "10.1254/jphs.CPJ04006X"}, {"pmid": "18675468", "authors": "  Bezprozvanny I, Mattson MP", "title": "Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease.", "journal": "Trends Neurosci 31:454-63 (2008)", "doi": "10.1016/j.tins.2008.06.005"}, {"pmid": "9848086", "authors": "  Holscher C", "title": "Possible causes of Alzheimer's disease: amyloid fragments, free radicals, and calcium homeostasis.", "journal": "Neurobiol Dis 5:129-41 (1998)", "doi": "10.1006/nbdi.1998.0193"}, {"pmid": "18035450", "authors": "  Bojarski L, Herms J, Kuznicki J", "title": "Calcium dysregulation in Alzheimer's disease.", "journal": "Neurochem Int 52:621-33 (2008)", "doi": "10.1016/j.neuint.2007.10.002"}, {"pmid": "25450339", "authors": "  Kondratskyi A, Kondratska K, Skryma R, Prevarskaya N", "title": "Ion channels in the regulation of apoptosis.", "journal": "Biochim Biophys Acta 1848:2532-46 (2015)", "doi": "10.1016/j.bbamem.2014.10.030"}, {"pmid": "29890840", "authors": "  Popugaeva E, Pchitskaya E, Bezprozvanny I", "title": "Dysregulation of Intracellular Calcium Signaling in Alzheimer's Disease.", "journal": "Antioxid Redox Signal 29:1176-1188 (2018)", "doi": "10.1089/ars.2018.7506"}, {"pmid": "25767489", "authors": "  Tan Y, Deng Y, Qing H", "title": "Calcium channel blockers and Alzheimer's disease.", "journal": "Neural Regen Res 7:137-40 (2012)", "doi": "10.3969/j.issn.1673-5374.2012.02.010"}, {"pmid": "11484003", "authors": "  Small DH, Mok SS, Bornstein JC", "title": "Alzheimer's disease and Abeta toxicity: from top to bottom.", "journal": "Nat Rev Neurosci 2:595-8 (2001)", "doi": "10.1038/35086072"}, {"pmid": "15177383", "authors": "  Parihar MS, Hemnani T", "title": "Alzheimer's disease pathogenesis and therapeutic interventions.", "journal": "J Clin Neurosci 11:456-67 (2004)", "doi": "10.1016/j.jocn.2003.12.007"}, {"pmid": "17568632", "authors": "  Cowburn RF, Popescu BO, Ankarcrona M, Dehvari N, Cedazo-Minguez A", "title": "Presenilin-mediated signal transduction.", "journal": "Physiol Behav 92:93-7 (2007)", "doi": "10.1016/j.physbeh.2007.05.053"}, {"pmid": "22842534", "authors": "  Honarnejad K, Herms J", "title": "Presenilins: role in calcium homeostasis.", "journal": "Int J Biochem Cell Biol 44:1983-6 (2012)", "doi": "10.1016/j.biocel.2012.07.019"}, {"pmid": "21663966", "authors": "  Supnet C, Bezprozvanny I", "title": "Presenilins function in ER calcium leak and Alzheimer's disease pathogenesis.", "journal": "Cell Calcium 50:303-9 (2011)", "doi": "10.1016/j.ceca.2011.05.013"}, {"pmid": "16677790", "authors": "  Hauptmann S, Keil U, Scherping I, Bonert A, Eckert A, Muller WE", "title": "Mitochondrial dysfunction in sporadic and genetic Alzheimer's disease.", "journal": "Exp Gerontol 41:668-73 (2006)", "doi": "10.1016/j.exger.2006.03.012"}, {"pmid": "14557245", "authors": "  Chen Y, Liu W, McPhie DL, Hassinger L, Neve RL", "title": "APP-BP1 mediates APP-induced apoptosis and DNA synthesis and is increased in Alzheimer's disease brain.", "journal": "J Cell Biol 163:27-33 (2003)", "doi": "10.1083/jcb.200304003"}, {"pmid": "24051203", "authors": "  Eckert A, Nisbet R, Grimm A, Gotz J", "title": "March separate, strike together--role of phosphorylated TAU in mitochondrial dysfunction in Alzheimer's disease.", "journal": "Biochim Biophys Acta 1842:1258-66 (2014)", "doi": "10.1016/j.bbadis.2013.08.013"}, {"pmid": "30741722", "authors": "  Strickland MR, Holtzman DM", "title": "Dr. Jekyll and Mr. Hyde: ApoE explains opposing effects of neuronal LRP1.", "journal": "J Clin Invest 129:969-971 (2019)", "doi": "10.1172/JCI127578"}, {"pmid": "10527810", "authors": "  Ivins KJ, Thornton PL, Rohn TT, Cotman CW", "title": "Neuronal apoptosis induced by beta-amyloid is mediated by caspase-8.", "journal": "Neurobiol Dis 6:440-9 (1999)", "doi": "10.1006/nbdi.1999.0268"}, {"pmid": "31655116", "authors": "  Sushma, Mondal AC", "title": "Role of GPCR signaling and calcium dysregulation in Alzheimer's disease.", "journal": "Mol Cell Neurosci 101:103414 (2019)", "doi": "10.1016/j.mcn.2019.103414"}, {"pmid": "18648507", "authors": "  Sanz-Blasco S, Valero RA, Rodriguez-Crespo I, Villalobos C, Nunez L", "title": "Mitochondrial Ca2+ overload underlies Abeta oligomers neurotoxicity providing an unexpected mechanism of neuroprotection by NSAIDs.", "journal": "PLoS One 3:e2718 (2008)", "doi": "10.1371/journal.pone.0002718"}, {"pmid": "20332425", "authors": "  Mattson MP", "title": "ER calcium and Alzheimer's disease: in a state of flux.", "journal": "Sci Signal 3:pe10 (2010)", "doi": "10.1126/scisignal.3114pe10"}, {"pmid": "16394273", "authors": "  Lee SY, Hwang DY, Kim YK, Lee JW, Shin IC, Oh KW, Lee MK, Lim JS, Yoon DY, Hwang SJ, Hong JT", "title": "PS2 mutation increases neuronal cell vulnerability to neurotoxicants through activation of caspase-3 by enhancing of ryanodine receptor-mediated calcium release.", "journal": "FASEB J 20:151-3 (2006)", "doi": "10.1096/fj.05-4017fje;1"}, {"pmid": "11551913", "authors": "  Katayama T, Imaizumi K, Honda A, Yoneda T, Kudo T, Takeda M, Mori K, Rozmahel R, Fraser P, George-Hyslop PS, Tohyama M", "title": "Disturbed activation of endoplasmic reticulum stress transducers by familial Alzheimer's disease-linked presenilin-1 mutations.", "journal": "J Biol Chem 276:43446-54 (2001)", "doi": "10.1074/jbc.M104096200"}, {"pmid": "28057414", "authors": "  Lane-Donovan C, Herz J", "title": "ApoE, ApoE Receptors, and the Synapse in Alzheimer's Disease.", "journal": "Trends Endocrinol Metab 28:273-284 (2017)", "doi": "10.1016/j.tem.2016.12.001"}, {"pmid": "27994051", "authors": "  Wasser CR, Herz J", "title": "Reelin: Neurodevelopmental Architect and Homeostatic Regulator of Excitatory Synapses.", "journal": "J Biol Chem 292:1330-1338 (2017)", "doi": "10.1074/jbc.R116.766782"}, {"pmid": "21116052", "authors": "  Lilja AM, Porras O, Storelli E, Nordberg A, Marutle A", "title": "Functional interactions of fibrillar and oligomeric amyloid-beta with alpha7 nicotinic receptors in Alzheimer's disease.", "journal": "J Alzheimers Dis 23:335-47 (2011)", "doi": "10.3233/JAD-2010-101242"}, {"pmid": "24847263", "authors": "  Anastasio TJ", "title": "Computational identification of potential multitarget treatments for ameliorating the adverse effects of amyloid-beta on synaptic plasticity.", "journal": "Front Pharmacol 5:85 (2014)", "doi": "10.3389/fphar.2014.00085"}, {"pmid": "29378302", "authors": "  Vargas LM, Cerpa W, Munoz FJ, Zanlungo S, Alvarez AR", "title": "Amyloid-beta oligomers synaptotoxicity: The emerging role of EphA4/c-Abl signaling in Alzheimer's disease.", "journal": "Biochim Biophys Acta Mol Basis Dis 1864:1148-1159 (2018)", "doi": "10.1016/j.bbadis.2018.01.023"}, {"pmid": "25394486", "authors": "  Tu S, Okamoto S, Lipton SA, Xu H", "title": "Oligomeric Abeta-induced synaptic dysfunction in Alzheimer's disease.", "journal": "Mol Neurodegener 9:48 (2014)", "doi": "10.1186/1750-1326-9-48"}, {"pmid": "31191253", "authors": "  Palomer E, Buechler J, Salinas PC", "title": "Wnt Signaling Deregulation in the Aging and Alzheimer's Brain.", "journal": "Front Cell Neurosci 13:227 (2019)", "doi": "10.3389/fncel.2019.00227"}, {"pmid": "27807401", "authors": "  Vallee A, Lecarpentier Y", "title": "Alzheimer Disease: Crosstalk between the Canonical Wnt/Beta-Catenin Pathway and PPARs Alpha and Gamma.", "journal": "Front Neurosci 10:459 (2016)", "doi": "10.3389/fnins.2016.00459"}, {"pmid": "19903023", "authors": "  Origlia N, Arancio O, Domenici L, Yan SS", "title": "MAPK, beta-amyloid and synaptic dysfunction: the role of RAGE.", "journal": "Expert Rev Neurother 9:1635-45 (2009)", "doi": "10.1586/ern.09.107"}, {"pmid": "19464758", "authors": "  Srikanth V, Maczurek A, Phan T, Steele M, Westcott B, Juskiw D, Munch G", "title": "Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.", "journal": "Neurobiol Aging 32:763-77 (2011)", "doi": "10.1016/j.neurobiolaging.2009.04.016"}, {"pmid": "12805290", "authors": "  Pigino G, Morfini G, Pelsman A, Mattson MP, Brady ST, Busciglio J", "title": "Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport.", "journal": "J Neurosci 23:4499-508 (2003)", "doi": "10.1523/JNEUROSCI.23-11-04499.2003"}, {"pmid": "15645263", "authors": "  Roy S, Zhang B, Lee VM, Trojanowski JQ", "title": "Axonal transport defects: a common theme in neurodegenerative diseases.", "journal": "Acta Neuropathol 109:5-13 (2005)", "doi": "10.1007/s00401-004-0952-x"}, {"pmid": "26074767", "authors": "  Ferreira ST, Lourenco MV, Oliveira MM, De Felice FG", "title": "Soluble amyloid-beta oligomers as synaptotoxins leading to cognitive impairment in Alzheimer's disease.", "journal": "Front Cell Neurosci 9:191 (2015)", "doi": "10.3389/fncel.2015.00191"}, {"pmid": "24529521", "authors": "  De Felice FG, Lourenco MV, Ferreira ST", "title": "How does brain insulin resistance develop in Alzheimer's disease?", "journal": "Alzheimers Dement 10:S26-32 (2014)", "doi": "10.1016/j.jalz.2013.12.004"}, {"pmid": "26136647", "authors": "  Bedse G, Di Domenico F, Serviddio G, Cassano T", "title": "Aberrant insulin signaling in Alzheimer's disease: current knowledge.", "journal": "Front Neurosci 9:204 (2015)", "doi": "10.3389/fnins.2015.00204"}], "rel_pathway": ["hsa00190  Oxidative phosphorylation", "hsa03050  Proteasome", "hsa04020  Calcium signaling pathway", "hsa04140  Autophagy - animal", "hsa04141  Protein processing in endoplasmic reticulum", "hsa04210  Apoptosis", "hsa04310  Wnt signaling pathway", "hsa04910  Insulin signaling pathway", "hsa04933  AGE-RAGE signaling pathway in diabetic complications"], "ko_pathway": "ko05010", "genes": ["BRAF", "CSF1", "AKT2", "AKT1", "NRAS"]}, {"kegg_id": "hsa05034", "name": "Alcoholism - Homo sapiens (human)", "description": "Alcoholism, also called dependence on alcohol (ethanol), is a chronic relapsing disorder that is progressive and has serious detrimental health outcomes. As one of the primary mediators of the rewarding effects of alcohol, dopaminergic ventral tegmental area (VTA) projections to the nucleus accumbens (NAc) have been identified. Acute exposure to alcohol stimulates dopamine release into the NAc, which activates D1 receptors, stimulating PKA signaling and subsequent CREB-mediated gene expression, whereas chronic alcohol exposure leads to an adaptive downregulation of this pathway, in particular of CREB function. The decreased CREB function in the NAc may promote the intake of drugs of abuse to achieve an increase in reward and thus may be involved in the regulation of positive affective states of addiction. PKA signaling also affects NMDA receptor activity and may play an important role in neuroadaptation in response to chronic alcohol exposure.", "class": "Human Diseases; Substance dependence", "pathway_map": "hsa05034  Alcoholism", "disease": ["H01611  Alcohol dependence"], "drug": ["D02780  Acamprosate calcium (JAN/USAN)", "D05145  Neramexane mesylate (USAN)", "D07058  Acamprosate (INN)"], "dblinks": "GO: 0045471", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["7054  TH; tyrosine hydroxylase [KO:K00501] [EC:1.14.16.2]", "1644  DDC; dopa decarboxylase [KO:K01593] [EC:4.1.1.28 4.1.1.105]", "6570  SLC18A1; solute carrier family 18 member A1 [KO:K08155]", "6571  SLC18A2; solute carrier family 18 member A2 [KO:K08155]", "4129  MAOB; monoamine oxidase B [KO:K00274] [EC:1.4.3.4]", "4128  MAOA; monoamine oxidase A [KO:K00274] [EC:1.4.3.4]", "6531  SLC6A3; solute carrier family 6 member 3 [KO:K05036]", "2902  GRIN1; glutamate ionotropic receptor NMDA type subunit 1 [KO:K05208]", "2903  GRIN2A; glutamate ionotropic receptor NMDA type subunit 2A [KO:K05209]", "2904  GRIN2B; glutamate ionotropic receptor NMDA type subunit 2B [KO:K05210]", "2905  GRIN2C; glutamate ionotropic receptor NMDA type subunit 2C [KO:K05211]", "2906  GRIN2D; glutamate ionotropic receptor NMDA type subunit 2D [KO:K05212]", "116443  GRIN3A; glutamate ionotropic receptor NMDA type subunit 3A [KO:K05213]", "116444  GRIN3B; glutamate ionotropic receptor NMDA type subunit 3B [KO:K05214]", "3065  HDAC1; histone deacetylase 1 [KO:K06067] [EC:3.5.1.98]", "3066  HDAC2; histone deacetylase 2 [KO:K06067] [EC:3.5.1.98]", "8841  HDAC3; histone deacetylase 3 [KO:K11404] [EC:3.5.1.98]", "9759  HDAC4; histone deacetylase 4 [KO:K11406] [EC:3.5.1.98]", "10014  HDAC5; histone deacetylase 5 [KO:K11406] [EC:3.5.1.98]", "10013  HDAC6; histone deacetylase 6 [KO:K11407] [EC:3.5.1.98]", "51564  HDAC7; histone deacetylase 7 [KO:K11408] [EC:3.5.1.98]", "55869  HDAC8; histone deacetylase 8 [KO:K11405] [EC:3.5.1.98]", "9734  HDAC9; histone deacetylase 9 [KO:K11409] [EC:3.5.1.98]", "83933  HDAC10; histone deacetylase 10 [KO:K18671] [EC:3.5.1.98]", "79885  HDAC11; histone deacetylase 11 [KO:K11418] [EC:3.5.1.98]", "3014  H2AX; H2A.X variant histone [KO:K11251]", "8338  H2AC20; H2A clustered histone 20 [KO:K11251]", "85235  H2AC12; H2A clustered histone 12 [KO:K11251]", "221613  H2AC1; H2A clustered histone 1 [KO:K11251]", "92815  H2AC25; H2A clustered histone 25 [KO:K11251]", "83740  H2AB3; H2A.B variant histone 3 [KO:K11251]", "3012  H2AC8; H2A clustered histone 8 [KO:K11251]", "8335  H2AC4; H2A clustered histone 4 [KO:K11251]", "55506  MACROH2A2; macroH2A.2 histone [KO:K11251]", "9555  MACROH2A1; macroH2A.1 histone [KO:K11251]", "723790  H2AC19; H2A clustered histone 19 [KO:K11251]", "55766  H2AJ; H2A.J histone [KO:K11251]", "474382  H2AB1; H2A.B variant histone 1 [KO:K11251]", "8336  H2AC17; H2A clustered histone 17 [KO:K11251]", "8337  H2AC18; H2A clustered histone 18 [KO:K11251]", "8969  H2AC11; H2A clustered histone 11 [KO:K11251]", "317772  H2AC21; H2A clustered histone 21 [KO:K11251]", "94239  H2AZ2; H2A.Z variant histone 2 [KO:K11251]", "3013  H2AC7; H2A clustered histone 7 [KO:K11251]", "3015  H2AZ1; H2A.Z variant histone 1 [KO:K11251]", "8330  H2AC15; H2A clustered histone 15 [KO:K11251]", "8334  H2AC6; H2A clustered histone 6 [KO:K11251]", "8329  H2AC13; H2A clustered histone 13 [KO:K11251]", "8331  H2AC14; H2A clustered histone 14 [KO:K11251]", "8332  H2AC16; H2A clustered histone 16 [KO:K11251]", "474381  H2AB2; H2A.B variant histone 2 [KO:K11251]", "115482686  H2AL3; H2A.L variant histone 3 [KO:K11251]", "8341  H2BC15; H2B clustered histone 15 [KO:K11252]", "8345  H2BC9; H2B clustered histone 9 [KO:K11252]", "8342  H2BC14; H2B clustered histone 14 [KO:K11252]", "158983  H2BW1; H2B.W histone 1 [KO:K11252]", "255626  H2BC1; H2B clustered histone 1 [KO:K11252]", "440689  H2BC18; H2B clustered histone 18 [KO:K11252]", "8348  H2BC17; H2B clustered histone 17 [KO:K11252]", "3018  H2BC3; H2B clustered histone 3 [KO:K11252]", "8339  H2BC8; H2B clustered histone 8 [KO:K11252]", "8340  H2BC13; H2B clustered histone 13 [KO:K11252]", "8347  H2BC4; H2B clustered histone 4 [KO:K11252]", "3017  H2BC5; H2B clustered histone 5 [KO:K11252]", "8344  H2BC6; H2B clustered histone 6 [KO:K11252]", "8346  H2BC10; H2B clustered histone 10 [KO:K11252]", "8349  H2BC21; H2B clustered histone 21 [KO:K11252]", "8970  H2BC11; H2B clustered histone 11 [KO:K11252]", "85236  H2BC12; H2B clustered histone 12 [KO:K11252]", "128312  H2BC26; H2B clustered histone 26 [KO:K11252]", "8343  H2BC7; H2B clustered histone 7 [KO:K11252]", "286436  H2BW2; H2B.W histone 2 [KO:K11252]", "102724334  histone H2B type F-S-like [KO:K11252]", "114483833  H2BK1; H2B.K variant histone 1 [KO:K11252]", "54145  H2BC12L; H2B clustered histone 12 like [KO:K11252]", "440093  H3-5; H3.5 histone [KO:K11253]", "3021  H3-3B; H3.3 histone B [KO:K11253]", "8351  H3C4; H3 clustered histone 4 [KO:K11253]", "8352  H3C3; H3 clustered histone 3 [KO:K11253]", "8350  H3C1; H3 clustered histone 1 [KO:K11253]", "3020  H3-3A; H3.3 histone A [KO:K11253]", "8290  H3-4; H3.4 histone, cluster member [KO:K11253]", "126961  H3C14; H3 clustered histone 14 [KO:K11253]", "333932  H3C15; H3 clustered histone 15 [KO:K11253]", "653604  H3C13; H3 clustered histone 13 [KO:K11253]", "8353  H3C6; H3 clustered histone 6 [KO:K11253]", "8354  H3C11; H3 clustered histone 11 [KO:K11253]", "8355  H3C8; H3 clustered histone 8 [KO:K11253]", "8356  H3C12; H3 clustered histone 12 [KO:K11253]", "8357  H3C10; H3 clustered histone 10 [KO:K11253]", "8358  H3C2; H3 clustered histone 2 [KO:K11253]", "8968  H3C7; H3 clustered histone 7 [KO:K11253]", "121504  H4C16; H4 histone 16 [KO:K11254]", "554313  H4C15; H4 clustered histone 15 [KO:K11254]", "8294  H4C9; H4 clustered histone 9 [KO:K11254]", "8360  H4C4; H4 clustered histone 4 [KO:K11254]", "8361  H4C6; H4 clustered histone 6 [KO:K11254]", "8362  H4C12; H4 clustered histone 12 [KO:K11254]", "8363  H4C11; H4 clustered histone 11 [KO:K11254]", "8364  H4C3; H4 clustered histone 3 [KO:K11254]", "8365  H4C8; H4 clustered histone 8 [KO:K11254]", "8366  H4C2; H4 clustered histone 2 [KO:K11254]", "8367  H4C5; H4 clustered histone 5 [KO:K11254]", "8368  H4C13; H4 clustered histone 13 [KO:K11254]", "8370  H4C14; H4 clustered histone 14 [KO:K11254]", "8359  H4C1; H4 clustered histone 1 [KO:K11254]", "8369  H4C7; H4 clustered histone 7 [KO:K11254]", "8520  HAT1; histone acetyltransferase 1 [KO:K11303] [EC:2.3.1.48]", "1812  DRD1; dopamine receptor D1 [KO:K04144]", "2778  GNAS; GNAS complex locus [KO:K04632]", "1813  DRD2; dopamine receptor D2 [KO:K04145]", "2770  GNAI1; G protein subunit alpha i1 [KO:K04630]", "2773  GNAI3; G protein subunit alpha i3 [KO:K04630]", "2771  GNAI2; G protein subunit alpha i2 [KO:K04630]", "2775  GNAO1; G protein subunit alpha o1 [KO:K04534]", "2782  GNB1; G protein subunit beta 1 [KO:K04536]", "2783  GNB2; G protein subunit beta 2 [KO:K04537]", "2784  GNB3; G protein subunit beta 3 [KO:K07825]", "59345  GNB4; G protein subunit beta 4 [KO:K04538]", "10681  GNB5; G protein subunit beta 5 [KO:K04539]", "54331  GNG2; G protein subunit gamma 2 [KO:K07826]", "2785  GNG3; G protein subunit gamma 3 [KO:K04540]", "2786  GNG4; G protein subunit gamma 4 [KO:K04541]", "2787  GNG5; G protein subunit gamma 5 [KO:K04542]", "2788  GNG7; G protein subunit gamma 7 [KO:K04543]", "94235  GNG8; G protein subunit gamma 8 [KO:K04544]", "2790  GNG10; G protein subunit gamma 10 [KO:K04545]", "2791  GNG11; G protein subunit gamma 11 [KO:K04546]", "55970  GNG12; G protein subunit gamma 12 [KO:K04347]", "51764  GNG13; G protein subunit gamma 13 [KO:K04547]", "2792  GNGT1; G protein subunit gamma transducin 1 [KO:K04548]", "2793  GNGT2; G protein subunit gamma transducin 2 [KO:K04549]", "55315  SLC29A3; solute carrier family 29 member 3 [KO:K15014]", "2030  SLC29A1; solute carrier family 29 member 1 (Augustine blood group) [KO:K15014]", "3177  SLC29A2; solute carrier family 29 member 2 [KO:K15014]", "135  ADORA2A; adenosine A2a receptor [KO:K04266]", "136  ADORA2B; adenosine A2b receptor [KO:K04267]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]", "1386  ATF2; activating transcription factor 2 [KO:K04450]", "468  ATF4; activating transcription factor 4 [KO:K04374]", "10488  CREB3; cAMP responsive element binding protein 3 [KO:K09048]", "90993  CREB3L1; cAMP responsive element binding protein 3 like 1 [KO:K09048]", "64764  CREB3L2; cAMP responsive element binding protein 3 like 2 [KO:K09048]", "84699  CREB3L3; cAMP responsive element binding protein 3 like 3 [KO:K09048]", "148327  CREB3L4; cAMP responsive element binding protein 3 like 4 [KO:K09048]", "9586  CREB5; cAMP responsive element binding protein 5 [KO:K09047]", "1388  ATF6B; activating transcription factor 6 beta [KO:K09049]", "1392  CRH; corticotropin releasing hormone [KO:K05256]", "4852  NPY; neuropeptide Y [KO:K05232]", "627  BDNF; brain derived neurotrophic factor [KO:K04355]", "4915  NTRK2; neurotrophic receptor tyrosine kinase 2 [KO:K04360] [EC:2.7.10.1]", "6464  SHC1; SHC adaptor protein 1 [KO:K06279]", "25759  SHC2; SHC adaptor protein 2 [KO:K17447]", "53358  SHC3; SHC adaptor protein 3 [KO:K17448]", "399694  SHC4; SHC adaptor protein 4 [KO:K17449]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "369  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]", "673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "5173  PDYN; prodynorphin [KO:K15840]", "810  CALML3; calmodulin like 3 [KO:K02183]", "805  CALM2; calmodulin 2 [KO:K02183]", "808  CALM3; calmodulin 3 [KO:K02183]", "801  CALM1; calmodulin 1 [KO:K02183]", "163688  CALML6; calmodulin like 6 [KO:K02183]", "51806  CALML5; calmodulin like 5 [KO:K02183]", "91860  CALML4; calmodulin like 4 [KO:K02183]", "84254  CAMKK1; calcium/calmodulin dependent protein kinase kinase 1 [KO:K00908] [EC:2.7.11.17]", "10645  CAMKK2; calcium/calmodulin dependent protein kinase kinase 2 [KO:K07359] [EC:2.7.11.17]", "814  CAMK4; calcium/calmodulin dependent protein kinase IV [KO:K05869] [EC:2.7.11.17]", "2354  FOSB; FosB proto-oncogene, AP-1 transcription factor subunit [KO:K09029]", "84152  PPP1R1B; protein phosphatase 1 regulatory inhibitor subunit 1B [KO:K15494]", "5499  PPP1CA; protein phosphatase 1 catalytic subunit alpha [KO:K06269] [EC:3.1.3.16]", "5500  PPP1CB; protein phosphatase 1 catalytic subunit beta [KO:K06269] [EC:3.1.3.16]", "5501  PPP1CC; protein phosphatase 1 catalytic subunit gamma [KO:K06269] [EC:3.1.3.16]", "5569  PKIA; cAMP-dependent protein kinase inhibitor alpha [KO:K15985]"], "compound": ["C00025  L-Glutamate", "C00027  Hydrogen peroxide", "C00076  Calcium cation", "C00082  L-Tyrosine", "C00212  Adenosine", "C00355  3,4-Dihydroxy-L-phenylalanine", "C00469  Ethanol", "C00575  3',5'-Cyclic AMP", "C01161  3,4-Dihydroxyphenylacetate", "C03758  Dopamine"], "refs": [{"pmid": "19342616", "authors": "  Spanagel R", "title": "Alcoholism: a systems approach from molecular physiology to addictive behavior.", "journal": "Physiol Rev 89:649-705 (2009)", "doi": "10.1152/physrev.00013.2008"}, {"pmid": "16102840", "authors": "  Newton PM, Messing RO", "title": "Intracellular signaling pathways that regulate behavioral responses to ethanol.", "journal": "Pharmacol Ther 109:227-37 (2006)", "doi": "10.1016/j.pharmthera.2005.07.004"}, {"pmid": "14729391", "authors": "  Mailliard WS, Diamond I", "title": "Recent advances in the neurobiology of alcoholism: the role of adenosine.", "journal": "Pharmacol Ther 101:39-46 (2004)", "doi": "10.1016/j.pharmthera.2003.10.002"}, {"pmid": "16278489", "authors": "  Ron D, Jurd R", "title": "The \"ups and downs\" of signaling cascades in addiction.", "journal": "Sci STKE 2005:re14 (2005)", "doi": "10.1126/stke.3092005re14"}, {"pmid": "12605085", "authors": "  Diana M, Brodie M, Muntoni A, Puddu MC, Pillolla G, Steffensen S, Spiga S, Little HJ", "title": "Enduring effects of chronic ethanol in the CNS: basis for alcoholism.", "journal": "Alcohol Clin Exp Res 27:354-61 (2003)", "doi": "10.1097/01.ALC.0000057121.36127.19"}, {"pmid": "19756388", "authors": "  Moonat S, Starkman BG, Sakharkar A, Pandey SC", "title": "Neuroscience of alcoholism: molecular and cellular mechanisms.", "journal": "Cell Mol Life Sci 67:73-88 (2010)", "doi": "10.1007/s00018-009-0135-y"}, {"pmid": "15500908", "authors": "  Pandey SC", "title": "The gene transcription factor cyclic AMP-responsive element binding protein: role in positive and negative affective states of alcohol addiction.", "journal": "Pharmacol Ther 104:47-58 (2004)", "doi": "10.1016/j.pharmthera.2004.08.002"}, {"pmid": "16764827", "authors": "  Zhang TA, Maldve RE, Morrisett RA", "title": "Coincident signaling in mesolimbic structures underlying alcohol reinforcement.", "journal": "Biochem Pharmacol 72:919-27 (2006)", "doi": "10.1016/j.bcp.2006.04.022"}, {"pmid": "12068305", "authors": "  Maldve RE, Zhang TA, Ferrani-Kile K, Schreiber SS, Lippmann MJ, Snyder GL, Fienberg AA, Leslie SW, Gonzales RA, Morrisett RA", "title": "DARPP-32 and regulation of the ethanol sensitivity of NMDA receptors in the nucleus accumbens.", "journal": "Nat Neurosci 5:641-8 (2002)", "doi": "10.1038/nn877"}, {"pmid": "12085089", "authors": "  Lovinger DM", "title": "NMDA receptors lose their inhibitions.", "journal": "Nat Neurosci 5:614-6 (2002)", "doi": "10.1038/nn0702-614"}, {"pmid": "16776597", "authors": "  Hyman SE, Malenka RC, Nestler EJ", "title": "Neural mechanisms of addiction: the role of reward-related learning and memory.", "journal": "Annu Rev Neurosci 29:565-98 (2006)", "doi": "10.1146/annurev.neuro.29.051605.113009"}, {"pmid": "10774721", "authors": "  Berke JD, Hyman SE", "title": "Addiction, dopamine, and the molecular mechanisms of memory.", "journal": "Neuron 25:515-32 (2000)", "doi": "10.1016/S0896-6273(00)81056-9"}, {"pmid": "20947635", "authors": "  Jeanes ZM, Buske TR, Morrisett RA", "title": "In vivo chronic intermittent ethanol exposure reverses the polarity of synaptic plasticity in the nucleus accumbens shell.", "journal": "J Pharmacol Exp Ther 336:155-64 (2011)", "doi": "10.1124/jpet.110.171009"}, {"pmid": "18991950", "authors": "  Lee AM, Messing RO", "title": "Protein kinases and addiction.", "journal": "Ann N Y Acad Sci 1141:22-57 (2008)", "doi": "10.1196/annals.1441.022"}, {"pmid": "17270154", "authors": "  Repunte-Canonigo V, Lutjens R, van der Stap LD, Sanna PP", "title": "Increased expression of protein kinase A inhibitor alpha (PKI-alpha) and decreased PKA-regulated genes in chronic intermittent alcohol exposure.", "journal": "Brain Res 1138:48-56 (2007)", "doi": "10.1016/j.brainres.2006.09.115"}, {"pmid": "18310464", "authors": "  Logrip ML, Janak PH, Ron D", "title": "Dynorphin is a downstream effector of striatal BDNF regulation of ethanol intake.", "journal": "FASEB J 22:2393-404 (2008)", "doi": "10.1096/fj.07-099135"}, {"pmid": "18616668", "authors": "  Shukla SD, Velazquez J, French SW, Lu SC, Ticku MK, Zakhari S", "title": "Emerging role of epigenetics in the actions of alcohol.", "journal": "Alcohol Clin Exp Res 32:1525-34 (2008)", "doi": "10.1111/j.1530-0277.2008.00729.x"}, {"pmid": "19077056", "authors": "  Pascual M, Boix J, Felipo V, Guerri C", "title": "Repeated alcohol administration during adolescence causes changes in the mesolimbic dopaminergic and glutamatergic systems and promotes alcohol intake in the adult rat.", "journal": "J Neurochem 108:920-31 (2009)", "doi": "10.1111/j.1471-4159.2008.05835.x"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04728  Dopaminergic synapse"], "ko_pathway": "ko05034", "genes": ["BRAF", "SOS1", "NRAS"]}, {"kegg_id": "hsa04114", "name": "Oocyte meiosis - Homo sapiens (human)", "description": "During meiosis, a single round of DNA replication is followed by two rounds of chromosome segregation, called meiosis I and meiosis II. At meiosis I, homologous chromosomes recombine and then segregate to opposite poles, while the sister chromatids segregate from each other at meoisis II. In vertebrates, immature oocytes are arrested at the PI (prophase of meiosis I). The resumption of meiosis is stimulated by progesterone, which carries the oocyte through two consecutive M-phases (MI and MII) to a second arrest at MII. The key activity driving meiotic progression is the MPF (maturation-promoting factor), a heterodimer of CDC2 (cell division cycle 2 kinase) and cyclin B. In PI-arrested oocytes, MPF is initially inactive and is activated by the dual-specificity CDC25C phosphatase as the result of new synthesis of Mos induced by progesterone. MPF activation mediates the transition from the PI arrest to MI. The subsequent decrease in MPF levels, required to exit from MI into interkinesis, is induced by a negative feedback loop, where CDC2 brings about the activation of the APC (anaphase-promoting complex), which mediates destruction of cyclin B. Re-activation of MPF for MII requires re-accumulation of high levels of cyclin B as well as the inactivation of the APC by newly synthesized Emi2 and other components of the CSF (cytostatic factor), such as cyclin E or high levels of Mos. CSF antagonizes the ubiquitin ligase activity of the APC, preventing cyclin B destruction and meiotic exit until fertilization occurs. Fertilization triggers a transient increase in cytosolic free Ca2+, which leads to CSF inactivation and cyclin B destruction through the APC. Then eggs are released from MII into the first embryonic cell cycle.", "class": "Cellular Processes; Cell growth and death", "pathway_map": "hsa04114  Oocyte meiosis", "drug": ["D00066  Progesterone (JP18/USP/INN)", "D00075  Testosterone (JAN/USP)", "D00182  Norethindrone (USP)", "D00289  Danazol (JP18/USP/INN)", "D00327  Fluoxymesterone (JAN/USP/INN)", "D00408  Methyltestosterone (JP18/USP/INN)", "D00585  Mifepristone (JAN/USAN/INN)", "D00949  Hydroxyprogesterone caproate (JAN/USP/INN)", "D00950  Levonorgestrel (JAN/USP/INN)", "D00951  Medroxyprogesterone acetate (JP18/USP)", "D00952  Megestrol acetate (USP)", "D00953  Norethindrone acetate (USP)", "D00954  Norgestrel (JP18/USP/INN)", "D00957  Testosterone cypionate (USP)", "D00958  Testosterone enanthate (JP18/USP)", "D00959  Testosterone propionate (JP18/USP)", "D01159  Gestonorone caproate (JAN/USAN)", "D01217  Dydrogesterone (JP18/USP/INN)", "D01294  Ethynodiol diacetate (JAN/USP)", "D01299  Chlormadinone acetate (JP18/USAN)", "D01368  Cyproterone acetate (JAN/USAN)", "D01374  Allylestrenol (JAN/INN)", "D01533  Mestanolone (JAN/INN)", "D01534  Dromostanolone propionate (USAN)", "D01580  Lynestrenol (JAN/USAN)", "D02367  Desogestrel (USAN/INN)", "D02996  Asoprisnil (USAN/INN)", "D03675  Delmadinone acetate (USAN)", "D03799  Dienogest (JAN/USAN/INN)", "D03917  Drospirenone (JAN/USP/INN)", "D04104  Etonogestrel (USAN/INN)", "D04316  Gestodene (USAN/INN)", "D04885  Medrogestone (USAN/INN)", "D04947  Mesterolone (USAN/INN)", "D05003  Methynodiol diacetate (USAN)", "D05009  Metogest (USAN/INN)", "D05025  Mibolerone (USP/INN)", "D05205  Norelgestromin (USP/INN)", "D05207  Norethynodrel (USAN)", "D05209  Norgestimate (USP/INN)", "D05308  Oxogestone phenpropionate (USAN)", "D05679  Quingestanol acetate (USAN)", "D05680  Quingestrone (USAN/INN)", "D06003  Tanaproget (USAN/INN)", "D06085  Testosterone ketolaurate (USAN/INN)", "D06086  Testosterone phenylacetate (USAN)", "D06087  Testosterone undecanoate (USAN)", "D06145  Tigestol (USAN/INN)", "D06197  Tosagestin (USAN/INN)", "D06235  Trimegestone (USAN/INN)", "D07096  Aglepristone (INN)", "D07220  Norgestrienone (INN)", "D07222  Nomegestrol (USAN/INN)", "D07223  Demegestone (INN)", "D07670  Chlormadinone (INN)", "D07766  Cyproterone (INN)", "D07939  Etynodiol (INN)", "D07968  Flugestone (INN)", "D08052  Hydroxyprogesterone (INN)", "D08053  Hydroxyprogesterone 17alfa-acetate", "D08166  Medroxyprogesterone (INN)", "D08167  Megestrol (INN)", "D08281  Nomegestrol acetate (USAN)", "D08285  Norethisterone enantate", "D08431  Promegestone (INN)", "D08573  Testosterone decanoate", "D08574  Testosterone phenylpropionate", "D09567  Ulipristal (USAN/INN)", "D09687  Ulipristal acetate (JAN/USAN)", "D09972  Telapristone acetate (USAN)", "D10986  Segesterone acetate (USAN)", "D10987  Segesterone (USAN/INN)", "D11181  Vilaprisan (JAN/USAN/INN)", "D12736  Lunresertib (USAN)"], "dblinks": "GO: 0051321", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["3630  INS; insulin [KO:K04526]", "3479  IGF1; insulin like growth factor 1 [KO:K05459]", "3480  IGF1R; insulin like growth factor 1 receptor [KO:K05087] [EC:2.7.10.1]", "5241  PGR; progesterone receptor [KO:K08556]", "367  AR; androgen receptor [KO:K08557]", "107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]", "108  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]", "109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]", "196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]", "113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]", "114  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]", "115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "6790  AURKA; aurora kinase A [KO:K11481] [EC:2.7.11.1]", "64506  CPEB1; cytoplasmic polyadenylation element binding protein 1 [KO:K02602]", "132864  CPEB2; cytoplasmic polyadenylation element binding protein 2 [KO:K02602]", "22849  CPEB3; cytoplasmic polyadenylation element binding protein 3 [KO:K02602]", "80315  CPEB4; cytoplasmic polyadenylation element binding protein 4 [KO:K02602]", "4342  MOS; MOS proto-oncogene, serine/threonine kinase [KO:K04367] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "6197  RPS6KA3; ribosomal protein S6 kinase A3 [KO:K04373] [EC:2.7.11.1]", "6195  RPS6KA1; ribosomal protein S6 kinase A1 [KO:K04373] [EC:2.7.11.1]", "6196  RPS6KA2; ribosomal protein S6 kinase A2 [KO:K04373] [EC:2.7.11.1]", "27330  RPS6KA6; ribosomal protein S6 kinase A6 [KO:K04373] [EC:2.7.11.1]", "9088  PKMYT1; protein kinase, membrane associated tyrosine/threonine 1 [KO:K06633] [EC:2.7.11.1]", "7534  YWHAZ; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta [KO:K16197]", "7529  YWHAB; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta [KO:K16197]", "10971  YWHAQ; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta [KO:K16197]", "7531  YWHAE; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon [KO:K06630]", "7533  YWHAH; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta [KO:K16198]", "7532  YWHAG; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma [KO:K16198]", "245711  SPDYA; speedy/RINGO cell cycle regulator family member A [KO:K08694]", "387778  SPDYC; speedy/RINGO cell cycle regulator family member C [KO:K08694]", "100310812  SPDYE2B; speedy/RINGO cell cycle regulator family member E2B [KO:K08694]", "100505767  SPDYE18; speedy/RINGO cell cycle regulator family member E18 [KO:K08694]", "100996746  SPDYE11; speedy/RINGO cell cycle regulator family member E11 [KO:K08694]", "102723555  SPDYE16; speedy/RINGO cell cycle regulator family member E16 [KO:K08694]", "102723849  SPDYE17; speedy/RINGO cell cycle regulator family member E17 [KO:K08694]", "285955  SPDYE1; speedy/RINGO cell cycle regulator family member E1 [KO:K08694]", "388333  SPDYE4; speedy/RINGO cell cycle regulator family member E4 [KO:K08694]", "441272  SPDYE3; speedy/RINGO cell cycle regulator family member E3 [KO:K08694]", "441273  SPDYE2; speedy/RINGO cell cycle regulator family member E2 [KO:K08694]", "442590  SPDYE5; speedy/RINGO cell cycle regulator family member E5 [KO:K08694]", "729597  SPDYE6; speedy/RINGO cell cycle regulator family member E6 [KO:K08694]", "105180391  SPDYE15; speedy/RINGO cell cycle regulator family member E15 [KO:K08694]", "100101268  SPDYE12; speedy/RINGO cell cycle regulator family member E12 [KO:K08694]", "124906603  putative speedy protein E9 [KO:K08694]", "643862  SPDYE10; speedy/RINGO cell cycle regulator family member E10 [KO:K08694]", "643909  SPDYE9; speedy/RINGO cell cycle regulator family member E9 [KO:K08694]", "728524  SPDYE8; speedy/RINGO cell cycle regulator family member E8 [KO:K08694]", "105180390  SPDYE13; speedy/RINGO cell cycle regulator family member E13 [KO:K08694]", "641776  SPDYE14; speedy/RINGO cell cycle regulator family member E14 [KO:K08694]", "983  CDK1; cyclin dependent kinase 1 [KO:K02087] [EC:2.7.11.22 2.7.11.23]", "1017  CDK2; cyclin dependent kinase 2 [KO:K02206] [EC:2.7.11.22]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "5499  PPP1CA; protein phosphatase 1 catalytic subunit alpha [KO:K06269] [EC:3.1.3.16]", "5500  PPP1CB; protein phosphatase 1 catalytic subunit beta [KO:K06269] [EC:3.1.3.16]", "5501  PPP1CC; protein phosphatase 1 catalytic subunit gamma [KO:K06269] [EC:3.1.3.16]", "9748  SLK; STE20 like kinase [KO:K08836] [EC:2.7.11.1]", "5347  PLK1; polo like kinase 1 [KO:K06631] [EC:2.7.11.21]", "995  CDC25C; cell division cycle 25C [KO:K05867] [EC:3.1.3.48]", "9133  CCNB2; cyclin B2 [KO:K21770]", "9978  RBX1; ring-box 1 [KO:K03868] [EC:2.3.2.32]", "8454  CUL1; cullin 1 [KO:K03347]", "6500  SKP1; S-phase kinase associated protein 1 [KO:K03094]", "8945  BTRC; beta-transducin repeat containing E3 ubiquitin protein ligase [KO:K03362]", "23291  FBXW11; F-box and WD repeat domain containing 11 [KO:K03362]", "26271  FBXO5; F-box protein 5 [KO:K10292]", "64682  ANAPC1; anaphase promoting complex subunit 1 [KO:K03348]", "29882  ANAPC2; anaphase promoting complex subunit 2 [KO:K03349]", "996  CDC27; cell division cycle 27 [KO:K03350]", "29945  ANAPC4; anaphase promoting complex subunit 4 [KO:K03351]", "51433  ANAPC5; anaphase promoting complex subunit 5 [KO:K03352]", "8881  CDC16; cell division cycle 16 [KO:K03353]", "51434  ANAPC7; anaphase promoting complex subunit 7 [KO:K03354]", "8697  CDC23; cell division cycle 23 [KO:K03355]", "10393  ANAPC10; anaphase promoting complex subunit 10 [KO:K03357]", "51529  ANAPC11; anaphase promoting complex subunit 11 [KO:K03358]", "246184  CDC26; cell division cycle 26 [KO:K03359]", "25847  ANAPC13; anaphase promoting complex subunit 13 [KO:K12456]", "25906  ANAPC15; anaphase promoting complex subunit 15 [KO:K25228]", "119504  ANAPC16; anaphase promoting complex subunit 16 [KO:K25229]", "991  CDC20; cell division cycle 20 [KO:K03363]", "286151  FBXO43; F-box protein 43 [KO:K10318]", "9232  PTTG1; PTTG1 regulator of sister chromatid separation, securin [KO:K06635]", "10744  PTTG2; pituitary tumor-transforming 2 [KO:K06635]", "9700  ESPL1; extra spindle pole bodies like 1, separase [KO:K02365] [EC:3.4.22.49]", "9985  REC8; REC8 meiotic recombination protein [KO:K13054]", "10734  STAG3; STAG3 cohesin complex component [KO:K13055]", "8243  SMC1A; structural maintenance of chromosomes 1A [KO:K06636]", "27127  SMC1B; structural maintenance of chromosomes 1B [KO:K06636]", "9126  SMC3; structural maintenance of chromosomes 3 [KO:K06669]", "891  CCNB1; cyclin B1 [KO:K05868]", "699  BUB1; BUB1 mitotic checkpoint serine/threonine kinase [KO:K02178] [EC:2.7.11.1]", "4085  MAD2L1; mitotic arrest deficient 2 like 1 [KO:K02537]", "10459  MAD2L2; mitotic arrest deficient 2 like 2 [KO:K13728]", "8379  MAD1L1; mitotic arrest deficient 1 like 1 [KO:K06679]", "898  CCNE1; cyclin E1 [KO:K06626]", "9134  CCNE2; cyclin E2 [KO:K06626]", "151648  SGO1; shugoshin 1 [KO:K11580]", "5526  PPP2R5B; protein phosphatase 2 regulatory subunit B'beta [KO:K11584]", "5527  PPP2R5C; protein phosphatase 2 regulatory subunit B'gamma [KO:K11584]", "5528  PPP2R5D; protein phosphatase 2 regulatory subunit B'delta [KO:K11584]", "5529  PPP2R5E; protein phosphatase 2 regulatory subunit B'epsilon [KO:K11584]", "5525  PPP2R5A; protein phosphatase 2 regulatory subunit B'alpha [KO:K11584]", "5519  PPP2R1B; protein phosphatase 2 scaffold subunit Abeta [KO:K03456]", "5518  PPP2R1A; protein phosphatase 2 scaffold subunit Aalpha [KO:K03456]", "5515  PPP2CA; protein phosphatase 2 catalytic subunit alpha [KO:K04382] [EC:3.1.3.16]", "5516  PPP2CB; protein phosphatase 2 catalytic subunit beta [KO:K04382] [EC:3.1.3.16]", "89869  PLCZ1; phospholipase C zeta 1 [KO:K05861] [EC:3.1.4.11]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "810  CALML3; calmodulin like 3 [KO:K02183]", "805  CALM2; calmodulin 2 [KO:K02183]", "808  CALM3; calmodulin 3 [KO:K02183]", "801  CALM1; calmodulin 1 [KO:K02183]", "163688  CALML6; calmodulin like 6 [KO:K02183]", "51806  CALML5; calmodulin like 5 [KO:K02183]", "91860  CALML4; calmodulin like 4 [KO:K02183]", "5530  PPP3CA; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]", "5532  PPP3CB; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]", "5533  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]", "5534  PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]", "5535  PPP3R2; protein phosphatase 3 regulatory subunit B, beta [KO:K06268]", "815  CAMK2A; calcium/calmodulin dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]", "817  CAMK2D; calcium/calmodulin dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]", "816  CAMK2B; calcium/calmodulin dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]", "818  CAMK2G; calcium/calmodulin dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]"], "compound": ["C00076  Calcium cation", "C00410  Progesterone", "C00575  3',5'-Cyclic AMP", "C01245  D-myo-Inositol 1,4,5-trisphosphate"], "refs": [{"pmid": "16760654", "authors": "  Haccard O, Jessus C", "title": "Oocyte maturation, Mos and cyclins--a matter of synthesis: two functionally redundant ways to induce meiotic maturation.", "journal": "Cell Cycle 5:1152-9 (2006)", "doi": "10.4161/cc.5.11.2800"}, {"pmid": "15182704", "authors": "  Crane R, Gadea B, Littlepage L, Wu H, Ruderman JV", "title": "Aurora A, meiosis and mitosis.", "journal": "Biol Cell 96:215-29 (2004)", "doi": "10.1016/j.biolcel.2003.09.008"}, {"pmid": "15136768", "authors": "  Perdiguero E, Nebreda AR", "title": "Regulation of Cdc25C activity during the meiotic G2/M transition.", "journal": "Cell Cycle 3:733-7 (2004)", "doi": "10.4161/cc.3.6.906"}, {"pmid": "17480229", "authors": "  Perry JA, Kornbluth S", "title": "Cdc25 and Wee1: analogous opposites?", "journal": "Cell Div 2:12 (2007)", "doi": "10.1186/1747-1028-2-12"}, {"pmid": "15182701", "authors": "  Jessus C, Ozon R", "title": "How does Xenopus oocyte acquire its competence to undergo meiotic maturation?", "journal": "Biol Cell 96:187-92 (2004)", "doi": "10.1016/j.biolcel.2003.12.007"}, {"pmid": "16518630", "authors": "  Revenkova E, Jessberger R", "title": "Shaping meiotic prophase chromosomes: cohesins and synaptonemal complex proteins.", "journal": "Chromosoma 115:235-40 (2006)", "doi": "10.1007/s00412-006-0060-x"}, {"pmid": "18631137", "authors": "  Belloc E, Pique M, Mendez R", "title": "Sequential waves of polyadenylation and deadenylation define a translation circuit that drives meiotic progression.", "journal": "Biochem Soc Trans 36:665-70 (2008)", "doi": "10.1042/BST0360665"}, {"pmid": "18598214", "authors": "  Pesin JA, Orr-Weaver TL", "title": "Regulation of APC/C activators in mitosis and meiosis.", "journal": "Annu Rev Cell Dev Biol 24:475-99 (2008)", "doi": "10.1146/annurev.cellbio.041408.115949"}, {"pmid": "18550795", "authors": "  Tang W, Wu JQ, Guo Y, Hansen DV, Perry JA, Freel CD, Nutt L, Jackson PK, Kornbluth S", "title": "Cdc2 and Mos regulate Emi2 stability to promote the meiosis I-meiosis II transition.", "journal": "Mol Biol Cell 19:3536-43 (2008)", "doi": "10.1091/mbc.E08-04-0417"}, {"pmid": "18946022", "authors": "  Wu JQ, Kornbluth S", "title": "Across the meiotic divide - CSF activity in the post-Emi2/XErp1 era.", "journal": "J Cell Sci 121:3509-14 (2008)", "doi": "10.1242/jcs.036855"}, {"pmid": "16554437", "authors": "  Schmidt A, Rauh NR, Nigg EA, Mayer TU", "title": "Cytostatic factor: an activity that puts the cell cycle on hold.", "journal": "J Cell Sci 119:1213-8 (2006)", "doi": "10.1242/jcs.02919"}, {"pmid": "18096427", "authors": "  Vogt E, Kirsch-Volders M, Parry J, Eichenlaub-Ritter U", "title": "Spindle formation, chromosome segregation and the spindle checkpoint in mammalian oocytes and susceptibility to meiotic error.", "journal": "Mutat Res 651:14-29 (2008)", "doi": "10.1016/j.mrgentox.2007.10.015"}, {"pmid": "18311174", "authors": "  Perry AC, Verlhac MH", "title": "Second meiotic arrest and exit in frogs and mice.", "journal": "EMBO Rep 9:246-51 (2008)", "doi": "10.1038/embor.2008.22"}, {"pmid": "14691134", "authors": "  Tunquist BJ, Eyers PA, Chen LG, Lewellyn AL, Maller JL", "title": "Spindle checkpoint proteins Mad1 and Mad2 are required for cytostatic factor-mediated metaphase arrest.", "journal": "J Cell Biol 163:1231-42 (2003)", "doi": "10.1083/jcb.200306153"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04120  Ubiquitin mediated proteolysis", "hsa04914  Progesterone-mediated oocyte maturation"], "ko_pathway": "ko04114", "genes": ["CUL1", "MAPK13"]}, {"kegg_id": "hsa04120", "name": "Ubiquitin mediated proteolysis - Homo sapiens (human)", "description": "Protein ubiquitination plays an important role in eukaryotic cellular processes. It mainly functions as a signal for 26S proteasome dependent protein degradation. The addition of ubiquitin to proteins being degraded is performed by a reaction cascade consisting of three enzymes, named E1 (ubiquitin activating enzyme), E2 (ubiquitin conjugating enzyme), and E3 (ubiquitin ligase). Each E3 has specificity to its substrate, or proteins to be targeted by ubiquitination. Many E3s are discovered in eukaryotes and they are classified into four types: HECT type, U-box type, single RING-finger type, and multi-subunit RING-finger type. Multi-subunit RING-finger E3s are exemplified by cullin-Rbx E3s and APC/C. They consist of a RING-finger-containing subunit (RBX1 or RBX2) that functions to bind E2s, a scaffold-like cullin molecule, adaptor proteins, and a target recognizing subunit that binds substrates.", "class": "Genetic Information Processing; Folding, sorting and degradation", "pathway_map": "hsa04120  Ubiquitin mediated proteolysis", "network": ["", "ELEMENT   N01019  Parkin-mediated ubiquitination", "N01021  Parkin-mediated ubiquitination", "N01023  Parkin-mediated ubiquitination", "N01025  Parkin-mediated ubiquitination"], "drug": ["D11219  Idasanutlin (USAN/INN)", "D12268  Subasumstat (USAN/INN)", "D12378  Navtemadlin (USAN/INN)", "D12417  Siremadlin (USAN/INN)", "D12418  Siremadlin succinate (USAN)", "D12621  Milademetan (USAN/INN)", "D12622  Milademetan tosylate (USAN)", "D12842  Brigimadlin (JAN/USAN/INN)"], "dblinks": "GO: 0016567", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["7314  UBB; ubiquitin B [KO:K04551]", "7316  UBC; ubiquitin C [KO:K08770]", "7311  UBA52; ubiquitin A-52 residue ribosomal protein fusion product 1 [KO:K02927]", "6233  RPS27A; ribosomal protein S27a [KO:K02977]", "7317  UBA1; ubiquitin like modifier activating enzyme 1 [KO:K03178] [EC:6.2.1.45]", "10055  SAE1; SUMO1 activating enzyme subunit 1 [KO:K10684] [EC:6.2.1.45]", "10054  UBA2; ubiquitin like modifier activating enzyme 2 [KO:K10685] [EC:6.2.1.45]", "9039  UBA3; ubiquitin like modifier activating enzyme 3 [KO:K10686] [EC:6.2.1.64]", "7318  UBA7; ubiquitin like modifier activating enzyme 7 [KO:K10698] [EC:6.2.1.45]", "55236  UBA6; ubiquitin like modifier activating enzyme 6 [KO:K10699] [EC:6.2.1.45]", "7319  UBE2A; ubiquitin conjugating enzyme E2 A [KO:K10573] [EC:2.3.2.23]", "7320  UBE2B; ubiquitin conjugating enzyme E2 B [KO:K10574] [EC:2.3.2.23]", "11065  UBE2C; ubiquitin conjugating enzyme E2 C [KO:K06688] [EC:2.3.2.23]", "51619  UBE2D4; ubiquitin conjugating enzyme E2 D4 (putative) [KO:K06689] [EC:2.3.2.23]", "7321  UBE2D1; ubiquitin conjugating enzyme E2 D1 [KO:K06689] [EC:2.3.2.23]", "7322  UBE2D2; ubiquitin conjugating enzyme E2 D2 [KO:K06689] [EC:2.3.2.23]", "7323  UBE2D3; ubiquitin conjugating enzyme E2 D3 [KO:K06689] [EC:2.3.2.23]", "10477  UBE2E3; ubiquitin conjugating enzyme E2 E3 [KO:K20217] [EC:2.3.2.23]", "7324  UBE2E1; ubiquitin conjugating enzyme E2 E1 [KO:K20217] [EC:2.3.2.23]", "7325  UBE2E2; ubiquitin conjugating enzyme E2 E2 [KO:K20217] [EC:2.3.2.23]", "140739  UBE2F; ubiquitin conjugating enzyme E2 F (putative) [KO:K10687] [EC:2.3.2.34]", "7326  UBE2G1; ubiquitin conjugating enzyme E2 G1 [KO:K10575] [EC:2.3.2.23]", "7327  UBE2G2; ubiquitin conjugating enzyme E2 G2 [KO:K04555] [EC:2.3.2.23]", "7328  UBE2H; ubiquitin conjugating enzyme E2 H [KO:K10576] [EC:2.3.2.23]", "7329  UBE2I; ubiquitin conjugating enzyme E2 I [KO:K10577]", "51465  UBE2J1; ubiquitin conjugating enzyme E2 J1 [KO:K10578] [EC:2.3.2.23]", "118424  UBE2J2; ubiquitin conjugating enzyme E2 J2 [KO:K04554] [EC:2.3.2.23]", "3093  UBE2K; ubiquitin conjugating enzyme E2 K [KO:K04649] [EC:2.3.2.23]", "7332  UBE2L3; ubiquitin conjugating enzyme E2 L3 [KO:K04552] [EC:2.3.2.23]", "9246  UBE2L6; ubiquitin conjugating enzyme E2 L6 [KO:K04553] [EC:2.3.2.23]", "9040  UBE2M; ubiquitin conjugating enzyme E2 M [KO:K10579] [EC:2.3.2.34]", "389898  UBE2NL; ubiquitin conjugating enzyme E2 N like (gene/pseudogene) [KO:K10580] [EC:2.3.2.23]", "7334  UBE2N; ubiquitin conjugating enzyme E2 N [KO:K10580] [EC:2.3.2.23]", "63893  UBE2O; ubiquitin conjugating enzyme E2 O [KO:K10581] [EC:2.3.2.24]", "55585  UBE2Q1; ubiquitin conjugating enzyme E2 Q1 [KO:K10582] [EC:2.3.2.23]", "92912  UBE2Q2; ubiquitin conjugating enzyme E2 Q2 [KO:K10582] [EC:2.3.2.23]", "134111  UBE2QL1; ubiquitin conjugating enzyme E2 QL1 [KO:K10582] [EC:2.3.2.23]", "54926  UBE2R2; ubiquitin conjugating enzyme E2 R2 [KO:K02207] [EC:2.3.2.23]", "997  CDC34; cell division cycle 34, ubiqiutin conjugating enzyme [KO:K02207] [EC:2.3.2.23]", "27338  UBE2S; ubiquitin conjugating enzyme E2 S [KO:K10583] [EC:2.3.2.23]", "148581  UBE2U; ubiquitin conjugating enzyme E2 U [KO:K10584] [EC:2.3.2.23]", "55284  UBE2W; ubiquitin conjugating enzyme E2 W [KO:K10688] [EC:2.3.2.23 2.3.2.25]", "65264  UBE2Z; ubiquitin conjugating enzyme E2 Z [KO:K10585] [EC:2.3.2.23]", "57448  BIRC6; baculoviral IAP repeat containing 6 [KO:K10586] [EC:2.3.2.23]", "7337  UBE3A; ubiquitin protein ligase E3A [KO:K10587] [EC:2.3.2.26]", "89910  UBE3B; ubiquitin protein ligase E3B [KO:K10588] [EC:2.3.2.26]", "9690  UBE3C; ubiquitin protein ligase E3C [KO:K10589] [EC:2.3.2.26]", "57154  SMURF1; SMAD specific E3 ubiquitin protein ligase 1 [KO:K04678] [EC:2.3.2.26]", "64750  SMURF2; SMAD specific E3 ubiquitin protein ligase 2 [KO:K04678] [EC:2.3.2.26]", "83737  ITCH; itchy E3 ubiquitin protein ligase [KO:K05632] [EC:2.3.2.26]", "11059  WWP1; WW domain containing E3 ubiquitin protein ligase 1 [KO:K05633] [EC:2.3.2.26]", "11060  WWP2; WW domain containing E3 ubiquitin protein ligase 2 [KO:K05630] [EC:2.3.2.26]", "9320  TRIP12; thyroid hormone receptor interactor 12 [KO:K10590] [EC:2.3.2.26]", "4734  NEDD4; NEDD4 E3 ubiquitin protein ligase [KO:K10591] [EC:2.3.2.26]", "23327  NEDD4L; NEDD4 like E3 ubiquitin protein ligase [KO:K13305] [EC:2.3.2.26]", "10075  HUWE1; HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1 [KO:K10592] [EC:2.3.2.26]", "51366  UBR5; ubiquitin protein ligase E3 component n-recognin 5 [KO:K10593] [EC:2.3.2.26]", "8925  HERC1; HECT and RLD domain containing E3 ubiquitin protein ligase family member 1 [KO:K10594] [EC:2.3.2.26]", "8924  HERC2; HECT and RLD domain containing E3 ubiquitin protein ligase 2 [KO:K10595] [EC:2.3.2.26]", "8916  HERC3; HECT and RLD domain containing E3 ubiquitin protein ligase 3 [KO:K10614] [EC:2.3.2.26]", "26091  HERC4; HECT and RLD domain containing E3 ubiquitin protein ligase 4 [KO:K10615] [EC:2.3.2.26]", "9354  UBE4A; ubiquitination factor E4A [KO:K10596] [EC:2.3.2.27]", "10277  UBE4B; ubiquitination factor E4B [KO:K10597] [EC:2.3.2.27]", "10273  STUB1; STIP1 homology and U-box containing protein 1 [KO:K09561] [EC:2.3.2.27]", "23759  PPIL2; peptidylprolyl isomerase like 2 [KO:K10598] [EC:5.2.1.8]", "27339  PRPF19; pre-mRNA processing factor 19 [KO:K10599] [EC:2.3.2.27]", "22888  UBOX5; U-box domain containing 5 [KO:K10600]", "4193  MDM2; MDM2 proto-oncogene [KO:K06643] [EC:2.3.2.27]", "867  CBL; Cbl proto-oncogene [KO:K04707] [EC:2.3.2.27]", "868  CBLB; Cbl proto-oncogene B [KO:K22517] [EC:2.3.2.27]", "23624  CBLC; Cbl proto-oncogene C [KO:K22518] [EC:2.3.2.27]", "5071  PRKN; parkin RBR E3 ubiquitin protein ligase [KO:K04556] [EC:2.3.2.31]", "6477  SIAH1; siah E3 ubiquitin protein ligase 1 [KO:K04506] [EC:2.3.2.27]", "5371  PML; PML nuclear body scaffold [KO:K10054] [EC:2.3.2.-]", "7189  TRAF6; TNF receptor associated factor 6 [KO:K03175] [EC:2.3.2.27]", "4214  MAP3K1; mitogen-activated protein kinase kinase kinase 1 [KO:K04416] [EC:2.7.11.25]", "64326  COP1; COP1 E3 ubiquitin ligase [KO:K10143] [EC:2.3.2.27]", "25898  RCHY1; ring finger and CHY zinc finger domain containing 1 [KO:K10144] [EC:2.3.2.27]", "329  BIRC2; baculoviral IAP repeat containing 2 [KO:K16060]", "330  BIRC3; baculoviral IAP repeat containing 3 [KO:K16060]", "331  XIAP; X-linked inhibitor of apoptosis [KO:K04725] [EC:2.3.2.27]", "79444  BIRC7; baculoviral IAP repeat containing 7 [KO:K16061]", "8554  PIAS1; protein inhibitor of activated STAT 1 [KO:K04706] [EC:2.3.2.-]", "9063  PIAS2; protein inhibitor of activated STAT 2 [KO:K16063] [EC:2.3.2.-]", "10401  PIAS3; protein inhibitor of activated STAT 3 [KO:K16064] [EC:2.3.2.-]", "51588  PIAS4; protein inhibitor of activated STAT 4 [KO:K16065] [EC:2.3.2.27]", "84447  SYVN1; synoviolin 1 [KO:K10601] [EC:2.3.2.27]", "378884  NHLRC1; NHL repeat containing E3 ubiquitin protein ligase 1 [KO:K10602] [EC:2.3.2.27]", "326  AIRE; autoimmune regulator [KO:K10603]", "23295  MGRN1; mahogunin ring finger 1 [KO:K10604] [EC:2.3.2.27]", "672  BRCA1; BRCA1 DNA repair associated [KO:K10605] [EC:2.3.2.27]", "55120  FANCL; FA complementation group L [KO:K10606] [EC:2.3.2.27]", "4281  MID1; midline 1 [KO:K08285] [EC:2.3.2.27]", "22954  TRIM32; tripartite motif containing 32 [KO:K10607] [EC:2.3.2.27]", "4591  TRIM37; tripartite motif containing 37 [KO:K10608] [EC:2.3.2.27]", "9978  RBX1; ring-box 1 [KO:K03868] [EC:2.3.2.32]", "8454  CUL1; cullin 1 [KO:K03347]", "6500  SKP1; S-phase kinase associated protein 1 [KO:K03094]", "8945  BTRC; beta-transducin repeat containing E3 ubiquitin protein ligase [KO:K03362]", "23291  FBXW11; F-box and WD repeat domain containing 11 [KO:K03362]", "6502  SKP2; S-phase kinase associated protein 2 [KO:K03875]", "55294  FBXW7; F-box and WD repeat domain containing 7 [KO:K10260]", "26232  FBXO2; F-box protein 2 [KO:K10099]", "26272  FBXO4; F-box protein 4 [KO:K10291]", "8453  CUL2; cullin 2 [KO:K03870]", "6921  ELOC; elongin C [KO:K03872]", "6923  ELOB; elongin B [KO:K03873]", "7428  VHL; von Hippel-Lindau tumor suppressor [KO:K03871]", "8452  CUL3; cullin 3 [KO:K03869]", "9817  KEAP1; kelch like ECH associated protein 1 [KO:K10456]", "55958  KLHL9; kelch like family member 9 [KO:K10447]", "90293  KLHL13; kelch like family member 13 [KO:K10447]", "23221  RHOBTB2; Rho related BTB domain containing 2 [KO:K07868]", "9886  RHOBTB1; Rho related BTB domain containing 1 [KO:K07868]", "8450  CUL4B; cullin 4B [KO:K10609]", "8451  CUL4A; cullin 4A [KO:K10609]", "1642  DDB1; damage specific DNA binding protein 1 [KO:K10610]", "1643  DDB2; damage specific DNA binding protein 2 [KO:K10140]", "1161  ERCC8; ERCC excision repair 8, CSA ubiquitin ligase complex subunit [KO:K10570]", "55070  DET1; DET1 partner of COP1 E3 ubiquitin ligase [KO:K10571]", "9616  RNF7; ring finger protein 7 [KO:K10611]", "8065  CUL5; cullin 5 [KO:K10612]", "8651  SOCS1; suppressor of cytokine signaling 1 [KO:K04694]", "9021  SOCS3; suppressor of cytokine signaling 3 [KO:K04696]", "9820  CUL7; cullin 7 [KO:K10613]", "26259  FBXW8; F-box and WD repeat domain containing 8 [KO:K10264]", "51529  ANAPC11; anaphase promoting complex subunit 11 [KO:K03358]", "29882  ANAPC2; anaphase promoting complex subunit 2 [KO:K03349]", "991  CDC20; cell division cycle 20 [KO:K03363]", "51343  FZR1; fizzy and cell division cycle 20 related 1 [KO:K03364]", "64682  ANAPC1; anaphase promoting complex subunit 1 [KO:K03348]", "996  CDC27; cell division cycle 27 [KO:K03350]", "29945  ANAPC4; anaphase promoting complex subunit 4 [KO:K03351]", "51433  ANAPC5; anaphase promoting complex subunit 5 [KO:K03352]", "8881  CDC16; cell division cycle 16 [KO:K03353]", "51434  ANAPC7; anaphase promoting complex subunit 7 [KO:K03354]", "8697  CDC23; cell division cycle 23 [KO:K03355]", "10393  ANAPC10; anaphase promoting complex subunit 10 [KO:K03357]", "246184  CDC26; cell division cycle 26 [KO:K03359]", "25847  ANAPC13; anaphase promoting complex subunit 13 [KO:K12456]", "25906  ANAPC15; anaphase promoting complex subunit 15 [KO:K25228]", "119504  ANAPC16; anaphase promoting complex subunit 16 [KO:K25229]"], "refs": [{"pmid": "16816840", "authors": "  Nalepa G, Rolfe M, Harper JW.", "title": "Drug discovery in the ubiquitin-proteasome system.", "journal": "Nat Rev Drug Discov 5:596-613 (2006)", "doi": "10.1038/nrd2056"}, {"pmid": "12944364", "authors": "  Hatakeyama S, Nakayama KI.", "title": "Ubiquitylation as a quality control system for intracellular proteins.", "journal": "J Biochem 134:1-8 (2003)", "doi": "10.1093/jb/mvg106"}], "rel_pathway": ["hsa03050  Proteasome"], "ko_pathway": "ko04120", "genes": ["CUL1", "CUL3", "BIRC3"]}, {"kegg_id": "hsa04340", "name": "Hedgehog signaling pathway - Homo sapiens (human)", "description": "The Hedgehog (Hh) signaling pathway has numerous roles in the control of cell proliferation, tissue patterning, stem cell maintenance and development. The primary cilium is an important center for transduction of the Hedgehog signal in vertebrates. In Hh's absence, the Ptch receptor localizes to the cilium, where it inhibits Smo activation. Gli proteins are phosphorylated by PKA, CKI and GSK3B and partially degraded into truncated Gli repressor form (GliR) that suppresses Hh target gene transcription in the nucleus. In Hh's presence, Ptch disappears from the cilium, and activated Smo contributes to the translocation of the protein complex Gli, Sufu, Kif7 to ciliary tip, where Gli dissociates from the negative regulator Sufu. The production of Gli activator form (GliA) occurs and the increased nuclear accumulation of GliA results in activation transcription of Hh target genes.", "class": "Environmental Information Processing; Signal transduction", "pathway_map": "hsa04340  Hedgehog signaling pathway", "network": ["", "ELEMENT   N00062  Hedgehog signaling pathway", "N01537  Hedgehog signaling pathway, HH ligand secretion", "N01538  Hedgehog signaling pathway, PTCH coreceptor"], "drug": ["D09992  Vismodegib (USAN/INN)", "D10119  Sonidegib (USAN/INN)", "D10324  Patidegib (USAN/INN)", "D10325  Patidegib hydrochloride (USAN)", "D10636  Glasdegib (USAN/INN)", "D10671  Taladegib (USAN/INN)", "D10729  Sonidegib phosphate (USAN)", "D11107  Glasdegib maleate (JAN)", "D11322  Umbralisib (USAN/INN)", "D11323  Umbralisib tosylate (USAN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["5727  PTCH1; patched 1 [KO:K06225]", "8643  PTCH2; patched 2 [KO:K11101]", "6608  SMO; smoothened, frizzled class receptor [KO:K06226]", "23432  GPR161; G protein-coupled receptor 161 [KO:K08439]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "122011  CSNK1A1L; casein kinase 1 alpha 1 like [KO:K08957] [EC:2.7.11.1]", "1452  CSNK1A1; casein kinase 1 alpha 1 [KO:K08957] [EC:2.7.11.1]", "1455  CSNK1G2; casein kinase 1 gamma 2 [KO:K08958] [EC:2.7.11.1]", "1456  CSNK1G3; casein kinase 1 gamma 3 [KO:K08958] [EC:2.7.11.1]", "53944  CSNK1G1; casein kinase 1 gamma 1 [KO:K08958] [EC:2.7.11.1]", "1453  CSNK1D; casein kinase 1 delta [KO:K08959] [EC:2.7.11.1]", "1454  CSNK1E; casein kinase 1 epsilon [KO:K08960] [EC:2.7.11.1]", "102800317  TPTEP2-CSNK1E; TPTEP2-CSNK1E readthrough [KO:K08960] [EC:2.7.11.1]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "2735  GLI1; GLI family zinc finger 1 [KO:K16797]", "2736  GLI2; GLI family zinc finger 2 [KO:K16798]", "2737  GLI3; GLI family zinc finger 3 [KO:K06230]", "51684  SUFU; SUFU negative regulator of hedgehog signaling [KO:K06229]", "374654  KIF7; kinesin family member 7 [KO:K18806]", "64399  HHIP; hedgehog interacting protein [KO:K06231]", "595  CCND1; cyclin D1 [KO:K04503]", "894  CCND2; cyclin D2 [KO:K10151]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]", "8454  CUL1; cullin 1 [KO:K03347]", "8945  BTRC; beta-transducin repeat containing E3 ubiquitin protein ligase [KO:K03362]", "23291  FBXW11; F-box and WD repeat domain containing 11 [KO:K03362]", "55733  HHAT; hedgehog acyltransferase [KO:K24678] [EC:2.3.1.-]", "57467  HHATL; hedgehog acyltransferase like [KO:K24679]", "6469  SHH; sonic hedgehog signaling molecule [KO:K11988]", "3549  IHH; Indian hedgehog signaling molecule [KO:K11989]", "50846  DHH; desert hedgehog signaling molecule [KO:K11990]", "84976  DISP1; dispatched RND transporter family member 1 [KO:K24680]", "57758  SCUBE2; signal peptide, CUB domain and EGF like domain containing 2 [KO:K24706]", "91653  BOC; BOC cell adhesion associated, oncogene regulated [KO:K20020]", "50937  CDON; cell adhesion associated, oncogene regulated [KO:K20033]", "2619  GAS1; growth arrest specific 1 [KO:K06232]", "4036  LRP2; LDL receptor related protein 2 [KO:K06233]", "730094  MOSMO; modulator of smoothened [KO:K23663]", "1954  MEGF8; multiple EGF like domains 8 [KO:K23664]", "23295  MGRN1; mahogunin ring finger 1 [KO:K10604] [EC:2.3.2.27]", "57154  SMURF1; SMAD specific E3 ubiquitin protein ligase 1 [KO:K04678] [EC:2.3.2.26]", "64750  SMURF2; SMAD specific E3 ubiquitin protein ligase 2 [KO:K04678] [EC:2.3.2.26]", "156  GRK2; G protein-coupled receptor kinase 2 [KO:K00910] [EC:2.7.11.15]", "157  GRK3; G protein-coupled receptor kinase 3 [KO:K00910] [EC:2.7.11.15]", "2121  EVC; EvC ciliary complex subunit 1 [KO:K19605]", "132884  EVC2; EvC ciliary complex subunit 2 [KO:K19608]", "84455  EFCAB7; EF-hand calcium binding domain 7 [KO:K23852]", "23288  IQCE; IQ motif containing E [KO:K24677]", "408  ARRB1; arrestin beta 1 [KO:K04439]", "409  ARRB2; arrestin beta 2 [KO:K04439]", "11127  KIF3A; kinesin family member 3A [KO:K10394]", "8452  CUL3; cullin 3 [KO:K03869]", "8405  SPOP; speckle type BTB/POZ protein [KO:K10523]", "339745  SPOPL; speckle type BTB/POZ protein like [KO:K10523]"], "compound": ["C00575  3',5'-Cyclic AMP"], "refs": [{"pmid": "26875496", "authors": "  Xavier GM, Seppala M, Barrell W, Birjandi AA, Geoghegan F, Cobourne MT", "title": "Hedgehog receptor function during craniofacial development.", "journal": "Dev Biol 415:198-215 (2016)", "doi": "10.1016/j.ydbio.2016.02.009"}, {"pmid": "23719536", "authors": "  Briscoe J, Therond PP", "title": "The mechanisms of Hedgehog signalling and its roles in development and disease.", "journal": "Nat Rev Mol Cell Biol 14:416-29 (2013)", "doi": "10.1038/nrm3598"}, {"pmid": "26077918", "authors": "  Alman BA", "title": "The role of hedgehog signalling in skeletal health and disease.", "journal": "Nat Rev Rheumatol 11:552-60 (2015)", "doi": "10.1038/nrrheum.2015.84"}, {"pmid": "26064136", "authors": "  Mooney CJ, Hakimjavadi R, Fitzpatrick E, Kennedy E, Walls D, Morrow D, Redmond EM, Cahill PA", "title": "Hedgehog and Resident Vascular Stem Cell Fate.", "journal": "Stem Cells Int 2015:468428 (2015)", "doi": "10.1155/2015/468428"}, {"pmid": "23799571", "authors": "  Sasai N, Briscoe J", "title": "Primary cilia and graded Sonic Hedgehog signaling.", "journal": "Wiley Interdiscip Rev Dev Biol 1:753-72 (2012)", "doi": "10.1002/wdev.43"}, {"pmid": "20708941", "authors": "  Heretsch P, Tzagkaroulaki L, Giannis A", "title": "Modulators of the hedgehog signaling pathway.", "journal": "Bioorg Med Chem 18:6613-24 (2010)", "doi": "10.1016/j.bmc.2010.07.038"}, {"pmid": "22534646", "authors": "  Anderson E, Peluso S, Lettice LA, Hill RE", "title": "Human limb abnormalities caused by disruption of hedgehog signaling.", "journal": "Trends Genet 28:364-73 (2012)", "doi": "10.1016/j.tig.2012.03.012"}, {"pmid": "18583599", "authors": "  Rohatgi R, Scott MP", "title": "Cell biology. Arrestin' movement in cilia.", "journal": "Science 320:1726-7 (2008)", "doi": "10.1126/science.1160448"}, {"pmid": "24925320", "authors": "  Yue S, Tang LY, Tang Y, Tang Y, Shen QH, Ding J, Chen Y, Zhang Z, Yu TT, Zhang YE, Cheng SY", "title": "Requirement of Smurf-mediated endocytosis of Patched1 in sonic hedgehog signal reception.", "journal": "Elife 3:e02555 (2014)", "doi": "10.7554/eLife.02555"}, {"pmid": "22056910", "authors": "  Ok CY, Singh RR, Vega F", "title": "Aberrant activation of the hedgehog signaling pathway in malignant hematological neoplasms.", "journal": "Am J Pathol 180:2-11 (2012)", "doi": "10.1016/j.ajpath.2011.09.009"}, {"pmid": "26366162", "authors": "  Hsia EY, Gui Y, Zheng X", "title": "Regulation of Hedgehog signaling by ubiquitination.", "journal": "Front Biol (Beijing) 10:203-220 (2015)", "doi": "10.1007/s11515-015-1343-5"}, {"pmid": "29290584", "authors": "  Pusapati GV, Kong JH, Patel BB, Krishnan A, Sagner A, Kinnebrew M, Briscoe J, Aravind L, Rohatgi R", "title": "CRISPR Screens Uncover Genes that Regulate Target Cell Sensitivity to the Morphogen Sonic Hedgehog.", "journal": "Dev Cell 44:113-129.e8 (2018)", "doi": "10.1016/j.devcel.2017.12.003"}, {"pmid": "24582806", "authors": "  Pusapati GV, Hughes CE, Dorn KV, Zhang D, Sugianto P, Aravind L, Rohatgi R", "title": "EFCAB7 and IQCE regulate hedgehog signaling by tethering the EVC-EVC2 complex to the base of primary cilia.", "journal": "Dev Cell 28:483-96 (2014)", "doi": "10.1016/j.devcel.2014.01.021"}], "rel_pathway": ["hsa04120  Ubiquitin mediated proteolysis"], "ko_pathway": "ko04340", "genes": ["CUL1", "CUL3"]}, {"kegg_id": "hsa04350", "name": "TGF-beta signaling pathway - Homo sapiens (human)", "description": "The transforming growth factor-beta (TGF-beta) family members, which include TGF-betas, activins and bone morphogenetic proteins (BMPs), are structurally related secreted cytokines found in species ranging from worms and insects to mammals. A wide spectrum of cellular functions such as proliferation, apoptosis, differentiation and migration are regulated by TGF-beta family members. TGF-beta family member binds to the Type II receptor and recruits Type I, whereby Type II receptor phosphorylates and activates Type I. The Type I receptor, in turn, phosphorylates receptor-activated Smads ( R-Smads: Smad1, Smad2, Smad3, Smad5, and Smad8). Once phosphorylated, R-Smads associate with the co-mediator Smad, Smad4, and the heteromeric complex then translocates into the nucleus. In the nucleus, Smad complexes activate specific genes through cooperative interactions with other DNA-binding and coactivator (or co-repressor) proteins.", "class": "Environmental Information Processing; Signal transduction", "pathway_map": "hsa04350  TGF-beta signaling pathway", "network": ["", "ELEMENT   N00063  TGF-beta signaling pathway", "N01426  BMP9/10 signaling pathway", "N01428  BMP signaling pathway, BMP antagonist", "N01453  BMP signaling pathway", "N01454  AMH signaling pathway", "N01455  BMP15 signaling pathway", "N01456  Activin signaling pathway", "N01457  Myostatin signaling pathway", "N01458  BMP-HAMP signaling pathway", "N01459  Nodal signaling pathway", "N01460  Plasmin mediated activation of latent TGF-beta", "N01462  BMP9/10 signaling pathway, BMP9/10 coreceptor"], "drug": ["D00742  Etanercept (USAN/INN)", "D01583  Pirfenidone (JAN/USAN/INN)", "D02597  Adalimumab (USAN/INN)", "D02598  Infliximab (USAN/INN)", "D03441  Certolizumab pegol (USAN/INN)", "D04358  Golimumab (USAN/INN)", "D05146  Nerelimomab (USAN/INN)", "D05263  Onercept (USAN/INN)", "D05393  Pegsunercept (USAN)", "D06563  Belagenpumatucel-L (USAN)", "D07436  Afelimomab (INN)", "D09014  Terameprocol (INN/USAN)", "D09620  Fresolimumab (USAN/INN)", "D09670  Sotatercept (USAN/INN)", "D09944  Ozoralizumab (USAN)", "D10437  Galunisertib (USAN/INN)", "D11355  Elezanumab (USAN/INN)", "D11701  Luspatercept (USAN/INN)", "D11703  Opinercept (INN)", "D11893  Bintrafusp alfa (USAN/INN)", "D12547  Zilurgisertib (USAN/INN)", "D12548  Zilurgisertib fumarate (USAN)", "D12649  Unasnemab (USAN/INN)", "D12711  Fidrisertib (USAN/INN)", "D12793  Livmoniplimab (USAN/INN)", "D12801  Linavonkibart (USAN/INN)", "D12806  Tividenofusp alfa (USAN/INN)", "D12891  Elritercept (USAN/INN)"], "dblinks": "GO: 0007179", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["8646  CHRD; chordin [KO:K04657]", "9241  NOG; noggin [KO:K04658]", "4681  NBL1; NBL1, DAN family BMP antagonist [KO:K19558]", "100532736  MICOS10-NBL1; MICOS10-NBL1 readthrough [KO:K19558]", "26585  GREM1; gremlin 1, DAN family BMP antagonist [KO:K23318]", "64388  GREM2; gremlin 2, DAN family BMP antagonist [KO:K23318]", "7057  THBS1; thrombospondin 1 [KO:K16857]", "1634  DCN; decorin [KO:K04660]", "2331  FMOD; fibromodulin [KO:K08121]", "10637  LEFTY1; left-right determination factor 1 [KO:K04668]", "7044  LEFTY2; left-right determination factor 2 [KO:K04668]", "10468  FST; follistatin [KO:K04661]", "650  BMP2; bone morphogenetic protein 2 [KO:K21283]", "652  BMP4; bone morphogenetic protein 4 [KO:K04662]", "654  BMP6; bone morphogenetic protein 6 [KO:K16620]", "3625  INHBB; inhibin subunit beta B [KO:K22687]", "7018  TF; transferrin [KO:K14736]", "653  BMP5; bone morphogenetic protein 5 [KO:K04663]", "655  BMP7; bone morphogenetic protein 7 [KO:K16621]", "656  BMP8B; bone morphogenetic protein 8b [KO:K16622]", "353500  BMP8A; bone morphogenetic protein 8a [KO:K16622]", "8200  GDF5; growth differentiation factor 5 [KO:K04664]", "392255  GDF6; growth differentiation factor 6 [KO:K20012]", "151449  GDF7; growth differentiation factor 7 [KO:K20013]", "268  AMH; anti-Mullerian hormone [KO:K04665]", "3458  IFNG; interferon gamma [KO:K04687]", "7124  TNF; tumor necrosis factor [KO:K03156]", "79875  THSD4; thrombospondin type 1 domain containing 4 [KO:K23377]", "2200  FBN1; fibrillin 1 [KO:K06825]", "4052  LTBP1; latent transforming growth factor beta binding protein 1 [KO:K19559]", "7040  TGFB1; transforming growth factor beta 1 [KO:K13375]", "7042  TGFB2; transforming growth factor beta 2 [KO:K13376]", "7043  TGFB3; transforming growth factor beta 3 [KO:K13377]", "3624  INHBA; inhibin subunit beta A [KO:K04667]", "3626  INHBC; inhibin subunit beta C [KO:K22688]", "83729  INHBE; inhibin subunit beta E [KO:K22689]", "4838  NODAL; nodal growth differentiation factor [KO:K04666]", "657  BMPR1A; bone morphogenetic protein receptor type 1A [KO:K04673] [EC:2.7.11.30]", "658  BMPR1B; bone morphogenetic protein receptor type 1B [KO:K13578] [EC:2.7.11.30]", "90  ACVR1; activin A receptor type 1 [KO:K04675] [EC:2.7.11.30]", "659  BMPR2; bone morphogenetic protein receptor type 2 [KO:K04671] [EC:2.7.11.30]", "92  ACVR2A; activin A receptor type 2A [KO:K04670] [EC:2.7.11.30]", "148738  HJV; hemojuvelin BMP co-receptor [KO:K23100]", "4756  NEO1; neogenin 1 [KO:K06766]", "3077  HFE; homeostatic iron regulator [KO:K26535]", "7036  TFR2; transferrin receptor 2 [KO:K23910]", "7037  TFRC; transferrin receptor [KO:K06503]", "56963  RGMA; repulsive guidance molecule BMP co-receptor a [KO:K23096]", "285704  RGMB; repulsive guidance molecule BMP co-receptor b [KO:K06847]", "269  AMHR2; anti-Mullerian hormone receptor type 2 [KO:K04672] [EC:2.7.11.30]", "7046  TGFBR1; transforming growth factor beta receptor 1 [KO:K04674] [EC:2.7.11.30]", "7048  TGFBR2; transforming growth factor beta receptor 2 [KO:K04388] [EC:2.7.11.30]", "2014  EMP3; epithelial membrane protein 3 (MAM blood group) [KO:K26257]", "2615  LRRC32; leucine rich repeat containing 32 [KO:K26316]", "375387  NRROS; negative regulator of reactive oxygen species [KO:K26317]", "91  ACVR1B; activin A receptor type 1B [KO:K13567] [EC:2.7.11.30]", "93  ACVR2B; activin A receptor type 2B [KO:K13596] [EC:2.7.11.30]", "130399  ACVR1C; activin A receptor type 1C [KO:K13568] [EC:2.7.11.30]", "3547  IGSF1; immunoglobulin superfamily member 1 [KO:K26168]", "25805  BAMBI; BMP and activin membrane bound inhibitor [KO:K10162]", "4086  SMAD1; SMAD family member 1 [KO:K04676]", "4090  SMAD5; SMAD family member 5 [KO:K16790]", "4093  SMAD9; SMAD family member 9 [KO:K16791]", "4087  SMAD2; SMAD family member 2 [KO:K04500]", "4088  SMAD3; SMAD family member 3 [KO:K23605]", "4089  SMAD4; SMAD family member 4 [KO:K04501]", "4091  SMAD6; SMAD family member 6 [KO:K04677]", "4092  SMAD7; SMAD family member 7 [KO:K19631]", "57154  SMURF1; SMAD specific E3 ubiquitin protein ligase 1 [KO:K04678] [EC:2.3.2.26]", "64750  SMURF2; SMAD specific E3 ubiquitin protein ligase 2 [KO:K04678] [EC:2.3.2.26]", "9372  ZFYVE9; zinc finger FYVE-type containing 9 [KO:K04679]", "9765  ZFYVE16; zinc finger FYVE-type containing 16 [KO:K04679]", "9978  RBX1; ring-box 1 [KO:K03868] [EC:2.3.2.32]", "8454  CUL1; cullin 1 [KO:K03347]", "6500  SKP1; S-phase kinase associated protein 1 [KO:K03094]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "387  RHOA; ras homolog family member A [KO:K04513]", "6093  ROCK1; Rho associated coiled-coil containing protein kinase 1 [KO:K04514] [EC:2.7.11.1]", "5519  PPP2R1B; protein phosphatase 2 scaffold subunit Abeta [KO:K03456]", "5518  PPP2R1A; protein phosphatase 2 scaffold subunit Aalpha [KO:K03456]", "5515  PPP2CA; protein phosphatase 2 catalytic subunit alpha [KO:K04382] [EC:3.1.3.16]", "5516  PPP2CB; protein phosphatase 2 catalytic subunit beta [KO:K04382] [EC:3.1.3.16]", "6198  RPS6KB1; ribosomal protein S6 kinase B1 [KO:K04688] [EC:2.7.11.1]", "6199  RPS6KB2; ribosomal protein S6 kinase B2 [KO:K04688] [EC:2.7.11.1]", "57817  HAMP; hepcidin antimicrobial peptide [KO:K23106]", "3397  ID1; inhibitor of DNA binding 1 [KO:K04680]", "3398  ID2; inhibitor of DNA binding 2 [KO:K17693]", "3399  ID3; inhibitor of DNA binding 3 [KO:K17694]", "3400  ID4; inhibitor of DNA binding 4 [KO:K17695]", "5933  RBL1; RB transcriptional corepressor like 1 [KO:K04681]", "1874  E2F4; E2F transcription factor 4 [KO:K04682]", "1875  E2F5; E2F transcription factor 5 [KO:K04682]", "7027  TFDP1; transcription factor Dp-1 [KO:K04683]", "1387  CREBBP; CREB binding protein [KO:K04498] [EC:2.3.1.48]", "2033  EP300; E1A binding protein p300 [KO:K04498] [EC:2.3.1.48]", "6667  SP1; Sp1 transcription factor [KO:K04684]", "6498  SKIL; SKI like proto-oncogene [KO:K18499]", "6497  SKI; SKI proto-oncogene [KO:K26503]", "25942  SIN3A; SIN3 transcription regulator family member A [KO:K11644]", "3065  HDAC1; histone deacetylase 1 [KO:K06067] [EC:3.5.1.98]", "3066  HDAC2; histone deacetylase 2 [KO:K06067] [EC:3.5.1.98]", "9611  NCOR1; nuclear receptor corepressor 1 [KO:K04650]", "7050  TGIF1; TGFB induced factor homeobox 1 [KO:K19383]", "60436  TGIF2; TGFB induced factor homeobox 2 [KO:K19553]", "4609  MYC; MYC proto-oncogene, bHLH transcription factor [KO:K04377]", "1030  CDKN2B; cyclin dependent kinase inhibitor 2B [KO:K04685]", "5308  PITX2; paired like homeodomain 2 [KO:K04686]"], "compound": ["C14819  Fe3+"], "refs": [{"pmid": "12809600", "authors": "  Shi Y, Massague J.", "title": "Mechanisms of TGF-beta signaling from cell membrane to the nucleus.", "journal": "Cell 113:685-700 (2003)", "doi": "10.1016/S0092-8674(03)00432-X"}, {"pmid": "14534577", "authors": "  Derynck R, Zhang YE.", "title": "Smad-dependent and Smad-independent pathways in TGF-beta family signalling.", "journal": "Nature 425:577-84 (2003)", "doi": "10.1038/nature02006"}, {"pmid": "11252892", "authors": "  Massague J.", "title": "How cells read TGF-beta signals.", "journal": "Nat Rev Mol Cell Biol 1:169-78 (2000)", "doi": "10.1038/35043051"}, {"pmid": "14557817", "authors": "  Siegel PM, Massague J.", "title": "Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer.", "journal": "Nat Rev Cancer 3:807-21 (2003)", "doi": "10.1038/nrc1208"}, {"pmid": "14769828", "authors": "  Shimasaki S, Moore RK, Otsuka F, Erickson GF.", "title": "The bone morphogenetic protein system in mammalian reproduction.", "journal": "Endocr Rev 25:72-101 (2004)", "doi": "10.1210/er.2003-0007"}, {"pmid": "11252746", "authors": "  De Robertis EM, Larrain J, Oelgeschlager M, Wessely O.", "title": "The establishment of Spemann's organizer and patterning of the vertebrate embryo.", "journal": "Nat Rev Genet 1:171-81 (2000)", "doi": "10.1038/35042039"}, {"pmid": "12163231", "authors": "  Gumienny TL, Padgett RW.", "title": "The other side of TGF-beta superfamily signal regulation: thinking outside the cell.", "journal": "Trends Endocrinol Metab 13:295-9 (2002)", "doi": "10.1016/S1043-2760(02)00615-X"}, {"pmid": "11836504", "authors": "  Hamada H, Meno C, Watanabe D, Saijoh Y.", "title": "Establishment of vertebrate left-right asymmetry.", "journal": "Nat Rev Genet 3:103-13 (2002)", "doi": "10.1038/nrg732"}, {"pmid": "12466190", "authors": "  Chang H, Brown CW, Matzuk MM.", "title": "Genetic analysis of the mammalian transforming growth factor-beta superfamily.", "journal": "Endocr Rev 23:787-823 (2002)", "doi": "10.1210/er.2002-0003"}, {"pmid": "15063168", "authors": "  Chen Y, Mironova E, Whitaker LL, Edwards L, Yost HJ, Ramsdell AF.", "title": "ALK4 functions as a receptor for multiple TGF beta-related ligands to regulate left-right axis determination and mesoderm induction in Xenopus.", "journal": "Dev Biol 268:280-94 (2004)", "doi": "10.1016/j.ydbio.2003.12.035"}, {"pmid": "10519551", "authors": "  Onichtchouk D, Chen YG, Dosch R, Gawantka V, Delius H, Massague J, Niehrs C", "title": "Silencing of TGF-beta signalling by the pseudoreceptor BAMBI.", "journal": "Nature 401:480-5 (1999)", "doi": "10.1038/46794"}, {"pmid": "19758997", "authors": "  Yan X, Lin Z, Chen F, Zhao X, Chen H, Ning Y, Chen YG", "title": "Human BAMBI cooperates with Smad7 to inhibit transforming growth factor-beta signaling.", "journal": "J Biol Chem 284:30097-104 (2009)", "doi": "10.1074/jbc.M109.049304"}, {"pmid": "8093006", "authors": "  Hildebrand A, Romaris M, Rasmussen LM, Heinegard D, Twardzik DR, Border WA, Ruoslahti E", "title": "Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta.", "journal": "Biochem J 302 ( Pt 2):527-34 (1994)", "doi": "10.1042/bj3020527"}, {"pmid": "10934147", "authors": "  Soo C, Hu FY, Zhang X, Wang Y, Beanes SR, Lorenz HP, Hedrick MH, Mackool RJ, Plaas A, Kim SJ, Longaker MT, Freymiller E, Ting K", "title": "Differential expression of fibromodulin, a transforming growth factor-beta modulator, in fetal skin development and scarless repair.", "journal": "Am J Pathol 157:423-33 (2000)", "doi": "10.1016/s0002-9440(10)64555-5"}, {"pmid": "16642010", "authors": "  Anderson GJ, Frazer DM", "title": "Iron metabolism meets signal transduction.", "journal": "Nat Genet 38:503-4 (2006)", "doi": "10.1038/ng0506-503"}, {"pmid": "26735394", "authors": "  Canali S, Core AB, Zumbrennen-Bullough KB, Merkulova M, Wang CY, Schneyer AL, Pietrangelo A, Babitt JL", "title": "Activin B Induces Noncanonical SMAD1/5/8 Signaling via BMP Type I Receptors in Hepatocytes: Evidence for a Role in Hepcidin Induction by Inflammation in Male Mice.", "journal": "Endocrinology 157:1146-62 (2016)", "doi": "10.1210/en.2015-1747"}, {"pmid": "26160612", "authors": "  Ganz T, Nemeth E", "title": "Iron homeostasis in host defence and inflammation.", "journal": "Nat Rev Immunol 15:500-10 (2015)", "doi": "10.1038/nri3863"}, {"pmid": "15975920", "authors": "  Babitt JL, Zhang Y, Samad TA, Xia Y, Tang J, Campagna JA, Schneyer AL, Woolf CJ, Lin HY", "title": "Repulsive guidance molecule (RGMa), a DRAGON homologue, is a bone morphogenetic protein co-receptor.", "journal": "J Biol Chem 280:29820-7 (2005)", "doi": "10.1074/jbc.M503511200"}, {"pmid": "15671031", "authors": "  Samad TA, Rebbapragada A, Bell E, Zhang Y, Sidis Y, Jeong SJ, Campagna JA, Perusini S, Fabrizio DA, Schneyer AL, Lin HY, Brivanlou AH, Attisano L, Woolf CJ", "title": "DRAGON, a bone morphogenetic protein co-receptor.", "journal": "J Biol Chem 280:14122-9 (2005)", "doi": "10.1074/jbc.M410034200"}, {"pmid": "33925597", "authors": "  Vogt AS, Arsiwala T, Mohsen M, Vogel M, Manolova V, Bachmann MF", "title": "On Iron Metabolism and Its Regulation.", "journal": "Int J Mol Sci 22:ijms22094591 (2021)", "doi": "10.3390/ijms22094591"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04110  Cell cycle", "hsa04120  Ubiquitin mediated proteolysis", "hsa04210  Apoptosis"], "ko_pathway": "ko04350", "genes": ["CUL1"]}, {"kegg_id": "hsa04710", "name": "Circadian rhythm - Homo sapiens (human)", "description": "Circadian rhythm is an internal biological clock, which enables to sustain an approximately 24-hour rhythm in the absence of environmental cues. In mammals, the circadian clock mechanism consists of cell-autonomous transcription-translation feedback loops that drive rhythmic, 24-hour expression patterns of core clock components. The first negative feedback loop is a rhythmic transcription of period genes (PER1, PER2, and PER3) and chryptochrome genes (CRY1 and CRY2). PER and CRY proteins form a heterodimer, which acts on the CLOCK/BMAL1 heterodimer to repress its own transcription. PER and CRY proteins are phosphorylated by casein kinase epsilon (CKIepsilon), which leads to degradation and restarting of the cycle. The second loop is a positive feedback loop driven by the CLOCK/BMAL1 heterodimer, which initiates transcription of target genes containing E-box cis-regulatory enhancer sequences.", "class": "Organismal Systems; Environmental adaptation", "pathway_map": "hsa04710  Circadian rhythm", "dblinks": "GO: 0007623", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["6095  RORA; RAR related orphan receptor A [KO:K08532]", "6096  RORB; RAR related orphan receptor B [KO:K08533]", "6097  RORC; RAR related orphan receptor C [KO:K08534]", "9572  NR1D1; nuclear receptor subfamily 1 group D member 1 [KO:K03728]", "9975  NR1D2; nuclear receptor subfamily 1 group D member 2 [KO:K08531]", "4783  NFIL3; nuclear factor, interleukin 3 regulated [KO:K09059]", "406  BMAL1; basic helix-loop-helix ARNT like 1 [KO:K02296]", "1628  DBP; D-box binding PAR bZIP transcription factor [KO:K09056]", "8553  BHLHE40; basic helix-loop-helix family member e40 [KO:K03729]", "79365  BHLHE41; basic helix-loop-helix family member e41 [KO:K03730]", "1453  CSNK1D; casein kinase 1 delta [KO:K08959] [EC:2.7.11.1]", "1454  CSNK1E; casein kinase 1 epsilon [KO:K08960] [EC:2.7.11.1]", "102800317  TPTEP2-CSNK1E; TPTEP2-CSNK1E readthrough [KO:K08960] [EC:2.7.11.1]", "5187  PER1; period circadian regulator 1 [KO:K21944]", "8864  PER2; period circadian regulator 2 [KO:K02633]", "8863  PER3; period circadian regulator 3 [KO:K21945]", "1407  CRY1; cryptochrome circadian regulator 1 [KO:K02295]", "1408  CRY2; cryptochrome circadian regulator 2 [KO:K02295]", "9575  CLOCK; clock circadian regulator [KO:K02223] [EC:2.3.1.48]", "4862  NPAS2; neuronal PAS domain protein 2 [KO:K09026]", "1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]", "5562  PRKAA1; protein kinase AMP-activated catalytic subunit alpha 1 [KO:K07198] [EC:2.7.11.31]", "5563  PRKAA2; protein kinase AMP-activated catalytic subunit alpha 2 [KO:K07198] [EC:2.7.11.31]", "5564  PRKAB1; protein kinase AMP-activated non-catalytic subunit beta 1 [KO:K07199]", "5565  PRKAB2; protein kinase AMP-activated non-catalytic subunit beta 2 [KO:K07199]", "5571  PRKAG1; protein kinase AMP-activated non-catalytic subunit gamma 1 [KO:K07200]", "53632  PRKAG3; protein kinase AMP-activated non-catalytic subunit gamma 3 [KO:K07200]", "51422  PRKAG2; protein kinase AMP-activated non-catalytic subunit gamma 2 [KO:K07200]", "9978  RBX1; ring-box 1 [KO:K03868] [EC:2.3.2.32]", "8454  CUL1; cullin 1 [KO:K03347]", "6500  SKP1; S-phase kinase associated protein 1 [KO:K03094]", "8945  BTRC; beta-transducin repeat containing E3 ubiquitin protein ligase [KO:K03362]", "23291  FBXW11; F-box and WD repeat domain containing 11 [KO:K03362]", "26224  FBXL3; F-box and leucine rich repeat protein 3 [KO:K10269]"], "compound": ["C00076  Calcium cation", "C00575  3',5'-Cyclic AMP"], "refs": [{"pmid": "27990019", "authors": "  Takahashi JS", "title": "Transcriptional architecture of the mammalian circadian clock.", "journal": "Nat Rev Genet 18:164-179 (2017)", "doi": "10.1038/nrg.2016.150"}, {"pmid": "32226546", "authors": "  Wang S, Li F, Lin Y, Wu B", "title": "Targeting REV-ERBalpha for therapeutic purposes: promises and challenges.", "journal": "Theranostics 10:4168-4182 (2020)", "doi": "10.7150/thno.43834"}, {"pmid": "12015613", "authors": "  Panda S, Hogenesch JB, Kay SA.", "title": "Circadian rhythms from flies to human.", "journal": "Nature 417:329-35 (2002)", "doi": "10.1038/417329a"}, {"pmid": "12397359", "authors": "  Honma S, Kawamoto T, Takagi Y, Fujimoto K, Sato F, Noshiro M, Kato Y, Honma K.", "title": "Dec1 and Dec2 are regulators of the mammalian molecular clock.", "journal": "Nature 419:841-4 (2002)", "doi": "10.1038/nature01123"}, {"pmid": "12724733", "authors": "  Fu L, Lee CC.", "title": "The circadian clock: pacemaker and tumour suppressor.", "journal": "Nat Rev Cancer 3:350-61 (2003)", "doi": "10.1038/nrc1072"}, {"pmid": "12507418", "authors": "  Schibler U, Sassone-Corsi P.", "title": "A web of circadian pacemakers.", "journal": "Cell 111:919-22 (2002)", "doi": "10.1016/S0092-8674(02)01225-4"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04120  Ubiquitin mediated proteolysis", "hsa04713  Circadian entrainment"], "ko_pathway": "ko04710", "genes": ["CUL1", "PER1"]}, {"kegg_id": "hsa04971", "name": "Gastric acid secretion - Homo sapiens (human)", "description": "Gastric acid is a key factor in normal upper gastrointestinal functions, including protein digestion and calcium and iron absorption, as well as providing some protection against bacterial infections. The principal stimulants of acid secretion at the level of the parietal cell are histamine (paracrine), gastrin (hormonal), and acetycholine (ACh; neurocrine). Stimulation of acid secretion typically involves an initial elevation of intracellular calcium and cAMP, followed by activation of protein kinase cascades, which trigger the translocation of the proton pump, H+,K+-ATPase, from cytoplasmic tubulovesicles to the apical plasma membrane and thereby H+ secretion into the stomach lumen.", "class": "Organismal Systems; Digestive system", "pathway_map": "hsa04971  Gastric acid secretion", "drug": ["D00113  Atropine (USP)", "D00147  Hyoscyamine (USP)", "D00295  Cimetidine (JP18/USP/INN)", "D00318  Famotidine (JP18/USP/INN)", "D00355  Lansoprazole (JP18/USP/INN)", "D00397  Tropicamide (JP18/USP/INN)", "D00422  Ranitidine (USAN/INN)", "D00440  Nizatidine (JP18/USP/INN)", "D00442  Octreotide (USAN/INN)", "D00455  Omeprazole (JP18/USP/INN)", "D00481  Propantheline bromide (JP18/USP/INN)", "D00540  Glycopyrrolate (USP)", "D00673  Ranitidine hydrochloride (JP18/USP)", "D00715  Methscopolamine bromide (USP)", "D00716  Clidinium bromide (USP/INN)", "D00717  Dicyclomine hydrochloride (JAN/USP)", "D00719  Hyoscyamine sulfate (USP)", "D00720  Mepenzolate bromide (JP18/INN)", "D00721  Methanthelinium bromide (INN)", "D00724  Rabeprazole sodium (JP18/USP)", "D00999  Acetylcholine chloride (JP18/USP/INN)", "D01000  Bethanechol chloride (JP18/USP)", "D01003  Hexocyclium metilsulfate (INN)", "D01005  Isopropamide iodide (JAN/USP/INN)", "D01006  Oxyphencyclimine hydrochloride (JAN)", "D01131  Lafutidine (JP18/INN)", "D01165  Piperidolate hydrochloride (JAN)", "D01187  Betazole hydrochloride (JAN)", "D01207  Omeprazole sodium (USAN)", "D01297  Pirenzepine hydrochloride (USAN)", "D01315  Methylbenactyzium bromide (JP18/INN)", "D01359  Etomidoline (JAN/INN)", "D01451  Scopolamine butylbromide (JP18)", "D01467  Roxatidine acetate hydrochloride (JP18/USAN)", "D01491  Butropium bromide (JP18/INN)", "D01521  Pipethanate hydrochloride (JAN)", "D01538  Valethamate bromide (JAN)", "D01600  Diphenylpiperidinomethyldioxolan iodide (JAN)", "D01631  Pentagastrin (JAN/USAN/INN)", "D01648  Hyoscyamine methylbromide (JAN)", "D01815  Oxapium iodide (JP18/INN)", "D01818  Proglumide (JP18/USAN/INN)", "D01861  Pibutidine hydrochloride (JAN)", "D01875  Tiquizium bromide (JAN/INN)", "D01920  Tenatoprazole (JAN/INN)", "D01955  Aclatonium napadisilate (JAN)", "D01976  N-Methylscopolamine methylsulfate (JAN)", "D01984  Esomeprazole magnesium (USP)", "D01987  Pipethanate ethobromide (JAN)", "D02069  Atropine sulfate (JP18/USP)", "D02108  Indium In 111 pentetreotide (USP)", "D02250  Octreotide acetate (JAN)", "D02535  Timepidium bromide hydrate (JP18)", "D02593  Pantoprazole sodium (USP)", "D03503  Cimetidine hydrochloride (USP)", "D03605  Crofelemer (USAN)", "D03889  Donetidine (USAN)", "D03979  Elucaine (USAN)", "D04056  Esomeprazole sodium (USAN)", "D04057  Esoxybutynin chloride (USAN)", "D04098  Etintidine hydrochloride (USAN)", "D04445  Histamine phosphate (USP)", "D04479  Hyoscyamine hydrobromide (USP)", "D04517  Impromidine hydrochloride (USAN)", "D04666  Lanreotide acetate (JAN/USAN)", "D04680  Lavoltidine succinate (USAN)", "D04794  Lupitidine hydrochloride (USAN)", "D04970  Methacholine chloride (JAN/USP/INN)", "D05004  Metiamide (USAN/INN)", "D05012  Metoquizine (USAN/INN)", "D05230  Octreotide pamoate (USAN)", "D05259  Omeprazole magnesium (USP)", "D05261  Omeprazole sodium injection (JAN)", "D05276  Pirenzepine hydrochloride hydrate (JP18)", "D05353  Pantoprazole (USAN/INN)", "D05699  Ranitidine bismuth citrate (USAN)", "D05722  Revaprazan hydrochloride (USAN)", "D05812  Seglitide acetate (USAN)", "D05900  Timoprazole (INN)", "D05901  Picoprazole (INN)", "D05906  Leminoprazole (INN)", "D05939  Sufotidine (USAN/INN)", "D06157  Tiotidine (USAN/INN)", "D06192  Toquizine (USAN)", "D06281  Vapreotide (USAN/INN)", "D06355  Zaltidine hydrochloride (USAN)", "D06495  Octreotide acetate (USP)", "D06878  Diphemanil metilsulfate (INN)", "D07072  Niperotidine (INN)", "D07431  Somatostatin (INN)", "D07820  Dicycloverine (INN)", "D07917  Esomeprazole (INN)", "D08325  Oxyphencyclimine (INN)", "D08382  Piperidolate (INN)", "D08384  Pipethanate (INN)", "D08389  Pirenzepine (USAN/INN)", "D08463  Rabeprazole (INN)", "D08494  Roxatidine (INN)", "D08495  Roxatidine acetate (BAN)", "D08595  Tiemonium methylsulfate", "D08903  Dexlansoprazole (INN/USAN)", "D09339  Esomeprazole potassium (USAN)", "D09837  Penaprazole sodium hydrate (JAN)", "D09988  Vapreotide acetate (USAN)", "D10120  Esomeprazole strontium (USAN)", "D10134  Lumacaftor (USAN/INN)", "D10147  Pasireotide (USAN)", "D10466  Vonoprazan fumarate (JAN/USAN)", "D10497  Pasireotide diaspartate", "D10566  Pasireotide pamoate (JAN)", "D10685  Lumacaftor and ivacaftor", "D11033  Lutetium (177Lu) oxodotreotide (INN)", "D11042  Tezacaftor and ivacaftor", "D11114  Esomeprazole magnesium dihydrate", "D11192  Veldoreotide (USAN/INN)", "D11204  Octreotide hydrochloride (USAN)", "D11700  Elexacaftor, ivacaftor and tezacaftor", "D11724  Galicaftor (USAN/INN)", "D11784  Vonoprazan (USAN/INN)", "D11882  Copper Cu 64 dotatate", "D12140  Navocaftor (USAN/INN)", "D12246  Tegoprazan (INN)", "D12431  Lutetium Lu177 edotreotide (USAN)", "D12454  Icenticaftor (USAN/INN)", "D12477  Paltusotine (USAN/INN)", "D12478  Paltusotine hydrochloride (USAN)", "D12718  Vanzacaftor (USAN/INN)", "D12719  Vanzacaftor calcium (USAN)", "D12816  Dexlansoprazole sesquihydrate", "D12907  Actinium Ac 225 dotatate (USAN)"], "dblinks": "GO: 0001696", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["1131  CHRM3; cholinergic receptor muscarinic 3 [KO:K04131]", "2520  GAST; gastrin [KO:K13768]", "887  CCKBR; cholecystokinin B receptor [KO:K04195]", "2776  GNAQ; G protein subunit alpha q [KO:K04634]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "7430  EZR; ezrin [KO:K08007]", "71  ACTG1; actin gamma 1 [KO:K05692]", "60  ACTB; actin beta [KO:K05692]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "810  CALML3; calmodulin like 3 [KO:K02183]", "805  CALM2; calmodulin 2 [KO:K02183]", "808  CALM3; calmodulin 3 [KO:K02183]", "801  CALM1; calmodulin 1 [KO:K02183]", "163688  CALML6; calmodulin like 6 [KO:K02183]", "51806  CALML5; calmodulin like 5 [KO:K02183]", "91860  CALML4; calmodulin like 4 [KO:K02183]", "815  CAMK2A; calcium/calmodulin dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]", "817  CAMK2D; calcium/calmodulin dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]", "816  CAMK2B; calcium/calmodulin dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]", "818  CAMK2G; calcium/calmodulin dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]", "4638  MYLK; myosin light chain kinase [KO:K00907] [EC:2.7.11.18]", "85366  MYLK2; myosin light chain kinase 2 [KO:K00907] [EC:2.7.11.18]", "91807  MYLK3; myosin light chain kinase 3 [KO:K00907] [EC:2.7.11.18]", "340156  MYLK4; myosin light chain kinase family member 4 [KO:K00907] [EC:2.7.11.18]", "3274  HRH2; histamine receptor H2 [KO:K04150]", "2778  GNAS; GNAS complex locus [KO:K04632]", "107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]", "108  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]", "109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]", "196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]", "113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]", "114  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]", "115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]", "6750  SST; somatostatin [KO:K05237]", "6752  SSTR2; somatostatin receptor 2 [KO:K04218]", "2770  GNAI1; G protein subunit alpha i1 [KO:K04630]", "2773  GNAI3; G protein subunit alpha i3 [KO:K04630]", "2771  GNAI2; G protein subunit alpha i2 [KO:K04630]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "495  ATP4A; ATPase H+/K+ transporting subunit alpha [KO:K01542] [EC:7.2.2.19]", "496  ATP4B; ATPase H+/K+ transporting subunit beta [KO:K01543] [EC:7.2.2.19]", "9992  KCNE2; potassium voltage-gated channel subfamily E regulatory subunit 2 [KO:K04896]", "3784  KCNQ1; potassium voltage-gated channel subfamily Q member 1 [KO:K04926]", "3758  KCNJ1; potassium inwardly rectifying channel subfamily J member 1 [KO:K04995]", "3759  KCNJ2; potassium inwardly rectifying channel subfamily J member 2 [KO:K04996]", "3766  KCNJ10; potassium inwardly rectifying channel subfamily J member 10 [KO:K05003]", "3772  KCNJ15; potassium inwardly rectifying channel subfamily J member 15 [KO:K05008]", "3773  KCNJ16; potassium inwardly rectifying channel subfamily J member 16 [KO:K05009]", "1080  CFTR; CF transmembrane conductance regulator [KO:K05031] [EC:5.6.1.6]", "3776  KCNK2; potassium two pore domain channel subfamily K member 2 [KO:K04913]", "54207  KCNK10; potassium two pore domain channel subfamily K member 10 [KO:K04920]", "476  ATP1A1; ATPase Na+/K+ transporting subunit alpha 1 [KO:K01539] [EC:7.2.2.13]", "477  ATP1A2; ATPase Na+/K+ transporting subunit alpha 2 [KO:K01539] [EC:7.2.2.13]", "478  ATP1A3; ATPase Na+/K+ transporting subunit alpha 3 [KO:K01539] [EC:7.2.2.13]", "480  ATP1A4; ATPase Na+/K+ transporting subunit alpha 4 [KO:K01539] [EC:7.2.2.13]", "23439  ATP1B4; ATPase Na+/K+ transporting family member beta 4 [KO:K01540]", "481  ATP1B1; ATPase Na+/K+ transporting subunit beta 1 [KO:K01540]", "482  ATP1B2; ATPase Na+/K+ transporting subunit beta 2 [KO:K01540]", "483  ATP1B3; ATPase Na+/K+ transporting subunit beta 3 [KO:K01540]", "6548  SLC9A1; solute carrier family 9 member A1 [KO:K05742]", "389015  SLC9A4; solute carrier family 9 member A4 [KO:K13961]", "760  CA2; carbonic anhydrase 2 [KO:K18245] [EC:4.2.1.1]", "115111  SLC26A7; solute carrier family 26 member 7 [KO:K13962]", "6522  SLC4A2; solute carrier family 4 member 2 [KO:K13855]"], "compound": ["C00001  H2O", "C00011  CO2", "C00076  Calcium cation", "C00080  H+", "C00165  Diacylglycerol", "C00238  Potassium cation", "C00288  HCO3-", "C00388  Histamine", "C00575  3',5'-Cyclic AMP", "C00698  Cl-", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C01330  Sodium cation", "C01353  Carbonic acid", "C01996  Acetylcholine"], "refs": [{"pmid": "18474247", "authors": "  Schubert ML, Peura DA", "title": "Control of gastric acid secretion in health and disease.", "journal": "Gastroenterology 134:1842-60 (2008)", "doi": "10.1053/j.gastro.2008.05.021"}, {"pmid": "9307437", "authors": "  Urushidani T, Forte JG", "title": "Signal transduction and activation of acid secretion in the parietal cell.", "journal": "J Membr Biol 159:99-111 (1997)", "doi": "10.1007/s002329900274"}, {"pmid": "12500969", "authors": "  Yao X, Forte JG", "title": "Cell biology of acid secretion by the parietal cell.", "journal": "Annu Rev Physiol 65:103-31 (2003)", "doi": "10.1146/annurev.physiol.65.072302.114200"}, {"pmid": "17928547", "authors": "  Heitzmann D, Warth R", "title": "No potassium, no acid: K+ channels and gastric acid secretion.", "journal": "Physiology (Bethesda) 22:335-41 (2007)", "doi": "10.1152/physiol.00016.2007"}, {"pmid": "19889964", "authors": "  Kopic S, Murek M, Geibel JP", "title": "Revisiting the parietal cell.", "journal": "Am J Physiol Cell Physiol 298:C1-C10 (2010)", "doi": "10.1152/ajpcell.00478.2009"}, {"pmid": "15703676", "authors": "  Schubert ML", "title": "Gastric secretion.", "journal": "Curr Opin Gastroenterol 20:519-25 (2004)", "doi": "10.1097/00001574-200411000-00003"}, {"pmid": "20148676", "authors": "  Forte JG, Zhu L", "title": "Apical recycling of the gastric parietal cell H,K-ATPase.", "journal": "Annu Rev Physiol 72:273-96 (2010)", "doi": "10.1146/annurev-physiol-021909-135744"}, {"pmid": "18061403", "authors": "  Szaszak M, Christian F, Rosenthal W, Klussmann E", "title": "Compartmentalized cAMP signalling in regulated exocytic processes in non-neuronal cells.", "journal": "Cell Signal 20:590-601 (2008)", "doi": "10.1016/j.cellsig.2007.10.020"}, {"pmid": "18626068", "authors": "  Heitzmann D, Warth R", "title": "Physiology and pathophysiology of potassium channels in gastrointestinal epithelia.", "journal": "Physiol Rev 88:1119-82 (2008)", "doi": "10.1152/physrev.00020.2007"}, {"pmid": "15579540", "authors": "  Heitzmann D, Grahammer F, von Hahn T, Schmitt-Graff A, Romeo E, Nitschke R, Gerlach U, Lang HJ, Verrey F, Barhanin J, Warth R", "title": "Heteromeric KCNE2/KCNQ1 potassium channels in the luminal membrane of gastric parietal cells.", "journal": "J Physiol 561:547-57 (2004)", "doi": "10.1113/jphysiol.2004.075168"}], "rel_pathway": ["hsa04020  Calcium signaling pathway", "hsa04530  Tight junction", "hsa04974  Protein digestion and absorption"], "ko_pathway": "ko04971", "genes": ["EZR"]}, {"kegg_id": "hsa04668", "name": "TNF signaling pathway - Homo sapiens (human)", "description": "Tumor necrosis factor (TNF), as a critical cytokine, can induce a wide range of intracellular signal pathways including apoptosis and cell survival as well as inflammation and immunity. Activated TNF is assembled to a homotrimer and binds to its receptors (TNFR1, TNFR2) resulting in the trimerization of TNFR1 or TNFR2. TNFR1 is expressed by nearly all cells and is the major receptor for TNF (also called TNF-alpha). In contrast, TNFR2 is expressed in limited cells such as CD4 and CD8 T lymphocytes, endothelial cells, microglia, oligodendrocytes, neuron subtypes, cardiac myocytes, thymocytes and human mesenchymal stem cells. It is the receptor for both TNF and LTA (also called TNF-beta). Upon binding of the ligand, TNFR mediates the association of some adaptor proteins such as TRADD or TRAF2, which in turn initiate recruitment of signal transducers. TNFR1 signaling induces activation of many genes, primarily controlled by two distinct pathways, NF-kappa B pathway and the MAPK cascade, or apoptosis and necroptosis. TNFR2 signaling activates NF-kappa B pathway including PI3K-dependent NF-kappa B pathway and JNK pathway leading to survival.", "class": "Environmental Information Processing; Signal transduction", "pathway_map": "hsa04668  TNF signaling pathway", "network": ["", "ELEMENT   N00145  Extrinsic apoptotic pathway", "N00151  TNF-NFKB signaling pathway", "N00374  TNF-IRF1 signaling pathway", "N00444  TNF-p38 signaling pathway", "N00446  TNF-JNK signaling pathway", "N01583  Regulation of extrinsic apoptotic pathway, XIAP"], "drug": ["D00754  Thalidomide (JAN/USP/INN)", "D01583  Pirfenidone (JAN/USAN/INN)", "D03793  Ilomastat (USAN/INN)", "D03795  Marimastat (USAN/INN)", "D03797  Prinomastat (USAN/INN)", "D03800  Rebimastat (USAN/INN)", "D04687  Lenalidomide (JAN/USAN/INN)", "D04690  Lenercept (USAN/INN)", "D06017  Tebufelone (USAN/INN)", "D06570  Camobucol (USAN/INN)", "D06582  Elsibucol (USAN/INN)", "D06619  Mifamurtide (USAN)", "D06648  Succinobucol (USAN)", "D08562  Tasonermin (INN)", "D08976  Pomalidomide (JAN/USAN/INN)", "D09813  Lenalidomide hydrate (JAN)", "D11121  Gimsilumab (USAN/INN)", "D11385  Inarigivir soproxil (USAN)", "D11498  Quetmolimab (USAN)", "D11703  Opinercept (INN)", "D12306  Ordesekimab (USAN)", "D12352  Eclitasertib (USAN/INN)", "D12464  Dazukibart (USAN)", "D12790  Adalimumab fosimdesonide (USAN/INN)", "D12810  Falbikitug (USAN/INN)", "D12821  Flizasertib (USAN/INN)", "D12846  Ocadusertib (USAN)"], "dblinks": "GO: 0033209", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["7124  TNF; tumor necrosis factor [KO:K03156]", "7132  TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158]", "9530  BAG4; BAG cochaperone 4 [KO:K09558]", "6868  ADAM17; ADAM metallopeptidase domain 17 [KO:K06059] [EC:3.4.24.86]", "64285  RHBDF1; rhomboid 5 homolog 1 [KO:K27588]", "79651  RHBDF2; rhomboid 5 homolog 2 [KO:K27588]", "83786  FRMD8; FERM domain containing 8 [KO:K23972]", "8717  TRADD; TNFRSF1A associated via death domain [KO:K03171]", "7186  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]", "7188  TRAF5; TNF receptor associated factor 5 [KO:K09849]", "8737  RIPK1; receptor interacting serine/threonine kinase 1 [KO:K02861] [EC:2.7.11.1]", "329  BIRC2; baculoviral IAP repeat containing 2 [KO:K16060]", "330  BIRC3; baculoviral IAP repeat containing 3 [KO:K16060]", "6885  MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO:K04427] [EC:2.7.11.25]", "10454  TAB1; TGF-beta activated kinase 1 (MAP3K7) binding protein 1 [KO:K04403]", "23118  TAB2; TGF-beta activated kinase 1 (MAP3K7) binding protein 2 [KO:K04404]", "257397  TAB3; TGF-beta activated kinase 1 (MAP3K7) binding protein 3 [KO:K12793]", "6416  MAP2K4; mitogen-activated protein kinase kinase 4 [KO:K04430] [EC:2.7.12.2]", "5609  MAP2K7; mitogen-activated protein kinase kinase 7 [KO:K04431] [EC:2.7.12.2]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "83737  ITCH; itchy E3 ubiquitin protein ligase [KO:K05632] [EC:2.3.2.26]", "8837  CFLAR; CASP8 and FADD like apoptosis regulator [KO:K04724]", "5606  MAP2K3; mitogen-activated protein kinase kinase 3 [KO:K04432] [EC:2.7.12.2]", "5608  MAP2K6; mitogen-activated protein kinase kinase 6 [KO:K04433] [EC:2.7.12.2]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "1051  CEBPB; CCAAT enhancer binding protein beta [KO:K10048]", "4217  MAP3K5; mitogen-activated protein kinase kinase kinase 5 [KO:K04426] [EC:2.7.11.25]", "9020  MAP3K14; mitogen-activated protein kinase kinase kinase 14 [KO:K04466] [EC:2.7.11.25]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "1326  MAP3K8; mitogen-activated protein kinase kinase kinase 8 [KO:K04415] [EC:2.7.11.25]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "9252  RPS6KA5; ribosomal protein S6 kinase A5 [KO:K04445] [EC:2.7.11.1]", "8986  RPS6KA4; ribosomal protein S6 kinase A4 [KO:K16510] [EC:2.7.11.1]", "1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]", "10488  CREB3; cAMP responsive element binding protein 3 [KO:K09048]", "90993  CREB3L1; cAMP responsive element binding protein 3 like 1 [KO:K09048]", "64764  CREB3L2; cAMP responsive element binding protein 3 like 2 [KO:K09048]", "84699  CREB3L3; cAMP responsive element binding protein 3 like 3 [KO:K09048]", "148327  CREB3L4; cAMP responsive element binding protein 3 like 4 [KO:K09048]", "1386  ATF2; activating transcription factor 2 [KO:K04450]", "468  ATF4; activating transcription factor 4 [KO:K04374]", "9586  CREB5; cAMP responsive element binding protein 5 [KO:K09047]", "1388  ATF6B; activating transcription factor 6 beta [KO:K09049]", "11035  RIPK3; receptor interacting serine/threonine kinase 3 [KO:K08847] [EC:2.7.11.1]", "8772  FADD; Fas associated via death domain [KO:K02373]", "841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]", "843  CASP10; caspase 10 [KO:K04400] [EC:3.4.22.63]", "840  CASP7; caspase 7 [KO:K04397] [EC:3.4.22.60]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "197259  MLKL; mixed lineage kinase domain like pseudokinase [KO:K08849] [EC:2.7.11.1]", "192111  PGAM5; PGAM family member 5, mitochondrial serine/threonine protein phosphatase [KO:K15637] [EC:3.1.3.16]", "10059  DNM1L; dynamin 1 like [KO:K17065] [EC:3.6.5.5]", "1540  CYLD; CYLD lysine 63 deubiquitinase [KO:K08601] [EC:3.4.19.12]", "331  XIAP; X-linked inhibitor of apoptosis [KO:K04725] [EC:2.3.2.27]", "6347  CCL2; C-C motif chemokine ligand 2 [KO:K14624]", "6352  CCL5; C-C motif chemokine ligand 5 [KO:K12499]", "6364  CCL20; C-C motif chemokine ligand 20 [KO:K14625]", "2919  CXCL1; C-X-C motif chemokine ligand 1 [KO:K05505]", "2920  CXCL2; C-X-C motif chemokine ligand 2 [KO:K05505]", "2921  CXCL3; C-X-C motif chemokine ligand 3 [KO:K05505]", "6374  CXCL5; C-X-C motif chemokine ligand 5 [KO:K05506]", "6372  CXCL6; C-X-C motif chemokine ligand 6 [KO:K05506]", "3627  CXCL10; C-X-C motif chemokine ligand 10 [KO:K12671]", "6376  CX3CL1; C-X3-C motif chemokine ligand 1 [KO:K05508]", "1435  CSF1; colony stimulating factor 1 [KO:K05453]", "1437  CSF2; colony stimulating factor 2 [KO:K05427]", "355  FAS; Fas cell surface death receptor [KO:K04390]", "8809  IL18R1; interleukin 18 receptor 1 [KO:K05173]", "182  JAG1; jagged canonical Notch ligand 1 [KO:K06052]", "3553  IL1B; interleukin 1 beta [KO:K04519]", "3569  IL6; interleukin 6 [KO:K05405]", "3600  IL15; interleukin 15 [KO:K05433]", "3976  LIF; LIF interleukin 6 family cytokine [KO:K05419]", "4049  LTA; lymphotoxin alpha [KO:K05468]", "602  BCL3; BCL3 transcription coactivator [KO:K09258]", "9021  SOCS3; suppressor of cytokine signaling 3 [KO:K04696]", "7128  TNFAIP3; TNF alpha induced protein 3 [KO:K11859] [EC:3.4.19.12]", "7185  TRAF1; TNF receptor associated factor 1 [KO:K03172]", "3726  JUNB; JunB proto-oncogene, AP-1 transcription factor subunit [KO:K09028]", "4314  MMP3; matrix metallopeptidase 3 [KO:K01394] [EC:3.4.24.17]", "4318  MMP9; matrix metallopeptidase 9 [KO:K01403] [EC:3.4.24.35]", "4323  MMP14; matrix metallopeptidase 14 [KO:K07763] [EC:3.4.24.80]", "1906  EDN1; endothelin 1 [KO:K16366]", "7424  VEGFC; vascular endothelial growth factor C [KO:K05449]", "2277  VEGFD; vascular endothelial growth factor D [KO:K05449]", "64127  NOD2; nucleotide binding oligomerization domain containing 2 [KO:K10165]", "3383  ICAM1; intercellular adhesion molecule 1 [KO:K06490]", "6401  SELE; selectin E [KO:K06494]", "7412  VCAM1; vascular cell adhesion molecule 1 [KO:K06527]", "5743  PTGS2; prostaglandin-endoperoxide synthase 2 [KO:K11987] [EC:1.14.99.1]", "7133  TNFRSF1B; TNF receptor superfamily member 1B [KO:K05141]", "7187  TRAF3; TNF receptor associated factor 3 [KO:K03174]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "153090  DAB2IP; DAB2 interacting protein [KO:K19901]", "3659  IRF1; interferon regulatory factor 1 [KO:K09444]", "3456  IFNB1; interferon beta 1 [KO:K05415]"], "refs": [{"pmid": "23085193", "authors": "  Chu WM", "title": "Tumor necrosis factor.", "journal": "Cancer Lett 328:222-5 (2013)", "doi": "10.1016/j.canlet.2012.10.014"}, {"pmid": "11897488", "authors": "  MacEwan DJ", "title": "TNF receptor subtype signalling: differences and cellular consequences.", "journal": "Cell Signal 14:477-92 (2002)", "doi": "10.1016/S0898-6568(01)00262-5"}, {"pmid": "22296764", "authors": "  Newton K, Dixit VM", "title": "Signaling in innate immunity and inflammation.", "journal": "Cold Spring Harb Perspect Biol 4:a006049 (2012)", "doi": "10.1101/cshperspect.a006049"}, {"pmid": "10581243", "authors": "  Pomerantz JL, Baltimore D", "title": "NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase.", "journal": "EMBO J 18:6694-704 (1999)", "doi": "10.1093/emboj/18.23.6694"}, {"pmid": "21232019", "authors": "  Naude PJ, den Boer JA, Luiten PG, Eisel UL", "title": "Tumor necrosis factor receptor cross-talk.", "journal": "FEBS J 278:888-98 (2011)", "doi": "10.1111/j.1742-4658.2011.08017.x"}, {"pmid": "20489699", "authors": "  Faustman D, Davis M", "title": "TNF receptor 2 pathway: drug target for autoimmune diseases.", "journal": "Nat Rev Drug Discov 9:482-93 (2010)", "doi": "10.1038/nrd3030"}, {"pmid": "14532286", "authors": "  Chan FK, Shisler J, Bixby JG, Felices M, Zheng L, Appel M, Orenstein J, Moss B, Lenardo MJ", "title": "A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses.", "journal": "J Biol Chem 278:51613-21 (2003)", "doi": "10.1074/jbc.M305633200"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04064  NF-kappa B signaling pathway", "hsa04120  Ubiquitin mediated proteolysis", "hsa04151  PI3K-Akt signaling pathway", "hsa04210  Apoptosis"], "ko_pathway": "ko04668", "genes": ["CSF1", "AKT2", "BIRC3", "AKT1", "MAPK13"]}, {"kegg_id": "hsa05323", "name": "Rheumatoid arthritis - Homo sapiens (human)", "description": "Rheumatoid arthritis (RA) is a chronic autoimmune joint disease where persistent inflammation affects bone remodeling leading to progressive bone destruction. In RA, abnormal activation of the immune system elevates pro-inflammatory cytokines and chemokines levels, which can promote synovial angiogenesis and leukocyte infiltration. The synovium forms a hyperplastic pannus with infiltrated macrophage-like and fibroblast-like synoviocytes and invades joints by secreting proteinases and inducing osteoclast differentiation.", "class": "Human Diseases; Immune disease", "pathway_map": "hsa05323  Rheumatoid arthritis", "disease": ["H00630  Rheumatoid arthritis"], "drug": ["D00742  Etanercept (USAN/INN)", "D02597  Adalimumab (USAN/INN)", "D02598  Infliximab (USAN/INN)", "D03203  Abatacept (USAN/INN)", "D03441  Certolizumab pegol (USAN/INN)", "D04358  Golimumab (USAN/INN)", "D08866  Baminercept (USAN/INN)", "D08955  Odanacatib (JAN/USAN)", "D09704  Atacicept (USAN/INN)", "D09967  Secukinumab (USAN/INN)", "D11020  Diclofenac etalhyaluronate sodium (JAN)", "D11121  Gimsilumab (USAN/INN)", "D11343  Otilimab (USAN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["941  CD80; CD80 molecule [KO:K05412]", "942  CD86; CD86 molecule [KO:K05413]", "940  CD28; CD28 molecule [KO:K06470]", "1493  CTLA4; cytotoxic T-lymphocyte associated protein 4 [KO:K06538]", "3108  HLA-DMA; major histocompatibility complex, class II, DM alpha [KO:K06752]", "3109  HLA-DMB; major histocompatibility complex, class II, DM beta [KO:K06752]", "3111  HLA-DOA; major histocompatibility complex, class II, DO alpha [KO:K06752]", "3112  HLA-DOB; major histocompatibility complex, class II, DO beta [KO:K06752]", "3113  HLA-DPA1; major histocompatibility complex, class II, DP alpha 1 [KO:K06752]", "3115  HLA-DPB1; major histocompatibility complex, class II, DP beta 1 [KO:K06752]", "3117  HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 [KO:K06752]", "3118  HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2 [KO:K06752]", "3119  HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 [KO:K06752]", "3122  HLA-DRA; major histocompatibility complex, class II, DR alpha [KO:K06752]", "3123  HLA-DRB1; major histocompatibility complex, class II, DR beta 1 [KO:K06752]", "3125  HLA-DRB3; major histocompatibility complex, class II, DR beta 3 [KO:K06752]", "3126  HLA-DRB4; major histocompatibility complex, class II, DR beta 4 [KO:K06752]", "3127  HLA-DRB5; major histocompatibility complex, class II, DR beta 5 [KO:K06752]", "3683  ITGAL; integrin subunit alpha L [KO:K05718]", "3689  ITGB2; integrin subunit beta 2 [KO:K06464]", "3383  ICAM1; intercellular adhesion molecule 1 [KO:K06490]", "3600  IL15; interleukin 15 [KO:K05433]", "8741  TNFSF13; TNF superfamily member 13 [KO:K05475]", "10673  TNFSF13B; TNF superfamily member 13b [KO:K05476]", "102723407  IGH; immunoglobulin heavy variable 4-38-2-like [KO:K06856]", "4050  LTB; lymphotoxin beta [KO:K03157]", "7124  TNF; tumor necrosis factor [KO:K03156]", "3552  IL1A; interleukin 1 alpha [KO:K04383]", "3553  IL1B; interleukin 1 beta [KO:K04519]", "3569  IL6; interleukin 6 [KO:K05405]", "3589  IL11; interleukin 11 [KO:K05417]", "3606  IL18; interleukin 18 [KO:K05482]", "7097  TLR2; toll like receptor 2 [KO:K10159]", "7099  TLR4; toll like receptor 4 [KO:K10160]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "7040  TGFB1; transforming growth factor beta 1 [KO:K13375]", "7042  TGFB2; transforming growth factor beta 2 [KO:K13376]", "7043  TGFB3; transforming growth factor beta 3 [KO:K13377]", "51561  IL23A; interleukin 23 subunit alpha [KO:K05426]", "3605  IL17A; interleukin 17A [KO:K05489]", "5741  PTH; parathyroid hormone [KO:K05261]", "1435  CSF1; colony stimulating factor 1 [KO:K05453]", "8600  TNFSF11; TNF superfamily member 11 [KO:K05473]", "8792  TNFRSF11A; TNF receptor superfamily member 11a [KO:K05147]", "523  ATP6V1A; ATPase H+ transporting V1 subunit A [KO:K02145] [EC:7.1.2.2]", "525  ATP6V1B1; ATPase H+ transporting V1 subunit B1 [KO:K02147]", "526  ATP6V1B2; ATPase H+ transporting V1 subunit B2 [KO:K02147]", "245973  ATP6V1C2; ATPase H+ transporting V1 subunit C2 [KO:K02148]", "528  ATP6V1C1; ATPase H+ transporting V1 subunit C1 [KO:K02148]", "51382  ATP6V1D; ATPase H+ transporting V1 subunit D [KO:K02149]", "90423  ATP6V1E2; ATPase H+ transporting V1 subunit E2 [KO:K02150]", "529  ATP6V1E1; ATPase H+ transporting V1 subunit E1 [KO:K02150]", "9296  ATP6V1F; ATPase H+ transporting V1 subunit F [KO:K02151]", "9550  ATP6V1G1; ATPase H+ transporting V1 subunit G1 [KO:K02152]", "127124  ATP6V1G3; ATPase H+ transporting V1 subunit G3 [KO:K02152]", "534  ATP6V1G2; ATPase H+ transporting V1 subunit G2 [KO:K02152]", "8992  ATP6V0E1; ATPase H+ transporting V0 subunit e1 [KO:K02153]", "155066  ATP6V0E2; ATPase H+ transporting V0 subunit e2 [KO:K02153]", "10312  TCIRG1; T cell immune regulator 1, ATPase H+ transporting V0 subunit a3 [KO:K02154]", "23545  ATP6V0A2; ATPase H+ transporting V0 subunit a2 [KO:K02154]", "50617  ATP6V0A4; ATPase H+ transporting V0 subunit a4 [KO:K02154]", "535  ATP6V0A1; ATPase H+ transporting V0 subunit a1 [KO:K02154]", "9114  ATP6V0D1; ATPase H+ transporting V0 subunit d1 [KO:K02146]", "245972  ATP6V0D2; ATPase H+ transporting V0 subunit d2 [KO:K02146]", "51606  ATP6V1H; ATPase H+ transporting V1 subunit H [KO:K02144]", "537  ATP6AP1; ATPase H+ transporting accessory protein 1 [KO:K03662]", "527  ATP6V0C; ATPase H+ transporting V0 subunit c [KO:K02155]", "533  ATP6V0B; ATPase H+ transporting V0 subunit b [KO:K03661]", "1513  CTSK; cathepsin K [KO:K01371] [EC:3.4.22.38]", "54  ACP5; acid phosphatase 5, tartrate resistant [KO:K14379] [EC:3.1.3.2]", "4312  MMP1; matrix metallopeptidase 1 [KO:K01388] [EC:3.4.24.7]", "4314  MMP3; matrix metallopeptidase 3 [KO:K01394] [EC:3.4.24.17]", "1514  CTSL; cathepsin L [KO:K01365] [EC:3.4.22.15]", "1437  CSF2; colony stimulating factor 2 [KO:K05427]", "6352  CCL5; C-C motif chemokine ligand 5 [KO:K12499]", "6347  CCL2; C-C motif chemokine ligand 2 [KO:K14624]", "6348  CCL3; C-C motif chemokine ligand 3 [KO:K05408]", "6349  CCL3L1; C-C motif chemokine ligand 3 like 1 [KO:K05408]", "414062  CCL3L3; C-C motif chemokine ligand 3 like 3 [KO:K05408]", "6364  CCL20; C-C motif chemokine ligand 20 [KO:K14625]", "2919  CXCL1; C-X-C motif chemokine ligand 1 [KO:K05505]", "2920  CXCL2; C-X-C motif chemokine ligand 2 [KO:K05505]", "2921  CXCL3; C-X-C motif chemokine ligand 3 [KO:K05505]", "6374  CXCL5; C-X-C motif chemokine ligand 5 [KO:K05506]", "6372  CXCL6; C-X-C motif chemokine ligand 6 [KO:K05506]", "3576  CXCL8; C-X-C motif chemokine ligand 8 [KO:K10030]", "6387  CXCL12; C-X-C motif chemokine ligand 12 [KO:K10031]", "7422  VEGFA; vascular endothelial growth factor A [KO:K05448]", "2321  FLT1; fms related receptor tyrosine kinase 1 [KO:K05096] [EC:2.7.10.1]", "284  ANGPT1; angiopoietin 1 [KO:K05465]", "7010  TEK; TEK receptor tyrosine kinase [KO:K05121] [EC:2.7.10.1]", "3458  IFNG; interferon gamma [KO:K04687]"], "compound": ["C00080  H+", "C00584  Prostaglandin E2", "C05443  Vitamin D3"], "refs": [{"pmid": "16127012", "authors": "  Zwerina J, Redlich K, Schett G, Smolen JS", "title": "Pathogenesis of rheumatoid arthritis: targeting cytokines.", "journal": "Ann N Y Acad Sci 1051:716-29 (2005)", "doi": "10.1196/annals.1361.116"}, {"pmid": "20036936", "authors": "  Szekanecz Z, Vegvari A, Szabo Z, Koch AE", "title": "Chemokines and chemokine receptors in arthritis.", "journal": "Front Biosci (Schol Ed) 2:153-67 (2010)", "doi": "10.2741/53"}, {"pmid": "20651747", "authors": "  Isaacs JD", "title": "The changing face of rheumatoid arthritis: sustained remission for all?", "journal": "Nat Rev Immunol 10:605-11 (2010)", "doi": "10.1038/nri2804"}, {"pmid": "17195034", "authors": "  Strand V, Kimberly R, Isaacs JD", "title": "Biologic therapies in rheumatology: lessons learned, future directions.", "journal": "Nat Rev Drug Discov 6:75-92 (2007)", "doi": "10.1038/nrd2196"}, {"pmid": "20193003", "authors": "  Bartok B, Firestein GS", "title": "Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis.", "journal": "Immunol Rev 233:233-55 (2010)", "doi": "10.1111/j.0105-2896.2009.00859.x"}, {"pmid": "17502360", "authors": "  Dai SM, Shan ZZ, Xu H, Nishioka K", "title": "Cellular targets of interleukin-18 in rheumatoid arthritis.", "journal": "Ann Rheum Dis 66:1411-8 (2007)", "doi": "10.1136/ard.2006.067793"}, {"pmid": "9627005", "authors": "  Koch AE", "title": "Review: angiogenesis: implications for rheumatoid arthritis.", "journal": "Arthritis Rheum 41:951-62 (1998)", "doi": "10.1002/1529-0131(199806)41:6<951::AID-ART2>3.0.CO;2-D"}, {"pmid": "20305562", "authors": "  Szekanecz Z, Besenyei T, Szentpetery A, Koch AE", "title": "Angiogenesis and vasculogenesis in rheumatoid arthritis.", "journal": "Curr Opin Rheumatol 22:299-306 (2010)", "doi": "10.1097/BOR.0b013e328337c95a"}, {"pmid": "15059264", "authors": "  Brunner-Weinzierl MC, Hoff H, Burmester GR", "title": "Multiple functions for CD28 and cytotoxic T lymphocyte antigen-4 during different phases of T cell responses: implications for arthritis and autoimmune diseases.", "journal": "Arthritis Res Ther 6:45-54 (2004)", "doi": "10.1186/ar1158"}, {"pmid": "11861618", "authors": "  Theill LE, Boyle WJ, Penninger JM", "title": "RANK-L and RANK: T cells, bone loss, and mammalian evolution.", "journal": "Annu Rev Immunol 20:795-823 (2002)", "doi": "10.1146/annurev.immunol.20.100301.064753"}, {"pmid": "19184540", "authors": "  Mensah KA, Li J, Schwarz EM", "title": "The emerging field of osteoimmunology.", "journal": "Immunol Res 45:100-13 (2009)", "doi": "10.1007/s12026-009-8093-x"}, {"pmid": "16313349", "authors": "  Takayanagi H, Sato K, Takaoka A, Taniguchi T", "title": "Interplay between interferon and other cytokine systems in bone metabolism.", "journal": "Immunol Rev 208:181-93 (2005)", "doi": "10.1111/j.0105-2896.2005.00337.x"}, {"pmid": "20392226", "authors": "  Takayanagi H", "title": "New immune connections in osteoclast formation.", "journal": "Ann N Y Acad Sci 1192:117-23 (2010)", "doi": "10.1111/j.1749-6632.2009.05303.x"}, {"pmid": "19585227", "authors": "  Nakashima T, Takayanagi H", "title": "Osteoimmunology: crosstalk between the immune and bone systems.", "journal": "J Clin Immunol 29:555-67 (2009)", "doi": "10.1007/s10875-009-9316-6"}, {"pmid": "19455385", "authors": "  Nakashima T, Takayanagi H", "title": "Osteoclasts and the immune system.", "journal": "J Bone Miner Metab 27:519-29 (2009)", "doi": "10.1007/s00774-009-0089-z"}, {"pmid": "17380158", "authors": "  Takayanagi H", "title": "Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems.", "journal": "Nat Rev Immunol 7:292-304 (2007)", "doi": "10.1038/nri2062"}, {"pmid": "20510236", "authors": "  Fox DA, Gizinski A, Morgan R, Lundy SK", "title": "Cell-cell interactions in rheumatoid arthritis synovium.", "journal": "Rheum Dis Clin North Am 36:311-23 (2010)", "doi": "10.1016/j.rdc.2010.02.004"}], "rel_pathway": ["hsa04370  VEGF signaling pathway", "hsa04380  Osteoclast differentiation", "hsa04620  Toll-like receptor signaling pathway", "hsa04659  Th17 cell differentiation", "hsa04660  T cell receptor signaling pathway", "hsa04670  Leukocyte transendothelial migration"], "ko_pathway": "ko05323", "genes": ["CSF1"]}, {"kegg_id": "hsa04390", "name": "Hippo signaling pathway - Homo sapiens (human)", "description": "Hippo signaling is an evolutionarily conserved signaling pathway that controls organ size from flies to humans. In humans and mice, the pathway consists of the MST1 and MST2 kinases, their cofactor Salvador and LATS1 and LATS2. In response to high cell densities, activated LATS1/2 phosphorylates the transcriptional coactivators YAP and TAZ, promoting its cytoplasmic localization, leading to cell apoptosis and restricting organ size overgrowth. When the Hippo pathway is inactivated at low cell density, YAP/TAZ translocates into the nucleus to bind to the transcription enhancer factor (TEAD/TEF) family of transcriptional factors to promote cell growth and proliferation. YAP/TAZ also interacts with other transcriptional factors or signaling molecules, by which Hippo pathway-mediated processes are interconnected with those of other key signaling cascades, such as those mediated by TGF-beta and Wnt growth factors.", "class": "Environmental Information Processing; Signal transduction", "pathway_map": "hsa04390  Hippo signaling pathway", "drug": ["D04262  Fostriecin sodium (USAN)", "D10969  Pamrevlumab (USAN/INN)"], "dblinks": "GO: 0035329", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["286204  CRB2; crumbs cell polarity complex component 2 [KO:K16681]", "23418  CRB1; crumbs cell polarity complex component 1 [KO:K16681]", "56288  PARD3; par-3 family cell polarity regulator [KO:K04237]", "50855  PARD6A; par-6 family cell polarity regulator alpha [KO:K06093]", "84552  PARD6G; par-6 family cell polarity regulator gamma [KO:K06093]", "84612  PARD6B; par-6 family cell polarity regulator beta [KO:K06093]", "5590  PRKCZ; protein kinase C zeta [KO:K18952] [EC:2.7.11.13]", "5584  PRKCI; protein kinase C iota [KO:K06069] [EC:2.7.11.13]", "10207  PATJ; PATJ crumbs cell polarity complex component [KO:K06092]", "64398  PALS1; protein associated with LIN7 1, MAGUK p55 family member [KO:K06091]", "154796  AMOT; angiomotin [KO:K16819]", "10413  YAP1; Yes1 associated transcriptional regulator [KO:K16687]", "25937  WWTR1; WW domain containing transcription regulator 1 [KO:K16820]", "999  CDH1; cadherin 1 [KO:K05689]", "8994  LIMD1; LIM domain containing 1 [KO:K16682]", "84962  AJUBA; ajuba LIM protein [KO:K16682]", "126374  WTIP; WT1 interacting protein [KO:K16682]", "4771  NF2; NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor [KO:K16684]", "23286  WWC1; WW and C2 domain containing 1 [KO:K16685]", "79981  FRMD1; FERM domain containing 1 [KO:K16821]", "122786  FRMD6; FERM domain containing 6 [KO:K16822]", "60485  SAV1; salvador family WW domain containing protein 1 [KO:K16686]", "6788  STK3; serine/threonine kinase 3 [KO:K04412]", "166824  RASSF6; Ras association domain family member 6 [KO:K09854]", "11186  RASSF1; Ras association domain family member 1 [KO:K09850]", "5515  PPP2CA; protein phosphatase 2 catalytic subunit alpha [KO:K04382] [EC:3.1.3.16]", "5516  PPP2CB; protein phosphatase 2 catalytic subunit beta [KO:K04382] [EC:3.1.3.16]", "5519  PPP2R1B; protein phosphatase 2 scaffold subunit Abeta [KO:K03456]", "5518  PPP2R1A; protein phosphatase 2 scaffold subunit Aalpha [KO:K03456]", "5520  PPP2R2A; protein phosphatase 2 regulatory subunit Balpha [KO:K04354]", "5521  PPP2R2B; protein phosphatase 2 regulatory subunit Bbeta [KO:K04354]", "5522  PPP2R2C; protein phosphatase 2 regulatory subunit Bgamma [KO:K04354]", "55844  PPP2R2D; protein phosphatase 2 regulatory subunit Bdelta [KO:K04354]", "26524  LATS2; large tumor suppressor kinase 2 [KO:K08791] [EC:2.7.11.1]", "9113  LATS1; large tumor suppressor kinase 1 [KO:K08791] [EC:2.7.11.1]", "55233  MOB1A; MOB kinase activator 1A [KO:K06685]", "92597  MOB1B; MOB kinase activator 1B [KO:K06685]", "5499  PPP1CA; protein phosphatase 1 catalytic subunit alpha [KO:K06269] [EC:3.1.3.16]", "5500  PPP1CB; protein phosphatase 1 catalytic subunit beta [KO:K06269] [EC:3.1.3.16]", "5501  PPP1CC; protein phosphatase 1 catalytic subunit gamma [KO:K06269] [EC:3.1.3.16]", "7159  TP53BP2; tumor protein p53 binding protein 2 [KO:K16823]", "3993  LLGL2; LLGL scribble cell polarity complex component 2 [KO:K06094]", "3996  LLGL1; LLGL scribble cell polarity complex component 1 [KO:K06094]", "23513  SCRIB; scribble planar cell polarity protein [KO:K16175]", "1739  DLG1; discs large MAGUK scaffold protein 1 [KO:K12076]", "1740  DLG2; discs large MAGUK scaffold protein 2 [KO:K12075]", "1741  DLG3; discs large MAGUK scaffold protein 3 [KO:K21098]", "1742  DLG4; discs large MAGUK scaffold protein 4 [KO:K11828]", "9231  DLG5; discs large MAGUK scaffold protein 5 [KO:K24050]", "1453  CSNK1D; casein kinase 1 delta [KO:K08959] [EC:2.7.11.1]", "1454  CSNK1E; casein kinase 1 epsilon [KO:K08960] [EC:2.7.11.1]", "102800317  TPTEP2-CSNK1E; TPTEP2-CSNK1E readthrough [KO:K08960] [EC:2.7.11.1]", "8945  BTRC; beta-transducin repeat containing E3 ubiquitin protein ligase [KO:K03362]", "23291  FBXW11; F-box and WD repeat domain containing 11 [KO:K03362]", "7161  TP73; tumor protein p73 [KO:K10148]", "27113  BBC3; BCL2 binding component 3 [KO:K10132]", "7003  TEAD1; TEA domain transcription factor 1 [KO:K09448]", "7004  TEAD4; TEA domain transcription factor 4 [KO:K09448]", "7005  TEAD3; TEA domain transcription factor 3 [KO:K09448]", "8463  TEAD2; TEA domain transcription factor 2 [KO:K09448]", "1490  CCN2; cellular communication network factor 2 [KO:K06827]", "2736  GLI2; GLI family zinc finger 2 [KO:K16798]", "374  AREG; amphiregulin [KO:K09782]", "332  BIRC5; baculoviral IAP repeat containing 5 [KO:K08731]", "174  AFP; alpha fetoprotein [KO:K16144]", "3689  ITGB2; integrin subunit beta 2 [KO:K06464]", "2246  FGF1; fibroblast growth factor 1 [KO:K18496]", "7040  TGFB1; transforming growth factor beta 1 [KO:K13375]", "7042  TGFB2; transforming growth factor beta 2 [KO:K13376]", "7043  TGFB3; transforming growth factor beta 3 [KO:K13377]", "7046  TGFBR1; transforming growth factor beta receptor 1 [KO:K04674] [EC:2.7.11.30]", "7048  TGFBR2; transforming growth factor beta receptor 2 [KO:K04388] [EC:2.7.11.30]", "4092  SMAD7; SMAD family member 7 [KO:K19631]", "4087  SMAD2; SMAD family member 2 [KO:K04500]", "4088  SMAD3; SMAD family member 3 [KO:K23605]", "4089  SMAD4; SMAD family member 4 [KO:K04501]", "5054  SERPINE1; serpin family E member 1 [KO:K03982]", "650  BMP2; bone morphogenetic protein 2 [KO:K21283]", "652  BMP4; bone morphogenetic protein 4 [KO:K04662]", "653  BMP5; bone morphogenetic protein 5 [KO:K04663]", "654  BMP6; bone morphogenetic protein 6 [KO:K16620]", "655  BMP7; bone morphogenetic protein 7 [KO:K16621]", "656  BMP8B; bone morphogenetic protein 8b [KO:K16622]", "353500  BMP8A; bone morphogenetic protein 8a [KO:K16622]", "8200  GDF5; growth differentiation factor 5 [KO:K04664]", "392255  GDF6; growth differentiation factor 6 [KO:K20012]", "151449  GDF7; growth differentiation factor 7 [KO:K20013]", "268  AMH; anti-Mullerian hormone [KO:K04665]", "657  BMPR1A; bone morphogenetic protein receptor type 1A [KO:K04673] [EC:2.7.11.30]", "658  BMPR1B; bone morphogenetic protein receptor type 1B [KO:K13578] [EC:2.7.11.30]", "659  BMPR2; bone morphogenetic protein receptor type 2 [KO:K04671] [EC:2.7.11.30]", "4086  SMAD1; SMAD family member 1 [KO:K04676]", "3397  ID1; inhibitor of DNA binding 1 [KO:K04680]", "3398  ID2; inhibitor of DNA binding 2 [KO:K17693]", "7471  WNT1; Wnt family member 1 [KO:K03209]", "7472  WNT2; Wnt family member 2 [KO:K00182]", "7482  WNT2B; Wnt family member 2B [KO:K00182]", "7473  WNT3; Wnt family member 3 [KO:K00312]", "89780  WNT3A; Wnt family member 3A [KO:K00312]", "54361  WNT4; Wnt family member 4 [KO:K00408]", "7474  WNT5A; Wnt family member 5A [KO:K00444]", "81029  WNT5B; Wnt family member 5B [KO:K00444]", "7475  WNT6; Wnt family member 6 [KO:K00445]", "7476  WNT7A; Wnt family member 7A [KO:K00572]", "7477  WNT7B; Wnt family member 7B [KO:K00572]", "7478  WNT8A; Wnt family member 8A [KO:K00714]", "7479  WNT8B; Wnt family member 8B [KO:K00714]", "7483  WNT9A; Wnt family member 9A [KO:K01064]", "7484  WNT9B; Wnt family member 9B [KO:K01064]", "7480  WNT10B; Wnt family member 10B [KO:K01357]", "80326  WNT10A; Wnt family member 10A [KO:K01357]", "7481  WNT11; Wnt family member 11 [KO:K01384]", "51384  WNT16; Wnt family member 16 [KO:K01558]", "8321  FZD1; frizzled class receptor 1 [KO:K02432]", "8324  FZD7; frizzled class receptor 7 [KO:K02432]", "2535  FZD2; frizzled class receptor 2 [KO:K02235]", "7976  FZD3; frizzled class receptor 3 [KO:K02329]", "8322  FZD4; frizzled class receptor 4 [KO:K02354]", "7855  FZD5; frizzled class receptor 5 [KO:K02375]", "8325  FZD8; frizzled class receptor 8 [KO:K02375]", "8323  FZD6; frizzled class receptor 6 [KO:K02376]", "11211  FZD10; frizzled class receptor 10 [KO:K02842]", "8326  FZD9; frizzled class receptor 9 [KO:K02842]", "1857  DVL3; dishevelled segment polarity protein 3 [KO:K02353]", "1856  DVL2; dishevelled segment polarity protein 2 [KO:K02353]", "1855  DVL1; dishevelled segment polarity protein 1 [KO:K02353]", "7534  YWHAZ; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta [KO:K16197]", "7529  YWHAB; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta [KO:K16197]", "10971  YWHAQ; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta [KO:K16197]", "7531  YWHAE; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon [KO:K06630]", "7533  YWHAH; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta [KO:K16198]", "7532  YWHAG; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma [KO:K16198]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "1499  CTNNB1; catenin beta 1 [KO:K02105]", "324  APC; APC regulator of WNT signaling pathway [KO:K02085]", "10297  APC2; APC regulator of WNT signaling pathway 2 [KO:K02085]", "8312  AXIN1; axin 1 [KO:K02157]", "8313  AXIN2; axin 2 [KO:K04385]", "85407  NKD1; NKD inhibitor of WNT signaling pathway 1 [KO:K03213]", "85409  NKD2; NKD inhibitor of WNT signaling pathway 2 [KO:K03213]", "6932  TCF7; transcription factor 7 [KO:K02620]", "83439  TCF7L1; transcription factor 7 like 1 [KO:K04490]", "6934  TCF7L2; transcription factor 7 like 2 [KO:K04491]", "51176  LEF1; lymphoid enhancer binding factor 1 [KO:K04492]", "4609  MYC; MYC proto-oncogene, bHLH transcription factor [KO:K04377]", "595  CCND1; cyclin D1 [KO:K04503]", "894  CCND2; cyclin D2 [KO:K10151]", "896  CCND3; cyclin D3 [KO:K10152]", "6657  SOX2; SRY-box transcription factor 2 [KO:K16796]", "6591  SNAI2; snail family transcriptional repressor 2 [KO:K05706]", "329  BIRC2; baculoviral IAP repeat containing 2 [KO:K16060]", "330  BIRC3; baculoviral IAP repeat containing 3 [KO:K16060]", "71  ACTG1; actin gamma 1 [KO:K05692]", "60  ACTB; actin beta [KO:K05692]", "29119  CTNNA3; catenin alpha 3 [KO:K05691]", "1495  CTNNA1; catenin alpha 1 [KO:K05691]", "1496  CTNNA2; catenin alpha 2 [KO:K05691]"], "refs": [{"pmid": "22750148", "authors": "  Schroeder MC, Halder G", "title": "Regulation of the Hippo pathway by cell architecture and mechanical signals.", "journal": "Semin Cell Dev Biol 23:803-11 (2012)", "doi": "10.1016/j.semcdb.2012.06.001"}, {"pmid": "21808241", "authors": "  Zhao B, Tumaneng K, Guan KL", "title": "The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal.", "journal": "Nat Cell Biol 13:877-83 (2011)", "doi": "10.1038/ncb2303"}, {"pmid": "21874053", "authors": "  Mauviel A, Nallet-Staub F, Varelas X", "title": "Integrating developmental signals: a Hippo in the (path)way.", "journal": "Oncogene 31:1743-56 (2012)", "doi": "10.1038/onc.2011.363"}, {"pmid": "21084559", "authors": "  Zhao B, Li L, Guan KL", "title": "Hippo signaling at a glance.", "journal": "J Cell Sci 123:4001-6 (2010)", "doi": "10.1242/jcs.069070"}, {"pmid": "20439427", "authors": "  Zhao B, Li L, Lei Q, Guan KL", "title": "The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version.", "journal": "Genes Dev 24:862-74 (2010)", "doi": "10.1101/gad.1909210"}, {"pmid": "23034192", "authors": "  Tremblay AM, Camargo FD", "title": "Hippo signaling in mammalian stem cells.", "journal": "Semin Cell Dev Biol 23:818-26 (2012)", "doi": "10.1016/j.semcdb.2012.08.001"}, {"pmid": "21138973", "authors": "  Halder G, Johnson RL", "title": "Hippo signaling: growth control and beyond.", "journal": "Development 138:9-22 (2011)", "doi": "10.1242/dev.045500"}, {"pmid": "22658639", "authors": "  Ramos A, Camargo FD", "title": "The Hippo signaling pathway and stem cell biology.", "journal": "Trends Cell Biol 22:339-46 (2012)", "doi": "10.1016/j.tcb.2012.04.006"}, {"pmid": "20951342", "authors": "  Pan D", "title": "The hippo signaling pathway in development and cancer.", "journal": "Dev Cell 19:491-505 (2010)", "doi": "10.1016/j.devcel.2010.09.011"}, {"pmid": "21324984", "authors": "  Bao Y, Hata Y, Ikeda M, Withanage K", "title": "Mammalian Hippo pathway: from development to cancer and beyond.", "journal": "J Biochem 149:361-79 (2011)", "doi": "10.1093/jb/mvr021"}, {"pmid": "18955139", "authors": "  Zhao B, Lei QY, Guan KL", "title": "The Hippo-YAP pathway: new connections between regulation of organ size and cancer.", "journal": "Curr Opin Cell Biol 20:638-46 (2008)", "doi": "10.1016/j.ceb.2008.10.001"}, {"pmid": "20945341", "authors": "  Chan SW, Lim CJ, Chen L, Chong YF, Huang C, Song H, Hong W", "title": "The Hippo pathway in biological control and cancer development.", "journal": "J Cell Physiol 226:928-39 (2011)", "doi": "10.1002/jcp.22435"}, {"pmid": "18328423", "authors": "  Zeng Q, Hong W", "title": "The emerging role of the hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals.", "journal": "Cancer Cell 13:188-92 (2008)", "doi": "10.1016/j.ccr.2008.02.011"}, {"pmid": "19846288", "authors": "  Badouel C, Garg A, McNeill H", "title": "Herding Hippos: regulating growth in flies and man.", "journal": "Curr Opin Cell Biol 21:837-43 (2009)", "doi": "10.1016/j.ceb.2009.09.010"}, {"pmid": "17975546", "authors": "  Buttitta LA, Edgar BA", "title": "How size is controlled: from Hippos to Yorkies.", "journal": "Nat Cell Biol 9:1225-7 (2007)", "doi": "10.1038/ncb1107-1225"}, {"pmid": "22683405", "authors": "  Liu AM, Wong KF, Jiang X, Qiao Y, Luk JM", "title": "Regulators of mammalian Hippo pathway in cancer.", "journal": "Biochim Biophys Acta 1826:357-64 (2012)", "doi": "10.1016/j.bbcan.2012.05.006"}, {"pmid": "22830020", "authors": "  Fausti F, Di Agostino S, Sacconi A, Strano S, Blandino G", "title": "Hippo and rassf1a Pathways: A Growing Affair.", "journal": "Mol Biol Int 2012:307628 (2012)", "doi": "10.1155/2012/307628"}, {"pmid": "22895435", "authors": "  Halder G, Dupont S, Piccolo S", "title": "Transduction of mechanical and cytoskeletal cues by YAP and TAZ.", "journal": "Nat Rev Mol Cell Biol 13:591-600 (2012)", "doi": "10.1038/nrm3416"}, {"pmid": "22153608", "authors": "  Varelas X, Wrana JL", "title": "Coordinating developmental signaling: novel roles for the Hippo pathway.", "journal": "Trends Cell Biol 22:88-96 (2012)", "doi": "10.1016/j.tcb.2011.10.002"}], "rel_pathway": ["hsa04120  Ubiquitin mediated proteolysis", "hsa04310  Wnt signaling pathway", "hsa04350  TGF-beta signaling pathway", "hsa04520  Adherens junction", "hsa04530  Tight junction"], "ko_pathway": "ko04390", "genes": ["AJUBA", "BIRC3"]}, {"kegg_id": "hsa04392", "name": "Hippo signaling pathway - multiple species - Homo sapiens (human)", "description": "Hippo signaling pathways control diverse aspects of cell proliferation, survival, and morphogenesis in eukaryotes. The core organization of these networks is conserved over a billion years of evolution, with related forms described in animals and fungi. In Drosophila and mammals, Hippo/MST co-operate with Mats/Mob1 and Salvador/WW45 to activate Warts/LATS, which negatively regulates Yorkie/YAP. Yorkie/YAP interact with Scalloped/TEAD to promote gene transcriptions and control organ size through the balance between cell proliferation and apoptosis. In C. elegans, WTS-1 YAP-1 EGL-44 axis is conserved and regulates thermotolerance and healthy lifespan. In S. cerevisiae, the LATS-related Dbf2 or Dbf20 kinase in complex with Mob1 controls mitotic exit and cytokinesis, and the Hippo/MST family of kinases, STE-20, modulates Tec1, the putative yeast TEAD ortholog.", "class": "Environmental Information Processing; Signal transduction", "pathway_map": "hsa04392  Hippo signaling pathway - multiple species", "dblinks": "GO: 0035329", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["8642  DCHS1; dachsous cadherin-related 1 [KO:K16507]", "54798  DCHS2; dachsous cadherin-related 2 [KO:K16507]", "79633  FAT4; FAT atypical cadherin 4 [KO:K16669]", "1454  CSNK1E; casein kinase 1 epsilon [KO:K08960] [EC:2.7.11.1]", "102800317  TPTEP2-CSNK1E; TPTEP2-CSNK1E readthrough [KO:K08960] [EC:2.7.11.1]", "4771  NF2; NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor [KO:K16684]", "23286  WWC1; WW and C2 domain containing 1 [KO:K16685]", "79981  FRMD1; FERM domain containing 1 [KO:K16821]", "122786  FRMD6; FERM domain containing 6 [KO:K16822]", "11186  RASSF1; Ras association domain family member 1 [KO:K09850]", "166824  RASSF6; Ras association domain family member 6 [KO:K09854]", "6788  STK3; serine/threonine kinase 3 [KO:K04412]", "60485  SAV1; salvador family WW domain containing protein 1 [KO:K16686]", "26524  LATS2; large tumor suppressor kinase 2 [KO:K08791] [EC:2.7.11.1]", "9113  LATS1; large tumor suppressor kinase 1 [KO:K08791] [EC:2.7.11.1]", "55233  MOB1A; MOB kinase activator 1A [KO:K06685]", "92597  MOB1B; MOB kinase activator 1B [KO:K06685]", "8994  LIMD1; LIM domain containing 1 [KO:K16682]", "84962  AJUBA; ajuba LIM protein [KO:K16682]", "126374  WTIP; WT1 interacting protein [KO:K16682]", "10413  YAP1; Yes1 associated transcriptional regulator [KO:K16687]", "25937  WWTR1; WW domain containing transcription regulator 1 [KO:K16820]", "7003  TEAD1; TEA domain transcription factor 1 [KO:K09448]", "7004  TEAD4; TEA domain transcription factor 4 [KO:K09448]", "7005  TEAD3; TEA domain transcription factor 3 [KO:K09448]", "8463  TEAD2; TEA domain transcription factor 2 [KO:K09448]", "9770  RASSF2; Ras association domain family member 2 [KO:K09851]", "83937  RASSF4; Ras association domain family member 4 [KO:K09851]", "5058  PAK1; p21 (RAC1) activated kinase 1 [KO:K04409] [EC:2.7.11.1]"], "refs": [{"pmid": "21415026", "authors": "  Hilman D, Gat U", "title": "The evolutionary history of YAP and the hippo/YAP pathway.", "journal": "Mol Biol Evol 28:2403-17 (2011)", "doi": "10.1093/molbev/msr065"}, {"pmid": "24715453", "authors": "  Varelas X", "title": "The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease.", "journal": "Development 141:1614-26 (2014)", "doi": "10.1242/dev.102376"}, {"pmid": "21808241", "authors": "  Zhao B, Tumaneng K, Guan KL", "title": "The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal.", "journal": "Nat Cell Biol 13:877-83 (2011)", "doi": "10.1038/ncb2303"}, {"pmid": "21138973", "authors": "  Halder G, Johnson RL", "title": "Hippo signaling: growth control and beyond.", "journal": "Development 138:9-22 (2011)", "doi": "10.1242/dev.045500"}, {"pmid": "20951342", "authors": "  Pan D", "title": "The hippo signaling pathway in development and cancer.", "journal": "Dev Cell 19:491-505 (2010)", "doi": "10.1016/j.devcel.2010.09.011"}, {"pmid": "20439427", "authors": "  Zhao B, Li L, Lei Q, Guan KL", "title": "The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version.", "journal": "Genes Dev 24:862-74 (2010)", "doi": "10.1101/gad.1909210"}, {"pmid": "22830020", "authors": "  Fausti F, Di Agostino S, Sacconi A, Strano S, Blandino G", "title": "Hippo and rassf1a Pathways: A Growing Affair.", "journal": "Mol Biol Int 2012:307628 (2012)", "doi": "10.1155/2012/307628"}, {"pmid": "25966461", "authors": "  Gogl G, Schneider KD, Yeh BJ, Alam N, Nguyen Ba AN, Moses AM, Hetenyi C, Remenyi A, Weiss EL", "title": "The Structure of an NDR/LATS Kinase-Mob Complex Reveals a Novel Kinase-Coactivator System and Substrate Docking Mechanism.", "journal": "PLoS Biol 13:e1002146 (2015)", "doi": "10.1371/journal.pbio.1002146"}, {"pmid": "23396260", "authors": "  Iwasa H, Maimaiti S, Kuroyanagi H, Kawano S, Inami K, Timalsina S, Ikeda M, Nakagawa K, Hata Y", "title": "Yes-associated protein homolog, YAP-1, is involved in the thermotolerance and aging in the nematode Caenorhabditis elegans.", "journal": "Exp Cell Res 319:931-45 (2013)", "doi": "10.1016/j.yexcr.2013.01.020"}, {"pmid": "23843471", "authors": "  Yang Z, Hata Y", "title": "What is the Hippo pathway? Is the Hippo pathway conserved in Caenorhabditis elegans?", "journal": "J Biochem 154:207-9 (2013)", "doi": "10.1093/jb/mvt060"}, {"pmid": "24594661", "authors": "  Hotz M, Barral Y", "title": "The Mitotic Exit Network: new turns on old pathways.", "journal": "Trends Cell Biol 24:145-52 (2014)", "doi": "10.1016/j.tcb.2013.09.010"}, {"pmid": "23579499", "authors": "  Rock JM, Lim D, Stach L, Ogrodowicz RW, Keck JM, Jones MH, Wong CC, Yates JR 3rd, Winey M, Smerdon SJ, Yaffe MB, Amon A", "title": "Activation of the yeast Hippo pathway by phosphorylation-dependent assembly of signaling complexes.", "journal": "Science 340:871-5 (2013)", "doi": "10.1126/science.1235822"}, {"pmid": "22525225", "authors": "  Hergovich A, Hemmings BA", "title": "Hippo signalling in the G2/M cell cycle phase: lessons learned from the yeast MEN and SIN pathways.", "journal": "Semin Cell Dev Biol 23:794-802 (2012)", "doi": "10.1016/j.semcdb.2012.04.001"}], "rel_pathway": ["hsa04390  Hippo signaling pathway"], "ko_pathway": "ko04392", "genes": ["AJUBA"]}, {"kegg_id": "hsa04022", "name": "cGMP-PKG signaling pathway - Homo sapiens (human)", "description": "Cyclic GMP (cGMP) is the intracellular second messenger that mediates the action of nitric oxide (NO) and natriuretic peptides (NPs), regulating a broad array of physiologic processes. The elevated intracellular cGMP level exerts its physiological action through two forms of cGMP-dependent protein kinase (PKG), cGMP-regulated phosphodiesterases (PDE2, PDE3) and cGMP-gated cation channels, among which PKGs might be the primary mediator. PKG1 isoform-specific activation of established substrates leads to reduction of cytosolic calcium concentration and/or decrease in the sensitivity of myofilaments to Ca2+ (Ca2+-desensitization), resulting in smooth muscle relaxation. In cardiac myocyte, PKG directly phosphorylates a member of the transient potential receptor canonical channel family, TRPC6, suppressing this nonselective ion channel's Ca2+ conductance, G-alpha-q agonist-induced NFAT activation, and myocyte hypertrophic responses. PKG also opens mitochondrial ATP-sensitive K+ (mitoKATP) channels and subsequent release of ROS triggers cardioprotection.", "class": "Environmental Information Processing; Signal transduction", "pathway_map": "hsa04022  cGMP-PKG signaling pathway", "drug": ["D00095  Epinephrine (USP/INN)", "D00227  Aminophylline (USP/INN)", "D00231  Inamrinone (USP)", "D00255  Carvedilol (JP18/USP/INN)", "D00281  Clonidine (JAN/USP/INN)", "D00302  Dipyridamole (JP18/USP/INN)", "D00371  Theophylline (JP18)", "D00378  Timolol (USAN)", "D00405  Methyldopa (USP)", "D00417  Milrinone (JAN/USP/INN)", "D00432  Nadolol (JP18/USP/INN)", "D00598  Betaxolol hydrochloride (JP18/USP)", "D00599  Carteolol hydrochloride (JP18/USP)", "D00600  Labetalol hydrochloride (JP18/USP)", "D00603  Timolol maleate (JP18/USP)", "D00604  Clonidine hydrochloride (JP18/USP)", "D00606  Guanfacine hydrochloride (JAN/USP)", "D00610  Terazosin hydrochloride (USP)", "D00631  Bepridil hydrochloride (USAN)", "D00632  Dobutamine hydrochloride (JP18/USP)", "D00634  Bisoprolol fumarate (JP18/USP)", "D00636  Amiodarone hydrochloride (JP18/USP)", "D00680  Methylergonovine maleate (USP)", "D00996  Epinephrine hydrochloride (JAN)", "D01024  Tamsulosin hydrochloride (JP18/USP)", "D01163  Ergonovine maleate (USP)", "D01220  Trapidil (JP18/INN)", "D01238  Bucladesine sodium (JAN)", "D01385  Ibudilast (JP18/INN)", "D01469  Amosulalol hydrochloride (JP18)", "D01573  Etilefrine hydrochloride (JP18)", "D01691  Nipradilol (JAN/INN)", "D01692  Alfuzosin hydrochloride (JAN/USAN)", "D01712  Theophylline sodium acetate (JAN)", "D01771  Proxyphylline (JAN/INN)", "D01810  Nicorandil (JP18/USAN/INN)", "D01830  Arotinolol hydrochloride (JP18)", "D01840  Fasudil hydrochloride (JAN)", "D01896  Cilostazol (JP18/USP/INN)", "D01958  Indenolol hydrochloride (JP18)", "D01965  Silodosin (JP18/INN)", "D02017  Oxtriphylline (USP)", "D02084  Inamrinone ethylenelactate", "D02085  Milrinone lactate", "D02149  Epinephrine bitartrate (JAN/USP)", "D02218  Papaverine hydrochloride (JP18/USP)", "D02229  Sildenafil citrate (JAN/USP)", "D02342  Bisoprolol (JAN/USAN/INN)", "D02731  Vardenafil dihydrochoride (USAN)", "D02774  Adrenalone (USAN/INN)", "D02910  Amiodarone (USAN/INN)", "D02976  Arbutamine hydrochloride (USAN)", "D03051  Bamifylline hydrochloride (USAN)", "D03115  Fasudil hydrochloride hydrate (JAN)", "D03177  Bunolol hydrochloride (USAN)", "D03217  Avanafil (USAN/INN)", "D03260  Vardenafil hydrochloride hydrate (JAN)", "D03328  Carperitide (USAN/INN)", "D03415  Carvedilol phosphate (USAN)", "D03657  Dasantafil (USAN/INN)", "D03879  Dobutamine (USAN/INN)", "D03891  Dopexamine (USAN/INN)", "D03892  Dopexamine hydrochloride (USAN)", "D03898  Doxofylline (USAN/INN)", "D03953  Edonentan (USAN)", "D04004  Enoximone (USAN/INN)", "D04508  Imazodan hydrochloride (USAN)", "D04510  Imciromab pentetate (USAN)", "D04529  Indolidan (USAN/INN)", "D04628  Isomazole hydrochloride (USAN)", "D04710  Levobetaxolol hydrochloride (USAN)", "D04720  Levosimendan (USAN/INN)", "D04751  Lixazinone sulfate (USAN)", "D05087  Moxonidine (USAN/INN)", "D05429  Aminophylline hydrate (JP18)", "D05514  Piroximone (USAN)", "D05688  Racepinephrine (USP/INN)", "D05689  Racepinephrine hydrochloride (USP)", "D05879  Solabegron hydrochloride (USAN)", "D06103  Theophylline (USP)", "D06104  Theophylline sodium glycinate (USP)", "D06562  Bedoradrine sulfate (USAN)", "D06671  Yohimbine hydrochloride (USP)", "D07124  Alfuzosin (INN)", "D07181  Mepindolol (INN)", "D07425  Papaverine (BAN)", "D07439  Papaverine sulfate", "D07451  Amosulalol (INN)", "D07465  Arotinolol (INN)", "D07491  Bamifylline (INN)", "D07520  Bepridil (INN)", "D07526  Betaxolol (INN)", "D07546  Bucladesine (INN)", "D07560  Adrenalone hydrochloride", "D07624  Carteolol (INN)", "D07905  Ergometrine (INN)", "D07906  Ergotamine (INN)", "D07931  Etilefrine (INN)", "D07941  Fasudil (INN)", "D08031  Guanfacine (INN)", "D08078  Indenolol (INN)", "D08106  Labetalol (INN)", "D08205  Methyldopa (INN)", "D08207  Methylergometrine (INN)", "D08482  Rilmenidine (INN)", "D08514  Sildenafil (INN)", "D08560  Tamsulosin (INN)", "D08569  Terazosin (INN)", "D08600  Timolol (INN)", "D08668  Vardenafil (USAN/INN)", "D08685  Yohimbine (DCF)", "D09822  Theosalicin (JAN)", "D09989  Vardenafil hydrochloride (USP)", "D10027  Udenafil (USAN/INN)", "D10971  Piclidenoson (USAN/INN)", "D11030  Netarsudil (USAN/INN)", "D11031  Netarsudil mesylate (USAN)", "D11128  Namodenoson (USAN/INN)", "D11190  Vosoritide (USAN/INN)", "D11320  Vatinoxan (USAN)", "D11321  Vatinoxan hydrochloride (USAN)", "D11585  Terazosin hydrochloride anhydrous", "D11630  Aminophylline dihydrate", "D11743  Ensifentrine (USAN/INN)", "D11776  Sparsentan (USAN/INN)", "D11974  Centhaquine (USAN)", "D11975  Centhaquine citrate (USAN)", "D12265  Mavacamten (JAN/USAN/INN)", "D12516  Zagociguat (USAN/INN)"], "dblinks": "GO: 0070305", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["185  AGTR1; angiotensin II receptor type 1 [KO:K04166]", "1909  EDNRA; endothelin receptor type A [KO:K04197]", "1910  EDNRB; endothelin receptor type B [KO:K04198]", "148  ADRA1A; adrenoceptor alpha 1A [KO:K04135]", "147  ADRA1B; adrenoceptor alpha 1B [KO:K04136]", "146  ADRA1D; adrenoceptor alpha 1D [KO:K04137]", "150  ADRA2A; adrenoceptor alpha 2A [KO:K04138]", "151  ADRA2B; adrenoceptor alpha 2B [KO:K04139]", "152  ADRA2C; adrenoceptor alpha 2C [KO:K04140]", "2776  GNAQ; G protein subunit alpha q [KO:K04634]", "2767  GNA11; G protein subunit alpha 11 [KO:K04635]", "2768  GNA12; G protein subunit alpha 12 [KO:K04346]", "10672  GNA13; G protein subunit alpha 13 [KO:K04639]", "7225  TRPC6; transient receptor potential cation channel subfamily C member 6 [KO:K04969]", "5530  PPP3CA; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]", "5532  PPP3CB; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]", "5533  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]", "5534  PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]", "5535  PPP3R2; protein phosphatase 3 regulatory subunit B, beta [KO:K06268]", "4205  MEF2A; myocyte enhancer factor 2A [KO:K09260]", "4207  BORCS8-MEF2B; BORCS8-MEF2B readthrough [KO:K09261]", "100271849  MEF2B; myocyte enhancer factor 2B [KO:K09261]", "4208  MEF2C; myocyte enhancer factor 2C [KO:K04454]", "4209  MEF2D; myocyte enhancer factor 2D [KO:K09262]", "4772  NFATC1; nuclear factor of activated T cells 1 [KO:K04446]", "4773  NFATC2; nuclear factor of activated T cells 2 [KO:K17332]", "4775  NFATC3; nuclear factor of activated T cells 3 [KO:K17333]", "4776  NFATC4; nuclear factor of activated T cells 4 [KO:K17334]", "6722  SRF; serum response factor [KO:K04378]", "2626  GATA4; GATA binding protein 4 [KO:K09183]", "4625  MYH7; myosin heavy chain 7 [KO:K17751]", "4624  MYH6; myosin heavy chain 6 [KO:K17751]", "4879  NPPB; natriuretic peptide B [KO:K12335]", "4878  NPPA; natriuretic peptide A [KO:K12334]", "4881  NPR1; natriuretic peptide receptor 1 [KO:K12323] [EC:4.6.1.2]", "4880  NPPC; natriuretic peptide C [KO:K12336]", "4882  NPR2; natriuretic peptide receptor 2 [KO:K12324] [EC:4.6.1.2]", "5592  PRKG1; protein kinase cGMP-dependent 1 [KO:K07376] [EC:2.7.11.12]", "5593  PRKG2; protein kinase cGMP-dependent 2 [KO:K19477] [EC:2.7.11.12]", "775  CACNA1C; calcium voltage-gated channel subunit alpha1 C [KO:K04850]", "776  CACNA1D; calcium voltage-gated channel subunit alpha1 D [KO:K04851]", "778  CACNA1F; calcium voltage-gated channel subunit alpha1 F [KO:K04853]", "779  CACNA1S; calcium voltage-gated channel subunit alpha1 S [KO:K04857]", "3778  KCNMA1; potassium calcium-activated channel subfamily M alpha 1 [KO:K04936]", "157855  KCNU1; potassium calcium-activated channel subfamily U member 1 [KO:K05274]", "3779  KCNMB1; potassium calcium-activated channel subfamily M regulatory beta subunit 1 [KO:K04937]", "10242  KCNMB2; potassium calcium-activated channel subfamily M regulatory beta subunit 2 [KO:K04938]", "27094  KCNMB3; potassium calcium-activated channel subfamily M regulatory beta subunit 3 [KO:K04939]", "27345  KCNMB4; potassium calcium-activated channel subfamily M regulatory beta subunit 4 [KO:K04941]", "6546  SLC8A1; solute carrier family 8 member A1 [KO:K05849]", "6543  SLC8A2; solute carrier family 8 member A2 [KO:K05849]", "6547  SLC8A3; solute carrier family 8 member A3 [KO:K05849]", "476  ATP1A1; ATPase Na+/K+ transporting subunit alpha 1 [KO:K01539] [EC:7.2.2.13]", "477  ATP1A2; ATPase Na+/K+ transporting subunit alpha 2 [KO:K01539] [EC:7.2.2.13]", "478  ATP1A3; ATPase Na+/K+ transporting subunit alpha 3 [KO:K01539] [EC:7.2.2.13]", "480  ATP1A4; ATPase Na+/K+ transporting subunit alpha 4 [KO:K01539] [EC:7.2.2.13]", "23439  ATP1B4; ATPase Na+/K+ transporting family member beta 4 [KO:K01540]", "481  ATP1B1; ATPase Na+/K+ transporting subunit beta 1 [KO:K01540]", "482  ATP1B2; ATPase Na+/K+ transporting subunit beta 2 [KO:K01540]", "483  ATP1B3; ATPase Na+/K+ transporting subunit beta 3 [KO:K01540]", "486  FXYD2; FXYD domain containing ion transport regulator 2 [KO:K01538]", "490  ATP2B1; ATPase plasma membrane Ca2+ transporting 1 [KO:K05850] [EC:7.2.2.10]", "492  ATP2B3; ATPase plasma membrane Ca2+ transporting 3 [KO:K05850] [EC:7.2.2.10]", "493  ATP2B4; ATPase plasma membrane Ca2+ transporting 4 [KO:K05850] [EC:7.2.2.10]", "491  ATP2B2; ATPase plasma membrane Ca2+ transporting 2 [KO:K05850] [EC:7.2.2.10]", "5997  RGS2; regulator of G protein signaling 2 [KO:K18154]", "2969  GTF2I; general transcription factor IIi [KO:K03121]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "10335  IRAG1; inositol 1,4,5-triphosphate receptor associated 1 [KO:K12337]", "5350  PLN; phospholamban [KO:K05852]", "487  ATP2A1; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 [KO:K05853] [EC:7.2.2.10]", "489  ATP2A3; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 [KO:K05853] [EC:7.2.2.10]", "488  ATP2A2; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 [KO:K05853] [EC:7.2.2.10]", "387  RHOA; ras homolog family member A [KO:K04513]", "6093  ROCK1; Rho associated coiled-coil containing protein kinase 1 [KO:K04514] [EC:2.7.11.1]", "9475  ROCK2; Rho associated coiled-coil containing protein kinase 2 [KO:K17388] [EC:2.7.11.1]", "4659  PPP1R12A; protein phosphatase 1 regulatory subunit 12A [KO:K06270]", "5499  PPP1CA; protein phosphatase 1 catalytic subunit alpha [KO:K06269] [EC:3.1.3.16]", "5500  PPP1CB; protein phosphatase 1 catalytic subunit beta [KO:K06269] [EC:3.1.3.16]", "5501  PPP1CC; protein phosphatase 1 catalytic subunit gamma [KO:K06269] [EC:3.1.3.16]", "810  CALML3; calmodulin like 3 [KO:K02183]", "805  CALM2; calmodulin 2 [KO:K02183]", "808  CALM3; calmodulin 3 [KO:K02183]", "801  CALM1; calmodulin 1 [KO:K02183]", "163688  CALML6; calmodulin like 6 [KO:K02183]", "51806  CALML5; calmodulin like 5 [KO:K02183]", "91860  CALML4; calmodulin like 4 [KO:K02183]", "4638  MYLK; myosin light chain kinase [KO:K00907] [EC:2.7.11.18]", "85366  MYLK2; myosin light chain kinase 2 [KO:K00907] [EC:2.7.11.18]", "91807  MYLK3; myosin light chain kinase 3 [KO:K00907] [EC:2.7.11.18]", "340156  MYLK4; myosin light chain kinase family member 4 [KO:K00907] [EC:2.7.11.18]", "10398  MYL9; myosin light chain 9 [KO:K12755]", "1259  CNGA1; cyclic nucleotide gated channel subunit alpha 1 [KO:K04948]", "1258  CNGB1; cyclic nucleotide gated channel subunit beta 1 [KO:K04952]", "107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]", "108  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]", "109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]", "196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]", "113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]", "114  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]", "115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]", "5138  PDE2A; phosphodiesterase 2A [KO:K18283] [EC:3.1.4.17]", "5139  PDE3A; phosphodiesterase 3A [KO:K19021] [EC:3.1.4.17]", "5140  PDE3B; phosphodiesterase 3B [KO:K13296] [EC:3.1.4.17]", "8654  PDE5A; phosphodiesterase 5A [KO:K13762] [EC:3.1.4.35]", "2977  GUCY1A2; guanylate cyclase 1 soluble subunit alpha 2 [KO:K12318] [EC:4.6.1.2]", "2982  GUCY1A1; guanylate cyclase 1 soluble subunit alpha 1 [KO:K12318] [EC:4.6.1.2]", "2983  GUCY1B1; guanylate cyclase 1 soluble subunit beta 1 [KO:K12319] [EC:4.6.1.2]", "3827  KNG1; kininogen 1 [KO:K03898]", "624  BDKRB2; bradykinin receptor B2 [KO:K03916]", "4985  OPRD1; opioid receptor delta 1 [KO:K04213]", "134  ADORA1; adenosine A1 receptor [KO:K04265]", "140  ADORA3; adenosine A3 receptor [KO:K04268]", "2770  GNAI1; G protein subunit alpha i1 [KO:K04630]", "2773  GNAI3; G protein subunit alpha i3 [KO:K04630]", "2771  GNAI2; G protein subunit alpha i2 [KO:K04630]", "3630  INS; insulin [KO:K04526]", "3643  INSR; insulin receptor [KO:K04527] [EC:2.7.10.1]", "3667  IRS1; insulin receptor substrate 1 [KO:K16172]", "8660  IRS2; insulin receptor substrate 2 [KO:K07187]", "8471  IRS4; insulin receptor substrate 4 [KO:K17446]", "5294  PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma [KO:K21289] [EC:2.7.1.153]", "23533  PIK3R5; phosphoinositide-3-kinase regulatory subunit 5 [KO:K21290]", "146850  PIK3R6; phosphoinositide-3-kinase regulatory subunit 6 [KO:K21290]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "4846  NOS3; nitric oxide synthase 3 [KO:K13242] [EC:1.14.13.39]", "153  ADRB1; adrenoceptor beta 1 [KO:K04141]", "154  ADRB2; adrenoceptor beta 2 [KO:K04142]", "155  ADRB3; adrenoceptor beta 3 [KO:K04143]", "5581  PRKCE; protein kinase C epsilon [KO:K18050] [EC:2.7.11.13]", "3764  KCNJ8; potassium inwardly rectifying channel subfamily J member 8 [KO:K05001]", "7416  VDAC1; voltage dependent anion channel 1 [KO:K05862]", "7417  VDAC2; voltage dependent anion channel 2 [KO:K15040]", "7419  VDAC3; voltage dependent anion channel 3 [KO:K15041]", "291  SLC25A4; solute carrier family 25 member 4 [KO:K05863]", "292  SLC25A5; solute carrier family 25 member 5 [KO:K05863]", "293  SLC25A6; solute carrier family 25 member 6 [KO:K05863]", "83447  SLC25A31; solute carrier family 25 member 31 [KO:K05863]", "10105  PPIF; peptidylprolyl isomerase F [KO:K09565] [EC:5.2.1.8]", "1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]", "1386  ATF2; activating transcription factor 2 [KO:K04450]", "468  ATF4; activating transcription factor 4 [KO:K04374]", "10488  CREB3; cAMP responsive element binding protein 3 [KO:K09048]", "90993  CREB3L1; cAMP responsive element binding protein 3 like 1 [KO:K09048]", "64764  CREB3L2; cAMP responsive element binding protein 3 like 2 [KO:K09048]", "84699  CREB3L3; cAMP responsive element binding protein 3 like 3 [KO:K09048]", "148327  CREB3L4; cAMP responsive element binding protein 3 like 4 [KO:K09048]", "9586  CREB5; cAMP responsive element binding protein 5 [KO:K09047]", "1388  ATF6B; activating transcription factor 6 beta [KO:K09049]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]", "7408  VASP; vasodilator stimulated phosphoprotein [KO:K06274]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]"], "compound": ["C00020  AMP", "C00027  Hydrogen peroxide", "C00076  Calcium cation", "C00144  GMP", "C00212  Adenosine", "C00238  Potassium cation", "C00533  Nitric oxide", "C00575  3',5'-Cyclic AMP", "C00942  3',5'-Cyclic GMP", "C01245  D-myo-Inositol 1,4,5-trisphosphate"], "refs": [{"pmid": "20716671", "authors": "  Francis SH, Busch JL, Corbin JD, Sibley D", "title": "cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.", "journal": "Pharmacol Rev 62:525-63 (2010)", "doi": "10.1124/pr.110.002907"}, {"pmid": "16439998", "authors": "  Feil R, Kemp-Harper B", "title": "cGMP signalling: from bench to bedside. Conference on cGMP generators, effectors and therapeutic implications.", "journal": "EMBO Rep 7:149-53 (2006)", "doi": "10.1038/sj.embor.7400627"}, {"pmid": "22785374", "authors": "  Takimoto E", "title": "Cyclic GMP-dependent signaling in cardiac myocytes.", "journal": "Circ J 76:1819-25 (2012)", "doi": "10.1253/circj.CJ-12-0664"}, {"pmid": "16371594", "authors": "  Hofmann F, Feil R, Kleppisch T, Schlossmann J", "title": "Function of cGMP-dependent protein kinases as revealed by gene deletion.", "journal": "Physiol Rev 86:1-23 (2006)", "doi": "10.1152/physrev.00015.2005"}, {"pmid": "21685243", "authors": "  Kuebler WM", "title": "The Janus-faced regulation of endothelial permeability by cyclic GMP.", "journal": "Am J Physiol Lung Cell Mol Physiol 301:L157-60 (2011)", "doi": "10.1152/ajplung.00192.2011"}, {"pmid": "21666108", "authors": "  Schlossmann J, Desch M", "title": "IRAG and novel PKG targeting in the cardiovascular system.", "journal": "Am J Physiol Heart Circ Physiol 301:H672-82 (2011)", "doi": "10.1152/ajpheart.00198.2011"}, {"pmid": "16460276", "authors": "  Murthy KS", "title": "Signaling for contraction and relaxation in smooth muscle of the gut.", "journal": "Annu Rev Physiol 68:345-74 (2006)", "doi": "10.1146/annurev.physiol.68.040504.094707"}, {"pmid": "22965426", "authors": "  Sanders KM, Koh SD, Ro S, Ward SM", "title": "Regulation of gastrointestinal motility--insights from smooth muscle biology.", "journal": "Nat Rev Gastroenterol Hepatol 9:633-45 (2012)", "doi": "10.1038/nrgastro.2012.168"}, {"pmid": "20024580", "authors": "  Gao Y", "title": "The multiple actions of NO.", "journal": "Pflugers Arch 459:829-39 (2010)", "doi": "10.1007/s00424-009-0773-9"}, {"pmid": "9003029", "authors": "  Wang X, Robinson PJ", "title": "Cyclic GMP-dependent protein kinase and cellular signaling in the nervous system.", "journal": "J Neurochem 68:443-56 (1997)", "doi": "10.1046/j.1471-4159.1997.68020443.x"}, {"pmid": "19306895", "authors": "  Tsai EJ, Kass DA", "title": "Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics.", "journal": "Pharmacol Ther 122:216-38 (2009)", "doi": "10.1016/j.pharmthera.2009.02.009"}, {"pmid": "20388537", "authors": "  Villanueva C, Giulivi C", "title": "Subcellular and cellular locations of nitric oxide synthase isoforms as determinants of health and disease.", "journal": "Free Radic Biol Med 49:307-16 (2010)", "doi": "10.1016/j.freeradbiomed.2010.04.004"}, {"pmid": "15894227", "authors": "  Schlossmann J, Hofmann F", "title": "cGMP-dependent protein kinases in drug discovery.", "journal": "Drug Discov Today 10:627-34 (2005)", "doi": "10.1016/S1359-6446(05)03406-9"}, {"pmid": "18040025", "authors": "  Kass DA, Champion HC, Beavo JA", "title": "Phosphodiesterase type 5: expanding roles in cardiovascular regulation.", "journal": "Circ Res 101:1084-95 (2007)", "doi": "10.1161/CIRCRESAHA.107.162511"}, {"pmid": "16815627", "authors": "  Uckert S, Hedlund P, Andersson KE, Truss MC, Jonas U, Stief CG", "title": "Update on phosphodiesterase (PDE) isoenzymes as pharmacologic targets in urology: present and future.", "journal": "Eur Urol 50:1194-207; discussion 1207 (2006)", "doi": "10.1016/j.eururo.2006.05.025"}, {"pmid": "12524221", "authors": "  Yan C, Kim D, Aizawa T, Berk BC", "title": "Functional interplay between angiotensin II and nitric oxide: cyclic GMP as a key mediator.", "journal": "Arterioscler Thromb Vasc Biol 23:26-36 (2003)", "doi": "10.1161/01.ATV.0000046231.17365.9D"}, {"pmid": "17643091", "authors": "  McKinsey TA, Kass DA", "title": "Small-molecule therapies for cardiac hypertrophy: moving beneath the cell surface.", "journal": "Nat Rev Drug Discov 6:617-35 (2007)", "doi": "10.1038/nrd2193"}, {"pmid": "19961855", "authors": "  Koitabashi N, Aiba T, Hesketh GG, Rowell J, Zhang M, Takimoto E, Tomaselli GF, Kass DA", "title": "Cyclic GMP/PKG-dependent inhibition of TRPC6 channel activity and expression negatively regulates cardiomyocyte NFAT activation Novel mechanism of cardiac stress modulation by PDE5 inhibition.", "journal": "J Mol Cell Cardiol 48:713-24 (2010)", "doi": "10.1016/j.yjmcc.2009.11.015"}, {"pmid": "18006449", "authors": "  Costa AD, Pierre SV, Cohen MV, Downey JM, Garlid KD", "title": "cGMP signalling in pre- and post-conditioning: the role of mitochondria.", "journal": "Cardiovasc Res 77:344-52 (2008)", "doi": "10.1093/cvr/cvm050"}, {"pmid": "19176601", "authors": "  Boengler K, Schulz R, Heusch G", "title": "Loss of cardioprotection with ageing.", "journal": "Cardiovasc Res 83:247-61 (2009)", "doi": "10.1093/cvr/cvp033"}, {"pmid": "18757523", "authors": "  Gao Y, Portugal AD, Liu J, Negash S, Zhou W, Tian J, Xiang R, Longo LD, Raj JU", "title": "Preservation of cGMP-induced relaxation of pulmonary veins of fetal lambs exposed to chronic high altitude hypoxia: role of PKG and Rho kinase.", "journal": "Am J Physiol Lung Cell Mol Physiol 295:L889-96 (2008)", "doi": "10.1152/ajplung.00463.2007"}, {"pmid": "11522789", "authors": "  Li Z, Xi X, Du X", "title": "A mitogen-activated protein kinase-dependent signaling pathway in the activation of platelet integrin alpha IIbbeta3.", "journal": "J Biol Chem 276:42226-32 (2001)", "doi": "10.1074/jbc.M106129200"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04210  Apoptosis", "hsa04270  Vascular smooth muscle contraction", "hsa04744  Phototransduction"], "ko_pathway": "ko04022", "genes": ["AKT2", "AKT1"]}, {"kegg_id": "hsa04152", "name": "AMPK signaling pathway - Homo sapiens (human)", "description": "AMP-activated protein kinase (AMPK) is a serine threonine kinase that is highly conserved through evolution. AMPK system acts as a sensor of cellular energy status. It is activated by increases in the cellular AMP:ATP ratio caused by metabolic stresses that either interfere with ATP production (eg, deprivation for glucose or oxygen) or that accelerate ATP consumption (eg, muscle contraction). Several upstream kinases, including liver kinase B1 (LKB1), calcium/calmodulin kinase kinase-beta (CaMKK beta), and TGF-beta-activated kinase-1 (TAK-1), can activate AMPK by phosphorylating a threonine residue on its catalytic alpha-subunit. Once activated, AMPK leads to a concomitant inhibition of energy-consuming biosynthetic pathways, such as protein, fatty acid and glycogen synthesis, and activation of ATP-producing catabolic pathways, such as fatty acid oxidation and glycolysis.", "class": "Environmental Information Processing; Signal transduction", "pathway_map": "hsa04152  AMPK signaling pathway", "drug": ["D00395  Troglitazone (JAN/USAN/INN)", "D00595  Buformin (USAN/INN)", "D00596  Rosiglitazone maleate (JAN/USP)", "D00944  Metformin hydrochloride (JP18/USP)", "D00945  Pioglitazone hydrochloride (JP18/USP)", "D02206  Buformin hydrochloride (JP18)", "D04132  Farglitazar (USAN/INN)", "D04966  Metformin (USAN/INN)", "D05397  Peliglitazar (USAN)", "D08351  Phenformin (BAN)", "D08352  Phenformin hydrochloride", "D08378  Pioglitazone (INN)", "D08491  Rosiglitazone (INN)", "D11604  Leriglitazone hydrochloride (USAN)", "D11923  Lobeglitazone (INN)", "D12242  Bocidelpar (USAN)", "D12243  Bocidelpar sulfate (USAN)", "D12391  Denifanstat (USAN/INN)"], "dblinks": "GO: 2000479", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["6885  MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO:K04427] [EC:2.7.11.25]", "6794  STK11; serine/threonine kinase 11 [KO:K07298] [EC:2.7.11.1]", "51719  CAB39; calcium binding protein 39 [KO:K08272]", "81617  CAB39L; calcium binding protein 39 like [KO:K08272]", "92335  STRADA; STE20 related adaptor alpha [KO:K08271]", "55437  STRADB; STE20 related adaptor beta [KO:K17532]", "3952  LEP; leptin [KO:K05424]", "3953  LEPR; leptin receptor [KO:K05062]", "10645  CAMKK2; calcium/calmodulin dependent protein kinase kinase 2 [KO:K07359] [EC:2.7.11.17]", "148  ADRA1A; adrenoceptor alpha 1A [KO:K04135]", "9370  ADIPOQ; adiponectin, C1Q and collagen domain containing [KO:K07296]", "51094  ADIPOR1; adiponectin receptor 1 [KO:K07297]", "79602  ADIPOR2; adiponectin receptor 2 [KO:K07297]", "5562  PRKAA1; protein kinase AMP-activated catalytic subunit alpha 1 [KO:K07198] [EC:2.7.11.31]", "5563  PRKAA2; protein kinase AMP-activated catalytic subunit alpha 2 [KO:K07198] [EC:2.7.11.31]", "5564  PRKAB1; protein kinase AMP-activated non-catalytic subunit beta 1 [KO:K07199]", "5565  PRKAB2; protein kinase AMP-activated non-catalytic subunit beta 2 [KO:K07199]", "5571  PRKAG1; protein kinase AMP-activated non-catalytic subunit gamma 1 [KO:K07200]", "53632  PRKAG3; protein kinase AMP-activated non-catalytic subunit gamma 3 [KO:K07200]", "51422  PRKAG2; protein kinase AMP-activated non-catalytic subunit gamma 2 [KO:K07200]", "5207  PFKFB1; 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 [KO:K19028] [EC:2.7.1.105 3.1.3.46]", "5208  PFKFB2; 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 [KO:K19029] [EC:2.7.1.105 3.1.3.46]", "5209  PFKFB3; 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 [KO:K01103] [EC:2.7.1.105 3.1.3.46]", "5210  PFKFB4; 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 [KO:K19030] [EC:2.7.1.105 3.1.3.46]", "2203  FBP1; fructose-bisphosphatase 1 [KO:K03841] [EC:3.1.3.11]", "8789  FBP2; fructose-bisphosphatase 2 [KO:K03841] [EC:3.1.3.11]", "5213  PFKM; phosphofructokinase, muscle [KO:K00850] [EC:2.7.1.11]", "5214  PFKP; phosphofructokinase, platelet [KO:K00850] [EC:2.7.1.11]", "5211  PFKL; phosphofructokinase, liver type [KO:K00850] [EC:2.7.1.11]", "3172  HNF4A; hepatocyte nuclear factor 4 alpha [KO:K07292]", "2538  G6PC1; glucose-6-phosphatase catalytic subunit 1 [KO:K01084] [EC:3.1.3.9]", "57818  G6PC2; glucose-6-phosphatase catalytic subunit 2 [KO:K01084] [EC:3.1.3.9]", "92579  G6PC3; glucose-6-phosphatase catalytic subunit 3 [KO:K01084] [EC:3.1.3.9]", "5105  PCK1; phosphoenolpyruvate carboxykinase 1 [KO:K01596] [EC:4.1.1.32]", "5106  PCK2; phosphoenolpyruvate carboxykinase 2, mitochondrial [KO:K01596] [EC:4.1.1.32]", "200186  CRTC2; CREB regulated transcription coactivator 2 [KO:K16333]", "1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]", "10488  CREB3; cAMP responsive element binding protein 3 [KO:K09048]", "90993  CREB3L1; cAMP responsive element binding protein 3 like 1 [KO:K09048]", "64764  CREB3L2; cAMP responsive element binding protein 3 like 2 [KO:K09048]", "84699  CREB3L3; cAMP responsive element binding protein 3 like 3 [KO:K09048]", "148327  CREB3L4; cAMP responsive element binding protein 3 like 4 [KO:K09048]", "9586  CREB5; cAMP responsive element binding protein 5 [KO:K09047]", "10891  PPARGC1A; PPARG coactivator 1 alpha [KO:K07202]", "1994  ELAVL1; ELAV like RNA binding protein 1 [KO:K13088]", "595  CCND1; cyclin D1 [KO:K04503]", "890  CCNA2; cyclin A2 [KO:K06627]", "8900  CCNA1; cyclin A1 [KO:K06627]", "29904  EEF2K; eukaryotic elongation factor 2 kinase [KO:K08292] [EC:2.7.11.20]", "1938  EEF2; eukaryotic translation elongation factor 2 [KO:K03234]", "2308  FOXO1; forkhead box O1 [KO:K07201]", "2309  FOXO3; forkhead box O3 [KO:K09408]", "23411  SIRT1; sirtuin 1 [KO:K11411] [EC:2.3.1.286]", "6517  SLC2A4; solute carrier family 2 member 4 [KO:K07191]", "2998  GYS2; glycogen synthase 2 [KO:K00693] [EC:2.4.1.11]", "2997  GYS1; glycogen synthase 1 [KO:K00693] [EC:2.4.1.11]", "3991  LIPE; lipase E, hormone sensitive type [KO:K07188] [EC:3.1.1.79]", "3156  HMGCR; 3-hydroxy-3-methylglutaryl-CoA reductase [KO:K00021] [EC:1.1.1.34]", "6720  SREBF1; sterol regulatory element binding transcription factor 1 [KO:K07197]", "2194  FASN; fatty acid synthase [KO:K00665] [EC:2.3.1.85]", "31  ACACA; acetyl-CoA carboxylase alpha [KO:K11262] [EC:6.4.1.2 6.3.4.14 2.1.3.15]", "6319  SCD; stearoyl-CoA desaturase [KO:K00507] [EC:1.14.19.1]", "79966  SCD5; stearoyl-CoA desaturase 5 [KO:K00507] [EC:1.14.19.1]", "32  ACACB; acetyl-CoA carboxylase beta [KO:K01946] [EC:6.4.1.2 6.3.4.14 2.1.3.15]", "23417  MLYCD; malonyl-CoA decarboxylase [KO:K01578] [EC:4.1.1.9]", "1374  CPT1A; carnitine palmitoyltransferase 1A [KO:K08765] [EC:2.3.1.21]", "1375  CPT1B; carnitine palmitoyltransferase 1B [KO:K19523] [EC:2.3.1.21]", "126129  CPT1C; carnitine palmitoyltransferase 1C [KO:K19524] [EC:2.3.1.21]", "1149  CIDEA; cell death inducing DFFA like effector a [KO:K25893]", "5515  PPP2CA; protein phosphatase 2 catalytic subunit alpha [KO:K04382] [EC:3.1.3.16]", "5516  PPP2CB; protein phosphatase 2 catalytic subunit beta [KO:K04382] [EC:3.1.3.16]", "5519  PPP2R1B; protein phosphatase 2 scaffold subunit Abeta [KO:K03456]", "5518  PPP2R1A; protein phosphatase 2 scaffold subunit Aalpha [KO:K03456]", "5520  PPP2R2A; protein phosphatase 2 regulatory subunit Balpha [KO:K04354]", "5521  PPP2R2B; protein phosphatase 2 regulatory subunit Bbeta [KO:K04354]", "5522  PPP2R2C; protein phosphatase 2 regulatory subunit Bgamma [KO:K04354]", "55844  PPP2R2D; protein phosphatase 2 regulatory subunit Bdelta [KO:K04354]", "28227  PPP2R3B; protein phosphatase 2 regulatory subunit B''beta [KO:K11583]", "55012  PPP2R3C; protein phosphatase 2 regulatory subunit B''gamma [KO:K11583]", "5523  PPP2R3A; protein phosphatase 2 regulatory subunit B''alpha [KO:K11583]", "5526  PPP2R5B; protein phosphatase 2 regulatory subunit B'beta [KO:K11584]", "5527  PPP2R5C; protein phosphatase 2 regulatory subunit B'gamma [KO:K11584]", "5528  PPP2R5D; protein phosphatase 2 regulatory subunit B'delta [KO:K11584]", "5529  PPP2R5E; protein phosphatase 2 regulatory subunit B'epsilon [KO:K11584]", "5525  PPP2R5A; protein phosphatase 2 regulatory subunit B'alpha [KO:K11584]", "23216  TBC1D1; TBC1 domain family member 1 [KO:K18341]", "5862  RAB2A; RAB2A, member RAS oncogene family [KO:K07877]", "4218  RAB8A; RAB8A, member RAS oncogene family [KO:K07901]", "10890  RAB10; RAB10, member RAS oncogene family [KO:K07903]", "9230  RAB11B; RAB11B, member RAS oncogene family [KO:K07905]", "51552  RAB14; RAB14, member RAS oncogene family [KO:K07881]", "1080  CFTR; CF transmembrane conductance regulator [KO:K05031] [EC:5.6.1.6]", "948  CD36; CD36 molecule (CD36 blood group) [KO:K06259]", "3479  IGF1; insulin like growth factor 1 [KO:K05459]", "3480  IGF1R; insulin like growth factor 1 receptor [KO:K05087] [EC:2.7.10.1]", "3630  INS; insulin [KO:K04526]", "3643  INSR; insulin receptor [KO:K04527] [EC:2.7.10.1]", "3667  IRS1; insulin receptor substrate 1 [KO:K16172]", "8660  IRS2; insulin receptor substrate 2 [KO:K07187]", "8471  IRS4; insulin receptor substrate 4 [KO:K17446]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5170  PDPK1; 3-phosphoinositide dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "7249  TSC2; TSC complex subunit 2 [KO:K07207]", "7248  TSC1; TSC complex subunit 1 [KO:K07206]", "6009  RHEB; Ras homolog, mTORC1 binding [KO:K07208]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "57521  RPTOR; regulatory associated protein of MTOR complex 1 [KO:K07204]", "84335  AKT1S1; AKT1 substrate 1 [KO:K16184]", "6198  RPS6KB1; ribosomal protein S6 kinase B1 [KO:K04688] [EC:2.7.11.1]", "6199  RPS6KB2; ribosomal protein S6 kinase B2 [KO:K04688] [EC:2.7.11.1]", "1978  EIF4EBP1; eukaryotic translation initiation factor 4E binding protein 1 [KO:K07205]", "5468  PPARG; peroxisome proliferator activated receptor gamma [KO:K08530]", "8408  ULK1; unc-51 like autophagy activating kinase 1 [KO:K21357] [EC:2.7.11.1]"], "compound": ["C00003  NAD+", "C00008  ADP", "C00020  AMP", "C00022  Pyruvate", "C00024  Acetyl-CoA", "C00031  D-Glucose", "C00040  Acyl-CoA", "C00076  Calcium cation", "C00083  Malonyl-CoA", "C00085  D-Fructose 6-phosphate", "C00162  Fatty acid", "C00354  D-Fructose 1,6-bisphosphate", "C00389  Quercetin", "C00665  beta-D-Fructose 2,6-bisphosphate", "C00668  alpha-D-Glucose 6-phosphate", "C00698  Cl-", "C00757  Berberine", "C01172  beta-D-Glucose 6-phosphate", "C04677  1-(5'-Phosphoribosyl)-5-amino-4-imidazolecarboxamide", "C05981  Phosphatidylinositol-3,4,5-trisphosphate", "C07151  Metformin", "C09731  Epigallocatechin gallate", "D08351  Phenformin (BAN)"], "refs": [{"pmid": "19584320", "authors": "  Steinberg GR, Kemp BE", "title": "AMPK in Health and Disease.", "journal": "Physiol Rev 89:1025-78 (2009)", "doi": "10.1152/physrev.00011.2008"}, {"pmid": "15509864", "authors": "  Hardie DG.", "title": "The AMP-activated protein kinase pathway--new players upstream and downstream.", "journal": "J Cell Sci 117:5479-87 (2004)", "doi": "10.1242/jcs.01540"}, {"pmid": "23747347", "authors": "  Russo GL, Russo M, Ungaro P", "title": "AMP-activated protein kinase: a target for old drugs against diabetes and cancer.", "journal": "Biochem Pharmacol 86:339-50 (2013)", "doi": "10.1016/j.bcp.2013.05.023"}, {"pmid": "19393004", "authors": "  Ronnett GV, Ramamurthy S, Kleman AM, Landree LE, Aja S", "title": "AMPK in the brain: its roles in energy balance and neuroprotection.", "journal": "J Neurochem 109 Suppl 1:17-23 (2009)", "doi": "10.1111/j.1471-4159.2009.05916.x"}, {"pmid": "20010958", "authors": "  Li J, McCullough LD", "title": "Effects of AMP-activated protein kinase in cerebral ischemia.", "journal": "J Cereb Blood Flow Metab 30:480-92 (2010)", "doi": "10.1038/jcbfm.2009.255"}, {"pmid": "22700795", "authors": "  Sanchez AM, Candau RB, Csibi A, Pagano AF, Raibon A, Bernardi H", "title": "The role of AMP-activated protein kinase in the coordination of skeletal muscle turnover and energy homeostasis.", "journal": "Am J Physiol Cell Physiol 303:C475-85 (2012)", "doi": "10.1152/ajpcell.00125.2012"}, {"pmid": "16644802", "authors": "  Viollet B, Foretz M, Guigas B, Horman S, Dentin R, Bertrand L, Hue L, Andreelli F", "title": "Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders.", "journal": "J Physiol 574:41-53 (2006)", "doi": "10.1113/jphysiol.2006.108506"}, {"pmid": "19629071", "authors": "  Shackelford DB, Shaw RJ", "title": "The LKB1-AMPK pathway: metabolism and growth control in tumour suppression.", "journal": "Nat Rev Cancer 9:563-75 (2009)", "doi": "10.1038/nrc2676"}, {"pmid": "22885100", "authors": "  Chung JH, Manganiello V, Dyck JR", "title": "Resveratrol as a calorie restriction mimetic: therapeutic implications.", "journal": "Trends Cell Biol 22:546-54 (2012)", "doi": "10.1016/j.tcb.2012.07.004"}, {"pmid": "20357764", "authors": "  Iwabu M, Yamauchi T, Okada-Iwabu M, Sato K, Nakagawa T, Funata M, Yamaguchi M, Namiki S, Nakayama R, Tabata M, Ogata H, Kubota N, Takamoto I, Hayashi YK, Yamauchi N, Waki H, Fukayama M, Nishino I, Tokuyama K, Ueki K, Oike Y, Ishii S, Hirose K, Shimizu T, Touhara K, Kadowaki T", "title": "Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1.", "journal": "Nature 464:1313-9 (2010)", "doi": "10.1038/nature08991"}, {"pmid": "17307971", "authors": "  Towler MC, Hardie DG", "title": "AMP-activated protein kinase in metabolic control and insulin signaling.", "journal": "Circ Res 100:328-41 (2007)", "doi": "10.1161/01.RES.0000256090.42690.05"}, {"pmid": "23899560", "authors": "  Richter EA, Hargreaves M", "title": "Exercise, GLUT4, and skeletal muscle glucose uptake.", "journal": "Physiol Rev 93:993-1017 (2013)", "doi": "10.1152/physrev.00038.2012"}, {"pmid": "16054041", "authors": "  Kahn BB, Alquier T, Carling D, Hardie DG", "title": "AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism.", "journal": "Cell Metab 1:15-25 (2005)", "doi": "10.1016/j.cmet.2004.12.003"}, {"pmid": "23565491", "authors": "  Minokoshi Y, Toda C, Okamoto S", "title": "Regulatory role of leptin in glucose and lipid metabolism in skeletal muscle.", "journal": "Indian J Endocrinol Metab 16:S562-8 (2012)", "doi": "10.4103/2230-8210.105573"}, {"pmid": "16723978", "authors": "  Guggino WB, Stanton BA", "title": "New insights into cystic fibrosis: molecular switches that regulate CFTR.", "journal": "Nat Rev Mol Cell Biol 7:426-36 (2006)", "doi": "10.1038/nrm1949"}, {"pmid": "16479585", "authors": "  Cheng A, Saltiel AR", "title": "More TORC for the gluconeogenic engine.", "journal": "Bioessays 28:231-4 (2006)", "doi": "10.1002/bies.20375"}, {"pmid": "19197243", "authors": "  Herrero-Martin G, Hoyer-Hansen M, Garcia-Garcia C, Fumarola C, Farkas T, Lopez-Rivas A, Jaattela M", "title": "TAK1 activates AMPK-dependent cytoprotective autophagy in TRAIL-treated epithelial cells.", "journal": "EMBO J 28:677-85 (2009)", "doi": "10.1038/emboj.2009.8"}, {"pmid": "19724019", "authors": "  Morris DL, Rui L", "title": "Recent advances in understanding leptin signaling and leptin resistance.", "journal": "Am J Physiol Endocrinol Metab 297:E1247-59 (2009)", "doi": "10.1152/ajpendo.00274.2009"}, {"pmid": "18725075", "authors": "  Minokoshi Y, Shiuchi T, Lee S, Suzuki A, Okamoto S", "title": "Role of hypothalamic AMP-kinase in food intake regulation.", "journal": "Nutrition 24:786-90 (2008)", "doi": "10.1016/j.nut.2008.06.002"}], "rel_pathway": ["hsa00010  Glycolysis / Gluconeogenesis", "hsa00061  Fatty acid biosynthesis", "hsa00500  Starch and sucrose metabolism", "hsa01040  Biosynthesis of unsaturated fatty acids", "hsa04110  Cell cycle", "hsa04140  Autophagy - animal", "hsa04150  mTOR signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04910  Insulin signaling pathway", "hsa04920  Adipocytokine signaling pathway"], "ko_pathway": "ko04152", "genes": ["AKT2", "AKT1", "CD36"]}, {"kegg_id": "hsa04213", "name": "Longevity regulating pathway - multiple species - Homo sapiens (human)", "description": "Aging is a complex process of accumulation of molecular, cellular, and organ damage, leading to loss of function and increased vulnerability to disease and death. Despite the complexity of aging, recent work has shown that dietary restriction (DR) and genetic down-regulation of nutrient-sensing pathways, namely IIS (insulin/insulin-like growth factor signalling) and TOR (target-of- rapamycin) can substantially increase healthy life span of laboratory model organisms. These nutrient signaling pathways are conserved in various organisms. In worms, flies, and mammals, DR reduces signalling through IIS/TOR pathways, deactivating the PI3K/Akt/TOR intracellular signalling cascade and consequently activating the antiaging FOXO family transcription factor(s). In yeast, the effects of DR on life- span extension are associated with reduced activities of the TOR/Sch9 and Ras/PKA pathways and require the serine-threonine kinase Rim15 and transcription factors Gis1 and Msn2/4. These transcription factors (FOXO, DAF-16, Gis1, and Msn2/4) transactivate genes involved in resistance to oxidative stress, energy metabolism, DNA damage repair, glucose metabolism, autophagy and protection of proteins by chaperones.", "class": "Organismal Systems; Aging", "pathway_map": "hsa04213  Longevity regulating pathway - multiple species", "drug": ["D11811  Tofersen (JAN/USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["3630  INS; insulin [KO:K04526]", "3643  INSR; insulin receptor [KO:K04527] [EC:2.7.10.1]", "3479  IGF1; insulin like growth factor 1 [KO:K05459]", "3480  IGF1R; insulin like growth factor 1 receptor [KO:K05087] [EC:2.7.10.1]", "3667  IRS1; insulin receptor substrate 1 [KO:K16172]", "8660  IRS2; insulin receptor substrate 2 [KO:K07187]", "8471  IRS4; insulin receptor substrate 4 [KO:K17446]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]", "108  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]", "109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]", "196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]", "113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]", "114  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]", "115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "2308  FOXO1; forkhead box O1 [KO:K07201]", "2309  FOXO3; forkhead box O3 [KO:K09408]", "6648  SOD2; superoxide dismutase 2 [KO:K04564] [EC:1.15.1.1]", "847  CAT; catalase [KO:K03781] [EC:1.11.1.6]", "9474  ATG5; autophagy related 5 [KO:K08339]", "5562  PRKAA1; protein kinase AMP-activated catalytic subunit alpha 1 [KO:K07198] [EC:2.7.11.31]", "5563  PRKAA2; protein kinase AMP-activated catalytic subunit alpha 2 [KO:K07198] [EC:2.7.11.31]", "5564  PRKAB1; protein kinase AMP-activated non-catalytic subunit beta 1 [KO:K07199]", "5565  PRKAB2; protein kinase AMP-activated non-catalytic subunit beta 2 [KO:K07199]", "5571  PRKAG1; protein kinase AMP-activated non-catalytic subunit gamma 1 [KO:K07200]", "53632  PRKAG3; protein kinase AMP-activated non-catalytic subunit gamma 3 [KO:K07200]", "51422  PRKAG2; protein kinase AMP-activated non-catalytic subunit gamma 2 [KO:K07200]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "57521  RPTOR; regulatory associated protein of MTOR complex 1 [KO:K07204]", "84335  AKT1S1; AKT1 substrate 1 [KO:K16184]", "6198  RPS6KB1; ribosomal protein S6 kinase B1 [KO:K04688] [EC:2.7.11.1]", "6199  RPS6KB2; ribosomal protein S6 kinase B2 [KO:K04688] [EC:2.7.11.1]", "23411  SIRT1; sirtuin 1 [KO:K11411] [EC:2.3.1.286]", "6647  SOD1; superoxide dismutase 1 [KO:K04565] [EC:1.15.1.1]", "1979  EIF4EBP2; eukaryotic translation initiation factor 4E binding protein 2 [KO:K18644]", "3312  HSPA8; heat shock protein family A (Hsp70) member 8 [KO:K03283]", "3303  HSPA1A; heat shock protein family A (Hsp70) member 1A [KO:K03283]", "3305  HSPA1L; heat shock protein family A (Hsp70) member 1 like [KO:K03283]", "3304  HSPA1B; heat shock protein family A (Hsp70) member 1B [KO:K03283]", "3310  HSPA6; heat shock protein family A (Hsp70) member 6 [KO:K03283]", "1410  CRYAB; crystallin alpha B [KO:K09542]", "3065  HDAC1; histone deacetylase 1 [KO:K06067] [EC:3.5.1.98]", "3066  HDAC2; histone deacetylase 2 [KO:K06067] [EC:3.5.1.98]", "3170  FOXA2; forkhead box A2 [KO:K08035]", "81570  CLPB; ClpB family mitochondrial disaggregase [KO:K03695]"], "compound": ["C00575  3',5'-Cyclic AMP", "C05981  Phosphatidylinositol-3,4,5-trisphosphate"], "refs": [{"pmid": "20395504", "authors": "  Fontana L, Partridge L, Longo VD", "title": "Extending healthy life span--from yeast to humans.", "journal": "Science 328:321-6 (2010)", "doi": "10.1126/science.1172539"}, {"pmid": "20098959", "authors": "  Parrella E, Longo VD", "title": "Insulin/IGF-I and related signaling pathways regulate aging in nondividing cells: from yeast to the mammalian brain.", "journal": "ScientificWorldJournal 10:161-77 (2010)", "doi": "10.1100/tsw.2010.8"}, {"pmid": "26682004", "authors": "  Santos J, Leitao-Correia F, Sousa MJ, Leao C", "title": "Dietary Restriction and Nutrient Balance in Aging.", "journal": "Oxid Med Cell Longev 2016:4010357 (2016)", "doi": "10.1155/2016/4010357"}, {"pmid": "18946478", "authors": "  Longo VD, Lieber MR, Vijg J", "title": "Turning anti-ageing genes against cancer.", "journal": "Nat Rev Mol Cell Biol 9:903-10 (2008)", "doi": "10.1038/nrm2526"}, {"pmid": "16304601", "authors": "  Longo VD, Mitteldorf J, Skulachev VP", "title": "Programmed and altruistic ageing.", "journal": "Nat Rev Genet 6:866-72 (2005)", "doi": "10.1038/nrg1706"}, {"pmid": "12610293", "authors": "  Longo VD, Finch CE", "title": "Evolutionary medicine: from dwarf model systems to healthy centenarians?", "journal": "Science 299:1342-6 (2003)", "doi": "10.1126/science.1077991"}, {"pmid": "25153840", "authors": "  Mirzaei H, Suarez JA, Longo VD", "title": "Protein and amino acid restriction, aging and disease: from yeast to humans.", "journal": "Trends Endocrinol Metab 25:558-66 (2014)", "doi": "10.1016/j.tem.2014.07.002"}, {"pmid": "20336132", "authors": "  Kenyon CJ", "title": "The genetics of ageing.", "journal": "Nature 464:504-12 (2010)", "doi": "10.1038/nature08980"}, {"pmid": "20097433", "authors": "  Longo VD, Fontana L", "title": "Calorie restriction and cancer prevention: metabolic and molecular mechanisms.", "journal": "Trends Pharmacol Sci 31:89-98 (2010)", "doi": "10.1016/j.tips.2009.11.004"}, {"pmid": "22094419", "authors": "  Longo VD, Fabrizio P", "title": "Chronological aging in Saccharomyces cerevisiae.", "journal": "Subcell Biochem 57:101-21 (2012)", "doi": "10.1007/978-94-007-2561-4_5"}, {"pmid": "26525455", "authors": "  Bitto A, Wang AM, Bennett CF, Kaeberlein M", "title": "Biochemical Genetic Pathways that Modulate Aging in Multiple Species.", "journal": "Cold Spring Harb Perspect Med 5:a025114 (2015)", "doi": "10.1101/cshperspect.a025114"}, {"pmid": "18373439", "authors": "  Mair W, Dillin A", "title": "Aging and survival: the genetics of life span extension by dietary restriction.", "journal": "Annu Rev Biochem 77:727-54 (2008)", "doi": "10.1146/annurev.biochem.77.061206.171059"}, {"pmid": "17701476", "authors": "  Dali-Youcef N, Lagouge M, Froelich S, Koehl C, Schoonjans K, Auwerx J", "title": "Sirtuins: the 'magnificent seven', function, metabolism and longevity.", "journal": "Ann Med 39:335-45 (2007)", "doi": "10.1080/07853890701408194"}, {"pmid": "21909281", "authors": "  Rizki G, Iwata TN, Li J, Riedel CG, Picard CL, Jan M, Murphy CT, Lee SS", "title": "The evolutionarily conserved longevity determinants HCF-1 and SIR-2.1/SIRT1 collaborate to regulate DAF-16/FOXO.", "journal": "PLoS Genet 7:e1002235 (2011)", "doi": "10.1371/journal.pgen.1002235"}, {"pmid": "23615258", "authors": "  Lee SH, Min KJ", "title": "Caloric restriction and its mimetics.", "journal": "BMB Rep 46:181-7 (2013)", "doi": "10.5483/BMBRep.2013.46.4.033"}, {"pmid": "15768047", "authors": "  Bordone L, Guarente L", "title": "Calorie restriction, SIRT1 and metabolism: understanding longevity.", "journal": "Nat Rev Mol Cell Biol 6:298-305 (2005)", "doi": "10.1038/nrm1616"}, {"pmid": "21841070", "authors": "  Canto C, Auwerx J", "title": "Calorie restriction: is AMPK a key sensor and effector?", "journal": "Physiology (Bethesda) 26:214-24 (2011)", "doi": "10.1152/physiol.00010.2011"}, {"pmid": "14534077", "authors": "  Barbieri M, Bonafe M, Franceschi C, Paolisso G", "title": "Insulin/IGF-I-signaling pathway: an evolutionarily conserved mechanism of longevity from yeast to humans.", "journal": "Am J Physiol Endocrinol Metab 285:E1064-71 (2003)", "doi": "10.1152/ajpendo.00296.2003"}], "rel_pathway": ["hsa04068  FoxO signaling pathway", "hsa04150  mTOR signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04152  AMPK signaling pathway", "hsa04211  Longevity regulating pathway", "hsa04910  Insulin signaling pathway"], "ko_pathway": "ko04213", "genes": ["AKT2", "AKT1", "NRAS"]}, {"kegg_id": "hsa04371", "name": "Apelin signaling pathway - Homo sapiens (human)", "description": "Apelin is an endogenous peptide capable of binding the apelin receptor (APJ), which was originally described as an orphan G-protein-coupled receptor. Apelin and APJ are widely expressed in various tissues and organ systems. They are implicated in different key physiological processes such as angiogenesis, cardiovascular functions, cell proliferation and energy metabolism regulation. On the other hand, this ligand receptor couple is also involved in several pathologies including diabetes, obesity, cardiovascular disease and cancer.", "class": "Environmental Information Processing; Signal transduction", "pathway_map": "hsa04371  Apelin signaling pathway", "drug": ["D00231  Inamrinone (USP)", "D00417  Milrinone (JAN/USP/INN)", "D01133  Pimobendan (JAN/USAN/INN)", "D01238  Bucladesine sodium (JAN)", "D01697  Colforsin daropate hydrochloride (JAN)", "D02084  Inamrinone ethylenelactate", "D02085  Milrinone lactate", "D04004  Enoximone (USAN/INN)", "D04508  Imazodan hydrochloride (USAN)", "D04529  Indolidan (USAN/INN)", "D04628  Isomazole hydrochloride (USAN)", "D04720  Levosimendan (USAN/INN)", "D04751  Lixazinone sulfate (USAN)", "D07546  Bucladesine (INN)", "D10969  Pamrevlumab (USAN/INN)"], "dblinks": "GO: 0060183", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]", "108  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]", "109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]", "196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]", "113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]", "114  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]", "115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]", "55811  ADCY10; adenylate cyclase 10 [KO:K11265] [EC:4.6.1.1]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "3991  LIPE; lipase E, hormone sensitive type [KO:K07188] [EC:3.1.1.79]", "8862  APLN; apelin [KO:K05225]", "100506013  APELA; apelin receptor early endogenous ligand [KO:K25355]", "187  APLNR; apelin receptor [KO:K04174]", "2770  GNAI1; G protein subunit alpha i1 [KO:K04630]", "2773  GNAI3; G protein subunit alpha i3 [KO:K04630]", "2771  GNAI2; G protein subunit alpha i2 [KO:K04630]", "2782  GNB1; G protein subunit beta 1 [KO:K04536]", "2783  GNB2; G protein subunit beta 2 [KO:K04537]", "2784  GNB3; G protein subunit beta 3 [KO:K07825]", "59345  GNB4; G protein subunit beta 4 [KO:K04538]", "10681  GNB5; G protein subunit beta 5 [KO:K04539]", "54331  GNG2; G protein subunit gamma 2 [KO:K07826]", "2785  GNG3; G protein subunit gamma 3 [KO:K04540]", "2786  GNG4; G protein subunit gamma 4 [KO:K04541]", "2787  GNG5; G protein subunit gamma 5 [KO:K04542]", "2788  GNG7; G protein subunit gamma 7 [KO:K04543]", "94235  GNG8; G protein subunit gamma 8 [KO:K04544]", "2790  GNG10; G protein subunit gamma 10 [KO:K04545]", "2791  GNG11; G protein subunit gamma 11 [KO:K04546]", "55970  GNG12; G protein subunit gamma 12 [KO:K04347]", "51764  GNG13; G protein subunit gamma 13 [KO:K04547]", "2792  GNGT1; G protein subunit gamma transducin 1 [KO:K04548]", "2793  GNGT2; G protein subunit gamma transducin 2 [KO:K04549]", "2776  GNAQ; G protein subunit alpha q [KO:K04634]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "6261  RYR1; ryanodine receptor 1 [KO:K04961]", "6262  RYR2; ryanodine receptor 2 [KO:K04962]", "6263  RYR3; ryanodine receptor 3 [KO:K04963]", "810  CALML3; calmodulin like 3 [KO:K02183]", "805  CALM2; calmodulin 2 [KO:K02183]", "808  CALM3; calmodulin 3 [KO:K02183]", "801  CALM1; calmodulin 1 [KO:K02183]", "163688  CALML6; calmodulin like 6 [KO:K02183]", "51806  CALML5; calmodulin like 5 [KO:K02183]", "91860  CALML4; calmodulin like 4 [KO:K02183]", "4842  NOS1; nitric oxide synthase 1 [KO:K13240] [EC:1.14.13.39]", "4843  NOS2; nitric oxide synthase 2 [KO:K13241] [EC:1.14.13.39]", "4846  NOS3; nitric oxide synthase 3 [KO:K13242] [EC:1.14.13.39]", "5581  PRKCE; protein kinase C epsilon [KO:K18050] [EC:2.7.11.13]", "6548  SLC9A1; solute carrier family 9 member A1 [KO:K05742]", "6546  SLC8A1; solute carrier family 8 member A1 [KO:K05849]", "6543  SLC8A2; solute carrier family 8 member A2 [KO:K05849]", "6547  SLC8A3; solute carrier family 8 member A3 [KO:K05849]", "4638  MYLK; myosin light chain kinase [KO:K00907] [EC:2.7.11.18]", "85366  MYLK2; myosin light chain kinase 2 [KO:K00907] [EC:2.7.11.18]", "91807  MYLK3; myosin light chain kinase 3 [KO:K00907] [EC:2.7.11.18]", "340156  MYLK4; myosin light chain kinase family member 4 [KO:K00907] [EC:2.7.11.18]", "4633  MYL2; myosin light chain 2 [KO:K10351]", "4634  MYL3; myosin light chain 3 [KO:K12749]", "4635  MYL4; myosin light chain 4 [KO:K12750]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "6237  RRAS; RAS related [KO:K07829]", "22800  RRAS2; RAS related 2 [KO:K07830]", "22808  MRAS; muscle RAS oncogene homolog [KO:K07831]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "6198  RPS6KB1; ribosomal protein S6 kinase B1 [KO:K04688] [EC:2.7.11.1]", "6199  RPS6KB2; ribosomal protein S6 kinase B2 [KO:K04688] [EC:2.7.11.1]", "6194  RPS6; ribosomal protein S6 [KO:K02991]", "5294  PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma [KO:K21289] [EC:2.7.1.153]", "23533  PIK3R5; phosphoinositide-3-kinase regulatory subunit 5 [KO:K21290]", "146850  PIK3R6; phosphoinositide-3-kinase regulatory subunit 6 [KO:K21290]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "1958  EGR1; early growth response 1 [KO:K09203]", "6696  SPP1; secreted phosphoprotein 1 [KO:K06250]", "182  JAG1; jagged canonical Notch ligand 1 [KO:K06052]", "4854  NOTCH3; notch receptor 3 [KO:K20995]", "595  CCND1; cyclin D1 [KO:K04503]", "5140  PDE3B; phosphodiesterase 3B [KO:K13296] [EC:3.1.4.17]", "5289  PIK3C3; phosphatidylinositol 3-kinase catalytic subunit type 3 [KO:K00914] [EC:2.7.1.137]", "30849  PIK3R4; phosphoinositide-3-kinase regulatory subunit 4 [KO:K08333] [EC:2.7.11.1]", "8678  BECN1; beclin 1 [KO:K08334]", "441925  BECN2; beclin 2 [KO:K08334]", "440738  MAP1LC3C; microtubule associated protein 1 light chain 3 gamma [KO:K10435]", "81631  MAP1LC3B; microtubule associated protein 1 light chain 3 beta [KO:K10435]", "84557  MAP1LC3A; microtubule associated protein 1 light chain 3 alpha [KO:K10435]", "643246  MAP1LC3B2; microtubule associated protein 1 light chain 3 beta 2 [KO:K10435]", "5562  PRKAA1; protein kinase AMP-activated catalytic subunit alpha 1 [KO:K07198] [EC:2.7.11.31]", "5563  PRKAA2; protein kinase AMP-activated catalytic subunit alpha 2 [KO:K07198] [EC:2.7.11.31]", "5564  PRKAB1; protein kinase AMP-activated non-catalytic subunit beta 1 [KO:K07199]", "5565  PRKAB2; protein kinase AMP-activated non-catalytic subunit beta 2 [KO:K07199]", "5571  PRKAG1; protein kinase AMP-activated non-catalytic subunit gamma 1 [KO:K07200]", "53632  PRKAG3; protein kinase AMP-activated non-catalytic subunit gamma 3 [KO:K07200]", "51422  PRKAG2; protein kinase AMP-activated non-catalytic subunit gamma 2 [KO:K07200]", "5346  PLIN1; perilipin 1 [KO:K08768]", "10891  PPARGC1A; PPARG coactivator 1 alpha [KO:K07202]", "7350  UCP1; uncoupling protein 1 [KO:K08769]", "4899  NRF1; nuclear respiratory factor 1 [KO:K11831]", "7019  TFAM; transcription factor A, mitochondrial [KO:K11830]", "10365  KLF2; KLF transcription factor 2 [KO:K17845]", "8877  SPHK1; sphingosine kinase 1 [KO:K04718] [EC:2.7.1.91]", "56848  SPHK2; sphingosine kinase 2 [KO:K04718] [EC:2.7.1.91]", "10672  GNA13; G protein subunit alpha 13 [KO:K04639]", "814  CAMK4; calcium/calmodulin dependent protein kinase IV [KO:K05869] [EC:2.7.11.17]", "9759  HDAC4; histone deacetylase 4 [KO:K11406] [EC:3.5.1.98]", "10014  HDAC5; histone deacetylase 5 [KO:K11406] [EC:3.5.1.98]", "4205  MEF2A; myocyte enhancer factor 2A [KO:K09260]", "4207  BORCS8-MEF2B; BORCS8-MEF2B readthrough [KO:K09261]", "100271849  MEF2B; myocyte enhancer factor 2B [KO:K09261]", "4208  MEF2C; myocyte enhancer factor 2C [KO:K04454]", "4209  MEF2D; myocyte enhancer factor 2D [KO:K09262]", "7046  TGFBR1; transforming growth factor beta receptor 1 [KO:K04674] [EC:2.7.11.30]", "4087  SMAD2; SMAD family member 2 [KO:K04500]", "4088  SMAD3; SMAD family member 3 [KO:K23605]", "4089  SMAD4; SMAD family member 4 [KO:K04501]", "59  ACTA2; actin alpha 2, smooth muscle [KO:K12313]", "999  CDH1; cadherin 1 [KO:K05689]", "1490  CCN2; cellular communication network factor 2 [KO:K06827]", "185  AGTR1; angiotensin II receptor type 1 [KO:K04166]", "5054  SERPINE1; serpin family E member 1 [KO:K03982]", "5327  PLAT; plasminogen activator, tissue type [KO:K01343] [EC:3.4.21.68]"], "compound": ["C00076  Calcium cation", "C00080  H+", "C00165  Diacylglycerol", "C00290  Fibrin", "C00533  Nitric oxide", "C00575  3',5'-Cyclic AMP", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C01330  Sodium cation", "C06124  Sphingosine 1-phosphate"], "refs": [{"pmid": "26143239", "authors": "  Yang P, Maguire JJ, Davenport AP", "title": "Apelin, Elabela/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular system.", "journal": "Trends Pharmacol Sci 36:560-7 (2015)", "doi": "10.1016/j.tips.2015.06.002"}, {"pmid": "22140623", "authors": "  Andersen CU, Hilberg O, Mellemkjaer S, Nielsen-Kudsk JE, Simonsen U", "title": "Apelin and pulmonary hypertension.", "journal": "Pulm Circ 1:334-46 (2011)", "doi": "10.4103/2045-8932.87299"}, {"pmid": "25275559", "authors": "  Chapman NA, Dupre DJ, Rainey JK", "title": "The apelin receptor: physiology, pathology, cell signalling, and ligand modulation of a peptide-activated class A GPCR.", "journal": "Biochem Cell Biol 92:431-40 (2014)", "doi": "10.1139/bcb-2014-0072"}, {"pmid": "18272138", "authors": "  Japp AG, Newby DE", "title": "The apelin-APJ system in heart failure: pathophysiologic relevance and therapeutic potential.", "journal": "Biochem Pharmacol 75:1882-92 (2008)", "doi": "10.1016/j.bcp.2007.12.015"}, {"pmid": "25652330", "authors": "  Folino A, Montarolo PG, Samaja M, Rastaldo R", "title": "Effects of apelin on the cardiovascular system.", "journal": "Heart Fail Rev 20:505-18 (2015)", "doi": "10.1007/s10741-015-9475-x"}, {"pmid": "23943882", "authors": "  O'Carroll AM, Lolait SJ, Harris LE, Pope GR", "title": "The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis.", "journal": "J Endocrinol 219:R13-35 (2013)", "doi": "10.1530/JOE-13-0227"}, {"pmid": "23973488", "authors": "  Liu QF, Yu HW, You L, Liu MX, Li KY, Tao GZ", "title": "Apelin-13-induced proliferation and migration induced of rat vascular smooth muscle cells is mediated by the upregulation of Egr-1.", "journal": "Biochem Biophys Res Commun 439:235-40 (2013)", "doi": "10.1016/j.bbrc.2013.08.051"}, {"pmid": "26254105", "authors": "  Novakova V, Sandhu GS, Dragomir-Daescu D, Klabusay M", "title": "Apelinergic system in endothelial cells and its role in angiogenesis in myocardial ischemia.", "journal": "Vascul Pharmacol 76:1-10 (2016)", "doi": "10.1016/j.vph.2015.08.005"}, {"pmid": "21725702", "authors": "  Castan-Laurell I, Dray C, Attane C, Duparc T, Knauf C, Valet P", "title": "Apelin, diabetes, and obesity.", "journal": "Endocrine 40:1-9 (2011)", "doi": "10.1007/s12020-011-9507-9"}, {"pmid": "23924696", "authors": "  Li L, Li L, Xie F, Zhang Z, Guo Y, Tang G, Lv D, Lu Q, Chen L, Li J", "title": "Jagged-1/Notch3 signaling transduction pathway is involved in apelin-13-induced vascular smooth muscle cells proliferation.", "journal": "Acta Biochim Biophys Sin (Shanghai) 45:875-81 (2013)", "doi": "10.1093/abbs/gmt085"}, {"pmid": "24990699", "authors": "  Wu D, He L, Chen L", "title": "Apelin/APJ system: a promising therapy target for hypertension.", "journal": "Mol Biol Rep 41:6691-703 (2014)", "doi": "10.1007/s11033-014-3552-4"}, {"pmid": "20539939", "authors": "  Liu C, Su T, Li F, Li L, Qin X, Pan W, Feng F, Chen F, Liao D, Chen L", "title": "PI3K/Akt signaling transduction pathway is involved in rat vascular smooth muscle cell proliferation induced by apelin-13.", "journal": "Acta Biochim Biophys Sin (Shanghai) 42:396-402 (2010)", "doi": "10.1093/abbs/gmq035"}, {"pmid": "26607438", "authors": "  Xie F, Liu W, Feng F, Li X, He L, Lv D, Qin X, Li L, Li L, Chen L", "title": "Apelin-13 promotes cardiomyocyte hypertrophy via PI3K-Akt-ERK1/2-p70S6K and PI3K-induced autophagy.", "journal": "Acta Biochim Biophys Sin (Shanghai) 47:969-80 (2015)", "doi": "10.1093/abbs/gmv111"}, {"pmid": "27979574", "authors": "  Lu L, Wu D, Li L, Chen L", "title": "Apelin/APJ system: A bifunctional target for cardiac hypertrophy.", "journal": "Int J Cardiol 230:164-170 (2017)", "doi": "10.1016/j.ijcard.2016.11.215"}, {"pmid": "16182514", "authors": "  Carmen GY, Victor SM", "title": "Signalling mechanisms regulating lipolysis.", "journal": "Cell Signal 18:401-8 (2006)", "doi": "10.1016/j.cellsig.2005.08.009"}, {"pmid": "27650065", "authors": "  Hu H, He L, Li L, Chen L", "title": "Apelin/APJ system as a therapeutic target in diabetes and its complications.", "journal": "Mol Genet Metab 119:20-7 (2016)", "doi": "10.1016/j.ymgme.2016.07.012"}, {"pmid": "25914650", "authors": "  Bertrand C, Valet P, Castan-Laurell I", "title": "Apelin and energy metabolism.", "journal": "Front Physiol 6:115 (2015)", "doi": "10.3389/fphys.2015.00115"}, {"pmid": "26385179", "authors": "  Yao F, Lv YC, Zhang M, Xie W, Tan YL, Gong D, Cheng HP, Liu D, Li L, Liu XY, Zheng XL, Tang CK", "title": "Apelin-13 impedes foam cell formation by activating Class III PI3K/Beclin-1-mediated autophagic pathway.", "journal": "Biochem Biophys Res Commun 466:637-43 (2015)", "doi": "10.1016/j.bbrc.2015.09.045"}, {"pmid": "22842084", "authors": "  Than A, Cheng Y, Foh LC, Leow MK, Lim SC, Chuah YJ, Kang Y, Chen P", "title": "Apelin inhibits adipogenesis and lipolysis through distinct molecular pathways.", "journal": "Mol Cell Endocrinol 362:227-41 (2012)", "doi": "10.1016/j.mce.2012.07.002"}, {"pmid": "24055369", "authors": "  Yu XH, Tang ZB, Liu LJ, Qian H, Tang SL, Zhang DW, Tian GP, Tang CK", "title": "Apelin and its receptor APJ in cardiovascular diseases.", "journal": "Clin Chim Acta 428:1-8 (2014)", "doi": "10.1016/j.cca.2013.09.001"}, {"pmid": "25931124", "authors": "  Than A, He HL, Chua SH, Xu D, Sun L, Leow MK, Chen P", "title": "Apelin Enhances Brown Adipogenesis and Browning of White Adipocytes.", "journal": "J Biol Chem 290:14679-91 (2015)", "doi": "10.1074/jbc.M115.643817"}, {"pmid": "25139773", "authors": "  Fu J, Li Z, Zhang H, Mao Y, Wang A, Wang X, Zou Z, Zhang X", "title": "Molecular pathways regulating the formation of brown-like adipocytes in white adipose tissue.", "journal": "Diabetes Metab Res Rev 31:433-52 (2015)", "doi": "10.1002/dmrr.2600"}, {"pmid": "21464822", "authors": "  Aharoni-Simon M, Hann-Obercyger M, Pen S, Madar Z, Tirosh O", "title": "Fatty liver is associated with impaired activity of PPARgamma-coactivator 1alpha (PGC1alpha) and mitochondrial biogenesis in mice.", "journal": "Lab Invest 91:1018-28 (2011)", "doi": "10.1038/labinvest.2011.55"}, {"pmid": "22995518", "authors": "  McLean DL, Kim J, Kang Y, Shi H, Atkins GB, Jain MK, Chun HJ", "title": "Apelin/APJ signaling is a critical regulator of statin effects in vascular endothelial cells--brief report.", "journal": "Arterioscler Thromb Vasc Biol 32:2640-3 (2012)", "doi": "10.1161/ATVBAHA.112.300317"}, {"pmid": "22028387", "authors": "  Pchejetski D, Foussal C, Alfarano C, Lairez O, Calise D, Guilbeau-Frugier C, Schaak S, Seguelas MH, Wanecq E, Valet P, Parini A, Kunduzova O", "title": "Apelin prevents cardiac fibroblast activation and collagen production through inhibition of sphingosine kinase 1.", "journal": "Eur Heart J 33:2360-9 (2012)", "doi": "10.1093/eurheartj/ehr389"}, {"pmid": "26944568", "authors": "  Huang S, Chen L, Lu L, Li L", "title": "The apelin-APJ axis: A novel potential therapeutic target for organ fibrosis.", "journal": "Clin Chim Acta 456:81-8 (2016)", "doi": "10.1016/j.cca.2016.02.025"}, {"pmid": "19093215", "authors": "  Liu G, Han J, Profirovic J, Strekalova E, Voyno-Yasenetskaya TA", "title": "Galpha13 regulates MEF2-dependent gene transcription in endothelial cells: role in angiogenesis.", "journal": "Angiogenesis 12:1-15 (2009)", "doi": "10.1007/s10456-008-9123-3"}, {"pmid": "23603510", "authors": "  Kang Y, Kim J, Anderson JP, Wu J, Gleim SR, Kundu RK, McLean DL, Kim JD, Park H, Jin SW, Hwa J, Quertermous T, Chun HJ", "title": "Apelin-APJ signaling is a critical regulator of endothelial MEF2 activation in cardiovascular development.", "journal": "Circ Res 113:22-31 (2013)", "doi": "10.1161/CIRCRESAHA.113.301324"}, {"pmid": "25164121", "authors": "  Wang LY, Diao ZL, Zhang DL, Zheng JF, Zhang QD, Ding JX, Liu WH", "title": "The regulatory peptide apelin: a novel inhibitor of renal interstitial fibrosis.", "journal": "Amino Acids 46:2693-704 (2014)", "doi": "10.1007/s00726-014-1826-8"}, {"pmid": "26756969", "authors": "  Zhou Y, Deng L, Zhao D, Chen L, Yao Z, Guo X, Liu X, Lv L, Leng B, Xu W, Qiao G, Shan H", "title": "MicroRNA-503 promotes angiotensin II-induced cardiac fibrosis by targeting Apelin-13.", "journal": "J Cell Mol Med 20:495-505 (2016)", "doi": "10.1111/jcmm.12754"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04140  Autophagy - animal", "hsa04150  mTOR signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04152  AMPK signaling pathway", "hsa04270  Vascular smooth muscle contraction", "hsa04530  Tight junction", "hsa04923  Regulation of lipolysis in adipocytes"], "ko_pathway": "ko04371", "genes": ["AKT2", "AKT1", "NRAS"]}, {"kegg_id": "hsa04550", "name": "Signaling pathways regulating pluripotency of stem cells - Homo sapiens (human)", "description": "Pluripotent stem cells (PSCs) are basic cells with an indefinite self-renewal capacity and the potential to generate all the cell types of the three germinal layers. The types of PSCs known to date include embryonic stem (ES) and induced pluripotent stem (iPS) cells. ES cells are derived from the inner cell mass (ICM) of blastocyst-stage embryos. iPS cells are generated by reprogramming somatic cells back to pluripotent state with defined reprogramming factors, Oct4, Sox2, Klf4 and c-Myc (also known as Yamanaka factors). PSCs including ES cells and iPS cells are categorized into two groups by their morphology, gene expression profile and external signal dependence. Conventional mouse-type ES/iPS cells are called 'naive state' cells. They are mainly maintained under the control of LIF and BMP signaling. On the other hand, human-type ES/iPS cells, which are in need of Activin and FGF signaling, are termed 'primed state'. However, these signaling pathways converge towards the activation of a core transcriptional network that is similar in both groups and involves OCt4, Nanog and Sox2. The three transcription factors and their downstream target genes coordinately promote self-renewal and pluripotency.", "class": "Cellular Processes; Cellular community - eukaryotes", "pathway_map": "hsa04550  Signaling pathways regulating pluripotency of stem cells", "drug": ["D05338  Palifermin (USAN/INN)", "D05716  Repifermin (USAN/INN)", "D09670  Sotatercept (USAN/INN)", "D10889  Momelotinib hydrochloride hydrate (JAN)", "D10903  Amcasertib (USAN/INN)", "D11701  Luspatercept (USAN/INN)", "D11889  Unesblin (USAN)", "D12547  Zilurgisertib (USAN/INN)", "D12548  Zilurgisertib fumarate (USAN)", "D12711  Fidrisertib (USAN/INN)", "D12810  Falbikitug (USAN/INN)"], "dblinks": "GO: 2000036", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["3976  LIF; LIF interleukin 6 family cytokine [KO:K05419]", "3977  LIFR; LIF receptor subunit alpha [KO:K05058]", "3572  IL6ST; interleukin 6 cytokine family signal transducer [KO:K05060]", "3716  JAK1; Janus kinase 1 [KO:K11217] [EC:2.7.10.2]", "3717  JAK2; Janus kinase 2 [KO:K04447] [EC:2.7.10.2]", "3718  JAK3; Janus kinase 3 [KO:K11218] [EC:2.7.10.2]", "6774  STAT3; signal transducer and activator of transcription 3 [KO:K04692]", "9314  KLF4; KLF transcription factor 4 [KO:K17846]", "6657  SOX2; SRY-box transcription factor 2 [KO:K16796]", "4609  MYC; MYC proto-oncogene, bHLH transcription factor [KO:K04377]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "6926  TBX3; T-box transcription factor 3 [KO:K10177]", "79923  NANOG; Nanog homeobox [KO:K10164]", "388112  NANOGP8; Nanog homeobox retrogene P8 [KO:K10164]", "3624  INHBA; inhibin subunit beta A [KO:K04667]", "3625  INHBB; inhibin subunit beta B [KO:K22687]", "3626  INHBC; inhibin subunit beta C [KO:K22688]", "83729  INHBE; inhibin subunit beta E [KO:K22689]", "4838  NODAL; nodal growth differentiation factor [KO:K04666]", "91  ACVR1B; activin A receptor type 1B [KO:K13567] [EC:2.7.11.30]", "130399  ACVR1C; activin A receptor type 1C [KO:K13568] [EC:2.7.11.30]", "92  ACVR2A; activin A receptor type 2A [KO:K04670] [EC:2.7.11.30]", "93  ACVR2B; activin A receptor type 2B [KO:K13596] [EC:2.7.11.30]", "4087  SMAD2; SMAD family member 2 [KO:K04500]", "4088  SMAD3; SMAD family member 3 [KO:K23605]", "652  BMP4; bone morphogenetic protein 4 [KO:K04662]", "657  BMPR1A; bone morphogenetic protein receptor type 1A [KO:K04673] [EC:2.7.11.30]", "658  BMPR1B; bone morphogenetic protein receptor type 1B [KO:K13578] [EC:2.7.11.30]", "90  ACVR1; activin A receptor type 1 [KO:K04675] [EC:2.7.11.30]", "659  BMPR2; bone morphogenetic protein receptor type 2 [KO:K04671] [EC:2.7.11.30]", "4086  SMAD1; SMAD family member 1 [KO:K04676]", "4090  SMAD5; SMAD family member 5 [KO:K16790]", "4093  SMAD9; SMAD family member 9 [KO:K16791]", "4089  SMAD4; SMAD family member 4 [KO:K04501]", "3397  ID1; inhibitor of DNA binding 1 [KO:K04680]", "3398  ID2; inhibitor of DNA binding 2 [KO:K17693]", "3399  ID3; inhibitor of DNA binding 3 [KO:K17694]", "3400  ID4; inhibitor of DNA binding 4 [KO:K17695]", "1852  DUSP9; dual specificity phosphatase 9 [KO:K18498] [EC:3.1.3.16 3.1.3.48]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "7471  WNT1; Wnt family member 1 [KO:K03209]", "7472  WNT2; Wnt family member 2 [KO:K00182]", "7482  WNT2B; Wnt family member 2B [KO:K00182]", "7473  WNT3; Wnt family member 3 [KO:K00312]", "89780  WNT3A; Wnt family member 3A [KO:K00312]", "54361  WNT4; Wnt family member 4 [KO:K00408]", "7474  WNT5A; Wnt family member 5A [KO:K00444]", "81029  WNT5B; Wnt family member 5B [KO:K00444]", "7475  WNT6; Wnt family member 6 [KO:K00445]", "7476  WNT7A; Wnt family member 7A [KO:K00572]", "7477  WNT7B; Wnt family member 7B [KO:K00572]", "7478  WNT8A; Wnt family member 8A [KO:K00714]", "7479  WNT8B; Wnt family member 8B [KO:K00714]", "7483  WNT9A; Wnt family member 9A [KO:K01064]", "7484  WNT9B; Wnt family member 9B [KO:K01064]", "7480  WNT10B; Wnt family member 10B [KO:K01357]", "80326  WNT10A; Wnt family member 10A [KO:K01357]", "7481  WNT11; Wnt family member 11 [KO:K01384]", "51384  WNT16; Wnt family member 16 [KO:K01558]", "8321  FZD1; frizzled class receptor 1 [KO:K02432]", "8324  FZD7; frizzled class receptor 7 [KO:K02432]", "2535  FZD2; frizzled class receptor 2 [KO:K02235]", "7976  FZD3; frizzled class receptor 3 [KO:K02329]", "8322  FZD4; frizzled class receptor 4 [KO:K02354]", "7855  FZD5; frizzled class receptor 5 [KO:K02375]", "8325  FZD8; frizzled class receptor 8 [KO:K02375]", "8323  FZD6; frizzled class receptor 6 [KO:K02376]", "11211  FZD10; frizzled class receptor 10 [KO:K02842]", "8326  FZD9; frizzled class receptor 9 [KO:K02842]", "1857  DVL3; dishevelled segment polarity protein 3 [KO:K02353]", "1856  DVL2; dishevelled segment polarity protein 2 [KO:K02353]", "1855  DVL1; dishevelled segment polarity protein 1 [KO:K02353]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "8312  AXIN1; axin 1 [KO:K02157]", "8313  AXIN2; axin 2 [KO:K04385]", "324  APC; APC regulator of WNT signaling pathway [KO:K02085]", "10297  APC2; APC regulator of WNT signaling pathway 2 [KO:K02085]", "1499  CTNNB1; catenin beta 1 [KO:K02105]", "6929  TCF3; transcription factor 3 [KO:K09063]", "2103  ESRRB; estrogen related receptor beta [KO:K08553]", "6932  TCF7; transcription factor 7 [KO:K02620]", "5460  POU5F1; POU class 5 homeobox 1 [KO:K09367]", "5462  POU5F1B; POU class 5 homeobox 1B [KO:K09367]", "2247  FGF2; fibroblast growth factor 2 [KO:K18497]", "2260  FGFR1; fibroblast growth factor receptor 1 [KO:K04362] [EC:2.7.10.1]", "2263  FGFR2; fibroblast growth factor receptor 2 [KO:K05093] [EC:2.7.10.1]", "2261  FGFR3; fibroblast growth factor receptor 3 [KO:K05094] [EC:2.7.10.1]", "2264  FGFR4; fibroblast growth factor receptor 4 [KO:K05095] [EC:2.7.10.1]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "3479  IGF1; insulin like growth factor 1 [KO:K05459]", "3480  IGF1R; insulin like growth factor 1 receptor [KO:K05087] [EC:2.7.10.1]", "8820  HESX1; HESX homeobox 1 [KO:K09354]", "7547  ZIC3; Zic family member 3 [KO:K18487]", "10637  LEFTY1; left-right determination factor 1 [KO:K04668]", "7044  LEFTY2; left-right determination factor 2 [KO:K04668]", "6498  SKIL; SKI like proto-oncogene [KO:K18499]", "56916  SMARCAD1; SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1 [KO:K14439] [EC:5.6.2.-]", "7994  KAT6A; lysine acetyltransferase 6A [KO:K11305] [EC:2.3.1.48]", "9869  SETDB1; SET domain bifurcated histone lysine methyltransferase 1 [KO:K11421] [EC:2.1.1.366]", "3720  JARID2; jumonji and AT-rich interaction domain containing 2 [KO:K11478]", "5978  REST; RE1 silencing transcription factor [KO:K09222]", "55183  RIF1; replication timing regulatory factor 1 [KO:K11138]", "84759  PCGF1; polycomb group ring finger 1 [KO:K11487]", "7703  PCGF2; polycomb group ring finger 2 [KO:K11460]", "10336  PCGF3; polycomb group ring finger 3 [KO:K11488]", "648  BMI1; BMI1 proto-oncogene, polycomb ring finger [KO:K11459]", "100532731  COMMD3-BMI1; COMMD3-BMI1 readthrough [KO:K11459]", "84333  PCGF5; polycomb group ring finger 5 [KO:K11489]", "84108  PCGF6; polycomb group ring finger 6 [KO:K11470]", "5080  PAX6; paired box 6 [KO:K08031]", "4211  MEIS1; Meis homeobox 1 [KO:K15613]", "3211  HOXB1; homeobox B1 [KO:K09301]", "3198  HOXA1; homeobox A1 [KO:K09301]", "3231  HOXD1; homeobox D1 [KO:K09301]", "64211  LHX5; LIM homeobox 5 [KO:K18493]", "5013  OTX1; orthodenticle homeobox 1 [KO:K09326]", "4762  NEUROG1; neurogenin 1 [KO:K09081]", "9421  HAND1; heart and neural crest derivatives expressed 1 [KO:K09071]", "1749  DLX5; distal-less homeobox 5 [KO:K18489]", "4617  MYF5; myogenic factor 5 [KO:K18484]", "3175  ONECUT1; one cut homeobox 1 [KO:K08026]", "3670  ISL1; ISL LIM homeobox 1 [KO:K09370]", "463  ZFHX3; zinc finger homeobox 3 [KO:K09378]", "80712  ESX1; ESX homeobox 1 [KO:K18491]"], "refs": [{"pmid": "24147644", "authors": "  Hassani SN, Totonchi M, Gourabi H, Scholer HR, Baharvand H", "title": "Signaling roadmap modulating naive and primed pluripotency.", "journal": "Stem Cells Dev 23:193-208 (2014)", "doi": "10.1089/scd.2013.0368"}, {"pmid": "18295576", "authors": "  Jaenisch R, Young R", "title": "Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming.", "journal": "Cell 132:567-82 (2008)", "doi": "10.1016/j.cell.2008.01.015"}, {"pmid": "17647265", "authors": "  Zhang H, Wang ZZ", "title": "Mechanisms that mediate stem cell self-renewal and differentiation.", "journal": "J Cell Biochem 103:709-18 (2008)", "doi": "10.1002/jcb.21460"}, {"pmid": "24910449", "authors": "  Itoh F, Watabe T, Miyazono K", "title": "Roles of TGF-beta family signals in the fate determination of pluripotent stem cells.", "journal": "Semin Cell Dev Biol 32C:98-106 (2014)", "doi": "10.1016/j.semcdb.2014.05.017"}, {"pmid": "23653415", "authors": "  Saunders A, Faiola F, Wang J", "title": "Concise review: pursuing self-renewal and pluripotency with the stem cell factor Nanog.", "journal": "Stem Cells 31:1227-36 (2013)", "doi": "10.1002/stem.1384"}, {"pmid": "20705693", "authors": "  Kuijk EW, Chuva de Sousa Lopes SM, Geijsen N, Macklon N, Roelen BA", "title": "The different shades of mammalian pluripotent stem cells.", "journal": "Hum Reprod Update 17:254-71 (2011)", "doi": "10.1093/humupd/dmq035"}, {"pmid": "18220859", "authors": "  Okita K, Yamanaka S", "title": "Intracellular signaling pathways regulating pluripotency of embryonic stem cells.", "journal": "Curr Stem Cell Res Ther 1:103-11 (2006)", "doi": "10.2174/157488806775269061"}, {"pmid": "19571885", "authors": "  Niwa H, Ogawa K, Shimosato D, Adachi K", "title": "A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells.", "journal": "Nature 460:118-22 (2009)", "doi": "10.1038/nature08113"}, {"pmid": "23370346", "authors": "  Nakai-Futatsugi Y, Niwa H", "title": "Transcription factor network in embryonic stem cells: heterogeneity under the stringency.", "journal": "Biol Pharm Bull 36:166-70 (2013)", "doi": "10.1248/bpb.b12-00958"}, {"pmid": "19551525", "authors": "  Scheper W, Copray S", "title": "The molecular mechanism of induced pluripotency: a two-stage switch.", "journal": "Stem Cell Rev 5:204-23 (2009)", "doi": "10.1007/s12015-009-9077-x"}, {"pmid": "16153702", "authors": "  Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray HL, Jenner RG, Gifford DK, Melton DA, Jaenisch R, Young RA", "title": "Core transcriptional regulatory circuitry in human embryonic stem cells.", "journal": "Cell 122:947-56 (2005)", "doi": "10.1016/j.cell.2005.08.020"}, {"pmid": "24315442", "authors": "  Wang L, Miao YL, Zheng X, Lackford B, Zhou B, Han L, Yao C, Ward JM, Burkholder A, Lipchina I, Fargo DC, Hochedlinger K, Shi Y, Williams CJ, Hu G", "title": "The THO complex regulates pluripotency gene mRNA export and controls embryonic stem cell self-renewal and somatic cell reprogramming.", "journal": "Cell Stem Cell 13:676-90 (2013)", "doi": "10.1016/j.stem.2013.10.008"}, {"pmid": "24957798", "authors": "  Hasegawa Y, Tang D, Takahashi N, Hayashizaki Y, Forrest AR, Suzuki H", "title": "CCL2 enhances pluripotency of human induced pluripotent stem cells by activating hypoxia related genes.", "journal": "Sci Rep 4:5228 (2014)", "doi": "10.1038/srep05228"}, {"pmid": "23585347", "authors": "  Sui L, Bouwens L, Mfopou JK", "title": "Signaling pathways during maintenance and definitive endoderm differentiation of embryonic stem cells.", "journal": "Int J Dev Biol 57:1-12 (2013)", "doi": "10.1387/ijdb.120115ls"}, {"pmid": "19427042", "authors": "  Do JT, Scholer HR", "title": "Regulatory circuits underlying pluripotency and reprogramming.", "journal": "Trends Pharmacol Sci 30:296-302 (2009)", "doi": "10.1016/j.tips.2009.03.003"}, {"pmid": "17211451", "authors": "  Pan G, Thomson JA", "title": "Nanog and transcriptional networks in embryonic stem cell pluripotency.", "journal": "Cell Res 17:42-9 (2007)", "doi": "10.1038/sj.cr.7310125"}, {"pmid": "16518401", "authors": "  Loh YH, Wu Q, Chew JL, Vega VB, Zhang W, Chen X, Bourque G, George J, Leong B, Liu J, Wong KY, Sung KW, Lee CW, Zhao XD, Chiu KP, Lipovich L, Kuznetsov VA, Robson P, Stanton LW, Wei CL, Ruan Y, Lim B, Ng HH", "title": "The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells.", "journal": "Nat Genet 38:431-40 (2006)", "doi": "10.1038/ng1760"}, {"pmid": "18414030", "authors": "  Loh YH, Ng JH, Ng HH", "title": "Molecular framework underlying pluripotency.", "journal": "Cell Cycle 7:885-91 (2008)", "doi": "10.4161/cc.7.7.5636"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04310  Wnt signaling pathway", "hsa04350  TGF-beta signaling pathway", "hsa04630  JAK-STAT signaling pathway"], "ko_pathway": "ko04550", "genes": ["AKT2", "AKT1", "MAPK13", "NRAS"]}, {"kegg_id": "hsa04611", "name": "Platelet activation - Homo sapiens (human)", "description": "Platelets play a key and beneficial role for primary hemostasis on the disruption of the integrity of vessel wall. Platelet adhesion and activation at sites of vascular wall injury is initiated by adhesion to adhesive macromolecules, such as collagen and von Willebrand factor (vWF), or by soluble platelet agonists, such as ADP, thrombin, and thromboxane A2. Different receptors are stimulated by various agonists, almost converging in increasing intracellular Ca2+ concentration that stimulate platelet shape change and granule secretion and ultimately induce the \"inside-out\" signaling process leading to activation of the ligand-binding function of integrin alpha IIb beta 3. Binding of alpha IIb beta 3 to its ligands, mainly fibrinogen, mediates platelet adhesion and aggregation and triggers \"outside-in\" signaling, resulting in platelet spreading, additional granule secretion, stabilization of platelet adhesion and aggregation, and clot retraction.", "class": "Organismal Systems; Immune system", "pathway_map": "hsa04611  Platelet activation", "drug": ["D00106  Epoprostenol (USAN/INN)", "D00109  Aspirin (JP18/USP)", "D00769  Clopidogrel bisulfate (USP)", "D01028  Ticlopidine hydrochloride (JP18/USP)", "D01029  Tirofiban hydrochloride (USAN)", "D01188  Pimilprost (JAN/INN)", "D01220  Trapidil (JP18/INN)", "D01337  Epoprostenol sodium (JAN/USAN)", "D01551  Beraprost sodium (JP18/USAN)", "D01683  Ozagrel hydrochloride hydrate (JAN)", "D01684  Ozagrel sodium (JP18)", "D01896  Cilostazol (JP18/USP/INN)", "D02048  Clinprost (JAN/INN)", "D02720  Beraprost (USAN)", "D02721  Iloprost (USAN/INN)", "D02778  Abciximab (USAN/INN)", "D03359  Cangrelor (USAN/INN)", "D03361  Cangrelor tetrasodium (USAN)", "D03522  Ciprostene calcium (USAN)", "D03642  Daltroban (USAN/INN)", "D03661  Dazmegrel (USAN/INN)", "D03663  Dazoxiben hydrochloride (USAN)", "D03971  Elarofiban (USAN)", "D04276  Furegrelate sodium (USAN)", "D04500  Ifetroban (USAN/INN)", "D04501  Ifetroban sodium (USAN)", "D04659  Lamifiban (USAN/INN)", "D04785  Lotrafiban hydrochloride (USAN)", "D05267  Orbofiban acetate (USAN)", "D05502  Pirmagrel (USAN/INN)", "D05597  Prasugrel hydrochloride (JAN/USAN)", "D05727  Ridogrel (USAN/INN)", "D05772  Roxifiban acetate (USAN)", "D05834  Sibrafiban (USAN/INN)", "D05970  Sulotroban (USAN/INN)", "D06077  Terbogrel (USAN/INN)", "D06213  Treprostinil (JAN/USAN/INN)", "D06280  Vapiprost hydrochloride (JAN/USAN)", "D06335  Xemilofiban hydrochloride (USAN)", "D06600  Giripladib (USAN)", "D06649  Tadocizumab (USAN)", "D06888  Eptifibatide (INN)", "D07140  Picotamide (BAN)", "D07141  Indobufen (INN)", "D07577  Cinaciguat (JAN/INN)", "D07729  Clopidogrel (USP/INN)", "D08065  Iloprost tromethamine", "D08327  Ozagrel (INN)", "D08594  Ticlopidine (INN)", "D08607  Tirofiban (INN)", "D08628  Treprostinil monosodium salt", "D08983  Regrelor disodium (USAN)", "D09017  Ticagrelor (JAN/USAN/INN)", "D09348  Fostamatinib disodium (USAN)", "D09572  Riociguat (JAN/USAN/INN)", "D09607  Elinogrel (USAN/INN)", "D09608  Elinogrel potassium (USAN)", "D09765  Vorapaxar (USAN/INN)", "D09766  Vorapaxar sulfate (JAN/USAN)", "D09892  Egaptivon pegol (USAN)", "D09994  Selexipag (JAN/USAN/INN)", "D10430  Treprostinil diolamine (USAN)", "D10758  Turoctocog alfa pegol (genetical recombination) (JAN)", "D10823  Clopidogrel hydrochloride", "D10824  Clopidogrel besilate", "D10893  Acalabrutinib (JAN/USAN/INN)", "D11051  Vericiguat (JAN/USAN/INN)", "D11070  Tirabrutinib hydrochloride (JAN/USAN)", "D11160  Caplacizumab (USAN/INN)", "D11209  Entospletinib (USAN/INN)", "D11274  Praliciguat (USAN/INN)", "D11428  Vecabrutinib (USAN/INN)", "D11457  Fenebrutinib (USAN/INN)", "D11475  Olinciguat (USAN/INN)", "D11478  Branebrutinib (USAN)", "D11502  Vecabrutinib succinate (USAN)", "D11720  Acalabrutinib maleate (USAN)", "D11789  Mivavotinib (USAN/INN)", "D11790  Mivavotinib citrate (USAN)", "D12050  Pirtobrutinib (JAN/USAN)", "D12051  Zalunfiban (USAN)", "D12052  Luxeptinib (USAN)", "D12160  Orelabrutinib (USAN/INN)", "D12163  Zalunfiban acetate (USAN)", "D12383  Edralbrutinib (USAN/INN)", "D12413  Glenzocimab (USAN/INN)", "D12504  Nemtabrutinib (USAN/INN)", "D12594  Tirabrutinib (USAN/INN)", "D12629  Treprostinil phosphate (USAN)", "D12704  Acalabrutinib maleate hydrate (JAN)", "D12722  Bexotegrast (USAN/INN)", "D12858  Zelebrudomide (USAN)", "D12863  Rondaptivon pegol"], "dblinks": "GO: 0030168", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["6915  TBXA2R; thromboxane A2 receptor [KO:K04264]", "2147  F2; coagulation factor II, thrombin [KO:K01313] [EC:3.4.21.5]", "2149  F2R; coagulation factor II thrombin receptor [KO:K03914]", "9002  F2RL3; F2R like thrombin or trypsin receptor 3 [KO:K04236]", "10672  GNA13; G protein subunit alpha 13 [KO:K04639]", "9138  ARHGEF1; Rho guanine nucleotide exchange factor 1 [KO:K12330]", "23365  ARHGEF12; Rho guanine nucleotide exchange factor 12 [KO:K07532]", "387  RHOA; ras homolog family member A [KO:K04513]", "6093  ROCK1; Rho associated coiled-coil containing protein kinase 1 [KO:K04514] [EC:2.7.11.1]", "9475  ROCK2; Rho associated coiled-coil containing protein kinase 2 [KO:K17388] [EC:2.7.11.1]", "5499  PPP1CA; protein phosphatase 1 catalytic subunit alpha [KO:K06269] [EC:3.1.3.16]", "5500  PPP1CB; protein phosphatase 1 catalytic subunit beta [KO:K06269] [EC:3.1.3.16]", "5501  PPP1CC; protein phosphatase 1 catalytic subunit gamma [KO:K06269] [EC:3.1.3.16]", "4659  PPP1R12A; protein phosphatase 1 regulatory subunit 12A [KO:K06270]", "103910  MYL12B; myosin light chain 12B [KO:K12757]", "10627  MYL12A; myosin light chain 12A [KO:K12757]", "5023  P2RX1; purinergic receptor P2X 1 [KO:K05215]", "84876  ORAI1; ORAI calcium release-activated calcium modulator 1 [KO:K16056]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "6786  STIM1; stromal interaction molecule 1 [KO:K16059]", "4638  MYLK; myosin light chain kinase [KO:K00907] [EC:2.7.11.18]", "85366  MYLK2; myosin light chain kinase 2 [KO:K00907] [EC:2.7.11.18]", "91807  MYLK3; myosin light chain kinase 3 [KO:K00907] [EC:2.7.11.18]", "340156  MYLK4; myosin light chain kinase family member 4 [KO:K00907] [EC:2.7.11.18]", "5028  P2RY1; purinergic receptor P2Y1 [KO:K04270]", "2776  GNAQ; G protein subunit alpha q [KO:K04634]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "5590  PRKCZ; protein kinase C zeta [KO:K18952] [EC:2.7.11.13]", "5584  PRKCI; protein kinase C iota [KO:K06069] [EC:2.7.11.13]", "10125  RASGRP1; RAS guanyl releasing protein 1 [KO:K04350]", "10235  RASGRP2; RAS guanyl releasing protein 2 [KO:K12361]", "5906  RAP1A; RAP1A, member of RAS oncogene family [KO:K04353]", "5908  RAP1B; RAP1B, member of RAS oncogene family [KO:K07836]", "54518  APBB1IP; amyloid beta precursor protein binding family B member 1 interacting protein [KO:K17704]", "7094  TLN1; talin 1 [KO:K06271]", "83660  TLN2; talin 2 [KO:K06271]", "3674  ITGA2B; integrin subunit alpha 2b [KO:K06476]", "3690  ITGB3; integrin subunit beta 3 [KO:K06493]", "83706  FERMT3; FERM domain containing kindlin 3 [KO:K17084]", "2243  FGA; fibrinogen alpha chain [KO:K03903]", "2244  FGB; fibrinogen beta chain [KO:K03904]", "2266  FGG; fibrinogen gamma chain [KO:K03905]", "64805  P2RY12; purinergic receptor P2Y12 [KO:K04298]", "2770  GNAI1; G protein subunit alpha i1 [KO:K04630]", "2773  GNAI3; G protein subunit alpha i3 [KO:K04630]", "2771  GNAI2; G protein subunit alpha i2 [KO:K04630]", "107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]", "108  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]", "109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]", "196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]", "113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]", "114  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]", "115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]", "5739  PTGIR; prostaglandin I2 receptor [KO:K04263]", "2778  GNAS; GNAS complex locus [KO:K04632]", "5294  PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma [KO:K21289] [EC:2.7.1.153]", "23533  PIK3R5; phosphoinositide-3-kinase regulatory subunit 5 [KO:K21290]", "146850  PIK3R6; phosphoinositide-3-kinase regulatory subunit 6 [KO:K21290]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "7408  VASP; vasodilator stimulated phosphoprotein [KO:K06274]", "71  ACTG1; actin gamma 1 [KO:K05692]", "60  ACTB; actin beta [KO:K05692]", "6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "2909  ARHGAP35; Rho GTPase activating protein 35 [KO:K05732]", "2212  FCGR2A; Fc gamma receptor IIa [KO:K06472]", "6850  SYK; spleen associated tyrosine kinase [KO:K05855] [EC:2.7.10.2]", "1277  COL1A1; collagen type I alpha 1 chain [KO:K06236]", "1278  COL1A2; collagen type I alpha 2 chain [KO:K06236]", "1281  COL3A1; collagen type III alpha 1 chain [KO:K19720]", "51206  GP6; glycoprotein VI platelet [KO:K06264]", "2207  FCER1G; Fc epsilon receptor Ig [KO:K07983]", "4067  LYN; LYN proto-oncogene, Src family tyrosine kinase [KO:K05854] [EC:2.7.10.2]", "2534  FYN; FYN proto-oncogene, Src family tyrosine kinase [KO:K05703] [EC:2.7.10.2]", "3673  ITGA2; integrin subunit alpha 2 [KO:K06481]", "3688  ITGB1; integrin subunit beta 1 [KO:K05719]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "3937  LCP2; lymphocyte cytosolic protein 2 [KO:K07361]", "5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]", "695  BTK; Bruton tyrosine kinase [KO:K07370] [EC:2.7.10.2]", "7450  VWF; von Willebrand factor [KO:K03900]", "2814  GP5; glycoprotein V platelet [KO:K06260]", "2811  GP1BA; glycoprotein Ib platelet subunit alpha [KO:K06261]", "2812  GP1BB; glycoprotein Ib platelet subunit beta [KO:K06262]", "2815  GP9; glycoprotein IX platelet [KO:K06263]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "4846  NOS3; nitric oxide synthase 3 [KO:K13242] [EC:1.14.13.39]", "2977  GUCY1A2; guanylate cyclase 1 soluble subunit alpha 2 [KO:K12318] [EC:4.6.1.2]", "2982  GUCY1A1; guanylate cyclase 1 soluble subunit alpha 1 [KO:K12318] [EC:4.6.1.2]", "2983  GUCY1B1; guanylate cyclase 1 soluble subunit beta 1 [KO:K12319] [EC:4.6.1.2]", "5592  PRKG1; protein kinase cGMP-dependent 1 [KO:K07376] [EC:2.7.11.12]", "5593  PRKG2; protein kinase cGMP-dependent 2 [KO:K19477] [EC:2.7.11.12]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "123745  PLA2G4E; phospholipase A2 group IVE [KO:K16342] [EC:3.1.1.4]", "5321  PLA2G4A; phospholipase A2 group IVA [KO:K16342] [EC:3.1.1.4]", "8681  JMJD7-PLA2G4B; JMJD7-PLA2G4B readthrough [KO:K16342] [EC:3.1.1.4]", "100137049  PLA2G4B; phospholipase A2 group IVB [KO:K16342] [EC:3.1.1.4]", "8605  PLA2G4C; phospholipase A2 group IVC [KO:K16342] [EC:3.1.1.4]", "283748  PLA2G4D; phospholipase A2 group IVD [KO:K16342] [EC:3.1.1.4]", "255189  PLA2G4F; phospholipase A2 group IVF [KO:K16342] [EC:3.1.1.4]", "5742  PTGS1; prostaglandin-endoperoxide synthase 1 [KO:K00509] [EC:1.14.99.1]", "6916  TBXAS1; thromboxane A synthase 1 [KO:K01832] [EC:5.3.99.5]", "8773  SNAP23; synaptosome associated protein 23 [KO:K08508]", "8673  VAMP8; vesicle associated membrane protein 8 [KO:K08512]"], "compound": ["C00002  ATP", "C00008  ADP", "C00076  Calcium cation", "C00165  Diacylglycerol", "C00219  Arachidonate", "C00427  Prostaglandin H2", "C00533  Nitric oxide", "C00575  3',5'-Cyclic AMP", "C00942  3',5'-Cyclic GMP", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C01312  Prostaglandin I2", "C02198  Thromboxane A2", "C05956  Prostaglandin G2", "C05981  Phosphatidylinositol-3,4,5-trisphosphate"], "refs": [{"pmid": "21071698", "authors": "  Li Z, Delaney MK, O'Brien KA, Du X", "title": "Signaling during platelet adhesion and activation.", "journal": "Arterioscler Thromb Vasc Biol 30:2341-9 (2010)", "doi": "10.1161/ATVBAHA.110.207522"}, {"pmid": "22119499", "authors": "  Broos K, De Meyer SF, Feys HB, Vanhoorelbeke K, Deckmyn H", "title": "Blood platelet biochemistry.", "journal": "Thromb Res 129:245-9 (2012)", "doi": "10.1016/j.thromres.2011.11.002"}, {"pmid": "16149014", "authors": "  Jurk K, Kehrel BE", "title": "Platelets: physiology and biochemistry.", "journal": "Semin Thromb Hemost 31:381-92 (2005)", "doi": "10.1055/s-2005-916671"}, {"pmid": "17158345", "authors": "  Offermanns S", "title": "Activation of platelet function through G protein-coupled receptors.", "journal": "Circ Res 99:1293-304 (2006)", "doi": "10.1161/01.RES.0000251742.71301.16"}, {"pmid": "18174460", "authors": "  Varga-Szabo D, Pleines I, Nieswandt B", "title": "Cell adhesion mechanisms in platelets.", "journal": "Arterioscler Thromb Vasc Biol 28:403-12 (2008)", "doi": "10.1161/ATVBAHA.107.150474"}, {"pmid": "18550847", "authors": "  Yin H, Liu J, Li Z, Berndt MC, Lowell CA, Du X", "title": "Src family tyrosine kinase Lyn mediates VWF/GPIb-IX-induced platelet activation via the cGMP signaling pathway.", "journal": "Blood 112:1139-46 (2008)", "doi": "10.1182/blood-2008-02-140970"}, {"pmid": "19630797", "authors": "  Bergmeier W, Stefanini L", "title": "Novel molecules in calcium signaling in platelets.", "journal": "J Thromb Haemost 7 Suppl 1:187-90 (2009)", "doi": "10.1111/j.1538-7836.2009.03379.x"}, {"pmid": "18544684", "authors": "  Cifuni SM, Wagner DD, Bergmeier W", "title": "CalDAG-GEFI and protein kinase C represent alternative pathways leading to activation of integrin alphaIIbbeta3 in platelets.", "journal": "Blood 112:1696-703 (2008)", "doi": "10.1182/blood-2008-02-139733"}, {"pmid": "23106920", "authors": "  Heemskerk JW, Mattheij NJ, Cosemans JM", "title": "Platelet-based coagulation: different populations, different functions.", "journal": "J Thromb Haemost 11:2-16 (2013)", "doi": "10.1111/jth.12045"}, {"pmid": "19286885", "authors": "  Rivera J, Lozano ML, Navarro-Nunez L, Vicente V", "title": "Platelet receptors and signaling in the dynamics of thrombus formation.", "journal": "Haematologica 94:700-11 (2009)", "doi": "10.3324/haematol.2008.003178"}, {"pmid": "18363565", "authors": "  Banno A, Ginsberg MH", "title": "Integrin activation.", "journal": "Biochem Soc Trans 36:229-34 (2008)", "doi": "10.1042/BST0360229"}, {"pmid": "20089227", "authors": "  Angiolillo DJ, Ferreiro JL", "title": "Platelet adenosine diphosphate P2Y12 receptor antagonism: benefits and limitations of current treatment strategies and future directions.", "journal": "Rev Esp Cardiol 63:60-76 (2010)", "doi": "10.1016/s1885-5857(10)70010-4"}, {"pmid": "22701130", "authors": "  Joo SJ", "title": "Mechanisms of Platelet Activation and Integrin alphaIIbeta3.", "journal": "Korean Circ J 42:295-301 (2012)", "doi": "10.4070/kcj.2012.42.5.295"}, {"pmid": "20002545", "authors": "  Harper MT, Poole AW", "title": "Diverse functions of protein kinase C isoforms in platelet activation and thrombus formation.", "journal": "J Thromb Haemost 8:454-62 (2010)", "doi": "10.1111/j.1538-7836.2009.03722.x"}, {"pmid": "23805129", "authors": "  Fitch-Tewfik JL, Flaumenhaft R", "title": "Platelet granule exocytosis: a comparison with chromaffin cells.", "journal": "Front Endocrinol (Lausanne) 4:77 (2013)", "doi": "10.3389/fendo.2013.00077"}], "rel_pathway": ["hsa00590  Arachidonic acid metabolism", "hsa04015  Rap1 signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04610  Complement and coagulation cascades", "hsa05211  Renal cell carcinoma"], "ko_pathway": "ko04611", "genes": ["AKT2", "AKT1", "MAPK13"]}, {"kegg_id": "hsa04725", "name": "Cholinergic synapse - Homo sapiens (human)", "description": "Acetylcholine (ACh) is a neurotransmitter widely distributed in the central (and also peripheral, autonomic and enteric) nervous system (CNS). In the CNS, ACh facilitates many functions, such as learning, memory, attention and motor control. When released in the synaptic cleft, ACh binds to two distinct types of receptors: Ionotropic nicotinic acetylcholine receptors (nAChR) and metabotropic muscarinic acetylcholine receptors (mAChRs). The activation of nAChR by ACh leads to the rapid influx of Na+ and Ca2+ and subsequent cellular depolarization. Activation of mAChRs is relatively slow (milliseconds to seconds) and, depending on the subtypes present (M1-M5), they directly alter cellular homeostasis of phospholipase C, inositol trisphosphate, cAMP, and free calcium. In the cleft, ACh may also be hydrolyzed by acetylcholinesterase (AChE) into choline and acetate. The choline derived from ACh hydrolysis is recovered by a presynaptic high-affinity choline transporter (CHT).", "class": "Organismal Systems; Nervous system", "pathway_map": "hsa04725  Cholinergic synapse", "drug": ["D00043  Isoflurophate", "D00113  Atropine (USP)", "D00138  Scopolamine (INN)", "D00147  Hyoscyamine (USP)", "D00193  Dexpanthenol (USP/INN)", "D00196  Physostigmine (USP)", "D00232  Anisotropine methylbromide (USAN)", "D00270  Chlorpromazine (USP/INN)", "D00397  Tropicamide (JP18/USP/INN)", "D00465  Oxybutynin (USAN/INN)", "D00469  Pralidoxime chloride (USP)", "D00481  Propantheline bromide (JP18/USP/INN)", "D00487  Pyridostigmine bromide (JP18/USP/INN)", "D00524  Carbachol (JAN/USP/INN)", "D00525  Pilocarpine (JAN/USP)", "D00540  Glycopyrrolate (USP)", "D00611  Mecamylamine hydrochloride (USP)", "D00646  Tolterodine (USAN/INN)", "D00661  Cevimeline hydrochloride (USAN)", "D00667  Demecarium bromide (USP/INN)", "D00670  Donepezil hydrochloride (JP18/USP)", "D00715  Methscopolamine bromide (USP)", "D00716  Clidinium bromide (USP/INN)", "D00717  Dicyclomine hydrochloride (JAN/USP)", "D00719  Hyoscyamine sulfate (USP)", "D00720  Mepenzolate bromide (JP18/INN)", "D00721  Methanthelinium bromide (INN)", "D00722  Oxybutynin chloride (USP)", "D00723  Tridihexethyl chloride (BAN)", "D00765  Rocuronium bromide (JAN/USP/INN)", "D00778  Benztropine mesylate (USP)", "D00779  Biperiden (JAN/USP/INN)", "D00782  Procyclidine hydrochloride (USP)", "D00787  Trihexyphenidyl hydrochloride (JP18/USP)", "D00789  Chlorpromazine hydrochloride (JP18/USP)", "D00994  Edrophonium chloride (JP18/USP/INN)", "D00995  Neostigmine bromide (JAN/USP/INN)", "D00998  Neostigmine methylsulfate (JP18/USP)", "D00999  Acetylcholine chloride (JP18/USP/INN)", "D01000  Bethanechol chloride (JP18/USP)", "D01001  Ambenonium chloride (JP18/INN)", "D01002  Cyclopentolate hydrochloride (JP18/USP)", "D01003  Hexocyclium metilsulfate (INN)", "D01004  Homatropine hydrobromide (JP18/USP)", "D01005  Isopropamide iodide (JAN/USP/INN)", "D01006  Oxyphencyclimine hydrochloride (JAN)", "D01007  Propiverine hydrochloride (JP18)", "D01077  Methylatropine nitrate (USAN)", "D01103  Trospium chloride (JAN/USP/INN)", "D01118  Profenamine hydrochloride (JAN)", "D01148  Tolterodine tartrate (JAN/USP)", "D01165  Piperidolate hydrochloride (JAN)", "D01175  Carpronium chloride (JAN/INN)", "D01201  Tiemonium iodide (JAN/INN)", "D01228  Distigmine bromide (JP18/INN)", "D01231  Piroheptine hydrochloride (JAN)", "D01269  Solifenacin succinate (JAN/USAN/INN)", "D01297  Pirenzepine hydrochloride (USAN)", "D01315  Methylbenactyzium bromide (JP18/INN)", "D01318  Diphenidol hydrochloride (USAN)", "D01359  Etomidoline (JAN/INN)", "D01377  Prifinium bromide (JAN/INN)", "D01451  Scopolamine butylbromide (JP18)", "D01463  Diponium bromide (JAN/INN)", "D01491  Butropium bromide (JP18/INN)", "D01521  Pipethanate hydrochloride (JAN)", "D01532  Bevonium methylsulfate (JAN)", "D01538  Valethamate bromide (JAN)", "D01572  Pralidoxime iodide (JAN/USAN)", "D01600  Diphenylpiperidinomethyldioxolan iodide (JAN)", "D01648  Hyoscyamine methylbromide (JAN)", "D01699  Darifenacin hydrobromide (JAN/USAN)", "D01815  Oxapium iodide (JP18/INN)", "D01871  Methixene hydrochloride (USAN)", "D01875  Tiquizium bromide (JAN/INN)", "D01929  Tiotropium bromide hydrate (JAN)", "D01946  Oxitropium bromide (JAN/INN)", "D01955  Aclatonium napadisilate (JAN)", "D01976  N-Methylscopolamine methylsulfate (JAN)", "D01987  Pipethanate ethobromide (JAN)", "D02064  Pridinol mesilate (JAN)", "D02068  Tacrine hydrochloride (USP)", "D02069  Atropine sulfate (JP18/USP)", "D02070  Homatropine methylbromide (USP)", "D02071  Scopolamine hydrobromide (USP)", "D02173  Galantamine hydrobromide (JAN/USP)", "D02193  Echothiophate iodide (USP)", "D02200  Pilocarpine hydrochloride (JP18/USP)", "D02202  Lobeline hydrochloride (JAN)", "D02204  Hexamethonium bromide (JAN/INN)", "D02212  Ipratropium bromide (USP)", "D02246  Biperiden hydrochloride (JP18/USP)", "D02247  Biperiden lactate (JAN/USP)", "D02292  Gallamine triethiodide (USP)", "D02364  Lobeline (INN)", "D02417  Flutropium bromide (JAN)", "D02418  Physostigmine salicylate (JAN/USP)", "D02535  Timepidium bromide hydrate (JP18)", "D02558  Rivastigmine tartrate", "D02565  Dimetacrine (INN)", "D02603  Diethazine hydrochloride", "D02729  Itopride hydrochloride (JAN)", "D02750  Aceclidine (USAN/INN)", "D02839  Altinicline maleate (USAN)", "D02876  Alvameline maleate (USAN)", "D03011  Atropine oxide hydrochloride (USAN)", "D03076  Benapryzine hydrochloride (USAN)", "D03087  Benzetimide hydrochloride (USAN)", "D03088  Benzilonium bromide (USAN/INN)", "D03239  Ladostigil tartrate (USAN)", "D03264  Mazaticol hydrochloride hydrate (JAN)", "D03274  Chlorpromazine hibenzate (JAN)", "D03276  Profenamine hibenzate (JAN)", "D03365  Nicotine (USP)", "D03584  Colforsin (USAN/INN)", "D03654  Darifenacin (USAN/INN)", "D03711  Dexetimide (USAN/INN)", "D03751  Icopezil maleate (USAN)", "D03814  Atropine methylbromide (JAN)", "D03822  Rivastigmine (JAN/USP/INN)", "D03823  Quilostigmine (USAN/INN)", "D03824  Dihexyverine hydrochloride (USAN)", "D03826  Physostigmine sulfate (USP)", "D03858  Diphenidol (USAN/INN)", "D03859  Diphenidol pamoate (USAN)", "D03970  Elantrine (USAN)", "D03979  Elucaine (USAN)", "D04034  Chlorpromazine phenolphthalinate (JAN)", "D04057  Esoxybutynin chloride (USAN)", "D04087  Ethybenztropine (USAN)", "D04116  Eucatropine hydrochloride (USP XXXII)", "D04192  Flindokalner (USAN/INN)", "D04292  Galantamine (USAN/INN)", "D04434  Heteronium bromide (USAN/INN)", "D04479  Hyoscyamine hydrobromide (USP)", "D04868  Mebeverine hydrochloride (USAN)", "D04970  Methacholine chloride (JAN/USP/INN)", "D05012  Metoquizine (USAN/INN)", "D05035  Milameline hydrochloride (USAN)", "D05156  Nicotine bitartrate (USAN)", "D05157  Nicotine polacrilex (USP)", "D05276  Pirenzepine hydrochloride hydrate (JP18)", "D05360  Parapenzolate bromide (USAN/INN)", "D05418  Pentapiperium methylsulfate (USAN)", "D05452  Phencarbamide (USAN)", "D05478  Pilocarpine nitrate (USP)", "D05535  Poldine methylsulfate (USAN)", "D05590  Pralidoxime mesylate (USAN)", "D05628  Propenzolate hydrochloride (USAN)", "D05703  Rapacuronium bromide (USAN/INN)", "D05779  Sabcomeline hydrochloride (USAN)", "D05981  Suronacrine maleate (USAN)", "D06000  Talsaclidine fumarate (USAN)", "D06015  Tazomeline citrate (USAN)", "D06016  Tebanicline tosylate (USAN)", "D06061  Tematropium methylsulfate (USAN)", "D06175  Tofenacin hydrochloride (USAN)", "D06192  Toquizine (USAN)", "D06217  Triampyzine sulfate (USAN)", "D06273  Imidafenacin (JAN/INN)", "D06282  Varenicline tartrate (JAN/USAN)", "D06288  Velnacrine maleate (USAN)", "D06330  Xanomeline (USAN)", "D06331  Xanomeline tartrate (USAN)", "D06365  Zifrosilone (USAN)", "D06877  Oxyphenonium bromide (INN)", "D06878  Diphemanil metilsulfate (INN)", "D07070  Fenpiverinium bromide (INN)", "D07078  Rociverine (INN)", "D07079  Difemerine (INN)", "D07081  Penthienate bromide (NF XIII)", "D07083  Otilonium bromide (INN)", "D07084  Pipenzolate bromide (INN)", "D07099  Cimetropium bromide (JAN/INN)", "D07226  Fesoterodine (INN)", "D07301  Phenglutarimide (INN)", "D07302  Bornaprine (INN)", "D07303  Tropatepine (INN)", "D07349  Choline alfoscerate (INN)", "D07477  Atropine oxide (INN)", "D07511  Benzatropine (INN)", "D07513  Benzetimide (INN)", "D07667  Cevimeline (INN)", "D07759  Cyclopentolate (INN)", "D07770  Cytisinicline (USAN)", "D07804  Dexetimide hydrochloride", "D07820  Dicycloverine (INN)", "D07821  Dihexyverine (INN)", "D07823  Diethazine (INN)", "D07869  Donepezil (JAN/INN)", "D07951  Fentonium bromide (INN)", "D08094  Itopride (INN)", "D08138  Lobeline sulfate", "D08157  Mazaticol (INN)", "D08160  Mebeverine (INN)", "D08209  Metixene (INN)", "D08261  Neostigmine (BAN)", "D08325  Oxyphencyclimine (INN)", "D08376  Pilocarpine borate", "D08382  Piperidolate (INN)", "D08384  Pipethanate (INN)", "D08389  Pirenzepine (USAN/INN)", "D08395  Piroheptine (INN)", "D08418  Pridinol (INN)", "D08419  Pridinol hydrochloride", "D08425  Procyclidine (INN)", "D08426  Profenamine (INN)", "D08441  Propiverine (INN)", "D08522  Solifenacin (INN)", "D08555  Tacrine (INN)", "D08595  Tiemonium methylsulfate", "D08638  Trihexyphenidyl (INN)", "D08653  Tropatepine hydrochloride", "D08669  Varenicline (INN)", "D08837  Aclidinium bromide (JAN/USAN/INN)", "D08838  Acotiamide hydrochloride (USAN)", "D08923  Fesoterodine fumarate (JAN/USAN)", "D08935  Ispronicline (INN/USAN)", "D08987  Rivanicline galactarate (USAN)", "D09367  Pozanicline (USAN)", "D09368  Pozanicline tartrate (USAN)", "D09382  Sofinicline (USAN)", "D09383  Sofinicline benzenesulfonate (USAN)", "D09402  Darotropium bromide (USAN/INN)", "D09569  Ezogabine (USAN)", "D09750  Ipidacrine hydrochloride hydrate (JAN)", "D09752  Carpronium chloride hydrate (JAN)", "D09819  Chlorpromazine tannate (JAN)", "D09835  Zanapezil fumarate (JAN)", "D09917  Latrepirdine (USAN/INN)", "D09918  Latrepirdine dihydrochloride (USAN)", "D10111  Dexmecamylamine (USAN)", "D10112  Dexmecamylamine hydrochloride (USAN)", "D10180  Umeclidinium (USAN)", "D10181  Umeclidinium bromide (JAN/USAN)", "D10529  Paraoxon", "D10613  Bradanicline (USAN/INN)", "D10693  Bradanicline hydrochloride (USAN)", "D10853  Desfesoterodine (INN)", "D10938  Glycopyrronium (USAN)", "D10939  Glycopyrronium tosylate (USAN)", "D10978  Revefenacin (USAN/INN)", "D10989  Sofpironium bromide (JAN/USAN/INN)", "D11098  Telenzepine hydrochloride hydrate (JAN)", "D11383  Blarcamesine (USAN)", "D11549  Blarcamesine hydrochloride (USAN)", "D12318  Buntanetap (USAN)", "D12319  Buntanetap tartrate (USAN)", "D12468  Emraclidine (USAN/INN)", "D12890  Azetukalner (USAN/INN)"], "dblinks": "GO: 0032222", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["1103  CHAT; choline O-acetyltransferase [KO:K00623] [EC:2.3.1.6]", "43  ACHE; acetylcholinesterase (Yt blood group) [KO:K01049] [EC:3.1.1.7]", "6572  SLC18A3; solute carrier family 18 member A3 [KO:K14636]", "1128  CHRM1; cholinergic receptor muscarinic 1 [KO:K04129]", "1131  CHRM3; cholinergic receptor muscarinic 3 [KO:K04131]", "1133  CHRM5; cholinergic receptor muscarinic 5 [KO:K04133]", "2776  GNAQ; G protein subunit alpha q [KO:K04634]", "2767  GNA11; G protein subunit alpha 11 [KO:K04635]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "3784  KCNQ1; potassium voltage-gated channel subfamily Q member 1 [KO:K04926]", "3785  KCNQ2; potassium voltage-gated channel subfamily Q member 2 [KO:K04927]", "3786  KCNQ3; potassium voltage-gated channel subfamily Q member 3 [KO:K04928]", "9132  KCNQ4; potassium voltage-gated channel subfamily Q member 4 [KO:K04929]", "56479  KCNQ5; potassium voltage-gated channel subfamily Q member 5 [KO:K04930]", "3759  KCNJ2; potassium inwardly rectifying channel subfamily J member 2 [KO:K04996]", "3768  KCNJ12; potassium inwardly rectifying channel subfamily J member 12 [KO:K05005]", "100134444  KCNJ18; potassium inwardly rectifying channel subfamily J member 18 [KO:K05005]", "3761  KCNJ4; potassium inwardly rectifying channel subfamily J member 4 [KO:K04998]", "3770  KCNJ14; potassium inwardly rectifying channel subfamily J member 14 [KO:K05007]", "1129  CHRM2; cholinergic receptor muscarinic 2 [KO:K04130]", "1132  CHRM4; cholinergic receptor muscarinic 4 [KO:K04132]", "2770  GNAI1; G protein subunit alpha i1 [KO:K04630]", "2773  GNAI3; G protein subunit alpha i3 [KO:K04630]", "2771  GNAI2; G protein subunit alpha i2 [KO:K04630]", "2775  GNAO1; G protein subunit alpha o1 [KO:K04534]", "2782  GNB1; G protein subunit beta 1 [KO:K04536]", "2783  GNB2; G protein subunit beta 2 [KO:K04537]", "2784  GNB3; G protein subunit beta 3 [KO:K07825]", "59345  GNB4; G protein subunit beta 4 [KO:K04538]", "10681  GNB5; G protein subunit beta 5 [KO:K04539]", "54331  GNG2; G protein subunit gamma 2 [KO:K07826]", "2785  GNG3; G protein subunit gamma 3 [KO:K04540]", "2786  GNG4; G protein subunit gamma 4 [KO:K04541]", "2787  GNG5; G protein subunit gamma 5 [KO:K04542]", "2788  GNG7; G protein subunit gamma 7 [KO:K04543]", "94235  GNG8; G protein subunit gamma 8 [KO:K04544]", "2790  GNG10; G protein subunit gamma 10 [KO:K04545]", "2791  GNG11; G protein subunit gamma 11 [KO:K04546]", "55970  GNG12; G protein subunit gamma 12 [KO:K04347]", "51764  GNG13; G protein subunit gamma 13 [KO:K04547]", "2792  GNGT1; G protein subunit gamma transducin 1 [KO:K04548]", "2793  GNGT2; G protein subunit gamma transducin 2 [KO:K04549]", "3760  KCNJ3; potassium inwardly rectifying channel subfamily J member 3 [KO:K04997]", "3763  KCNJ6; potassium inwardly rectifying channel subfamily J member 6 [KO:K05000]", "5294  PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma [KO:K21289] [EC:2.7.1.153]", "23533  PIK3R5; phosphoinositide-3-kinase regulatory subunit 5 [KO:K21290]", "146850  PIK3R6; phosphoinositide-3-kinase regulatory subunit 6 [KO:K21290]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "1139  CHRNA7; cholinergic receptor nicotinic alpha 7 subunit [KO:K04809]", "1137  CHRNA4; cholinergic receptor nicotinic alpha 4 subunit [KO:K04806]", "1141  CHRNB2; cholinergic receptor nicotinic beta 2 subunit [KO:K04813]", "1136  CHRNA3; cholinergic receptor nicotinic alpha 3 subunit [KO:K04805]", "1143  CHRNB4; cholinergic receptor nicotinic beta 4 subunit [KO:K04815]", "8973  CHRNA6; cholinergic receptor nicotinic alpha 6 subunit [KO:K04808]", "107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]", "108  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]", "109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]", "196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]", "113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]", "114  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]", "115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]", "468  ATF4; activating transcription factor 4 [KO:K04374]", "10488  CREB3; cAMP responsive element binding protein 3 [KO:K09048]", "90993  CREB3L1; cAMP responsive element binding protein 3 like 1 [KO:K09048]", "64764  CREB3L2; cAMP responsive element binding protein 3 like 2 [KO:K09048]", "84699  CREB3L3; cAMP responsive element binding protein 3 like 3 [KO:K09048]", "148327  CREB3L4; cAMP responsive element binding protein 3 like 4 [KO:K09048]", "9586  CREB5; cAMP responsive element binding protein 5 [KO:K09047]", "815  CAMK2A; calcium/calmodulin dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]", "817  CAMK2D; calcium/calmodulin dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]", "816  CAMK2B; calcium/calmodulin dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]", "818  CAMK2G; calcium/calmodulin dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]", "814  CAMK4; calcium/calmodulin dependent protein kinase IV [KO:K05869] [EC:2.7.11.17]", "3717  JAK2; Janus kinase 2 [KO:K04447] [EC:2.7.10.2]", "2534  FYN; FYN proto-oncogene, Src family tyrosine kinase [KO:K05703] [EC:2.7.10.2]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]", "773  CACNA1A; calcium voltage-gated channel subunit alpha1 A [KO:K04344]", "774  CACNA1B; calcium voltage-gated channel subunit alpha1 B [KO:K04849]", "775  CACNA1C; calcium voltage-gated channel subunit alpha1 C [KO:K04850]", "776  CACNA1D; calcium voltage-gated channel subunit alpha1 D [KO:K04851]", "778  CACNA1F; calcium voltage-gated channel subunit alpha1 F [KO:K04853]", "779  CACNA1S; calcium voltage-gated channel subunit alpha1 S [KO:K04857]", "60482  SLC5A7; solute carrier family 5 member 7 [KO:K14387]"], "compound": ["C00010  CoA", "C00024  Acetyl-CoA", "C00033  Acetate", "C00076  Calcium cation", "C00114  Choline", "C00165  Diacylglycerol", "C00238  Potassium cation", "C00575  3',5'-Cyclic AMP", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C01330  Sodium cation", "C01996  Acetylcholine", "C04637  1-Phosphatidyl-D-myo-inositol 4,5-bisphosphate"], "refs": [{"pmid": "15165747", "authors": "  Dajas-Bailador F, Wonnacott S", "title": "Nicotinic acetylcholine receptors and the regulation of neuronal signalling.", "journal": "Trends Pharmacol Sci 25:317-24 (2004)", "doi": "10.1016/j.tips.2004.04.006"}, {"pmid": "19712465", "authors": "  Resende RR, Adhikari A", "title": "Cholinergic receptor pathways involved in apoptosis, cell proliferation and neuronal differentiation.", "journal": "Cell Commun Signal 7:20 (2009)", "doi": "10.1186/1478-811X-7-20"}, {"pmid": "21550798", "authors": "  Oldenburg IA, Ding JB", "title": "Cholinergic modulation of synaptic integration and dendritic excitability in the striatum.", "journal": "Curr Opin Neurobiol 21:425-32 (2011)", "doi": "10.1016/j.conb.2011.04.004"}, {"pmid": "12893537", "authors": "  Lanzafame AA, Christopoulos A, Mitchelson F", "title": "Cellular signaling mechanisms for muscarinic acetylcholine receptors.", "journal": "Receptors Channels 9:241-60 (2003)", "doi": "10.3109/10606820308263"}, {"pmid": "20446119", "authors": "  Brown DA", "title": "Muscarinic acetylcholine receptors (mAChRs) in the nervous system: some functions and mechanisms.", "journal": "J Mol Neurosci 41:340-6 (2010)", "doi": "10.1007/s12031-010-9377-2"}, {"pmid": "11738031", "authors": "  Chang KT, Berg DK", "title": "Voltage-gated channels block nicotinic regulation of CREB phosphorylation and gene expression in neurons.", "journal": "Neuron 32:855-65 (2001)", "doi": "10.1016/S0896-6273(01)00516-5"}, {"pmid": "11283752", "authors": "  Soreq H, Seidman S", "title": "Acetylcholinesterase--new roles for an old actor.", "journal": "Nat Rev Neurosci 2:294-302 (2001)", "doi": "10.1038/35067589"}, {"pmid": "12436417", "authors": "  Sharma G, Vijayaraghavan S", "title": "Nicotinic receptor signaling in nonexcitable cells.", "journal": "J Neurobiol 53:524-34 (2002)", "doi": "10.1002/neu.10114"}, {"pmid": "11923408", "authors": "  Araque A, Martin ED, Perea G, Arellano JI, Buno W", "title": "Synaptically released acetylcholine evokes Ca2+ elevations in astrocytes in hippocampal slices.", "journal": "J Neurosci 22:2443-50 (2002)", "doi": "10.1523/JNEUROSCI.22-07-02443.2002"}, {"pmid": "12690458", "authors": "  Lucas-Meunier E, Fossier P, Baux G, Amar M", "title": "Cholinergic modulation of the cortical neuronal network.", "journal": "Pflugers Arch 446:17-29 (2003)", "doi": "10.1007/s00424-002-0999-2"}], "rel_pathway": ["hsa00564  Glycerophospholipid metabolism", "hsa04010  MAPK signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04721  Synaptic vesicle cycle", "hsa04975  Fat digestion and absorption"], "ko_pathway": "ko04725", "genes": ["AKT2", "AKT1", "NRAS"]}, {"kegg_id": "hsa04728", "name": "Dopaminergic synapse - Homo sapiens (human)", "description": "Dopamine (DA) is an important and prototypical slow neurotransmitter in the mammalian brain, where it controls a variety of functions including locomotor activity, motivation and reward, learning and memory, and endocrine regulation. Once released from presynaptic axonal terminals, DA interacts with at least five receptor subtypes in the central nervous system (CNS), which have been divided into two groups: the D1-like receptors (D1Rs), comprising D1 and D5 receptors, both positively coupled to adenylyl cyclase and cAMP production, and the D2-like receptors (D2Rs), comprising D2, D3, and D4 receptors, whose activation results in inhibition of adenylyl cyclase and suppression of cAMP production. In addition, D1Rs and D2Rs modulate intracellular Ca2+ levels and a number of Ca2+ -dependent intracellular signaling processes. Through diverse cAMP- and Ca2+-dependent and - independent mechanisms, DA influences neuronal activity, synaptic plasticity, and behavior. Presynaptically localized D2Rs regulate synthesis and release of DA as the main autoreceptor of the dopaminergic system.", "class": "Organismal Systems; Nervous system", "pathway_map": "hsa04728  Dopaminergic synapse", "network": ["", "ELEMENT   N00410  DRD1-GNAS-AC-PKA signaling pathway", "N01040  Transport of dopamine to synaptic vesicle", "N01530  Dopamine metabolism", "N01790  Transport of dopamine into the neuron"], "drug": ["D00059  Levodopa (JP18/USP/INN)", "D00110  Cocaine (USP)", "D00136  Haloperidol (JP18/USP/INN)", "D00152  Phloroglucinol (JAN)", "D00197  Reserpine (JP18/USP/INN)", "D00199  Ajmaline (JP18)", "D00252  Carbamazepine (JP18/USP/INN)", "D00270  Chlorpromazine (USP/INN)", "D00283  Clozapine (JAN/USP/INN)", "D00303  Disopyramide (JP18/USAN/INN)", "D00308  Droperidol (JP18/USP/INN)", "D00354  Lamotrigine (JAN/USP/INN)", "D00358  Lidocaine (JP18/USP/INN)", "D00367  Mazindol (JAN/USP/INN)", "D00373  Thioridazine (USP/INN)", "D00374  Thiothixene (USP)", "D00375  Mephenytoin (USP/INN)", "D00390  Triflupromazine (USP/INN)", "D00403  Methotrimeprazine (USP)", "D00426  Risperidone (JP18/USP/INN)", "D00454  Olanzapine (JAN/USP/INN)", "D00458  Quetiapine fumarate (JP18/USP)", "D00477  Procainamide hydrochloride (JP18/USP)", "D00479  Prochlorperazine maleate (JP18/USP)", "D00493  Prochlorperazine (JAN/USP/INN)", "D00502  Pergolide mesylate (USP)", "D00503  Perphenazine (JP18/USP/INN)", "D00505  Phenelzine sulfate (USP)", "D00512  Phenytoin (JP18/USP/INN)", "D00533  Oxcarbazepine (JAN/USP/INN)", "D00538  Zonisamide (JP18/USP/INN)", "D00551  Tetracaine (USP/INN)", "D00552  Benzocaine (USP/INN)", "D00553  Prilocaine (USP/INN)", "D00558  Carbidopa (USP)", "D00559  Pramipexole dihydrochloride (USP)", "D00560  Pimozide (JP18/USP/INN)", "D00561  Sertindole (USAN/INN)", "D00613  Fenoldopam mesylate (USP)", "D00633  Dopamine hydrochloride (JP18/USP)", "D00637  Disopyramide phosphate (JAN/USP)", "D00638  Flecainide acetate (JP18/USP)", "D00639  Mexiletine hydrochloride (JP18/USP)", "D00640  Propafenone hydrochloride (JP18/USP)", "D00642  Quinidine gluconate (USP)", "D00643  Quinidine polygalacturonate", "D00702  Buspirone hydrochloride (USP)", "D00726  Metoclopramide (JP18/INN)", "D00732  Chloroprocaine hydrochloride (USP)", "D00733  Dibucaine (USP)", "D00737  Etidocaine hydrochloride", "D00738  Mepivacaine hydrochloride (JP18/USP)", "D00739  Pramoxine hydrochloride (USP)", "D00740  Procaine hydrochloride (JP18/USP)", "D00741  Tetracaine hydrochloride (JP18/USP)", "D00775  Riluzole (JAN/USP/INN)", "D00777  Amantadine hydrochloride (JP18/USP)", "D00780  Bromocriptine mesylate (USP)", "D00781  Entacapone (JP18/USP/INN)", "D00784  Ropinirole hydrochloride (JAN/USP)", "D00785  Selegiline hydrochloride (JAN/USP)", "D00786  Tolcapone (JAN/USP/INN)", "D00788  Acetophenazine maleate (USAN)", "D00789  Chlorpromazine hydrochloride (JP18/USP)", "D00790  Chlorprothixene (JAN/USAN/INN)", "D00791  Fluphenazine hydrochloride (JAN/USP)", "D00792  Fluphenazine enanthate (JP18/USP)", "D00793  Fluphenazine decanoate (JAN/USP)", "D00794  Loxapine succinate (USP)", "D00795  Mesoridazine besylate (USP)", "D00796  Molindone hydrochloride (USP)", "D00797  Promazine hydrochloride (USP)", "D00798  Thioridazine hydrochloride (JP18/USP)", "D00799  Trifluoperazine hydrochloride (JAN/USP)", "D00800  Triflupromazine hydrochloride (JAN/USP)", "D00817  Bupropion hydrochloride (JAN/USP)", "D00826  Tranylcypromine sulfate (USP)", "D00987  Cabergoline (JP18/USP/INN)", "D01041  Sparteine (INN)", "D01044  Flupentixol (INN)", "D01051  Spiperone (JAN/USAN)", "D01097  Lazabemide hydrochloride (JAN/USAN)", "D01101  Bromperidol (JAN/USAN/INN)", "D01130  Thiethylperazine maleate (JAN/USP)", "D01152  Oxethazaine (JP18/USAN)", "D01164  Aripiprazole (JAN/USP/INN)", "D01176  Blonanserin (JAN/INN)", "D01226  Sulpiride (JP18/USAN/INN)", "D01243  Prilocaine hydrochloride (USP)", "D01259  Flopropione (JP18/INN)", "D01287  Levobupivacaine hydrochloride (JAN/USAN)", "D01296  Methylphenidate hydrochloride (JAN/USP)", "D01321  Zotepine (JAN/INN)", "D01326  Aprindine hydrochloride (JP18/USAN)", "D01348  Terguride (JAN/INN)", "D01412  Perazine maleate (JAN)", "D01447  Thioproperazine mesilate (JAN)", "D01448  Trifluoperazine maleate (JAN)", "D01450  Bupivacaine hydrochloride (USP)", "D01455  Cifenline succinate (USAN)", "D01462  Lisuride maleate (JAN)", "D01468  Nemonapride (JAN/INN)", "D01477  Opipramol hydrochloride (JAN/USAN)", "D01482  Pipamperone hydrochloride (JAN)", "D01485  Propericiazine (JAN)", "D01505  Talipexole hydrochloride (JAN)", "D01520  Levomepromazine hydrochloride (JAN/USAN)", "D01522  Tiapride hydrochloride (JP18)", "D01548  Mosapramine hydrochloride (JAN)", "D01653  Benserazide hydrochloride (JP18)", "D01742  Clebopride malate (JP18)", "D01745  Domperidone (JP18/USAN/INN)", "D01768  Benoxinate hydrochloride (USP)", "D01785  Pirmenol hydrochloride hydrate (JAN)", "D01860  Perazine dimalonate (JAN)", "D01888  Safrazine hydrochloride (JAN)", "D01898  Haloperidol decanoate (JAN/USP)", "D01903  Docarpamine (JAN/INN)", "D01939  Ziprasidone hydrochloride (USP)", "D02004  Apomorphine hydrochloride (USP)", "D02022  Prochlorperazine mesilate (JAN)", "D02037  Perphenazine maleate (JP18)", "D02074  Amphetamine sulfate (USP)", "D02078  Dextroamphetamine sulfate (USP)", "D02086  Lidocaine hydrochloride (JAN/USP)", "D02088  Tocainide hydrochloride (USP)", "D02096  Fosphenytoin sodium (USP)", "D02100  Ziprasidone mesylate (USAN)", "D02102  Methadone hydrochloride (JAN/USP)", "D02103  Phenytoin sodium (USP)", "D02162  Chlorprothixene hydrochloride (JAN)", "D02163  Fluphenazine maleate (JAN)", "D02182  Cocaine hydrochloride (JP18/USP)", "D02208  Sultopride hydrochloride (JAN)", "D02213  Metoclopramide hydrochloride (JAN)", "D02220  Dibucaine hydrochloride (JP18/USP)", "D02236  Flupentixol dihydrochloride (JAN)", "D02239  Sparteine sulfate (JAN/USAN)", "D02242  Methamphetamine hydrochloride (JP18/USP)", "D02248  Levomepromazine maleate (JP18/USAN)", "D02272  Quinidine sulfate (USP)", "D02340  Loxapine (USAN/INN)", "D02354  Thiethylperazine (USAN/INN)", "D02559  Toloxatone (INN)", "D02560  Brofaromine (INN)", "D02561  Moclobemide (USAN/INN)", "D02562  Rasagiline mesylate (USAN)", "D02563  Befloxatone (INN)", "D02564  Pargyline hydrochloride (USAN)", "D02571  Sibutramine hydrochloride (USP)", "D02579  Iproniazid (INN)", "D02580  Isocarboxazid (INN)", "D02581  Cimoxatone (INN)", "D02604  Acepromazine maleate (USP)", "D02608  Perazine fendizoate (JAN)", "D02609  Prochlorperazine edisylate (USP)", "D02610  Thiethylperazine malate (JAN)", "D02612  Thiothixene hydrochloride (USP)", "D02613  Clopenthixol (USAN)", "D02622  Pipamperone (USAN/INN)", "D02625  Trifluperidol (USAN/INN)", "D02626  Bromperidol decanoate (USAN)", "D02627  Benperidol (USAN/INN)", "D02634  Alentemol hydrobromide (USAN)", "D02644  Carphenazine maleate (USAN)", "D02656  Fananserin (USAN/INN)", "D02666  Iloperidone (USAN/INN)", "D02671  Mesoridazine (USAN/INN)", "D02675  Ocaperidone (USAN)", "D02676  Oxiperomide (USAN/INN)", "D02680  Pipotiazine palmitate (USAN)", "D02688  Tiospirone hydrochloride (USAN)", "D02696  Talampanel (INN)", "D02729  Itopride hydrochloride (JAN)", "D02762  Actisomide (USAN/INN)", "D02775  Adrogolide hydrochloride (USAN)", "D02780  Acamprosate calcium (JAN/USAN)", "D02991  Articaine hydrochloride (JAN/USP)", "D02995  Asenapine maleate (JAN/USAN)", "D03082  Benserazide (USAN/INN)", "D03153  Brasofensine maleate (USAN)", "D03165  Bromocriptine (USAN/INN)", "D03214  Aplindore fumarate (USAN)", "D03215  Armodafinil (USAN/INN)", "D03239  Ladostigil tartrate (USAN)", "D03241  Nitecapone (INN)", "D03248  Clorgiline (INN)", "D03274  Chlorpromazine hibenzate (JAN)", "D03409  Caroxazone (USAN/INN)", "D03492  Cifenline (USAN)", "D03494  Ciladopa hydrochloride (USAN)", "D03534  Clebopride (USAN)", "D03556  Zuclopenthixol (INN)", "D03721  Dexmethylphenidate hydrochloride (USAN)", "D03731  Selegiline (USAN/INN)", "D03733  Mofegiline hydrochloride (USAN)", "D03740  Dextroamphetamine (USAN)", "D03801  Diethylpropion hydrochloride (USP)", "D03878  Dizocilpine maleate (USAN)", "D03891  Dopexamine (USAN/INN)", "D03892  Dopexamine hydrochloride (USAN)", "D03937  Ecopipam hydrochloride (USAN)", "D03991  Encainide hydrochloride (USAN)", "D04034  Chlorpromazine phenolphthalinate (JAN)", "D04038  Perphenazine fendizoate (JAN)", "D04048  Ropivacaine hydrochloride (USP)", "D04092  Etryptamine acetate (USAN)", "D04095  Etidocaine (USAN/INN)", "D04097  Etilevodopa (USAN/INN)", "D04131  Farampator (USAN/INN)", "D04308  Gavestinel (USAN/INN)", "D04488  Ibopamine (USAN/INN)", "D04521  Indecainide hydrochloride (USAN)", "D04681  Lazabemide (USAN/INN)", "D04693  Lergotrile (USAN/INN)", "D04694  Lergotrile mesylate (USAN)", "D04728  Licostinel (USAN/INN)", "D04747  Lisdexamfetamine dimesylate (USAN)", "D04774  Lorajmine hydrochloride (USAN)", "D04820  Lurasidone hydrochloride (JAN/USAN)", "D04965  Perphenazine hydrochloride", "D04997  Methyldopate hydrochloride (USP)", "D04999  Methylphenidate (USAN/INN)", "D05008  Metoclopramide hydrochloride (USP)", "D05010  Metopimazine (USAN/INN)", "D05033  Milacemide hydrochloride (USAN)", "D05039  Minaprine (USAN/INN)", "D05040  Minaprine hydrochloride (USAN)", "D05119  Napamezole hydrochloride (USAN)", "D05124  Naxagolide hydrochloride (USAN)", "D05339  Paliperidone (JAN/USP/INN)", "D05340  Paliperidone palmitate (JAN/USAN)", "D05454  Phenmetrazine hydrochloride (USP)", "D05458  Phentermine (USAN/INN)", "D05459  Phentermine hydrochloride (USP)", "D05575  Pramipexole (USAN/INN)", "D05663  Pyrovalerone hydrochloride (USAN)", "D05677  Quinelorane hydrochloride (USAN)", "D05682  Quinpirole hydrochloride (USAN)", "D05692  Radafaxine hydrochloride (USAN)", "D05768  Rotigotine (JAN/USAN/INN)", "D05775  Rufinamide (JAN/USP/INN)", "D05804  Sarizotan hydrochloride (USAN)", "D05832  Sibenadet hydrochloride (USAN)", "D05891  Sonepiprazole mesylate (USAN)", "D06172  Tocainide (USAN/INN)", "D06203  Transcainide (USAN/INN)", "D06204  Traxoprodil mesylate (USAN)", "D06517  Pirmenol hydrochloride (USAN)", "D06566  Bifeprunox (USAN/INN)", "D06567  Bifeprunox mesylate (USAN)", "D06623  Olanzapine pamoate (USAN)", "D06656  Tezampanel (USAN)", "D07058  Acamprosate (INN)", "D07065  Acepromazine (INN)", "D07101  Bromopride (INN)", "D07102  Alizapride (INN)", "D07217  Quinagolide (INN/BAN)", "D07305  Piribedil (INN)", "D07306  Budipine (INN)", "D07309  Melperone (INN)", "D07310  Amisulpride (INN)", "D07312  Levosulpiride (INN)", "D07316  Captodiame (BAN)", "D07337  Nialamide (INN)", "D07338  Iproclozide (INN)", "D07441  Amantadine (INN)", "D07444  Amfepramone (INN)", "D07445  Amfetamine (INN)", "D07460  Apomorphine (BAN)", "D07468  Articaine (INN)", "D07514  Benzfetamine (INN)", "D07515  Benzfetamine hydrochloride", "D07552  Bupivacaine (USAN/INN)", "D07563  Alizapride hydrochloride", "D07589  Budipine hydrochloride", "D07591  Bupropion (INN)", "D07593  Buspirone (INN)", "D07595  Fosphenytoin sodium hydrate (JAN)", "D07678  Chloroprocaine (INN)", "D07686  Chlorprothixene acetate", "D07687  Chlorprothixene citrate", "D07806  Dexmethylphenidate (INN)", "D07835  Dihydroergocryptine", "D07836  Dihydroergocryptine mesilate", "D07868  Domperidone maleate", "D07870  Dopamine (INN)", "D07894  Encainide (INN)", "D07938  Bupropion hydrobromide (USAN)", "D07946  Fenoldopam (INN)", "D07962  Flecainide (INN)", "D07976  Flupentixol decanoate", "D07977  Fluphenazine (INN)", "D07993  Fosphenytoin (INN)", "D08035  Haloperidol lactate", "D08057  Ibopamine hydrochloride", "D08085  Iproniazid phosphate", "D08094  Itopride (INN)", "D08116  Levobupivacaine (INN)", "D08121  Levomethadone (INN)", "D08122  Levomethadone hydrochloride", "D08127  Lidocaine hydrochloride monohydrate", "D08130  Lisdexamfetamine (INN)", "D08132  Lisuride (INN)", "D08148  Loxapine hydrochloride", "D08172  Melperone hydrochloride", "D08181  Mepivacaine (INN)", "D08187  Metamfetamine (INN)", "D08195  Methadone (BAN)", "D08215  Mexiletine (INN)", "D08226  Molindone (INN)", "D08235  Mosapramine (INN)", "D08297  Opipramol (INN)", "D08311  Oxetacaine hydrochloride", "D08319  Oxybuprocaine (INN)", "D08339  Pergolide (INN)", "D08341  Perphenazine decanoate", "D08342  Perphenazine enantate", "D08349  Phenelzine (BAN)", "D08369  Polyphloroglucinol phosphate", "D08385  Pipotiazine (INN)", "D08392  Pirlindole (INN)", "D08393  Pirlindole hydrochloride", "D08394  Pirmenol (INN)", "D08407  Pramocaine (INN)", "D08421  Procainamide (INN)", "D08422  Procaine (INN)", "D08430  Promazine (INN)", "D08435  Propafenone (INN)", "D08453  Pargyline (INN)", "D08456  Quetiapine (INN)", "D08457  Quinagolide hydrochloride (BAN)", "D08458  Quinidine (BAN)", "D08459  Quinidine phenylethylbarbiturate", "D08469  Rasagiline (USAN/INN)", "D08489  Ropinirole (USAN/INN)", "D08490  Ropivacaine (INN)", "D08513  Sibutramine (INN)", "D08549  Sultopride (INN)", "D08558  Talipexole (INN)", "D08575  Tetrabenazine (JAN/INN)", "D08585  Thioproperazine (INN)", "D08590  Tiapride (INN)", "D08625  Tranylcypromine (INN)", "D08636  Trifluoperazine (INN)", "D08637  Trifluperidol hydrochloride", "D08687  Ziprasidone (INN)", "D08691  Zuclopenthixol acetate", "D08692  Zuclopenthixol decanoate", "D08693  Zuclopenthixol dihydrochloride", "D08964  Perampanel (USAN)", "D09035  Zonampanel (INN/USAN)", "D09215  Eslicarbazepine (USAN/INN)", "D09366  Pardoprunox hydrochloride (USAN)", "D09397  Pardoprunox (USAN/INN)", "D09612  Eslicarbazepine acetate (USAN)", "D09819  Chlorpromazine tannate (JAN)", "D09876  Cariprazine hydrochloride (JAN/USAN)", "D09931  Mibampator (USAN/INN)", "D09953  Pridopidine (USAN/INN)", "D09954  Pridopidine hydrochloride (USAN)", "D09997  Cariprazine (USAN/INN)", "D10014  Ioflupane I 123 (USAN)", "D10088  Amitifadine (USAN)", "D10089  Amitifadine hydrochloride (USAN)", "D10107  Dasolampanel (USAN/INN)", "D10108  Dasolampanel etibutil (USAN)", "D10109  Dasolampanel etibutil tosylate (USAN)", "D10158  Safinamide (USAN/INN)", "D10191  Safinamide mesylate (USAN)", "D10309  Brexpiprazole (JAN/USAN/INN)", "D10355  Aripiprazole cavoxil (USAN)", "D10364  Aripiprazole lauroxil (USAN)", "D10516  Aripiprazole hydrate (JAN)", "D10675  Valbenazine (USAN/INN)", "D10697  Centanafadine (USAN/INN)", "D10698  Centanafadine hydrochloride (USAN)", "D10700  Dasotraline (USAN/INN)", "D10701  Deutetrabenazine (USAN/INN)", "D10780  Perampanel hydrate (JAN)", "D10825  Opicapone (JAN/USAN/INN)", "D10829  Rasagiline tartrate", "D10870  Dasotraline hydrochloride (USAN)", "D10999  Valbenazine tosylate (USAN)", "D11169  Lumateperone (USAN/INN)", "D11170  Lumateperone tosylate (USAN)", "D11172  Midomafetamine (USAN/INN)", "D11224  Sembragiline (USAN/INN)", "D11315  Solriamfetol (USAN)", "D11328  Solriamfetol hydrochloride (USAN)", "D11431  Tavapadon (USAN/INN)", "D11622  Amphetamine aspartate monohydrate", "D11623  Dextroamphetamine saccharate", "D11769  Asenapine (INN)", "D11822  Mevidalen hydroxybenzoate (USAN)", "D11826  Mevidalen (USAN)", "D11839  Foslevodopa (JAN/USAN/INN)", "D11982  Trazpiroben (USAN/INN)", "D12196  Laduviglusib (USAN)", "D12214  Esmethadone (USAN)", "D12215  Esmethadone hydrochloride (USAN)", "D12239  Pesampator (USAN)", "D12616  Bliretrigine (JAN/INN)", "D12716  Mesocarb (INN)", "D12766  Razpipadon (USAN/INN)", "D12787  Onfasprodil (USAN/INN)", "D12813  Brilaroxazine (USAN/INN)", "D12814  Brilaroxazine hydrochloride (USAN)"], "dblinks": "GO: 0001963", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["7054  TH; tyrosine hydroxylase [KO:K00501] [EC:1.14.16.2]", "1644  DDC; dopa decarboxylase [KO:K01593] [EC:4.1.1.28 4.1.1.105]", "6570  SLC18A1; solute carrier family 18 member A1 [KO:K08155]", "6571  SLC18A2; solute carrier family 18 member A2 [KO:K08155]", "1812  DRD1; dopamine receptor D1 [KO:K04144]", "1816  DRD5; dopamine receptor D5 [KO:K05840]", "50632  CALY; calcyon neuron specific vesicular protein [KO:K15493]", "2776  GNAQ; G protein subunit alpha q [KO:K04634]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "810  CALML3; calmodulin like 3 [KO:K02183]", "805  CALM2; calmodulin 2 [KO:K02183]", "808  CALM3; calmodulin 3 [KO:K02183]", "801  CALM1; calmodulin 1 [KO:K02183]", "163688  CALML6; calmodulin like 6 [KO:K02183]", "51806  CALML5; calmodulin like 5 [KO:K02183]", "91860  CALML4; calmodulin like 4 [KO:K02183]", "815  CAMK2A; calcium/calmodulin dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]", "817  CAMK2D; calcium/calmodulin dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]", "816  CAMK2B; calcium/calmodulin dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]", "818  CAMK2G; calcium/calmodulin dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]", "5530  PPP3CA; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]", "5532  PPP3CB; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]", "5533  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "2778  GNAS; GNAS complex locus [KO:K04632]", "2774  GNAL; G protein subunit alpha L [KO:K04633]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]", "1386  ATF2; activating transcription factor 2 [KO:K04450]", "468  ATF4; activating transcription factor 4 [KO:K04374]", "10488  CREB3; cAMP responsive element binding protein 3 [KO:K09048]", "90993  CREB3L1; cAMP responsive element binding protein 3 like 1 [KO:K09048]", "64764  CREB3L2; cAMP responsive element binding protein 3 like 2 [KO:K09048]", "84699  CREB3L3; cAMP responsive element binding protein 3 like 3 [KO:K09048]", "148327  CREB3L4; cAMP responsive element binding protein 3 like 4 [KO:K09048]", "9586  CREB5; cAMP responsive element binding protein 5 [KO:K09047]", "1388  ATF6B; activating transcription factor 6 beta [KO:K09049]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "84152  PPP1R1B; protein phosphatase 1 regulatory inhibitor subunit 1B [KO:K15494]", "5499  PPP1CA; protein phosphatase 1 catalytic subunit alpha [KO:K06269] [EC:3.1.3.16]", "5500  PPP1CB; protein phosphatase 1 catalytic subunit beta [KO:K06269] [EC:3.1.3.16]", "5501  PPP1CC; protein phosphatase 1 catalytic subunit gamma [KO:K06269] [EC:3.1.3.16]", "6323  SCN1A; sodium voltage-gated channel alpha subunit 1 [KO:K04833]", "775  CACNA1C; calcium voltage-gated channel subunit alpha1 C [KO:K04850]", "776  CACNA1D; calcium voltage-gated channel subunit alpha1 D [KO:K04851]", "773  CACNA1A; calcium voltage-gated channel subunit alpha1 A [KO:K04344]", "774  CACNA1B; calcium voltage-gated channel subunit alpha1 B [KO:K04849]", "3760  KCNJ3; potassium inwardly rectifying channel subfamily J member 3 [KO:K04997]", "3763  KCNJ6; potassium inwardly rectifying channel subfamily J member 6 [KO:K05000]", "3765  KCNJ9; potassium inwardly rectifying channel subfamily J member 9 [KO:K05002]", "3762  KCNJ5; potassium inwardly rectifying channel subfamily J member 5 [KO:K04999]", "1814  DRD3; dopamine receptor D3 [KO:K04146]", "1815  DRD4; dopamine receptor D4 [KO:K04147]", "2770  GNAI1; G protein subunit alpha i1 [KO:K04630]", "2773  GNAI3; G protein subunit alpha i3 [KO:K04630]", "2771  GNAI2; G protein subunit alpha i2 [KO:K04630]", "2775  GNAO1; G protein subunit alpha o1 [KO:K04534]", "2782  GNB1; G protein subunit beta 1 [KO:K04536]", "2783  GNB2; G protein subunit beta 2 [KO:K04537]", "2784  GNB3; G protein subunit beta 3 [KO:K07825]", "59345  GNB4; G protein subunit beta 4 [KO:K04538]", "10681  GNB5; G protein subunit beta 5 [KO:K04539]", "54331  GNG2; G protein subunit gamma 2 [KO:K07826]", "2785  GNG3; G protein subunit gamma 3 [KO:K04540]", "2786  GNG4; G protein subunit gamma 4 [KO:K04541]", "2787  GNG5; G protein subunit gamma 5 [KO:K04542]", "2788  GNG7; G protein subunit gamma 7 [KO:K04543]", "94235  GNG8; G protein subunit gamma 8 [KO:K04544]", "2790  GNG10; G protein subunit gamma 10 [KO:K04545]", "2791  GNG11; G protein subunit gamma 11 [KO:K04546]", "55970  GNG12; G protein subunit gamma 12 [KO:K04347]", "51764  GNG13; G protein subunit gamma 13 [KO:K04547]", "2792  GNGT1; G protein subunit gamma transducin 1 [KO:K04548]", "2793  GNGT2; G protein subunit gamma transducin 2 [KO:K04549]", "1813  DRD2; dopamine receptor D2 [KO:K04145]", "408  ARRB1; arrestin beta 1 [KO:K04439]", "409  ARRB2; arrestin beta 2 [KO:K04439]", "5515  PPP2CA; protein phosphatase 2 catalytic subunit alpha [KO:K04382] [EC:3.1.3.16]", "5516  PPP2CB; protein phosphatase 2 catalytic subunit beta [KO:K04382] [EC:3.1.3.16]", "5519  PPP2R1B; protein phosphatase 2 scaffold subunit Abeta [KO:K03456]", "5518  PPP2R1A; protein phosphatase 2 scaffold subunit Aalpha [KO:K03456]", "5520  PPP2R2A; protein phosphatase 2 regulatory subunit Balpha [KO:K04354]", "5521  PPP2R2B; protein phosphatase 2 regulatory subunit Bbeta [KO:K04354]", "5522  PPP2R2C; protein phosphatase 2 regulatory subunit Bgamma [KO:K04354]", "55844  PPP2R2D; protein phosphatase 2 regulatory subunit Bdelta [KO:K04354]", "28227  PPP2R3B; protein phosphatase 2 regulatory subunit B''beta [KO:K11583]", "55012  PPP2R3C; protein phosphatase 2 regulatory subunit B''gamma [KO:K11583]", "5523  PPP2R3A; protein phosphatase 2 regulatory subunit B''alpha [KO:K11583]", "5526  PPP2R5B; protein phosphatase 2 regulatory subunit B'beta [KO:K11584]", "5527  PPP2R5C; protein phosphatase 2 regulatory subunit B'gamma [KO:K11584]", "5528  PPP2R5D; protein phosphatase 2 regulatory subunit B'delta [KO:K11584]", "5529  PPP2R5E; protein phosphatase 2 regulatory subunit B'epsilon [KO:K11584]", "5525  PPP2R5A; protein phosphatase 2 regulatory subunit B'alpha [KO:K11584]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "2931  GSK3A; glycogen synthase kinase 3 alpha [KO:K08822] [EC:2.7.11.26]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "2903  GRIN2A; glutamate ionotropic receptor NMDA type subunit 2A [KO:K05209]", "2904  GRIN2B; glutamate ionotropic receptor NMDA type subunit 2B [KO:K05210]", "2890  GRIA1; glutamate ionotropic receptor AMPA type subunit 1 [KO:K05197]", "2891  GRIA2; glutamate ionotropic receptor AMPA type subunit 2 [KO:K05198]", "2892  GRIA3; glutamate ionotropic receptor AMPA type subunit 3 [KO:K05199]", "2893  GRIA4; glutamate ionotropic receptor AMPA type subunit 4 [KO:K05200]", "3798  KIF5A; kinesin family member 5A [KO:K10396]", "3799  KIF5B; kinesin family member 5B [KO:K10396]", "3800  KIF5C; kinesin family member 5C [KO:K10396]", "9575  CLOCK; clock circadian regulator [KO:K02223] [EC:2.3.1.48]", "406  BMAL1; basic helix-loop-helix ARNT like 1 [KO:K02296]", "6531  SLC6A3; solute carrier family 6 member 3 [KO:K05036]", "4129  MAOB; monoamine oxidase B [KO:K00274] [EC:1.4.3.4]", "4128  MAOA; monoamine oxidase A [KO:K00274] [EC:1.4.3.4]", "1312  COMT; catechol-O-methyltransferase [KO:K00545] [EC:2.1.1.6]", "220074  LRTOMT; leucine rich transmembrane and O-methyltransferase domain containing [KO:K00545] [EC:2.1.1.6]"], "compound": ["C00076  Calcium cation", "C00082  L-Tyrosine", "C00165  Diacylglycerol", "C00238  Potassium cation", "C00355  3,4-Dihydroxy-L-phenylalanine", "C00575  3',5'-Cyclic AMP", "C01161  3,4-Dihydroxyphenylacetate", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C01330  Sodium cation", "C03758  Dopamine", "C05582  Homovanillate", "C05587  3-Methoxytyramine"], "refs": [{"pmid": "21303898", "authors": "  Beaulieu JM, Gainetdinov RR", "title": "The physiology, signaling, and pharmacology of dopamine receptors.", "journal": "Pharmacol Rev 63:182-217 (2011)", "doi": "10.1124/pr.110.002642"}, {"pmid": "15521361", "authors": "  Neve KA, Seamans JK, Trantham-Davidson H", "title": "Dopamine receptor signaling.", "journal": "J Recept Signal Transduct Res 24:165-205 (2004)", "doi": "10.1081/RRS-200029981"}, {"pmid": "17408758", "authors": "  Surmeier DJ, Ding J, Day M, Wang Z, Shen W", "title": "D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons.", "journal": "Trends Neurosci 30:228-35 (2007)", "doi": "10.1016/j.tins.2007.03.008"}, {"pmid": "20224735", "authors": "  Knab AM, Lightfoot JT", "title": "Does the difference between physically active and couch potato lie in the dopamine system?", "journal": "Int J Biol Sci 6:133-50 (2010)", "doi": "10.7150/ijbs.6.133"}, {"pmid": "10433257", "authors": "  Greengard P, Allen PB, Nairn AC", "title": "Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade.", "journal": "Neuron 23:435-47 (1999)", "doi": "10.1016/S0896-6273(00)80798-9"}, {"pmid": "15590733", "authors": "  Hu XT, Dong Y, Zhang XF, White FJ", "title": "Dopamine D2 receptor-activated Ca2+ signaling modulates voltage-sensitive sodium currents in rat nucleus accumbens neurons.", "journal": "J Neurophysiol 93:1406-17 (2005)", "doi": "10.1152/jn.00771.2004"}, {"pmid": "17349698", "authors": "  Beaulieu JM, Gainetdinov RR, Caron MG", "title": "The Akt-GSK-3 signaling cascade in the actions of dopamine.", "journal": "Trends Pharmacol Sci 28:166-72 (2007)", "doi": "10.1016/j.tips.2007.02.006"}, {"pmid": "19138563", "authors": "  De Mei C, Ramos M, Iitaka C, Borrelli E", "title": "Getting specialized: presynaptic and postsynaptic dopamine D2 receptors.", "journal": "Curr Opin Pharmacol 9:53-8 (2009)", "doi": "10.1016/j.coph.2008.12.002"}, {"pmid": "15381316", "authors": "  Seamans JK, Yang CR", "title": "The principal features and mechanisms of dopamine modulation in the prefrontal cortex.", "journal": "Prog Neurobiol 74:1-58 (2004)", "doi": "10.1016/j.pneurobio.2004.05.006"}, {"pmid": "18353279", "authors": "  Yao WD, Spealman RD, Zhang J", "title": "Dopaminergic signaling in dendritic spines.", "journal": "Biochem Pharmacol 75:2055-69 (2008)", "doi": "10.1016/j.bcp.2008.01.018"}, {"pmid": "20727368", "authors": "  Li YC, Gao WJ", "title": "GSK-3beta activity and hyperdopamine-dependent behaviors.", "journal": "Neurosci Biobehav Rev 35:645-54 (2011)", "doi": "10.1016/j.neubiorev.2010.08.001"}, {"pmid": "15292232", "authors": "  Tang TS, Bezprozvanny I", "title": "Dopamine receptor-mediated Ca(2+) signaling in striatal medium spiny neurons.", "journal": "J Biol Chem 279:42082-94 (2004)", "doi": "10.1074/jbc.M407389200"}, {"pmid": "12967774", "authors": "  Bergson C, Levenson R, Goldman-Rakic PS, Lidow MS", "title": "Dopamine receptor-interacting proteins: the Ca(2+) connection in dopamine signaling.", "journal": "Trends Pharmacol Sci 24:486-92 (2003)", "doi": "10.1016/S0165-6147(03)00232-3"}, {"pmid": "9457173", "authors": "  Missale C, Nash SR, Robinson SW, Jaber M, Caron MG", "title": "Dopamine receptors: from structure to function.", "journal": "Physiol Rev 78:189-225 (1998)", "doi": "10.1152/physrev.1998.78.1.189"}], "rel_pathway": ["hsa00350  Tyrosine metabolism", "hsa04020  Calcium signaling pathway", "hsa04721  Synaptic vesicle cycle", "hsa04724  Glutamatergic synapse", "hsa05012  Parkinson disease"], "ko_pathway": "ko04728", "genes": ["AKT2", "AKT1", "MAPK13"]}, {"kegg_id": "hsa04917", "name": "Prolactin signaling pathway - Homo sapiens (human)", "description": "Prolactin (PRL) is a polypeptide hormone known to be involved in a wide range of biological functions including osmoregulation, lactation, reproduction, growth and development, endocrinology and metabolism, brain and behavior, and immunomodulation. PRL mediates its action through PRLR, a transmembrane protein of the hematopoietin cytokine receptor superfamily. At the protein level, the long PRLR isoform (long-R) and several short PRLR isoforms (short-R) have been detected. Acting through the long-R, PRL activates many signaling cascades including Jak2/Stat, the major cascade, Src kinase, phosphatidylinositol-3-kinase (PI3K)/AKT, and mitogen-activated protein kinase (MAPK) pathways. PRL cannot activate Jak2/Stat5 through the short-R, but can activate pathways including MAPK and PI3K pathways.", "class": "Organismal Systems; Endocrine system", "pathway_map": "hsa04917  Prolactin signaling pathway", "network": ["", "ELEMENT   N00920  PRL-JAK-STAT signaling pathway"], "drug": ["D00780  Bromocriptine mesylate (USP)", "D00987  Cabergoline (JP18/USP/INN)", "D01281  Cyclofenil (JAN/INN)", "D01348  Terguride (JAN/INN)", "D03165  Bromocriptine (USAN/INN)", "D06631  Prinaberel (USAN/INN)", "D12628  Vepdegestrant (JAN/USAN/INN)", "D12827  Palazestrant (USAN/INN)"], "dblinks": "GO: 0038161", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["5617  PRL; prolactin [KO:K05439]", "5618  PRLR; prolactin receptor [KO:K05081]", "3717  JAK2; Janus kinase 2 [KO:K04447] [EC:2.7.10.2]", "6464  SHC1; SHC adaptor protein 1 [KO:K06279]", "25759  SHC2; SHC adaptor protein 2 [KO:K17447]", "53358  SHC3; SHC adaptor protein 3 [KO:K17448]", "399694  SHC4; SHC adaptor protein 4 [KO:K17449]", "6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "2309  FOXO3; forkhead box O3 [KO:K09408]", "2592  GALT; galactose-1-phosphate uridylyltransferase [KO:K00965] [EC:2.7.7.12]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "595  CCND1; cyclin D1 [KO:K04503]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "1154  CISH; cytokine inducible SH2 containing protein [KO:K04701]", "8651  SOCS1; suppressor of cytokine signaling 1 [KO:K04694]", "8835  SOCS2; suppressor of cytokine signaling 2 [KO:K04695]", "9021  SOCS3; suppressor of cytokine signaling 3 [KO:K04696]", "122809  SOCS4; suppressor of cytokine signaling 4 [KO:K04697]", "9655  SOCS5; suppressor of cytokine signaling 5 [KO:K04698]", "30837  SOCS7; suppressor of cytokine signaling 7 [KO:K04699]", "9306  SOCS6; suppressor of cytokine signaling 6 [KO:K04699]", "6772  STAT1; signal transducer and activator of transcription 1 [KO:K11220]", "6774  STAT3; signal transducer and activator of transcription 3 [KO:K04692]", "6776  STAT5A; signal transducer and activator of transcription 5A [KO:K11223]", "6777  STAT5B; signal transducer and activator of transcription 5B [KO:K11224]", "8600  TNFSF11; TNF superfamily member 11 [KO:K05473]", "8792  TNFRSF11A; TNF receptor superfamily member 11a [KO:K05147]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "2001  ELF5; E74 like ETS transcription factor 5 [KO:K17101]", "1447  CSN2; casein beta [KO:K17107]", "1081  CGA; glycoprotein hormones, alpha polypeptide [KO:K08522]", "3972  LHB; luteinizing hormone subunit beta [KO:K08521]", "3973  LHCGR; luteinizing hormone/choriogonadotropin receptor [KO:K04248]", "1586  CYP17A1; cytochrome P450 family 17 subfamily A member 1 [KO:K00512] [EC:1.14.14.19 1.14.14.32]", "2099  ESR1; estrogen receptor 1 [KO:K08550]", "2100  ESR2; estrogen receptor 2 [KO:K08551]", "3659  IRF1; interferon regulatory factor 1 [KO:K09444]", "7054  TH; tyrosine hydroxylase [KO:K00501] [EC:1.14.16.2]", "6514  SLC2A2; solute carrier family 2 member 2 [KO:K07593]", "2645  GCK; glucokinase [KO:K12407] [EC:2.7.1.2]", "894  CCND2; cyclin D2 [KO:K10151]", "3630  INS; insulin [KO:K04526]"], "compound": ["C00002  ATP", "C00031  D-Glucose", "C00082  L-Tyrosine", "C00092  D-Glucose 6-phosphate", "C00280  Androstenedione", "C00355  3,4-Dihydroxy-L-phenylalanine", "C00410  Progesterone", "C00468  Estrone", "C00951  Estradiol-17beta", "C03758  Dopamine", "C05981  Phosphatidylinositol-3,4,5-trisphosphate"], "refs": [{"pmid": "20149678", "authors": "  Binart N, Bachelot A, Bouilly J", "title": "Impact of prolactin receptor isoforms on reproduction.", "journal": "Trends Endocrinol Metab 21:362-8 (2010)", "doi": "10.1016/j.tem.2010.01.008"}, {"pmid": "17307904", "authors": "  Bachelot A, Binart N", "title": "Reproductive role of prolactin.", "journal": "Reproduction 133:361-9 (2007)", "doi": "10.1530/REP-06-0299"}, {"pmid": "16231422", "authors": "  Hennighausen L, Robinson GW", "title": "Information networks in the mammary gland.", "journal": "Nat Rev Mol Cell Biol 6:715-25 (2005)", "doi": "10.1038/nrm1714"}, {"pmid": "21664429", "authors": "  Bouilly J, Sonigo C, Auffret J, Gibori G, Binart N", "title": "Prolactin signaling mechanisms in ovary.", "journal": "Mol Cell Endocrinol 356:80-7 (2012)", "doi": "10.1016/j.mce.2011.05.004"}, {"pmid": "18219564", "authors": "  Oakes SR, Rogers RL, Naylor MJ, Ormandy CJ", "title": "Prolactin regulation of mammary gland development.", "journal": "J Mammary Gland Biol Neoplasia 13:13-28 (2008)", "doi": "10.1007/s10911-008-9069-5"}, {"pmid": "12670737", "authors": "  Frasor J, Gibori G", "title": "Prolactin regulation of estrogen receptor expression.", "journal": "Trends Endocrinol Metab 14:118-23 (2003)", "doi": "10.1016/S1043-2760(03)00030-4"}, {"pmid": "9626554", "authors": "  Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA", "title": "Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice.", "journal": "Endocr Rev 19:225-68 (1998)", "doi": "10.1210/edrv.19.3.0334"}, {"pmid": "17535875", "authors": "  Weinhaus AJ, Stout LE, Bhagroo NV, Brelje TC, Sorenson RL", "title": "Regulation of glucokinase in pancreatic islets by prolactin: a mechanism for increasing glucose-stimulated insulin secretion during pregnancy.", "journal": "J Endocrinol 193:367-81 (2007)", "doi": "10.1677/JOE-07-0043"}, {"pmid": "18601698", "authors": "  Grattan DR, Kokay IC", "title": "Prolactin: a pleiotropic neuroendocrine hormone.", "journal": "J Neuroendocrinol 20:752-63 (2008)", "doi": "10.1111/j.1365-2826.2008.01736.x"}, {"pmid": "9475379", "authors": "  Yu-Lee LY, Luo G, Book ML, Morris SM", "title": "Lactogenic hormone signal transduction.", "journal": "Biol Reprod 58:295-301 (1998)", "doi": "10.1095/biolreprod58.2.295"}, {"pmid": "11606470", "authors": "  Tam SP, Lau P, Djiane J, Hilton DJ, Waters MJ", "title": "Tissue-specific induction of SOCS gene expression by PRL.", "journal": "Endocrinology 142:5015-26 (2001)", "doi": "10.1210/endo.142.11.8466"}, {"pmid": "17975019", "authors": "  Halperin J, Devi SY, Elizur S, Stocco C, Shehu A, Rebourcet D, Unterman TG, Leslie ND, Le J, Binart N, Gibori G", "title": "Prolactin signaling through the short form of its receptor represses forkhead transcription factor FOXO3 and its target gene galt causing a severe ovarian defect.", "journal": "Mol Endocrinol 22:513-22 (2008)", "doi": "10.1210/me.2007-0399"}, {"pmid": "17519353", "authors": "  Sakamoto K, Creamer BA, Triplett AA, Wagner KU", "title": "The Janus kinase 2 is required for expression and nuclear accumulation of cyclin D1 in proliferating mammary epithelial cells.", "journal": "Mol Endocrinol 21:1877-92 (2007)", "doi": "10.1210/me.2006-0316"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04630  JAK-STAT signaling pathway", "hsa04728  Dopaminergic synapse", "hsa04911  Insulin secretion", "hsa04913  Ovarian steroidogenesis", "hsa04915  Estrogen signaling pathway"], "ko_pathway": "ko04917", "genes": ["AKT2", "AKT1", "SOS1", "MAPK13", "NRAS"]}, {"kegg_id": "hsa04920", "name": "Adipocytokine signaling pathway - Homo sapiens (human)", "description": "Increased adipocyte volume and number are positively correlated with leptin production, and negatively correlated with production of adiponectin.\nLeptin is an important regulator of energy intake and metabolic rate primarily by acting at hypothalamic nuclei. Leptin exerts its anorectic effects by modulating the levels of neuropeptides such as NPY, AGRP, and alpha-MSH. This leptin action is through the JAK kinase, STAT3 phosphorylation, and nuclear transcriptional effect.\nAdiponectin lowers plasma glucose and FFAs. These effects are partly accounted for by adiponectin-induced AMPK activation, which in turn stimulates skeletal muscle fatty acid oxidation and glucose uptake. Furthermore, activation of AMPK by adiponectin suppresses endogenous glucose production, concomitantly with inhibition of PEPCK and G6Pase expression.\nThe proinflammatory cytokine TNFalpha has been implicated as a link between obesity and insulin resistance. TNFalpha interferes with early steps of insulin signaling. Several data have shown that TNFalpha inhibits IRS1 tyrosine phosphorylation by promoting its serine phosphorylation. Among the serine/threonine kinases activated by TNFalpha, JNK, mTOR and IKK have been shown to be involved in this phosphorylation.", "class": "Organismal Systems; Endocrine system", "pathway_map": "hsa04920  Adipocytokine signaling pathway", "network": ["", "ELEMENT   N01788  ADIPOQ-ADIPOR signaling pathway", "N01800  LEP-LEPR signaling pathway"], "drug": ["D00279  Clofibrate (JP18/USP/INN)", "D00334  Gemfibrozil (JAN/USP/INN)", "D00565  Fenofibrate (JP18/USP/INN)", "D00595  Buformin (USAN/INN)", "D00742  Etanercept (USAN/INN)", "D00944  Metformin hydrochloride (JP18/USP)", "D01208  Aluminum clofibrate (JAN/INN)", "D01366  Bezafibrate (JP18/USAN/INN)", "D02206  Buformin hydrochloride (JP18)", "D02598  Infliximab (USAN/INN)", "D03106  Bexarotene (JAN/USAN/INN)", "D03441  Certolizumab pegol (USAN/INN)", "D03521  Ciprofibrate (USAN/INN)", "D04358  Golimumab (USAN/INN)", "D04966  Metformin (USAN/INN)", "D05014  Metreleptin (USAN/INN)", "D05292  Oxfenicine (USAN/INN)", "D07187  Etofibrate (INN)", "D07436  Afelimomab (INN)", "D07724  Magnesium clofibrate (INN)", "D08351  Phenformin (BAN)", "D08352  Phenformin hydrochloride", "D08890  Choline fenofibrate (USAN/INN)", "D11186  Olumacostat glasaretil (USAN/INN)", "D11208  Elafibranor (USAN)", "D11579  Fenofibric acid", "D12769  Nisotirostide (USAN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["7124  TNF; tumor necrosis factor [KO:K03156]", "7132  TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158]", "8717  TRADD; TNFRSF1A associated via death domain [KO:K03171]", "7133  TNFRSF1B; TNF receptor superfamily member 1B [KO:K05141]", "7186  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "4793  NFKBIB; NFKB inhibitor beta [KO:K02581]", "4794  NFKBIE; NFKB inhibitor epsilon [KO:K05872]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "9021  SOCS3; suppressor of cytokine signaling 3 [KO:K04696]", "3667  IRS1; insulin receptor substrate 1 [KO:K16172]", "8660  IRS2; insulin receptor substrate 2 [KO:K07187]", "8471  IRS4; insulin receptor substrate 4 [KO:K17446]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "948  CD36; CD36 molecule (CD36 blood group) [KO:K06259]", "23305  ACSL6; acyl-CoA synthetase long chain family member 6 [KO:K01897] [EC:6.2.1.3]", "2182  ACSL4; acyl-CoA synthetase long chain family member 4 [KO:K01897] [EC:6.2.1.3]", "2180  ACSL1; acyl-CoA synthetase long chain family member 1 [KO:K01897] [EC:6.2.1.3]", "51703  ACSL5; acyl-CoA synthetase long chain family member 5 [KO:K01897] [EC:6.2.1.3]", "2181  ACSL3; acyl-CoA synthetase long chain family member 3 [KO:K01897] [EC:6.2.1.3]", "23205  ACSBG1; acyl-CoA synthetase bubblegum family member 1 [KO:K15013] [EC:6.2.1.3]", "81616  ACSBG2; acyl-CoA synthetase bubblegum family member 2 [KO:K15013] [EC:6.2.1.3]", "5588  PRKCQ; protein kinase C theta [KO:K18052] [EC:2.7.11.13]", "3952  LEP; leptin [KO:K05424]", "3953  LEPR; leptin receptor [KO:K05062]", "3717  JAK2; Janus kinase 2 [KO:K04447] [EC:2.7.10.2]", "6774  STAT3; signal transducer and activator of transcription 3 [KO:K04692]", "5443  POMC; proopiomelanocortin [KO:K05228]", "181  AGRP; agouti related neuropeptide [KO:K05231]", "4852  NPY; neuropeptide Y [KO:K05232]", "10891  PPARGC1A; PPARG coactivator 1 alpha [KO:K07202]", "5105  PCK1; phosphoenolpyruvate carboxykinase 1 [KO:K01596] [EC:4.1.1.32]", "5106  PCK2; phosphoenolpyruvate carboxykinase 2, mitochondrial [KO:K01596] [EC:4.1.1.32]", "2538  G6PC1; glucose-6-phosphatase catalytic subunit 1 [KO:K01084] [EC:3.1.3.9]", "57818  G6PC2; glucose-6-phosphatase catalytic subunit 2 [KO:K01084] [EC:3.1.3.9]", "92579  G6PC3; glucose-6-phosphatase catalytic subunit 3 [KO:K01084] [EC:3.1.3.9]", "5781  PTPN11; protein tyrosine phosphatase non-receptor type 11 [KO:K07293] [EC:3.1.3.48]", "5465  PPARA; peroxisome proliferator activated receptor alpha [KO:K07294]", "6256  RXRA; retinoid X receptor alpha [KO:K08524]", "6257  RXRB; retinoid X receptor beta [KO:K08525]", "6258  RXRG; retinoid X receptor gamma [KO:K08526]", "9370  ADIPOQ; adiponectin, C1Q and collagen domain containing [KO:K07296]", "51094  ADIPOR1; adiponectin receptor 1 [KO:K07297]", "79602  ADIPOR2; adiponectin receptor 2 [KO:K07297]", "26060  APPL1; adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1 [KO:K08733]", "6794  STK11; serine/threonine kinase 11 [KO:K07298] [EC:2.7.11.1]", "10645  CAMKK2; calcium/calmodulin dependent protein kinase kinase 2 [KO:K07359] [EC:2.7.11.17]", "5562  PRKAA1; protein kinase AMP-activated catalytic subunit alpha 1 [KO:K07198] [EC:2.7.11.31]", "5563  PRKAA2; protein kinase AMP-activated catalytic subunit alpha 2 [KO:K07198] [EC:2.7.11.31]", "5564  PRKAB1; protein kinase AMP-activated non-catalytic subunit beta 1 [KO:K07199]", "5565  PRKAB2; protein kinase AMP-activated non-catalytic subunit beta 2 [KO:K07199]", "5571  PRKAG1; protein kinase AMP-activated non-catalytic subunit gamma 1 [KO:K07200]", "53632  PRKAG3; protein kinase AMP-activated non-catalytic subunit gamma 3 [KO:K07200]", "51422  PRKAG2; protein kinase AMP-activated non-catalytic subunit gamma 2 [KO:K07200]", "32  ACACB; acetyl-CoA carboxylase beta [KO:K01946] [EC:6.4.1.2 6.3.4.14 2.1.3.15]", "1374  CPT1A; carnitine palmitoyltransferase 1A [KO:K08765] [EC:2.3.1.21]", "1375  CPT1B; carnitine palmitoyltransferase 1B [KO:K19523] [EC:2.3.1.21]", "126129  CPT1C; carnitine palmitoyltransferase 1C [KO:K19524] [EC:2.3.1.21]", "6513  SLC2A1; solute carrier family 2 member 1 [KO:K07299]", "6517  SLC2A4; solute carrier family 2 member 4 [KO:K07191]"], "compound": ["C00040  Acyl-CoA", "C00076  Calcium cation", "C00083  Malonyl-CoA", "C00162  Fatty acid", "C00165  Diacylglycerol", "C00195  N-Acylsphingosine", "C00638  Long-chain fatty acid", "C15493  9-cis-Retinoic acid"], "refs": [{"pmid": "15733744", "authors": "  Gual P, Le Marchand-Brustel Y, Tanti JF.", "title": "Positive and negative regulation of insulin signaling through IRS-1 phosphorylation.", "journal": "Biochimie 87:99-109 (2005)", "doi": "10.1016/j.biochi.2004.10.019"}, {"pmid": "12829246", "authors": "  Hardie DG, Scott JW, Pan DA, Hudson ER.", "title": "Management of cellular energy by the AMP-activated protein kinase system.", "journal": "FEBS Lett 546:113-20 (2003)", "doi": "10.1016/S0014-5793(03)00560-X"}, {"pmid": "15980064", "authors": "  Hurley RL, Anderson KA, Franzone JM, Kemp BE, Means AR, Witters LA.", "title": "The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases.", "journal": "J Biol Chem 280:29060-6 (2005)", "doi": "10.1074/jbc.M503824200"}, {"pmid": "10766253", "authors": "  Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG.", "title": "Central nervous system control of food intake.", "journal": "Nature 404:661-71 (2000)", "doi": "10.1038/35007534"}, {"pmid": "15856064", "authors": "  Munzberg H, Myers MG Jr.", "title": "Molecular and anatomical determinants of central leptin resistance.", "journal": "Nat Neurosci 8:566-70 (2005)", "doi": "10.1038/nn1454"}, {"pmid": "12754525", "authors": "  Puigserver P, Rhee J, Donovan J, Walkey CJ, Yoon JC, Oriente F, Kitamura Y, Altomonte J, Dong H, Accili D, Spiegelman BM.", "title": "Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction.", "journal": "Nature 423:550-5 (2003)", "doi": "10.1038/nature01667"}, {"pmid": "11557972", "authors": "  Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J, Adelmant G, Stafford J, Kahn CR, Granner DK, Newgard CB, Spiegelman BM.", "title": "Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1.", "journal": "Nature 413:131-8 (2001)", "doi": "10.1038/35093050"}, {"pmid": "14716305", "authors": "  Inoue H, Ogawa W, Ozaki M, Haga S, Matsumoto M, Furukawa K, Hashimoto N, Kido Y, Mori T, Sakaue H, Teshigawara K, Jin S, Iguchi H, Hiramatsu R, LeRoith D, Takeda K, Akira S, Kasuga M.", "title": "Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo.", "journal": "Nat Med 10:168-74 (2004)", "doi": "10.1038/nm980"}, {"pmid": "9671776", "authors": "  Zhou YT, Shimabukuro M, Wang MY, Lee Y, Higa M, Milburn JL, Newgard CB, Unger RH.", "title": "Role of peroxisome proliferator-activated receptor alpha in disease of pancreatic beta cells.", "journal": "Proc Natl Acad Sci U S A 95:8898-903 (1998)", "doi": "10.1073/pnas.95.15.8898"}, {"pmid": "10905472", "authors": "  Kelley DE, Mandarino LJ.", "title": "Fuel selection in human skeletal muscle in insulin resistance: a reexamination.", "journal": "Diabetes 49:677-83 (2000)", "doi": "10.2337/diabetes.49.5.677"}, {"pmid": "12368907", "authors": "  Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T.", "title": "Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.", "journal": "Nat Med 8:1288-95 (2002)", "doi": "10.1038/nm788"}, {"pmid": "11479627", "authors": "  Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T.", "title": "The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity.", "journal": "Nat Med 7:941-6 (2001)", "doi": "10.1038/90984"}, {"pmid": "15058305", "authors": "  Minokoshi Y, Alquier T, Furukawa N, Kim YB, Lee A, Xue B, Mu J, Foufelle F, Ferre P, Birnbaum MJ, Stuck BJ, Kahn BB.", "title": "AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus.", "journal": "Nature 428:569-74 (2004)", "doi": "10.1038/nature02440"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04910  Insulin signaling pathway"], "ko_pathway": "ko04920", "genes": ["AKT2", "AKT1", "CD36"]}, {"kegg_id": "hsa04922", "name": "Glucagon signaling pathway - Homo sapiens (human)", "description": "Glucagon is conventionally regarded as a counterregulatory hormone for insulin and plays a critical anti-hypoglycemic role by maintaining glucose homeostasis in both animals and humans. To increase blood glucose, glucagon promotes hepatic glucose output by increasing glycogenolysis and gluconeogenesis and by decreasing glycogenesis and glycolysis in a concerted fashion via multiple mechanisms. Glucagon also stimulates hepatic mitochondrial beta-oxidation to supply energy for glucose production. Glucagon performs its main effect via activation of adenylate cyclase. The adenylate-cyclase-derived cAMP activates protein kinase A (PKA), which then phosphorylates downstream targets, such as cAMP response element binding protein (CREB) and the bifunctional enzyme 6-phosphofructo-2-kinase/ fructose-2,6-bisphosphatase (one of the isoforms being PFK/FBPase 1, encoded by PFKFB1).", "class": "Organismal Systems; Endocrine system", "pathway_map": "hsa04922  Glucagon signaling pathway", "drug": ["D00116  Glucagon (genetical recombination) (JP18)", "D01238  Bucladesine sodium (JAN)", "D01274  Tesaglitazar (JAN/USAN/INN)", "D01896  Cilostazol (JP18/USP/INN)", "D02118  Glucagon hydrochloride", "D04537  Ingliforib (USAN/INN)", "D05091  Muraglitazar (USAN/INN)", "D06102  Theofibrate (USAN)", "D07546  Bucladesine (INN)", "D08845  Aleglitazar (USAN)", "D08949  Naveglitazar (USAN/INN)", "D09350  Indeglitazar (USAN)", "D11230  Crotedumab (USAN/INN)", "D11359  Dasiglucagon (USAN)", "D11614  Volagidemab (USAN/INN)", "D11640  Firsocostat (USAN/INN)", "D11902  Clesacostat (USAN)", "D11903  Clesacostat tromethamine (USAN)", "D12225  Mazdutide (USAN)", "D12314  Dasiglucagon hydrochloride", "D12430  Retatrutide (USAN)", "D12484  Carfloglitazar (INN)", "D12861  Pemvidutide (USAN/INN)", "D12898  Survodutide (USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "5140  PDE3B; phosphodiesterase 3B [KO:K13296] [EC:3.1.4.17]", "2641  GCG; glucagon [KO:K05259]", "2642  GCGR; glucagon receptor [KO:K04583]", "2778  GNAS; GNAS complex locus [KO:K04632]", "108  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]", "1386  ATF2; activating transcription factor 2 [KO:K04450]", "468  ATF4; activating transcription factor 4 [KO:K04374]", "10488  CREB3; cAMP responsive element binding protein 3 [KO:K09048]", "90993  CREB3L1; cAMP responsive element binding protein 3 like 1 [KO:K09048]", "64764  CREB3L2; cAMP responsive element binding protein 3 like 2 [KO:K09048]", "84699  CREB3L3; cAMP responsive element binding protein 3 like 3 [KO:K09048]", "148327  CREB3L4; cAMP responsive element binding protein 3 like 4 [KO:K09048]", "9586  CREB5; cAMP responsive element binding protein 5 [KO:K09047]", "55671  PPP4R3A; protein phosphatase 4 regulatory subunit 3A [KO:K17491]", "57223  PPP4R3B; protein phosphatase 4 regulatory subunit 3B [KO:K17491]", "139420  PPP4R3C; protein phosphatase 4 regulatory subunit 3C [KO:K17491]", "5531  PPP4C; protein phosphatase 4 catalytic subunit [KO:K15423] [EC:3.1.3.16]", "200186  CRTC2; CREB regulated transcription coactivator 2 [KO:K16333]", "23235  SIK2; salt inducible kinase 2 [KO:K16311] [EC:2.7.11.1]", "1387  CREBBP; CREB binding protein [KO:K04498] [EC:2.3.1.48]", "2033  EP300; E1A binding protein p300 [KO:K04498] [EC:2.3.1.48]", "10891  PPARGC1A; PPARG coactivator 1 alpha [KO:K07202]", "102724428  SIK; salt inducible kinase 1B (putative) [KO:K19008] [EC:2.7.11.1]", "150094  SIK1; salt inducible kinase 1 [KO:K19008] [EC:2.7.11.1]", "2776  GNAQ; G protein subunit alpha q [KO:K04634]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "5530  PPP3CA; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]", "5532  PPP3CB; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]", "5533  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]", "5534  PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]", "5535  PPP3R2; protein phosphatase 3 regulatory subunit B, beta [KO:K06268]", "815  CAMK2A; calcium/calmodulin dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]", "817  CAMK2D; calcium/calmodulin dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]", "816  CAMK2B; calcium/calmodulin dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]", "818  CAMK2G; calcium/calmodulin dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]", "2308  FOXO1; forkhead box O1 [KO:K07201]", "23411  SIRT1; sirtuin 1 [KO:K11411] [EC:2.3.1.286]", "5465  PPARA; peroxisome proliferator activated receptor alpha [KO:K07294]", "3276  PRMT1; protein arginine methyltransferase 1 [KO:K11434] [EC:2.1.1.319]", "2538  G6PC1; glucose-6-phosphatase catalytic subunit 1 [KO:K01084] [EC:3.1.3.9]", "57818  G6PC2; glucose-6-phosphatase catalytic subunit 2 [KO:K01084] [EC:3.1.3.9]", "92579  G6PC3; glucose-6-phosphatase catalytic subunit 3 [KO:K01084] [EC:3.1.3.9]", "5105  PCK1; phosphoenolpyruvate carboxykinase 1 [KO:K01596] [EC:4.1.1.32]", "5106  PCK2; phosphoenolpyruvate carboxykinase 2, mitochondrial [KO:K01596] [EC:4.1.1.32]", "1374  CPT1A; carnitine palmitoyltransferase 1A [KO:K08765] [EC:2.3.1.21]", "1375  CPT1B; carnitine palmitoyltransferase 1B [KO:K19523] [EC:2.3.1.21]", "126129  CPT1C; carnitine palmitoyltransferase 1C [KO:K19524] [EC:2.3.1.21]", "2998  GYS2; glycogen synthase 2 [KO:K00693] [EC:2.4.1.11]", "2997  GYS1; glycogen synthase 1 [KO:K00693] [EC:2.4.1.11]", "5257  PHKB; phosphorylase kinase regulatory subunit beta [KO:K07190]", "5256  PHKA2; phosphorylase kinase regulatory subunit alpha 2 [KO:K07190]", "5255  PHKA1; phosphorylase kinase regulatory subunit alpha 1 [KO:K07190]", "5260  PHKG1; phosphorylase kinase catalytic subunit gamma 1 [KO:K00871] [EC:2.7.11.19]", "5261  PHKG2; phosphorylase kinase catalytic subunit gamma 2 [KO:K00871] [EC:2.7.11.19]", "810  CALML3; calmodulin like 3 [KO:K02183]", "805  CALM2; calmodulin 2 [KO:K02183]", "808  CALM3; calmodulin 3 [KO:K02183]", "801  CALM1; calmodulin 1 [KO:K02183]", "163688  CALML6; calmodulin like 6 [KO:K02183]", "51806  CALML5; calmodulin like 5 [KO:K02183]", "91860  CALML4; calmodulin like 4 [KO:K02183]", "5836  PYGL; glycogen phosphorylase L [KO:K00688] [EC:2.4.1.1]", "5837  PYGM; glycogen phosphorylase, muscle associated [KO:K00688] [EC:2.4.1.1]", "5834  PYGB; glycogen phosphorylase B [KO:K00688] [EC:2.4.1.1]", "5207  PFKFB1; 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 [KO:K19028] [EC:2.7.1.105 3.1.3.46]", "5562  PRKAA1; protein kinase AMP-activated catalytic subunit alpha 1 [KO:K07198] [EC:2.7.11.31]", "5563  PRKAA2; protein kinase AMP-activated catalytic subunit alpha 2 [KO:K07198] [EC:2.7.11.31]", "5564  PRKAB1; protein kinase AMP-activated non-catalytic subunit beta 1 [KO:K07199]", "5565  PRKAB2; protein kinase AMP-activated non-catalytic subunit beta 2 [KO:K07199]", "5571  PRKAG1; protein kinase AMP-activated non-catalytic subunit gamma 1 [KO:K07200]", "53632  PRKAG3; protein kinase AMP-activated non-catalytic subunit gamma 3 [KO:K07200]", "51422  PRKAG2; protein kinase AMP-activated non-catalytic subunit gamma 2 [KO:K07200]", "31  ACACA; acetyl-CoA carboxylase alpha [KO:K11262] [EC:6.4.1.2 6.3.4.14 2.1.3.15]", "32  ACACB; acetyl-CoA carboxylase beta [KO:K01946] [EC:6.4.1.2 6.3.4.14 2.1.3.15]", "6513  SLC2A1; solute carrier family 2 member 1 [KO:K07299]", "6514  SLC2A2; solute carrier family 2 member 2 [KO:K07593]", "2645  GCK; glucokinase [KO:K12407] [EC:2.7.1.2]", "2203  FBP1; fructose-bisphosphatase 1 [KO:K03841] [EC:3.1.3.11]", "8789  FBP2; fructose-bisphosphatase 2 [KO:K03841] [EC:3.1.3.11]", "5213  PFKM; phosphofructokinase, muscle [KO:K00850] [EC:2.7.1.11]", "5214  PFKP; phosphofructokinase, platelet [KO:K00850] [EC:2.7.1.11]", "5211  PFKL; phosphofructokinase, liver type [KO:K00850] [EC:2.7.1.11]", "5223  PGAM1; phosphoglycerate mutase 1 [KO:K01834] [EC:5.4.2.11]", "5224  PGAM2; phosphoglycerate mutase 2 [KO:K01834] [EC:5.4.2.11]", "441531  PGAM4; phosphoglycerate mutase family member 4 [KO:K01834] [EC:5.4.2.11]", "5315  PKM; pyruvate kinase M1/2 [KO:K00873] [EC:2.7.1.40]", "5161  PDHA2; pyruvate dehydrogenase E1 subunit alpha 2 [KO:K00161] [EC:1.2.4.1]", "5160  PDHA1; pyruvate dehydrogenase E1 subunit alpha 1 [KO:K00161] [EC:1.2.4.1]", "5162  PDHB; pyruvate dehydrogenase E1 subunit beta [KO:K00162] [EC:1.2.4.1]", "160287  LDHAL6A; lactate dehydrogenase A like 6A [KO:K00016] [EC:1.1.1.27]", "92483  LDHAL6B; lactate dehydrogenase A like 6B [KO:K00016] [EC:1.1.1.27]", "3939  LDHA; lactate dehydrogenase A [KO:K00016] [EC:1.1.1.27]", "3945  LDHB; lactate dehydrogenase B [KO:K00016] [EC:1.1.1.27]", "3948  LDHC; lactate dehydrogenase C [KO:K00016] [EC:1.1.1.27]"], "compound": ["C00022  Pyruvate", "C00024  Acetyl-CoA", "C00026  2-Oxoglutarate", "C00031  D-Glucose", "C00036  Oxaloacetate", "C00040  Acyl-CoA", "C00042  Succinate", "C00074  Phosphoenolpyruvate", "C00076  Calcium cation", "C00083  Malonyl-CoA", "C00085  D-Fructose 6-phosphate", "C00103  D-Glucose 1-phosphate", "C00122  Fumarate", "C00149  (S)-Malate", "C00158  Citrate", "C00182  Glycogen", "C00186  (S)-Lactate", "C00197  3-Phospho-D-glycerate", "C00311  Isocitrate", "C00354  D-Fructose 1,6-bisphosphate", "C00575  3',5'-Cyclic AMP", "C00631  2-Phospho-D-glycerate", "C00665  beta-D-Fructose 2,6-bisphosphate", "C00668  alpha-D-Glucose 6-phosphate", "C01172  beta-D-Glucose 6-phosphate", "C01245  D-myo-Inositol 1,4,5-trisphosphate"], "refs": [{"pmid": "12626323", "authors": "  Jiang G, Zhang BB", "title": "Glucagon and regulation of glucose metabolism.", "journal": "Am J Physiol Endocrinol Metab 284:E671-8 (2003)", "doi": "10.1152/ajpendo.00492.2002"}, {"pmid": "24692138", "authors": "  Rui L", "title": "Energy metabolism in the liver.", "journal": "Compr Physiol 4:177-97 (2014)", "doi": "10.1002/cphy.c130024"}, {"pmid": "22004992", "authors": "  Jitrapakdee S", "title": "Transcription factors and coactivators controlling nutrient and hormonal regulation of hepatic gluconeogenesis.", "journal": "Int J Biochem Cell Biol 44:33-45 (2012)", "doi": "10.1016/j.biocel.2011.10.001"}, {"pmid": "16601267", "authors": "  Desvergne B, Michalik L, Wahli W.", "title": "Transcriptional regulation of metabolism.", "journal": "Physiol Rev 86:465-514 (2006)", "doi": "10.1152/physrev.00025.2005"}, {"pmid": "22550228", "authors": "  Hardie DG", "title": "Organismal carbohydrate and lipid homeostasis.", "journal": "Cold Spring Harb Perspect Biol 4:a006031 (2012)", "doi": "10.1101/cshperspect.a006031"}, {"pmid": "22796337", "authors": "  Hasenour CM, Berglund ED, Wasserman DH", "title": "Emerging role of AMP-activated protein kinase in endocrine control of metabolism in the liver.", "journal": "Mol Cell Endocrinol 366:152-62 (2013)", "doi": "10.1016/j.mce.2012.06.018"}, {"pmid": "18669612", "authors": "  Quesada I, Tuduri E, Ripoll C, Nadal A", "title": "Physiology of the pancreatic alpha-cell and glucagon secretion: role in glucose homeostasis and diabetes.", "journal": "J Endocrinol 199:5-19 (2008)", "doi": "10.1677/JOE-08-0290"}, {"pmid": "24238363", "authors": "  Oh KJ, Han HS, Kim MJ, Koo SH", "title": "CREB and FoxO1: two transcription factors for the regulation of hepatic gluconeogenesis.", "journal": "BMB Rep 46:567-74 (2013)", "doi": "10.5483/BMBRep.2013.46.12.248"}, {"pmid": "16479585", "authors": "  Cheng A, Saltiel AR", "title": "More TORC for the gluconeogenic engine.", "journal": "Bioessays 28:231-4 (2006)", "doi": "10.1002/bies.20375"}, {"pmid": "21346730", "authors": "  Altarejos JY, Montminy M", "title": "CREB and the CRTC co-activators: sensors for hormonal and metabolic signals.", "journal": "Nat Rev Mol Cell Biol 12:141-51 (2011)", "doi": "10.1038/nrm3072"}, {"pmid": "24393785", "authors": "  Pernicova I, Korbonits M", "title": "Metformin--mode of action and clinical implications for diabetes and cancer.", "journal": "Nat Rev Endocrinol 10:143-56 (2014)", "doi": "10.1038/nrendo.2013.256"}, {"pmid": "20735177", "authors": "  Hirota K, Fukamizu A", "title": "Transcriptional regulation of energy metabolism in the liver.", "journal": "J Recept Signal Transduct Res 30:403-9 (2010)", "doi": "10.3109/10799893.2010.509730"}, {"pmid": "21941300", "authors": "  Chalkiadaki A, Guarente L", "title": "Metabolic signals regulate SIRT1 expression.", "journal": "EMBO Rep 12:985-6 (2011)", "doi": "10.1038/embor.2011.179"}, {"pmid": "22249520", "authors": "  Chalkiadaki A, Guarente L", "title": "Sirtuins mediate mammalian metabolic responses to nutrient availability.", "journal": "Nat Rev Endocrinol 8:287-96 (2012)", "doi": "10.1038/nrendo.2011.225"}, {"pmid": "19912989", "authors": "  Tang BL, Chua CE", "title": "Is systemic activation of Sirt1 beneficial for ageing-associated metabolic disorders?", "journal": "Biochem Biophys Res Commun 391:6-10 (2010)", "doi": "10.1016/j.bbrc.2009.11.016"}, {"pmid": "22503562", "authors": "  Ozcan L, Wong CC, Li G, Xu T, Pajvani U, Park SK, Wronska A, Chen BX, Marks AR, Fukamizu A, Backs J, Singer HA, Yates JR 3rd, Accili D, Tabas I", "title": "Calcium signaling through CaMKII regulates hepatic glucose production in fasting and obesity.", "journal": "Cell Metab 15:739-51 (2012)", "doi": "10.1016/j.cmet.2012.03.002"}], "rel_pathway": ["hsa00010  Glycolysis / Gluconeogenesis", "hsa00020  Citrate cycle (TCA cycle)", "hsa00061  Fatty acid biosynthesis", "hsa00190  Oxidative phosphorylation", "hsa04020  Calcium signaling pathway", "hsa04024  cAMP signaling pathway", "hsa04068  FoxO signaling pathway", "hsa04910  Insulin signaling pathway"], "ko_pathway": "ko04922", "genes": ["AKT2", "AKT1"]}, {"kegg_id": "hsa04923", "name": "Regulation of lipolysis in adipocytes - Homo sapiens (human)", "description": "Lipolysis in adipocytes, the hydrolysis of triacylglycerol (TAG) to release fatty acids (FAs) and glycerol for use by other organs as energy substrates, is a unique function of white adipose tissue. Lipolysis is under tight hormonal control. During fasting, catecholamines, by binding to Gs-coupled-adrenergic receptors (-AR), activate adenylate cyclase (AC) to increase cAMP and activate protein kinase A (PKA). PKA phosphorylates target protein such as hormone-sensitive lipase (HSL) and perilipin 1 (PLIN). PLIN phosphorylation is a key event in the sequential activation of TAG hydrolysis involving adipose triglyceride lipase (ATGL), HSL, and monoglyceride lipase (MGL). During the fed state, insulin, through activation of phosphodiesterase-3B (PDE-3B), inhibits catecholamine-induced lipolysis via the degradation of cAMP.", "class": "Organismal Systems; Endocrine system", "pathway_map": "hsa04923  Regulation of lipolysis in adipocytes", "network": ["", "ELEMENT   N01708  INS-AKT signaling pathway"], "drug": ["D01238  Bucladesine sodium (JAN)", "D02702  Talibegron hydrochloride (USAN)", "D07546  Bucladesine (INN)", "D12769  Nisotirostide (USAN)"], "dblinks": "GO: 0016042", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["7252  TSHB; thyroid stimulating hormone subunit beta [KO:K05251]", "1081  CGA; glycoprotein hormones, alpha polypeptide [KO:K08522]", "7253  TSHR; thyroid stimulating hormone receptor [KO:K04249]", "153  ADRB1; adrenoceptor beta 1 [KO:K04141]", "154  ADRB2; adrenoceptor beta 2 [KO:K04142]", "155  ADRB3; adrenoceptor beta 3 [KO:K04143]", "2778  GNAS; GNAS complex locus [KO:K04632]", "107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]", "108  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]", "109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]", "196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]", "113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]", "114  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]", "115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "4878  NPPA; natriuretic peptide A [KO:K12334]", "4881  NPR1; natriuretic peptide receptor 1 [KO:K12323] [EC:4.6.1.2]", "5592  PRKG1; protein kinase cGMP-dependent 1 [KO:K07376] [EC:2.7.11.12]", "5593  PRKG2; protein kinase cGMP-dependent 2 [KO:K19477] [EC:2.7.11.12]", "5346  PLIN1; perilipin 1 [KO:K08768]", "63924  CIDEC; cell death inducing DFFA like effector c [KO:K25878]", "3991  LIPE; lipase E, hormone sensitive type [KO:K07188] [EC:3.1.1.79]", "57104  PNPLA2; patatin like phospholipase domain containing 2 [KO:K16816] [EC:3.1.1.3]", "51099  ABHD5; abhydrolase domain containing 5, lysophosphatidic acid acyltransferase [KO:K13699] [EC:2.3.1.51]", "11343  MGLL; monoglyceride lipase [KO:K01054] [EC:3.1.1.23]", "2167  FABP4; fatty acid binding protein 4 [KO:K08753]", "364  AQP7; aquaporin 7 [KO:K08771]", "100509620  AQP7B; aquaporin 7B [KO:K08771]", "3630  INS; insulin [KO:K04526]", "3643  INSR; insulin receptor [KO:K04527] [EC:2.7.10.1]", "3667  IRS1; insulin receptor substrate 1 [KO:K16172]", "8660  IRS2; insulin receptor substrate 2 [KO:K07187]", "8471  IRS4; insulin receptor substrate 4 [KO:K17446]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "5140  PDE3B; phosphodiesterase 3B [KO:K13296] [EC:3.1.4.17]", "11145  PLAAT3; phospholipase A and acyltransferase 3 [KO:K16817] [EC:3.1.1.32 3.1.1.4]", "54979  PLAAT2; phospholipase A and acyltransferase 2 [KO:K16817] [EC:3.1.1.32 3.1.1.4]", "5742  PTGS1; prostaglandin-endoperoxide synthase 1 [KO:K00509] [EC:1.14.99.1]", "5743  PTGS2; prostaglandin-endoperoxide synthase 2 [KO:K11987] [EC:1.14.99.1]", "134  ADORA1; adenosine A1 receptor [KO:K04265]", "5733  PTGER3; prostaglandin E receptor 3 [KO:K04260]", "4852  NPY; neuropeptide Y [KO:K05232]", "4886  NPY1R; neuropeptide Y receptor Y1 [KO:K04204]", "2770  GNAI1; G protein subunit alpha i1 [KO:K04630]", "2773  GNAI3; G protein subunit alpha i3 [KO:K04630]", "2771  GNAI2; G protein subunit alpha i2 [KO:K04630]"], "compound": ["C00020  AMP", "C00116  Glycerol", "C00162  Fatty acid", "C00165  Diacylglycerol", "C00212  Adenosine", "C00219  Arachidonate", "C00422  Triacylglycerol", "C00547  L-Noradrenaline", "C00575  3',5'-Cyclic AMP", "C00584  Prostaglandin E2", "C00788  L-Adrenaline", "C00942  3',5'-Cyclic GMP", "C01885  1-Acylglycerol", "C02140  Corticosterone"], "refs": [{"pmid": "20025992", "authors": "  Ahmadian M, Wang Y, Sul HS", "title": "Lipolysis in adipocytes.", "journal": "Int J Biochem Cell Biol 42:555-9 (2010)", "doi": "10.1016/j.biocel.2009.12.009"}, {"pmid": "19796963", "authors": "  Ahmadian M, Duncan RE, Sul HS", "title": "The skinny on fat: lipolysis and fatty acid utilization in adipocytes.", "journal": "Trends Endocrinol Metab 20:424-8 (2009)", "doi": "10.1016/j.tem.2009.06.002"}, {"pmid": "18762440", "authors": "  Wang S, Soni KG, Semache M, Casavant S, Fortier M, Pan L, Mitchell GA", "title": "Lipolysis and the integrated physiology of lipid energy metabolism.", "journal": "Mol Genet Metab 95:117-26 (2008)", "doi": "10.1016/j.ymgme.2008.06.012"}, {"pmid": "21900692", "authors": "  Lafontan M", "title": "Historical perspectives in fat cell biology: the fat cell as a model for the investigation of hormonal and metabolic pathways.", "journal": "Am J Physiol Cell Physiol 302:C327-59 (2012)", "doi": "10.1152/ajpcell.00168.2011"}, {"pmid": "24872083", "authors": "  Fruhbeck G, Mendez-Gimenez L, Fernandez-Formoso JA, Fernandez S, Rodriguez A", "title": "Regulation of adipocyte lipolysis.", "journal": "Nutr Res Rev 27:63-93 (2014)", "doi": "10.1017/S095442241400002X"}, {"pmid": "24676492", "authors": "  Proenca AR, Sertie RA, Oliveira AC, Campana AB, Caminhotto RO, Chimin P, Lima FB", "title": "New concepts in white adipose tissue physiology.", "journal": "Braz J Med Biol Res 47:192-205 (2014)", "doi": "10.1590/1414-431X20132911"}, {"pmid": "17313320", "authors": "  Duncan RE, Ahmadian M, Jaworski K, Sarkadi-Nagy E, Sul HS", "title": "Regulation of lipolysis in adipocytes.", "journal": "Annu Rev Nutr 27:79-101 (2007)", "doi": "10.1146/annurev.nutr.27.061406.093734"}, {"pmid": "19136990", "authors": "  Lafontan M", "title": "Advances in adipose tissue metabolism.", "journal": "Int J Obes (Lond) 32 Suppl 7:S39-51 (2008)", "doi": "10.1038/ijo.2008.237"}, {"pmid": "17218471", "authors": "  Jaworski K, Sarkadi-Nagy E, Duncan RE, Ahmadian M, Sul HS", "title": "Regulation of triglyceride metabolism. IV. Hormonal regulation of lipolysis in adipose tissue.", "journal": "Am J Physiol Gastrointest Liver Physiol 293:G1-4 (2007)", "doi": "10.1152/ajpgi.00554.2006"}, {"pmid": "22298655", "authors": "  Thompson D, Karpe F, Lafontan M, Frayn K", "title": "Physical activity and exercise in the regulation of human adipose tissue physiology.", "journal": "Physiol Rev 92:157-91 (2012)", "doi": "10.1152/physrev.00012.2011"}, {"pmid": "19464318", "authors": "  Lafontan M, Langin D", "title": "Lipolysis and lipid mobilization in human adipose tissue.", "journal": "Prog Lipid Res 48:275-97 (2009)", "doi": "10.1016/j.plipres.2009.05.001"}, {"pmid": "24731595", "authors": "  Arner P, Langin D", "title": "Lipolysis in lipid turnover, cancer cachexia, and obesity-induced insulin resistance.", "journal": "Trends Endocrinol Metab 25:255-62 (2014)", "doi": "10.1016/j.tem.2014.03.002"}, {"pmid": "17878492", "authors": "  Brasaemle DL", "title": "Thematic review series: adipocyte biology. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis.", "journal": "J Lipid Res 48:2547-59 (2007)", "doi": "10.1194/jlr.R700014-JLR200"}, {"pmid": "21241784", "authors": "  Lampidonis AD, Rogdakis E, Voutsinas GE, Stravopodis DJ", "title": "The resurgence of Hormone-Sensitive Lipase (HSL) in mammalian lipolysis.", "journal": "Gene 477:1-11 (2011)", "doi": "10.1016/j.gene.2011.01.007"}, {"pmid": "19375517", "authors": "  Bickel PE, Tansey JT, Welte MA", "title": "PAT proteins, an ancient family of lipid droplet proteins that regulate cellular lipid stores.", "journal": "Biochim Biophys Acta 1791:419-40 (2009)", "doi": "10.1016/j.bbalip.2009.04.002"}], "rel_pathway": ["hsa00561  Glycerolipid metabolism", "hsa00590  Arachidonic acid metabolism", "hsa04022  cGMP-PKG signaling pathway", "hsa04024  cAMP signaling pathway", "hsa04910  Insulin signaling pathway"], "ko_pathway": "ko04923", "genes": ["AKT2", "AKT1"]}, {"kegg_id": "hsa04929", "name": "GnRH secretion - Homo sapiens (human)", "description": "Hypothalamic gonadotropin-releasing hormone (GnRH) neurons are key regulators of reproduction. They release GnRH into the portal circulation. In turn, GnRH stimulates the pituitary gland to secrete follicle-stimulating hormone and luteinizing hormone (LH) to regulate gonadal functions. Gonadal steroids provide feedback to regulate GnRH release. GnRH neurons express the kisspeptin receptor, GPR 54, and kisspeptins potently stimulate the release of GnRH by depolarising and inducing sustained action potential firing in GnRH neurons. It is also demonstrated that Kisspeptin-GPR54 system positively regulates the GnRH expression  with a time course consistent with activation of Akt and MAP kinase signaling pathways.", "class": "Organismal Systems; Endocrine system", "pathway_map": "hsa04929  GnRH secretion", "network": ["", "ELEMENT   N00869  KISS1-KISS1R-PLCB-PKC signaling pathway"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["3814  KISS1; KiSS-1 metastasis suppressor [KO:K23140]", "84634  KISS1R; KISS1 receptor [KO:K08374]", "2776  GNAQ; G protein subunit alpha q [KO:K04634]", "2767  GNA11; G protein subunit alpha 11 [KO:K04635]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "348980  HCN1; hyperpolarization activated cyclic nucleotide gated potassium channel 1 [KO:K04954]", "610  HCN2; hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2 [KO:K04955]", "57657  HCN3; hyperpolarization activated cyclic nucleotide gated potassium channel 3 [KO:K04956]", "8913  CACNA1G; calcium voltage-gated channel subunit alpha1 G [KO:K04854]", "8912  CACNA1H; calcium voltage-gated channel subunit alpha1 H [KO:K04855]", "8911  CACNA1I; calcium voltage-gated channel subunit alpha1 I [KO:K04856]", "7220  TRPC1; transient receptor potential cation channel subfamily C member 1 [KO:K04964]", "7223  TRPC4; transient receptor potential cation channel subfamily C member 4 [KO:K04967]", "7224  TRPC5; transient receptor potential cation channel subfamily C member 5 [KO:K04968]", "3767  KCNJ11; potassium inwardly rectifying channel subfamily J member 11 [KO:K05004]", "3760  KCNJ3; potassium inwardly rectifying channel subfamily J member 3 [KO:K04997]", "3763  KCNJ6; potassium inwardly rectifying channel subfamily J member 6 [KO:K05000]", "3765  KCNJ9; potassium inwardly rectifying channel subfamily J member 9 [KO:K05002]", "3762  KCNJ5; potassium inwardly rectifying channel subfamily J member 5 [KO:K04999]", "2550  GABBR1; gamma-aminobutyric acid type B receptor subunit 1 [KO:K04615]", "9568  GABBR2; gamma-aminobutyric acid type B receptor subunit 2 [KO:K04615]", "3780  KCNN1; potassium calcium-activated channel subfamily N member 1 [KO:K04942]", "3781  KCNN2; potassium calcium-activated channel subfamily N member 2 [KO:K04943]", "3782  KCNN3; potassium calcium-activated channel subfamily N member 3 [KO:K04944]", "3783  KCNN4; potassium calcium-activated channel subfamily N member 4 [KO:K04945]", "779  CACNA1S; calcium voltage-gated channel subunit alpha1 S [KO:K04857]", "775  CACNA1C; calcium voltage-gated channel subunit alpha1 C [KO:K04850]", "776  CACNA1D; calcium voltage-gated channel subunit alpha1 D [KO:K04851]", "778  CACNA1F; calcium voltage-gated channel subunit alpha1 F [KO:K04853]", "408  ARRB1; arrestin beta 1 [KO:K04439]", "409  ARRB2; arrestin beta 2 [KO:K04439]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "2796  GNRH1; gonadotropin releasing hormone 1 [KO:K05252]", "2797  GNRH2; gonadotropin releasing hormone 2 [KO:K05252]", "2100  ESR2; estrogen receptor 2 [KO:K08551]", "2852  GPER1; G protein-coupled estrogen receptor 1 [KO:K04246]", "3972  LHB; luteinizing hormone subunit beta [KO:K08521]", "6696  SPP1; secreted phosphoprotein 1 [KO:K06250]", "1081  CGA; glycoprotein hormones, alpha polypeptide [KO:K08522]"], "compound": ["C00076  Calcium cation", "C00165  Diacylglycerol", "C00238  Potassium cation", "C00334  4-Aminobutanoate", "C00535  Testosterone", "C00951  Estradiol-17beta", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C01330  Sodium cation", "C04637  1-Phosphatidyl-D-myo-inositol 4,5-bisphosphate"], "refs": [{"pmid": "23550004", "authors": "  Ronnekleiv OK, Kelly MJ", "title": "Kisspeptin excitation of GnRH neurons.", "journal": "Adv Exp Med Biol 784:113-31 (2013)", "doi": "10.1007/978-1-4614-6199-9_6"}, {"pmid": "24145132", "authors": "  Beltramo M, Dardente H, Cayla X, Caraty A", "title": "Cellular mechanisms and integrative timing of neuroendocrine control of GnRH secretion by kisspeptin.", "journal": "Mol Cell Endocrinol 382:387-399 (2014)", "doi": "10.1016/j.mce.2013.10.015"}, {"pmid": "19770291", "authors": "  Oakley AE, Clifton DK, Steiner RA", "title": "Kisspeptin signaling in the brain.", "journal": "Endocr Rev 30:713-43 (2009)", "doi": "10.1210/er.2009-0005"}, {"pmid": "22811428", "authors": "  Pinilla L, Aguilar E, Dieguez C, Millar RP, Tena-Sempere M", "title": "Kisspeptins and reproduction: physiological roles and regulatory mechanisms.", "journal": "Physiol Rev 92:1235-316 (2012)", "doi": "10.1152/physrev.00037.2010"}, {"pmid": "20699467", "authors": "  d'Anglemont de Tassigny X, Colledge WH", "title": "The role of kisspeptin signaling in reproduction.", "journal": "Physiology (Bethesda) 25:207-17 (2010)", "doi": "10.1152/physiol.00009.2010"}, {"pmid": "19464345", "authors": "  Tena-Sempere M", "title": "Kisspeptin signaling in the brain: recent developments and future challenges.", "journal": "Mol Cell Endocrinol 314:164-9 (2010)", "doi": "10.1016/j.mce.2009.05.004"}, {"pmid": "19097915", "authors": "  Colledge WH", "title": "Kisspeptins and GnRH neuronal signalling.", "journal": "Trends Endocrinol Metab 20:115-21 (2009)", "doi": "10.1016/j.tem.2008.10.005"}, {"pmid": "18793689", "authors": "  Roa J, Castellano JM, Navarro VM, Handelsman DJ, Pinilla L, Tena-Sempere M", "title": "Kisspeptins and the control of gonadotropin secretion in male and female rodents.", "journal": "Peptides 30:57-66 (2009)", "doi": "10.1016/j.peptides.2008.08.009"}, {"pmid": "24907402", "authors": "  Piet R, de Croft S, Liu X, Herbison AE", "title": "Electrical properties of kisspeptin neurons and their regulation of GnRH neurons.", "journal": "Front Neuroendocrinol 36:15-27 (2015)", "doi": "10.1016/j.yfrne.2014.05.006"}, {"pmid": "23744639", "authors": "  Zhang C, Bosch MA, Ronnekleiv OK, Kelly MJ", "title": "Kisspeptin activation of TRPC4 channels in female GnRH neurons requires PIP2 depletion and cSrc kinase activation.", "journal": "Endocrinology 154:2772-83 (2013)", "doi": "10.1210/en.2013-1180"}, {"pmid": "20816765", "authors": "  Ronnekleiv OK, Bosch MA, Zhang C", "title": "Regulation of endogenous conductances in GnRH neurons by estrogens.", "journal": "Brain Res 1364:25-34 (2010)", "doi": "10.1016/j.brainres.2010.08.096"}, {"pmid": "25612870", "authors": "  Ronnekleiv OK, Zhang C, Bosch MA, Kelly MJ", "title": "Kisspeptin and Gonadotropin-Releasing Hormone Neuronal Excitability: Molecular Mechanisms Driven by 17beta-Estradiol.", "journal": "Neuroendocrinology 102:184-93 (2015)", "doi": "10.1159/000370311"}, {"pmid": "22343183", "authors": "  Zhang XB, Spergel DJ", "title": "Kisspeptin inhibits high-voltage activated Ca2+ channels in GnRH neurons via multiple Ca2+ influx and release pathways.", "journal": "Neuroendocrinology 96:68-80 (2012)", "doi": "10.1159/000335985"}, {"pmid": "19576263", "authors": "  Novaira HJ, Ng Y, Wolfe A, Radovick S", "title": "Kisspeptin increases GnRH mRNA expression and secretion in GnRH secreting neuronal cell lines.", "journal": "Mol Cell Endocrinol 311:126-34 (2009)", "doi": "10.1016/j.mce.2009.06.011"}, {"pmid": "25314270", "authors": "  Glanowska KM, Moenter SM", "title": "Differential regulation of GnRH secretion in the preoptic area (POA) and the median eminence (ME) in male mice.", "journal": "Endocrinology 156:231-41 (2015)", "doi": "10.1210/en.2014-1458"}, {"pmid": "20886089", "authors": "  Szereszewski JM, Pampillo M, Ahow MR, Offermanns S, Bhattacharya M, Babwah AV", "title": "GPR54 regulates ERK1/2 activity and hypothalamic gene expression in a Galpha(q/11) and beta-arrestin-dependent manner.", "journal": "PLoS One 5:e12964 (2010)", "doi": "10.1371/journal.pone.0012964"}, {"pmid": "19710308", "authors": "  Zhang C, Bosch MA, Rick EA, Kelly MJ, Ronnekleiv OK", "title": "17Beta-estradiol regulation of T-type calcium channels in gonadotropin-releasing hormone neurons.", "journal": "J Neurosci 29:10552-62 (2009)", "doi": "10.1523/JNEUROSCI.2962-09.2009"}, {"pmid": "23880664", "authors": "  Terasaka T, Otsuka F, Tsukamoto N, Nakamura E, Inagaki K, Toma K, Ogura-Ochi K, Glidewell-Kenney C, Lawson MA, Makino H", "title": "Mutual interaction of kisspeptin, estrogen and bone morphogenetic protein-4 activity in GnRH regulation by GT1-7 cells.", "journal": "Mol Cell Endocrinol 381:8-15 (2013)", "doi": "10.1016/j.mce.2013.07.009"}, {"pmid": "22654870", "authors": "  Radovick S, Levine JE, Wolfe A", "title": "Estrogenic regulation of the GnRH neuron.", "journal": "Front Endocrinol (Lausanne) 3:52 (2012)", "doi": "10.3389/fendo.2012.00052"}, {"pmid": "16373418", "authors": "  Dungan HM, Clifton DK, Steiner RA", "title": "Minireview: kisspeptin neurons as central processors in the regulation of gonadotropin-releasing hormone secretion.", "journal": "Endocrinology 147:1154-8 (2006)", "doi": "10.1210/en.2005-1282"}, {"pmid": "16627563", "authors": "  Kato M, Tanaka N, Usui S, Sakuma Y", "title": "The SK channel blocker apamin inhibits slow afterhyperpolarization currents in rat gonadotropin-releasing hormone neurones.", "journal": "J Physiol 574:431-42 (2006)", "doi": "10.1113/jphysiol.2006.110155"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04151  PI3K-Akt signaling pathway", "hsa04912  GnRH signaling pathway", "hsa04913  Ovarian steroidogenesis", "hsa04915  Estrogen signaling pathway"], "ko_pathway": "ko04929", "genes": ["AKT2", "AKT1", "NRAS"]}, {"kegg_id": "hsa04935", "name": "Growth hormone synthesis, secretion and action - Homo sapiens (human)", "description": "Growth hormone (GH) is a peptide hormone secreted from the anterior pituitary and plays a critical role in cell growth, development, and metabolism throughout the body. GH secretion occurs episodically and is primarily under the control of two hypothalamic neuroendocrine hormones: GH-releasing hormone (GHRH), which stimulates GH secretion, and somatostatin, which inhibits GH secretion. GHRH interacts with a G protein-coupled receptor (GHRHR) in somatotroph cells to activate the cAMP signaling pathway, which leads to increased GH mRNA transcription and release. Once released into the circulation, GH binds to cell-surface GHR in target tissues such as liver, muscle, bone, and adipose tissue. Binding leads to activation of JAK2 that in turn triggers an array of signaling cascade including Raf-MEK-ERK, PI3K-Akt, and STAT5. ERK, Akt, and STAT5 all promote growth via the synthesis and secretion of IGF-1.", "class": "Organismal Systems; Endocrine system", "pathway_map": "hsa04935  Growth hormone synthesis, secretion and action", "network": ["", "ELEMENT   N00907  GH-Jak-STAT signaling pathway", "N00910  GHRHR-PKA-GH signaling pathway"], "drug": ["D02250  Octreotide acetate (JAN)", "D02691  Somatropin (USP/INN)", "D03297  Mecasermin (USAN/INN)", "D04666  Lanreotide acetate (JAN/USAN)", "D05394  Pegvisomant (USAN/INN)", "D06495  Octreotide acetate (USP)", "D09015  Tesamorelin acetate (USAN)", "D10497  Pasireotide diaspartate", "D10566  Pasireotide pamoate (JAN)", "D10990  Somatrogon (USAN/INN)", "D11033  Lutetium (177Lu) oxodotreotide (INN)", "D11194  Somapacitan (USAN/INN)", "D11486  Lonapegsomatropin (USAN/INN)", "D11651  Edotreotide gallium Ga-68", "D11882  Copper Cu 64 dotatate", "D12431  Lutetium Lu177 edotreotide (USAN)", "D12477  Paltusotine (USAN/INN)", "D12478  Paltusotine hydrochloride (USAN)", "D12907  Actinium Ac 225 dotatate (USAN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["2691  GHRH; growth hormone releasing hormone [KO:K05260]", "2692  GHRHR; growth hormone releasing hormone receptor [KO:K04584]", "2778  GNAS; GNAS complex locus [KO:K04632]", "107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]", "108  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]", "109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]", "196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]", "113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]", "114  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]", "115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]", "55811  ADCY10; adenylate cyclase 10 [KO:K11265] [EC:4.6.1.1]", "6750  SST; somatostatin [KO:K05237]", "6751  SSTR1; somatostatin receptor 1 [KO:K04217]", "6752  SSTR2; somatostatin receptor 2 [KO:K04218]", "6753  SSTR3; somatostatin receptor 3 [KO:K04219]", "6755  SSTR5; somatostatin receptor 5 [KO:K04221]", "2770  GNAI1; G protein subunit alpha i1 [KO:K04630]", "2773  GNAI3; G protein subunit alpha i3 [KO:K04630]", "2771  GNAI2; G protein subunit alpha i2 [KO:K04630]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]", "1386  ATF2; activating transcription factor 2 [KO:K04450]", "468  ATF4; activating transcription factor 4 [KO:K04374]", "10488  CREB3; cAMP responsive element binding protein 3 [KO:K09048]", "90993  CREB3L1; cAMP responsive element binding protein 3 like 1 [KO:K09048]", "64764  CREB3L2; cAMP responsive element binding protein 3 like 2 [KO:K09048]", "84699  CREB3L3; cAMP responsive element binding protein 3 like 3 [KO:K09048]", "148327  CREB3L4; cAMP responsive element binding protein 3 like 4 [KO:K09048]", "9586  CREB5; cAMP responsive element binding protein 5 [KO:K09047]", "1388  ATF6B; activating transcription factor 6 beta [KO:K09049]", "1387  CREBBP; CREB binding protein [KO:K04498] [EC:2.3.1.48]", "2033  EP300; E1A binding protein p300 [KO:K04498] [EC:2.3.1.48]", "5449  POU1F1; POU class 1 homeobox 1 [KO:K09363]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "2688  GH1; growth hormone 1 [KO:K05438]", "2689  GH2; growth hormone 2 [KO:K05438]", "1442  CSH1; chorionic somatomammotropin hormone 1 [KO:K05438]", "1443  CSH2; chorionic somatomammotropin hormone 2 [KO:K05438]", "51738  GHRL; ghrelin and obestatin prepropeptide [KO:K05254]", "2693  GHSR; growth hormone secretagogue receptor [KO:K04284]", "112609  MRAP2; melanocortin 2 receptor accessory protein 2 [KO:K25968]", "2776  GNAQ; G protein subunit alpha q [KO:K04634]", "2767  GNA11; G protein subunit alpha 11 [KO:K04635]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "779  CACNA1S; calcium voltage-gated channel subunit alpha1 S [KO:K04857]", "775  CACNA1C; calcium voltage-gated channel subunit alpha1 C [KO:K04850]", "776  CACNA1D; calcium voltage-gated channel subunit alpha1 D [KO:K04851]", "778  CACNA1F; calcium voltage-gated channel subunit alpha1 F [KO:K04853]", "2690  GHR; growth hormone receptor [KO:K05080]", "3717  JAK2; Janus kinase 2 [KO:K04447] [EC:2.7.10.2]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]", "6464  SHC1; SHC adaptor protein 1 [KO:K06279]", "25759  SHC2; SHC adaptor protein 2 [KO:K17447]", "53358  SHC3; SHC adaptor protein 3 [KO:K17448]", "399694  SHC4; SHC adaptor protein 4 [KO:K17449]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "6772  STAT1; signal transducer and activator of transcription 1 [KO:K11220]", "6774  STAT3; signal transducer and activator of transcription 3 [KO:K04692]", "6776  STAT5A; signal transducer and activator of transcription 5A [KO:K11223]", "6777  STAT5B; signal transducer and activator of transcription 5B [KO:K11224]", "3667  IRS1; insulin receptor substrate 1 [KO:K16172]", "8660  IRS2; insulin receptor substrate 2 [KO:K07187]", "8471  IRS4; insulin receptor substrate 4 [KO:K17446]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "3479  IGF1; insulin like growth factor 1 [KO:K05459]", "3726  JUNB; JunB proto-oncogene, AP-1 transcription factor subunit [KO:K09028]", "8651  SOCS1; suppressor of cytokine signaling 1 [KO:K04694]", "8835  SOCS2; suppressor of cytokine signaling 2 [KO:K04695]", "9021  SOCS3; suppressor of cytokine signaling 3 [KO:K04696]", "3483  IGFALS; insulin like growth factor binding protein acid labile subunit [KO:K17256]", "3486  IGFBP3; insulin like growth factor binding protein 3 [KO:K10138]", "5747  PTK2; protein tyrosine kinase 2 [KO:K05725] [EC:2.7.10.2]", "9564  BCAR1; BCAR1 scaffold protein, Cas family member [KO:K05726]", "1398  CRK; CRK proto-oncogene, adaptor protein [KO:K04438]", "1399  CRKL; CRK like proto-oncogene, adaptor protein [KO:K04438]", "4214  MAP3K1; mitogen-activated protein kinase kinase kinase 1 [KO:K04416] [EC:2.7.11.25]", "5606  MAP2K3; mitogen-activated protein kinase kinase 3 [KO:K04432] [EC:2.7.12.2]", "6416  MAP2K4; mitogen-activated protein kinase kinase 4 [KO:K04430] [EC:2.7.12.2]", "5608  MAP2K6; mitogen-activated protein kinase kinase 6 [KO:K04433] [EC:2.7.12.2]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]"], "compound": ["C00076  Calcium cation", "C00165  Diacylglycerol", "C00575  3',5'-Cyclic AMP", "C01245  D-myo-Inositol 1,4,5-trisphosphate"], "refs": [{"pmid": "30775002", "authors": "  Lu M, Flanagan JU, Langley RJ, Hay MP, Perry JK", "title": "Targeting growth hormone function: strategies and therapeutic applications.", "journal": "Signal Transduct Target Ther 4:3 (2019)", "doi": "10.1038/s41392-019-0036-y"}, {"pmid": "8874495", "authors": "  Argetsinger LS, Carter-Su C", "title": "Mechanism of signaling by growth hormone receptor.", "journal": "Physiol Rev 76:1089-107 (1996)", "doi": "10.1152/physrev.1996.76.4.1089"}, {"pmid": "8815791", "authors": "  Carter-Su C, Schwartz J, Smit LS", "title": "Molecular mechanism of growth hormone action.", "journal": "Annu Rev Physiol 58:187-207 (1996)", "doi": "10.1146/annurev.ph.58.030196.001155"}, {"pmid": "10912517", "authors": "  Carter-Su C, Rui L, Herrington J", "title": "Role of the tyrosine kinase JAK2 in signal transduction by growth hormone.", "journal": "Pediatr Nephrol 14:550-7 (2000)", "doi": "10.1007/s004670000366"}, {"pmid": "29487568", "authors": "  Dehkhoda F, Lee CMM, Medina J, Brooks AJ", "title": "The Growth Hormone Receptor: Mechanism of Receptor Activation, Cell Signaling, and Physiological Aspects.", "journal": "Front Endocrinol (Lausanne) 9:35 (2018)", "doi": "10.3389/fendo.2018.00035"}, {"pmid": "26421979", "authors": "  Carter-Su C, Schwartz J, Argetsinger LS", "title": "Growth hormone signaling pathways.", "journal": "Growth Horm IGF Res 28:11-5 (2016)", "doi": "10.1016/j.ghir.2015.09.002"}, {"pmid": "28435436", "authors": "  Berryman DE, Henry B, Hjortebjerg R, List EO, Kopchick JJ", "title": "Developments in our understanding of the effects of growth hormone on white adipose tissue from mice: implications to the clinic.", "journal": "Expert Rev Endocrinol Metab 11:197-207 (2016)", "doi": "10.1586/17446651.2016.1147950"}, {"pmid": "9837978", "authors": "  Zhu T, Goh EL, LeRoith D, Lobie PE", "title": "Growth hormone stimulates the formation of a multiprotein signaling complex involving p130(Cas) and CrkII. Resultant activation of c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK).", "journal": "J Biol Chem 273:33864-75 (1998)", "doi": "10.1074/jbc.273.50.33864"}, {"pmid": "11997217", "authors": "  Gracia-Navarro F, Castano JP, Malagon MM, Sanchez-Hormigo A, Luque RM, Hickey GJ, Peinado JR, Delgado E, Martinez-Fuentes AJ", "title": "Research progress in the stimulatory inputs regulating growth hormone (GH) secretion.", "journal": "Comp Biochem Physiol B Biochem Mol Biol 132:141-50 (2002)", "doi": "10.1016/s1096-4959(01)00544-9"}, {"pmid": "9167959", "authors": "  Bertherat J", "title": "Nuclear effects of the cAMP pathway activation in somatotrophs.", "journal": "Horm Res 47:245-50 (1997)", "doi": "10.1159/000185471"}, {"pmid": "8625613", "authors": "  Tuggle CK, Trenkle A", "title": "Control of growth hormone synthesis.", "journal": "Domest Anim Endocrinol 13:1-33 (1996)", "doi": "10.1016/0739-7240(95)00059-3"}, {"pmid": "10525051", "authors": "  Cohen LE, Hashimoto Y, Zanger K, Wondisford F, Radovick S", "title": "CREB-independent regulation by CBP is a novel mechanism of human growth hormone gene expression.", "journal": "J Clin Invest 104:1123-30 (1999)", "doi": "10.1172/JCI7308"}, {"pmid": "25302229", "authors": "  Khatib N, Gaidhane S, Gaidhane AM, Khatib M, Simkhada P, Gode D, Zahiruddin QS", "title": "Ghrelin: ghrelin as a regulatory Peptide in growth hormone secretion.", "journal": "J Clin Diagn Res 8:MC13-7 (2014)", "doi": "10.7860/JCDR/2014/9863.4767"}, {"pmid": "16628271", "authors": "  Lengyel AM", "title": "From growth hormone-releasing peptides to ghrelin: discovery of new modulators of GH secretion.", "journal": "Arq Bras Endocrinol Metabol 50:17-24 (2006)", "doi": "10.1590/s0004-27302006000100004"}, {"pmid": "15927771", "authors": "  Anderson LL, Jeftinija S, Scanes CG, Stromer MH, Lee JS, Jeftinija K, Glavaski-Joksimovic A", "title": "Physiology of ghrelin and related peptides.", "journal": "Domest Anim Endocrinol 29:111-44 (2005)", "doi": "10.1016/j.domaniend.2005.02.033"}, {"pmid": "14610293", "authors": "  Camina JP, Carreira MC, Micic D, Pombo M, Kelestimur F, Dieguez C, Casanueva FF", "title": "Regulation of ghrelin secretion and action.", "journal": "Endocrine 22:5-12 (2003)", "doi": "10.1385/ENDO:22:1:5"}, {"pmid": "22243899", "authors": "  Yang SK, Steyn F, Chen C", "title": "Influence of membrane ion channel in pituitary somatotrophs by hypothalamic regulators.", "journal": "Cell Calcium 51:231-9 (2012)", "doi": "10.1016/j.ceca.2011.12.005"}, {"pmid": "19884662", "authors": "  Melmed S", "title": "Acromegaly pathogenesis and treatment.", "journal": "J Clin Invest 119:3189-202 (2009)", "doi": "10.1172/JCI39375"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04024  cAMP signaling pathway", "hsa04630  JAK-STAT signaling pathway"], "ko_pathway": "ko04935", "genes": ["AKT2", "AKT1", "SOS1", "MAPK13", "NRAS"]}, {"kegg_id": "hsa04936", "name": "Alcoholic liver disease - Homo sapiens (human)", "description": "Alcoholic liver disease (ALD) refers to the damages to the liver and its functions due to alcohol overconsumption. It ranges from simple steatosis to steatohepatitis, cirrhosis, and even hepatocellular carcinoma. Alcohol consumption promotes liver inflammation by increasing the translocation of gut-derived endotoxins to the portal circulation and activating Kupffer cells to produce TNF-alpha through the LPS/Toll like receptor (TLR) 4 pathways. TNF-alpha\u0005 induces hepatocellular damage. When alcohol intake is chronic and heavy, steatosis is caused via generation of acetaldehyde, reactive oxygen species (ROS) and ER stress. ROS inhibits key hepatic transcriptional regulators such as AMP-activated kinase (AMPK) and peroxisome proliferator-activated receptor alpha (PPAR-alpha), which are responsible for fatty acid oxidation and export via ACC and CPT-1. The blockade of AMPK also leads to overexpression of SREBP-1, resulting in an increase of de novo lipogenesis. Moreover, excessive intracellular ROS production induced by ethanol and its metabolite have a critical role in ethanol-induced apoptosis, which may be the critical process in the exacerbation of ALD. It is inferred that the apoptotic signal derived from ROS that was produced by NOX, is mainly transduced through the JNK and p38 MAPK pathways.", "class": "Human Diseases; Endocrine and metabolic disease", "pathway_map": "hsa04936  Alcoholic liver disease", "disease": ["H02516  Alcoholic liver disease"], "drug": ["D12391  Denifanstat (USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["712  C1QA; complement C1q A chain [KO:K03986]", "713  C1QB; complement C1q B chain [KO:K03987]", "714  C1QC; complement C1q C chain [KO:K03988]", "717  C2; complement C2 [KO:K01332] [EC:3.4.21.43]", "720  C4A; complement C4A (Chido/Rodgers blood group) [KO:K03989]", "721  C4B; complement C4B (Chido/Rodgers blood group) [KO:K03989]", "718  C3; complement C3 [KO:K03990]", "719  C3AR1; complement C3a receptor 1 [KO:K04009]", "727  C5; complement C5 [KO:K03994]", "728  C5AR1; complement C5a receptor 1 [KO:K04010]", "3929  LBP; lipopolysaccharide binding protein [KO:K05399]", "929  CD14; CD14 molecule [KO:K04391]", "23643  LY96; lymphocyte antigen 96 [KO:K05400]", "7099  TLR4; toll like receptor 4 [KO:K10160]", "114609  TIRAP; TIR domain containing adaptor protein [KO:K05403]", "4615  MYD88; MYD88 innate immune signal transduction adaptor [KO:K04729]", "51135  IRAK4; interleukin 1 receptor associated kinase 4 [KO:K04733] [EC:2.7.11.1]", "3654  IRAK1; interleukin 1 receptor associated kinase 1 [KO:K04730] [EC:2.7.11.1]", "7189  TRAF6; TNF receptor associated factor 6 [KO:K03175] [EC:2.3.2.27]", "10454  TAB1; TGF-beta activated kinase 1 (MAP3K7) binding protein 1 [KO:K04403]", "23118  TAB2; TGF-beta activated kinase 1 (MAP3K7) binding protein 2 [KO:K04404]", "6885  MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO:K04427] [EC:2.7.11.25]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "7124  TNF; tumor necrosis factor [KO:K03156]", "3553  IL1B; interleukin 1 beta [KO:K04519]", "3569  IL6; interleukin 6 [KO:K05405]", "3592  IL12A; interleukin 12A [KO:K05406]", "3593  IL12B; interleukin 12B [KO:K05425]", "3576  CXCL8; C-X-C motif chemokine ligand 8 [KO:K10030]", "148022  TICAM1; TIR domain containing adaptor molecule 1 [KO:K05842]", "7187  TRAF3; TNF receptor associated factor 3 [KO:K03174]", "9641  IKBKE; inhibitor of nuclear factor kappa B kinase subunit epsilon [KO:K07211] [EC:2.7.11.10]", "29110  TBK1; TANK binding kinase 1 [KO:K05410] [EC:2.7.11.10]", "3661  IRF3; interferon regulatory factor 3 [KO:K05411]", "3439  IFNA1; interferon alpha 1 [KO:K05414]", "3440  IFNA2; interferon alpha 2 [KO:K05414]", "3441  IFNA4; interferon alpha 4 [KO:K05414]", "3442  IFNA5; interferon alpha 5 [KO:K05414]", "3443  IFNA6; interferon alpha 6 [KO:K05414]", "3444  IFNA7; interferon alpha 7 [KO:K05414]", "3445  IFNA8; interferon alpha 8 [KO:K05414]", "3446  IFNA10; interferon alpha 10 [KO:K05414]", "3447  IFNA13; interferon alpha 13 [KO:K05414]", "3448  IFNA14; interferon alpha 14 [KO:K05414]", "3449  IFNA16; interferon alpha 16 [KO:K05414]", "3451  IFNA17; interferon alpha 17 [KO:K05414]", "3452  IFNA21; interferon alpha 21 [KO:K05414]", "3456  IFNB1; interferon beta 1 [KO:K05415]", "3605  IL17A; interleukin 17A [KO:K05489]", "23765  IL17RA; interleukin 17 receptor A [KO:K05164]", "84818  IL17RC; interleukin 17 receptor C [KO:K05166]", "2919  CXCL1; C-X-C motif chemokine ligand 1 [KO:K05505]", "2920  CXCL2; C-X-C motif chemokine ligand 2 [KO:K05505]", "2921  CXCL3; C-X-C motif chemokine ligand 3 [KO:K05505]", "356  FASLG; Fas ligand [KO:K04389]", "355  FAS; Fas cell surface death receptor [KO:K04390]", "8772  FADD; Fas associated via death domain [KO:K02373]", "7132  TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158]", "8717  TRADD; TNFRSF1A associated via death domain [KO:K03171]", "841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "8737  RIPK1; receptor interacting serine/threonine kinase 1 [KO:K02861] [EC:2.7.11.1]", "257397  TAB3; TGF-beta activated kinase 1 (MAP3K7) binding protein 3 [KO:K12793]", "6720  SREBF1; sterol regulatory element binding transcription factor 1 [KO:K07197]", "2194  FASN; fatty acid synthase [KO:K00665] [EC:2.3.1.85]", "31  ACACA; acetyl-CoA carboxylase alpha [KO:K11262] [EC:6.4.1.2 6.3.4.14 2.1.3.15]", "6319  SCD; stearoyl-CoA desaturase [KO:K00507] [EC:1.14.19.1]", "79966  SCD5; stearoyl-CoA desaturase 5 [KO:K00507] [EC:1.14.19.1]", "23175  LPIN1; lipin 1 [KO:K15728] [EC:3.1.3.4]", "64900  LPIN3; lipin 3 [KO:K15728] [EC:3.1.3.4]", "9663  LPIN2; lipin 2 [KO:K15728] [EC:3.1.3.4]", "406999  MIR217; microRNA 217 [KO:K17125]", "23411  SIRT1; sirtuin 1 [KO:K11411] [EC:2.3.1.286]", "29896  TRA2A; transformer 2 alpha homolog [KO:K12897]", "6434  TRA2B; transformer 2 beta homolog [KO:K12897]", "9370  ADIPOQ; adiponectin, C1Q and collagen domain containing [KO:K07296]", "51094  ADIPOR1; adiponectin receptor 1 [KO:K07297]", "79602  ADIPOR2; adiponectin receptor 2 [KO:K07297]", "10645  CAMKK2; calcium/calmodulin dependent protein kinase kinase 2 [KO:K07359] [EC:2.7.11.17]", "5562  PRKAA1; protein kinase AMP-activated catalytic subunit alpha 1 [KO:K07198] [EC:2.7.11.31]", "5563  PRKAA2; protein kinase AMP-activated catalytic subunit alpha 2 [KO:K07198] [EC:2.7.11.31]", "5564  PRKAB1; protein kinase AMP-activated non-catalytic subunit beta 1 [KO:K07199]", "5565  PRKAB2; protein kinase AMP-activated non-catalytic subunit beta 2 [KO:K07199]", "5571  PRKAG1; protein kinase AMP-activated non-catalytic subunit gamma 1 [KO:K07200]", "53632  PRKAG3; protein kinase AMP-activated non-catalytic subunit gamma 3 [KO:K07200]", "51422  PRKAG2; protein kinase AMP-activated non-catalytic subunit gamma 2 [KO:K07200]", "2308  FOXO1; forkhead box O1 [KO:K07201]", "2309  FOXO3; forkhead box O3 [KO:K09408]", "10891  PPARGC1A; PPARG coactivator 1 alpha [KO:K07202]", "5465  PPARA; peroxisome proliferator activated receptor alpha [KO:K07294]", "1374  CPT1A; carnitine palmitoyltransferase 1A [KO:K08765] [EC:2.3.1.21]", "37  ACADVL; acyl-CoA dehydrogenase very long chain [KO:K09479] [EC:1.3.8.9]", "34  ACADM; acyl-CoA dehydrogenase medium chain [KO:K00249] [EC:1.3.8.7]", "8310  ACOX3; acyl-CoA oxidase 3, pristanoyl [KO:K00232] [EC:1.3.3.6]", "51  ACOX1; acyl-CoA oxidase 1 [KO:K00232] [EC:1.3.3.6]", "2168  FABP1; fatty acid binding protein 1 [KO:K08750]", "124  ADH1A; alcohol dehydrogenase 1A (class I), alpha polypeptide [KO:K13951] [EC:1.1.1.1]", "125  ADH1B; alcohol dehydrogenase 1B (class I), beta polypeptide [KO:K13951] [EC:1.1.1.1]", "126  ADH1C; alcohol dehydrogenase 1C (class I), gamma polypeptide [KO:K13951] [EC:1.1.1.1]", "131  ADH7; alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide [KO:K13951] [EC:1.1.1.1]", "127  ADH4; alcohol dehydrogenase 4 (class II), pi polypeptide [KO:K13980] [EC:1.1.1.1]", "128  ADH5; alcohol dehydrogenase 5 (class III), chi polypeptide [KO:K00121] [EC:1.1.1.284 1.1.1.1]", "130  ADH6; alcohol dehydrogenase 6 (class V) [KO:K13952] [EC:1.1.1.1]", "217  ALDH2; aldehyde dehydrogenase 2 family member [KO:K00128] [EC:1.2.1.3]", "224  ALDH3A2; aldehyde dehydrogenase 3 family member A2 [KO:K00128] [EC:1.2.1.3]", "219  ALDH1B1; aldehyde dehydrogenase 1 family member B1 [KO:K00128] [EC:1.2.1.3]", "501  ALDH7A1; aldehyde dehydrogenase 7 family member A1 [KO:K14085] [EC:1.2.1.31 1.2.1.8 1.2.1.3]", "223  ALDH9A1; aldehyde dehydrogenase 9 family member A1 [KO:K00149] [EC:1.2.1.47 1.2.1.3]", "1571  CYP2E1; cytochrome P450 family 2 subfamily E member 1 [KO:K07415] [EC:1.14.14.-]", "32  ACACB; acetyl-CoA carboxylase beta [KO:K01946] [EC:6.4.1.2 6.3.4.14 2.1.3.15]", "23417  MLYCD; malonyl-CoA decarboxylase [KO:K01578] [EC:4.1.1.9]", "1375  CPT1B; carnitine palmitoyltransferase 1B [KO:K19523] [EC:2.3.1.21]", "126129  CPT1C; carnitine palmitoyltransferase 1C [KO:K19524] [EC:2.3.1.21]", "50507  NOX4; NADPH oxidase 4 [KO:K21423] [EC:1.6.3.-]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "1499  CTNNB1; catenin beta 1 [KO:K02105]", "6932  TCF7; transcription factor 7 [KO:K02620]", "83439  TCF7L1; transcription factor 7 like 1 [KO:K04490]", "6934  TCF7L2; transcription factor 7 like 2 [KO:K04491]", "51176  LEF1; lymphoid enhancer binding factor 1 [KO:K04492]", "595  CCND1; cyclin D1 [KO:K04503]", "4217  MAP3K5; mitogen-activated protein kinase kinase kinase 5 [KO:K04426] [EC:2.7.11.25]", "6416  MAP2K4; mitogen-activated protein kinase kinase 4 [KO:K04430] [EC:2.7.12.2]", "5609  MAP2K7; mitogen-activated protein kinase kinase 7 [KO:K04431] [EC:2.7.12.2]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "5606  MAP2K3; mitogen-activated protein kinase kinase 3 [KO:K04432] [EC:2.7.12.2]", "5608  MAP2K6; mitogen-activated protein kinase kinase 6 [KO:K04433] [EC:2.7.12.2]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "9020  MAP3K14; mitogen-activated protein kinase kinase kinase 14 [KO:K04466] [EC:2.7.11.25]"], "compound": ["C00003  NAD+", "C00005  NADPH", "C00006  NADP+", "C00024  Acetyl-CoA", "C00033  Acetate", "C00040  Acyl-CoA", "C00076  Calcium cation", "C00083  Malonyl-CoA", "C00084  Acetaldehyde", "C00469  Ethanol", "C22381  Reactive oxygen species"], "refs": [{"pmid": "25782093", "authors": "  Louvet A, Mathurin P", "title": "Alcoholic liver disease: mechanisms of injury and targeted treatment.", "journal": "Nat Rev Gastroenterol Hepatol 12:231-42 (2015)", "doi": "10.1038/nrgastro.2015.35"}, {"pmid": "21920463", "authors": "  Gao B, Bataller R", "title": "Alcoholic liver disease: pathogenesis and new therapeutic targets.", "journal": "Gastroenterology 141:1572-85 (2011)", "doi": "10.1053/j.gastro.2011.09.002"}, {"pmid": "28134813", "authors": "  Magdaleno F, Blajszczak CC, Nieto N", "title": "Key Events Participating in the Pathogenesis of Alcoholic Liver Disease.", "journal": "Biomolecules 7:E9 (2017)", "doi": "10.3390/biom7010009"}, {"pmid": "19553649", "authors": "  Lucey MR, Mathurin P, Morgan TR", "title": "Alcoholic hepatitis.", "journal": "N Engl J Med 360:2758-69 (2009)", "doi": "10.1056/NEJMra0805786"}, {"pmid": "26919968", "authors": "  Nagy LE, Ding WX, Cresci G, Saikia P, Shah VH", "title": "Linking Pathogenic Mechanisms of Alcoholic Liver Disease With Clinical Phenotypes.", "journal": "Gastroenterology 150:1756-68 (2016)", "doi": "10.1053/j.gastro.2016.02.035"}, {"pmid": "25009376", "authors": "  Fujii H, Kawada N", "title": "Fibrogenesis in alcoholic liver disease.", "journal": "World J Gastroenterol 20:8048-54 (2014)", "doi": "10.3748/wjg.v20.i25.8048"}, {"pmid": "26755857", "authors": "  Kim MS, Ong M, Qu X", "title": "Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination?", "journal": "World J Gastroenterol 22:8-23 (2016)", "doi": "10.3748/wjg.v22.i1.8"}, {"pmid": "15194557", "authors": "  You M, Crabb DW", "title": "Recent advances in alcoholic liver disease II. Minireview: molecular mechanisms of alcoholic fatty liver.", "journal": "Am J Physiol Gastrointest Liver Physiol 287:G1-6 (2004)", "doi": "10.1152/ajpgi.00056.2004"}, {"pmid": "21252049", "authors": "  Gao B, Seki E, Brenner DA, Friedman S, Cohen JI, Nagy L, Szabo G, Zakhari S", "title": "Innate immunity in alcoholic liver disease.", "journal": "Am J Physiol Gastrointest Liver Physiol 300:G516-25 (2011)", "doi": "10.1152/ajpgi.00537.2010"}, {"pmid": "22524187", "authors": "  Wang HJ, Gao B, Zakhari S, Nagy LE", "title": "Inflammation in alcoholic liver disease.", "journal": "Annu Rev Nutr 32:343-68 (2012)", "doi": "10.1146/annurev-nutr-072610-145138"}, {"pmid": "29597356", "authors": "  McCullough RL, McMullen MR, Sheehan MM, Poulsen KL, Roychowdhury S, Chiang DJ, Pritchard MT, Caballeria J, Nagy LE", "title": "Complement Factor D protects mice from ethanol-induced inflammation and liver injury.", "journal": "Am J Physiol Gastrointest Liver Physiol 315:G66-G79 (2018)", "doi": "10.1152/ajpgi.00334.2017"}, {"pmid": "24385684", "authors": "  Kawaratani H, Tsujimoto T, Douhara A, Takaya H, Moriya K, Namisaki T, Noguchi R, Yoshiji H, Fujimoto M, Fukui H", "title": "The effect of inflammatory cytokines in alcoholic liver disease.", "journal": "Mediators Inflamm 2013:495156 (2013)", "doi": "10.1155/2013/495156"}, {"pmid": "20238398", "authors": "  Szabo G, Bala S", "title": "Alcoholic liver disease and the gut-liver axis.", "journal": "World J Gastroenterol 16:1321-9 (2010)", "doi": "10.3748/wjg.v16.i11.1321"}, {"pmid": "28627645", "authors": "  Kawaratani H, Moriya K, Namisaki T, Uejima M, Kitade M, Takeda K, Okura Y, Kaji K, Takaya H, Nishimura N, Sato S, Sawada Y, Seki K, Kubo T, Mitoro A, Yamao J, Yoshiji H", "title": "Therapeutic strategies for alcoholic liver disease: Focusing on inflammation and fibrosis (Review).", "journal": "Int J Mol Med 40:263-270 (2017)", "doi": "10.3892/ijmm.2017.3015"}, {"pmid": "23855294", "authors": "  Roh YS, Seki E", "title": "Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis.", "journal": "J Gastroenterol Hepatol 28 Suppl 1:38-42 (2013)", "doi": "10.1111/jgh.12019"}, {"pmid": "18709650", "authors": "  Rogers CQ, Ajmo JM, You M", "title": "Adiponectin and alcoholic fatty liver disease.", "journal": "IUBMB Life 60:790-7 (2008)", "doi": "10.1002/iub.124"}, {"pmid": "26278388", "authors": "  You M, Jogasuria A, Lee K, Wu J, Zhang Y, Lee YK, Sadana P", "title": "Signal Transduction Mechanisms of Alcoholic Fatty Liver Disease: Emer ging Role of Lipin-1.", "journal": "Curr Mol Pharmacol 10:226-236 (2017)", "doi": "10.2174/1874467208666150817112109"}, {"pmid": "26005675", "authors": "  You M, Jogasuria A, Taylor C, Wu J", "title": "Sirtuin 1 signaling and alcoholic fatty liver disease.", "journal": "Hepatobiliary Surg Nutr 4:88-100 (2015)", "doi": "10.3978/j.issn.2304-3881.2014.12.06"}, {"pmid": "33162823", "authors": "  Ren R, Wang Z, Wu M, Wang H", "title": "Emerging Roles of SIRT1 in Alcoholic Liver Disease.", "journal": "Int J Biol Sci 16:3174-3183 (2020)", "doi": "10.7150/ijbs.49535"}, {"pmid": "19032584", "authors": "  Purohit V, Gao B, Song BJ", "title": "Molecular mechanisms of alcoholic fatty liver.", "journal": "Alcohol Clin Exp Res 33:191-205 (2009)", "doi": "10.1111/j.1530-0277.2008.00827.x"}, {"pmid": "34071962", "authors": "  Hyun J, Han J, Lee C, Yoon M, Jung Y", "title": "Pathophysiological Aspects of Alcohol Metabolism in the Liver.", "journal": "Int J Mol Sci 22:5717 (2021)", "doi": "10.3390/ijms22115717"}, {"pmid": "24297186", "authors": "  Combs TP, Marliss EB", "title": "Adiponectin signaling in the liver.", "journal": "Rev Endocr Metab Disord 15:137-47 (2014)", "doi": "10.1007/s11154-013-9280-6"}, {"pmid": "25548474", "authors": "  Ceni E, Mello T, Galli A", "title": "Pathogenesis of alcoholic liver disease: role of oxidative metabolism.", "journal": "World J Gastroenterol 20:17756-72 (2014)", "doi": "10.3748/wjg.v20.i47.17756"}, {"pmid": "31159489", "authors": "  Kong LZ, Chandimali N, Han YH, Lee DH, Kim JS, Kim SU, Kim TD, Jeong DK, Sun HN, Lee DS, Kwon T", "title": "Pathogenesis, Early Diagnosis, and Therapeutic Management of Alcoholic Liver Disease.", "journal": "Int J Mol Sci 20:E2712 (2019)", "doi": "10.3390/ijms20112712"}, {"pmid": "31214376", "authors": "  Ohashi K, Pimienta M, Seki E", "title": "Alcoholic liver disease: A current molecular and clinical perspective.", "journal": "Liver Res 2:161-172 (2018)", "doi": "10.1016/j.livres.2018.11.002"}, {"pmid": "30658725", "authors": "  You M, Arteel GE", "title": "Effect of ethanol on lipid metabolism.", "journal": "J Hepatol 70:237-248 (2019)", "doi": "10.1016/j.jhep.2018.10.037"}, {"pmid": "25595739", "authors": "  Bi L, Jiang Z, Zhou J", "title": "The role of lipin-1 in the pathogenesis of alcoholic fatty liver.", "journal": "Alcohol Alcohol 50:146-51 (2015)", "doi": "10.1093/alcalc/agu102"}, {"pmid": "31263795", "authors": "  Ali H, Assiri MA, Shearn CT, Fritz KS", "title": "Lipid peroxidation derived reactive aldehydes in alcoholic liver disease.", "journal": "Curr Opin Toxicol 13:110-117 (2019)", "doi": "10.1016/j.cotox.2018.10.003"}, {"pmid": "24262277", "authors": "  Yin H, Hu M, Liang X, Ajmo JM, Li X, Bataller R, Odena G, Stevens SM Jr, You M", "title": "Deletion of SIRT1 from hepatocytes in mice disrupts lipin-1 signaling and aggravates alcoholic fatty liver.", "journal": "Gastroenterology 146:801-11 (2014)", "doi": "10.1053/j.gastro.2013.11.008"}, {"pmid": "22110053", "authors": "  Stickel F, Hampe J", "title": "Genetic determinants of alcoholic liver disease.", "journal": "Gut 61:150-9 (2012)", "doi": "10.1136/gutjnl-2011-301239"}], "rel_pathway": ["hsa00061  Fatty acid biosynthesis", "hsa00071  Fatty acid degradation", "hsa01040  Biosynthesis of unsaturated fatty acids", "hsa03040  Spliceosome", "hsa04010  MAPK signaling pathway", "hsa04064  NF-kappa B signaling pathway", "hsa04152  AMPK signaling pathway", "hsa04210  Apoptosis", "hsa04310  Wnt signaling pathway", "hsa04610  Complement and coagulation cascades", "hsa04620  Toll-like receptor signaling pathway", "hsa04657  IL-17 signaling pathway", "hsa04668  TNF signaling pathway", "hsa04920  Adipocytokine signaling pathway", "hsa05034  Alcoholism", "hsa05225  Hepatocellular carcinoma"], "ko_pathway": "ko04936", "genes": ["AKT2", "AKT1", "MAPK13"]}, {"kegg_id": "hsa04973", "name": "Carbohydrate digestion and absorption - Homo sapiens (human)", "description": "Dietary carbohydrate in humans and omnivorous animals is a major nutrient. The carbohydrates that we ingest vary from the lactose in milk to complex carbohydrates. These carbohydrates are digested to monosaccharides, mostly glucose, galactose and fructose, prior to absorption in the small intestine. Glucose and galactose are initially transported into the enterocyte by SGLT1 located in the apical brush border membrane and then exit through the basolateral membrane by either GLUT2 or exocytosis. In a new model of intestinal glucose absorption, transport by SGLT1 induces rapid insertion and activation of GLUT2 in the brush border membrane by a PKC betaII-dependent mechanism. Moreover, trafficking of apical GLUT2 is rapidly up-regulated by glucose and artificial sweeteners, which act through T1R2 + T1R3/alpha-gustducin to activate PLC-beta2 and PKC-beta II. Fructose is transported separately by the brush border GLUT5 and then released out of the enterocyte into the blood by GLUT2.", "class": "Organismal Systems; Digestive system", "pathway_map": "hsa04973  Carbohydrate digestion and absorption", "drug": ["D00216  Acarbose (JAN/USAN/INN)", "D00625  Miglitol (JP18/USAN/INN)", "D01665  Voglibose (JP18/USAN/INN)", "D02381  Aspartame (NF/INN)", "D08836  Acesulfame potassium (NF)", "D08862  Aspartame acesulfame (NF)", "D09779  Emiglitate (JAN/INN)", "D10669  Sotagliflozin (USAN/INN)"], "dblinks": "GO: 0044245 0001951", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["278  AMY1C; amylase alpha 1C [KO:K01176] [EC:3.2.1.1]", "279  AMY2A; amylase alpha 2A [KO:K01176] [EC:3.2.1.1]", "276  AMY1A; amylase alpha 1A [KO:K01176] [EC:3.2.1.1]", "280  AMY2B; amylase alpha 2B [KO:K01176] [EC:3.2.1.1]", "277  AMY1B; amylase alpha 1B [KO:K01176] [EC:3.2.1.1]", "3938  LCT; lactase [KO:K01229] [EC:3.2.1.108 3.2.1.62]", "8972  MGAM; maltase-glucoamylase [KO:K12047] [EC:3.2.1.20 3.2.1.3]", "93432  MGAM2; maltase-glucoamylase 2 (putative) [KO:K12047] [EC:3.2.1.20 3.2.1.3]", "6476  SI; sucrase-isomaltase [KO:K01203] [EC:3.2.1.48 3.2.1.10]", "6523  SLC5A1; solute carrier family 5 member 1 [KO:K14158]", "476  ATP1A1; ATPase Na+/K+ transporting subunit alpha 1 [KO:K01539] [EC:7.2.2.13]", "477  ATP1A2; ATPase Na+/K+ transporting subunit alpha 2 [KO:K01539] [EC:7.2.2.13]", "478  ATP1A3; ATPase Na+/K+ transporting subunit alpha 3 [KO:K01539] [EC:7.2.2.13]", "480  ATP1A4; ATPase Na+/K+ transporting subunit alpha 4 [KO:K01539] [EC:7.2.2.13]", "23439  ATP1B4; ATPase Na+/K+ transporting family member beta 4 [KO:K01540]", "481  ATP1B1; ATPase Na+/K+ transporting subunit beta 1 [KO:K01540]", "482  ATP1B2; ATPase Na+/K+ transporting subunit beta 2 [KO:K01540]", "483  ATP1B3; ATPase Na+/K+ transporting subunit beta 3 [KO:K01540]", "486  FXYD2; FXYD domain containing ion transport regulator 2 [KO:K01538]", "6514  SLC2A2; solute carrier family 2 member 2 [KO:K07593]", "3101  HK3; hexokinase 3 [KO:K00844] [EC:2.7.1.1]", "3098  HK1; hexokinase 1 [KO:K00844] [EC:2.7.1.1]", "3099  HK2; hexokinase 2 [KO:K00844] [EC:2.7.1.1]", "80201  HKDC1; hexokinase domain containing 1 [KO:K00844] [EC:2.7.1.1]", "2542  SLC37A4; solute carrier family 37 member 4 [KO:K08171]", "2538  G6PC1; glucose-6-phosphatase catalytic subunit 1 [KO:K01084] [EC:3.1.3.9]", "57818  G6PC2; glucose-6-phosphatase catalytic subunit 2 [KO:K01084] [EC:3.1.3.9]", "92579  G6PC3; glucose-6-phosphatase catalytic subunit 3 [KO:K01084] [EC:3.1.3.9]", "6518  SLC2A5; solute carrier family 2 member 5 [KO:K08143]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "776  CACNA1D; calcium voltage-gated channel subunit alpha1 D [KO:K04851]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "80834  TAS1R2; taste 1 receptor member 2 [KO:K04625]", "83756  TAS1R3; taste 1 receptor member 3 [KO:K04626]", "346562  GNAT3; G protein subunit alpha transducin 3 [KO:K19729]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]"], "compound": ["C00011  CO2", "C00031  D-Glucose", "C00033  Acetate", "C00076  Calcium cation", "C00089  Sucrose", "C00092  D-Glucose 6-phosphate", "C00095  D-Fructose", "C00124  D-Galactose", "C00163  Propanoate", "C00165  Diacylglycerol", "C00208  Maltose", "C00238  Potassium cation", "C00243  Lactose", "C00246  Butanoic acid", "C00282  Hydrogen", "C00369  Starch", "C00707  Xylan", "C00714  Pectin", "C00760  Cellulose", "C01330  Sodium cation", "C01355  Fructan", "C01835  Maltotriose", "C02049  Limit dextrin", "C05981  Phosphatidylinositol-3,4,5-trisphosphate", "C08822  Gum arabic", "C12284  Saccharin sodium anhydrous", "C12285  Sucralose"], "refs": [{"pmid": "16586532", "authors": "  Drozdowski LA, Thomson AB", "title": "Intestinal sugar transport.", "journal": "World J Gastroenterol 12:1657-70 (2006)", "doi": "10.3748/wjg.v12.i11.1657"}, {"pmid": "14642859", "authors": "  Wright EM, Martin MG, Turk E", "title": "Intestinal absorption in health and disease--sugars.", "journal": "Best Pract Res Clin Gastroenterol 17:943-56 (2003)", "doi": "10.1016/S1521-6918(03)00107-0"}, {"pmid": "18393659", "authors": "  Kellett GL, Brot-Laroche E, Mace OJ, Leturque A", "title": "Sugar absorption in the intestine: the role of GLUT2.", "journal": "Annu Rev Nutr 28:35-54 (2008)", "doi": "10.1146/annurev.nutr.28.061807.155518"}, {"pmid": "19001049", "authors": "  Mace OJ, Lister N, Morgan E, Shepherd E, Affleck J, Helliwell P, Bronk JR, Kellett GL, Meredith D, Boyd R, Pieri M, Bailey PD, Pettcrew R, Foley D", "title": "An energy supply network of nutrient absorption coordinated by calcium and T1R taste receptors in rat small intestine.", "journal": "J Physiol 587:195-210 (2009)", "doi": "10.1113/jphysiol.2008.159616"}, {"pmid": "16186415", "authors": "  Kellett GL, Brot-Laroche E", "title": "Apical GLUT2: a major pathway of intestinal sugar absorption.", "journal": "Diabetes 54:3056-62 (2005)", "doi": "10.2337/diabetes.54.10.3056"}, {"pmid": "20522896", "authors": "  Goodman BE", "title": "Insights into digestion and absorption of major nutrients in humans.", "journal": "Adv Physiol Educ 34:44-53 (2010)", "doi": "10.1152/advan.00094.2009"}, {"pmid": "17222166", "authors": "  Wright EM, Hirayama BA, Loo DF", "title": "Active sugar transport in health and disease.", "journal": "J Intern Med 261:32-43 (2007)", "doi": "10.1111/j.1365-2796.2006.01746.x"}, {"pmid": "12512027", "authors": "  Santer R, Hillebrand G, Steinmann B, Schaub J", "title": "Intestinal glucose transport: evidence for a membrane traffic-based pathway in humans.", "journal": "Gastroenterology 124:34-9 (2003)", "doi": "10.1053/gast.2003.50009"}, {"pmid": "11562503", "authors": "  Stumpel F, Burcelin R, Jungermann K, Thorens B", "title": "Normal kinetics of intestinal glucose absorption in the absence of GLUT2: evidence for a transport pathway requiring glucose phosphorylation and transfer into the endoplasmic reticulum.", "journal": "Proc Natl Acad Sci U S A 98:11330-5 (2001)", "doi": "10.1073/pnas.211357698"}, {"pmid": "15546855", "authors": "  Wright EM, Loo DD, Hirayama BA, Turk E", "title": "Surprising versatility of Na+-glucose cotransporters: SLC5.", "journal": "Physiology (Bethesda) 19:370-6 (2004)", "doi": "10.1152/physiol.00026.2004"}, {"pmid": "12750891", "authors": "  Uldry M, Thorens B", "title": "The SLC2 family of facilitated hexose and polyol transporters.", "journal": "Pflugers Arch 447:480-9 (2004)", "doi": "10.1007/s00424-003-1085-0"}, {"pmid": "7555019", "authors": "  Van Beers EH, Buller HA, Grand RJ, Einerhand AW, Dekker J", "title": "Intestinal brush border glycohydrolases: structure, function, and development.", "journal": "Crit Rev Biochem Mol Biol 30:197-262 (1995)", "doi": "10.3109/10409239509085143"}, {"pmid": "12583961", "authors": "  Guarner F, Malagelada JR", "title": "Gut flora in health and disease.", "journal": "Lancet 361:512-9 (2003)", "doi": "10.1016/S0140-6736(03)12489-0"}], "rel_pathway": ["hsa04530  Tight junction", "hsa04742  Taste transduction", "hsa04970  Salivary secretion", "hsa04972  Pancreatic secretion"], "ko_pathway": "ko04973", "genes": ["AKT2", "AKT1"]}, {"kegg_id": "hsa05017", "name": "Spinocerebellar ataxia - Homo sapiens (human)", "description": "The autosomal dominant spinocerebellar ataxias (SCAs) are a group of progressive neurodegenerative diseases characterised by loss of balance and motor coordination due to the primary dysfunction of the cerebellum. Compelling evidence points to major aetiological roles for transcriptional dysregulation, protein aggregation and clearance, autophagy, the ubiquitin-proteasome system, alterations of calcium homeostasis, mitochondria defects, toxic RNA gain-of-function mechanisms and eventual cell death with apoptotic features of neurons during SCA disease progression.", "class": "Human Diseases; Neurodegenerative disease", "pathway_map": "hsa05017  Spinocerebellar ataxia", "network": ["", "ELEMENT   N00954  Mutation-activated GRM1 to mGluR1-TRPC3 signaling pathway", "N00955  Mutation-inactivated PRKCG to mGluR1-TRPC3 signaling pathway", "N00956  Mutation-activated PRKCG to mGluR1-TRPC3 signaling pathway", "N00957  Mutation-caused abberant ATXN2/3 to mGluR5-Ca2+ -apoptotic pathway", "N00958  Mutation-activated ITPR1 to mGluR1-TRPC3 signaling pathway", "N00959  ITPR1-reduced expression to mGluR1-TRPC3 signaling pathway", "N00960  Mutation-caused aberrant SPTBN2 to mGluR1-TRPC3 signaling pathway", "N00961  Mutation-activated TRPC3 to mGluR1-TRPC3 signaling pathway", "N00962  Mutation-inactivated ATXN3 to autophagy-vesicle nucleation", "N00964  DAB1-overexpression to RELN-VLDLR-PI3K signaling pathway", "N00966  Mutation-caused aberrant ATXN1 to RORA-mediated transcription", "N00968  Mutation-activated CACNA1A to VGCC-Ca2+ -apoptotic pathway", "N00969  Mutation-inactivated CACNA1A to VGCC-Ca2- -apoptotic pathway", "N00971  Mutation-caused aberrant PDYN to transport of calcium", "N00973  Mutation-inactivated KCNC3 to transport of potassium", "N00975  Mutation-inactivated KCND3 to transport of potassium"], "disease": ["H00063  Spinocerebellar ataxia (SCA)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["7222  TRPC3; transient receptor potential cation channel subfamily C member 3 [KO:K04966]", "2911  GRM1; glutamate metabotropic receptor 1 [KO:K04603]", "2776  GNAQ; G protein subunit alpha q [KO:K04634]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "2890  GRIA1; glutamate ionotropic receptor AMPA type subunit 1 [KO:K05197]", "2891  GRIA2; glutamate ionotropic receptor AMPA type subunit 2 [KO:K05198]", "2892  GRIA3; glutamate ionotropic receptor AMPA type subunit 3 [KO:K05199]", "773  CACNA1A; calcium voltage-gated channel subunit alpha1 A [KO:K04344]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "11273  ATXN2L; ataxin 2 like [KO:K23625]", "6311  ATXN2; ataxin 2 [KO:K23625]", "4287  ATXN3; ataxin 3 [KO:K11863] [EC:3.4.22.-]", "92552  ATXN3L; ataxin 3 like [KO:K11863] [EC:3.4.22.-]", "6261  RYR1; ryanodine receptor 1 [KO:K04961]", "5173  PDYN; prodynorphin [KO:K15840]", "2902  GRIN1; glutamate ionotropic receptor NMDA type subunit 1 [KO:K05208]", "2903  GRIN2A; glutamate ionotropic receptor NMDA type subunit 2A [KO:K05209]", "2904  GRIN2B; glutamate ionotropic receptor NMDA type subunit 2B [KO:K05210]", "2905  GRIN2C; glutamate ionotropic receptor NMDA type subunit 2C [KO:K05211]", "2906  GRIN2D; glutamate ionotropic receptor NMDA type subunit 2D [KO:K05212]", "116443  GRIN3A; glutamate ionotropic receptor NMDA type subunit 3A [KO:K05213]", "116444  GRIN3B; glutamate ionotropic receptor NMDA type subunit 3B [KO:K05214]", "90550  MCU; mitochondrial calcium uniporter [KO:K20858]", "7416  VDAC1; voltage dependent anion channel 1 [KO:K05862]", "7417  VDAC2; voltage dependent anion channel 2 [KO:K15040]", "7419  VDAC3; voltage dependent anion channel 3 [KO:K15041]", "291  SLC25A4; solute carrier family 25 member 4 [KO:K05863]", "292  SLC25A5; solute carrier family 25 member 5 [KO:K05863]", "293  SLC25A6; solute carrier family 25 member 6 [KO:K05863]", "83447  SLC25A31; solute carrier family 25 member 31 [KO:K05863]", "10105  PPIF; peptidylprolyl isomerase F [KO:K09565] [EC:5.2.1.8]", "54205  CYCS; cytochrome c, somatic [KO:K08738]", "10939  AFG3L2; AFG3 like matrix AAA peptidase subunit 2 [KO:K08956] [EC:3.4.24.-]", "115209  OMA1; OMA1 zinc metallopeptidase [KO:K23010] [EC:3.4.24.-]", "4976  OPA1; OPA1 mitochondrial dynamin like GTPase [KO:K17079] [EC:3.6.5.5]", "2259  FGF14; fibroblast growth factor 14 [KO:K23920]", "6712  SPTBN2; spectrin beta, non-erythrocytic 2 [KO:K23932]", "5687  PSMA6; proteasome 20S subunit alpha 6 [KO:K02730] [EC:3.4.25.1]", "5683  PSMA2; proteasome 20S subunit alpha 2 [KO:K02726] [EC:3.4.25.1]", "5685  PSMA4; proteasome 20S subunit alpha 4 [KO:K02728] [EC:3.4.25.1]", "5688  PSMA7; proteasome 20S subunit alpha 7 [KO:K02731] [EC:3.4.25.1]", "143471  PSMA8; proteasome 20S subunit alpha 8 [KO:K02731] [EC:3.4.25.1]", "5686  PSMA5; proteasome 20S subunit alpha 5 [KO:K02729] [EC:3.4.25.1]", "5682  PSMA1; proteasome 20S subunit alpha 1 [KO:K02725] [EC:3.4.25.1]", "5684  PSMA3; proteasome 20S subunit alpha 3 [KO:K02727] [EC:3.4.25.1]", "5694  PSMB6; proteasome 20S subunit beta 6 [KO:K02738] [EC:3.4.25.1]", "5695  PSMB7; proteasome 20S subunit beta 7 [KO:K02739] [EC:3.4.25.1]", "5691  PSMB3; proteasome 20S subunit beta 3 [KO:K02735] [EC:3.4.25.1]", "5690  PSMB2; proteasome 20S subunit beta 2 [KO:K02734] [EC:3.4.25.1]", "5693  PSMB5; proteasome 20S subunit beta 5 [KO:K02737] [EC:3.4.25.1]", "5689  PSMB1; proteasome 20S subunit beta 1 [KO:K02732] [EC:3.4.25.1]", "5692  PSMB4; proteasome 20S subunit beta 4 [KO:K02736] [EC:3.4.25.1]", "5701  PSMC2; proteasome 26S subunit, ATPase 2 [KO:K03061]", "5700  PSMC1; proteasome 26S subunit, ATPase 1 [KO:K03062]", "5704  PSMC4; proteasome 26S subunit, ATPase 4 [KO:K03063]", "5706  PSMC6; proteasome 26S subunit, ATPase 6 [KO:K03064]", "5702  PSMC3; proteasome 26S subunit, ATPase 3 [KO:K03065]", "5705  PSMC5; proteasome 26S subunit, ATPase 5 [KO:K03066]", "5708  PSMD2; proteasome 26S subunit ubiquitin receptor, non-ATPase 2 [KO:K03028]", "5707  PSMD1; proteasome 26S subunit, non-ATPase 1 [KO:K03032]", "5709  PSMD3; proteasome 26S subunit, non-ATPase 3 [KO:K03033]", "5715  PSMD9; proteasome 26S subunit, non-ATPase 9 [KO:K06693]", "5718  PSMD12; proteasome 26S subunit, non-ATPase 12 [KO:K03035]", "5717  PSMD11; proteasome 26S subunit, non-ATPase 11 [KO:K03036]", "9861  PSMD6; proteasome 26S subunit, non-ATPase 6 [KO:K03037]", "5713  PSMD7; proteasome 26S subunit, non-ATPase 7 [KO:K03038]", "5719  PSMD13; proteasome 26S subunit, non-ATPase 13 [KO:K03039]", "5710  PSMD4; proteasome 26S subunit ubiquitin receptor, non-ATPase 4 [KO:K03029]", "10213  PSMD14; proteasome 26S subunit, non-ATPase 14 [KO:K03030]", "5714  PSMD8; proteasome 26S subunit, non-ATPase 8 [KO:K03031]", "11047  ADRM1; ADRM1 26S proteasome ubiquitin receptor [KO:K06691]", "7979  SEM1; SEM1 26S proteasome subunit [KO:K10881]", "2081  ERN1; endoplasmic reticulum to nucleus signaling 1 [KO:K08852] [EC:2.7.11.1 3.1.26.-]", "7186  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]", "4217  MAP3K5; mitogen-activated protein kinase kinase kinase 5 [KO:K04426] [EC:2.7.11.25]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "342371  ATXN1L; ataxin 1 like [KO:K23616]", "6310  ATXN1; ataxin 1 [KO:K23616]", "10524  KAT5; lysine acetyltransferase 5 [KO:K11304] [EC:2.3.1.48]", "6095  RORA; RAR related orphan receptor A [KO:K08532]", "487  ATP2A1; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 [KO:K05853] [EC:7.2.2.10]", "489  ATP2A3; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 [KO:K05853] [EC:7.2.2.10]", "488  ATP2A2; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 [KO:K05853] [EC:7.2.2.10]", "6511  SLC1A6; solute carrier family 1 member 6 [KO:K05617]", "23152  CIC; capicua transcriptional repressor [KO:K20225]", "23369  PUM2; pumilio RNA binding family member 2 [KO:K17943]", "9698  PUM1; pumilio RNA binding family member 1 [KO:K17943]", "387332  TBPL2; TATA-box binding protein like 2 [KO:K03120]", "9519  TBPL1; TATA-box binding protein like 1 [KO:K03120]", "6908  TBP; TATA-box binding protein [KO:K03120]", "11317  RBPJL; recombination signal binding protein for immunoglobulin kappa J region like [KO:K06053]", "3516  RBPJ; recombination signal binding protein for immunoglobulin kappa J region [KO:K06053]", "6667  SP1; Sp1 transcription factor [KO:K04684]", "2959  GTF2B; general transcription factor IIB [KO:K03124]", "4800  NFYA; nuclear transcription factor Y subunit alpha [KO:K08064]", "7494  XBP1; X-box binding protein 1 [KO:K09027]", "4654  MYOD1; myogenic differentiation 1 [KO:K09064]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "8408  ULK1; unc-51 like autophagy activating kinase 1 [KO:K21357] [EC:2.7.11.1]", "9706  ULK2; unc-51 like autophagy activating kinase 2 [KO:K08269] [EC:2.7.11.1]", "60673  ATG101; autophagy related 101 [KO:K19730]", "9776  ATG13; autophagy related 13 [KO:K08331]", "9821  RB1CC1; RB1 inducible coiled-coil 1 [KO:K17589]", "55626  AMBRA1; autophagy and beclin 1 regulator 1 [KO:K17985]", "8678  BECN1; beclin 1 [KO:K08334]", "441925  BECN2; beclin 2 [KO:K08334]", "30849  PIK3R4; phosphoinositide-3-kinase regulatory subunit 4 [KO:K08333] [EC:2.7.11.1]", "22863  ATG14; autophagy related 14 [KO:K17889]", "29982  NRBF2; nuclear receptor binding factor 2 [KO:K21246]", "5289  PIK3C3; phosphatidylinositol 3-kinase catalytic subunit type 3 [KO:K00914] [EC:2.7.1.137]", "23130  ATG2A; autophagy related 2A [KO:K17906]", "55102  ATG2B; autophagy related 2B [KO:K17906]", "26100  WIPI2; WD repeat domain, phosphoinositide interacting 2 [KO:K17908]", "55062  WIPI1; WD repeat domain, phosphoinositide interacting 1 [KO:K17908]", "3748  KCNC3; potassium voltage-gated channel subfamily C member 3 [KO:K04889]", "3752  KCND3; potassium voltage-gated channel subfamily D member 3 [KO:K04893]", "5649  RELN; reelin [KO:K06249] [EC:3.4.21.-]", "7436  VLDLR; very low density lipoprotein receptor [KO:K20053]", "1600  DAB1; DAB adaptor protein 1 [KO:K20054]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "56652  TWNK; twinkle mtDNA helicase [KO:K17680] [EC:5.6.2.3]", "6315  ATXN8OS; ATXN8 opposite strand lncRNA [KO:K23933]", "25814  ATXN10; ataxin 10 [KO:K19323]", "146227  BEAN1; brain expressed associated with NEDD4 1 [KO:K19324]", "10528  NOP56; NOP56 ribonucleoprotein [KO:K14564]"], "compound": ["C00025  L-Glutamate", "C00076  Calcium cation", "C00165  Diacylglycerol", "C00238  Potassium cation", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C01330  Sodium cation", "C04549  1-Phosphatidyl-1D-myo-inositol 3-phosphate"], "refs": [{"pmid": "19890685", "authors": "  Matilla-Duenas A, Sanchez I, Corral-Juan M, Davalos A, Alvarez R, Latorre P", "title": "Cellular and molecular pathways triggering neurodegeneration in the spinocerebellar ataxias.", "journal": "Cerebellum 9:148-66 (2010)", "doi": "10.1007/s12311-009-0144-2"}, {"pmid": "16613893", "authors": "  Duenas AM, Goold R, Giunti P", "title": "Molecular pathogenesis of spinocerebellar ataxias.", "journal": "Brain 129:1357-70 (2006)", "doi": "10.1093/brain/awl081"}, {"pmid": "27392710", "authors": "  Mark MD, Schwitalla JC, Groemmke M, Herlitze S", "title": "Keeping Our Calcium in Balance to Maintain Our Balance.", "journal": "Biochem Biophys Res Commun 483:1040-1050 (2017)", "doi": "10.1016/j.bbrc.2016.07.020"}, {"pmid": "29253316", "authors": "  Egorova PA, Bezprozvanny IB", "title": "Inositol 1,4,5-trisphosphate receptors and neurodegenerative disorders.", "journal": "FEBS J 285:3547-3565 (2018)", "doi": "10.1111/febs.14366"}, {"pmid": "28554312", "authors": "  Shimobayashi E, Kapfhammer JP", "title": "Calcium Signaling, PKC Gamma, IP3R1 and CAR8 Link Spinocerebellar Ataxias and Purkinje Cell Dendritic Development.", "journal": "Curr Neuropharmacol 16:151-159 (2018)", "doi": "10.2174/1570159X15666170529104000"}, {"pmid": "20480274", "authors": "  Kasumu A, Bezprozvanny I", "title": "Deranged calcium signaling in Purkinje cells and pathogenesis in spinocerebellar ataxia 2 (SCA2) and other ataxias.", "journal": "Cerebellum 11:630-9 (2012)", "doi": "10.1007/s12311-010-0182-9"}, {"pmid": "25846864", "authors": "  Egorova P, Popugaeva E, Bezprozvanny I", "title": "Disturbed calcium signaling in spinocerebellar ataxias and Alzheimer's disease.", "journal": "Semin Cell Dev Biol 40:127-33 (2015)", "doi": "10.1016/j.semcdb.2015.03.010"}, {"pmid": "29777722", "authors": "  Hisatsune C, Hamada K, Mikoshiba K", "title": "Ca(2+) signaling and spinocerebellar ataxia.", "journal": "Biochim Biophys Acta Mol Cell Res 1865:1733-1744 (2018)", "doi": "10.1016/j.bbamcr.2018.05.009"}, {"pmid": "27771899", "authors": "  Takada SH, Ikebara JM, de Sousa E, Cardoso DS, Resende RR, Ulrich H, Ruckl M, Rudiger S, Kihara AH", "title": "Determining the Roles of Inositol Trisphosphate Receptors in Neurodegeneration: Interdisciplinary Perspectives on a Complex Topic.", "journal": "Mol Neurobiol 54:6870-6884 (2017)", "doi": "10.1007/s12035-016-0205-8"}, {"pmid": "25653583", "authors": "  Brown SA, Loew LM", "title": "Integration of modeling with experimental and clinical findings synthesizes and refines the central role of inositol 1,4,5-trisphosphate receptor 1 in spinocerebellar ataxia.", "journal": "Front Neurosci 8:453 (2014)", "doi": "10.3389/fnins.2014.00453"}, {"pmid": "14748477", "authors": "  Inoue T", "title": "Dynamics of calcium and its roles in the dendrite of the cerebellar Purkinje cell.", "journal": "Keio J Med 52:244-9 (2003)", "doi": "10.2302/kjm.52.244"}, {"pmid": "18499672", "authors": "  Adachi N, Kobayashi T, Takahashi H, Kawasaki T, Shirai Y, Ueyama T, Matsuda T, Seki T, Sakai N, Saito N", "title": "Enzymological analysis of mutant protein kinase Cgamma causing spinocerebellar ataxia type 14 and dysfunction in Ca2+ homeostasis.", "journal": "J Biol Chem 283:19854-63 (2008)", "doi": "10.1074/jbc.M801492200"}, {"pmid": "26169942", "authors": "  Smeets CJ, Jezierska J, Watanabe H, Duarri A, Fokkens MR, Meijer M, Zhou Q, Yakovleva T, Boddeke E, den Dunnen W, van Deursen J, Bakalkin G, Kampinga HH, van de Sluis B, Verbeek DS", "title": "Elevated mutant dynorphin A causes Purkinje cell loss and motor dysfunction in spinocerebellar ataxia type 23.", "journal": "Brain 138:2537-52 (2015)", "doi": "10.1093/brain/awv195"}, {"pmid": "30910913", "authors": "  Tulli S, Del Bondio A, Baderna V, Mazza D, Codazzi F, Pierson TM, Ambrosi A, Nolte D, Goizet C, Toro C, Baets J, Deconinck T, DeJonghe P, Mandich P, Casari G, Maltecca F", "title": "Pathogenic variants in the AFG3L2 proteolytic domain cause SCA28 through haploinsufficiency and proteostatic stress-driven OMA1 activation.", "journal": "J Med Genet 56:499-511 (2019)", "doi": "10.1136/jmedgenet-2018-105766"}, {"pmid": "30389403", "authors": "  Mancini C, Hoxha E, Iommarini L, Brussino A, Richter U, Montarolo F, Cagnoli C, Parolisi R, Gondor Morosini DI, Nicolo V, Maltecca F, Muratori L, Ronchi G, Geuna S, Arnaboldi F, Donetti E, Giorgio E, Cavalieri S, Di Gregorio E, Pozzi E, Ferrero M, Riberi E, Casari G, Altruda F, Turco E, Gasparre G, Battersby BJ, Porcelli AM, Ferrero E, Brusco A, Tempia F", "title": "Mice harbouring a SCA28 patient mutation in AFG3L2 develop late-onset ataxia associated with enhanced mitochondrial proteotoxicity.", "journal": "Neurobiol Dis 124:14-28 (2019)", "doi": "10.1016/j.nbd.2018.10.018"}, {"pmid": "25772041", "authors": "  Becker EBE", "title": "From Mice to Men: TRPC3 in Cerebellar Ataxia.", "journal": "Cerebellum 16:877-879 (2017)", "doi": "10.1007/s12311-015-0663-y"}, {"pmid": "27857688", "authors": "  Hoxha E, Tempia F, Lippiello P, Miniaci MC", "title": "Modulation, Plasticity and Pathophysiology of the Parallel Fiber-Purkinje Cell Synapse.", "journal": "Front Synaptic Neurosci 8:35 (2016)", "doi": "10.3389/fnsyn.2016.00035"}, {"pmid": "23831029", "authors": "  Yan H, Pablo JL, Pitt GS", "title": "FGF14 regulates presynaptic Ca2+ channels and synaptic transmission.", "journal": "Cell Rep 4:66-75 (2013)", "doi": "10.1016/j.celrep.2013.06.012"}, {"pmid": "26827887", "authors": "  Tada M, Nishizawa M, Onodera O", "title": "Roles of inositol 1,4,5-trisphosphate receptors in spinocerebellar ataxias.", "journal": "Neurochem Int 94:1-8 (2016)", "doi": "10.1016/j.neuint.2016.01.007"}, {"pmid": "20204399", "authors": "  Pietrobon D", "title": "CaV2.1 channelopathies.", "journal": "Pflugers Arch 460:375-93 (2010)", "doi": "10.1007/s00424-010-0802-8"}, {"pmid": "15474358", "authors": "  Matsuyama Z, Yanagisawa NK, Aoki Y, Black JL 3rd, Lennon VA, Mori Y, Imoto K, Inuzuka T", "title": "Polyglutamine repeats of spinocerebellar ataxia 6 impair the cell-death-preventing effect of CaV2.1 Ca2+ channel--loss-of-function cellular model of SCA6.", "journal": "Neurobiol Dis 17:198-204 (2004)", "doi": "10.1016/j.nbd.2004.07.013"}, {"pmid": "12050113", "authors": "  Nishitoh H, Matsuzawa A, Tobiume K, Saegusa K, Takeda K, Inoue K, Hori S, Kakizuka A, Ichijo H", "title": "ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats.", "journal": "Genes Dev 16:1345-55 (2002)", "doi": "10.1101/gad.992302"}, {"pmid": "24293103", "authors": "  Evers MM, Toonen LJ, van Roon-Mom WM", "title": "Ataxin-3 protein and RNA toxicity in spinocerebellar ataxia type 3: current insights and emerging therapeutic strategies.", "journal": "Mol Neurobiol 49:1513-31 (2014)", "doi": "10.1007/s12035-013-8596-2"}, {"pmid": "28722507", "authors": "  Ashkenazi A, Bento CF, Ricketts T, Vicinanza M, Siddiqi F, Pavel M, Squitieri F, Hardenberg MC, Imarisio S, Menzies FM, Rubinsztein DC", "title": "Polyglutamine tracts regulate autophagy.", "journal": "Autophagy 13:1613-1614 (2017)", "doi": "10.1080/15548627.2017.1336278"}, {"pmid": "31630678", "authors": "  Chen RH, Chen YH, Huang TY", "title": "Ubiquitin-mediated regulation of autophagy.", "journal": "J Biomed Sci 26:80 (2019)", "doi": "10.1186/s12929-019-0569-y"}, {"pmid": "17110330", "authors": "  Serra HG, Duvick L, Zu T, Carlson K, Stevens S, Jorgensen N, Lysholm A, Burright E, Zoghbi HY, Clark HB, Andresen JM, Orr HT", "title": "RORalpha-mediated Purkinje cell development determines disease severity in adult SCA1 mice.", "journal": "Cell 127:697-708 (2006)", "doi": "10.1016/j.cell.2006.09.036"}, {"pmid": "29526553", "authors": "  Rousseaux MWC, Tschumperlin T, Lu HC, Lackey EP, Bondar VV, Wan YW, Tan Q, Adamski CJ, Friedrich J, Twaroski K, Chen W, Tolar J, Henzler C, Sharma A, Bajic A, Lin T, Duvick L, Liu Z, Sillitoe RV, Zoghbi HY, Orr HT", "title": "ATXN1-CIC Complex Is the Primary Driver of Cerebellar Pathology in Spinocerebellar Ataxia Type 1 through a Gain-of-Function Mechanism.", "journal": "Neuron 97:1235-1243.e5 (2018)", "doi": "10.1016/j.neuron.2018.02.013"}, {"pmid": "22526417", "authors": "  Jimenez G, Shvartsman SY, Paroush Z", "title": "The Capicua repressor--a general sensor of RTK signaling in development and disease.", "journal": "J Cell Sci 125:1383-91 (2012)", "doi": "10.1242/jcs.092965"}, {"pmid": "29474920", "authors": "  Gennarino VA, Palmer EE, McDonell LM, Wang L, Adamski CJ, Koire A, See L, Chen CA, Schaaf CP, Rosenfeld JA, Panzer JA, Moog U, Hao S, Bye A, Kirk EP, Stankiewicz P, Breman AM, McBride A, Kandula T, Dubbs HA, Macintosh R, Cardamone M, Zhu Y, Ying K, Dias KR, Cho MT, Henderson LB, Baskin B, Morris P, Tao J, Cowley MJ, Dinger ME, Roscioli T, Caluseriu O, Suchowersky O, Sachdev RK, Lichtarge O, Tang J, Boycott KM, Holder JL Jr, Zoghbi HY", "title": "A Mild PUM1 Mutation Is Associated with Adult-Onset Ataxia, whereas Haploinsufficiency Causes Developmental Delay and Seizures.", "journal": "Cell 172:924-936.e11 (2018)", "doi": "10.1016/j.cell.2018.02.006"}, {"pmid": "24218544", "authors": "  Irie T, Matsuzaki Y, Sekino Y, Hirai H", "title": "Kv3.3 channels harbouring a mutation of spinocerebellar ataxia type 13 alter excitability and induce cell death in cultured cerebellar Purkinje cells.", "journal": "J Physiol 592:229-47 (2014)", "doi": "10.1113/jphysiol.2013.264309"}, {"pmid": "26889478", "authors": "  Bushart DD, Murphy GG, Shakkottai VG", "title": "Precision medicine in spinocerebellar ataxias: treatment based on common mechanisms of disease.", "journal": "Ann Transl Med 4:25 (2016)", "doi": "10.3978/j.issn.2305-5839.2016.01.06"}, {"pmid": "31293010", "authors": "  Hsiao CT, Fu SJ, Liu YT, Lu YH, Zhong CY, Tang CY, Soong BW, Jeng CJ", "title": "Novel SCA19/22-associated KCND3 mutations disrupt human KV 4.3 protein biosynthesis and channel gating.", "journal": "Hum Mutat 40:2088-2107 (2019)", "doi": "10.1002/humu.23865"}, {"pmid": "25854634", "authors": "  Duarri A, Lin MC, Fokkens MR, Meijer M, Smeets CJ, Nibbeling EA, Boddeke E, Sinke RJ, Kampinga HH, Papazian DM, Verbeek DS", "title": "Spinocerebellar ataxia type 19/22 mutations alter heterocomplex Kv4.3 channel function and gating in a dominant manner.", "journal": "Cell Mol Life Sci 72:3387-99 (2015)", "doi": "10.1007/s00018-015-1894-2"}, {"pmid": "29939198", "authors": "  Corral-Juan M, Serrano-Munuera C, Rabano A, Cota-Gonzalez D, Segarra-Roca A, Ispierto L, Cano-Orgaz AT, Adarmes AD, Mendez-Del-Barrio C, Jesus S, Mir P, Volpini V, Alvarez-Ramo R, Sanchez I, Matilla-Duenas A", "title": "Clinical, genetic and neuropathological characterization of spinocerebellar ataxia type 37.", "journal": "Brain 141:1981-1997 (2018)", "doi": "10.1093/brain/awy137"}, {"pmid": "31721251", "authors": "  Swinnen B, Robberecht W, Van Den Bosch L", "title": "RNA toxicity in non-coding repeat expansion disorders.", "journal": "EMBO J e101112 (2019)", "doi": "10.15252/embj.2018101112"}, {"pmid": "31755042", "authors": "  Ishikawa K, Nagai Y", "title": "Molecular Mechanisms and Future Therapeutics for Spinocerebellar Ataxia Type 31 (SCA31).", "journal": "Neurotherapeutics 10.1007/s13311-019-00804-6 (2019)", "doi": "10.1007/s13311-019-00804-6"}, {"pmid": "23607545", "authors": "  Niimi Y, Takahashi M, Sugawara E, Umeda S, Obayashi M, Sato N, Ishiguro T, Higashi M, Eishi Y, Mizusawa H, Ishikawa K", "title": "Abnormal RNA structures (RNA foci) containing a penta-nucleotide repeat (UGGAA)n in the Purkinje cell nucleus is associated with spinocerebellar ataxia type 31 pathogenesis.", "journal": "Neuropathology 33:600-11 (2013)", "doi": "10.1111/neup.12032"}], "rel_pathway": ["hsa03050  Proteasome", "hsa04020  Calcium signaling pathway", "hsa04140  Autophagy - animal", "hsa04141  Protein processing in endoplasmic reticulum", "hsa04210  Apoptosis", "hsa04724  Glutamatergic synapse", "hsa04730  Long-term depression"], "ko_pathway": "ko05017", "genes": ["AKT2", "AKT1"]}, {"kegg_id": "hsa05142", "name": "Chagas disease - Homo sapiens (human)", "description": "Trypanosoma cruzi is an intracellular protozoan parasite that causes Chagas disease, also called American trypanosomiasis. The parasite life cycle involves hematophagous reduviid bugs as vectors. Once parasites enter the host body, they invade diverse host cells including cardiomyocytes. Establishment of infection depends on various parasite molecules such as cruzipain, oligopeptidase B, and trans-sialidase that activate Ca2+ signaling. Internalized parasites escape from the parasitophorous vacuole using secreted pore-forming TcTOX molecule and replicate in the cytosol. Multiplied parasites eventually lyse infected host cells and are released in the circulation. During these events, the parasites manipulate host innate immunity and elicit cardiomyocyte hypertrophy. T lymphocyte responses are also disturbed.", "class": "Human Diseases; Infectious disease: parasitic", "pathway_map": "hsa05142  Chagas disease", "disease": ["H00358  Chagas disease"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["7099  TLR4; toll like receptor 4 [KO:K10160]", "148022  TICAM1; TIR domain containing adaptor molecule 1 [KO:K05842]", "7097  TLR2; toll like receptor 2 [KO:K10159]", "10333  TLR6; toll like receptor 6 [KO:K10169]", "54106  TLR9; toll like receptor 9 [KO:K10161]", "4615  MYD88; MYD88 innate immune signal transduction adaptor [KO:K04729]", "3654  IRAK1; interleukin 1 receptor associated kinase 1 [KO:K04730] [EC:2.7.11.1]", "51135  IRAK4; interleukin 1 receptor associated kinase 4 [KO:K04733] [EC:2.7.11.1]", "7189  TRAF6; TNF receptor associated factor 6 [KO:K03175] [EC:2.3.2.27]", "6416  MAP2K4; mitogen-activated protein kinase kinase 4 [KO:K04430] [EC:2.7.12.2]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "3456  IFNB1; interferon beta 1 [KO:K05415]", "6352  CCL5; C-C motif chemokine ligand 5 [KO:K12499]", "6347  CCL2; C-C motif chemokine ligand 2 [KO:K14624]", "7124  TNF; tumor necrosis factor [KO:K03156]", "3592  IL12A; interleukin 12A [KO:K05406]", "3593  IL12B; interleukin 12B [KO:K05425]", "3569  IL6; interleukin 6 [KO:K05405]", "3576  CXCL8; C-X-C motif chemokine ligand 8 [KO:K10030]", "6348  CCL3; C-C motif chemokine ligand 3 [KO:K05408]", "6349  CCL3L1; C-C motif chemokine ligand 3 like 1 [KO:K05408]", "414062  CCL3L3; C-C motif chemokine ligand 3 like 3 [KO:K05408]", "3553  IL1B; interleukin 1 beta [KO:K04519]", "5519  PPP2R1B; protein phosphatase 2 scaffold subunit Abeta [KO:K03456]", "5518  PPP2R1A; protein phosphatase 2 scaffold subunit Aalpha [KO:K03456]", "5520  PPP2R2A; protein phosphatase 2 regulatory subunit Balpha [KO:K04354]", "5521  PPP2R2B; protein phosphatase 2 regulatory subunit Bbeta [KO:K04354]", "5522  PPP2R2C; protein phosphatase 2 regulatory subunit Bgamma [KO:K04354]", "55844  PPP2R2D; protein phosphatase 2 regulatory subunit Bdelta [KO:K04354]", "5515  PPP2CA; protein phosphatase 2 catalytic subunit alpha [KO:K04382] [EC:3.1.3.16]", "5516  PPP2CB; protein phosphatase 2 catalytic subunit beta [KO:K04382] [EC:3.1.3.16]", "3458  IFNG; interferon gamma [KO:K04687]", "3459  IFNGR1; interferon gamma receptor 1 [KO:K05132]", "3460  IFNGR2; interferon gamma receptor 2 [KO:K05133]", "7132  TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158]", "4843  NOS2; nitric oxide synthase 2 [KO:K13241] [EC:1.14.13.39]", "718  C3; complement C3 [KO:K03990]", "811  CALR; calreticulin [KO:K08057]", "712  C1QA; complement C1q A chain [KO:K03986]", "713  C1QB; complement C1q B chain [KO:K03987]", "714  C1QC; complement C1q C chain [KO:K03988]", "3586  IL10; interleukin 10 [KO:K05443]", "7040  TGFB1; transforming growth factor beta 1 [KO:K13375]", "7042  TGFB2; transforming growth factor beta 2 [KO:K13376]", "7043  TGFB3; transforming growth factor beta 3 [KO:K13377]", "1636  ACE; angiotensin I converting enzyme [KO:K01283] [EC:3.4.15.1]", "3827  KNG1; kininogen 1 [KO:K03898]", "624  BDKRB2; bradykinin receptor B2 [KO:K03916]", "2776  GNAQ; G protein subunit alpha q [KO:K04634]", "2767  GNA11; G protein subunit alpha 11 [KO:K04635]", "9630  GNA14; G protein subunit alpha 14 [KO:K04636]", "2769  GNA15; G protein subunit alpha 15 [KO:K04637]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "2770  GNAI1; G protein subunit alpha i1 [KO:K04630]", "2773  GNAI3; G protein subunit alpha i3 [KO:K04630]", "2771  GNAI2; G protein subunit alpha i2 [KO:K04630]", "2775  GNAO1; G protein subunit alpha o1 [KO:K04534]", "2778  GNAS; GNAS complex locus [KO:K04632]", "2774  GNAL; G protein subunit alpha L [KO:K04633]", "107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "7048  TGFBR2; transforming growth factor beta receptor 2 [KO:K04388] [EC:2.7.11.30]", "7046  TGFBR1; transforming growth factor beta receptor 1 [KO:K04674] [EC:2.7.11.30]", "4087  SMAD2; SMAD family member 2 [KO:K04500]", "5054  SERPINE1; serpin family E member 1 [KO:K03982]", "356  FASLG; Fas ligand [KO:K04389]", "355  FAS; Fas cell surface death receptor [KO:K04390]", "8772  FADD; Fas associated via death domain [KO:K02373]", "841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]", "8837  CFLAR; CASP8 and FADD like apoptosis regulator [KO:K04724]", "915  CD3D; CD3 delta subunit of T-cell receptor complex [KO:K06450]", "916  CD3E; CD3 epsilon subunit of T-cell receptor complex [KO:K06451]", "917  CD3G; CD3 gamma subunit of T-cell receptor complex [KO:K06452]", "919  CD247; CD247 molecule [KO:K06453]", "3558  IL2; interleukin 2 [KO:K05429]"], "compound": ["C00062  L-Arginine", "C00076  Calcium cation", "C00533  Nitric oxide", "C00575  3',5'-Cyclic AMP", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C05981  Phosphatidylinositol-3,4,5-trisphosphate"], "refs": [{"pmid": "10234174", "authors": "  Bogdan C, Rollinghoff M", "title": "How do protozoan parasites survive inside macrophages?", "journal": "Parasitol Today 15:22-8 (1999)", "doi": "10.1016/S0169-4758(98)01362-3"}, {"pmid": "17110955", "authors": "  Gazzinelli RT, Denkers EY", "title": "Protozoan encounters with Toll-like receptor signalling pathways: implications for host parasitism.", "journal": "Nat Rev Immunol 6:895-906 (2006)", "doi": "10.1038/nri1978"}, {"pmid": "16238097", "authors": "  Aguilar L, Ramirez G, Valck C, Molina MC, Rojas A, Schwaeble W, Ferreira V, Ferreira A", "title": "F(ab')2 antibody fragments against Trypanosoma cruzi calreticulin inhibit its interaction with the first component of human complement.", "journal": "Biol Res 38:187-95 (2005)", "doi": "10.4067/S0716-97602005000200008"}, {"pmid": "15223603", "authors": "  Campos MA, Gazzinelli RT", "title": "Trypanosoma cruzi and its components as exogenous mediators of inflammation recognized through Toll-like receptors.", "journal": "Mediators Inflamm 13:139-43 (2004)", "doi": "10.1080/09511920410001713565"}, {"pmid": "12427093", "authors": "  Burleigh BA, Woolsey AM", "title": "Cell signalling and Trypanosoma cruzi invasion.", "journal": "Cell Microbiol 4:701-11 (2002)", "doi": "10.1046/j.1462-5822.2002.00226.x"}, {"pmid": "17651955", "authors": "  Tarleton RL", "title": "Immune system recognition of Trypanosoma cruzi.", "journal": "Curr Opin Immunol 19:430-4 (2007)", "doi": "10.1016/j.coi.2007.06.003"}, {"pmid": "16175174", "authors": "  Andrade LO, Andrews NW", "title": "The Trypanosoma cruzi-host-cell interplay: location, invasion, retention.", "journal": "Nat Rev Microbiol 3:819-23 (2005)", "doi": "10.1038/nrmicro1249"}, {"pmid": "12377585", "authors": "  Tan H, Andrews NW", "title": "Don't bother to knock--the cell invasion strategy of Trypanosoma cruzi.", "journal": "Trends Parasitol 18:427-8 (2002)", "doi": "10.1016/S1471-4922(02)02368-1"}, {"pmid": "10066513", "authors": "  Burleigh BA, Andrews NW", "title": "Signaling and host cell invasion by Trypanosoma cruzi.", "journal": "Curr Opin Microbiol 1:461-5 (1998)", "doi": "10.1016/S1369-5274(98)80066-0"}, {"pmid": "12377942", "authors": "  Stempin C, Giordanengo L, Gea S, Cerban F", "title": "Alternative activation and increase of Trypanosoma cruzi survival in murine macrophages stimulated by cruzipain, a parasite antigen.", "journal": "J Leukoc Biol 72:727-34 (2002)", "doi": "10.1189/jlb.72.4.727"}, {"pmid": "16030288", "authors": "  Burleigh BA", "title": "Host cell signaling and Trypanosoma cruzi invasion: do all roads lead to lysosomes?", "journal": "Sci STKE 2005:pe36 (2005)", "doi": "10.1126/stke.2932005pe36"}, {"pmid": "1396957", "authors": "  Gazzinelli RT, Oswald IP, Hieny S, James SL, Sher A", "title": "The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta.", "journal": "Eur J Immunol 22:2501-6 (1992)", "doi": "10.1002/eji.1830221006"}, {"pmid": "2194668", "authors": "  Andrews NW, Abrams CK, Slatin SL, Griffiths G", "title": "A T. cruzi-secreted protein immunologically related to the complement component C9: evidence for membrane pore-forming activity at low pH.", "journal": "Cell 61:1277-87 (1990)", "doi": "10.1016/0092-8674(90)90692-8"}, {"pmid": "15917295", "authors": "  Hashimoto M, Nakajima-Shimada J, Aoki T", "title": "Trypanosoma cruzi posttranscriptionally up-regulates and exploits cellular FLIP for inhibition of death-inducing signal.", "journal": "Mol Biol Cell 16:3521-8 (2005)", "doi": "10.1091/mbc.E04-12-1051"}, {"pmid": "12874238", "authors": "  Ropert C, Closel M, Chaves AC, Gazzinelli RT", "title": "Inhibition of a p38/stress-activated protein kinase-2-dependent phosphatase restores function of IL-1 receptor-associate kinase-1 and reverses Toll-like receptor 2- and 4-dependent tolerance of macrophages.", "journal": "J Immunol 171:1456-65 (2003)", "doi": "10.4049/jimmunol.171.3.1456"}, {"pmid": "12055254", "authors": "  Ouaissi A, Guilvard E, Delneste Y, Caron G, Magistrelli G, Herbault N, Thieblemont N, Jeannin P", "title": "The Trypanosoma cruzi Tc52-released protein induces human dendritic cell maturation, signals via Toll-like receptor 2, and confers protection against lethal infection.", "journal": "J Immunol 168:6366-74 (2002)", "doi": "10.4049/jimmunol.168.12.6366"}, {"pmid": "12036740", "authors": "  Teixeira MM, Gazzinelli RT, Silva JS", "title": "Chemokines, inflammation and Trypanosoma cruzi infection.", "journal": "Trends Parasitol 18:262-5 (2002)", "doi": "10.1016/S1471-4922(02)02283-3"}], "rel_pathway": ["hsa00330  Arginine and proline metabolism", "hsa04020  Calcium signaling pathway", "hsa04070  Phosphatidylinositol signaling system", "hsa04210  Apoptosis", "hsa04350  TGF-beta signaling pathway", "hsa04610  Complement and coagulation cascades", "hsa04620  Toll-like receptor signaling pathway", "hsa04670  Leukocyte transendothelial migration"], "ko_pathway": "ko05142", "genes": ["AKT2", "AKT1", "MAPK13"]}, {"kegg_id": "hsa05145", "name": "Toxoplasmosis - Homo sapiens (human)", "description": "Toxoplasma gondii is an obligate intracellular parasite that is prevalent worldwide. The tachyzoite form acquired by oral ingestion downmodulates proinflammatory signaling pathways via various mechanisms. During early infection, nuclear translocation of NFkB is temporally blocked and p38 MAPK phosphorylation is prevented, suppressing IL-12 production. Another pathway for IL-12 induction occurs through CCR5 dependent pathway, but parasitic induction of an eicosanoid LXA4 contributes to the downregulation of IL-12. Direct activation of STAT3 by the parasite enhance anti-inflammatory function of IL-10 and TGF beta. T. gondii can cause lifelong chronic infection by establishing an anti-apoptotic environment through induction of bcl-2 or IAPs and by redirecting LDL-mediated cholesterol transport to scavenge nutrients from the host.", "class": "Human Diseases; Infectious disease: parasitic", "pathway_map": "hsa05145  Toxoplasmosis", "disease": ["H00435  Toxoplasmosis"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["3458  IFNG; interferon gamma [KO:K04687]", "3459  IFNGR1; interferon gamma receptor 1 [KO:K05132]", "3460  IFNGR2; interferon gamma receptor 2 [KO:K05133]", "3716  JAK1; Janus kinase 1 [KO:K11217] [EC:2.7.10.2]", "3717  JAK2; Janus kinase 2 [KO:K04447] [EC:2.7.10.2]", "6772  STAT1; signal transducer and activator of transcription 1 [KO:K11220]", "4261  CIITA; class II major histocompatibility complex transactivator [KO:K08060] [EC:2.7.11.1]", "3108  HLA-DMA; major histocompatibility complex, class II, DM alpha [KO:K06752]", "3109  HLA-DMB; major histocompatibility complex, class II, DM beta [KO:K06752]", "3111  HLA-DOA; major histocompatibility complex, class II, DO alpha [KO:K06752]", "3112  HLA-DOB; major histocompatibility complex, class II, DO beta [KO:K06752]", "3113  HLA-DPA1; major histocompatibility complex, class II, DP alpha 1 [KO:K06752]", "3115  HLA-DPB1; major histocompatibility complex, class II, DP beta 1 [KO:K06752]", "3117  HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 [KO:K06752]", "3118  HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2 [KO:K06752]", "3119  HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 [KO:K06752]", "3122  HLA-DRA; major histocompatibility complex, class II, DR alpha [KO:K06752]", "3123  HLA-DRB1; major histocompatibility complex, class II, DR beta 1 [KO:K06752]", "3125  HLA-DRB3; major histocompatibility complex, class II, DR beta 3 [KO:K06752]", "3126  HLA-DRB4; major histocompatibility complex, class II, DR beta 4 [KO:K06752]", "3127  HLA-DRB5; major histocompatibility complex, class II, DR beta 5 [KO:K06752]", "345611  IRGM; immunity related GTPase M [KO:K14139] [EC:3.6.5.-]", "4843  NOS2; nitric oxide synthase 2 [KO:K13241] [EC:1.14.13.39]", "8651  SOCS1; suppressor of cytokine signaling 1 [KO:K04694]", "4615  MYD88; MYD88 innate immune signal transduction adaptor [KO:K04729]", "3654  IRAK1; interleukin 1 receptor associated kinase 1 [KO:K04730] [EC:2.7.11.1]", "51135  IRAK4; interleukin 1 receptor associated kinase 4 [KO:K04733] [EC:2.7.11.1]", "7189  TRAF6; TNF receptor associated factor 6 [KO:K03175] [EC:2.3.2.27]", "6885  MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO:K04427] [EC:2.7.11.25]", "10454  TAB1; TGF-beta activated kinase 1 (MAP3K7) binding protein 1 [KO:K04403]", "23118  TAB2; TGF-beta activated kinase 1 (MAP3K7) binding protein 2 [KO:K04404]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "5606  MAP2K3; mitogen-activated protein kinase kinase 3 [KO:K04432] [EC:2.7.12.2]", "5608  MAP2K6; mitogen-activated protein kinase kinase 6 [KO:K04433] [EC:2.7.12.2]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "4793  NFKBIB; NFKB inhibitor beta [KO:K02581]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "3592  IL12A; interleukin 12A [KO:K05406]", "3593  IL12B; interleukin 12B [KO:K05425]", "7124  TNF; tumor necrosis factor [KO:K03156]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]", "598  BCL2L1; BCL2 like 1 [KO:K04570]", "329  BIRC2; baculoviral IAP repeat containing 2 [KO:K16060]", "330  BIRC3; baculoviral IAP repeat containing 3 [KO:K16060]", "331  XIAP; X-linked inhibitor of apoptosis [KO:K04725] [EC:2.3.2.27]", "79444  BIRC7; baculoviral IAP repeat containing 7 [KO:K16061]", "23643  LY96; lymphocyte antigen 96 [KO:K05400]", "7099  TLR4; toll like receptor 4 [KO:K10160]", "3312  HSPA8; heat shock protein family A (Hsp70) member 8 [KO:K03283]", "3303  HSPA1A; heat shock protein family A (Hsp70) member 1A [KO:K03283]", "3305  HSPA1L; heat shock protein family A (Hsp70) member 1 like [KO:K03283]", "3304  HSPA1B; heat shock protein family A (Hsp70) member 1B [KO:K03283]", "3310  HSPA6; heat shock protein family A (Hsp70) member 6 [KO:K03283]", "7097  TLR2; toll like receptor 2 [KO:K10159]", "284217  LAMA1; laminin subunit alpha 1 [KO:K05637]", "3908  LAMA2; laminin subunit alpha 2 [KO:K05637]", "3909  LAMA3; laminin subunit alpha 3 [KO:K06240]", "3911  LAMA5; laminin subunit alpha 5 [KO:K06240]", "3910  LAMA4; laminin subunit alpha 4 [KO:K06241]", "3912  LAMB1; laminin subunit beta 1 [KO:K05636]", "3913  LAMB2; laminin subunit beta 2 [KO:K06243]", "3914  LAMB3; laminin subunit beta 3 [KO:K06244]", "22798  LAMB4; laminin subunit beta 4 [KO:K06245]", "3915  LAMC1; laminin subunit gamma 1 [KO:K05635]", "3918  LAMC2; laminin subunit gamma 2 [KO:K06246]", "10319  LAMC3; laminin subunit gamma 3 [KO:K06247]", "3655  ITGA6; integrin subunit alpha 6 [KO:K06485]", "3688  ITGB1; integrin subunit beta 1 [KO:K05719]", "3949  LDLR; low density lipoprotein receptor [KO:K12473]", "7132  TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158]", "841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "54205  CYCS; cytochrome c, somatic [KO:K08738]", "842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]", "2770  GNAI1; G protein subunit alpha i1 [KO:K04630]", "2773  GNAI3; G protein subunit alpha i3 [KO:K04630]", "2771  GNAI2; G protein subunit alpha i2 [KO:K04630]", "2775  GNAO1; G protein subunit alpha o1 [KO:K04534]", "5294  PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma [KO:K21289] [EC:2.7.1.153]", "23533  PIK3R5; phosphoinositide-3-kinase regulatory subunit 5 [KO:K21290]", "146850  PIK3R6; phosphoinositide-3-kinase regulatory subunit 6 [KO:K21290]", "5170  PDPK1; 3-phosphoinositide dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "572  BAD; BCL2 associated agonist of cell death [KO:K02158]", "959  CD40LG; CD40 ligand [KO:K03161]", "958  CD40; CD40 molecule [KO:K03160]", "10105  PPIF; peptidylprolyl isomerase F [KO:K09565] [EC:5.2.1.8]", "1234  CCR5; C-C motif chemokine receptor 5 [KO:K04180]", "240  ALOX5; arachidonate 5-lipoxygenase [KO:K00461] [EC:1.13.11.34]", "3586  IL10; interleukin 10 [KO:K05443]", "3587  IL10RA; interleukin 10 receptor subunit alpha [KO:K05134]", "3588  IL10RB; interleukin 10 receptor subunit beta [KO:K05135]", "7297  TYK2; tyrosine kinase 2 [KO:K11219] [EC:2.7.10.2]", "6774  STAT3; signal transducer and activator of transcription 3 [KO:K04692]", "7040  TGFB1; transforming growth factor beta 1 [KO:K13375]", "7042  TGFB2; transforming growth factor beta 2 [KO:K13376]", "7043  TGFB3; transforming growth factor beta 3 [KO:K13377]"], "compound": ["C00076  Calcium cation", "C05981  Phosphatidylinositol-3,4,5-trisphosphate", "C06314  Lipoxin A4"], "refs": [{"pmid": "15639739", "authors": "  Denkers EY, Butcher BA", "title": "Sabotage and exploitation in macrophages parasitized by intracellular protozoans.", "journal": "Trends Parasitol 21:35-41 (2005)", "doi": "10.1016/j.pt.2004.10.004"}, {"pmid": "14642303", "authors": "  Denkers EY", "title": "From cells to signaling cascades: manipulation of innate immunity by Toxoplasma gondii.", "journal": "FEMS Immunol Med Microbiol 39:193-203 (2003)", "doi": "10.1016/S0928-8244(03)00279-7"}, {"pmid": "19744886", "authors": "  Pollard AM, Knoll LJ, Mordue DG", "title": "The role of specific Toxoplasma gondii molecules in manipulation of innate immunity.", "journal": "Trends Parasitol 25:491-4 (2009)", "doi": "10.1016/j.pt.2009.07.009"}, {"pmid": "19891610", "authors": "  Leng J, Butcher BA, Denkers EY", "title": "Dysregulation of macrophage signal transduction by Toxoplasma gondii: past progress and recent advances.", "journal": "Parasite Immunol 31:717-28 (2009)", "doi": "10.1111/j.1365-3024.2009.01122.x"}, {"pmid": "18775432", "authors": "  Miller CM, Boulter NR, Ikin RJ, Smith NC", "title": "The immunobiology of the innate response to Toxoplasma gondii.", "journal": "Int J Parasitol 39:23-39 (2009)", "doi": "10.1016/j.ijpara.2008.08.002"}, {"pmid": "12580944", "authors": "  Denkers EY, Kim L, Butcher BA", "title": "In the belly of the beast: subversion of macrophage proinflammatory signalling cascades during Toxoplasma gondii infection.", "journal": "Cell Microbiol 5:75-83 (2003)", "doi": "10.1046/j.1462-5822.2003.00258.x"}, {"pmid": "17110955", "authors": "  Gazzinelli RT, Denkers EY", "title": "Protozoan encounters with Toll-like receptor signalling pathways: implications for host parasitism.", "journal": "Nat Rev Immunol 6:895-906 (2006)", "doi": "10.1038/nri1978"}, {"pmid": "17024357", "authors": "  Lang C, Gross U, Luder CG", "title": "Subversion of innate and adaptive immune responses by Toxoplasma gondii.", "journal": "Parasitol Res 100:191-203 (2007)", "doi": "10.1007/s00436-006-0306-9"}, {"pmid": "19400868", "authors": "  Blader IJ, Saeij JP", "title": "Communication between Toxoplasma gondii and its host: impact on parasite growth, development, immune evasion, and virulence.", "journal": "APMIS 117:458-76 (2009)", "doi": "10.1111/j.1600-0463.2009.02453.x"}, {"pmid": "18059289", "authors": "  Boothroyd JC, Dubremetz JF", "title": "Kiss and spit: the dual roles of Toxoplasma rhoptries.", "journal": "Nat Rev Microbiol 6:79-88 (2008)", "doi": "10.1038/nrmicro1800"}, {"pmid": "15361242", "authors": "  Denkers EY, Butcher BA, Del Rio L, Kim L", "title": "Manipulation of mitogen-activated protein kinase/nuclear factor-kappaB-signaling cascades during intracellular Toxoplasma gondii infection.", "journal": "Immunol Rev 201:191-205 (2004)", "doi": "10.1111/j.0105-2896.2004.00180.x"}, {"pmid": "18617274", "authors": "  Yarovinsky F", "title": "Toll-like receptors and their role in host resistance to Toxoplasma gondii.", "journal": "Immunol Lett 119:17-21 (2008)", "doi": "10.1016/j.imlet.2008.05.007"}, {"pmid": "14987366", "authors": "  Coppens I, Joiner KA", "title": "Parasitehost cell interactions in toxoplasmosis: new avenues for intervention?", "journal": "Expert Rev Mol Med 2001:1-20 (2001)", "doi": "10.1017/S1462399401002277"}, {"pmid": "12106793", "authors": "  Aliberti J, Sher A", "title": "Role of G-protein-coupled signaling in the induction and regulation of dendritic cell function by Toxoplasma gondii.", "journal": "Microbes Infect 4:991-7 (2002)", "doi": "10.1016/S1286-4579(02)01618-0"}, {"pmid": "12857995", "authors": "  Sher A, Collazzo C, Scanga C, Jankovic D, Yap G, Aliberti J", "title": "Induction and regulation of IL-12-dependent host resistance to Toxoplasma gondii.", "journal": "Immunol Res 27:521-8 (2003)", "doi": "10.1385/IR:27:2-3:521"}, {"pmid": "10525166", "authors": "  Bonhomme A, Bouchot A, Pezzella N, Gomez J, Le Moal H, Pinon JM", "title": "Signaling during the invasion of host cells by Toxoplasma gondii.", "journal": "FEMS Microbiol Rev 23:551-61 (1999)", "doi": "10.1111/j.1574-6976.1999.tb00413.x"}, {"pmid": "18327664", "authors": "  Laliberte J, Carruthers VB", "title": "Host cell manipulation by the human pathogen Toxoplasma gondii.", "journal": "Cell Mol Life Sci 65:1900-15 (2008)", "doi": "10.1007/s00018-008-7556-x"}, {"pmid": "10234174", "authors": "  Bogdan C, Rollinghoff M", "title": "How do protozoan parasites survive inside macrophages?", "journal": "Parasitol Today 15:22-8 (1999)", "doi": "10.1016/S0169-4758(98)01362-3"}], "rel_pathway": ["hsa00590  Arachidonic acid metabolism", "hsa04010  MAPK signaling pathway", "hsa04144  Endocytosis", "hsa04210  Apoptosis", "hsa04620  Toll-like receptor signaling pathway", "hsa04630  JAK-STAT signaling pathway"], "ko_pathway": "ko05145", "genes": ["AKT2", "BIRC3", "AKT1", "MAPK13"]}, {"kegg_id": "hsa05164", "name": "Influenza A - Homo sapiens (human)", "description": "Influenza is a contagious respiratory disease caused by influenza virus infection. Influenza A virus is responsible for both annual seasonal epidemics and periodic worldwide pandemics. Novel strains that cause pandemics arise from avian influenza virus by genetic reassortment among influenza viruses and two surface glycoproteins HA and NA form the basis of serologically distinct virus types. The innate immune system recognizes invaded virus through multiple mechanisms. Viral non-structural NS1 protein is a multifunctional virulence factor that interfere IFN-mediated antiviral response. It inhibits IFN production by blocking activation of transcription factors such as NF-kappa B and IRF3. NS1 further inhibits the activation of IFN-induced antiviral genes. PB1-F2 protein is another virulence factor that induce apoptosis of infected cells, which results in life-threatening bronchiolitis.", "class": "Human Diseases; Infectious disease: viral", "pathway_map": "hsa05164  Influenza A", "network": ["", "ELEMENT   N00724  IAV NS1 to oligoadenylate synthetase (OAS)/RNase L pathway", "N00725  IAV NS1 to PKR-eIF2alpha signaling pathway", "N00726  IAV NP to PKR-eIF2alpha signaling pathway", "N00727  IAV NS1 to RIG-I-like receptor signaling pathway", "N00728  IAV NS1 to RIG-I-like receptor signaling pathway", "N00729  IAV NS1 to RIG-I-like receptor signaling pathway", "N00730  IAV NS1 to RIG-I-like receptor signaling pathway", "N00732  IAV PB1-F2/PB2 to RIG-I-like receptor signaling pathway", "N00734  IAV PB1-F2/PB2 to RIG-I-like receptor signaling pathway", "N00736  IAV NS1 to PI3K signaling pathway", "N00738  IAV NS1 to IFN signaling pathway", "N00741  IAV M2 to cell cycle G1/S", "N00743  IAV NS1 to NLRP3 inflammasome signaling pathway", "N00744  IAV HA to ERK signaling pathway", "N00745  IAV PB1-F2 to intrinsic apoptotic pathway", "N00746  IAV NS1 to nuclear export of mRNA"], "disease": ["H00398  Influenza", "H00399  Avian influenza"], "drug": ["D12473  Zapnometinib (USAN/INN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["23430  TPSD1; tryptase delta 1 [KO:K01340] [EC:3.4.21.59]", "7177  TPSAB1; tryptase alpha/beta 1 [KO:K01340] [EC:3.4.21.59]", "64499  TPSB2; tryptase beta 2 [KO:K01340] [EC:3.4.21.59]", "5340  PLG; plasminogen [KO:K01315] [EC:3.4.21.7]", "5646  PRSS3; serine protease 3 [KO:K01312] [EC:3.4.21.4]", "5645  PRSS2; serine protease 2 [KO:K01312] [EC:3.4.21.4]", "5644  PRSS1; serine protease 1 [KO:K01312] [EC:3.4.21.4]", "7113  TMPRSS2; transmembrane serine protease 2 [KO:K09633] [EC:3.4.21.122]", "56649  TMPRSS4; transmembrane serine protease 4 [KO:K09635] [EC:3.4.21.-]", "9407  TMPRSS11D; transmembrane serine protease 11D [KO:K09641] [EC:3.4.21.-]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "4938  OAS1; 2'-5'-oligoadenylate synthetase 1 [KO:K14216] [EC:2.7.7.84]", "4939  OAS2; 2'-5'-oligoadenylate synthetase 2 [KO:K14216] [EC:2.7.7.84]", "4940  OAS3; 2'-5'-oligoadenylate synthetase 3 [KO:K14216] [EC:2.7.7.84]", "6041  RNASEL; ribonuclease L [KO:K01165]", "3337  DNAJB1; DnaJ heat shock protein family (Hsp40) member B1 [KO:K09507]", "5611  DNAJC3; DnaJ heat shock protein family (Hsp40) member C3 [KO:K09523]", "5610  EIF2AK2; eukaryotic translation initiation factor 2 alpha kinase 2 [KO:K16195] [EC:2.7.11.1]", "1965  EIF2S1; eukaryotic translation initiation factor 2 subunit alpha [KO:K03237]", "7706  TRIM25; tripartite motif containing 25 [KO:K10652] [EC:2.3.2.27]", "23586  RIGI; RNA sensor RIG-I [KO:K12646] [EC:5.6.2.6]", "64135  IFIH1; interferon induced with helicase C domain 1 [KO:K12647] [EC:5.6.2.6]", "79671  NLRX1; NLR family member X1 [KO:K12653]", "57506  MAVS; mitochondrial antiviral signaling protein [KO:K12648]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "4793  NFKBIB; NFKB inhibitor beta [KO:K02581]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "10241  CALCOCO2; calcium binding and coiled-coil domain 2 [KO:K21348]", "7098  TLR3; toll like receptor 3 [KO:K05401]", "148022  TICAM1; TIR domain containing adaptor molecule 1 [KO:K05842]", "7187  TRAF3; TNF receptor associated factor 3 [KO:K03174]", "29110  TBK1; TANK binding kinase 1 [KO:K05410] [EC:2.7.11.10]", "9641  IKBKE; inhibitor of nuclear factor kappa B kinase subunit epsilon [KO:K07211] [EC:2.7.11.10]", "3661  IRF3; interferon regulatory factor 3 [KO:K05411]", "1387  CREBBP; CREB binding protein [KO:K04498] [EC:2.3.1.48]", "2033  EP300; E1A binding protein p300 [KO:K04498] [EC:2.3.1.48]", "7099  TLR4; toll like receptor 4 [KO:K10160]", "51284  TLR7; toll like receptor 7 [KO:K05404]", "4615  MYD88; MYD88 innate immune signal transduction adaptor [KO:K04729]", "51135  IRAK4; interleukin 1 receptor associated kinase 4 [KO:K04733] [EC:2.7.11.1]", "3665  IRF7; interferon regulatory factor 7 [KO:K09447]", "3552  IL1A; interleukin 1 alpha [KO:K04383]", "3553  IL1B; interleukin 1 beta [KO:K04519]", "3569  IL6; interleukin 6 [KO:K05405]", "3592  IL12A; interleukin 12A [KO:K05406]", "3593  IL12B; interleukin 12B [KO:K05425]", "7124  TNF; tumor necrosis factor [KO:K03156]", "3576  CXCL8; C-X-C motif chemokine ligand 8 [KO:K10030]", "6347  CCL2; C-C motif chemokine ligand 2 [KO:K14624]", "6352  CCL5; C-C motif chemokine ligand 5 [KO:K12499]", "3627  CXCL10; C-X-C motif chemokine ligand 10 [KO:K12671]", "3383  ICAM1; intercellular adhesion molecule 1 [KO:K06490]", "3439  IFNA1; interferon alpha 1 [KO:K05414]", "3440  IFNA2; interferon alpha 2 [KO:K05414]", "3441  IFNA4; interferon alpha 4 [KO:K05414]", "3442  IFNA5; interferon alpha 5 [KO:K05414]", "3443  IFNA6; interferon alpha 6 [KO:K05414]", "3444  IFNA7; interferon alpha 7 [KO:K05414]", "3445  IFNA8; interferon alpha 8 [KO:K05414]", "3446  IFNA10; interferon alpha 10 [KO:K05414]", "3447  IFNA13; interferon alpha 13 [KO:K05414]", "3448  IFNA14; interferon alpha 14 [KO:K05414]", "3449  IFNA16; interferon alpha 16 [KO:K05414]", "3451  IFNA17; interferon alpha 17 [KO:K05414]", "3452  IFNA21; interferon alpha 21 [KO:K05414]", "3456  IFNB1; interferon beta 1 [KO:K05415]", "3454  IFNAR1; interferon alpha and beta receptor subunit 1 [KO:K05130]", "3455  IFNAR2; interferon alpha and beta receptor subunit 2 [KO:K05131]", "3716  JAK1; Janus kinase 1 [KO:K11217] [EC:2.7.10.2]", "7297  TYK2; tyrosine kinase 2 [KO:K11219] [EC:2.7.10.2]", "9021  SOCS3; suppressor of cytokine signaling 3 [KO:K04696]", "6772  STAT1; signal transducer and activator of transcription 1 [KO:K11220]", "6773  STAT2; signal transducer and activator of transcription 2 [KO:K11221]", "10379  IRF9; interferon regulatory factor 9 [KO:K04693]", "4599  MX1; MX dynamin like GTPase 1 [KO:K14754]", "4600  MX2; MX dynamin like GTPase 2 [KO:K14754]", "103  ADAR; adenosine deaminase RNA specific [KO:K12968] [EC:3.5.4.37]", "5371  PML; PML nuclear body scaffold [KO:K10054] [EC:2.3.2.-]", "3458  IFNG; interferon gamma [KO:K04687]", "3459  IFNGR1; interferon gamma receptor 1 [KO:K05132]", "3460  IFNGR2; interferon gamma receptor 2 [KO:K05133]", "3717  JAK2; Janus kinase 2 [KO:K04447] [EC:2.7.10.2]", "4261  CIITA; class II major histocompatibility complex transactivator [KO:K08060] [EC:2.7.11.1]", "3108  HLA-DMA; major histocompatibility complex, class II, DM alpha [KO:K06752]", "3109  HLA-DMB; major histocompatibility complex, class II, DM beta [KO:K06752]", "3111  HLA-DOA; major histocompatibility complex, class II, DO alpha [KO:K06752]", "3112  HLA-DOB; major histocompatibility complex, class II, DO beta [KO:K06752]", "3113  HLA-DPA1; major histocompatibility complex, class II, DP alpha 1 [KO:K06752]", "3115  HLA-DPB1; major histocompatibility complex, class II, DP beta 1 [KO:K06752]", "3117  HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 [KO:K06752]", "3118  HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2 [KO:K06752]", "3119  HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 [KO:K06752]", "3122  HLA-DRA; major histocompatibility complex, class II, DR alpha [KO:K06752]", "3123  HLA-DRB1; major histocompatibility complex, class II, DR beta 1 [KO:K06752]", "3125  HLA-DRB3; major histocompatibility complex, class II, DR beta 3 [KO:K06752]", "3126  HLA-DRB4; major histocompatibility complex, class II, DR beta 4 [KO:K06752]", "3127  HLA-DRB5; major histocompatibility complex, class II, DR beta 5 [KO:K06752]", "114548  NLRP3; NLR family pyrin domain containing 3 [KO:K12800]", "29108  PYCARD; PYD and CARD domain containing [KO:K12799]", "834  CASP1; caspase 1 [KO:K01370] [EC:3.4.22.36]", "3606  IL18; interleukin 18 [KO:K05482]", "90865  IL33; interleukin 33 [KO:K12967]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]", "208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]", "10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]", "896  CCND3; cyclin D3 [KO:K10152]", "1019  CDK4; cyclin dependent kinase 4 [KO:K02089] [EC:2.7.11.22]", "1021  CDK6; cyclin dependent kinase 6 [KO:K02091] [EC:2.7.11.22]", "8743  TNFSF10; TNF superfamily member 10 [KO:K04721]", "8797  TNFRSF10A; TNF receptor superfamily member 10a [KO:K04722]", "8795  TNFRSF10B; TNF receptor superfamily member 10b [KO:K04722]", "356  FASLG; Fas ligand [KO:K04389]", "355  FAS; Fas cell surface death receptor [KO:K04390]", "7132  TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158]", "8717  TRADD; TNFRSF1A associated via death domain [KO:K03171]", "8772  FADD; Fas associated via death domain [KO:K02373]", "841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]", "637  BID; BH3 interacting domain death agonist [KO:K04726]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "578  BAK1; BCL2 antagonist/killer 1 [KO:K14021]", "7416  VDAC1; voltage dependent anion channel 1 [KO:K05862]", "291  SLC25A4; solute carrier family 25 member 4 [KO:K05863]", "292  SLC25A5; solute carrier family 25 member 5 [KO:K05863]", "293  SLC25A6; solute carrier family 25 member 6 [KO:K05863]", "83447  SLC25A31; solute carrier family 25 member 31 [KO:K05863]", "54205  CYCS; cytochrome c, somatic [KO:K08738]", "317  APAF1; apoptotic peptidase activating factor 1 [KO:K02084]", "842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "10898  CPSF4; cleavage and polyadenylation specific factor 4 [KO:K14404]", "642843  CPSF4L; cleavage and polyadenylation specific factor 4 like [KO:K14404]", "8106  PABPN1; poly(A) binding protein nuclear 1 [KO:K14396]", "390748  PABPN1L; PABPN1 like, cytoplasmic [KO:K14396]", "100529063  BCL2L2-PABPN1; BCL2L2-PABPN1 readthrough [KO:K14396]", "10482  NXF1; nuclear RNA export factor 1 [KO:K14284]", "56001  NXF2; nuclear RNA export factor 2 [KO:K14284]", "728343  NXF2B; nuclear RNA export factor 2B [KO:K14284]", "56000  NXF3; nuclear RNA export factor 3 [KO:K14284]", "29107  NXT1; nuclear transport factor 2 like export factor 1 [KO:K14285]", "55916  NXT2; nuclear transport factor 2 like export factor 2 [KO:K14285]", "11100  HNRNPUL1; heterogeneous nuclear ribonucleoprotein U like 1 [KO:K15047]", "8480  RAE1; ribonucleic acid export 1 [KO:K14298]", "4928  NUP98; nucleoporin 98 and 96 precursor [KO:K14297]", "91543  RSAD2; radical S-adenosyl methionine domain containing 2 [KO:K15045]", "2224  FDPS; farnesyl diphosphate synthase [KO:K00787] [EC:2.5.1.1 2.5.1.10]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "71  ACTG1; actin gamma 1 [KO:K05692]", "60  ACTB; actin beta [KO:K05692]", "8766  RAB11A; RAB11A, member RAS oncogene family [KO:K07904]", "9230  RAB11B; RAB11B, member RAS oncogene family [KO:K07905]", "7514  XPO1; exportin 1 [KO:K14290]", "3836  KPNA1; karyopherin subunit alpha 1 [KO:K23940]", "3838  KPNA2; karyopherin subunit alpha 2 [KO:K15043]", "402569  KPNA7; karyopherin subunit alpha 7 [KO:K15043]", "23633  KPNA6; karyopherin subunit alpha 6 [KO:K15042]", "3841  KPNA5; karyopherin subunit alpha 5 [KO:K15042]"], "compound": ["C00027  Hydrogen peroxide", "C00080  H+", "C05981  Phosphatidylinositol-3,4,5-trisphosphate"], "refs": [{"pmid": "24225499", "authors": "  Edinger TO, Pohl MO, Stertz S", "title": "Entry of influenza A virus: host factors and antiviral targets.", "journal": "J Gen Virol 95:263-77 (2014)", "doi": "10.1099/vir.0.059477-0"}, {"pmid": "27751627", "authors": "  Ramakrishnan B, Viswanathan K, Tharakaraman K, Dancik V, Raman R, Babcock GJ, Shriver Z, Sasisekharan R", "title": "A Structural and Mathematical Modeling Analysis of the Likelihood of Antibody-Dependent Enhancement in Influenza.", "journal": "Trends Microbiol 24:933-943 (2016)", "doi": "10.1016/j.tim.2016.09.003"}, {"pmid": "18588994", "authors": "  Thanh TT, van Doorn HR, de Jong MD", "title": "Human H5N1 influenza: current insight into pathogenesis.", "journal": "Int J Biochem Cell Biol 40:2671-4 (2008)", "doi": "10.1016/j.biocel.2008.05.019"}, {"pmid": "23977434", "authors": "  Michael P, Brabant D, Bleiblo F, Ramana CV, Rutherford M, Khurana S, Tai TC, Kumar A, Kumar A", "title": "Influenza A induced cellular signal transduction pathways.", "journal": "J Thorac Dis 5 Suppl 2:S132-41 (2013)", "doi": "10.3978/j.issn.2072-1439.2013.07.42"}, {"pmid": "20020828", "authors": "  Hale BG, Albrecht RA, Garcia-Sastre A", "title": "Innate immune evasion strategies of influenza viruses.", "journal": "Future Microbiol 5:23-41 (2010)", "doi": "10.2217/fmb.09.108"}, {"pmid": "21698289", "authors": "  Sharma K, Tripathi S, Ranjan P, Kumar P, Garten R, Deyde V, Katz JM, Cox NJ, Lal RB, Sambhara S, Lal SK", "title": "Influenza A virus nucleoprotein exploits Hsp40 to inhibit PKR activation.", "journal": "PLoS One 6:e20215 (2011)", "doi": "10.1371/journal.pone.0020215"}, {"pmid": "19782761", "authors": "  Ehrhardt C, Seyer R, Hrincius ER, Eierhoff T, Wolff T, Ludwig S", "title": "Interplay between influenza A virus and the innate immune signaling.", "journal": "Microbes Infect 12:81-7 (2010)", "doi": "10.1016/j.micinf.2009.09.007"}, {"pmid": "23170167", "authors": "  van de Sandt CE, Kreijtz JH, Rimmelzwaan GF", "title": "Evasion of influenza A viruses from innate and adaptive immune responses.", "journal": "Viruses 4:1438-76 (2012)", "doi": "10.3390/v4091438"}, {"pmid": "30487536", "authors": "  Long JS, Mistry B, Haslam SM, Barclay WS", "title": "Host and viral determinants of influenza A virus species specificity.", "journal": "Nat Rev Microbiol 17:67-81 (2019)", "doi": "10.1038/s41579-018-0115-z"}, {"pmid": "29556226", "authors": "  Chen X, Liu S, Goraya MU, Maarouf M, Huang S, Chen JL", "title": "Host Immune Response to Influenza A Virus Infection.", "journal": "Front Immunol 9:320 (2018)", "doi": "10.3389/fimmu.2018.00320"}, {"pmid": "20130137", "authors": "  Lu X, Masic A, Li Y, Shin Y, Liu Q, Zhou Y", "title": "The PI3K/Akt pathway inhibits influenza A virus-induced Bax-mediated apoptosis by negatively regulating the JNK pathway via ASK1.", "journal": "J Gen Virol 91:1439-49 (2010)", "doi": "10.1099/vir.0.018465-0"}, {"pmid": "18980544", "authors": "  Ichinohe T, Iwasaki A, Hasegawa H", "title": "Innate sensors of influenza virus: clues to developing better intranasal vaccines.", "journal": "Expert Rev Vaccines 7:1435-45 (2008)", "doi": "10.1586/14760584.7.9.1435"}, {"pmid": "27231932", "authors": "  Le Sage V, Cinti A, Amorim R, Mouland AJ", "title": "Adapting the Stress Response: Viral Subversion of the mTOR Signaling Pathway.", "journal": "Viruses 8:E152 (2016)", "doi": "10.3390/v8060152"}, {"pmid": "30510918", "authors": "  Fan Y, Sanyal S, Bruzzone R", "title": "Breaking Bad: How Viruses Subvert the Cell Cycle.", "journal": "Front Cell Infect Microbiol 8:396 (2018)", "doi": "10.3389/fcimb.2018.00396"}, {"pmid": "21971186", "authors": "  Varga ZT, Palese P", "title": "The influenza A virus protein PB1-F2: killing two birds with one stone?", "journal": "Virulence 2:542-6 (2011)", "doi": "10.4161/viru.2.6.17812"}, {"pmid": "30254192", "authors": "  Atkin-Smith GK, Duan M, Chen W, Poon IKH", "title": "The induction and consequences of Influenza A virus-induced cell death.", "journal": "Cell Death Dis 9:1002 (2018)", "doi": "10.1038/s41419-018-1035-6"}, {"pmid": "30545063", "authors": "  Nogales A, Martinez-Sobrido L, Topham DJ, DeDiego ML", "title": "Modulation of Innate Immune Responses by the Influenza A NS1 and PA-X Proteins.", "journal": "Viruses 10:E708 (2018)", "doi": "10.3390/v10120708"}, {"pmid": "21253874", "authors": "  Dai X, Zhang L, Hong T", "title": "Host cellular signaling induced by influenza virus.", "journal": "Sci China Life Sci 54:68-74 (2011)", "doi": "10.1007/s11427-010-4116-z"}, {"pmid": "26008706", "authors": "  Li J, Yu M, Zheng W, Liu W", "title": "Nucleocytoplasmic shuttling of influenza A virus proteins.", "journal": "Viruses 7:2668-82 (2015)", "doi": "10.3390/v7052668"}, {"pmid": "30079062", "authors": "  Dou D, Revol R, Ostbye H, Wang H, Daniels R", "title": "Influenza A Virus Cell Entry, Replication, Virion Assembly and Movement.", "journal": "Front Immunol 9:1581 (2018)", "doi": "10.3389/fimmu.2018.01581"}], "rel_pathway": ["hsa00900  Terpenoid backbone biosynthesis", "hsa03013  Nucleocytoplasmic transport", "hsa03015  mRNA surveillance pathway", "hsa04010  MAPK signaling pathway", "hsa04110  Cell cycle", "hsa04144  Endocytosis", "hsa04210  Apoptosis", "hsa04620  Toll-like receptor signaling pathway", "hsa04621  NOD-like receptor signaling pathway", "hsa04622  RIG-I-like receptor signaling pathway", "hsa04630  JAK-STAT signaling pathway", "hsa05416  Viral myocarditis"], "ko_pathway": "ko05164", "genes": ["AKT2", "AKT1", "BAX"]}, {"kegg_id": "hsa05144", "name": "Malaria - Homo sapiens (human)", "description": "Plasmodium protozoa are parasites that account for malaria infection. Sporozoite forms of the parasite are injected by mosquito bites under the skin and are carried to the liver where they develop into the merozoite form.\nSporozoite invasion of hepatocytes is mediated by parasite surface protein like CSP. Subsequent infection into red blood cells (RBCs) by merozoites causes malaria disease via aberrant cytokine production and sequestration of parasite-infected red blood cells (pRBCs) to host endothelium. Microvasculature sequestration in the brain brings about cerebral malaria that can results in death or persisting neurological impairment. PfEMP1 has been suggested as the key adhesive molecule of pRBCs.", "class": "Human Diseases; Infectious disease: parasitic", "pathway_map": "hsa05144  Malaria", "disease": ["H00361  Malaria"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["6382  SDC1; syndecan 1 [KO:K06257]", "6383  SDC2; syndecan 2 [KO:K16336]", "4035  LRP1; LDL receptor related protein 1 [KO:K04550]", "975  CD81; CD81 molecule [KO:K06508]", "3082  HGF; hepatocyte growth factor [KO:K05460]", "4233  MET; MET proto-oncogene, receptor tyrosine kinase [KO:K05099] [EC:2.7.10.1]", "2532  ACKR1; atypical chemokine receptor 1 (Duffy blood group) [KO:K06574]", "2993  GYPA; glycophorin A (MNS blood group) [KO:K06575]", "2994  GYPB; glycophorin B (MNS blood group) [KO:K20925]", "2995  GYPC; glycophorin C (Gerbich blood group) [KO:K06576]", "3039  HBA1; hemoglobin subunit alpha 1 [KO:K13822]", "3040  HBA2; hemoglobin subunit alpha 2 [KO:K13822]", "3043  HBB; hemoglobin subunit beta [KO:K13823]", "54106  TLR9; toll like receptor 9 [KO:K10161]", "4615  MYD88; MYD88 innate immune signal transduction adaptor [KO:K04729]", "7097  TLR2; toll like receptor 2 [KO:K10159]", "7099  TLR4; toll like receptor 4 [KO:K10160]", "3586  IL10; interleukin 10 [KO:K05443]", "7040  TGFB1; transforming growth factor beta 1 [KO:K13375]", "7042  TGFB2; transforming growth factor beta 2 [KO:K13376]", "7043  TGFB3; transforming growth factor beta 3 [KO:K13377]", "3576  CXCL8; C-X-C motif chemokine ligand 8 [KO:K10030]", "3569  IL6; interleukin 6 [KO:K05405]", "6347  CCL2; C-C motif chemokine ligand 2 [KO:K14624]", "1440  CSF3; colony stimulating factor 3 [KO:K05423]", "3553  IL1B; interleukin 1 beta [KO:K04519]", "7124  TNF; tumor necrosis factor [KO:K03156]", "3592  IL12A; interleukin 12A [KO:K05406]", "3606  IL18; interleukin 18 [KO:K05482]", "3820  KLRB1; killer cell lectin like receptor B1 [KO:K06543]", "22914  KLRK1; killer cell lectin like receptor K1 [KO:K06728]", "100528032  KLRC4-KLRK1; KLRC4-KLRK1 readthrough [KO:K06728]", "3458  IFNG; interferon gamma [KO:K04687]", "948  CD36; CD36 molecule (CD36 blood group) [KO:K06259]", "1378  CR1; complement C3b/C4b receptor 1 (Knops blood group) [KO:K04011]", "1379  CR1L; complement C3b/C4b receptor 1 like [KO:K04011]", "5175  PECAM1; platelet and endothelial cell adhesion molecule 1 [KO:K06471]", "7412  VCAM1; vascular cell adhesion molecule 1 [KO:K06527]", "7057  THBS1; thrombospondin 1 [KO:K16857]", "1311  COMP; cartilage oligomeric matrix protein [KO:K04659]", "7058  THBS2; thrombospondin 2 [KO:K04659]", "7059  THBS3; thrombospondin 3 [KO:K04659]", "7060  THBS4; thrombospondin 4 [KO:K04659]", "6401  SELE; selectin E [KO:K06494]", "3683  ITGAL; integrin subunit alpha L [KO:K05718]", "3689  ITGB2; integrin subunit beta 2 [KO:K06464]", "3383  ICAM1; intercellular adhesion molecule 1 [KO:K06490]", "959  CD40LG; CD40 ligand [KO:K03161]", "958  CD40; CD40 molecule [KO:K03160]", "6403  SELP; selectin P [KO:K06496]"], "compound": ["C00533  Nitric oxide", "C00634  Chondroitin 4-sulfate", "G00052  Type II B antigen", "G00054  Type II A antigen", "G10505  Hyaluronic acid"], "refs": [{"pmid": "19101208", "authors": "  Morahan BJ, Wang L, Coppel RL", "title": "No TRAP, no invasion.", "journal": "Trends Parasitol 25:77-84 (2009)", "doi": "10.1016/j.pt.2008.11.004"}, {"pmid": "8920859", "authors": "  Shakibaei M, Frevert U", "title": "Dual interaction of the malaria circumsporozoite protein with the low density lipoprotein receptor-related protein (LRP) and heparan sulfate proteoglycans.", "journal": "J Exp Med 184:1699-711 (1996)", "doi": "10.1084/jem.184.5.1699"}, {"pmid": "15106591", "authors": "  Silvie O, Franetich JF, Renia L, Mazier D", "title": "Malaria sporozoite: migrating for a living.", "journal": "Trends Mol Med 10:97-100; discussion 100-1 (2004)", "doi": "10.1016/j.molmed.2004.01.004"}, {"pmid": "15464448", "authors": "  Mota MM, Giordano S, Rodriguez A", "title": "Targeting Plasmodium host cells: survival within hepatocytes.", "journal": "Trends Mol Med 10:487-92 (2004)", "doi": "10.1016/j.molmed.2004.08.003"}, {"pmid": "12364790", "authors": "  Cowman AF, Crabb BS", "title": "The Plasmodium falciparum genome--a blueprint for erythrocyte invasion.", "journal": "Science 298:126-8 (2002)", "doi": "10.1126/science.1078169"}, {"pmid": "16019257", "authors": "  O'Donnell RA, Blackman MJ", "title": "The role of malaria merozoite proteases in red blood cell invasion.", "journal": "Curr Opin Microbiol 8:422-7 (2005)", "doi": "10.1016/j.mib.2005.06.018"}, {"pmid": "17630968", "authors": "  Iyer J, Gruner AC, Renia L, Snounou G, Preiser PR", "title": "Invasion of host cells by malaria parasites: a tale of two protein families.", "journal": "Mol Microbiol 65:231-49 (2007)", "doi": "10.1111/j.1365-2958.2007.05791.x"}, {"pmid": "11224682", "authors": "  Chitnis CE", "title": "Molecular insights into receptors used by malaria parasites for erythrocyte invasion.", "journal": "Curr Opin Hematol 8:85-91 (2001)", "doi": "10.1097/00062752-200103000-00005"}, {"pmid": "15094163", "authors": "  Rasti N, Wahlgren M, Chen Q", "title": "Molecular aspects of malaria pathogenesis.", "journal": "FEMS Immunol Med Microbiol 41:9-26 (2004)", "doi": "10.1016/j.femsim.2004.01.010"}, {"pmid": "15463497", "authors": "  Clark IA, Rockett KA, Cowden WB", "title": "Proposed link between cytokines, nitric oxide and human cerebral malaria.", "journal": "Parasitol Today 7:205-7 (1991)", "doi": "10.1016/0169-4758(91)90142-B"}, {"pmid": "18250459", "authors": "  Hisaeda H, Tetsutani K, Imai T, Moriya C, Tu L, Hamano S, Duan X, Chou B, Ishida H, Aramaki A, Shen J, Ishii KJ, Coban C, Akira S, Takeda K, Yasutomo K, Torii M, Himeno K", "title": "Malaria parasites require TLR9 signaling for immune evasion by activating regulatory T cells.", "journal": "J Immunol 180:2496-503 (2008)", "doi": "10.4049/jimmunol.180.4.2496"}, {"pmid": "10885986", "authors": "  Chen Q, Schlichtherle M, Wahlgren M", "title": "Molecular aspects of severe malaria.", "journal": "Clin Microbiol Rev 13:439-50 (2000)", "doi": "10.1128/CMR.13.3.439-450.2000"}, {"pmid": "11832955", "authors": "  Miller LH, Baruch DI, Marsh K, Doumbo OK", "title": "The pathogenic basis of malaria.", "journal": "Nature 415:673-9 (2002)", "doi": "10.1038/415673a"}, {"pmid": "19967139", "authors": "  Faille D, El-Assaad F, Alessi MC, Fusai T, Combes V, Grau GE", "title": "Platelet-endothelial cell interactions in cerebral malaria: the end of a cordial understanding.", "journal": "Thromb Haemost 102:1093-102 (2009)", "doi": "10.1160/TH09-05-0337"}, {"pmid": "16138104", "authors": "  Schofield L, Grau GE", "title": "Immunological processes in malaria pathogenesis.", "journal": "Nat Rev Immunol 5:722-35 (2005)", "doi": "10.1038/nri1686"}, {"pmid": "14737184", "authors": "  Ishino T, Yano K, Chinzei Y, Yuda M", "title": "Cell-passage activity is required for the malarial parasite to cross the liver sinusoidal cell layer.", "journal": "PLoS Biol 2:E4 (2004)", "doi": "10.1371/journal.pbio.0020004"}, {"pmid": "16468982", "authors": "  Kariu T, Ishino T, Yano K, Chinzei Y, Yuda M", "title": "CelTOS, a novel malarial protein that mediates transmission to mosquito and vertebrate hosts.", "journal": "Mol Microbiol 59:1369-79 (2006)", "doi": "10.1111/j.1365-2958.2005.05024.x"}], "rel_pathway": ["hsa04210  Apoptosis", "hsa04514  Cell adhesion molecules", "hsa04610  Complement and coagulation cascades", "hsa04620  Toll-like receptor signaling pathway"], "ko_pathway": "ko05144", "genes": ["MET", "CD36"]}, {"kegg_id": "hsa04130", "name": "SNARE interactions in vesicular transport - Homo sapiens (human)", "class": "Genetic Information Processing; Folding, sorting and degradation", "pathway_map": "hsa04130  SNARE interactions in vesicular transport", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["6804  STX1A; syntaxin 1A [KO:K04560]", "2054  STX2; syntaxin 2 [KO:K08486]", "6809  STX3; syntaxin 3 [KO:K08486]", "112755  STX1B; syntaxin 1B [KO:K08486]", "6810  STX4; syntaxin 4 [KO:K13502]", "415117  STX19; syntaxin 19 [KO:K08487]", "8676  STX11; syntaxin 11 [KO:K08487]", "8417  STX7; syntaxin 7 [KO:K08488]", "8675  STX16; syntaxin 16 [KO:K08489]", "6811  STX5; syntaxin 5 [KO:K08490]", "55014  STX17; syntaxin 17 [KO:K08491]", "53407  STX18; syntaxin 18 [KO:K08492]", "10490  VTI1B; vesicle transport through interaction with t-SNAREs 1B [KO:K08493]", "143187  VTI1A; vesicle transport through interaction with t-SNAREs 1A [KO:K08493]", "9527  GOSR1; golgi SNAP receptor complex member 1 [KO:K08495]", "9570  GOSR2; golgi SNAP receptor complex member 2 [KO:K08496]", "662  BNIP1; BCL2 interacting protein 1 [KO:K08497]", "10228  STX6; syntaxin 6 [KO:K08498]", "9482  STX8; syntaxin 8 [KO:K08501]", "51272  BET1L; Bet1 golgi vesicular membrane trafficking protein like [KO:K08504]", "10282  BET1; Bet1 golgi vesicular membrane trafficking protein [KO:K08504]", "55850  USE1; unconventional SNARE in the ER 1 [KO:K08507]", "8773  SNAP23; synaptosome associated protein 23 [KO:K08508]", "9342  SNAP29; synaptosome associated protein 29 [KO:K08509]", "6843  VAMP1; vesicle associated membrane protein 1 [KO:K08510]", "6844  VAMP2; vesicle associated membrane protein 2 [KO:K13504]", "9341  VAMP3; vesicle associated membrane protein 3 [KO:K13505]", "8673  VAMP8; vesicle associated membrane protein 8 [KO:K08512]", "8674  VAMP4; vesicle associated membrane protein 4 [KO:K08513]", "10791  VAMP5; vesicle associated membrane protein 5 [KO:K08514]", "6845  VAMP7; vesicle associated membrane protein 7 [KO:K08515]", "10652  YKT6; YKT6 v-SNARE homolog [KO:K08516]", "9554  SEC22B; SEC22 homolog B, vesicle trafficking protein [KO:K08517]"], "refs": [{"pmid": "16882042", "authors": "  Yoshizawa AC, Kawashima S, Okuda S, Fujita M, Itoh M, Moriya Y, Hattori M, Kanehisa M", "title": "Extracting sequence motifs and the phylogenetic features of SNARE-dependent membrane traffic.", "journal": "Traffic 7:1104-18 (2006)", "doi": "10.1111/j.1600-0854.2006.00451.x"}, {"pmid": "10839363", "authors": "  Scales SJ, Chen YA, Yoo BY, Patel SM, Doung YC, Scheller RH.", "title": "SNAREs contribute to the specificity of membrane fusion.", "journal": "Neuron 26:457-64 (2000)", "doi": "10.1016/S0896-6273(00)81177-0"}, {"pmid": "11737951", "authors": "  Teng FY, Wang Y, Tang BL.", "title": "The syntaxins.", "journal": "Genome Biol 2:REVIEWS3012 (2001)", "doi": "10.1186/gb-2001-2-11-reviews3012"}, {"pmid": "11115874", "authors": "  Sanderfoot AA, Assaad FF, Raikhel NV.", "title": "The Arabidopsis genome. An abundance of soluble N-ethylmaleimide-sensitive factor adaptor protein receptors.", "journal": "Plant Physiol 124:1558-69 (2000)", "doi": "10.1104/pp.124.4.1558"}, {"pmid": "15342965", "authors": "  Uemura T, Ueda T, Ohniwa RL, Nakano A, Takeyasu K, Sato MH.", "title": "Systematic analysis of SNARE molecules in Arabidopsis: dissection of the post-Golgi network in plant cells.", "journal": "Cell Struct Funct 29:49-65 (2004)", "doi": "10.1247/csf.29.49"}, {"pmid": "10872468", "authors": "  Jahn R, Sudhof TC.", "title": "Membrane fusion and exocytosis.", "journal": "Annu Rev Biochem 68:863-911 (1999)", "doi": "10.1146/annurev.biochem.68.1.863"}, {"pmid": "11306253", "authors": "  Pelham HR.", "title": "SNAREs and the specificity of membrane fusion.", "journal": "Trends Cell Biol 11:99-101 (2001)", "doi": "10.1016/S0962-8924(01)01929-8"}, {"pmid": "11104523", "authors": "  Armstrong J", "title": "Membrane traffic between genomes.", "journal": "Genome Biol 1:REVIEWS104 (2000)", "doi": "10.1186/gb-2000-1-1-reviews104"}, {"pmid": "11237004", "authors": "  Bock JB, Matern HT, Peden AA, Scheller RH.", "title": "A genomic perspective on membrane compartment organization.", "journal": "Nature 409:839-41 (2001)", "doi": "10.1038/35057024"}, {"pmid": "11252968", "authors": "  Chen YA, Scheller RH.", "title": "SNARE-mediated membrane fusion.", "journal": "Nat Rev Mol Cell Biol 2:98-106 (2001)", "doi": "10.1038/35052017"}, {"pmid": "9763449", "authors": "  Seron K, Tieaho V, Prescianotto-Baschong C, Aust T, Blondel MO, Guillaud P, Devilliers G, Rossanese OW, Glick BS, Riezman H, Keranen S, Haguenauer-Tsapis R.", "title": "A yeast t-SNARE involved in endocytosis.", "journal": "Mol Biol Cell 9:2873-89 (1998)", "doi": "10.1091/mbc.9.10.2873"}, {"pmid": "10213783", "authors": "  Sanderfoot AA, Raikhel NV.", "title": "The specificity of vesicle trafficking: coat proteins and SNAREs.", "journal": "Plant Cell 11:629-42 (1999)", "doi": "10.1105/tpc.11.4.629"}, {"pmid": "9565594", "authors": "  Abeliovich H, Grote E, Novick P, Ferro-Novick S.", "title": "Tlg2p, a yeast syntaxin homolog that resides on the Golgi and endocytic structures.", "journal": "J Biol Chem 273:11719-27 (1998)", "doi": "10.1074/jbc.273.19.11719"}, {"pmid": "9553086", "authors": "  Advani RJ, Bae HR, Bock JB, Chao DS, Doung YC, Prekeris R, Yoo JS, Scheller RH.", "title": "Seven novel mammalian SNARE proteins localize to distinct membrane compartments.", "journal": "J Biol Chem 273:10317-24 (1998)", "doi": "10.1074/jbc.273.17.10317"}, {"pmid": "10459012", "authors": "  Advani RJ, Yang B, Prekeris R, Lee KC, Klumperman J, Scheller RH.", "title": "VAMP-7 mediates vesicular transport from endosomes to lysosomes.", "journal": "J Cell Biol 146:765-76 (1999)", "doi": "10.1083/jcb.146.4.765"}, {"pmid": "12893879", "authors": "  Burri L, Varlamov O, Doege CA, Hofmann K, Beilharz T, Rothman JE, Sollner TH, Lithgow T.", "title": "A SNARE required for retrograde transport to the endoplasmic reticulum.", "journal": "Proc Natl Acad Sci U S A 100:9873-7 (2003)", "doi": "10.1073/pnas.1734000100"}, {"pmid": "10085287", "authors": "  Chao DS, Hay JC, Winnick S, Prekeris R, Klumperman J, Scheller RH.", "title": "SNARE membrane trafficking dynamics in vivo.", "journal": "J Cell Biol 144:869-81 (1999)", "doi": "10.1083/jcb.144.5.869"}, {"pmid": "10397773", "authors": "  Coe JG, Lim AC, Xu J, Hong W.", "title": "A role for Tlg1p in the transport of proteins within the Golgi apparatus of Saccharomyces cerevisiae.", "journal": "Mol Biol Cell 10:2407-23 (1999)", "doi": "10.1091/mbc.10.7.2407"}, {"pmid": "11445562", "authors": "  Dilcher M, Kohler B, von Mollard GF.", "title": "Genetic interactions with the yeast Q-SNARE VTI1 reveal novel functions for the R-SNARE YKT6.", "journal": "J Biol Chem 276:34537-44 (2001)", "doi": "10.1074/jbc.M101551200"}, {"pmid": "12853481", "authors": "  Dilcher M, Veith B, Chidambaram S, Hartmann E, Schmitt HD, Fischer von Mollard G.", "title": "Use1p is a yeast SNARE protein required for retrograde traffic to the ER.", "journal": "EMBO J 22:3664-74 (2003)", "doi": "10.1093/emboj/cdg339"}, {"pmid": "9446565", "authors": "  Fischer von Mollard G, Stevens TH.", "title": "A human homolog can functionally replace the yeast vesicle-associated SNARE Vti1p in two vesicle transport pathways.", "journal": "J Biol Chem 273:2624-30 (1998)", "doi": "10.1074/jbc.273.5.2624"}, {"pmid": "10359592", "authors": "  Fischer von Mollard G, Stevens TH.", "title": "The Saccharomyces cerevisiae v-SNARE Vti1p is required for multiple membrane transport pathways to the vacuole.", "journal": "Mol Biol Cell 10:1719-32 (1999)", "doi": "10.1091/mbc.10.6.1719"}, {"pmid": "9614185", "authors": "  Galli T, Zahraoui A, Vaidyanathan VV, Raposo G, Tian JM, Karin M, Niemann H, Louvard D.", "title": "A novel tetanus neurotoxin-insensitive vesicle-associated membrane protein in SNARE complexes of the apical plasma membrane of epithelial cells.", "journal": "Mol Biol Cell 9:1437-48 (1998)", "doi": "10.1091/mbc.9.6.1437"}, {"pmid": "11208059", "authors": "  Gerrard SR, Mecklem AB, Stevens TH.", "title": "The yeast endosomal t-SNARE, Pep12p, functions in the absence of its transmembrane domain.", "journal": "Traffic 1:45-55 (2000)", "doi": "10.1034/j.1600-0854.2000.010108.x"}, {"pmid": "10379359", "authors": "  Gerst JE.", "title": "SNAREs and SNARE regulators in membrane fusion and exocytosis.", "journal": "Cell Mol Life Sci 55:707-34 (1999)", "doi": "10.1007/s000180050328"}, {"pmid": "11029060", "authors": "  Gurunathan S, Chapman-Shimshoni D, Trajkovic S, Gerst JE.", "title": "Yeast exocytic v-SNAREs confer endocytosis.", "journal": "Mol Biol Cell 11:3629-43 (2000)", "doi": "10.1091/mbc.11.10.3629"}, {"pmid": "10788491", "authors": "  Hatsuzawa K, Hirose H, Tani K, Yamamoto A, Scheller RH, Tagaya M.", "title": "Syntaxin 18, a SNAP receptor that functions in the endoplasmic reticulum, intermediate compartment, and cis-Golgi vesicle trafficking.", "journal": "J Biol Chem 275:13713-20 (2000)", "doi": "10.1074/jbc.275.18.13713"}, {"pmid": "8621431", "authors": "  Hay JC, Hirling H, Scheller RH.", "title": "Mammalian vesicle trafficking proteins of the endoplasmic reticulum and Golgi apparatus.", "journal": "J Biol Chem 271:5671-9 (1996)", "doi": "10.1074/jbc.271.10.5671"}, {"pmid": "9647643", "authors": "  Hay JC, Klumperman J, Oorschot V, Steegmaier M, Kuo CS, Scheller RH.", "title": "Localization, dynamics, and protein interactions reveal distinct roles for ER and Golgi SNAREs.", "journal": "J Cell Biol 141:1489-502 (1998)", "doi": "10.1083/jcb.141.7.1489"}, {"pmid": "9427746", "authors": "  Holthuis JC, Nichols BJ, Dhruvakumar S, Pelham HR.", "title": "Two syntaxin homologues in the TGN/endosomal system of yeast.", "journal": "EMBO J 17:113-26 (1998)", "doi": "10.1093/emboj/17.1.113"}, {"pmid": "9843576", "authors": "  Holthuis JC, Nichols BJ, Pelham HR.", "title": "The syntaxin Tlg1p mediates trafficking of chitin synthase III to polarized growth sites in yeast.", "journal": "Mol Biol Cell 9:3383-97 (1998)", "doi": "10.1091/mbc.9.12.3383"}, {"pmid": "12600315", "authors": "  Jahn R, Lang T, Sudhof TC.", "title": "Membrane fusion.", "journal": "Cell 112:519-33 (2003)", "doi": "10.1016/S0092-8674(03)00112-0"}, {"pmid": "10097106", "authors": "  Lafont F, Verkade P, Galli T, Wimmer C, Louvard D, Simons K.", "title": "Raft association of SNAP receptors acting in apical trafficking in Madin-Darby canine kidney cells.", "journal": "Proc Natl Acad Sci U S A 96:3734-8 (1999)", "doi": "10.1073/pnas.96.7.3734"}, {"pmid": "9214619", "authors": "  Lewis MJ, Rayner JC, Pelham HR.", "title": "A novel SNARE complex implicated in vesicle fusion with the endoplasmic reticulum.", "journal": "EMBO J 16:3017-24 (1997)", "doi": "10.1093/emboj/16.11.3017"}, {"pmid": "9647644", "authors": "  Low SH, Chapin SJ, Wimmer C, Whiteheart SW, Komuves LG, Mostov KE, Weimbs T.", "title": "The SNARE machinery is involved in apical plasma membrane trafficking in MDCK cells.", "journal": "J Cell Biol 141:1503-13 (1998)", "doi": "10.1083/jcb.141.7.1503"}, {"pmid": "9452464", "authors": "  Low SH, Roche PA, Anderson HA, van Ijzendoorn SC, Zhang M, Mostov KE, Weimbs T.", "title": "Targeting of SNAP-23 and SNAP-25 in polarized epithelial cells.", "journal": "J Biol Chem 273:3422-30 (1998)", "doi": "10.1074/jbc.273.6.3422"}, {"pmid": "12669082", "authors": "  Mostov K, Su T, ter Beest M.", "title": "Polarized epithelial membrane traffic: conservation and plasticity.", "journal": "Nat Cell Biol 5:287-93 (2003)", "doi": "10.1038/ncb0403-287"}, {"pmid": "10873817", "authors": "  Mostov KE, Verges M, Altschuler Y.", "title": "Membrane traffic in polarized epithelial cells.", "journal": "Curr Opin Cell Biol 12:483-90 (2000)", "doi": "10.1016/S0955-0674(00)00120-4"}, {"pmid": "10982406", "authors": "  Mullock BM, Smith CW, Ihrke G, Bright NA, Lindsay M, Parkinson EJ, Brooks DA, Parton RG, James DE, Luzio JP, Piper RC.", "title": "Syntaxin 7 is localized to late endosome compartments, associates with Vamp 8, and Is required for late endosome-lysosome fusion.", "journal": "Mol Biol Cell 11:3137-53 (2000)", "doi": "10.1091/mbc.11.9.3137"}, {"pmid": "9817754", "authors": "  Prekeris R, Klumperman J, Chen YA, Scheller RH.", "title": "Syntaxin 13 mediates cycling of plasma membrane proteins via tubulovesicular recycling endosomes.", "journal": "J Cell Biol 143:957-71 (1998)", "doi": "10.1083/jcb.143.4.957"}, {"pmid": "10564279", "authors": "  Prekeris R, Yang B, Oorschot V, Klumperman J, Scheller RH.", "title": "Differential roles of syntaxin 7 and syntaxin 8 in endosomal trafficking.", "journal": "Mol Biol Cell 10:3891-908 (1999)", "doi": "10.1091/mbc.10.11.3891"}, {"pmid": "9707576", "authors": "  Sanderfoot AA, Ahmed SU, Marty-Mazars D, Rapoport I, Kirchhausen T, Marty F, Raikhel NV.", "title": "A putative vacuolar cargo receptor partially colocalizes with AtPEP12p on a prevacuolar compartment in Arabidopsis roots.", "journal": "Proc Natl Acad Sci U S A 95:9920-5 (1998)", "doi": "10.1073/pnas.95.17.9920"}, {"pmid": "11739776", "authors": "  Sanderfoot AA, Kovaleva V, Bassham DC, Raikhel NV.", "title": "Interactions between syntaxins identify at least five SNARE complexes within the Golgi/prevacuolar system of the Arabidopsis cell.", "journal": "Mol Biol Cell 12:3733-43 (2001)", "doi": "10.1091/mbc.12.12.3733"}, {"pmid": "10557242", "authors": "  Sanderfoot AA, Kovaleva V, Zheng H, Raikhel NV.", "title": "The t-SNARE AtVAM3p resides on the prevacuolar compartment in Arabidopsis root cells.", "journal": "Plant Physiol 121:929-38 (1999)", "doi": "10.1104/pp.121.3.929"}, {"pmid": "11251103", "authors": "  Sanderfoot AA, Pilgrim M, Adam L, Raikhel NV.", "title": "Disruption of individual members of Arabidopsis syntaxin gene families indicates each has essential functions.", "journal": "Plant Cell 13:659-66 (2001)", "doi": "10.1105/tpc.13.3.659"}, {"pmid": "9305917", "authors": "  Sato MH, Nakamura N, Ohsumi Y, Kouchi H, Kondo M, Hara-Nishimura I, Nishimura M, Wada Y.", "title": "The AtVAM3 encodes a syntaxin-related molecule implicated in the vacuolar assembly in Arabidopsis thaliana.", "journal": "J Biol Chem 272:24530-5 (1997)", "doi": "10.1074/jbc.272.39.24530"}, {"pmid": "9710615", "authors": "  Sato TK, Darsow T, Emr SD.", "title": "Vam7p, a SNAP-25-like molecule, and Vam3p, a syntaxin homolog, function together in yeast vacuolar protein trafficking.", "journal": "Mol Cell Biol 18:5308-19 (1998)", "doi": "10.1128/MCB.18.9.5308"}, {"pmid": "9813082", "authors": "  Spang A, Schekman R.", "title": "Reconstitution of retrograde transport from the Golgi to the ER in vitro.", "journal": "J Cell Biol 143:589-99 (1998)", "doi": "10.1083/jcb.143.3.589"}, {"pmid": "10359608", "authors": "  Steegmaier M, Klumperman J, Foletti DL, Yoo JS, Scheller RH.", "title": "Vesicle-associated membrane protein 4 is implicated in trans-Golgi network vesicle trafficking.", "journal": "Mol Biol Cell 10:1957-72 (1999)", "doi": "10.1091/mbc.10.6.1957"}, {"pmid": "11208143", "authors": "  Steegmaier M, Lee KC, Prekeris R, Scheller RH.", "title": "SNARE protein trafficking in polarized MDCK cells.", "journal": "Traffic 1:553-60 (2000)", "doi": "10.1034/j.1600-0854.2000.010705.x"}, {"pmid": "9852078", "authors": "  Steegmaier M, Yang B, Yoo JS, Huang B, Shen M, Yu S, Luo Y, Scheller RH.", "title": "Three novel proteins of the syntaxin/SNAP-25 family.", "journal": "J Biol Chem 273:34171-9 (1998)", "doi": "10.1074/jbc.273.51.34171"}, {"pmid": "9507000", "authors": "  Tang BL, Tan AE, Lim LK, Lee SS, Low DY, Hong W.", "title": "Syntaxin 12, a member of the syntaxin family localized to the endosome.", "journal": "J Biol Chem 273:6944-50 (1998)", "doi": "10.1074/jbc.273.12.6944"}, {"pmid": "9628864", "authors": "  Ungermann C, Wickner W.", "title": "Vam7p, a vacuolar SNAP-25 homolog, is required for SNARE complex integrity and vacuole docking and fusion.", "journal": "EMBO J 17:3269-76 (1998)", "doi": "10.1093/emboj/17.12.3269"}, {"pmid": "9199167", "authors": "  von Mollard GF, Nothwehr SF, Stevens TH.", "title": "The yeast v-SNARE Vti1p mediates two vesicle transport pathways through interactions with the t-SNAREs Sed5p and Pep12p.", "journal": "J Cell Biol 137:1511-24 (1997)", "doi": "10.1083/jcb.137.7.1511"}, {"pmid": "11278762", "authors": "  Wade N, Bryant NJ, Connolly LM, Simpson RJ, Luzio JP, Piper RC, James DE.", "title": "Syntaxin 7 complexes with mouse Vps10p tail interactor 1b, syntaxin 6, vesicle-associated membrane protein (VAMP)8, and VAMP7 in b16 melanoma cells.", "journal": "J Biol Chem 276:19820-7 (2001)", "doi": "10.1074/jbc.M010838200"}, {"pmid": "11555414", "authors": "  Wendler F, Tooze S.", "title": "Syntaxin 6: the promiscuous behaviour of a SNARE protein.", "journal": "Traffic 2:606-11 (2001)", "doi": "10.1034/j.1600-0854.2001.20903.x"}, {"pmid": "9614193", "authors": "  Wong SH, Zhang T, Xu Y, Subramaniam VN, Griffiths G, Hong W.", "title": "Endobrevin, a novel synaptobrevin/VAMP-like protein preferentially associated with the early endosome.", "journal": "Mol Biol Cell 9:1549-63 (1998)", "doi": "10.1091/mbc.9.6.1549"}, {"pmid": "11035026", "authors": "  Xu D, Joglekar AP, Williams AL, Hay JC.", "title": "Subunit structure of a mammalian ER/Golgi SNARE complex.", "journal": "J Biol Chem 275:39631-9 (2000)", "doi": "10.1074/jbc.M007684200"}, {"pmid": "11323436", "authors": "  Zhang T, Hong W.", "title": "Ykt6 forms a SNARE complex with syntaxin 5, GS28, and Bet1 and participates in a late stage in endoplasmic reticulum-Golgi transport.", "journal": "J Biol Chem 276:27480-7 (2001)", "doi": "10.1074/jbc.M102786200"}, {"pmid": "12068098", "authors": "  Zheng H, Bednarek SY, Sanderfoot AA, Alonso J, Ecker JR, Raikhel NV.", "title": "NPSN11 is a cell plate-associated SNARE protein that interacts with the syntaxin KNOLLE.", "journal": "Plant Physiol 129:530-9 (2002)", "doi": "10.1104/pp.003970"}], "ko_pathway": "ko04130", "genes": ["STX8"]}, {"kegg_id": "hsa00790", "name": "Folate biosynthesis - Homo sapiens (human)", "class": "Metabolism; Metabolism of cofactors and vitamins", "pathway_map": "hsa00790  Folate biosynthesis", "module": ["hsa_M00842  Tetrahydrobiopterin biosynthesis, GTP => BH4 [PATH:hsa00790]", "hsa_M00880  Molybdenum cofactor biosynthesis, GTP => molybdenum cofactor [PATH:hsa00790]"], "network": ["", "ELEMENT   N00700  Tyrosine biosynthesis", "N00702  Tetrahydrobiopterin biosynthesis, GTP to BH4", "N00705  Tetrahydrobiopterin biosynthesis, BH4OH to BH4", "N00890  Molybdenum cofactor biosynthesis"], "drug": ["D00142  Methotrexate (JP18/USP/INN)", "D02115  Methotrexate sodium", "D03828  Pemetrexed disodium (USAN)", "D03942  Edatrexate (USAN/INN)", "D05500  Piritrexim isethionate (USAN)", "D05589  Pralatrexate (JAN/USAN/INN)", "D05999  Talotrexin ammonium (USAN)", "D06238  Trimetrexate (USAN/INN)", "D06239  Trimetrexate glucuronate (USAN)", "D06503  Pemetrexed sodium hydrate (JAN)", "D07472  Pemetrexed (INN)", "D10596  Pemetrexed sodium hemipentahydrate (JAN)", "D11352  Pemetrexed tromethamine (USAN)", "D11779  Fosdenopterin (USAN)", "D11780  Fosdenopterin hydrobromide (USAN)", "D12277  Ilofotase alfa (USAN/INN)"], "dblinks": "GO: 0046656", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["2643  GCH1; GTP cyclohydrolase 1 [KO:K01495] [EC:3.5.4.16]", "249  ALPL; alkaline phosphatase, biomineralization associated [KO:K01077] [EC:3.1.3.1]", "248  ALPI; alkaline phosphatase, intestinal [KO:K01077] [EC:3.1.3.1]", "250  ALPP; alkaline phosphatase, placental [KO:K01077] [EC:3.1.3.1]", "251  ALPG; alkaline phosphatase, germ cell [KO:K01077] [EC:3.1.3.1]", "1719  DHFR; dihydrofolate reductase [KO:K00287] [EC:1.5.1.3]", "200895  DHFR2; dihydrofolate reductase 2 [KO:K00287] [EC:1.5.1.3]", "2356  FPGS; folylpolyglutamate synthase [KO:K01930] [EC:6.3.2.17]", "8836  GGH; gamma-glutamyl hydrolase [KO:K01307] [EC:3.4.19.9]", "5805  PTS; 6-pyruvoyltetrahydropterin synthase [KO:K01737] [EC:4.2.3.12 4.1.2.50]", "6697  SPR; sepiapterin reductase [KO:K00072] [EC:1.1.1.153]", "231  AKR1B1; aldo-keto reductase family 1 member B [KO:K00011] [EC:1.1.1.21]", "57016  AKR1B10; aldo-keto reductase family 1 member B10 [KO:K00011] [EC:1.1.1.21]", "441282  AKR1B15; aldo-keto reductase family 1 member B15 [KO:K00011] [EC:1.1.1.21]", "873  CBR1; carbonyl reductase 1 [KO:K00079] [EC:1.1.1.184 1.1.1.189 1.1.1.197]", "8644  AKR1C3; aldo-keto reductase family 1 member C3 [KO:K04119] [EC:1.1.1.51 1.1.1.188 1.1.1.213 1.1.1.357]", "5860  QDPR; quinoid dihydropteridine reductase [KO:K00357] [EC:1.5.1.34]", "84105  PCBD2; pterin-4 alpha-carbinolamine dehydratase 2 [KO:K01724] [EC:4.2.1.96]", "5092  PCBD1; pterin-4 alpha-carbinolamine dehydratase 1 [KO:K01724] [EC:4.2.1.96]", "5053  PAH; phenylalanine hydroxylase [KO:K00500] [EC:1.14.16.1]", "7054  TH; tyrosine hydroxylase [KO:K00501] [EC:1.14.16.2]", "121278  TPH2; tryptophan hydroxylase 2 [KO:K00502] [EC:1.14.16.4]", "7166  TPH1; tryptophan hydroxylase 1 [KO:K00502] [EC:1.14.16.4]", "4337  MOCS1; molybdenum cofactor synthesis 1 [KO:K20967] [EC:4.1.99.22 4.6.1.17]", "4338  MOCS2; molybdenum cofactor synthesis 2 [KO:K03635] [EC:2.8.1.12]", "10243  GPHN; gephyrin [KO:K15376] [EC:2.10.1.1 2.7.7.75]", "55034  MOCOS; molybdenum cofactor sulfurase [KO:K15631] [EC:2.8.1.9]"], "compound": ["C00044  GTP", "C00101  Tetrahydrofolate", "C00119  5-Phospho-alpha-D-ribose 1-diphosphate", "C00156  4-Hydroxybenzoate", "C00251  Chorismate", "C00266  Glycolaldehyde", "C00268  Dihydrobiopterin", "C00272  Tetrahydrobiopterin", "C00415  Dihydrofolate", "C00504  Folate", "C00568  4-Aminobenzoate", "C00835  Sepiapterin", "C00921  Dihydropteroate", "C01217  5,6,7,8-Tetrahydromethanopterin", "C01300  6-(Hydroxymethyl)-7,8-dihydropterin", "C01304  2,5-Diamino-6-(5-phospho-D-ribosylamino)pyrimidin-4(3H)-one", "C02587  Pyrimidodiazepine", "C02953  7,8-Dihydrobiopterin", "C03541  THF-polyglutamate", "C03684  6-Pyruvoyltetrahydropterin", "C04244  6-Lactoyl-5,6,7,8-tetrahydropterin", "C04807  6-Hydroxymethyl-7,8-dihydropterin diphosphate", "C04874  7,8-Dihydroneopterin", "C04895  7,8-Dihydroneopterin 3'-triphosphate", "C05922  Formamidopyrimidine nucleoside triphosphate", "C05923  2,5-Diaminopyrimidine nucleoside triphosphate", "C05924  Molybdopterin", "C05925  Dihydroneopterin phosphate", "C05926  Neopterin", "C05927  7,8-Dihydromethanopterin", "C06148  2,5-Diamino-6-(5'-triphosphoryl-3',4'-trihydroxy-2'-oxopentyl)-amino-4-oxopyrimidine", "C06313  Biopterin", "C09332  THF-L-glutamate", "C11355  4-Amino-4-deoxychorismate", "C15522  4a-Hydroxytetrahydrobiopterin", "C15996  7-Cyano-7-carbaguanine", "C16675  7-Aminomethyl-7-carbaguanine", "C18237  Molybdoenzyme molybdenum cofactor", "C18239  Precursor Z", "C18802  Tetrahydrosarcinapterin", "C19848  Adenylated molybdopterin", "C19871  Guanylyl molybdenum cofactor", "C20239  6-Carboxy-5,6,7,8-tetrahydropterin", "C20248  7-Carboxy-7-carbaguanine", "C20264  L-threo-Tetrahydrobiopterin", "C20559  4-(beta-D-Ribofuranosyl)aniline 5'-phosphate", "C20562  N-[(7,8-Dihydropterin-6-yl)methyl]-4-(beta-D-ribofuranosyl)aniline 5'-phosphate", "C20566  7,8-Dihydroneopterin 2'-phosphate", "C20567  7,8-Dihydroneopterin 2',3'-cyclic phosphate", "C21007  5,6,7,8-Tetrahydromonapterin", "C21008  7,8-Dihydromonapterin", "C21065  7,8-Dihydroxanthopterin", "C21094  7,8-Dihydromonapterin 3'-triphosphate", "C21107  4-(beta-D-Ribofuranosyl)phenol 5'-phosphate", "C21310  (8S)-3',8-Cyclo-7,8-dihydroguanosine 5'-triphosphate", "C21485  Cytidylyl molybdenum cofactor", "C21486  Thio-molybdenum cofactor", "C21640  6-(1'-Hydroxy-2'-oxopropyl)-tetrahydropterin"], "refs": [{"pmid": "19675644", "authors": "  Schwarz G, Mendel RR, Ribbe MW", "title": "Molybdenum cofactors, enzymes and pathways.", "journal": "Nature 460:839-47 (2009)", "doi": "10.1038/nature08302"}, {"pmid": "16632608", "authors": "  Hanzelmann P, Schindelin H", "title": "Binding of 5'-GTP to the C-terminal FeS cluster of the radical S-adenosylmethionine enzyme MoaA provides insights into its mechanism.", "journal": "Proc Natl Acad Sci U S A 103:6829-34 (2006)", "doi": "10.1073/pnas.0510711103"}, {"pmid": "18092812", "authors": "  Daniels JN, Wuebbens MM, Rajagopalan KV, Schindelin H", "title": "Crystal structure of a molybdopterin synthase-precursor Z complex: insight into its sulfur transfer mechanism and its role in molybdenum cofactor deficiency.", "journal": "Biochemistry 47:615-26 (2008)", "doi": "10.1021/bi701734g"}, {"pmid": "12571226", "authors": "  Wuebbens MM, Rajagopalan KV", "title": "Mechanistic and mutational studies of Escherichia coli molybdopterin synthase clarify the final step of molybdopterin biosynthesis.", "journal": "J Biol Chem 278:14523-32 (2003)", "doi": "10.1074/jbc.M300453200"}, {"pmid": "21867484", "authors": "  Werner ER, Blau N, Thony B", "title": "Tetrahydrobiopterin: biochemistry and pathophysiology.", "journal": "Biochem J 438:397-414 (2011)", "doi": "10.1042/BJ20110293"}, {"pmid": "12893295", "authors": "  Iino T, Tabata M, Takikawa S, Sawada H, Shintaku H, Ishikura S, Hara A", "title": "Tetrahydrobiopterin is synthesized from 6-pyruvoyl-tetrahydropterin by the human aldo-keto reductase AKR1 family members.", "journal": "Arch Biochem Biophys 416:180-7 (2003)", "doi": "10.1016/S0003-9861(03)00295-9"}], "rel_pathway": ["hsa00230  Purine metabolism", "hsa00400  Phenylalanine, tyrosine and tryptophan biosynthesis", "hsa00670  One carbon pool by folate"], "ko_pathway": "ko00790", "genes": ["GPHN"]}, {"kegg_id": "hsa01240", "name": "Biosynthesis of cofactors - Homo sapiens (human)", "pathway_map": "hsa01240  Biosynthesis of cofactors", "module": ["hsa_M00049  Adenine ribonucleotide biosynthesis, IMP => ADP,ATP [PATH:hsa01240]", "hsa_M00051  De novo pyrimidine biosynthesis, glutamine (+ PRPP) => UMP [PATH:hsa01240]", "hsa_M00052  Pyrimidine ribonucleotide biosynthesis, UMP => UDP/UTP,CDP/CTP [PATH:hsa01240]", "hsa_M00118  Glutathione biosynthesis, glutamate => glutathione [PATH:hsa01240]", "hsa_M00120  Coenzyme A biosynthesis, pantothenate => CoA [PATH:hsa01240]", "hsa_M00128  Ubiquinone biosynthesis, eukaryotes, 4-hydroxybenzoate + polyprenyl-PP => ubiquinol [PATH:hsa01240]", "hsa_M00141  C1-unit interconversion, eukaryotes [PATH:hsa01240]", "hsa_M00842  Tetrahydrobiopterin biosynthesis, GTP => BH4 [PATH:hsa01240]", "hsa_M00868  Heme biosynthesis, animals and fungi, glycine => heme [PATH:hsa01240]", "hsa_M00880  Molybdenum cofactor biosynthesis, GTP => molybdenum cofactor [PATH:hsa01240]", "hsa_M00882  Lipoic acid biosynthesis, eukaryotes, octanoyl-ACP => dihydrolipoyl-H [PATH:hsa01240]", "hsa_M00883  Lipoic acid biosynthesis, animals and bacteria, octanoyl-ACP => dihydrolipoyl-H => dihydrolipoyl-E2 [PATH:hsa01240]", "hsa_M00912  NAD biosynthesis, tryptophan => quinolinate => NAD [PATH:hsa01240]"], "organism": "Homo sapiens (human) [GN:hsa]", "ko_pathway": "ko01240", "genes": ["GPHN"]}, {"kegg_id": "hsa04727", "name": "GABAergic synapse - Homo sapiens (human)", "description": "Gamma aminobutyric acid (GABA) is the most abundant inhibitory neurotransmitter in the mammalian central nervous system (CNS). When released in the synaptic cleft, GABA binds to three major classes of receptors: GABAA, GABAB, and GABAC receptors. GABAA and GABAC receptors are ionotropic and mediate fast GABA responses by triggering chloride channel openings, while GABAB receptors are metabotropic and mediate slower GABA responses by activating G-proteins and influencing second messenger systems. GABAA receptors, the major sites for fast inhibitory neurotransmission in the CNS, are regulated by phosphorylation mechanisms, affecting both their functional properties and their cell surface mobility and trafficking. GABA release by the presynaptic terminal is negatively regulated by GABAB autoreceptors, and is cleared from the extracellular space by GABA transporters (GATs) located either on the presynaptic terminal or neighboring glial cells.", "class": "Organismal Systems; Nervous system", "pathway_map": "hsa04727  GABAergic synapse", "drug": ["D00058  gamma-Aminobutyric acid (JAN)", "D00225  Alprazolam (JP18/USP/INN)", "D00241  Baclofen (JP18/USP/INN)", "D00267  Chlordiazepoxide (JP18/USP/INN)", "D00280  Clonazepam (JP18/USP/INN)", "D00293  Diazepam (JP18/USP/INN)", "D00304  Divalproex sodium (USP)", "D00311  Estazolam (JP18/USP/INN)", "D00329  Flurazepam (JAN/INN)", "D00332  Gabapentin (JAN/USP/INN)", "D00338  Halazepam (USAN/INN)", "D00365  Lorazepam (JP18/USP/INN)", "D00370  Temazepam (USP/INN)", "D00376  Meprobamate (JAN/USP/INN)", "D00387  Triazolam (JP18/USP/INN)", "D00399  Valproic acid (USP)", "D00430  Secobarbital (USP/INN)", "D00457  Quazepam (JAN/USP/INN)", "D00464  Oxazepam (JAN/USP/INN)", "D00470  Prazepam (JP18/USAN/INN)", "D00499  Pentobarbital (USP/INN)", "D00500  Pentobarbital sodium (JAN/USP)", "D00506  Phenobarbital (JP18/USP/INN)", "D00530  Zaleplon (JAN/USP/INN)", "D00531  Nitrazepam (JP18/USAN/INN)", "D00532  Glutethimide (JAN/INN)", "D00535  Vigabatrin (JAN/USP/INN)", "D00537  Topiramate (JAN/USP/INN)", "D00549  Propofol (JAN/USP/INN)", "D00550  Midazolam (JAN/USP/INN)", "D00555  Amobarbital (JP18/INN)", "D00693  Chlordiazepoxide hydrochloride (JAN/USP)", "D00694  Clorazepate dipotassium (JP18/USP)", "D00695  Flurazepam hydrochloride (USP)", "D00696  Midazolam hydrochloride (USAN)", "D00697  Flumazenil (JAN/USP/INN)", "D00698  Aprobarbital (INN)", "D00699  Butabarbital sodium (USP)", "D00700  Mephobarbital (JAN/USP)", "D00701  Phenobarbital sodium (JAN/USP/INN)", "D00706  Zolpidem tartrate (JP18/USP)", "D00710  Valproate sodium (USAN)", "D00713  Thiamylal sodium (JP18)", "D00714  Thiopental sodium (JP18/USP/INN)", "D01071  Hexobarbital (JAN/INN)", "D01150  Methyprylon (JAN/INN)", "D01230  Flunitrazepam (JP18/USAN/INN)", "D01245  Bromazepam (JP18/USAN/INN)", "D01253  Clobazam (JAN/USAN/INN)", "D01254  Tofisopam (JP18/INN)", "D01268  Cloxazolam (JP18/INN)", "D01278  Oxazolam (JP18/INN)", "D01279  Flutoprazepam (JP18/INN)", "D01286  Flutazolam (JAN/INN)", "D01292  Medazepam (JP18/INN)", "D01293  Ethyl loflazepate (JP18/INN)", "D01310  Secobarbital sodium (JAN/USP)", "D01316  Mexazolam (JAN/INN)", "D01328  Clotiazepam (JP18/INN)", "D01354  Fludiazepam (JP18/INN)", "D01372  Zopiclone (JP18/INN)", "D01382  Metharbital (JAN/INN)", "D01408  Flurazepam hydrochloride (JP18)", "D01514  Etizolam (JP18/INN)", "D01564  Rilmazafone hydrochloride hydrate (JP18)", "D01593  Nimetazepam (JAN/INN)", "D01657  Lormetazepam (JAN/USAN/INN)", "D01740  Barbital (JP18/INN)", "D01744  Brotizolam (JP18/USAN/INN)", "D01758  Haloxazolam (JP18/INN)", "D02097  Tiagabine hydrochloride (USP)", "D02252  Amobarbital sodium (JAN/USP)", "D02253  Pentobarbital calcium (JP18)", "D02283  Iomazenil (123I) (JAN/INN)", "D02594  Abecarnil (INN)", "D02616  Pagoclone (USAN/INN)", "D02617  Ocinaplon (USAN/INN)", "D02618  Butobarbital (BAN)", "D02624  Eszopiclone (JAN/USP/INN)", "D02640  Indiplon (USAN/INN)", "D02770  Adinazolam (USAN/INN)", "D02771  Adinazolam mesylate (USAN)", "D02833  Alpidem (USAN/INN)", "D03155  Bretazenil (USAN/INN)", "D03180  Butabarbital (USP)", "D03562  Clorazepate monopotassium (USAN)", "D03584  Colforsin (USAN/INN)", "D03737  Dextofisopam (USAN/INN)", "D04257  Fospropofol disodium (USAN)", "D04282  Gaboxadol (USAN/INN)", "D04300  Ganaxolone (USAN/INN)", "D04650  Ketazolam (USAN/INN)", "D04721  Levotofisopam (USAN/INN)", "D04882  Medazepam hydrochloride (USAN)", "D05028  Midazolam maleate (USAN)", "D05346  Panadiplon (USAN/INN)", "D05378  Pazinaclone (USAN/INN)", "D05621  Progabide (USAN/INN)", "D05980  Suritozole (USAN/INN)", "D06106  Thiamylal", "D06887  Talbutal (INN)", "D07298  Barbexaclone (INN)", "D07326  Loprazolam (INN)", "D07328  Cinolazepam (INN)", "D07330  Clomethiazole (INN)", "D07725  Clomethiazole edisilate", "D07784  Delorazepam (INN)", "D08145  Loprazolam mesilate", "D08283  Nordazepam (INN)", "D08356  Phenobarbital diethylamine", "D08481  Rilmazafone (INN)", "D08507  Sarmazenil (INN)", "D08588  Tiagabine (INN)", "D08667  Calcium valproate", "D08690  Zolpidem (INN)", "D08840  Adipiplon (USAN)", "D08861  Arbaclofen placarbil (USAN/INN)", "D09539  Gabapentin enacarbil (JAN/USAN/INN)", "D09791  Arbaclofen (USAN)", "D10194  Remimazolam besylate (USAN)", "D11149  Brexanolone (USAN/INN)", "D11150  Cenobamate (USAN/INN)", "D11788  Remimazolam (USAN/INN)", "D12146  Darigabat (USAN)", "D12240  Valiloxybate (USAN)", "D12382  Alogabat (USAN)", "D12449  Cipepofol (USAN/INN)"], "dblinks": "GO: 0051932", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["81539  SLC38A1; solute carrier family 38 member 1 [KO:K14990]", "54407  SLC38A2; solute carrier family 38 member 2 [KO:K14207]", "27165  GLS2; glutaminase 2 [KO:K01425] [EC:3.5.1.2]", "2744  GLS; glutaminase [KO:K01425] [EC:3.5.1.2]", "2571  GAD1; glutamate decarboxylase 1 [KO:K01580] [EC:4.1.1.15]", "2572  GAD2; glutamate decarboxylase 2 [KO:K01580] [EC:4.1.1.15]", "140679  SLC32A1; solute carrier family 32 member 1 [KO:K15015]", "18  ABAT; 4-aminobutyrate aminotransferase [KO:K13524] [EC:2.6.1.19 2.6.1.22]", "2554  GABRA1; gamma-aminobutyric acid type A receptor subunit alpha1 [KO:K05175]", "2555  GABRA2; gamma-aminobutyric acid type A receptor subunit alpha2 [KO:K05175]", "2556  GABRA3; gamma-aminobutyric acid type A receptor subunit alpha3 [KO:K05175]", "2557  GABRA4; gamma-aminobutyric acid type A receptor subunit alpha4 [KO:K05175]", "2558  GABRA5; gamma-aminobutyric acid type A receptor subunit alpha5 [KO:K05175]", "2559  GABRA6; gamma-aminobutyric acid type A receptor subunit alpha6 [KO:K05175]", "2560  GABRB1; gamma-aminobutyric acid type A receptor subunit beta1 [KO:K05181]", "2562  GABRB3; gamma-aminobutyric acid type A receptor subunit beta3 [KO:K05181]", "2561  GABRB2; gamma-aminobutyric acid type A receptor subunit beta2 [KO:K05181]", "2565  GABRG1; gamma-aminobutyric acid type A receptor subunit gamma1 [KO:K05186]", "2566  GABRG2; gamma-aminobutyric acid type A receptor subunit gamma2 [KO:K05186]", "2567  GABRG3; gamma-aminobutyric acid type A receptor subunit gamma3 [KO:K05186]", "2563  GABRD; gamma-aminobutyric acid type A receptor subunit delta [KO:K05184]", "2564  GABRE; gamma-aminobutyric acid type A receptor subunit epsilon [KO:K05185]", "55879  GABRQ; gamma-aminobutyric acid type A receptor subunit theta [KO:K05192]", "2568  GABRP; gamma-aminobutyric acid type A receptor subunit pi [KO:K05189]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "9001  HAP1; huntingtin associated protein 1 [KO:K04647]", "11337  GABARAP; GABA type A receptor-associated protein [KO:K08341]", "23710  GABARAPL1; GABA type A receptor associated protein like 1 [KO:K08341]", "11345  GABARAPL2; GABA type A receptor associated protein like 2 [KO:K08341]", "4905  NSF; N-ethylmaleimide sensitive factor, vesicle fusing ATPase [KO:K06027] [EC:3.6.4.6]", "66008  TRAK2; trafficking kinesin protein 2 [KO:K15374]", "5334  PLCL1; phospholipase C like 1 (inactive) [KO:K15375]", "10243  GPHN; gephyrin [KO:K15376] [EC:2.10.1.1 2.7.7.75]", "57468  SLC12A5; solute carrier family 12 member 5 [KO:K23967]", "2569  GABRR1; gamma-aminobutyric acid type A receptor subunit rho1 [KO:K05190]", "2570  GABRR2; gamma-aminobutyric acid type A receptor subunit rho2 [KO:K05190]", "200959  GABRR3; gamma-aminobutyric acid type A receptor subunit rho3 [KO:K05190]", "773  CACNA1A; calcium voltage-gated channel subunit alpha1 A [KO:K04344]", "774  CACNA1B; calcium voltage-gated channel subunit alpha1 B [KO:K04849]", "775  CACNA1C; calcium voltage-gated channel subunit alpha1 C [KO:K04850]", "776  CACNA1D; calcium voltage-gated channel subunit alpha1 D [KO:K04851]", "778  CACNA1F; calcium voltage-gated channel subunit alpha1 F [KO:K04853]", "779  CACNA1S; calcium voltage-gated channel subunit alpha1 S [KO:K04857]", "2550  GABBR1; gamma-aminobutyric acid type B receptor subunit 1 [KO:K04615]", "9568  GABBR2; gamma-aminobutyric acid type B receptor subunit 2 [KO:K04615]", "2770  GNAI1; G protein subunit alpha i1 [KO:K04630]", "2773  GNAI3; G protein subunit alpha i3 [KO:K04630]", "2771  GNAI2; G protein subunit alpha i2 [KO:K04630]", "2775  GNAO1; G protein subunit alpha o1 [KO:K04534]", "2782  GNB1; G protein subunit beta 1 [KO:K04536]", "2783  GNB2; G protein subunit beta 2 [KO:K04537]", "2784  GNB3; G protein subunit beta 3 [KO:K07825]", "59345  GNB4; G protein subunit beta 4 [KO:K04538]", "10681  GNB5; G protein subunit beta 5 [KO:K04539]", "54331  GNG2; G protein subunit gamma 2 [KO:K07826]", "2785  GNG3; G protein subunit gamma 3 [KO:K04540]", "2786  GNG4; G protein subunit gamma 4 [KO:K04541]", "2787  GNG5; G protein subunit gamma 5 [KO:K04542]", "2788  GNG7; G protein subunit gamma 7 [KO:K04543]", "94235  GNG8; G protein subunit gamma 8 [KO:K04544]", "2790  GNG10; G protein subunit gamma 10 [KO:K04545]", "2791  GNG11; G protein subunit gamma 11 [KO:K04546]", "55970  GNG12; G protein subunit gamma 12 [KO:K04347]", "51764  GNG13; G protein subunit gamma 13 [KO:K04547]", "2792  GNGT1; G protein subunit gamma transducin 1 [KO:K04548]", "2793  GNGT2; G protein subunit gamma transducin 2 [KO:K04549]", "107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]", "108  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]", "109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]", "196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]", "113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]", "114  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]", "115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]", "3763  KCNJ6; potassium inwardly rectifying channel subfamily J member 6 [KO:K05000]", "6529  SLC6A1; solute carrier family 6 member 1 [KO:K05034]", "6540  SLC6A13; solute carrier family 6 member 13 [KO:K05046]", "6538  SLC6A11; solute carrier family 6 member 11 [KO:K05044]", "6539  SLC6A12; solute carrier family 6 member 12 [KO:K05045]", "2752  GLUL; glutamate-ammonia ligase [KO:K01915] [EC:6.3.1.2]", "10991  SLC38A3; solute carrier family 38 member 3 [KO:K13576]", "92745  SLC38A5; solute carrier family 38 member 5 [KO:K14992]"], "compound": ["C00025  L-Glutamate", "C00026  2-Oxoglutarate", "C00042  Succinate", "C00064  L-Glutamine", "C00076  Calcium cation", "C00238  Potassium cation", "C00334  4-Aminobutanoate", "C00575  3',5'-Cyclic AMP", "C00698  Cl-"], "refs": [{"pmid": "17499109", "authors": "  Farrant M, Kaila K", "title": "The cellular, molecular and ionic basis of GABA(A) receptor signalling.", "journal": "Prog Brain Res 160:59-87 (2007)", "doi": "10.1016/S0079-6123(06)60005-8"}, {"pmid": "9364667", "authors": "  Ben-Ari Y, Khazipov R, Leinekugel X, Caillard O, Gaiarsa JL", "title": "GABAA, NMDA and AMPA receptors: a developmentally regulated 'menage a trois'.", "journal": "Trends Neurosci 20:523-9 (1997)", "doi": "10.1016/S0166-2236(97)01147-8"}, {"pmid": "20655485", "authors": "  Pinard A, Seddik R, Bettler B", "title": "GABAB receptors: physiological functions and mechanisms of diversity.", "journal": "Adv Pharmacol 58:231-55 (2010)", "doi": "10.1016/S1054-3589(10)58010-4"}, {"pmid": "21376567", "authors": "  Chalifoux JR, Carter AG", "title": "GABAB receptor modulation of synaptic function.", "journal": "Curr Opin Neurobiol 21:339-44 (2011)", "doi": "10.1016/j.conb.2011.02.004"}, {"pmid": "20655481", "authors": "  Padgett CL, Slesinger PA", "title": "GABAB receptor coupling to G-proteins and ion channels.", "journal": "Adv Pharmacol 58:123-47 (2010)", "doi": "10.1016/S1054-3589(10)58006-2"}, {"pmid": "17499108", "authors": "  Emson PC", "title": "GABA(B) receptors: structure and function.", "journal": "Prog Brain Res 160:43-57 (2007)", "doi": "10.1016/S0079-6123(06)60004-6"}, {"pmid": "16932937", "authors": "  Kornau HC", "title": "GABA(B) receptors and synaptic modulation.", "journal": "Cell Tissue Res 326:517-33 (2006)", "doi": "10.1007/s00441-006-0264-7"}, {"pmid": "18382465", "authors": "  Jacob TC, Moss SJ, Jurd R", "title": "GABA(A) receptor trafficking and its role in the dynamic modulation of neuronal inhibition.", "journal": "Nat Rev Neurosci 9:331-43 (2008)", "doi": "10.1038/nrn2370"}, {"pmid": "12086709", "authors": "  Kneussel M", "title": "Dynamic regulation of GABA(A) receptors at synaptic sites.", "journal": "Brain Res Brain Res Rev 39:74-83 (2002)", "doi": "10.1016/S0165-0173(02)00159-5"}, {"pmid": "21555068", "authors": "  Luscher B, Fuchs T, Kilpatrick CL", "title": "GABAA receptor trafficking-mediated plasticity of inhibitory synapses.", "journal": "Neuron 70:385-409 (2011)", "doi": "10.1016/j.neuron.2011.03.024"}, {"pmid": "19374920", "authors": "  Arancibia-Carcamo IL, Kittler JT", "title": "Regulation of GABA(A) receptor membrane trafficking and synaptic localization.", "journal": "Pharmacol Ther 123:17-31 (2009)", "doi": "10.1016/j.pharmthera.2009.03.012"}, {"pmid": "16787421", "authors": "  Bak LK, Schousboe A, Waagepetersen HS", "title": "The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer.", "journal": "J Neurochem 98:641-53 (2006)", "doi": "10.1111/j.1471-4159.2006.03913.x"}, {"pmid": "15210304", "authors": "  Conti F, Minelli A, Melone M", "title": "GABA transporters in the mammalian cerebral cortex: localization, development and pathological implications.", "journal": "Brain Res Brain Res Rev 45:196-212 (2004)", "doi": "10.1016/j.brainresrev.2004.03.003"}, {"pmid": "12888801", "authors": "  Brambilla P, Perez J, Barale F, Schettini G, Soares JC", "title": "GABAergic dysfunction in mood disorders.", "journal": "Mol Psychiatry 8:721-37, 715 (2003)", "doi": "10.1038/sj.mp.4001362"}], "rel_pathway": ["hsa00020  Citrate cycle (TCA cycle)", "hsa00250  Alanine, aspartate and glutamate metabolism", "hsa04144  Endocytosis", "hsa04721  Synaptic vesicle cycle"], "ko_pathway": "ko04727", "genes": ["GPHN"]}, {"kegg_id": "hsa04215", "name": "Apoptosis - multiple species - Homo sapiens (human)", "description": "Apoptosis is an evolutionarily conserved process used by multicellular organisms to developmentally regulate cell number or to eliminate cells that are potentially detrimental to the organism. The major players are caspases, caspase inhibitors, members of the Bcl-2 family of pro- and anti-apoptotic proteins and adaptors of the Ced-4/APAF-1 type. Mammals, by comparison with Caenorhabditis and Drosophila, exhibit highly complex extrinsic and intrinsic pathways for apoptosis induction. However, recent analyses of whole genome sequences from cnidarians (e.g. Hydra) suggest that the caspase and Bcl-2 families were already highly complex in cnidarians and that Caenorhabditis and Drosophila lost many of the genes involved in apoptosis.", "class": "Cellular Processes; Cell growth and death", "pathway_map": "hsa04215  Apoptosis - multiple species", "drug": ["D12565  Xevinapant (JAN/USAN/INN)"], "dblinks": "GO: 0006915", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["7132  TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158]", "8772  FADD; Fas associated via death domain [KO:K02373]", "841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]", "840  CASP7; caspase 7 [KO:K04397] [EC:3.4.22.60]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "637  BID; BH3 interacting domain death agonist [KO:K04726]", "10018  BCL2L11; BCL2 like 11 [KO:K16341]", "5366  PMAIP1; phorbol-12-myristate-13-acetate-induced protein 1 [KO:K10131]", "27113  BBC3; BCL2 binding component 3 [KO:K10132]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]", "598  BCL2L1; BCL2 like 1 [KO:K04570]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "578  BAK1; BCL2 antagonist/killer 1 [KO:K14021]", "54205  CYCS; cytochrome c, somatic [KO:K08738]", "317  APAF1; apoptotic peptidase activating factor 1 [KO:K02084]", "842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]", "56616  DIABLO; diablo IAP-binding mitochondrial protein [KO:K10522]", "27429  HTRA2; HtrA serine peptidase 2 [KO:K08669] [EC:3.4.21.108]", "5414  SEPTIN4; septin 4 [KO:K16943]", "329  BIRC2; baculoviral IAP repeat containing 2 [KO:K16060]", "330  BIRC3; baculoviral IAP repeat containing 3 [KO:K16060]", "331  XIAP; X-linked inhibitor of apoptosis [KO:K04725] [EC:2.3.2.27]", "332  BIRC5; baculoviral IAP repeat containing 5 [KO:K08731]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "666  BOK; BCL2 family apoptosis regulator BOK [KO:K02561]", "79444  BIRC7; baculoviral IAP repeat containing 7 [KO:K16061]", "4804  NGFR; nerve growth factor receptor [KO:K02583]", "8678  BECN1; beclin 1 [KO:K08334]", "441925  BECN2; beclin 2 [KO:K08334]", "57448  BIRC6; baculoviral IAP repeat containing 6 [KO:K10586] [EC:2.3.2.23]"], "refs": [{"pmid": "25991373", "authors": "  Fuchs Y, Steller H", "title": "Live to die another way: modes of programmed cell death and the signals emanating from dying cells.", "journal": "Nat Rev Mol Cell Biol 16:329-44 (2015)", "doi": "10.1038/nrm3999"}, {"pmid": "15082313", "authors": "  Kumar S, Cakouros D", "title": "Transcriptional control of the core cell-death machinery.", "journal": "Trends Biochem Sci 29:193-9 (2004)", "doi": "10.1016/j.tibs.2004.02.001"}, {"pmid": "20978240", "authors": "  Bergmann A, Steller H", "title": "Apoptosis, stem cells, and tissue regeneration.", "journal": "Sci Signal 3:re8 (2010)", "doi": "10.1126/scisignal.3145re8"}, {"pmid": "23457257", "authors": "  Zmasek CM, Godzik A", "title": "Evolution of the animal apoptosis network.", "journal": "Cold Spring Harb Perspect Biol 5:a008649 (2013)", "doi": "10.1101/cshperspect.a008649"}, {"pmid": "15963254", "authors": "  Twomey C, McCarthy JV", "title": "Pathways of apoptosis and importance in development.", "journal": "J Cell Mol Med 9:345-59 (2005)", "doi": "10.1111/j.1582-4934.2005.tb00360.x"}, {"pmid": "10578171", "authors": "  Nicholson DW", "title": "Caspase structure, proteolytic substrates, and function during apoptotic cell death.", "journal": "Cell Death Differ 6:1028-42 (1999)", "doi": "10.1038/sj.cdd.4400598"}, {"pmid": "19659442", "authors": "  Wang C, Youle RJ", "title": "The role of mitochondria in apoptosis*.", "journal": "Annu Rev Genet 43:95-118 (2009)", "doi": "10.1146/annurev-genet-102108-134850"}, {"pmid": "20028968", "authors": "  Choi D, Woo M", "title": "Executioners of apoptosis in pancreatic {beta}-cells: not just for cell death.", "journal": "Am J Physiol Endocrinol Metab 298:E735-41 (2010)", "doi": "10.1152/ajpendo.00696.2009"}, {"pmid": "11858838", "authors": "  Joza N, Kroemer G, Penninger JM", "title": "Genetic analysis of the mammalian cell death machinery.", "journal": "Trends Genet 18:142-9 (2002)", "doi": "10.1016/S0168-9525(01)02618-X"}, {"pmid": "15107838", "authors": "  Yan N, Wu JW, Chai J, Li W, Shi Y", "title": "Molecular mechanisms of DrICE inhibition by DIAP1 and removal of inhibition by Reaper, Hid and Grim.", "journal": "Nat Struct Mol Biol 11:420-8 (2004)", "doi": "10.1038/nsmb764"}, {"pmid": "22689371", "authors": "  Reiter S, Crescenzi M, Galliot B, Buzgariu W", "title": "Hydra, a versatile model to study the homeostatic and developmental functions of cell death.", "journal": "Int J Dev Biol 56:593-604 (2012)", "doi": "10.1387/ijdb.123499sr"}, {"pmid": "20479784", "authors": "  Lasi M, Pauly B, Schmidt N, Cikala M, Stiening B, Kasbauer T, Zenner G, Popp T, Wagner A, Knapp RT, Huber AH, Grunert M, Soding J, David CN, Bottger A", "title": "The molecular cell death machinery in the simple cnidarian Hydra includes an expanded caspase family and pro- and anti-apoptotic Bcl-2 proteins.", "journal": "Cell Res 20:812-25 (2010)", "doi": "10.1038/cr.2010.66"}, {"pmid": "20041301", "authors": "  Lasi M, David CN, Bottger A", "title": "Apoptosis in pre-Bilaterians: Hydra as a model.", "journal": "Apoptosis 15:269-78 (2010)", "doi": "10.1007/s10495-009-0442-7"}, {"pmid": "25862972", "authors": "  Romero A, Novoa B, Figueras A", "title": "The complexity of apoptotic cell death in mollusks: An update.", "journal": "Fish Shellfish Immunol 46:79-87 (2015)", "doi": "10.1016/j.fsi.2015.03.038"}, {"pmid": "21150934", "authors": "  Potts MB, Cameron S", "title": "Cell lineage and cell death: Caenorhabditis elegans and cancer research.", "journal": "Nat Rev Cancer 11:50-8 (2011)", "doi": "10.1038/nrc2984"}], "rel_pathway": ["hsa04210  Apoptosis"], "ko_pathway": "ko04215", "genes": ["BIRC3", "BAX"]}, {"kegg_id": "hsa04217", "name": "Necroptosis - Homo sapiens (human)", "description": "Necroptosis is a programmed form of necrosis. It can be initiated by different stimuli, such as tumor necrosis factor (TNF), TNF-related apoptosis-inducing ligand (TRAIL), Fas ligand (FasL), interferon (IFN), LPS, viral DNA or RNA, DNA-damage agent and requires the kinase activity of receptor-interacting protein 1 (RIPK1) and RIPK3. Its execution involves ROS generation, calcium overload, the opening of the mitochondrial permeability transition pore, mitochondrial fission, inflammatory response and chromatinolysis. Necroptosis participates in many pathogenesis of diseases, including neurological diseases, retinal disorders, acute kidney injury, inflammatory diseases and microbial infections.", "class": "Cellular Processes; Cell growth and death", "pathway_map": "hsa04217  Necroptosis", "network": ["", "ELEMENT   N01621  TNF-RIPK1/3 signaling pathway", "N01625  CYLD regulation of RIPK1/3", "N01633  TLR3-RIPK3 signaling pathway", "N01634  TLR4-RIPK3 signaling pathway", "N01650  SQSTM1 regulation of RIPK1/3", "N01662  IFN-RIPK1/3 signaling pathway", "N01663  CASP8 regulation of RIPK1/3"], "drug": ["D09692  Veliparib (JAN/USAN/INN)", "D09730  Olaparib (JAN/USAN/INN)", "D09913  Iniparib (USAN/INN)", "D10079  Rucaparib (USAN/INN)", "D10140  Niraparib (USAN)", "D10157  Rucaparib phosphate (USAN)", "D10732  Talazoparib (USAN/INN)", "D10733  Talazoparib tosylate (USAN)", "D10982  Rucaparib camsylate (USAN)", "D11046  Delgocitinib (JAN/USAN/INN)", "D11426  Pamiparib (USAN/INN)", "D11449  Etokimab (USAN)", "D11817  Deucravacitinib (JAN/USAN)", "D11895  Niraparib tosilate hydrate (JAN)", "D11999  Itepekimab (USAN/INN)", "D12352  Eclitasertib (USAN/INN)", "D12375  Tozorakimab (USAN/INN)", "D12422  Selnoflast (USAN/INN)", "D12423  Selnoflast potassium (USAN)", "D12458  Ozekibart (USAN)", "D12510  Utreloxastat (JAN/USAN/INN)", "D12720  Nibrozetone (USAN)", "D12725  Lomedeucitinib (USAN)", "D12821  Flizasertib (USAN/INN)", "D12846  Ocadusertib (USAN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["7124  TNF; tumor necrosis factor [KO:K03156]", "7132  TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158]", "8717  TRADD; TNFRSF1A associated via death domain [KO:K03171]", "7186  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]", "7188  TRAF5; TNF receptor associated factor 5 [KO:K09849]", "8737  RIPK1; receptor interacting serine/threonine kinase 1 [KO:K02861] [EC:2.7.11.1]", "329  BIRC2; baculoviral IAP repeat containing 2 [KO:K16060]", "330  BIRC3; baculoviral IAP repeat containing 3 [KO:K16060]", "331  XIAP; X-linked inhibitor of apoptosis [KO:K04725] [EC:2.3.2.27]", "10616  RBCK1; RANBP2-type and C3HC4-type zinc finger containing 1 [KO:K10630] [EC:2.3.2.31]", "55072  RNF31; ring finger protein 31 [KO:K11974] [EC:2.3.2.31]", "81858  SHARPIN; SHANK associated RH domain interactor [KO:K20894]", "124044  SPATA2L; spermatogenesis associated 2 like [KO:K17595]", "9825  SPATA2; spermatogenesis associated 2 [KO:K17595]", "1540  CYLD; CYLD lysine 63 deubiquitinase [KO:K08601] [EC:3.4.19.12]", "8772  FADD; Fas associated via death domain [KO:K02373]", "841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]", "8837  CFLAR; CASP8 and FADD like apoptosis regulator [KO:K04724]", "11035  RIPK3; receptor interacting serine/threonine kinase 3 [KO:K08847] [EC:2.7.11.1]", "1536  CYBB; cytochrome b-245 beta chain [KO:K21421] [EC:1.-.-.-]", "815  CAMK2A; calcium/calmodulin dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]", "817  CAMK2D; calcium/calmodulin dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]", "816  CAMK2B; calcium/calmodulin dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]", "818  CAMK2G; calcium/calmodulin dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]", "291  SLC25A4; solute carrier family 25 member 4 [KO:K05863]", "292  SLC25A5; solute carrier family 25 member 5 [KO:K05863]", "293  SLC25A6; solute carrier family 25 member 6 [KO:K05863]", "83447  SLC25A31; solute carrier family 25 member 31 [KO:K05863]", "5481  PPID; peptidylprolyl isomerase D [KO:K05864] [EC:5.2.1.8]", "7416  VDAC1; voltage dependent anion channel 1 [KO:K05862]", "7417  VDAC2; voltage dependent anion channel 2 [KO:K15040]", "7419  VDAC3; voltage dependent anion channel 3 [KO:K15041]", "2747  GLUD2; glutamate dehydrogenase 2 [KO:K00261] [EC:1.4.1.3]", "2746  GLUD1; glutamate dehydrogenase 1 [KO:K00261] [EC:1.4.1.3]", "2752  GLUL; glutamate-ammonia ligase [KO:K01915] [EC:6.3.1.2]", "5836  PYGL; glycogen phosphorylase L [KO:K00688] [EC:2.4.1.1]", "5837  PYGM; glycogen phosphorylase, muscle associated [KO:K00688] [EC:2.4.1.1]", "5834  PYGB; glycogen phosphorylase B [KO:K00688] [EC:2.4.1.1]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "2495  FTH1; ferritin heavy chain 1 [KO:K00522] [EC:1.16.3.1]", "2512  FTL; ferritin light chain [KO:K13625]", "123745  PLA2G4E; phospholipase A2 group IVE [KO:K16342] [EC:3.1.1.4]", "5321  PLA2G4A; phospholipase A2 group IVA [KO:K16342] [EC:3.1.1.4]", "8681  JMJD7-PLA2G4B; JMJD7-PLA2G4B readthrough [KO:K16342] [EC:3.1.1.4]", "100137049  PLA2G4B; phospholipase A2 group IVB [KO:K16342] [EC:3.1.1.4]", "8605  PLA2G4C; phospholipase A2 group IVC [KO:K16342] [EC:3.1.1.4]", "283748  PLA2G4D; phospholipase A2 group IVD [KO:K16342] [EC:3.1.1.4]", "255189  PLA2G4F; phospholipase A2 group IVF [KO:K16342] [EC:3.1.1.4]", "246  ALOX15; arachidonate 15-lipoxygenase [KO:K00460] [EC:1.13.11.33]", "823  CAPN1; calpain 1 [KO:K01367] [EC:3.4.22.52]", "824  CAPN2; calpain 2 [KO:K03853] [EC:3.4.22.53]", "6609  SMPD1; sphingomyelin phosphodiesterase 1 [KO:K12350] [EC:3.1.4.12]", "197259  MLKL; mixed lineage kinase domain like pseudokinase [KO:K08849] [EC:2.7.11.1]", "192111  PGAM5; PGAM family member 5, mitochondrial serine/threonine protein phosphatase [KO:K15637] [EC:3.1.3.16]", "10059  DNM1L; dynamin 1 like [KO:K17065] [EC:3.6.5.5]", "114548  NLRP3; NLR family pyrin domain containing 3 [KO:K12800]", "29108  PYCARD; PYD and CARD domain containing [KO:K12799]", "834  CASP1; caspase 1 [KO:K01370] [EC:3.4.22.36]", "3553  IL1B; interleukin 1 beta [KO:K04519]", "27243  CHMP2A; charged multivesicular body protein 2A [KO:K12191]", "25978  CHMP2B; charged multivesicular body protein 2B [KO:K12192]", "51652  CHMP3; charged multivesicular body protein 3 [KO:K12193]", "100526767  RNF103-CHMP3; RNF103-CHMP3 readthrough [KO:K12193]", "128866  CHMP4B; charged multivesicular body protein 4B [KO:K12194]", "29082  CHMP4A; charged multivesicular body protein 4A [KO:K12194]", "92421  CHMP4C; charged multivesicular body protein 4C [KO:K24782]", "79643  CHMP6; charged multivesicular body protein 6 [KO:K12195]", "9525  VPS4B; vacuolar protein sorting 4 homolog B [KO:K12196]", "27183  VPS4A; vacuolar protein sorting 4 homolog A [KO:K12196]", "57132  CHMP1B; charged multivesicular body protein 1B [KO:K12197]", "5119  CHMP1A; charged multivesicular body protein 1A [KO:K12197]", "51510  CHMP5; charged multivesicular body protein 5 [KO:K12198]", "91782  CHMP7; charged multivesicular body protein 7 [KO:K15053]", "54822  TRPM7; transient receptor potential cation channel subfamily M member 7 [KO:K04982] [EC:2.7.11.1]", "3552  IL1A; interleukin 1 alpha [KO:K04383]", "90865  IL33; interleukin 33 [KO:K12967]", "3146  HMGB1; high mobility group box 1 [KO:K10802]", "8743  TNFSF10; TNF superfamily member 10 [KO:K04721]", "8797  TNFRSF10A; TNF receptor superfamily member 10a [KO:K04722]", "8795  TNFRSF10B; TNF receptor superfamily member 10b [KO:K04722]", "356  FASLG; Fas ligand [KO:K04389]", "355  FAS; Fas cell surface death receptor [KO:K04390]", "3439  IFNA1; interferon alpha 1 [KO:K05414]", "3440  IFNA2; interferon alpha 2 [KO:K05414]", "3441  IFNA4; interferon alpha 4 [KO:K05414]", "3442  IFNA5; interferon alpha 5 [KO:K05414]", "3443  IFNA6; interferon alpha 6 [KO:K05414]", "3444  IFNA7; interferon alpha 7 [KO:K05414]", "3445  IFNA8; interferon alpha 8 [KO:K05414]", "3446  IFNA10; interferon alpha 10 [KO:K05414]", "3447  IFNA13; interferon alpha 13 [KO:K05414]", "3448  IFNA14; interferon alpha 14 [KO:K05414]", "3449  IFNA16; interferon alpha 16 [KO:K05414]", "3451  IFNA17; interferon alpha 17 [KO:K05414]", "3452  IFNA21; interferon alpha 21 [KO:K05414]", "3456  IFNB1; interferon beta 1 [KO:K05415]", "3458  IFNG; interferon gamma [KO:K04687]", "3454  IFNAR1; interferon alpha and beta receptor subunit 1 [KO:K05130]", "3455  IFNAR2; interferon alpha and beta receptor subunit 2 [KO:K05131]", "3459  IFNGR1; interferon gamma receptor 1 [KO:K05132]", "3460  IFNGR2; interferon gamma receptor 2 [KO:K05133]", "3716  JAK1; Janus kinase 1 [KO:K11217] [EC:2.7.10.2]", "3717  JAK2; Janus kinase 2 [KO:K04447] [EC:2.7.10.2]", "3718  JAK3; Janus kinase 3 [KO:K11218] [EC:2.7.10.2]", "7297  TYK2; tyrosine kinase 2 [KO:K11219] [EC:2.7.10.2]", "6772  STAT1; signal transducer and activator of transcription 1 [KO:K11220]", "6773  STAT2; signal transducer and activator of transcription 2 [KO:K11221]", "6774  STAT3; signal transducer and activator of transcription 3 [KO:K04692]", "6775  STAT4; signal transducer and activator of transcription 4 [KO:K11222]", "6776  STAT5A; signal transducer and activator of transcription 5A [KO:K11223]", "6777  STAT5B; signal transducer and activator of transcription 5B [KO:K11224]", "6778  STAT6; signal transducer and activator of transcription 6 [KO:K11225]", "10379  IRF9; interferon regulatory factor 9 [KO:K04693]", "5610  EIF2AK2; eukaryotic translation initiation factor 2 alpha kinase 2 [KO:K16195] [EC:2.7.11.1]", "7099  TLR4; toll like receptor 4 [KO:K10160]", "353376  TICAM2; TIR domain containing adaptor molecule 2 [KO:K05409]", "148022  TICAM1; TIR domain containing adaptor molecule 1 [KO:K05842]", "7098  TLR3; toll like receptor 3 [KO:K05401]", "81030  ZBP1; Z-DNA binding protein 1 [KO:K12965]", "27005  USP21; ubiquitin specific peptidase 21 [KO:K21634] [EC:3.4.19.12]", "8878  SQSTM1; sequestosome 1 [KO:K14381]", "3320  HSP90AA1; heat shock protein 90 alpha family class A member 1 [KO:K04079]", "3326  HSP90AB1; heat shock protein 90 alpha family class B member 1 [KO:K04079]", "7128  TNFAIP3; TNF alpha induced protein 3 [KO:K11859] [EC:3.4.19.12]", "142  PARP1; poly(ADP-ribose) polymerase 1 [KO:K24070] [EC:2.4.2.30]", "637  BID; BH3 interacting domain death agonist [KO:K04726]", "581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]", "9131  AIFM1; apoptosis inducing factor mitochondria associated 1 [KO:K04727] [EC:1.-.-.-]", "3014  H2AX; H2A.X variant histone [KO:K11251]", "8338  H2AC20; H2A clustered histone 20 [KO:K11251]", "85235  H2AC12; H2A clustered histone 12 [KO:K11251]", "221613  H2AC1; H2A clustered histone 1 [KO:K11251]", "92815  H2AC25; H2A clustered histone 25 [KO:K11251]", "83740  H2AB3; H2A.B variant histone 3 [KO:K11251]", "3012  H2AC8; H2A clustered histone 8 [KO:K11251]", "8335  H2AC4; H2A clustered histone 4 [KO:K11251]", "55506  MACROH2A2; macroH2A.2 histone [KO:K11251]", "9555  MACROH2A1; macroH2A.1 histone [KO:K11251]", "723790  H2AC19; H2A clustered histone 19 [KO:K11251]", "55766  H2AJ; H2A.J histone [KO:K11251]", "474382  H2AB1; H2A.B variant histone 1 [KO:K11251]", "8336  H2AC17; H2A clustered histone 17 [KO:K11251]", "8337  H2AC18; H2A clustered histone 18 [KO:K11251]", "8969  H2AC11; H2A clustered histone 11 [KO:K11251]", "317772  H2AC21; H2A clustered histone 21 [KO:K11251]", "94239  H2AZ2; H2A.Z variant histone 2 [KO:K11251]", "3013  H2AC7; H2A clustered histone 7 [KO:K11251]", "3015  H2AZ1; H2A.Z variant histone 1 [KO:K11251]", "8330  H2AC15; H2A clustered histone 15 [KO:K11251]", "8334  H2AC6; H2A clustered histone 6 [KO:K11251]", "8329  H2AC13; H2A clustered histone 13 [KO:K11251]", "8331  H2AC14; H2A clustered histone 14 [KO:K11251]", "8332  H2AC16; H2A clustered histone 16 [KO:K11251]", "474381  H2AB2; H2A.B variant histone 2 [KO:K11251]", "115482686  H2AL3; H2A.L variant histone 3 [KO:K11251]", "5478  PPIA; peptidylprolyl isomerase A [KO:K03767] [EC:5.2.1.8]", "596  BCL2; BCL2 apoptosis regulator [KO:K02161]"], "compound": ["C00002  ATP", "C00027  Hydrogen peroxide", "C00076  Calcium cation", "C00195  N-Acylsphingosine", "C00219  Arachidonate", "C00305  Magnesium cation", "C00319  Sphingosine", "C00550  Sphingomyelin", "C14592  N-Methyl-N'-nitro-N-nitrosoguanidine", "C16844  Hydroxyl radical"], "refs": [{"pmid": "20823910", "authors": "  Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G", "title": "Molecular mechanisms of necroptosis: an ordered cellular explosion.", "journal": "Nat Rev Mol Cell Biol 11:700-14 (2010)", "doi": "10.1038/nrm2970"}, {"pmid": "26008591", "authors": "  Brenner D, Blaser H, Mak TW", "title": "Regulation of tumour necrosis factor signalling: live or let die.", "journal": "Nat Rev Immunol 15:362-74 (2015)", "doi": "10.1038/nri3834"}, {"pmid": "26775689", "authors": "  Conrad M, Angeli JP, Vandenabeele P, Stockwell BR", "title": "Regulated necrosis: disease relevance and therapeutic opportunities.", "journal": "Nat Rev Drug Discov 15:348-66 (2016)", "doi": "10.1038/nrd.2015.6"}, {"pmid": "24129419", "authors": "  Ofengeim D, Yuan J", "title": "Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death.", "journal": "Nat Rev Mol Cell Biol 14:727-36 (2013)", "doi": "10.1038/nrm3683"}, {"pmid": "27158445", "authors": "  Murphy JM, Vince JE", "title": "Post-translational control of RIPK3 and MLKL mediated necroptotic cell death.", "journal": "F1000Res 4:F1000 Faculty Rev-1297 (2015)", "doi": "10.12688/f1000research.7046.1"}, {"pmid": "24452471", "authors": "  Vanden Berghe T, Linkermann A, Jouan-Lanhouet S, Walczak H, Vandenabeele P", "title": "Regulated necrosis: the expanding network of non-apoptotic cell death pathways.", "journal": "Nat Rev Mol Cell Biol 15:135-47 (2014)", "doi": "10.1038/nrm3737"}, {"pmid": "27368376", "authors": "  Dondelinger Y, Hulpiau P, Saeys Y, Bertrand MJ, Vandenabeele P", "title": "An evolutionary perspective on the necroptotic pathway.", "journal": "Trends Cell Biol 26:721-32 (2016)", "doi": "10.1016/j.tcb.2016.06.004"}, {"pmid": "27746097", "authors": "  Thapa RJ, Ingram JP, Ragan KB, Nogusa S, Boyd DF, Benitez AA, Sridharan H, Kosoff R, Shubina M, Landsteiner VJ, Andrake M, Vogel P, Sigal LJ, tenOever BR, Thomas PG, Upton JW, Balachandran S", "title": "DAI Senses Influenza A Virus Genomic RNA and Activates RIPK3-Dependent Cell Death.", "journal": "Cell Host Microbe 20:674-681 (2016)", "doi": "10.1016/j.chom.2016.09.014"}, {"pmid": "27984721", "authors": "  Yuan J, Najafov A, Py BF", "title": "Roles of Caspases in Necrotic Cell Death.", "journal": "Cell 167:1693-1704 (2016)", "doi": "10.1016/j.cell.2016.11.047"}, {"pmid": "28138137", "authors": "  Jorgensen I, Rayamajhi M, Miao EA", "title": "Programmed cell death as a defence against infection.", "journal": "Nat Rev Immunol 17:151-164 (2017)", "doi": "10.1038/nri.2016.147"}, {"pmid": "20354226", "authors": "  Vandenabeele P, Declercq W, Van Herreweghe F, Vanden Berghe T", "title": "The role of the kinases RIP1 and RIP3 in TNF-induced necrosis.", "journal": "Sci Signal 3:re4 (2010)", "doi": "10.1126/scisignal.3115re4"}, {"pmid": "22075985", "authors": "  Vanlangenakker N, Vanden Berghe T, Vandenabeele P", "title": "Many stimuli pull the necrotic trigger, an overview.", "journal": "Cell Death Differ 19:75-86 (2012)", "doi": "10.1038/cdd.2011.164"}, {"pmid": "23913919", "authors": "  Moriwaki K, Chan FK", "title": "RIP3: a molecular switch for necrosis and inflammation.", "journal": "Genes Dev 27:1640-9 (2013)", "doi": "10.1101/gad.223321.113"}, {"pmid": "25146926", "authors": "  Humphries F, Yang S, Wang B, Moynagh PN", "title": "RIP kinases: key decision makers in cell death and innate immunity.", "journal": "Cell Death Differ 22:225-36 (2015)", "doi": "10.1038/cdd.2014.126"}, {"pmid": "28126382", "authors": "  Wegner KW, Saleh D, Degterev A", "title": "Complex Pathologic Roles of RIPK1 and RIPK3: Moving Beyond Necroptosis.", "journal": "Trends Pharmacol Sci 38:202-225 (2017)", "doi": "10.1016/j.tips.2016.12.005"}, {"pmid": "27545878", "authors": "  Kupka S, De Miguel D, Draber P, Martino L, Surinova S, Rittinger K, Walczak H", "title": "SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes.", "journal": "Cell Rep 16:2271-80 (2016)", "doi": "10.1016/j.celrep.2016.07.086"}, {"pmid": "27219062", "authors": "  Goodall ML, Fitzwalter BE, Zahedi S, Wu M, Rodriguez D, Mulcahy-Levy JM, Green DR, Morgan M, Cramer SD, Thorburn A", "title": "The Autophagy Machinery Controls Cell Death Switching between Apoptosis and Necroptosis.", "journal": "Dev Cell 37:337-49 (2016)", "doi": "10.1016/j.devcel.2016.04.018"}, {"pmid": "19910467", "authors": "  Xu G, Tan X, Wang H, Sun W, Shi Y, Burlingame S, Gu X, Cao G, Zhang T, Qin J, Yang J", "title": "Ubiquitin-specific peptidase 21 inhibits tumor necrosis factor alpha-induced nuclear factor kappaB activation via binding to and deubiquitinating receptor-interacting protein 1.", "journal": "J Biol Chem 285:969-78 (2010)", "doi": "10.1074/jbc.M109.042689"}, {"pmid": "26971869", "authors": "  Jacobsen AV, Silke J", "title": "The importance of being chaperoned: HSP90 and necroptosis.", "journal": "Cell Chem Biol 23:205-7 (2016)", "doi": "10.1016/j.chembiol.2016.02.003"}, {"pmid": "25988900", "authors": "  Gurung P, Man SM, Kanneganti TD", "title": "A20 is a regulator of necroptosis.", "journal": "Nat Immunol 16:596-7 (2015)", "doi": "10.1038/ni.3174"}, {"pmid": "28025046", "authors": "  Feng N, Anderson ME", "title": "CaMKII is a nodal signal for multiple programmed cell death pathways in heart.", "journal": "J Mol Cell Cardiol 103:102-109 (2017)", "doi": "10.1016/j.yjmcc.2016.12.007"}, {"pmid": "19696789", "authors": "  Zhivotovsky B, Galluzzi L, Kepp O, Kroemer G", "title": "Adenine nucleotide translocase: a component of the phylogenetically conserved cell death machinery.", "journal": "Cell Death Differ 16:1419-25 (2009)", "doi": "10.1038/cdd.2009.118"}, {"pmid": "23898178", "authors": "  Thapa RJ, Nogusa S, Chen P, Maki JL, Lerro A, Andrake M, Rall GF, Degterev A, Balachandran S", "title": "Interferon-induced RIP1/RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases.", "journal": "Proc Natl Acad Sci U S A 110:E3109-18 (2013)", "doi": "10.1073/pnas.1301218110"}, {"pmid": "21576359", "authors": "  Thapa RJ, Basagoudanavar SH, Nogusa S, Irrinki K, Mallilankaraman K, Slifker MJ, Beg AA, Madesh M, Balachandran S", "title": "NF-kappaB protects cells from gamma interferon-induced RIP1-dependent necroptosis.", "journal": "Mol Cell Biol 31:2934-46 (2011)", "doi": "10.1128/MCB.05445-11"}, {"pmid": "24565922", "authors": "  Sridharan H, Upton JW", "title": "Programmed necrosis in microbial pathogenesis.", "journal": "Trends Microbiol 22:199-207 (2014)", "doi": "10.1016/j.tim.2014.01.005"}, {"pmid": "21738214", "authors": "  Cabon L, Galan-Malo P, Bouharrour A, Delavallee L, Brunelle-Navas MN, Lorenzo HK, Gross A, Susin SA", "title": "BID regulates AIF-mediated caspase-independent necroptosis by promoting BAX activation.", "journal": "Cell Death Differ 19:245-56 (2012)", "doi": "10.1038/cdd.2011.91"}, {"pmid": "20697198", "authors": "  Baritaud M, Boujrad H, Lorenzo HK, Krantic S, Susin SA", "title": "Histone H2AX: The missing link in AIF-mediated caspase-independent programmed necrosis.", "journal": "Cell Cycle 9:3166-73 (2010)", "doi": "10.4161/cc.9.16.12887"}, {"pmid": "28279333", "authors": "  Upton JW, Kaiser WJ", "title": "DAI Another Way: Necroptotic Control of Viral Infection.", "journal": "Cell Host Microbe 21:290-293 (2017)", "doi": "10.1016/j.chom.2017.01.016"}, {"pmid": "26086143", "authors": "  Silke J, Rickard JA, Gerlic M", "title": "The diverse role of RIP kinases in necroptosis and inflammation.", "journal": "Nat Immunol 16:689-97 (2015)", "doi": "10.1038/ni.3206"}, {"pmid": "28388403", "authors": "  Guo H, Kaiser WJ", "title": "ESCRTing Necroptosis.", "journal": "Cell 169:186-187 (2017)", "doi": "10.1016/j.cell.2017.03.030"}, {"pmid": "28388412", "authors": "  Gong YN, Guy C, Olauson H, Becker JU, Yang M, Fitzgerald P, Linkermann A, Green DR", "title": "ESCRT-III Acts Downstream of MLKL to Regulate Necroptotic Cell Death and Its Consequences.", "journal": "Cell 169:286-300.e16 (2017)", "doi": "10.1016/j.cell.2017.03.020"}, {"pmid": "27999433", "authors": "  Petrie EJ, Hildebrand JM, Murphy JM", "title": "Insane in the membrane: a structural perspective of MLKL function in necroptosis.", "journal": "Immunol Cell Biol 95:152-159 (2017)", "doi": "10.1038/icb.2016.125"}, {"pmid": "24316671", "authors": "  Cai Z, Jitkaew S, Zhao J, Chiang HC, Choksi S, Liu J, Ward Y, Wu LG, Liu ZG", "title": "Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis.", "journal": "Nat Cell Biol 16:55-65 (2014)", "doi": "10.1038/ncb2883"}, {"pmid": "25693118", "authors": "  Lawlor KE, Khan N, Mildenhall A, Gerlic M, Croker BA, D'Cruz AA, Hall C, Kaur Spall S, Anderton H, Masters SL, Rashidi M, Wicks IP, Alexander WS, Mitsuuchi Y, Benetatos CA, Condon SM, Wong WW, Silke J, Vaux DL, Vince JE", "title": "RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL.", "journal": "Nat Commun 6:6282 (2015)", "doi": "10.1038/ncomms7282"}], "rel_pathway": ["hsa00250  Alanine, aspartate and glutamate metabolism", "hsa04210  Apoptosis", "hsa04668  TNF signaling pathway", "hsa04922  Glucagon signaling pathway"], "ko_pathway": "ko04217", "genes": ["BIRC3", "BAX"]}, {"kegg_id": "hsa03320", "name": "PPAR signaling pathway - Homo sapiens (human)", "description": "Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors that are activated by fatty acids and their derivatives. PPAR has three subtypes (PPARalpha, beta/delta, and gamma) showing different expression patterns in vertebrates. Each of them is encoded in a separate gene and binds fatty acids and eicosanoids. PPARalpha plays a role in the clearance of circulating or cellular lipids via the regulation of gene expression involved in lipid metabolism in liver and skeletal muscle. PPARbeta/delta is involved in lipid oxidation and cell proliferation. PPARgamma promotes adipocyte differentiation to enhance blood glucose uptake.", "class": "Organismal Systems; Endocrine system", "pathway_map": "hsa03320  PPAR signaling pathway", "drug": ["D00279  Clofibrate (JP18/USP/INN)", "D00334  Gemfibrozil (JAN/USP/INN)", "D00395  Troglitazone (JAN/USAN/INN)", "D00565  Fenofibrate (JP18/USP/INN)", "D00596  Rosiglitazone maleate (JAN/USP)", "D00945  Pioglitazone hydrochloride (JP18/USP)", "D01208  Aluminum clofibrate (JAN/INN)", "D01274  Tesaglitazar (JAN/USAN/INN)", "D01366  Bezafibrate (JP18/USAN/INN)", "D01971  Reglitazar (JAN/INN)", "D02047  Dextran sulfate sodium (JAN)", "D02815  Alitretinoin (USAN)", "D03106  Bexarotene (JAN/USAN/INN)", "D03343  Dextran sulfate sodium sulfur 5 (JP18)", "D03493  Ciglitazone (USAN/INN)", "D03521  Ciprofibrate (USAN/INN)", "D03747  Ibrolipim (USAN/INN)", "D03941  Edaglitazone sodium (USAN)", "D03996  Englitazone sodium (USAN)", "D04132  Farglitazar (USAN/INN)", "D04268  Elastase ES", "D04411  Halofenate (USAN/INN)", "D05030  Mifobate (USAN/INN)", "D05091  Muraglitazar (USAN/INN)", "D05150  Netoglitazone (USAN/INN)", "D05255  Omega-3-acid ethyl esters (USP)", "D05397  Peliglitazar (USAN)", "D05739  Rivoglitazone (USAN/INN)", "D06102  Theofibrate (USAN)", "D06647  Sodelglitazar (USAN)", "D07187  Etofibrate (INN)", "D07724  Magnesium clofibrate (INN)", "D08378  Pioglitazone (INN)", "D08491  Rosiglitazone (INN)", "D08845  Aleglitazar (USAN)", "D08890  Choline fenofibrate (USAN/INN)", "D08949  Naveglitazar (USAN/INN)", "D09350  Indeglitazar (USAN)", "D09579  Arhalofenate (USAN/INN)", "D11208  Elafibranor (USAN)", "D11256  Seladelpar (USAN/INN)", "D11257  Seladelpar lysine (USAN)", "D11579  Fenofibric acid", "D11604  Leriglitazone hydrochloride (USAN)", "D11648  Volanesorsen (USAN/INN)", "D11650  Volanesorsen sodium (USAN)", "D11923  Lobeglitazone (INN)", "D12242  Bocidelpar (USAN)", "D12243  Bocidelpar sulfate (USAN)", "D12298  Abequolixron (USAN/INN)", "D12299  Abequolixron zinc (USAN)", "D12484  Carfloglitazar (INN)", "D12614  Trisdecanoin (JAN/INN)", "D12644  Mavodelpar (USAN/INN)", "D12645  Mavodelpar sodium (USAN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["948  CD36; CD36 molecule (CD36 blood group) [KO:K06259]", "376497  SLC27A1; solute carrier family 27 member 1 [KO:K08745] [EC:6.2.1.-]", "10999  SLC27A4; solute carrier family 27 member 4 [KO:K08745] [EC:6.2.1.-]", "11001  SLC27A2; solute carrier family 27 member 2 [KO:K08746] [EC:6.2.1.- 6.2.1.3]", "10998  SLC27A5; solute carrier family 27 member 5 [KO:K08748] [EC:6.2.1.7]", "28965  SLC27A6; solute carrier family 27 member 6 [KO:K08749]", "2168  FABP1; fatty acid binding protein 1 [KO:K08750]", "2169  FABP2; fatty acid binding protein 2 [KO:K08751]", "2170  FABP3; fatty acid binding protein 3 [KO:K08752]", "2167  FABP4; fatty acid binding protein 4 [KO:K08753]", "2171  FABP5; fatty acid binding protein 5 [KO:K08754]", "2172  FABP6; fatty acid binding protein 6 [KO:K08755]", "2173  FABP7; fatty acid binding protein 7 [KO:K08756]", "5465  PPARA; peroxisome proliferator activated receptor alpha [KO:K07294]", "6256  RXRA; retinoid X receptor alpha [KO:K08524]", "6257  RXRB; retinoid X receptor beta [KO:K08525]", "6258  RXRG; retinoid X receptor gamma [KO:K08526]", "5467  PPARD; peroxisome proliferator activated receptor delta [KO:K04504]", "5468  PPARG; peroxisome proliferator activated receptor gamma [KO:K08530]", "3157  HMGCS1; 3-hydroxy-3-methylglutaryl-CoA synthase 1 [KO:K01641] [EC:2.3.3.10]", "3158  HMGCS2; 3-hydroxy-3-methylglutaryl-CoA synthase 2 [KO:K01641] [EC:2.3.3.10]", "335  APOA1; apolipoprotein A1 [KO:K08757]", "336  APOA2; apolipoprotein A2 [KO:K08758]", "345  APOC3; apolipoprotein C3 [KO:K08759]", "116519  APOA5; apolipoprotein A5 [KO:K09025]", "5360  PLTP; phospholipid transfer protein [KO:K08761]", "10873  ME3; malic enzyme 3 [KO:K00029] [EC:1.1.1.40]", "4199  ME1; malic enzyme 1 [KO:K00029] [EC:1.1.1.40]", "9415  FADS2; fatty acid desaturase 2 [KO:K10226] [EC:1.14.19.3]", "6319  SCD; stearoyl-CoA desaturase [KO:K00507] [EC:1.14.19.1]", "79966  SCD5; stearoyl-CoA desaturase 5 [KO:K00507] [EC:1.14.19.1]", "1581  CYP7A1; cytochrome P450 family 7 subfamily A member 1 [KO:K00489] [EC:1.14.14.23]", "1582  CYP8B1; cytochrome P450 family 8 subfamily B member 1 [KO:K07431] [EC:1.14.14.139]", "10062  NR1H3; nuclear receptor subfamily 1 group H member 3 [KO:K08536]", "1593  CYP27A1; cytochrome P450 family 27 subfamily A member 1 [KO:K00488] [EC:1.14.15.15]", "1622  DBI; diazepam binding inhibitor, acyl-CoA binding protein [KO:K08762]", "4023  LPL; lipoprotein lipase [KO:K01059] [EC:3.1.1.34]", "23305  ACSL6; acyl-CoA synthetase long chain family member 6 [KO:K01897] [EC:6.2.1.3]", "2182  ACSL4; acyl-CoA synthetase long chain family member 4 [KO:K01897] [EC:6.2.1.3]", "2180  ACSL1; acyl-CoA synthetase long chain family member 1 [KO:K01897] [EC:6.2.1.3]", "51703  ACSL5; acyl-CoA synthetase long chain family member 5 [KO:K01897] [EC:6.2.1.3]", "2181  ACSL3; acyl-CoA synthetase long chain family member 3 [KO:K01897] [EC:6.2.1.3]", "23205  ACSBG1; acyl-CoA synthetase bubblegum family member 1 [KO:K15013] [EC:6.2.1.3]", "81616  ACSBG2; acyl-CoA synthetase bubblegum family member 2 [KO:K15013] [EC:6.2.1.3]", "4973  OLR1; oxidized low density lipoprotein receptor 1 [KO:K08763]", "1962  EHHADH; enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase [KO:K07514] [EC:4.2.1.17 1.1.1.35 5.3.3.8]", "30  ACAA1; acetyl-CoA acyltransferase 1 [KO:K07513] [EC:2.3.1.16]", "6342  SCP2; sterol carrier protein 2 [KO:K08764] [EC:2.3.1.176]", "8310  ACOX3; acyl-CoA oxidase 3, pristanoyl [KO:K00232] [EC:1.3.3.6]", "51  ACOX1; acyl-CoA oxidase 1 [KO:K00232] [EC:1.3.3.6]", "8309  ACOX2; acyl-CoA oxidase 2 [KO:K10214] [EC:1.17.99.3]", "1374  CPT1A; carnitine palmitoyltransferase 1A [KO:K08765] [EC:2.3.1.21]", "1375  CPT1B; carnitine palmitoyltransferase 1B [KO:K19523] [EC:2.3.1.21]", "126129  CPT1C; carnitine palmitoyltransferase 1C [KO:K19524] [EC:2.3.1.21]", "1376  CPT2; carnitine palmitoyltransferase 2 [KO:K08766] [EC:2.3.1.21]", "33  ACADL; acyl-CoA dehydrogenase long chain [KO:K00255] [EC:1.3.8.8]", "34  ACADM; acyl-CoA dehydrogenase medium chain [KO:K00249] [EC:1.3.8.7]", "51129  ANGPTL4; angiopoietin like 4 [KO:K08767]", "10580  SORBS1; sorbin and SH3 domain containing 1 [KO:K06086]", "5346  PLIN1; perilipin 1 [KO:K08768]", "123  PLIN2; perilipin 2 [KO:K17284]", "729359  PLIN4; perilipin 4 [KO:K20254]", "440503  PLIN5; perilipin 5 [KO:K20255]", "9370  ADIPOQ; adiponectin, C1Q and collagen domain containing [KO:K07296]", "4312  MMP1; matrix metallopeptidase 1 [KO:K01388] [EC:3.4.24.7]", "7350  UCP1; uncoupling protein 1 [KO:K08769]", "3611  ILK; integrin linked kinase [KO:K06272] [EC:2.7.11.1]", "5170  PDPK1; 3-phosphoinositide dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]", "7316  UBC; ubiquitin C [KO:K08770]", "5105  PCK1; phosphoenolpyruvate carboxykinase 1 [KO:K01596] [EC:4.1.1.32]", "5106  PCK2; phosphoenolpyruvate carboxykinase 2, mitochondrial [KO:K01596] [EC:4.1.1.32]", "2712  GK2; glycerol kinase 2 [KO:K00864] [EC:2.7.1.30]", "2710  GK; glycerol kinase [KO:K00864] [EC:2.7.1.30]", "364  AQP7; aquaporin 7 [KO:K08771]", "100509620  AQP7B; aquaporin 7B [KO:K08771]"], "compound": ["C02165  Leukotriene B4", "C14762  13(S)-HODE", "C14767  9(S)-HODE", "C14776  8(S)-HETE", "C15493  9-cis-Retinoic acid"], "refs": [{"pmid": "16476485", "authors": "  Feige JN, Gelman L, Michalik L, Desvergne B, Wahli W.", "title": "From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions.", "journal": "Prog Lipid Res 45:120-59 (2006)", "doi": "10.1016/j.plipres.2005.12.002"}, {"pmid": "16601267", "authors": "  Desvergne B, Michalik L, Wahli W.", "title": "Transcriptional regulation of metabolism.", "journal": "Physiol Rev 86:465-514 (2006)", "doi": "10.1152/physrev.00025.2005"}, {"pmid": "14999402", "authors": "  Mandard S, Muller M, Kersten S.", "title": "Peroxisome proliferator-activated receptor alpha target genes.", "journal": "Cell Mol Life Sci 61:393-416 (2004)", "doi": "10.1007/s00018-003-3216-3"}, {"pmid": "10529898", "authors": "  Desvergne B, Wahli W.", "title": "Peroxisome proliferator-activated receptors: nuclear control of metabolism.", "journal": "Endocr Rev 20:649-88 (1999)", "doi": "10.1210/edrv.20.5.0380"}, {"pmid": "15673477", "authors": "  Savage DB.", "title": "PPARgamma as a metabolic regulator: insights from genomics and pharmacology.", "journal": "Expert Rev Mol Med 2005:1-16 (2005)", "doi": "10.1017/S1462399405008793"}, {"pmid": "16511590", "authors": "  Semple RK, Chatterjee VK, O'Rahilly S.", "title": "PPAR gamma and human metabolic disease.", "journal": "J Clin Invest 116:581-9 (2006)", "doi": "10.1172/JCI28003"}, {"pmid": "16360030", "authors": "  Lehrke M, Lazar MA.", "title": "The many faces of PPARgamma.", "journal": "Cell 123:993-9 (2005)", "doi": "10.1016/j.cell.2005.11.026"}], "rel_pathway": ["hsa00071  Fatty acid degradation", "hsa00120  Primary bile acid biosynthesis", "hsa00564  Glycerophospholipid metabolism", "hsa04920  Adipocytokine signaling pathway"], "ko_pathway": "ko03320", "genes": ["CD36"]}, {"kegg_id": "hsa04975", "name": "Fat digestion and absorption - Homo sapiens (human)", "description": "Fat is an important energy source from food. More than 95% of dietary fat is long-chain triacylglycerols (TAG), the remaining being phospholipids (4.5%) and sterols. In the small intestine lumen, dietary TAG is hydrolyzed to fatty acids (FA) and monoacylglycerols (MAG) by pancreatic lipase. These products are then emulsified with the help of phospholipids (PL) and bile acids (BA) present in bile to form micelles. Free FAs and MAGs are taken up by the enterocyte where they are rapidly resynthesized in endoplasmic reticulum (ER) to form TAG. PLs from the diet as well as bile - mainly LPA - too are absorbed by the enterocyte and are acylated to form phosphatidic acid (PA), which is also converted into TAG. Absorbed cholesterol (CL) is acylated to cholesterol esters (CE). Within the ER, TAG joins CE and apolipoprotein B (ApoB) to form chylomicrons that enter circulation through the lymph.", "class": "Organismal Systems; Digestive system", "pathway_map": "hsa04975  Fat digestion and absorption", "drug": ["D01966  Ezetimibe (JAN/USP/INN)", "D04028  Orlistat (JAN/USP/INN)", "D05060  Mitratapide (USAN/INN)", "D06283  Varespladib sodium (USAN)", "D09208  Cetilistat (JAN/USAN/INN)", "D09637  Lomitapide (USAN/INN)", "D09638  Lomitapide mesylate (USAN)", "D10657  Pradigastat sodium (USAN)", "D10664  Pradigastat (USAN)"], "dblinks": "GO: 0044241 0030299", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["8513  LIPF; lipase F, gastric type [KO:K14452] [EC:3.1.1.3]", "5406  PNLIP; pancreatic lipase [KO:K14073] [EC:3.1.1.3]", "5407  PNLIPRP1; pancreatic lipase related protein 1 [KO:K14074] [EC:3.1.1.3]", "5408  PNLIPRP2; pancreatic lipase related protein 2 (gene/pseudogene) [KO:K14075] [EC:3.1.1.3]", "1056  CEL; carboxyl ester lipase [KO:K12298] [EC:3.1.1.13 3.1.1.3]", "8399  PLA2G10; phospholipase A2 group X [KO:K01047] [EC:3.1.1.4]", "26279  PLA2G2D; phospholipase A2 group IID [KO:K01047] [EC:3.1.1.4]", "30814  PLA2G2E; phospholipase A2 group IIE [KO:K01047] [EC:3.1.1.4]", "50487  PLA2G3; phospholipase A2 group III [KO:K01047] [EC:3.1.1.4]", "64600  PLA2G2F; phospholipase A2 group IIF [KO:K01047] [EC:3.1.1.4]", "81579  PLA2G12A; phospholipase A2 group XIIA [KO:K01047] [EC:3.1.1.4]", "84647  PLA2G12B; phospholipase A2 group XIIB [KO:K01047] [EC:3.1.1.4]", "5319  PLA2G1B; phospholipase A2 group IB [KO:K01047] [EC:3.1.1.4]", "5322  PLA2G5; phospholipase A2 group V [KO:K01047] [EC:3.1.1.4]", "5320  PLA2G2A; phospholipase A2 group IIA [KO:K01047] [EC:3.1.1.4]", "391013  PLA2G2C; phospholipase A2 group IIC [KO:K01047] [EC:3.1.1.4]", "1208  CLPS; colipase [KO:K14460]", "948  CD36; CD36 molecule (CD36 blood group) [KO:K06259]", "2806  GOT2; glutamic-oxaloacetic transaminase 2 [KO:K14455] [EC:2.6.1.1]", "2169  FABP2; fatty acid binding protein 2 [KO:K08751]", "2168  FABP1; fatty acid binding protein 1 [KO:K08750]", "376497  SLC27A1; solute carrier family 27 member 1 [KO:K08745] [EC:6.2.1.-]", "10999  SLC27A4; solute carrier family 27 member 4 [KO:K08745] [EC:6.2.1.-]", "10554  AGPAT1; 1-acylglycerol-3-phosphate O-acyltransferase 1 [KO:K13509] [EC:2.3.1.51]", "10555  AGPAT2; 1-acylglycerol-3-phosphate O-acyltransferase 2 [KO:K13509] [EC:2.3.1.51]", "8611  PLPP1; phospholipid phosphatase 1 [KO:K01080] [EC:3.1.3.4]", "8613  PLPP3; phospholipid phosphatase 3 [KO:K01080] [EC:3.1.3.4]", "8612  PLPP2; phospholipid phosphatase 2 [KO:K01080] [EC:3.1.3.4]", "80168  MOGAT2; monoacylglycerol O-acyltransferase 2 [KO:K14457] [EC:2.3.1.22]", "346606  MOGAT3; monoacylglycerol O-acyltransferase 3 [KO:K14456] [EC:2.3.1.20 2.3.1.22]", "8694  DGAT1; diacylglycerol O-acyltransferase 1 [KO:K11155] [EC:2.3.1.20 2.3.1.75 2.3.1.76]", "84649  DGAT2; diacylglycerol O-acyltransferase 2 [KO:K11160] [EC:2.3.1.20 2.3.1.75]", "949  SCARB1; scavenger receptor class B member 1 [KO:K13885]", "29881  NPC1L1; NPC1 like intracellular cholesterol transporter 1 [KO:K14461]", "39  ACAT2; acetyl-CoA acetyltransferase 2 [KO:K00626] [EC:2.3.1.9]", "38  ACAT1; acetyl-CoA acetyltransferase 1 [KO:K00626] [EC:2.3.1.9]", "64240  ABCG5; ATP binding cassette subfamily G member 5 [KO:K05683]", "64241  ABCG8; ATP binding cassette subfamily G member 8 [KO:K05684]", "337  APOA4; apolipoprotein A4 [KO:K08760]", "338  APOB; apolipoprotein B [KO:K14462]", "4547  MTTP; microsomal triglyceride transfer protein [KO:K14463]", "335  APOA1; apolipoprotein A1 [KO:K08757]", "19  ABCA1; ATP binding cassette subfamily A member 1 [KO:K05641]"], "compound": ["C00010  CoA", "C00040  Acyl-CoA", "C00162  Fatty acid", "C00165  Diacylglycerol", "C00187  Cholesterol", "C00416  Phosphatidate", "C00422  Triacylglycerol", "C00681  1-Acyl-sn-glycerol 3-phosphate", "C00865  Phospholipid", "C01558  Bile salt", "C01885  1-Acylglycerol", "C02112  2-Acylglycerol", "C02530  Cholesterol ester"], "refs": [{"pmid": "19158321", "authors": "  Iqbal J, Hussain MM", "title": "Intestinal lipid absorption.", "journal": "Am J Physiol Endocrinol Metab 296:E1183-94 (2009)", "doi": "10.1152/ajpendo.90899.2008"}, {"pmid": "20522896", "authors": "  Goodman BE", "title": "Insights into digestion and absorption of major nutrients in humans.", "journal": "Adv Physiol Educ 34:44-53 (2010)", "doi": "10.1152/advan.00094.2009"}, {"pmid": "19280719", "authors": "  Niot I, Poirier H, Tran TT, Besnard P", "title": "Intestinal absorption of long-chain fatty acids: evidence and uncertainties.", "journal": "Prog Lipid Res 48:101-15 (2009)", "doi": "10.1016/j.plipres.2009.01.001"}, {"pmid": "15286736", "authors": "  Shi Y, Burn P", "title": "Lipid metabolic enzymes: emerging drug targets for the treatment of obesity.", "journal": "Nat Rev Drug Discov 3:695-710 (2004)", "doi": "10.1038/nrd1469"}, {"pmid": "20148678", "authors": "  Mansbach CM, Siddiqi SA", "title": "The biogenesis of chylomicrons.", "journal": "Annu Rev Physiol 72:315-33 (2010)", "doi": "10.1146/annurev-physiol-021909-135801"}, {"pmid": "19116371", "authors": "  Shi Y, Cheng D", "title": "Beyond triglyceride synthesis: the dynamic functional roles of MGAT and DGAT enzymes in energy metabolism.", "journal": "Am J Physiol Endocrinol Metab 297:E10-8 (2009)", "doi": "10.1152/ajpendo.90949.2008"}, {"pmid": "10924713", "authors": "  Ros E", "title": "Intestinal absorption of triglyceride and cholesterol. Dietary and pharmacological inhibition to reduce cardiovascular risk.", "journal": "Atherosclerosis 151:357-79 (2000)", "doi": "10.1016/S0021-9150(00)00456-1"}, {"pmid": "12621063", "authors": "  Yen CL, Farese RV Jr", "title": "MGAT2, a monoacylglycerol acyltransferase expressed in the small intestine.", "journal": "J Biol Chem 278:18532-7 (2003)", "doi": "10.1074/jbc.M301633200"}, {"pmid": "17495606", "authors": "  Levy E, Spahis S, Sinnett D, Peretti N, Maupas-Schwalm F, Delvin E, Lambert M, Lavoie MA", "title": "Intestinal cholesterol transport proteins: an update and beyond.", "journal": "Curr Opin Lipidol 18:310-8 (2007)", "doi": "10.1097/MOL.0b013e32813fa2e2"}, {"pmid": "18830418", "authors": "  Williams KJ", "title": "Molecular processes that handle -- and mishandle -- dietary lipids.", "journal": "J Clin Invest 118:3247-59 (2008)", "doi": "10.1172/JCI35206"}, {"pmid": "11504671", "authors": "  Lu K, Lee MH, Patel SB", "title": "Dietary cholesterol absorption; more than just bile.", "journal": "Trends Endocrinol Metab 12:314-20 (2001)", "doi": "10.1016/S1043-2760(01)00433-7"}, {"pmid": "14976303", "authors": "  Klett EL, Patel SB", "title": "Biomedicine. Will the real cholesterol transporter please stand up.", "journal": "Science 303:1149-50 (2004)", "doi": "10.1126/science.1095519"}, {"pmid": "17002594", "authors": "  Wang DQ", "title": "Regulation of intestinal cholesterol absorption.", "journal": "Annu Rev Physiol 69:221-48 (2007)", "doi": "10.1146/annurev.physiol.69.031905.160725"}, {"pmid": "19663632", "authors": "  Patel JP, Brocks DR", "title": "The effect of oral lipids and circulating lipoproteins on the metabolism of drugs.", "journal": "Expert Opin Drug Metab Toxicol 5:1385-98 (2009)", "doi": "10.1517/17425250903176439"}, {"pmid": "15891388", "authors": "  Hussain MM, Fatma S, Pan X, Iqbal J", "title": "Intestinal lipoprotein assembly.", "journal": "Curr Opin Lipidol 16:281-5 (2005)", "doi": "10.1097/01.mol.0000169347.53568.5a"}], "rel_pathway": ["hsa00561  Glycerolipid metabolism", "hsa04530  Tight junction", "hsa04972  Pancreatic secretion", "hsa04976  Bile secretion"], "ko_pathway": "ko04975", "genes": ["CD36"]}, {"kegg_id": "hsa04979", "name": "Cholesterol metabolism - Homo sapiens (human)", "description": "Cholesterol is an essential component of mammalian cell membranes as well as a precursor of bile acids, vitamin D and steroid hormones. Cholesterol homeostasis in humans is regulated by well-balanced mechanisms of intestinal uptake, endogenous synthesis, transport in lipoprotein particles, and biliary excretion. Its abnormal metabolism can lead to increased risk for various endocrine disorders and cardiovascular diseases.", "class": "Organismal Systems; Digestive system", "pathway_map": "hsa04979  Cholesterol metabolism", "network": ["", "ELEMENT   N00332  Vesicular uptake of lipoproteins", "N00336  PCSK9-mediated LDLR degradation"], "drug": ["D01202  Melinamide (JAN)", "D02047  Dextran sulfate sodium (JAN)", "D03012  Avasimibe (USAN/INN)", "D03343  Dextran sulfate sodium sulfur 5 (JP18)", "D03447  Cetaben sodium (USAN)", "D03734  Eldacimibe (USAN/INN)", "D03735  Lecimibide (USAN)", "D03747  Ibrolipim (USAN/INN)", "D04268  Elastase ES", "D05255  Omega-3-acid ethyl esters (USP)", "D06195  Torcetrapib (USAN/INN)", "D10335  Alirocumab (USAN)", "D10557  Evolocumab (USAN/INN)", "D10621  Bococizumab (USAN/INN)", "D11398  Frovocimab (USAN/INN)", "D11648  Volanesorsen (USAN/INN)", "D11650  Volanesorsen sodium (USAN)", "D11753  Evinacumab (USAN/INN)", "D11931  Inclisiran (USAN/INN)", "D12293  Inclisiran sodium (JAN)", "D12460  Muvalaplin (USAN)", "D12580  Sudotaxel zendusortide (USAN/INN)", "D12581  Zendusortide (USAN/INN)", "D12900  Obicetrapib (USAN/INN)", "D12901  Obicetrapib calcium (USAN)"], "dblinks": "GO: 0008203", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["19  ABCA1; ATP binding cassette subfamily A member 1 [KO:K05641]", "335  APOA1; apolipoprotein A1 [KO:K08757]", "4023  LPL; lipoprotein lipase [KO:K01059] [EC:3.1.1.34]", "3931  LCAT; lecithin-cholesterol acyltransferase [KO:K00650] [EC:2.3.1.43]", "9388  LIPG; lipase G, endothelial type [KO:K22284] [EC:3.1.1.3]", "5360  PLTP; phospholipid transfer protein [KO:K08761]", "1071  CETP; cholesteryl ester transfer protein [KO:K16835]", "3990  LIPC; lipase C, hepatic type [KO:K22283] [EC:3.1.1.3]", "4018  LPA; lipoprotein(a) [KO:K09644] [EC:3.4.21.-]", "948  CD36; CD36 molecule (CD36 blood group) [KO:K06259]", "3949  LDLR; low density lipoprotein receptor [KO:K12473]", "57552  NCEH1; neutral cholesterol ester hydrolase 1 [KO:K14349] [EC:3.1.1.-]", "8435  SOAT2; sterol O-acyltransferase 2 [KO:K00637] [EC:2.3.1.26]", "6646  SOAT1; sterol O-acyltransferase 1 [KO:K00637] [EC:2.3.1.26]", "341  APOC1; apolipoprotein C1 [KO:K22286]", "344  APOC2; apolipoprotein C2 [KO:K22287]", "350  APOH; apolipoprotein H [KO:K17305]", "27329  ANGPTL3; angiopoietin like 3 [KO:K22288]", "51129  ANGPTL4; angiopoietin like 4 [KO:K08767]", "55908  ANGPTL8; angiopoietin like 8 [KO:K22289]", "949  SCARB1; scavenger receptor class B member 1 [KO:K13885]", "6272  SORT1; sortilin 1 [KO:K12388]", "338  APOB; apolipoprotein B [KO:K14462]", "255738  PCSK9; proprotein convertase subtilisin/kexin type 9 [KO:K13050] [EC:3.4.21.-]", "26119  LDLRAP1; low density lipoprotein receptor adaptor protein 1 [KO:K12474]", "29116  MYLIP; myosin regulatory light chain interacting protein [KO:K10637] [EC:2.3.2.27]", "348  APOE; apolipoprotein E [KO:K04524]", "4035  LRP1; LDL receptor related protein 1 [KO:K04550]", "4036  LRP2; LDL receptor related protein 2 [KO:K06233]", "4043  LRPAP1; LDL receptor related protein associated protein 1 [KO:K22290]", "3988  LIPA; lipase A, lysosomal acid type [KO:K01052] [EC:3.1.1.13]", "10948  STARD3; StAR related lipid transfer domain containing 3 [KO:K22291]", "7416  VDAC1; voltage dependent anion channel 1 [KO:K05862]", "7417  VDAC2; voltage dependent anion channel 2 [KO:K15040]", "7419  VDAC3; voltage dependent anion channel 3 [KO:K15041]", "706  TSPO; translocator protein [KO:K05770]", "1593  CYP27A1; cytochrome P450 family 27 subfamily A member 1 [KO:K00488] [EC:1.14.15.15]", "9218  VAPA; VAMP associated protein A [KO:K06096]", "9217  VAPB; VAMP associated protein B and C [KO:K10707]", "4864  NPC1; NPC intracellular cholesterol transporter 1 [KO:K12385]", "114879  OSBPL5; oxysterol binding protein like 5 [KO:K20464]", "10577  NPC2; NPC intracellular cholesterol transporter 2 [KO:K13443]", "6770  STAR; steroidogenic acute regulatory protein [KO:K16931]", "27141  CIDEB; cell death inducing DFFA like effector b [KO:K25914]", "1581  CYP7A1; cytochrome P450 family 7 subfamily A member 1 [KO:K00489] [EC:1.14.14.23]", "8647  ABCB11; ATP binding cassette subfamily B member 11 [KO:K05664]", "64240  ABCG5; ATP binding cassette subfamily G member 5 [KO:K05683]", "64241  ABCG8; ATP binding cassette subfamily G member 8 [KO:K05684]", "336  APOA2; apolipoprotein A2 [KO:K08758]", "345  APOC3; apolipoprotein C3 [KO:K08759]", "337  APOA4; apolipoprotein A4 [KO:K08760]"], "compound": ["C00162  Fatty acid", "C00187  Cholesterol", "C00422  Triacylglycerol", "C00865  Phospholipid", "C01921  Glycocholate", "C02530  Cholesterol ester", "C05122  Taurocholate", "C05465  Taurochenodeoxycholate", "C05466  Glycochenodeoxycholate", "C15610  Cholest-5-ene-3beta,26-diol"], "refs": [{"pmid": "28577571", "authors": "  Paththinige CS, Sirisena ND, Dissanayake V", "title": "Genetic determinants of inherited susceptibility to hypercholesterolemia - a comprehensive literature review.", "journal": "Lipids Health Dis 16:103 (2017)", "doi": "10.1186/s12944-017-0488-4"}, {"pmid": "24385507", "authors": "  Oldoni F, Sinke RJ, Kuivenhoven JA", "title": "Mendelian disorders of high-density lipoprotein metabolism.", "journal": "Circ Res 114:124-42 (2014)", "doi": "10.1161/CIRCRESAHA.113.300634"}, {"pmid": "15451808", "authors": "  Lusis AJ, Fogelman AM, Fonarow GC", "title": "Genetic basis of atherosclerosis: part I: new genes and pathways.", "journal": "Circulation 110:1868-73 (2004)", "doi": "10.1161/01.CIR.0000143041.58692.CC"}, {"pmid": "18079757", "authors": "  Wasan KM, Brocks DR, Lee SD, Sachs-Barrable K, Thornton SJ", "title": "Impact of lipoproteins on the biological activity and disposition of hydrophobic drugs: implications for drug discovery.", "journal": "Nat Rev Drug Discov 7:84-99 (2008)", "doi": "10.1038/nrd2353"}, {"pmid": "18216769", "authors": "  Ikonen E", "title": "Cellular cholesterol trafficking and compartmentalization.", "journal": "Nat Rev Mol Cell Biol 9:125-38 (2008)", "doi": "10.1038/nrm2336"}, {"pmid": "26568191", "authors": "  Vaziri ND", "title": "HDL abnormalities in nephrotic syndrome and chronic kidney disease.", "journal": "Nat Rev Nephrol 12:37-47 (2016)", "doi": "10.1038/nrneph.2015.180"}, {"pmid": "24854407", "authors": "  Kingwell BA, Chapman MJ, Kontush A, Miller NE", "title": "HDL-targeted therapies: progress, failures and future.", "journal": "Nat Rev Drug Discov 13:445-64 (2014)", "doi": "10.1038/nrd4279"}, {"pmid": "25172365", "authors": "  Do RQ, Nicholls SJ, Schwartz GG", "title": "Evolving targets for lipid-modifying therapy.", "journal": "EMBO Mol Med 6:1215-30 (2014)", "doi": "10.15252/emmm.201404000"}, {"pmid": "25551803", "authors": "  Sacks FM", "title": "The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia.", "journal": "Curr Opin Lipidol 26:56-63 (2015)", "doi": "10.1097/MOL.0000000000000146"}, {"pmid": "20962428", "authors": "  Yasuda T, Ishida T, Rader DJ", "title": "Update on the role of endothelial lipase in high-density lipoprotein metabolism, reverse cholesterol transport, and atherosclerosis.", "journal": "Circ J 74:2263-70 (2010)", "doi": "10.1253/circj.CJ-10-0934"}, {"pmid": "25359426", "authors": "  Wang S, Smith JD", "title": "ABCA1 and nascent HDL biogenesis.", "journal": "Biofactors 40:547-54 (2014)", "doi": "10.1002/biof.1187"}, {"pmid": "28971105", "authors": "  Hassan M", "title": "ANGPLT3: A novel modulator of lipid metabolism.", "journal": "Glob Cardiol Sci Pract 2017:e201706 (2017)", "doi": "10.21542/gcsp.2017.6"}, {"pmid": "24397894", "authors": "  Dijk W, Kersten S", "title": "Regulation of lipoprotein lipase by Angptl4.", "journal": "Trends Endocrinol Metab 25:146-55 (2014)", "doi": "10.1016/j.tem.2013.12.005"}, {"pmid": "11254896", "authors": "  Huuskonen J, Olkkonen VM, Jauhiainen M, Ehnholm C", "title": "The impact of phospholipid transfer protein (PLTP) on HDL metabolism.", "journal": "Atherosclerosis 155:269-81 (2001)", "doi": "10.1016/S0021-9150(01)00447-6"}, {"pmid": "22661899", "authors": "  Shinkai H", "title": "Cholesteryl ester transfer-protein modulator and inhibitors and their potential for the treatment of cardiovascular diseases.", "journal": "Vasc Health Risk Manag 8:323-31 (2012)", "doi": "10.2147/VHRM.S25238"}, {"pmid": "26435212", "authors": "  Norata GD, Tsimikas S, Pirillo A, Catapano AL", "title": "Apolipoprotein C-III: From Pathophysiology to Pharmacology.", "journal": "Trends Pharmacol Sci 36:675-87 (2015)", "doi": "10.1016/j.tips.2015.07.001"}, {"pmid": "27312323", "authors": "  Zhong LY, Cayabyab FS, Tang CK, Zheng XL, Peng TH, Lv YC", "title": "Sortilin: A novel regulator in lipid metabolism and atherogenesis.", "journal": "Clin Chim Acta 460:11-7 (2016)", "doi": "10.1016/j.cca.2016.06.013"}, {"pmid": "22510808", "authors": "  Sorrentino V, Zelcer N", "title": "Post-transcriptional regulation of lipoprotein receptors by the E3-ubiquitin ligase inducible degrader of the low-density lipoprotein receptor.", "journal": "Curr Opin Lipidol 23:213-9 (2012)", "doi": "10.1097/MOL.0b013e3283532947"}, {"pmid": "25003069", "authors": "  Jiang W, Song BL", "title": "Ubiquitin ligases in cholesterol metabolism.", "journal": "Diabetes Metab J 38:171-80 (2014)", "doi": "10.4093/dmj.2014.38.3.171"}, {"pmid": "22811413", "authors": "  Lambert G, Sjouke B, Choque B, Kastelein JJ, Hovingh GK", "title": "The PCSK9 decade.", "journal": "J Lipid Res 53:2515-24 (2012)", "doi": "10.1194/jlr.R026658"}, {"pmid": "26015858", "authors": "  Graham A, Allen AM", "title": "Mitochondrial function and regulation of macrophage sterol metabolism and inflammatory responses.", "journal": "World J Cardiol 7:277-86 (2015)", "doi": "10.4330/wjc.v7.i5.277"}, {"pmid": "27565112", "authors": "  Elustondo P, Martin LA, Karten B", "title": "Mitochondrial cholesterol import.", "journal": "Biochim Biophys Acta 1862:90-101 (2017)", "doi": "10.1016/j.bbalip.2016.08.012"}, {"pmid": "26041457", "authors": "  Raiborg C, Wenzel EM, Stenmark H", "title": "ER-endosome contact sites: molecular compositions and functions.", "journal": "EMBO J 34:1848-58 (2015)", "doi": "10.15252/embj.201591481"}, {"pmid": "24554437", "authors": "  van der Kant R, Neefjes J", "title": "Small regulators, major consequences - Ca(2)(+) and cholesterol at the endosome-ER interface.", "journal": "J Cell Sci 127:929-38 (2014)", "doi": "10.1242/jcs.137539"}], "rel_pathway": ["hsa00100  Steroid biosynthesis", "hsa00120  Primary bile acid biosynthesis", "hsa00900  Terpenoid backbone biosynthesis", "hsa04975  Fat digestion and absorption", "hsa04976  Bile secretion"], "ko_pathway": "ko04979", "genes": ["CD36"]}, {"kegg_id": "hsa04713", "name": "Circadian entrainment - Homo sapiens (human)", "description": "Circadian entrainment is a fundamental property by which the period of the internal biological clock is entrained by recurring exogenous signals, such that the organism's endocrine and behavioral rhythms are synchronized to environmental cues. In mammals, a master clock is located in the suprachiasmatic nuclei (SCN) of the hypothalamus and may synchronize circadian oscillators in peripheral tissues. Light signal is the dominant synchronizer for master SCN clock. Downstream from the retina, glutamate and PACAP are released and trigger the activation of signal transduction cascades, including CamKII and nNOS activity, cAMP- and cGMP-dependent protein kinases, and mitogen-activated protein kinase (MAPK). Of non-photic entrainment, important phase shifting capabilities have been found for melatonin, which inhibits light-induced phase shifts through inhibition of adenylate cyclase (AC). Multiple entrainment pathways converge into CREB regulation. In turn, phosphorylated CREB activates clock gene expression.", "class": "Organismal Systems; Environmental adaptation", "pathway_map": "hsa04713  Circadian entrainment", "drug": ["D02578  Agomelatine (INN)", "D02689  Ramelteon (JAN/USAN/INN)", "D08170  Melatonin (JAN)", "D09388  Tasimelteon (USAN/INN)"], "dblinks": "GO: 0009649", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["2902  GRIN1; glutamate ionotropic receptor NMDA type subunit 1 [KO:K05208]", "2903  GRIN2A; glutamate ionotropic receptor NMDA type subunit 2A [KO:K05209]", "2904  GRIN2B; glutamate ionotropic receptor NMDA type subunit 2B [KO:K05210]", "2905  GRIN2C; glutamate ionotropic receptor NMDA type subunit 2C [KO:K05211]", "2906  GRIN2D; glutamate ionotropic receptor NMDA type subunit 2D [KO:K05212]", "810  CALML3; calmodulin like 3 [KO:K02183]", "805  CALM2; calmodulin 2 [KO:K02183]", "808  CALM3; calmodulin 3 [KO:K02183]", "801  CALM1; calmodulin 1 [KO:K02183]", "163688  CALML6; calmodulin like 6 [KO:K02183]", "51806  CALML5; calmodulin like 5 [KO:K02183]", "91860  CALML4; calmodulin like 4 [KO:K02183]", "815  CAMK2A; calcium/calmodulin dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]", "817  CAMK2D; calcium/calmodulin dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]", "816  CAMK2B; calcium/calmodulin dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]", "818  CAMK2G; calcium/calmodulin dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]", "4842  NOS1; nitric oxide synthase 1 [KO:K13240] [EC:1.14.13.39]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "9252  RPS6KA5; ribosomal protein S6 kinase A5 [KO:K04445] [EC:2.7.11.1]", "1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "6261  RYR1; ryanodine receptor 1 [KO:K04961]", "6262  RYR2; ryanodine receptor 2 [KO:K04962]", "6263  RYR3; ryanodine receptor 3 [KO:K04963]", "9722  NOS1AP; nitric oxide synthase 1 adaptor protein [KO:K16513]", "51655  RASD1; ras related dexamethasone induced 1 [KO:K07843]", "2770  GNAI1; G protein subunit alpha i1 [KO:K04630]", "2773  GNAI3; G protein subunit alpha i3 [KO:K04630]", "2771  GNAI2; G protein subunit alpha i2 [KO:K04630]", "2775  GNAO1; G protein subunit alpha o1 [KO:K04534]", "2782  GNB1; G protein subunit beta 1 [KO:K04536]", "2783  GNB2; G protein subunit beta 2 [KO:K04537]", "2784  GNB3; G protein subunit beta 3 [KO:K07825]", "59345  GNB4; G protein subunit beta 4 [KO:K04538]", "10681  GNB5; G protein subunit beta 5 [KO:K04539]", "54331  GNG2; G protein subunit gamma 2 [KO:K07826]", "2785  GNG3; G protein subunit gamma 3 [KO:K04540]", "2786  GNG4; G protein subunit gamma 4 [KO:K04541]", "2787  GNG5; G protein subunit gamma 5 [KO:K04542]", "2788  GNG7; G protein subunit gamma 7 [KO:K04543]", "94235  GNG8; G protein subunit gamma 8 [KO:K04544]", "2790  GNG10; G protein subunit gamma 10 [KO:K04545]", "2791  GNG11; G protein subunit gamma 11 [KO:K04546]", "55970  GNG12; G protein subunit gamma 12 [KO:K04347]", "51764  GNG13; G protein subunit gamma 13 [KO:K04547]", "2792  GNGT1; G protein subunit gamma transducin 1 [KO:K04548]", "2793  GNGT2; G protein subunit gamma transducin 2 [KO:K04549]", "2890  GRIA1; glutamate ionotropic receptor AMPA type subunit 1 [KO:K05197]", "2891  GRIA2; glutamate ionotropic receptor AMPA type subunit 2 [KO:K05198]", "2892  GRIA3; glutamate ionotropic receptor AMPA type subunit 3 [KO:K05199]", "2893  GRIA4; glutamate ionotropic receptor AMPA type subunit 4 [KO:K05200]", "8913  CACNA1G; calcium voltage-gated channel subunit alpha1 G [KO:K04854]", "8912  CACNA1H; calcium voltage-gated channel subunit alpha1 H [KO:K04855]", "8911  CACNA1I; calcium voltage-gated channel subunit alpha1 I [KO:K04856]", "116  ADCYAP1; adenylate cyclase activating polypeptide 1 [KO:K05262]", "117  ADCYAP1R1; ADCYAP receptor type I [KO:K04587]", "2778  GNAS; GNAS complex locus [KO:K04632]", "107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]", "108  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]", "109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]", "196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]", "113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]", "114  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]", "115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]", "55811  ADCY10; adenylate cyclase 10 [KO:K11265] [EC:4.6.1.1]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "2977  GUCY1A2; guanylate cyclase 1 soluble subunit alpha 2 [KO:K12318] [EC:4.6.1.2]", "2982  GUCY1A1; guanylate cyclase 1 soluble subunit alpha 1 [KO:K12318] [EC:4.6.1.2]", "2983  GUCY1B1; guanylate cyclase 1 soluble subunit beta 1 [KO:K12319] [EC:4.6.1.2]", "5592  PRKG1; protein kinase cGMP-dependent 1 [KO:K07376] [EC:2.7.11.12]", "5593  PRKG2; protein kinase cGMP-dependent 2 [KO:K19477] [EC:2.7.11.12]", "775  CACNA1C; calcium voltage-gated channel subunit alpha1 C [KO:K04850]", "776  CACNA1D; calcium voltage-gated channel subunit alpha1 D [KO:K04851]", "4544  MTNR1B; melatonin receptor 1B [KO:K04286]", "4543  MTNR1A; melatonin receptor 1A [KO:K04285]", "2776  GNAQ; G protein subunit alpha q [KO:K04634]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "3760  KCNJ3; potassium inwardly rectifying channel subfamily J member 3 [KO:K04997]", "3762  KCNJ5; potassium inwardly rectifying channel subfamily J member 5 [KO:K04999]", "3763  KCNJ6; potassium inwardly rectifying channel subfamily J member 6 [KO:K05000]", "3765  KCNJ9; potassium inwardly rectifying channel subfamily J member 9 [KO:K05002]", "5187  PER1; period circadian regulator 1 [KO:K21944]", "8864  PER2; period circadian regulator 2 [KO:K02633]", "8863  PER3; period circadian regulator 3 [KO:K21945]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]"], "compound": ["C00025  L-Glutamate", "C00076  Calcium cation", "C00165  Diacylglycerol", "C00238  Potassium cation", "C00533  Nitric oxide", "C00575  3',5'-Cyclic AMP", "C00942  3',5'-Cyclic GMP", "C01330  Sodium cation", "C01598  Melatonin"], "refs": [{"pmid": "17646042", "authors": "  Brown TM, Piggins HD", "title": "Electrophysiology of the suprachiasmatic circadian clock.", "journal": "Prog Neurobiol 82:229-55 (2007)", "doi": "10.1016/j.pneurobio.2007.05.002"}, {"pmid": "19109992", "authors": "  Dickson L, Finlayson K", "title": "VPAC and PAC receptors: From ligands to function.", "journal": "Pharmacol Ther 121:294-316 (2009)", "doi": "10.1016/j.pharmthera.2008.11.006"}, {"pmid": "20664079", "authors": "  Golombek DA, Rosenstein RE", "title": "Physiology of circadian entrainment.", "journal": "Physiol Rev 90:1063-102 (2010)", "doi": "10.1152/physrev.00009.2009"}, {"pmid": "16217123", "authors": "  Dubocovich ML, Markowska M", "title": "Functional MT1 and MT2 melatonin receptors in mammals.", "journal": "Endocrine 27:101-10 (2005)", "doi": "10.1385/ENDO:27:2:101"}, {"pmid": "20605968", "authors": "  Dubocovich ML, Delagrange P, Krause DN, Sugden D, Cardinali DP, Olcese J", "title": "International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors.", "journal": "Pharmacol Rev 62:343-80 (2010)", "doi": "10.1124/pr.110.002832"}, {"pmid": "19449447", "authors": "  Hardeland R", "title": "Melatonin: signaling mechanisms of a pleiotropic agent.", "journal": "Biofactors 35:183-92 (2009)", "doi": "10.1002/biof.23"}, {"pmid": "12700026", "authors": "  Golombek DA, Ferreyra GA, Agostino PV, Murad AD, Rubio MF, Pizzio GA, Katz ME, Marpegan L, Bekinschtein TA", "title": "From light to genes: moving the hands of the circadian clock.", "journal": "Front Biosci 8:s285-93 (2003)", "doi": "10.2741/1038"}, {"pmid": "17586087", "authors": "  Mertens I, Husson SJ, Janssen T, Lindemans M, Schoofs L", "title": "PACAP and PDF signaling in the regulation of mammalian and insect circadian rhythms.", "journal": "Peptides 28:1775-83 (2007)", "doi": "10.1016/j.peptides.2007.05.005"}, {"pmid": "15813931", "authors": "  Kim DY, Choi HJ, Kim JS, Kim YS, Jeong DU, Shin HC, Kim MJ, Han HC, Hong SK, Kim YI", "title": "Voltage-gated calcium channels play crucial roles in the glutamate-induced phase shifts of the rat suprachiasmatic circadian clock.", "journal": "Eur J Neurosci 21:1215-22 (2005)", "doi": "10.1111/j.1460-9568.2005.03950.x"}, {"pmid": "15016477", "authors": "  Agostino PV, Ferreyra GA, Murad AD, Watanabe Y, Golombek DA", "title": "Diurnal, circadian and photic regulation of calcium/calmodulin-dependent kinase II and neuronal nitric oxide synthase in the hamster suprachiasmatic nuclei.", "journal": "Neurochem Int 44:617-25 (2004)", "doi": "10.1016/j.neuint.2003.09.005"}, {"pmid": "11294753", "authors": "  Ferreyra GA, Golombek DA", "title": "Rhythmicity of the cGMP-related signal transduction pathway in the mammalian circadian system.", "journal": "Am J Physiol Regul Integr Comp Physiol 280:R1348-55 (2001)", "doi": "10.1152/ajpregu.2001.280.5.R1348"}, {"pmid": "15930378", "authors": "  Butcher GQ, Lee B, Cheng HY, Obrietan K", "title": "Light stimulates MSK1 activation in the suprachiasmatic nucleus via a PACAP-ERK/MAP kinase-dependent mechanism.", "journal": "J Neurosci 25:5305-13 (2005)", "doi": "10.1523/JNEUROSCI.4361-04.2005"}, {"pmid": "10446325", "authors": "  Hamada T, Niki T, Ziging P, Sugiyama T, Watanabe S, Mikoshiba K, Ishida N", "title": "Differential expression patterns of inositol trisphosphate receptor types 1 and 3 in the rat suprachiasmatic nucleus.", "journal": "Brain Res 838:131-5 (1999)", "doi": "10.1016/S0006-8993(99)01719-9"}, {"pmid": "10208575", "authors": "  Diaz-Munoz M, Dent MA, Granados-Fuentes D, Hall AC, Hernandez-Cruz A, Harrington ME, Aguilar-Roblero R", "title": "Circadian modulation of the ryanodine receptor type 2 in the SCN of rodents.", "journal": "Neuroreport 10:481-6 (1999)", "doi": "10.1097/00001756-199902250-00007"}, {"pmid": "11086993", "authors": "  Fang M, Jaffrey SR, Sawa A, Ye K, Luo X, Snyder SH", "title": "Dexras1: a G protein specifically coupled to neuronal nitric oxide synthase via CAPON.", "journal": "Neuron 28:183-93 (2000)", "doi": "10.1016/S0896-6273(00)00095-7"}, {"pmid": "12573527", "authors": "  Takahashi H, Umeda N, Tsutsumi Y, Fukumura R, Ohkaze H, Sujino M, van der Horst G, Yasui A, Inouye ST, Fujimori A, Ohhata T, Araki R, Abe M", "title": "Mouse dexamethasone-induced RAS protein 1 gene is expressed in a circadian rhythmic manner in the suprachiasmatic nucleus.", "journal": "Brain Res Mol Brain Res 110:1-6 (2003)", "doi": "10.1016/S0169-328X(02)00543-0"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04710  Circadian rhythm"], "ko_pathway": "ko04713", "genes": ["PER1"]}, {"kegg_id": "hsa02010", "name": "ABC transporters - Homo sapiens (human)", "description": "The ATP-binding cassette (ABC) transporters form one of the largest known protein families, and are widespread in bacteria, archaea, and eukaryotes. They couple ATP hydrolysis to active transport of a wide variety of substrates such as ions, sugars, lipids, sterols, peptides, proteins, and drugs. The structure of a prokaryotic ABC transporter usually consists of three components; typically two integral membrane proteins each having six transmembrane segments, two peripheral proteins that bind and hydrolyze ATP, and a periplasmic (or lipoprotein) substrate-binding protein. Many of the genes for the three components form operons as in fact observed in many bacterial and archaeal genomes. On the other hand, in a typical eukaryotic ABC transporter, the membrane spanning protein and the ATP-binding protein are fused, forming a multi-domain protein with the membrane-spanning domain (MSD) and the nucleotide-binding domain (NBD).", "class": "Environmental Information Processing; Membrane transport", "pathway_map": "hsa02010  ABC transporters", "drug": ["D00219  Acetohexamide (JP18/USP/INN)", "D00271  Chlorpropamide (JP18/USP/INN)", "D00335  Glipizide (USP/INN)", "D00336  Glyburide (USP)", "D00379  Tolazamide (JAN/USP/INN)", "D00380  Tolbutamide (JP18/USP/INN)", "D00418  Minoxidil (JAN/USP/INN)", "D00593  Glimepiride (JP18/USP/INN)", "D00594  Repaglinide (JAN/USP/INN)", "D01111  Nateglinide (JP18/USP/INN)", "D01356  Glymidine sodium (JAN/USAN/INN)", "D01599  Gliclazide (JP18/INN)", "D01799  Glyclopyramide (JAN/INN)", "D01810  Nicorandil (JP18/USAN/INN)", "D01854  Mitiglinide calcium hydrate (JP18)", "D02385  Levcromakalim (USAN/INN)", "D02425  Carbutamide (INN)", "D02427  Glibornuride (USAN/INN)", "D02430  Gliquidone (INN)", "D03128  Biricodar dicitrate (USAN)", "D03968  Elacridar hydrochloride (USAN)", "D04739  Linogliride (USAN/INN)", "D04740  Linogliride fumarate (USAN)", "D05114  Naminidil (USAN/INN)", "D05482  Pinacidil (USAN)", "D06008  Tariquidar (USAN/INN)", "D06084  Tesmilifene hydrochloride (USAN)", "D06177  Tolbutamide sodium, sterile", "D06277  Valspodar (USAN/INN)", "D06387  Zosuquidar trihydrochloride (USAN)", "D07117  Metahexamide (INN)", "D07118  Glisoxepide (INN)", "D10134  Lumacaftor (USAN/INN)", "D10685  Lumacaftor and ivacaftor", "D11041  Tezacaftor (USAN/INN)", "D11042  Tezacaftor and ivacaftor", "D11402  Olacaftor (USAN/INN)", "D11423  Deutivacaftor (USAN/INN)", "D11507  Elexacaftor (USAN)", "D11535  Bamocaftor (USAN)", "D11536  Bamocaftor potassium (USAN)", "D11683  Posenacaftor (USAN)", "D11700  Elexacaftor, ivacaftor and tezacaftor", "D11724  Galicaftor (USAN/INN)", "D11782  Encequidar (USAN/INN)", "D11783  Encequidar mesylate (USAN)", "D12140  Navocaftor (USAN/INN)", "D12150  Elivaldogene autotemcel (USAN/INN)", "D12454  Icenticaftor (USAN/INN)", "D12718  Vanzacaftor (USAN/INN)", "D12719  Vanzacaftor calcium (USAN)"], "dblinks": ["GO: 0043190 0043191 0043192", "TC: 3.A.1"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["1672  DEFB1; defensin beta 1 [KO:K23125]", "19  ABCA1; ATP binding cassette subfamily A member 1 [KO:K05641]", "20  ABCA2; ATP binding cassette subfamily A member 2 [KO:K05642]", "21  ABCA3; ATP binding cassette subfamily A member 3 [KO:K05643]", "24  ABCA4; ATP binding cassette subfamily A member 4 [KO:K05644]", "10347  ABCA7; ATP binding cassette subfamily A member 7 [KO:K05645]", "26154  ABCA12; ATP binding cassette subfamily A member 12 [KO:K05646]", "154664  ABCA13; ATP binding cassette subfamily A member 13 [KO:K05647]", "23461  ABCA5; ATP binding cassette subfamily A member 5 [KO:K05648]", "23460  ABCA6; ATP binding cassette subfamily A member 6 [KO:K05649]", "10351  ABCA8; ATP binding cassette subfamily A member 8 [KO:K05650]", "10350  ABCA9; ATP binding cassette subfamily A member 9 [KO:K05651]", "10349  ABCA10; ATP binding cassette subfamily A member 10 [KO:K05652]", "6890  TAP1; transporter 1, ATP binding cassette subfamily B member [KO:K05653] [EC:7.4.2.14]", "6891  TAP2; transporter 2, ATP binding cassette subfamily B member [KO:K05654] [EC:7.4.2.14]", "11194  ABCB8; ATP binding cassette subfamily B member 8 [KO:K05655]", "23457  ABCB9; ATP binding cassette subfamily B member 9 [KO:K05656]", "23456  ABCB10; ATP binding cassette subfamily B member 10 [KO:K05657]", "5243  ABCB1; ATP binding cassette subfamily B member 1 [KO:K05658] [EC:7.6.2.2]", "5244  ABCB4; ATP binding cassette subfamily B member 4 [KO:K05659] [EC:7.6.2.2]", "340273  ABCB5; ATP binding cassette subfamily B member 5 [KO:K05660]", "10058  ABCB6; ATP binding cassette subfamily B member 6 (LAN blood group) [KO:K05661]", "22  ABCB7; ATP binding cassette subfamily B member 7 [KO:K05662]", "8647  ABCB11; ATP binding cassette subfamily B member 11 [KO:K05664]", "4363  ABCC1; ATP binding cassette subfamily C member 1 (ABCC1 blood group) [KO:K05665] [EC:7.6.2.3]", "1244  ABCC2; ATP binding cassette subfamily C member 2 [KO:K05666]", "8714  ABCC3; ATP binding cassette subfamily C member 3 [KO:K05667]", "10257  ABCC4; ATP binding cassette subfamily C member 4 (PEL blood group) [KO:K05673]", "10057  ABCC5; ATP binding cassette subfamily C member 5 [KO:K05668]", "368  ABCC6; ATP binding cassette subfamily C member 6 [KO:K05669]", "89845  ABCC10; ATP binding cassette subfamily C member 10 [KO:K05674]", "85320  ABCC11; ATP binding cassette subfamily C member 11 [KO:K05671]", "94160  ABCC12; ATP binding cassette subfamily C member 12 [KO:K05672]", "1080  CFTR; CF transmembrane conductance regulator [KO:K05031] [EC:5.6.1.6]", "6833  ABCC8; ATP binding cassette subfamily C member 8 [KO:K05032]", "10060  ABCC9; ATP binding cassette subfamily C member 9 [KO:K05033]", "215  ABCD1; ATP binding cassette subfamily D member 1 [KO:K05675] [EC:7.6.2.4]", "225  ABCD2; ATP binding cassette subfamily D member 2 [KO:K05676] [EC:7.6.2.4]", "5825  ABCD3; ATP binding cassette subfamily D member 3 [KO:K05677] [EC:7.6.2.4]", "5826  ABCD4; ATP binding cassette subfamily D member 4 [KO:K05678] [EC:7.6.2.8]", "9619  ABCG1; ATP binding cassette subfamily G member 1 [KO:K05679]", "64137  ABCG4; ATP binding cassette subfamily G member 4 [KO:K05680]", "9429  ABCG2; ATP binding cassette subfamily G member 2 (JR blood group) [KO:K05681]", "64240  ABCG5; ATP binding cassette subfamily G member 5 [KO:K05683]", "64241  ABCG8; ATP binding cassette subfamily G member 8 [KO:K05684]"], "compound": ["C00009  Orthophosphate", "C00025  L-Glutamate", "C00031  D-Glucose", "C00032  Heme", "C00034  Manganese", "C00037  Glycine", "C00038  Zinc cation", "C00041  L-Alanine", "C00047  L-Lysine", "C00049  L-Aspartate", "C00051  Glutathione", "C00059  Sulfate", "C00062  L-Arginine", "C00064  L-Glutamine", "C00065  L-Serine", "C00070  Copper", "C00077  L-Ornithine", "C00079  L-Phenylalanine", "C00086  Urea", "C00088  Nitrite", "C00089  Sucrose", "C00093  sn-Glycerol 3-phosphate", "C00095  D-Fructose", "C00098  Oligopeptide", "C00107  Dipeptide", "C00114  Choline", "C00116  Glycerol", "C00120  Biotin", "C00121  D-Ribose", "C00123  L-Leucine", "C00134  Putrescine", "C00135  L-Histidine", "C00137  myo-Inositol", "C00140  N-Acetyl-D-glucosamine", "C00148  L-Proline", "C00151  L-Amino acid", "C00159  D-Mannose", "C00175  Cobalt ion", "C00181  D-Xylose", "C00183  L-Valine", "C00185  Cellobiose", "C00188  L-Threonine", "C00208  Maltose", "C00212  Adenosine", "C00243  Lactose", "C00244  Nitrate", "C00245  Taurine", "C00255  Riboflavin", "C00259  L-Arabinose", "C00288  HCO3-", "C00291  Nickel", "C00294  Inosine", "C00299  Uridine", "C00315  Spermidine", "C00320  Thiosulfate", "C00330  Deoxyguanosine", "C00333  D-Galacturonate", "C00338  Lipopolysaccharide", "C00378  Thiamine", "C00379  Xylitol", "C00387  Guanosine", "C00392  Mannitol", "C00407  L-Isoleucine", "C00430  5-Aminolevulinate", "C00470  Pectate", "C00475  Cytidine", "C00487  Carnitine", "C00491  L-Cystine", "C00492  Raffinose", "C00503  Erythritol", "C00526  Deoxyuridine", "C00559  Deoxyadenosine", "C00719  Betaine", "C00794  D-Sorbitol", "C00855  D-Methionine", "C00865  Phospholipid", "C00881  Deoxycytidine", "C00919  Choline sulfate", "C00973  Cyclomaltodextrin", "C01083  alpha,alpha-Trehalose", "C01153  Orthophosphoric monoester", "C01157  Hydroxyproline", "C01177  Inositol 1-phosphate", "C01181  4-Trimethylammoniobutanoate", "C01279  4-Amino-5-hydroxymethyl-2-methylpyrimidine", "C01330  Sodium cation", "C01417  Cyanate", "C01487  D-Allose", "C01606  Phthalate", "C01630  Xylobiose", "C01667  Bacitracin", "C01674  Chitobiose", "C01682  Nopaline", "C01684  D-Rhamnose", "C01762  Xanthosine", "C01834  Lipoprotein", "C01835  Maltotriose", "C01935  Maltodextrin", "C01946  Oleandomycin", "C02160  Isomaltotriose", "C02273  Digalacturonate", "C03557  2-Aminoethylphosphonate", "C03611  Galactose oligosaccharide", "C03619  Methyl beta-D-galactoside", "C04114  (E)-4-(Trimethylammonio)but-2-enoate", "C04137  Octopine", "C05349  Ciprofloxacin", "C05402  Melibiose", "C05512  Deoxyinosine", "C05776  Vitamin B12", "C06227  Fe(III)hydroxamate", "C06229  Fe(III)dicitrate", "C06230  Fe-enterobactin", "C06232  Molybdate", "C06687  Norfloxacin", "C06705  Capsular polysaccharide", "C06706  Lipo-oligosaccharide", "C06707  Teichoic acid", "C06767  Hemine", "C07662  Sparfloxacin", "C07663  Moxifloxacin", "C11612  Polymyxin B", "C13768  Colistin sulfate", "C14818  Fe2+", "C14819  Fe3+", "C15521  Alkanesulfonate", "C15719  Coelichelin", "C16421  AI-2", "C16692  Mannopine", "C19609  Nickel(2+)", "C19872  N-Formyl-4-amino-5-aminomethyl-2-methylpyrimidine", "C20570  alpha-1,5-L-Arabinobiose", "C20571  alpha-1,5-L-Arabinotriose", "C20572  alpha-1,5-L-Arabinotetraose", "C20573  Aldotetraouronic acid", "C20679  Tungstate", "C21066  D-Galactofuranose", "C22040  S-Methyl-L-cysteine", "G00457  Maltotetraose"], "refs": [{"pmid": "9799792", "authors": "  Tomii K, Kanehisa M.", "title": "A comparative analysis of ABC transporters in complete microbial genomes.", "journal": "Genome Res 8:1048-59 (1998)", "doi": "10.1101/gr.8.10.1048"}, {"pmid": "18424520", "authors": "  Sperandeo P, Lau FK, Carpentieri A, De Castro C, Molinaro A, Deho G, Silhavy TJ, Polissi A", "title": "Functional analysis of the protein machinery required for transport of lipopolysaccharide to the outer membrane of Escherichia coli.", "journal": "J Bacteriol 190:4460-9 (2008)", "doi": "10.1128/JB.00270-08"}, {"pmid": "18375759", "authors": "  Ruiz N, Gronenberg LS, Kahne D, Silhavy TJ", "title": "Identification of two inner-membrane proteins required for the transport of lipopolysaccharide to the outer membrane of Escherichia coli.", "journal": "Proc Natl Acad Sci U S A 105:5537-42 (2008)", "doi": "10.1073/pnas.0801196105"}, {"pmid": "10557362", "authors": "  Omata T, Price GD, Badger MR, Okamura M, Gohta S, Ogawa T", "title": "Identification of an ATP-binding cassette transporter involved in bicarbonate uptake in the cyanobacterium Synechococcus sp. strain PCC 7942.", "journal": "Proc Natl Acad Sci U S A 96:13571-6 (1999)", "doi": "10.1073/pnas.96.23.13571"}, {"pmid": "11731493", "authors": "  Quintero MJ, Montesinos ML, Herrero A, Flores E", "title": "Identification of genes encoding amino acid permeases by inactivation of selected ORFs from the Synechocystis genomic sequence.", "journal": "Genome Res 11:2034-40 (2001)", "doi": "10.1101/gr.196301"}, {"pmid": "16135226", "authors": "  Picossi S, Montesinos ML, Pernil R, Lichtle C, Herrero A, Flores E", "title": "ABC-type neutral amino acid permease N-I is required for optimal diazotrophic growth and is repressed in the heterocysts of Anabaena sp. strain PCC 7120.", "journal": "Mol Microbiol 57:1582-92 (2005)", "doi": "10.1111/j.1365-2958.2005.04791.x"}, {"pmid": "11929526", "authors": "  Valladares A, Montesinos ML, Herrero A, Flores E.", "title": "An ABC-type, high-affinity urea permease identified in cyanobacteria.", "journal": "Mol Microbiol 43:703-15 (2002)", "doi": "10.1046/j.1365-2958.2002.02778.x"}, {"pmid": "18326572", "authors": "  Richard-Fogal CL, Frawley ER, Kranz RG", "title": "Topology and function of CcmD in cytochrome c maturation.", "journal": "J Bacteriol 190:3489-93 (2008)", "doi": "10.1128/JB.00146-08"}, {"pmid": "16109926", "authors": "  Suzuki H, Koyanagi T, Izuka S, Onishi A, Kumagai H", "title": "The yliA, -B, -C, and -D genes of Escherichia coli K-12 encode a novel glutathione importer with an ATP-binding cassette.", "journal": "J Bacteriol 187:5861-7 (2005)", "doi": "10.1128/JB.187.17.5861-5867.2005"}, {"pmid": "17873039", "authors": "  Novikova M, Metlitskaya A, Datsenko K, Kazakov T, Kazakov A, Wanner B, Severinov K", "title": "The Escherichia coli Yej transporter is required for the uptake of translation inhibitor microcin C.", "journal": "J Bacteriol 189:8361-5 (2007)", "doi": "10.1128/JB.01028-07"}, {"pmid": "17214741", "authors": "  Tikhonova EB, Devroy VK, Lau SY, Zgurskaya HI", "title": "Reconstitution of the Escherichia coli macrolide transporter: the periplasmic membrane fusion protein MacA stimulates the ATPase activity of MacB.", "journal": "Mol Microbiol 63:895-910 (2007)", "doi": "10.1111/j.1365-2958.2006.05549.x"}], "ko_pathway": "ko02010", "genes": ["ABCA7"]}, {"kegg_id": "hsa03082", "name": "ATP-dependent chromatin remodeling - Homo sapiens (human)", "class": "Genetic Information Processing; Chromosome", "pathway_map": "hsa03082  ATP-dependent chromatin remodeling", "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["8467  SMARCA5; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5 [KO:K11654] [EC:5.6.2.-]", "11177  BAZ1A; bromodomain adjacent to zinc finger domain 1A [KO:K11655]", "9031  BAZ1B; bromodomain adjacent to zinc finger domain 1B [KO:K11658]", "11176  BAZ2A; bromodomain adjacent to zinc finger domain 2A [KO:K15224]", "29994  BAZ2B; bromodomain adjacent to zinc finger domain 2B [KO:K26167]", "54108  CHRAC1; chromatin accessibility complex subunit 1 [KO:K11656]", "54107  POLE3; DNA polymerase epsilon 3, accessory subunit [KO:K02326] [EC:2.7.7.7]", "51773  RSF1; remodeling and spacing factor 1 [KO:K11657]", "6594  SMARCA1; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 [KO:K11727] [EC:5.6.2.-]", "2186  BPTF; bromodomain PHD finger transcription factor [KO:K11728]", "5928  RBBP4; RB binding protein 4, chromatin remodeling factor [KO:K10752]", "5931  RBBP7; RB binding protein 7, chromatin remodeling factor [KO:K11659]", "124944  C17orf49; chromosome 17 open reading frame 49 [KO:K23406]", "27443  CECR2; CECR2 histone acetyl-lysine reader [KO:K25830]", "1107  CHD3; chromodomain helicase DNA binding protein 3 [KO:K11642] [EC:5.6.2.-]", "1108  CHD4; chromodomain helicase DNA binding protein 4 [KO:K11643] [EC:5.6.2.-]", "3065  HDAC1; histone deacetylase 1 [KO:K06067] [EC:3.5.1.98]", "3066  HDAC2; histone deacetylase 2 [KO:K06067] [EC:3.5.1.98]", "8932  MBD2; methyl-CpG binding domain protein 2 [KO:K11590]", "53615  MBD3; methyl-CpG binding domain protein 3 [KO:K11591]", "9219  MTA2; metastasis associated 1 family member 2 [KO:K11660]", "9112  MTA1; metastasis associated 1 [KO:K11660]", "57504  MTA3; metastasis associated 1 family member 3 [KO:K11660]", "54815  GATAD2A; GATA zinc finger domain containing 2A [KO:K23194]", "57459  GATAD2B; GATA zinc finger domain containing 2B [KO:K23194]", "84295  PHF6; PHD finger protein 6 [KO:K23310]", "8099  CDK2AP1; cyclin dependent kinase 2 associated protein 1 [KO:K26454]", "10263  CDK2AP2; cyclin dependent kinase 2 associated protein 2 [KO:K26455]", "6595  SMARCA2; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 [KO:K11647] [EC:5.6.2.-]", "6597  SMARCA4; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 [KO:K11647] [EC:5.6.2.-]", "6598  SMARCB1; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 [KO:K11648]", "6599  SMARCC1; SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1 [KO:K11649]", "6601  SMARCC2; SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 2 [KO:K11649]", "6602  SMARCD1; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 [KO:K11650]", "6603  SMARCD2; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2 [KO:K11650]", "6604  SMARCD3; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 [KO:K11650]", "6605  SMARCE1; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1 [KO:K11651]", "71  ACTG1; actin gamma 1 [KO:K05692]", "60  ACTB; actin beta [KO:K05692]", "86  ACTL6A; actin like 6A [KO:K11340]", "51412  ACTL6B; actin like 6B [KO:K11652]", "9275  BCL7B; BAF chromatin remodeling complex subunit BCL7B [KO:K25605]", "9274  BCL7C; BAF chromatin remodeling complex subunit BCL7C [KO:K25605]", "605  BCL7A; BAF chromatin remodeling complex subunit BCL7A [KO:K25605]", "26039  SS18L1; SS18L1 subunit of BAF chromatin remodeling complex [KO:K15623]", "6760  SS18; SS18 subunit of BAF chromatin remodeling complex [KO:K15623]", "57492  ARID1B; AT-rich interaction domain 1B [KO:K11653]", "8289  ARID1A; AT-rich interaction domain 1A [KO:K11653]", "8193  DPF1; double PHD fingers 1 [KO:K22198]", "8110  DPF3; double PHD fingers 3 [KO:K22198]", "5977  DPF2; double PHD fingers 2 [KO:K13196]", "196528  ARID2; AT-rich interaction domain 2 [KO:K11765]", "55193  PBRM1; polybromo 1 [KO:K11757]", "29117  BRD7; bromodomain containing 7 [KO:K11723]", "55274  PHF10; PHD finger protein 10 [KO:K22197]", "65980  BRD9; bromodomain containing 9 [KO:K22184]", "29998  BICRA; BRD4 interacting chromatin remodeling complex associated protein [KO:K25612]", "23506  BICRAL; BICRA like chromatin remodeling complex associated protein [KO:K25613]", "54617  INO80; INO80 complex ATPase subunit [KO:K11665] [EC:5.6.2.-]", "83444  INO80B; INO80 complex subunit B [KO:K11666]", "125476  INO80C; INO80 complex subunit C [KO:K11667]", "54891  INO80D; INO80 complex subunit D [KO:K11668]", "283899  INO80E; INO80 complex subunit E [KO:K11669]", "29844  TFPT; TCF3 fusion partner [KO:K11670]", "4798  NFRKB; nuclear factor related to kappaB binding protein [KO:K11671]", "10445  MCRS1; microspherule protein 1 [KO:K11674]", "51377  UCHL5; ubiquitin C-terminal hydrolase L5 [KO:K05610] [EC:3.4.19.12]", "8607  RUVBL1; RuvB like AAA ATPase 1 [KO:K04499] [EC:5.6.2.4]", "10856  RUVBL2; RuvB like AAA ATPase 2 [KO:K11338] [EC:5.6.2.3]", "79913  ACTR5; actin related protein 5 [KO:K11672]", "93973  ACTR8; actin related protein 8 [KO:K11673]", "7528  YY1; YY1 transcription factor [KO:K09201]", "404281  YY2; YY2 transcription factor [KO:K09201]", "10847  SRCAP; Snf2 related CREBBP activator protein [KO:K11661] [EC:5.6.2.-]", "55929  DMAP1; DNA methyltransferase 1 associated protein 1 [KO:K11324]", "8089  YEATS4; YEATS domain containing 4 [KO:K11341]", "6944  VPS72; vacuolar protein sorting 72 homolog [KO:K11664]", "3014  H2AX; H2A.X variant histone [KO:K11251]", "8338  H2AC20; H2A clustered histone 20 [KO:K11251]", "85235  H2AC12; H2A clustered histone 12 [KO:K11251]", "221613  H2AC1; H2A clustered histone 1 [KO:K11251]", "92815  H2AC25; H2A clustered histone 25 [KO:K11251]", "83740  H2AB3; H2A.B variant histone 3 [KO:K11251]", "3012  H2AC8; H2A clustered histone 8 [KO:K11251]", "8335  H2AC4; H2A clustered histone 4 [KO:K11251]", "55506  MACROH2A2; macroH2A.2 histone [KO:K11251]", "9555  MACROH2A1; macroH2A.1 histone [KO:K11251]", "723790  H2AC19; H2A clustered histone 19 [KO:K11251]", "55766  H2AJ; H2A.J histone [KO:K11251]", "474382  H2AB1; H2A.B variant histone 1 [KO:K11251]", "8336  H2AC17; H2A clustered histone 17 [KO:K11251]", "8337  H2AC18; H2A clustered histone 18 [KO:K11251]", "8969  H2AC11; H2A clustered histone 11 [KO:K11251]", "317772  H2AC21; H2A clustered histone 21 [KO:K11251]", "94239  H2AZ2; H2A.Z variant histone 2 [KO:K11251]", "3013  H2AC7; H2A clustered histone 7 [KO:K11251]", "3015  H2AZ1; H2A.Z variant histone 1 [KO:K11251]", "8330  H2AC15; H2A clustered histone 15 [KO:K11251]", "8334  H2AC6; H2A clustered histone 6 [KO:K11251]", "8329  H2AC13; H2A clustered histone 13 [KO:K11251]", "8331  H2AC14; H2A clustered histone 14 [KO:K11251]", "8332  H2AC16; H2A clustered histone 16 [KO:K11251]", "474381  H2AB2; H2A.B variant histone 2 [KO:K11251]", "115482686  H2AL3; H2A.L variant histone 3 [KO:K11251]", "64431  ACTR6; actin related protein 6 [KO:K11662]", "10467  ZNHIT1; zinc finger HIT-type containing 1 [KO:K11663]", "57634  EP400; E1A binding protein p400 [KO:K11320] [EC:5.6.2.-]", "8295  TRRAP; transformation/transcription domain associated protein [KO:K08874]", "10933  MORF4L1; mortality factor 4 like 1 [KO:K11339]", "9643  MORF4L2; mortality factor 4 like 2 [KO:K11342]", "55257  MRGBP; MRG domain binding protein [KO:K11343]", "10902  BRD8; bromodomain containing 8 [KO:K11321]", "54556  ING3; inhibitor of growth family member 3 [KO:K11319]", "80314  EPC1; enhancer of polycomb homolog 1 [KO:K11322]", "26122  EPC2; enhancer of polycomb homolog 2 [KO:K11322]", "64769  MEAF6; MYST/Esa1 associated factor 6 [KO:K11344]", "10524  KAT5; lysine acetyltransferase 5 [KO:K11304] [EC:2.3.1.48]"], "refs": [{"pmid": "31769422", "authors": "  Hasan N, Ahuja N", "title": "The Emerging Roles of ATP-Dependent Chromatin Remodeling Complexes in Pancreatic Cancer.", "journal": "Cancers (Basel) 11:cancers11121859 (2019)", "doi": "10.3390/cancers11121859"}, {"pmid": "32001526", "authors": "  He S, Wu Z, Tian Y, Yu Z, Yu J, Wang X, Li J, Liu B, Xu Y", "title": "Structure of nucleosome-bound human BAF complex.", "journal": "Science 367:875-881 (2020)", "doi": "10.1126/science.aaz9761"}, {"pmid": "33941852", "authors": "  Wanior M, Kramer A, Knapp S, Joerger AC", "title": "Exploiting vulnerabilities of SWI/SNF chromatin remodelling complexes for cancer therapy.", "journal": "Oncogene 40:3637-3654 (2021)", "doi": "10.1038/s41388-021-01781-x"}], "ko_pathway": "ko03082", "genes": ["CHD4", "MTA3"]}, {"kegg_id": "hsa03013", "name": "Nucleocytoplasmic transport - Homo sapiens (human)", "description": "The exchange of molecules between the nucleus and cytoplasm is mediated through nuclear pore complexes (NPCs) embedded in the nuclear envelope. The NPC is composed of highly conserved, distinct structural modules: the inner pore ring, the cytoplasmic and nuclear rings as well as the cytoplasmic filaments and the nuclear basket. Nuclear transport receptors (e.g. importins and exportins) mediate translocation of cargos through the NPC. Cargo proteins harbouring a nuclear export signal (NES) bind to exportins and Ran-GTP to form an export complex in the nucleoplasm. Nuclear export of bulk mRNA is provided by the non-karyopherin transport proteins TAP-p15 in a Ran-GTP-independent manner. Several EJC factors are known to function in mRNA export.", "class": "Genetic Information Processing; Translation", "pathway_map": "hsa03013  Nucleocytoplasmic transport", "network": ["", "ELEMENT   N01152  Nuclear export of mRNA", "N01154  TDP-43-regulated splicing", "N01156  FUS-regulated splicing"], "drug": ["D11222  Selinexor (USAN/INN)", "D11223  Verdinexor (USAN/INN)", "D11406  Risdiplam (JAN/USAN/INN)", "D11499  Eltanexor (USAN/INN)", "D11837  Zotatifin (USAN/INN)", "D12345  Obefazimod (USAN)"], "dblinks": ["GO: 0050658"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["8086  AAAS; aladin WD repeat nucleoporin [KO:K14320]", "11097  NUP42; nucleoporin 42 [KO:K14321]", "2733  GLE1; GLE1 RNA export mediator [KO:K18723]", "11269  DDX19B; DEAD-box helicase 19B [KO:K18655] [EC:5.6.2.7]", "55308  DDX19A; DEAD-box helicase 19A [KO:K18655] [EC:5.6.2.7]", "8480  RAE1; ribonucleic acid export 1 [KO:K14298]", "4928  NUP98; nucleoporin 98 and 96 precursor [KO:K14297]", "8021  NUP214; nucleoporin 214 [KO:K14317]", "4927  NUP88; nucleoporin 88 [KO:K14318]", "5903  RANBP2; RAN binding protein 2 [KO:K12172] [EC:2.3.2.-]", "5905  RANGAP1; Ran GTPase activating protein 1 [KO:K14319]", "7329  UBE2I; ubiquitin conjugating enzyme E2 I [KO:K10577]", "6612  SUMO3; small ubiquitin like modifier 3 [KO:K12160]", "6613  SUMO2; small ubiquitin like modifier 2 [KO:K12160]", "7341  SUMO1; small ubiquitin like modifier 1 [KO:K12160]", "387082  SUMO4; small ubiquitin like modifier 4 [KO:K12160]", "23279  NUP160; nucleoporin 160 [KO:K14303]", "79902  NUP85; nucleoporin 85 [KO:K14304]", "6396  SEC13; SEC13 homolog, nuclear pore and COPII coat complex component [KO:K14004]", "57122  NUP107; nucleoporin 107 [KO:K14301]", "55746  NUP133; nucleoporin 133 [KO:K14300]", "81929  SEH1L; SEH1 like nucleoporin [KO:K14299]", "348995  NUP43; nucleoporin 43 [KO:K14305]", "79023  NUP37; nucleoporin 37 [KO:K14302]", "25909  AHCTF1; AT-hook containing transcription factor 1 [KO:K25129]", "23636  NUP62; nucleoporin 62 [KO:K14306]", "9818  NUP58; nucleoporin 58 [KO:K14307]", "53371  NUP54; nucleoporin 54 [KO:K14308]", "23165  NUP205; nucleoporin 205 [KO:K14310]", "23511  NUP188; nucleoporin 188 [KO:K14311]", "9631  NUP155; nucleoporin 155 [KO:K14312]", "9688  NUP93; nucleoporin 93 [KO:K14309]", "129401  NUP35; nucleoporin 35 [KO:K14313]", "55706  NDC1; NDC1 transmembrane nucleoporin [KO:K14315]", "23225  NUP210; nucleoporin 210 [KO:K14314]", "91181  NUP210L; nucleoporin 210 like [KO:K14314]", "100101267  POM121C; POM121 transmembrane nucleoporin C [KO:K14316]", "9883  POM121; POM121 transmembrane nucleoporin [KO:K14316]", "94026  POM121L2; POM121 transmembrane nucleoporin like 2 [KO:K14316]", "55161  TMEM33; transmembrane protein 33 [KO:K20724]", "7175  TPR; translocated promoter region, nuclear basket protein [KO:K09291]", "10762  NUP50; nucleoporin 50 [KO:K14295]", "9972  NUP153; nucleoporin 153 [KO:K14296]", "59343  SENP2; SUMO specific peptidase 2 [KO:K03345] [EC:3.4.22.68]", "3836  KPNA1; karyopherin subunit alpha 1 [KO:K23940]", "3838  KPNA2; karyopherin subunit alpha 2 [KO:K15043]", "402569  KPNA7; karyopherin subunit alpha 7 [KO:K15043]", "3839  KPNA3; karyopherin subunit alpha 3 [KO:K23583]", "3840  KPNA4; karyopherin subunit alpha 4 [KO:K23583]", "23633  KPNA6; karyopherin subunit alpha 6 [KO:K15042]", "3841  KPNA5; karyopherin subunit alpha 5 [KO:K15042]", "3837  KPNB1; karyopherin subunit beta 1 [KO:K14293]", "3842  TNPO1; transportin 1 [KO:K18752]", "30000  TNPO2; transportin 2 [KO:K18727]", "23534  TNPO3; transportin 3 [KO:K15436]", "79711  IPO4; importin 4 [KO:K20221]", "3843  IPO5; importin 5 [KO:K20222]", "10527  IPO7; importin 7 [KO:K20223]", "10526  IPO8; importin 8 [KO:K18755]", "55705  IPO9; importin 9 [KO:K20224]", "51194  IPO11; importin 11 [KO:K25201]", "9670  IPO13; importin 13 [KO:K25202]", "10073  SNUPN; snurportin 1 [KO:K13151]", "7514  XPO1; exportin 1 [KO:K14290]", "1434  CSE1L; chromosome segregation 1 like [KO:K18423]", "11260  XPOT; exportin for tRNA [KO:K14288]", "64328  XPO4; exportin 4 [KO:K25203]", "57510  XPO5; exportin 5 [KO:K14289]", "23214  XPO6; exportin 6 [KO:K25204]", "23039  XPO7; exportin 7 [KO:K18460]", "64901  RANBP17; RAN binding protein 17 [KO:K24115]", "5901  RAN; RAN, member RAS oncogene family [KO:K07936]", "1915  EEF1A1; eukaryotic translation elongation factor 1 alpha 1 [KO:K03231]", "1917  EEF1A2; eukaryotic translation elongation factor 1 alpha 2 [KO:K03231]", "51808  PHAX; phosphorylated adaptor for RNA export [KO:K14291]", "4686  NCBP1; nuclear cap binding protein subunit 1 [KO:K12882]", "22916  NCBP2; nuclear cap binding protein subunit 2 [KO:K12883]", "392517  NCBP2L; nuclear cap binding protein subunit 2 like [KO:K12883]", "51068  NMD3; NMD3 ribosome export adaptor [KO:K07562]", "9939  RBM8A; RNA binding motif protein 8A [KO:K12876]", "4116  MAGOH; mago homolog, exon junction complex subunit [KO:K12877]", "55110  MAGOHB; mago homolog B, exon junction complex subunit [KO:K12877]", "22794  CASC3; CASC3 exon junction complex subunit [KO:K14323]", "9775  EIF4A3; eukaryotic translation initiation factor 4A3 [KO:K13025] [EC:5.6.2.7]", "22985  ACIN1; apoptotic chromatin condensation inducer 1 [KO:K12875]", "10284  SAP18; Sin3A associated protein 18 [KO:K14324]", "10921  RNPS1; RNA binding protein with serine rich domain 1 [KO:K14325]", "5411  PNN; pinin, desmosome associated protein [KO:K13114]", "10189  ALYREF; Aly/REF export factor [KO:K12881]", "5976  UPF1; UPF1 RNA helicase and ATPase [KO:K14326] [EC:5.6.2.5 5.6.2.3]", "26019  UPF2; UPF2 regulator of nonsense mediated mRNA decay [KO:K14327]", "65109  UPF3B; UPF3B regulator of nonsense mediated mRNA decay [KO:K14328]", "65110  UPF3A; UPF3A regulator of nonsense mediated mRNA decay [KO:K14328]", "10482  NXF1; nuclear RNA export factor 1 [KO:K14284]", "56001  NXF2; nuclear RNA export factor 2 [KO:K14284]", "728343  NXF2B; nuclear RNA export factor 2B [KO:K14284]", "56000  NXF3; nuclear RNA export factor 3 [KO:K14284]", "29107  NXT1; nuclear transport factor 2 like export factor 1 [KO:K14285]", "55916  NXT2; nuclear transport factor 2 like export factor 2 [KO:K14285]", "7919  DDX39B; DExD-box helicase 39B [KO:K12812] [EC:5.6.2.7]", "10250  SRRM1; serine and arginine repetitive matrix 1 [KO:K13171]", "84305  PYM1; PYM homolog 1, exon junction complex associated factor [KO:K14294]", "9984  THOC1; THO complex subunit 1 [KO:K12878]", "57187  THOC2; THO complex subunit 2 [KO:K12879]", "8563  THOC5; THO complex subunit 5 [KO:K13174]", "79228  THOC6; THO complex subunit 6 [KO:K13175]", "80145  THOC7; THO complex subunit 7 [KO:K13176]", "84321  THOC3; THO complex subunit 3 [KO:K12880]"], "refs": [{"pmid": "16777596", "authors": "  Tran EJ, Wente SR", "title": "Dynamic nuclear pore complexes: life on the edge.", "journal": "Cell 125:1041-53 (2006)", "doi": "10.1016/j.cell.2006.05.027"}, {"pmid": "15519698", "authors": "  Rodriguez MS, Dargemont C, Stutz F", "title": "Nuclear export of RNA.", "journal": "Biol Cell 96:639-55 (2004)", "doi": "10.1016/j.biolcel.2004.04.014"}, {"pmid": "18313922", "authors": "  Palancade B, Doye V", "title": "Sumoylating and desumoylating enzymes at nuclear pores: underpinning their unexpected duties?", "journal": "Trends Cell Biol 18:174-83 (2008)", "doi": "10.1016/j.tcb.2008.02.001"}, {"pmid": "15901496", "authors": "  Reed R, Cheng H", "title": "TREX, SR proteins and export of mRNA.", "journal": "Curr Opin Cell Biol 17:269-73 (2005)", "doi": "10.1016/j.ceb.2005.04.011"}, {"pmid": "16314458", "authors": "  Tange TO, Shibuya T, Jurica MS, Moore MJ", "title": "Biochemical analysis of the EJC reveals two new factors and a stable tetrameric protein core.", "journal": "RNA 11:1869-83 (2005)", "doi": "10.1261/rna.2155905"}], "rel_pathway": ["hsa03015  mRNA surveillance pathway"], "ko_pathway": "ko03013", "genes": ["UPF1"]}, {"kegg_id": "hsa03015", "name": "mRNA surveillance pathway - Homo sapiens (human)", "description": "The mRNA surveillance pathway is a quality control mechanism that detects and degrades abnormal mRNAs. These pathways include nonsense-mediated mRNA decay (NMD), nonstop mRNA decay (NSD), and no-go decay (NGD). NMD is a mechanism that eliminates mRNAs containing premature translation-termination codons (PTCs). In vertebrates, PTCs trigger efficient NMD when located upstream of an exon junction complex (EJC). Upf3, together with Upf1 and Upf2, may signal the presence of the PTC to the 5'end of the transcript, resulting in decapping and rapid exonucleolytic digestion of the mRNA. In the NSD pathway, which targets mRNAs lacking termination codons, the ribosome is believed to translate through the 3' untranslated region and stall at the end of the poly(A) tail. NSD involves an eRF3-like protein, Ski7p, which is hypothesized to bind the empty A site of the ribosome and recruit the exosome to degrade the mRNA from the 3' end. NGD targets mRNAs with stalls in translation elongation for endonucleolytic cleavage in a process involving the Dom34 and Hbs1 proteins.", "class": "Genetic Information Processing; Translation", "pathway_map": "hsa03015  mRNA surveillance pathway", "drug": ["D11837  Zotatifin (USAN/INN)", "D12345  Obefazimod (USAN)"], "dblinks": ["GO: 0071028"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["4686  NCBP1; nuclear cap binding protein subunit 1 [KO:K12882]", "22916  NCBP2; nuclear cap binding protein subunit 2 [KO:K12883]", "392517  NCBP2L; nuclear cap binding protein subunit 2 like [KO:K12883]", "65109  UPF3B; UPF3B regulator of nonsense mediated mRNA decay [KO:K14328]", "65110  UPF3A; UPF3A regulator of nonsense mediated mRNA decay [KO:K14328]", "9939  RBM8A; RNA binding motif protein 8A [KO:K12876]", "4116  MAGOH; mago homolog, exon junction complex subunit [KO:K12877]", "55110  MAGOHB; mago homolog B, exon junction complex subunit [KO:K12877]", "22794  CASC3; CASC3 exon junction complex subunit [KO:K14323]", "9775  EIF4A3; eukaryotic translation initiation factor 4A3 [KO:K13025] [EC:5.6.2.7]", "10284  SAP18; Sin3A associated protein 18 [KO:K14324]", "5411  PNN; pinin, desmosome associated protein [KO:K13114]", "22985  ACIN1; apoptotic chromatin condensation inducer 1 [KO:K12875]", "10921  RNPS1; RNA binding protein with serine rich domain 1 [KO:K14325]", "10189  ALYREF; Aly/REF export factor [KO:K12881]", "11269  DDX19B; DEAD-box helicase 19B [KO:K18655] [EC:5.6.2.7]", "55308  DDX19A; DEAD-box helicase 19A [KO:K18655] [EC:5.6.2.7]", "2733  GLE1; GLE1 RNA export mediator [KO:K18723]", "10482  NXF1; nuclear RNA export factor 1 [KO:K14284]", "56001  NXF2; nuclear RNA export factor 2 [KO:K14284]", "728343  NXF2B; nuclear RNA export factor 2B [KO:K14284]", "56000  NXF3; nuclear RNA export factor 3 [KO:K14284]", "29107  NXT1; nuclear transport factor 2 like export factor 1 [KO:K14285]", "55916  NXT2; nuclear transport factor 2 like export factor 2 [KO:K14285]", "7919  DDX39B; DExD-box helicase 39B [KO:K12812] [EC:5.6.2.7]", "84305  PYM1; PYM homolog 1, exon junction complex associated factor [KO:K14294]", "10250  SRRM1; serine and arginine repetitive matrix 1 [KO:K13171]", "8732  RNGTT; RNA guanylyltransferase and 5'-phosphatase [KO:K13917] [EC:2.7.7.50 3.6.1.74]", "8731  RNMT; RNA guanine-7 methyltransferase [KO:K00565] [EC:2.1.1.56]", "2521  FUS; FUS RNA binding protein [KO:K13098]", "23435  TARDBP; TAR DNA binding protein [KO:K23600]", "8106  PABPN1; poly(A) binding protein nuclear 1 [KO:K14396]", "390748  PABPN1L; PABPN1 like, cytoplasmic [KO:K14396]", "100529063  BCL2L2-PABPN1; BCL2L2-PABPN1 readthrough [KO:K14396]", "11051  NUDT21; nudix hydrolase 21 [KO:K14397]", "11052  CPSF6; cleavage and polyadenylation specific factor 6 [KO:K14398]", "79869  CPSF7; cleavage and polyadenylation specific factor 7 [KO:K14398]", "64895  PAPOLG; poly(A) polymerase gamma [KO:K14376] [EC:2.7.7.19]", "56903  PAPOLB; poly(A) polymerase beta [KO:K14376] [EC:2.7.7.19]", "10914  PAPOLA; poly(A) polymerase alpha [KO:K14376] [EC:2.7.7.19]", "10978  CLP1; cleavage factor polyribonucleotide kinase subunit 1 [KO:K14399] [EC:2.7.1.78]", "51585  PCF11; PCF11 cleavage and polyadenylation factor subunit [KO:K14400]", "29894  CPSF1; cleavage and polyadenylation specific factor 1 [KO:K14401]", "53981  CPSF2; cleavage and polyadenylation specific factor 2 [KO:K14402]", "51692  CPSF3; cleavage and polyadenylation specific factor 3 [KO:K14403] [EC:3.1.27.-]", "10898  CPSF4; cleavage and polyadenylation specific factor 4 [KO:K14404]", "642843  CPSF4L; cleavage and polyadenylation specific factor 4 like [KO:K14404]", "81608  FIP1L1; factor interacting with PAPOLA and CPSF1 [KO:K14405]", "55339  WDR33; WD repeat domain 33 [KO:K15542]", "80335  WDR82; WD repeat domain 82 [KO:K14962]", "5499  PPP1CA; protein phosphatase 1 catalytic subunit alpha [KO:K06269] [EC:3.1.3.16]", "5500  PPP1CB; protein phosphatase 1 catalytic subunit beta [KO:K06269] [EC:3.1.3.16]", "5501  PPP1CC; protein phosphatase 1 catalytic subunit gamma [KO:K06269] [EC:3.1.3.16]", "29101  SSU72; SSU72 homolog, RNA polymerase II CTD phosphatase [KO:K15544] [EC:3.1.3.16]", "143506  SSU72L3; SSU72 like 3 [KO:K15544] [EC:3.1.3.16]", "441584  SSU72L4; SSU72 like 4 [KO:K15544] [EC:3.1.3.16]", "390031  SSU72L2; SSU72 like 2 [KO:K15544] [EC:3.1.3.16]", "390033  SSU72L1; SSU72 like 1 [KO:K15544] [EC:3.1.3.16]", "196120  SSU72L5; SSU72 like 5 [KO:K15544] [EC:3.1.3.16]", "136157  SSU72L6; SSU72 like 6 [KO:K15544] [EC:3.1.3.16]", "1477  CSTF1; cleavage stimulation factor subunit 1 [KO:K14406]", "1478  CSTF2; cleavage stimulation factor subunit 2 [KO:K14407]", "23283  CSTF2T; cleavage stimulation factor subunit 2 tau variant [KO:K14407]", "1479  CSTF3; cleavage stimulation factor subunit 3 [KO:K14408]", "8189  SYMPK; symplekin scaffold protein [KO:K06100]", "26528  DAZAP1; DAZ associated protein 1 [KO:K14411]", "4440  MSI1; musashi RNA binding protein 1 [KO:K14411]", "124540  MSI2; musashi RNA binding protein 2 [KO:K14411]", "26986  PABPC1; poly(A) binding protein cytoplasmic 1 [KO:K13126]", "140886  PABPC5; poly(A) binding protein cytoplasmic 5 [KO:K13126]", "5042  PABPC3; poly(A) binding protein cytoplasmic 3 [KO:K13126]", "645974  PABPC1L2B; poly(A) binding protein cytoplasmic 1 like 2B [KO:K13126]", "80336  PABPC1L; poly(A) binding protein cytoplasmic 1 like [KO:K13126]", "340529  PABPC1L2A; poly(A) binding protein cytoplasmic 1 like 2A [KO:K13126]", "8761  PABPC4; poly(A) binding protein cytoplasmic 4 [KO:K13126]", "132430  PABPC4L; poly(A) binding protein cytoplasmic 4 like [KO:K13126]", "2107  ETF1; eukaryotic translation termination factor 1 [KO:K03265]", "23708  GSPT2; G1 to S phase transition 2 [KO:K03267]", "2935  GSPT1; G1 to S phase transition 1 [KO:K03267]", "5976  UPF1; UPF1 RNA helicase and ATPase [KO:K14326] [EC:5.6.2.5 5.6.2.3]", "26019  UPF2; UPF2 regulator of nonsense mediated mRNA decay [KO:K14327]", "23049  SMG1; SMG1 nonsense mediated mRNA decay associated PI3K related kinase [KO:K08873] [EC:2.7.11.1]", "9887  SMG7; SMG7 nonsense mediated mRNA decay factor [KO:K14409]", "23381  SMG5; SMG5 nonsense mediated mRNA decay factor [KO:K11125]", "23293  SMG6; SMG6 nonsense mediated mRNA decay factor [KO:K11124] [EC:3.1.-.-]", "5515  PPP2CA; protein phosphatase 2 catalytic subunit alpha [KO:K04382] [EC:3.1.3.16]", "5516  PPP2CB; protein phosphatase 2 catalytic subunit beta [KO:K04382] [EC:3.1.3.16]", "5519  PPP2R1B; protein phosphatase 2 scaffold subunit Abeta [KO:K03456]", "5518  PPP2R1A; protein phosphatase 2 scaffold subunit Aalpha [KO:K03456]", "5520  PPP2R2A; protein phosphatase 2 regulatory subunit Balpha [KO:K04354]", "5521  PPP2R2B; protein phosphatase 2 regulatory subunit Bbeta [KO:K04354]", "5522  PPP2R2C; protein phosphatase 2 regulatory subunit Bgamma [KO:K04354]", "55844  PPP2R2D; protein phosphatase 2 regulatory subunit Bdelta [KO:K04354]", "28227  PPP2R3B; protein phosphatase 2 regulatory subunit B''beta [KO:K11583]", "55012  PPP2R3C; protein phosphatase 2 regulatory subunit B''gamma [KO:K11583]", "5523  PPP2R3A; protein phosphatase 2 regulatory subunit B''alpha [KO:K11583]", "5526  PPP2R5B; protein phosphatase 2 regulatory subunit B'beta [KO:K11584]", "5527  PPP2R5C; protein phosphatase 2 regulatory subunit B'gamma [KO:K11584]", "5528  PPP2R5D; protein phosphatase 2 regulatory subunit B'delta [KO:K11584]", "5529  PPP2R5E; protein phosphatase 2 regulatory subunit B'epsilon [KO:K11584]", "5525  PPP2R5A; protein phosphatase 2 regulatory subunit B'alpha [KO:K11584]", "10767  HBS1L; HBS1 like translational GTPase [KO:K14416]", "53918  PELO; pelota mRNA surveillance and ribosome rescue factor [KO:K06965]"], "refs": [{"pmid": "15040442", "authors": "  Maquat LE", "title": "Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics.", "journal": "Nat Rev Mol Cell Biol 5:89-99 (2004)", "doi": "10.1038/nrm1310"}, {"pmid": "16723977", "authors": "  Amrani N, Sachs MS, Jacobson A", "title": "Early nonsense: mRNA decay solves a translational problem.", "journal": "Nat Rev Mol Cell Biol 7:415-25 (2006)", "doi": "10.1038/nrm1942"}, {"pmid": "17183357", "authors": "  Eulalio A, Behm-Ansmant I, Izaurralde E", "title": "P bodies: at the crossroads of post-transcriptional pathways.", "journal": "Nat Rev Mol Cell Biol 8:9-22 (2007)", "doi": "10.1038/nrm2080"}, {"pmid": "18158581", "authors": "  Mandel CR, Bai Y, Tong L", "title": "Protein factors in pre-mRNA 3'-end processing.", "journal": "Cell Mol Life Sci 65:1099-122 (2008)", "doi": "10.1007/s00018-007-7474-3"}], "rel_pathway": ["hsa03013  Nucleocytoplasmic transport", "hsa03018  RNA degradation", "hsa03040  Spliceosome"], "ko_pathway": "ko03015", "genes": ["UPF1"]}, {"kegg_id": "hsa04714", "name": "Thermogenesis - Homo sapiens (human)", "description": "Thermogenesis is essential for warm-blooded animals, ensuring normal cellular and physiological function under conditions of environmental challenge. Thermogenesis in brown and beige adipose tissue is mainly controlled by norepinephrine, which is released from sympathetic nervous system in response to cold or dietary stimuli. The mitochondrial uncoupling protein 1 (UCP1) is responsible for the process whereby chemical energy is converted into heat in these adipocytes. Activation of these adipocytes leads to an increase in calorie consumption and is expected to improve overweight conditions, providing a potential strategy for treating obesity and its related metabolic disorders.", "class": "Organismal Systems; Environmental adaptation", "pathway_map": "hsa04714  Thermogenesis", "network": ["", "ELEMENT   N01688  ADRB3-UCP1 signaling pathway", "N01691  mitochondrial complex - UCP1 in Thermogenesis"], "drug": ["D12263  Bomedemstat (USAN/INN)", "D12264  Bomedemstat tosylate (USAN)", "D12490  Fazpilodemab (USAN/INN)", "D12577  Seclidemstat (USAN/INN)", "D12578  Seclidemstat mesylate (USAN)"], "dblinks": ["GO: 1990845"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["155  ADRB3; adrenoceptor beta 3 [KO:K04143]", "2778  GNAS; GNAS complex locus [KO:K04632]", "107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]", "108  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]", "109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]", "196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]", "113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]", "114  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]", "115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]", "55811  ADCY10; adenylate cyclase 10 [KO:K11265] [EC:4.6.1.1]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]", "10488  CREB3; cAMP responsive element binding protein 3 [KO:K09048]", "90993  CREB3L1; cAMP responsive element binding protein 3 like 1 [KO:K09048]", "64764  CREB3L2; cAMP responsive element binding protein 3 like 2 [KO:K09048]", "84699  CREB3L3; cAMP responsive element binding protein 3 like 3 [KO:K09048]", "148327  CREB3L4; cAMP responsive element binding protein 3 like 4 [KO:K09048]", "9586  CREB5; cAMP responsive element binding protein 5 [KO:K09047]", "63976  PRDM16; PR/SET domain 16 [KO:K22410] [EC:2.1.1.367]", "9658  ZNF516; zinc finger protein 516 [KO:K22411]", "23028  KDM1A; lysine demethylase 1A [KO:K11450] [EC:1.14.99.66]", "7350  UCP1; uncoupling protein 1 [KO:K08769]", "55818  KDM3A; lysine demethylase 3A [KO:K15601] [EC:1.14.11.65]", "51780  KDM3B; lysine demethylase 3B [KO:K15601] [EC:1.14.11.65]", "6595  SMARCA2; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 [KO:K11647] [EC:5.6.2.-]", "6597  SMARCA4; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 [KO:K11647] [EC:5.6.2.-]", "6598  SMARCB1; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 [KO:K11648]", "6599  SMARCC1; SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1 [KO:K11649]", "6601  SMARCC2; SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 2 [KO:K11649]", "6602  SMARCD1; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 [KO:K11650]", "6603  SMARCD2; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2 [KO:K11650]", "6604  SMARCD3; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 [KO:K11650]", "6605  SMARCE1; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1 [KO:K11651]", "71  ACTG1; actin gamma 1 [KO:K05692]", "60  ACTB; actin beta [KO:K05692]", "86  ACTL6A; actin like 6A [KO:K11340]", "51412  ACTL6B; actin like 6B [KO:K11652]", "57492  ARID1B; AT-rich interaction domain 1B [KO:K11653]", "8289  ARID1A; AT-rich interaction domain 1A [KO:K11653]", "8193  DPF1; double PHD fingers 1 [KO:K22198]", "8110  DPF3; double PHD fingers 3 [KO:K22198]", "5468  PPARG; peroxisome proliferator activated receptor gamma [KO:K08530]", "4217  MAP3K5; mitogen-activated protein kinase kinase kinase 5 [KO:K04426] [EC:2.7.11.25]", "5606  MAP2K3; mitogen-activated protein kinase kinase 3 [KO:K04432] [EC:2.7.12.2]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "10891  PPARGC1A; PPARG coactivator 1 alpha [KO:K07202]", "1386  ATF2; activating transcription factor 2 [KO:K04450]", "51548  SIRT6; sirtuin 6 [KO:K11416] [EC:2.3.1.286]", "26291  FGF21; fibroblast growth factor 21 [KO:K22429]", "5346  PLIN1; perilipin 1 [KO:K08768]", "3991  LIPE; lipase E, hormone sensitive type [KO:K07188] [EC:3.1.1.79]", "57104  PNPLA2; patatin like phospholipase domain containing 2 [KO:K16816] [EC:3.1.1.3]", "11343  MGLL; monoglyceride lipase [KO:K01054] [EC:3.1.1.23]", "5562  PRKAA1; protein kinase AMP-activated catalytic subunit alpha 1 [KO:K07198] [EC:2.7.11.31]", "5563  PRKAA2; protein kinase AMP-activated catalytic subunit alpha 2 [KO:K07198] [EC:2.7.11.31]", "5564  PRKAB1; protein kinase AMP-activated non-catalytic subunit beta 1 [KO:K07199]", "5565  PRKAB2; protein kinase AMP-activated non-catalytic subunit beta 2 [KO:K07199]", "5571  PRKAG1; protein kinase AMP-activated non-catalytic subunit gamma 1 [KO:K07200]", "53632  PRKAG3; protein kinase AMP-activated non-catalytic subunit gamma 3 [KO:K07200]", "51422  PRKAG2; protein kinase AMP-activated non-catalytic subunit gamma 2 [KO:K07200]", "2641  GCG; glucagon [KO:K05259]", "656  BMP8B; bone morphogenetic protein 8b [KO:K16622]", "353500  BMP8A; bone morphogenetic protein 8a [KO:K16622]", "1268  CNR1; cannabinoid receptor 1 [KO:K04277]", "4878  NPPA; natriuretic peptide A [KO:K12334]", "4879  NPPB; natriuretic peptide B [KO:K12335]", "4881  NPR1; natriuretic peptide receptor 1 [KO:K12323] [EC:4.6.1.2]", "5592  PRKG1; protein kinase cGMP-dependent 1 [KO:K07376] [EC:2.7.11.12]", "5593  PRKG2; protein kinase cGMP-dependent 2 [KO:K19477] [EC:2.7.11.12]", "152831  KLB; klotho beta [KO:K22404]", "2260  FGFR1; fibroblast growth factor receptor 1 [KO:K04362] [EC:2.7.10.1]", "10818  FRS2; fibroblast growth factor receptor substrate 2 [KO:K12461]", "2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]", "6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]", "6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "6197  RPS6KA3; ribosomal protein S6 kinase A3 [KO:K04373] [EC:2.7.11.1]", "6195  RPS6KA1; ribosomal protein S6 kinase A1 [KO:K04373] [EC:2.7.11.1]", "6196  RPS6KA2; ribosomal protein S6 kinase A2 [KO:K04373] [EC:2.7.11.1]", "27330  RPS6KA6; ribosomal protein S6 kinase A6 [KO:K04373] [EC:2.7.11.1]", "7248  TSC1; TSC complex subunit 1 [KO:K07206]", "7249  TSC2; TSC complex subunit 2 [KO:K07207]", "6009  RHEB; Ras homolog, mTORC1 binding [KO:K07208]", "57521  RPTOR; regulatory associated protein of MTOR complex 1 [KO:K07204]", "2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]", "64223  MLST8; MTOR associated protein, LST8 homolog [KO:K08266]", "84335  AKT1S1; AKT1 substrate 1 [KO:K16184]", "6198  RPS6KB1; ribosomal protein S6 kinase B1 [KO:K04688] [EC:2.7.11.1]", "6199  RPS6KB2; ribosomal protein S6 kinase B2 [KO:K04688] [EC:2.7.11.1]", "6194  RPS6; ribosomal protein S6 [KO:K02991]", "23305  ACSL6; acyl-CoA synthetase long chain family member 6 [KO:K01897] [EC:6.2.1.3]", "2182  ACSL4; acyl-CoA synthetase long chain family member 4 [KO:K01897] [EC:6.2.1.3]", "2180  ACSL1; acyl-CoA synthetase long chain family member 1 [KO:K01897] [EC:6.2.1.3]", "51703  ACSL5; acyl-CoA synthetase long chain family member 5 [KO:K01897] [EC:6.2.1.3]", "2181  ACSL3; acyl-CoA synthetase long chain family member 3 [KO:K01897] [EC:6.2.1.3]", "4535  ND1; NADH dehydrogenase subunit 1 [KO:K03878] [EC:7.1.1.2]", "4536  ND2; NADH dehydrogenase subunit 2 [KO:K03879] [EC:7.1.1.2]", "4537  ND3; NADH dehydrogenase subunit 3 [KO:K03880] [EC:7.1.1.2]", "4538  ND4; NADH dehydrogenase subunit 4 [KO:K03881] [EC:7.1.1.2]", "4539  ND4L; NADH dehydrogenase subunit 4L [KO:K03882] [EC:7.1.1.2]", "4540  ND5; NADH dehydrogenase subunit 5 [KO:K03883] [EC:7.1.1.2]", "4541  ND6; NADH dehydrogenase subunit 6 [KO:K03884] [EC:7.1.1.2]", "4719  NDUFS1; NADH:ubiquinone oxidoreductase core subunit S1 [KO:K03934] [EC:7.1.1.2]", "4720  NDUFS2; NADH:ubiquinone oxidoreductase core subunit S2 [KO:K03935] [EC:7.1.1.2]", "4722  NDUFS3; NADH:ubiquinone oxidoreductase core subunit S3 [KO:K03936] [EC:7.1.1.2]", "4724  NDUFS4; NADH:ubiquinone oxidoreductase subunit S4 [KO:K03937]", "4725  NDUFS5; NADH:ubiquinone oxidoreductase subunit S5 [KO:K03938]", "4726  NDUFS6; NADH:ubiquinone oxidoreductase subunit S6 [KO:K03939]", "374291  NDUFS7; NADH:ubiquinone oxidoreductase core subunit S7 [KO:K03940] [EC:7.1.1.2]", "4728  NDUFS8; NADH:ubiquinone oxidoreductase core subunit S8 [KO:K03941] [EC:7.1.1.2]", "4723  NDUFV1; NADH:ubiquinone oxidoreductase core subunit V1 [KO:K03942] [EC:7.1.1.2]", "4729  NDUFV2; NADH:ubiquinone oxidoreductase core subunit V2 [KO:K03943] [EC:7.1.1.2]", "4731  NDUFV3; NADH:ubiquinone oxidoreductase subunit V3 [KO:K03944]", "4694  NDUFA1; NADH:ubiquinone oxidoreductase subunit A1 [KO:K03945]", "4695  NDUFA2; NADH:ubiquinone oxidoreductase subunit A2 [KO:K03946]", "4696  NDUFA3; NADH:ubiquinone oxidoreductase subunit A3 [KO:K03947]", "4697  NDUFA4; NDUFA4 mitochondrial complex associated [KO:K03948]", "56901  NDUFA4L2; NDUFA4 mitochondrial complex associated like 2 [KO:K03948]", "4698  NDUFA5; NADH:ubiquinone oxidoreductase subunit A5 [KO:K03949]", "4700  NDUFA6; NADH:ubiquinone oxidoreductase subunit A6 [KO:K03950]", "4701  NDUFA7; NADH:ubiquinone oxidoreductase subunit A7 [KO:K03951]", "4702  NDUFA8; NADH:ubiquinone oxidoreductase subunit A8 [KO:K03952]", "4704  NDUFA9; NADH:ubiquinone oxidoreductase subunit A9 [KO:K03953]", "4705  NDUFA10; NADH:ubiquinone oxidoreductase subunit A10 [KO:K03954]", "4706  NDUFAB1; NADH:ubiquinone oxidoreductase subunit AB1 [KO:K03955]", "126328  NDUFA11; NADH:ubiquinone oxidoreductase subunit A11 [KO:K03956]", "55967  NDUFA12; NADH:ubiquinone oxidoreductase subunit A12 [KO:K11352]", "51079  NDUFA13; NADH:ubiquinone oxidoreductase subunit A13 [KO:K11353]", "4707  NDUFB1; NADH:ubiquinone oxidoreductase subunit B1 [KO:K03957]", "4708  NDUFB2; NADH:ubiquinone oxidoreductase subunit B2 [KO:K03958]", "4709  NDUFB3; NADH:ubiquinone oxidoreductase subunit B3 [KO:K03959]", "4710  NDUFB4; NADH:ubiquinone oxidoreductase subunit B4 [KO:K03960]", "4711  NDUFB5; NADH:ubiquinone oxidoreductase subunit B5 [KO:K03961]", "4712  NDUFB6; NADH:ubiquinone oxidoreductase subunit B6 [KO:K03962]", "4713  NDUFB7; NADH:ubiquinone oxidoreductase subunit B7 [KO:K03963]", "4714  NDUFB8; NADH:ubiquinone oxidoreductase subunit B8 [KO:K03964]", "4715  NDUFB9; NADH:ubiquinone oxidoreductase subunit B9 [KO:K03965]", "4716  NDUFB10; NADH:ubiquinone oxidoreductase subunit B10 [KO:K03966]", "54539  NDUFB11; NADH:ubiquinone oxidoreductase subunit B11 [KO:K11351]", "4717  NDUFC1; NADH:ubiquinone oxidoreductase subunit C1 [KO:K03967]", "4718  NDUFC2; NADH:ubiquinone oxidoreductase subunit C2 [KO:K03968]", "100532726  NDUFC2-KCTD14; NDUFC2-KCTD14 readthrough [KO:K03968]", "51103  NDUFAF1; NADH:ubiquinone oxidoreductase complex assembly factor 1 [KO:K18159]", "91942  NDUFAF2; NADH:ubiquinone oxidoreductase complex assembly factor 2 [KO:K18160]", "25915  NDUFAF3; NADH:ubiquinone oxidoreductase complex assembly factor 3 [KO:K09008]", "29078  NDUFAF4; NADH:ubiquinone oxidoreductase complex assembly factor 4 [KO:K18161]", "79133  NDUFAF5; NADH:ubiquinone oxidoreductase complex assembly factor 5 [KO:K18162] [EC:2.1.1.-]", "137682  NDUFAF6; NADH:ubiquinone oxidoreductase complex assembly factor 6 [KO:K18163]", "55471  NDUFAF7; NADH:ubiquinone oxidoreductase complex assembly factor 7 [KO:K18164]", "284184  NDUFAF8; NADH:ubiquinone oxidoreductase complex assembly factor 8 [KO:K24726]", "6389  SDHA; succinate dehydrogenase complex flavoprotein subunit A [KO:K00234] [EC:1.3.5.1]", "6390  SDHB; succinate dehydrogenase complex iron sulfur subunit B [KO:K00235] [EC:1.3.5.1]", "6391  SDHC; succinate dehydrogenase complex subunit C [KO:K00236]", "6392  SDHD; succinate dehydrogenase complex subunit D [KO:K00237]", "7386  UQCRFS1; ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 [KO:K00411] [EC:7.1.1.8]", "4519  CYTB; cytochrome b [KO:K00412]", "1537  CYC1; cytochrome c1 [KO:K00413]", "7384  UQCRC1; ubiquinol-cytochrome c reductase core protein 1 [KO:K00414]", "7385  UQCRC2; ubiquinol-cytochrome c reductase core protein 2 [KO:K00415]", "7388  UQCRH; ubiquinol-cytochrome c reductase hinge protein [KO:K00416]", "440567  UQCRHL; ubiquinol-cytochrome c reductase hinge protein like [KO:K00416]", "7381  UQCRB; ubiquinol-cytochrome c reductase binding protein [KO:K00417]", "27089  UQCRQ; ubiquinol-cytochrome c reductase complex III subunit VII [KO:K00418]", "29796  UQCR10; ubiquinol-cytochrome c reductase, complex III subunit X [KO:K00419]", "10975  UQCR11; ubiquinol-cytochrome c reductase, complex III subunit XI [KO:K00420]", "4512  COX1; cytochrome c oxidase subunit I [KO:K02256] [EC:7.1.1.9]", "4513  COX2; cytochrome c oxidase subunit II [KO:K02261]", "4514  COX3; cytochrome c oxidase subunit III [KO:K02262]", "84701  COX4I2; cytochrome c oxidase subunit 4I2 [KO:K02263]", "1327  COX4I1; cytochrome c oxidase subunit 4I1 [KO:K02263]", "9377  COX5A; cytochrome c oxidase subunit 5A [KO:K02264]", "1329  COX5B; cytochrome c oxidase subunit 5B [KO:K02265]", "1337  COX6A1; cytochrome c oxidase subunit 6A1 [KO:K02266]", "1339  COX6A2; cytochrome c oxidase subunit 6A2 [KO:K02266]", "1340  COX6B1; cytochrome c oxidase subunit 6B1 [KO:K02267]", "125965  COX6B2; cytochrome c oxidase subunit 6B2 [KO:K02267]", "1345  COX6C; cytochrome c oxidase subunit 6C [KO:K02268]", "1346  COX7A1; cytochrome c oxidase subunit 7A1 [KO:K02270]", "1347  COX7A2; cytochrome c oxidase subunit 7A2 [KO:K02270]", "9167  COX7A2L; cytochrome c oxidase subunit 7A2 like [KO:K02270]", "1349  COX7B; cytochrome c oxidase subunit 7B [KO:K02271]", "170712  COX7B2; cytochrome c oxidase subunit 7B2 [KO:K02271]", "1350  COX7C; cytochrome c oxidase subunit 7C [KO:K02272]", "341947  COX8C; cytochrome c oxidase subunit 8C [KO:K02273]", "1351  COX8A; cytochrome c oxidase subunit 8A [KO:K02273]", "1352  COX10; cytochrome c oxidase assembly factor heme A:farnesyltransferase COX10 [KO:K02257] [EC:2.5.1.141]", "1353  COX11; cytochrome c oxidase copper chaperone COX11 [KO:K02258]", "84987  COX14; cytochrome c oxidase assembly factor COX14 [KO:K18181]", "1355  COX15; cytochrome c oxidase assembly homolog COX15 [KO:K02259] [EC:1.17.99.9]", "51241  COX16; cytochrome c oxidase assembly factor COX16 [KO:K18182]", "10063  COX17; cytochrome c oxidase copper chaperone COX17 [KO:K02260]", "285521  COX18; cytochrome c oxidase assembly factor COX18 [KO:K17797]", "90639  COX19; cytochrome c oxidase assembly factor COX19 [KO:K18183]", "116228  COX20; cytochrome c oxidase assembly factor COX20 [KO:K18184]", "55744  COA1; cytochrome c oxidase assembly factor 1 [KO:K18173]", "28958  COA3; cytochrome c oxidase assembly factor 3 [KO:K18175]", "51287  COA4; cytochrome c oxidase assembly factor 4 homolog [KO:K18177]", "493753  COA5; cytochrome c oxidase assembly factor 5 [KO:K18178]", "388753  COA6; cytochrome c oxidase assembly factor 6 [KO:K18179]", "65260  COA7; cytochrome c oxidase assembly factor 7 [KO:K18180]", "498  ATP5F1A; ATP synthase F1 subunit alpha [KO:K02132]", "506  ATP5F1B; ATP synthase F1 subunit beta [KO:K02133] [EC:7.1.2.2]", "509  ATP5F1C; ATP synthase F1 subunit gamma [KO:K02136]", "513  ATP5F1D; ATP synthase F1 subunit delta [KO:K02134]", "514  ATP5F1E; ATP synthase F1 subunit epsilon [KO:K02135]", "539  ATP5PO; ATP synthase peripheral stalk subunit OSCP [KO:K02137]", "4508  ATP6; ATP synthase F0 subunit 6 [KO:K02126]", "515  ATP5PB; ATP synthase peripheral stalk-membrane subunit b [KO:K02127]", "516  ATP5MC1; ATP synthase membrane subunit c locus 1 [KO:K02128]", "517  ATP5MC2; ATP synthase membrane subunit c locus 2 [KO:K02128]", "518  ATP5MC3; ATP synthase membrane subunit c locus 3 [KO:K02128]", "10476  ATP5PD; ATP synthase peripheral stalk subunit d [KO:K02138]", "521  ATP5ME; ATP synthase membrane subunit e [KO:K02129]", "9551  ATP5MF; ATP synthase membrane subunit f [KO:K02130]", "522  ATP5PF; ATP synthase peripheral stalk subunit F6 [KO:K02131]", "4509  ATP8; ATP synthase F0 subunit 8 [KO:K02125]", "10632  ATP5MG; ATP synthase membrane subunit g [KO:K02140]", "1376  CPT2; carnitine palmitoyltransferase 2 [KO:K08766] [EC:2.3.1.21]", "123096  SLC25A29; solute carrier family 25 member 29 [KO:K15109]", "788  SLC25A20; solute carrier family 25 member 20 [KO:K15109]", "1374  CPT1A; carnitine palmitoyltransferase 1A [KO:K08765] [EC:2.3.1.21]", "1375  CPT1B; carnitine palmitoyltransferase 1B [KO:K19523] [EC:2.3.1.21]", "126129  CPT1C; carnitine palmitoyltransferase 1C [KO:K19524] [EC:2.3.1.21]"], "compound": ["C00002  ATP", "C00004  NADH", "C00008  ADP", "C00010  CoA", "C00024  Acetyl-CoA", "C00040  Acyl-CoA", "C00080  H+", "C00116  Glycerol", "C00162  Fatty acid", "C00165  Diacylglycerol", "C00318  L-Carnitine", "C00422  Triacylglycerol", "C00547  L-Noradrenaline", "C00575  3',5'-Cyclic AMP", "C00745  Nicotine", "C00942  3',5'-Cyclic GMP", "C00951  Estradiol-17beta", "C01352  FADH2", "C01885  1-Acylglycerol", "C02301  O-Acylcarnitine", "C02465  Triiodothyronine", "C11695  Anandamide", "C13856  2-Arachidonoylglycerol"], "refs": [{"pmid": "27251423", "authors": "  Inagaki T, Sakai J, Kajimura S", "title": "Transcriptional and epigenetic control of brown and beige adipose cell fate and function.", "journal": "Nat Rev Mol Cell Biol 17:480-95 (2016)", "doi": "10.1038/nrm.2016.62"}, {"pmid": "24100998", "authors": "  Harms M, Seale P", "title": "Brown and beige fat: development, function and therapeutic potential.", "journal": "Nat Med 19:1252-63 (2013)", "doi": "10.1038/nm.3361"}, {"pmid": "25154875", "authors": "  Boon MR, Kooijman S, van Dam AD, Pelgrom LR, Berbee JF, Visseren CA, van Aggele RC, van den Hoek AM, Sips HC, Lombes M, Havekes LM, Tamsma JT, Guigas B, Meijer OC, Jukema JW, Rensen PC", "title": "Peripheral cannabinoid 1 receptor blockade activates brown adipose tissue and diminishes dyslipidemia and obesity.", "journal": "FASEB J 28:5361-75 (2014)", "doi": "10.1096/fj.13-247643"}, {"pmid": "26201764", "authors": "  Merlin J, Evans BA, Dehvari N, Sato M, Bengtsson T, Hutchinson DS", "title": "Could burning fat start with a brite spark? Pharmacological and nutritional ways to promote thermogenesis.", "journal": "Mol Nutr Food Res 60:18-42 (2016)", "doi": "10.1002/mnfr.201500251"}, {"pmid": "26271143", "authors": "  van Dam AD, Kooijman S, Schilperoort M, Rensen PC, Boon MR", "title": "Regulation of brown fat by AMP-activated protein kinase.", "journal": "Trends Mol Med 21:571-9 (2015)", "doi": "10.1016/j.molmed.2015.07.003"}, {"pmid": "26482876", "authors": "  Kooijman S, van den Heuvel JK, Rensen PC", "title": "Neuronal Control of Brown Fat Activity.", "journal": "Trends Endocrinol Metab 26:657-68 (2015)", "doi": "10.1016/j.tem.2015.09.008"}, {"pmid": "28448947", "authors": "  Contreras C, Nogueiras R, Dieguez C, Rahmouni K, Lopez M", "title": "Traveling from the hypothalamus to the adipose tissue: The thermogenic pathway.", "journal": "Redox Biol 12:854-863 (2017)", "doi": "10.1016/j.redox.2017.04.019"}, {"pmid": "24872083", "authors": "  Fruhbeck G, Mendez-Gimenez L, Fernandez-Formoso JA, Fernandez S, Rodriguez A", "title": "Regulation of adipocyte lipolysis.", "journal": "Nutr Res Rev 27:63-93 (2014)", "doi": "10.1017/S095442241400002X"}, {"pmid": "15545214", "authors": "  Tansey JT, Sztalryd C, Hlavin EM, Kimmel AR, Londos C", "title": "The central role of perilipin a in lipid metabolism and adipocyte lipolysis.", "journal": "IUBMB Life 56:379-85 (2004)", "doi": "10.1080/15216540400009968"}, {"pmid": "20935662", "authors": "  Collins S, Yehuda-Shnaidman E, Wang H", "title": "Positive and negative control of Ucp1 gene transcription and the role of beta-adrenergic signaling networks.", "journal": "Int J Obes (Lond) 34 Suppl 1:S28-33 (2010)", "doi": "10.1038/ijo.2010.180"}, {"pmid": "15964803", "authors": "  Robidoux J, Cao W, Quan H, Daniel KW, Moukdar F, Bai X, Floering LM, Collins S", "title": "Selective activation of mitogen-activated protein (MAP) kinase kinase 3 and p38alpha MAP kinase is essential for cyclic AMP-dependent UCP1 expression in adipocytes.", "journal": "Mol Cell Biol 25:5466-79 (2005)", "doi": "10.1128/MCB.25.13.5466-5479.2005"}, {"pmid": "27045525", "authors": "  Hattori K, Naguro I, Okabe K, Funatsu T, Furutani S, Takeda K, Ichijo H", "title": "ASK1 signalling regulates brown and beige adipocyte function.", "journal": "Nat Commun 7:11158 (2016)", "doi": "10.1038/ncomms11158"}, {"pmid": "25948511", "authors": "  Abe Y, Rozqie R, Matsumura Y, Kawamura T, Nakaki R, Tsurutani Y, Tanimura-Inagaki K, Shiono A, Magoori K, Nakamura K, Ogi S, Kajimura S, Kimura H, Tanaka T, Fukami K, Osborne TF, Kodama T, Aburatani H, Inagaki T, Sakai J", "title": "JMJD1A is a signal-sensing scaffold that regulates acute chromatin dynamics via SWI/SNF association for thermogenesis.", "journal": "Nat Commun 6:7052 (2015)", "doi": "10.1038/ncomms8052"}, {"pmid": "25578880", "authors": "  Dempersmier J, Sambeat A, Gulyaeva O, Paul SM, Hudak CS, Raposo HF, Kwan HY, Kang C, Wong RH, Sul HS", "title": "Cold-inducible Zfp516 activates UCP1 transcription to promote browning of white fat and development of brown fat.", "journal": "Mol Cell 57:235-46 (2015)", "doi": "10.1016/j.molcel.2014.12.005"}, {"pmid": "27264172", "authors": "  Sambeat A, Gulyaeva O, Dempersmier J, Tharp KM, Stahl A, Paul SM, Sul HS", "title": "LSD1 Interacts with Zfp516 to Promote UCP1 Transcription and Brown Fat Program.", "journal": "Cell Rep 15:2536-49 (2016)", "doi": "10.1016/j.celrep.2016.05.019"}, {"pmid": "27693079", "authors": "  Villarroya F, Peyrou M, Giralt M", "title": "Transcriptional regulation of the uncoupling protein-1 gene.", "journal": "Biochimie 134:86-92 (2017)", "doi": "10.1016/j.biochi.2016.09.017"}, {"pmid": "15024092", "authors": "  Cao W, Daniel KW, Robidoux J, Puigserver P, Medvedev AV, Bai X, Floering LM, Spiegelman BM, Collins S", "title": "p38 mitogen-activated protein kinase is the central regulator of cyclic AMP-dependent transcription of the brown fat uncoupling protein 1 gene.", "journal": "Mol Cell Biol 24:3057-67 (2004)", "doi": "10.1128/MCB.24.7.3057-3067.2004"}, {"pmid": "21317437", "authors": "  Hondares E, Iglesias R, Giralt A, Gonzalez FJ, Giralt M, Mampel T, Villarroya F", "title": "Thermogenic activation induces FGF21 expression and release in brown adipose tissue.", "journal": "J Biol Chem 286:12983-90 (2011)", "doi": "10.1074/jbc.M110.215889"}, {"pmid": "28723567", "authors": "  Yao L, Cui X, Chen Q, Yang X, Fang F, Zhang J, Liu G, Jin W, Chang Y", "title": "Cold-Inducible SIRT6 Regulates Thermogenesis of Brown and Beige Fat.", "journal": "Cell Rep 20:641-654 (2017)", "doi": "10.1016/j.celrep.2017.06.069"}, {"pmid": "27794497", "authors": "  Klingenberg M", "title": "UCP1 - A sophisticated energy valve.", "journal": "Biochimie 134:19-27 (2017)", "doi": "10.1016/j.biochi.2016.10.012"}, {"pmid": "27984203", "authors": "  Bertholet AM, Kirichok Y", "title": "UCP1: A transporter for H(+) and fatty acid anions.", "journal": "Biochimie 134:28-34 (2017)", "doi": "10.1016/j.biochi.2016.10.013"}, {"pmid": "29052591", "authors": "  Betz MJ, Enerback S", "title": "Targeting thermogenesis in brown fat and muscle to treat obesity and metabolic disease.", "journal": "Nat Rev Endocrinol 14:77-87 (2018)", "doi": "10.1038/nrendo.2017.132"}, {"pmid": "20514071", "authors": "  Tseng YH, Cypess AM, Kahn CR", "title": "Cellular bioenergetics as a target for obesity therapy.", "journal": "Nat Rev Drug Discov 9:465-82 (2010)", "doi": "10.1038/nrd3138"}, {"pmid": "25390014", "authors": "  Fenzl A, Kiefer FW", "title": "Brown adipose tissue and thermogenesis.", "journal": "Horm Mol Biol Clin Investig 19:25-37 (2014)", "doi": "10.1515/hmbci-2014-0022"}, {"pmid": "27681418", "authors": "  Minard AY, Tan SX, Yang P, Fazakerley DJ, Domanova W, Parker BL, Humphrey SJ, Jothi R, Stockli J, James DE", "title": "mTORC1 Is a Major Regulatory Node in the FGF21 Signaling Network in Adipocytes.", "journal": "Cell Rep 17:29-36 (2016)", "doi": "10.1016/j.celrep.2016.08.086"}, {"pmid": "22302939", "authors": "  Fisher FM, Kleiner S, Douris N, Fox EC, Mepani RJ, Verdeguer F, Wu J, Kharitonenkov A, Flier JS, Maratos-Flier E, Spiegelman BM", "title": "FGF21 regulates PGC-1alpha and browning of white adipose tissues in adaptive thermogenesis.", "journal": "Genes Dev 26:271-81 (2012)", "doi": "10.1101/gad.177857.111"}, {"pmid": "24820868", "authors": "  Zois NE, Bartels ED, Hunter I, Kousholt BS, Olsen LH, Goetze JP", "title": "Natriuretic peptides in cardiometabolic regulation and disease.", "journal": "Nat Rev Cardiol 11:403-12 (2014)", "doi": "10.1038/nrcardio.2014.64"}, {"pmid": "22020112", "authors": "  Indiveri C, Iacobazzi V, Tonazzi A, Giangregorio N, Infantino V, Convertini P, Console L, Palmieri F", "title": "The mitochondrial carnitine/acylcarnitine carrier: function, structure and physiopathology.", "journal": "Mol Aspects Med 32:223-33 (2011)", "doi": "10.1016/j.mam.2011.10.008"}, {"pmid": "26303601", "authors": "  McCoin CS, Knotts TA, Adams SH", "title": "Acylcarnitines--old actors auditioning for new roles in metabolic physiology.", "journal": "Nat Rev Endocrinol 11:617-25 (2015)", "doi": "10.1038/nrendo.2015.129"}], "rel_pathway": ["hsa00020  Citrate cycle (TCA cycle)", "hsa00190  Oxidative phosphorylation", "hsa04010  MAPK signaling pathway", "hsa04022  cGMP-PKG signaling pathway", "hsa04024  cAMP signaling pathway", "hsa04150  mTOR signaling pathway", "hsa04923  Regulation of lipolysis in adipocytes"], "ko_pathway": "ko04714", "genes": ["SOS1", "MAPK13", "NRAS"]}, {"kegg_id": "hsa04622", "name": "RIG-I-like receptor signaling pathway - Homo sapiens (human)", "description": "Specific families of pattern recognition receptors are responsible for detecting viral pathogens and generating innate immune responses. Non-self RNA appearing in a cell as a result of intracellular viral replication is recognized by a family of cytosolic RNA helicases termed RIG-I-like receptors (RLRs). The RLR proteins include RIG-I, MDA5, and LGP2 and are expressed in both immune and nonimmune cells. Upon recognition of viral nucleic acids, RLRs recruit specific intracellular adaptor proteins to initiate signaling pathways that lead to the synthesis of type I interferon and other inflammatory cytokines, which are important for eliminating viruses.", "class": "Organismal Systems; Immune system", "pathway_map": "hsa04622  RIG-I-like receptor signaling pathway", "network": ["", "ELEMENT   N00469  RIG-I-IRF7/3 signaling pathway", "N00688  RIG-I-NFKB signaling pathway", "N01308  MDA5-IRF7/3 signaling pathway", "N01564  Post-translational modifications of RIG-I and MDA5", "N01565  Adenosine-to-inosine RNA editing by ADAR"], "drug": ["D12352  Eclitasertib (USAN/INN)", "D12821  Flizasertib (USAN/INN)", "D12846  Ocadusertib (USAN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["23586  RIGI; RNA sensor RIG-I [KO:K12646] [EC:5.6.2.6]", "64135  IFIH1; interferon induced with helicase C domain 1 [KO:K12647] [EC:5.6.2.6]", "57169  ZNFX1; zinc finger NFX1-type containing 1 [KO:K27391]", "57506  MAVS; mitochondrial antiviral signaling protein [KO:K12648]", "79132  DHX58; DExH-box helicase 58 [KO:K12649] [EC:5.6.2.6]", "7187  TRAF3; TNF receptor associated factor 3 [KO:K03174]", "10010  TANK; TRAF family member associated NFKB activator [KO:K12650]", "64343  AZI2; 5-azacytidine induced 2 [KO:K12651]", "9755  TBKBP1; TBK1 binding protein 1 [KO:K12652]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "29110  TBK1; TANK binding kinase 1 [KO:K05410] [EC:2.7.11.10]", "9641  IKBKE; inhibitor of nuclear factor kappa B kinase subunit epsilon [KO:K07211] [EC:2.7.11.10]", "3661  IRF3; interferon regulatory factor 3 [KO:K05411]", "3665  IRF7; interferon regulatory factor 7 [KO:K09447]", "3439  IFNA1; interferon alpha 1 [KO:K05414]", "3440  IFNA2; interferon alpha 2 [KO:K05414]", "3441  IFNA4; interferon alpha 4 [KO:K05414]", "3442  IFNA5; interferon alpha 5 [KO:K05414]", "3443  IFNA6; interferon alpha 6 [KO:K05414]", "3444  IFNA7; interferon alpha 7 [KO:K05414]", "3445  IFNA8; interferon alpha 8 [KO:K05414]", "3446  IFNA10; interferon alpha 10 [KO:K05414]", "3447  IFNA13; interferon alpha 13 [KO:K05414]", "3448  IFNA14; interferon alpha 14 [KO:K05414]", "3449  IFNA16; interferon alpha 16 [KO:K05414]", "3451  IFNA17; interferon alpha 17 [KO:K05414]", "3452  IFNA21; interferon alpha 21 [KO:K05414]", "3456  IFNB1; interferon beta 1 [KO:K05415]", "3467  IFNW1; interferon omega 1 [KO:K05440]", "338376  IFNE; interferon epsilon [KO:K05442]", "56832  IFNK; interferon kappa [KO:K05441]", "8717  TRADD; TNFRSF1A associated via death domain [KO:K03171]", "8772  FADD; Fas associated via death domain [KO:K02373]", "8737  RIPK1; receptor interacting serine/threonine kinase 1 [KO:K02861] [EC:2.7.11.1]", "841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]", "843  CASP10; caspase 10 [KO:K04400] [EC:3.4.22.63]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "4793  NFKBIB; NFKB inhibitor beta [KO:K02581]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "7186  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]", "6885  MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO:K04427] [EC:2.7.11.25]", "7189  TRAF6; TNF receptor associated factor 6 [KO:K03175] [EC:2.3.2.27]", "4214  MAP3K1; mitogen-activated protein kinase kinase kinase 1 [KO:K04416] [EC:2.7.11.25]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "3576  CXCL8; C-X-C motif chemokine ligand 8 [KO:K10030]", "7124  TNF; tumor necrosis factor [KO:K03156]", "3592  IL12A; interleukin 12A [KO:K05406]", "3593  IL12B; interleukin 12B [KO:K05425]", "3627  CXCL10; C-X-C motif chemokine ligand 10 [KO:K12671]", "103  ADAR; adenosine deaminase RNA specific [KO:K12968] [EC:3.5.4.37]", "7706  TRIM25; tripartite motif containing 25 [KO:K10652] [EC:2.3.2.27]", "1540  CYLD; CYLD lysine 63 deubiquitinase [KO:K08601] [EC:3.4.19.12]", "54941  RNF125; ring finger protein 125 [KO:K12170] [EC:2.3.2.27]", "9636  ISG15; ISG15 ubiquitin like modifier [KO:K12159]", "9474  ATG5; autophagy related 5 [KO:K08339]", "9140  ATG12; autophagy related 12 [KO:K08336]", "79671  NLRX1; NLR family member X1 [KO:K12653]", "340061  STING1; stimulator of interferon response cGAMP interactor 1 [KO:K12654]", "55593  OTUD5; OTU deubiquitinase 5 [KO:K12655] [EC:3.4.19.12]", "80143  SIKE1; suppressor of IKBKE 1 [KO:K12656]", "1654  DDX3X; DEAD-box helicase 3 X-linked [KO:K11594] [EC:5.6.2.7]", "5300  PIN1; peptidylprolyl cis/trans isomerase, NIMA-interacting 1 [KO:K09578] [EC:5.2.1.8]", "26007  TKFC; triokinase and FMN cyclase [KO:K00863] [EC:2.7.1.28 2.7.1.29 4.6.1.15]"], "compound": ["C00046  RNA"], "refs": [{"pmid": "15208624", "authors": "  Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T", "title": "The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses.", "journal": "Nat Immunol 5:730-7 (2004)", "doi": "10.1038/ni1087"}, {"pmid": "18272355", "authors": "  Takeuchi O, Akira S", "title": "MDA5/RIG-I and virus recognition.", "journal": "Curr Opin Immunol 20:17-22 (2008)", "doi": "10.1016/j.coi.2008.01.002"}, {"pmid": "19120475", "authors": "  Yoneyama M, Fujita T", "title": "RNA recognition and signal transduction by RIG-I-like receptors.", "journal": "Immunol Rev 227:54-65 (2009)", "doi": "10.1111/j.1600-065X.2008.00727.x"}, {"pmid": "19539500", "authors": "  Nakhaei P, Genin P, Civas A, Hiscott J", "title": "RIG-I-like receptors: sensing and responding to RNA virus infection.", "journal": "Semin Immunol 21:215-22 (2009)", "doi": "10.1016/j.smim.2009.05.001"}, {"pmid": "18549796", "authors": "  Moore CB, Ting JP", "title": "Regulation of mitochondrial antiviral signaling pathways.", "journal": "Immunity 28:735-9 (2008)", "doi": "10.1016/j.immuni.2008.05.005"}, {"pmid": "19615405", "authors": "  Barral PM, Sarkar D, Su ZZ, Barber GN, DeSalle R, Racaniello VR, Fisher PB", "title": "Functions of the cytoplasmic RNA sensors RIG-I and MDA-5: key regulators of innate immunity.", "journal": "Pharmacol Ther 124:219-34 (2009)", "doi": "10.1016/j.pharmthera.2009.06.012"}, {"pmid": "19120476", "authors": "  Schlee M, Hartmann E, Coch C, Wimmenauer V, Janke M, Barchet W, Hartmann G", "title": "Approaching the RNA ligand for RIG-I?", "journal": "Immunol Rev 227:66-74 (2009)", "doi": "10.1111/j.1600-065X.2008.00724.x"}, {"pmid": "18591413", "authors": "  Saito T, Gale M Jr", "title": "Differential recognition of double-stranded RNA by RIG-I-like receptors in antiviral immunity.", "journal": "J Exp Med 205:1523-7 (2008)", "doi": "10.1084/jem.20081210"}, {"pmid": "19076341", "authors": "  Kawai T, Akira S", "title": "Toll-like receptor and RIG-I-like receptor signaling.", "journal": "Ann N Y Acad Sci 1143:1-20 (2008)", "doi": "10.1196/annals.1443.020"}, {"pmid": "18439848", "authors": "  Michallet MC, Meylan E, Ermolaeva MA, Vazquez J, Rebsamen M, Curran J, Poeck H, Bscheider M, Hartmann G, Konig M, Kalinke U, Pasparakis M, Tschopp J", "title": "TRADD protein is an essential component of the RIG-like helicase antiviral pathway.", "journal": "Immunity 28:651-61 (2008)", "doi": "10.1016/j.immuni.2008.03.013"}, {"pmid": "18984593", "authors": "  Yoshida R, Takaesu G, Yoshida H, Okamoto F, Yoshioka T, Choi Y, Akira S, Kawai T, Yoshimura A, Kobayashi T", "title": "TRAF6 and MEKK1 play a pivotal role in the RIG-I-like helicase antiviral pathway.", "journal": "J Biol Chem 283:36211-20 (2008)", "doi": "10.1074/jbc.M806576200"}, {"pmid": "19224920", "authors": "  Mikkelsen SS, Jensen SB, Chiliveru S, Melchjorsen J, Julkunen I, Gaestel M, Arthur JS, Flavell RA, Ghosh S, Paludan SR", "title": "RIG-I-mediated activation of p38 MAPK is essential for viral induction of interferon and activation of dendritic cells: dependence on TRAF2 and TAK1.", "journal": "J Biol Chem 284:10774-82 (2009)", "doi": "10.1074/jbc.M807272200"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04120  Ubiquitin mediated proteolysis", "hsa04210  Apoptosis", "hsa04630  JAK-STAT signaling pathway"], "ko_pathway": "ko04622", "genes": ["MAPK13"]}, {"kegg_id": "hsa04657", "name": "IL-17 signaling pathway - Homo sapiens (human)", "description": "The interleukin 17 (IL-17) family, a subset of cytokines consisting of IL-17A-F, plays crucial roles in both acute and chronic inflammatory responses. IL-17A, the hallmark cytokine of the newly defined T helper 17 (TH17) cell subset, has important roles in protecting the host against extracellular pathogens, but also promotes inflammatory pathology in autoimmune disease, whereas IL-17F is mainly involved in mucosal host defense mechanisms. IL-17E (IL-25) is an amplifier of Th2 immune responses. IL-17C has biological functions similar to those of IL-17A. The functions of IL-17B and IL-17D remain largely elusive. The IL-17 family signals via their correspondent receptors and activates downstream pathways that include NF-kappaB, MAPKs and C/EBPs to induce the expression of antimicrobial peptides, cytokines and chemokines. The receptor proximal adaptor Act1 (an NF-kappaB activator 1) is considered as the master mediator in IL-17A signaling. It is likely that Act1 is a common signal adaptor also shared by other members mediated signalings in this family.", "class": "Organismal Systems; Immune system", "pathway_map": "hsa04657  IL-17 signaling pathway", "drug": ["D03116  Bindarit (USAN/INN)", "D03517  Cipemastat (USAN/INN)", "D03800  Rebimastat (USAN/INN)", "D10061  Brodalumab (USAN)", "D10071  Ixekizumab (USAN)", "D10902  Afasevikumab (USAN/INN)", "D11127  Tibulizumab (USAN/INN)", "D11343  Otilimab (USAN)", "D11550  Bimekizumab (USAN/INN)", "D12278  Izokibep (USAN/INN)"], "dblinks": ["GO: 0097400"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["64806  IL25; interleukin 25 [KO:K05493]", "23765  IL17RA; interleukin 17 receptor A [KO:K05164]", "55540  IL17RB; interleukin 17 receptor B [KO:K05165]", "8717  TRADD; TNFRSF1A associated via death domain [KO:K03171]", "8772  FADD; Fas associated via death domain [KO:K02373]", "836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]", "841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]", "10758  TRAF3IP2; TRAF3 interacting protein 2 [KO:K21124]", "7189  TRAF6; TNF receptor associated factor 6 [KO:K03175] [EC:2.3.2.27]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "2354  FOSB; FosB proto-oncogene, AP-1 transcription factor subunit [KO:K09029]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "3727  JUND; JunD proto-oncogene, AP-1 transcription factor subunit [KO:K04449]", "8061  FOSL1; FOS like 1, AP-1 transcription factor subunit [KO:K04502]", "3565  IL4; interleukin 4 [KO:K05430]", "3567  IL5; interleukin 5 [KO:K05428]", "3596  IL13; interleukin 13 [KO:K05435]", "6361  CCL17; C-C motif chemokine ligand 17 [KO:K21083]", "6356  CCL11; C-C motif chemokine ligand 11 [KO:K16597]", "3605  IL17A; interleukin 17A [KO:K05489]", "112744  IL17F; interleukin 17F [KO:K05494]", "84818  IL17RC; interleukin 17 receptor C [KO:K05166]", "7187  TRAF3; TNF receptor associated factor 3 [KO:K03174]", "51433  ANAPC5; anaphase promoting complex subunit 5 [KO:K03352]", "7128  TNFAIP3; TNF alpha induced protein 3 [KO:K11859] [EC:3.4.19.12]", "3320  HSP90AA1; heat shock protein 90 alpha family class A member 1 [KO:K04079]", "3326  HSP90AB1; heat shock protein 90 alpha family class B member 1 [KO:K04079]", "7184  HSP90B1; heat shock protein 90 beta family member 1 [KO:K09487]", "29110  TBK1; TANK binding kinase 1 [KO:K05410] [EC:2.7.11.10]", "23118  TAB2; TGF-beta activated kinase 1 (MAP3K7) binding protein 2 [KO:K04404]", "257397  TAB3; TGF-beta activated kinase 1 (MAP3K7) binding protein 3 [KO:K12793]", "6885  MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO:K04427] [EC:2.7.11.25]", "8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]", "1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]", "3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "5596  MAPK4; mitogen-activated protein kinase 4 [KO:K06855] [EC:2.7.11.24]", "5597  MAPK6; mitogen-activated protein kinase 6 [KO:K06855] [EC:2.7.11.24]", "5598  MAPK7; mitogen-activated protein kinase 7 [KO:K04464] [EC:2.7.11.24]", "225689  MAPK15; mitogen-activated protein kinase 15 [KO:K19603] [EC:2.7.11.24]", "1051  CEBPB; CCAAT enhancer binding protein beta [KO:K10048]", "9618  TRAF4; TNF receptor associated factor 4 [KO:K09848]", "9641  IKBKE; inhibitor of nuclear factor kappa B kinase subunit epsilon [KO:K07211] [EC:2.7.11.10]", "29761  USP25; ubiquitin specific peptidase 25 [KO:K11849] [EC:3.4.19.12]", "7188  TRAF5; TNF receptor associated factor 5 [KO:K09849]", "7186  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]", "6426  SRSF1; serine and arginine rich splicing factor 1 [KO:K12890]", "1994  ELAVL1; ELAV like RNA binding protein 1 [KO:K13088]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "2919  CXCL1; C-X-C motif chemokine ligand 1 [KO:K05505]", "2920  CXCL2; C-X-C motif chemokine ligand 2 [KO:K05505]", "2921  CXCL3; C-X-C motif chemokine ligand 3 [KO:K05505]", "6374  CXCL5; C-X-C motif chemokine ligand 5 [KO:K05506]", "6372  CXCL6; C-X-C motif chemokine ligand 6 [KO:K05506]", "3576  CXCL8; C-X-C motif chemokine ligand 8 [KO:K10030]", "3627  CXCL10; C-X-C motif chemokine ligand 10 [KO:K12671]", "6347  CCL2; C-C motif chemokine ligand 2 [KO:K14624]", "6354  CCL7; C-C motif chemokine ligand 7 [KO:K05509]", "6364  CCL20; C-C motif chemokine ligand 20 [KO:K14625]", "3569  IL6; interleukin 6 [KO:K05405]", "7124  TNF; tumor necrosis factor [KO:K03156]", "5743  PTGS2; prostaglandin-endoperoxide synthase 2 [KO:K11987] [EC:1.14.99.1]", "1440  CSF3; colony stimulating factor 3 [KO:K05423]", "1437  CSF2; colony stimulating factor 2 [KO:K05427]", "1673  DEFB4A; defensin beta 4A [KO:K21100]", "100289462  DEFB4B; defensin beta 4B [KO:K21100]", "727897  MUC5B; mucin 5B, oligomeric mucus/gel-forming [KO:K13908]", "4586  MUC5AC; mucin 5AC, oligomeric mucus/gel-forming [KO:K13908]", "6278  S100A7; S100 calcium binding protein A7 [KO:K21126]", "338324  S100A7A; S100 calcium binding protein A7A [KO:K21126]", "6279  S100A8; S100 calcium binding protein A8 [KO:K21127]", "6280  S100A9; S100 calcium binding protein A9 [KO:K21128]", "3934  LCN2; lipocalin 2 [KO:K21129]", "4312  MMP1; matrix metallopeptidase 1 [KO:K01388] [EC:3.4.24.7]", "4314  MMP3; matrix metallopeptidase 3 [KO:K01394] [EC:3.4.24.17]", "4318  MMP9; matrix metallopeptidase 9 [KO:K01403] [EC:3.4.24.35]", "4322  MMP13; matrix metallopeptidase 13 [KO:K07994] [EC:3.4.24.-]", "27189  IL17C; interleukin 17C [KO:K05491]", "132014  IL17RE; interleukin 17 receptor E [KO:K05168]", "3553  IL1B; interleukin 1 beta [KO:K04519]", "3458  IFNG; interferon gamma [KO:K04687]", "27190  IL17B; interleukin 17B [KO:K05490]", "53342  IL17D; interleukin 17D [KO:K05492]"], "refs": [{"pmid": "23917206", "authors": "  Song X, Qian Y", "title": "IL-17 family cytokines mediated signaling in the pathogenesis of inflammatory diseases.", "journal": "Cell Signal 25:2335-47 (2013)", "doi": "10.1016/j.cellsig.2013.07.021"}, {"pmid": "23557798", "authors": "  Song X, Qian Y", "title": "The activation and regulation of IL-17 receptor mediated signaling.", "journal": "Cytokine 62:175-82 (2013)", "doi": "10.1016/j.cyto.2013.03.014"}, {"pmid": "24011563", "authors": "  Gu C, Wu L, Li X", "title": "IL-17 family: cytokines, receptors and signaling.", "journal": "Cytokine 64:477-85 (2013)", "doi": "10.1016/j.cyto.2013.07.022"}, {"pmid": "25145755", "authors": "  Gaffen SL, Jain R, Garg AV, Cua DJ", "title": "The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing.", "journal": "Nat Rev Immunol 14:585-600 (2014)", "doi": "10.1038/nri3707"}, {"pmid": "21349428", "authors": "  Iwakura Y, Ishigame H, Saijo S, Nakae S", "title": "Functional specialization of interleukin-17 family members.", "journal": "Immunity 34:149-62 (2011)", "doi": "10.1016/j.immuni.2011.02.012"}, {"pmid": "20514051", "authors": "  Qian Y, Kang Z, Liu C, Li X", "title": "IL-17 signaling in host defense and inflammatory diseases.", "journal": "Cell Mol Immunol 7:328-33 (2010)", "doi": "10.1038/cmi.2010.27"}, {"pmid": "22324470", "authors": "  Zhu S, Qian Y", "title": "IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential.", "journal": "Clin Sci (Lond) 122:487-511 (2012)", "doi": "10.1042/CS20110496"}, {"pmid": "26252407", "authors": "  Zenobia C, Hajishengallis G", "title": "Basic biology and role of interleukin-17 in immunity and inflammation.", "journal": "Periodontol 2000 69:142-59 (2015)", "doi": "10.1111/prd.12083"}, {"pmid": "21074482", "authors": "  Reynolds JM, Angkasekwinai P, Dong C", "title": "IL-17 family member cytokines: regulation and function in innate immunity.", "journal": "Cytokine Growth Factor Rev 21:413-23 (2010)", "doi": "10.1016/j.cytogfr.2010.10.002"}, {"pmid": "21852080", "authors": "  Gaffen SL", "title": "Recent advances in the IL-17 cytokine family.", "journal": "Curr Opin Immunol 23:613-9 (2011)", "doi": "10.1016/j.coi.2011.07.006"}, {"pmid": "18701318", "authors": "  Gaffen SL", "title": "An overview of IL-17 function and signaling.", "journal": "Cytokine 43:402-7 (2008)", "doi": "10.1016/j.cyto.2008.07.017"}, {"pmid": "21155836", "authors": "  Hu Y, Shen F, Crellin NK, Ouyang W", "title": "The IL-17 pathway as a major therapeutic target in autoimmune diseases.", "journal": "Ann N Y Acad Sci 1217:60-76 (2011)", "doi": "10.1111/j.1749-6632.2010.05825.x"}, {"pmid": "20383173", "authors": "  Xu S, Cao X", "title": "Interleukin-17 and its expanding biological functions.", "journal": "Cell Mol Immunol 7:164-74 (2010)", "doi": "10.1038/cmi.2010.21"}, {"pmid": "20177959", "authors": "  Pappu R, Ramirez-Carrozzi V, Ota N, Ouyang W, Hu Y", "title": "The IL-17 family cytokines in immunity and disease.", "journal": "J Clin Immunol 30:185-95 (2010)", "doi": "10.1007/s10875-010-9369-6"}, {"pmid": "19575028", "authors": "  Gaffen SL", "title": "Structure and signalling in the IL-17 receptor family.", "journal": "Nat Rev Immunol 9:556-67 (2009)", "doi": "10.1038/nri2586"}, {"pmid": "18178098", "authors": "  Shen F, Gaffen SL", "title": "Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy.", "journal": "Cytokine 41:92-104 (2008)", "doi": "10.1016/j.cyto.2007.11.013"}, {"pmid": "23116200", "authors": "  Doyle MS, Collins ES, FitzGerald OM, Pennington SR", "title": "New insight into the functions of the interleukin-17 receptor adaptor protein Act1 in psoriatic arthritis.", "journal": "Arthritis Res Ther 14:226 (2012)", "doi": "10.1186/ar4071"}, {"pmid": "17027518", "authors": "  Gaffen SL, Kramer JM, Yu JJ, Shen F", "title": "The IL-17 cytokine family.", "journal": "Vitam Horm 74:255-82 (2006)", "doi": "10.1016/S0083-6729(06)74010-9"}, {"pmid": "21130872", "authors": "  Chang SH, Dong C", "title": "Signaling of interleukin-17 family cytokines in immunity and inflammation.", "journal": "Cell Signal 23:1069-75 (2011)", "doi": "10.1016/j.cellsig.2010.11.022"}, {"pmid": "17921324", "authors": "  Cortez DM, Feldman MD, Mummidi S, Valente AJ, Steffensen B, Vincenti M, Barnes JL, Chandrasekar B", "title": "IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-beta , NF-kappaB, and AP-1 activation.", "journal": "Am J Physiol Heart Circ Physiol 293:H3356-65 (2007)", "doi": "10.1152/ajpheart.00928.2007"}, {"pmid": "22851696", "authors": "  Qu F, Gao H, Zhu S, Shi P, Zhang Y, Liu Y, Jallal B, Yao Y, Shi Y, Qian Y", "title": "TRAF6-dependent Act1 phosphorylation by the IkappaB kinase-related kinases suppresses interleukin-17-induced NF-kappaB activation.", "journal": "Mol Cell Biol 32:3925-37 (2012)", "doi": "10.1128/MCB.00268-12"}], "rel_pathway": ["hsa04010  MAPK signaling pathway", "hsa04060  Cytokine-cytokine receptor interaction", "hsa04064  NF-kappa B signaling pathway", "hsa04210  Apoptosis", "hsa04659  Th17 cell differentiation"], "ko_pathway": "ko04657", "genes": ["MAPK13"]}, {"kegg_id": "hsa04723", "name": "Retrograde endocannabinoid signaling - Homo sapiens (human)", "description": "Endogenous cannabinoids (endocannabinoids) serve as retrograde messengers at synapses in various regions of the brain. The family of endocannabinoids includes at least five derivatives of arachidonic acid; the two best characterized are arachydonoyl ethanolamide (anandamide, AEA) and 2-arachydonoil glycerol (2AG). They are released from postsynaptic neurons upon postsynaptic depolarization and/or receptor activation. The released endocannabinoids then activate the CB1 receptors (CB1R) at presynaptic terminals and suppress the release of inhibitory transmitter GABA (depolarization-induced suppression of inhibition, DSI) or excitatory transmitter glutamate (depolarization-induced suppression of excitation, DSE) by inhibiting Ca2+ channels. Besides the well-known expression of the CB1R in the plasma membrane, this receptor is also present in mitochondrial membranes, where it reduces the mitochondrial respiration and contributes to DSI. Whereas DSI and DSE result in short-term synaptic plasticity, endocannabinoids also mediate long-term synaptic changes (eCB-LTD). Persistent activation of CB1 receptors over a period of minutes triggers eCB-LTD by a RIM1alpha-dependent mechanism.", "class": "Organismal Systems; Nervous system", "pathway_map": "hsa04723  Retrograde endocannabinoid signaling", "drug": ["D04717  Levonantradol hydrochloride (USAN)", "D05117  Nantradol hydrochloride (USAN)", "D05731  Rimonabant (JAN/USAN/INN)", "D11435  Nimacimab (USAN)", "D12382  Alogabat (USAN)"], "dblinks": ["GO: 0071926"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["57084  SLC17A6; solute carrier family 17 member 6 [KO:K12302]", "246213  SLC17A8; solute carrier family 17 member 8 [KO:K12302]", "57030  SLC17A7; solute carrier family 17 member 7 [KO:K12302]", "2890  GRIA1; glutamate ionotropic receptor AMPA type subunit 1 [KO:K05197]", "2891  GRIA2; glutamate ionotropic receptor AMPA type subunit 2 [KO:K05198]", "2892  GRIA3; glutamate ionotropic receptor AMPA type subunit 3 [KO:K05199]", "2893  GRIA4; glutamate ionotropic receptor AMPA type subunit 4 [KO:K05200]", "775  CACNA1C; calcium voltage-gated channel subunit alpha1 C [KO:K04850]", "776  CACNA1D; calcium voltage-gated channel subunit alpha1 D [KO:K04851]", "778  CACNA1F; calcium voltage-gated channel subunit alpha1 F [KO:K04853]", "779  CACNA1S; calcium voltage-gated channel subunit alpha1 S [KO:K04857]", "2911  GRM1; glutamate metabotropic receptor 1 [KO:K04603]", "2915  GRM5; glutamate metabotropic receptor 5 [KO:K04604]", "2776  GNAQ; G protein subunit alpha q [KO:K04634]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "222236  NAPEPLD; N-acyl phosphatidylethanolamine phospholipase D [KO:K13985] [EC:3.1.4.54]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "747  DAGLA; diacylglycerol lipase alpha [KO:K13806] [EC:3.1.1.116]", "221955  DAGLB; diacylglycerol lipase beta [KO:K13806] [EC:3.1.1.116]", "5743  PTGS2; prostaglandin-endoperoxide synthase 2 [KO:K11987] [EC:1.14.99.1]", "57406  ABHD6; abhydrolase domain containing 6, acylglycerol lipase [KO:K13700] [EC:3.1.1.23]", "2166  FAAH; fatty acid amide hydrolase [KO:K15528] [EC:3.5.1.99]", "1268  CNR1; cannabinoid receptor 1 [KO:K04277]", "2770  GNAI1; G protein subunit alpha i1 [KO:K04630]", "2773  GNAI3; G protein subunit alpha i3 [KO:K04630]", "2771  GNAI2; G protein subunit alpha i2 [KO:K04630]", "2775  GNAO1; G protein subunit alpha o1 [KO:K04534]", "2782  GNB1; G protein subunit beta 1 [KO:K04536]", "2783  GNB2; G protein subunit beta 2 [KO:K04537]", "2784  GNB3; G protein subunit beta 3 [KO:K07825]", "59345  GNB4; G protein subunit beta 4 [KO:K04538]", "10681  GNB5; G protein subunit beta 5 [KO:K04539]", "54331  GNG2; G protein subunit gamma 2 [KO:K07826]", "2785  GNG3; G protein subunit gamma 3 [KO:K04540]", "2786  GNG4; G protein subunit gamma 4 [KO:K04541]", "2787  GNG5; G protein subunit gamma 5 [KO:K04542]", "2788  GNG7; G protein subunit gamma 7 [KO:K04543]", "94235  GNG8; G protein subunit gamma 8 [KO:K04544]", "2790  GNG10; G protein subunit gamma 10 [KO:K04545]", "2791  GNG11; G protein subunit gamma 11 [KO:K04546]", "55970  GNG12; G protein subunit gamma 12 [KO:K04347]", "51764  GNG13; G protein subunit gamma 13 [KO:K04547]", "2792  GNGT1; G protein subunit gamma transducin 1 [KO:K04548]", "2793  GNGT2; G protein subunit gamma transducin 2 [KO:K04549]", "3760  KCNJ3; potassium inwardly rectifying channel subfamily J member 3 [KO:K04997]", "3763  KCNJ6; potassium inwardly rectifying channel subfamily J member 6 [KO:K05000]", "3765  KCNJ9; potassium inwardly rectifying channel subfamily J member 9 [KO:K05002]", "3762  KCNJ5; potassium inwardly rectifying channel subfamily J member 5 [KO:K04999]", "773  CACNA1A; calcium voltage-gated channel subunit alpha1 A [KO:K04344]", "774  CACNA1B; calcium voltage-gated channel subunit alpha1 B [KO:K04849]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]", "108  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]", "109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]", "196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]", "113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]", "114  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]", "115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "11343  MGLL; monoglyceride lipase [KO:K01054] [EC:3.1.1.23]", "4535  ND1; NADH dehydrogenase subunit 1 [KO:K03878] [EC:7.1.1.2]", "4536  ND2; NADH dehydrogenase subunit 2 [KO:K03879] [EC:7.1.1.2]", "4537  ND3; NADH dehydrogenase subunit 3 [KO:K03880] [EC:7.1.1.2]", "4538  ND4; NADH dehydrogenase subunit 4 [KO:K03881] [EC:7.1.1.2]", "4539  ND4L; NADH dehydrogenase subunit 4L [KO:K03882] [EC:7.1.1.2]", "4540  ND5; NADH dehydrogenase subunit 5 [KO:K03883] [EC:7.1.1.2]", "4541  ND6; NADH dehydrogenase subunit 6 [KO:K03884] [EC:7.1.1.2]", "4723  NDUFV1; NADH:ubiquinone oxidoreductase core subunit V1 [KO:K03942] [EC:7.1.1.2]", "4729  NDUFV2; NADH:ubiquinone oxidoreductase core subunit V2 [KO:K03943] [EC:7.1.1.2]", "4731  NDUFV3; NADH:ubiquinone oxidoreductase subunit V3 [KO:K03944]", "4694  NDUFA1; NADH:ubiquinone oxidoreductase subunit A1 [KO:K03945]", "4695  NDUFA2; NADH:ubiquinone oxidoreductase subunit A2 [KO:K03946]", "4696  NDUFA3; NADH:ubiquinone oxidoreductase subunit A3 [KO:K03947]", "4697  NDUFA4; NDUFA4 mitochondrial complex associated [KO:K03948]", "56901  NDUFA4L2; NDUFA4 mitochondrial complex associated like 2 [KO:K03948]", "4698  NDUFA5; NADH:ubiquinone oxidoreductase subunit A5 [KO:K03949]", "4700  NDUFA6; NADH:ubiquinone oxidoreductase subunit A6 [KO:K03950]", "4701  NDUFA7; NADH:ubiquinone oxidoreductase subunit A7 [KO:K03951]", "4702  NDUFA8; NADH:ubiquinone oxidoreductase subunit A8 [KO:K03952]", "4704  NDUFA9; NADH:ubiquinone oxidoreductase subunit A9 [KO:K03953]", "4705  NDUFA10; NADH:ubiquinone oxidoreductase subunit A10 [KO:K03954]", "4706  NDUFAB1; NADH:ubiquinone oxidoreductase subunit AB1 [KO:K03955]", "126328  NDUFA11; NADH:ubiquinone oxidoreductase subunit A11 [KO:K03956]", "55967  NDUFA12; NADH:ubiquinone oxidoreductase subunit A12 [KO:K11352]", "51079  NDUFA13; NADH:ubiquinone oxidoreductase subunit A13 [KO:K11353]", "4707  NDUFB1; NADH:ubiquinone oxidoreductase subunit B1 [KO:K03957]", "4708  NDUFB2; NADH:ubiquinone oxidoreductase subunit B2 [KO:K03958]", "4709  NDUFB3; NADH:ubiquinone oxidoreductase subunit B3 [KO:K03959]", "4710  NDUFB4; NADH:ubiquinone oxidoreductase subunit B4 [KO:K03960]", "4711  NDUFB5; NADH:ubiquinone oxidoreductase subunit B5 [KO:K03961]", "4712  NDUFB6; NADH:ubiquinone oxidoreductase subunit B6 [KO:K03962]", "4713  NDUFB7; NADH:ubiquinone oxidoreductase subunit B7 [KO:K03963]", "4714  NDUFB8; NADH:ubiquinone oxidoreductase subunit B8 [KO:K03964]", "4715  NDUFB9; NADH:ubiquinone oxidoreductase subunit B9 [KO:K03965]", "4716  NDUFB10; NADH:ubiquinone oxidoreductase subunit B10 [KO:K03966]", "54539  NDUFB11; NADH:ubiquinone oxidoreductase subunit B11 [KO:K11351]", "4719  NDUFS1; NADH:ubiquinone oxidoreductase core subunit S1 [KO:K03934] [EC:7.1.1.2]", "4720  NDUFS2; NADH:ubiquinone oxidoreductase core subunit S2 [KO:K03935] [EC:7.1.1.2]", "4722  NDUFS3; NADH:ubiquinone oxidoreductase core subunit S3 [KO:K03936] [EC:7.1.1.2]", "4724  NDUFS4; NADH:ubiquinone oxidoreductase subunit S4 [KO:K03937]", "4725  NDUFS5; NADH:ubiquinone oxidoreductase subunit S5 [KO:K03938]", "4726  NDUFS6; NADH:ubiquinone oxidoreductase subunit S6 [KO:K03939]", "374291  NDUFS7; NADH:ubiquinone oxidoreductase core subunit S7 [KO:K03940] [EC:7.1.1.2]", "4728  NDUFS8; NADH:ubiquinone oxidoreductase core subunit S8 [KO:K03941] [EC:7.1.1.2]", "4717  NDUFC1; NADH:ubiquinone oxidoreductase subunit C1 [KO:K03967]", "4718  NDUFC2; NADH:ubiquinone oxidoreductase subunit C2 [KO:K03968]", "100532726  NDUFC2-KCTD14; NDUFC2-KCTD14 readthrough [KO:K03968]", "140679  SLC32A1; solute carrier family 32 member 1 [KO:K15015]", "22999  RIMS1; regulating synaptic membrane exocytosis 1 [KO:K15291]", "2554  GABRA1; gamma-aminobutyric acid type A receptor subunit alpha1 [KO:K05175]", "2555  GABRA2; gamma-aminobutyric acid type A receptor subunit alpha2 [KO:K05175]", "2556  GABRA3; gamma-aminobutyric acid type A receptor subunit alpha3 [KO:K05175]", "2557  GABRA4; gamma-aminobutyric acid type A receptor subunit alpha4 [KO:K05175]", "2558  GABRA5; gamma-aminobutyric acid type A receptor subunit alpha5 [KO:K05175]", "2559  GABRA6; gamma-aminobutyric acid type A receptor subunit alpha6 [KO:K05175]", "2560  GABRB1; gamma-aminobutyric acid type A receptor subunit beta1 [KO:K05181]", "2562  GABRB3; gamma-aminobutyric acid type A receptor subunit beta3 [KO:K05181]", "2561  GABRB2; gamma-aminobutyric acid type A receptor subunit beta2 [KO:K05181]", "2565  GABRG1; gamma-aminobutyric acid type A receptor subunit gamma1 [KO:K05186]", "2566  GABRG2; gamma-aminobutyric acid type A receptor subunit gamma2 [KO:K05186]", "2567  GABRG3; gamma-aminobutyric acid type A receptor subunit gamma3 [KO:K05186]", "2563  GABRD; gamma-aminobutyric acid type A receptor subunit delta [KO:K05184]", "2564  GABRE; gamma-aminobutyric acid type A receptor subunit epsilon [KO:K05185]", "55879  GABRQ; gamma-aminobutyric acid type A receptor subunit theta [KO:K05192]", "2568  GABRP; gamma-aminobutyric acid type A receptor subunit pi [KO:K05189]", "2569  GABRR1; gamma-aminobutyric acid type A receptor subunit rho1 [KO:K05190]", "2570  GABRR2; gamma-aminobutyric acid type A receptor subunit rho2 [KO:K05190]", "200959  GABRR3; gamma-aminobutyric acid type A receptor subunit rho3 [KO:K05190]"], "compound": ["C00025  L-Glutamate", "C00076  Calcium cation", "C00116  Glycerol", "C00157  Phosphatidylcholine", "C00165  Diacylglycerol", "C00189  Ethanolamine", "C00219  Arachidonate", "C00238  Potassium cation", "C00334  4-Aminobutanoate", "C00350  Phosphatidylethanolamine", "C00427  Prostaglandin H2", "C00575  3',5'-Cyclic AMP", "C00689  alpha,alpha'-Trehalose 6-phosphate", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C01330  Sodium cation", "C11695  Anandamide", "C13856  2-Arachidonoylglycerol", "C19912  N-Arachidonoyl-phosphatidylethanolamine", "C19913  Phospho-anandamide"], "refs": [{"pmid": "17419048", "authors": "  Hashimotodani Y, Ohno-Shosaku T, Kano M", "title": "Ca(2+)-assisted receptor-driven endocannabinoid release: mechanisms that associate presynaptic and postsynaptic activities.", "journal": "Curr Opin Neurobiol 17:360-5 (2007)", "doi": "10.1016/j.conb.2007.03.012"}, {"pmid": "21531987", "authors": "  Ohno-Shosaku T, Tanimura A, Hashimotodani Y, Kano M", "title": "Endocannabinoids and retrograde modulation of synaptic transmission.", "journal": "Neuroscientist 18:119-32 (2012)", "doi": "10.1177/1073858410397377"}, {"pmid": "18084639", "authors": "  Basavarajappa BS", "title": "Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity.", "journal": "Curr Neuropharmacol 5:81-97 (2007)", "doi": "10.2174/157015907780866910"}, {"pmid": "16968947", "authors": "  Pacher P, Batkai S, Kunos G", "title": "The endocannabinoid system as an emerging target of pharmacotherapy.", "journal": "Pharmacol Rev 58:389-462 (2006)", "doi": "10.1124/pr.58.3.2"}, {"pmid": "15340387", "authors": "  Di Marzo V, Bifulco M, De Petrocellis L", "title": "The endocannabinoid system and its therapeutic exploitation.", "journal": "Nat Rev Drug Discov 3:771-84 (2004)", "doi": "10.1038/nrd1495"}, {"pmid": "17404373", "authors": "  Hashimotodani Y, Ohno-Shosaku T, Kano M", "title": "Endocannabinoids and synaptic function in the CNS.", "journal": "Neuroscientist 13:127-37 (2007)", "doi": "10.1177/1073858406296716"}, {"pmid": "19126760", "authors": "  Kano M, Ohno-Shosaku T, Hashimotodani Y, Uchigashima M, Watanabe M", "title": "Endocannabinoid-mediated control of synaptic transmission.", "journal": "Physiol Rev 89:309-80 (2009)", "doi": "10.1152/physrev.00019.2008"}, {"pmid": "19640475", "authors": "  Regehr WG, Carey MR, Best AR", "title": "Activity-dependent regulation of synapses by retrograde messengers.", "journal": "Neuron 63:154-70 (2009)", "doi": "10.1016/j.neuron.2009.06.021"}, {"pmid": "17636069", "authors": "  Benarroch E", "title": "Endocannabinoids in basal ganglia circuits: implications for Parkinson disease.", "journal": "Neurology 69:306-9 (2007)", "doi": "10.1212/01.wnl.0000267407.79757.75"}, {"pmid": "16085309", "authors": "  Ohno-Shosaku T, Hashimotodani Y, Maejima T, Kano M", "title": "Calcium signaling and synaptic modulation: regulation of endocannabinoid-mediated synaptic modulation by calcium.", "journal": "Cell Calcium 38:369-74 (2005)", "doi": "10.1016/j.ceca.2005.06.014"}, {"pmid": "18801434", "authors": "  Harkany T, Mackie K, Doherty P", "title": "Wiring and firing neuronal networks: endocannabinoids take center stage.", "journal": "Curr Opin Neurobiol 18:338-45 (2008)", "doi": "10.1016/j.conb.2008.08.007"}, {"pmid": "18515270", "authors": "  Hosking RD, Zajicek JP", "title": "Therapeutic potential of cannabis in pain medicine.", "journal": "Br J Anaesth 101:59-68 (2008)", "doi": "10.1093/bja/aen119"}, {"pmid": "21187849", "authors": "  Di Marzo V", "title": "Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight.", "journal": "Nat Neurosci 14:9-15 (2011)", "doi": "10.1038/nn.2720"}, {"pmid": "18948642", "authors": "  McPartland JM", "title": "The endocannabinoid system: an osteopathic perspective.", "journal": "J Am Osteopath Assoc 108:586-600 (2008)", "doi": "10.7556/jaoa.2008.108.10.586"}, {"pmid": "17553427", "authors": "  Chevaleyre V, Heifets BD, Kaeser PS, Sudhof TC, Castillo PE", "title": "Endocannabinoid-mediated long-term plasticity requires cAMP/PKA signaling and RIM1alpha.", "journal": "Neuron 54:801-12 (2007)", "doi": "10.1016/j.neuron.2007.05.020"}, {"pmid": "19553483", "authors": "  Lafourcade CA", "title": "Presynaptic mechanisms of endocannabinoid-mediated long-term depression in the hippocampus.", "journal": "J Neurophysiol 102:2009-12 (2009)", "doi": "10.1152/jn.00441.2009"}, {"pmid": "21328621", "authors": "  Ueda N, Tsuboi K, Uyama T, Ohnishi T", "title": "Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol.", "journal": "Biofactors 37:1-7 (2011)", "doi": "10.1002/biof.131"}, {"pmid": "14978245", "authors": "  Guo J, Ikeda SR", "title": "Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons.", "journal": "Mol Pharmacol 65:665-74 (2004)", "doi": "10.1124/mol.65.3.665"}, {"pmid": "22388959", "authors": "  Benard G, Massa F, Puente N, Lourenco J, Bellocchio L, Soria-Gomez E, Matias I, Delamarre A, Metna-Laurent M, Cannich A, Hebert-Chatelain E, Mulle C, Ortega-Gutierrez S, Martin-Fontecha M, Klugmann M, Guggenhuber S, Lutz B, Gertsch J, Chaouloff F, Lopez-Rodriguez ML, Grandes P, Rossignol R, Marsicano G", "title": "Mitochondrial CB(1) receptors regulate neuronal energy metabolism.", "journal": "Nat Neurosci 15:558-64 (2012)", "doi": "10.1038/nn.3053"}, {"pmid": "26260530", "authors": "  Busquets-Garcia A, Desprez T, Metna-Laurent M, Bellocchio L, Marsicano G, Soria-Gomez E", "title": "Dissecting the cannabinergic control of behavior: The where matters.", "journal": "Bioessays 37:1215-25 (2015)", "doi": "10.1002/bies.201500046"}, {"pmid": "28076767", "authors": "  Harkany T, Horvath TL", "title": "(S)Pot on Mitochondria: Cannabinoids Disrupt Cellular Respiration to Limit Neuronal Activity.", "journal": "Cell Metab 25:8-10 (2017)", "doi": "10.1016/j.cmet.2016.12.020"}], "rel_pathway": ["hsa00190  Oxidative phosphorylation", "hsa04020  Calcium signaling pathway", "hsa04721  Synaptic vesicle cycle", "hsa04724  Glutamatergic synapse", "hsa04727  GABAergic synapse"], "ko_pathway": "ko04723", "genes": ["MAPK13"]}, {"kegg_id": "hsa04750", "name": "Inflammatory mediator regulation of TRP channels - Homo sapiens (human)", "description": "The TRP channels that exhibit a unique response to temperature have been given the name thermo-TRPs. Among all thermo- TRP channels, TRPV1-4, TRPM8, and TRPA1 are expressed in subsets of nociceptive dorsal root ganglion (DRG) neuron cell bodies including their peripheral and central projections. These channels can be modulated indirectly by inflammatory mediators such as PGE2, bradykinin, ATP, NGF, and proinflammatory cytokines that are generated during tissue injury. While the noxious heat receptor TRPV1 is sensitized (that is, their excitability can be increased) by post-translational modifications upon activation of G-protein coupled receptors (GPCRs) or tyrosine kinase receptors, the receptors for inflammatory mediators, the same action appears to mainly desensitize TRPM8, the main somatic innocuous cold sensor. This aforementioned sensitization could allow the receptor to become active at body temperature, so it not only contributes toward thermal hypersensitivity but also is possibly a substrate for ongoing persistent pain.", "class": "Organismal Systems; Sensory system", "pathway_map": "hsa04750  Inflammatory mediator regulation of TRP channels", "drug": ["D00234  Astemizole (JAN/USP/INN)", "D00364  Loratadine (JAN/USP/INN)", "D00419  Misoprostol (JAN/USP/INN)", "D00480  Promethazine hydrochloride (JP18/USP)", "D00494  Promethazine (JAN/INN)", "D00521  Terfenadine (JAN/USAN/INN)", "D00662  Azatadine maleate (USP)", "D00663  Brompheniramine maleate (USP)", "D00664  Cetirizine hydrochloride (JP18/USP)", "D00665  Chlorpheniramine maleate (JP18/USP)", "D00668  Dexchlorpheniramine maleate (USP)", "D00671  Fexofenadine hydrochloride (JP18/USP)", "D00814  Doxepin hydrochloride (USP)", "D01117  Mizolastine (JAN/INN)", "D01172  Diphenylpyraline hydrochloride (JAN)", "D01242  Promethazine teoclate (JAN/INN)", "D01317  Meclizine hydrochloride (JAN/USP)", "D01332  Ketotifen fumarate (JP18/USAN)", "D01336  Carbinoxamine maleate (JAN/USP)", "D01460  Homochlorcyclizine hydrochloride (JP18)", "D01478  Ebastine (JP18/USAN/INN)", "D01627  Diphenylpyraline teoclate (JAN)", "D01701  Difeterol hydrochloride (JAN)", "D01713  Epinastine hydrochloride (JAN)", "D01782  Triprolidine hydrochloride (USP)", "D01786  Mebhydrolin napadisilate (JAN)", "D01891  Enprostil (JAN/USAN/INN)", "D02067  Diphenylimidazole (JAN)", "D02089  Buclizine hydrochloride (USAN)", "D02090  Cyclizine lactate (BAN)", "D02148  Phenindamine tartrate (USAN)", "D02234  Cyproheptadine hydrochloride (JP18/USP)", "D02245  Trimeprazine tartrate (USP)", "D02249  Emedastine difumarate (JP18/USP)", "D02327  Doxylamine succinate (USP)", "D02760  Acrivastine (USAN/INN)", "D02934  Anakinra (USAN/INN)", "D02975  Arbaprostil (USAN/INN)", "D03056  Barmastine (USAN/INN)", "D03166  Bromodiphenhydramine hydrochloride (USP)", "D03290  Promethazine methylenedisalicylate (JAN)", "D03475  Chlorpheniramine polistirex (USAN)", "D03491  Cidoxepin hydrochloride (USAN)", "D03568  Closiramine aceturate (USAN)", "D03620  Cycliramine maleate (USAN)", "D03621  Cyclizine (INN)", "D03622  Cyclizine hydrochloride (USP)", "D03677  Deltibant (USAN/INN)", "D03693  Desloratadine (JAN/USP/INN)", "D03704  Dexbrompheniramine maleate (USP)", "D03893  Dorastine hydrochloride (USAN)", "D03963  Efletirizine dihydrochloride (USAN)", "D04492  Icatibant acetate (JAN/USAN)", "D04494  Icotidine (USAN)", "D04979  Methdilazine (INN)", "D04980  Methdilazine hydrochloride (USP)", "D05196  Noberastine (USAN/INN)", "D05664  Pyroxamine maleate (USAN)", "D05742  Rocastine hydrochloride (USAN)", "D05769  Rotoxamine (USAN/INN)", "D06012  Tazifylline hydrochloride (USAN)", "D06021  Tecastemizole (USAN/INN)", "D06063  Temelastine (USAN/INN)", "D06084  Tesmilifene hydrochloride (USAN)", "D06240  Trimoprostil (USAN/INN)", "D06376  Zolamine hydrochloride (USAN)", "D06552  Alcaftadine (JAN/USAN/INN)", "D07125  Alimemazine (INN)", "D07194  Thenalidine (INN)", "D07398  Chlorphenamine (INN)", "D07400  Histapyrrodine (INN)", "D07401  Oxomemazine (INN)", "D07402  Levocetirizine (USAN/INN)", "D07403  Pyrrobutamine (BAN)", "D07404  Deptropine (INN)", "D07406  Pimethixene (INN)", "D07407  Rupatadine (INN)", "D07482  Azatadine (INN)", "D07532  Bisulepin", "D07533  Bisulepin hydrochloride", "D07543  Brompheniramine (INN)", "D07547  Buclizine (INN)", "D07617  Carbinoxamine (INN)", "D07662  Cetirizine (INN)", "D07765  Cyproheptadine (INN)", "D07790  Deptropine citrate", "D07803  Dexchlorpheniramine (INN)", "D07860  Dioxopromethazine hydrochloride", "D07862  Diphenylpyraline (INN)", "D07875  Doxepin (INN)", "D07878  Doxylamine (INN)", "D07889  Embramine (INN)", "D07890  Emedastine (INN)", "D07900  Epinastine (INN)", "D07958  Fexofenadine (INN)", "D08041  Homochlorcyclizine (INN)", "D08105  Ketotifen (INN)", "D08118  Levocetirizine dihydrochloride (USP)", "D08161  Mebhydrolin (INN)", "D08163  Meclozine (BAN)", "D08353  Phenindamine (INN)", "D08432  Promethazine maleate", "D08497  Rupatadine fumarate (JAN)", "D08648  Triprolidine (INN)", "D08768  Promethazine hibenzate", "D08967  Phenyltoloxamine citrate (USP)", "D09570  Bilastine (JAN/INN)", "D09671  Sotrastaurin (USAN/INN)", "D09718  Sotrastaurin acetate (USAN)", "D09747  Difeterol phosphate (JAN)", "D09748  Difeterol (JAN/INN)", "D09808  Carbinoxamine diphenyldisulfonate (JAN)", "D09838  Broizine (JAN)", "D10230  Quifenadine (INN)", "D10510  Sequifenadine", "D10959  Neflamapimod (USAN/INN)", "D11484  Pegcantratinib (USAN/INN)", "D11759  Isunakinra (USAN/INN)", "D12841  Motugivatrep (JAN/INN)"], "dblinks": ["GO: 0019233"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["3827  KNG1; kininogen 1 [KO:K03898]", "623  BDKRB1; bradykinin receptor B1 [KO:K03915]", "624  BDKRB2; bradykinin receptor B2 [KO:K03916]", "3356  HTR2A; 5-hydroxytryptamine receptor 2A [KO:K04157]", "3357  HTR2B; 5-hydroxytryptamine receptor 2B [KO:K04157]", "3358  HTR2C; 5-hydroxytryptamine receptor 2C [KO:K04157]", "3269  HRH1; histamine receptor H1 [KO:K04149]", "5029  P2RY2; purinergic receptor P2Y2 [KO:K04269]", "2776  GNAQ; G protein subunit alpha q [KO:K04634]", "123745  PLA2G4E; phospholipase A2 group IVE [KO:K16342] [EC:3.1.1.4]", "5321  PLA2G4A; phospholipase A2 group IVA [KO:K16342] [EC:3.1.1.4]", "8681  JMJD7-PLA2G4B; JMJD7-PLA2G4B readthrough [KO:K16342] [EC:3.1.1.4]", "100137049  PLA2G4B; phospholipase A2 group IVB [KO:K16342] [EC:3.1.1.4]", "8605  PLA2G4C; phospholipase A2 group IVC [KO:K16342] [EC:3.1.1.4]", "283748  PLA2G4D; phospholipase A2 group IVD [KO:K16342] [EC:3.1.1.4]", "255189  PLA2G4F; phospholipase A2 group IVF [KO:K16342] [EC:3.1.1.4]", "8398  PLA2G6; phospholipase A2 group VI [KO:K16343] [EC:3.1.1.4]", "239  ALOX12; arachidonate 12-lipoxygenase, 12S type [KO:K00458] [EC:1.13.11.31]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]", "3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]", "3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]", "5581  PRKCE; protein kinase C epsilon [KO:K18050] [EC:2.7.11.13]", "5499  PPP1CA; protein phosphatase 1 catalytic subunit alpha [KO:K06269] [EC:3.1.3.16]", "5500  PPP1CB; protein phosphatase 1 catalytic subunit beta [KO:K06269] [EC:3.1.3.16]", "5501  PPP1CC; protein phosphatase 1 catalytic subunit gamma [KO:K06269] [EC:3.1.3.16]", "8989  TRPA1; transient receptor potential cation channel subfamily A member 1 [KO:K04984]", "7442  TRPV1; transient receptor potential cation channel subfamily V member 1 [KO:K05222]", "41  ASIC1; acid sensing ion channel subunit 1 [KO:K04829]", "40  ASIC2; acid sensing ion channel subunit 2 [KO:K04828]", "9311  ASIC3; acid sensing ion channel subunit 3 [KO:K04830]", "55515  ASIC4; acid sensing ion channel subunit family member 4 [KO:K04831]", "51802  ASIC5; acid sensing ion channel subunit family member 5 [KO:K04832]", "810  CALML3; calmodulin like 3 [KO:K02183]", "805  CALM2; calmodulin 2 [KO:K02183]", "808  CALM3; calmodulin 3 [KO:K02183]", "801  CALM1; calmodulin 1 [KO:K02183]", "163688  CALML6; calmodulin like 6 [KO:K02183]", "51806  CALML5; calmodulin like 5 [KO:K02183]", "91860  CALML4; calmodulin like 4 [KO:K02183]", "815  CAMK2A; calcium/calmodulin dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]", "817  CAMK2D; calcium/calmodulin dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]", "816  CAMK2B; calcium/calmodulin dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]", "818  CAMK2G; calcium/calmodulin dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]", "3553  IL1B; interleukin 1 beta [KO:K04519]", "3554  IL1R1; interleukin 1 receptor type 1 [KO:K04386]", "3556  IL1RAP; interleukin 1 receptor accessory protein [KO:K04723]", "5606  MAP2K3; mitogen-activated protein kinase kinase 3 [KO:K04432] [EC:2.7.12.2]", "5608  MAP2K6; mitogen-activated protein kinase kinase 6 [KO:K04433] [EC:2.7.12.2]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]", "5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]", "5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]", "4803  NGF; nerve growth factor [KO:K02582]", "4914  NTRK1; neurotrophic receptor tyrosine kinase 1 [KO:K03176] [EC:2.7.10.1]", "5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]", "5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]", "5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]", "5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]", "5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]", "5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]", "5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]", "8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]", "5580  PRKCD; protein kinase C delta [KO:K06068] [EC:2.7.11.13]", "6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]", "79054  TRPM8; transient receptor potential cation channel subfamily M member 8 [KO:K04983]", "5732  PTGER2; prostaglandin E receptor 2 [KO:K04259]", "5734  PTGER4; prostaglandin E receptor 4 [KO:K04261]", "2778  GNAS; GNAS complex locus [KO:K04632]", "107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]", "108  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]", "109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]", "196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]", "113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]", "114  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]", "115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "59341  TRPV4; transient receptor potential cation channel subfamily V member 4 [KO:K04973]", "2150  F2RL1; F2R like trypsin receptor 1 [KO:K04234]", "1573  CYP2J2; cytochrome P450 family 2 subfamily J member 2 [KO:K07418] [EC:1.14.14.1 1.14.14.73 1.14.14.74 1.14.14.75]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]", "5583  PRKCH; protein kinase C eta [KO:K18051] [EC:2.7.11.13]", "5588  PRKCQ; protein kinase C theta [KO:K18052] [EC:2.7.11.13]", "3479  IGF1; insulin like growth factor 1 [KO:K05459]", "51393  TRPV2; transient receptor potential cation channel subfamily V member 2 [KO:K04971]", "162514  TRPV3; transient receptor potential cation channel subfamily V member 3 [KO:K04972]"], "compound": ["C00002  ATP", "C00076  Calcium cation", "C00080  H+", "C00165  Diacylglycerol", "C00219  Arachidonate", "C00388  Histamine", "C00400  (-)-Menthol", "C00469  Ethanol", "C00575  3',5'-Cyclic AMP", "C00584  Prostaglandin E2", "C00780  Serotonin", "C00808  (+)-Camphor", "C00809  (-)-Camphor", "C00903  Cinnamaldehyde", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C01330  Sodium cation", "C02165  Leukotriene B4", "C04742  (15S)-15-Hydroxy-5,8,11-cis-13-trans-eicosatetraenoate", "C04805  5(S)-HETE", "C05965  12(S)-HPETE", "C05966  15(S)-HPETE", "C06254  Lysophospholipid", "C06866  Capsaicin", "C07600  Allicin", "C09155  Phorbol", "C09179  Resiniferatoxin", "C09844  1,8-Cineole", "C11695  Anandamide", "C12083  (5Z,7E,9E,14Z,17Z)-Icosapentaenoate", "C12271  N-Arachidonyldopamine", "C14768  5,6-EET", "C14769  8,9-EET", "C19317  Allyl isothiocyanate", "C20171  Icilin", "C20698  2-Aminoethyl diphenylborinate"], "refs": [{"pmid": "15820689", "authors": "  Wang H, Woolf CJ", "title": "Pain TRPs.", "journal": "Neuron 46:9-12 (2005)", "doi": "10.1016/j.neuron.2005.03.011"}, {"pmid": "17321113", "authors": "  Levine JD, Alessandri-Haber N", "title": "TRP channels: targets for the relief of pain.", "journal": "Biochim Biophys Acta 1772:989-1003 (2007)", "doi": "10.1016/j.bbadis.2007.01.008"}, {"pmid": "18427980", "authors": "  Cheng JK, Ji RR", "title": "Intracellular signaling in primary sensory neurons and persistent pain.", "journal": "Neurochem Res 33:1970-8 (2008)", "doi": "10.1007/s11064-008-9711-z"}, {"pmid": "24099085", "authors": "  Julius D", "title": "TRP channels and pain.", "journal": "Annu Rev Cell Dev Biol 29:355-84 (2013)", "doi": "10.1146/annurev-cellbio-101011-155833"}, {"pmid": "12838328", "authors": "  Patapoutian A, Peier AM, Story GM, Viswanath V", "title": "ThermoTRP channels and beyond: mechanisms of temperature sensation.", "journal": "Nat Rev Neurosci 4:529-39 (2003)", "doi": "10.1038/nrn1141"}, {"pmid": "16776582", "authors": "  Dhaka A, Viswanath V, Patapoutian A", "title": "Trp ion channels and temperature sensation.", "journal": "Annu Rev Neurosci 29:135-61 (2006)", "doi": "10.1146/annurev.neuro.29.051605.112958"}, {"pmid": "18615141", "authors": "  Story GM", "title": "The emerging role of TRP channels in mechanisms of temperature and pain sensation.", "journal": "Curr Neuropharmacol 4:183-96 (2006)", "doi": "10.2174/157015906778019482"}, {"pmid": "17548207", "authors": "  Velazquez KT, Mohammad H, Sweitzer SM", "title": "Protein kinase C in pain: involvement of multiple isoforms.", "journal": "Pharmacol Res 55:578-89 (2007)", "doi": "10.1016/j.phrs.2007.04.006"}, {"pmid": "16319926", "authors": "  Zhang X, Huang J, McNaughton PA", "title": "NGF rapidly increases membrane expression of TRPV1 heat-gated ion channels.", "journal": "EMBO J 24:4211-23 (2005)", "doi": "10.1038/sj.emboj.7600893"}, {"pmid": "19074743", "authors": "  Bessac BF, Jordt SE", "title": "Breathtaking TRP channels: TRPA1 and TRPV1 in airway chemosensation and reflex control.", "journal": "Physiology (Bethesda) 23:360-70 (2008)", "doi": "10.1152/physiol.00026.2008"}, {"pmid": "17684094", "authors": "  Trevisani M, Siemens J, Materazzi S, Bautista DM, Nassini R, Campi B, Imamachi N, Andre E, Patacchini R, Cottrell GS, Gatti R, Basbaum AI, Bunnett NW, Julius D, Geppetti P", "title": "4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1.", "journal": "Proc Natl Acad Sci U S A 104:13519-24 (2007)", "doi": "10.1073/pnas.0705923104"}, {"pmid": "21841075", "authors": "  Latorre R, Brauchi S, Madrid R, Orio P", "title": "A cool channel in cold transduction.", "journal": "Physiology (Bethesda) 26:273-85 (2011)", "doi": "10.1152/physiol.00004.2011"}, {"pmid": "20932256", "authors": "  Babes A, Ciobanu AC, Neacsu C, Babes RM", "title": "TRPM8, a sensor for mild cooling in mammalian sensory nerve endings.", "journal": "Curr Pharm Biotechnol 12:78-88 (2011)", "doi": "10.2174/138920111793937835"}, {"pmid": "23000387", "authors": "  Loyd DR, Henry MA, Hargreaves KM", "title": "Serotonergic neuromodulation of peripheral nociceptors.", "journal": "Semin Cell Dev Biol 24:51-7 (2013)", "doi": "10.1016/j.semcdb.2012.09.002"}, {"pmid": "17124270", "authors": "  Grant AD, Cottrell GS, Amadesi S, Trevisani M, Nicoletti P, Materazzi S, Altier C, Cenac N, Zamponi GW, Bautista-Cruz F, Lopez CB, Joseph EK, Levine JD, Liedtke W, Vanner S, Vergnolle N, Geppetti P, Bunnett NW", "title": "Protease-activated receptor 2 sensitizes the transient receptor potential vanilloid 4 ion channel to cause mechanical hyperalgesia in mice.", "journal": "J Physiol 578:715-33 (2007)", "doi": "10.1113/jphysiol.2006.121111"}], "rel_pathway": ["hsa00590  Arachidonic acid metabolism", "hsa04010  MAPK signaling pathway", "hsa04020  Calcium signaling pathway"], "ko_pathway": "ko04750", "genes": ["MAPK13"]}, {"kegg_id": "hsa05140", "name": "Leishmaniasis - Homo sapiens (human)", "description": "Leishmania is an intracellular protozoan parasite of macrophages that causes visceral, mucosal, and cutaneous diseases. The parasite is transmitted to humans by sandflies, where they survive and proliferate intracellularly by deactivating the macrophage. Successful infection of Leishmania is achieved by alteration of signaling events in the host cell, leading to enhanced production of the autoinhibitory molecules like TGF-beta and decreased induction of cytokines such as IL12 for protective immunity. Nitric oxide production is also inhibited. In addition, defective expression of major histocompatibility complex (MHC) genes silences subsequent T cell activation mediated by macrophages, resulting in abnormal immune responses.", "class": "Human Diseases; Infectious disease: parasitic", "pathway_map": "hsa05140  Leishmaniasis", "disease": ["H00359  Leishmaniasis"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["7097  TLR2; toll like receptor 2 [KO:K10159]", "7099  TLR4; toll like receptor 4 [KO:K10160]", "4615  MYD88; MYD88 innate immune signal transduction adaptor [KO:K04729]", "3654  IRAK1; interleukin 1 receptor associated kinase 1 [KO:K04730] [EC:2.7.11.1]", "51135  IRAK4; interleukin 1 receptor associated kinase 4 [KO:K04733] [EC:2.7.11.1]", "7189  TRAF6; TNF receptor associated factor 6 [KO:K03175] [EC:2.3.2.27]", "6885  MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO:K04427] [EC:2.7.11.25]", "10454  TAB1; TGF-beta activated kinase 1 (MAP3K7) binding protein 1 [KO:K04403]", "23118  TAB2; TGF-beta activated kinase 1 (MAP3K7) binding protein 2 [KO:K04404]", "4793  NFKBIB; NFKB inhibitor beta [KO:K02581]", "4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]", "4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]", "5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]", "3552  IL1A; interleukin 1 alpha [KO:K04383]", "3553  IL1B; interleukin 1 beta [KO:K04519]", "3592  IL12A; interleukin 12A [KO:K05406]", "3593  IL12B; interleukin 12B [KO:K05425]", "7124  TNF; tumor necrosis factor [KO:K03156]", "3565  IL4; interleukin 4 [KO:K05430]", "4843  NOS2; nitric oxide synthase 2 [KO:K13241] [EC:1.14.13.39]", "3586  IL10; interleukin 10 [KO:K05443]", "7040  TGFB1; transforming growth factor beta 1 [KO:K13375]", "7042  TGFB2; transforming growth factor beta 2 [KO:K13376]", "7043  TGFB3; transforming growth factor beta 3 [KO:K13377]", "718  C3; complement C3 [KO:K03990]", "1378  CR1; complement C3b/C4b receptor 1 (Knops blood group) [KO:K04011]", "1379  CR1L; complement C3b/C4b receptor 1 like [KO:K04011]", "3684  ITGAM; integrin subunit alpha M [KO:K06461]", "3689  ITGB2; integrin subunit beta 2 [KO:K06464]", "102723407  IGH; immunoglobulin heavy variable 4-38-2-like [KO:K06856]", "2209  FCGR1A; Fc gamma receptor Ia [KO:K06498]", "2212  FCGR2A; Fc gamma receptor IIa [KO:K06472]", "9103  FCGR2C; Fc gamma receptor IIc (gene/pseudogene) [KO:K16824]", "2214  FCGR3A; Fc gamma receptor IIIa [KO:K06463]", "2215  FCGR3B; Fc gamma receptor IIIb [KO:K06463]", "3676  ITGA4; integrin subunit alpha 4 [KO:K06483]", "3688  ITGB1; integrin subunit beta 1 [KO:K05719]", "5743  PTGS2; prostaglandin-endoperoxide synthase 2 [KO:K11987] [EC:1.14.99.1]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "653361  NCF1; neutrophil cytosolic factor 1 [KO:K08011]", "4688  NCF2; neutrophil cytosolic factor 2 [KO:K08010]", "4689  NCF4; neutrophil cytosolic factor 4 [KO:K08012]", "1536  CYBB; cytochrome b-245 beta chain [KO:K21421] [EC:1.-.-.-]", "1535  CYBA; cytochrome b-245 alpha chain [KO:K08009]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "2002  ELK1; ETS transcription factor ELK1 [KO:K04375]", "2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]", "3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]", "5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]", "6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]", "5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]", "1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]", "3458  IFNG; interferon gamma [KO:K04687]", "3459  IFNGR1; interferon gamma receptor 1 [KO:K05132]", "3460  IFNGR2; interferon gamma receptor 2 [KO:K05133]", "3716  JAK1; Janus kinase 1 [KO:K11217] [EC:2.7.10.2]", "3717  JAK2; Janus kinase 2 [KO:K04447] [EC:2.7.10.2]", "6772  STAT1; signal transducer and activator of transcription 1 [KO:K11220]", "3108  HLA-DMA; major histocompatibility complex, class II, DM alpha [KO:K06752]", "3109  HLA-DMB; major histocompatibility complex, class II, DM beta [KO:K06752]", "3111  HLA-DOA; major histocompatibility complex, class II, DO alpha [KO:K06752]", "3112  HLA-DOB; major histocompatibility complex, class II, DO beta [KO:K06752]", "3113  HLA-DPA1; major histocompatibility complex, class II, DP alpha 1 [KO:K06752]", "3115  HLA-DPB1; major histocompatibility complex, class II, DP beta 1 [KO:K06752]", "3117  HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 [KO:K06752]", "3118  HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2 [KO:K06752]", "3119  HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 [KO:K06752]", "3122  HLA-DRA; major histocompatibility complex, class II, DR alpha [KO:K06752]", "3123  HLA-DRB1; major histocompatibility complex, class II, DR beta 1 [KO:K06752]", "3125  HLA-DRB3; major histocompatibility complex, class II, DR beta 3 [KO:K06752]", "3126  HLA-DRB4; major histocompatibility complex, class II, DR beta 4 [KO:K06752]", "3127  HLA-DRB5; major histocompatibility complex, class II, DR beta 5 [KO:K06752]", "65108  MARCKSL1; MARCKS like 1 [KO:K13536]", "1915  EEF1A1; eukaryotic translation elongation factor 1 alpha 1 [KO:K03231]", "1917  EEF1A2; eukaryotic translation elongation factor 1 alpha 2 [KO:K03231]", "5777  PTPN6; protein tyrosine phosphatase non-receptor type 6 [KO:K05697] [EC:3.1.3.48]"], "compound": ["C00076  Calcium cation", "C00195  N-Acylsphingosine", "C00219  Arachidonate", "C00533  Nitric oxide", "C00584  Prostaglandin E2", "C02737  Phosphatidylserine"], "refs": [{"pmid": "11890722", "authors": "  Cunningham AC", "title": "Parasitic adaptive mechanisms in infection by leishmania.", "journal": "Exp Mol Pathol 72:132-41 (2002)", "doi": "10.1006/exmp.2002.2418"}, {"pmid": "10770277", "authors": "  Nandan D, Knutson KL, Lo R, Reiner NE", "title": "Exploitation of host cell signaling machinery: activation of macrophage phosphotyrosine phosphatases as a novel mechanism of molecular microbial pathogenesis.", "journal": "J Leukoc Biol 67:464-70 (2000)", "doi": "10.1002/jlb.67.4.464"}, {"pmid": "7591091", "authors": "  Nandan D, Reiner NE", "title": "Attenuation of gamma interferon-induced tyrosine phosphorylation in mononuclear phagocytes infected with Leishmania donovani: selective inhibition of signaling through Janus kinases and Stat1.", "journal": "Infect Immun 63:4495-500 (1995)", "doi": "10.1128/IAI.63.11.4495-4500.1995"}, {"pmid": "10417174", "authors": "  Nandan D, Lo R, Reiner NE", "title": "Activation of phosphotyrosine phosphatase activity attenuates mitogen-activated protein kinase signaling and inhibits c-FOS and nitric oxide synthase expression in macrophages infected with Leishmania donovani.", "journal": "Infect Immun 67:4055-63 (1999)", "doi": "10.1128/IAI.67.8.4055-4063.1999"}, {"pmid": "7916951", "authors": "  Reiner NE", "title": "Altered cell signaling and mononuclear phagocyte deactivation during intracellular infection.", "journal": "Immunol Today 15:374-81 (1994)", "doi": "10.1016/0167-5699(94)90176-7"}, {"pmid": "15721837", "authors": "  Nandan D, Reiner NE", "title": "Leishmania donovani engages in regulatory interference by targeting macrophage protein tyrosine phosphatase SHP-1.", "journal": "Clin Immunol 114:266-77 (2005)", "doi": "10.1016/j.clim.2004.07.017"}, {"pmid": "17543969", "authors": "  Kima PE", "title": "The amastigote forms of Leishmania are experts at exploiting host cell processes to establish infection and persist.", "journal": "Int J Parasitol 37:1087-96 (2007)", "doi": "10.1016/j.ijpara.2007.04.007"}, {"pmid": "15983048", "authors": "  Forget G, Gregory DJ, Olivier M", "title": "Proteasome-mediated degradation of STAT1alpha following infection of macrophages with Leishmania donovani.", "journal": "J Biol Chem 280:30542-9 (2005)", "doi": "10.1074/jbc.M414126200"}, {"pmid": "15322192", "authors": "  Cameron P, McGachy A, Anderson M, Paul A, Coombs GH, Mottram JC, Alexander J, Plevin R", "title": "Inhibition of lipopolysaccharide-induced macrophage IL-12 production by Leishmania mexicana amastigotes: the role of cysteine peptidases and the NF-kappaB signaling pathway.", "journal": "J Immunol 173:3297-304 (2004)", "doi": "10.4049/jimmunol.173.5.3297"}, {"pmid": "18070909", "authors": "  Tuon FF, Amato VS, Bacha HA, Almusawi T, Duarte MI, Amato Neto V", "title": "Toll-like receptors and leishmaniasis.", "journal": "Infect Immun 76:866-72 (2008)", "doi": "10.1128/IAI.01090-07"}, {"pmid": "15039466", "authors": "  Kropf P, Freudenberg N, Kalis C, Modolell M, Herath S, Galanos C, Freudenberg M, Muller I", "title": "Infection of C57BL/10ScCr and C57BL/10ScNCr mice with Leishmania major reveals a role for Toll-like receptor 4 in the control of parasite replication.", "journal": "J Leukoc Biol 76:48-57 (2004)", "doi": "10.1189/jlb.1003484"}, {"pmid": "15831826", "authors": "  Olivier M, Gregory DJ, Forget G", "title": "Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view.", "journal": "Clin Microbiol Rev 18:293-305 (2005)", "doi": "10.1128/CMR.18.2.293-305.2005"}, {"pmid": "11298294", "authors": "  Matte C, Maion G, Mourad W, Olivier M", "title": "Leishmania donovani-induced macrophages cyclooxygenase-2 and prostaglandin E2 synthesis.", "journal": "Parasite Immunol 23:177-84 (2001)", "doi": "10.1046/j.1365-3024.2001.00372.x"}, {"pmid": "12438359", "authors": "  Ghosh S, Bhattacharyya S, Sirkar M, Sa GS, Das T, Majumdar D, Roy S, Majumdar S", "title": "Leishmania donovani suppresses activated protein 1 and NF-kappaB activation in host macrophages via ceramide generation: involvement of extracellular signal-regulated kinase.", "journal": "Infect Immun 70:6828-38 (2002)", "doi": "10.1128/IAI.70.12.6828-6838.2002"}, {"pmid": "9504340", "authors": "  Bogdan C, Rollinghoff M", "title": "The immune response to Leishmania: mechanisms of parasite control and evasion.", "journal": "Int J Parasitol 28:121-34 (1998)", "doi": "10.1016/S0020-7519(97)00169-0"}, {"pmid": "18793215", "authors": "  Blanchette J, Abu-Dayyeh I, Hassani K, Whitcombe L, Olivier M", "title": "Regulation of macrophage nitric oxide production by the protein tyrosine phosphatase Src homology 2 domain phosphotyrosine phosphatase 1 (SHP-1).", "journal": "Immunology 127:123-33 (2009)", "doi": "10.1111/j.1365-2567.2008.02929.x"}, {"pmid": "15639739", "authors": "  Denkers EY, Butcher BA", "title": "Sabotage and exploitation in macrophages parasitized by intracellular protozoans.", "journal": "Trends Parasitol 21:35-41 (2005)", "doi": "10.1016/j.pt.2004.10.004"}, {"pmid": "16848789", "authors": "  Lodge R, Diallo TO, Descoteaux A", "title": "Leishmania donovani lipophosphoglycan blocks NADPH oxidase assembly at the phagosome membrane.", "journal": "Cell Microbiol 8:1922-31 (2006)", "doi": "10.1111/j.1462-5822.2006.00758.x"}, {"pmid": "11728310", "authors": "  de Freitas Balanco JM, Moreira ME, Bonomo A, Bozza PT, Amarante-Mendes G, Pirmez C, Barcinski MA", "title": "Apoptotic mimicry by an obligate intracellular parasite downregulates macrophage microbicidal activity.", "journal": "Curr Biol 11:1870-3 (2001)", "doi": "10.1016/S0960-9822(01)00563-2"}, {"pmid": "10608501", "authors": "  Kane MM, Mosser DM", "title": "Leishmania parasites and their ploys to disrupt macrophage activation.", "journal": "Curr Opin Hematol 7:26-31 (2000)", "doi": "10.1097/00062752-200001000-00006"}], "rel_pathway": ["hsa00590  Arachidonic acid metabolism", "hsa04010  MAPK signaling pathway", "hsa04020  Calcium signaling pathway", "hsa04120  Ubiquitin mediated proteolysis", "hsa04145  Phagosome", "hsa04610  Complement and coagulation cascades", "hsa04620  Toll-like receptor signaling pathway", "hsa04630  JAK-STAT signaling pathway", "hsa04666  Fc gamma R-mediated phagocytosis"], "ko_pathway": "ko05140", "genes": ["MAPK13"]}, {"kegg_id": "hsa04916", "name": "Melanogenesis - Homo sapiens (human)", "description": "Cutaneous melanin pigment plays a critical role in camouflage, mimicry, social communication, and protection against harmful effects of solar radiation. Melanogenesis is under complex regulatory control by multiple agents. The most important positive regulator of melanogenesis is the MC1 receptor with its ligands melanocortic peptides. MC1R activates the cyclic AMP (cAMP) response-element binding protein (CREB). Increased expression of MITF and its activation by phosphorylation (P) stimulate the transcription of tyrosinase (TYR), tyrosinase-related protein 1 (TYRP1), and dopachrome tautomerase (DCT), which produce melanin. Melanin synthesis takes place within specialized intracellular organelles named melanosomes. Melanin-containing melanosomes then move from the perinuclear region to the dendrite tips and are transferred to keratinocytes by a still not well-characterized mechanism.", "class": "Organismal Systems; Endocrine system", "pathway_map": "hsa04916  Melanogenesis", "drug": ["D00073  Hydroquinone (USP)", "D06569  Bremelanotide (USAN/INN)", "D10511  Afamelanotide (USAN/INN)", "D11334  Afamelanotide acetate (USAN)", "D11629  Bremelanotide acetate (USAN)", "D12147  Dersimelagon (USAN/INN)", "D12148  Dersimelagon phosphate (USAN)"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["5443  POMC; proopiomelanocortin [KO:K05228]", "434  ASIP; agouti signaling protein [KO:K08725]", "4157  MC1R; melanocortin 1 receptor [KO:K04199]", "2778  GNAS; GNAS complex locus [KO:K04632]", "107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]", "108  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]", "109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]", "196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]", "111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]", "112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]", "113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]", "114  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]", "115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]", "5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]", "5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]", "5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]", "1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]", "10488  CREB3; cAMP responsive element binding protein 3 [KO:K09048]", "90993  CREB3L1; cAMP responsive element binding protein 3 like 1 [KO:K09048]", "64764  CREB3L2; cAMP responsive element binding protein 3 like 2 [KO:K09048]", "84699  CREB3L3; cAMP responsive element binding protein 3 like 3 [KO:K09048]", "148327  CREB3L4; cAMP responsive element binding protein 3 like 4 [KO:K09048]", "1387  CREBBP; CREB binding protein [KO:K04498] [EC:2.3.1.48]", "2033  EP300; E1A binding protein p300 [KO:K04498] [EC:2.3.1.48]", "4286  MITF; melanocyte inducing transcription factor [KO:K09455]", "7471  WNT1; Wnt family member 1 [KO:K03209]", "7472  WNT2; Wnt family member 2 [KO:K00182]", "7482  WNT2B; Wnt family member 2B [KO:K00182]", "7473  WNT3; Wnt family member 3 [KO:K00312]", "89780  WNT3A; Wnt family member 3A [KO:K00312]", "54361  WNT4; Wnt family member 4 [KO:K00408]", "7474  WNT5A; Wnt family member 5A [KO:K00444]", "81029  WNT5B; Wnt family member 5B [KO:K00444]", "7475  WNT6; Wnt family member 6 [KO:K00445]", "7476  WNT7A; Wnt family member 7A [KO:K00572]", "7477  WNT7B; Wnt family member 7B [KO:K00572]", "7478  WNT8A; Wnt family member 8A [KO:K00714]", "7479  WNT8B; Wnt family member 8B [KO:K00714]", "7483  WNT9A; Wnt family member 9A [KO:K01064]", "7484  WNT9B; Wnt family member 9B [KO:K01064]", "7480  WNT10B; Wnt family member 10B [KO:K01357]", "80326  WNT10A; Wnt family member 10A [KO:K01357]", "7481  WNT11; Wnt family member 11 [KO:K01384]", "51384  WNT16; Wnt family member 16 [KO:K01558]", "8321  FZD1; frizzled class receptor 1 [KO:K02432]", "8324  FZD7; frizzled class receptor 7 [KO:K02432]", "2535  FZD2; frizzled class receptor 2 [KO:K02235]", "7976  FZD3; frizzled class receptor 3 [KO:K02329]", "8322  FZD4; frizzled class receptor 4 [KO:K02354]", "7855  FZD5; frizzled class receptor 5 [KO:K02375]", "8325  FZD8; frizzled class receptor 8 [KO:K02375]", "8323  FZD6; frizzled class receptor 6 [KO:K02376]", "11211  FZD10; frizzled class receptor 10 [KO:K02842]", "8326  FZD9; frizzled class receptor 9 [KO:K02842]", "2775  GNAO1; G protein subunit alpha o1 [KO:K04534]", "2776  GNAQ; G protein subunit alpha q [KO:K04634]", "1857  DVL3; dishevelled segment polarity protein 3 [KO:K02353]", "1856  DVL2; dishevelled segment polarity protein 2 [KO:K02353]", "1855  DVL1; dishevelled segment polarity protein 1 [KO:K02353]", "2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]", "1499  CTNNB1; catenin beta 1 [KO:K02105]", "6932  TCF7; transcription factor 7 [KO:K02620]", "83439  TCF7L1; transcription factor 7 like 1 [KO:K04490]", "6934  TCF7L2; transcription factor 7 like 2 [KO:K04491]", "51176  LEF1; lymphoid enhancer binding factor 1 [KO:K04492]", "4254  KITLG; KIT ligand [KO:K05461]", "3815  KIT; KIT proto-oncogene, receptor tyrosine kinase [KO:K05091] [EC:2.7.10.1]", "3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]", "3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]", "4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]", "5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]", "5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]", "5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]", "5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]", "5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]", "7299  TYR; tyrosinase [KO:K00505] [EC:1.14.18.1]", "7306  TYRP1; tyrosinase related protein 1 [KO:K00506] [EC:1.14.18.-]", "1638  DCT; dopachrome tautomerase [KO:K01827] [EC:5.3.3.12]", "1906  EDN1; endothelin 1 [KO:K16366]", "1910  EDNRB; endothelin receptor type B [KO:K04198]", "2770  GNAI1; G protein subunit alpha i1 [KO:K04630]", "2773  GNAI3; G protein subunit alpha i3 [KO:K04630]", "2771  GNAI2; G protein subunit alpha i2 [KO:K04630]", "23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]", "5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]", "5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]", "5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]", "810  CALML3; calmodulin like 3 [KO:K02183]", "805  CALM2; calmodulin 2 [KO:K02183]", "808  CALM3; calmodulin 3 [KO:K02183]", "801  CALM1; calmodulin 1 [KO:K02183]", "163688  CALML6; calmodulin like 6 [KO:K02183]", "51806  CALML5; calmodulin like 5 [KO:K02183]", "91860  CALML4; calmodulin like 4 [KO:K02183]", "815  CAMK2A; calcium/calmodulin dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]", "817  CAMK2D; calcium/calmodulin dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]", "816  CAMK2B; calcium/calmodulin dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]", "818  CAMK2G; calcium/calmodulin dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]", "5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]", "5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]", "5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]"], "compound": ["C00076  Calcium cation", "C00082  L-Tyrosine", "C00165  Diacylglycerol", "C00575  3',5'-Cyclic AMP", "C01245  D-myo-Inositol 1,4,5-trisphosphate", "C05606  Melanin"], "refs": [{"pmid": "15383650", "authors": "  Slominski A, Tobin DJ, Shibahara S, Wortsman J.", "title": "Melanin pigmentation in mammalian skin and its hormonal regulation.", "journal": "Physiol Rev 84:1155-228 (2004)", "doi": "10.1152/physrev.00044.2003"}, {"pmid": "10841026", "authors": "  Busca R, Ballotti R.", "title": "Cyclic AMP a key messenger in the regulation of skin pigmentation.", "journal": "Pigment Cell Res 13:60-9 (2000)", "doi": "10.1034/j.1600-0749.2000.130203.x"}, {"pmid": "15016298", "authors": "  Imokawa G.", "title": "Autocrine and paracrine regulation of melanocytes in human skin and in pigmentary disorders.", "journal": "Pigment Cell Res 17:96-110 (2004)", "doi": "10.1111/j.1600-0749.2003.00126.x"}, {"pmid": "11023702", "authors": "  Wikberg JE, Muceniece R, Mandrika I, Prusis P, Lindblom J, Post C, Skottner A.", "title": "New aspects on the melanocortins and their receptors.", "journal": "Pharmacol Res 42:393-420 (2000)", "doi": "10.1006/phrs.2000.0725"}, {"pmid": "12894244", "authors": "  Chin L.", "title": "The genetics of malignant melanoma: lessons from mouse and man.", "journal": "Nat Rev Cancer 3:559-70 (2003)", "doi": "10.1038/nrc1145"}, {"pmid": "16822996", "authors": "  Miller AJ, Mihm MC Jr.", "title": "Melanoma.", "journal": "N Engl J Med 355:51-65 (2006)", "doi": "10.1056/NEJMra052166"}, {"pmid": "12753399", "authors": "  Saito H, Yasumoto K, Takeda K, Takahashi K, Yamamoto H, Shibahara S.", "title": "Microphthalmia-associated transcription factor in the Wnt signaling pathway.", "journal": "Pigment Cell Res 16:261-5 (2003)", "doi": "10.1034/j.1600-0749.2003.00039.x"}, {"pmid": "9263329", "authors": "  Imokawa G, Kobayashi T, Miyagishi M, Higashi K, Yada Y.", "title": "The role of endothelin-1 in epidermal hyperpigmentation and signaling mechanisms of mitogenesis and melanogenesis.", "journal": "Pigment Cell Res 10:218-28 (1997)", "doi": "10.1111/j.1600-0749.1997.tb00488.x"}, {"pmid": "10347209", "authors": "  Park HY, Perez JM, Laursen R, Hara M, Gilchrest BA.", "title": "Protein kinase C-beta activates tyrosinase by phosphorylating serine residues in its cytoplasmic domain.", "journal": "J Biol Chem 274:16470-8 (1999)", "doi": "10.1074/jbc.274.23.16470"}, {"pmid": "11602344", "authors": "  Sturm RA, Teasdale RD, Box NF.", "title": "Human pigmentation genes: identification, structure and consequences of polymorphic variation.", "journal": "Gene 277:49-62 (2001)", "doi": "10.1016/S0378-1119(01)00694-1"}, {"pmid": "11041354", "authors": "  Hearing VJ.", "title": "The melanosome: the perfect model for cellular responses to the environment.", "journal": "Pigment Cell Res 13 Suppl 8:23-34 (2000)", "doi": "10.1034/j.1600-0749.13.s8.7.x"}], "rel_pathway": ["hsa00350  Tyrosine metabolism", "hsa04010  MAPK signaling pathway", "hsa04310  Wnt signaling pathway", "hsa05218  Melanoma"], "ko_pathway": "ko04916", "genes": ["NRAS"]}, {"kegg_id": "hsa00760", "name": "Nicotinate and nicotinamide metabolism - Homo sapiens (human)", "class": "Metabolism; Metabolism of cofactors and vitamins", "pathway_map": "hsa00760  Nicotinate and nicotinamide metabolism", "module": ["hsa_M00912  NAD biosynthesis, tryptophan => quinolinate => NAD [PATH:hsa00760]"], "network": ["", "ELEMENT   N01723  NAD biosynthesis", "N01724  NAD+ phosphorylation"], "drug": ["D04245  Forodesine hydrochloride (JAN/USAN)", "D05396  Peldesine (USAN)", "D06596  Forodesine (USAN/INN)", "D09678  Teglarinad chloride (USAN/INN)", "D10431  Ulodesine (USAN/INN)", "D10432  Ulodesine succinate (USAN)", "D12373  Quemliclustat (USAN/INN)", "D12401  Uliledlimab (USAN/INN)"], "dblinks": ["UMBBD: nic", "GO: 0046497 0006769"], "organism": "Homo sapiens (human) [GN:hsa]", "gene": ["554235  ASPDH; aspartate dehydrogenase domain containing [KO:K06989] [EC:1.4.1.21]", "23475  QPRT; quinolinate phosphoribosyltransferase [KO:K00767] [EC:2.4.2.19]", "93100  NAPRT; nicotinate phosphoribosyltransferase [KO:K00763] [EC:6.3.4.21]", "4860  PNP; purine nucleoside phosphorylase [KO:K03783] [EC:2.4.2.1]", "54981  NMRK1; nicotinamide riboside kinase 1 [KO:K10524] [EC:2.7.1.22 2.7.1.173]", "27231  NMRK2; nicotinamide riboside kinase 2 [KO:K10524] [EC:2.7.1.22 2.7.1.173]", "22978  NT5C2; 5'-nucleotidase, cytosolic II [KO:K01081] [EC:3.1.3.5]", "84618  NT5C1A; 5'-nucleotidase, cytosolic IA [KO:K01081] [EC:3.1.3.5]", "93034  NT5C1B; 5'-nucleotidase, cytosolic IB [KO:K01081] [EC:3.1.3.5]", "30833  NT5C; 5', 3'-nucleotidase, cytosolic [KO:K01081] [EC:3.1.3.5]", "56953  NT5M; 5',3'-nucleotidase, mitochondrial [KO:K01081] [EC:3.1.3.5]", "100526794  NT5C1B-RDH14; NT5C1B-RDH14 readthrough [KO:K01081] [EC:3.1.3.5]", "284958  NT5DC4; 5'-nucleotidase domain containing 4 [KO:K01081] [EC:3.1.3.5]", "4907  NT5E; 5'-nucleotidase ecto [KO:K19970] [EC:3.1.3.5]", "349565  NMNAT3; nicotinamide nucleotide adenylyltransferase 3 [KO:K06210] [EC:2.7.7.1 2.7.7.18]", "64802  NMNAT1; nicotinamide nucleotide adenylyltransferase 1 [KO:K06210] [EC:2.7.7.1 2.7.7.18]", "23057  NMNAT2; nicotinamide nucleotide adenylyltransferase 2 [KO:K06210] [EC:2.7.7.1 2.7.7.18]", "5167  ENPP1; ectonucleotide pyrophosphatase/phosphodiesterase 1 [KO:K01513] [EC:3.1.4.1 3.6.1.9]", "5169  ENPP3; ectonucleotide pyrophosphatase/phosphodiesterase 3 [KO:K01513] [EC:3.1.4.1 3.6.1.9]", "83594  NUDT12; nudix hydrolase 12 [KO:K03426] [EC:3.6.1.22]", "25961  NUDT13; nudix hydrolase 13 [KO:K03426] [EC:3.6.1.22]", "55191  NADSYN1; NAD synthetase 1 [KO:K01950] [EC:6.3.5.1]", "10135  NAMPT; nicotinamide phosphoribosyltransferase [KO:K03462] [EC:2.4.2.12]", "952  CD38; CD38 molecule [KO:K01242] [EC:3.2.2.6 2.4.99.20]", "683  BST1; bone marrow stromal cell antigen 1 [KO:K18152] [EC:3.2.2.6 2.4.99.20]", "23098  SARM1; sterile alpha and TIR motif containing 1 [KO:K27536] [EC:3.2.2.6]", "23411  SIRT1; sirtuin 1 [KO:K11411] [EC:2.3.1.286]", "22933  SIRT2; sirtuin 2 [KO:K11412] [EC:2.3.1.286]", "23410  SIRT3; sirtuin 3 [KO:K11413] [EC:2.3.1.286]", "23409  SIRT4; sirtuin 4 [KO:K11414] [EC:2.3.1.286 2.3.1.313]", "23408  SIRT5; sirtuin 5 [KO:K11415] [EC:2.3.1.286]", "51548  SIRT6; sirtuin 6 [KO:K11416] [EC:2.3.1.286]", "51547  SIRT7; sirtuin 7 [KO:K11417] [EC:2.3.1.286]", "65220  NADK; NAD kinase [KO:K00858] [EC:2.7.1.23]", "133686  NADK2; NAD kinase 2, mitochondrial [KO:K00858] [EC:2.7.1.23]", "23530  NNT; nicotinamide nucleotide transhydrogenase [KO:K00323] [EC:7.1.1.1]", "4837  NNMT; nicotinamide N-methyltransferase [KO:K00541] [EC:2.1.1.1]", "316  AOX1; aldehyde oxidase 1 [KO:K00157] [EC:1.2.3.1]"], "compound": ["C00003  NAD+", "C00006  NADP+", "C00022  Pyruvate", "C00042  Succinate", "C00049  L-Aspartate", "C00111  Glycerone phosphate", "C00122  Fumarate", "C00153  Nicotinamide", "C00163  Propanoate", "C00232  Succinate semialdehyde", "C00253  Nicotinate", "C00334  4-Aminobutanoate", "C00455  Nicotinamide D-ribonucleotide", "C00745  Nicotine", "C00857  Deamino-NAD+", "C00922  2,3-Dimethylmaleate", "C01020  6-Hydroxynicotinate", "C01056  (S)-6-Hydroxynicotine", "C01059  2,5-Dihydroxypyridine", "C01185  Nicotinate D-ribonucleotide", "C01297  6-Hydroxypseudooxynicotine", "C01384  Maleic acid", "C01596  Maleamate", "C02295  Methylitaconate", "C02918  1-Methylnicotinamide", "C02930  2-Methyleneglutarate", "C03043  (R)-6-Hydroxynicotine", "C03056  2,6-Dihydroxypyridine", "C03150  Nicotinamide-beta-riboside", "C03458  2,3,6-Trihydroxypyridine", "C03652  (2R,3S)-2,3-Dimethylmalate", "C03722  Quinolinate", "C04226  6-Oxo-1,4,5,6-tetrahydronicotinate", "C05380  Nicotinurate", "C05840  Iminoaspartate", "C05841  Nicotinate D-ribonucleoside", "C05842  N1-Methyl-2-pyridone-5-carboxamide", "C05843  N1-Methyl-4-pyridone-5-carboxamide", "C06178  1-Methylpyrrolinium", "C15523  2,6-Dihydroxynicotinate", "C15986  2,6-Dihydroxypseudooxynicotine", "C15987  4-Methylaminobutyrate", "C16151  2,6-Dihydroxy-N-methylmyosmine", "C16152  Blue pigment", "C16159  2-Formylglutarate", "C16386  (R)-Nicotine", "C16390  (S)-2-(Hydroxymethyl)glutarate", "C18232  N-Formylmaleamic acid", "C19567  4-Oxo-1-(3-pyridyl)-1-butanone", "C19569  3-Succinoylpyridine", "C19631  6-Hydroxy-3-succinoylpyridine", "C20361  Pseudooxynicotine", "C20381  3,3'-Bipyridine-2,2',5,5',6,6'-hexol", "C21075  5-(N-Methyl-4,5-dihydro-1H-pyrrol-2-yl)pyridin-2-ol", "C21154  N-Methylmyosmine"], "refs": [{"pmid": "16894175", "authors": "  Alhapel A, Darley DJ, Wagener N, Eckel E, Elsner N, Pierik AJ.", "title": "Molecular and functional analysis of nicotinate catabolism in Eubacterium barkeri.", "journal": "Proc Natl Acad Sci U S A 103:12341-6 (2006)", "doi": "10.1073/pnas.0601635103"}, {"pmid": "11514508", "authors": "  Baitsch D, Sandu C, Brandsch R, Igloi GL.", "title": "Gene cluster on pAO1 of Arthrobacter nicotinovorans involved in degradation of the plant alkaloid nicotine: cloning, purification, and characterization of 2,6-dihydroxypyridine 3-hydroxylase.", "journal": "J Bacteriol 183:5262-7 (2001)", "doi": "10.1128/JB.183.18.5262-5267.2001"}, {"pmid": "16321959", "authors": "  Sachelaru P, Schiltz E, Igloi GL, Brandsch R.", "title": "An alpha/beta-fold C--C bond hydrolase is involved in a central step of nicotine catabolism by Arthrobacter nicotinovorans.", "journal": "J Bacteriol 187:8516-9 (2005)", "doi": "10.1128/JB.187.24.8516-8519.2005"}], "rel_pathway": ["hsa00020  Citrate cycle (TCA cycle)", "hsa00250  Alanine, aspartate and glutamate metabolism", "hsa00380  Tryptophan metabolism", "hsa00620  Pyruvate metabolism"], "ko_pathway": "ko00760", "genes": ["SIRT7"]}]